id|nct_id|result_group_id|ctgov_group_code|period|reason|count
6816473|NCT00064701|10821034|FG000|One Year Post-transplant|Did not receive study drug|7
6898045|NCT00643760|10917159|FG000|Overall Study|Adverse Event|11
6898046|NCT00643760|10917160|FG001|Overall Study|Adverse Event|5
6898047|NCT00643760|10917161|FG002|Overall Study|Adverse Event|12
6898048|NCT00643760|10917162|FG003|Overall Study|Adverse Event|21
6898049|NCT00643760|10917163|FG004|Overall Study|Adverse Event|6
6898050|NCT00643760|10917159|FG000|Overall Study|Lack of Efficacy|3
6898051|NCT00643760|10917160|FG001|Overall Study|Lack of Efficacy|1
6898052|NCT00643760|10917161|FG002|Overall Study|Lack of Efficacy|0
6898053|NCT00643760|10917162|FG003|Overall Study|Lack of Efficacy|4
6898054|NCT00643760|10917163|FG004|Overall Study|Lack of Efficacy|3
6898055|NCT00643760|10917159|FG000|Overall Study|Protocol Violation|7
6898056|NCT00643760|10917160|FG001|Overall Study|Protocol Violation|6
6898057|NCT00643760|10917161|FG002|Overall Study|Protocol Violation|4
6898058|NCT00643760|10917162|FG003|Overall Study|Protocol Violation|4
6898059|NCT00643760|10917163|FG004|Overall Study|Protocol Violation|6
6898060|NCT00643760|10917159|FG000|Overall Study|Lost to Follow-up|6
6898061|NCT00643760|10917160|FG001|Overall Study|Lost to Follow-up|2
6898062|NCT00643760|10917161|FG002|Overall Study|Lost to Follow-up|1
6898063|NCT00643760|10917162|FG003|Overall Study|Lost to Follow-up|3
6898064|NCT00643760|10917163|FG004|Overall Study|Lost to Follow-up|3
6898065|NCT00643760|10917159|FG000|Overall Study|Investigator Discretion|0
6898066|NCT00643760|10917160|FG001|Overall Study|Investigator Discretion|0
6898067|NCT00643760|10917161|FG002|Overall Study|Investigator Discretion|0
6898068|NCT00643760|10917162|FG003|Overall Study|Investigator Discretion|2
6898069|NCT00643760|10917163|FG004|Overall Study|Investigator Discretion|0
6898070|NCT00643760|10917159|FG000|Overall Study|Withdrawal by Subject|3
6898071|NCT00643760|10917160|FG001|Overall Study|Withdrawal by Subject|1
6898072|NCT00643760|10917161|FG002|Overall Study|Withdrawal by Subject|2
6898073|NCT00643760|10917162|FG003|Overall Study|Withdrawal by Subject|4
6898074|NCT00643760|10917163|FG004|Overall Study|Withdrawal by Subject|1
6898075|NCT00643851|10917178|FG000|Overall Study|Death|0
6898076|NCT00643851|10917179|FG001|Overall Study|Death|1
6898077|NCT00643851|10917180|FG002|Overall Study|Death|0
6898078|NCT00643851|10917178|FG000|Overall Study|Lack of Efficacy|0
6898079|NCT00643851|10917179|FG001|Overall Study|Lack of Efficacy|1
6898080|NCT00643851|10917180|FG002|Overall Study|Lack of Efficacy|0
6898081|NCT00643851|10917178|FG000|Overall Study|Adverse Event|2
6898082|NCT00643851|10917179|FG001|Overall Study|Adverse Event|6
6898083|NCT00643851|10917180|FG002|Overall Study|Adverse Event|6
6898084|NCT00643851|10917178|FG000|Overall Study|Lost to Follow-up|4
6898085|NCT00643851|10917179|FG001|Overall Study|Lost to Follow-up|6
6898086|NCT00643851|10917180|FG002|Overall Study|Lost to Follow-up|9
6898087|NCT00643851|10917178|FG000|Overall Study|Withdrawal by Subject|8
6898088|NCT00643851|10917179|FG001|Overall Study|Withdrawal by Subject|15
6898089|NCT00643851|10917180|FG002|Overall Study|Withdrawal by Subject|9
6898090|NCT00643851|10917178|FG000|Overall Study|Non-compl., not met criteria, etc.|3
6898091|NCT00643851|10917179|FG001|Overall Study|Non-compl., not met criteria, etc.|4
6898092|NCT00643851|10917180|FG002|Overall Study|Non-compl., not met criteria, etc.|6
6898093|NCT00643916|10917194|FG000|Overall Study|Protocol Violation|0
6898094|NCT00643916|10917195|FG001|Overall Study|Protocol Violation|1
6898095|NCT00643916|10917196|FG002|Overall Study|Protocol Violation|1
6898096|NCT00643916|10917197|FG003|Overall Study|Protocol Violation|1
6898097|NCT00643916|10917198|FG004|Overall Study|Protocol Violation|0
6898098|NCT00643916|10917199|FG005|Overall Study|Protocol Violation|0
6898099|NCT00643916|10917194|FG000|Overall Study|Lost to Follow-up|0
6898100|NCT00643916|10917195|FG001|Overall Study|Lost to Follow-up|1
6898101|NCT00643916|10917196|FG002|Overall Study|Lost to Follow-up|0
6898102|NCT00643916|10917197|FG003|Overall Study|Lost to Follow-up|0
6898103|NCT00643916|10917198|FG004|Overall Study|Lost to Follow-up|0
6898104|NCT00643916|10917199|FG005|Overall Study|Lost to Follow-up|0
6898105|NCT00643916|10917194|FG000|Overall Study|Withdrawal by Subject|2
6898106|NCT00643916|10917195|FG001|Overall Study|Withdrawal by Subject|2
6898107|NCT00643916|10917196|FG002|Overall Study|Withdrawal by Subject|2
6898108|NCT00643916|10917197|FG003|Overall Study|Withdrawal by Subject|1
6898109|NCT00643916|10917198|FG004|Overall Study|Withdrawal by Subject|0
6898110|NCT00643916|10917199|FG005|Overall Study|Withdrawal by Subject|1
6898111|NCT00643916|10917194|FG000|Overall Study|Not Vaccinated|2
6898112|NCT00643916|10917195|FG001|Overall Study|Not Vaccinated|2
6898113|NCT00643916|10917196|FG002|Overall Study|Not Vaccinated|3
6898114|NCT00643916|10917197|FG003|Overall Study|Not Vaccinated|0
6898115|NCT00643916|10917198|FG004|Overall Study|Not Vaccinated|2
6898116|NCT00643916|10917199|FG005|Overall Study|Not Vaccinated|0
6898117|NCT00644059|10917216|FG000|Overall Study|Lost to Follow-up|37
6898118|NCT00644059|10917217|FG001|Overall Study|Lost to Follow-up|34
6898119|NCT00644059|10917218|FG002|Overall Study|Lost to Follow-up|16
6898120|NCT00644059|10917216|FG000|Overall Study|Withdrawal by Subject|52
6898121|NCT00644059|10917217|FG001|Overall Study|Withdrawal by Subject|60
6898122|NCT00644059|10917218|FG002|Overall Study|Withdrawal by Subject|30
6816474|NCT00064701|10821035|FG001|One Year Post-transplant|Did not receive study drug|12
6978150|NCT01212770|11031716|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
6898123|NCT00644059|10917216|FG000|Overall Study|Adverse Event|8
6898124|NCT00644059|10917217|FG001|Overall Study|Adverse Event|5
6898125|NCT00644059|10917218|FG002|Overall Study|Adverse Event|1
6898126|NCT00644059|10917216|FG000|Overall Study|Inappropriate Enrollment|1
6816475|NCT00064701|10821036|FG002|One Year Post-transplant|Did not receive study drug|11
6816476|NCT00064701|10821034|FG000|One Year Post-transplant|Adverse Event|23
6816477|NCT00064701|10821035|FG001|One Year Post-transplant|Adverse Event|19
6816478|NCT00064701|10821036|FG002|One Year Post-transplant|Adverse Event|37
6816479|NCT00064701|10821034|FG000|One Year Post-transplant|Rejection|0
6816480|NCT00064701|10821035|FG001|One Year Post-transplant|Rejection|1
6898127|NCT00644059|10917217|FG001|Overall Study|Inappropriate Enrollment|3
6898128|NCT00644059|10917218|FG002|Overall Study|Inappropriate Enrollment|0
7140552|NCT02973087|11294812|FG000|Overall Study|Withdrawal by Subject|2
7140553|NCT02973087|11294813|FG001|Overall Study|Withdrawal by Subject|1
7140554|NCT02973087|11294812|FG000|Overall Study|Adverse Event|1
7140555|NCT02973087|11294813|FG001|Overall Study|Adverse Event|0
7140556|NCT02973087|11294812|FG000|Overall Study|other|1
7140557|NCT02973087|11294813|FG001|Overall Study|other|1
7140558|NCT02973100|11294824|FG000|Overall Study|Adverse Event|1
7140559|NCT02973100|11294825|FG001|Overall Study|Adverse Event|2
7140560|NCT02973100|11294826|FG002|Overall Study|Adverse Event|1
7140561|NCT02973100|11294827|FG003|Overall Study|Adverse Event|2
7140562|NCT02973100|11294824|FG000|Overall Study|Lost to Follow-up|3
7140563|NCT02973100|11294825|FG001|Overall Study|Lost to Follow-up|1
7140564|NCT02973100|11294826|FG002|Overall Study|Lost to Follow-up|1
7140565|NCT02973100|11294827|FG003|Overall Study|Lost to Follow-up|0
7140566|NCT02973100|11294824|FG000|Overall Study|Withdrawal by Subject|3
7140567|NCT02973100|11294825|FG001|Overall Study|Withdrawal by Subject|5
7140568|NCT02973100|11294826|FG002|Overall Study|Withdrawal by Subject|1
7140569|NCT02973100|11294827|FG003|Overall Study|Withdrawal by Subject|4
6898129|NCT00644059|10917216|FG000|Overall Study|Protocol Deviation/violation|20
6898130|NCT00644059|10917217|FG001|Overall Study|Protocol Deviation/violation|19
6898131|NCT00644059|10917218|FG002|Overall Study|Protocol Deviation/violation|15
6898132|NCT00644059|10917216|FG000|Overall Study|Unable to classify|6
6898133|NCT00644059|10917217|FG001|Overall Study|Unable to classify|2
6898134|NCT00644059|10917218|FG002|Overall Study|Unable to classify|3
6978151|NCT01212770|11031717|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
6978152|NCT01212770|11031718|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8
6978153|NCT01212770|11031719|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
6978154|NCT01212770|11031720|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
6978155|NCT01212770|11031721|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
6978156|NCT01212770|11031722|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
6978157|NCT01212770|11031723|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
6978158|NCT01212770|11031724|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
6978159|NCT01212770|11031716|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6
6978160|NCT01212770|11031717|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5
6978161|NCT01212770|11031718|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7
6978162|NCT01212770|11031719|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
6978163|NCT01212770|11031720|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
6978164|NCT01212770|11031721|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
6978165|NCT01212770|11031722|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
6978166|NCT01212770|11031723|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
6978167|NCT01212770|11031724|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
6978168|NCT01212770|11031716|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
6978169|NCT01212770|11031717|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
6978170|NCT01212770|11031718|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1
6978171|NCT01212770|11031719|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
6978172|NCT01212770|11031720|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
6978173|NCT01212770|11031721|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
6978174|NCT01212770|11031722|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
6978175|NCT01212770|11031723|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
6978176|NCT01212770|11031724|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
6978177|NCT01212770|11031716|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
6978178|NCT01212770|11031717|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
6978179|NCT01212770|11031718|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3
6978180|NCT01212770|11031719|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
6978181|NCT01212770|11031720|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
6978182|NCT01212770|11031721|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
6978183|NCT01212770|11031722|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
6978184|NCT01212770|11031723|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
6978185|NCT01212770|11031724|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7059128|NCT01903811|11154633|FG000|Overall Study|No measurable disease|1
7059129|NCT01903811|11154634|FG001|Overall Study|No measurable disease|1
7140570|NCT02973100|11294824|FG000|Overall Study|Notification of change in address|0
7140571|NCT02973100|11294825|FG001|Overall Study|Notification of change in address|0
7140572|NCT02973100|11294826|FG002|Overall Study|Notification of change in address|0
7140573|NCT02973100|11294827|FG003|Overall Study|Notification of change in address|1
7140574|NCT02973100|11294824|FG000|Overall Study|Failed to attend Safety followup period|0
7140575|NCT02973100|11294825|FG001|Overall Study|Failed to attend Safety followup period|0
6898135|NCT00644332|10917285|FG000|Overall Study|Adverse Event|11
6898136|NCT00644332|10917285|FG000|Overall Study|Withdrawal by Subject|6
6898137|NCT00644332|10917285|FG000|Overall Study|Completion Status Unknown|2
6898138|NCT00644332|10917285|FG000|Overall Study|Did Not Meet Eligibility Requirements|1
6898139|NCT00644332|10917285|FG000|Overall Study|Could Not Attend Scheduled Visits|1
6898140|NCT00644358|10917289|FG000|Overall Study|Adverse Event|124
6898141|NCT00644358|10917289|FG000|Overall Study|Lost to Follow-up|105
6898142|NCT00644358|10917289|FG000|Overall Study|Consent Withdrawal|64
6898143|NCT00644358|10917289|FG000|Overall Study|Lack of Effectiveness|39
6898144|NCT00644358|10917289|FG000|Overall Study|Protocol Violation|5
6898145|NCT00644358|10917289|FG000|Overall Study|Noncompliance|14
6898146|NCT00644358|10917289|FG000|Overall Study|Other Unspecified|11
6898147|NCT00644423|10917295|FG000|Overall Study|Lost to Follow-up|1
6978186|NCT01212770|11031716|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
6978187|NCT01212770|11031717|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
6978188|NCT01212770|11031718|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
6978189|NCT01212770|11031719|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
6978190|NCT01212770|11031720|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
6978191|NCT01212770|11031721|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
6978192|NCT01212770|11031722|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
6978193|NCT01212770|11031723|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
6978194|NCT01212770|11031724|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
6978195|NCT01212770|11031716|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3
6978196|NCT01212770|11031717|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1
6978197|NCT01212770|11031718|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2
6978198|NCT01212770|11031719|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
6978199|NCT01212770|11031720|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
6978200|NCT01212770|11031721|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
6978201|NCT01212770|11031722|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
6978202|NCT01212770|11031723|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
6978203|NCT01212770|11031724|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
6978204|NCT01212770|11031716|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
6978205|NCT01212770|11031717|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6
6978206|NCT01212770|11031718|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
6978207|NCT01212770|11031719|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
6978208|NCT01212770|11031720|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
6978209|NCT01212770|11031721|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
6978210|NCT01212770|11031722|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1
6978211|NCT01212770|11031723|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
6978212|NCT01212770|11031724|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
6978213|NCT01212770|11031716|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
6978214|NCT01212770|11031717|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7
6978215|NCT01212770|11031718|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5
6978216|NCT01212770|11031719|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4
6978217|NCT01212770|11031720|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1
6978218|NCT01212770|11031721|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2
6978219|NCT01212770|11031722|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
6978220|NCT01212770|11031723|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
6978221|NCT01212770|11031724|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
6978222|NCT01212770|11031716|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
6978223|NCT01212770|11031717|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6
6978224|NCT01212770|11031718|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
6978225|NCT01212770|11031719|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
6978226|NCT01212770|11031720|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
6978227|NCT01212770|11031721|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
6978228|NCT01212770|11031722|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
6978229|NCT01212770|11031723|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
6978230|NCT01212770|11031724|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
6978231|NCT01212770|11031716|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
6978232|NCT01212770|11031717|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
6978233|NCT01212770|11031718|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
6978234|NCT01212770|11031719|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
6978235|NCT01212770|11031720|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
6978236|NCT01212770|11031721|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
6978237|NCT01212770|11031722|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
6978238|NCT01212770|11031723|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
6978239|NCT01212770|11031724|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
6978240|NCT01212770|11031716|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
6978241|NCT01212770|11031717|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
6978242|NCT01212770|11031718|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
6978243|NCT01212770|11031719|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1
6978244|NCT01212770|11031720|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
6978245|NCT01212770|11031721|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
6978246|NCT01212770|11031722|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
6978247|NCT01212770|11031723|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
6978248|NCT01212770|11031724|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
6978249|NCT01212770|11031716|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
7059130|NCT01903811|11154633|FG000|Overall Study|Incomplete/discontinued prior therapy|1
7059131|NCT01903811|11154634|FG001|Overall Study|Incomplete/discontinued prior therapy|1
7059132|NCT01903811|11154633|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6
7059133|NCT01903811|11154634|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11
7059134|NCT01903811|11154633|FG000|Overall Study|Withdrawal by Subject|0
7059135|NCT01903811|11154634|FG001|Overall Study|Withdrawal by Subject|1
7059136|NCT01903837|11154647|FG000|Part A|Withdrawal by Subject|4
7059137|NCT01903837|11154648|FG001|Part A|Withdrawal by Subject|9
7059138|NCT01903837|11154649|FG002|Part A|Withdrawal by Subject|8
7059139|NCT01903837|11154650|FG003|Part A|Withdrawal by Subject|5
7059140|NCT01903837|11154647|FG000|Part A|Adverse Event|3
7059141|NCT01903837|11154648|FG001|Part A|Adverse Event|6
7059142|NCT01903837|11154649|FG002|Part A|Adverse Event|9
7059143|NCT01903837|11154650|FG003|Part A|Adverse Event|6
7059144|NCT01903837|11154647|FG000|Part A|Lost to Follow-up|9
7059145|NCT01903837|11154648|FG001|Part A|Lost to Follow-up|7
7059146|NCT01903837|11154649|FG002|Part A|Lost to Follow-up|7
7059147|NCT01903837|11154650|FG003|Part A|Lost to Follow-up|2
7059148|NCT01903837|11154647|FG000|Part A|Non-compliance with study drug|1
7059149|NCT01903837|11154648|FG001|Part A|Non-compliance with study drug|4
7059150|NCT01903837|11154649|FG002|Part A|Non-compliance with study drug|4
7059151|NCT01903837|11154650|FG003|Part A|Non-compliance with study drug|0
7059152|NCT01903837|11154647|FG000|Part A|Physician Decision|1
7059153|NCT01903837|11154648|FG001|Part A|Physician Decision|1
7059154|NCT01903837|11154649|FG002|Part A|Physician Decision|0
7059155|NCT01903837|11154650|FG003|Part A|Physician Decision|0
7059156|NCT01903837|11154647|FG000|Part A|Protocol Violation|1
7059157|NCT01903837|11154648|FG001|Part A|Protocol Violation|1
7059158|NCT01903837|11154649|FG002|Part A|Protocol Violation|0
7059159|NCT01903837|11154650|FG003|Part A|Protocol Violation|0
7059160|NCT01903837|11154647|FG000|Part B|Lost to Follow-up|0
7059161|NCT01903837|11154648|FG001|Part B|Lost to Follow-up|3
7059162|NCT01903837|11154649|FG002|Part B|Lost to Follow-up|3
7059163|NCT01903837|11154650|FG003|Part B|Lost to Follow-up|4
7059164|NCT01903837|11154647|FG000|Part B|Withdrawal by Subject|1
7059165|NCT01903837|11154648|FG001|Part B|Withdrawal by Subject|2
7059166|NCT01903837|11154649|FG002|Part B|Withdrawal by Subject|0
7059167|NCT01903837|11154650|FG003|Part B|Withdrawal by Subject|3
7059168|NCT01903837|11154647|FG000|Part B|Adverse Event|3
7059169|NCT01903837|11154648|FG001|Part B|Adverse Event|0
7059170|NCT01903837|11154649|FG002|Part B|Adverse Event|2
7059171|NCT01903837|11154650|FG003|Part B|Adverse Event|0
7059172|NCT01903837|11154647|FG000|Part B|Non-compliance with study drug|2
7059173|NCT01903837|11154648|FG001|Part B|Non-compliance with study drug|0
7059174|NCT01903837|11154649|FG002|Part B|Non-compliance with study drug|0
7059175|NCT01903837|11154650|FG003|Part B|Non-compliance with study drug|1
7059176|NCT01903837|11154647|FG000|Part B|Incarceration|2
7059177|NCT01903837|11154648|FG001|Part B|Incarceration|0
7059178|NCT01903837|11154649|FG002|Part B|Incarceration|0
7059179|NCT01903837|11154650|FG003|Part B|Incarceration|1
7059180|NCT01903837|11154647|FG000|Part B|Physician Decision|1
7059181|NCT01903837|11154648|FG001|Part B|Physician Decision|0
7059182|NCT01903837|11154649|FG002|Part B|Physician Decision|0
7059183|NCT01903837|11154650|FG003|Part B|Physician Decision|2
7059184|NCT01903837|11154647|FG000|Part B|Lack of Efficacy|0
7059185|NCT01903837|11154648|FG001|Part B|Lack of Efficacy|1
7059186|NCT01903837|11154649|FG002|Part B|Lack of Efficacy|0
7059187|NCT01903837|11154650|FG003|Part B|Lack of Efficacy|0
7059188|NCT01903863|11154683|FG000|Overall Study|Physician Decision|2
7059189|NCT01903863|11154684|FG001|Overall Study|Physician Decision|0
7059190|NCT01903876|11154692|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184
7059191|NCT01903876|11154693|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108
7059192|NCT01903876|11154692|FG000|Six-Month Follow-up Period|Lost to Follow-up|91
7059193|NCT01903876|11154693|FG001|Six-Month Follow-up Period|Lost to Follow-up|145
7059194|NCT01903993|11154701|FG000|Overall Study|Death|118
7059195|NCT01903993|11154702|FG001|Overall Study|Death|121
7059196|NCT01903993|11154701|FG000|Overall Study|Withdrawal by Subject|15
7059197|NCT01903993|11154702|FG001|Overall Study|Withdrawal by Subject|4
7059198|NCT01903993|11154701|FG000|Overall Study|Lost to Follow-up|2
7059199|NCT01903993|11154702|FG001|Overall Study|Lost to Follow-up|3
7059200|NCT01903993|11154701|FG000|Overall Study|Study Terminated by Sponsor|8
7059201|NCT01903993|11154702|FG001|Overall Study|Study Terminated by Sponsor|14
7059202|NCT01903993|11154701|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0
7059203|NCT01903993|11154702|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2
7140576|NCT02973100|11294826|FG002|Overall Study|Failed to attend Safety followup period|1
7059204|NCT01904019|11154709|FG000|1 Year Follow-up|Withdrawal by Subject|4
7059205|NCT01904019|11154709|FG000|1 Year Follow-up|Impossibility to contact patient|5
7059206|NCT01904019|11154709|FG000|3 Year Follow-up|Withdrawal by Subject|1
7059207|NCT01904019|11154709|FG000|3 Year Follow-up|Impossibility to contact patient|14
6978250|NCT01212770|11031717|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
6978251|NCT01212770|11031718|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
6978252|NCT01212770|11031719|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
6978253|NCT01212770|11031720|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
6978254|NCT01212770|11031721|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
6978255|NCT01212770|11031722|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
6978256|NCT01212770|11031723|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
6978257|NCT01212770|11031724|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
6978258|NCT01212770|11031716|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0
6978259|NCT01212770|11031717|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3
6978260|NCT01212770|11031718|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3
6978261|NCT01212770|11031719|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0
6978262|NCT01212770|11031720|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0
6978263|NCT01212770|11031721|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0
6978264|NCT01212770|11031722|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0
6978265|NCT01212770|11031723|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0
6978266|NCT01212770|11031724|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2
6978267|NCT01212770|11031716|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
6978268|NCT01212770|11031717|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
6978269|NCT01212770|11031718|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7
6978270|NCT01212770|11031719|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
6978271|NCT01212770|11031720|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
6978272|NCT01212770|11031721|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
6978273|NCT01212770|11031722|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
6978274|NCT01212770|11031723|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4
6978275|NCT01212770|11031724|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
6978276|NCT01212770|11031716|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
6978277|NCT01212770|11031717|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1
6978278|NCT01212770|11031718|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
6978279|NCT01212770|11031719|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
6978280|NCT01212770|11031720|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
6978281|NCT01212770|11031721|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
6978282|NCT01212770|11031722|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
6978283|NCT01212770|11031723|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
6978284|NCT01212770|11031724|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
6978285|NCT01212770|11031716|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
6978286|NCT01212770|11031717|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9
6978287|NCT01212770|11031718|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3
6978288|NCT01212770|11031719|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
6978289|NCT01212770|11031720|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
6978290|NCT01212770|11031721|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
6978291|NCT01212770|11031722|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
6978292|NCT01212770|11031723|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
6978293|NCT01212770|11031724|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
6978294|NCT01212770|11031716|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
6978295|NCT01212770|11031717|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2
6978296|NCT01212770|11031718|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
6978297|NCT01212770|11031719|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
6978298|NCT01212770|11031720|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
6978299|NCT01212770|11031721|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
6978300|NCT01212770|11031722|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
6978301|NCT01212770|11031723|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
6978302|NCT01212770|11031724|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
6978303|NCT01212770|11031716|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0
6978304|NCT01212770|11031717|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2
6978305|NCT01212770|11031718|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1
6978306|NCT01212770|11031719|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0
6978307|NCT01212770|11031720|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0
6978308|NCT01212770|11031721|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0
6978309|NCT01212770|11031722|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0
6978310|NCT01212770|11031723|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0
6978311|NCT01212770|11031724|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1
6978312|NCT01212770|11031716|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0
6978313|NCT01212770|11031717|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2
6978314|NCT01212770|11031718|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2
6978315|NCT01212770|11031719|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0
6978316|NCT01212770|11031720|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0
6978317|NCT01212770|11031721|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0
6978318|NCT01212770|11031722|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0
6978319|NCT01212770|11031723|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2
6978320|NCT01212770|11031724|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1
6978321|NCT01212770|11031716|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
6978322|NCT01212770|11031717|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3
6978323|NCT01212770|11031718|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4
6978324|NCT01212770|11031719|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
6978325|NCT01212770|11031720|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
6978326|NCT01212770|11031721|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
6978327|NCT01212770|11031722|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
6978328|NCT01212770|11031723|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
7059208|NCT01904019|11154709|FG000|5 Year Follow-up|Withdrawal by Subject|2
7059209|NCT01904019|11154709|FG000|5 Year Follow-up|Impossibility to contact patient|4
7059210|NCT01904058|11154717|FG000|Overall Study|Adverse Event|2
7059211|NCT01904058|11154718|FG001|Overall Study|Adverse Event|0
7059212|NCT01904058|11154719|FG002|Overall Study|Adverse Event|0
7059213|NCT01904058|11154720|FG003|Overall Study|Adverse Event|0
7059214|NCT01904058|11154717|FG000|Overall Study|Withdrawal by Subject|1
7059215|NCT01904058|11154718|FG001|Overall Study|Withdrawal by Subject|0
7059216|NCT01904058|11154719|FG002|Overall Study|Withdrawal by Subject|1
7059217|NCT01904058|11154720|FG003|Overall Study|Withdrawal by Subject|0
7059218|NCT01904058|11154717|FG000|Overall Study|Pregnancy|0
7059219|NCT01904058|11154718|FG001|Overall Study|Pregnancy|0
7059220|NCT01904058|11154719|FG002|Overall Study|Pregnancy|0
7059221|NCT01904058|11154720|FG003|Overall Study|Pregnancy|1
7059222|NCT01904149|11154755|FG000|Overall Study|Adverse Event|3
7059223|NCT01904149|11154756|FG001|Overall Study|Adverse Event|4
7059224|NCT01904149|11154757|FG002|Overall Study|Adverse Event|0
7059225|NCT01904149|11154758|FG003|Overall Study|Adverse Event|1
7059226|NCT01904149|11154759|FG004|Overall Study|Adverse Event|1
7059227|NCT01904149|11154760|FG005|Overall Study|Adverse Event|2
7059228|NCT01904149|11154755|FG000|Overall Study|Lack of Efficacy|0
7059229|NCT01904149|11154756|FG001|Overall Study|Lack of Efficacy|3
7059230|NCT01904149|11154757|FG002|Overall Study|Lack of Efficacy|1
7059231|NCT01904149|11154758|FG003|Overall Study|Lack of Efficacy|3
7059232|NCT01904149|11154759|FG004|Overall Study|Lack of Efficacy|3
7059233|NCT01904149|11154760|FG005|Overall Study|Lack of Efficacy|1
7059234|NCT01904149|11154755|FG000|Overall Study|Withdrawal by Subject|1
7059235|NCT01904149|11154756|FG001|Overall Study|Withdrawal by Subject|3
7059236|NCT01904149|11154757|FG002|Overall Study|Withdrawal by Subject|1
7059237|NCT01904149|11154758|FG003|Overall Study|Withdrawal by Subject|0
7059238|NCT01904149|11154759|FG004|Overall Study|Withdrawal by Subject|1
7059239|NCT01904149|11154760|FG005|Overall Study|Withdrawal by Subject|0
7059240|NCT01904149|11154755|FG000|Overall Study|Protocol Violation|0
7059241|NCT01904149|11154756|FG001|Overall Study|Protocol Violation|1
7059242|NCT01904149|11154757|FG002|Overall Study|Protocol Violation|0
7059243|NCT01904149|11154758|FG003|Overall Study|Protocol Violation|0
7059244|NCT01904149|11154759|FG004|Overall Study|Protocol Violation|0
7059245|NCT01904149|11154760|FG005|Overall Study|Protocol Violation|0
7059246|NCT01904149|11154755|FG000|Overall Study|non compliance with study drug|1
7059247|NCT01904149|11154756|FG001|Overall Study|non compliance with study drug|0
7059248|NCT01904149|11154757|FG002|Overall Study|non compliance with study drug|0
7059249|NCT01904149|11154758|FG003|Overall Study|non compliance with study drug|0
7059250|NCT01904149|11154759|FG004|Overall Study|non compliance with study drug|0
7059251|NCT01904149|11154760|FG005|Overall Study|non compliance with study drug|0
7059252|NCT01904383|11154776|FG000|Overall Study|CRF not collected|117
7059253|NCT01904383|11154776|FG000|Overall Study|Reason not listed|147
7059254|NCT01904383|11154776|FG000|Overall Study|Lost to Follow-up|674
7059255|NCT01904383|11154776|FG000|Overall Study|Lack of Efficacy|370
7059256|NCT01904383|11154776|FG000|Overall Study|Improvement|141
7059257|NCT01904383|11154776|FG000|Overall Study|Adverse Event|271
7059258|NCT01904383|11154776|FG000|Overall Study|No patient visit after entry|54
7059259|NCT01904604|11154796|FG000|Overall Study|Withdrew before receiving dosing|0
7059260|NCT01904604|11154797|FG001|Overall Study|Withdrew before receiving dosing|1
7059261|NCT01904604|11154798|FG002|Overall Study|Withdrew before receiving dosing|0
7059262|NCT01904604|11154796|FG000|Overall Study|Non-compliance|1
7059263|NCT01904604|11154797|FG001|Overall Study|Non-compliance|0
7059264|NCT01904604|11154798|FG002|Overall Study|Non-compliance|0
7059265|NCT01904604|11154796|FG000|Overall Study|Anxiety about OFC/Refused OFC|2
7059266|NCT01904604|11154797|FG001|Overall Study|Anxiety about OFC/Refused OFC|0
7059267|NCT01904604|11154798|FG002|Overall Study|Anxiety about OFC/Refused OFC|0
7059268|NCT01904604|11154796|FG000|Overall Study|Patch site reactions|1
7059269|NCT01904604|11154797|FG001|Overall Study|Patch site reactions|1
7059270|NCT01904604|11154798|FG002|Overall Study|Patch site reactions|0
7059271|NCT01904604|11154796|FG000|Overall Study|Increased syncope|0
7059272|NCT01904604|11154797|FG001|Overall Study|Increased syncope|1
7059273|NCT01904604|11154798|FG002|Overall Study|Increased syncope|0
7059274|NCT01904604|11154796|FG000|Overall Study|Unrelated illness|0
7059275|NCT01904604|11154797|FG001|Overall Study|Unrelated illness|1
7059276|NCT01904604|11154798|FG002|Overall Study|Unrelated illness|0
7059277|NCT01904604|11154796|FG000|Overall Study|Passed Week 52 OFC|1
7059278|NCT01904604|11154797|FG001|Overall Study|Passed Week 52 OFC|0
7059279|NCT01904604|11154798|FG002|Overall Study|Passed Week 52 OFC|0
7059280|NCT01904604|11154796|FG000|Overall Study|Withdrawal by Subject|1
7059281|NCT01904604|11154797|FG001|Overall Study|Withdrawal by Subject|2
7059282|NCT01904604|11154798|FG002|Overall Study|Withdrawal by Subject|0
7059283|NCT01904604|11154796|FG000|Overall Study|Participant Relocated|1
6978329|NCT01212770|11031724|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
6978330|NCT01212770|11031716|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
6978331|NCT01212770|11031717|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3
6978332|NCT01212770|11031718|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4
6978333|NCT01212770|11031719|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
6978334|NCT01212770|11031720|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
6978335|NCT01212770|11031721|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
6978336|NCT01212770|11031722|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
6978337|NCT01212770|11031723|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
6978338|NCT01212770|11031724|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
6978339|NCT01212770|11031716|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
6978340|NCT01212770|11031717|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
6978341|NCT01212770|11031718|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
6978342|NCT01212770|11031719|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
6978343|NCT01212770|11031720|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
6978344|NCT01212770|11031721|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
6978345|NCT01212770|11031722|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
6978346|NCT01212770|11031723|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
6978347|NCT01212770|11031724|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
6978348|NCT01212770|11031716|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0
6978349|NCT01212770|11031717|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0
6978350|NCT01212770|11031718|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0
6978351|NCT01212770|11031719|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0
6978352|NCT01212770|11031720|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0
6978353|NCT01212770|11031721|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0
6978354|NCT01212770|11031722|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0
6978355|NCT01212770|11031723|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1
6978356|NCT01212770|11031724|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0
6978357|NCT01212770|11031716|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0
6978358|NCT01212770|11031717|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2
6978359|NCT01212770|11031718|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1
6978360|NCT01212770|11031719|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0
6978361|NCT01212770|11031720|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0
6978362|NCT01212770|11031721|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0
6978363|NCT01212770|11031722|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0
6978364|NCT01212770|11031723|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1
6978365|NCT01212770|11031724|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1
6978366|NCT01212770|11031716|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0
6978367|NCT01212770|11031717|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1
6978368|NCT01212770|11031718|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1
6978369|NCT01212770|11031719|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0
6978370|NCT01212770|11031720|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0
6978371|NCT01212770|11031721|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0
6978372|NCT01212770|11031722|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0
6978373|NCT01212770|11031723|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0
6978374|NCT01212770|11031724|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1
6978375|NCT01212770|11031716|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
6978376|NCT01212770|11031717|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
6978377|NCT01212770|11031718|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5
6978378|NCT01212770|11031719|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
6978379|NCT01212770|11031720|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
6978380|NCT01212770|11031721|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7059284|NCT01904604|11154797|FG001|Overall Study|Participant Relocated|1
7059285|NCT01904604|11154798|FG002|Overall Study|Participant Relocated|1
7059286|NCT01904604|11154796|FG000|Overall Study|Lost to Follow-up|0
7059287|NCT01904604|11154797|FG001|Overall Study|Lost to Follow-up|0
7059288|NCT01904604|11154798|FG002|Overall Study|Lost to Follow-up|1
7059289|NCT01904721|11154816|FG000|Overall Study|Other Reasons|0
7059290|NCT01904721|11154817|FG001|Overall Study|Other Reasons|0
7059291|NCT01904721|11154818|FG002|Overall Study|Other Reasons|1
7059292|NCT01904721|11154819|FG003|Overall Study|Other Reasons|1
7059293|NCT01904721|11154820|FG004|Overall Study|Other Reasons|2
7059294|NCT01904721|11154821|FG005|Overall Study|Other Reasons|2
7059295|NCT01904721|11154822|FG006|Overall Study|Other Reasons|2
7059296|NCT01904721|11154816|FG000|Overall Study|Personal Reasons|0
7059297|NCT01904721|11154817|FG001|Overall Study|Personal Reasons|0
7059298|NCT01904721|11154818|FG002|Overall Study|Personal Reasons|0
7059299|NCT01904721|11154819|FG003|Overall Study|Personal Reasons|0
7059300|NCT01904721|11154820|FG004|Overall Study|Personal Reasons|2
7059301|NCT01904721|11154821|FG005|Overall Study|Personal Reasons|3
7059302|NCT01904721|11154822|FG006|Overall Study|Personal Reasons|3
7059303|NCT01904721|11154816|FG000|Overall Study|Lost to Follow-up|0
7059304|NCT01904721|11154817|FG001|Overall Study|Lost to Follow-up|0
7059305|NCT01904721|11154818|FG002|Overall Study|Lost to Follow-up|0
7059306|NCT01904721|11154819|FG003|Overall Study|Lost to Follow-up|0
7059307|NCT01904721|11154820|FG004|Overall Study|Lost to Follow-up|1
7059308|NCT01904721|11154821|FG005|Overall Study|Lost to Follow-up|3
7059309|NCT01904721|11154822|FG006|Overall Study|Lost to Follow-up|1
7059310|NCT01904721|11154816|FG000|Overall Study|Lack of Efficacy|0
7059311|NCT01904721|11154817|FG001|Overall Study|Lack of Efficacy|0
7059312|NCT01904721|11154818|FG002|Overall Study|Lack of Efficacy|0
7059313|NCT01904721|11154819|FG003|Overall Study|Lack of Efficacy|0
7059314|NCT01904721|11154820|FG004|Overall Study|Lack of Efficacy|0
7059315|NCT01904721|11154821|FG005|Overall Study|Lack of Efficacy|0
7059316|NCT01904721|11154822|FG006|Overall Study|Lack of Efficacy|1
7059317|NCT01904721|11154816|FG000|Overall Study|Adverse Event|0
7059318|NCT01904721|11154817|FG001|Overall Study|Adverse Event|0
7059319|NCT01904721|11154818|FG002|Overall Study|Adverse Event|0
7059320|NCT01904721|11154819|FG003|Overall Study|Adverse Event|0
7059321|NCT01904721|11154820|FG004|Overall Study|Adverse Event|3
7059322|NCT01904721|11154821|FG005|Overall Study|Adverse Event|1
7059323|NCT01904721|11154822|FG006|Overall Study|Adverse Event|0
7059324|NCT01904760|11154836|FG000|Overall Study|Protocol Violation|1
7059325|NCT01904760|11154837|FG001|Overall Study|Protocol Violation|0
7059326|NCT01904773|11154843|FG000|Screen|Screen failure|3
7059327|NCT01904773|11154844|FG001|Screen|Screen failure|0
7059328|NCT01904773|11154845|FG002|Screen|Screen failure|0
7059329|NCT01904773|11154846|FG003|Screen|Screen failure|0
7059330|NCT01904773|11154847|FG004|Screen|Screen failure|0
7059331|NCT01904773|11154848|FG005|Screen|Screen failure|0
7059332|NCT01904773|11154849|FG006|Screen|Screen failure|0
7059333|NCT01904773|11154850|FG007|Screen|Screen failure|0
7059334|NCT01904773|11154851|FG008|Screen|Screen failure|0
7059335|NCT01904773|11154843|FG000|Screen|Withdrawal by Subject|1
7059336|NCT01904773|11154844|FG001|Screen|Withdrawal by Subject|0
7059337|NCT01904773|11154845|FG002|Screen|Withdrawal by Subject|0
7059338|NCT01904773|11154846|FG003|Screen|Withdrawal by Subject|0
7059339|NCT01904773|11154847|FG004|Screen|Withdrawal by Subject|0
7059340|NCT01904773|11154848|FG005|Screen|Withdrawal by Subject|0
7059341|NCT01904773|11154849|FG006|Screen|Withdrawal by Subject|0
7059342|NCT01904773|11154850|FG007|Screen|Withdrawal by Subject|0
7059343|NCT01904773|11154851|FG008|Screen|Withdrawal by Subject|0
7059344|NCT01904773|11154843|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1
7059345|NCT01904773|11154844|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
7059346|NCT01904773|11154845|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
7059347|NCT01904773|11154846|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
7059348|NCT01904773|11154847|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
7059349|NCT01904773|11154848|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
7059350|NCT01904773|11154849|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
7059351|NCT01904773|11154850|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
7059352|NCT01904773|11154851|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
7059353|NCT01904773|11154843|FG000|First Intervention|Adverse Event|0
7059354|NCT01904773|11154844|FG001|First Intervention|Adverse Event|0
7059355|NCT01904773|11154845|FG002|First Intervention|Adverse Event|0
7059356|NCT01904773|11154846|FG003|First Intervention|Adverse Event|0
7059357|NCT01904773|11154847|FG004|First Intervention|Adverse Event|0
7059358|NCT01904773|11154848|FG005|First Intervention|Adverse Event|0
7059359|NCT01904773|11154849|FG006|First Intervention|Adverse Event|1
7140577|NCT02973100|11294827|FG003|Overall Study|Failed to attend Safety followup period|0
7140578|NCT02973477|11294860|FG000|First Intervention|Lost to Follow-up|0
7140579|NCT02973477|11294861|FG001|First Intervention|Lost to Follow-up|2
7140580|NCT02973477|11294860|FG000|Washout|Withdrawal by Subject|1
7140581|NCT02973477|11294861|FG001|Washout|Withdrawal by Subject|0
7140582|NCT02973477|11294860|FG000|Second Intervention|Lost to Follow-up|1
7140583|NCT02973477|11294861|FG001|Second Intervention|Lost to Follow-up|0
7183569|NCT01499095|11383677|FG001|Overall Study|Lack of Efficacy|1
7183570|NCT01499095|11383676|FG000|Overall Study|Protocol Violation|6
7183571|NCT01499095|11383677|FG001|Overall Study|Protocol Violation|7
7183572|NCT01499095|11383676|FG000|Overall Study|Received Rescue Therapy|32
7183573|NCT01499095|11383677|FG001|Overall Study|Received Rescue Therapy|40
7183574|NCT01499095|11383676|FG000|Overall Study|Diverse Reasons|22
7183575|NCT01499095|11383677|FG001|Overall Study|Diverse Reasons|25
7183576|NCT01499095|11383676|FG000|Overall Study|Lost to Follow-up|6
7183577|NCT01499095|11383677|FG001|Overall Study|Lost to Follow-up|4
7183578|NCT01499095|11383676|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0
7183579|NCT01499095|11383677|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5
7059360|NCT01904773|11154850|FG007|First Intervention|Adverse Event|0
7059361|NCT01904773|11154851|FG008|First Intervention|Adverse Event|0
7059362|NCT01904773|11154843|FG000|Placebo Washout First Intervention|Condition worsened|0
7059363|NCT01904773|11154844|FG001|Placebo Washout First Intervention|Condition worsened|1
7059364|NCT01904773|11154845|FG002|Placebo Washout First Intervention|Condition worsened|0
7059365|NCT01904773|11154846|FG003|Placebo Washout First Intervention|Condition worsened|0
7059366|NCT01904773|11154847|FG004|Placebo Washout First Intervention|Condition worsened|0
7059367|NCT01904773|11154848|FG005|Placebo Washout First Intervention|Condition worsened|0
7059368|NCT01904773|11154849|FG006|Placebo Washout First Intervention|Condition worsened|0
7059369|NCT01904773|11154850|FG007|Placebo Washout First Intervention|Condition worsened|0
7183580|NCT01499095|11383676|FG000|Overall Study|Hypoglycemia|3
7183581|NCT01499095|11383677|FG001|Overall Study|Hypoglycemia|1
7187149|NCT02561962|11387635|FG004|Overall Study|Withdrawal by Subject|1
7059370|NCT01904773|11154851|FG008|Placebo Washout First Intervention|Condition worsened|0
7059371|NCT01904773|11154843|FG000|Fifth Intervention|Adverse Event|0
7059372|NCT01904773|11154844|FG001|Fifth Intervention|Adverse Event|0
7059373|NCT01904773|11154845|FG002|Fifth Intervention|Adverse Event|0
7059374|NCT01904773|11154846|FG003|Fifth Intervention|Adverse Event|0
7059375|NCT01904773|11154847|FG004|Fifth Intervention|Adverse Event|0
7059376|NCT01904773|11154848|FG005|Fifth Intervention|Adverse Event|0
7059377|NCT01904773|11154849|FG006|Fifth Intervention|Adverse Event|0
7059378|NCT01904773|11154850|FG007|Fifth Intervention|Adverse Event|1
7059379|NCT01904773|11154851|FG008|Fifth Intervention|Adverse Event|0
7059380|NCT01904773|11154843|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
7059381|NCT01904773|11154844|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1
7059382|NCT01904773|11154845|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
7059383|NCT01904773|11154846|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
7059384|NCT01904773|11154847|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
7059385|NCT01904773|11154848|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
7059386|NCT01904773|11154849|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
7059387|NCT01904773|11154850|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
7059388|NCT01904773|11154851|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
7059389|NCT01905267|11154882|FG000|Overall Study|Physician Decision|2
7059390|NCT01905267|11154883|FG001|Overall Study|Physician Decision|2
7059391|NCT01905540|11154914|FG000|Period 3|Other|1
7059392|NCT01905540|11154915|FG001|Period 3|Other|0
7059393|NCT01905540|11154916|FG002|Period 3|Other|1
7059394|NCT01905540|11154917|FG003|Period 3|Other|1
7059395|NCT01905553|11154929|FG000|Period 2|Adverse Event|1
7059396|NCT01905553|11154930|FG001|Period 2|Adverse Event|0
7059397|NCT01905592|11154938|FG000|Overall Study|Disease Progression|51
7059398|NCT01905592|11154939|FG001|Overall Study|Disease Progression|104
7059399|NCT01905592|11154938|FG000|Overall Study|Toxicity|1
7059400|NCT01905592|11154939|FG001|Overall Study|Toxicity|16
7059401|NCT01905592|11154938|FG000|Overall Study|Physician Decision|0
7059402|NCT01905592|11154939|FG001|Overall Study|Physician Decision|2
7059403|NCT01905592|11154938|FG000|Overall Study|New anti-cancer|1
7059404|NCT01905592|11154939|FG001|Overall Study|New anti-cancer|0
7059405|NCT01905592|11154938|FG000|Overall Study|Protocol Violation|0
7059406|NCT01905592|11154939|FG001|Overall Study|Protocol Violation|1
7059407|NCT01905592|11154938|FG000|Overall Study|Sponsor's decision|1
7059408|NCT01905592|11154939|FG001|Overall Study|Sponsor's decision|0
7059409|NCT01905592|11154938|FG000|Overall Study|Not treated|7
7059410|NCT01905592|11154939|FG001|Overall Study|Not treated|3
7059411|NCT01905592|11154938|FG000|Overall Study|Ongoing in Study|0
7059412|NCT01905592|11154939|FG001|Overall Study|Ongoing in Study|7
7059413|NCT01905592|11154938|FG000|Overall Study|Withdrawal by Subject|10
7059414|NCT01905592|11154939|FG001|Overall Study|Withdrawal by Subject|2
7059415|NCT01905657|11154948|FG000|Overall Study|Adverse Event|23
7059416|NCT01905657|11154949|FG001|Overall Study|Adverse Event|17
7059417|NCT01905657|11154950|FG002|Overall Study|Adverse Event|18
6816481|NCT00064701|10821036|FG002|One Year Post-transplant|Rejection|16
6816482|NCT00064701|10821034|FG000|One Year Post-transplant|Non-compliance|4
7059418|NCT01905657|11154948|FG000|Overall Study|Clinical Progression|103
7059419|NCT01905657|11154949|FG001|Overall Study|Clinical Progression|78
7059420|NCT01905657|11154950|FG002|Overall Study|Clinical Progression|59
7059421|NCT01905657|11154948|FG000|Overall Study|Death|40
7059422|NCT01905657|11154949|FG001|Overall Study|Death|43
7059423|NCT01905657|11154950|FG002|Overall Study|Death|47
7059424|NCT01905657|11154948|FG000|Overall Study|Excluded Medication|13
7059425|NCT01905657|11154949|FG001|Overall Study|Excluded Medication|16
7059426|NCT01905657|11154950|FG002|Overall Study|Excluded Medication|9
7059427|NCT01905657|11154948|FG000|Overall Study|Lost to Follow-up|1
7059428|NCT01905657|11154949|FG001|Overall Study|Lost to Follow-up|2
7059429|NCT01905657|11154950|FG002|Overall Study|Lost to Follow-up|1
7059430|NCT01905657|11154948|FG000|Overall Study|Physician Decision|5
7059431|NCT01905657|11154949|FG001|Overall Study|Physician Decision|8
7059432|NCT01905657|11154950|FG002|Overall Study|Physician Decision|12
7059433|NCT01905657|11154948|FG000|Overall Study|Protocol Violation|2
7059434|NCT01905657|11154949|FG001|Overall Study|Protocol Violation|1
7059435|NCT01905657|11154950|FG002|Overall Study|Protocol Violation|1
7059436|NCT01905657|11154948|FG000|Overall Study|Screen Failure|0
7059437|NCT01905657|11154949|FG001|Overall Study|Screen Failure|1
7059438|NCT01905657|11154950|FG002|Overall Study|Screen Failure|0
7059439|NCT01905657|11154948|FG000|Overall Study|Withdrawal by Subject|15
7059440|NCT01905657|11154949|FG001|Overall Study|Withdrawal by Subject|21
7059441|NCT01905657|11154950|FG002|Overall Study|Withdrawal by Subject|53
7059442|NCT01905657|11154948|FG000|Overall Study|Sponsor Decision|1
7059443|NCT01905657|11154949|FG001|Overall Study|Sponsor Decision|0
7059444|NCT01905657|11154950|FG002|Overall Study|Sponsor Decision|0
7059445|NCT01905683|11154961|FG000|Overall Study|Protocol Violation|1
7059446|NCT01905683|11154961|FG000|Overall Study|Re-injection criteria not met; others|13
7059447|NCT01905683|11154961|FG000|Overall Study|Physician Decision|1
7059448|NCT01905683|11154961|FG000|Overall Study|Lack of Efficacy|8
7059449|NCT01905683|11154961|FG000|Overall Study|Withdrawal by Subject|20
7059450|NCT01905683|11154961|FG000|Overall Study|Adverse Event|4
7059451|NCT01905683|11154961|FG000|Overall Study|Lost to Follow-up|4
7059452|NCT01905943|11154965|FG000|Overall Study|Withdrawal of consent|90
7059453|NCT01905943|11154965|FG000|Overall Study|Lost to Follow-up|16
7059454|NCT01905943|11154965|FG000|Overall Study|Investigator discretion|7
7059455|NCT01905943|11154965|FG000|Overall Study|Death|186
7059456|NCT01905943|11154965|FG000|Overall Study|Adverse Event|3
7059457|NCT01905943|11154965|FG000|Overall Study|Other|12
7059458|NCT01906008|11154995|FG000|Overall Study|Lost to Follow-up|2
7059459|NCT01906008|11154996|FG001|Overall Study|Lost to Follow-up|0
7059460|NCT01906008|11154995|FG000|Overall Study|Oxaliplatin toxicity|2
7059461|NCT01906008|11154996|FG001|Overall Study|Oxaliplatin toxicity|0
7059462|NCT01906008|11154995|FG000|Overall Study|Protocol Violation|0
7059463|NCT01906008|11154996|FG001|Overall Study|Protocol Violation|1
7059464|NCT01906008|11154995|FG000|Overall Study|Withdrawal by Subject|1
7059465|NCT01906008|11154996|FG001|Overall Study|Withdrawal by Subject|5
7059466|NCT01906008|11154995|FG000|Overall Study|Did not start study med|3
7059467|NCT01906008|11154996|FG001|Overall Study|Did not start study med|4
7059468|NCT01906008|11154995|FG000|Overall Study|Oxaliplatin stops|10
7059469|NCT01906008|11154996|FG001|Overall Study|Oxaliplatin stops|8
7059470|NCT01906008|11154995|FG000|Overall Study|Hospice|1
7059471|NCT01906008|11154996|FG001|Overall Study|Hospice|0
7059472|NCT01906008|11154995|FG000|Overall Study|Physician Decision|3
7140584|NCT02973802|11294891|FG000|Overall Study|Lost to Follow-up|1
7140585|NCT02973802|11294891|FG000|Overall Study|Withdrawal by Subject|1
7140586|NCT02974010|11294900|FG000|Overall Study|Lost to Follow-up|3
7140587|NCT02974010|11294901|FG001|Overall Study|Lost to Follow-up|1
7140588|NCT02974010|11294902|FG002|Overall Study|Lost to Follow-up|0
7140589|NCT02974010|11294903|FG003|Overall Study|Lost to Follow-up|0
7140590|NCT02974010|11294900|FG000|Overall Study|Withdrawal by Subject|2
7140591|NCT02974010|11294901|FG001|Overall Study|Withdrawal by Subject|1
7140592|NCT02974010|11294902|FG002|Overall Study|Withdrawal by Subject|0
7140593|NCT02974010|11294903|FG003|Overall Study|Withdrawal by Subject|0
7140594|NCT02974010|11294900|FG000|Overall Study|Adverse Event|0
7140595|NCT02974010|11294901|FG001|Overall Study|Adverse Event|1
7140596|NCT02974010|11294902|FG002|Overall Study|Adverse Event|0
7140597|NCT02974010|11294903|FG003|Overall Study|Adverse Event|0
7140598|NCT02974010|11294900|FG000|Overall Study|Completed day 42 but did not return for day 70|1
7140599|NCT02974010|11294901|FG001|Overall Study|Completed day 42 but did not return for day 70|0
7140600|NCT02974010|11294902|FG002|Overall Study|Completed day 42 but did not return for day 70|1
7140601|NCT02974010|11294903|FG003|Overall Study|Completed day 42 but did not return for day 70|0
7140602|NCT02974010|11294900|FG000|Overall Study|Lack of Efficacy|0
7059473|NCT01906008|11154996|FG001|Overall Study|Physician Decision|3
7059474|NCT01906008|11154995|FG000|Overall Study|Lack of compliance of study med|5
7059475|NCT01906008|11154996|FG001|Overall Study|Lack of compliance of study med|3
7059476|NCT01906008|11154995|FG000|Overall Study|Adverse Event|0
7059477|NCT01906008|11154996|FG001|Overall Study|Adverse Event|3
7059478|NCT01906346|11155002|FG000|Overall Study|AEs|1
7059479|NCT01906372|11155008|FG000|Overall Study|Withdrawal by Subject|2
7059480|NCT01906476|11155015|FG000|Overall Study|Lost to Follow-up|17
7059481|NCT01906476|11155016|FG001|Overall Study|Lost to Follow-up|16
7059482|NCT01907087|11155061|FG000|Overall Study|Withdrawal by Subject|1
7059483|NCT01907100|11155069|FG000|Overall Study|PD based on modified RECIST criteria|31
7059484|NCT01907100|11155070|FG001|Overall Study|PD based on modified RECIST criteria|32
7059485|NCT01907100|11155071|FG002|Overall Study|PD based on modified RECIST criteria|95
7059486|NCT01907100|11155072|FG003|Overall Study|PD based on modified RECIST criteria|92
7059487|NCT01907100|11155069|FG000|Overall Study|Withdrawal by Subject|2
7059488|NCT01907100|11155070|FG001|Overall Study|Withdrawal by Subject|5
7059489|NCT01907100|11155071|FG002|Overall Study|Withdrawal by Subject|10
7059490|NCT01907100|11155072|FG003|Overall Study|Withdrawal by Subject|13
7059491|NCT01907100|11155069|FG000|Overall Study|Protocol Violation|0
7059492|NCT01907100|11155070|FG001|Overall Study|Protocol Violation|0
7059493|NCT01907100|11155071|FG002|Overall Study|Protocol Violation|1
7059494|NCT01907100|11155072|FG003|Overall Study|Protocol Violation|1
7059495|NCT01907100|11155069|FG000|Overall Study|Lost to Follow-up|0
7059496|NCT01907100|11155070|FG001|Overall Study|Lost to Follow-up|0
7059497|NCT01907100|11155071|FG002|Overall Study|Lost to Follow-up|0
7059498|NCT01907100|11155072|FG003|Overall Study|Lost to Follow-up|1
7059499|NCT01907100|11155069|FG000|Overall Study|Not treated|2
7059500|NCT01907100|11155070|FG001|Overall Study|Not treated|0
7059501|NCT01907100|11155071|FG002|Overall Study|Not treated|1
7059502|NCT01907100|11155072|FG003|Overall Study|Not treated|2
7140603|NCT02974010|11294901|FG001|Overall Study|Lack of Efficacy|0
7059503|NCT01907100|11155069|FG000|Overall Study|Other than reasons specified|1
7059504|NCT01907100|11155070|FG001|Overall Study|Other than reasons specified|0
7059505|NCT01907100|11155071|FG002|Overall Study|Other than reasons specified|10
7059506|NCT01907100|11155072|FG003|Overall Study|Other than reasons specified|6
7059507|NCT01907100|11155069|FG000|Overall Study|Adverse event (AE)|6
7059508|NCT01907100|11155070|FG001|Overall Study|Adverse event (AE)|3
7059509|NCT01907100|11155071|FG002|Overall Study|Adverse event (AE)|22
7059510|NCT01907100|11155072|FG003|Overall Study|Adverse event (AE)|23
7059511|NCT01907100|11155069|FG000|Overall Study|Worsening/AE underlying cancer disease|0
7059512|NCT01907100|11155070|FG001|Overall Study|Worsening/AE underlying cancer disease|0
7140604|NCT02974010|11294902|FG002|Overall Study|Lack of Efficacy|1
7140605|NCT02974010|11294903|FG003|Overall Study|Lack of Efficacy|0
7059513|NCT01907100|11155071|FG002|Overall Study|Worsening/AE underlying cancer disease|8
7059514|NCT01907100|11155072|FG003|Overall Study|Worsening/AE underlying cancer disease|8
7059515|NCT01907217|11155103|FG000|Overall Study|Withdrawal by Subject|0
7059516|NCT01907217|11155104|FG001|Overall Study|Withdrawal by Subject|2
7082185|NCT02139644|11192564|FG002|Run-In Period (Pre-assignment)|Adverse Event|0
7082186|NCT02139644|11192565|FG003|Run-In Period (Pre-assignment)|Adverse Event|0
7082187|NCT02139644|11192566|FG004|Run-In Period (Pre-assignment)|Adverse Event|0
7082188|NCT02139644|11192567|FG005|Run-In Period (Pre-assignment)|Adverse Event|0
7082189|NCT02139644|11192562|FG000|Run-In Period (Pre-assignment)|Other|6
7082190|NCT02139644|11192563|FG001|Run-In Period (Pre-assignment)|Other|0
7082191|NCT02139644|11192564|FG002|Run-In Period (Pre-assignment)|Other|0
7082192|NCT02139644|11192565|FG003|Run-In Period (Pre-assignment)|Other|0
7082193|NCT02139644|11192566|FG004|Run-In Period (Pre-assignment)|Other|0
7082194|NCT02139644|11192567|FG005|Run-In Period (Pre-assignment)|Other|0
7082195|NCT02139644|11192562|FG000|Treatment Period|Adverse Event|0
7140606|NCT02974088|11294915|FG000|Overall Study|Lost to Follow-up|0
7140607|NCT02974088|11294916|FG001|Overall Study|Lost to Follow-up|2
7140608|NCT02974088|11294915|FG000|Overall Study|Adverse Event|0
7140609|NCT02974088|11294916|FG001|Overall Study|Adverse Event|1
7140610|NCT02974114|11294925|FG000|Overall Study|Other (Not specified)|0
7140611|NCT02974114|11294926|FG001|Overall Study|Other (Not specified)|1
7140612|NCT02974114|11294927|FG002|Overall Study|Other (Not specified)|2
7140613|NCT02974140|11294937|FG000|Overall Study|Adverse Event|2
7140614|NCT02974140|11294937|FG000|Overall Study|Lost to Follow-up|1
7140615|NCT02974140|11294937|FG000|Overall Study|Study Terminated by Sponsor|36
7140616|NCT02974153|11294947|FG000|Overall Study|Adverse Event|6
7140617|NCT02974153|11294948|FG001|Overall Study|Adverse Event|0
7140618|NCT02974153|11294949|FG002|Overall Study|Adverse Event|1
7140619|NCT02974153|11294947|FG000|Overall Study|Lack of Efficacy|6
7140620|NCT02974153|11294948|FG001|Overall Study|Lack of Efficacy|5
7140621|NCT02974153|11294949|FG002|Overall Study|Lack of Efficacy|10
7140622|NCT02974153|11294947|FG000|Overall Study|Lost to Follow-up|9
7140623|NCT02974153|11294948|FG001|Overall Study|Lost to Follow-up|10
7140624|NCT02974153|11294949|FG002|Overall Study|Lost to Follow-up|17
7140625|NCT02974153|11294947|FG000|Overall Study|Physician Decision|0
7140626|NCT02974153|11294948|FG001|Overall Study|Physician Decision|2
7140627|NCT02974153|11294949|FG002|Overall Study|Physician Decision|1
7140628|NCT02974153|11294947|FG000|Overall Study|Withdrawal by Subject|9
7140629|NCT02974153|11294948|FG001|Overall Study|Withdrawal by Subject|16
7140630|NCT02974153|11294949|FG002|Overall Study|Withdrawal by Subject|11
7140631|NCT02974153|11294947|FG000|Overall Study|Study Burden|8
7140632|NCT02974153|11294948|FG001|Overall Study|Study Burden|7
7140633|NCT02974153|11294949|FG002|Overall Study|Study Burden|3
7140634|NCT02974153|11294947|FG000|Overall Study|Other|14
7140635|NCT02974153|11294948|FG001|Overall Study|Other|8
7140636|NCT02974153|11294949|FG002|Overall Study|Other|7
7140637|NCT02974543|11294968|FG000|Overall Study|Withdrawal by Subject|1
7140638|NCT02974543|11294969|FG001|Overall Study|Withdrawal by Subject|0
7140639|NCT02974634|11294985|FG000|Overall Study|Advanced disease|12
7140640|NCT02974634|11294986|FG001|Overall Study|Advanced disease|3
7140641|NCT02974634|11294985|FG000|Overall Study|Noncompliance|3
7140642|NCT02974634|11294986|FG001|Overall Study|Noncompliance|7
7059517|NCT01907516|11155138|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5
7059518|NCT01907516|11155139|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9
7059519|NCT01907516|11155138|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1
7059520|NCT01907516|11155139|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3
7059521|NCT01907516|11155138|FG000|First Intervention (3 Weeks)|Delivered before second arm|3
7059522|NCT01907516|11155139|FG001|First Intervention (3 Weeks)|Delivered before second arm|4
7059523|NCT01907516|11155138|FG000|First Intervention (3 Weeks)|Developed DKA during study|1
7059524|NCT01907516|11155139|FG001|First Intervention (3 Weeks)|Developed DKA during study|0
7059525|NCT01907737|11155150|FG000|Overall Study|Withdrawal by Subject|1
7059526|NCT01907815|11155162|FG000|Overall Study|Withdrawal by Subject|1
7059527|NCT01907815|11155163|FG001|Overall Study|Withdrawal by Subject|0
7059528|NCT01907828|11155173|FG000|Overall Study|Exclusion criteria not met|0
7059529|NCT01907828|11155174|FG001|Overall Study|Exclusion criteria not met|1
7140643|NCT02974634|11294985|FG000|Overall Study|intervention technology related issues|5
7140644|NCT02974634|11294986|FG001|Overall Study|intervention technology related issues|0
7140645|NCT02974634|11294985|FG000|Overall Study|Death|8
7140646|NCT02974634|11294986|FG001|Overall Study|Death|11
7140647|NCT02974842|11294993|FG000|Overall Study|Withdrawal by Subject|4
6816483|NCT00064701|10821035|FG001|One Year Post-transplant|Non-compliance|2
6816484|NCT00064701|10821036|FG002|One Year Post-transplant|Non-compliance|5
6816485|NCT00064701|10821034|FG000|One Year Post-transplant|Graft Failure|3
6816486|NCT00064701|10821035|FG001|One Year Post-transplant|Graft Failure|2
6816487|NCT00064701|10821036|FG002|One Year Post-transplant|Graft Failure|1
6816488|NCT00064701|10821034|FG000|One Year Post-transplant|Withdrawal by Subject|0
6816489|NCT00064701|10821035|FG001|One Year Post-transplant|Withdrawal by Subject|4
6816490|NCT00064701|10821036|FG002|One Year Post-transplant|Withdrawal by Subject|1
6816491|NCT00064701|10821034|FG000|One Year Post-transplant|Lost to Follow-up|1
6816492|NCT00064701|10821035|FG001|One Year Post-transplant|Lost to Follow-up|0
6816493|NCT00064701|10821036|FG002|One Year Post-transplant|Lost to Follow-up|0
6816494|NCT00064701|10821034|FG000|One Year Post-transplant|Converted to rapamycin|1
6816495|NCT00064701|10821035|FG001|One Year Post-transplant|Converted to rapamycin|0
6816496|NCT00064701|10821036|FG002|One Year Post-transplant|Converted to rapamycin|0
6816497|NCT00064701|10821034|FG000|One Year Post-transplant|Acute tubular necrosis|1
6816498|NCT00064701|10821035|FG001|One Year Post-transplant|Acute tubular necrosis|0
6816499|NCT00064701|10821036|FG002|One Year Post-transplant|Acute tubular necrosis|0
6816500|NCT00064701|10821034|FG000|One Year Post-transplant|Incorrect study drug dispensed|0
6816501|NCT00064701|10821035|FG001|One Year Post-transplant|Incorrect study drug dispensed|1
6816502|NCT00064701|10821036|FG002|One Year Post-transplant|Incorrect study drug dispensed|0
6816503|NCT00064701|10821034|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0
6816504|NCT00064701|10821035|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1
6816505|NCT00064701|10821036|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0
6816506|NCT00064701|10821034|FG000|One Year Post-transplant|Poor absorption|0
6816507|NCT00064701|10821035|FG001|One Year Post-transplant|Poor absorption|1
6816508|NCT00064701|10821036|FG002|One Year Post-transplant|Poor absorption|0
6816509|NCT00064701|10821034|FG000|One Year Post-transplant|Pancreas transplant|0
6816510|NCT00064701|10821035|FG001|One Year Post-transplant|Pancreas transplant|0
6816511|NCT00064701|10821036|FG002|One Year Post-transplant|Pancreas transplant|1
6816512|NCT00064701|10821034|FG000|Clinical Continuation Phase|Adverse Event|12
6816513|NCT00064701|10821035|FG001|Clinical Continuation Phase|Adverse Event|21
6816514|NCT00064701|10821036|FG002|Clinical Continuation Phase|Adverse Event|14
6816515|NCT00064701|10821034|FG000|Clinical Continuation Phase|Non-compliance|8
6816516|NCT00064701|10821035|FG001|Clinical Continuation Phase|Non-compliance|6
6816517|NCT00064701|10821036|FG002|Clinical Continuation Phase|Non-compliance|7
6816518|NCT00064701|10821034|FG000|Clinical Continuation Phase|Withdrawal by Subject|22
6816519|NCT00064701|10821035|FG001|Clinical Continuation Phase|Withdrawal by Subject|3
6816520|NCT00064701|10821036|FG002|Clinical Continuation Phase|Withdrawal by Subject|22
6816521|NCT00064701|10821034|FG000|Clinical Continuation Phase|Lost to Follow-up|6
6816522|NCT00064701|10821035|FG001|Clinical Continuation Phase|Lost to Follow-up|3
6816523|NCT00064701|10821036|FG002|Clinical Continuation Phase|Lost to Follow-up|6
6816524|NCT00064701|10821034|FG000|Clinical Continuation Phase|Graft Failure|5
6816525|NCT00064701|10821035|FG001|Clinical Continuation Phase|Graft Failure|5
6816526|NCT00064701|10821036|FG002|Clinical Continuation Phase|Graft Failure|2
6816527|NCT00064701|10821034|FG000|Clinical Continuation Phase|Rejection|1
6816528|NCT00064701|10821035|FG001|Clinical Continuation Phase|Rejection|2
6816529|NCT00064701|10821036|FG002|Clinical Continuation Phase|Rejection|2
6816530|NCT00064701|10821034|FG000|Clinical Continuation Phase|Sponsor discontinued study|113
6816531|NCT00064701|10821035|FG001|Clinical Continuation Phase|Sponsor discontinued study|129
6816532|NCT00064701|10821036|FG002|Clinical Continuation Phase|Sponsor discontinued study|79
6816533|NCT00064701|10821034|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0
6816534|NCT00064701|10821035|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3
6816535|NCT00064701|10821036|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6
6816536|NCT00064701|10821034|FG000|Clinical Continuation Phase|Physician Decision|1
6816537|NCT00064701|10821035|FG001|Clinical Continuation Phase|Physician Decision|3
6816538|NCT00064701|10821036|FG002|Clinical Continuation Phase|Physician Decision|0
6816539|NCT00064701|10821034|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1
7140648|NCT02974842|11294993|FG000|Overall Study|Screen failures|4
7140649|NCT02974855|11295001|FG000|Overall Study|Adverse Event|0
7140650|NCT02974855|11295002|FG001|Overall Study|Adverse Event|1
7140651|NCT02974855|11295003|FG002|Overall Study|Adverse Event|0
7140652|NCT02974855|11295004|FG003|Overall Study|Adverse Event|1
7140653|NCT02974868|11295021|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1
7140654|NCT02974868|11295022|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1
7140655|NCT02974868|11295023|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2
7140656|NCT02974868|11295024|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4
7140657|NCT02974868|11295021|FG000|Initial 24-Week Treatment Period (TP)|others|3
7140658|NCT02974868|11295022|FG001|Initial 24-Week Treatment Period (TP)|others|8
7140659|NCT02974868|11295023|FG002|Initial 24-Week Treatment Period (TP)|others|1
7140660|NCT02974868|11295024|FG003|Initial 24-Week Treatment Period (TP)|others|8
7140661|NCT02974868|11295021|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2
7140662|NCT02974868|11295022|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1
7140663|NCT02974868|11295023|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11
7140664|NCT02974868|11295024|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6
7140665|NCT02974868|11295021|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2
7140666|NCT02974868|11295022|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1
7140667|NCT02974868|11295023|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3
7140668|NCT02974868|11295024|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0
7140669|NCT02975206|11295068|FG000|Overall Study|Withdrawal by Subject|14
7140670|NCT02975206|11295069|FG001|Overall Study|Withdrawal by Subject|11
7140671|NCT02975206|11295070|FG002|Overall Study|Withdrawal by Subject|11
7140672|NCT02975206|11295068|FG000|Overall Study|Other (e.g., lost to follow up)|13
7140673|NCT02975206|11295069|FG001|Overall Study|Other (e.g., lost to follow up)|6
7140674|NCT02975206|11295070|FG002|Overall Study|Other (e.g., lost to follow up)|6
7140675|NCT02975336|11295091|FG000|DBPC (52 Weeks)|Adverse Event|16
7140676|NCT02975336|11295092|FG001|DBPC (52 Weeks)|Adverse Event|17
7140677|NCT02975336|11295093|FG002|DBPC (52 Weeks)|Adverse Event|13
7140678|NCT02975336|11295094|FG003|DBPC (52 Weeks)|Adverse Event|18
7140679|NCT02975336|11295095|FG004|DBPC (52 Weeks)|Adverse Event|0
7140680|NCT02975336|11295096|FG005|DBPC (52 Weeks)|Adverse Event|0
7140681|NCT02975336|11295097|FG006|DBPC (52 Weeks)|Adverse Event|0
7140682|NCT02975336|11295098|FG007|DBPC (52 Weeks)|Adverse Event|0
7140683|NCT02975336|11295091|FG000|DBPC (52 Weeks)|Lost to Follow-up|2
7140684|NCT02975336|11295092|FG001|DBPC (52 Weeks)|Lost to Follow-up|1
7140685|NCT02975336|11295093|FG002|DBPC (52 Weeks)|Lost to Follow-up|2
7140686|NCT02975336|11295094|FG003|DBPC (52 Weeks)|Lost to Follow-up|4
7140687|NCT02975336|11295095|FG004|DBPC (52 Weeks)|Lost to Follow-up|0
7140688|NCT02975336|11295096|FG005|DBPC (52 Weeks)|Lost to Follow-up|0
7140689|NCT02975336|11295097|FG006|DBPC (52 Weeks)|Lost to Follow-up|0
7140690|NCT02975336|11295098|FG007|DBPC (52 Weeks)|Lost to Follow-up|0
7140691|NCT02975336|11295091|FG000|DBPC (52 Weeks)|Protocol Violation|4
7140692|NCT02975336|11295092|FG001|DBPC (52 Weeks)|Protocol Violation|1
7140693|NCT02975336|11295093|FG002|DBPC (52 Weeks)|Protocol Violation|3
7140694|NCT02975336|11295094|FG003|DBPC (52 Weeks)|Protocol Violation|1
7140695|NCT02975336|11295095|FG004|DBPC (52 Weeks)|Protocol Violation|0
7140696|NCT02975336|11295096|FG005|DBPC (52 Weeks)|Protocol Violation|0
7140697|NCT02975336|11295097|FG006|DBPC (52 Weeks)|Protocol Violation|0
7140698|NCT02975336|11295098|FG007|DBPC (52 Weeks)|Protocol Violation|0
7140699|NCT02975336|11295091|FG000|DBPC (52 Weeks)|Lack of Efficacy|4
7140700|NCT02975336|11295092|FG001|DBPC (52 Weeks)|Lack of Efficacy|4
7140701|NCT02975336|11295093|FG002|DBPC (52 Weeks)|Lack of Efficacy|2
7140702|NCT02975336|11295094|FG003|DBPC (52 Weeks)|Lack of Efficacy|3
7140703|NCT02975336|11295095|FG004|DBPC (52 Weeks)|Lack of Efficacy|0
7140704|NCT02975336|11295096|FG005|DBPC (52 Weeks)|Lack of Efficacy|0
7140705|NCT02975336|11295097|FG006|DBPC (52 Weeks)|Lack of Efficacy|0
7140706|NCT02975336|11295098|FG007|DBPC (52 Weeks)|Lack of Efficacy|0
7140707|NCT02975336|11295091|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1
7140708|NCT02975336|11295092|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0
7140709|NCT02975336|11295093|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1
7140710|NCT02975336|11295094|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3
7140711|NCT02975336|11295095|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0
7140712|NCT02975336|11295096|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0
7140713|NCT02975336|11295097|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0
7140714|NCT02975336|11295098|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0
7140715|NCT02975336|11295091|FG000|DBPC (52 Weeks)|Premature termination of the study|5
7140716|NCT02975336|11295092|FG001|DBPC (52 Weeks)|Premature termination of the study|6
7140717|NCT02975336|11295093|FG002|DBPC (52 Weeks)|Premature termination of the study|6
7140718|NCT02975336|11295094|FG003|DBPC (52 Weeks)|Premature termination of the study|4
7140719|NCT02975336|11295095|FG004|DBPC (52 Weeks)|Premature termination of the study|0
7140720|NCT02975336|11295096|FG005|DBPC (52 Weeks)|Premature termination of the study|0
7140721|NCT02975336|11295097|FG006|DBPC (52 Weeks)|Premature termination of the study|0
7140722|NCT02975336|11295098|FG007|DBPC (52 Weeks)|Premature termination of the study|0
7140723|NCT02975336|11295091|FG000|LTE (104 Weeks)|Adverse Event|0
7140724|NCT02975336|11295092|FG001|LTE (104 Weeks)|Adverse Event|0
7140725|NCT02975336|11295093|FG002|LTE (104 Weeks)|Adverse Event|0
7140726|NCT02975336|11295094|FG003|LTE (104 Weeks)|Adverse Event|0
7140727|NCT02975336|11295095|FG004|LTE (104 Weeks)|Adverse Event|7
7140728|NCT02975336|11295096|FG005|LTE (104 Weeks)|Adverse Event|4
7140729|NCT02975336|11295097|FG006|LTE (104 Weeks)|Adverse Event|2
7140730|NCT02975336|11295098|FG007|LTE (104 Weeks)|Adverse Event|0
7140731|NCT02975336|11295091|FG000|LTE (104 Weeks)|Lost to Follow-up|0
7140732|NCT02975336|11295092|FG001|LTE (104 Weeks)|Lost to Follow-up|0
7140733|NCT02975336|11295093|FG002|LTE (104 Weeks)|Lost to Follow-up|0
7140734|NCT02975336|11295094|FG003|LTE (104 Weeks)|Lost to Follow-up|0
7140735|NCT02975336|11295095|FG004|LTE (104 Weeks)|Lost to Follow-up|0
7140736|NCT02975336|11295096|FG005|LTE (104 Weeks)|Lost to Follow-up|1
7140737|NCT02975336|11295097|FG006|LTE (104 Weeks)|Lost to Follow-up|0
7140738|NCT02975336|11295098|FG007|LTE (104 Weeks)|Lost to Follow-up|0
7140739|NCT02975336|11295091|FG000|LTE (104 Weeks)|Lack of Efficacy|0
7140740|NCT02975336|11295092|FG001|LTE (104 Weeks)|Lack of Efficacy|0
7140741|NCT02975336|11295093|FG002|LTE (104 Weeks)|Lack of Efficacy|0
7140742|NCT02975336|11295094|FG003|LTE (104 Weeks)|Lack of Efficacy|0
7140743|NCT02975336|11295095|FG004|LTE (104 Weeks)|Lack of Efficacy|0
7140744|NCT02975336|11295096|FG005|LTE (104 Weeks)|Lack of Efficacy|1
7140745|NCT02975336|11295097|FG006|LTE (104 Weeks)|Lack of Efficacy|2
7140746|NCT02975336|11295098|FG007|LTE (104 Weeks)|Lack of Efficacy|0
7140747|NCT02975336|11295091|FG000|LTE (104 Weeks)|Other|0
7140748|NCT02975336|11295092|FG001|LTE (104 Weeks)|Other|0
7140749|NCT02975336|11295093|FG002|LTE (104 Weeks)|Other|0
7140750|NCT02975336|11295094|FG003|LTE (104 Weeks)|Other|0
7140751|NCT02975336|11295095|FG004|LTE (104 Weeks)|Other|55
7140752|NCT02975336|11295096|FG005|LTE (104 Weeks)|Other|63
7140753|NCT02975336|11295097|FG006|LTE (104 Weeks)|Other|76
7140754|NCT02975336|11295098|FG007|LTE (104 Weeks)|Other|72
7140755|NCT02975349|11295117|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0
7140756|NCT02975349|11295118|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0
7140757|NCT02975349|11295119|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3
7140758|NCT02975349|11295120|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3
7140759|NCT02975349|11295121|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0
7140760|NCT02975349|11295122|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0
7140761|NCT02975349|11295117|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1
7140762|NCT02975349|11295118|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
7140763|NCT02975349|11295119|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
7140764|NCT02975349|11295120|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
7140765|NCT02975349|11295121|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
7140766|NCT02975349|11295122|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
7140767|NCT02975349|11295117|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4
7140768|NCT02975349|11295118|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0
7140769|NCT02975349|11295119|FG002|Active Treatment Period (24 Weeks)|Adverse Event|1
7140770|NCT02975349|11295120|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2
7140771|NCT02975349|11295121|FG004|Active Treatment Period (24 Weeks)|Adverse Event|6
7140772|NCT02975349|11295122|FG005|Active Treatment Period (24 Weeks)|Adverse Event|2
7140773|NCT02975349|11295117|FG000|Active Treatment Period (24 Weeks)|Un-specified|0
7140774|NCT02975349|11295118|FG001|Active Treatment Period (24 Weeks)|Un-specified|0
7140775|NCT02975349|11295119|FG002|Active Treatment Period (24 Weeks)|Un-specified|1
7140776|NCT02975349|11295120|FG003|Active Treatment Period (24 Weeks)|Un-specified|0
7140777|NCT02975349|11295121|FG004|Active Treatment Period (24 Weeks)|Un-specified|0
7140778|NCT02975349|11295122|FG005|Active Treatment Period (24 Weeks)|Un-specified|0
7140779|NCT02975349|11295117|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0
7140780|NCT02975349|11295118|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1
7140781|NCT02975349|11295119|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|1
7140782|NCT02975349|11295120|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|2
7140783|NCT02975349|11295121|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|1
7140784|NCT02975349|11295122|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|0
7140785|NCT02975349|11295117|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0
7140786|NCT02975349|11295118|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5
7140787|NCT02975349|11295119|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2
7140788|NCT02975349|11295120|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1
7140789|NCT02975349|11295121|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1
7140790|NCT02975349|11295122|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0
7140791|NCT02975349|11295117|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
7140792|NCT02975349|11295118|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
7140793|NCT02975349|11295119|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1
7140794|NCT02975349|11295120|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
7140795|NCT02975349|11295121|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
7140796|NCT02975349|11295122|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
7140797|NCT02975349|11295117|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0
7140798|NCT02975349|11295118|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1
7140799|NCT02975349|11295119|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0
7140800|NCT02975349|11295120|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0
7140801|NCT02975349|11295121|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0
7140802|NCT02975349|11295122|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0
7140803|NCT02975349|11295117|FG000|Blinded Extension Period (24 Weeks)|Un-specified|0
7140804|NCT02975349|11295118|FG001|Blinded Extension Period (24 Weeks)|Un-specified|0
7140805|NCT02975349|11295119|FG002|Blinded Extension Period (24 Weeks)|Un-specified|0
7140806|NCT02975349|11295120|FG003|Blinded Extension Period (24 Weeks)|Un-specified|1
7140807|NCT02975349|11295121|FG004|Blinded Extension Period (24 Weeks)|Un-specified|0
7140808|NCT02975349|11295122|FG005|Blinded Extension Period (24 Weeks)|Un-specified|0
7140809|NCT02975973|11295167|FG000|Overall Study|Adverse Event|1
7140810|NCT02975973|11295168|FG001|Overall Study|Adverse Event|1
7140811|NCT02975973|11295169|FG002|Overall Study|Adverse Event|1
7140812|NCT02975973|11295170|FG003|Overall Study|Adverse Event|0
7140813|NCT02976103|11295182|FG000|Overall Study|Withdrawal by Subject|1
7140814|NCT02976103|11295183|FG001|Overall Study|Withdrawal by Subject|0
7140815|NCT02976103|11295182|FG000|Overall Study|Lost to Follow-up|12
7140816|NCT02976103|11295183|FG001|Overall Study|Lost to Follow-up|8
7140817|NCT02976519|11295202|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
7140818|NCT02976519|11295203|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1
7140819|NCT02976519|11295204|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
7140820|NCT02976519|11295205|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
7140821|NCT02976519|11295206|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
7140822|NCT02976519|11295207|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
7140823|NCT02976519|11295208|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
7140824|NCT02976519|11295202|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
7140825|NCT02976519|11295203|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
7140826|NCT02976519|11295204|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
7140827|NCT02976519|11295205|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1
7140828|NCT02976519|11295206|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
7140829|NCT02976519|11295207|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
7140830|NCT02976519|11295208|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
7140831|NCT02976519|11295202|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0
7140832|NCT02976519|11295203|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0
7140833|NCT02976519|11295204|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0
7140834|NCT02976519|11295205|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0
7140835|NCT02976519|11295206|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0
7140836|NCT02976519|11295207|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0
7140837|NCT02976519|11295208|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1
7140838|NCT02976519|11295202|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
7140839|NCT02976519|11295203|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
7140840|NCT02976519|11295204|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
7140841|NCT02976519|11295205|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
7140842|NCT02976519|11295206|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
7140843|NCT02976519|11295207|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
7140844|NCT02976519|11295208|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1
7140845|NCT02976519|11295202|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0
7140846|NCT02976519|11295203|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0
7140847|NCT02976519|11295204|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0
7140848|NCT02976519|11295205|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0
7140849|NCT02976519|11295206|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0
7140850|NCT02976519|11295207|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0
7140851|NCT02976519|11295208|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1
7140852|NCT02977507|11295228|FG000|Overall Study|Protocol Deviation|1
7140853|NCT02977507|11295229|FG001|Overall Study|Protocol Deviation|0
7140854|NCT02977507|11295228|FG000|Overall Study|Lost to Follow-up|1
7140855|NCT02977507|11295229|FG001|Overall Study|Lost to Follow-up|0
7140856|NCT02977572|11295238|FG000|Overall Study|Exclusion criterion|2
7140857|NCT02977572|11295239|FG001|Overall Study|Exclusion criterion|2
7140858|NCT02978417|11295273|FG000|Overall Study|Lost to Follow-up|2
7140859|NCT02978417|11295274|FG001|Overall Study|Lost to Follow-up|2
7140860|NCT02979197|11295301|FG000|Overall Study|Adverse Event|4
7140861|NCT02979197|11295302|FG001|Overall Study|Adverse Event|2
7140862|NCT02979197|11295303|FG002|Overall Study|Adverse Event|0
7140863|NCT02979197|11295301|FG000|Overall Study|Protocol Violation|0
7140864|NCT02979197|11295302|FG001|Overall Study|Protocol Violation|1
7140865|NCT02979197|11295303|FG002|Overall Study|Protocol Violation|0
7140866|NCT02979197|11295301|FG000|Overall Study|Subject unable to commit to study dates|0
7140867|NCT02979197|11295302|FG001|Overall Study|Subject unable to commit to study dates|1
7140868|NCT02979197|11295303|FG002|Overall Study|Subject unable to commit to study dates|0
7140869|NCT02979249|11295311|FG000|Overall Study|Lost to Follow-up|2
7140870|NCT02979249|11295311|FG000|Overall Study|Withdrawal by Subject|4
7140871|NCT02979431|11295337|FG000|Overall Study|Parent/guardian withdrew consent|2
7140872|NCT02979431|11295338|FG001|Overall Study|Parent/guardian withdrew consent|1
7140873|NCT02979431|11295339|FG002|Overall Study|Parent/guardian withdrew consent|1
7140874|NCT02979431|11295340|FG003|Overall Study|Parent/guardian withdrew consent|1
7140875|NCT02979431|11295337|FG000|Overall Study|Randomized but received no study drug|1
7140876|NCT02979431|11295338|FG001|Overall Study|Randomized but received no study drug|1
7140877|NCT02979431|11295339|FG002|Overall Study|Randomized but received no study drug|0
7140878|NCT02979431|11295340|FG003|Overall Study|Randomized but received no study drug|0
7140879|NCT02979431|11295337|FG000|Overall Study|Adverse Event|0
7140880|NCT02979431|11295338|FG001|Overall Study|Adverse Event|0
7140881|NCT02979431|11295339|FG002|Overall Study|Adverse Event|1
7140882|NCT02979431|11295340|FG003|Overall Study|Adverse Event|0
7140883|NCT02979431|11295337|FG000|Overall Study|Subject left country after Day14|1
7140884|NCT02979431|11295338|FG001|Overall Study|Subject left country after Day14|0
7140885|NCT02979431|11295339|FG002|Overall Study|Subject left country after Day14|0
7140886|NCT02979431|11295340|FG003|Overall Study|Subject left country after Day14|0
7140887|NCT02979613|11295365|FG000|Double-Blind Phase|Withdrew Consent|2
7140888|NCT02979613|11295366|FG001|Double-Blind Phase|Withdrew Consent|4
7140889|NCT02979613|11295365|FG000|Double-Blind Phase|Pregnancy|2
7140890|NCT02979613|11295366|FG001|Double-Blind Phase|Pregnancy|2
7140891|NCT02979613|11295365|FG000|Double-Blind Phase|Adverse Event|2
7140892|NCT02979613|11295366|FG001|Double-Blind Phase|Adverse Event|0
7140893|NCT02979613|11295365|FG000|Double-Blind Phase|Lost to Follow-up|1
7140894|NCT02979613|11295366|FG001|Double-Blind Phase|Lost to Follow-up|1
7140895|NCT02979613|11295365|FG000|Double-Blind Phase|Protocol Violation|1
7140896|NCT02979613|11295366|FG001|Double-Blind Phase|Protocol Violation|1
7140897|NCT02979613|11295365|FG000|Double-Blind Phase|Randomized but Never Treated|2
7140898|NCT02979613|11295366|FG001|Double-Blind Phase|Randomized but Never Treated|0
7140899|NCT02979613|11295365|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2
7140900|NCT02979613|11295366|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4
7140901|NCT02979613|11295365|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1
7140902|NCT02979613|11295366|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0
7140903|NCT02979613|11295365|FG000|Open-Label Extension (OLE) Phase|Death|0
7140904|NCT02979613|11295366|FG001|Open-Label Extension (OLE) Phase|Death|1
7140905|NCT02979613|11295365|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0
7140906|NCT02979613|11295366|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1
7140907|NCT02979639|11295383|FG000|Overall Study|Withdrawal based on medical judgement|1
7140908|NCT02979639|11295383|FG000|Overall Study|Lost to Follow-up|8
7140909|NCT02979639|11295383|FG000|Overall Study|Withdrawal by Subject|3
7140910|NCT02979639|11295383|FG000|Overall Study|Adverse Event|2
7140911|NCT02980042|11295407|FG000|Overall Study|Lost to Follow-up|5
7140912|NCT02980042|11295408|FG001|Overall Study|Lost to Follow-up|0
7140913|NCT02980042|11295407|FG000|Overall Study|Insurance issues/treatment plan changes|2
7140914|NCT02980042|11295408|FG001|Overall Study|Insurance issues/treatment plan changes|0
7140915|NCT02980107|11295428|FG000|Overall Study|Withdrawal by Subject|51
7140916|NCT02980107|11295429|FG001|Overall Study|Withdrawal by Subject|62
7140917|NCT02980133|11295439|FG000|Overall Study|Other than specified|1
7140918|NCT02980133|11295440|FG001|Overall Study|Other than specified|1
7140919|NCT02980133|11295441|FG002|Overall Study|Other than specified|2
7140920|NCT02980133|11295442|FG003|Overall Study|Other than specified|2
6816540|NCT00064701|10821035|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0
6816541|NCT00064701|10821036|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1
6816542|NCT00064701|10821034|FG000|Clinical Continuation Phase|Pancreas transplant|1
6816543|NCT00064701|10821035|FG001|Clinical Continuation Phase|Pancreas transplant|0
6898148|NCT00644423|10917296|FG001|Overall Study|Lost to Follow-up|1
6898149|NCT00644787|10917315|FG000|Period 1: Titration Phase|Adverse Event|11
6898150|NCT00644787|10917316|FG001|Period 1: Titration Phase|Adverse Event|0
6898151|NCT00644787|10917317|FG002|Period 1: Titration Phase|Adverse Event|0
6898152|NCT00644787|10917315|FG000|Period 1: Titration Phase|Withdrawal by Subject|2
6898153|NCT00644787|10917316|FG001|Period 1: Titration Phase|Withdrawal by Subject|0
6898154|NCT00644787|10917317|FG002|Period 1: Titration Phase|Withdrawal by Subject|0
6898155|NCT00644787|10917315|FG000|Period 1: Titration Phase|Physician Decision|1
6898156|NCT00644787|10917316|FG001|Period 1: Titration Phase|Physician Decision|0
6898157|NCT00644787|10917317|FG002|Period 1: Titration Phase|Physician Decision|0
6898158|NCT00644787|10917315|FG000|Period 1: Titration Phase|Worsening of underlying disease|5
6898159|NCT00644787|10917316|FG001|Period 1: Titration Phase|Worsening of underlying disease|0
6898160|NCT00644787|10917317|FG002|Period 1: Titration Phase|Worsening of underlying disease|0
6898161|NCT00644787|10917315|FG000|Period 1: Titration Phase|Worsening of complications|1
6898162|NCT00644787|10917316|FG001|Period 1: Titration Phase|Worsening of complications|0
6898163|NCT00644787|10917317|FG002|Period 1: Titration Phase|Worsening of complications|0
6898164|NCT00644787|10917315|FG000|Period 1: Titration Phase|Worsening of symptoms|1
6898165|NCT00644787|10917316|FG001|Period 1: Titration Phase|Worsening of symptoms|0
6898166|NCT00644787|10917317|FG002|Period 1: Titration Phase|Worsening of symptoms|0
6898167|NCT00644787|10917315|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3
6898168|NCT00644787|10917316|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
6898169|NCT00644787|10917317|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
6898170|NCT00644787|10917315|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3
6898171|NCT00644787|10917316|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0
6898172|NCT00644787|10917317|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0
7140921|NCT02980133|11295439|FG000|Overall Study|Lost to Follow-up|0
7140922|NCT02980133|11295440|FG001|Overall Study|Lost to Follow-up|0
7140923|NCT02980133|11295441|FG002|Overall Study|Lost to Follow-up|1
7140924|NCT02980133|11295442|FG003|Overall Study|Lost to Follow-up|3
7140925|NCT02980133|11295439|FG000|Overall Study|Protocol Violation|0
7140926|NCT02980133|11295440|FG001|Overall Study|Protocol Violation|1
7140927|NCT02980133|11295441|FG002|Overall Study|Protocol Violation|0
7140928|NCT02980133|11295442|FG003|Overall Study|Protocol Violation|0
7140929|NCT02980133|11295439|FG000|Overall Study|Withdrawal by parent/guardian|6
7140930|NCT02980133|11295440|FG001|Overall Study|Withdrawal by parent/guardian|3
7140931|NCT02980133|11295441|FG002|Overall Study|Withdrawal by parent/guardian|3
7140932|NCT02980133|11295442|FG003|Overall Study|Withdrawal by parent/guardian|1
7140933|NCT02980133|11295439|FG000|Overall Study|Withdrawal by Subject|0
7140934|NCT02980133|11295440|FG001|Overall Study|Withdrawal by Subject|0
7140935|NCT02980133|11295441|FG002|Overall Study|Withdrawal by Subject|1
7140936|NCT02980133|11295442|FG003|Overall Study|Withdrawal by Subject|0
7140937|NCT02980224|11295461|FG000|Overall Study|Adverse Event|4
7140938|NCT02980224|11295462|FG001|Overall Study|Adverse Event|1
7140939|NCT02980224|11295461|FG000|Overall Study|Withdrawal by Subject|0
7140940|NCT02980224|11295462|FG001|Overall Study|Withdrawal by Subject|2
7140941|NCT02980523|11295473|FG000|Overall Study|Lost to Follow-up|1
7140942|NCT02980523|11295474|FG001|Overall Study|Lost to Follow-up|4
7140943|NCT02980523|11295475|FG002|Overall Study|Lost to Follow-up|1
7140944|NCT02980523|11295476|FG003|Overall Study|Lost to Follow-up|2
7140945|NCT02980523|11295477|FG004|Overall Study|Lost to Follow-up|1
7140946|NCT02980523|11295473|FG000|Overall Study|Excluded from analysis|1
7140947|NCT02980523|11295474|FG001|Overall Study|Excluded from analysis|3
7140948|NCT02980523|11295475|FG002|Overall Study|Excluded from analysis|1
7140949|NCT02980523|11295476|FG003|Overall Study|Excluded from analysis|1
7140950|NCT02980523|11295477|FG004|Overall Study|Excluded from analysis|1
7140951|NCT02980523|11295473|FG000|Overall Study|Lack of Efficacy|1
7140952|NCT02980523|11295474|FG001|Overall Study|Lack of Efficacy|4
7140953|NCT02980523|11295475|FG002|Overall Study|Lack of Efficacy|4
7140954|NCT02980523|11295476|FG003|Overall Study|Lack of Efficacy|5
7140955|NCT02980523|11295477|FG004|Overall Study|Lack of Efficacy|8
7140956|NCT02980523|11295473|FG000|Overall Study|Did not receive intervention|0
7140957|NCT02980523|11295474|FG001|Overall Study|Did not receive intervention|0
7140958|NCT02980523|11295475|FG002|Overall Study|Did not receive intervention|0
7140959|NCT02980523|11295476|FG003|Overall Study|Did not receive intervention|1
7140960|NCT02980523|11295477|FG004|Overall Study|Did not receive intervention|0
7140961|NCT02980601|11295494|FG000|Overall Study|Lost to Follow-up|2
7140962|NCT02980601|11295495|FG001|Overall Study|Lost to Follow-up|2
7140963|NCT02980601|11295494|FG000|Overall Study|Death|0
7140964|NCT02980601|11295495|FG001|Overall Study|Death|1
7140965|NCT02980601|11295494|FG000|Overall Study|Graft loss|1
7140966|NCT02980601|11295495|FG001|Overall Study|Graft loss|0
7140967|NCT02980601|11295494|FG000|Overall Study|Failed to sign consent|2
7140968|NCT02980601|11295495|FG001|Overall Study|Failed to sign consent|0
7140969|NCT02980692|11295506|FG000|Overall Study|Adverse Event|0
7140970|NCT02980692|11295507|FG001|Overall Study|Adverse Event|2
7140971|NCT02980692|11295508|FG002|Overall Study|Adverse Event|0
7140972|NCT02980692|11295509|FG003|Overall Study|Adverse Event|0
7140973|NCT02980692|11295510|FG004|Overall Study|Adverse Event|1
7140974|NCT02980692|11295506|FG000|Overall Study|Withdrawal by Subject|4
7140975|NCT02980692|11295507|FG001|Overall Study|Withdrawal by Subject|3
7140976|NCT02980692|11295508|FG002|Overall Study|Withdrawal by Subject|6
7140977|NCT02980692|11295509|FG003|Overall Study|Withdrawal by Subject|6
7140978|NCT02980692|11295510|FG004|Overall Study|Withdrawal by Subject|7
7140979|NCT02980692|11295506|FG000|Overall Study|Lost to Follow-up|3
7140980|NCT02980692|11295507|FG001|Overall Study|Lost to Follow-up|0
7140981|NCT02980692|11295508|FG002|Overall Study|Lost to Follow-up|4
7140982|NCT02980692|11295509|FG003|Overall Study|Lost to Follow-up|1
7140983|NCT02980692|11295510|FG004|Overall Study|Lost to Follow-up|1
7140984|NCT02980692|11295506|FG000|Overall Study|Death|1
7140985|NCT02980692|11295507|FG001|Overall Study|Death|0
7140986|NCT02980692|11295508|FG002|Overall Study|Death|0
7140987|NCT02980692|11295509|FG003|Overall Study|Death|0
7140988|NCT02980692|11295510|FG004|Overall Study|Death|0
7140989|NCT02980692|11295506|FG000|Overall Study|Physician Decision|0
7140990|NCT02980692|11295507|FG001|Overall Study|Physician Decision|0
7140991|NCT02980692|11295508|FG002|Overall Study|Physician Decision|1
7140992|NCT02980692|11295509|FG003|Overall Study|Physician Decision|1
7140993|NCT02980692|11295510|FG004|Overall Study|Physician Decision|0
7140994|NCT02980692|11295506|FG000|Overall Study|NON COMPLIANCE|1
7140995|NCT02980692|11295507|FG001|Overall Study|NON COMPLIANCE|0
7140996|NCT02980692|11295508|FG002|Overall Study|NON COMPLIANCE|0
7140997|NCT02980692|11295509|FG003|Overall Study|NON COMPLIANCE|0
7140998|NCT02980692|11295510|FG004|Overall Study|NON COMPLIANCE|0
7140999|NCT02980692|11295506|FG000|Overall Study|DOES NOT WANT TO RETURN FOR FOLLOW UP VISITS|0
7141000|NCT02980692|11295507|FG001|Overall Study|DOES NOT WANT TO RETURN FOR FOLLOW UP VISITS|1
7141001|NCT02980692|11295508|FG002|Overall Study|DOES NOT WANT TO RETURN FOR FOLLOW UP VISITS|0
7141002|NCT02980692|11295509|FG003|Overall Study|DOES NOT WANT TO RETURN FOR FOLLOW UP VISITS|0
6973457|NCT01181128|11025237|FG001|Overall Study|Physician Decision|0
7141003|NCT02980692|11295510|FG004|Overall Study|DOES NOT WANT TO RETURN FOR FOLLOW UP VISITS|0
7141004|NCT02980692|11295506|FG000|Overall Study|LACK OF EFFICACY OF THE STUDY TREATMENT|0
7141005|NCT02980692|11295507|FG001|Overall Study|LACK OF EFFICACY OF THE STUDY TREATMENT|0
7141006|NCT02980692|11295508|FG002|Overall Study|LACK OF EFFICACY OF THE STUDY TREATMENT|1
7141007|NCT02980692|11295509|FG003|Overall Study|LACK OF EFFICACY OF THE STUDY TREATMENT|0
7141008|NCT02980692|11295510|FG004|Overall Study|LACK OF EFFICACY OF THE STUDY TREATMENT|0
7141009|NCT02980692|11295506|FG000|Overall Study|Lack of Efficacy|0
7141010|NCT02980692|11295507|FG001|Overall Study|Lack of Efficacy|0
7141011|NCT02980692|11295508|FG002|Overall Study|Lack of Efficacy|0
7141012|NCT02980692|11295509|FG003|Overall Study|Lack of Efficacy|1
7141013|NCT02980692|11295510|FG004|Overall Study|Lack of Efficacy|0
7141014|NCT02980692|11295506|FG000|Overall Study|RELOCATION|0
7141015|NCT02980692|11295507|FG001|Overall Study|RELOCATION|0
7141016|NCT02980692|11295508|FG002|Overall Study|RELOCATION|0
7141017|NCT02980692|11295509|FG003|Overall Study|RELOCATION|0
7141018|NCT02980692|11295510|FG004|Overall Study|RELOCATION|1
7141019|NCT02980692|11295506|FG000|Overall Study|SUBJECT ENROLLED IN STUDY WITH POSITIVE QUANT & DISCHARGED FROM STUDY BY SPONSOR|0
7141020|NCT02980692|11295507|FG001|Overall Study|SUBJECT ENROLLED IN STUDY WITH POSITIVE QUANT & DISCHARGED FROM STUDY BY SPONSOR|0
7141021|NCT02980692|11295508|FG002|Overall Study|SUBJECT ENROLLED IN STUDY WITH POSITIVE QUANT & DISCHARGED FROM STUDY BY SPONSOR|0
7141022|NCT02980692|11295509|FG003|Overall Study|SUBJECT ENROLLED IN STUDY WITH POSITIVE QUANT & DISCHARGED FROM STUDY BY SPONSOR|0
7141023|NCT02980692|11295510|FG004|Overall Study|SUBJECT ENROLLED IN STUDY WITH POSITIVE QUANT & DISCHARGED FROM STUDY BY SPONSOR|1
7141024|NCT02980705|11295525|FG000|Overall Study|Adverse Event|0
7141025|NCT02980705|11295526|FG001|Overall Study|Adverse Event|1
7141026|NCT02980705|11295525|FG000|Overall Study|Withdrawal by Subject|6
7141027|NCT02980705|11295526|FG001|Overall Study|Withdrawal by Subject|9
7141028|NCT02980705|11295525|FG000|Overall Study|withdrew participation|0
7141029|NCT02980705|11295526|FG001|Overall Study|withdrew participation|1
7141030|NCT02980705|11295525|FG000|Overall Study|Lost to Follow-up|2
7141031|NCT02980705|11295526|FG001|Overall Study|Lost to Follow-up|0
7141032|NCT02980783|11295533|FG000|Overall Study|Lost to Follow-up|1
7141033|NCT02980874|11295539|FG000|Overall Study|Adverse Event|2
7141034|NCT02980874|11295540|FG001|Overall Study|Adverse Event|7
7141035|NCT02980874|11295539|FG000|Overall Study|Withdrawal by Subject|7
7141036|NCT02980874|11295540|FG001|Overall Study|Withdrawal by Subject|2
7141037|NCT02980874|11295539|FG000|Overall Study|Lost to Follow-up|5
7141038|NCT02980874|11295540|FG001|Overall Study|Lost to Follow-up|5
7141039|NCT02980874|11295539|FG000|Overall Study|Includes premature discontinuation due to study termination.|88
7141040|NCT02980874|11295540|FG001|Overall Study|Includes premature discontinuation due to study termination.|88
7141041|NCT02980874|11295539|FG000|Overall Study|Unknown study completion status|1
7141042|NCT02980874|11295540|FG001|Overall Study|Unknown study completion status|0
7141043|NCT02981342|11295559|FG000|Overall Study|Adverse Event|0
7141044|NCT02981342|11295560|FG001|Overall Study|Adverse Event|0
7141045|NCT02981342|11295561|FG002|Overall Study|Adverse Event|0
7141046|NCT02981342|11295562|FG003|Overall Study|Adverse Event|1
7141047|NCT02981342|11295559|FG000|Overall Study|Death|0
7141048|NCT02981342|11295560|FG001|Overall Study|Death|9
7141049|NCT02981342|11295561|FG002|Overall Study|Death|9
7141050|NCT02981342|11295562|FG003|Overall Study|Death|4
7141051|NCT02981342|11295559|FG000|Overall Study|Withdrawal by Subject|0
7141052|NCT02981342|11295560|FG001|Overall Study|Withdrawal by Subject|0
7141053|NCT02981342|11295561|FG002|Overall Study|Withdrawal by Subject|3
7141054|NCT02981342|11295562|FG003|Overall Study|Withdrawal by Subject|1
7141055|NCT02981342|11295559|FG000|Overall Study|Study closed by sponsor|0
7141056|NCT02981342|11295560|FG001|Overall Study|Study closed by sponsor|0
7141057|NCT02981342|11295561|FG002|Overall Study|Study closed by sponsor|1
7141058|NCT02981342|11295562|FG003|Overall Study|Study closed by sponsor|1
7141059|NCT02981342|11295559|FG000|Overall Study|Randomized, Never Treated|0
7141060|NCT02981342|11295560|FG001|Overall Study|Randomized, Never Treated|1
7141061|NCT02981342|11295561|FG002|Overall Study|Randomized, Never Treated|0
7141062|NCT02981342|11295562|FG003|Overall Study|Randomized, Never Treated|7
7141063|NCT02981342|11295559|FG000|Overall Study|Lost to Follow-up|0
7141064|NCT02981342|11295560|FG001|Overall Study|Lost to Follow-up|1
7141065|NCT02981342|11295561|FG002|Overall Study|Lost to Follow-up|0
7141066|NCT02981342|11295562|FG003|Overall Study|Lost to Follow-up|0
7141067|NCT02981524|11295610|FG000|Overall Study|Progressive Disease|14
7141068|NCT02981524|11295610|FG000|Overall Study|Death (unrelated)|1
7141069|NCT02981524|11295610|FG000|Overall Study|Treatment Related Toxicity|1
7141070|NCT02981524|11295610|FG000|Overall Study|Withdrawal by Subject|1
7141071|NCT02981602|11295619|FG000|Overall Study|Adverse Event|0
7141072|NCT02981602|11295620|FG001|Overall Study|Adverse Event|0
7141073|NCT02981602|11295621|FG002|Overall Study|Adverse Event|0
7141074|NCT02981602|11295622|FG003|Overall Study|Adverse Event|1
7141075|NCT02981602|11295623|FG004|Overall Study|Adverse Event|0
7141076|NCT02981953|11295636|FG000|Overall Study|Death|9
7141077|NCT02981953|11295636|FG000|Overall Study|Withdrawal by Subject|1
6816544|NCT00064701|10821036|FG002|Clinical Continuation Phase|Pancreas transplant|0
6816545|NCT00064701|10821034|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
7141078|NCT02981953|11295636|FG000|Overall Study|Withdrawal to non-compliance|1
7141079|NCT02982018|11295642|FG000|Overall Study|Incorrect Lens Dispensed|1
7141080|NCT02982018|11295643|FG001|Overall Study|Incorrect Lens Dispensed|0
7141081|NCT02982018|11295642|FG000|Overall Study|Protocol Violation|1
7141082|NCT02982018|11295643|FG001|Overall Study|Protocol Violation|1
7141083|NCT02982018|11295642|FG000|Overall Study|Adverse Event|1
7141084|NCT02982018|11295643|FG001|Overall Study|Adverse Event|1
7141085|NCT02982018|11295642|FG000|Overall Study|Lens Discomfort|2
7141086|NCT02982018|11295643|FG001|Overall Study|Lens Discomfort|0
7141087|NCT02982018|11295642|FG000|Overall Study|Withdrawal by Subject|0
7141088|NCT02982018|11295643|FG001|Overall Study|Withdrawal by Subject|1
7141089|NCT02982187|11295651|FG000|Overall Study|Withdrawal by Subject|0
7141090|NCT02982187|11295652|FG001|Overall Study|Withdrawal by Subject|0
7141091|NCT02982187|11295653|FG002|Overall Study|Withdrawal by Subject|0
7141092|NCT02982187|11295654|FG003|Overall Study|Withdrawal by Subject|0
7141093|NCT02982187|11295655|FG004|Overall Study|Withdrawal by Subject|0
7141094|NCT02982187|11295656|FG005|Overall Study|Withdrawal by Subject|0
7141095|NCT02982187|11295657|FG006|Overall Study|Withdrawal by Subject|1
7141096|NCT02982187|11295658|FG007|Overall Study|Withdrawal by Subject|0
7141097|NCT02982213|11295670|FG000|Overall Study|Did not complete follow up questionnaire|5
7141098|NCT02982213|11295671|FG001|Overall Study|Did not complete follow up questionnaire|1
7141099|NCT02982239|11295679|FG000|Overall Study|Lost to Follow-up|3
7141100|NCT02982239|11295680|FG001|Overall Study|Lost to Follow-up|2
7141101|NCT02982590|11295689|FG000|Overall Study|Lost to Follow-up|0
7141102|NCT02982590|11295690|FG001|Overall Study|Lost to Follow-up|1
7141103|NCT02982590|11295689|FG000|Overall Study|Death|4
7141104|NCT02982590|11295690|FG001|Overall Study|Death|0
7141105|NCT02982772|11295698|FG000|Intervention|Lost to Follow-up|19
7141106|NCT02982772|11295699|FG001|Intervention|Lost to Follow-up|13
7141107|NCT02982772|11295698|FG000|1M Follow-Up|Lost to Follow-up|21
7141108|NCT02982772|11295699|FG001|1M Follow-Up|Lost to Follow-up|18
7141109|NCT02982772|11295698|FG000|3M Follow-Up|Lost to Follow-up|17
6816546|NCT00064701|10821035|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1
6816547|NCT00064701|10821036|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
6816548|NCT00064701|10821034|FG000|Clinical Continuation Phase|Discharged to nursing home|0
6816549|NCT00064701|10821035|FG001|Clinical Continuation Phase|Discharged to nursing home|1
6816550|NCT00064701|10821036|FG002|Clinical Continuation Phase|Discharged to nursing home|0
6816551|NCT00064701|10821034|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0
6816552|NCT00064701|10821035|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1
6816553|NCT00064701|10821036|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0
6816554|NCT00064701|10821034|FG000|Clinical Continuation Phase|Patient opted out|0
6816555|NCT00064701|10821035|FG001|Clinical Continuation Phase|Patient opted out|0
6816556|NCT00064701|10821036|FG002|Clinical Continuation Phase|Patient opted out|1
6816557|NCT00064753|10821046|FG000|Overall Study|Death|251
6816558|NCT00064753|10821047|FG001|Overall Study|Death|242
6898173|NCT00644787|10917315|FG000|Period 2: Double Blind Phase|Adverse Event|0
6898174|NCT00644787|10917316|FG001|Period 2: Double Blind Phase|Adverse Event|2
6898175|NCT00644787|10917317|FG002|Period 2: Double Blind Phase|Adverse Event|4
6898176|NCT00644787|10917315|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0
6898177|NCT00644787|10917316|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1
6898178|NCT00644787|10917317|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0
6898179|NCT00644787|10917315|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0
6898180|NCT00644787|10917316|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6
6898181|NCT00644787|10917317|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2
6898182|NCT00644787|10917315|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0
6898183|NCT00644787|10917316|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0
6898184|NCT00644787|10917317|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1
6898185|NCT00644878|10917325|FG000|Overall Study|Adverse Event|2
6898186|NCT00644878|10917325|FG000|Overall Study|Abnormal laboratory value|3
6898187|NCT00644878|10917325|FG000|Overall Study|Protocol deviation|2
6898188|NCT00644878|10917325|FG000|Overall Study|Treatment duration completed as per protocol|11
6898189|NCT00644917|10917329|FG000|Overall Study|Withdrawal by Subject|2
6898190|NCT00644969|10917339|FG000|Treatment Phase|Randomized, not treated|1
6898191|NCT00644969|10917340|FG001|Treatment Phase|Randomized, not treated|0
6898192|NCT00644969|10917339|FG000|Treatment Phase|Adverse Event|3
6898193|NCT00644969|10917340|FG001|Treatment Phase|Adverse Event|0
6898194|NCT00644969|10917339|FG000|Treatment Phase|Withdrawal by Subject|4
6898195|NCT00644969|10917340|FG001|Treatment Phase|Withdrawal by Subject|0
6898196|NCT00644969|10917339|FG000|Treatment Phase|Lost to Follow-up|2
6898197|NCT00644969|10917340|FG001|Treatment Phase|Lost to Follow-up|2
6898198|NCT00644969|10917339|FG000|Treatment Phase|Other|4
6898199|NCT00644969|10917340|FG001|Treatment Phase|Other|1
6898200|NCT00644969|10917339|FG000|Post Treatment Phase|Death|1
6898201|NCT00644969|10917340|FG001|Post Treatment Phase|Death|0
6898202|NCT00644969|10917339|FG000|Post Treatment Phase|Withdrawal by Subject|4
6898203|NCT00644969|10917340|FG001|Post Treatment Phase|Withdrawal by Subject|2
6898204|NCT00644969|10917339|FG000|Post Treatment Phase|Lost to Follow-up|4
6898205|NCT00644969|10917340|FG001|Post Treatment Phase|Lost to Follow-up|1
6898206|NCT00644969|10917339|FG000|Post Treatment Phase|Other|1
6898207|NCT00644969|10917340|FG001|Post Treatment Phase|Other|0
6898208|NCT00644995|10917348|FG000|Overall Study|Lost to Follow-up|1
6898209|NCT00644995|10917349|FG001|Overall Study|Lost to Follow-up|4
6898210|NCT00644995|10917348|FG000|Overall Study|Refused|1
6898211|NCT00644995|10917349|FG001|Overall Study|Refused|0
6898212|NCT00645099|10917368|FG000|Overall Study|Lack of Efficacy|15
6898213|NCT00645099|10917369|FG001|Overall Study|Lack of Efficacy|6
7141110|NCT02982772|11295699|FG001|3M Follow-Up|Lost to Follow-up|11
7141111|NCT02982772|11295698|FG000|6M Follow-Up|Lost to Follow-up|11
7141112|NCT02982772|11295699|FG001|6M Follow-Up|Lost to Follow-up|9
6816559|NCT00064753|10821046|FG000|Overall Study|Withdrawal by Subject|198
6816560|NCT00064753|10821047|FG001|Overall Study|Withdrawal by Subject|171
6816561|NCT00064753|10821046|FG000|Overall Study|Lost to Follow-up|225
6816562|NCT00064753|10821047|FG001|Overall Study|Lost to Follow-up|235
6816563|NCT00064792|10821055|FG000|Overall Study|Withdrawal by Subject|2
6816564|NCT00064792|10821056|FG001|Overall Study|Withdrawal by Subject|0
6816565|NCT00064792|10821055|FG000|Overall Study|Adverse Event|3
6816566|NCT00064792|10821056|FG001|Overall Study|Adverse Event|0
6816567|NCT00064987|10821073|FG000|Overall Study|Physician Decision|3
6816568|NCT00064987|10821074|FG001|Overall Study|Physician Decision|0
6816569|NCT00065065|10821082|FG000|Overall Study|Adverse Event|3
6816570|NCT00065065|10821083|FG001|Overall Study|Adverse Event|2
6816571|NCT00065065|10821082|FG000|Overall Study|Withdrawal by Subject|1
6816572|NCT00065065|10821083|FG001|Overall Study|Withdrawal by Subject|5
6816573|NCT00065065|10821082|FG000|Overall Study|Lack of Efficacy|4
6816574|NCT00065065|10821083|FG001|Overall Study|Lack of Efficacy|11
6816575|NCT00065065|10821082|FG000|Overall Study|Other|2
6816576|NCT00065065|10821083|FG001|Overall Study|Other|2
6816577|NCT00065156|10821091|FG000|Overall Study|Adverse Event|37
6816578|NCT00065156|10821091|FG000|Overall Study|Lack of Efficacy|52
6816579|NCT00065156|10821091|FG000|Overall Study|Withdrawal by Subject|8
6816580|NCT00065156|10821091|FG000|Overall Study|Lost to Follow-up|1
6816581|NCT00065156|10821091|FG000|Overall Study|Death|11
6816582|NCT00065156|10821091|FG000|Overall Study|Study Closed by Sponsor|2
6816583|NCT00065156|10821091|FG000|Overall Study|Disease Progression|7
6816584|NCT00065156|10821091|FG000|Overall Study|Investigator Decision|2
6816585|NCT00065156|10821091|FG000|Overall Study|Non-Compliance|2
6816586|NCT00065156|10821091|FG000|Overall Study|Loss of Response|1
6816587|NCT00065156|10821091|FG000|Overall Study|Secondary Malign Disease|1
6816588|NCT00065182|10821097|FG000|Overall Study|Adverse Event|24
6816589|NCT00065182|10821098|FG001|Overall Study|Adverse Event|17
6816590|NCT00065182|10821097|FG000|Overall Study|Lost to Follow-up|0
6816591|NCT00065182|10821098|FG001|Overall Study|Lost to Follow-up|4
6816592|NCT00065182|10821097|FG000|Overall Study|Protocol Violation|3
6816593|NCT00065182|10821098|FG001|Overall Study|Protocol Violation|4
6816594|NCT00065182|10821097|FG000|Overall Study|Serious adverse events (SAE)|1
6816595|NCT00065182|10821098|FG001|Overall Study|Serious adverse events (SAE)|0
6816596|NCT00065182|10821097|FG000|Overall Study|Sponsor Decision|11
6816597|NCT00065182|10821098|FG001|Overall Study|Sponsor Decision|7
6816598|NCT00065182|10821097|FG000|Overall Study|Withdrawal by Subject|8
6816599|NCT00065182|10821098|FG001|Overall Study|Withdrawal by Subject|3
6816600|NCT00065182|10821097|FG000|Overall Study|No clinical benefit|1
6816601|NCT00065182|10821098|FG001|Overall Study|No clinical benefit|0
6816602|NCT00065182|10821097|FG000|Overall Study|Death|0
6816603|NCT00065182|10821098|FG001|Overall Study|Death|1
6816604|NCT00065182|10821097|FG000|Overall Study|Decline in Status|0
6816605|NCT00065182|10821098|FG001|Overall Study|Decline in Status|1
6816606|NCT00065260|10821106|FG000|Overall Study|Death|0
6816607|NCT00065260|10821107|FG001|Overall Study|Death|1
6816608|NCT00065429|10821120|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
6816609|NCT00065429|10821121|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
6816610|NCT00065429|10821122|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
6816611|NCT00065429|10821123|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
6816612|NCT00065429|10821124|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
6816613|NCT00065429|10821125|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1
6816614|NCT00065429|10821126|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
6816615|NCT00065429|10821120|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
6816616|NCT00065429|10821121|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
6816617|NCT00065429|10821122|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1
6816618|NCT00065429|10821123|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
6816619|NCT00065429|10821124|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
6816620|NCT00065429|10821125|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
6816621|NCT00065429|10821126|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
6816622|NCT00065429|10821120|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1
6816623|NCT00065429|10821121|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0
6816624|NCT00065429|10821122|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0
6816625|NCT00065429|10821123|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0
6816626|NCT00065429|10821124|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0
6816627|NCT00065429|10821125|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0
6816628|NCT00065429|10821126|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0
6816629|NCT00065429|10821120|FG000|Phase I - May 2001 - Oct 2002|Death|0
6816630|NCT00065429|10821121|FG001|Phase I - May 2001 - Oct 2002|Death|0
6816631|NCT00065429|10821122|FG002|Phase I - May 2001 - Oct 2002|Death|0
6816632|NCT00065429|10821123|FG003|Phase I - May 2001 - Oct 2002|Death|0
6816633|NCT00065429|10821124|FG004|Phase I - May 2001 - Oct 2002|Death|1
6816634|NCT00065429|10821125|FG005|Phase I - May 2001 - Oct 2002|Death|0
6816635|NCT00065429|10821126|FG006|Phase I - May 2001 - Oct 2002|Death|0
6816636|NCT00065429|10821120|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0
6816637|NCT00065429|10821121|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0
6816638|NCT00065429|10821122|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0
6816639|NCT00065429|10821123|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1
6816640|NCT00065429|10821124|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0
6898214|NCT00645099|10917368|FG000|Overall Study|Withdrawal by Subject|30
6898215|NCT00645099|10917369|FG001|Overall Study|Withdrawal by Subject|22
6898216|NCT00645099|10917368|FG000|Overall Study|Lost to Follow-up|6
6898217|NCT00645099|10917369|FG001|Overall Study|Lost to Follow-up|4
6898218|NCT00645099|10917368|FG000|Overall Study|Adverse Event|11
6898219|NCT00645099|10917369|FG001|Overall Study|Adverse Event|5
6898220|NCT00645099|10917368|FG000|Overall Study|Other|9
6898221|NCT00645099|10917369|FG001|Overall Study|Other|5
6898222|NCT00645164|10917375|FG000|Overall Study|Lost to Follow-up|2
6898223|NCT00645164|10917375|FG000|Overall Study|Withdrawal by Subject|4
6898224|NCT00645164|10917375|FG000|Overall Study|Protocol Violation|1
6898225|NCT00645411|10917387|FG000|Overall Study|Adverse Event|0
6898226|NCT00645411|10917388|FG001|Overall Study|Adverse Event|0
6898227|NCT00645411|10917389|FG002|Overall Study|Adverse Event|0
6898228|NCT00645411|10917390|FG003|Overall Study|Adverse Event|2
6898229|NCT00645411|10917387|FG000|Overall Study|Withdrawal by Subject|2
6898230|NCT00645411|10917388|FG001|Overall Study|Withdrawal by Subject|1
6898231|NCT00645411|10917389|FG002|Overall Study|Withdrawal by Subject|19
6898232|NCT00645411|10917390|FG003|Overall Study|Withdrawal by Subject|21
6898233|NCT00645411|10917387|FG000|Overall Study|Lost to Follow-up|10
6898234|NCT00645411|10917388|FG001|Overall Study|Lost to Follow-up|5
6898235|NCT00645411|10917389|FG002|Overall Study|Lost to Follow-up|124
6898236|NCT00645411|10917390|FG003|Overall Study|Lost to Follow-up|75
6898237|NCT00645411|10917387|FG000|Overall Study|Protocol Violation|1
6898238|NCT00645411|10917388|FG001|Overall Study|Protocol Violation|0
6898239|NCT00645411|10917389|FG002|Overall Study|Protocol Violation|1
6898240|NCT00645411|10917390|FG003|Overall Study|Protocol Violation|0
6898241|NCT00645411|10917387|FG000|Overall Study|Inappropriate enrollment|0
6898242|NCT00645411|10917388|FG001|Overall Study|Inappropriate enrollment|0
6898243|NCT00645411|10917389|FG002|Overall Study|Inappropriate enrollment|4
6898244|NCT00645411|10917390|FG003|Overall Study|Inappropriate enrollment|1
6898245|NCT00645411|10917387|FG000|Overall Study|Unable to classify|0
6898246|NCT00645411|10917388|FG001|Overall Study|Unable to classify|0
6898247|NCT00645411|10917389|FG002|Overall Study|Unable to classify|3
6898248|NCT00645411|10917390|FG003|Overall Study|Unable to classify|4
6898249|NCT00645528|10917416|FG000|Overall Study|Did not show up for Visit 2|7
6898250|NCT00645593|10917422|FG000|Overall Study|Later found to be ineligible|1
6898251|NCT00645593|10917423|FG001|Overall Study|Later found to be ineligible|0
6898252|NCT00645671|10917431|FG000|Overall Study|Protocol Violation|1
6898253|NCT00645671|10917432|FG001|Overall Study|Protocol Violation|0
6898254|NCT00645671|10917431|FG000|Overall Study|Withdrawal by Subject|0
6898255|NCT00645671|10917432|FG001|Overall Study|Withdrawal by Subject|4
6898256|NCT00645671|10917431|FG000|Overall Study|Adverse Event|0
6898257|NCT00645671|10917432|FG001|Overall Study|Adverse Event|1
6898258|NCT00645671|10917431|FG000|Overall Study|Physician Decision|0
6898259|NCT00645671|10917432|FG001|Overall Study|Physician Decision|1
6898260|NCT00645788|10917462|FG000|Overall Study|Did not receive study drug|1
6898261|NCT00645788|10917463|FG001|Overall Study|Did not receive study drug|1
6898262|NCT00645788|10917464|FG002|Overall Study|Did not receive study drug|0
6898263|NCT00645788|10917465|FG003|Overall Study|Did not receive study drug|0
6898264|NCT00645788|10917462|FG000|Overall Study|Adverse Event|4
6898265|NCT00645788|10917463|FG001|Overall Study|Adverse Event|9
6898266|NCT00645788|10917464|FG002|Overall Study|Adverse Event|5
6898267|NCT00645788|10917465|FG003|Overall Study|Adverse Event|3
6898268|NCT00645788|10917462|FG000|Overall Study|Lost to Follow-up|1
6898269|NCT00645788|10917463|FG001|Overall Study|Lost to Follow-up|0
6898270|NCT00645788|10917464|FG002|Overall Study|Lost to Follow-up|0
6898271|NCT00645788|10917465|FG003|Overall Study|Lost to Follow-up|0
6898272|NCT00645788|10917462|FG000|Overall Study|Protocol Violation|1
6898273|NCT00645788|10917463|FG001|Overall Study|Protocol Violation|0
6898274|NCT00645788|10917464|FG002|Overall Study|Protocol Violation|2
6898275|NCT00645788|10917465|FG003|Overall Study|Protocol Violation|0
6898276|NCT00645788|10917462|FG000|Overall Study|Withdrawal by Subject|0
6898277|NCT00645788|10917463|FG001|Overall Study|Withdrawal by Subject|1
6898278|NCT00645788|10917464|FG002|Overall Study|Withdrawal by Subject|0
6898279|NCT00645788|10917465|FG003|Overall Study|Withdrawal by Subject|2
6898280|NCT00645788|10917462|FG000|Overall Study|Pulmonary exacerbation|13
6898281|NCT00645788|10917463|FG001|Overall Study|Pulmonary exacerbation|16
6898282|NCT00645788|10917464|FG002|Overall Study|Pulmonary exacerbation|11
6898283|NCT00645788|10917465|FG003|Overall Study|Pulmonary exacerbation|9
6973458|NCT01181128|11025238|FG002|Overall Study|Physician Decision|0
6973459|NCT01181128|11025236|FG000|Overall Study|Adverse Event|0
6973460|NCT01181128|11025237|FG001|Overall Study|Adverse Event|2
6973461|NCT01181128|11025238|FG002|Overall Study|Adverse Event|0
6973462|NCT01181128|11025236|FG000|Overall Study|Other|1
6973463|NCT01181128|11025237|FG001|Overall Study|Other|1
6973464|NCT01181128|11025238|FG002|Overall Study|Other|1
6973465|NCT01181141|11025260|FG000|Overall Study|Adverse Event|2
6973466|NCT01181141|11025261|FG001|Overall Study|Adverse Event|1
6973467|NCT01181141|11025260|FG000|Overall Study|Lack of Efficacy|1
6973468|NCT01181141|11025261|FG001|Overall Study|Lack of Efficacy|0
6973469|NCT01181141|11025260|FG000|Overall Study|Lost to Follow-up|1
6973470|NCT01181141|11025261|FG001|Overall Study|Lost to Follow-up|1
6973471|NCT01181141|11025260|FG000|Overall Study|Physician Decision|2
6973472|NCT01181141|11025261|FG001|Overall Study|Physician Decision|0
6816641|NCT00065429|10821125|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1
6816642|NCT00065429|10821126|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2
6816643|NCT00065429|10821120|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
6816644|NCT00065429|10821121|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
6816645|NCT00065429|10821122|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
6816646|NCT00065429|10821123|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
6816647|NCT00065429|10821124|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4
6816648|NCT00065429|10821125|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
6816649|NCT00065429|10821126|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
6816650|NCT00065429|10821120|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
6816651|NCT00065429|10821121|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
6816652|NCT00065429|10821122|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
6816653|NCT00065429|10821123|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
6816654|NCT00065429|10821124|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2
6816655|NCT00065429|10821125|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
6816656|NCT00065429|10821126|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
6816657|NCT00065442|10821139|FG000|Overall Study|Lost to Follow-up|1
6816658|NCT00065442|10821140|FG001|Overall Study|Lost to Follow-up|1
6816659|NCT00065442|10821139|FG000|Overall Study|Death|121
6816660|NCT00065442|10821140|FG001|Overall Study|Death|210
6816661|NCT00065442|10821139|FG000|Overall Study|Withdrawal by Subject|3
6816662|NCT00065442|10821140|FG001|Overall Study|Withdrawal by Subject|9
6816663|NCT00065468|10821149|FG000|Overall Study|Death|172
6816664|NCT00065468|10821150|FG001|Overall Study|Death|169
6816665|NCT00065468|10821151|FG002|Overall Study|Death|171
6816666|NCT00065468|10821149|FG000|Overall Study|Withdrawal by Subject|3
6816667|NCT00065468|10821150|FG001|Overall Study|Withdrawal by Subject|4
6816668|NCT00065468|10821151|FG002|Overall Study|Withdrawal by Subject|5
6816669|NCT00065468|10821149|FG000|Overall Study|Lost to Follow-up|5
6816670|NCT00065468|10821150|FG001|Overall Study|Lost to Follow-up|3
6816671|NCT00065468|10821151|FG002|Overall Study|Lost to Follow-up|2
6816672|NCT00065468|10821149|FG000|Overall Study|Discontinuation of study by Sponsor|13
6816673|NCT00065468|10821150|FG001|Overall Study|Discontinuation of study by Sponsor|9
6816674|NCT00065468|10821151|FG002|Overall Study|Discontinuation of study by Sponsor|13
6816675|NCT00065468|10821149|FG000|Overall Study|Disease progression|0
6816676|NCT00065468|10821150|FG001|Overall Study|Disease progression|0
6816677|NCT00065468|10821151|FG002|Overall Study|Disease progression|1
6816678|NCT00065468|10821149|FG000|Overall Study|Other|14
6816679|NCT00065468|10821150|FG001|Overall Study|Other|24
6816680|NCT00065468|10821151|FG002|Overall Study|Other|18
6816681|NCT00065507|10821161|FG000|Overall Study|Death|16
6816682|NCT00065507|10821162|FG001|Overall Study|Death|17
6816683|NCT00065507|10821161|FG000|Overall Study|Adverse Event|4
6816684|NCT00065507|10821162|FG001|Overall Study|Adverse Event|3
6816685|NCT00065507|10821161|FG000|Overall Study|Lack of Efficacy|0
6816686|NCT00065507|10821162|FG001|Overall Study|Lack of Efficacy|6
6816687|NCT00065507|10821161|FG000|Overall Study|Poor/Non-compliance|3
6816688|NCT00065507|10821162|FG001|Overall Study|Poor/Non-compliance|2
6816689|NCT00065507|10821161|FG000|Overall Study|Lost to Follow-up|3
6816690|NCT00065507|10821162|FG001|Overall Study|Lost to Follow-up|0
6816691|NCT00065507|10821161|FG000|Overall Study|Subject Withdrew Consent|2
6816692|NCT00065507|10821162|FG001|Overall Study|Subject Withdrew Consent|1
6816693|NCT00065507|10821161|FG000|Overall Study|Subject No Longer Meets Study Criteria|1
6816694|NCT00065507|10821162|FG001|Overall Study|Subject No Longer Meets Study Criteria|0
6816695|NCT00066066|10821193|FG000|Overall Study|Lost to Follow-up|6
6816696|NCT00066066|10821194|FG001|Overall Study|Lost to Follow-up|4
6816697|NCT00066066|10821195|FG002|Overall Study|Lost to Follow-up|7
6816698|NCT00066066|10821196|FG003|Overall Study|Lost to Follow-up|4
6816699|NCT00066066|10821197|FG004|Overall Study|Lost to Follow-up|3
6816700|NCT00066066|10821198|FG005|Overall Study|Lost to Follow-up|5
6816701|NCT00066170|10821216|FG000|Overall Study|Adverse Event|2
6816702|NCT00066170|10821217|FG001|Overall Study|Adverse Event|4
6816703|NCT00066170|10821218|FG002|Overall Study|Adverse Event|1
6816704|NCT00066170|10821219|FG003|Overall Study|Adverse Event|7
6816705|NCT00066170|10821216|FG000|Overall Study|Serious Adverse Event|0
6816706|NCT00066170|10821217|FG001|Overall Study|Serious Adverse Event|0
6816707|NCT00066170|10821218|FG002|Overall Study|Serious Adverse Event|1
6816708|NCT00066170|10821219|FG003|Overall Study|Serious Adverse Event|1
6816709|NCT00066170|10821216|FG000|Overall Study|Lost to Follow-up|0
6816710|NCT00066170|10821217|FG001|Overall Study|Lost to Follow-up|1
6816711|NCT00066170|10821218|FG002|Overall Study|Lost to Follow-up|0
6816712|NCT00066170|10821219|FG003|Overall Study|Lost to Follow-up|0
6816713|NCT00066170|10821216|FG000|Overall Study|Non-Compliance with Trial Medicine|1
6816714|NCT00066170|10821217|FG001|Overall Study|Non-Compliance with Trial Medicine|0
6816715|NCT00066170|10821218|FG002|Overall Study|Non-Compliance with Trial Medicine|0
6816716|NCT00066170|10821219|FG003|Overall Study|Non-Compliance with Trial Medicine|1
6816717|NCT00066170|10821216|FG000|Overall Study|Protocol Violation|3
6816718|NCT00066170|10821217|FG001|Overall Study|Protocol Violation|0
6816719|NCT00066170|10821218|FG002|Overall Study|Protocol Violation|0
6816720|NCT00066170|10821219|FG003|Overall Study|Protocol Violation|0
6816721|NCT00066170|10821216|FG000|Overall Study|Other|1
6816722|NCT00066170|10821217|FG001|Overall Study|Other|5
6816723|NCT00066170|10821218|FG002|Overall Study|Other|2
6816724|NCT00066170|10821219|FG003|Overall Study|Other|0
6816725|NCT00066222|10821229|FG000|Overall Study|No protocol treatment received|1
6816726|NCT00066365|10821235|FG000|Overall Study|Adverse Event|1
6816727|NCT00066365|10821236|FG001|Overall Study|Adverse Event|0
6816728|NCT00066365|10821235|FG000|Overall Study|Lack of Efficacy|15
6816729|NCT00066365|10821236|FG001|Overall Study|Lack of Efficacy|12
6816730|NCT00066365|10821235|FG000|Overall Study|Physician Decision|1
6816731|NCT00066365|10821236|FG001|Overall Study|Physician Decision|0
6816732|NCT00066365|10821235|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2
6816733|NCT00066365|10821236|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0
6816734|NCT00066365|10821235|FG000|Overall Study|Ineligible|4
6816735|NCT00066365|10821236|FG001|Overall Study|Ineligible|2
6816736|NCT00066469|10821244|FG000|Overall Study|Death|3
6816737|NCT00066469|10821244|FG000|Overall Study|Lack of Efficacy|9
6816738|NCT00066469|10821244|FG000|Overall Study|Lost to Follow-up|1
6816739|NCT00066469|10821244|FG000|Overall Study|Physician Decision|1
6816740|NCT00066469|10821244|FG000|Overall Study|Withdrawal by Subject|1
6816741|NCT00066469|10821244|FG000|Overall Study|ineligible|1
6816742|NCT00066573|10821250|FG000|Overall Study|Did not received protocol treatment|28
6816743|NCT00066573|10821251|FG001|Overall Study|Did not received protocol treatment|28
6816744|NCT00066690|10821269|FG000|Overall Study|Adverse Event|145
6816745|NCT00066690|10821270|FG001|Overall Study|Adverse Event|58
6816746|NCT00066690|10821271|FG002|Overall Study|Adverse Event|126
6816747|NCT00066690|10821269|FG000|Overall Study|Death|3
6816748|NCT00066690|10821270|FG001|Overall Study|Death|0
6816749|NCT00066690|10821271|FG002|Overall Study|Death|2
6816750|NCT00066690|10821269|FG000|Overall Study|Lack of Efficacy|114
6816751|NCT00066690|10821270|FG001|Overall Study|Lack of Efficacy|110
6898284|NCT00645840|10917484|FG000|Overall Study|Protocol Violation|3
6898285|NCT00645853|10917490|FG000|Overall Study|Adverse Event|18
6898286|NCT00645853|10917491|FG001|Overall Study|Adverse Event|7
6898287|NCT00645853|10917490|FG000|Overall Study|AZ study closure in Hungary|60
6898288|NCT00645853|10917491|FG001|Overall Study|AZ study closure in Hungary|40
6898289|NCT00645853|10917490|FG000|Overall Study|Withdrawal by Subject|5
6898290|NCT00645853|10917491|FG001|Overall Study|Withdrawal by Subject|2
6898291|NCT00645853|10917490|FG000|Overall Study|Protocol Violation|0
6898292|NCT00645853|10917491|FG001|Overall Study|Protocol Violation|2
6898293|NCT00645853|10917490|FG000|Overall Study|Discontinuation criteria|2
6898294|NCT00645853|10917491|FG001|Overall Study|Discontinuation criteria|2
6898295|NCT00645853|10917490|FG000|Overall Study|recall of ICF, planned operation, death|7
6898296|NCT00645853|10917491|FG001|Overall Study|recall of ICF, planned operation, death|4
6898297|NCT00645944|10917499|FG000|Randomized|Withdrawal by Subject|1
6898298|NCT00645944|10917500|FG001|Randomized|Withdrawal by Subject|2
6898299|NCT00645944|10917499|FG000|Received Medication|Adverse Event|2
6898300|NCT00645944|10917500|FG001|Received Medication|Adverse Event|1
6898301|NCT00645944|10917499|FG000|Received Medication|Withdrawal by Subject|1
6898302|NCT00645944|10917500|FG001|Received Medication|Withdrawal by Subject|1
6898303|NCT00645944|10917499|FG000|Received Medication|Lost to Follow-up|1
6898304|NCT00645944|10917500|FG001|Received Medication|Lost to Follow-up|0
6898305|NCT00645944|10917499|FG000|Received Medication|Protocol Violation|2
6898306|NCT00645944|10917500|FG001|Received Medication|Protocol Violation|1
6898307|NCT00646113|10917519|FG000|Overall Study|Lost to Follow-up|5
6898308|NCT00646113|10917519|FG000|Overall Study|Adverse Event|3
6898309|NCT00646399|10917525|FG000|Overall Study|Death|63
6898310|NCT00646399|10917526|FG001|Overall Study|Death|53
6898311|NCT00646399|10917525|FG000|Overall Study|Withdrawal by Subject|9
6898312|NCT00646399|10917526|FG001|Overall Study|Withdrawal by Subject|10
6898313|NCT00646399|10917525|FG000|Overall Study|Other Reason|11
6898314|NCT00646399|10917526|FG001|Overall Study|Other Reason|11
6898315|NCT00646451|10917532|FG000|Overall Study|Adverse Event|3
6898316|NCT00646451|10917533|FG001|Overall Study|Adverse Event|0
6898317|NCT00646451|10917532|FG000|Overall Study|Exacerbation of pre-existing condition|1
6898318|NCT00646451|10917533|FG001|Overall Study|Exacerbation of pre-existing condition|0
6898319|NCT00646776|10917578|FG000|Overall Study|Adverse Event|1
6898320|NCT00646776|10917579|FG001|Overall Study|Adverse Event|9
6898321|NCT00646776|10917578|FG000|Overall Study|Investigator discretion|0
6898322|NCT00646776|10917579|FG001|Overall Study|Investigator discretion|4
6898323|NCT00646906|10917592|FG000|Crossover Period 1|Withdrawal by Subject|1
6898324|NCT00646906|10917593|FG001|Crossover Period 1|Withdrawal by Subject|0
6898325|NCT00646906|10917594|FG002|Crossover Period 1|Withdrawal by Subject|0
6898326|NCT00646906|10917595|FG003|Crossover Period 1|Withdrawal by Subject|0
6898327|NCT00646906|10917596|FG004|Crossover Period 1|Withdrawal by Subject|0
6898328|NCT00646906|10917597|FG005|Crossover Period 1|Withdrawal by Subject|1
6898329|NCT00646906|10917598|FG006|Crossover Period 1|Withdrawal by Subject|0
6898330|NCT00646906|10917592|FG000|Crossover Period 2|Withdrawal by Subject|0
6898331|NCT00646906|10917593|FG001|Crossover Period 2|Withdrawal by Subject|1
6898332|NCT00646906|10917594|FG002|Crossover Period 2|Withdrawal by Subject|2
6898333|NCT00646906|10917595|FG003|Crossover Period 2|Withdrawal by Subject|1
6898334|NCT00646906|10917596|FG004|Crossover Period 2|Withdrawal by Subject|0
6898335|NCT00646906|10917597|FG005|Crossover Period 2|Withdrawal by Subject|0
6898336|NCT00646906|10917598|FG006|Crossover Period 2|Withdrawal by Subject|0
6898337|NCT00646906|10917592|FG000|Crossover Period 2|Physician Decision|0
6898338|NCT00646906|10917593|FG001|Crossover Period 2|Physician Decision|0
6898339|NCT00646906|10917594|FG002|Crossover Period 2|Physician Decision|0
6816752|NCT00066690|10821271|FG002|Overall Study|Lack of Efficacy|76
6816753|NCT00066690|10821269|FG000|Overall Study|Lost to Follow-up|40
6816754|NCT00066690|10821270|FG001|Overall Study|Lost to Follow-up|21
6816755|NCT00066690|10821271|FG002|Overall Study|Lost to Follow-up|29
6816756|NCT00066690|10821269|FG000|Overall Study|Withdrawal by Subject|50
6816757|NCT00066690|10821270|FG001|Overall Study|Withdrawal by Subject|55
6816758|NCT00066690|10821271|FG002|Overall Study|Withdrawal by Subject|49
6816759|NCT00066690|10821269|FG000|Overall Study|Treatment Ongoing|246
6816760|NCT00066690|10821270|FG001|Overall Study|Treatment Ongoing|278
6816761|NCT00066690|10821271|FG002|Overall Study|Treatment Ongoing|282
6816762|NCT00066703|10821284|FG000|Overall Study|Adverse Event|80
6816763|NCT00066703|10821285|FG001|Overall Study|Adverse Event|111
6816764|NCT00066703|10821284|FG000|Overall Study|Death|3
6816765|NCT00066703|10821285|FG001|Overall Study|Death|0
6816766|NCT00066703|10821284|FG000|Overall Study|Lack of Efficacy|114
6816767|NCT00066703|10821285|FG001|Overall Study|Lack of Efficacy|69
6816768|NCT00066703|10821284|FG000|Overall Study|Lost to Follow-up|31
6816769|NCT00066703|10821285|FG001|Overall Study|Lost to Follow-up|28
6816770|NCT00066703|10821284|FG000|Overall Study|Withdrawal by Subject|38
6816771|NCT00066703|10821285|FG001|Overall Study|Withdrawal by Subject|63
6816772|NCT00066703|10821284|FG000|Overall Study|Treatment ongoing|346
6816773|NCT00066703|10821285|FG001|Overall Study|Treatment ongoing|311
6816774|NCT00066729|10821291|FG000|Overall Study|Lost to Follow-up|1
6816775|NCT00066729|10821291|FG000|Overall Study|Disease progression|1
6816776|NCT00066742|10821295|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1
6816777|NCT00066742|10821295|FG000|Induction Chemoradiotherapy|Adverse Event|21
6816778|NCT00066742|10821295|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2
6816779|NCT00066742|10821295|FG000|Induction Chemoradiotherapy|not protocol specified|2
6816780|NCT00066742|10821295|FG000|Induction Chemoradiotherapy|Ineligible|3
6816781|NCT00066742|10821295|FG000|Consolidation Chemotherapy|not protocol specified|1
6816782|NCT00066742|10821295|FG000|Consolidation Chemotherapy|Ineligible|2
6816783|NCT00067002|10821329|FG000|Overall Study|Early Death|1
6816784|NCT00067002|10821330|FG001|Overall Study|Early Death|2
6816785|NCT00067002|10821329|FG000|Overall Study|Delayed|1
6816786|NCT00067002|10821330|FG001|Overall Study|Delayed|1
6816787|NCT00067002|10821329|FG000|Overall Study|Graft Failure|5
6816788|NCT00067002|10821330|FG001|Overall Study|Graft Failure|6
6816789|NCT00067470|10821362|FG000|Overall Study|Withdrawal by Subject|0
6816790|NCT00067470|10821363|FG001|Overall Study|Withdrawal by Subject|1
6816791|NCT00067990|10821384|FG000|Overall Study|Death|5
6816792|NCT00067990|10821385|FG001|Overall Study|Death|7
6816793|NCT00067990|10821384|FG000|Overall Study|ESRD, Non IF/TA|1
6816794|NCT00067990|10821385|FG001|Overall Study|ESRD, Non IF/TA|3
6816795|NCT00067990|10821384|FG000|Overall Study|Withdrawal by Subject|4
6816796|NCT00067990|10821385|FG001|Overall Study|Withdrawal by Subject|12
6816797|NCT00068107|10821391|FG000|Overall Study|end-stage renal disease|6
6816798|NCT00068107|10821391|FG000|Overall Study|Death|2
6816799|NCT00068107|10821391|FG000|Overall Study|Withdrawal by Subject|1
6816800|NCT00068237|10821398|FG000|Overall Study|Ineligible|3
6816801|NCT00068237|10821398|FG000|Overall Study|No protocol treatment received|2
6816802|NCT00068250|10821405|FG000|Phase I: Dose Level 2|Protocol Violation|0
6816803|NCT00068250|10821406|FG001|Phase I: Dose Level 2|Protocol Violation|1
6816804|NCT00068250|10821407|FG002|Phase I: Dose Level 2|Protocol Violation|0
6816805|NCT00068250|10821408|FG003|Phase I: Dose Level 2|Protocol Violation|0
6816806|NCT00068380|10821446|FG000|Overall Study|Withdrawal by Subject|3
6816807|NCT00068380|10821446|FG000|Overall Study|Adverse Event|2
6816808|NCT00068393|10821450|FG000|Overall Study|Adverse Event|2
6816809|NCT00068393|10821450|FG000|Overall Study|Death|3
6816810|NCT00068393|10821450|FG000|Overall Study|Withdrawal by Subject|3
6816811|NCT00068393|10821450|FG000|Overall Study|Alternative treatment|1
6816812|NCT00068393|10821450|FG000|Overall Study|Quality of life worsening|1
6816813|NCT00068406|10821454|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1
6816814|NCT00068406|10821454|FG000|Overall Study|Ineligible-Inadequate Pathology|2
6816815|NCT00068419|10821458|FG000|Overall Study|Adverse Event|3
6816816|NCT00068419|10821458|FG000|Overall Study|Lack of Efficacy|24
6816817|NCT00068419|10821458|FG000|Overall Study|Lost to Follow-up|1
6816818|NCT00068419|10821458|FG000|Overall Study|Physician Decision|7
6816819|NCT00068419|10821458|FG000|Overall Study|Withdrawal by Subject|14
6816820|NCT00068419|10821458|FG000|Overall Study|Ineligible|11
6816821|NCT00068445|10821464|FG000|Randomization|Cancel|1
6816822|NCT00068445|10821465|FG001|Randomization|Cancel|3
6816823|NCT00068445|10821464|FG000|Randomization|Ineligible|1
6816824|NCT00068445|10821465|FG001|Randomization|Ineligible|1
6816825|NCT00068445|10821464|FG000|Treatment|Refused Further Treatment|13
6816826|NCT00068445|10821465|FG001|Treatment|Refused Further Treatment|10
6816827|NCT00068445|10821464|FG000|Treatment|Adverse Event|7
6816828|NCT00068445|10821465|FG001|Treatment|Adverse Event|1
6816829|NCT00068445|10821464|FG000|Treatment|Other (Specifics not available)|9
6816830|NCT00068445|10821465|FG001|Treatment|Other (Specifics not available)|5
6816831|NCT00068588|10821478|FG000|Overall Study|Adverse Event|0
6816832|NCT00068588|10821479|FG001|Overall Study|Adverse Event|0
6816833|NCT00068588|10821480|FG002|Overall Study|Adverse Event|2
6816834|NCT00068588|10821478|FG000|Overall Study|Withdrawal by Subject|0
6816835|NCT00068588|10821479|FG001|Overall Study|Withdrawal by Subject|0
6816836|NCT00068588|10821480|FG002|Overall Study|Withdrawal by Subject|1
6816837|NCT00068588|10821478|FG000|Overall Study|Poor KPS|0
6816838|NCT00068588|10821479|FG001|Overall Study|Poor KPS|0
6816839|NCT00068588|10821480|FG002|Overall Study|Poor KPS|1
6816840|NCT00068601|10821489|FG000|Overall Study|Ineligible|11
6816841|NCT00068601|10821490|FG001|Overall Study|Ineligible|13
6816842|NCT00068601|10821489|FG000|Overall Study|Not evaluable: withdrew consent|5
6816843|NCT00068601|10821490|FG001|Overall Study|Not evaluable: withdrew consent|4
6816844|NCT00068601|10821489|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2
6816845|NCT00068601|10821490|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4
6816846|NCT00068601|10821489|FG000|Overall Study|Death|11
6816847|NCT00068601|10821490|FG001|Overall Study|Death|3
6816848|NCT00068601|10821489|FG000|Overall Study|Lost to Follow-up|3
6816849|NCT00068601|10821490|FG001|Overall Study|Lost to Follow-up|2
6816850|NCT00068601|10821489|FG000|Overall Study|Missing primary outcome data|30
6816851|NCT00068601|10821490|FG001|Overall Study|Missing primary outcome data|34
6816852|NCT00068692|10821499|FG000|Step 1: Registration|Disese progression/relapse|5
6816853|NCT00068692|10821500|FG001|Step 1: Registration|Disese progression/relapse|0
6816854|NCT00068692|10821501|FG002|Step 1: Registration|Disese progression/relapse|0
6816855|NCT00068692|10821502|FG003|Step 1: Registration|Disese progression/relapse|0
6816856|NCT00068692|10821503|FG004|Step 1: Registration|Disese progression/relapse|0
6816857|NCT00068692|10821504|FG005|Step 1: Registration|Disese progression/relapse|0
6816858|NCT00068692|10821505|FG006|Step 1: Registration|Disese progression/relapse|0
6816859|NCT00068692|10821506|FG007|Step 1: Registration|Disese progression/relapse|0
6816860|NCT00068692|10821499|FG000|Step 1: Registration|Adverse Event|7
6816861|NCT00068692|10821500|FG001|Step 1: Registration|Adverse Event|0
6816862|NCT00068692|10821501|FG002|Step 1: Registration|Adverse Event|0
6816863|NCT00068692|10821502|FG003|Step 1: Registration|Adverse Event|0
6816864|NCT00068692|10821503|FG004|Step 1: Registration|Adverse Event|0
6816865|NCT00068692|10821504|FG005|Step 1: Registration|Adverse Event|0
6816866|NCT00068692|10821505|FG006|Step 1: Registration|Adverse Event|0
6816867|NCT00068692|10821506|FG007|Step 1: Registration|Adverse Event|0
6816868|NCT00068692|10821499|FG000|Step 1: Registration|Death|1
6816869|NCT00068692|10821500|FG001|Step 1: Registration|Death|0
6816870|NCT00068692|10821501|FG002|Step 1: Registration|Death|0
6816871|NCT00068692|10821502|FG003|Step 1: Registration|Death|0
6816872|NCT00068692|10821503|FG004|Step 1: Registration|Death|0
6816873|NCT00068692|10821504|FG005|Step 1: Registration|Death|0
6816874|NCT00068692|10821505|FG006|Step 1: Registration|Death|0
6816875|NCT00068692|10821506|FG007|Step 1: Registration|Death|0
6816876|NCT00068692|10821499|FG000|Step 1: Registration|Withdrawal by Subject|11
6816877|NCT00068692|10821500|FG001|Step 1: Registration|Withdrawal by Subject|0
6816878|NCT00068692|10821501|FG002|Step 1: Registration|Withdrawal by Subject|0
6816879|NCT00068692|10821502|FG003|Step 1: Registration|Withdrawal by Subject|0
6816880|NCT00068692|10821503|FG004|Step 1: Registration|Withdrawal by Subject|0
6816881|NCT00068692|10821504|FG005|Step 1: Registration|Withdrawal by Subject|0
6816882|NCT00068692|10821505|FG006|Step 1: Registration|Withdrawal by Subject|0
6816883|NCT00068692|10821506|FG007|Step 1: Registration|Withdrawal by Subject|0
6816884|NCT00068692|10821499|FG000|Step 1: Registration|Alternative therapy|2
6816885|NCT00068692|10821500|FG001|Step 1: Registration|Alternative therapy|0
6816886|NCT00068692|10821501|FG002|Step 1: Registration|Alternative therapy|0
6816887|NCT00068692|10821502|FG003|Step 1: Registration|Alternative therapy|0
6816888|NCT00068692|10821503|FG004|Step 1: Registration|Alternative therapy|0
6816889|NCT00068692|10821504|FG005|Step 1: Registration|Alternative therapy|0
6816890|NCT00068692|10821505|FG006|Step 1: Registration|Alternative therapy|0
6816891|NCT00068692|10821506|FG007|Step 1: Registration|Alternative therapy|0
6816892|NCT00068692|10821499|FG000|Step 1: Registration|Complicating disease|2
6816893|NCT00068692|10821500|FG001|Step 1: Registration|Complicating disease|0
6816894|NCT00068692|10821501|FG002|Step 1: Registration|Complicating disease|0
6816895|NCT00068692|10821502|FG003|Step 1: Registration|Complicating disease|0
6816896|NCT00068692|10821503|FG004|Step 1: Registration|Complicating disease|0
6816897|NCT00068692|10821504|FG005|Step 1: Registration|Complicating disease|0
6816898|NCT00068692|10821505|FG006|Step 1: Registration|Complicating disease|0
6816899|NCT00068692|10821506|FG007|Step 1: Registration|Complicating disease|0
6816900|NCT00068692|10821499|FG000|Step 1: Registration|Protocol Violation|1
6816901|NCT00068692|10821500|FG001|Step 1: Registration|Protocol Violation|0
6816902|NCT00068692|10821501|FG002|Step 1: Registration|Protocol Violation|0
6816903|NCT00068692|10821502|FG003|Step 1: Registration|Protocol Violation|0
6816904|NCT00068692|10821503|FG004|Step 1: Registration|Protocol Violation|0
6816905|NCT00068692|10821504|FG005|Step 1: Registration|Protocol Violation|0
6816906|NCT00068692|10821505|FG006|Step 1: Registration|Protocol Violation|0
6816907|NCT00068692|10821506|FG007|Step 1: Registration|Protocol Violation|0
6816908|NCT00068692|10821499|FG000|Step 1: Registration|Not eligible|6
6816909|NCT00068692|10821500|FG001|Step 1: Registration|Not eligible|0
6816910|NCT00068692|10821501|FG002|Step 1: Registration|Not eligible|0
6816911|NCT00068692|10821502|FG003|Step 1: Registration|Not eligible|0
6816912|NCT00068692|10821503|FG004|Step 1: Registration|Not eligible|0
6816913|NCT00068692|10821504|FG005|Step 1: Registration|Not eligible|0
6816914|NCT00068692|10821505|FG006|Step 1: Registration|Not eligible|0
6816915|NCT00068692|10821506|FG007|Step 1: Registration|Not eligible|0
6816916|NCT00068692|10821499|FG000|Step 1: Registration|Other|2
6816917|NCT00068692|10821500|FG001|Step 1: Registration|Other|0
6816918|NCT00068692|10821501|FG002|Step 1: Registration|Other|0
6816919|NCT00068692|10821502|FG003|Step 1: Registration|Other|0
6816920|NCT00068692|10821503|FG004|Step 1: Registration|Other|0
6816921|NCT00068692|10821504|FG005|Step 1: Registration|Other|0
6816922|NCT00068692|10821505|FG006|Step 1: Registration|Other|0
6816923|NCT00068692|10821506|FG007|Step 1: Registration|Other|0
6816924|NCT00068692|10821499|FG000|Step 1: Registration|Not start protocol therapy|3
6816925|NCT00068692|10821500|FG001|Step 1: Registration|Not start protocol therapy|0
6816926|NCT00068692|10821501|FG002|Step 1: Registration|Not start protocol therapy|0
6816927|NCT00068692|10821502|FG003|Step 1: Registration|Not start protocol therapy|0
6816928|NCT00068692|10821503|FG004|Step 1: Registration|Not start protocol therapy|0
6816929|NCT00068692|10821504|FG005|Step 1: Registration|Not start protocol therapy|0
6816930|NCT00068692|10821505|FG006|Step 1: Registration|Not start protocol therapy|0
6816931|NCT00068692|10821506|FG007|Step 1: Registration|Not start protocol therapy|0
6816932|NCT00068692|10821499|FG000|Step 1: Registration|Registered but not randomized|0
6816933|NCT00068692|10821500|FG001|Step 1: Registration|Registered but not randomized|1
6898340|NCT00646906|10917595|FG003|Crossover Period 2|Physician Decision|0
6898341|NCT00646906|10917596|FG004|Crossover Period 2|Physician Decision|0
6898342|NCT00646906|10917597|FG005|Crossover Period 2|Physician Decision|0
6898343|NCT00646906|10917598|FG006|Crossover Period 2|Physician Decision|1
6898344|NCT00646958|10917614|FG000|Overall Study|Lack of Efficacy|1
6898345|NCT00646958|10917615|FG001|Overall Study|Lack of Efficacy|0
6898346|NCT00646958|10917616|FG002|Overall Study|Lack of Efficacy|0
6898347|NCT00646958|10917614|FG000|Overall Study|Adverse Event|4
6898348|NCT00646958|10917615|FG001|Overall Study|Adverse Event|0
6898349|NCT00646958|10917616|FG002|Overall Study|Adverse Event|0
6898350|NCT00646958|10917614|FG000|Overall Study|Lost to Follow-up|1
6898351|NCT00646958|10917615|FG001|Overall Study|Lost to Follow-up|5
6898352|NCT00646958|10917616|FG002|Overall Study|Lost to Follow-up|7
6898353|NCT00646958|10917614|FG000|Overall Study|Protocol Violation|1
6898354|NCT00646958|10917615|FG001|Overall Study|Protocol Violation|1
6898355|NCT00646958|10917616|FG002|Overall Study|Protocol Violation|0
6898356|NCT00646958|10917614|FG000|Overall Study|Abnormal screening lab tests|1
6898357|NCT00646958|10917615|FG001|Overall Study|Abnormal screening lab tests|1
6898358|NCT00646958|10917616|FG002|Overall Study|Abnormal screening lab tests|0
6898359|NCT00646958|10917614|FG000|Overall Study|Withdrawal by Subject|1
6898360|NCT00646958|10917615|FG001|Overall Study|Withdrawal by Subject|2
6898361|NCT00646958|10917616|FG002|Overall Study|Withdrawal by Subject|0
6898362|NCT00646958|10917614|FG000|Overall Study|Did not receive study drug|2
6898363|NCT00646958|10917615|FG001|Overall Study|Did not receive study drug|0
6898364|NCT00646958|10917616|FG002|Overall Study|Did not receive study drug|2
6898365|NCT00647270|10917627|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2
6898366|NCT00647270|10917628|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
6898367|NCT00647270|10917629|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
6898368|NCT00647270|10917627|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0
6898369|NCT00647270|10917628|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
6898370|NCT00647270|10917629|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
6898371|NCT00647270|10917627|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2
6898372|NCT00647270|10917628|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1
6898373|NCT00647270|10917629|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7
6898374|NCT00647270|10917627|FG000|Period 1, Placebo-control (12 Weeks)|Other|4
6898375|NCT00647270|10917628|FG001|Period 1, Placebo-control (12 Weeks)|Other|4
6898376|NCT00647270|10917629|FG002|Period 1, Placebo-control (12 Weeks)|Other|8
6898377|NCT00647270|10917627|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1
6898378|NCT00647270|10917628|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
6898379|NCT00647270|10917629|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
6898380|NCT00647270|10917627|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
6898381|NCT00647270|10917628|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
6898382|NCT00647270|10917629|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4
6898383|NCT00647270|10917627|FG000|Period 2, Placebo Switched to Adalimumab|Other|2
6898384|NCT00647270|10917628|FG001|Period 2, Placebo Switched to Adalimumab|Other|6
6898385|NCT00647270|10917629|FG002|Period 2, Placebo Switched to Adalimumab|Other|0
6898386|NCT00647296|10917644|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0
6898387|NCT00647296|10917645|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0
6898388|NCT00647296|10917646|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0
6898389|NCT00647296|10917647|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1
6898390|NCT00647296|10917644|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1
6898391|NCT00647296|10917645|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0
6898392|NCT00647296|10917646|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0
6898393|NCT00647296|10917647|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1
6898394|NCT00647296|10917644|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0
6898395|NCT00647296|10917645|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1
6898396|NCT00647296|10917646|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0
6898397|NCT00647296|10917647|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0
6898398|NCT00647296|10917644|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1
6898399|NCT00647296|10917645|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0
6898400|NCT00647296|10917646|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0
6816934|NCT00068692|10821501|FG002|Step 1: Registration|Registered but not randomized|0
6816935|NCT00068692|10821502|FG003|Step 1: Registration|Registered but not randomized|0
6816936|NCT00068692|10821503|FG004|Step 1: Registration|Registered but not randomized|0
6816937|NCT00068692|10821504|FG005|Step 1: Registration|Registered but not randomized|0
6816938|NCT00068692|10821505|FG006|Step 1: Registration|Registered but not randomized|0
6816939|NCT00068692|10821506|FG007|Step 1: Registration|Registered but not randomized|0
6816940|NCT00068692|10821499|FG000|Step 2: Randomization|Disesae progression/replase|0
6816941|NCT00068692|10821500|FG001|Step 2: Randomization|Disesae progression/replase|0
6816942|NCT00068692|10821501|FG002|Step 2: Randomization|Disesae progression/replase|1
6816943|NCT00068692|10821502|FG003|Step 2: Randomization|Disesae progression/replase|1
6816944|NCT00068692|10821503|FG004|Step 2: Randomization|Disesae progression/replase|0
6816945|NCT00068692|10821504|FG005|Step 2: Randomization|Disesae progression/replase|0
6816946|NCT00068692|10821505|FG006|Step 2: Randomization|Disesae progression/replase|0
6816947|NCT00068692|10821506|FG007|Step 2: Randomization|Disesae progression/replase|0
6816948|NCT00068692|10821499|FG000|Step 2: Randomization|Adverse Event|0
6816949|NCT00068692|10821500|FG001|Step 2: Randomization|Adverse Event|0
6816950|NCT00068692|10821501|FG002|Step 2: Randomization|Adverse Event|4
6816951|NCT00068692|10821502|FG003|Step 2: Randomization|Adverse Event|2
6816952|NCT00068692|10821503|FG004|Step 2: Randomization|Adverse Event|2
6816953|NCT00068692|10821504|FG005|Step 2: Randomization|Adverse Event|3
6816954|NCT00068692|10821505|FG006|Step 2: Randomization|Adverse Event|4
6816955|NCT00068692|10821506|FG007|Step 2: Randomization|Adverse Event|4
6816956|NCT00068692|10821499|FG000|Step 2: Randomization|Death|0
6816957|NCT00068692|10821500|FG001|Step 2: Randomization|Death|0
6816958|NCT00068692|10821501|FG002|Step 2: Randomization|Death|0
6816959|NCT00068692|10821502|FG003|Step 2: Randomization|Death|0
6816960|NCT00068692|10821503|FG004|Step 2: Randomization|Death|1
6816961|NCT00068692|10821504|FG005|Step 2: Randomization|Death|0
6816962|NCT00068692|10821505|FG006|Step 2: Randomization|Death|0
6816963|NCT00068692|10821506|FG007|Step 2: Randomization|Death|1
6816964|NCT00068692|10821499|FG000|Step 2: Randomization|Withdrawal by Subject|0
6816965|NCT00068692|10821500|FG001|Step 2: Randomization|Withdrawal by Subject|0
6816966|NCT00068692|10821501|FG002|Step 2: Randomization|Withdrawal by Subject|4
6816967|NCT00068692|10821502|FG003|Step 2: Randomization|Withdrawal by Subject|6
6816968|NCT00068692|10821503|FG004|Step 2: Randomization|Withdrawal by Subject|3
6816969|NCT00068692|10821504|FG005|Step 2: Randomization|Withdrawal by Subject|2
6816970|NCT00068692|10821505|FG006|Step 2: Randomization|Withdrawal by Subject|0
6816971|NCT00068692|10821506|FG007|Step 2: Randomization|Withdrawal by Subject|3
6816972|NCT00068692|10821499|FG000|Step 2: Randomization|alternative therapy|0
6816973|NCT00068692|10821500|FG001|Step 2: Randomization|alternative therapy|0
6816974|NCT00068692|10821501|FG002|Step 2: Randomization|alternative therapy|0
6816975|NCT00068692|10821502|FG003|Step 2: Randomization|alternative therapy|1
6816976|NCT00068692|10821503|FG004|Step 2: Randomization|alternative therapy|1
6816977|NCT00068692|10821504|FG005|Step 2: Randomization|alternative therapy|0
6816978|NCT00068692|10821505|FG006|Step 2: Randomization|alternative therapy|0
6816979|NCT00068692|10821506|FG007|Step 2: Randomization|alternative therapy|0
6816980|NCT00068692|10821499|FG000|Step 2: Randomization|Physician Decision|0
6816981|NCT00068692|10821500|FG001|Step 2: Randomization|Physician Decision|0
6816982|NCT00068692|10821501|FG002|Step 2: Randomization|Physician Decision|0
6816983|NCT00068692|10821502|FG003|Step 2: Randomization|Physician Decision|1
6816984|NCT00068692|10821503|FG004|Step 2: Randomization|Physician Decision|1
6816985|NCT00068692|10821504|FG005|Step 2: Randomization|Physician Decision|0
6816986|NCT00068692|10821505|FG006|Step 2: Randomization|Physician Decision|0
6816987|NCT00068692|10821506|FG007|Step 2: Randomization|Physician Decision|0
6816988|NCT00068692|10821499|FG000|Step 2: Randomization|Other|0
6816989|NCT00068692|10821500|FG001|Step 2: Randomization|Other|0
6816990|NCT00068692|10821501|FG002|Step 2: Randomization|Other|0
6816991|NCT00068692|10821502|FG003|Step 2: Randomization|Other|1
6816992|NCT00068692|10821503|FG004|Step 2: Randomization|Other|0
6816993|NCT00068692|10821504|FG005|Step 2: Randomization|Other|1
6816994|NCT00068692|10821505|FG006|Step 2: Randomization|Other|0
6816995|NCT00068692|10821506|FG007|Step 2: Randomization|Other|0
6816996|NCT00068692|10821499|FG000|Step 2: Randomization|never start protocol therapy|0
6816997|NCT00068692|10821500|FG001|Step 2: Randomization|never start protocol therapy|0
6816998|NCT00068692|10821501|FG002|Step 2: Randomization|never start protocol therapy|1
6816999|NCT00068692|10821502|FG003|Step 2: Randomization|never start protocol therapy|0
6817000|NCT00068692|10821503|FG004|Step 2: Randomization|never start protocol therapy|1
6817001|NCT00068692|10821504|FG005|Step 2: Randomization|never start protocol therapy|0
6817002|NCT00068692|10821505|FG006|Step 2: Randomization|never start protocol therapy|0
6817003|NCT00068692|10821506|FG007|Step 2: Randomization|never start protocol therapy|0
6817004|NCT00068822|10821536|FG000|First Randomized Intervention|Lost to Follow-up|1
6817005|NCT00068822|10821537|FG001|First Randomized Intervention|Lost to Follow-up|2
6817006|NCT00069095|10821549|FG000|Primary Treatment Phase|Ongoing|0
6817007|NCT00069095|10821550|FG001|Primary Treatment Phase|Ongoing|0
6817008|NCT00069095|10821551|FG002|Primary Treatment Phase|Ongoing|5
6817009|NCT00069095|10821552|FG003|Primary Treatment Phase|Ongoing|7
6817010|NCT00069095|10821553|FG004|Primary Treatment Phase|Ongoing|7
6817011|NCT00069095|10821554|FG005|Primary Treatment Phase|Ongoing|4
6817012|NCT00069095|10821549|FG000|Primary Treatment Phase|Admin/Other|29
6817013|NCT00069095|10821550|FG001|Primary Treatment Phase|Admin/Other|38
6817014|NCT00069095|10821551|FG002|Primary Treatment Phase|Admin/Other|31
6817015|NCT00069095|10821552|FG003|Primary Treatment Phase|Admin/Other|45
6817016|NCT00069095|10821553|FG004|Primary Treatment Phase|Admin/Other|48
6817017|NCT00069095|10821554|FG005|Primary Treatment Phase|Admin/Other|42
6817018|NCT00069095|10821549|FG000|Primary Treatment Phase|Adverse Event|99
6817019|NCT00069095|10821550|FG001|Primary Treatment Phase|Adverse Event|92
6817020|NCT00069095|10821551|FG002|Primary Treatment Phase|Adverse Event|71
6817021|NCT00069095|10821552|FG003|Primary Treatment Phase|Adverse Event|72
6817022|NCT00069095|10821553|FG004|Primary Treatment Phase|Adverse Event|109
6817023|NCT00069095|10821554|FG005|Primary Treatment Phase|Adverse Event|101
6817024|NCT00069095|10821549|FG000|Primary Treatment Phase|Death|14
6817025|NCT00069095|10821550|FG001|Primary Treatment Phase|Death|8
6817026|NCT00069095|10821551|FG002|Primary Treatment Phase|Death|2
6817027|NCT00069095|10821552|FG003|Primary Treatment Phase|Death|5
6817028|NCT00069095|10821553|FG004|Primary Treatment Phase|Death|8
6817029|NCT00069095|10821554|FG005|Primary Treatment Phase|Death|8
6817030|NCT00069095|10821549|FG000|Primary Treatment Phase|Failure to return|5
6817031|NCT00069095|10821550|FG001|Primary Treatment Phase|Failure to return|5
6817032|NCT00069095|10821551|FG002|Primary Treatment Phase|Failure to return|0
6817033|NCT00069095|10821552|FG003|Primary Treatment Phase|Failure to return|0
6817034|NCT00069095|10821553|FG004|Primary Treatment Phase|Failure to return|0
6817035|NCT00069095|10821554|FG005|Primary Treatment Phase|Failure to return|2
6817036|NCT00069095|10821549|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131
6817037|NCT00069095|10821550|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127
6817038|NCT00069095|10821551|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175
6817039|NCT00069095|10821552|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154
6817040|NCT00069095|10821553|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101
6817041|NCT00069095|10821554|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102
6817042|NCT00069095|10821549|FG000|Primary Treatment Phase|Refused treatment|15
6817043|NCT00069095|10821550|FG001|Primary Treatment Phase|Refused treatment|26
6817044|NCT00069095|10821551|FG002|Primary Treatment Phase|Refused treatment|17
6817045|NCT00069095|10821552|FG003|Primary Treatment Phase|Refused treatment|31
6817046|NCT00069095|10821553|FG004|Primary Treatment Phase|Refused treatment|24
6817047|NCT00069095|10821554|FG005|Primary Treatment Phase|Refused treatment|27
6817048|NCT00069095|10821549|FG000|Primary Treatment Phase|Withdrew|2
6817049|NCT00069095|10821550|FG001|Primary Treatment Phase|Withdrew|3
6817050|NCT00069095|10821551|FG002|Primary Treatment Phase|Withdrew|8
6817051|NCT00069095|10821552|FG003|Primary Treatment Phase|Withdrew|2
6817052|NCT00069095|10821553|FG004|Primary Treatment Phase|Withdrew|4
6817053|NCT00069095|10821554|FG005|Primary Treatment Phase|Withdrew|9
6817054|NCT00069095|10821549|FG000|Primary Treatment Phase|Other Violation|0
6817055|NCT00069095|10821550|FG001|Primary Treatment Phase|Other Violation|1
6817056|NCT00069095|10821551|FG002|Primary Treatment Phase|Other Violation|1
6817057|NCT00069095|10821552|FG003|Primary Treatment Phase|Other Violation|1
6817058|NCT00069095|10821553|FG004|Primary Treatment Phase|Other Violation|0
6817059|NCT00069095|10821554|FG005|Primary Treatment Phase|Other Violation|1
6817060|NCT00069095|10821549|FG000|Primary Treatment Phase|Violation criteria|0
6817061|NCT00069095|10821550|FG001|Primary Treatment Phase|Violation criteria|2
6817062|NCT00069095|10821551|FG002|Primary Treatment Phase|Violation criteria|4
6817063|NCT00069095|10821552|FG003|Primary Treatment Phase|Violation criteria|3
6817064|NCT00069095|10821553|FG004|Primary Treatment Phase|Violation criteria|1
6817065|NCT00069095|10821554|FG005|Primary Treatment Phase|Violation criteria|5
6817066|NCT00069095|10821549|FG000|Post-study Treatment Phase|Missing reason|1
6817067|NCT00069095|10821550|FG001|Post-study Treatment Phase|Missing reason|3
6817068|NCT00069095|10821551|FG002|Post-study Treatment Phase|Missing reason|12
6817069|NCT00069095|10821552|FG003|Post-study Treatment Phase|Missing reason|8
6817070|NCT00069095|10821553|FG004|Post-study Treatment Phase|Missing reason|18
6817071|NCT00069095|10821554|FG005|Post-study Treatment Phase|Missing reason|17
6817072|NCT00069095|10821549|FG000|Post-study Treatment Phase|Adverse Event|2
6817073|NCT00069095|10821550|FG001|Post-study Treatment Phase|Adverse Event|3
6817074|NCT00069095|10821551|FG002|Post-study Treatment Phase|Adverse Event|1
6817075|NCT00069095|10821552|FG003|Post-study Treatment Phase|Adverse Event|0
6817076|NCT00069095|10821553|FG004|Post-study Treatment Phase|Adverse Event|5
6817077|NCT00069095|10821554|FG005|Post-study Treatment Phase|Adverse Event|1
6817078|NCT00069095|10821549|FG000|Post-study Treatment Phase|Eligible for surgery|2
6817079|NCT00069095|10821550|FG001|Post-study Treatment Phase|Eligible for surgery|0
6817080|NCT00069095|10821551|FG002|Post-study Treatment Phase|Eligible for surgery|0
6817081|NCT00069095|10821552|FG003|Post-study Treatment Phase|Eligible for surgery|0
6817082|NCT00069095|10821553|FG004|Post-study Treatment Phase|Eligible for surgery|0
6817083|NCT00069095|10821554|FG005|Post-study Treatment Phase|Eligible for surgery|0
6817084|NCT00069095|10821549|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1
6817085|NCT00069095|10821550|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4
6817086|NCT00069095|10821551|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5
6817087|NCT00069095|10821552|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6
6817088|NCT00069095|10821553|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7
6817089|NCT00069095|10821554|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9
6817090|NCT00069095|10821549|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1
6817091|NCT00069095|10821550|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0
6817092|NCT00069095|10821551|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0
6817093|NCT00069095|10821552|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0
6817094|NCT00069095|10821553|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0
6817095|NCT00069095|10821554|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1
6817096|NCT00069095|10821549|FG000|Post-study Treatment Phase|Participant had complete response|1
6817097|NCT00069095|10821550|FG001|Post-study Treatment Phase|Participant had complete response|1
6817098|NCT00069095|10821551|FG002|Post-study Treatment Phase|Participant had complete response|0
6817099|NCT00069095|10821552|FG003|Post-study Treatment Phase|Participant had complete response|0
6817100|NCT00069095|10821553|FG004|Post-study Treatment Phase|Participant had complete response|0
6817101|NCT00069095|10821554|FG005|Post-study Treatment Phase|Participant had complete response|0
6817102|NCT00069095|10821549|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0
6817103|NCT00069095|10821550|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1
6817104|NCT00069095|10821551|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0
6817105|NCT00069095|10821552|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0
6817106|NCT00069095|10821553|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0
6817107|NCT00069095|10821554|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0
6817108|NCT00069095|10821549|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0
6817109|NCT00069095|10821550|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1
6817110|NCT00069095|10821551|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1
6817111|NCT00069095|10821552|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0
6817112|NCT00069095|10821553|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1
6817113|NCT00069095|10821554|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0
6817114|NCT00069095|10821549|FG000|Post-study Treatment Phase|Participant withdrew consent|0
6817115|NCT00069095|10821550|FG001|Post-study Treatment Phase|Participant withdrew consent|0
6817116|NCT00069095|10821551|FG002|Post-study Treatment Phase|Participant withdrew consent|1
6817117|NCT00069095|10821552|FG003|Post-study Treatment Phase|Participant withdrew consent|0
6817118|NCT00069095|10821553|FG004|Post-study Treatment Phase|Participant withdrew consent|0
6817119|NCT00069095|10821554|FG005|Post-study Treatment Phase|Participant withdrew consent|0
6817120|NCT00069095|10821549|FG000|Post-study Treatment Phase|Participant will start new treatment|0
6817121|NCT00069095|10821550|FG001|Post-study Treatment Phase|Participant will start new treatment|0
6817122|NCT00069095|10821551|FG002|Post-study Treatment Phase|Participant will start new treatment|1
6817123|NCT00069095|10821552|FG003|Post-study Treatment Phase|Participant will start new treatment|0
6817124|NCT00069095|10821553|FG004|Post-study Treatment Phase|Participant will start new treatment|0
6898401|NCT00647296|10917647|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0
6898402|NCT00647296|10917644|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1
6898403|NCT00647296|10917645|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0
6898404|NCT00647296|10917646|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0
6898405|NCT00647296|10917647|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0
6898406|NCT00647296|10917644|FG000|Part 2: 4-week Placebo Washout|Death|3
6898407|NCT00647296|10917645|FG001|Part 2: 4-week Placebo Washout|Death|0
6898408|NCT00647296|10917646|FG002|Part 2: 4-week Placebo Washout|Death|0
6898409|NCT00647296|10917647|FG003|Part 2: 4-week Placebo Washout|Death|0
6898410|NCT00647296|10917644|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0
6898411|NCT00647296|10917645|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5
6898412|NCT00647296|10917646|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0
6898413|NCT00647296|10917647|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4
6898414|NCT00647296|10917644|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0
6898415|NCT00647296|10917645|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1
6898416|NCT00647296|10917646|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0
6898417|NCT00647296|10917647|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4
6898418|NCT00647296|10917644|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0
6898419|NCT00647296|10917645|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1
6898420|NCT00647296|10917646|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0
6898421|NCT00647296|10917647|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0
6898422|NCT00647296|10917644|FG000|Part 2: 76-week Double-Blind Treatment|Death|0
6898423|NCT00647296|10917645|FG001|Part 2: 76-week Double-Blind Treatment|Death|7
6898424|NCT00647296|10917646|FG002|Part 2: 76-week Double-Blind Treatment|Death|0
6898425|NCT00647296|10917647|FG003|Part 2: 76-week Double-Blind Treatment|Death|5
6898426|NCT00647296|10917644|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0
6898427|NCT00647296|10917645|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1
6898428|NCT00647296|10917646|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0
6898429|NCT00647296|10917647|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1
6898430|NCT00647348|10917671|FG000|Overall Study|Lost to Follow-up|3
6898431|NCT00647348|10917672|FG001|Overall Study|Lost to Follow-up|6
6898432|NCT00647556|10917689|FG000|Overall Study|Adverse Event|0
6898433|NCT00647556|10917690|FG001|Overall Study|Adverse Event|1
6898434|NCT00647556|10917689|FG000|Overall Study|Lost to Follow-up|1
6817125|NCT00069095|10821554|FG005|Post-study Treatment Phase|Participant will start new treatment|0
6817126|NCT00069095|10821549|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0
6817127|NCT00069095|10821550|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0
6817128|NCT00069095|10821551|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0
6817129|NCT00069095|10821552|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1
6817130|NCT00069095|10821553|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0
6817131|NCT00069095|10821554|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0
6817132|NCT00069095|10821549|FG000|Post-study Treatment Phase|Participant completed treatment|0
6817133|NCT00069095|10821550|FG001|Post-study Treatment Phase|Participant completed treatment|0
6817134|NCT00069095|10821551|FG002|Post-study Treatment Phase|Participant completed treatment|0
6817135|NCT00069095|10821552|FG003|Post-study Treatment Phase|Participant completed treatment|1
6817136|NCT00069095|10821553|FG004|Post-study Treatment Phase|Participant completed treatment|0
6817137|NCT00069095|10821554|FG005|Post-study Treatment Phase|Participant completed treatment|0
6817138|NCT00069095|10821549|FG000|Post-study Treatment Phase|Surgery|0
6817139|NCT00069095|10821550|FG001|Post-study Treatment Phase|Surgery|0
6817140|NCT00069095|10821551|FG002|Post-study Treatment Phase|Surgery|0
6817141|NCT00069095|10821552|FG003|Post-study Treatment Phase|Surgery|1
6817142|NCT00069095|10821553|FG004|Post-study Treatment Phase|Surgery|1
6817143|NCT00069095|10821554|FG005|Post-study Treatment Phase|Surgery|0
6817144|NCT00069095|10821549|FG000|Post-study Treatment Phase|Death|0
6817145|NCT00069095|10821550|FG001|Post-study Treatment Phase|Death|0
6817146|NCT00069095|10821551|FG002|Post-study Treatment Phase|Death|0
6817147|NCT00069095|10821552|FG003|Post-study Treatment Phase|Death|0
6817148|NCT00069095|10821553|FG004|Post-study Treatment Phase|Death|1
6817149|NCT00069095|10821554|FG005|Post-study Treatment Phase|Death|0
6817150|NCT00069095|10821549|FG000|Post-study Treatment Phase|Participant had progressive disease|0
6817151|NCT00069095|10821550|FG001|Post-study Treatment Phase|Participant had progressive disease|0
6817152|NCT00069095|10821551|FG002|Post-study Treatment Phase|Participant had progressive disease|0
6817153|NCT00069095|10821552|FG003|Post-study Treatment Phase|Participant had progressive disease|0
6817154|NCT00069095|10821553|FG004|Post-study Treatment Phase|Participant had progressive disease|1
6817155|NCT00069095|10821554|FG005|Post-study Treatment Phase|Participant had progressive disease|0
6817156|NCT00069095|10821549|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0
6817157|NCT00069095|10821550|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0
6817158|NCT00069095|10821551|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0
6817159|NCT00069095|10821552|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0
6817160|NCT00069095|10821553|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1
6817161|NCT00069095|10821554|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0
6817162|NCT00069095|10821549|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
6817163|NCT00069095|10821550|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
6817164|NCT00069095|10821551|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
6817165|NCT00069095|10821552|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
6817166|NCT00069095|10821553|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1
6817167|NCT00069095|10821554|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
6817168|NCT00069095|10821549|FG000|Post-study Treatment Phase|Investigator decision|0
6817169|NCT00069095|10821550|FG001|Post-study Treatment Phase|Investigator decision|0
6817170|NCT00069095|10821551|FG002|Post-study Treatment Phase|Investigator decision|0
6817171|NCT00069095|10821552|FG003|Post-study Treatment Phase|Investigator decision|0
6817172|NCT00069095|10821553|FG004|Post-study Treatment Phase|Investigator decision|0
6817173|NCT00069095|10821554|FG005|Post-study Treatment Phase|Investigator decision|1
6817174|NCT00069095|10821549|FG000|Follow-up Phase|Death|174
6817175|NCT00069095|10821550|FG001|Follow-up Phase|Death|206
6817176|NCT00069095|10821551|FG002|Follow-up Phase|Death|120
6817177|NCT00069095|10821552|FG003|Follow-up Phase|Death|112
6817178|NCT00069095|10821553|FG004|Follow-up Phase|Death|92
6817179|NCT00069095|10821554|FG005|Follow-up Phase|Death|101
6817180|NCT00069108|10821568|FG000|Overall Study|Withdrawal by Subject|5
6817181|NCT00069108|10821569|FG001|Overall Study|Withdrawal by Subject|9
6817182|NCT00069108|10821568|FG000|Overall Study|Adverse Event|64
6817183|NCT00069108|10821569|FG001|Overall Study|Adverse Event|42
6817184|NCT00069108|10821568|FG000|Overall Study|Death|6
6817185|NCT00069108|10821569|FG001|Overall Study|Death|6
6817186|NCT00069108|10821568|FG000|Overall Study|Administration|15
6817187|NCT00069108|10821569|FG001|Overall Study|Administration|4
6817188|NCT00069108|10821568|FG000|Overall Study|Insufficient therapy|117
6817189|NCT00069108|10821569|FG001|Overall Study|Insufficient therapy|144
6817190|NCT00069108|10821568|FG000|Overall Study|Violation criteria|1
6817191|NCT00069108|10821569|FG001|Overall Study|Violation criteria|4
6817192|NCT00069108|10821568|FG000|Overall Study|Refused treatment|5
6817193|NCT00069108|10821569|FG001|Overall Study|Refused treatment|10
6817194|NCT00069121|10821578|FG000|Overall Study|Death|286
6817195|NCT00069121|10821579|FG001|Overall Study|Death|242
6817196|NCT00069121|10821578|FG000|Overall Study|Withdrawal by Subject|18
6817197|NCT00069121|10821579|FG001|Overall Study|Withdrawal by Subject|20
6817198|NCT00069121|10821578|FG000|Overall Study|Lost to Follow-up|63
6817199|NCT00069121|10821579|FG001|Overall Study|Lost to Follow-up|63
6817200|NCT00069264|10821601|FG000|Overall Study|Adverse Event|3
6817201|NCT00069264|10821601|FG000|Overall Study|Progressive Disease|23
6817202|NCT00069264|10821601|FG000|Overall Study|Withdrawal by Subject|3
6817203|NCT00069264|10821601|FG000|Overall Study|Discon Therapy|3
6817204|NCT00069277|10821605|FG000|Overall Study|Adverse Event|3
6817205|NCT00069277|10821605|FG000|Overall Study|Withdrawal by Subject|1
6817206|NCT00069277|10821605|FG000|Overall Study|Progressive Disease|15
6817207|NCT00069277|10821605|FG000|Overall Study|Physician Decision|2
6817208|NCT00069576|10821615|FG000|Original Trial|Lost to Follow-up|25
6817209|NCT00069576|10821616|FG001|Original Trial|Lost to Follow-up|33
6817210|NCT00069576|10821615|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196
6817211|NCT00069576|10821616|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204
6817212|NCT00069641|10821625|FG000|Overall Study|Death|1
6817213|NCT00069641|10821626|FG001|Overall Study|Death|0
6817214|NCT00069641|10821627|FG002|Overall Study|Death|1
6817215|NCT00069784|10821638|FG000|Overall Study|Adverse Event|105
6817216|NCT00069784|10821639|FG001|Overall Study|Adverse Event|0
6817217|NCT00069784|10821638|FG000|Overall Study|Withdrawal by Subject|1090
6817218|NCT00069784|10821639|FG001|Overall Study|Withdrawal by Subject|0
6817219|NCT00069784|10821638|FG000|Overall Study|Other|17
6817220|NCT00069784|10821639|FG001|Overall Study|Other|0
6817221|NCT00069823|10821647|FG000|Overall Study|Did not have follow-up diary cards|6
6817222|NCT00069823|10821648|FG001|Overall Study|Did not have follow-up diary cards|3
6817223|NCT00069953|10821654|FG000|Overall Study|Protocol Violation|2
6896466|NCT00633243|10914916|FG001|Overall Study|Homeless--no refrigeration for meds|1
6896467|NCT00633243|10914915|FG000|Overall Study|Not comfortable with self-injecting|0
6896468|NCT00633243|10914916|FG001|Overall Study|Not comfortable with self-injecting|1
6896469|NCT00633243|10914915|FG000|Overall Study|Mental Health--Depression|0
6896470|NCT00633243|10914916|FG001|Overall Study|Mental Health--Depression|1
6896471|NCT00633243|10914915|FG000|Overall Study|Couldn't tolerate side-effects|1
6896472|NCT00633243|10914916|FG001|Overall Study|Couldn't tolerate side-effects|1
6896473|NCT00633360|10914933|FG000|Overall Study|Lost to Follow-up|1
6896474|NCT00633360|10914934|FG001|Overall Study|Lost to Follow-up|1
6896475|NCT00633360|10914933|FG000|Overall Study|Adverse Event|3
6896476|NCT00633360|10914934|FG001|Overall Study|Adverse Event|1
6896477|NCT00633360|10914933|FG000|Overall Study|Protocol Violation|0
6896478|NCT00633360|10914934|FG001|Overall Study|Protocol Violation|1
6896479|NCT00633464|10914953|FG000|Overall Study|Never Treated (Not met study criteria)|0
6896480|NCT00633464|10914954|FG001|Overall Study|Never Treated (Not met study criteria)|1
6896481|NCT00633464|10914953|FG000|Overall Study|Never Treated (Randomized in error)|0
6896482|NCT00633464|10914954|FG001|Overall Study|Never Treated (Randomized in error)|1
6896483|NCT00633477|10914962|FG000|Overall Study|Death|1
6896484|NCT00633477|10914963|FG001|Overall Study|Death|0
6896485|NCT00633477|10914962|FG000|Overall Study|Randomized but not treated|1
6896486|NCT00633477|10914963|FG001|Overall Study|Randomized but not treated|0
6896487|NCT00633594|10914972|FG000|Overall Study|Adverse Event|0
6896488|NCT00633594|10914973|FG001|Overall Study|Adverse Event|4
6896489|NCT00633594|10914974|FG002|Overall Study|Adverse Event|7
6896490|NCT00633594|10914972|FG000|Overall Study|Death|0
6896491|NCT00633594|10914973|FG001|Overall Study|Death|1
6896492|NCT00633594|10914974|FG002|Overall Study|Death|2
6896493|NCT00633594|10914972|FG000|Overall Study|Disease Progression|0
6896494|NCT00633594|10914973|FG001|Overall Study|Disease Progression|0
6896495|NCT00633594|10914974|FG002|Overall Study|Disease Progression|1
6896496|NCT00633750|10914985|FG000|Overall Study|Adverse Event|2
6896497|NCT00633750|10914985|FG000|Overall Study|Withdrawal by Subject|3
6896498|NCT00633880|10915003|FG000|Open Label Titration|Lack of Efficacy|1
6896499|NCT00633880|10915004|FG001|Open Label Titration|Lack of Efficacy|0
6896500|NCT00633880|10915005|FG002|Open Label Titration|Lack of Efficacy|0
6896501|NCT00633880|10915003|FG000|Open Label Titration|Adverse Event|13
6896502|NCT00633880|10915004|FG001|Open Label Titration|Adverse Event|0
6896503|NCT00633880|10915005|FG002|Open Label Titration|Adverse Event|0
6896504|NCT00633880|10915003|FG000|Open Label Titration|Treatment Failure|55
6896505|NCT00633880|10915004|FG001|Open Label Titration|Treatment Failure|0
6896506|NCT00633880|10915005|FG002|Open Label Titration|Treatment Failure|0
6896507|NCT00633880|10915003|FG000|Open Label Titration|Protocol Violation|6
6896508|NCT00633880|10915004|FG001|Open Label Titration|Protocol Violation|0
6896509|NCT00633880|10915005|FG002|Open Label Titration|Protocol Violation|0
6896510|NCT00633880|10915003|FG000|Open Label Titration|Physician Decision|1
6896511|NCT00633880|10915004|FG001|Open Label Titration|Physician Decision|0
6896512|NCT00633880|10915005|FG002|Open Label Titration|Physician Decision|0
6896513|NCT00633880|10915003|FG000|Open Label Titration|Withdrawal by Subject|4
6896514|NCT00633880|10915004|FG001|Open Label Titration|Withdrawal by Subject|0
6896515|NCT00633880|10915005|FG002|Open Label Titration|Withdrawal by Subject|0
6896516|NCT00633893|10915015|FG000|Overall Study|Death|1
6896517|NCT00633893|10915016|FG001|Overall Study|Death|3
6896518|NCT00633893|10915017|FG002|Overall Study|Death|9
6896519|NCT00633893|10915015|FG000|Overall Study|Adverse Event|65
6896520|NCT00633893|10915016|FG001|Overall Study|Adverse Event|58
6896521|NCT00633893|10915017|FG002|Overall Study|Adverse Event|126
6896522|NCT00633893|10915015|FG000|Overall Study|Withdrawal by Subject|7
6896523|NCT00633893|10915016|FG001|Overall Study|Withdrawal by Subject|12
6896524|NCT00633893|10915017|FG002|Overall Study|Withdrawal by Subject|6
6896525|NCT00633893|10915015|FG000|Overall Study|Lost to Follow-up|2
6817224|NCT00070109|10821680|FG000|Overall Study|Death|1
6817225|NCT00070109|10821681|FG001|Overall Study|Death|1
6817226|NCT00070109|10821682|FG002|Overall Study|Death|0
6817227|NCT00070109|10821683|FG003|Overall Study|Death|0
6817228|NCT00070109|10821684|FG004|Overall Study|Death|1
6817229|NCT00070109|10821680|FG000|Overall Study|Lack of Efficacy|6
6817230|NCT00070109|10821681|FG001|Overall Study|Lack of Efficacy|4
6817231|NCT00070109|10821682|FG002|Overall Study|Lack of Efficacy|5
6817232|NCT00070109|10821683|FG003|Overall Study|Lack of Efficacy|15
6817233|NCT00070109|10821684|FG004|Overall Study|Lack of Efficacy|5
6817234|NCT00070109|10821680|FG000|Overall Study|Physician Decision|1
6817235|NCT00070109|10821681|FG001|Overall Study|Physician Decision|0
6817236|NCT00070109|10821682|FG002|Overall Study|Physician Decision|0
6817237|NCT00070109|10821683|FG003|Overall Study|Physician Decision|0
6817238|NCT00070109|10821684|FG004|Overall Study|Physician Decision|0
6817239|NCT00070109|10821680|FG000|Overall Study|Withdrawal by Subject|0
6817240|NCT00070109|10821681|FG001|Overall Study|Withdrawal by Subject|1
6817241|NCT00070109|10821682|FG002|Overall Study|Withdrawal by Subject|1
6817242|NCT00070109|10821683|FG003|Overall Study|Withdrawal by Subject|0
6817243|NCT00070109|10821684|FG004|Overall Study|Withdrawal by Subject|0
6817244|NCT00070109|10821680|FG000|Overall Study|Adverse Event|0
6817245|NCT00070109|10821681|FG001|Overall Study|Adverse Event|0
6817246|NCT00070109|10821682|FG002|Overall Study|Adverse Event|2
6817247|NCT00070109|10821683|FG003|Overall Study|Adverse Event|4
6817248|NCT00070109|10821684|FG004|Overall Study|Adverse Event|2
6817249|NCT00070109|10821680|FG000|Overall Study|removed from prot thpy prior to chemo|0
6817250|NCT00070109|10821681|FG001|Overall Study|removed from prot thpy prior to chemo|0
6817251|NCT00070109|10821682|FG002|Overall Study|removed from prot thpy prior to chemo|0
6817252|NCT00070109|10821683|FG003|Overall Study|removed from prot thpy prior to chemo|1
6817253|NCT00070109|10821684|FG004|Overall Study|removed from prot thpy prior to chemo|0
6817254|NCT00070291|10821707|FG000|Step 1|Withdrawal by Subject|1
6817255|NCT00070291|10821707|FG000|Step 1|Adverse Event|1
6817256|NCT00070291|10821707|FG000|Step 2|Adverse Event|1
6817257|NCT00070317|10821711|FG000|Overall Study|Inevaluable (Never Treated)|1
6817258|NCT00070317|10821711|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3
6817259|NCT00070317|10821711|FG000|Overall Study|Ineligible required test not done|1
6817260|NCT00070317|10821711|FG000|Overall Study|Ineligible-Improper prior treatment|2
6817261|NCT00070317|10821711|FG000|Overall Study|Ineligible-Inadequate pathology|6
6817262|NCT00070941|10821718|FG000|Overall Study|Adverse Event|10
6817263|NCT00070941|10821719|FG001|Overall Study|Adverse Event|8
6817264|NCT00070941|10821720|FG002|Overall Study|Adverse Event|4
6817265|NCT00071006|10821728|FG000|Overall Study|Lack of Efficacy|7
6817266|NCT00071006|10821728|FG000|Overall Study|Adverse Event|1
6817267|NCT00071006|10821728|FG000|Overall Study|Withdrawal by Subject|1
6817268|NCT00071006|10821728|FG000|Overall Study|Other|3
6817269|NCT00071032|10821734|FG000|Overall Study|Lost to Follow-up|1
6817270|NCT00071032|10821735|FG001|Overall Study|Lost to Follow-up|1
6817271|NCT00071032|10821734|FG000|Overall Study|Withdrawal by Subject|8
6817272|NCT00071032|10821735|FG001|Overall Study|Withdrawal by Subject|6
6817273|NCT00071032|10821734|FG000|Overall Study|Missing Primary Outcome|0
6817274|NCT00071032|10821735|FG001|Overall Study|Missing Primary Outcome|1
6817275|NCT00071058|10821742|FG000|Overall Study|brain tumor-removed from study|1
6817276|NCT00071110|10821749|FG000|Overall Study|Protocol Violation|0
6817277|NCT00071110|10821750|FG001|Overall Study|Protocol Violation|4
6817278|NCT00071396|10821756|FG000|Overall Study|Withdrawal by Subject|1
6817279|NCT00071396|10821756|FG000|Overall Study|Physician Decision|2
6817280|NCT00071487|10821764|FG000|52-Week Double-Blind Period|Adverse Event|5
6817281|NCT00071487|10821765|FG001|52-Week Double-Blind Period|Adverse Event|8
6817282|NCT00071487|10821766|FG002|52-Week Double-Blind Period|Adverse Event|4
6817283|NCT00071487|10821767|FG003|52-Week Double-Blind Period|Adverse Event|8
6817284|NCT00071487|10821764|FG000|52-Week Double-Blind Period|Lack of Efficacy|1
6817285|NCT00071487|10821765|FG001|52-Week Double-Blind Period|Lack of Efficacy|2
6817286|NCT00071487|10821766|FG002|52-Week Double-Blind Period|Lack of Efficacy|0
6817287|NCT00071487|10821767|FG003|52-Week Double-Blind Period|Lack of Efficacy|1
6817288|NCT00071487|10821764|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7
6817289|NCT00071487|10821765|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11
6817290|NCT00071487|10821766|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7
6817291|NCT00071487|10821767|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7
6817292|NCT00071487|10821764|FG000|52-Week Double-Blind Period|Physician Decision|1
6817293|NCT00071487|10821765|FG001|52-Week Double-Blind Period|Physician Decision|0
6817294|NCT00071487|10821766|FG002|52-Week Double-Blind Period|Physician Decision|0
6817295|NCT00071487|10821767|FG003|52-Week Double-Blind Period|Physician Decision|0
6817296|NCT00071487|10821764|FG000|52-Week Double-Blind Period|Lost to Follow-up|0
6817297|NCT00071487|10821765|FG001|52-Week Double-Blind Period|Lost to Follow-up|0
6817298|NCT00071487|10821766|FG002|52-Week Double-Blind Period|Lost to Follow-up|2
6817299|NCT00071487|10821767|FG003|52-Week Double-Blind Period|Lost to Follow-up|2
6817300|NCT00071487|10821764|FG000|52-Week Double-Blind Period|Pregnancy|0
6817301|NCT00071487|10821765|FG001|52-Week Double-Blind Period|Pregnancy|1
6817302|NCT00071487|10821766|FG002|52-Week Double-Blind Period|Pregnancy|0
6817303|NCT00071487|10821767|FG003|52-Week Double-Blind Period|Pregnancy|0
6817304|NCT00071487|10821764|FG000|52-Week Double-Blind Period|Protocol Violation|0
6896526|NCT00633893|10915016|FG001|Overall Study|Lost to Follow-up|4
6817305|NCT00071487|10821765|FG001|52-Week Double-Blind Period|Protocol Violation|1
6817306|NCT00071487|10821766|FG002|52-Week Double-Blind Period|Protocol Violation|1
6817307|NCT00071487|10821767|FG003|52-Week Double-Blind Period|Protocol Violation|0
6817308|NCT00071487|10821764|FG000|52-Week Double-Blind Period|Death|0
6817309|NCT00071487|10821765|FG001|52-Week Double-Blind Period|Death|1
6817310|NCT00071487|10821766|FG002|52-Week Double-Blind Period|Death|0
6817311|NCT00071487|10821767|FG003|52-Week Double-Blind Period|Death|0
6817312|NCT00071487|10821764|FG000|52-Week Double-Blind Period|Lack of Compliance|6
6817313|NCT00071487|10821765|FG001|52-Week Double-Blind Period|Lack of Compliance|3
6817314|NCT00071487|10821766|FG002|52-Week Double-Blind Period|Lack of Compliance|3
6817315|NCT00071487|10821767|FG003|52-Week Double-Blind Period|Lack of Compliance|3
6817316|NCT00071487|10821764|FG000|24-Week Open-Label Extension Period|Adverse Event|0
6817317|NCT00071487|10821765|FG001|24-Week Open-Label Extension Period|Adverse Event|0
6817318|NCT00071487|10821766|FG002|24-Week Open-Label Extension Period|Adverse Event|1
6817319|NCT00071487|10821767|FG003|24-Week Open-Label Extension Period|Adverse Event|6
6817320|NCT00071487|10821764|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0
6817321|NCT00071487|10821765|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0
6817322|NCT00071487|10821766|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0
6817323|NCT00071487|10821767|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3
6898435|NCT00647556|10917690|FG001|Overall Study|Lost to Follow-up|0
6898436|NCT00647556|10917689|FG000|Overall Study|Protocol Violation|0
6898437|NCT00647556|10917690|FG001|Overall Study|Protocol Violation|1
6898438|NCT00647556|10917689|FG000|Overall Study|Withdrawal by Subject|1
6898439|NCT00647556|10917690|FG001|Overall Study|Withdrawal by Subject|0
6898440|NCT00647556|10917689|FG000|Overall Study|Surgery for pre-existing neck pain|1
6898441|NCT00647556|10917690|FG001|Overall Study|Surgery for pre-existing neck pain|0
6898442|NCT00647699|10917698|FG000|Overall Study|Lost to Follow-up|5
6898443|NCT00647699|10917699|FG001|Overall Study|Lost to Follow-up|4
6898444|NCT00647699|10917698|FG000|Overall Study|Withdrawal by Subject|3
6898445|NCT00647699|10917699|FG001|Overall Study|Withdrawal by Subject|8
6898446|NCT00648037|10917716|FG000|Overall Study|Not Treated|1
6898447|NCT00648037|10917716|FG000|Overall Study|Withdrawal by Subject|1
6898448|NCT00648037|10917716|FG000|Overall Study|Adverse Event|11
6898449|NCT00648037|10917716|FG000|Overall Study|Relapse|2
6898450|NCT00648037|10917716|FG000|Overall Study|Other|1
6898451|NCT00648167|10917733|FG000|Overall Study|Adverse Event|6
6898452|NCT00648167|10917733|FG000|Overall Study|unable to swallow tablets|1
6898453|NCT00648739|10917859|FG000|Overall Study|Adverse Event|1
6898454|NCT00648739|10917860|FG001|Overall Study|Adverse Event|0
6898455|NCT00648739|10917861|FG002|Overall Study|Adverse Event|1
6898456|NCT00648739|10917862|FG003|Overall Study|Adverse Event|2
6898457|NCT00648739|10917863|FG004|Overall Study|Adverse Event|1
6898458|NCT00648739|10917864|FG005|Overall Study|Adverse Event|0
6898459|NCT00648739|10917865|FG006|Overall Study|Adverse Event|0
6898460|NCT00648739|10917859|FG000|Overall Study|Withdrawal by Subject|1
6898461|NCT00648739|10917860|FG001|Overall Study|Withdrawal by Subject|0
6898462|NCT00648739|10917861|FG002|Overall Study|Withdrawal by Subject|1
6898463|NCT00648739|10917862|FG003|Overall Study|Withdrawal by Subject|0
6898464|NCT00648739|10917863|FG004|Overall Study|Withdrawal by Subject|0
6898465|NCT00648739|10917864|FG005|Overall Study|Withdrawal by Subject|2
6898466|NCT00648739|10917865|FG006|Overall Study|Withdrawal by Subject|0
6898467|NCT00648739|10917859|FG000|Overall Study|Lack of Efficacy|0
6898468|NCT00648739|10917860|FG001|Overall Study|Lack of Efficacy|0
6898469|NCT00648739|10917861|FG002|Overall Study|Lack of Efficacy|0
6898470|NCT00648739|10917862|FG003|Overall Study|Lack of Efficacy|0
6898471|NCT00648739|10917863|FG004|Overall Study|Lack of Efficacy|1
6898472|NCT00648739|10917864|FG005|Overall Study|Lack of Efficacy|2
6898473|NCT00648739|10917865|FG006|Overall Study|Lack of Efficacy|0
6898474|NCT00648739|10917859|FG000|Overall Study|Investigator Considered it Advisable|0
6898475|NCT00648739|10917860|FG001|Overall Study|Investigator Considered it Advisable|0
6898476|NCT00648739|10917861|FG002|Overall Study|Investigator Considered it Advisable|0
6898477|NCT00648739|10917862|FG003|Overall Study|Investigator Considered it Advisable|0
6898478|NCT00648739|10917863|FG004|Overall Study|Investigator Considered it Advisable|0
6898479|NCT00648739|10917864|FG005|Overall Study|Investigator Considered it Advisable|1
6898480|NCT00648739|10917865|FG006|Overall Study|Investigator Considered it Advisable|1
6898481|NCT00648739|10917859|FG000|Overall Study|Death|0
6898482|NCT00648739|10917860|FG001|Overall Study|Death|1
6898483|NCT00648739|10917861|FG002|Overall Study|Death|0
6898484|NCT00648739|10917862|FG003|Overall Study|Death|0
6898485|NCT00648739|10917863|FG004|Overall Study|Death|0
6898486|NCT00648739|10917864|FG005|Overall Study|Death|0
6898487|NCT00648739|10917865|FG006|Overall Study|Death|0
6898488|NCT00648739|10917859|FG000|Overall Study|Positive Human Anti-human Antibody|0
6898489|NCT00648739|10917860|FG001|Overall Study|Positive Human Anti-human Antibody|0
6898490|NCT00648739|10917861|FG002|Overall Study|Positive Human Anti-human Antibody|1
6898491|NCT00648739|10917862|FG003|Overall Study|Positive Human Anti-human Antibody|0
6898492|NCT00648739|10917863|FG004|Overall Study|Positive Human Anti-human Antibody|0
6898493|NCT00648739|10917864|FG005|Overall Study|Positive Human Anti-human Antibody|0
6898494|NCT00648739|10917865|FG006|Overall Study|Positive Human Anti-human Antibody|0
6898495|NCT00648739|10917859|FG000|Overall Study|Follow-up Visits Not Completed|0
6898496|NCT00648739|10917860|FG001|Overall Study|Follow-up Visits Not Completed|1
6898497|NCT00648739|10917861|FG002|Overall Study|Follow-up Visits Not Completed|0
6898498|NCT00648739|10917862|FG003|Overall Study|Follow-up Visits Not Completed|0
6898499|NCT00648739|10917863|FG004|Overall Study|Follow-up Visits Not Completed|0
6898500|NCT00648739|10917864|FG005|Overall Study|Follow-up Visits Not Completed|0
6898501|NCT00648739|10917865|FG006|Overall Study|Follow-up Visits Not Completed|0
6898502|NCT00649220|10917891|FG000|Overall Study|Adverse Event|2
6898503|NCT00649220|10917891|FG000|Overall Study|Withdrawal by Subject|1
6898504|NCT00649389|10917899|FG000|Overall Study|Adverse Event|22
6898505|NCT00649389|10917900|FG001|Overall Study|Adverse Event|46
6898506|NCT00649389|10917901|FG002|Overall Study|Adverse Event|38
6898507|NCT00649389|10917902|FG003|Overall Study|Adverse Event|48
6898508|NCT00649389|10917899|FG000|Overall Study|Lost to Follow-up|15
6898509|NCT00649389|10917900|FG001|Overall Study|Lost to Follow-up|17
6898510|NCT00649389|10917901|FG002|Overall Study|Lost to Follow-up|21
6898511|NCT00649389|10917902|FG003|Overall Study|Lost to Follow-up|26
6898512|NCT00649389|10917899|FG000|Overall Study|Protocol Violation|11
6898513|NCT00649389|10917900|FG001|Overall Study|Protocol Violation|13
6898514|NCT00649389|10917901|FG002|Overall Study|Protocol Violation|9
6898515|NCT00649389|10917902|FG003|Overall Study|Protocol Violation|8
6898516|NCT00649389|10917899|FG000|Overall Study|Withdrawal by Subject|20
6898517|NCT00649389|10917900|FG001|Overall Study|Withdrawal by Subject|21
6898518|NCT00649389|10917901|FG002|Overall Study|Withdrawal by Subject|19
6898519|NCT00649389|10917902|FG003|Overall Study|Withdrawal by Subject|23
6898520|NCT00649389|10917899|FG000|Overall Study|Other|3
6898521|NCT00649389|10917900|FG001|Overall Study|Other|9
6898522|NCT00649389|10917901|FG002|Overall Study|Other|1
6898523|NCT00649389|10917902|FG003|Overall Study|Other|6
6898524|NCT00649428|10917914|FG000|Overall Study|Adverse Event|2
6898525|NCT00649428|10917915|FG001|Overall Study|Adverse Event|2
6898526|NCT00649428|10917914|FG000|Overall Study|Withdrawal by Subject|6
6898527|NCT00649428|10917915|FG001|Overall Study|Withdrawal by Subject|6
6898528|NCT00649428|10917914|FG000|Overall Study|Lost to Follow-up|1
6898529|NCT00649428|10917915|FG001|Overall Study|Lost to Follow-up|3
6898530|NCT00649428|10917914|FG000|Overall Study|Insufficient manufacturing yield|5
6898531|NCT00649428|10917915|FG001|Overall Study|Insufficient manufacturing yield|1
6898532|NCT00649428|10917914|FG000|Overall Study|Protocol Violation|6
6898533|NCT00649428|10917915|FG001|Overall Study|Protocol Violation|2
6898534|NCT00649428|10917914|FG000|Overall Study|Physician Decision|0
6898535|NCT00649428|10917915|FG001|Overall Study|Physician Decision|1
6898536|NCT00650091|10917941|FG000|Amended Study Design|Withdrawal by Subject|12
6898537|NCT00650091|10917942|FG001|Amended Study Design|Withdrawal by Subject|11
6898538|NCT00650091|10917943|FG002|Amended Study Design|Withdrawal by Subject|0
6898539|NCT00650091|10917941|FG000|Amended Study Design|Physician Decision|5
6898540|NCT00650091|10917942|FG001|Amended Study Design|Physician Decision|0
6898541|NCT00650091|10917943|FG002|Amended Study Design|Physician Decision|0
6898542|NCT00650091|10917941|FG000|Amended Study Design|Adverse Event|1
6898543|NCT00650091|10917942|FG001|Amended Study Design|Adverse Event|4
6898544|NCT00650091|10917943|FG002|Amended Study Design|Adverse Event|0
6898545|NCT00650091|10917941|FG000|Amended Study Design|Lung transplantation|4
6898546|NCT00650091|10917942|FG001|Amended Study Design|Lung transplantation|2
6898547|NCT00650091|10917943|FG002|Amended Study Design|Lung transplantation|0
6898548|NCT00650091|10917941|FG000|Amended Study Design|Other|1
6898549|NCT00650091|10917942|FG001|Amended Study Design|Other|3
6898550|NCT00650091|10917943|FG002|Amended Study Design|Other|0
6898551|NCT00650104|10917951|FG000|Overall Study|Adverse Event|17
6898552|NCT00650104|10917951|FG000|Overall Study|Death|2
6898553|NCT00650104|10917951|FG000|Overall Study|Withdrawal by Subject|11
6898554|NCT00650104|10917951|FG000|Overall Study|Physician Decision|7
6898555|NCT00650104|10917951|FG000|Overall Study|Lost to Follow-up|1
6898556|NCT00650104|10917951|FG000|Overall Study|Non-compliance|2
6898557|NCT00650104|10917951|FG000|Overall Study|Sponsor Terminated Dosing|1
6898558|NCT00650585|10917971|FG000|Overall Study|Lost to Follow-up|505
6898559|NCT00650585|10917972|FG001|Overall Study|Lost to Follow-up|482
6898560|NCT00650585|10917971|FG000|Overall Study|No parental consent|935
6898561|NCT00650585|10917972|FG001|Overall Study|No parental consent|866
6898562|NCT00650585|10917971|FG000|Overall Study|Excluded/ruled ineligible|357
6898563|NCT00650585|10917972|FG001|Overall Study|Excluded/ruled ineligible|129
6898564|NCT00650767|10917982|FG000|Overall Study|Adverse Event|0
6898565|NCT00650767|10917983|FG001|Overall Study|Adverse Event|3
6898566|NCT00650767|10917984|FG002|Overall Study|Adverse Event|10
6898567|NCT00650767|10917985|FG003|Overall Study|Adverse Event|8
6978381|NCT01212770|11031722|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
6978382|NCT01212770|11031723|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2
6978383|NCT01212770|11031724|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
6978384|NCT01212770|11031716|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
6978385|NCT01212770|11031717|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
6978386|NCT01212770|11031718|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
6978387|NCT01212770|11031719|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
6978388|NCT01212770|11031720|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
6898568|NCT00650767|10917982|FG000|Overall Study|Death|1
6898569|NCT00650767|10917983|FG001|Overall Study|Death|0
6898570|NCT00650767|10917984|FG002|Overall Study|Death|0
6898571|NCT00650767|10917985|FG003|Overall Study|Death|0
6898572|NCT00650767|10917982|FG000|Overall Study|Withdrawal by Subject|2
6898573|NCT00650767|10917983|FG001|Overall Study|Withdrawal by Subject|4
6898574|NCT00650767|10917984|FG002|Overall Study|Withdrawal by Subject|3
6898575|NCT00650767|10917985|FG003|Overall Study|Withdrawal by Subject|3
6898576|NCT00650767|10917982|FG000|Overall Study|Lost to Follow-up|1
6898577|NCT00650767|10917983|FG001|Overall Study|Lost to Follow-up|1
6898578|NCT00650767|10917984|FG002|Overall Study|Lost to Follow-up|1
6898579|NCT00650767|10917985|FG003|Overall Study|Lost to Follow-up|0
6817324|NCT00071487|10821764|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0
6817325|NCT00071487|10821765|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0
6817326|NCT00071487|10821766|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0
6817327|NCT00071487|10821767|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9
6817328|NCT00071487|10821764|FG000|24-Week Open-Label Extension Period|Pregnancy|0
6817329|NCT00071487|10821765|FG001|24-Week Open-Label Extension Period|Pregnancy|0
6817330|NCT00071487|10821766|FG002|24-Week Open-Label Extension Period|Pregnancy|0
6817331|NCT00071487|10821767|FG003|24-Week Open-Label Extension Period|Pregnancy|1
6817332|NCT00071487|10821764|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0
6817333|NCT00071487|10821765|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0
6817334|NCT00071487|10821766|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0
6817335|NCT00071487|10821767|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2
6817336|NCT00071487|10821764|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0
6817337|NCT00071487|10821765|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0
6817338|NCT00071487|10821766|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0
6817339|NCT00071487|10821767|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2
6817340|NCT00071513|10821781|FG000|Intervention Component|Withdrawal by Subject|2
6817341|NCT00071513|10821782|FG001|Intervention Component|Withdrawal by Subject|3
6817342|NCT00071513|10821781|FG000|Follow-up Assessment|Withdrawal by Subject|6
6817343|NCT00071513|10821782|FG001|Follow-up Assessment|Withdrawal by Subject|6
6817344|NCT00071760|10821799|FG000|Overall Study|Adverse Event|3
6817345|NCT00071760|10821799|FG000|Overall Study|Lost to Follow-up|4
6817346|NCT00071760|10821799|FG000|Overall Study|Protocol Violation|1
6817347|NCT00071760|10821799|FG000|Overall Study|Withdrawal by Subject|3
6817348|NCT00071760|10821799|FG000|Overall Study|Insufficient Viral Load Response|3
6817349|NCT00071760|10821799|FG000|Overall Study|Pulmonary Tuberculosis|1
6817350|NCT00071760|10821799|FG000|Overall Study|Unavailability of RTV|8
6817351|NCT00071760|10821799|FG000|Overall Study|Relocation|1
6817352|NCT00071760|10821799|FG000|Overall Study|Investigator's Recommendation (Rec.)|4
6817353|NCT00071760|10821799|FG000|Overall Study|Study Team Rec./Resistance|1
6817354|NCT00071760|10821799|FG000|Overall Study|Ongoing|25
6817355|NCT00071799|10821811|FG000|Overall Study|Adverse Event|19
6817356|NCT00071799|10821812|FG001|Overall Study|Adverse Event|10
6817357|NCT00071799|10821811|FG000|Overall Study|Protocol Violation|1
6817358|NCT00071799|10821812|FG001|Overall Study|Protocol Violation|7
6817359|NCT00071799|10821811|FG000|Overall Study|Lost to Follow-up|1
6817360|NCT00071799|10821812|FG001|Overall Study|Lost to Follow-up|1
6817361|NCT00071799|10821811|FG000|Overall Study|Withdrawal by Subject|15
6817362|NCT00071799|10821812|FG001|Overall Study|Withdrawal by Subject|37
6817363|NCT00071799|10821811|FG000|Overall Study|Physician Decision|0
6817364|NCT00071799|10821812|FG001|Overall Study|Physician Decision|2
6817365|NCT00071799|10821811|FG000|Overall Study|Lack of Efficacy|11
6817366|NCT00071799|10821812|FG001|Overall Study|Lack of Efficacy|18
6817367|NCT00071799|10821811|FG000|Overall Study|Disease Progression|23
6817368|NCT00071799|10821812|FG001|Overall Study|Disease Progression|20
6817369|NCT00071799|10821811|FG000|Overall Study|Different Central+Local Pathology Review|0
6817370|NCT00071799|10821812|FG001|Overall Study|Different Central+Local Pathology Review|1
6817371|NCT00071799|10821811|FG000|Overall Study|Not Documented|0
6817372|NCT00071799|10821812|FG001|Overall Study|Not Documented|2
6817373|NCT00071812|10821828|FG000|24-Week Double-Blind Period|Adverse Event|2
6817374|NCT00071812|10821829|FG001|24-Week Double-Blind Period|Adverse Event|3
6817375|NCT00071812|10821830|FG002|24-Week Double-Blind Period|Adverse Event|4
6817376|NCT00071812|10821831|FG003|24-Week Double-Blind Period|Adverse Event|4
6817377|NCT00071812|10821828|FG000|24-Week Double-Blind Period|Lack of Efficacy|3
6817378|NCT00071812|10821829|FG001|24-Week Double-Blind Period|Lack of Efficacy|1
6817379|NCT00071812|10821830|FG002|24-Week Double-Blind Period|Lack of Efficacy|2
6817380|NCT00071812|10821831|FG003|24-Week Double-Blind Period|Lack of Efficacy|1
6817381|NCT00071812|10821828|FG000|24-Week Double-Blind Period|Lost to Follow-up|0
6817382|NCT00071812|10821829|FG001|24-Week Double-Blind Period|Lost to Follow-up|1
6817383|NCT00071812|10821830|FG002|24-Week Double-Blind Period|Lost to Follow-up|1
6817384|NCT00071812|10821831|FG003|24-Week Double-Blind Period|Lost to Follow-up|0
6817385|NCT00071812|10821828|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5
6817386|NCT00071812|10821829|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1
6817387|NCT00071812|10821830|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1
6817388|NCT00071812|10821831|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5
6817389|NCT00071812|10821828|FG000|24-Week Double-Blind Period|Protocol Violation|0
6817390|NCT00071812|10821829|FG001|24-Week Double-Blind Period|Protocol Violation|0
6817391|NCT00071812|10821830|FG002|24-Week Double-Blind Period|Protocol Violation|0
6817392|NCT00071812|10821831|FG003|24-Week Double-Blind Period|Protocol Violation|1
6817393|NCT00071812|10821828|FG000|24-Week Open-Label Extension Period|Adverse Event|0
6817394|NCT00071812|10821829|FG001|24-Week Open-Label Extension Period|Adverse Event|0
6817395|NCT00071812|10821830|FG002|24-Week Open-Label Extension Period|Adverse Event|0
6817396|NCT00071812|10821831|FG003|24-Week Open-Label Extension Period|Adverse Event|7
6817397|NCT00071812|10821828|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0
6898580|NCT00650767|10917982|FG000|Overall Study|Other|1
6898581|NCT00650767|10917983|FG001|Overall Study|Other|1
6898582|NCT00650767|10917984|FG002|Overall Study|Other|0
6898583|NCT00650767|10917985|FG003|Overall Study|Other|0
6898584|NCT00650806|10917999|FG000|Overall Study|Adverse Event|0
6898585|NCT00650806|10918000|FG001|Overall Study|Adverse Event|5
6898586|NCT00650806|10918001|FG002|Overall Study|Adverse Event|3
6898587|NCT00650806|10918002|FG003|Overall Study|Adverse Event|4
6898588|NCT00650806|10917999|FG000|Overall Study|Lost to Follow-up|7
6898589|NCT00650806|10918000|FG001|Overall Study|Lost to Follow-up|6
6898590|NCT00650806|10918001|FG002|Overall Study|Lost to Follow-up|11
6898591|NCT00650806|10918002|FG003|Overall Study|Lost to Follow-up|10
6898592|NCT00650806|10917999|FG000|Overall Study|Protocol Violation|0
6898593|NCT00650806|10918000|FG001|Overall Study|Protocol Violation|0
6898594|NCT00650806|10918001|FG002|Overall Study|Protocol Violation|0
6898595|NCT00650806|10918002|FG003|Overall Study|Protocol Violation|1
6898596|NCT00650806|10917999|FG000|Overall Study|Pregnancy|0
6898597|NCT00650806|10918000|FG001|Overall Study|Pregnancy|0
6898598|NCT00650806|10918001|FG002|Overall Study|Pregnancy|0
6898599|NCT00650806|10918002|FG003|Overall Study|Pregnancy|1
6898600|NCT00650806|10917999|FG000|Overall Study|Withdrawal by Subject|7
6898601|NCT00650806|10918000|FG001|Overall Study|Withdrawal by Subject|5
6898602|NCT00650806|10918001|FG002|Overall Study|Withdrawal by Subject|8
6898603|NCT00650806|10918002|FG003|Overall Study|Withdrawal by Subject|6
6898604|NCT00650806|10917999|FG000|Overall Study|Noncompliance with study drug regimen|1
6898605|NCT00650806|10918000|FG001|Overall Study|Noncompliance with study drug regimen|1
6898606|NCT00650806|10918001|FG002|Overall Study|Noncompliance with study drug regimen|0
6898607|NCT00650806|10918002|FG003|Overall Study|Noncompliance with study drug regimen|0
6898608|NCT00650806|10917999|FG000|Overall Study|Study terminated by sponsor|2
6898609|NCT00650806|10918000|FG001|Overall Study|Study terminated by sponsor|3
6898610|NCT00650806|10918001|FG002|Overall Study|Study terminated by sponsor|5
6898611|NCT00650806|10918002|FG003|Overall Study|Study terminated by sponsor|4
6898612|NCT00650806|10917999|FG000|Overall Study|Other|1
6898613|NCT00650806|10918000|FG001|Overall Study|Other|1
6898614|NCT00650806|10918001|FG002|Overall Study|Other|2
6898615|NCT00650806|10918002|FG003|Overall Study|Other|0
6898616|NCT00650845|10918016|FG000|Overall Study|Withdrawal by Subject|5
6898617|NCT00650845|10918017|FG001|Overall Study|Withdrawal by Subject|0
6898618|NCT00650845|10918016|FG000|Overall Study|Protocol Violation|0
6898619|NCT00650845|10918017|FG001|Overall Study|Protocol Violation|13
6898620|NCT00651118|10918054|FG000|Overall Study|Adverse Event|4
6898621|NCT00651118|10918055|FG001|Overall Study|Adverse Event|0
6898622|NCT00651118|10918056|FG002|Overall Study|Adverse Event|1
6898623|NCT00651118|10918057|FG003|Overall Study|Adverse Event|1
6898624|NCT00651118|10918054|FG000|Overall Study|Protocol Violation|2
6898625|NCT00651118|10918055|FG001|Overall Study|Protocol Violation|2
6898626|NCT00651118|10918056|FG002|Overall Study|Protocol Violation|6
6898627|NCT00651118|10918057|FG003|Overall Study|Protocol Violation|2
6898628|NCT00651118|10918054|FG000|Overall Study|Lost to Follow-up|2
6898629|NCT00651118|10918055|FG001|Overall Study|Lost to Follow-up|0
6898630|NCT00651118|10918056|FG002|Overall Study|Lost to Follow-up|1
6898631|NCT00651118|10918057|FG003|Overall Study|Lost to Follow-up|2
6898632|NCT00651118|10918054|FG000|Overall Study|administrative|1
6898633|NCT00651118|10918055|FG001|Overall Study|administrative|4
6898634|NCT00651118|10918056|FG002|Overall Study|administrative|2
6898635|NCT00651118|10918057|FG003|Overall Study|administrative|1
6898636|NCT00651118|10918054|FG000|Overall Study|Withdrawal by Subject|0
6898637|NCT00651118|10918055|FG001|Overall Study|Withdrawal by Subject|1
6898638|NCT00651118|10918056|FG002|Overall Study|Withdrawal by Subject|1
6898639|NCT00651118|10918057|FG003|Overall Study|Withdrawal by Subject|1
6898640|NCT00651157|10918070|FG000|Overall Study|Death|1
6898641|NCT00651157|10918070|FG000|Overall Study|Protocol Violation|1
6898642|NCT00651183|10918076|FG000|Overall Study|Lack of Efficacy|1
6898643|NCT00651183|10918077|FG001|Overall Study|Lack of Efficacy|0
6898644|NCT00651183|10918076|FG000|Overall Study|Efficacy insufficient + patients wish|0
6898645|NCT00651183|10918077|FG001|Overall Study|Efficacy insufficient + patients wish|1
6898646|NCT00651183|10918076|FG000|Overall Study|Tolerability insufficient|5
6898647|NCT00651183|10918077|FG001|Overall Study|Tolerability insufficient|2
6898648|NCT00651183|10918076|FG000|Overall Study|Tolerability insufficient +Patients wish|0
6898649|NCT00651183|10918077|FG001|Overall Study|Tolerability insufficient +Patients wish|1
6898650|NCT00651183|10918076|FG000|Overall Study|Withdrawal by Subject|6
6898651|NCT00651183|10918077|FG001|Overall Study|Withdrawal by Subject|3
6898652|NCT00651183|10918076|FG000|Overall Study|Lost to Follow-up|3
6898653|NCT00651183|10918077|FG001|Overall Study|Lost to Follow-up|1
6898654|NCT00651183|10918076|FG000|Overall Study|Other reasons|4
6898655|NCT00651183|10918077|FG001|Overall Study|Other reasons|2
6898656|NCT00651183|10918076|FG000|Overall Study|missing|1
6898657|NCT00651183|10918077|FG001|Overall Study|missing|0
6898658|NCT00651261|10918085|FG000|Overall Study|Adverse Event|32
6898659|NCT00651261|10918086|FG001|Overall Study|Adverse Event|22
6898660|NCT00651261|10918085|FG000|Overall Study|Death|18
6817398|NCT00071812|10821829|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0
6817399|NCT00071812|10821830|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0
6817400|NCT00071812|10821831|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17
6817401|NCT00071812|10821828|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0
6817402|NCT00071812|10821829|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0
6817403|NCT00071812|10821830|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0
6817404|NCT00071812|10821831|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2
6817405|NCT00071812|10821828|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0
6817406|NCT00071812|10821829|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0
6817407|NCT00071812|10821830|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0
6817408|NCT00071812|10821831|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12
6817409|NCT00071812|10821828|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0
6817410|NCT00071812|10821829|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0
6817411|NCT00071812|10821830|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1
6817412|NCT00071812|10821831|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2
6817413|NCT00071981|10821856|FG000|Overall Study|Lack of Efficacy|37
6817414|NCT00071981|10821857|FG001|Overall Study|Lack of Efficacy|29
6817415|NCT00071981|10821858|FG002|Overall Study|Lack of Efficacy|30
6817416|NCT00071981|10821859|FG003|Overall Study|Lack of Efficacy|43
6817417|NCT00071981|10821856|FG000|Overall Study|Adverse Event|4
6817418|NCT00071981|10821857|FG001|Overall Study|Adverse Event|4
6817419|NCT00071981|10821858|FG002|Overall Study|Adverse Event|3
6817420|NCT00071981|10821859|FG003|Overall Study|Adverse Event|1
6817421|NCT00071981|10821856|FG000|Overall Study|Death|0
6817422|NCT00071981|10821857|FG001|Overall Study|Death|0
6817423|NCT00071981|10821858|FG002|Overall Study|Death|1
6817424|NCT00071981|10821859|FG003|Overall Study|Death|1
6817425|NCT00071981|10821856|FG000|Overall Study|Withdrawal by Subject|3
6817426|NCT00071981|10821857|FG001|Overall Study|Withdrawal by Subject|1
6817427|NCT00071981|10821858|FG002|Overall Study|Withdrawal by Subject|0
6817428|NCT00071981|10821859|FG003|Overall Study|Withdrawal by Subject|0
6817429|NCT00071981|10821856|FG000|Overall Study|No protocol therapy|2
6817430|NCT00071981|10821857|FG001|Overall Study|No protocol therapy|5
6817431|NCT00071981|10821858|FG002|Overall Study|No protocol therapy|1
6817432|NCT00071981|10821859|FG003|Overall Study|No protocol therapy|0
6817433|NCT00071981|10821856|FG000|Overall Study|others (not specified in the study)|0
6817434|NCT00071981|10821857|FG001|Overall Study|others (not specified in the study)|2
6817435|NCT00071981|10821858|FG002|Overall Study|others (not specified in the study)|2
6817436|NCT00071981|10821859|FG003|Overall Study|others (not specified in the study)|0
6817437|NCT00072176|10821871|FG000|Overall Study|Withdrawal by Subject|1
6817438|NCT00072176|10821872|FG001|Overall Study|Withdrawal by Subject|0
6817439|NCT00072176|10821871|FG000|Overall Study|Protocol Violation|0
6817440|NCT00072176|10821872|FG001|Overall Study|Protocol Violation|1
6817441|NCT00072189|10821878|FG000|Overall Study|Withdrawal by Subject|1
6817442|NCT00072280|10821884|FG000|Treatment|Found ineligible|1
6817443|NCT00072280|10821885|FG001|Treatment|Found ineligible|2
6817444|NCT00072280|10821884|FG000|Follow-up|Early termination of study|2
6817445|NCT00072280|10821885|FG001|Follow-up|Early termination of study|2
6817446|NCT00072293|10821892|FG000|Overall Study|Lost to Follow-up|1
6817447|NCT00072293|10821893|FG001|Overall Study|Lost to Follow-up|1
6817448|NCT00072293|10821892|FG000|Overall Study|Withdrawal by Subject|0
6817449|NCT00072293|10821893|FG001|Overall Study|Withdrawal by Subject|1
6817450|NCT00072384|10821899|FG000|Overall Study|Physician Decision|1
6817451|NCT00072384|10821899|FG000|Overall Study|Ineligible|8
6817452|NCT00072475|10821909|FG000|Overall Study|Adverse Event|44
6817453|NCT00072475|10821909|FG000|Overall Study|Death|3
6817454|NCT00072475|10821909|FG000|Overall Study|Withdrawal by Subject|46
6817455|NCT00072475|10821909|FG000|Overall Study|Patient/Investigator Decision|4
6817456|NCT00073008|10821932|FG000|Overall Study|Missing|6
6817457|NCT00073008|10821933|FG001|Overall Study|Missing|6
6817458|NCT00073008|10821932|FG000|Overall Study|Withdrawal by Subject|2
6817459|NCT00073008|10821933|FG001|Overall Study|Withdrawal by Subject|2
6817460|NCT00073008|10821932|FG000|Overall Study|Lost to Follow-up|1
6817461|NCT00073008|10821933|FG001|Overall Study|Lost to Follow-up|3
6817462|NCT00073008|10821932|FG000|Overall Study|Death|46
6817463|NCT00073008|10821933|FG001|Overall Study|Death|47
6817464|NCT00073008|10821932|FG000|Overall Study|"Other selected on Case Report Form"|7
6817465|NCT00073008|10821933|FG001|Overall Study|"Other selected on Case Report Form"|5
6817466|NCT00073021|10821941|FG000|Overall Study|Protocol Violation|2
6817467|NCT00073021|10821942|FG001|Overall Study|Protocol Violation|1
6817468|NCT00073021|10821941|FG000|Overall Study|Adverse Event|4
6817469|NCT00073021|10821942|FG001|Overall Study|Adverse Event|4
6817470|NCT00073021|10821941|FG000|Overall Study|Withdrawal by Subject|6
6817471|NCT00073021|10821942|FG001|Overall Study|Withdrawal by Subject|5
6817472|NCT00073021|10821941|FG000|Overall Study|Physician Decision|3
6817473|NCT00073021|10821942|FG001|Overall Study|Physician Decision|1
6817474|NCT00073021|10821941|FG000|Overall Study|Lack of Efficacy|11
6817475|NCT00073021|10821942|FG001|Overall Study|Lack of Efficacy|5
6817476|NCT00073307|10821954|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22
6817477|NCT00073307|10821955|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17
6817478|NCT00073307|10821956|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0
6896527|NCT00633893|10915017|FG002|Overall Study|Lost to Follow-up|8
6817479|NCT00073307|10821954|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1
6817480|NCT00073307|10821955|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6
6817481|NCT00073307|10821956|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0
6817482|NCT00073307|10821954|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6
6817483|NCT00073307|10821955|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11
6817484|NCT00073307|10821956|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0
6817485|NCT00073307|10821954|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
6817486|NCT00073307|10821955|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
6817487|NCT00073307|10821956|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0
6817488|NCT00073307|10821954|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1
6817489|NCT00073307|10821955|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2
6817490|NCT00073307|10821956|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0
6817491|NCT00073307|10821954|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1
6817492|NCT00073307|10821955|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
6817493|NCT00073307|10821956|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
6817494|NCT00073307|10821954|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
6817495|NCT00073307|10821955|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1
6817496|NCT00073307|10821956|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
6817497|NCT00073307|10821954|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165
6817498|NCT00073307|10821955|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114
6817499|NCT00073307|10821956|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0
6817500|NCT00073307|10821954|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
6817501|NCT00073307|10821955|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1
6817502|NCT00073307|10821956|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
6817503|NCT00073307|10821954|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17
6817504|NCT00073307|10821955|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0
6817505|NCT00073307|10821956|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19
6817506|NCT00073307|10821954|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
6817507|NCT00073307|10821955|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0
6817508|NCT00073307|10821956|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
6817509|NCT00073307|10821954|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19
6817510|NCT00073307|10821955|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0
6817511|NCT00073307|10821956|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9
6817512|NCT00073307|10821954|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37
6817513|NCT00073307|10821955|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0
6817514|NCT00073307|10821956|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28
6817515|NCT00073307|10821954|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
6817516|NCT00073307|10821955|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0
6817517|NCT00073307|10821956|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
6817518|NCT00073307|10821954|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
6817519|NCT00073307|10821955|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0
6817520|NCT00073307|10821956|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
6817521|NCT00073307|10821954|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
6817522|NCT00073307|10821955|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
6817523|NCT00073307|10821956|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3
6817524|NCT00073307|10821954|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3
6817525|NCT00073307|10821955|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0
6817526|NCT00073307|10821956|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1
6817527|NCT00073307|10821954|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19
6817528|NCT00073307|10821955|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0
6817529|NCT00073307|10821956|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9
6817530|NCT00073307|10821954|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35
6817531|NCT00073307|10821955|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0
6817532|NCT00073307|10821956|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83
6817533|NCT00073528|10821980|FG000|Overall Study|Death|488
6817534|NCT00073528|10821981|FG001|Overall Study|Death|473
6817535|NCT00073528|10821980|FG000|Overall Study|Lost to Follow-up|52
6817536|NCT00073528|10821981|FG001|Overall Study|Lost to Follow-up|45
6817537|NCT00073528|10821980|FG000|Overall Study|Withdrawal by Subject|50
6898661|NCT00651261|10918086|FG001|Overall Study|Death|18
6898662|NCT00651261|10918085|FG000|Overall Study|Withdrawal by Subject|22
6898663|NCT00651261|10918086|FG001|Overall Study|Withdrawal by Subject|40
6898664|NCT00651261|10918085|FG000|Overall Study|Induction failure|24
6898665|NCT00651261|10918086|FG001|Overall Study|Induction failure|35
6898666|NCT00651261|10918085|FG000|Overall Study|Disease progression|58
6898667|NCT00651261|10918086|FG001|Overall Study|Disease progression|58
6898668|NCT00651261|10918085|FG000|Overall Study|Alternative therapy|109
6817538|NCT00073528|10821981|FG001|Overall Study|Withdrawal by Subject|45
6817539|NCT00073528|10821980|FG000|Overall Study|Study terminated by Sponsor|10
6817540|NCT00073528|10821981|FG001|Overall Study|Study terminated by Sponsor|29
6817541|NCT00073528|10821980|FG000|Overall Study|Other|18
6817542|NCT00073528|10821981|FG001|Overall Study|Other|19
6817543|NCT00073528|10821980|FG000|Overall Study|Other|9
6817544|NCT00073528|10821981|FG001|Overall Study|Other|12
6817545|NCT00073528|10821980|FG000|Overall Study|Protocol Violation|3
6817546|NCT00073528|10821981|FG001|Overall Study|Protocol Violation|5
6817547|NCT00073749|10821994|FG000|Overall Study|Disease Progression|2
6817548|NCT00073749|10821995|FG001|Overall Study|Disease Progression|0
6817549|NCT00073749|10821996|FG002|Overall Study|Disease Progression|3
6817550|NCT00073749|10821997|FG003|Overall Study|Disease Progression|2
6817551|NCT00073749|10821998|FG004|Overall Study|Disease Progression|3
6817552|NCT00073749|10821999|FG005|Overall Study|Disease Progression|1
6817553|NCT00073749|10822000|FG006|Overall Study|Disease Progression|3
6817554|NCT00073749|10821994|FG000|Overall Study|Death|0
6817555|NCT00073749|10821995|FG001|Overall Study|Death|1
6817556|NCT00073749|10821996|FG002|Overall Study|Death|1
6817557|NCT00073749|10821997|FG003|Overall Study|Death|0
6817558|NCT00073749|10821998|FG004|Overall Study|Death|0
6817559|NCT00073749|10821999|FG005|Overall Study|Death|0
6817560|NCT00073749|10822000|FG006|Overall Study|Death|29
6817561|NCT00073749|10821994|FG000|Overall Study|Adverse Event|0
6817562|NCT00073749|10821995|FG001|Overall Study|Adverse Event|3
6817563|NCT00073749|10821996|FG002|Overall Study|Adverse Event|6
6817564|NCT00073749|10821997|FG003|Overall Study|Adverse Event|4
6817565|NCT00073749|10821998|FG004|Overall Study|Adverse Event|2
6817566|NCT00073749|10821999|FG005|Overall Study|Adverse Event|1
6817567|NCT00073749|10822000|FG006|Overall Study|Adverse Event|0
6817568|NCT00073749|10821994|FG000|Overall Study|Physician Decision|0
6817569|NCT00073749|10821995|FG001|Overall Study|Physician Decision|0
6817570|NCT00073749|10821996|FG002|Overall Study|Physician Decision|1
6817571|NCT00073749|10821997|FG003|Overall Study|Physician Decision|0
6817572|NCT00073749|10821998|FG004|Overall Study|Physician Decision|0
6817573|NCT00073749|10821999|FG005|Overall Study|Physician Decision|2
6817574|NCT00073749|10822000|FG006|Overall Study|Physician Decision|0
6817575|NCT00073749|10821994|FG000|Overall Study|Withdrawal by Subject|0
6817576|NCT00073749|10821995|FG001|Overall Study|Withdrawal by Subject|1
6817577|NCT00073749|10821996|FG002|Overall Study|Withdrawal by Subject|0
6817578|NCT00073749|10821997|FG003|Overall Study|Withdrawal by Subject|0
6817579|NCT00073749|10821998|FG004|Overall Study|Withdrawal by Subject|1
6817580|NCT00073749|10821999|FG005|Overall Study|Withdrawal by Subject|0
6817581|NCT00073749|10822000|FG006|Overall Study|Withdrawal by Subject|2
6817582|NCT00073749|10821994|FG000|Overall Study|Discontinuation of Study by Sponsor|0
6817583|NCT00073749|10821995|FG001|Overall Study|Discontinuation of Study by Sponsor|0
6817584|NCT00073749|10821996|FG002|Overall Study|Discontinuation of Study by Sponsor|0
6817585|NCT00073749|10821997|FG003|Overall Study|Discontinuation of Study by Sponsor|0
6817586|NCT00073749|10821998|FG004|Overall Study|Discontinuation of Study by Sponsor|0
6817587|NCT00073749|10821999|FG005|Overall Study|Discontinuation of Study by Sponsor|0
6817588|NCT00073749|10822000|FG006|Overall Study|Discontinuation of Study by Sponsor|4
6817589|NCT00073749|10821994|FG000|Overall Study|Lost to Follow-up|0
6817590|NCT00073749|10821995|FG001|Overall Study|Lost to Follow-up|0
6817591|NCT00073749|10821996|FG002|Overall Study|Lost to Follow-up|0
6817592|NCT00073749|10821997|FG003|Overall Study|Lost to Follow-up|0
6817593|NCT00073749|10821998|FG004|Overall Study|Lost to Follow-up|0
6817594|NCT00073749|10821999|FG005|Overall Study|Lost to Follow-up|0
6817595|NCT00073749|10822000|FG006|Overall Study|Lost to Follow-up|2
6817596|NCT00073749|10821994|FG000|Overall Study|Other|0
6817597|NCT00073749|10821995|FG001|Overall Study|Other|0
6817598|NCT00073749|10821996|FG002|Overall Study|Other|0
6817599|NCT00073749|10821997|FG003|Overall Study|Other|0
6817600|NCT00073749|10821998|FG004|Overall Study|Other|0
6817601|NCT00073749|10821999|FG005|Overall Study|Other|2
6817602|NCT00073749|10822000|FG006|Overall Study|Other|0
6817603|NCT00073918|10822019|FG000|Overall Study|Eligibility requirement not met - HAMA+|1
6817604|NCT00073918|10822019|FG000|Overall Study|Rapid disease progression|2
6817605|NCT00073918|10822019|FG000|Overall Study|Eligibility requirement not met-low CD20|1
6817606|NCT00073983|10822029|FG000|Overall Study|not evaluable|1
6817607|NCT00074152|10822041|FG000|Overall Study|Death|21
6817608|NCT00074152|10822042|FG001|Overall Study|Death|9
6817609|NCT00074152|10822041|FG000|Overall Study|Lack of Efficacy|34
6817610|NCT00074152|10822042|FG001|Overall Study|Lack of Efficacy|24
6817611|NCT00074282|10822061|FG000|Step 1|Adverse Event|32
6817612|NCT00074282|10822062|FG001|Step 1|Adverse Event|0
6817613|NCT00074282|10822063|FG002|Step 1|Adverse Event|0
6817614|NCT00074282|10822061|FG000|Step 1|Death|6
6817615|NCT00074282|10822062|FG001|Step 1|Death|0
6817616|NCT00074282|10822063|FG002|Step 1|Death|0
6817617|NCT00074282|10822061|FG000|Step 1|Withdrawal by Subject|7
6817618|NCT00074282|10822062|FG001|Step 1|Withdrawal by Subject|0
6817619|NCT00074282|10822063|FG002|Step 1|Withdrawal by Subject|0
6817620|NCT00074282|10822061|FG000|Step 1|Disease progression|2
6817621|NCT00074282|10822062|FG001|Step 1|Disease progression|0
6817622|NCT00074282|10822063|FG002|Step 1|Disease progression|0
6817623|NCT00074282|10822061|FG000|Step 1|Alternative therapy|2
6817624|NCT00074282|10822062|FG001|Step 1|Alternative therapy|0
6817625|NCT00074282|10822063|FG002|Step 1|Alternative therapy|0
6817626|NCT00074282|10822061|FG000|Step 1|Other complicating disease|2
6817627|NCT00074282|10822062|FG001|Step 1|Other complicating disease|0
6817628|NCT00074282|10822063|FG002|Step 1|Other complicating disease|0
6817629|NCT00074282|10822061|FG000|Step 1|Physician Decision|1
6817630|NCT00074282|10822062|FG001|Step 1|Physician Decision|0
6817631|NCT00074282|10822063|FG002|Step 1|Physician Decision|0
6817632|NCT00074282|10822061|FG000|Step 1|Ineligible|4
6817633|NCT00074282|10822062|FG001|Step 1|Ineligible|0
6817634|NCT00074282|10822063|FG002|Step 1|Ineligible|0
6817635|NCT00074282|10822061|FG000|Step 1|Never started treatment|2
6817636|NCT00074282|10822062|FG001|Step 1|Never started treatment|0
6817637|NCT00074282|10822063|FG002|Step 1|Never started treatment|0
6817638|NCT00074282|10822061|FG000|Step 2|Adverse Event|0
6817639|NCT00074282|10822062|FG001|Step 2|Adverse Event|2
6817640|NCT00074282|10822063|FG002|Step 2|Adverse Event|12
6817641|NCT00074282|10822061|FG000|Step 2|Disease progression|0
6817642|NCT00074282|10822062|FG001|Step 2|Disease progression|0
6817643|NCT00074282|10822063|FG002|Step 2|Disease progression|5
6817644|NCT00074282|10822061|FG000|Step 2|Death|0
6817645|NCT00074282|10822062|FG001|Step 2|Death|0
6817646|NCT00074282|10822063|FG002|Step 2|Death|3
6898669|NCT00651261|10918086|FG001|Overall Study|Alternative therapy|107
6898670|NCT00651261|10918085|FG000|Overall Study|Other disease or participant decisions|23
6898671|NCT00651261|10918086|FG001|Overall Study|Other disease or participant decisions|23
6898672|NCT00651261|10918085|FG000|Overall Study|Never treated|5
6898673|NCT00651261|10918086|FG001|Overall Study|Never treated|3
6898674|NCT00651313|10918094|FG000|Overall Study|Adverse Event|0
6898675|NCT00651313|10918095|FG001|Overall Study|Adverse Event|1
6898676|NCT00651313|10918094|FG000|Overall Study|Withdrawal by Subject|3
6898677|NCT00651313|10918095|FG001|Overall Study|Withdrawal by Subject|1
6898678|NCT00651313|10918094|FG000|Overall Study|Lost to Follow-up|1
6898679|NCT00651313|10918095|FG001|Overall Study|Lost to Follow-up|1
6898680|NCT00651313|10918094|FG000|Overall Study|Adminstrative Discontinuation|2
6898681|NCT00651313|10918095|FG001|Overall Study|Adminstrative Discontinuation|3
6973473|NCT01181141|11025260|FG000|Overall Study|Protocol Violation|3
6973474|NCT01181141|11025261|FG001|Overall Study|Protocol Violation|1
6973475|NCT01181141|11025260|FG000|Overall Study|Withdrawal by Subject|3
6973476|NCT01181141|11025261|FG001|Overall Study|Withdrawal by Subject|1
6973477|NCT01181167|11025269|FG000|Overall Study|Adverse Event|11
6973478|NCT01181167|11025270|FG001|Overall Study|Adverse Event|21
6973479|NCT01181167|11025269|FG000|Overall Study|Lost to Follow-up|1
6973480|NCT01181167|11025270|FG001|Overall Study|Lost to Follow-up|0
6973481|NCT01181167|11025269|FG000|Overall Study|Physician Decision|2
6973482|NCT01181167|11025270|FG001|Overall Study|Physician Decision|3
6973483|NCT01181167|11025269|FG000|Overall Study|Protocol Violation|3
6973484|NCT01181167|11025270|FG001|Overall Study|Protocol Violation|0
6973485|NCT01181167|11025269|FG000|Overall Study|Withdrawal by Subject|6
6973486|NCT01181167|11025270|FG001|Overall Study|Withdrawal by Subject|8
6973487|NCT01181271|11025280|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6
6973488|NCT01181271|11025280|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4
6973489|NCT01181271|11025280|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2
6973490|NCT01181271|11025280|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1
6973491|NCT01181531|11025350|FG000|Overall Study|Other|17
6973492|NCT01181531|11025351|FG001|Overall Study|Other|12
6973493|NCT01181531|11025350|FG000|Overall Study|Partial consent by subject withdrawn|0
6973494|NCT01181531|11025351|FG001|Overall Study|Partial consent by subject withdrawn|1
6973495|NCT01181531|11025350|FG000|Overall Study|Physician Decision|3
6973496|NCT01181531|11025351|FG001|Overall Study|Physician Decision|1
6973497|NCT01181531|11025350|FG000|Overall Study|Noncompliance|2
6973498|NCT01181531|11025351|FG001|Overall Study|Noncompliance|2
6973499|NCT01181531|11025350|FG000|Overall Study|Ineligibility determined|1
6973500|NCT01181531|11025351|FG001|Overall Study|Ineligibility determined|2
6973501|NCT01181531|11025350|FG000|Overall Study|Protocol Specified Criteria|15
6973502|NCT01181531|11025351|FG001|Overall Study|Protocol Specified Criteria|8
6973503|NCT01181531|11025350|FG000|Overall Study|Pregnancy|0
6973504|NCT01181531|11025351|FG001|Overall Study|Pregnancy|1
6973505|NCT01181531|11025350|FG000|Overall Study|Withdrawal by Subject|8
6973506|NCT01181531|11025351|FG001|Overall Study|Withdrawal by Subject|7
6973507|NCT01181531|11025350|FG000|Overall Study|Protocol Violation|6
6973508|NCT01181531|11025351|FG001|Overall Study|Protocol Violation|6
6973509|NCT01181531|11025350|FG000|Overall Study|Death|9
6973510|NCT01181531|11025351|FG001|Overall Study|Death|12
6973511|NCT01181531|11025350|FG000|Overall Study|Adverse Event|0
6973512|NCT01181531|11025351|FG001|Overall Study|Adverse Event|1
6817647|NCT00074282|10822061|FG000|Step 2|Withdrawal by Subject|0
6817648|NCT00074282|10822062|FG001|Step 2|Withdrawal by Subject|0
6817649|NCT00074282|10822063|FG002|Step 2|Withdrawal by Subject|2
6817650|NCT00074282|10822061|FG000|Step 2|Physician Decision|0
6817651|NCT00074282|10822062|FG001|Step 2|Physician Decision|0
6973513|NCT01181609|11025362|FG000|Overall Study|Adverse Event|1
6973514|NCT01181609|11025362|FG000|Overall Study|Withdrawal by Subject|1
6973515|NCT01181609|11025362|FG000|Overall Study|Lost to Follow-up|1
6973516|NCT01181609|11025362|FG000|Overall Study|Death|50
6973517|NCT01181726|11025381|FG000|First Intervention|Adverse Event|1
6973518|NCT01181726|11025382|FG001|First Intervention|Adverse Event|0
6973519|NCT01181895|11025408|FG000|Overall Study|Adverse Event|3
6973520|NCT01181895|11025409|FG001|Overall Study|Adverse Event|1
6817652|NCT00074282|10822063|FG002|Step 2|Physician Decision|1
6817653|NCT00074282|10822061|FG000|Step 2|Ineligible|0
6817654|NCT00074282|10822062|FG001|Step 2|Ineligible|0
6817655|NCT00074282|10822063|FG002|Step 2|Ineligible|1
6817656|NCT00074412|10822089|FG000|Overall Study|Death|30
6817657|NCT00074412|10822090|FG001|Overall Study|Death|26
6817658|NCT00074412|10822089|FG000|Overall Study|Lost to Follow-up|52
6817659|NCT00074412|10822090|FG001|Overall Study|Lost to Follow-up|58
6817660|NCT00074490|10822102|FG000|Overall Study|Progressive malignancy|0
6817661|NCT00074490|10822103|FG001|Overall Study|Progressive malignancy|7
6817662|NCT00074490|10822104|FG002|Overall Study|Progressive malignancy|0
6817663|NCT00074490|10822105|FG003|Overall Study|Progressive malignancy|0
6817664|NCT00074490|10822106|FG004|Overall Study|Progressive malignancy|3
6817665|NCT00074490|10822107|FG005|Overall Study|Progressive malignancy|0
6817666|NCT00074581|10822122|FG000|Overall Study|Death|15
6817667|NCT00074581|10822123|FG001|Overall Study|Death|16
6817668|NCT00074581|10822122|FG000|Overall Study|Withdrawal by Subject|50
6817669|NCT00074581|10822123|FG001|Overall Study|Withdrawal by Subject|49
6817670|NCT00074581|10822122|FG000|Overall Study|Unable to adhere to visit schedule|13
6817671|NCT00074581|10822123|FG001|Overall Study|Unable to adhere to visit schedule|14
6817672|NCT00074581|10822122|FG000|Overall Study|Relocated|14
6817673|NCT00074581|10822123|FG001|Overall Study|Relocated|9
6817674|NCT00074581|10822122|FG000|Overall Study|Were withdrawn by investigator|5
6817675|NCT00074581|10822123|FG001|Overall Study|Were withdrawn by investigator|2
6817676|NCT00074581|10822122|FG000|Overall Study|Lost to Follow-up|16
6817677|NCT00074581|10822123|FG001|Overall Study|Lost to Follow-up|11
6817678|NCT00074581|10822122|FG000|Overall Study|Ended relationship w. index participant|117
6817679|NCT00074581|10822123|FG001|Overall Study|Ended relationship w. index participant|106
6817680|NCT00074581|10822122|FG000|Overall Study|Other|14
6817681|NCT00074581|10822123|FG001|Overall Study|Other|19
6817682|NCT00074711|10822131|FG000|Overall Study|Withdrawal by Subject|1
6817683|NCT00074711|10822132|FG001|Overall Study|Withdrawal by Subject|1
6817684|NCT00074711|10822131|FG000|Overall Study|Lost to Follow-up|10
6817685|NCT00074711|10822132|FG001|Overall Study|Lost to Follow-up|8
6817686|NCT00074711|10822131|FG000|Overall Study|Participant stopped study drug|4
6817687|NCT00074711|10822132|FG001|Overall Study|Participant stopped study drug|6
6817688|NCT00074958|10822160|FG000|Overall Study|Adverse Event|1
6817689|NCT00074984|10822166|FG000|Overall Study|Death|1
6817690|NCT00074984|10822167|FG001|Overall Study|Death|2
6817691|NCT00074984|10822166|FG000|Overall Study|Withdrawal by Subject|2
6817692|NCT00074984|10822167|FG001|Overall Study|Withdrawal by Subject|3
6817693|NCT00074984|10822166|FG000|Overall Study|Patient Withdrawn Per Protocol|0
6817694|NCT00074984|10822167|FG001|Overall Study|Patient Withdrawn Per Protocol|3
6817695|NCT00075023|10822176|FG000|Pilot Study|Physician Decision|1
6817696|NCT00075023|10822177|FG001|Pilot Study|Physician Decision|2
6817697|NCT00075023|10822176|FG000|Pilot Study|Withdrawal by Subject|1
6817698|NCT00075023|10822177|FG001|Pilot Study|Withdrawal by Subject|0
6817699|NCT00075218|10822196|FG000|Double-Blind Treatment|Adverse Event|23
6817700|NCT00075218|10822197|FG001|Double-Blind Treatment|Adverse Event|4
6817701|NCT00075218|10822198|FG002|Double-Blind Treatment|Adverse Event|0
6817702|NCT00075218|10822196|FG000|Double-Blind Treatment|Withdrawal by Subject|7
6817703|NCT00075218|10822197|FG001|Double-Blind Treatment|Withdrawal by Subject|4
6817704|NCT00075218|10822198|FG002|Double-Blind Treatment|Withdrawal by Subject|0
6817705|NCT00075218|10822196|FG000|Double-Blind Treatment|Lost to Follow-up|1
6817706|NCT00075218|10822197|FG001|Double-Blind Treatment|Lost to Follow-up|0
6817707|NCT00075218|10822198|FG002|Double-Blind Treatment|Lost to Follow-up|0
6817708|NCT00075218|10822196|FG000|Double-Blind Treatment|Lack of Efficacy|58
6817709|NCT00075218|10822197|FG001|Double-Blind Treatment|Lack of Efficacy|6
6817710|NCT00075218|10822198|FG002|Double-Blind Treatment|Lack of Efficacy|0
6817711|NCT00075218|10822196|FG000|Double-Blind Treatment|Decision of Sponsor|0
6817712|NCT00075218|10822197|FG001|Double-Blind Treatment|Decision of Sponsor|1
6817713|NCT00075218|10822198|FG002|Double-Blind Treatment|Decision of Sponsor|0
6817714|NCT00075218|10822196|FG000|Double-Blind Treatment|No study medication taken|2
6817715|NCT00075218|10822197|FG001|Double-Blind Treatment|No study medication taken|0
6817716|NCT00075218|10822198|FG002|Double-Blind Treatment|No study medication taken|0
6817717|NCT00075218|10822196|FG000|Open-Label Treatment|Lack of Efficacy|0
6817718|NCT00075218|10822197|FG001|Open-Label Treatment|Lack of Efficacy|0
6817719|NCT00075218|10822198|FG002|Open-Label Treatment|Lack of Efficacy|174
6817720|NCT00075218|10822196|FG000|Open-Label Treatment|Adverse Event|0
6817721|NCT00075218|10822197|FG001|Open-Label Treatment|Adverse Event|0
6817722|NCT00075218|10822198|FG002|Open-Label Treatment|Adverse Event|51
6817723|NCT00075218|10822196|FG000|Open-Label Treatment|Withdrawal by Subject|0
6817724|NCT00075218|10822197|FG001|Open-Label Treatment|Withdrawal by Subject|0
6817725|NCT00075218|10822198|FG002|Open-Label Treatment|Withdrawal by Subject|12
6817726|NCT00075218|10822196|FG000|Open-Label Treatment|Decision of Sponsor|0
6817727|NCT00075218|10822197|FG001|Open-Label Treatment|Decision of Sponsor|0
6817728|NCT00075218|10822198|FG002|Open-Label Treatment|Decision of Sponsor|8
6817729|NCT00075218|10822196|FG000|Open-Label Treatment|Protocol Violation|0
6817730|NCT00075218|10822197|FG001|Open-Label Treatment|Protocol Violation|0
6817731|NCT00075218|10822198|FG002|Open-Label Treatment|Protocol Violation|1
6817732|NCT00075218|10822196|FG000|Open-Label Treatment|enrolled in a separate continuation|0
6817733|NCT00075218|10822197|FG001|Open-Label Treatment|enrolled in a separate continuation|0
6817734|NCT00075218|10822198|FG002|Open-Label Treatment|enrolled in a separate continuation|9
6817735|NCT00075270|10822207|FG000|Overall Study|Withdrawal by Subject|28
6817736|NCT00075270|10822208|FG001|Overall Study|Withdrawal by Subject|21
6817737|NCT00075270|10822207|FG000|Overall Study|Lost to Follow-up|25
6817738|NCT00075270|10822208|FG001|Overall Study|Lost to Follow-up|28
6817739|NCT00075270|10822207|FG000|Overall Study|Protocol Violation|0
6817740|NCT00075270|10822208|FG001|Overall Study|Protocol Violation|2
6817741|NCT00075270|10822207|FG000|Overall Study|Death|198
6817742|NCT00075270|10822208|FG001|Overall Study|Death|215
6898682|NCT00651664|10918134|FG000|Overall Study|Occurrence of Adverse Event(s)|0
6898683|NCT00651664|10918135|FG001|Overall Study|Occurrence of Adverse Event(s)|0
6898684|NCT00651664|10918136|FG002|Overall Study|Occurrence of Adverse Event(s)|0
6898685|NCT00651664|10918137|FG003|Overall Study|Occurrence of Adverse Event(s)|0
6898686|NCT00651664|10918138|FG004|Overall Study|Occurrence of Adverse Event(s)|0
6898687|NCT00651664|10918139|FG005|Overall Study|Occurrence of Adverse Event(s)|0
6898688|NCT00651664|10918140|FG006|Overall Study|Occurrence of Adverse Event(s)|1
6898689|NCT00651664|10918141|FG007|Overall Study|Occurrence of Adverse Event(s)|0
6898690|NCT00651664|10918142|FG008|Overall Study|Occurrence of Adverse Event(s)|1
6898691|NCT00651664|10918143|FG009|Overall Study|Occurrence of Adverse Event(s)|0
6898692|NCT00651664|10918134|FG000|Overall Study|Unsatisfactory Therapeutic Response|0
6898693|NCT00651664|10918135|FG001|Overall Study|Unsatisfactory Therapeutic Response|0
6898694|NCT00651664|10918136|FG002|Overall Study|Unsatisfactory Therapeutic Response|0
6898695|NCT00651664|10918137|FG003|Overall Study|Unsatisfactory Therapeutic Response|0
6898696|NCT00651664|10918138|FG004|Overall Study|Unsatisfactory Therapeutic Response|1
6898697|NCT00651664|10918139|FG005|Overall Study|Unsatisfactory Therapeutic Response|1
6898698|NCT00651664|10918140|FG006|Overall Study|Unsatisfactory Therapeutic Response|0
6898699|NCT00651664|10918141|FG007|Overall Study|Unsatisfactory Therapeutic Response|1
6898700|NCT00651664|10918142|FG008|Overall Study|Unsatisfactory Therapeutic Response|0
6898701|NCT00651664|10918143|FG009|Overall Study|Unsatisfactory Therapeutic Response|1
6898702|NCT00651664|10918134|FG000|Overall Study|Progressive Disease|3
6898703|NCT00651664|10918135|FG001|Overall Study|Progressive Disease|3
6898704|NCT00651664|10918136|FG002|Overall Study|Progressive Disease|3
6898705|NCT00651664|10918137|FG003|Overall Study|Progressive Disease|12
6898706|NCT00651664|10918138|FG004|Overall Study|Progressive Disease|4
6898707|NCT00651664|10918139|FG005|Overall Study|Progressive Disease|1
6898708|NCT00651664|10918140|FG006|Overall Study|Progressive Disease|3
6898709|NCT00651664|10918141|FG007|Overall Study|Progressive Disease|6
6898710|NCT00651664|10918142|FG008|Overall Study|Progressive Disease|5
6898711|NCT00651664|10918143|FG009|Overall Study|Progressive Disease|5
6898712|NCT00651664|10918134|FG000|Overall Study|Patient Declined Further Treatment|0
6898713|NCT00651664|10918135|FG001|Overall Study|Patient Declined Further Treatment|0
6898714|NCT00651664|10918136|FG002|Overall Study|Patient Declined Further Treatment|0
6898715|NCT00651664|10918137|FG003|Overall Study|Patient Declined Further Treatment|1
6898716|NCT00651664|10918138|FG004|Overall Study|Patient Declined Further Treatment|1
6898717|NCT00651664|10918139|FG005|Overall Study|Patient Declined Further Treatment|1
6898718|NCT00651664|10918140|FG006|Overall Study|Patient Declined Further Treatment|0
6898719|NCT00651664|10918141|FG007|Overall Study|Patient Declined Further Treatment|0
6898720|NCT00651664|10918142|FG008|Overall Study|Patient Declined Further Treatment|0
6898721|NCT00651664|10918143|FG009|Overall Study|Patient Declined Further Treatment|1
6898722|NCT00651664|10918134|FG000|Overall Study|Symptomatic Deterioration|0
6898723|NCT00651664|10918135|FG001|Overall Study|Symptomatic Deterioration|0
6898724|NCT00651664|10918136|FG002|Overall Study|Symptomatic Deterioration|0
6898725|NCT00651664|10918137|FG003|Overall Study|Symptomatic Deterioration|1
6898726|NCT00651664|10918138|FG004|Overall Study|Symptomatic Deterioration|0
6898727|NCT00651664|10918139|FG005|Overall Study|Symptomatic Deterioration|0
6898728|NCT00651664|10918140|FG006|Overall Study|Symptomatic Deterioration|1
6898729|NCT00651664|10918141|FG007|Overall Study|Symptomatic Deterioration|0
6898730|NCT00651664|10918142|FG008|Overall Study|Symptomatic Deterioration|1
6898731|NCT00651664|10918143|FG009|Overall Study|Symptomatic Deterioration|0
6898732|NCT00651664|10918134|FG000|Overall Study|Reason not Specified|0
6898733|NCT00651664|10918135|FG001|Overall Study|Reason not Specified|0
6898734|NCT00651664|10918136|FG002|Overall Study|Reason not Specified|0
6898735|NCT00651664|10918137|FG003|Overall Study|Reason not Specified|0
6898736|NCT00651664|10918138|FG004|Overall Study|Reason not Specified|0
6898737|NCT00651664|10918139|FG005|Overall Study|Reason not Specified|0
6898738|NCT00651664|10918140|FG006|Overall Study|Reason not Specified|1
6898739|NCT00651664|10918141|FG007|Overall Study|Reason not Specified|0
6898740|NCT00651664|10918142|FG008|Overall Study|Reason not Specified|0
6898741|NCT00651664|10918143|FG009|Overall Study|Reason not Specified|0
6898742|NCT00651755|10918169|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1
6898743|NCT00651755|10918170|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0
6898744|NCT00651755|10918169|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0
6898745|NCT00651755|10918170|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1
6898746|NCT00651820|10918190|FG000|Overall Study|Lost to Follow-up|2
6898747|NCT00651924|10918198|FG000|Overall Study|Withdrawal by PI|0
6898748|NCT00651924|10918199|FG001|Overall Study|Withdrawal by PI|2
6898749|NCT00651924|10918198|FG000|Overall Study|Withdrawal by Subject|0
6898750|NCT00651924|10918199|FG001|Overall Study|Withdrawal by Subject|5
6898751|NCT00651937|10918207|FG000|Overall Study|Withdrawal by Subject|4
6898752|NCT00651937|10918208|FG001|Overall Study|Withdrawal by Subject|1
6817743|NCT00075270|10822207|FG000|Overall Study|Other/Unknown|9
6817744|NCT00075270|10822208|FG001|Overall Study|Other/Unknown|5
6817745|NCT00075270|10822207|FG000|Overall Study|Missing|26
6817746|NCT00075270|10822208|FG001|Overall Study|Missing|13
6817747|NCT00075400|10822219|FG000|Overall Study|Ineligible: wrong primary|1
6817748|NCT00075400|10822219|FG000|Overall Study|Never treated|2
6817749|NCT00075478|10822230|FG000|Overall Study|not eligible|1
6817750|NCT00075478|10822231|FG001|Overall Study|not eligible|0
6817751|NCT00075478|10822230|FG000|Overall Study|Physician Decision|0
6817752|NCT00075478|10822231|FG001|Overall Study|Physician Decision|1
6817753|NCT00075504|10822239|FG000|Overall Study|Withdrawal by Subject|9
6817754|NCT00075504|10822240|FG001|Overall Study|Withdrawal by Subject|7
6817755|NCT00075582|10822248|FG000|Overall Study|Adverse Event|3
6817756|NCT00075582|10822249|FG001|Overall Study|Adverse Event|1
6817757|NCT00075582|10822248|FG000|Overall Study|Lack of Efficacy|4
6817758|NCT00075582|10822249|FG001|Overall Study|Lack of Efficacy|8
6817759|NCT00075582|10822248|FG000|Overall Study|Physician Decision|5
6817760|NCT00075582|10822249|FG001|Overall Study|Physician Decision|8
6817761|NCT00075582|10822248|FG000|Overall Study|Withdrawal by Subject|2
6817762|NCT00075582|10822249|FG001|Overall Study|Withdrawal by Subject|2
6817763|NCT00075582|10822248|FG000|Overall Study|Ineligible for study|36
6817764|NCT00075582|10822249|FG001|Overall Study|Ineligible for study|16
6817765|NCT00075725|10822271|FG000|Overall Study|Adverse Event|6
6817766|NCT00075725|10822272|FG001|Overall Study|Adverse Event|6
6817767|NCT00075725|10822273|FG002|Overall Study|Adverse Event|20
6817768|NCT00075725|10822274|FG003|Overall Study|Adverse Event|8
6817769|NCT00075725|10822275|FG004|Overall Study|Adverse Event|4
6817770|NCT00075725|10822276|FG005|Overall Study|Adverse Event|38
6817771|NCT00075725|10822277|FG006|Overall Study|Adverse Event|3
6817772|NCT00075725|10822278|FG007|Overall Study|Adverse Event|51
6817773|NCT00075725|10822279|FG008|Overall Study|Adverse Event|15
6817774|NCT00075725|10822280|FG009|Overall Study|Adverse Event|4
6817775|NCT00075725|10822281|FG010|Overall Study|Adverse Event|2
6817776|NCT00075725|10822282|FG011|Overall Study|Adverse Event|2
6817777|NCT00075725|10822271|FG000|Overall Study|Death|3
6817778|NCT00075725|10822272|FG001|Overall Study|Death|5
6817779|NCT00075725|10822273|FG002|Overall Study|Death|10
6817780|NCT00075725|10822274|FG003|Overall Study|Death|2
6817781|NCT00075725|10822275|FG004|Overall Study|Death|3
6817782|NCT00075725|10822276|FG005|Overall Study|Death|25
6817783|NCT00075725|10822277|FG006|Overall Study|Death|4
6817784|NCT00075725|10822278|FG007|Overall Study|Death|22
6817785|NCT00075725|10822279|FG008|Overall Study|Death|14
6817786|NCT00075725|10822280|FG009|Overall Study|Death|4
6817787|NCT00075725|10822281|FG010|Overall Study|Death|3
6817788|NCT00075725|10822282|FG011|Overall Study|Death|0
6817789|NCT00075725|10822271|FG000|Overall Study|Lost to Follow-up|1
6817790|NCT00075725|10822272|FG001|Overall Study|Lost to Follow-up|1
6817791|NCT00075725|10822273|FG002|Overall Study|Lost to Follow-up|4
6817792|NCT00075725|10822274|FG003|Overall Study|Lost to Follow-up|1
6978389|NCT01212770|11031721|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
6817793|NCT00075725|10822275|FG004|Overall Study|Lost to Follow-up|0
6817794|NCT00075725|10822276|FG005|Overall Study|Lost to Follow-up|13
6817795|NCT00075725|10822277|FG006|Overall Study|Lost to Follow-up|2
6817796|NCT00075725|10822278|FG007|Overall Study|Lost to Follow-up|4
6817797|NCT00075725|10822279|FG008|Overall Study|Lost to Follow-up|1
6817798|NCT00075725|10822280|FG009|Overall Study|Lost to Follow-up|0
6817799|NCT00075725|10822281|FG010|Overall Study|Lost to Follow-up|0
6817800|NCT00075725|10822282|FG011|Overall Study|Lost to Follow-up|0
6817801|NCT00075725|10822271|FG000|Overall Study|Physician Decision|2
6817802|NCT00075725|10822272|FG001|Overall Study|Physician Decision|6
6898753|NCT00652028|10918218|FG000|Overall Study|Adverse Event|1
6898754|NCT00652028|10918219|FG001|Overall Study|Adverse Event|0
6898755|NCT00652028|10918220|FG002|Overall Study|Adverse Event|0
6898756|NCT00652028|10918221|FG003|Overall Study|Adverse Event|0
6898757|NCT00652028|10918218|FG000|Overall Study|No Longer Meets Entry Criteria|0
6898758|NCT00652028|10918219|FG001|Overall Study|No Longer Meets Entry Criteria|1
6898759|NCT00652028|10918220|FG002|Overall Study|No Longer Meets Entry Criteria|0
6898760|NCT00652028|10918221|FG003|Overall Study|No Longer Meets Entry Criteria|0
6898761|NCT00652028|10918218|FG000|Overall Study|Physician Decision|0
6898762|NCT00652028|10918219|FG001|Overall Study|Physician Decision|0
6817803|NCT00075725|10822273|FG002|Overall Study|Physician Decision|5
6817804|NCT00075725|10822274|FG003|Overall Study|Physician Decision|8
6817805|NCT00075725|10822275|FG004|Overall Study|Physician Decision|4
6817806|NCT00075725|10822276|FG005|Overall Study|Physician Decision|19
6817807|NCT00075725|10822277|FG006|Overall Study|Physician Decision|3
6817808|NCT00075725|10822278|FG007|Overall Study|Physician Decision|17
6817809|NCT00075725|10822279|FG008|Overall Study|Physician Decision|5
6898763|NCT00652028|10918220|FG002|Overall Study|Physician Decision|1
6817810|NCT00075725|10822280|FG009|Overall Study|Physician Decision|0
6817811|NCT00075725|10822281|FG010|Overall Study|Physician Decision|1
6817812|NCT00075725|10822282|FG011|Overall Study|Physician Decision|0
6817813|NCT00075725|10822271|FG000|Overall Study|Pregnancy|0
6817814|NCT00075725|10822272|FG001|Overall Study|Pregnancy|0
6817815|NCT00075725|10822273|FG002|Overall Study|Pregnancy|0
6817816|NCT00075725|10822274|FG003|Overall Study|Pregnancy|0
6817817|NCT00075725|10822275|FG004|Overall Study|Pregnancy|0
6898764|NCT00652028|10918221|FG003|Overall Study|Physician Decision|0
6817818|NCT00075725|10822276|FG005|Overall Study|Pregnancy|1
6817819|NCT00075725|10822277|FG006|Overall Study|Pregnancy|0
6817820|NCT00075725|10822278|FG007|Overall Study|Pregnancy|1
6817821|NCT00075725|10822279|FG008|Overall Study|Pregnancy|0
6817822|NCT00075725|10822280|FG009|Overall Study|Pregnancy|0
6817823|NCT00075725|10822281|FG010|Overall Study|Pregnancy|0
6817824|NCT00075725|10822282|FG011|Overall Study|Pregnancy|0
6817825|NCT00075725|10822271|FG000|Overall Study|Protocol Violation|1
6817826|NCT00075725|10822272|FG001|Overall Study|Protocol Violation|1
6817827|NCT00075725|10822273|FG002|Overall Study|Protocol Violation|0
6817828|NCT00075725|10822274|FG003|Overall Study|Protocol Violation|3
6817829|NCT00075725|10822275|FG004|Overall Study|Protocol Violation|3
6817830|NCT00075725|10822276|FG005|Overall Study|Protocol Violation|2
6817831|NCT00075725|10822277|FG006|Overall Study|Protocol Violation|1
6817832|NCT00075725|10822278|FG007|Overall Study|Protocol Violation|2
6817833|NCT00075725|10822279|FG008|Overall Study|Protocol Violation|3
6817834|NCT00075725|10822280|FG009|Overall Study|Protocol Violation|0
6817835|NCT00075725|10822281|FG010|Overall Study|Protocol Violation|0
6817836|NCT00075725|10822282|FG011|Overall Study|Protocol Violation|1
6817837|NCT00075725|10822271|FG000|Overall Study|Withdrawal by Subject|12
6817838|NCT00075725|10822272|FG001|Overall Study|Withdrawal by Subject|3
6817839|NCT00075725|10822273|FG002|Overall Study|Withdrawal by Subject|6
6817840|NCT00075725|10822274|FG003|Overall Study|Withdrawal by Subject|10
6817841|NCT00075725|10822275|FG004|Overall Study|Withdrawal by Subject|6
6817842|NCT00075725|10822276|FG005|Overall Study|Withdrawal by Subject|27
6817843|NCT00075725|10822277|FG006|Overall Study|Withdrawal by Subject|7
6817844|NCT00075725|10822278|FG007|Overall Study|Withdrawal by Subject|31
6817845|NCT00075725|10822279|FG008|Overall Study|Withdrawal by Subject|10
6817846|NCT00075725|10822280|FG009|Overall Study|Withdrawal by Subject|2
6817847|NCT00075725|10822281|FG010|Overall Study|Withdrawal by Subject|0
6817848|NCT00075725|10822282|FG011|Overall Study|Withdrawal by Subject|0
6817849|NCT00075725|10822271|FG000|Overall Study|Disease Progression, all other reasons|17
6817850|NCT00075725|10822272|FG001|Overall Study|Disease Progression, all other reasons|5
6817851|NCT00075725|10822273|FG002|Overall Study|Disease Progression, all other reasons|33
6817852|NCT00075725|10822274|FG003|Overall Study|Disease Progression, all other reasons|6
6817853|NCT00075725|10822275|FG004|Overall Study|Disease Progression, all other reasons|21
6817854|NCT00075725|10822276|FG005|Overall Study|Disease Progression, all other reasons|59
6817855|NCT00075725|10822277|FG006|Overall Study|Disease Progression, all other reasons|20
6817856|NCT00075725|10822278|FG007|Overall Study|Disease Progression, all other reasons|46
6817857|NCT00075725|10822279|FG008|Overall Study|Disease Progression, all other reasons|21
6817858|NCT00075725|10822280|FG009|Overall Study|Disease Progression, all other reasons|4
6817859|NCT00075725|10822281|FG010|Overall Study|Disease Progression, all other reasons|0
6817860|NCT00075725|10822282|FG011|Overall Study|Disease Progression, all other reasons|5
6817861|NCT00075725|10822271|FG000|Overall Study|Patient off treatment|0
6817862|NCT00075725|10822272|FG001|Overall Study|Patient off treatment|0
6817863|NCT00075725|10822273|FG002|Overall Study|Patient off treatment|1
6817864|NCT00075725|10822274|FG003|Overall Study|Patient off treatment|2
6817865|NCT00075725|10822275|FG004|Overall Study|Patient off treatment|1
6817866|NCT00075725|10822276|FG005|Overall Study|Patient off treatment|0
6817867|NCT00075725|10822277|FG006|Overall Study|Patient off treatment|0
6817868|NCT00075725|10822278|FG007|Overall Study|Patient off treatment|2
6817869|NCT00075725|10822279|FG008|Overall Study|Patient off treatment|1
6817870|NCT00075725|10822280|FG009|Overall Study|Patient off treatment|0
6817871|NCT00075725|10822281|FG010|Overall Study|Patient off treatment|0
6817872|NCT00075725|10822282|FG011|Overall Study|Patient off treatment|0
6817873|NCT00075725|10822271|FG000|Overall Study|Ineligible or wrong diagnosis|8
6817874|NCT00075725|10822272|FG001|Overall Study|Ineligible or wrong diagnosis|3
6817875|NCT00075725|10822273|FG002|Overall Study|Ineligible or wrong diagnosis|3
6817876|NCT00075725|10822274|FG003|Overall Study|Ineligible or wrong diagnosis|10
6817877|NCT00075725|10822275|FG004|Overall Study|Ineligible or wrong diagnosis|3
6817878|NCT00075725|10822276|FG005|Overall Study|Ineligible or wrong diagnosis|17
6817879|NCT00075725|10822277|FG006|Overall Study|Ineligible or wrong diagnosis|6
6817880|NCT00075725|10822278|FG007|Overall Study|Ineligible or wrong diagnosis|9
6817881|NCT00075725|10822279|FG008|Overall Study|Ineligible or wrong diagnosis|10
6817882|NCT00075725|10822280|FG009|Overall Study|Ineligible or wrong diagnosis|1
6817883|NCT00075725|10822281|FG010|Overall Study|Ineligible or wrong diagnosis|2
6817884|NCT00075725|10822282|FG011|Overall Study|Ineligible or wrong diagnosis|4
6817885|NCT00075725|10822271|FG000|Overall Study|Pt/Guardian refused RT therapy|1
6817886|NCT00075725|10822272|FG001|Overall Study|Pt/Guardian refused RT therapy|0
6817887|NCT00075725|10822273|FG002|Overall Study|Pt/Guardian refused RT therapy|1
6817888|NCT00075725|10822274|FG003|Overall Study|Pt/Guardian refused RT therapy|2
6817889|NCT00075725|10822275|FG004|Overall Study|Pt/Guardian refused RT therapy|1
6817890|NCT00075725|10822276|FG005|Overall Study|Pt/Guardian refused RT therapy|0
6817891|NCT00075725|10822277|FG006|Overall Study|Pt/Guardian refused RT therapy|0
6817892|NCT00075725|10822278|FG007|Overall Study|Pt/Guardian refused RT therapy|0
6817893|NCT00075725|10822279|FG008|Overall Study|Pt/Guardian refused RT therapy|0
6817894|NCT00075725|10822280|FG009|Overall Study|Pt/Guardian refused RT therapy|0
6817895|NCT00075725|10822281|FG010|Overall Study|Pt/Guardian refused RT therapy|0
6817896|NCT00075725|10822282|FG011|Overall Study|Pt/Guardian refused RT therapy|0
6817897|NCT00075725|10822271|FG000|Overall Study|Pt non compliant with therapy|2
6817898|NCT00075725|10822272|FG001|Overall Study|Pt non compliant with therapy|1
6817899|NCT00075725|10822273|FG002|Overall Study|Pt non compliant with therapy|1
6817900|NCT00075725|10822274|FG003|Overall Study|Pt non compliant with therapy|0
6817901|NCT00075725|10822275|FG004|Overall Study|Pt non compliant with therapy|2
6817902|NCT00075725|10822276|FG005|Overall Study|Pt non compliant with therapy|14
6817903|NCT00075725|10822277|FG006|Overall Study|Pt non compliant with therapy|2
6817904|NCT00075725|10822278|FG007|Overall Study|Pt non compliant with therapy|5
6817905|NCT00075725|10822279|FG008|Overall Study|Pt non compliant with therapy|3
6817906|NCT00075725|10822280|FG009|Overall Study|Pt non compliant with therapy|0
6817907|NCT00075725|10822281|FG010|Overall Study|Pt non compliant with therapy|0
6817908|NCT00075725|10822282|FG011|Overall Study|Pt non compliant with therapy|0
6817909|NCT00075725|10822271|FG000|Overall Study|Pt age out of range for treatment|0
6817910|NCT00075725|10822272|FG001|Overall Study|Pt age out of range for treatment|1
6817911|NCT00075725|10822273|FG002|Overall Study|Pt age out of range for treatment|0
6817912|NCT00075725|10822274|FG003|Overall Study|Pt age out of range for treatment|0
6817913|NCT00075725|10822275|FG004|Overall Study|Pt age out of range for treatment|0
6817914|NCT00075725|10822276|FG005|Overall Study|Pt age out of range for treatment|1
6817915|NCT00075725|10822277|FG006|Overall Study|Pt age out of range for treatment|0
6817916|NCT00075725|10822278|FG007|Overall Study|Pt age out of range for treatment|1
6817917|NCT00075725|10822279|FG008|Overall Study|Pt age out of range for treatment|0
6817918|NCT00075725|10822280|FG009|Overall Study|Pt age out of range for treatment|0
6817919|NCT00075725|10822281|FG010|Overall Study|Pt age out of range for treatment|0
6817920|NCT00075725|10822282|FG011|Overall Study|Pt age out of range for treatment|0
6898765|NCT00652093|10918243|FG000|Overall Study|Withdrawal by Subject|0
6898766|NCT00652093|10918244|FG001|Overall Study|Withdrawal by Subject|0
6898767|NCT00652093|10918245|FG002|Overall Study|Withdrawal by Subject|1
6898768|NCT00652093|10918246|FG003|Overall Study|Withdrawal by Subject|0
6898769|NCT00652093|10918247|FG004|Overall Study|Withdrawal by Subject|1
6898770|NCT00652093|10918248|FG005|Overall Study|Withdrawal by Subject|0
6898771|NCT00652093|10918243|FG000|Overall Study|Physician Decision|0
6898772|NCT00652093|10918244|FG001|Overall Study|Physician Decision|0
6898773|NCT00652093|10918245|FG002|Overall Study|Physician Decision|0
6898774|NCT00652093|10918246|FG003|Overall Study|Physician Decision|0
6898775|NCT00652093|10918247|FG004|Overall Study|Physician Decision|1
6898776|NCT00652093|10918248|FG005|Overall Study|Physician Decision|0
6898777|NCT00652340|10918284|FG000|Overall Study|Had not progressed.|4
6898778|NCT00652340|10918285|FG001|Overall Study|Had not progressed.|3
6898779|NCT00652366|10918296|FG000|Overall Study|Adverse Event|8
6898780|NCT00652366|10918297|FG001|Overall Study|Adverse Event|4
6898781|NCT00652366|10918298|FG002|Overall Study|Adverse Event|7
6898782|NCT00652366|10918299|FG003|Overall Study|Adverse Event|17
6898783|NCT00652366|10918300|FG004|Overall Study|Adverse Event|13
6898784|NCT00652366|10918296|FG000|Overall Study|Death|5
6898785|NCT00652366|10918297|FG001|Overall Study|Death|4
6898786|NCT00652366|10918298|FG002|Overall Study|Death|1
6898787|NCT00652366|10918299|FG003|Overall Study|Death|8
6898788|NCT00652366|10918300|FG004|Overall Study|Death|5
6898789|NCT00652366|10918296|FG000|Overall Study|Lack of Efficacy|84
6898790|NCT00652366|10918297|FG001|Overall Study|Lack of Efficacy|58
6898791|NCT00652366|10918298|FG002|Overall Study|Lack of Efficacy|53
6898792|NCT00652366|10918299|FG003|Overall Study|Lack of Efficacy|133
6898793|NCT00652366|10918300|FG004|Overall Study|Lack of Efficacy|13
6898794|NCT00652366|10918296|FG000|Overall Study|Violation of Selection Criteria|0
6898795|NCT00652366|10918297|FG001|Overall Study|Violation of Selection Criteria|0
6898796|NCT00652366|10918298|FG002|Overall Study|Violation of Selection Criteria|1
6898797|NCT00652366|10918299|FG003|Overall Study|Violation of Selection Criteria|0
6898798|NCT00652366|10918300|FG004|Overall Study|Violation of Selection Criteria|0
6898799|NCT00652366|10918296|FG000|Overall Study|Protocol Violation|1
6898800|NCT00652366|10918297|FG001|Overall Study|Protocol Violation|0
6898801|NCT00652366|10918298|FG002|Overall Study|Protocol Violation|0
6898802|NCT00652366|10918299|FG003|Overall Study|Protocol Violation|0
6898803|NCT00652366|10918300|FG004|Overall Study|Protocol Violation|0
6898804|NCT00652366|10918296|FG000|Overall Study|Refused treatment|3
6898805|NCT00652366|10918297|FG001|Overall Study|Refused treatment|7
6898806|NCT00652366|10918298|FG002|Overall Study|Refused treatment|6
6898807|NCT00652366|10918299|FG003|Overall Study|Refused treatment|17
6898808|NCT00652366|10918300|FG004|Overall Study|Refused treatment|5
6898809|NCT00652366|10918296|FG000|Overall Study|Other|5
6898810|NCT00652366|10918297|FG001|Overall Study|Other|2
6898811|NCT00652366|10918298|FG002|Overall Study|Other|3
6898812|NCT00652366|10918299|FG003|Overall Study|Other|4
6898813|NCT00652366|10918300|FG004|Overall Study|Other|0
6898814|NCT00652626|10918321|FG000|Initial Treatment Phase|Adverse Event|0
6898815|NCT00652626|10918322|FG001|Initial Treatment Phase|Adverse Event|0
6898816|NCT00652626|10918323|FG002|Initial Treatment Phase|Adverse Event|0
6898817|NCT00652626|10918324|FG003|Initial Treatment Phase|Adverse Event|0
6898818|NCT00652626|10918325|FG004|Initial Treatment Phase|Adverse Event|1
6898819|NCT00652626|10918326|FG005|Initial Treatment Phase|Adverse Event|0
6898820|NCT00652626|10918327|FG006|Initial Treatment Phase|Adverse Event|0
6898821|NCT00652626|10918321|FG000|Initial Treatment Phase|Protocol Violation|0
6898822|NCT00652626|10918322|FG001|Initial Treatment Phase|Protocol Violation|0
6817921|NCT00075725|10822271|FG000|Overall Study|Insurance issues|0
6817922|NCT00075725|10822272|FG001|Overall Study|Insurance issues|1
6817923|NCT00075725|10822273|FG002|Overall Study|Insurance issues|0
6817924|NCT00075725|10822274|FG003|Overall Study|Insurance issues|1
6817925|NCT00075725|10822275|FG004|Overall Study|Insurance issues|1
6817926|NCT00075725|10822276|FG005|Overall Study|Insurance issues|1
6817927|NCT00075725|10822277|FG006|Overall Study|Insurance issues|0
6817928|NCT00075725|10822278|FG007|Overall Study|Insurance issues|1
6817929|NCT00075725|10822279|FG008|Overall Study|Insurance issues|0
6817930|NCT00075725|10822280|FG009|Overall Study|Insurance issues|0
6817931|NCT00075725|10822281|FG010|Overall Study|Insurance issues|0
6817932|NCT00075725|10822282|FG011|Overall Study|Insurance issues|0
6817933|NCT00075725|10822271|FG000|Overall Study|MRD positive after extended ind|0
6817934|NCT00075725|10822272|FG001|Overall Study|MRD positive after extended ind|1
6817935|NCT00075725|10822273|FG002|Overall Study|MRD positive after extended ind|1
6817936|NCT00075725|10822274|FG003|Overall Study|MRD positive after extended ind|0
6817937|NCT00075725|10822275|FG004|Overall Study|MRD positive after extended ind|1
6817938|NCT00075725|10822276|FG005|Overall Study|MRD positive after extended ind|2
6817939|NCT00075725|10822277|FG006|Overall Study|MRD positive after extended ind|0
6817940|NCT00075725|10822278|FG007|Overall Study|MRD positive after extended ind|1
6817941|NCT00075725|10822279|FG008|Overall Study|MRD positive after extended ind|0
6817942|NCT00075725|10822280|FG009|Overall Study|MRD positive after extended ind|0
6817943|NCT00075725|10822281|FG010|Overall Study|MRD positive after extended ind|0
6817944|NCT00075725|10822282|FG011|Overall Study|MRD positive after extended ind|0
6817945|NCT00075725|10822271|FG000|Overall Study|Pt has very high risk ALL characteristic|15
6817946|NCT00075725|10822272|FG001|Overall Study|Pt has very high risk ALL characteristic|11
6817947|NCT00075725|10822273|FG002|Overall Study|Pt has very high risk ALL characteristic|26
6817948|NCT00075725|10822274|FG003|Overall Study|Pt has very high risk ALL characteristic|18
6817949|NCT00075725|10822275|FG004|Overall Study|Pt has very high risk ALL characteristic|11
6817950|NCT00075725|10822276|FG005|Overall Study|Pt has very high risk ALL characteristic|75
6817951|NCT00075725|10822277|FG006|Overall Study|Pt has very high risk ALL characteristic|23
6817952|NCT00075725|10822278|FG007|Overall Study|Pt has very high risk ALL characteristic|74
6817953|NCT00075725|10822279|FG008|Overall Study|Pt has very high risk ALL characteristic|29
6817954|NCT00075725|10822280|FG009|Overall Study|Pt has very high risk ALL characteristic|1
6817955|NCT00075725|10822281|FG010|Overall Study|Pt has very high risk ALL characteristic|0
6817956|NCT00075725|10822282|FG011|Overall Study|Pt has very high risk ALL characteristic|3
6817957|NCT00075725|10822271|FG000|Overall Study|Inevaluable|1
6817958|NCT00075725|10822272|FG001|Overall Study|Inevaluable|1
6817959|NCT00075725|10822273|FG002|Overall Study|Inevaluable|4
6817960|NCT00075725|10822274|FG003|Overall Study|Inevaluable|2
6817961|NCT00075725|10822275|FG004|Overall Study|Inevaluable|2
6817962|NCT00075725|10822276|FG005|Overall Study|Inevaluable|9
6817963|NCT00075725|10822277|FG006|Overall Study|Inevaluable|1
6817964|NCT00075725|10822278|FG007|Overall Study|Inevaluable|11
6817965|NCT00075725|10822279|FG008|Overall Study|Inevaluable|2
6817966|NCT00075725|10822280|FG009|Overall Study|Inevaluable|0
6817967|NCT00075725|10822281|FG010|Overall Study|Inevaluable|1
6817968|NCT00075725|10822282|FG011|Overall Study|Inevaluable|0
6817969|NCT00075725|10822271|FG000|Overall Study|Other|4
6817970|NCT00075725|10822272|FG001|Overall Study|Other|2
6817971|NCT00075725|10822273|FG002|Overall Study|Other|1
6817972|NCT00075725|10822274|FG003|Overall Study|Other|1
6817973|NCT00075725|10822275|FG004|Overall Study|Other|1
6817974|NCT00075725|10822276|FG005|Overall Study|Other|4
6817975|NCT00075725|10822277|FG006|Overall Study|Other|2
6817976|NCT00075725|10822278|FG007|Overall Study|Other|9
6817977|NCT00075725|10822279|FG008|Overall Study|Other|2
6817978|NCT00075725|10822280|FG009|Overall Study|Other|1
6817979|NCT00075725|10822281|FG010|Overall Study|Other|0
6817980|NCT00075725|10822282|FG011|Overall Study|Other|3
6817981|NCT00075725|10822271|FG000|Overall Study|Pt trying to find a BM donor|0
6817982|NCT00075725|10822272|FG001|Overall Study|Pt trying to find a BM donor|1
6817983|NCT00075725|10822273|FG002|Overall Study|Pt trying to find a BM donor|0
6817984|NCT00075725|10822274|FG003|Overall Study|Pt trying to find a BM donor|0
6817985|NCT00075725|10822275|FG004|Overall Study|Pt trying to find a BM donor|0
6817986|NCT00075725|10822276|FG005|Overall Study|Pt trying to find a BM donor|0
6817987|NCT00075725|10822277|FG006|Overall Study|Pt trying to find a BM donor|0
6817988|NCT00075725|10822278|FG007|Overall Study|Pt trying to find a BM donor|0
6817989|NCT00075725|10822279|FG008|Overall Study|Pt trying to find a BM donor|0
6817990|NCT00075725|10822280|FG009|Overall Study|Pt trying to find a BM donor|0
6817991|NCT00075725|10822281|FG010|Overall Study|Pt trying to find a BM donor|0
6817992|NCT00075725|10822282|FG011|Overall Study|Pt trying to find a BM donor|0
6817993|NCT00075725|10822271|FG000|Overall Study|Clinic chart lost unable to recreate|0
6817994|NCT00075725|10822272|FG001|Overall Study|Clinic chart lost unable to recreate|0
6817995|NCT00075725|10822273|FG002|Overall Study|Clinic chart lost unable to recreate|1
6817996|NCT00075725|10822274|FG003|Overall Study|Clinic chart lost unable to recreate|0
6817997|NCT00075725|10822275|FG004|Overall Study|Clinic chart lost unable to recreate|0
6817998|NCT00075725|10822276|FG005|Overall Study|Clinic chart lost unable to recreate|0
6817999|NCT00075725|10822277|FG006|Overall Study|Clinic chart lost unable to recreate|0
6896528|NCT00633893|10915015|FG000|Overall Study|Poor/non-compliance|5
6973521|NCT01181895|11025410|FG002|Overall Study|Adverse Event|1
6818000|NCT00075725|10822278|FG007|Overall Study|Clinic chart lost unable to recreate|0
6818001|NCT00075725|10822279|FG008|Overall Study|Clinic chart lost unable to recreate|0
6818002|NCT00075725|10822280|FG009|Overall Study|Clinic chart lost unable to recreate|0
6818003|NCT00075725|10822281|FG010|Overall Study|Clinic chart lost unable to recreate|0
6818004|NCT00075725|10822282|FG011|Overall Study|Clinic chart lost unable to recreate|0
6818005|NCT00075725|10822271|FG000|Overall Study|Unsuccessful institutional transfer|0
6818006|NCT00075725|10822272|FG001|Overall Study|Unsuccessful institutional transfer|0
6818007|NCT00075725|10822273|FG002|Overall Study|Unsuccessful institutional transfer|2
6818008|NCT00075725|10822274|FG003|Overall Study|Unsuccessful institutional transfer|0
6818009|NCT00075725|10822275|FG004|Overall Study|Unsuccessful institutional transfer|0
6818010|NCT00075725|10822276|FG005|Overall Study|Unsuccessful institutional transfer|0
6818011|NCT00075725|10822277|FG006|Overall Study|Unsuccessful institutional transfer|0
6818012|NCT00075725|10822278|FG007|Overall Study|Unsuccessful institutional transfer|0
6818013|NCT00075725|10822279|FG008|Overall Study|Unsuccessful institutional transfer|0
6818014|NCT00075725|10822280|FG009|Overall Study|Unsuccessful institutional transfer|1
6818015|NCT00075725|10822281|FG010|Overall Study|Unsuccessful institutional transfer|0
6818016|NCT00075725|10822282|FG011|Overall Study|Unsuccessful institutional transfer|0
6818017|NCT00075725|10822271|FG000|Overall Study|specimen(s) not submitted|0
6818018|NCT00075725|10822272|FG001|Overall Study|specimen(s) not submitted|0
6818019|NCT00075725|10822273|FG002|Overall Study|specimen(s) not submitted|2
6818020|NCT00075725|10822274|FG003|Overall Study|specimen(s) not submitted|0
6818021|NCT00075725|10822275|FG004|Overall Study|specimen(s) not submitted|0
6818022|NCT00075725|10822276|FG005|Overall Study|specimen(s) not submitted|0
6818023|NCT00075725|10822277|FG006|Overall Study|specimen(s) not submitted|0
6818024|NCT00075725|10822278|FG007|Overall Study|specimen(s) not submitted|0
6818025|NCT00075725|10822279|FG008|Overall Study|specimen(s) not submitted|0
6898823|NCT00652626|10918323|FG002|Initial Treatment Phase|Protocol Violation|0
6898824|NCT00652626|10918324|FG003|Initial Treatment Phase|Protocol Violation|1
6898825|NCT00652626|10918325|FG004|Initial Treatment Phase|Protocol Violation|0
6898826|NCT00652626|10918326|FG005|Initial Treatment Phase|Protocol Violation|0
6898827|NCT00652626|10918327|FG006|Initial Treatment Phase|Protocol Violation|0
6898828|NCT00652626|10918321|FG000|Initial Treatment Phase|Physician Decision|0
6898829|NCT00652626|10918322|FG001|Initial Treatment Phase|Physician Decision|0
6898830|NCT00652626|10918323|FG002|Initial Treatment Phase|Physician Decision|0
6898831|NCT00652626|10918324|FG003|Initial Treatment Phase|Physician Decision|0
6898832|NCT00652626|10918325|FG004|Initial Treatment Phase|Physician Decision|1
6898833|NCT00652626|10918326|FG005|Initial Treatment Phase|Physician Decision|0
6898834|NCT00652626|10918327|FG006|Initial Treatment Phase|Physician Decision|0
6898835|NCT00652626|10918321|FG000|Initial Treatment Phase|Sponsor Request|0
6898836|NCT00652626|10918322|FG001|Initial Treatment Phase|Sponsor Request|0
6898837|NCT00652626|10918323|FG002|Initial Treatment Phase|Sponsor Request|1
6898838|NCT00652626|10918324|FG003|Initial Treatment Phase|Sponsor Request|0
6898839|NCT00652626|10918325|FG004|Initial Treatment Phase|Sponsor Request|0
6898840|NCT00652626|10918326|FG005|Initial Treatment Phase|Sponsor Request|0
6898841|NCT00652626|10918327|FG006|Initial Treatment Phase|Sponsor Request|0
6898842|NCT00652626|10918321|FG000|Initial Treatment Phase|Lost to Follow-up|0
6898843|NCT00652626|10918322|FG001|Initial Treatment Phase|Lost to Follow-up|0
6898844|NCT00652626|10918323|FG002|Initial Treatment Phase|Lost to Follow-up|0
6898845|NCT00652626|10918324|FG003|Initial Treatment Phase|Lost to Follow-up|0
6898846|NCT00652626|10918325|FG004|Initial Treatment Phase|Lost to Follow-up|1
6898847|NCT00652626|10918326|FG005|Initial Treatment Phase|Lost to Follow-up|0
6898848|NCT00652626|10918327|FG006|Initial Treatment Phase|Lost to Follow-up|0
6898849|NCT00652626|10918321|FG000|Extension Phase|Withdrawal by Subject|0
6898850|NCT00652626|10918322|FG001|Extension Phase|Withdrawal by Subject|0
6898851|NCT00652626|10918323|FG002|Extension Phase|Withdrawal by Subject|0
6898852|NCT00652626|10918324|FG003|Extension Phase|Withdrawal by Subject|0
6898853|NCT00652626|10918325|FG004|Extension Phase|Withdrawal by Subject|0
6898854|NCT00652626|10918326|FG005|Extension Phase|Withdrawal by Subject|2
6898855|NCT00652626|10918327|FG006|Extension Phase|Withdrawal by Subject|0
6898856|NCT00652626|10918321|FG000|Extension Phase|Adverse Event|0
6898857|NCT00652626|10918322|FG001|Extension Phase|Adverse Event|0
6898858|NCT00652626|10918323|FG002|Extension Phase|Adverse Event|0
6898859|NCT00652626|10918324|FG003|Extension Phase|Adverse Event|0
6898860|NCT00652626|10918325|FG004|Extension Phase|Adverse Event|0
6898861|NCT00652626|10918326|FG005|Extension Phase|Adverse Event|2
6898862|NCT00652626|10918327|FG006|Extension Phase|Adverse Event|1
6898863|NCT00652626|10918321|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0
6898864|NCT00652626|10918322|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0
6898865|NCT00652626|10918323|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0
6898866|NCT00652626|10918324|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0
6898867|NCT00652626|10918325|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0
6898868|NCT00652626|10918326|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6
6898869|NCT00652626|10918327|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0
6898870|NCT00652626|10918321|FG000|Extension Phase|Physician Decision|0
6898871|NCT00652626|10918322|FG001|Extension Phase|Physician Decision|0
6898872|NCT00652626|10918323|FG002|Extension Phase|Physician Decision|0
6898873|NCT00652626|10918324|FG003|Extension Phase|Physician Decision|0
6898874|NCT00652626|10918325|FG004|Extension Phase|Physician Decision|0
6818026|NCT00075725|10822280|FG009|Overall Study|specimen(s) not submitted|0
6818027|NCT00075725|10822281|FG010|Overall Study|specimen(s) not submitted|0
6818028|NCT00075725|10822282|FG011|Overall Study|specimen(s) not submitted|0
6818029|NCT00075725|10822271|FG000|Overall Study|Pt went to transplant|0
6818030|NCT00075725|10822272|FG001|Overall Study|Pt went to transplant|0
6818031|NCT00075725|10822273|FG002|Overall Study|Pt went to transplant|0
6818032|NCT00075725|10822274|FG003|Overall Study|Pt went to transplant|1
6818033|NCT00075725|10822275|FG004|Overall Study|Pt went to transplant|0
6818034|NCT00075725|10822276|FG005|Overall Study|Pt went to transplant|1
6818035|NCT00075725|10822277|FG006|Overall Study|Pt went to transplant|0
6818036|NCT00075725|10822278|FG007|Overall Study|Pt went to transplant|0
6818037|NCT00075725|10822279|FG008|Overall Study|Pt went to transplant|0
6818038|NCT00075725|10822280|FG009|Overall Study|Pt went to transplant|0
6818039|NCT00075725|10822281|FG010|Overall Study|Pt went to transplant|0
6818040|NCT00075725|10822282|FG011|Overall Study|Pt went to transplant|0
6818041|NCT00075725|10822271|FG000|Overall Study|Pt received additional steroids|0
6818042|NCT00075725|10822272|FG001|Overall Study|Pt received additional steroids|0
6818043|NCT00075725|10822273|FG002|Overall Study|Pt received additional steroids|0
6818044|NCT00075725|10822274|FG003|Overall Study|Pt received additional steroids|1
6818045|NCT00075725|10822275|FG004|Overall Study|Pt received additional steroids|0
6818046|NCT00075725|10822276|FG005|Overall Study|Pt received additional steroids|0
6818047|NCT00075725|10822277|FG006|Overall Study|Pt received additional steroids|0
6818048|NCT00075725|10822278|FG007|Overall Study|Pt received additional steroids|0
6818049|NCT00075725|10822279|FG008|Overall Study|Pt received additional steroids|0
6818050|NCT00075725|10822280|FG009|Overall Study|Pt received additional steroids|0
6818051|NCT00075725|10822281|FG010|Overall Study|Pt received additional steroids|0
6818052|NCT00075725|10822282|FG011|Overall Study|Pt received additional steroids|0
6818053|NCT00075725|10822271|FG000|Overall Study|Pt relocated|0
6818054|NCT00075725|10822272|FG001|Overall Study|Pt relocated|0
6818055|NCT00075725|10822273|FG002|Overall Study|Pt relocated|0
6818056|NCT00075725|10822274|FG003|Overall Study|Pt relocated|2
6818057|NCT00075725|10822275|FG004|Overall Study|Pt relocated|0
6818058|NCT00075725|10822276|FG005|Overall Study|Pt relocated|1
6818059|NCT00075725|10822277|FG006|Overall Study|Pt relocated|1
6818060|NCT00075725|10822278|FG007|Overall Study|Pt relocated|2
6818061|NCT00075725|10822279|FG008|Overall Study|Pt relocated|1
6818062|NCT00075725|10822280|FG009|Overall Study|Pt relocated|0
6818063|NCT00075725|10822281|FG010|Overall Study|Pt relocated|0
6818064|NCT00075725|10822282|FG011|Overall Study|Pt relocated|0
6818065|NCT00075725|10822271|FG000|Overall Study|Institution Terminated|0
6818066|NCT00075725|10822272|FG001|Overall Study|Institution Terminated|0
6818067|NCT00075725|10822273|FG002|Overall Study|Institution Terminated|0
6818068|NCT00075725|10822274|FG003|Overall Study|Institution Terminated|0
6818069|NCT00075725|10822275|FG004|Overall Study|Institution Terminated|1
6818070|NCT00075725|10822276|FG005|Overall Study|Institution Terminated|0
6818071|NCT00075725|10822277|FG006|Overall Study|Institution Terminated|0
6818072|NCT00075725|10822278|FG007|Overall Study|Institution Terminated|3
6818073|NCT00075725|10822279|FG008|Overall Study|Institution Terminated|0
6818074|NCT00075725|10822280|FG009|Overall Study|Institution Terminated|0
6818075|NCT00075725|10822281|FG010|Overall Study|Institution Terminated|0
6818076|NCT00075725|10822282|FG011|Overall Study|Institution Terminated|0
6818077|NCT00075725|10822271|FG000|Overall Study|Study Closure|1
6818078|NCT00075725|10822272|FG001|Overall Study|Study Closure|0
6818079|NCT00075725|10822273|FG002|Overall Study|Study Closure|0
6818080|NCT00075725|10822274|FG003|Overall Study|Study Closure|0
6818081|NCT00075725|10822275|FG004|Overall Study|Study Closure|1
6818082|NCT00075725|10822276|FG005|Overall Study|Study Closure|3
6818083|NCT00075725|10822277|FG006|Overall Study|Study Closure|0
6818084|NCT00075725|10822278|FG007|Overall Study|Study Closure|1
6818085|NCT00075725|10822279|FG008|Overall Study|Study Closure|0
6818086|NCT00075725|10822280|FG009|Overall Study|Study Closure|0
6818087|NCT00075725|10822281|FG010|Overall Study|Study Closure|0
6818088|NCT00075725|10822282|FG011|Overall Study|Study Closure|0
6818089|NCT00075725|10822271|FG000|Overall Study|Other complications|0
6818090|NCT00075725|10822272|FG001|Overall Study|Other complications|0
6818091|NCT00075725|10822273|FG002|Overall Study|Other complications|0
6818092|NCT00075725|10822274|FG003|Overall Study|Other complications|0
6818093|NCT00075725|10822275|FG004|Overall Study|Other complications|0
6818094|NCT00075725|10822276|FG005|Overall Study|Other complications|1
6818095|NCT00075725|10822277|FG006|Overall Study|Other complications|0
6818096|NCT00075725|10822278|FG007|Overall Study|Other complications|0
6818097|NCT00075725|10822279|FG008|Overall Study|Other complications|0
6818098|NCT00075725|10822280|FG009|Overall Study|Other complications|0
6818099|NCT00075725|10822281|FG010|Overall Study|Other complications|0
6818100|NCT00075725|10822282|FG011|Overall Study|Other complications|0
6818101|NCT00075725|10822271|FG000|Overall Study|Pt care terminated due to pt behavior|0
6818102|NCT00075725|10822272|FG001|Overall Study|Pt care terminated due to pt behavior|0
6818103|NCT00075725|10822273|FG002|Overall Study|Pt care terminated due to pt behavior|0
6818104|NCT00075725|10822274|FG003|Overall Study|Pt care terminated due to pt behavior|0
6818105|NCT00075725|10822275|FG004|Overall Study|Pt care terminated due to pt behavior|0
6818106|NCT00075725|10822276|FG005|Overall Study|Pt care terminated due to pt behavior|0
6818107|NCT00075725|10822277|FG006|Overall Study|Pt care terminated due to pt behavior|0
6818108|NCT00075725|10822278|FG007|Overall Study|Pt care terminated due to pt behavior|1
6818109|NCT00075725|10822279|FG008|Overall Study|Pt care terminated due to pt behavior|0
6818110|NCT00075725|10822280|FG009|Overall Study|Pt care terminated due to pt behavior|0
6818111|NCT00075725|10822281|FG010|Overall Study|Pt care terminated due to pt behavior|0
6818112|NCT00075725|10822282|FG011|Overall Study|Pt care terminated due to pt behavior|0
6818113|NCT00075725|10822271|FG000|Overall Study|Pt incarcerated|0
6818114|NCT00075725|10822272|FG001|Overall Study|Pt incarcerated|0
6818115|NCT00075725|10822273|FG002|Overall Study|Pt incarcerated|0
6818116|NCT00075725|10822274|FG003|Overall Study|Pt incarcerated|0
6818117|NCT00075725|10822275|FG004|Overall Study|Pt incarcerated|0
6818118|NCT00075725|10822276|FG005|Overall Study|Pt incarcerated|0
6818119|NCT00075725|10822277|FG006|Overall Study|Pt incarcerated|0
6818120|NCT00075725|10822278|FG007|Overall Study|Pt incarcerated|1
6818121|NCT00075725|10822279|FG008|Overall Study|Pt incarcerated|0
6818122|NCT00075725|10822280|FG009|Overall Study|Pt incarcerated|0
6818123|NCT00075725|10822281|FG010|Overall Study|Pt incarcerated|0
6818124|NCT00075725|10822282|FG011|Overall Study|Pt incarcerated|0
6818125|NCT00075764|10822315|FG000|Overall Study|Adverse Event|5
6818126|NCT00075764|10822316|FG001|Overall Study|Adverse Event|12
6818127|NCT00075764|10822315|FG000|Overall Study|Death|4
6818128|NCT00075764|10822316|FG001|Overall Study|Death|8
6818129|NCT00075764|10822315|FG000|Overall Study|Withdrawal by Subject|28
6818130|NCT00075764|10822316|FG001|Overall Study|Withdrawal by Subject|18
6818131|NCT00075764|10822315|FG000|Overall Study|Progression|269
6818132|NCT00075764|10822316|FG001|Overall Study|Progression|274
6818133|NCT00075764|10822315|FG000|Overall Study|Still on treatment|8
6818134|NCT00075764|10822316|FG001|Overall Study|Still on treatment|15
6818135|NCT00075764|10822315|FG000|Overall Study|Delinquent|4
6818136|NCT00075764|10822316|FG001|Overall Study|Delinquent|2
6818137|NCT00075764|10822315|FG000|Overall Study|Not protocol specified|27
6818138|NCT00075764|10822316|FG001|Overall Study|Not protocol specified|19
6818139|NCT00075764|10822315|FG000|Overall Study|Under review|0
6818140|NCT00075764|10822316|FG001|Overall Study|Under review|1
6818141|NCT00075816|10822335|FG000|Overall Study|Did not undergo transplantation|14
6818142|NCT00075816|10822336|FG001|Overall Study|Did not undergo transplantation|11
6818143|NCT00075881|10822364|FG000|Overall Study|Lack of Efficacy|18
6818144|NCT00075881|10822364|FG000|Overall Study|Adverse Event|7
6818145|NCT00075881|10822364|FG000|Overall Study|Death|1
6818146|NCT00075881|10822364|FG000|Overall Study|Withdrawal by Subject|2
6818147|NCT00075881|10822364|FG000|Overall Study|Protocol Violation|4
6818148|NCT00075881|10822364|FG000|Overall Study|other complicating disease|3
6818149|NCT00075881|10822364|FG000|Overall Study|other|4
6818150|NCT00075881|10822364|FG000|Overall Study|missing data|2
6818151|NCT00075881|10822364|FG000|Overall Study|Ineligible|1
6818152|NCT00075881|10822364|FG000|Overall Study|never start protocol therapy|1
6818153|NCT00076011|10822370|FG000|Overall Study|Death|1
6818154|NCT00076011|10822370|FG000|Overall Study|Adverse Event|10
6818155|NCT00076011|10822370|FG000|Overall Study|Lack of Efficacy|25
6818156|NCT00076011|10822370|FG000|Overall Study|Withdrawal by Subject|1
6818157|NCT00076011|10822370|FG000|Overall Study|Study terminated by sponsor|3
6818158|NCT00076011|10822370|FG000|Overall Study|Other|11
6818159|NCT00076011|10822370|FG000|Overall Study|Ongoing|1
6818160|NCT00076024|10822377|FG000|Phase 1, Lead-in|Lack of Efficacy|4
6818161|NCT00076024|10822378|FG001|Phase 1, Lead-in|Lack of Efficacy|0
6818162|NCT00076024|10822379|FG002|Phase 1, Lead-in|Lack of Efficacy|0
6818163|NCT00076024|10822380|FG003|Phase 1, Lead-in|Lack of Efficacy|0
6818164|NCT00076024|10822377|FG000|Phase 1, Lead-in|Adverse Event|1
6818165|NCT00076024|10822378|FG001|Phase 1, Lead-in|Adverse Event|0
6818166|NCT00076024|10822379|FG002|Phase 1, Lead-in|Adverse Event|0
6818167|NCT00076024|10822380|FG003|Phase 1, Lead-in|Adverse Event|0
6818168|NCT00076024|10822377|FG000|Phase 1, Lead-in|Clinical progression|1
6818169|NCT00076024|10822378|FG001|Phase 1, Lead-in|Clinical progression|0
6818170|NCT00076024|10822379|FG002|Phase 1, Lead-in|Clinical progression|0
6818171|NCT00076024|10822380|FG003|Phase 1, Lead-in|Clinical progression|0
6818172|NCT00076024|10822377|FG000|Phase 2, Double-blind|Lack of Efficacy|0
6818173|NCT00076024|10822378|FG001|Phase 2, Double-blind|Lack of Efficacy|59
6818174|NCT00076024|10822379|FG002|Phase 2, Double-blind|Lack of Efficacy|40
6818175|NCT00076024|10822380|FG003|Phase 2, Double-blind|Lack of Efficacy|0
6818176|NCT00076024|10822377|FG000|Phase 2, Double-blind|Withdrawal by Subject|0
6818177|NCT00076024|10822378|FG001|Phase 2, Double-blind|Withdrawal by Subject|13
6818178|NCT00076024|10822379|FG002|Phase 2, Double-blind|Withdrawal by Subject|4
6818179|NCT00076024|10822380|FG003|Phase 2, Double-blind|Withdrawal by Subject|0
6818180|NCT00076024|10822377|FG000|Phase 2, Double-blind|Adverse Event|0
6818181|NCT00076024|10822378|FG001|Phase 2, Double-blind|Adverse Event|25
6818182|NCT00076024|10822379|FG002|Phase 2, Double-blind|Adverse Event|6
6818183|NCT00076024|10822380|FG003|Phase 2, Double-blind|Adverse Event|0
6818184|NCT00076024|10822377|FG000|Phase 2, Double-blind|Un-specified|0
6818185|NCT00076024|10822378|FG001|Phase 2, Double-blind|Un-specified|14
6818186|NCT00076024|10822379|FG002|Phase 2, Double-blind|Un-specified|6
6818187|NCT00076024|10822380|FG003|Phase 2, Double-blind|Un-specified|0
6818188|NCT00076024|10822377|FG000|Phase 2, Double-blind|Randomized but not treated|0
6818189|NCT00076024|10822378|FG001|Phase 2, Double-blind|Randomized but not treated|1
6818190|NCT00076024|10822379|FG002|Phase 2, Double-blind|Randomized but not treated|0
6818191|NCT00076024|10822380|FG003|Phase 2, Double-blind|Randomized but not treated|0
6818192|NCT00076024|10822377|FG000|Phase 2, Open-label|Adverse Event|0
6818193|NCT00076024|10822378|FG001|Phase 2, Open-label|Adverse Event|0
6818194|NCT00076024|10822379|FG002|Phase 2, Open-label|Adverse Event|0
6818195|NCT00076024|10822380|FG003|Phase 2, Open-label|Adverse Event|2
6818196|NCT00076024|10822377|FG000|Phase 2, Open-label|Lack of Efficacy|0
6818197|NCT00076024|10822378|FG001|Phase 2, Open-label|Lack of Efficacy|0
6818198|NCT00076024|10822379|FG002|Phase 2, Open-label|Lack of Efficacy|0
6818199|NCT00076024|10822380|FG003|Phase 2, Open-label|Lack of Efficacy|11
6818200|NCT00076024|10822377|FG000|Phase 2, Open-label|Withdrawal by Subject|0
6818201|NCT00076024|10822378|FG001|Phase 2, Open-label|Withdrawal by Subject|0
6818202|NCT00076024|10822379|FG002|Phase 2, Open-label|Withdrawal by Subject|0
6818203|NCT00076024|10822380|FG003|Phase 2, Open-label|Withdrawal by Subject|1
6818204|NCT00076024|10822377|FG000|Phase 2, Open-label|Other|0
6818205|NCT00076024|10822378|FG001|Phase 2, Open-label|Other|0
6818206|NCT00076024|10822379|FG002|Phase 2, Open-label|Other|0
6818207|NCT00076024|10822380|FG003|Phase 2, Open-label|Other|2
6818208|NCT00076102|10822398|FG000|Overall Study|Clinical progression|1
6818209|NCT00076102|10822398|FG000|Overall Study|Progression in pre-existing brain tumor|1
6818210|NCT00076102|10822398|FG000|Overall Study|plexiform neurofibroma surgery|1
6818211|NCT00076102|10822398|FG000|Overall Study|refusal of further therapy|2
6818212|NCT00076336|10822441|FG000|Overall Study|Death|13
6818213|NCT00076336|10822442|FG001|Overall Study|Death|17
6818214|NCT00076336|10822441|FG000|Overall Study|Adverse Event|4
6818215|NCT00076336|10822442|FG001|Overall Study|Adverse Event|4
6818216|NCT00076336|10822441|FG000|Overall Study|Lost to Follow-up|4
6818217|NCT00076336|10822442|FG001|Overall Study|Lost to Follow-up|4
6898875|NCT00652626|10918326|FG005|Extension Phase|Physician Decision|1
6898876|NCT00652626|10918327|FG006|Extension Phase|Physician Decision|1
6898877|NCT00652626|10918321|FG000|Extension Phase|Death|0
6898878|NCT00652626|10918322|FG001|Extension Phase|Death|0
6898879|NCT00652626|10918323|FG002|Extension Phase|Death|0
6898880|NCT00652626|10918324|FG003|Extension Phase|Death|0
6898881|NCT00652626|10918325|FG004|Extension Phase|Death|0
6898882|NCT00652626|10918326|FG005|Extension Phase|Death|1
6898883|NCT00652626|10918327|FG006|Extension Phase|Death|1
6898884|NCT00652743|10918348|FG000|Months 12-18|Lost to Follow-up|1
6898885|NCT00652743|10918349|FG001|Months 12-18|Lost to Follow-up|2
6898886|NCT00652743|10918350|FG002|Months 12-18|Lost to Follow-up|7
6898887|NCT00652743|10918348|FG000|Months 24-30|Other|5
6898888|NCT00652743|10918349|FG001|Months 24-30|Other|1
6898889|NCT00652743|10918350|FG002|Months 24-30|Other|11
6898890|NCT00652743|10918348|FG000|Months 36-42|Serious Adverse Events|0
6898891|NCT00652743|10918349|FG001|Months 36-42|Serious Adverse Events|1
6898892|NCT00652743|10918350|FG002|Months 36-42|Serious Adverse Events|1
6898893|NCT00652743|10918348|FG000|Months 36-42|Withdrawal by Subject|1
6898894|NCT00652743|10918349|FG001|Months 36-42|Withdrawal by Subject|1
6898895|NCT00652743|10918350|FG002|Months 36-42|Withdrawal by Subject|0
6898896|NCT00652743|10918348|FG000|Months 36-42|Lost to Follow-up|0
6898897|NCT00652743|10918349|FG001|Months 36-42|Lost to Follow-up|1
6898898|NCT00652743|10918350|FG002|Months 36-42|Lost to Follow-up|0
6898899|NCT00652743|10918348|FG000|Months 36-42|Migrated/moved from study area|1
6898900|NCT00652743|10918349|FG001|Months 36-42|Migrated/moved from study area|0
6898901|NCT00652743|10918350|FG002|Months 36-42|Migrated/moved from study area|0
6898902|NCT00652743|10918348|FG000|Months 36-42|Other|4
6898903|NCT00652743|10918349|FG001|Months 36-42|Other|2
6898904|NCT00652743|10918350|FG002|Months 36-42|Other|8
6898905|NCT00652834|10918361|FG000|Overall Study|Withdrawal by Subject|3
6898906|NCT00652834|10918361|FG000|Overall Study|Lost to Follow-up|2
6898907|NCT00652899|10918365|FG000|Overall Study|Death|1
6898908|NCT00652899|10918365|FG000|Overall Study|Treating physician decision|1
6898909|NCT00652938|10918376|FG000|Overall Study|Adverse Event|1
6898910|NCT00652938|10918377|FG001|Overall Study|Adverse Event|0
6898911|NCT00652938|10918378|FG002|Overall Study|Adverse Event|2
6898912|NCT00652938|10918376|FG000|Overall Study|Withdrawal by Subject|0
6898913|NCT00652938|10918377|FG001|Overall Study|Withdrawal by Subject|6
6898914|NCT00652938|10918378|FG002|Overall Study|Withdrawal by Subject|1
6898915|NCT00652938|10918376|FG000|Overall Study|Lost to Follow-up|0
6898916|NCT00652938|10918377|FG001|Overall Study|Lost to Follow-up|0
6898917|NCT00652938|10918378|FG002|Overall Study|Lost to Follow-up|2
6898918|NCT00652938|10918376|FG000|Overall Study|fear of blood sampling|0
6898919|NCT00652938|10918377|FG001|Overall Study|fear of blood sampling|1
6898920|NCT00652938|10918378|FG002|Overall Study|fear of blood sampling|0
6898921|NCT00652951|10918389|FG000|Booster Phase|Adverse event, non-fatal|0
6898922|NCT00652951|10918390|FG001|Booster Phase|Adverse event, non-fatal|1
6898923|NCT00652951|10918391|FG002|Booster Phase|Adverse event, non-fatal|0
6898924|NCT00652951|10918389|FG000|Booster Phase|Other|1
6898925|NCT00652951|10918390|FG001|Booster Phase|Other|0
6898926|NCT00652951|10918391|FG002|Booster Phase|Other|0
6898927|NCT00653159|10918410|FG000|Overall Study|Adverse Event|4
6898928|NCT00653159|10918411|FG001|Overall Study|Adverse Event|1
6818218|NCT00076336|10822441|FG000|Overall Study|Non-Compliance|2
6818219|NCT00076336|10822442|FG001|Overall Study|Non-Compliance|0
6898929|NCT00653159|10918410|FG000|Overall Study|Lost to Follow-up|1
6898930|NCT00653159|10918411|FG001|Overall Study|Lost to Follow-up|2
6898931|NCT00653224|10918419|FG000|Overall Study|Adverse Event|2
6898932|NCT00653224|10918420|FG001|Overall Study|Adverse Event|1
6898933|NCT00653224|10918419|FG000|Overall Study|Lack of Efficacy|1
6818220|NCT00076336|10822441|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0
6818221|NCT00076336|10822442|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1
6818222|NCT00076336|10822441|FG000|Overall Study|Patient, Investigator, Sponsor request|8
6818223|NCT00076336|10822442|FG001|Overall Study|Patient, Investigator, Sponsor request|6
6818224|NCT00076336|10822441|FG000|Overall Study|Liver Transplantation|3
6818225|NCT00076336|10822442|FG001|Overall Study|Liver Transplantation|3
6818226|NCT00076336|10822441|FG000|Overall Study|Virologic Breakthrough|14
6818227|NCT00076336|10822442|FG001|Overall Study|Virologic Breakthrough|16
6818228|NCT00076336|10822441|FG000|Overall Study|Treatment failure|4
6818229|NCT00076336|10822442|FG001|Overall Study|Treatment failure|5
6818230|NCT00076570|10822450|FG000|Overall Study|Drug intolerance|8
6818231|NCT00076570|10822451|FG001|Overall Study|Drug intolerance|8
6818232|NCT00076752|10822491|FG000|Overall Study|Death|2
6818233|NCT00076752|10822491|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1
6818234|NCT00076804|10822498|FG000|Overall Study|Death|9
6818235|NCT00076804|10822499|FG001|Overall Study|Death|20
6818236|NCT00076804|10822498|FG000|Overall Study|Lost to Follow-up|9
6818237|NCT00076804|10822499|FG001|Overall Study|Lost to Follow-up|9
6818238|NCT00076804|10822498|FG000|Overall Study|Withdrawal by Subject|10
6818239|NCT00076804|10822499|FG001|Overall Study|Withdrawal by Subject|8
6818240|NCT00076804|10822498|FG000|Overall Study|Early study Closure|32
6818241|NCT00076804|10822499|FG001|Overall Study|Early study Closure|32
6818242|NCT00076999|10822509|FG000|Overall Study|Adverse Event|2
6818243|NCT00076999|10822510|FG001|Overall Study|Adverse Event|8
6818244|NCT00076999|10822511|FG002|Overall Study|Adverse Event|6
6818245|NCT00076999|10822512|FG003|Overall Study|Adverse Event|0
6818246|NCT00076999|10822513|FG004|Overall Study|Adverse Event|2
6818247|NCT00076999|10822509|FG000|Overall Study|Protocol Violation|0
6818248|NCT00076999|10822510|FG001|Overall Study|Protocol Violation|3
6818249|NCT00076999|10822511|FG002|Overall Study|Protocol Violation|4
6818250|NCT00076999|10822512|FG003|Overall Study|Protocol Violation|0
6818251|NCT00076999|10822513|FG004|Overall Study|Protocol Violation|9
6818252|NCT00076999|10822509|FG000|Overall Study|Lost to Follow-up|2
6818253|NCT00076999|10822510|FG001|Overall Study|Lost to Follow-up|1
6818254|NCT00076999|10822511|FG002|Overall Study|Lost to Follow-up|0
6818255|NCT00076999|10822512|FG003|Overall Study|Lost to Follow-up|0
6818256|NCT00076999|10822513|FG004|Overall Study|Lost to Follow-up|0
6818257|NCT00076999|10822509|FG000|Overall Study|Withdrawal by Subject|0
6818258|NCT00076999|10822510|FG001|Overall Study|Withdrawal by Subject|4
6818259|NCT00076999|10822511|FG002|Overall Study|Withdrawal by Subject|3
6818260|NCT00076999|10822512|FG003|Overall Study|Withdrawal by Subject|0
6818261|NCT00076999|10822513|FG004|Overall Study|Withdrawal by Subject|1
6818262|NCT00076999|10822509|FG000|Overall Study|Other reason (not specified)|8
6818263|NCT00076999|10822510|FG001|Overall Study|Other reason (not specified)|8
6818264|NCT00076999|10822511|FG002|Overall Study|Other reason (not specified)|4
6818265|NCT00076999|10822512|FG003|Overall Study|Other reason (not specified)|1
6818266|NCT00076999|10822513|FG004|Overall Study|Other reason (not specified)|13
6818267|NCT00077064|10822528|FG000|Overall Study|Adverse Event|0
6818268|NCT00077064|10822529|FG001|Overall Study|Adverse Event|4
6818269|NCT00077064|10822528|FG000|Overall Study|Patient refusal|0
6818270|NCT00077064|10822529|FG001|Overall Study|Patient refusal|2
6818271|NCT00077207|10822536|FG000|Overall Study|Adverse Event|5
6818272|NCT00077207|10822536|FG000|Overall Study|Lack of Efficacy|12
6818273|NCT00077207|10822536|FG000|Overall Study|Physician Decision|6
6898934|NCT00653224|10918420|FG001|Overall Study|Lack of Efficacy|2
6898935|NCT00653224|10918419|FG000|Overall Study|Loss of efficacy|1
6898936|NCT00653224|10918420|FG001|Overall Study|Loss of efficacy|0
6898937|NCT00653224|10918419|FG000|Overall Study|Lost to Follow-up|1
6898938|NCT00653224|10918420|FG001|Overall Study|Lost to Follow-up|0
6898939|NCT00653224|10918419|FG000|Overall Study|Other|2
6898940|NCT00653224|10918420|FG001|Overall Study|Other|4
6898941|NCT00653263|10918426|FG000|Overall Study|Withdrawal by Subject|1
6898942|NCT00653263|10918426|FG000|Overall Study|Physician Decision|1
6898943|NCT00653328|10918430|FG000|Overall Study|Withdrawal by Subject|1
6898944|NCT00653328|10918430|FG000|Overall Study|Adverse Event|2
6898945|NCT00653328|10918430|FG000|Overall Study|Disease progression|10
6898946|NCT00653328|10918430|FG000|Overall Study|Drug manufacturer no longing making drug|2
6898947|NCT00653432|10918436|FG000|Overall Study|Adverse Event|4
6898948|NCT00653432|10918437|FG001|Overall Study|Adverse Event|1
6898949|NCT00653432|10918436|FG000|Overall Study|Withdrawal by Subject|4
6898950|NCT00653432|10918437|FG001|Overall Study|Withdrawal by Subject|5
6898951|NCT00653432|10918436|FG000|Overall Study|Lost to Follow-up|7
6898952|NCT00653432|10918437|FG001|Overall Study|Lost to Follow-up|6
6898953|NCT00653432|10918436|FG000|Overall Study|Use/Need of Con Therapy|2
6898954|NCT00653432|10918437|FG001|Overall Study|Use/Need of Con Therapy|1
6818274|NCT00077207|10822536|FG000|Overall Study|Withdrawal by Subject|6
6818275|NCT00077207|10822536|FG000|Overall Study|Ineligible|1
6818276|NCT00077376|10822541|FG000|Overall Study|Adverse Event|8
6898955|NCT00653432|10918436|FG000|Overall Study|Other - Reason Not Provided|5
6898956|NCT00653432|10918437|FG001|Overall Study|Other - Reason Not Provided|3
6898957|NCT00653939|10918454|FG000|Overall Study|Adverse Event|1
6898958|NCT00653939|10918455|FG001|Overall Study|Adverse Event|3
6898959|NCT00653939|10918454|FG000|Overall Study|Withdrawal by Subject|3
6898960|NCT00653939|10918455|FG001|Overall Study|Withdrawal by Subject|3
6818277|NCT00077376|10822541|FG000|Overall Study|Withdrawal by Subject|2
6818278|NCT00077376|10822541|FG000|Overall Study|Death|1
6818279|NCT00077376|10822541|FG000|Overall Study|Physician Decision|1
6818280|NCT00077376|10822541|FG000|Overall Study|Alternative therapy|5
6818281|NCT00077376|10822541|FG000|Overall Study|Complicating disease|1
6818282|NCT00077376|10822541|FG000|Overall Study|Still on treatment|1
6818283|NCT00077376|10822541|FG000|Overall Study|Symptomatic deterioration|1
6818284|NCT00077376|10822541|FG000|Overall Study|Surgery|1
6818285|NCT00077376|10822541|FG000|Overall Study|Insurance ran out|1
6818286|NCT00077610|10822548|FG000|Overall Study|Adverse Event|9
6818287|NCT00077610|10822549|FG001|Overall Study|Adverse Event|7
6818288|NCT00077610|10822550|FG002|Overall Study|Adverse Event|1
6818289|NCT00077610|10822548|FG000|Overall Study|Lost to Follow-up|0
6818290|NCT00077610|10822549|FG001|Overall Study|Lost to Follow-up|1
6818291|NCT00077610|10822550|FG002|Overall Study|Lost to Follow-up|2
6818292|NCT00077610|10822548|FG000|Overall Study|Withdrawal by Subject|4
6818293|NCT00077610|10822549|FG001|Overall Study|Withdrawal by Subject|10
6818294|NCT00077610|10822550|FG002|Overall Study|Withdrawal by Subject|6
6818295|NCT00077610|10822548|FG000|Overall Study|Death|17
6818296|NCT00077610|10822549|FG001|Overall Study|Death|13
6818297|NCT00077610|10822550|FG002|Overall Study|Death|13
6818298|NCT00077610|10822548|FG000|Overall Study|Renal transplant|12
6818299|NCT00077610|10822549|FG001|Overall Study|Renal transplant|15
6818300|NCT00077610|10822550|FG002|Overall Study|Renal transplant|11
6818301|NCT00077610|10822548|FG000|Overall Study|Withdrew from dialysis care|5
6818302|NCT00077610|10822549|FG001|Overall Study|Withdrew from dialysis care|0
6818303|NCT00077610|10822550|FG002|Overall Study|Withdrew from dialysis care|3
6818304|NCT00077610|10822548|FG000|Overall Study|Insufficient Therapeutic Response|1
6818305|NCT00077610|10822549|FG001|Overall Study|Insufficient Therapeutic Response|0
6818306|NCT00077610|10822550|FG002|Overall Study|Insufficient Therapeutic Response|0
6818307|NCT00077610|10822548|FG000|Overall Study|Multiple blood transfusions|0
6818308|NCT00077610|10822549|FG001|Overall Study|Multiple blood transfusions|0
6818309|NCT00077610|10822550|FG002|Overall Study|Multiple blood transfusions|1
6818310|NCT00077610|10822548|FG000|Overall Study|Principal Investigator's decision|1
6818311|NCT00077610|10822549|FG001|Overall Study|Principal Investigator's decision|0
6818312|NCT00077610|10822550|FG002|Overall Study|Principal Investigator's decision|1
6818313|NCT00077610|10822548|FG000|Overall Study|Worsening of health condition|1
6818314|NCT00077610|10822549|FG001|Overall Study|Worsening of health condition|1
6818315|NCT00077610|10822550|FG002|Overall Study|Worsening of health condition|0
6818316|NCT00077610|10822548|FG000|Overall Study|Given Epogen in hospital|1
6818317|NCT00077610|10822549|FG001|Overall Study|Given Epogen in hospital|0
6818318|NCT00077610|10822550|FG002|Overall Study|Given Epogen in hospital|0
6818319|NCT00077610|10822548|FG000|Overall Study|Transferred to other unit|0
6818320|NCT00077610|10822549|FG001|Overall Study|Transferred to other unit|0
6818321|NCT00077610|10822550|FG002|Overall Study|Transferred to other unit|1
6818322|NCT00077610|10822548|FG000|Overall Study|Transferred to nursing home|0
6818323|NCT00077610|10822549|FG001|Overall Study|Transferred to nursing home|0
6818324|NCT00077610|10822550|FG002|Overall Study|Transferred to nursing home|1
6818325|NCT00077610|10822548|FG000|Overall Study|Transfer to satellite unit|1
6818326|NCT00077610|10822549|FG001|Overall Study|Transfer to satellite unit|0
6818327|NCT00077610|10822550|FG002|Overall Study|Transfer to satellite unit|0
6818328|NCT00077610|10822548|FG000|Overall Study|Transfer to other center for surgery|1
6818329|NCT00077610|10822549|FG001|Overall Study|Transfer to other center for surgery|0
6818330|NCT00077610|10822550|FG002|Overall Study|Transfer to other center for surgery|0
6818331|NCT00077610|10822548|FG000|Overall Study|Change in dialysis modality|1
6818332|NCT00077610|10822549|FG001|Overall Study|Change in dialysis modality|0
6818333|NCT00077610|10822550|FG002|Overall Study|Change in dialysis modality|0
6818334|NCT00077610|10822548|FG000|Overall Study|Relocation|0
6818335|NCT00077610|10822549|FG001|Overall Study|Relocation|8
6818336|NCT00077610|10822550|FG002|Overall Study|Relocation|5
6818337|NCT00077610|10822548|FG000|Overall Study|Financial issues|0
6818338|NCT00077610|10822549|FG001|Overall Study|Financial issues|1
6818339|NCT00077610|10822550|FG002|Overall Study|Financial issues|0
6818340|NCT00077610|10822548|FG000|Overall Study|Sponsors decision to withdraw|0
6818341|NCT00077610|10822549|FG001|Overall Study|Sponsors decision to withdraw|0
6818342|NCT00077610|10822550|FG002|Overall Study|Sponsors decision to withdraw|1
6818343|NCT00077623|10822566|FG000|Overall Study|Adverse Event|1
6818344|NCT00077623|10822567|FG001|Overall Study|Adverse Event|0
6818345|NCT00077623|10822568|FG002|Overall Study|Adverse Event|1
6818346|NCT00077623|10822566|FG000|Overall Study|Withdrawal by Subject|2
6818347|NCT00077623|10822567|FG001|Overall Study|Withdrawal by Subject|10
6818348|NCT00077623|10822568|FG002|Overall Study|Withdrawal by Subject|1
6818349|NCT00077623|10822566|FG000|Overall Study|Other-Non safety reason|18
6818350|NCT00077623|10822567|FG001|Overall Study|Other-Non safety reason|15
6818351|NCT00077623|10822568|FG002|Overall Study|Other-Non safety reason|19
6818352|NCT00077623|10822566|FG000|Overall Study|Insufficient therapeutic response|2
6818353|NCT00077623|10822567|FG001|Overall Study|Insufficient therapeutic response|0
6818354|NCT00077623|10822568|FG002|Overall Study|Insufficient therapeutic response|0
6818355|NCT00077623|10822566|FG000|Overall Study|Death|12
6818356|NCT00077623|10822567|FG001|Overall Study|Death|18
6818357|NCT00077623|10822568|FG002|Overall Study|Death|11
6818358|NCT00077623|10822566|FG000|Overall Study|Failure to return|1
6818359|NCT00077623|10822567|FG001|Overall Study|Failure to return|0
6818360|NCT00077623|10822568|FG002|Overall Study|Failure to return|0
6818361|NCT00077636|10822578|FG000|Overall Study|Refused Treatment|9
6818362|NCT00077636|10822579|FG001|Overall Study|Refused Treatment|31
6818363|NCT00077636|10822578|FG000|Overall Study|Admin|3
6818364|NCT00077636|10822579|FG001|Overall Study|Admin|3
6818365|NCT00077636|10822578|FG000|Overall Study|Withdrawal by Subject|2
6818366|NCT00077636|10822579|FG001|Overall Study|Withdrawal by Subject|2
6818367|NCT00077636|10822578|FG000|Overall Study|Adverse Event|17
6818368|NCT00077636|10822579|FG001|Overall Study|Adverse Event|34
6818369|NCT00077636|10822578|FG000|Overall Study|Protocol Violation|0
6818370|NCT00077636|10822579|FG001|Overall Study|Protocol Violation|2
6818371|NCT00077636|10822578|FG000|Overall Study|Lost to Follow-up|10
6818372|NCT00077636|10822579|FG001|Overall Study|Lost to Follow-up|18
6818373|NCT00077636|10822578|FG000|Overall Study|Abnormality Of Laboratory Test|3
6818374|NCT00077636|10822579|FG001|Overall Study|Abnormality Of Laboratory Test|2
6818375|NCT00077649|10822590|FG000|Overall Study|Adverse Event|5
6818376|NCT00077649|10822591|FG001|Overall Study|Adverse Event|1
6818377|NCT00077649|10822592|FG002|Overall Study|Adverse Event|7
6818378|NCT00077649|10822593|FG003|Overall Study|Adverse Event|9
6818379|NCT00077649|10822590|FG000|Overall Study|Lack of Efficacy|5
6818380|NCT00077649|10822591|FG001|Overall Study|Lack of Efficacy|3
6818381|NCT00077649|10822592|FG002|Overall Study|Lack of Efficacy|3
6818382|NCT00077649|10822593|FG003|Overall Study|Lack of Efficacy|2
6818383|NCT00077649|10822590|FG000|Overall Study|Withdrawal by Subject|0
6818384|NCT00077649|10822591|FG001|Overall Study|Withdrawal by Subject|1
6818385|NCT00077649|10822592|FG002|Overall Study|Withdrawal by Subject|1
6818386|NCT00077649|10822593|FG003|Overall Study|Withdrawal by Subject|2
6818387|NCT00077649|10822590|FG000|Overall Study|Lost to Follow-up|2
6818388|NCT00077649|10822591|FG001|Overall Study|Lost to Follow-up|2
6818389|NCT00077649|10822592|FG002|Overall Study|Lost to Follow-up|3
6818390|NCT00077649|10822593|FG003|Overall Study|Lost to Follow-up|2
6818391|NCT00077649|10822590|FG000|Overall Study|Abnormality of Laboratory Test|1
6818392|NCT00077649|10822591|FG001|Overall Study|Abnormality of Laboratory Test|2
6818393|NCT00077649|10822592|FG002|Overall Study|Abnormality of Laboratory Test|1
6818394|NCT00077649|10822593|FG003|Overall Study|Abnormality of Laboratory Test|2
6818395|NCT00077649|10822590|FG000|Overall Study|Randomized but never dosed|1
6818396|NCT00077649|10822591|FG001|Overall Study|Randomized but never dosed|0
6818397|NCT00077649|10822592|FG002|Overall Study|Randomized but never dosed|0
6818398|NCT00077649|10822593|FG003|Overall Study|Randomized but never dosed|0
6818399|NCT00077675|10822609|FG000|Overall Study|Adverse Event|1
6818400|NCT00077675|10822610|FG001|Overall Study|Adverse Event|2
6818401|NCT00077675|10822609|FG000|Overall Study|Lost to Follow-up|6
6818402|NCT00077675|10822610|FG001|Overall Study|Lost to Follow-up|3
6818403|NCT00077675|10822609|FG000|Overall Study|Withdrawal by Subject|1
6818404|NCT00077675|10822610|FG001|Overall Study|Withdrawal by Subject|0
6818405|NCT00077675|10822609|FG000|Overall Study|Other|0
6818406|NCT00077675|10822610|FG001|Overall Study|Other|1
6818407|NCT00077675|10822609|FG000|Overall Study|Never received study treatment|3
6818408|NCT00077675|10822610|FG001|Overall Study|Never received study treatment|3
6818409|NCT00077766|10822618|FG000|Overall Study|Adverse Event|1
6818410|NCT00077766|10822619|FG001|Overall Study|Adverse Event|1
6818411|NCT00077766|10822618|FG000|Overall Study|Withdrawal by Subject|4
6818412|NCT00077766|10822619|FG001|Overall Study|Withdrawal by Subject|3
6818413|NCT00077766|10822618|FG000|Overall Study|Death|12
6818414|NCT00077766|10822619|FG001|Overall Study|Death|10
6818415|NCT00077766|10822618|FG000|Overall Study|Lost to Follow-up|2
6818416|NCT00077766|10822619|FG001|Overall Study|Lost to Follow-up|0
6818417|NCT00077766|10822618|FG000|Overall Study|Protocol Violation|1
6818418|NCT00077766|10822619|FG001|Overall Study|Protocol Violation|0
6818419|NCT00077766|10822618|FG000|Overall Study|Kidney Transplantation|9
6818420|NCT00077766|10822619|FG001|Overall Study|Kidney Transplantation|5
6818421|NCT00077766|10822618|FG000|Overall Study|Transplantation|5
6818422|NCT00077766|10822619|FG001|Overall Study|Transplantation|1
6818423|NCT00077766|10822618|FG000|Overall Study|Investigators Discretion|1
6818424|NCT00077766|10822619|FG001|Overall Study|Investigators Discretion|0
6818425|NCT00077766|10822618|FG000|Overall Study|Participant's decision|1
6818426|NCT00077766|10822619|FG001|Overall Study|Participant's decision|0
6818427|NCT00077766|10822618|FG000|Overall Study|Dialysis Discontinued|1
6818428|NCT00077766|10822619|FG001|Overall Study|Dialysis Discontinued|0
6818429|NCT00077766|10822618|FG000|Overall Study|Dialysis|0
6818430|NCT00077766|10822619|FG001|Overall Study|Dialysis|1
6818431|NCT00077766|10822618|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0
6818432|NCT00077766|10822619|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1
6818433|NCT00077766|10822618|FG000|Overall Study|Started Nocturnal Dialysis|0
6818434|NCT00077766|10822619|FG001|Overall Study|Started Nocturnal Dialysis|1
6818435|NCT00077766|10822618|FG000|Overall Study|Stop Dialysis|0
6818436|NCT00077766|10822619|FG001|Overall Study|Stop Dialysis|1
6818437|NCT00077766|10822618|FG000|Overall Study|Participants Vacation|2
6818438|NCT00077766|10822619|FG001|Overall Study|Participants Vacation|1
6818439|NCT00077857|10822628|FG000|Overall Study|Adverse Event|30
6818440|NCT00077857|10822629|FG001|Overall Study|Adverse Event|32
6818441|NCT00077857|10822628|FG000|Overall Study|Death|7
6818442|NCT00077857|10822629|FG001|Overall Study|Death|3
6818443|NCT00077857|10822628|FG000|Overall Study|Insufficient therapeutic response|112
6818444|NCT00077857|10822629|FG001|Overall Study|Insufficient therapeutic response|128
6818445|NCT00077857|10822628|FG000|Overall Study|Violation of selection criteria at entry|3
6818446|NCT00077857|10822629|FG001|Overall Study|Violation of selection criteria at entry|1
6818447|NCT00077857|10822628|FG000|Overall Study|Other protocol violation|0
6818448|NCT00077857|10822629|FG001|Overall Study|Other protocol violation|1
6818449|NCT00077857|10822628|FG000|Overall Study|Refused treatment|29
6818450|NCT00077857|10822629|FG001|Overall Study|Refused treatment|21
6818451|NCT00077857|10822628|FG000|Overall Study|Failure to return|5
6818452|NCT00077857|10822629|FG001|Overall Study|Failure to return|5
6818453|NCT00077857|10822628|FG000|Overall Study|Other|15
6818454|NCT00077857|10822629|FG001|Overall Study|Other|13
6818455|NCT00077974|10822639|FG000|Overall Study|Adverse Event|22
6818456|NCT00077974|10822639|FG000|Overall Study|Protocol Violation|1
6818457|NCT00077974|10822639|FG000|Overall Study|Withdrawal by Subject|3
6818458|NCT00077974|10822639|FG000|Overall Study|Lack of Efficacy|76
6818459|NCT00077974|10822639|FG000|Overall Study|Decision of Sponsor|2
6818460|NCT00078312|10822652|FG000|Overall Study|Adverse Event|43
6818461|NCT00078312|10822652|FG000|Overall Study|Lack of Efficacy|15
6818462|NCT00078312|10822652|FG000|Overall Study|Lost to Follow-up|41
6818463|NCT00078312|10822652|FG000|Overall Study|Physician Decision|9
6818464|NCT00078312|10822652|FG000|Overall Study|Protocol Violation|3
6818465|NCT00078312|10822652|FG000|Overall Study|Withdrawal by Subject|33
6818466|NCT00078312|10822652|FG000|Overall Study|Miscellaneous|33
6818467|NCT00078325|10822659|FG000|Overall Study|Adverse Event|15
6818468|NCT00078325|10822660|FG001|Overall Study|Adverse Event|10
6818469|NCT00078325|10822661|FG002|Overall Study|Adverse Event|5
6818470|NCT00078325|10822659|FG000|Overall Study|Protocol Violation|2
6818471|NCT00078325|10822660|FG001|Overall Study|Protocol Violation|2
6818472|NCT00078325|10822661|FG002|Overall Study|Protocol Violation|0
6818473|NCT00078325|10822659|FG000|Overall Study|Withdrawal by Subject|1
6818474|NCT00078325|10822660|FG001|Overall Study|Withdrawal by Subject|5
6818475|NCT00078325|10822661|FG002|Overall Study|Withdrawal by Subject|3
6818476|NCT00078325|10822659|FG000|Overall Study|Lost to Follow-up|0
6818477|NCT00078325|10822660|FG001|Overall Study|Lost to Follow-up|1
6818478|NCT00078325|10822661|FG002|Overall Study|Lost to Follow-up|1
6818479|NCT00078325|10822659|FG000|Overall Study|Physician Decision|2
6818480|NCT00078325|10822660|FG001|Overall Study|Physician Decision|0
6818481|NCT00078325|10822661|FG002|Overall Study|Physician Decision|1
6818482|NCT00078325|10822659|FG000|Overall Study|Miscellaneous|1
6818483|NCT00078325|10822660|FG001|Overall Study|Miscellaneous|1
6818484|NCT00078325|10822661|FG002|Overall Study|Miscellaneous|1
6818485|NCT00078338|10822671|FG000|Overall Study|Adverse Event|31
6818486|NCT00078338|10822672|FG001|Overall Study|Adverse Event|24
6818487|NCT00078338|10822671|FG000|Overall Study|Lost to Follow-up|17
6818488|NCT00078338|10822672|FG001|Overall Study|Lost to Follow-up|2
6818489|NCT00078338|10822671|FG000|Overall Study|Protocol Violation|2
6818490|NCT00078338|10822672|FG001|Overall Study|Protocol Violation|2
6818491|NCT00078338|10822671|FG000|Overall Study|Disease Progression|4
6818492|NCT00078338|10822672|FG001|Overall Study|Disease Progression|7
6818493|NCT00078338|10822671|FG000|Overall Study|Other|28
6818494|NCT00078338|10822672|FG001|Overall Study|Other|16
6818495|NCT00078338|10822671|FG000|Overall Study|Subjects randomized, but not treated|3
6818496|NCT00078338|10822672|FG001|Overall Study|Subjects randomized, but not treated|3
6818497|NCT00078377|10822681|FG000|Overall Study|Adverse Event|2
6818498|NCT00078377|10822682|FG001|Overall Study|Adverse Event|5
6818499|NCT00078377|10822683|FG002|Overall Study|Adverse Event|1
6818500|NCT00078377|10822681|FG000|Overall Study|Lack of Efficacy|2
6818501|NCT00078377|10822682|FG001|Overall Study|Lack of Efficacy|0
6818502|NCT00078377|10822683|FG002|Overall Study|Lack of Efficacy|2
6818503|NCT00078377|10822681|FG000|Overall Study|Lost to Follow-up|0
6818504|NCT00078377|10822682|FG001|Overall Study|Lost to Follow-up|1
6818505|NCT00078377|10822683|FG002|Overall Study|Lost to Follow-up|1
6818506|NCT00078377|10822681|FG000|Overall Study|Physician Decision|2
6818507|NCT00078377|10822682|FG001|Overall Study|Physician Decision|0
6818508|NCT00078377|10822683|FG002|Overall Study|Physician Decision|0
6818509|NCT00078377|10822681|FG000|Overall Study|Withdrawal by Subject|3
6818510|NCT00078377|10822682|FG001|Overall Study|Withdrawal by Subject|4
6818511|NCT00078377|10822683|FG002|Overall Study|Withdrawal by Subject|4
6818512|NCT00078377|10822681|FG000|Overall Study|Miscellaneous|2
6818513|NCT00078377|10822682|FG001|Overall Study|Miscellaneous|6
6818514|NCT00078377|10822683|FG002|Overall Study|Miscellaneous|1
6896529|NCT00633893|10915016|FG001|Overall Study|Poor/non-compliance|12
6896530|NCT00633893|10915017|FG002|Overall Study|Poor/non-compliance|3
6896531|NCT00633893|10915015|FG000|Overall Study|Pregnancy|2
6896532|NCT00633893|10915016|FG001|Overall Study|Pregnancy|1
6896533|NCT00633893|10915017|FG002|Overall Study|Pregnancy|1
6896534|NCT00633893|10915015|FG000|Overall Study|Not meet/no longer meets criteria|4
6896535|NCT00633893|10915016|FG001|Overall Study|Not meet/no longer meets criteria|6
6896536|NCT00633893|10915017|FG002|Overall Study|Not meet/no longer meets criteria|4
6896537|NCT00633893|10915015|FG000|Overall Study|Other|28
6896538|NCT00633893|10915016|FG001|Overall Study|Other|33
6896539|NCT00633893|10915017|FG002|Overall Study|Other|31
6896540|NCT00633932|10915037|FG000|Overall Study|Adverse Event|1
6896541|NCT00633932|10915038|FG001|Overall Study|Adverse Event|3
6896542|NCT00633932|10915039|FG002|Overall Study|Adverse Event|4
6896543|NCT00633932|10915037|FG000|Overall Study|Withdrawal by Subject|3
6818515|NCT00078767|10822748|FG000|Overall Study|Withdrawal by Subject|1
6818516|NCT00078767|10822749|FG001|Overall Study|Withdrawal by Subject|1
6818517|NCT00078819|10822757|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0
6818518|NCT00078819|10822758|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1
6818519|NCT00078819|10822759|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0
6818520|NCT00078819|10822760|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0
6818521|NCT00078819|10822757|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1
6818522|NCT00078819|10822758|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
6818523|NCT00078819|10822759|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
6818524|NCT00078819|10822760|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
6818525|NCT00078819|10822757|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1
6818526|NCT00078819|10822758|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1
6818527|NCT00078819|10822759|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0
6818528|NCT00078819|10822760|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0
6818529|NCT00078819|10822757|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3
6818530|NCT00078819|10822758|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2
6818531|NCT00078819|10822759|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0
6818532|NCT00078819|10822760|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0
6818533|NCT00078819|10822757|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2
6818534|NCT00078819|10822758|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2
6818535|NCT00078819|10822759|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0
6818536|NCT00078819|10822760|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0
6818537|NCT00078819|10822757|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34
6818538|NCT00078819|10822758|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25
6818539|NCT00078819|10822759|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0
6818540|NCT00078819|10822760|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0
6818541|NCT00078819|10822757|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0
6818542|NCT00078819|10822758|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0
6818543|NCT00078819|10822759|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29
6818544|NCT00078819|10822760|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13
6818545|NCT00078819|10822757|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
6818546|NCT00078819|10822758|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
6818547|NCT00078819|10822759|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
6818548|NCT00078819|10822760|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1
6818549|NCT00078949|10822790|FG000|Overall Study|No treated|4
6818550|NCT00078949|10822791|FG001|Overall Study|No treated|5
6818551|NCT00078949|10822792|FG002|Overall Study|No treated|3
6818552|NCT00078949|10822793|FG003|Overall Study|No treated|3
6818553|NCT00079040|10822814|FG000|Overall Study|Withdrew before treatment|1
6818554|NCT00079040|10822814|FG000|Overall Study|Ineligible|1
6818555|NCT00079183|10822818|FG000|Overall Study|Withdrawal by Subject|4
6818556|NCT00079183|10822818|FG000|Overall Study|Study medication non-compliance|2
6818557|NCT00079183|10822818|FG000|Overall Study|Specimen collection non-compliance|1
6818558|NCT00079274|10822830|FG000|Overall Study|Withdrawal by Subject|111
6818559|NCT00079274|10822831|FG001|Overall Study|Withdrawal by Subject|10
6818560|NCT00079274|10822832|FG002|Overall Study|Withdrawal by Subject|12
6818561|NCT00079274|10822833|FG003|Overall Study|Withdrawal by Subject|163
6818562|NCT00079274|10822834|FG004|Overall Study|Withdrawal by Subject|7
6818563|NCT00079274|10822835|FG005|Overall Study|Withdrawal by Subject|8
6818564|NCT00079274|10822836|FG006|Overall Study|Withdrawal by Subject|0
6818565|NCT00079274|10822830|FG000|Overall Study|Adverse Event|130
6818566|NCT00079274|10822831|FG001|Overall Study|Adverse Event|8
6818567|NCT00079274|10822832|FG002|Overall Study|Adverse Event|8
6818568|NCT00079274|10822833|FG003|Overall Study|Adverse Event|184
6818569|NCT00079274|10822834|FG004|Overall Study|Adverse Event|7
6818570|NCT00079274|10822835|FG005|Overall Study|Adverse Event|8
6818571|NCT00079274|10822836|FG006|Overall Study|Adverse Event|0
6818572|NCT00079274|10822830|FG000|Overall Study|Recurrence|21
6818573|NCT00079274|10822831|FG001|Overall Study|Recurrence|0
6818574|NCT00079274|10822832|FG002|Overall Study|Recurrence|1
6818575|NCT00079274|10822833|FG003|Overall Study|Recurrence|15
6818576|NCT00079274|10822834|FG004|Overall Study|Recurrence|0
6818577|NCT00079274|10822835|FG005|Overall Study|Recurrence|2
6818578|NCT00079274|10822836|FG006|Overall Study|Recurrence|0
6818579|NCT00079274|10822830|FG000|Overall Study|Alternate Treatment|6
6818580|NCT00079274|10822831|FG001|Overall Study|Alternate Treatment|1
6818581|NCT00079274|10822832|FG002|Overall Study|Alternate Treatment|0
6818582|NCT00079274|10822833|FG003|Overall Study|Alternate Treatment|3
6818583|NCT00079274|10822834|FG004|Overall Study|Alternate Treatment|0
6818584|NCT00079274|10822835|FG005|Overall Study|Alternate Treatment|0
6818585|NCT00079274|10822836|FG006|Overall Study|Alternate Treatment|0
6818586|NCT00079274|10822830|FG000|Overall Study|Other Medical Problems|6
6818587|NCT00079274|10822831|FG001|Overall Study|Other Medical Problems|1
6818588|NCT00079274|10822832|FG002|Overall Study|Other Medical Problems|0
6818589|NCT00079274|10822833|FG003|Overall Study|Other Medical Problems|7
6818590|NCT00079274|10822834|FG004|Overall Study|Other Medical Problems|0
6818591|NCT00079274|10822835|FG005|Overall Study|Other Medical Problems|0
6818592|NCT00079274|10822836|FG006|Overall Study|Other Medical Problems|0
6818593|NCT00079274|10822830|FG000|Overall Study|Death|4
6818594|NCT00079274|10822831|FG001|Overall Study|Death|0
6818595|NCT00079274|10822832|FG002|Overall Study|Death|1
6818596|NCT00079274|10822833|FG003|Overall Study|Death|15
6818597|NCT00079274|10822834|FG004|Overall Study|Death|0
6818598|NCT00079274|10822835|FG005|Overall Study|Death|0
6818599|NCT00079274|10822836|FG006|Overall Study|Death|0
6818600|NCT00079274|10822830|FG000|Overall Study|Cytogenetic resistance|0
6818601|NCT00079274|10822831|FG001|Overall Study|Cytogenetic resistance|0
6818602|NCT00079274|10822832|FG002|Overall Study|Cytogenetic resistance|0
6818603|NCT00079274|10822833|FG003|Overall Study|Cytogenetic resistance|2
6818604|NCT00079274|10822834|FG004|Overall Study|Cytogenetic resistance|0
6818605|NCT00079274|10822835|FG005|Overall Study|Cytogenetic resistance|0
6818606|NCT00079274|10822836|FG006|Overall Study|Cytogenetic resistance|0
6818607|NCT00079274|10822830|FG000|Overall Study|Other|43
6818608|NCT00079274|10822831|FG001|Overall Study|Other|7
6818609|NCT00079274|10822832|FG002|Overall Study|Other|5
6818610|NCT00079274|10822833|FG003|Overall Study|Other|55
6818611|NCT00079274|10822834|FG004|Overall Study|Other|1
6818612|NCT00079274|10822835|FG005|Overall Study|Other|2
6898961|NCT00653939|10918454|FG000|Overall Study|Physician Decision|4
6898962|NCT00653939|10918455|FG001|Overall Study|Physician Decision|0
6898963|NCT00653939|10918454|FG000|Overall Study|Disease Progression|2
6898964|NCT00653939|10918455|FG001|Overall Study|Disease Progression|3
6898965|NCT00653939|10918454|FG000|Overall Study|Other|2
6898966|NCT00653939|10918455|FG001|Overall Study|Other|6
6898967|NCT00653991|10918465|FG000|3 Month Follow-up|Participant would not respond|150
6898968|NCT00653991|10918466|FG001|3 Month Follow-up|Participant would not respond|157
6898969|NCT00653991|10918465|FG000|6 Month Follow-up|Participant would not respond|133
6898970|NCT00653991|10918466|FG001|6 Month Follow-up|Participant would not respond|141
6898971|NCT00654004|10918476|FG000|Overall Study|Lost to Follow-up|1
6898972|NCT00654004|10918477|FG001|Overall Study|Lost to Follow-up|0
6898973|NCT00654186|10918509|FG000|Overall Study|Withdrawal by Subject|5
6898974|NCT00654238|10918513|FG000|Overall Study|Screen Failures|4
6898975|NCT00654355|10918537|FG000|Overall Study|Lost to Follow-up|2
6898976|NCT00654355|10918538|FG001|Overall Study|Lost to Follow-up|2
6898977|NCT00654368|10918547|FG000|Overall Study|Ineligibility determined|6
6898978|NCT00654368|10918548|FG001|Overall Study|Ineligibility determined|0
6898979|NCT00654368|10918549|FG002|Overall Study|Ineligibility determined|0
6898980|NCT00654368|10918547|FG000|Overall Study|Protocol deviation|3
6898981|NCT00654368|10918548|FG001|Overall Study|Protocol deviation|2
6898982|NCT00654368|10918549|FG002|Overall Study|Protocol deviation|1
6898983|NCT00654368|10918547|FG000|Overall Study|Non-compliance|2
6898984|NCT00654368|10918548|FG001|Overall Study|Non-compliance|1
6898985|NCT00654368|10918549|FG002|Overall Study|Non-compliance|2
6898986|NCT00654368|10918547|FG000|Overall Study|Withdrawal by Subject|5
6898987|NCT00654368|10918548|FG001|Overall Study|Withdrawal by Subject|2
6898988|NCT00654368|10918549|FG002|Overall Study|Withdrawal by Subject|2
6898989|NCT00654368|10918547|FG000|Overall Study|Disease progression|21
6898990|NCT00654368|10918548|FG001|Overall Study|Disease progression|31
6898991|NCT00654368|10918549|FG002|Overall Study|Disease progression|13
6898992|NCT00654368|10918547|FG000|Overall Study|Requirement for alternative therapy|1
6898993|NCT00654368|10918548|FG001|Overall Study|Requirement for alternative therapy|1
6898994|NCT00654368|10918549|FG002|Overall Study|Requirement for alternative therapy|1
6898995|NCT00654368|10918547|FG000|Overall Study|Physician Decision|0
6898996|NCT00654368|10918548|FG001|Overall Study|Physician Decision|0
6898997|NCT00654368|10918549|FG002|Overall Study|Physician Decision|2
6898998|NCT00654368|10918547|FG000|Overall Study|Death|1
6898999|NCT00654368|10918548|FG001|Overall Study|Death|0
6899000|NCT00654368|10918549|FG002|Overall Study|Death|0
6899001|NCT00654368|10918547|FG000|Overall Study|Pregnancy|0
6899002|NCT00654368|10918548|FG001|Overall Study|Pregnancy|0
6899003|NCT00654368|10918549|FG002|Overall Study|Pregnancy|2
6899004|NCT00654368|10918547|FG000|Overall Study|Other|0
6899005|NCT00654368|10918548|FG001|Overall Study|Other|2
6899006|NCT00654368|10918549|FG002|Overall Study|Other|3
6899007|NCT00654368|10918547|FG000|Overall Study|Adverse Event|14
6899008|NCT00654368|10918548|FG001|Overall Study|Adverse Event|9
6899009|NCT00654368|10918549|FG002|Overall Study|Adverse Event|6
6899010|NCT00654381|10918560|FG000|1st Stage|Adverse Event|3
6899011|NCT00654381|10918561|FG001|1st Stage|Adverse Event|3
6818613|NCT00079274|10822836|FG006|Overall Study|Other|0
6899012|NCT00654381|10918562|FG002|1st Stage|Adverse Event|3
6899013|NCT00654381|10918563|FG003|1st Stage|Adverse Event|3
6899014|NCT00654381|10918564|FG004|1st Stage|Adverse Event|2
6899015|NCT00654381|10918565|FG005|1st Stage|Adverse Event|1
6899016|NCT00654381|10918560|FG000|1st Stage|Withdrawal by Subject|0
6899017|NCT00654381|10918561|FG001|1st Stage|Withdrawal by Subject|0
6899018|NCT00654381|10918562|FG002|1st Stage|Withdrawal by Subject|0
6899019|NCT00654381|10918563|FG003|1st Stage|Withdrawal by Subject|1
6899020|NCT00654381|10918564|FG004|1st Stage|Withdrawal by Subject|0
6899021|NCT00654381|10918565|FG005|1st Stage|Withdrawal by Subject|1
6899022|NCT00654381|10918560|FG000|1st Stage|Investigator's decision|0
6899023|NCT00654381|10918561|FG001|1st Stage|Investigator's decision|0
6899024|NCT00654381|10918562|FG002|1st Stage|Investigator's decision|0
6899025|NCT00654381|10918563|FG003|1st Stage|Investigator's decision|1
6899026|NCT00654381|10918564|FG004|1st Stage|Investigator's decision|0
6818614|NCT00079339|10822860|FG000|Overall Study|Adverse Event|1
6818615|NCT00079339|10822861|FG001|Overall Study|Adverse Event|7
6818616|NCT00079339|10822862|FG002|Overall Study|Adverse Event|2
6818617|NCT00079339|10822860|FG000|Overall Study|Death|1
6818618|NCT00079339|10822861|FG001|Overall Study|Death|0
6818619|NCT00079339|10822862|FG002|Overall Study|Death|0
6818620|NCT00079339|10822860|FG000|Overall Study|Non-compliance|0
6818621|NCT00079339|10822861|FG001|Overall Study|Non-compliance|0
6818622|NCT00079339|10822862|FG002|Overall Study|Non-compliance|1
6818623|NCT00079339|10822860|FG000|Overall Study|Withdrawal by Subject|0
6818624|NCT00079339|10822861|FG001|Overall Study|Withdrawal by Subject|4
6818625|NCT00079339|10822862|FG002|Overall Study|Withdrawal by Subject|1
6818626|NCT00079339|10822860|FG000|Overall Study|Disease progression|3
6818627|NCT00079339|10822861|FG001|Overall Study|Disease progression|28
6818628|NCT00079339|10822862|FG002|Overall Study|Disease progression|2
6818629|NCT00079391|10822875|FG000|Overall Study|Withdrawal by Subject|1
6818630|NCT00079417|10822881|FG000|Overall Study|Physician Decision|2
6818631|NCT00079417|10822881|FG000|Overall Study|Ineligible|7
6818632|NCT00079677|10822887|FG000|Overall Study|Adverse Event|5
6818633|NCT00079677|10822888|FG001|Overall Study|Adverse Event|6
6818634|NCT00079677|10822887|FG000|Overall Study|Lack of Efficacy|1
6818635|NCT00079677|10822888|FG001|Overall Study|Lack of Efficacy|0
6818636|NCT00079677|10822887|FG000|Overall Study|Lost to Follow-up|2
6818637|NCT00079677|10822888|FG001|Overall Study|Lost to Follow-up|2
6818638|NCT00079677|10822887|FG000|Overall Study|Physician Decision|3
6818639|NCT00079677|10822888|FG001|Overall Study|Physician Decision|0
6818640|NCT00079677|10822887|FG000|Overall Study|Protocol Violation|2
6818641|NCT00079677|10822888|FG001|Overall Study|Protocol Violation|3
6818642|NCT00079677|10822887|FG000|Overall Study|Withdrawal by Subject|5
6818643|NCT00079677|10822888|FG001|Overall Study|Withdrawal by Subject|3
6818644|NCT00079677|10822887|FG000|Overall Study|Miscellaneous|2
6818645|NCT00079677|10822888|FG001|Overall Study|Miscellaneous|0
6818646|NCT00079781|10822897|FG000|Pre-implant Period|Withdrawal by Subject|2
6818647|NCT00079781|10822898|FG001|Pre-implant Period|Withdrawal by Subject|0
6818648|NCT00079781|10822899|FG002|Pre-implant Period|Withdrawal by Subject|0
6818649|NCT00079781|10822897|FG000|Pre-implant Period|Did not meet I/E criteria|1
6818650|NCT00079781|10822898|FG001|Pre-implant Period|Did not meet I/E criteria|1
6818651|NCT00079781|10822899|FG002|Pre-implant Period|Did not meet I/E criteria|1
6818652|NCT00079781|10822897|FG000|Follow-up Period|Withdrawal by Subject|3
6818653|NCT00079781|10822898|FG001|Follow-up Period|Withdrawal by Subject|0
6818654|NCT00079781|10822899|FG002|Follow-up Period|Withdrawal by Subject|1
6818655|NCT00079781|10822897|FG000|Follow-up Period|Lost to Follow-up|1
6818656|NCT00079781|10822898|FG001|Follow-up Period|Lost to Follow-up|0
6818657|NCT00079781|10822899|FG002|Follow-up Period|Lost to Follow-up|0
6818658|NCT00079781|10822897|FG000|Follow-up Period|Death|0
6818659|NCT00079781|10822898|FG001|Follow-up Period|Death|0
6818660|NCT00079781|10822899|FG002|Follow-up Period|Death|1
6818661|NCT00079937|10822907|FG000|Overall Study|Adverse Event|2
6818662|NCT00079937|10822908|FG001|Overall Study|Adverse Event|1
6818663|NCT00079937|10822907|FG000|Overall Study|Unsatisfactory therapeutic effect|1
6818664|NCT00079937|10822908|FG001|Overall Study|Unsatisfactory therapeutic effect|2
6818665|NCT00079937|10822907|FG000|Overall Study|Subject no longer requires study drug|3
6818666|NCT00079937|10822908|FG001|Overall Study|Subject no longer requires study drug|0
6818667|NCT00079937|10822907|FG000|Overall Study|Protocol Violation|8
6818668|NCT00079937|10822908|FG001|Overall Study|Protocol Violation|6
6818669|NCT00079937|10822907|FG000|Overall Study|Withdrawal by Subject|21
6818670|NCT00079937|10822908|FG001|Overall Study|Withdrawal by Subject|7
6818671|NCT00079937|10822907|FG000|Overall Study|Lost to Follow-up|12
6818672|NCT00079937|10822908|FG001|Overall Study|Lost to Follow-up|5
6818673|NCT00079937|10822907|FG000|Overall Study|Administrative problems|22
6818674|NCT00079937|10822908|FG001|Overall Study|Administrative problems|11
6818675|NCT00080119|10822918|FG000|Overall Study|Discontinued because of study closure|0
6818676|NCT00080119|10822919|FG001|Overall Study|Discontinued because of study closure|0
6818677|NCT00080119|10822920|FG002|Overall Study|Discontinued because of study closure|130
6818678|NCT00080119|10822921|FG003|Overall Study|Discontinued because of study closure|141
6818679|NCT00080119|10822918|FG000|Overall Study|Unable to get to clinic|24
6818680|NCT00080119|10822919|FG001|Overall Study|Unable to get to clinic|24
6818681|NCT00080119|10822920|FG002|Overall Study|Unable to get to clinic|7
6818682|NCT00080119|10822921|FG003|Overall Study|Unable to get to clinic|1
6818683|NCT00080119|10822918|FG000|Overall Study|Consent withdrawn|13
6818684|NCT00080119|10822919|FG001|Overall Study|Consent withdrawn|17
6818685|NCT00080119|10822920|FG002|Overall Study|Consent withdrawn|4
6818686|NCT00080119|10822921|FG003|Overall Study|Consent withdrawn|6
6818687|NCT00080119|10822918|FG000|Overall Study|Unwilling to adhere to study requirement|3
6818688|NCT00080119|10822919|FG001|Overall Study|Unwilling to adhere to study requirement|2
6818689|NCT00080119|10822920|FG002|Overall Study|Unwilling to adhere to study requirement|5
6818690|NCT00080119|10822921|FG003|Overall Study|Unwilling to adhere to study requirement|1
6818691|NCT00080119|10822918|FG000|Overall Study|Lost to Follow-up|16
6818692|NCT00080119|10822919|FG001|Overall Study|Lost to Follow-up|19
6818693|NCT00080119|10822920|FG002|Overall Study|Lost to Follow-up|19
6818694|NCT00080119|10822921|FG003|Overall Study|Lost to Follow-up|14
6818695|NCT00080223|10822933|FG000|Overall Study|Adverse Event|23
6818696|NCT00080223|10822933|FG000|Overall Study|Death|21
6818697|NCT00080223|10822933|FG000|Overall Study|Withdrawal by Subject|13
6818698|NCT00080223|10822933|FG000|Overall Study|Lung Transplantation|9
6818699|NCT00080223|10822933|FG000|Overall Study|Non-compliance With Study Treatment|7
6818700|NCT00080223|10822933|FG000|Overall Study|Participant unwilling to continue|2
6818701|NCT00080223|10822933|FG000|Overall Study|Physician Decision|1
6818702|NCT00080288|10822939|FG000|Overall Study|Adverse Event|7
6818703|NCT00080288|10822940|FG001|Overall Study|Adverse Event|4
6818704|NCT00080288|10822939|FG000|Overall Study|Lost to Follow-up|3
6818705|NCT00080288|10822940|FG001|Overall Study|Lost to Follow-up|5
6818706|NCT00080288|10822939|FG000|Overall Study|Physician Decision|6
6818707|NCT00080288|10822940|FG001|Overall Study|Physician Decision|2
6818708|NCT00080288|10822939|FG000|Overall Study|Withdrawal by Subject|3
6818709|NCT00080288|10822940|FG001|Overall Study|Withdrawal by Subject|16
6818710|NCT00080288|10822939|FG000|Overall Study|Miscellaneous|11
6818711|NCT00080288|10822940|FG001|Overall Study|Miscellaneous|11
6818712|NCT00080301|10822948|FG000|Overall Study|Randomized but Never Treated|5
6818713|NCT00080301|10822949|FG001|Overall Study|Randomized but Never Treated|10
6818714|NCT00080301|10822948|FG000|Overall Study|Still on Treatment as of CSR date|0
6818715|NCT00080301|10822949|FG001|Overall Study|Still on Treatment as of CSR date|1
6818716|NCT00080483|10822969|FG000|Overall Study|Lost to Follow-up|1
6818717|NCT00080483|10822970|FG001|Overall Study|Lost to Follow-up|1
6818718|NCT00080483|10822969|FG000|Overall Study|Physician Decision|1
6818719|NCT00080483|10822970|FG001|Overall Study|Physician Decision|1
6818720|NCT00080899|10822980|FG000|Overall Study|Adverse Event|1
6818721|NCT00080938|10822993|FG000|Overall Study|Adverse Event|3
6818722|NCT00080938|10822993|FG000|Overall Study|Withdrawal by Subject|6
6818723|NCT00080938|10822993|FG000|Overall Study|Death|2
6818724|NCT00080938|10822993|FG000|Overall Study|Lack of Efficacy|7
6818725|NCT00080938|10822993|FG000|Overall Study|other disease|1
6818726|NCT00080938|10822993|FG000|Overall Study|Not started protocol therapy|1
6818727|NCT00080938|10822993|FG000|Overall Study|Ineligible|4
6818728|NCT00081159|10822999|FG000|Overall Study|Withdrawal by Subject|0
6818729|NCT00081159|10823000|FG001|Overall Study|Withdrawal by Subject|3
6818730|NCT00081159|10822999|FG000|Overall Study|Myelosuppression prior to treatment|0
6818731|NCT00081159|10823000|FG001|Overall Study|Myelosuppression prior to treatment|1
6818732|NCT00081159|10822999|FG000|Overall Study|Lost to Follow-up|2
6818733|NCT00081159|10823000|FG001|Overall Study|Lost to Follow-up|1
6818734|NCT00081263|10823008|FG000|Overall Study|clerical error|1
6818735|NCT00081263|10823009|FG001|Overall Study|clerical error|0
6899027|NCT00654381|10918565|FG005|1st Stage|Investigator's decision|0
6899028|NCT00654381|10918560|FG000|2nd Stage|Adverse Event|2
6899029|NCT00654381|10918561|FG001|2nd Stage|Adverse Event|0
6899030|NCT00654381|10918562|FG002|2nd Stage|Adverse Event|2
6899031|NCT00654381|10918563|FG003|2nd Stage|Adverse Event|3
6899032|NCT00654381|10918564|FG004|2nd Stage|Adverse Event|7
6899033|NCT00654381|10918565|FG005|2nd Stage|Adverse Event|2
6899034|NCT00654381|10918560|FG000|2nd Stage|Withdrawal by Subject|0
6899035|NCT00654381|10918561|FG001|2nd Stage|Withdrawal by Subject|0
6899036|NCT00654381|10918562|FG002|2nd Stage|Withdrawal by Subject|0
6899037|NCT00654381|10918563|FG003|2nd Stage|Withdrawal by Subject|0
6899038|NCT00654381|10918564|FG004|2nd Stage|Withdrawal by Subject|1
6899039|NCT00654381|10918565|FG005|2nd Stage|Withdrawal by Subject|1
6899040|NCT00654381|10918560|FG000|2nd Stage|Investigator's decision|0
6899041|NCT00654381|10918561|FG001|2nd Stage|Investigator's decision|0
6899042|NCT00654381|10918562|FG002|2nd Stage|Investigator's decision|1
6899043|NCT00654381|10918563|FG003|2nd Stage|Investigator's decision|1
6899044|NCT00654381|10918564|FG004|2nd Stage|Investigator's decision|0
6899045|NCT00654381|10918565|FG005|2nd Stage|Investigator's decision|0
6899046|NCT00654381|10918560|FG000|Extension Stage|Adverse Event|1
6899047|NCT00654381|10918561|FG001|Extension Stage|Adverse Event|2
6899048|NCT00654381|10918562|FG002|Extension Stage|Adverse Event|9
6899049|NCT00654381|10918563|FG003|Extension Stage|Adverse Event|7
6899050|NCT00654381|10918564|FG004|Extension Stage|Adverse Event|1
6899051|NCT00654381|10918565|FG005|Extension Stage|Adverse Event|1
6899052|NCT00654381|10918560|FG000|Extension Stage|Protocol Violation|0
6899053|NCT00654381|10918561|FG001|Extension Stage|Protocol Violation|0
6899054|NCT00654381|10918562|FG002|Extension Stage|Protocol Violation|0
6899055|NCT00654381|10918563|FG003|Extension Stage|Protocol Violation|1
6818736|NCT00081263|10823008|FG000|Overall Study|wrong cell type|7
6818737|NCT00081263|10823009|FG001|Overall Study|wrong cell type|5
6818738|NCT00081263|10823008|FG000|Overall Study|improper pre-protocol therapy|0
6818739|NCT00081263|10823009|FG001|Overall Study|improper pre-protocol therapy|1
6818740|NCT00081263|10823008|FG000|Overall Study|Inadequate pathology|0
6818741|NCT00081263|10823009|FG001|Overall Study|Inadequate pathology|1
6818742|NCT00081263|10823008|FG000|Overall Study|Never treated|4
6818743|NCT00081263|10823009|FG001|Overall Study|Never treated|5
6818744|NCT00081263|10823008|FG000|Overall Study|Inadequate data|5
6818745|NCT00081263|10823009|FG001|Overall Study|Inadequate data|10
6818746|NCT00081289|10823017|FG000|Overall Study|Accrued prior to chemotherapy amendment|18
6818747|NCT00081289|10823018|FG001|Overall Study|Accrued prior to chemotherapy amendment|17
6899056|NCT00654381|10918564|FG004|Extension Stage|Protocol Violation|0
6899057|NCT00654381|10918565|FG005|Extension Stage|Protocol Violation|0
6899058|NCT00654381|10918560|FG000|Extension Stage|Lack of Efficacy|0
6899059|NCT00654381|10918561|FG001|Extension Stage|Lack of Efficacy|0
6899060|NCT00654381|10918562|FG002|Extension Stage|Lack of Efficacy|1
6818748|NCT00081289|10823017|FG000|Overall Study|Ineligible / no protocol treatment|3
6818749|NCT00081289|10823018|FG001|Overall Study|Ineligible / no protocol treatment|4
6818750|NCT00081458|10823042|FG000|Overall Study|Adverse Event|1
6818751|NCT00081458|10823043|FG001|Overall Study|Adverse Event|5
6818752|NCT00081458|10823044|FG002|Overall Study|Adverse Event|2
6818753|NCT00081458|10823042|FG000|Overall Study|Withdrawal by Subject|0
6818754|NCT00081458|10823043|FG001|Overall Study|Withdrawal by Subject|3
6818755|NCT00081458|10823044|FG002|Overall Study|Withdrawal by Subject|1
6818756|NCT00081458|10823042|FG000|Overall Study|Randomized but not dosed|0
6818757|NCT00081458|10823043|FG001|Overall Study|Randomized but not dosed|0
6818758|NCT00081458|10823044|FG002|Overall Study|Randomized but not dosed|1
6818759|NCT00081497|10823055|FG000|Overall Study|Adverse Event|2
6818760|NCT00081497|10823056|FG001|Overall Study|Adverse Event|0
6818761|NCT00081497|10823055|FG000|Overall Study|Death|0
6818762|NCT00081497|10823056|FG001|Overall Study|Death|1
6818763|NCT00081497|10823055|FG000|Overall Study|Withdrawal by Subject|1
6818764|NCT00081497|10823056|FG001|Overall Study|Withdrawal by Subject|0
6818765|NCT00081497|10823055|FG000|Overall Study|Non-compliance|0
6818766|NCT00081497|10823056|FG001|Overall Study|Non-compliance|1
6818767|NCT00081653|10823070|FG000|Overall Study|Adverse Event|23
6818768|NCT00081653|10823071|FG001|Overall Study|Adverse Event|17
6818769|NCT00081653|10823070|FG000|Overall Study|Lost to Follow-up|2
6818770|NCT00081653|10823071|FG001|Overall Study|Lost to Follow-up|4
6818771|NCT00081653|10823070|FG000|Overall Study|Refused Treatment|18
6818772|NCT00081653|10823071|FG001|Overall Study|Refused Treatment|14
6818773|NCT00081653|10823070|FG000|Overall Study|Low bone mineral density|1
6818774|NCT00081653|10823071|FG001|Overall Study|Low bone mineral density|0
6818775|NCT00081653|10823070|FG000|Overall Study|Bone loss|2
6818776|NCT00081653|10823071|FG001|Overall Study|Bone loss|0
6818777|NCT00081653|10823070|FG000|Overall Study|Participant leaving country|1
6818778|NCT00081653|10823071|FG001|Overall Study|Participant leaving country|0
6818779|NCT00081653|10823070|FG000|Overall Study|Loss of bone mass|0
6818780|NCT00081653|10823071|FG001|Overall Study|Loss of bone mass|2
6818781|NCT00081731|10823080|FG000|Overall Study|scientific integrity issue|8
6818782|NCT00081731|10823081|FG001|Overall Study|scientific integrity issue|8
6818783|NCT00081770|10823090|FG000|Overall Study|Adverse Event|130
6818784|NCT00081770|10823091|FG001|Overall Study|Adverse Event|98
6818785|NCT00081770|10823092|FG002|Overall Study|Adverse Event|136
6818786|NCT00081770|10823090|FG000|Overall Study|Lack of Efficacy|262
6818787|NCT00081770|10823091|FG001|Overall Study|Lack of Efficacy|357
6818788|NCT00081770|10823092|FG002|Overall Study|Lack of Efficacy|211
6818789|NCT00081770|10823090|FG000|Overall Study|Lost to Follow-up|45
6818790|NCT00081770|10823091|FG001|Overall Study|Lost to Follow-up|34
6818791|NCT00081770|10823092|FG002|Overall Study|Lost to Follow-up|45
6818792|NCT00081770|10823090|FG000|Overall Study|Protocol Violation|15
6818793|NCT00081770|10823091|FG001|Overall Study|Protocol Violation|10
6818794|NCT00081770|10823092|FG002|Overall Study|Protocol Violation|10
6818795|NCT00081770|10823090|FG000|Overall Study|Withdrawal by Subject|45
6818796|NCT00081770|10823091|FG001|Overall Study|Withdrawal by Subject|40
6818797|NCT00081770|10823092|FG002|Overall Study|Withdrawal by Subject|42
6818798|NCT00081770|10823090|FG000|Overall Study|Did not meet protocol eligibility|2
6818799|NCT00081770|10823091|FG001|Overall Study|Did not meet protocol eligibility|0
6818800|NCT00081770|10823092|FG002|Overall Study|Did not meet protocol eligibility|3
6818801|NCT00081770|10823090|FG000|Overall Study|Administrative|1
6818802|NCT00081770|10823091|FG001|Overall Study|Administrative|0
6818803|NCT00081770|10823092|FG002|Overall Study|Administrative|1
6818804|NCT00081770|10823090|FG000|Overall Study|Other|2
6818805|NCT00081770|10823091|FG001|Overall Study|Other|7
6818806|NCT00081770|10823092|FG002|Overall Study|Other|8
6818807|NCT00082173|10823117|FG000|Overall Study|Withdrawal by Subject|3
6818808|NCT00082173|10823118|FG001|Overall Study|Withdrawal by Subject|5
6818809|NCT00082173|10823117|FG000|Overall Study|Lost to Follow-up|1
6818810|NCT00082173|10823118|FG001|Overall Study|Lost to Follow-up|0
6818811|NCT00082173|10823117|FG000|Overall Study|Adverse Event|1
6818812|NCT00082173|10823118|FG001|Overall Study|Adverse Event|0
6818813|NCT00082173|10823117|FG000|Overall Study|Culture negative or resistant at baselin|5
6818814|NCT00082173|10823118|FG001|Overall Study|Culture negative or resistant at baselin|6
6818815|NCT00082355|10823151|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1
6818816|NCT00082355|10823151|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1
6818817|NCT00082355|10823151|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28
6818818|NCT00082368|10823155|FG000|Overall Study|Not treated-pt had poor IV access|1
6818819|NCT00082381|10823161|FG000|Overall Study|Adverse Event|27
6818820|NCT00082381|10823162|FG001|Overall Study|Adverse Event|2
6818821|NCT00082381|10823161|FG000|Overall Study|Lost to Follow-up|5
6818822|NCT00082381|10823162|FG001|Overall Study|Lost to Follow-up|7
6818823|NCT00082381|10823161|FG000|Overall Study|Patient Decision|8
6818824|NCT00082381|10823162|FG001|Overall Study|Patient Decision|4
6818825|NCT00082381|10823161|FG000|Overall Study|Physician Decision|1
6818826|NCT00082381|10823162|FG001|Overall Study|Physician Decision|2
6818827|NCT00082381|10823161|FG000|Overall Study|Protocol Violation|10
6818828|NCT00082381|10823162|FG001|Overall Study|Protocol Violation|11
6818829|NCT00082381|10823161|FG000|Overall Study|Loss of Glucose Control|4
6818830|NCT00082381|10823162|FG001|Overall Study|Loss of Glucose Control|0
6818831|NCT00082407|10823170|FG000|Overall Study|Adverse Event|20
6818832|NCT00082407|10823171|FG001|Overall Study|Adverse Event|0
6818833|NCT00082407|10823170|FG000|Overall Study|Protocol Violation|14
6818834|NCT00082407|10823171|FG001|Overall Study|Protocol Violation|12
6818835|NCT00082407|10823170|FG000|Overall Study|Patient Decision|13
6818836|NCT00082407|10823171|FG001|Overall Study|Patient Decision|6
6818837|NCT00082407|10823170|FG000|Overall Study|Physician Decision|5
6818838|NCT00082407|10823171|FG001|Overall Study|Physician Decision|3
6818839|NCT00082407|10823170|FG000|Overall Study|Loss of Glucose Control|2
6818840|NCT00082407|10823171|FG001|Overall Study|Loss of Glucose Control|2
6899061|NCT00654381|10918563|FG003|Extension Stage|Lack of Efficacy|0
6899062|NCT00654381|10918564|FG004|Extension Stage|Lack of Efficacy|0
6899063|NCT00654381|10918565|FG005|Extension Stage|Lack of Efficacy|0
6899064|NCT00654381|10918560|FG000|Extension Stage|Withdrawal by Subject|0
6899065|NCT00654381|10918561|FG001|Extension Stage|Withdrawal by Subject|0
6899066|NCT00654381|10918562|FG002|Extension Stage|Withdrawal by Subject|1
6899067|NCT00654381|10918563|FG003|Extension Stage|Withdrawal by Subject|1
6899068|NCT00654381|10918564|FG004|Extension Stage|Withdrawal by Subject|1
6899069|NCT00654381|10918565|FG005|Extension Stage|Withdrawal by Subject|1
6899070|NCT00654381|10918560|FG000|Extension Stage|Closure of the trial site|0
6899071|NCT00654381|10918561|FG001|Extension Stage|Closure of the trial site|0
6899072|NCT00654381|10918562|FG002|Extension Stage|Closure of the trial site|0
6899073|NCT00654381|10918563|FG003|Extension Stage|Closure of the trial site|0
6899074|NCT00654381|10918564|FG004|Extension Stage|Closure of the trial site|1
6899075|NCT00654381|10918565|FG005|Extension Stage|Closure of the trial site|1
6899076|NCT00654420|10918586|FG000|Phase I (Dose Escalation)|Adverse Event|0
6899077|NCT00654420|10918587|FG001|Phase I (Dose Escalation)|Adverse Event|1
6899078|NCT00654420|10918588|FG002|Phase I (Dose Escalation)|Adverse Event|0
6899079|NCT00654420|10918589|FG003|Phase I (Dose Escalation)|Adverse Event|0
6899080|NCT00654420|10918586|FG000|Phase I (Dose Escalation)|Progressive Disease|4
6899081|NCT00654420|10918587|FG001|Phase I (Dose Escalation)|Progressive Disease|15
6899082|NCT00654420|10918588|FG002|Phase I (Dose Escalation)|Progressive Disease|0
6899083|NCT00654420|10918589|FG003|Phase I (Dose Escalation)|Progressive Disease|0
6899084|NCT00654420|10918586|FG000|Phase II|Adverse Event|0
6899085|NCT00654420|10918587|FG001|Phase II|Adverse Event|0
6899086|NCT00654420|10918588|FG002|Phase II|Adverse Event|3
6899087|NCT00654420|10918589|FG003|Phase II|Adverse Event|3
6899088|NCT00654420|10918586|FG000|Phase II|Lost to Follow-up|0
6899089|NCT00654420|10918587|FG001|Phase II|Lost to Follow-up|0
6899090|NCT00654420|10918588|FG002|Phase II|Lost to Follow-up|0
6899091|NCT00654420|10918589|FG003|Phase II|Lost to Follow-up|1
6899092|NCT00654420|10918586|FG000|Phase II|Physician Decision|0
6899093|NCT00654420|10918587|FG001|Phase II|Physician Decision|0
6899094|NCT00654420|10918588|FG002|Phase II|Physician Decision|0
6899095|NCT00654420|10918589|FG003|Phase II|Physician Decision|4
6899096|NCT00654420|10918586|FG000|Phase II|Progressive Disease|0
6899097|NCT00654420|10918587|FG001|Phase II|Progressive Disease|0
6899098|NCT00654420|10918588|FG002|Phase II|Progressive Disease|29
6899099|NCT00654420|10918589|FG003|Phase II|Progressive Disease|29
6899100|NCT00654420|10918586|FG000|Phase II|Withdrawal by Subject|0
6899101|NCT00654420|10918587|FG001|Phase II|Withdrawal by Subject|0
6899102|NCT00654420|10918588|FG002|Phase II|Withdrawal by Subject|4
6899103|NCT00654420|10918589|FG003|Phase II|Withdrawal by Subject|1
6899104|NCT00654420|10918586|FG000|Phase II|Missing Disposition Record|0
6899105|NCT00654420|10918587|FG001|Phase II|Missing Disposition Record|0
6899106|NCT00654420|10918588|FG002|Phase II|Missing Disposition Record|1
6899107|NCT00654420|10918589|FG003|Phase II|Missing Disposition Record|0
6899108|NCT00654498|10918601|FG000|Overall Study|Not Treated|1
6899109|NCT00654498|10918602|FG001|Overall Study|Not Treated|0
6899110|NCT00654498|10918601|FG000|Overall Study|Adverse Event|6
6899111|NCT00654498|10918602|FG001|Overall Study|Adverse Event|1
6899112|NCT00654498|10918601|FG000|Overall Study|Protocol Violation|1
6899113|NCT00654498|10918602|FG001|Overall Study|Protocol Violation|1
6899114|NCT00654498|10918601|FG000|Overall Study|Lost to Follow-up|1
6899115|NCT00654498|10918602|FG001|Overall Study|Lost to Follow-up|5
6899116|NCT00654498|10918601|FG000|Overall Study|Withdrawal by Subject|1
6899117|NCT00654498|10918602|FG001|Overall Study|Withdrawal by Subject|0
6899118|NCT00654498|10918601|FG000|Overall Study|Other reason not defined above|4
6899119|NCT00654498|10918602|FG001|Overall Study|Other reason not defined above|5
6899120|NCT00654641|10918640|FG000|Overall Study|Lost to Follow-up|2
6899121|NCT00654641|10918641|FG001|Overall Study|Lost to Follow-up|3
6899122|NCT00654732|10918653|FG000|Overall Study|Adverse Event|4
6899123|NCT00654732|10918654|FG001|Overall Study|Adverse Event|6
6899124|NCT00654745|10918660|FG000|Overall Study|Adverse Event|12
6899125|NCT00654745|10918660|FG000|Overall Study|Lost to Follow-up|7
6899126|NCT00654745|10918660|FG000|Overall Study|Protocol Violation|11
6899127|NCT00654745|10918660|FG000|Overall Study|Withdrawal by Subject|10
6899128|NCT00654745|10918660|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3
6899129|NCT00654875|10918685|FG000|Overall Study|Adverse Event|5
6899130|NCT00654875|10918686|FG001|Overall Study|Adverse Event|5
6899131|NCT00654875|10918685|FG000|Overall Study|Withdrawal by Subject|4
6899132|NCT00654875|10918686|FG001|Overall Study|Withdrawal by Subject|4
6899133|NCT00654875|10918685|FG000|Overall Study|Protocol Violation|3
6818841|NCT00082407|10823170|FG000|Overall Study|Death|2
6818842|NCT00082407|10823171|FG001|Overall Study|Death|1
6818843|NCT00082407|10823170|FG000|Overall Study|Lost to Follow-up|0
6818844|NCT00082407|10823171|FG001|Overall Study|Lost to Follow-up|3
6818845|NCT00082433|10823179|FG000|Overall Study|Adverse Event|12
6818846|NCT00082433|10823180|FG001|Overall Study|Adverse Event|17
6818847|NCT00082433|10823179|FG000|Overall Study|Death|8
6818848|NCT00082433|10823180|FG001|Overall Study|Death|18
6818849|NCT00082433|10823179|FG000|Overall Study|Disease Progression/Relapse|270
6818850|NCT00082433|10823180|FG001|Overall Study|Disease Progression/Relapse|388
6818851|NCT00082433|10823179|FG000|Overall Study|Physician Decision|50
6818852|NCT00082433|10823180|FG001|Overall Study|Physician Decision|61
6818853|NCT00082433|10823179|FG000|Overall Study|Lost to Follow-up|1
6818854|NCT00082433|10823180|FG001|Overall Study|Lost to Follow-up|2
6818855|NCT00082433|10823179|FG000|Overall Study|Study Drug Toxicity|179
6818856|NCT00082433|10823180|FG001|Overall Study|Study Drug Toxicity|66
6818857|NCT00082433|10823179|FG000|Overall Study|Withdrawal by Subject|55
6818858|NCT00082433|10823180|FG001|Overall Study|Withdrawal by Subject|30
6818859|NCT00082433|10823179|FG000|Overall Study|Still On Treatment|2
6899134|NCT00654875|10918686|FG001|Overall Study|Protocol Violation|3
6899135|NCT00654875|10918685|FG000|Overall Study|Lack of Efficacy|2
6899136|NCT00654875|10918686|FG001|Overall Study|Lack of Efficacy|2
6899137|NCT00654875|10918685|FG000|Overall Study|Lost to Follow-up|1
6899138|NCT00654875|10918686|FG001|Overall Study|Lost to Follow-up|3
6899139|NCT00654875|10918685|FG000|Overall Study|Abnormal Test Procedure Result(s)|1
6899140|NCT00654875|10918686|FG001|Overall Study|Abnormal Test Procedure Result(s)|0
6899141|NCT00654875|10918685|FG000|Overall Study|Administrative Problems|1
6899142|NCT00654875|10918686|FG001|Overall Study|Administrative Problems|0
6899143|NCT00654901|10918696|FG000|Overall Study|Lost to Follow-up|1
6899144|NCT00654901|10918697|FG001|Overall Study|Lost to Follow-up|0
6899145|NCT00654901|10918698|FG002|Overall Study|Lost to Follow-up|1
6899146|NCT00654901|10918699|FG003|Overall Study|Lost to Follow-up|0
6899147|NCT00654901|10918696|FG000|Overall Study|Withdrawal by Subject|3
6899148|NCT00654901|10918697|FG001|Overall Study|Withdrawal by Subject|0
6899149|NCT00654901|10918698|FG002|Overall Study|Withdrawal by Subject|1
6899150|NCT00654901|10918699|FG003|Overall Study|Withdrawal by Subject|0
6899151|NCT00654940|10918715|FG000|Period 1|Adverse Event|0
6899152|NCT00654940|10918716|FG001|Period 1|Adverse Event|1
6899153|NCT00654940|10918715|FG000|Period 1|Intolerable Pain Level|1
6899154|NCT00654940|10918716|FG001|Period 1|Intolerable Pain Level|0
6899155|NCT00655356|10918752|FG000|Overall Study|Withdrawal by Subject|3
6899156|NCT00655356|10918753|FG001|Overall Study|Withdrawal by Subject|4
6899157|NCT00655356|10918752|FG000|Overall Study|Sponsor Request|10
6899158|NCT00655356|10918753|FG001|Overall Study|Sponsor Request|4
6899159|NCT00655356|10918752|FG000|Overall Study|Adverse Event|1
6899160|NCT00655356|10918753|FG001|Overall Study|Adverse Event|1
6899161|NCT00655356|10918752|FG000|Overall Study|Protocol Violation|2
6899162|NCT00655356|10918753|FG001|Overall Study|Protocol Violation|1
6899163|NCT00655356|10918752|FG000|Overall Study|Other Reason|1
6899164|NCT00655356|10918753|FG001|Overall Study|Other Reason|0
6899165|NCT00655486|10918768|FG000|Overall Study|Adverse Event|10
6899166|NCT00655486|10918768|FG000|Overall Study|Lack of Efficacy|8
6899167|NCT00655486|10918768|FG000|Overall Study|Withdrawal by Subject|4
6899168|NCT00655486|10918768|FG000|Overall Study|Protocol Violation|1
6899169|NCT00655486|10918768|FG000|Overall Study|Unsatisfactory compliance|2
6899170|NCT00655486|10918768|FG000|Overall Study|Other: Pregnancy|1
6899171|NCT00655486|10918768|FG000|Overall Study|Other: Could not tolerate BID dosing|1
6899172|NCT00655486|10918768|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1
6899173|NCT00655499|10918772|FG000|Overall Study|not eligible|4
6899174|NCT00655551|10918789|FG000|All Periods Combined|Adverse Event|0
6899175|NCT00655551|10918790|FG001|All Periods Combined|Adverse Event|3
6899176|NCT00655551|10918791|FG002|All Periods Combined|Adverse Event|4
6899177|NCT00655551|10918789|FG000|Period 2 (up to 7 Days)|Adverse Event|0
6899178|NCT00655551|10918790|FG001|Period 2 (up to 7 Days)|Adverse Event|1
6899179|NCT00655551|10918791|FG002|Period 2 (up to 7 Days)|Adverse Event|0
6899180|NCT00655551|10918789|FG000|Period 3 (up to 7 Days)|Adverse Event|0
6899181|NCT00655551|10918790|FG001|Period 3 (up to 7 Days)|Adverse Event|0
6899182|NCT00655551|10918791|FG002|Period 3 (up to 7 Days)|Adverse Event|4
6899183|NCT00655551|10918789|FG000|Period 4 (up to 7 Days)|Adverse Event|0
6899184|NCT00655551|10918790|FG001|Period 4 (up to 7 Days)|Adverse Event|2
6899185|NCT00655551|10918791|FG002|Period 4 (up to 7 Days)|Adverse Event|0
6899186|NCT00655564|10918799|FG000|Overall Study|Adverse Event|1
6899187|NCT00655564|10918799|FG000|Overall Study|Lost to Follow-up|1
6899188|NCT00655564|10918799|FG000|Overall Study|Desired Alternate Therapy|1
6899189|NCT00655629|10918806|FG000|Overall Study|Adverse Event|4
6899190|NCT00655629|10918807|FG001|Overall Study|Adverse Event|1
6899191|NCT00655629|10918806|FG000|Overall Study|Lack of Efficacy|2
6899192|NCT00655629|10918807|FG001|Overall Study|Lack of Efficacy|12
6899193|NCT00655629|10918806|FG000|Overall Study|Lost to Follow-up|4
6899194|NCT00655629|10918807|FG001|Overall Study|Lost to Follow-up|3
6899195|NCT00655629|10918806|FG000|Overall Study|Protocol Violation|5
6899196|NCT00655629|10918807|FG001|Overall Study|Protocol Violation|3
6899197|NCT00655629|10918806|FG000|Overall Study|consent withdrawn|6
6899198|NCT00655629|10918807|FG001|Overall Study|consent withdrawn|4
6899199|NCT00655668|10918830|FG000|Overall Study|Adverse Event|6
6899200|NCT00655668|10918830|FG000|Overall Study|Death|5
6899201|NCT00655668|10918830|FG000|Overall Study|Disease Progression|27
6818860|NCT00082433|10823180|FG001|Overall Study|Still On Treatment|1
6818861|NCT00082433|10823179|FG000|Overall Study|Not Treated|12
6818862|NCT00082433|10823180|FG001|Overall Study|Not Treated|11
6818863|NCT00082433|10823179|FG000|Overall Study|Ineligible|2
6818864|NCT00082433|10823180|FG001|Overall Study|Ineligible|1
6818865|NCT00082433|10823179|FG000|Overall Study|Noncompliance|2
6818866|NCT00082433|10823180|FG001|Overall Study|Noncompliance|1
6818867|NCT00082433|10823179|FG000|Overall Study|New primary cancer|1
6818868|NCT00082433|10823180|FG001|Overall Study|New primary cancer|0
6818869|NCT00082433|10823179|FG000|Overall Study|Impending surgery|0
6818870|NCT00082433|10823180|FG001|Overall Study|Impending surgery|1
6818871|NCT00082628|10823188|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
6818872|NCT00082628|10823189|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1
6818873|NCT00082628|10823190|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
6818874|NCT00082628|10823191|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
6818875|NCT00082628|10823192|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
6818876|NCT00082628|10823188|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2
6818877|NCT00082628|10823189|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1
6818878|NCT00082628|10823190|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
6818879|NCT00082628|10823191|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
6818880|NCT00082628|10823192|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
6818881|NCT00082628|10823188|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5
6818882|NCT00082628|10823189|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43
6818883|NCT00082628|10823190|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
6818884|NCT00082628|10823191|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
6818885|NCT00082628|10823192|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
6818886|NCT00082628|10823188|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1
6818887|NCT00082628|10823189|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15
6818888|NCT00082628|10823190|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
6818889|NCT00082628|10823191|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
6818890|NCT00082628|10823192|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
6818891|NCT00082628|10823188|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
6818892|NCT00082628|10823189|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
6818893|NCT00082628|10823190|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
6818894|NCT00082628|10823191|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
6818895|NCT00082628|10823192|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1
6818896|NCT00082628|10823188|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
6818897|NCT00082628|10823189|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
6818898|NCT00082628|10823190|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
6818899|NCT00082628|10823191|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1
6818900|NCT00082628|10823192|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
6818901|NCT00082628|10823188|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0
6818902|NCT00082628|10823189|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0
6818903|NCT00082628|10823190|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15
6818904|NCT00082628|10823191|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15
6818905|NCT00082628|10823192|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17
6818906|NCT00082758|10823217|FG000|Overall Study|Adverse Event|0
6818907|NCT00082758|10823218|FG001|Overall Study|Adverse Event|2
6818908|NCT00082758|10823219|FG002|Overall Study|Adverse Event|0
6818909|NCT00082758|10823217|FG000|Overall Study|Lack of Efficacy|12
6818910|NCT00082758|10823218|FG001|Overall Study|Lack of Efficacy|13
6818911|NCT00082758|10823219|FG002|Overall Study|Lack of Efficacy|0
6818912|NCT00082758|10823217|FG000|Overall Study|Physician Decision|0
6818913|NCT00082758|10823218|FG001|Overall Study|Physician Decision|1
6818914|NCT00082758|10823219|FG002|Overall Study|Physician Decision|0
6818915|NCT00082758|10823217|FG000|Overall Study|Withdrawal by Subject|3
6818916|NCT00082758|10823218|FG001|Overall Study|Withdrawal by Subject|0
6818917|NCT00082758|10823219|FG002|Overall Study|Withdrawal by Subject|0
6818918|NCT00082758|10823217|FG000|Overall Study|Protocol Violation|0
6818919|NCT00082758|10823218|FG001|Overall Study|Protocol Violation|1
6818920|NCT00082758|10823219|FG002|Overall Study|Protocol Violation|0
6818921|NCT00082810|10823227|FG000|Overall Study|Adverse Event|3
6818922|NCT00082810|10823227|FG000|Overall Study|Progressive disease|24
6818923|NCT00082810|10823227|FG000|Overall Study|Withdrawal by Subject|4
6818924|NCT00082888|10823235|FG000|Overall Study|Ineligible|1
6818925|NCT00082888|10823236|FG001|Overall Study|Ineligible|0
6818926|NCT00082888|10823237|FG002|Overall Study|Ineligible|0
6818927|NCT00083226|10823269|FG000|Overall Study|Lack of Efficacy|19
6818928|NCT00083226|10823269|FG000|Overall Study|Adverse Event|9
6818929|NCT00083226|10823269|FG000|Overall Study|Death|4
6818930|NCT00083226|10823269|FG000|Overall Study|Withdrawal by Subject|4
6818931|NCT00083226|10823269|FG000|Overall Study|Other|2
6818932|NCT00083226|10823269|FG000|Overall Study|ineligible or not receiving treatment|4
6818933|NCT00083616|10823286|FG000|Overall Study|Disease Progression|16
6818934|NCT00083616|10823286|FG000|Overall Study|Lost to Follow-up|1
6818935|NCT00083616|10823286|FG000|Overall Study|Physician Decision|2
6818936|NCT00083616|10823286|FG000|Overall Study|Withdrawal by Subject|3
6818937|NCT00083616|10823286|FG000|Overall Study|Ineligibility determined|2
6818938|NCT00083616|10823286|FG000|Overall Study|Non-compliance|1
6818939|NCT00083616|10823286|FG000|Overall Study|Other|6
6818940|NCT00083889|10823296|FG000|Overall Study|Adverse Event|76
6818941|NCT00083889|10823297|FG001|Overall Study|Adverse Event|86
6818942|NCT00083889|10823296|FG000|Overall Study|Protocol Violation|2
6818943|NCT00083889|10823297|FG001|Overall Study|Protocol Violation|2
6818944|NCT00083889|10823296|FG000|Overall Study|Withdrawal by Subject|22
6818945|NCT00083889|10823297|FG001|Overall Study|Withdrawal by Subject|24
6818946|NCT00083889|10823296|FG000|Overall Study|Lack of Efficacy|240
6818947|NCT00083889|10823297|FG001|Overall Study|Lack of Efficacy|219
6978390|NCT01212770|11031722|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
6978391|NCT01212770|11031723|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
6978392|NCT01212770|11031724|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
6978393|NCT01212770|11031716|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
6978394|NCT01212770|11031717|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2
6978395|NCT01212770|11031718|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3
6818948|NCT00083889|10823296|FG000|Overall Study|Decision of sponsor|32
6818949|NCT00083889|10823297|FG001|Overall Study|Decision of sponsor|4
6818950|NCT00083889|10823296|FG000|Overall Study|Randomized: did not take study drug|0
6818951|NCT00083889|10823297|FG001|Overall Study|Randomized: did not take study drug|15
6818952|NCT00083889|10823296|FG000|Overall Study|Completed on marketed sunitinub|3
6818953|NCT00083889|10823297|FG001|Overall Study|Completed on marketed sunitinub|0
6818954|NCT00083889|10823296|FG000|Overall Study|Crossover to SU011248|0
6818955|NCT00083889|10823297|FG001|Overall Study|Crossover to SU011248|25
6818956|NCT00084084|10823306|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1
6818957|NCT00084084|10823306|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1
6818958|NCT00084136|10823314|FG000|PI Comparison|Death|10
6818959|NCT00084136|10823315|FG001|PI Comparison|Death|9
6818960|NCT00084136|10823316|FG002|PI Comparison|Death|0
6818961|NCT00084136|10823314|FG000|PI Comparison|Lost to Follow-up|11
6818962|NCT00084136|10823315|FG001|PI Comparison|Lost to Follow-up|8
6818963|NCT00084136|10823316|FG002|PI Comparison|Lost to Follow-up|0
6818964|NCT00084136|10823314|FG000|PI Comparison|Withdrawal by Subject|33
6818965|NCT00084136|10823315|FG001|PI Comparison|Withdrawal by Subject|30
6818966|NCT00084136|10823316|FG002|PI Comparison|Withdrawal by Subject|0
6818967|NCT00084136|10823314|FG000|PI Comparison|Clinic site closed|1
6818968|NCT00084136|10823315|FG001|PI Comparison|Clinic site closed|0
6818969|NCT00084136|10823316|FG002|PI Comparison|Clinic site closed|0
6818970|NCT00084136|10823314|FG000|NRTI Comparison|Death|20
6818971|NCT00084136|10823315|FG001|NRTI Comparison|Death|0
6818972|NCT00084136|10823316|FG002|NRTI Comparison|Death|18
6818973|NCT00084136|10823314|FG000|NRTI Comparison|Lost to Follow-up|14
6818974|NCT00084136|10823315|FG001|NRTI Comparison|Lost to Follow-up|0
6818975|NCT00084136|10823316|FG002|NRTI Comparison|Lost to Follow-up|12
6818976|NCT00084136|10823314|FG000|NRTI Comparison|Withdrawal by Subject|54
6818977|NCT00084136|10823315|FG001|NRTI Comparison|Withdrawal by Subject|0
6818978|NCT00084136|10823316|FG002|NRTI Comparison|Withdrawal by Subject|38
6818979|NCT00084136|10823314|FG000|NRTI Comparison|Clinic site closed|12
6818980|NCT00084136|10823315|FG001|NRTI Comparison|Clinic site closed|0
6818981|NCT00084136|10823316|FG002|NRTI Comparison|Clinic site closed|14
6818982|NCT00084136|10823314|FG000|NRTI Comparison|Not reason above|1
6818983|NCT00084136|10823315|FG001|NRTI Comparison|Not reason above|0
6818984|NCT00084136|10823316|FG002|NRTI Comparison|Not reason above|0
6818985|NCT00084266|10823340|FG000|Overall Study|Death|42
6818986|NCT00084266|10823341|FG001|Overall Study|Death|39
6818987|NCT00084266|10823340|FG000|Overall Study|Adverse Event|8
6818988|NCT00084266|10823341|FG001|Overall Study|Adverse Event|5
6818989|NCT00084266|10823340|FG000|Overall Study|Lack of Efficacy|2
6818990|NCT00084266|10823341|FG001|Overall Study|Lack of Efficacy|4
6818991|NCT00084266|10823340|FG000|Overall Study|Lost to Follow-up|5
6818992|NCT00084266|10823341|FG001|Overall Study|Lost to Follow-up|3
6818993|NCT00084266|10823340|FG000|Overall Study|Participant not willing to participate|3
6818994|NCT00084266|10823341|FG001|Overall Study|Participant not willing to participate|8
6818995|NCT00084266|10823340|FG000|Overall Study|Other|360
6818996|NCT00084266|10823341|FG001|Overall Study|Other|344
6818997|NCT00084266|10823340|FG000|Overall Study|Randomized not treated|21
6818998|NCT00084266|10823341|FG001|Overall Study|Randomized not treated|20
6818999|NCT00084318|10823349|FG000|Overall Study|Withdrawal by Subject|5
6819000|NCT00084318|10823350|FG001|Overall Study|Withdrawal by Subject|2
6819001|NCT00084318|10823349|FG000|Overall Study|Protocol Violation|15
6819002|NCT00084318|10823350|FG001|Overall Study|Protocol Violation|11
6819003|NCT00084318|10823349|FG000|Overall Study|No protocol treatment|2
6819004|NCT00084318|10823350|FG001|Overall Study|No protocol treatment|0
6819005|NCT00084487|10823373|FG000|Overall Study|Death|1
6819006|NCT00084617|10823386|FG000|Overall Study|Withdrawal by Subject|7
6819007|NCT00084617|10823386|FG000|Overall Study|Lack of Efficacy|1
6819008|NCT00084617|10823386|FG000|Overall Study|Protocol Violation|1
6819009|NCT00084682|10823390|FG000|Overall Study|Withdrawal by Subject|1
6819010|NCT00084747|10823395|FG000|Overall Study|Relapsed|8
6819011|NCT00084747|10823395|FG000|Overall Study|Death|3
6819012|NCT00084747|10823395|FG000|Overall Study|Withdrawal by Subject|2
6819013|NCT00084838|10823400|FG000|Overall Study|Death|1
6819014|NCT00084838|10823400|FG000|Overall Study|Adverse Event|2
6819015|NCT00084838|10823400|FG000|Overall Study|Withdrawal by Subject|1
6819016|NCT00084838|10823400|FG000|Overall Study|Progressive Disease|4
6819017|NCT00084838|10823400|FG000|Overall Study|Pt Non-Compliance|1
6819018|NCT00084838|10823400|FG000|Overall Study|Ineligible|4
6819019|NCT00084864|10823410|FG000|Overall Study|Adverse Event|1
6819020|NCT00084864|10823411|FG001|Overall Study|Adverse Event|0
6819021|NCT00084864|10823412|FG002|Overall Study|Adverse Event|0
6819022|NCT00084864|10823413|FG003|Overall Study|Adverse Event|0
6819023|NCT00084929|10823423|FG000|Overall Study|ineligible - medical contraindication|1
6819024|NCT00084929|10823423|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1
6819025|NCT00084929|10823423|FG000|Overall Study|Ineligible - Medical history|6
6819026|NCT00084929|10823423|FG000|Overall Study|Withdrawal by Subject|10
6819027|NCT00084929|10823423|FG000|Overall Study|Missing/incomplete CTC exam|9
6819028|NCT00084929|10823423|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42
6819029|NCT00085098|10823433|FG000|Overall Study|Withdrawal by Subject|0
6819030|NCT00085098|10823434|FG001|Overall Study|Withdrawal by Subject|1
6819031|NCT00085098|10823433|FG000|Overall Study|Ineligible|1
6819032|NCT00085098|10823434|FG001|Overall Study|Ineligible|1
6819033|NCT00085423|10823471|FG000|Overall Study|Withdrawal by Subject|1
6819034|NCT00085423|10823471|FG000|Overall Study|screen failure|1
6819035|NCT00085540|10823482|FG000|Overall Study|Withdrawal by Subject|0
6819036|NCT00085540|10823483|FG001|Overall Study|Withdrawal by Subject|1
6819037|NCT00085540|10823482|FG000|Overall Study|Protocol Violation|0
6819038|NCT00085540|10823483|FG001|Overall Study|Protocol Violation|1
6819039|NCT00085566|10823492|FG000|Overall Study|Adverse Event|0
6819040|NCT00085566|10823493|FG001|Overall Study|Adverse Event|0
6819041|NCT00085566|10823494|FG002|Overall Study|Adverse Event|10
6819042|NCT00085566|10823492|FG000|Overall Study|Patient Not treated|0
6819043|NCT00085566|10823493|FG001|Overall Study|Patient Not treated|0
6819044|NCT00085566|10823494|FG002|Overall Study|Patient Not treated|3
6819045|NCT00085566|10823492|FG000|Overall Study|Clinical progression|0
6819046|NCT00085566|10823493|FG001|Overall Study|Clinical progression|0
6819047|NCT00085566|10823494|FG002|Overall Study|Clinical progression|1
6819048|NCT00085644|10823504|FG000|Double-Blind Period|Adverse Event|5
6819049|NCT00085644|10823505|FG001|Double-Blind Period|Adverse Event|2
6819050|NCT00085644|10823506|FG002|Double-Blind Period|Adverse Event|0
6819051|NCT00085644|10823504|FG000|Double-Blind Period|Withdrawal by Subject|3
6899202|NCT00655668|10918830|FG000|Overall Study|Study Terminated|9
6899203|NCT00655668|10918830|FG000|Overall Study|Other|1
6899204|NCT00655668|10918830|FG000|Overall Study|New Lymphoma Treatment Started|4
6899205|NCT00655668|10918830|FG000|Overall Study|Withdrawal by Subject|2
6899206|NCT00655733|10918841|FG000|Overall Study|Lost to Follow-up|2
6899207|NCT00655733|10918842|FG001|Overall Study|Lost to Follow-up|2
6899208|NCT00655733|10918841|FG000|Overall Study|Adverse Event|2
6899209|NCT00655733|10918842|FG001|Overall Study|Adverse Event|2
6899210|NCT00655733|10918841|FG000|Overall Study|Withdrawal by Subject|3
6899211|NCT00655733|10918842|FG001|Overall Study|Withdrawal by Subject|3
6899212|NCT00655733|10918841|FG000|Overall Study|Physician Decision|0
6899213|NCT00655733|10918842|FG001|Overall Study|Physician Decision|1
6899214|NCT00655746|10918850|FG000|Overall Study|Withdrawal by Subject|1
6899215|NCT00655850|10918868|FG000|Overall Study|Death|2
6899216|NCT00655850|10918868|FG000|Overall Study|Withdrawal by Subject|1
6899217|NCT00655863|10918877|FG000|Overall Study|Lost to Follow-up|0
6899218|NCT00655863|10918878|FG001|Overall Study|Lost to Follow-up|0
6899219|NCT00655863|10918879|FG002|Overall Study|Lost to Follow-up|1
6899220|NCT00655889|10918887|FG000|Overall Study|Inadequate cell growth|1
6899221|NCT00655889|10918887|FG000|Overall Study|Protocol Violation|1
6899222|NCT00655928|10918893|FG000|Overall Study|Withdrawal by Subject|2
6899223|NCT00655928|10918894|FG001|Overall Study|Withdrawal by Subject|1
6899224|NCT00655928|10918893|FG000|Overall Study|Physician Decision|1
6899225|NCT00655928|10918894|FG001|Overall Study|Physician Decision|1
6899226|NCT00655980|10918903|FG000|Overall Study|surgery canceled; or subject or anesthes|26
6899227|NCT00655980|10918904|FG001|Overall Study|surgery canceled; or subject or anesthes|31
6899228|NCT00655980|10918905|FG002|Overall Study|surgery canceled; or subject or anesthes|5
6899229|NCT00656019|10918920|FG000|Overall Study|Not Eligible|10
6899230|NCT00656019|10918921|FG001|Overall Study|Not Eligible|0
6899231|NCT00656019|10918922|FG002|Overall Study|Not Eligible|0
6899232|NCT00656019|10918923|FG003|Overall Study|Not Eligible|0
6899233|NCT00656019|10918920|FG000|Overall Study|Withdrawal by Subject|2
6899234|NCT00656019|10918921|FG001|Overall Study|Withdrawal by Subject|0
6899235|NCT00656019|10918922|FG002|Overall Study|Withdrawal by Subject|0
6899236|NCT00656019|10918923|FG003|Overall Study|Withdrawal by Subject|0
6899237|NCT00656019|10918920|FG000|Overall Study|Lost to Follow-up|2
6819052|NCT00085644|10823505|FG001|Double-Blind Period|Withdrawal by Subject|0
6899238|NCT00656019|10918921|FG001|Overall Study|Lost to Follow-up|1
6899239|NCT00656019|10918922|FG002|Overall Study|Lost to Follow-up|0
6899240|NCT00656019|10918923|FG003|Overall Study|Lost to Follow-up|0
6899241|NCT00656058|10918933|FG000|Overall Study|Withdrawal by Subject|2
6819053|NCT00085644|10823506|FG002|Double-Blind Period|Withdrawal by Subject|0
6819054|NCT00085644|10823504|FG000|Double-Blind Period|Lost to Follow-up|2
6819055|NCT00085644|10823505|FG001|Double-Blind Period|Lost to Follow-up|1
6819056|NCT00085644|10823506|FG002|Double-Blind Period|Lost to Follow-up|0
6819057|NCT00085644|10823504|FG000|Double-Blind Period|Lack/loss of efficacy|2
6819058|NCT00085644|10823505|FG001|Double-Blind Period|Lack/loss of efficacy|2
6819059|NCT00085644|10823506|FG002|Double-Blind Period|Lack/loss of efficacy|0
6819060|NCT00085644|10823504|FG000|Double-Blind Period|Contemplating pregnancy|1
6819061|NCT00085644|10823505|FG001|Double-Blind Period|Contemplating pregnancy|0
6819062|NCT00085644|10823506|FG002|Double-Blind Period|Contemplating pregnancy|0
6819063|NCT00085644|10823504|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0
6819064|NCT00085644|10823505|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1
6819065|NCT00085644|10823506|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0
6819066|NCT00085644|10823504|FG000|Open-Label Period|Adverse Event|0
6819067|NCT00085644|10823505|FG001|Open-Label Period|Adverse Event|0
6819068|NCT00085644|10823506|FG002|Open-Label Period|Adverse Event|38
6819069|NCT00085644|10823504|FG000|Open-Label Period|Withdrawal by Subject|0
6819070|NCT00085644|10823505|FG001|Open-Label Period|Withdrawal by Subject|0
6819071|NCT00085644|10823506|FG002|Open-Label Period|Withdrawal by Subject|29
6819072|NCT00085644|10823504|FG000|Open-Label Period|Lost to Follow-up|0
6819073|NCT00085644|10823505|FG001|Open-Label Period|Lost to Follow-up|0
6819074|NCT00085644|10823506|FG002|Open-Label Period|Lost to Follow-up|13
6819075|NCT00085644|10823504|FG000|Open-Label Period|Lack of Efficacy|0
6819076|NCT00085644|10823505|FG001|Open-Label Period|Lack of Efficacy|0
6819077|NCT00085644|10823506|FG002|Open-Label Period|Lack of Efficacy|15
6819078|NCT00085644|10823504|FG000|Open-Label Period|Pregnancy|0
6899242|NCT00656058|10918933|FG000|Overall Study|Withdrawal by Subject|4
6899243|NCT00656084|10918937|FG000|Overall Study|Adverse Event|4
6899244|NCT00656084|10918937|FG000|Overall Study|Withdrawal by Subject|1
6899245|NCT00656084|10918937|FG000|Overall Study|Patient Request|1
6899246|NCT00656084|10918937|FG000|Overall Study|Investigator Request|1
6899247|NCT00656136|10918943|FG000|Overall Study|Progressive disease|177
6899248|NCT00656136|10918944|FG001|Overall Study|Progressive disease|322
6899249|NCT00656136|10918943|FG000|Overall Study|Other Adverse Event|5
6899250|NCT00656136|10918944|FG001|Overall Study|Other Adverse Event|51
6899251|NCT00656136|10918943|FG000|Overall Study|Protocol Violation|2
6899252|NCT00656136|10918944|FG001|Overall Study|Protocol Violation|3
6899253|NCT00656136|10918943|FG000|Overall Study|Patient refused to take study medication|7
6899254|NCT00656136|10918944|FG001|Overall Study|Patient refused to take study medication|10
6899255|NCT00656136|10918943|FG000|Overall Study|Unknown and others|4
6899256|NCT00656136|10918944|FG001|Overall Study|Unknown and others|4
6899257|NCT00656175|10918952|FG000|Overall Study|Adverse Event|1
6899258|NCT00656175|10918953|FG001|Overall Study|Adverse Event|0
6899259|NCT00656175|10918952|FG000|Overall Study|Transportation issues|0
6899260|NCT00656175|10918953|FG001|Overall Study|Transportation issues|1
6899261|NCT00656292|10918970|FG000|Overall Study|Withdrawal by Subject|2
6899262|NCT00656292|10918971|FG001|Overall Study|Withdrawal by Subject|3
6899263|NCT00656292|10918970|FG000|Overall Study|Screen failure|1
6899264|NCT00656292|10918971|FG001|Overall Study|Screen failure|2
6899265|NCT00656370|10918986|FG000|Overall Study|Screen Failures|7
6899266|NCT00656370|10918986|FG000|Overall Study|Alternates|3
6899267|NCT00656474|10919002|FG000|Overall Study|Other Reason|1
6899268|NCT00656513|10919023|FG000|Overall Study|Protocol Violation|1
6899269|NCT00656513|10919024|FG001|Overall Study|Protocol Violation|0
6899270|NCT00656513|10919025|FG002|Overall Study|Protocol Violation|2
6899271|NCT00656513|10919023|FG000|Overall Study|Withdrawal by Subject|0
6899272|NCT00656513|10919024|FG001|Overall Study|Withdrawal by Subject|11
6899273|NCT00656513|10919025|FG002|Overall Study|Withdrawal by Subject|4
6899274|NCT00656513|10919023|FG000|Overall Study|Death|0
6899275|NCT00656513|10919024|FG001|Overall Study|Death|0
6899276|NCT00656513|10919025|FG002|Overall Study|Death|1
6899277|NCT00656513|10919023|FG000|Overall Study|Missing data|0
6899278|NCT00656513|10919024|FG001|Overall Study|Missing data|11
6899279|NCT00656513|10919025|FG002|Overall Study|Missing data|9
6899280|NCT00656513|10919023|FG000|Overall Study|Incomplete treatment|3
6899281|NCT00656513|10919024|FG001|Overall Study|Incomplete treatment|0
6899282|NCT00656513|10919025|FG002|Overall Study|Incomplete treatment|0
6899283|NCT00656513|10919023|FG000|Overall Study|Treatment completed outside of timeframe|0
6899284|NCT00656513|10919024|FG001|Overall Study|Treatment completed outside of timeframe|3
6899285|NCT00656513|10919025|FG002|Overall Study|Treatment completed outside of timeframe|1
6899286|NCT00656513|10919023|FG000|Overall Study|Missing baseline form|0
6899287|NCT00656513|10919024|FG001|Overall Study|Missing baseline form|5
6899288|NCT00656513|10919025|FG002|Overall Study|Missing baseline form|5
6899289|NCT00656617|10919033|FG000|Overall Study|Adverse Event|1
6899290|NCT00656617|10919033|FG000|Overall Study|Death|2
6899291|NCT00656617|10919033|FG000|Overall Study|Insurance Issues|2
6899292|NCT00656617|10919033|FG000|Overall Study|Move to different clinical trial|2
6899293|NCT00656669|10919055|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4
6899294|NCT00656669|10919055|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2
6899295|NCT00656669|10919055|FG000|AC (Cycles 6-9)|Adverse Event|1
6899296|NCT00656669|10919055|FG000|AC (Cycles 6-9)|Did not start segment 3|1
6899297|NCT00656799|10919064|FG000|Overall Study|Death|2
6819079|NCT00085644|10823505|FG001|Open-Label Period|Pregnancy|0
6819080|NCT00085644|10823506|FG002|Open-Label Period|Pregnancy|3
6819081|NCT00085644|10823504|FG000|Open-Label Period|Contemplating pregnancy|0
6819082|NCT00085644|10823505|FG001|Open-Label Period|Contemplating pregnancy|0
6819083|NCT00085644|10823506|FG002|Open-Label Period|Contemplating pregnancy|3
6819084|NCT00085644|10823504|FG000|Open-Label Period|Protocol Violation|0
6819085|NCT00085644|10823505|FG001|Open-Label Period|Protocol Violation|0
6819086|NCT00085644|10823506|FG002|Open-Label Period|Protocol Violation|4
6819087|NCT00085644|10823504|FG000|Open-Label Period|Personal reason|0
6819088|NCT00085644|10823505|FG001|Open-Label Period|Personal reason|0
6819089|NCT00085644|10823506|FG002|Open-Label Period|Personal reason|4
6819090|NCT00085709|10823515|FG000|Overall Study|Adverse Event|8
6819091|NCT00085709|10823516|FG001|Overall Study|Adverse Event|0
6819092|NCT00085709|10823515|FG000|Overall Study|Death|8
6819093|NCT00085709|10823516|FG001|Overall Study|Death|2
6819094|NCT00085709|10823515|FG000|Overall Study|Refusal unrelated to adverse events|1
6819095|NCT00085709|10823516|FG001|Overall Study|Refusal unrelated to adverse events|2
6819096|NCT00085709|10823515|FG000|Overall Study|Progression|3
6819097|NCT00085709|10823516|FG001|Overall Study|Progression|4
6819098|NCT00085709|10823515|FG000|Overall Study|Not protocol specified|12
6819099|NCT00085709|10823516|FG001|Overall Study|Not protocol specified|22
6819100|NCT00085709|10823515|FG000|Overall Study|Not eligible|19
6819101|NCT00085709|10823516|FG001|Overall Study|Not eligible|19
6819102|NCT00085709|10823515|FG000|Overall Study|Withdrawal by Subject|2
6819103|NCT00085709|10823516|FG001|Overall Study|Withdrawal by Subject|1
6819104|NCT00085917|10823541|FG000|Overall Study|Adverse Event|4
6819105|NCT00085917|10823542|FG001|Overall Study|Adverse Event|3
6819106|NCT00086047|10823550|FG000|Overall Study|Lost to Follow-up|7
6819107|NCT00086047|10823551|FG001|Overall Study|Lost to Follow-up|6
6819108|NCT00086047|10823550|FG000|Overall Study|Physician Decision|0
6819109|NCT00086047|10823551|FG001|Overall Study|Physician Decision|1
6819110|NCT00086190|10823569|FG000|Overall Study|Adverse Event|6
6819111|NCT00086190|10823570|FG001|Overall Study|Adverse Event|2
6819112|NCT00086190|10823571|FG002|Overall Study|Adverse Event|2
6819113|NCT00086190|10823569|FG000|Overall Study|Withdrawal by Subject|0
6819114|NCT00086190|10823570|FG001|Overall Study|Withdrawal by Subject|2
6819115|NCT00086190|10823571|FG002|Overall Study|Withdrawal by Subject|2
6819116|NCT00086190|10823569|FG000|Overall Study|Protocol Violation|1
6819117|NCT00086190|10823570|FG001|Overall Study|Protocol Violation|0
6819118|NCT00086190|10823571|FG002|Overall Study|Protocol Violation|0
6819119|NCT00086190|10823569|FG000|Overall Study|Moved|1
6819120|NCT00086190|10823570|FG001|Overall Study|Moved|0
6819121|NCT00086190|10823571|FG002|Overall Study|Moved|0
6819122|NCT00086190|10823569|FG000|Overall Study|Worsening depression|0
6819123|NCT00086190|10823570|FG001|Overall Study|Worsening depression|0
6819124|NCT00086190|10823571|FG002|Overall Study|Worsening depression|2
6819125|NCT00086281|10823594|FG000|Phase 1|Adverse Event|0
6819126|NCT00086281|10823595|FG001|Phase 1|Adverse Event|0
6819127|NCT00086281|10823596|FG002|Phase 1|Adverse Event|0
6819128|NCT00086281|10823597|FG003|Phase 1|Adverse Event|0
6819129|NCT00086281|10823598|FG004|Phase 1|Adverse Event|0
6819130|NCT00086281|10823599|FG005|Phase 1|Adverse Event|0
6819131|NCT00086281|10823600|FG006|Phase 1|Adverse Event|0
6819132|NCT00086281|10823601|FG007|Phase 1|Adverse Event|0
6819133|NCT00086281|10823602|FG008|Phase 1|Adverse Event|0
6819134|NCT00086281|10823603|FG009|Phase 1|Adverse Event|1
6819135|NCT00086281|10823604|FG010|Phase 1|Adverse Event|2
6819136|NCT00086281|10823605|FG011|Phase 1|Adverse Event|1
6819137|NCT00086281|10823606|FG012|Phase 1|Adverse Event|1
6819138|NCT00086281|10823607|FG013|Phase 1|Adverse Event|1
6819139|NCT00086281|10823608|FG014|Phase 1|Adverse Event|2
6819140|NCT00086281|10823594|FG000|Phase 1|Protocol Violation|0
6819141|NCT00086281|10823595|FG001|Phase 1|Protocol Violation|0
6819142|NCT00086281|10823596|FG002|Phase 1|Protocol Violation|0
6819143|NCT00086281|10823597|FG003|Phase 1|Protocol Violation|0
6819144|NCT00086281|10823598|FG004|Phase 1|Protocol Violation|0
6819145|NCT00086281|10823599|FG005|Phase 1|Protocol Violation|0
6819146|NCT00086281|10823600|FG006|Phase 1|Protocol Violation|0
6819147|NCT00086281|10823601|FG007|Phase 1|Protocol Violation|0
6819148|NCT00086281|10823602|FG008|Phase 1|Protocol Violation|0
6819149|NCT00086281|10823603|FG009|Phase 1|Protocol Violation|0
6819150|NCT00086281|10823604|FG010|Phase 1|Protocol Violation|1
6819151|NCT00086281|10823605|FG011|Phase 1|Protocol Violation|0
6819152|NCT00086281|10823606|FG012|Phase 1|Protocol Violation|0
6819153|NCT00086281|10823607|FG013|Phase 1|Protocol Violation|0
6819154|NCT00086281|10823608|FG014|Phase 1|Protocol Violation|0
6819155|NCT00086281|10823594|FG000|Phase 1|Serious Adverse Event|0
6899298|NCT00656851|10919070|FG000|Overall Study|Withdrawal by Subject|0
6819156|NCT00086281|10823595|FG001|Phase 1|Serious Adverse Event|0
6819157|NCT00086281|10823596|FG002|Phase 1|Serious Adverse Event|0
6819158|NCT00086281|10823597|FG003|Phase 1|Serious Adverse Event|0
6819159|NCT00086281|10823598|FG004|Phase 1|Serious Adverse Event|0
6819160|NCT00086281|10823599|FG005|Phase 1|Serious Adverse Event|0
6819161|NCT00086281|10823600|FG006|Phase 1|Serious Adverse Event|0
6819162|NCT00086281|10823601|FG007|Phase 1|Serious Adverse Event|0
6819163|NCT00086281|10823602|FG008|Phase 1|Serious Adverse Event|0
6819164|NCT00086281|10823603|FG009|Phase 1|Serious Adverse Event|0
6819165|NCT00086281|10823604|FG010|Phase 1|Serious Adverse Event|0
6819166|NCT00086281|10823605|FG011|Phase 1|Serious Adverse Event|0
6819167|NCT00086281|10823606|FG012|Phase 1|Serious Adverse Event|0
6819168|NCT00086281|10823607|FG013|Phase 1|Serious Adverse Event|0
6819169|NCT00086281|10823608|FG014|Phase 1|Serious Adverse Event|1
6819170|NCT00086281|10823594|FG000|Phase 2|Adverse Event|0
6819171|NCT00086281|10823595|FG001|Phase 2|Adverse Event|0
6819172|NCT00086281|10823596|FG002|Phase 2|Adverse Event|0
6819173|NCT00086281|10823597|FG003|Phase 2|Adverse Event|0
6819174|NCT00086281|10823598|FG004|Phase 2|Adverse Event|0
6819175|NCT00086281|10823599|FG005|Phase 2|Adverse Event|0
6819176|NCT00086281|10823600|FG006|Phase 2|Adverse Event|0
6819177|NCT00086281|10823601|FG007|Phase 2|Adverse Event|0
6819178|NCT00086281|10823602|FG008|Phase 2|Adverse Event|0
6819179|NCT00086281|10823603|FG009|Phase 2|Adverse Event|0
6819180|NCT00086281|10823604|FG010|Phase 2|Adverse Event|0
6819181|NCT00086281|10823605|FG011|Phase 2|Adverse Event|0
6819182|NCT00086281|10823606|FG012|Phase 2|Adverse Event|1
6819183|NCT00086281|10823607|FG013|Phase 2|Adverse Event|1
6819184|NCT00086281|10823608|FG014|Phase 2|Adverse Event|0
6819185|NCT00086307|10823621|FG000|Overall Study|Lack of Efficacy|1
6819186|NCT00086307|10823622|FG001|Overall Study|Lack of Efficacy|1
6819187|NCT00086307|10823623|FG002|Overall Study|Lack of Efficacy|2
6819188|NCT00086307|10823621|FG000|Overall Study|Shortness of breath and muscle spasms|1
6819189|NCT00086307|10823622|FG001|Overall Study|Shortness of breath and muscle spasms|0
6819190|NCT00086307|10823623|FG002|Overall Study|Shortness of breath and muscle spasms|0
6819191|NCT00086307|10823621|FG000|Overall Study|Nausea and headaches|0
6819192|NCT00086307|10823622|FG001|Overall Study|Nausea and headaches|0
6819193|NCT00086307|10823623|FG002|Overall Study|Nausea and headaches|1
6819194|NCT00086307|10823621|FG000|Overall Study|Constipation and sleepiness|0
6819195|NCT00086307|10823622|FG001|Overall Study|Constipation and sleepiness|0
6819196|NCT00086307|10823623|FG002|Overall Study|Constipation and sleepiness|1
6819197|NCT00086307|10823621|FG000|Overall Study|Suicidal ideation|0
6819198|NCT00086307|10823622|FG001|Overall Study|Suicidal ideation|0
6819199|NCT00086307|10823623|FG002|Overall Study|Suicidal ideation|1
6819200|NCT00086307|10823621|FG000|Overall Study|Fatigue and difficulty falling asleep|0
6819201|NCT00086307|10823622|FG001|Overall Study|Fatigue and difficulty falling asleep|0
6819202|NCT00086307|10823623|FG002|Overall Study|Fatigue and difficulty falling asleep|1
6819203|NCT00086307|10823621|FG000|Overall Study|Withdrawal by Subject|0
6819204|NCT00086307|10823622|FG001|Overall Study|Withdrawal by Subject|0
6819205|NCT00086307|10823623|FG002|Overall Study|Withdrawal by Subject|2
6819206|NCT00086346|10823633|FG000|Randomization|Did not receive test article|4
6819207|NCT00086346|10823634|FG001|Randomization|Did not receive test article|4
6819208|NCT00086346|10823633|FG000|Patients Dosed With Test Article|Adverse Event|94
6819209|NCT00086346|10823634|FG001|Patients Dosed With Test Article|Adverse Event|11
6819210|NCT00086346|10823633|FG000|Patients Dosed With Test Article|Lost to Follow-up|1
6819211|NCT00086346|10823634|FG001|Patients Dosed With Test Article|Lost to Follow-up|3
6819212|NCT00086346|10823633|FG000|Patients Dosed With Test Article|Nonmedical event|7
6819213|NCT00086346|10823634|FG001|Patients Dosed With Test Article|Nonmedical event|3
6819214|NCT00086346|10823633|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16
6819215|NCT00086346|10823634|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3
6819216|NCT00086346|10823633|FG000|Patients Dosed With Test Article|Protocol Violation|11
6819217|NCT00086346|10823634|FG001|Patients Dosed With Test Article|Protocol Violation|3
6819218|NCT00086346|10823633|FG000|Patients Dosed With Test Article|Lack of Efficacy|11
6819219|NCT00086346|10823634|FG001|Patients Dosed With Test Article|Lack of Efficacy|0
6819220|NCT00086385|10823644|FG000|Overall Study|Death|2
6819221|NCT00086385|10823645|FG001|Overall Study|Death|2
6819222|NCT00086385|10823646|FG002|Overall Study|Death|1
6819223|NCT00086385|10823647|FG003|Overall Study|Death|1
6819224|NCT00086411|10823661|FG000|Overall Study|Lost to Follow-up|11
6819225|NCT00086411|10823662|FG001|Overall Study|Lost to Follow-up|11
6819226|NCT00086411|10823663|FG002|Overall Study|Lost to Follow-up|13
6819227|NCT00086411|10823664|FG003|Overall Study|Lost to Follow-up|12
6819228|NCT00086502|10823686|FG000|Overall Study|Adverse Event|11
6819229|NCT00086502|10823687|FG001|Overall Study|Adverse Event|2
6819230|NCT00086502|10823686|FG000|Overall Study|Lack of Efficacy|0
6819231|NCT00086502|10823687|FG001|Overall Study|Lack of Efficacy|2
6819232|NCT00086502|10823686|FG000|Overall Study|Lost to Follow-up|3
6819233|NCT00086502|10823687|FG001|Overall Study|Lost to Follow-up|1
6819234|NCT00086502|10823686|FG000|Overall Study|Physician Decision|1
6819235|NCT00086502|10823687|FG001|Overall Study|Physician Decision|1
6819236|NCT00086502|10823686|FG000|Overall Study|Pregnancy|0
6819237|NCT00086502|10823687|FG001|Overall Study|Pregnancy|1
6819238|NCT00086502|10823686|FG000|Overall Study|Protocol Violation|3
6819239|NCT00086502|10823687|FG001|Overall Study|Protocol Violation|3
6819240|NCT00086502|10823686|FG000|Overall Study|Withdrawal by Subject|5
6819241|NCT00086502|10823687|FG001|Overall Study|Withdrawal by Subject|6
6819242|NCT00086502|10823686|FG000|Overall Study|Patient Moved|1
6819243|NCT00086502|10823687|FG001|Overall Study|Patient Moved|1
6819244|NCT00086502|10823686|FG000|Overall Study|Protocol Discontinuation Criteria|1
6819245|NCT00086502|10823687|FG001|Overall Study|Protocol Discontinuation Criteria|3
6819246|NCT00086502|10823686|FG000|Overall Study|Patient Accidentally Unblinded|1
6819247|NCT00086502|10823687|FG001|Overall Study|Patient Accidentally Unblinded|0
6819248|NCT00086515|10823695|FG000|Phase A (Weeks 0-24)|Adverse Event|17
6819249|NCT00086515|10823696|FG001|Phase A (Weeks 0-24)|Adverse Event|9
6819250|NCT00086515|10823695|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7
6819251|NCT00086515|10823696|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13
6819252|NCT00086515|10823695|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4
6819253|NCT00086515|10823696|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5
6819254|NCT00086515|10823695|FG000|Phase A (Weeks 0-24)|Protocol Violation|3
6819255|NCT00086515|10823696|FG001|Phase A (Weeks 0-24)|Protocol Violation|1
6819256|NCT00086515|10823695|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10
6819257|NCT00086515|10823696|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10
6819258|NCT00086515|10823695|FG000|Phase A (Weeks 0-24)|Patient Moved|2
6819259|NCT00086515|10823696|FG001|Phase A (Weeks 0-24)|Patient Moved|3
6819260|NCT00086515|10823695|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4
6819261|NCT00086515|10823696|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3
6819262|NCT00086515|10823695|FG000|Phase A (Weeks 0-24)|Poor compliance|1
6819263|NCT00086515|10823696|FG001|Phase A (Weeks 0-24)|Poor compliance|0
6819264|NCT00086515|10823695|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0
6819265|NCT00086515|10823696|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1
6819266|NCT00086515|10823695|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1
6819267|NCT00086515|10823696|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0
6819268|NCT00086515|10823695|FG000|Phase A to Phase B Transition Period|Adverse Event|2
6819269|NCT00086515|10823696|FG001|Phase A to Phase B Transition Period|Adverse Event|1
6819270|NCT00086515|10823695|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2
6819271|NCT00086515|10823696|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2
6819272|NCT00086515|10823695|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1
6819273|NCT00086515|10823696|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0
6819274|NCT00086515|10823695|FG000|Phase A to Phase B Transition Period|Protocol Violation|0
6819275|NCT00086515|10823696|FG001|Phase A to Phase B Transition Period|Protocol Violation|1
6819276|NCT00086515|10823695|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16
6819277|NCT00086515|10823696|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23
6819278|NCT00086515|10823695|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
6819279|NCT00086515|10823696|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
6819280|NCT00086515|10823695|FG000|Phase A to Phase B Transition Period|Poor compliance|1
6819281|NCT00086515|10823696|FG001|Phase A to Phase B Transition Period|Poor compliance|0
6819282|NCT00086515|10823695|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1
6819283|NCT00086515|10823696|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0
6819284|NCT00086515|10823695|FG000|Phase B (Weeks 24-104)|Adverse Event|16
6819285|NCT00086515|10823696|FG001|Phase B (Weeks 24-104)|Adverse Event|10
6819286|NCT00086515|10823695|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94
6819287|NCT00086515|10823696|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19
6819288|NCT00086515|10823695|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13
6819289|NCT00086515|10823696|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4
6819290|NCT00086515|10823695|FG000|Phase B (Weeks 24-104)|Physician Decision|3
6819291|NCT00086515|10823696|FG001|Phase B (Weeks 24-104)|Physician Decision|0
6819292|NCT00086515|10823695|FG000|Phase B (Weeks 24-104)|Protocol Violation|1
6819293|NCT00086515|10823696|FG001|Phase B (Weeks 24-104)|Protocol Violation|0
6819294|NCT00086515|10823695|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15
6819295|NCT00086515|10823696|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5
6819296|NCT00086515|10823695|FG000|Phase B (Weeks 24-104)|Patient Moved|2
6819297|NCT00086515|10823696|FG001|Phase B (Weeks 24-104)|Patient Moved|2
6819298|NCT00086515|10823695|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5
6819299|NCT00086515|10823696|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3
6819300|NCT00086515|10823695|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36
6819301|NCT00086515|10823696|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10
6819302|NCT00086515|10823695|FG000|Phase B (Weeks 24-104)|Patient Died|3
6819303|NCT00086515|10823696|FG001|Phase B (Weeks 24-104)|Patient Died|1
6819304|NCT00086515|10823695|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0
6819305|NCT00086515|10823696|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1
6819306|NCT00086515|10823695|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1
6819307|NCT00086515|10823696|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0
6819308|NCT00086515|10823695|FG000|Phase B (Weeks 24-104)|Discontinued in error|1
6819309|NCT00086515|10823696|FG001|Phase B (Weeks 24-104)|Discontinued in error|0
6819310|NCT00086580|10823704|FG000|Treatment Period|Disease progression|9
6819311|NCT00086580|10823705|FG001|Treatment Period|Disease progression|8
6819312|NCT00086580|10823704|FG000|Treatment Period|Unable to comply with protocol|3
6819313|NCT00086580|10823705|FG001|Treatment Period|Unable to comply with protocol|1
6819314|NCT00086580|10823704|FG000|Treatment Period|Withdrawal by Subject|7
6819315|NCT00086580|10823705|FG001|Treatment Period|Withdrawal by Subject|8
6819316|NCT00086580|10823704|FG000|Treatment Period|Physician Decision|13
6819317|NCT00086580|10823705|FG001|Treatment Period|Physician Decision|7
6819318|NCT00086580|10823704|FG000|Treatment Period|AE - not treatment related|7
6819319|NCT00086580|10823705|FG001|Treatment Period|AE - not treatment related|7
6819320|NCT00086580|10823704|FG000|Treatment Period|Toxicity - treatment related|15
6819321|NCT00086580|10823705|FG001|Treatment Period|Toxicity - treatment related|15
6819322|NCT00086580|10823704|FG000|Treatment Period|Anemia or thrombocytopenia|1
6819323|NCT00086580|10823705|FG001|Treatment Period|Anemia or thrombocytopenia|4
6819324|NCT00086580|10823704|FG000|Treatment Period|Death|5
6819325|NCT00086580|10823705|FG001|Treatment Period|Death|7
6819326|NCT00086580|10823704|FG000|Treatment Period|Other|5
6819327|NCT00086580|10823705|FG001|Treatment Period|Other|3
6819328|NCT00086580|10823704|FG000|Follow-up Period|Disease progression|72
6819329|NCT00086580|10823705|FG001|Follow-up Period|Disease progression|99
6899299|NCT00656851|10919071|FG001|Overall Study|Withdrawal by Subject|4
6899300|NCT00657020|10919086|FG000|PERIOD 1|Adverse Event|0
6899301|NCT00657020|10919087|FG001|PERIOD 1|Adverse Event|1
6899302|NCT00657046|10919102|FG000|Overall Study|Adverse Event|1
6899303|NCT00657046|10919103|FG001|Overall Study|Adverse Event|1
6899304|NCT00657046|10919104|FG002|Overall Study|Adverse Event|0
6899305|NCT00657046|10919102|FG000|Overall Study|Protocol Violation|2
6899306|NCT00657046|10919103|FG001|Overall Study|Protocol Violation|2
6899307|NCT00657046|10919104|FG002|Overall Study|Protocol Violation|0
6899308|NCT00657046|10919102|FG000|Overall Study|Withdrawal by Subject|1
6899309|NCT00657046|10919103|FG001|Overall Study|Withdrawal by Subject|0
6899310|NCT00657046|10919104|FG002|Overall Study|Withdrawal by Subject|0
6899311|NCT00657046|10919102|FG000|Overall Study|Death|0
6899312|NCT00657046|10919103|FG001|Overall Study|Death|0
6899313|NCT00657046|10919104|FG002|Overall Study|Death|1
6899314|NCT00657046|10919102|FG000|Overall Study|Surgery|0
6899315|NCT00657046|10919103|FG001|Overall Study|Surgery|0
6899316|NCT00657046|10919104|FG002|Overall Study|Surgery|1
6899317|NCT00657150|10919114|FG000|Overall Study|Adverse Event|19
6899318|NCT00657150|10919115|FG001|Overall Study|Adverse Event|10
6899319|NCT00657150|10919114|FG000|Overall Study|Non-compliant with protocol|5
6899320|NCT00657150|10919115|FG001|Overall Study|Non-compliant with protocol|9
6899321|NCT00657150|10919114|FG000|Overall Study|Lost to Follow-up|2
6899322|NCT00657150|10919115|FG001|Overall Study|Lost to Follow-up|0
6899323|NCT00657150|10919114|FG000|Overall Study|Withdrawal by Subject|51
6899324|NCT00657150|10919115|FG001|Overall Study|Withdrawal by Subject|36
6899325|NCT00657150|10919114|FG000|Overall Study|Other|38
6899326|NCT00657150|10919115|FG001|Overall Study|Other|38
6899327|NCT00657150|10919114|FG000|Treatment|Adverse Event|60
6899328|NCT00657150|10919115|FG001|Treatment|Adverse Event|53
6899329|NCT00657150|10919114|FG000|Treatment|Non-compliant with protocol|10
6899330|NCT00657150|10919115|FG001|Treatment|Non-compliant with protocol|9
6899331|NCT00657150|10919114|FG000|Treatment|Lost to Follow-up|1
6899332|NCT00657150|10919115|FG001|Treatment|Lost to Follow-up|0
6899333|NCT00657150|10919114|FG000|Treatment|Withdrawal by Subject|23
6899334|NCT00657150|10919115|FG001|Treatment|Withdrawal by Subject|20
6899335|NCT00657150|10919114|FG000|Treatment|Other|13
6899336|NCT00657150|10919115|FG001|Treatment|Other|15
6899337|NCT00657267|10919121|FG000|Overall Study|Progressive disease|45
6899338|NCT00657267|10919121|FG000|Overall Study|Adverse Event|9
6973522|NCT01181895|11025408|FG000|Overall Study|Lack of Efficacy|8
6973523|NCT01181895|11025409|FG001|Overall Study|Lack of Efficacy|9
6973524|NCT01181895|11025410|FG002|Overall Study|Lack of Efficacy|9
6973525|NCT01181895|11025408|FG000|Overall Study|Protocol Violation|2
6973526|NCT01181895|11025409|FG001|Overall Study|Protocol Violation|1
6973527|NCT01181895|11025410|FG002|Overall Study|Protocol Violation|0
6973528|NCT01181895|11025408|FG000|Overall Study|Lost to Follow-up|0
6973529|NCT01181895|11025409|FG001|Overall Study|Lost to Follow-up|1
6973530|NCT01181895|11025410|FG002|Overall Study|Lost to Follow-up|2
6973531|NCT01181895|11025408|FG000|Overall Study|Investigator Discretion|1
6973532|NCT01181895|11025409|FG001|Overall Study|Investigator Discretion|2
6973533|NCT01181895|11025410|FG002|Overall Study|Investigator Discretion|1
6973534|NCT01181895|11025408|FG000|Overall Study|Withdrawal by Subject|3
6973535|NCT01181895|11025409|FG001|Overall Study|Withdrawal by Subject|0
6973536|NCT01181895|11025410|FG002|Overall Study|Withdrawal by Subject|5
6977120|NCT01205126|11030145|FG000|Titration Phase|Withdrawal by Subject|5
6977121|NCT01205126|11030146|FG001|Titration Phase|Withdrawal by Subject|5
6977122|NCT01205126|11030145|FG000|Titration Phase|Lost to Follow-up|2
6977123|NCT01205126|11030146|FG001|Titration Phase|Lost to Follow-up|2
6977124|NCT01205126|11030145|FG000|Titration Phase|No stable titration dose|1
6977125|NCT01205126|11030146|FG001|Titration Phase|No stable titration dose|0
6977126|NCT01205126|11030145|FG000|Titration Phase|More than maximum dosage required|2
6977127|NCT01205126|11030146|FG001|Titration Phase|More than maximum dosage required|3
6977128|NCT01205126|11030145|FG000|Titration Phase|Other|8
6977129|NCT01205126|11030146|FG001|Titration Phase|Other|6
6977130|NCT01205126|11030145|FG000|Between Titration & Maintenance Phase|Other|0
6977131|NCT01205126|11030146|FG001|Between Titration & Maintenance Phase|Other|4
6977132|NCT01205126|11030145|FG000|Maintenance Phase|Adverse Event|3
6977133|NCT01205126|11030146|FG001|Maintenance Phase|Adverse Event|7
6977134|NCT01205126|11030145|FG000|Maintenance Phase|Death|4
6978396|NCT01212770|11031719|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
6978397|NCT01212770|11031720|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
6978398|NCT01212770|11031721|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
6978399|NCT01212770|11031722|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
7059530|NCT01907828|11155173|FG000|Overall Study|Withdrawal by Subject|3
6819330|NCT00086580|10823704|FG000|Follow-up Period|Unable to comply with protocol|5
6977135|NCT01205126|11030146|FG001|Maintenance Phase|Death|4
6977136|NCT01205126|11030145|FG000|Maintenance Phase|More than the maximum dosage required|5
6977137|NCT01205126|11030146|FG001|Maintenance Phase|More than the maximum dosage required|5
6819331|NCT00086580|10823705|FG001|Follow-up Period|Unable to comply with protocol|0
6819332|NCT00086580|10823704|FG000|Follow-up Period|Withdrawal by Subject|6
6819333|NCT00086580|10823705|FG001|Follow-up Period|Withdrawal by Subject|6
6819334|NCT00086580|10823704|FG000|Follow-up Period|Physician Decision|0
6819335|NCT00086580|10823705|FG001|Follow-up Period|Physician Decision|1
6819336|NCT00086580|10823704|FG000|Follow-up Period|AE - not related|1
6819337|NCT00086580|10823705|FG001|Follow-up Period|AE - not related|0
6819338|NCT00086580|10823704|FG000|Follow-up Period|Death|13
6819339|NCT00086580|10823705|FG001|Follow-up Period|Death|7
6819340|NCT00086580|10823704|FG000|Follow-up Period|Other|7
6819341|NCT00086580|10823705|FG001|Follow-up Period|Other|6
6819342|NCT00086580|10823704|FG000|Observation Period|Unable to comply with protocol|1
6819343|NCT00086580|10823705|FG001|Observation Period|Unable to comply with protocol|1
6819344|NCT00086580|10823704|FG000|Observation Period|Withdrawal by Subject|4
6819345|NCT00086580|10823705|FG001|Observation Period|Withdrawal by Subject|2
6819346|NCT00086580|10823704|FG000|Observation Period|Death|33
6819347|NCT00086580|10823705|FG001|Observation Period|Death|55
6819348|NCT00086580|10823704|FG000|Observation Period|Other|8
6819349|NCT00086580|10823705|FG001|Observation Period|Other|7
6896544|NCT00633932|10915038|FG001|Overall Study|Withdrawal by Subject|9
6896545|NCT00633932|10915039|FG002|Overall Study|Withdrawal by Subject|1
6896546|NCT00633932|10915037|FG000|Overall Study|Lost to Follow-up|1
6896547|NCT00633932|10915038|FG001|Overall Study|Lost to Follow-up|0
6896548|NCT00633932|10915039|FG002|Overall Study|Lost to Follow-up|2
6896549|NCT00633932|10915037|FG000|Overall Study|Protocol Violation|5
6896550|NCT00633932|10915038|FG001|Overall Study|Protocol Violation|2
6896551|NCT00633932|10915039|FG002|Overall Study|Protocol Violation|3
6896552|NCT00633932|10915037|FG000|Overall Study|Physician Decision|0
6896553|NCT00633932|10915038|FG001|Overall Study|Physician Decision|0
6896554|NCT00633932|10915039|FG002|Overall Study|Physician Decision|1
6896555|NCT00633932|10915037|FG000|Overall Study|Doctor's judgement|1
6896556|NCT00633932|10915038|FG001|Overall Study|Doctor's judgement|0
6896557|NCT00633932|10915039|FG002|Overall Study|Doctor's judgement|0
6896558|NCT00633932|10915037|FG000|Overall Study|Moved Away|1
6896559|NCT00633932|10915038|FG001|Overall Study|Moved Away|0
6896560|NCT00633932|10915039|FG002|Overall Study|Moved Away|0
6896561|NCT00633945|10915047|FG000|Overall Study|Physician Decision|2
6896562|NCT00633984|10915055|FG000|Overall Study|Lost to Follow-up|0
6896563|NCT00633984|10915056|FG001|Overall Study|Lost to Follow-up|6
6896564|NCT00633984|10915055|FG000|Overall Study|Withdrawal by Subject|8
6896565|NCT00633984|10915056|FG001|Overall Study|Withdrawal by Subject|7
6896566|NCT00633984|10915055|FG000|Overall Study|Hospitalized|1
6896567|NCT00633984|10915056|FG001|Overall Study|Hospitalized|0
6896568|NCT00634036|10915064|FG000|Overall Study|Lost to Follow-up|1
6896569|NCT00634036|10915065|FG001|Overall Study|Lost to Follow-up|1
6896570|NCT00634036|10915064|FG000|Overall Study|Withdrawal by Subject|1
6896571|NCT00634036|10915065|FG001|Overall Study|Withdrawal by Subject|1
6896572|NCT00634049|10915071|FG000|Overall Study|Never received study drug|1
6896573|NCT00634049|10915071|FG000|Overall Study|Died prior to receiving study drug|1
6896574|NCT00634049|10915071|FG000|Overall Study|Screening failure|1
6896575|NCT00634088|10915108|FG000|Time Period 1: Dose Level 1|Disease progression|2
6896576|NCT00634088|10915109|FG001|Time Period 1: Dose Level 1|Disease progression|0
6896577|NCT00634088|10915110|FG002|Time Period 1: Dose Level 1|Disease progression|0
6896578|NCT00634088|10915111|FG003|Time Period 1: Dose Level 1|Disease progression|0
6896579|NCT00634088|10915108|FG000|Time Period 1: Dose Level 1|Physician Decision|1
6896580|NCT00634088|10915109|FG001|Time Period 1: Dose Level 1|Physician Decision|0
6896581|NCT00634088|10915110|FG002|Time Period 1: Dose Level 1|Physician Decision|0
6896582|NCT00634088|10915111|FG003|Time Period 1: Dose Level 1|Physician Decision|0
6896583|NCT00634088|10915108|FG000|Time Period 1: Dose Level 1|Adverse Event|3
6896584|NCT00634088|10915109|FG001|Time Period 1: Dose Level 1|Adverse Event|0
6896585|NCT00634088|10915110|FG002|Time Period 1: Dose Level 1|Adverse Event|0
6896586|NCT00634088|10915111|FG003|Time Period 1: Dose Level 1|Adverse Event|0
6896587|NCT00634088|10915108|FG000|Time Period 2: Dose Level 2|Adverse Event|0
6896588|NCT00634088|10915109|FG001|Time Period 2: Dose Level 2|Adverse Event|2
6896589|NCT00634088|10915110|FG002|Time Period 2: Dose Level 2|Adverse Event|0
6896590|NCT00634088|10915111|FG003|Time Period 2: Dose Level 2|Adverse Event|0
6896591|NCT00634088|10915108|FG000|Time Period 2: Dose Level 2|Progressive disease|0
6896592|NCT00634088|10915109|FG001|Time Period 2: Dose Level 2|Progressive disease|1
6896593|NCT00634088|10915110|FG002|Time Period 2: Dose Level 2|Progressive disease|0
6896594|NCT00634088|10915111|FG003|Time Period 2: Dose Level 2|Progressive disease|0
6896595|NCT00634088|10915108|FG000|Time Period 3: Dose Level 3|Progressive disease|0
6896596|NCT00634088|10915109|FG001|Time Period 3: Dose Level 3|Progressive disease|0
6896597|NCT00634088|10915110|FG002|Time Period 3: Dose Level 3|Progressive disease|1
6896598|NCT00634088|10915111|FG003|Time Period 3: Dose Level 3|Progressive disease|0
6896599|NCT00634101|10915123|FG000|Overall Study|Study Terminated|3
6896600|NCT00634101|10915124|FG001|Overall Study|Study Terminated|3
6896601|NCT00634101|10915123|FG000|Overall Study|Lost to Follow-up|2
6896602|NCT00634101|10915124|FG001|Overall Study|Lost to Follow-up|0
6896603|NCT00634114|10915133|FG000|Overall Study|Adverse Event|6
6896604|NCT00634114|10915134|FG001|Overall Study|Adverse Event|8
6896605|NCT00634114|10915135|FG002|Overall Study|Adverse Event|3
6896606|NCT00634114|10915133|FG000|Overall Study|Withdrawal by Subject|9
6896607|NCT00634114|10915134|FG001|Overall Study|Withdrawal by Subject|6
6819350|NCT00086619|10823713|FG000|Overall Study|Withdrawal by Subject|6
6819351|NCT00086619|10823714|FG001|Overall Study|Withdrawal by Subject|6
6819352|NCT00086619|10823713|FG000|Overall Study|Adverse Event|8
6819353|NCT00086619|10823714|FG001|Overall Study|Adverse Event|10
6819354|NCT00086619|10823713|FG000|Overall Study|Protocol Violation|1
6819355|NCT00086619|10823714|FG001|Overall Study|Protocol Violation|1
6819356|NCT00086684|10823723|FG000|Overall Study|Adverse Event|12
6819357|NCT00086684|10823724|FG001|Overall Study|Adverse Event|17
6819358|NCT00086684|10823725|FG002|Overall Study|Adverse Event|14
6819359|NCT00086684|10823723|FG000|Overall Study|Lack of Efficacy|6
6819360|NCT00086684|10823724|FG001|Overall Study|Lack of Efficacy|6
6819361|NCT00086684|10823725|FG002|Overall Study|Lack of Efficacy|5
6819362|NCT00086684|10823723|FG000|Overall Study|Lost to Follow-up|15
6819363|NCT00086684|10823724|FG001|Overall Study|Lost to Follow-up|8
6819364|NCT00086684|10823725|FG002|Overall Study|Lost to Follow-up|10
6819365|NCT00086684|10823723|FG000|Overall Study|Protocol Violation|8
6819366|NCT00086684|10823724|FG001|Overall Study|Protocol Violation|3
6819367|NCT00086684|10823725|FG002|Overall Study|Protocol Violation|0
6819368|NCT00086684|10823723|FG000|Overall Study|Withdrawal by Subject|0
6819369|NCT00086684|10823724|FG001|Overall Study|Withdrawal by Subject|4
6819370|NCT00086684|10823725|FG002|Overall Study|Withdrawal by Subject|10
6819371|NCT00086684|10823723|FG000|Overall Study|NONCOMPLIANCE|5
6819372|NCT00086684|10823724|FG001|Overall Study|NONCOMPLIANCE|7
6819373|NCT00086684|10823725|FG002|Overall Study|NONCOMPLIANCE|6
6819374|NCT00086684|10823723|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0
6819375|NCT00086684|10823724|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1
6819376|NCT00086684|10823725|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0
6819377|NCT00086684|10823723|FG000|Overall Study|WITHDRAWAL OF CONSENT|5
6819378|NCT00086684|10823724|FG001|Overall Study|WITHDRAWAL OF CONSENT|7
6819379|NCT00086684|10823725|FG002|Overall Study|WITHDRAWAL OF CONSENT|5
6819380|NCT00086684|10823723|FG000|Overall Study|Other|4
6819381|NCT00086684|10823724|FG001|Overall Study|Other|2
6819382|NCT00086684|10823725|FG002|Overall Study|Other|3
6819383|NCT00086996|10823744|FG000|Overall Study|Adverse Event|29
6819384|NCT00086996|10823744|FG000|Overall Study|Death|4
6819385|NCT00086996|10823744|FG000|Overall Study|progression/relapse|7
6819386|NCT00086996|10823744|FG000|Overall Study|Withdrawal by Subject|13
6819387|NCT00086996|10823744|FG000|Overall Study|Other|6
6819388|NCT00086996|10823744|FG000|Overall Study|not eligible|5
6819389|NCT00087126|10823757|FG000|Overall Study|Ineligible - second primary|1
6819390|NCT00087126|10823757|FG000|Overall Study|Never treated|1
6819391|NCT00087139|10823769|FG000|Overall Study|Adverse Event|18
6819392|NCT00087139|10823770|FG001|Overall Study|Adverse Event|17
6819393|NCT00087139|10823771|FG002|Overall Study|Adverse Event|13
6819394|NCT00087139|10823769|FG000|Overall Study|Death|2
6819395|NCT00087139|10823770|FG001|Overall Study|Death|1
6819396|NCT00087139|10823771|FG002|Overall Study|Death|0
6819397|NCT00087139|10823769|FG000|Overall Study|Withdrawal by Subject|3
6819398|NCT00087139|10823770|FG001|Overall Study|Withdrawal by Subject|2
6819399|NCT00087139|10823771|FG002|Overall Study|Withdrawal by Subject|2
6819400|NCT00087139|10823769|FG000|Overall Study|Physician Decision|1
6819401|NCT00087139|10823770|FG001|Overall Study|Physician Decision|1
6819402|NCT00087139|10823771|FG002|Overall Study|Physician Decision|1
6819403|NCT00087139|10823769|FG000|Overall Study|Disease progression|9
6819404|NCT00087139|10823770|FG001|Overall Study|Disease progression|19
6819405|NCT00087139|10823771|FG002|Overall Study|Disease progression|12
6819406|NCT00087139|10823769|FG000|Overall Study|Ineligible|4
6819407|NCT00087139|10823770|FG001|Overall Study|Ineligible|7
6819408|NCT00087139|10823771|FG002|Overall Study|Ineligible|4
6819409|NCT00087139|10823769|FG000|Overall Study|Symptomatic deterioration|1
6819410|NCT00087139|10823770|FG001|Overall Study|Symptomatic deterioration|1
6819411|NCT00087139|10823771|FG002|Overall Study|Symptomatic deterioration|3
6819412|NCT00087139|10823769|FG000|Overall Study|Use of coumadin|1
6819413|NCT00087139|10823770|FG001|Overall Study|Use of coumadin|0
6819414|NCT00087139|10823771|FG002|Overall Study|Use of coumadin|0
6819415|NCT00087139|10823769|FG000|Overall Study|Response achieved|0
6819416|NCT00087139|10823770|FG001|Overall Study|Response achieved|1
6819417|NCT00087139|10823771|FG002|Overall Study|Response achieved|0
6819418|NCT00087139|10823769|FG000|Overall Study|Extradural disease|0
6819419|NCT00087139|10823770|FG001|Overall Study|Extradural disease|0
6819420|NCT00087139|10823771|FG002|Overall Study|Extradural disease|1
6819421|NCT00087152|10823777|FG000|Overall Study|Ineligible|6
6819422|NCT00087438|10823782|FG000|Overall Study|Ineligible / No protocol treatment|4
6819423|NCT00087490|10823790|FG000|Overall Study|Death|6
6819424|NCT00087490|10823791|FG001|Overall Study|Death|4
6819425|NCT00087490|10823790|FG000|Overall Study|Adverse Event|3
6819426|NCT00087490|10823791|FG001|Overall Study|Adverse Event|8
6819427|NCT00087490|10823790|FG000|Overall Study|Lack of Efficacy|0
6819428|NCT00087490|10823791|FG001|Overall Study|Lack of Efficacy|2
6819429|NCT00087490|10823790|FG000|Overall Study|Protocol Violation or (/) Unspecified|214
6819430|NCT00087490|10823791|FG001|Overall Study|Protocol Violation or (/) Unspecified|201
6819431|NCT00087490|10823790|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28
6819432|NCT00087490|10823791|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36
6819433|NCT00087490|10823790|FG000|Overall Study|Randomized but not treated|7
6819434|NCT00087490|10823791|FG001|Overall Study|Randomized but not treated|18
6819435|NCT00087516|10823800|FG000|Overall Study|Adverse Event|10
6819436|NCT00087516|10823801|FG001|Overall Study|Adverse Event|10
6819437|NCT00087516|10823802|FG002|Overall Study|Adverse Event|3
6819438|NCT00087516|10823803|FG003|Overall Study|Adverse Event|6
6819439|NCT00087516|10823800|FG000|Overall Study|Lack of Efficacy|82
6819440|NCT00087516|10823801|FG001|Overall Study|Lack of Efficacy|80
6819441|NCT00087516|10823802|FG002|Overall Study|Lack of Efficacy|39
6819442|NCT00087516|10823803|FG003|Overall Study|Lack of Efficacy|29
6819443|NCT00087516|10823800|FG000|Overall Study|Lost to Follow-up|8
6819444|NCT00087516|10823801|FG001|Overall Study|Lost to Follow-up|6
6819445|NCT00087516|10823802|FG002|Overall Study|Lost to Follow-up|5
6819446|NCT00087516|10823803|FG003|Overall Study|Lost to Follow-up|5
6819447|NCT00087516|10823800|FG000|Overall Study|Protocol Violation|4
6819448|NCT00087516|10823801|FG001|Overall Study|Protocol Violation|8
6819449|NCT00087516|10823802|FG002|Overall Study|Protocol Violation|3
6819450|NCT00087516|10823803|FG003|Overall Study|Protocol Violation|6
6819451|NCT00087516|10823800|FG000|Overall Study|Withdrawal by Subject|16
6819452|NCT00087516|10823801|FG001|Overall Study|Withdrawal by Subject|27
6819453|NCT00087516|10823802|FG002|Overall Study|Withdrawal by Subject|11
6819454|NCT00087516|10823803|FG003|Overall Study|Withdrawal by Subject|12
6819455|NCT00087516|10823800|FG000|Overall Study|Site terminated|0
6819456|NCT00087516|10823801|FG001|Overall Study|Site terminated|2
6819457|NCT00087516|10823802|FG002|Overall Study|Site terminated|1
6819458|NCT00087516|10823803|FG003|Overall Study|Site terminated|0
6819459|NCT00087516|10823800|FG000|Overall Study|Protocol specified discontinuation|35
6819460|NCT00087516|10823801|FG001|Overall Study|Protocol specified discontinuation|33
6819461|NCT00087516|10823802|FG002|Overall Study|Protocol specified discontinuation|33
6819462|NCT00087516|10823803|FG003|Overall Study|Protocol specified discontinuation|26
6819463|NCT00087516|10823800|FG000|Overall Study|Patient moved|3
6819464|NCT00087516|10823801|FG001|Overall Study|Patient moved|2
6819465|NCT00087516|10823802|FG002|Overall Study|Patient moved|1
6819466|NCT00087516|10823803|FG003|Overall Study|Patient moved|0
6819467|NCT00087516|10823800|FG000|Overall Study|Patient was non-compliant|3
6819468|NCT00087516|10823801|FG001|Overall Study|Patient was non-compliant|1
6819469|NCT00087516|10823802|FG002|Overall Study|Patient was non-compliant|0
6819470|NCT00087516|10823803|FG003|Overall Study|Patient was non-compliant|0
6819471|NCT00087516|10823800|FG000|Overall Study|Recommendation of Primary Care Physician|0
6819472|NCT00087516|10823801|FG001|Overall Study|Recommendation of Primary Care Physician|0
6819473|NCT00087516|10823802|FG002|Overall Study|Recommendation of Primary Care Physician|0
6819474|NCT00087516|10823803|FG003|Overall Study|Recommendation of Primary Care Physician|1
6819475|NCT00087516|10823800|FG000|Overall Study|Other|0
6819476|NCT00087516|10823801|FG001|Overall Study|Other|0
6819477|NCT00087516|10823802|FG002|Overall Study|Other|1
6819478|NCT00087516|10823803|FG003|Overall Study|Other|0
6819479|NCT00087529|10823819|FG000|Overall Study|Death|1
6819480|NCT00087529|10823820|FG001|Overall Study|Death|0
6819481|NCT00087529|10823819|FG000|Overall Study|Adverse Event|0
6819482|NCT00087529|10823820|FG001|Overall Study|Adverse Event|8
6819483|NCT00087529|10823819|FG000|Overall Study|Pregnancy|0
6819484|NCT00087529|10823820|FG001|Overall Study|Pregnancy|1
6819485|NCT00087529|10823819|FG000|Overall Study|Lost to Follow-up|2
6819486|NCT00087529|10823820|FG001|Overall Study|Lost to Follow-up|3
6819487|NCT00087529|10823819|FG000|Overall Study|Participant Decision|14
6819488|NCT00087529|10823820|FG001|Overall Study|Participant Decision|37
6819489|NCT00087529|10823819|FG000|Overall Study|Physician Decision|4
6819490|NCT00087529|10823820|FG001|Overall Study|Physician Decision|8
6819491|NCT00087529|10823819|FG000|Overall Study|Initiation of Excluded Therapy|0
6819492|NCT00087529|10823820|FG001|Overall Study|Initiation of Excluded Therapy|1
6819493|NCT00087529|10823819|FG000|Overall Study|Participant Noncompliance|0
6819494|NCT00087529|10823820|FG001|Overall Study|Participant Noncompliance|1
6819495|NCT00087529|10823819|FG000|Overall Study|Disease Progression|5
6819496|NCT00087529|10823820|FG001|Overall Study|Disease Progression|4
6819497|NCT00087529|10823819|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5
6819498|NCT00087529|10823820|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5
6819499|NCT00087555|10823829|FG000|Overall Study|Adverse Event|3
6819500|NCT00087555|10823830|FG001|Overall Study|Adverse Event|6
6819501|NCT00087555|10823831|FG002|Overall Study|Adverse Event|14
6819502|NCT00087555|10823829|FG000|Overall Study|Lost to Follow-up|0
6819503|NCT00087555|10823830|FG001|Overall Study|Lost to Follow-up|1
6819504|NCT00087555|10823831|FG002|Overall Study|Lost to Follow-up|1
6819505|NCT00087555|10823829|FG000|Overall Study|Non - Compliance|1
6819506|NCT00087555|10823830|FG001|Overall Study|Non - Compliance|0
6819507|NCT00087555|10823831|FG002|Overall Study|Non - Compliance|0
6819508|NCT00087555|10823829|FG000|Overall Study|Protocol Violation|0
6819509|NCT00087555|10823830|FG001|Overall Study|Protocol Violation|0
6819510|NCT00087555|10823831|FG002|Overall Study|Protocol Violation|2
6819511|NCT00087555|10823829|FG000|Overall Study|Screen Failure|1
6819512|NCT00087555|10823830|FG001|Overall Study|Screen Failure|1
6819513|NCT00087555|10823831|FG002|Overall Study|Screen Failure|0
6819514|NCT00087555|10823829|FG000|Overall Study|Pregnancy|0
6819515|NCT00087555|10823830|FG001|Overall Study|Pregnancy|1
6819516|NCT00087555|10823831|FG002|Overall Study|Pregnancy|1
6819517|NCT00087555|10823829|FG000|Overall Study|Withdrawal by Subject|3
6819518|NCT00087555|10823830|FG001|Overall Study|Withdrawal by Subject|2
6819519|NCT00087555|10823831|FG002|Overall Study|Withdrawal by Subject|1
6819520|NCT00087555|10823829|FG000|Overall Study|Lack of Efficacy|2
6819521|NCT00087555|10823830|FG001|Overall Study|Lack of Efficacy|0
6819522|NCT00087555|10823831|FG002|Overall Study|Lack of Efficacy|1
6819523|NCT00087555|10823829|FG000|Overall Study|Non Compliance|0
6819524|NCT00087555|10823830|FG001|Overall Study|Non Compliance|0
6819525|NCT00087555|10823831|FG002|Overall Study|Non Compliance|1
6819526|NCT00087555|10823829|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1
6819527|NCT00087555|10823830|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0
6819528|NCT00087555|10823831|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0
6819529|NCT00087555|10823829|FG000|Overall Study|Patient wanted to go back on Med|1
6819530|NCT00087555|10823830|FG001|Overall Study|Patient wanted to go back on Med|0
6819531|NCT00087555|10823831|FG002|Overall Study|Patient wanted to go back on Med|0
6819532|NCT00087568|10823841|FG000|Overall Study|Adverse Event|4
6819533|NCT00087568|10823842|FG001|Overall Study|Adverse Event|0
6819534|NCT00087568|10823841|FG000|Overall Study|Withdrawal by Subject|1
6819535|NCT00087568|10823842|FG001|Overall Study|Withdrawal by Subject|1
6819536|NCT00087568|10823841|FG000|Overall Study|Lost to Follow-up|1
6819537|NCT00087568|10823842|FG001|Overall Study|Lost to Follow-up|0
6819538|NCT00087568|10823841|FG000|Overall Study|Lack of Efficacy|24
6819539|NCT00087568|10823842|FG001|Overall Study|Lack of Efficacy|1
6819540|NCT00087594|10823850|FG000|Overall Study|Adverse Event|2
6819541|NCT00087594|10823851|FG001|Overall Study|Adverse Event|3
6819542|NCT00087594|10823850|FG000|Overall Study|Lost to Follow-up|0
6819543|NCT00087594|10823851|FG001|Overall Study|Lost to Follow-up|2
6819544|NCT00087594|10823850|FG000|Overall Study|Withdrawal by Subject|4
6819545|NCT00087594|10823851|FG001|Overall Study|Withdrawal by Subject|2
6819546|NCT00087594|10823850|FG000|Overall Study|Lack of Efficacy|2
6819547|NCT00087594|10823851|FG001|Overall Study|Lack of Efficacy|5
6819548|NCT00087607|10823859|FG000|Overall Study|Adverse Event|14
6819549|NCT00087607|10823860|FG001|Overall Study|Adverse Event|24
6819550|NCT00087607|10823859|FG000|Overall Study|Death|0
6899339|NCT00657358|10919131|FG000|Overall Study|Lack of Efficacy|6
6899340|NCT00657371|10919136|FG000|Overall Study|Poor bowel preparation|15
6899341|NCT00657371|10919136|FG000|Overall Study|Unable to intubate the cecum|5
6899342|NCT00657371|10919136|FG000|Overall Study|Protocol Violation|2
6899343|NCT00657371|10919136|FG000|Overall Study|Device- related reasons|13
6899344|NCT00657371|10919136|FG000|Overall Study|Pre-existing medical condition|4
6899345|NCT00657540|10919142|FG000|Overall Study|Lost to Follow-up|1
6899346|NCT00657540|10919143|FG001|Overall Study|Lost to Follow-up|4
6899347|NCT00657618|10919153|FG000|Overall Study|Adverse Event|32
6899348|NCT00657618|10919153|FG000|Overall Study|Withdrawal by Subject|8
6899349|NCT00657618|10919153|FG000|Overall Study|negative for leishmaniasis|2
6899350|NCT00657618|10919153|FG000|Overall Study|didn't start due to schedule conflicts|1
6899351|NCT00657709|10919166|FG000|Overall Study|AE or Death|7
6899352|NCT00657709|10919167|FG001|Overall Study|AE or Death|7
6899353|NCT00657709|10919168|FG002|Overall Study|AE or Death|6
6899354|NCT00657709|10919169|FG003|Overall Study|AE or Death|7
6899355|NCT00657709|10919170|FG004|Overall Study|AE or Death|1
6899356|NCT00657709|10919166|FG000|Overall Study|Withdrawal by Subject|7
6899357|NCT00657709|10919167|FG001|Overall Study|Withdrawal by Subject|15
6899358|NCT00657709|10919168|FG002|Overall Study|Withdrawal by Subject|15
6899359|NCT00657709|10919169|FG003|Overall Study|Withdrawal by Subject|5
6899360|NCT00657709|10919170|FG004|Overall Study|Withdrawal by Subject|9
6899361|NCT00657709|10919166|FG000|Overall Study|Lost to Follow-up|9
6899362|NCT00657709|10919167|FG001|Overall Study|Lost to Follow-up|9
6899363|NCT00657709|10919168|FG002|Overall Study|Lost to Follow-up|7
6899364|NCT00657709|10919169|FG003|Overall Study|Lost to Follow-up|1
6899365|NCT00657709|10919170|FG004|Overall Study|Lost to Follow-up|21
6899366|NCT00657709|10919166|FG000|Overall Study|Protocol Violation|0
6899367|NCT00657709|10919167|FG001|Overall Study|Protocol Violation|2
6899368|NCT00657709|10919168|FG002|Overall Study|Protocol Violation|0
6899369|NCT00657709|10919169|FG003|Overall Study|Protocol Violation|1
6899370|NCT00657709|10919170|FG004|Overall Study|Protocol Violation|2
6899371|NCT00658021|10919199|FG000|28-Week Treatment Period|Adverse Event|3
6899372|NCT00658021|10919200|FG001|28-Week Treatment Period|Adverse Event|1
6899373|NCT00658021|10919201|FG002|28-Week Treatment Period|Adverse Event|0
6899374|NCT00658021|10919199|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0
6899375|NCT00658021|10919200|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2
6899376|NCT00658021|10919201|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0
6899377|NCT00658021|10919199|FG000|28-Week Treatment Period|Protocol Violation|0
6899378|NCT00658021|10919200|FG001|28-Week Treatment Period|Protocol Violation|2
6899379|NCT00658021|10919201|FG002|28-Week Treatment Period|Protocol Violation|1
6899380|NCT00658021|10919199|FG000|28-Week Treatment Period|Withdrawal by Subject|1
6899381|NCT00658021|10919200|FG001|28-Week Treatment Period|Withdrawal by Subject|1
6899382|NCT00658021|10919201|FG002|28-Week Treatment Period|Withdrawal by Subject|3
6899383|NCT00658021|10919199|FG000|28-Week Treatment Period|Physician Decision|1
6899384|NCT00658021|10919200|FG001|28-Week Treatment Period|Physician Decision|2
6819551|NCT00087607|10823860|FG001|Overall Study|Death|1
6819552|NCT00087607|10823859|FG000|Overall Study|Insufficient Therapeutic Response|53
6819553|NCT00087607|10823860|FG001|Overall Study|Insufficient Therapeutic Response|42
6819554|NCT00087607|10823859|FG000|Overall Study|Failure to return|21
6819555|NCT00087607|10823860|FG001|Overall Study|Failure to return|17
6819556|NCT00087607|10823859|FG000|Overall Study|Withdrew Consent|12
6819557|NCT00087607|10823860|FG001|Overall Study|Withdrew Consent|16
6819558|NCT00087607|10823859|FG000|Overall Study|Administrative|12
6819559|NCT00087607|10823860|FG001|Overall Study|Administrative|12
6819560|NCT00087607|10823859|FG000|Overall Study|Refused Treatment|5
6819561|NCT00087607|10823860|FG001|Overall Study|Refused Treatment|7
6819562|NCT00087607|10823859|FG000|Overall Study|Other Protocol Violation|5
6819563|NCT00087607|10823860|FG001|Overall Study|Other Protocol Violation|2
6819564|NCT00087607|10823859|FG000|Overall Study|Violation of Selection Criteria at Entry|0
6819565|NCT00087607|10823860|FG001|Overall Study|Violation of Selection Criteria at Entry|1
6819566|NCT00087646|10823883|FG000|Overall Study|Adverse Event|37
6819567|NCT00087646|10823884|FG001|Overall Study|Adverse Event|6
6819568|NCT00087646|10823885|FG002|Overall Study|Adverse Event|18
6819569|NCT00087646|10823886|FG003|Overall Study|Adverse Event|20
6819570|NCT00087646|10823883|FG000|Overall Study|Death|0
6819571|NCT00087646|10823884|FG001|Overall Study|Death|1
6819572|NCT00087646|10823885|FG002|Overall Study|Death|0
6819573|NCT00087646|10823886|FG003|Overall Study|Death|0
6819574|NCT00087646|10823883|FG000|Overall Study|Withdrawal by Subject|6
6819575|NCT00087646|10823884|FG001|Overall Study|Withdrawal by Subject|1
6819576|NCT00087646|10823885|FG002|Overall Study|Withdrawal by Subject|2
6819577|NCT00087646|10823886|FG003|Overall Study|Withdrawal by Subject|2
6819578|NCT00087646|10823883|FG000|Overall Study|Insufficient therapeutic response|64
6819579|NCT00087646|10823884|FG001|Overall Study|Insufficient therapeutic response|24
6819580|NCT00087646|10823885|FG002|Overall Study|Insufficient therapeutic response|38
6819581|NCT00087646|10823886|FG003|Overall Study|Insufficient therapeutic response|51
6819582|NCT00087646|10823883|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13
6819583|NCT00087646|10823884|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6
6819584|NCT00087646|10823885|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4
6819585|NCT00087646|10823886|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5
6819586|NCT00087646|10823883|FG000|Overall Study|Failure to Return|5
6819587|NCT00087646|10823884|FG001|Overall Study|Failure to Return|2
6819588|NCT00087646|10823885|FG002|Overall Study|Failure to Return|2
6819589|NCT00087646|10823886|FG003|Overall Study|Failure to Return|3
6819590|NCT00087646|10823883|FG000|Overall Study|Administrative/Other|6
6819591|NCT00087646|10823884|FG001|Overall Study|Administrative/Other|1
6899385|NCT00658021|10919201|FG002|28-Week Treatment Period|Physician Decision|1
6899386|NCT00658021|10919199|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1
6899387|NCT00658021|10919200|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1
6899388|NCT00658021|10919201|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1
6899389|NCT00658021|10919199|FG000|28-Week Treatment Period|Loss of glucose control|1
6899390|NCT00658021|10919200|FG001|28-Week Treatment Period|Loss of glucose control|1
6899391|NCT00658021|10919201|FG002|28-Week Treatment Period|Loss of glucose control|10
6899392|NCT00658021|10919199|FG000|28-Week Treatment Period|Other|2
6899393|NCT00658021|10919200|FG001|28-Week Treatment Period|Other|3
6899394|NCT00658021|10919201|FG002|28-Week Treatment Period|Other|1
6899395|NCT00658021|10919199|FG000|28-Week Treatment Period|Did not receive treatment|2
6899396|NCT00658021|10919200|FG001|28-Week Treatment Period|Did not receive treatment|0
6899397|NCT00658021|10919201|FG002|28-Week Treatment Period|Did not receive treatment|0
6899398|NCT00658021|10919199|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0
6899399|NCT00658021|10919200|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1
6899400|NCT00658021|10919201|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0
6899401|NCT00658021|10919199|FG000|Long-term Safety Follow-up Period|Physician Decision|0
6899402|NCT00658021|10919200|FG001|Long-term Safety Follow-up Period|Physician Decision|2
6899403|NCT00658021|10919201|FG002|Long-term Safety Follow-up Period|Physician Decision|0
6899404|NCT00658320|10919222|FG000|Core Study: 12 Months|Subject withdrew consent|5
6899405|NCT00658320|10919223|FG001|Core Study: 12 Months|Subject withdrew consent|3
6899406|NCT00658320|10919222|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3
6899407|NCT00658320|10919223|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0
6899408|NCT00658320|10919222|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3
6899409|NCT00658320|10919223|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7
6899410|NCT00658320|10919222|FG000|Extension Study: After Month 24|Subject withdrew consent|2
6899411|NCT00658320|10919223|FG001|Extension Study: After Month 24|Subject withdrew consent|0
6899412|NCT00658333|10919233|FG000|Overall Study|Adverse Event|2
6899413|NCT00658333|10919234|FG001|Overall Study|Adverse Event|1
6899414|NCT00658359|10919243|FG000|Overall Study|Death|3
6899415|NCT00658359|10919244|FG001|Overall Study|Death|1
6899416|NCT00658359|10919245|FG002|Overall Study|Death|2
6899417|NCT00658359|10919243|FG000|Overall Study|Adverse Event|13
6899418|NCT00658359|10919244|FG001|Overall Study|Adverse Event|6
6899419|NCT00658359|10919245|FG002|Overall Study|Adverse Event|9
6899420|NCT00658359|10919243|FG000|Overall Study|Protocol Violation|1
6899421|NCT00658359|10919244|FG001|Overall Study|Protocol Violation|0
6819592|NCT00087646|10823885|FG002|Overall Study|Administrative/Other|1
6819593|NCT00087646|10823886|FG003|Overall Study|Administrative/Other|2
6819594|NCT00087646|10823883|FG000|Overall Study|Other Protocol Violation|3
6819595|NCT00087646|10823884|FG001|Overall Study|Other Protocol Violation|1
6819596|NCT00087646|10823885|FG002|Overall Study|Other Protocol Violation|0
6819597|NCT00087646|10823886|FG003|Overall Study|Other Protocol Violation|0
6819598|NCT00087646|10823883|FG000|Overall Study|Violation of Selection Criteria at Entry|1
6819599|NCT00087646|10823884|FG001|Overall Study|Violation of Selection Criteria at Entry|0
6819600|NCT00087646|10823885|FG002|Overall Study|Violation of Selection Criteria at Entry|0
6819601|NCT00087646|10823886|FG003|Overall Study|Violation of Selection Criteria at Entry|1
6819602|NCT00087685|10823905|FG000|Overall Study|Adverse Event|5
6819603|NCT00087685|10823905|FG000|Overall Study|Non-Compliance|1
6819604|NCT00087685|10823905|FG000|Overall Study|Progressive Disease|5
6819605|NCT00087685|10823905|FG000|Overall Study|Withdrawal by Subject|3
6819606|NCT00087698|10823909|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14
6819607|NCT00087698|10823909|FG000|Overall Study|Death from Other Causes|3
6819608|NCT00087698|10823909|FG000|Overall Study|Adverse Event|4
6819609|NCT00087698|10823909|FG000|Overall Study|Withdrawal by Subject|4
6819610|NCT00087698|10823909|FG000|Overall Study|Lack of Efficacy, Physician Perception|3
6819611|NCT00087698|10823909|FG000|Overall Study|Protocol Entry Criteria Not Met|2
6819612|NCT00087698|10823909|FG000|Overall Study|Clinical Relapse|1
6819613|NCT00087698|10823909|FG000|Overall Study|Death from Study Disease|2
6819614|NCT00087698|10823909|FG000|Overall Study|Death from Study Drug Toxicity|2
6819615|NCT00087698|10823909|FG000|Overall Study|Protocol Violation|1
6819616|NCT00088153|10823915|FG000|Overall Study|Physician Decision|3
6819617|NCT00088153|10823916|FG001|Overall Study|Physician Decision|3
6819618|NCT00088153|10823915|FG000|Overall Study|Withdrawal by Subject|10
6819619|NCT00088153|10823916|FG001|Overall Study|Withdrawal by Subject|10
6819620|NCT00088153|10823915|FG000|Overall Study|Lost to Follow-up|11
6819621|NCT00088153|10823916|FG001|Overall Study|Lost to Follow-up|12
6819622|NCT00088166|10823924|FG000|Overall Study|Adverse Event|11
6819623|NCT00088166|10823925|FG001|Overall Study|Adverse Event|9
6819624|NCT00088166|10823924|FG000|Overall Study|Death|3
6819625|NCT00088166|10823925|FG001|Overall Study|Death|1
6819626|NCT00088166|10823924|FG000|Overall Study|Lost to Follow-up|0
6819627|NCT00088166|10823925|FG001|Overall Study|Lost to Follow-up|1
6819628|NCT00088166|10823924|FG000|Overall Study|Physician Decision|4
6819629|NCT00088166|10823925|FG001|Overall Study|Physician Decision|1
6819630|NCT00088166|10823924|FG000|Overall Study|Protocol Violation|1
6819631|NCT00088166|10823925|FG001|Overall Study|Protocol Violation|5
6819632|NCT00088166|10823924|FG000|Overall Study|Patient deterioration|29
6819633|NCT00088166|10823925|FG001|Overall Study|Patient deterioration|39
6819634|NCT00088166|10823924|FG000|Overall Study|Withdrawal by Subject|5
6819635|NCT00088166|10823925|FG001|Overall Study|Withdrawal by Subject|5
6819636|NCT00088205|10823931|FG000|Overall Study|Adverse Event|4
6819637|NCT00088205|10823931|FG000|Overall Study|Progressive Disease|51
6819638|NCT00088205|10823931|FG000|Overall Study|Physician Decision|1
6819639|NCT00088205|10823931|FG000|Overall Study|Death Due to Study Disease|4
6819640|NCT00088374|10823944|FG000|Overall Study|patient did not receive any 17AAG|1
6819641|NCT00088374|10823944|FG000|Overall Study|patient received <1 cycle only of 17AAG|1
6819642|NCT00088413|10823952|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
6819643|NCT00088413|10823953|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
6819644|NCT00088413|10823954|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1
6819645|NCT00088413|10823955|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
6819646|NCT00088413|10823952|FG000|Overall Study|Adverse Events/Side Effects|0
6819647|NCT00088413|10823953|FG001|Overall Study|Adverse Events/Side Effects|1
6819648|NCT00088413|10823954|FG002|Overall Study|Adverse Events/Side Effects|1
6819649|NCT00088413|10823955|FG003|Overall Study|Adverse Events/Side Effects|0
6819650|NCT00088413|10823952|FG000|Overall Study|Refused trmt Off-study per pt wishes|0
6819651|NCT00088413|10823953|FG001|Overall Study|Refused trmt Off-study per pt wishes|1
6819652|NCT00088413|10823954|FG002|Overall Study|Refused trmt Off-study per pt wishes|1
6819653|NCT00088413|10823955|FG003|Overall Study|Refused trmt Off-study per pt wishes|0
6819654|NCT00088413|10823952|FG000|Overall Study|Off study due to missing a vaccine dose|1
6819655|NCT00088413|10823953|FG001|Overall Study|Off study due to missing a vaccine dose|0
6819656|NCT00088413|10823954|FG002|Overall Study|Off study due to missing a vaccine dose|0
6819657|NCT00088413|10823955|FG003|Overall Study|Off study due to missing a vaccine dose|0
6819658|NCT00088413|10823952|FG000|Overall Study|Death|0
6819659|NCT00088413|10823953|FG001|Overall Study|Death|1
6819660|NCT00088413|10823954|FG002|Overall Study|Death|0
6819661|NCT00088413|10823955|FG003|Overall Study|Death|0
6819662|NCT00088413|10823952|FG000|Overall Study|Progressive disease|9
6819663|NCT00088413|10823953|FG001|Overall Study|Progressive disease|11
6819664|NCT00088413|10823954|FG002|Overall Study|Progressive disease|8
6819665|NCT00088413|10823955|FG003|Overall Study|Progressive disease|14
6819666|NCT00088413|10823952|FG000|Overall Study|Other|0
6819667|NCT00088413|10823953|FG001|Overall Study|Other|1
6819668|NCT00088413|10823954|FG002|Overall Study|Other|0
6819669|NCT00088413|10823955|FG003|Overall Study|Other|0
6819670|NCT00088413|10823952|FG000|Overall Study|Patient unevaluable due to adverse event|0
6819671|NCT00088413|10823953|FG001|Overall Study|Patient unevaluable due to adverse event|0
6819672|NCT00088413|10823954|FG002|Overall Study|Patient unevaluable due to adverse event|1
6819673|NCT00088413|10823955|FG003|Overall Study|Patient unevaluable due to adverse event|0
6819674|NCT00088452|10823970|FG000|Overall Study|Did not receive intervention|1
6819675|NCT00088452|10823971|FG001|Overall Study|Did not receive intervention|0
6819676|NCT00088452|10823972|FG002|Overall Study|Did not receive intervention|1
6819677|NCT00088465|10823980|FG000|Overall Study|Withdrawal by Subject|290
6819678|NCT00088465|10823980|FG000|Overall Study|Adverse Event|77
6819679|NCT00088465|10823980|FG000|Overall Study|Lost to Follow-up|57
6819680|NCT00088465|10823980|FG000|Overall Study|Physician Decision|45
6819681|NCT00088465|10823980|FG000|Overall Study|Sponsor Decision|37
6819682|NCT00088465|10823980|FG000|Overall Study|Lack of Efficacy|27
6819683|NCT00088465|10823980|FG000|Overall Study|Protocol Violation|17
6819684|NCT00088465|10823980|FG000|Overall Study|Death|11
6819685|NCT00088530|10823986|FG000|Overall Study|Progressive/Relapsed Disease|28
6819686|NCT00088530|10823987|FG001|Overall Study|Progressive/Relapsed Disease|39
6819687|NCT00088530|10823986|FG000|Overall Study|Adverse Event|15
6819688|NCT00088530|10823987|FG001|Overall Study|Adverse Event|9
6819689|NCT00088530|10823986|FG000|Overall Study|Withdrawal by Subject|2
6819690|NCT00088530|10823987|FG001|Overall Study|Withdrawal by Subject|5
6819691|NCT00088530|10823986|FG000|Overall Study|Lost to Follow-up|2
6819692|NCT00088530|10823987|FG001|Overall Study|Lost to Follow-up|0
6819693|NCT00088530|10823986|FG000|Overall Study|Physician Decision|2
6819694|NCT00088530|10823987|FG001|Overall Study|Physician Decision|0
6819695|NCT00088530|10823986|FG000|Overall Study|Sponsor decision|0
6819696|NCT00088530|10823987|FG001|Overall Study|Sponsor decision|1
6819697|NCT00088530|10823986|FG000|Overall Study|Patient never treated|1
6819698|NCT00088530|10823987|FG001|Overall Study|Patient never treated|0
6819699|NCT00088595|10823993|FG000|Overall Study|Adverse Event|11
6819700|NCT00088595|10823993|FG000|Overall Study|Withdrawal by Subject|8
6819701|NCT00088595|10823993|FG000|Overall Study|Ongoing (After Core)|7
6819702|NCT00088595|10823993|FG000|Overall Study|New Cancer Therapy|2
6819703|NCT00088881|10824035|FG000|Step 1 - R-CHOP|Patient ineligible|9
6819704|NCT00088881|10824035|FG000|Step 1 - R-CHOP|Adverse Event|1
6819705|NCT00088881|10824035|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2
6819706|NCT00088881|10824035|FG000|Step 1 - R-CHOP|Physician Decision|1
6819707|NCT00088881|10824035|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1
6819708|NCT00088881|10824035|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8
6819709|NCT00088881|10824035|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3
6819710|NCT00088907|10824043|FG000|Randomized Study (Step 1)|Lack of Efficacy|55
6819711|NCT00088907|10824044|FG001|Randomized Study (Step 1)|Lack of Efficacy|62
6819712|NCT00088907|10824043|FG000|Randomized Study (Step 1)|Adverse Event|14
6819713|NCT00088907|10824044|FG001|Randomized Study (Step 1)|Adverse Event|19
6819714|NCT00088907|10824043|FG000|Randomized Study (Step 1)|Death|11
6819715|NCT00088907|10824044|FG001|Randomized Study (Step 1)|Death|12
6819716|NCT00088907|10824043|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10
6819717|NCT00088907|10824044|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15
6819718|NCT00088907|10824043|FG000|Randomized Study (Step 1)|complicating disease|3
6819719|NCT00088907|10824044|FG001|Randomized Study (Step 1)|complicating disease|1
6819720|NCT00088907|10824043|FG000|Randomized Study (Step 1)|unknown/not specify|24
6819721|NCT00088907|10824044|FG001|Randomized Study (Step 1)|unknown/not specify|13
6819722|NCT00088907|10824043|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19
6819723|NCT00088907|10824044|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12
6819724|NCT00088907|10824043|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16
6819725|NCT00088907|10824044|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0
6819726|NCT00088907|10824043|FG000|Single Gefitinib Treatment (Step 2)|Death|1
6819727|NCT00088907|10824044|FG001|Single Gefitinib Treatment (Step 2)|Death|0
6819728|NCT00088907|10824043|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2
6819729|NCT00088907|10824044|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0
6819730|NCT00088907|10824043|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5
6819731|NCT00088907|10824044|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0
6819732|NCT00089076|10824068|FG000|Overall Study|Alternate Therapy|1
6819733|NCT00089076|10824068|FG000|Overall Study|Withdrawal by Subject|2
6819734|NCT00089076|10824068|FG000|Overall Study|Progression|7
6819735|NCT00089284|10824081|FG000|Overall Study|Adverse event before starting treatment|0
6819736|NCT00089284|10824082|FG001|Overall Study|Adverse event before starting treatment|0
6819737|NCT00089284|10824083|FG002|Overall Study|Adverse event before starting treatment|0
6819738|NCT00089284|10824084|FG003|Overall Study|Adverse event before starting treatment|0
6819739|NCT00089284|10824085|FG004|Overall Study|Adverse event before starting treatment|0
6819740|NCT00089284|10824086|FG005|Overall Study|Adverse event before starting treatment|0
6819741|NCT00089284|10824087|FG006|Overall Study|Adverse event before starting treatment|1
6819742|NCT00089297|10824109|FG000|Overall Study|Adverse Event|9
6819743|NCT00089297|10824109|FG000|Overall Study|Death|1
6819744|NCT00089297|10824109|FG000|Overall Study|Withdrawal by Subject|12
6819745|NCT00089297|10824109|FG000|Overall Study|Disease progression|2
6819746|NCT00089297|10824109|FG000|Overall Study|Ineligible|11
6819747|NCT00089297|10824109|FG000|Overall Study|Secondary malignancy|1
6819748|NCT00089297|10824109|FG000|Overall Study|IRB approval not ready|1
6819749|NCT00089297|10824109|FG000|Overall Study|Non-compliance|1
6819750|NCT00089479|10824115|FG000|Overall Study|Death|108
6819751|NCT00089479|10824116|FG001|Overall Study|Death|75
6819752|NCT00089479|10824115|FG000|Overall Study|Withdrawal by Subject|86
6819753|NCT00089479|10824116|FG001|Overall Study|Withdrawal by Subject|107
6819754|NCT00089479|10824115|FG000|Overall Study|Lost to Follow-up|137
6819755|NCT00089479|10824116|FG001|Overall Study|Lost to Follow-up|107
6819756|NCT00089505|10824126|FG000|Overall Study|Death|4
6819757|NCT00089505|10824127|FG001|Overall Study|Death|1
6819758|NCT00089505|10824128|FG002|Overall Study|Death|5
6819759|NCT00089505|10824129|FG003|Overall Study|Death|8
6819760|NCT00089505|10824126|FG000|Overall Study|Withdrawal by Subject|3
6819761|NCT00089505|10824127|FG001|Overall Study|Withdrawal by Subject|0
6819762|NCT00089505|10824128|FG002|Overall Study|Withdrawal by Subject|6
6819763|NCT00089505|10824129|FG003|Overall Study|Withdrawal by Subject|6
6819764|NCT00089505|10824126|FG000|Overall Study|Lost to Follow-up|1
6819765|NCT00089505|10824127|FG001|Overall Study|Lost to Follow-up|1
6819766|NCT00089505|10824128|FG002|Overall Study|Lost to Follow-up|9
6819767|NCT00089505|10824129|FG003|Overall Study|Lost to Follow-up|7
6819768|NCT00089505|10824126|FG000|Overall Study|Physician Decision|1
6819769|NCT00089505|10824127|FG001|Overall Study|Physician Decision|0
6819770|NCT00089505|10824128|FG002|Overall Study|Physician Decision|0
6819771|NCT00089505|10824129|FG003|Overall Study|Physician Decision|0
6819772|NCT00089505|10824126|FG000|Overall Study|Protocol Violation|0
6819773|NCT00089505|10824127|FG001|Overall Study|Protocol Violation|0
6819774|NCT00089505|10824128|FG002|Overall Study|Protocol Violation|1
6819775|NCT00089505|10824129|FG003|Overall Study|Protocol Violation|0
6819776|NCT00089544|10824141|FG000|Overall Study|Ineligible|1
6819777|NCT00089544|10824142|FG001|Overall Study|Ineligible|0
6819778|NCT00089583|10824150|FG000|Overall Study|Adverse Event|0
6819779|NCT00089583|10824151|FG001|Overall Study|Adverse Event|3
6819780|NCT00089583|10824150|FG000|Overall Study|Insufficient Viral Load Response|5
6819781|NCT00089583|10824151|FG001|Overall Study|Insufficient Viral Load Response|5
6819782|NCT00089583|10824150|FG000|Overall Study|Withdrawal by Subject|0
6819783|NCT00089583|10824151|FG001|Overall Study|Withdrawal by Subject|4
6819784|NCT00089583|10824150|FG000|Overall Study|Participant (Par) Didn't Take Medication|1
6819785|NCT00089583|10824151|FG001|Overall Study|Participant (Par) Didn't Take Medication|0
6819786|NCT00089583|10824150|FG000|Overall Study|Participant Refused Study Medication|0
6819787|NCT00089583|10824151|FG001|Overall Study|Participant Refused Study Medication|2
6819788|NCT00089583|10824150|FG000|Overall Study|Non-Compliance|0
6819789|NCT00089583|10824151|FG001|Overall Study|Non-Compliance|4
6819790|NCT00089583|10824150|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0
6819791|NCT00089583|10824151|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3
6819792|NCT00089583|10824150|FG000|Overall Study|Participant Management Criteria Met|0
6819793|NCT00089583|10824151|FG001|Overall Study|Participant Management Criteria Met|1
6819794|NCT00089583|10824150|FG000|Overall Study|Reason Not Provided|0
6819795|NCT00089583|10824151|FG001|Overall Study|Reason Not Provided|1
6819796|NCT00089583|10824150|FG000|Overall Study|Protocol Violation|0
6819797|NCT00089583|10824151|FG001|Overall Study|Protocol Violation|3
6819798|NCT00089583|10824150|FG000|Overall Study|Principal Investigator Decision|0
6819799|NCT00089583|10824151|FG001|Overall Study|Principal Investigator Decision|10
6819800|NCT00089583|10824150|FG000|Overall Study|Start of Disallowed Medication|0
6819801|NCT00089583|10824151|FG001|Overall Study|Start of Disallowed Medication|1
6819802|NCT00089583|10824150|FG000|Overall Study|Necessity to Use Prohibited Drug|1
6819803|NCT00089583|10824151|FG001|Overall Study|Necessity to Use Prohibited Drug|0
6819804|NCT00089583|10824150|FG000|Overall Study|Participant Incarcerated|0
6819805|NCT00089583|10824151|FG001|Overall Study|Participant Incarcerated|1
6819806|NCT00089609|10824165|FG000|Overall Study|Withdrawal by Subject|3
6819807|NCT00089609|10824166|FG001|Overall Study|Withdrawal by Subject|1
6819808|NCT00089635|10824175|FG000|Overall Study|Adverse Event|2
6819809|NCT00089635|10824175|FG000|Overall Study|Death|17
6819810|NCT00089635|10824175|FG000|Overall Study|Disease Progression|12
6819811|NCT00089635|10824175|FG000|Overall Study|Lost to Follow-up|3
6819812|NCT00089635|10824175|FG000|Overall Study|Withdrawal by Subject|6
6819813|NCT00089635|10824175|FG000|Overall Study|Ineligibility determined|1
6819814|NCT00089635|10824175|FG000|Overall Study|Other|2
6819815|NCT00089648|10824179|FG000|Overall Study|Adverse Event|7
6819816|NCT00089648|10824179|FG000|Overall Study|Withdrawal by Subject|1
6819817|NCT00089648|10824179|FG000|Overall Study|Lack of Efficacy|33
6819818|NCT00089661|10824185|FG000|Overall Study|Adverse Event|0
6819819|NCT00089661|10824186|FG001|Overall Study|Adverse Event|2
6819820|NCT00089661|10824185|FG000|Overall Study|Death|1
6819821|NCT00089661|10824186|FG001|Overall Study|Death|0
6819822|NCT00089661|10824185|FG000|Overall Study|Lost to Follow-up|0
6819823|NCT00089661|10824186|FG001|Overall Study|Lost to Follow-up|3
6819824|NCT00089661|10824185|FG000|Overall Study|Withdrawal by Subject|11
6819825|NCT00089661|10824186|FG001|Overall Study|Withdrawal by Subject|9
6819826|NCT00089661|10824185|FG000|Overall Study|Disease progression|1
6819827|NCT00089661|10824186|FG001|Overall Study|Disease progression|3
6819828|NCT00089661|10824185|FG000|Overall Study|Ineligibility determined|4
6819829|NCT00089661|10824186|FG001|Overall Study|Ineligibility determined|4
6819830|NCT00089661|10824185|FG000|Overall Study|Noncompliance|2
6819831|NCT00089661|10824186|FG001|Overall Study|Noncompliance|4
6819832|NCT00089661|10824185|FG000|Overall Study|Other|2
6819833|NCT00089661|10824186|FG001|Overall Study|Other|1
6819834|NCT00089674|10824194|FG000|Overall Study|Physician Decision|4
6819835|NCT00089674|10824195|FG001|Overall Study|Physician Decision|2
6819836|NCT00089674|10824194|FG000|Overall Study|Adverse Event|23
6819837|NCT00089674|10824195|FG001|Overall Study|Adverse Event|29
6819838|NCT00089674|10824194|FG000|Overall Study|Withdrawal by Subject|143
6819839|NCT00089674|10824195|FG001|Overall Study|Withdrawal by Subject|127
6819840|NCT00089674|10824194|FG000|Overall Study|Death|43
6819841|NCT00089674|10824195|FG001|Overall Study|Death|43
6819842|NCT00089674|10824194|FG000|Overall Study|Disease progression|21
6819843|NCT00089674|10824195|FG001|Overall Study|Disease progression|23
6819844|NCT00089674|10824194|FG000|Overall Study|Ineligibility determined|8
6819845|NCT00089674|10824195|FG001|Overall Study|Ineligibility determined|10
6819846|NCT00089674|10824194|FG000|Overall Study|Lost to Follow-up|21
6819847|NCT00089674|10824195|FG001|Overall Study|Lost to Follow-up|17
6819848|NCT00089674|10824194|FG000|Overall Study|Noncompliance|7
6819849|NCT00089674|10824195|FG001|Overall Study|Noncompliance|3
6819850|NCT00089674|10824194|FG000|Overall Study|Other|5
6819851|NCT00089674|10824195|FG001|Overall Study|Other|9
6819852|NCT00089674|10824194|FG000|Overall Study|Requirement for alternative therapy|14
6819853|NCT00089674|10824195|FG001|Overall Study|Requirement for alternative therapy|4
6819854|NCT00089778|10824215|FG000|Overall Study|Protocol Violation|0
6819855|NCT00089778|10824216|FG001|Overall Study|Protocol Violation|0
6819856|NCT00089778|10824217|FG002|Overall Study|Protocol Violation|1
6819857|NCT00089843|10824231|FG000|Overall Study|Withdrawal by Subject|1
6819858|NCT00089843|10824232|FG001|Overall Study|Withdrawal by Subject|4
6819859|NCT00089843|10824233|FG002|Overall Study|Withdrawal by Subject|5
6819860|NCT00089843|10824234|FG003|Overall Study|Withdrawal by Subject|6
6819861|NCT00089843|10824231|FG000|Overall Study|Physician Decision|1
6819862|NCT00089843|10824232|FG001|Overall Study|Physician Decision|0
6819863|NCT00089843|10824233|FG002|Overall Study|Physician Decision|0
6819864|NCT00089843|10824234|FG003|Overall Study|Physician Decision|1
6819865|NCT00089973|10824244|FG000|Overall Study|Adverse Event|3
6819866|NCT00089973|10824244|FG000|Overall Study|Withdrawal by Subject|1
6819867|NCT00089973|10824244|FG000|Overall Study|Disease progression|45
6819868|NCT00089973|10824244|FG000|Overall Study|Death|1
6819869|NCT00089986|10824251|FG000|Overall Study|Adverse Event|6
6819870|NCT00089986|10824252|FG001|Overall Study|Adverse Event|9
6819871|NCT00089986|10824253|FG002|Overall Study|Adverse Event|6
6819872|NCT00089986|10824251|FG000|Overall Study|Lost to Follow-up|3
6819873|NCT00089986|10824252|FG001|Overall Study|Lost to Follow-up|1
6819874|NCT00089986|10824253|FG002|Overall Study|Lost to Follow-up|1
6819875|NCT00089986|10824251|FG000|Overall Study|Protocol Violation|0
6819876|NCT00089986|10824252|FG001|Overall Study|Protocol Violation|1
6819877|NCT00089986|10824253|FG002|Overall Study|Protocol Violation|0
6819878|NCT00089986|10824251|FG000|Overall Study|Patient transferred to another hospital|2
6819879|NCT00089986|10824252|FG001|Overall Study|Patient transferred to another hospital|1
6819880|NCT00089986|10824253|FG002|Overall Study|Patient transferred to another hospital|0
6819881|NCT00089986|10824251|FG000|Overall Study|Subject withdrew but agreed follow up|1
6819882|NCT00089986|10824252|FG001|Overall Study|Subject withdrew but agreed follow up|2
6819883|NCT00089986|10824253|FG002|Overall Study|Subject withdrew but agreed follow up|0
6819884|NCT00089986|10824251|FG000|Overall Study|Hemohlobin stopping rule|0
6819885|NCT00089986|10824252|FG001|Overall Study|Hemohlobin stopping rule|1
6819886|NCT00089986|10824253|FG002|Overall Study|Hemohlobin stopping rule|0
6819887|NCT00089986|10824251|FG000|Overall Study|Investigator decision to withdrew|0
6819888|NCT00089986|10824252|FG001|Overall Study|Investigator decision to withdrew|1
6819889|NCT00089986|10824253|FG002|Overall Study|Investigator decision to withdrew|0
6819890|NCT00089986|10824251|FG000|Overall Study|Enrollment in another study|0
6819891|NCT00089986|10824252|FG001|Overall Study|Enrollment in another study|1
6819892|NCT00089986|10824253|FG002|Overall Study|Enrollment in another study|0
6819893|NCT00089986|10824251|FG000|Overall Study|Family decision|0
6819894|NCT00089986|10824252|FG001|Overall Study|Family decision|1
6819895|NCT00089986|10824253|FG002|Overall Study|Family decision|0
6819896|NCT00089986|10824251|FG000|Overall Study|Do not resuscitate (DNR)|0
6819897|NCT00089986|10824252|FG001|Overall Study|Do not resuscitate (DNR)|0
6819898|NCT00089986|10824253|FG002|Overall Study|Do not resuscitate (DNR)|1
6819899|NCT00089986|10824251|FG000|Overall Study|Withdrawal by Subject|3
6819900|NCT00089986|10824252|FG001|Overall Study|Withdrawal by Subject|6
6819901|NCT00089986|10824253|FG002|Overall Study|Withdrawal by Subject|2
6819902|NCT00089999|10824263|FG000|Overall Study|Adverse Event|4
6819903|NCT00089999|10824264|FG001|Overall Study|Adverse Event|7
6819904|NCT00089999|10824263|FG000|Overall Study|Withdrawal by Subject|0
6819905|NCT00089999|10824264|FG001|Overall Study|Withdrawal by Subject|4
6819906|NCT00089999|10824263|FG000|Overall Study|Lost to Follow-up|2
6819907|NCT00089999|10824264|FG001|Overall Study|Lost to Follow-up|1
6819908|NCT00089999|10824263|FG000|Overall Study|Radiological Progression of Cancer|52
6819909|NCT00089999|10824264|FG001|Overall Study|Radiological Progression of Cancer|44
6819910|NCT00089999|10824263|FG000|Overall Study|Symptomatic Progression of Cancer|2
6899422|NCT00658359|10919245|FG002|Overall Study|Protocol Violation|0
6973537|NCT01181986|11025425|FG000|Phase 1|Lost to Follow-up|0
6819911|NCT00089999|10824264|FG001|Overall Study|Symptomatic Progression of Cancer|5
6819912|NCT00089999|10824263|FG000|Overall Study|Death|3
6819913|NCT00089999|10824264|FG001|Overall Study|Death|3
6819914|NCT00089999|10824263|FG000|Overall Study|Poor General Condition|1
6819915|NCT00089999|10824264|FG001|Overall Study|Poor General Condition|0
6819916|NCT00089999|10824263|FG000|Overall Study|Clinical Progression|1
6819917|NCT00089999|10824264|FG001|Overall Study|Clinical Progression|2
6819918|NCT00089999|10824263|FG000|Overall Study|Physician Decision|2
6819919|NCT00089999|10824264|FG001|Overall Study|Physician Decision|2
6819920|NCT00089999|10824263|FG000|Overall Study|Patient Underwent Surgery|2
6819921|NCT00089999|10824264|FG001|Overall Study|Patient Underwent Surgery|0
6819922|NCT00089999|10824263|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0
6819923|NCT00089999|10824264|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1
6896608|NCT00634114|10915135|FG002|Overall Study|Withdrawal by Subject|11
6819924|NCT00090103|10824295|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211
6819925|NCT00090103|10824296|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185
6819926|NCT00090103|10824297|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210
6819927|NCT00090103|10824295|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114
6819928|NCT00090103|10824296|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160
6819929|NCT00090103|10824297|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148
6819930|NCT00090103|10824295|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53
6819931|NCT00090103|10824296|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48
6819932|NCT00090103|10824297|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58
6819933|NCT00090103|10824295|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29
6819934|NCT00090103|10824296|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29
6819935|NCT00090103|10824297|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34
6819936|NCT00090103|10824295|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53
6819937|NCT00090103|10824296|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71
6819938|NCT00090103|10824297|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104
6819939|NCT00090103|10824295|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7
6819940|NCT00090103|10824296|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2
6819941|NCT00090103|10824297|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8
6819942|NCT00090103|10824295|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
6819943|NCT00090103|10824296|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
6819944|NCT00090103|10824297|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4
6819945|NCT00090103|10824295|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6
6819946|NCT00090103|10824296|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4
6819947|NCT00090103|10824297|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7
6819948|NCT00090103|10824295|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3
6819949|NCT00090103|10824296|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7
6819950|NCT00090103|10824297|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19
6819951|NCT00090103|10824295|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2
6819952|NCT00090103|10824296|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0
6819953|NCT00090103|10824297|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4
6819954|NCT00090103|10824295|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2
6819955|NCT00090103|10824296|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3
6819956|NCT00090103|10824297|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6
6819957|NCT00090103|10824295|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
6819958|NCT00090103|10824296|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
6819959|NCT00090103|10824297|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8
6819960|NCT00090103|10824295|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2
6819961|NCT00090103|10824296|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0
6819962|NCT00090103|10824297|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0
6819963|NCT00090103|10824295|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1
6819964|NCT00090103|10824296|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
6819965|NCT00090103|10824297|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
6819966|NCT00090103|10824295|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1
6819967|NCT00090103|10824296|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0
6819968|NCT00090103|10824297|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0
6819969|NCT00090103|10824295|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1
6819970|NCT00090103|10824296|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0
6819971|NCT00090103|10824297|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0
6819972|NCT00090103|10824295|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1
6819973|NCT00090103|10824296|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0
6819974|NCT00090103|10824297|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5
6819975|NCT00090103|10824295|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1
6819976|NCT00090103|10824296|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0
6819977|NCT00090103|10824297|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0
6819978|NCT00090103|10824295|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1
6819979|NCT00090103|10824296|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0
6819980|NCT00090103|10824297|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0
6819981|NCT00090103|10824295|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
6819982|NCT00090103|10824296|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2
6819983|NCT00090103|10824297|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
6819984|NCT00090103|10824295|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0
6819985|NCT00090103|10824296|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1
6819986|NCT00090103|10824297|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0
6819987|NCT00090103|10824295|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0
6819988|NCT00090103|10824296|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
6819989|NCT00090103|10824297|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
6819990|NCT00090103|10824295|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
6819991|NCT00090103|10824296|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2
6819992|NCT00090103|10824297|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
6819993|NCT00090103|10824295|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
6819994|NCT00090103|10824296|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1
6819995|NCT00090103|10824297|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
6819996|NCT00090103|10824295|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0
6819997|NCT00090103|10824296|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1
6819998|NCT00090103|10824297|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0
6819999|NCT00090103|10824295|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
6820000|NCT00090103|10824296|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1
6820001|NCT00090103|10824297|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
6820002|NCT00090103|10824295|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
6820003|NCT00090103|10824296|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1
6820004|NCT00090103|10824297|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
6820005|NCT00090103|10824295|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0
6820006|NCT00090103|10824296|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1
6820007|NCT00090103|10824297|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3
6820008|NCT00090103|10824295|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0
6820009|NCT00090103|10824296|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0
6820010|NCT00090103|10824297|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2
6820011|NCT00090103|10824295|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
6820012|NCT00090103|10824296|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
6820013|NCT00090103|10824297|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1
6820014|NCT00090103|10824295|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
6820015|NCT00090103|10824296|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1
6820016|NCT00090103|10824297|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
6820017|NCT00090103|10824295|FG000|16-Week Safety Follow-up Period|Adverse Event|34
6820018|NCT00090103|10824296|FG001|16-Week Safety Follow-up Period|Adverse Event|39
6820019|NCT00090103|10824297|FG002|16-Week Safety Follow-up Period|Adverse Event|44
6820020|NCT00090103|10824295|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185
6820021|NCT00090103|10824296|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212
6820022|NCT00090103|10824297|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229
6820023|NCT00090103|10824295|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101
6820024|NCT00090103|10824296|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97
6820025|NCT00090103|10824297|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111
6820026|NCT00090103|10824295|FG000|16-Week Safety Follow-up Period|Protocol Violation|18
6820027|NCT00090103|10824296|FG001|16-Week Safety Follow-up Period|Protocol Violation|18
6820028|NCT00090103|10824297|FG002|16-Week Safety Follow-up Period|Protocol Violation|17
6820029|NCT00090103|10824295|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8
6820030|NCT00090103|10824296|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5
6820031|NCT00090103|10824297|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4
6820032|NCT00090103|10824295|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8
6820033|NCT00090103|10824296|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6
6820034|NCT00090103|10824297|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4
6899423|NCT00658359|10919243|FG000|Overall Study|Includes protocol Amendments 3 and 4|2
6899424|NCT00658359|10919244|FG001|Overall Study|Includes protocol Amendments 3 and 4|31
6899425|NCT00658359|10919245|FG002|Overall Study|Includes protocol Amendments 3 and 4|29
6899426|NCT00658359|10919243|FG000|Overall Study|Withdrawal by Subject|7
6899427|NCT00658359|10919244|FG001|Overall Study|Withdrawal by Subject|4
6899428|NCT00658359|10919245|FG002|Overall Study|Withdrawal by Subject|2
6899429|NCT00658359|10919243|FG000|Overall Study|Lost to Follow-up|2
6899430|NCT00658359|10919244|FG001|Overall Study|Lost to Follow-up|2
6899431|NCT00658359|10919245|FG002|Overall Study|Lost to Follow-up|4
6899432|NCT00658359|10919243|FG000|Overall Study|Lack of Efficacy|0
6899433|NCT00658359|10919244|FG001|Overall Study|Lack of Efficacy|1
6899434|NCT00658359|10919245|FG002|Overall Study|Lack of Efficacy|0
6899435|NCT00658528|10919278|FG000|Overall Study|Adverse Event|5
6899436|NCT00658528|10919279|FG001|Overall Study|Adverse Event|7
6899437|NCT00658528|10919278|FG000|Overall Study|Lost to Follow-up|14
6899438|NCT00658528|10919279|FG001|Overall Study|Lost to Follow-up|22
6899439|NCT00658528|10919278|FG000|Overall Study|Withdrawal by Subject|8
6899440|NCT00658528|10919279|FG001|Overall Study|Withdrawal by Subject|6
6899441|NCT00658528|10919278|FG000|Overall Study|Withdrawal of consent|5
6899442|NCT00658528|10919279|FG001|Overall Study|Withdrawal of consent|6
6899443|NCT00658528|10919278|FG000|Overall Study|Other|8
6899444|NCT00658528|10919279|FG001|Overall Study|Other|4
6899445|NCT00658541|10919285|FG000|Washout Period of 7 Days|Withdrawal by Subject|1
6899446|NCT00658541|10919286|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
6899447|NCT00658541|10919285|FG000|Washout Period of 7 Days|Withdrawal by Subject|0
6820035|NCT00090103|10824295|FG000|16-Week Safety Follow-up Period|Loss of Contact|4
6820036|NCT00090103|10824296|FG001|16-Week Safety Follow-up Period|Loss of Contact|0
6899448|NCT00658541|10919286|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
6899449|NCT00658567|10919295|FG000|Overall Study|Adverse Event|5
6899450|NCT00658567|10919296|FG001|Overall Study|Adverse Event|2
6899451|NCT00658567|10919297|FG002|Overall Study|Adverse Event|3
6899452|NCT00658567|10919295|FG000|Overall Study|Voluntary Withdrawal of Consent|2
6899453|NCT00658567|10919296|FG001|Overall Study|Voluntary Withdrawal of Consent|0
6899454|NCT00658567|10919297|FG002|Overall Study|Voluntary Withdrawal of Consent|2
6899455|NCT00658567|10919295|FG000|Overall Study|Physician Decision|0
6899456|NCT00658567|10919296|FG001|Overall Study|Physician Decision|1
6899457|NCT00658567|10919297|FG002|Overall Study|Physician Decision|0
6899458|NCT00658567|10919295|FG000|Overall Study|At Discretion of Sponsor|1
6899459|NCT00658567|10919296|FG001|Overall Study|At Discretion of Sponsor|1
6899460|NCT00658567|10919297|FG002|Overall Study|At Discretion of Sponsor|1
6899461|NCT00658606|10919307|FG000|Overall Study|Adverse Event|2
6899462|NCT00658606|10919308|FG001|Overall Study|Adverse Event|1
6899463|NCT00658606|10919307|FG000|Overall Study|Lack of Efficacy|6
6899464|NCT00658606|10919308|FG001|Overall Study|Lack of Efficacy|3
6899465|NCT00658606|10919307|FG000|Overall Study|Lost to Follow-up|1
6899466|NCT00658606|10919308|FG001|Overall Study|Lost to Follow-up|0
6899467|NCT00658606|10919307|FG000|Overall Study|Withdrawal by Subject|7
6899468|NCT00658606|10919308|FG001|Overall Study|Withdrawal by Subject|16
6899469|NCT00658606|10919307|FG000|Overall Study|Lack of Compliance|0
6899470|NCT00658606|10919308|FG001|Overall Study|Lack of Compliance|3
6899471|NCT00658632|10919334|FG000|Overall Study|Adverse Event|13
6899472|NCT00658632|10919335|FG001|Overall Study|Adverse Event|11
6899473|NCT00658632|10919334|FG000|Overall Study|Lost to Follow-up|25
6899474|NCT00658632|10919335|FG001|Overall Study|Lost to Follow-up|23
6899475|NCT00658632|10919334|FG000|Overall Study|Withdrawal by Subject|10
6899476|NCT00658632|10919335|FG001|Overall Study|Withdrawal by Subject|7
6899477|NCT00658632|10919334|FG000|Overall Study|Lack of Efficacy|0
6899478|NCT00658632|10919335|FG001|Overall Study|Lack of Efficacy|1
6899479|NCT00658632|10919334|FG000|Overall Study|Withdrawal of consent|8
6899480|NCT00658632|10919335|FG001|Overall Study|Withdrawal of consent|14
6899481|NCT00658632|10919334|FG000|Overall Study|Pregnancy|1
6899482|NCT00658632|10919335|FG001|Overall Study|Pregnancy|1
6899483|NCT00658632|10919334|FG000|Overall Study|Other|7
6899484|NCT00658632|10919335|FG001|Overall Study|Other|8
6899485|NCT00658658|10919346|FG000|Overall Study|Withdrawal by Subject|0
6899486|NCT00658658|10919347|FG001|Overall Study|Withdrawal by Subject|1
6899487|NCT00658658|10919348|FG002|Overall Study|Withdrawal by Subject|0
6899488|NCT00658658|10919349|FG003|Overall Study|Withdrawal by Subject|0
6899489|NCT00658658|10919350|FG004|Overall Study|Withdrawal by Subject|0
6899490|NCT00658658|10919346|FG000|Overall Study|Death|4
6899491|NCT00658658|10919347|FG001|Overall Study|Death|0
6899492|NCT00658658|10919348|FG002|Overall Study|Death|0
6899493|NCT00658658|10919349|FG003|Overall Study|Death|1
6899494|NCT00658658|10919350|FG004|Overall Study|Death|1
6899495|NCT00658658|10919346|FG000|Overall Study|Disease Progression|0
6899496|NCT00658658|10919347|FG001|Overall Study|Disease Progression|1
6899497|NCT00658658|10919348|FG002|Overall Study|Disease Progression|0
6899498|NCT00658658|10919349|FG003|Overall Study|Disease Progression|1
6899499|NCT00658658|10919350|FG004|Overall Study|Disease Progression|3
6899500|NCT00658658|10919346|FG000|Overall Study|Protocol-specified Criteria|1
6899501|NCT00658658|10919347|FG001|Overall Study|Protocol-specified Criteria|0
6899502|NCT00658658|10919348|FG002|Overall Study|Protocol-specified Criteria|0
6899503|NCT00658658|10919349|FG003|Overall Study|Protocol-specified Criteria|0
6899504|NCT00658658|10919350|FG004|Overall Study|Protocol-specified Criteria|0
6899505|NCT00658658|10919346|FG000|Overall Study|Other|0
6899506|NCT00658658|10919347|FG001|Overall Study|Other|0
6899507|NCT00658658|10919348|FG002|Overall Study|Other|0
6899508|NCT00658658|10919349|FG003|Overall Study|Other|0
6899509|NCT00658658|10919350|FG004|Overall Study|Other|1
6899510|NCT00658684|10919365|FG000|Overall Study|Adverse Event|10
6899511|NCT00658684|10919366|FG001|Overall Study|Adverse Event|8
6899512|NCT00658684|10919367|FG002|Overall Study|Adverse Event|2
6899513|NCT00658684|10919368|FG003|Overall Study|Adverse Event|0
6899514|NCT00658684|10919365|FG000|Overall Study|Withdrawal by Subject|6
6899515|NCT00658684|10919366|FG001|Overall Study|Withdrawal by Subject|4
6899516|NCT00658684|10919367|FG002|Overall Study|Withdrawal by Subject|1
6899517|NCT00658684|10919368|FG003|Overall Study|Withdrawal by Subject|1
6899518|NCT00658684|10919365|FG000|Overall Study|Lack of Efficacy|1
6899519|NCT00658684|10919366|FG001|Overall Study|Lack of Efficacy|1
6899520|NCT00658684|10919367|FG002|Overall Study|Lack of Efficacy|0
6899521|NCT00658684|10919368|FG003|Overall Study|Lack of Efficacy|0
6899522|NCT00658684|10919365|FG000|Overall Study|Protocol Violation|1
6899523|NCT00658684|10919366|FG001|Overall Study|Protocol Violation|1
6899524|NCT00658684|10919367|FG002|Overall Study|Protocol Violation|0
6899525|NCT00658684|10919368|FG003|Overall Study|Protocol Violation|0
6899526|NCT00658684|10919365|FG000|Overall Study|Pregnancy|1
6899527|NCT00658684|10919366|FG001|Overall Study|Pregnancy|1
6899528|NCT00658684|10919367|FG002|Overall Study|Pregnancy|0
6899529|NCT00658684|10919368|FG003|Overall Study|Pregnancy|0
6899530|NCT00658723|10919386|FG000|Overall Study|Lost to Follow-up|0
6899531|NCT00658723|10919387|FG001|Overall Study|Lost to Follow-up|2
6899532|NCT00658723|10919388|FG002|Overall Study|Lost to Follow-up|2
6820037|NCT00090103|10824297|FG002|16-Week Safety Follow-up Period|Loss of Contact|2
6820038|NCT00090103|10824295|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3
6820039|NCT00090103|10824296|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
6820040|NCT00090103|10824297|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
6820041|NCT00090103|10824295|FG000|16-Week Safety Follow-up Period|Participant relocated|2
6820042|NCT00090103|10824296|FG001|16-Week Safety Follow-up Period|Participant relocated|3
6820043|NCT00090103|10824297|FG002|16-Week Safety Follow-up Period|Participant relocated|1
6820044|NCT00090103|10824295|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
6820045|NCT00090103|10824296|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1
6820046|NCT00090103|10824297|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
6820047|NCT00090103|10824295|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2
6820048|NCT00090103|10824296|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3
6820049|NCT00090103|10824297|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5
6820050|NCT00090103|10824295|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1
6820051|NCT00090103|10824296|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0
6820052|NCT00090103|10824297|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1
6820053|NCT00090103|10824295|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1
6820054|NCT00090103|10824296|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5
6820055|NCT00090103|10824297|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13
6820056|NCT00090103|10824295|FG000|16-Week Safety Follow-up Period|Loss of Libido|1
6820057|NCT00090103|10824296|FG001|16-Week Safety Follow-up Period|Loss of Libido|0
6820058|NCT00090103|10824297|FG002|16-Week Safety Follow-up Period|Loss of Libido|0
6820059|NCT00090103|10824295|FG000|16-Week Safety Follow-up Period|Enrollment Error|1
6820060|NCT00090103|10824296|FG001|16-Week Safety Follow-up Period|Enrollment Error|0
6820061|NCT00090103|10824297|FG002|16-Week Safety Follow-up Period|Enrollment Error|2
6820062|NCT00090103|10824295|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1
6820063|NCT00090103|10824296|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3
6899533|NCT00658723|10919386|FG000|Overall Study|Death|2
6899534|NCT00658723|10919387|FG001|Overall Study|Death|1
6899535|NCT00658723|10919388|FG002|Overall Study|Death|4
6899536|NCT00658723|10919386|FG000|Overall Study|Scheduling Issue|1
6899537|NCT00658723|10919387|FG001|Overall Study|Scheduling Issue|1
6899538|NCT00658723|10919388|FG002|Overall Study|Scheduling Issue|0
6899539|NCT00658723|10919386|FG000|Overall Study|Withdrawal by Subject|1
6899540|NCT00658723|10919387|FG001|Overall Study|Withdrawal by Subject|0
6899541|NCT00658723|10919388|FG002|Overall Study|Withdrawal by Subject|1
6899542|NCT00658775|10919410|FG000|Overall Study|Adverse Event|4
6899543|NCT00658775|10919411|FG001|Overall Study|Adverse Event|6
6899544|NCT00658775|10919410|FG000|Overall Study|Lost to Follow-up|17
6899545|NCT00658775|10919411|FG001|Overall Study|Lost to Follow-up|18
6899546|NCT00658775|10919410|FG000|Overall Study|Withdrawal by Subject|6
6899547|NCT00658775|10919411|FG001|Overall Study|Withdrawal by Subject|4
6899548|NCT00658775|10919410|FG000|Overall Study|Withdrawal of consent|8
6899549|NCT00658775|10919411|FG001|Overall Study|Withdrawal of consent|7
6899550|NCT00658775|10919410|FG000|Overall Study|Other|7
6899551|NCT00658775|10919411|FG001|Overall Study|Other|8
6899552|NCT00658788|10919417|FG000|Overall Study|Adverse Event|11
6899553|NCT00658788|10919417|FG000|Overall Study|Withdrawal by Subject|13
6899554|NCT00658788|10919417|FG000|Overall Study|Lost to Follow-up|18
6899555|NCT00658788|10919417|FG000|Overall Study|Treatment Discontinuation|32
6899556|NCT00658879|10919430|FG000|Overall Study|Protocol Violation|1
6899557|NCT00658996|10919434|FG000|First Intervention|Positive slit lamp finding|1
6899558|NCT00658996|10919435|FG001|First Intervention|Positive slit lamp finding|0
6899559|NCT00658996|10919434|FG000|First Intervention|Lack of lenses|0
6899560|NCT00658996|10919435|FG001|First Intervention|Lack of lenses|1
6899561|NCT00658996|10919434|FG000|Crossover Period|Physician Decision|1
6899562|NCT00658996|10919435|FG001|Crossover Period|Physician Decision|0
6899563|NCT00658996|10919434|FG000|Crossover Period|Ineligible|1
6899564|NCT00658996|10919435|FG001|Crossover Period|Ineligible|1
6899565|NCT00658996|10919434|FG000|Second Intervention|Developed a stye on upper lid|1
6899566|NCT00658996|10919435|FG001|Second Intervention|Developed a stye on upper lid|0
6899567|NCT00658996|10919434|FG000|Second Intervention|Positive slit lamp finding|0
6899568|NCT00658996|10919435|FG001|Second Intervention|Positive slit lamp finding|1
6899569|NCT00659230|10919452|FG000|Overall Study|Lost to Follow-up|2
6899570|NCT00659230|10919453|FG001|Overall Study|Lost to Follow-up|5
6899571|NCT00659230|10919452|FG000|Overall Study|Lost source documentation|5
6899572|NCT00659230|10919453|FG001|Overall Study|Lost source documentation|4
6899573|NCT00659230|10919452|FG000|Overall Study|Did not return post-randomization|2
6899574|NCT00659230|10919453|FG001|Overall Study|Did not return post-randomization|3
6899575|NCT00659269|10919461|FG000|Overall Study|Physician Decision|1
6899576|NCT00659269|10919462|FG001|Overall Study|Physician Decision|1
6978400|NCT01212770|11031723|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
6978401|NCT01212770|11031724|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
6820064|NCT00090103|10824297|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6
6820065|NCT00090103|10824295|FG000|16-Week Safety Follow-up Period|Death|1
6978402|NCT01212770|11031716|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
6978403|NCT01212770|11031717|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
6820066|NCT00090103|10824296|FG001|16-Week Safety Follow-up Period|Death|0
6820067|NCT00090103|10824297|FG002|16-Week Safety Follow-up Period|Death|1
6820068|NCT00090103|10824295|FG000|16-Week Safety Follow-up Period|Gyneomastia|1
6820069|NCT00090103|10824296|FG001|16-Week Safety Follow-up Period|Gyneomastia|0
6820070|NCT00090103|10824297|FG002|16-Week Safety Follow-up Period|Gyneomastia|0
6820071|NCT00090103|10824295|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0
6820072|NCT00090103|10824296|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5
6820073|NCT00090103|10824297|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4
6820074|NCT00090103|10824295|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0
6820075|NCT00090103|10824296|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2
6820076|NCT00090103|10824297|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3
6820077|NCT00090103|10824295|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0
6820078|NCT00090103|10824296|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1
6820079|NCT00090103|10824297|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0
6820080|NCT00090103|10824295|FG000|16-Week Safety Follow-up Period|Back Pain|0
6820081|NCT00090103|10824296|FG001|16-Week Safety Follow-up Period|Back Pain|1
6820082|NCT00090103|10824297|FG002|16-Week Safety Follow-up Period|Back Pain|0
6820083|NCT00090103|10824295|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0
6820084|NCT00090103|10824296|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2
6820085|NCT00090103|10824297|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4
6820086|NCT00090103|10824295|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0
6820087|NCT00090103|10824296|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2
6899577|NCT00659334|10919493|FG000|Overall Study|Screen Failure|8
6899578|NCT00659334|10919494|FG001|Overall Study|Screen Failure|5
6899579|NCT00659334|10919495|FG002|Overall Study|Screen Failure|0
6899580|NCT00659334|10919496|FG003|Overall Study|Screen Failure|0
6899581|NCT00659334|10919497|FG004|Overall Study|Screen Failure|0
6899582|NCT00659334|10919498|FG005|Overall Study|Screen Failure|0
6899583|NCT00659334|10919499|FG006|Overall Study|Screen Failure|1
6899584|NCT00659373|10919523|FG000|Overall Study|Withdrawal by Subject|3
6899585|NCT00659373|10919524|FG001|Overall Study|Withdrawal by Subject|5
6899586|NCT00659373|10919523|FG000|Overall Study|Assessment Missed|2
6899587|NCT00659373|10919524|FG001|Overall Study|Assessment Missed|2
6899588|NCT00659425|10919540|FG000|Overall Study|Disease progression|1
6899589|NCT00659425|10919541|FG001|Overall Study|Disease progression|0
6899590|NCT00659425|10919542|FG002|Overall Study|Disease progression|0
6899591|NCT00659425|10919543|FG003|Overall Study|Disease progression|1
6899592|NCT00659425|10919544|FG004|Overall Study|Disease progression|0
6899593|NCT00659425|10919545|FG005|Overall Study|Disease progression|2
6899594|NCT00659425|10919546|FG006|Overall Study|Disease progression|4
6899595|NCT00659425|10919547|FG007|Overall Study|Disease progression|3
6899596|NCT00659425|10919548|FG008|Overall Study|Disease progression|5
6899597|NCT00659425|10919549|FG009|Overall Study|Disease progression|3
6899598|NCT00659425|10919540|FG000|Overall Study|Death|0
6899599|NCT00659425|10919541|FG001|Overall Study|Death|0
6899600|NCT00659425|10919542|FG002|Overall Study|Death|0
6899601|NCT00659425|10919543|FG003|Overall Study|Death|1
6899602|NCT00659425|10919544|FG004|Overall Study|Death|0
6899603|NCT00659425|10919545|FG005|Overall Study|Death|0
6899604|NCT00659425|10919546|FG006|Overall Study|Death|1
6899605|NCT00659425|10919547|FG007|Overall Study|Death|0
6899606|NCT00659425|10919548|FG008|Overall Study|Death|0
6899607|NCT00659425|10919549|FG009|Overall Study|Death|0
6899608|NCT00659425|10919540|FG000|Overall Study|Adverse Event|0
6899609|NCT00659425|10919541|FG001|Overall Study|Adverse Event|0
6899610|NCT00659425|10919542|FG002|Overall Study|Adverse Event|0
6899611|NCT00659425|10919543|FG003|Overall Study|Adverse Event|0
6899612|NCT00659425|10919544|FG004|Overall Study|Adverse Event|0
6899613|NCT00659425|10919545|FG005|Overall Study|Adverse Event|1
6899614|NCT00659425|10919546|FG006|Overall Study|Adverse Event|0
6899615|NCT00659425|10919547|FG007|Overall Study|Adverse Event|3
6899616|NCT00659425|10919548|FG008|Overall Study|Adverse Event|1
6899617|NCT00659425|10919549|FG009|Overall Study|Adverse Event|4
6899618|NCT00659425|10919540|FG000|Overall Study|Investigator Discretion|0
6899619|NCT00659425|10919541|FG001|Overall Study|Investigator Discretion|0
6899620|NCT00659425|10919542|FG002|Overall Study|Investigator Discretion|0
6899621|NCT00659425|10919543|FG003|Overall Study|Investigator Discretion|0
6899622|NCT00659425|10919544|FG004|Overall Study|Investigator Discretion|0
6899623|NCT00659425|10919545|FG005|Overall Study|Investigator Discretion|1
6978404|NCT01212770|11031718|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1
6978405|NCT01212770|11031719|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
6978406|NCT01212770|11031720|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
6978407|NCT01212770|11031721|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
6978408|NCT01212770|11031722|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
6978409|NCT01212770|11031723|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
6899624|NCT00659425|10919546|FG006|Overall Study|Investigator Discretion|0
6899625|NCT00659425|10919547|FG007|Overall Study|Investigator Discretion|3
6899626|NCT00659425|10919548|FG008|Overall Study|Investigator Discretion|0
6899627|NCT00659425|10919549|FG009|Overall Study|Investigator Discretion|0
6899628|NCT00659425|10919540|FG000|Overall Study|Other|0
6899629|NCT00659425|10919541|FG001|Overall Study|Other|1
6978410|NCT01212770|11031724|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
6820088|NCT00090103|10824297|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3
6820089|NCT00090103|10824295|FG000|16-Week Safety Follow-up Period|Depression|0
6820090|NCT00090103|10824296|FG001|16-Week Safety Follow-up Period|Depression|1
6820091|NCT00090103|10824297|FG002|16-Week Safety Follow-up Period|Depression|0
6820092|NCT00090103|10824295|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
6820093|NCT00090103|10824296|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1
6820094|NCT00090103|10824297|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
6820095|NCT00090103|10824295|FG000|16-Week Safety Follow-up Period|Jailed|0
6820096|NCT00090103|10824296|FG001|16-Week Safety Follow-up Period|Jailed|1
6820097|NCT00090103|10824297|FG002|16-Week Safety Follow-up Period|Jailed|0
6820098|NCT00090103|10824295|FG000|16-Week Safety Follow-up Period|Other|0
6820099|NCT00090103|10824296|FG001|16-Week Safety Follow-up Period|Other|1
6820100|NCT00090103|10824297|FG002|16-Week Safety Follow-up Period|Other|0
6820101|NCT00090220|10824307|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1
6820102|NCT00090220|10824308|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1
6820103|NCT00090220|10824309|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0
6820104|NCT00090220|10824310|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0
6820105|NCT00090220|10824311|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0
6820106|NCT00090220|10824312|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0
6820107|NCT00090220|10824307|FG000|Base Study Vaccination Period|Adverse Event|6
6820108|NCT00090220|10824308|FG001|Base Study Vaccination Period|Adverse Event|1
6820109|NCT00090220|10824309|FG002|Base Study Vaccination Period|Adverse Event|0
6820110|NCT00090220|10824310|FG003|Base Study Vaccination Period|Adverse Event|0
6820111|NCT00090220|10824311|FG004|Base Study Vaccination Period|Adverse Event|0
6820112|NCT00090220|10824312|FG005|Base Study Vaccination Period|Adverse Event|0
6820113|NCT00090220|10824307|FG000|Base Study Vaccination Period|Lost to Follow-up|24
6820114|NCT00090220|10824308|FG001|Base Study Vaccination Period|Lost to Follow-up|28
6820115|NCT00090220|10824309|FG002|Base Study Vaccination Period|Lost to Follow-up|0
6820116|NCT00090220|10824310|FG003|Base Study Vaccination Period|Lost to Follow-up|0
6820117|NCT00090220|10824311|FG004|Base Study Vaccination Period|Lost to Follow-up|0
6820118|NCT00090220|10824312|FG005|Base Study Vaccination Period|Lost to Follow-up|0
6820119|NCT00090220|10824307|FG000|Base Study Vaccination Period|Withdrawal by Subject|23
6820120|NCT00090220|10824308|FG001|Base Study Vaccination Period|Withdrawal by Subject|27
6820121|NCT00090220|10824309|FG002|Base Study Vaccination Period|Withdrawal by Subject|0
6820122|NCT00090220|10824310|FG003|Base Study Vaccination Period|Withdrawal by Subject|0
6820123|NCT00090220|10824311|FG004|Base Study Vaccination Period|Withdrawal by Subject|0
6820124|NCT00090220|10824312|FG005|Base Study Vaccination Period|Withdrawal by Subject|0
6820125|NCT00090220|10824307|FG000|Base Study Vaccination Period|Patient Moved|6
6820126|NCT00090220|10824308|FG001|Base Study Vaccination Period|Patient Moved|2
6820127|NCT00090220|10824309|FG002|Base Study Vaccination Period|Patient Moved|0
6820128|NCT00090220|10824310|FG003|Base Study Vaccination Period|Patient Moved|0
6820129|NCT00090220|10824311|FG004|Base Study Vaccination Period|Patient Moved|0
6820130|NCT00090220|10824312|FG005|Base Study Vaccination Period|Patient Moved|0
6820131|NCT00090220|10824307|FG000|Base Study Vaccination Period|Other|4
6820132|NCT00090220|10824308|FG001|Base Study Vaccination Period|Other|4
6820133|NCT00090220|10824309|FG002|Base Study Vaccination Period|Other|0
6820134|NCT00090220|10824310|FG003|Base Study Vaccination Period|Other|0
6820135|NCT00090220|10824311|FG004|Base Study Vaccination Period|Other|0
6820136|NCT00090220|10824312|FG005|Base Study Vaccination Period|Other|0
6820137|NCT00090220|10824307|FG000|Base Study Follow-up Period|Adverse Event|6
6820138|NCT00090220|10824308|FG001|Base Study Follow-up Period|Adverse Event|1
6820139|NCT00090220|10824309|FG002|Base Study Follow-up Period|Adverse Event|0
6820140|NCT00090220|10824310|FG003|Base Study Follow-up Period|Adverse Event|0
6820141|NCT00090220|10824311|FG004|Base Study Follow-up Period|Adverse Event|0
6820142|NCT00090220|10824312|FG005|Base Study Follow-up Period|Adverse Event|0
6899630|NCT00659425|10919542|FG002|Overall Study|Other|1
6899631|NCT00659425|10919543|FG003|Overall Study|Other|2
6899632|NCT00659425|10919544|FG004|Overall Study|Other|4
6899633|NCT00659425|10919545|FG005|Overall Study|Other|0
6899634|NCT00659425|10919546|FG006|Overall Study|Other|3
6899635|NCT00659425|10919547|FG007|Overall Study|Other|2
6899636|NCT00659425|10919548|FG008|Overall Study|Other|0
6899637|NCT00659425|10919549|FG009|Overall Study|Other|6
6899638|NCT00659438|10919586|FG000|Overall Study|Withdrawal by Subject|2
6899639|NCT00659438|10919587|FG001|Overall Study|Withdrawal by Subject|2
6899640|NCT00659438|10919586|FG000|Overall Study|Death|11
6899641|NCT00659438|10919587|FG001|Overall Study|Death|6
6899642|NCT00659438|10919586|FG000|Overall Study|Lost to Follow-up|1
6899643|NCT00659438|10919587|FG001|Overall Study|Lost to Follow-up|0
6899644|NCT00659490|10919596|FG000|Overall Study|Lost to Follow-up|2
6899645|NCT00659490|10919597|FG001|Overall Study|Lost to Follow-up|0
6899646|NCT00659490|10919598|FG002|Overall Study|Lost to Follow-up|1
6899647|NCT00659529|10919606|FG000|Overall Study|Withdrawal by Subject|4
6899648|NCT00659529|10919606|FG000|Overall Study|Protocol Violation|3
6899649|NCT00659529|10919606|FG000|Overall Study|Screen failure|9
6899650|NCT00659581|10919610|FG000|Overall Study|Adverse Event|1006
6899651|NCT00659581|10919610|FG000|Overall Study|Lack of Efficacy|1183
6899652|NCT00659581|10919610|FG000|Overall Study|Other|6393
6899653|NCT00659607|10919614|FG000|Overall Study|No blood pressure recorded|147
6820143|NCT00090220|10824307|FG000|Base Study Follow-up Period|Lost to Follow-up|88
6820144|NCT00090220|10824308|FG001|Base Study Follow-up Period|Lost to Follow-up|78
6820145|NCT00090220|10824309|FG002|Base Study Follow-up Period|Lost to Follow-up|0
6820146|NCT00090220|10824310|FG003|Base Study Follow-up Period|Lost to Follow-up|0
6820147|NCT00090220|10824311|FG004|Base Study Follow-up Period|Lost to Follow-up|0
6820148|NCT00090220|10824312|FG005|Base Study Follow-up Period|Lost to Follow-up|0
6820149|NCT00090220|10824307|FG000|Base Study Follow-up Period|Withdrawal by Subject|27
6820150|NCT00090220|10824308|FG001|Base Study Follow-up Period|Withdrawal by Subject|36
6820151|NCT00090220|10824309|FG002|Base Study Follow-up Period|Withdrawal by Subject|0
6820152|NCT00090220|10824310|FG003|Base Study Follow-up Period|Withdrawal by Subject|0
6820153|NCT00090220|10824311|FG004|Base Study Follow-up Period|Withdrawal by Subject|0
6820154|NCT00090220|10824312|FG005|Base Study Follow-up Period|Withdrawal by Subject|0
6820155|NCT00090220|10824307|FG000|Base Study Follow-up Period|Patient Moved|20
6820156|NCT00090220|10824308|FG001|Base Study Follow-up Period|Patient Moved|28
6820157|NCT00090220|10824309|FG002|Base Study Follow-up Period|Patient Moved|0
6820158|NCT00090220|10824310|FG003|Base Study Follow-up Period|Patient Moved|0
6820159|NCT00090220|10824311|FG004|Base Study Follow-up Period|Patient Moved|0
6820160|NCT00090220|10824312|FG005|Base Study Follow-up Period|Patient Moved|0
6820161|NCT00090220|10824307|FG000|Base Study Follow-up Period|Other|19
6820162|NCT00090220|10824308|FG001|Base Study Follow-up Period|Other|21
6820163|NCT00090220|10824309|FG002|Base Study Follow-up Period|Other|0
6820164|NCT00090220|10824310|FG003|Base Study Follow-up Period|Other|0
6820165|NCT00090220|10824311|FG004|Base Study Follow-up Period|Other|0
6820166|NCT00090220|10824312|FG005|Base Study Follow-up Period|Other|0
6820167|NCT00090220|10824307|FG000|Extension 1 (EXT1)|Adverse Event|0
6820168|NCT00090220|10824308|FG001|Extension 1 (EXT1)|Adverse Event|0
6820169|NCT00090220|10824309|FG002|Extension 1 (EXT1)|Adverse Event|4
6820170|NCT00090220|10824310|FG003|Extension 1 (EXT1)|Adverse Event|0
6820171|NCT00090220|10824311|FG004|Extension 1 (EXT1)|Adverse Event|0
6820172|NCT00090220|10824312|FG005|Extension 1 (EXT1)|Adverse Event|0
6899654|NCT00659607|10919614|FG000|Overall Study|Unknown measuring date of blood pressure|85
6899655|NCT00659607|10919614|FG000|Overall Study|'Unable to evaluate' for the final asses|67
6899656|NCT00659607|10919614|FG000|Overall Study|No recorded efficacy data|15
6899657|NCT00659607|10919614|FG000|Overall Study|Inconsistent BP measuring date|2
6899658|NCT00659815|10919663|FG000|Overall Study|Study related symptoms and complaints|2
6899659|NCT00659815|10919664|FG001|Overall Study|Study related symptoms and complaints|1
6899660|NCT00659815|10919663|FG000|Overall Study|Inability to maintain wearing schedule|1
6899661|NCT00659815|10919664|FG001|Overall Study|Inability to maintain wearing schedule|2
6899662|NCT00659815|10919663|FG000|Overall Study|Withdrawal by Subject|1
6899663|NCT00659815|10919664|FG001|Overall Study|Withdrawal by Subject|1
6899664|NCT00659880|10919674|FG000|Overall Study|Lost to Follow-up|5
6899665|NCT00659984|10919688|FG000|Overall Study|Adverse Event|1
6899666|NCT00660010|10919698|FG000|Overall Study|Withdrawal by Subject|2
6899667|NCT00660010|10919698|FG000|Overall Study|Lost to Follow-up|3
6899668|NCT00660010|10919698|FG000|Overall Study|Adverse Event|1
6899669|NCT00660010|10919698|FG000|Overall Study|Noncompliance with visit schedule|3
6899670|NCT00660023|10919702|FG000|Overall Study|Adverse Event|2
6899671|NCT00660023|10919702|FG000|Overall Study|Death|8
6899672|NCT00660023|10919702|FG000|Overall Study|Blood Transfusion|5
6899673|NCT00660023|10919702|FG000|Overall Study|Renal Transplantation|3
6899674|NCT00660023|10919702|FG000|Overall Study|Withdrawal by Subject|1
6899675|NCT00660023|10919702|FG000|Overall Study|Missed Pregnancy Test|1
6899676|NCT00660023|10919702|FG000|Overall Study|Other Screening Failure|9
6899677|NCT00660179|10919722|FG000|Overall Study|Death|44
6899678|NCT00660179|10919723|FG001|Overall Study|Death|47
6899679|NCT00660179|10919724|FG002|Overall Study|Death|34
6899680|NCT00660179|10919722|FG000|Overall Study|Withdrawal of consent|4
6899681|NCT00660179|10919723|FG001|Overall Study|Withdrawal of consent|6
6899682|NCT00660179|10919724|FG002|Overall Study|Withdrawal of consent|4
6899683|NCT00660179|10919722|FG000|Overall Study|Lost to Follow-up|7
6899684|NCT00660179|10919723|FG001|Overall Study|Lost to Follow-up|5
6899685|NCT00660179|10919724|FG002|Overall Study|Lost to Follow-up|2
6899686|NCT00660179|10919722|FG000|Overall Study|Administrative reason|0
6899687|NCT00660179|10919723|FG001|Overall Study|Administrative reason|0
6978411|NCT01212770|11031716|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0
6978412|NCT01212770|11031717|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1
6978413|NCT01212770|11031718|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0
6978414|NCT01212770|11031719|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0
6978415|NCT01212770|11031720|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0
6978416|NCT01212770|11031721|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0
6978417|NCT01212770|11031722|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0
6978418|NCT01212770|11031723|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0
6820173|NCT00090220|10824307|FG000|Extension 1 (EXT1)|Lost to Follow-up|0
6820174|NCT00090220|10824308|FG001|Extension 1 (EXT1)|Lost to Follow-up|0
6899688|NCT00660179|10919724|FG002|Overall Study|Administrative reason|1
6978419|NCT01212770|11031724|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1
6820175|NCT00090220|10824309|FG002|Extension 1 (EXT1)|Lost to Follow-up|22
6820176|NCT00090220|10824310|FG003|Extension 1 (EXT1)|Lost to Follow-up|0
6820177|NCT00090220|10824311|FG004|Extension 1 (EXT1)|Lost to Follow-up|0
6820178|NCT00090220|10824312|FG005|Extension 1 (EXT1)|Lost to Follow-up|0
6820179|NCT00090220|10824307|FG000|Extension 1 (EXT1)|Moved|0
6820180|NCT00090220|10824308|FG001|Extension 1 (EXT1)|Moved|0
6820181|NCT00090220|10824309|FG002|Extension 1 (EXT1)|Moved|2
6820182|NCT00090220|10824310|FG003|Extension 1 (EXT1)|Moved|1
6820183|NCT00090220|10824311|FG004|Extension 1 (EXT1)|Moved|0
6820184|NCT00090220|10824312|FG005|Extension 1 (EXT1)|Moved|0
6820185|NCT00090220|10824307|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0
6820186|NCT00090220|10824308|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0
6820187|NCT00090220|10824309|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25
6820188|NCT00090220|10824310|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0
6820189|NCT00090220|10824311|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0
6820190|NCT00090220|10824312|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0
6820191|NCT00090220|10824307|FG000|Extension 1 (EXT1)|Protocol Violation|0
6820192|NCT00090220|10824308|FG001|Extension 1 (EXT1)|Protocol Violation|0
6820193|NCT00090220|10824309|FG002|Extension 1 (EXT1)|Protocol Violation|0
6820194|NCT00090220|10824310|FG003|Extension 1 (EXT1)|Protocol Violation|1
6820195|NCT00090220|10824311|FG004|Extension 1 (EXT1)|Protocol Violation|0
6820196|NCT00090220|10824312|FG005|Extension 1 (EXT1)|Protocol Violation|0
6820197|NCT00090220|10824307|FG000|Extension 1 (EXT1)|Other reason|0
6820198|NCT00090220|10824308|FG001|Extension 1 (EXT1)|Other reason|0
6820199|NCT00090220|10824309|FG002|Extension 1 (EXT1)|Other reason|2
6820200|NCT00090220|10824310|FG003|Extension 1 (EXT1)|Other reason|0
6820201|NCT00090220|10824311|FG004|Extension 1 (EXT1)|Other reason|0
6820202|NCT00090220|10824312|FG005|Extension 1 (EXT1)|Other reason|0
6820203|NCT00090220|10824307|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0
6820204|NCT00090220|10824308|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0
6820205|NCT00090220|10824309|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0
6820206|NCT00090220|10824310|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0
6899689|NCT00660179|10919722|FG000|Overall Study|Incorrect randomization|1
6899690|NCT00660179|10919723|FG001|Overall Study|Incorrect randomization|0
6899691|NCT00660179|10919724|FG002|Overall Study|Incorrect randomization|0
6899692|NCT00660192|10919734|FG000|Overall Study|Lost to Follow-up|2
6899693|NCT00660192|10919735|FG001|Overall Study|Lost to Follow-up|3
6978420|NCT01212770|11031716|FG000|Long-term Safety Phase (Year 5)|Missing|0
6978421|NCT01212770|11031717|FG001|Long-term Safety Phase (Year 5)|Missing|0
6978422|NCT01212770|11031718|FG002|Long-term Safety Phase (Year 5)|Missing|1
6978423|NCT01212770|11031719|FG003|Long-term Safety Phase (Year 5)|Missing|0
6978424|NCT01212770|11031720|FG004|Long-term Safety Phase (Year 5)|Missing|0
6978425|NCT01212770|11031721|FG005|Long-term Safety Phase (Year 5)|Missing|0
6978426|NCT01212770|11031722|FG006|Long-term Safety Phase (Year 5)|Missing|0
6978427|NCT01212770|11031723|FG007|Long-term Safety Phase (Year 5)|Missing|0
6978428|NCT01212770|11031724|FG008|Long-term Safety Phase (Year 5)|Missing|0
6978429|NCT01212770|11031716|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0
6978430|NCT01212770|11031717|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0
6978431|NCT01212770|11031718|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3
6978432|NCT01212770|11031719|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0
6978433|NCT01212770|11031720|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0
6978434|NCT01212770|11031721|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0
6978435|NCT01212770|11031722|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0
6978436|NCT01212770|11031723|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0
6978437|NCT01212770|11031724|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0
6978438|NCT01212770|11031716|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0
6978439|NCT01212770|11031717|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0
6978440|NCT01212770|11031718|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2
6978441|NCT01212770|11031719|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0
6978442|NCT01212770|11031720|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0
6978443|NCT01212770|11031721|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0
6978444|NCT01212770|11031722|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0
6978445|NCT01212770|11031723|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0
6978446|NCT01212770|11031724|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1
6978447|NCT01212770|11031716|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
6978448|NCT01212770|11031717|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
6978449|NCT01212770|11031718|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4
6978450|NCT01212770|11031719|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
6978451|NCT01212770|11031720|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
6978452|NCT01212770|11031721|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
6978453|NCT01212770|11031722|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
6978454|NCT01212770|11031723|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
6978455|NCT01212770|11031724|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
6978456|NCT01212770|11031716|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
6978457|NCT01212770|11031717|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2
6978458|NCT01212770|11031718|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
6978459|NCT01212770|11031719|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
6978460|NCT01212770|11031720|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
6978461|NCT01212770|11031721|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
6978462|NCT01212770|11031722|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
7059531|NCT01907828|11155174|FG001|Overall Study|Withdrawal by Subject|4
6978463|NCT01212770|11031723|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
6978464|NCT01212770|11031724|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
6820207|NCT00090220|10824311|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38
6820208|NCT00090220|10824312|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23
6820209|NCT00090220|10824307|FG000|Long-term Follow-up (EXT2)|Death|0
6820210|NCT00090220|10824308|FG001|Long-term Follow-up (EXT2)|Death|0
6820211|NCT00090220|10824309|FG002|Long-term Follow-up (EXT2)|Death|0
6820212|NCT00090220|10824310|FG003|Long-term Follow-up (EXT2)|Death|0
6820213|NCT00090220|10824311|FG004|Long-term Follow-up (EXT2)|Death|1
6820214|NCT00090220|10824312|FG005|Long-term Follow-up (EXT2)|Death|1
6820215|NCT00090220|10824307|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
6820216|NCT00090220|10824308|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
6820217|NCT00090220|10824309|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
6820218|NCT00090220|10824310|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
6820219|NCT00090220|10824311|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
6820220|NCT00090220|10824312|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
6820221|NCT00090220|10824307|FG000|Long-term Follow-up (EXT2)|Other|0
6820222|NCT00090220|10824308|FG001|Long-term Follow-up (EXT2)|Other|0
6820223|NCT00090220|10824309|FG002|Long-term Follow-up (EXT2)|Other|0
6820224|NCT00090220|10824310|FG003|Long-term Follow-up (EXT2)|Other|0
6820225|NCT00090220|10824311|FG004|Long-term Follow-up (EXT2)|Other|1
6820226|NCT00090220|10824312|FG005|Long-term Follow-up (EXT2)|Other|0
6820227|NCT00090233|10824331|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609
6820228|NCT00090233|10824332|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627
6820229|NCT00090233|10824331|FG000|Overall Study|Adverse Event|214
6820230|NCT00090233|10824332|FG001|Overall Study|Adverse Event|198
6820231|NCT00090233|10824331|FG000|Overall Study|Lost to Follow-up|68
6820232|NCT00090233|10824332|FG001|Overall Study|Lost to Follow-up|95
6820233|NCT00090233|10824331|FG000|Overall Study|Protocol Violation|960
6820234|NCT00090233|10824332|FG001|Overall Study|Protocol Violation|1022
6820235|NCT00090233|10824331|FG000|Overall Study|Withdrawal by Subject|182
6820236|NCT00090233|10824332|FG001|Overall Study|Withdrawal by Subject|211
6820237|NCT00090233|10824331|FG000|Overall Study|Moved|203
6820238|NCT00090233|10824332|FG001|Overall Study|Moved|189
6820239|NCT00090233|10824331|FG000|Overall Study|Other|1211
6820240|NCT00090233|10824332|FG001|Overall Study|Other|1160
6820241|NCT00090233|10824331|FG000|Overall Study|Data not available at data cut-off point|1552
6820242|NCT00090233|10824332|FG001|Overall Study|Data not available at data cut-off point|1563
6820243|NCT00090285|10824344|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7
6820244|NCT00090285|10824345|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3
6820245|NCT00090285|10824346|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0
6820246|NCT00090285|10824347|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0
6820247|NCT00090285|10824348|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0
6820248|NCT00090285|10824349|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0
6820249|NCT00090285|10824344|FG000|Base Study Vaccination Period|Adverse Event|2
6820250|NCT00090285|10824345|FG001|Base Study Vaccination Period|Adverse Event|4
6820251|NCT00090285|10824346|FG002|Base Study Vaccination Period|Adverse Event|0
6820252|NCT00090285|10824347|FG003|Base Study Vaccination Period|Adverse Event|0
6820253|NCT00090285|10824348|FG004|Base Study Vaccination Period|Adverse Event|0
6820254|NCT00090285|10824349|FG005|Base Study Vaccination Period|Adverse Event|0
6820255|NCT00090285|10824344|FG000|Base Study Vaccination Period|Lost to Follow-up|111
6820256|NCT00090285|10824345|FG001|Base Study Vaccination Period|Lost to Follow-up|112
6820257|NCT00090285|10824346|FG002|Base Study Vaccination Period|Lost to Follow-up|0
6820258|NCT00090285|10824347|FG003|Base Study Vaccination Period|Lost to Follow-up|0
6820259|NCT00090285|10824348|FG004|Base Study Vaccination Period|Lost to Follow-up|0
6820260|NCT00090285|10824349|FG005|Base Study Vaccination Period|Lost to Follow-up|0
6820261|NCT00090285|10824344|FG000|Base Study Vaccination Period|Protocol Violation|2
6820262|NCT00090285|10824345|FG001|Base Study Vaccination Period|Protocol Violation|3
6820263|NCT00090285|10824346|FG002|Base Study Vaccination Period|Protocol Violation|0
6820264|NCT00090285|10824347|FG003|Base Study Vaccination Period|Protocol Violation|0
6820265|NCT00090285|10824348|FG004|Base Study Vaccination Period|Protocol Violation|0
6820266|NCT00090285|10824349|FG005|Base Study Vaccination Period|Protocol Violation|0
6820267|NCT00090285|10824344|FG000|Base Study Vaccination Period|Withdrawal by Subject|64
6820268|NCT00090285|10824345|FG001|Base Study Vaccination Period|Withdrawal by Subject|69
6820269|NCT00090285|10824346|FG002|Base Study Vaccination Period|Withdrawal by Subject|0
6820270|NCT00090285|10824347|FG003|Base Study Vaccination Period|Withdrawal by Subject|0
6820271|NCT00090285|10824348|FG004|Base Study Vaccination Period|Withdrawal by Subject|0
6820272|NCT00090285|10824349|FG005|Base Study Vaccination Period|Withdrawal by Subject|0
6820273|NCT00090285|10824344|FG000|Base Study Vaccination Period|Uncooperative|2
6820274|NCT00090285|10824345|FG001|Base Study Vaccination Period|Uncooperative|2
6820275|NCT00090285|10824346|FG002|Base Study Vaccination Period|Uncooperative|0
6820276|NCT00090285|10824347|FG003|Base Study Vaccination Period|Uncooperative|0
6820277|NCT00090285|10824348|FG004|Base Study Vaccination Period|Uncooperative|0
6820278|NCT00090285|10824349|FG005|Base Study Vaccination Period|Uncooperative|0
6820279|NCT00090285|10824344|FG000|Base Study Vaccination Period|Moved|20
6820280|NCT00090285|10824345|FG001|Base Study Vaccination Period|Moved|21
6820281|NCT00090285|10824346|FG002|Base Study Vaccination Period|Moved|0
6820282|NCT00090285|10824347|FG003|Base Study Vaccination Period|Moved|0
6820283|NCT00090285|10824348|FG004|Base Study Vaccination Period|Moved|0
6820284|NCT00090285|10824349|FG005|Base Study Vaccination Period|Moved|0
6896609|NCT00634114|10915133|FG000|Overall Study|Lost to Follow-up|0
6899694|NCT00660309|10919743|FG000|Overall Study|Adverse Event|2
6899695|NCT00660309|10919744|FG001|Overall Study|Adverse Event|0
6899696|NCT00660309|10919743|FG000|Overall Study|Withdrawal by Subject|0
6899697|NCT00660309|10919744|FG001|Overall Study|Withdrawal by Subject|3
6978465|NCT01212770|11031716|FG000|Long-term Safety Phase (Year 5)|Death|0
6978466|NCT01212770|11031717|FG001|Long-term Safety Phase (Year 5)|Death|0
6978467|NCT01212770|11031718|FG002|Long-term Safety Phase (Year 5)|Death|0
6978468|NCT01212770|11031719|FG003|Long-term Safety Phase (Year 5)|Death|0
6978469|NCT01212770|11031720|FG004|Long-term Safety Phase (Year 5)|Death|0
6978470|NCT01212770|11031721|FG005|Long-term Safety Phase (Year 5)|Death|0
6978471|NCT01212770|11031722|FG006|Long-term Safety Phase (Year 5)|Death|0
6978472|NCT01212770|11031723|FG007|Long-term Safety Phase (Year 5)|Death|1
6978473|NCT01212770|11031724|FG008|Long-term Safety Phase (Year 5)|Death|0
6978474|NCT01212991|11031781|FG000|Double-blind|Lost to Follow-up|8
6978475|NCT01212991|11031782|FG001|Double-blind|Lost to Follow-up|4
6978476|NCT01212991|11031783|FG002|Double-blind|Lost to Follow-up|0
6978477|NCT01212991|11031781|FG000|Double-blind|Death|699
6978478|NCT01212991|11031782|FG001|Double-blind|Death|550
6978479|NCT01212991|11031783|FG002|Double-blind|Death|0
6978480|NCT01212991|11031781|FG000|Double-blind|Withdrawal by Subject|16
6978481|NCT01212991|11031782|FG001|Double-blind|Withdrawal by Subject|19
6978482|NCT01212991|11031783|FG002|Double-blind|Withdrawal by Subject|0
6978483|NCT01212991|11031781|FG000|Double-blind|Other|7
6978484|NCT01212991|11031782|FG001|Double-blind|Other|0
6978485|NCT01212991|11031783|FG002|Double-blind|Other|0
6978486|NCT01212991|11031781|FG000|Double-blind|Sponsor decision|142
6978487|NCT01212991|11031782|FG001|Double-blind|Sponsor decision|38
6978488|NCT01212991|11031783|FG002|Double-blind|Sponsor decision|0
6978489|NCT01212991|11031781|FG000|Open-label|Death|0
6978490|NCT01212991|11031782|FG001|Open-label|Death|0
6978491|NCT01212991|11031783|FG002|Open-label|Death|166
6978492|NCT01212991|11031781|FG000|Open-label|Lost to Follow-up|0
6978493|NCT01212991|11031782|FG001|Open-label|Lost to Follow-up|0
6978494|NCT01212991|11031783|FG002|Open-label|Lost to Follow-up|5
6978495|NCT01212991|11031781|FG000|Open-label|Withdrawal by Subject|0
6978496|NCT01212991|11031782|FG001|Open-label|Withdrawal by Subject|0
6978497|NCT01212991|11031783|FG002|Open-label|Withdrawal by Subject|7
6978498|NCT01212991|11031781|FG000|Open-label|Sponsor decision|0
6978499|NCT01212991|11031782|FG001|Open-label|Sponsor decision|0
6978500|NCT01212991|11031783|FG002|Open-label|Sponsor decision|53
6978501|NCT01212991|11031781|FG000|Open-label|Other|0
6978502|NCT01212991|11031782|FG001|Open-label|Other|0
6978503|NCT01212991|11031783|FG002|Open-label|Other|3
6978504|NCT01213082|11031803|FG000|Overall Study|Lost to Follow-up|6
6978505|NCT01213082|11031804|FG001|Overall Study|Lost to Follow-up|7
6978506|NCT01213082|11031805|FG002|Overall Study|Lost to Follow-up|4
6978507|NCT01213082|11031803|FG000|Overall Study|Physician Decision|0
6978508|NCT01213082|11031804|FG001|Overall Study|Physician Decision|0
6978509|NCT01213082|11031805|FG002|Overall Study|Physician Decision|1
6978510|NCT01213173|11031815|FG000|Overall Study|Protocol Violation|2
6978511|NCT01213173|11031816|FG001|Overall Study|Protocol Violation|0
6978512|NCT01213173|11031815|FG000|Overall Study|Adverse Event|4
6978513|NCT01213173|11031816|FG001|Overall Study|Adverse Event|8
6978514|NCT01213173|11031815|FG000|Overall Study|Withdrawal by Subject|5
6978515|NCT01213173|11031816|FG001|Overall Study|Withdrawal by Subject|5
6978516|NCT01213173|11031815|FG000|Overall Study|Incorrect Enrollment|1
6978517|NCT01213173|11031816|FG001|Overall Study|Incorrect Enrollment|3
6978518|NCT01213251|11031829|FG000|Overall Study|Death|2
6978519|NCT01213251|11031830|FG001|Overall Study|Death|1
6978520|NCT01213251|11031831|FG002|Overall Study|Death|2
6978521|NCT01213251|11031829|FG000|Overall Study|Exit|3
6978522|NCT01213251|11031830|FG001|Overall Study|Exit|2
6978523|NCT01213251|11031831|FG002|Overall Study|Exit|8
6978524|NCT01213251|11031829|FG000|Overall Study|Protocol Violation|1
6978525|NCT01213251|11031830|FG001|Overall Study|Protocol Violation|1
6978526|NCT01213251|11031831|FG002|Overall Study|Protocol Violation|0
6978527|NCT01213251|11031829|FG000|Overall Study|Missed 18-Month Follow-up|0
6978528|NCT01213251|11031830|FG001|Overall Study|Missed 18-Month Follow-up|0
6978529|NCT01213251|11031831|FG002|Overall Study|Missed 18-Month Follow-up|1
6978530|NCT01213264|11031847|FG000|Overall Study|Adverse Event|1
6978531|NCT01213264|11031848|FG001|Overall Study|Adverse Event|0
6978532|NCT01213264|11031849|FG002|Overall Study|Adverse Event|0
6978533|NCT01213264|11031847|FG000|Overall Study|Lost to Follow-up|1
6978534|NCT01213264|11031848|FG001|Overall Study|Lost to Follow-up|2
6978535|NCT01213264|11031849|FG002|Overall Study|Lost to Follow-up|6
6978536|NCT01213472|11031868|FG000|Overall Study|Recurrence/Progressive disease|25
6978537|NCT01213472|11031868|FG000|Overall Study|Withdrawal by Subject|1
6896610|NCT00634114|10915134|FG001|Overall Study|Lost to Follow-up|0
6896611|NCT00634114|10915135|FG002|Overall Study|Lost to Follow-up|1
6896612|NCT00634114|10915133|FG000|Overall Study|Protocol Violation|3
6896613|NCT00634114|10915134|FG001|Overall Study|Protocol Violation|3
6896614|NCT00634114|10915135|FG002|Overall Study|Protocol Violation|1
6896615|NCT00634114|10915133|FG000|Overall Study|Pregnancy|1
6978538|NCT01213472|11031868|FG000|Overall Study|Physician Decision|1
6978539|NCT01213524|11031874|FG000|Baseline|Withdrawal by Subject|5
6978540|NCT01213524|11031874|FG000|Baseline|high breath alcohol levels|1
6978541|NCT01213524|11031874|FG000|Baseline|Physician Decision|1
6820285|NCT00090285|10824344|FG000|Base Study Vaccination Period|Site Terminated|1
6820286|NCT00090285|10824345|FG001|Base Study Vaccination Period|Site Terminated|0
6820287|NCT00090285|10824346|FG002|Base Study Vaccination Period|Site Terminated|0
6820288|NCT00090285|10824347|FG003|Base Study Vaccination Period|Site Terminated|0
6820289|NCT00090285|10824348|FG004|Base Study Vaccination Period|Site Terminated|0
6820290|NCT00090285|10824349|FG005|Base Study Vaccination Period|Site Terminated|0
6820291|NCT00090285|10824344|FG000|Base Study Vaccination Period|Other|2
6820292|NCT00090285|10824345|FG001|Base Study Vaccination Period|Other|2
6820293|NCT00090285|10824346|FG002|Base Study Vaccination Period|Other|0
6820294|NCT00090285|10824347|FG003|Base Study Vaccination Period|Other|0
6820295|NCT00090285|10824348|FG004|Base Study Vaccination Period|Other|0
6820296|NCT00090285|10824349|FG005|Base Study Vaccination Period|Other|0
6820297|NCT00090285|10824344|FG000|Base Study Vaccination Period|Subject Incarcerated|2
6820298|NCT00090285|10824345|FG001|Base Study Vaccination Period|Subject Incarcerated|2
6820299|NCT00090285|10824346|FG002|Base Study Vaccination Period|Subject Incarcerated|0
6820300|NCT00090285|10824347|FG003|Base Study Vaccination Period|Subject Incarcerated|0
6820301|NCT00090285|10824348|FG004|Base Study Vaccination Period|Subject Incarcerated|0
6820302|NCT00090285|10824349|FG005|Base Study Vaccination Period|Subject Incarcerated|0
6820303|NCT00090285|10824344|FG000|Base Study Vaccination Period|HIV positive|1
6978542|NCT01213524|11031874|FG000|Session 2|Withdrawal by Subject|5
6978543|NCT01213524|11031874|FG000|Session 3|Withdrawal by Subject|4
6978544|NCT01213524|11031874|FG000|Session 4|Physician Decision|1
6978545|NCT01213524|11031874|FG000|Session 4|Withdrawal by Subject|2
6978546|NCT01213836|11031932|FG000|Period 1, First Intervention|Adverse Event|2
6978547|NCT01213836|11031933|FG001|Period 1, First Intervention|Adverse Event|1
6820304|NCT00090285|10824345|FG001|Base Study Vaccination Period|HIV positive|1
6820305|NCT00090285|10824346|FG002|Base Study Vaccination Period|HIV positive|0
6820306|NCT00090285|10824347|FG003|Base Study Vaccination Period|HIV positive|0
6820307|NCT00090285|10824348|FG004|Base Study Vaccination Period|HIV positive|0
6820308|NCT00090285|10824349|FG005|Base Study Vaccination Period|HIV positive|0
6820309|NCT00090285|10824344|FG000|Base Study Follow-up Period|Adverse Event|3
6820310|NCT00090285|10824345|FG001|Base Study Follow-up Period|Adverse Event|10
6820311|NCT00090285|10824346|FG002|Base Study Follow-up Period|Adverse Event|0
6820312|NCT00090285|10824347|FG003|Base Study Follow-up Period|Adverse Event|0
6820313|NCT00090285|10824348|FG004|Base Study Follow-up Period|Adverse Event|0
6820314|NCT00090285|10824349|FG005|Base Study Follow-up Period|Adverse Event|0
6820315|NCT00090285|10824344|FG000|Base Study Follow-up Period|Lost to Follow-up|232
6820316|NCT00090285|10824345|FG001|Base Study Follow-up Period|Lost to Follow-up|226
6820317|NCT00090285|10824346|FG002|Base Study Follow-up Period|Lost to Follow-up|0
6820318|NCT00090285|10824347|FG003|Base Study Follow-up Period|Lost to Follow-up|0
6820319|NCT00090285|10824348|FG004|Base Study Follow-up Period|Lost to Follow-up|0
6820320|NCT00090285|10824349|FG005|Base Study Follow-up Period|Lost to Follow-up|0
6820321|NCT00090285|10824344|FG000|Base Study Follow-up Period|Withdrawal by Subject|53
6820322|NCT00090285|10824345|FG001|Base Study Follow-up Period|Withdrawal by Subject|64
6820323|NCT00090285|10824346|FG002|Base Study Follow-up Period|Withdrawal by Subject|0
6820324|NCT00090285|10824347|FG003|Base Study Follow-up Period|Withdrawal by Subject|0
6820325|NCT00090285|10824348|FG004|Base Study Follow-up Period|Withdrawal by Subject|0
6820326|NCT00090285|10824349|FG005|Base Study Follow-up Period|Withdrawal by Subject|0
6820327|NCT00090285|10824344|FG000|Base Study Follow-up Period|Moved|41
6820328|NCT00090285|10824345|FG001|Base Study Follow-up Period|Moved|36
6820329|NCT00090285|10824346|FG002|Base Study Follow-up Period|Moved|0
6820330|NCT00090285|10824347|FG003|Base Study Follow-up Period|Moved|0
6820331|NCT00090285|10824348|FG004|Base Study Follow-up Period|Moved|0
6820332|NCT00090285|10824349|FG005|Base Study Follow-up Period|Moved|0
6820333|NCT00090285|10824344|FG000|Base Study Follow-up Period|Other|2
6820334|NCT00090285|10824345|FG001|Base Study Follow-up Period|Other|0
6820335|NCT00090285|10824346|FG002|Base Study Follow-up Period|Other|0
6820336|NCT00090285|10824347|FG003|Base Study Follow-up Period|Other|0
6820337|NCT00090285|10824348|FG004|Base Study Follow-up Period|Other|0
6820338|NCT00090285|10824349|FG005|Base Study Follow-up Period|Other|0
6820339|NCT00090285|10824344|FG000|Base Study Follow-up Period|Protocol Violation|1
6820340|NCT00090285|10824345|FG001|Base Study Follow-up Period|Protocol Violation|0
6820341|NCT00090285|10824346|FG002|Base Study Follow-up Period|Protocol Violation|0
6820342|NCT00090285|10824347|FG003|Base Study Follow-up Period|Protocol Violation|0
6820343|NCT00090285|10824348|FG004|Base Study Follow-up Period|Protocol Violation|0
6820344|NCT00090285|10824349|FG005|Base Study Follow-up Period|Protocol Violation|0
6820345|NCT00090285|10824344|FG000|Base Study Follow-up Period|Uncooperative|3
6820346|NCT00090285|10824345|FG001|Base Study Follow-up Period|Uncooperative|4
6820347|NCT00090285|10824346|FG002|Base Study Follow-up Period|Uncooperative|0
6820348|NCT00090285|10824347|FG003|Base Study Follow-up Period|Uncooperative|0
6820349|NCT00090285|10824348|FG004|Base Study Follow-up Period|Uncooperative|0
6820350|NCT00090285|10824349|FG005|Base Study Follow-up Period|Uncooperative|0
6820351|NCT00090285|10824344|FG000|Base Study Follow-up Period|Subject Incarcerated|0
6820352|NCT00090285|10824345|FG001|Base Study Follow-up Period|Subject Incarcerated|2
6820353|NCT00090285|10824346|FG002|Base Study Follow-up Period|Subject Incarcerated|0
6820354|NCT00090285|10824347|FG003|Base Study Follow-up Period|Subject Incarcerated|0
6978548|NCT01213836|11031932|FG000|Period 1, First Intervention|Protocol Violation|0
6820355|NCT00090285|10824348|FG004|Base Study Follow-up Period|Subject Incarcerated|0
6820356|NCT00090285|10824349|FG005|Base Study Follow-up Period|Subject Incarcerated|0
6820357|NCT00090285|10824344|FG000|Extension 1|Adverse Event|0
6820358|NCT00090285|10824345|FG001|Extension 1|Adverse Event|0
6820359|NCT00090285|10824346|FG002|Extension 1|Adverse Event|2
6820360|NCT00090285|10824347|FG003|Extension 1|Adverse Event|0
6820361|NCT00090285|10824348|FG004|Extension 1|Adverse Event|0
6820362|NCT00090285|10824349|FG005|Extension 1|Adverse Event|0
6820363|NCT00090285|10824344|FG000|Extension 1|Lost to Follow-up|0
6820364|NCT00090285|10824345|FG001|Extension 1|Lost to Follow-up|0
6820365|NCT00090285|10824346|FG002|Extension 1|Lost to Follow-up|35
6820366|NCT00090285|10824347|FG003|Extension 1|Lost to Follow-up|0
6820367|NCT00090285|10824348|FG004|Extension 1|Lost to Follow-up|0
6820368|NCT00090285|10824349|FG005|Extension 1|Lost to Follow-up|0
6820369|NCT00090285|10824344|FG000|Extension 1|Withdrawal by Subject|0
6820370|NCT00090285|10824345|FG001|Extension 1|Withdrawal by Subject|0
6820371|NCT00090285|10824346|FG002|Extension 1|Withdrawal by Subject|13
6899698|NCT00660387|10919753|FG000|Overall Study|Adverse Event|1
6899699|NCT00660387|10919754|FG001|Overall Study|Adverse Event|2
6899700|NCT00660387|10919753|FG000|Overall Study|Lack of Efficacy|0
6899701|NCT00660387|10919754|FG001|Overall Study|Lack of Efficacy|1
6899702|NCT00660387|10919753|FG000|Overall Study|Protocol Violation|1
6899703|NCT00660387|10919754|FG001|Overall Study|Protocol Violation|0
6899704|NCT00660400|10919760|FG000|Overall Study|Lack of insurance approval|1
6899705|NCT00660400|10919760|FG000|Overall Study|Suboptimal organ function|1
6899706|NCT00660400|10919760|FG000|Overall Study|Intracranial hemorrhage|1
6899707|NCT00660400|10919760|FG000|Overall Study|Withdrawal by Subject|1
6899708|NCT00660660|10919808|FG000|Overall Study|Adverse Event|1
6899709|NCT00660660|10919809|FG001|Overall Study|Adverse Event|0
6899710|NCT00660660|10919808|FG000|Overall Study|Lost to Follow-up|0
6899711|NCT00660660|10919809|FG001|Overall Study|Lost to Follow-up|6
6899712|NCT00660660|10919808|FG000|Overall Study|Lack of Efficacy|0
6899713|NCT00660660|10919809|FG001|Overall Study|Lack of Efficacy|2
6899714|NCT00660660|10919808|FG000|Overall Study|Withdrawal by Subject|3
6899715|NCT00660660|10919809|FG001|Overall Study|Withdrawal by Subject|0
6899716|NCT00660660|10919808|FG000|Overall Study|Incorrect enrollment and other|0
6899717|NCT00660660|10919809|FG001|Overall Study|Incorrect enrollment and other|1
6899718|NCT00660660|10919808|FG000|Overall Study|New medication after randomization|1
6899719|NCT00660660|10919809|FG001|Overall Study|New medication after randomization|0
6899720|NCT00660699|10919815|FG000|Overall Study|Withdrawal by Subject|2
6899721|NCT00660790|10919819|FG000|Baseline to 3 Months|Death|1
6899722|NCT00660790|10919819|FG000|Baseline to 3 Months|Withdrawal by Subject|2
6899723|NCT00660790|10919819|FG000|3 Months to 2 Years|Withdrawal by Subject|17
6899724|NCT00660816|10919825|FG000|Overall Study|Adverse Event|1
6899725|NCT00660816|10919826|FG001|Overall Study|Adverse Event|2
6899726|NCT00660816|10919825|FG000|Overall Study|Withdrawal by Subject|1
6899727|NCT00660816|10919826|FG001|Overall Study|Withdrawal by Subject|0
6899728|NCT00660816|10919825|FG000|Overall Study|Death|0
6899729|NCT00660816|10919826|FG001|Overall Study|Death|2
6899730|NCT00660816|10919825|FG000|Overall Study|Lack of Efficacy|1
6899731|NCT00660816|10919826|FG001|Overall Study|Lack of Efficacy|0
6899732|NCT00660816|10919825|FG000|Overall Study|Physician Decision|0
6899733|NCT00660816|10919826|FG001|Overall Study|Physician Decision|2
6899734|NCT00660816|10919825|FG000|Overall Study|Protocol Violation|1
6899735|NCT00660816|10919826|FG001|Overall Study|Protocol Violation|0
6899736|NCT00660816|10919825|FG000|Overall Study|Disease Progression|16
6899737|NCT00660816|10919826|FG001|Overall Study|Disease Progression|12
6899738|NCT00660816|10919825|FG000|Overall Study|Complicating Disease|0
6899739|NCT00660816|10919826|FG001|Overall Study|Complicating Disease|1
6899740|NCT00660829|10919834|FG000|Overall Study|Adverse Event|3
6899741|NCT00660829|10919835|FG001|Overall Study|Adverse Event|4
6899742|NCT00660829|10919834|FG000|Overall Study|Lack of Efficacy|2
6899743|NCT00660829|10919835|FG001|Overall Study|Lack of Efficacy|3
6899744|NCT00660829|10919834|FG000|Overall Study|Non-Compliance|0
6899745|NCT00660829|10919835|FG001|Overall Study|Non-Compliance|4
6899746|NCT00660829|10919834|FG000|Overall Study|Withdrawal by Subject|1
6899747|NCT00660829|10919835|FG001|Overall Study|Withdrawal by Subject|2
6899748|NCT00660829|10919834|FG000|Overall Study|Lost to Follow-up|3
6899749|NCT00660829|10919835|FG001|Overall Study|Lost to Follow-up|2
6899750|NCT00660829|10919834|FG000|Overall Study|Other|9
6899751|NCT00660829|10919835|FG001|Overall Study|Other|4
6899752|NCT00660907|10919843|FG000|Overall Study|Incorrect Enrollment|1
6899753|NCT00660907|10919844|FG001|Overall Study|Incorrect Enrollment|1
6899754|NCT00660907|10919843|FG000|Overall Study|Adverse Event|33
6899755|NCT00660907|10919844|FG001|Overall Study|Adverse Event|19
6899756|NCT00660907|10919843|FG000|Overall Study|Subject No Longer Meets Study Criteria|6
6899757|NCT00660907|10919844|FG001|Overall Study|Subject No Longer Meets Study Criteria|27
6899758|NCT00660907|10919843|FG000|Overall Study|Withdrawal by Subject|23
6899759|NCT00660907|10919844|FG001|Overall Study|Withdrawal by Subject|32
6899760|NCT00660907|10919843|FG000|Overall Study|Lost to Follow-up|3
6899761|NCT00660907|10919844|FG001|Overall Study|Lost to Follow-up|3
6820372|NCT00090285|10824347|FG003|Extension 1|Withdrawal by Subject|1
6820373|NCT00090285|10824348|FG004|Extension 1|Withdrawal by Subject|0
6820374|NCT00090285|10824349|FG005|Extension 1|Withdrawal by Subject|0
6820375|NCT00090285|10824344|FG000|Extension 1|Other|0
6899762|NCT00660907|10919843|FG000|Overall Study|Poor/Non-Compliance|5
6820376|NCT00090285|10824345|FG001|Extension 1|Other|0
6820377|NCT00090285|10824346|FG002|Extension 1|Other|4
6820378|NCT00090285|10824347|FG003|Extension 1|Other|0
6820379|NCT00090285|10824348|FG004|Extension 1|Other|0
6820380|NCT00090285|10824349|FG005|Extension 1|Other|0
6820381|NCT00090285|10824344|FG000|Extension 1|Moved|0
6820382|NCT00090285|10824345|FG001|Extension 1|Moved|0
6820383|NCT00090285|10824346|FG002|Extension 1|Moved|3
6820384|NCT00090285|10824347|FG003|Extension 1|Moved|0
6820385|NCT00090285|10824348|FG004|Extension 1|Moved|0
6820386|NCT00090285|10824349|FG005|Extension 1|Moved|0
6820387|NCT00090285|10824344|FG000|Long-term Follow-up (EXT2)|Adverse Event|0
6820388|NCT00090285|10824345|FG001|Long-term Follow-up (EXT2)|Adverse Event|0
6820389|NCT00090285|10824346|FG002|Long-term Follow-up (EXT2)|Adverse Event|0
6820390|NCT00090285|10824347|FG003|Long-term Follow-up (EXT2)|Adverse Event|0
6820391|NCT00090285|10824348|FG004|Long-term Follow-up (EXT2)|Adverse Event|5
6820392|NCT00090285|10824349|FG005|Long-term Follow-up (EXT2)|Adverse Event|2
6820393|NCT00090285|10824344|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0
6820394|NCT00090285|10824345|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0
6820395|NCT00090285|10824346|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0
6820396|NCT00090285|10824347|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0
6820397|NCT00090285|10824348|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156
6820398|NCT00090285|10824349|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143
6820399|NCT00090285|10824344|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
6820400|NCT00090285|10824345|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
6820401|NCT00090285|10824346|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
6820402|NCT00090285|10824347|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
6820403|NCT00090285|10824348|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60
6820404|NCT00090285|10824349|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53
6820405|NCT00090285|10824344|FG000|Long-term Follow-up (EXT2)|Physician Decision|0
6820406|NCT00090285|10824345|FG001|Long-term Follow-up (EXT2)|Physician Decision|0
6820407|NCT00090285|10824346|FG002|Long-term Follow-up (EXT2)|Physician Decision|0
6820408|NCT00090285|10824347|FG003|Long-term Follow-up (EXT2)|Physician Decision|0
6820409|NCT00090285|10824348|FG004|Long-term Follow-up (EXT2)|Physician Decision|6
6820410|NCT00090285|10824349|FG005|Long-term Follow-up (EXT2)|Physician Decision|5
6899763|NCT00660907|10919844|FG001|Overall Study|Poor/Non-Compliance|1
6899764|NCT00660907|10919843|FG000|Overall Study|Safety|1
6899765|NCT00660907|10919844|FG001|Overall Study|Safety|0
6899766|NCT00660907|10919843|FG000|Overall Study|Death|1
6899767|NCT00660907|10919844|FG001|Overall Study|Death|3
6899768|NCT00660907|10919843|FG000|Overall Study|Various|11
6899769|NCT00660907|10919844|FG001|Overall Study|Various|8
6899770|NCT00661089|10919872|FG000|Overall Study|1 subject withdrawal|0
6820411|NCT00090363|10824367|FG000|Overall Study|Lost to Follow-up|1
6820412|NCT00090363|10824368|FG001|Overall Study|Lost to Follow-up|2
6820413|NCT00090363|10824369|FG002|Overall Study|Lost to Follow-up|1
6820414|NCT00090363|10824367|FG000|Overall Study|Withdrawal by Subject|7
6820415|NCT00090363|10824368|FG001|Overall Study|Withdrawal by Subject|7
6820416|NCT00090363|10824369|FG002|Overall Study|Withdrawal by Subject|6
6820417|NCT00090363|10824367|FG000|Overall Study|Study-specific discontinuation criteria|75
6820418|NCT00090363|10824368|FG001|Overall Study|Study-specific discontinuation criteria|74
6820419|NCT00090363|10824369|FG002|Overall Study|Study-specific discontinuation criteria|62
6820420|NCT00090363|10824367|FG000|Overall Study|Eligibility criteria not fulfilled|0
6820421|NCT00090363|10824368|FG001|Overall Study|Eligibility criteria not fulfilled|0
6820422|NCT00090363|10824369|FG002|Overall Study|Eligibility criteria not fulfilled|1
6820423|NCT00090363|10824367|FG000|Overall Study|Consent expired|7
6820424|NCT00090363|10824368|FG001|Overall Study|Consent expired|10
6820425|NCT00090363|10824369|FG002|Overall Study|Consent expired|9
6820426|NCT00090363|10824367|FG000|Overall Study|Reasons not specified|2
6820427|NCT00090363|10824368|FG001|Overall Study|Reasons not specified|1
6820428|NCT00090363|10824369|FG002|Overall Study|Reasons not specified|1
6899771|NCT00661089|10919873|FG001|Overall Study|1 subject withdrawal|1
6899772|NCT00661089|10919872|FG000|Overall Study|death at 8 weeks due to new stroke|0
6899773|NCT00661089|10919873|FG001|Overall Study|death at 8 weeks due to new stroke|1
6899774|NCT00661193|10919909|FG000|Overall Study|Adverse Event|2
6899775|NCT00661193|10919910|FG001|Overall Study|Adverse Event|1
6899776|NCT00661193|10919909|FG000|Overall Study|Withdrawal by Subject|3
6899777|NCT00661193|10919910|FG001|Overall Study|Withdrawal by Subject|1
6899778|NCT00661193|10919909|FG000|Overall Study|Progression|27
6899779|NCT00661193|10919910|FG001|Overall Study|Progression|24
6899780|NCT00661193|10919909|FG000|Overall Study|Not protocol specified|1
6899781|NCT00661193|10919910|FG001|Overall Study|Not protocol specified|0
6899782|NCT00661258|10919918|FG000|Overall Study|Death|1
6899783|NCT00661258|10919919|FG001|Overall Study|Death|0
6899784|NCT00661258|10919918|FG000|Overall Study|caught by police and in detox center|2
6899785|NCT00661258|10919919|FG001|Overall Study|caught by police and in detox center|1
6820429|NCT00090363|10824367|FG000|Overall Study|Continuing on study off treatment|14
6899786|NCT00661271|10919927|FG000|Overall Study|Lost to Follow-up|28
6899787|NCT00661271|10919928|FG001|Overall Study|Lost to Follow-up|25
6899788|NCT00661362|10919936|FG000|Overall Study|Adverse Event|5
6899789|NCT00661362|10919937|FG001|Overall Study|Adverse Event|4
6899790|NCT00661362|10919936|FG000|Overall Study|Incorrect enrollment|2
6899791|NCT00661362|10919937|FG001|Overall Study|Incorrect enrollment|0
6820430|NCT00090363|10824368|FG001|Overall Study|Continuing on study off treatment|13
6820431|NCT00090363|10824369|FG002|Overall Study|Continuing on study off treatment|16
6820432|NCT00090402|10824380|FG000|Overall Study|Death|1
6820433|NCT00090402|10824381|FG001|Overall Study|Death|1
6820434|NCT00090402|10824382|FG002|Overall Study|Death|0
6820435|NCT00090402|10824380|FG000|Overall Study|subject moved|0
6820436|NCT00090402|10824381|FG001|Overall Study|subject moved|1
6820437|NCT00090402|10824382|FG002|Overall Study|subject moved|0
6820438|NCT00090402|10824380|FG000|Overall Study|stopped taking study medication|1
6820439|NCT00090402|10824381|FG001|Overall Study|stopped taking study medication|0
6820440|NCT00090402|10824382|FG002|Overall Study|stopped taking study medication|1
6820441|NCT00090493|10824393|FG000|Overall Study|Physician Decision|2
6820442|NCT00090519|10824399|FG000|Overall Study|Adverse Event|5
6820443|NCT00090519|10824400|FG001|Overall Study|Adverse Event|4
6820444|NCT00090519|10824399|FG000|Overall Study|Death|9
6820445|NCT00090519|10824400|FG001|Overall Study|Death|9
6820446|NCT00090519|10824399|FG000|Overall Study|Lost to Follow-up|26
6820447|NCT00090519|10824400|FG001|Overall Study|Lost to Follow-up|29
6820448|NCT00090519|10824399|FG000|Overall Study|Withdrawal by Subject|28
6820449|NCT00090519|10824400|FG001|Overall Study|Withdrawal by Subject|29
6820450|NCT00090519|10824399|FG000|Overall Study|Physician Decision|2
6820451|NCT00090519|10824400|FG001|Overall Study|Physician Decision|3
6820452|NCT00090519|10824399|FG000|Overall Study|Sponsor Decision|3
6820453|NCT00090519|10824400|FG001|Overall Study|Sponsor Decision|1
6820454|NCT00090545|10824408|FG000|Overall Study|Disease progression on study|21
6820455|NCT00090545|10824409|FG001|Overall Study|Disease progression on study|17
6820456|NCT00090545|10824408|FG000|Overall Study|Refused further treatment|1
6820457|NCT00090545|10824409|FG001|Overall Study|Refused further treatment|4
6820458|NCT00090545|10824408|FG000|Overall Study|Death|0
6820459|NCT00090545|10824409|FG001|Overall Study|Death|1
6820460|NCT00090545|10824408|FG000|Overall Study|Adverse Event|0
6820461|NCT00090545|10824409|FG001|Overall Study|Adverse Event|2
6820462|NCT00090584|10824419|FG000|Baseline to 10 Weeks|Lost to Follow-up|15
6820463|NCT00090584|10824420|FG001|Baseline to 10 Weeks|Lost to Follow-up|12
6820464|NCT00090584|10824419|FG000|Baseline to 8 Months|Lost to Follow-up|44
6820465|NCT00090584|10824420|FG001|Baseline to 8 Months|Lost to Follow-up|41
6820466|NCT00090610|10824436|FG000|Overall Study|Withdrawal by Subject|1
6820467|NCT00090610|10824437|FG001|Overall Study|Withdrawal by Subject|1
6820468|NCT00090753|10824445|FG000|First Treatment Period|Adverse Event|20
6820469|NCT00090753|10824446|FG001|First Treatment Period|Adverse Event|8
6820470|NCT00090753|10824445|FG000|First Treatment Period|Death|88
6820471|NCT00090753|10824446|FG001|First Treatment Period|Death|62
6820472|NCT00090753|10824445|FG000|First Treatment Period|Lack of Efficacy|2
6820473|NCT00090753|10824446|FG001|First Treatment Period|Lack of Efficacy|1
6820474|NCT00090753|10824445|FG000|First Treatment Period|Refused Treatment|32
6820475|NCT00090753|10824446|FG001|First Treatment Period|Refused Treatment|25
6820476|NCT00090753|10824445|FG000|First Treatment Period|Lost to Follow-up|4
6820477|NCT00090753|10824446|FG001|First Treatment Period|Lost to Follow-up|4
6820478|NCT00090753|10824445|FG000|First Treatment Period|Renal Transplant|70
6820479|NCT00090753|10824446|FG001|First Treatment Period|Renal Transplant|50
6820480|NCT00090753|10824445|FG000|First Treatment Period|Mircera Commercialization|1
6820481|NCT00090753|10824446|FG001|First Treatment Period|Mircera Commercialization|0
6820482|NCT00090753|10824445|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39
6820483|NCT00090753|10824446|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28
6820484|NCT00090753|10824445|FG000|Extended Treatment Period|Adverse Event|11
6820485|NCT00090753|10824446|FG001|Extended Treatment Period|Adverse Event|0
6820486|NCT00090753|10824445|FG000|Extended Treatment Period|Death|58
6820487|NCT00090753|10824446|FG001|Extended Treatment Period|Death|30
6820488|NCT00090753|10824445|FG000|Extended Treatment Period|Lack of Efficacy|1
6820489|NCT00090753|10824446|FG001|Extended Treatment Period|Lack of Efficacy|0
6820490|NCT00090753|10824445|FG000|Extended Treatment Period|Refused Treatment|18
6820491|NCT00090753|10824446|FG001|Extended Treatment Period|Refused Treatment|12
6820492|NCT00090753|10824445|FG000|Extended Treatment Period|Lost to Follow-up|3
6820493|NCT00090753|10824446|FG001|Extended Treatment Period|Lost to Follow-up|1
6820494|NCT00090753|10824445|FG000|Extended Treatment Period|Renal Transplant|15
6820495|NCT00090753|10824446|FG001|Extended Treatment Period|Renal Transplant|12
6820496|NCT00090753|10824445|FG000|Extended Treatment Period|Mircera Commercialization|188
6820497|NCT00090753|10824446|FG001|Extended Treatment Period|Mircera Commercialization|93
6820498|NCT00090753|10824445|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65
6820499|NCT00090753|10824446|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43
6820500|NCT00090766|10824455|FG000|Overall Study|Nephrectomy Planned|0
6820501|NCT00090766|10824456|FG001|Overall Study|Nephrectomy Planned|0
6820502|NCT00090766|10824457|FG002|Overall Study|Nephrectomy Planned|1
6820503|NCT00090766|10824455|FG000|Overall Study|Death|1
6820504|NCT00090766|10824456|FG001|Overall Study|Death|0
6820505|NCT00090766|10824457|FG002|Overall Study|Death|0
6820506|NCT00090766|10824455|FG000|Overall Study|Admin|0
6820507|NCT00090766|10824456|FG001|Overall Study|Admin|2
6820508|NCT00090766|10824457|FG002|Overall Study|Admin|0
6820509|NCT00090766|10824455|FG000|Overall Study|Lost to Follow-up|2
6820510|NCT00090766|10824456|FG001|Overall Study|Lost to Follow-up|0
6820511|NCT00090766|10824457|FG002|Overall Study|Lost to Follow-up|2
6820512|NCT00090779|10824469|FG000|Step 1|Withdrawal by Subject|4
6820513|NCT00090779|10824470|FG001|Step 1|Withdrawal by Subject|2
6820514|NCT00090779|10824469|FG000|Step 1|Lost to Follow-up|3
6820515|NCT00090779|10824470|FG001|Step 1|Lost to Follow-up|2
6820516|NCT00090779|10824469|FG000|Step 1|Death|0
6820517|NCT00090779|10824470|FG001|Step 1|Death|2
6820518|NCT00090779|10824469|FG000|Step 1|Physician Decision|1
6820519|NCT00090779|10824470|FG001|Step 1|Physician Decision|0
6820520|NCT00090779|10824469|FG000|Step 1|Pregnancy|1
6820521|NCT00090779|10824470|FG001|Step 1|Pregnancy|0
6820522|NCT00090779|10824469|FG000|Step 1|Non-compliance to study requirements|0
6820523|NCT00090779|10824470|FG001|Step 1|Non-compliance to study requirements|1
6820524|NCT00090779|10824469|FG000|Step 1|Subject relocated|2
6820525|NCT00090779|10824470|FG001|Step 1|Subject relocated|8
6820526|NCT00090779|10824469|FG000|Step 2|Off study per study closure|6
6820527|NCT00090779|10824470|FG001|Step 2|Off study per study closure|16
6820528|NCT00090779|10824469|FG000|Step 2|Subject relocated|0
6820529|NCT00090779|10824470|FG001|Step 2|Subject relocated|1
6820530|NCT00090779|10824469|FG000|Step 2|Non-compliance to study requirements|0
6820531|NCT00090779|10824470|FG001|Step 2|Non-compliance to study requirements|1
6820532|NCT00090779|10824469|FG000|Step 3|Initiation of ART and off extended study|3
6820533|NCT00090779|10824470|FG001|Step 3|Initiation of ART and off extended study|2
6820534|NCT00090779|10824469|FG000|Step 3|Off extended study due to study closure|4
6820535|NCT00090779|10824470|FG001|Step 3|Off extended study due to study closure|3
6820536|NCT00090857|10824488|FG000|Overall Study|Lost to Follow-up|0
6820537|NCT00090857|10824489|FG001|Overall Study|Lost to Follow-up|1
6820538|NCT00090857|10824488|FG000|Overall Study|Withdrawal by Subject|2
6820539|NCT00090857|10824489|FG001|Overall Study|Withdrawal by Subject|0
6820540|NCT00090857|10824488|FG000|Overall Study|Adverse Event|2
6820541|NCT00090857|10824489|FG001|Overall Study|Adverse Event|2
6820542|NCT00090987|10824495|FG000|Overall Study|Adverse Event|5
6820543|NCT00090987|10824495|FG000|Overall Study|Lack of Efficacy|7
6820544|NCT00090987|10824495|FG000|Overall Study|Withdrawal by Subject|3
6820545|NCT00090987|10824495|FG000|Overall Study|alternative therapy|1
6820546|NCT00090987|10824495|FG000|Overall Study|Non-compliance|4
6820547|NCT00090987|10824495|FG000|Overall Study|Incarcerated|1
6820548|NCT00091026|10824501|FG000|Overall Study|Patient deemed non eligible-never receiv|1
6820549|NCT00091026|10824502|FG001|Overall Study|Patient deemed non eligible-never receiv|0
6820550|NCT00091026|10824501|FG000|Overall Study|Patient withdrew and never received trea|0
6820551|NCT00091026|10824502|FG001|Overall Study|Patient withdrew and never received trea|2
6820552|NCT00091026|10824501|FG000|Overall Study|Unknown-never received treatment|0
6820553|NCT00091026|10824502|FG001|Overall Study|Unknown-never received treatment|1
6820554|NCT00091169|10824510|FG000|Overall Study|Disease progression|3
6820555|NCT00091169|10824511|FG001|Overall Study|Disease progression|1
6820556|NCT00091169|10824510|FG000|Overall Study|Adverse Event|11
6820557|NCT00091169|10824511|FG001|Overall Study|Adverse Event|17
6820558|NCT00091169|10824510|FG000|Overall Study|Death|4
6820559|NCT00091169|10824511|FG001|Overall Study|Death|1
6820560|NCT00091169|10824510|FG000|Overall Study|Withdrawal by Subject|10
6820561|NCT00091169|10824511|FG001|Overall Study|Withdrawal by Subject|13
6820562|NCT00091169|10824510|FG000|Overall Study|Other|3
6820563|NCT00091169|10824511|FG001|Overall Study|Other|4
6820564|NCT00091169|10824510|FG000|Overall Study|Not start protocol therapy|26
6820565|NCT00091169|10824511|FG001|Overall Study|Not start protocol therapy|17
6820566|NCT00091390|10824528|FG000|Overall Study|Protocol Violation|1
6820567|NCT00091390|10824528|FG000|Overall Study|No protocol treatment|3
6820568|NCT00091442|10824534|FG000|Overall Study|Progressive Disease|220
6820569|NCT00091442|10824535|FG001|Overall Study|Progressive Disease|189
6820570|NCT00091442|10824534|FG000|Overall Study|Physician Decision|61
6820571|NCT00091442|10824535|FG001|Overall Study|Physician Decision|58
6820572|NCT00091442|10824534|FG000|Overall Study|Withdrawal by Subject|38
6820573|NCT00091442|10824535|FG001|Overall Study|Withdrawal by Subject|46
6820574|NCT00091442|10824534|FG000|Overall Study|Adverse Event|29
6820575|NCT00091442|10824535|FG001|Overall Study|Adverse Event|48
6820576|NCT00091442|10824534|FG000|Overall Study|2cycles therapy beyond Complete response|9
6820577|NCT00091442|10824535|FG001|Overall Study|2cycles therapy beyond Complete response|16
6820578|NCT00091442|10824534|FG000|Overall Study|Death|9
6820579|NCT00091442|10824535|FG001|Overall Study|Death|7
6820580|NCT00091442|10824534|FG000|Overall Study|Lost to Follow-up|1
6820581|NCT00091442|10824535|FG001|Overall Study|Lost to Follow-up|3
6820582|NCT00091442|10824534|FG000|Overall Study|Other|2
6820583|NCT00091442|10824535|FG001|Overall Study|Other|6
6820584|NCT00091572|10824552|FG000|Overall Study|Lost to Follow-up|1
6820585|NCT00091572|10824553|FG001|Overall Study|Lost to Follow-up|1
6820586|NCT00091572|10824552|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14
6820587|NCT00091572|10824553|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22
6820588|NCT00091572|10824552|FG000|Overall Study|Death not due to malignancy/toxicity|1
6820589|NCT00091572|10824553|FG001|Overall Study|Death not due to malignancy/toxicity|3
6820590|NCT00091572|10824552|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10
6820591|NCT00091572|10824553|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22
6820592|NCT00091572|10824552|FG000|Overall Study|Other Reason|6
6820593|NCT00091572|10824553|FG001|Overall Study|Other Reason|13
6820594|NCT00091572|10824552|FG000|Overall Study|Ongoing (still on treatment)|8
6820595|NCT00091572|10824553|FG001|Overall Study|Ongoing (still on treatment)|12
6820596|NCT00091572|10824552|FG000|Overall Study|Major Protocol Violation|2
6820597|NCT00091572|10824553|FG001|Overall Study|Major Protocol Violation|0
6820598|NCT00091572|10824552|FG000|Overall Study|Toxicity (Related AE)|53
6820599|NCT00091572|10824553|FG001|Overall Study|Toxicity (Related AE)|9
6820600|NCT00091793|10824561|FG000|Overall Study|Adverse Event|1
6820601|NCT00091793|10824562|FG001|Overall Study|Adverse Event|2
6820602|NCT00091793|10824561|FG000|Overall Study|Withdrawal by Subject|10
6820603|NCT00091793|10824562|FG001|Overall Study|Withdrawal by Subject|15
6899792|NCT00661362|10919936|FG000|Overall Study|Study specific discontinuation criteria|4
6899793|NCT00661362|10919937|FG001|Overall Study|Study specific discontinuation criteria|11
6899794|NCT00661362|10919936|FG000|Overall Study|Withdrawal by Subject|13
6899795|NCT00661362|10919937|FG001|Overall Study|Withdrawal by Subject|23
6899796|NCT00661362|10919936|FG000|Overall Study|Lost to Follow-up|3
6899797|NCT00661362|10919937|FG001|Overall Study|Lost to Follow-up|1
6899798|NCT00661362|10919936|FG000|Overall Study|Severe non-compliance to protocol|0
6899799|NCT00661362|10919937|FG001|Overall Study|Severe non-compliance to protocol|1
6820604|NCT00091793|10824561|FG000|Overall Study|Ineligibility determined|2
6820605|NCT00091793|10824562|FG001|Overall Study|Ineligibility determined|0
6820606|NCT00091793|10824561|FG000|Overall Study|Lost to Follow-up|7
6820607|NCT00091793|10824562|FG001|Overall Study|Lost to Follow-up|5
6820608|NCT00091793|10824561|FG000|Overall Study|Noncompliance|2
6820609|NCT00091793|10824562|FG001|Overall Study|Noncompliance|0
6820610|NCT00091793|10824561|FG000|Overall Study|Other|2
6820611|NCT00091793|10824562|FG001|Overall Study|Other|0
6820612|NCT00091819|10824570|FG000|Overall Study|Adverse Event|1
6820613|NCT00091819|10824571|FG001|Overall Study|Adverse Event|1
6820614|NCT00091819|10824570|FG000|Overall Study|Death|4
6820615|NCT00091819|10824571|FG001|Overall Study|Death|5
6820616|NCT00091819|10824570|FG000|Overall Study|Lost to Follow-up|26
6820617|NCT00091819|10824571|FG001|Overall Study|Lost to Follow-up|23
6820618|NCT00091819|10824570|FG000|Overall Study|Withdrawal by Subject|5
6820619|NCT00091819|10824571|FG001|Overall Study|Withdrawal by Subject|8
6820620|NCT00091819|10824570|FG000|Overall Study|Protocol Violation|1
6820621|NCT00091819|10824571|FG001|Overall Study|Protocol Violation|2
6820622|NCT00091819|10824570|FG000|Overall Study|Other|2
6820623|NCT00091819|10824571|FG001|Overall Study|Other|3
6820624|NCT00091819|10824570|FG000|Overall Study|Never received study treatment|3
6820625|NCT00091819|10824571|FG001|Overall Study|Never received study treatment|4
6820626|NCT00091832|10824583|FG000|Overall Study|Physician Decision|1
6820627|NCT00091832|10824584|FG001|Overall Study|Physician Decision|0
6820628|NCT00091832|10824585|FG002|Overall Study|Physician Decision|0
6820629|NCT00091832|10824586|FG003|Overall Study|Physician Decision|0
6820630|NCT00091832|10824587|FG004|Overall Study|Physician Decision|0
6820631|NCT00091832|10824588|FG005|Overall Study|Physician Decision|0
6820632|NCT00091832|10824583|FG000|Overall Study|Adverse Event|0
6820633|NCT00091832|10824584|FG001|Overall Study|Adverse Event|0
6820634|NCT00091832|10824585|FG002|Overall Study|Adverse Event|0
6820635|NCT00091832|10824586|FG003|Overall Study|Adverse Event|1
6820636|NCT00091832|10824587|FG004|Overall Study|Adverse Event|3
6820637|NCT00091832|10824588|FG005|Overall Study|Adverse Event|0
6820638|NCT00091832|10824583|FG000|Overall Study|Withdrawal by Subject|4
6820639|NCT00091832|10824584|FG001|Overall Study|Withdrawal by Subject|5
6899800|NCT00661362|10919936|FG000|Overall Study|Safety reasons|1
6899801|NCT00661362|10919937|FG001|Overall Study|Safety reasons|0
6899802|NCT00661362|10919936|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1
6899803|NCT00661362|10919937|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0
6899804|NCT00661388|10919943|FG000|Overall Study|Adverse Event|14
6899805|NCT00661388|10919943|FG000|Overall Study|Protocol Violation|7
6899806|NCT00661388|10919943|FG000|Overall Study|Renal transplantation|1
6899807|NCT00661388|10919943|FG000|Overall Study|Dialysis initiation|1
6899808|NCT00661388|10919943|FG000|Overall Study|Administrative reasons|1
6899809|NCT00661427|10919949|FG000|Overall Study|Adverse Event|5
6899810|NCT00661427|10919950|FG001|Overall Study|Adverse Event|5
6899811|NCT00661427|10919949|FG000|Overall Study|Patient not treated|0
6899812|NCT00661427|10919950|FG001|Overall Study|Patient not treated|2
6899813|NCT00661492|10919978|FG000|Overall Study|Adverse Event|16
6899814|NCT00661492|10919979|FG001|Overall Study|Adverse Event|13
6899815|NCT00661492|10919978|FG000|Overall Study|Disease Progression|44
6899816|NCT00661492|10919979|FG001|Overall Study|Disease Progression|14
6899817|NCT00661492|10919978|FG000|Overall Study|Patient Request|6
6899818|NCT00661492|10919979|FG001|Overall Study|Patient Request|1
6899819|NCT00661492|10919978|FG000|Overall Study|Investigator Request|1
6899820|NCT00661492|10919979|FG001|Overall Study|Investigator Request|0
6899821|NCT00661492|10919978|FG000|Overall Study|Lost to Follow-up|0
6899822|NCT00661492|10919979|FG001|Overall Study|Lost to Follow-up|1
6899823|NCT00661492|10919978|FG000|Overall Study|Other|1
6899824|NCT00661492|10919979|FG001|Overall Study|Other|0
6899825|NCT00661505|10919985|FG000|Overall Study|Adverse Event|3
6899826|NCT00661505|10919985|FG000|Overall Study|Protocol Violation|14
6899827|NCT00661505|10919985|FG000|Overall Study|Withdrawal by Subject|8
6899828|NCT00661505|10919985|FG000|Overall Study|Lost to Follow-up|3
6899829|NCT00661505|10919985|FG000|Overall Study|Other|2
6899830|NCT00661531|10919990|FG000|Overall Study|Withdrawal by Subject|3
6820640|NCT00091832|10824585|FG002|Overall Study|Withdrawal by Subject|0
6820641|NCT00091832|10824586|FG003|Overall Study|Withdrawal by Subject|1
6820642|NCT00091832|10824587|FG004|Overall Study|Withdrawal by Subject|3
6820643|NCT00091832|10824588|FG005|Overall Study|Withdrawal by Subject|1
6820644|NCT00091832|10824583|FG000|Overall Study|Death|6
6820645|NCT00091832|10824584|FG001|Overall Study|Death|4
6820646|NCT00091832|10824585|FG002|Overall Study|Death|5
6820647|NCT00091832|10824586|FG003|Overall Study|Death|8
6820648|NCT00091832|10824587|FG004|Overall Study|Death|5
6820649|NCT00091832|10824588|FG005|Overall Study|Death|6
6820650|NCT00091832|10824583|FG000|Overall Study|Disease Progression|2
6820651|NCT00091832|10824584|FG001|Overall Study|Disease Progression|0
6820652|NCT00091832|10824585|FG002|Overall Study|Disease Progression|0
6820653|NCT00091832|10824586|FG003|Overall Study|Disease Progression|1
6820654|NCT00091832|10824587|FG004|Overall Study|Disease Progression|1
6820655|NCT00091832|10824588|FG005|Overall Study|Disease Progression|2
6820656|NCT00091832|10824583|FG000|Overall Study|Ineligibility Determined|0
6820657|NCT00091832|10824584|FG001|Overall Study|Ineligibility Determined|0
6820658|NCT00091832|10824585|FG002|Overall Study|Ineligibility Determined|1
6820659|NCT00091832|10824586|FG003|Overall Study|Ineligibility Determined|0
6820660|NCT00091832|10824587|FG004|Overall Study|Ineligibility Determined|1
6820661|NCT00091832|10824588|FG005|Overall Study|Ineligibility Determined|0
6820662|NCT00091832|10824583|FG000|Overall Study|Lost to Follow-up|1
6820663|NCT00091832|10824584|FG001|Overall Study|Lost to Follow-up|0
6820664|NCT00091832|10824585|FG002|Overall Study|Lost to Follow-up|3
6820665|NCT00091832|10824586|FG003|Overall Study|Lost to Follow-up|3
6820666|NCT00091832|10824587|FG004|Overall Study|Lost to Follow-up|2
6820667|NCT00091832|10824588|FG005|Overall Study|Lost to Follow-up|1
6820668|NCT00091832|10824583|FG000|Overall Study|Noncompliance|0
6899831|NCT00661609|10920024|FG000|Overall Study|Adverse Event|4
6899832|NCT00661609|10920024|FG000|Overall Study|Death|20
6899833|NCT00661609|10920024|FG000|Overall Study|Withdrawal by Subject|2
6899834|NCT00661609|10920024|FG000|Overall Study|PI Decision|1
6899835|NCT00661609|10920024|FG000|Overall Study|Survival follow up stage discontinued|11
6899836|NCT00661609|10920024|FG000|Overall Study|Disease progression|3
6899837|NCT00661622|10920030|FG000|Overall Study|Protocol Violation|1
6899838|NCT00661622|10920031|FG001|Overall Study|Protocol Violation|0
6899839|NCT00661661|10920040|FG000|Overall Study|Adverse Event|99
6899840|NCT00661661|10920041|FG001|Overall Study|Adverse Event|24
6899841|NCT00661661|10920040|FG000|Overall Study|Lack of Efficacy|3
6899842|NCT00661661|10920041|FG001|Overall Study|Lack of Efficacy|2
6899843|NCT00661661|10920040|FG000|Overall Study|Lost to Follow-up|0
6899844|NCT00661661|10920041|FG001|Overall Study|Lost to Follow-up|1
6899845|NCT00661661|10920040|FG000|Overall Study|Withdrawal by Subject|15
6899846|NCT00661661|10920041|FG001|Overall Study|Withdrawal by Subject|5
6899847|NCT00661661|10920040|FG000|Overall Study|Other|22
6899848|NCT00661661|10920041|FG001|Overall Study|Other|7
6899849|NCT00661661|10920040|FG000|Overall Study|Not assigned treatment|1
6899850|NCT00661661|10920041|FG001|Overall Study|Not assigned treatment|0
6899851|NCT00661687|10920062|FG000|Overall Study|Study related symptoms and complaints|5
6899852|NCT00661687|10920062|FG000|Overall Study|Positive slit lamp findings|4
6899853|NCT00661687|10920062|FG000|Overall Study|Inability to maintain wearing schedule|3
6899854|NCT00661687|10920062|FG000|Overall Study|Physician Decision|1
6899855|NCT00661687|10920062|FG000|Overall Study|Adverse Event|2
6899856|NCT00661713|10920076|FG000|Overall Study|Death|1
6899857|NCT00661713|10920077|FG001|Overall Study|Death|0
6899858|NCT00661713|10920078|FG002|Overall Study|Death|0
6899859|NCT00661713|10920079|FG003|Overall Study|Death|0
6899860|NCT00661713|10920080|FG004|Overall Study|Death|1
6899861|NCT00661713|10920081|FG005|Overall Study|Death|0
6899862|NCT00661713|10920082|FG006|Overall Study|Death|0
6899863|NCT00661713|10920083|FG007|Overall Study|Death|0
6899864|NCT00661713|10920076|FG000|Overall Study|Unable to Classify|1
6899865|NCT00661713|10920077|FG001|Overall Study|Unable to Classify|0
6899866|NCT00661713|10920078|FG002|Overall Study|Unable to Classify|0
6899867|NCT00661713|10920079|FG003|Overall Study|Unable to Classify|0
6899868|NCT00661713|10920080|FG004|Overall Study|Unable to Classify|0
6899869|NCT00661713|10920081|FG005|Overall Study|Unable to Classify|0
6899870|NCT00661713|10920082|FG006|Overall Study|Unable to Classify|0
6899871|NCT00661713|10920083|FG007|Overall Study|Unable to Classify|0
6899872|NCT00661713|10920076|FG000|Overall Study|Protocol Violation|1
6899873|NCT00661713|10920077|FG001|Overall Study|Protocol Violation|6
6899874|NCT00661713|10920078|FG002|Overall Study|Protocol Violation|3
6899875|NCT00661713|10920079|FG003|Overall Study|Protocol Violation|3
6899876|NCT00661713|10920080|FG004|Overall Study|Protocol Violation|0
6899877|NCT00661713|10920081|FG005|Overall Study|Protocol Violation|2
6899878|NCT00661713|10920082|FG006|Overall Study|Protocol Violation|2
6899879|NCT00661713|10920083|FG007|Overall Study|Protocol Violation|1
6899880|NCT00661713|10920076|FG000|Overall Study|Withdrawal by Subject|11
6899881|NCT00661713|10920077|FG001|Overall Study|Withdrawal by Subject|25
6899882|NCT00661713|10920078|FG002|Overall Study|Withdrawal by Subject|12
6899883|NCT00661713|10920079|FG003|Overall Study|Withdrawal by Subject|21
6899884|NCT00661713|10920080|FG004|Overall Study|Withdrawal by Subject|12
6899885|NCT00661713|10920081|FG005|Overall Study|Withdrawal by Subject|26
6899886|NCT00661713|10920082|FG006|Overall Study|Withdrawal by Subject|45
6899887|NCT00661713|10920083|FG007|Overall Study|Withdrawal by Subject|9
6899888|NCT00661713|10920076|FG000|Overall Study|Lost to Follow-up|2
6820669|NCT00091832|10824584|FG001|Overall Study|Noncompliance|1
6899889|NCT00661713|10920077|FG001|Overall Study|Lost to Follow-up|7
6820670|NCT00091832|10824585|FG002|Overall Study|Noncompliance|0
6820671|NCT00091832|10824586|FG003|Overall Study|Noncompliance|0
6820672|NCT00091832|10824587|FG004|Overall Study|Noncompliance|0
6820673|NCT00091832|10824588|FG005|Overall Study|Noncompliance|0
6820674|NCT00091832|10824583|FG000|Overall Study|Other|0
6820675|NCT00091832|10824584|FG001|Overall Study|Other|1
6820676|NCT00091832|10824585|FG002|Overall Study|Other|2
6820677|NCT00091832|10824586|FG003|Overall Study|Other|0
6820678|NCT00091832|10824587|FG004|Overall Study|Other|0
6820679|NCT00091832|10824588|FG005|Overall Study|Other|0
6820680|NCT00091832|10824583|FG000|Overall Study|Protocol Violation|0
6820681|NCT00091832|10824584|FG001|Overall Study|Protocol Violation|0
6820682|NCT00091832|10824585|FG002|Overall Study|Protocol Violation|1
6820683|NCT00091832|10824586|FG003|Overall Study|Protocol Violation|0
6820684|NCT00091832|10824587|FG004|Overall Study|Protocol Violation|0
6820685|NCT00091832|10824588|FG005|Overall Study|Protocol Violation|1
6820686|NCT00091949|10824604|FG000|Overall Study|Withdrawal by Subject|117
6820687|NCT00091949|10824605|FG001|Overall Study|Withdrawal by Subject|110
6820688|NCT00091949|10824604|FG000|Overall Study|Lost to Follow-up|58
6820689|NCT00091949|10824605|FG001|Overall Study|Lost to Follow-up|41
6820690|NCT00092417|10824629|FG000|Overall Study|Lost to Follow-up|2
6820691|NCT00092417|10824630|FG001|Overall Study|Lost to Follow-up|0
6820692|NCT00092417|10824629|FG000|Overall Study|Withdrawal by Subject|2
6820693|NCT00092417|10824630|FG001|Overall Study|Withdrawal by Subject|1
6820694|NCT00092417|10824629|FG000|Overall Study|Other|1
6820695|NCT00092417|10824630|FG001|Overall Study|Other|0
6820696|NCT00092443|10824638|FG000|Overall Study|Adverse Event|9
6820697|NCT00092443|10824639|FG001|Overall Study|Adverse Event|13
6820698|NCT00092443|10824638|FG000|Overall Study|Lost to Follow-up|7
6820699|NCT00092443|10824639|FG001|Overall Study|Lost to Follow-up|3
6820700|NCT00092443|10824638|FG000|Overall Study|Protocol Violation|11
6820701|NCT00092443|10824639|FG001|Overall Study|Protocol Violation|9
6820702|NCT00092443|10824638|FG000|Overall Study|Withdrawal by Subject|9
6820703|NCT00092443|10824639|FG001|Overall Study|Withdrawal by Subject|11
6820704|NCT00092443|10824638|FG000|Overall Study|Moved|5
6820705|NCT00092443|10824639|FG001|Overall Study|Moved|5
6820706|NCT00092443|10824638|FG000|Overall Study|Other|17
6899890|NCT00661713|10920078|FG002|Overall Study|Lost to Follow-up|2
6899891|NCT00661713|10920079|FG003|Overall Study|Lost to Follow-up|2
6899892|NCT00661713|10920080|FG004|Overall Study|Lost to Follow-up|5
6899893|NCT00661713|10920081|FG005|Overall Study|Lost to Follow-up|7
6899894|NCT00661713|10920082|FG006|Overall Study|Lost to Follow-up|14
6899895|NCT00661713|10920083|FG007|Overall Study|Lost to Follow-up|1
6899896|NCT00661713|10920076|FG000|Overall Study|Administrative Reason|0
6899897|NCT00661713|10920077|FG001|Overall Study|Administrative Reason|1
6899898|NCT00661713|10920078|FG002|Overall Study|Administrative Reason|0
6899899|NCT00661713|10920079|FG003|Overall Study|Administrative Reason|2
6899900|NCT00661713|10920080|FG004|Overall Study|Administrative Reason|2
6899901|NCT00661713|10920081|FG005|Overall Study|Administrative Reason|2
6899902|NCT00661713|10920082|FG006|Overall Study|Administrative Reason|1
6899903|NCT00661713|10920083|FG007|Overall Study|Administrative Reason|0
6899904|NCT00661713|10920076|FG000|Overall Study|Adverse Event|0
6899905|NCT00661713|10920077|FG001|Overall Study|Adverse Event|0
6899906|NCT00661713|10920078|FG002|Overall Study|Adverse Event|0
6899907|NCT00661713|10920079|FG003|Overall Study|Adverse Event|0
6899908|NCT00661713|10920080|FG004|Overall Study|Adverse Event|0
6899909|NCT00661713|10920081|FG005|Overall Study|Adverse Event|0
6899910|NCT00661713|10920082|FG006|Overall Study|Adverse Event|1
6899911|NCT00661713|10920083|FG007|Overall Study|Adverse Event|0
6899912|NCT00661713|10920076|FG000|Overall Study|Inappropriate Enrollment|0
6899913|NCT00661713|10920077|FG001|Overall Study|Inappropriate Enrollment|0
6899914|NCT00661713|10920078|FG002|Overall Study|Inappropriate Enrollment|0
6899915|NCT00661713|10920079|FG003|Overall Study|Inappropriate Enrollment|0
6899916|NCT00661713|10920080|FG004|Overall Study|Inappropriate Enrollment|0
6899917|NCT00661713|10920081|FG005|Overall Study|Inappropriate Enrollment|0
6899918|NCT00661713|10920082|FG006|Overall Study|Inappropriate Enrollment|1
6899919|NCT00661713|10920083|FG007|Overall Study|Inappropriate Enrollment|0
6973538|NCT01181986|11025426|FG001|Phase 1|Lost to Follow-up|1
6973539|NCT01181986|11025427|FG002|Phase 1|Lost to Follow-up|1
6973540|NCT01181986|11025425|FG000|Phase 1|Adverse Event|0
6973541|NCT01181986|11025426|FG001|Phase 1|Adverse Event|0
6973542|NCT01181986|11025427|FG002|Phase 1|Adverse Event|1
6973543|NCT01181986|11025425|FG000|Phase 1|Protocol Violation|1
6973544|NCT01181986|11025426|FG001|Phase 1|Protocol Violation|0
6973545|NCT01181986|11025427|FG002|Phase 1|Protocol Violation|0
6973546|NCT01181986|11025425|FG000|Phase 2|Adverse Event|0
6973547|NCT01181986|11025426|FG001|Phase 2|Adverse Event|3
6973548|NCT01181986|11025427|FG002|Phase 2|Adverse Event|0
6973549|NCT01181986|11025425|FG000|Phase 2|Medical condition|0
6973550|NCT01181986|11025426|FG001|Phase 2|Medical condition|1
6820707|NCT00092443|10824639|FG001|Overall Study|Other|13
6820708|NCT00092456|10824659|FG000|Overall Study|Adverse Event|0
6820709|NCT00092456|10824660|FG001|Overall Study|Adverse Event|0
6820710|NCT00092456|10824661|FG002|Overall Study|Adverse Event|1
6973551|NCT01181986|11025427|FG002|Phase 2|Medical condition|0
6973552|NCT01182181|11025455|FG000|First Intervention|Adverse Event|1
6973553|NCT01182181|11025456|FG001|First Intervention|Adverse Event|0
6973554|NCT01182181|11025455|FG000|Washout of 21 Days|Withdrawal by Subject|0
6820711|NCT00092456|10824662|FG003|Overall Study|Adverse Event|1
6820712|NCT00092456|10824659|FG000|Overall Study|Lost to Follow-up|2
6820713|NCT00092456|10824660|FG001|Overall Study|Lost to Follow-up|2
6820714|NCT00092456|10824661|FG002|Overall Study|Lost to Follow-up|1
6820715|NCT00092456|10824662|FG003|Overall Study|Lost to Follow-up|2
6820716|NCT00092456|10824659|FG000|Overall Study|Protocol Violation|5
6820717|NCT00092456|10824660|FG001|Overall Study|Protocol Violation|7
6820718|NCT00092456|10824661|FG002|Overall Study|Protocol Violation|8
6820719|NCT00092456|10824662|FG003|Overall Study|Protocol Violation|6
6820720|NCT00092456|10824659|FG000|Overall Study|Withdrawal by Subject|13
6820721|NCT00092456|10824660|FG001|Overall Study|Withdrawal by Subject|5
6820722|NCT00092456|10824661|FG002|Overall Study|Withdrawal by Subject|16
6820723|NCT00092456|10824662|FG003|Overall Study|Withdrawal by Subject|6
6820724|NCT00092456|10824659|FG000|Overall Study|Moved|1
6820725|NCT00092456|10824660|FG001|Overall Study|Moved|1
6820726|NCT00092456|10824661|FG002|Overall Study|Moved|0
6820727|NCT00092456|10824662|FG003|Overall Study|Moved|1
6820728|NCT00092456|10824659|FG000|Overall Study|Other|4
6820729|NCT00092456|10824660|FG001|Overall Study|Other|2
6820730|NCT00092456|10824661|FG002|Overall Study|Other|3
6820731|NCT00092456|10824662|FG003|Overall Study|Other|0
6899920|NCT00661726|10920103|FG000|Overall Study|Adverse Event|1
6899921|NCT00661778|10920107|FG000|Overall Study|Disease Progression|23
6899922|NCT00661778|10920107|FG000|Overall Study|Adverse Event|18
6820732|NCT00092495|10824676|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1
6820733|NCT00092495|10824677|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1
6820734|NCT00092495|10824678|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0
6820735|NCT00092495|10824679|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4
6820736|NCT00092495|10824680|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0
6820737|NCT00092495|10824676|FG000|Base Study Vaccination Period|Extended|0
6820738|NCT00092495|10824677|FG001|Base Study Vaccination Period|Extended|0
6820739|NCT00092495|10824678|FG002|Base Study Vaccination Period|Extended|0
6820740|NCT00092495|10824679|FG003|Base Study Vaccination Period|Extended|1
6820741|NCT00092495|10824680|FG004|Base Study Vaccination Period|Extended|0
6820742|NCT00092495|10824676|FG000|Base Study Vaccination Period|*Clinical AE|1
6820743|NCT00092495|10824677|FG001|Base Study Vaccination Period|*Clinical AE|0
6820744|NCT00092495|10824678|FG002|Base Study Vaccination Period|*Clinical AE|1
6820745|NCT00092495|10824679|FG003|Base Study Vaccination Period|*Clinical AE|2
6820746|NCT00092495|10824680|FG004|Base Study Vaccination Period|*Clinical AE|0
6820747|NCT00092495|10824676|FG000|Base Study Vaccination Period|*Other reasons|1
6820748|NCT00092495|10824677|FG001|Base Study Vaccination Period|*Other reasons|0
6820749|NCT00092495|10824678|FG002|Base Study Vaccination Period|*Other reasons|0
6820750|NCT00092495|10824679|FG003|Base Study Vaccination Period|*Other reasons|1
6820751|NCT00092495|10824680|FG004|Base Study Vaccination Period|*Other reasons|0
6899923|NCT00661778|10920107|FG000|Overall Study|Reason not Specified|6
6899924|NCT00661778|10920107|FG000|Overall Study|Protocol Violation|2
6899925|NCT00661778|10920107|FG000|Overall Study|Withdrawal of Consent|1
6899926|NCT00661830|10920113|FG000|Overall Study|Death|37
6899927|NCT00661830|10920114|FG001|Overall Study|Death|33
6899928|NCT00661830|10920113|FG000|Overall Study|Lost to Follow-up|1
6899929|NCT00661830|10920114|FG001|Overall Study|Lost to Follow-up|3
6899930|NCT00661830|10920113|FG000|Overall Study|Withdrawal by Subject|1
6899931|NCT00661830|10920114|FG001|Overall Study|Withdrawal by Subject|1
6899932|NCT00661830|10920113|FG000|Overall Study|Other reason|1
6899933|NCT00661830|10920114|FG001|Overall Study|Other reason|5
6899934|NCT00661999|10920145|FG000|Overall Study|Adverse Event|11
6899935|NCT00661999|10920146|FG001|Overall Study|Adverse Event|5
6899936|NCT00661999|10920147|FG002|Overall Study|Adverse Event|8
6899937|NCT00661999|10920145|FG000|Overall Study|Death|8
6899938|NCT00661999|10920146|FG001|Overall Study|Death|6
6899939|NCT00661999|10920147|FG002|Overall Study|Death|3
6899940|NCT00661999|10920145|FG000|Overall Study|Other Reasons|5
6899941|NCT00661999|10920146|FG001|Overall Study|Other Reasons|12
6899942|NCT00661999|10920147|FG002|Overall Study|Other Reasons|23
6899943|NCT00661999|10920145|FG000|Overall Study|Withdrawal by Subject|30
6899944|NCT00661999|10920146|FG001|Overall Study|Withdrawal by Subject|23
6899945|NCT00661999|10920147|FG002|Overall Study|Withdrawal by Subject|14
6899946|NCT00661999|10920145|FG000|Overall Study|Alternative Treatment|1
6899947|NCT00661999|10920146|FG001|Overall Study|Alternative Treatment|0
6899948|NCT00661999|10920147|FG002|Overall Study|Alternative Treatment|0
6899949|NCT00661999|10920145|FG000|Overall Study|Other Medical Problems|4
6899950|NCT00661999|10920146|FG001|Overall Study|Other Medical Problems|4
6899951|NCT00661999|10920147|FG002|Overall Study|Other Medical Problems|9
6899952|NCT00662012|10920155|FG000|Overall Study|Lost to Follow-up|85
6899953|NCT00662012|10920155|FG000|Overall Study|Death|1
6899954|NCT00662012|10920155|FG000|Overall Study|Withdrawal by Subject|1
6899955|NCT00662025|10920159|FG000|Overall Study|Objective progression or relapse|51
6899956|NCT00662025|10920159|FG000|Overall Study|Adverse Event|7
6899957|NCT00662025|10920159|FG000|Overall Study|Withdrawal by Subject|1
6899958|NCT00662025|10920159|FG000|Overall Study|Results of other clinical study|2
6899959|NCT00662025|10920159|FG000|Overall Study|Target lesion cannot be evaluated|1
6899960|NCT00662025|10920159|FG000|Overall Study|Domestic circumstances|1
6899961|NCT00662038|10920163|FG000|Overall Study|Reason not specified|3
6899962|NCT00662038|10920163|FG000|Overall Study|Withdrawn consent|22
6899963|NCT00662038|10920163|FG000|Overall Study|Withdrawal by Subject|83
6899964|NCT00662038|10920163|FG000|Overall Study|Sponsor decision|1
6899965|NCT00662038|10920163|FG000|Overall Study|Physician Decision|19
6899966|NCT00662038|10920163|FG000|Overall Study|Lung transplantation|44
6978549|NCT01213836|11031933|FG001|Period 1, First Intervention|Protocol Violation|1
6978550|NCT01213836|11031932|FG000|Period 1, First Intervention|Withdrawal by Subject|1
6820752|NCT00092495|10824676|FG000|Base Study Vaccination Period|*Pregnancy|0
6820753|NCT00092495|10824677|FG001|Base Study Vaccination Period|*Pregnancy|2
6820754|NCT00092495|10824678|FG002|Base Study Vaccination Period|*Pregnancy|5
6820755|NCT00092495|10824679|FG003|Base Study Vaccination Period|*Pregnancy|7
6820756|NCT00092495|10824680|FG004|Base Study Vaccination Period|*Pregnancy|0
6820757|NCT00092495|10824676|FG000|Base Study Vaccination Period|Adverse Event|1
6820758|NCT00092495|10824677|FG001|Base Study Vaccination Period|Adverse Event|0
6820759|NCT00092495|10824678|FG002|Base Study Vaccination Period|Adverse Event|0
6820760|NCT00092495|10824679|FG003|Base Study Vaccination Period|Adverse Event|3
6820761|NCT00092495|10824680|FG004|Base Study Vaccination Period|Adverse Event|0
6820762|NCT00092495|10824676|FG000|Base Study Vaccination Period|Lost to Follow-up|16
6820763|NCT00092495|10824677|FG001|Base Study Vaccination Period|Lost to Follow-up|6
6820764|NCT00092495|10824678|FG002|Base Study Vaccination Period|Lost to Follow-up|11
6820765|NCT00092495|10824679|FG003|Base Study Vaccination Period|Lost to Follow-up|36
6820766|NCT00092495|10824680|FG004|Base Study Vaccination Period|Lost to Follow-up|0
6820767|NCT00092495|10824676|FG000|Base Study Vaccination Period|Moved|3
6820768|NCT00092495|10824677|FG001|Base Study Vaccination Period|Moved|1
6820769|NCT00092495|10824678|FG002|Base Study Vaccination Period|Moved|2
6820770|NCT00092495|10824679|FG003|Base Study Vaccination Period|Moved|2
6820771|NCT00092495|10824680|FG004|Base Study Vaccination Period|Moved|0
6820772|NCT00092495|10824676|FG000|Base Study Vaccination Period|Other|1
6820773|NCT00092495|10824677|FG001|Base Study Vaccination Period|Other|1
6820774|NCT00092495|10824678|FG002|Base Study Vaccination Period|Other|0
6820775|NCT00092495|10824679|FG003|Base Study Vaccination Period|Other|2
6820776|NCT00092495|10824680|FG004|Base Study Vaccination Period|Other|0
6820777|NCT00092495|10824676|FG000|Base Study Vaccination Period|Pregnancy|2
6820778|NCT00092495|10824677|FG001|Base Study Vaccination Period|Pregnancy|0
6820779|NCT00092495|10824678|FG002|Base Study Vaccination Period|Pregnancy|0
6820780|NCT00092495|10824679|FG003|Base Study Vaccination Period|Pregnancy|0
6820781|NCT00092495|10824680|FG004|Base Study Vaccination Period|Pregnancy|0
6820782|NCT00092495|10824676|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1
6820783|NCT00092495|10824677|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1
6896616|NCT00634114|10915134|FG001|Overall Study|Pregnancy|0
6896617|NCT00634114|10915135|FG002|Overall Study|Pregnancy|0
6896618|NCT00634114|10915133|FG000|Overall Study|Incorrect enrolment|0
6896619|NCT00634114|10915134|FG001|Overall Study|Incorrect enrolment|1
6896620|NCT00634114|10915135|FG002|Overall Study|Incorrect enrolment|0
6899967|NCT00662038|10920163|FG000|Overall Study|Lost to Follow-up|1
6978551|NCT01213836|11031933|FG001|Period 1, First Intervention|Withdrawal by Subject|1
6978552|NCT01213966|11031955|FG000|Overall Study|Protocol Violation|1
6978553|NCT01213966|11031956|FG001|Overall Study|Protocol Violation|0
6978554|NCT01213966|11031957|FG002|Overall Study|Protocol Violation|3
6978555|NCT01213966|11031958|FG003|Overall Study|Protocol Violation|1
6978556|NCT01214044|11031968|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5
6978557|NCT01214044|11031968|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3
6978558|NCT01214044|11031968|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4
6978559|NCT01214044|11031968|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3
6978560|NCT01214044|11031968|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3
6978561|NCT01214044|11031968|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1
6978562|NCT01214174|11032028|FG000|Overall Study|Withdrawal by Subject|0
6978563|NCT01214174|11032029|FG001|Overall Study|Withdrawal by Subject|0
6978564|NCT01214174|11032030|FG002|Overall Study|Withdrawal by Subject|1
6978565|NCT01214187|11032040|FG000|Overall Study|Adverse Event|6
6978566|NCT01214187|11032041|FG001|Overall Study|Adverse Event|2
6978567|NCT01214187|11032040|FG000|Overall Study|Death|1
6978568|NCT01214187|11032041|FG001|Overall Study|Death|1
6978569|NCT01214187|11032040|FG000|Overall Study|Withdrawal by Subject|0
6978570|NCT01214187|11032041|FG001|Overall Study|Withdrawal by Subject|3
6978571|NCT01214200|11032047|FG000|Overall Study|Did not meet inclusion/exclusion|9
6978572|NCT01214200|11032047|FG000|Overall Study|Withdrawal by Subject|2
6978573|NCT01214239|11032055|FG000|Overall Study|Adverse Event|3
6978574|NCT01214239|11032056|FG001|Overall Study|Adverse Event|4
6978575|NCT01214239|11032055|FG000|Overall Study|Protocol Violation|2
6896621|NCT00634114|10915133|FG000|Overall Study|Recurrence of reflux esophagitis|5
6896622|NCT00634114|10915134|FG001|Overall Study|Recurrence of reflux esophagitis|15
6896623|NCT00634114|10915135|FG002|Overall Study|Recurrence of reflux esophagitis|21
6896624|NCT00634114|10915133|FG000|Overall Study|Difficult to continue|3
6896625|NCT00634114|10915134|FG001|Overall Study|Difficult to continue|1
6896626|NCT00634114|10915135|FG002|Overall Study|Difficult to continue|1
6978576|NCT01214239|11032056|FG001|Overall Study|Protocol Violation|1
6978577|NCT01214239|11032055|FG000|Overall Study|Lost to Follow-up|1
6978578|NCT01214239|11032056|FG001|Overall Study|Lost to Follow-up|1
6978579|NCT01214239|11032055|FG000|Overall Study|Withdrawal by Subject|4
6978580|NCT01214239|11032056|FG001|Overall Study|Withdrawal by Subject|9
6978581|NCT01214239|11032055|FG000|Overall Study|Lack of Efficacy|1
6978582|NCT01214239|11032056|FG001|Overall Study|Lack of Efficacy|2
6978583|NCT01214239|11032055|FG000|Overall Study|patient's private reason|1
6978584|NCT01214239|11032056|FG001|Overall Study|patient's private reason|1
6820784|NCT00092495|10824678|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1
6820785|NCT00092495|10824679|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5
6820786|NCT00092495|10824680|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0
6820787|NCT00092495|10824676|FG000|Base Study Vaccination Period|Protocol Violation|1
6820788|NCT00092495|10824677|FG001|Base Study Vaccination Period|Protocol Violation|0
6820789|NCT00092495|10824678|FG002|Base Study Vaccination Period|Protocol Violation|0
6820790|NCT00092495|10824679|FG003|Base Study Vaccination Period|Protocol Violation|0
6820791|NCT00092495|10824680|FG004|Base Study Vaccination Period|Protocol Violation|0
6820792|NCT00092495|10824676|FG000|Base Study Vaccination Period|Withdrawal by Subject|9
6820793|NCT00092495|10824677|FG001|Base Study Vaccination Period|Withdrawal by Subject|10
6820794|NCT00092495|10824678|FG002|Base Study Vaccination Period|Withdrawal by Subject|14
6820795|NCT00092495|10824679|FG003|Base Study Vaccination Period|Withdrawal by Subject|25
6820796|NCT00092495|10824680|FG004|Base Study Vaccination Period|Withdrawal by Subject|0
6820797|NCT00092495|10824676|FG000|Base Study Follow-up Period|Extended|0
6820798|NCT00092495|10824677|FG001|Base Study Follow-up Period|Extended|0
6820799|NCT00092495|10824678|FG002|Base Study Follow-up Period|Extended|1
6820800|NCT00092495|10824679|FG003|Base Study Follow-up Period|Extended|2
6820801|NCT00092495|10824680|FG004|Base Study Follow-up Period|Extended|0
6820802|NCT00092495|10824676|FG000|Base Study Follow-up Period|Lost to Follow-up|1
6820803|NCT00092495|10824677|FG001|Base Study Follow-up Period|Lost to Follow-up|3
6820804|NCT00092495|10824678|FG002|Base Study Follow-up Period|Lost to Follow-up|3
6820805|NCT00092495|10824679|FG003|Base Study Follow-up Period|Lost to Follow-up|12
6820806|NCT00092495|10824680|FG004|Base Study Follow-up Period|Lost to Follow-up|0
6820807|NCT00092495|10824676|FG000|Base Study Follow-up Period|Withdrawal by Subject|2
6820808|NCT00092495|10824677|FG001|Base Study Follow-up Period|Withdrawal by Subject|0
6820809|NCT00092495|10824678|FG002|Base Study Follow-up Period|Withdrawal by Subject|0
6820810|NCT00092495|10824679|FG003|Base Study Follow-up Period|Withdrawal by Subject|0
6820811|NCT00092495|10824680|FG004|Base Study Follow-up Period|Withdrawal by Subject|0
6820812|NCT00092521|10824696|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6
6820813|NCT00092521|10824697|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
6820814|NCT00092521|10824698|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7
6820815|NCT00092521|10824699|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
6820816|NCT00092521|10824696|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1
6820817|NCT00092521|10824697|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0
6820818|NCT00092521|10824698|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7
6820819|NCT00092521|10824699|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0
6820820|NCT00092521|10824696|FG000|Vaccination (Day 1 Through Month 7)|Death|0
6820821|NCT00092521|10824697|FG001|Vaccination (Day 1 Through Month 7)|Death|0
6820822|NCT00092521|10824698|FG002|Vaccination (Day 1 Through Month 7)|Death|1
6820823|NCT00092521|10824699|FG003|Vaccination (Day 1 Through Month 7)|Death|0
6820824|NCT00092521|10824696|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51
6820825|NCT00092521|10824697|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6
6820826|NCT00092521|10824698|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44
6820827|NCT00092521|10824699|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0
6820828|NCT00092521|10824696|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5
6820829|NCT00092521|10824697|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0
6820830|NCT00092521|10824698|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7
6820831|NCT00092521|10824699|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0
6820832|NCT00092521|10824696|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59
6820833|NCT00092521|10824697|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7
6820834|NCT00092521|10824698|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62
6820835|NCT00092521|10824699|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0
6820836|NCT00092521|10824696|FG000|Vaccination (Day 1 Through Month 7)|Moved|14
6820837|NCT00092521|10824697|FG001|Vaccination (Day 1 Through Month 7)|Moved|1
6820838|NCT00092521|10824698|FG002|Vaccination (Day 1 Through Month 7)|Moved|18
6820839|NCT00092521|10824699|FG003|Vaccination (Day 1 Through Month 7)|Moved|0
6820840|NCT00092521|10824696|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2
6820841|NCT00092521|10824697|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0
6820842|NCT00092521|10824698|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0
6820843|NCT00092521|10824699|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0
6820844|NCT00092521|10824696|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2
6820845|NCT00092521|10824697|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
6820846|NCT00092521|10824698|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
6820847|NCT00092521|10824699|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
6978585|NCT01214252|11032062|FG000|Overall Study|Not eligible per protocol|82
6820848|NCT00092521|10824696|FG000|Follow-Up (After Month 7)|Subjects Continuing|34
6820849|NCT00092521|10824697|FG001|Follow-Up (After Month 7)|Subjects Continuing|4
6820850|NCT00092521|10824698|FG002|Follow-Up (After Month 7)|Subjects Continuing|35
6820851|NCT00092521|10824699|FG003|Follow-Up (After Month 7)|Subjects Continuing|0
6820852|NCT00092521|10824696|FG000|Follow-Up (After Month 7)|Subjects in Extension|13
6820853|NCT00092521|10824697|FG001|Follow-Up (After Month 7)|Subjects in Extension|109
6820854|NCT00092521|10824698|FG002|Follow-Up (After Month 7)|Subjects in Extension|412
6820855|NCT00092521|10824699|FG003|Follow-Up (After Month 7)|Subjects in Extension|0
6820856|NCT00092521|10824696|FG000|Follow-Up (After Month 7)|Adverse Event|1
6820857|NCT00092521|10824697|FG001|Follow-Up (After Month 7)|Adverse Event|0
6820858|NCT00092521|10824698|FG002|Follow-Up (After Month 7)|Adverse Event|0
6820859|NCT00092521|10824699|FG003|Follow-Up (After Month 7)|Adverse Event|0
6820860|NCT00092521|10824696|FG000|Follow-Up (After Month 7)|Death|2
6820861|NCT00092521|10824697|FG001|Follow-Up (After Month 7)|Death|0
6820862|NCT00092521|10824698|FG002|Follow-Up (After Month 7)|Death|1
6820863|NCT00092521|10824699|FG003|Follow-Up (After Month 7)|Death|0
6820864|NCT00092521|10824696|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113
6820865|NCT00092521|10824697|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14
6820866|NCT00092521|10824698|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108
6820867|NCT00092521|10824699|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0
6820868|NCT00092521|10824696|FG000|Follow-Up (After Month 7)|Protocol Violation|1
6820869|NCT00092521|10824697|FG001|Follow-Up (After Month 7)|Protocol Violation|1
6820870|NCT00092521|10824698|FG002|Follow-Up (After Month 7)|Protocol Violation|5
6820871|NCT00092521|10824699|FG003|Follow-Up (After Month 7)|Protocol Violation|0
6820872|NCT00092521|10824696|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40
6820873|NCT00092521|10824697|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6
6820874|NCT00092521|10824698|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51
6820875|NCT00092521|10824699|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0
6820876|NCT00092521|10824696|FG000|Follow-Up (After Month 7)|Moved|32
6820877|NCT00092521|10824697|FG001|Follow-Up (After Month 7)|Moved|2
6820878|NCT00092521|10824698|FG002|Follow-Up (After Month 7)|Moved|28
6820879|NCT00092521|10824699|FG003|Follow-Up (After Month 7)|Moved|0
6820880|NCT00092521|10824696|FG000|Follow-Up (After Month 7)|Site Terminated|3
6820881|NCT00092521|10824697|FG001|Follow-Up (After Month 7)|Site Terminated|0
6820882|NCT00092521|10824698|FG002|Follow-Up (After Month 7)|Site Terminated|3
6820883|NCT00092521|10824699|FG003|Follow-Up (After Month 7)|Site Terminated|0
6820884|NCT00092521|10824696|FG000|Follow-Up (After Month 7)|Travel|2
6820885|NCT00092521|10824697|FG001|Follow-Up (After Month 7)|Travel|0
6820886|NCT00092521|10824698|FG002|Follow-Up (After Month 7)|Travel|0
6820887|NCT00092521|10824699|FG003|Follow-Up (After Month 7)|Travel|0
6820888|NCT00092521|10824696|FG000|Follow-Up (After Month 7)|Visits Compressed|5
6820889|NCT00092521|10824697|FG001|Follow-Up (After Month 7)|Visits Compressed|0
6820890|NCT00092521|10824698|FG002|Follow-Up (After Month 7)|Visits Compressed|5
6820891|NCT00092521|10824699|FG003|Follow-Up (After Month 7)|Visits Compressed|0
6820892|NCT00092521|10824696|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0
6820893|NCT00092521|10824697|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0
6820894|NCT00092521|10824698|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0
6820895|NCT00092521|10824699|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23
6820896|NCT00092521|10824696|FG000|Extension Study (Group 4)|Adverse Event|0
6820897|NCT00092521|10824697|FG001|Extension Study (Group 4)|Adverse Event|0
6820898|NCT00092521|10824698|FG002|Extension Study (Group 4)|Adverse Event|0
6899968|NCT00662038|10920163|FG000|Overall Study|Death|95
6899969|NCT00662038|10920163|FG000|Overall Study|Adverse Event|358
6899970|NCT00662038|10920163|FG000|Overall Study|Continued treatment|5
6899971|NCT00662129|10920167|FG000|Overall Study|Protocol Violation|1
6899972|NCT00662129|10920167|FG000|Overall Study|Cancel prior to beginning treatment|1
6899973|NCT00662129|10920167|FG000|Overall Study|Ineligible|1
6899974|NCT00662259|10920194|FG000|Overall Study|Adverse Event|2
6899975|NCT00662259|10920195|FG001|Overall Study|Adverse Event|0
6899976|NCT00662311|10920208|FG000|Overall Study|Respiratory Infection|1
6899977|NCT00662311|10920209|FG001|Overall Study|Respiratory Infection|0
6899978|NCT00662311|10920210|FG002|Overall Study|Respiratory Infection|0
6899979|NCT00662363|10920220|FG000|Overall Study|Withdrawal by Subject|6
6899980|NCT00662363|10920221|FG001|Overall Study|Withdrawal by Subject|5
6899981|NCT00662363|10920220|FG000|Overall Study|Adverse Event|0
6899982|NCT00662363|10920221|FG001|Overall Study|Adverse Event|3
6899983|NCT00662363|10920220|FG000|Overall Study|Discharged early from rehab|4
6899984|NCT00662363|10920221|FG001|Overall Study|Discharged early from rehab|1
6899985|NCT00662363|10920220|FG000|Overall Study|Protocol Violation|1
6899986|NCT00662363|10920221|FG001|Overall Study|Protocol Violation|1
6899987|NCT00662532|10920231|FG000|Overall Study|Adverse Event|0
6899988|NCT00662532|10920232|FG001|Overall Study|Adverse Event|1
6899989|NCT00662532|10920231|FG000|Overall Study|Lost to Follow-up|0
6899990|NCT00662532|10920232|FG001|Overall Study|Lost to Follow-up|1
6899991|NCT00662558|10920249|FG000|Overall Study|Adverse Event|21
6899992|NCT00662558|10920250|FG001|Overall Study|Adverse Event|59
6899993|NCT00662558|10920249|FG000|Overall Study|Lack of Efficacy|4
6899994|NCT00662558|10920250|FG001|Overall Study|Lack of Efficacy|7
6899995|NCT00662558|10920249|FG000|Overall Study|Lost to Follow-up|13
6899996|NCT00662558|10920250|FG001|Overall Study|Lost to Follow-up|10
6899997|NCT00662558|10920249|FG000|Overall Study|Other|9
6820899|NCT00092521|10824699|FG003|Extension Study (Group 4)|Adverse Event|2
6820900|NCT00092521|10824696|FG000|Extension Study (Group 4)|Lost to Follow-up|0
6820901|NCT00092521|10824697|FG001|Extension Study (Group 4)|Lost to Follow-up|0
6820902|NCT00092521|10824698|FG002|Extension Study (Group 4)|Lost to Follow-up|0
6820903|NCT00092521|10824699|FG003|Extension Study (Group 4)|Lost to Follow-up|87
6820904|NCT00092521|10824696|FG000|Extension Study (Group 4)|Pregnancy|0
6820905|NCT00092521|10824697|FG001|Extension Study (Group 4)|Pregnancy|0
6820906|NCT00092521|10824698|FG002|Extension Study (Group 4)|Pregnancy|0
6820907|NCT00092521|10824699|FG003|Extension Study (Group 4)|Pregnancy|4
6820908|NCT00092521|10824696|FG000|Extension Study (Group 4)|Protocol Violation|0
6820909|NCT00092521|10824697|FG001|Extension Study (Group 4)|Protocol Violation|0
6820910|NCT00092521|10824698|FG002|Extension Study (Group 4)|Protocol Violation|0
6820911|NCT00092521|10824699|FG003|Extension Study (Group 4)|Protocol Violation|2
6820912|NCT00092521|10824696|FG000|Extension Study (Group 4)|Withdrawal by Subject|0
6820913|NCT00092521|10824697|FG001|Extension Study (Group 4)|Withdrawal by Subject|0
6820914|NCT00092521|10824698|FG002|Extension Study (Group 4)|Withdrawal by Subject|0
6820915|NCT00092521|10824699|FG003|Extension Study (Group 4)|Withdrawal by Subject|46
6820916|NCT00092521|10824696|FG000|Extension Study (Group 4)|Moved|0
6820917|NCT00092521|10824697|FG001|Extension Study (Group 4)|Moved|0
6820918|NCT00092521|10824698|FG002|Extension Study (Group 4)|Moved|0
6820919|NCT00092521|10824699|FG003|Extension Study (Group 4)|Moved|16
6820920|NCT00092521|10824696|FG000|Extension Study (Group 4)|Site Terminated|0
6820921|NCT00092521|10824697|FG001|Extension Study (Group 4)|Site Terminated|0
6820922|NCT00092521|10824698|FG002|Extension Study (Group 4)|Site Terminated|0
6820923|NCT00092521|10824699|FG003|Extension Study (Group 4)|Site Terminated|4
6820924|NCT00092521|10824696|FG000|Extension Study (Group 4)|Unable/unwilling to return|0
6820925|NCT00092521|10824697|FG001|Extension Study (Group 4)|Unable/unwilling to return|0
6820926|NCT00092521|10824698|FG002|Extension Study (Group 4)|Unable/unwilling to return|0
6820927|NCT00092521|10824699|FG003|Extension Study (Group 4)|Unable/unwilling to return|25
6820928|NCT00092534|10824709|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5
6820929|NCT00092534|10824710|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5
6820930|NCT00092534|10824711|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0
6820931|NCT00092534|10824712|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0
6820932|NCT00092534|10824713|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0
6820933|NCT00092534|10824709|FG000|Base Study Vaccination Period|Adverse Event|3
6820934|NCT00092534|10824710|FG001|Base Study Vaccination Period|Adverse Event|1
6820935|NCT00092534|10824711|FG002|Base Study Vaccination Period|Adverse Event|0
6820936|NCT00092534|10824712|FG003|Base Study Vaccination Period|Adverse Event|0
6820937|NCT00092534|10824713|FG004|Base Study Vaccination Period|Adverse Event|0
6820938|NCT00092534|10824709|FG000|Base Study Vaccination Period|Death|5
6820939|NCT00092534|10824710|FG001|Base Study Vaccination Period|Death|4
6820940|NCT00092534|10824711|FG002|Base Study Vaccination Period|Death|0
6820941|NCT00092534|10824712|FG003|Base Study Vaccination Period|Death|0
6820942|NCT00092534|10824713|FG004|Base Study Vaccination Period|Death|0
6820943|NCT00092534|10824709|FG000|Base Study Vaccination Period|Lost to Follow-up|41
6820944|NCT00092534|10824710|FG001|Base Study Vaccination Period|Lost to Follow-up|37
6820945|NCT00092534|10824711|FG002|Base Study Vaccination Period|Lost to Follow-up|0
6820946|NCT00092534|10824712|FG003|Base Study Vaccination Period|Lost to Follow-up|0
6820947|NCT00092534|10824713|FG004|Base Study Vaccination Period|Lost to Follow-up|0
6820948|NCT00092534|10824709|FG000|Base Study Vaccination Period|Physician Decision|1
6820949|NCT00092534|10824710|FG001|Base Study Vaccination Period|Physician Decision|0
6820950|NCT00092534|10824711|FG002|Base Study Vaccination Period|Physician Decision|0
6820951|NCT00092534|10824712|FG003|Base Study Vaccination Period|Physician Decision|0
6820952|NCT00092534|10824713|FG004|Base Study Vaccination Period|Physician Decision|0
6820953|NCT00092534|10824709|FG000|Base Study Vaccination Period|Pregnancy|9
6820954|NCT00092534|10824710|FG001|Base Study Vaccination Period|Pregnancy|7
6820955|NCT00092534|10824711|FG002|Base Study Vaccination Period|Pregnancy|0
6820956|NCT00092534|10824712|FG003|Base Study Vaccination Period|Pregnancy|0
6820957|NCT00092534|10824713|FG004|Base Study Vaccination Period|Pregnancy|0
6820958|NCT00092534|10824709|FG000|Base Study Vaccination Period|Protocol Violation|2
6820959|NCT00092534|10824710|FG001|Base Study Vaccination Period|Protocol Violation|1
6820960|NCT00092534|10824711|FG002|Base Study Vaccination Period|Protocol Violation|0
6820961|NCT00092534|10824712|FG003|Base Study Vaccination Period|Protocol Violation|0
6820962|NCT00092534|10824713|FG004|Base Study Vaccination Period|Protocol Violation|0
6820963|NCT00092534|10824709|FG000|Base Study Vaccination Period|Withdrawal by Subject|85
6820964|NCT00092534|10824710|FG001|Base Study Vaccination Period|Withdrawal by Subject|58
6820965|NCT00092534|10824711|FG002|Base Study Vaccination Period|Withdrawal by Subject|0
6820966|NCT00092534|10824712|FG003|Base Study Vaccination Period|Withdrawal by Subject|0
6820967|NCT00092534|10824713|FG004|Base Study Vaccination Period|Withdrawal by Subject|0
6820968|NCT00092534|10824709|FG000|Base Study Vaccination Period|Moved|14
6820969|NCT00092534|10824710|FG001|Base Study Vaccination Period|Moved|12
6820970|NCT00092534|10824711|FG002|Base Study Vaccination Period|Moved|0
6820971|NCT00092534|10824712|FG003|Base Study Vaccination Period|Moved|0
6820972|NCT00092534|10824713|FG004|Base Study Vaccination Period|Moved|0
6820973|NCT00092534|10824709|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5
6820974|NCT00092534|10824710|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0
6820975|NCT00092534|10824711|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0
6820976|NCT00092534|10824712|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0
6820977|NCT00092534|10824713|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0
6820978|NCT00092534|10824709|FG000|Base Study Vaccination Period|Travel|1
6820979|NCT00092534|10824710|FG001|Base Study Vaccination Period|Travel|0
6820980|NCT00092534|10824711|FG002|Base Study Vaccination Period|Travel|0
6820981|NCT00092534|10824712|FG003|Base Study Vaccination Period|Travel|0
6820982|NCT00092534|10824713|FG004|Base Study Vaccination Period|Travel|0
6820983|NCT00092534|10824709|FG000|Base Study Vaccination Period|Site Closed|0
6820984|NCT00092534|10824710|FG001|Base Study Vaccination Period|Site Closed|1
6820985|NCT00092534|10824711|FG002|Base Study Vaccination Period|Site Closed|0
6820986|NCT00092534|10824712|FG003|Base Study Vaccination Period|Site Closed|0
6820987|NCT00092534|10824713|FG004|Base Study Vaccination Period|Site Closed|0
6820988|NCT00092534|10824709|FG000|Base Study Follow-Up Period|Adverse Event|2
6820989|NCT00092534|10824710|FG001|Base Study Follow-Up Period|Adverse Event|4
6820990|NCT00092534|10824711|FG002|Base Study Follow-Up Period|Adverse Event|0
6820991|NCT00092534|10824712|FG003|Base Study Follow-Up Period|Adverse Event|0
6820992|NCT00092534|10824713|FG004|Base Study Follow-Up Period|Adverse Event|0
6820993|NCT00092534|10824709|FG000|Base Study Follow-Up Period|Death|2
6820994|NCT00092534|10824710|FG001|Base Study Follow-Up Period|Death|1
6820995|NCT00092534|10824711|FG002|Base Study Follow-Up Period|Death|0
6820996|NCT00092534|10824712|FG003|Base Study Follow-Up Period|Death|0
6820997|NCT00092534|10824713|FG004|Base Study Follow-Up Period|Death|0
6820998|NCT00092534|10824709|FG000|Base Study Follow-Up Period|Lost to Follow-up|120
6820999|NCT00092534|10824710|FG001|Base Study Follow-Up Period|Lost to Follow-up|146
6821000|NCT00092534|10824711|FG002|Base Study Follow-Up Period|Lost to Follow-up|0
6821001|NCT00092534|10824712|FG003|Base Study Follow-Up Period|Lost to Follow-up|0
6899998|NCT00662558|10920250|FG001|Overall Study|Other|14
6899999|NCT00662558|10920249|FG000|Overall Study|Withdrawal by Subject|7
6900000|NCT00662558|10920250|FG001|Overall Study|Withdrawal by Subject|12
6900001|NCT00662558|10920249|FG000|Overall Study|Randomized But Did Not Receive Treatment|2
6900002|NCT00662558|10920250|FG001|Overall Study|Randomized But Did Not Receive Treatment|8
6900003|NCT00662649|10920260|FG000|Core Study (24 Months)|Withdrawal by Subject|31
6900004|NCT00662649|10920261|FG001|Core Study (24 Months)|Withdrawal by Subject|17
6900005|NCT00662649|10920262|FG002|Core Study (24 Months)|Withdrawal by Subject|28
6900006|NCT00662649|10920263|FG003|Core Study (24 Months)|Withdrawal by Subject|0
6900007|NCT00662649|10920264|FG004|Core Study (24 Months)|Withdrawal by Subject|0
6900008|NCT00662649|10920260|FG000|Core Study (24 Months)|Adverse Event|22
6900009|NCT00662649|10920261|FG001|Core Study (24 Months)|Adverse Event|13
6900010|NCT00662649|10920262|FG002|Core Study (24 Months)|Adverse Event|18
6900011|NCT00662649|10920263|FG003|Core Study (24 Months)|Adverse Event|0
6900012|NCT00662649|10920264|FG004|Core Study (24 Months)|Adverse Event|0
6900013|NCT00662649|10920260|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13
6900014|NCT00662649|10920261|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6
6900015|NCT00662649|10920262|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25
6900016|NCT00662649|10920263|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
6900017|NCT00662649|10920264|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
6900018|NCT00662649|10920260|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20
6900019|NCT00662649|10920261|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9
6900020|NCT00662649|10920262|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1
6900021|NCT00662649|10920263|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0
6900022|NCT00662649|10920264|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0
6900023|NCT00662649|10920260|FG000|Core Study (24 Months)|Lost to Follow-up|3
6900024|NCT00662649|10920261|FG001|Core Study (24 Months)|Lost to Follow-up|5
6900025|NCT00662649|10920262|FG002|Core Study (24 Months)|Lost to Follow-up|7
6900026|NCT00662649|10920263|FG003|Core Study (24 Months)|Lost to Follow-up|0
6900027|NCT00662649|10920264|FG004|Core Study (24 Months)|Lost to Follow-up|0
6900028|NCT00662649|10920260|FG000|Core Study (24 Months)|Protocol Violation|5
6900029|NCT00662649|10920261|FG001|Core Study (24 Months)|Protocol Violation|5
6900030|NCT00662649|10920262|FG002|Core Study (24 Months)|Protocol Violation|4
6900031|NCT00662649|10920263|FG003|Core Study (24 Months)|Protocol Violation|0
6900032|NCT00662649|10920264|FG004|Core Study (24 Months)|Protocol Violation|0
6900033|NCT00662649|10920260|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2
6900034|NCT00662649|10920261|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1
6900035|NCT00662649|10920262|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1
6900036|NCT00662649|10920263|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0
6900037|NCT00662649|10920264|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0
6900038|NCT00662649|10920260|FG000|Core Study (24 Months)|Death|1
6900039|NCT00662649|10920261|FG001|Core Study (24 Months)|Death|0
6900040|NCT00662649|10920262|FG002|Core Study (24 Months)|Death|2
6900041|NCT00662649|10920263|FG003|Core Study (24 Months)|Death|0
6900042|NCT00662649|10920264|FG004|Core Study (24 Months)|Death|0
6900043|NCT00662649|10920260|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10
6900044|NCT00662649|10920261|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5
6900045|NCT00662649|10920262|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0
6900046|NCT00662649|10920263|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8
6973555|NCT01182181|11025456|FG001|Washout of 21 Days|Withdrawal by Subject|1
6821002|NCT00092534|10824713|FG004|Base Study Follow-Up Period|Lost to Follow-up|0
6821003|NCT00092534|10824709|FG000|Base Study Follow-Up Period|Pregnancy|6
6821004|NCT00092534|10824710|FG001|Base Study Follow-Up Period|Pregnancy|10
6821005|NCT00092534|10824711|FG002|Base Study Follow-Up Period|Pregnancy|0
6821006|NCT00092534|10824712|FG003|Base Study Follow-Up Period|Pregnancy|0
6821007|NCT00092534|10824713|FG004|Base Study Follow-Up Period|Pregnancy|0
6821008|NCT00092534|10824709|FG000|Base Study Follow-Up Period|Protocol Violation|1
6821009|NCT00092534|10824710|FG001|Base Study Follow-Up Period|Protocol Violation|2
6821010|NCT00092534|10824711|FG002|Base Study Follow-Up Period|Protocol Violation|0
6821011|NCT00092534|10824712|FG003|Base Study Follow-Up Period|Protocol Violation|0
6821012|NCT00092534|10824713|FG004|Base Study Follow-Up Period|Protocol Violation|0
6821013|NCT00092534|10824709|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71
6821014|NCT00092534|10824710|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62
6821015|NCT00092534|10824711|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0
6821016|NCT00092534|10824712|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0
6821017|NCT00092534|10824713|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0
6821018|NCT00092534|10824709|FG000|Base Study Follow-Up Period|Moved|62
6821019|NCT00092534|10824710|FG001|Base Study Follow-Up Period|Moved|58
6900047|NCT00662649|10920264|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3
6900048|NCT00662649|10920260|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
6900049|NCT00662649|10920261|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
6900050|NCT00662649|10920262|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0
6900051|NCT00662649|10920263|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
6900052|NCT00662649|10920264|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
6900053|NCT00662649|10920260|FG000|Extension Study (Month 24 to 60)|Administrative problems|0
6900054|NCT00662649|10920261|FG001|Extension Study (Month 24 to 60)|Administrative problems|0
6900055|NCT00662649|10920262|FG002|Extension Study (Month 24 to 60)|Administrative problems|0
6900056|NCT00662649|10920263|FG003|Extension Study (Month 24 to 60)|Administrative problems|1
6900057|NCT00662649|10920264|FG004|Extension Study (Month 24 to 60)|Administrative problems|0
6900058|NCT00662649|10920260|FG000|Extension Study (Month 24 to 60)|Adverse Event|6
6900059|NCT00662649|10920261|FG001|Extension Study (Month 24 to 60)|Adverse Event|9
6900060|NCT00662649|10920262|FG002|Extension Study (Month 24 to 60)|Adverse Event|0
6900061|NCT00662649|10920263|FG003|Extension Study (Month 24 to 60)|Adverse Event|6
6900062|NCT00662649|10920264|FG004|Extension Study (Month 24 to 60)|Adverse Event|10
6900063|NCT00662649|10920260|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2
6900064|NCT00662649|10920261|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0
6900065|NCT00662649|10920262|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0
6900066|NCT00662649|10920263|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1
6900067|NCT00662649|10920264|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1
6900068|NCT00662649|10920260|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1
6900069|NCT00662649|10920261|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1
6900070|NCT00662649|10920262|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0
6900071|NCT00662649|10920263|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0
6900072|NCT00662649|10920264|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0
6900073|NCT00662649|10920260|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19
6900074|NCT00662649|10920261|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23
6900075|NCT00662649|10920262|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0
6900076|NCT00662649|10920263|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15
6900077|NCT00662649|10920264|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9
6900078|NCT00662649|10920260|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
6900079|NCT00662649|10920261|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1
6900080|NCT00662649|10920262|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
6900081|NCT00662649|10920263|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
6900082|NCT00662649|10920264|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
6900083|NCT00662649|10920260|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
6900084|NCT00662649|10920261|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
6900085|NCT00662649|10920262|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0
6900086|NCT00662649|10920263|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
6900087|NCT00662649|10920264|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
6900088|NCT00662831|10920300|FG000|Overall Study|Death|4
6900089|NCT00662831|10920301|FG001|Overall Study|Death|1
6900090|NCT00662831|10920300|FG000|Overall Study|Lack of Efficacy|6
6900091|NCT00662831|10920301|FG001|Overall Study|Lack of Efficacy|6
6900092|NCT00662831|10920300|FG000|Overall Study|Lost to Follow-up|1
6900093|NCT00662831|10920301|FG001|Overall Study|Lost to Follow-up|0
6900094|NCT00662831|10920300|FG000|Overall Study|Withdrawal by Subject|2
6900095|NCT00662831|10920301|FG001|Overall Study|Withdrawal by Subject|1
6900096|NCT00662831|10920300|FG000|Overall Study|Other|62
6900097|NCT00662831|10920301|FG001|Overall Study|Other|31
6900098|NCT00662831|10920300|FG000|Overall Study|Protocol Violation|8
6821020|NCT00092534|10824711|FG002|Base Study Follow-Up Period|Moved|0
6821021|NCT00092534|10824712|FG003|Base Study Follow-Up Period|Moved|0
6821022|NCT00092534|10824713|FG004|Base Study Follow-Up Period|Moved|0
6821023|NCT00092534|10824709|FG000|Base Study Follow-Up Period|Travel|10
6821024|NCT00092534|10824710|FG001|Base Study Follow-Up Period|Travel|7
6821025|NCT00092534|10824711|FG002|Base Study Follow-Up Period|Travel|0
6821026|NCT00092534|10824712|FG003|Base Study Follow-Up Period|Travel|0
6821027|NCT00092534|10824713|FG004|Base Study Follow-Up Period|Travel|0
6821028|NCT00092534|10824709|FG000|Base Study Follow-Up Period|Site Closed|0
6821029|NCT00092534|10824710|FG001|Base Study Follow-Up Period|Site Closed|2
6821030|NCT00092534|10824711|FG002|Base Study Follow-Up Period|Site Closed|0
6821031|NCT00092534|10824712|FG003|Base Study Follow-Up Period|Site Closed|0
6821032|NCT00092534|10824713|FG004|Base Study Follow-Up Period|Site Closed|0
6821033|NCT00092534|10824709|FG000|Base Study Follow-Up Period|Subjects continuing|27
6821034|NCT00092534|10824710|FG001|Base Study Follow-Up Period|Subjects continuing|31
6821035|NCT00092534|10824711|FG002|Base Study Follow-Up Period|Subjects continuing|0
6821036|NCT00092534|10824712|FG003|Base Study Follow-Up Period|Subjects continuing|0
6821037|NCT00092534|10824713|FG004|Base Study Follow-Up Period|Subjects continuing|0
6821038|NCT00092534|10824709|FG000|Base Study Follow-Up Period|Subjects in extension|15
6821039|NCT00092534|10824710|FG001|Base Study Follow-Up Period|Subjects in extension|371
6821040|NCT00092534|10824711|FG002|Base Study Follow-Up Period|Subjects in extension|0
6821041|NCT00092534|10824712|FG003|Base Study Follow-Up Period|Subjects in extension|0
6821042|NCT00092534|10824713|FG004|Base Study Follow-Up Period|Subjects in extension|0
6821043|NCT00092534|10824709|FG000|Base Study EXT|Lost to Follow-up|0
6821044|NCT00092534|10824710|FG001|Base Study EXT|Lost to Follow-up|0
6821045|NCT00092534|10824711|FG002|Base Study EXT|Lost to Follow-up|41
6821046|NCT00092534|10824712|FG003|Base Study EXT|Lost to Follow-up|0
6821047|NCT00092534|10824713|FG004|Base Study EXT|Lost to Follow-up|0
6821048|NCT00092534|10824709|FG000|Base Study EXT|Physician Decision|0
6821049|NCT00092534|10824710|FG001|Base Study EXT|Physician Decision|0
6821050|NCT00092534|10824711|FG002|Base Study EXT|Physician Decision|1
6821051|NCT00092534|10824712|FG003|Base Study EXT|Physician Decision|0
6821052|NCT00092534|10824713|FG004|Base Study EXT|Physician Decision|0
6821053|NCT00092534|10824709|FG000|Base Study EXT|Pregnancy|0
6821054|NCT00092534|10824710|FG001|Base Study EXT|Pregnancy|0
6821055|NCT00092534|10824711|FG002|Base Study EXT|Pregnancy|12
6821056|NCT00092534|10824712|FG003|Base Study EXT|Pregnancy|0
6821057|NCT00092534|10824713|FG004|Base Study EXT|Pregnancy|0
6821058|NCT00092534|10824709|FG000|Base Study EXT|Withdrawal by Subject|0
6821059|NCT00092534|10824710|FG001|Base Study EXT|Withdrawal by Subject|0
6821060|NCT00092534|10824711|FG002|Base Study EXT|Withdrawal by Subject|18
6821061|NCT00092534|10824712|FG003|Base Study EXT|Withdrawal by Subject|0
6821062|NCT00092534|10824713|FG004|Base Study EXT|Withdrawal by Subject|0
6821063|NCT00092534|10824709|FG000|Base Study EXT|Participant moved|0
6821064|NCT00092534|10824710|FG001|Base Study EXT|Participant moved|0
6821065|NCT00092534|10824711|FG002|Base Study EXT|Participant moved|6
6821066|NCT00092534|10824712|FG003|Base Study EXT|Participant moved|0
6821067|NCT00092534|10824713|FG004|Base Study EXT|Participant moved|0
6821068|NCT00092534|10824709|FG000|Base Study EXT|Travel|0
6821069|NCT00092534|10824710|FG001|Base Study EXT|Travel|0
6821070|NCT00092534|10824711|FG002|Base Study EXT|Travel|2
6821071|NCT00092534|10824712|FG003|Base Study EXT|Travel|0
6821072|NCT00092534|10824713|FG004|Base Study EXT|Travel|0
6821073|NCT00092534|10824709|FG000|Base Study EXT|Site closed|0
6821074|NCT00092534|10824710|FG001|Base Study EXT|Site closed|0
6821075|NCT00092534|10824711|FG002|Base Study EXT|Site closed|21
6821076|NCT00092534|10824712|FG003|Base Study EXT|Site closed|0
6821077|NCT00092534|10824713|FG004|Base Study EXT|Site closed|0
6821078|NCT00092534|10824709|FG000|Base Study EXT|Study ended|0
6821079|NCT00092534|10824710|FG001|Base Study EXT|Study ended|0
6821080|NCT00092534|10824711|FG002|Base Study EXT|Study ended|29
6821081|NCT00092534|10824712|FG003|Base Study EXT|Study ended|0
6821082|NCT00092534|10824713|FG004|Base Study EXT|Study ended|0
6821083|NCT00092534|10824709|FG000|Base Study EXT|Protocol Violation|0
6821084|NCT00092534|10824710|FG001|Base Study EXT|Protocol Violation|0
6821085|NCT00092534|10824711|FG002|Base Study EXT|Protocol Violation|15
6821086|NCT00092534|10824712|FG003|Base Study EXT|Protocol Violation|0
6821087|NCT00092534|10824713|FG004|Base Study EXT|Protocol Violation|0
6821088|NCT00092534|10824709|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
6821089|NCT00092534|10824710|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
6821090|NCT00092534|10824711|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
6821091|NCT00092534|10824712|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1
6821092|NCT00092534|10824713|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
6821093|NCT00092547|10824725|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5
6821094|NCT00092547|10824726|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1
6821095|NCT00092547|10824727|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0
6821096|NCT00092547|10824725|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4
6821097|NCT00092547|10824726|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1
6821098|NCT00092547|10824727|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0
6821099|NCT00092547|10824725|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18
6821100|NCT00092547|10824726|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7
6821101|NCT00092547|10824727|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0
6821102|NCT00092547|10824725|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28
6896627|NCT00634114|10915133|FG000|Overall Study|Other reason|1
6821103|NCT00092547|10824726|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21
6821104|NCT00092547|10824727|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0
6821105|NCT00092547|10824725|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3
6821106|NCT00092547|10824726|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1
6900099|NCT00662831|10920301|FG001|Overall Study|Protocol Violation|4
6900100|NCT00662831|10920300|FG000|Overall Study|Adverse Event|23
6900101|NCT00662831|10920301|FG001|Overall Study|Adverse Event|16
6900102|NCT00662857|10920307|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0
6900103|NCT00662857|10920308|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1
6900104|NCT00662857|10920307|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0
6900105|NCT00662857|10920308|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1
6900106|NCT00662857|10920307|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1
6900107|NCT00662857|10920308|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0
6900108|NCT00662909|10920320|FG000|Overall Study|Adverse Event|17
6900109|NCT00662909|10920321|FG001|Overall Study|Adverse Event|18
6900110|NCT00662909|10920322|FG002|Overall Study|Adverse Event|19
6900111|NCT00662909|10920320|FG000|Overall Study|Lack of Efficacy|9
6900112|NCT00662909|10920321|FG001|Overall Study|Lack of Efficacy|1
6900113|NCT00662909|10920322|FG002|Overall Study|Lack of Efficacy|5
6900114|NCT00662909|10920320|FG000|Overall Study|Withdrawal by Subject|29
6900115|NCT00662909|10920321|FG001|Overall Study|Withdrawal by Subject|22
6900116|NCT00662909|10920322|FG002|Overall Study|Withdrawal by Subject|16
6900117|NCT00662909|10920320|FG000|Overall Study|Lost to Follow-up|2
6900118|NCT00662909|10920321|FG001|Overall Study|Lost to Follow-up|9
6900119|NCT00662909|10920322|FG002|Overall Study|Lost to Follow-up|3
6900120|NCT00662909|10920320|FG000|Overall Study|Protocol Violation|7
6900121|NCT00662909|10920321|FG001|Overall Study|Protocol Violation|4
6900122|NCT00662909|10920322|FG002|Overall Study|Protocol Violation|5
6900123|NCT00662909|10920320|FG000|Overall Study|Randomized- never received study drug|1
6900124|NCT00662909|10920321|FG001|Overall Study|Randomized- never received study drug|0
6900125|NCT00662909|10920322|FG002|Overall Study|Randomized- never received study drug|0
6900126|NCT00662909|10920320|FG000|Overall Study|Non-compliance with study procedures|3
6900127|NCT00662909|10920321|FG001|Overall Study|Non-compliance with study procedures|3
6900128|NCT00662909|10920322|FG002|Overall Study|Non-compliance with study procedures|2
6900129|NCT00662909|10920320|FG000|Overall Study|Physician Decision|1
6900130|NCT00662909|10920321|FG001|Overall Study|Physician Decision|1
6900131|NCT00662909|10920322|FG002|Overall Study|Physician Decision|2
6900132|NCT00662909|10920320|FG000|Overall Study|Eligibility criterion not met|0
6900133|NCT00662909|10920321|FG001|Overall Study|Eligibility criterion not met|1
6900134|NCT00662909|10920322|FG002|Overall Study|Eligibility criterion not met|1
6900135|NCT00663026|10920333|FG000|Overall Study|Lost to Follow-up|1
6900136|NCT00663026|10920334|FG001|Overall Study|Lost to Follow-up|0
6900137|NCT00663026|10920335|FG002|Overall Study|Lost to Follow-up|0
6900138|NCT00663026|10920333|FG000|Overall Study|Other|1
6900139|NCT00663026|10920334|FG001|Overall Study|Other|2
6900140|NCT00663026|10920335|FG002|Overall Study|Other|0
6900141|NCT00663026|10920333|FG000|Overall Study|Adverse Event|0
6900142|NCT00663026|10920334|FG001|Overall Study|Adverse Event|2
6900143|NCT00663026|10920335|FG002|Overall Study|Adverse Event|3
6900144|NCT00663026|10920333|FG000|Overall Study|Caregiver Request|0
6900145|NCT00663026|10920334|FG001|Overall Study|Caregiver Request|2
6900146|NCT00663026|10920335|FG002|Overall Study|Caregiver Request|0
6900147|NCT00663026|10920333|FG000|Overall Study|Withdrawal by Subject|0
6900148|NCT00663026|10920334|FG001|Overall Study|Withdrawal by Subject|0
6900149|NCT00663026|10920335|FG002|Overall Study|Withdrawal by Subject|1
6900150|NCT00663117|10920354|FG000|Overall Study|Lack of Efficacy|1
6900151|NCT00663117|10920355|FG001|Overall Study|Lack of Efficacy|0
6900152|NCT00663208|10920383|FG000|Treatment Period|Lost to Follow-up|0
6900153|NCT00663208|10920384|FG001|Treatment Period|Lost to Follow-up|1
6900154|NCT00663208|10920385|FG002|Treatment Period|Lost to Follow-up|0
6900155|NCT00663208|10920386|FG003|Treatment Period|Lost to Follow-up|0
6900156|NCT00663208|10920387|FG004|Treatment Period|Lost to Follow-up|0
6900157|NCT00663208|10920388|FG005|Treatment Period|Lost to Follow-up|0
6900158|NCT00663208|10920389|FG006|Treatment Period|Lost to Follow-up|0
6900159|NCT00663208|10920383|FG000|Follow-up Period|Lost to Follow-up|2
6900160|NCT00663208|10920384|FG001|Follow-up Period|Lost to Follow-up|0
6900161|NCT00663208|10920385|FG002|Follow-up Period|Lost to Follow-up|3
6900162|NCT00663208|10920386|FG003|Follow-up Period|Lost to Follow-up|2
6900163|NCT00663208|10920387|FG004|Follow-up Period|Lost to Follow-up|0
6900164|NCT00663208|10920388|FG005|Follow-up Period|Lost to Follow-up|0
6900165|NCT00663208|10920389|FG006|Follow-up Period|Lost to Follow-up|0
6900166|NCT00663208|10920383|FG000|Follow-up Period|Other reason|1
6900167|NCT00663208|10920384|FG001|Follow-up Period|Other reason|0
6978586|NCT01214395|11032091|FG000|Overall Study|All patients had infection|5
6900168|NCT00663208|10920385|FG002|Follow-up Period|Other reason|0
6900169|NCT00663208|10920386|FG003|Follow-up Period|Other reason|0
6900170|NCT00663208|10920387|FG004|Follow-up Period|Other reason|0
6900171|NCT00663208|10920388|FG005|Follow-up Period|Other reason|0
6900172|NCT00663208|10920389|FG006|Follow-up Period|Other reason|1
6900173|NCT00663234|10920407|FG000|Overall Study|Not willing to adhere to requirements|1
6900174|NCT00663260|10920418|FG000|Overall Study|Lack of Efficacy|2
6900175|NCT00663260|10920419|FG001|Overall Study|Lack of Efficacy|0
6821107|NCT00092547|10824727|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0
6821108|NCT00092547|10824725|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
6821109|NCT00092547|10824726|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1
6821110|NCT00092547|10824727|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
6821111|NCT00092547|10824725|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
6821112|NCT00092547|10824726|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1
6821113|NCT00092547|10824727|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
6821114|NCT00092547|10824725|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5
6821115|NCT00092547|10824726|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3
6821116|NCT00092547|10824727|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0
6821117|NCT00092547|10824725|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1
6821118|NCT00092547|10824726|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5
6821119|NCT00092547|10824727|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0
6821120|NCT00092547|10824725|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4
6821121|NCT00092547|10824726|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2
6821122|NCT00092547|10824727|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0
6821123|NCT00092547|10824725|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13
6821124|NCT00092547|10824726|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7
6821125|NCT00092547|10824727|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0
6821126|NCT00092547|10824725|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1
6821127|NCT00092547|10824726|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
6821128|NCT00092547|10824727|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
6821129|NCT00092547|10824725|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1
6821130|NCT00092547|10824726|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
6821131|NCT00092547|10824727|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
6821132|NCT00092547|10824725|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4
6821133|NCT00092547|10824726|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2
6821134|NCT00092547|10824727|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0
6821135|NCT00092547|10824725|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1
6821136|NCT00092547|10824726|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3
6821137|NCT00092547|10824727|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0
6821138|NCT00092547|10824725|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2
6821139|NCT00092547|10824726|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
6821140|NCT00092547|10824727|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
6821141|NCT00092547|10824725|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1
6821142|NCT00092547|10824726|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
6821143|NCT00092547|10824727|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
6821144|NCT00092547|10824725|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3
6821145|NCT00092547|10824726|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
6821146|NCT00092547|10824727|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
6821147|NCT00092547|10824725|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6
6821148|NCT00092547|10824726|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0
6821149|NCT00092547|10824727|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9
6821150|NCT00092547|10824725|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14
6821151|NCT00092547|10824726|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0
6821152|NCT00092547|10824727|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7
6821153|NCT00092547|10824725|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1
6821154|NCT00092547|10824726|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
6821155|NCT00092547|10824727|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
6821156|NCT00093015|10824740|FG000|Overall Study|Withdrawal by Subject|194
6821157|NCT00093015|10824741|FG001|Overall Study|Withdrawal by Subject|171
6821158|NCT00093015|10824740|FG000|Overall Study|Lost to Follow-up|96
6821159|NCT00093015|10824741|FG001|Overall Study|Lost to Follow-up|108
6821160|NCT00093015|10824740|FG000|Overall Study|Death|375
6821161|NCT00093015|10824741|FG001|Overall Study|Death|385
6821162|NCT00093145|10824772|FG000|Overall Study|Unacceptable Toxicity Only|2
6821163|NCT00093145|10824772|FG000|Overall Study|Physician Decision|5
6821164|NCT00093145|10824772|FG000|Overall Study|Withdrawal by Subject|9
6821165|NCT00093145|10824772|FG000|Overall Study|Other|1
6896628|NCT00634114|10915134|FG001|Overall Study|Other reason|1
6896629|NCT00634114|10915135|FG002|Overall Study|Other reason|1
6896630|NCT00634179|10915152|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1
6896631|NCT00634244|10915162|FG000|Overall Study|Never started treatment|0
6896632|NCT00634244|10915163|FG001|Overall Study|Never started treatment|1
6896633|NCT00634244|10915164|FG002|Overall Study|Never started treatment|0
6896634|NCT00634244|10915162|FG000|Overall Study|Death|1
6896635|NCT00634244|10915163|FG001|Overall Study|Death|6
6896636|NCT00634244|10915164|FG002|Overall Study|Death|0
6896637|NCT00634244|10915162|FG000|Overall Study|Adverse Event|0
6896638|NCT00634244|10915163|FG001|Overall Study|Adverse Event|2
6896639|NCT00634244|10915164|FG002|Overall Study|Adverse Event|0
6896640|NCT00634244|10915162|FG000|Overall Study|Withdrawal by Subject|0
6821166|NCT00093470|10824782|FG000|Overall Study|Disease progression|39
6821167|NCT00093470|10824783|FG001|Overall Study|Disease progression|0
6821168|NCT00093470|10824782|FG000|Overall Study|Adverse Event|15
6821169|NCT00093470|10824783|FG001|Overall Study|Adverse Event|0
6821170|NCT00093470|10824782|FG000|Overall Study|Death|2
6821171|NCT00093470|10824783|FG001|Overall Study|Death|0
6821172|NCT00093470|10824782|FG000|Overall Study|Withdrawal by Subject|8
6821173|NCT00093470|10824783|FG001|Overall Study|Withdrawal by Subject|0
6821174|NCT00093470|10824782|FG000|Overall Study|Alternative therapy|2
6821175|NCT00093470|10824783|FG001|Overall Study|Alternative therapy|0
6821176|NCT00093470|10824782|FG000|Overall Study|Other complicating disease|3
6821177|NCT00093470|10824783|FG001|Overall Study|Other complicating disease|0
6821178|NCT00093470|10824782|FG000|Overall Study|Physician Decision|2
6821179|NCT00093470|10824783|FG001|Overall Study|Physician Decision|0
6821180|NCT00093470|10824782|FG000|Overall Study|Never started treatment|1
6821181|NCT00093470|10824783|FG001|Overall Study|Never started treatment|0
6821182|NCT00093470|10824782|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1
6821183|NCT00093470|10824783|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0
6821184|NCT00093496|10824791|FG000|Overall Study|Protocol Violation|1
6821185|NCT00093496|10824792|FG001|Overall Study|Protocol Violation|3
6821186|NCT00093795|10824815|FG000|Overall Study|No follow up data|20
6821187|NCT00093795|10824816|FG001|Overall Study|No follow up data|16
6821188|NCT00093795|10824817|FG002|Overall Study|No follow up data|17
6821189|NCT00093808|10824825|FG000|Overall Study|Cancel participation before receiving tx|1
6821190|NCT00093808|10824825|FG000|Overall Study|Protocol Violation|1
6821191|NCT00094055|10824849|FG000|Overall Study|Adverse Event|11
6821192|NCT00094055|10824849|FG000|Overall Study|Death|4
6821193|NCT00094055|10824849|FG000|Overall Study|Lack of Efficacy|17
6821194|NCT00094055|10824849|FG000|Overall Study|Lost to Follow-up|2
6821195|NCT00094055|10824849|FG000|Overall Study|progressive disease|2
6821196|NCT00094055|10824849|FG000|Overall Study|clinical progression|1
6821197|NCT00094055|10824849|FG000|Overall Study|roll-over to another study|14
6821198|NCT00094055|10824849|FG000|Overall Study|Withdrawal by Subject|9
6821199|NCT00094094|10824853|FG000|Overall Study|Death|2
6821200|NCT00094094|10824853|FG000|Overall Study|Lack of Efficacy|23
6821201|NCT00094094|10824853|FG000|Overall Study|Adverse Event|7
6821202|NCT00094107|10824857|FG000|Overall Study|Lack of Efficacy|23
6821203|NCT00094107|10824857|FG000|Overall Study|Death|5
6821204|NCT00094107|10824857|FG000|Overall Study|Adverse Event|3
6821205|NCT00094107|10824857|FG000|Overall Study|Withdrawal due to Disease Progression|1
6821206|NCT00094172|10824863|FG000|Overall Study|Adverse Event|0
6821207|NCT00094172|10824864|FG001|Overall Study|Adverse Event|1
6821208|NCT00094172|10824863|FG000|Overall Study|Lost to Follow-up|2
6821209|NCT00094172|10824864|FG001|Overall Study|Lost to Follow-up|0
6821210|NCT00094172|10824863|FG000|Overall Study|Protocol Violation|0
6821211|NCT00094172|10824864|FG001|Overall Study|Protocol Violation|1
6821212|NCT00094172|10824863|FG000|Overall Study|Withdrawal by Subject|10
6821213|NCT00094172|10824864|FG001|Overall Study|Withdrawal by Subject|5
6821214|NCT00094172|10824863|FG000|Overall Study|Primary endpoint met.|1
6821215|NCT00094172|10824864|FG001|Overall Study|Primary endpoint met.|0
6821216|NCT00094172|10824863|FG000|Overall Study|Started other MS therapy due to disease|1
6821217|NCT00094172|10824864|FG001|Overall Study|Started other MS therapy due to disease|0
6821218|NCT00094302|10824893|FG000|Overall Study|Lost to Follow-up|43
6821219|NCT00094302|10824894|FG001|Overall Study|Lost to Follow-up|41
6821220|NCT00094302|10824893|FG000|Overall Study|Physician Decision|5
6821221|NCT00094302|10824894|FG001|Overall Study|Physician Decision|8
6821222|NCT00094302|10824893|FG000|Overall Study|Withdrawal by Subject|103
6821223|NCT00094302|10824894|FG001|Overall Study|Withdrawal by Subject|111
6821224|NCT00094302|10824893|FG000|Overall Study|Death|266
6821225|NCT00094302|10824894|FG001|Overall Study|Death|246
6821226|NCT00094328|10824900|FG000|Overall Study|Lost to Follow-up|1
6821227|NCT00094445|10824904|FG000|Overall Study|Withdrawal by Subject|3
6821228|NCT00094445|10824904|FG000|Overall Study|Lost to Follow-up|1
6821229|NCT00094445|10824904|FG000|Overall Study|Progressive Disease|2
6821230|NCT00094458|10824911|FG000|Main Study: Through Week 30|Eligibility criteria not met|3
6900176|NCT00663260|10920420|FG002|Overall Study|Lack of Efficacy|0
6900177|NCT00663260|10920418|FG000|Overall Study|Adverse Event|12
6900178|NCT00663260|10920419|FG001|Overall Study|Adverse Event|7
6900179|NCT00663260|10920420|FG002|Overall Study|Adverse Event|6
6900180|NCT00663260|10920418|FG000|Overall Study|Withdrawal by Subject|3
6900181|NCT00663260|10920419|FG001|Overall Study|Withdrawal by Subject|1
6900182|NCT00663260|10920420|FG002|Overall Study|Withdrawal by Subject|6
6900183|NCT00663260|10920418|FG000|Overall Study|Death|1
6900184|NCT00663260|10920419|FG001|Overall Study|Death|0
6900185|NCT00663260|10920420|FG002|Overall Study|Death|1
6900186|NCT00663260|10920418|FG000|Overall Study|Lost to Follow-up|0
6900187|NCT00663260|10920419|FG001|Overall Study|Lost to Follow-up|1
6900188|NCT00663260|10920420|FG002|Overall Study|Lost to Follow-up|0
6978587|NCT01214421|11032100|FG000|Overall Study|Lost to Follow-up|7
6821231|NCT00094458|10824912|FG001|Main Study: Through Week 30|Eligibility criteria not met|8
6821232|NCT00094458|10824913|FG002|Main Study: Through Week 30|Eligibility criteria not met|2
6821233|NCT00094458|10824914|FG003|Main Study: Through Week 30|Eligibility criteria not met|0
6900189|NCT00663260|10920418|FG000|Overall Study|non-compliance, not met criteria, etc.|3
6900190|NCT00663260|10920419|FG001|Overall Study|non-compliance, not met criteria, etc.|2
6896641|NCT00634244|10915163|FG001|Overall Study|Withdrawal by Subject|1
6900191|NCT00663260|10920420|FG002|Overall Study|non-compliance, not met criteria, etc.|3
6900192|NCT00663702|10920434|FG000|Overall Study|Adverse Event|8
6900193|NCT00663702|10920435|FG001|Overall Study|Adverse Event|4
6900194|NCT00663702|10920434|FG000|Overall Study|Withdrawal by Subject|3
6900195|NCT00663702|10920435|FG001|Overall Study|Withdrawal by Subject|1
6900196|NCT00663702|10920434|FG000|Overall Study|Pregnancy|0
6900197|NCT00663702|10920435|FG001|Overall Study|Pregnancy|1
6900198|NCT00663702|10920434|FG000|Overall Study|Lost to Follow-up|3
6900199|NCT00663702|10920435|FG001|Overall Study|Lost to Follow-up|0
6900200|NCT00663702|10920434|FG000|Overall Study|Death|1
6900201|NCT00663702|10920435|FG001|Overall Study|Death|1
6900202|NCT00663702|10920434|FG000|Overall Study|Lack of Efficacy|3
6900203|NCT00663702|10920435|FG001|Overall Study|Lack of Efficacy|3
6900204|NCT00663858|10920464|FG000|Overall Study|Adverse Event|9
6900205|NCT00663858|10920465|FG001|Overall Study|Adverse Event|1
6900206|NCT00663858|10920466|FG002|Overall Study|Adverse Event|6
6900207|NCT00663858|10920464|FG000|Overall Study|Lack of Efficacy|5
6900208|NCT00663858|10920465|FG001|Overall Study|Lack of Efficacy|1
6900209|NCT00663858|10920466|FG002|Overall Study|Lack of Efficacy|3
6900210|NCT00663858|10920464|FG000|Overall Study|Withdrawal by Subject|7
6900211|NCT00663858|10920465|FG001|Overall Study|Withdrawal by Subject|3
6900212|NCT00663858|10920466|FG002|Overall Study|Withdrawal by Subject|3
6900213|NCT00663858|10920464|FG000|Overall Study|Protocol Violation|5
6900214|NCT00663858|10920465|FG001|Overall Study|Protocol Violation|3
6900215|NCT00663858|10920466|FG002|Overall Study|Protocol Violation|4
6900216|NCT00663858|10920464|FG000|Overall Study|Other|8
6900217|NCT00663858|10920465|FG001|Overall Study|Other|2
6900218|NCT00663858|10920466|FG002|Overall Study|Other|4
6900219|NCT00663871|10920476|FG000|Overall Study|Lost to Follow-up|5
6900220|NCT00663871|10920477|FG001|Overall Study|Lost to Follow-up|5
6900221|NCT00663871|10920476|FG000|Overall Study|Withdrawal by Subject|5
6900222|NCT00663871|10920477|FG001|Overall Study|Withdrawal by Subject|2
6900223|NCT00663923|10920485|FG000|Overall Study|Lost to Follow-up|2
6900224|NCT00663962|10920493|FG000|Overall Study|somnolence|1
6900225|NCT00663962|10920494|FG001|Overall Study|somnolence|0
6900226|NCT00664105|10920500|FG000|Overall Study|Death|3
6900227|NCT00664105|10920500|FG000|Overall Study|Withdrawal by Subject|5
6900228|NCT00664105|10920500|FG000|Overall Study|Adverse Event|9
6900229|NCT00664105|10920500|FG000|Overall Study|Disease progression|7
6900230|NCT00664209|10920505|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7
6900231|NCT00664209|10920505|FG000|Study Treatment Period|Physician Decision|4
6900232|NCT00664209|10920505|FG000|Study Treatment Period|Withdrawal by Subject|2
6900233|NCT00664326|10920510|FG000|Overall Study|Adverse Event|14
6900234|NCT00664326|10920510|FG000|Overall Study|Noncompliance with study medication|3
6900235|NCT00664326|10920510|FG000|Overall Study|Withdrawal by Subject|1
6900236|NCT00664326|10920510|FG000|Overall Study|Physician Decision|1
6900237|NCT00664326|10920510|FG000|Overall Study|Other Reasons|3
6900238|NCT00664326|10920510|FG000|Overall Study|Death|2
6900239|NCT00664326|10920510|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24
6900240|NCT00664521|10920520|FG000|Overall Study|Adverse Event|4
6900241|NCT00664521|10920521|FG001|Overall Study|Adverse Event|1
6900242|NCT00664521|10920520|FG000|Overall Study|Lost to Follow-up|1
6900243|NCT00664521|10920521|FG001|Overall Study|Lost to Follow-up|0
6900244|NCT00664521|10920520|FG000|Overall Study|Other|1
6900245|NCT00664521|10920521|FG001|Overall Study|Other|0
6896642|NCT00634244|10915164|FG002|Overall Study|Withdrawal by Subject|0
6896643|NCT00634244|10915162|FG000|Overall Study|Physician Decision|0
6896644|NCT00634244|10915163|FG001|Overall Study|Physician Decision|1
6896645|NCT00634244|10915164|FG002|Overall Study|Physician Decision|0
6896646|NCT00634244|10915162|FG000|Overall Study|Disease progression/relapse|0
6896647|NCT00634244|10915163|FG001|Overall Study|Disease progression/relapse|1
6896648|NCT00634244|10915164|FG002|Overall Study|Disease progression/relapse|0
6896649|NCT00634244|10915162|FG000|Overall Study|Other complicating disease|0
6896650|NCT00634244|10915163|FG001|Overall Study|Other complicating disease|1
6896651|NCT00634244|10915164|FG002|Overall Study|Other complicating disease|0
6896652|NCT00634543|10915195|FG000|Overall Study|Other|1
6896653|NCT00634543|10915196|FG001|Overall Study|Other|2
6896654|NCT00634543|10915195|FG000|Overall Study|Protocol Violation|3
6896655|NCT00634543|10915196|FG001|Overall Study|Protocol Violation|3
6896656|NCT00634543|10915195|FG000|Overall Study|Adverse Event|11
6896657|NCT00634543|10915196|FG001|Overall Study|Adverse Event|11
6896658|NCT00634543|10915195|FG000|Overall Study|Withdrawal by Subject|4
6896659|NCT00634543|10915196|FG001|Overall Study|Withdrawal by Subject|4
6896660|NCT00634543|10915195|FG000|Overall Study|Lost to Follow-up|0
6896661|NCT00634543|10915196|FG001|Overall Study|Lost to Follow-up|1
6896662|NCT00634569|10915204|FG000|Overall Study|Withdrawal by Subject|0
6896663|NCT00634569|10915205|FG001|Overall Study|Withdrawal by Subject|4
6896664|NCT00634569|10915204|FG000|Overall Study|Physician Decision|0
6896665|NCT00634569|10915205|FG001|Overall Study|Physician Decision|1
6896666|NCT00634647|10915219|FG000|Overall Study|death on study|3
6896667|NCT00634647|10915219|FG000|Overall Study|refused further treatment|3
6896668|NCT00634647|10915219|FG000|Overall Study|declined to participate before treatment|1
6896669|NCT00634751|10915227|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1
6896670|NCT00634751|10915228|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0
6821234|NCT00094458|10824915|FG004|Main Study: Through Week 30|Eligibility criteria not met|0
6821235|NCT00094458|10824916|FG005|Main Study: Through Week 30|Eligibility criteria not met|0
6821236|NCT00094458|10824911|FG000|Main Study: Through Week 30|Lost to Follow-up|5
6821237|NCT00094458|10824912|FG001|Main Study: Through Week 30|Lost to Follow-up|5
6821238|NCT00094458|10824913|FG002|Main Study: Through Week 30|Lost to Follow-up|2
6821239|NCT00094458|10824914|FG003|Main Study: Through Week 30|Lost to Follow-up|0
6821240|NCT00094458|10824915|FG004|Main Study: Through Week 30|Lost to Follow-up|0
6821241|NCT00094458|10824916|FG005|Main Study: Through Week 30|Lost to Follow-up|0
6821242|NCT00094458|10824911|FG000|Main Study: Through Week 30|Withdrawal by Subject|18
6821243|NCT00094458|10824912|FG001|Main Study: Through Week 30|Withdrawal by Subject|9
6821244|NCT00094458|10824913|FG002|Main Study: Through Week 30|Withdrawal by Subject|7
6821245|NCT00094458|10824914|FG003|Main Study: Through Week 30|Withdrawal by Subject|0
6821246|NCT00094458|10824915|FG004|Main Study: Through Week 30|Withdrawal by Subject|0
6821247|NCT00094458|10824916|FG005|Main Study: Through Week 30|Withdrawal by Subject|0
6821248|NCT00094458|10824911|FG000|Main Study: Through Week 30|Adverse Event|38
6821249|NCT00094458|10824912|FG001|Main Study: Through Week 30|Adverse Event|20
6821250|NCT00094458|10824913|FG002|Main Study: Through Week 30|Adverse Event|28
6821251|NCT00094458|10824914|FG003|Main Study: Through Week 30|Adverse Event|0
6821252|NCT00094458|10824915|FG004|Main Study: Through Week 30|Adverse Event|0
6821253|NCT00094458|10824916|FG005|Main Study: Through Week 30|Adverse Event|0
6821254|NCT00094458|10824911|FG000|Main Study: Through Week 30|Death|1
6821255|NCT00094458|10824912|FG001|Main Study: Through Week 30|Death|0
6821256|NCT00094458|10824913|FG002|Main Study: Through Week 30|Death|0
6821257|NCT00094458|10824914|FG003|Main Study: Through Week 30|Death|0
6821258|NCT00094458|10824915|FG004|Main Study: Through Week 30|Death|0
6821259|NCT00094458|10824916|FG005|Main Study: Through Week 30|Death|0
6821260|NCT00094458|10824911|FG000|Main Study: Through Week 30|Other|19
6821261|NCT00094458|10824912|FG001|Main Study: Through Week 30|Other|16
6821262|NCT00094458|10824913|FG002|Main Study: Through Week 30|Other|9
6821263|NCT00094458|10824914|FG003|Main Study: Through Week 30|Other|0
6821264|NCT00094458|10824915|FG004|Main Study: Through Week 30|Other|0
6821265|NCT00094458|10824916|FG005|Main Study: Through Week 30|Other|0
6821266|NCT00094458|10824911|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2
6821267|NCT00094458|10824912|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1
6821268|NCT00094458|10824913|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4
6821269|NCT00094458|10824914|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
6821270|NCT00094458|10824915|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
6821271|NCT00094458|10824916|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
6821272|NCT00094458|10824911|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2
6821273|NCT00094458|10824912|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
6821274|NCT00094458|10824913|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4
6821275|NCT00094458|10824914|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
6821276|NCT00094458|10824915|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
6821277|NCT00094458|10824916|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
6821278|NCT00094458|10824911|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3
6821279|NCT00094458|10824912|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9
6821280|NCT00094458|10824913|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7
6821281|NCT00094458|10824914|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0
6821282|NCT00094458|10824915|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0
6821283|NCT00094458|10824916|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0
6821284|NCT00094458|10824911|FG000|Study Extension: Week 30 Through Week 50|Other|1
6821285|NCT00094458|10824912|FG001|Study Extension: Week 30 Through Week 50|Other|2
6821286|NCT00094458|10824913|FG002|Study Extension: Week 30 Through Week 50|Other|3
6821287|NCT00094458|10824914|FG003|Study Extension: Week 30 Through Week 50|Other|0
6821288|NCT00094458|10824915|FG004|Study Extension: Week 30 Through Week 50|Other|0
6821289|NCT00094458|10824916|FG005|Study Extension: Week 30 Through Week 50|Other|0
6821290|NCT00094458|10824911|FG000|OLE: Open-Label Extension|Adverse Event|0
6821291|NCT00094458|10824912|FG001|OLE: Open-Label Extension|Adverse Event|0
6821292|NCT00094458|10824913|FG002|OLE: Open-Label Extension|Adverse Event|0
6821293|NCT00094458|10824914|FG003|OLE: Open-Label Extension|Adverse Event|0
6821294|NCT00094458|10824915|FG004|OLE: Open-Label Extension|Adverse Event|3
6821295|NCT00094458|10824916|FG005|OLE: Open-Label Extension|Adverse Event|4
6821296|NCT00094458|10824911|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0
6821297|NCT00094458|10824912|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0
6821298|NCT00094458|10824913|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0
6821299|NCT00094458|10824914|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1
6821300|NCT00094458|10824915|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1
6821301|NCT00094458|10824916|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0
6821302|NCT00094458|10824911|FG000|OLE: Open-Label Extension|Patient decision|0
6821303|NCT00094458|10824912|FG001|OLE: Open-Label Extension|Patient decision|0
6821304|NCT00094458|10824913|FG002|OLE: Open-Label Extension|Patient decision|0
6821305|NCT00094458|10824914|FG003|OLE: Open-Label Extension|Patient decision|0
6821306|NCT00094458|10824915|FG004|OLE: Open-Label Extension|Patient decision|1
6821307|NCT00094458|10824916|FG005|OLE: Open-Label Extension|Patient decision|0
6821308|NCT00094536|10824939|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24
6821309|NCT00094536|10824939|FG000|Treatment and Follow-up|Adverse Event|4
6821310|NCT00094536|10824939|FG000|Treatment and Follow-up|Lack of Efficacy|9
6821311|NCT00094536|10824939|FG000|Treatment and Follow-up|Lost to Follow-up|7
6821312|NCT00094536|10824939|FG000|Treatment and Follow-up|Withdrawal by Subject|1
6821313|NCT00094536|10824939|FG000|Treatment and Follow-up|Subject non-compliance|9
6821314|NCT00094536|10824939|FG000|Treatment and Follow-up|Unable to attend visits|1
6821315|NCT00094575|10824945|FG000|Overall Study|Death|146
6900246|NCT00664534|10920529|FG000|Overall Study|Adverse Event|2
6900247|NCT00664534|10920530|FG001|Overall Study|Adverse Event|3
6900248|NCT00664534|10920529|FG000|Overall Study|Lost to Follow-up|6
6900249|NCT00664534|10920530|FG001|Overall Study|Lost to Follow-up|10
6900250|NCT00664534|10920529|FG000|Overall Study|Protocol Violation|10
6900251|NCT00664534|10920530|FG001|Overall Study|Protocol Violation|8
6900252|NCT00664534|10920529|FG000|Overall Study|Withdrawal by Subject|7
6900253|NCT00664534|10920530|FG001|Overall Study|Withdrawal by Subject|6
6900254|NCT00664534|10920529|FG000|Overall Study|Physician Decision|8
6900255|NCT00664534|10920530|FG001|Overall Study|Physician Decision|0
6900256|NCT00664534|10920529|FG000|Overall Study|Sponsor decision|8
6900257|NCT00664534|10920530|FG001|Overall Study|Sponsor decision|6
6900258|NCT00664560|10920539|FG000|Overall Study|Adverse Event|19
6900259|NCT00664560|10920540|FG001|Overall Study|Adverse Event|16
6900260|NCT00664560|10920541|FG002|Overall Study|Adverse Event|7
6900261|NCT00664560|10920539|FG000|Overall Study|Withdrawal by Subject|9
6900262|NCT00664560|10920540|FG001|Overall Study|Withdrawal by Subject|13
6900263|NCT00664560|10920541|FG002|Overall Study|Withdrawal by Subject|7
6900264|NCT00664560|10920539|FG000|Overall Study|Lost to Follow-up|0
6900265|NCT00664560|10920540|FG001|Overall Study|Lost to Follow-up|2
6900266|NCT00664560|10920541|FG002|Overall Study|Lost to Follow-up|0
6900267|NCT00664560|10920539|FG000|Overall Study|Other|11
6900268|NCT00664560|10920540|FG001|Overall Study|Other|4
6900269|NCT00664560|10920541|FG002|Overall Study|Other|5
6900270|NCT00664742|10920549|FG000|Overall Study|Withdrawn due to adverse events|3
6900271|NCT00664742|10920549|FG000|Overall Study|Withdrawal by Subject|31
6900272|NCT00664742|10920549|FG000|Overall Study|Lost to Follow-up|92
6900273|NCT00664859|10920565|FG000|Overall Study|Adverse Event|2
6900274|NCT00664859|10920566|FG001|Overall Study|Adverse Event|1
6900275|NCT00664859|10920567|FG002|Overall Study|Adverse Event|3
6900276|NCT00664859|10920565|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6
6900277|NCT00664859|10920566|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4
6900278|NCT00664859|10920567|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4
6900279|NCT00664859|10920565|FG000|Overall Study|Noncompliance with protocol|1
6900280|NCT00664859|10920566|FG001|Overall Study|Noncompliance with protocol|0
6900281|NCT00664859|10920567|FG002|Overall Study|Noncompliance with protocol|4
6900282|NCT00664859|10920565|FG000|Overall Study|Laboratory abnormality|2
6900283|NCT00664859|10920566|FG001|Overall Study|Laboratory abnormality|1
6900284|NCT00664859|10920567|FG002|Overall Study|Laboratory abnormality|4
6900285|NCT00664859|10920565|FG000|Overall Study|Withdrawal by Subject|4
6900286|NCT00664859|10920566|FG001|Overall Study|Withdrawal by Subject|1
6900287|NCT00664859|10920567|FG002|Overall Study|Withdrawal by Subject|3
6900288|NCT00664859|10920565|FG000|Overall Study|Lost to Follow-up|2
6900289|NCT00664859|10920566|FG001|Overall Study|Lost to Follow-up|2
6900290|NCT00664859|10920567|FG002|Overall Study|Lost to Follow-up|1
6900291|NCT00664859|10920565|FG000|Overall Study|Other|0
6900292|NCT00664859|10920566|FG001|Overall Study|Other|1
6900293|NCT00664859|10920567|FG002|Overall Study|Other|2
6900294|NCT00665002|10920575|FG000|Overall Study|Progression/relapse during treatment|11
6900295|NCT00665002|10920575|FG000|Overall Study|Cytogenetic resistance|1
6900296|NCT00665353|10920583|FG000|Study Step 1|Adverse Event|1
6900297|NCT00665353|10920583|FG000|Study Step 1|Withdrawal by Subject|2
6900298|NCT00665353|10920583|FG000|Study Step 2|Lost to Follow-up|2
6900299|NCT00665353|10920583|FG000|Study Step 2|Lack of Efficacy|12
6900300|NCT00665366|10920589|FG000|Overall Study|Lack of Efficacy|11
6900301|NCT00665366|10920590|FG001|Overall Study|Lack of Efficacy|10
6900302|NCT00665366|10920589|FG000|Overall Study|Adverse Event|25
6900303|NCT00665366|10920590|FG001|Overall Study|Adverse Event|23
6900304|NCT00665366|10920589|FG000|Overall Study|Withdrawal by Subject|11
6900305|NCT00665366|10920590|FG001|Overall Study|Withdrawal by Subject|14
6900306|NCT00665366|10920589|FG000|Overall Study|Lost to Follow-up|3
6900307|NCT00665366|10920590|FG001|Overall Study|Lost to Follow-up|5
6900308|NCT00665366|10920589|FG000|Overall Study|Poor compliance/noncompliance|3
6900309|NCT00665366|10920590|FG001|Overall Study|Poor compliance/noncompliance|5
6900310|NCT00665366|10920589|FG000|Overall Study|Pregnancy|1
6900311|NCT00665366|10920590|FG001|Overall Study|Pregnancy|0
6900312|NCT00665366|10920589|FG000|Overall Study|No longer meets study criteria|0
6900313|NCT00665366|10920590|FG001|Overall Study|No longer meets study criteria|1
6900314|NCT00665366|10920589|FG000|Overall Study|Other reasons|4
6900315|NCT00665366|10920590|FG001|Overall Study|Other reasons|1
6900316|NCT00665392|10920596|FG000|Overall Study|not treated|1
6900317|NCT00665431|10920604|FG000|Overall Study|Adverse Event|16
6900318|NCT00665431|10920605|FG001|Overall Study|Adverse Event|22
6900319|NCT00665431|10920606|FG002|Overall Study|Adverse Event|6
6900320|NCT00665431|10920604|FG000|Overall Study|Withdrawal by Subject|17
6900321|NCT00665431|10920605|FG001|Overall Study|Withdrawal by Subject|25
6821316|NCT00094575|10824946|FG001|Overall Study|Death|146
6821317|NCT00094653|10824957|FG000|Overall Study|Death|306
6821318|NCT00094653|10824958|FG001|Overall Study|Death|100
6821319|NCT00094653|10824959|FG002|Overall Study|Death|119
6821320|NCT00094653|10824957|FG000|Overall Study|Subject Withdrew Consent|10
6821321|NCT00094653|10824958|FG001|Overall Study|Subject Withdrew Consent|2
6821322|NCT00094653|10824959|FG002|Overall Study|Subject Withdrew Consent|3
6821323|NCT00094653|10824957|FG000|Overall Study|Other|2
6821324|NCT00094653|10824958|FG001|Overall Study|Other|2
6821325|NCT00094653|10824959|FG002|Overall Study|Other|2
6821326|NCT00094653|10824957|FG000|Overall Study|Lost to Follow-up|3
6821327|NCT00094653|10824958|FG001|Overall Study|Lost to Follow-up|2
6821328|NCT00094653|10824959|FG002|Overall Study|Lost to Follow-up|1
6821329|NCT00094653|10824957|FG000|Overall Study|Protocol Violation|0
6821330|NCT00094653|10824958|FG001|Overall Study|Protocol Violation|0
6821331|NCT00094653|10824959|FG002|Overall Study|Protocol Violation|1
6821332|NCT00094757|10824971|FG000|Overall Study|Adverse Event|11
6821333|NCT00094757|10824972|FG001|Overall Study|Adverse Event|9
6821334|NCT00094757|10824973|FG002|Overall Study|Adverse Event|6
6821335|NCT00094757|10824971|FG000|Overall Study|Lack of Efficacy|11
6821336|NCT00094757|10824972|FG001|Overall Study|Lack of Efficacy|15
6821337|NCT00094757|10824973|FG002|Overall Study|Lack of Efficacy|8
6821338|NCT00094757|10824971|FG000|Overall Study|Lost to Follow-up|3
6821339|NCT00094757|10824972|FG001|Overall Study|Lost to Follow-up|5
6821340|NCT00094757|10824973|FG002|Overall Study|Lost to Follow-up|6
6821341|NCT00094757|10824971|FG000|Overall Study|Patient Moved|2
6821342|NCT00094757|10824972|FG001|Overall Study|Patient Moved|1
6821343|NCT00094757|10824973|FG002|Overall Study|Patient Moved|1
6821344|NCT00094757|10824971|FG000|Overall Study|Protocol Violation|8
6821345|NCT00094757|10824972|FG001|Overall Study|Protocol Violation|5
6821346|NCT00094757|10824973|FG002|Overall Study|Protocol Violation|3
6821347|NCT00094757|10824971|FG000|Overall Study|Withdrawal by Subject|14
6821348|NCT00094757|10824972|FG001|Overall Study|Withdrawal by Subject|21
6821349|NCT00094757|10824973|FG002|Overall Study|Withdrawal by Subject|5
6821350|NCT00094757|10824971|FG000|Overall Study|Other|3
6821351|NCT00094757|10824972|FG001|Overall Study|Other|3
6821352|NCT00094757|10824973|FG002|Overall Study|Other|1
6821353|NCT00094757|10824971|FG000|Overall Study|Protocol specified discontinuation|1
6821354|NCT00094757|10824972|FG001|Overall Study|Protocol specified discontinuation|3
6821355|NCT00094757|10824973|FG002|Overall Study|Protocol specified discontinuation|0
6821356|NCT00094770|10824983|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25
6821357|NCT00094770|10824984|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26
6821358|NCT00094770|10824983|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86
6821359|NCT00094770|10824984|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58
6821360|NCT00094770|10824983|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19
6821361|NCT00094770|10824984|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10
6821362|NCT00094770|10824983|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
6821363|NCT00094770|10824984|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
6821364|NCT00094770|10824983|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19
6821365|NCT00094770|10824984|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25
6821366|NCT00094770|10824983|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6
6821367|NCT00094770|10824984|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2
6821368|NCT00094770|10824983|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25
6821369|NCT00094770|10824984|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28
6821370|NCT00094770|10824983|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2
6821371|NCT00094770|10824984|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2
6821372|NCT00094770|10824983|FG000|Year 1 ( Week 0 to Week 52)|Other|10
6821373|NCT00094770|10824984|FG001|Year 1 ( Week 0 to Week 52)|Other|11
6821374|NCT00094770|10824983|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35
6821375|NCT00094770|10824984|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36
6821376|NCT00094770|10824983|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180
6821377|NCT00094770|10824984|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162
6821378|NCT00094770|10824983|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25
6821379|NCT00094770|10824984|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15
6821380|NCT00094770|10824983|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13
6821381|NCT00094770|10824984|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12
6821382|NCT00094770|10824983|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29
6821383|NCT00094770|10824984|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30
6821384|NCT00094770|10824983|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6
6821385|NCT00094770|10824984|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2
6821386|NCT00094770|10824983|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28
6821387|NCT00094770|10824984|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38
6821388|NCT00094770|10824983|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2
6821389|NCT00094770|10824984|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2
6821390|NCT00094770|10824983|FG000|Year 2 (Week 0 to Week 104)|Other|15
6821391|NCT00094770|10824984|FG001|Year 2 (Week 0 to Week 104)|Other|23
6821392|NCT00094809|10824992|FG000|Overall Study|Protocol deviation|2
6821393|NCT00094809|10824993|FG001|Overall Study|Protocol deviation|2
6821394|NCT00094809|10824992|FG000|Overall Study|Noncompliance|1
6821395|NCT00094809|10824993|FG001|Overall Study|Noncompliance|0
6821396|NCT00094809|10824992|FG000|Overall Study|Adverse Event|3
6821397|NCT00094809|10824993|FG001|Overall Study|Adverse Event|1
6821398|NCT00094809|10824992|FG000|Overall Study|Withdrawal by Subject|8
6821399|NCT00094809|10824993|FG001|Overall Study|Withdrawal by Subject|9
6821400|NCT00094809|10824992|FG000|Overall Study|Disease progression|3
6821401|NCT00094809|10824993|FG001|Overall Study|Disease progression|3
6821402|NCT00094809|10824992|FG000|Overall Study|Physician Decision|3
6821403|NCT00094809|10824993|FG001|Overall Study|Physician Decision|5
6821404|NCT00094809|10824992|FG000|Overall Study|Lost to Follow-up|6
6821405|NCT00094809|10824993|FG001|Overall Study|Lost to Follow-up|6
6821406|NCT00094809|10824992|FG000|Overall Study|Death|19
6821407|NCT00094809|10824993|FG001|Overall Study|Death|25
6821408|NCT00094809|10824992|FG000|Overall Study|Protocol-specified criteria|1
6821409|NCT00094809|10824993|FG001|Overall Study|Protocol-specified criteria|1
6821410|NCT00094809|10824992|FG000|Overall Study|Other|2
6821411|NCT00094809|10824993|FG001|Overall Study|Other|4
6821412|NCT00094809|10824992|FG000|Overall Study|Informed consent signed after treatment|1
6821413|NCT00094809|10824993|FG001|Overall Study|Informed consent signed after treatment|0
6821414|NCT00094809|10824992|FG000|Overall Study|Study drug not received|2
6821415|NCT00094809|10824993|FG001|Overall Study|Study drug not received|8
6821416|NCT00094809|10824992|FG000|Overall Study|Other|1
6821417|NCT00094809|10824993|FG001|Overall Study|Other|1
6821418|NCT00094835|10825006|FG000|Overall Study|Physician Decision|1
6821419|NCT00094835|10825007|FG001|Overall Study|Physician Decision|0
6821420|NCT00094835|10825008|FG002|Overall Study|Physician Decision|0
6821421|NCT00094835|10825009|FG003|Overall Study|Physician Decision|0
6821422|NCT00094835|10825010|FG004|Overall Study|Physician Decision|0
6821423|NCT00094835|10825011|FG005|Overall Study|Physician Decision|1
6821424|NCT00094835|10825012|FG006|Overall Study|Physician Decision|0
6821425|NCT00094835|10825006|FG000|Overall Study|Withdrawal by Subject|0
6821426|NCT00094835|10825007|FG001|Overall Study|Withdrawal by Subject|0
6821427|NCT00094835|10825008|FG002|Overall Study|Withdrawal by Subject|0
6821428|NCT00094835|10825009|FG003|Overall Study|Withdrawal by Subject|0
6821429|NCT00094835|10825010|FG004|Overall Study|Withdrawal by Subject|0
6821430|NCT00094835|10825011|FG005|Overall Study|Withdrawal by Subject|0
6821431|NCT00094835|10825012|FG006|Overall Study|Withdrawal by Subject|1
6821432|NCT00094835|10825006|FG000|Overall Study|Lost to Follow-up|0
6821433|NCT00094835|10825007|FG001|Overall Study|Lost to Follow-up|0
6821434|NCT00094835|10825008|FG002|Overall Study|Lost to Follow-up|0
6821435|NCT00094835|10825009|FG003|Overall Study|Lost to Follow-up|0
6821436|NCT00094835|10825010|FG004|Overall Study|Lost to Follow-up|1
6821437|NCT00094835|10825011|FG005|Overall Study|Lost to Follow-up|0
6821438|NCT00094835|10825012|FG006|Overall Study|Lost to Follow-up|0
6821439|NCT00094835|10825006|FG000|Overall Study|Death|1
6821440|NCT00094835|10825007|FG001|Overall Study|Death|0
6821441|NCT00094835|10825008|FG002|Overall Study|Death|0
6821442|NCT00094835|10825009|FG003|Overall Study|Death|0
6821443|NCT00094835|10825010|FG004|Overall Study|Death|1
6821444|NCT00094835|10825011|FG005|Overall Study|Death|0
6821445|NCT00094835|10825012|FG006|Overall Study|Death|0
6821446|NCT00094835|10825006|FG000|Overall Study|Non-compliance|1
6821447|NCT00094835|10825007|FG001|Overall Study|Non-compliance|2
6821448|NCT00094835|10825008|FG002|Overall Study|Non-compliance|2
6821449|NCT00094835|10825009|FG003|Overall Study|Non-compliance|0
6821450|NCT00094835|10825010|FG004|Overall Study|Non-compliance|2
6821451|NCT00094835|10825011|FG005|Overall Study|Non-compliance|2
6821452|NCT00094835|10825012|FG006|Overall Study|Non-compliance|1
6821453|NCT00094835|10825006|FG000|Overall Study|Other|1
6821454|NCT00094835|10825007|FG001|Overall Study|Other|1
6821455|NCT00094835|10825008|FG002|Overall Study|Other|1
6821456|NCT00094835|10825009|FG003|Overall Study|Other|1
6821457|NCT00094835|10825010|FG004|Overall Study|Other|0
6821458|NCT00094835|10825011|FG005|Overall Study|Other|0
6821459|NCT00094835|10825012|FG006|Overall Study|Other|0
6821460|NCT00094861|10825035|FG000|Overall Study|Adverse Event|5
6821461|NCT00094861|10825036|FG001|Overall Study|Adverse Event|2
6821462|NCT00094861|10825035|FG000|Overall Study|Withdrawal by Subject|5
6821463|NCT00094861|10825036|FG001|Overall Study|Withdrawal by Subject|3
6821464|NCT00094861|10825035|FG000|Overall Study|Physician Decision|1
6821465|NCT00094861|10825036|FG001|Overall Study|Physician Decision|1
6821466|NCT00094861|10825035|FG000|Overall Study|Lost to Follow-up|0
6821467|NCT00094861|10825036|FG001|Overall Study|Lost to Follow-up|1
6821468|NCT00094861|10825035|FG000|Overall Study|Death|4
6821469|NCT00094861|10825036|FG001|Overall Study|Death|2
6821470|NCT00094861|10825035|FG000|Overall Study|Other|3
6821471|NCT00094861|10825036|FG001|Overall Study|Other|0
6821472|NCT00095056|10825057|FG000|Phase A (Weeks 0-12)|Adverse Event|1
6821473|NCT00095056|10825058|FG001|Phase A (Weeks 0-12)|Adverse Event|1
6821474|NCT00095056|10825057|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3
6821475|NCT00095056|10825058|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0
6821476|NCT00095056|10825057|FG000|Phase A (Weeks 0-12)|Death|1
6821477|NCT00095056|10825058|FG001|Phase A (Weeks 0-12)|Death|0
6821478|NCT00095056|10825057|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2
6821479|NCT00095056|10825058|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0
6821480|NCT00095056|10825057|FG000|Phase B (Weeks 12-54)|Adverse Event|2
6821481|NCT00095056|10825058|FG001|Phase B (Weeks 12-54)|Adverse Event|2
6821482|NCT00095056|10825057|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1
6821483|NCT00095056|10825058|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0
6821484|NCT00095056|10825057|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2
6821485|NCT00095056|10825058|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1
6821486|NCT00095056|10825057|FG000|Phase B (Weeks 12-54)|Patient Moved|1
6821487|NCT00095056|10825058|FG001|Phase B (Weeks 12-54)|Patient Moved|0
6821488|NCT00095056|10825057|FG000|Phase B (Weeks 12-54)|Death|3
6821489|NCT00095056|10825058|FG001|Phase B (Weeks 12-54)|Death|1
6821490|NCT00095056|10825057|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1
6821491|NCT00095056|10825058|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0
6821492|NCT00095056|10825057|FG000|Phase B (Weeks 12-54)|Protocol Violation|0
6821493|NCT00095056|10825058|FG001|Phase B (Weeks 12-54)|Protocol Violation|1
6821494|NCT00095121|10825066|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1
6821495|NCT00095121|10825067|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0
6821496|NCT00095121|10825066|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2
6821497|NCT00095121|10825067|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0
6821498|NCT00095147|10825086|FG000|Double-blind Period 1 (Days 1-197)|Death|1
6821499|NCT00095147|10825087|FG001|Double-blind Period 1 (Days 1-197)|Death|0
6821500|NCT00095147|10825088|FG002|Double-blind Period 1 (Days 1-197)|Death|0
6821501|NCT00095147|10825089|FG003|Double-blind Period 1 (Days 1-197)|Death|0
6821502|NCT00095147|10825090|FG004|Double-blind Period 1 (Days 1-197)|Death|0
6821503|NCT00095147|10825086|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2
6821504|NCT00095147|10825087|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8
6821505|NCT00095147|10825088|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1
6821506|NCT00095147|10825089|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0
6821507|NCT00095147|10825090|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0
6821508|NCT00095147|10825086|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
6821509|NCT00095147|10825087|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
6821510|NCT00095147|10825088|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1
6821511|NCT00095147|10825089|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
6821512|NCT00095147|10825090|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
6821513|NCT00095147|10825086|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
6821514|NCT00095147|10825087|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
6900322|NCT00665431|10920606|FG002|Overall Study|Withdrawal by Subject|15
6900323|NCT00665431|10920604|FG000|Overall Study|Lost to Follow-up|3
6900324|NCT00665431|10920605|FG001|Overall Study|Lost to Follow-up|3
6900325|NCT00665431|10920606|FG002|Overall Study|Lost to Follow-up|1
6900326|NCT00665431|10920604|FG000|Overall Study|Other|4
6900327|NCT00665431|10920605|FG001|Overall Study|Other|7
6900328|NCT00665431|10920606|FG002|Overall Study|Other|2
6900329|NCT00665561|10920629|FG000|Overall Study|Death recorded on subject summary pages|75
6900330|NCT00665561|10920630|FG001|Overall Study|Death recorded on subject summary pages|75
6900331|NCT00665561|10920629|FG000|Overall Study|Does not meet entrance criteria|19
6900332|NCT00665561|10920630|FG001|Overall Study|Does not meet entrance criteria|21
6900333|NCT00665561|10920629|FG000|Overall Study|Lost to Follow-up|203
6900334|NCT00665561|10920630|FG001|Overall Study|Lost to Follow-up|264
6900335|NCT00665561|10920629|FG000|Overall Study|Withdrawal by Subject|74
6900336|NCT00665561|10920630|FG001|Overall Study|Withdrawal by Subject|65
6900337|NCT00665561|10920629|FG000|Overall Study|Other|123
6900338|NCT00665561|10920630|FG001|Overall Study|Other|108
6900339|NCT00665561|10920629|FG000|Overall Study|Site closed|8
6900340|NCT00665561|10920630|FG001|Overall Study|Site closed|0
6900341|NCT00665561|10920629|FG000|Overall Study|Withdrawn due to pregnancy|0
6900342|NCT00665561|10920630|FG001|Overall Study|Withdrawn due to pregnancy|1
6900343|NCT00665626|10920638|FG000|Overall Study|Lack of Efficacy|8
6900344|NCT00665626|10920639|FG001|Overall Study|Lack of Efficacy|5
6900345|NCT00665626|10920638|FG000|Overall Study|Lost to Follow-up|0
6900346|NCT00665626|10920639|FG001|Overall Study|Lost to Follow-up|2
6900347|NCT00665626|10920638|FG000|Overall Study|Withdrawal by Subject|0
6900348|NCT00665626|10920639|FG001|Overall Study|Withdrawal by Subject|1
6900349|NCT00665626|10920638|FG000|Overall Study|Protocol Violation|0
6900350|NCT00665626|10920639|FG001|Overall Study|Protocol Violation|2
6900351|NCT00665626|10920638|FG000|Overall Study|Adverse Event|1
6900352|NCT00665626|10920639|FG001|Overall Study|Adverse Event|9
6900353|NCT00665626|10920638|FG000|Overall Study|Due to exclusion criteria|0
6900354|NCT00665626|10920639|FG001|Overall Study|Due to exclusion criteria|1
6900355|NCT00665626|10920638|FG000|Overall Study|Did not fulfil inclusion criteria|0
6900356|NCT00665626|10920639|FG001|Overall Study|Did not fulfil inclusion criteria|1
6900357|NCT00665626|10920638|FG000|Overall Study|Unably to comply with dosing regimen|0
6900358|NCT00665626|10920639|FG001|Overall Study|Unably to comply with dosing regimen|1
6900359|NCT00665626|10920638|FG000|Overall Study|Death|1
6900360|NCT00665626|10920639|FG001|Overall Study|Death|0
6900361|NCT00665652|10920645|FG000|Overall Study|Adverse Event|4
6900362|NCT00665652|10920645|FG000|Overall Study|Death|1
6900363|NCT00665652|10920645|FG000|Overall Study|No longer met inclusion criteria.|1
6900364|NCT00665847|10920653|FG000|Overall Study|Adverse Event|8
6900365|NCT00665847|10920653|FG000|Overall Study|Withdrawal by Subject|2
6900366|NCT00665847|10920653|FG000|Overall Study|Subject non-compliant|8
6900367|NCT00665847|10920653|FG000|Overall Study|Subject reached a virologic endpoint|4
6900368|NCT00665847|10920653|FG000|Overall Study|Resistance to TMC125|1
6900369|NCT00665847|10920653|FG000|Overall Study|Subject ineligible to continue the trial|1
6900370|NCT00665847|10920653|FG000|Overall Study|Switch to Commercial Medication|1
6900371|NCT00665925|10920661|FG000|Overall Study|Lack of Efficacy|10
6821515|NCT00095147|10825088|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
6821516|NCT00095147|10825089|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
6821517|NCT00095147|10825090|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
6821518|NCT00095147|10825086|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
6821519|NCT00095147|10825087|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
6821520|NCT00095147|10825088|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
6821521|NCT00095147|10825089|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
6821522|NCT00095147|10825090|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
6821523|NCT00095147|10825086|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1
6821524|NCT00095147|10825087|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1
6821525|NCT00095147|10825088|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0
6821526|NCT00095147|10825089|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0
6821527|NCT00095147|10825090|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0
6821528|NCT00095147|10825086|FG000|Double-blind Period 2 (Days 198-365)|Death|0
6821529|NCT00095147|10825087|FG001|Double-blind Period 2 (Days 198-365)|Death|1
6821530|NCT00095147|10825088|FG002|Double-blind Period 2 (Days 198-365)|Death|0
6821531|NCT00095147|10825089|FG003|Double-blind Period 2 (Days 198-365)|Death|1
6821532|NCT00095147|10825090|FG004|Double-blind Period 2 (Days 198-365)|Death|0
6821533|NCT00095147|10825086|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2
6821534|NCT00095147|10825087|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4
6900372|NCT00665925|10920662|FG001|Overall Study|Lack of Efficacy|8
6900373|NCT00665925|10920663|FG002|Overall Study|Lack of Efficacy|9
6900374|NCT00665925|10920664|FG003|Overall Study|Lack of Efficacy|8
6900375|NCT00665925|10920661|FG000|Overall Study|Lost to Follow-up|1
6900376|NCT00665925|10920662|FG001|Overall Study|Lost to Follow-up|2
6900377|NCT00665925|10920663|FG002|Overall Study|Lost to Follow-up|2
6900378|NCT00665925|10920664|FG003|Overall Study|Lost to Follow-up|2
6900379|NCT00665925|10920661|FG000|Overall Study|Withdrawal by Subject|2
6900380|NCT00665925|10920662|FG001|Overall Study|Withdrawal by Subject|2
6900381|NCT00665925|10920663|FG002|Overall Study|Withdrawal by Subject|3
6900382|NCT00665925|10920664|FG003|Overall Study|Withdrawal by Subject|2
6900383|NCT00665925|10920661|FG000|Overall Study|Physician Decision|0
6900384|NCT00665925|10920662|FG001|Overall Study|Physician Decision|0
6900385|NCT00665925|10920663|FG002|Overall Study|Physician Decision|1
6900386|NCT00665925|10920664|FG003|Overall Study|Physician Decision|2
6900387|NCT00665925|10920661|FG000|Overall Study|Severe Non-Compliance to Protocol|0
6900388|NCT00665925|10920662|FG001|Overall Study|Severe Non-Compliance to Protocol|0
6900389|NCT00665925|10920663|FG002|Overall Study|Severe Non-Compliance to Protocol|1
6900390|NCT00665925|10920664|FG003|Overall Study|Severe Non-Compliance to Protocol|1
6900391|NCT00665925|10920661|FG000|Overall Study|Adverse Event|1
6900392|NCT00665925|10920662|FG001|Overall Study|Adverse Event|5
6900393|NCT00665925|10920663|FG002|Overall Study|Adverse Event|10
6900394|NCT00665925|10920664|FG003|Overall Study|Adverse Event|5
6900395|NCT00665925|10920661|FG000|Overall Study|Enrolled by mistake|0
6900396|NCT00665925|10920662|FG001|Overall Study|Enrolled by mistake|0
6900397|NCT00665925|10920663|FG002|Overall Study|Enrolled by mistake|0
6978588|NCT01214421|11032101|FG001|Overall Study|Lost to Follow-up|3
6900398|NCT00665925|10920664|FG003|Overall Study|Enrolled by mistake|1
6900399|NCT00665925|10920661|FG000|Overall Study|Due to exclusion criteria|1
6900400|NCT00665925|10920662|FG001|Overall Study|Due to exclusion criteria|0
6900401|NCT00665925|10920663|FG002|Overall Study|Due to exclusion criteria|0
6900402|NCT00665925|10920664|FG003|Overall Study|Due to exclusion criteria|0
6900403|NCT00666198|10920685|FG000|Overall Study|Protocol Violation|10
6900404|NCT00666198|10920685|FG000|Overall Study|No Visit After First Day of Treatment|13
6900405|NCT00666198|10920685|FG000|Overall Study|Safety Not Assessable|6
6900406|NCT00666198|10920685|FG000|Overall Study|No Drug Administration|4
6900407|NCT00666211|10920691|FG000|Overall Study|Withdrawal by Subject|10
6900408|NCT00666211|10920692|FG001|Overall Study|Withdrawal by Subject|13
6900409|NCT00666211|10920691|FG000|Overall Study|went off medication, no more pain|1
6900410|NCT00666211|10920692|FG001|Overall Study|went off medication, no more pain|0
6900411|NCT00666211|10920691|FG000|Overall Study|patient non-compliant|6
6900412|NCT00666211|10920692|FG001|Overall Study|patient non-compliant|6
6900413|NCT00666211|10920691|FG000|Overall Study|disease progression|1
6900414|NCT00666211|10920692|FG001|Overall Study|disease progression|8
6900415|NCT00666211|10920691|FG000|Overall Study|Lost to Follow-up|2
6900416|NCT00666211|10920692|FG001|Overall Study|Lost to Follow-up|0
6900417|NCT00666211|10920691|FG000|Overall Study|toxicity|0
6900418|NCT00666211|10920692|FG001|Overall Study|toxicity|2
6900419|NCT00666211|10920691|FG000|Overall Study|hospital admission|0
6900420|NCT00666211|10920692|FG001|Overall Study|hospital admission|5
6900421|NCT00666211|10920691|FG000|Overall Study|Death|0
6900422|NCT00666211|10920692|FG001|Overall Study|Death|2
6900423|NCT00666211|10920691|FG000|Overall Study|off tx for other complicating disease|0
6900424|NCT00666211|10920692|FG001|Overall Study|off tx for other complicating disease|1
6900425|NCT00666211|10920691|FG000|Overall Study|Physician Decision|0
6900426|NCT00666211|10920692|FG001|Overall Study|Physician Decision|1
6900427|NCT00666224|10920700|FG000|Double-Blind|Adverse Event|15
6900428|NCT00666224|10920701|FG001|Double-Blind|Adverse Event|5
6900429|NCT00666224|10920700|FG000|Double-Blind|Lost to Follow-up|2
6900430|NCT00666224|10920701|FG001|Double-Blind|Lost to Follow-up|2
6900431|NCT00666224|10920700|FG000|Double-Blind|Withdrawal by Subject|18
6821535|NCT00095147|10825088|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0
6821536|NCT00095147|10825089|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0
6821537|NCT00095147|10825090|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0
6821538|NCT00095147|10825086|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2
6821539|NCT00095147|10825087|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4
6821540|NCT00095147|10825088|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
6821541|NCT00095147|10825089|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1
6821542|NCT00095147|10825090|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
6821543|NCT00095147|10825086|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3
6821544|NCT00095147|10825087|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2
6821545|NCT00095147|10825088|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
6821546|NCT00095147|10825089|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
6821547|NCT00095147|10825090|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
6821548|NCT00095147|10825086|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1
6821549|NCT00095147|10825087|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0
6821550|NCT00095147|10825088|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0
6821551|NCT00095147|10825089|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1
6821552|NCT00095147|10825090|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0
6821553|NCT00095147|10825086|FG000|Long-term Extension Period|Death|0
6821554|NCT00095147|10825087|FG001|Long-term Extension Period|Death|0
6821555|NCT00095147|10825088|FG002|Long-term Extension Period|Death|0
6821556|NCT00095147|10825089|FG003|Long-term Extension Period|Death|0
6821557|NCT00095147|10825090|FG004|Long-term Extension Period|Death|3
6821558|NCT00095147|10825086|FG000|Long-term Extension Period|Adverse Event|0
6821559|NCT00095147|10825087|FG001|Long-term Extension Period|Adverse Event|0
6821560|NCT00095147|10825088|FG002|Long-term Extension Period|Adverse Event|0
6821561|NCT00095147|10825089|FG003|Long-term Extension Period|Adverse Event|0
6821562|NCT00095147|10825090|FG004|Long-term Extension Period|Adverse Event|11
6821563|NCT00095147|10825086|FG000|Long-term Extension Period|Lack of Efficacy|0
6821564|NCT00095147|10825087|FG001|Long-term Extension Period|Lack of Efficacy|0
6821565|NCT00095147|10825088|FG002|Long-term Extension Period|Lack of Efficacy|0
6821566|NCT00095147|10825089|FG003|Long-term Extension Period|Lack of Efficacy|0
6821567|NCT00095147|10825090|FG004|Long-term Extension Period|Lack of Efficacy|9
6821568|NCT00095147|10825086|FG000|Long-term Extension Period|Lost to Follow-up|0
6821569|NCT00095147|10825087|FG001|Long-term Extension Period|Lost to Follow-up|0
6821570|NCT00095147|10825088|FG002|Long-term Extension Period|Lost to Follow-up|0
6821571|NCT00095147|10825089|FG003|Long-term Extension Period|Lost to Follow-up|0
6821572|NCT00095147|10825090|FG004|Long-term Extension Period|Lost to Follow-up|6
6821573|NCT00095147|10825086|FG000|Long-term Extension Period|Withdrawal of consent|0
6821574|NCT00095147|10825087|FG001|Long-term Extension Period|Withdrawal of consent|0
6821575|NCT00095147|10825088|FG002|Long-term Extension Period|Withdrawal of consent|0
6821576|NCT00095147|10825089|FG003|Long-term Extension Period|Withdrawal of consent|0
6821577|NCT00095147|10825090|FG004|Long-term Extension Period|Withdrawal of consent|12
6821578|NCT00095147|10825086|FG000|Long-term Extension Period|Pregnancy|0
6821579|NCT00095147|10825087|FG001|Long-term Extension Period|Pregnancy|0
6821580|NCT00095147|10825088|FG002|Long-term Extension Period|Pregnancy|0
6821581|NCT00095147|10825089|FG003|Long-term Extension Period|Pregnancy|0
6821582|NCT00095147|10825090|FG004|Long-term Extension Period|Pregnancy|1
6821583|NCT00095147|10825086|FG000|Long-term Extension Period|No longer meets study criteria|0
6821584|NCT00095147|10825087|FG001|Long-term Extension Period|No longer meets study criteria|0
6821585|NCT00095147|10825088|FG002|Long-term Extension Period|No longer meets study criteria|0
6821586|NCT00095147|10825089|FG003|Long-term Extension Period|No longer meets study criteria|0
6821587|NCT00095147|10825090|FG004|Long-term Extension Period|No longer meets study criteria|1
6821588|NCT00095147|10825086|FG000|Long-term Extension Period|Participant chose to use Revellex|0
6821589|NCT00095147|10825087|FG001|Long-term Extension Period|Participant chose to use Revellex|0
6821590|NCT00095147|10825088|FG002|Long-term Extension Period|Participant chose to use Revellex|0
6821591|NCT00095147|10825089|FG003|Long-term Extension Period|Participant chose to use Revellex|0
6821592|NCT00095147|10825090|FG004|Long-term Extension Period|Participant chose to use Revellex|1
6821593|NCT00095147|10825086|FG000|Long-term Extension Period|Leaving country|0
6821594|NCT00095147|10825087|FG001|Long-term Extension Period|Leaving country|0
6821595|NCT00095147|10825088|FG002|Long-term Extension Period|Leaving country|0
6821596|NCT00095147|10825089|FG003|Long-term Extension Period|Leaving country|0
6821597|NCT00095147|10825090|FG004|Long-term Extension Period|Leaving country|1
6821598|NCT00095173|10825108|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1
6821599|NCT00095173|10825109|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0
6821600|NCT00095173|10825110|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0
6821601|NCT00095173|10825111|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0
6821602|NCT00095173|10825112|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0
6821603|NCT00095173|10825113|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0
6821604|NCT00095173|10825108|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17
6821605|NCT00095173|10825109|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
6821606|NCT00095173|10825110|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
6896671|NCT00634751|10915229|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0
6821607|NCT00095173|10825111|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
6821608|NCT00095173|10825112|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
6821609|NCT00095173|10825113|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
6821610|NCT00095173|10825108|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1
6821611|NCT00095173|10825109|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
6821612|NCT00095173|10825110|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
6821613|NCT00095173|10825111|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
6821614|NCT00095173|10825112|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
6821615|NCT00095173|10825113|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
6821616|NCT00095173|10825108|FG000|Open-Label Lead-In Phase (Period A)|Other|1
6821617|NCT00095173|10825109|FG001|Open-Label Lead-In Phase (Period A)|Other|0
6821618|NCT00095173|10825110|FG002|Open-Label Lead-In Phase (Period A)|Other|0
6821619|NCT00095173|10825111|FG003|Open-Label Lead-In Phase (Period A)|Other|0
6821620|NCT00095173|10825112|FG004|Open-Label Lead-In Phase (Period A)|Other|0
6821621|NCT00095173|10825113|FG005|Open-Label Lead-In Phase (Period A)|Other|0
6821622|NCT00095173|10825108|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0
6821623|NCT00095173|10825109|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10
6821624|NCT00095173|10825110|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31
6821625|NCT00095173|10825111|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0
6821626|NCT00095173|10825112|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0
6821627|NCT00095173|10825113|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0
6821628|NCT00095173|10825108|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0
6821629|NCT00095173|10825109|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1
6821630|NCT00095173|10825110|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0
6821631|NCT00095173|10825111|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0
6821632|NCT00095173|10825112|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0
6821633|NCT00095173|10825113|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0
6821634|NCT00095173|10825108|FG000|Open-Label Extension Phase (Period C)|Death|0
6821635|NCT00095173|10825109|FG001|Open-Label Extension Phase (Period C)|Death|0
6821636|NCT00095173|10825110|FG002|Open-Label Extension Phase (Period C)|Death|0
6821637|NCT00095173|10825111|FG003|Open-Label Extension Phase (Period C)|Death|0
6821638|NCT00095173|10825112|FG004|Open-Label Extension Phase (Period C)|Death|0
6821639|NCT00095173|10825113|FG005|Open-Label Extension Phase (Period C)|Death|1
6900432|NCT00666224|10920701|FG001|Double-Blind|Withdrawal by Subject|14
6900433|NCT00666224|10920700|FG000|Double-Blind|Physician Decision|0
6900434|NCT00666224|10920701|FG001|Double-Blind|Physician Decision|3
6900435|NCT00666224|10920700|FG000|Double-Blind|Sponsor decision|1
6900436|NCT00666224|10920701|FG001|Double-Blind|Sponsor decision|0
6900437|NCT00666224|10920700|FG000|Double-Blind|Pregnancy|3
6900438|NCT00666224|10920701|FG001|Double-Blind|Pregnancy|2
6900439|NCT00666224|10920700|FG000|Double-Blind|Noncompliance|1
6900440|NCT00666224|10920701|FG001|Double-Blind|Noncompliance|0
6900441|NCT00666224|10920700|FG000|Double-Blind|Death|1
6900442|NCT00666224|10920701|FG001|Double-Blind|Death|0
6900443|NCT00666224|10920700|FG000|Double-Blind|Undefined/Unknown|4
6900444|NCT00666224|10920701|FG001|Double-Blind|Undefined/Unknown|1
6900445|NCT00666224|10920700|FG000|Open-Label|Adverse Event|8
6900446|NCT00666224|10920701|FG001|Open-Label|Adverse Event|43
6900447|NCT00666224|10920700|FG000|Open-Label|Lost to Follow-up|4
6900448|NCT00666224|10920701|FG001|Open-Label|Lost to Follow-up|5
6900449|NCT00666224|10920700|FG000|Open-Label|Withdrawal by Subject|12
6900450|NCT00666224|10920701|FG001|Open-Label|Withdrawal by Subject|25
6900451|NCT00666224|10920700|FG000|Open-Label|Physician Decision|7
6900452|NCT00666224|10920701|FG001|Open-Label|Physician Decision|5
6900453|NCT00666224|10920700|FG000|Open-Label|Pregnancy|1
6900454|NCT00666224|10920701|FG001|Open-Label|Pregnancy|5
6900455|NCT00666224|10920700|FG000|Open-Label|Noncompliance|2
6900456|NCT00666224|10920701|FG001|Open-Label|Noncompliance|1
6900457|NCT00666224|10920700|FG000|Open-Label|Undefined/Unknown|1
6900458|NCT00666224|10920701|FG001|Open-Label|Undefined/Unknown|1
6900459|NCT00666263|10920708|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0
6900460|NCT00666263|10920709|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1
6900461|NCT00666263|10920708|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1
6900462|NCT00666263|10920709|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0
6900463|NCT00666263|10920708|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0
6900464|NCT00666263|10920709|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1
6900465|NCT00666276|10920754|FG000|Overall Study|Protocol Violation|34
6900466|NCT00666328|10920777|FG000|Overall Study|Death|2
6900467|NCT00666328|10920777|FG000|Overall Study|Lost to Follow-up|2
6900468|NCT00666328|10920777|FG000|Overall Study|No longer met eligibility criteria|1
6900469|NCT00666458|10920791|FG000|Overall Study|Adverse Event|8
6900470|NCT00666458|10920792|FG001|Overall Study|Adverse Event|7
6900471|NCT00666458|10920791|FG000|Overall Study|Withdrawal by Subject|5
6900472|NCT00666458|10920792|FG001|Overall Study|Withdrawal by Subject|4
6900473|NCT00666458|10920791|FG000|Overall Study|Lost to Follow-up|0
6900474|NCT00666458|10920792|FG001|Overall Study|Lost to Follow-up|3
6900475|NCT00666458|10920791|FG000|Overall Study|Administrative reason by sponsor|1
6900476|NCT00666458|10920792|FG001|Overall Study|Administrative reason by sponsor|1
6900477|NCT00666458|10920791|FG000|Overall Study|Incorrect enrollment|7
6900478|NCT00666458|10920792|FG001|Overall Study|Incorrect enrollment|1
6821640|NCT00095173|10825108|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0
6821641|NCT00095173|10825109|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0
6821642|NCT00095173|10825110|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0
6821643|NCT00095173|10825111|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1
6821644|NCT00095173|10825112|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2
6821645|NCT00095173|10825113|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3
6821646|NCT00095173|10825108|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
6821647|NCT00095173|10825109|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
6821648|NCT00095173|10825110|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
6821649|NCT00095173|10825111|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11
6821650|NCT00095173|10825112|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5
6821651|NCT00095173|10825113|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8
6821652|NCT00095173|10825108|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
6821653|NCT00095173|10825109|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
6821654|NCT00095173|10825110|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
6821655|NCT00095173|10825111|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2
6821656|NCT00095173|10825112|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5
6900479|NCT00666458|10920791|FG000|Overall Study|Study specific discontinuation criteria|14
6900480|NCT00666458|10920792|FG001|Overall Study|Study specific discontinuation criteria|7
6900481|NCT00666458|10920791|FG000|Overall Study|Severe non-compliance to the protocol|1
6900482|NCT00666458|10920792|FG001|Overall Study|Severe non-compliance to the protocol|1
6900483|NCT00666458|10920791|FG000|Overall Study|Safety reasons|1
6900484|NCT00666458|10920792|FG001|Overall Study|Safety reasons|0
6900485|NCT00666458|10920791|FG000|Overall Study|Medical history of anemia|1
6900486|NCT00666458|10920792|FG001|Overall Study|Medical history of anemia|0
6900487|NCT00666536|10920800|FG000|Overall Study|Adverse Event|9
6900488|NCT00666536|10920801|FG001|Overall Study|Adverse Event|19
6900489|NCT00666536|10920800|FG000|Overall Study|Unsatisfactory therapeutic effect|2
6900490|NCT00666536|10920801|FG001|Overall Study|Unsatisfactory therapeutic effect|0
6900491|NCT00666536|10920800|FG000|Overall Study|Protocol deviation(s)|8
6900492|NCT00666536|10920801|FG001|Overall Study|Protocol deviation(s)|6
6900493|NCT00666536|10920800|FG000|Overall Study|Withdrawal by Subject|10
6900494|NCT00666536|10920801|FG001|Overall Study|Withdrawal by Subject|9
6900495|NCT00666536|10920800|FG000|Overall Study|Lost to Follow-up|4
6900496|NCT00666536|10920801|FG001|Overall Study|Lost to Follow-up|3
6900497|NCT00666562|10920810|FG000|Overall Study|Withdrawal by Subject|0
6900498|NCT00666562|10920811|FG001|Overall Study|Withdrawal by Subject|1
6900499|NCT00666562|10920812|FG002|Overall Study|Withdrawal by Subject|0
6900500|NCT00666562|10920810|FG000|Overall Study|Concomitant Medication|0
6900501|NCT00666562|10920811|FG001|Overall Study|Concomitant Medication|1
6900502|NCT00666562|10920812|FG002|Overall Study|Concomitant Medication|0
6900503|NCT00666588|10920831|FG000|Overall Study|ineligible|2
6900504|NCT00666588|10920832|FG001|Overall Study|ineligible|0
6900505|NCT00666588|10920833|FG002|Overall Study|ineligible|0
6900506|NCT00666588|10920834|FG003|Overall Study|ineligible|2
6900507|NCT00666588|10920831|FG000|Overall Study|inevaluable|2
6900508|NCT00666588|10920832|FG001|Overall Study|inevaluable|0
6900509|NCT00666588|10920833|FG002|Overall Study|inevaluable|0
6900510|NCT00666588|10920834|FG003|Overall Study|inevaluable|0
6900511|NCT00666679|10920850|FG000|First Intervention|Lost to Follow-up|1
6900512|NCT00666679|10920851|FG001|First Intervention|Lost to Follow-up|0
6900513|NCT00666679|10920850|FG000|First Intervention|Protocol Violation|1
6900514|NCT00666679|10920851|FG001|First Intervention|Protocol Violation|0
6900515|NCT00666679|10920850|FG000|First Intervention|Withdrawal by Subject|1
6900516|NCT00666679|10920851|FG001|First Intervention|Withdrawal by Subject|0
6900517|NCT00666679|10920850|FG000|First Intervention|Randomized did not start treatment|1
6900518|NCT00666679|10920851|FG001|First Intervention|Randomized did not start treatment|1
6900519|NCT00666679|10920850|FG000|Washout Period of 1 Week|Lost to Follow-up|0
6900520|NCT00666679|10920851|FG001|Washout Period of 1 Week|Lost to Follow-up|1
6900521|NCT00666679|10920850|FG000|Washout Period of 1 Week|Protocol Violation|0
6900522|NCT00666679|10920851|FG001|Washout Period of 1 Week|Protocol Violation|1
6900523|NCT00666679|10920850|FG000|Second Intervention|Adverse Event|1
6900524|NCT00666679|10920851|FG001|Second Intervention|Adverse Event|0
6900525|NCT00666679|10920850|FG000|Second Intervention|Death|0
6900526|NCT00666679|10920851|FG001|Second Intervention|Death|1
6900527|NCT00666705|10920857|FG000|Overall Study|Withdrawal by Subject|1
6900528|NCT00666718|10920868|FG000|Overall Study|Adverse Event|0
6900529|NCT00666718|10920869|FG001|Overall Study|Adverse Event|1
6900530|NCT00666718|10920868|FG000|Overall Study|Death|1
6900531|NCT00666718|10920869|FG001|Overall Study|Death|0
6900532|NCT00666718|10920868|FG000|Overall Study|Lost to Follow-up|1
6900533|NCT00666718|10920869|FG001|Overall Study|Lost to Follow-up|0
6900534|NCT00666718|10920868|FG000|Overall Study|Entry Criteria Not Met|2
6900535|NCT00666718|10920869|FG001|Overall Study|Entry Criteria Not Met|0
6900536|NCT00666718|10920868|FG000|Overall Study|Protocol Violation|1
6900537|NCT00666718|10920869|FG001|Overall Study|Protocol Violation|3
6900538|NCT00666718|10920868|FG000|Overall Study|Withdrawal by Subject|7
6900539|NCT00666718|10920869|FG001|Overall Study|Withdrawal by Subject|12
6900540|NCT00666718|10920868|FG000|Overall Study|Physician Decision|0
6900541|NCT00666718|10920869|FG001|Overall Study|Physician Decision|2
6978589|NCT01214421|11032102|FG002|Overall Study|Lost to Follow-up|7
7059532|NCT01907828|11155173|FG000|Overall Study|Lost to Follow-up|3
6821657|NCT00095173|10825113|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6
6900542|NCT00666757|10920877|FG000|Overall Study|Lost to Follow-up|39
6900543|NCT00666757|10920878|FG001|Overall Study|Lost to Follow-up|35
6900544|NCT00666757|10920877|FG000|Overall Study|Protocol Violation|23
6900545|NCT00666757|10920878|FG001|Overall Study|Protocol Violation|24
6900546|NCT00666757|10920877|FG000|Overall Study|Adverse Event|22
6900547|NCT00666757|10920878|FG001|Overall Study|Adverse Event|12
6900548|NCT00666757|10920877|FG000|Overall Study|Withdrawal by Subject|13
6900549|NCT00666757|10920878|FG001|Overall Study|Withdrawal by Subject|17
6900550|NCT00666757|10920877|FG000|Overall Study|Lack of Efficacy|3
6900551|NCT00666757|10920878|FG001|Overall Study|Lack of Efficacy|6
6900552|NCT00666757|10920877|FG000|Overall Study|Physician Decision|0
6900553|NCT00666757|10920878|FG001|Overall Study|Physician Decision|2
6900554|NCT00666757|10920877|FG000|Overall Study|Sponsor decision|0
6900555|NCT00666757|10920878|FG001|Overall Study|Sponsor decision|1
6900556|NCT00666835|10920889|FG000|Overall Study|Withdrawal by Subject|5
6900557|NCT00666835|10920890|FG001|Overall Study|Withdrawal by Subject|2
6900558|NCT00666835|10920889|FG000|Overall Study|Lack of Efficacy|0
6900559|NCT00666835|10920890|FG001|Overall Study|Lack of Efficacy|1
6900560|NCT00666835|10920889|FG000|Overall Study|Incl./excl. not fulfilled|7
6900561|NCT00666835|10920890|FG001|Overall Study|Incl./excl. not fulfilled|2
6900562|NCT00666835|10920889|FG000|Overall Study|Adverse Event|7
6900563|NCT00666835|10920890|FG001|Overall Study|Adverse Event|6
6900564|NCT00666835|10920889|FG000|Overall Study|Protocol Violation|2
6900565|NCT00666835|10920890|FG001|Overall Study|Protocol Violation|0
6900566|NCT00666835|10920889|FG000|Overall Study|Death|15
6900567|NCT00666835|10920890|FG001|Overall Study|Death|4
6900568|NCT00666835|10920889|FG000|Overall Study|Kidney Transplantation (NTX)|10
6900569|NCT00666835|10920890|FG001|Overall Study|Kidney Transplantation (NTX)|2
6900570|NCT00666835|10920889|FG000|Overall Study|Hemoglobulin concentration|4
6900571|NCT00666835|10920890|FG001|Overall Study|Hemoglobulin concentration|3
6900572|NCT00666835|10920889|FG000|Overall Study|Planned operation|2
6900573|NCT00666835|10920890|FG001|Overall Study|Planned operation|0
6900574|NCT00666835|10920889|FG000|Overall Study|Physician Decision|1
6900575|NCT00666835|10920890|FG001|Overall Study|Physician Decision|2
6900576|NCT00666926|10920910|FG000|Overall Study|Adverse Event|0
6900577|NCT00666926|10920911|FG001|Overall Study|Adverse Event|0
6900578|NCT00666926|10920912|FG002|Overall Study|Adverse Event|0
6900579|NCT00666926|10920913|FG003|Overall Study|Adverse Event|0
6900580|NCT00666926|10920914|FG004|Overall Study|Adverse Event|0
6900581|NCT00666926|10920915|FG005|Overall Study|Adverse Event|0
6900582|NCT00666926|10920916|FG006|Overall Study|Adverse Event|0
6900583|NCT00666926|10920917|FG007|Overall Study|Adverse Event|0
6900584|NCT00666926|10920918|FG008|Overall Study|Adverse Event|0
6900585|NCT00666926|10920919|FG009|Overall Study|Adverse Event|2
6900586|NCT00666926|10920920|FG010|Overall Study|Adverse Event|2
6900587|NCT00666926|10920921|FG011|Overall Study|Adverse Event|2
6900588|NCT00666926|10920922|FG012|Overall Study|Adverse Event|0
6900589|NCT00666926|10920923|FG013|Overall Study|Adverse Event|1
6900590|NCT00666926|10920924|FG014|Overall Study|Adverse Event|0
6900591|NCT00666926|10920925|FG015|Overall Study|Adverse Event|0
6900592|NCT00666926|10920910|FG000|Overall Study|Laboratory abnormality|0
6900593|NCT00666926|10920911|FG001|Overall Study|Laboratory abnormality|0
6900594|NCT00666926|10920912|FG002|Overall Study|Laboratory abnormality|0
6900595|NCT00666926|10920913|FG003|Overall Study|Laboratory abnormality|0
6900596|NCT00666926|10920914|FG004|Overall Study|Laboratory abnormality|0
6900597|NCT00666926|10920915|FG005|Overall Study|Laboratory abnormality|0
6900598|NCT00666926|10920916|FG006|Overall Study|Laboratory abnormality|0
6900599|NCT00666926|10920917|FG007|Overall Study|Laboratory abnormality|0
6900600|NCT00666926|10920918|FG008|Overall Study|Laboratory abnormality|0
6900601|NCT00666926|10920919|FG009|Overall Study|Laboratory abnormality|0
6900602|NCT00666926|10920920|FG010|Overall Study|Laboratory abnormality|1
6900603|NCT00666926|10920921|FG011|Overall Study|Laboratory abnormality|0
6900604|NCT00666926|10920922|FG012|Overall Study|Laboratory abnormality|0
6900605|NCT00666926|10920923|FG013|Overall Study|Laboratory abnormality|0
6900606|NCT00666926|10920924|FG014|Overall Study|Laboratory abnormality|0
6900607|NCT00666926|10920925|FG015|Overall Study|Laboratory abnormality|1
6900608|NCT00666926|10920910|FG000|Overall Study|Lack of Efficacy|0
6900609|NCT00666926|10920911|FG001|Overall Study|Lack of Efficacy|0
6900610|NCT00666926|10920912|FG002|Overall Study|Lack of Efficacy|0
6900611|NCT00666926|10920913|FG003|Overall Study|Lack of Efficacy|0
6900612|NCT00666926|10920914|FG004|Overall Study|Lack of Efficacy|0
6900613|NCT00666926|10920915|FG005|Overall Study|Lack of Efficacy|1
6900614|NCT00666926|10920916|FG006|Overall Study|Lack of Efficacy|0
6900615|NCT00666926|10920917|FG007|Overall Study|Lack of Efficacy|0
6900616|NCT00666926|10920918|FG008|Overall Study|Lack of Efficacy|0
6900617|NCT00666926|10920919|FG009|Overall Study|Lack of Efficacy|0
6900618|NCT00666926|10920920|FG010|Overall Study|Lack of Efficacy|0
6900619|NCT00666926|10920921|FG011|Overall Study|Lack of Efficacy|1
6900620|NCT00666926|10920922|FG012|Overall Study|Lack of Efficacy|0
6900621|NCT00666926|10920923|FG013|Overall Study|Lack of Efficacy|0
6821658|NCT00095173|10825108|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
6821659|NCT00095173|10825109|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
6821660|NCT00095173|10825110|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
6821661|NCT00095173|10825111|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4
6821662|NCT00095173|10825112|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6
6821663|NCT00095173|10825113|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
6821664|NCT00095173|10825108|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
6821665|NCT00095173|10825109|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
6821666|NCT00095173|10825110|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
6821667|NCT00095173|10825111|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
6821668|NCT00095173|10825112|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
6821669|NCT00095173|10825113|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
6821670|NCT00095173|10825108|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
6821671|NCT00095173|10825109|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
6821672|NCT00095173|10825110|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
6821673|NCT00095173|10825111|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
6821674|NCT00095173|10825112|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
6821675|NCT00095173|10825113|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
6821676|NCT00095173|10825108|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0
6821677|NCT00095173|10825109|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0
6821678|NCT00095173|10825110|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0
6821679|NCT00095173|10825111|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1
6821680|NCT00095173|10825112|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2
6821681|NCT00095173|10825113|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3
6821682|NCT00095173|10825108|FG000|Open-Label Extension Phase (Period C)|Other|0
6821683|NCT00095173|10825109|FG001|Open-Label Extension Phase (Period C)|Other|0
6821684|NCT00095173|10825110|FG002|Open-Label Extension Phase (Period C)|Other|0
6821685|NCT00095173|10825111|FG003|Open-Label Extension Phase (Period C)|Other|4
6821686|NCT00095173|10825112|FG004|Open-Label Extension Phase (Period C)|Other|6
6821687|NCT00095173|10825113|FG005|Open-Label Extension Phase (Period C)|Other|8
6821688|NCT00095199|10825131|FG000|Overall Study|Adverse Event|40
6821689|NCT00095199|10825132|FG001|Overall Study|Adverse Event|22
6821690|NCT00095199|10825133|FG002|Overall Study|Adverse Event|26
6821691|NCT00095199|10825134|FG003|Overall Study|Adverse Event|11
6821692|NCT00095199|10825131|FG000|Overall Study|Progressive disease|213
6821693|NCT00095199|10825132|FG001|Overall Study|Progressive disease|179
6821694|NCT00095199|10825133|FG002|Overall Study|Progressive disease|105
6821695|NCT00095199|10825134|FG003|Overall Study|Progressive disease|98
6821696|NCT00095199|10825131|FG000|Overall Study|Death|10
6821697|NCT00095199|10825132|FG001|Overall Study|Death|6
6821698|NCT00095199|10825133|FG002|Overall Study|Death|11
6821699|NCT00095199|10825134|FG003|Overall Study|Death|9
6821700|NCT00095199|10825131|FG000|Overall Study|Withdrawal by Subject|21
6821701|NCT00095199|10825132|FG001|Overall Study|Withdrawal by Subject|16
6821702|NCT00095199|10825133|FG002|Overall Study|Withdrawal by Subject|13
6821703|NCT00095199|10825134|FG003|Overall Study|Withdrawal by Subject|22
6821704|NCT00095199|10825131|FG000|Overall Study|Protocol Violation|4
6821705|NCT00095199|10825132|FG001|Overall Study|Protocol Violation|4
6821706|NCT00095199|10825133|FG002|Overall Study|Protocol Violation|2
6821707|NCT00095199|10825134|FG003|Overall Study|Protocol Violation|0
6821708|NCT00095199|10825131|FG000|Overall Study|Liver function test results elevated|0
6821709|NCT00095199|10825132|FG001|Overall Study|Liver function test results elevated|0
6821710|NCT00095199|10825133|FG002|Overall Study|Liver function test results elevated|1
6821711|NCT00095199|10825134|FG003|Overall Study|Liver function test results elevated|1
6821712|NCT00095199|10825131|FG000|Overall Study|Surgery needed could not start in 7 days|0
6821713|NCT00095199|10825132|FG001|Overall Study|Surgery needed could not start in 7 days|0
6821714|NCT00095199|10825133|FG002|Overall Study|Surgery needed could not start in 7 days|1
6821715|NCT00095199|10825134|FG003|Overall Study|Surgery needed could not start in 7 days|0
6821716|NCT00095199|10825131|FG000|Overall Study|Physician Decision|5
6821717|NCT00095199|10825132|FG001|Overall Study|Physician Decision|6
6821718|NCT00095199|10825133|FG002|Overall Study|Physician Decision|1
6821719|NCT00095199|10825134|FG003|Overall Study|Physician Decision|1
6821720|NCT00095199|10825131|FG000|Overall Study|Not eligible|1
6821721|NCT00095199|10825132|FG001|Overall Study|Not eligible|7
6821722|NCT00095199|10825133|FG002|Overall Study|Not eligible|0
6821723|NCT00095199|10825134|FG003|Overall Study|Not eligible|1
6821724|NCT00095199|10825131|FG000|Overall Study|Started Palliative Radiotherapy|1
6821725|NCT00095199|10825132|FG001|Overall Study|Started Palliative Radiotherapy|0
6821726|NCT00095199|10825133|FG002|Overall Study|Started Palliative Radiotherapy|0
6821727|NCT00095199|10825134|FG003|Overall Study|Started Palliative Radiotherapy|0
6821728|NCT00095199|10825131|FG000|Overall Study|Started radiotherapy regimen|0
6821729|NCT00095199|10825132|FG001|Overall Study|Started radiotherapy regimen|1
6821730|NCT00095199|10825133|FG002|Overall Study|Started radiotherapy regimen|0
6821731|NCT00095199|10825134|FG003|Overall Study|Started radiotherapy regimen|0
6821732|NCT00095199|10825131|FG000|Overall Study|Primary tumor removed in other surgery|0
6896672|NCT00634751|10915230|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0
6821733|NCT00095199|10825132|FG001|Overall Study|Primary tumor removed in other surgery|1
6821734|NCT00095199|10825133|FG002|Overall Study|Primary tumor removed in other surgery|0
6821735|NCT00095199|10825134|FG003|Overall Study|Primary tumor removed in other surgery|0
6821736|NCT00095199|10825131|FG000|Overall Study|Data inadvertently lost by site|1
6821737|NCT00095199|10825132|FG001|Overall Study|Data inadvertently lost by site|0
6821738|NCT00095199|10825133|FG002|Overall Study|Data inadvertently lost by site|0
6821739|NCT00095199|10825134|FG003|Overall Study|Data inadvertently lost by site|0
6821740|NCT00095212|10825151|FG000|Overall Study|Withdrawal by Subject|1
6821741|NCT00095212|10825152|FG001|Overall Study|Withdrawal by Subject|3
6821742|NCT00095238|10825160|FG000|Overall Study|Lack of Efficacy|9
6821743|NCT00095238|10825161|FG001|Overall Study|Lack of Efficacy|9
6821744|NCT00095238|10825160|FG000|Overall Study|Adverse Event|331
6821745|NCT00095238|10825161|FG001|Overall Study|Adverse Event|287
6821746|NCT00095238|10825160|FG000|Overall Study|Subject Withdrew Consent|208
6821747|NCT00095238|10825161|FG001|Overall Study|Subject Withdrew Consent|223
6821748|NCT00095238|10825160|FG000|Overall Study|Death|154
6821749|NCT00095238|10825161|FG001|Overall Study|Death|170
6821750|NCT00095238|10825160|FG000|Overall Study|Lost to Follow-up|19
6821751|NCT00095238|10825161|FG001|Overall Study|Lost to Follow-up|24
6821752|NCT00095238|10825160|FG000|Overall Study|Noncompliance|44
6821753|NCT00095238|10825161|FG001|Overall Study|Noncompliance|45
6821754|NCT00095238|10825160|FG000|Overall Study|No longer met study criteria|4
6821755|NCT00095238|10825161|FG001|Overall Study|No longer met study criteria|5
6900622|NCT00666926|10920924|FG014|Overall Study|Lack of Efficacy|0
6900623|NCT00666926|10920925|FG015|Overall Study|Lack of Efficacy|0
6900624|NCT00666926|10920910|FG000|Overall Study|Lost to Follow-up|0
6900625|NCT00666926|10920911|FG001|Overall Study|Lost to Follow-up|0
6900626|NCT00666926|10920912|FG002|Overall Study|Lost to Follow-up|0
6900627|NCT00666926|10920913|FG003|Overall Study|Lost to Follow-up|1
6900628|NCT00666926|10920914|FG004|Overall Study|Lost to Follow-up|0
6900629|NCT00666926|10920915|FG005|Overall Study|Lost to Follow-up|0
6900630|NCT00666926|10920916|FG006|Overall Study|Lost to Follow-up|0
6900631|NCT00666926|10920917|FG007|Overall Study|Lost to Follow-up|0
6900632|NCT00666926|10920918|FG008|Overall Study|Lost to Follow-up|0
6900633|NCT00666926|10920919|FG009|Overall Study|Lost to Follow-up|0
6900634|NCT00666926|10920920|FG010|Overall Study|Lost to Follow-up|0
6900635|NCT00666926|10920921|FG011|Overall Study|Lost to Follow-up|0
6900636|NCT00666926|10920922|FG012|Overall Study|Lost to Follow-up|0
6900637|NCT00666926|10920923|FG013|Overall Study|Lost to Follow-up|0
6900638|NCT00666926|10920924|FG014|Overall Study|Lost to Follow-up|0
6900639|NCT00666926|10920925|FG015|Overall Study|Lost to Follow-up|0
6900640|NCT00666926|10920910|FG000|Overall Study|Other|2
6900641|NCT00666926|10920911|FG001|Overall Study|Other|4
6900642|NCT00666926|10920912|FG002|Overall Study|Other|3
6900643|NCT00666926|10920913|FG003|Overall Study|Other|3
6900644|NCT00666926|10920914|FG004|Overall Study|Other|3
6900645|NCT00666926|10920915|FG005|Overall Study|Other|3
6900646|NCT00666926|10920916|FG006|Overall Study|Other|4
6900647|NCT00666926|10920917|FG007|Overall Study|Other|0
6900648|NCT00666926|10920918|FG008|Overall Study|Other|3
6900649|NCT00666926|10920919|FG009|Overall Study|Other|5
6900650|NCT00666926|10920920|FG010|Overall Study|Other|3
6900651|NCT00666926|10920921|FG011|Overall Study|Other|26
6900652|NCT00666926|10920922|FG012|Overall Study|Other|3
6900653|NCT00666926|10920923|FG013|Overall Study|Other|2
6900654|NCT00666926|10920924|FG014|Overall Study|Other|4
6900655|NCT00666926|10920925|FG015|Overall Study|Other|4
6900656|NCT00666926|10920910|FG000|Overall Study|Withdrawal by Subject|0
6900657|NCT00666926|10920911|FG001|Overall Study|Withdrawal by Subject|0
6900658|NCT00666926|10920912|FG002|Overall Study|Withdrawal by Subject|0
6900659|NCT00666926|10920913|FG003|Overall Study|Withdrawal by Subject|0
6900660|NCT00666926|10920914|FG004|Overall Study|Withdrawal by Subject|0
6900661|NCT00666926|10920915|FG005|Overall Study|Withdrawal by Subject|0
6900662|NCT00666926|10920916|FG006|Overall Study|Withdrawal by Subject|0
6900663|NCT00666926|10920917|FG007|Overall Study|Withdrawal by Subject|1
6900664|NCT00666926|10920918|FG008|Overall Study|Withdrawal by Subject|0
6900665|NCT00666926|10920919|FG009|Overall Study|Withdrawal by Subject|3
6900666|NCT00666926|10920920|FG010|Overall Study|Withdrawal by Subject|0
6900667|NCT00666926|10920921|FG011|Overall Study|Withdrawal by Subject|3
6900668|NCT00666926|10920922|FG012|Overall Study|Withdrawal by Subject|0
6900669|NCT00666926|10920923|FG013|Overall Study|Withdrawal by Subject|1
6900670|NCT00666926|10920924|FG014|Overall Study|Withdrawal by Subject|3
6900671|NCT00666926|10920925|FG015|Overall Study|Withdrawal by Subject|3
6900672|NCT00666926|10920910|FG000|Overall Study|Death|0
6900673|NCT00666926|10920911|FG001|Overall Study|Death|0
6900674|NCT00666926|10920912|FG002|Overall Study|Death|0
6900675|NCT00666926|10920913|FG003|Overall Study|Death|0
6900676|NCT00666926|10920914|FG004|Overall Study|Death|0
6900677|NCT00666926|10920915|FG005|Overall Study|Death|0
6900678|NCT00666926|10920916|FG006|Overall Study|Death|0
6900679|NCT00666926|10920917|FG007|Overall Study|Death|0
6900680|NCT00666926|10920918|FG008|Overall Study|Death|0
6900681|NCT00666926|10920919|FG009|Overall Study|Death|0
6900682|NCT00666926|10920920|FG010|Overall Study|Death|0
6900683|NCT00666926|10920921|FG011|Overall Study|Death|1
6900684|NCT00666926|10920922|FG012|Overall Study|Death|0
6900685|NCT00666926|10920923|FG013|Overall Study|Death|0
6900686|NCT00666926|10920924|FG014|Overall Study|Death|0
6821756|NCT00095238|10825160|FG000|Overall Study|Study terminated by sponsor|0
6821757|NCT00095238|10825161|FG001|Overall Study|Study terminated by sponsor|1
6821758|NCT00095238|10825160|FG000|Overall Study|Missing|1
6821759|NCT00095238|10825161|FG001|Overall Study|Missing|0
6821760|NCT00095238|10825160|FG000|Overall Study|Other Reasons|87
6821761|NCT00095238|10825161|FG001|Overall Study|Other Reasons|88
6821762|NCT00095303|10825201|FG000|Main Study|Lost to Follow-up|91
6821763|NCT00095303|10825202|FG001|Main Study|Lost to Follow-up|87
6821764|NCT00095303|10825201|FG000|Follow Up Study|Lost to Follow-up|59
6821765|NCT00095303|10825202|FG001|Follow Up Study|Lost to Follow-up|58
6821766|NCT00095498|10825211|FG000|Overall Study|Physician Decision|9
6821767|NCT00095498|10825212|FG001|Overall Study|Physician Decision|10
6821768|NCT00095498|10825213|FG002|Overall Study|Physician Decision|8
6821769|NCT00095498|10825211|FG000|Overall Study|Adverse Event|1
6821770|NCT00095498|10825212|FG001|Overall Study|Adverse Event|0
6821771|NCT00095498|10825213|FG002|Overall Study|Adverse Event|1
6821772|NCT00095498|10825211|FG000|Overall Study|Withdrawal by Subject|15
6821773|NCT00095498|10825212|FG001|Overall Study|Withdrawal by Subject|16
6821774|NCT00095498|10825213|FG002|Overall Study|Withdrawal by Subject|15
6821775|NCT00095498|10825211|FG000|Overall Study|Disease progression|0
6821776|NCT00095498|10825212|FG001|Overall Study|Disease progression|1
6821777|NCT00095498|10825213|FG002|Overall Study|Disease progression|1
6821778|NCT00095498|10825211|FG000|Overall Study|Ineligibility determined|3
6821779|NCT00095498|10825212|FG001|Overall Study|Ineligibility determined|0
6821780|NCT00095498|10825213|FG002|Overall Study|Ineligibility determined|2
6821781|NCT00095498|10825211|FG000|Overall Study|Lost to Follow-up|1
6821782|NCT00095498|10825212|FG001|Overall Study|Lost to Follow-up|1
6821783|NCT00095498|10825213|FG002|Overall Study|Lost to Follow-up|2
6821784|NCT00095498|10825211|FG000|Overall Study|Noncompliance|1
6821785|NCT00095498|10825212|FG001|Overall Study|Noncompliance|0
6821786|NCT00095498|10825213|FG002|Overall Study|Noncompliance|1
6821787|NCT00095498|10825211|FG000|Overall Study|Other|6
6821788|NCT00095498|10825212|FG001|Overall Study|Other|7
6821789|NCT00095498|10825213|FG002|Overall Study|Other|6
6821790|NCT00095498|10825211|FG000|Overall Study|Protocol Violation|0
6821791|NCT00095498|10825212|FG001|Overall Study|Protocol Violation|0
6821792|NCT00095498|10825213|FG002|Overall Study|Protocol Violation|1
6821793|NCT00095498|10825211|FG000|Overall Study|Requirement for alternative therapy|1
6821794|NCT00095498|10825212|FG001|Overall Study|Requirement for alternative therapy|0
6821795|NCT00095498|10825213|FG002|Overall Study|Requirement for alternative therapy|2
6821796|NCT00095576|10825227|FG000|Overall Study|Adverse Event|5
6821797|NCT00095576|10825228|FG001|Overall Study|Adverse Event|3
6821798|NCT00095576|10825227|FG000|Overall Study|Lost to Follow-up|233
6821799|NCT00095576|10825228|FG001|Overall Study|Lost to Follow-up|229
6821800|NCT00095576|10825227|FG000|Overall Study|Protocol Violation|1
6821801|NCT00095576|10825228|FG001|Overall Study|Protocol Violation|0
6821802|NCT00095576|10825227|FG000|Overall Study|Withdrawal by Subject|34
6821803|NCT00095576|10825228|FG001|Overall Study|Withdrawal by Subject|47
6821804|NCT00095576|10825227|FG000|Overall Study|Option to switch to a rollover study|1097
6821805|NCT00095576|10825228|FG001|Overall Study|Option to switch to a rollover study|1099
6821806|NCT00095576|10825227|FG000|Overall Study|Site terminated|75
6821807|NCT00095576|10825228|FG001|Overall Study|Site terminated|67
6821808|NCT00095576|10825227|FG000|Overall Study|Subject moved|30
6821809|NCT00095576|10825228|FG001|Overall Study|Subject moved|36
6821810|NCT00095628|10825234|FG000|Overall Study|Disease progression prior to treatment|1
6821811|NCT00095836|10825238|FG000|Overall Study|Lost to Follow-up|1
6821812|NCT00095836|10825238|FG000|Overall Study|Adverse Event|1
6821813|NCT00095836|10825238|FG000|Overall Study|Death|2
6821814|NCT00095940|10825258|FG000|Lapatinib Continuation/Phase II|Disease Progression|1
6821815|NCT00095940|10825259|FG001|Lapatinib Continuation/Phase II|Disease Progression|1
6821816|NCT00095940|10825260|FG002|Lapatinib Continuation/Phase II|Disease Progression|15
6821817|NCT00095940|10825261|FG003|Lapatinib Continuation/Phase II|Disease Progression|0
6821818|NCT00095940|10825262|FG004|Lapatinib Continuation/Phase II|Disease Progression|0
6821819|NCT00095940|10825263|FG005|Lapatinib Continuation/Phase II|Disease Progression|13
6821820|NCT00095940|10825264|FG006|Lapatinib Continuation/Phase II|Disease Progression|2
6821821|NCT00095940|10825265|FG007|Lapatinib Continuation/Phase II|Disease Progression|1
6821822|NCT00095940|10825266|FG008|Lapatinib Continuation/Phase II|Disease Progression|12
6821823|NCT00095940|10825258|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
6821824|NCT00095940|10825259|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
6821825|NCT00095940|10825260|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
6821826|NCT00095940|10825261|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
6821827|NCT00095940|10825262|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
6821828|NCT00095940|10825263|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
6821829|NCT00095940|10825264|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
6821830|NCT00095940|10825265|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
6821831|NCT00095940|10825266|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
6821832|NCT00095940|10825258|FG000|Lapatinib Continuation/Phase II|Adverse Event|0
6821833|NCT00095940|10825259|FG001|Lapatinib Continuation/Phase II|Adverse Event|0
6821834|NCT00095940|10825260|FG002|Lapatinib Continuation/Phase II|Adverse Event|0
6821835|NCT00095940|10825261|FG003|Lapatinib Continuation/Phase II|Adverse Event|0
6821836|NCT00095940|10825262|FG004|Lapatinib Continuation/Phase II|Adverse Event|0
6821837|NCT00095940|10825263|FG005|Lapatinib Continuation/Phase II|Adverse Event|0
6821838|NCT00095940|10825264|FG006|Lapatinib Continuation/Phase II|Adverse Event|0
6821839|NCT00095940|10825265|FG007|Lapatinib Continuation/Phase II|Adverse Event|1
6821840|NCT00095940|10825266|FG008|Lapatinib Continuation/Phase II|Adverse Event|0
6821841|NCT00095979|10825284|FG000|Overall Study|Ineligible: Second primary cancer site|2
6900687|NCT00666926|10920925|FG015|Overall Study|Death|0
6900688|NCT00666965|10920980|FG000|Overall Study|Adverse Event|0
6900689|NCT00666965|10920981|FG001|Overall Study|Adverse Event|2
6900690|NCT00666965|10920982|FG002|Overall Study|Adverse Event|1
6900691|NCT00666965|10920983|FG003|Overall Study|Adverse Event|9
6900692|NCT00666965|10920980|FG000|Overall Study|Lack of Efficacy|1
6900693|NCT00666965|10920981|FG001|Overall Study|Lack of Efficacy|1
6900694|NCT00666965|10920982|FG002|Overall Study|Lack of Efficacy|0
6900695|NCT00666965|10920983|FG003|Overall Study|Lack of Efficacy|0
6900696|NCT00666965|10920980|FG000|Overall Study|Protocol Violation|0
6900697|NCT00666965|10920981|FG001|Overall Study|Protocol Violation|0
6900698|NCT00666965|10920982|FG002|Overall Study|Protocol Violation|0
6900699|NCT00666965|10920983|FG003|Overall Study|Protocol Violation|2
6900700|NCT00666965|10920980|FG000|Overall Study|Discontinuation criteria|2
6900701|NCT00666965|10920981|FG001|Overall Study|Discontinuation criteria|1
6900702|NCT00666965|10920982|FG002|Overall Study|Discontinuation criteria|1
6900703|NCT00666965|10920983|FG003|Overall Study|Discontinuation criteria|2
6900704|NCT00666965|10920980|FG000|Overall Study|Withdrawal by Subject|0
6900705|NCT00666965|10920981|FG001|Overall Study|Withdrawal by Subject|0
6900706|NCT00666965|10920982|FG002|Overall Study|Withdrawal by Subject|0
6900707|NCT00666965|10920983|FG003|Overall Study|Withdrawal by Subject|2
6900708|NCT00667095|10921015|FG000|Overall Study|Withdrawal by Subject|0
6900709|NCT00667095|10921016|FG001|Overall Study|Withdrawal by Subject|1
6900710|NCT00667225|10921033|FG000|Overall Study|Subject had no more lesions to treat.|1
6900711|NCT00667225|10921034|FG001|Overall Study|Subject had no more lesions to treat.|0
6900712|NCT00667225|10921033|FG000|Overall Study|Lost to Follow-up|0
6900713|NCT00667225|10921034|FG001|Overall Study|Lost to Follow-up|1
6900714|NCT00667277|10921040|FG000|Overall Study|Withdrawal by Subject|2
6900715|NCT00667342|10921047|FG000|Overall Study|Protocol Violation|1
6900716|NCT00667342|10921048|FG001|Overall Study|Protocol Violation|0
6900717|NCT00667342|10921049|FG002|Overall Study|Protocol Violation|0
6900718|NCT00667342|10921047|FG000|Overall Study|Withdrawal by Subject|1
6900719|NCT00667342|10921048|FG001|Overall Study|Withdrawal by Subject|0
6900720|NCT00667342|10921049|FG002|Overall Study|Withdrawal by Subject|0
6900721|NCT00667342|10921047|FG000|Overall Study|Physician Decision|3
6900722|NCT00667342|10921048|FG001|Overall Study|Physician Decision|0
6900723|NCT00667342|10921049|FG002|Overall Study|Physician Decision|0
6900724|NCT00667342|10921047|FG000|Overall Study|Relapse or tumor progression|9
6900725|NCT00667342|10921048|FG001|Overall Study|Relapse or tumor progression|0
6900726|NCT00667342|10921049|FG002|Overall Study|Relapse or tumor progression|7
6900727|NCT00667342|10921047|FG000|Overall Study|Adverse Event|0
6900728|NCT00667342|10921048|FG001|Overall Study|Adverse Event|0
6900729|NCT00667342|10921049|FG002|Overall Study|Adverse Event|1
6900730|NCT00667342|10921047|FG000|Overall Study|Ineligible|0
6900731|NCT00667342|10921048|FG001|Overall Study|Ineligible|0
6900732|NCT00667342|10921049|FG002|Overall Study|Ineligible|1
6900733|NCT00667355|10921063|FG000|Overall Study|Adverse Event|5
6900734|NCT00667355|10921063|FG000|Overall Study|Lost to Follow-up|1
6900735|NCT00667355|10921063|FG000|Overall Study|Other reason was not specified|5
6900736|NCT00667368|10921069|FG000|Overall Study|Lost to Follow-up|176
6900737|NCT00667368|10921070|FG001|Overall Study|Lost to Follow-up|155
6900738|NCT00667368|10921069|FG000|Overall Study|Discontinued early|24
6900739|NCT00667368|10921070|FG001|Overall Study|Discontinued early|17
6900740|NCT00667394|10921087|FG000|Overall Study|Adverse Event|3
6900741|NCT00667394|10921088|FG001|Overall Study|Adverse Event|0
6900742|NCT00667394|10921087|FG000|Overall Study|Progressive disease|1
6900743|NCT00667394|10921088|FG001|Overall Study|Progressive disease|0
6900744|NCT00667420|10921094|FG000|Overall Study|Adverse Event|2
6900745|NCT00667420|10921094|FG000|Overall Study|Lack of Efficacy|5
6900746|NCT00667420|10921094|FG000|Overall Study|Physician Decision|1
6900747|NCT00667420|10921094|FG000|Overall Study|Withdrawal by Subject|2
6900748|NCT00667446|10921101|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13
6900749|NCT00667446|10921102|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15
6900750|NCT00667446|10921101|FG000|Treatment Period (36 Months)|Other|2
6900751|NCT00667446|10921102|FG001|Treatment Period (36 Months)|Other|2
6900752|NCT00667446|10921101|FG000|Treatment Period (36 Months)|Personal reasons|2
6900753|NCT00667446|10921102|FG001|Treatment Period (36 Months)|Personal reasons|2
6900754|NCT00667446|10921101|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0
6900755|NCT00667446|10921102|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4
6900756|NCT00667446|10921101|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3
6900757|NCT00667446|10921102|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0
6900758|NCT00667446|10921101|FG000|Treatment Period (36 Months)|Lost to Follow-up|1
6900759|NCT00667446|10921102|FG001|Treatment Period (36 Months)|Lost to Follow-up|0
6900760|NCT00667446|10921101|FG000|Treatment Period (36 Months)|Protocol Violation|1
6900761|NCT00667446|10921102|FG001|Treatment Period (36 Months)|Protocol Violation|1
6900762|NCT00667446|10921101|FG000|Treatment Period (36 Months)|Therapeutic Failure|1
6821842|NCT00096018|10825295|FG000|Overall Study|Became Ineligible (not treated)|0
6821843|NCT00096018|10825296|FG001|Overall Study|Became Ineligible (not treated)|3
6821844|NCT00096018|10825295|FG000|Overall Study|Miscellaneous (not treated)|0
6821845|NCT00096018|10825296|FG001|Overall Study|Miscellaneous (not treated)|2
6821846|NCT00096018|10825295|FG000|Overall Study|Adverse Event|0
6821847|NCT00096018|10825296|FG001|Overall Study|Adverse Event|5
6821848|NCT00096018|10825295|FG000|Overall Study|Death|0
6821849|NCT00096018|10825296|FG001|Overall Study|Death|1
6821850|NCT00096018|10825295|FG000|Overall Study|Withdrawal by Subject|0
6821851|NCT00096018|10825296|FG001|Overall Study|Withdrawal by Subject|2
6821852|NCT00096018|10825295|FG000|Overall Study|Miscellaneous|2
6821853|NCT00096018|10825296|FG001|Overall Study|Miscellaneous|1
6821854|NCT00096031|10825302|FG000|Overall Study|Adverse Event|3
6821855|NCT00096031|10825302|FG000|Overall Study|Lack of Efficacy|42
6821856|NCT00096031|10825302|FG000|Overall Study|Death|4
6821857|NCT00096031|10825302|FG000|Overall Study|Withdrawal by Subject|1
6821858|NCT00096031|10825302|FG000|Overall Study|Ineligible|8
6821859|NCT00096031|10825302|FG000|Overall Study|Not protocol specified|5
6821860|NCT00096044|10825306|FG000|Overall Study|Withdrawal by Subject|9
6821861|NCT00096044|10825306|FG000|Overall Study|Adverse Event|21
6821862|NCT00096044|10825306|FG000|Overall Study|Disease Progression|4
6821863|NCT00096135|10825320|FG000|Overall Study|Physician Decision|20
6821864|NCT00096135|10825321|FG001|Overall Study|Physician Decision|4
6821865|NCT00096135|10825320|FG000|Overall Study|Refusal of further protocol therapy|4
6821866|NCT00096135|10825321|FG001|Overall Study|Refusal of further protocol therapy|1
6821867|NCT00096135|10825320|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22
6821868|NCT00096135|10825321|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7
6821869|NCT00096135|10825320|FG000|Overall Study|Other, specify|15
6821870|NCT00096135|10825321|FG001|Overall Study|Other, specify|3
6821871|NCT00096135|10825320|FG000|Overall Study|Ineligible|2
6821872|NCT00096135|10825321|FG001|Overall Study|Ineligible|0
6821873|NCT00096174|10825344|FG000|Overall Study|Lack of Efficacy|9
6821874|NCT00096174|10825344|FG000|Overall Study|Adverse Event|15
6821875|NCT00096174|10825344|FG000|Overall Study|Death|6
6821876|NCT00096174|10825344|FG000|Overall Study|Withdrawal by Subject|15
6821877|NCT00096174|10825344|FG000|Overall Study|Not started protocol therapy|3
6821878|NCT00096174|10825344|FG000|Overall Study|Ineligible|6
6821879|NCT00096174|10825344|FG000|Overall Study|other reason|8
6821880|NCT00096226|10825348|FG000|Overall Study|Ineligible|2
6821881|NCT00096226|10825348|FG000|Overall Study|Protocol treatment not started|1
6821882|NCT00096265|10825355|FG000|Overall Study|Ineligible|1
6821883|NCT00096265|10825356|FG001|Overall Study|Ineligible|0
6821884|NCT00096265|10825357|FG002|Overall Study|Ineligible|0
6821885|NCT00096278|10825368|FG000|Overall Study|No follow-up data|15
6821886|NCT00096278|10825369|FG001|Overall Study|No follow-up data|18
6821887|NCT00096278|10825368|FG000|Overall Study|Patient not at risk for primary endpoint|3
6821888|NCT00096278|10825369|FG001|Overall Study|Patient not at risk for primary endpoint|2
6821889|NCT00096356|10825379|FG000|Overall Study|Adverse Event|11
6821890|NCT00096356|10825380|FG001|Overall Study|Adverse Event|9
6821891|NCT00096356|10825379|FG000|Overall Study|Physician Decision|5
6821892|NCT00096356|10825380|FG001|Overall Study|Physician Decision|3
6821893|NCT00096356|10825379|FG000|Overall Study|Withdrawal by Subject|17
6821894|NCT00096356|10825380|FG001|Overall Study|Withdrawal by Subject|23
6821895|NCT00096356|10825379|FG000|Overall Study|Lack of Efficacy|1
6821896|NCT00096356|10825380|FG001|Overall Study|Lack of Efficacy|0
6821897|NCT00096356|10825379|FG000|Overall Study|multiple reasons|10
6821898|NCT00096356|10825380|FG001|Overall Study|multiple reasons|18
6821899|NCT00096382|10825389|FG000|Overall Study|Not treated|1
6821900|NCT00096382|10825390|FG001|Overall Study|Not treated|0
6821901|NCT00096382|10825389|FG000|Overall Study|Death during treatment|1
6821902|NCT00096382|10825390|FG001|Overall Study|Death during treatment|0
6821903|NCT00096447|10825396|FG000|Overall Study|Never treated|1
6821904|NCT00096486|10825418|FG000|Overall Study|Withdrawal by Subject|0
6821905|NCT00096486|10825419|FG001|Overall Study|Withdrawal by Subject|0
6821906|NCT00096486|10825420|FG002|Overall Study|Withdrawal by Subject|1
6821907|NCT00096486|10825421|FG003|Overall Study|Withdrawal by Subject|1
6821908|NCT00096486|10825418|FG000|Overall Study|Not Treated|0
6821909|NCT00096486|10825419|FG001|Overall Study|Not Treated|0
6821910|NCT00096486|10825420|FG002|Overall Study|Not Treated|1
6821911|NCT00096486|10825421|FG003|Overall Study|Not Treated|1
6821912|NCT00096538|10825431|FG000|Overall Study|Withdrawal by Subject|1
6821913|NCT00096785|10825441|FG000|Overall Study|Lost to Follow-up|1
6821914|NCT00096785|10825442|FG001|Overall Study|Lost to Follow-up|0
6821915|NCT00096785|10825441|FG000|Overall Study|Withdrawal by Subject|0
6821916|NCT00096785|10825442|FG001|Overall Study|Withdrawal by Subject|1
6821917|NCT00096785|10825441|FG000|Overall Study|Relocated|1
6821918|NCT00096785|10825442|FG001|Overall Study|Relocated|0
6821919|NCT00096941|10825448|FG000|Overall Study|disease progression|3
6821920|NCT00096954|10825454|FG000|Overall Study|Adverse Event|3
6821921|NCT00096954|10825455|FG001|Overall Study|Adverse Event|1
6821922|NCT00096954|10825454|FG000|Overall Study|Withdrawal by Subject|9
6821923|NCT00096954|10825455|FG001|Overall Study|Withdrawal by Subject|8
6821924|NCT00096954|10825454|FG000|Overall Study|Physician Decision|1
6821925|NCT00096954|10825455|FG001|Overall Study|Physician Decision|1
6821926|NCT00096954|10825454|FG000|Overall Study|Sponsors Decision|1
6821927|NCT00096954|10825455|FG001|Overall Study|Sponsors Decision|1
6821928|NCT00096954|10825454|FG000|Overall Study|Pregnancy|1
6821929|NCT00096954|10825455|FG001|Overall Study|Pregnancy|1
6821930|NCT00096954|10825454|FG000|Overall Study|Initiation of immunotherapy|1
6821931|NCT00096954|10825455|FG001|Overall Study|Initiation of immunotherapy|0
6821932|NCT00096954|10825454|FG000|Overall Study|Non-compliance|0
6821933|NCT00096954|10825455|FG001|Overall Study|Non-compliance|3
6821934|NCT00096954|10825454|FG000|Overall Study|Lost to Follow-up|8
6821935|NCT00096954|10825455|FG001|Overall Study|Lost to Follow-up|5
6821936|NCT00096993|10825463|FG000|Overall Study|Death|1
6821937|NCT00096993|10825464|FG001|Overall Study|Death|0
6821938|NCT00096993|10825463|FG000|Overall Study|Disease progression|56
6821939|NCT00096993|10825464|FG001|Overall Study|Disease progression|53
6821940|NCT00096993|10825463|FG000|Overall Study|Adverse Event|2
6821941|NCT00096993|10825464|FG001|Overall Study|Adverse Event|8
6821942|NCT00096993|10825463|FG000|Overall Study|Subject's decision|3
6821943|NCT00096993|10825464|FG001|Overall Study|Subject's decision|1
6821944|NCT00096993|10825463|FG000|Overall Study|Physician Decision|2
6821945|NCT00096993|10825464|FG001|Overall Study|Physician Decision|1
6821946|NCT00096993|10825463|FG000|Overall Study|Non-compliance|0
6821947|NCT00096993|10825464|FG001|Overall Study|Non-compliance|1
6821948|NCT00096993|10825463|FG000|Overall Study|Other unspecified|1
6821949|NCT00096993|10825464|FG001|Overall Study|Other unspecified|1
6821950|NCT00097370|10825478|FG000|Stage 1|Adverse Event|3
6821951|NCT00097370|10825478|FG000|Stage 1|Withdrawal by Subject|1
6821952|NCT00097370|10825478|FG000|Stage 1|Lack of Efficacy|2
6821953|NCT00097370|10825478|FG000|Stage 2|Adverse Event|5
6821954|NCT00097370|10825478|FG000|Stage 2|Withdrawal by Subject|1
6821955|NCT00097370|10825478|FG000|Stage 2|Lack of Efficacy|3
6821956|NCT00097370|10825478|FG000|Stage 2|Pregnancy|1
6821957|NCT00097370|10825478|FG000|Stage 2|Sponsor Terminated Study|2
6821958|NCT00097370|10825478|FG000|Stage 2|Lost to Follow-up|1
6821959|NCT00097370|10825478|FG000|Stage 3|Adverse Event|2
6821960|NCT00097370|10825478|FG000|Stage 3|Withdrawal by Subject|3
6821961|NCT00097370|10825478|FG000|Stage 3|Lack of Efficacy|1
6821962|NCT00097370|10825478|FG000|Stage 3|Sponsor Terminated Study|52
6821963|NCT00097370|10825478|FG000|Stage 3|Lost to Follow-up|1
6821964|NCT00097500|10825493|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
6821965|NCT00097500|10825494|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
6821966|NCT00097500|10825493|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5
6821967|NCT00097500|10825494|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0
6821968|NCT00097500|10825493|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0
6821969|NCT00097500|10825494|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1
6821970|NCT00097500|10825493|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0
6821971|NCT00097500|10825494|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1
6821972|NCT00097500|10825493|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2
6821973|NCT00097500|10825494|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1
6821974|NCT00097500|10825493|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0
6821975|NCT00097500|10825494|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1
6821976|NCT00097500|10825493|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3
6821977|NCT00097500|10825494|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2
6821978|NCT00097539|10825507|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959
6821979|NCT00097539|10825508|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948
6821980|NCT00097539|10825509|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646
6821981|NCT00097539|10825510|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170
6821982|NCT00097539|10825511|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106
6821983|NCT00097539|10825512|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546
6821984|NCT00097539|10825513|FG006|Overall Study|Status Unknown (Or no final evaluation)|108
6821985|NCT00097539|10825507|FG000|Overall Study|Withdrawal by Subject|925
6821986|NCT00097539|10825508|FG001|Overall Study|Withdrawal by Subject|323
6821987|NCT00097539|10825509|FG002|Overall Study|Withdrawal by Subject|346
6821988|NCT00097539|10825510|FG003|Overall Study|Withdrawal by Subject|217
6821989|NCT00097539|10825511|FG004|Overall Study|Withdrawal by Subject|68
6821990|NCT00097539|10825512|FG005|Overall Study|Withdrawal by Subject|229
6821991|NCT00097539|10825513|FG006|Overall Study|Withdrawal by Subject|3
6821992|NCT00097539|10825507|FG000|Overall Study|Participant Non-compliant|2140
6821993|NCT00097539|10825508|FG001|Overall Study|Participant Non-compliant|567
6821994|NCT00097539|10825509|FG002|Overall Study|Participant Non-compliant|1067
6821995|NCT00097539|10825510|FG003|Overall Study|Participant Non-compliant|353
6821996|NCT00097539|10825511|FG004|Overall Study|Participant Non-compliant|136
6821997|NCT00097539|10825512|FG005|Overall Study|Participant Non-compliant|543
6821998|NCT00097539|10825513|FG006|Overall Study|Participant Non-compliant|18
6821999|NCT00097539|10825507|FG000|Overall Study|Lack of Efficacy|249
6822000|NCT00097539|10825508|FG001|Overall Study|Lack of Efficacy|122
6822001|NCT00097539|10825509|FG002|Overall Study|Lack of Efficacy|202
6822002|NCT00097539|10825510|FG003|Overall Study|Lack of Efficacy|105
6822003|NCT00097539|10825511|FG004|Overall Study|Lack of Efficacy|45
6822004|NCT00097539|10825512|FG005|Overall Study|Lack of Efficacy|228
6822005|NCT00097539|10825513|FG006|Overall Study|Lack of Efficacy|5
6822006|NCT00097539|10825507|FG000|Overall Study|Adverse Event|78
6822007|NCT00097539|10825508|FG001|Overall Study|Adverse Event|133
6822008|NCT00097539|10825509|FG002|Overall Study|Adverse Event|37
6822009|NCT00097539|10825510|FG003|Overall Study|Adverse Event|27
7059533|NCT01907828|11155174|FG001|Overall Study|Lost to Follow-up|0
6822010|NCT00097539|10825511|FG004|Overall Study|Adverse Event|30
6822011|NCT00097539|10825512|FG005|Overall Study|Adverse Event|59
6822012|NCT00097539|10825513|FG006|Overall Study|Adverse Event|1
6822013|NCT00097539|10825507|FG000|Overall Study|Death|2
6822014|NCT00097539|10825508|FG001|Overall Study|Death|7
6822015|NCT00097539|10825509|FG002|Overall Study|Death|0
6822016|NCT00097539|10825510|FG003|Overall Study|Death|0
6822017|NCT00097539|10825511|FG004|Overall Study|Death|1
6822018|NCT00097539|10825512|FG005|Overall Study|Death|3
6822019|NCT00097539|10825513|FG006|Overall Study|Death|0
6822020|NCT00097539|10825507|FG000|Overall Study|Reasons Other Than Above|3602
6822021|NCT00097539|10825508|FG001|Overall Study|Reasons Other Than Above|1382
6822022|NCT00097539|10825509|FG002|Overall Study|Reasons Other Than Above|1757
6822023|NCT00097539|10825510|FG003|Overall Study|Reasons Other Than Above|692
6822024|NCT00097539|10825511|FG004|Overall Study|Reasons Other Than Above|361
6822025|NCT00097539|10825512|FG005|Overall Study|Reasons Other Than Above|1244
6822026|NCT00097539|10825513|FG006|Overall Study|Reasons Other Than Above|34
6822027|NCT00097539|10825507|FG000|Overall Study|Reason not Specified|111
6822028|NCT00097539|10825508|FG001|Overall Study|Reason not Specified|49
6822029|NCT00097539|10825509|FG002|Overall Study|Reason not Specified|53
6822030|NCT00097539|10825510|FG003|Overall Study|Reason not Specified|21
6822031|NCT00097539|10825511|FG004|Overall Study|Reason not Specified|11
6822032|NCT00097539|10825512|FG005|Overall Study|Reason not Specified|40
6822033|NCT00097539|10825513|FG006|Overall Study|Reason not Specified|2
6822034|NCT00097591|10825531|FG000|Overall Study|Withdrawal of consent|342
6822035|NCT00097591|10825532|FG001|Overall Study|Withdrawal of consent|323
6822036|NCT00097591|10825531|FG000|Overall Study|Less than 6 months on study drug|9
6822037|NCT00097591|10825532|FG001|Overall Study|Less than 6 months on study drug|7
6822038|NCT00097591|10825531|FG000|Overall Study|Unable to attend termination visit|53
6822039|NCT00097591|10825532|FG001|Overall Study|Unable to attend termination visit|51
6822040|NCT00097591|10825531|FG000|Overall Study|Lost to follow up|6
6822041|NCT00097591|10825532|FG001|Overall Study|Lost to follow up|10
6822042|NCT00097591|10825531|FG000|Overall Study|Other|0
6822043|NCT00097591|10825532|FG001|Overall Study|Other|3
6822044|NCT00097721|10825581|FG000|Overall Study|Adverse Event|8
6822045|NCT00097721|10825582|FG001|Overall Study|Adverse Event|1
6822046|NCT00097721|10825581|FG000|Overall Study|Withdrawal by Subject|6
6822047|NCT00097721|10825582|FG001|Overall Study|Withdrawal by Subject|1
6822048|NCT00097721|10825581|FG000|Overall Study|Progressive Disease|55
6822049|NCT00097721|10825582|FG001|Overall Study|Progressive Disease|27
6822050|NCT00097721|10825581|FG000|Overall Study|Physician Decision|1
6822051|NCT00097721|10825582|FG001|Overall Study|Physician Decision|3
6822052|NCT00097721|10825581|FG000|Overall Study|Reason not given|1
6822053|NCT00097721|10825582|FG001|Overall Study|Reason not given|1
6822054|NCT00097773|10825592|FG000|Overall Study|Lost to Follow-up|2
6822055|NCT00097773|10825593|FG001|Overall Study|Lost to Follow-up|2
6822056|NCT00097773|10825594|FG002|Overall Study|Lost to Follow-up|0
6822057|NCT00097773|10825595|FG003|Overall Study|Lost to Follow-up|1
6822058|NCT00097773|10825592|FG000|Overall Study|Physician Decision|2
6822059|NCT00097773|10825593|FG001|Overall Study|Physician Decision|2
6822060|NCT00097773|10825594|FG002|Overall Study|Physician Decision|3
6822061|NCT00097773|10825595|FG003|Overall Study|Physician Decision|1
6822062|NCT00097773|10825592|FG000|Overall Study|Withdrawal by Subject|3
6822063|NCT00097773|10825593|FG001|Overall Study|Withdrawal by Subject|3
6822064|NCT00097773|10825594|FG002|Overall Study|Withdrawal by Subject|3
6822065|NCT00097773|10825595|FG003|Overall Study|Withdrawal by Subject|1
6822066|NCT00097773|10825592|FG000|Overall Study|Adverse Event|0
6822067|NCT00097773|10825593|FG001|Overall Study|Adverse Event|1
6822068|NCT00097773|10825594|FG002|Overall Study|Adverse Event|0
6822069|NCT00097773|10825595|FG003|Overall Study|Adverse Event|0
6822070|NCT00097773|10825592|FG000|Overall Study|Other|1
6822071|NCT00097773|10825593|FG001|Overall Study|Other|0
6822072|NCT00097773|10825594|FG002|Overall Study|Other|2
6822073|NCT00097773|10825595|FG003|Overall Study|Other|0
6822074|NCT00097786|10825614|FG000|Overall Study|lost to follow-up for all-cause death|296
6822075|NCT00097786|10825615|FG001|Overall Study|lost to follow-up for all-cause death|292
6822076|NCT00097786|10825616|FG002|Overall Study|lost to follow-up for all-cause death|313
6822077|NCT00097786|10825617|FG003|Overall Study|lost to follow-up for all-cause death|310
6822078|NCT00097981|10825629|FG000|Overall Study|Adverse Event|31
6822079|NCT00097981|10825630|FG001|Overall Study|Adverse Event|44
6822080|NCT00097981|10825629|FG000|Overall Study|Withdrawal by Subject|10
6822081|NCT00097981|10825630|FG001|Overall Study|Withdrawal by Subject|8
6822082|NCT00097981|10825629|FG000|Overall Study|Protocol Violation|1
6822083|NCT00097981|10825630|FG001|Overall Study|Protocol Violation|1
6822084|NCT00097981|10825629|FG000|Overall Study|Death|2
6822085|NCT00097981|10825630|FG001|Overall Study|Death|4
6822086|NCT00097981|10825629|FG000|Overall Study|Physician Decision|7
6822087|NCT00097981|10825630|FG001|Overall Study|Physician Decision|1
6822088|NCT00097981|10825629|FG000|Overall Study|Disease Progression|8
6822089|NCT00097981|10825630|FG001|Overall Study|Disease Progression|2
6822090|NCT00097981|10825629|FG000|Overall Study|Transplant planned|28
6822091|NCT00097981|10825630|FG001|Overall Study|Transplant planned|27
6822092|NCT00097981|10825629|FG000|Overall Study|Other|19
6822093|NCT00097981|10825630|FG001|Overall Study|Other|13
6822094|NCT00098020|10825636|FG000|Overall Study|Adverse Event|2
6822095|NCT00098020|10825636|FG000|Overall Study|Lost to Follow-up|1
6822096|NCT00098020|10825636|FG000|Overall Study|elevated liver enzymes|1
6822097|NCT00098020|10825636|FG000|Overall Study|Low urine PCR|1
6822098|NCT00098020|10825636|FG000|Overall Study|Low epidermal growth factor receptor|1
6822099|NCT00098254|10825654|FG000|Overall Study|Adverse Event|2
6822100|NCT00098254|10825654|FG000|Overall Study|Death|1
6822101|NCT00098293|10825661|FG000|Double-blind (DB) Phase|Adverse Event|14
6822102|NCT00098293|10825662|FG001|Double-blind (DB) Phase|Adverse Event|27
6822103|NCT00098293|10825663|FG002|Double-blind (DB) Phase|Adverse Event|60
6822104|NCT00098293|10825664|FG003|Double-blind (DB) Phase|Adverse Event|0
6822105|NCT00098293|10825665|FG004|Double-blind (DB) Phase|Adverse Event|0
6822106|NCT00098293|10825661|FG000|Double-blind (DB) Phase|Pregnancy|0
6822107|NCT00098293|10825662|FG001|Double-blind (DB) Phase|Pregnancy|7
6822108|NCT00098293|10825663|FG002|Double-blind (DB) Phase|Pregnancy|9
6822109|NCT00098293|10825664|FG003|Double-blind (DB) Phase|Pregnancy|0
6822110|NCT00098293|10825665|FG004|Double-blind (DB) Phase|Pregnancy|0
6822111|NCT00098293|10825661|FG000|Double-blind (DB) Phase|Participant Defaulted|11
6822112|NCT00098293|10825662|FG001|Double-blind (DB) Phase|Participant Defaulted|40
6822113|NCT00098293|10825663|FG002|Double-blind (DB) Phase|Participant Defaulted|36
6822114|NCT00098293|10825664|FG003|Double-blind (DB) Phase|Participant Defaulted|0
6822115|NCT00098293|10825665|FG004|Double-blind (DB) Phase|Participant Defaulted|0
6822116|NCT00098293|10825661|FG000|Double-blind (DB) Phase|Lack of Efficacy|11
6822117|NCT00098293|10825662|FG001|Double-blind (DB) Phase|Lack of Efficacy|64
6822118|NCT00098293|10825663|FG002|Double-blind (DB) Phase|Lack of Efficacy|30
6822119|NCT00098293|10825664|FG003|Double-blind (DB) Phase|Lack of Efficacy|0
6822120|NCT00098293|10825665|FG004|Double-blind (DB) Phase|Lack of Efficacy|0
6822121|NCT00098293|10825661|FG000|Double-blind (DB) Phase|Death|1
6822122|NCT00098293|10825662|FG001|Double-blind (DB) Phase|Death|2
6822123|NCT00098293|10825663|FG002|Double-blind (DB) Phase|Death|2
6822124|NCT00098293|10825664|FG003|Double-blind (DB) Phase|Death|0
6822125|NCT00098293|10825665|FG004|Double-blind (DB) Phase|Death|0
6822126|NCT00098293|10825661|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3
6822127|NCT00098293|10825662|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8
6822128|NCT00098293|10825663|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11
6822129|NCT00098293|10825664|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0
6822130|NCT00098293|10825665|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0
6822131|NCT00098293|10825661|FG000|Double-blind (DB) Phase|Protocol Violation|2
6822132|NCT00098293|10825662|FG001|Double-blind (DB) Phase|Protocol Violation|18
6822133|NCT00098293|10825663|FG002|Double-blind (DB) Phase|Protocol Violation|22
6822134|NCT00098293|10825664|FG003|Double-blind (DB) Phase|Protocol Violation|0
6822135|NCT00098293|10825665|FG004|Double-blind (DB) Phase|Protocol Violation|0
6822136|NCT00098293|10825661|FG000|Double-blind (DB) Phase|Terminated by sponsor|135
6822137|NCT00098293|10825662|FG001|Double-blind (DB) Phase|Terminated by sponsor|0
6822138|NCT00098293|10825663|FG002|Double-blind (DB) Phase|Terminated by sponsor|0
6822139|NCT00098293|10825664|FG003|Double-blind (DB) Phase|Terminated by sponsor|0
6822140|NCT00098293|10825665|FG004|Double-blind (DB) Phase|Terminated by sponsor|0
6822141|NCT00098293|10825661|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0
6822142|NCT00098293|10825662|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0
6822143|NCT00098293|10825663|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3
6822144|NCT00098293|10825664|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0
6822145|NCT00098293|10825665|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0
6822146|NCT00098293|10825661|FG000|Open-label (OL) Phase|Adverse Event|0
6822147|NCT00098293|10825662|FG001|Open-label (OL) Phase|Adverse Event|3
6822148|NCT00098293|10825663|FG002|Open-label (OL) Phase|Adverse Event|7
6822149|NCT00098293|10825664|FG003|Open-label (OL) Phase|Adverse Event|6
6822150|NCT00098293|10825665|FG004|Open-label (OL) Phase|Adverse Event|0
6822151|NCT00098293|10825661|FG000|Open-label (OL) Phase|Lack of Efficacy|0
6822152|NCT00098293|10825662|FG001|Open-label (OL) Phase|Lack of Efficacy|7
6822153|NCT00098293|10825663|FG002|Open-label (OL) Phase|Lack of Efficacy|2
6822154|NCT00098293|10825664|FG003|Open-label (OL) Phase|Lack of Efficacy|20
6822155|NCT00098293|10825665|FG004|Open-label (OL) Phase|Lack of Efficacy|0
6822156|NCT00098293|10825661|FG000|Open-label (OL) Phase|Pregnancy|0
6822157|NCT00098293|10825662|FG001|Open-label (OL) Phase|Pregnancy|1
6822158|NCT00098293|10825663|FG002|Open-label (OL) Phase|Pregnancy|0
6822159|NCT00098293|10825664|FG003|Open-label (OL) Phase|Pregnancy|3
6822160|NCT00098293|10825665|FG004|Open-label (OL) Phase|Pregnancy|0
6822161|NCT00098293|10825661|FG000|Open-label (OL) Phase|Protocol Violation|0
6822162|NCT00098293|10825662|FG001|Open-label (OL) Phase|Protocol Violation|6
6822163|NCT00098293|10825663|FG002|Open-label (OL) Phase|Protocol Violation|13
6822164|NCT00098293|10825664|FG003|Open-label (OL) Phase|Protocol Violation|16
6822165|NCT00098293|10825665|FG004|Open-label (OL) Phase|Protocol Violation|0
6822166|NCT00098293|10825661|FG000|Open-label (OL) Phase|Participant Defaulted|0
6822167|NCT00098293|10825662|FG001|Open-label (OL) Phase|Participant Defaulted|6
6822168|NCT00098293|10825663|FG002|Open-label (OL) Phase|Participant Defaulted|16
6822169|NCT00098293|10825664|FG003|Open-label (OL) Phase|Participant Defaulted|20
6822170|NCT00098293|10825665|FG004|Open-label (OL) Phase|Participant Defaulted|0
6822171|NCT00098293|10825661|FG000|Open-label (OL) Phase|Death|0
6822172|NCT00098293|10825662|FG001|Open-label (OL) Phase|Death|2
6822173|NCT00098293|10825663|FG002|Open-label (OL) Phase|Death|3
6822174|NCT00098293|10825664|FG003|Open-label (OL) Phase|Death|0
6822175|NCT00098293|10825665|FG004|Open-label (OL) Phase|Death|0
6822176|NCT00098293|10825661|FG000|Supplemental Phase (SP)|Death|0
6822177|NCT00098293|10825662|FG001|Supplemental Phase (SP)|Death|0
6822178|NCT00098293|10825663|FG002|Supplemental Phase (SP)|Death|0
6822179|NCT00098293|10825664|FG003|Supplemental Phase (SP)|Death|0
6822180|NCT00098293|10825665|FG004|Supplemental Phase (SP)|Death|1
6822181|NCT00098293|10825661|FG000|Supplemental Phase (SP)|Lost to Follow-up|0
6822182|NCT00098293|10825662|FG001|Supplemental Phase (SP)|Lost to Follow-up|0
6822183|NCT00098293|10825663|FG002|Supplemental Phase (SP)|Lost to Follow-up|0
6822184|NCT00098293|10825664|FG003|Supplemental Phase (SP)|Lost to Follow-up|0
6822185|NCT00098293|10825665|FG004|Supplemental Phase (SP)|Lost to Follow-up|2
6822186|NCT00098293|10825661|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0
6822187|NCT00098293|10825662|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0
6822188|NCT00098293|10825663|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0
6822189|NCT00098293|10825664|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0
6822190|NCT00098293|10825665|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8
6822191|NCT00098293|10825661|FG000|Supplemental Phase (SP)|Other|0
6822192|NCT00098293|10825662|FG001|Supplemental Phase (SP)|Other|0
6822193|NCT00098293|10825663|FG002|Supplemental Phase (SP)|Other|0
6822194|NCT00098293|10825664|FG003|Supplemental Phase (SP)|Other|0
6822195|NCT00098293|10825665|FG004|Supplemental Phase (SP)|Other|22
6822196|NCT00098306|10825679|FG000|Double Blind|Randomized, not treated|9
6822197|NCT00098306|10825680|FG001|Double Blind|Randomized, not treated|5
6822198|NCT00098306|10825681|FG002|Double Blind|Randomized, not treated|2
6822199|NCT00098306|10825682|FG003|Double Blind|Randomized, not treated|0
6822200|NCT00098306|10825683|FG004|Double Blind|Randomized, not treated|0
6822201|NCT00098306|10825684|FG005|Double Blind|Randomized, not treated|0
6822202|NCT00098306|10825685|FG006|Double Blind|Randomized, not treated|0
6822203|NCT00098306|10825679|FG000|Double Blind|Ongoing at cut-off date|151
6822204|NCT00098306|10825680|FG001|Double Blind|Ongoing at cut-off date|166
6822205|NCT00098306|10825681|FG002|Double Blind|Ongoing at cut-off date|72
6822206|NCT00098306|10825682|FG003|Double Blind|Ongoing at cut-off date|0
6822207|NCT00098306|10825683|FG004|Double Blind|Ongoing at cut-off date|0
6822208|NCT00098306|10825684|FG005|Double Blind|Ongoing at cut-off date|0
6822209|NCT00098306|10825685|FG006|Double Blind|Ongoing at cut-off date|0
6822210|NCT00098306|10825679|FG000|Double Blind|Adverse Event|11
6822211|NCT00098306|10825680|FG001|Double Blind|Adverse Event|10
6822212|NCT00098306|10825681|FG002|Double Blind|Adverse Event|6
6822213|NCT00098306|10825682|FG003|Double Blind|Adverse Event|0
6822214|NCT00098306|10825683|FG004|Double Blind|Adverse Event|0
6822215|NCT00098306|10825684|FG005|Double Blind|Adverse Event|0
6822216|NCT00098306|10825685|FG006|Double Blind|Adverse Event|0
6822217|NCT00098306|10825679|FG000|Double Blind|Lack of Efficacy|43
6822218|NCT00098306|10825680|FG001|Double Blind|Lack of Efficacy|34
6822219|NCT00098306|10825681|FG002|Double Blind|Lack of Efficacy|17
6822220|NCT00098306|10825682|FG003|Double Blind|Lack of Efficacy|0
6822221|NCT00098306|10825683|FG004|Double Blind|Lack of Efficacy|0
6822222|NCT00098306|10825684|FG005|Double Blind|Lack of Efficacy|0
6822223|NCT00098306|10825685|FG006|Double Blind|Lack of Efficacy|0
6822224|NCT00098306|10825679|FG000|Double Blind|Death|1
6822225|NCT00098306|10825680|FG001|Double Blind|Death|4
6822226|NCT00098306|10825681|FG002|Double Blind|Death|1
6822227|NCT00098306|10825682|FG003|Double Blind|Death|0
6822228|NCT00098306|10825683|FG004|Double Blind|Death|0
6822229|NCT00098306|10825684|FG005|Double Blind|Death|0
6822230|NCT00098306|10825685|FG006|Double Blind|Death|0
6822231|NCT00098306|10825679|FG000|Double Blind|Participant defaulted|19
6822232|NCT00098306|10825680|FG001|Double Blind|Participant defaulted|18
6822233|NCT00098306|10825681|FG002|Double Blind|Participant defaulted|11
6822234|NCT00098306|10825682|FG003|Double Blind|Participant defaulted|0
6822235|NCT00098306|10825683|FG004|Double Blind|Participant defaulted|0
6822236|NCT00098306|10825684|FG005|Double Blind|Participant defaulted|0
6822237|NCT00098306|10825685|FG006|Double Blind|Participant defaulted|0
6822238|NCT00098306|10825679|FG000|Double Blind|Un-specified|7
6822239|NCT00098306|10825680|FG001|Double Blind|Un-specified|3
6822240|NCT00098306|10825681|FG002|Double Blind|Un-specified|11
6822241|NCT00098306|10825682|FG003|Double Blind|Un-specified|0
6822242|NCT00098306|10825683|FG004|Double Blind|Un-specified|0
6822243|NCT00098306|10825684|FG005|Double Blind|Un-specified|0
6822244|NCT00098306|10825685|FG006|Double Blind|Un-specified|0
6822245|NCT00098306|10825679|FG000|Open Label|Lack of Efficacy|0
6822246|NCT00098306|10825680|FG001|Open Label|Lack of Efficacy|0
6822247|NCT00098306|10825681|FG002|Open Label|Lack of Efficacy|0
6822248|NCT00098306|10825682|FG003|Open Label|Lack of Efficacy|13
6822249|NCT00098306|10825683|FG004|Open Label|Lack of Efficacy|0
6822250|NCT00098306|10825684|FG005|Open Label|Lack of Efficacy|0
6822251|NCT00098306|10825685|FG006|Open Label|Lack of Efficacy|0
6822252|NCT00098306|10825679|FG000|Open Label|Adverse Event|0
6822253|NCT00098306|10825680|FG001|Open Label|Adverse Event|0
6822254|NCT00098306|10825681|FG002|Open Label|Adverse Event|0
6822255|NCT00098306|10825682|FG003|Open Label|Adverse Event|2
6822256|NCT00098306|10825683|FG004|Open Label|Adverse Event|0
6822257|NCT00098306|10825684|FG005|Open Label|Adverse Event|0
6822258|NCT00098306|10825685|FG006|Open Label|Adverse Event|0
6822259|NCT00098306|10825679|FG000|Open Label|Death|0
6822260|NCT00098306|10825680|FG001|Open Label|Death|0
6822261|NCT00098306|10825681|FG002|Open Label|Death|0
6822262|NCT00098306|10825682|FG003|Open Label|Death|4
6822263|NCT00098306|10825683|FG004|Open Label|Death|0
6822264|NCT00098306|10825684|FG005|Open Label|Death|0
6822265|NCT00098306|10825685|FG006|Open Label|Death|0
6822266|NCT00098306|10825679|FG000|Open Label|Participant defaulted|0
6822267|NCT00098306|10825680|FG001|Open Label|Participant defaulted|0
6822268|NCT00098306|10825681|FG002|Open Label|Participant defaulted|0
6822269|NCT00098306|10825682|FG003|Open Label|Participant defaulted|24
6822270|NCT00098306|10825683|FG004|Open Label|Participant defaulted|0
6822271|NCT00098306|10825684|FG005|Open Label|Participant defaulted|0
6822272|NCT00098306|10825685|FG006|Open Label|Participant defaulted|0
6822273|NCT00098306|10825679|FG000|Open Label|Un-specified|0
6822274|NCT00098306|10825680|FG001|Open Label|Un-specified|0
6822275|NCT00098306|10825681|FG002|Open Label|Un-specified|0
6822276|NCT00098306|10825682|FG003|Open Label|Un-specified|15
6822277|NCT00098306|10825683|FG004|Open Label|Un-specified|0
6822278|NCT00098306|10825684|FG005|Open Label|Un-specified|0
6822279|NCT00098306|10825685|FG006|Open Label|Un-specified|0
6822280|NCT00098306|10825679|FG000|Open Label|Ongoing at cut-off date|0
6822281|NCT00098306|10825680|FG001|Open Label|Ongoing at cut-off date|0
6822282|NCT00098306|10825681|FG002|Open Label|Ongoing at cut-off date|0
6822283|NCT00098306|10825682|FG003|Open Label|Ongoing at cut-off date|269
6822284|NCT00098306|10825683|FG004|Open Label|Ongoing at cut-off date|62
6822285|NCT00098306|10825684|FG005|Open Label|Ongoing at cut-off date|0
6822286|NCT00098306|10825685|FG006|Open Label|Ongoing at cut-off date|0
6822287|NCT00098306|10825679|FG000|Observational Phase|Death|0
6822288|NCT00098306|10825680|FG001|Observational Phase|Death|0
6822289|NCT00098306|10825681|FG002|Observational Phase|Death|0
6822290|NCT00098306|10825682|FG003|Observational Phase|Death|0
6822291|NCT00098306|10825683|FG004|Observational Phase|Death|0
6822292|NCT00098306|10825684|FG005|Observational Phase|Death|5
6822293|NCT00098306|10825685|FG006|Observational Phase|Death|4
6822294|NCT00098306|10825679|FG000|Observational Phase|Participant defaulted|0
6822295|NCT00098306|10825680|FG001|Observational Phase|Participant defaulted|0
6822296|NCT00098306|10825681|FG002|Observational Phase|Participant defaulted|0
6822297|NCT00098306|10825682|FG003|Observational Phase|Participant defaulted|0
6822298|NCT00098306|10825683|FG004|Observational Phase|Participant defaulted|0
6822299|NCT00098306|10825684|FG005|Observational Phase|Participant defaulted|34
6822300|NCT00098306|10825685|FG006|Observational Phase|Participant defaulted|18
6822301|NCT00098306|10825679|FG000|Observational Phase|Un-specified|0
6900763|NCT00667446|10921102|FG001|Treatment Period (36 Months)|Therapeutic Failure|1
6900764|NCT00667446|10921101|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0
6900765|NCT00667446|10921102|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1
6900766|NCT00667459|10921110|FG000|Overall Study|Death|0
6900767|NCT00667459|10921111|FG001|Overall Study|Death|2
6900768|NCT00667459|10921110|FG000|Overall Study|Lost to Follow-up|8
6900769|NCT00667459|10921111|FG001|Overall Study|Lost to Follow-up|43
6973556|NCT01182194|11025464|FG000|Washout of 28 Days|Withdrawal by Subject|1
6973557|NCT01182194|11025465|FG001|Washout of 28 Days|Withdrawal by Subject|0
6973558|NCT01182207|11025473|FG000|First Intervention|Positive Hepatitis Results|0
6973559|NCT01182207|11025474|FG001|First Intervention|Positive Hepatitis Results|1
6973560|NCT01182207|11025473|FG000|Second Intervention|Emeses within 1 hour of dosing|1
6973561|NCT01182207|11025474|FG001|Second Intervention|Emeses within 1 hour of dosing|0
6973562|NCT01182285|11025480|FG000|First Intervention Week 1-10|Disease progression|1
6973563|NCT01182285|11025481|FG001|First Intervention Week 1-10|Disease progression|0
6973564|NCT01182285|11025482|FG002|First Intervention Week 1-10|Disease progression|0
6973565|NCT01182285|11025480|FG000|First Intervention Week 1-10|Adverse Event|1
6973566|NCT01182285|11025481|FG001|First Intervention Week 1-10|Adverse Event|0
6973567|NCT01182285|11025482|FG002|First Intervention Week 1-10|Adverse Event|0
6973568|NCT01182285|11025480|FG000|First Intervention Week 1-10|Non-compliance|1
6973569|NCT01182285|11025481|FG001|First Intervention Week 1-10|Non-compliance|0
6973570|NCT01182285|11025482|FG002|First Intervention Week 1-10|Non-compliance|0
6973571|NCT01182285|11025480|FG000|Third Intervention Week 11-52|Disease Progression|0
6973572|NCT01182285|11025481|FG001|Third Intervention Week 11-52|Disease Progression|0
6973573|NCT01182285|11025482|FG002|Third Intervention Week 11-52|Disease Progression|6
6973574|NCT01182285|11025480|FG000|Third Intervention Week 11-52|Other|0
6973575|NCT01182285|11025481|FG001|Third Intervention Week 11-52|Other|0
6973576|NCT01182285|11025482|FG002|Third Intervention Week 11-52|Other|2
6973577|NCT01182298|11025489|FG000|Overall Study|Lack of Efficacy|4
6973578|NCT01182298|11025489|FG000|Overall Study|Withdrawal by Subject|2
6973579|NCT01182337|11025495|FG000|Overall Study|Withdrawal by Subject|3
6973580|NCT01182337|11025496|FG001|Overall Study|Withdrawal by Subject|1
6973581|NCT01182337|11025495|FG000|Overall Study|Lost to Follow-up|0
6973582|NCT01182337|11025496|FG001|Overall Study|Lost to Follow-up|1
6973583|NCT01182350|11025503|FG000|Overall Study|Adverse Event|5
6973584|NCT01182350|11025504|FG001|Overall Study|Adverse Event|0
6973585|NCT01182350|11025505|FG002|Overall Study|Adverse Event|0
6973586|NCT01182350|11025506|FG003|Overall Study|Adverse Event|0
6973587|NCT01182350|11025507|FG004|Overall Study|Adverse Event|0
6822302|NCT00098306|10825680|FG001|Observational Phase|Un-specified|0
6822303|NCT00098306|10825681|FG002|Observational Phase|Un-specified|0
6822304|NCT00098306|10825682|FG003|Observational Phase|Un-specified|0
6822305|NCT00098306|10825683|FG004|Observational Phase|Un-specified|0
6822306|NCT00098306|10825684|FG005|Observational Phase|Un-specified|7
6822307|NCT00098306|10825685|FG006|Observational Phase|Un-specified|4
6822308|NCT00098345|10825698|FG000|Overall Study|Adverse Event|7
6822309|NCT00098345|10825698|FG000|Overall Study|Withdrawal by Subject|2
6822310|NCT00098345|10825698|FG000|Overall Study|progression|4
6822311|NCT00098722|10825725|FG000|Double Blind Phase|Adverse Event|7
6822312|NCT00098722|10825726|FG001|Double Blind Phase|Adverse Event|7
6822313|NCT00098722|10825727|FG002|Double Blind Phase|Adverse Event|3
6822314|NCT00098722|10825728|FG003|Double Blind Phase|Adverse Event|0
6822315|NCT00098722|10825729|FG004|Double Blind Phase|Adverse Event|0
6822316|NCT00098722|10825730|FG005|Double Blind Phase|Adverse Event|0
6822317|NCT00098722|10825731|FG006|Double Blind Phase|Adverse Event|0
6822318|NCT00098722|10825725|FG000|Double Blind Phase|Death|2
6822319|NCT00098722|10825726|FG001|Double Blind Phase|Death|5
6822320|NCT00098722|10825727|FG002|Double Blind Phase|Death|0
6822321|NCT00098722|10825728|FG003|Double Blind Phase|Death|0
6822322|NCT00098722|10825729|FG004|Double Blind Phase|Death|0
6822323|NCT00098722|10825730|FG005|Double Blind Phase|Death|0
6822324|NCT00098722|10825731|FG006|Double Blind Phase|Death|0
6822325|NCT00098722|10825725|FG000|Double Blind Phase|Lack of Efficacy|21
6822326|NCT00098722|10825726|FG001|Double Blind Phase|Lack of Efficacy|23
6822327|NCT00098722|10825727|FG002|Double Blind Phase|Lack of Efficacy|15
6822328|NCT00098722|10825728|FG003|Double Blind Phase|Lack of Efficacy|0
6822329|NCT00098722|10825729|FG004|Double Blind Phase|Lack of Efficacy|0
6822330|NCT00098722|10825730|FG005|Double Blind Phase|Lack of Efficacy|0
6822331|NCT00098722|10825731|FG006|Double Blind Phase|Lack of Efficacy|0
6822332|NCT00098722|10825725|FG000|Double Blind Phase|Participant defaulted|16
6822333|NCT00098722|10825726|FG001|Double Blind Phase|Participant defaulted|11
6822334|NCT00098722|10825727|FG002|Double Blind Phase|Participant defaulted|9
6822335|NCT00098722|10825728|FG003|Double Blind Phase|Participant defaulted|0
6822336|NCT00098722|10825729|FG004|Double Blind Phase|Participant defaulted|0
6978590|NCT01214421|11032103|FG003|Overall Study|Lost to Follow-up|3
6978591|NCT01214421|11032100|FG000|Overall Study|Adverse Event|16
6978592|NCT01214421|11032101|FG001|Overall Study|Adverse Event|35
6978593|NCT01214421|11032102|FG002|Overall Study|Adverse Event|14
6978594|NCT01214421|11032103|FG003|Overall Study|Adverse Event|3
6978595|NCT01214421|11032100|FG000|Overall Study|Sponsor Discontinued Site|1
6978596|NCT01214421|11032101|FG001|Overall Study|Sponsor Discontinued Site|2
6978597|NCT01214421|11032102|FG002|Overall Study|Sponsor Discontinued Site|0
6978598|NCT01214421|11032103|FG003|Overall Study|Sponsor Discontinued Site|0
6978599|NCT01214421|11032100|FG000|Overall Study|Withdrawal Criteria Met|3
6978600|NCT01214421|11032101|FG001|Overall Study|Withdrawal Criteria Met|0
6978601|NCT01214421|11032102|FG002|Overall Study|Withdrawal Criteria Met|2
6978602|NCT01214421|11032103|FG003|Overall Study|Withdrawal Criteria Met|1
6978603|NCT01214421|11032100|FG000|Overall Study|Physician Decision|2
6978604|NCT01214421|11032101|FG001|Overall Study|Physician Decision|0
6978605|NCT01214421|11032102|FG002|Overall Study|Physician Decision|4
6978606|NCT01214421|11032103|FG003|Overall Study|Physician Decision|0
6978607|NCT01214421|11032100|FG000|Overall Study|Withdrawal by Subject|21
6978608|NCT01214421|11032101|FG001|Overall Study|Withdrawal by Subject|18
6978609|NCT01214421|11032102|FG002|Overall Study|Withdrawal by Subject|11
6978610|NCT01214421|11032103|FG003|Overall Study|Withdrawal by Subject|2
6978611|NCT01214434|11032115|FG000|Overall Study|Withdrawal by Subject|1
6978612|NCT01214434|11032116|FG001|Overall Study|Withdrawal by Subject|0
6978613|NCT01214434|11032115|FG000|Overall Study|Lost to Follow-up|2
6978614|NCT01214434|11032116|FG001|Overall Study|Lost to Follow-up|2
6978615|NCT01214434|11032115|FG000|Overall Study|Site error|1
6978616|NCT01214434|11032116|FG001|Overall Study|Site error|0
6978617|NCT01214603|11032125|FG000|Overall Study|Adverse Event|0
6978618|NCT01214603|11032126|FG001|Overall Study|Adverse Event|0
6978619|NCT01214603|11032127|FG002|Overall Study|Adverse Event|1
6978620|NCT01214603|11032125|FG000|Overall Study|Death|1
6978621|NCT01214603|11032126|FG001|Overall Study|Death|0
6978622|NCT01214603|11032127|FG002|Overall Study|Death|0
6978623|NCT01214603|11032125|FG000|Overall Study|Progressive Disease|4
6978624|NCT01214603|11032126|FG001|Overall Study|Progressive Disease|1
6978625|NCT01214603|11032127|FG002|Overall Study|Progressive Disease|3
6978626|NCT01214616|11032140|FG000|Overall Study|Progressive disease|2
6978627|NCT01214616|11032141|FG001|Overall Study|Progressive disease|2
6978628|NCT01214616|11032142|FG002|Overall Study|Progressive disease|2
6978629|NCT01214616|11032143|FG003|Overall Study|Progressive disease|4
6978630|NCT01214616|11032140|FG000|Overall Study|Dose limiting toxicity|0
6978631|NCT01214616|11032141|FG001|Overall Study|Dose limiting toxicity|2
6978632|NCT01214616|11032142|FG002|Overall Study|Dose limiting toxicity|0
6978633|NCT01214616|11032143|FG003|Overall Study|Dose limiting toxicity|0
7059534|NCT01907828|11155173|FG000|Overall Study|Participant refused 24-month follow-up|1
7059535|NCT01907828|11155174|FG001|Overall Study|Participant refused 24-month follow-up|0
7059536|NCT01907828|11155173|FG000|Overall Study|Participant met exclusion criteria|0
7059537|NCT01907828|11155174|FG001|Overall Study|Participant met exclusion criteria|1
6822337|NCT00098722|10825730|FG005|Double Blind Phase|Participant defaulted|0
6822338|NCT00098722|10825731|FG006|Double Blind Phase|Participant defaulted|0
6978634|NCT01214616|11032140|FG000|Overall Study|Other adverse events|0
6978635|NCT01214616|11032141|FG001|Overall Study|Other adverse events|1
6978636|NCT01214616|11032142|FG002|Overall Study|Other adverse events|1
6978637|NCT01214616|11032143|FG003|Overall Study|Other adverse events|1
6978638|NCT01214616|11032140|FG000|Overall Study|Withdrawal by Subject|1
6978639|NCT01214616|11032141|FG001|Overall Study|Withdrawal by Subject|0
7059538|NCT01907854|11155182|FG000|Overall Study|Protocol Violation|1
7059539|NCT01907854|11155183|FG001|Overall Study|Protocol Violation|1
7059540|NCT01907854|11155182|FG000|Overall Study|Withdrawal by Subject|9
7059541|NCT01907854|11155183|FG001|Overall Study|Withdrawal by Subject|7
7059542|NCT01907854|11155182|FG000|Overall Study|Lost to Follow-up|2
7059543|NCT01907854|11155183|FG001|Overall Study|Lost to Follow-up|2
7059544|NCT01907854|11155182|FG000|Overall Study|Unclassified|4
7059545|NCT01907854|11155183|FG001|Overall Study|Unclassified|3
7059546|NCT01907906|11155191|FG000|Overall Study|Withdrawal by Subject|1
7059547|NCT01907906|11155192|FG001|Overall Study|Withdrawal by Subject|0
7059548|NCT01907906|11155191|FG000|Overall Study|Physician Decision|3
7059549|NCT01907906|11155192|FG001|Overall Study|Physician Decision|1
7059550|NCT01908101|11155212|FG000|Overall Study|Physician Decision|1
7059551|NCT01908101|11155212|FG000|Overall Study|Withdrawal by Subject|1
6822339|NCT00098722|10825725|FG000|Double Blind Phase|Pregnancy|1
6822340|NCT00098722|10825726|FG001|Double Blind Phase|Pregnancy|0
6822341|NCT00098722|10825727|FG002|Double Blind Phase|Pregnancy|0
6822342|NCT00098722|10825728|FG003|Double Blind Phase|Pregnancy|0
6822343|NCT00098722|10825729|FG004|Double Blind Phase|Pregnancy|0
6822344|NCT00098722|10825730|FG005|Double Blind Phase|Pregnancy|0
6822345|NCT00098722|10825731|FG006|Double Blind Phase|Pregnancy|0
6822346|NCT00098722|10825725|FG000|Double Blind Phase|Randomized, not treated|4
6822347|NCT00098722|10825726|FG001|Double Blind Phase|Randomized, not treated|3
6822348|NCT00098722|10825727|FG002|Double Blind Phase|Randomized, not treated|3
6822349|NCT00098722|10825728|FG003|Double Blind Phase|Randomized, not treated|0
6822350|NCT00098722|10825729|FG004|Double Blind Phase|Randomized, not treated|0
6822351|NCT00098722|10825730|FG005|Double Blind Phase|Randomized, not treated|0
6822352|NCT00098722|10825731|FG006|Double Blind Phase|Randomized, not treated|0
6822353|NCT00098722|10825725|FG000|Double Blind Phase|Ongoing at cut-off date|128
6822354|NCT00098722|10825726|FG001|Double Blind Phase|Ongoing at cut-off date|137
6822355|NCT00098722|10825727|FG002|Double Blind Phase|Ongoing at cut-off date|57
6822356|NCT00098722|10825728|FG003|Double Blind Phase|Ongoing at cut-off date|0
6822357|NCT00098722|10825729|FG004|Double Blind Phase|Ongoing at cut-off date|0
6822358|NCT00098722|10825730|FG005|Double Blind Phase|Ongoing at cut-off date|0
6822359|NCT00098722|10825731|FG006|Double Blind Phase|Ongoing at cut-off date|0
6822360|NCT00098722|10825725|FG000|Double Blind Phase|Other|7
6822361|NCT00098722|10825726|FG001|Double Blind Phase|Other|8
6822362|NCT00098722|10825727|FG002|Double Blind Phase|Other|7
6822363|NCT00098722|10825728|FG003|Double Blind Phase|Other|0
6822364|NCT00098722|10825729|FG004|Double Blind Phase|Other|0
6822365|NCT00098722|10825730|FG005|Double Blind Phase|Other|0
6822366|NCT00098722|10825731|FG006|Double Blind Phase|Other|0
6822367|NCT00098722|10825725|FG000|Open Label Phase|Adverse Event|0
6822368|NCT00098722|10825726|FG001|Open Label Phase|Adverse Event|0
6822369|NCT00098722|10825727|FG002|Open Label Phase|Adverse Event|0
6822370|NCT00098722|10825728|FG003|Open Label Phase|Adverse Event|5
6822371|NCT00098722|10825729|FG004|Open Label Phase|Adverse Event|0
6822372|NCT00098722|10825730|FG005|Open Label Phase|Adverse Event|0
6822373|NCT00098722|10825731|FG006|Open Label Phase|Adverse Event|0
6900770|NCT00667563|10921123|FG000|Overall Study|Protocol Violation|24
6900771|NCT00667576|10921132|FG000|Overall Study|Withdrawal by Subject|1
6900772|NCT00667576|10921133|FG001|Overall Study|Withdrawal by Subject|0
6900773|NCT00667576|10921134|FG002|Overall Study|Withdrawal by Subject|1
6900774|NCT00667576|10921135|FG003|Overall Study|Withdrawal by Subject|1
6900775|NCT00667576|10921136|FG004|Overall Study|Withdrawal by Subject|1
6900776|NCT00667576|10921132|FG000|Overall Study|Adverse Event|1
6900777|NCT00667576|10921133|FG001|Overall Study|Adverse Event|1
6900778|NCT00667576|10921134|FG002|Overall Study|Adverse Event|0
6900779|NCT00667576|10921135|FG003|Overall Study|Adverse Event|0
6900780|NCT00667576|10921136|FG004|Overall Study|Adverse Event|0
6900781|NCT00667576|10921132|FG000|Overall Study|Lost to Follow-up|0
6900782|NCT00667576|10921133|FG001|Overall Study|Lost to Follow-up|0
6900783|NCT00667576|10921134|FG002|Overall Study|Lost to Follow-up|1
6900784|NCT00667576|10921135|FG003|Overall Study|Lost to Follow-up|0
6900785|NCT00667576|10921136|FG004|Overall Study|Lost to Follow-up|0
6900786|NCT00667576|10921132|FG000|Overall Study|Protocol Violation|0
6900787|NCT00667576|10921133|FG001|Overall Study|Protocol Violation|0
6900788|NCT00667576|10921134|FG002|Overall Study|Protocol Violation|0
6900789|NCT00667576|10921135|FG003|Overall Study|Protocol Violation|1
6900790|NCT00667576|10921136|FG004|Overall Study|Protocol Violation|0
6900791|NCT00667576|10921132|FG000|Overall Study|Physician Decision|0
6900792|NCT00667576|10921133|FG001|Overall Study|Physician Decision|0
6900793|NCT00667576|10921134|FG002|Overall Study|Physician Decision|0
6900794|NCT00667576|10921135|FG003|Overall Study|Physician Decision|1
6900795|NCT00667576|10921136|FG004|Overall Study|Physician Decision|0
6900796|NCT00667576|10921132|FG000|Overall Study|Missed Visit|0
6900797|NCT00667576|10921133|FG001|Overall Study|Missed Visit|0
6900798|NCT00667576|10921134|FG002|Overall Study|Missed Visit|0
6900799|NCT00667576|10921135|FG003|Overall Study|Missed Visit|1
6900800|NCT00667576|10921136|FG004|Overall Study|Missed Visit|0
6900801|NCT00667602|10921168|FG000|Overall Study|Withdrawal by Subject|4
6900802|NCT00667602|10921169|FG001|Overall Study|Withdrawal by Subject|9
7059552|NCT01908101|11155212|FG000|Overall Study|Incorrect Diagnosis|2
7059553|NCT01908101|11155212|FG000|Overall Study|Incorrect Starting Dose|1
7141113|NCT02982772|11295698|FG000|12M Follow-Up|Lost to Follow-up|11
6822374|NCT00098722|10825725|FG000|Open Label Phase|Death|0
6822375|NCT00098722|10825726|FG001|Open Label Phase|Death|0
6822376|NCT00098722|10825727|FG002|Open Label Phase|Death|0
6822377|NCT00098722|10825728|FG003|Open Label Phase|Death|2
6822378|NCT00098722|10825729|FG004|Open Label Phase|Death|0
6822379|NCT00098722|10825730|FG005|Open Label Phase|Death|0
6822380|NCT00098722|10825731|FG006|Open Label Phase|Death|0
6822381|NCT00098722|10825725|FG000|Open Label Phase|Lack of Efficacy|0
6822382|NCT00098722|10825726|FG001|Open Label Phase|Lack of Efficacy|0
6822383|NCT00098722|10825727|FG002|Open Label Phase|Lack of Efficacy|0
6822384|NCT00098722|10825728|FG003|Open Label Phase|Lack of Efficacy|8
6822385|NCT00098722|10825729|FG004|Open Label Phase|Lack of Efficacy|0
6822386|NCT00098722|10825730|FG005|Open Label Phase|Lack of Efficacy|0
6822387|NCT00098722|10825731|FG006|Open Label Phase|Lack of Efficacy|0
6822388|NCT00098722|10825725|FG000|Open Label Phase|Pregnancy|0
6822389|NCT00098722|10825726|FG001|Open Label Phase|Pregnancy|0
6822390|NCT00098722|10825727|FG002|Open Label Phase|Pregnancy|0
6822391|NCT00098722|10825728|FG003|Open Label Phase|Pregnancy|1
6822392|NCT00098722|10825729|FG004|Open Label Phase|Pregnancy|0
6822393|NCT00098722|10825730|FG005|Open Label Phase|Pregnancy|0
6822394|NCT00098722|10825731|FG006|Open Label Phase|Pregnancy|0
6822395|NCT00098722|10825725|FG000|Open Label Phase|Participant defaulted|0
6822396|NCT00098722|10825726|FG001|Open Label Phase|Participant defaulted|0
6822397|NCT00098722|10825727|FG002|Open Label Phase|Participant defaulted|0
6822398|NCT00098722|10825728|FG003|Open Label Phase|Participant defaulted|18
6822399|NCT00098722|10825729|FG004|Open Label Phase|Participant defaulted|0
6822400|NCT00098722|10825730|FG005|Open Label Phase|Participant defaulted|0
6822401|NCT00098722|10825731|FG006|Open Label Phase|Participant defaulted|0
6822402|NCT00098722|10825725|FG000|Open Label Phase|Ongoing at cut-off date|0
6822403|NCT00098722|10825726|FG001|Open Label Phase|Ongoing at cut-off date|0
6822404|NCT00098722|10825727|FG002|Open Label Phase|Ongoing at cut-off date|0
6822405|NCT00098722|10825728|FG003|Open Label Phase|Ongoing at cut-off date|220
6822406|NCT00098722|10825729|FG004|Open Label Phase|Ongoing at cut-off date|50
6822407|NCT00098722|10825730|FG005|Open Label Phase|Ongoing at cut-off date|0
6822408|NCT00098722|10825731|FG006|Open Label Phase|Ongoing at cut-off date|0
6822409|NCT00098722|10825725|FG000|Open Label Phase|Other|0
6822410|NCT00098722|10825726|FG001|Open Label Phase|Other|0
6822411|NCT00098722|10825727|FG002|Open Label Phase|Other|0
6822412|NCT00098722|10825728|FG003|Open Label Phase|Other|18
6822413|NCT00098722|10825729|FG004|Open Label Phase|Other|0
6822414|NCT00098722|10825730|FG005|Open Label Phase|Other|0
6822415|NCT00098722|10825731|FG006|Open Label Phase|Other|0
6822416|NCT00098722|10825725|FG000|Observation Phase|Death|0
6822417|NCT00098722|10825726|FG001|Observation Phase|Death|0
6822418|NCT00098722|10825727|FG002|Observation Phase|Death|0
6822419|NCT00098722|10825728|FG003|Observation Phase|Death|0
6822420|NCT00098722|10825729|FG004|Observation Phase|Death|0
6822421|NCT00098722|10825730|FG005|Observation Phase|Death|5
6822422|NCT00098722|10825731|FG006|Observation Phase|Death|3
6822423|NCT00098722|10825725|FG000|Observation Phase|Lack of Efficacy|0
6822424|NCT00098722|10825726|FG001|Observation Phase|Lack of Efficacy|0
6822425|NCT00098722|10825727|FG002|Observation Phase|Lack of Efficacy|0
6822426|NCT00098722|10825728|FG003|Observation Phase|Lack of Efficacy|0
6822427|NCT00098722|10825729|FG004|Observation Phase|Lack of Efficacy|0
6822428|NCT00098722|10825730|FG005|Observation Phase|Lack of Efficacy|2
6822429|NCT00098722|10825731|FG006|Observation Phase|Lack of Efficacy|0
6822430|NCT00098722|10825725|FG000|Observation Phase|Participant defaulted|0
6822431|NCT00098722|10825726|FG001|Observation Phase|Participant defaulted|0
6822432|NCT00098722|10825727|FG002|Observation Phase|Participant defaulted|0
6822433|NCT00098722|10825728|FG003|Observation Phase|Participant defaulted|0
6822434|NCT00098722|10825729|FG004|Observation Phase|Participant defaulted|0
6822435|NCT00098722|10825730|FG005|Observation Phase|Participant defaulted|17
6822436|NCT00098722|10825731|FG006|Observation Phase|Participant defaulted|4
6822437|NCT00098722|10825725|FG000|Observation Phase|Other|0
6822438|NCT00098722|10825726|FG001|Observation Phase|Other|0
6822439|NCT00098722|10825727|FG002|Observation Phase|Other|0
6822440|NCT00098722|10825728|FG003|Observation Phase|Other|0
6822441|NCT00098722|10825729|FG004|Observation Phase|Other|0
6822442|NCT00098722|10825730|FG005|Observation Phase|Other|21
6822443|NCT00098722|10825731|FG006|Observation Phase|Other|10
6822444|NCT00098748|10825746|FG000|Assigned to Study Treatment|Randomized, but not treated|0
6822445|NCT00098748|10825747|FG001|Assigned to Study Treatment|Randomized, but not treated|2
6822446|NCT00098748|10825748|FG002|Assigned to Study Treatment|Randomized, but not treated|2
6822447|NCT00098748|10825746|FG000|Received Study Treatment|Death|2
6822448|NCT00098748|10825747|FG001|Received Study Treatment|Death|1
6822449|NCT00098748|10825748|FG002|Received Study Treatment|Death|2
6822450|NCT00098748|10825746|FG000|Received Study Treatment|Adverse Event|1
6822451|NCT00098748|10825747|FG001|Received Study Treatment|Adverse Event|2
6822452|NCT00098748|10825748|FG002|Received Study Treatment|Adverse Event|5
6822453|NCT00098748|10825746|FG000|Received Study Treatment|Lack of Efficacy|40
6822454|NCT00098748|10825747|FG001|Received Study Treatment|Lack of Efficacy|27
6822455|NCT00098748|10825748|FG002|Received Study Treatment|Lack of Efficacy|27
6822456|NCT00098748|10825746|FG000|Received Study Treatment|Other|2
6822457|NCT00098748|10825747|FG001|Received Study Treatment|Other|2
6822458|NCT00098748|10825748|FG002|Received Study Treatment|Other|6
6822459|NCT00098748|10825746|FG000|Received Study Treatment|Subject defaulted|3
6896673|NCT00634751|10915227|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0
6822460|NCT00098748|10825747|FG001|Received Study Treatment|Subject defaulted|4
6822461|NCT00098748|10825748|FG002|Received Study Treatment|Subject defaulted|4
6822462|NCT00098748|10825746|FG000|Continued on Open-Label Treatment|Adverse Event|0
6822463|NCT00098748|10825747|FG001|Continued on Open-Label Treatment|Adverse Event|1
6822464|NCT00098748|10825748|FG002|Continued on Open-Label Treatment|Adverse Event|0
6822465|NCT00098748|10825746|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1
6822466|NCT00098748|10825747|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2
6822467|NCT00098748|10825748|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0
6822468|NCT00098748|10825746|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6
6822469|NCT00098748|10825747|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7
6822470|NCT00098748|10825748|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0
6822471|NCT00098748|10825746|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1
6822472|NCT00098748|10825747|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1
6822473|NCT00098748|10825748|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0
6822474|NCT00098748|10825746|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0
6822475|NCT00098748|10825747|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4
6822476|NCT00098748|10825748|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0
6822477|NCT00098774|10825756|FG000|Overall Study|Adverse Event|2
6822478|NCT00098774|10825756|FG000|Overall Study|Disease Progression|9
6822479|NCT00098774|10825756|FG000|Overall Study|Withdrawal by Subject|1
6822480|NCT00098774|10825756|FG000|Overall Study|Failed (to respond) during induction|4
6822481|NCT00098774|10825756|FG000|Overall Study|Physician Decision|2
6822482|NCT00098787|10825763|FG000|Overall Study|Never started treatment|3
6822483|NCT00098787|10825764|FG001|Overall Study|Never started treatment|2
6822484|NCT00098787|10825765|FG002|Overall Study|Never started treatment|1
6822485|NCT00098787|10825763|FG000|Overall Study|Ineligible|9
6822486|NCT00098787|10825764|FG001|Overall Study|Ineligible|7
6822487|NCT00098787|10825765|FG002|Overall Study|Ineligible|3
6822488|NCT00098787|10825763|FG000|Overall Study|Disease progression|28
6822489|NCT00098787|10825764|FG001|Overall Study|Disease progression|17
6822490|NCT00098787|10825765|FG002|Overall Study|Disease progression|23
6822491|NCT00098787|10825763|FG000|Overall Study|Adverse Event|8
6822492|NCT00098787|10825764|FG001|Overall Study|Adverse Event|17
6822493|NCT00098787|10825765|FG002|Overall Study|Adverse Event|8
6822494|NCT00098787|10825763|FG000|Overall Study|Death|6
6822495|NCT00098787|10825764|FG001|Overall Study|Death|1
6822496|NCT00098787|10825765|FG002|Overall Study|Death|0
6822497|NCT00098787|10825763|FG000|Overall Study|Withdrawal by Subject|4
6822498|NCT00098787|10825764|FG001|Overall Study|Withdrawal by Subject|12
6822499|NCT00098787|10825765|FG002|Overall Study|Withdrawal by Subject|6
6822500|NCT00098787|10825763|FG000|Overall Study|Alternative therapy|8
6822501|NCT00098787|10825764|FG001|Overall Study|Alternative therapy|13
6822502|NCT00098787|10825765|FG002|Overall Study|Alternative therapy|13
6822503|NCT00098787|10825763|FG000|Overall Study|Other|7
6822504|NCT00098787|10825764|FG001|Overall Study|Other|6
6822505|NCT00098787|10825765|FG002|Overall Study|Other|9
6822506|NCT00098813|10825773|FG000|Overall Study|Death|8
6822507|NCT00098813|10825773|FG000|Overall Study|Protocol Violation|1
6822508|NCT00098813|10825773|FG000|Overall Study|Withdrawal by Subject|7
6822509|NCT00098813|10825773|FG000|Overall Study|Progression of Disease|1
6822510|NCT00098813|10825773|FG000|Overall Study|Other complicating disease|1
6822511|NCT00098813|10825773|FG000|Overall Study|Reversal of RAI resistance|1
6822512|NCT00098839|10825779|FG000|Overall Study|Adverse Event|5
6822513|NCT00098839|10825780|FG001|Overall Study|Adverse Event|2
6822514|NCT00098839|10825779|FG000|Overall Study|Death|1
6822515|NCT00098839|10825780|FG001|Overall Study|Death|2
6822516|NCT00098839|10825779|FG000|Overall Study|Physician Decision|4
6822517|NCT00098839|10825780|FG001|Overall Study|Physician Decision|14
6822518|NCT00098839|10825779|FG000|Overall Study|Withdrawal by Subject|1
6822519|NCT00098839|10825780|FG001|Overall Study|Withdrawal by Subject|0
6822520|NCT00098839|10825779|FG000|Overall Study|Refusal of further protocol therapy|3
6822521|NCT00098839|10825780|FG001|Overall Study|Refusal of further protocol therapy|1
6822522|NCT00098839|10825779|FG000|Overall Study|Relapse|6
6822523|NCT00098839|10825780|FG001|Overall Study|Relapse|3
6822524|NCT00098839|10825779|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10
6822525|NCT00098839|10825780|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11
6822526|NCT00098839|10825779|FG000|Overall Study|Ineligible|2
6822527|NCT00098839|10825780|FG001|Overall Study|Ineligible|0
6822528|NCT00098865|10825787|FG000|Overall Study|Progressive Disease|6
6822529|NCT00098865|10825787|FG000|Overall Study|Adverse Event|2
6822530|NCT00098865|10825787|FG000|Overall Study|Alternative Therapy|1
6822531|NCT00099268|10825810|FG000|Overall Study|Withdrawal by Subject|46
6822532|NCT00099268|10825811|FG001|Overall Study|Withdrawal by Subject|28
6822533|NCT00099268|10825810|FG000|Overall Study|Adverse Event|19
6822534|NCT00099268|10825811|FG001|Overall Study|Adverse Event|19
6822535|NCT00099268|10825810|FG000|Overall Study|Protocol Violation|9
6822536|NCT00099268|10825811|FG001|Overall Study|Protocol Violation|8
6822537|NCT00099268|10825810|FG000|Overall Study|Lost to Follow-up|6
6822538|NCT00099268|10825811|FG001|Overall Study|Lost to Follow-up|4
6822539|NCT00099268|10825810|FG000|Overall Study|Lack of Efficacy|5
6822540|NCT00099268|10825811|FG001|Overall Study|Lack of Efficacy|18
6822541|NCT00099268|10825810|FG000|Overall Study|Administrative problems|4
6822542|NCT00099268|10825811|FG001|Overall Study|Administrative problems|4
6822543|NCT00099268|10825810|FG000|Overall Study|Death|3
6822544|NCT00099268|10825811|FG001|Overall Study|Death|1
6822545|NCT00099359|10825820|FG000|Overall Study|Death|11
6822546|NCT00099359|10825821|FG001|Overall Study|Death|15
6822547|NCT00099359|10825822|FG002|Overall Study|Death|17
6822548|NCT00099359|10825820|FG000|Overall Study|Withdrawal by Subject|19
6822549|NCT00099359|10825821|FG001|Overall Study|Withdrawal by Subject|19
6822550|NCT00099359|10825822|FG002|Overall Study|Withdrawal by Subject|23
6822551|NCT00099359|10825820|FG000|Overall Study|Lost to Follow-up|15
6822552|NCT00099359|10825821|FG001|Overall Study|Lost to Follow-up|24
6822553|NCT00099359|10825822|FG002|Overall Study|Lost to Follow-up|24
6822554|NCT00099359|10825820|FG000|Overall Study|moved out of area|9
6822555|NCT00099359|10825821|FG001|Overall Study|moved out of area|7
6822556|NCT00099359|10825822|FG002|Overall Study|moved out of area|4
6896674|NCT00634751|10915228|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1
6896675|NCT00634751|10915229|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0
6896676|NCT00634751|10915230|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0
6896677|NCT00634751|10915227|FG000|Pancreatic and Bilial Tract Cancer|Death|0
6896678|NCT00634751|10915228|FG001|Pancreatic and Bilial Tract Cancer|Death|0
6896679|NCT00634751|10915229|FG002|Pancreatic and Bilial Tract Cancer|Death|1
6896680|NCT00634751|10915230|FG003|Pancreatic and Bilial Tract Cancer|Death|1
6896681|NCT00634803|10915243|FG000|Overall Study|Lost to Follow-up|6
6896682|NCT00634803|10915244|FG001|Overall Study|Lost to Follow-up|7
6896683|NCT00634803|10915245|FG002|Overall Study|Lost to Follow-up|7
6896684|NCT00634842|10915255|FG000|Overall Study|Adverse Event|2
6896685|NCT00634842|10915256|FG001|Overall Study|Adverse Event|3
6896686|NCT00634842|10915255|FG000|Overall Study|Protocol Violation|8
6896687|NCT00634842|10915256|FG001|Overall Study|Protocol Violation|4
6896688|NCT00634842|10915255|FG000|Overall Study|Move to another state|1
6896689|NCT00634842|10915256|FG001|Overall Study|Move to another state|0
6896690|NCT00634842|10915255|FG000|Overall Study|Inclusion criteria were not met|1
6896691|NCT00634842|10915256|FG001|Overall Study|Inclusion criteria were not met|0
6896692|NCT00634842|10915255|FG000|Overall Study|Lost to Follow-up|1
6896693|NCT00634842|10915256|FG001|Overall Study|Lost to Follow-up|2
6896694|NCT00634842|10915255|FG000|Overall Study|Physician Decision|1
6896695|NCT00634842|10915256|FG001|Overall Study|Physician Decision|0
6896696|NCT00634842|10915255|FG000|Overall Study|Withdrawal by Subject|1
6896697|NCT00634842|10915256|FG001|Overall Study|Withdrawal by Subject|3
6896698|NCT00634842|10915255|FG000|Overall Study|Lack of time and intolerance to drug|0
6896699|NCT00634842|10915256|FG001|Overall Study|Lack of time and intolerance to drug|1
6896700|NCT00634842|10915255|FG000|Overall Study|Discontinued due to injection|0
6896701|NCT00634842|10915256|FG001|Overall Study|Discontinued due to injection|2
6896702|NCT00634842|10915255|FG000|Overall Study|No need of study drug to treat diabetes|0
6896703|NCT00634842|10915256|FG001|Overall Study|No need of study drug to treat diabetes|1
6896704|NCT00634842|10915255|FG000|Overall Study|No wish to keep taking Avandia|0
6896705|NCT00634842|10915256|FG001|Overall Study|No wish to keep taking Avandia|1
6896706|NCT00634842|10915255|FG000|Overall Study|Subject off study drug for too long|0
6896707|NCT00634842|10915256|FG001|Overall Study|Subject off study drug for too long|1
6896708|NCT00634907|10915264|FG000|Overall Study|Withdrawal by Subject|3
6896709|NCT00634907|10915265|FG001|Overall Study|Withdrawal by Subject|0
6896710|NCT00634907|10915264|FG000|Overall Study|Physician Decision|3
6896711|NCT00634907|10915265|FG001|Overall Study|Physician Decision|9
6896712|NCT00634907|10915264|FG000|Overall Study|Withdrawal by Subject|11
6896713|NCT00634907|10915265|FG001|Overall Study|Withdrawal by Subject|8
6896714|NCT00634920|10915274|FG000|Period 1 - Pre-Randomization|Adverse Event|0
6896715|NCT00634920|10915275|FG001|Period 1 - Pre-Randomization|Adverse Event|0
6896716|NCT00634920|10915276|FG002|Period 1 - Pre-Randomization|Adverse Event|36
6896717|NCT00634920|10915274|FG000|Period 1 - Pre-Randomization|Wound healing problems|0
6896718|NCT00634920|10915275|FG001|Period 1 - Pre-Randomization|Wound healing problems|0
6896719|NCT00634920|10915276|FG002|Period 1 - Pre-Randomization|Wound healing problems|16
6896720|NCT00634920|10915274|FG000|Period 1 - Pre-Randomization|Rejections|0
6896721|NCT00634920|10915275|FG001|Period 1 - Pre-Randomization|Rejections|0
6896722|NCT00634920|10915276|FG002|Period 1 - Pre-Randomization|Rejections|55
6896723|NCT00634920|10915274|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0
6896724|NCT00634920|10915275|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0
6896725|NCT00634920|10915276|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21
6896726|NCT00634920|10915274|FG000|Period 1 - Pre-Randomization|Non-Compliance|0
6896727|NCT00634920|10915275|FG001|Period 1 - Pre-Randomization|Non-Compliance|0
6896728|NCT00634920|10915276|FG002|Period 1 - Pre-Randomization|Non-Compliance|3
6896729|NCT00634920|10915274|FG000|Period 1 - Pre-Randomization|Other issues|0
6896730|NCT00634920|10915275|FG001|Period 1 - Pre-Randomization|Other issues|0
6896731|NCT00634920|10915276|FG002|Period 1 - Pre-Randomization|Other issues|6
6896732|NCT00634920|10915274|FG000|Period 2 - Post-Randomization|Adverse Event|37
6896733|NCT00634920|10915275|FG001|Period 2 - Post-Randomization|Adverse Event|9
6896734|NCT00634920|10915276|FG002|Period 2 - Post-Randomization|Adverse Event|0
6896735|NCT00634920|10915274|FG000|Period 2 - Post-Randomization|Rejection|11
6896736|NCT00634920|10915275|FG001|Period 2 - Post-Randomization|Rejection|5
6896737|NCT00634920|10915276|FG002|Period 2 - Post-Randomization|Rejection|0
6896738|NCT00634920|10915274|FG000|Period 2 - Post-Randomization|Death|2
6822557|NCT00099632|10825857|FG000|Overall Study|Lost to Follow-up|1
6822558|NCT00099632|10825858|FG001|Overall Study|Lost to Follow-up|0
6822559|NCT00099632|10825859|FG002|Overall Study|Lost to Follow-up|3
6822560|NCT00099632|10825860|FG003|Overall Study|Lost to Follow-up|1
6822561|NCT00099632|10825861|FG004|Overall Study|Lost to Follow-up|1
6822562|NCT00099632|10825862|FG005|Overall Study|Lost to Follow-up|0
6822563|NCT00099632|10825857|FG000|Overall Study|Withdrawal by Subject|0
6822564|NCT00099632|10825858|FG001|Overall Study|Withdrawal by Subject|1
6822565|NCT00099632|10825859|FG002|Overall Study|Withdrawal by Subject|0
6822566|NCT00099632|10825860|FG003|Overall Study|Withdrawal by Subject|0
6822567|NCT00099632|10825861|FG004|Overall Study|Withdrawal by Subject|0
6822568|NCT00099632|10825862|FG005|Overall Study|Withdrawal by Subject|1
6822569|NCT00099632|10825857|FG000|Overall Study|Protocol Violation|0
6822570|NCT00099632|10825858|FG001|Overall Study|Protocol Violation|0
6822571|NCT00099632|10825859|FG002|Overall Study|Protocol Violation|0
6822572|NCT00099632|10825860|FG003|Overall Study|Protocol Violation|0
6822573|NCT00099632|10825861|FG004|Overall Study|Protocol Violation|0
6822574|NCT00099632|10825862|FG005|Overall Study|Protocol Violation|1
6822575|NCT00099983|10825878|FG000|Overall Study|Lost to Follow-up|2
6822576|NCT00099983|10825879|FG001|Overall Study|Lost to Follow-up|3
6822577|NCT00099983|10825878|FG000|Overall Study|Missing Source Documents|14
6822578|NCT00099983|10825879|FG001|Overall Study|Missing Source Documents|15
6822579|NCT00099983|10825878|FG000|Overall Study|Withdrawal by Subject|3
6822580|NCT00099983|10825879|FG001|Overall Study|Withdrawal by Subject|2
6822581|NCT00099983|10825878|FG000|Overall Study|Adverse Event|1
6822582|NCT00099983|10825879|FG001|Overall Study|Adverse Event|1
6822583|NCT00099983|10825878|FG000|Overall Study|Lack of Efficacy|0
6822584|NCT00099983|10825879|FG001|Overall Study|Lack of Efficacy|1
6822585|NCT00099983|10825878|FG000|Overall Study|Unable to return for appointments|1
6822586|NCT00099983|10825879|FG001|Overall Study|Unable to return for appointments|1
6822587|NCT00099983|10825878|FG000|Overall Study|Moved|1
6822588|NCT00099983|10825879|FG001|Overall Study|Moved|0
6822589|NCT00099983|10825878|FG000|Overall Study|Other psychiatric problem|1
6822590|NCT00099983|10825879|FG001|Overall Study|Other psychiatric problem|0
6822591|NCT00099983|10825878|FG000|Overall Study|Incarcerated|0
6822592|NCT00099983|10825879|FG001|Overall Study|Incarcerated|1
6822593|NCT00099983|10825878|FG000|Overall Study|Intolerant of burden of visits|0
6822594|NCT00099983|10825879|FG001|Overall Study|Intolerant of burden of visits|1
6822595|NCT00099983|10825878|FG000|Overall Study|Other issue|1
6822596|NCT00099983|10825879|FG001|Overall Study|Other issue|0
6822597|NCT00100048|10825890|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2
6822598|NCT00100048|10825891|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0
6822599|NCT00100048|10825892|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0
6822600|NCT00100048|10825893|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0
6822601|NCT00100048|10825894|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0
6822602|NCT00100048|10825895|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1
6822603|NCT00100048|10825890|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0
6822604|NCT00100048|10825891|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1
6822605|NCT00100048|10825892|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2
6822606|NCT00100048|10825893|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0
6822607|NCT00100048|10825894|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0
6822608|NCT00100048|10825895|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1
6822609|NCT00100048|10825890|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1
6822610|NCT00100048|10825891|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3
6822611|NCT00100048|10825892|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
6822612|NCT00100048|10825893|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
6822613|NCT00100048|10825894|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
6822614|NCT00100048|10825895|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2
6822615|NCT00100048|10825890|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
6822616|NCT00100048|10825891|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1
6822617|NCT00100048|10825892|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
6822618|NCT00100048|10825893|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
6822619|NCT00100048|10825894|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0
6822620|NCT00100048|10825895|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
6822621|NCT00100048|10825890|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1
6822622|NCT00100048|10825891|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
6822623|NCT00100048|10825892|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
6822624|NCT00100048|10825893|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5
6822625|NCT00100048|10825894|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0
6822626|NCT00100048|10825895|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4
6822627|NCT00100048|10825890|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7
6822628|NCT00100048|10825891|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1
6822629|NCT00100048|10825892|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4
6822630|NCT00100048|10825893|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2
6822631|NCT00100048|10825894|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0
6822632|NCT00100048|10825895|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0
6896739|NCT00634920|10915275|FG001|Period 2 - Post-Randomization|Death|5
6822633|NCT00100048|10825890|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
6822634|NCT00100048|10825891|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
6822635|NCT00100048|10825892|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
6822636|NCT00100048|10825893|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
6822637|NCT00100048|10825894|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
6822638|NCT00100048|10825895|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
6822639|NCT00100048|10825890|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
6822640|NCT00100048|10825891|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
6822641|NCT00100048|10825892|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
6822642|NCT00100048|10825893|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1
6822643|NCT00100048|10825894|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
6822644|NCT00100048|10825895|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
6822645|NCT00100178|10825939|FG000|Overall Study|Lost to Follow-up|0
6822646|NCT00100178|10825940|FG001|Overall Study|Lost to Follow-up|6
6822647|NCT00100178|10825941|FG002|Overall Study|Lost to Follow-up|5
6822648|NCT00100178|10825939|FG000|Overall Study|Adverse Event|2
6822649|NCT00100178|10825940|FG001|Overall Study|Adverse Event|2
6822650|NCT00100178|10825941|FG002|Overall Study|Adverse Event|1
6822651|NCT00100178|10825939|FG000|Overall Study|Withdrawal by Subject|1
6822652|NCT00100178|10825940|FG001|Overall Study|Withdrawal by Subject|1
6822653|NCT00100178|10825941|FG002|Overall Study|Withdrawal by Subject|1
6822654|NCT00100178|10825939|FG000|Overall Study|Physician Decision|6
6822655|NCT00100178|10825940|FG001|Overall Study|Physician Decision|1
6822656|NCT00100178|10825941|FG002|Overall Study|Physician Decision|3
6822657|NCT00100789|10825980|FG000|Overall Study|Adverse Event|10
6822658|NCT00100789|10825980|FG000|Overall Study|Withdrawal by Subject|1
6822659|NCT00100789|10825980|FG000|Overall Study|Progression/relapse|42
6822660|NCT00100789|10825980|FG000|Overall Study|Death|2
6900803|NCT00667602|10921170|FG002|Overall Study|Withdrawal by Subject|10
6900804|NCT00667602|10921168|FG000|Overall Study|Lost to Follow-up|4
6900805|NCT00667602|10921169|FG001|Overall Study|Lost to Follow-up|5
6900806|NCT00667602|10921170|FG002|Overall Study|Lost to Follow-up|6
6900807|NCT00667602|10921168|FG000|Overall Study|Administrative reason|0
6900808|NCT00667602|10921169|FG001|Overall Study|Administrative reason|0
6900809|NCT00667602|10921170|FG002|Overall Study|Administrative reason|2
6900810|NCT00667602|10921168|FG000|Overall Study|Protocol Violation|0
6900811|NCT00667602|10921169|FG001|Overall Study|Protocol Violation|1
6900812|NCT00667602|10921170|FG002|Overall Study|Protocol Violation|0
6900813|NCT00667719|10921196|FG000|Overall Study|Adverse Event|39
6900814|NCT00667719|10921196|FG000|Overall Study|Abnormal Test Procedure|1
6900815|NCT00667719|10921196|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3
6900816|NCT00667719|10921196|FG000|Overall Study|Protocol Violation|3
6900817|NCT00667719|10921196|FG000|Overall Study|Withdrawal by Subject|17
6900818|NCT00667719|10921196|FG000|Overall Study|Lost to Follow-up|8
6900819|NCT00667732|10921207|FG000|Run -In (8 Weeks)|Adverse Event|4
6900820|NCT00667732|10921208|FG001|Run -In (8 Weeks)|Adverse Event|0
6900821|NCT00667732|10921209|FG002|Run -In (8 Weeks)|Adverse Event|0
6900822|NCT00667732|10921207|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3
6900823|NCT00667732|10921208|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0
6900824|NCT00667732|10921209|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0
6900825|NCT00667732|10921207|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0
6900826|NCT00667732|10921208|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1
6900827|NCT00667732|10921209|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0
6900828|NCT00667810|10921233|FG000|Overall Study|Adverse Event|13
6900829|NCT00667810|10921234|FG001|Overall Study|Adverse Event|14
6900830|NCT00667810|10921235|FG002|Overall Study|Adverse Event|19
6900831|NCT00667810|10921236|FG003|Overall Study|Adverse Event|1
6900832|NCT00667810|10921233|FG000|Overall Study|Death|1
6900833|NCT00667810|10921234|FG001|Overall Study|Death|1
6900834|NCT00667810|10921235|FG002|Overall Study|Death|3
6900835|NCT00667810|10921236|FG003|Overall Study|Death|0
6900836|NCT00667810|10921233|FG000|Overall Study|Lack of Efficacy|1
6900837|NCT00667810|10921234|FG001|Overall Study|Lack of Efficacy|0
6900838|NCT00667810|10921235|FG002|Overall Study|Lack of Efficacy|2
6900839|NCT00667810|10921236|FG003|Overall Study|Lack of Efficacy|0
6900840|NCT00667810|10921233|FG000|Overall Study|Lost to Follow-up|1
6900841|NCT00667810|10921234|FG001|Overall Study|Lost to Follow-up|4
6900842|NCT00667810|10921235|FG002|Overall Study|Lost to Follow-up|2
6900843|NCT00667810|10921236|FG003|Overall Study|Lost to Follow-up|0
6900844|NCT00667810|10921233|FG000|Overall Study|Physician Decision|1
6900845|NCT00667810|10921234|FG001|Overall Study|Physician Decision|1
6900846|NCT00667810|10921235|FG002|Overall Study|Physician Decision|2
6900847|NCT00667810|10921236|FG003|Overall Study|Physician Decision|0
6900848|NCT00667810|10921233|FG000|Overall Study|Protocol Violation|0
6900849|NCT00667810|10921234|FG001|Overall Study|Protocol Violation|2
6900850|NCT00667810|10921235|FG002|Overall Study|Protocol Violation|0
6900851|NCT00667810|10921236|FG003|Overall Study|Protocol Violation|0
6900852|NCT00667810|10921233|FG000|Overall Study|Withdrawal by Subject|14
6900853|NCT00667810|10921234|FG001|Overall Study|Withdrawal by Subject|20
6900854|NCT00667810|10921235|FG002|Overall Study|Withdrawal by Subject|29
6900855|NCT00667810|10921236|FG003|Overall Study|Withdrawal by Subject|1
6822661|NCT00100789|10825980|FG000|Overall Study|Not protocol specified|5
6822662|NCT00100789|10825980|FG000|Overall Study|Ineligible|3
6822663|NCT00100789|10825980|FG000|Overall Study|Never received treatment|1
6822664|NCT00100802|10825985|FG000|Overall Study|Adverse Event|9
6822665|NCT00100802|10825985|FG000|Overall Study|Death|1
6822666|NCT00100802|10825985|FG000|Overall Study|Lack of Efficacy|47
6822667|NCT00100802|10825985|FG000|Overall Study|Physician Decision|5
6822668|NCT00100802|10825985|FG000|Overall Study|Protocol Violation|1
6822669|NCT00100802|10825985|FG000|Overall Study|Withdrawal by Subject|5
6822670|NCT00100802|10825985|FG000|Overall Study|Ineligible|12
6822671|NCT00100815|10825989|FG000|Overall Study|Progression|24
6822672|NCT00100815|10825989|FG000|Overall Study|Adverse Event|18
6822673|NCT00100815|10825989|FG000|Overall Study|Death|4
6822674|NCT00100815|10825989|FG000|Overall Study|Other|3
6822675|NCT00100932|10825999|FG000|Overall Study|Adverse Event|11
6822676|NCT00100932|10826000|FG001|Overall Study|Adverse Event|2
6822677|NCT00100932|10825999|FG000|Overall Study|Withdrawal by Subject|6
6822678|NCT00100932|10826000|FG001|Overall Study|Withdrawal by Subject|0
6822679|NCT00100932|10825999|FG000|Overall Study|Progressive Disease|44
6822680|NCT00100932|10826000|FG001|Overall Study|Progressive Disease|18
6822681|NCT00100932|10825999|FG000|Overall Study|Physician Decision|7
6822682|NCT00100932|10826000|FG001|Overall Study|Physician Decision|5
6822683|NCT00100932|10825999|FG000|Overall Study|Other|5
6822684|NCT00100932|10826000|FG001|Overall Study|Other|2
6822685|NCT00101010|10826006|FG000|Overall Study|Physician Decision|1
6822686|NCT00101101|10826019|FG000|Overall Study|never received vaccine|20
6822687|NCT00101166|10826023|FG000|Overall Study|progressive disease|10
6822688|NCT00101192|10826027|FG000|Overall Study|Ineligible|6
6822689|NCT00101192|10826027|FG000|Overall Study|Inevaluable|1
6822690|NCT00101283|10826033|FG000|Overall Study|Withdrawal by Subject|0
6822691|NCT00101283|10826034|FG001|Overall Study|Withdrawal by Subject|1
6822692|NCT00101283|10826033|FG000|Overall Study|Insurance Refusal|0
6822693|NCT00101283|10826034|FG001|Overall Study|Insurance Refusal|1
6822694|NCT00101283|10826033|FG000|Overall Study|Prostate Cancer Recurrence|0
6822695|NCT00101283|10826034|FG001|Overall Study|Prostate Cancer Recurrence|1
6822696|NCT00101400|10826049|FG000|Survival Follow-Up|Alive|7
6822697|NCT00101452|10826060|FG000|Overall Study|Adverse Event|2
6822698|NCT00101452|10826061|FG001|Overall Study|Adverse Event|0
6822699|NCT00101452|10826062|FG002|Overall Study|Adverse Event|1
6822700|NCT00101452|10826060|FG000|Overall Study|Lost to Follow-up|13
6822701|NCT00101452|10826061|FG001|Overall Study|Lost to Follow-up|8
6822702|NCT00101452|10826062|FG002|Overall Study|Lost to Follow-up|14
6822703|NCT00101452|10826060|FG000|Overall Study|Withdrawal by Subject|10
6822704|NCT00101452|10826061|FG001|Overall Study|Withdrawal by Subject|14
6822705|NCT00101452|10826062|FG002|Overall Study|Withdrawal by Subject|9
6822706|NCT00101452|10826060|FG000|Overall Study|Baseline Fail|2
6822707|NCT00101452|10826061|FG001|Overall Study|Baseline Fail|1
6822708|NCT00101452|10826062|FG002|Overall Study|Baseline Fail|2
6822709|NCT00101452|10826060|FG000|Overall Study|Physician Decision|0
6822710|NCT00101452|10826061|FG001|Overall Study|Physician Decision|3
6822711|NCT00101452|10826062|FG002|Overall Study|Physician Decision|2
6822712|NCT00101452|10826060|FG000|Overall Study|Protocol Violation|2
6822713|NCT00101452|10826061|FG001|Overall Study|Protocol Violation|1
6822714|NCT00101452|10826062|FG002|Overall Study|Protocol Violation|3
6822715|NCT00101452|10826060|FG000|Overall Study|Other|15
6822716|NCT00101452|10826061|FG001|Overall Study|Other|16
6822717|NCT00101452|10826062|FG002|Overall Study|Other|12
6822718|NCT00101582|10826076|FG000|Overall Study|Ineligibility determined|0
6822719|NCT00101582|10826077|FG001|Overall Study|Ineligibility determined|1
6822720|NCT00101582|10826076|FG000|Overall Study|Adverse Event|1
6822721|NCT00101582|10826077|FG001|Overall Study|Adverse Event|4
6822722|NCT00101582|10826076|FG000|Overall Study|Withdrawal by Subject|6
6822723|NCT00101582|10826077|FG001|Overall Study|Withdrawal by Subject|4
6822724|NCT00101582|10826076|FG000|Overall Study|Physician Decision|1
6822725|NCT00101582|10826077|FG001|Overall Study|Physician Decision|0
6822726|NCT00101582|10826076|FG000|Overall Study|Death|3
6822727|NCT00101582|10826077|FG001|Overall Study|Death|5
6822728|NCT00101582|10826076|FG000|Overall Study|Other|0
6822729|NCT00101582|10826077|FG001|Overall Study|Other|1
6822730|NCT00101686|10826127|FG000|Overall Study|Progressive Disease|37
6822731|NCT00101686|10826128|FG001|Overall Study|Progressive Disease|28
6822732|NCT00101686|10826129|FG002|Overall Study|Progressive Disease|37
6822733|NCT00101686|10826130|FG003|Overall Study|Progressive Disease|38
6822734|NCT00101686|10826131|FG004|Overall Study|Progressive Disease|28
6822735|NCT00101686|10826132|FG005|Overall Study|Progressive Disease|25
6822736|NCT00101686|10826133|FG006|Overall Study|Progressive Disease|5
6822737|NCT00101686|10826134|FG007|Overall Study|Progressive Disease|7
6822738|NCT00101686|10826135|FG008|Overall Study|Progressive Disease|10
6822739|NCT00101686|10826136|FG009|Overall Study|Progressive Disease|8
6822740|NCT00101686|10826127|FG000|Overall Study|initiation other anti-cancer treatment|4
6822741|NCT00101686|10826128|FG001|Overall Study|initiation other anti-cancer treatment|3
6822742|NCT00101686|10826129|FG002|Overall Study|initiation other anti-cancer treatment|4
6822743|NCT00101686|10826130|FG003|Overall Study|initiation other anti-cancer treatment|3
6822744|NCT00101686|10826131|FG004|Overall Study|initiation other anti-cancer treatment|1
6822745|NCT00101686|10826132|FG005|Overall Study|initiation other anti-cancer treatment|1
6822746|NCT00101686|10826133|FG006|Overall Study|initiation other anti-cancer treatment|2
6822747|NCT00101686|10826134|FG007|Overall Study|initiation other anti-cancer treatment|2
6822748|NCT00101686|10826135|FG008|Overall Study|initiation other anti-cancer treatment|3
6822749|NCT00101686|10826136|FG009|Overall Study|initiation other anti-cancer treatment|3
6822750|NCT00101686|10826127|FG000|Overall Study|>3 week delay treatment due toxicity|6
6822751|NCT00101686|10826128|FG001|Overall Study|>3 week delay treatment due toxicity|2
6822752|NCT00101686|10826129|FG002|Overall Study|>3 week delay treatment due toxicity|1
6822753|NCT00101686|10826130|FG003|Overall Study|>3 week delay treatment due toxicity|2
6822754|NCT00101686|10826131|FG004|Overall Study|>3 week delay treatment due toxicity|7
6822755|NCT00101686|10826132|FG005|Overall Study|>3 week delay treatment due toxicity|3
6822756|NCT00101686|10826133|FG006|Overall Study|>3 week delay treatment due toxicity|2
6822757|NCT00101686|10826134|FG007|Overall Study|>3 week delay treatment due toxicity|1
6822758|NCT00101686|10826135|FG008|Overall Study|>3 week delay treatment due toxicity|3
6822759|NCT00101686|10826136|FG009|Overall Study|>3 week delay treatment due toxicity|0
6822760|NCT00101686|10826127|FG000|Overall Study|unacceptable toxicity|3
6822761|NCT00101686|10826128|FG001|Overall Study|unacceptable toxicity|9
6822762|NCT00101686|10826129|FG002|Overall Study|unacceptable toxicity|10
6822763|NCT00101686|10826130|FG003|Overall Study|unacceptable toxicity|6
6822764|NCT00101686|10826131|FG004|Overall Study|unacceptable toxicity|16
6822765|NCT00101686|10826132|FG005|Overall Study|unacceptable toxicity|10
6822766|NCT00101686|10826133|FG006|Overall Study|unacceptable toxicity|4
6822767|NCT00101686|10826134|FG007|Overall Study|unacceptable toxicity|2
6822768|NCT00101686|10826135|FG008|Overall Study|unacceptable toxicity|1
6822769|NCT00101686|10826136|FG009|Overall Study|unacceptable toxicity|4
6822770|NCT00101686|10826127|FG000|Overall Study|Randomized but did not receive treament|1
6822771|NCT00101686|10826128|FG001|Overall Study|Randomized but did not receive treament|6
6822772|NCT00101686|10826129|FG002|Overall Study|Randomized but did not receive treament|2
6822773|NCT00101686|10826130|FG003|Overall Study|Randomized but did not receive treament|2
6822774|NCT00101686|10826131|FG004|Overall Study|Randomized but did not receive treament|2
6822775|NCT00101686|10826132|FG005|Overall Study|Randomized but did not receive treament|2
6822776|NCT00101686|10826133|FG006|Overall Study|Randomized but did not receive treament|0
6822777|NCT00101686|10826134|FG007|Overall Study|Randomized but did not receive treament|1
6822778|NCT00101686|10826135|FG008|Overall Study|Randomized but did not receive treament|0
6822779|NCT00101686|10826136|FG009|Overall Study|Randomized but did not receive treament|1
6822780|NCT00101686|10826127|FG000|Overall Study|intercurrent non-cancer related illness|0
6822781|NCT00101686|10826128|FG001|Overall Study|intercurrent non-cancer related illness|0
6822782|NCT00101686|10826129|FG002|Overall Study|intercurrent non-cancer related illness|2
6822783|NCT00101686|10826130|FG003|Overall Study|intercurrent non-cancer related illness|0
6822784|NCT00101686|10826131|FG004|Overall Study|intercurrent non-cancer related illness|1
6822785|NCT00101686|10826132|FG005|Overall Study|intercurrent non-cancer related illness|3
6822786|NCT00101686|10826133|FG006|Overall Study|intercurrent non-cancer related illness|1
6822787|NCT00101686|10826134|FG007|Overall Study|intercurrent non-cancer related illness|0
6822788|NCT00101686|10826135|FG008|Overall Study|intercurrent non-cancer related illness|1
6822789|NCT00101686|10826136|FG009|Overall Study|intercurrent non-cancer related illness|1
6822790|NCT00101686|10826127|FG000|Overall Study|Physician Decision|10
6822791|NCT00101686|10826128|FG001|Overall Study|Physician Decision|13
6822792|NCT00101686|10826129|FG002|Overall Study|Physician Decision|6
6822793|NCT00101686|10826130|FG003|Overall Study|Physician Decision|7
6822794|NCT00101686|10826131|FG004|Overall Study|Physician Decision|8
6822795|NCT00101686|10826132|FG005|Overall Study|Physician Decision|9
6822796|NCT00101686|10826133|FG006|Overall Study|Physician Decision|5
6822797|NCT00101686|10826134|FG007|Overall Study|Physician Decision|5
6822798|NCT00101686|10826135|FG008|Overall Study|Physician Decision|1
6822799|NCT00101686|10826136|FG009|Overall Study|Physician Decision|1
6822800|NCT00101686|10826127|FG000|Overall Study|Other|1
6822801|NCT00101686|10826128|FG001|Overall Study|Other|4
6822802|NCT00101686|10826129|FG002|Overall Study|Other|1
6822803|NCT00101686|10826130|FG003|Overall Study|Other|6
6822804|NCT00101686|10826131|FG004|Overall Study|Other|2
6822805|NCT00101686|10826132|FG005|Overall Study|Other|12
6822806|NCT00101686|10826133|FG006|Overall Study|Other|1
6822807|NCT00101686|10826134|FG007|Overall Study|Other|5
6822808|NCT00101686|10826135|FG008|Overall Study|Other|3
6822809|NCT00101686|10826136|FG009|Overall Study|Other|3
6822810|NCT00101686|10826127|FG000|Overall Study|Withdrawal by Subject|9
6822811|NCT00101686|10826128|FG001|Overall Study|Withdrawal by Subject|8
6822812|NCT00101686|10826129|FG002|Overall Study|Withdrawal by Subject|6
6822813|NCT00101686|10826130|FG003|Overall Study|Withdrawal by Subject|8
6822814|NCT00101686|10826131|FG004|Overall Study|Withdrawal by Subject|8
6822815|NCT00101686|10826132|FG005|Overall Study|Withdrawal by Subject|7
6822816|NCT00101686|10826133|FG006|Overall Study|Withdrawal by Subject|7
6822817|NCT00101686|10826134|FG007|Overall Study|Withdrawal by Subject|7
6822818|NCT00101686|10826135|FG008|Overall Study|Withdrawal by Subject|8
6822819|NCT00101686|10826136|FG009|Overall Study|Withdrawal by Subject|9
6822820|NCT00101868|10826172|FG000|Overall Study|Death|10
6822821|NCT00101868|10826173|FG001|Overall Study|Death|10
6822822|NCT00101868|10826172|FG000|Overall Study|Withdrawal by Subject|8
6822823|NCT00101868|10826173|FG001|Overall Study|Withdrawal by Subject|9
6822824|NCT00101868|10826172|FG000|Overall Study|Protocol Violation|3
6822825|NCT00101868|10826173|FG001|Overall Study|Protocol Violation|0
6822826|NCT00101868|10826172|FG000|Overall Study|Lost to Follow-up|8
6822827|NCT00101868|10826173|FG001|Overall Study|Lost to Follow-up|13
6822828|NCT00101907|10826187|FG000|Overall Study|Adverse Event|1
6822829|NCT00101907|10826188|FG001|Overall Study|Adverse Event|0
6822830|NCT00101907|10826189|FG002|Overall Study|Adverse Event|0
6822831|NCT00101907|10826190|FG003|Overall Study|Adverse Event|0
6822832|NCT00101907|10826191|FG004|Overall Study|Adverse Event|0
6822833|NCT00101907|10826192|FG005|Overall Study|Adverse Event|0
6822834|NCT00101907|10826187|FG000|Overall Study|Death|0
6822835|NCT00101907|10826188|FG001|Overall Study|Death|1
6822836|NCT00101907|10826189|FG002|Overall Study|Death|0
6822837|NCT00101907|10826190|FG003|Overall Study|Death|0
6822838|NCT00101907|10826191|FG004|Overall Study|Death|3
6822839|NCT00101907|10826192|FG005|Overall Study|Death|0
6822840|NCT00101907|10826187|FG000|Overall Study|Physician Decision|0
6822841|NCT00101907|10826188|FG001|Overall Study|Physician Decision|0
6822842|NCT00101907|10826189|FG002|Overall Study|Physician Decision|0
6822843|NCT00101907|10826190|FG003|Overall Study|Physician Decision|1
6822844|NCT00101907|10826191|FG004|Overall Study|Physician Decision|1
6822845|NCT00101907|10826192|FG005|Overall Study|Physician Decision|0
6822846|NCT00101907|10826187|FG000|Overall Study|Withdrawal by Subject|1
6822847|NCT00101907|10826188|FG001|Overall Study|Withdrawal by Subject|0
6822848|NCT00101907|10826189|FG002|Overall Study|Withdrawal by Subject|1
6822849|NCT00101907|10826190|FG003|Overall Study|Withdrawal by Subject|0
6822850|NCT00101907|10826191|FG004|Overall Study|Withdrawal by Subject|1
6822851|NCT00101907|10826192|FG005|Overall Study|Withdrawal by Subject|0
6822852|NCT00102063|10826226|FG000|Overall Study|Lack of Efficacy|5
6822853|NCT00102063|10826227|FG001|Overall Study|Lack of Efficacy|1
6822854|NCT00102063|10826228|FG002|Overall Study|Lack of Efficacy|1
6822855|NCT00102063|10826226|FG000|Overall Study|Adverse Event|7
6822856|NCT00102063|10826227|FG001|Overall Study|Adverse Event|4
6822857|NCT00102063|10826228|FG002|Overall Study|Adverse Event|2
6822858|NCT00102063|10826226|FG000|Overall Study|Withdrawal by Subject|4
6822859|NCT00102063|10826227|FG001|Overall Study|Withdrawal by Subject|12
6822860|NCT00102063|10826228|FG002|Overall Study|Withdrawal by Subject|5
6822861|NCT00102063|10826226|FG000|Overall Study|Lost to Follow-up|0
6822862|NCT00102063|10826227|FG001|Overall Study|Lost to Follow-up|0
6822863|NCT00102063|10826228|FG002|Overall Study|Lost to Follow-up|1
6822864|NCT00102063|10826226|FG000|Overall Study|Protocol Violation|0
6822865|NCT00102063|10826227|FG001|Overall Study|Protocol Violation|1
6822866|NCT00102063|10826228|FG002|Overall Study|Protocol Violation|1
6822867|NCT00102440|10826239|FG000|Overall Study|Lost to Follow-up|25
6822868|NCT00102440|10826240|FG001|Overall Study|Lost to Follow-up|18
6822869|NCT00102440|10826241|FG002|Overall Study|Lost to Follow-up|21
6822870|NCT00102440|10826239|FG000|Overall Study|Adverse Event|16
6822871|NCT00102440|10826240|FG001|Overall Study|Adverse Event|23
6822872|NCT00102440|10826241|FG002|Overall Study|Adverse Event|8
6822873|NCT00102440|10826239|FG000|Overall Study|Gout Flare|10
6822874|NCT00102440|10826240|FG001|Overall Study|Gout Flare|28
6822875|NCT00102440|10826241|FG002|Overall Study|Gout Flare|9
6822876|NCT00102440|10826239|FG000|Overall Study|Personal Reason(s)|19
6822877|NCT00102440|10826240|FG001|Overall Study|Personal Reason(s)|13
6822878|NCT00102440|10826241|FG002|Overall Study|Personal Reason(s)|13
6822879|NCT00102440|10826239|FG000|Overall Study|Other|11
6822880|NCT00102440|10826240|FG001|Overall Study|Other|14
6822881|NCT00102440|10826241|FG002|Overall Study|Other|14
6900856|NCT00667810|10921233|FG000|Overall Study|Discontinuation of Study by Sponsor|130
6900857|NCT00667810|10921234|FG001|Overall Study|Discontinuation of Study by Sponsor|118
6900858|NCT00667810|10921235|FG002|Overall Study|Discontinuation of Study by Sponsor|155
6900859|NCT00667810|10921236|FG003|Overall Study|Discontinuation of Study by Sponsor|0
6900860|NCT00667810|10921233|FG000|Overall Study|Failed to Return|0
6900861|NCT00667810|10921234|FG001|Overall Study|Failed to Return|0
6900862|NCT00667810|10921235|FG002|Overall Study|Failed to Return|2
6900863|NCT00667810|10921236|FG003|Overall Study|Failed to Return|0
6900864|NCT00667810|10921233|FG000|Overall Study|Loss of Caregiver|0
6900865|NCT00667810|10921234|FG001|Overall Study|Loss of Caregiver|1
6900866|NCT00667810|10921235|FG002|Overall Study|Loss of Caregiver|3
6900867|NCT00667810|10921236|FG003|Overall Study|Loss of Caregiver|0
6900868|NCT00667810|10921233|FG000|Overall Study|Vasogenic Edema Recurrence|0
6900869|NCT00667810|10921234|FG001|Overall Study|Vasogenic Edema Recurrence|3
6900870|NCT00667810|10921235|FG002|Overall Study|Vasogenic Edema Recurrence|0
6900871|NCT00667810|10921236|FG003|Overall Study|Vasogenic Edema Recurrence|0
6900872|NCT00667810|10921233|FG000|Overall Study|Other|6
6900873|NCT00667810|10921234|FG001|Overall Study|Other|6
6900874|NCT00667810|10921235|FG002|Overall Study|Other|5
6900875|NCT00667810|10921236|FG003|Overall Study|Other|0
6900876|NCT00667862|10921263|FG000|Overall Study|Adverse Event|9
6900877|NCT00667862|10921263|FG000|Overall Study|Death|1
6900878|NCT00667862|10921263|FG000|Overall Study|Disease Progression|22
6900879|NCT00667862|10921263|FG000|Overall Study|Withdrawal by Subject|3
6900880|NCT00667875|10921270|FG000|Overall Study|Adverse Event|0
6900881|NCT00667875|10921271|FG001|Overall Study|Adverse Event|2
6822882|NCT00102440|10826239|FG000|Overall Study|Protocol Violation|7
6822883|NCT00102440|10826240|FG001|Overall Study|Protocol Violation|2
6822884|NCT00102440|10826241|FG002|Overall Study|Protocol Violation|1
6900882|NCT00667875|10921272|FG002|Overall Study|Adverse Event|6
6900883|NCT00667875|10921270|FG000|Overall Study|Withdrawal by Subject|10
6822885|NCT00102531|10826255|FG000|Overall Study|Adverse Event|0
6822886|NCT00102531|10826256|FG001|Overall Study|Adverse Event|1
6822887|NCT00102531|10826255|FG000|Overall Study|Disease Progression|5
6822888|NCT00102531|10826256|FG001|Overall Study|Disease Progression|9
6822889|NCT00102531|10826255|FG000|Overall Study|Physician Decision|0
6822890|NCT00102531|10826256|FG001|Overall Study|Physician Decision|1
6822891|NCT00102596|10826262|FG000|Part A|Screen failures|6
6822892|NCT00102596|10826263|FG001|Part A|Screen failures|0
6822893|NCT00102596|10826262|FG000|Part A|Adverse Event|1
6822894|NCT00102596|10826263|FG001|Part A|Adverse Event|0
6822895|NCT00102687|10826273|FG000|Initial Period|Withdrawal by Subject|6
6822896|NCT00102687|10826274|FG001|Initial Period|Withdrawal by Subject|3
6822897|NCT00102687|10826275|FG002|Initial Period|Withdrawal by Subject|5
6822898|NCT00102687|10826276|FG003|Initial Period|Withdrawal by Subject|0
6822899|NCT00102687|10826277|FG004|Initial Period|Withdrawal by Subject|0
6822900|NCT00102687|10826273|FG000|Initial Period|Adverse Event|4
6822901|NCT00102687|10826274|FG001|Initial Period|Adverse Event|7
6822902|NCT00102687|10826275|FG002|Initial Period|Adverse Event|9
6822903|NCT00102687|10826276|FG003|Initial Period|Adverse Event|0
6822904|NCT00102687|10826277|FG004|Initial Period|Adverse Event|0
6822905|NCT00102687|10826273|FG000|Initial Period|Transformation to AML (blast > 30%)|1
6822906|NCT00102687|10826274|FG001|Initial Period|Transformation to AML (blast > 30%)|3
6822907|NCT00102687|10826275|FG002|Initial Period|Transformation to AML (blast > 30%)|0
6822908|NCT00102687|10826276|FG003|Initial Period|Transformation to AML (blast > 30%)|0
6822909|NCT00102687|10826277|FG004|Initial Period|Transformation to AML (blast > 30%)|0
6822910|NCT00102687|10826273|FG000|Initial Period|Protocol Violation|0
6822911|NCT00102687|10826274|FG001|Initial Period|Protocol Violation|0
6822912|NCT00102687|10826275|FG002|Initial Period|Protocol Violation|2
6822913|NCT00102687|10826276|FG003|Initial Period|Protocol Violation|0
6822914|NCT00102687|10826277|FG004|Initial Period|Protocol Violation|0
6822915|NCT00102687|10826273|FG000|Initial Period|Physician Decision|2
6822916|NCT00102687|10826274|FG001|Initial Period|Physician Decision|9
6822917|NCT00102687|10826275|FG002|Initial Period|Physician Decision|6
6822918|NCT00102687|10826276|FG003|Initial Period|Physician Decision|0
6822919|NCT00102687|10826277|FG004|Initial Period|Physician Decision|0
6822920|NCT00102687|10826273|FG000|Initial Period|Sponsor's decision|0
6822921|NCT00102687|10826274|FG001|Initial Period|Sponsor's decision|1
6822922|NCT00102687|10826275|FG002|Initial Period|Sponsor's decision|1
6822923|NCT00102687|10826276|FG003|Initial Period|Sponsor's decision|0
6822924|NCT00102687|10826277|FG004|Initial Period|Sponsor's decision|0
6822925|NCT00102687|10826273|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4
6822926|NCT00102687|10826274|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4
6822927|NCT00102687|10826275|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2
6822928|NCT00102687|10826276|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0
6822929|NCT00102687|10826277|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0
6822930|NCT00102687|10826273|FG000|Initial Period|Death|1
6822931|NCT00102687|10826274|FG001|Initial Period|Death|1
6822932|NCT00102687|10826275|FG002|Initial Period|Death|1
6822933|NCT00102687|10826276|FG003|Initial Period|Death|0
6822934|NCT00102687|10826277|FG004|Initial Period|Death|0
6822935|NCT00102687|10826273|FG000|Maintenance Period|Withdrawal by Subject|4
6822936|NCT00102687|10826274|FG001|Maintenance Period|Withdrawal by Subject|0
6822937|NCT00102687|10826275|FG002|Maintenance Period|Withdrawal by Subject|2
6822938|NCT00102687|10826276|FG003|Maintenance Period|Withdrawal by Subject|3
6822939|NCT00102687|10826277|FG004|Maintenance Period|Withdrawal by Subject|1
6822940|NCT00102687|10826273|FG000|Maintenance Period|Adverse Event|1
6822941|NCT00102687|10826274|FG001|Maintenance Period|Adverse Event|0
6822942|NCT00102687|10826275|FG002|Maintenance Period|Adverse Event|0
6822943|NCT00102687|10826276|FG003|Maintenance Period|Adverse Event|1
6822944|NCT00102687|10826277|FG004|Maintenance Period|Adverse Event|3
6822945|NCT00102687|10826273|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0
6822946|NCT00102687|10826274|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1
6822947|NCT00102687|10826275|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0
6822948|NCT00102687|10826276|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2
6822949|NCT00102687|10826277|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0
6822950|NCT00102687|10826273|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1
6822951|NCT00102687|10826274|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1
6822952|NCT00102687|10826275|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1
6822953|NCT00102687|10826276|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3
6822954|NCT00102687|10826277|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4
6822955|NCT00102687|10826273|FG000|Maintenance Period|Death|0
6822956|NCT00102687|10826274|FG001|Maintenance Period|Death|0
6822957|NCT00102687|10826275|FG002|Maintenance Period|Death|0
6822958|NCT00102687|10826276|FG003|Maintenance Period|Death|1
6822959|NCT00102687|10826277|FG004|Maintenance Period|Death|1
6822960|NCT00102687|10826273|FG000|Maintenance Period|Physician Decision|1
6822961|NCT00102687|10826274|FG001|Maintenance Period|Physician Decision|2
6822962|NCT00102687|10826275|FG002|Maintenance Period|Physician Decision|3
6822963|NCT00102687|10826276|FG003|Maintenance Period|Physician Decision|0
6822964|NCT00102687|10826277|FG004|Maintenance Period|Physician Decision|4
6822965|NCT00102804|10826295|FG000|Overall Study|Progressive Disease (PD)|307
6822966|NCT00102804|10826296|FG001|Overall Study|Progressive Disease (PD)|196
6822967|NCT00102804|10826295|FG000|Overall Study|Withdrawal by Subject|46
6822968|NCT00102804|10826296|FG001|Overall Study|Withdrawal by Subject|7
6822969|NCT00102804|10826295|FG000|Overall Study|Adverse Event|37
6822970|NCT00102804|10826296|FG001|Overall Study|Adverse Event|3
6822971|NCT00102804|10826295|FG000|Overall Study|Physician Decision|24
6822972|NCT00102804|10826296|FG001|Overall Study|Physician Decision|6
6822973|NCT00102804|10826295|FG000|Overall Study|Death|5
6822974|NCT00102804|10826296|FG001|Overall Study|Death|6
6822975|NCT00102804|10826295|FG000|Overall Study|Enrollment Criteria Not Met|6
6822976|NCT00102804|10826296|FG001|Overall Study|Enrollment Criteria Not Met|0
6822977|NCT00102804|10826295|FG000|Overall Study|Lost to Follow-up|4
6822978|NCT00102804|10826296|FG001|Overall Study|Lost to Follow-up|1
6822979|NCT00102804|10826295|FG000|Overall Study|Protocol Violation|2
6822980|NCT00102804|10826296|FG001|Overall Study|Protocol Violation|1
6822981|NCT00102804|10826295|FG000|Overall Study|Satisfactory Response|2
6822982|NCT00102804|10826296|FG001|Overall Study|Satisfactory Response|0
6822983|NCT00102804|10826295|FG000|Overall Study|Sponsor Decision|1
6822984|NCT00102804|10826296|FG001|Overall Study|Sponsor Decision|0
6822985|NCT00102804|10826295|FG000|Overall Study|Alive, Receiving Treatment|7
6822986|NCT00102804|10826296|FG001|Overall Study|Alive, Receiving Treatment|2
6822987|NCT00102960|10826305|FG000|Overall Study|Death|23
6822988|NCT00102960|10826306|FG001|Overall Study|Death|11
6822989|NCT00102960|10826307|FG002|Overall Study|Death|11
6822990|NCT00102960|10826305|FG000|Overall Study|Lost to Follow-up|6
6822991|NCT00102960|10826306|FG001|Overall Study|Lost to Follow-up|12
6822992|NCT00102960|10826307|FG002|Overall Study|Lost to Follow-up|16
6822993|NCT00102960|10826305|FG000|Overall Study|Withdrawal by Subject|1
6822994|NCT00102960|10826306|FG001|Overall Study|Withdrawal by Subject|0
6822995|NCT00102960|10826307|FG002|Overall Study|Withdrawal by Subject|1
6822996|NCT00103012|10826322|FG000|Overall Study|Withdrawal by Subject|2
6822997|NCT00103012|10826323|FG001|Overall Study|Withdrawal by Subject|1
6822998|NCT00103012|10826324|FG002|Overall Study|Withdrawal by Subject|2
6822999|NCT00103012|10826322|FG000|Overall Study|Pregnancy|1
6823000|NCT00103012|10826323|FG001|Overall Study|Pregnancy|0
6823001|NCT00103012|10826324|FG002|Overall Study|Pregnancy|0
6823002|NCT00103012|10826322|FG000|Overall Study|Adverse Event|0
6823003|NCT00103012|10826323|FG001|Overall Study|Adverse Event|0
6823004|NCT00103012|10826324|FG002|Overall Study|Adverse Event|1
6823005|NCT00103012|10826322|FG000|Overall Study|Subject non-compliant with medications|0
6823006|NCT00103012|10826323|FG001|Overall Study|Subject non-compliant with medications|0
6823007|NCT00103012|10826324|FG002|Overall Study|Subject non-compliant with medications|1
6823008|NCT00103142|10826338|FG000|Overall Study|Adverse Event|1
6823009|NCT00103142|10826339|FG001|Overall Study|Adverse Event|0
6823010|NCT00103142|10826338|FG000|Overall Study|Progression of disease|2
6823011|NCT00103142|10826339|FG001|Overall Study|Progression of disease|1
6823012|NCT00103207|10826351|FG000|Overall Study|Adverse Event|3
6823013|NCT00103207|10826351|FG000|Overall Study|Death|1
6823014|NCT00103207|10826351|FG000|Overall Study|Withdrawal by Subject|2
6823015|NCT00103207|10826351|FG000|Overall Study|Other complicating disease|1
6823016|NCT00103207|10826351|FG000|Overall Study|Ineligible|4
6823017|NCT00103207|10826351|FG000|Overall Study|Diagnosis of BAC not confirmed|27
6823018|NCT00103259|10826359|FG000|Overall Study|Death|3
6823019|NCT00103259|10826360|FG001|Overall Study|Death|2
6823020|NCT00103259|10826359|FG000|Overall Study|Withdrawal by Subject|2
6823021|NCT00103259|10826360|FG001|Overall Study|Withdrawal by Subject|3
6823022|NCT00103259|10826359|FG000|Overall Study|alternative therapy|1
6823023|NCT00103259|10826360|FG001|Overall Study|alternative therapy|0
6823024|NCT00103259|10826359|FG000|Overall Study|other (reasons were not specified)|2
6823025|NCT00103259|10826360|FG001|Overall Study|other (reasons were not specified)|1
6823026|NCT00103259|10826359|FG000|Overall Study|ineligible/no protocol therapy|4
6823027|NCT00103259|10826360|FG001|Overall Study|ineligible/no protocol therapy|6
6823028|NCT00103285|10826368|FG000|Induction|Adverse Event|14
6823029|NCT00103285|10826369|FG001|Induction|Adverse Event|0
6823030|NCT00103285|10826370|FG002|Induction|Adverse Event|0
6823031|NCT00103285|10826371|FG003|Induction|Adverse Event|0
6823032|NCT00103285|10826372|FG004|Induction|Adverse Event|0
6823033|NCT00103285|10826373|FG005|Induction|Adverse Event|0
6823034|NCT00103285|10826374|FG006|Induction|Adverse Event|0
6823035|NCT00103285|10826375|FG007|Induction|Adverse Event|0
6823036|NCT00103285|10826368|FG000|Induction|Death|24
6823037|NCT00103285|10826369|FG001|Induction|Death|0
6823038|NCT00103285|10826370|FG002|Induction|Death|0
6823039|NCT00103285|10826371|FG003|Induction|Death|0
6823040|NCT00103285|10826372|FG004|Induction|Death|0
6823041|NCT00103285|10826373|FG005|Induction|Death|0
6823042|NCT00103285|10826374|FG006|Induction|Death|0
6823043|NCT00103285|10826375|FG007|Induction|Death|0
6823044|NCT00103285|10826368|FG000|Induction|Physician Decision|103
6823045|NCT00103285|10826369|FG001|Induction|Physician Decision|0
6823046|NCT00103285|10826370|FG002|Induction|Physician Decision|0
6823047|NCT00103285|10826371|FG003|Induction|Physician Decision|0
6823048|NCT00103285|10826372|FG004|Induction|Physician Decision|0
6823049|NCT00103285|10826373|FG005|Induction|Physician Decision|0
6823050|NCT00103285|10826374|FG006|Induction|Physician Decision|0
6823051|NCT00103285|10826375|FG007|Induction|Physician Decision|0
6823052|NCT00103285|10826368|FG000|Induction|Withdrawal by Subject|1
6823053|NCT00103285|10826369|FG001|Induction|Withdrawal by Subject|0
6823054|NCT00103285|10826370|FG002|Induction|Withdrawal by Subject|0
6823055|NCT00103285|10826371|FG003|Induction|Withdrawal by Subject|0
6823056|NCT00103285|10826372|FG004|Induction|Withdrawal by Subject|0
6900884|NCT00667875|10921271|FG001|Overall Study|Withdrawal by Subject|9
6900885|NCT00667875|10921272|FG002|Overall Study|Withdrawal by Subject|7
6900886|NCT00667888|10921288|FG000|Overall Study|Death|1
6900887|NCT00667888|10921289|FG001|Overall Study|Death|1
6900888|NCT00667888|10921288|FG000|Overall Study|Withdrawal by Subject|6
6900889|NCT00667888|10921289|FG001|Overall Study|Withdrawal by Subject|3
6900890|NCT00667888|10921288|FG000|Overall Study|Proceed with other treatment|3
6900891|NCT00667888|10921289|FG001|Overall Study|Proceed with other treatment|3
6900892|NCT00667888|10921288|FG000|Overall Study|Ineligible after SIM|0
6900893|NCT00667888|10921289|FG001|Overall Study|Ineligible after SIM|2
6900894|NCT00667992|10921297|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2
6900895|NCT00667992|10921298|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3
6900896|NCT00667992|10921297|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2
6900897|NCT00667992|10921298|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
6900898|NCT00667992|10921297|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0
6900899|NCT00667992|10921298|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1
6900900|NCT00667992|10921297|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1
6900901|NCT00667992|10921298|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0
6900902|NCT00667992|10921297|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0
6900903|NCT00667992|10921298|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1
6900904|NCT00667992|10921297|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1
6900905|NCT00667992|10921298|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0
6900906|NCT00667992|10921297|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2
6900907|NCT00667992|10921298|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3
6900908|NCT00667992|10921297|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0
6900909|NCT00667992|10921298|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1
6900910|NCT00667992|10921297|FG000|Wash-out|Not within one doubling dilution|4
6900911|NCT00667992|10921298|FG001|Wash-out|Not within one doubling dilution|3
6900912|NCT00667992|10921297|FG000|Wash-out|Failure to wash-out|2
6900913|NCT00667992|10921298|FG001|Wash-out|Failure to wash-out|2
6900914|NCT00667992|10921297|FG000|Wash-out|Withdrawal by Subject|1
6900915|NCT00667992|10921298|FG001|Wash-out|Withdrawal by Subject|0
6900916|NCT00667992|10921297|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1
6900917|NCT00667992|10921298|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
6900918|NCT00667992|10921297|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0
6900919|NCT00667992|10921298|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1
6900920|NCT00668148|10921314|FG000|Overall Study|Adverse Event|5
6900921|NCT00668148|10921314|FG000|Overall Study|Subject Non-compliance|1
6900922|NCT00668148|10921314|FG000|Overall Study|Progressive Disease Before Treatment|2
6900923|NCT00668148|10921314|FG000|Overall Study|Withdrawal of Consent|2
6900924|NCT00668200|10921329|FG000|Overall Study|Withdrawal by Subject|2
6900925|NCT00668200|10921329|FG000|Overall Study|Lost to Follow-up|1
6900926|NCT00668317|10921333|FG000|Overall Study|Adverse Event|2
6900927|NCT00668395|10921344|FG000|Overall Study|Withdrawal by Subject|4
6900928|NCT00668395|10921345|FG001|Overall Study|Withdrawal by Subject|4
6900929|NCT00668395|10921346|FG002|Overall Study|Withdrawal by Subject|1
6900930|NCT00668395|10921344|FG000|Overall Study|Adverse Event|1
6900931|NCT00668395|10921345|FG001|Overall Study|Adverse Event|1
6900932|NCT00668395|10921346|FG002|Overall Study|Adverse Event|0
6900933|NCT00668395|10921344|FG000|Overall Study|Physician Decision|1
6900934|NCT00668395|10921345|FG001|Overall Study|Physician Decision|1
6900935|NCT00668395|10921346|FG002|Overall Study|Physician Decision|0
6900936|NCT00668707|10921382|FG000|Overall Study|Cancer Recurrence|58
6900937|NCT00668707|10921383|FG001|Overall Study|Cancer Recurrence|58
6900938|NCT00668707|10921382|FG000|Overall Study|Withdrawal by Subject|117
6900939|NCT00668707|10921383|FG001|Overall Study|Withdrawal by Subject|100
6900940|NCT00668707|10921382|FG000|Overall Study|Lost to Follow-up|3
6900941|NCT00668707|10921383|FG001|Overall Study|Lost to Follow-up|6
6900942|NCT00668707|10921382|FG000|Overall Study|Protocol Violation|10
6900943|NCT00668707|10921383|FG001|Overall Study|Protocol Violation|12
6900944|NCT00668707|10921382|FG000|Overall Study|Death|11
6900945|NCT00668707|10921383|FG001|Overall Study|Death|4
6900946|NCT00668733|10921396|FG000|Overall Study|Lost to Follow-up|2
6900947|NCT00668733|10921397|FG001|Overall Study|Lost to Follow-up|3
6900948|NCT00668733|10921396|FG000|Overall Study|Withdrawal by Subject|0
6900949|NCT00668733|10921397|FG001|Overall Study|Withdrawal by Subject|4
6900950|NCT00668746|10921405|FG000|Overall Study|Lost to Follow-up|2
6900951|NCT00668746|10921406|FG001|Overall Study|Lost to Follow-up|1
6900952|NCT00668863|10921426|FG000|Overall Study|Objective Progression or Relapse|42
6900953|NCT00668863|10921426|FG000|Overall Study|Adverse Event|13
6900954|NCT00668863|10921426|FG000|Overall Study|Study Terminated by Sponsor|8
6900955|NCT00668863|10921426|FG000|Overall Study|Global Deterioration of Health Status|4
6900956|NCT00668863|10921426|FG000|Overall Study|Withdrawal by Subject|1
6900957|NCT00668863|10921426|FG000|Overall Study|Surgery|1
6900958|NCT00668863|10921426|FG000|Overall Study|Subject's work scheduling problem|1
6823057|NCT00103285|10826373|FG005|Induction|Withdrawal by Subject|0
6823058|NCT00103285|10826374|FG006|Induction|Withdrawal by Subject|0
6823059|NCT00103285|10826375|FG007|Induction|Withdrawal by Subject|0
6823060|NCT00103285|10826368|FG000|Induction|Ineligible|43
6823061|NCT00103285|10826369|FG001|Induction|Ineligible|0
6823062|NCT00103285|10826370|FG002|Induction|Ineligible|0
6823063|NCT00103285|10826371|FG003|Induction|Ineligible|0
6823064|NCT00103285|10826372|FG004|Induction|Ineligible|0
6823065|NCT00103285|10826373|FG005|Induction|Ineligible|0
6823066|NCT00103285|10826374|FG006|Induction|Ineligible|0
6823067|NCT00103285|10826375|FG007|Induction|Ineligible|0
6823068|NCT00103285|10826368|FG000|Induction|Refusal|906
6823069|NCT00103285|10826369|FG001|Induction|Refusal|0
6823070|NCT00103285|10826370|FG002|Induction|Refusal|0
6823071|NCT00103285|10826371|FG003|Induction|Refusal|0
6823072|NCT00103285|10826372|FG004|Induction|Refusal|0
6823073|NCT00103285|10826373|FG005|Induction|Refusal|0
6823074|NCT00103285|10826374|FG006|Induction|Refusal|0
6823075|NCT00103285|10826375|FG007|Induction|Refusal|0
6823076|NCT00103285|10826368|FG000|Induction|Other|258
6823077|NCT00103285|10826369|FG001|Induction|Other|0
6823078|NCT00103285|10826370|FG002|Induction|Other|0
6823079|NCT00103285|10826371|FG003|Induction|Other|0
6823080|NCT00103285|10826372|FG004|Induction|Other|0
6823081|NCT00103285|10826373|FG005|Induction|Other|0
6823082|NCT00103285|10826374|FG006|Induction|Other|0
6823083|NCT00103285|10826375|FG007|Induction|Other|0
6823084|NCT00103285|10826368|FG000|Response Assignment|Adverse Event|0
6823085|NCT00103285|10826369|FG001|Response Assignment|Adverse Event|8
6823086|NCT00103285|10826370|FG002|Response Assignment|Adverse Event|3
6823087|NCT00103285|10826371|FG003|Response Assignment|Adverse Event|2
6823088|NCT00103285|10826372|FG004|Response Assignment|Adverse Event|3
6823089|NCT00103285|10826373|FG005|Response Assignment|Adverse Event|1
6823090|NCT00103285|10826374|FG006|Response Assignment|Adverse Event|1
6823091|NCT00103285|10826375|FG007|Response Assignment|Adverse Event|2
6823092|NCT00103285|10826368|FG000|Response Assignment|Death|0
6823093|NCT00103285|10826369|FG001|Response Assignment|Death|5
6823094|NCT00103285|10826370|FG002|Response Assignment|Death|2
6823095|NCT00103285|10826371|FG003|Response Assignment|Death|2
6823096|NCT00103285|10826372|FG004|Response Assignment|Death|3
6823097|NCT00103285|10826373|FG005|Response Assignment|Death|1
6823098|NCT00103285|10826374|FG006|Response Assignment|Death|0
6823099|NCT00103285|10826375|FG007|Response Assignment|Death|8
6823100|NCT00103285|10826368|FG000|Response Assignment|Lost to Follow-up|0
6823101|NCT00103285|10826369|FG001|Response Assignment|Lost to Follow-up|9
6823102|NCT00103285|10826370|FG002|Response Assignment|Lost to Follow-up|5
6823103|NCT00103285|10826371|FG003|Response Assignment|Lost to Follow-up|5
6823104|NCT00103285|10826372|FG004|Response Assignment|Lost to Follow-up|1
6823105|NCT00103285|10826373|FG005|Response Assignment|Lost to Follow-up|2
6823106|NCT00103285|10826374|FG006|Response Assignment|Lost to Follow-up|2
6823107|NCT00103285|10826375|FG007|Response Assignment|Lost to Follow-up|5
6823108|NCT00103285|10826368|FG000|Response Assignment|Physician Decision|0
6823109|NCT00103285|10826369|FG001|Response Assignment|Physician Decision|13
6823110|NCT00103285|10826370|FG002|Response Assignment|Physician Decision|14
6823111|NCT00103285|10826371|FG003|Response Assignment|Physician Decision|9
6823112|NCT00103285|10826372|FG004|Response Assignment|Physician Decision|13
6823113|NCT00103285|10826373|FG005|Response Assignment|Physician Decision|7
6823114|NCT00103285|10826374|FG006|Response Assignment|Physician Decision|4
6823115|NCT00103285|10826375|FG007|Response Assignment|Physician Decision|35
6823116|NCT00103285|10826368|FG000|Response Assignment|Protocol Violation|0
6823117|NCT00103285|10826369|FG001|Response Assignment|Protocol Violation|2
6823118|NCT00103285|10826370|FG002|Response Assignment|Protocol Violation|0
6823119|NCT00103285|10826371|FG003|Response Assignment|Protocol Violation|0
6823120|NCT00103285|10826372|FG004|Response Assignment|Protocol Violation|0
6823121|NCT00103285|10826373|FG005|Response Assignment|Protocol Violation|0
6823122|NCT00103285|10826374|FG006|Response Assignment|Protocol Violation|0
6823123|NCT00103285|10826375|FG007|Response Assignment|Protocol Violation|0
6823124|NCT00103285|10826368|FG000|Response Assignment|Withdrawal by Subject|0
6823125|NCT00103285|10826369|FG001|Response Assignment|Withdrawal by Subject|4
6823126|NCT00103285|10826370|FG002|Response Assignment|Withdrawal by Subject|1
6823127|NCT00103285|10826371|FG003|Response Assignment|Withdrawal by Subject|1
6823128|NCT00103285|10826372|FG004|Response Assignment|Withdrawal by Subject|2
6823129|NCT00103285|10826373|FG005|Response Assignment|Withdrawal by Subject|2
6823130|NCT00103285|10826374|FG006|Response Assignment|Withdrawal by Subject|0
6823131|NCT00103285|10826375|FG007|Response Assignment|Withdrawal by Subject|2
6823132|NCT00103285|10826368|FG000|Response Assignment|Ineligible|0
6823133|NCT00103285|10826369|FG001|Response Assignment|Ineligible|8
6823134|NCT00103285|10826370|FG002|Response Assignment|Ineligible|6
6823135|NCT00103285|10826371|FG003|Response Assignment|Ineligible|2
6823136|NCT00103285|10826372|FG004|Response Assignment|Ineligible|0
6823137|NCT00103285|10826373|FG005|Response Assignment|Ineligible|3
6823138|NCT00103285|10826374|FG006|Response Assignment|Ineligible|1
6823139|NCT00103285|10826375|FG007|Response Assignment|Ineligible|5
6823140|NCT00103285|10826368|FG000|Response Assignment|Refusal|0
6823141|NCT00103285|10826369|FG001|Response Assignment|Refusal|53
6823142|NCT00103285|10826370|FG002|Response Assignment|Refusal|5
6823143|NCT00103285|10826371|FG003|Response Assignment|Refusal|3
6823144|NCT00103285|10826372|FG004|Response Assignment|Refusal|25
6823145|NCT00103285|10826373|FG005|Response Assignment|Refusal|15
6823146|NCT00103285|10826374|FG006|Response Assignment|Refusal|30
6823147|NCT00103285|10826375|FG007|Response Assignment|Refusal|10
6823148|NCT00103285|10826368|FG000|Response Assignment|Other|0
6823149|NCT00103285|10826369|FG001|Response Assignment|Other|30
6823150|NCT00103285|10826370|FG002|Response Assignment|Other|48
6823151|NCT00103285|10826371|FG003|Response Assignment|Other|38
6823152|NCT00103285|10826372|FG004|Response Assignment|Other|37
6823153|NCT00103285|10826373|FG005|Response Assignment|Other|17
6823154|NCT00103285|10826374|FG006|Response Assignment|Other|11
6823155|NCT00103285|10826375|FG007|Response Assignment|Other|53
6823156|NCT00103311|10826402|FG000|Overall Study|Lost to Follow-up|1
6823157|NCT00103311|10826403|FG001|Overall Study|Lost to Follow-up|0
6823158|NCT00103311|10826402|FG000|Overall Study|Withdrawal by Subject|2
6823159|NCT00103311|10826403|FG001|Overall Study|Withdrawal by Subject|1
6823160|NCT00103311|10826402|FG000|Overall Study|Adverse Event|1
6823161|NCT00103311|10826403|FG001|Overall Study|Adverse Event|0
6823162|NCT00103402|10826430|FG000|Overall Study|Adverse Event|3
6823163|NCT00103402|10826431|FG001|Overall Study|Adverse Event|4
6823164|NCT00103402|10826430|FG000|Overall Study|Lost to Follow-up|8
6823165|NCT00103402|10826431|FG001|Overall Study|Lost to Follow-up|7
6823166|NCT00103402|10826430|FG000|Overall Study|Dissatisfied/No longer interested|6
6823167|NCT00103402|10826431|FG001|Overall Study|Dissatisfied/No longer interested|6
6823168|NCT00103402|10826430|FG000|Overall Study|Personal constraints/Other|5
6823169|NCT00103402|10826431|FG001|Overall Study|Personal constraints/Other|0
6900959|NCT00668863|10921426|FG000|Overall Study|Physician Decision|1
6900960|NCT00669032|10921449|FG000|Overall Study|Lost to Follow-up|6
6900961|NCT00669032|10921450|FG001|Overall Study|Lost to Follow-up|5
6900962|NCT00669032|10921449|FG000|Overall Study|Lack of Efficacy|8
6900963|NCT00669032|10921450|FG001|Overall Study|Lack of Efficacy|19
6900964|NCT00669032|10921449|FG000|Overall Study|Withdrawal by Subject|12
6900965|NCT00669032|10921450|FG001|Overall Study|Withdrawal by Subject|13
6900966|NCT00669032|10921449|FG000|Overall Study|Adverse Event|12
6900967|NCT00669032|10921450|FG001|Overall Study|Adverse Event|16
6900968|NCT00669032|10921449|FG000|Overall Study|Physician Decision|1
6900969|NCT00669032|10921450|FG001|Overall Study|Physician Decision|1
6900970|NCT00669032|10921449|FG000|Overall Study|No fulfilment of the selection criteria|5
6900971|NCT00669032|10921450|FG001|Overall Study|No fulfilment of the selection criteria|5
6900972|NCT00669071|10921456|FG000|Overall Study|Lost to Follow-up|3
6900973|NCT00669071|10921456|FG000|Overall Study|Final visit 40 days out of window|1
6900974|NCT00669110|10921464|FG000|Overall Study|Adverse Event|4
6900975|NCT00669110|10921465|FG001|Overall Study|Adverse Event|3
6900976|NCT00669110|10921464|FG000|Overall Study|Caregiver request|3
6900977|NCT00669110|10921465|FG001|Overall Study|Caregiver request|2
6900978|NCT00669110|10921464|FG000|Overall Study|Physician Decision|0
6900979|NCT00669110|10921465|FG001|Overall Study|Physician Decision|1
6900980|NCT00669110|10921464|FG000|Overall Study|Lost to Follow-up|1
6900981|NCT00669110|10921465|FG001|Overall Study|Lost to Follow-up|0
6900982|NCT00669110|10921464|FG000|Overall Study|Protocol Violation|0
6900983|NCT00669110|10921465|FG001|Overall Study|Protocol Violation|5
6900984|NCT00669110|10921464|FG000|Overall Study|Withdrawal by Subject|0
6900985|NCT00669110|10921465|FG001|Overall Study|Withdrawal by Subject|2
6900986|NCT00669162|10921471|FG000|Overall Study|Withdrawal by Subject|1
6900987|NCT00669240|10921488|FG000|Overall Study|Lack of Efficacy|33
6900988|NCT00669240|10921488|FG000|Overall Study|Withdrawal by Subject|42
6900989|NCT00669240|10921488|FG000|Overall Study|Lost to Follow-up|34
6900990|NCT00669240|10921488|FG000|Overall Study|Adverse Event|21
6900991|NCT00669240|10921488|FG000|Overall Study|Other|19
6900992|NCT00669240|10921488|FG000|Overall Study|Enrolled but not treated|15
6900993|NCT00669240|10921488|FG000|Overall Study|Enrolled but no dosing record|1
6900994|NCT00669318|10921501|FG000|Overall Study|Withdrawal by Subject|2
6900995|NCT00669331|10921507|FG000|Randomisation to First Dose|Adverse Event|1
6900996|NCT00669331|10921508|FG001|Randomisation to First Dose|Adverse Event|0
6900997|NCT00669331|10921507|FG000|Randomisation to First Dose|Protocol Violation|1
6900998|NCT00669331|10921508|FG001|Randomisation to First Dose|Protocol Violation|0
6900999|NCT00669331|10921507|FG000|Randomisation to First Dose|Withdrawal by Subject|3
6901000|NCT00669331|10921508|FG001|Randomisation to First Dose|Withdrawal by Subject|2
6901001|NCT00669331|10921507|FG000|Randomisation to First Dose|Lost to Follow-up|2
6901002|NCT00669331|10921508|FG001|Randomisation to First Dose|Lost to Follow-up|0
6901003|NCT00669331|10921507|FG000|Randomisation to First Dose|Death|1
6901004|NCT00669331|10921508|FG001|Randomisation to First Dose|Death|0
6901005|NCT00669331|10921507|FG000|Randomisation to First Dose|Sponsor decision|0
6823170|NCT00103506|10826439|FG000|Overall Study|Study closed by sponsor|34
6823171|NCT00103506|10826440|FG001|Overall Study|Study closed by sponsor|37
6823172|NCT00103506|10826439|FG000|Overall Study|Death|257
6823173|NCT00103506|10826440|FG001|Overall Study|Death|253
6823174|NCT00103506|10826439|FG000|Overall Study|Lost to Follow-up|13
6823175|NCT00103506|10826440|FG001|Overall Study|Lost to Follow-up|13
6901006|NCT00669331|10921508|FG001|Randomisation to First Dose|Sponsor decision|1
6901007|NCT00669331|10921507|FG000|Randomisation to First Dose|Randomised in error|3
6901008|NCT00669331|10921508|FG001|Randomisation to First Dose|Randomised in error|10
6901009|NCT00669331|10921507|FG000|Blinded Treatment Period|Adverse Event|16
6901010|NCT00669331|10921508|FG001|Blinded Treatment Period|Adverse Event|10
6901011|NCT00669331|10921507|FG000|Blinded Treatment Period|Protocol Violation|1
6901012|NCT00669331|10921508|FG001|Blinded Treatment Period|Protocol Violation|1
6901013|NCT00669331|10921507|FG000|Blinded Treatment Period|Withdrawal by Subject|17
6901014|NCT00669331|10921508|FG001|Blinded Treatment Period|Withdrawal by Subject|19
6823176|NCT00103506|10826439|FG000|Overall Study|Withdrawal by Subject|18
6823177|NCT00103506|10826440|FG001|Overall Study|Withdrawal by Subject|21
6823178|NCT00103610|10826448|FG000|Overall Study|Entered Rescue Procedure|10
6823179|NCT00103610|10826449|FG001|Overall Study|Entered Rescue Procedure|52
6823180|NCT00103610|10826448|FG000|Overall Study|Death|16
6823181|NCT00103610|10826449|FG001|Overall Study|Death|12
6823182|NCT00103610|10826448|FG000|Overall Study|Elective Withdrawal|4
6823183|NCT00103610|10826449|FG001|Overall Study|Elective Withdrawal|0
6823184|NCT00103610|10826448|FG000|Overall Study|Lost to Follow-up|3
6823185|NCT00103610|10826449|FG001|Overall Study|Lost to Follow-up|1
6823186|NCT00103610|10826448|FG000|Overall Study|Adverse Event|2
6823187|NCT00103610|10826449|FG001|Overall Study|Adverse Event|2
6823188|NCT00103610|10826448|FG000|Overall Study|Other|2
6823189|NCT00103610|10826449|FG001|Overall Study|Other|7
6823190|NCT00103610|10826448|FG000|Overall Study|Failed mobilization|1
6823191|NCT00103610|10826449|FG001|Overall Study|Failed mobilization|5
6823192|NCT00103610|10826448|FG000|Overall Study|Noncompliance|0
6823193|NCT00103610|10826449|FG001|Overall Study|Noncompliance|1
6823194|NCT00103662|10826458|FG000|Overall Study|Entered Rescue Procedure|0
6823195|NCT00103662|10826459|FG001|Overall Study|Entered Rescue Procedure|7
6823196|NCT00103662|10826458|FG000|Overall Study|Death|7
6823197|NCT00103662|10826459|FG001|Overall Study|Death|7
6823198|NCT00103662|10826458|FG000|Overall Study|Elective Withdrawal|5
6823199|NCT00103662|10826459|FG001|Overall Study|Elective Withdrawal|5
6823200|NCT00103662|10826458|FG000|Overall Study|Lost to Follow-up|0
6823201|NCT00103662|10826459|FG001|Overall Study|Lost to Follow-up|1
6823202|NCT00103662|10826458|FG000|Overall Study|Other|6
6823203|NCT00103662|10826459|FG001|Overall Study|Other|9
6823204|NCT00103662|10826458|FG000|Overall Study|Failed mobilization|0
6823205|NCT00103662|10826459|FG001|Overall Study|Failed mobilization|4
6823206|NCT00103662|10826458|FG000|Overall Study|Intercurrent illness|1
6823207|NCT00103662|10826459|FG001|Overall Study|Intercurrent illness|0
6823208|NCT00103740|10826467|FG000|Period 1 - Core|Adverse Event|1
6901015|NCT00669331|10921507|FG000|Blinded Treatment Period|Lost to Follow-up|3
6901016|NCT00669331|10921508|FG001|Blinded Treatment Period|Lost to Follow-up|2
6901017|NCT00669331|10921507|FG000|Blinded Treatment Period|Death|0
6901018|NCT00669331|10921508|FG001|Blinded Treatment Period|Death|2
6901019|NCT00669331|10921507|FG000|Blinded Treatment Period|Physician Decision|3
6901020|NCT00669331|10921508|FG001|Blinded Treatment Period|Physician Decision|3
6901021|NCT00669331|10921507|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
6901022|NCT00669331|10921508|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
6901023|NCT00669396|10921527|FG000|Overall Study|Lost to Follow-up|10
6901024|NCT00669396|10921528|FG001|Overall Study|Lost to Follow-up|12
6901025|NCT00669409|10921540|FG000|Part 2|Withdrawal by Subject|0
6901026|NCT00669409|10921541|FG001|Part 2|Withdrawal by Subject|0
6901027|NCT00669409|10921542|FG002|Part 2|Withdrawal by Subject|0
6901028|NCT00669409|10921543|FG003|Part 2|Withdrawal by Subject|0
6901029|NCT00669409|10921544|FG004|Part 2|Withdrawal by Subject|0
6901030|NCT00669409|10921545|FG005|Part 2|Withdrawal by Subject|0
6901031|NCT00669409|10921546|FG006|Part 2|Withdrawal by Subject|0
6901032|NCT00669409|10921547|FG007|Part 2|Withdrawal by Subject|0
6901033|NCT00669409|10921548|FG008|Part 2|Withdrawal by Subject|0
6901034|NCT00669409|10921549|FG009|Part 2|Withdrawal by Subject|1
6901035|NCT00669409|10921550|FG010|Part 2|Withdrawal by Subject|0
6901036|NCT00669617|10921600|FG000|Period 1|Withdrawal by Subject|0
6901037|NCT00669617|10921601|FG001|Period 1|Withdrawal by Subject|0
6901038|NCT00669617|10921602|FG002|Period 1|Withdrawal by Subject|1
6901039|NCT00669617|10921603|FG003|Period 1|Withdrawal by Subject|0
6901040|NCT00669617|10921604|FG004|Period 1|Withdrawal by Subject|0
6901041|NCT00669617|10921600|FG000|Period 1|Protocol Deviation|0
6901042|NCT00669617|10921601|FG001|Period 1|Protocol Deviation|0
6901043|NCT00669617|10921602|FG002|Period 1|Protocol Deviation|0
6901044|NCT00669617|10921603|FG003|Period 1|Protocol Deviation|0
6901045|NCT00669617|10921604|FG004|Period 1|Protocol Deviation|1
6901046|NCT00669617|10921600|FG000|Period 3|Lost to Follow-up|1
6901047|NCT00669617|10921601|FG001|Period 3|Lost to Follow-up|0
6901048|NCT00669617|10921602|FG002|Period 3|Lost to Follow-up|0
6901049|NCT00669617|10921603|FG003|Period 3|Lost to Follow-up|0
6901050|NCT00669617|10921604|FG004|Period 3|Lost to Follow-up|0
6901051|NCT00669864|10921621|FG000|Overall Study|Lost to Follow-up|2
6901052|NCT00669864|10921621|FG000|Overall Study|Protocol Violation|2
6901053|NCT00669864|10921621|FG000|Overall Study|Withdrawal by Subject|3
6901054|NCT00669864|10921621|FG000|Overall Study|Other|2
6901055|NCT00669877|10921625|FG000|Overall Study|Disease Progression/Death|4
6901056|NCT00669903|10921633|FG000|Overall Study|Adverse Event|0
6901057|NCT00669903|10921634|FG001|Overall Study|Adverse Event|1
6823209|NCT00103740|10826468|FG001|Period 1 - Core|Adverse Event|0
6823210|NCT00103740|10826467|FG000|Period 1 - Core|Protocol Violation|3
6823211|NCT00103740|10826468|FG001|Period 1 - Core|Protocol Violation|2
6901058|NCT00669903|10921635|FG002|Overall Study|Adverse Event|3
6901059|NCT00669903|10921636|FG003|Overall Study|Adverse Event|1
6901060|NCT00669903|10921633|FG000|Overall Study|Withdrawal by Subject|0
6901061|NCT00669903|10921634|FG001|Overall Study|Withdrawal by Subject|2
6901062|NCT00669903|10921635|FG002|Overall Study|Withdrawal by Subject|2
6901063|NCT00669903|10921636|FG003|Overall Study|Withdrawal by Subject|2
6901064|NCT00669903|10921633|FG000|Overall Study|Lost to Follow-up|1
6823212|NCT00103740|10826467|FG000|Period 1 - Core|Patient withdrew consent|3
6823213|NCT00103740|10826468|FG001|Period 1 - Core|Patient withdrew consent|2
6823214|NCT00103740|10826467|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7
6823215|NCT00103740|10826468|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6
6823216|NCT00103740|10826467|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21
6823217|NCT00103740|10826468|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13
6823218|NCT00103740|10826467|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5
6823219|NCT00103740|10826468|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6
6823220|NCT00103740|10826467|FG000|Period 2 - Extended Observation Period|Death|6
6823221|NCT00103740|10826468|FG001|Period 2 - Extended Observation Period|Death|2
6823222|NCT00103740|10826467|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30
6823223|NCT00103740|10826468|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9
6823224|NCT00103857|10826490|FG000|54-Week Base Study|Adverse Event|12
6823225|NCT00103857|10826491|FG001|54-Week Base Study|Adverse Event|9
6823226|NCT00103857|10826492|FG002|54-Week Base Study|Adverse Event|11
6823227|NCT00103857|10826493|FG003|54-Week Base Study|Adverse Event|6
6823228|NCT00103857|10826494|FG004|54-Week Base Study|Adverse Event|5
6823229|NCT00103857|10826495|FG005|54-Week Base Study|Adverse Event|11
6823230|NCT00103857|10826496|FG006|54-Week Base Study|Adverse Event|3
6823231|NCT00103857|10826490|FG000|54-Week Base Study|Death|0
6823232|NCT00103857|10826491|FG001|54-Week Base Study|Death|0
6823233|NCT00103857|10826492|FG002|54-Week Base Study|Death|0
6823234|NCT00103857|10826493|FG003|54-Week Base Study|Death|0
6823235|NCT00103857|10826494|FG004|54-Week Base Study|Death|1
6823236|NCT00103857|10826495|FG005|54-Week Base Study|Death|1
6823237|NCT00103857|10826496|FG006|54-Week Base Study|Death|0
6823238|NCT00103857|10826490|FG000|54-Week Base Study|Lack of Efficacy|11
6823239|NCT00103857|10826491|FG001|54-Week Base Study|Lack of Efficacy|14
6823240|NCT00103857|10826492|FG002|54-Week Base Study|Lack of Efficacy|8
6823241|NCT00103857|10826493|FG003|54-Week Base Study|Lack of Efficacy|4
6823242|NCT00103857|10826494|FG004|54-Week Base Study|Lack of Efficacy|3
6823243|NCT00103857|10826495|FG005|54-Week Base Study|Lack of Efficacy|14
6823244|NCT00103857|10826496|FG006|54-Week Base Study|Lack of Efficacy|19
6823245|NCT00103857|10826490|FG000|54-Week Base Study|Lost to Follow-up|5
6823246|NCT00103857|10826491|FG001|54-Week Base Study|Lost to Follow-up|4
6823247|NCT00103857|10826492|FG002|54-Week Base Study|Lost to Follow-up|7
6823248|NCT00103857|10826493|FG003|54-Week Base Study|Lost to Follow-up|5
6823249|NCT00103857|10826494|FG004|54-Week Base Study|Lost to Follow-up|10
6823250|NCT00103857|10826495|FG005|54-Week Base Study|Lost to Follow-up|9
6823251|NCT00103857|10826496|FG006|54-Week Base Study|Lost to Follow-up|3
6823252|NCT00103857|10826490|FG000|54-Week Base Study|Physician Decision|1
6823253|NCT00103857|10826491|FG001|54-Week Base Study|Physician Decision|1
6823254|NCT00103857|10826492|FG002|54-Week Base Study|Physician Decision|0
6823255|NCT00103857|10826493|FG003|54-Week Base Study|Physician Decision|0
6823256|NCT00103857|10826494|FG004|54-Week Base Study|Physician Decision|1
6823257|NCT00103857|10826495|FG005|54-Week Base Study|Physician Decision|0
6823258|NCT00103857|10826496|FG006|54-Week Base Study|Physician Decision|0
6823259|NCT00103857|10826490|FG000|54-Week Base Study|Pregnancy|1
6823260|NCT00103857|10826491|FG001|54-Week Base Study|Pregnancy|0
6823261|NCT00103857|10826492|FG002|54-Week Base Study|Pregnancy|0
6823262|NCT00103857|10826493|FG003|54-Week Base Study|Pregnancy|0
6823263|NCT00103857|10826494|FG004|54-Week Base Study|Pregnancy|1
6823264|NCT00103857|10826495|FG005|54-Week Base Study|Pregnancy|0
6823265|NCT00103857|10826496|FG006|54-Week Base Study|Pregnancy|1
6823266|NCT00103857|10826490|FG000|54-Week Base Study|Protocol Violation|6
6823267|NCT00103857|10826491|FG001|54-Week Base Study|Protocol Violation|4
6823268|NCT00103857|10826492|FG002|54-Week Base Study|Protocol Violation|2
6823269|NCT00103857|10826493|FG003|54-Week Base Study|Protocol Violation|4
6823270|NCT00103857|10826494|FG004|54-Week Base Study|Protocol Violation|0
6823271|NCT00103857|10826495|FG005|54-Week Base Study|Protocol Violation|3
6823272|NCT00103857|10826496|FG006|54-Week Base Study|Protocol Violation|3
6823273|NCT00103857|10826490|FG000|54-Week Base Study|Withdrawal by Subject|17
6823274|NCT00103857|10826491|FG001|54-Week Base Study|Withdrawal by Subject|16
6823275|NCT00103857|10826492|FG002|54-Week Base Study|Withdrawal by Subject|16
6823276|NCT00103857|10826493|FG003|54-Week Base Study|Withdrawal by Subject|15
6823277|NCT00103857|10826494|FG004|54-Week Base Study|Withdrawal by Subject|10
6823278|NCT00103857|10826495|FG005|54-Week Base Study|Withdrawal by Subject|15
6823279|NCT00103857|10826496|FG006|54-Week Base Study|Withdrawal by Subject|4
6823280|NCT00103857|10826490|FG000|54-Week Base Study|protocol discontinuation criteria|2
6823281|NCT00103857|10826491|FG001|54-Week Base Study|protocol discontinuation criteria|5
6823282|NCT00103857|10826492|FG002|54-Week Base Study|protocol discontinuation criteria|2
6823283|NCT00103857|10826493|FG003|54-Week Base Study|protocol discontinuation criteria|6
6823284|NCT00103857|10826494|FG004|54-Week Base Study|protocol discontinuation criteria|5
6823285|NCT00103857|10826495|FG005|54-Week Base Study|protocol discontinuation criteria|3
6823286|NCT00103857|10826496|FG006|54-Week Base Study|protocol discontinuation criteria|5
6823287|NCT00103857|10826490|FG000|54-Week Base Study|patient moved|0
6823288|NCT00103857|10826491|FG001|54-Week Base Study|patient moved|1
6823289|NCT00103857|10826492|FG002|54-Week Base Study|patient moved|1
6823290|NCT00103857|10826493|FG003|54-Week Base Study|patient moved|2
6823291|NCT00103857|10826494|FG004|54-Week Base Study|patient moved|3
6823292|NCT00103857|10826495|FG005|54-Week Base Study|patient moved|1
6823293|NCT00103857|10826496|FG006|54-Week Base Study|patient moved|0
6823294|NCT00103857|10826490|FG000|54-Week Base Study|non-compliance with study procedures|1
6823295|NCT00103857|10826491|FG001|54-Week Base Study|non-compliance with study procedures|2
6823296|NCT00103857|10826492|FG002|54-Week Base Study|non-compliance with study procedures|0
6823297|NCT00103857|10826493|FG003|54-Week Base Study|non-compliance with study procedures|0
6823298|NCT00103857|10826494|FG004|54-Week Base Study|non-compliance with study procedures|0
6823299|NCT00103857|10826495|FG005|54-Week Base Study|non-compliance with study procedures|2
6823300|NCT00103857|10826496|FG006|54-Week Base Study|non-compliance with study procedures|0
6823301|NCT00103857|10826490|FG000|54-Week Base Study|patient incarcerated|0
6823302|NCT00103857|10826491|FG001|54-Week Base Study|patient incarcerated|0
6823303|NCT00103857|10826492|FG002|54-Week Base Study|patient incarcerated|0
6823304|NCT00103857|10826493|FG003|54-Week Base Study|patient incarcerated|0
6823305|NCT00103857|10826494|FG004|54-Week Base Study|patient incarcerated|1
6823306|NCT00103857|10826495|FG005|54-Week Base Study|patient incarcerated|1
6823307|NCT00103857|10826496|FG006|54-Week Base Study|patient incarcerated|0
6823308|NCT00103857|10826490|FG000|54-Week Base Study|laboratory reporting error|0
6823309|NCT00103857|10826491|FG001|54-Week Base Study|laboratory reporting error|0
6823310|NCT00103857|10826492|FG002|54-Week Base Study|laboratory reporting error|0
6823311|NCT00103857|10826493|FG003|54-Week Base Study|laboratory reporting error|0
6823312|NCT00103857|10826494|FG004|54-Week Base Study|laboratory reporting error|1
6823313|NCT00103857|10826495|FG005|54-Week Base Study|laboratory reporting error|0
6823314|NCT00103857|10826496|FG006|54-Week Base Study|laboratory reporting error|0
6823315|NCT00103857|10826490|FG000|54-Week Base Study|site error|0
6823316|NCT00103857|10826491|FG001|54-Week Base Study|site error|0
6823317|NCT00103857|10826492|FG002|54-Week Base Study|site error|0
6823318|NCT00103857|10826493|FG003|54-Week Base Study|site error|0
6823319|NCT00103857|10826494|FG004|54-Week Base Study|site error|0
6901065|NCT00669903|10921634|FG001|Overall Study|Lost to Follow-up|1
6901066|NCT00669903|10921635|FG002|Overall Study|Lost to Follow-up|0
6901067|NCT00669903|10921636|FG003|Overall Study|Lost to Follow-up|1
6901068|NCT00669903|10921633|FG000|Overall Study|Protocol Violation|0
6901069|NCT00669903|10921634|FG001|Overall Study|Protocol Violation|1
6901070|NCT00669903|10921635|FG002|Overall Study|Protocol Violation|0
6901071|NCT00669903|10921636|FG003|Overall Study|Protocol Violation|0
6901072|NCT00669942|10921667|FG000|Parts 2 and 3|Adverse Event|0
6901073|NCT00669942|10921668|FG001|Parts 2 and 3|Adverse Event|0
6901074|NCT00669942|10921669|FG002|Parts 2 and 3|Adverse Event|0
6901075|NCT00669942|10921670|FG003|Parts 2 and 3|Adverse Event|0
6901076|NCT00669942|10921671|FG004|Parts 2 and 3|Adverse Event|0
6901077|NCT00669942|10921672|FG005|Parts 2 and 3|Adverse Event|0
6901078|NCT00669942|10921673|FG006|Parts 2 and 3|Adverse Event|0
6901079|NCT00669942|10921674|FG007|Parts 2 and 3|Adverse Event|2
6901080|NCT00669942|10921675|FG008|Parts 2 and 3|Adverse Event|1
6901081|NCT00669942|10921676|FG009|Parts 2 and 3|Adverse Event|0
6901082|NCT00669942|10921677|FG010|Parts 2 and 3|Adverse Event|0
6901083|NCT00669942|10921678|FG011|Parts 2 and 3|Adverse Event|0
6901084|NCT00669942|10921667|FG000|Parts 2 and 3|Withdrawal by Subject|0
6901085|NCT00669942|10921668|FG001|Parts 2 and 3|Withdrawal by Subject|0
6901086|NCT00669942|10921669|FG002|Parts 2 and 3|Withdrawal by Subject|0
6901087|NCT00669942|10921670|FG003|Parts 2 and 3|Withdrawal by Subject|0
6901088|NCT00669942|10921671|FG004|Parts 2 and 3|Withdrawal by Subject|0
6901089|NCT00669942|10921672|FG005|Parts 2 and 3|Withdrawal by Subject|1
6901090|NCT00669942|10921673|FG006|Parts 2 and 3|Withdrawal by Subject|0
6901091|NCT00669942|10921674|FG007|Parts 2 and 3|Withdrawal by Subject|0
6901092|NCT00669942|10921675|FG008|Parts 2 and 3|Withdrawal by Subject|2
6901093|NCT00669942|10921676|FG009|Parts 2 and 3|Withdrawal by Subject|0
6901094|NCT00669942|10921677|FG010|Parts 2 and 3|Withdrawal by Subject|0
6901095|NCT00669942|10921678|FG011|Parts 2 and 3|Withdrawal by Subject|0
6901096|NCT00669942|10921667|FG000|Parts 2 and 3|Protocol Violation|0
6901097|NCT00669942|10921668|FG001|Parts 2 and 3|Protocol Violation|0
6901098|NCT00669942|10921669|FG002|Parts 2 and 3|Protocol Violation|0
6901099|NCT00669942|10921670|FG003|Parts 2 and 3|Protocol Violation|0
6901100|NCT00669942|10921671|FG004|Parts 2 and 3|Protocol Violation|0
6901101|NCT00669942|10921672|FG005|Parts 2 and 3|Protocol Violation|1
6901102|NCT00669942|10921673|FG006|Parts 2 and 3|Protocol Violation|0
6901103|NCT00669942|10921674|FG007|Parts 2 and 3|Protocol Violation|0
6901104|NCT00669942|10921675|FG008|Parts 2 and 3|Protocol Violation|0
6901105|NCT00669942|10921676|FG009|Parts 2 and 3|Protocol Violation|0
6901106|NCT00669942|10921677|FG010|Parts 2 and 3|Protocol Violation|0
6901107|NCT00669942|10921678|FG011|Parts 2 and 3|Protocol Violation|0
6901108|NCT00669955|10921703|FG000|Overall Study|Adverse Event|3
6901109|NCT00669955|10921704|FG001|Overall Study|Adverse Event|5
6901110|NCT00669955|10921703|FG000|Overall Study|Death|0
6901111|NCT00669955|10921704|FG001|Overall Study|Death|1
6901112|NCT00669955|10921703|FG000|Overall Study|Withdrawal by Subject|2
6901113|NCT00669955|10921704|FG001|Overall Study|Withdrawal by Subject|3
6901114|NCT00669955|10921703|FG000|Overall Study|Lost to Follow-up|5
6901115|NCT00669955|10921704|FG001|Overall Study|Lost to Follow-up|7
6901116|NCT00669955|10921703|FG000|Overall Study|Protocol Violation|2
6901117|NCT00669955|10921704|FG001|Overall Study|Protocol Violation|7
6901118|NCT00669955|10921703|FG000|Overall Study|Investigator Sponsor Judgement|0
6901119|NCT00669955|10921704|FG001|Overall Study|Investigator Sponsor Judgement|1
6823320|NCT00103857|10826495|FG005|54-Week Base Study|site error|1
6823321|NCT00103857|10826496|FG006|54-Week Base Study|site error|0
6823322|NCT00103857|10826490|FG000|54-Week Base Study|patient intolerance to rescue therapy|1
6823323|NCT00103857|10826491|FG001|54-Week Base Study|patient intolerance to rescue therapy|0
6823324|NCT00103857|10826492|FG002|54-Week Base Study|patient intolerance to rescue therapy|0
6823325|NCT00103857|10826493|FG003|54-Week Base Study|patient intolerance to rescue therapy|0
6823326|NCT00103857|10826494|FG004|54-Week Base Study|patient intolerance to rescue therapy|0
6823327|NCT00103857|10826495|FG005|54-Week Base Study|patient intolerance to rescue therapy|0
6823328|NCT00103857|10826496|FG006|54-Week Base Study|patient intolerance to rescue therapy|0
6823329|NCT00103857|10826490|FG000|50-Week Extension Study|Adverse Event|2
6823330|NCT00103857|10826491|FG001|50-Week Extension Study|Adverse Event|3
6823331|NCT00103857|10826492|FG002|50-Week Extension Study|Adverse Event|2
6823332|NCT00103857|10826493|FG003|50-Week Extension Study|Adverse Event|0
6823333|NCT00103857|10826494|FG004|50-Week Extension Study|Adverse Event|1
6823334|NCT00103857|10826495|FG005|50-Week Extension Study|Adverse Event|1
6823335|NCT00103857|10826496|FG006|50-Week Extension Study|Adverse Event|0
6823336|NCT00103857|10826490|FG000|50-Week Extension Study|Death|0
6823337|NCT00103857|10826491|FG001|50-Week Extension Study|Death|0
6823338|NCT00103857|10826492|FG002|50-Week Extension Study|Death|0
6823339|NCT00103857|10826493|FG003|50-Week Extension Study|Death|1
6823340|NCT00103857|10826494|FG004|50-Week Extension Study|Death|0
6823341|NCT00103857|10826495|FG005|50-Week Extension Study|Death|1
6823342|NCT00103857|10826496|FG006|50-Week Extension Study|Death|0
6823343|NCT00103857|10826490|FG000|50-Week Extension Study|Lack of Efficacy|26
6823344|NCT00103857|10826491|FG001|50-Week Extension Study|Lack of Efficacy|15
6823345|NCT00103857|10826492|FG002|50-Week Extension Study|Lack of Efficacy|13
6823346|NCT00103857|10826493|FG003|50-Week Extension Study|Lack of Efficacy|16
6823347|NCT00103857|10826494|FG004|50-Week Extension Study|Lack of Efficacy|8
6823348|NCT00103857|10826495|FG005|50-Week Extension Study|Lack of Efficacy|8
6823349|NCT00103857|10826496|FG006|50-Week Extension Study|Lack of Efficacy|0
6823350|NCT00103857|10826490|FG000|50-Week Extension Study|Lost to Follow-up|4
6823351|NCT00103857|10826491|FG001|50-Week Extension Study|Lost to Follow-up|0
6823352|NCT00103857|10826492|FG002|50-Week Extension Study|Lost to Follow-up|1
6823353|NCT00103857|10826493|FG003|50-Week Extension Study|Lost to Follow-up|4
6823354|NCT00103857|10826494|FG004|50-Week Extension Study|Lost to Follow-up|3
6823355|NCT00103857|10826495|FG005|50-Week Extension Study|Lost to Follow-up|3
6823356|NCT00103857|10826496|FG006|50-Week Extension Study|Lost to Follow-up|0
6823357|NCT00103857|10826490|FG000|50-Week Extension Study|Physician Decision|0
6823358|NCT00103857|10826491|FG001|50-Week Extension Study|Physician Decision|1
6823359|NCT00103857|10826492|FG002|50-Week Extension Study|Physician Decision|1
6823360|NCT00103857|10826493|FG003|50-Week Extension Study|Physician Decision|0
6823361|NCT00103857|10826494|FG004|50-Week Extension Study|Physician Decision|0
6823362|NCT00103857|10826495|FG005|50-Week Extension Study|Physician Decision|0
6823363|NCT00103857|10826496|FG006|50-Week Extension Study|Physician Decision|0
6823364|NCT00103857|10826490|FG000|50-Week Extension Study|Pregnancy|0
6823365|NCT00103857|10826491|FG001|50-Week Extension Study|Pregnancy|0
6823366|NCT00103857|10826492|FG002|50-Week Extension Study|Pregnancy|1
6823367|NCT00103857|10826493|FG003|50-Week Extension Study|Pregnancy|0
6823368|NCT00103857|10826494|FG004|50-Week Extension Study|Pregnancy|1
6823369|NCT00103857|10826495|FG005|50-Week Extension Study|Pregnancy|0
6823370|NCT00103857|10826496|FG006|50-Week Extension Study|Pregnancy|0
6823371|NCT00103857|10826490|FG000|50-Week Extension Study|Protocol Violation|1
6823372|NCT00103857|10826491|FG001|50-Week Extension Study|Protocol Violation|1
6823373|NCT00103857|10826492|FG002|50-Week Extension Study|Protocol Violation|1
6823374|NCT00103857|10826493|FG003|50-Week Extension Study|Protocol Violation|2
6823375|NCT00103857|10826494|FG004|50-Week Extension Study|Protocol Violation|0
6823376|NCT00103857|10826495|FG005|50-Week Extension Study|Protocol Violation|1
6823377|NCT00103857|10826496|FG006|50-Week Extension Study|Protocol Violation|0
6823378|NCT00103857|10826490|FG000|50-Week Extension Study|Withdrawal by Subject|2
6823379|NCT00103857|10826491|FG001|50-Week Extension Study|Withdrawal by Subject|5
6823380|NCT00103857|10826492|FG002|50-Week Extension Study|Withdrawal by Subject|2
6823381|NCT00103857|10826493|FG003|50-Week Extension Study|Withdrawal by Subject|8
6823382|NCT00103857|10826494|FG004|50-Week Extension Study|Withdrawal by Subject|3
6823383|NCT00103857|10826495|FG005|50-Week Extension Study|Withdrawal by Subject|3
6823384|NCT00103857|10826496|FG006|50-Week Extension Study|Withdrawal by Subject|0
6823385|NCT00103857|10826490|FG000|50-Week Extension Study|protocol discontinuation criteria|2
6823386|NCT00103857|10826491|FG001|50-Week Extension Study|protocol discontinuation criteria|2
6823387|NCT00103857|10826492|FG002|50-Week Extension Study|protocol discontinuation criteria|3
6823388|NCT00103857|10826493|FG003|50-Week Extension Study|protocol discontinuation criteria|2
6823389|NCT00103857|10826494|FG004|50-Week Extension Study|protocol discontinuation criteria|3
6823390|NCT00103857|10826495|FG005|50-Week Extension Study|protocol discontinuation criteria|3
6823391|NCT00103857|10826496|FG006|50-Week Extension Study|protocol discontinuation criteria|0
6823392|NCT00103857|10826490|FG000|50-Week Extension Study|non-compliance with study procedures|1
6823393|NCT00103857|10826491|FG001|50-Week Extension Study|non-compliance with study procedures|0
6823394|NCT00103857|10826492|FG002|50-Week Extension Study|non-compliance with study procedures|0
6823395|NCT00103857|10826493|FG003|50-Week Extension Study|non-compliance with study procedures|1
6823396|NCT00103857|10826494|FG004|50-Week Extension Study|non-compliance with study procedures|1
6823397|NCT00103857|10826495|FG005|50-Week Extension Study|non-compliance with study procedures|0
6823398|NCT00103857|10826496|FG006|50-Week Extension Study|non-compliance with study procedures|0
6823399|NCT00103857|10826490|FG000|50-Week Extension Study|patient moved|0
6823400|NCT00103857|10826491|FG001|50-Week Extension Study|patient moved|0
6823401|NCT00103857|10826492|FG002|50-Week Extension Study|patient moved|1
6823402|NCT00103857|10826493|FG003|50-Week Extension Study|patient moved|2
6823403|NCT00103857|10826494|FG004|50-Week Extension Study|patient moved|0
6823404|NCT00103857|10826495|FG005|50-Week Extension Study|patient moved|0
6823405|NCT00103857|10826496|FG006|50-Week Extension Study|patient moved|0
6823406|NCT00103857|10826490|FG000|50-Week Extension Study|patient scheduled for elective surgery|0
6823407|NCT00103857|10826491|FG001|50-Week Extension Study|patient scheduled for elective surgery|0
6823408|NCT00103857|10826492|FG002|50-Week Extension Study|patient scheduled for elective surgery|1
6823409|NCT00103857|10826493|FG003|50-Week Extension Study|patient scheduled for elective surgery|0
6823410|NCT00103857|10826494|FG004|50-Week Extension Study|patient scheduled for elective surgery|0
6823411|NCT00103857|10826495|FG005|50-Week Extension Study|patient scheduled for elective surgery|0
6823412|NCT00103857|10826496|FG006|50-Week Extension Study|patient scheduled for elective surgery|0
6823413|NCT00103857|10826490|FG000|50-Week Extension Study|reason unspecified|0
6823414|NCT00103857|10826491|FG001|50-Week Extension Study|reason unspecified|0
6823415|NCT00103857|10826492|FG002|50-Week Extension Study|reason unspecified|0
6823416|NCT00103857|10826493|FG003|50-Week Extension Study|reason unspecified|0
6823417|NCT00103857|10826494|FG004|50-Week Extension Study|reason unspecified|1
6823418|NCT00103857|10826495|FG005|50-Week Extension Study|reason unspecified|0
6823419|NCT00103857|10826496|FG006|50-Week Extension Study|reason unspecified|0
6823420|NCT00104052|10826511|FG000|Overall Study|Adverse Event|1
6823421|NCT00104052|10826511|FG000|Overall Study|Lack of Efficacy|26
6823422|NCT00104052|10826511|FG000|Overall Study|Discontinuation unrelated to treatment|2
6823423|NCT00104104|10826517|FG000|Overall Study|Adverse Event|8
6823424|NCT00104104|10826518|FG001|Overall Study|Adverse Event|8
6823425|NCT00104104|10826517|FG000|Overall Study|Abnormal laboratory value(s)|20
6823426|NCT00104104|10826518|FG001|Overall Study|Abnormal laboratory value(s)|14
6823427|NCT00104104|10826517|FG000|Overall Study|Lack of Efficacy|0
6823428|NCT00104104|10826518|FG001|Overall Study|Lack of Efficacy|3
6823429|NCT00104104|10826517|FG000|Overall Study|Condition no longer requires study drug|7
6823430|NCT00104104|10826518|FG001|Overall Study|Condition no longer requires study drug|4
6823431|NCT00104104|10826517|FG000|Overall Study|Protocol Violation|5
6823432|NCT00104104|10826518|FG001|Overall Study|Protocol Violation|2
6823433|NCT00104104|10826517|FG000|Overall Study|Withdrawal by Subject|11
6823434|NCT00104104|10826518|FG001|Overall Study|Withdrawal by Subject|15
6823435|NCT00104104|10826517|FG000|Overall Study|Lost to Follow-up|3
6823436|NCT00104104|10826518|FG001|Overall Study|Lost to Follow-up|7
6823437|NCT00104104|10826517|FG000|Overall Study|Administrative problems|12
6823438|NCT00104104|10826518|FG001|Overall Study|Administrative problems|13
6823439|NCT00104104|10826517|FG000|Overall Study|Death|9
6823440|NCT00104104|10826518|FG001|Overall Study|Death|6
6823441|NCT00104247|10826535|FG000|Overall Study|Withdrawal by Subject|1
6823442|NCT00104247|10826536|FG001|Overall Study|Withdrawal by Subject|0
6823443|NCT00104247|10826535|FG000|Overall Study|Noncompliant with dosing|0
6823444|NCT00104247|10826536|FG001|Overall Study|Noncompliant with dosing|1
6823445|NCT00104299|10826544|FG000|Overall Study|Adverse Event|3
6823446|NCT00104299|10826545|FG001|Overall Study|Adverse Event|1
6823447|NCT00104299|10826544|FG000|Overall Study|Death|2
6823448|NCT00104299|10826545|FG001|Overall Study|Death|2
6823449|NCT00104299|10826544|FG000|Overall Study|Withdrawal by Subject|2
6823450|NCT00104299|10826545|FG001|Overall Study|Withdrawal by Subject|6
6823451|NCT00104299|10826544|FG000|Overall Study|Physician Decision|1
6823452|NCT00104299|10826545|FG001|Overall Study|Physician Decision|1
6823453|NCT00104299|10826544|FG000|Overall Study|To have renal transplant|1
6823454|NCT00104299|10826545|FG001|Overall Study|To have renal transplant|0
6823455|NCT00104416|10826553|FG000|Double-Blind Phase|Adverse Event|2
6823456|NCT00104416|10826554|FG001|Double-Blind Phase|Adverse Event|1
6823457|NCT00104416|10826555|FG002|Double-Blind Phase|Adverse Event|0
6823458|NCT00104416|10826556|FG003|Double-Blind Phase|Adverse Event|0
6823459|NCT00104416|10826557|FG004|Double-Blind Phase|Adverse Event|0
6823460|NCT00104416|10826553|FG000|Double-Blind Phase|Lost to Follow-up|0
6823461|NCT00104416|10826554|FG001|Double-Blind Phase|Lost to Follow-up|1
6823462|NCT00104416|10826555|FG002|Double-Blind Phase|Lost to Follow-up|0
6823463|NCT00104416|10826556|FG003|Double-Blind Phase|Lost to Follow-up|0
6823464|NCT00104416|10826557|FG004|Double-Blind Phase|Lost to Follow-up|0
6823465|NCT00104416|10826553|FG000|Double-Blind Phase|Protocol Violation|0
6823466|NCT00104416|10826554|FG001|Double-Blind Phase|Protocol Violation|1
6823467|NCT00104416|10826555|FG002|Double-Blind Phase|Protocol Violation|0
6823468|NCT00104416|10826556|FG003|Double-Blind Phase|Protocol Violation|0
6823469|NCT00104416|10826557|FG004|Double-Blind Phase|Protocol Violation|0
6823470|NCT00104416|10826553|FG000|Double-Blind Phase|Withdrawal by Subject|2
6823471|NCT00104416|10826554|FG001|Double-Blind Phase|Withdrawal by Subject|3
6823472|NCT00104416|10826555|FG002|Double-Blind Phase|Withdrawal by Subject|0
6823473|NCT00104416|10826556|FG003|Double-Blind Phase|Withdrawal by Subject|0
6823474|NCT00104416|10826557|FG004|Double-Blind Phase|Withdrawal by Subject|0
6823475|NCT00104416|10826553|FG000|Double-Blind Phase|Pregnancy|1
6823476|NCT00104416|10826554|FG001|Double-Blind Phase|Pregnancy|0
6823477|NCT00104416|10826555|FG002|Double-Blind Phase|Pregnancy|0
6823478|NCT00104416|10826556|FG003|Double-Blind Phase|Pregnancy|0
6823479|NCT00104416|10826557|FG004|Double-Blind Phase|Pregnancy|0
6823480|NCT00104416|10826553|FG000|Double-Blind Phase|Participant Did Not Take Drug|3
6823481|NCT00104416|10826554|FG001|Double-Blind Phase|Participant Did Not Take Drug|4
6823482|NCT00104416|10826555|FG002|Double-Blind Phase|Participant Did Not Take Drug|0
6823483|NCT00104416|10826556|FG003|Double-Blind Phase|Participant Did Not Take Drug|0
6823484|NCT00104416|10826557|FG004|Double-Blind Phase|Participant Did Not Take Drug|0
6823485|NCT00104416|10826553|FG000|Continuation Phase|Adverse Event|0
6823486|NCT00104416|10826554|FG001|Continuation Phase|Adverse Event|0
6823487|NCT00104416|10826555|FG002|Continuation Phase|Adverse Event|2
6823488|NCT00104416|10826556|FG003|Continuation Phase|Adverse Event|0
6823489|NCT00104416|10826557|FG004|Continuation Phase|Adverse Event|2
6823490|NCT00104416|10826553|FG000|Continuation Phase|Lost to Follow-up|0
6823491|NCT00104416|10826554|FG001|Continuation Phase|Lost to Follow-up|0
6823492|NCT00104416|10826555|FG002|Continuation Phase|Lost to Follow-up|1
6823493|NCT00104416|10826556|FG003|Continuation Phase|Lost to Follow-up|0
6823494|NCT00104416|10826557|FG004|Continuation Phase|Lost to Follow-up|1
6823495|NCT00104416|10826553|FG000|Continuation Phase|Withdrawal by Subject|0
6823496|NCT00104416|10826554|FG001|Continuation Phase|Withdrawal by Subject|0
6823497|NCT00104416|10826555|FG002|Continuation Phase|Withdrawal by Subject|2
6823498|NCT00104416|10826556|FG003|Continuation Phase|Withdrawal by Subject|1
6823499|NCT00104416|10826557|FG004|Continuation Phase|Withdrawal by Subject|1
6823500|NCT00104416|10826553|FG000|Continuation Phase|Pregnancy|0
6823501|NCT00104416|10826554|FG001|Continuation Phase|Pregnancy|0
6823502|NCT00104416|10826555|FG002|Continuation Phase|Pregnancy|1
6823503|NCT00104416|10826556|FG003|Continuation Phase|Pregnancy|1
6823504|NCT00104416|10826557|FG004|Continuation Phase|Pregnancy|0
6823505|NCT00104416|10826553|FG000|Continuation Phase|Non-compliance|0
6823506|NCT00104416|10826554|FG001|Continuation Phase|Non-compliance|0
6823507|NCT00104416|10826555|FG002|Continuation Phase|Non-compliance|0
6823508|NCT00104416|10826556|FG003|Continuation Phase|Non-compliance|0
6823509|NCT00104416|10826557|FG004|Continuation Phase|Non-compliance|1
6823510|NCT00104520|10826571|FG000|Overall Study|Unrelated adverse event|34
6823511|NCT00104520|10826572|FG001|Overall Study|Unrelated adverse event|47
6823512|NCT00104520|10826571|FG000|Overall Study|Study drug intolerance|0
6823513|NCT00104520|10826572|FG001|Overall Study|Study drug intolerance|1
6823514|NCT00104520|10826571|FG000|Overall Study|Related adverse event|13
6823515|NCT00104520|10826572|FG001|Overall Study|Related adverse event|15
6823516|NCT00104520|10826571|FG000|Overall Study|Lost to Follow-up|1
6823517|NCT00104520|10826572|FG001|Overall Study|Lost to Follow-up|0
6823518|NCT00104520|10826571|FG000|Overall Study|Noncompliance|0
6823519|NCT00104520|10826572|FG001|Overall Study|Noncompliance|2
6823520|NCT00104520|10826571|FG000|Overall Study|Personal/administrative|1
6823521|NCT00104520|10826572|FG001|Overall Study|Personal/administrative|1
6823522|NCT00104520|10826571|FG000|Overall Study|Other|1
6823523|NCT00104520|10826572|FG001|Overall Study|Other|5
6823524|NCT00104572|10826581|FG000|Overall Study|Withdrawal by Subject|3
6823525|NCT00104572|10826582|FG001|Overall Study|Withdrawal by Subject|3
6823526|NCT00104572|10826583|FG002|Overall Study|Withdrawal by Subject|0
6823527|NCT00104637|10826591|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1
6823528|NCT00104637|10826592|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0
6823529|NCT00104650|10826604|FG000|Treatment Period (25 Weeks)|Physician Decision|0
6823530|NCT00104650|10826605|FG001|Treatment Period (25 Weeks)|Physician Decision|0
6823531|NCT00104650|10826606|FG002|Treatment Period (25 Weeks)|Physician Decision|1
6823532|NCT00104650|10826604|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2
6823533|NCT00104650|10826605|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1
6823534|NCT00104650|10826606|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1
6823535|NCT00104650|10826604|FG000|Treatment Period (25 Weeks)|Death|7
6823536|NCT00104650|10826605|FG001|Treatment Period (25 Weeks)|Death|5
6823537|NCT00104650|10826606|FG002|Treatment Period (25 Weeks)|Death|6
6823538|NCT00104650|10826604|FG000|Treatment Period (25 Weeks)|Disease progression|2
6823539|NCT00104650|10826605|FG001|Treatment Period (25 Weeks)|Disease progression|3
6823540|NCT00104650|10826606|FG002|Treatment Period (25 Weeks)|Disease progression|2
6823541|NCT00104650|10826604|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0
6823542|NCT00104650|10826605|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1
6823543|NCT00104650|10826606|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0
6823544|NCT00104650|10826604|FG000|Treatment Period (25 Weeks)|Other|1
6823545|NCT00104650|10826605|FG001|Treatment Period (25 Weeks)|Other|0
6823546|NCT00104650|10826606|FG002|Treatment Period (25 Weeks)|Other|0
6823547|NCT00104650|10826604|FG000|Treatment Period (25 Weeks)|Protocol deviation|0
6823548|NCT00104650|10826605|FG001|Treatment Period (25 Weeks)|Protocol deviation|1
6823549|NCT00104650|10826606|FG002|Treatment Period (25 Weeks)|Protocol deviation|0
6823550|NCT00104650|10826604|FG000|Follow-up Period|Physician Decision|1
6823551|NCT00104650|10826605|FG001|Follow-up Period|Physician Decision|1
6823552|NCT00104650|10826606|FG002|Follow-up Period|Physician Decision|0
6823553|NCT00104650|10826604|FG000|Follow-up Period|Adverse Event|1
6823554|NCT00104650|10826605|FG001|Follow-up Period|Adverse Event|0
6823555|NCT00104650|10826606|FG002|Follow-up Period|Adverse Event|1
6823556|NCT00104650|10826604|FG000|Follow-up Period|Withdrawal by Subject|0
6823557|NCT00104650|10826605|FG001|Follow-up Period|Withdrawal by Subject|3
6823558|NCT00104650|10826606|FG002|Follow-up Period|Withdrawal by Subject|3
6823559|NCT00104650|10826604|FG000|Follow-up Period|Death|6
6823560|NCT00104650|10826605|FG001|Follow-up Period|Death|6
6823561|NCT00104650|10826606|FG002|Follow-up Period|Death|4
6823562|NCT00104650|10826604|FG000|Follow-up Period|Disease progression|3
6823563|NCT00104650|10826605|FG001|Follow-up Period|Disease progression|1
6823564|NCT00104650|10826606|FG002|Follow-up Period|Disease progression|0
6823565|NCT00104650|10826604|FG000|Follow-up Period|Lost to Follow-up|0
6823566|NCT00104650|10826605|FG001|Follow-up Period|Lost to Follow-up|1
6823567|NCT00104650|10826606|FG002|Follow-up Period|Lost to Follow-up|2
6823568|NCT00104650|10826604|FG000|Follow-up Period|Other|0
6823569|NCT00104650|10826605|FG001|Follow-up Period|Other|1
6823570|NCT00104650|10826606|FG002|Follow-up Period|Other|0
6823571|NCT00104871|10826620|FG000|Overall Study|Not evaluable|1
6823572|NCT00104884|10826624|FG000|Overall Study|Disease progression|4
6823573|NCT00105066|10826668|FG000|Overall Study|Adverse Event|2
6823574|NCT00105066|10826669|FG001|Overall Study|Adverse Event|5
6823575|NCT00105079|10826677|FG000|Overall Study|Adverse Event|5
6823576|NCT00105079|10826678|FG001|Overall Study|Adverse Event|12
6823577|NCT00105079|10826677|FG000|Overall Study|Death|3
6823578|NCT00105079|10826678|FG001|Overall Study|Death|1
6823579|NCT00105079|10826677|FG000|Overall Study|Lost to Follow-up|12
6823580|NCT00105079|10826678|FG001|Overall Study|Lost to Follow-up|12
6823581|NCT00105079|10826677|FG000|Overall Study|Lack of Efficacy|9
6823582|NCT00105079|10826678|FG001|Overall Study|Lack of Efficacy|3
6823583|NCT00105079|10826677|FG000|Overall Study|Refused treatment|6
6823584|NCT00105079|10826678|FG001|Overall Study|Refused treatment|4
6823585|NCT00105079|10826677|FG000|Overall Study|Violation of selection criteria at entry|0
6823586|NCT00105079|10826678|FG001|Overall Study|Violation of selection criteria at entry|2
6823587|NCT00105079|10826677|FG000|Overall Study|Protocol Violation|1
6823588|NCT00105079|10826678|FG001|Overall Study|Protocol Violation|0
6823589|NCT00105079|10826677|FG000|Overall Study|Other|3
6823590|NCT00105079|10826678|FG001|Overall Study|Other|1
6823591|NCT00105157|10826688|FG000|Double-Blind (DB)|Never Treated|1
6823592|NCT00105157|10826689|FG001|Double-Blind (DB)|Never Treated|0
6823593|NCT00105157|10826690|FG002|Double-Blind (DB)|Never Treated|0
6823594|NCT00105157|10826691|FG003|Double-Blind (DB)|Never Treated|0
6823595|NCT00105157|10826688|FG000|Double-Blind (DB)|Adverse Event|2
6823596|NCT00105157|10826689|FG001|Double-Blind (DB)|Adverse Event|0
6823597|NCT00105157|10826690|FG002|Double-Blind (DB)|Adverse Event|1
6823598|NCT00105157|10826691|FG003|Double-Blind (DB)|Adverse Event|1
6823599|NCT00105157|10826688|FG000|Double-Blind (DB)|Lack of Efficacy|11
6823600|NCT00105157|10826689|FG001|Double-Blind (DB)|Lack of Efficacy|14
6823601|NCT00105157|10826690|FG002|Double-Blind (DB)|Lack of Efficacy|11
6823602|NCT00105157|10826691|FG003|Double-Blind (DB)|Lack of Efficacy|38
6823603|NCT00105157|10826688|FG000|Open-Label Continuation of DB|Adverse Event|3
6823604|NCT00105157|10826689|FG001|Open-Label Continuation of DB|Adverse Event|1
6823605|NCT00105157|10826690|FG002|Open-Label Continuation of DB|Adverse Event|0
6823606|NCT00105157|10826691|FG003|Open-Label Continuation of DB|Adverse Event|0
6823607|NCT00105157|10826688|FG000|Open-Label Continuation of DB|Lack of Efficacy|1
6823608|NCT00105157|10826689|FG001|Open-Label Continuation of DB|Lack of Efficacy|4
6823609|NCT00105157|10826690|FG002|Open-Label Continuation of DB|Lack of Efficacy|3
6823610|NCT00105157|10826691|FG003|Open-Label Continuation of DB|Lack of Efficacy|1
6823611|NCT00105157|10826688|FG000|Open-Label Continuation of DB|Lost to Follow-up|1
6823612|NCT00105157|10826689|FG001|Open-Label Continuation of DB|Lost to Follow-up|1
6823613|NCT00105157|10826690|FG002|Open-Label Continuation of DB|Lost to Follow-up|1
6823614|NCT00105157|10826691|FG003|Open-Label Continuation of DB|Lost to Follow-up|0
6823615|NCT00105157|10826688|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0
6823616|NCT00105157|10826689|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1
6823617|NCT00105157|10826690|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3
6823618|NCT00105157|10826691|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0
6823619|NCT00105157|10826688|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1
6823620|NCT00105157|10826689|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0
6823621|NCT00105157|10826690|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0
6823622|NCT00105157|10826691|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0
6823623|NCT00105157|10826688|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1
6823624|NCT00105157|10826689|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3
6823625|NCT00105157|10826690|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2
6823626|NCT00105157|10826691|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0
6823627|NCT00105157|10826688|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
6823628|NCT00105157|10826689|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
6823629|NCT00105157|10826690|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
6823630|NCT00105157|10826691|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1
6823631|NCT00105157|10826688|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7
6823632|NCT00105157|10826689|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6
6823633|NCT00105157|10826690|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5
6823634|NCT00105157|10826691|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10
6823635|NCT00105157|10826688|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
6823636|NCT00105157|10826689|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
6823637|NCT00105157|10826690|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
6823638|NCT00105157|10826691|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
6823639|NCT00105157|10826688|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
6823640|NCT00105157|10826689|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
6823641|NCT00105157|10826690|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
6823642|NCT00105157|10826691|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5
6823643|NCT00105157|10826688|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
6823644|NCT00105157|10826689|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0
6823645|NCT00105157|10826690|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
6823646|NCT00105157|10826691|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
6823647|NCT00105183|10826702|FG000|Overall Study|Death|19
6823648|NCT00105183|10826703|FG001|Overall Study|Death|13
6823649|NCT00105183|10826704|FG002|Overall Study|Death|15
6823650|NCT00105183|10826702|FG000|Overall Study|Withdrawal by Subject|1
6823651|NCT00105183|10826703|FG001|Overall Study|Withdrawal by Subject|1
6823652|NCT00105183|10826704|FG002|Overall Study|Withdrawal by Subject|4
6823653|NCT00105183|10826702|FG000|Overall Study|Physician Decision|1
6823654|NCT00105183|10826703|FG001|Overall Study|Physician Decision|2
6823655|NCT00105183|10826704|FG002|Overall Study|Physician Decision|3
6823656|NCT00105183|10826702|FG000|Overall Study|Lost to Follow-up|0
6823657|NCT00105183|10826703|FG001|Overall Study|Lost to Follow-up|1
6823658|NCT00105183|10826704|FG002|Overall Study|Lost to Follow-up|1
6823659|NCT00105183|10826702|FG000|Overall Study|Other reason|1
6823660|NCT00105183|10826703|FG001|Overall Study|Other reason|2
6823661|NCT00105183|10826704|FG002|Overall Study|Other reason|0
6823662|NCT00105196|10826714|FG000|Overall Study|Lack of Efficacy|2
6823663|NCT00105196|10826715|FG001|Overall Study|Lack of Efficacy|3
6823664|NCT00105196|10826714|FG000|Overall Study|Adverse Event|11
6823665|NCT00105196|10826715|FG001|Overall Study|Adverse Event|3
6823666|NCT00105196|10826714|FG000|Overall Study|Withdrawal by Subject|6
6823667|NCT00105196|10826715|FG001|Overall Study|Withdrawal by Subject|6
6823668|NCT00105196|10826714|FG000|Overall Study|Lost to Follow-up|3
6823669|NCT00105196|10826715|FG001|Overall Study|Lost to Follow-up|2
6823670|NCT00105196|10826714|FG000|Overall Study|Poor/noncompliance|3
6823671|NCT00105196|10826715|FG001|Overall Study|Poor/noncompliance|4
6823672|NCT00105196|10826714|FG000|Overall Study|Protocol Violation|5
6823673|NCT00105196|10826715|FG001|Overall Study|Protocol Violation|2
6823674|NCT00105196|10826714|FG000|Overall Study|pending surgery|0
6823675|NCT00105196|10826715|FG001|Overall Study|pending surgery|1
6823676|NCT00105196|10826714|FG000|Overall Study|marijuana use|0
6823677|NCT00105196|10826715|FG001|Overall Study|marijuana use|1
6823678|NCT00105196|10826714|FG000|Overall Study|Subject became unblinded|0
6823679|NCT00105196|10826715|FG001|Overall Study|Subject became unblinded|1
6823680|NCT00105235|10826721|FG000|Overall Study|Death|4
6823681|NCT00105235|10826721|FG000|Overall Study|Physician Decision|1
6823682|NCT00105235|10826721|FG000|Overall Study|Withdrawal by Subject|2
6823683|NCT00105443|10826731|FG000|Double-Blind Treatment|Adverse Event|1
6823684|NCT00105443|10826732|FG001|Double-Blind Treatment|Adverse Event|0
6823685|NCT00105443|10826733|FG002|Double-Blind Treatment|Adverse Event|0
6823686|NCT00105443|10826734|FG003|Double-Blind Treatment|Adverse Event|0
6823687|NCT00105443|10826731|FG000|Double-Blind Treatment|Lost to Follow-up|0
6823688|NCT00105443|10826732|FG001|Double-Blind Treatment|Lost to Follow-up|0
6823689|NCT00105443|10826733|FG002|Double-Blind Treatment|Lost to Follow-up|1
6823690|NCT00105443|10826734|FG003|Double-Blind Treatment|Lost to Follow-up|0
6823691|NCT00105443|10826731|FG000|Double-Blind Treatment|Withdrawal by Subject|8
6823692|NCT00105443|10826732|FG001|Double-Blind Treatment|Withdrawal by Subject|0
6823693|NCT00105443|10826733|FG002|Double-Blind Treatment|Withdrawal by Subject|7
6823694|NCT00105443|10826734|FG003|Double-Blind Treatment|Withdrawal by Subject|0
6823695|NCT00105443|10826731|FG000|Double-Blind Treatment|Physician Decision|1
6823696|NCT00105443|10826732|FG001|Double-Blind Treatment|Physician Decision|0
6823697|NCT00105443|10826733|FG002|Double-Blind Treatment|Physician Decision|2
6823698|NCT00105443|10826734|FG003|Double-Blind Treatment|Physician Decision|0
6823699|NCT00105443|10826731|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4
6823700|NCT00105443|10826732|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0
6823701|NCT00105443|10826733|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1
6823702|NCT00105443|10826734|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0
6823703|NCT00105443|10826731|FG000|Follow-up and/or Open Label Nexavar|Death|180
6823704|NCT00105443|10826732|FG001|Follow-up and/or Open Label Nexavar|Death|7
6823705|NCT00105443|10826733|FG002|Follow-up and/or Open Label Nexavar|Death|219
6823706|NCT00105443|10826734|FG003|Follow-up and/or Open Label Nexavar|Death|4
7059554|NCT01908101|11155212|FG000|Overall Study|Did not complete the first cycle|4
6823707|NCT00105443|10826731|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14
6823708|NCT00105443|10826732|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
6823709|NCT00105443|10826733|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10
6823710|NCT00105443|10826734|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
6823711|NCT00105443|10826731|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24
6823712|NCT00105443|10826732|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3
6823713|NCT00105443|10826733|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13
6823714|NCT00105443|10826734|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4
6823715|NCT00105443|10826731|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0
6823716|NCT00105443|10826732|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14
6823717|NCT00105443|10826733|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0
6823718|NCT00105443|10826734|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16
6823719|NCT00105443|10826731|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1
6823720|NCT00105443|10826732|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0
6823721|NCT00105443|10826733|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1
6823722|NCT00105443|10826734|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0
6823723|NCT00105443|10826731|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0
6901120|NCT00669955|10921703|FG000|Overall Study|not compliant with study drug/visit|2
6901121|NCT00669955|10921704|FG001|Overall Study|not compliant with study drug/visit|3
6901122|NCT00670007|10921710|FG000|Overall Study|Drug abuse|1
6901123|NCT00670007|10921710|FG000|Overall Study|Lung transplant|1
6901124|NCT00670007|10921710|FG000|Overall Study|Travel/Vacation|1
6901125|NCT00670007|10921710|FG000|Overall Study|Adverse event, serious fatal|1
6901126|NCT00670007|10921710|FG000|Overall Study|Adverse Event|1
6901127|NCT00670007|10921710|FG000|Overall Study|Withdrawal by Subject|4
6901128|NCT00670046|10921717|FG000|Overall Study|Lost to Follow-up|1
6901129|NCT00670046|10921718|FG001|Overall Study|Lost to Follow-up|1
6901130|NCT00670046|10921717|FG000|Overall Study|Withdrawal by Subject|0
6901131|NCT00670046|10921718|FG001|Overall Study|Withdrawal by Subject|1
6901132|NCT00670111|10921727|FG000|Enrollment to One Month|Testing Failure|0
6901133|NCT00670111|10921728|FG001|Enrollment to One Month|Testing Failure|0
6901134|NCT00670111|10921729|FG002|Enrollment to One Month|Testing Failure|13
6901135|NCT00670111|10921727|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0
6901136|NCT00670111|10921728|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0
6901137|NCT00670111|10921729|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6
6901138|NCT00670111|10921727|FG000|Enrollment to One Month|Physician Decision|1
6901139|NCT00670111|10921728|FG001|Enrollment to One Month|Physician Decision|0
6901140|NCT00670111|10921729|FG002|Enrollment to One Month|Physician Decision|0
6901141|NCT00670228|10921748|FG000|Overall Study|Adverse Event|1
6901142|NCT00670228|10921749|FG001|Overall Study|Adverse Event|0
6901143|NCT00670228|10921748|FG000|Overall Study|Death or MACE|0
6901144|NCT00670228|10921749|FG001|Overall Study|Death or MACE|1
6901145|NCT00670228|10921748|FG000|Overall Study|Not treated|2
6901146|NCT00670228|10921749|FG001|Overall Study|Not treated|2
6901147|NCT00670228|10921748|FG000|Overall Study|Not meeting the selection criteria|2
6901148|NCT00670228|10921749|FG001|Overall Study|Not meeting the selection criteria|0
6901149|NCT00670306|10921774|FG000|Overall Study|Adverse Event|8
6901150|NCT00670306|10921774|FG000|Overall Study|Lack of Efficacy|10
6901151|NCT00670306|10921774|FG000|Overall Study|Withdrawal by Subject|9
6901152|NCT00670306|10921774|FG000|Overall Study|Physician Decision|1
6901153|NCT00670306|10921774|FG000|Overall Study|Lost to Follow-up|8
6901154|NCT00670306|10921774|FG000|Overall Study|incl/excl criterias did not meet|19
6901155|NCT00670449|10921782|FG000|Overall Study|Adverse Event|6
6901156|NCT00670449|10921783|FG001|Overall Study|Adverse Event|2
6901157|NCT00670449|10921784|FG002|Overall Study|Adverse Event|8
6901158|NCT00670449|10921785|FG003|Overall Study|Adverse Event|5
6901159|NCT00670449|10921782|FG000|Overall Study|Protocol Deviation|1
6901160|NCT00670449|10921783|FG001|Overall Study|Protocol Deviation|2
6901161|NCT00670449|10921784|FG002|Overall Study|Protocol Deviation|0
6901162|NCT00670449|10921785|FG003|Overall Study|Protocol Deviation|1
7059555|NCT01908140|11155227|FG000|Overall Study|Other or Progressive Disease|5
7059556|NCT01908140|11155228|FG001|Overall Study|Other or Progressive Disease|12
7059557|NCT01908140|11155227|FG000|Overall Study|Lack of Efficacy|7
7059558|NCT01908140|11155228|FG001|Overall Study|Lack of Efficacy|5
7059559|NCT01908140|11155227|FG000|Overall Study|Withdrawal by Subject|23
7059560|NCT01908140|11155228|FG001|Overall Study|Withdrawal by Subject|24
7059561|NCT01908140|11155227|FG000|Overall Study|Lost to Follow-up|1
7059562|NCT01908140|11155228|FG001|Overall Study|Lost to Follow-up|6
7059563|NCT01908140|11155227|FG000|Overall Study|Protocol Violation|8
7059564|NCT01908140|11155228|FG001|Overall Study|Protocol Violation|9
7059565|NCT01908140|11155227|FG000|Overall Study|Adverse Event|22
7059566|NCT01908140|11155228|FG001|Overall Study|Adverse Event|23
7059567|NCT01908205|11155236|FG000|Overall Study|Lost to Follow-up|2
7059568|NCT01908205|11155237|FG001|Overall Study|Lost to Follow-up|0
7059569|NCT01908205|11155236|FG000|Overall Study|Withdrawal by Subject|3
7059570|NCT01908205|11155237|FG001|Overall Study|Withdrawal by Subject|1
7059571|NCT01908426|11155258|FG000|Overall Study|Adverse Event|98
6901163|NCT00670449|10921782|FG000|Overall Study|Administrative Problems|0
6901164|NCT00670449|10921783|FG001|Overall Study|Administrative Problems|2
6901165|NCT00670449|10921784|FG002|Overall Study|Administrative Problems|0
6901166|NCT00670449|10921785|FG003|Overall Study|Administrative Problems|1
7059572|NCT01908426|11155259|FG001|Overall Study|Adverse Event|11
6901167|NCT00670449|10921782|FG000|Overall Study|Subject Withdrew Consent|0
7059573|NCT01908426|11155258|FG000|Overall Study|Clinical Deterioration|72
6901168|NCT00670449|10921783|FG001|Overall Study|Subject Withdrew Consent|2
7059574|NCT01908426|11155259|FG001|Overall Study|Clinical Deterioration|38
7059575|NCT01908426|11155258|FG000|Overall Study|Lack of Efficacy|3
7059576|NCT01908426|11155259|FG001|Overall Study|Lack of Efficacy|0
6823724|NCT00105443|10826732|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2
6823725|NCT00105443|10826733|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0
6823726|NCT00105443|10826734|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0
6823727|NCT00105443|10826731|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
6823728|NCT00105443|10826732|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2
6823729|NCT00105443|10826733|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
6823730|NCT00105443|10826734|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5
6823731|NCT00105443|10826731|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
6823732|NCT00105443|10826732|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
6823733|NCT00105443|10826733|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
6823734|NCT00105443|10826734|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
6823735|NCT00105443|10826731|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6
6823736|NCT00105443|10826732|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
6823737|NCT00105443|10826733|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1
6823738|NCT00105443|10826734|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
6823739|NCT00105443|10826731|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
6823740|NCT00105443|10826732|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
6823741|NCT00105443|10826733|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1
6823742|NCT00105443|10826734|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
6823743|NCT00105443|10826731|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1
6823744|NCT00105443|10826732|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
6823745|NCT00105443|10826733|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
6823746|NCT00105443|10826734|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
6823747|NCT00105443|10826731|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
6901169|NCT00670449|10921784|FG002|Overall Study|Subject Withdrew Consent|0
6901170|NCT00670449|10921785|FG003|Overall Study|Subject Withdrew Consent|1
6901171|NCT00670449|10921782|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2
6901172|NCT00670449|10921783|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0
6901173|NCT00670449|10921784|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1
6901174|NCT00670449|10921785|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0
6901175|NCT00670449|10921782|FG000|Overall Study|Abnormal Laboratory Value(s)|0
6901176|NCT00670449|10921783|FG001|Overall Study|Abnormal Laboratory Value(s)|2
6901177|NCT00670449|10921784|FG002|Overall Study|Abnormal Laboratory Value(s)|0
6901178|NCT00670449|10921785|FG003|Overall Study|Abnormal Laboratory Value(s)|0
6901179|NCT00670488|10921815|FG000|Overall Study|Adverse Event|0
6901180|NCT00670488|10921816|FG001|Overall Study|Adverse Event|7
6901181|NCT00670488|10921817|FG002|Overall Study|Adverse Event|0
6901182|NCT00670488|10921818|FG003|Overall Study|Adverse Event|3
6901183|NCT00670488|10921819|FG004|Overall Study|Adverse Event|1
6901184|NCT00670488|10921820|FG005|Overall Study|Adverse Event|1
6901185|NCT00670488|10921821|FG006|Overall Study|Adverse Event|5
6901186|NCT00670488|10921822|FG007|Overall Study|Adverse Event|1
6901187|NCT00670488|10921823|FG008|Overall Study|Adverse Event|0
6901188|NCT00670488|10921824|FG009|Overall Study|Adverse Event|1
6901189|NCT00670488|10921815|FG000|Overall Study|Physician Decision|1
6901190|NCT00670488|10921816|FG001|Overall Study|Physician Decision|9
6901191|NCT00670488|10921817|FG002|Overall Study|Physician Decision|0
6901192|NCT00670488|10921818|FG003|Overall Study|Physician Decision|1
6901193|NCT00670488|10921819|FG004|Overall Study|Physician Decision|0
6901194|NCT00670488|10921820|FG005|Overall Study|Physician Decision|0
6901195|NCT00670488|10921821|FG006|Overall Study|Physician Decision|0
6901196|NCT00670488|10921822|FG007|Overall Study|Physician Decision|0
6901197|NCT00670488|10921823|FG008|Overall Study|Physician Decision|0
6901198|NCT00670488|10921824|FG009|Overall Study|Physician Decision|0
6901199|NCT00670488|10921815|FG000|Overall Study|Progressive Disease|2
6901200|NCT00670488|10921816|FG001|Overall Study|Progressive Disease|41
6901201|NCT00670488|10921817|FG002|Overall Study|Progressive Disease|3
6901202|NCT00670488|10921818|FG003|Overall Study|Progressive Disease|2
7059577|NCT01908426|11155258|FG000|Overall Study|Lost to Follow-up|0
7059578|NCT01908426|11155259|FG001|Overall Study|Lost to Follow-up|1
7059579|NCT01908426|11155258|FG000|Overall Study|Physician Decision|3
7059580|NCT01908426|11155259|FG001|Overall Study|Physician Decision|3
7059581|NCT01908426|11155258|FG000|Overall Study|Withdrawal by Subject|11
7059582|NCT01908426|11155259|FG001|Overall Study|Withdrawal by Subject|6
7059583|NCT01908426|11155258|FG000|Overall Study|Progressive Disease|206
7059584|NCT01908426|11155259|FG001|Overall Study|Progressive Disease|152
7059585|NCT01908426|11155258|FG000|Overall Study|Protocol Violation|1
7059586|NCT01908426|11155259|FG001|Overall Study|Protocol Violation|0
7059587|NCT01908426|11155258|FG000|Overall Study|No Study Treatment Given|3
7059588|NCT01908426|11155259|FG001|Overall Study|No Study Treatment Given|0
6901203|NCT00670488|10921819|FG004|Overall Study|Progressive Disease|2
6901204|NCT00670488|10921820|FG005|Overall Study|Progressive Disease|4
6901205|NCT00670488|10921821|FG006|Overall Study|Progressive Disease|11
6901206|NCT00670488|10921822|FG007|Overall Study|Progressive Disease|2
7059589|NCT01908582|11155281|FG000|Period 2|Physician Decision|1
6823748|NCT00105443|10826732|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
6823749|NCT00105443|10826733|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
6823750|NCT00105443|10826734|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1
6823751|NCT00105443|10826731|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
6823752|NCT00105443|10826732|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
6823753|NCT00105443|10826733|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
6823754|NCT00105443|10826734|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
6823755|NCT00105443|10826731|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
6823756|NCT00105443|10826732|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23
6823757|NCT00105443|10826733|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
6823758|NCT00105443|10826734|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11
6823759|NCT00105469|10826745|FG000|Overall Study|Adverse Event|9
6823760|NCT00105469|10826746|FG001|Overall Study|Adverse Event|8
6823761|NCT00105469|10826745|FG000|Overall Study|Protocol Violation|4
6823762|NCT00105469|10826746|FG001|Overall Study|Protocol Violation|0
6823763|NCT00105469|10826745|FG000|Overall Study|Withdrawal by Subject|2
6823764|NCT00105469|10826746|FG001|Overall Study|Withdrawal by Subject|3
7059590|NCT01908582|11155281|FG000|Period 2|Withdrawal by Subject|1
7059591|NCT01908634|11155288|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1
7059592|NCT01908634|11155288|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5
7059593|NCT01908699|11155298|FG000|Overall Study|Adverse Event|8
7059594|NCT01908699|11155299|FG001|Overall Study|Adverse Event|12
7059595|NCT01908699|11155298|FG000|Overall Study|Lack of Efficacy|2
7059596|NCT01908699|11155299|FG001|Overall Study|Lack of Efficacy|2
7059597|NCT01908699|11155298|FG000|Overall Study|Lost to Follow-up|2
7059598|NCT01908699|11155299|FG001|Overall Study|Lost to Follow-up|4
7059599|NCT01908699|11155298|FG000|Overall Study|Physician Decision|8
7059600|NCT01908699|11155299|FG001|Overall Study|Physician Decision|8
7059601|NCT01908699|11155298|FG000|Overall Study|Withdrawal by Subject|15
7059602|NCT01908699|11155299|FG001|Overall Study|Withdrawal by Subject|10
7059603|NCT01908699|11155298|FG000|Overall Study|Pregnancy|0
7059604|NCT01908699|11155299|FG001|Overall Study|Pregnancy|1
7059605|NCT01908699|11155298|FG000|Overall Study|Randomized in Error|1
7059606|NCT01908699|11155299|FG001|Overall Study|Randomized in Error|0
7059607|NCT01908699|11155298|FG000|Overall Study|Death|9
7059608|NCT01908699|11155299|FG001|Overall Study|Death|12
7059609|NCT01908699|11155298|FG000|Overall Study|Progressive Disease|30
7059610|NCT01908699|11155299|FG001|Overall Study|Progressive Disease|29
7059611|NCT01908803|11155324|FG000|Overall Study|Adverse Event|1
7059612|NCT01908803|11155325|FG001|Overall Study|Adverse Event|0
7059613|NCT01908803|11155324|FG000|Overall Study|Physician Decision|0
7059614|NCT01908803|11155325|FG001|Overall Study|Physician Decision|1
7059615|NCT01908803|11155324|FG000|Overall Study|Withdrawal by Subject|1
7059616|NCT01908803|11155325|FG001|Overall Study|Withdrawal by Subject|0
7059617|NCT01908803|11155324|FG000|Overall Study|Randomization Error|1
7059618|NCT01908803|11155325|FG001|Overall Study|Randomization Error|0
7059619|NCT01908803|11155324|FG000|Overall Study|Adverse Event (pre-treatment)|1
7059620|NCT01908803|11155325|FG001|Overall Study|Adverse Event (pre-treatment)|0
7059621|NCT01908816|11155336|FG000|Overall Study|Subject's no longer requires study drug|0
7059622|NCT01908816|11155337|FG001|Overall Study|Subject's no longer requires study drug|0
7059623|NCT01908816|11155338|FG002|Overall Study|Subject's no longer requires study drug|0
7059624|NCT01908816|11155339|FG003|Overall Study|Subject's no longer requires study drug|1
7059625|NCT01908816|11155336|FG000|Overall Study|Protocol deviation|1
7141114|NCT02982772|11295699|FG001|12M Follow-Up|Lost to Follow-up|5
7141115|NCT02982863|11295712|FG000|Overall Study|Not eligible patients|809
7141116|NCT02982863|11295713|FG001|Overall Study|Not eligible patients|4261
7141117|NCT02982863|11295714|FG002|Overall Study|Not eligible patients|1852
7141118|NCT02982863|11295715|FG003|Overall Study|Not eligible patients|1400
7141119|NCT02982863|11295716|FG004|Overall Study|Not eligible patients|492
7141120|NCT02983227|11295747|FG000|Overall Study|Adverse Event|21
7141121|NCT02983227|11295748|FG001|Overall Study|Adverse Event|3
7141122|NCT02983227|11295747|FG000|Overall Study|Death|3
7141123|NCT02983227|11295748|FG001|Overall Study|Death|0
7141124|NCT02983227|11295747|FG000|Overall Study|Lack of Efficacy|8
7141125|NCT02983227|11295748|FG001|Overall Study|Lack of Efficacy|1
7141126|NCT02983227|11295747|FG000|Overall Study|Lost to Follow-up|3
7141127|NCT02983227|11295748|FG001|Overall Study|Lost to Follow-up|0
7141128|NCT02983227|11295747|FG000|Overall Study|Multiple Reasons|2
7141129|NCT02983227|11295748|FG001|Overall Study|Multiple Reasons|1
7141130|NCT02983227|11295747|FG000|Overall Study|Physician Decision|3
7141131|NCT02983227|11295748|FG001|Overall Study|Physician Decision|1
7141132|NCT02983227|11295747|FG000|Overall Study|Withdrawal by Subject|19
7141133|NCT02983227|11295748|FG001|Overall Study|Withdrawal by Subject|8
7141134|NCT02983305|11295756|FG000|Overall Study|incomplete data|2
7141135|NCT02983305|11295757|FG001|Overall Study|incomplete data|0
6823765|NCT00105469|10826745|FG000|Overall Study|Lost to Follow-up|1
7141136|NCT02983604|11295797|FG000|Overall Study|Enrolled but not Treated|0
7141137|NCT02983604|11295798|FG001|Overall Study|Enrolled but not Treated|0
7141138|NCT02983604|11295799|FG002|Overall Study|Enrolled but not Treated|1
7141139|NCT02983604|11295800|FG003|Overall Study|Enrolled but not Treated|0
7141140|NCT02984267|11295825|FG000|Overall Study|Protocol Violation|1
6823766|NCT00105469|10826746|FG001|Overall Study|Lost to Follow-up|0
6823767|NCT00105469|10826745|FG000|Overall Study|Lack of Efficacy|2
6823768|NCT00105469|10826746|FG001|Overall Study|Lack of Efficacy|0
6823769|NCT00105469|10826745|FG000|Overall Study|Other Reason|4
6823770|NCT00105469|10826746|FG001|Overall Study|Other Reason|0
6823771|NCT00105482|10826754|FG000|Overall Study|Adverse Event|1
6823772|NCT00105482|10826755|FG001|Overall Study|Adverse Event|1
6823773|NCT00105482|10826754|FG000|Overall Study|Lost to Follow-up|26
6823774|NCT00105482|10826755|FG001|Overall Study|Lost to Follow-up|17
6823775|NCT00105482|10826754|FG000|Overall Study|Withdrawal by Subject|0
6823776|NCT00105482|10826755|FG001|Overall Study|Withdrawal by Subject|1
6823777|NCT00105482|10826754|FG000|Overall Study|Lost Interest|29
6823778|NCT00105482|10826755|FG001|Overall Study|Lost Interest|32
6823779|NCT00105482|10826754|FG000|Overall Study|Scheduling Conflict|2
6823780|NCT00105482|10826755|FG001|Overall Study|Scheduling Conflict|3
6901207|NCT00670488|10921823|FG008|Overall Study|Progressive Disease|2
6901208|NCT00670488|10921824|FG009|Overall Study|Progressive Disease|1
6901209|NCT00670488|10921815|FG000|Overall Study|Withdrawal by Subject|0
6901210|NCT00670488|10921816|FG001|Overall Study|Withdrawal by Subject|1
6901211|NCT00670488|10921817|FG002|Overall Study|Withdrawal by Subject|0
6901212|NCT00670488|10921818|FG003|Overall Study|Withdrawal by Subject|1
6901213|NCT00670488|10921819|FG004|Overall Study|Withdrawal by Subject|0
6901214|NCT00670488|10921820|FG005|Overall Study|Withdrawal by Subject|0
6901215|NCT00670488|10921821|FG006|Overall Study|Withdrawal by Subject|1
6978640|NCT01214616|11032142|FG002|Overall Study|Withdrawal by Subject|0
6978641|NCT01214616|11032143|FG003|Overall Study|Withdrawal by Subject|1
6978642|NCT01214629|11032172|FG000|Overall Study|Progressive Disease|1
6978643|NCT01214629|11032173|FG001|Overall Study|Progressive Disease|1
6978644|NCT01214629|11032174|FG002|Overall Study|Progressive Disease|0
6978645|NCT01214629|11032175|FG003|Overall Study|Progressive Disease|1
6978646|NCT01214629|11032176|FG004|Overall Study|Progressive Disease|2
6978647|NCT01214629|11032177|FG005|Overall Study|Progressive Disease|3
6978648|NCT01214629|11032178|FG006|Overall Study|Progressive Disease|1
6978649|NCT01214629|11032179|FG007|Overall Study|Progressive Disease|1
6978650|NCT01214629|11032180|FG008|Overall Study|Progressive Disease|1
6978651|NCT01214629|11032181|FG009|Overall Study|Progressive Disease|5
6978652|NCT01214629|11032182|FG010|Overall Study|Progressive Disease|1
6978653|NCT01214629|11032172|FG000|Overall Study|Adverse Event|0
6978654|NCT01214629|11032173|FG001|Overall Study|Adverse Event|0
6978655|NCT01214629|11032174|FG002|Overall Study|Adverse Event|0
6978656|NCT01214629|11032175|FG003|Overall Study|Adverse Event|1
7059626|NCT01908816|11155337|FG001|Overall Study|Protocol deviation|2
7059627|NCT01908816|11155338|FG002|Overall Study|Protocol deviation|1
7059628|NCT01908816|11155339|FG003|Overall Study|Protocol deviation|1
7059629|NCT01908816|11155336|FG000|Overall Study|Withdrawal by Subject|0
7059630|NCT01908816|11155337|FG001|Overall Study|Withdrawal by Subject|4
7059631|NCT01908816|11155338|FG002|Overall Study|Withdrawal by Subject|2
7059632|NCT01908816|11155339|FG003|Overall Study|Withdrawal by Subject|2
7059633|NCT01908816|11155336|FG000|Overall Study|Lost to Follow-up|3
7059634|NCT01908816|11155337|FG001|Overall Study|Lost to Follow-up|5
7059635|NCT01908816|11155338|FG002|Overall Study|Lost to Follow-up|4
7059636|NCT01908816|11155339|FG003|Overall Study|Lost to Follow-up|2
7059637|NCT01908816|11155336|FG000|Overall Study|Death|1
7059638|NCT01908816|11155337|FG001|Overall Study|Death|0
7059639|NCT01908816|11155338|FG002|Overall Study|Death|7
7059640|NCT01908816|11155339|FG003|Overall Study|Death|1
7059641|NCT01908816|11155336|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7059642|NCT01908816|11155337|FG001|Overall Study|Unsatisfactory therapeutic effect|13
7059643|NCT01908816|11155338|FG002|Overall Study|Unsatisfactory therapeutic effect|1
6978657|NCT01214629|11032176|FG004|Overall Study|Adverse Event|0
6978658|NCT01214629|11032177|FG005|Overall Study|Adverse Event|1
6978659|NCT01214629|11032178|FG006|Overall Study|Adverse Event|0
6978660|NCT01214629|11032179|FG007|Overall Study|Adverse Event|0
6978661|NCT01214629|11032180|FG008|Overall Study|Adverse Event|0
6978662|NCT01214629|11032181|FG009|Overall Study|Adverse Event|1
6978663|NCT01214629|11032182|FG010|Overall Study|Adverse Event|0
6978664|NCT01214629|11032172|FG000|Overall Study|Physician Decision|0
6978665|NCT01214629|11032173|FG001|Overall Study|Physician Decision|0
6978666|NCT01214629|11032174|FG002|Overall Study|Physician Decision|0
6978667|NCT01214629|11032175|FG003|Overall Study|Physician Decision|0
6978668|NCT01214629|11032176|FG004|Overall Study|Physician Decision|0
7059644|NCT01908816|11155339|FG003|Overall Study|Unsatisfactory therapeutic effect|0
7059645|NCT01908816|11155336|FG000|Overall Study|Early termination|87
7059646|NCT01908816|11155337|FG001|Overall Study|Early termination|60
7059647|NCT01908816|11155338|FG002|Overall Study|Early termination|43
7059648|NCT01908816|11155339|FG003|Overall Study|Early termination|28
7059649|NCT01908829|11155355|FG000|Overall Study|Adverse Event|13
7059650|NCT01908829|11155356|FG001|Overall Study|Adverse Event|11
7059651|NCT01908829|11155357|FG002|Overall Study|Adverse Event|13
7059652|NCT01908829|11155355|FG000|Overall Study|Lost to Follow-up|4
7059653|NCT01908829|11155356|FG001|Overall Study|Lost to Follow-up|2
6978669|NCT01214629|11032177|FG005|Overall Study|Physician Decision|0
6978670|NCT01214629|11032178|FG006|Overall Study|Physician Decision|0
6978671|NCT01214629|11032179|FG007|Overall Study|Physician Decision|0
6978672|NCT01214629|11032180|FG008|Overall Study|Physician Decision|0
6978673|NCT01214629|11032181|FG009|Overall Study|Physician Decision|0
6823781|NCT00105482|10826754|FG000|Overall Study|Withdrawn by PI|1
6823782|NCT00105482|10826755|FG001|Overall Study|Withdrawn by PI|1
6823783|NCT00105508|10826763|FG000|Overall Study|Prephase Dropout|1
6823784|NCT00105508|10826764|FG001|Overall Study|Prephase Dropout|0
6823785|NCT00105508|10826763|FG000|Overall Study|Adverse Event|16
6823786|NCT00105508|10826764|FG001|Overall Study|Adverse Event|19
6823787|NCT00105508|10826763|FG000|Overall Study|Insufficient Efficacy|1
6823788|NCT00105508|10826764|FG001|Overall Study|Insufficient Efficacy|0
6823789|NCT00105508|10826763|FG000|Overall Study|Withdrawal by Subject|10
6823790|NCT00105508|10826764|FG001|Overall Study|Withdrawal by Subject|6
6823791|NCT00105508|10826763|FG000|Overall Study|Lost to Follow-up|3
6823792|NCT00105508|10826764|FG001|Overall Study|Lost to Follow-up|0
6823793|NCT00105508|10826763|FG000|Overall Study|Protocol Violation|1
6823794|NCT00105508|10826764|FG001|Overall Study|Protocol Violation|2
6823795|NCT00105508|10826763|FG000|Overall Study|Other|8
6823796|NCT00105508|10826764|FG001|Overall Study|Other|9
6823797|NCT00105521|10826774|FG000|Overall Study|Other|1
6823798|NCT00105521|10826775|FG001|Overall Study|Other|1
6823799|NCT00105521|10826776|FG002|Overall Study|Other|2
6823800|NCT00105521|10826777|FG003|Overall Study|Other|0
6823801|NCT00105521|10826774|FG000|Overall Study|Adverse Event|10
6823802|NCT00105521|10826775|FG001|Overall Study|Adverse Event|4
6823803|NCT00105521|10826776|FG002|Overall Study|Adverse Event|10
6823804|NCT00105521|10826777|FG003|Overall Study|Adverse Event|8
6823805|NCT00105521|10826774|FG000|Overall Study|Withdrawal by Subject|1
6823806|NCT00105521|10826775|FG001|Overall Study|Withdrawal by Subject|0
6823807|NCT00105521|10826776|FG002|Overall Study|Withdrawal by Subject|1
6823808|NCT00105521|10826777|FG003|Overall Study|Withdrawal by Subject|4
6823809|NCT00105521|10826774|FG000|Overall Study|Lack of Efficacy|0
6823810|NCT00105521|10826775|FG001|Overall Study|Lack of Efficacy|0
6823811|NCT00105521|10826776|FG002|Overall Study|Lack of Efficacy|0
6823812|NCT00105521|10826777|FG003|Overall Study|Lack of Efficacy|1
6823813|NCT00105521|10826774|FG000|Overall Study|Protocol Violation|3
6823814|NCT00105521|10826775|FG001|Overall Study|Protocol Violation|5
6823815|NCT00105521|10826776|FG002|Overall Study|Protocol Violation|4
6823816|NCT00105521|10826777|FG003|Overall Study|Protocol Violation|4
6823817|NCT00105521|10826774|FG000|Overall Study|Lost to Follow-up|0
6823818|NCT00105521|10826775|FG001|Overall Study|Lost to Follow-up|1
6823819|NCT00105521|10826776|FG002|Overall Study|Lost to Follow-up|0
6823820|NCT00105521|10826777|FG003|Overall Study|Lost to Follow-up|0
6823821|NCT00105534|10826789|FG000|Overall Study|Adverse Event|2
6823822|NCT00105534|10826790|FG001|Overall Study|Adverse Event|5
6823823|NCT00105534|10826789|FG000|Overall Study|Protocol Violation|1
6823824|NCT00105534|10826790|FG001|Overall Study|Protocol Violation|4
6823825|NCT00105534|10826789|FG000|Overall Study|Withdrawal by Subject|6
6823826|NCT00105534|10826790|FG001|Overall Study|Withdrawal by Subject|6
6823827|NCT00105534|10826789|FG000|Overall Study|Lost to Follow-up|5
6823828|NCT00105534|10826790|FG001|Overall Study|Lost to Follow-up|1
6823829|NCT00105534|10826789|FG000|Overall Study|Lack of Efficacy|7
6823830|NCT00105534|10826790|FG001|Overall Study|Lack of Efficacy|15
6823831|NCT00105534|10826789|FG000|Overall Study|Treatment unmasked|1
6823832|NCT00105534|10826790|FG001|Overall Study|Treatment unmasked|0
6823833|NCT00105534|10826789|FG000|Overall Study|Other Reason|0
6823834|NCT00105534|10826790|FG001|Overall Study|Other Reason|2
6823835|NCT00105586|10826798|FG000|Overall Study|Adverse Event|4
6823836|NCT00105586|10826799|FG001|Overall Study|Adverse Event|3
6823837|NCT00105586|10826798|FG000|Overall Study|Physician Decision|13
6823838|NCT00105586|10826799|FG001|Overall Study|Physician Decision|13
6823839|NCT00105989|10826807|FG000|Acute - Open Label: Week 0-10|Adverse Event|33
7059654|NCT01908829|11155357|FG002|Overall Study|Lost to Follow-up|1
7059655|NCT01908829|11155355|FG000|Overall Study|Randomized no double-blind drug received|1
6823840|NCT00105989|10826808|FG001|Acute - Open Label: Week 0-10|Adverse Event|0
6823841|NCT00105989|10826807|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24
6823842|NCT00105989|10826808|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0
6823843|NCT00105989|10826807|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17
6823844|NCT00105989|10826808|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0
6823845|NCT00105989|10826807|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14
6823846|NCT00105989|10826808|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0
6823847|NCT00105989|10826807|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8
6823848|NCT00105989|10826808|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0
6823849|NCT00105989|10826807|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4
6823850|NCT00105989|10826808|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0
6823851|NCT00105989|10826807|FG000|Acute - Open Label: Week 0-10|Physician Decision|0
6823852|NCT00105989|10826808|FG001|Acute - Open Label: Week 0-10|Physician Decision|0
6901216|NCT00670488|10921822|FG007|Overall Study|Withdrawal by Subject|0
6901217|NCT00670488|10921823|FG008|Overall Study|Withdrawal by Subject|1
6901218|NCT00670488|10921824|FG009|Overall Study|Withdrawal by Subject|0
6901219|NCT00670540|10921846|FG000|Overall Study|ineligible|17
6901220|NCT00670540|10921846|FG000|Overall Study|not living in France|348
6901221|NCT00670540|10921846|FG000|Overall Study|refused to participate|189
6901222|NCT00670540|10921846|FG000|Overall Study|controls randomised for no follow up|2770
6901223|NCT00670540|10921846|FG000|Overall Study|missing information inclusion criteria|1
6901224|NCT00670748|10921863|FG000|Overall Study|Death during treatment|1
6823853|NCT00105989|10826807|FG000|Acute - Open Label: Week 0-10|Death|1
6823854|NCT00105989|10826808|FG001|Acute - Open Label: Week 0-10|Death|0
6823855|NCT00105989|10826807|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
6823856|NCT00105989|10826808|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
6823857|NCT00105989|10826807|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
6823858|NCT00105989|10826808|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
6823859|NCT00105989|10826807|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25
6823860|NCT00105989|10826808|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0
6823861|NCT00105989|10826807|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50
6823862|NCT00105989|10826808|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0
6823863|NCT00105989|10826807|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15
6823864|NCT00105989|10826808|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0
6823865|NCT00105989|10826807|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16
6823866|NCT00105989|10826808|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0
6823867|NCT00105989|10826807|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5
6823868|NCT00105989|10826808|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0
6823869|NCT00105989|10826807|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9
6823870|NCT00105989|10826808|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0
6823871|NCT00105989|10826807|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3
6823872|NCT00105989|10826808|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0
6823873|NCT00105989|10826807|FG000|Continuation - Open Label:Week 10-34|Death|0
6823874|NCT00105989|10826808|FG001|Continuation - Open Label:Week 10-34|Death|0
6823875|NCT00105989|10826807|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2
6823876|NCT00105989|10826808|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0
6823877|NCT00105989|10826807|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
6823878|NCT00105989|10826808|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
6823879|NCT00105989|10826807|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6
6823880|NCT00105989|10826808|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3
6823881|NCT00105989|10826807|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17
6823882|NCT00105989|10826808|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18
6823883|NCT00105989|10826807|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
6823884|NCT00105989|10826808|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
6823885|NCT00105989|10826807|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
6823886|NCT00105989|10826808|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
6823887|NCT00105989|10826807|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5
6823888|NCT00105989|10826808|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4
6823889|NCT00105989|10826807|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4
6823890|NCT00105989|10826808|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0
6823891|NCT00105989|10826807|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4
6823892|NCT00105989|10826808|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1
6823893|NCT00105989|10826807|FG000|Maintenance - Double-Blind:Week 34-86|Death|0
6823894|NCT00105989|10826808|FG001|Maintenance - Double-Blind:Week 34-86|Death|0
6823895|NCT00105989|10826807|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14
6823896|NCT00105989|10826808|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43
6823897|NCT00105989|10826807|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
6823898|NCT00105989|10826808|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
6823899|NCT00106002|10826824|FG000|Overall Study|Did not take any study drug|1
6823900|NCT00106002|10826824|FG000|Overall Study|Ineligible after Registration|1
6823901|NCT00106028|10826830|FG000|Overall Study|Adverse Event|3
6823902|NCT00106028|10826831|FG001|Overall Study|Adverse Event|2
6823903|NCT00106028|10826830|FG000|Overall Study|Protocol Violation|1
6823904|NCT00106028|10826831|FG001|Overall Study|Protocol Violation|1
6823905|NCT00106028|10826830|FG000|Overall Study|Withdrawal by Subject|2
6823906|NCT00106028|10826831|FG001|Overall Study|Withdrawal by Subject|8
6823907|NCT00106028|10826830|FG000|Overall Study|Lost to Follow-up|0
6823908|NCT00106028|10826831|FG001|Overall Study|Lost to Follow-up|1
6823909|NCT00106080|10826841|FG000|Overall Study|Withdrew/Loss to follow-up|43
6823910|NCT00106080|10826842|FG001|Overall Study|Withdrew/Loss to follow-up|27
6823911|NCT00106184|10826866|FG000|Overall Study|Withdrawal by Subject|3
6823912|NCT00106184|10826867|FG001|Overall Study|Withdrawal by Subject|2
6823913|NCT00106249|10826877|FG000|Overall Study|Lost to Follow-up|3
7059656|NCT01908829|11155356|FG001|Overall Study|Randomized no double-blind drug received|0
7059657|NCT01908829|11155357|FG002|Overall Study|Randomized no double-blind drug received|1
7059658|NCT01908829|11155355|FG000|Overall Study|Discontinued (no EoT page)|2
7059659|NCT01908829|11155356|FG001|Overall Study|Discontinued (no EoT page)|0
7059660|NCT01908829|11155357|FG002|Overall Study|Discontinued (no EoT page)|0
7059661|NCT01908829|11155355|FG000|Overall Study|Miscellaneous|0
7059662|NCT01908829|11155356|FG001|Overall Study|Miscellaneous|2
7059663|NCT01908829|11155357|FG002|Overall Study|Miscellaneous|0
7059664|NCT01908829|11155355|FG000|Overall Study|Protocol Violation|2
7059665|NCT01908829|11155356|FG001|Overall Study|Protocol Violation|2
7059666|NCT01908829|11155357|FG002|Overall Study|Protocol Violation|0
7059667|NCT01908829|11155355|FG000|Overall Study|Lack of Efficacy|1
7059668|NCT01908829|11155356|FG001|Overall Study|Lack of Efficacy|3
7059669|NCT01908829|11155357|FG002|Overall Study|Lack of Efficacy|2
7059670|NCT01908829|11155355|FG000|Overall Study|Withdrawal by Subject|26
6823914|NCT00106249|10826878|FG001|Overall Study|Lost to Follow-up|2
6823915|NCT00106353|10826886|FG000|Part 1|Disease progression|3
6823916|NCT00106353|10826887|FG001|Part 1|Disease progression|4
6823917|NCT00106353|10826888|FG002|Part 1|Disease progression|1
6823918|NCT00106353|10826889|FG003|Part 1|Disease progression|3
6823919|NCT00106353|10826890|FG004|Part 1|Disease progression|0
6823920|NCT00106353|10826891|FG005|Part 1|Disease progression|0
6823921|NCT00106353|10826892|FG006|Part 1|Disease progression|0
6823922|NCT00106353|10826886|FG000|Part 1|Withdrawal by Subject|0
6823923|NCT00106353|10826887|FG001|Part 1|Withdrawal by Subject|0
6823924|NCT00106353|10826888|FG002|Part 1|Withdrawal by Subject|1
6823925|NCT00106353|10826889|FG003|Part 1|Withdrawal by Subject|2
6823926|NCT00106353|10826890|FG004|Part 1|Withdrawal by Subject|0
6823927|NCT00106353|10826891|FG005|Part 1|Withdrawal by Subject|0
6823928|NCT00106353|10826892|FG006|Part 1|Withdrawal by Subject|0
6823929|NCT00106353|10826886|FG000|Part 1|Symptomatic deterioration|0
6823930|NCT00106353|10826887|FG001|Part 1|Symptomatic deterioration|0
6823931|NCT00106353|10826888|FG002|Part 1|Symptomatic deterioration|1
6823932|NCT00106353|10826889|FG003|Part 1|Symptomatic deterioration|0
6823933|NCT00106353|10826890|FG004|Part 1|Symptomatic deterioration|0
6823934|NCT00106353|10826891|FG005|Part 1|Symptomatic deterioration|0
6823935|NCT00106353|10826892|FG006|Part 1|Symptomatic deterioration|0
6823936|NCT00106353|10826886|FG000|Part 1|Entered follow-up phase|1
6823937|NCT00106353|10826887|FG001|Part 1|Entered follow-up phase|1
6823938|NCT00106353|10826888|FG002|Part 1|Entered follow-up phase|0
6823939|NCT00106353|10826889|FG003|Part 1|Entered follow-up phase|1
6823940|NCT00106353|10826890|FG004|Part 1|Entered follow-up phase|0
6823941|NCT00106353|10826891|FG005|Part 1|Entered follow-up phase|0
6823942|NCT00106353|10826892|FG006|Part 1|Entered follow-up phase|0
6823943|NCT00106353|10826886|FG000|Part 1|Adverse Event|0
6823944|NCT00106353|10826887|FG001|Part 1|Adverse Event|0
6823945|NCT00106353|10826888|FG002|Part 1|Adverse Event|0
6823946|NCT00106353|10826889|FG003|Part 1|Adverse Event|1
6823947|NCT00106353|10826890|FG004|Part 1|Adverse Event|0
6823948|NCT00106353|10826891|FG005|Part 1|Adverse Event|0
6823949|NCT00106353|10826892|FG006|Part 1|Adverse Event|0
6823950|NCT00106353|10826886|FG000|Part 2|Disease progression|0
6823951|NCT00106353|10826887|FG001|Part 2|Disease progression|0
6823952|NCT00106353|10826888|FG002|Part 2|Disease progression|0
6823953|NCT00106353|10826889|FG003|Part 2|Disease progression|0
6823954|NCT00106353|10826890|FG004|Part 2|Disease progression|8
6823955|NCT00106353|10826891|FG005|Part 2|Disease progression|14
6823956|NCT00106353|10826892|FG006|Part 2|Disease progression|13
6823957|NCT00106353|10826886|FG000|Part 2|Death|0
6823958|NCT00106353|10826887|FG001|Part 2|Death|0
6823959|NCT00106353|10826888|FG002|Part 2|Death|0
6823960|NCT00106353|10826889|FG003|Part 2|Death|0
6823961|NCT00106353|10826890|FG004|Part 2|Death|3
6823962|NCT00106353|10826891|FG005|Part 2|Death|0
6823963|NCT00106353|10826892|FG006|Part 2|Death|1
6823964|NCT00106353|10826886|FG000|Part 2|Symptomatic deterioration|0
6823965|NCT00106353|10826887|FG001|Part 2|Symptomatic deterioration|0
6823966|NCT00106353|10826888|FG002|Part 2|Symptomatic deterioration|0
6823967|NCT00106353|10826889|FG003|Part 2|Symptomatic deterioration|0
6823968|NCT00106353|10826890|FG004|Part 2|Symptomatic deterioration|3
6823969|NCT00106353|10826891|FG005|Part 2|Symptomatic deterioration|0
6823970|NCT00106353|10826892|FG006|Part 2|Symptomatic deterioration|0
6823971|NCT00106353|10826886|FG000|Part 2|Adverse Event|0
6823972|NCT00106353|10826887|FG001|Part 2|Adverse Event|0
6823973|NCT00106353|10826888|FG002|Part 2|Adverse Event|0
6823974|NCT00106353|10826889|FG003|Part 2|Adverse Event|0
6823975|NCT00106353|10826890|FG004|Part 2|Adverse Event|0
6823976|NCT00106353|10826891|FG005|Part 2|Adverse Event|2
6823977|NCT00106353|10826892|FG006|Part 2|Adverse Event|1
6823978|NCT00106353|10826886|FG000|Part 2|Other|0
6823979|NCT00106353|10826887|FG001|Part 2|Other|0
6823980|NCT00106353|10826888|FG002|Part 2|Other|0
6823981|NCT00106353|10826889|FG003|Part 2|Other|0
6823982|NCT00106353|10826890|FG004|Part 2|Other|1
6823983|NCT00106353|10826891|FG005|Part 2|Other|1
6823984|NCT00106353|10826892|FG006|Part 2|Other|1
6823985|NCT00106353|10826886|FG000|Part 2|Withdrawal by Subject|0
7059671|NCT01908829|11155356|FG001|Overall Study|Withdrawal by Subject|29
6823986|NCT00106353|10826887|FG001|Part 2|Withdrawal by Subject|0
6823987|NCT00106353|10826888|FG002|Part 2|Withdrawal by Subject|0
6823988|NCT00106353|10826889|FG003|Part 2|Withdrawal by Subject|0
6823989|NCT00106353|10826890|FG004|Part 2|Withdrawal by Subject|1
6823990|NCT00106353|10826891|FG005|Part 2|Withdrawal by Subject|0
6823991|NCT00106353|10826892|FG006|Part 2|Withdrawal by Subject|0
6823992|NCT00106353|10826886|FG000|Part 2|Physician Decision|0
6823993|NCT00106353|10826887|FG001|Part 2|Physician Decision|0
6823994|NCT00106353|10826888|FG002|Part 2|Physician Decision|0
6823995|NCT00106353|10826889|FG003|Part 2|Physician Decision|0
6823996|NCT00106353|10826890|FG004|Part 2|Physician Decision|0
6823997|NCT00106353|10826891|FG005|Part 2|Physician Decision|1
6823998|NCT00106353|10826892|FG006|Part 2|Physician Decision|0
6823999|NCT00106639|10826947|FG000|Overall Study|Adverse Event|3
6824000|NCT00106639|10826948|FG001|Overall Study|Adverse Event|4
6824001|NCT00106639|10826949|FG002|Overall Study|Adverse Event|1
6824002|NCT00106639|10826947|FG000|Overall Study|Protocol Violation|0
6824003|NCT00106639|10826948|FG001|Overall Study|Protocol Violation|1
6824004|NCT00106639|10826949|FG002|Overall Study|Protocol Violation|0
6824005|NCT00106639|10826947|FG000|Overall Study|Withdrawal by Subject|0
6824006|NCT00106639|10826948|FG001|Overall Study|Withdrawal by Subject|1
6824007|NCT00106639|10826949|FG002|Overall Study|Withdrawal by Subject|0
6824008|NCT00106639|10826947|FG000|Overall Study|Participant defaulted|0
6824009|NCT00106639|10826948|FG001|Overall Study|Participant defaulted|1
7059672|NCT01908829|11155357|FG002|Overall Study|Withdrawal by Subject|22
7059673|NCT01908907|11155376|FG000|Overall Study|Physician Decision|1
7059674|NCT01908907|11155377|FG001|Overall Study|Physician Decision|0
7059675|NCT01908907|11155376|FG000|Overall Study|Protocol Violation|1
7059676|NCT01908907|11155377|FG001|Overall Study|Protocol Violation|0
7059677|NCT01909336|11155429|FG000|Overall Study|Lost to Follow-up|4
7059678|NCT01909336|11155430|FG001|Overall Study|Lost to Follow-up|2
7059679|NCT01909336|11155431|FG002|Overall Study|Lost to Follow-up|2
7059680|NCT01909336|11155429|FG000|Overall Study|Physician Decision|0
7059681|NCT01909336|11155430|FG001|Overall Study|Physician Decision|1
7059682|NCT01909336|11155431|FG002|Overall Study|Physician Decision|1
6824010|NCT00106639|10826949|FG002|Overall Study|Participant defaulted|1
6824011|NCT00106704|10826960|FG000|Overall Study|Adverse Event|10
6824012|NCT00106704|10826961|FG001|Overall Study|Adverse Event|7
6824013|NCT00106704|10826960|FG000|Overall Study|Death|2
7059683|NCT01909466|11155439|FG000|Overall Study|Lost to Follow-up|5
7059684|NCT01909466|11155440|FG001|Overall Study|Lost to Follow-up|7
7059685|NCT01909466|11155439|FG000|Overall Study|Adverse Event|3
7059686|NCT01909466|11155440|FG001|Overall Study|Adverse Event|4
7059687|NCT01909466|11155439|FG000|Overall Study|Met Withdrawal Criteria|0
7059688|NCT01909466|11155440|FG001|Overall Study|Met Withdrawal Criteria|3
7059689|NCT01909466|11155439|FG000|Overall Study|Physician Decision|2
7059690|NCT01909466|11155440|FG001|Overall Study|Physician Decision|0
7059691|NCT01909466|11155439|FG000|Overall Study|Withdrawal by Subject|11
7059692|NCT01909466|11155440|FG001|Overall Study|Withdrawal by Subject|9
7059693|NCT01909466|11155439|FG000|Overall Study|Lack of Efficacy|1
7059694|NCT01909466|11155440|FG001|Overall Study|Lack of Efficacy|0
7059695|NCT01909674|11155446|FG000|Overall Study|Withdrawal by Subject|5
7059696|NCT01909674|11155447|FG001|Overall Study|Withdrawal by Subject|2
7059697|NCT01909778|11155478|FG000|Overall Study|failed screening|1
7059698|NCT01909791|11155487|FG000|Overall Study|Death|9
7059699|NCT01909791|11155488|FG001|Overall Study|Death|8
7059700|NCT01909791|11155489|FG002|Overall Study|Death|4
7059701|NCT01909791|11155487|FG000|Overall Study|Withdrawal by Subject|5
7059702|NCT01909791|11155488|FG001|Overall Study|Withdrawal by Subject|9
7059703|NCT01909791|11155489|FG002|Overall Study|Withdrawal by Subject|13
7059704|NCT01909791|11155487|FG000|Overall Study|Lost to Follow-up|5
7059705|NCT01909791|11155488|FG001|Overall Study|Lost to Follow-up|11
7059706|NCT01909791|11155489|FG002|Overall Study|Lost to Follow-up|10
7059707|NCT01909791|11155487|FG000|Overall Study|Missed Visit|2
7059708|NCT01909791|11155488|FG001|Overall Study|Missed Visit|0
7059709|NCT01909791|11155489|FG002|Overall Study|Missed Visit|1
7059710|NCT01909804|11155514|FG000|Overall Study|Randomized but Never Treated|0
7059711|NCT01909804|11155515|FG001|Overall Study|Randomized but Never Treated|0
7059712|NCT01909804|11155516|FG002|Overall Study|Randomized but Never Treated|0
7059713|NCT01909804|11155517|FG003|Overall Study|Randomized but Never Treated|0
7059714|NCT01909804|11155518|FG004|Overall Study|Randomized but Never Treated|0
7059715|NCT01909804|11155519|FG005|Overall Study|Randomized but Never Treated|0
7059716|NCT01909804|11155520|FG006|Overall Study|Randomized but Never Treated|1
7059717|NCT01909804|11155521|FG007|Overall Study|Randomized but Never Treated|0
7059718|NCT01909804|11155522|FG008|Overall Study|Randomized but Never Treated|0
7059719|NCT01909804|11155523|FG009|Overall Study|Randomized but Never Treated|0
7059720|NCT01909804|11155524|FG010|Overall Study|Randomized but Never Treated|0
7059721|NCT01909804|11155525|FG011|Overall Study|Randomized but Never Treated|1
7059722|NCT01909804|11155514|FG000|Overall Study|Death|0
7059723|NCT01909804|11155515|FG001|Overall Study|Death|0
7059724|NCT01909804|11155516|FG002|Overall Study|Death|0
7059725|NCT01909804|11155517|FG003|Overall Study|Death|0
7059726|NCT01909804|11155518|FG004|Overall Study|Death|0
7059727|NCT01909804|11155519|FG005|Overall Study|Death|0
7059728|NCT01909804|11155520|FG006|Overall Study|Death|0
7059729|NCT01909804|11155521|FG007|Overall Study|Death|0
7059730|NCT01909804|11155522|FG008|Overall Study|Death|0
7059731|NCT01909804|11155523|FG009|Overall Study|Death|0
7059732|NCT01909804|11155524|FG010|Overall Study|Death|1
7059733|NCT01909804|11155525|FG011|Overall Study|Death|0
6824014|NCT00106704|10826961|FG001|Overall Study|Death|1
6824015|NCT00106704|10826960|FG000|Overall Study|Lack of Efficacy|67
6824016|NCT00106704|10826961|FG001|Overall Study|Lack of Efficacy|69
6824017|NCT00106704|10826960|FG000|Overall Study|Lost to Follow-up|7
6824018|NCT00106704|10826961|FG001|Overall Study|Lost to Follow-up|3
6824019|NCT00106704|10826960|FG000|Overall Study|Pregnancy|1
7059734|NCT01909804|11155514|FG000|Overall Study|Lack of Efficacy|4
7059735|NCT01909804|11155515|FG001|Overall Study|Lack of Efficacy|1
7059736|NCT01909804|11155516|FG002|Overall Study|Lack of Efficacy|0
7059737|NCT01909804|11155517|FG003|Overall Study|Lack of Efficacy|0
7059738|NCT01909804|11155518|FG004|Overall Study|Lack of Efficacy|7
7141141|NCT02984267|11295826|FG001|Overall Study|Protocol Violation|0
6824020|NCT00106704|10826961|FG001|Overall Study|Pregnancy|0
6824021|NCT00106704|10826960|FG000|Overall Study|Protocol Violation|4
6824022|NCT00106704|10826961|FG001|Overall Study|Protocol Violation|7
6824023|NCT00106704|10826960|FG000|Overall Study|Withdrawal by Subject|14
6824024|NCT00106704|10826961|FG001|Overall Study|Withdrawal by Subject|21
6824025|NCT00106704|10826960|FG000|Overall Study|Patient moved|1
6824026|NCT00106704|10826961|FG001|Overall Study|Patient moved|0
6824027|NCT00106704|10826960|FG000|Overall Study|Site terminated|0
6824028|NCT00106704|10826961|FG001|Overall Study|Site terminated|1
6824029|NCT00106704|10826960|FG000|Overall Study|Planned major surgery|1
6824030|NCT00106704|10826961|FG001|Overall Study|Planned major surgery|0
6824031|NCT00106704|10826960|FG000|Overall Study|Patient Received Glycemic Medication|22
6824032|NCT00106704|10826961|FG001|Overall Study|Patient Received Glycemic Medication|41
6824033|NCT00106704|10826960|FG000|Overall Study|Unable to re-enter US|1
6824034|NCT00106704|10826961|FG001|Overall Study|Unable to re-enter US|0
6824035|NCT00106704|10826960|FG000|Overall Study|Laboratory test|1
6824036|NCT00106704|10826961|FG001|Overall Study|Laboratory test|1
6824037|NCT00106964|10826979|FG000|Overall Study|Lost to Follow-up|8
6824038|NCT00106964|10826980|FG001|Overall Study|Lost to Follow-up|6
6824039|NCT00106964|10826981|FG002|Overall Study|Lost to Follow-up|2
6824040|NCT00106964|10826979|FG000|Overall Study|Pregnancy|2
6824041|NCT00106964|10826980|FG001|Overall Study|Pregnancy|3
6824042|NCT00106964|10826981|FG002|Overall Study|Pregnancy|2
6824043|NCT00106964|10826979|FG000|Overall Study|Death|1
6824044|NCT00106964|10826980|FG001|Overall Study|Death|1
6824045|NCT00106964|10826981|FG002|Overall Study|Death|0
6824046|NCT00106964|10826979|FG000|Overall Study|Incarceration|0
6824047|NCT00106964|10826980|FG001|Overall Study|Incarceration|1
6824048|NCT00106964|10826981|FG002|Overall Study|Incarceration|0
6824049|NCT00106964|10826979|FG000|Overall Study|Site Funding Terminated|0
6824050|NCT00106964|10826980|FG001|Overall Study|Site Funding Terminated|1
6824051|NCT00106964|10826981|FG002|Overall Study|Site Funding Terminated|1
6824052|NCT00106964|10826979|FG000|Overall Study|Failure to adhere|2
7059739|NCT01909804|11155519|FG005|Overall Study|Lack of Efficacy|3
7059740|NCT01909804|11155520|FG006|Overall Study|Lack of Efficacy|1
7059741|NCT01909804|11155521|FG007|Overall Study|Lack of Efficacy|1
7059742|NCT01909804|11155522|FG008|Overall Study|Lack of Efficacy|0
6824053|NCT00106964|10826980|FG001|Overall Study|Failure to adhere|0
6824054|NCT00106964|10826981|FG002|Overall Study|Failure to adhere|0
6824055|NCT00106964|10826979|FG000|Overall Study|Did not meet eligibility criteria|0
6824056|NCT00106964|10826980|FG001|Overall Study|Did not meet eligibility criteria|2
6824057|NCT00106964|10826981|FG002|Overall Study|Did not meet eligibility criteria|2
6824058|NCT00106964|10826979|FG000|Overall Study|Required disallowed medication|0
6824059|NCT00106964|10826980|FG001|Overall Study|Required disallowed medication|1
6824060|NCT00106964|10826981|FG002|Overall Study|Required disallowed medication|0
6896740|NCT00634920|10915276|FG002|Period 2 - Post-Randomization|Death|0
6896741|NCT00634920|10915274|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9
6896742|NCT00634920|10915275|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13
6896743|NCT00634920|10915276|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0
6896744|NCT00634920|10915274|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2
6896745|NCT00634920|10915275|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0
6896746|NCT00634920|10915276|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0
6896747|NCT00634933|10915285|FG000|Part A: Baseline to Week 24|Adverse Event|4
6896748|NCT00634933|10915286|FG001|Part A: Baseline to Week 24|Adverse Event|4
6896749|NCT00634933|10915287|FG002|Part A: Baseline to Week 24|Adverse Event|8
6896750|NCT00634933|10915288|FG003|Part A: Baseline to Week 24|Adverse Event|0
6896751|NCT00634933|10915289|FG004|Part A: Baseline to Week 24|Adverse Event|0
6896752|NCT00634933|10915285|FG000|Part A: Baseline to Week 24|Death|1
6896753|NCT00634933|10915286|FG001|Part A: Baseline to Week 24|Death|0
6896754|NCT00634933|10915287|FG002|Part A: Baseline to Week 24|Death|0
6896755|NCT00634933|10915288|FG003|Part A: Baseline to Week 24|Death|0
6896756|NCT00634933|10915289|FG004|Part A: Baseline to Week 24|Death|0
6896757|NCT00634933|10915285|FG000|Part A: Baseline to Week 24|Failed to Return|1
6896758|NCT00634933|10915286|FG001|Part A: Baseline to Week 24|Failed to Return|0
6896759|NCT00634933|10915287|FG002|Part A: Baseline to Week 24|Failed to Return|0
6896760|NCT00634933|10915288|FG003|Part A: Baseline to Week 24|Failed to Return|0
6896761|NCT00634933|10915289|FG004|Part A: Baseline to Week 24|Failed to Return|0
6896762|NCT00634933|10915285|FG000|Part A: Baseline to Week 24|Investigator Request|1
6896763|NCT00634933|10915286|FG001|Part A: Baseline to Week 24|Investigator Request|1
6896764|NCT00634933|10915287|FG002|Part A: Baseline to Week 24|Investigator Request|1
6896765|NCT00634933|10915288|FG003|Part A: Baseline to Week 24|Investigator Request|0
6896766|NCT00634933|10915289|FG004|Part A: Baseline to Week 24|Investigator Request|0
6896767|NCT00634933|10915285|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0
6896768|NCT00634933|10915286|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1
6896769|NCT00634933|10915287|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1
6896770|NCT00634933|10915288|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0
6896771|NCT00634933|10915289|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0
6896772|NCT00634933|10915285|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0
6896773|NCT00634933|10915286|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3
6896774|NCT00634933|10915287|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3
6824061|NCT00107042|10827000|FG000|Overall Study|Lost to Follow-up|9
6824062|NCT00107042|10827001|FG001|Overall Study|Lost to Follow-up|7
6824063|NCT00107042|10827000|FG000|Overall Study|Withdrawal by Subject|6
6824064|NCT00107042|10827001|FG001|Overall Study|Withdrawal by Subject|1
6824065|NCT00107042|10827000|FG000|Overall Study|Moved out of area|5
6824066|NCT00107042|10827001|FG001|Overall Study|Moved out of area|3
6824067|NCT00107042|10827000|FG000|Overall Study|Pregnancy|1
6824068|NCT00107042|10827001|FG001|Overall Study|Pregnancy|1
6824069|NCT00107042|10827000|FG000|Overall Study|Inadvertent enrollment|0
6824070|NCT00107042|10827001|FG001|Overall Study|Inadvertent enrollment|1
6824071|NCT00107042|10827000|FG000|Overall Study|vaccinated outside window|1
6824072|NCT00107042|10827001|FG001|Overall Study|vaccinated outside window|1
6824073|NCT00107042|10827000|FG000|Overall Study|Disallowed medications|0
6824074|NCT00107042|10827001|FG001|Overall Study|Disallowed medications|2
6824075|NCT00107120|10827051|FG000|Overall Study|Adverse Event|4
6824076|NCT00107120|10827052|FG001|Overall Study|Adverse Event|1
6824077|NCT00107120|10827051|FG000|Overall Study|Lack of Efficacy|5
6824078|NCT00107120|10827052|FG001|Overall Study|Lack of Efficacy|5
6824079|NCT00107120|10827051|FG000|Overall Study|Protocol Violation|3
7059743|NCT01909804|11155523|FG009|Overall Study|Lack of Efficacy|1
7059744|NCT01909804|11155524|FG010|Overall Study|Lack of Efficacy|0
7059745|NCT01909804|11155525|FG011|Overall Study|Lack of Efficacy|1
7059746|NCT01909804|11155514|FG000|Overall Study|Withdrew Consent|0
7059747|NCT01909804|11155515|FG001|Overall Study|Withdrew Consent|0
7059748|NCT01909804|11155516|FG002|Overall Study|Withdrew Consent|0
7059749|NCT01909804|11155517|FG003|Overall Study|Withdrew Consent|0
7059750|NCT01909804|11155518|FG004|Overall Study|Withdrew Consent|1
7059751|NCT01909804|11155519|FG005|Overall Study|Withdrew Consent|1
7059752|NCT01909804|11155520|FG006|Overall Study|Withdrew Consent|0
7059753|NCT01909804|11155521|FG007|Overall Study|Withdrew Consent|0
7059754|NCT01909804|11155522|FG008|Overall Study|Withdrew Consent|0
7059755|NCT01909804|11155523|FG009|Overall Study|Withdrew Consent|0
7059756|NCT01909804|11155524|FG010|Overall Study|Withdrew Consent|0
7059757|NCT01909804|11155525|FG011|Overall Study|Withdrew Consent|0
7059758|NCT01909804|11155514|FG000|Overall Study|Protocol Violation|0
7059759|NCT01909804|11155515|FG001|Overall Study|Protocol Violation|0
7059760|NCT01909804|11155516|FG002|Overall Study|Protocol Violation|0
7059761|NCT01909804|11155517|FG003|Overall Study|Protocol Violation|0
7059762|NCT01909804|11155518|FG004|Overall Study|Protocol Violation|0
7059763|NCT01909804|11155519|FG005|Overall Study|Protocol Violation|0
7059764|NCT01909804|11155520|FG006|Overall Study|Protocol Violation|0
7059765|NCT01909804|11155521|FG007|Overall Study|Protocol Violation|0
7059766|NCT01909804|11155522|FG008|Overall Study|Protocol Violation|0
7059767|NCT01909804|11155523|FG009|Overall Study|Protocol Violation|0
7059768|NCT01909804|11155524|FG010|Overall Study|Protocol Violation|0
7059769|NCT01909804|11155525|FG011|Overall Study|Protocol Violation|1
7059770|NCT01909973|11155549|FG000|Overall Study|Lost to Follow-up|1
7059771|NCT01909973|11155550|FG001|Overall Study|Lost to Follow-up|0
7059772|NCT01910116|11155562|FG000|Overall Study|Adverse Event|0
7059773|NCT01910116|11155563|FG001|Overall Study|Adverse Event|3
7059774|NCT01910116|11155562|FG000|Overall Study|Lack of Efficacy|3
7059775|NCT01910116|11155563|FG001|Overall Study|Lack of Efficacy|4
7059776|NCT01910116|11155562|FG000|Overall Study|Lost to Follow-up|1
7059777|NCT01910116|11155563|FG001|Overall Study|Lost to Follow-up|0
7059778|NCT01910116|11155562|FG000|Overall Study|Protocol Violation|1
7059779|NCT01910116|11155563|FG001|Overall Study|Protocol Violation|2
7059780|NCT01910116|11155562|FG000|Overall Study|Withdrawal by Subject|8
7059781|NCT01910116|11155563|FG001|Overall Study|Withdrawal by Subject|3
7059782|NCT01910116|11155562|FG000|Overall Study|uncertain allocation|1
6824080|NCT00107120|10827052|FG001|Overall Study|Protocol Violation|0
6824081|NCT00107120|10827051|FG000|Overall Study|Withdrawal by Subject|8
6824082|NCT00107120|10827052|FG001|Overall Study|Withdrawal by Subject|9
6824083|NCT00107120|10827051|FG000|Overall Study|Lost to Follow-up|8
6824084|NCT00107120|10827052|FG001|Overall Study|Lost to Follow-up|6
6824085|NCT00107120|10827051|FG000|Overall Study|Pregnancy|0
6824086|NCT00107120|10827052|FG001|Overall Study|Pregnancy|1
6901225|NCT00670748|10921864|FG001|Overall Study|Death during treatment|1
6901226|NCT00670748|10921865|FG002|Overall Study|Death during treatment|1
6901227|NCT00670748|10921866|FG003|Overall Study|Death during treatment|0
6901228|NCT00670748|10921863|FG000|Overall Study|Not off study|2
7059783|NCT01910116|11155563|FG001|Overall Study|uncertain allocation|3
7059784|NCT01910116|11155562|FG000|Overall Study|incomplete data|0
7059785|NCT01910116|11155563|FG001|Overall Study|incomplete data|1
6901229|NCT00670748|10921864|FG001|Overall Study|Not off study|1
6901230|NCT00670748|10921865|FG002|Overall Study|Not off study|1
6901231|NCT00670748|10921866|FG003|Overall Study|Not off study|1
6901232|NCT00670800|10921882|FG000|Overall Study|2 controls were insulin resistant|0
6901233|NCT00670800|10921883|FG001|Overall Study|2 controls were insulin resistant|2
6901234|NCT00670930|10921893|FG000|Overall Study|Adminstrative Problem|0
6901235|NCT00670930|10921894|FG001|Overall Study|Adminstrative Problem|1
6901236|NCT00670930|10921893|FG000|Overall Study|Lost to Follow-up|1
6901237|NCT00670930|10921894|FG001|Overall Study|Lost to Follow-up|0
6901238|NCT00671034|10921915|FG000|Overall Study|Adverse Event|5
6901239|NCT00671034|10921916|FG001|Overall Study|Adverse Event|7
6901240|NCT00671034|10921917|FG002|Overall Study|Adverse Event|1
6901241|NCT00671034|10921915|FG000|Overall Study|Death|3
6824087|NCT00107120|10827051|FG000|Overall Study|moving away from site|1
6824088|NCT00107120|10827052|FG001|Overall Study|moving away from site|1
6824089|NCT00107120|10827051|FG000|Overall Study|death of parent|0
6824090|NCT00107120|10827052|FG001|Overall Study|death of parent|1
6824091|NCT00107172|10827060|FG000|Overall Study|Withdrawal by Subject|1
6824092|NCT00107172|10827061|FG001|Overall Study|Withdrawal by Subject|0
6824093|NCT00107172|10827060|FG000|Overall Study|Death|0
6824094|NCT00107172|10827061|FG001|Overall Study|Death|2
6824095|NCT00107172|10827060|FG000|Overall Study|Other Reason|4
6824096|NCT00107172|10827061|FG001|Overall Study|Other Reason|3
6824097|NCT00107198|10827067|FG000|Overall Study|Lack of Efficacy|28
6901242|NCT00671034|10921916|FG001|Overall Study|Death|2
6901243|NCT00671034|10921917|FG002|Overall Study|Death|1
6901244|NCT00671034|10921915|FG000|Overall Study|Physician Decision|12
6901245|NCT00671034|10921916|FG001|Overall Study|Physician Decision|4
6901246|NCT00671034|10921917|FG002|Overall Study|Physician Decision|5
6901247|NCT00671034|10921915|FG000|Overall Study|VHR ALL feature|8
6901248|NCT00671034|10921916|FG001|Overall Study|VHR ALL feature|3
6901249|NCT00671034|10921917|FG002|Overall Study|VHR ALL feature|5
6901250|NCT00671034|10921915|FG000|Overall Study|Refusal|5
6901251|NCT00671034|10921916|FG001|Overall Study|Refusal|3
6901252|NCT00671034|10921917|FG002|Overall Study|Refusal|5
6901253|NCT00671034|10921915|FG000|Overall Study|includes Alternative therapy, etc.|6
6901254|NCT00671034|10921916|FG001|Overall Study|includes Alternative therapy, etc.|1
6901255|NCT00671034|10921917|FG002|Overall Study|includes Alternative therapy, etc.|7
6901256|NCT00671060|10921928|FG000|Overall Study|Protocol Violation|1
6901257|NCT00671060|10921929|FG001|Overall Study|Protocol Violation|0
6901258|NCT00671060|10921928|FG000|Overall Study|Physician Decision|0
6901259|NCT00671060|10921929|FG001|Overall Study|Physician Decision|1
6901260|NCT00671437|10921944|FG000|Overall Study|Progressive disease before C1 week 8|8
6901261|NCT00671437|10921944|FG000|Overall Study|Cutaneous SCC of head and neck|3
6901262|NCT00671437|10921944|FG000|Overall Study|Adverse Event|3
6901263|NCT00671437|10921944|FG000|Overall Study|Ineligible post-hoc|1
7059786|NCT01910129|11155571|FG000|Randomized Phase 2|Withdrawal by Subject|2
7059787|NCT01910129|11155572|FG001|Randomized Phase 2|Withdrawal by Subject|1
7059788|NCT01910129|11155573|FG002|Randomized Phase 2|Withdrawal by Subject|0
7059789|NCT01910129|11155571|FG000|Randomized Phase 3|Withdrawal by Subject|0
7059790|NCT01910129|11155572|FG001|Randomized Phase 3|Withdrawal by Subject|1
6901264|NCT00671554|10921973|FG000|Overall Study|Disease progression|3
6901265|NCT00671658|10921978|FG000|Overall Study|Physician Decision|5
6901266|NCT00671749|10922005|FG000|Overall Study|Adverse Event|2
6901267|NCT00671749|10922005|FG000|Overall Study|Withdrawal by Subject|4
6901268|NCT00671749|10922005|FG000|Overall Study|Protocol Violation|1
6901269|NCT00671749|10922005|FG000|Overall Study|Lost to Follow-up|1
6901270|NCT00671788|10922009|FG000|Overall Study|Adverse Event|8
6901271|NCT00671788|10922009|FG000|Overall Study|Refused further treatment|3
6901272|NCT00671788|10922009|FG000|Overall Study|Ineligible|1
6901273|NCT00671788|10922009|FG000|Overall Study|MD Decision|1
6901274|NCT00671788|10922009|FG000|Overall Study|Other|1
6901275|NCT00671853|10922015|FG000|Overall Study|Lack of Efficacy|3
6901276|NCT00671853|10922016|FG001|Overall Study|Lack of Efficacy|7
6901277|NCT00671853|10922015|FG000|Overall Study|Adverse Event|7
6901278|NCT00671853|10922016|FG001|Overall Study|Adverse Event|1
6901279|NCT00671853|10922015|FG000|Overall Study|Withdrawal by Subject|1
6901280|NCT00671853|10922016|FG001|Overall Study|Withdrawal by Subject|5
6901281|NCT00671853|10922015|FG000|Overall Study|Lost to Follow-up|8
6901282|NCT00671853|10922016|FG001|Overall Study|Lost to Follow-up|8
6901283|NCT00671853|10922015|FG000|Overall Study|Physician Decision|0
6901284|NCT00671853|10922016|FG001|Overall Study|Physician Decision|2
6901285|NCT00671853|10922015|FG000|Overall Study|Non-adherence with study procedures|1
6901286|NCT00671853|10922016|FG001|Overall Study|Non-adherence with study procedures|4
6901287|NCT00671879|10922027|FG000|Overall Study|Withdrawal by Subject|0
6901288|NCT00671879|10922028|FG001|Overall Study|Withdrawal by Subject|4
6901289|NCT00671879|10922029|FG002|Overall Study|Withdrawal by Subject|6
6901290|NCT00671931|10922048|FG000|Overall Study|Physician Decision|1
6901291|NCT00671931|10922049|FG001|Overall Study|Physician Decision|0
6901292|NCT00671931|10922050|FG002|Overall Study|Physician Decision|0
6901293|NCT00671931|10922051|FG003|Overall Study|Physician Decision|2
6901294|NCT00671931|10922052|FG004|Overall Study|Physician Decision|1
6901295|NCT00672139|10922104|FG000|Overall Study|Death|14
6901296|NCT00672139|10922105|FG001|Overall Study|Death|23
6901297|NCT00672139|10922104|FG000|Overall Study|Withdrawal by Subject|2
6901298|NCT00672139|10922105|FG001|Overall Study|Withdrawal by Subject|11
6901299|NCT00672139|10922104|FG000|Overall Study|Adverse Event|4
6901300|NCT00672139|10922105|FG001|Overall Study|Adverse Event|7
6901301|NCT00672139|10922104|FG000|Overall Study|Physician Decision|2
6901302|NCT00672139|10922105|FG001|Overall Study|Physician Decision|0
6901303|NCT00672139|10922104|FG000|Overall Study|Lack of Efficacy|4
6824098|NCT00107198|10827067|FG000|Overall Study|Lost to Follow-up|12
6901304|NCT00672139|10922105|FG001|Overall Study|Lack of Efficacy|1
6901305|NCT00672139|10922104|FG000|Overall Study|Protocol Violation|1
6901306|NCT00672139|10922105|FG001|Overall Study|Protocol Violation|1
6901307|NCT00672139|10922104|FG000|Overall Study|hospice discharge, caregiver requests|3
6901308|NCT00672139|10922105|FG001|Overall Study|hospice discharge, caregiver requests|2
6901309|NCT00672256|10922120|FG000|Overall Study|PI dropped, bad data|44
6901310|NCT00672477|10922144|FG000|Overall Study|Adverse Event|10
6824099|NCT00107198|10827067|FG000|Overall Study|Protocol Violation|1
6824100|NCT00107198|10827067|FG000|Overall Study|Withdrawal by Subject|6
6824101|NCT00107198|10827067|FG000|Overall Study|Ineligible|5
6824102|NCT00107276|10827071|FG000|Overall Study|Progression|46
6824103|NCT00107276|10827071|FG000|Overall Study|Adverse Event|6
6824104|NCT00107276|10827071|FG000|Overall Study|M.D. decision|2
6824105|NCT00107276|10827071|FG000|Overall Study|Patient refusal|1
6824106|NCT00107276|10827071|FG000|Overall Study|Death|1
6824107|NCT00107276|10827071|FG000|Overall Study|Ineligible|16
6824108|NCT00107380|10827076|FG000|Overall Study|Adverse Event|7
6824109|NCT00107380|10827076|FG000|Overall Study|Refusal Unrelated to Adverse Event|7
6824110|NCT00107380|10827076|FG000|Overall Study|Progression/relapse|4
6824111|NCT00107380|10827076|FG000|Overall Study|Death|3
6824112|NCT00107380|10827076|FG000|Overall Study|Other - not protocol specified|7
7059791|NCT01910129|11155573|FG002|Randomized Phase 3|Withdrawal by Subject|0
7059792|NCT01910181|11155591|FG000|Overall Study|Death|37
7059793|NCT01910181|11155591|FG000|Overall Study|Lost to Follow-up|3
7059794|NCT01910181|11155591|FG000|Overall Study|Study Terminated by Sponsor|6
7059795|NCT01910298|11155598|FG000|Overall Study|Adverse Event|1
7059796|NCT01910298|11155599|FG001|Overall Study|Adverse Event|0
7059797|NCT01910298|11155598|FG000|Overall Study|Withdrawal by Subject|2
7059798|NCT01910298|11155599|FG001|Overall Study|Withdrawal by Subject|7
7059799|NCT01910298|11155598|FG000|Overall Study|Protocol Deviation|0
6824113|NCT00107380|10827076|FG000|Overall Study|Ineligible|2
6824114|NCT00107653|10827096|FG000|Overall Study|Adverse Event|24
6824115|NCT00107653|10827097|FG001|Overall Study|Adverse Event|43
6824116|NCT00107653|10827096|FG000|Overall Study|Insufficient Therapeutic Response|25
6824117|NCT00107653|10827097|FG001|Overall Study|Insufficient Therapeutic Response|11
6824118|NCT00107653|10827096|FG000|Overall Study|Violation of Selection Criteria at Entry|1
6824119|NCT00107653|10827097|FG001|Overall Study|Violation of Selection Criteria at Entry|1
6824120|NCT00107653|10827096|FG000|Overall Study|Protocol Violation|1
6824121|NCT00107653|10827097|FG001|Overall Study|Protocol Violation|0
6824122|NCT00107653|10827096|FG000|Overall Study|Withdrawal by Subject|12
6824123|NCT00107653|10827097|FG001|Overall Study|Withdrawal by Subject|13
6824124|NCT00107653|10827096|FG000|Overall Study|Lost to Follow-up|13
6824125|NCT00107653|10827097|FG001|Overall Study|Lost to Follow-up|5
6824126|NCT00107653|10827096|FG000|Overall Study|Administrative Reasons|3
7059800|NCT01910298|11155599|FG001|Overall Study|Protocol Deviation|5
7059801|NCT01910298|11155598|FG000|Overall Study|Lost to Follow-up|1
7059802|NCT01910298|11155599|FG001|Overall Study|Lost to Follow-up|1
7059803|NCT01910298|11155598|FG000|Overall Study|Study Terminated by Sponsor|1
7059804|NCT01910298|11155599|FG001|Overall Study|Study Terminated by Sponsor|17
7059805|NCT01910298|11155598|FG000|Overall Study|Other Miscellaneous Reasons|0
7059806|NCT01910298|11155599|FG001|Overall Study|Other Miscellaneous Reasons|2
7059807|NCT01910519|11155615|FG000|Overall Study|Withdrawal by Subject|2
7059808|NCT01910519|11155616|FG001|Overall Study|Withdrawal by Subject|0
7059809|NCT01910519|11155615|FG000|Overall Study|Adverse Event|2
7059810|NCT01910519|11155616|FG001|Overall Study|Adverse Event|0
7059811|NCT01911260|11155675|FG000|Supplementation Period|transference or evasion of school|7
7059812|NCT01911260|11155676|FG001|Supplementation Period|transference or evasion of school|9
7059813|NCT01911260|11155677|FG002|Supplementation Period|transference or evasion of school|7
7059814|NCT01911260|11155678|FG003|Supplementation Period|transference or evasion of school|6
7059815|NCT01911260|11155675|FG000|Supplementation Period|Adverse Event|2
7059816|NCT01911260|11155676|FG001|Supplementation Period|Adverse Event|0
7059817|NCT01911260|11155677|FG002|Supplementation Period|Adverse Event|1
7059818|NCT01911260|11155678|FG003|Supplementation Period|Adverse Event|0
7059819|NCT01911260|11155675|FG000|Supplementation Period|refused to receive supplement|1
7059820|NCT01911260|11155676|FG001|Supplementation Period|refused to receive supplement|0
7059821|NCT01911260|11155677|FG002|Supplementation Period|refused to receive supplement|1
6824127|NCT00107653|10827097|FG001|Overall Study|Administrative Reasons|3
6824128|NCT00107783|10827118|FG000|Overall Study|Adverse Event|0
6824129|NCT00107783|10827119|FG001|Overall Study|Adverse Event|2
6824130|NCT00107783|10827118|FG000|Overall Study|Death|0
6824131|NCT00107783|10827119|FG001|Overall Study|Death|1
6824132|NCT00107783|10827118|FG000|Overall Study|Withdrawal by Subject|2
6824133|NCT00107783|10827119|FG001|Overall Study|Withdrawal by Subject|0
6824134|NCT00107783|10827118|FG000|Overall Study|Second hip replacement|1
6824135|NCT00107783|10827119|FG001|Overall Study|Second hip replacement|1
6824136|NCT00107900|10827131|FG000|Overall Study|Adverse Event|3
6824137|NCT00107900|10827132|FG001|Overall Study|Adverse Event|2
6824138|NCT00107900|10827133|FG002|Overall Study|Adverse Event|10
6824139|NCT00107900|10827134|FG003|Overall Study|Adverse Event|3
6824140|NCT00107900|10827135|FG004|Overall Study|Adverse Event|5
6824141|NCT00107900|10827136|FG005|Overall Study|Adverse Event|3
6901311|NCT00672477|10922145|FG001|Overall Study|Adverse Event|7
6824142|NCT00107900|10827131|FG000|Overall Study|Death|0
6824143|NCT00107900|10827132|FG001|Overall Study|Death|0
6824144|NCT00107900|10827133|FG002|Overall Study|Death|0
6824145|NCT00107900|10827134|FG003|Overall Study|Death|0
6824146|NCT00107900|10827135|FG004|Overall Study|Death|1
6824147|NCT00107900|10827136|FG005|Overall Study|Death|0
6824148|NCT00107900|10827131|FG000|Overall Study|Lost to Follow-up|4
6824149|NCT00107900|10827132|FG001|Overall Study|Lost to Follow-up|1
6824150|NCT00107900|10827133|FG002|Overall Study|Lost to Follow-up|3
6824151|NCT00107900|10827134|FG003|Overall Study|Lost to Follow-up|2
6824152|NCT00107900|10827135|FG004|Overall Study|Lost to Follow-up|5
6824153|NCT00107900|10827136|FG005|Overall Study|Lost to Follow-up|5
6824154|NCT00107900|10827131|FG000|Overall Study|Protocol Violation|1
6824155|NCT00107900|10827132|FG001|Overall Study|Protocol Violation|0
6824156|NCT00107900|10827133|FG002|Overall Study|Protocol Violation|5
6824157|NCT00107900|10827134|FG003|Overall Study|Protocol Violation|5
6824158|NCT00107900|10827135|FG004|Overall Study|Protocol Violation|7
6824159|NCT00107900|10827136|FG005|Overall Study|Protocol Violation|0
6824160|NCT00107900|10827131|FG000|Overall Study|Withdrawal by Subject|1
6824161|NCT00107900|10827132|FG001|Overall Study|Withdrawal by Subject|0
7059822|NCT01911260|11155678|FG003|Supplementation Period|refused to receive supplement|0
7059823|NCT01911260|11155675|FG000|Supplementation Period|less than 12 weeks supplementation|0
7059824|NCT01911260|11155676|FG001|Supplementation Period|less than 12 weeks supplementation|3
7059825|NCT01911260|11155677|FG002|Supplementation Period|less than 12 weeks supplementation|1
7059826|NCT01911260|11155678|FG003|Supplementation Period|less than 12 weeks supplementation|2
7059827|NCT01911260|11155675|FG000|Follow-up Period|transference or evasion of school|13
7059828|NCT01911260|11155676|FG001|Follow-up Period|transference or evasion of school|20
7059829|NCT01911260|11155677|FG002|Follow-up Period|transference or evasion of school|15
7059830|NCT01911260|11155678|FG003|Follow-up Period|transference or evasion of school|12
7059831|NCT01911273|11155690|FG000|Overall Study|Progression of Disease|1
6824162|NCT00107900|10827133|FG002|Overall Study|Withdrawal by Subject|5
6824163|NCT00107900|10827134|FG003|Overall Study|Withdrawal by Subject|0
6824164|NCT00107900|10827135|FG004|Overall Study|Withdrawal by Subject|1
6824165|NCT00107900|10827136|FG005|Overall Study|Withdrawal by Subject|1
6824166|NCT00107900|10827131|FG000|Overall Study|Administrative Reasons|1
6824167|NCT00107900|10827132|FG001|Overall Study|Administrative Reasons|0
6824168|NCT00107900|10827133|FG002|Overall Study|Administrative Reasons|2
6824169|NCT00107900|10827134|FG003|Overall Study|Administrative Reasons|2
6824170|NCT00107900|10827135|FG004|Overall Study|Administrative Reasons|2
6824171|NCT00107900|10827136|FG005|Overall Study|Administrative Reasons|0
6824172|NCT00107952|10827152|FG000|Overall Study|Death|75
6824173|NCT00107952|10827153|FG001|Overall Study|Death|61
6824174|NCT00107952|10827152|FG000|Overall Study|Lost to Follow-up|0
6824175|NCT00107952|10827153|FG001|Overall Study|Lost to Follow-up|3
6824176|NCT00107952|10827152|FG000|Overall Study|Withdrawal by Subject|9
6824177|NCT00107952|10827153|FG001|Overall Study|Withdrawal by Subject|6
6824178|NCT00107952|10827152|FG000|Overall Study|Other|2
6824179|NCT00107952|10827153|FG001|Overall Study|Other|5
6824180|NCT00107952|10827152|FG000|Overall Study|Never received study treatment|9
6824181|NCT00107952|10827153|FG001|Overall Study|Never received study treatment|6
7059832|NCT01911273|11155691|FG001|Overall Study|Progression of Disease|0
6824182|NCT00107978|10827161|FG000|Overall Study|Adverse Event|1
7059833|NCT01911273|11155690|FG000|Overall Study|Withdrawal by Subject|0
6824183|NCT00107978|10827162|FG001|Overall Study|Adverse Event|5
6824184|NCT00107978|10827161|FG000|Overall Study|Death|3
6824185|NCT00107978|10827162|FG001|Overall Study|Death|3
6824186|NCT00107978|10827161|FG000|Overall Study|Lost to Follow-up|20
6824187|NCT00107978|10827162|FG001|Overall Study|Lost to Follow-up|28
7059834|NCT01911273|11155691|FG001|Overall Study|Withdrawal by Subject|2
6824188|NCT00107978|10827161|FG000|Overall Study|Withdrawal by Subject|4
6824189|NCT00107978|10827162|FG001|Overall Study|Withdrawal by Subject|9
6824190|NCT00107978|10827161|FG000|Overall Study|Protocol Violation|0
6824191|NCT00107978|10827162|FG001|Overall Study|Protocol Violation|1
6824192|NCT00107978|10827161|FG000|Overall Study|Other|5
6824193|NCT00107978|10827162|FG001|Overall Study|Other|4
6824194|NCT00107991|10827168|FG000|Eligibility Assessment|Disease not severe enough|7
7059835|NCT01911429|11155735|FG000|Overall Study|Adverse Event|5
7059836|NCT01911429|11155736|FG001|Overall Study|Adverse Event|3
7059837|NCT01911429|11155737|FG002|Overall Study|Adverse Event|9
7059838|NCT01911429|11155735|FG000|Overall Study|Lack of Efficacy|1
7059839|NCT01911429|11155736|FG001|Overall Study|Lack of Efficacy|2
7059840|NCT01911429|11155737|FG002|Overall Study|Lack of Efficacy|4
7059841|NCT01911429|11155735|FG000|Overall Study|Lost to Follow-up|0
7059842|NCT01911429|11155736|FG001|Overall Study|Lost to Follow-up|0
7059843|NCT01911429|11155737|FG002|Overall Study|Lost to Follow-up|1
7059844|NCT01911429|11155735|FG000|Overall Study|Protocol Violation|0
7059845|NCT01911429|11155736|FG001|Overall Study|Protocol Violation|0
7059846|NCT01911429|11155737|FG002|Overall Study|Protocol Violation|1
7059847|NCT01911429|11155735|FG000|Overall Study|Withdrawal by Subject|5
7059848|NCT01911429|11155736|FG001|Overall Study|Withdrawal by Subject|5
7059849|NCT01911429|11155737|FG002|Overall Study|Withdrawal by Subject|4
7059850|NCT01911429|11155735|FG000|Overall Study|Accidental randomization|0
7059851|NCT01911429|11155736|FG001|Overall Study|Accidental randomization|0
7059852|NCT01911429|11155737|FG002|Overall Study|Accidental randomization|1
7059853|NCT01911429|11155735|FG000|Overall Study|subject left study|1
7059854|NCT01911429|11155736|FG001|Overall Study|subject left study|0
7059855|NCT01911429|11155737|FG002|Overall Study|subject left study|0
6824195|NCT00107991|10827168|FG000|Eligibility Assessment|Unwilling to participate|7
6824196|NCT00107991|10827168|FG000|Eligibility Assessment|Positive purified protein derivative|4
6824197|NCT00107991|10827168|FG000|Eligibility Assessment|Abnormal labs|2
6824198|NCT00107991|10827168|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1
6824199|NCT00107991|10827168|FG000|Eligibility Assessment|chronic uncontrolled asthma|1
6824200|NCT00107991|10827168|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1
6824201|NCT00107991|10827168|FG000|12 Week Treatment Period|Lack of Efficacy|2
6824202|NCT00107991|10827168|FG000|12 Week Treatment Period|Adverse Event|1
6824203|NCT00107991|10827168|FG000|12 Week Treatment Period|Protocol Violation|1
6824204|NCT00107991|10827168|FG000|12 Week Treatment Period|Incarcerated|1
6824205|NCT00107991|10827168|FG000|18-Week Post Treatment Assessment|Adverse Event|2
7059856|NCT01911442|11155748|FG000|Overall Study|Adverse Event|2
7059857|NCT01911442|11155749|FG001|Overall Study|Adverse Event|2
7059858|NCT01911442|11155750|FG002|Overall Study|Adverse Event|4
7059859|NCT01911442|11155748|FG000|Overall Study|Lack of Efficacy|1
7059860|NCT01911442|11155749|FG001|Overall Study|Lack of Efficacy|1
7059861|NCT01911442|11155750|FG002|Overall Study|Lack of Efficacy|1
7059862|NCT01911442|11155748|FG000|Overall Study|Lost to Follow-up|2
7059863|NCT01911442|11155749|FG001|Overall Study|Lost to Follow-up|0
7059864|NCT01911442|11155750|FG002|Overall Study|Lost to Follow-up|1
7059865|NCT01911442|11155748|FG000|Overall Study|Withdrawal by Subject|1
7059866|NCT01911442|11155749|FG001|Overall Study|Withdrawal by Subject|0
7059867|NCT01911442|11155750|FG002|Overall Study|Withdrawal by Subject|6
7059868|NCT01911442|11155748|FG000|Overall Study|Mother's Work Schedule|0
7059869|NCT01911442|11155749|FG001|Overall Study|Mother's Work Schedule|1
6824206|NCT00108069|10827174|FG000|Overall Study|Never rec'd study drug|0
6824207|NCT00108069|10827175|FG001|Overall Study|Never rec'd study drug|1
6824208|NCT00108069|10827174|FG000|Overall Study|Adverse Event|1
6824209|NCT00108069|10827175|FG001|Overall Study|Adverse Event|1
6824210|NCT00108069|10827174|FG000|Overall Study|Withdrawal by Subject|1
6824211|NCT00108069|10827175|FG001|Overall Study|Withdrawal by Subject|0
6824212|NCT00108069|10827174|FG000|Overall Study|Death|1
6824213|NCT00108069|10827175|FG001|Overall Study|Death|0
6824214|NCT00108069|10827174|FG000|Overall Study|Progessive disease|27
6824215|NCT00108069|10827175|FG001|Overall Study|Progessive disease|11
6824216|NCT00108082|10827190|FG000|Overall Study|Adverse Event|14
6824217|NCT00108082|10827191|FG001|Overall Study|Adverse Event|12
6824218|NCT00108082|10827192|FG002|Overall Study|Adverse Event|17
7059870|NCT01911442|11155750|FG002|Overall Study|Mother's Work Schedule|0
7059871|NCT01911546|11155762|FG000|Overall Study|Lost to Follow-up|1
7059872|NCT01911546|11155762|FG000|Overall Study|Everolimus was discontinued|5
7059873|NCT01911780|11155784|FG000|Double-blind Period (8 Weeks)|Adverse Event|1
7059874|NCT01911780|11155785|FG001|Double-blind Period (8 Weeks)|Adverse Event|2
7059875|NCT01911780|11155784|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
7059876|NCT01911780|11155785|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
7059877|NCT01911780|11155784|FG000|Double-blind Period (8 Weeks)|Personal reason|1
7059878|NCT01911780|11155785|FG001|Double-blind Period (8 Weeks)|Personal reason|0
7059879|NCT01911780|11155784|FG000|Extension Period (52 Weeks)|Adverse Event|3
7059880|NCT01911780|11155785|FG001|Extension Period (52 Weeks)|Adverse Event|0
7059881|NCT01911780|11155784|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0
7059882|NCT01911780|11155785|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2
7059883|NCT01911780|11155784|FG000|Extension Period (52 Weeks)|Personal reason|1
7059884|NCT01911780|11155785|FG001|Extension Period (52 Weeks)|Personal reason|1
7059885|NCT01911819|11155798|FG000|Overall Study|Adverse Event|0
7059886|NCT01911819|11155799|FG001|Overall Study|Adverse Event|1
7059887|NCT01911819|11155800|FG002|Overall Study|Adverse Event|0
7059888|NCT01911819|11155798|FG000|Overall Study|Withdrawal by Subject|1
7059889|NCT01911819|11155799|FG001|Overall Study|Withdrawal by Subject|1
7059890|NCT01911819|11155800|FG002|Overall Study|Withdrawal by Subject|0
7059891|NCT01911845|11155808|FG000|Overall Study|Adverse Event|2
7059892|NCT01911845|11155808|FG000|Overall Study|Lost to Follow-up|1
7059893|NCT01911845|11155808|FG000|Overall Study|Other (not specified)|3
7059894|NCT01912222|11155826|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1
7059895|NCT01912222|11155827|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
7059896|NCT01912222|11155828|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
7059897|NCT01912222|11155826|FG000|Part B: Treatment Period|Progressive disease|10
7059898|NCT01912222|11155827|FG001|Part B: Treatment Period|Progressive disease|12
7059899|NCT01912222|11155828|FG002|Part B: Treatment Period|Progressive disease|15
7059900|NCT01912222|11155826|FG000|Part B: Treatment Period|Adverse Event|1
7059901|NCT01912222|11155827|FG001|Part B: Treatment Period|Adverse Event|2
7059902|NCT01912222|11155828|FG002|Part B: Treatment Period|Adverse Event|3
7059903|NCT01912222|11155826|FG000|Part B: Treatment Period|Withdrawal by Subject|2
7059904|NCT01912222|11155827|FG001|Part B: Treatment Period|Withdrawal by Subject|1
6824219|NCT00108082|10827190|FG000|Overall Study|Lost to Follow-up|6
6824220|NCT00108082|10827191|FG001|Overall Study|Lost to Follow-up|3
6824221|NCT00108082|10827192|FG002|Overall Study|Lost to Follow-up|7
6824222|NCT00108082|10827190|FG000|Overall Study|Consent Withdrawn|3
6824223|NCT00108082|10827191|FG001|Overall Study|Consent Withdrawn|3
7059905|NCT01912222|11155828|FG002|Part B: Treatment Period|Withdrawal by Subject|2
7059906|NCT01912287|11155844|FG000|Overall Study|Ineligible|1
7059907|NCT01912287|11155845|FG001|Overall Study|Ineligible|0
7059908|NCT01912287|11155846|FG002|Overall Study|Ineligible|1
6824224|NCT00108082|10827192|FG002|Overall Study|Consent Withdrawn|5
6824225|NCT00108082|10827190|FG000|Overall Study|Protocol Violation|1
6824226|NCT00108082|10827191|FG001|Overall Study|Protocol Violation|2
6824227|NCT00108082|10827192|FG002|Overall Study|Protocol Violation|0
6824228|NCT00108082|10827190|FG000|Overall Study|Lack of Efficacy|3
6824229|NCT00108082|10827191|FG001|Overall Study|Lack of Efficacy|1
6824230|NCT00108082|10827192|FG002|Overall Study|Lack of Efficacy|2
6824231|NCT00108082|10827190|FG000|Overall Study|Amendment 4: > Month 12|5
6824232|NCT00108082|10827191|FG001|Overall Study|Amendment 4: > Month 12|7
6824233|NCT00108082|10827192|FG002|Overall Study|Amendment 4: > Month 12|5
6824234|NCT00108082|10827190|FG000|Overall Study|Woman of Child-bearing Potential|2
6824235|NCT00108082|10827191|FG001|Overall Study|Woman of Child-bearing Potential|0
6824236|NCT00108082|10827192|FG002|Overall Study|Woman of Child-bearing Potential|2
6824237|NCT00108082|10827190|FG000|Overall Study|Incorrectly Randomized|0
6824238|NCT00108082|10827191|FG001|Overall Study|Incorrectly Randomized|0
6824239|NCT00108082|10827192|FG002|Overall Study|Incorrectly Randomized|2
6824240|NCT00108082|10827190|FG000|Overall Study|Non-compliance|1
6824241|NCT00108082|10827191|FG001|Overall Study|Non-compliance|0
6824242|NCT00108082|10827192|FG002|Overall Study|Non-compliance|2
6824243|NCT00108082|10827190|FG000|Overall Study|Stopped Study Medication|0
6824244|NCT00108082|10827191|FG001|Overall Study|Stopped Study Medication|0
7059909|NCT01912287|11155844|FG000|Overall Study|No-show|0
7059910|NCT01912287|11155845|FG001|Overall Study|No-show|0
7059911|NCT01912287|11155846|FG002|Overall Study|No-show|1
7059912|NCT01912287|11155844|FG000|Overall Study|Dissatisfaction with assigned treatment|4
7059913|NCT01912287|11155845|FG001|Overall Study|Dissatisfaction with assigned treatment|2
7059914|NCT01912287|11155846|FG002|Overall Study|Dissatisfaction with assigned treatment|1
7059915|NCT01912287|11155844|FG000|Overall Study|Felt treatment no longer needed|0
7059916|NCT01912287|11155845|FG001|Overall Study|Felt treatment no longer needed|1
7059917|NCT01912287|11155846|FG002|Overall Study|Felt treatment no longer needed|0
7059918|NCT01912287|11155844|FG000|Overall Study|Life circumstances|4
7059919|NCT01912287|11155845|FG001|Overall Study|Life circumstances|2
7059920|NCT01912287|11155846|FG002|Overall Study|Life circumstances|0
7059921|NCT01912287|11155844|FG000|Overall Study|Lost Interest|1
7059922|NCT01912287|11155845|FG001|Overall Study|Lost Interest|0
7059923|NCT01912287|11155846|FG002|Overall Study|Lost Interest|0
7059924|NCT01912287|11155844|FG000|Overall Study|Uknown reason - subject drop out|5
7059925|NCT01912287|11155845|FG001|Overall Study|Uknown reason - subject drop out|7
7059926|NCT01912287|11155846|FG002|Overall Study|Uknown reason - subject drop out|3
7059927|NCT01912287|11155844|FG000|Overall Study|Missed Assesment|1
7059928|NCT01912287|11155845|FG001|Overall Study|Missed Assesment|1
7059929|NCT01912287|11155846|FG002|Overall Study|Missed Assesment|1
7059930|NCT01912287|11155844|FG000|Overall Study|Scheduling/change in availability|17
7059931|NCT01912287|11155845|FG001|Overall Study|Scheduling/change in availability|10
7059932|NCT01912287|11155846|FG002|Overall Study|Scheduling/change in availability|8
7059933|NCT01912339|11155856|FG000|Blinded (0 to 3 Months)|Declined to participate|1
7059934|NCT01912339|11155857|FG001|Blinded (0 to 3 Months)|Declined to participate|0
7059935|NCT01912339|11155858|FG002|Blinded (0 to 3 Months)|Declined to participate|0
7059936|NCT01912339|11155856|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1
7059937|NCT01912339|11155857|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0
7059938|NCT01912339|11155858|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0
6824245|NCT00108082|10827192|FG002|Overall Study|Stopped Study Medication|1
6824246|NCT00108082|10827190|FG000|Overall Study|Site Closed Study|0
6824247|NCT00108082|10827191|FG001|Overall Study|Site Closed Study|2
6824248|NCT00108082|10827192|FG002|Overall Study|Site Closed Study|0
6824249|NCT00108082|10827190|FG000|Overall Study|Protocol Amendment|0
6824250|NCT00108082|10827191|FG001|Overall Study|Protocol Amendment|1
6824251|NCT00108082|10827192|FG002|Overall Study|Protocol Amendment|0
6824252|NCT00108082|10827190|FG000|Overall Study|Study Medication Not Tapered|0
6824253|NCT00108082|10827191|FG001|Overall Study|Study Medication Not Tapered|1
6824254|NCT00108082|10827192|FG002|Overall Study|Study Medication Not Tapered|0
6824255|NCT00108082|10827190|FG000|Overall Study|Subject Left Site Location|1
6824256|NCT00108082|10827191|FG001|Overall Study|Subject Left Site Location|0
6824257|NCT00108082|10827192|FG002|Overall Study|Subject Left Site Location|0
6824258|NCT00108082|10827190|FG000|Overall Study|Investigator Not at Site|1
6824259|NCT00108082|10827191|FG001|Overall Study|Investigator Not at Site|0
6824260|NCT00108082|10827192|FG002|Overall Study|Investigator Not at Site|0
6824261|NCT00108082|10827190|FG000|Overall Study|Blood Pressure Not Controlled|1
6824262|NCT00108082|10827191|FG001|Overall Study|Blood Pressure Not Controlled|0
6824263|NCT00108082|10827192|FG002|Overall Study|Blood Pressure Not Controlled|0
6824264|NCT00108160|10827202|FG000|Overall Study|Lost to Follow-up|25
6824265|NCT00108160|10827203|FG001|Overall Study|Lost to Follow-up|12
6824266|NCT00108160|10827202|FG000|Overall Study|Death|1
6824267|NCT00108160|10827203|FG001|Overall Study|Death|2
6824268|NCT00108160|10827202|FG000|Overall Study|Withdrawal by Subject|4
6824269|NCT00108160|10827203|FG001|Overall Study|Withdrawal by Subject|2
6824270|NCT00108160|10827202|FG000|Overall Study|Protocol Violation|9
6824271|NCT00108160|10827203|FG001|Overall Study|Protocol Violation|5
6824272|NCT00108355|10827243|FG000|Overall Study|Peritonitis at index paracentesis|1
6824273|NCT00108355|10827244|FG001|Overall Study|Peritonitis at index paracentesis|1
7059939|NCT01912339|11155856|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1
7059940|NCT01912339|11155857|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
6824274|NCT00108355|10827243|FG000|Overall Study|Loculated ascites, limiting paracentesis|1
6824275|NCT00108355|10827244|FG001|Overall Study|Loculated ascites, limiting paracentesis|1
6824276|NCT00108485|10827252|FG000|Overall Study|Withdrawal by Subject|3
6824277|NCT00108485|10827253|FG001|Overall Study|Withdrawal by Subject|0
6824278|NCT00108485|10827252|FG000|Overall Study|Lost to Follow-up|0
6824279|NCT00108485|10827253|FG001|Overall Study|Lost to Follow-up|2
6824280|NCT00108628|10827279|FG000|Overall Study|Withdrawal by Subject|17
6824281|NCT00108628|10827280|FG001|Overall Study|Withdrawal by Subject|9
6824282|NCT00108628|10827279|FG000|Overall Study|Lack of Efficacy|2
6824283|NCT00108628|10827280|FG001|Overall Study|Lack of Efficacy|1
6824284|NCT00108628|10827279|FG000|Overall Study|Death|1
6824285|NCT00108628|10827280|FG001|Overall Study|Death|0
6824286|NCT00108732|10827286|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1
6824287|NCT00108732|10827286|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2
6824288|NCT00108732|10827286|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10
6824289|NCT00108732|10827286|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1
6824290|NCT00108732|10827286|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3
6824291|NCT00108732|10827286|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1
7059941|NCT01912339|11155858|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
7059942|NCT01912339|11155856|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5
7059943|NCT01912339|11155857|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
7059944|NCT01912339|11155858|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
7059945|NCT01912339|11155856|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5
7059946|NCT01912339|11155857|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
7059947|NCT01912339|11155858|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
7059948|NCT01912339|11155856|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1
7059949|NCT01912339|11155857|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0
7059950|NCT01912339|11155858|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3
7059951|NCT01912339|11155856|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1
7059952|NCT01912339|11155857|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
7059953|NCT01912339|11155858|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
7059954|NCT01912339|11155856|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1
7059955|NCT01912339|11155857|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
7059956|NCT01912339|11155858|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
7059957|NCT01912339|11155856|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
7059958|NCT01912339|11155857|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
7059959|NCT01912339|11155858|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1
7059960|NCT01912339|11155856|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
7059961|NCT01912339|11155857|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
7059962|NCT01912339|11155858|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1
7059963|NCT01912339|11155856|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
7059964|NCT01912339|11155857|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
7059965|NCT01912339|11155858|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1
7059966|NCT01912339|11155856|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
7059967|NCT01912339|11155857|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
7059968|NCT01912339|11155858|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1
7059969|NCT01912339|11155856|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120
6824292|NCT00108732|10827286|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1
6824293|NCT00108745|10827293|FG000|Overall Study|Withdrawal by Subject|19
6824294|NCT00108745|10827294|FG001|Overall Study|Withdrawal by Subject|12
6824295|NCT00108745|10827295|FG002|Overall Study|Withdrawal by Subject|12
6824296|NCT00108745|10827293|FG000|Overall Study|Never Treated|8
6824297|NCT00108745|10827294|FG001|Overall Study|Never Treated|10
6824298|NCT00108745|10827295|FG002|Overall Study|Never Treated|12
6824299|NCT00108745|10827293|FG000|Overall Study|Ineligible|7
6824300|NCT00108745|10827294|FG001|Overall Study|Ineligible|13
6824301|NCT00108745|10827295|FG002|Overall Study|Ineligible|13
6824302|NCT00108862|10827305|FG000|Overall Study|Death|31
6824303|NCT00108862|10827306|FG001|Overall Study|Death|37
6901312|NCT00672477|10922144|FG000|Overall Study|Death|7
6901313|NCT00672477|10922145|FG001|Overall Study|Death|11
6901314|NCT00672477|10922144|FG000|Overall Study|Physician Decision|2
6901315|NCT00672477|10922145|FG001|Overall Study|Physician Decision|0
6824304|NCT00108862|10827305|FG000|Overall Study|Withdrawal by Subject|10
6824305|NCT00108862|10827306|FG001|Overall Study|Withdrawal by Subject|6
6824306|NCT00108862|10827305|FG000|Overall Study|Lost to Follow-up|27
6824307|NCT00108862|10827306|FG001|Overall Study|Lost to Follow-up|19
6824308|NCT00108953|10827314|FG000|Follow-up|Death|18
6824309|NCT00108953|10827315|FG001|Follow-up|Death|26
6824310|NCT00108953|10827314|FG000|Follow-up|Lost to Follow-up|1
6824311|NCT00108953|10827315|FG001|Follow-up|Lost to Follow-up|1
6901316|NCT00672477|10922144|FG000|Overall Study|Protocol Violation|1
6901317|NCT00672477|10922145|FG001|Overall Study|Protocol Violation|1
6901318|NCT00672477|10922144|FG000|Overall Study|Withdrawal by Subject|5
6901319|NCT00672477|10922145|FG001|Overall Study|Withdrawal by Subject|3
6901320|NCT00672477|10922144|FG000|Overall Study|Lack of Efficacy|1
6901321|NCT00672477|10922145|FG001|Overall Study|Lack of Efficacy|1
6901322|NCT00672477|10922144|FG000|Overall Study|no study drug for low GFR, health cond.|1
6901323|NCT00672477|10922145|FG001|Overall Study|no study drug for low GFR, health cond.|3
6824312|NCT00108953|10827314|FG000|Follow-up|Study terminated by sponsor|10
6824313|NCT00108953|10827315|FG001|Follow-up|Study terminated by sponsor|6
6824314|NCT00109031|10827337|FG000|Overall Study|Adverse Event|0
6824315|NCT00109031|10827338|FG001|Overall Study|Adverse Event|0
6824316|NCT00109031|10827339|FG002|Overall Study|Adverse Event|1
6824317|NCT00109031|10827340|FG003|Overall Study|Adverse Event|0
6824318|NCT00109031|10827337|FG000|Overall Study|Withdrawal by Subject|0
6824319|NCT00109031|10827338|FG001|Overall Study|Withdrawal by Subject|1
6824320|NCT00109031|10827339|FG002|Overall Study|Withdrawal by Subject|0
6824321|NCT00109031|10827340|FG003|Overall Study|Withdrawal by Subject|0
6824322|NCT00109031|10827337|FG000|Overall Study|Physician Decision|0
7059970|NCT01912339|11155857|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0
7059971|NCT01912339|11155858|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46
7059972|NCT01912456|11155870|FG000|Period 1|Physician Decision|0
7059973|NCT01912456|11155871|FG001|Period 1|Physician Decision|0
6824323|NCT00109031|10827338|FG001|Overall Study|Physician Decision|1
7059974|NCT01912456|11155872|FG002|Period 1|Physician Decision|1
7059975|NCT01912456|11155873|FG003|Period 1|Physician Decision|0
7059976|NCT01912456|11155870|FG000|Period 1|non-compliance|1
7059977|NCT01912456|11155871|FG001|Period 1|non-compliance|0
7059978|NCT01912456|11155872|FG002|Period 1|non-compliance|0
7059979|NCT01912456|11155873|FG003|Period 1|non-compliance|1
7059980|NCT01912456|11155870|FG000|Period 1|Adverse Event|1
7059981|NCT01912456|11155871|FG001|Period 1|Adverse Event|0
7059982|NCT01912456|11155872|FG002|Period 1|Adverse Event|0
7059983|NCT01912456|11155873|FG003|Period 1|Adverse Event|1
7059984|NCT01912456|11155870|FG000|Period 1|Withdrawal by Subject|0
7059985|NCT01912456|11155871|FG001|Period 1|Withdrawal by Subject|1
7059986|NCT01912456|11155872|FG002|Period 1|Withdrawal by Subject|1
7059987|NCT01912456|11155873|FG003|Period 1|Withdrawal by Subject|1
7059988|NCT01912456|11155870|FG000|Period 2|Lack of Efficacy|0
7059989|NCT01912456|11155871|FG001|Period 2|Lack of Efficacy|2
7059990|NCT01912456|11155872|FG002|Period 2|Lack of Efficacy|0
7059991|NCT01912456|11155873|FG003|Period 2|Lack of Efficacy|0
7059992|NCT01912456|11155870|FG000|Period 2|Adverse Event|0
7059993|NCT01912456|11155871|FG001|Period 2|Adverse Event|0
6824324|NCT00109031|10827339|FG002|Overall Study|Physician Decision|0
6824325|NCT00109031|10827340|FG003|Overall Study|Physician Decision|0
6824326|NCT00109031|10827337|FG000|Overall Study|Protocol Violation|0
6824327|NCT00109031|10827338|FG001|Overall Study|Protocol Violation|0
6824328|NCT00109031|10827339|FG002|Overall Study|Protocol Violation|1
6824329|NCT00109031|10827340|FG003|Overall Study|Protocol Violation|0
6824330|NCT00109343|10827353|FG000|Overall Study|Adverse Event|1
6824331|NCT00109343|10827354|FG001|Overall Study|Adverse Event|0
6824332|NCT00109343|10827355|FG002|Overall Study|Adverse Event|2
6824333|NCT00109343|10827353|FG000|Overall Study|Lack of Efficacy|1
6824334|NCT00109343|10827354|FG001|Overall Study|Lack of Efficacy|0
6824335|NCT00109343|10827355|FG002|Overall Study|Lack of Efficacy|0
6824336|NCT00109343|10827353|FG000|Overall Study|Lost to Follow-up|35
6824337|NCT00109343|10827354|FG001|Overall Study|Lost to Follow-up|20
6824338|NCT00109343|10827355|FG002|Overall Study|Lost to Follow-up|14
6824339|NCT00109343|10827353|FG000|Overall Study|Protocol Violation|1
6824340|NCT00109343|10827354|FG001|Overall Study|Protocol Violation|2
6824341|NCT00109343|10827355|FG002|Overall Study|Protocol Violation|2
6824342|NCT00109343|10827353|FG000|Overall Study|Withdrawal by Subject|15
6824343|NCT00109343|10827354|FG001|Overall Study|Withdrawal by Subject|11
6824344|NCT00109343|10827355|FG002|Overall Study|Withdrawal by Subject|10
6824345|NCT00109343|10827353|FG000|Overall Study|Subject Moved|6
6824346|NCT00109343|10827354|FG001|Overall Study|Subject Moved|2
6824347|NCT00109343|10827355|FG002|Overall Study|Subject Moved|1
6824348|NCT00109343|10827353|FG000|Overall Study|Other|5
6824349|NCT00109343|10827354|FG001|Overall Study|Other|2
6824350|NCT00109343|10827355|FG002|Overall Study|Other|1
6824351|NCT00109577|10827377|FG000|Overall Study|Withdrawal by Subject|3
6824352|NCT00109577|10827378|FG001|Overall Study|Withdrawal by Subject|3
6824353|NCT00109590|10827387|FG000|Overall Study|Lost to Follow-up|1
6824354|NCT00109590|10827388|FG001|Overall Study|Lost to Follow-up|0
6824355|NCT00109590|10827389|FG002|Overall Study|Lost to Follow-up|1
6824356|NCT00109590|10827387|FG000|Overall Study|Never Started Treatment|1
6824357|NCT00109590|10827388|FG001|Overall Study|Never Started Treatment|2
6824358|NCT00109590|10827389|FG002|Overall Study|Never Started Treatment|3
6824359|NCT00109707|10827414|FG000|Overall Study|Discontinued in core study without entering the extension study|215
6901324|NCT00672490|10922153|FG000|Overall Study|Withdrawal by Subject|8
6901325|NCT00672490|10922154|FG001|Overall Study|Withdrawal by Subject|8
6901326|NCT00672490|10922153|FG000|Overall Study|Lack of Compliance|2
6901327|NCT00672490|10922154|FG001|Overall Study|Lack of Compliance|7
7059994|NCT01912456|11155872|FG002|Period 2|Adverse Event|0
7059995|NCT01912456|11155873|FG003|Period 2|Adverse Event|1
7059996|NCT01912599|11155892|FG000|Overall Study|Withdrawal by Subject|0
6824360|NCT00109707|10827415|FG001|Overall Study|Discontinued in core study without entering the extension study|122
6824361|NCT00109707|10827416|FG002|Overall Study|Discontinued in core study without entering the extension study|34
7059997|NCT01912599|11155893|FG001|Overall Study|Withdrawal by Subject|1
7059998|NCT01912612|11155901|FG000|Overall Study|Adverse Event|4
7059999|NCT01912612|11155902|FG001|Overall Study|Adverse Event|0
7060000|NCT01912612|11155903|FG002|Overall Study|Adverse Event|0
6824362|NCT00109707|10827414|FG000|Overall Study|Abnormal laboratory values|1
6824363|NCT00109707|10827415|FG001|Overall Study|Abnormal laboratory values|0
6824364|NCT00109707|10827416|FG002|Overall Study|Abnormal laboratory values|0
6824365|NCT00109707|10827414|FG000|Overall Study|Administrative problems|2
6824366|NCT00109707|10827415|FG001|Overall Study|Administrative problems|0
6824367|NCT00109707|10827416|FG002|Overall Study|Administrative problems|1
6824368|NCT00109707|10827414|FG000|Overall Study|Adverse Event|10
6824369|NCT00109707|10827415|FG001|Overall Study|Adverse Event|2
7060001|NCT01912612|11155901|FG000|Overall Study|Withdrew consent|1
7060002|NCT01912612|11155902|FG001|Overall Study|Withdrew consent|0
7060003|NCT01912612|11155903|FG002|Overall Study|Withdrew consent|0
7060004|NCT01912612|11155901|FG000|Overall Study|Study design change|0
7060005|NCT01912612|11155902|FG001|Overall Study|Study design change|0
7060006|NCT01912612|11155903|FG002|Overall Study|Study design change|3
7060007|NCT01912729|11155922|FG000|Overall Study|Withdrawal by Subject|0
7060008|NCT01912729|11155923|FG001|Overall Study|Withdrawal by Subject|1
7060009|NCT01912768|11155931|FG000|Overall Study|Adverse Event|2
7060010|NCT01912768|11155932|FG001|Overall Study|Adverse Event|0
7060011|NCT01912768|11155931|FG000|Overall Study|Lost to Follow-up|2
7060012|NCT01912768|11155932|FG001|Overall Study|Lost to Follow-up|1
7060013|NCT01912768|11155931|FG000|Overall Study|Withdrawal by Subject|5
7060014|NCT01912768|11155932|FG001|Overall Study|Withdrawal by Subject|3
7060015|NCT01912768|11155931|FG000|Overall Study|Randomized in error|1
7060016|NCT01912768|11155932|FG001|Overall Study|Randomized in error|0
7060017|NCT01912781|11155941|FG000|Overall Study|Withdrawal by Subject|2
7060018|NCT01912781|11155942|FG001|Overall Study|Withdrawal by Subject|0
7060019|NCT01912807|11155951|FG000|Overall Study|Did not meet elegibility criteria|6
7060020|NCT01912807|11155952|FG001|Overall Study|Did not meet elegibility criteria|4
7060021|NCT01912807|11155951|FG000|Overall Study|Lost to Follow-up|36
7060022|NCT01912807|11155952|FG001|Overall Study|Lost to Follow-up|37
7060023|NCT01912872|11155962|FG000|Overall Study|Lost to Follow-up|2
7060024|NCT01912872|11155963|FG001|Overall Study|Lost to Follow-up|3
7060025|NCT01912872|11155964|FG002|Overall Study|Lost to Follow-up|5
7060026|NCT01912872|11155965|FG003|Overall Study|Lost to Follow-up|5
7060027|NCT01912872|11155962|FG000|Overall Study|Other unspecified|3
7060028|NCT01912872|11155963|FG001|Overall Study|Other unspecified|1
7060029|NCT01912872|11155964|FG002|Overall Study|Other unspecified|3
7060030|NCT01912872|11155965|FG003|Overall Study|Other unspecified|0
7060031|NCT01912872|11155962|FG000|Overall Study|Informed consent withdrawn|0
7060032|NCT01912872|11155963|FG001|Overall Study|Informed consent withdrawn|0
7060033|NCT01912872|11155964|FG002|Overall Study|Informed consent withdrawn|1
7060034|NCT01912872|11155965|FG003|Overall Study|Informed consent withdrawn|1
7060035|NCT01912872|11155962|FG000|Overall Study|Non-compliance with lab inc/exclusion|0
7060036|NCT01912872|11155963|FG001|Overall Study|Non-compliance with lab inc/exclusion|0
7060037|NCT01912872|11155964|FG002|Overall Study|Non-compliance with lab inc/exclusion|0
7060038|NCT01912872|11155965|FG003|Overall Study|Non-compliance with lab inc/exclusion|1
7060039|NCT01912872|11155962|FG000|Overall Study|Protocol Violation|0
7060040|NCT01912872|11155963|FG001|Overall Study|Protocol Violation|0
7060041|NCT01912872|11155964|FG002|Overall Study|Protocol Violation|1
7060042|NCT01912872|11155965|FG003|Overall Study|Protocol Violation|0
7060043|NCT01912872|11155962|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7060044|NCT01912872|11155963|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7060045|NCT01912872|11155964|FG002|Overall Study|Unsatisfactory therapeutic effect|0
7060046|NCT01912872|11155965|FG003|Overall Study|Unsatisfactory therapeutic effect|2
7060047|NCT01912872|11155962|FG000|Overall Study|Withdrawal of study medication|0
7060048|NCT01912872|11155963|FG001|Overall Study|Withdrawal of study medication|0
7060049|NCT01912872|11155964|FG002|Overall Study|Withdrawal of study medication|0
7060050|NCT01912872|11155965|FG003|Overall Study|Withdrawal of study medication|2
7060051|NCT01912872|11155962|FG000|Overall Study|Missing|0
7060052|NCT01912872|11155963|FG001|Overall Study|Missing|0
7060053|NCT01912872|11155964|FG002|Overall Study|Missing|0
7060054|NCT01912872|11155965|FG003|Overall Study|Missing|1
7060055|NCT01912963|11155979|FG000|Overall Study|Disease Progression (RECIST1.1)|6
7060056|NCT01912963|11155980|FG001|Overall Study|Disease Progression (RECIST1.1)|9
7060057|NCT01912963|11155981|FG002|Overall Study|Disease Progression (RECIST1.1)|5
7060058|NCT01912963|11155979|FG000|Overall Study|Disease Progression (not RECIST1.1)|0
7060059|NCT01912963|11155980|FG001|Overall Study|Disease Progression (not RECIST1.1)|7
7060060|NCT01912963|11155981|FG002|Overall Study|Disease Progression (not RECIST1.1)|1
6824370|NCT00109707|10827416|FG002|Overall Study|Adverse Event|3
6824371|NCT00109707|10827414|FG000|Overall Study|Death|4
7060061|NCT01912963|11155979|FG000|Overall Study|Adverse Event|0
7060062|NCT01912963|11155980|FG001|Overall Study|Adverse Event|1
7060063|NCT01912963|11155981|FG002|Overall Study|Adverse Event|1
7060064|NCT01912963|11155979|FG000|Overall Study|Withdrawal by Subject|0
6824372|NCT00109707|10827415|FG001|Overall Study|Death|0
6824373|NCT00109707|10827416|FG002|Overall Study|Death|0
6824374|NCT00109707|10827414|FG000|Overall Study|Disease progression|12
7060065|NCT01912963|11155980|FG001|Overall Study|Withdrawal by Subject|1
7060066|NCT01912963|11155981|FG002|Overall Study|Withdrawal by Subject|0
6824375|NCT00109707|10827415|FG001|Overall Study|Disease progression|4
7060067|NCT01912963|11155979|FG000|Overall Study|Sought treatment locally|0
7060068|NCT01912963|11155980|FG001|Overall Study|Sought treatment locally|1
7060069|NCT01912963|11155981|FG002|Overall Study|Sought treatment locally|0
6824376|NCT00109707|10827416|FG002|Overall Study|Disease progression|3
6824377|NCT00109707|10827414|FG000|Overall Study|Lost to Follow-up|3
6824378|NCT00109707|10827415|FG001|Overall Study|Lost to Follow-up|0
6901328|NCT00672490|10922153|FG000|Overall Study|Mismatch Include/Exclude Criteria|1
6901329|NCT00672490|10922154|FG001|Overall Study|Mismatch Include/Exclude Criteria|0
6901330|NCT00672490|10922153|FG000|Overall Study|Adverse Event|5
6901331|NCT00672490|10922154|FG001|Overall Study|Adverse Event|8
6901332|NCT00672490|10922153|FG000|Overall Study|Violation of Concomitant Medicine|1
6901333|NCT00672490|10922154|FG001|Overall Study|Violation of Concomitant Medicine|0
6901334|NCT00672490|10922153|FG000|Overall Study|Intolerance|0
6901335|NCT00672490|10922154|FG001|Overall Study|Intolerance|2
6901336|NCT00672490|10922153|FG000|Overall Study|Lost to Follow-up|1
6901337|NCT00672490|10922154|FG001|Overall Study|Lost to Follow-up|5
7060070|NCT01913041|11155989|FG000|Overall Study|Protocol Violation|35
7060071|NCT01913041|11155989|FG000|Overall Study|Withdrawal by Subject|3
7060072|NCT01913041|11155989|FG000|Overall Study|Physician Decision|1
7060073|NCT01913340|11155999|FG000|Overall Study|Death|2
7060074|NCT01913340|11156000|FG001|Overall Study|Death|5
7060075|NCT01913340|11155999|FG000|Overall Study|Lost to Follow-up|1
7060076|NCT01913340|11156000|FG001|Overall Study|Lost to Follow-up|1
7060077|NCT01913353|11156008|FG000|Overall Study|Adverse Event|2
7060078|NCT01913353|11156009|FG001|Overall Study|Adverse Event|0
7060079|NCT01913353|11156008|FG000|Overall Study|Physician Decision|0
7060080|NCT01913353|11156009|FG001|Overall Study|Physician Decision|2
7060081|NCT01913353|11156008|FG000|Overall Study|Withdrawal by Subject|20
7060082|NCT01913353|11156009|FG001|Overall Study|Withdrawal by Subject|6
7060083|NCT01913353|11156008|FG000|Overall Study|multiple reasons|10
7060084|NCT01913353|11156009|FG001|Overall Study|multiple reasons|7
7060085|NCT01913405|11156022|FG000|Overall Study|Withdrawal by Subject|1
7060086|NCT01913405|11156022|FG000|Overall Study|Adverse Event|1
7060087|NCT01913470|11156041|FG000|Overall Study|Lost to Follow-up|0
7060088|NCT01913470|11156042|FG001|Overall Study|Lost to Follow-up|1
7060089|NCT01913470|11156041|FG000|Overall Study|Physician Decision|0
7060090|NCT01913470|11156042|FG001|Overall Study|Physician Decision|1
6901338|NCT00672490|10922153|FG000|Overall Study|No reason was provided|6
6901339|NCT00672490|10922154|FG001|Overall Study|No reason was provided|2
6901340|NCT00672555|10922160|FG000|Overall Study|Lost to Follow-up|4
6901341|NCT00672555|10922160|FG000|Overall Study|Did not want to answer questionnaire|2
6973588|NCT01182350|11025503|FG000|Overall Study|Disease Progression|15
6973589|NCT01182350|11025504|FG001|Overall Study|Disease Progression|12
6973590|NCT01182350|11025505|FG002|Overall Study|Disease Progression|0
6973591|NCT01182350|11025506|FG003|Overall Study|Disease Progression|1
6973592|NCT01182350|11025507|FG004|Overall Study|Disease Progression|0
6973593|NCT01182350|11025503|FG000|Overall Study|Death|0
6973594|NCT01182350|11025504|FG001|Overall Study|Death|1
6973595|NCT01182350|11025505|FG002|Overall Study|Death|1
6973596|NCT01182350|11025506|FG003|Overall Study|Death|0
6973597|NCT01182350|11025507|FG004|Overall Study|Death|0
6973598|NCT01182350|11025503|FG000|Overall Study|Withdrawal by Subject|3
6973599|NCT01182350|11025504|FG001|Overall Study|Withdrawal by Subject|1
6973600|NCT01182350|11025505|FG002|Overall Study|Withdrawal by Subject|0
6973601|NCT01182350|11025506|FG003|Overall Study|Withdrawal by Subject|1
6973602|NCT01182350|11025507|FG004|Overall Study|Withdrawal by Subject|0
6973603|NCT01182350|11025503|FG000|Overall Study|Alternative Therapy|2
6973604|NCT01182350|11025504|FG001|Overall Study|Alternative Therapy|0
6973605|NCT01182350|11025505|FG002|Overall Study|Alternative Therapy|1
6973606|NCT01182350|11025506|FG003|Overall Study|Alternative Therapy|0
6973607|NCT01182350|11025507|FG004|Overall Study|Alternative Therapy|0
6973608|NCT01182350|11025503|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2
6973609|NCT01182350|11025504|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0
6973610|NCT01182350|11025505|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1
6973611|NCT01182350|11025506|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1
6973612|NCT01182350|11025507|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0
6973613|NCT01182350|11025503|FG000|Overall Study|Unevaluable for Biopsy|0
6973614|NCT01182350|11025504|FG001|Overall Study|Unevaluable for Biopsy|0
6973615|NCT01182350|11025505|FG002|Overall Study|Unevaluable for Biopsy|0
6973616|NCT01182350|11025506|FG003|Overall Study|Unevaluable for Biopsy|0
6973617|NCT01182350|11025507|FG004|Overall Study|Unevaluable for Biopsy|3
6973618|NCT01182415|11025532|FG000|Overall Study|Lost to Follow-up|1
6973619|NCT01182428|11025538|FG000|Overall Study|Physician Decision|1
6973620|NCT01182428|11025539|FG001|Overall Study|Physician Decision|0
6973621|NCT01182428|11025538|FG000|Overall Study|Lost to Follow-up|9
6824379|NCT00109707|10827416|FG002|Overall Study|Lost to Follow-up|0
6973622|NCT01182428|11025539|FG001|Overall Study|Lost to Follow-up|1
6973623|NCT01182428|11025538|FG000|Overall Study|Withdrawal by Subject|1
6973624|NCT01182428|11025539|FG001|Overall Study|Withdrawal by Subject|0
6973625|NCT01182441|11025547|FG000|Overall Study|Patient Still in Follow-up|152
6973626|NCT01182441|11025548|FG001|Overall Study|Patient Still in Follow-up|72
7060091|NCT01913470|11156041|FG000|Overall Study|Withdrawal by Subject|0
7060092|NCT01913470|11156042|FG001|Overall Study|Withdrawal by Subject|1
7060093|NCT01913483|11156051|FG000|Overall Study|Withdrawal by Subject|1
7060094|NCT01913483|11156052|FG001|Overall Study|Withdrawal by Subject|2
7060095|NCT01913483|11156051|FG000|Overall Study|Lost to Follow-up|6
7060096|NCT01913483|11156052|FG001|Overall Study|Lost to Follow-up|3
6824380|NCT00109707|10827414|FG000|Overall Study|Protocol Violation|1
6824381|NCT00109707|10827415|FG001|Overall Study|Protocol Violation|0
6824382|NCT00109707|10827416|FG002|Overall Study|Protocol Violation|0
6824383|NCT00109707|10827414|FG000|Overall Study|Patient withdrew consent|6
6824384|NCT00109707|10827415|FG001|Overall Study|Patient withdrew consent|1
6824385|NCT00109707|10827416|FG002|Overall Study|Patient withdrew consent|0
6824386|NCT00109733|10827430|FG000|Overall Study|Protocol Violation|0
6824387|NCT00109733|10827431|FG001|Overall Study|Protocol Violation|1
6824388|NCT00109733|10827430|FG000|Overall Study|Stopped taking study drug|1
7141142|NCT02984267|11295825|FG000|Overall Study|Withdrawal by Subject|0
6824389|NCT00109733|10827431|FG001|Overall Study|Stopped taking study drug|1
6824390|NCT00109733|10827430|FG000|Overall Study|Non-compliant|0
6824391|NCT00109733|10827431|FG001|Overall Study|Non-compliant|1
6824392|NCT00109733|10827430|FG000|Overall Study|Could not commit time for study|1
6824393|NCT00109733|10827431|FG001|Overall Study|Could not commit time for study|1
6824394|NCT00109772|10827439|FG000|Double-blind Treatment|Adverse Event|14
6824395|NCT00109772|10827440|FG001|Double-blind Treatment|Adverse Event|5
6824396|NCT00109772|10827439|FG000|Double-blind Treatment|Lack of Efficacy|1
6824397|NCT00109772|10827440|FG001|Double-blind Treatment|Lack of Efficacy|0
6824398|NCT00109772|10827439|FG000|Double-blind Treatment|Withdrawal by Subject|2
6824399|NCT00109772|10827440|FG001|Double-blind Treatment|Withdrawal by Subject|1
6824400|NCT00109772|10827439|FG000|Double-blind Treatment|Lost to Follow-up|2
6824401|NCT00109772|10827440|FG001|Double-blind Treatment|Lost to Follow-up|3
6824402|NCT00109772|10827439|FG000|Double-blind Treatment|Protocol Violation|0
6824403|NCT00109772|10827440|FG001|Double-blind Treatment|Protocol Violation|1
6824404|NCT00109772|10827439|FG000|Double-blind Treatment|Other|0
6824405|NCT00109772|10827440|FG001|Double-blind Treatment|Other|4
6824406|NCT00109772|10827439|FG000|Double-blind Treatment|Withdrew prior to treatment|3
6824407|NCT00109772|10827440|FG001|Double-blind Treatment|Withdrew prior to treatment|1
6824408|NCT00109772|10827439|FG000|Open-label Extension|Adverse Event|10
6824409|NCT00109772|10827440|FG001|Open-label Extension|Adverse Event|19
6824410|NCT00109772|10827439|FG000|Open-label Extension|Lack of Efficacy|19
6824411|NCT00109772|10827440|FG001|Open-label Extension|Lack of Efficacy|11
6824412|NCT00109772|10827439|FG000|Open-label Extension|Withdrawal by Subject|9
6824413|NCT00109772|10827440|FG001|Open-label Extension|Withdrawal by Subject|6
6824414|NCT00109772|10827439|FG000|Open-label Extension|Lost to Follow-up|1
6824415|NCT00109772|10827440|FG001|Open-label Extension|Lost to Follow-up|0
6824416|NCT00109772|10827439|FG000|Open-label Extension|Death|0
6824417|NCT00109772|10827440|FG001|Open-label Extension|Death|1
6824418|NCT00109772|10827439|FG000|Open-label Extension|Protocol Violation|2
6824419|NCT00109772|10827440|FG001|Open-label Extension|Protocol Violation|2
6824420|NCT00109772|10827439|FG000|Open-label Extension|Other|4
6824421|NCT00109772|10827440|FG001|Open-label Extension|Other|10
6824422|NCT00109837|10827446|FG000|Overall Study|Adverse Event|2
6824423|NCT00109837|10827446|FG000|Overall Study|Refusal unrelated to adverse effects|1
6824424|NCT00109837|10827446|FG000|Overall Study|Death|1
6824425|NCT00109837|10827446|FG000|Overall Study|BCR/ABL+ or Ph+|17
6824426|NCT00109837|10827446|FG000|Overall Study|Not treated|1
6824427|NCT00109837|10827446|FG000|Overall Study|Ineligible|1
6824428|NCT00109850|10827454|FG000|Overall Study|Adverse Event|1
6824429|NCT00109850|10827454|FG000|Overall Study|Death|2
6824430|NCT00109850|10827454|FG000|Overall Study|Ineligible|1
6824431|NCT00109928|10827462|FG000|Overall Study|Adverse Event|2
6824432|NCT00109928|10827462|FG000|Overall Study|Progression|6
6824433|NCT00109928|10827462|FG000|Overall Study|Death|2
6824434|NCT00109928|10827462|FG000|Overall Study|not protocol specified|2
6824435|NCT00109928|10827462|FG000|Overall Study|not eligible|1
6824436|NCT00109967|10827469|FG000|Overall Study|Cancel Prior to Treatment|2
6824437|NCT00109967|10827470|FG001|Overall Study|Cancel Prior to Treatment|0
6824438|NCT00109967|10827469|FG000|Overall Study|Adverse Event|12
6824439|NCT00109967|10827470|FG001|Overall Study|Adverse Event|1
6824440|NCT00109967|10827469|FG000|Overall Study|Withdrawal by Subject|5
6824441|NCT00109967|10827470|FG001|Overall Study|Withdrawal by Subject|0
6824442|NCT00109967|10827469|FG000|Overall Study|Physician Decision|1
6824443|NCT00109967|10827470|FG001|Overall Study|Physician Decision|3
6824444|NCT00109967|10827469|FG000|Overall Study|Death|0
6824445|NCT00109967|10827470|FG001|Overall Study|Death|2
6824446|NCT00110019|10827478|FG000|Overall Study|Lack of Efficacy|253
6824447|NCT00110019|10827479|FG001|Overall Study|Lack of Efficacy|285
6824448|NCT00110019|10827478|FG000|Overall Study|Adverse Event|61
6824449|NCT00110019|10827479|FG001|Overall Study|Adverse Event|40
6824450|NCT00110019|10827478|FG000|Overall Study|Death|13
6824451|NCT00110019|10827479|FG001|Overall Study|Death|15
6824452|NCT00110019|10827478|FG000|Overall Study|Withdrawal by Subject|21
6824453|NCT00110019|10827479|FG001|Overall Study|Withdrawal by Subject|9
6824454|NCT00110019|10827478|FG000|Overall Study|alternative therapy|5
6824455|NCT00110019|10827479|FG001|Overall Study|alternative therapy|1
6824456|NCT00110019|10827478|FG000|Overall Study|complicating disease|1
6824457|NCT00110019|10827479|FG001|Overall Study|complicating disease|1
6824458|NCT00110019|10827478|FG000|Overall Study|symptom deterioration|13
6824459|NCT00110019|10827479|FG001|Overall Study|symptom deterioration|16
6824460|NCT00110019|10827478|FG000|Overall Study|Not start protocol therapy|17
6824461|NCT00110019|10827479|FG001|Overall Study|Not start protocol therapy|16
6824462|NCT00110019|10827478|FG000|Overall Study|other reasons|22
6824463|NCT00110019|10827479|FG001|Overall Study|other reasons|30
6824464|NCT00110084|10827485|FG000|Overall Study|Adverse Event|9
6824465|NCT00110084|10827485|FG000|Overall Study|Death|1
6824466|NCT00110084|10827485|FG000|Overall Study|Patient Refusal|10
6824467|NCT00110084|10827485|FG000|Overall Study|Alternate Therapy|5
6824468|NCT00110084|10827485|FG000|Overall Study|Intercurrent Illness|1
6824469|NCT00110084|10827485|FG000|Overall Study|Other|2
6824470|NCT00110149|10827494|FG000|Overall Study|Physician Decision|3
6824471|NCT00110214|10827501|FG000|Overall Study|Never started treatment|21
6824472|NCT00110214|10827502|FG001|Overall Study|Never started treatment|20
6824473|NCT00110214|10827501|FG000|Overall Study|Disease progression or death|260
6824474|NCT00110214|10827502|FG001|Overall Study|Disease progression or death|151
6824475|NCT00110214|10827501|FG000|Overall Study|Adverse Event|115
6824476|NCT00110214|10827502|FG001|Overall Study|Adverse Event|192
6824477|NCT00110214|10827501|FG000|Overall Study|Refused further treatment|52
6901342|NCT00672620|10922172|FG000|Overall Study|Adverse Event|7
6901343|NCT00672620|10922173|FG001|Overall Study|Adverse Event|7
6901344|NCT00672620|10922174|FG002|Overall Study|Adverse Event|12
7060097|NCT01913483|11156051|FG000|Overall Study|Death|14
7060098|NCT01913483|11156052|FG001|Overall Study|Death|17
7060099|NCT01913639|11156084|FG000|Overall Study|Not Eligible|3
7060100|NCT01914393|11156104|FG000|Overall Study|Protocol Violation|11
7060101|NCT01914393|11156105|FG001|Overall Study|Protocol Violation|3
7060102|NCT01914393|11156106|FG002|Overall Study|Protocol Violation|19
7060103|NCT01914393|11156104|FG000|Overall Study|Lack of Efficacy|11
7060104|NCT01914393|11156105|FG001|Overall Study|Lack of Efficacy|16
7060105|NCT01914393|11156106|FG002|Overall Study|Lack of Efficacy|5
7060106|NCT01914393|11156104|FG000|Overall Study|no reason given|14
7060107|NCT01914393|11156105|FG001|Overall Study|no reason given|8
7060108|NCT01914393|11156106|FG002|Overall Study|no reason given|16
7060109|NCT01914393|11156104|FG000|Overall Study|Adverse Event|29
7060110|NCT01914393|11156105|FG001|Overall Study|Adverse Event|18
7060111|NCT01914393|11156106|FG002|Overall Study|Adverse Event|31
7060112|NCT01914393|11156104|FG000|Overall Study|Withdrawal by Subject|38
6901345|NCT00672620|10922175|FG003|Overall Study|Adverse Event|17
6901346|NCT00672620|10922172|FG000|Overall Study|Lack of Efficacy|1
6901347|NCT00672620|10922173|FG001|Overall Study|Lack of Efficacy|2
6901348|NCT00672620|10922174|FG002|Overall Study|Lack of Efficacy|2
6901349|NCT00672620|10922175|FG003|Overall Study|Lack of Efficacy|0
6901350|NCT00672620|10922172|FG000|Overall Study|Noncompliance with Study Drug|3
6901351|NCT00672620|10922173|FG001|Overall Study|Noncompliance with Study Drug|4
6901352|NCT00672620|10922174|FG002|Overall Study|Noncompliance with Study Drug|0
6901353|NCT00672620|10922175|FG003|Overall Study|Noncompliance with Study Drug|2
6901354|NCT00672620|10922172|FG000|Overall Study|Protocol Deviations|5
7060113|NCT01914393|11156105|FG001|Overall Study|Withdrawal by Subject|20
7060114|NCT01914393|11156106|FG002|Overall Study|Withdrawal by Subject|47
7060115|NCT01914393|11156104|FG000|Overall Study|Lost to Follow-up|12
7060116|NCT01914393|11156105|FG001|Overall Study|Lost to Follow-up|6
7060117|NCT01914393|11156106|FG002|Overall Study|Lost to Follow-up|19
7060118|NCT01914393|11156104|FG000|Overall Study|subject never dosed|0
7060119|NCT01914393|11156105|FG001|Overall Study|subject never dosed|0
7060120|NCT01914393|11156106|FG002|Overall Study|subject never dosed|1
7060121|NCT01914666|11156126|FG000|Treatment Period|Lack of Efficacy|0
7060122|NCT01914666|11156127|FG001|Treatment Period|Lack of Efficacy|0
7060123|NCT01914666|11156128|FG002|Treatment Period|Lack of Efficacy|2
7060124|NCT01914666|11156126|FG000|Treatment Period|Adverse Event|10
7060125|NCT01914666|11156127|FG001|Treatment Period|Adverse Event|4
7060126|NCT01914666|11156128|FG002|Treatment Period|Adverse Event|2
7060127|NCT01914666|11156126|FG000|Treatment Period|Withdrawal by Subject|3
7060128|NCT01914666|11156127|FG001|Treatment Period|Withdrawal by Subject|2
7060129|NCT01914666|11156128|FG002|Treatment Period|Withdrawal by Subject|2
7060130|NCT01914666|11156126|FG000|Treatment Period|Physician Decision|0
7060131|NCT01914666|11156127|FG001|Treatment Period|Physician Decision|0
7060132|NCT01914666|11156128|FG002|Treatment Period|Physician Decision|2
7060133|NCT01914679|11156134|FG000|Overall Study|Lack of Efficacy|1
7060134|NCT01914679|11156134|FG000|Overall Study|Sponsor terminated study|4
7060135|NCT01914757|11156141|FG000|Overall Study|Severe non-compliance to protocol|3
7060136|NCT01914757|11156142|FG001|Overall Study|Severe non-compliance to protocol|1
7060137|NCT01914757|11156143|FG002|Overall Study|Severe non-compliance to protocol|2
6901355|NCT00672620|10922173|FG001|Overall Study|Protocol Deviations|7
6901356|NCT00672620|10922174|FG002|Overall Study|Protocol Deviations|2
7060138|NCT01914757|11156141|FG000|Overall Study|Lost to Follow-up|5
7060139|NCT01914757|11156142|FG001|Overall Study|Lost to Follow-up|8
7060140|NCT01914757|11156143|FG002|Overall Study|Lost to Follow-up|6
7060141|NCT01914757|11156141|FG000|Overall Study|Withdrawal by Subject|15
7060142|NCT01914757|11156142|FG001|Overall Study|Withdrawal by Subject|27
7060143|NCT01914757|11156143|FG002|Overall Study|Withdrawal by Subject|19
6824478|NCT00110214|10827502|FG001|Overall Study|Refused further treatment|65
6824479|NCT00110214|10827501|FG000|Overall Study|Other (not specified)|61
6824480|NCT00110214|10827502|FG001|Overall Study|Other (not specified)|75
7060144|NCT01914757|11156141|FG000|Overall Study|Death|2
7060145|NCT01914757|11156142|FG001|Overall Study|Death|2
7060146|NCT01914757|11156143|FG002|Overall Study|Death|1
7060147|NCT01914757|11156141|FG000|Overall Study|Adverse Event|4
7060148|NCT01914757|11156142|FG001|Overall Study|Adverse Event|3
6824481|NCT00110266|10827508|FG000|Overall Study|Adverse Event|27
6824482|NCT00110266|10827508|FG000|Overall Study|Abnormal laboratory value|15
6824483|NCT00110266|10827508|FG000|Overall Study|Withdrawal by Subject|16
6824484|NCT00110266|10827508|FG000|Overall Study|Death|17
6824485|NCT00110266|10827508|FG000|Overall Study|Unsatisfactory therapeutic effect|2
6824486|NCT00110266|10827508|FG000|Overall Study|Participant condition no longer requires study drug|1
6824487|NCT00110305|10827517|FG000|Overall Study|Adverse Event|46
6824488|NCT00110305|10827518|FG001|Overall Study|Adverse Event|13
6824489|NCT00110305|10827517|FG000|Overall Study|Sponsors Decision|1
6824490|NCT00110305|10827518|FG001|Overall Study|Sponsors Decision|0
6824491|NCT00110305|10827517|FG000|Overall Study|Subject Non-Compliant|9
6824492|NCT00110305|10827518|FG001|Overall Study|Subject Non-Compliant|2
6824493|NCT00110305|10827517|FG000|Overall Study|Subject Ineligible To Continue The Trial|2
6824494|NCT00110305|10827518|FG001|Overall Study|Subject Ineligible To Continue The Trial|1
7060149|NCT01914757|11156143|FG002|Overall Study|Adverse Event|4
7060150|NCT01914757|11156141|FG000|Overall Study|Study specific withdrawal criteria|0
7060151|NCT01914757|11156142|FG001|Overall Study|Study specific withdrawal criteria|1
7060152|NCT01914757|11156143|FG002|Overall Study|Study specific withdrawal criteria|0
7060153|NCT01914757|11156141|FG000|Overall Study|Eligibility criteria not fulfilled|2
7060154|NCT01914757|11156142|FG001|Overall Study|Eligibility criteria not fulfilled|0
7060155|NCT01914757|11156143|FG002|Overall Study|Eligibility criteria not fulfilled|2
7060156|NCT01914757|11156141|FG000|Overall Study|Other reasons|5
7060157|NCT01914757|11156142|FG001|Overall Study|Other reasons|9
7060158|NCT01914757|11156143|FG002|Overall Study|Other reasons|4
7082196|NCT02139644|11192563|FG001|Treatment Period|Adverse Event|0
7082197|NCT02139644|11192564|FG002|Treatment Period|Adverse Event|3
7082198|NCT02139644|11192565|FG003|Treatment Period|Adverse Event|2
7082199|NCT02139644|11192566|FG004|Treatment Period|Adverse Event|1
7082200|NCT02139644|11192567|FG005|Treatment Period|Adverse Event|6
7082201|NCT02139644|11192562|FG000|Treatment Period|Withdrawal by Subject|0
7082202|NCT02139644|11192563|FG001|Treatment Period|Withdrawal by Subject|0
7141143|NCT02984267|11295826|FG001|Overall Study|Withdrawal by Subject|1
7141144|NCT02984683|11295864|FG000|Overall Study|Adverse Event|3
7141145|NCT02984683|11295865|FG001|Overall Study|Adverse Event|3
7141146|NCT02984683|11295864|FG000|Overall Study|Withdrawal by Subject|1
7141147|NCT02984683|11295865|FG001|Overall Study|Withdrawal by Subject|0
7141148|NCT02984683|11295864|FG000|Overall Study|Disease progression|7
7141149|NCT02984683|11295865|FG001|Overall Study|Disease progression|9
7141150|NCT02984943|11295894|FG000|Overall Study|Withdrawal by Subject|3
7141151|NCT02984943|11295894|FG000|Overall Study|Physician Decision|1
7141152|NCT02984982|11295900|FG000|Overall Study|Adverse Event|2
7141153|NCT02984982|11295901|FG001|Overall Study|Adverse Event|5
7141154|NCT02984982|11295900|FG000|Overall Study|Poor Compliance to Protocol|4
7141155|NCT02984982|11295901|FG001|Overall Study|Poor Compliance to Protocol|4
7141156|NCT02984982|11295900|FG000|Overall Study|Withdrawal by Subject|2
7141157|NCT02984982|11295901|FG001|Overall Study|Withdrawal by Subject|0
7141158|NCT02984982|11295900|FG000|Overall Study|Randomized but not treated|0
7141159|NCT02984982|11295901|FG001|Overall Study|Randomized but not treated|1
7141160|NCT02984995|11295910|FG000|Overall Study|Required stem cell transplant|13
7141161|NCT02984995|11295911|FG001|Overall Study|Required stem cell transplant|2
7141162|NCT02984995|11295910|FG000|Overall Study|Progressive disease|11
7141163|NCT02984995|11295911|FG001|Overall Study|Progressive disease|1
7141164|NCT02984995|11295910|FG000|Overall Study|Adverse Event|1
7141165|NCT02984995|11295911|FG001|Overall Study|Adverse Event|0
7141166|NCT02985021|11295923|FG000|Overall Study|Inability to comply with study procedures|1
7141167|NCT02985398|11295927|FG000|Overall Study|Adverse Event|1
7141168|NCT02985398|11295927|FG000|Overall Study|Lost to Follow-up|4
7141169|NCT02985398|11295927|FG000|Overall Study|Withdrawal by Subject|8
7141170|NCT02985398|11295927|FG000|Overall Study|Study Burden|9
7141171|NCT02985450|11295931|FG000|Overall Study|Lost to Follow-up|7
7141172|NCT02985879|11295959|FG000|Overall Study|Adverse Event|7
7141173|NCT02985879|11295960|FG001|Overall Study|Adverse Event|9
7141174|NCT02985879|11295961|FG002|Overall Study|Adverse Event|7
7141175|NCT02985879|11295959|FG000|Overall Study|Withdrew consent|6
7141176|NCT02985879|11295960|FG001|Overall Study|Withdrew consent|8
7141177|NCT02985879|11295961|FG002|Overall Study|Withdrew consent|10
7141178|NCT02985879|11295959|FG000|Overall Study|Lost to Follow-up|1
6824495|NCT00110305|10827517|FG000|Overall Study|Subject Reached A Virologic Endpoint|21
6824496|NCT00110305|10827518|FG001|Overall Study|Subject Reached A Virologic Endpoint|3
6824497|NCT00110305|10827517|FG000|Overall Study|Protocol Violation|0
7141179|NCT02985879|11295960|FG001|Overall Study|Lost to Follow-up|0
6824498|NCT00110305|10827518|FG001|Overall Study|Protocol Violation|1
7141180|NCT02985879|11295961|FG002|Overall Study|Lost to Follow-up|2
7141181|NCT02985879|11295959|FG000|Overall Study|Other, not specified|62
7141182|NCT02985879|11295960|FG001|Overall Study|Other, not specified|58
7141183|NCT02985879|11295961|FG002|Overall Study|Other, not specified|58
7141184|NCT02985996|11295980|FG000|Overall Study|Withdrawal by Subject|0
7141185|NCT02985996|11295981|FG001|Overall Study|Withdrawal by Subject|0
7141186|NCT02985996|11295982|FG002|Overall Study|Withdrawal by Subject|1
7141187|NCT02985996|11295983|FG003|Overall Study|Withdrawal by Subject|0
7141188|NCT02985996|11295984|FG004|Overall Study|Withdrawal by Subject|0
7141189|NCT02985996|11295980|FG000|Overall Study|Protocol Violation|0
6824499|NCT00110305|10827517|FG000|Overall Study|Withdrawal by Subject|7
6824500|NCT00110305|10827518|FG001|Overall Study|Withdrawal by Subject|7
6824501|NCT00110305|10827517|FG000|Overall Study|Lost to Follow-up|20
6824502|NCT00110305|10827518|FG001|Overall Study|Lost to Follow-up|3
6824503|NCT00110305|10827517|FG000|Overall Study|Other|8
6824504|NCT00110305|10827518|FG001|Overall Study|Other|2
6824505|NCT00110357|10827537|FG000|Overall Study|Deterioration without progression|2
6824506|NCT00110357|10827538|FG001|Overall Study|Deterioration without progression|0
6824507|NCT00110357|10827537|FG000|Overall Study|Disease progression/relapse|20
6824508|NCT00110357|10827538|FG001|Overall Study|Disease progression/relapse|15
6824509|NCT00110357|10827537|FG000|Overall Study|Study Closure|1
6824510|NCT00110357|10827538|FG001|Overall Study|Study Closure|0
6824511|NCT00110357|10827537|FG000|Overall Study|Study Drug Toxicity|1
6824512|NCT00110357|10827538|FG001|Overall Study|Study Drug Toxicity|3
6824513|NCT00110357|10827537|FG000|Overall Study|Withdrawal by Subject|3
6824514|NCT00110357|10827538|FG001|Overall Study|Withdrawal by Subject|1
6824515|NCT00110396|10827571|FG000|Overall Study|Adverse Event|15
6824516|NCT00110396|10827571|FG000|Overall Study|Lost to Follow-up|1
6824517|NCT00110396|10827571|FG000|Overall Study|Administration of plasmapheresis|1
6824518|NCT00110396|10827571|FG000|Overall Study|Initiated mitoxantrone therapy|1
6824519|NCT00110396|10827571|FG000|Overall Study|Lack of Efficacy|1
6824520|NCT00110396|10827571|FG000|Overall Study|Decided not to continue treatment|1
6824521|NCT00110396|10827571|FG000|Overall Study|Patient non-compliance|1
6824522|NCT00110396|10827571|FG000|Overall Study|Patient refused to continue|1
6824523|NCT00110396|10827571|FG000|Overall Study|Patient refused to participate|1
6824524|NCT00110396|10827571|FG000|Overall Study|Patient will|1
6824525|NCT00110396|10827571|FG000|Overall Study|Patient's decision|1
6824526|NCT00110396|10827571|FG000|Overall Study|Participation in MS vaccine study|1
6824527|NCT00110396|10827571|FG000|Overall Study|Pregnancy|1
6901357|NCT00672620|10922175|FG003|Overall Study|Protocol Deviations|5
6901358|NCT00672620|10922172|FG000|Overall Study|Withdrawal of Consent|6
6901359|NCT00672620|10922173|FG001|Overall Study|Withdrawal of Consent|12
7141190|NCT02985996|11295981|FG001|Overall Study|Protocol Violation|1
7141191|NCT02985996|11295982|FG002|Overall Study|Protocol Violation|0
7141192|NCT02985996|11295983|FG003|Overall Study|Protocol Violation|0
7141193|NCT02985996|11295984|FG004|Overall Study|Protocol Violation|0
7141194|NCT02986074|11296000|FG000|First Trial Period|Adverse Event|1
7141195|NCT02986074|11296001|FG001|First Trial Period|Adverse Event|0
7141196|NCT02986074|11296002|FG002|First Trial Period|Adverse Event|0
7141197|NCT02986074|11296003|FG003|First Trial Period|Adverse Event|0
7141198|NCT02986074|11296000|FG000|Follow up Period|system explant|0
7141199|NCT02986074|11296001|FG001|Follow up Period|system explant|0
7141200|NCT02986074|11296002|FG002|Follow up Period|system explant|1
7141201|NCT02986074|11296003|FG003|Follow up Period|system explant|2
7141202|NCT02986074|11296000|FG000|Follow up Period|Physician Decision|0
7141203|NCT02986074|11296001|FG001|Follow up Period|Physician Decision|0
7141204|NCT02986074|11296002|FG002|Follow up Period|Physician Decision|0
7141205|NCT02986074|11296003|FG003|Follow up Period|Physician Decision|1
7141206|NCT02986139|11296010|FG000|Overall Study|Sponsor Decision|1
7141207|NCT02986139|11296011|FG001|Overall Study|Sponsor Decision|2
7141208|NCT02986139|11296010|FG000|Overall Study|Withdrawal by Subject|0
7141209|NCT02986139|11296011|FG001|Overall Study|Withdrawal by Subject|1
7141210|NCT02986139|11296010|FG000|Overall Study|Lost to Follow-up|0
7141211|NCT02986139|11296011|FG001|Overall Study|Lost to Follow-up|1
7141212|NCT02986373|11296025|FG000|Overall Study|Adverse Event|4
7141213|NCT02986373|11296025|FG000|Overall Study|Lost to Follow-up|1
7141214|NCT02986373|11296025|FG000|Overall Study|Withdrawal by Subject|10
7141215|NCT02986373|11296025|FG000|Overall Study|Other|24
7141216|NCT02986854|11296058|FG000|Overall Study|Withdrawal by Subject|0
7141217|NCT02986854|11296059|FG001|Overall Study|Withdrawal by Subject|1
7141218|NCT02986854|11296060|FG002|Overall Study|Withdrawal by Subject|1
7141219|NCT02986854|11296058|FG000|Overall Study|Lost to Follow-up|3
7141220|NCT02986854|11296059|FG001|Overall Study|Lost to Follow-up|11
7141221|NCT02986854|11296060|FG002|Overall Study|Lost to Follow-up|2
7183582|NCT01499095|11383676|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2
7183583|NCT01499095|11383677|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1
7183584|NCT01499095|11383676|FG000|Overall Study|Change in Injection Schedule|2
7183585|NCT01499095|11383677|FG001|Overall Study|Change in Injection Schedule|0
7183586|NCT01499095|11383676|FG000|Overall Study|Perceived Lack of Efficacy|1
6901360|NCT00672620|10922174|FG002|Overall Study|Withdrawal of Consent|5
6901361|NCT00672620|10922175|FG003|Overall Study|Withdrawal of Consent|6
7183587|NCT01499095|11383677|FG001|Overall Study|Perceived Lack of Efficacy|1
7183588|NCT01499082|11383688|FG000|Overall Study|Randomized but not Treated|0
7183589|NCT01499082|11383689|FG001|Overall Study|Randomized but not Treated|1
6824528|NCT00110396|10827571|FG000|Overall Study|Pregnancy (Protocol violation)|2
6824529|NCT00110396|10827571|FG000|Overall Study|Protocol Violation|2
6824530|NCT00110396|10827571|FG000|Overall Study|Patient refused to come back|1
6824531|NCT00110396|10827571|FG000|Overall Study|The patient has refused|2
6824532|NCT00110396|10827571|FG000|Overall Study|The patient has refused to visit site|1
6901362|NCT00672620|10922172|FG000|Overall Study|Lost to Follow-up|8
7183590|NCT01499082|11383688|FG000|Overall Study|Adverse Event|12
7183591|NCT01499082|11383689|FG001|Overall Study|Adverse Event|16
7183592|NCT01499082|11383688|FG000|Overall Study|Lack of Efficacy|1
6824533|NCT00110396|10827571|FG000|Overall Study|Patient is to be administered copaxone|1
6824534|NCT00110617|10827594|FG000|Overall Study|Adverse Event|2
6824535|NCT00110617|10827595|FG001|Overall Study|Adverse Event|4
6824536|NCT00110617|10827594|FG000|Overall Study|Abnormal Laboratory Value|4
6824537|NCT00110617|10827595|FG001|Overall Study|Abnormal Laboratory Value|2
6824538|NCT00110617|10827594|FG000|Overall Study|Lack of Efficacy|1
6824539|NCT00110617|10827595|FG001|Overall Study|Lack of Efficacy|0
6824540|NCT00110617|10827594|FG000|Overall Study|Patient no longer requires study drug|1
6824541|NCT00110617|10827595|FG001|Overall Study|Patient no longer requires study drug|0
6824542|NCT00110617|10827594|FG000|Overall Study|Protocol Violation|5
6824543|NCT00110617|10827595|FG001|Overall Study|Protocol Violation|0
6824544|NCT00110617|10827594|FG000|Overall Study|Withdrawal by Subject|10
6824545|NCT00110617|10827595|FG001|Overall Study|Withdrawal by Subject|4
6824546|NCT00110617|10827594|FG000|Overall Study|Lost to Follow-up|9
6824547|NCT00110617|10827595|FG001|Overall Study|Lost to Follow-up|1
6824548|NCT00110617|10827594|FG000|Overall Study|Administrative problems|6
6824549|NCT00110617|10827595|FG001|Overall Study|Administrative problems|5
6824550|NCT00110617|10827594|FG000|Overall Study|Death|1
6824551|NCT00110617|10827595|FG001|Overall Study|Death|1
6824552|NCT00110617|10827594|FG000|Overall Study|Did not receive study drug|0
6824553|NCT00110617|10827595|FG001|Overall Study|Did not receive study drug|12
6824554|NCT00110812|10827606|FG000|Main Study|Death|0
6824555|NCT00110812|10827607|FG001|Main Study|Death|0
6824556|NCT00110812|10827608|FG002|Main Study|Death|2
6824557|NCT00110812|10827606|FG000|Main Study|Withdrawal by Subject|0
6824558|NCT00110812|10827607|FG001|Main Study|Withdrawal by Subject|0
6824559|NCT00110812|10827608|FG002|Main Study|Withdrawal by Subject|1
6824560|NCT00110812|10827606|FG000|Main Study|Lost to Follow-up|8
7141222|NCT02987205|11296079|FG000|Overall Study|Adverse Event|1
7141223|NCT02987205|11296079|FG000|Overall Study|Withdrawal by Subject|3
7141224|NCT02987660|11296109|FG000|Overall Study|Study terminated by sponsor|10
7141225|NCT02987660|11296110|FG001|Overall Study|Study terminated by sponsor|10
7141226|NCT02987972|11296154|FG000|Overall Study|Adverse Event|1
7141227|NCT02987972|11296155|FG001|Overall Study|Adverse Event|1
7141228|NCT02987972|11296156|FG002|Overall Study|Adverse Event|0
7141229|NCT02987972|11296154|FG000|Overall Study|Death|1
7141230|NCT02987972|11296155|FG001|Overall Study|Death|0
7141231|NCT02987972|11296156|FG002|Overall Study|Death|0
7141232|NCT02987972|11296154|FG000|Overall Study|Lack of Efficacy|9
7141233|NCT02987972|11296155|FG001|Overall Study|Lack of Efficacy|12
7141234|NCT02987972|11296156|FG002|Overall Study|Lack of Efficacy|12
7141235|NCT02987972|11296154|FG000|Overall Study|Lost to Follow-up|7
7141236|NCT02987972|11296155|FG001|Overall Study|Lost to Follow-up|8
7141237|NCT02987972|11296156|FG002|Overall Study|Lost to Follow-up|4
7141238|NCT02987972|11296154|FG000|Overall Study|Physician Decision|1
7141239|NCT02987972|11296155|FG001|Overall Study|Physician Decision|6
7141240|NCT02987972|11296156|FG002|Overall Study|Physician Decision|0
7141241|NCT02987972|11296154|FG000|Overall Study|Protocol Violation|2
7141242|NCT02987972|11296155|FG001|Overall Study|Protocol Violation|1
7141243|NCT02987972|11296156|FG002|Overall Study|Protocol Violation|5
7141244|NCT02987972|11296154|FG000|Overall Study|Withdrawal by Subject|22
7141245|NCT02987972|11296155|FG001|Overall Study|Withdrawal by Subject|17
7141246|NCT02987972|11296156|FG002|Overall Study|Withdrawal by Subject|21
7141247|NCT02988115|11296175|FG000|Overall Study|Adverse Event|6
7141248|NCT02988115|11296176|FG001|Overall Study|Adverse Event|1
7141249|NCT02988115|11296175|FG000|Overall Study|Sponsor Decision|5
7141250|NCT02988115|11296176|FG001|Overall Study|Sponsor Decision|2
7141251|NCT02988115|11296175|FG000|Overall Study|Withdrawal by Subject|1
7141252|NCT02988115|11296176|FG001|Overall Study|Withdrawal by Subject|1
7141253|NCT02988115|11296175|FG000|Overall Study|Withdrawn by Mistake|1
7141254|NCT02988115|11296176|FG001|Overall Study|Withdrawn by Mistake|0
7141255|NCT02988115|11296175|FG000|Overall Study|Lost to Follow-up|1
7141256|NCT02988115|11296176|FG001|Overall Study|Lost to Follow-up|0
7141257|NCT02988219|11296193|FG000|Overall Study|Lack of Efficacy|1
7141258|NCT02988219|11296194|FG001|Overall Study|Lack of Efficacy|1
7141259|NCT02988219|11296193|FG000|Overall Study|Withdrawal by Subject|0
7141260|NCT02988219|11296194|FG001|Overall Study|Withdrawal by Subject|2
7141261|NCT02988622|11296209|FG000|Overall Study|Lost to Follow-up|17
7141262|NCT02989168|11296239|FG000|Overall Study|Withdrawal by Subject|2
6824561|NCT00110812|10827607|FG001|Main Study|Lost to Follow-up|11
6824562|NCT00110812|10827608|FG002|Main Study|Lost to Follow-up|10
6824563|NCT00110812|10827606|FG000|Extended Follow-up|Death|1
6824564|NCT00110812|10827607|FG001|Extended Follow-up|Death|0
6824565|NCT00110812|10827608|FG002|Extended Follow-up|Death|3
7141263|NCT02989168|11296240|FG001|Overall Study|Withdrawal by Subject|0
7141264|NCT02989168|11296239|FG000|Overall Study|Physician Decision|0
7141265|NCT02989168|11296240|FG001|Overall Study|Physician Decision|1
7141266|NCT02989168|11296239|FG000|Overall Study|Adverse Event|1
7141267|NCT02989168|11296240|FG001|Overall Study|Adverse Event|2
6824566|NCT00110812|10827606|FG000|Extended Follow-up|Withdrawal by Subject|0
7141268|NCT02989168|11296239|FG000|Overall Study|Sponsor stopped study.|1
7141269|NCT02989168|11296240|FG001|Overall Study|Sponsor stopped study.|0
7141270|NCT02989389|11296262|FG000|Period 1|Lost to Follow-up|0
7141271|NCT02989389|11296263|FG001|Period 1|Lost to Follow-up|1
6824567|NCT00110812|10827607|FG001|Extended Follow-up|Withdrawal by Subject|1
6824568|NCT00110812|10827608|FG002|Extended Follow-up|Withdrawal by Subject|0
6824569|NCT00110812|10827606|FG000|Extended Follow-up|Lost to Follow-up|1
6824570|NCT00110812|10827607|FG001|Extended Follow-up|Lost to Follow-up|3
6824571|NCT00110812|10827608|FG002|Extended Follow-up|Lost to Follow-up|1
6824572|NCT00110890|10827623|FG000|Overall Study|Adverse Event|30
6824573|NCT00110890|10827624|FG001|Overall Study|Adverse Event|7
6824574|NCT00110890|10827623|FG000|Overall Study|Death|16
6824575|NCT00110890|10827624|FG001|Overall Study|Death|9
6824576|NCT00110890|10827623|FG000|Overall Study|Lost to Follow-up|3
6824577|NCT00110890|10827624|FG001|Overall Study|Lost to Follow-up|1
6824578|NCT00110890|10827623|FG000|Overall Study|Physician Decision|4
6824579|NCT00110890|10827624|FG001|Overall Study|Physician Decision|5
6824580|NCT00110890|10827623|FG000|Overall Study|Withdrawal by Subject|17
6901363|NCT00672620|10922173|FG001|Overall Study|Lost to Follow-up|19
6901364|NCT00672620|10922174|FG002|Overall Study|Lost to Follow-up|8
6901365|NCT00672620|10922175|FG003|Overall Study|Lost to Follow-up|11
6901366|NCT00672620|10922172|FG000|Overall Study|Reason not Specified|3
6901367|NCT00672620|10922173|FG001|Overall Study|Reason not Specified|3
6901368|NCT00672620|10922174|FG002|Overall Study|Reason not Specified|2
6901369|NCT00672620|10922175|FG003|Overall Study|Reason not Specified|1
6901370|NCT00672633|10922187|FG000|Overall Study|Withdrawal by Subject|0
6901371|NCT00672633|10922188|FG001|Overall Study|Withdrawal by Subject|1
7141272|NCT02989389|11296264|FG002|Period 1|Lost to Follow-up|0
7141273|NCT02989389|11296265|FG003|Period 1|Lost to Follow-up|0
7141274|NCT02989389|11296266|FG004|Period 1|Lost to Follow-up|0
7141275|NCT02989389|11296267|FG005|Period 1|Lost to Follow-up|0
7141276|NCT02989389|11296268|FG006|Period 1|Lost to Follow-up|0
7141277|NCT02989389|11296269|FG007|Period 1|Lost to Follow-up|0
7141278|NCT02989389|11296270|FG008|Period 1|Lost to Follow-up|0
7141279|NCT02989389|11296271|FG009|Period 1|Lost to Follow-up|0
7141280|NCT02989389|11296262|FG000|Period 1|Physician Decision|0
7141281|NCT02989389|11296263|FG001|Period 1|Physician Decision|0
7141282|NCT02989389|11296264|FG002|Period 1|Physician Decision|0
7141283|NCT02989389|11296265|FG003|Period 1|Physician Decision|0
7141284|NCT02989389|11296266|FG004|Period 1|Physician Decision|0
7141285|NCT02989389|11296267|FG005|Period 1|Physician Decision|0
6824581|NCT00110890|10827624|FG001|Overall Study|Withdrawal by Subject|5
6824582|NCT00110890|10827623|FG000|Overall Study|Protocol Deviation|1
6824583|NCT00110890|10827624|FG001|Overall Study|Protocol Deviation|0
6824584|NCT00110890|10827623|FG000|Overall Study|Noncompliance|10
6824585|NCT00110890|10827624|FG001|Overall Study|Noncompliance|0
6824586|NCT00110890|10827623|FG000|Overall Study|Kidney Transplant|16
6824587|NCT00110890|10827624|FG001|Overall Study|Kidney Transplant|12
6824588|NCT00110890|10827623|FG000|Overall Study|Invest. Product Commercially Available|217
6824589|NCT00110890|10827624|FG001|Overall Study|Invest. Product Commercially Available|110
6824590|NCT00110890|10827623|FG000|Overall Study|Other|34
6824591|NCT00110890|10827624|FG001|Overall Study|Other|23
6824592|NCT00110890|10827623|FG000|Overall Study|Ineligibility determined|3
6824593|NCT00110890|10827624|FG001|Overall Study|Ineligibility determined|0
6824594|NCT00110890|10827623|FG000|Overall Study|Requirement for alternative therapy|0
6824595|NCT00110890|10827624|FG001|Overall Study|Requirement for alternative therapy|1
6824596|NCT00110890|10827623|FG000|Overall Study|Disease progression|0
6978674|NCT01214629|11032182|FG010|Overall Study|Physician Decision|1
6824597|NCT00110890|10827624|FG001|Overall Study|Disease progression|1
6824598|NCT00110890|10827623|FG000|Overall Study|Parathyroidectomy|0
6824599|NCT00110890|10827624|FG001|Overall Study|Parathyroidectomy|1
6824600|NCT00110890|10827623|FG000|Overall Study|Did not enter follow-up phase|10
6824601|NCT00110890|10827624|FG001|Overall Study|Did not enter follow-up phase|4
6824602|NCT00110994|10827632|FG000|Double-blind (DB) Treatment|Adverse Event|3
6824603|NCT00110994|10827633|FG001|Double-blind (DB) Treatment|Adverse Event|0
6824604|NCT00110994|10827632|FG000|Double-blind (DB) Treatment|Death|1
6824605|NCT00110994|10827633|FG001|Double-blind (DB) Treatment|Death|0
6824606|NCT00110994|10827632|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0
6824607|NCT00110994|10827633|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2
6824608|NCT00110994|10827632|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2
6824609|NCT00110994|10827633|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1
6824610|NCT00110994|10827632|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34
7141286|NCT02989389|11296268|FG006|Period 1|Physician Decision|0
7141287|NCT02989389|11296269|FG007|Period 1|Physician Decision|0
7141288|NCT02989389|11296270|FG008|Period 1|Physician Decision|1
7141289|NCT02989389|11296271|FG009|Period 1|Physician Decision|0
7141290|NCT02989610|11296328|FG000|Overall Study|Withdrawal/Other reasons|39
7141291|NCT02989649|11296332|FG000|Overall Study|Patient/Investigator's Decision to Stop|403
6824611|NCT00110994|10827633|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41
6824612|NCT00110994|10827632|FG000|Double-blind (DB) Treatment|other reasons|2
6824613|NCT00110994|10827633|FG001|Double-blind (DB) Treatment|other reasons|3
6824614|NCT00110994|10827632|FG000|Active Follow-up|Disease progression/recurrence/replace|1
6824615|NCT00110994|10827633|FG001|Active Follow-up|Disease progression/recurrence/replace|0
6901372|NCT00672646|10922197|FG000|Overall Study|Lost to Follow-up|0
6901373|NCT00672646|10922198|FG001|Overall Study|Lost to Follow-up|1
7141292|NCT02989649|11296332|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1
7141293|NCT02989649|11296332|FG000|Overall Study|Lost For Observation During Study|3
7141294|NCT02989649|11296332|FG000|Overall Study|Reason Not Specified|13
6824616|NCT00110994|10827632|FG000|Active Follow-up|Other reasons|0
6824617|NCT00110994|10827633|FG001|Active Follow-up|Other reasons|2
6824618|NCT00110994|10827632|FG000|Long Term Follow-up|Death|19
6824619|NCT00110994|10827633|FG001|Long Term Follow-up|Death|17
6824620|NCT00111007|10827641|FG000|Double-blind (DB) Treatment|Adverse Event|12
6824621|NCT00111007|10827642|FG001|Double-blind (DB) Treatment|Adverse Event|4
6824622|NCT00111007|10827641|FG000|Double-blind (DB) Treatment|Death|5
6824623|NCT00111007|10827642|FG001|Double-blind (DB) Treatment|Death|2
6824624|NCT00111007|10827641|FG000|Double-blind (DB) Treatment|Protocol Violation|0
6824625|NCT00111007|10827642|FG001|Double-blind (DB) Treatment|Protocol Violation|1
6824626|NCT00111007|10827641|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6
6824627|NCT00111007|10827642|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8
6824628|NCT00111007|10827641|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1
6824629|NCT00111007|10827642|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0
6824630|NCT00111007|10827641|FG000|Double-blind (DB) Treatment|Relapse|1
6824631|NCT00111007|10827642|FG001|Double-blind (DB) Treatment|Relapse|0
6824632|NCT00111007|10827641|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0
6824633|NCT00111007|10827642|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2
7141295|NCT02989805|11296358|FG000|Overall Study|invalid consent|6
7141296|NCT02989805|11296359|FG001|Overall Study|invalid consent|4
7141297|NCT02990000|11296367|FG000|Overall Study|Failed to provide data beyond baseline|36
7141298|NCT02990000|11296368|FG001|Overall Study|Failed to provide data beyond baseline|34
7141299|NCT02990910|11296376|FG000|Overall Study|Lack of Efficacy|6
7141300|NCT02990910|11296377|FG001|Overall Study|Lack of Efficacy|10
7141301|NCT02991040|11296383|FG000|Overall Study|Withdrawal by Subject|2
7141302|NCT02991040|11296383|FG000|Overall Study|Lost to Follow-up|2
7141303|NCT02991118|11296391|FG000|Overall Study|Death|3
7141304|NCT02991118|11296392|FG001|Overall Study|Death|8
7141305|NCT02991118|11296391|FG000|Overall Study|Protocol Violation|0
7141306|NCT02991118|11296392|FG001|Overall Study|Protocol Violation|3
7141307|NCT02991118|11296391|FG000|Overall Study|Physician Decision|0
7141308|NCT02991118|11296392|FG001|Overall Study|Physician Decision|1
7141309|NCT02991118|11296391|FG000|Overall Study|Moved out of the country|0
7141310|NCT02991118|11296392|FG001|Overall Study|Moved out of the country|1
7141311|NCT02991118|11296391|FG000|Overall Study|Adverse Event|2
7141312|NCT02991118|11296392|FG001|Overall Study|Adverse Event|2
6824634|NCT00111007|10827641|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83
6824635|NCT00111007|10827642|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93
6824636|NCT00111007|10827641|FG000|Double-blind (DB) Treatment|Primary reason with other category|0
6824637|NCT00111007|10827642|FG001|Double-blind (DB) Treatment|Primary reason with other category|1
6824638|NCT00111007|10827641|FG000|Active Follow-up|Adverse Event|1
6824639|NCT00111007|10827642|FG001|Active Follow-up|Adverse Event|0
6824640|NCT00111007|10827641|FG000|Active Follow-up|Death|2
6824641|NCT00111007|10827642|FG001|Active Follow-up|Death|0
6824642|NCT00111007|10827641|FG000|Active Follow-up|Disease progression/recurrence/relapse|3
6824643|NCT00111007|10827642|FG001|Active Follow-up|Disease progression/recurrence/relapse|2
6824644|NCT00111007|10827641|FG000|Long Term Follow-up|Death|34
6824645|NCT00111007|10827642|FG001|Long Term Follow-up|Death|39
6824646|NCT00111007|10827641|FG000|Long Term Follow-up|Lost to Follow-up|1
6824647|NCT00111007|10827642|FG001|Long Term Follow-up|Lost to Follow-up|1
6824648|NCT00111007|10827641|FG000|Long Term Follow-up|Withdrawal by Subject|0
6824649|NCT00111007|10827642|FG001|Long Term Follow-up|Withdrawal by Subject|1
6824650|NCT00111007|10827641|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2
6824651|NCT00111007|10827642|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1
6824652|NCT00111007|10827641|FG000|Long Term Follow-up|Missing|10
6824653|NCT00111007|10827642|FG001|Long Term Follow-up|Missing|3
6824654|NCT00111228|10827651|FG000|Overall Study|Withdrawal by Subject|5
6824655|NCT00111228|10827652|FG001|Overall Study|Withdrawal by Subject|1
6824656|NCT00111228|10827653|FG002|Overall Study|Withdrawal by Subject|0
6824657|NCT00111241|10827663|FG000|Overall Study|Lost to Follow-up|1
6824658|NCT00111241|10827664|FG001|Overall Study|Lost to Follow-up|0
6824659|NCT00111241|10827663|FG000|Overall Study|Withdrawal by Subject|4
6824660|NCT00111241|10827664|FG001|Overall Study|Withdrawal by Subject|0
6824661|NCT00111241|10827663|FG000|Overall Study|Protocol Violation|9
6824662|NCT00111241|10827664|FG001|Overall Study|Protocol Violation|8
6824663|NCT00111241|10827663|FG000|Overall Study|Adverse Event|1
6824664|NCT00111241|10827664|FG001|Overall Study|Adverse Event|0
6824665|NCT00111475|10827682|FG000|Overall Study|Lost to Follow-up|0
6824666|NCT00111475|10827683|FG001|Overall Study|Lost to Follow-up|0
6824667|NCT00111475|10827684|FG002|Overall Study|Lost to Follow-up|0
6824668|NCT00111475|10827685|FG003|Overall Study|Lost to Follow-up|0
6824669|NCT00111475|10827686|FG004|Overall Study|Lost to Follow-up|0
6824670|NCT00111475|10827687|FG005|Overall Study|Lost to Follow-up|1
6824671|NCT00111475|10827688|FG006|Overall Study|Lost to Follow-up|0
6824672|NCT00111475|10827689|FG007|Overall Study|Lost to Follow-up|0
6824673|NCT00111475|10827690|FG008|Overall Study|Lost to Follow-up|0
6824674|NCT00111475|10827691|FG009|Overall Study|Lost to Follow-up|0
6824675|NCT00111761|10827726|FG000|Part 1|Physician Decision|0
6824676|NCT00111761|10827727|FG001|Part 1|Physician Decision|1
6824677|NCT00111761|10827726|FG000|Part 1|Death|0
7141313|NCT02991118|11296391|FG000|Overall Study|Withdrawal by Subject|1
7141314|NCT02991118|11296392|FG001|Overall Study|Withdrawal by Subject|7
6824678|NCT00111761|10827727|FG001|Part 1|Death|2
6824679|NCT00111761|10827726|FG000|Part 1|Other|0
6824680|NCT00111761|10827727|FG001|Part 1|Other|1
6824681|NCT00111761|10827726|FG000|Part 1|Withdrawal by Subject|0
6824682|NCT00111761|10827727|FG001|Part 1|Withdrawal by Subject|1
6824683|NCT00111761|10827726|FG000|Part 2|Adverse Event|1
6824684|NCT00111761|10827727|FG001|Part 2|Adverse Event|0
6824685|NCT00111761|10827726|FG000|Part 2|Physician Decision|1
6824686|NCT00111761|10827727|FG001|Part 2|Physician Decision|0
6824687|NCT00111761|10827726|FG000|Part 2|Death|1
7141315|NCT02991118|11296391|FG000|Overall Study|Could not attend study visits|0
7141316|NCT02991118|11296392|FG001|Overall Study|Could not attend study visits|1
7141317|NCT02991118|11296391|FG000|Overall Study|Lost to Follow-up|1
6824688|NCT00111761|10827727|FG001|Part 2|Death|0
6824689|NCT00111761|10827726|FG000|Part 2|Disease progression|3
7141318|NCT02991118|11296392|FG001|Overall Study|Lost to Follow-up|9
7141319|NCT02991859|11296437|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7141320|NCT02991859|11296438|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1
7141321|NCT02991859|11296439|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7141322|NCT02991859|11296440|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7141323|NCT02991859|11296441|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1
7141324|NCT02991859|11296442|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7141325|NCT02991859|11296443|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7141326|NCT02991859|11296444|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7141327|NCT02991859|11296445|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7141328|NCT02991859|11296446|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7141329|NCT02991859|11296447|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7141330|NCT02991859|11296448|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7141331|NCT02991859|11296449|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7141332|NCT02991859|11296450|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7141333|NCT02991859|11296451|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7141334|NCT02991859|11296452|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7141335|NCT02991859|11296453|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7141336|NCT02991859|11296437|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7141337|NCT02991859|11296438|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7141338|NCT02991859|11296439|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7141339|NCT02991859|11296440|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7141340|NCT02991859|11296441|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7141341|NCT02991859|11296442|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7141342|NCT02991859|11296443|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7141343|NCT02991859|11296444|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7141344|NCT02991859|11296445|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7141345|NCT02991859|11296446|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7141346|NCT02991859|11296447|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7141347|NCT02991859|11296448|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7141348|NCT02991859|11296449|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1
7141349|NCT02991859|11296450|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1
7141350|NCT02991859|11296451|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7141351|NCT02991859|11296452|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7141352|NCT02991859|11296453|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7141353|NCT02991859|11296437|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0
7141354|NCT02991859|11296438|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0
7141355|NCT02991859|11296439|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0
7141356|NCT02991859|11296440|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0
7141357|NCT02991859|11296441|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0
7141358|NCT02991859|11296442|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1
7141359|NCT02991859|11296443|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0
7141360|NCT02991859|11296444|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0
7141361|NCT02991859|11296445|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0
7141362|NCT02991859|11296446|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0
7141363|NCT02991859|11296447|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0
7141364|NCT02991859|11296448|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0
7141365|NCT02991859|11296449|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0
7141366|NCT02991859|11296450|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0
7141367|NCT02991859|11296451|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0
7141368|NCT02991859|11296452|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0
7141369|NCT02991859|11296453|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0
7141370|NCT02991859|11296437|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0
7141371|NCT02991859|11296438|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0
6824690|NCT00111761|10827727|FG001|Part 2|Disease progression|0
6824691|NCT00111761|10827726|FG000|Part 2|Protocol-specified criteria|1
6824692|NCT00111761|10827727|FG001|Part 2|Protocol-specified criteria|0
6824693|NCT00111761|10827726|FG000|Part 2|Other|1
6824694|NCT00111761|10827727|FG001|Part 2|Other|0
6824695|NCT00111800|10827739|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5
6824696|NCT00111800|10827740|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4
6824697|NCT00111800|10827741|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0
6824698|NCT00111800|10827742|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0
6824699|NCT00111800|10827743|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1
6824700|NCT00111800|10827744|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0
6824701|NCT00111800|10827739|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1
6824702|NCT00111800|10827740|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
6824703|NCT00111800|10827741|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
6824704|NCT00111800|10827742|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
6824705|NCT00111800|10827743|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
6824706|NCT00111800|10827744|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
6824707|NCT00111800|10827739|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0
6824708|NCT00111800|10827740|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
6824709|NCT00111800|10827741|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4
6824710|NCT00111800|10827742|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
6824711|NCT00111800|10827743|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
6824712|NCT00111800|10827744|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
6901374|NCT00672646|10922199|FG002|Overall Study|Lost to Follow-up|2
6901375|NCT00672646|10922197|FG000|Overall Study|Withdrawal by Subject|0
6901376|NCT00672646|10922198|FG001|Overall Study|Withdrawal by Subject|0
6901377|NCT00672646|10922199|FG002|Overall Study|Withdrawal by Subject|1
6901378|NCT00672841|10922214|FG000|Overall Study|Comfort care|1
6901379|NCT00672841|10922215|FG001|Overall Study|Comfort care|4
6901380|NCT00672841|10922214|FG000|Overall Study|icteric specimens|0
6901381|NCT00672841|10922215|FG001|Overall Study|icteric specimens|3
6901382|NCT00672841|10922214|FG000|Overall Study|Antifungal therapy, negative glucan|0
6901383|NCT00672841|10922215|FG001|Overall Study|Antifungal therapy, negative glucan|4
6901384|NCT00672841|10922214|FG000|Overall Study|Adverse Event|0
6901385|NCT00672841|10922215|FG001|Overall Study|Adverse Event|3
6901386|NCT00672841|10922214|FG000|Overall Study|Pregnancy|0
6901387|NCT00672841|10922215|FG001|Overall Study|Pregnancy|1
6901388|NCT00672958|10922246|FG000|Overall Study|Adverse Event|11
6901389|NCT00672958|10922247|FG001|Overall Study|Adverse Event|9
6901390|NCT00672958|10922246|FG000|Overall Study|Lack of Efficacy|6
6901391|NCT00672958|10922247|FG001|Overall Study|Lack of Efficacy|11
6901392|NCT00672958|10922246|FG000|Overall Study|Non-compliance with study drug|2
6901393|NCT00672958|10922247|FG001|Overall Study|Non-compliance with study drug|3
6901394|NCT00672958|10922246|FG000|Overall Study|Protocol deviations|11
7141372|NCT02991859|11296439|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0
7141373|NCT02991859|11296440|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0
7141374|NCT02991859|11296441|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0
7141375|NCT02991859|11296442|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0
7141376|NCT02991859|11296443|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0
7141377|NCT02991859|11296444|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0
7141378|NCT02991859|11296445|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0
7141379|NCT02991859|11296446|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1
7141380|NCT02991859|11296447|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0
7141381|NCT02991859|11296448|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0
7141382|NCT02991859|11296449|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0
7141383|NCT02991859|11296450|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0
7141384|NCT02991859|11296451|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0
7141385|NCT02991859|11296452|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0
7141386|NCT02991859|11296453|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0
7141387|NCT02991859|11296437|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7141388|NCT02991859|11296438|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7141389|NCT02991859|11296439|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7141390|NCT02991859|11296440|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
6901395|NCT00672958|10922247|FG001|Overall Study|Protocol deviations|5
6901396|NCT00672958|10922246|FG000|Overall Study|Voluntary withdrawal|12
6901397|NCT00672958|10922247|FG001|Overall Study|Voluntary withdrawal|8
6901398|NCT00672958|10922246|FG000|Overall Study|Lost to Follow-up|22
6901399|NCT00672958|10922247|FG001|Overall Study|Lost to Follow-up|17
6901400|NCT00672958|10922246|FG000|Overall Study|Reason not specified|0
6901401|NCT00672958|10922247|FG001|Overall Study|Reason not specified|3
6901402|NCT00672984|10922256|FG000|First Intervention|Adverse Event|5
6901403|NCT00672984|10922257|FG001|First Intervention|Adverse Event|0
6901404|NCT00672984|10922258|FG002|First Intervention|Adverse Event|0
6901405|NCT00672984|10922256|FG000|First Intervention|Withdrawal by Subject|1
6901406|NCT00672984|10922257|FG001|First Intervention|Withdrawal by Subject|2
6901407|NCT00672984|10922258|FG002|First Intervention|Withdrawal by Subject|2
7141391|NCT02991859|11296441|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7141392|NCT02991859|11296442|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7141393|NCT02991859|11296443|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7141394|NCT02991859|11296444|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
6901408|NCT00672984|10922256|FG000|First Intervention|Sponsor decision|3
6824713|NCT00111800|10827739|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
6824714|NCT00111800|10827740|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
6824715|NCT00111800|10827741|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3
6824716|NCT00111800|10827742|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
6824717|NCT00111800|10827743|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
6824718|NCT00111800|10827744|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1
6824719|NCT00111800|10827739|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3
7141395|NCT02991859|11296445|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1
7141396|NCT02991859|11296446|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7141397|NCT02991859|11296447|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7141398|NCT02991859|11296448|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7141399|NCT02991859|11296449|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7141400|NCT02991859|11296450|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7141401|NCT02991859|11296451|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7141402|NCT02991859|11296452|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7141403|NCT02991859|11296453|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7141404|NCT02992132|11296539|FG000|Overall Study|Adverse Event|4
7141405|NCT02992132|11296540|FG001|Overall Study|Adverse Event|1
7141406|NCT02992132|11296541|FG002|Overall Study|Adverse Event|3
7141407|NCT02992132|11296539|FG000|Overall Study|Lack of Efficacy|2
7141408|NCT02992132|11296540|FG001|Overall Study|Lack of Efficacy|0
7141409|NCT02992132|11296541|FG002|Overall Study|Lack of Efficacy|0
7141410|NCT02992132|11296539|FG000|Overall Study|Non-compliance with study drug|2
7141411|NCT02992132|11296540|FG001|Overall Study|Non-compliance with study drug|0
7141412|NCT02992132|11296541|FG002|Overall Study|Non-compliance with study drug|0
7141413|NCT02992132|11296539|FG000|Overall Study|Progressive disease|1
7141414|NCT02992132|11296540|FG001|Overall Study|Progressive disease|0
7141415|NCT02992132|11296541|FG002|Overall Study|Progressive disease|0
7141416|NCT02992132|11296539|FG000|Overall Study|Protocol Violation|2
7141417|NCT02992132|11296540|FG001|Overall Study|Protocol Violation|2
7141418|NCT02992132|11296541|FG002|Overall Study|Protocol Violation|0
7141419|NCT02992132|11296539|FG000|Overall Study|Caregiver withdrew consent|2
7141420|NCT02992132|11296540|FG001|Overall Study|Caregiver withdrew consent|3
7141421|NCT02992132|11296541|FG002|Overall Study|Caregiver withdrew consent|2
7141422|NCT02992132|11296539|FG000|Overall Study|Withdrawal by Subject|0
7141423|NCT02992132|11296540|FG001|Overall Study|Withdrawal by Subject|2
7141424|NCT02992132|11296541|FG002|Overall Study|Withdrawal by Subject|1
7141425|NCT02992132|11296539|FG000|Overall Study|Physician Decision|0
7141426|NCT02992132|11296540|FG001|Overall Study|Physician Decision|0
7141427|NCT02992132|11296541|FG002|Overall Study|Physician Decision|1
7141428|NCT02992288|11296575|FG000|Overall Study|Adverse Event|8
7141429|NCT02992288|11296576|FG001|Overall Study|Adverse Event|2
7141430|NCT02992288|11296577|FG002|Overall Study|Adverse Event|2
7141431|NCT02992288|11296578|FG003|Overall Study|Adverse Event|2
7141432|NCT02992288|11296579|FG004|Overall Study|Adverse Event|2
7141433|NCT02992288|11296580|FG005|Overall Study|Adverse Event|7
7141434|NCT02992288|11296575|FG000|Overall Study|Non-compliance with study drug|0
7141435|NCT02992288|11296576|FG001|Overall Study|Non-compliance with study drug|1
7141436|NCT02992288|11296577|FG002|Overall Study|Non-compliance with study drug|1
7141437|NCT02992288|11296578|FG003|Overall Study|Non-compliance with study drug|0
7141438|NCT02992288|11296579|FG004|Overall Study|Non-compliance with study drug|1
7141439|NCT02992288|11296580|FG005|Overall Study|Non-compliance with study drug|0
7141440|NCT02992288|11296575|FG000|Overall Study|Physician Decision|3
7141441|NCT02992288|11296576|FG001|Overall Study|Physician Decision|0
7141442|NCT02992288|11296577|FG002|Overall Study|Physician Decision|1
7141443|NCT02992288|11296578|FG003|Overall Study|Physician Decision|0
7141444|NCT02992288|11296579|FG004|Overall Study|Physician Decision|0
7141445|NCT02992288|11296580|FG005|Overall Study|Physician Decision|1
7141446|NCT02992288|11296575|FG000|Overall Study|Death|2
7141447|NCT02992288|11296576|FG001|Overall Study|Death|0
7141448|NCT02992288|11296577|FG002|Overall Study|Death|2
7141449|NCT02992288|11296578|FG003|Overall Study|Death|1
7141450|NCT02992288|11296579|FG004|Overall Study|Death|2
7141451|NCT02992288|11296580|FG005|Overall Study|Death|0
7141452|NCT02992288|11296575|FG000|Overall Study|Lost to Follow-up|0
7141453|NCT02992288|11296576|FG001|Overall Study|Lost to Follow-up|0
7141454|NCT02992288|11296577|FG002|Overall Study|Lost to Follow-up|0
7141455|NCT02992288|11296578|FG003|Overall Study|Lost to Follow-up|1
7141456|NCT02992288|11296579|FG004|Overall Study|Lost to Follow-up|0
7141457|NCT02992288|11296580|FG005|Overall Study|Lost to Follow-up|0
7141458|NCT02992288|11296575|FG000|Overall Study|Protocol Violation|0
7141459|NCT02992288|11296576|FG001|Overall Study|Protocol Violation|0
7141460|NCT02992288|11296577|FG002|Overall Study|Protocol Violation|0
7141461|NCT02992288|11296578|FG003|Overall Study|Protocol Violation|0
7141462|NCT02992288|11296579|FG004|Overall Study|Protocol Violation|0
7141463|NCT02992288|11296580|FG005|Overall Study|Protocol Violation|1
7141464|NCT02992288|11296575|FG000|Overall Study|Withdrawal by Subject|4
7141465|NCT02992288|11296576|FG001|Overall Study|Withdrawal by Subject|2
7141466|NCT02992288|11296577|FG002|Overall Study|Withdrawal by Subject|1
7141467|NCT02992288|11296578|FG003|Overall Study|Withdrawal by Subject|5
6901409|NCT00672984|10922257|FG001|First Intervention|Sponsor decision|0
7141468|NCT02992288|11296579|FG004|Overall Study|Withdrawal by Subject|3
7141469|NCT02992288|11296580|FG005|Overall Study|Withdrawal by Subject|4
7141470|NCT02992691|11296594|FG000|Overall Study|Adverse Event|2
7141471|NCT02992691|11296594|FG000|Overall Study|Withdrawal by Subject|1
7141472|NCT02992899|11296611|FG000|Overall Study|Withdrawal by Subject|1
7141473|NCT02992899|11296612|FG001|Overall Study|Withdrawal by Subject|0
7141474|NCT02992899|11296611|FG000|Overall Study|Lost to Follow-up|1
7141475|NCT02992899|11296612|FG001|Overall Study|Lost to Follow-up|3
7141476|NCT02993224|11296618|FG000|Core Phase - Period 1|Adverse Event|4
7141477|NCT02993224|11296618|FG000|Core Phase - Period 1|Withdrawal by Subject|1
7141478|NCT02993224|11296618|FG000|Core Phase - Period 1|Lost to Follow-up|3
7141479|NCT02993224|11296618|FG000|Core Phase- Period 2|Adverse Event|1
7141480|NCT02993224|11296618|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2
7141481|NCT02993224|11296618|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1
7141482|NCT02993224|11296618|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1
7141483|NCT02993224|11296618|FG000|Extension Phase|Adverse Event|3
7141484|NCT02993224|11296618|FG000|Extension Phase|Withdrawal by Subject|3
7141485|NCT02993224|11296618|FG000|Extension Phase|Lost to Follow-up|2
7141486|NCT02993224|11296618|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27
7141487|NCT02993250|11296626|FG000|Overall Study|Lost to Follow-up|0
7141488|NCT02993250|11296627|FG001|Overall Study|Lost to Follow-up|1
7141489|NCT02993471|11296651|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1
7141490|NCT02993471|11296651|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1
7141491|NCT02993783|11296675|FG000|Overall Study|Reason not Specified|6
7141492|NCT02993783|11296676|FG001|Overall Study|Reason not Specified|9
7141493|NCT02994056|11296682|FG000|Overall Study|Death|8
7141494|NCT02994056|11296682|FG000|Overall Study|Withdrew Consent|1
7141495|NCT02994108|11296697|FG000|Intervention Messages|Withdrawal by Subject|2
7141496|NCT02994108|11296698|FG001|Intervention Messages|Withdrawal by Subject|0
7141497|NCT02994108|11296697|FG000|Phase 1 Assessment|Lost to Follow-up|5
7141498|NCT02994108|11296698|FG001|Phase 1 Assessment|Lost to Follow-up|3
7141499|NCT02994108|11296697|FG000|Phase 2 Assessment|Lost to Follow-up|8
7141500|NCT02994108|11296698|FG001|Phase 2 Assessment|Lost to Follow-up|7
7141501|NCT02994108|11296697|FG000|Phase 2 Assessment|Withdrawal by Subject|1
7141502|NCT02994108|11296698|FG001|Phase 2 Assessment|Withdrawal by Subject|0
7141503|NCT02994394|11296716|FG000|Period 1 (Days 1 to 3)|Adverse Event|0
7141504|NCT02994394|11296717|FG001|Period 1 (Days 1 to 3)|Adverse Event|0
7141505|NCT02994394|11296718|FG002|Period 1 (Days 1 to 3)|Adverse Event|1
7141506|NCT02994394|11296719|FG003|Period 1 (Days 1 to 3)|Adverse Event|0
7141507|NCT02994394|11296720|FG004|Period 1 (Days 1 to 3)|Adverse Event|0
7141508|NCT02994394|11296721|FG005|Period 1 (Days 1 to 3)|Adverse Event|0
6824720|NCT00111800|10827740|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
6824721|NCT00111800|10827741|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
6824722|NCT00111800|10827742|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1
6824723|NCT00111800|10827743|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
6824724|NCT00111800|10827744|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
6824725|NCT00111800|10827739|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
6824726|NCT00111800|10827740|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
6824727|NCT00111800|10827741|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
6824728|NCT00111800|10827742|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
6824729|NCT00111800|10827743|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
7141509|NCT02994394|11296716|FG000|Period 2 (Days 4 to 6)|Adverse Event|0
7141510|NCT02994394|11296717|FG001|Period 2 (Days 4 to 6)|Adverse Event|1
7141511|NCT02994394|11296718|FG002|Period 2 (Days 4 to 6)|Adverse Event|0
7141512|NCT02994394|11296719|FG003|Period 2 (Days 4 to 6)|Adverse Event|0
7141513|NCT02994394|11296720|FG004|Period 2 (Days 4 to 6)|Adverse Event|1
7141514|NCT02994394|11296721|FG005|Period 2 (Days 4 to 6)|Adverse Event|0
7141515|NCT02994654|11296735|FG000|Overall Study|Lost to Follow-up|1
7141516|NCT02994940|11296747|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6
7141517|NCT02994940|11296748|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0
7141518|NCT02994940|11296747|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1
7141519|NCT02994940|11296748|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0
7141520|NCT02994940|11296747|FG000|Overall Study|Did not receive study medications: red dye allergy|0
7141521|NCT02994940|11296748|FG001|Overall Study|Did not receive study medications: red dye allergy|1
7141522|NCT02995980|11296772|FG000|Overall Study|Lost to Follow-up|14
7141523|NCT02996097|11296777|FG000|Overall Study|Lost to Follow-up|11
7141524|NCT02996097|11296778|FG001|Overall Study|Lost to Follow-up|11
7141525|NCT02996448|11296783|FG000|Overall Study|Study terminated due to adverse effects|3
7141526|NCT02996474|11296788|FG000|Overall Study|Physician Decision|5
7141527|NCT02996500|11296798|FG000|Overall Study|Adverse Event|1
7141528|NCT02996500|11296799|FG001|Overall Study|Adverse Event|1
7141529|NCT02996500|11296800|FG002|Overall Study|Adverse Event|4
7141530|NCT02996500|11296801|FG003|Overall Study|Adverse Event|3
7141531|NCT02996500|11296802|FG004|Overall Study|Adverse Event|1
7141532|NCT02996500|11296803|FG005|Overall Study|Adverse Event|2
7141533|NCT02996500|11296798|FG000|Overall Study|Lack of Efficacy|0
7141534|NCT02996500|11296799|FG001|Overall Study|Lack of Efficacy|0
7141535|NCT02996500|11296800|FG002|Overall Study|Lack of Efficacy|0
7141536|NCT02996500|11296801|FG003|Overall Study|Lack of Efficacy|0
7141537|NCT02996500|11296802|FG004|Overall Study|Lack of Efficacy|2
7141538|NCT02996500|11296803|FG005|Overall Study|Lack of Efficacy|0
7141539|NCT02996500|11296798|FG000|Overall Study|Lost to Follow-up|1
7141540|NCT02996500|11296799|FG001|Overall Study|Lost to Follow-up|0
7141541|NCT02996500|11296800|FG002|Overall Study|Lost to Follow-up|0
7141542|NCT02996500|11296801|FG003|Overall Study|Lost to Follow-up|0
7141543|NCT02996500|11296802|FG004|Overall Study|Lost to Follow-up|0
7141544|NCT02996500|11296803|FG005|Overall Study|Lost to Follow-up|1
7141545|NCT02996500|11296798|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
7141546|NCT02996500|11296799|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
7141547|NCT02996500|11296800|FG002|Overall Study|No Longer Meets Eligibility Criteria|1
7141548|NCT02996500|11296801|FG003|Overall Study|No Longer Meets Eligibility Criteria|0
7141549|NCT02996500|11296802|FG004|Overall Study|No Longer Meets Eligibility Criteria|0
7141550|NCT02996500|11296803|FG005|Overall Study|No Longer Meets Eligibility Criteria|0
7141551|NCT02996500|11296798|FG000|Overall Study|Non-Compliance With Study Drug|0
7141552|NCT02996500|11296799|FG001|Overall Study|Non-Compliance With Study Drug|0
7141553|NCT02996500|11296800|FG002|Overall Study|Non-Compliance With Study Drug|0
7141554|NCT02996500|11296801|FG003|Overall Study|Non-Compliance With Study Drug|0
7141555|NCT02996500|11296802|FG004|Overall Study|Non-Compliance With Study Drug|0
7141556|NCT02996500|11296803|FG005|Overall Study|Non-Compliance With Study Drug|1
7141557|NCT02996500|11296798|FG000|Overall Study|Progressive Disease|1
7141558|NCT02996500|11296799|FG001|Overall Study|Progressive Disease|0
7141559|NCT02996500|11296800|FG002|Overall Study|Progressive Disease|0
7141560|NCT02996500|11296801|FG003|Overall Study|Progressive Disease|0
7141561|NCT02996500|11296802|FG004|Overall Study|Progressive Disease|0
7141562|NCT02996500|11296803|FG005|Overall Study|Progressive Disease|0
7141563|NCT02996500|11296798|FG000|Overall Study|Other|2
7141564|NCT02996500|11296799|FG001|Overall Study|Other|0
7141565|NCT02996500|11296800|FG002|Overall Study|Other|2
7141566|NCT02996500|11296801|FG003|Overall Study|Other|0
7141567|NCT02996500|11296802|FG004|Overall Study|Other|0
7141568|NCT02996500|11296803|FG005|Overall Study|Other|0
7141569|NCT02996500|11296798|FG000|Overall Study|Protocol Violation|0
7141570|NCT02996500|11296799|FG001|Overall Study|Protocol Violation|0
7141571|NCT02996500|11296800|FG002|Overall Study|Protocol Violation|0
7141572|NCT02996500|11296801|FG003|Overall Study|Protocol Violation|1
7141573|NCT02996500|11296802|FG004|Overall Study|Protocol Violation|0
7141574|NCT02996500|11296803|FG005|Overall Study|Protocol Violation|0
6824730|NCT00111800|10827744|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
6824731|NCT00111800|10827739|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
6824732|NCT00111800|10827740|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
6824733|NCT00111800|10827741|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
6824734|NCT00111800|10827742|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
6824735|NCT00111800|10827743|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
6824736|NCT00111800|10827744|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
6824737|NCT00111800|10827739|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
6824738|NCT00111800|10827740|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
6824739|NCT00111800|10827741|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
6824740|NCT00111800|10827742|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
6824741|NCT00111800|10827743|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
6824742|NCT00111800|10827744|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
6824743|NCT00111800|10827739|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1
6824744|NCT00111800|10827740|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
6824745|NCT00111800|10827741|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
6824746|NCT00111800|10827742|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
6824747|NCT00111800|10827743|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
6824748|NCT00111800|10827744|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
6824749|NCT00111800|10827739|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
6824750|NCT00111800|10827740|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1
6824751|NCT00111800|10827741|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
6824752|NCT00111800|10827742|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
6824753|NCT00111800|10827743|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
6824754|NCT00111800|10827744|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
7141575|NCT02996500|11296798|FG000|Overall Study|Withdrawal by Subject|3
7141576|NCT02996500|11296799|FG001|Overall Study|Withdrawal by Subject|0
7141577|NCT02996500|11296800|FG002|Overall Study|Withdrawal by Subject|3
7141578|NCT02996500|11296801|FG003|Overall Study|Withdrawal by Subject|0
7141579|NCT02996500|11296802|FG004|Overall Study|Withdrawal by Subject|2
7141580|NCT02996500|11296803|FG005|Overall Study|Withdrawal by Subject|0
7141581|NCT02996682|11296832|FG000|Overall Study|Death|0
7141582|NCT02996682|11296833|FG001|Overall Study|Death|3
7141583|NCT02996968|11296850|FG000|Overall Study|Withdrawal by Subject|1
7141584|NCT02996968|11296851|FG001|Overall Study|Withdrawal by Subject|0
7141585|NCT02997163|11296873|FG000|Overall Study|Adverse Event|1
7141586|NCT02997163|11296874|FG001|Overall Study|Adverse Event|0
7141587|NCT02997163|11296875|FG002|Overall Study|Adverse Event|0
7141588|NCT02997163|11296876|FG003|Overall Study|Adverse Event|1
7141589|NCT02997176|11296890|FG000|Overall Study|Adverse Event|0
7141590|NCT02997176|11296891|FG001|Overall Study|Adverse Event|0
7141591|NCT02997176|11296892|FG002|Overall Study|Adverse Event|0
7141592|NCT02997176|11296893|FG003|Overall Study|Adverse Event|8
7141593|NCT02997176|11296890|FG000|Overall Study|Progressive Disease|1
7141594|NCT02997176|11296891|FG001|Overall Study|Progressive Disease|0
7141595|NCT02997176|11296892|FG002|Overall Study|Progressive Disease|1
7141596|NCT02997176|11296893|FG003|Overall Study|Progressive Disease|1
7141597|NCT02997176|11296890|FG000|Overall Study|Death|0
7141598|NCT02997176|11296891|FG001|Overall Study|Death|0
7141599|NCT02997176|11296892|FG002|Overall Study|Death|1
7141600|NCT02997176|11296893|FG003|Overall Study|Death|1
7141601|NCT02997176|11296890|FG000|Overall Study|Withdrawal by Subject|0
7141602|NCT02997176|11296891|FG001|Overall Study|Withdrawal by Subject|2
7141603|NCT02997176|11296892|FG002|Overall Study|Withdrawal by Subject|0
7141604|NCT02997176|11296893|FG003|Overall Study|Withdrawal by Subject|1
7141605|NCT02998021|11296936|FG000|Overall Study|Withdrawal by Subject|3
7141606|NCT02998021|11296937|FG001|Overall Study|Withdrawal by Subject|1
7141607|NCT02998021|11296936|FG000|Overall Study|unsafe home|0
7141608|NCT02998021|11296937|FG001|Overall Study|unsafe home|1
7141609|NCT02998151|11296943|FG000|Overall Study|Withdrawal by Subject|3
7141610|NCT02998151|11296943|FG000|Overall Study|Participant declined to re-enroll for baclofen|8
7141611|NCT02998151|11296943|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13
7141612|NCT02998541|11296958|FG000|Overall Study|Adverse Event|4
7141613|NCT02998541|11296959|FG001|Overall Study|Adverse Event|5
7141614|NCT02998541|11296960|FG002|Overall Study|Adverse Event|1
7141615|NCT02998541|11296958|FG000|Overall Study|Protocol Violation|1
7141616|NCT02998541|11296959|FG001|Overall Study|Protocol Violation|0
7141617|NCT02998541|11296960|FG002|Overall Study|Protocol Violation|0
7141618|NCT02998541|11296958|FG000|Overall Study|Withdrawal by Subject|3
7141619|NCT02998541|11296959|FG001|Overall Study|Withdrawal by Subject|1
7141620|NCT02998541|11296960|FG002|Overall Study|Withdrawal by Subject|0
7141621|NCT02998541|11296958|FG000|Overall Study|Lost to Follow-up|0
7141622|NCT02998541|11296959|FG001|Overall Study|Lost to Follow-up|3
7141623|NCT02998541|11296960|FG002|Overall Study|Lost to Follow-up|1
7141624|NCT02998541|11296958|FG000|Overall Study|Physician Decision|0
7141625|NCT02998541|11296959|FG001|Overall Study|Physician Decision|0
7141626|NCT02998541|11296960|FG002|Overall Study|Physician Decision|3
7141627|NCT02998541|11296958|FG000|Overall Study|Withdrawal by Parent/Guardian|0
7141628|NCT02998541|11296959|FG001|Overall Study|Withdrawal by Parent/Guardian|0
7141629|NCT02998541|11296960|FG002|Overall Study|Withdrawal by Parent/Guardian|1
7141630|NCT02998554|11296970|FG000|Overall Study|Adverse Event|8
7141631|NCT02998554|11296971|FG001|Overall Study|Adverse Event|3
7141632|NCT02998554|11296970|FG000|Overall Study|Protocol deviation|1
7141633|NCT02998554|11296971|FG001|Overall Study|Protocol deviation|0
7141634|NCT02998554|11296970|FG000|Overall Study|Withdrawal by Subject|2
7141635|NCT02998554|11296971|FG001|Overall Study|Withdrawal by Subject|6
7141636|NCT02998554|11296970|FG000|Overall Study|Lost to Follow-up|0
7141637|NCT02998554|11296971|FG001|Overall Study|Lost to Follow-up|1
7141638|NCT02998554|11296970|FG000|Overall Study|Lack of Efficacy|0
7141639|NCT02998554|11296971|FG001|Overall Study|Lack of Efficacy|1
7141640|NCT02998671|11296984|FG000|Period 1|Study Terminated By Sponsor|2
7141641|NCT02998671|11296985|FG001|Period 1|Study Terminated By Sponsor|1
7141642|NCT02998671|11296986|FG002|Period 1|Study Terminated By Sponsor|0
7141643|NCT02998671|11296987|FG003|Period 1|Study Terminated By Sponsor|0
7141644|NCT02998671|11296988|FG004|Period 1|Study Terminated By Sponsor|1
7141645|NCT02998671|11296984|FG000|Period 1|Withdrawal by Subject|1
7141646|NCT02998671|11296985|FG001|Period 1|Withdrawal by Subject|2
7141647|NCT02998671|11296986|FG002|Period 1|Withdrawal by Subject|0
7141648|NCT02998671|11296987|FG003|Period 1|Withdrawal by Subject|0
7141649|NCT02998671|11296988|FG004|Period 1|Withdrawal by Subject|2
7141650|NCT02998671|11296984|FG000|Period 1|Pregnancy|1
7141651|NCT02998671|11296985|FG001|Period 1|Pregnancy|0
7141652|NCT02998671|11296986|FG002|Period 1|Pregnancy|0
7141653|NCT02998671|11296987|FG003|Period 1|Pregnancy|0
7141654|NCT02998671|11296988|FG004|Period 1|Pregnancy|0
7141655|NCT02998671|11296984|FG000|Period 1|Adverse Event|0
7141656|NCT02998671|11296985|FG001|Period 1|Adverse Event|0
7141657|NCT02998671|11296986|FG002|Period 1|Adverse Event|0
7141658|NCT02998671|11296987|FG003|Period 1|Adverse Event|0
7141659|NCT02998671|11296988|FG004|Period 1|Adverse Event|1
7141660|NCT02998671|11296984|FG000|Period 2|Adverse Event|0
7141661|NCT02998671|11296985|FG001|Period 2|Adverse Event|1
7141662|NCT02998671|11296986|FG002|Period 2|Adverse Event|0
7141663|NCT02998671|11296987|FG003|Period 2|Adverse Event|0
7141664|NCT02998671|11296988|FG004|Period 2|Adverse Event|0
7141665|NCT02998671|11296984|FG000|Period 2|Study Terminated By Sponsor|3
7141666|NCT02998671|11296985|FG001|Period 2|Study Terminated By Sponsor|5
7141667|NCT02998671|11296986|FG002|Period 2|Study Terminated By Sponsor|1
7141668|NCT02998671|11296987|FG003|Period 2|Study Terminated By Sponsor|3
7141669|NCT02998671|11296988|FG004|Period 2|Study Terminated By Sponsor|0
7141670|NCT02998671|11296984|FG000|Period 2|Withdrawal by Subject|0
7141671|NCT02998671|11296985|FG001|Period 2|Withdrawal by Subject|1
7141672|NCT02998671|11296986|FG002|Period 2|Withdrawal by Subject|0
7141673|NCT02998671|11296987|FG003|Period 2|Withdrawal by Subject|0
7141674|NCT02998671|11296988|FG004|Period 2|Withdrawal by Subject|0
7141675|NCT02998671|11296984|FG000|Period 2|Lost to Follow-up|0
7141676|NCT02998671|11296985|FG001|Period 2|Lost to Follow-up|0
6824755|NCT00111800|10827739|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
7141677|NCT02998671|11296986|FG002|Period 2|Lost to Follow-up|0
7141678|NCT02998671|11296987|FG003|Period 2|Lost to Follow-up|1
7141679|NCT02998671|11296988|FG004|Period 2|Lost to Follow-up|0
7141680|NCT02998996|11297023|FG000|Overall Study|Lost to Follow-up|0
7141681|NCT02998996|11297024|FG001|Overall Study|Lost to Follow-up|0
7141682|NCT02998996|11297025|FG002|Overall Study|Lost to Follow-up|1
7141683|NCT02998996|11297026|FG003|Overall Study|Lost to Follow-up|0
7141684|NCT02998996|11297027|FG004|Overall Study|Lost to Follow-up|0
7141685|NCT02998996|11297028|FG005|Overall Study|Lost to Follow-up|0
7141686|NCT02998996|11297023|FG000|Overall Study|Pregnancy|0
7141687|NCT02998996|11297024|FG001|Overall Study|Pregnancy|1
7141688|NCT02998996|11297025|FG002|Overall Study|Pregnancy|0
7141689|NCT02998996|11297026|FG003|Overall Study|Pregnancy|0
7141690|NCT02998996|11297027|FG004|Overall Study|Pregnancy|0
7141691|NCT02998996|11297028|FG005|Overall Study|Pregnancy|0
7141692|NCT02998996|11297023|FG000|Overall Study|Family reasons|0
7141693|NCT02998996|11297024|FG001|Overall Study|Family reasons|0
7141694|NCT02998996|11297025|FG002|Overall Study|Family reasons|0
7141695|NCT02998996|11297026|FG003|Overall Study|Family reasons|0
7141696|NCT02998996|11297027|FG004|Overall Study|Family reasons|1
7141697|NCT02998996|11297028|FG005|Overall Study|Family reasons|0
7141698|NCT02999100|11297048|FG000|Part 1 (up to 15 Days)|Adverse Event|0
7141699|NCT02999100|11297049|FG001|Part 1 (up to 15 Days)|Adverse Event|1
7141700|NCT02999100|11297050|FG002|Part 1 (up to 15 Days)|Adverse Event|0
6824756|NCT00111800|10827740|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1
6824757|NCT00111800|10827741|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
6824758|NCT00111800|10827742|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
6824759|NCT00111800|10827743|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
6901410|NCT00672984|10922258|FG002|First Intervention|Sponsor decision|0
6901411|NCT00672984|10922256|FG000|Second Intervention|Non-compliance with facility policies|0
6901412|NCT00672984|10922257|FG001|Second Intervention|Non-compliance with facility policies|2
6901413|NCT00672984|10922258|FG002|Second Intervention|Non-compliance with facility policies|0
6901414|NCT00672984|10922256|FG000|Second Intervention|Withdrawal by Subject|0
6901415|NCT00672984|10922257|FG001|Second Intervention|Withdrawal by Subject|3
6901416|NCT00672984|10922258|FG002|Second Intervention|Withdrawal by Subject|0
6901417|NCT00672984|10922256|FG000|Second Intervention|Protocol Violation|0
6901418|NCT00672984|10922257|FG001|Second Intervention|Protocol Violation|1
6901419|NCT00672984|10922258|FG002|Second Intervention|Protocol Violation|1
6901420|NCT00672984|10922256|FG000|Third Intervention|Adverse Event|1
6901421|NCT00672984|10922257|FG001|Third Intervention|Adverse Event|0
7141701|NCT02999100|11297051|FG003|Part 1 (up to 15 Days)|Adverse Event|0
7141702|NCT02999100|11297052|FG004|Part 1 (up to 15 Days)|Adverse Event|0
7141703|NCT02999100|11297053|FG005|Part 1 (up to 15 Days)|Adverse Event|0
7141704|NCT02999100|11297048|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
7141705|NCT02999100|11297049|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
7141706|NCT02999100|11297050|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
7141707|NCT02999100|11297051|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
7141708|NCT02999100|11297052|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
7141709|NCT02999100|11297053|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1
7141710|NCT02999100|11297048|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
7141711|NCT02999100|11297049|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
7141712|NCT02999100|11297050|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1
7141713|NCT02999100|11297051|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
7141714|NCT02999100|11297052|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
7141715|NCT02999100|11297053|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
7141716|NCT02999178|11297077|FG000|Overall Study|Adverse Event|85
7141717|NCT02999178|11297078|FG001|Overall Study|Adverse Event|62
7141718|NCT02999178|11297077|FG000|Overall Study|Protocol Violation|1
7141719|NCT02999178|11297078|FG001|Overall Study|Protocol Violation|2
7141720|NCT02999178|11297077|FG000|Overall Study|Lost to Follow-up|0
7141721|NCT02999178|11297078|FG001|Overall Study|Lost to Follow-up|2
7141722|NCT02999178|11297077|FG000|Overall Study|Withdrawal by Subject|21
7141723|NCT02999178|11297078|FG001|Overall Study|Withdrawal by Subject|21
7141724|NCT02999178|11297077|FG000|Overall Study|Other reason not defined above|7
7141725|NCT02999178|11297078|FG001|Overall Study|Other reason not defined above|13
7141726|NCT02999191|11297087|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0
7141727|NCT02999191|11297088|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1
7141728|NCT02999191|11297089|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0
7141729|NCT02999672|11297099|FG000|Overall Study|Death|0
7141730|NCT02999672|11297100|FG001|Overall Study|Death|1
7141731|NCT02999672|11297099|FG000|Overall Study|Study Terminated by Sponsor|0
7141732|NCT02999672|11297100|FG001|Overall Study|Study Terminated by Sponsor|1
7141733|NCT02999672|11297099|FG000|Overall Study|Progressive Disease|9
7141734|NCT02999672|11297100|FG001|Overall Study|Progressive Disease|5
7141735|NCT02999672|11297099|FG000|Overall Study|Adverse Event|4
7141736|NCT02999672|11297100|FG001|Overall Study|Adverse Event|0
7141737|NCT03000075|11297122|FG000|Part A|Adverse Event|4
7141738|NCT03000075|11297123|FG001|Part A|Adverse Event|0
7141739|NCT03000075|11297124|FG002|Part A|Adverse Event|0
7141740|NCT03000075|11297125|FG003|Part A|Adverse Event|0
7141741|NCT03000075|11297126|FG004|Part A|Adverse Event|0
7141742|NCT03000075|11297127|FG005|Part A|Adverse Event|0
7141743|NCT03000075|11297128|FG006|Part A|Adverse Event|0
7141744|NCT03000075|11297122|FG000|Part B|Not dosed due to AE|0
7141745|NCT03000075|11297123|FG001|Part B|Not dosed due to AE|0
7141746|NCT03000075|11297124|FG002|Part B|Not dosed due to AE|0
7141747|NCT03000075|11297125|FG003|Part B|Not dosed due to AE|0
7141748|NCT03000075|11297126|FG004|Part B|Not dosed due to AE|0
7141749|NCT03000075|11297127|FG005|Part B|Not dosed due to AE|2
7141750|NCT03000075|11297128|FG006|Part B|Not dosed due to AE|1
7141751|NCT03000075|11297122|FG000|Part B|Adverse Event|0
7141752|NCT03000075|11297123|FG001|Part B|Adverse Event|0
7141753|NCT03000075|11297124|FG002|Part B|Adverse Event|0
7141754|NCT03000075|11297125|FG003|Part B|Adverse Event|0
7141755|NCT03000075|11297126|FG004|Part B|Adverse Event|1
7141756|NCT03000075|11297127|FG005|Part B|Adverse Event|0
7141757|NCT03000075|11297128|FG006|Part B|Adverse Event|0
7141758|NCT03000348|11297177|FG000|Overall Study|Adverse Event|1
7141759|NCT03000348|11297178|FG001|Overall Study|Adverse Event|1
7141760|NCT03000348|11297179|FG002|Overall Study|Adverse Event|1
7141761|NCT03000348|11297180|FG003|Overall Study|Adverse Event|1
7141762|NCT03000348|11297181|FG004|Overall Study|Adverse Event|1
7141763|NCT03000348|11297182|FG005|Overall Study|Adverse Event|1
6824760|NCT00111800|10827744|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
7141764|NCT03000348|11297177|FG000|Overall Study|Lost to Follow-up|0
7141765|NCT03000348|11297178|FG001|Overall Study|Lost to Follow-up|0
7141766|NCT03000348|11297179|FG002|Overall Study|Lost to Follow-up|1
7141767|NCT03000348|11297180|FG003|Overall Study|Lost to Follow-up|0
7141768|NCT03000348|11297181|FG004|Overall Study|Lost to Follow-up|0
7141769|NCT03000348|11297182|FG005|Overall Study|Lost to Follow-up|0
7141770|NCT03000348|11297177|FG000|Overall Study|Withdrawal by Subject|0
7141771|NCT03000348|11297178|FG001|Overall Study|Withdrawal by Subject|1
7141772|NCT03000348|11297179|FG002|Overall Study|Withdrawal by Subject|0
7141773|NCT03000348|11297180|FG003|Overall Study|Withdrawal by Subject|0
7141774|NCT03000348|11297181|FG004|Overall Study|Withdrawal by Subject|0
7141775|NCT03000348|11297182|FG005|Overall Study|Withdrawal by Subject|0
7141776|NCT03000348|11297177|FG000|Overall Study|Consent|0
7141777|NCT03000348|11297178|FG001|Overall Study|Consent|0
7141778|NCT03000348|11297179|FG002|Overall Study|Consent|0
7141779|NCT03000348|11297180|FG003|Overall Study|Consent|0
7141780|NCT03000348|11297181|FG004|Overall Study|Consent|1
7141781|NCT03000348|11297182|FG005|Overall Study|Consent|0
7141782|NCT03000348|11297177|FG000|Overall Study|Failure to expectorate sputum|1
7141783|NCT03000348|11297178|FG001|Overall Study|Failure to expectorate sputum|0
7141784|NCT03000348|11297179|FG002|Overall Study|Failure to expectorate sputum|1
7141785|NCT03000348|11297180|FG003|Overall Study|Failure to expectorate sputum|0
7141786|NCT03000348|11297181|FG004|Overall Study|Failure to expectorate sputum|1
7141787|NCT03000348|11297182|FG005|Overall Study|Failure to expectorate sputum|0
7141788|NCT03000348|11297177|FG000|Overall Study|No gram negative|1
7141789|NCT03000348|11297178|FG001|Overall Study|No gram negative|2
7141790|NCT03000348|11297179|FG002|Overall Study|No gram negative|1
7141791|NCT03000348|11297180|FG003|Overall Study|No gram negative|1
7141792|NCT03000348|11297181|FG004|Overall Study|No gram negative|1
7141793|NCT03000348|11297182|FG005|Overall Study|No gram negative|1
7141794|NCT03000348|11297177|FG000|Overall Study|Patient had no transport|0
6824761|NCT00111800|10827739|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
6824762|NCT00111800|10827740|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1
6824763|NCT00111800|10827741|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
7141795|NCT03000348|11297178|FG001|Overall Study|Patient had no transport|0
7141796|NCT03000348|11297179|FG002|Overall Study|Patient had no transport|0
7141797|NCT03000348|11297180|FG003|Overall Study|Patient had no transport|1
7141798|NCT03000348|11297181|FG004|Overall Study|Patient had no transport|0
7141799|NCT03000348|11297182|FG005|Overall Study|Patient had no transport|0
7141800|NCT03000348|11297177|FG000|Overall Study|Dosing|0
7141801|NCT03000348|11297178|FG001|Overall Study|Dosing|0
7141802|NCT03000348|11297179|FG002|Overall Study|Dosing|0
7141803|NCT03000348|11297180|FG003|Overall Study|Dosing|0
7141804|NCT03000348|11297181|FG004|Overall Study|Dosing|1
7141805|NCT03000348|11297182|FG005|Overall Study|Dosing|0
7141806|NCT03000452|11297199|FG000|Treatment Period|Death|1
7141807|NCT03000452|11297199|FG000|Treatment Period|Progressive Disease (PD)|14
7141808|NCT03000452|11297199|FG000|Treatment Period|Physician Decision|1
6824764|NCT00111800|10827742|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
6824765|NCT00111800|10827743|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
6824766|NCT00111800|10827744|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
6824767|NCT00111800|10827739|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
6824768|NCT00111800|10827740|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1
6824769|NCT00111800|10827741|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
6824770|NCT00111800|10827742|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
6824771|NCT00111800|10827743|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
6824772|NCT00111800|10827744|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
6824773|NCT00111800|10827739|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
7141809|NCT03000452|11297199|FG000|Treatment Period|Miscellaneous|2
7141810|NCT03000452|11297199|FG000|Follow-Up Period|Study Terminated by Sponsor|1
7141811|NCT03000452|11297199|FG000|Follow-Up Period|Death|3
7141812|NCT03000452|11297199|FG000|Follow-Up Period|Withdrawal by Subject|3
7141813|NCT03000673|11297216|FG000|Overall Study|Withdrawal by Subject|1
7141814|NCT03000673|11297217|FG001|Overall Study|Withdrawal by Subject|0
7141815|NCT03000673|11297218|FG002|Overall Study|Withdrawal by Subject|0
7141816|NCT03000673|11297219|FG003|Overall Study|Withdrawal by Subject|0
7141817|NCT03000686|11297232|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0
7141818|NCT03000686|11297233|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1
7141819|NCT03000686|11297234|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0
7141820|NCT03000686|11297235|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0
7141821|NCT03001076|11297249|FG000|Overall Study|Withdrawal by patient|2
7141822|NCT03001076|11297250|FG001|Overall Study|Withdrawal by patient|0
7141823|NCT03001076|11297249|FG000|Overall Study|Other|1
7141824|NCT03001076|11297250|FG001|Overall Study|Other|0
7141825|NCT03001076|11297249|FG000|Overall Study|Adverse Event|3
7141826|NCT03001076|11297250|FG001|Overall Study|Adverse Event|3
7141827|NCT03001076|11297249|FG000|Overall Study|Sponsor decision|1
7141828|NCT03001076|11297250|FG001|Overall Study|Sponsor decision|0
7141829|NCT03001076|11297249|FG000|Overall Study|Lost to Follow-up|0
7141830|NCT03001076|11297250|FG001|Overall Study|Lost to Follow-up|2
7141831|NCT03001219|11297258|FG000|Proof of Concept|Study Termination by Sponsor|0
7141832|NCT03001219|11297259|FG001|Proof of Concept|Study Termination by Sponsor|1
7141833|NCT03001219|11297258|FG000|Proof of Concept|Withdrawal by Subject|0
7141834|NCT03001219|11297259|FG001|Proof of Concept|Withdrawal by Subject|4
7141835|NCT03001219|11297258|FG000|Proof of Concept|Protocol Deviation|0
7141836|NCT03001219|11297259|FG001|Proof of Concept|Protocol Deviation|1
7141837|NCT03001219|11297258|FG000|Proof of Concept|Adverse Event|1
7141838|NCT03001219|11297259|FG001|Proof of Concept|Adverse Event|1
7141839|NCT03001219|11297258|FG000|Proof of Concept|Physician Decision|1
7141840|NCT03001219|11297259|FG001|Proof of Concept|Physician Decision|0
7141841|NCT03001219|11297258|FG000|Extension Period Analysis|Study Termination by Sponsor|0
7141842|NCT03001219|11297259|FG001|Extension Period Analysis|Study Termination by Sponsor|36
7141843|NCT03001219|11297258|FG000|Extension Period Analysis|Participant Non-Compliance|0
7141844|NCT03001219|11297259|FG001|Extension Period Analysis|Participant Non-Compliance|1
7141845|NCT03001219|11297258|FG000|Extension Period Analysis|Physician Decision|0
7141846|NCT03001219|11297259|FG001|Extension Period Analysis|Physician Decision|1
7141847|NCT03001219|11297258|FG000|Extension Period Analysis|Adverse Event|1
7141848|NCT03001219|11297259|FG001|Extension Period Analysis|Adverse Event|1
7141849|NCT03001219|11297258|FG000|Extension Period Analysis|Protocol Deviation|0
7141850|NCT03001219|11297259|FG001|Extension Period Analysis|Protocol Deviation|1
7141851|NCT03001219|11297258|FG000|Extension Period Analysis|Withdrawal by Subject|4
7141852|NCT03001219|11297259|FG001|Extension Period Analysis|Withdrawal by Subject|5
7183593|NCT01499082|11383689|FG001|Overall Study|Lack of Efficacy|1
7183594|NCT01499082|11383688|FG000|Overall Study|Protocol Violation|6
7183595|NCT01499082|11383689|FG001|Overall Study|Protocol Violation|8
7141853|NCT03001557|11297297|FG000|Core Phase|Randomized but not treated|0
7141854|NCT03001557|11297298|FG001|Core Phase|Randomized but not treated|0
7141855|NCT03001557|11297299|FG002|Core Phase|Randomized but not treated|1
7141856|NCT03001557|11297300|FG003|Core Phase|Randomized but not treated|0
7141857|NCT03001557|11297301|FG004|Core Phase|Randomized but not treated|0
6824774|NCT00111800|10827740|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
6824775|NCT00111800|10827741|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
6824776|NCT00111800|10827742|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1
6824777|NCT00111800|10827743|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
6824778|NCT00111800|10827744|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
6824779|NCT00111800|10827739|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
6824780|NCT00111800|10827740|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
6824781|NCT00111800|10827741|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
6824782|NCT00111800|10827742|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1
6824783|NCT00111800|10827743|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
6824784|NCT00111800|10827744|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
6824785|NCT00111800|10827739|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
6824786|NCT00111800|10827740|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
6824787|NCT00111800|10827741|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
6824788|NCT00111800|10827742|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
6824789|NCT00111800|10827743|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1
6824790|NCT00111800|10827744|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
6824791|NCT00111800|10827739|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
6824792|NCT00111800|10827740|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
6824793|NCT00111800|10827741|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
6824794|NCT00111800|10827742|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
6824795|NCT00111800|10827743|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1
6824796|NCT00111800|10827744|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
6824797|NCT00111800|10827739|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
6824798|NCT00111800|10827740|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
6824799|NCT00111800|10827741|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
6824800|NCT00111800|10827742|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
6824801|NCT00111800|10827743|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
6824802|NCT00111800|10827744|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1
6824803|NCT00111800|10827739|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
6824804|NCT00111800|10827740|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2
6824805|NCT00111800|10827741|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1
6824806|NCT00111800|10827742|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3
6824807|NCT00111800|10827743|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
6824808|NCT00111800|10827744|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
6824809|NCT00111800|10827739|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
6824810|NCT00111800|10827740|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
6824811|NCT00111800|10827741|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
6824812|NCT00111800|10827742|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
6824813|NCT00111800|10827743|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
6824814|NCT00111800|10827744|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
6824815|NCT00111800|10827739|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
6824816|NCT00111800|10827740|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
6824817|NCT00111800|10827741|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
6824818|NCT00111800|10827742|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
6824819|NCT00111800|10827743|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3
6824820|NCT00111800|10827744|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
6824821|NCT00111800|10827739|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
6824822|NCT00111800|10827740|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
6824823|NCT00111800|10827741|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
6824824|NCT00111800|10827742|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
6824825|NCT00111800|10827743|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
6824826|NCT00111800|10827744|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
6824827|NCT00111800|10827739|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
6824828|NCT00111800|10827740|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
6824829|NCT00111800|10827741|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0
6824830|NCT00111800|10827742|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
6824831|NCT00111800|10827743|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
6824832|NCT00111800|10827744|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
6824833|NCT00111800|10827739|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
7141858|NCT03001557|11297302|FG005|Core Phase|Randomized but not treated|0
6824834|NCT00111800|10827740|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1
6824835|NCT00111800|10827741|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
6824836|NCT00111800|10827742|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
6824837|NCT00111800|10827743|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
6824838|NCT00111800|10827744|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
6824839|NCT00111800|10827739|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
6824840|NCT00111800|10827740|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
6824841|NCT00111800|10827741|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1
6824842|NCT00111800|10827742|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
6824843|NCT00111800|10827743|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
6824844|NCT00111800|10827744|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
6824845|NCT00111800|10827739|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
6824846|NCT00111800|10827740|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
6824847|NCT00111800|10827741|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1
6824848|NCT00111800|10827742|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
6824849|NCT00111800|10827743|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
6824850|NCT00111800|10827744|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
6824851|NCT00111813|10827767|FG000|Overall Study|Adverse Event|1
6824852|NCT00111813|10827768|FG001|Overall Study|Adverse Event|2
6824853|NCT00111813|10827769|FG002|Overall Study|Adverse Event|4
6824854|NCT00111813|10827770|FG003|Overall Study|Adverse Event|2
6824855|NCT00111813|10827771|FG004|Overall Study|Adverse Event|2
6824856|NCT00111813|10827772|FG005|Overall Study|Adverse Event|2
6824857|NCT00111813|10827767|FG000|Overall Study|Progressive disease|2
6824858|NCT00111813|10827768|FG001|Overall Study|Progressive disease|1
6824859|NCT00111813|10827769|FG002|Overall Study|Progressive disease|5
6824860|NCT00111813|10827770|FG003|Overall Study|Progressive disease|3
6824861|NCT00111813|10827771|FG004|Overall Study|Progressive disease|4
6824862|NCT00111813|10827772|FG005|Overall Study|Progressive disease|3
6824863|NCT00111813|10827767|FG000|Overall Study|Lack of Efficacy|0
6824864|NCT00111813|10827768|FG001|Overall Study|Lack of Efficacy|0
6824865|NCT00111813|10827769|FG002|Overall Study|Lack of Efficacy|0
6824866|NCT00111813|10827770|FG003|Overall Study|Lack of Efficacy|0
6824867|NCT00111813|10827771|FG004|Overall Study|Lack of Efficacy|0
6824868|NCT00111813|10827772|FG005|Overall Study|Lack of Efficacy|1
6824869|NCT00111813|10827767|FG000|Overall Study|Other|0
6824870|NCT00111813|10827768|FG001|Overall Study|Other|0
6824871|NCT00111813|10827769|FG002|Overall Study|Other|1
6824872|NCT00111813|10827770|FG003|Overall Study|Other|0
6824873|NCT00111813|10827771|FG004|Overall Study|Other|0
6824874|NCT00111813|10827772|FG005|Overall Study|Other|0
6824875|NCT00111839|10827790|FG000|Overall Study|Disease Progression|30
6824876|NCT00111839|10827791|FG001|Overall Study|Disease Progression|33
6824877|NCT00111839|10827792|FG002|Overall Study|Disease Progression|33
6824878|NCT00111839|10827790|FG000|Overall Study|Adverse Event|5
6824879|NCT00111839|10827791|FG001|Overall Study|Adverse Event|3
6824880|NCT00111839|10827792|FG002|Overall Study|Adverse Event|1
6824881|NCT00111839|10827790|FG000|Overall Study|Protocol Violation|2
6824882|NCT00111839|10827791|FG001|Overall Study|Protocol Violation|4
6824883|NCT00111839|10827792|FG002|Overall Study|Protocol Violation|2
6824884|NCT00111839|10827790|FG000|Overall Study|Death|1
6824885|NCT00111839|10827791|FG001|Overall Study|Death|1
6824886|NCT00111839|10827792|FG002|Overall Study|Death|6
6824887|NCT00111839|10827790|FG000|Overall Study|Withdrawal by Subject|2
6824888|NCT00111839|10827791|FG001|Overall Study|Withdrawal by Subject|2
6824889|NCT00111839|10827792|FG002|Overall Study|Withdrawal by Subject|2
6824890|NCT00111839|10827790|FG000|Overall Study|Lost to Follow-up|1
6824891|NCT00111839|10827791|FG001|Overall Study|Lost to Follow-up|0
6824892|NCT00111839|10827792|FG002|Overall Study|Lost to Follow-up|0
6824893|NCT00111839|10827790|FG000|Overall Study|Logistical Constraint|1
6824894|NCT00111839|10827791|FG001|Overall Study|Logistical Constraint|0
6824895|NCT00111839|10827792|FG002|Overall Study|Logistical Constraint|0
6824896|NCT00111839|10827790|FG000|Overall Study|Other|6
6824897|NCT00111839|10827791|FG001|Overall Study|Other|3
6824898|NCT00111839|10827792|FG002|Overall Study|Other|3
6824899|NCT00111839|10827790|FG000|Overall Study|Randomized but Not Treated|0
6824900|NCT00111839|10827791|FG001|Overall Study|Randomized but Not Treated|0
6824901|NCT00111839|10827792|FG002|Overall Study|Randomized but Not Treated|2
6824902|NCT00111917|10827802|FG000|Overall Study|Withdrawal by Subject|1
6824903|NCT00111917|10827803|FG001|Overall Study|Withdrawal by Subject|1
6824904|NCT00112047|10827815|FG000|Randomized Phase|Lost to Follow-up|26
6824905|NCT00112047|10827816|FG001|Randomized Phase|Lost to Follow-up|33
6824906|NCT00112047|10827815|FG000|Randomized Phase|Adverse Event|10
6824907|NCT00112047|10827816|FG001|Randomized Phase|Adverse Event|10
6824908|NCT00112047|10827815|FG000|Randomized Phase|Withrawal of consent|10
6824909|NCT00112047|10827816|FG001|Randomized Phase|Withrawal of consent|18
6824910|NCT00112047|10827815|FG000|Randomized Phase|Sub-optimal virological response|3
6824911|NCT00112047|10827816|FG001|Randomized Phase|Sub-optimal virological response|13
6824912|NCT00112047|10827815|FG000|Randomized Phase|Noncompliance|8
6824913|NCT00112047|10827816|FG001|Randomized Phase|Noncompliance|4
6824914|NCT00112047|10827815|FG000|Randomized Phase|Protocol Violation|2
6824915|NCT00112047|10827816|FG001|Randomized Phase|Protocol Violation|0
6824916|NCT00112047|10827815|FG000|Randomized Phase|Pregnancy|3
6824917|NCT00112047|10827816|FG001|Randomized Phase|Pregnancy|1
6824918|NCT00112047|10827815|FG000|Randomized Phase|Death|1
6824919|NCT00112047|10827816|FG001|Randomized Phase|Death|3
6824920|NCT00112047|10827815|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0
6824921|NCT00112047|10827816|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1
6824922|NCT00112047|10827815|FG000|Randomized Phase|Inability to swallow pills|0
6824923|NCT00112047|10827816|FG001|Randomized Phase|Inability to swallow pills|1
6824924|NCT00112047|10827815|FG000|Randomized Phase|Incarceration|3
7141859|NCT03001557|11297303|FG006|Core Phase|Randomized but not treated|0
7141860|NCT03001557|11297304|FG007|Core Phase|Randomized but not treated|0
7141861|NCT03001557|11297297|FG000|Extension Phase|Adverse Event|0
7141862|NCT03001557|11297298|FG001|Extension Phase|Adverse Event|0
7141863|NCT03001557|11297299|FG002|Extension Phase|Adverse Event|0
7141864|NCT03001557|11297300|FG003|Extension Phase|Adverse Event|0
7141865|NCT03001557|11297301|FG004|Extension Phase|Adverse Event|0
7141866|NCT03001557|11297302|FG005|Extension Phase|Adverse Event|2
7141867|NCT03001557|11297303|FG006|Extension Phase|Adverse Event|0
7141868|NCT03001557|11297304|FG007|Extension Phase|Adverse Event|0
7141869|NCT03001557|11297297|FG000|Extension Phase|Withdrawal by Subject|0
7141870|NCT03001557|11297298|FG001|Extension Phase|Withdrawal by Subject|0
7141871|NCT03001557|11297299|FG002|Extension Phase|Withdrawal by Subject|0
7141872|NCT03001557|11297300|FG003|Extension Phase|Withdrawal by Subject|0
7141873|NCT03001557|11297301|FG004|Extension Phase|Withdrawal by Subject|0
7141874|NCT03001557|11297302|FG005|Extension Phase|Withdrawal by Subject|1
7141875|NCT03001557|11297303|FG006|Extension Phase|Withdrawal by Subject|5
7141876|NCT03001557|11297304|FG007|Extension Phase|Withdrawal by Subject|2
7141877|NCT03001557|11297297|FG000|Extension Phase|Lost to Follow-up|0
7141878|NCT03001557|11297298|FG001|Extension Phase|Lost to Follow-up|0
7141879|NCT03001557|11297299|FG002|Extension Phase|Lost to Follow-up|0
6824925|NCT00112047|10827816|FG001|Randomized Phase|Incarceration|2
6824926|NCT00112047|10827815|FG000|Randomized Phase|Moved out of State|0
6824927|NCT00112047|10827816|FG001|Randomized Phase|Moved out of State|1
6824928|NCT00112047|10827815|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4
6824929|NCT00112047|10827816|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0
6824930|NCT00112047|10827815|FG000|Randomized Phase|High Hepatitis B DNA|0
6824931|NCT00112047|10827816|FG001|Randomized Phase|High Hepatitis B DNA|1
6824932|NCT00112047|10827815|FG000|Atripla Phase|Adverse Event|2
6824933|NCT00112047|10827816|FG001|Atripla Phase|Adverse Event|1
6824934|NCT00112047|10827815|FG000|Atripla Phase|Lost to Follow-up|5
6824935|NCT00112047|10827816|FG001|Atripla Phase|Lost to Follow-up|7
6824936|NCT00112047|10827815|FG000|Atripla Phase|Pregnancy|0
6824937|NCT00112047|10827816|FG001|Atripla Phase|Pregnancy|1
6824938|NCT00112047|10827815|FG000|Atripla Phase|Death|0
6824939|NCT00112047|10827816|FG001|Atripla Phase|Death|2
6824940|NCT00112047|10827815|FG000|Atripla Phase|Withdrew consent|7
6824941|NCT00112047|10827816|FG001|Atripla Phase|Withdrew consent|7
6824942|NCT00112047|10827815|FG000|Atripla Phase|Sub-optimal virological response|0
6824943|NCT00112047|10827816|FG001|Atripla Phase|Sub-optimal virological response|1
6824944|NCT00112047|10827815|FG000|Atripla Phase|Non-compliance|1
6824945|NCT00112047|10827816|FG001|Atripla Phase|Non-compliance|0
6824946|NCT00112047|10827815|FG000|Atripla Phase|Other|3
6824947|NCT00112047|10827816|FG001|Atripla Phase|Other|1
6824948|NCT00112294|10827898|FG000|Overall Study|Still on study|5
6824949|NCT00112294|10827899|FG001|Overall Study|Still on study|0
6824950|NCT00112359|10827907|FG000|Overall Study|Unrelated adverse event|16
6824951|NCT00112359|10827908|FG001|Overall Study|Unrelated adverse event|8
6824952|NCT00112359|10827907|FG000|Overall Study|Trial drug intolerance (adverse event)|2
6824953|NCT00112359|10827908|FG001|Overall Study|Trial drug intolerance (adverse event)|0
6824954|NCT00112359|10827907|FG000|Overall Study|Related adverse event|5
6824955|NCT00112359|10827908|FG001|Overall Study|Related adverse event|3
6824956|NCT00112359|10827907|FG000|Overall Study|Lost to Follow-up|0
7141880|NCT03001557|11297300|FG003|Extension Phase|Lost to Follow-up|0
7141881|NCT03001557|11297301|FG004|Extension Phase|Lost to Follow-up|0
7141882|NCT03001557|11297302|FG005|Extension Phase|Lost to Follow-up|0
7141883|NCT03001557|11297303|FG006|Extension Phase|Lost to Follow-up|2
7141884|NCT03001557|11297304|FG007|Extension Phase|Lost to Follow-up|1
7141885|NCT03001557|11297297|FG000|Extension Phase|Administrative Reason|0
7141886|NCT03001557|11297298|FG001|Extension Phase|Administrative Reason|0
6824957|NCT00112359|10827908|FG001|Overall Study|Lost to Follow-up|1
6824958|NCT00112359|10827907|FG000|Overall Study|Personal/administrative|1
6824959|NCT00112359|10827908|FG001|Overall Study|Personal/administrative|1
6824960|NCT00112359|10827907|FG000|Overall Study|Other|3
6824961|NCT00112359|10827908|FG001|Overall Study|Other|0
6824962|NCT00112385|10827916|FG000|Overall Study|Lost to Follow-up|1
6824963|NCT00112385|10827917|FG001|Overall Study|Lost to Follow-up|0
6824964|NCT00112385|10827916|FG000|Overall Study|Withdrawal by Subject|0
7141887|NCT03001557|11297299|FG002|Extension Phase|Administrative Reason|0
7141888|NCT03001557|11297300|FG003|Extension Phase|Administrative Reason|0
7141889|NCT03001557|11297301|FG004|Extension Phase|Administrative Reason|0
7141890|NCT03001557|11297302|FG005|Extension Phase|Administrative Reason|1
7141891|NCT03001557|11297303|FG006|Extension Phase|Administrative Reason|3
7141892|NCT03001557|11297304|FG007|Extension Phase|Administrative Reason|3
7141893|NCT03001557|11297297|FG000|Extension Phase|Loss of caregiver|0
7141894|NCT03001557|11297298|FG001|Extension Phase|Loss of caregiver|0
7141895|NCT03001557|11297299|FG002|Extension Phase|Loss of caregiver|0
7141896|NCT03001557|11297300|FG003|Extension Phase|Loss of caregiver|0
7141897|NCT03001557|11297301|FG004|Extension Phase|Loss of caregiver|0
7141898|NCT03001557|11297302|FG005|Extension Phase|Loss of caregiver|0
7141899|NCT03001557|11297303|FG006|Extension Phase|Loss of caregiver|1
7141900|NCT03001557|11297304|FG007|Extension Phase|Loss of caregiver|0
7141901|NCT03001557|11297297|FG000|Extension Phase|Others|0
7141902|NCT03001557|11297298|FG001|Extension Phase|Others|0
7141903|NCT03001557|11297299|FG002|Extension Phase|Others|0
7141904|NCT03001557|11297300|FG003|Extension Phase|Others|0
7141905|NCT03001557|11297301|FG004|Extension Phase|Others|0
7141906|NCT03001557|11297302|FG005|Extension Phase|Others|1
7141907|NCT03001557|11297303|FG006|Extension Phase|Others|3
7141908|NCT03001557|11297304|FG007|Extension Phase|Others|0
7141909|NCT03002038|11297364|FG000|Overall Study|Adverse Event|3
7141910|NCT03002038|11297365|FG001|Overall Study|Adverse Event|1
7141911|NCT03002038|11297364|FG000|Overall Study|Withdrawal by Subject|8
7141912|NCT03002038|11297365|FG001|Overall Study|Withdrawal by Subject|4
7141913|NCT03002038|11297364|FG000|Overall Study|Immigration to another region|0
7141914|NCT03002038|11297365|FG001|Overall Study|Immigration to another region|2
7141915|NCT03002077|11297371|FG000|Overall Study|Non-compliance with Study Drug|4
7141916|NCT03002077|11297371|FG000|Overall Study|Non-compliance w/Background ADT|1
7141917|NCT03002077|11297371|FG000|Overall Study|Study Terminated by Sponsor|257
7141918|NCT03002077|11297371|FG000|Overall Study|Site Terminated by Sponsor|5
7141919|NCT03002077|11297371|FG000|Overall Study|Miscellaneous Reasons|10
7141920|NCT03002077|11297371|FG000|Overall Study|Adverse Event|23
7141921|NCT03002077|11297371|FG000|Overall Study|Lack of Efficacy|20
7141922|NCT03002077|11297371|FG000|Overall Study|Withdrawal by Subject|72
7141923|NCT03002077|11297371|FG000|Overall Study|Lost to Follow-up|21
7141924|NCT03002077|11297371|FG000|Overall Study|Pregnancy|4
7141925|NCT03002077|11297371|FG000|Overall Study|Protocol Violation|21
7141926|NCT03002194|11297375|FG000|Overall Study|Lost to Follow-up|6
7141927|NCT03002194|11297375|FG000|Overall Study|Adverse Event|1
7141928|NCT03002194|11297375|FG000|Overall Study|Lack of Efficacy|1
7141929|NCT03002194|11297375|FG000|Overall Study|Withdrawal by Subject|2
7141930|NCT03002311|11297381|FG000|Overall Study|Lost to Follow-up|13
7141931|NCT03002311|11297382|FG001|Overall Study|Lost to Follow-up|26
7141932|NCT03002311|11297381|FG000|Overall Study|Referral provider called to schedule app|3
7141933|NCT03002311|11297382|FG001|Overall Study|Referral provider called to schedule app|3
7141934|NCT03002311|11297381|FG000|Overall Study|Physician Decision|3
7141935|NCT03002311|11297382|FG001|Overall Study|Physician Decision|1
7141936|NCT03002610|11297400|FG000|Overall Study|Withdrawal by Subject|6
7141937|NCT03002610|11297401|FG001|Overall Study|Withdrawal by Subject|25
7141938|NCT03002610|11297402|FG002|Overall Study|Withdrawal by Subject|13
7141939|NCT03002623|11297412|FG000|Overall Study|Lost to Follow-up|1
7141940|NCT03002623|11297413|FG001|Overall Study|Lost to Follow-up|0
7141941|NCT03002623|11297412|FG000|Overall Study|Physician Decision|1
7141942|NCT03002623|11297413|FG001|Overall Study|Physician Decision|1
7141943|NCT03002818|11297433|FG000|Overall Study|Decision of the investigator|1
7141944|NCT03003000|11297453|FG000|Overall Study|Adverse Event|1
7141945|NCT03003000|11297454|FG001|Overall Study|Adverse Event|2
7141946|NCT03003000|11297455|FG002|Overall Study|Adverse Event|3
7141947|NCT03003000|11297453|FG000|Overall Study|Lack of Efficacy|1
7141948|NCT03003000|11297454|FG001|Overall Study|Lack of Efficacy|0
7141949|NCT03003000|11297455|FG002|Overall Study|Lack of Efficacy|0
7141950|NCT03003000|11297453|FG000|Overall Study|Non-compliant with protocol|0
7141951|NCT03003000|11297454|FG001|Overall Study|Non-compliant with protocol|1
7141952|NCT03003000|11297455|FG002|Overall Study|Non-compliant with protocol|1
7141953|NCT03003000|11297453|FG000|Overall Study|Refused to continue medication|2
7141954|NCT03003000|11297454|FG001|Overall Study|Refused to continue medication|0
7141955|NCT03003000|11297455|FG002|Overall Study|Refused to continue medication|0
7141956|NCT03003000|11297453|FG000|Overall Study|Other than listed|1
7141957|NCT03003000|11297454|FG001|Overall Study|Other than listed|1
7141958|NCT03003000|11297455|FG002|Overall Study|Other than listed|1
7141959|NCT03003390|11297474|FG000|Overall Study|Physician Decision|2
7141960|NCT03003390|11297475|FG001|Overall Study|Physician Decision|0
7141961|NCT03003390|11297474|FG000|Overall Study|Parent refused intervention|2
7141962|NCT03003390|11297475|FG001|Overall Study|Parent refused intervention|0
6824965|NCT00112385|10827917|FG001|Overall Study|Withdrawal by Subject|1
6824966|NCT00112437|10827928|FG000|Year 1 (12-Month Base Study)|Adverse Event|9
6824967|NCT00112437|10827929|FG001|Year 1 (12-Month Base Study)|Adverse Event|10
6824968|NCT00112437|10827930|FG002|Year 1 (12-Month Base Study)|Adverse Event|6
6824969|NCT00112437|10827931|FG003|Year 1 (12-Month Base Study)|Adverse Event|4
6824970|NCT00112437|10827932|FG004|Year 1 (12-Month Base Study)|Adverse Event|3
6824971|NCT00112437|10827933|FG005|Year 1 (12-Month Base Study)|Adverse Event|0
6824972|NCT00112437|10827934|FG006|Year 1 (12-Month Base Study)|Adverse Event|0
7141963|NCT03003494|11297486|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28
7141964|NCT03003676|11297492|FG000|Overall Study|Lack of Efficacy|5
7141965|NCT03003676|11297493|FG001|Overall Study|Lack of Efficacy|7
7141966|NCT03003676|11297492|FG000|Overall Study|Withdrawal by Subject|0
7141967|NCT03003676|11297493|FG001|Overall Study|Withdrawal by Subject|1
7141968|NCT03003676|11297492|FG000|Overall Study|Hepatitis B infection|1
7141969|NCT03003676|11297493|FG001|Overall Study|Hepatitis B infection|0
7141970|NCT03004469|11297522|FG000|Overall Study|Adverse Event|6
7141971|NCT03004469|11297523|FG001|Overall Study|Adverse Event|4
7141972|NCT03004469|11297524|FG002|Overall Study|Adverse Event|6
7141973|NCT03004469|11297522|FG000|Overall Study|Lack of Efficacy|1
7141974|NCT03004469|11297523|FG001|Overall Study|Lack of Efficacy|0
7141975|NCT03004469|11297524|FG002|Overall Study|Lack of Efficacy|1
7141976|NCT03004469|11297522|FG000|Overall Study|Lost to Follow-up|23
7141977|NCT03004469|11297523|FG001|Overall Study|Lost to Follow-up|14
7141978|NCT03004469|11297524|FG002|Overall Study|Lost to Follow-up|6
7141979|NCT03004469|11297522|FG000|Overall Study|Non-Compliance with Study Drug|2
7141980|NCT03004469|11297523|FG001|Overall Study|Non-Compliance with Study Drug|0
7141981|NCT03004469|11297524|FG002|Overall Study|Non-Compliance with Study Drug|0
7141982|NCT03004469|11297522|FG000|Overall Study|Protocol Violation|0
7141983|NCT03004469|11297523|FG001|Overall Study|Protocol Violation|0
7141984|NCT03004469|11297524|FG002|Overall Study|Protocol Violation|1
7141985|NCT03004469|11297522|FG000|Overall Study|Withdrawal by Subject|29
7141986|NCT03004469|11297523|FG001|Overall Study|Withdrawal by Subject|27
7141987|NCT03004469|11297524|FG002|Overall Study|Withdrawal by Subject|10
7141988|NCT03004469|11297522|FG000|Overall Study|Other unspecified reason|0
6824973|NCT00112437|10827935|FG007|Year 1 (12-Month Base Study)|Adverse Event|0
6824974|NCT00112437|10827936|FG008|Year 1 (12-Month Base Study)|Adverse Event|0
6824975|NCT00112437|10827937|FG009|Year 1 (12-Month Base Study)|Adverse Event|0
6824976|NCT00112437|10827938|FG010|Year 1 (12-Month Base Study)|Adverse Event|0
6824977|NCT00112437|10827939|FG011|Year 1 (12-Month Base Study)|Adverse Event|0
6824978|NCT00112437|10827940|FG012|Year 1 (12-Month Base Study)|Adverse Event|0
6824979|NCT00112437|10827941|FG013|Year 1 (12-Month Base Study)|Adverse Event|0
6824980|NCT00112437|10827942|FG014|Year 1 (12-Month Base Study)|Adverse Event|0
6824981|NCT00112437|10827943|FG015|Year 1 (12-Month Base Study)|Adverse Event|0
6824982|NCT00112437|10827944|FG016|Year 1 (12-Month Base Study)|Adverse Event|0
6824983|NCT00112437|10827945|FG017|Year 1 (12-Month Base Study)|Adverse Event|0
6824984|NCT00112437|10827946|FG018|Year 1 (12-Month Base Study)|Adverse Event|0
6824985|NCT00112437|10827947|FG019|Year 1 (12-Month Base Study)|Adverse Event|0
6824986|NCT00112437|10827948|FG020|Year 1 (12-Month Base Study)|Adverse Event|0
6824987|NCT00112437|10827949|FG021|Year 1 (12-Month Base Study)|Adverse Event|0
6824988|NCT00112437|10827950|FG022|Year 1 (12-Month Base Study)|Adverse Event|0
6824989|NCT00112437|10827951|FG023|Year 1 (12-Month Base Study)|Adverse Event|0
6824990|NCT00112437|10827952|FG024|Year 1 (12-Month Base Study)|Adverse Event|0
6824991|NCT00112437|10827953|FG025|Year 1 (12-Month Base Study)|Adverse Event|0
6824992|NCT00112437|10827928|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6824993|NCT00112437|10827929|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1
6824994|NCT00112437|10827930|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6824995|NCT00112437|10827931|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6824996|NCT00112437|10827932|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6824997|NCT00112437|10827933|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6824998|NCT00112437|10827934|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7141989|NCT03004469|11297523|FG001|Overall Study|Other unspecified reason|4
7141990|NCT03004469|11297524|FG002|Overall Study|Other unspecified reason|1
7141991|NCT03004924|11297592|FG000|Overall Study|Adverse Event|6
7141992|NCT03004924|11297593|FG001|Overall Study|Adverse Event|5
7141993|NCT03004924|11297594|FG002|Overall Study|Adverse Event|10
7141994|NCT03004924|11297592|FG000|Overall Study|Protocol Violation|4
7141995|NCT03004924|11297593|FG001|Overall Study|Protocol Violation|0
7141996|NCT03004924|11297594|FG002|Overall Study|Protocol Violation|1
7141997|NCT03004924|11297592|FG000|Overall Study|Withdrawal by Subject|5
7141998|NCT03004924|11297593|FG001|Overall Study|Withdrawal by Subject|3
7141999|NCT03004924|11297594|FG002|Overall Study|Withdrawal by Subject|5
7142000|NCT03004924|11297592|FG000|Overall Study|Lost to Follow-up|6
7142001|NCT03004924|11297593|FG001|Overall Study|Lost to Follow-up|1
7142002|NCT03004924|11297594|FG002|Overall Study|Lost to Follow-up|4
7142003|NCT03004924|11297592|FG000|Overall Study|Lack of Efficacy|2
6824999|NCT00112437|10827935|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6825000|NCT00112437|10827936|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6825001|NCT00112437|10827937|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6825002|NCT00112437|10827938|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6825003|NCT00112437|10827939|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6825004|NCT00112437|10827940|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6825005|NCT00112437|10827941|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7142004|NCT03004924|11297593|FG001|Overall Study|Lack of Efficacy|4
7142005|NCT03004924|11297594|FG002|Overall Study|Lack of Efficacy|2
7142006|NCT03004924|11297592|FG000|Overall Study|Physician Decision|1
7142007|NCT03004924|11297593|FG001|Overall Study|Physician Decision|0
7142008|NCT03004924|11297594|FG002|Overall Study|Physician Decision|1
7142009|NCT03004924|11297592|FG000|Overall Study|Withdrawal by parent/guardian|1
7142010|NCT03004924|11297593|FG001|Overall Study|Withdrawal by parent/guardian|0
7142011|NCT03004924|11297594|FG002|Overall Study|Withdrawal by parent/guardian|2
7142012|NCT03004924|11297592|FG000|Overall Study|Screen Failure|1
7142013|NCT03004924|11297593|FG001|Overall Study|Screen Failure|0
6825006|NCT00112437|10827942|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7142014|NCT03004924|11297594|FG002|Overall Study|Screen Failure|0
7142015|NCT03004924|11297592|FG000|Overall Study|Pregnancy|0
7142016|NCT03004924|11297593|FG001|Overall Study|Pregnancy|1
7142017|NCT03004924|11297594|FG002|Overall Study|Pregnancy|0
7142018|NCT03004924|11297592|FG000|Overall Study|Terminated by Sponsor|0
7142019|NCT03004924|11297593|FG001|Overall Study|Terminated by Sponsor|0
7142020|NCT03004924|11297594|FG002|Overall Study|Terminated by Sponsor|1
7142021|NCT03004924|11297592|FG000|Overall Study|Missed Study Visit|0
7142022|NCT03004924|11297593|FG001|Overall Study|Missed Study Visit|0
7142023|NCT03004924|11297594|FG002|Overall Study|Missed Study Visit|2
7142024|NCT03004924|11297592|FG000|Overall Study|HSV1 Positive|1
7142025|NCT03004924|11297593|FG001|Overall Study|HSV1 Positive|0
7142026|NCT03004924|11297594|FG002|Overall Study|HSV1 Positive|0
7142027|NCT03005067|11297616|FG000|Overall Study|Withdrawal by Subject|3
7142028|NCT03005067|11297617|FG001|Overall Study|Withdrawal by Subject|2
7142029|NCT03005067|11297616|FG000|Overall Study|Adverse Event|4
7142030|NCT03005067|11297617|FG001|Overall Study|Adverse Event|3
7142031|NCT03005067|11297616|FG000|Overall Study|Other (reason not specified)|3
7142032|NCT03005067|11297617|FG001|Overall Study|Other (reason not specified)|1
7142033|NCT03005067|11297616|FG000|Overall Study|Protocol Violation|0
7142034|NCT03005067|11297617|FG001|Overall Study|Protocol Violation|1
7142035|NCT03005106|11297623|FG000|Overall Study|Lost to Follow-up|16
7142036|NCT03005106|11297623|FG000|Overall Study|Adverse Event|1
7142037|NCT03005106|11297623|FG000|Overall Study|Physician Decision|1
7142038|NCT03005106|11297623|FG000|Overall Study|Death|2
7142039|NCT03005288|11297629|FG000|Overall Study|Withdrawal by Subject|7
7142040|NCT03005288|11297630|FG001|Overall Study|Withdrawal by Subject|5
7142041|NCT03005288|11297629|FG000|Overall Study|Lost to Follow-up|0
7142042|NCT03005288|11297630|FG001|Overall Study|Lost to Follow-up|1
7142043|NCT03005288|11297629|FG000|Overall Study|Adverse Event|5
7142044|NCT03005288|11297630|FG001|Overall Study|Adverse Event|0
7142045|NCT03005288|11297629|FG000|Overall Study|Protocol deviation|0
7142046|NCT03005288|11297630|FG001|Overall Study|Protocol deviation|1
7142047|NCT03005288|11297629|FG000|Overall Study|Physician Decision|0
7142048|NCT03005288|11297630|FG001|Overall Study|Physician Decision|1
7142049|NCT03006341|11297640|FG000|Overall Study|Not linked in the EMR|25069
7142050|NCT03006341|11297641|FG001|Overall Study|Not linked in the EMR|67505
7142051|NCT03006341|11297642|FG002|Overall Study|Not linked in the EMR|30993
7142052|NCT03006341|11297643|FG003|Overall Study|Not linked in the EMR|10685
7142053|NCT03006393|11297653|FG000|Overall Study|Withdrawal by Subject|1
7142054|NCT03006393|11297654|FG001|Overall Study|Withdrawal by Subject|1
7142055|NCT03006393|11297653|FG000|Overall Study|Pregnancy|0
7142056|NCT03006393|11297654|FG001|Overall Study|Pregnancy|1
7142057|NCT03006393|11297653|FG000|Overall Study|Lost to Follow-up|0
7142058|NCT03006393|11297654|FG001|Overall Study|Lost to Follow-up|1
7142059|NCT03006458|11297660|FG000|First Intervention|Unsatisfied Vision|0
7142060|NCT03006458|11297661|FG001|First Intervention|Unsatisfied Vision|3
7142061|NCT03006562|11297678|FG000|Overall Study|Lost to Follow-up|0
6825007|NCT00112437|10827943|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7142062|NCT03006562|11297679|FG001|Overall Study|Lost to Follow-up|1
7142063|NCT03006848|11297685|FG000|Overall Study|Adverse Event|1
7142064|NCT03006848|11297685|FG000|Overall Study|Physician Decision|1
7142065|NCT03006848|11297685|FG000|Overall Study|Lack of Efficacy|16
7142066|NCT03006887|11297696|FG000|Overall Study|Adverse Event|1
7142067|NCT03007472|11297718|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2
7142068|NCT03007472|11297718|FG000|Overall Study|Death|2
7142069|NCT03007472|11297718|FG000|Overall Study|Loss to Follow Up|1
7142070|NCT03007953|11297724|FG000|Overall Study|Withdrawal by Subject|5
7142071|NCT03007953|11297725|FG001|Overall Study|Withdrawal by Subject|2
7142072|NCT03007953|11297724|FG000|Overall Study|Death|5
7142073|NCT03007953|11297725|FG001|Overall Study|Death|7
7142074|NCT03007953|11297724|FG000|Overall Study|Lost to Follow-up|3
7142075|NCT03007953|11297725|FG001|Overall Study|Lost to Follow-up|2
7142076|NCT03007953|11297724|FG000|Overall Study|Enrolled in Hospice|3
7142077|NCT03007953|11297725|FG001|Overall Study|Enrolled in Hospice|2
7142078|NCT03007966|11297733|FG000|Overall Study|Did not meeting inclusion/exclusion|1
7142079|NCT03007966|11297734|FG001|Overall Study|Did not meeting inclusion/exclusion|0
7142080|NCT03008070|11297744|FG000|Overall Study|Adverse Event|3
7142081|NCT03008070|11297745|FG001|Overall Study|Adverse Event|3
7142082|NCT03008070|11297746|FG002|Overall Study|Adverse Event|3
7142083|NCT03008070|11297744|FG000|Overall Study|Lost to Follow-up|1
7142084|NCT03008070|11297745|FG001|Overall Study|Lost to Follow-up|1
7142085|NCT03008070|11297746|FG002|Overall Study|Lost to Follow-up|0
7142086|NCT03008070|11297744|FG000|Overall Study|Non compliance|0
7142087|NCT03008070|11297745|FG001|Overall Study|Non compliance|1
7142088|NCT03008070|11297746|FG002|Overall Study|Non compliance|1
7142089|NCT03008070|11297744|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0
7142090|NCT03008070|11297745|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1
7142091|NCT03008070|11297746|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0
7142092|NCT03008070|11297744|FG000|Overall Study|Withdrawal by Subject|2
7142093|NCT03008070|11297745|FG001|Overall Study|Withdrawal by Subject|0
7142094|NCT03008070|11297746|FG002|Overall Study|Withdrawal by Subject|1
7142095|NCT03008070|11297744|FG000|Overall Study|Use of prohibited drug|0
6825008|NCT00112437|10827944|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6825009|NCT00112437|10827945|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6825010|NCT00112437|10827946|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7142096|NCT03008070|11297745|FG001|Overall Study|Use of prohibited drug|0
7142097|NCT03008070|11297746|FG002|Overall Study|Use of prohibited drug|2
7142098|NCT03008460|11297771|FG000|Overall Study|Protocol deviation|0
7142099|NCT03008460|11297772|FG001|Overall Study|Protocol deviation|2
7142100|NCT03008460|11297771|FG000|Overall Study|Study drug not dispensed|0
6825011|NCT00112437|10827947|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6825012|NCT00112437|10827948|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6825013|NCT00112437|10827949|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6825014|NCT00112437|10827950|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7142101|NCT03008460|11297772|FG001|Overall Study|Study drug not dispensed|1
7142102|NCT03008460|11297771|FG000|Overall Study|Adverse Event|0
7142103|NCT03008460|11297772|FG001|Overall Study|Adverse Event|1
7142104|NCT03008460|11297771|FG000|Overall Study|Withdrawal by Subject|5
7142105|NCT03008460|11297772|FG001|Overall Study|Withdrawal by Subject|6
7142106|NCT03008460|11297771|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1
7142107|NCT03008460|11297772|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0
7142108|NCT03008460|11297771|FG000|Overall Study|End of study visit outside permitted time window|0
7142109|NCT03008460|11297772|FG001|Overall Study|End of study visit outside permitted time window|1
7142110|NCT03008460|11297771|FG000|Overall Study|Lost to Follow-up|1
7142111|NCT03008460|11297772|FG001|Overall Study|Lost to Follow-up|3
7142112|NCT03008915|11297818|FG000|Treatment 1|Withdrawal by Subject|0
7142113|NCT03008915|11297819|FG001|Treatment 1|Withdrawal by Subject|1
7142114|NCT03010254|11297854|FG000|Overall Study|Adverse Event|0
7142115|NCT03010254|11297855|FG001|Overall Study|Adverse Event|1
7142116|NCT03010254|11297854|FG000|Overall Study|Lost to Follow-up|4
7142117|NCT03010254|11297855|FG001|Overall Study|Lost to Follow-up|0
7142118|NCT03010254|11297854|FG000|Overall Study|Withdrawal by Subject|1
7142119|NCT03010254|11297855|FG001|Overall Study|Withdrawal by Subject|1
7142120|NCT03010254|11297854|FG000|Overall Study|Other|2
7142121|NCT03010254|11297855|FG001|Overall Study|Other|3
7142122|NCT03010462|11297870|FG000|Overall Study|Withdrawal by Subject|3
7142123|NCT03010462|11297871|FG001|Overall Study|Withdrawal by Subject|1
7142124|NCT03010501|11297886|FG000|Study Week 1|Withdrawal by Subject|2
7142125|NCT03010501|11297887|FG001|Study Week 1|Withdrawal by Subject|1
7142126|NCT03010501|11297888|FG002|Study Week 1|Withdrawal by Subject|0
7142127|NCT03010501|11297889|FG003|Study Week 1|Withdrawal by Subject|2
7142128|NCT03010501|11297890|FG004|Study Week 1|Withdrawal by Subject|0
7142129|NCT03010501|11297891|FG005|Study Week 1|Withdrawal by Subject|0
7142130|NCT03010501|11297886|FG000|Study Week 3|Withdrawal by Subject|0
7142131|NCT03010501|11297887|FG001|Study Week 3|Withdrawal by Subject|0
7142132|NCT03010501|11297888|FG002|Study Week 3|Withdrawal by Subject|0
7142133|NCT03010501|11297889|FG003|Study Week 3|Withdrawal by Subject|1
6825015|NCT00112437|10827951|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6825016|NCT00112437|10827952|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6825017|NCT00112437|10827953|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6825018|NCT00112437|10827928|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6825019|NCT00112437|10827929|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1
6825020|NCT00112437|10827930|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7142134|NCT03010501|11297890|FG004|Study Week 3|Withdrawal by Subject|0
7142135|NCT03010501|11297891|FG005|Study Week 3|Withdrawal by Subject|0
7142136|NCT03010527|11297902|FG000|Overall Study|Death|0
7142137|NCT03010527|11297903|FG001|Overall Study|Death|0
7142138|NCT03010527|11297904|FG002|Overall Study|Death|1
7142139|NCT03010527|11297902|FG000|Overall Study|Adverse Event|0
7142140|NCT03010527|11297903|FG001|Overall Study|Adverse Event|4
7142141|NCT03010527|11297904|FG002|Overall Study|Adverse Event|2
7142142|NCT03010527|11297902|FG000|Overall Study|Protocol Violation|0
7142143|NCT03010527|11297903|FG001|Overall Study|Protocol Violation|1
7142144|NCT03010527|11297904|FG002|Overall Study|Protocol Violation|0
7142145|NCT03010527|11297902|FG000|Overall Study|Lost to Follow-up|0
7142146|NCT03010527|11297903|FG001|Overall Study|Lost to Follow-up|2
6825021|NCT00112437|10827931|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6825022|NCT00112437|10827932|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6825023|NCT00112437|10827933|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6825024|NCT00112437|10827934|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6825025|NCT00112437|10827935|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6825026|NCT00112437|10827936|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6825027|NCT00112437|10827937|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6825028|NCT00112437|10827938|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6825029|NCT00112437|10827939|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6825030|NCT00112437|10827940|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6825031|NCT00112437|10827941|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6825032|NCT00112437|10827942|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6825033|NCT00112437|10827943|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6825034|NCT00112437|10827944|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6825035|NCT00112437|10827945|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6825036|NCT00112437|10827946|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6825037|NCT00112437|10827947|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6825038|NCT00112437|10827948|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6825039|NCT00112437|10827949|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6825040|NCT00112437|10827950|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6825041|NCT00112437|10827951|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6825042|NCT00112437|10827952|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6825043|NCT00112437|10827953|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6825044|NCT00112437|10827928|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1
6825045|NCT00112437|10827929|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0
6825046|NCT00112437|10827930|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3
6825047|NCT00112437|10827931|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1
6825048|NCT00112437|10827932|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1
6825049|NCT00112437|10827933|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0
6825050|NCT00112437|10827934|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0
6825051|NCT00112437|10827935|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0
6825052|NCT00112437|10827936|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0
6825053|NCT00112437|10827937|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0
6825054|NCT00112437|10827938|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0
6825055|NCT00112437|10827939|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0
6825056|NCT00112437|10827940|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0
6825057|NCT00112437|10827941|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0
6825058|NCT00112437|10827942|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0
6825059|NCT00112437|10827943|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0
6825060|NCT00112437|10827944|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0
6825061|NCT00112437|10827945|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0
6825062|NCT00112437|10827946|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0
6825063|NCT00112437|10827947|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0
6825064|NCT00112437|10827948|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0
6825065|NCT00112437|10827949|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0
6825066|NCT00112437|10827950|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0
6825067|NCT00112437|10827951|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0
6825068|NCT00112437|10827952|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0
7142147|NCT03010527|11297904|FG002|Overall Study|Lost to Follow-up|1
7142148|NCT03010527|11297902|FG000|Overall Study|Withdrawal by Subject|0
7142149|NCT03010527|11297903|FG001|Overall Study|Withdrawal by Subject|3
7142150|NCT03010527|11297904|FG002|Overall Study|Withdrawal by Subject|4
7142151|NCT03010527|11297902|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0
7142152|NCT03010527|11297903|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4
7142153|NCT03010527|11297904|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6
7142154|NCT03010527|11297902|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0
7142155|NCT03010527|11297903|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4
7142156|NCT03010527|11297904|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2
7142157|NCT03010527|11297902|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0
7142158|NCT03010527|11297903|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1
7142159|NCT03010527|11297904|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0
7142160|NCT03011099|11297962|FG000|Overall Study|Withdrawal by Subject|0
6825069|NCT00112437|10827953|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0
6825070|NCT00112437|10827928|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
6825071|NCT00112437|10827929|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
6978675|NCT01214629|11032172|FG000|Overall Study|Withdrawal by Subject|0
7142161|NCT03011099|11297963|FG001|Overall Study|Withdrawal by Subject|2
7142162|NCT03011333|11297978|FG000|Overall Study|Lost to Follow-up|0
6825072|NCT00112437|10827930|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2
6825073|NCT00112437|10827931|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1
6901422|NCT00672984|10922258|FG002|Third Intervention|Adverse Event|1
7142163|NCT03011333|11297979|FG001|Overall Study|Lost to Follow-up|1
7142164|NCT03011333|11297980|FG002|Overall Study|Lost to Follow-up|0
7142165|NCT03011333|11297981|FG003|Overall Study|Lost to Follow-up|1
7142166|NCT03011333|11297982|FG004|Overall Study|Lost to Follow-up|4
7142167|NCT03011333|11297983|FG005|Overall Study|Lost to Follow-up|4
7142168|NCT03011333|11297984|FG006|Overall Study|Lost to Follow-up|5
7142169|NCT03011840|11298002|FG000|Overall Study|Not received PIL in post PIL phase|0
7142170|NCT03011840|11298003|FG001|Overall Study|Not received PIL in post PIL phase|21
7142171|NCT03011892|11298015|FG000|Double Blind (DB) Period|Adverse Event|0
7142172|NCT03011892|11298016|FG001|Double Blind (DB) Period|Adverse Event|1
7142173|NCT03011892|11298017|FG002|Double Blind (DB) Period|Adverse Event|1
7142174|NCT03011892|11298018|FG003|Double Blind (DB) Period|Adverse Event|0
7142175|NCT03011892|11298019|FG004|Double Blind (DB) Period|Adverse Event|0
7142176|NCT03011892|11298020|FG005|Double Blind (DB) Period|Adverse Event|0
7142177|NCT03011892|11298021|FG006|Double Blind (DB) Period|Adverse Event|0
7142178|NCT03011892|11298022|FG007|Double Blind (DB) Period|Adverse Event|0
7142179|NCT03011892|11298023|FG008|Double Blind (DB) Period|Adverse Event|0
7142180|NCT03011892|11298024|FG009|Double Blind (DB) Period|Adverse Event|0
7142181|NCT03011892|11298025|FG010|Double Blind (DB) Period|Adverse Event|0
7142182|NCT03011892|11298026|FG011|Double Blind (DB) Period|Adverse Event|0
7142183|NCT03011892|11298015|FG000|Double Blind (DB) Period|Lack of Efficacy|1
7142184|NCT03011892|11298016|FG001|Double Blind (DB) Period|Lack of Efficacy|0
7142185|NCT03011892|11298017|FG002|Double Blind (DB) Period|Lack of Efficacy|0
7142186|NCT03011892|11298018|FG003|Double Blind (DB) Period|Lack of Efficacy|0
7142187|NCT03011892|11298019|FG004|Double Blind (DB) Period|Lack of Efficacy|0
7142188|NCT03011892|11298020|FG005|Double Blind (DB) Period|Lack of Efficacy|0
7142189|NCT03011892|11298021|FG006|Double Blind (DB) Period|Lack of Efficacy|0
7142190|NCT03011892|11298022|FG007|Double Blind (DB) Period|Lack of Efficacy|0
7142191|NCT03011892|11298023|FG008|Double Blind (DB) Period|Lack of Efficacy|0
7142192|NCT03011892|11298024|FG009|Double Blind (DB) Period|Lack of Efficacy|0
7142193|NCT03011892|11298025|FG010|Double Blind (DB) Period|Lack of Efficacy|0
7142194|NCT03011892|11298026|FG011|Double Blind (DB) Period|Lack of Efficacy|0
7142195|NCT03011892|11298015|FG000|Double Blind (DB) Period|Lost to Follow-up|0
7142196|NCT03011892|11298016|FG001|Double Blind (DB) Period|Lost to Follow-up|3
7142197|NCT03011892|11298017|FG002|Double Blind (DB) Period|Lost to Follow-up|2
7142198|NCT03011892|11298018|FG003|Double Blind (DB) Period|Lost to Follow-up|5
7142199|NCT03011892|11298019|FG004|Double Blind (DB) Period|Lost to Follow-up|0
7142200|NCT03011892|11298020|FG005|Double Blind (DB) Period|Lost to Follow-up|2
7142201|NCT03011892|11298021|FG006|Double Blind (DB) Period|Lost to Follow-up|0
7142202|NCT03011892|11298022|FG007|Double Blind (DB) Period|Lost to Follow-up|0
7142203|NCT03011892|11298023|FG008|Double Blind (DB) Period|Lost to Follow-up|0
7142204|NCT03011892|11298024|FG009|Double Blind (DB) Period|Lost to Follow-up|0
7142205|NCT03011892|11298025|FG010|Double Blind (DB) Period|Lost to Follow-up|0
7142206|NCT03011892|11298026|FG011|Double Blind (DB) Period|Lost to Follow-up|0
7142207|NCT03011892|11298015|FG000|Double Blind (DB) Period|Other|1
7142208|NCT03011892|11298016|FG001|Double Blind (DB) Period|Other|1
7142209|NCT03011892|11298017|FG002|Double Blind (DB) Period|Other|1
7142210|NCT03011892|11298018|FG003|Double Blind (DB) Period|Other|0
7142211|NCT03011892|11298019|FG004|Double Blind (DB) Period|Other|1
7142212|NCT03011892|11298020|FG005|Double Blind (DB) Period|Other|0
7142213|NCT03011892|11298021|FG006|Double Blind (DB) Period|Other|0
7142214|NCT03011892|11298022|FG007|Double Blind (DB) Period|Other|0
7142215|NCT03011892|11298023|FG008|Double Blind (DB) Period|Other|0
7142216|NCT03011892|11298024|FG009|Double Blind (DB) Period|Other|0
7142217|NCT03011892|11298025|FG010|Double Blind (DB) Period|Other|0
7142218|NCT03011892|11298026|FG011|Double Blind (DB) Period|Other|0
7142219|NCT03011892|11298015|FG000|Double Blind (DB) Period|Physician Decision|1
7142220|NCT03011892|11298016|FG001|Double Blind (DB) Period|Physician Decision|0
7142221|NCT03011892|11298017|FG002|Double Blind (DB) Period|Physician Decision|1
7142222|NCT03011892|11298018|FG003|Double Blind (DB) Period|Physician Decision|0
7142223|NCT03011892|11298019|FG004|Double Blind (DB) Period|Physician Decision|0
7142224|NCT03011892|11298020|FG005|Double Blind (DB) Period|Physician Decision|0
7142225|NCT03011892|11298021|FG006|Double Blind (DB) Period|Physician Decision|0
7142226|NCT03011892|11298022|FG007|Double Blind (DB) Period|Physician Decision|0
7142227|NCT03011892|11298023|FG008|Double Blind (DB) Period|Physician Decision|0
7142228|NCT03011892|11298024|FG009|Double Blind (DB) Period|Physician Decision|0
7142229|NCT03011892|11298025|FG010|Double Blind (DB) Period|Physician Decision|0
7142230|NCT03011892|11298026|FG011|Double Blind (DB) Period|Physician Decision|0
7142231|NCT03011892|11298015|FG000|Double Blind (DB) Period|Pregnancy|0
7142232|NCT03011892|11298016|FG001|Double Blind (DB) Period|Pregnancy|0
7142233|NCT03011892|11298017|FG002|Double Blind (DB) Period|Pregnancy|0
7142234|NCT03011892|11298018|FG003|Double Blind (DB) Period|Pregnancy|0
7142235|NCT03011892|11298019|FG004|Double Blind (DB) Period|Pregnancy|1
7142236|NCT03011892|11298020|FG005|Double Blind (DB) Period|Pregnancy|0
7142237|NCT03011892|11298021|FG006|Double Blind (DB) Period|Pregnancy|0
7142238|NCT03011892|11298022|FG007|Double Blind (DB) Period|Pregnancy|0
7142239|NCT03011892|11298023|FG008|Double Blind (DB) Period|Pregnancy|0
7142240|NCT03011892|11298024|FG009|Double Blind (DB) Period|Pregnancy|0
7142241|NCT03011892|11298025|FG010|Double Blind (DB) Period|Pregnancy|0
7142242|NCT03011892|11298026|FG011|Double Blind (DB) Period|Pregnancy|0
7142243|NCT03011892|11298015|FG000|Double Blind (DB) Period|Protocol Violation|1
7142244|NCT03011892|11298016|FG001|Double Blind (DB) Period|Protocol Violation|0
7142245|NCT03011892|11298017|FG002|Double Blind (DB) Period|Protocol Violation|0
7142246|NCT03011892|11298018|FG003|Double Blind (DB) Period|Protocol Violation|0
7142247|NCT03011892|11298019|FG004|Double Blind (DB) Period|Protocol Violation|0
7142248|NCT03011892|11298020|FG005|Double Blind (DB) Period|Protocol Violation|0
6825074|NCT00112437|10827932|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7
6825075|NCT00112437|10827933|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6825076|NCT00112437|10827934|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7142249|NCT03011892|11298021|FG006|Double Blind (DB) Period|Protocol Violation|0
7142250|NCT03011892|11298022|FG007|Double Blind (DB) Period|Protocol Violation|0
7142251|NCT03011892|11298023|FG008|Double Blind (DB) Period|Protocol Violation|0
7142252|NCT03011892|11298024|FG009|Double Blind (DB) Period|Protocol Violation|0
7142253|NCT03011892|11298025|FG010|Double Blind (DB) Period|Protocol Violation|0
7142254|NCT03011892|11298026|FG011|Double Blind (DB) Period|Protocol Violation|0
7142255|NCT03011892|11298015|FG000|Double Blind (DB) Period|Withdrawal by Subject|7
7142256|NCT03011892|11298016|FG001|Double Blind (DB) Period|Withdrawal by Subject|5
7142257|NCT03011892|11298017|FG002|Double Blind (DB) Period|Withdrawal by Subject|1
7142258|NCT03011892|11298018|FG003|Double Blind (DB) Period|Withdrawal by Subject|2
7142259|NCT03011892|11298019|FG004|Double Blind (DB) Period|Withdrawal by Subject|4
7142260|NCT03011892|11298020|FG005|Double Blind (DB) Period|Withdrawal by Subject|3
7142261|NCT03011892|11298021|FG006|Double Blind (DB) Period|Withdrawal by Subject|0
7142262|NCT03011892|11298022|FG007|Double Blind (DB) Period|Withdrawal by Subject|0
7142263|NCT03011892|11298023|FG008|Double Blind (DB) Period|Withdrawal by Subject|0
7142264|NCT03011892|11298024|FG009|Double Blind (DB) Period|Withdrawal by Subject|0
7142265|NCT03011892|11298025|FG010|Double Blind (DB) Period|Withdrawal by Subject|0
7142266|NCT03011892|11298026|FG011|Double Blind (DB) Period|Withdrawal by Subject|0
7142267|NCT03011892|11298015|FG000|Double Blind (DB) Period|Randomized but not treated|0
7142268|NCT03011892|11298016|FG001|Double Blind (DB) Period|Randomized but not treated|0
7142269|NCT03011892|11298017|FG002|Double Blind (DB) Period|Randomized but not treated|0
7142270|NCT03011892|11298018|FG003|Double Blind (DB) Period|Randomized but not treated|0
7142271|NCT03011892|11298019|FG004|Double Blind (DB) Period|Randomized but not treated|1
7142272|NCT03011892|11298020|FG005|Double Blind (DB) Period|Randomized but not treated|0
7142273|NCT03011892|11298021|FG006|Double Blind (DB) Period|Randomized but not treated|0
7142274|NCT03011892|11298022|FG007|Double Blind (DB) Period|Randomized but not treated|0
7142275|NCT03011892|11298023|FG008|Double Blind (DB) Period|Randomized but not treated|0
7142276|NCT03011892|11298024|FG009|Double Blind (DB) Period|Randomized but not treated|0
7142277|NCT03011892|11298025|FG010|Double Blind (DB) Period|Randomized but not treated|0
7142278|NCT03011892|11298026|FG011|Double Blind (DB) Period|Randomized but not treated|0
7142279|NCT03011892|11298015|FG000|Open Label (OL) Period|Lost to Follow-up|0
7142280|NCT03011892|11298016|FG001|Open Label (OL) Period|Lost to Follow-up|0
7142281|NCT03011892|11298017|FG002|Open Label (OL) Period|Lost to Follow-up|0
7142282|NCT03011892|11298018|FG003|Open Label (OL) Period|Lost to Follow-up|0
7142283|NCT03011892|11298019|FG004|Open Label (OL) Period|Lost to Follow-up|0
7142284|NCT03011892|11298020|FG005|Open Label (OL) Period|Lost to Follow-up|0
7142285|NCT03011892|11298021|FG006|Open Label (OL) Period|Lost to Follow-up|4
7142286|NCT03011892|11298022|FG007|Open Label (OL) Period|Lost to Follow-up|2
7142287|NCT03011892|11298023|FG008|Open Label (OL) Period|Lost to Follow-up|1
7142288|NCT03011892|11298024|FG009|Open Label (OL) Period|Lost to Follow-up|0
7142289|NCT03011892|11298025|FG010|Open Label (OL) Period|Lost to Follow-up|1
7142290|NCT03011892|11298026|FG011|Open Label (OL) Period|Lost to Follow-up|1
7142291|NCT03011892|11298015|FG000|Open Label (OL) Period|Withdrawal by Subject|0
7142292|NCT03011892|11298016|FG001|Open Label (OL) Period|Withdrawal by Subject|0
7142293|NCT03011892|11298017|FG002|Open Label (OL) Period|Withdrawal by Subject|0
7142294|NCT03011892|11298018|FG003|Open Label (OL) Period|Withdrawal by Subject|0
7142295|NCT03011892|11298019|FG004|Open Label (OL) Period|Withdrawal by Subject|0
7142296|NCT03011892|11298020|FG005|Open Label (OL) Period|Withdrawal by Subject|0
7142297|NCT03011892|11298021|FG006|Open Label (OL) Period|Withdrawal by Subject|3
7142298|NCT03011892|11298022|FG007|Open Label (OL) Period|Withdrawal by Subject|0
7142299|NCT03011892|11298023|FG008|Open Label (OL) Period|Withdrawal by Subject|1
7142300|NCT03011892|11298024|FG009|Open Label (OL) Period|Withdrawal by Subject|0
7142301|NCT03011892|11298025|FG010|Open Label (OL) Period|Withdrawal by Subject|1
7142302|NCT03011892|11298026|FG011|Open Label (OL) Period|Withdrawal by Subject|2
7142303|NCT03011892|11298015|FG000|Open Label (OL) Period|Reason not specified|0
7142304|NCT03011892|11298016|FG001|Open Label (OL) Period|Reason not specified|0
7142305|NCT03011892|11298017|FG002|Open Label (OL) Period|Reason not specified|0
7142306|NCT03011892|11298018|FG003|Open Label (OL) Period|Reason not specified|0
7142307|NCT03011892|11298019|FG004|Open Label (OL) Period|Reason not specified|0
7142308|NCT03011892|11298020|FG005|Open Label (OL) Period|Reason not specified|0
6825077|NCT00112437|10827935|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6825078|NCT00112437|10827936|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6825079|NCT00112437|10827937|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6901423|NCT00673049|10922270|FG000|Before Progression on Erlotinib|Randomized but not treated|3
6901424|NCT00673049|10922271|FG001|Before Progression on Erlotinib|Randomized but not treated|1
6825080|NCT00112437|10827938|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7142309|NCT03011892|11298021|FG006|Open Label (OL) Period|Reason not specified|0
7142310|NCT03011892|11298022|FG007|Open Label (OL) Period|Reason not specified|1
7142311|NCT03011892|11298023|FG008|Open Label (OL) Period|Reason not specified|0
7142312|NCT03011892|11298024|FG009|Open Label (OL) Period|Reason not specified|0
7142313|NCT03011892|11298025|FG010|Open Label (OL) Period|Reason not specified|0
7142314|NCT03011892|11298026|FG011|Open Label (OL) Period|Reason not specified|0
7142315|NCT03012061|11298056|FG000|Overall Study|Withdrawal by Subject|1
7142316|NCT03012061|11298057|FG001|Overall Study|Withdrawal by Subject|5
6825081|NCT00112437|10827939|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6825082|NCT00112437|10827940|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6825083|NCT00112437|10827941|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6825084|NCT00112437|10827942|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6825085|NCT00112437|10827943|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6825086|NCT00112437|10827944|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6825087|NCT00112437|10827945|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6825088|NCT00112437|10827946|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6825089|NCT00112437|10827947|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6825090|NCT00112437|10827948|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6825091|NCT00112437|10827949|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6825092|NCT00112437|10827950|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6825093|NCT00112437|10827951|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6825094|NCT00112437|10827952|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6825095|NCT00112437|10827953|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6825096|NCT00112437|10827928|FG000|Year 1 (12-Month Base Study)|moved|0
6825097|NCT00112437|10827929|FG001|Year 1 (12-Month Base Study)|moved|1
6825098|NCT00112437|10827930|FG002|Year 1 (12-Month Base Study)|moved|1
6825099|NCT00112437|10827931|FG003|Year 1 (12-Month Base Study)|moved|0
6825100|NCT00112437|10827932|FG004|Year 1 (12-Month Base Study)|moved|0
6825101|NCT00112437|10827933|FG005|Year 1 (12-Month Base Study)|moved|0
6825102|NCT00112437|10827934|FG006|Year 1 (12-Month Base Study)|moved|0
6825103|NCT00112437|10827935|FG007|Year 1 (12-Month Base Study)|moved|0
6825104|NCT00112437|10827936|FG008|Year 1 (12-Month Base Study)|moved|0
6825105|NCT00112437|10827937|FG009|Year 1 (12-Month Base Study)|moved|0
6825106|NCT00112437|10827938|FG010|Year 1 (12-Month Base Study)|moved|0
6825107|NCT00112437|10827939|FG011|Year 1 (12-Month Base Study)|moved|0
6825108|NCT00112437|10827940|FG012|Year 1 (12-Month Base Study)|moved|0
6825109|NCT00112437|10827941|FG013|Year 1 (12-Month Base Study)|moved|0
6825110|NCT00112437|10827942|FG014|Year 1 (12-Month Base Study)|moved|0
6825111|NCT00112437|10827943|FG015|Year 1 (12-Month Base Study)|moved|0
6825112|NCT00112437|10827944|FG016|Year 1 (12-Month Base Study)|moved|0
6825113|NCT00112437|10827945|FG017|Year 1 (12-Month Base Study)|moved|0
6825114|NCT00112437|10827946|FG018|Year 1 (12-Month Base Study)|moved|0
6825115|NCT00112437|10827947|FG019|Year 1 (12-Month Base Study)|moved|0
6825116|NCT00112437|10827948|FG020|Year 1 (12-Month Base Study)|moved|0
6825117|NCT00112437|10827949|FG021|Year 1 (12-Month Base Study)|moved|0
6825118|NCT00112437|10827950|FG022|Year 1 (12-Month Base Study)|moved|0
6825119|NCT00112437|10827951|FG023|Year 1 (12-Month Base Study)|moved|0
6825120|NCT00112437|10827952|FG024|Year 1 (12-Month Base Study)|moved|0
6825121|NCT00112437|10827953|FG025|Year 1 (12-Month Base Study)|moved|0
6825122|NCT00112437|10827928|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6825123|NCT00112437|10827929|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6825124|NCT00112437|10827930|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6825125|NCT00112437|10827931|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2
6825126|NCT00112437|10827932|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6825127|NCT00112437|10827933|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6825128|NCT00112437|10827934|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6825129|NCT00112437|10827935|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6825130|NCT00112437|10827936|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6825131|NCT00112437|10827937|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6825132|NCT00112437|10827938|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6825133|NCT00112437|10827939|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6825134|NCT00112437|10827940|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6825135|NCT00112437|10827941|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6825136|NCT00112437|10827942|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6825137|NCT00112437|10827943|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6825138|NCT00112437|10827944|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6825139|NCT00112437|10827945|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6825140|NCT00112437|10827946|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6825141|NCT00112437|10827947|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6825142|NCT00112437|10827948|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7142317|NCT03012061|11298058|FG002|Overall Study|Withdrawal by Subject|4
7142318|NCT03012061|11298056|FG000|Overall Study|Investigator Site Closed|1
7142319|NCT03012061|11298057|FG001|Overall Study|Investigator Site Closed|2
7142320|NCT03012061|11298058|FG002|Overall Study|Investigator Site Closed|0
7142321|NCT03012061|11298056|FG000|Overall Study|Lost to Follow-up|2
7142322|NCT03012061|11298057|FG001|Overall Study|Lost to Follow-up|1
7142323|NCT03012061|11298058|FG002|Overall Study|Lost to Follow-up|0
7142324|NCT03012061|11298056|FG000|Overall Study|Study closed/ Terminated|0
7142325|NCT03012061|11298057|FG001|Overall Study|Study closed/ Terminated|0
7142326|NCT03012061|11298058|FG002|Overall Study|Study closed/ Terminated|1
7142327|NCT03012061|11298056|FG000|Overall Study|Met Protocol Withdrawal Criterion|0
7142328|NCT03012061|11298057|FG001|Overall Study|Met Protocol Withdrawal Criterion|0
7142329|NCT03012061|11298058|FG002|Overall Study|Met Protocol Withdrawal Criterion|1
7142330|NCT03012061|11298056|FG000|Overall Study|Protocol Violation|0
7142331|NCT03012061|11298057|FG001|Overall Study|Protocol Violation|0
7142332|NCT03012061|11298058|FG002|Overall Study|Protocol Violation|2
7142333|NCT03012061|11298056|FG000|Overall Study|Lack of Efficacy|0
7142334|NCT03012061|11298057|FG001|Overall Study|Lack of Efficacy|1
7142335|NCT03012061|11298058|FG002|Overall Study|Lack of Efficacy|0
7142336|NCT03012061|11298056|FG000|Overall Study|Adverse Event|2
7142337|NCT03012061|11298057|FG001|Overall Study|Adverse Event|0
7142338|NCT03012061|11298058|FG002|Overall Study|Adverse Event|0
7142339|NCT03012334|11298090|FG000|Period 1|Withdrawal by Subject|0
6978676|NCT01214629|11032173|FG001|Overall Study|Withdrawal by Subject|0
7142340|NCT03012334|11298091|FG001|Period 1|Withdrawal by Subject|0
7142341|NCT03012334|11298092|FG002|Period 1|Withdrawal by Subject|0
7142342|NCT03012334|11298093|FG003|Period 1|Withdrawal by Subject|0
7142343|NCT03012334|11298094|FG004|Period 1|Withdrawal by Subject|0
7142344|NCT03012334|11298095|FG005|Period 1|Withdrawal by Subject|0
6825143|NCT00112437|10827949|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6825144|NCT00112437|10827950|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6825145|NCT00112437|10827951|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6825146|NCT00112437|10827952|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6825147|NCT00112437|10827953|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6825148|NCT00112437|10827928|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6825149|NCT00112437|10827929|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6825150|NCT00112437|10827930|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6825151|NCT00112437|10827931|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6825152|NCT00112437|10827932|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1
6825153|NCT00112437|10827933|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6825154|NCT00112437|10827934|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6825155|NCT00112437|10827935|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6825156|NCT00112437|10827936|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6825157|NCT00112437|10827937|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6825158|NCT00112437|10827938|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6825159|NCT00112437|10827939|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6825160|NCT00112437|10827940|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7142345|NCT03012334|11298096|FG006|Period 1|Withdrawal by Subject|0
7142346|NCT03012334|11298097|FG007|Period 1|Withdrawal by Subject|0
7142347|NCT03012334|11298098|FG008|Period 1|Withdrawal by Subject|0
7142348|NCT03012334|11298099|FG009|Period 1|Withdrawal by Subject|1
7142349|NCT03012334|11298090|FG000|Period 2|Withdrawal by Subject|0
7142350|NCT03012334|11298091|FG001|Period 2|Withdrawal by Subject|1
7142351|NCT03012334|11298092|FG002|Period 2|Withdrawal by Subject|0
7142352|NCT03012334|11298093|FG003|Period 2|Withdrawal by Subject|0
7142353|NCT03012334|11298094|FG004|Period 2|Withdrawal by Subject|0
7142354|NCT03012334|11298095|FG005|Period 2|Withdrawal by Subject|0
7142355|NCT03012334|11298096|FG006|Period 2|Withdrawal by Subject|0
7142356|NCT03012334|11298097|FG007|Period 2|Withdrawal by Subject|0
7142357|NCT03012334|11298098|FG008|Period 2|Withdrawal by Subject|0
7142358|NCT03012334|11298099|FG009|Period 2|Withdrawal by Subject|0
7142359|NCT03012334|11298090|FG000|Period 2|Protocol Violation|0
7142360|NCT03012334|11298091|FG001|Period 2|Protocol Violation|0
7142361|NCT03012334|11298092|FG002|Period 2|Protocol Violation|1
7142362|NCT03012334|11298093|FG003|Period 2|Protocol Violation|0
7142363|NCT03012334|11298094|FG004|Period 2|Protocol Violation|0
7142364|NCT03012334|11298095|FG005|Period 2|Protocol Violation|0
7142365|NCT03012334|11298096|FG006|Period 2|Protocol Violation|0
7142366|NCT03012334|11298097|FG007|Period 2|Protocol Violation|1
7142367|NCT03012334|11298098|FG008|Period 2|Protocol Violation|0
7142368|NCT03012334|11298099|FG009|Period 2|Protocol Violation|0
7142369|NCT03012334|11298090|FG000|Period 4|Non-Compliance|0
7142370|NCT03012334|11298091|FG001|Period 4|Non-Compliance|0
7142371|NCT03012334|11298092|FG002|Period 4|Non-Compliance|0
7142372|NCT03012334|11298093|FG003|Period 4|Non-Compliance|0
7142373|NCT03012334|11298094|FG004|Period 4|Non-Compliance|0
7142374|NCT03012334|11298095|FG005|Period 4|Non-Compliance|0
7142375|NCT03012334|11298096|FG006|Period 4|Non-Compliance|1
7142376|NCT03012334|11298097|FG007|Period 4|Non-Compliance|0
7142377|NCT03012334|11298098|FG008|Period 4|Non-Compliance|0
7142378|NCT03012334|11298099|FG009|Period 4|Non-Compliance|0
7142379|NCT03012334|11298090|FG000|Period 4|Adverse Event|0
7142380|NCT03012334|11298091|FG001|Period 4|Adverse Event|0
7142381|NCT03012334|11298092|FG002|Period 4|Adverse Event|0
7142382|NCT03012334|11298093|FG003|Period 4|Adverse Event|0
7142383|NCT03012334|11298094|FG004|Period 4|Adverse Event|0
7142384|NCT03012334|11298095|FG005|Period 4|Adverse Event|0
7142385|NCT03012334|11298096|FG006|Period 4|Adverse Event|0
7142386|NCT03012334|11298097|FG007|Period 4|Adverse Event|0
7142387|NCT03012334|11298098|FG008|Period 4|Adverse Event|1
7142388|NCT03012334|11298099|FG009|Period 4|Adverse Event|0
6825161|NCT00112437|10827941|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6825162|NCT00112437|10827942|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7142389|NCT03012828|11298126|FG000|Overall Study|Lost to Follow-up|1
7142390|NCT03012828|11298127|FG001|Overall Study|Lost to Follow-up|0
7142391|NCT03012828|11298128|FG002|Overall Study|Lost to Follow-up|1
7142392|NCT03012828|11298129|FG003|Overall Study|Lost to Follow-up|0
7142393|NCT03012828|11298130|FG004|Overall Study|Lost to Follow-up|1
7142394|NCT03012828|11298131|FG005|Overall Study|Lost to Follow-up|0
7142395|NCT03012828|11298126|FG000|Overall Study|Withdrawal by Subject|0
7142396|NCT03012828|11298127|FG001|Overall Study|Withdrawal by Subject|0
7142397|NCT03012828|11298128|FG002|Overall Study|Withdrawal by Subject|1
7142398|NCT03012828|11298129|FG003|Overall Study|Withdrawal by Subject|0
7142399|NCT03012828|11298130|FG004|Overall Study|Withdrawal by Subject|0
7142400|NCT03012828|11298131|FG005|Overall Study|Withdrawal by Subject|1
7142401|NCT03012828|11298126|FG000|Overall Study|Non-compliance with protocol|0
7142402|NCT03012828|11298127|FG001|Overall Study|Non-compliance with protocol|0
7142403|NCT03012828|11298128|FG002|Overall Study|Non-compliance with protocol|0
7142404|NCT03012828|11298129|FG003|Overall Study|Non-compliance with protocol|0
7142405|NCT03012828|11298130|FG004|Overall Study|Non-compliance with protocol|1
7142406|NCT03012828|11298131|FG005|Overall Study|Non-compliance with protocol|0
7142407|NCT03012828|11298126|FG000|Overall Study|Delay to last visit would delay DBL|0
7142408|NCT03012828|11298127|FG001|Overall Study|Delay to last visit would delay DBL|0
7142409|NCT03012828|11298128|FG002|Overall Study|Delay to last visit would delay DBL|0
7142410|NCT03012828|11298129|FG003|Overall Study|Delay to last visit would delay DBL|0
7142411|NCT03012828|11298130|FG004|Overall Study|Delay to last visit would delay DBL|0
7142412|NCT03012828|11298131|FG005|Overall Study|Delay to last visit would delay DBL|1
7142413|NCT03012841|11298147|FG000|Overall Study|Protocol Violation|0
7142414|NCT03012841|11298148|FG001|Overall Study|Protocol Violation|10
7142415|NCT03012841|11298147|FG000|Overall Study|Lost to Follow-up|6
7142416|NCT03012841|11298148|FG001|Overall Study|Lost to Follow-up|1
7142417|NCT03012841|11298147|FG000|Overall Study|Withdrawal by Subject|6
7142418|NCT03012841|11298148|FG001|Overall Study|Withdrawal by Subject|0
7142419|NCT03012841|11298147|FG000|Overall Study|Unable to complete 12 month visit|6
7142420|NCT03012841|11298148|FG001|Overall Study|Unable to complete 12 month visit|0
7142421|NCT03012841|11298147|FG000|Overall Study|Subject relocation|1
7142422|NCT03012841|11298148|FG001|Overall Study|Subject relocation|0
7142423|NCT03012841|11298147|FG000|Overall Study|Seasonal winter travel|1
7142424|NCT03012841|11298148|FG001|Overall Study|Seasonal winter travel|0
7142425|NCT03012841|11298147|FG000|Overall Study|Physician Decision|0
7142426|NCT03012841|11298148|FG001|Overall Study|Physician Decision|2
7142427|NCT03012841|11298147|FG000|Overall Study|No ablation performed|0
7142428|NCT03012841|11298148|FG001|Overall Study|No ablation performed|2
7142429|NCT03012841|11298147|FG000|Overall Study|Study reached n=165 treated subject cap|0
7142430|NCT03012841|11298148|FG001|Overall Study|Study reached n=165 treated subject cap|5
7142431|NCT03012841|11298147|FG000|Overall Study|Insurance change|0
7142432|NCT03012841|11298148|FG001|Overall Study|Insurance change|1
7142433|NCT03013985|11298155|FG000|Overall Study|Protocol Violation|2
7142434|NCT03013985|11298156|FG001|Overall Study|Protocol Violation|2
7142435|NCT03013985|11298155|FG000|Overall Study|Withdrawal by Subject|14
7142436|NCT03013985|11298156|FG001|Overall Study|Withdrawal by Subject|17
7142437|NCT03014011|11298162|FG000|First Intervention|Withdrawal by Subject|1
7142438|NCT03014011|11298163|FG001|First Intervention|Withdrawal by Subject|0
7142439|NCT03014011|11298162|FG000|Washout|Withdrawal by Subject|1
7142440|NCT03014011|11298163|FG001|Washout|Withdrawal by Subject|0
7142441|NCT03014180|11298169|FG000|Overall Study|Protocol Violation|2
7142442|NCT03014206|11298177|FG000|Overall Study|Registration Violation|12
7142443|NCT03014453|11298181|FG000|Overall Study|Lost to Follow-up|12
7142444|NCT03014453|11298181|FG000|Overall Study|Discontinued GER|3
7142445|NCT03014453|11298181|FG000|Overall Study|Excluded|19
7142446|NCT03014453|11298181|FG000|Overall Study|Refused to take part in|37
7142447|NCT03014479|11298187|FG000|Overall Study|Adverse Event|0
7142448|NCT03014479|11298188|FG001|Overall Study|Adverse Event|1
7142449|NCT03014479|11298187|FG000|Overall Study|Voluntary Withdrawal|0
7142450|NCT03014479|11298188|FG001|Overall Study|Voluntary Withdrawal|2
7142451|NCT03014479|11298187|FG000|Overall Study|Unacceptable Inability of Site Visit|0
7142452|NCT03014479|11298188|FG001|Overall Study|Unacceptable Inability of Site Visit|1
7142453|NCT03014674|11298206|FG000|Overall Study|Withdrawal by Subject|1
7142454|NCT03014674|11298207|FG001|Overall Study|Withdrawal by Subject|0
7142455|NCT03014674|11298208|FG002|Overall Study|Withdrawal by Subject|0
7142456|NCT03015116|11298228|FG000|Overall Study|Lost to Follow-up|3
7142457|NCT03015116|11298229|FG001|Overall Study|Lost to Follow-up|0
7142458|NCT03015116|11298230|FG002|Overall Study|Lost to Follow-up|2
7142459|NCT03015116|11298228|FG000|Overall Study|Withdrawal by Subject|3
7142460|NCT03015116|11298229|FG001|Overall Study|Withdrawal by Subject|1
7142461|NCT03015116|11298230|FG002|Overall Study|Withdrawal by Subject|0
7142462|NCT03015116|11298228|FG000|Overall Study|Subject has New Medical Status|1
7142463|NCT03015116|11298229|FG001|Overall Study|Subject has New Medical Status|0
7142464|NCT03015116|11298230|FG002|Overall Study|Subject has New Medical Status|0
7142465|NCT03015116|11298228|FG000|Overall Study|Physician Decision|0
7142466|NCT03015116|11298229|FG001|Overall Study|Physician Decision|1
7142467|NCT03015116|11298230|FG002|Overall Study|Physician Decision|0
7142468|NCT03015181|11298247|FG000|Overall Study|Enrolled, but product never administered|1
7142469|NCT03015181|11298248|FG001|Overall Study|Enrolled, but product never administered|0
6825163|NCT00112437|10827943|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6825164|NCT00112437|10827944|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7142470|NCT03015181|11298249|FG002|Overall Study|Enrolled, but product never administered|0
7142471|NCT03015181|11298250|FG003|Overall Study|Enrolled, but product never administered|0
7142472|NCT03015181|11298251|FG004|Overall Study|Enrolled, but product never administered|0
7142473|NCT03015181|11298252|FG005|Overall Study|Enrolled, but product never administered|0
7142474|NCT03015181|11298253|FG006|Overall Study|Enrolled, but product never administered|0
7142475|NCT03015181|11298247|FG000|Overall Study|Withdrawal by Subject|0
7142476|NCT03015181|11298248|FG001|Overall Study|Withdrawal by Subject|0
7142477|NCT03015181|11298249|FG002|Overall Study|Withdrawal by Subject|0
7142478|NCT03015181|11298250|FG003|Overall Study|Withdrawal by Subject|0
7142479|NCT03015181|11298251|FG004|Overall Study|Withdrawal by Subject|0
7142480|NCT03015181|11298252|FG005|Overall Study|Withdrawal by Subject|1
7142481|NCT03015181|11298253|FG006|Overall Study|Withdrawal by Subject|0
7142482|NCT03015181|11298247|FG000|Overall Study|Physician Decision|0
7142483|NCT03015181|11298248|FG001|Overall Study|Physician Decision|0
7142484|NCT03015181|11298249|FG002|Overall Study|Physician Decision|0
7142485|NCT03015181|11298250|FG003|Overall Study|Physician Decision|0
7142486|NCT03015181|11298251|FG004|Overall Study|Physician Decision|0
7142487|NCT03015181|11298252|FG005|Overall Study|Physician Decision|0
7142488|NCT03015181|11298253|FG006|Overall Study|Physician Decision|1
7142489|NCT03015220|11298293|FG000|Overall Study|Withdrawal by Subject|3
7142490|NCT03015220|11298294|FG001|Overall Study|Withdrawal by Subject|2
7142491|NCT03015220|11298295|FG002|Overall Study|Withdrawal by Subject|2
7142492|NCT03015220|11298296|FG003|Overall Study|Withdrawal by Subject|2
7142493|NCT03015220|11298293|FG000|Overall Study|Lost to Follow-up|0
7142494|NCT03015220|11298294|FG001|Overall Study|Lost to Follow-up|0
7142495|NCT03015220|11298295|FG002|Overall Study|Lost to Follow-up|1
7142496|NCT03015220|11298296|FG003|Overall Study|Lost to Follow-up|0
6825165|NCT00112437|10827945|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6825166|NCT00112437|10827946|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7142497|NCT03015363|11298306|FG000|Overall Study|Physician Decision|14
7142498|NCT03015363|11298306|FG000|Overall Study|Withdrawal by Subject|3
7142499|NCT03015532|11298318|FG000|Overall Study|Adverse Event|0
7142500|NCT03015532|11298319|FG001|Overall Study|Adverse Event|0
7142501|NCT03015532|11298320|FG002|Overall Study|Adverse Event|0
7142502|NCT03015532|11298321|FG003|Overall Study|Adverse Event|0
7142503|NCT03015532|11298322|FG004|Overall Study|Adverse Event|0
7142504|NCT03015532|11298323|FG005|Overall Study|Adverse Event|2
7142505|NCT03015532|11298324|FG006|Overall Study|Adverse Event|1
7142506|NCT03015532|11298325|FG007|Overall Study|Adverse Event|0
7142507|NCT03015532|11298318|FG000|Overall Study|Withdrawal by Subject|0
7142508|NCT03015532|11298319|FG001|Overall Study|Withdrawal by Subject|0
7142509|NCT03015532|11298320|FG002|Overall Study|Withdrawal by Subject|0
7142510|NCT03015532|11298321|FG003|Overall Study|Withdrawal by Subject|0
7142511|NCT03015532|11298322|FG004|Overall Study|Withdrawal by Subject|0
7142512|NCT03015532|11298323|FG005|Overall Study|Withdrawal by Subject|0
7142513|NCT03015532|11298324|FG006|Overall Study|Withdrawal by Subject|1
7142514|NCT03015532|11298325|FG007|Overall Study|Withdrawal by Subject|0
7142515|NCT03016078|11298358|FG000|Overall Study|Protocol Violation|1
7142516|NCT03016078|11298358|FG000|Overall Study|Protocol Violation|1
7142517|NCT03016325|11298370|FG000|Treatment Period|Participant withdrew consent|0
7142518|NCT03016325|11298371|FG001|Treatment Period|Participant withdrew consent|1
7142519|NCT03016325|11298372|FG002|Treatment Period|Participant withdrew consent|0
7142520|NCT03016325|11298373|FG003|Treatment Period|Participant withdrew consent|0
7142521|NCT03016325|11298374|FG004|Treatment Period|Participant withdrew consent|0
7142522|NCT03016325|11298375|FG005|Treatment Period|Participant withdrew consent|0
7142523|NCT03016325|11298376|FG006|Treatment Period|Participant withdrew consent|0
7142524|NCT03016325|11298377|FG007|Treatment Period|Participant withdrew consent|0
7142525|NCT03016325|11298370|FG000|Treatment Period|Death|0
7142526|NCT03016325|11298371|FG001|Treatment Period|Death|0
7142527|NCT03016325|11298372|FG002|Treatment Period|Death|0
7142528|NCT03016325|11298373|FG003|Treatment Period|Death|0
7142529|NCT03016325|11298374|FG004|Treatment Period|Death|2
7142530|NCT03016325|11298375|FG005|Treatment Period|Death|0
7142531|NCT03016325|11298376|FG006|Treatment Period|Death|0
7142532|NCT03016325|11298377|FG007|Treatment Period|Death|0
7142533|NCT03016325|11298370|FG000|Treatment Period|Participant refuses assessments|0
7142534|NCT03016325|11298371|FG001|Treatment Period|Participant refuses assessments|0
7142535|NCT03016325|11298372|FG002|Treatment Period|Participant refuses assessments|1
7142536|NCT03016325|11298373|FG003|Treatment Period|Participant refuses assessments|0
7142537|NCT03016325|11298374|FG004|Treatment Period|Participant refuses assessments|0
7142538|NCT03016325|11298375|FG005|Treatment Period|Participant refuses assessments|0
7142539|NCT03016325|11298376|FG006|Treatment Period|Participant refuses assessments|0
7142540|NCT03016325|11298377|FG007|Treatment Period|Participant refuses assessments|0
7142541|NCT03016325|11298370|FG000|32-Day Follow-Up Period|Death|2
7142542|NCT03016325|11298371|FG001|32-Day Follow-Up Period|Death|0
7142543|NCT03016325|11298372|FG002|32-Day Follow-Up Period|Death|5
7142544|NCT03016325|11298373|FG003|32-Day Follow-Up Period|Death|6
7142545|NCT03016325|11298374|FG004|32-Day Follow-Up Period|Death|3
7142546|NCT03016325|11298375|FG005|32-Day Follow-Up Period|Death|0
7142547|NCT03016325|11298376|FG006|32-Day Follow-Up Period|Death|0
7142548|NCT03016325|11298377|FG007|32-Day Follow-Up Period|Death|0
7142549|NCT03016325|11298370|FG000|32-Day Follow-Up Period|Lost to Follow-up|1
7142550|NCT03016325|11298371|FG001|32-Day Follow-Up Period|Lost to Follow-up|0
7142551|NCT03016325|11298372|FG002|32-Day Follow-Up Period|Lost to Follow-up|1
7142552|NCT03016325|11298373|FG003|32-Day Follow-Up Period|Lost to Follow-up|1
7142553|NCT03016325|11298374|FG004|32-Day Follow-Up Period|Lost to Follow-up|0
7142554|NCT03016325|11298375|FG005|32-Day Follow-Up Period|Lost to Follow-up|0
7142555|NCT03016325|11298376|FG006|32-Day Follow-Up Period|Lost to Follow-up|0
7142556|NCT03016325|11298377|FG007|32-Day Follow-Up Period|Lost to Follow-up|0
7142557|NCT03016325|11298370|FG000|32-Day Follow-Up Period|Poor/non-compliance|1
7142558|NCT03016325|11298371|FG001|32-Day Follow-Up Period|Poor/non-compliance|0
7142559|NCT03016325|11298372|FG002|32-Day Follow-Up Period|Poor/non-compliance|0
7142560|NCT03016325|11298373|FG003|32-Day Follow-Up Period|Poor/non-compliance|1
7142561|NCT03016325|11298374|FG004|32-Day Follow-Up Period|Poor/non-compliance|1
7142562|NCT03016325|11298375|FG005|32-Day Follow-Up Period|Poor/non-compliance|0
7142563|NCT03016325|11298376|FG006|32-Day Follow-Up Period|Poor/non-compliance|0
7142564|NCT03016325|11298377|FG007|32-Day Follow-Up Period|Poor/non-compliance|0
7142565|NCT03016325|11298370|FG000|32-Day Follow-Up Period|Participant refused to visit|0
7142566|NCT03016325|11298371|FG001|32-Day Follow-Up Period|Participant refused to visit|1
7142567|NCT03016325|11298372|FG002|32-Day Follow-Up Period|Participant refused to visit|2
7142568|NCT03016325|11298373|FG003|32-Day Follow-Up Period|Participant refused to visit|0
7142569|NCT03016325|11298374|FG004|32-Day Follow-Up Period|Participant refused to visit|2
7142570|NCT03016325|11298375|FG005|32-Day Follow-Up Period|Participant refused to visit|0
7142571|NCT03016325|11298376|FG006|32-Day Follow-Up Period|Participant refused to visit|0
7142572|NCT03016325|11298377|FG007|32-Day Follow-Up Period|Participant refused to visit|0
7142573|NCT03016325|11298370|FG000|32-Day Follow-Up Period|Participant withdrew consent|0
7142574|NCT03016325|11298371|FG001|32-Day Follow-Up Period|Participant withdrew consent|0
7142575|NCT03016325|11298372|FG002|32-Day Follow-Up Period|Participant withdrew consent|0
7142576|NCT03016325|11298373|FG003|32-Day Follow-Up Period|Participant withdrew consent|0
7142577|NCT03016325|11298374|FG004|32-Day Follow-Up Period|Participant withdrew consent|2
7142578|NCT03016325|11298375|FG005|32-Day Follow-Up Period|Participant withdrew consent|0
7142579|NCT03016325|11298376|FG006|32-Day Follow-Up Period|Participant withdrew consent|1
7142580|NCT03016325|11298377|FG007|32-Day Follow-Up Period|Participant withdrew consent|0
7142581|NCT03016325|11298370|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
7142582|NCT03016325|11298371|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
7142583|NCT03016325|11298372|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1
7142584|NCT03016325|11298373|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
7142585|NCT03016325|11298374|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
7142586|NCT03016325|11298375|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
7142587|NCT03016325|11298376|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
7142588|NCT03016325|11298377|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
7142589|NCT03016325|11298370|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
7142590|NCT03016325|11298371|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1
7142591|NCT03016325|11298372|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
7142592|NCT03016325|11298373|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
7142593|NCT03016325|11298374|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
7142594|NCT03016325|11298375|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
7142595|NCT03016325|11298376|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
7142596|NCT03016325|11298377|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
7142597|NCT03016325|11298370|FG000|182-Day Follow-Up Period|Death|3
7142598|NCT03016325|11298371|FG001|182-Day Follow-Up Period|Death|3
7142599|NCT03016325|11298372|FG002|182-Day Follow-Up Period|Death|11
7142600|NCT03016325|11298373|FG003|182-Day Follow-Up Period|Death|12
7142601|NCT03016325|11298374|FG004|182-Day Follow-Up Period|Death|9
7142602|NCT03016325|11298375|FG005|182-Day Follow-Up Period|Death|0
7142603|NCT03016325|11298376|FG006|182-Day Follow-Up Period|Death|0
7142604|NCT03016325|11298377|FG007|182-Day Follow-Up Period|Death|1
7142605|NCT03016325|11298370|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1
7142606|NCT03016325|11298371|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0
7142607|NCT03016325|11298372|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0
7142608|NCT03016325|11298373|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0
7142609|NCT03016325|11298374|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0
7142610|NCT03016325|11298375|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0
7142611|NCT03016325|11298376|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0
7142612|NCT03016325|11298377|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0
7142613|NCT03016325|11298370|FG000|182-Day Follow-Up Period|Participant withdrew consent|0
7142614|NCT03016325|11298371|FG001|182-Day Follow-Up Period|Participant withdrew consent|0
7142615|NCT03016325|11298372|FG002|182-Day Follow-Up Period|Participant withdrew consent|0
7142616|NCT03016325|11298373|FG003|182-Day Follow-Up Period|Participant withdrew consent|0
7142617|NCT03016325|11298374|FG004|182-Day Follow-Up Period|Participant withdrew consent|1
7142618|NCT03016325|11298375|FG005|182-Day Follow-Up Period|Participant withdrew consent|0
7142619|NCT03016325|11298376|FG006|182-Day Follow-Up Period|Participant withdrew consent|1
7142620|NCT03016325|11298377|FG007|182-Day Follow-Up Period|Participant withdrew consent|0
7142621|NCT03016325|11298370|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0
7142622|NCT03016325|11298371|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0
7142623|NCT03016325|11298372|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0
7142624|NCT03016325|11298373|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0
7142625|NCT03016325|11298374|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1
7142626|NCT03016325|11298375|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0
7142627|NCT03016325|11298376|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0
7142628|NCT03016325|11298377|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0
7142629|NCT03016325|11298370|FG000|182-Day Follow-Up Period|Alive, per civil unit|0
7142630|NCT03016325|11298371|FG001|182-Day Follow-Up Period|Alive, per civil unit|0
7142631|NCT03016325|11298372|FG002|182-Day Follow-Up Period|Alive, per civil unit|0
7142632|NCT03016325|11298373|FG003|182-Day Follow-Up Period|Alive, per civil unit|0
7142633|NCT03016325|11298374|FG004|182-Day Follow-Up Period|Alive, per civil unit|1
7142634|NCT03016325|11298375|FG005|182-Day Follow-Up Period|Alive, per civil unit|0
7142635|NCT03016325|11298376|FG006|182-Day Follow-Up Period|Alive, per civil unit|0
7142636|NCT03016325|11298377|FG007|182-Day Follow-Up Period|Alive, per civil unit|0
7142637|NCT03016325|11298370|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0
7142638|NCT03016325|11298371|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0
7142639|NCT03016325|11298372|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0
7142640|NCT03016325|11298373|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1
7142641|NCT03016325|11298374|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0
7142642|NCT03016325|11298375|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0
7142643|NCT03016325|11298376|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0
7142644|NCT03016325|11298377|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0
7142645|NCT03016325|11298370|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
7183596|NCT01499082|11383688|FG000|Overall Study|Diverse Reasons|18
6811736|NCT01208207|10815564|FG002|Part II|Withdrawal by Subject|0
7142646|NCT03016325|11298371|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1
7142647|NCT03016325|11298372|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
7142648|NCT03016325|11298373|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
7142649|NCT03016325|11298374|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
7142650|NCT03016325|11298375|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
7142651|NCT03016325|11298376|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
7142652|NCT03016325|11298377|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
7142653|NCT03016325|11298370|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
7142654|NCT03016325|11298371|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
7142655|NCT03016325|11298372|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
7142656|NCT03016325|11298373|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
7142657|NCT03016325|11298374|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
7142658|NCT03016325|11298375|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5
7142659|NCT03016325|11298376|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3
7142660|NCT03016325|11298377|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4
7142661|NCT03016403|11298402|FG000|Baseline|Death|5
7142662|NCT03016403|11298403|FG001|Baseline|Death|8
7142663|NCT03016403|11298404|FG002|Baseline|Death|1
7142664|NCT03016403|11298405|FG003|Baseline|Death|0
7142665|NCT03016403|11298402|FG000|Baseline|Withdrawal by Subject|2
7142666|NCT03016403|11298403|FG001|Baseline|Withdrawal by Subject|8
7142667|NCT03016403|11298404|FG002|Baseline|Withdrawal by Subject|4
7142668|NCT03016403|11298405|FG003|Baseline|Withdrawal by Subject|10
7142669|NCT03016403|11298402|FG000|Baseline|Lost to Follow-up|9
6825167|NCT00112437|10827947|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6825168|NCT00112437|10827948|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6825169|NCT00112437|10827949|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7142670|NCT03016403|11298403|FG001|Baseline|Lost to Follow-up|11
7142671|NCT03016403|11298404|FG002|Baseline|Lost to Follow-up|6
7142672|NCT03016403|11298405|FG003|Baseline|Lost to Follow-up|24
7142673|NCT03016403|11298402|FG000|6-week Follow-up|Death|1
7142674|NCT03016403|11298403|FG001|6-week Follow-up|Death|4
7142675|NCT03016403|11298404|FG002|6-week Follow-up|Death|0
7142676|NCT03016403|11298405|FG003|6-week Follow-up|Death|0
7142677|NCT03016403|11298402|FG000|6-week Follow-up|Lost to Follow-up|2
7142678|NCT03016403|11298403|FG001|6-week Follow-up|Lost to Follow-up|7
7142679|NCT03016403|11298404|FG002|6-week Follow-up|Lost to Follow-up|4
7142680|NCT03016403|11298405|FG003|6-week Follow-up|Lost to Follow-up|8
7142681|NCT03016403|11298402|FG000|6-week Follow-up|Withdrawal by Subject|0
7142682|NCT03016403|11298403|FG001|6-week Follow-up|Withdrawal by Subject|2
7142683|NCT03016403|11298404|FG002|6-week Follow-up|Withdrawal by Subject|0
7142684|NCT03016403|11298405|FG003|6-week Follow-up|Withdrawal by Subject|1
7142685|NCT03016403|11298402|FG000|3-month Follow-up and 6-month Follow-up|Death|6
7142686|NCT03016403|11298403|FG001|3-month Follow-up and 6-month Follow-up|Death|4
7142687|NCT03016403|11298404|FG002|3-month Follow-up and 6-month Follow-up|Death|0
7142688|NCT03016403|11298405|FG003|3-month Follow-up and 6-month Follow-up|Death|0
7142689|NCT03016403|11298402|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6
7142690|NCT03016403|11298403|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7
7142691|NCT03016403|11298404|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8
7142692|NCT03016403|11298405|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6
7142693|NCT03016403|11298402|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0
7142694|NCT03016403|11298403|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0
7142695|NCT03016403|11298404|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0
7142696|NCT03016403|11298405|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1
7142697|NCT03016598|11298419|FG000|Overall Study|Lost to Follow-up|0
7142698|NCT03016598|11298420|FG001|Overall Study|Lost to Follow-up|2
7142699|NCT03017079|11298428|FG000|Overall Study|Physician Decision|1
7142700|NCT03017079|11298429|FG001|Overall Study|Physician Decision|1
7142701|NCT03017079|11298428|FG000|Overall Study|Death|3
7142702|NCT03017079|11298429|FG001|Overall Study|Death|2
7142703|NCT03017079|11298428|FG000|Overall Study|Lack of Efficacy|2
7142704|NCT03017079|11298429|FG001|Overall Study|Lack of Efficacy|2
7142705|NCT03017079|11298428|FG000|Overall Study|Protocol Violation|0
7142706|NCT03017079|11298429|FG001|Overall Study|Protocol Violation|1
7142707|NCT03017235|11298444|FG000|Overall Study|Withdrawal by Subject|4
7142708|NCT03017235|11298445|FG001|Overall Study|Withdrawal by Subject|3
7142709|NCT03017235|11298444|FG000|Overall Study|Lost to Follow-up|2
7142710|NCT03017235|11298445|FG001|Overall Study|Lost to Follow-up|7
7142711|NCT03017235|11298444|FG000|Overall Study|Adverse Event|0
7142712|NCT03017235|11298445|FG001|Overall Study|Adverse Event|1
7142713|NCT03017235|11298444|FG000|Overall Study|Protocol Violation|2
7142714|NCT03017235|11298445|FG001|Overall Study|Protocol Violation|1
7142715|NCT03017235|11298444|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4
7142716|NCT03017235|11298445|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2
7183597|NCT01499082|11383689|FG001|Overall Study|Diverse Reasons|14
7183598|NCT01499082|11383688|FG000|Overall Study|Site Closure for Noncompliance|5
7142717|NCT03017612|11298464|FG000|Overall Study|Adverse Event|2
7142718|NCT03017846|11298468|FG000|Overall Study|Lost to Follow-up|3
7142719|NCT03017846|11298468|FG000|Overall Study|Adverse Event|2
7142720|NCT03018028|11298495|FG000|Overall Study|Withdrawal by Subject|3
7142721|NCT03018028|11298496|FG001|Overall Study|Withdrawal by Subject|0
7142722|NCT03018028|11298497|FG002|Overall Study|Withdrawal by Subject|1
7142723|NCT03018028|11298498|FG003|Overall Study|Withdrawal by Subject|2
7142724|NCT03018028|11298499|FG004|Overall Study|Withdrawal by Subject|0
7142725|NCT03018106|11298513|FG000|Overall Study|Lost to Follow-up|0
7142726|NCT03018106|11298514|FG001|Overall Study|Lost to Follow-up|1
7142727|NCT03018249|11298524|FG000|Overall Study|Withdrawal by Subject|2
7142728|NCT03018249|11298525|FG001|Overall Study|Withdrawal by Subject|2
7142729|NCT03018340|11298533|FG000|Overall Study|Adverse Event|1
7142730|NCT03018340|11298534|FG001|Overall Study|Adverse Event|2
7142731|NCT03018340|11298533|FG000|Overall Study|Withdrawal by Subject|0
7142732|NCT03018340|11298534|FG001|Overall Study|Withdrawal by Subject|8
7142733|NCT03018340|11298533|FG000|Overall Study|Lack of Efficacy|0
7142734|NCT03018340|11298534|FG001|Overall Study|Lack of Efficacy|1
7142735|NCT03018340|11298533|FG000|Overall Study|Non-compliance with study drug/procedure|3
7142736|NCT03018340|11298534|FG001|Overall Study|Non-compliance with study drug/procedure|4
7142737|NCT03018340|11298533|FG000|Overall Study|Lost to Follow-up|1
7142738|NCT03018340|11298534|FG001|Overall Study|Lost to Follow-up|7
7142739|NCT03018340|11298533|FG000|Overall Study|Protocol Violation|3
7142740|NCT03018340|11298534|FG001|Overall Study|Protocol Violation|7
7142741|NCT03018340|11298533|FG000|Overall Study|Not further specified|0
7142742|NCT03018340|11298534|FG001|Overall Study|Not further specified|1
7142743|NCT03018691|11298547|FG000|Overall Study|Adverse Event|1
7142744|NCT03018691|11298548|FG001|Overall Study|Adverse Event|1
7142745|NCT03018691|11298549|FG002|Overall Study|Adverse Event|4
7142746|NCT03018691|11298547|FG000|Overall Study|Lack of Efficacy|0
7142747|NCT03018691|11298548|FG001|Overall Study|Lack of Efficacy|0
7142748|NCT03018691|11298549|FG002|Overall Study|Lack of Efficacy|1
7142749|NCT03018691|11298547|FG000|Overall Study|Withdrawal by Subject|0
7142750|NCT03018691|11298548|FG001|Overall Study|Withdrawal by Subject|0
7142751|NCT03018691|11298549|FG002|Overall Study|Withdrawal by Subject|1
7142752|NCT03018691|11298547|FG000|Overall Study|Withdrawal by parent/guardian|1
7142753|NCT03018691|11298548|FG001|Overall Study|Withdrawal by parent/guardian|0
7142754|NCT03018691|11298549|FG002|Overall Study|Withdrawal by parent/guardian|1
7142755|NCT03018938|11298586|FG000|Overall Study|Death|0
7142756|NCT03018938|11298587|FG001|Overall Study|Death|1
7142757|NCT03018938|11298586|FG000|Overall Study|Lost to Follow-up|21
7142758|NCT03018938|11298587|FG001|Overall Study|Lost to Follow-up|32
7142759|NCT03018938|11298586|FG000|Overall Study|Withdrawal by Subject|38
7142760|NCT03018938|11298587|FG001|Overall Study|Withdrawal by Subject|45
7142761|NCT03018938|11298586|FG000|Overall Study|Physician Decision|3
7142762|NCT03018938|11298587|FG001|Overall Study|Physician Decision|2
7142763|NCT03018938|11298586|FG000|Overall Study|Sponsor Decision|0
7142764|NCT03018938|11298587|FG001|Overall Study|Sponsor Decision|1
7142765|NCT03018938|11298586|FG000|Overall Study|Screen failure-After randomization|4
7142766|NCT03018938|11298587|FG001|Overall Study|Screen failure-After randomization|2
7142767|NCT03018938|11298586|FG000|Overall Study|Not recorded|0
7142768|NCT03018938|11298587|FG001|Overall Study|Not recorded|2
7142769|NCT03019289|11298628|FG000|Overall Study|Adverse Event|1
7142770|NCT03019289|11298629|FG001|Overall Study|Adverse Event|0
7142771|NCT03019289|11298630|FG002|Overall Study|Adverse Event|0
7142772|NCT03019289|11298631|FG003|Overall Study|Adverse Event|0
7142773|NCT03019289|11298632|FG004|Overall Study|Adverse Event|0
7142774|NCT03019289|11298633|FG005|Overall Study|Adverse Event|0
7142775|NCT03019289|11298634|FG006|Overall Study|Adverse Event|0
7142776|NCT03019289|11298635|FG007|Overall Study|Adverse Event|0
7142777|NCT03019289|11298636|FG008|Overall Study|Adverse Event|1
7142778|NCT03019289|11298628|FG000|Overall Study|Other|1
7142779|NCT03019289|11298629|FG001|Overall Study|Other|0
7142780|NCT03019289|11298630|FG002|Overall Study|Other|0
7142781|NCT03019289|11298631|FG003|Overall Study|Other|0
7142782|NCT03019289|11298632|FG004|Overall Study|Other|0
7142783|NCT03019289|11298633|FG005|Overall Study|Other|0
7142784|NCT03019289|11298634|FG006|Overall Study|Other|0
7142785|NCT03019289|11298635|FG007|Overall Study|Other|0
7142786|NCT03019289|11298636|FG008|Overall Study|Other|0
7142787|NCT03019458|11298659|FG000|Overall Study|Death|0
7142788|NCT03019458|11298660|FG001|Overall Study|Death|1
6973627|NCT01182441|11025547|FG000|Overall Study|Death|37
7142789|NCT03019549|11298668|FG000|Washout|DId not meet genotype criteria|11
7142790|NCT03019549|11298668|FG000|Period 2|Adverse Event|2
7142791|NCT03019549|11298668|FG000|Period 2|Physician Decision|2
7142792|NCT03019549|11298668|FG000|Period 2|Withdrawal by Subject|1
7142793|NCT03019627|11298679|FG000|Overall Study|Adverse Event|8
7142794|NCT03019627|11298680|FG001|Overall Study|Adverse Event|0
7142795|NCT03019627|11298679|FG000|Overall Study|Unrelated to adverse event|1
7142796|NCT03019627|11298680|FG001|Overall Study|Unrelated to adverse event|3
7142797|NCT03019627|11298679|FG000|Overall Study|Lost to Follow-up|2
7142798|NCT03019627|11298680|FG001|Overall Study|Lost to Follow-up|1
7142799|NCT03019627|11298679|FG000|Overall Study|not compliance|2
7142800|NCT03019627|11298680|FG001|Overall Study|not compliance|2
7142801|NCT03019627|11298679|FG000|Overall Study|Other|2
7142802|NCT03019627|11298680|FG001|Overall Study|Other|2
7142803|NCT03019965|11298722|FG000|Overall Study|Withdrawal by Subject|1
7142804|NCT03019965|11298723|FG001|Overall Study|Withdrawal by Subject|0
7142805|NCT03019965|11298722|FG000|Overall Study|Protocol Violation|1
7142806|NCT03019965|11298723|FG001|Overall Study|Protocol Violation|3
7142807|NCT03019965|11298722|FG000|Overall Study|viral or fungal infection|3
7142808|NCT03019965|11298723|FG001|Overall Study|viral or fungal infection|4
7142809|NCT03019965|11298722|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4
7142810|NCT03019965|11298723|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5
7142811|NCT03019965|11298722|FG000|Overall Study|Physician Decision|1
7142812|NCT03019965|11298723|FG001|Overall Study|Physician Decision|1
7142813|NCT03020069|11298735|FG000|Overall Study|Lost to Follow-up|0
7142814|NCT03020069|11298736|FG001|Overall Study|Lost to Follow-up|1
7142815|NCT03020407|11298752|FG000|Overall Study|Withdrawal by Subject|2
7142816|NCT03020407|11298753|FG001|Overall Study|Withdrawal by Subject|1
7142817|NCT03020407|11298752|FG000|Overall Study|Lost to Follow-up|2
7142818|NCT03020407|11298753|FG001|Overall Study|Lost to Follow-up|3
7142819|NCT03020407|11298752|FG000|Overall Study|Protocol Violation|0
7142820|NCT03020407|11298753|FG001|Overall Study|Protocol Violation|1
7142821|NCT03020576|11298809|FG000|Overall Study|Withdrawal by Subject|1
7142822|NCT03020576|11298810|FG001|Overall Study|Withdrawal by Subject|2
7142823|NCT03020615|11298819|FG000|Overall Study|Physician Decision|3
7142824|NCT03020615|11298820|FG001|Overall Study|Physician Decision|1
7142825|NCT03020615|11298821|FG002|Overall Study|Physician Decision|2
7142826|NCT03020615|11298819|FG000|Overall Study|Parent/guardian/patient choice|3
7142827|NCT03020615|11298820|FG001|Overall Study|Parent/guardian/patient choice|0
7142828|NCT03020615|11298821|FG002|Overall Study|Parent/guardian/patient choice|4
7142829|NCT03020615|11298819|FG000|Overall Study|Screen failure|0
7142830|NCT03020615|11298820|FG001|Overall Study|Screen failure|0
7142831|NCT03020615|11298821|FG002|Overall Study|Screen failure|1
7142832|NCT03020615|11298819|FG000|Overall Study|Death|1
7142833|NCT03020615|11298820|FG001|Overall Study|Death|0
7142834|NCT03020615|11298821|FG002|Overall Study|Death|0
7142835|NCT03020615|11298819|FG000|Overall Study|Lost to Follow-up|0
7142836|NCT03020615|11298820|FG001|Overall Study|Lost to Follow-up|1
7142837|NCT03020615|11298821|FG002|Overall Study|Lost to Follow-up|0
7142838|NCT03020641|11298834|FG000|Overall Study|Lost to Follow-up|0
7142839|NCT03020641|11298835|FG001|Overall Study|Lost to Follow-up|1
7142840|NCT03020641|11298834|FG000|Overall Study|Converted to open surgery|2
7142841|NCT03020641|11298835|FG001|Overall Study|Converted to open surgery|1
7142842|NCT03020641|11298834|FG000|Overall Study|for surgery not performed|0
7142843|NCT03020641|11298835|FG001|Overall Study|for surgery not performed|1
7142844|NCT03020745|11298861|FG000|Part 2 (Up to 169 Days)|Adverse Event|0
7142845|NCT03020745|11298862|FG001|Part 2 (Up to 169 Days)|Adverse Event|0
7142846|NCT03020745|11298863|FG002|Part 2 (Up to 169 Days)|Adverse Event|0
7142847|NCT03020745|11298864|FG003|Part 2 (Up to 169 Days)|Adverse Event|0
7142848|NCT03020745|11298865|FG004|Part 2 (Up to 169 Days)|Adverse Event|0
7142849|NCT03020745|11298866|FG005|Part 2 (Up to 169 Days)|Adverse Event|0
7142850|NCT03020745|11298867|FG006|Part 2 (Up to 169 Days)|Adverse Event|0
7142851|NCT03020745|11298868|FG007|Part 2 (Up to 169 Days)|Adverse Event|0
7142852|NCT03020745|11298869|FG008|Part 2 (Up to 169 Days)|Adverse Event|1
7142853|NCT03020745|11298870|FG009|Part 2 (Up to 169 Days)|Adverse Event|0
7142854|NCT03020745|11298861|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
7142855|NCT03020745|11298862|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
7142856|NCT03020745|11298863|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
7142857|NCT03020745|11298864|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
7142858|NCT03020745|11298865|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
7142859|NCT03020745|11298866|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
7142860|NCT03020745|11298867|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
7142861|NCT03020745|11298868|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1
7142862|NCT03020745|11298869|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
7142863|NCT03020745|11298870|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
7142864|NCT03020745|11298861|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
7142865|NCT03020745|11298862|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
7142866|NCT03020745|11298863|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
7142867|NCT03020745|11298864|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
7142868|NCT03020745|11298865|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
7142869|NCT03020745|11298866|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1
7142870|NCT03020745|11298867|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
7142871|NCT03020745|11298868|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
7142872|NCT03020745|11298869|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1
7142873|NCT03020745|11298870|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
7142874|NCT03020745|11298861|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
7142875|NCT03020745|11298862|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
7142876|NCT03020745|11298863|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
7142877|NCT03020745|11298864|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
7142878|NCT03020745|11298865|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
7142879|NCT03020745|11298866|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
7142880|NCT03020745|11298867|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
7142881|NCT03020745|11298868|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
7142882|NCT03020745|11298869|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2
7142883|NCT03020745|11298870|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
7142884|NCT03020888|11298894|FG000|Overall Study|Physician Decision|4
6825170|NCT00112437|10827950|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6825171|NCT00112437|10827951|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6825172|NCT00112437|10827952|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6825173|NCT00112437|10827953|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6825174|NCT00112437|10827928|FG000|Year 2 (12-Month Extension)|Adverse Event|0
6825175|NCT00112437|10827929|FG001|Year 2 (12-Month Extension)|Adverse Event|0
6825176|NCT00112437|10827930|FG002|Year 2 (12-Month Extension)|Adverse Event|0
6825177|NCT00112437|10827931|FG003|Year 2 (12-Month Extension)|Adverse Event|0
6825178|NCT00112437|10827932|FG004|Year 2 (12-Month Extension)|Adverse Event|0
6825179|NCT00112437|10827933|FG005|Year 2 (12-Month Extension)|Adverse Event|1
6825180|NCT00112437|10827934|FG006|Year 2 (12-Month Extension)|Adverse Event|2
6825181|NCT00112437|10827935|FG007|Year 2 (12-Month Extension)|Adverse Event|6
6825182|NCT00112437|10827936|FG008|Year 2 (12-Month Extension)|Adverse Event|1
6825183|NCT00112437|10827937|FG009|Year 2 (12-Month Extension)|Adverse Event|7
6825184|NCT00112437|10827938|FG010|Year 2 (12-Month Extension)|Adverse Event|0
6825185|NCT00112437|10827939|FG011|Year 2 (12-Month Extension)|Adverse Event|0
6825186|NCT00112437|10827940|FG012|Year 2 (12-Month Extension)|Adverse Event|0
6825187|NCT00112437|10827941|FG013|Year 2 (12-Month Extension)|Adverse Event|0
6825188|NCT00112437|10827942|FG014|Year 2 (12-Month Extension)|Adverse Event|0
6825189|NCT00112437|10827943|FG015|Year 2 (12-Month Extension)|Adverse Event|0
6825190|NCT00112437|10827944|FG016|Year 2 (12-Month Extension)|Adverse Event|0
6825191|NCT00112437|10827945|FG017|Year 2 (12-Month Extension)|Adverse Event|0
6825192|NCT00112437|10827946|FG018|Year 2 (12-Month Extension)|Adverse Event|0
6825193|NCT00112437|10827947|FG019|Year 2 (12-Month Extension)|Adverse Event|0
6825194|NCT00112437|10827948|FG020|Year 2 (12-Month Extension)|Adverse Event|0
6825195|NCT00112437|10827949|FG021|Year 2 (12-Month Extension)|Adverse Event|0
6825196|NCT00112437|10827950|FG022|Year 2 (12-Month Extension)|Adverse Event|0
6825197|NCT00112437|10827951|FG023|Year 2 (12-Month Extension)|Adverse Event|0
6825198|NCT00112437|10827952|FG024|Year 2 (12-Month Extension)|Adverse Event|0
6825199|NCT00112437|10827953|FG025|Year 2 (12-Month Extension)|Adverse Event|0
6825200|NCT00112437|10827928|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0
6825201|NCT00112437|10827929|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0
6825202|NCT00112437|10827930|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0
6825203|NCT00112437|10827931|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0
6825204|NCT00112437|10827932|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0
6825205|NCT00112437|10827933|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1
6825206|NCT00112437|10827934|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6
6825207|NCT00112437|10827935|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0
6825208|NCT00112437|10827936|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0
6825209|NCT00112437|10827937|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2
6825210|NCT00112437|10827938|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0
6825211|NCT00112437|10827939|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0
6825212|NCT00112437|10827940|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0
6825213|NCT00112437|10827941|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0
6825214|NCT00112437|10827942|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0
6825215|NCT00112437|10827943|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0
6825216|NCT00112437|10827944|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0
6825217|NCT00112437|10827945|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0
6825218|NCT00112437|10827946|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0
6825219|NCT00112437|10827947|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0
6825220|NCT00112437|10827948|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0
6825221|NCT00112437|10827949|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0
6825222|NCT00112437|10827950|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0
7142885|NCT03020888|11298894|FG000|Overall Study|Withdrawal by Subject|6
7142886|NCT03020888|11298894|FG000|Overall Study|Insurance coverage|2
7142887|NCT03020888|11298894|FG000|Overall Study|Lost to Follow-up|1
7142888|NCT03020966|11298900|FG000|Overall Study|Withdrawal by Subject|2
7142889|NCT03020966|11298901|FG001|Overall Study|Withdrawal by Subject|0
7142890|NCT03020992|11298907|FG000|Overall Study|Adverse Event|5
7142891|NCT03020992|11298907|FG000|Overall Study|Withdrawal by Subject|1
7142892|NCT03021005|11298914|FG000|Overall Study|Lost to Follow-up|39
7142893|NCT03021005|11298915|FG001|Overall Study|Lost to Follow-up|26
7142894|NCT03021018|11298924|FG000|Overall Study|Adverse Event|1
7142895|NCT03021018|11298925|FG001|Overall Study|Adverse Event|0
7142896|NCT03021018|11298926|FG002|Overall Study|Adverse Event|0
7142897|NCT03021018|11298924|FG000|Overall Study|Fall with subsequent nasal fracture|1
7142898|NCT03021018|11298925|FG001|Overall Study|Fall with subsequent nasal fracture|0
7142899|NCT03021018|11298926|FG002|Overall Study|Fall with subsequent nasal fracture|0
7142900|NCT03021187|11298938|FG000|Overall Study|Death|0
7142901|NCT03021187|11298939|FG001|Overall Study|Death|0
6825223|NCT00112437|10827951|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0
7142902|NCT03021187|11298940|FG002|Overall Study|Death|3
6825224|NCT00112437|10827952|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0
6825225|NCT00112437|10827953|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0
6825226|NCT00112437|10827928|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0
6825227|NCT00112437|10827929|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0
6825228|NCT00112437|10827930|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0
6825229|NCT00112437|10827931|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0
6825230|NCT00112437|10827932|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0
6825231|NCT00112437|10827933|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0
6825232|NCT00112437|10827934|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0
6825233|NCT00112437|10827935|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0
6825234|NCT00112437|10827936|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1
6825235|NCT00112437|10827937|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0
6825236|NCT00112437|10827938|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0
6825237|NCT00112437|10827939|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0
6825238|NCT00112437|10827940|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0
6825239|NCT00112437|10827941|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0
6825240|NCT00112437|10827942|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0
6825241|NCT00112437|10827943|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0
6825242|NCT00112437|10827944|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0
6825243|NCT00112437|10827945|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0
6825244|NCT00112437|10827946|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0
6825245|NCT00112437|10827947|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0
6825246|NCT00112437|10827948|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0
6825247|NCT00112437|10827949|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0
6825248|NCT00112437|10827950|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0
6825249|NCT00112437|10827951|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0
6825250|NCT00112437|10827952|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0
6825251|NCT00112437|10827953|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0
6825252|NCT00112437|10827928|FG000|Year 2 (12-Month Extension)|Protocol Violation|0
6825253|NCT00112437|10827929|FG001|Year 2 (12-Month Extension)|Protocol Violation|0
6825254|NCT00112437|10827930|FG002|Year 2 (12-Month Extension)|Protocol Violation|0
6825255|NCT00112437|10827931|FG003|Year 2 (12-Month Extension)|Protocol Violation|0
6825256|NCT00112437|10827932|FG004|Year 2 (12-Month Extension)|Protocol Violation|0
6825257|NCT00112437|10827933|FG005|Year 2 (12-Month Extension)|Protocol Violation|0
6825258|NCT00112437|10827934|FG006|Year 2 (12-Month Extension)|Protocol Violation|0
6825259|NCT00112437|10827935|FG007|Year 2 (12-Month Extension)|Protocol Violation|0
6825260|NCT00112437|10827936|FG008|Year 2 (12-Month Extension)|Protocol Violation|1
6825261|NCT00112437|10827937|FG009|Year 2 (12-Month Extension)|Protocol Violation|0
6825262|NCT00112437|10827938|FG010|Year 2 (12-Month Extension)|Protocol Violation|0
6825263|NCT00112437|10827939|FG011|Year 2 (12-Month Extension)|Protocol Violation|0
6825264|NCT00112437|10827940|FG012|Year 2 (12-Month Extension)|Protocol Violation|0
6825265|NCT00112437|10827941|FG013|Year 2 (12-Month Extension)|Protocol Violation|0
6825266|NCT00112437|10827942|FG014|Year 2 (12-Month Extension)|Protocol Violation|0
6825267|NCT00112437|10827943|FG015|Year 2 (12-Month Extension)|Protocol Violation|0
6825268|NCT00112437|10827944|FG016|Year 2 (12-Month Extension)|Protocol Violation|0
6825269|NCT00112437|10827945|FG017|Year 2 (12-Month Extension)|Protocol Violation|0
6825270|NCT00112437|10827946|FG018|Year 2 (12-Month Extension)|Protocol Violation|0
6825271|NCT00112437|10827947|FG019|Year 2 (12-Month Extension)|Protocol Violation|0
6825272|NCT00112437|10827948|FG020|Year 2 (12-Month Extension)|Protocol Violation|0
6825273|NCT00112437|10827949|FG021|Year 2 (12-Month Extension)|Protocol Violation|0
6825274|NCT00112437|10827950|FG022|Year 2 (12-Month Extension)|Protocol Violation|0
6825275|NCT00112437|10827951|FG023|Year 2 (12-Month Extension)|Protocol Violation|0
6825276|NCT00112437|10827952|FG024|Year 2 (12-Month Extension)|Protocol Violation|0
6825277|NCT00112437|10827953|FG025|Year 2 (12-Month Extension)|Protocol Violation|0
6825278|NCT00112437|10827928|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6825279|NCT00112437|10827929|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6825280|NCT00112437|10827930|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6825281|NCT00112437|10827931|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6825282|NCT00112437|10827932|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6825283|NCT00112437|10827933|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1
6825284|NCT00112437|10827934|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1
6825285|NCT00112437|10827935|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2
6825286|NCT00112437|10827936|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4
6825287|NCT00112437|10827937|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1
6825288|NCT00112437|10827938|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6825289|NCT00112437|10827939|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6825290|NCT00112437|10827940|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6825291|NCT00112437|10827941|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6825292|NCT00112437|10827942|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6825293|NCT00112437|10827943|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6825294|NCT00112437|10827944|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6825295|NCT00112437|10827945|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6825296|NCT00112437|10827946|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6825297|NCT00112437|10827947|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6825298|NCT00112437|10827948|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6825299|NCT00112437|10827949|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6825300|NCT00112437|10827950|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6825301|NCT00112437|10827951|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6825302|NCT00112437|10827952|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6825303|NCT00112437|10827953|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6825304|NCT00112437|10827928|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6825305|NCT00112437|10827929|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6825306|NCT00112437|10827930|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6825307|NCT00112437|10827931|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6825308|NCT00112437|10827932|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6825309|NCT00112437|10827933|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6825310|NCT00112437|10827934|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6825311|NCT00112437|10827935|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6825312|NCT00112437|10827936|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6825313|NCT00112437|10827937|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1
6825314|NCT00112437|10827938|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6825315|NCT00112437|10827939|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6825316|NCT00112437|10827940|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6825317|NCT00112437|10827941|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6825318|NCT00112437|10827942|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6825319|NCT00112437|10827943|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6825320|NCT00112437|10827944|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6825321|NCT00112437|10827945|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6825322|NCT00112437|10827946|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6825323|NCT00112437|10827947|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6825324|NCT00112437|10827948|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6825325|NCT00112437|10827949|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6825326|NCT00112437|10827950|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6825327|NCT00112437|10827951|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6825328|NCT00112437|10827952|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6825329|NCT00112437|10827953|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6825330|NCT00112437|10827928|FG000|Year 2 (12-Month Extension)|patient was out of windows|0
6825331|NCT00112437|10827929|FG001|Year 2 (12-Month Extension)|patient was out of windows|0
6825332|NCT00112437|10827930|FG002|Year 2 (12-Month Extension)|patient was out of windows|0
6825333|NCT00112437|10827931|FG003|Year 2 (12-Month Extension)|patient was out of windows|0
6825334|NCT00112437|10827932|FG004|Year 2 (12-Month Extension)|patient was out of windows|0
6825335|NCT00112437|10827933|FG005|Year 2 (12-Month Extension)|patient was out of windows|0
6825336|NCT00112437|10827934|FG006|Year 2 (12-Month Extension)|patient was out of windows|0
6825337|NCT00112437|10827935|FG007|Year 2 (12-Month Extension)|patient was out of windows|0
6825338|NCT00112437|10827936|FG008|Year 2 (12-Month Extension)|patient was out of windows|0
6825339|NCT00112437|10827937|FG009|Year 2 (12-Month Extension)|patient was out of windows|1
6825340|NCT00112437|10827938|FG010|Year 2 (12-Month Extension)|patient was out of windows|0
6825341|NCT00112437|10827939|FG011|Year 2 (12-Month Extension)|patient was out of windows|0
6825342|NCT00112437|10827940|FG012|Year 2 (12-Month Extension)|patient was out of windows|0
6825343|NCT00112437|10827941|FG013|Year 2 (12-Month Extension)|patient was out of windows|0
6825344|NCT00112437|10827942|FG014|Year 2 (12-Month Extension)|patient was out of windows|0
6825345|NCT00112437|10827943|FG015|Year 2 (12-Month Extension)|patient was out of windows|0
6825346|NCT00112437|10827944|FG016|Year 2 (12-Month Extension)|patient was out of windows|0
6825347|NCT00112437|10827945|FG017|Year 2 (12-Month Extension)|patient was out of windows|0
6825348|NCT00112437|10827946|FG018|Year 2 (12-Month Extension)|patient was out of windows|0
6825349|NCT00112437|10827947|FG019|Year 2 (12-Month Extension)|patient was out of windows|0
6825350|NCT00112437|10827948|FG020|Year 2 (12-Month Extension)|patient was out of windows|0
6825351|NCT00112437|10827949|FG021|Year 2 (12-Month Extension)|patient was out of windows|0
6825352|NCT00112437|10827950|FG022|Year 2 (12-Month Extension)|patient was out of windows|0
6825353|NCT00112437|10827951|FG023|Year 2 (12-Month Extension)|patient was out of windows|0
6825354|NCT00112437|10827952|FG024|Year 2 (12-Month Extension)|patient was out of windows|0
6825355|NCT00112437|10827953|FG025|Year 2 (12-Month Extension)|patient was out of windows|0
6825356|NCT00112437|10827928|FG000|Year 2 (12-Month Extension)|Moved|0
6825357|NCT00112437|10827929|FG001|Year 2 (12-Month Extension)|Moved|0
6825358|NCT00112437|10827930|FG002|Year 2 (12-Month Extension)|Moved|0
6825359|NCT00112437|10827931|FG003|Year 2 (12-Month Extension)|Moved|0
6825360|NCT00112437|10827932|FG004|Year 2 (12-Month Extension)|Moved|0
6825361|NCT00112437|10827933|FG005|Year 2 (12-Month Extension)|Moved|0
6825362|NCT00112437|10827934|FG006|Year 2 (12-Month Extension)|Moved|0
6825363|NCT00112437|10827935|FG007|Year 2 (12-Month Extension)|Moved|0
6825364|NCT00112437|10827936|FG008|Year 2 (12-Month Extension)|Moved|0
6825365|NCT00112437|10827937|FG009|Year 2 (12-Month Extension)|Moved|1
6825366|NCT00112437|10827938|FG010|Year 2 (12-Month Extension)|Moved|0
6825367|NCT00112437|10827939|FG011|Year 2 (12-Month Extension)|Moved|0
6825368|NCT00112437|10827940|FG012|Year 2 (12-Month Extension)|Moved|0
6825369|NCT00112437|10827941|FG013|Year 2 (12-Month Extension)|Moved|0
6825370|NCT00112437|10827942|FG014|Year 2 (12-Month Extension)|Moved|0
6825371|NCT00112437|10827943|FG015|Year 2 (12-Month Extension)|Moved|0
6825372|NCT00112437|10827944|FG016|Year 2 (12-Month Extension)|Moved|0
6825373|NCT00112437|10827945|FG017|Year 2 (12-Month Extension)|Moved|0
6825374|NCT00112437|10827946|FG018|Year 2 (12-Month Extension)|Moved|0
6825375|NCT00112437|10827947|FG019|Year 2 (12-Month Extension)|Moved|0
6825376|NCT00112437|10827948|FG020|Year 2 (12-Month Extension)|Moved|0
6825377|NCT00112437|10827949|FG021|Year 2 (12-Month Extension)|Moved|0
6825378|NCT00112437|10827950|FG022|Year 2 (12-Month Extension)|Moved|0
6825379|NCT00112437|10827951|FG023|Year 2 (12-Month Extension)|Moved|0
6825380|NCT00112437|10827952|FG024|Year 2 (12-Month Extension)|Moved|0
6825381|NCT00112437|10827953|FG025|Year 2 (12-Month Extension)|Moved|0
6825382|NCT00112437|10827928|FG000|Year 3 (12-Month Extension)|Adverse Event|0
6825383|NCT00112437|10827929|FG001|Year 3 (12-Month Extension)|Adverse Event|0
6825384|NCT00112437|10827930|FG002|Year 3 (12-Month Extension)|Adverse Event|0
6825385|NCT00112437|10827931|FG003|Year 3 (12-Month Extension)|Adverse Event|0
6825386|NCT00112437|10827932|FG004|Year 3 (12-Month Extension)|Adverse Event|0
6825387|NCT00112437|10827933|FG005|Year 3 (12-Month Extension)|Adverse Event|0
6825388|NCT00112437|10827934|FG006|Year 3 (12-Month Extension)|Adverse Event|0
6825389|NCT00112437|10827935|FG007|Year 3 (12-Month Extension)|Adverse Event|0
6825390|NCT00112437|10827936|FG008|Year 3 (12-Month Extension)|Adverse Event|0
6825391|NCT00112437|10827937|FG009|Year 3 (12-Month Extension)|Adverse Event|0
6825392|NCT00112437|10827938|FG010|Year 3 (12-Month Extension)|Adverse Event|1
6825393|NCT00112437|10827939|FG011|Year 3 (12-Month Extension)|Adverse Event|0
6825394|NCT00112437|10827940|FG012|Year 3 (12-Month Extension)|Adverse Event|0
6825395|NCT00112437|10827941|FG013|Year 3 (12-Month Extension)|Adverse Event|0
6825396|NCT00112437|10827942|FG014|Year 3 (12-Month Extension)|Adverse Event|0
6825397|NCT00112437|10827943|FG015|Year 3 (12-Month Extension)|Adverse Event|1
6825398|NCT00112437|10827944|FG016|Year 3 (12-Month Extension)|Adverse Event|3
6825399|NCT00112437|10827945|FG017|Year 3 (12-Month Extension)|Adverse Event|1
6825400|NCT00112437|10827946|FG018|Year 3 (12-Month Extension)|Adverse Event|0
6825401|NCT00112437|10827947|FG019|Year 3 (12-Month Extension)|Adverse Event|1
6825402|NCT00112437|10827948|FG020|Year 3 (12-Month Extension)|Adverse Event|0
6825403|NCT00112437|10827949|FG021|Year 3 (12-Month Extension)|Adverse Event|0
6825404|NCT00112437|10827950|FG022|Year 3 (12-Month Extension)|Adverse Event|0
6825405|NCT00112437|10827951|FG023|Year 3 (12-Month Extension)|Adverse Event|0
6825406|NCT00112437|10827952|FG024|Year 3 (12-Month Extension)|Adverse Event|0
6825407|NCT00112437|10827953|FG025|Year 3 (12-Month Extension)|Adverse Event|0
6825408|NCT00112437|10827928|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0
6825409|NCT00112437|10827929|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0
6825410|NCT00112437|10827930|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0
6825411|NCT00112437|10827931|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0
6825412|NCT00112437|10827932|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0
6825413|NCT00112437|10827933|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0
6825414|NCT00112437|10827934|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0
6825415|NCT00112437|10827935|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0
6825416|NCT00112437|10827936|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0
6825417|NCT00112437|10827937|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0
6825418|NCT00112437|10827938|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0
6825419|NCT00112437|10827939|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1
6825420|NCT00112437|10827940|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0
6825421|NCT00112437|10827941|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1
6825422|NCT00112437|10827942|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0
6825423|NCT00112437|10827943|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1
6825424|NCT00112437|10827944|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0
6825425|NCT00112437|10827945|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0
6825426|NCT00112437|10827946|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2
6825427|NCT00112437|10827947|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0
6825428|NCT00112437|10827948|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0
6825429|NCT00112437|10827949|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0
6825430|NCT00112437|10827950|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0
6825431|NCT00112437|10827951|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0
6825432|NCT00112437|10827952|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0
6825433|NCT00112437|10827953|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0
6825434|NCT00112437|10827928|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0
6825435|NCT00112437|10827929|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0
6825436|NCT00112437|10827930|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0
6825437|NCT00112437|10827931|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0
6825438|NCT00112437|10827932|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0
6825439|NCT00112437|10827933|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0
6825440|NCT00112437|10827934|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0
6825441|NCT00112437|10827935|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0
6825442|NCT00112437|10827936|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0
6825443|NCT00112437|10827937|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0
6825444|NCT00112437|10827938|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0
6825445|NCT00112437|10827939|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0
6825446|NCT00112437|10827940|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0
6825447|NCT00112437|10827941|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0
6825448|NCT00112437|10827942|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0
6825449|NCT00112437|10827943|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1
6825450|NCT00112437|10827944|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0
6825451|NCT00112437|10827945|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0
6825452|NCT00112437|10827946|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0
6825453|NCT00112437|10827947|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0
6825454|NCT00112437|10827948|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0
6825455|NCT00112437|10827949|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0
6825456|NCT00112437|10827950|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0
6825457|NCT00112437|10827951|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0
6825458|NCT00112437|10827952|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0
6825459|NCT00112437|10827953|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0
6825460|NCT00112437|10827928|FG000|Year 3 (12-Month Extension)|Protocol Violation|0
6825461|NCT00112437|10827929|FG001|Year 3 (12-Month Extension)|Protocol Violation|0
6825462|NCT00112437|10827930|FG002|Year 3 (12-Month Extension)|Protocol Violation|0
6825463|NCT00112437|10827931|FG003|Year 3 (12-Month Extension)|Protocol Violation|0
6825464|NCT00112437|10827932|FG004|Year 3 (12-Month Extension)|Protocol Violation|0
6825465|NCT00112437|10827933|FG005|Year 3 (12-Month Extension)|Protocol Violation|0
6825466|NCT00112437|10827934|FG006|Year 3 (12-Month Extension)|Protocol Violation|0
6825467|NCT00112437|10827935|FG007|Year 3 (12-Month Extension)|Protocol Violation|0
6825468|NCT00112437|10827936|FG008|Year 3 (12-Month Extension)|Protocol Violation|0
6825469|NCT00112437|10827937|FG009|Year 3 (12-Month Extension)|Protocol Violation|0
6825470|NCT00112437|10827938|FG010|Year 3 (12-Month Extension)|Protocol Violation|0
6825471|NCT00112437|10827939|FG011|Year 3 (12-Month Extension)|Protocol Violation|0
6825472|NCT00112437|10827940|FG012|Year 3 (12-Month Extension)|Protocol Violation|0
6825473|NCT00112437|10827941|FG013|Year 3 (12-Month Extension)|Protocol Violation|0
6825474|NCT00112437|10827942|FG014|Year 3 (12-Month Extension)|Protocol Violation|0
6825475|NCT00112437|10827943|FG015|Year 3 (12-Month Extension)|Protocol Violation|1
6901425|NCT00673049|10922272|FG002|Before Progression on Erlotinib|Randomized but not treated|0
6901426|NCT00673049|10922273|FG003|Before Progression on Erlotinib|Randomized but not treated|0
6901427|NCT00673049|10922270|FG000|Before Progression on Erlotinib|Death|235
6901428|NCT00673049|10922271|FG001|Before Progression on Erlotinib|Death|167
6901429|NCT00673049|10922272|FG002|Before Progression on Erlotinib|Death|1
6901430|NCT00673049|10922273|FG003|Before Progression on Erlotinib|Death|0
6901431|NCT00673049|10922270|FG000|Before Progression on Erlotinib|Lost to Follow-up|9
6901432|NCT00673049|10922271|FG001|Before Progression on Erlotinib|Lost to Follow-up|5
6901433|NCT00673049|10922272|FG002|Before Progression on Erlotinib|Lost to Follow-up|0
6901434|NCT00673049|10922273|FG003|Before Progression on Erlotinib|Lost to Follow-up|0
6901435|NCT00673049|10922270|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26
6901436|NCT00673049|10922271|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18
6901437|NCT00673049|10922272|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0
6901438|NCT00673049|10922273|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0
6901439|NCT00673049|10922270|FG000|Before Progression on Erlotinib|Other|1
6901440|NCT00673049|10922271|FG001|Before Progression on Erlotinib|Other|2
6901441|NCT00673049|10922272|FG002|Before Progression on Erlotinib|Other|0
6901442|NCT00673049|10922273|FG003|Before Progression on Erlotinib|Other|0
6901443|NCT00673049|10922270|FG000|Before Progression on Erlotinib|study terminated by sponsor|18
6901444|NCT00673049|10922271|FG001|Before Progression on Erlotinib|study terminated by sponsor|14
6901445|NCT00673049|10922272|FG002|Before Progression on Erlotinib|study terminated by sponsor|0
6901446|NCT00673049|10922273|FG003|Before Progression on Erlotinib|study terminated by sponsor|0
6901447|NCT00673049|10922270|FG000|Before Progression on Erlotinib|Switched to figitumumab|0
6901448|NCT00673049|10922271|FG001|Before Progression on Erlotinib|Switched to figitumumab|83
6901449|NCT00673049|10922272|FG002|Before Progression on Erlotinib|Switched to figitumumab|0
6901450|NCT00673049|10922273|FG003|Before Progression on Erlotinib|Switched to figitumumab|0
6901451|NCT00673049|10922270|FG000|After Progression on Erlotinib|Death|0
6901452|NCT00673049|10922271|FG001|After Progression on Erlotinib|Death|0
6901453|NCT00673049|10922272|FG002|After Progression on Erlotinib|Death|0
6901454|NCT00673049|10922273|FG003|After Progression on Erlotinib|Death|71
6901455|NCT00673049|10922270|FG000|After Progression on Erlotinib|Lost to Follow-up|0
6901456|NCT00673049|10922271|FG001|After Progression on Erlotinib|Lost to Follow-up|0
6901457|NCT00673049|10922272|FG002|After Progression on Erlotinib|Lost to Follow-up|0
6901458|NCT00673049|10922273|FG003|After Progression on Erlotinib|Lost to Follow-up|3
6901459|NCT00673049|10922270|FG000|After Progression on Erlotinib|Withdrawal by Subject|0
6901460|NCT00673049|10922271|FG001|After Progression on Erlotinib|Withdrawal by Subject|0
6901461|NCT00673049|10922272|FG002|After Progression on Erlotinib|Withdrawal by Subject|0
6901462|NCT00673049|10922273|FG003|After Progression on Erlotinib|Withdrawal by Subject|5
6901463|NCT00673049|10922270|FG000|After Progression on Erlotinib|study terminated by sponsor|0
6901464|NCT00673049|10922271|FG001|After Progression on Erlotinib|study terminated by sponsor|0
6901465|NCT00673049|10922272|FG002|After Progression on Erlotinib|study terminated by sponsor|0
6901466|NCT00673049|10922273|FG003|After Progression on Erlotinib|study terminated by sponsor|4
6901467|NCT00673231|10922309|FG000|Overall Study|Withdrawal by Subject|14
6901468|NCT00673231|10922310|FG001|Overall Study|Withdrawal by Subject|10
6901469|NCT00673231|10922311|FG002|Overall Study|Withdrawal by Subject|8
6825476|NCT00112437|10827944|FG016|Year 3 (12-Month Extension)|Protocol Violation|0
6825477|NCT00112437|10827945|FG017|Year 3 (12-Month Extension)|Protocol Violation|0
6825478|NCT00112437|10827946|FG018|Year 3 (12-Month Extension)|Protocol Violation|0
6825479|NCT00112437|10827947|FG019|Year 3 (12-Month Extension)|Protocol Violation|0
6825480|NCT00112437|10827948|FG020|Year 3 (12-Month Extension)|Protocol Violation|0
6825481|NCT00112437|10827949|FG021|Year 3 (12-Month Extension)|Protocol Violation|0
6825482|NCT00112437|10827950|FG022|Year 3 (12-Month Extension)|Protocol Violation|0
6825483|NCT00112437|10827951|FG023|Year 3 (12-Month Extension)|Protocol Violation|0
6825484|NCT00112437|10827952|FG024|Year 3 (12-Month Extension)|Protocol Violation|0
6825485|NCT00112437|10827953|FG025|Year 3 (12-Month Extension)|Protocol Violation|0
6825486|NCT00112437|10827928|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6825487|NCT00112437|10827929|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6825488|NCT00112437|10827930|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6825489|NCT00112437|10827931|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6825490|NCT00112437|10827932|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6825491|NCT00112437|10827933|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6825492|NCT00112437|10827934|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6825493|NCT00112437|10827935|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6825494|NCT00112437|10827936|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6825495|NCT00112437|10827937|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6825496|NCT00112437|10827938|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6825497|NCT00112437|10827939|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3
6825498|NCT00112437|10827940|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6825499|NCT00112437|10827941|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6825500|NCT00112437|10827942|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1
6825501|NCT00112437|10827943|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6825502|NCT00112437|10827944|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6825503|NCT00112437|10827945|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6825504|NCT00112437|10827946|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6825505|NCT00112437|10827947|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6825506|NCT00112437|10827948|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6825507|NCT00112437|10827949|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6825508|NCT00112437|10827950|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6825509|NCT00112437|10827951|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6825510|NCT00112437|10827952|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6825511|NCT00112437|10827953|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6825512|NCT00112437|10827928|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6825513|NCT00112437|10827929|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6825514|NCT00112437|10827930|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6825515|NCT00112437|10827931|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6825516|NCT00112437|10827932|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6825517|NCT00112437|10827933|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6825518|NCT00112437|10827934|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6825519|NCT00112437|10827935|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6825520|NCT00112437|10827936|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6825521|NCT00112437|10827937|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6825522|NCT00112437|10827938|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
6825523|NCT00112437|10827939|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
6825524|NCT00112437|10827940|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6825525|NCT00112437|10827941|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6825526|NCT00112437|10827942|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6825527|NCT00112437|10827943|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6825528|NCT00112437|10827944|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6825529|NCT00112437|10827945|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6825530|NCT00112437|10827946|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6825531|NCT00112437|10827947|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6825532|NCT00112437|10827948|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6825533|NCT00112437|10827949|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6825534|NCT00112437|10827950|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6825535|NCT00112437|10827951|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6825536|NCT00112437|10827952|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6825537|NCT00112437|10827953|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6825538|NCT00112437|10827928|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6825539|NCT00112437|10827929|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6825540|NCT00112437|10827930|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6825541|NCT00112437|10827931|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6825542|NCT00112437|10827932|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6825543|NCT00112437|10827933|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6825544|NCT00112437|10827934|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6825545|NCT00112437|10827935|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6825546|NCT00112437|10827936|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6825547|NCT00112437|10827937|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6825548|NCT00112437|10827938|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6825549|NCT00112437|10827939|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6825550|NCT00112437|10827940|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6825551|NCT00112437|10827941|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6825552|NCT00112437|10827942|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6825553|NCT00112437|10827943|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6825554|NCT00112437|10827944|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6825555|NCT00112437|10827945|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6825556|NCT00112437|10827946|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6825557|NCT00112437|10827947|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6825558|NCT00112437|10827948|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2
6825559|NCT00112437|10827949|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1
6825560|NCT00112437|10827950|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6825561|NCT00112437|10827951|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6825562|NCT00112437|10827952|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6825563|NCT00112437|10827953|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6825564|NCT00112437|10827928|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6825565|NCT00112437|10827929|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6825566|NCT00112437|10827930|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6825567|NCT00112437|10827931|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6825568|NCT00112437|10827932|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6825569|NCT00112437|10827933|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6825570|NCT00112437|10827934|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6825571|NCT00112437|10827935|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6825572|NCT00112437|10827936|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6825573|NCT00112437|10827937|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6825574|NCT00112437|10827938|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6825575|NCT00112437|10827939|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6825576|NCT00112437|10827940|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6825577|NCT00112437|10827941|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6825578|NCT00112437|10827942|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6825579|NCT00112437|10827943|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6825580|NCT00112437|10827944|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6825581|NCT00112437|10827945|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6825582|NCT00112437|10827946|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6825583|NCT00112437|10827947|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6825584|NCT00112437|10827948|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1
6825585|NCT00112437|10827949|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6825586|NCT00112437|10827950|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6825587|NCT00112437|10827951|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6825588|NCT00112437|10827952|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6825589|NCT00112437|10827953|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6825590|NCT00112437|10827928|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0
6825591|NCT00112437|10827929|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0
6825592|NCT00112437|10827930|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0
6825593|NCT00112437|10827931|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0
6825594|NCT00112437|10827932|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0
6825595|NCT00112437|10827933|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0
6825596|NCT00112437|10827934|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0
6825597|NCT00112437|10827935|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0
6825598|NCT00112437|10827936|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0
6825599|NCT00112437|10827937|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0
6825600|NCT00112437|10827938|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0
6825601|NCT00112437|10827939|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0
6825602|NCT00112437|10827940|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0
6825603|NCT00112437|10827941|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0
6825604|NCT00112437|10827942|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0
6825605|NCT00112437|10827943|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0
6825606|NCT00112437|10827944|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0
6825607|NCT00112437|10827945|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0
6825608|NCT00112437|10827946|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0
6825609|NCT00112437|10827947|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0
6825610|NCT00112437|10827948|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0
6825611|NCT00112437|10827949|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4
6825612|NCT00112437|10827950|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0
6825613|NCT00112437|10827951|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0
6825614|NCT00112437|10827952|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0
6825615|NCT00112437|10827953|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0
6825616|NCT00112437|10827928|FG000|Years 4-5 (24-Month Extension)|Participant moved|0
6825617|NCT00112437|10827929|FG001|Years 4-5 (24-Month Extension)|Participant moved|0
6825618|NCT00112437|10827930|FG002|Years 4-5 (24-Month Extension)|Participant moved|0
6825619|NCT00112437|10827931|FG003|Years 4-5 (24-Month Extension)|Participant moved|0
6825620|NCT00112437|10827932|FG004|Years 4-5 (24-Month Extension)|Participant moved|0
6825621|NCT00112437|10827933|FG005|Years 4-5 (24-Month Extension)|Participant moved|0
6825622|NCT00112437|10827934|FG006|Years 4-5 (24-Month Extension)|Participant moved|0
6825623|NCT00112437|10827935|FG007|Years 4-5 (24-Month Extension)|Participant moved|0
6825624|NCT00112437|10827936|FG008|Years 4-5 (24-Month Extension)|Participant moved|0
6825625|NCT00112437|10827937|FG009|Years 4-5 (24-Month Extension)|Participant moved|0
6825626|NCT00112437|10827938|FG010|Years 4-5 (24-Month Extension)|Participant moved|0
6825627|NCT00112437|10827939|FG011|Years 4-5 (24-Month Extension)|Participant moved|0
6825628|NCT00112437|10827940|FG012|Years 4-5 (24-Month Extension)|Participant moved|0
6825629|NCT00112437|10827941|FG013|Years 4-5 (24-Month Extension)|Participant moved|0
6825630|NCT00112437|10827942|FG014|Years 4-5 (24-Month Extension)|Participant moved|0
6825631|NCT00112437|10827943|FG015|Years 4-5 (24-Month Extension)|Participant moved|0
6825632|NCT00112437|10827944|FG016|Years 4-5 (24-Month Extension)|Participant moved|0
6825633|NCT00112437|10827945|FG017|Years 4-5 (24-Month Extension)|Participant moved|0
6825634|NCT00112437|10827946|FG018|Years 4-5 (24-Month Extension)|Participant moved|0
6825635|NCT00112437|10827947|FG019|Years 4-5 (24-Month Extension)|Participant moved|0
6825636|NCT00112437|10827948|FG020|Years 4-5 (24-Month Extension)|Participant moved|0
6825637|NCT00112437|10827949|FG021|Years 4-5 (24-Month Extension)|Participant moved|1
6825638|NCT00112437|10827950|FG022|Years 4-5 (24-Month Extension)|Participant moved|0
6825639|NCT00112437|10827951|FG023|Years 4-5 (24-Month Extension)|Participant moved|0
6825640|NCT00112437|10827952|FG024|Years 4-5 (24-Month Extension)|Participant moved|0
6825641|NCT00112437|10827953|FG025|Years 4-5 (24-Month Extension)|Participant moved|0
6825642|NCT00112437|10827928|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6825643|NCT00112437|10827929|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6825644|NCT00112437|10827930|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6825645|NCT00112437|10827931|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6825646|NCT00112437|10827932|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6825647|NCT00112437|10827933|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6825648|NCT00112437|10827934|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6825649|NCT00112437|10827935|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6825650|NCT00112437|10827936|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6825651|NCT00112437|10827937|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6825652|NCT00112437|10827938|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6825653|NCT00112437|10827939|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6825654|NCT00112437|10827940|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6825655|NCT00112437|10827941|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6825656|NCT00112437|10827942|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6825657|NCT00112437|10827943|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6825658|NCT00112437|10827944|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6825659|NCT00112437|10827945|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6825660|NCT00112437|10827946|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6825661|NCT00112437|10827947|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6825662|NCT00112437|10827948|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1
6825663|NCT00112437|10827949|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2
6825664|NCT00112437|10827950|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6825665|NCT00112437|10827951|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6825666|NCT00112437|10827952|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6825667|NCT00112437|10827953|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6825668|NCT00112437|10827928|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0
6825669|NCT00112437|10827929|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0
6825670|NCT00112437|10827930|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0
6825671|NCT00112437|10827931|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0
6825672|NCT00112437|10827932|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0
6825673|NCT00112437|10827933|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0
6825674|NCT00112437|10827934|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0
6825675|NCT00112437|10827935|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0
6825676|NCT00112437|10827936|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0
6825677|NCT00112437|10827937|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0
6825678|NCT00112437|10827938|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0
6825679|NCT00112437|10827939|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0
6825680|NCT00112437|10827940|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0
6825681|NCT00112437|10827941|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0
6825682|NCT00112437|10827942|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0
6825683|NCT00112437|10827943|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0
6825684|NCT00112437|10827944|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0
6825685|NCT00112437|10827945|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0
6825686|NCT00112437|10827946|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0
6825687|NCT00112437|10827947|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0
6825688|NCT00112437|10827948|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0
6825689|NCT00112437|10827949|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0
6825690|NCT00112437|10827950|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1
6825691|NCT00112437|10827951|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2
6825692|NCT00112437|10827952|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0
6825693|NCT00112437|10827953|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1
6825694|NCT00112437|10827928|FG000|Years 6-10 (60-Month Extension)|Death|0
6825695|NCT00112437|10827929|FG001|Years 6-10 (60-Month Extension)|Death|0
6825696|NCT00112437|10827930|FG002|Years 6-10 (60-Month Extension)|Death|0
6825697|NCT00112437|10827931|FG003|Years 6-10 (60-Month Extension)|Death|0
6825698|NCT00112437|10827932|FG004|Years 6-10 (60-Month Extension)|Death|0
6825699|NCT00112437|10827933|FG005|Years 6-10 (60-Month Extension)|Death|0
6825700|NCT00112437|10827934|FG006|Years 6-10 (60-Month Extension)|Death|0
6825701|NCT00112437|10827935|FG007|Years 6-10 (60-Month Extension)|Death|0
6825702|NCT00112437|10827936|FG008|Years 6-10 (60-Month Extension)|Death|0
6825703|NCT00112437|10827937|FG009|Years 6-10 (60-Month Extension)|Death|0
6825704|NCT00112437|10827938|FG010|Years 6-10 (60-Month Extension)|Death|0
6825705|NCT00112437|10827939|FG011|Years 6-10 (60-Month Extension)|Death|0
6825706|NCT00112437|10827940|FG012|Years 6-10 (60-Month Extension)|Death|0
6825707|NCT00112437|10827941|FG013|Years 6-10 (60-Month Extension)|Death|0
6825708|NCT00112437|10827942|FG014|Years 6-10 (60-Month Extension)|Death|0
6825709|NCT00112437|10827943|FG015|Years 6-10 (60-Month Extension)|Death|0
6825710|NCT00112437|10827944|FG016|Years 6-10 (60-Month Extension)|Death|0
6825711|NCT00112437|10827945|FG017|Years 6-10 (60-Month Extension)|Death|0
6825712|NCT00112437|10827946|FG018|Years 6-10 (60-Month Extension)|Death|0
6825713|NCT00112437|10827947|FG019|Years 6-10 (60-Month Extension)|Death|0
6825714|NCT00112437|10827948|FG020|Years 6-10 (60-Month Extension)|Death|0
6825715|NCT00112437|10827949|FG021|Years 6-10 (60-Month Extension)|Death|0
6825716|NCT00112437|10827950|FG022|Years 6-10 (60-Month Extension)|Death|0
6825717|NCT00112437|10827951|FG023|Years 6-10 (60-Month Extension)|Death|2
6825718|NCT00112437|10827952|FG024|Years 6-10 (60-Month Extension)|Death|0
6825719|NCT00112437|10827953|FG025|Years 6-10 (60-Month Extension)|Death|0
6825720|NCT00112437|10827928|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6825721|NCT00112437|10827929|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6825722|NCT00112437|10827930|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6825723|NCT00112437|10827931|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6825724|NCT00112437|10827932|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6825725|NCT00112437|10827933|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6825726|NCT00112437|10827934|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6825727|NCT00112437|10827935|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6825728|NCT00112437|10827936|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6825729|NCT00112437|10827937|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6825730|NCT00112437|10827938|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6825731|NCT00112437|10827939|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6825732|NCT00112437|10827940|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6825733|NCT00112437|10827941|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6825734|NCT00112437|10827942|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6825735|NCT00112437|10827943|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6825736|NCT00112437|10827944|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6825737|NCT00112437|10827945|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6825738|NCT00112437|10827946|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6825739|NCT00112437|10827947|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6825740|NCT00112437|10827948|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6825741|NCT00112437|10827949|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6825742|NCT00112437|10827950|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6825743|NCT00112437|10827951|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6825744|NCT00112437|10827952|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6825745|NCT00112437|10827953|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1
6825746|NCT00112437|10827928|FG000|Years 6-10 (60-Month Extension)|Other|0
6825747|NCT00112437|10827929|FG001|Years 6-10 (60-Month Extension)|Other|0
6825748|NCT00112437|10827930|FG002|Years 6-10 (60-Month Extension)|Other|0
6825749|NCT00112437|10827931|FG003|Years 6-10 (60-Month Extension)|Other|0
6825750|NCT00112437|10827932|FG004|Years 6-10 (60-Month Extension)|Other|0
6825751|NCT00112437|10827933|FG005|Years 6-10 (60-Month Extension)|Other|0
6825752|NCT00112437|10827934|FG006|Years 6-10 (60-Month Extension)|Other|0
6825753|NCT00112437|10827935|FG007|Years 6-10 (60-Month Extension)|Other|0
6825754|NCT00112437|10827936|FG008|Years 6-10 (60-Month Extension)|Other|0
6825755|NCT00112437|10827937|FG009|Years 6-10 (60-Month Extension)|Other|0
6825756|NCT00112437|10827938|FG010|Years 6-10 (60-Month Extension)|Other|0
6825757|NCT00112437|10827939|FG011|Years 6-10 (60-Month Extension)|Other|0
6825758|NCT00112437|10827940|FG012|Years 6-10 (60-Month Extension)|Other|0
6825759|NCT00112437|10827941|FG013|Years 6-10 (60-Month Extension)|Other|0
6825760|NCT00112437|10827942|FG014|Years 6-10 (60-Month Extension)|Other|0
6825761|NCT00112437|10827943|FG015|Years 6-10 (60-Month Extension)|Other|0
6825762|NCT00112437|10827944|FG016|Years 6-10 (60-Month Extension)|Other|0
6825763|NCT00112437|10827945|FG017|Years 6-10 (60-Month Extension)|Other|0
6825764|NCT00112437|10827946|FG018|Years 6-10 (60-Month Extension)|Other|0
6825765|NCT00112437|10827947|FG019|Years 6-10 (60-Month Extension)|Other|0
6825766|NCT00112437|10827948|FG020|Years 6-10 (60-Month Extension)|Other|0
6825767|NCT00112437|10827949|FG021|Years 6-10 (60-Month Extension)|Other|0
6825768|NCT00112437|10827950|FG022|Years 6-10 (60-Month Extension)|Other|0
6825769|NCT00112437|10827951|FG023|Years 6-10 (60-Month Extension)|Other|0
6825770|NCT00112437|10827952|FG024|Years 6-10 (60-Month Extension)|Other|1
6825771|NCT00112437|10827953|FG025|Years 6-10 (60-Month Extension)|Other|0
6825772|NCT00112437|10827928|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0
6825773|NCT00112437|10827929|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0
6825774|NCT00112437|10827930|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0
6825775|NCT00112437|10827931|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0
6825776|NCT00112437|10827932|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0
6825777|NCT00112437|10827933|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0
6825778|NCT00112437|10827934|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0
6825779|NCT00112437|10827935|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0
6825780|NCT00112437|10827936|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0
6825781|NCT00112437|10827937|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0
6825782|NCT00112437|10827938|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0
6825783|NCT00112437|10827939|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0
6825784|NCT00112437|10827940|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0
6825785|NCT00112437|10827941|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0
6825786|NCT00112437|10827942|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0
6825787|NCT00112437|10827943|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0
6825788|NCT00112437|10827944|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0
6825789|NCT00112437|10827945|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0
6825790|NCT00112437|10827946|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0
6825791|NCT00112437|10827947|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0
6825792|NCT00112437|10827948|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0
6825793|NCT00112437|10827949|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0
6825794|NCT00112437|10827950|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0
6825795|NCT00112437|10827951|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2
6825796|NCT00112437|10827952|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0
6825797|NCT00112437|10827953|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0
6825798|NCT00112437|10827928|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6825799|NCT00112437|10827929|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6825800|NCT00112437|10827930|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6825801|NCT00112437|10827931|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6825802|NCT00112437|10827932|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6825803|NCT00112437|10827933|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6825804|NCT00112437|10827934|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6825805|NCT00112437|10827935|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6825806|NCT00112437|10827936|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6825807|NCT00112437|10827937|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6825808|NCT00112437|10827938|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6825809|NCT00112437|10827939|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6825810|NCT00112437|10827940|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6825811|NCT00112437|10827941|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6825812|NCT00112437|10827942|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6825813|NCT00112437|10827943|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6825814|NCT00112437|10827944|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6825815|NCT00112437|10827945|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6825816|NCT00112437|10827946|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6825817|NCT00112437|10827947|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6825818|NCT00112437|10827948|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6825819|NCT00112437|10827949|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6825820|NCT00112437|10827950|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4
6825821|NCT00112437|10827951|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6
6825822|NCT00112437|10827952|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6825823|NCT00112437|10827953|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3
6825824|NCT00112463|10828007|FG000|Overall Study|Physician Decision|1
6825825|NCT00112463|10828007|FG000|Overall Study|Progression|30
6825826|NCT00112463|10828007|FG000|Overall Study|Second Primary|1
6825827|NCT00112463|10828007|FG000|Overall Study|Toxicity|3
6825828|NCT00112463|10828007|FG000|Overall Study|Withdrawal by Subject|2
6825829|NCT00112463|10828007|FG000|Overall Study|Never started treatment|2
6825830|NCT00112489|10828012|FG000|Overall Study|Refused further treatment|8
6825831|NCT00112489|10828012|FG000|Overall Study|Adverse Event|12
6825832|NCT00112489|10828012|FG000|Overall Study|Death|2
6825833|NCT00112489|10828012|FG000|Overall Study|Other, Not Specified|9
6825834|NCT00112489|10828012|FG000|Overall Study|Patient never treated|2
6825835|NCT00112489|10828012|FG000|Overall Study|Ineligible|7
6825836|NCT00112502|10828030|FG000|Overall Study|Withdrawal by Subject|0
6825837|NCT00112502|10828031|FG001|Overall Study|Withdrawal by Subject|1
6825838|NCT00112502|10828032|FG002|Overall Study|Withdrawal by Subject|1
6825839|NCT00112502|10828033|FG003|Overall Study|Withdrawal by Subject|4
6978677|NCT01214629|11032174|FG002|Overall Study|Withdrawal by Subject|0
6825840|NCT00112502|10828034|FG004|Overall Study|Withdrawal by Subject|2
6825841|NCT00112502|10828035|FG005|Overall Study|Withdrawal by Subject|5
6825842|NCT00112502|10828036|FG006|Overall Study|Withdrawal by Subject|3
6825843|NCT00112502|10828037|FG007|Overall Study|Withdrawal by Subject|7
6825844|NCT00112580|10828067|FG000|Overall Study|Adverse Event|1
6825845|NCT00112580|10828068|FG001|Overall Study|Adverse Event|2
6825846|NCT00112580|10828067|FG000|Overall Study|Disease progression|5
6825847|NCT00112580|10828068|FG001|Overall Study|Disease progression|16
6825848|NCT00112580|10828067|FG000|Overall Study|Participant withdrew consent|2
6825849|NCT00112580|10828068|FG001|Overall Study|Participant withdrew consent|1
6825850|NCT00112736|10828107|FG000|Overall Study|1 pt never had had RX due rapid decline|1
6825851|NCT00112736|10828108|FG001|Overall Study|1 pt never had had RX due rapid decline|0
6825852|NCT00112866|10828144|FG000|Overall Study|Protocol Violation|1
6825853|NCT00112866|10828145|FG001|Overall Study|Protocol Violation|0
6825854|NCT00112866|10828144|FG000|Overall Study|did not start treatment post-op|1
6825855|NCT00112866|10828145|FG001|Overall Study|did not start treatment post-op|2
6825856|NCT00112905|10828159|FG000|Overall Study|Adverse Event|4
6825857|NCT00112905|10828159|FG000|Overall Study|Death|1
6825858|NCT00112905|10828159|FG000|Overall Study|Ineligibility|5
6825859|NCT00112905|10828159|FG000|Overall Study|Alternative treatment|1
6825860|NCT00112905|10828159|FG000|Overall Study|performance status was deteiorating|1
6825861|NCT00112957|10828176|FG000|Overall Study|Progressive disease|18
6825862|NCT00112957|10828176|FG000|Overall Study|Physician Decision|1
6825863|NCT00113087|10828191|FG000|Overall Study|Death or Transplant|14
6825864|NCT00113087|10828192|FG001|Overall Study|Death or Transplant|16
6825865|NCT00113087|10828191|FG000|Overall Study|Family or MD withdrew subject|10
6825866|NCT00113087|10828192|FG001|Overall Study|Family or MD withdrew subject|5
6825867|NCT00113269|10828210|FG000|Overall Study|Not transplanted, donor issues|4
6825868|NCT00113269|10828211|FG001|Overall Study|Not transplanted, donor issues|0
6825869|NCT00113269|10828212|FG002|Overall Study|Not transplanted, donor issues|2
6825870|NCT00113269|10828213|FG003|Overall Study|Not transplanted, donor issues|2
6825871|NCT00113269|10828210|FG000|Overall Study|Not transplanted, recipient issues|2
6825872|NCT00113269|10828211|FG001|Overall Study|Not transplanted, recipient issues|1
6825873|NCT00113269|10828212|FG002|Overall Study|Not transplanted, recipient issues|7
6825874|NCT00113269|10828213|FG003|Overall Study|Not transplanted, recipient issues|4
6825875|NCT00113269|10828210|FG000|Overall Study|Early graft loss, technical|0
6825876|NCT00113269|10828211|FG001|Overall Study|Early graft loss, technical|0
6825877|NCT00113269|10828212|FG002|Overall Study|Early graft loss, technical|2
6825878|NCT00113269|10828213|FG003|Overall Study|Early graft loss, technical|0
6825879|NCT00113269|10828210|FG000|Overall Study|Death in operating room|0
6825880|NCT00113269|10828211|FG001|Overall Study|Death in operating room|0
6825881|NCT00113269|10828212|FG002|Overall Study|Death in operating room|0
6825882|NCT00113269|10828213|FG003|Overall Study|Death in operating room|1
6825883|NCT00113269|10828210|FG000|Overall Study|Did not meet eligibility - pre-treatment|0
6825884|NCT00113269|10828211|FG001|Overall Study|Did not meet eligibility - pre-treatment|0
6825885|NCT00113269|10828212|FG002|Overall Study|Did not meet eligibility - pre-treatment|0
6825886|NCT00113269|10828213|FG003|Overall Study|Did not meet eligibility - pre-treatment|2
6825887|NCT00113269|10828210|FG000|Overall Study|Adverse Event|2
6825888|NCT00113269|10828211|FG001|Overall Study|Adverse Event|7
6825889|NCT00113269|10828212|FG002|Overall Study|Adverse Event|11
6825890|NCT00113269|10828213|FG003|Overall Study|Adverse Event|7
6825891|NCT00113269|10828210|FG000|Overall Study|Withdrawal by Subject|4
6825892|NCT00113269|10828211|FG001|Overall Study|Withdrawal by Subject|3
6825893|NCT00113269|10828212|FG002|Overall Study|Withdrawal by Subject|4
6825894|NCT00113269|10828213|FG003|Overall Study|Withdrawal by Subject|2
6825895|NCT00113269|10828210|FG000|Overall Study|Graft loss|6
6825896|NCT00113269|10828211|FG001|Overall Study|Graft loss|6
6825897|NCT00113269|10828212|FG002|Overall Study|Graft loss|4
6825898|NCT00113269|10828213|FG003|Overall Study|Graft loss|9
6825899|NCT00113269|10828210|FG000|Overall Study|Protocol Violation|1
6825900|NCT00113269|10828211|FG001|Overall Study|Protocol Violation|0
6825901|NCT00113269|10828212|FG002|Overall Study|Protocol Violation|4
6825902|NCT00113269|10828213|FG003|Overall Study|Protocol Violation|2
6825903|NCT00113269|10828210|FG000|Overall Study|Lost to Follow-up|2
6825904|NCT00113269|10828211|FG001|Overall Study|Lost to Follow-up|3
6825905|NCT00113269|10828212|FG002|Overall Study|Lost to Follow-up|6
6825906|NCT00113269|10828213|FG003|Overall Study|Lost to Follow-up|3
6825907|NCT00113269|10828210|FG000|Overall Study|Sponsor elected to discontinue patient|1
6825908|NCT00113269|10828211|FG001|Overall Study|Sponsor elected to discontinue patient|0
6825909|NCT00113269|10828212|FG002|Overall Study|Sponsor elected to discontinue patient|0
6825910|NCT00113269|10828213|FG003|Overall Study|Sponsor elected to discontinue patient|1
6825911|NCT00113269|10828210|FG000|Overall Study|Discontinued due to rejection|0
6825912|NCT00113269|10828211|FG001|Overall Study|Discontinued due to rejection|0
6825913|NCT00113269|10828212|FG002|Overall Study|Discontinued due to rejection|1
6825914|NCT00113269|10828213|FG003|Overall Study|Discontinued due to rejection|0
6825915|NCT00113269|10828210|FG000|Overall Study|Moved|0
6825916|NCT00113269|10828211|FG001|Overall Study|Moved|1
6825917|NCT00113269|10828212|FG002|Overall Study|Moved|0
6825918|NCT00113269|10828213|FG003|Overall Study|Moved|3
6825919|NCT00113269|10828210|FG000|Overall Study|Received pancreas transplant|0
6825920|NCT00113269|10828211|FG001|Overall Study|Received pancreas transplant|0
6825921|NCT00113269|10828212|FG002|Overall Study|Received pancreas transplant|0
6825922|NCT00113269|10828213|FG003|Overall Study|Received pancreas transplant|2
6825923|NCT00113269|10828210|FG000|Overall Study|Withdrew consent, Prednisone initiated|0
6825924|NCT00113269|10828211|FG001|Overall Study|Withdrew consent, Prednisone initiated|0
6825925|NCT00113269|10828212|FG002|Overall Study|Withdrew consent, Prednisone initiated|0
6825926|NCT00113269|10828213|FG003|Overall Study|Withdrew consent, Prednisone initiated|1
6825927|NCT00113269|10828210|FG000|Overall Study|Did not meet eligibility criteria|1
6825928|NCT00113269|10828211|FG001|Overall Study|Did not meet eligibility criteria|0
6825929|NCT00113269|10828212|FG002|Overall Study|Did not meet eligibility criteria|0
6825930|NCT00113269|10828213|FG003|Overall Study|Did not meet eligibility criteria|1
6825931|NCT00113269|10828210|FG000|Overall Study|Unable to return for follow up|2
6825932|NCT00113269|10828211|FG001|Overall Study|Unable to return for follow up|1
6825933|NCT00113269|10828212|FG002|Overall Study|Unable to return for follow up|0
6825934|NCT00113269|10828213|FG003|Overall Study|Unable to return for follow up|0
6825935|NCT00113295|10828225|FG000|Overall Study|Adverse Event|4
6825936|NCT00113295|10828226|FG001|Overall Study|Adverse Event|1
6825937|NCT00113295|10828225|FG000|Overall Study|Unrelated Medical Illness|1
6825938|NCT00113295|10828226|FG001|Overall Study|Unrelated Medical Illness|0
6825939|NCT00113360|10828242|FG000|Overall Study|Adverse Event|3
6825940|NCT00113360|10828242|FG000|Overall Study|Subject required surgery|1
6825941|NCT00113360|10828242|FG000|Overall Study|Did not meet eligibility criteria|3
6825942|NCT00113373|10828246|FG000|Overall Study|Ineligible: wrong primary|1
6825943|NCT00113373|10828246|FG000|Overall Study|Ineligible: second primary|1
6825944|NCT00113373|10828246|FG000|Overall Study|Never Treated|1
6896775|NCT00634933|10915288|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0
6896776|NCT00634933|10915289|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0
6896777|NCT00634933|10915285|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3
6896778|NCT00634933|10915286|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1
6896779|NCT00634933|10915287|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0
6896780|NCT00634933|10915288|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0
6896781|NCT00634933|10915289|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0
6896782|NCT00634933|10915285|FG000|Part A: Baseline to Week 24|Other|1
6896783|NCT00634933|10915286|FG001|Part A: Baseline to Week 24|Other|8
6896784|NCT00634933|10915287|FG002|Part A: Baseline to Week 24|Other|5
6896785|NCT00634933|10915288|FG003|Part A: Baseline to Week 24|Other|0
6896786|NCT00634933|10915289|FG004|Part A: Baseline to Week 24|Other|0
6896787|NCT00634933|10915285|FG000|Between Part A and Part B|Physician Decision|0
6896788|NCT00634933|10915286|FG001|Between Part A and Part B|Physician Decision|1
6896789|NCT00634933|10915287|FG002|Between Part A and Part B|Physician Decision|0
6896790|NCT00634933|10915288|FG003|Between Part A and Part B|Physician Decision|0
6896791|NCT00634933|10915289|FG004|Between Part A and Part B|Physician Decision|0
6896792|NCT00634933|10915285|FG000|Part B: Week 24 to Week 52|Adverse Event|0
6896793|NCT00634933|10915286|FG001|Part B: Week 24 to Week 52|Adverse Event|1
6896794|NCT00634933|10915287|FG002|Part B: Week 24 to Week 52|Adverse Event|1
6896795|NCT00634933|10915288|FG003|Part B: Week 24 to Week 52|Adverse Event|1
6896796|NCT00634933|10915289|FG004|Part B: Week 24 to Week 52|Adverse Event|0
6896797|NCT00634933|10915285|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0
6896798|NCT00634933|10915286|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11
6896799|NCT00634933|10915287|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14
6896800|NCT00634933|10915288|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3
6896801|NCT00634933|10915289|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7
6896802|NCT00634933|10915285|FG000|Part B: Week 24 to Week 52|Physician Decision|0
6896803|NCT00634933|10915286|FG001|Part B: Week 24 to Week 52|Physician Decision|1
6896804|NCT00634933|10915287|FG002|Part B: Week 24 to Week 52|Physician Decision|1
6896805|NCT00634933|10915288|FG003|Part B: Week 24 to Week 52|Physician Decision|0
6896806|NCT00634933|10915289|FG004|Part B: Week 24 to Week 52|Physician Decision|0
6896807|NCT00634933|10915285|FG000|Part B: Week 24 to Week 52|Protocol Violation|0
6896808|NCT00634933|10915286|FG001|Part B: Week 24 to Week 52|Protocol Violation|0
6896809|NCT00634933|10915287|FG002|Part B: Week 24 to Week 52|Protocol Violation|0
6896810|NCT00634933|10915288|FG003|Part B: Week 24 to Week 52|Protocol Violation|0
6896811|NCT00634933|10915289|FG004|Part B: Week 24 to Week 52|Protocol Violation|1
6896812|NCT00634933|10915285|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0
6896813|NCT00634933|10915286|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0
6896814|NCT00634933|10915287|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0
6896815|NCT00634933|10915288|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2
6896816|NCT00634933|10915289|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1
6896817|NCT00634933|10915285|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0
6896818|NCT00634933|10915286|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1
6896819|NCT00634933|10915287|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1
6896820|NCT00634933|10915288|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0
6896821|NCT00634933|10915289|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0
6896822|NCT00634933|10915285|FG000|Part B: Week 24 to Week 52|Other|0
6896823|NCT00634933|10915286|FG001|Part B: Week 24 to Week 52|Other|0
6896824|NCT00634933|10915287|FG002|Part B: Week 24 to Week 52|Other|5
6896825|NCT00634933|10915288|FG003|Part B: Week 24 to Week 52|Other|0
6896826|NCT00634933|10915289|FG004|Part B: Week 24 to Week 52|Other|1
6896827|NCT00635024|10915301|FG000|Overall Study|Adverse Event|1
6825945|NCT00113490|10828262|FG000|Overall Study|Withdrawal by Subject|1
6825946|NCT00113490|10828263|FG001|Overall Study|Withdrawal by Subject|3
6825947|NCT00113490|10828262|FG000|Overall Study|Lost to Follow-up|1
6825948|NCT00113490|10828263|FG001|Overall Study|Lost to Follow-up|0
6825949|NCT00113516|10828269|FG000|Part 1|Adverse Event|6
6825950|NCT00113516|10828270|FG001|Part 1|Adverse Event|0
6825951|NCT00113516|10828269|FG000|Part 1|Death|3
6825952|NCT00113516|10828270|FG001|Part 1|Death|0
6825953|NCT00113516|10828269|FG000|Part 1|Other|3
6825954|NCT00113516|10828270|FG001|Part 1|Other|0
6825955|NCT00113516|10828269|FG000|Part 1|Withdrawal by Subject|2
6825956|NCT00113516|10828270|FG001|Part 1|Withdrawal by Subject|0
6825957|NCT00113516|10828269|FG000|Part 1|Lack of Efficacy|2
6825958|NCT00113516|10828270|FG001|Part 1|Lack of Efficacy|0
6825959|NCT00113516|10828269|FG000|Part 1|Did Not Meet Entrance Criteria|1
6825960|NCT00113516|10828270|FG001|Part 1|Did Not Meet Entrance Criteria|0
6825961|NCT00113516|10828269|FG000|Part 1|Laboratory Abnormality|1
6825962|NCT00113516|10828270|FG001|Part 1|Laboratory Abnormality|0
6825963|NCT00113516|10828269|FG000|Part 1|Ongoing|1
6825964|NCT00113516|10828270|FG001|Part 1|Ongoing|0
6825965|NCT00113516|10828269|FG000|Part 1|Missing|65
6825966|NCT00113516|10828270|FG001|Part 1|Missing|0
6825967|NCT00113516|10828269|FG000|Part 2|Adverse Event|0
6825968|NCT00113516|10828270|FG001|Part 2|Adverse Event|16
6825969|NCT00113516|10828269|FG000|Part 2|Death|0
6825970|NCT00113516|10828270|FG001|Part 2|Death|5
6825971|NCT00113516|10828269|FG000|Part 2|Lack of Efficacy|0
6825972|NCT00113516|10828270|FG001|Part 2|Lack of Efficacy|37
6825973|NCT00113516|10828269|FG000|Part 2|Withdrawal by Subject|0
6825974|NCT00113516|10828270|FG001|Part 2|Withdrawal by Subject|3
6825975|NCT00113516|10828269|FG000|Part 2|Other|0
6825976|NCT00113516|10828270|FG001|Part 2|Other|3
6825977|NCT00113516|10828269|FG000|Part 2|Laboratory Abnormality|0
6825978|NCT00113516|10828270|FG001|Part 2|Laboratory Abnormality|1
6825979|NCT00113516|10828269|FG000|Part 2|Ongoing|0
6825980|NCT00113516|10828270|FG001|Part 2|Ongoing|1
6825981|NCT00113529|10828276|FG000|Overall Study|Adverse Event|4
6825982|NCT00113529|10828276|FG000|Overall Study|Lack of Efficacy|20
6825983|NCT00113529|10828276|FG000|Overall Study|Decision of sponsor|6
6825984|NCT00113529|10828276|FG000|Overall Study|Withdrawal by Subject|4
6825985|NCT00113555|10828280|FG000|Overall Study|Baseline Failure|59
6825986|NCT00113555|10828280|FG000|Overall Study|Permanently Explanted|7
6825987|NCT00113555|10828280|FG000|Overall Study|Death|1
6825988|NCT00113555|10828280|FG000|Overall Study|Missed Followup|4
6825989|NCT00113555|10828280|FG000|Overall Study|Lost to Follow-up|8
6825990|NCT00113568|10828285|FG000|Overall Study|Adverse Event|97
6825991|NCT00113568|10828285|FG000|Overall Study|Death|1
6825992|NCT00113568|10828285|FG000|Overall Study|Lack of Efficacy|30
6825993|NCT00113568|10828285|FG000|Overall Study|Lost to Follow-up|156
6825994|NCT00113568|10828285|FG000|Overall Study|Protocol Violation|32
6825995|NCT00113568|10828285|FG000|Overall Study|Withdrawal by Subject|117
6825996|NCT00113568|10828285|FG000|Overall Study|Other|112
6825997|NCT00113607|10828291|FG000|Overall Study|Adverse Event|40
6825998|NCT00113607|10828292|FG001|Overall Study|Adverse Event|71
6825999|NCT00113607|10828291|FG000|Overall Study|Death|8
6826000|NCT00113607|10828292|FG001|Overall Study|Death|8
6826001|NCT00113607|10828291|FG000|Overall Study|Withdrawal by Subject|50
6826002|NCT00113607|10828292|FG001|Overall Study|Withdrawal by Subject|58
6826003|NCT00113607|10828291|FG000|Overall Study|Lost to Follow-up|0
6826004|NCT00113607|10828292|FG001|Overall Study|Lost to Follow-up|2
6826005|NCT00113607|10828291|FG000|Overall Study|Disease Progression|180
6826006|NCT00113607|10828292|FG001|Overall Study|Disease Progression|142
6826007|NCT00113607|10828291|FG000|Overall Study|Complete Response (Confirmed)|14
6826008|NCT00113607|10828292|FG001|Overall Study|Complete Response (Confirmed)|24
6826009|NCT00113607|10828291|FG000|Overall Study|Other|43
6826010|NCT00113607|10828292|FG001|Overall Study|Other|32
6826011|NCT00113763|10828301|FG000|Overall Study|Adverse Event|5
6826012|NCT00113763|10828302|FG001|Overall Study|Adverse Event|2
6826013|NCT00113763|10828301|FG000|Overall Study|Disease Progression|28
6826014|NCT00113763|10828302|FG001|Overall Study|Disease Progression|14
6826015|NCT00113763|10828301|FG000|Overall Study|Lost to Follow-up|10
6826016|NCT00113763|10828302|FG001|Overall Study|Lost to Follow-up|0
6826017|NCT00113763|10828301|FG000|Overall Study|Withdrawal by Subject|1
6826018|NCT00113763|10828302|FG001|Overall Study|Withdrawal by Subject|4
6826019|NCT00113763|10828301|FG000|Overall Study|Other|27
6826020|NCT00113763|10828302|FG001|Overall Study|Other|6
6826021|NCT00113763|10828301|FG000|Overall Study|Non-compliance|1
6826022|NCT00113763|10828302|FG001|Overall Study|Non-compliance|0
6826023|NCT00113763|10828301|FG000|Overall Study|Ongoing|1
6826024|NCT00113763|10828302|FG001|Overall Study|Ongoing|0
6826025|NCT00113841|10828311|FG000|Overall Study|Disease progression|0
6826026|NCT00113841|10828312|FG001|Overall Study|Disease progression|2
6826027|NCT00113841|10828311|FG000|Overall Study|Non-compliant|1
6826028|NCT00113841|10828312|FG001|Overall Study|Non-compliant|0
6826029|NCT00114127|10828367|FG000|Overall Study|Adverse Event|2
6826030|NCT00114127|10828368|FG001|Overall Study|Adverse Event|1
6826031|NCT00114127|10828367|FG000|Overall Study|Lost to Follow-up|1
6826032|NCT00114127|10828368|FG001|Overall Study|Lost to Follow-up|0
6826033|NCT00114127|10828367|FG000|Overall Study|Withdrawal by Subject|1
6826034|NCT00114127|10828368|FG001|Overall Study|Withdrawal by Subject|3
6826035|NCT00114166|10828376|FG000|Overall Study|Wrong primary|0
6826036|NCT00114166|10828377|FG001|Overall Study|Wrong primary|1
6826037|NCT00114218|10828385|FG000|Overall Study|Wrong Cell Type|2
6826038|NCT00114218|10828385|FG000|Overall Study|Wrong Primary|1
6826039|NCT00114218|10828385|FG000|Overall Study|Never Treated|1
6826040|NCT00114231|10828391|FG000|Overall Study|No consent|2
6826041|NCT00114231|10828392|FG001|Overall Study|No consent|0
6826042|NCT00114231|10828391|FG000|Overall Study|QARC requirement not met|1
6826043|NCT00114231|10828392|FG001|Overall Study|QARC requirement not met|0
6826044|NCT00114231|10828391|FG000|Overall Study|Suspected metastatic disease|1
6826045|NCT00114231|10828392|FG001|Overall Study|Suspected metastatic disease|0
6826046|NCT00114231|10828391|FG000|Overall Study|No adenocarcinoma|1
6826047|NCT00114231|10828392|FG001|Overall Study|No adenocarcinoma|0
6826048|NCT00114231|10828391|FG000|Overall Study|Low creatinine clearance|0
6826049|NCT00114231|10828392|FG001|Overall Study|Low creatinine clearance|1
6826050|NCT00114231|10828391|FG000|Overall Study|Tumor size > 4cm|1
6826051|NCT00114231|10828392|FG001|Overall Study|Tumor size > 4cm|0
6826052|NCT00114231|10828391|FG000|Overall Study|Tumor fixed on digital exam|0
6826053|NCT00114231|10828392|FG001|Overall Study|Tumor fixed on digital exam|1
6826054|NCT00114231|10828391|FG000|Overall Study|No Absolute Neutrophil Count|2
6826055|NCT00114231|10828392|FG001|Overall Study|No Absolute Neutrophil Count|0
6826056|NCT00114231|10828391|FG000|Overall Study|Biopsy done after registration|1
6826057|NCT00114231|10828392|FG001|Overall Study|Biopsy done after registration|0
6826058|NCT00114244|10828399|FG000|Overall Study|Adverse Event|2
6826059|NCT00114244|10828400|FG001|Overall Study|Adverse Event|5
6826060|NCT00114244|10828399|FG000|Overall Study|Withdrawal by Subject|0
6826061|NCT00114244|10828400|FG001|Overall Study|Withdrawal by Subject|2
6826062|NCT00114530|10828434|FG000|Overall Study|Death|3
6826063|NCT00114530|10828435|FG001|Overall Study|Death|11
6826064|NCT00114530|10828434|FG000|Overall Study|Lost to Follow-up|1
6826065|NCT00114530|10828435|FG001|Overall Study|Lost to Follow-up|1
6826066|NCT00114530|10828434|FG000|Overall Study|Physician Decision|1
6826067|NCT00114530|10828435|FG001|Overall Study|Physician Decision|1
6826068|NCT00114530|10828434|FG000|Overall Study|Withdrawal by Subject|2
6826069|NCT00114530|10828435|FG001|Overall Study|Withdrawal by Subject|6
6826070|NCT00114530|10828434|FG000|Overall Study|Breast Cancer|1
6826071|NCT00114530|10828435|FG001|Overall Study|Breast Cancer|0
6826072|NCT00114530|10828434|FG000|Overall Study|Subject decision after endpoint failure|0
6826073|NCT00114530|10828435|FG001|Overall Study|Subject decision after endpoint failure|1
6826074|NCT00114530|10828434|FG000|Overall Study|Ineligible|1
6826075|NCT00114530|10828435|FG001|Overall Study|Ineligible|0
6826076|NCT00114634|10828445|FG000|Overall Study|failure to return forms|3
6826077|NCT00114738|10828451|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1
6826078|NCT00114738|10828452|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0
6826079|NCT00114738|10828453|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0
6826080|NCT00114738|10828451|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1
6826081|NCT00114738|10828452|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0
6826082|NCT00114738|10828453|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0
6826083|NCT00114738|10828451|FG000|Screening for Randomization|Neuropathy|17
6826084|NCT00114738|10828452|FG001|Screening for Randomization|Neuropathy|0
6826085|NCT00114738|10828453|FG002|Screening for Randomization|Neuropathy|0
6826086|NCT00114738|10828451|FG000|Screening for Randomization|Progressive disease|2
6826087|NCT00114738|10828452|FG001|Screening for Randomization|Progressive disease|0
6826088|NCT00114738|10828453|FG002|Screening for Randomization|Progressive disease|0
6826089|NCT00114738|10828451|FG000|Screening for Randomization|CNS Hemorrhage|1
6826090|NCT00114738|10828452|FG001|Screening for Randomization|CNS Hemorrhage|0
6826091|NCT00114738|10828453|FG002|Screening for Randomization|CNS Hemorrhage|0
6826092|NCT00114738|10828451|FG000|Screening for Randomization|Other|1
6826093|NCT00114738|10828452|FG001|Screening for Randomization|Other|0
6826094|NCT00114738|10828453|FG002|Screening for Randomization|Other|0
6826095|NCT00114777|10828463|FG000|Randomization to Month 36|Death|10
6826096|NCT00114777|10828464|FG001|Randomization to Month 36|Death|4
6826097|NCT00114777|10828465|FG002|Randomization to Month 36|Death|3
6826098|NCT00114777|10828463|FG000|Randomization to Month 36|No Longer Met Study Criteria|0
6826099|NCT00114777|10828464|FG001|Randomization to Month 36|No Longer Met Study Criteria|0
6826100|NCT00114777|10828465|FG002|Randomization to Month 36|No Longer Met Study Criteria|2
6826101|NCT00114777|10828463|FG000|Randomization to Month 36|Lack of Efficacy|19
6826102|NCT00114777|10828464|FG001|Randomization to Month 36|Lack of Efficacy|15
6826103|NCT00114777|10828465|FG002|Randomization to Month 36|Lack of Efficacy|17
6826104|NCT00114777|10828463|FG000|Randomization to Month 36|Poor or Non-Compliance|0
6826105|NCT00114777|10828464|FG001|Randomization to Month 36|Poor or Non-Compliance|0
6826106|NCT00114777|10828465|FG002|Randomization to Month 36|Poor or Non-Compliance|1
6826107|NCT00114777|10828463|FG000|Randomization to Month 36|Adverse Event|34
6826108|NCT00114777|10828464|FG001|Randomization to Month 36|Adverse Event|35
6826109|NCT00114777|10828465|FG002|Randomization to Month 36|Adverse Event|44
6826110|NCT00114777|10828463|FG000|Randomization to Month 36|Withdrawal by Subject|3
6826111|NCT00114777|10828464|FG001|Randomization to Month 36|Withdrawal by Subject|4
6826112|NCT00114777|10828465|FG002|Randomization to Month 36|Withdrawal by Subject|5
6826113|NCT00114777|10828463|FG000|Randomization to Month 36|Other|9
6826114|NCT00114777|10828464|FG001|Randomization to Month 36|Other|3
6826115|NCT00114777|10828465|FG002|Randomization to Month 36|Other|12
6826116|NCT00114777|10828463|FG000|Long-Term Extension to Month 84|Death|8
6826117|NCT00114777|10828464|FG001|Long-Term Extension to Month 84|Death|13
6826118|NCT00114777|10828465|FG002|Long-Term Extension to Month 84|Death|7
6826119|NCT00114777|10828463|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
6826120|NCT00114777|10828464|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0
6826121|NCT00114777|10828465|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
6826122|NCT00114777|10828463|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1
6826123|NCT00114777|10828464|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0
6826124|NCT00114777|10828465|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1
6826125|NCT00114777|10828463|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1
6826126|NCT00114777|10828464|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1
6826127|NCT00114777|10828465|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3
6826128|NCT00114777|10828463|FG000|Long-Term Extension to Month 84|Adverse Event|15
6826129|NCT00114777|10828464|FG001|Long-Term Extension to Month 84|Adverse Event|14
6826130|NCT00114777|10828465|FG002|Long-Term Extension to Month 84|Adverse Event|7
6826131|NCT00114777|10828463|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2
6826132|NCT00114777|10828464|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1
6826133|NCT00114777|10828465|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6
6826134|NCT00114777|10828463|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0
6826135|NCT00114777|10828464|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0
6826136|NCT00114777|10828465|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2
6826137|NCT00114777|10828463|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
6826138|NCT00114777|10828464|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
6826139|NCT00114777|10828465|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1
6826140|NCT00114777|10828463|FG000|Long-Term Extension to Month 84|Other|2
6826141|NCT00114777|10828464|FG001|Long-Term Extension to Month 84|Other|0
6826142|NCT00114777|10828465|FG002|Long-Term Extension to Month 84|Other|2
6826143|NCT00114959|10828474|FG000|Overall Study|Lack of Efficacy|6
6826144|NCT00114959|10828474|FG000|Overall Study|Physician Decision|1
6826145|NCT00114959|10828474|FG000|Overall Study|Death|1
6826146|NCT00114972|10828480|FG000|Overall Study|Withdrawal by Subject|40
6826147|NCT00114972|10828481|FG001|Overall Study|Withdrawal by Subject|7
6826148|NCT00114972|10828480|FG000|Overall Study|Lost to Follow-up|8
6826149|NCT00114972|10828481|FG001|Overall Study|Lost to Follow-up|5
6826150|NCT00115037|10828489|FG000|Phase1|Lost to Follow-up|16
6826151|NCT00115037|10828490|FG001|Phase1|Lost to Follow-up|23
6826152|NCT00115037|10828491|FG002|Phase1|Lost to Follow-up|0
6826153|NCT00115037|10828492|FG003|Phase1|Lost to Follow-up|0
6826154|NCT00115037|10828493|FG004|Phase1|Lost to Follow-up|0
6826155|NCT00115037|10828494|FG005|Phase1|Lost to Follow-up|0
6826156|NCT00115037|10828489|FG000|Phase1|Withdrawal by Subject|9
6826157|NCT00115037|10828490|FG001|Phase1|Withdrawal by Subject|4
6826158|NCT00115037|10828491|FG002|Phase1|Withdrawal by Subject|0
6826159|NCT00115037|10828492|FG003|Phase1|Withdrawal by Subject|0
6826160|NCT00115037|10828493|FG004|Phase1|Withdrawal by Subject|0
6826161|NCT00115037|10828494|FG005|Phase1|Withdrawal by Subject|0
6826162|NCT00115037|10828489|FG000|Phase2|Death|0
6826163|NCT00115037|10828490|FG001|Phase2|Death|0
6826164|NCT00115037|10828491|FG002|Phase2|Death|1
6826165|NCT00115037|10828492|FG003|Phase2|Death|0
6826166|NCT00115037|10828493|FG004|Phase2|Death|0
6826167|NCT00115037|10828494|FG005|Phase2|Death|1
6826168|NCT00115037|10828489|FG000|Phase2|Withdrawal by Subject|0
6826169|NCT00115037|10828490|FG001|Phase2|Withdrawal by Subject|0
6826170|NCT00115037|10828491|FG002|Phase2|Withdrawal by Subject|2
6826171|NCT00115037|10828492|FG003|Phase2|Withdrawal by Subject|1
6826172|NCT00115037|10828493|FG004|Phase2|Withdrawal by Subject|2
6826173|NCT00115037|10828494|FG005|Phase2|Withdrawal by Subject|1
6826174|NCT00115037|10828489|FG000|Phase2|Lost to Follow-up|0
6826175|NCT00115037|10828490|FG001|Phase2|Lost to Follow-up|0
6826176|NCT00115037|10828491|FG002|Phase2|Lost to Follow-up|12
6826177|NCT00115037|10828492|FG003|Phase2|Lost to Follow-up|14
6826178|NCT00115037|10828493|FG004|Phase2|Lost to Follow-up|4
6826179|NCT00115037|10828494|FG005|Phase2|Lost to Follow-up|10
6826180|NCT00115063|10828510|FG000|Overall Study|Lost to Follow-up|98
6826181|NCT00115063|10828511|FG001|Overall Study|Lost to Follow-up|104
6826182|NCT00115063|10828510|FG000|Overall Study|Death|1
6826183|NCT00115063|10828511|FG001|Overall Study|Death|0
6826184|NCT00115336|10828535|FG000|Overall Study|Hospital discharge before study drug|0
6826185|NCT00115336|10828536|FG001|Overall Study|Hospital discharge before study drug|1
6826186|NCT00115349|10828546|FG000|Overall Study|Study closed due to low enrollment.|11
6826187|NCT00115349|10828547|FG001|Overall Study|Study closed due to low enrollment.|9
6826188|NCT00115739|10828553|FG000|Overall Study|Lost to Follow-up|3
6826189|NCT00115765|10828563|FG000|Overall Study|Withdrawal by Subject|22
6826190|NCT00115765|10828564|FG001|Overall Study|Withdrawal by Subject|53
6826191|NCT00115765|10828565|FG002|Overall Study|Withdrawal by Subject|76
6826192|NCT00115765|10828566|FG003|Overall Study|Withdrawal by Subject|15
6826193|NCT00115765|10828563|FG000|Overall Study|Physician Decision|4
6826194|NCT00115765|10828564|FG001|Overall Study|Physician Decision|15
6826195|NCT00115765|10828565|FG002|Overall Study|Physician Decision|18
6826196|NCT00115765|10828566|FG003|Overall Study|Physician Decision|13
6826197|NCT00115765|10828563|FG000|Overall Study|Lost to Follow-up|3
6826198|NCT00115765|10828564|FG001|Overall Study|Lost to Follow-up|20
6826199|NCT00115765|10828565|FG002|Overall Study|Lost to Follow-up|18
6826200|NCT00115765|10828566|FG003|Overall Study|Lost to Follow-up|1
6826201|NCT00115765|10828563|FG000|Overall Study|Other|6
6826202|NCT00115765|10828564|FG001|Overall Study|Other|12
6826203|NCT00115765|10828565|FG002|Overall Study|Other|9
6826204|NCT00115765|10828566|FG003|Overall Study|Other|2
6826205|NCT00115778|10828574|FG000|Overall Study|Withdrawal by Subject|0
6826206|NCT00115778|10828575|FG001|Overall Study|Withdrawal by Subject|1
6826207|NCT00115804|10828581|FG000|Overall Study|Adverse Event|2
6826208|NCT00115934|10828600|FG000|Overall Study|Lost to Follow-up|1
6826209|NCT00115934|10828601|FG001|Overall Study|Lost to Follow-up|0
6826210|NCT00115934|10828600|FG000|Overall Study|Did not receive intervention|3
6826211|NCT00115934|10828601|FG001|Overall Study|Did not receive intervention|2
6826212|NCT00116168|10828611|FG000|Overall Study|Lost to Follow-up|6
6826213|NCT00116168|10828612|FG001|Overall Study|Lost to Follow-up|5
6826214|NCT00116168|10828613|FG002|Overall Study|Lost to Follow-up|0
6826215|NCT00116168|10828614|FG003|Overall Study|Lost to Follow-up|0
6826216|NCT00116272|10828635|FG000|Overall Study|Lost to Follow-up|11
6826217|NCT00116272|10828636|FG001|Overall Study|Lost to Follow-up|6
6826218|NCT00116428|10828657|FG000|Overall Study|Withdrawal by Subject|2
6826219|NCT00116428|10828658|FG001|Overall Study|Withdrawal by Subject|5
6826220|NCT00116428|10828657|FG000|Overall Study|Did not meet inclusion criteria|1
6826221|NCT00116428|10828658|FG001|Overall Study|Did not meet inclusion criteria|0
6826222|NCT00116558|10828670|FG000|Overall Study|Death|11
6826223|NCT00116558|10828671|FG001|Overall Study|Death|5
6826224|NCT00116558|10828672|FG002|Overall Study|Death|3
6826225|NCT00116558|10828670|FG000|Overall Study|Withdrawal by Subject|17
6826226|NCT00116558|10828671|FG001|Overall Study|Withdrawal by Subject|3
6826227|NCT00116558|10828672|FG002|Overall Study|Withdrawal by Subject|12
6826228|NCT00116558|10828670|FG000|Overall Study|disease progression|3
6826229|NCT00116558|10828671|FG001|Overall Study|disease progression|7
6826230|NCT00116558|10828672|FG002|Overall Study|disease progression|18
6826231|NCT00116584|10828681|FG000|Overall Study|Withdrawal by Subject|1
6826232|NCT00116584|10828682|FG001|Overall Study|Withdrawal by Subject|0
6826233|NCT00116584|10828681|FG000|Overall Study|Protocol Violation|1
6826234|NCT00116584|10828682|FG001|Overall Study|Protocol Violation|1
6826235|NCT00116649|10828688|FG000|Overall Study|Adverse Event|20
6826236|NCT00116649|10828688|FG000|Overall Study|Lack of Efficacy|1
6826237|NCT00116649|10828688|FG000|Overall Study|Lost to Follow-up|32
6826238|NCT00116649|10828688|FG000|Overall Study|Withdrawal by Subject|68
6826239|NCT00116649|10828688|FG000|Overall Study|Local Skin Reaction|9
6826240|NCT00116649|10828688|FG000|Overall Study|Various Reasons|18
6826241|NCT00116649|10828688|FG000|Overall Study|Protocol Specified|7
6826242|NCT00116688|10828694|FG000|Overall Study|Protocol deviation|1
6826243|NCT00116688|10828695|FG001|Overall Study|Protocol deviation|0
6826244|NCT00116688|10828694|FG000|Overall Study|Noncompliance|3
6826245|NCT00116688|10828695|FG001|Overall Study|Noncompliance|1
6826246|NCT00116688|10828694|FG000|Overall Study|Adverse Event|11
6826247|NCT00116688|10828695|FG001|Overall Study|Adverse Event|0
6826248|NCT00116688|10828694|FG000|Overall Study|Withdrawal by Subject|26
6826249|NCT00116688|10828695|FG001|Overall Study|Withdrawal by Subject|2
6826250|NCT00116688|10828694|FG000|Overall Study|Requirement for alternative therapy|11
6826251|NCT00116688|10828695|FG001|Overall Study|Requirement for alternative therapy|1
6826252|NCT00116688|10828694|FG000|Overall Study|Physician Decision|7
6826253|NCT00116688|10828695|FG001|Overall Study|Physician Decision|0
6826254|NCT00116688|10828694|FG000|Overall Study|Lost to Follow-up|3
6826255|NCT00116688|10828695|FG001|Overall Study|Lost to Follow-up|0
6826256|NCT00116688|10828694|FG000|Overall Study|Death|15
6826257|NCT00116688|10828695|FG001|Overall Study|Death|0
6826258|NCT00116688|10828694|FG000|Overall Study|Protocol-specified criteria|3
6826259|NCT00116688|10828695|FG001|Overall Study|Protocol-specified criteria|0
6826260|NCT00116688|10828694|FG000|Overall Study|Pregnancy|1
6826261|NCT00116688|10828695|FG001|Overall Study|Pregnancy|0
6826262|NCT00116688|10828694|FG000|Overall Study|Other|11
6826263|NCT00116688|10828695|FG001|Overall Study|Other|0
6826264|NCT00116753|10828704|FG000|Overall Study|Adverse Event|16
6826265|NCT00116753|10828705|FG001|Overall Study|Adverse Event|10
6826266|NCT00116753|10828706|FG002|Overall Study|Adverse Event|7
6826267|NCT00116753|10828704|FG000|Overall Study|Withdrawal by Subject|11
6826268|NCT00116753|10828705|FG001|Overall Study|Withdrawal by Subject|12
6826269|NCT00116753|10828706|FG002|Overall Study|Withdrawal by Subject|8
6826270|NCT00116753|10828704|FG000|Overall Study|Lost to Follow-up|0
6826271|NCT00116753|10828705|FG001|Overall Study|Lost to Follow-up|2
6826272|NCT00116753|10828706|FG002|Overall Study|Lost to Follow-up|1
6826273|NCT00116753|10828704|FG000|Overall Study|Protocol Violation|0
6826274|NCT00116753|10828705|FG001|Overall Study|Protocol Violation|0
6978678|NCT01214629|11032175|FG003|Overall Study|Withdrawal by Subject|0
6826275|NCT00116753|10828706|FG002|Overall Study|Protocol Violation|1
6826276|NCT00116753|10828704|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1
6826277|NCT00116753|10828705|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1
6826278|NCT00116753|10828706|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3
6826279|NCT00116753|10828704|FG000|Overall Study|Disease Progression|3
6826280|NCT00116753|10828705|FG001|Overall Study|Disease Progression|4
6826281|NCT00116753|10828706|FG002|Overall Study|Disease Progression|3
6826282|NCT00116753|10828704|FG000|Overall Study|Abnormal Echocardiogram|0
6826283|NCT00116753|10828705|FG001|Overall Study|Abnormal Echocardiogram|0
6826284|NCT00116753|10828706|FG002|Overall Study|Abnormal Echocardiogram|1
6826285|NCT00116753|10828704|FG000|Overall Study|Progressive Parkinson's Disease|1
6826286|NCT00116753|10828705|FG001|Overall Study|Progressive Parkinson's Disease|0
6826287|NCT00116753|10828706|FG002|Overall Study|Progressive Parkinson's Disease|0
6826288|NCT00116753|10828704|FG000|Overall Study|Dosing Error|0
6826289|NCT00116753|10828705|FG001|Overall Study|Dosing Error|1
6826290|NCT00116753|10828706|FG002|Overall Study|Dosing Error|0
6826291|NCT00116779|10828716|FG000|Overall Study|Adverse Event|4
6826292|NCT00116779|10828717|FG001|Overall Study|Adverse Event|2
6826293|NCT00116779|10828716|FG000|Overall Study|Protocol Violation|1
6826294|NCT00116779|10828717|FG001|Overall Study|Protocol Violation|4
6826295|NCT00116779|10828716|FG000|Overall Study|Withdrawal by Subject|4
6826296|NCT00116779|10828717|FG001|Overall Study|Withdrawal by Subject|1
6826297|NCT00116779|10828716|FG000|Overall Study|Inadequate testosterone suppression|7
6826298|NCT00116779|10828717|FG001|Overall Study|Inadequate testosterone suppression|9
6826299|NCT00116779|10828716|FG000|Overall Study|Physician Decision|3
6826300|NCT00116779|10828717|FG001|Overall Study|Physician Decision|1
6826301|NCT00116779|10828716|FG000|Overall Study|Elevated PSA levels|2
6826302|NCT00116779|10828717|FG001|Overall Study|Elevated PSA levels|2
6826303|NCT00116805|10828725|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6
6826304|NCT00116805|10828726|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2
6826305|NCT00116805|10828725|FG000|Double-blind Period Through Week 48|Protocol Violation|1
6826306|NCT00116805|10828726|FG001|Double-blind Period Through Week 48|Protocol Violation|1
6826307|NCT00116805|10828725|FG000|Double-blind Period Through Week 48|Withdrew Consent|4
6826308|NCT00116805|10828726|FG001|Double-blind Period Through Week 48|Withdrew Consent|2
6826309|NCT00116805|10828725|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1
6826310|NCT00116805|10828726|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0
6826311|NCT00116805|10828725|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2
6826312|NCT00116805|10828726|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0
6826313|NCT00116805|10828725|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2
6826314|NCT00116805|10828726|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0
6826315|NCT00116805|10828725|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
6826316|NCT00116805|10828726|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0
6826317|NCT00116805|10828725|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2
6826318|NCT00116805|10828726|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0
6826319|NCT00116805|10828725|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2
6826320|NCT00116805|10828726|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1
6826321|NCT00116805|10828725|FG000|Open-label Period Weeks 97 - 144|Completed Study|1
6826322|NCT00116805|10828726|FG001|Open-label Period Weeks 97 - 144|Completed Study|0
6826323|NCT00116805|10828725|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2
6826324|NCT00116805|10828726|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0
6826325|NCT00116805|10828725|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5
6826326|NCT00116805|10828726|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2
6826327|NCT00116805|10828725|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0
6826328|NCT00116805|10828726|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1
6826329|NCT00116805|10828725|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2
6826330|NCT00116805|10828726|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3
6826331|NCT00116805|10828725|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1
6826332|NCT00116805|10828726|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3
6826333|NCT00116805|10828725|FG000|Open-label Period Weeks 145 - 192|Completed Study|1
6826334|NCT00116805|10828726|FG001|Open-label Period Weeks 145 - 192|Completed Study|1
6826335|NCT00116805|10828725|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2
6826336|NCT00116805|10828726|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0
6826337|NCT00116805|10828725|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3
6826338|NCT00116805|10828726|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1
6826339|NCT00116805|10828725|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1
6826340|NCT00116805|10828726|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0
6826341|NCT00116805|10828725|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0
6826342|NCT00116805|10828726|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1
6826343|NCT00116805|10828725|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0
6826344|NCT00116805|10828726|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1
6826345|NCT00116805|10828725|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3
6826346|NCT00116805|10828726|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2
6826347|NCT00116805|10828725|FG000|Open-label Period Weeks 193 - 240|Completed Study|0
6826348|NCT00116805|10828726|FG001|Open-label Period Weeks 193 - 240|Completed Study|1
6826349|NCT00116805|10828725|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1
6826350|NCT00116805|10828726|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0
6826351|NCT00116805|10828725|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3
6826352|NCT00116805|10828726|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0
6826353|NCT00116805|10828725|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
6826354|NCT00116805|10828726|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
6826355|NCT00116805|10828725|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7
6826356|NCT00116805|10828726|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1
6826357|NCT00116805|10828725|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2
6826358|NCT00116805|10828726|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
6826359|NCT00116805|10828725|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4
6826360|NCT00116805|10828726|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0
6826361|NCT00116805|10828725|FG000|Open-label Period Weeks 289 - 336|Completed Study|0
6826362|NCT00116805|10828726|FG001|Open-label Period Weeks 289 - 336|Completed Study|1
6826363|NCT00116805|10828725|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3
6826364|NCT00116805|10828726|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2
6826365|NCT00116805|10828725|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
6826366|NCT00116805|10828726|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
6826367|NCT00116805|10828725|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0
6826368|NCT00116805|10828726|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1
6826369|NCT00116805|10828725|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0
6826370|NCT00116805|10828726|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1
6826371|NCT00116805|10828725|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0
6826372|NCT00116805|10828726|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1
6826373|NCT00116805|10828725|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2
6826374|NCT00116805|10828726|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0
6826375|NCT00116805|10828725|FG000|Open-label Period Weeks 337 - 384|Completed Study|1
6826376|NCT00116805|10828726|FG001|Open-label Period Weeks 337 - 384|Completed Study|0
6826377|NCT00116805|10828725|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1
6826378|NCT00116805|10828726|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0
6826379|NCT00116805|10828725|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2
6826380|NCT00116805|10828726|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0
6826381|NCT00116805|10828725|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1
6826382|NCT00116805|10828726|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0
6826383|NCT00116805|10828725|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3
6826384|NCT00116805|10828726|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1
6826385|NCT00116805|10828725|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1
6826386|NCT00116805|10828726|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0
6826387|NCT00116805|10828725|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1
6826388|NCT00116805|10828726|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0
6826389|NCT00116805|10828725|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1
6826390|NCT00116805|10828726|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0
6826391|NCT00116805|10828725|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3
6826392|NCT00116805|10828726|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0
6826393|NCT00116831|10828743|FG000|Overall Study|Adverse Event|14
6826394|NCT00116831|10828744|FG001|Overall Study|Adverse Event|16
6826395|NCT00116831|10828743|FG000|Overall Study|Baseline IVUS determined unevaluable|12
6826396|NCT00116831|10828744|FG001|Overall Study|Baseline IVUS determined unevaluable|11
6826397|NCT00116831|10828743|FG000|Overall Study|Lost to Follow-up|8
6826398|NCT00116831|10828744|FG001|Overall Study|Lost to Follow-up|6
6826399|NCT00116831|10828743|FG000|Overall Study|Protocol Violation|3
6826400|NCT00116831|10828744|FG001|Overall Study|Protocol Violation|6
6826401|NCT00116831|10828743|FG000|Overall Study|Hypoglycaemic events|1
6826402|NCT00116831|10828744|FG001|Overall Study|Hypoglycaemic events|0
6826403|NCT00116831|10828743|FG000|Overall Study|Low haemoglobin on screening|1
6826404|NCT00116831|10828744|FG001|Overall Study|Low haemoglobin on screening|0
6826405|NCT00116831|10828743|FG000|Overall Study|Withdrawn investigational product|1
6826406|NCT00116831|10828744|FG001|Overall Study|Withdrawn investigational product|0
6826407|NCT00116831|10828743|FG000|Overall Study|Withdrawal by Subject|32
6826408|NCT00116831|10828744|FG001|Overall Study|Withdrawal by Subject|32
6826409|NCT00116831|10828743|FG000|Overall Study|Insufficient therapeutic effect|0
6826410|NCT00116831|10828744|FG001|Overall Study|Insufficient therapeutic effect|1
6826411|NCT00116831|10828743|FG000|Overall Study|Missing data for participant|1
6826412|NCT00116831|10828744|FG001|Overall Study|Missing data for participant|0
6826413|NCT00116844|10828752|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
6826414|NCT00116844|10828753|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
6826415|NCT00116844|10828752|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0
6826416|NCT00116844|10828753|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1
6826417|NCT00116844|10828752|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5
6826418|NCT00116844|10828753|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0
6826419|NCT00116844|10828752|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1
6826420|NCT00116844|10828753|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1
6826421|NCT00116844|10828752|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1
6826422|NCT00116844|10828753|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0
6826423|NCT00116844|10828752|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2
6826424|NCT00116844|10828753|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1
6826425|NCT00116844|10828752|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0
6826426|NCT00116844|10828753|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2
6826427|NCT00116844|10828752|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0
6826428|NCT00116844|10828753|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1
6826429|NCT00116844|10828752|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
6826430|NCT00116844|10828753|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
6826431|NCT00117156|10828785|FG000|Overall Study|Adverse Event|9
6826432|NCT00117156|10828785|FG000|Overall Study|Physician Decision|1
6826433|NCT00117156|10828785|FG000|Overall Study|Trt for Pre-Exist Second Primary|1
6826434|NCT00117286|10828791|FG000|Overall Study|Adverse Event|12
6826435|NCT00117286|10828792|FG001|Overall Study|Adverse Event|6
6826436|NCT00117286|10828791|FG000|Overall Study|Lost to Follow-up|2
6826437|NCT00117286|10828792|FG001|Overall Study|Lost to Follow-up|0
6826438|NCT00117286|10828791|FG000|Overall Study|Protocol Violation|3
6826439|NCT00117286|10828792|FG001|Overall Study|Protocol Violation|3
6826440|NCT00117286|10828791|FG000|Overall Study|Withdrawal by Subject|6
6826441|NCT00117286|10828792|FG001|Overall Study|Withdrawal by Subject|2
6826442|NCT00117286|10828791|FG000|Overall Study|Physician Decision|3
6826443|NCT00117286|10828792|FG001|Overall Study|Physician Decision|7
6826444|NCT00117286|10828791|FG000|Overall Study|Lack of Efficacy|2
6826445|NCT00117286|10828792|FG001|Overall Study|Lack of Efficacy|1
6826446|NCT00117286|10828791|FG000|Overall Study|Research site closing|0
6826447|NCT00117286|10828792|FG001|Overall Study|Research site closing|2
6826448|NCT00117312|10828802|FG000|Overall Study|Testosterone >1.0 ng/mL|9
6826449|NCT00117312|10828803|FG001|Overall Study|Testosterone >1.0 ng/mL|9
6826450|NCT00117312|10828804|FG002|Overall Study|Testosterone >1.0 ng/mL|5
6826451|NCT00117312|10828805|FG003|Overall Study|Testosterone >1.0 ng/mL|9
6826452|NCT00117312|10828802|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
6826453|NCT00117312|10828803|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
6826454|NCT00117312|10828804|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
6826455|NCT00117312|10828805|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
6826456|NCT00117312|10828802|FG000|Overall Study|Prostate-specific antigen increase >=25%|0
6826457|NCT00117312|10828803|FG001|Overall Study|Prostate-specific antigen increase >=25%|1
6826458|NCT00117312|10828804|FG002|Overall Study|Prostate-specific antigen increase >=25%|5
6826459|NCT00117312|10828805|FG003|Overall Study|Prostate-specific antigen increase >=25%|3
6826460|NCT00117312|10828802|FG000|Overall Study|Other|0
6826461|NCT00117312|10828803|FG001|Overall Study|Other|1
6826462|NCT00117312|10828804|FG002|Overall Study|Other|3
6826463|NCT00117312|10828805|FG003|Overall Study|Other|1
6826464|NCT00117312|10828802|FG000|Overall Study|Patient choice|0
6826465|NCT00117312|10828803|FG001|Overall Study|Patient choice|0
6826466|NCT00117312|10828804|FG002|Overall Study|Patient choice|2
6826467|NCT00117312|10828805|FG003|Overall Study|Patient choice|1
6826468|NCT00117312|10828802|FG000|Overall Study|Adverse Event|0
6826469|NCT00117312|10828803|FG001|Overall Study|Adverse Event|2
6826470|NCT00117312|10828804|FG002|Overall Study|Adverse Event|0
6826471|NCT00117312|10828805|FG003|Overall Study|Adverse Event|0
6826472|NCT00117312|10828802|FG000|Overall Study|Protocol Violation|0
6826473|NCT00117312|10828803|FG001|Overall Study|Protocol Violation|1
6826474|NCT00117312|10828804|FG002|Overall Study|Protocol Violation|3
6826475|NCT00117312|10828805|FG003|Overall Study|Protocol Violation|0
6826476|NCT00117312|10828802|FG000|Overall Study|PSA decrease <=50%|0
6826477|NCT00117312|10828803|FG001|Overall Study|PSA decrease <=50%|2
6826478|NCT00117312|10828804|FG002|Overall Study|PSA decrease <=50%|2
6826479|NCT00117312|10828805|FG003|Overall Study|PSA decrease <=50%|4
6826480|NCT00117312|10828802|FG000|Overall Study|PSA increase >= 10ng/mL|0
6826481|NCT00117312|10828803|FG001|Overall Study|PSA increase >= 10ng/mL|1
6826482|NCT00117312|10828804|FG002|Overall Study|PSA increase >= 10ng/mL|1
6826483|NCT00117312|10828805|FG003|Overall Study|PSA increase >= 10ng/mL|0
6826484|NCT00117312|10828802|FG000|Overall Study|Hepatic abnormality|0
6826485|NCT00117312|10828803|FG001|Overall Study|Hepatic abnormality|1
6826486|NCT00117312|10828804|FG002|Overall Study|Hepatic abnormality|0
6826487|NCT00117312|10828805|FG003|Overall Study|Hepatic abnormality|1
6826488|NCT00117312|10828802|FG000|Overall Study|Withdrawal by Subject|0
6826489|NCT00117312|10828803|FG001|Overall Study|Withdrawal by Subject|2
6826490|NCT00117312|10828804|FG002|Overall Study|Withdrawal by Subject|0
6826491|NCT00117312|10828805|FG003|Overall Study|Withdrawal by Subject|0
6826492|NCT00117325|10828817|FG000|Overall Study|Adverse Event|3
6826493|NCT00117325|10828818|FG001|Overall Study|Adverse Event|3
6826494|NCT00117325|10828817|FG000|Overall Study|Lost to Follow-up|1
6826495|NCT00117325|10828818|FG001|Overall Study|Lost to Follow-up|1
6826496|NCT00117325|10828817|FG000|Overall Study|Protocol Violation|2
6826497|NCT00117325|10828818|FG001|Overall Study|Protocol Violation|3
6826498|NCT00117325|10828817|FG000|Overall Study|Withdrawal by Subject|3
6826499|NCT00117325|10828818|FG001|Overall Study|Withdrawal by Subject|2
6826500|NCT00117325|10828817|FG000|Overall Study|Lack of Efficacy|1
6826501|NCT00117325|10828818|FG001|Overall Study|Lack of Efficacy|0
6826502|NCT00117325|10828817|FG000|Overall Study|Use of prohibited medicine|1
6826503|NCT00117325|10828818|FG001|Overall Study|Use of prohibited medicine|2
6826504|NCT00117325|10828817|FG000|Overall Study|Early termination|1
6826505|NCT00117325|10828818|FG001|Overall Study|Early termination|1
6826506|NCT00117325|10828817|FG000|Overall Study|Admisnitrative|1
6826507|NCT00117325|10828818|FG001|Overall Study|Admisnitrative|0
6826508|NCT00117507|10828825|FG000|Overall Study|Adverse Event|4
6826509|NCT00117507|10828825|FG000|Overall Study|Abnormal laboratory values|3
6826510|NCT00117507|10828825|FG000|Overall Study|Unsatisfactory therapeutic effect|1
6826511|NCT00117507|10828825|FG000|Overall Study|Patient withdrew consent|4
6826512|NCT00117507|10828825|FG000|Overall Study|Death|3
6826513|NCT00117572|10828841|FG000|Overall Study|Site withdrew before starting treatment|2
6826514|NCT00117572|10828842|FG001|Overall Study|Site withdrew before starting treatment|3
6826515|NCT00117572|10828841|FG000|Overall Study|Withdrawal by Subject|3
6826516|NCT00117572|10828842|FG001|Overall Study|Withdrawal by Subject|3
6826517|NCT00117572|10828841|FG000|Overall Study|Protocol Violation|1
6826518|NCT00117572|10828842|FG001|Overall Study|Protocol Violation|0
6826519|NCT00117598|10828855|FG000|Prior to Treatment Cross Over|Death|40
6826520|NCT00117598|10828856|FG001|Prior to Treatment Cross Over|Death|41
6826521|NCT00117598|10828857|FG002|Prior to Treatment Cross Over|Death|37
6826522|NCT00117598|10828858|FG003|Prior to Treatment Cross Over|Death|0
6826523|NCT00117598|10828859|FG004|Prior to Treatment Cross Over|Death|0
6826524|NCT00117598|10828855|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0
6826525|NCT00117598|10828856|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2
6826526|NCT00117598|10828857|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2
6826527|NCT00117598|10828858|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0
6826528|NCT00117598|10828859|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0
6826529|NCT00117598|10828855|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2
6826530|NCT00117598|10828856|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1
6826531|NCT00117598|10828857|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4
6826532|NCT00117598|10828858|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0
6826533|NCT00117598|10828859|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0
6826534|NCT00117598|10828855|FG000|Prior to Treatment Cross Over|Other|15
6826535|NCT00117598|10828856|FG001|Prior to Treatment Cross Over|Other|9
6826536|NCT00117598|10828857|FG002|Prior to Treatment Cross Over|Other|9
6826537|NCT00117598|10828858|FG003|Prior to Treatment Cross Over|Other|0
6826538|NCT00117598|10828859|FG004|Prior to Treatment Cross Over|Other|0
6826539|NCT00117598|10828855|FG000|After Treament Cross Over|Death|0
6826540|NCT00117598|10828856|FG001|After Treament Cross Over|Death|0
6826541|NCT00117598|10828857|FG002|After Treament Cross Over|Death|0
6826542|NCT00117598|10828858|FG003|After Treament Cross Over|Death|1
6826543|NCT00117598|10828859|FG004|After Treament Cross Over|Death|2
6826544|NCT00117598|10828855|FG000|After Treament Cross Over|Withdrawal by Subject|0
6826545|NCT00117598|10828856|FG001|After Treament Cross Over|Withdrawal by Subject|0
6826546|NCT00117598|10828857|FG002|After Treament Cross Over|Withdrawal by Subject|0
6826547|NCT00117598|10828858|FG003|After Treament Cross Over|Withdrawal by Subject|1
6826548|NCT00117598|10828859|FG004|After Treament Cross Over|Withdrawal by Subject|0
6826549|NCT00117598|10828855|FG000|After Treament Cross Over|Other|0
6826550|NCT00117598|10828856|FG001|After Treament Cross Over|Other|0
6826551|NCT00117598|10828857|FG002|After Treament Cross Over|Other|0
6826552|NCT00117598|10828858|FG003|After Treament Cross Over|Other|1
6826553|NCT00117598|10828859|FG004|After Treament Cross Over|Other|2
6826554|NCT00117637|10828871|FG000|First Intervention (Period 1)|Adverse Event|11
6826555|NCT00117637|10828872|FG001|First Intervention (Period 1)|Adverse Event|16
6826556|NCT00117637|10828871|FG000|First Intervention (Period 1)|Lost to Follow-up|0
6826557|NCT00117637|10828872|FG001|First Intervention (Period 1)|Lost to Follow-up|2
6826558|NCT00117637|10828871|FG000|First Intervention (Period 1)|Protocol Violation|1
6826559|NCT00117637|10828872|FG001|First Intervention (Period 1)|Protocol Violation|0
6826560|NCT00117637|10828871|FG000|First Intervention (Period 1)|Withdrawal by Subject|2
6826561|NCT00117637|10828872|FG001|First Intervention (Period 1)|Withdrawal by Subject|4
6826562|NCT00117637|10828871|FG000|First Intervention (Period 1)|study terminated by the sponsor|3
6826563|NCT00117637|10828872|FG001|First Intervention (Period 1)|study terminated by the sponsor|1
6826564|NCT00117637|10828871|FG000|First Intervention (Period 1)|protocol driven decision point|1
6826565|NCT00117637|10828872|FG001|First Intervention (Period 1)|protocol driven decision point|0
6826566|NCT00117637|10828871|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0
6826567|NCT00117637|10828872|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1
6826568|NCT00117637|10828871|FG000|First Intervention (Period 1)|reason not reported|0
6826569|NCT00117637|10828872|FG001|First Intervention (Period 1)|reason not reported|1
6826570|NCT00117637|10828871|FG000|Second Intervention (Period 2)|Adverse Event|0
6826571|NCT00117637|10828872|FG001|Second Intervention (Period 2)|Adverse Event|9
6826572|NCT00117637|10828871|FG000|Second Intervention (Period 2)|Lost to Follow-up|1
6826573|NCT00117637|10828872|FG001|Second Intervention (Period 2)|Lost to Follow-up|0
6826574|NCT00117637|10828871|FG000|Second Intervention (Period 2)|Protocol Violation|1
6826575|NCT00117637|10828872|FG001|Second Intervention (Period 2)|Protocol Violation|0
6826576|NCT00117637|10828871|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4
6901470|NCT00673231|10922312|FG003|Overall Study|Withdrawal by Subject|6
6978679|NCT01214629|11032176|FG004|Overall Study|Withdrawal by Subject|0
6826577|NCT00117637|10828872|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3
6826578|NCT00117637|10828871|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2
6826579|NCT00117637|10828872|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9
6978680|NCT01214629|11032177|FG005|Overall Study|Withdrawal by Subject|0
6826580|NCT00117637|10828871|FG000|Second Intervention (Period 2)|non compliant with study medication|1
6826581|NCT00117637|10828872|FG001|Second Intervention (Period 2)|non compliant with study medication|1
6901471|NCT00673231|10922309|FG000|Overall Study|Adverse Event|6
6826582|NCT00117637|10828871|FG000|Second Intervention (Period 2)|reason not reported|1
6826583|NCT00117637|10828872|FG001|Second Intervention (Period 2)|reason not reported|0
6826584|NCT00117676|10828887|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4
6826585|NCT00117676|10828888|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3
6826586|NCT00117676|10828887|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1
6826587|NCT00117676|10828888|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0
6826588|NCT00117676|10828887|FG000|Double-blind Period Through Week 48|Protocol Violation|0
6826589|NCT00117676|10828888|FG001|Double-blind Period Through Week 48|Protocol Violation|1
6826590|NCT00117676|10828887|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5
6826591|NCT00117676|10828888|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2
6826592|NCT00117676|10828887|FG000|Double-blind Period Through Week 48|Withdrew Consent|0
6826593|NCT00117676|10828888|FG001|Double-blind Period Through Week 48|Withdrew Consent|1
6826594|NCT00117676|10828887|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2
6826595|NCT00117676|10828888|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0
6826596|NCT00117676|10828887|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3
6826597|NCT00117676|10828888|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
6826598|NCT00117676|10828887|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5
6826599|NCT00117676|10828888|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1
6826600|NCT00117676|10828887|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4
6826601|NCT00117676|10828888|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1
6826602|NCT00117676|10828887|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1
6826603|NCT00117676|10828888|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0
6826604|NCT00117676|10828887|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1
6826605|NCT00117676|10828888|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0
6826606|NCT00117676|10828887|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2
6826607|NCT00117676|10828888|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0
6826608|NCT00117676|10828887|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3
6826609|NCT00117676|10828888|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1
6826610|NCT00117676|10828887|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5
6826611|NCT00117676|10828888|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2
6826612|NCT00117676|10828887|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
6826613|NCT00117676|10828888|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
6826614|NCT00117676|10828887|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0
6826615|NCT00117676|10828888|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1
6826616|NCT00117676|10828887|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
6826617|NCT00117676|10828888|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0
6826618|NCT00117676|10828887|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4
6826619|NCT00117676|10828888|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1
6826620|NCT00117676|10828887|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0
6826621|NCT00117676|10828888|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1
6826622|NCT00117676|10828887|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2
6826623|NCT00117676|10828888|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1
6826624|NCT00117676|10828887|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2
6826625|NCT00117676|10828888|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0
6826626|NCT00117676|10828887|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1
6826627|NCT00117676|10828888|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
6826628|NCT00117676|10828887|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5
6826629|NCT00117676|10828888|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1
6826630|NCT00117676|10828887|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7
6826631|NCT00117676|10828888|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4
6826632|NCT00117676|10828887|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
6826633|NCT00117676|10828888|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
6826634|NCT00117676|10828887|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0
6826635|NCT00117676|10828888|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1
6826636|NCT00117676|10828887|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
6826637|NCT00117676|10828888|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
6826638|NCT00117676|10828887|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3
6826639|NCT00117676|10828888|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1
6826640|NCT00117676|10828887|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1
6826641|NCT00117676|10828888|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0
6826642|NCT00117676|10828887|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2
6826643|NCT00117676|10828888|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1
6826644|NCT00117676|10828887|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0
6826645|NCT00117676|10828888|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1
6826646|NCT00117676|10828887|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0
6826647|NCT00117676|10828888|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1
6826648|NCT00117676|10828887|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1
6826649|NCT00117676|10828888|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0
6826650|NCT00117676|10828887|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
6826651|NCT00117676|10828888|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
6826652|NCT00117676|10828887|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0
6826653|NCT00117676|10828888|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1
6826654|NCT00117793|10828903|FG000|Overall Study|Withdrawal by Subject|12
6826655|NCT00117845|10828920|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1
6826656|NCT00117949|10828928|FG000|Overall Study|Testosterone >1.0 ng/mL|10
6826657|NCT00117949|10828929|FG001|Overall Study|Testosterone >1.0 ng/mL|18
6826658|NCT00117949|10828930|FG002|Overall Study|Testosterone >1.0 ng/mL|17
6826659|NCT00117949|10828931|FG003|Overall Study|Testosterone >1.0 ng/mL|15
6826660|NCT00117949|10828928|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
6826661|NCT00117949|10828929|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
6826662|NCT00117949|10828930|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
6826663|NCT00117949|10828931|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
6826664|NCT00117949|10828928|FG000|Overall Study|Prostate-specific antigen increase >=25%|0
6826665|NCT00117949|10828929|FG001|Overall Study|Prostate-specific antigen increase >=25%|1
6826666|NCT00117949|10828930|FG002|Overall Study|Prostate-specific antigen increase >=25%|1
6826667|NCT00117949|10828931|FG003|Overall Study|Prostate-specific antigen increase >=25%|2
6826668|NCT00117949|10828928|FG000|Overall Study|PSA increase >=10ng/mL|0
6826669|NCT00117949|10828929|FG001|Overall Study|PSA increase >=10ng/mL|1
6826670|NCT00117949|10828930|FG002|Overall Study|PSA increase >=10ng/mL|1
6826671|NCT00117949|10828931|FG003|Overall Study|PSA increase >=10ng/mL|0
6826672|NCT00117949|10828928|FG000|Overall Study|PSA reduction <=50%|0
6826673|NCT00117949|10828929|FG001|Overall Study|PSA reduction <=50%|2
6826674|NCT00117949|10828930|FG002|Overall Study|PSA reduction <=50%|2
6826675|NCT00117949|10828931|FG003|Overall Study|PSA reduction <=50%|4
6826676|NCT00117949|10828928|FG000|Overall Study|Hepatic abnormalities|0
6826677|NCT00117949|10828929|FG001|Overall Study|Hepatic abnormalities|1
6826678|NCT00117949|10828930|FG002|Overall Study|Hepatic abnormalities|0
6826679|NCT00117949|10828931|FG003|Overall Study|Hepatic abnormalities|1
6826680|NCT00117988|10828950|FG000|Overall Study|Death|3
6826681|NCT00117988|10828950|FG000|Overall Study|Adverse Event|1
6826682|NCT00118040|10828957|FG000|Overall Study|Adverse Event|0
6826683|NCT00118040|10828958|FG001|Overall Study|Adverse Event|1
6826684|NCT00118040|10828959|FG002|Overall Study|Adverse Event|0
6826685|NCT00118040|10828957|FG000|Overall Study|Withdrawal by Subject|0
6826686|NCT00118040|10828958|FG001|Overall Study|Withdrawal by Subject|0
6826687|NCT00118040|10828959|FG002|Overall Study|Withdrawal by Subject|2
6826688|NCT00118040|10828957|FG000|Overall Study|Medical Contraindication|0
6826689|NCT00118040|10828958|FG001|Overall Study|Medical Contraindication|0
6826690|NCT00118040|10828959|FG002|Overall Study|Medical Contraindication|1
6826691|NCT00118040|10828957|FG000|Overall Study|Non-Compliant Participant|1
6826692|NCT00118040|10828958|FG001|Overall Study|Non-Compliant Participant|1
6826693|NCT00118040|10828959|FG002|Overall Study|Non-Compliant Participant|2
6826694|NCT00118040|10828957|FG000|Overall Study|Other|0
6826695|NCT00118040|10828958|FG001|Overall Study|Other|0
6826696|NCT00118040|10828959|FG002|Overall Study|Other|1
6826697|NCT00118092|10828972|FG000|Overall Study|Withdrawal by Subject|1
6826698|NCT00118092|10828972|FG000|Overall Study|Protocol Violation|1
6826699|NCT00118157|10828986|FG000|Overall Study|Adverse Event|2
6826700|NCT00118157|10828986|FG000|Overall Study|Death|8
6826701|NCT00118157|10828986|FG000|Overall Study|Withdrawal by Subject|2
6826702|NCT00118287|10829025|FG000|Overall Study|Intracranial haemorrhage|1
6826703|NCT00118287|10829025|FG000|Overall Study|Muscle pain|1
6826704|NCT00118417|10829105|FG000|Phase I (Weeks 0 to 6)|Remission|8
6826705|NCT00118417|10829106|FG001|Phase I (Weeks 0 to 6)|Remission|0
6826706|NCT00118417|10829105|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6
6826707|NCT00118417|10829106|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0
6826708|NCT00118417|10829105|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4
6826709|NCT00118417|10829106|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0
6901472|NCT00673231|10922310|FG001|Overall Study|Adverse Event|5
6901473|NCT00673231|10922311|FG002|Overall Study|Adverse Event|9
6901474|NCT00673231|10922312|FG003|Overall Study|Adverse Event|6
6901475|NCT00673231|10922309|FG000|Overall Study|Lost to Follow-up|1
6901476|NCT00673231|10922310|FG001|Overall Study|Lost to Follow-up|2
6901477|NCT00673231|10922311|FG002|Overall Study|Lost to Follow-up|1
6901478|NCT00673231|10922312|FG003|Overall Study|Lost to Follow-up|2
6901479|NCT00673231|10922309|FG000|Overall Study|Death|0
6901480|NCT00673231|10922310|FG001|Overall Study|Death|0
6901481|NCT00673231|10922311|FG002|Overall Study|Death|1
6901482|NCT00673231|10922312|FG003|Overall Study|Death|0
6901483|NCT00673231|10922309|FG000|Overall Study|Study criteria,compliance,safety, other|8
6901484|NCT00673231|10922310|FG001|Overall Study|Study criteria,compliance,safety, other|5
6901485|NCT00673231|10922311|FG002|Overall Study|Study criteria,compliance,safety, other|7
6901486|NCT00673231|10922312|FG003|Overall Study|Study criteria,compliance,safety, other|4
6901487|NCT00673257|10922331|FG000|Overall Study|Withdrawal by Subject|4
6901488|NCT00673257|10922331|FG000|Overall Study|Unable to obtain specimen|1
6901489|NCT00673387|10922343|FG000|Overall Study|Withdrawal by Subject|15
6901490|NCT00673387|10922344|FG001|Overall Study|Withdrawal by Subject|16
6826710|NCT00118417|10829105|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
6826711|NCT00118417|10829106|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
6826712|NCT00118417|10829105|FG000|Phase II (Weeks 6 to 12)|Remission|1
6826713|NCT00118417|10829106|FG001|Phase II (Weeks 6 to 12)|Remission|2
6826714|NCT00118430|10829119|FG000|Overall Study|Withdrawal by Subject|6
6826715|NCT00118430|10829120|FG001|Overall Study|Withdrawal by Subject|2
6826716|NCT00118430|10829121|FG002|Overall Study|Withdrawal by Subject|0
6826717|NCT00118430|10829119|FG000|Overall Study|Lost to Follow-up|15
6826718|NCT00118430|10829120|FG001|Overall Study|Lost to Follow-up|22
6826719|NCT00118430|10829121|FG002|Overall Study|Lost to Follow-up|28
6826720|NCT00118482|10829130|FG000|Overall Study|Lost to Follow-up|7
6826721|NCT00118482|10829131|FG001|Overall Study|Lost to Follow-up|7
6826722|NCT00118482|10829130|FG000|Overall Study|Withdrawal by Subject|23
6826723|NCT00118482|10829131|FG001|Overall Study|Withdrawal by Subject|22
6826724|NCT00118703|10829149|FG000|Overall Study|Protocol Violation|1
6826725|NCT00118703|10829150|FG001|Overall Study|Protocol Violation|0
6826726|NCT00118703|10829149|FG000|Overall Study|Adverse Event|1
6826727|NCT00118703|10829150|FG001|Overall Study|Adverse Event|1
6826728|NCT00118703|10829149|FG000|Overall Study|Participant took two different treatment|0
6826729|NCT00118703|10829150|FG001|Overall Study|Participant took two different treatment|1
6826730|NCT00118703|10829149|FG000|Overall Study|Withdrawal by Subject|2
6826731|NCT00118703|10829150|FG001|Overall Study|Withdrawal by Subject|5
6826732|NCT00118703|10829149|FG000|Overall Study|Lost to Follow-up|1
6826733|NCT00118703|10829150|FG001|Overall Study|Lost to Follow-up|2
6826734|NCT00118716|10829158|FG000|Overall Study|Adverse Event|2
6826735|NCT00118716|10829159|FG001|Overall Study|Adverse Event|7
6826736|NCT00118716|10829158|FG000|Overall Study|Protocol Violation|5
6826737|NCT00118716|10829159|FG001|Overall Study|Protocol Violation|4
6826738|NCT00118716|10829158|FG000|Overall Study|Withdrawal by Subject|0
6826739|NCT00118716|10829159|FG001|Overall Study|Withdrawal by Subject|1
6826740|NCT00118716|10829158|FG000|Overall Study|Exacerbation|2
6826741|NCT00118716|10829159|FG001|Overall Study|Exacerbation|2
6826742|NCT00118716|10829158|FG000|Overall Study|Discontinued by sponsor|1
6826743|NCT00118716|10829159|FG001|Overall Study|Discontinued by sponsor|1
6826744|NCT00118716|10829158|FG000|Overall Study|Non-compliance|1
6826745|NCT00118716|10829159|FG001|Overall Study|Non-compliance|3
6826746|NCT00118716|10829158|FG000|Overall Study|misrandomized|1
6826747|NCT00118716|10829159|FG001|Overall Study|misrandomized|1
6826748|NCT00118716|10829158|FG000|Overall Study|Expired drug use|1
6826749|NCT00118716|10829159|FG001|Overall Study|Expired drug use|2
6826750|NCT00118716|10829158|FG000|Overall Study|Investigator discretion|0
6826751|NCT00118716|10829159|FG001|Overall Study|Investigator discretion|1
6826752|NCT00118898|10829187|FG000|Overall Study|Death|6
6826753|NCT00118898|10829188|FG001|Overall Study|Death|11
6826754|NCT00118898|10829189|FG002|Overall Study|Death|6
6826755|NCT00118898|10829190|FG003|Overall Study|Death|8
6826756|NCT00118898|10829187|FG000|Overall Study|Lost to Follow-up|26
6826757|NCT00118898|10829188|FG001|Overall Study|Lost to Follow-up|34
6826758|NCT00118898|10829189|FG002|Overall Study|Lost to Follow-up|33
6826759|NCT00118898|10829190|FG003|Overall Study|Lost to Follow-up|33
6826760|NCT00118898|10829187|FG000|Overall Study|Withdrawal by Subject|10
6826761|NCT00118898|10829188|FG001|Overall Study|Withdrawal by Subject|5
6826762|NCT00118898|10829189|FG002|Overall Study|Withdrawal by Subject|8
6826763|NCT00118898|10829190|FG003|Overall Study|Withdrawal by Subject|8
6826764|NCT00118898|10829187|FG000|Overall Study|Site Closure|33
6826765|NCT00118898|10829188|FG001|Overall Study|Site Closure|31
6826766|NCT00118898|10829189|FG002|Overall Study|Site Closure|28
6826767|NCT00118898|10829190|FG003|Overall Study|Site Closure|37
6826768|NCT00118898|10829187|FG000|Overall Study|Severe debilitation|1
6826769|NCT00118898|10829188|FG001|Overall Study|Severe debilitation|4
6826770|NCT00118898|10829189|FG002|Overall Study|Severe debilitation|6
6826771|NCT00118898|10829190|FG003|Overall Study|Severe debilitation|4
6826772|NCT00118898|10829187|FG000|Overall Study|Not compliant with requirements|11
6826773|NCT00118898|10829188|FG001|Overall Study|Not compliant with requirements|13
6826774|NCT00118898|10829189|FG002|Overall Study|Not compliant with requirements|11
6826775|NCT00118898|10829190|FG003|Overall Study|Not compliant with requirements|11
6826776|NCT00118898|10829187|FG000|Overall Study|Not able to get to clinic|34
6826777|NCT00118898|10829188|FG001|Overall Study|Not able to get to clinic|43
6826778|NCT00118898|10829189|FG002|Overall Study|Not able to get to clinic|31
6826779|NCT00118898|10829190|FG003|Overall Study|Not able to get to clinic|40
6826780|NCT00118911|10829202|FG000|Overall Study|Withdrawal by Subject|2
6826781|NCT00118911|10829203|FG001|Overall Study|Withdrawal by Subject|5
6826782|NCT00119015|10829211|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48
6826783|NCT00119015|10829212|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
6826784|NCT00119015|10829213|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
6826785|NCT00119106|10829235|FG000|Overall Study|HIV infected at baseline|179
6826786|NCT00119106|10829236|FG001|Overall Study|HIV infected at baseline|178
6826787|NCT00119262|10829261|FG000|Overall Study|Lack of Efficacy|0
6826788|NCT00119262|10829262|FG001|Overall Study|Lack of Efficacy|3
6826789|NCT00119262|10829261|FG000|Overall Study|Withdrawal by Subject|12
6826790|NCT00119262|10829262|FG001|Overall Study|Withdrawal by Subject|11
6826791|NCT00119262|10829261|FG000|Overall Study|Adverse Event|33
6826792|NCT00119262|10829262|FG001|Overall Study|Adverse Event|35
6826793|NCT00119262|10829261|FG000|Overall Study|other disease|0
6826794|NCT00119262|10829262|FG001|Overall Study|other disease|2
6826795|NCT00119262|10829261|FG000|Overall Study|ineligble|1
6826796|NCT00119262|10829262|FG001|Overall Study|ineligble|2
6826797|NCT00119262|10829261|FG000|Overall Study|others|0
6826798|NCT00119262|10829262|FG001|Overall Study|others|5
6826799|NCT00119379|10829270|FG000|Overall Study|Adverse Event|4
6826800|NCT00119379|10829271|FG001|Overall Study|Adverse Event|1
6896828|NCT00635050|10915305|FG000|Overall Study|Withdrawal by Subject|1
6896829|NCT00635089|10915312|FG000|Overall Study|Adverse Event|7
6896830|NCT00635089|10915312|FG000|Overall Study|Lack of Efficacy|28
6896831|NCT00635089|10915312|FG000|Overall Study|Protocol Deviation|4
6896832|NCT00635089|10915312|FG000|Overall Study|Lost to Follow-up|8
6896833|NCT00635089|10915312|FG000|Overall Study|Other|31
6896834|NCT00635102|10915331|FG000|Overall Study|Withdrawal by Subject|7
6896835|NCT00635102|10915332|FG001|Overall Study|Withdrawal by Subject|8
6896836|NCT00635154|10915349|FG000|Overall Study|Alternative Treatment|8
6896837|NCT00635154|10915349|FG000|Overall Study|Other|4
6896838|NCT00635154|10915349|FG000|Overall Study|Still on treatment|21
6896839|NCT00635219|10915360|FG000|Overall Study|Adverse Event|12
6896840|NCT00635219|10915361|FG001|Overall Study|Adverse Event|10
6896841|NCT00635219|10915362|FG002|Overall Study|Adverse Event|18
6896842|NCT00635219|10915363|FG003|Overall Study|Adverse Event|15
6896843|NCT00635219|10915364|FG004|Overall Study|Adverse Event|19
6896844|NCT00635219|10915360|FG000|Overall Study|Lack of Efficacy|5
6896845|NCT00635219|10915361|FG001|Overall Study|Lack of Efficacy|6
6896846|NCT00635219|10915362|FG002|Overall Study|Lack of Efficacy|3
6896847|NCT00635219|10915363|FG003|Overall Study|Lack of Efficacy|4
6896848|NCT00635219|10915364|FG004|Overall Study|Lack of Efficacy|6
6896849|NCT00635219|10915360|FG000|Overall Study|Non-compliance With Study Product|0
6896850|NCT00635219|10915361|FG001|Overall Study|Non-compliance With Study Product|0
6896851|NCT00635219|10915362|FG002|Overall Study|Non-compliance With Study Product|0
6896852|NCT00635219|10915363|FG003|Overall Study|Non-compliance With Study Product|2
6896853|NCT00635219|10915364|FG004|Overall Study|Non-compliance With Study Product|1
6896854|NCT00635219|10915360|FG000|Overall Study|Protocol Violation|0
6896855|NCT00635219|10915361|FG001|Overall Study|Protocol Violation|2
6896856|NCT00635219|10915362|FG002|Overall Study|Protocol Violation|3
6896857|NCT00635219|10915363|FG003|Overall Study|Protocol Violation|2
6896858|NCT00635219|10915364|FG004|Overall Study|Protocol Violation|4
6896859|NCT00635219|10915360|FG000|Overall Study|Withdrawal of Consent|8
6896860|NCT00635219|10915361|FG001|Overall Study|Withdrawal of Consent|6
6896861|NCT00635219|10915362|FG002|Overall Study|Withdrawal of Consent|8
6896862|NCT00635219|10915363|FG003|Overall Study|Withdrawal of Consent|11
6896863|NCT00635219|10915364|FG004|Overall Study|Withdrawal of Consent|8
6896864|NCT00635219|10915360|FG000|Overall Study|Lost to Follow-up|0
6896865|NCT00635219|10915361|FG001|Overall Study|Lost to Follow-up|0
6896866|NCT00635219|10915362|FG002|Overall Study|Lost to Follow-up|2
6896867|NCT00635219|10915363|FG003|Overall Study|Lost to Follow-up|0
6896868|NCT00635219|10915364|FG004|Overall Study|Lost to Follow-up|3
6896869|NCT00635219|10915360|FG000|Overall Study|Administrative or Other Reasons|0
6896870|NCT00635219|10915361|FG001|Overall Study|Administrative or Other Reasons|1
6896871|NCT00635219|10915362|FG002|Overall Study|Administrative or Other Reasons|1
6896872|NCT00635219|10915363|FG003|Overall Study|Administrative or Other Reasons|0
6896873|NCT00635219|10915364|FG004|Overall Study|Administrative or Other Reasons|1
6896874|NCT00635349|10915399|FG000|Overall Study|Other|8
6896875|NCT00635349|10915400|FG001|Overall Study|Other|6
6896876|NCT00635349|10915399|FG000|Overall Study|Protocol Violation|18
6896877|NCT00635349|10915400|FG001|Overall Study|Protocol Violation|22
6896878|NCT00635349|10915399|FG000|Overall Study|Withdrawal by Subject|3
6896879|NCT00635349|10915400|FG001|Overall Study|Withdrawal by Subject|8
6896880|NCT00635349|10915399|FG000|Overall Study|Lost to Follow-up|4
6896881|NCT00635349|10915400|FG001|Overall Study|Lost to Follow-up|3
6896882|NCT00635349|10915399|FG000|Overall Study|Adverse Event|11
6896883|NCT00635349|10915400|FG001|Overall Study|Adverse Event|9
6896884|NCT00635427|10915420|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0
6896885|NCT00635427|10915421|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0
6896886|NCT00635427|10915422|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1
6896887|NCT00635427|10915423|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0
6896888|NCT00635427|10915424|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0
6896889|NCT00635427|10915420|FG000|Overall Study|Death|0
6896890|NCT00635427|10915421|FG001|Overall Study|Death|0
6896891|NCT00635427|10915422|FG002|Overall Study|Death|0
6896892|NCT00635427|10915423|FG003|Overall Study|Death|1
6896893|NCT00635427|10915424|FG004|Overall Study|Death|0
6896894|NCT00635427|10915420|FG000|Overall Study|Termination Of Study By Sponsor|12
6896895|NCT00635427|10915421|FG001|Overall Study|Termination Of Study By Sponsor|6
6896896|NCT00635427|10915422|FG002|Overall Study|Termination Of Study By Sponsor|10
6896897|NCT00635427|10915423|FG003|Overall Study|Termination Of Study By Sponsor|6
6896898|NCT00635427|10915424|FG004|Overall Study|Termination Of Study By Sponsor|6
6896899|NCT00635427|10915420|FG000|Overall Study|Withdrawal Of Consent|0
6896900|NCT00635427|10915421|FG001|Overall Study|Withdrawal Of Consent|0
6896901|NCT00635427|10915422|FG002|Overall Study|Withdrawal Of Consent|0
6896902|NCT00635427|10915423|FG003|Overall Study|Withdrawal Of Consent|2
6896903|NCT00635427|10915424|FG004|Overall Study|Withdrawal Of Consent|2
6896904|NCT00635492|10915454|FG000|Overall Study|Death|12
6826801|NCT00119405|10829281|FG000|Overall Study|Withdrawal by Subject|1
6826802|NCT00119678|10829287|FG000|Double-blind Treatment Period|Death|1
6826803|NCT00119678|10829288|FG001|Double-blind Treatment Period|Death|0
6826804|NCT00119678|10829287|FG000|Double-blind Treatment Period|Adverse Event|7
6826805|NCT00119678|10829288|FG001|Double-blind Treatment Period|Adverse Event|1
6826806|NCT00119678|10829287|FG000|Double-blind Treatment Period|Lack of Efficacy|21
6826807|NCT00119678|10829288|FG001|Double-blind Treatment Period|Lack of Efficacy|12
6826808|NCT00119678|10829287|FG000|Double-blind Treatment Period|Lost to Follow-up|1
6826809|NCT00119678|10829288|FG001|Double-blind Treatment Period|Lost to Follow-up|2
6826810|NCT00119678|10829287|FG000|Double-blind Treatment Period|Participant withdrew consent|4
6826811|NCT00119678|10829288|FG001|Double-blind Treatment Period|Participant withdrew consent|4
6826812|NCT00119678|10829287|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0
6826813|NCT00119678|10829288|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1
6826814|NCT00119678|10829287|FG000|Double-blind Treatment Period|Poor/Non-compliance|3
6826815|NCT00119678|10829288|FG001|Double-blind Treatment Period|Poor/Non-compliance|0
6826816|NCT00119678|10829287|FG000|Double-blind Treatment Period|Pregnancy|0
6826817|NCT00119678|10829288|FG001|Double-blind Treatment Period|Pregnancy|2
6826818|NCT00119678|10829287|FG000|Double-blind Treatment Period|Not treated|1
6826819|NCT00119678|10829288|FG001|Double-blind Treatment Period|Not treated|2
6826820|NCT00119678|10829287|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3
6826821|NCT00119678|10829288|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2
6826822|NCT00119678|10829287|FG000|Open-label Treatment Period|Death|1
6826823|NCT00119678|10829288|FG001|Open-label Treatment Period|Death|0
6826824|NCT00119678|10829287|FG000|Open-label Treatment Period|Adverse Event|3
6826825|NCT00119678|10829288|FG001|Open-label Treatment Period|Adverse Event|0
6826826|NCT00119678|10829287|FG000|Open-label Treatment Period|Lack of Efficacy|9
6826827|NCT00119678|10829288|FG001|Open-label Treatment Period|Lack of Efficacy|0
6826828|NCT00119678|10829287|FG000|Open-label Treatment Period|Lost to Follow-up|3
6826829|NCT00119678|10829288|FG001|Open-label Treatment Period|Lost to Follow-up|0
6826830|NCT00119678|10829287|FG000|Open-label Treatment Period|Participant withdrew consent|4
6826831|NCT00119678|10829288|FG001|Open-label Treatment Period|Participant withdrew consent|0
6826832|NCT00119678|10829287|FG000|Open-label Treatment Period|Participants not meeting study criteria|2
6826833|NCT00119678|10829288|FG001|Open-label Treatment Period|Participants not meeting study criteria|0
6826834|NCT00119678|10829287|FG000|Open-label Treatment Period|Pregnancy|1
6826835|NCT00119678|10829288|FG001|Open-label Treatment Period|Pregnancy|0
6826836|NCT00119678|10829287|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87
6826837|NCT00119678|10829288|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0
6826838|NCT00120250|10829296|FG000|Overall Study|Lost to Follow-up|1
6826839|NCT00120250|10829297|FG001|Overall Study|Lost to Follow-up|1
6826840|NCT00120250|10829296|FG000|Overall Study|Protocol Violation|0
6826841|NCT00120250|10829297|FG001|Overall Study|Protocol Violation|1
6826842|NCT00120289|10829306|FG000|Overall Study|Death|96
6826843|NCT00120289|10829307|FG001|Overall Study|Death|82
6826844|NCT00120289|10829306|FG000|Overall Study|Lost to Follow-up|11
6826845|NCT00120289|10829307|FG001|Overall Study|Lost to Follow-up|14
6826846|NCT00120289|10829306|FG000|Overall Study|Withdrawal by Subject|14
6826847|NCT00120289|10829307|FG001|Overall Study|Withdrawal by Subject|13
6826848|NCT00120406|10829315|FG000|Overall Study|Death|9
6826849|NCT00120406|10829316|FG001|Overall Study|Death|4
6826850|NCT00120406|10829315|FG000|Overall Study|Withdrawal by Subject|5
6826851|NCT00120406|10829316|FG001|Overall Study|Withdrawal by Subject|7
6826852|NCT00120406|10829315|FG000|Overall Study|Lost to Follow-up|5
6826853|NCT00120406|10829316|FG001|Overall Study|Lost to Follow-up|2
6826854|NCT00120406|10829315|FG000|Overall Study|received non-study stent|0
6826855|NCT00120406|10829316|FG001|Overall Study|received non-study stent|2
6826856|NCT00120406|10829315|FG000|Overall Study|patient moved but has not withdrawn|0
6826857|NCT00120406|10829316|FG001|Overall Study|patient moved but has not withdrawn|1
6826858|NCT00120627|10829334|FG000|Overall Study|Withdrawal by Subject|5
6826859|NCT00120627|10829335|FG001|Overall Study|Withdrawal by Subject|5
6826860|NCT00120874|10829352|FG000|Overall Study|Death|0
6826861|NCT00120874|10829353|FG001|Overall Study|Death|1
6826862|NCT00121134|10829363|FG000|Overall Study|Progression of Disease|5
6826863|NCT00121134|10829364|FG001|Overall Study|Progression of Disease|3
6826864|NCT00121134|10829365|FG002|Overall Study|Progression of Disease|4
6826865|NCT00121134|10829366|FG003|Overall Study|Progression of Disease|2
6826866|NCT00121134|10829363|FG000|Overall Study|Toxicity|4
6826867|NCT00121134|10829364|FG001|Overall Study|Toxicity|7
6826868|NCT00121134|10829365|FG002|Overall Study|Toxicity|13
6826869|NCT00121134|10829366|FG003|Overall Study|Toxicity|5
6826870|NCT00121134|10829363|FG000|Overall Study|Physician Decision|6
6826871|NCT00121134|10829364|FG001|Overall Study|Physician Decision|4
6826872|NCT00121134|10829365|FG002|Overall Study|Physician Decision|4
6826873|NCT00121134|10829366|FG003|Overall Study|Physician Decision|1
6826874|NCT00121134|10829363|FG000|Overall Study|Treatment Delay|1
6826875|NCT00121134|10829364|FG001|Overall Study|Treatment Delay|0
6826876|NCT00121134|10829365|FG002|Overall Study|Treatment Delay|0
6826877|NCT00121134|10829366|FG003|Overall Study|Treatment Delay|0
6826878|NCT00121134|10829363|FG000|Overall Study|Intercurrent Illness|0
6826879|NCT00121134|10829364|FG001|Overall Study|Intercurrent Illness|0
6826880|NCT00121134|10829365|FG002|Overall Study|Intercurrent Illness|0
6826881|NCT00121134|10829366|FG003|Overall Study|Intercurrent Illness|1
6826882|NCT00121134|10829363|FG000|Overall Study|Patient Personal Reasons|0
6826883|NCT00121134|10829364|FG001|Overall Study|Patient Personal Reasons|1
6826884|NCT00121134|10829365|FG002|Overall Study|Patient Personal Reasons|0
6826885|NCT00121134|10829366|FG003|Overall Study|Patient Personal Reasons|0
6826886|NCT00121199|10829396|FG000|Overall Study|Adverse Event|11
6826887|NCT00121199|10829396|FG000|Overall Study|Refusal Unrelated to Adverse Event|1
6826888|NCT00121199|10829396|FG000|Overall Study|Progression/Relapse|1
6826889|NCT00121199|10829396|FG000|Overall Study|Death|3
6826890|NCT00121199|10829396|FG000|Overall Study|Other - Not Protocol Specified|3
6826891|NCT00121199|10829396|FG000|Overall Study|Ineligible|9
6826892|NCT00121238|10829405|FG000|Overall Study|disease progression before intervention|1
6826893|NCT00121238|10829405|FG000|Overall Study|Protocol Violation|2
6826898|NCT00121641|10829435|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15
6826899|NCT00121641|10829436|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21
6826900|NCT00121641|10829437|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14
6826901|NCT00121641|10829438|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25
6826902|NCT00121641|10829439|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30
6826903|NCT00121641|10829435|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9
6826904|NCT00121641|10829436|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11
6826905|NCT00121641|10829437|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5
6826906|NCT00121641|10829438|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10
6826907|NCT00121641|10829439|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3
6826908|NCT00121641|10829435|FG000|24-week Short-term Treatment Period|Adverse Event|3
6826909|NCT00121641|10829436|FG001|24-week Short-term Treatment Period|Adverse Event|3
6826910|NCT00121641|10829437|FG002|24-week Short-term Treatment Period|Adverse Event|4
6826911|NCT00121641|10829438|FG003|24-week Short-term Treatment Period|Adverse Event|0
6826912|NCT00121641|10829439|FG004|24-week Short-term Treatment Period|Adverse Event|2
6826913|NCT00121641|10829435|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0
6826914|NCT00121641|10829436|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2
6826915|NCT00121641|10829437|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3
6826916|NCT00121641|10829438|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4
6826917|NCT00121641|10829439|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4
6826918|NCT00121641|10829435|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0
6826919|NCT00121641|10829436|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0
6826920|NCT00121641|10829437|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3
6826921|NCT00121641|10829438|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1
6826922|NCT00121641|10829439|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1
6826923|NCT00121641|10829435|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
6826924|NCT00121641|10829436|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
6826925|NCT00121641|10829437|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
6826926|NCT00121641|10829438|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
6826927|NCT00121641|10829439|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
6826928|NCT00121641|10829435|FG000|24-week Short-term Treatment Period|Other Reason|1
6826929|NCT00121641|10829436|FG001|24-week Short-term Treatment Period|Other Reason|0
6826930|NCT00121641|10829437|FG002|24-week Short-term Treatment Period|Other Reason|0
6826931|NCT00121641|10829438|FG003|24-week Short-term Treatment Period|Other Reason|0
6826932|NCT00121641|10829439|FG004|24-week Short-term Treatment Period|Other Reason|0
6826933|NCT00121641|10829435|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26
6826934|NCT00121641|10829436|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27
6826935|NCT00121641|10829437|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21
6826936|NCT00121641|10829438|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26
6826937|NCT00121641|10829439|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25
6826938|NCT00121641|10829435|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25
6826939|NCT00121641|10829436|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28
6826940|NCT00121641|10829437|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17
6826941|NCT00121641|10829438|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24
6826942|NCT00121641|10829439|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10
6826943|NCT00121641|10829435|FG000|48-month Short Term + Long Term Period|Adverse Event|9
6826944|NCT00121641|10829436|FG001|48-month Short Term + Long Term Period|Adverse Event|10
6826945|NCT00121641|10829437|FG002|48-month Short Term + Long Term Period|Adverse Event|10
6826946|NCT00121641|10829438|FG003|48-month Short Term + Long Term Period|Adverse Event|5
6826947|NCT00121641|10829439|FG004|48-month Short Term + Long Term Period|Adverse Event|5
6826948|NCT00121641|10829435|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9
6826949|NCT00121641|10829436|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7
6826950|NCT00121641|10829437|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12
6826951|NCT00121641|10829438|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11
6826952|NCT00121641|10829439|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12
6826953|NCT00121641|10829435|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4
6826954|NCT00121641|10829436|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1
6826955|NCT00121641|10829437|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4
6826956|NCT00121641|10829438|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2
6826957|NCT00121641|10829439|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2
6826958|NCT00121641|10829435|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
6826959|NCT00121641|10829436|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3
6896905|NCT00635492|10915455|FG001|Overall Study|Death|40
6896906|NCT00635492|10915454|FG000|Overall Study|Lost to Follow-up|151
6896907|NCT00635492|10915455|FG001|Overall Study|Lost to Follow-up|172
6896908|NCT00635492|10915454|FG000|Overall Study|Physician Decision|32
6896909|NCT00635492|10915455|FG001|Overall Study|Physician Decision|22
6896910|NCT00635492|10915454|FG000|Overall Study|Sponsor decision|2
6896911|NCT00635492|10915455|FG001|Overall Study|Sponsor decision|3
6896912|NCT00635492|10915454|FG000|Overall Study|Withdrawal by Subject|82
6896913|NCT00635492|10915455|FG001|Overall Study|Withdrawal by Subject|45
6896914|NCT00635570|10915467|FG000|Overall Study|Lost to Follow-up|8
6896915|NCT00635570|10915468|FG001|Overall Study|Lost to Follow-up|8
6896916|NCT00635570|10915467|FG000|Overall Study|Withdrawal by Subject|1
6896917|NCT00635570|10915468|FG001|Overall Study|Withdrawal by Subject|1
6896918|NCT00635570|10915467|FG000|Overall Study|Adverse Event|2
6896919|NCT00635570|10915468|FG001|Overall Study|Adverse Event|0
6896920|NCT00635570|10915467|FG000|Overall Study|Physician Decision|1
6896921|NCT00635570|10915468|FG001|Overall Study|Physician Decision|0
6896922|NCT00635570|10915467|FG000|Overall Study|Did not complete survey|2
6896923|NCT00635570|10915468|FG001|Overall Study|Did not complete survey|1
6896924|NCT00635570|10915467|FG000|Overall Study|Early termination(No sexual activity)|1
6896925|NCT00635570|10915468|FG001|Overall Study|Early termination(No sexual activity)|1
6896926|NCT00635648|10915483|FG000|Overall Study|Adverse Event|12
6896927|NCT00635648|10915483|FG000|Overall Study|Withdrawal by Subject|9
6896928|NCT00635648|10915483|FG000|Overall Study|Physician Decision|4
6896929|NCT00635648|10915483|FG000|Overall Study|Rapid progression of baseline disease|4
6896930|NCT00635648|10915483|FG000|Overall Study|Use of other antifungal agent needed|1
6896931|NCT00635648|10915483|FG000|Overall Study|No improvement after 7-10 days treatment|4
6896932|NCT00635648|10915483|FG000|Overall Study|Noncompliance with protocol|1
6896933|NCT00635648|10915483|FG000|Overall Study|Other reason|2
6896934|NCT00635661|10915487|FG000|Overall Study|Withdrawal by Subject|4
6896935|NCT00635778|10915516|FG000|Overall Study|Adverse Event|1
6896936|NCT00635778|10915517|FG001|Overall Study|Adverse Event|0
6896937|NCT00635778|10915518|FG002|Overall Study|Adverse Event|0
6896938|NCT00635778|10915519|FG003|Overall Study|Adverse Event|3
6896939|NCT00635778|10915520|FG004|Overall Study|Adverse Event|3
6896940|NCT00635778|10915521|FG005|Overall Study|Adverse Event|6
6896941|NCT00635778|10915522|FG006|Overall Study|Adverse Event|1
6896942|NCT00635778|10915516|FG000|Overall Study|Withdrawal by Subject|0
6896943|NCT00635778|10915517|FG001|Overall Study|Withdrawal by Subject|0
6896944|NCT00635778|10915518|FG002|Overall Study|Withdrawal by Subject|0
6896945|NCT00635778|10915519|FG003|Overall Study|Withdrawal by Subject|1
6896946|NCT00635778|10915520|FG004|Overall Study|Withdrawal by Subject|0
6896947|NCT00635778|10915521|FG005|Overall Study|Withdrawal by Subject|1
6896948|NCT00635778|10915522|FG006|Overall Study|Withdrawal by Subject|1
6896949|NCT00635778|10915516|FG000|Overall Study|Progressive disease|0
6896950|NCT00635778|10915517|FG001|Overall Study|Progressive disease|3
6896951|NCT00635778|10915518|FG002|Overall Study|Progressive disease|3
6896952|NCT00635778|10915519|FG003|Overall Study|Progressive disease|4
6896953|NCT00635778|10915520|FG004|Overall Study|Progressive disease|5
6896954|NCT00635778|10915521|FG005|Overall Study|Progressive disease|14
6896955|NCT00635778|10915522|FG006|Overall Study|Progressive disease|4
6896956|NCT00635804|10915547|FG000|Overall Study|Adverse Event|0
6896957|NCT00635804|10915548|FG001|Overall Study|Adverse Event|0
6896958|NCT00635804|10915549|FG002|Overall Study|Adverse Event|0
6896959|NCT00635804|10915550|FG003|Overall Study|Adverse Event|0
6896960|NCT00635804|10915551|FG004|Overall Study|Adverse Event|0
6896961|NCT00635804|10915552|FG005|Overall Study|Adverse Event|1
6896962|NCT00635804|10915553|FG006|Overall Study|Adverse Event|0
6896963|NCT00635804|10915554|FG007|Overall Study|Adverse Event|0
6896964|NCT00635804|10915547|FG000|Overall Study|Withdrawal by Subject|1
6896965|NCT00635804|10915548|FG001|Overall Study|Withdrawal by Subject|0
6896966|NCT00635804|10915549|FG002|Overall Study|Withdrawal by Subject|0
6896967|NCT00635804|10915550|FG003|Overall Study|Withdrawal by Subject|0
6896968|NCT00635804|10915551|FG004|Overall Study|Withdrawal by Subject|0
6896969|NCT00635804|10915552|FG005|Overall Study|Withdrawal by Subject|0
6896970|NCT00635804|10915553|FG006|Overall Study|Withdrawal by Subject|0
6896971|NCT00635804|10915554|FG007|Overall Study|Withdrawal by Subject|0
6896972|NCT00635999|10915606|FG000|Overall Study|Withdrawal by Subject|4
6896973|NCT00635999|10915607|FG001|Overall Study|Withdrawal by Subject|2
6896974|NCT00635999|10915608|FG002|Overall Study|Withdrawal by Subject|1
6901491|NCT00673387|10922345|FG002|Overall Study|Withdrawal by Subject|20
6901492|NCT00673387|10922346|FG003|Overall Study|Withdrawal by Subject|16
6901493|NCT00673387|10922347|FG004|Overall Study|Withdrawal by Subject|18
6901494|NCT00673387|10922348|FG005|Overall Study|Withdrawal by Subject|21
6901495|NCT00673387|10922349|FG006|Overall Study|Withdrawal by Subject|15
6901496|NCT00673387|10922350|FG007|Overall Study|Withdrawal by Subject|21
6901497|NCT00673387|10922343|FG000|Overall Study|Adverse Event|3
6901498|NCT00673387|10922344|FG001|Overall Study|Adverse Event|1
6901499|NCT00673387|10922345|FG002|Overall Study|Adverse Event|5
6901500|NCT00673387|10922346|FG003|Overall Study|Adverse Event|2
6901501|NCT00673387|10922347|FG004|Overall Study|Adverse Event|6
6901502|NCT00673387|10922348|FG005|Overall Study|Adverse Event|2
6901503|NCT00673387|10922349|FG006|Overall Study|Adverse Event|5
6901504|NCT00673387|10922350|FG007|Overall Study|Adverse Event|5
6901505|NCT00673387|10922343|FG000|Overall Study|Physician Decision|0
6901506|NCT00673387|10922344|FG001|Overall Study|Physician Decision|0
6901507|NCT00673387|10922345|FG002|Overall Study|Physician Decision|0
6901508|NCT00673387|10922346|FG003|Overall Study|Physician Decision|0
6901509|NCT00673387|10922347|FG004|Overall Study|Physician Decision|0
6901510|NCT00673387|10922348|FG005|Overall Study|Physician Decision|5
6901511|NCT00673387|10922349|FG006|Overall Study|Physician Decision|1
6901512|NCT00673387|10922350|FG007|Overall Study|Physician Decision|1
6901513|NCT00673387|10922343|FG000|Overall Study|Protocol Violation|3
6901514|NCT00673387|10922344|FG001|Overall Study|Protocol Violation|0
6901515|NCT00673387|10922345|FG002|Overall Study|Protocol Violation|1
6901516|NCT00673387|10922346|FG003|Overall Study|Protocol Violation|2
6901517|NCT00673387|10922347|FG004|Overall Study|Protocol Violation|0
6901518|NCT00673387|10922348|FG005|Overall Study|Protocol Violation|1
6901519|NCT00673387|10922349|FG006|Overall Study|Protocol Violation|1
6901520|NCT00673387|10922350|FG007|Overall Study|Protocol Violation|3
6901521|NCT00673387|10922343|FG000|Overall Study|Lost to Follow-up|8
6901522|NCT00673387|10922344|FG001|Overall Study|Lost to Follow-up|6
6901523|NCT00673387|10922345|FG002|Overall Study|Lost to Follow-up|5
6901524|NCT00673387|10922346|FG003|Overall Study|Lost to Follow-up|6
6901525|NCT00673387|10922347|FG004|Overall Study|Lost to Follow-up|6
6901526|NCT00673387|10922348|FG005|Overall Study|Lost to Follow-up|5
6901527|NCT00673387|10922349|FG006|Overall Study|Lost to Follow-up|8
6901528|NCT00673387|10922350|FG007|Overall Study|Lost to Follow-up|5
6901529|NCT00673452|10922395|FG000|Acute Double-Blind Phase|Adverse Event|41
6901530|NCT00673452|10922396|FG001|Acute Double-Blind Phase|Adverse Event|24
6901531|NCT00673452|10922395|FG000|Acute Double-Blind Phase|Lack of Efficacy|9
6901532|NCT00673452|10922396|FG001|Acute Double-Blind Phase|Lack of Efficacy|14
6901533|NCT00673452|10922395|FG000|Acute Double-Blind Phase|Lost to Follow-up|16
6901534|NCT00673452|10922396|FG001|Acute Double-Blind Phase|Lost to Follow-up|19
6901535|NCT00673452|10922395|FG000|Acute Double-Blind Phase|Physician Decision|0
6901536|NCT00673452|10922396|FG001|Acute Double-Blind Phase|Physician Decision|6
6901537|NCT00673452|10922395|FG000|Acute Double-Blind Phase|Protocol Violation|5
6901538|NCT00673452|10922396|FG001|Acute Double-Blind Phase|Protocol Violation|3
6901539|NCT00673452|10922395|FG000|Acute Double-Blind Phase|Sponsor Decision|0
6901540|NCT00673452|10922396|FG001|Acute Double-Blind Phase|Sponsor Decision|1
6901541|NCT00673452|10922395|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16
6901542|NCT00673452|10922396|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13
6901543|NCT00673452|10922395|FG000|Continuation Double-Blind Phase|Adverse Event|5
6901544|NCT00673452|10922396|FG001|Continuation Double-Blind Phase|Adverse Event|13
6901545|NCT00673452|10922395|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9
6901546|NCT00673452|10922396|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5
6901547|NCT00673452|10922395|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4
6901548|NCT00673452|10922396|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5
6901549|NCT00673452|10922395|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2
6901550|NCT00673452|10922396|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5
6901551|NCT00673452|10922395|FG000|Continuation Double-Blind Phase|Protocol Violation|2
6901552|NCT00673452|10922396|FG001|Continuation Double-Blind Phase|Protocol Violation|3
6901553|NCT00673452|10922395|FG000|Continuation Double-Blind Phase|Sponsor Decision|0
6901554|NCT00673452|10922396|FG001|Continuation Double-Blind Phase|Sponsor Decision|3
6901555|NCT00673452|10922395|FG000|Continuation Double-Blind Phase|Physician Decision|2
6901556|NCT00673452|10922396|FG001|Continuation Double-Blind Phase|Physician Decision|0
6901557|NCT00673452|10922395|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1
6901558|NCT00673452|10922396|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0
6901559|NCT00673465|10922402|FG000|Part 1/Period 1 (United States)|Protocol Violation|0
6901560|NCT00673465|10922403|FG001|Part 1/Period 1 (United States)|Protocol Violation|0
6901561|NCT00673465|10922404|FG002|Part 1/Period 1 (United States)|Protocol Violation|0
6901562|NCT00673465|10922405|FG003|Part 1/Period 1 (United States)|Protocol Violation|0
6901563|NCT00673465|10922406|FG004|Part 1/Period 1 (United States)|Protocol Violation|1
6901564|NCT00673465|10922407|FG005|Part 1/Period 1 (United States)|Protocol Violation|1
6901565|NCT00673465|10922408|FG006|Part 1/Period 1 (United States)|Protocol Violation|0
6901566|NCT00673465|10922409|FG007|Part 1/Period 1 (United States)|Protocol Violation|0
6901567|NCT00673465|10922410|FG008|Part 1/Period 1 (United States)|Protocol Violation|0
6901568|NCT00673465|10922411|FG009|Part 1/Period 1 (United States)|Protocol Violation|0
6901569|NCT00673465|10922412|FG010|Part 1/Period 1 (United States)|Protocol Violation|0
6901570|NCT00673465|10922413|FG011|Part 1/Period 1 (United States)|Protocol Violation|0
6901571|NCT00673465|10922402|FG000|Part 1/Period 2 (United States)|Protocol Violation|0
6901572|NCT00673465|10922403|FG001|Part 1/Period 2 (United States)|Protocol Violation|0
6901573|NCT00673465|10922404|FG002|Part 1/Period 2 (United States)|Protocol Violation|0
6901574|NCT00673465|10922405|FG003|Part 1/Period 2 (United States)|Protocol Violation|0
6901575|NCT00673465|10922406|FG004|Part 1/Period 2 (United States)|Protocol Violation|1
6901576|NCT00673465|10922407|FG005|Part 1/Period 2 (United States)|Protocol Violation|0
6901577|NCT00673465|10922408|FG006|Part 1/Period 2 (United States)|Protocol Violation|0
6901578|NCT00673465|10922409|FG007|Part 1/Period 2 (United States)|Protocol Violation|0
6901579|NCT00673465|10922410|FG008|Part 1/Period 2 (United States)|Protocol Violation|0
6901580|NCT00673465|10922411|FG009|Part 1/Period 2 (United States)|Protocol Violation|0
6901581|NCT00673465|10922412|FG010|Part 1/Period 2 (United States)|Protocol Violation|0
6901582|NCT00673465|10922413|FG011|Part 1/Period 2 (United States)|Protocol Violation|0
6901583|NCT00673660|10922421|FG000|Overall Study|Lost to Follow-up|107
6901584|NCT00673673|10922430|FG000|Overall Study|Progressive disease|27
6901585|NCT00673673|10922430|FG000|Overall Study|Adverse Event|4
6901586|NCT00673673|10922430|FG000|Overall Study|Withdrawal by Subject|3
6901587|NCT00673673|10922430|FG000|Overall Study|Investigators' discretion|2
6901588|NCT00673790|10922457|FG000|Overall Study|Adverse Event|23
6901589|NCT00673790|10922458|FG001|Overall Study|Adverse Event|14
6901590|NCT00673790|10922459|FG002|Overall Study|Adverse Event|2
6901591|NCT00673790|10922457|FG000|Overall Study|Lack of Efficacy|2
6901592|NCT00673790|10922458|FG001|Overall Study|Lack of Efficacy|2
6901593|NCT00673790|10922459|FG002|Overall Study|Lack of Efficacy|2
6901594|NCT00673790|10922457|FG000|Overall Study|Protocol Violation|6
6901595|NCT00673790|10922458|FG001|Overall Study|Protocol Violation|9
6901596|NCT00673790|10922459|FG002|Overall Study|Protocol Violation|1
6901597|NCT00673790|10922457|FG000|Overall Study|Withdrawal by Subject|7
6901598|NCT00673790|10922458|FG001|Overall Study|Withdrawal by Subject|4
6901599|NCT00673790|10922459|FG002|Overall Study|Withdrawal by Subject|1
6901600|NCT00673790|10922457|FG000|Overall Study|Lost to Follow-up|6
6901601|NCT00673790|10922458|FG001|Overall Study|Lost to Follow-up|6
6901602|NCT00673790|10922459|FG002|Overall Study|Lost to Follow-up|5
6901603|NCT00673790|10922457|FG000|Overall Study|Sponsor Terminated due to PI oversight|0
6901604|NCT00673790|10922458|FG001|Overall Study|Sponsor Terminated due to PI oversight|1
6901605|NCT00673790|10922459|FG002|Overall Study|Sponsor Terminated due to PI oversight|0
6901606|NCT00673790|10922457|FG000|Overall Study|Poor compliance|1
6901607|NCT00673790|10922458|FG001|Overall Study|Poor compliance|0
6901608|NCT00673790|10922459|FG002|Overall Study|Poor compliance|0
6901609|NCT00673790|10922457|FG000|Overall Study|Participated in two Nebivolol studies|0
6901610|NCT00673790|10922458|FG001|Overall Study|Participated in two Nebivolol studies|0
6901611|NCT00673790|10922459|FG002|Overall Study|Participated in two Nebivolol studies|1
6901612|NCT00673790|10922457|FG000|Overall Study|Unconfirmed pregnancy|0
6901613|NCT00673790|10922458|FG001|Overall Study|Unconfirmed pregnancy|1
6901614|NCT00673790|10922459|FG002|Overall Study|Unconfirmed pregnancy|0
6901615|NCT00673790|10922457|FG000|Overall Study|Randomization criteria not met|0
6901616|NCT00673790|10922458|FG001|Overall Study|Randomization criteria not met|1
6901617|NCT00673790|10922459|FG002|Overall Study|Randomization criteria not met|0
6901618|NCT00673816|10922468|FG000|Overall Study|Adverse Event|1
6901619|NCT00673816|10922468|FG000|Overall Study|Withdrawal by Subject|1
6901620|NCT00673881|10922480|FG000|Overall Study|Withdrawal by Subject|1
6901621|NCT00673894|10922486|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1
6901622|NCT00673894|10922487|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0
6901623|NCT00673894|10922486|FG000|First Intervention 4 Weeks|Adverse Event|1
6901624|NCT00673894|10922487|FG001|First Intervention 4 Weeks|Adverse Event|0
6901625|NCT00673920|10922501|FG000|Baseline up to Week 48|Withdrew consent|1
6901626|NCT00673920|10922502|FG001|Baseline up to Week 48|Withdrew consent|0
6901627|NCT00673920|10922503|FG002|Baseline up to Week 48|Withdrew consent|2
6901628|NCT00673920|10922504|FG003|Baseline up to Week 48|Withdrew consent|0
6901629|NCT00673920|10922505|FG004|Baseline up to Week 48|Withdrew consent|0
6901630|NCT00673920|10922506|FG005|Baseline up to Week 48|Withdrew consent|0
6901631|NCT00673920|10922507|FG006|Baseline up to Week 48|Withdrew consent|0
6901632|NCT00673920|10922508|FG007|Baseline up to Week 48|Withdrew consent|0
6901633|NCT00673920|10922501|FG000|Baseline up to Week 48|Refused treatment|1
6901634|NCT00673920|10922502|FG001|Baseline up to Week 48|Refused treatment|0
6901635|NCT00673920|10922503|FG002|Baseline up to Week 48|Refused treatment|0
6901636|NCT00673920|10922504|FG003|Baseline up to Week 48|Refused treatment|0
6901637|NCT00673920|10922505|FG004|Baseline up to Week 48|Refused treatment|0
6901638|NCT00673920|10922506|FG005|Baseline up to Week 48|Refused treatment|0
6901639|NCT00673920|10922507|FG006|Baseline up to Week 48|Refused treatment|0
6901640|NCT00673920|10922508|FG007|Baseline up to Week 48|Refused treatment|0
6901641|NCT00673920|10922501|FG000|Baseline up to Week 48|Insufficient therapeutic response|2
6901642|NCT00673920|10922502|FG001|Baseline up to Week 48|Insufficient therapeutic response|1
6901643|NCT00673920|10922503|FG002|Baseline up to Week 48|Insufficient therapeutic response|0
6901644|NCT00673920|10922504|FG003|Baseline up to Week 48|Insufficient therapeutic response|0
6901645|NCT00673920|10922505|FG004|Baseline up to Week 48|Insufficient therapeutic response|0
6901646|NCT00673920|10922506|FG005|Baseline up to Week 48|Insufficient therapeutic response|0
6901647|NCT00673920|10922507|FG006|Baseline up to Week 48|Insufficient therapeutic response|0
6901648|NCT00673920|10922508|FG007|Baseline up to Week 48|Insufficient therapeutic response|0
6901649|NCT00673920|10922501|FG000|Baseline up to Week 48|Protocol Violation|0
6901650|NCT00673920|10922502|FG001|Baseline up to Week 48|Protocol Violation|0
6901651|NCT00673920|10922503|FG002|Baseline up to Week 48|Protocol Violation|1
6901652|NCT00673920|10922504|FG003|Baseline up to Week 48|Protocol Violation|0
6901653|NCT00673920|10922505|FG004|Baseline up to Week 48|Protocol Violation|0
6901654|NCT00673920|10922506|FG005|Baseline up to Week 48|Protocol Violation|0
6901655|NCT00673920|10922507|FG006|Baseline up to Week 48|Protocol Violation|0
6901656|NCT00673920|10922508|FG007|Baseline up to Week 48|Protocol Violation|0
6901657|NCT00673920|10922501|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0
6901658|NCT00673920|10922502|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0
6901659|NCT00673920|10922503|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1
6901660|NCT00673920|10922504|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0
6901661|NCT00673920|10922505|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0
6901662|NCT00673920|10922506|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0
6901663|NCT00673920|10922507|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0
6901664|NCT00673920|10922508|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0
6901665|NCT00673920|10922501|FG000|Baseline up to Week 48|Administrative/Other|0
6901666|NCT00673920|10922502|FG001|Baseline up to Week 48|Administrative/Other|1
6901667|NCT00673920|10922503|FG002|Baseline up to Week 48|Administrative/Other|2
6901668|NCT00673920|10922504|FG003|Baseline up to Week 48|Administrative/Other|0
6901669|NCT00673920|10922505|FG004|Baseline up to Week 48|Administrative/Other|0
6901670|NCT00673920|10922506|FG005|Baseline up to Week 48|Administrative/Other|0
6901671|NCT00673920|10922507|FG006|Baseline up to Week 48|Administrative/Other|0
6901672|NCT00673920|10922508|FG007|Baseline up to Week 48|Administrative/Other|0
6901673|NCT00673920|10922501|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0
6901674|NCT00673920|10922502|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1
6901675|NCT00673920|10922503|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1
6901676|NCT00673920|10922504|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0
6901677|NCT00673920|10922505|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0
6901678|NCT00673920|10922506|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0
6901679|NCT00673920|10922507|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0
6901680|NCT00673920|10922508|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0
6901681|NCT00673920|10922501|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0
6901682|NCT00673920|10922502|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0
6901683|NCT00673920|10922503|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0
6901684|NCT00673920|10922504|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0
6901685|NCT00673920|10922505|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0
6901686|NCT00673920|10922506|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0
6901687|NCT00673920|10922507|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1
6901688|NCT00673920|10922508|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0
6901689|NCT00673920|10922501|FG000|Week 24 to Week 48|Failure to return|0
6901690|NCT00673920|10922502|FG001|Week 24 to Week 48|Failure to return|0
6901691|NCT00673920|10922503|FG002|Week 24 to Week 48|Failure to return|0
6901692|NCT00673920|10922504|FG003|Week 24 to Week 48|Failure to return|0
6901693|NCT00673920|10922505|FG004|Week 24 to Week 48|Failure to return|0
6901694|NCT00673920|10922506|FG005|Week 24 to Week 48|Failure to return|1
6901695|NCT00673920|10922507|FG006|Week 24 to Week 48|Failure to return|0
6901696|NCT00673920|10922508|FG007|Week 24 to Week 48|Failure to return|0
6901697|NCT00673920|10922501|FG000|Week 24 to Week 48|Insufficient therapeutic response|0
6901698|NCT00673920|10922502|FG001|Week 24 to Week 48|Insufficient therapeutic response|0
6901699|NCT00673920|10922503|FG002|Week 24 to Week 48|Insufficient therapeutic response|0
6901700|NCT00673920|10922504|FG003|Week 24 to Week 48|Insufficient therapeutic response|0
6901701|NCT00673920|10922505|FG004|Week 24 to Week 48|Insufficient therapeutic response|0
6901702|NCT00673920|10922506|FG005|Week 24 to Week 48|Insufficient therapeutic response|1
6901703|NCT00673920|10922507|FG006|Week 24 to Week 48|Insufficient therapeutic response|0
6901704|NCT00673920|10922508|FG007|Week 24 to Week 48|Insufficient therapeutic response|0
6901705|NCT00673920|10922501|FG000|Week 24 to Week 48|Death|0
6901706|NCT00673920|10922502|FG001|Week 24 to Week 48|Death|0
6901707|NCT00673920|10922503|FG002|Week 24 to Week 48|Death|0
6901708|NCT00673920|10922504|FG003|Week 24 to Week 48|Death|0
6901709|NCT00673920|10922505|FG004|Week 24 to Week 48|Death|0
6901710|NCT00673920|10922506|FG005|Week 24 to Week 48|Death|1
6901711|NCT00673920|10922507|FG006|Week 24 to Week 48|Death|0
6901712|NCT00673920|10922508|FG007|Week 24 to Week 48|Death|0
6901713|NCT00673920|10922501|FG000|Week 24 to Week 48|Adminstrative/Other|0
6901714|NCT00673920|10922502|FG001|Week 24 to Week 48|Adminstrative/Other|0
6901715|NCT00673920|10922503|FG002|Week 24 to Week 48|Adminstrative/Other|0
6901716|NCT00673920|10922504|FG003|Week 24 to Week 48|Adminstrative/Other|1
6901717|NCT00673920|10922505|FG004|Week 24 to Week 48|Adminstrative/Other|0
6901718|NCT00673920|10922506|FG005|Week 24 to Week 48|Adminstrative/Other|0
6901719|NCT00673920|10922507|FG006|Week 24 to Week 48|Adminstrative/Other|0
6901720|NCT00673920|10922508|FG007|Week 24 to Week 48|Adminstrative/Other|0
6901721|NCT00673933|10922530|FG000|Overall Study|Withdrawal by Subject|2
6901722|NCT00673933|10922530|FG000|Overall Study|Lost to Follow-up|1
6901723|NCT00674128|10922557|FG000|Overall Study|Withdrawal by Subject|25
6901724|NCT00674128|10922558|FG001|Overall Study|Withdrawal by Subject|23
6901725|NCT00674154|10922566|FG000|Overall Study|Withdrawal by Subject|3
6901726|NCT00674154|10922567|FG001|Overall Study|Withdrawal by Subject|1
6901727|NCT00674154|10922566|FG000|Overall Study|Did not want parathyroidectomy|0
6901728|NCT00674154|10922567|FG001|Overall Study|Did not want parathyroidectomy|2
6901729|NCT00674323|10922599|FG000|Overall Study|Adverse Event|0
6901730|NCT00674323|10922600|FG001|Overall Study|Adverse Event|1
6901731|NCT00674323|10922601|FG002|Overall Study|Adverse Event|0
6901732|NCT00674323|10922599|FG000|Overall Study|Protocol Violation|1
6901733|NCT00674323|10922600|FG001|Overall Study|Protocol Violation|0
6901734|NCT00674323|10922601|FG002|Overall Study|Protocol Violation|0
6901735|NCT00674362|10922611|FG000|Double Blind|Adverse Event|6
6901736|NCT00674362|10922612|FG001|Double Blind|Adverse Event|6
6901737|NCT00674362|10922611|FG000|Double Blind|Lack of Efficacy|2
6901738|NCT00674362|10922612|FG001|Double Blind|Lack of Efficacy|6
6901739|NCT00674362|10922611|FG000|Double Blind|Loss of efficacy|0
6901740|NCT00674362|10922612|FG001|Double Blind|Loss of efficacy|1
6901741|NCT00674362|10922611|FG000|Double Blind|Withdrawal by Subject|4
6901742|NCT00674362|10922612|FG001|Double Blind|Withdrawal by Subject|3
6901743|NCT00674362|10922611|FG000|Double Blind|Other: Loss of Patient Compliance|0
6901744|NCT00674362|10922612|FG001|Double Blind|Other: Loss of Patient Compliance|1
6901745|NCT00674362|10922611|FG000|Double Blind|Other: Surgery|0
6901746|NCT00674362|10922612|FG001|Double Blind|Other: Surgery|1
6901747|NCT00674362|10922611|FG000|Open Label|Adverse Event|1
6901748|NCT00674362|10922612|FG001|Open Label|Adverse Event|0
6901749|NCT00674362|10922611|FG000|Open Label|Other: Subject moved to extension study|1
6901750|NCT00674362|10922612|FG001|Open Label|Other: Subject moved to extension study|0
6901751|NCT00674570|10922643|FG000|Overall Study|Withdrawal by Subject|0
6901752|NCT00674570|10922644|FG001|Overall Study|Withdrawal by Subject|2
6901753|NCT00674570|10922645|FG002|Overall Study|Withdrawal by Subject|0
6901754|NCT00674661|10922694|FG000|Overall Study|Other|5
6901755|NCT00674661|10922695|FG001|Overall Study|Other|7
6901756|NCT00674661|10922694|FG000|Overall Study|Lost to Follow-up|6
6901757|NCT00674661|10922695|FG001|Overall Study|Lost to Follow-up|3
6901758|NCT00674661|10922694|FG000|Overall Study|Withdrawal by Subject|0
6901759|NCT00674661|10922695|FG001|Overall Study|Withdrawal by Subject|5
6901760|NCT00674700|10922704|FG000|Year 1|Adverse Event|17
6901761|NCT00674700|10922705|FG001|Year 1|Adverse Event|20
6901762|NCT00674700|10922706|FG002|Year 1|Adverse Event|5
6901763|NCT00674700|10922704|FG000|Year 1|Withdrawal by Subject|7
6901764|NCT00674700|10922705|FG001|Year 1|Withdrawal by Subject|7
6901765|NCT00674700|10922706|FG002|Year 1|Withdrawal by Subject|6
6901766|NCT00674700|10922704|FG000|Year 1|Any other reason not above-mentioned|7
6901767|NCT00674700|10922705|FG001|Year 1|Any other reason not above-mentioned|7
6901768|NCT00674700|10922706|FG002|Year 1|Any other reason not above-mentioned|6
6901769|NCT00674700|10922704|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0
6901770|NCT00674700|10922705|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1
6901771|NCT00674700|10922706|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1
6901772|NCT00674700|10922704|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
6901773|NCT00674700|10922705|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
6901774|NCT00674700|10922706|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4
6901775|NCT00674700|10922704|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5
6901776|NCT00674700|10922705|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10
6901777|NCT00674700|10922706|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7
6901778|NCT00674817|10922736|FG000|Period 1|Withdrawal by Subject|2
6901779|NCT00674817|10922736|FG000|Period 1|Protocol Violation|1
6901780|NCT00674817|10922736|FG000|Period 3|Adverse Event|1
6901781|NCT00674817|10922736|FG000|Period 3|Protocol Violation|1
6901782|NCT00674817|10922736|FG000|Period 4|Adverse Event|1
6901783|NCT00674973|10922752|FG000|Overall Study|Insufficient Therapeutic Response|77
6901784|NCT00674973|10922753|FG001|Overall Study|Insufficient Therapeutic Response|72
6901785|NCT00674973|10922752|FG000|Overall Study|Refused Treatment|1
6901786|NCT00674973|10922753|FG001|Overall Study|Refused Treatment|5
6901787|NCT00674973|10922752|FG000|Overall Study|Failure to Return|1
6901788|NCT00674973|10922753|FG001|Overall Study|Failure to Return|0
6901789|NCT00674973|10922752|FG000|Overall Study|Adverse Event|2
6901790|NCT00674973|10922753|FG001|Overall Study|Adverse Event|9
6901791|NCT00674973|10922752|FG000|Overall Study|Death|19
6901792|NCT00674973|10922753|FG001|Overall Study|Death|15
6901793|NCT00674973|10922752|FG000|Overall Study|Protocol Violation|0
6901794|NCT00674973|10922753|FG001|Overall Study|Protocol Violation|1
6901795|NCT00674986|10922761|FG000|Overall Study|Adverse Event|2
6901796|NCT00674986|10922762|FG001|Overall Study|Adverse Event|1
6901797|NCT00674986|10922761|FG000|Overall Study|Subject withdrew consent|12
6901798|NCT00674986|10922762|FG001|Overall Study|Subject withdrew consent|19
6901799|NCT00674986|10922761|FG000|Overall Study|Lost to Follow-up|25
6901800|NCT00674986|10922762|FG001|Overall Study|Lost to Follow-up|53
6901801|NCT00674986|10922761|FG000|Overall Study|Other reasons|4
6901802|NCT00674986|10922762|FG001|Overall Study|Other reasons|8
6901803|NCT00675025|10922771|FG000|Overall Study|Study Terminated by Sponsor|38
6901804|NCT00675025|10922772|FG001|Overall Study|Study Terminated by Sponsor|42
6901805|NCT00675025|10922771|FG000|Overall Study|Adverse Event|6
6901806|NCT00675025|10922772|FG001|Overall Study|Adverse Event|11
6901807|NCT00675025|10922771|FG000|Overall Study|Lost to Follow-up|6
6901808|NCT00675025|10922772|FG001|Overall Study|Lost to Follow-up|4
6901809|NCT00675025|10922771|FG000|Overall Study|Withdrawal by Subject|4
6901810|NCT00675025|10922772|FG001|Overall Study|Withdrawal by Subject|6
6901811|NCT00675103|10922778|FG000|Overall Study|Lack of Efficacy|2
6901812|NCT00675103|10922778|FG000|Overall Study|Adverse Event|1
6901813|NCT00675428|10922801|FG000|Overall Study|Disease Progression|2
6901814|NCT00675428|10922802|FG001|Overall Study|Disease Progression|2
6901815|NCT00675428|10922801|FG000|Overall Study|No Disease Response After Cycle 6|0
6901816|NCT00675428|10922802|FG001|Overall Study|No Disease Response After Cycle 6|1
6901817|NCT00675428|10922801|FG000|Overall Study|Physician Decision|1
6901818|NCT00675428|10922802|FG001|Overall Study|Physician Decision|0
6901819|NCT00675441|10922808|FG000|Overall Study|Withdrawal by Subject|2
6901820|NCT00675441|10922808|FG000|Overall Study|Death|1
6901821|NCT00675506|10922814|FG000|Overall Study|Lost to Follow-up|1
6901822|NCT00675506|10922815|FG001|Overall Study|Lost to Follow-up|5
6901823|NCT00675506|10922814|FG000|Overall Study|Lost interest|3
6901824|NCT00675506|10922815|FG001|Overall Study|Lost interest|5
6901825|NCT00675506|10922814|FG000|Overall Study|Elevated fasting glucose|2
6901826|NCT00675506|10922815|FG001|Overall Study|Elevated fasting glucose|1
6901827|NCT00675506|10922814|FG000|Overall Study|Elevated IGF-1 prior to treatment|1
6901828|NCT00675506|10922815|FG001|Overall Study|Elevated IGF-1 prior to treatment|0
6901829|NCT00675506|10922814|FG000|Overall Study|Elevated IGF-1|2
6901830|NCT00675506|10922815|FG001|Overall Study|Elevated IGF-1|0
6901831|NCT00675506|10922814|FG000|Overall Study|Hypersensitivity Reaction|1
6901832|NCT00675506|10922815|FG001|Overall Study|Hypersensitivity Reaction|0
6901833|NCT00675506|10922814|FG000|Overall Study|Disclosed history of cancer|1
6901834|NCT00675506|10922815|FG001|Overall Study|Disclosed history of cancer|0
6901835|NCT00675506|10922814|FG000|Overall Study|Declined participation|1
6901836|NCT00675506|10922815|FG001|Overall Study|Declined participation|0
6901837|NCT00675506|10922814|FG000|Overall Study|Schedule conflict|0
6901838|NCT00675506|10922815|FG001|Overall Study|Schedule conflict|1
6901839|NCT00675597|10922844|FG000|Overall Study|Withdrawal by Subject|3
6901840|NCT00675766|10922852|FG000|Overall Study|Lost to Follow-up|6
6901841|NCT00675766|10922853|FG001|Overall Study|Lost to Follow-up|5
6901842|NCT00675766|10922854|FG002|Overall Study|Lost to Follow-up|21
6901843|NCT00675766|10922855|FG003|Overall Study|Lost to Follow-up|26
6901844|NCT00675948|10922894|FG000|Overall Study|Adverse Event|23
6901845|NCT00675948|10922895|FG001|Overall Study|Adverse Event|1
6901846|NCT00675948|10922894|FG000|Overall Study|Lack of Efficacy|3
6901847|NCT00675948|10922895|FG001|Overall Study|Lack of Efficacy|0
6901848|NCT00675948|10922894|FG000|Overall Study|Withdrawal by Subject|7
6901849|NCT00675948|10922895|FG001|Overall Study|Withdrawal by Subject|0
6901850|NCT00675948|10922894|FG000|Overall Study|Lost to Follow-up|2
6901851|NCT00675948|10922895|FG001|Overall Study|Lost to Follow-up|0
6901852|NCT00675948|10922894|FG000|Overall Study|Protocol Violation|1
6901853|NCT00675948|10922895|FG001|Overall Study|Protocol Violation|0
6901854|NCT00675948|10922894|FG000|Overall Study|Pain under control|1
6901855|NCT00675948|10922895|FG001|Overall Study|Pain under control|0
6901856|NCT00675948|10922894|FG000|Overall Study|Sponsor decision|0
6901857|NCT00675948|10922895|FG001|Overall Study|Sponsor decision|1
6901858|NCT00675948|10922894|FG000|Overall Study|Patient died|1
6901859|NCT00675948|10922895|FG001|Overall Study|Patient died|0
6901860|NCT00675948|10922894|FG000|Overall Study|Patient unable to comply with diaries|1
6901861|NCT00675948|10922895|FG001|Overall Study|Patient unable to comply with diaries|0
6901862|NCT00675948|10922894|FG000|Overall Study|Patient feels unable to take medication|0
6901863|NCT00675948|10922895|FG001|Overall Study|Patient feels unable to take medication|1
6901864|NCT00676052|10922926|FG000|Overall Study|Adverse Event|0
6901865|NCT00676052|10922927|FG001|Overall Study|Adverse Event|1
6901866|NCT00676052|10922928|FG002|Overall Study|Adverse Event|1
6901867|NCT00676052|10922929|FG003|Overall Study|Adverse Event|2
6901868|NCT00676052|10922930|FG004|Overall Study|Adverse Event|2
6901869|NCT00676052|10922931|FG005|Overall Study|Adverse Event|2
6901870|NCT00676052|10922926|FG000|Overall Study|Lack of Efficacy|2
6901871|NCT00676052|10922927|FG001|Overall Study|Lack of Efficacy|2
6901872|NCT00676052|10922928|FG002|Overall Study|Lack of Efficacy|1
6901873|NCT00676052|10922929|FG003|Overall Study|Lack of Efficacy|1
6901874|NCT00676052|10922930|FG004|Overall Study|Lack of Efficacy|2
6901875|NCT00676052|10922931|FG005|Overall Study|Lack of Efficacy|1
6901876|NCT00676052|10922926|FG000|Overall Study|Protocol Violation|5
6901877|NCT00676052|10922927|FG001|Overall Study|Protocol Violation|3
6901878|NCT00676052|10922928|FG002|Overall Study|Protocol Violation|2
6901879|NCT00676052|10922929|FG003|Overall Study|Protocol Violation|2
6901880|NCT00676052|10922930|FG004|Overall Study|Protocol Violation|1
6901881|NCT00676052|10922931|FG005|Overall Study|Protocol Violation|2
6901882|NCT00676052|10922926|FG000|Overall Study|Lost to Follow-up|0
6901883|NCT00676052|10922927|FG001|Overall Study|Lost to Follow-up|0
6901884|NCT00676052|10922928|FG002|Overall Study|Lost to Follow-up|0
6901885|NCT00676052|10922929|FG003|Overall Study|Lost to Follow-up|0
6901886|NCT00676052|10922930|FG004|Overall Study|Lost to Follow-up|1
6901887|NCT00676052|10922931|FG005|Overall Study|Lost to Follow-up|0
6901888|NCT00676052|10922926|FG000|Overall Study|Physician Decision|1
6901889|NCT00676052|10922927|FG001|Overall Study|Physician Decision|1
6901890|NCT00676052|10922928|FG002|Overall Study|Physician Decision|1
6901891|NCT00676052|10922929|FG003|Overall Study|Physician Decision|0
6901892|NCT00676052|10922930|FG004|Overall Study|Physician Decision|0
6901893|NCT00676052|10922931|FG005|Overall Study|Physician Decision|1
6901894|NCT00676052|10922926|FG000|Overall Study|Withdrawal by Subject|1
6901895|NCT00676052|10922927|FG001|Overall Study|Withdrawal by Subject|0
6901896|NCT00676052|10922928|FG002|Overall Study|Withdrawal by Subject|1
6901897|NCT00676052|10922929|FG003|Overall Study|Withdrawal by Subject|0
6901898|NCT00676052|10922930|FG004|Overall Study|Withdrawal by Subject|0
6901899|NCT00676052|10922931|FG005|Overall Study|Withdrawal by Subject|0
6901900|NCT00676091|10922960|FG000|Infant Series|Parent or legal guardian request|10
6901901|NCT00676091|10922961|FG001|Infant Series|Parent or legal guardian request|8
6901902|NCT00676091|10922960|FG000|Infant Series|Protocol Violation|6
6901903|NCT00676091|10922961|FG001|Infant Series|Protocol Violation|3
6901904|NCT00676091|10922960|FG000|Infant Series|Adverse Event|2
6901905|NCT00676091|10922961|FG001|Infant Series|Adverse Event|3
6901906|NCT00676091|10922960|FG000|Infant Series|Failed to return|1
6901907|NCT00676091|10922961|FG001|Infant Series|Failed to return|3
6901908|NCT00676091|10922960|FG000|Infant Series|Lost to Follow-up|1
6901909|NCT00676091|10922961|FG001|Infant Series|Lost to Follow-up|0
6901910|NCT00676091|10922960|FG000|Infant Series|Died prior to receiving 7vPnC|0
6901911|NCT00676091|10922961|FG001|Infant Series|Died prior to receiving 7vPnC|1
6901912|NCT00676091|10922960|FG000|After Infant Series|Adverse Event|0
6901913|NCT00676091|10922961|FG001|After Infant Series|Adverse Event|1
6901914|NCT00676091|10922960|FG000|After Infant Series|Protocol Violation|0
6901915|NCT00676091|10922961|FG001|After Infant Series|Protocol Violation|1
6901916|NCT00676091|10922960|FG000|After Infant Series|Failed to return|1
6901917|NCT00676091|10922961|FG001|After Infant Series|Failed to return|1
6901918|NCT00676091|10922960|FG000|Toddler Dose|Failed to return|2
6901919|NCT00676091|10922961|FG001|Toddler Dose|Failed to return|0
6901920|NCT00676091|10922960|FG000|Toddler Dose|Parent or legal guardian request|1
6901921|NCT00676091|10922961|FG001|Toddler Dose|Parent or legal guardian request|0
6901922|NCT00676130|10922973|FG000|Overall Study|Lost to Follow-up|0
6901923|NCT00676130|10922974|FG001|Overall Study|Lost to Follow-up|1
6901924|NCT00676130|10922973|FG000|Overall Study|Found ineligible|3
6901925|NCT00676130|10922974|FG001|Overall Study|Found ineligible|2
6901926|NCT00676130|10922973|FG000|Overall Study|Withdrawal by Subject|0
6901927|NCT00676130|10922974|FG001|Overall Study|Withdrawal by Subject|1
6901928|NCT00676143|10922982|FG000|Overall Study|Adverse Event|34
6901929|NCT00676143|10922983|FG001|Overall Study|Adverse Event|60
6901930|NCT00676143|10922982|FG000|Overall Study|Death|4
6901931|NCT00676143|10922983|FG001|Overall Study|Death|4
6901932|NCT00676143|10922982|FG000|Overall Study|Lack of Efficacy|0
6901933|NCT00676143|10922983|FG001|Overall Study|Lack of Efficacy|6
6901934|NCT00676143|10922982|FG000|Overall Study|Lost to Follow-up|0
6901935|NCT00676143|10922983|FG001|Overall Study|Lost to Follow-up|13
6901936|NCT00676143|10922982|FG000|Overall Study|Physician Decision|5
6901937|NCT00676143|10922983|FG001|Overall Study|Physician Decision|8
6901938|NCT00676143|10922982|FG000|Overall Study|Protocol Violation|4
6901939|NCT00676143|10922983|FG001|Overall Study|Protocol Violation|8
6901940|NCT00676143|10922982|FG000|Overall Study|Withdrawal by Subject|24
6901941|NCT00676143|10922983|FG001|Overall Study|Withdrawal by Subject|42
6901942|NCT00676143|10922982|FG000|Overall Study|Discontinuation of study by sponsor|65
6901943|NCT00676143|10922983|FG001|Overall Study|Discontinuation of study by sponsor|88
6901944|NCT00676143|10922982|FG000|Overall Study|Failed to return|2
6901945|NCT00676143|10922983|FG001|Overall Study|Failed to return|1
6901946|NCT00676143|10922982|FG000|Overall Study|Loss of caregiver|5
6901947|NCT00676143|10922983|FG001|Overall Study|Loss of caregiver|3
6901948|NCT00676143|10922982|FG000|Overall Study|Other|11
6901949|NCT00676143|10922983|FG001|Overall Study|Other|20
6901950|NCT00676143|10922982|FG000|Overall Study|Participant participation unknown|1
6901951|NCT00676143|10922983|FG001|Overall Study|Participant participation unknown|4
6901952|NCT00676143|10922982|FG000|Overall Study|Vasogenic edema recurrence|1
6901953|NCT00676143|10922983|FG001|Overall Study|Vasogenic edema recurrence|3
6901954|NCT00676195|10923002|FG000|Overall Study|Lost to Follow-up|1
6901955|NCT00676195|10923002|FG000|Overall Study|Adverse Event|1
6901956|NCT00676195|10923002|FG000|Overall Study|Physician Decision|1
6901957|NCT00676208|10923009|FG000|Overall Study|Lost to Follow-up|0
6901958|NCT00676208|10923010|FG001|Overall Study|Lost to Follow-up|2
6901959|NCT00676208|10923009|FG000|Overall Study|Incomplete data|2
6901960|NCT00676208|10923010|FG001|Overall Study|Incomplete data|4
6901961|NCT00676338|10923022|FG000|Overall Study|Adverse Event|6
6901962|NCT00676338|10923023|FG001|Overall Study|Adverse Event|6
6901963|NCT00676338|10923024|FG002|Overall Study|Adverse Event|5
6901964|NCT00676338|10923025|FG003|Overall Study|Adverse Event|1
6901965|NCT00676338|10923022|FG000|Overall Study|Lost to Follow-up|4
6901966|NCT00676338|10923023|FG001|Overall Study|Lost to Follow-up|1
6901967|NCT00676338|10923024|FG002|Overall Study|Lost to Follow-up|3
6901968|NCT00676338|10923025|FG003|Overall Study|Lost to Follow-up|4
6901969|NCT00676338|10923022|FG000|Overall Study|Physician Decision|3
6901970|NCT00676338|10923023|FG001|Overall Study|Physician Decision|3
6901971|NCT00676338|10923024|FG002|Overall Study|Physician Decision|2
6901972|NCT00676338|10923025|FG003|Overall Study|Physician Decision|3
6901973|NCT00676338|10923022|FG000|Overall Study|Protocol Violation|5
6901974|NCT00676338|10923023|FG001|Overall Study|Protocol Violation|9
6901975|NCT00676338|10923024|FG002|Overall Study|Protocol Violation|2
6901976|NCT00676338|10923025|FG003|Overall Study|Protocol Violation|5
6901977|NCT00676338|10923022|FG000|Overall Study|Withdrawal by Subject|17
6901978|NCT00676338|10923023|FG001|Overall Study|Withdrawal by Subject|9
6901979|NCT00676338|10923024|FG002|Overall Study|Withdrawal by Subject|12
6901980|NCT00676338|10923025|FG003|Overall Study|Withdrawal by Subject|6
6901981|NCT00676338|10923022|FG000|Overall Study|Entry Criteria Not Met|0
6901982|NCT00676338|10923023|FG001|Overall Study|Entry Criteria Not Met|2
6901983|NCT00676338|10923024|FG002|Overall Study|Entry Criteria Not Met|1
6901984|NCT00676338|10923025|FG003|Overall Study|Entry Criteria Not Met|1
6901985|NCT00676338|10923022|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
6901986|NCT00676338|10923023|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
6901987|NCT00676338|10923024|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5
6901988|NCT00676338|10923025|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
6901989|NCT00676403|10923052|FG000|Overall Study|Adverse Event|1
6901990|NCT00676403|10923053|FG001|Overall Study|Adverse Event|2
6901991|NCT00676403|10923054|FG002|Overall Study|Adverse Event|0
6901992|NCT00676403|10923055|FG003|Overall Study|Adverse Event|5
6901993|NCT00676403|10923056|FG004|Overall Study|Adverse Event|1
6901994|NCT00676403|10923057|FG005|Overall Study|Adverse Event|2
6901995|NCT00676403|10923052|FG000|Overall Study|Lost to Follow-up|0
6901996|NCT00676403|10923053|FG001|Overall Study|Lost to Follow-up|0
6901997|NCT00676403|10923054|FG002|Overall Study|Lost to Follow-up|0
6901998|NCT00676403|10923055|FG003|Overall Study|Lost to Follow-up|0
6901999|NCT00676403|10923056|FG004|Overall Study|Lost to Follow-up|0
6902000|NCT00676403|10923057|FG005|Overall Study|Lost to Follow-up|1
6902001|NCT00676403|10923052|FG000|Overall Study|Reason Unspecified|1
6902002|NCT00676403|10923053|FG001|Overall Study|Reason Unspecified|0
6902003|NCT00676403|10923054|FG002|Overall Study|Reason Unspecified|1
6902004|NCT00676403|10923055|FG003|Overall Study|Reason Unspecified|0
6902005|NCT00676403|10923056|FG004|Overall Study|Reason Unspecified|0
6902006|NCT00676403|10923057|FG005|Overall Study|Reason Unspecified|1
6902007|NCT00676403|10923052|FG000|Overall Study|Withdrawal by Subject|0
6902008|NCT00676403|10923053|FG001|Overall Study|Withdrawal by Subject|0
6902009|NCT00676403|10923054|FG002|Overall Study|Withdrawal by Subject|0
6902010|NCT00676403|10923055|FG003|Overall Study|Withdrawal by Subject|0
6902011|NCT00676403|10923056|FG004|Overall Study|Withdrawal by Subject|0
6902012|NCT00676403|10923057|FG005|Overall Study|Withdrawal by Subject|1
6902013|NCT00676520|10923077|FG000|Overall Study|Withdrawal by Subject|163
6902014|NCT00676520|10923077|FG000|Overall Study|Lost to Follow-up|162
6902015|NCT00676520|10923077|FG000|Overall Study|Death|159
6902016|NCT00676520|10923077|FG000|Overall Study|Physician Decision|20
6902017|NCT00676520|10923077|FG000|Overall Study|Ineligible for Randomization to DAPT|209
6902018|NCT00676520|10923077|FG000|Overall Study|Other Reason|18
6902019|NCT00676650|10923106|FG000|Overall Study|Death|45
6902020|NCT00676650|10923107|FG001|Overall Study|Death|14
6902021|NCT00676650|10923106|FG000|Overall Study|Adverse Event|159
6902022|NCT00676650|10923107|FG001|Overall Study|Adverse Event|21
6902023|NCT00676650|10923106|FG000|Overall Study|Global deterioration of health status|66
6902024|NCT00676650|10923107|FG001|Overall Study|Global deterioration of health status|31
6902025|NCT00676650|10923106|FG000|Overall Study|Lost to Follow-up|0
6902026|NCT00676650|10923107|FG001|Overall Study|Lost to Follow-up|1
6902027|NCT00676650|10923106|FG000|Overall Study|Objective progression or relapse|189
6902028|NCT00676650|10923107|FG001|Overall Study|Objective progression or relapse|140
6902029|NCT00676650|10923106|FG000|Overall Study|Other|14
6902030|NCT00676650|10923107|FG001|Overall Study|Other|10
6902031|NCT00676650|10923106|FG000|Overall Study|Protocol Violation|3
6902032|NCT00676650|10923107|FG001|Overall Study|Protocol Violation|1
6902033|NCT00676650|10923106|FG000|Overall Study|Study terminated by sponsor|57
6902034|NCT00676650|10923107|FG001|Overall Study|Study terminated by sponsor|43
6902035|NCT00676650|10923106|FG000|Overall Study|Withdrawal by Subject|48
6902036|NCT00676650|10923107|FG001|Overall Study|Withdrawal by Subject|24
6902037|NCT00676650|10923106|FG000|Overall Study|Randomized but not treated|3
6902038|NCT00676650|10923107|FG001|Overall Study|Randomized but not treated|4
6902039|NCT00676689|10923117|FG000|Overall Study|Screen Failure|2
6902040|NCT00676689|10923117|FG000|Overall Study|Death|2
6902041|NCT00676689|10923117|FG000|Overall Study|Lost to Follow-up|4
6902042|NCT00676689|10923117|FG000|Overall Study|Physician Decision|1
6902043|NCT00676689|10923117|FG000|Overall Study|Withdrawal by Subject|3
6902044|NCT00676689|10923117|FG000|Overall Study|Continuing FU|49
6902045|NCT00677014|10923157|FG000|Overall Study|Lost to Follow-up|20
6902046|NCT00677014|10923158|FG001|Overall Study|Lost to Follow-up|12
6902047|NCT00677014|10923159|FG002|Overall Study|Lost to Follow-up|24
6902048|NCT00677014|10923157|FG000|Overall Study|Death|6
6902049|NCT00677014|10923158|FG001|Overall Study|Death|15
6902050|NCT00677014|10923159|FG002|Overall Study|Death|7
6902051|NCT00677014|10923157|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18
6902052|NCT00677014|10923158|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14
6902053|NCT00677014|10923159|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18
6902054|NCT00677092|10923172|FG000|Overall Study|Adverse Event|1
6902055|NCT00677092|10923172|FG000|Overall Study|Lost to Follow-up|1
6902056|NCT00677092|10923172|FG000|Overall Study|Withdrawal by Subject|3
6902057|NCT00677092|10923172|FG000|Overall Study|Death Prior to Receiving Treatment|1
6902058|NCT00677235|10923179|FG000|Overall Study|Withdrawal by Subject|1
6902059|NCT00677235|10923180|FG001|Overall Study|Withdrawal by Subject|1
6902060|NCT00677235|10923179|FG000|Overall Study|Lost to Follow-up|2
6902061|NCT00677235|10923180|FG001|Overall Study|Lost to Follow-up|1
6902062|NCT00677235|10923179|FG000|Overall Study|Death|37
6902063|NCT00677235|10923180|FG001|Overall Study|Death|36
6902064|NCT00677235|10923179|FG000|Overall Study|Adverse Experience|1
6902065|NCT00677235|10923180|FG001|Overall Study|Adverse Experience|0
6902066|NCT00677352|10923188|FG000|Treatment Phase|Adverse Event|14
6902067|NCT00677352|10923189|FG001|Treatment Phase|Adverse Event|22
6902068|NCT00677352|10923188|FG000|Treatment Phase|Lack of Efficacy|2
6902069|NCT00677352|10923189|FG001|Treatment Phase|Lack of Efficacy|3
6902070|NCT00677352|10923188|FG000|Treatment Phase|Lost to Follow-up|0
6902071|NCT00677352|10923189|FG001|Treatment Phase|Lost to Follow-up|1
6902072|NCT00677352|10923188|FG000|Treatment Phase|Withdrawal by Subject|7
6902073|NCT00677352|10923189|FG001|Treatment Phase|Withdrawal by Subject|7
6902074|NCT00677352|10923188|FG000|Treatment Phase|Physician Decision|1
6902075|NCT00677352|10923189|FG001|Treatment Phase|Physician Decision|0
6902076|NCT00677352|10923188|FG000|Treatment Phase|Pregnancy|0
6902077|NCT00677352|10923189|FG001|Treatment Phase|Pregnancy|1
6902078|NCT00677352|10923188|FG000|Treatment Phase|Protocol Violation|1
6902079|NCT00677352|10923189|FG001|Treatment Phase|Protocol Violation|1
6902080|NCT00677352|10923188|FG000|Treatment Phase|Transference or work related matter|0
6902081|NCT00677352|10923189|FG001|Treatment Phase|Transference or work related matter|5
6902082|NCT00677352|10923188|FG000|Treatment Phase|Not treated|0
6902083|NCT00677352|10923189|FG001|Treatment Phase|Not treated|2
6902084|NCT00677352|10923188|FG000|Tapering Phase|Adverse Event|1
6902085|NCT00677352|10923189|FG001|Tapering Phase|Adverse Event|5
6902086|NCT00677352|10923188|FG000|Tapering Phase|Withdrawal by Subject|5
6902087|NCT00677352|10923189|FG001|Tapering Phase|Withdrawal by Subject|3
6902088|NCT00677352|10923188|FG000|Tapering Phase|Pregnancy|0
6902089|NCT00677352|10923189|FG001|Tapering Phase|Pregnancy|1
6902090|NCT00677352|10923188|FG000|Tapering Phase|Job transfer|0
6902091|NCT00677352|10923189|FG001|Tapering Phase|Job transfer|1
6973628|NCT01182441|11025548|FG001|Overall Study|Death|25
6973629|NCT01182441|11025547|FG000|Overall Study|Implant Attempt Unsuccessful|13
6973630|NCT01182441|11025548|FG001|Overall Study|Implant Attempt Unsuccessful|0
6973631|NCT01182441|11025547|FG000|Overall Study|Lost to Follow-up|5
6973632|NCT01182441|11025548|FG001|Overall Study|Lost to Follow-up|8
6973633|NCT01182441|11025547|FG000|Overall Study|Withdrawal by Subject|6
6973634|NCT01182441|11025548|FG001|Overall Study|Withdrawal by Subject|13
6973635|NCT01182441|11025547|FG000|Overall Study|Implant Not Attempted|4
6973636|NCT01182441|11025548|FG001|Overall Study|Implant Not Attempted|0
6973637|NCT01182441|11025547|FG000|Overall Study|Adverse Event|2
6973638|NCT01182441|11025548|FG001|Overall Study|Adverse Event|0
6973639|NCT01182441|11025547|FG000|Overall Study|Physician Decision|1
6973640|NCT01182441|11025548|FG001|Overall Study|Physician Decision|1
6973641|NCT01182844|11025586|FG000|Overall Study|Withdrawal by Subject|0
6973642|NCT01182844|11025587|FG001|Overall Study|Withdrawal by Subject|2
6973643|NCT01183013|11025600|FG000|Overall Study|Adverse Event|6
6973644|NCT01183013|11025601|FG001|Overall Study|Adverse Event|8
6973645|NCT01183013|11025602|FG002|Overall Study|Adverse Event|5
6973646|NCT01183013|11025603|FG003|Overall Study|Adverse Event|5
6973647|NCT01183013|11025604|FG004|Overall Study|Adverse Event|10
6973648|NCT01183013|11025605|FG005|Overall Study|Adverse Event|10
6973649|NCT01183013|11025606|FG006|Overall Study|Adverse Event|6
6973650|NCT01183013|11025600|FG000|Overall Study|Lack of Efficacy|3
6973651|NCT01183013|11025601|FG001|Overall Study|Lack of Efficacy|2
6973652|NCT01183013|11025602|FG002|Overall Study|Lack of Efficacy|1
6973653|NCT01183013|11025603|FG003|Overall Study|Lack of Efficacy|2
6973654|NCT01183013|11025604|FG004|Overall Study|Lack of Efficacy|1
6973655|NCT01183013|11025605|FG005|Overall Study|Lack of Efficacy|2
6973656|NCT01183013|11025606|FG006|Overall Study|Lack of Efficacy|0
6973657|NCT01183013|11025600|FG000|Overall Study|Protocol Violation|5
6973658|NCT01183013|11025601|FG001|Overall Study|Protocol Violation|2
6973659|NCT01183013|11025602|FG002|Overall Study|Protocol Violation|4
6973660|NCT01183013|11025603|FG003|Overall Study|Protocol Violation|0
6973661|NCT01183013|11025604|FG004|Overall Study|Protocol Violation|4
6973662|NCT01183013|11025605|FG005|Overall Study|Protocol Violation|3
6973663|NCT01183013|11025606|FG006|Overall Study|Protocol Violation|3
6973664|NCT01183013|11025600|FG000|Overall Study|Lost to Follow-up|7
6973665|NCT01183013|11025601|FG001|Overall Study|Lost to Follow-up|3
6973666|NCT01183013|11025602|FG002|Overall Study|Lost to Follow-up|4
6973667|NCT01183013|11025603|FG003|Overall Study|Lost to Follow-up|3
6973668|NCT01183013|11025604|FG004|Overall Study|Lost to Follow-up|2
6973669|NCT01183013|11025605|FG005|Overall Study|Lost to Follow-up|6
6973670|NCT01183013|11025606|FG006|Overall Study|Lost to Follow-up|5
6973671|NCT01183013|11025600|FG000|Overall Study|Withdrawal by Subject|9
6973672|NCT01183013|11025601|FG001|Overall Study|Withdrawal by Subject|13
6973673|NCT01183013|11025602|FG002|Overall Study|Withdrawal by Subject|10
6973674|NCT01183013|11025603|FG003|Overall Study|Withdrawal by Subject|8
6973675|NCT01183013|11025604|FG004|Overall Study|Withdrawal by Subject|7
6973676|NCT01183013|11025605|FG005|Overall Study|Withdrawal by Subject|9
6973677|NCT01183013|11025606|FG006|Overall Study|Withdrawal by Subject|10
6973678|NCT01183013|11025600|FG000|Overall Study|Reasons other than stated above|15
6973679|NCT01183013|11025601|FG001|Overall Study|Reasons other than stated above|11
6973680|NCT01183013|11025602|FG002|Overall Study|Reasons other than stated above|17
6902092|NCT00677365|10923199|FG000|Overall Study|Adverse Event|2
6902093|NCT00677365|10923200|FG001|Overall Study|Adverse Event|1
6902094|NCT00677365|10923201|FG002|Overall Study|Adverse Event|1
6902095|NCT00677365|10923202|FG003|Overall Study|Adverse Event|2
6902096|NCT00677365|10923199|FG000|Overall Study|Withdrawal by Subject|0
6902097|NCT00677365|10923200|FG001|Overall Study|Withdrawal by Subject|0
6902098|NCT00677365|10923201|FG002|Overall Study|Withdrawal by Subject|1
6902099|NCT00677365|10923202|FG003|Overall Study|Withdrawal by Subject|0
6902100|NCT00677365|10923199|FG000|Overall Study|Other reason|0
6902101|NCT00677365|10923200|FG001|Overall Study|Other reason|0
6902102|NCT00677365|10923201|FG002|Overall Study|Other reason|0
6902103|NCT00677365|10923202|FG003|Overall Study|Other reason|1
6902104|NCT00677534|10923212|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1
6902105|NCT00677534|10923212|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1
6902106|NCT00677534|10923212|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1
6902107|NCT00677807|10923228|FG000|Overall Study|Adverse Event|4
6902108|NCT00677807|10923229|FG001|Overall Study|Adverse Event|1
6902109|NCT00677807|10923230|FG002|Overall Study|Adverse Event|6
6902110|NCT00677807|10923228|FG000|Overall Study|Lack of Efficacy|0
6902111|NCT00677807|10923229|FG001|Overall Study|Lack of Efficacy|0
6902112|NCT00677807|10923230|FG002|Overall Study|Lack of Efficacy|2
6902113|NCT00677807|10923228|FG000|Overall Study|Participant no longer needs study drug|0
6902114|NCT00677807|10923229|FG001|Overall Study|Participant no longer needs study drug|0
6902115|NCT00677807|10923230|FG002|Overall Study|Participant no longer needs study drug|1
6902116|NCT00677807|10923228|FG000|Overall Study|Withdrawal by Subject|10
6902117|NCT00677807|10923229|FG001|Overall Study|Withdrawal by Subject|3
6902118|NCT00677807|10923230|FG002|Overall Study|Withdrawal by Subject|6
6902119|NCT00677807|10923228|FG000|Overall Study|Lost to Follow-up|2
6902120|NCT00677807|10923229|FG001|Overall Study|Lost to Follow-up|2
6902121|NCT00677807|10923230|FG002|Overall Study|Lost to Follow-up|2
6902122|NCT00677807|10923228|FG000|Overall Study|Administrative problems|1
6902123|NCT00677807|10923229|FG001|Overall Study|Administrative problems|1
6902124|NCT00677807|10923230|FG002|Overall Study|Administrative problems|2
6902125|NCT00677807|10923228|FG000|Overall Study|Death|0
6902126|NCT00677807|10923229|FG001|Overall Study|Death|1
6902127|NCT00677807|10923230|FG002|Overall Study|Death|1
6902128|NCT00677807|10923228|FG000|Overall Study|Protocol Deviation|1
6902129|NCT00677807|10923229|FG001|Overall Study|Protocol Deviation|3
6902130|NCT00677807|10923230|FG002|Overall Study|Protocol Deviation|0
6902131|NCT00677820|10923240|FG000|Overall Study|Lost to Follow-up|1
6902132|NCT00677820|10923241|FG001|Overall Study|Lost to Follow-up|0
6902133|NCT00677833|10923251|FG000|Overall Study|Withdrawal by Subject|4
6902134|NCT00677833|10923252|FG001|Overall Study|Withdrawal by Subject|0
6902135|NCT00677833|10923253|FG002|Overall Study|Withdrawal by Subject|1
6902136|NCT00677833|10923254|FG003|Overall Study|Withdrawal by Subject|3
6902137|NCT00677833|10923251|FG000|Overall Study|Lost to Follow-up|0
6902138|NCT00677833|10923252|FG001|Overall Study|Lost to Follow-up|0
6902139|NCT00677833|10923253|FG002|Overall Study|Lost to Follow-up|1
6902140|NCT00677833|10923254|FG003|Overall Study|Lost to Follow-up|0
6902141|NCT00678080|10923286|FG000|Overall Study|Physician Decision|2
6902142|NCT00678080|10923287|FG001|Overall Study|Physician Decision|0
6902143|NCT00678080|10923286|FG000|Overall Study|Lost to Follow-up|1
6902144|NCT00678080|10923287|FG001|Overall Study|Lost to Follow-up|0
6902145|NCT00678080|10923286|FG000|Overall Study|Withdrawal by Subject|0
6902146|NCT00678080|10923287|FG001|Overall Study|Withdrawal by Subject|1
6902147|NCT00678210|10923297|FG000|Overall Study|Adverse Event|1
6902148|NCT00678210|10923298|FG001|Overall Study|Adverse Event|2
6902149|NCT00678210|10923299|FG002|Overall Study|Adverse Event|3
6902150|NCT00678210|10923300|FG003|Overall Study|Adverse Event|3
6902151|NCT00678210|10923297|FG000|Overall Study|Lack of Efficacy|2
6902152|NCT00678210|10923298|FG001|Overall Study|Lack of Efficacy|3
6902153|NCT00678210|10923299|FG002|Overall Study|Lack of Efficacy|1
6902154|NCT00678210|10923300|FG003|Overall Study|Lack of Efficacy|9
6902155|NCT00678210|10923297|FG000|Overall Study|Lost to Follow-up|4
6902156|NCT00678210|10923298|FG001|Overall Study|Lost to Follow-up|2
6902157|NCT00678210|10923299|FG002|Overall Study|Lost to Follow-up|0
6902158|NCT00678210|10923300|FG003|Overall Study|Lost to Follow-up|1
6902159|NCT00678210|10923297|FG000|Overall Study|Withdrawal by Subject|3
6902160|NCT00678210|10923298|FG001|Overall Study|Withdrawal by Subject|4
6902161|NCT00678210|10923299|FG002|Overall Study|Withdrawal by Subject|1
6902162|NCT00678210|10923300|FG003|Overall Study|Withdrawal by Subject|7
6902163|NCT00678210|10923297|FG000|Overall Study|Other|1
6902164|NCT00678210|10923298|FG001|Overall Study|Other|0
6902165|NCT00678210|10923299|FG002|Overall Study|Other|1
6902166|NCT00678210|10923300|FG003|Overall Study|Other|0
6902167|NCT00678301|10923325|FG000|Overall Study|Non-compliance with study procedures|0
6902168|NCT00678301|10923326|FG001|Overall Study|Non-compliance with study procedures|1
6902169|NCT00678301|10923325|FG000|Overall Study|Adverse Event|1
6902170|NCT00678301|10923326|FG001|Overall Study|Adverse Event|0
6902171|NCT00678301|10923325|FG000|Overall Study|Withdrawal by Subject|4
6902172|NCT00678301|10923326|FG001|Overall Study|Withdrawal by Subject|0
6902173|NCT00678301|10923325|FG000|Overall Study|Lost to Follow-up|3
6902174|NCT00678301|10923326|FG001|Overall Study|Lost to Follow-up|1
6902175|NCT00678379|10923335|FG000|Overall Study|Injection performed after tonsillectomy|2
6902176|NCT00678379|10923336|FG001|Overall Study|Injection performed after tonsillectomy|0
6902177|NCT00678379|10923337|FG002|Overall Study|Injection performed after tonsillectomy|1
6902178|NCT00678379|10923335|FG000|Overall Study|Incomplete Data|4
6902179|NCT00678379|10923336|FG001|Overall Study|Incomplete Data|3
6902180|NCT00678379|10923337|FG002|Overall Study|Incomplete Data|3
6902181|NCT00678392|10923347|FG000|Overall Study|Adverse Event|0
6902182|NCT00678392|10923348|FG001|Overall Study|Adverse Event|6
6902183|NCT00678392|10923347|FG000|Overall Study|Death|280
6902184|NCT00678392|10923348|FG001|Overall Study|Death|269
6902185|NCT00678392|10923347|FG000|Overall Study|Lost to Follow-up|15
6902186|NCT00678392|10923348|FG001|Overall Study|Lost to Follow-up|13
6902187|NCT00678392|10923347|FG000|Overall Study|Objective Progression or Relapse|3
6902188|NCT00678392|10923348|FG001|Overall Study|Objective Progression or Relapse|8
6902189|NCT00678392|10923347|FG000|Overall Study|Sponsor's Decision|1
6902190|NCT00678392|10923348|FG001|Overall Study|Sponsor's Decision|2
6902191|NCT00678392|10923347|FG000|Overall Study|Withdrawal by Subject|4
6902192|NCT00678392|10923348|FG001|Overall Study|Withdrawal by Subject|4
6902193|NCT00678392|10923347|FG000|Overall Study|Randomized But Not Treated|2
6902194|NCT00678392|10923348|FG001|Overall Study|Randomized But Not Treated|7
6902195|NCT00678392|10923347|FG000|Overall Study|Other|56
6902196|NCT00678392|10923348|FG001|Overall Study|Other|53
6902197|NCT00678561|10923404|FG000|Overall Study|Adverse Event|0
6902198|NCT00678561|10923405|FG001|Overall Study|Adverse Event|1
6902199|NCT00678561|10923406|FG002|Overall Study|Adverse Event|1
6902200|NCT00678561|10923407|FG003|Overall Study|Adverse Event|0
6902201|NCT00678561|10923408|FG004|Overall Study|Adverse Event|1
6902202|NCT00678561|10923409|FG005|Overall Study|Adverse Event|0
6902203|NCT00678561|10923410|FG006|Overall Study|Adverse Event|0
6902204|NCT00678561|10923411|FG007|Overall Study|Adverse Event|0
6902205|NCT00678561|10923404|FG000|Overall Study|Protocol Violation|0
6902206|NCT00678561|10923405|FG001|Overall Study|Protocol Violation|0
6902207|NCT00678561|10923406|FG002|Overall Study|Protocol Violation|0
6902208|NCT00678561|10923407|FG003|Overall Study|Protocol Violation|0
6902209|NCT00678561|10923408|FG004|Overall Study|Protocol Violation|1
6902210|NCT00678561|10923409|FG005|Overall Study|Protocol Violation|1
6902211|NCT00678561|10923410|FG006|Overall Study|Protocol Violation|0
6902212|NCT00678561|10923411|FG007|Overall Study|Protocol Violation|0
6902213|NCT00678561|10923404|FG000|Overall Study|Withdrawal by Subject|0
6902214|NCT00678561|10923405|FG001|Overall Study|Withdrawal by Subject|0
6902215|NCT00678561|10923406|FG002|Overall Study|Withdrawal by Subject|0
6902216|NCT00678561|10923407|FG003|Overall Study|Withdrawal by Subject|0
6902217|NCT00678561|10923408|FG004|Overall Study|Withdrawal by Subject|0
6902218|NCT00678561|10923409|FG005|Overall Study|Withdrawal by Subject|0
6902219|NCT00678561|10923410|FG006|Overall Study|Withdrawal by Subject|0
6902220|NCT00678561|10923411|FG007|Overall Study|Withdrawal by Subject|1
6902221|NCT00678587|10923438|FG000|Overall Study|Adverse Event|3
6902222|NCT00678587|10923439|FG001|Overall Study|Adverse Event|3
6902223|NCT00678587|10923438|FG000|Overall Study|Lack of Efficacy|1
6902224|NCT00678587|10923439|FG001|Overall Study|Lack of Efficacy|0
6902225|NCT00678587|10923438|FG000|Overall Study|Protocol Violation|2
6902226|NCT00678587|10923439|FG001|Overall Study|Protocol Violation|1
6902227|NCT00678587|10923438|FG000|Overall Study|Study Closed/Terminated|1
6902228|NCT00678587|10923439|FG001|Overall Study|Study Closed/Terminated|0
6902229|NCT00678587|10923438|FG000|Overall Study|Lost to Follow-up|3
6902230|NCT00678587|10923439|FG001|Overall Study|Lost to Follow-up|5
6902231|NCT00678587|10923438|FG000|Overall Study|Investigator Discretion|2
6902232|NCT00678587|10923439|FG001|Overall Study|Investigator Discretion|6
6902233|NCT00678587|10923438|FG000|Overall Study|Withdrew Consent|8
6902234|NCT00678587|10923439|FG001|Overall Study|Withdrew Consent|3
6902235|NCT00678639|10923448|FG000|Overall Study|Lost to Follow-up at 30 days|2
6902236|NCT00678639|10923449|FG001|Overall Study|Lost to Follow-up at 30 days|0
6902237|NCT00678652|10923460|FG000|Overall Study|Protocol Violation|2
6902238|NCT00678652|10923461|FG001|Overall Study|Protocol Violation|0
6902239|NCT00678652|10923462|FG002|Overall Study|Protocol Violation|0
6902240|NCT00678652|10923463|FG003|Overall Study|Protocol Violation|0
6902241|NCT00678652|10923460|FG000|Overall Study|Pregnancy|0
6902242|NCT00678652|10923461|FG001|Overall Study|Pregnancy|0
6902243|NCT00678652|10923462|FG002|Overall Study|Pregnancy|1
6902244|NCT00678652|10923463|FG003|Overall Study|Pregnancy|0
6902245|NCT00678652|10923460|FG000|Overall Study|Relocation|1
6902246|NCT00678652|10923461|FG001|Overall Study|Relocation|0
6902247|NCT00678652|10923462|FG002|Overall Study|Relocation|0
6902248|NCT00678652|10923463|FG003|Overall Study|Relocation|0
6902249|NCT00678691|10923475|FG000|Overall Study|Adverse Event|6
6902250|NCT00678691|10923476|FG001|Overall Study|Adverse Event|4
6902251|NCT00678795|10923484|FG000|Overall Study|Adverse Event|7
6902252|NCT00678795|10923485|FG001|Overall Study|Adverse Event|3
6902253|NCT00678795|10923484|FG000|Overall Study|Withdrawal by Subject|3
6902254|NCT00678795|10923485|FG001|Overall Study|Withdrawal by Subject|0
6902255|NCT00678795|10923484|FG000|Overall Study|Protocol Violation|0
6902256|NCT00678795|10923485|FG001|Overall Study|Protocol Violation|1
6902257|NCT00678795|10923484|FG000|Overall Study|Lost to Follow-up|0
6902258|NCT00678795|10923485|FG001|Overall Study|Lost to Follow-up|1
6902259|NCT00678795|10923484|FG000|Overall Study|Lack of Efficacy|1
6902260|NCT00678795|10923485|FG001|Overall Study|Lack of Efficacy|1
6902261|NCT00678886|10923516|FG000|Overall Study|Withdrawal by Subject|0
6902262|NCT00678886|10923517|FG001|Overall Study|Withdrawal by Subject|0
6902263|NCT00678886|10923518|FG002|Overall Study|Withdrawal by Subject|4
6902264|NCT00678886|10923519|FG003|Overall Study|Withdrawal by Subject|6
6902265|NCT00678886|10923516|FG000|Overall Study|Physician Decision|0
6902266|NCT00678886|10923517|FG001|Overall Study|Physician Decision|0
6902267|NCT00678886|10923518|FG002|Overall Study|Physician Decision|1
6902268|NCT00678886|10923519|FG003|Overall Study|Physician Decision|1
6902269|NCT00678886|10923516|FG000|Overall Study|Lost to Follow-up|0
6902270|NCT00678886|10923517|FG001|Overall Study|Lost to Follow-up|0
6902271|NCT00678886|10923518|FG002|Overall Study|Lost to Follow-up|3
6902272|NCT00678886|10923519|FG003|Overall Study|Lost to Follow-up|2
6902273|NCT00678886|10923516|FG000|Overall Study|Other|0
6902274|NCT00678886|10923517|FG001|Overall Study|Other|0
6902275|NCT00678886|10923518|FG002|Overall Study|Other|1
6902276|NCT00678886|10923519|FG003|Overall Study|Other|0
6902277|NCT00678899|10923528|FG000|Overall Study|Adverse Event|1
6902278|NCT00679029|10923533|FG000|Overall Study|Adverse Event|3
6902279|NCT00679029|10923533|FG000|Overall Study|Withdrawal by Subject|1
6902280|NCT00679029|10923533|FG000|Overall Study|Lost to Follow-up|1
6902281|NCT00679042|10923537|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2
6902282|NCT00679042|10923537|FG000|5-Year Follow Up|In follow-up (ongoing)|6
6902283|NCT00679042|10923537|FG000|5-Year Follow Up|Death|1
6902284|NCT00679042|10923537|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7
6902285|NCT00679042|10923537|FG000|10-Year Follow Up|In follow-up (ongoing)|5
6902286|NCT00679055|10923543|FG000|Overall Study|Adverse Event|0
6902287|NCT00679055|10923544|FG001|Overall Study|Adverse Event|1
6902288|NCT00679055|10923543|FG000|Overall Study|Other|0
6902289|NCT00679055|10923544|FG001|Overall Study|Other|3
6902290|NCT00679055|10923543|FG000|Overall Study|Study Terminated|2
6902291|NCT00679055|10923544|FG001|Overall Study|Study Terminated|1
6902292|NCT00679081|10923550|FG000|Overall Study|Lost to Follow-up|1
6902293|NCT00679172|10923563|FG000|Overall Study|Non-compliance|1
6902294|NCT00679172|10923564|FG001|Overall Study|Non-compliance|1
6902295|NCT00679172|10923565|FG002|Overall Study|Non-compliance|0
6902296|NCT00679172|10923566|FG003|Overall Study|Non-compliance|1
6902297|NCT00679172|10923567|FG004|Overall Study|Non-compliance|0
6902298|NCT00679172|10923563|FG000|Overall Study|Other not specified|0
6902299|NCT00679172|10923564|FG001|Overall Study|Other not specified|0
6902300|NCT00679172|10923565|FG002|Overall Study|Other not specified|1
6902301|NCT00679172|10923566|FG003|Overall Study|Other not specified|0
6902302|NCT00679172|10923567|FG004|Overall Study|Other not specified|0
6902303|NCT00679211|10923582|FG000|Overall Study|Progressive disease|82
6902304|NCT00679211|10923582|FG000|Overall Study|Adverse Event|7
6902305|NCT00679211|10923582|FG000|Overall Study|Withdrawal by Subject|2
6902306|NCT00679211|10923582|FG000|Overall Study|Physician Decision|5
6902307|NCT00679211|10923582|FG000|Overall Study|Refused to undergo protocol procedures|1
6902308|NCT00679211|10923582|FG000|Overall Study|Transferred to extension study TDM4529g|12
6902309|NCT00679211|10923582|FG000|Overall Study|Other|1
6902310|NCT00679263|10923591|FG000|Visit 2/Dose 1|Adverse Event|1
6902311|NCT00679263|10923592|FG001|Visit 2/Dose 1|Adverse Event|0
6902312|NCT00679263|10923593|FG002|Visit 2/Dose 1|Adverse Event|0
6902313|NCT00679263|10923591|FG000|Visit 2/Dose 1|subject not compliance|1
6902314|NCT00679263|10923592|FG001|Visit 2/Dose 1|subject not compliance|1
6902315|NCT00679263|10923593|FG002|Visit 2/Dose 1|subject not compliance|0
6902316|NCT00679289|10923604|FG000|Overall Study|Progressive disease|4
6902317|NCT00679289|10923605|FG001|Overall Study|Progressive disease|5
6902318|NCT00679289|10923606|FG002|Overall Study|Progressive disease|18
6902319|NCT00679289|10923604|FG000|Overall Study|Withdrawal by Subject|0
6902320|NCT00679289|10923605|FG001|Overall Study|Withdrawal by Subject|1
6902321|NCT00679289|10923606|FG002|Overall Study|Withdrawal by Subject|1
6902322|NCT00679289|10923604|FG000|Overall Study|Adverse Event|0
6902323|NCT00679289|10923605|FG001|Overall Study|Adverse Event|0
6902324|NCT00679289|10923606|FG002|Overall Study|Adverse Event|3
6902325|NCT00679289|10923604|FG000|Overall Study|Physician Decision|1
6902326|NCT00679289|10923605|FG001|Overall Study|Physician Decision|0
6902327|NCT00679289|10923606|FG002|Overall Study|Physician Decision|1
6902328|NCT00679302|10923618|FG000|Overall Study|Lost to Follow-up|8
6902329|NCT00679302|10923619|FG001|Overall Study|Lost to Follow-up|4
6902330|NCT00679341|10923627|FG000|Overall Study|Disease progression|42
6902331|NCT00679341|10923628|FG001|Overall Study|Disease progression|36
6902332|NCT00679341|10923627|FG000|Overall Study|Adverse Event|5
6902333|NCT00679341|10923628|FG001|Overall Study|Adverse Event|6
6902334|NCT00679341|10923627|FG000|Overall Study|Subject/guardian decision to discontinue|3
6902335|NCT00679341|10923628|FG001|Overall Study|Subject/guardian decision to discontinue|0
6902336|NCT00679341|10923627|FG000|Overall Study|Death|1
6902337|NCT00679341|10923628|FG001|Overall Study|Death|1
6902338|NCT00679341|10923627|FG000|Overall Study|Other|1
6902339|NCT00679341|10923628|FG001|Overall Study|Other|0
6902340|NCT00679341|10923627|FG000|Overall Study|Physician Decision|1
6902341|NCT00679341|10923628|FG001|Overall Study|Physician Decision|0
6902342|NCT00679341|10923627|FG000|Overall Study|Not treated|0
6902343|NCT00679341|10923628|FG001|Overall Study|Not treated|2
6902344|NCT00679341|10923627|FG000|Overall Study|Physician/patient decision to withdraw|0
6902345|NCT00679341|10923628|FG001|Overall Study|Physician/patient decision to withdraw|6
6902346|NCT00679354|10923635|FG000|Overall Study|Death|3
6902347|NCT00679354|10923635|FG000|Overall Study|Lack of Efficacy|22
6902348|NCT00679354|10923635|FG000|Overall Study|Physician Decision|4
6902349|NCT00679354|10923635|FG000|Overall Study|Ineligible|1
6902350|NCT00679367|10923640|FG000|Overall Study|Adverse Event|7
6902351|NCT00679367|10923640|FG000|Overall Study|inability to swallow oral drugs|1
6902352|NCT00679367|10923640|FG000|Overall Study|Lack of Efficacy|3
6902353|NCT00679367|10923640|FG000|Overall Study|Withdrawal by Subject|1
6902354|NCT00679432|10923666|FG000|Overall Study|Adverse Event|5
6902355|NCT00679432|10923667|FG001|Overall Study|Adverse Event|6
6902356|NCT00679432|10923668|FG002|Overall Study|Adverse Event|10
6902357|NCT00679432|10923669|FG003|Overall Study|Adverse Event|7
6902358|NCT00679432|10923666|FG000|Overall Study|Protocol Violation|1
6902359|NCT00679432|10923667|FG001|Overall Study|Protocol Violation|1
6902360|NCT00679432|10923668|FG002|Overall Study|Protocol Violation|2
6902361|NCT00679432|10923669|FG003|Overall Study|Protocol Violation|1
6902362|NCT00679432|10923666|FG000|Overall Study|Withdrawal by Subject|8
6902363|NCT00679432|10923667|FG001|Overall Study|Withdrawal by Subject|11
6902364|NCT00679432|10923668|FG002|Overall Study|Withdrawal by Subject|10
6902365|NCT00679432|10923669|FG003|Overall Study|Withdrawal by Subject|9
6902366|NCT00679432|10923666|FG000|Overall Study|Lost to Follow-up|1
6902367|NCT00679432|10923667|FG001|Overall Study|Lost to Follow-up|5
6902368|NCT00679432|10923668|FG002|Overall Study|Lost to Follow-up|4
6902369|NCT00679432|10923669|FG003|Overall Study|Lost to Follow-up|2
6902370|NCT00679432|10923666|FG000|Overall Study|Physician Decision|3
6902371|NCT00679432|10923667|FG001|Overall Study|Physician Decision|2
6902372|NCT00679432|10923668|FG002|Overall Study|Physician Decision|2
6902373|NCT00679432|10923669|FG003|Overall Study|Physician Decision|2
6902374|NCT00679432|10923666|FG000|Overall Study|Sponsor decision|1
6902375|NCT00679432|10923667|FG001|Overall Study|Sponsor decision|0
6902376|NCT00679432|10923668|FG002|Overall Study|Sponsor decision|0
6902377|NCT00679432|10923669|FG003|Overall Study|Sponsor decision|0
6902378|NCT00679432|10923666|FG000|Overall Study|Lack of Efficacy|13
6902379|NCT00679432|10923667|FG001|Overall Study|Lack of Efficacy|9
6902380|NCT00679432|10923668|FG002|Overall Study|Lack of Efficacy|14
6902381|NCT00679432|10923669|FG003|Overall Study|Lack of Efficacy|8
6902382|NCT00679432|10923666|FG000|Overall Study|Infectious colitis, normal histology|5
6902383|NCT00679432|10923667|FG001|Overall Study|Infectious colitis, normal histology|4
6902384|NCT00679432|10923668|FG002|Overall Study|Infectious colitis, normal histology|8
6902385|NCT00679432|10923669|FG003|Overall Study|Infectious colitis, normal histology|3
6902386|NCT00679432|10923666|FG000|Overall Study|Randomization error, return to prior Rx|0
6902387|NCT00679432|10923667|FG001|Overall Study|Randomization error, return to prior Rx|0
6902388|NCT00679432|10923668|FG002|Overall Study|Randomization error, return to prior Rx|3
6902389|NCT00679432|10923669|FG003|Overall Study|Randomization error, return to prior Rx|0
6902390|NCT00679549|10923681|FG000|Overall Study|dropout|2
6902391|NCT00679549|10923682|FG001|Overall Study|dropout|4
6902392|NCT00679549|10923681|FG000|Overall Study|missing outcome echocardiograms|4
6902393|NCT00679549|10923682|FG001|Overall Study|missing outcome echocardiograms|5
6902394|NCT00679627|10923690|FG000|Overall Study|Death|41
6902395|NCT00679627|10923691|FG001|Overall Study|Death|29
6902396|NCT00679627|10923690|FG000|Overall Study|Adverse Event|43
6902397|NCT00679627|10923691|FG001|Overall Study|Adverse Event|53
6902398|NCT00679627|10923690|FG000|Overall Study|Withdrawal by Subject|168
6902399|NCT00679627|10923691|FG001|Overall Study|Withdrawal by Subject|172
6902400|NCT00679627|10923690|FG000|Overall Study|Lost to Follow-up|22
6902401|NCT00679627|10923691|FG001|Overall Study|Lost to Follow-up|26
6902402|NCT00679627|10923690|FG000|Overall Study|Early Study Closure|425
6902403|NCT00679627|10923691|FG001|Overall Study|Early Study Closure|405
6902404|NCT00679913|10923699|FG000|Overall Study|Protocol Violation|18
6902405|NCT00679913|10923700|FG001|Overall Study|Protocol Violation|13
6902406|NCT00679939|10923709|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17
6902407|NCT00679939|10923710|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13
6902408|NCT00679939|10923709|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14
6902409|NCT00679939|10923710|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12
6902410|NCT00679939|10923709|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5
6902411|NCT00679939|10923710|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0
6902412|NCT00679939|10923709|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1
6902413|NCT00679939|10923710|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0
6902414|NCT00679939|10923709|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
6902415|NCT00679939|10923710|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2
6902416|NCT00679939|10923709|FG000|24-Week Open-Label (OL) Period|Adverse Event|0
6902417|NCT00679939|10923710|FG001|24-Week Open-Label (OL) Period|Adverse Event|1
6902418|NCT00679939|10923709|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1
6902419|NCT00679939|10923710|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1
6902420|NCT00679939|10923709|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3
6902421|NCT00679939|10923710|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1
6902422|NCT00679939|10923709|FG000|24-Week Open-Label (OL) Period|Physician Decision|1
6902423|NCT00679939|10923710|FG001|24-Week Open-Label (OL) Period|Physician Decision|0
6902424|NCT00679939|10923709|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2
6902425|NCT00679939|10923710|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1
6902426|NCT00680017|10923731|FG000|Overall Study|Adverse Event|13
6902427|NCT00680017|10923732|FG001|Overall Study|Adverse Event|7
6902428|NCT00680017|10923731|FG000|Overall Study|Withdrawal by Subject|2
6902429|NCT00680017|10923732|FG001|Overall Study|Withdrawal by Subject|5
6902430|NCT00680017|10923731|FG000|Overall Study|Lost to Follow-up|2
6902431|NCT00680017|10923732|FG001|Overall Study|Lost to Follow-up|0
6902432|NCT00680043|10923741|FG000|Overall Study|Withdrawal by Subject|1
6902433|NCT00680043|10923742|FG001|Overall Study|Withdrawal by Subject|0
6902434|NCT00680043|10923743|FG002|Overall Study|Withdrawal by Subject|0
6902435|NCT00680043|10923741|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0
6902436|NCT00680043|10923742|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1
6902437|NCT00680043|10923743|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0
6902438|NCT00680043|10923741|FG000|Overall Study|Renal Transplant|1
6902439|NCT00680043|10923742|FG001|Overall Study|Renal Transplant|0
6902440|NCT00680043|10923743|FG002|Overall Study|Renal Transplant|4
6902441|NCT00680056|10923753|FG000|First Intervention|Mainly Exacerbation of COPD|1
6902442|NCT00680056|10923754|FG001|First Intervention|Mainly Exacerbation of COPD|2
6902443|NCT00680056|10923753|FG000|Second Intervention|Protocol Violation|3
6902444|NCT00680056|10923754|FG001|Second Intervention|Protocol Violation|1
6902445|NCT00680121|10923763|FG000|Overall Study|Lost to Follow-up|27
6902446|NCT00680121|10923764|FG001|Overall Study|Lost to Follow-up|23
6902447|NCT00680186|10923772|FG000|Overall Study|Adverse Event|47
6902448|NCT00680186|10923773|FG001|Overall Study|Adverse Event|44
6902449|NCT00680186|10923772|FG000|Overall Study|Protocol Violation|31
6902450|NCT00680186|10923773|FG001|Overall Study|Protocol Violation|26
6902451|NCT00680186|10923772|FG000|Overall Study|Lost to Follow-up|11
6902452|NCT00680186|10923773|FG001|Overall Study|Lost to Follow-up|6
6902453|NCT00680186|10923772|FG000|Overall Study|Withdrawal by Subject|32
6902454|NCT00680186|10923773|FG001|Overall Study|Withdrawal by Subject|39
6902455|NCT00680186|10923772|FG000|Overall Study|Other|4
6902456|NCT00680186|10923773|FG001|Overall Study|Other|1
6902457|NCT00680368|10923783|FG000|Overall Study|not supervised, not eligible|15
6902458|NCT00680407|10923792|FG000|Overall Study|Lost to Follow-up|3
6902459|NCT00680407|10923793|FG001|Overall Study|Lost to Follow-up|3
6902460|NCT00680407|10923794|FG002|Overall Study|Lost to Follow-up|1
6902461|NCT00680407|10923792|FG000|Overall Study|Withdrawal by Subject|5
6902462|NCT00680407|10923793|FG001|Overall Study|Withdrawal by Subject|2
6902463|NCT00680407|10923794|FG002|Overall Study|Withdrawal by Subject|2
6902464|NCT00680745|10923837|FG000|Overall Study|Withdrawal by Subject|8
6902465|NCT00680745|10923838|FG001|Overall Study|Withdrawal by Subject|3
6902466|NCT00680745|10923839|FG002|Overall Study|Withdrawal by Subject|2
6902467|NCT00680745|10923840|FG003|Overall Study|Withdrawal by Subject|8
6902468|NCT00680745|10923837|FG000|Overall Study|Lost to Follow-up|0
6902469|NCT00680745|10923838|FG001|Overall Study|Lost to Follow-up|1
6902470|NCT00680745|10923839|FG002|Overall Study|Lost to Follow-up|1
6902471|NCT00680745|10923840|FG003|Overall Study|Lost to Follow-up|0
6902472|NCT00680745|10923837|FG000|Overall Study|Death|1
6902473|NCT00680745|10923838|FG001|Overall Study|Death|0
6902474|NCT00680745|10923839|FG002|Overall Study|Death|1
6902475|NCT00680745|10923840|FG003|Overall Study|Death|0
6902476|NCT00680745|10923837|FG000|Overall Study|Adverse Event|5
6902477|NCT00680745|10923838|FG001|Overall Study|Adverse Event|3
6902478|NCT00680745|10923839|FG002|Overall Study|Adverse Event|3
6902479|NCT00680745|10923840|FG003|Overall Study|Adverse Event|3
6902480|NCT00680745|10923837|FG000|Overall Study|Poor/Non-compliance|0
6902481|NCT00680745|10923838|FG001|Overall Study|Poor/Non-compliance|3
6902482|NCT00680745|10923839|FG002|Overall Study|Poor/Non-compliance|0
6902483|NCT00680745|10923840|FG003|Overall Study|Poor/Non-compliance|0
6902484|NCT00680745|10923837|FG000|Overall Study|Subject No Longer Meets Study Criteria|0
6902485|NCT00680745|10923838|FG001|Overall Study|Subject No Longer Meets Study Criteria|2
6902486|NCT00680745|10923839|FG002|Overall Study|Subject No Longer Meets Study Criteria|0
6902487|NCT00680745|10923840|FG003|Overall Study|Subject No Longer Meets Study Criteria|2
6902488|NCT00680745|10923837|FG000|Overall Study|False Treatment|0
6902489|NCT00680745|10923838|FG001|Overall Study|False Treatment|1
6902490|NCT00680745|10923839|FG002|Overall Study|False Treatment|3
6902491|NCT00680745|10923840|FG003|Overall Study|False Treatment|0
6902492|NCT00680771|10923853|FG000|Overall Study|Withdrawal by Subject|1
6902493|NCT00680771|10923854|FG001|Overall Study|Withdrawal by Subject|0
6902494|NCT00680771|10923853|FG000|Overall Study|Sleep Apnea suspected after PSG|1
6902495|NCT00680771|10923854|FG001|Overall Study|Sleep Apnea suspected after PSG|0
6902496|NCT00680771|10923853|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4
6902497|NCT00680771|10923854|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2
6902498|NCT00680836|10923892|FG000|Overall Study|Withdrawal by Subject|3
6902499|NCT00680836|10923893|FG001|Overall Study|Withdrawal by Subject|0
6902500|NCT00680836|10923892|FG000|Overall Study|Lost to Follow-up|3
6902501|NCT00680836|10923893|FG001|Overall Study|Lost to Follow-up|1
6902502|NCT00680836|10923892|FG000|Overall Study|Physician Decision|2
6902503|NCT00680836|10923893|FG001|Overall Study|Physician Decision|1
6902504|NCT00680914|10923906|FG000|Overall Study|Consent withdrawal|6
6902505|NCT00680914|10923907|FG001|Overall Study|Consent withdrawal|3
6902506|NCT00680914|10923906|FG000|Overall Study|Lost to Follow-up|4
6902507|NCT00680914|10923907|FG001|Overall Study|Lost to Follow-up|0
6902508|NCT00680914|10923906|FG000|Overall Study|serious adverse event (SAE)|0
6902509|NCT00680914|10923907|FG001|Overall Study|serious adverse event (SAE)|1
6902510|NCT00680992|10923929|FG000|Overall Study|Complete Resection (as per protocol)|25
6902511|NCT00680992|10923930|FG001|Overall Study|Complete Resection (as per protocol)|121
6902512|NCT00680992|10923931|FG002|Overall Study|Complete Resection (as per protocol)|0
6902513|NCT00680992|10923929|FG000|Overall Study|Administrative Decision|83
6902514|NCT00680992|10923930|FG001|Overall Study|Administrative Decision|42
6902515|NCT00680992|10923931|FG002|Overall Study|Administrative Decision|5
6902516|NCT00680992|10923929|FG000|Overall Study|End of Trial|32
6902517|NCT00680992|10923930|FG001|Overall Study|End of Trial|12
6902518|NCT00680992|10923931|FG002|Overall Study|End of Trial|3
6902519|NCT00680992|10923929|FG000|Overall Study|Withdrawal by Subject|33
6902520|NCT00680992|10923930|FG001|Overall Study|Withdrawal by Subject|11
6902521|NCT00680992|10923931|FG002|Overall Study|Withdrawal by Subject|1
6902522|NCT00680992|10923929|FG000|Overall Study|Adverse Event|21
6902523|NCT00680992|10923930|FG001|Overall Study|Adverse Event|19
6902524|NCT00680992|10923931|FG002|Overall Study|Adverse Event|1
6902525|NCT00680992|10923929|FG000|Overall Study|Other|19
6902526|NCT00680992|10923930|FG001|Overall Study|Other|14
6902527|NCT00680992|10923931|FG002|Overall Study|Other|1
6902528|NCT00680992|10923929|FG000|Overall Study|Disease Progression|21
6902529|NCT00680992|10923930|FG001|Overall Study|Disease Progression|9
6902530|NCT00680992|10923931|FG002|Overall Study|Disease Progression|0
6902531|NCT00680992|10923929|FG000|Overall Study|Lost to Follow-up|12
6902532|NCT00680992|10923930|FG001|Overall Study|Lost to Follow-up|14
6902533|NCT00680992|10923931|FG002|Overall Study|Lost to Follow-up|0
6902534|NCT00680992|10923929|FG000|Overall Study|Noncompliance|4
6902535|NCT00680992|10923930|FG001|Overall Study|Noncompliance|6
6902536|NCT00680992|10923931|FG002|Overall Study|Noncompliance|0
6902537|NCT00680992|10923929|FG000|Overall Study|Requirement for Alternative Therapy|8
6902538|NCT00680992|10923930|FG001|Overall Study|Requirement for Alternative Therapy|2
6902539|NCT00680992|10923931|FG002|Overall Study|Requirement for Alternative Therapy|0
6902540|NCT00680992|10923929|FG000|Overall Study|Pregnancy|5
6902541|NCT00680992|10923930|FG001|Overall Study|Pregnancy|0
6902542|NCT00680992|10923931|FG002|Overall Study|Pregnancy|1
6902543|NCT00680992|10923929|FG000|Overall Study|Death|5
6902544|NCT00680992|10923930|FG001|Overall Study|Death|1
6902545|NCT00680992|10923931|FG002|Overall Study|Death|0
6902546|NCT00680992|10923929|FG000|Overall Study|Ineligibility Determined|0
6902547|NCT00680992|10923930|FG001|Overall Study|Ineligibility Determined|1
6902548|NCT00680992|10923931|FG002|Overall Study|Ineligibility Determined|0
6902549|NCT00681109|10923954|FG000|Overall Study|Lost to Follow-up|2
6902550|NCT00681109|10923955|FG001|Overall Study|Lost to Follow-up|6
6902551|NCT00681109|10923956|FG002|Overall Study|Lost to Follow-up|0
6902552|NCT00681187|10923969|FG000|Overall Study|Withdrawal by Subject|1
6902553|NCT00681187|10923970|FG001|Overall Study|Withdrawal by Subject|0
6902554|NCT00681187|10923969|FG000|Overall Study|Death|0
6902555|NCT00681187|10923970|FG001|Overall Study|Death|1
6902556|NCT00681187|10923969|FG000|Overall Study|Adverse Event|0
6902557|NCT00681187|10923970|FG001|Overall Study|Adverse Event|1
6902558|NCT00681564|10924019|FG000|Overall Study|Lost to Follow-up|6
6902559|NCT00681564|10924020|FG001|Overall Study|Lost to Follow-up|6
6902560|NCT00681564|10924019|FG000|Overall Study|Withdrawal by Subject|0
6902561|NCT00681564|10924020|FG001|Overall Study|Withdrawal by Subject|1
6902562|NCT00681564|10924019|FG000|Overall Study|Death|0
6902563|NCT00681564|10924020|FG001|Overall Study|Death|1
6902564|NCT00681590|10924028|FG000|Overall Study|Withdrawal by Subject|2
6902565|NCT00681590|10924029|FG001|Overall Study|Withdrawal by Subject|12
6902566|NCT00681668|10924035|FG000|Overall Study|Protocol Violation|1
6902567|NCT00681668|10924035|FG000|Overall Study|Withdrawal by Subject|1
6902568|NCT00681811|10924041|FG000|Overall Study|Adverse Event|1
6902569|NCT00681811|10924042|FG001|Overall Study|Adverse Event|1
6902570|NCT00681811|10924041|FG000|Overall Study|Withdrawal by Subject|2
6902571|NCT00681811|10924042|FG001|Overall Study|Withdrawal by Subject|2
6902572|NCT00681811|10924041|FG000|Overall Study|Non-compliance|0
6902573|NCT00681811|10924042|FG001|Overall Study|Non-compliance|1
6902574|NCT00681824|10924062|FG000|Overall Study|withdrawn by investigator|0
6902575|NCT00681824|10924063|FG001|Overall Study|withdrawn by investigator|0
6902576|NCT00681824|10924064|FG002|Overall Study|withdrawn by investigator|1
6902577|NCT00681824|10924062|FG000|Overall Study|scheduling conflict|1
6902578|NCT00681824|10924063|FG001|Overall Study|scheduling conflict|0
6902579|NCT00681824|10924064|FG002|Overall Study|scheduling conflict|0
6902580|NCT00681824|10924062|FG000|Overall Study|Death|0
6902581|NCT00681824|10924063|FG001|Overall Study|Death|1
6902582|NCT00681824|10924064|FG002|Overall Study|Death|0
6902583|NCT00681863|10924072|FG000|Overall Study|Adverse Event|1
6902584|NCT00681863|10924072|FG000|Overall Study|Lost to Follow-up|2
6902585|NCT00681863|10924072|FG000|Overall Study|Lack of Efficacy|2
6902586|NCT00681863|10924072|FG000|Overall Study|Other|18
6902587|NCT00682435|10924093|FG000|Overall Study|Insufficient data|5
6902588|NCT00682435|10924093|FG000|Overall Study|Erroneously enrolled twice|2
6902589|NCT00682448|10924099|FG000|Overall Study|Adverse Event|1
6902590|NCT00682448|10924100|FG001|Overall Study|Adverse Event|2
6902591|NCT00682448|10924099|FG000|Overall Study|Lack of Efficacy|1
6902592|NCT00682448|10924100|FG001|Overall Study|Lack of Efficacy|0
6902593|NCT00682448|10924099|FG000|Overall Study|Lost to Follow-up|1
6902594|NCT00682448|10924100|FG001|Overall Study|Lost to Follow-up|3
6902595|NCT00682448|10924099|FG000|Overall Study|Pregnancy|0
6902596|NCT00682448|10924100|FG001|Overall Study|Pregnancy|1
6902597|NCT00682448|10924099|FG000|Overall Study|Withdrawal by Subject|2
6902598|NCT00682448|10924100|FG001|Overall Study|Withdrawal by Subject|0
6902599|NCT00682539|10924109|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3
6902600|NCT00682539|10924110|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1
6902601|NCT00682539|10924111|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0
6902602|NCT00682539|10924109|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0
6902603|NCT00682539|10924110|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3
6902604|NCT00682539|10924111|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8
6902605|NCT00682461|10924135|FG000|Overall Study|Adverse Event|5
6902606|NCT00682461|10924136|FG001|Overall Study|Adverse Event|7
6902607|NCT00682461|10924135|FG000|Overall Study|Lost to Follow-up|8
6902608|NCT00682461|10924136|FG001|Overall Study|Lost to Follow-up|5
6902609|NCT00682461|10924135|FG000|Overall Study|Withdrawal by Subject|12
6902610|NCT00682461|10924136|FG001|Overall Study|Withdrawal by Subject|19
6902611|NCT00682643|10924154|FG000|Overall Study|Adverse Event|12
6902612|NCT00682643|10924155|FG001|Overall Study|Adverse Event|23
6902613|NCT00682643|10924154|FG000|Overall Study|Lack of Efficacy|2
6902614|NCT00682643|10924155|FG001|Overall Study|Lack of Efficacy|0
6902615|NCT00682643|10924154|FG000|Overall Study|Protocol Violation|38
6902616|NCT00682643|10924155|FG001|Overall Study|Protocol Violation|76
6902617|NCT00682643|10924154|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3
6902618|NCT00682643|10924155|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4
6902619|NCT00682643|10924154|FG000|Overall Study|Lost to Follow-up|1
6902620|NCT00682643|10924155|FG001|Overall Study|Lost to Follow-up|6
6902621|NCT00682643|10924154|FG000|Overall Study|Physician Decision|2
6902622|NCT00682643|10924155|FG001|Overall Study|Physician Decision|6
6902623|NCT00682643|10924154|FG000|Overall Study|Withdrawal by Subject|19
6902624|NCT00682643|10924155|FG001|Overall Study|Withdrawal by Subject|53
6902625|NCT00682643|10924154|FG000|Overall Study|Did Not Receive Study Drug|1
6902626|NCT00682643|10924155|FG001|Overall Study|Did Not Receive Study Drug|1
6902627|NCT00682786|10924177|FG000|Overall Study|Withdrawal by Subject|2
6902628|NCT00682786|10924178|FG001|Overall Study|Withdrawal by Subject|2
6902629|NCT00682786|10924177|FG000|Overall Study|Did not receive irinotecan|0
6902630|NCT00682786|10924178|FG001|Overall Study|Did not receive irinotecan|1
6902631|NCT00682890|10924218|FG000|Overall Study|Lost to Follow-up|1
6902632|NCT00682890|10924219|FG001|Overall Study|Lost to Follow-up|1
6902633|NCT00682890|10924218|FG000|Overall Study|subject moved away|0
6902634|NCT00682890|10924219|FG001|Overall Study|subject moved away|1
6902635|NCT00682890|10924218|FG000|Overall Study|heavy menstrual bleeding|1
6902636|NCT00682890|10924219|FG001|Overall Study|heavy menstrual bleeding|0
6902637|NCT00682929|10924228|FG000|Overall Study|Adverse Event|4
6902638|NCT00682929|10924229|FG001|Overall Study|Adverse Event|1
6902639|NCT00682929|10924230|FG002|Overall Study|Adverse Event|1
6902640|NCT00682929|10924228|FG000|Overall Study|Withdrawal by Subject|1
6902641|NCT00682929|10924229|FG001|Overall Study|Withdrawal by Subject|2
6902642|NCT00682929|10924230|FG002|Overall Study|Withdrawal by Subject|1
6902643|NCT00682929|10924228|FG000|Overall Study|dosing compliance < 80%|0
6902644|NCT00682929|10924229|FG001|Overall Study|dosing compliance < 80%|2
6902645|NCT00682929|10924230|FG002|Overall Study|dosing compliance < 80%|0
6902646|NCT00682929|10924228|FG000|Overall Study|lag in DEA renewal|1
6902647|NCT00682929|10924229|FG001|Overall Study|lag in DEA renewal|0
6902648|NCT00682929|10924230|FG002|Overall Study|lag in DEA renewal|0
6973681|NCT01183013|11025603|FG003|Overall Study|Reasons other than stated above|12
6973682|NCT01183013|11025604|FG004|Overall Study|Reasons other than stated above|12
6973683|NCT01183013|11025605|FG005|Overall Study|Reasons other than stated above|15
6973684|NCT01183013|11025606|FG006|Overall Study|Reasons other than stated above|13
6973685|NCT01183065|11025623|FG000|Overall Study|Patient no longer fits eligibility crite|1
6973686|NCT01183104|11025629|FG000|Overall Study|Adverse Event|8
6973687|NCT01183104|11025630|FG001|Overall Study|Adverse Event|6
6973688|NCT01183104|11025629|FG000|Overall Study|Death|0
6973689|NCT01183104|11025630|FG001|Overall Study|Death|1
6973690|NCT01183104|11025629|FG000|Overall Study|Lost to Follow-up|14
6973691|NCT01183104|11025630|FG001|Overall Study|Lost to Follow-up|7
6973692|NCT01183104|11025629|FG000|Overall Study|Physician Decision|5
6973693|NCT01183104|11025630|FG001|Overall Study|Physician Decision|8
6973694|NCT01183104|11025629|FG000|Overall Study|Withdrawal by Subject|6
6973695|NCT01183104|11025630|FG001|Overall Study|Withdrawal by Subject|11
6973696|NCT01183104|11025629|FG000|Overall Study|Nonparticipation in Extension Study|39
6973697|NCT01183104|11025630|FG001|Overall Study|Nonparticipation in Extension Study|50
6973698|NCT01183104|11025629|FG000|Overall Study|Did not receive study drug|5
6973699|NCT01183104|11025630|FG001|Overall Study|Did not receive study drug|9
6973700|NCT01183143|11025636|FG000|Overall Study|Protocol Violation|115
6973701|NCT01183143|11025636|FG000|Overall Study|Withdrawal by Subject|19
6973702|NCT01183143|11025636|FG000|Overall Study|Subject Questionnaires not returned|5
6973703|NCT01183143|11025636|FG000|Overall Study|Subjects enrolled, but not treated|11
6973704|NCT01183234|11025670|FG000|First Intervention|Adverse Event|1
6973705|NCT01183234|11025671|FG001|First Intervention|Adverse Event|0
6973706|NCT01183260|11025679|FG000|Overall Study|Intraop screen failure|2
6973707|NCT01183260|11025680|FG001|Overall Study|Intraop screen failure|0
6973708|NCT01183260|11025679|FG000|Overall Study|Withdrawal by Subject|1
6973709|NCT01183260|11025680|FG001|Overall Study|Withdrawal by Subject|1
6973710|NCT01183260|11025679|FG000|Overall Study|Revised within 30 days|0
6973711|NCT01183260|11025680|FG001|Overall Study|Revised within 30 days|1
6973712|NCT01183260|11025679|FG000|Overall Study|Death|1
6973713|NCT01183260|11025680|FG001|Overall Study|Death|0
6973714|NCT01183390|11025697|FG000|First Intervention|Adverse Event|0
6902649|NCT00683293|10924266|FG000|Overall Study|Withdrawal by Subject|2
6902650|NCT00683293|10924267|FG001|Overall Study|Withdrawal by Subject|3
6902651|NCT00683384|10924277|FG000|Overall Study|Death|1
6902652|NCT00683384|10924277|FG000|Overall Study|Adverse Event|1
6902653|NCT00683449|10924290|FG000|Overall Study|Lost to Follow-up|0
6902654|NCT00683449|10924291|FG001|Overall Study|Lost to Follow-up|1
6902655|NCT00683449|10924292|FG002|Overall Study|Lost to Follow-up|0
6902656|NCT00683449|10924293|FG003|Overall Study|Lost to Follow-up|0
6902657|NCT00683449|10924294|FG004|Overall Study|Lost to Follow-up|0
6902658|NCT00683475|10924313|FG000|Overall Study|Withdrawal by Subject|1
6902659|NCT00683475|10924314|FG001|Overall Study|Withdrawal by Subject|0
6902660|NCT00683475|10924313|FG000|Overall Study|Never Treated: Adverse Event|2
6902661|NCT00683475|10924314|FG001|Overall Study|Never Treated: Adverse Event|3
6902662|NCT00683475|10924313|FG000|Overall Study|Never Treated: Progressive Disease|1
6902663|NCT00683475|10924314|FG001|Overall Study|Never Treated: Progressive Disease|0
6902664|NCT00683592|10924323|FG000|Overall Study|Adverse Event|12
6902665|NCT00683592|10924324|FG001|Overall Study|Adverse Event|4
6902666|NCT00683592|10924323|FG000|Overall Study|Withdrawal by Subject|11
6902667|NCT00683592|10924324|FG001|Overall Study|Withdrawal by Subject|11
6902668|NCT00683592|10924323|FG000|Overall Study|Lost to Follow-up|17
6902669|NCT00683592|10924324|FG001|Overall Study|Lost to Follow-up|17
6902670|NCT00683592|10924323|FG000|Overall Study|Lack of Efficacy|3
6902671|NCT00683592|10924324|FG001|Overall Study|Lack of Efficacy|7
6902672|NCT00683592|10924323|FG000|Overall Study|Physician Decision|0
6902673|NCT00683592|10924324|FG001|Overall Study|Physician Decision|1
6902674|NCT00683592|10924323|FG000|Overall Study|Non-compliance|3
6902675|NCT00683592|10924324|FG001|Overall Study|Non-compliance|5
6902676|NCT00683592|10924323|FG000|Overall Study|Other|1
6902677|NCT00683592|10924324|FG001|Overall Study|Other|1
6902678|NCT00683618|10924333|FG000|Randomised Treatment Period|Withdrawal by Subject|4
6902679|NCT00683618|10924334|FG001|Randomised Treatment Period|Withdrawal by Subject|1
6902680|NCT00683618|10924335|FG002|Randomised Treatment Period|Withdrawal by Subject|2
6902681|NCT00683618|10924333|FG000|Randomised Treatment Period|Protocol Violation|0
6902682|NCT00683618|10924334|FG001|Randomised Treatment Period|Protocol Violation|1
6902683|NCT00683618|10924335|FG002|Randomised Treatment Period|Protocol Violation|0
6902684|NCT00683618|10924333|FG000|Randomised Treatment Period|Adverse Event|2
6902685|NCT00683618|10924334|FG001|Randomised Treatment Period|Adverse Event|0
6902686|NCT00683618|10924335|FG002|Randomised Treatment Period|Adverse Event|2
6902687|NCT00683618|10924333|FG000|Randomised Treatment Period|Reason not provided|0
6902688|NCT00683618|10924334|FG001|Randomised Treatment Period|Reason not provided|0
6902689|NCT00683618|10924335|FG002|Randomised Treatment Period|Reason not provided|2
6902690|NCT00683618|10924333|FG000|Extension Treatment Period|Withdrawal by Subject|1
6902691|NCT00683618|10924334|FG001|Extension Treatment Period|Withdrawal by Subject|0
6902692|NCT00683618|10924335|FG002|Extension Treatment Period|Withdrawal by Subject|0
6902693|NCT00683618|10924333|FG000|Extension Treatment Period|Adverse Event|1
6902694|NCT00683618|10924334|FG001|Extension Treatment Period|Adverse Event|0
6902695|NCT00683618|10924335|FG002|Extension Treatment Period|Adverse Event|0
6902696|NCT00683618|10924333|FG000|Extension Treatment Period|Protocol Violation|1
6902697|NCT00683618|10924334|FG001|Extension Treatment Period|Protocol Violation|0
6902698|NCT00683618|10924335|FG002|Extension Treatment Period|Protocol Violation|0
6902699|NCT00683644|10924347|FG000|Overall Study|Withdrawal by Subject|4
6902700|NCT00683644|10924348|FG001|Overall Study|Withdrawal by Subject|2
6902701|NCT00683644|10924347|FG000|Overall Study|Lost to Follow-up|1
6902702|NCT00683644|10924348|FG001|Overall Study|Lost to Follow-up|4
6902703|NCT00683644|10924347|FG000|Overall Study|Adverse Event|1
6902704|NCT00683644|10924348|FG001|Overall Study|Adverse Event|2
6902705|NCT00683644|10924347|FG000|Overall Study|Low copper, other health problems,|7
6902706|NCT00683644|10924348|FG001|Overall Study|Low copper, other health problems,|6
6902707|NCT00683657|10924360|FG000|Overall Study|Adverse Event|0
6902708|NCT00683657|10924361|FG001|Overall Study|Adverse Event|1
6902709|NCT00683657|10924360|FG000|Overall Study|Subject Withdrew Consent|1
6902710|NCT00683657|10924361|FG001|Overall Study|Subject Withdrew Consent|0
6902711|NCT00683696|10924369|FG000|Overall Study|Withdrawn due to study closure|337
6902712|NCT00683696|10924370|FG001|Overall Study|Withdrawn due to study closure|338
6902713|NCT00683696|10924369|FG000|Overall Study|Withdrawn prior to study closure|13
6902714|NCT00683696|10924370|FG001|Overall Study|Withdrawn prior to study closure|28
6902715|NCT00683696|10924369|FG000|Overall Study|Lost to Follow-up|5
6902716|NCT00683696|10924370|FG001|Overall Study|Lost to Follow-up|6
6902717|NCT00683696|10924369|FG000|Overall Study|Vital status follow-up only|3
6902718|NCT00683696|10924370|FG001|Overall Study|Vital status follow-up only|3
6902719|NCT00683696|10924369|FG000|Overall Study|Death|46
6902720|NCT00683696|10924370|FG001|Overall Study|Death|30
6902721|NCT00683774|10924379|FG000|Overall Study|Withdrawal by Subject|0
6902722|NCT00683774|10924380|FG001|Overall Study|Withdrawal by Subject|1
6902723|NCT00683774|10924379|FG000|Overall Study|Physician Decision|3
6902724|NCT00683774|10924380|FG001|Overall Study|Physician Decision|0
6902725|NCT00683800|10924388|FG000|Overall Study|Adverse Event|195
6902726|NCT00683800|10924389|FG001|Overall Study|Adverse Event|102
6902727|NCT00683800|10924388|FG000|Overall Study|Death|0
6902728|NCT00683800|10924389|FG001|Overall Study|Death|1
6902729|NCT00683800|10924388|FG000|Overall Study|Lost to Follow-up|57
6902730|NCT00683800|10924389|FG001|Overall Study|Lost to Follow-up|44
6902731|NCT00683800|10924388|FG000|Overall Study|Other|5
6902732|NCT00683800|10924389|FG001|Overall Study|Other|2
6902733|NCT00683800|10924388|FG000|Overall Study|Protocol Violation|13
6902734|NCT00683800|10924389|FG001|Overall Study|Protocol Violation|16
6902735|NCT00683800|10924388|FG000|Overall Study|Withdrawal by Subject|66
6902736|NCT00683800|10924389|FG001|Overall Study|Withdrawal by Subject|64
6902737|NCT00683800|10924388|FG000|Overall Study|Lack of Efficacy|61
6902738|NCT00683800|10924389|FG001|Overall Study|Lack of Efficacy|104
6902739|NCT00683800|10924388|FG000|Overall Study|Randomized, not treated|35
6902740|NCT00683800|10924389|FG001|Overall Study|Randomized, not treated|33
6902741|NCT00683878|10924428|FG000|Overall Study|Lack of Efficacy|3
6902742|NCT00683878|10924429|FG001|Overall Study|Lack of Efficacy|0
6902743|NCT00683878|10924430|FG002|Overall Study|Lack of Efficacy|1
6902744|NCT00683878|10924428|FG000|Overall Study|Adverse Event|4
6902745|NCT00683878|10924429|FG001|Overall Study|Adverse Event|3
6902746|NCT00683878|10924430|FG002|Overall Study|Adverse Event|3
6902747|NCT00683878|10924428|FG000|Overall Study|Withdrawal by Subject|9
6902748|NCT00683878|10924429|FG001|Overall Study|Withdrawal by Subject|8
6902749|NCT00683878|10924430|FG002|Overall Study|Withdrawal by Subject|6
6902750|NCT00683878|10924428|FG000|Overall Study|Death|0
6902751|NCT00683878|10924429|FG001|Overall Study|Death|1
6902752|NCT00683878|10924430|FG002|Overall Study|Death|0
7142903|NCT03021187|11298941|FG003|Overall Study|Death|0
7142904|NCT03021187|11298938|FG000|Overall Study|Withdrawal by Subject|0
7142905|NCT03021187|11298939|FG001|Overall Study|Withdrawal by Subject|6
7142906|NCT03021187|11298940|FG002|Overall Study|Withdrawal by Subject|2
7142907|NCT03021187|11298941|FG003|Overall Study|Withdrawal by Subject|5
7142908|NCT03021187|11298938|FG000|Overall Study|Lost to Follow-up|10
7142909|NCT03021187|11298939|FG001|Overall Study|Lost to Follow-up|3
7142910|NCT03021187|11298940|FG002|Overall Study|Lost to Follow-up|1
7142911|NCT03021187|11298941|FG003|Overall Study|Lost to Follow-up|4
7142912|NCT03021265|11298951|FG000|Overall Study|Adverse Event|29
7142913|NCT03021265|11298951|FG000|Overall Study|Lack of Efficacy|3
7142914|NCT03021265|11298951|FG000|Overall Study|Improved|17
7142915|NCT03021265|11298951|FG000|Overall Study|Lost to Follow-up|67
7142916|NCT03021265|11298951|FG000|Overall Study|No reason given|2
7142917|NCT03021265|11298951|FG000|Overall Study|No visit since the first visit|4
7142918|NCT03021304|11298955|FG000|Overall Study|Lack of Efficacy|1
7142919|NCT03021499|11298970|FG000|Overall Study|Adverse Event|1
7142920|NCT03021499|11298971|FG001|Overall Study|Adverse Event|0
7142921|NCT03021499|11298970|FG000|Overall Study|Death|1
7142922|NCT03021499|11298971|FG001|Overall Study|Death|5
7142923|NCT03021499|11298970|FG000|Overall Study|Lack of Efficacy|0
7142924|NCT03021499|11298971|FG001|Overall Study|Lack of Efficacy|1
6826960|NCT00121641|10829437|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
6826961|NCT00121641|10829438|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
6826962|NCT00121641|10829439|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
6826963|NCT00121641|10829435|FG000|48-month Short Term + Long Term Period|Pregnancy|0
6826964|NCT00121641|10829436|FG001|48-month Short Term + Long Term Period|Pregnancy|1
6826965|NCT00121641|10829437|FG002|48-month Short Term + Long Term Period|Pregnancy|0
6826966|NCT00121641|10829438|FG003|48-month Short Term + Long Term Period|Pregnancy|1
6826967|NCT00121641|10829439|FG004|48-month Short Term + Long Term Period|Pregnancy|0
6826968|NCT00121641|10829435|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
6826969|NCT00121641|10829436|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2
6826970|NCT00121641|10829437|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
6826971|NCT00121641|10829438|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
6826972|NCT00121641|10829439|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
6826973|NCT00121641|10829435|FG000|48-month Short Term + Long Term Period|Death|0
6826974|NCT00121641|10829436|FG001|48-month Short Term + Long Term Period|Death|0
6826975|NCT00121641|10829437|FG002|48-month Short Term + Long Term Period|Death|0
6826976|NCT00121641|10829438|FG003|48-month Short Term + Long Term Period|Death|1
6826977|NCT00121641|10829439|FG004|48-month Short Term + Long Term Period|Death|0
6826978|NCT00121641|10829435|FG000|48-month Short Term + Long Term Period|Missing|0
6826979|NCT00121641|10829436|FG001|48-month Short Term + Long Term Period|Missing|0
6826980|NCT00121641|10829437|FG002|48-month Short Term + Long Term Period|Missing|1
6826981|NCT00121641|10829438|FG003|48-month Short Term + Long Term Period|Missing|0
6826982|NCT00121641|10829439|FG004|48-month Short Term + Long Term Period|Missing|0
6826983|NCT00121641|10829435|FG000|48-month Short Term + Long Term Period|Other Reason|5
6826984|NCT00121641|10829436|FG001|48-month Short Term + Long Term Period|Other Reason|3
6826985|NCT00121641|10829437|FG002|48-month Short Term + Long Term Period|Other Reason|2
6826986|NCT00121641|10829438|FG003|48-month Short Term + Long Term Period|Other Reason|0
6902753|NCT00683878|10924428|FG000|Overall Study|Lost to Follow-up|4
6902754|NCT00683878|10924429|FG001|Overall Study|Lost to Follow-up|2
6902755|NCT00683878|10924430|FG002|Overall Study|Lost to Follow-up|4
6902756|NCT00683878|10924428|FG000|Overall Study|Non-compliance, not met criteria etc.|3
6902757|NCT00683878|10924429|FG001|Overall Study|Non-compliance, not met criteria etc.|2
6902758|NCT00683878|10924430|FG002|Overall Study|Non-compliance, not met criteria etc.|0
6902759|NCT00683904|10924440|FG000|Dose Level 1|Disease progression|2
6902760|NCT00683904|10924441|FG001|Dose Level 1|Disease progression|0
6902761|NCT00683904|10924440|FG000|Dose Level 1|Adverse Event|1
6902762|NCT00683904|10924441|FG001|Dose Level 1|Adverse Event|0
6902763|NCT00683904|10924440|FG000|Dose Level 2|Adverse Event|0
6902764|NCT00683904|10924441|FG001|Dose Level 2|Adverse Event|2
6902765|NCT00684021|10924471|FG000|Overall Study|MRI Contraindicated|1
6902766|NCT00684021|10924472|FG001|Overall Study|MRI Contraindicated|1
6902767|NCT00684021|10924473|FG002|Overall Study|MRI Contraindicated|1
6902768|NCT00684021|10924474|FG003|Overall Study|MRI Contraindicated|0
6902769|NCT00684021|10924471|FG000|Overall Study|MRI not performed|0
6902770|NCT00684021|10924472|FG001|Overall Study|MRI not performed|1
6902771|NCT00684021|10924473|FG002|Overall Study|MRI not performed|1
6902772|NCT00684021|10924474|FG003|Overall Study|MRI not performed|2
6902773|NCT00684021|10924471|FG000|Overall Study|Death|1
6902774|NCT00684021|10924472|FG001|Overall Study|Death|0
6902775|NCT00684021|10924473|FG002|Overall Study|Death|0
6902776|NCT00684021|10924474|FG003|Overall Study|Death|0
6902777|NCT00684060|10924499|FG000|Overall Study|Lost to Follow-up|1
6902778|NCT00684060|10924500|FG001|Overall Study|Lost to Follow-up|0
6902779|NCT00684060|10924499|FG000|Overall Study|New stenosis identified|1
6902780|NCT00684060|10924500|FG001|Overall Study|New stenosis identified|0
6902781|NCT00684060|10924499|FG000|Overall Study|Unable to collect MRI|1
6902782|NCT00684060|10924500|FG001|Overall Study|Unable to collect MRI|2
6902783|NCT00684060|10924499|FG000|Overall Study|Death|0
7142925|NCT03021499|11298970|FG000|Overall Study|Lost to Follow-up|1
7142926|NCT03021499|11298971|FG001|Overall Study|Lost to Follow-up|3
7142927|NCT03021499|11298970|FG000|Overall Study|Physician Decision|2
7142928|NCT03021499|11298971|FG001|Overall Study|Physician Decision|3
7142929|NCT03021499|11298970|FG000|Overall Study|Pregnancy|1
7142930|NCT03021499|11298971|FG001|Overall Study|Pregnancy|0
7142931|NCT03021499|11298970|FG000|Overall Study|Withdrawal by Subject|7
7142932|NCT03021499|11298971|FG001|Overall Study|Withdrawal by Subject|14
7142933|NCT03021499|11298970|FG000|Overall Study|Prohibited medication required|1
7142934|NCT03021499|11298971|FG001|Overall Study|Prohibited medication required|0
7142935|NCT03021499|11298970|FG000|Overall Study|Protocol non-compliance|1
7142936|NCT03021499|11298971|FG001|Overall Study|Protocol non-compliance|1
7142937|NCT03021499|11298970|FG000|Overall Study|None of the above|0
7142938|NCT03021499|11298971|FG001|Overall Study|None of the above|4
7142939|NCT03021499|11298970|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1
6902784|NCT00684060|10924500|FG001|Overall Study|Death|1
6902785|NCT00684073|10924506|FG000|Selection|Selection/non-selection criteria|3
6902786|NCT00684073|10924506|FG000|Selection|Death|1
6902787|NCT00684073|10924506|FG000|Selection|noncompliance|1
6902788|NCT00684073|10924506|FG000|Selection|Lost to Follow-up|1
6902789|NCT00684073|10924506|FG000|Selection|request of the sponsor|1
6902790|NCT00684073|10924506|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1
6902791|NCT00684177|10924527|FG000|Overall Study|Adverse Event|4
6902792|NCT00684177|10924528|FG001|Overall Study|Adverse Event|3
6902793|NCT00684177|10924527|FG000|Overall Study|Lack of Efficacy|10
6902794|NCT00684177|10924528|FG001|Overall Study|Lack of Efficacy|15
6902795|NCT00684177|10924527|FG000|Overall Study|Protocol Violation|1
6902796|NCT00684177|10924528|FG001|Overall Study|Protocol Violation|0
6902797|NCT00684177|10924527|FG000|Overall Study|Lost to Follow-up|2
6902798|NCT00684177|10924528|FG001|Overall Study|Lost to Follow-up|1
6902799|NCT00684177|10924527|FG000|Overall Study|Physician Decision|2
6902800|NCT00684177|10924528|FG001|Overall Study|Physician Decision|0
6902801|NCT00684177|10924527|FG000|Overall Study|Withdrawal by Subject|1
6902802|NCT00684177|10924528|FG001|Overall Study|Withdrawal by Subject|2
6902803|NCT00684177|10924527|FG000|Overall Study|Other|1
6902804|NCT00684177|10924528|FG001|Overall Study|Other|2
6902805|NCT00684203|10924540|FG000|Overall Study|Adverse Event|6
6902806|NCT00684203|10924541|FG001|Overall Study|Adverse Event|4
6902807|NCT00684203|10924542|FG002|Overall Study|Adverse Event|8
6902808|NCT00684203|10924543|FG003|Overall Study|Adverse Event|0
6902809|NCT00684203|10924544|FG004|Overall Study|Adverse Event|0
6902810|NCT00684203|10924545|FG005|Overall Study|Adverse Event|0
6902811|NCT00684203|10924540|FG000|Overall Study|Protocol-defined clinical event|3
6902812|NCT00684203|10924541|FG001|Overall Study|Protocol-defined clinical event|1
6902813|NCT00684203|10924542|FG002|Overall Study|Protocol-defined clinical event|0
6902814|NCT00684203|10924543|FG003|Overall Study|Protocol-defined clinical event|0
6902815|NCT00684203|10924544|FG004|Overall Study|Protocol-defined clinical event|0
6902816|NCT00684203|10924545|FG005|Overall Study|Protocol-defined clinical event|0
6902817|NCT00684203|10924540|FG000|Overall Study|Withdrawal by Subject|0
6902818|NCT00684203|10924541|FG001|Overall Study|Withdrawal by Subject|2
6902819|NCT00684203|10924542|FG002|Overall Study|Withdrawal by Subject|1
6902820|NCT00684203|10924543|FG003|Overall Study|Withdrawal by Subject|0
6902821|NCT00684203|10924544|FG004|Overall Study|Withdrawal by Subject|0
6902822|NCT00684203|10924545|FG005|Overall Study|Withdrawal by Subject|0
6902823|NCT00684203|10924540|FG000|Overall Study|Did not meet protocol eligibility|0
6902824|NCT00684203|10924541|FG001|Overall Study|Did not meet protocol eligibility|1
6902825|NCT00684203|10924542|FG002|Overall Study|Did not meet protocol eligibility|0
6902826|NCT00684203|10924543|FG003|Overall Study|Did not meet protocol eligibility|0
7142940|NCT03021499|11298971|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0
7142941|NCT03021564|11298990|FG000|Overall Study|Death|84
7142942|NCT03021564|11298991|FG001|Overall Study|Death|466
6902827|NCT00684203|10924544|FG004|Overall Study|Did not meet protocol eligibility|0
6902828|NCT00684203|10924545|FG005|Overall Study|Did not meet protocol eligibility|0
6902829|NCT00684307|10924575|FG000|Overall Study|Adverse Event|11
6902830|NCT00684307|10924576|FG001|Overall Study|Adverse Event|6
6902831|NCT00684307|10924577|FG002|Overall Study|Adverse Event|15
6902832|NCT00684307|10924578|FG003|Overall Study|Adverse Event|16
6902833|NCT00684307|10924579|FG004|Overall Study|Adverse Event|8
6902834|NCT00684307|10924575|FG000|Overall Study|Development of increasing Liver Function|0
6902835|NCT00684307|10924576|FG001|Overall Study|Development of increasing Liver Function|2
6902836|NCT00684307|10924577|FG002|Overall Study|Development of increasing Liver Function|0
6902837|NCT00684307|10924578|FG003|Overall Study|Development of increasing Liver Function|1
6902838|NCT00684307|10924579|FG004|Overall Study|Development of increasing Liver Function|0
6902839|NCT00684307|10924575|FG000|Overall Study|Fullfillment of exclusion criteria|1
6902840|NCT00684307|10924576|FG001|Overall Study|Fullfillment of exclusion criteria|0
6902841|NCT00684307|10924577|FG002|Overall Study|Fullfillment of exclusion criteria|0
6902842|NCT00684307|10924578|FG003|Overall Study|Fullfillment of exclusion criteria|3
6902843|NCT00684307|10924579|FG004|Overall Study|Fullfillment of exclusion criteria|1
6902844|NCT00684307|10924575|FG000|Overall Study|Incorrect enrolment or randomization|4
6902845|NCT00684307|10924576|FG001|Overall Study|Incorrect enrolment or randomization|0
6902846|NCT00684307|10924577|FG002|Overall Study|Incorrect enrolment or randomization|0
6902847|NCT00684307|10924578|FG003|Overall Study|Incorrect enrolment or randomization|0
6902848|NCT00684307|10924579|FG004|Overall Study|Incorrect enrolment or randomization|0
6902849|NCT00684307|10924575|FG000|Overall Study|Interupted IP for more than 7 days|0
6902850|NCT00684307|10924576|FG001|Overall Study|Interupted IP for more than 7 days|4
6902851|NCT00684307|10924577|FG002|Overall Study|Interupted IP for more than 7 days|1
6902852|NCT00684307|10924578|FG003|Overall Study|Interupted IP for more than 7 days|3
6902853|NCT00684307|10924579|FG004|Overall Study|Interupted IP for more than 7 days|3
6902854|NCT00684307|10924575|FG000|Overall Study|Severe non compliance to protocol|1
6902855|NCT00684307|10924576|FG001|Overall Study|Severe non compliance to protocol|0
6902856|NCT00684307|10924577|FG002|Overall Study|Severe non compliance to protocol|0
6902857|NCT00684307|10924578|FG003|Overall Study|Severe non compliance to protocol|1
6902858|NCT00684307|10924579|FG004|Overall Study|Severe non compliance to protocol|2
6902859|NCT00684307|10924575|FG000|Overall Study|Participant not willing to continue|7
6902860|NCT00684307|10924576|FG001|Overall Study|Participant not willing to continue|10
6902861|NCT00684307|10924577|FG002|Overall Study|Participant not willing to continue|11
6902862|NCT00684307|10924578|FG003|Overall Study|Participant not willing to continue|5
6902863|NCT00684307|10924579|FG004|Overall Study|Participant not willing to continue|8
6902864|NCT00684307|10924575|FG000|Overall Study|Criteria from the CSR|0
6902865|NCT00684307|10924576|FG001|Overall Study|Criteria from the CSR|0
6902866|NCT00684307|10924577|FG002|Overall Study|Criteria from the CSR|1
6902867|NCT00684307|10924578|FG003|Overall Study|Criteria from the CSR|3
6902868|NCT00684307|10924579|FG004|Overall Study|Criteria from the CSR|3
6902869|NCT00684411|10924600|FG000|Overall Study|New Primary Cancer|1
6902870|NCT00684411|10924600|FG000|Overall Study|Disease Progression|10
6902871|NCT00684411|10924600|FG000|Overall Study|Adverse Event|1
6902872|NCT00684424|10924604|FG000|Overall Study|Adverse Event|1
6902873|NCT00684424|10924604|FG000|Overall Study|Lost to Follow-up|2
6902874|NCT00684424|10924604|FG000|Overall Study|Other|2
6902875|NCT00684515|10924612|FG000|Overall Study|Adverse Event|3
6902876|NCT00684515|10924613|FG001|Overall Study|Adverse Event|3
6902877|NCT00684515|10924614|FG002|Overall Study|Adverse Event|1
6902878|NCT00684515|10924612|FG000|Overall Study|Protocol-Defined Clinical Event|1
6902879|NCT00684515|10924613|FG001|Overall Study|Protocol-Defined Clinical Event|0
6902880|NCT00684515|10924614|FG002|Overall Study|Protocol-Defined Clinical Event|0
6902881|NCT00684567|10924641|FG000|Concomitant Radiotherapy Period|Adverse Event|2
6902882|NCT00684567|10924641|FG000|Monotherapy Period|Adverse Event|2
6902883|NCT00684567|10924641|FG000|Monotherapy Period|Death|1
6902884|NCT00684567|10924641|FG000|Monotherapy Period|Progression of primary disease|11
6902885|NCT00684593|10924647|FG000|Overall Study|Adverse Event|0
6902886|NCT00684593|10924648|FG001|Overall Study|Adverse Event|2
6902887|NCT00684645|10924654|FG000|Overall Study|Death|2
6902888|NCT00684645|10924654|FG000|Overall Study|Progressive disease|67
6902889|NCT00684645|10924654|FG000|Overall Study|Adverse Event|27
6902890|NCT00684645|10924654|FG000|Overall Study|Lost to Follow-up|3
6902891|NCT00684645|10924654|FG000|Overall Study|Other|15
6902892|NCT00684671|10924661|FG000|Overall Study|Adverse Event|1
6902893|NCT00684671|10924662|FG001|Overall Study|Adverse Event|0
6902894|NCT00684671|10924663|FG002|Overall Study|Adverse Event|0
6902895|NCT00684671|10924661|FG000|Overall Study|Lost to Follow-up|1
6902896|NCT00684671|10924662|FG001|Overall Study|Lost to Follow-up|0
6902897|NCT00684671|10924663|FG002|Overall Study|Lost to Follow-up|0
6902898|NCT00684671|10924661|FG000|Overall Study|Alcoholic dependance|1
6902899|NCT00684671|10924662|FG001|Overall Study|Alcoholic dependance|0
6902900|NCT00684671|10924663|FG002|Overall Study|Alcoholic dependance|0
6902901|NCT00684762|10924682|FG000|Washout Period of 7 Days|Withdrawal by Subject|2
6902902|NCT00684762|10924683|FG001|Washout Period of 7 Days|Withdrawal by Subject|2
6902903|NCT00684814|10924721|FG000|Washout Period of 7 Days|Adverse Event|1
6902904|NCT00684814|10924722|FG001|Washout Period of 7 Days|Adverse Event|2
6902905|NCT00684814|10924721|FG000|Washout Period of 7 Days|Withdrawal by Subject|1
6973715|NCT01183390|11025698|FG001|First Intervention|Adverse Event|1
6902906|NCT00684814|10924722|FG001|Washout Period of 7 Days|Withdrawal by Subject|2
6902907|NCT00684814|10924721|FG000|Second Intervention|Adverse Event|1
6902908|NCT00684814|10924722|FG001|Second Intervention|Adverse Event|0
6902909|NCT00684996|10924739|FG000|Overall Study|Adverse Event|1
6902910|NCT00684996|10924739|FG000|Overall Study|Refusal unrelated to adverse event|1
6902911|NCT00684996|10924739|FG000|Overall Study|Progression/relapse|2
6902912|NCT00684996|10924739|FG000|Overall Study|Other reasons not protocol specified|1
6902913|NCT00685035|10924746|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1
6902914|NCT00685035|10924747|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0
6902915|NCT00685165|10924778|FG000|Washout Period of 14 Days|Adverse Event|1
6902916|NCT00685165|10924779|FG001|Washout Period of 14 Days|Adverse Event|0
6902917|NCT00685178|10924789|FG000|Overall Study|Adverse Event|1
6902918|NCT00685178|10924790|FG001|Overall Study|Adverse Event|5
6902919|NCT00685178|10924791|FG002|Overall Study|Adverse Event|2
6902920|NCT00685178|10924792|FG003|Overall Study|Adverse Event|4
6902921|NCT00685178|10924789|FG000|Overall Study|missed 3 consecutive methadone clin days|7
6902922|NCT00685178|10924790|FG001|Overall Study|missed 3 consecutive methadone clin days|5
6902923|NCT00685178|10924791|FG002|Overall Study|missed 3 consecutive methadone clin days|2
6902924|NCT00685178|10924792|FG003|Overall Study|missed 3 consecutive methadone clin days|6
6902925|NCT00685178|10924789|FG000|Overall Study|voluntary study discharge|4
6902926|NCT00685178|10924790|FG001|Overall Study|voluntary study discharge|5
6902927|NCT00685178|10924791|FG002|Overall Study|voluntary study discharge|1
6902928|NCT00685178|10924792|FG003|Overall Study|voluntary study discharge|1
6902929|NCT00685178|10924789|FG000|Overall Study|incarcerated|1
6902930|NCT00685178|10924790|FG001|Overall Study|incarcerated|3
6902931|NCT00685178|10924791|FG002|Overall Study|incarcerated|7
6902932|NCT00685178|10924792|FG003|Overall Study|incarcerated|0
6902933|NCT00685178|10924789|FG000|Overall Study|administrative (disciplinary) discharge|0
6902934|NCT00685178|10924790|FG001|Overall Study|administrative (disciplinary) discharge|1
6902935|NCT00685178|10924791|FG002|Overall Study|administrative (disciplinary) discharge|0
6902936|NCT00685178|10924792|FG003|Overall Study|administrative (disciplinary) discharge|2
6902937|NCT00685178|10924789|FG000|Overall Study|Pregnancy|0
6902938|NCT00685178|10924790|FG001|Overall Study|Pregnancy|0
6902939|NCT00685178|10924791|FG002|Overall Study|Pregnancy|0
6902940|NCT00685178|10924792|FG003|Overall Study|Pregnancy|1
6902941|NCT00685334|10924815|FG000|Overall Study|Withdrawal by Subject|5
6902942|NCT00685334|10924816|FG001|Overall Study|Withdrawal by Subject|6
6902943|NCT00685334|10924815|FG000|Overall Study|Lost to Follow-up|4
6902944|NCT00685334|10924816|FG001|Overall Study|Lost to Follow-up|0
6902945|NCT00685334|10924815|FG000|Overall Study|Chose to enter hospital|1
6902946|NCT00685334|10924816|FG001|Overall Study|Chose to enter hospital|1
6902947|NCT00685373|10924822|FG000|Overall Study|Adverse Event|3
6902948|NCT00685373|10924822|FG000|Overall Study|Withdrawal by Subject|5
6902949|NCT00685373|10924822|FG000|Overall Study|Lack of Efficacy|3
6902950|NCT00685373|10924822|FG000|Overall Study|Condition no longer requires study drug|1
6902951|NCT00685373|10924822|FG000|Overall Study|Lost to Follow-up|2
6902952|NCT00685373|10924822|FG000|Overall Study|Protocol Violation|1
6902953|NCT00685399|10924833|FG000|Treatment Period 1|Withdrawal by Subject|2
6902954|NCT00685399|10924834|FG001|Treatment Period 1|Withdrawal by Subject|0
6902955|NCT00685399|10924835|FG002|Treatment Period 1|Withdrawal by Subject|0
6902956|NCT00685399|10924836|FG003|Treatment Period 1|Withdrawal by Subject|0
6902957|NCT00685399|10924837|FG004|Treatment Period 1|Withdrawal by Subject|0
6902958|NCT00685399|10924838|FG005|Treatment Period 1|Withdrawal by Subject|0
6902959|NCT00685399|10924839|FG006|Treatment Period 1|Withdrawal by Subject|0
6902960|NCT00685399|10924840|FG007|Treatment Period 1|Withdrawal by Subject|0
6902961|NCT00685399|10924833|FG000|Treatment Period 1|Protocol Violation|1
6902962|NCT00685399|10924834|FG001|Treatment Period 1|Protocol Violation|0
6902963|NCT00685399|10924835|FG002|Treatment Period 1|Protocol Violation|0
6902964|NCT00685399|10924836|FG003|Treatment Period 1|Protocol Violation|0
6902965|NCT00685399|10924837|FG004|Treatment Period 1|Protocol Violation|0
6902966|NCT00685399|10924838|FG005|Treatment Period 1|Protocol Violation|0
6902967|NCT00685399|10924839|FG006|Treatment Period 1|Protocol Violation|0
6902968|NCT00685399|10924840|FG007|Treatment Period 1|Protocol Violation|0
6902969|NCT00685399|10924833|FG000|Treatment Period 1|Administrative|2
6902970|NCT00685399|10924834|FG001|Treatment Period 1|Administrative|0
6902971|NCT00685399|10924835|FG002|Treatment Period 1|Administrative|0
6902972|NCT00685399|10924836|FG003|Treatment Period 1|Administrative|0
6902973|NCT00685399|10924837|FG004|Treatment Period 1|Administrative|0
6902974|NCT00685399|10924838|FG005|Treatment Period 1|Administrative|0
6902975|NCT00685399|10924839|FG006|Treatment Period 1|Administrative|0
6902976|NCT00685399|10924840|FG007|Treatment Period 1|Administrative|0
6902977|NCT00685399|10924833|FG000|Treatment Period 1|Lack of Efficacy|1
6902978|NCT00685399|10924834|FG001|Treatment Period 1|Lack of Efficacy|0
6902979|NCT00685399|10924835|FG002|Treatment Period 1|Lack of Efficacy|0
6902980|NCT00685399|10924836|FG003|Treatment Period 1|Lack of Efficacy|0
6902981|NCT00685399|10924837|FG004|Treatment Period 1|Lack of Efficacy|0
6902982|NCT00685399|10924838|FG005|Treatment Period 1|Lack of Efficacy|0
6902983|NCT00685399|10924839|FG006|Treatment Period 1|Lack of Efficacy|0
6902984|NCT00685399|10924840|FG007|Treatment Period 1|Lack of Efficacy|0
6902985|NCT00685399|10924833|FG000|Treatment Period 2|Administrative Problems|0
6902986|NCT00685399|10924834|FG001|Treatment Period 2|Administrative Problems|2
6902987|NCT00685399|10924835|FG002|Treatment Period 2|Administrative Problems|1
6902988|NCT00685399|10924836|FG003|Treatment Period 2|Administrative Problems|0
6902989|NCT00685399|10924837|FG004|Treatment Period 2|Administrative Problems|0
6902990|NCT00685399|10924838|FG005|Treatment Period 2|Administrative Problems|0
6902991|NCT00685399|10924839|FG006|Treatment Period 2|Administrative Problems|0
6902992|NCT00685399|10924840|FG007|Treatment Period 2|Administrative Problems|0
6902993|NCT00685399|10924833|FG000|Treatment Period 2|Withdrawal by Subject|0
6902994|NCT00685399|10924834|FG001|Treatment Period 2|Withdrawal by Subject|0
6902995|NCT00685399|10924835|FG002|Treatment Period 2|Withdrawal by Subject|0
6902996|NCT00685399|10924836|FG003|Treatment Period 2|Withdrawal by Subject|0
6902997|NCT00685399|10924837|FG004|Treatment Period 2|Withdrawal by Subject|0
6902998|NCT00685399|10924838|FG005|Treatment Period 2|Withdrawal by Subject|0
6902999|NCT00685399|10924839|FG006|Treatment Period 2|Withdrawal by Subject|0
6903000|NCT00685399|10924840|FG007|Treatment Period 2|Withdrawal by Subject|2
6903001|NCT00685399|10924833|FG000|Treatment Period 2|Adverse Event|0
6903002|NCT00685399|10924834|FG001|Treatment Period 2|Adverse Event|0
6903003|NCT00685399|10924835|FG002|Treatment Period 2|Adverse Event|0
6903004|NCT00685399|10924836|FG003|Treatment Period 2|Adverse Event|0
6903005|NCT00685399|10924837|FG004|Treatment Period 2|Adverse Event|0
6903006|NCT00685399|10924838|FG005|Treatment Period 2|Adverse Event|1
6903007|NCT00685399|10924839|FG006|Treatment Period 2|Adverse Event|0
6903008|NCT00685399|10924840|FG007|Treatment Period 2|Adverse Event|0
6903009|NCT00685399|10924833|FG000|Treatment Period 2|Lack of Efficacy|0
6903010|NCT00685399|10924834|FG001|Treatment Period 2|Lack of Efficacy|10
6903011|NCT00685399|10924835|FG002|Treatment Period 2|Lack of Efficacy|2
6903012|NCT00685399|10924836|FG003|Treatment Period 2|Lack of Efficacy|0
6903013|NCT00685399|10924837|FG004|Treatment Period 2|Lack of Efficacy|0
6903014|NCT00685399|10924838|FG005|Treatment Period 2|Lack of Efficacy|1
6903015|NCT00685399|10924839|FG006|Treatment Period 2|Lack of Efficacy|0
6903016|NCT00685399|10924840|FG007|Treatment Period 2|Lack of Efficacy|0
6903017|NCT00685399|10924833|FG000|Extension|Administrative Issues|0
6903018|NCT00685399|10924834|FG001|Extension|Administrative Issues|0
6903019|NCT00685399|10924835|FG002|Extension|Administrative Issues|0
6903020|NCT00685399|10924836|FG003|Extension|Administrative Issues|1
6903021|NCT00685399|10924837|FG004|Extension|Administrative Issues|0
6903022|NCT00685399|10924838|FG005|Extension|Administrative Issues|0
6903023|NCT00685399|10924839|FG006|Extension|Administrative Issues|0
6903024|NCT00685399|10924840|FG007|Extension|Administrative Issues|0
6903025|NCT00685399|10924833|FG000|Extension|Withdrawal by Subject|0
6903026|NCT00685399|10924834|FG001|Extension|Withdrawal by Subject|0
6903027|NCT00685399|10924835|FG002|Extension|Withdrawal by Subject|0
6903028|NCT00685399|10924836|FG003|Extension|Withdrawal by Subject|1
6903029|NCT00685399|10924837|FG004|Extension|Withdrawal by Subject|0
6903030|NCT00685399|10924838|FG005|Extension|Withdrawal by Subject|0
6903031|NCT00685399|10924839|FG006|Extension|Withdrawal by Subject|0
6903032|NCT00685399|10924840|FG007|Extension|Withdrawal by Subject|0
6903033|NCT00685399|10924833|FG000|Extension|Protocol Violation|0
6903034|NCT00685399|10924834|FG001|Extension|Protocol Violation|0
6903035|NCT00685399|10924835|FG002|Extension|Protocol Violation|0
6903036|NCT00685399|10924836|FG003|Extension|Protocol Violation|1
6903037|NCT00685399|10924837|FG004|Extension|Protocol Violation|0
6903038|NCT00685399|10924838|FG005|Extension|Protocol Violation|0
6903039|NCT00685399|10924839|FG006|Extension|Protocol Violation|0
6903040|NCT00685399|10924840|FG007|Extension|Protocol Violation|0
6903041|NCT00685399|10924833|FG000|Extension|Lack of Efficacy|0
6903042|NCT00685399|10924834|FG001|Extension|Lack of Efficacy|0
6903043|NCT00685399|10924835|FG002|Extension|Lack of Efficacy|0
6903044|NCT00685399|10924836|FG003|Extension|Lack of Efficacy|2
6903045|NCT00685399|10924837|FG004|Extension|Lack of Efficacy|0
6903046|NCT00685399|10924838|FG005|Extension|Lack of Efficacy|0
6903047|NCT00685399|10924839|FG006|Extension|Lack of Efficacy|0
6903048|NCT00685399|10924840|FG007|Extension|Lack of Efficacy|0
6903049|NCT00685399|10924833|FG000|Extension|Adverse Event|0
6903050|NCT00685399|10924834|FG001|Extension|Adverse Event|0
6903051|NCT00685399|10924835|FG002|Extension|Adverse Event|0
6903052|NCT00685399|10924836|FG003|Extension|Adverse Event|2
6903053|NCT00685399|10924837|FG004|Extension|Adverse Event|0
6903054|NCT00685399|10924838|FG005|Extension|Adverse Event|0
6903055|NCT00685399|10924839|FG006|Extension|Adverse Event|0
6903056|NCT00685399|10924840|FG007|Extension|Adverse Event|0
6903057|NCT00685685|10924910|FG000|Washout Period of 7 Days|Adverse Event|2
6903058|NCT00685685|10924911|FG001|Washout Period of 7 Days|Adverse Event|0
6903059|NCT00685685|10924910|FG000|Washout Period of 7 Days|Withdrawal by Subject|0
6903060|NCT00685685|10924911|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
6903061|NCT00685698|10924917|FG000|Overall Study|Withdrawal by Subject|1
6903062|NCT00685698|10924917|FG000|Overall Study|Protocol Violation|6
6903063|NCT00685698|10924917|FG000|Overall Study|Adverse Event|3
6903064|NCT00685698|10924917|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1
6903065|NCT00685698|10924917|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1
6903066|NCT00685698|10924917|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1
6903067|NCT00685750|10924940|FG000|Overall Study|Tumor sampling failure|0
6903068|NCT00685750|10924941|FG001|Overall Study|Tumor sampling failure|0
6903069|NCT00685750|10924942|FG002|Overall Study|Tumor sampling failure|1
6903070|NCT00685750|10924943|FG003|Overall Study|Tumor sampling failure|0
6903071|NCT00685750|10924944|FG004|Overall Study|Tumor sampling failure|0
6903072|NCT00685750|10924945|FG005|Overall Study|Tumor sampling failure|0
6903073|NCT00685750|10924946|FG006|Overall Study|Tumor sampling failure|0
6903074|NCT00685750|10924940|FG000|Overall Study|Patient didn't receive the treatment|0
6903075|NCT00685750|10924941|FG001|Overall Study|Patient didn't receive the treatment|0
6903076|NCT00685750|10924942|FG002|Overall Study|Patient didn't receive the treatment|0
6903077|NCT00685750|10924943|FG003|Overall Study|Patient didn't receive the treatment|0
6903078|NCT00685750|10924944|FG004|Overall Study|Patient didn't receive the treatment|0
6903079|NCT00685750|10924945|FG005|Overall Study|Patient didn't receive the treatment|0
6903080|NCT00685750|10924946|FG006|Overall Study|Patient didn't receive the treatment|1
6903081|NCT00685750|10924940|FG000|Overall Study|Eligibility criteria not fulfilled|0
6903082|NCT00685750|10924941|FG001|Overall Study|Eligibility criteria not fulfilled|0
6903083|NCT00685750|10924942|FG002|Overall Study|Eligibility criteria not fulfilled|1
6903084|NCT00685750|10924943|FG003|Overall Study|Eligibility criteria not fulfilled|0
6903085|NCT00685750|10924944|FG004|Overall Study|Eligibility criteria not fulfilled|0
6903086|NCT00685750|10924945|FG005|Overall Study|Eligibility criteria not fulfilled|0
6903087|NCT00685750|10924946|FG006|Overall Study|Eligibility criteria not fulfilled|0
6903088|NCT00685763|10924966|FG000|Overall Study|Intercurrent death-incomplete treatment|1
6903089|NCT00685763|10924966|FG000|Overall Study|Protocol Violation|1
6903090|NCT00685802|10924970|FG000|Washout Period of 7 Days|Protocol Violation|2
6903091|NCT00685802|10924971|FG001|Washout Period of 7 Days|Protocol Violation|0
6903092|NCT00685802|10924970|FG000|Washout Period of 7 Days|Withdrawal by Subject|0
6903093|NCT00685802|10924971|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
6903094|NCT00685945|10924986|FG000|L-NMMA + Bradykinin|Physician Decision|1
6903095|NCT00686075|10925006|FG000|Overall Study|Withdrawal by Subject|4
6903096|NCT00686075|10925007|FG001|Overall Study|Withdrawal by Subject|3
6903097|NCT00686075|10925008|FG002|Overall Study|Withdrawal by Subject|3
6903098|NCT00686075|10925009|FG003|Overall Study|Withdrawal by Subject|7
6903099|NCT00686075|10925010|FG004|Overall Study|Withdrawal by Subject|1
6903100|NCT00686075|10925011|FG005|Overall Study|Withdrawal by Subject|0
6903101|NCT00686075|10925012|FG006|Overall Study|Withdrawal by Subject|0
6903102|NCT00686075|10925013|FG007|Overall Study|Withdrawal by Subject|2
6903103|NCT00686075|10925014|FG008|Overall Study|Withdrawal by Subject|4
6903104|NCT00686075|10925015|FG009|Overall Study|Withdrawal by Subject|6
6903105|NCT00686075|10925006|FG000|Overall Study|Lost to Follow-up|3
6903106|NCT00686075|10925007|FG001|Overall Study|Lost to Follow-up|6
6903107|NCT00686075|10925008|FG002|Overall Study|Lost to Follow-up|3
6903108|NCT00686075|10925009|FG003|Overall Study|Lost to Follow-up|2
6903109|NCT00686075|10925010|FG004|Overall Study|Lost to Follow-up|3
6903110|NCT00686075|10925011|FG005|Overall Study|Lost to Follow-up|3
6903111|NCT00686075|10925012|FG006|Overall Study|Lost to Follow-up|0
6903112|NCT00686075|10925013|FG007|Overall Study|Lost to Follow-up|0
6903113|NCT00686075|10925014|FG008|Overall Study|Lost to Follow-up|2
6903114|NCT00686075|10925015|FG009|Overall Study|Lost to Follow-up|3
6903115|NCT00686075|10925006|FG000|Overall Study|Other|1
6903116|NCT00686075|10925007|FG001|Overall Study|Other|1
6903117|NCT00686075|10925008|FG002|Overall Study|Other|0
6903118|NCT00686075|10925009|FG003|Overall Study|Other|0
6903119|NCT00686075|10925010|FG004|Overall Study|Other|0
6903120|NCT00686075|10925011|FG005|Overall Study|Other|0
6903121|NCT00686075|10925012|FG006|Overall Study|Other|0
6903122|NCT00686075|10925013|FG007|Overall Study|Other|0
6903123|NCT00686075|10925014|FG008|Overall Study|Other|0
6903124|NCT00686075|10925015|FG009|Overall Study|Other|1
6903125|NCT00686127|10925039|FG000|Overall Study|Withdrawal by Subject|14
6903126|NCT00686127|10925040|FG001|Overall Study|Withdrawal by Subject|6
6903127|NCT00686166|10925046|FG000|Overall Study|Adverse Event|7
6903128|NCT00686166|10925046|FG000|Overall Study|Withdrawal by Subject|1
6903129|NCT00686166|10925046|FG000|Overall Study|Progression/Relapse|1
6903130|NCT00686166|10925046|FG000|Overall Study|Death|1
6903131|NCT00686166|10925046|FG000|Overall Study|Not Protocol Specified|1
6903132|NCT00686166|10925046|FG000|Overall Study|Ineligible|5
6903133|NCT00686166|10925046|FG000|Overall Study|Did not begin protocol therapy|4
6903134|NCT00686205|10925057|FG000|Overall Study|Protocol Violation|127
6903135|NCT00686205|10925058|FG001|Overall Study|Protocol Violation|0
6903136|NCT00686205|10925057|FG000|Overall Study|Withdrawal by Subject|2
6903137|NCT00686205|10925058|FG001|Overall Study|Withdrawal by Subject|0
6903138|NCT00686205|10925057|FG000|Overall Study|Specimen handling procedure altered|5878
6903139|NCT00686205|10925058|FG001|Overall Study|Specimen handling procedure altered|0
6903140|NCT00686205|10925057|FG000|Overall Study|Specimens not confirmed HIV positive|0
6903141|NCT00686205|10925058|FG001|Overall Study|Specimens not confirmed HIV positive|981
6903142|NCT00686335|10925088|FG000|Run-in Period|Adverse Event|1
6903143|NCT00686335|10925088|FG000|Run-in Period|asthma exacerbation|1
6978681|NCT01214629|11032178|FG006|Overall Study|Withdrawal by Subject|0
6903144|NCT00686335|10925088|FG000|Run-in Period|violation of inclusion/exclusion criteri|3
6903145|NCT00686517|10925097|FG000|Treatment|Serious Adverse Event|1
6903146|NCT00686517|10925098|FG001|Treatment|Serious Adverse Event|2
6903147|NCT00686517|10925099|FG002|Treatment|Serious Adverse Event|1
6903148|NCT00686517|10925097|FG000|Treatment|Adverse Event|2
6903149|NCT00686517|10925098|FG001|Treatment|Adverse Event|0
6903150|NCT00686517|10925099|FG002|Treatment|Adverse Event|0
6903151|NCT00686517|10925097|FG000|Treatment|Poor Protocol Compliance|1
6903152|NCT00686517|10925098|FG001|Treatment|Poor Protocol Compliance|0
6903153|NCT00686517|10925099|FG002|Treatment|Poor Protocol Compliance|0
6903154|NCT00686517|10925097|FG000|Treatment|Protocol Violation|2
6903155|NCT00686517|10925098|FG001|Treatment|Protocol Violation|1
6903156|NCT00686517|10925099|FG002|Treatment|Protocol Violation|0
6903157|NCT00686543|10925111|FG000|Overall Study|Adverse Event|9
6903158|NCT00686543|10925112|FG001|Overall Study|Adverse Event|1
6903159|NCT00686543|10925113|FG002|Overall Study|Adverse Event|3
6903160|NCT00686543|10925114|FG003|Overall Study|Adverse Event|2
6903161|NCT00686543|10925111|FG000|Overall Study|Withdrawal by Subject|2
6903162|NCT00686543|10925112|FG001|Overall Study|Withdrawal by Subject|0
6903163|NCT00686543|10925113|FG002|Overall Study|Withdrawal by Subject|0
6903164|NCT00686543|10925114|FG003|Overall Study|Withdrawal by Subject|0
6903165|NCT00686543|10925111|FG000|Overall Study|Protocol Violation|3
6903166|NCT00686543|10925112|FG001|Overall Study|Protocol Violation|0
6903167|NCT00686543|10925113|FG002|Overall Study|Protocol Violation|2
6903168|NCT00686543|10925114|FG003|Overall Study|Protocol Violation|1
6903169|NCT00686595|10925135|FG000|Overall Study|Adverse Event|3
6903170|NCT00686595|10925135|FG000|Overall Study|Protocol Violation|1
6903171|NCT00686595|10925135|FG000|Overall Study|Lost to Follow-up|1
6903172|NCT00686595|10925135|FG000|Overall Study|Lack of Efficacy|1
6903173|NCT00686595|10925135|FG000|Overall Study|Poor Compliance|1
6903174|NCT00686634|10925139|FG000|Overall Study|Protocol Violation|6
6903175|NCT00686647|10925144|FG000|Overall Study|Lost to Follow-up|1
6903176|NCT00686647|10925144|FG000|Overall Study|Death|1
6903177|NCT00686686|10925149|FG000|Overall Study|Non-compliance|1
6903178|NCT00686686|10925149|FG000|Overall Study|Adverse Event|2
6903179|NCT00686686|10925149|FG000|Overall Study|Lost to Follow-up|3
6903180|NCT00686699|10925155|FG000|Treatment Period 1|Adverse Event|0
6903181|NCT00686699|10925156|FG001|Treatment Period 1|Adverse Event|2
6903182|NCT00686712|10925165|FG000|Overall Study|Protocol Violation|8
6903183|NCT00686712|10925166|FG001|Overall Study|Protocol Violation|8
6903184|NCT00686712|10925167|FG002|Overall Study|Protocol Violation|10
6903185|NCT00686712|10925165|FG000|Overall Study|Lost to Follow-up|1
6903186|NCT00686712|10925166|FG001|Overall Study|Lost to Follow-up|2
6903187|NCT00686712|10925167|FG002|Overall Study|Lost to Follow-up|3
6903188|NCT00686712|10925165|FG000|Overall Study|Adverse Event|1
6903189|NCT00686712|10925166|FG001|Overall Study|Adverse Event|1
6903190|NCT00686712|10925167|FG002|Overall Study|Adverse Event|0
6903191|NCT00686725|10925180|FG000|Overall Study|Adverse Event|1
6903192|NCT00686725|10925181|FG001|Overall Study|Adverse Event|1
6903193|NCT00686725|10925180|FG000|Overall Study|Progressive Disease|17
6903194|NCT00686725|10925181|FG001|Overall Study|Progressive Disease|23
6903195|NCT00686725|10925180|FG000|Overall Study|Lost to Follow-up|7
6903196|NCT00686725|10925181|FG001|Overall Study|Lost to Follow-up|5
6903197|NCT00686725|10925180|FG000|Overall Study|Death|6
6903198|NCT00686725|10925181|FG001|Overall Study|Death|3
6903199|NCT00686725|10925180|FG000|Overall Study|Withdrawal by Subject|13
6903200|NCT00686725|10925181|FG001|Overall Study|Withdrawal by Subject|4
6903201|NCT00686725|10925180|FG000|Overall Study|Protocol Violation|1
6903202|NCT00686725|10925181|FG001|Overall Study|Protocol Violation|3
6903203|NCT00686725|10925180|FG000|Overall Study|Other|1
6903204|NCT00686725|10925181|FG001|Overall Study|Other|3
6903205|NCT00686777|10925187|FG000|Overall Study|Adverse Event|2
6903206|NCT00686777|10925187|FG000|Overall Study|Pregnancy|1
6903207|NCT00686777|10925187|FG000|Overall Study|Withdrawal by Subject|2
6903208|NCT00686777|10925187|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4
6903209|NCT00686777|10925187|FG000|Overall Study|No Visit|1
6903210|NCT00686790|10925191|FG000|Overall Study|Adverse Event|2
6903211|NCT00686790|10925191|FG000|Overall Study|Withdrawal by Subject|1
6903212|NCT00686790|10925191|FG000|Overall Study|Death|1
6903213|NCT00686790|10925191|FG000|Overall Study|Lost to Follow-up|12
6903214|NCT00686829|10925208|FG000|Overall Study|Adverse Event|5
6903215|NCT00686829|10925208|FG000|Overall Study|Lack of Efficacy|6
6903216|NCT00686829|10925208|FG000|Overall Study|Lost to Follow-up|4
6903217|NCT00686829|10925208|FG000|Overall Study|Withdrawal by Subject|14
6903218|NCT00686829|10925208|FG000|Overall Study|Protocol Violation|3
6903219|NCT00686829|10925208|FG000|Overall Study|Sponsor discontinued VCV|47
6903220|NCT00686855|10925218|FG000|Overall Study|Lost to Follow-up|1
6903221|NCT00686855|10925219|FG001|Overall Study|Lost to Follow-up|0
6903222|NCT00686855|10925218|FG000|Overall Study|Progressive GVHD|0
6903223|NCT00686855|10925219|FG001|Overall Study|Progressive GVHD|1
6903224|NCT00686881|10925227|FG000|Overall Study|Withdrawal by Subject|11
6903225|NCT00686881|10925228|FG001|Overall Study|Withdrawal by Subject|18
6903226|NCT00686881|10925227|FG000|Overall Study|Lost to Follow-up|0
6903227|NCT00686881|10925228|FG001|Overall Study|Lost to Follow-up|1
6903228|NCT00686881|10925227|FG000|Overall Study|Treatment-related adverse event|10
6903229|NCT00686881|10925228|FG001|Overall Study|Treatment-related adverse event|9
6903230|NCT00686881|10925227|FG000|Overall Study|Met discontinuation criteria|5
6903231|NCT00686881|10925228|FG001|Overall Study|Met discontinuation criteria|0
6903232|NCT00686881|10925227|FG000|Overall Study|Onset of malignant tumor|11
6903233|NCT00686881|10925228|FG001|Overall Study|Onset of malignant tumor|11
6903234|NCT00686881|10925227|FG000|Overall Study|Lack of Efficacy|4
6903235|NCT00686881|10925228|FG001|Overall Study|Lack of Efficacy|3
6903236|NCT00686881|10925227|FG000|Overall Study|Physician Decision|1
6903237|NCT00686881|10925228|FG001|Overall Study|Physician Decision|0
6903238|NCT00686881|10925227|FG000|Overall Study|Circumstances of site|1
6903239|NCT00686881|10925228|FG001|Overall Study|Circumstances of site|1
6903240|NCT00686881|10925227|FG000|Overall Study|Did not meet protocol eligibility|1
6903241|NCT00686881|10925228|FG001|Overall Study|Did not meet protocol eligibility|0
6903242|NCT00686881|10925227|FG000|Overall Study|Irregular visits|1
6903243|NCT00686881|10925228|FG001|Overall Study|Irregular visits|0
6903244|NCT00686881|10925227|FG000|Overall Study|Study discontinuation|35
6903245|NCT00686881|10925228|FG001|Overall Study|Study discontinuation|32
6903246|NCT00686881|10925227|FG000|Overall Study|Never received study drug|2
6903247|NCT00686881|10925228|FG001|Overall Study|Never received study drug|6
6903248|NCT00686894|10925236|FG000|Overall Study|Relapse|2
6903249|NCT00686894|10925236|FG000|Overall Study|Protocol Violation|4
6903250|NCT00686920|10925242|FG000|Overall Study|Death|45
6903251|NCT00686920|10925243|FG001|Overall Study|Death|14
6903252|NCT00686920|10925242|FG000|Overall Study|Liver Transplant|23
6903253|NCT00686920|10925243|FG001|Overall Study|Liver Transplant|8
6903254|NCT00686920|10925242|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1
6903255|NCT00686920|10925243|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2
6903256|NCT00686920|10925242|FG000|Overall Study|Withdrawal by Subject|23
6903257|NCT00686920|10925243|FG001|Overall Study|Withdrawal by Subject|5
6903258|NCT00686920|10925242|FG000|Overall Study|Protocol Violation|2
6903259|NCT00686920|10925243|FG001|Overall Study|Protocol Violation|1
6903260|NCT00686920|10925242|FG000|Overall Study|Adverse Event|10
6903261|NCT00686920|10925243|FG001|Overall Study|Adverse Event|2
6903262|NCT00686920|10925242|FG000|Overall Study|Personal Reason|0
6903263|NCT00686920|10925243|FG001|Overall Study|Personal Reason|1
6903264|NCT00686920|10925242|FG000|Overall Study|Lost to Follow-up|15
6903265|NCT00686920|10925243|FG001|Overall Study|Lost to Follow-up|3
6903266|NCT00686920|10925242|FG000|Overall Study|Moved to Another State|1
6903267|NCT00686920|10925243|FG001|Overall Study|Moved to Another State|0
6903268|NCT00686920|10925242|FG000|Overall Study|Transferred to Nursing Home|1
6903269|NCT00686920|10925243|FG001|Overall Study|Transferred to Nursing Home|0
6903270|NCT00686920|10925242|FG000|Overall Study|Noncompliance|9
6903271|NCT00686920|10925243|FG001|Overall Study|Noncompliance|0
6903272|NCT00686920|10925242|FG000|Overall Study|Principal Investigator Decision|2
6903273|NCT00686920|10925243|FG001|Overall Study|Principal Investigator Decision|0
6903274|NCT00686959|10925251|FG000|Overall Study|Participants censored (no death events)|124
6903275|NCT00686959|10925252|FG001|Overall Study|Participants censored (no death events)|117
6903276|NCT00686998|10925261|FG000|Overall Study|Adverse Event|3
6903277|NCT00686998|10925262|FG001|Overall Study|Adverse Event|2
6903278|NCT00686998|10925263|FG002|Overall Study|Adverse Event|1
6903279|NCT00686998|10925261|FG000|Overall Study|Withdrawal by Subject|2
6903280|NCT00686998|10925262|FG001|Overall Study|Withdrawal by Subject|1
6903281|NCT00686998|10925263|FG002|Overall Study|Withdrawal by Subject|2
6903282|NCT00686998|10925261|FG000|Overall Study|Lack of Efficacy|7
6903283|NCT00686998|10925262|FG001|Overall Study|Lack of Efficacy|5
6903284|NCT00686998|10925263|FG002|Overall Study|Lack of Efficacy|0
6903285|NCT00686998|10925261|FG000|Overall Study|Other|0
6903286|NCT00686998|10925262|FG001|Overall Study|Other|0
6903287|NCT00686998|10925263|FG002|Overall Study|Other|1
6903288|NCT00686998|10925261|FG000|Overall Study|Safety Reasons|1
6903289|NCT00686998|10925262|FG001|Overall Study|Safety Reasons|0
6903290|NCT00686998|10925263|FG002|Overall Study|Safety Reasons|0
6903291|NCT00687193|10925302|FG000|Overall Study|Adverse Event|0
6903292|NCT00687193|10925303|FG001|Overall Study|Adverse Event|1
6903293|NCT00687193|10925304|FG002|Overall Study|Adverse Event|2
6903294|NCT00687193|10925305|FG003|Overall Study|Adverse Event|3
6903295|NCT00687193|10925306|FG004|Overall Study|Adverse Event|0
6903296|NCT00687193|10925307|FG005|Overall Study|Adverse Event|2
6903297|NCT00687193|10925302|FG000|Overall Study|Lack of Efficacy|1
6903298|NCT00687193|10925303|FG001|Overall Study|Lack of Efficacy|1
6903299|NCT00687193|10925304|FG002|Overall Study|Lack of Efficacy|0
6903300|NCT00687193|10925305|FG003|Overall Study|Lack of Efficacy|0
6903301|NCT00687193|10925306|FG004|Overall Study|Lack of Efficacy|0
6903302|NCT00687193|10925307|FG005|Overall Study|Lack of Efficacy|2
6903303|NCT00687193|10925302|FG000|Overall Study|Protocol Violation|1
6903304|NCT00687193|10925303|FG001|Overall Study|Protocol Violation|2
6903305|NCT00687193|10925304|FG002|Overall Study|Protocol Violation|0
6903306|NCT00687193|10925305|FG003|Overall Study|Protocol Violation|1
6903307|NCT00687193|10925306|FG004|Overall Study|Protocol Violation|2
6903308|NCT00687193|10925307|FG005|Overall Study|Protocol Violation|0
6903309|NCT00687219|10925324|FG000|Overall Study|Adverse Event|8
6903310|NCT00687219|10925324|FG000|Overall Study|Discontinuance criteria met|7
6903311|NCT00687219|10925324|FG000|Overall Study|HCV-RNA positive conversion|34
6903312|NCT00687219|10925324|FG000|Overall Study|Withdrawal by Subject|1
6903313|NCT00687219|10925324|FG000|Overall Study|Lack of Efficacy|1
6903314|NCT00687271|10925332|FG000|Overall Study|Adverse Event|1
6903315|NCT00687271|10925333|FG001|Overall Study|Adverse Event|3
6903316|NCT00687271|10925334|FG002|Overall Study|Adverse Event|1
6903317|NCT00687271|10925335|FG003|Overall Study|Adverse Event|0
6903318|NCT00687271|10925332|FG000|Overall Study|Lost to Follow-up|0
6903319|NCT00687271|10925333|FG001|Overall Study|Lost to Follow-up|1
6903320|NCT00687271|10925334|FG002|Overall Study|Lost to Follow-up|0
6903321|NCT00687271|10925335|FG003|Overall Study|Lost to Follow-up|0
6903322|NCT00687271|10925332|FG000|Overall Study|Protocol Violation|2
6903323|NCT00687271|10925333|FG001|Overall Study|Protocol Violation|1
6903324|NCT00687271|10925334|FG002|Overall Study|Protocol Violation|1
6903325|NCT00687271|10925335|FG003|Overall Study|Protocol Violation|0
6903326|NCT00687271|10925332|FG000|Overall Study|Withdrawal by Subject|0
6903327|NCT00687271|10925333|FG001|Overall Study|Withdrawal by Subject|1
6903328|NCT00687271|10925334|FG002|Overall Study|Withdrawal by Subject|3
6903329|NCT00687271|10925335|FG003|Overall Study|Withdrawal by Subject|0
6903330|NCT00687297|10925347|FG000|Randomization|Withdrawal by Subject|2
6903331|NCT00687297|10925348|FG001|Randomization|Withdrawal by Subject|0
6903332|NCT00687297|10925347|FG000|Randomization|Withdrew before treatment, ineligible|1
6903333|NCT00687297|10925348|FG001|Randomization|Withdrew before treatment, ineligible|1
6903334|NCT00687297|10925347|FG000|Induction|Withdrawal by Subject|4
6903335|NCT00687297|10925348|FG001|Induction|Withdrawal by Subject|4
6903336|NCT00687297|10925347|FG000|Induction|Adverse Event|16
6903337|NCT00687297|10925348|FG001|Induction|Adverse Event|15
6903338|NCT00687297|10925347|FG000|Induction|Death|7
6903339|NCT00687297|10925348|FG001|Induction|Death|11
6903340|NCT00687297|10925347|FG000|Induction|Lack of Efficacy|17
6903341|NCT00687297|10925348|FG001|Induction|Lack of Efficacy|21
6903342|NCT00687297|10925347|FG000|Induction|Ineligible|0
6903343|NCT00687297|10925348|FG001|Induction|Ineligible|1
6903344|NCT00687297|10925347|FG000|Induction|Patient Noncompliance|1
6903345|NCT00687297|10925348|FG001|Induction|Patient Noncompliance|0
6903346|NCT00687297|10925347|FG000|Induction|Physician Decision|0
6903347|NCT00687297|10925348|FG001|Induction|Physician Decision|2
6903348|NCT00687297|10925347|FG000|Induction|Other|0
6903349|NCT00687297|10925348|FG001|Induction|Other|1
6973716|NCT01183780|11025753|FG000|Overall Study|Withdrawal by Subject|25
6973717|NCT01183780|11025754|FG001|Overall Study|Withdrawal by Subject|14
6973718|NCT01183780|11025753|FG000|Overall Study|Lost to Follow-up|6
6973719|NCT01183780|11025754|FG001|Overall Study|Lost to Follow-up|11
6973720|NCT01183858|11025762|FG000|Overall Study|Death not related to Progressive Disease|5
6973721|NCT01183858|11025763|FG001|Overall Study|Death not related to Progressive Disease|6
6973722|NCT01183858|11025762|FG000|Overall Study|Adverse Event|14
6973723|NCT01183858|11025763|FG001|Overall Study|Adverse Event|11
6973724|NCT01183858|11025762|FG000|Overall Study|Investigator's Decision|0
6973725|NCT01183858|11025763|FG001|Overall Study|Investigator's Decision|3
6973726|NCT01183858|11025762|FG000|Overall Study|Insufficient Therapeutic Response|2
6973727|NCT01183858|11025763|FG001|Overall Study|Insufficient Therapeutic Response|0
6973728|NCT01183858|11025762|FG000|Overall Study|Refused Treatment|1
6973729|NCT01183858|11025763|FG001|Overall Study|Refused Treatment|4
6973730|NCT01183858|11025762|FG000|Overall Study|Withdrew Consent|4
6973731|NCT01183858|11025763|FG001|Overall Study|Withdrew Consent|4
6973732|NCT01183858|11025762|FG000|Overall Study|Discontinued Smoking|3
6973733|NCT01183858|11025763|FG001|Overall Study|Discontinued Smoking|1
6973734|NCT01183858|11025762|FG000|Overall Study|Protocol Violation|1
6973735|NCT01183858|11025763|FG001|Overall Study|Protocol Violation|0
6973736|NCT01183858|11025762|FG000|Overall Study|Administrative/Other|6
6973737|NCT01183858|11025763|FG001|Overall Study|Administrative/Other|6
6973738|NCT01183858|11025762|FG000|Overall Study|Progressive Disease|112
6973739|NCT01183858|11025763|FG001|Overall Study|Progressive Disease|115
6973740|NCT01183858|11025762|FG000|Overall Study|Death related to Progressive Disease|4
6973741|NCT01183858|11025763|FG001|Overall Study|Death related to Progressive Disease|5
6973742|NCT01183858|11025762|FG000|Overall Study|Lost to Follow-up|1
6973743|NCT01183858|11025763|FG001|Overall Study|Lost to Follow-up|1
6973744|NCT01183975|11025775|FG000|Overall Study|Lost to Follow-up|73
6973745|NCT01184053|11025788|FG000|Overall Study|progression while on treatment|3
6973746|NCT01184079|11025795|FG000|Overall Study|Lost to Follow-up|14
6973747|NCT01184079|11025796|FG001|Overall Study|Lost to Follow-up|2
6973748|NCT01184118|11025804|FG000|Overall Study|Only asthma step 1 - screen fail|1
6973749|NCT01184118|11025804|FG000|Overall Study|No physiologic confirmation of asthma|8
6973750|NCT01184118|11025804|FG000|Overall Study|FEV1 <60% predicted|2
6973751|NCT01184118|11025804|FG000|Overall Study|Exclusionary medical condition|2
6973752|NCT01184118|11025804|FG000|Overall Study|Withdrawal by Subject|5
6973753|NCT01184326|11025811|FG000|Overall Study|Adverse Event|1
6973754|NCT01184326|11025812|FG001|Overall Study|Adverse Event|2
6973755|NCT01184326|11025813|FG002|Overall Study|Adverse Event|0
6973756|NCT01184326|11025811|FG000|Overall Study|Death|0
6973757|NCT01184326|11025812|FG001|Overall Study|Death|0
6973758|NCT01184326|11025813|FG002|Overall Study|Death|1
6973759|NCT01184326|11025811|FG000|Overall Study|Withdrawal by Subject|0
6973760|NCT01184326|11025812|FG001|Overall Study|Withdrawal by Subject|0
6973761|NCT01184326|11025813|FG002|Overall Study|Withdrawal by Subject|1
6973762|NCT01184326|11025811|FG000|Overall Study|Physician Decision|1
6973763|NCT01184326|11025812|FG001|Overall Study|Physician Decision|1
6973764|NCT01184326|11025813|FG002|Overall Study|Physician Decision|0
6973765|NCT01184326|11025811|FG000|Overall Study|Disease Progression|1
6973766|NCT01184326|11025812|FG001|Overall Study|Disease Progression|3
6973767|NCT01184326|11025813|FG002|Overall Study|Disease Progression|12
6973768|NCT01184508|11025835|FG000|Overall Study|Adverse Event|4
6973769|NCT01184508|11025836|FG001|Overall Study|Adverse Event|6
6973770|NCT01184508|11025835|FG000|Overall Study|Lack of Efficacy|1
6973771|NCT01184508|11025836|FG001|Overall Study|Lack of Efficacy|1
6973772|NCT01184508|11025835|FG000|Overall Study|Lost to Follow-up|1
6903350|NCT00687323|10925356|FG000|Overall Study|Death|25
6903351|NCT00687323|10925356|FG000|Overall Study|Withdrawal by Subject|1
6903352|NCT00687323|10925356|FG000|Overall Study|Excluded from efficacy evaluations|6
6903353|NCT00687323|10925356|FG000|Overall Study|Screen failure|148
6903354|NCT00687362|10925360|FG000|Overall Study|Protocol Violation|2
6903355|NCT00687362|10925360|FG000|Overall Study|Withdrawal by Subject|1
6903356|NCT00687401|10925364|FG000|Overall Study|Protocol Violation|7
6903357|NCT00687401|10925364|FG000|Overall Study|Adverse Event|6
6903358|NCT00687401|10925364|FG000|Overall Study|Lack of Efficacy|6
6903359|NCT00687401|10925364|FG000|Overall Study|Withdrawal by Subject|4
6903360|NCT00687401|10925364|FG000|Overall Study|Did not return for visit|3
6903361|NCT00687401|10925364|FG000|Overall Study|For reasons different from those above|4
6903362|NCT00687440|10925369|FG000|Overall Study|Adverse Event|3
6903363|NCT00687440|10925369|FG000|Overall Study|Lost to Follow-up|3
6903364|NCT00687440|10925369|FG000|Overall Study|Lack of Efficacy|2
6903365|NCT00687440|10925369|FG000|Overall Study|Death|2
6903366|NCT00687440|10925369|FG000|Overall Study|Other|1
6903367|NCT00687440|10925369|FG000|Overall Study|Missing|1
6903368|NCT00687609|10925386|FG000|Overall Study|Physician Decision|1
6903369|NCT00687609|10925386|FG000|Overall Study|Withdrawal by Subject|2
6903370|NCT00687739|10925409|FG000|Overall Study|Lost to Follow-up|2
6903371|NCT00687739|10925410|FG001|Overall Study|Lost to Follow-up|2
6903372|NCT00687739|10925411|FG002|Overall Study|Lost to Follow-up|1
6903373|NCT00687739|10925412|FG003|Overall Study|Lost to Follow-up|2
6903374|NCT00687739|10925409|FG000|Overall Study|Adverse Event|0
6903375|NCT00687739|10925410|FG001|Overall Study|Adverse Event|1
6903376|NCT00687739|10925411|FG002|Overall Study|Adverse Event|1
6903377|NCT00687739|10925412|FG003|Overall Study|Adverse Event|0
6903378|NCT00687804|10925427|FG000|Core Study|Adverse Event|5
6903379|NCT00687804|10925428|FG001|Core Study|Adverse Event|3
6903380|NCT00687804|10925429|FG002|Core Study|Adverse Event|3
6903381|NCT00687804|10925427|FG000|Core Study|Abnormal laboratory value(s)|1
6903382|NCT00687804|10925428|FG001|Core Study|Abnormal laboratory value(s)|0
6903383|NCT00687804|10925429|FG002|Core Study|Abnormal laboratory value(s)|0
6903384|NCT00687804|10925427|FG000|Core Study|Lack of Efficacy|1
6903385|NCT00687804|10925428|FG001|Core Study|Lack of Efficacy|1
6903386|NCT00687804|10925429|FG002|Core Study|Lack of Efficacy|1
6903387|NCT00687804|10925427|FG000|Core Study|Withdrawal by Subject|4
6903388|NCT00687804|10925428|FG001|Core Study|Withdrawal by Subject|7
6903389|NCT00687804|10925429|FG002|Core Study|Withdrawal by Subject|7
6903390|NCT00687804|10925427|FG000|Core Study|Lost to Follow-up|0
6903391|NCT00687804|10925428|FG001|Core Study|Lost to Follow-up|1
6903392|NCT00687804|10925429|FG002|Core Study|Lost to Follow-up|0
6903393|NCT00687804|10925427|FG000|Core Study|Death|2
6903394|NCT00687804|10925428|FG001|Core Study|Death|2
6903395|NCT00687804|10925429|FG002|Core Study|Death|2
6903396|NCT00687804|10925427|FG000|Core Study|Protocol Violation|1
6903397|NCT00687804|10925428|FG001|Core Study|Protocol Violation|1
6903398|NCT00687804|10925429|FG002|Core Study|Protocol Violation|0
6903399|NCT00687804|10925427|FG000|Open-Label Extension Study|Adverse Event|2
6903400|NCT00687804|10925428|FG001|Open-Label Extension Study|Adverse Event|2
6903401|NCT00687804|10925429|FG002|Open-Label Extension Study|Adverse Event|2
6903402|NCT00687804|10925427|FG000|Open-Label Extension Study|Subject withdrew consent|3
6903403|NCT00687804|10925428|FG001|Open-Label Extension Study|Subject withdrew consent|4
6903404|NCT00687804|10925429|FG002|Open-Label Extension Study|Subject withdrew consent|4
6903405|NCT00687804|10925427|FG000|Open-Label Extension Study|Lost to Follow-up|2
6903406|NCT00687804|10925428|FG001|Open-Label Extension Study|Lost to Follow-up|1
6903407|NCT00687804|10925429|FG002|Open-Label Extension Study|Lost to Follow-up|2
6903408|NCT00687804|10925427|FG000|Open-Label Extension Study|Administrative problems|1
6903409|NCT00687804|10925428|FG001|Open-Label Extension Study|Administrative problems|1
6903410|NCT00687804|10925429|FG002|Open-Label Extension Study|Administrative problems|0
6903411|NCT00687804|10925427|FG000|Open-Label Extension Study|Death|2
6903412|NCT00687804|10925428|FG001|Open-Label Extension Study|Death|3
6903413|NCT00687804|10925429|FG002|Open-Label Extension Study|Death|3
6903414|NCT00687973|10925467|FG000|Overall Study|Adverse Event|18
6903415|NCT00687973|10925468|FG001|Overall Study|Adverse Event|28
6903416|NCT00687973|10925467|FG000|Overall Study|Lack of Efficacy|2
6903417|NCT00687973|10925468|FG001|Overall Study|Lack of Efficacy|3
6903418|NCT00687973|10925467|FG000|Overall Study|Protocol Violation|1
6903419|NCT00687973|10925468|FG001|Overall Study|Protocol Violation|2
6903420|NCT00687973|10925467|FG000|Overall Study|Administrative Reasons|0
6903421|NCT00687973|10925468|FG001|Overall Study|Administrative Reasons|2
6903422|NCT00687973|10925467|FG000|Overall Study|Withdrawal by Subject|3
6903423|NCT00687973|10925468|FG001|Overall Study|Withdrawal by Subject|3
6903424|NCT00688064|10925477|FG000|Overall Study|Protocol Violation|0
6903425|NCT00688064|10925478|FG001|Overall Study|Protocol Violation|1
6903426|NCT00688064|10925477|FG000|Overall Study|Adverse Event|2
6903427|NCT00688064|10925478|FG001|Overall Study|Adverse Event|4
6903428|NCT00688064|10925477|FG000|Overall Study|Withdrawal by Subject|7
6903429|NCT00688064|10925478|FG001|Overall Study|Withdrawal by Subject|7
6903430|NCT00688064|10925477|FG000|Overall Study|Lost to Follow-up|10
6903431|NCT00688064|10925478|FG001|Overall Study|Lost to Follow-up|10
6903432|NCT00688064|10925477|FG000|Overall Study|Lack of Efficacy|0
6903433|NCT00688064|10925478|FG001|Overall Study|Lack of Efficacy|1
6903434|NCT00688064|10925477|FG000|Overall Study|Pregnancy|1
6903435|NCT00688064|10925478|FG001|Overall Study|Pregnancy|0
6903436|NCT00688064|10925477|FG000|Overall Study|Any other reasons|1
6903437|NCT00688064|10925478|FG001|Overall Study|Any other reasons|3
6903438|NCT00688103|10925486|FG000|Overall Study|Adverse Event|4
6903439|NCT00688103|10925487|FG001|Overall Study|Adverse Event|1
6903440|NCT00688103|10925486|FG000|Overall Study|Lack of Efficacy|11
6903441|NCT00688103|10925487|FG001|Overall Study|Lack of Efficacy|1
6903442|NCT00688103|10925486|FG000|Overall Study|Withdrawal by Subject|4
6903443|NCT00688103|10925487|FG001|Overall Study|Withdrawal by Subject|2
6903444|NCT00688103|10925486|FG000|Overall Study|complex reasons|11
6903445|NCT00688103|10925487|FG001|Overall Study|complex reasons|9
6903446|NCT00688155|10925499|FG000|Overall Study|Withdrawal by Subject|2
6903447|NCT00688155|10925500|FG001|Overall Study|Withdrawal by Subject|2
6903448|NCT00688155|10925501|FG002|Overall Study|Withdrawal by Subject|1
6903449|NCT00688155|10925502|FG003|Overall Study|Withdrawal by Subject|1
6903450|NCT00688181|10925512|FG000|Overall Study|Lost to Follow-up|17
6903451|NCT00688181|10925512|FG000|Overall Study|Unknown Reason|4
6903452|NCT00688181|10925512|FG000|Overall Study|Non-clinical Reason|2
6903453|NCT00688259|10925520|FG000|Overall Study|Lost to Follow-up|2
6903454|NCT00688259|10925521|FG001|Overall Study|Lost to Follow-up|4
6903455|NCT00688259|10925520|FG000|Overall Study|Physician Decision|1
6903456|NCT00688259|10925521|FG001|Overall Study|Physician Decision|0
6903457|NCT00688259|10925520|FG000|Overall Study|Withdrawal by Subject|2
6903458|NCT00688259|10925521|FG001|Overall Study|Withdrawal by Subject|0
6903459|NCT00688259|10925520|FG000|Overall Study|Declined Interview|2
6903460|NCT00688259|10925521|FG001|Overall Study|Declined Interview|3
6903461|NCT00688259|10925520|FG000|Overall Study|Hospitalized at Follow-up|0
6903462|NCT00688259|10925521|FG001|Overall Study|Hospitalized at Follow-up|1
6903463|NCT00688324|10925527|FG000|Overall Study|Withdrawal by Subject|2
6903464|NCT00688324|10925527|FG000|Overall Study|Physician Decision|5
6903465|NCT00688324|10925527|FG000|Overall Study|Lost to Follow-up|1
6903466|NCT00688467|10925534|FG000|Treatment Period 1|Adverse Event|2
6903467|NCT00688467|10925535|FG001|Treatment Period 1|Adverse Event|1
6903468|NCT00688467|10925534|FG000|Treatment Period 1|Did not meet protocol eligibility|0
6903469|NCT00688467|10925535|FG001|Treatment Period 1|Did not meet protocol eligibility|1
6903470|NCT00688467|10925534|FG000|Treatment Period 2|Protocol Violation|0
6903471|NCT00688467|10925535|FG001|Treatment Period 2|Protocol Violation|1
6903472|NCT00688467|10925534|FG000|Treatment Period 2|Adverse Event|0
6903473|NCT00688467|10925535|FG001|Treatment Period 2|Adverse Event|1
6903474|NCT00688519|10925543|FG000|Overall Study|Adverse Event|2
6903475|NCT00688519|10925544|FG001|Overall Study|Adverse Event|3
6903476|NCT00688519|10925543|FG000|Overall Study|Lost to Follow-up|3
6903477|NCT00688519|10925544|FG001|Overall Study|Lost to Follow-up|3
6903478|NCT00688519|10925543|FG000|Overall Study|Lack of Efficacy|3
6903479|NCT00688519|10925544|FG001|Overall Study|Lack of Efficacy|1
6903480|NCT00688519|10925543|FG000|Overall Study|Withdrawal by Subject|7
6903481|NCT00688519|10925544|FG001|Overall Study|Withdrawal by Subject|6
6903482|NCT00688519|10925543|FG000|Overall Study|Prohibited medication|1
6903483|NCT00688519|10925544|FG001|Overall Study|Prohibited medication|0
6903484|NCT00688519|10925543|FG000|Overall Study|Non-compliance|0
6903485|NCT00688519|10925544|FG001|Overall Study|Non-compliance|1
6903486|NCT00688519|10925543|FG000|Overall Study|Subject moved out of state|1
6903487|NCT00688519|10925544|FG001|Overall Study|Subject moved out of state|0
6903488|NCT00688519|10925543|FG000|Overall Study|Investigator decision|1
6903489|NCT00688519|10925544|FG001|Overall Study|Investigator decision|0
6903490|NCT00688519|10925543|FG000|Overall Study|Subject moved out of area|1
6903491|NCT00688519|10925544|FG001|Overall Study|Subject moved out of area|0
6903492|NCT00688519|10925543|FG000|Overall Study|Pregnancy|0
6903493|NCT00688519|10925544|FG001|Overall Study|Pregnancy|1
6903494|NCT00688545|10925552|FG000|Overall Study|Lost to Follow-up|1
6903495|NCT00688545|10925553|FG001|Overall Study|Lost to Follow-up|4
6903496|NCT00688545|10925552|FG000|Overall Study|Insurance/cost of drug|0
6903497|NCT00688545|10925553|FG001|Overall Study|Insurance/cost of drug|1
6903498|NCT00688545|10925552|FG000|Overall Study|Withdrawal by Subject|2
6903499|NCT00688545|10925553|FG001|Overall Study|Withdrawal by Subject|3
6903500|NCT00688545|10925552|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2
6903501|NCT00688545|10925553|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7
6903502|NCT00688597|10925564|FG000|Overall Study|Adverse Event|2
6903503|NCT00688597|10925565|FG001|Overall Study|Adverse Event|0
6903504|NCT00688597|10925566|FG002|Overall Study|Adverse Event|0
6903505|NCT00688597|10925564|FG000|Overall Study|Physician Decision|1
6903506|NCT00688597|10925565|FG001|Overall Study|Physician Decision|0
6903507|NCT00688597|10925566|FG002|Overall Study|Physician Decision|0
6903508|NCT00688623|10925574|FG000|Overall Study|Adverse Event|22
6903509|NCT00688623|10925574|FG000|Overall Study|abnormal lab value|1
6903510|NCT00688623|10925574|FG000|Overall Study|Withdrawal by Subject|4
6903511|NCT00688623|10925574|FG000|Overall Study|Death|3
6903512|NCT00688623|10925574|FG000|Overall Study|disease progression|23
6903513|NCT00688623|10925574|FG000|Overall Study|Protocol Violation|2
6903514|NCT00688636|10925580|FG000|Overall Study|Adverse Event|2
6903515|NCT00688636|10925581|FG001|Overall Study|Adverse Event|1
6903516|NCT00688688|10925600|FG000|Overall Study|Eligibility criterion not met|7
6903517|NCT00688688|10925601|FG001|Overall Study|Eligibility criterion not met|7
6903518|NCT00688688|10925602|FG002|Overall Study|Eligibility criterion not met|10
6903519|NCT00688688|10925600|FG000|Overall Study|Adverse Event|52
6826987|NCT00121641|10829439|FG004|48-month Short Term + Long Term Period|Other Reason|1
6826988|NCT00121667|10829457|FG000|Short Term (ST) Period|Lack of Efficacy|25
6826989|NCT00121667|10829458|FG001|Short Term (ST) Period|Lack of Efficacy|22
6826990|NCT00121667|10829459|FG002|Short Term (ST) Period|Lack of Efficacy|27
6826991|NCT00121667|10829460|FG003|Short Term (ST) Period|Lack of Efficacy|44
6826992|NCT00121667|10829457|FG000|Short Term (ST) Period|Subject Withdrew Consent|8
6826993|NCT00121667|10829458|FG001|Short Term (ST) Period|Subject Withdrew Consent|13
6826994|NCT00121667|10829459|FG002|Short Term (ST) Period|Subject Withdrew Consent|4
6826995|NCT00121667|10829460|FG003|Short Term (ST) Period|Subject Withdrew Consent|11
6826996|NCT00121667|10829457|FG000|Short Term (ST) Period|Adverse Event|5
6826997|NCT00121667|10829458|FG001|Short Term (ST) Period|Adverse Event|6
6826998|NCT00121667|10829459|FG002|Short Term (ST) Period|Adverse Event|5
6826999|NCT00121667|10829460|FG003|Short Term (ST) Period|Adverse Event|3
6827000|NCT00121667|10829457|FG000|Short Term (ST) Period|Lost to Follow-up|3
6827001|NCT00121667|10829458|FG001|Short Term (ST) Period|Lost to Follow-up|4
6827002|NCT00121667|10829459|FG002|Short Term (ST) Period|Lost to Follow-up|4
6827003|NCT00121667|10829460|FG003|Short Term (ST) Period|Lost to Follow-up|3
6827004|NCT00121667|10829457|FG000|Short Term (ST) Period|Poor / Non-compliance|0
6827005|NCT00121667|10829458|FG001|Short Term (ST) Period|Poor / Non-compliance|1
6827006|NCT00121667|10829459|FG002|Short Term (ST) Period|Poor / Non-compliance|1
6827007|NCT00121667|10829460|FG003|Short Term (ST) Period|Poor / Non-compliance|2
6827008|NCT00121667|10829457|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
6827009|NCT00121667|10829458|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
6827010|NCT00121667|10829459|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
6827011|NCT00121667|10829460|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
6827012|NCT00121667|10829457|FG000|Short Term (ST) Period|Other Reason|3
6827013|NCT00121667|10829458|FG001|Short Term (ST) Period|Other Reason|0
6827014|NCT00121667|10829459|FG002|Short Term (ST) Period|Other Reason|0
6827015|NCT00121667|10829460|FG003|Short Term (ST) Period|Other Reason|0
6827016|NCT00121667|10829457|FG000|Short Term (ST) Period|Death|0
6827017|NCT00121667|10829458|FG001|Short Term (ST) Period|Death|0
6827018|NCT00121667|10829459|FG002|Short Term (ST) Period|Death|0
6827019|NCT00121667|10829460|FG003|Short Term (ST) Period|Death|1
6827020|NCT00121667|10829457|FG000|Short Term (ST) Period|Pregnancy|0
6827021|NCT00121667|10829458|FG001|Short Term (ST) Period|Pregnancy|0
6827022|NCT00121667|10829459|FG002|Short Term (ST) Period|Pregnancy|0
6827023|NCT00121667|10829460|FG003|Short Term (ST) Period|Pregnancy|1
6827024|NCT00121667|10829457|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54
6827025|NCT00121667|10829458|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51
6827026|NCT00121667|10829459|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42
6827027|NCT00121667|10829460|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65
6827028|NCT00121667|10829457|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38
6827029|NCT00121667|10829458|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34
6827030|NCT00121667|10829459|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26
6827031|NCT00121667|10829460|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30
6827032|NCT00121667|10829457|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12
6827033|NCT00121667|10829458|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18
6827034|NCT00121667|10829459|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13
6827035|NCT00121667|10829460|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10
6827036|NCT00121667|10829457|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
6827037|NCT00121667|10829458|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
6827038|NCT00121667|10829459|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13
6827039|NCT00121667|10829460|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16
6827040|NCT00121667|10829457|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5
6827041|NCT00121667|10829458|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7
6827042|NCT00121667|10829459|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6
6896975|NCT00636155|10915629|FG000|Overall Study|Adverse Event|8
6896976|NCT00636155|10915629|FG000|Overall Study|Lack of Efficacy|1
6896977|NCT00636155|10915629|FG000|Overall Study|Withdrawal by Subject|3
6896978|NCT00636155|10915629|FG000|Overall Study|Stem cell transplant|1
6896979|NCT00636155|10915629|FG000|Overall Study|Physician Decision|5
6896980|NCT00636168|10915635|FG000|Randomized to Study Drug|Withdrawal by Subject|2
6896981|NCT00636168|10915636|FG001|Randomized to Study Drug|Withdrawal by Subject|2
6896982|NCT00636168|10915635|FG000|Randomized to Study Drug|Adverse Event|1
6896983|NCT00636168|10915636|FG001|Randomized to Study Drug|Adverse Event|0
6896984|NCT00636168|10915635|FG000|Randomized to Study Drug|No longer meets study criteria|1
6896985|NCT00636168|10915636|FG001|Randomized to Study Drug|No longer meets study criteria|0
6896986|NCT00636168|10915635|FG000|Treated With Study Drug|Recurrence of disease|135
6896987|NCT00636168|10915636|FG001|Treated With Study Drug|Recurrence of disease|282
6896988|NCT00636168|10915635|FG000|Treated With Study Drug|Adverse Event|250
6896989|NCT00636168|10915636|FG001|Treated With Study Drug|Adverse Event|22
6896990|NCT00636168|10915635|FG000|Treated With Study Drug|Participant withdrew consent|16
6896991|NCT00636168|10915636|FG001|Treated With Study Drug|Participant withdrew consent|21
6896992|NCT00636168|10915635|FG000|Treated With Study Drug|Poor/non-compliance|1
6896993|NCT00636168|10915636|FG001|Treated With Study Drug|Poor/non-compliance|3
6903520|NCT00688688|10925601|FG001|Overall Study|Adverse Event|51
6903521|NCT00688688|10925602|FG002|Overall Study|Adverse Event|50
6903522|NCT00688688|10925600|FG000|Overall Study|Lack of Efficacy|34
6903523|NCT00688688|10925601|FG001|Overall Study|Lack of Efficacy|25
6903524|NCT00688688|10925602|FG002|Overall Study|Lack of Efficacy|45
6903525|NCT00688688|10925600|FG000|Overall Study|Withdrawal by Subject|66
6903526|NCT00688688|10925601|FG001|Overall Study|Withdrawal by Subject|75
6903527|NCT00688688|10925602|FG002|Overall Study|Withdrawal by Subject|65
6903528|NCT00688688|10925600|FG000|Overall Study|Lost to Follow-up|14
6903529|NCT00688688|10925601|FG001|Overall Study|Lost to Follow-up|7
6903530|NCT00688688|10925602|FG002|Overall Study|Lost to Follow-up|7
6903531|NCT00688688|10925600|FG000|Overall Study|Protocol Violation|6
6903532|NCT00688688|10925601|FG001|Overall Study|Protocol Violation|9
6903533|NCT00688688|10925602|FG002|Overall Study|Protocol Violation|11
6903534|NCT00688688|10925600|FG000|Overall Study|Randomized but never received study drug|1
6903535|NCT00688688|10925601|FG001|Overall Study|Randomized but never received study drug|0
6903536|NCT00688688|10925602|FG002|Overall Study|Randomized but never received study drug|0
6903537|NCT00688688|10925600|FG000|Overall Study|Non-compliance with study procedures|5
6903538|NCT00688688|10925601|FG001|Overall Study|Non-compliance with study procedures|3
6903539|NCT00688688|10925602|FG002|Overall Study|Non-compliance with study procedures|4
6903540|NCT00688688|10925600|FG000|Overall Study|Taking exclusionary medications|1
6903541|NCT00688688|10925601|FG001|Overall Study|Taking exclusionary medications|0
6903542|NCT00688688|10925602|FG002|Overall Study|Taking exclusionary medications|0
6903543|NCT00688688|10925600|FG000|Overall Study|Site closure|0
6903544|NCT00688688|10925601|FG001|Overall Study|Site closure|1
6903545|NCT00688688|10925602|FG002|Overall Study|Site closure|0
6903546|NCT00688688|10925600|FG000|Overall Study|Violation of exclusion criterion|0
6903547|NCT00688688|10925601|FG001|Overall Study|Violation of exclusion criterion|1
6903548|NCT00688688|10925602|FG002|Overall Study|Violation of exclusion criterion|0
6903549|NCT00688701|10925613|FG000|Overall Study|Adverse Event|1
6903550|NCT00688701|10925614|FG001|Overall Study|Adverse Event|0
6903551|NCT00688701|10925615|FG002|Overall Study|Adverse Event|5
6903552|NCT00688701|10925616|FG003|Overall Study|Adverse Event|3
6903553|NCT00688701|10925613|FG000|Overall Study|Lack of Efficacy|0
6903554|NCT00688701|10925614|FG001|Overall Study|Lack of Efficacy|1
6903555|NCT00688701|10925615|FG002|Overall Study|Lack of Efficacy|0
6903556|NCT00688701|10925616|FG003|Overall Study|Lack of Efficacy|0
6903557|NCT00688701|10925613|FG000|Overall Study|Withdrawal by Subject|3
6903558|NCT00688701|10925614|FG001|Overall Study|Withdrawal by Subject|3
6903559|NCT00688701|10925615|FG002|Overall Study|Withdrawal by Subject|4
6903560|NCT00688701|10925616|FG003|Overall Study|Withdrawal by Subject|8
6903561|NCT00688701|10925613|FG000|Overall Study|Poor compliance to protocol|0
6903562|NCT00688701|10925614|FG001|Overall Study|Poor compliance to protocol|1
6903563|NCT00688701|10925615|FG002|Overall Study|Poor compliance to protocol|1
6903564|NCT00688701|10925616|FG003|Overall Study|Poor compliance to protocol|0
6903565|NCT00688740|10925629|FG000|Overall Study|Adverse Event|45
6903566|NCT00688740|10925630|FG001|Overall Study|Adverse Event|8
6903567|NCT00688740|10925629|FG000|Overall Study|Death|2
6903568|NCT00688740|10925630|FG001|Overall Study|Death|2
6903569|NCT00688740|10925629|FG000|Overall Study|Lost to Follow-up|0
6903570|NCT00688740|10925630|FG001|Overall Study|Lost to Follow-up|1
6903571|NCT00688740|10925629|FG000|Overall Study|Consent Withdrawn|17
6903572|NCT00688740|10925630|FG001|Overall Study|Consent Withdrawn|17
6903573|NCT00688740|10925629|FG000|Overall Study|Breast Cancer Relapse|1
6903574|NCT00688740|10925630|FG001|Overall Study|Breast Cancer Relapse|4
6903575|NCT00688740|10925629|FG000|Overall Study|Violation of Inclusion Criteria|1
6903576|NCT00688740|10925630|FG001|Overall Study|Violation of Inclusion Criteria|3
6903577|NCT00688753|10925636|FG000|Overall Study|Disease progression|55
6903578|NCT00688753|10925636|FG000|Overall Study|Missing|1
6903579|NCT00688753|10925636|FG000|Overall Study|Death|9
6903580|NCT00688753|10925636|FG000|Overall Study|Withdrawal by Subject|3
6903581|NCT00688753|10925636|FG000|Overall Study|Adverse Event|20
6903582|NCT00688753|10925636|FG000|Overall Study|Protocol Violation|1
6903583|NCT00688753|10925636|FG000|Overall Study|Lost to Follow-up|3
6903584|NCT00688844|10925640|FG000|Overall Study|Lost to Follow-up|10
6903585|NCT00688870|10925646|FG000|Infant Series|Parent or legal guardian request|4
6903586|NCT00688870|10925647|FG001|Infant Series|Parent or legal guardian request|0
6903587|NCT00688909|10925657|FG000|Overall Study|Adverse Event|28
6903588|NCT00688909|10925657|FG000|Overall Study|Patient withdrew consent|2
6903589|NCT00688909|10925657|FG000|Overall Study|Administrative problems|1
6903590|NCT00688909|10925657|FG000|Overall Study|Protocol Violation|2
6903591|NCT00689026|10925664|FG000|Overall Study|Withdrawal by Subject|13
6903592|NCT00689026|10925665|FG001|Overall Study|Withdrawal by Subject|6
6903593|NCT00689104|10925705|FG000|Overall Study|Eligibility criterion not met|5
6903594|NCT00689104|10925706|FG001|Overall Study|Eligibility criterion not met|8
6903595|NCT00689104|10925707|FG002|Overall Study|Eligibility criterion not met|0
6903596|NCT00689104|10925708|FG003|Overall Study|Eligibility criterion not met|4
6903597|NCT00689104|10925705|FG000|Overall Study|Adverse Event|13
6903598|NCT00689104|10925706|FG001|Overall Study|Adverse Event|25
6903599|NCT00689104|10925707|FG002|Overall Study|Adverse Event|16
6903600|NCT00689104|10925708|FG003|Overall Study|Adverse Event|24
6903601|NCT00689104|10925705|FG000|Overall Study|Lack of Efficacy|5
6903602|NCT00689104|10925706|FG001|Overall Study|Lack of Efficacy|6
6903603|NCT00689104|10925707|FG002|Overall Study|Lack of Efficacy|2
6903604|NCT00689104|10925708|FG003|Overall Study|Lack of Efficacy|3
6903605|NCT00689104|10925705|FG000|Overall Study|Withdrawal by Subject|12
6903606|NCT00689104|10925706|FG001|Overall Study|Withdrawal by Subject|11
6903607|NCT00689104|10925707|FG002|Overall Study|Withdrawal by Subject|18
6903608|NCT00689104|10925708|FG003|Overall Study|Withdrawal by Subject|11
6903609|NCT00689104|10925705|FG000|Overall Study|Lost to Follow-up|4
6903610|NCT00689104|10925706|FG001|Overall Study|Lost to Follow-up|3
6903611|NCT00689104|10925707|FG002|Overall Study|Lost to Follow-up|2
6903612|NCT00689104|10925708|FG003|Overall Study|Lost to Follow-up|5
6903613|NCT00689104|10925705|FG000|Overall Study|Protocol Violation|2
6903614|NCT00689104|10925706|FG001|Overall Study|Protocol Violation|3
7142943|NCT03021564|11298990|FG000|Overall Study|Lost to Follow-up|0
6903615|NCT00689104|10925707|FG002|Overall Study|Protocol Violation|5
6903616|NCT00689104|10925708|FG003|Overall Study|Protocol Violation|3
6903617|NCT00689104|10925705|FG000|Overall Study|Randomized but never received study drug|2
6903618|NCT00689104|10925706|FG001|Overall Study|Randomized but never received study drug|1
6903619|NCT00689104|10925707|FG002|Overall Study|Randomized but never received study drug|1
6903620|NCT00689104|10925708|FG003|Overall Study|Randomized but never received study drug|0
6903621|NCT00689104|10925705|FG000|Overall Study|Physician Decision|1
6903622|NCT00689104|10925706|FG001|Overall Study|Physician Decision|0
6903623|NCT00689104|10925707|FG002|Overall Study|Physician Decision|0
6903624|NCT00689104|10925708|FG003|Overall Study|Physician Decision|0
6903625|NCT00689104|10925705|FG000|Overall Study|Non-compliance with study procedures|0
6903626|NCT00689104|10925706|FG001|Overall Study|Non-compliance with study procedures|0
6903627|NCT00689104|10925707|FG002|Overall Study|Non-compliance with study procedures|1
6903628|NCT00689104|10925708|FG003|Overall Study|Non-compliance with study procedures|0
6903629|NCT00689117|10925722|FG000|Overall Study|Adverse Event|6
6903630|NCT00689117|10925723|FG001|Overall Study|Adverse Event|0
6903631|NCT00689117|10925724|FG002|Overall Study|Adverse Event|5
7142944|NCT03021564|11298991|FG001|Overall Study|Lost to Follow-up|2
7142945|NCT03021642|11299001|FG000|Washout Period (21 Days)|Adverse Event|1
7142946|NCT03021642|11299002|FG001|Washout Period (21 Days)|Adverse Event|1
7142947|NCT03021668|11299010|FG000|Overall Study|Physician Decision|0
7142948|NCT03021668|11299011|FG001|Overall Study|Physician Decision|1
7142949|NCT03022045|11299032|FG000|Overall Study|Adverse Event|0
7142950|NCT03022045|11299033|FG001|Overall Study|Adverse Event|1
7142951|NCT03022045|11299032|FG000|Overall Study|Withdrawal by Subject|1
7142952|NCT03022045|11299033|FG001|Overall Study|Withdrawal by Subject|1
7142953|NCT03022084|11299045|FG000|Overall Study|Lost to Follow-up|2
7142954|NCT03022084|11299046|FG001|Overall Study|Lost to Follow-up|3
7142955|NCT03022370|11299056|FG000|Overall Study|Death|6
7142956|NCT03022370|11299057|FG001|Overall Study|Death|12
7142957|NCT03022370|11299056|FG000|Overall Study|Lost to Follow-up|174
7142958|NCT03022370|11299057|FG001|Overall Study|Lost to Follow-up|109
7142959|NCT03022422|11299098|FG000|Overall Study|3 subjects consented but not vaccinated|0
7142960|NCT03022422|11299099|FG001|Overall Study|3 subjects consented but not vaccinated|0
7142961|NCT03022422|11299100|FG002|Overall Study|3 subjects consented but not vaccinated|3
7142962|NCT03022422|11299101|FG003|Overall Study|3 subjects consented but not vaccinated|0
6903632|NCT00689117|10925725|FG003|Overall Study|Adverse Event|0
6903633|NCT00689117|10925722|FG000|Overall Study|Lost to Follow-up|26
6903634|NCT00689117|10925723|FG001|Overall Study|Lost to Follow-up|19
6903635|NCT00689117|10925724|FG002|Overall Study|Lost to Follow-up|17
6903636|NCT00689117|10925725|FG003|Overall Study|Lost to Follow-up|11
6903637|NCT00689117|10925722|FG000|Overall Study|Lack of Efficacy|1
6903638|NCT00689117|10925723|FG001|Overall Study|Lack of Efficacy|2
6903639|NCT00689117|10925724|FG002|Overall Study|Lack of Efficacy|2
6903640|NCT00689117|10925725|FG003|Overall Study|Lack of Efficacy|2
6903641|NCT00689117|10925722|FG000|Overall Study|Non-Compliance with Study Treatment|3
6903642|NCT00689117|10925723|FG001|Overall Study|Non-Compliance with Study Treatment|3
6903643|NCT00689117|10925724|FG002|Overall Study|Non-Compliance with Study Treatment|3
6903644|NCT00689117|10925725|FG003|Overall Study|Non-Compliance with Study Treatment|1
6903645|NCT00689117|10925722|FG000|Overall Study|Withdrawal by Subject|19
6903646|NCT00689117|10925723|FG001|Overall Study|Withdrawal by Subject|18
6903647|NCT00689117|10925724|FG002|Overall Study|Withdrawal by Subject|26
6903648|NCT00689117|10925725|FG003|Overall Study|Withdrawal by Subject|13
6903649|NCT00689117|10925722|FG000|Overall Study|Unable to Comply with Visit Schedule|0
6903650|NCT00689117|10925723|FG001|Overall Study|Unable to Comply with Visit Schedule|0
6903651|NCT00689117|10925724|FG002|Overall Study|Unable to Comply with Visit Schedule|1
6903652|NCT00689117|10925725|FG003|Overall Study|Unable to Comply with Visit Schedule|1
6903653|NCT00689117|10925722|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1
6903654|NCT00689117|10925723|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2
6903655|NCT00689117|10925724|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0
6903656|NCT00689117|10925725|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0
6903657|NCT00689117|10925722|FG000|Overall Study|Non-compliance with Treatment Regimen|0
6903658|NCT00689117|10925723|FG001|Overall Study|Non-compliance with Treatment Regimen|1
6903659|NCT00689117|10925724|FG002|Overall Study|Non-compliance with Treatment Regimen|0
6973773|NCT01184508|11025836|FG001|Overall Study|Lost to Follow-up|1
7142963|NCT03022422|11299102|FG004|Overall Study|3 subjects consented but not vaccinated|0
7187150|NCT02561962|11387636|FG005|Overall Study|Withdrawal by Subject|1
6903660|NCT00689117|10925725|FG003|Overall Study|Non-compliance with Treatment Regimen|0
6903661|NCT00689117|10925722|FG000|Overall Study|Change/Discontinuation of Birth Control|1
6903662|NCT00689117|10925723|FG001|Overall Study|Change/Discontinuation of Birth Control|1
6903663|NCT00689117|10925724|FG002|Overall Study|Change/Discontinuation of Birth Control|1
6903664|NCT00689117|10925725|FG003|Overall Study|Change/Discontinuation of Birth Control|0
6903665|NCT00689117|10925722|FG000|Overall Study|Use of Prohibitive Medication|2
6903666|NCT00689117|10925723|FG001|Overall Study|Use of Prohibitive Medication|1
6903667|NCT00689117|10925724|FG002|Overall Study|Use of Prohibitive Medication|3
6903668|NCT00689117|10925725|FG003|Overall Study|Use of Prohibitive Medication|0
6903669|NCT00689117|10925722|FG000|Overall Study|Pregnancy|0
6903670|NCT00689117|10925723|FG001|Overall Study|Pregnancy|2
6903671|NCT00689117|10925724|FG002|Overall Study|Pregnancy|0
6903672|NCT00689117|10925725|FG003|Overall Study|Pregnancy|2
6903673|NCT00689117|10925722|FG000|Overall Study|Incarceration|2
6903674|NCT00689117|10925723|FG001|Overall Study|Incarceration|0
6903675|NCT00689117|10925724|FG002|Overall Study|Incarceration|0
6903676|NCT00689117|10925725|FG003|Overall Study|Incarceration|0
6903677|NCT00689117|10925722|FG000|Overall Study|Fear of Birth Defects|0
6903678|NCT00689117|10925723|FG001|Overall Study|Fear of Birth Defects|0
6903679|NCT00689117|10925724|FG002|Overall Study|Fear of Birth Defects|1
6903680|NCT00689117|10925725|FG003|Overall Study|Fear of Birth Defects|0
6903681|NCT00689117|10925722|FG000|Overall Study|Transportation|1
6903682|NCT00689117|10925723|FG001|Overall Study|Transportation|0
6903683|NCT00689117|10925724|FG002|Overall Study|Transportation|0
6903684|NCT00689117|10925725|FG003|Overall Study|Transportation|0
6903685|NCT00689117|10925722|FG000|Overall Study|Patient Withdrew from Study|0
6903686|NCT00689117|10925723|FG001|Overall Study|Patient Withdrew from Study|0
6903687|NCT00689117|10925724|FG002|Overall Study|Patient Withdrew from Study|0
6903688|NCT00689117|10925725|FG003|Overall Study|Patient Withdrew from Study|1
6903689|NCT00689117|10925722|FG000|Overall Study|Personal Reason|0
6903690|NCT00689117|10925723|FG001|Overall Study|Personal Reason|1
6903691|NCT00689117|10925724|FG002|Overall Study|Personal Reason|0
6903692|NCT00689117|10925725|FG003|Overall Study|Personal Reason|0
6903693|NCT00689117|10925722|FG000|Overall Study|Dispensing Error|0
6903694|NCT00689117|10925723|FG001|Overall Study|Dispensing Error|1
6903695|NCT00689117|10925724|FG002|Overall Study|Dispensing Error|0
6903696|NCT00689117|10925725|FG003|Overall Study|Dispensing Error|0
6903697|NCT00689221|10925737|FG000|Overall Study|Ongoing at cut-off date|39
6903698|NCT00689221|10925738|FG001|Overall Study|Ongoing at cut-off date|36
6903699|NCT00689273|10925758|FG000|Overall Study|Adverse Event|3
6903700|NCT00689273|10925759|FG001|Overall Study|Adverse Event|1
6903701|NCT00689273|10925758|FG000|Overall Study|Lack of Efficacy|3
6903702|NCT00689273|10925759|FG001|Overall Study|Lack of Efficacy|0
6903703|NCT00689273|10925758|FG000|Overall Study|Lost to Follow-up|0
6903704|NCT00689273|10925759|FG001|Overall Study|Lost to Follow-up|2
6903705|NCT00689273|10925758|FG000|Overall Study|Other|6
6903706|NCT00689273|10925759|FG001|Overall Study|Other|2
6903707|NCT00689273|10925758|FG000|Overall Study|Randomized but not Treated|1
6903708|NCT00689273|10925759|FG001|Overall Study|Randomized but not Treated|0
6903709|NCT00689299|10925768|FG000|Overall Study|Adverse Event|2
6903710|NCT00689299|10925769|FG001|Overall Study|Adverse Event|1
6903711|NCT00689299|10925770|FG002|Overall Study|Adverse Event|1
6903712|NCT00689299|10925768|FG000|Overall Study|Lost to Follow-up|0
6903713|NCT00689299|10925769|FG001|Overall Study|Lost to Follow-up|1
6903714|NCT00689299|10925770|FG002|Overall Study|Lost to Follow-up|1
6903715|NCT00689299|10925768|FG000|Overall Study|Withdrawal by Subject|4
6903716|NCT00689299|10925769|FG001|Overall Study|Withdrawal by Subject|1
6903717|NCT00689299|10925770|FG002|Overall Study|Withdrawal by Subject|3
6903718|NCT00689299|10925768|FG000|Overall Study|Protocol Violation|1
6903719|NCT00689299|10925769|FG001|Overall Study|Protocol Violation|0
6903720|NCT00689299|10925770|FG002|Overall Study|Protocol Violation|0
6903721|NCT00689338|10925778|FG000|Overall Study|Death|65
6903722|NCT00689338|10925778|FG000|Overall Study|Adverse Event|13
6903723|NCT00689338|10925778|FG000|Overall Study|Insufficient Clinical Response|1
6903724|NCT00689338|10925778|FG000|Overall Study|Lack of Efficacy|6
6903725|NCT00689338|10925778|FG000|Overall Study|Other|8
6903726|NCT00689338|10925778|FG000|Overall Study|Did not Meet Entrance Criteria|27
6903727|NCT00689338|10925778|FG000|Overall Study|Lost to Follow-up|5
6903728|NCT00689338|10925778|FG000|Overall Study|Withdrawal by Subject|3
6903729|NCT00689338|10925778|FG000|Overall Study|Protocol Violation|15
6903730|NCT00689351|10925784|FG000|Infant Series of Dosing|Parent/legal guardian request|5
6903731|NCT00689351|10925785|FG001|Infant Series of Dosing|Parent/legal guardian request|0
6903732|NCT00689351|10925784|FG000|Infant Series of Dosing|Adverse Event|1
6903733|NCT00689351|10925785|FG001|Infant Series of Dosing|Adverse Event|0
6903734|NCT00689351|10925784|FG000|Infant Series of Dosing|Lost to Follow-up|0
6903735|NCT00689351|10925785|FG001|Infant Series of Dosing|Lost to Follow-up|1
6903736|NCT00689351|10925784|FG000|After Infant Series|Parent/legal guardian request|1
6903737|NCT00689351|10925785|FG001|After Infant Series|Parent/legal guardian request|0
6903738|NCT00689390|10925797|FG000|Overall Study|Adverse Event|19
6903739|NCT00689390|10925798|FG001|Overall Study|Adverse Event|0
6903740|NCT00689390|10925797|FG000|Overall Study|Lost to Follow-up|179
6903741|NCT00689390|10925798|FG001|Overall Study|Lost to Follow-up|7
6903742|NCT00689390|10925797|FG000|Overall Study|Withdrawal by Subject|117
6903743|NCT00689390|10925798|FG001|Overall Study|Withdrawal by Subject|3
6903744|NCT00689390|10925797|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52
6903745|NCT00689390|10925798|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0
6903746|NCT00689390|10925797|FG000|Overall Study|Non-Compliance With Protocol|21
6903747|NCT00689390|10925798|FG001|Overall Study|Non-Compliance With Protocol|0
6903748|NCT00689390|10925797|FG000|Overall Study|Did Not Meet Protocol Eligibility|1
6903749|NCT00689390|10925798|FG001|Overall Study|Did Not Meet Protocol Eligibility|0
6903750|NCT00689390|10925797|FG000|Overall Study|Administrative|37
6903751|NCT00689390|10925798|FG001|Overall Study|Administrative|0
6903752|NCT00689481|10925811|FG000|Overall Study|Adverse Event|7
6903753|NCT00689481|10925812|FG001|Overall Study|Adverse Event|1
6903754|NCT00689481|10925811|FG000|Overall Study|Lost to Follow-up|4
6903755|NCT00689481|10925812|FG001|Overall Study|Lost to Follow-up|3
6903756|NCT00689481|10925811|FG000|Overall Study|Lack of Efficacy|4
6903757|NCT00689481|10925812|FG001|Overall Study|Lack of Efficacy|3
6903758|NCT00689481|10925811|FG000|Overall Study|Non-compliance with study treatment|1
6903759|NCT00689481|10925812|FG001|Overall Study|Non-compliance with study treatment|1
6903760|NCT00689481|10925811|FG000|Overall Study|Withdrawal by Subject|8
6903761|NCT00689481|10925812|FG001|Overall Study|Withdrawal by Subject|4
6903762|NCT00689481|10925811|FG000|Overall Study|Excluded medication started during study|0
6903763|NCT00689481|10925812|FG001|Overall Study|Excluded medication started during study|1
6903764|NCT00689481|10925811|FG000|Overall Study|Subject early term, left on vacation|0
6903765|NCT00689481|10925812|FG001|Overall Study|Subject early term, left on vacation|1
6903766|NCT00689611|10925829|FG000|Overall Study|Death|6
6903767|NCT00689611|10925830|FG001|Overall Study|Death|9
6903768|NCT00689611|10925829|FG000|Overall Study|Withdrawal by Subject|8
6903769|NCT00689611|10925830|FG001|Overall Study|Withdrawal by Subject|9
6903770|NCT00689611|10925829|FG000|Overall Study|Lost to Follow-up|27
6903771|NCT00689611|10925830|FG001|Overall Study|Lost to Follow-up|28
6903772|NCT00689728|10925839|FG000|Double-Blind Treatment|Adverse Event|1
6903773|NCT00689728|10925840|FG001|Double-Blind Treatment|Adverse Event|0
6903774|NCT00689728|10925841|FG002|Double-Blind Treatment|Adverse Event|0
6903775|NCT00689728|10925839|FG000|Double-Blind Treatment|Protocol Violation|0
6903776|NCT00689728|10925840|FG001|Double-Blind Treatment|Protocol Violation|0
6903777|NCT00689728|10925841|FG002|Double-Blind Treatment|Protocol Violation|1
6903778|NCT00689728|10925839|FG000|Double-Blind Treatment|Withdrawal by Subject|3
6903779|NCT00689728|10925840|FG001|Double-Blind Treatment|Withdrawal by Subject|3
6903780|NCT00689728|10925841|FG002|Double-Blind Treatment|Withdrawal by Subject|2
6903781|NCT00689728|10925839|FG000|Double-Blind Treatment|Lack of Efficacy|0
6903782|NCT00689728|10925840|FG001|Double-Blind Treatment|Lack of Efficacy|1
6903783|NCT00689728|10925841|FG002|Double-Blind Treatment|Lack of Efficacy|2
6903784|NCT00689728|10925839|FG000|Rescue|Adverse Event|0
6903785|NCT00689728|10925840|FG001|Rescue|Adverse Event|1
6903786|NCT00689728|10925841|FG002|Rescue|Adverse Event|0
6903787|NCT00689728|10925839|FG000|Rescue|Withdrawal by Subject|1
6903788|NCT00689728|10925840|FG001|Rescue|Withdrawal by Subject|1
6903789|NCT00689728|10925841|FG002|Rescue|Withdrawal by Subject|1
6903790|NCT00689728|10925839|FG000|Optional Follow-Up|Adverse Event|1
6903791|NCT00689728|10925840|FG001|Optional Follow-Up|Adverse Event|0
6903792|NCT00689728|10925841|FG002|Optional Follow-Up|Adverse Event|0
6903793|NCT00689728|10925839|FG000|Optional Follow-Up|Lack of Efficacy|0
6903794|NCT00689728|10925840|FG001|Optional Follow-Up|Lack of Efficacy|1
6903795|NCT00689728|10925841|FG002|Optional Follow-Up|Lack of Efficacy|1
6903796|NCT00689728|10925839|FG000|Optional Follow-Up|Lost to Follow-up|0
6903797|NCT00689728|10925840|FG001|Optional Follow-Up|Lost to Follow-up|1
6903798|NCT00689728|10925841|FG002|Optional Follow-Up|Lost to Follow-up|1
6903799|NCT00689728|10925839|FG000|Optional Follow-Up|Protocol Violation|0
6903800|NCT00689728|10925840|FG001|Optional Follow-Up|Protocol Violation|0
6903801|NCT00689728|10925841|FG002|Optional Follow-Up|Protocol Violation|1
6903802|NCT00689728|10925839|FG000|Optional Follow-Up|Withdrawal by Subject|2
6903803|NCT00689728|10925840|FG001|Optional Follow-Up|Withdrawal by Subject|4
6903804|NCT00689728|10925841|FG002|Optional Follow-Up|Withdrawal by Subject|3
6903805|NCT00689793|10925872|FG000|Overall Study|Lost to Follow-up|4
6903806|NCT00689793|10925873|FG001|Overall Study|Lost to Follow-up|5
6903807|NCT00689871|10925894|FG000|Overall Study|Lost to Follow-up|123
6903808|NCT00689871|10925895|FG001|Overall Study|Lost to Follow-up|13
6903809|NCT00689871|10925896|FG002|Overall Study|Lost to Follow-up|37
6903810|NCT00689871|10925897|FG003|Overall Study|Lost to Follow-up|1
6903811|NCT00689871|10925894|FG000|Overall Study|Explanted of All Study Devices|36
6903812|NCT00689871|10925895|FG001|Overall Study|Explanted of All Study Devices|25
6903813|NCT00689871|10925896|FG002|Overall Study|Explanted of All Study Devices|29
6903814|NCT00689871|10925897|FG003|Overall Study|Explanted of All Study Devices|3
6903815|NCT00689871|10925894|FG000|Overall Study|Withdrawal by Subject|13
6903816|NCT00689871|10925895|FG001|Overall Study|Withdrawal by Subject|3
6903817|NCT00689871|10925896|FG002|Overall Study|Withdrawal by Subject|4
6903818|NCT00689871|10925897|FG003|Overall Study|Withdrawal by Subject|1
6903819|NCT00689871|10925894|FG000|Overall Study|Death|1
6903820|NCT00689871|10925895|FG001|Overall Study|Death|10
6903821|NCT00689871|10925896|FG002|Overall Study|Death|2
6903822|NCT00689871|10925897|FG003|Overall Study|Death|2
6903823|NCT00689871|10925894|FG000|Overall Study|Physician Decision|2
6903824|NCT00689871|10925895|FG001|Overall Study|Physician Decision|1
6903825|NCT00689871|10925896|FG002|Overall Study|Physician Decision|1
6903826|NCT00689871|10925897|FG003|Overall Study|Physician Decision|0
6903827|NCT00689936|10925910|FG000|Active Treatment Phase|Adverse Event|68
6903828|NCT00689936|10925911|FG001|Active Treatment Phase|Adverse Event|71
6903829|NCT00689936|10925912|FG002|Active Treatment Phase|Adverse Event|76
6903830|NCT00689936|10925910|FG000|Active Treatment Phase|Disease Progression|273
6903831|NCT00689936|10925911|FG001|Active Treatment Phase|Disease Progression|362
6903832|NCT00689936|10925912|FG002|Active Treatment Phase|Disease Progression|339
6903833|NCT00689936|10925910|FG000|Active Treatment Phase|Withdrawal by Subject|16
6903834|NCT00689936|10925911|FG001|Active Treatment Phase|Withdrawal by Subject|16
6903835|NCT00689936|10925912|FG002|Active Treatment Phase|Withdrawal by Subject|21
6903836|NCT00689936|10925910|FG000|Active Treatment Phase|Death|60
6903837|NCT00689936|10925911|FG001|Active Treatment Phase|Death|28
6903838|NCT00689936|10925912|FG002|Active Treatment Phase|Death|37
6903839|NCT00689936|10925910|FG000|Active Treatment Phase|Lost to Follow-up|0
6903840|NCT00689936|10925911|FG001|Active Treatment Phase|Lost to Follow-up|2
6903841|NCT00689936|10925912|FG002|Active Treatment Phase|Lost to Follow-up|2
6903842|NCT00689936|10925910|FG000|Active Treatment Phase|Protocol Violation|2
6903843|NCT00689936|10925911|FG001|Active Treatment Phase|Protocol Violation|2
6903844|NCT00689936|10925912|FG002|Active Treatment Phase|Protocol Violation|4
6903845|NCT00689936|10925910|FG000|Active Treatment Phase|Study Close Out|64
6903846|NCT00689936|10925911|FG001|Active Treatment Phase|Study Close Out|26
6903847|NCT00689936|10925912|FG002|Active Treatment Phase|Study Close Out|21
6903848|NCT00689936|10925910|FG000|Active Treatment Phase|Miscellaneous|52
6903849|NCT00689936|10925911|FG001|Active Treatment Phase|Miscellaneous|34
6903850|NCT00689936|10925912|FG002|Active Treatment Phase|Miscellaneous|47
6903851|NCT00689936|10925910|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127
6903852|NCT00689936|10925911|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188
6903853|NCT00689936|10925912|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144
6903854|NCT00690378|10925966|FG000|Overall Study|Adverse Event|1
6903855|NCT00690378|10925967|FG001|Overall Study|Adverse Event|0
6903856|NCT00690378|10925966|FG000|Overall Study|Withdrawal by Subject|2
6903857|NCT00690378|10925967|FG001|Overall Study|Withdrawal by Subject|0
6903858|NCT00690378|10925966|FG000|Overall Study|Protocol Violation|1
6903859|NCT00690378|10925967|FG001|Overall Study|Protocol Violation|0
6903860|NCT00690378|10925966|FG000|Overall Study|Lost to Follow-up|2
6903861|NCT00690378|10925967|FG001|Overall Study|Lost to Follow-up|3
6903862|NCT00690378|10925966|FG000|Overall Study|Did not meet inc/exc criteria|13
6903863|NCT00690378|10925967|FG001|Overall Study|Did not meet inc/exc criteria|11
6903864|NCT00690378|10925966|FG000|Overall Study|Social problem|1
6903865|NCT00690378|10925967|FG001|Overall Study|Social problem|0
6903866|NCT00690430|10925975|FG000|Core Phase|Abnormal Laboratory value|0
6903867|NCT00690430|10925976|FG001|Core Phase|Abnormal Laboratory value|1
6903868|NCT00690430|10925977|FG002|Core Phase|Abnormal Laboratory value|0
6903869|NCT00690430|10925975|FG000|Core Phase|Adverse Event|5
6903870|NCT00690430|10925976|FG001|Core Phase|Adverse Event|1
6903871|NCT00690430|10925977|FG002|Core Phase|Adverse Event|0
6903872|NCT00690430|10925975|FG000|Core Phase|Death|0
6903873|NCT00690430|10925976|FG001|Core Phase|Death|2
6903874|NCT00690430|10925977|FG002|Core Phase|Death|0
6903875|NCT00690430|10925975|FG000|Core Phase|Protocol Violation|1
6903876|NCT00690430|10925976|FG001|Core Phase|Protocol Violation|0
6903877|NCT00690430|10925977|FG002|Core Phase|Protocol Violation|0
6903878|NCT00690430|10925975|FG000|Core Phase|Withdrawal by Subject|3
6903879|NCT00690430|10925976|FG001|Core Phase|Withdrawal by Subject|3
6903880|NCT00690430|10925977|FG002|Core Phase|Withdrawal by Subject|0
6903881|NCT00690430|10925975|FG000|Core Phase|Subject no longer requires study drug|1
6903882|NCT00690430|10925976|FG001|Core Phase|Subject no longer requires study drug|0
6903883|NCT00690430|10925977|FG002|Core Phase|Subject no longer requires study drug|0
6903884|NCT00690430|10925975|FG000|Core Phase|Lack of Efficacy|8
6903885|NCT00690430|10925976|FG001|Core Phase|Lack of Efficacy|10
6903886|NCT00690430|10925977|FG002|Core Phase|Lack of Efficacy|0
6903887|NCT00690430|10925975|FG000|Core Phase|Administrative Problems|0
6903888|NCT00690430|10925976|FG001|Core Phase|Administrative Problems|1
6903889|NCT00690430|10925977|FG002|Core Phase|Administrative Problems|0
6903890|NCT00690430|10925975|FG000|Core Phase|Early Termination|0
6903891|NCT00690430|10925976|FG001|Core Phase|Early Termination|5
6903892|NCT00690430|10925977|FG002|Core Phase|Early Termination|0
6903893|NCT00690430|10925975|FG000|Extension Phase|Lack of Efficacy|3
6903894|NCT00690430|10925976|FG001|Extension Phase|Lack of Efficacy|1
6903895|NCT00690430|10925977|FG002|Extension Phase|Lack of Efficacy|4
6903896|NCT00690430|10925975|FG000|Extension Phase|Abnormal Lab Values|1
6903897|NCT00690430|10925976|FG001|Extension Phase|Abnormal Lab Values|0
6903898|NCT00690430|10925977|FG002|Extension Phase|Abnormal Lab Values|0
6978682|NCT01214629|11032179|FG007|Overall Study|Withdrawal by Subject|0
6903899|NCT00690430|10925975|FG000|Extension Phase|Abnormal test procedure results|1
6903900|NCT00690430|10925976|FG001|Extension Phase|Abnormal test procedure results|0
6903901|NCT00690430|10925977|FG002|Extension Phase|Abnormal test procedure results|0
6903902|NCT00690430|10925975|FG000|Extension Phase|Administrative Problems|0
6903903|NCT00690430|10925976|FG001|Extension Phase|Administrative Problems|1
6903904|NCT00690430|10925977|FG002|Extension Phase|Administrative Problems|1
6903905|NCT00690430|10925975|FG000|Extension Phase|Adverse Event|2
6903906|NCT00690430|10925976|FG001|Extension Phase|Adverse Event|1
6903907|NCT00690430|10925977|FG002|Extension Phase|Adverse Event|2
6903908|NCT00690430|10925975|FG000|Extension Phase|Death|1
6903909|NCT00690430|10925976|FG001|Extension Phase|Death|1
6903910|NCT00690430|10925977|FG002|Extension Phase|Death|1
6903911|NCT00690430|10925975|FG000|Extension Phase|Withdrawal by Subject|0
6903912|NCT00690430|10925976|FG001|Extension Phase|Withdrawal by Subject|0
6903913|NCT00690430|10925977|FG002|Extension Phase|Withdrawal by Subject|2
6903914|NCT00690430|10925975|FG000|Extension Phase|Early Termination|10
6903915|NCT00690430|10925976|FG001|Extension Phase|Early Termination|1
6903916|NCT00690430|10925977|FG002|Extension Phase|Early Termination|3
6903917|NCT00690443|10925988|FG000|Overall Study|Adverse Event|1
6903918|NCT00690443|10925989|FG001|Overall Study|Adverse Event|2
6903919|NCT00690482|10925997|FG000|Overall Study|Adverse Event|2
6903920|NCT00690482|10925998|FG001|Overall Study|Adverse Event|1
6903921|NCT00690482|10925997|FG000|Overall Study|Incorrect enrolment|0
6903922|NCT00690482|10925998|FG001|Overall Study|Incorrect enrolment|1
6903923|NCT00690482|10925997|FG000|Overall Study|Study-specific discontinuation criteria|1
6903924|NCT00690482|10925998|FG001|Overall Study|Study-specific discontinuation criteria|0
6903925|NCT00690482|10925997|FG000|Overall Study|Intake of prohibited medicine|1
6903926|NCT00690482|10925998|FG001|Overall Study|Intake of prohibited medicine|0
6903927|NCT00690482|10925997|FG000|Overall Study|withdrew consent at rand.day|0
6903928|NCT00690482|10925998|FG001|Overall Study|withdrew consent at rand.day|1
6903929|NCT00690573|10926013|FG000|Overall Study|Lack of Efficacy|8
6903930|NCT00690573|10926013|FG000|Overall Study|Withdrawal by Subject|1
6903931|NCT00690612|10926017|FG000|Overall Study|Adverse Event|1
6903932|NCT00690612|10926017|FG000|Overall Study|Withdrawal by Subject|2
6903933|NCT00690755|10926028|FG000|Overall Study|Physician Decision|2
6903934|NCT00690755|10926029|FG001|Overall Study|Physician Decision|0
6903935|NCT00690755|10926030|FG002|Overall Study|Physician Decision|46
6903936|NCT00690755|10926031|FG003|Overall Study|Physician Decision|5
6903937|NCT00690755|10926032|FG004|Overall Study|Physician Decision|0
6903938|NCT00690755|10926033|FG005|Overall Study|Physician Decision|4
6903939|NCT00690755|10926034|FG006|Overall Study|Physician Decision|0
6903940|NCT00690794|10926052|FG000|Overall Study|Adverse Event|12
6903941|NCT00690794|10926053|FG001|Overall Study|Adverse Event|10
6903942|NCT00690794|10926052|FG000|Overall Study|Lost to Follow-up|1
6903943|NCT00690794|10926053|FG001|Overall Study|Lost to Follow-up|4
6903944|NCT00690794|10926052|FG000|Overall Study|Withdrawal by Subject|0
6903945|NCT00690794|10926053|FG001|Overall Study|Withdrawal by Subject|9
6903946|NCT00690794|10926052|FG000|Overall Study|Protocol Violation|6
6903947|NCT00690794|10926053|FG001|Overall Study|Protocol Violation|7
6903948|NCT00690794|10926052|FG000|Overall Study|Noncompliance|1
6903949|NCT00690794|10926053|FG001|Overall Study|Noncompliance|2
6903950|NCT00690794|10926052|FG000|Overall Study|Other not specified|1
6903951|NCT00690794|10926053|FG001|Overall Study|Other not specified|3
6903952|NCT00690820|10926061|FG000|Period 1|Withdrawal by Subject|0
6903953|NCT00690820|10926062|FG001|Period 1|Withdrawal by Subject|1
6903954|NCT00690898|10926072|FG000|SCREENING|Screen failure|18
6903955|NCT00690898|10926072|FG000|TREATMENT|Adverse Event|3
6903956|NCT00690898|10926072|FG000|TREATMENT|Lack of Efficacy|18
6903957|NCT00690898|10926072|FG000|TREATMENT|Withdrawal by Subject|4
6903958|NCT00690898|10926072|FG000|TREATMENT|Other (not otherwise specified)|1
6903959|NCT00691015|10926099|FG000|Overall Study|Refused further treatment|1
6903960|NCT00691028|10926106|FG000|Open-label Period|Adverse Event|0
6903961|NCT00691028|10926107|FG001|Open-label Period|Adverse Event|0
6903962|NCT00691028|10926108|FG002|Open-label Period|Adverse Event|0
6903963|NCT00691028|10926109|FG003|Open-label Period|Adverse Event|16
6903964|NCT00691028|10926106|FG000|Open-label Period|Withdrawal by Subject|0
6903965|NCT00691028|10926107|FG001|Open-label Period|Withdrawal by Subject|0
6903966|NCT00691028|10926108|FG002|Open-label Period|Withdrawal by Subject|0
6903967|NCT00691028|10926109|FG003|Open-label Period|Withdrawal by Subject|3
6903968|NCT00691028|10926106|FG000|Open-label Period|not come to a hospital|0
6903969|NCT00691028|10926107|FG001|Open-label Period|not come to a hospital|0
6903970|NCT00691028|10926108|FG002|Open-label Period|not come to a hospital|0
6903971|NCT00691028|10926109|FG003|Open-label Period|not come to a hospital|1
6903972|NCT00691028|10926106|FG000|Double-blind Period|Adverse Event|8
6903973|NCT00691028|10926107|FG001|Double-blind Period|Adverse Event|9
6903974|NCT00691028|10926108|FG002|Double-blind Period|Adverse Event|6
6903975|NCT00691028|10926109|FG003|Double-blind Period|Adverse Event|0
6903976|NCT00691028|10926106|FG000|Double-blind Period|Lack of Efficacy|4
6903977|NCT00691028|10926107|FG001|Double-blind Period|Lack of Efficacy|3
6903978|NCT00691028|10926108|FG002|Double-blind Period|Lack of Efficacy|2
6903979|NCT00691028|10926109|FG003|Double-blind Period|Lack of Efficacy|0
6903980|NCT00691028|10926106|FG000|Double-blind Period|Withdrawal by Subject|1
6903981|NCT00691028|10926107|FG001|Double-blind Period|Withdrawal by Subject|0
6903982|NCT00691028|10926108|FG002|Double-blind Period|Withdrawal by Subject|1
6903983|NCT00691028|10926109|FG003|Double-blind Period|Withdrawal by Subject|0
6903984|NCT00691028|10926106|FG000|Double-blind Period|not come to a hospital.|0
6903985|NCT00691028|10926107|FG001|Double-blind Period|not come to a hospital.|1
6903986|NCT00691028|10926108|FG002|Double-blind Period|not come to a hospital.|0
6903987|NCT00691028|10926109|FG003|Double-blind Period|not come to a hospital.|0
6903988|NCT00691054|10926121|FG000|Overall Study|Withdrawal by Subject|1
6903989|NCT00691093|10926127|FG000|Overall Study|Adverse Event|1
6903990|NCT00691093|10926127|FG000|Overall Study|Lost to Follow-up|1
6903991|NCT00691093|10926127|FG000|Overall Study|Lack of Efficacy|1
6903992|NCT00691093|10926127|FG000|Overall Study|Ongoing at Date of Cut-Off|4
6903993|NCT00691132|10926138|FG000|Overall Study|Adverse Event|2
6903994|NCT00691132|10926139|FG001|Overall Study|Adverse Event|3
6903995|NCT00691132|10926138|FG000|Overall Study|Withdrawal by Subject|10
6903996|NCT00691132|10926139|FG001|Overall Study|Withdrawal by Subject|10
6903997|NCT00691210|10926172|FG000|Overall Study|Progression of Disease|0
6903998|NCT00691210|10926173|FG001|Overall Study|Progression of Disease|0
6903999|NCT00691210|10926174|FG002|Overall Study|Progression of Disease|0
6904000|NCT00691210|10926175|FG003|Overall Study|Progression of Disease|2
6904001|NCT00691210|10926176|FG004|Overall Study|Progression of Disease|0
6904002|NCT00691210|10926177|FG005|Overall Study|Progression of Disease|0
6978683|NCT01214629|11032180|FG008|Overall Study|Withdrawal by Subject|0
6978684|NCT01214629|11032181|FG009|Overall Study|Withdrawal by Subject|1
6978685|NCT01214629|11032182|FG010|Overall Study|Withdrawal by Subject|0
6978686|NCT01214642|11032232|FG000|Overall Study|Progressive Disease|3
6978687|NCT01214642|11032233|FG001|Overall Study|Progressive Disease|2
6978688|NCT01214642|11032234|FG002|Overall Study|Progressive Disease|3
6978689|NCT01214642|11032235|FG003|Overall Study|Progressive Disease|5
6978690|NCT01214642|11032236|FG004|Overall Study|Progressive Disease|5
6978691|NCT01214642|11032237|FG005|Overall Study|Progressive Disease|3
6978692|NCT01214642|11032238|FG006|Overall Study|Progressive Disease|5
6978693|NCT01214642|11032239|FG007|Overall Study|Progressive Disease|3
6978694|NCT01214642|11032240|FG008|Overall Study|Progressive Disease|10
6978695|NCT01214642|11032241|FG009|Overall Study|Progressive Disease|2
6904003|NCT00691210|10926178|FG006|Overall Study|Progression of Disease|0
6904004|NCT00691210|10926179|FG007|Overall Study|Progression of Disease|0
6904005|NCT00691210|10926172|FG000|Overall Study|Lack of Efficacy|0
6904006|NCT00691210|10926173|FG001|Overall Study|Lack of Efficacy|0
6904007|NCT00691210|10926174|FG002|Overall Study|Lack of Efficacy|0
6904008|NCT00691210|10926175|FG003|Overall Study|Lack of Efficacy|1
6904009|NCT00691210|10926176|FG004|Overall Study|Lack of Efficacy|0
6904010|NCT00691210|10926177|FG005|Overall Study|Lack of Efficacy|1
6904011|NCT00691210|10926178|FG006|Overall Study|Lack of Efficacy|0
6904012|NCT00691210|10926179|FG007|Overall Study|Lack of Efficacy|0
6904013|NCT00691301|10926197|FG000|Overall Study|Adverse Event|10
6904014|NCT00691301|10926197|FG000|Overall Study|Death|2
6904015|NCT00691301|10926197|FG000|Overall Study|Lack of Efficacy|32
6904016|NCT00691301|10926197|FG000|Overall Study|Withdrawal by Subject|4
6904017|NCT00691301|10926197|FG000|Overall Study|Concurrent illness|2
6904018|NCT00691301|10926197|FG000|Overall Study|other reason|3
6904019|NCT00691301|10926197|FG000|Overall Study|Did not initiate study treatment|1
6904020|NCT00691483|10926218|FG000|Overall Study|Adverse Event|14
6904021|NCT00691483|10926219|FG001|Overall Study|Adverse Event|6
6904022|NCT00691483|10926218|FG000|Overall Study|Lost to Follow-up|17
6904023|NCT00691483|10926219|FG001|Overall Study|Lost to Follow-up|10
6904024|NCT00691483|10926218|FG000|Overall Study|Withdrawal by Subject|24
6904025|NCT00691483|10926219|FG001|Overall Study|Withdrawal by Subject|7
6904026|NCT00691483|10926218|FG000|Overall Study|Other known cause|6
6904027|NCT00691483|10926219|FG001|Overall Study|Other known cause|1
6904028|NCT00691483|10926218|FG000|Overall Study|Randomized by not treated|7
6904029|NCT00691483|10926219|FG001|Overall Study|Randomized by not treated|1
6904030|NCT00691704|10926243|FG000|Induction Therapy|Disease Progression|1
6904031|NCT00691704|10926243|FG000|Induction Therapy|Active Hepatitis|1
6904032|NCT00691704|10926243|FG000|Two Years of Maintenance Therapy|Disease Progression|8
6904033|NCT00691704|10926243|FG000|Two Years of Maintenance Therapy|Physician Decision|4
6904034|NCT00691704|10926243|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1
6904035|NCT00691938|10926267|FG000|Overall Study|QTc prolongation|1
6904036|NCT00691938|10926268|FG001|Overall Study|QTc prolongation|0
6904037|NCT00691938|10926269|FG002|Overall Study|QTc prolongation|0
6904038|NCT00691938|10926270|FG003|Overall Study|QTc prolongation|0
6904039|NCT00691938|10926271|FG004|Overall Study|QTc prolongation|0
6904040|NCT00691938|10926272|FG005|Overall Study|QTc prolongation|0
6978696|NCT01214642|11032242|FG010|Overall Study|Progressive Disease|1
6978697|NCT01214642|11032243|FG011|Overall Study|Progressive Disease|4
6978698|NCT01214642|11032232|FG000|Overall Study|Adverse Event|0
6978699|NCT01214642|11032233|FG001|Overall Study|Adverse Event|1
6978700|NCT01214642|11032234|FG002|Overall Study|Adverse Event|0
6904041|NCT00691938|10926273|FG006|Overall Study|QTc prolongation|0
6904042|NCT00692237|10926316|FG000|Overall Study|Withdrawal by Subject|1
6904043|NCT00692237|10926317|FG001|Overall Study|Withdrawal by Subject|3
6904044|NCT00692237|10926316|FG000|Overall Study|Adverse Event|0
6904045|NCT00692237|10926317|FG001|Overall Study|Adverse Event|1
6904046|NCT00692406|10926345|FG000|Overall Study|PI dropped, bad data|57
6904047|NCT00692770|10926371|FG000|Overall Study|Protocol Violation|2
6904048|NCT00692770|10926372|FG001|Overall Study|Protocol Violation|7
6904049|NCT00692770|10926371|FG000|Overall Study|Withdrawal by Subject|97
6904050|NCT00692770|10926372|FG001|Overall Study|Withdrawal by Subject|36
6904051|NCT00692770|10926371|FG000|Overall Study|Adverse Event|136
6904052|NCT00692770|10926372|FG001|Overall Study|Adverse Event|41
6904053|NCT00692770|10926371|FG000|Overall Study|Death|10
6904054|NCT00692770|10926372|FG001|Overall Study|Death|5
6904055|NCT00692770|10926371|FG000|Overall Study|Lost to Follow-up|7
6904056|NCT00692770|10926372|FG001|Overall Study|Lost to Follow-up|3
6904057|NCT00692770|10926371|FG000|Overall Study|Non-compliant with study medication|11
6904058|NCT00692770|10926372|FG001|Overall Study|Non-compliant with study medication|5
6904059|NCT00692770|10926371|FG000|Overall Study|Progression by clinical judgment|2
6904060|NCT00692770|10926372|FG001|Overall Study|Progression by clinical judgment|3
6904061|NCT00692770|10926371|FG000|Overall Study|Physician decision not protocol driven|10
6904062|NCT00692770|10926372|FG001|Overall Study|Physician decision not protocol driven|14
6904063|NCT00692770|10926371|FG000|Overall Study|Disease progression, recurrence/relapse|170
6904064|NCT00692770|10926372|FG001|Overall Study|Disease progression, recurrence/relapse|279
6904065|NCT00692770|10926371|FG000|Overall Study|Protocol driven decision point|3
6904066|NCT00692770|10926372|FG001|Overall Study|Protocol driven decision point|7
6904067|NCT00692770|10926371|FG000|Overall Study|Completed all planned assessments|79
6904068|NCT00692770|10926372|FG001|Overall Study|Completed all planned assessments|101
6904069|NCT00692770|10926371|FG000|Overall Study|Radiological and clinical progression|8
6904070|NCT00692770|10926372|FG001|Overall Study|Radiological and clinical progression|8
6904071|NCT00692770|10926371|FG000|Overall Study|Clinical endpoint reached|16
6904072|NCT00692770|10926372|FG001|Overall Study|Clinical endpoint reached|43
6904073|NCT00692770|10926371|FG000|Overall Study|Study terminated by sponsor|2
6904074|NCT00692770|10926372|FG001|Overall Study|Study terminated by sponsor|2
6904075|NCT00692770|10926371|FG000|Overall Study|Randomized but not treated|3
6904076|NCT00692770|10926372|FG001|Overall Study|Randomized but not treated|4
6973774|NCT01184508|11025835|FG000|Overall Study|Physician Decision|1
6973775|NCT01184508|11025836|FG001|Overall Study|Physician Decision|0
6973776|NCT01184508|11025835|FG000|Overall Study|Protocol Violation|3
6973777|NCT01184508|11025836|FG001|Overall Study|Protocol Violation|1
6973778|NCT01184508|11025835|FG000|Overall Study|Sponsor Decision|5
6973779|NCT01184508|11025836|FG001|Overall Study|Sponsor Decision|2
6973780|NCT01184508|11025835|FG000|Overall Study|Withdrawal by Subject|1
6973781|NCT01184508|11025836|FG001|Overall Study|Withdrawal by Subject|3
6973782|NCT01184508|11025835|FG000|Overall Study|Randomized, Not Treated|0
6973783|NCT01184508|11025836|FG001|Overall Study|Randomized, Not Treated|1
6973784|NCT01184846|11025856|FG000|Overall Study|Adverse Event|2
6973785|NCT01184846|11025856|FG000|Overall Study|Insufficient response|1
6973786|NCT01184859|11025867|FG000|Period 1: Single Dose|Insufficient urine production|0
6973787|NCT01184859|11025868|FG001|Period 1: Single Dose|Insufficient urine production|1
6973788|NCT01184859|11025869|FG002|Period 1: Single Dose|Insufficient urine production|0
6973789|NCT01184859|11025870|FG003|Period 1: Single Dose|Insufficient urine production|0
6973790|NCT01184859|11025871|FG004|Period 1: Single Dose|Insufficient urine production|0
6973791|NCT01184859|11025867|FG000|Period 1: Single Dose|Protocol Violation|0
6973792|NCT01184859|11025868|FG001|Period 1: Single Dose|Protocol Violation|1
6973793|NCT01184859|11025869|FG002|Period 1: Single Dose|Protocol Violation|0
6973794|NCT01184859|11025870|FG003|Period 1: Single Dose|Protocol Violation|0
6973795|NCT01184859|11025871|FG004|Period 1: Single Dose|Protocol Violation|0
6973796|NCT01184859|11025867|FG000|Period 1: Single Dose|Adverse Event|0
6973797|NCT01184859|11025868|FG001|Period 1: Single Dose|Adverse Event|0
6973798|NCT01184859|11025869|FG002|Period 1: Single Dose|Adverse Event|0
6973799|NCT01184859|11025870|FG003|Period 1: Single Dose|Adverse Event|0
6973800|NCT01184859|11025871|FG004|Period 1: Single Dose|Adverse Event|1
6973801|NCT01184859|11025867|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
6973802|NCT01184859|11025868|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
6973803|NCT01184859|11025869|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
6973804|NCT01184859|11025870|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
6973805|NCT01184859|11025871|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1
6973806|NCT01184859|11025867|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1
6973807|NCT01184859|11025868|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0
6973808|NCT01184859|11025869|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0
6973809|NCT01184859|11025870|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0
6973810|NCT01184859|11025871|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0
6973811|NCT01184872|11025890|FG000|Overall Study|Adverse Event|3
6973812|NCT01184872|11025891|FG001|Overall Study|Adverse Event|4
6973813|NCT01184872|11025890|FG000|Overall Study|Unsatisfactory therapeutic effect|3
6973814|NCT01184872|11025891|FG001|Overall Study|Unsatisfactory therapeutic effect|2
6973815|NCT01184872|11025890|FG000|Overall Study|Withdrawal by Subject|2
6973816|NCT01184872|11025891|FG001|Overall Study|Withdrawal by Subject|0
6973817|NCT01184872|11025890|FG000|Overall Study|Lost to Follow-up|0
6973818|NCT01184872|11025891|FG001|Overall Study|Lost to Follow-up|1
6973819|NCT01184872|11025890|FG000|Overall Study|Administrative problems|1
6973820|NCT01184872|11025891|FG001|Overall Study|Administrative problems|1
6973821|NCT01184872|11025890|FG000|Overall Study|Protocol deviation|1
6973822|NCT01184872|11025891|FG001|Overall Study|Protocol deviation|0
6973823|NCT01184989|11025906|FG000|Overall Study|Adverse Event|11
6973824|NCT01184989|11025906|FG000|Overall Study|Withdrawal by Subject|1
6973825|NCT01185080|11025917|FG000|Overall Study|Adverse Event|1
6973826|NCT01185080|11025918|FG001|Overall Study|Adverse Event|1
6973827|NCT01185080|11025919|FG002|Overall Study|Adverse Event|0
6973828|NCT01185080|11025917|FG000|Overall Study|Personal reasons|0
6973829|NCT01185080|11025918|FG001|Overall Study|Personal reasons|0
6973830|NCT01185080|11025919|FG002|Overall Study|Personal reasons|1
6973831|NCT01185171|11025927|FG000|Induction Chemotherapy|Withdrawal by Subject|1
6973832|NCT01185171|11025927|FG000|Induction Chemotherapy|Duodenal Ulcer|1
6904077|NCT00693225|10926416|FG000|Overall Study|Lost to Follow-up|1
6904078|NCT00693225|10926417|FG001|Overall Study|Lost to Follow-up|2
6904079|NCT00693225|10926416|FG000|Overall Study|Adverse Event|1
6904080|NCT00693225|10926417|FG001|Overall Study|Adverse Event|3
6904081|NCT00693420|10926429|FG000|Overall Study|Adverse Event|4
6904082|NCT00693420|10926430|FG001|Overall Study|Adverse Event|4
6904083|NCT00693420|10926429|FG000|Overall Study|Lost to Follow-up|0
6904084|NCT00693420|10926430|FG001|Overall Study|Lost to Follow-up|3
6904085|NCT00693420|10926429|FG000|Overall Study|Withdrawal by Subject|1
6904086|NCT00693420|10926430|FG001|Overall Study|Withdrawal by Subject|0
6904087|NCT00693420|10926429|FG000|Overall Study|Protocol Violation|0
6904088|NCT00693420|10926430|FG001|Overall Study|Protocol Violation|2
6904089|NCT00693420|10926429|FG000|Overall Study|Sponsor Request - Conflict of Interest|0
6904090|NCT00693420|10926430|FG001|Overall Study|Sponsor Request - Conflict of Interest|2
6904091|NCT00693420|10926429|FG000|Overall Study|Personal Reasons|1
6904092|NCT00693420|10926430|FG001|Overall Study|Personal Reasons|4
6904093|NCT00693472|10926440|FG000|Part 1|Adverse Event|1
6904094|NCT00693472|10926441|FG001|Part 1|Adverse Event|1
6904095|NCT00693472|10926442|FG002|Part 1|Adverse Event|0
6904096|NCT00693472|10926443|FG003|Part 1|Adverse Event|0
6904097|NCT00693472|10926440|FG000|Part 1|Lost to Follow-up|0
6904098|NCT00693472|10926441|FG001|Part 1|Lost to Follow-up|1
6904099|NCT00693472|10926442|FG002|Part 1|Lost to Follow-up|0
6904100|NCT00693472|10926443|FG003|Part 1|Lost to Follow-up|0
6904101|NCT00693472|10926440|FG000|Part 1|Withdrew - reason unrelated to treatment|5
6904102|NCT00693472|10926441|FG001|Part 1|Withdrew - reason unrelated to treatment|2
6904103|NCT00693472|10926442|FG002|Part 1|Withdrew - reason unrelated to treatment|0
6904104|NCT00693472|10926443|FG003|Part 1|Withdrew - reason unrelated to treatment|0
6904105|NCT00693472|10926440|FG000|Part 2|Adverse Event|0
6904106|NCT00693472|10926441|FG001|Part 2|Adverse Event|0
6904107|NCT00693472|10926442|FG002|Part 2|Adverse Event|1
6904108|NCT00693472|10926443|FG003|Part 2|Adverse Event|0
6904109|NCT00693472|10926440|FG000|Part 2|Withdrew - reason unrelated to treatment|0
6904110|NCT00693472|10926441|FG001|Part 2|Withdrew - reason unrelated to treatment|0
6904111|NCT00693472|10926442|FG002|Part 2|Withdrew - reason unrelated to treatment|1
6904112|NCT00693472|10926443|FG003|Part 2|Withdrew - reason unrelated to treatment|2
6904113|NCT00693693|10926488|FG000|Overall Study|Lost to Follow-up|1
6904114|NCT00693693|10926489|FG001|Overall Study|Lost to Follow-up|1
6904115|NCT00693693|10926490|FG002|Overall Study|Lost to Follow-up|2
6904116|NCT00693706|10926500|FG000|Overall Study|Protocol Violation|0
6904117|NCT00693706|10926501|FG001|Overall Study|Protocol Violation|1
6904118|NCT00693784|10926511|FG000|Overall Study|Lost to Follow-up|2
6904119|NCT00693784|10926511|FG000|Overall Study|Withdrawal by Subject|2
6904120|NCT00694096|10926537|FG000|Overall Study|Withdrawal by Subject|5
6904121|NCT00694109|10926541|FG000|Overall Study|Physician Decision|3
6904122|NCT00694109|10926541|FG000|Overall Study|Adverse Event|74
6904123|NCT00694109|10926541|FG000|Overall Study|Not consent of more 2 years of treatment|18
6978701|NCT01214642|11032235|FG003|Overall Study|Adverse Event|0
6978702|NCT01214642|11032236|FG004|Overall Study|Adverse Event|0
6978703|NCT01214642|11032237|FG005|Overall Study|Adverse Event|0
6978704|NCT01214642|11032238|FG006|Overall Study|Adverse Event|1
6978705|NCT01214642|11032239|FG007|Overall Study|Adverse Event|0
6978706|NCT01214642|11032240|FG008|Overall Study|Adverse Event|0
6978707|NCT01214642|11032241|FG009|Overall Study|Adverse Event|1
6978708|NCT01214642|11032242|FG010|Overall Study|Adverse Event|1
7060159|NCT01914926|11156153|FG000|Overall Study|Adverse Event|1
6904124|NCT00694109|10926541|FG000|Overall Study|Lack of Efficacy|2
6904125|NCT00694109|10926541|FG000|Overall Study|Withdrawal by Subject|13
6904126|NCT00694109|10926541|FG000|Overall Study|Pregnancy|1
6904127|NCT00694109|10926541|FG000|Overall Study|Enrolled but not treated|1
6904128|NCT00694109|10926541|FG000|Overall Study|Other|2
6904129|NCT00694109|10926541|FG000|Overall Study|Consented but no additional treatment|3
6904130|NCT00694122|10926546|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7
6904131|NCT00694122|10926547|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0
6904132|NCT00694122|10926546|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1
6904133|NCT00694122|10926547|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1
6904134|NCT00694122|10926546|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2
6904135|NCT00694122|10926547|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1
6904136|NCT00694161|10926558|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1
6904137|NCT00694161|10926558|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1
6904138|NCT00694161|10926558|FG000|Part 2 (After Week 6 up to Month 12)|Death|1
6904139|NCT00694304|10926562|FG000|Overall Study|Adverse Event|42
6904140|NCT00694304|10926562|FG000|Overall Study|Lack of Efficacy|35
6904141|NCT00694304|10926562|FG000|Overall Study|Non-compliance With Study Product|16
6904142|NCT00694304|10926562|FG000|Overall Study|Protocol Violation|6
6904143|NCT00694304|10926562|FG000|Overall Study|Withdrawal of Consent|61
6904144|NCT00694304|10926562|FG000|Overall Study|Lost to Follow-up|15
6904145|NCT00694304|10926562|FG000|Overall Study|Administrative or Other Reasons|32
7060160|NCT01914926|11156154|FG001|Overall Study|Adverse Event|0
6904146|NCT00694356|10926569|FG000|Overall Study|Adverse Event|1
6904147|NCT00694356|10926570|FG001|Overall Study|Adverse Event|0
6904148|NCT00694356|10926571|FG002|Overall Study|Adverse Event|0
7060161|NCT01914926|11156153|FG000|Overall Study|uncooperative, agitated and removed|0
6904149|NCT00694356|10926569|FG000|Overall Study|Progressive Disease|2
6904150|NCT00694356|10926570|FG001|Overall Study|Progressive Disease|6
6904151|NCT00694356|10926571|FG002|Overall Study|Progressive Disease|6
6904152|NCT00694551|10926586|FG000|Overall Study|Disease Progression|1
6904153|NCT00694551|10926587|FG001|Overall Study|Disease Progression|0
6904154|NCT00694551|10926588|FG002|Overall Study|Disease Progression|1
6904155|NCT00694707|10926610|FG000|Overall Study|Did Not Receive Treatment|0
6904156|NCT00694707|10926611|FG001|Overall Study|Did Not Receive Treatment|0
6904157|NCT00694707|10926612|FG002|Overall Study|Did Not Receive Treatment|1
6904158|NCT00694707|10926613|FG003|Overall Study|Did Not Receive Treatment|1
6904159|NCT00694707|10926614|FG004|Overall Study|Did Not Receive Treatment|1
6904160|NCT00694707|10926610|FG000|Overall Study|Adverse Event|22
6904161|NCT00694707|10926611|FG001|Overall Study|Adverse Event|14
6904162|NCT00694707|10926612|FG002|Overall Study|Adverse Event|8
6904163|NCT00694707|10926613|FG003|Overall Study|Adverse Event|12
6904164|NCT00694707|10926614|FG004|Overall Study|Adverse Event|13
6904165|NCT00694707|10926610|FG000|Overall Study|Insufficient Therapeutic Response|33
6904166|NCT00694707|10926611|FG001|Overall Study|Insufficient Therapeutic Response|18
6904167|NCT00694707|10926612|FG002|Overall Study|Insufficient Therapeutic Response|17
6904168|NCT00694707|10926613|FG003|Overall Study|Insufficient Therapeutic Response|15
6904169|NCT00694707|10926614|FG004|Overall Study|Insufficient Therapeutic Response|10
6904170|NCT00694707|10926610|FG000|Overall Study|Protocol Violation|1
6904171|NCT00694707|10926611|FG001|Overall Study|Protocol Violation|2
6904172|NCT00694707|10926612|FG002|Overall Study|Protocol Violation|1
6904173|NCT00694707|10926613|FG003|Overall Study|Protocol Violation|3
6904174|NCT00694707|10926614|FG004|Overall Study|Protocol Violation|1
6904175|NCT00694707|10926610|FG000|Overall Study|Withdrawal of Consent|14
6904176|NCT00694707|10926611|FG001|Overall Study|Withdrawal of Consent|18
6904177|NCT00694707|10926612|FG002|Overall Study|Withdrawal of Consent|22
6904178|NCT00694707|10926613|FG003|Overall Study|Withdrawal of Consent|16
6904179|NCT00694707|10926614|FG004|Overall Study|Withdrawal of Consent|15
6904180|NCT00694707|10926610|FG000|Overall Study|Lost to Follow-up|0
6904181|NCT00694707|10926611|FG001|Overall Study|Lost to Follow-up|1
6904182|NCT00694707|10926612|FG002|Overall Study|Lost to Follow-up|2
6904183|NCT00694707|10926613|FG003|Overall Study|Lost to Follow-up|0
6904184|NCT00694707|10926614|FG004|Overall Study|Lost to Follow-up|0
6904185|NCT00694707|10926610|FG000|Overall Study|Jeopardizing Parole Status|1
6904186|NCT00694707|10926611|FG001|Overall Study|Jeopardizing Parole Status|0
6904187|NCT00694707|10926612|FG002|Overall Study|Jeopardizing Parole Status|0
6904188|NCT00694707|10926613|FG003|Overall Study|Jeopardizing Parole Status|0
6904189|NCT00694707|10926614|FG004|Overall Study|Jeopardizing Parole Status|0
6904190|NCT00694707|10926610|FG000|Overall Study|Death in the Family|1
6904191|NCT00694707|10926611|FG001|Overall Study|Death in the Family|0
6904192|NCT00694707|10926612|FG002|Overall Study|Death in the Family|0
6904193|NCT00694707|10926613|FG003|Overall Study|Death in the Family|0
6904194|NCT00694707|10926614|FG004|Overall Study|Death in the Family|0
6904195|NCT00694707|10926610|FG000|Overall Study|Arrest by Police|0
6904196|NCT00694707|10926611|FG001|Overall Study|Arrest by Police|1
6904197|NCT00694707|10926612|FG002|Overall Study|Arrest by Police|0
6904198|NCT00694707|10926613|FG003|Overall Study|Arrest by Police|0
6904199|NCT00694707|10926614|FG004|Overall Study|Arrest by Police|0
6904200|NCT00694707|10926610|FG000|Overall Study|Administrative Reasons|0
6904201|NCT00694707|10926611|FG001|Overall Study|Administrative Reasons|1
6904202|NCT00694707|10926612|FG002|Overall Study|Administrative Reasons|0
6904203|NCT00694707|10926613|FG003|Overall Study|Administrative Reasons|2
6904204|NCT00694707|10926614|FG004|Overall Study|Administrative Reasons|0
6904205|NCT00694707|10926610|FG000|Overall Study|Notification of Past Head Injury|0
6904206|NCT00694707|10926611|FG001|Overall Study|Notification of Past Head Injury|0
6904207|NCT00694707|10926612|FG002|Overall Study|Notification of Past Head Injury|0
6904208|NCT00694707|10926613|FG003|Overall Study|Notification of Past Head Injury|1
6904209|NCT00694707|10926614|FG004|Overall Study|Notification of Past Head Injury|0
6904210|NCT00695019|10926629|FG000|Overall Study|Withdrawal by Subject|8
6904211|NCT00695019|10926630|FG001|Overall Study|Withdrawal by Subject|6
6904212|NCT00695019|10926631|FG002|Overall Study|Withdrawal by Subject|4
6904213|NCT00695019|10926629|FG000|Overall Study|Protocol Violation|1
6904214|NCT00695019|10926630|FG001|Overall Study|Protocol Violation|3
6904215|NCT00695019|10926631|FG002|Overall Study|Protocol Violation|1
6904216|NCT00695019|10926629|FG000|Overall Study|Lack of Efficacy|0
6904217|NCT00695019|10926630|FG001|Overall Study|Lack of Efficacy|0
6904218|NCT00695019|10926631|FG002|Overall Study|Lack of Efficacy|1
6904219|NCT00695019|10926629|FG000|Overall Study|Various|4
6904220|NCT00695019|10926630|FG001|Overall Study|Various|5
6904221|NCT00695019|10926631|FG002|Overall Study|Various|4
6904222|NCT00695110|10926648|FG000|Treatment Period 1|Adverse Event|1
6904223|NCT00695110|10926648|FG000|Treatment Period 1|Withdrawal by Subject|2
6904224|NCT00695110|10926648|FG000|Treatment Period 3|Withdrawal by Subject|1
6904225|NCT00695110|10926648|FG000|Treatment Period 4|Adverse Event|1
6904226|NCT00695136|10926655|FG000|Overall Study|Withdrawal by Subject|1
6904227|NCT00695136|10926655|FG000|Overall Study|unrelated adverse event|1
6904228|NCT00695318|10926679|FG000|Overall Study|Lost to Follow-up|1
6904229|NCT00695318|10926680|FG001|Overall Study|Lost to Follow-up|0
6904230|NCT00695318|10926679|FG000|Overall Study|Withdrawal by Subject|2
6904231|NCT00695318|10926680|FG001|Overall Study|Withdrawal by Subject|0
6904232|NCT00695318|10926679|FG000|Overall Study|Death|1
6904233|NCT00695318|10926680|FG001|Overall Study|Death|1
6904234|NCT00695318|10926679|FG000|Overall Study|Study Terminated|1
6904235|NCT00695318|10926680|FG001|Overall Study|Study Terminated|0
6904236|NCT00695396|10926694|FG000|Overall Study|Study Closed Prematurely|5
6904237|NCT00695396|10926695|FG001|Overall Study|Study Closed Prematurely|6
6904238|NCT00695396|10926696|FG002|Overall Study|Study Closed Prematurely|8
6904239|NCT00695396|10926694|FG000|Overall Study|Withdrawal by Subject|2
6904240|NCT00695396|10926695|FG001|Overall Study|Withdrawal by Subject|2
6904241|NCT00695396|10926696|FG002|Overall Study|Withdrawal by Subject|0
6904242|NCT00695565|10926730|FG000|Overall Study|Lost to Follow-up|4
6904243|NCT00695565|10926731|FG001|Overall Study|Lost to Follow-up|4
6904244|NCT00695565|10926730|FG000|Overall Study|Adverse Event|3
6904245|NCT00695565|10926731|FG001|Overall Study|Adverse Event|1
6904246|NCT00695565|10926730|FG000|Overall Study|Protocol Violation|3
6904247|NCT00695565|10926731|FG001|Overall Study|Protocol Violation|1
6904248|NCT00695565|10926730|FG000|Overall Study|Withdrawal by Subject|1
6904249|NCT00695565|10926731|FG001|Overall Study|Withdrawal by Subject|1
6904250|NCT00695565|10926730|FG000|Overall Study|Lack of Efficacy|1
6904251|NCT00695565|10926731|FG001|Overall Study|Lack of Efficacy|1
6904252|NCT00695565|10926730|FG000|Overall Study|Subject did not follow instructions|1
6904253|NCT00695565|10926731|FG001|Overall Study|Subject did not follow instructions|1
6904254|NCT00695669|10926750|FG000|Overall Study|Adverse Event|0
6904255|NCT00695669|10926751|FG001|Overall Study|Adverse Event|0
6904256|NCT00695669|10926752|FG002|Overall Study|Adverse Event|2
6904257|NCT00695669|10926753|FG003|Overall Study|Adverse Event|0
6904258|NCT00695669|10926750|FG000|Overall Study|Lost to Follow-up|4
6904259|NCT00695669|10926751|FG001|Overall Study|Lost to Follow-up|4
6904260|NCT00695669|10926752|FG002|Overall Study|Lost to Follow-up|1
6904261|NCT00695669|10926753|FG003|Overall Study|Lost to Follow-up|4
6904262|NCT00695786|10926770|FG000|Overall Study|Adverse Event|0
6904263|NCT00695786|10926771|FG001|Overall Study|Adverse Event|3
6904264|NCT00695786|10926772|FG002|Overall Study|Adverse Event|4
6904265|NCT00695786|10926773|FG003|Overall Study|Adverse Event|2
6904266|NCT00695786|10926770|FG000|Overall Study|Lost to Follow-up|0
6904267|NCT00695786|10926771|FG001|Overall Study|Lost to Follow-up|5
6904268|NCT00695786|10926772|FG002|Overall Study|Lost to Follow-up|1
6904269|NCT00695786|10926773|FG003|Overall Study|Lost to Follow-up|1
6904270|NCT00695786|10926770|FG000|Overall Study|Withdrawal by Subject|0
6904271|NCT00695786|10926771|FG001|Overall Study|Withdrawal by Subject|4
6904272|NCT00695786|10926772|FG002|Overall Study|Withdrawal by Subject|3
6904273|NCT00695786|10926773|FG003|Overall Study|Withdrawal by Subject|1
6904274|NCT00695786|10926770|FG000|Overall Study|Deemed Ineligible|1
6904275|NCT00695786|10926771|FG001|Overall Study|Deemed Ineligible|0
6904276|NCT00695786|10926772|FG002|Overall Study|Deemed Ineligible|0
6904277|NCT00695786|10926773|FG003|Overall Study|Deemed Ineligible|0
6904278|NCT00695786|10926770|FG000|Overall Study|Lack of Efficacy|0
6904279|NCT00695786|10926771|FG001|Overall Study|Lack of Efficacy|0
6904280|NCT00695786|10926772|FG002|Overall Study|Lack of Efficacy|0
6904281|NCT00695786|10926773|FG003|Overall Study|Lack of Efficacy|4
6904282|NCT00695864|10926783|FG000|Placebo|Withdrawal by Subject|1
6904283|NCT00695864|10926783|FG000|Placebo|Physician Decision|4
6904284|NCT00695903|10926791|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0
6904285|NCT00695903|10926792|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2
6904286|NCT00695903|10926791|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
6904287|NCT00695903|10926792|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
6904288|NCT00695903|10926791|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1
6904289|NCT00695903|10926792|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0
6904290|NCT00695903|10926791|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
6904291|NCT00695903|10926792|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
6904292|NCT00695903|10926791|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0
6904293|NCT00695903|10926792|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1
6904294|NCT00695903|10926791|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1
6904295|NCT00695903|10926792|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2
6904296|NCT00695903|10926791|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1
6904297|NCT00695903|10926792|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0
6904298|NCT00695903|10926791|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1
6904299|NCT00695903|10926792|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0
6904300|NCT00695903|10926791|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0
6904301|NCT00695903|10926792|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1
6904302|NCT00695955|10926798|FG000|Cohort 1|Adverse Event|26
6904303|NCT00695955|10926798|FG000|Cohort 1|Protocol Violation|2
6904304|NCT00695955|10926798|FG000|Cohort 1|Lost to Follow-up|30
6904305|NCT00695955|10926798|FG000|Cohort 1|Withdrawal by Subject|25
6904306|NCT00695955|10926798|FG000|Cohort 1|Lack of Efficacy|3
6904307|NCT00695955|10926798|FG000|Cohort 1|Other|16
6904308|NCT00695955|10926798|FG000|Cohort 2|Adverse Event|24
6904309|NCT00695955|10926798|FG000|Cohort 2|Protocol Violation|5
6904310|NCT00695955|10926798|FG000|Cohort 2|Lost to Follow-up|38
6904311|NCT00695955|10926798|FG000|Cohort 2|Withdrawal by Subject|28
6904312|NCT00695955|10926798|FG000|Cohort 2|Lack of Efficacy|4
6904313|NCT00695955|10926798|FG000|Cohort 2|Other|5
6904314|NCT00696020|10926808|FG000|Overall Study|Adverse Event|3
6904315|NCT00696020|10926809|FG001|Overall Study|Adverse Event|1
6904316|NCT00696020|10926810|FG002|Overall Study|Adverse Event|2
6904317|NCT00696020|10926811|FG003|Overall Study|Adverse Event|1
6904318|NCT00696020|10926808|FG000|Overall Study|Lack of Efficacy|1
6904319|NCT00696020|10926809|FG001|Overall Study|Lack of Efficacy|0
6904320|NCT00696020|10926810|FG002|Overall Study|Lack of Efficacy|0
6904321|NCT00696020|10926811|FG003|Overall Study|Lack of Efficacy|0
6904322|NCT00696020|10926808|FG000|Overall Study|Protocol Violation|0
6904323|NCT00696020|10926809|FG001|Overall Study|Protocol Violation|0
6904324|NCT00696020|10926810|FG002|Overall Study|Protocol Violation|0
6904325|NCT00696020|10926811|FG003|Overall Study|Protocol Violation|1
6904326|NCT00696020|10926808|FG000|Overall Study|Withdrawal by Subject|0
6904327|NCT00696020|10926809|FG001|Overall Study|Withdrawal by Subject|1
6904328|NCT00696020|10926810|FG002|Overall Study|Withdrawal by Subject|0
6904329|NCT00696020|10926811|FG003|Overall Study|Withdrawal by Subject|1
6904330|NCT00696020|10926808|FG000|Overall Study|Other not stated above|0
6904331|NCT00696020|10926809|FG001|Overall Study|Other not stated above|0
6904332|NCT00696020|10926810|FG002|Overall Study|Other not stated above|1
6904333|NCT00696020|10926811|FG003|Overall Study|Other not stated above|1
6904334|NCT00696072|10926825|FG000|Overall Study|continuing active treatment|10
6904335|NCT00696072|10926826|FG001|Overall Study|continuing active treatment|13
6904336|NCT00696072|10926825|FG000|Overall Study|Adverse Event|10
6904337|NCT00696072|10926826|FG001|Overall Study|Adverse Event|6
6904338|NCT00696072|10926825|FG000|Overall Study|Patient Request|3
6904339|NCT00696072|10926826|FG001|Overall Study|Patient Request|7
6904340|NCT00696072|10926825|FG000|Overall Study|Investigator Request|1
6904341|NCT00696072|10926826|FG001|Overall Study|Investigator Request|4
6904342|NCT00696072|10926825|FG000|Overall Study|Sponsor Request|0
6904343|NCT00696072|10926826|FG001|Overall Study|Sponsor Request|1
6904344|NCT00696072|10926825|FG000|Overall Study|Disease Progression|32
6904345|NCT00696072|10926826|FG001|Overall Study|Disease Progression|30
6904346|NCT00696072|10926825|FG000|Overall Study|Non-specified|1
6904347|NCT00696072|10926826|FG001|Overall Study|Non-specified|2
6904348|NCT00696137|10926833|FG000|Overall Study|Withdrawal by Subject|2
6904349|NCT00696241|10926842|FG000|Overall Study|Adverse Event|11
6904350|NCT00696241|10926843|FG001|Overall Study|Adverse Event|3
6904351|NCT00696241|10926844|FG002|Overall Study|Adverse Event|6
6904352|NCT00696241|10926845|FG003|Overall Study|Adverse Event|4
6904353|NCT00696241|10926846|FG004|Overall Study|Adverse Event|5
6904354|NCT00696241|10926842|FG000|Overall Study|Protocol Violation|1
6904355|NCT00696241|10926843|FG001|Overall Study|Protocol Violation|1
6904356|NCT00696241|10926844|FG002|Overall Study|Protocol Violation|2
6904357|NCT00696241|10926845|FG003|Overall Study|Protocol Violation|0
6904358|NCT00696241|10926846|FG004|Overall Study|Protocol Violation|3
6978709|NCT01214642|11032243|FG011|Overall Study|Adverse Event|0
6978710|NCT01214642|11032232|FG000|Overall Study|Death|0
6978711|NCT01214642|11032233|FG001|Overall Study|Death|0
6978712|NCT01214642|11032234|FG002|Overall Study|Death|1
6978713|NCT01214642|11032235|FG003|Overall Study|Death|0
6978714|NCT01214642|11032236|FG004|Overall Study|Death|0
6978715|NCT01214642|11032237|FG005|Overall Study|Death|0
6978716|NCT01214642|11032238|FG006|Overall Study|Death|0
6978717|NCT01214642|11032239|FG007|Overall Study|Death|0
6978718|NCT01214642|11032240|FG008|Overall Study|Death|0
6978719|NCT01214642|11032241|FG009|Overall Study|Death|0
6978720|NCT01214642|11032242|FG010|Overall Study|Death|1
6978721|NCT01214642|11032243|FG011|Overall Study|Death|0
6978722|NCT01214642|11032232|FG000|Overall Study|Withdrawal by Subject|0
6904359|NCT00696241|10926842|FG000|Overall Study|Lost to Follow-up|1
6904360|NCT00696241|10926843|FG001|Overall Study|Lost to Follow-up|4
6904361|NCT00696241|10926844|FG002|Overall Study|Lost to Follow-up|1
6904362|NCT00696241|10926845|FG003|Overall Study|Lost to Follow-up|2
6904363|NCT00696241|10926846|FG004|Overall Study|Lost to Follow-up|0
6904364|NCT00696241|10926842|FG000|Overall Study|Withdrawal by Subject|4
6904365|NCT00696241|10926843|FG001|Overall Study|Withdrawal by Subject|8
6904366|NCT00696241|10926844|FG002|Overall Study|Withdrawal by Subject|6
6904367|NCT00696241|10926845|FG003|Overall Study|Withdrawal by Subject|1
6904368|NCT00696241|10926846|FG004|Overall Study|Withdrawal by Subject|0
6904369|NCT00696241|10926842|FG000|Overall Study|Lack of Efficacy|1
6904370|NCT00696241|10926843|FG001|Overall Study|Lack of Efficacy|5
6904371|NCT00696241|10926844|FG002|Overall Study|Lack of Efficacy|4
6978723|NCT01214642|11032233|FG001|Overall Study|Withdrawal by Subject|0
6978724|NCT01214642|11032234|FG002|Overall Study|Withdrawal by Subject|1
6904372|NCT00696241|10926845|FG003|Overall Study|Lack of Efficacy|5
6904373|NCT00696241|10926846|FG004|Overall Study|Lack of Efficacy|3
6904374|NCT00696241|10926842|FG000|Overall Study|Other|6
6904375|NCT00696241|10926843|FG001|Overall Study|Other|1
6904376|NCT00696241|10926844|FG002|Overall Study|Other|5
6904377|NCT00696241|10926845|FG003|Overall Study|Other|2
6904378|NCT00696241|10926846|FG004|Overall Study|Other|1
6904379|NCT00696384|10926863|FG000|Open Label Phase|Adverse Event|27
6904380|NCT00696384|10926864|FG001|Open Label Phase|Adverse Event|0
6904381|NCT00696384|10926865|FG002|Open Label Phase|Adverse Event|0
6904382|NCT00696384|10926863|FG000|Open Label Phase|Protocol Violation|18
6904383|NCT00696384|10926864|FG001|Open Label Phase|Protocol Violation|0
6904384|NCT00696384|10926865|FG002|Open Label Phase|Protocol Violation|0
6904385|NCT00696384|10926863|FG000|Open Label Phase|Lost to Follow-up|24
6978725|NCT01214642|11032235|FG003|Overall Study|Withdrawal by Subject|0
6904386|NCT00696384|10926864|FG001|Open Label Phase|Lost to Follow-up|0
6904387|NCT00696384|10926865|FG002|Open Label Phase|Lost to Follow-up|0
6904388|NCT00696384|10926863|FG000|Open Label Phase|Withdrawal by Subject|37
6904389|NCT00696384|10926864|FG001|Open Label Phase|Withdrawal by Subject|0
6904390|NCT00696384|10926865|FG002|Open Label Phase|Withdrawal by Subject|0
6904391|NCT00696384|10926863|FG000|Open Label Phase|Other|6
6904392|NCT00696384|10926864|FG001|Open Label Phase|Other|0
6904393|NCT00696384|10926865|FG002|Open Label Phase|Other|0
6904394|NCT00696384|10926863|FG000|Open Label Phase|Lack of Efficacy|3
6904395|NCT00696384|10926864|FG001|Open Label Phase|Lack of Efficacy|0
6904396|NCT00696384|10926865|FG002|Open Label Phase|Lack of Efficacy|0
6904397|NCT00696384|10926863|FG000|Open Label Phase|Physician Decision|4
6904398|NCT00696384|10926864|FG001|Open Label Phase|Physician Decision|0
6904399|NCT00696384|10926865|FG002|Open Label Phase|Physician Decision|0
6904400|NCT00696384|10926863|FG000|Double Blind Phase|Adverse Event|0
6904401|NCT00696384|10926864|FG001|Double Blind Phase|Adverse Event|2
6904402|NCT00696384|10926865|FG002|Double Blind Phase|Adverse Event|2
6904403|NCT00696384|10926863|FG000|Double Blind Phase|Lost to Follow-up|0
6904404|NCT00696384|10926864|FG001|Double Blind Phase|Lost to Follow-up|2
6904405|NCT00696384|10926865|FG002|Double Blind Phase|Lost to Follow-up|1
6904406|NCT00696384|10926863|FG000|Double Blind Phase|Withdrawal by Subject|0
6904407|NCT00696384|10926864|FG001|Double Blind Phase|Withdrawal by Subject|4
6904408|NCT00696384|10926865|FG002|Double Blind Phase|Withdrawal by Subject|3
6904409|NCT00696384|10926863|FG000|Double Blind Phase|Lack of Efficacy|0
6904410|NCT00696384|10926864|FG001|Double Blind Phase|Lack of Efficacy|1
6904411|NCT00696384|10926865|FG002|Double Blind Phase|Lack of Efficacy|0
6904412|NCT00696384|10926863|FG000|Double Blind Phase|Physician Decision|0
6904413|NCT00696384|10926864|FG001|Double Blind Phase|Physician Decision|2
6904414|NCT00696384|10926865|FG002|Double Blind Phase|Physician Decision|0
6904415|NCT00696410|10926876|FG000|Overall Study|Lost to Follow-up|2
6904416|NCT00696410|10926877|FG001|Overall Study|Lost to Follow-up|0
6904417|NCT00696410|10926876|FG000|Overall Study|Withdrawal by Subject|8
6904418|NCT00696410|10926877|FG001|Overall Study|Withdrawal by Subject|0
6904419|NCT00696410|10926876|FG000|Overall Study|Physician Decision|3
6904420|NCT00696410|10926877|FG001|Overall Study|Physician Decision|0
6904421|NCT00696423|10926890|FG000|Overall Study|Lost to Follow-up|0
6904422|NCT00696423|10926891|FG001|Overall Study|Lost to Follow-up|5
6904423|NCT00696436|10926902|FG000|Overall Study|Adverse Event|7
6904424|NCT00696436|10926903|FG001|Overall Study|Adverse Event|9
6904425|NCT00696436|10926904|FG002|Overall Study|Adverse Event|8
6904426|NCT00696436|10926905|FG003|Overall Study|Adverse Event|6
6904427|NCT00696436|10926906|FG004|Overall Study|Adverse Event|4
6904428|NCT00696436|10926902|FG000|Overall Study|Protocol Violation|3
6904429|NCT00696436|10926903|FG001|Overall Study|Protocol Violation|2
6904430|NCT00696436|10926904|FG002|Overall Study|Protocol Violation|2
6904431|NCT00696436|10926905|FG003|Overall Study|Protocol Violation|0
6904432|NCT00696436|10926906|FG004|Overall Study|Protocol Violation|1
6904433|NCT00696436|10926902|FG000|Overall Study|Lost to Follow-up|1
6904434|NCT00696436|10926903|FG001|Overall Study|Lost to Follow-up|6
6904435|NCT00696436|10926904|FG002|Overall Study|Lost to Follow-up|2
6904436|NCT00696436|10926905|FG003|Overall Study|Lost to Follow-up|4
6904437|NCT00696436|10926906|FG004|Overall Study|Lost to Follow-up|3
6904438|NCT00696436|10926902|FG000|Overall Study|Withdrawal by Subject|4
6904439|NCT00696436|10926903|FG001|Overall Study|Withdrawal by Subject|11
6904440|NCT00696436|10926904|FG002|Overall Study|Withdrawal by Subject|5
6904441|NCT00696436|10926905|FG003|Overall Study|Withdrawal by Subject|7
6904442|NCT00696436|10926906|FG004|Overall Study|Withdrawal by Subject|1
6904443|NCT00696436|10926902|FG000|Overall Study|Lack of Efficacy|3
6904444|NCT00696436|10926903|FG001|Overall Study|Lack of Efficacy|1
6904445|NCT00696436|10926904|FG002|Overall Study|Lack of Efficacy|5
6904446|NCT00696436|10926905|FG003|Overall Study|Lack of Efficacy|2
6904447|NCT00696436|10926906|FG004|Overall Study|Lack of Efficacy|4
6904448|NCT00696436|10926902|FG000|Overall Study|Participant Unavailability|2
6904449|NCT00696436|10926903|FG001|Overall Study|Participant Unavailability|0
6904450|NCT00696436|10926904|FG002|Overall Study|Participant Unavailability|2
6904451|NCT00696436|10926905|FG003|Overall Study|Participant Unavailability|1
6904452|NCT00696436|10926906|FG004|Overall Study|Participant Unavailability|0
6904453|NCT00696436|10926902|FG000|Overall Study|Administrative Error|2
6904454|NCT00696436|10926903|FG001|Overall Study|Administrative Error|0
6904455|NCT00696436|10926904|FG002|Overall Study|Administrative Error|2
6904456|NCT00696436|10926905|FG003|Overall Study|Administrative Error|0
6904457|NCT00696436|10926906|FG004|Overall Study|Administrative Error|0
6904458|NCT00696436|10926902|FG000|Overall Study|Participant Non-compliance|0
6904459|NCT00696436|10926903|FG001|Overall Study|Participant Non-compliance|0
6904460|NCT00696436|10926904|FG002|Overall Study|Participant Non-compliance|1
6904461|NCT00696436|10926905|FG003|Overall Study|Participant Non-compliance|2
6904462|NCT00696436|10926906|FG004|Overall Study|Participant Non-compliance|0
6904463|NCT00696436|10926902|FG000|Overall Study|Administrative Decision|1
6904464|NCT00696436|10926903|FG001|Overall Study|Administrative Decision|0
6904465|NCT00696436|10926904|FG002|Overall Study|Administrative Decision|0
6904466|NCT00696436|10926905|FG003|Overall Study|Administrative Decision|0
6904467|NCT00696436|10926906|FG004|Overall Study|Administrative Decision|0
6904468|NCT00696436|10926902|FG000|Overall Study|Missing|0
6904469|NCT00696436|10926903|FG001|Overall Study|Missing|1
6904470|NCT00696436|10926904|FG002|Overall Study|Missing|1
6904471|NCT00696436|10926905|FG003|Overall Study|Missing|0
6904472|NCT00696436|10926906|FG004|Overall Study|Missing|0
6904473|NCT00696657|10926961|FG000|Overall Study|Protocol Violation|0
6904474|NCT00696657|10926962|FG001|Overall Study|Protocol Violation|0
6904475|NCT00696657|10926963|FG002|Overall Study|Protocol Violation|0
6904476|NCT00696657|10926964|FG003|Overall Study|Protocol Violation|0
6904477|NCT00696657|10926965|FG004|Overall Study|Protocol Violation|0
6904478|NCT00696657|10926966|FG005|Overall Study|Protocol Violation|1
6904479|NCT00696657|10926967|FG006|Overall Study|Protocol Violation|0
6904480|NCT00696657|10926968|FG007|Overall Study|Protocol Violation|0
6904481|NCT00696657|10926969|FG008|Overall Study|Protocol Violation|1
6904482|NCT00696657|10926961|FG000|Overall Study|Lack of Efficacy|0
6904483|NCT00696657|10926962|FG001|Overall Study|Lack of Efficacy|1
6904484|NCT00696657|10926963|FG002|Overall Study|Lack of Efficacy|0
6904485|NCT00696657|10926964|FG003|Overall Study|Lack of Efficacy|0
6904486|NCT00696657|10926965|FG004|Overall Study|Lack of Efficacy|0
6904487|NCT00696657|10926966|FG005|Overall Study|Lack of Efficacy|0
6904488|NCT00696657|10926967|FG006|Overall Study|Lack of Efficacy|0
6904489|NCT00696657|10926968|FG007|Overall Study|Lack of Efficacy|0
6904490|NCT00696657|10926969|FG008|Overall Study|Lack of Efficacy|0
6904491|NCT00696657|10926961|FG000|Overall Study|Withdrawal criteria|1
6904492|NCT00696657|10926962|FG001|Overall Study|Withdrawal criteria|3
6904493|NCT00696657|10926963|FG002|Overall Study|Withdrawal criteria|2
6904494|NCT00696657|10926964|FG003|Overall Study|Withdrawal criteria|2
6904495|NCT00696657|10926965|FG004|Overall Study|Withdrawal criteria|0
6904496|NCT00696657|10926966|FG005|Overall Study|Withdrawal criteria|0
6904497|NCT00696657|10926967|FG006|Overall Study|Withdrawal criteria|1
6904498|NCT00696657|10926968|FG007|Overall Study|Withdrawal criteria|1
6904499|NCT00696657|10926969|FG008|Overall Study|Withdrawal criteria|2
6904500|NCT00696657|10926961|FG000|Overall Study|Unclassified|0
6904501|NCT00696657|10926962|FG001|Overall Study|Unclassified|1
6904502|NCT00696657|10926963|FG002|Overall Study|Unclassified|3
6904503|NCT00696657|10926964|FG003|Overall Study|Unclassified|2
6904504|NCT00696657|10926965|FG004|Overall Study|Unclassified|4
6904505|NCT00696657|10926966|FG005|Overall Study|Unclassified|2
6904506|NCT00696657|10926967|FG006|Overall Study|Unclassified|0
6904507|NCT00696657|10926968|FG007|Overall Study|Unclassified|0
6904508|NCT00696657|10926969|FG008|Overall Study|Unclassified|1
6904509|NCT00696657|10926961|FG000|Overall Study|Adverse Event|0
6904510|NCT00696657|10926962|FG001|Overall Study|Adverse Event|0
6904511|NCT00696657|10926963|FG002|Overall Study|Adverse Event|3
6904512|NCT00696657|10926964|FG003|Overall Study|Adverse Event|7
6904513|NCT00696657|10926965|FG004|Overall Study|Adverse Event|6
6904514|NCT00696657|10926966|FG005|Overall Study|Adverse Event|9
6904515|NCT00696657|10926967|FG006|Overall Study|Adverse Event|14
6904516|NCT00696657|10926968|FG007|Overall Study|Adverse Event|2
6904517|NCT00696657|10926969|FG008|Overall Study|Adverse Event|5
6904518|NCT00696696|10926989|FG000|Overall Study|Adverse Event|5
6904519|NCT00696696|10926989|FG000|Overall Study|Withdrawal by Subject|8
6904520|NCT00696696|10926989|FG000|Overall Study|Physician Decision|2
6904521|NCT00696696|10926989|FG000|Overall Study|Death|3
6904522|NCT00696709|10926998|FG000|Overall Study|Withdrawal by Subject|1
6904523|NCT00696709|10926999|FG001|Overall Study|Withdrawal by Subject|2
6904524|NCT00696709|10927000|FG002|Overall Study|Withdrawal by Subject|1
6904525|NCT00696709|10927001|FG003|Overall Study|Withdrawal by Subject|4
6904526|NCT00696709|10927002|FG004|Overall Study|Withdrawal by Subject|3
6904527|NCT00696709|10926998|FG000|Overall Study|Protocol Violation|1
6904528|NCT00696709|10926999|FG001|Overall Study|Protocol Violation|0
6904529|NCT00696709|10927000|FG002|Overall Study|Protocol Violation|0
6904530|NCT00696709|10927001|FG003|Overall Study|Protocol Violation|0
6904531|NCT00696709|10927002|FG004|Overall Study|Protocol Violation|0
6904532|NCT00696709|10926998|FG000|Overall Study|Lost to Follow-up|1
6904533|NCT00696709|10926999|FG001|Overall Study|Lost to Follow-up|1
6904534|NCT00696709|10927000|FG002|Overall Study|Lost to Follow-up|0
6904535|NCT00696709|10927001|FG003|Overall Study|Lost to Follow-up|0
6904536|NCT00696709|10927002|FG004|Overall Study|Lost to Follow-up|0
6904537|NCT00696709|10926998|FG000|Overall Study|Adverse Event|0
6904538|NCT00696709|10926999|FG001|Overall Study|Adverse Event|0
6904539|NCT00696709|10927000|FG002|Overall Study|Adverse Event|0
6904540|NCT00696709|10927001|FG003|Overall Study|Adverse Event|1
6904541|NCT00696709|10927002|FG004|Overall Study|Adverse Event|0
6904542|NCT00696774|10927046|FG000|Period II|Adverse Event|0
6904543|NCT00696774|10927047|FG001|Period II|Adverse Event|0
6904544|NCT00696774|10927048|FG002|Period II|Adverse Event|15
6904545|NCT00696774|10927046|FG000|Period II|Lost to Follow-up|0
6904546|NCT00696774|10927047|FG001|Period II|Lost to Follow-up|0
6904547|NCT00696774|10927048|FG002|Period II|Lost to Follow-up|4
6904548|NCT00696774|10927046|FG000|Period II|Protocol Violation|0
6904549|NCT00696774|10927047|FG001|Period II|Protocol Violation|0
6904550|NCT00696774|10927048|FG002|Period II|Protocol Violation|11
6904551|NCT00696774|10927046|FG000|Period II|Withdrawal by Subject|0
6904552|NCT00696774|10927047|FG001|Period II|Withdrawal by Subject|0
6904553|NCT00696774|10927048|FG002|Period II|Withdrawal by Subject|4
6904554|NCT00696774|10927046|FG000|Period II|Sponsor Decision|0
6904555|NCT00696774|10927047|FG001|Period II|Sponsor Decision|0
6904556|NCT00696774|10927048|FG002|Period II|Sponsor Decision|0
6904557|NCT00696774|10927046|FG000|Period II|Lack of Efficacy|0
6904558|NCT00696774|10927047|FG001|Period II|Lack of Efficacy|0
6904559|NCT00696774|10927048|FG002|Period II|Lack of Efficacy|2
6904560|NCT00696774|10927046|FG000|Period III|Adverse Event|1
6904561|NCT00696774|10927047|FG001|Period III|Adverse Event|1
6904562|NCT00696774|10927048|FG002|Period III|Adverse Event|0
6904563|NCT00696774|10927046|FG000|Period III|Lost to Follow-up|2
6904564|NCT00696774|10927047|FG001|Period III|Lost to Follow-up|1
6904565|NCT00696774|10927048|FG002|Period III|Lost to Follow-up|0
6904566|NCT00696774|10927046|FG000|Period III|Protocol Violation|1
6904567|NCT00696774|10927047|FG001|Period III|Protocol Violation|1
6904568|NCT00696774|10927048|FG002|Period III|Protocol Violation|0
6904569|NCT00696774|10927046|FG000|Period III|Withdrawal by Subject|1
6904570|NCT00696774|10927047|FG001|Period III|Withdrawal by Subject|2
6904571|NCT00696774|10927048|FG002|Period III|Withdrawal by Subject|0
6904572|NCT00696774|10927046|FG000|Period III|Sponsor Decision|2
6904573|NCT00696774|10927047|FG001|Period III|Sponsor Decision|0
6904574|NCT00696774|10927048|FG002|Period III|Sponsor Decision|0
6904575|NCT00696774|10927046|FG000|Period III|Lack of Efficacy|0
6904576|NCT00696774|10927047|FG001|Period III|Lack of Efficacy|2
6904577|NCT00696774|10927048|FG002|Period III|Lack of Efficacy|0
6904578|NCT00696787|10927059|FG000|Overall Study|Adverse Event|1
6904579|NCT00696787|10927060|FG001|Overall Study|Adverse Event|0
6904580|NCT00696787|10927061|FG002|Overall Study|Adverse Event|6
6904581|NCT00696787|10927059|FG000|Overall Study|Discontinuation by Sponsor|9
6904582|NCT00696787|10927060|FG001|Overall Study|Discontinuation by Sponsor|13
6904583|NCT00696787|10927061|FG002|Overall Study|Discontinuation by Sponsor|14
6904584|NCT00696787|10927059|FG000|Overall Study|Lack of Efficacy|0
6904585|NCT00696787|10927060|FG001|Overall Study|Lack of Efficacy|1
6904586|NCT00696787|10927061|FG002|Overall Study|Lack of Efficacy|0
6904587|NCT00696787|10927059|FG000|Overall Study|Lost to Follow-up|4
6904588|NCT00696787|10927060|FG001|Overall Study|Lost to Follow-up|0
6904589|NCT00696787|10927061|FG002|Overall Study|Lost to Follow-up|3
6904590|NCT00696787|10927059|FG000|Overall Study|Withdrawal by Subject|0
6904591|NCT00696787|10927060|FG001|Overall Study|Withdrawal by Subject|3
6904592|NCT00696787|10927061|FG002|Overall Study|Withdrawal by Subject|2
6904593|NCT00696787|10927059|FG000|Overall Study|Failed to return|1
6904594|NCT00696787|10927060|FG001|Overall Study|Failed to return|3
6904595|NCT00696787|10927061|FG002|Overall Study|Failed to return|1
6904596|NCT00697073|10927069|FG000|Overall Study|Withdrawal by Subject|2
6904597|NCT00697073|10927069|FG000|Overall Study|Pregnancy|1
6904598|NCT00697073|10927069|FG000|Overall Study|non compliance and other|6
6904599|NCT00697112|10927073|FG000|Overall Study|Adverse Event|8
6904600|NCT00697112|10927073|FG000|Overall Study|Lost to Follow-up|1
6904601|NCT00697112|10927073|FG000|Overall Study|Did not meet inclusion criteria|1
6904602|NCT00697346|10927108|FG000|Overall Study|Adverse Event|4
6904603|NCT00697346|10927109|FG001|Overall Study|Adverse Event|5
6904604|NCT00697346|10927110|FG002|Overall Study|Adverse Event|0
6904605|NCT00697346|10927108|FG000|Overall Study|Progressive Disease|19
6904606|NCT00697346|10927109|FG001|Overall Study|Progressive Disease|18
6904607|NCT00697346|10927110|FG002|Overall Study|Progressive Disease|0
6904608|NCT00697346|10927108|FG000|Overall Study|Symptomatic Deterioration|0
6904609|NCT00697346|10927109|FG001|Overall Study|Symptomatic Deterioration|1
6904610|NCT00697346|10927110|FG002|Overall Study|Symptomatic Deterioration|0
6904611|NCT00697346|10927108|FG000|Overall Study|Withdrawal by Subject|2
6904612|NCT00697346|10927109|FG001|Overall Study|Withdrawal by Subject|2
6904613|NCT00697346|10927110|FG002|Overall Study|Withdrawal by Subject|0
6904614|NCT00697346|10927108|FG000|Overall Study|Reason not Specified|3
6904615|NCT00697346|10927109|FG001|Overall Study|Reason not Specified|0
6904616|NCT00697346|10927110|FG002|Overall Study|Reason not Specified|1
6904617|NCT00697463|10927137|FG000|Overall Study|Withdrawal by Subject|1
6904618|NCT00697515|10927141|FG000|Dose Optimization Period|Adverse Event|4
6904619|NCT00697515|10927142|FG001|Dose Optimization Period|Adverse Event|0
6904620|NCT00697515|10927141|FG000|Dose Optimization Period|Withdrawal by Subject|5
6904621|NCT00697515|10927142|FG001|Dose Optimization Period|Withdrawal by Subject|0
6904622|NCT00697515|10927141|FG000|Dose Optimization Period|Lost to Follow-up|2
6904623|NCT00697515|10927142|FG001|Dose Optimization Period|Lost to Follow-up|0
6904624|NCT00697515|10927141|FG000|Dose Optimization Period|sponsor request|2
6904625|NCT00697515|10927142|FG001|Dose Optimization Period|sponsor request|0
6904626|NCT00697515|10927141|FG000|Dose Optimization Period|called to active duty|1
6904627|NCT00697515|10927142|FG001|Dose Optimization Period|called to active duty|0
6904628|NCT00697515|10927141|FG000|Dose Optimization Period|elevated QTc|1
6904629|NCT00697515|10927142|FG001|Dose Optimization Period|elevated QTc|0
6904630|NCT00697515|10927141|FG000|First Intervention (Crossover Period)|Natural disaster|8
6904631|NCT00697515|10927142|FG001|First Intervention (Crossover Period)|Natural disaster|9
6904632|NCT00697515|10927141|FG000|First Intervention (Crossover Period)|Adverse Event|0
6904633|NCT00697515|10927142|FG001|First Intervention (Crossover Period)|Adverse Event|2
6904634|NCT00697515|10927141|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2
6904635|NCT00697515|10927142|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1
6904636|NCT00697515|10927141|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1
6904637|NCT00697515|10927142|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1
6904638|NCT00697593|10927158|FG000|Overall Study|Adverse Event|3
6904639|NCT00697593|10927158|FG000|Overall Study|Protocol Violation|1
6904640|NCT00697593|10927158|FG000|Overall Study|Lack of Efficacy|3
6904641|NCT00697593|10927158|FG000|Overall Study|Suspension of the study by sponsor|12
6904642|NCT00697619|10927164|FG000|Overall Study|Lack of Efficacy|2
6904643|NCT00697619|10927165|FG001|Overall Study|Lack of Efficacy|2
6904644|NCT00697619|10927164|FG000|Overall Study|Adverse Event|4
6904645|NCT00697619|10927165|FG001|Overall Study|Adverse Event|6
6904646|NCT00697788|10927180|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
6904647|NCT00697788|10927181|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2
6904648|NCT00697788|10927182|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
6904649|NCT00697788|10927183|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
6904650|NCT00697788|10927184|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
6904651|NCT00697788|10927185|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
6904652|NCT00697788|10927186|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
6904653|NCT00697788|10927187|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
6904654|NCT00697788|10927180|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
6904655|NCT00697788|10927181|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
6904656|NCT00697788|10927182|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
6904657|NCT00697788|10927183|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
6904658|NCT00697788|10927184|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1
6904659|NCT00697788|10927185|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
6904660|NCT00697788|10927186|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
6904661|NCT00697788|10927187|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
6904662|NCT00697827|10927229|FG000|Overall Study|enrolled but not treated|2
6904663|NCT00697827|10927230|FG001|Overall Study|enrolled but not treated|1
6904664|NCT00698204|10927263|FG000|Overall Study|Withdrawal by Subject|1
6904665|NCT00698204|10927264|FG001|Overall Study|Withdrawal by Subject|0
6904666|NCT00698451|10927272|FG000|Overall Study|Adverse Event|22
6904667|NCT00698451|10927272|FG000|Overall Study|Physician Decision|2
6904668|NCT00698451|10927272|FG000|Overall Study|Protocol Violation|6
6904669|NCT00698451|10927272|FG000|Overall Study|Withdrawal by Subject|6
6904670|NCT00698451|10927272|FG000|Overall Study|Disease progression|3
6904671|NCT00698516|10927276|FG000|Overall Study|Study Termination|2
6904672|NCT00698516|10927276|FG000|Overall Study|Withdrawal by Subject|3
6904673|NCT00698581|10927286|FG000|Overall Study|Lack of Efficacy|23
6904674|NCT00698581|10927287|FG001|Overall Study|Lack of Efficacy|11
6904675|NCT00698581|10927286|FG000|Overall Study|Withdrawal by Subject|6
6904676|NCT00698581|10927287|FG001|Overall Study|Withdrawal by Subject|0
6904677|NCT00698581|10927286|FG000|Overall Study|Other reason|9
6904678|NCT00698581|10927287|FG001|Overall Study|Other reason|1
6904679|NCT00698581|10927286|FG000|Overall Study|SAE, non-fatal|1
6904680|NCT00698581|10927287|FG001|Overall Study|SAE, non-fatal|0
6904681|NCT00698581|10927286|FG000|Overall Study|AE, non-serious non-fatal|4
6904682|NCT00698581|10927287|FG001|Overall Study|AE, non-serious non-fatal|0
6904683|NCT00698581|10927286|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
6904684|NCT00698581|10927287|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
6904685|NCT00698581|10927286|FG000|Overall Study|AE of unknown type|1
6904686|NCT00698581|10927287|FG001|Overall Study|AE of unknown type|0
6904687|NCT00698646|10927297|FG000|Overall Study|Adverse Event|8
6904688|NCT00698646|10927298|FG001|Overall Study|Adverse Event|7
6904689|NCT00698646|10927299|FG002|Overall Study|Adverse Event|8
6904690|NCT00698646|10927297|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11
6904691|NCT00698646|10927298|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11
6904692|NCT00698646|10927299|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7
6904693|NCT00698646|10927297|FG000|Overall Study|Protocol Deviation|6
6904694|NCT00698646|10927298|FG001|Overall Study|Protocol Deviation|2
6904695|NCT00698646|10927299|FG002|Overall Study|Protocol Deviation|3
6904696|NCT00698646|10927297|FG000|Overall Study|Withdrawal by Subject|10
6904697|NCT00698646|10927298|FG001|Overall Study|Withdrawal by Subject|11
6904698|NCT00698646|10927299|FG002|Overall Study|Withdrawal by Subject|8
6904699|NCT00698646|10927297|FG000|Overall Study|Lost to Follow-up|0
6904700|NCT00698646|10927298|FG001|Overall Study|Lost to Follow-up|0
6904701|NCT00698646|10927299|FG002|Overall Study|Lost to Follow-up|2
6904702|NCT00698646|10927297|FG000|Overall Study|Administrative problems|1
6904703|NCT00698646|10927298|FG001|Overall Study|Administrative problems|0
6904704|NCT00698646|10927299|FG002|Overall Study|Administrative problems|1
6904705|NCT00698685|10927307|FG000|Overall Study|Sister withdrew as donor|1
6904706|NCT00698685|10927307|FG000|Overall Study|Off study pre transplant by clinic MD|1
6904707|NCT00698841|10927311|FG000|Overall Study|Withdrawal by Subject|2
6904708|NCT00698841|10927311|FG000|Overall Study|Adverse Event|3
6904709|NCT00698841|10927311|FG000|Overall Study|Disease progression|7
6904710|NCT00698841|10927311|FG000|Overall Study|Failure to meet eligibility criteria|2
6904711|NCT00698841|10927311|FG000|Overall Study|Study drug toxicity|2
6904712|NCT00698841|10927311|FG000|Overall Study|Other|2
6904713|NCT00698932|10927321|FG000|Overall Study|Adverse Event|0
6904714|NCT00698932|10927322|FG001|Overall Study|Adverse Event|2
6904715|NCT00698932|10927321|FG000|Overall Study|Incorrect enrollment|0
6904716|NCT00698932|10927322|FG001|Overall Study|Incorrect enrollment|2
6904717|NCT00698932|10927321|FG000|Overall Study|Study specific discontinuation criteria|3
6904718|NCT00698932|10927322|FG001|Overall Study|Study specific discontinuation criteria|4
6904719|NCT00698932|10927321|FG000|Overall Study|Withdrawal by Subject|11
6904720|NCT00698932|10927322|FG001|Overall Study|Withdrawal by Subject|23
6904721|NCT00698932|10927321|FG000|Overall Study|Lost to Follow-up|6
6904722|NCT00698932|10927322|FG001|Overall Study|Lost to Follow-up|1
6904723|NCT00698932|10927321|FG000|Overall Study|Severe non-compliance to protocol|1
6904724|NCT00698932|10927322|FG001|Overall Study|Severe non-compliance to protocol|2
6904725|NCT00698932|10927321|FG000|Overall Study|Safety reasons|0
6904726|NCT00698932|10927322|FG001|Overall Study|Safety reasons|2
6904727|NCT00698932|10927321|FG000|Overall Study|Death|1
6904728|NCT00698932|10927322|FG001|Overall Study|Death|0
6904729|NCT00698997|10927330|FG000|Overall Study|Lost to Follow-up|3
6904730|NCT00698997|10927331|FG001|Overall Study|Lost to Follow-up|0
6904731|NCT00698997|10927330|FG000|Overall Study|Withdrawal by Subject|7
6904732|NCT00698997|10927331|FG001|Overall Study|Withdrawal by Subject|27
6904733|NCT00699153|10927357|FG000|Overall Study|Lost to Follow-up|1
6904734|NCT00699153|10927358|FG001|Overall Study|Lost to Follow-up|0
6904735|NCT00699153|10927357|FG000|Overall Study|Adverse Event|0
6904736|NCT00699153|10927358|FG001|Overall Study|Adverse Event|2
6904737|NCT00699153|10927357|FG000|Overall Study|Protocol Violation|1
6904738|NCT00699153|10927358|FG001|Overall Study|Protocol Violation|0
6904739|NCT00699153|10927357|FG000|Overall Study|Travel Problem|1
6904740|NCT00699153|10927358|FG001|Overall Study|Travel Problem|0
6904741|NCT00699192|10927367|FG000|Overall Study|Missing|1
6904742|NCT00699192|10927368|FG001|Overall Study|Missing|1
6904743|NCT00699192|10927369|FG002|Overall Study|Missing|1
6904744|NCT00699192|10927367|FG000|Overall Study|Adverse Event|9
6904745|NCT00699192|10927368|FG001|Overall Study|Adverse Event|4
6904746|NCT00699192|10927369|FG002|Overall Study|Adverse Event|3
6904747|NCT00699192|10927367|FG000|Overall Study|Abnormal test procedure result(s)|0
6904748|NCT00699192|10927368|FG001|Overall Study|Abnormal test procedure result(s)|0
6904749|NCT00699192|10927369|FG002|Overall Study|Abnormal test procedure result(s)|1
6904750|NCT00699192|10927367|FG000|Overall Study|Lack of Efficacy|0
6904751|NCT00699192|10927368|FG001|Overall Study|Lack of Efficacy|0
6904752|NCT00699192|10927369|FG002|Overall Study|Lack of Efficacy|1
6904753|NCT00699192|10927367|FG000|Overall Study|Withdrawal by Subject|3
6904754|NCT00699192|10927368|FG001|Overall Study|Withdrawal by Subject|2
6904755|NCT00699192|10927369|FG002|Overall Study|Withdrawal by Subject|4
6904756|NCT00699192|10927367|FG000|Overall Study|Administrative problems|1
6904757|NCT00699192|10927368|FG001|Overall Study|Administrative problems|3
6904758|NCT00699192|10927369|FG002|Overall Study|Administrative problems|1
6904759|NCT00699192|10927367|FG000|Overall Study|Protocol Violation|2
6904760|NCT00699192|10927368|FG001|Overall Study|Protocol Violation|2
6904761|NCT00699192|10927369|FG002|Overall Study|Protocol Violation|0
6904762|NCT00699283|10927383|FG000|Overall Study|Lack of Efficacy|15
6904763|NCT00699283|10927384|FG001|Overall Study|Lack of Efficacy|5
6904764|NCT00699283|10927383|FG000|Overall Study|Lost to Follow-up|2
6904765|NCT00699283|10927384|FG001|Overall Study|Lost to Follow-up|0
6904766|NCT00699283|10927383|FG000|Overall Study|Withdrawal by Subject|1
6904767|NCT00699283|10927384|FG001|Overall Study|Withdrawal by Subject|0
6904768|NCT00699283|10927383|FG000|Overall Study|Other Reason|5
6904769|NCT00699283|10927384|FG001|Overall Study|Other Reason|1
6904770|NCT00699283|10927383|FG000|Overall Study|SAE, non-fatal|1
6904771|NCT00699283|10927384|FG001|Overall Study|SAE, non-fatal|1
6904772|NCT00699283|10927383|FG000|Overall Study|AE, non-serious non-fatal|8
6904773|NCT00699283|10927384|FG001|Overall Study|AE, non-serious non-fatal|1
6904774|NCT00699283|10927383|FG000|Overall Study|AE of unknown type|1
6904775|NCT00699283|10927384|FG001|Overall Study|AE of unknown type|0
6904776|NCT00699335|10927389|FG000|Overall Study|Combination of multiple reasons|176
6904777|NCT00699335|10927389|FG000|Overall Study|Missing data|52
6904778|NCT00699348|10927396|FG000|Overall Study|Death|6
6904779|NCT00699348|10927396|FG000|Overall Study|Adverse Event|15
6904780|NCT00699348|10927396|FG000|Overall Study|Withdrawal by Subject|11
6904781|NCT00699348|10927396|FG000|Overall Study|Protocol Violation|10
6904782|NCT00699348|10927396|FG000|Overall Study|Lack of Efficacy|8
6904783|NCT00699348|10927396|FG000|Overall Study|Failure to return|1
6904784|NCT00699348|10927396|FG000|Overall Study|Blood transfusion|24
6904785|NCT00699348|10927396|FG000|Overall Study|Renal transplantation|10
6904786|NCT00699348|10927396|FG000|Overall Study|Other|5
6904787|NCT00699374|10927402|FG000|Overall Study|Death|93
6904788|NCT00699374|10927403|FG001|Overall Study|Death|83
6904789|NCT00699374|10927402|FG000|Overall Study|Adverse Event|70
6904790|NCT00699374|10927403|FG001|Overall Study|Adverse Event|67
6904791|NCT00699374|10927402|FG000|Overall Study|Global deterioration of health status|7
6904792|NCT00699374|10927403|FG001|Overall Study|Global deterioration of health status|8
6904793|NCT00699374|10927402|FG000|Overall Study|Lost to Follow-up|3
6904794|NCT00699374|10927403|FG001|Overall Study|Lost to Follow-up|5
6904795|NCT00699374|10927402|FG000|Overall Study|Withdrawal by Subject|34
6904796|NCT00699374|10927403|FG001|Overall Study|Withdrawal by Subject|44
6904797|NCT00699374|10927402|FG000|Overall Study|Objective progression or relapse|281
6904798|NCT00699374|10927403|FG001|Overall Study|Objective progression or relapse|277
6904799|NCT00699374|10927402|FG000|Overall Study|Other|18
6904800|NCT00699374|10927403|FG001|Overall Study|Other|15
6904801|NCT00699374|10927402|FG000|Overall Study|Protocol Violation|2
6904802|NCT00699374|10927403|FG001|Overall Study|Protocol Violation|6
6904803|NCT00699374|10927402|FG000|Overall Study|Study terminated by sponsor|13
6904804|NCT00699374|10927403|FG001|Overall Study|Study terminated by sponsor|28
6904805|NCT00699374|10927402|FG000|Overall Study|Randomized but not treated|4
6904806|NCT00699374|10927403|FG001|Overall Study|Randomized but not treated|2
6904807|NCT00699374|10927402|FG000|Overall Study|Died 28 days after last dose|5
6904808|NCT00699374|10927403|FG001|Overall Study|Died 28 days after last dose|9
6973833|NCT01185171|11025927|FG000|Concurrent Chemo and Radiation Treatment|Death|3
6973834|NCT01185171|11025927|FG000|Maintenance|Elevated liver transaminases|3
6973835|NCT01185171|11025927|FG000|Maintenance|Rush|2
6973836|NCT01185171|11025927|FG000|Maintenance|Diarrhea|1
6973837|NCT01185171|11025927|FG000|Maintenance|Xerostomia|1
6973838|NCT01185171|11025927|FG000|Maintenance|Nausea|1
6973839|NCT01185171|11025927|FG000|Maintenance|Comorbid Illness|2
6973840|NCT01185171|11025927|FG000|Maintenance|Withdrawal by Subject|1
6973841|NCT01185171|11025927|FG000|Maintenance|Disease Recurrence|1
6973842|NCT01185249|11025931|FG000|Overall Study|Patients discharged or change in status|42
6973843|NCT01185288|11025938|FG000|Overall Study|Adverse Event|7
6973844|NCT01185288|11025939|FG001|Overall Study|Adverse Event|6
6973845|NCT01185288|11025938|FG000|Overall Study|Withdrawal by Subject|6
6973846|NCT01185288|11025939|FG001|Overall Study|Withdrawal by Subject|4
6973847|NCT01185288|11025938|FG000|Overall Study|Lost to Follow-up|2
6973848|NCT01185288|11025939|FG001|Overall Study|Lost to Follow-up|5
6973849|NCT01185288|11025938|FG000|Overall Study|Lack of Efficacy|2
6973850|NCT01185288|11025939|FG001|Overall Study|Lack of Efficacy|0
6973851|NCT01185288|11025938|FG000|Overall Study|Investigator discretion|1
6973852|NCT01185288|11025939|FG001|Overall Study|Investigator discretion|0
6973853|NCT01185288|11025938|FG000|Overall Study|Did not meet inclusion criteria|1
6973854|NCT01185288|11025939|FG001|Overall Study|Did not meet inclusion criteria|0
6973855|NCT01185288|11025938|FG000|Overall Study|Noncompliance|0
6973856|NCT01185288|11025939|FG001|Overall Study|Noncompliance|1
6973857|NCT01185301|11025949|FG000|Overall Study|Adverse Event|3
6973858|NCT01185301|11025950|FG001|Overall Study|Adverse Event|0
6973859|NCT01185301|11025951|FG002|Overall Study|Adverse Event|2
6973860|NCT01185301|11025952|FG003|Overall Study|Adverse Event|3
6973861|NCT01185301|11025949|FG000|Overall Study|Withdrawal by Subject|7
6973862|NCT01185301|11025950|FG001|Overall Study|Withdrawal by Subject|5
6973863|NCT01185301|11025951|FG002|Overall Study|Withdrawal by Subject|2
6973864|NCT01185301|11025952|FG003|Overall Study|Withdrawal by Subject|3
6973865|NCT01185301|11025949|FG000|Overall Study|Lost to Follow-up|2
6973866|NCT01185301|11025950|FG001|Overall Study|Lost to Follow-up|0
6973867|NCT01185301|11025951|FG002|Overall Study|Lost to Follow-up|0
6973868|NCT01185301|11025952|FG003|Overall Study|Lost to Follow-up|1
6973869|NCT01185301|11025949|FG000|Overall Study|Other Reason|3
6973870|NCT01185301|11025950|FG001|Overall Study|Other Reason|2
6973871|NCT01185301|11025951|FG002|Overall Study|Other Reason|2
6973872|NCT01185301|11025952|FG003|Overall Study|Other Reason|2
6973873|NCT01185340|11025965|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24
6973874|NCT01185340|11025966|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
6973875|NCT01185340|11025967|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
6973876|NCT01185340|11025968|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
6973877|NCT01185340|11025965|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6
6973878|NCT01185340|11025966|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
6973879|NCT01185340|11025967|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
6973880|NCT01185340|11025968|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
6973881|NCT01185340|11025965|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5
6973882|NCT01185340|11025966|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
6973883|NCT01185340|11025967|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
6973884|NCT01185340|11025968|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
6973885|NCT01185340|11025965|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
6973886|NCT01185340|11025966|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
6973887|NCT01185340|11025967|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
6973888|NCT01185340|11025968|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
6973889|NCT01185340|11025965|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16
6973890|NCT01185340|11025966|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
6973891|NCT01185340|11025967|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
6973892|NCT01185340|11025968|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
6973893|NCT01185340|11025965|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32
6973894|NCT01185340|11025966|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
6973895|NCT01185340|11025967|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
6973896|NCT01185340|11025968|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
6973897|NCT01185340|11025965|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3
6973898|NCT01185340|11025966|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
6973899|NCT01185340|11025967|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
6973900|NCT01185340|11025968|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
6973901|NCT01185340|11025965|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
6973902|NCT01185340|11025966|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
6973903|NCT01185340|11025967|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8
6973904|NCT01185340|11025968|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
6973905|NCT01185340|11025965|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
6973906|NCT01185340|11025966|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
6973907|NCT01185340|11025967|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7
6904809|NCT00699582|10927461|FG000|Overall Study|Adverse Event|4
6904810|NCT00699582|10927462|FG001|Overall Study|Adverse Event|11
6904811|NCT00699582|10927463|FG002|Overall Study|Adverse Event|23
6904812|NCT00699582|10927461|FG000|Overall Study|Withdrawal by Subject|6
6904813|NCT00699582|10927462|FG001|Overall Study|Withdrawal by Subject|7
6904814|NCT00699582|10927463|FG002|Overall Study|Withdrawal by Subject|4
6904815|NCT00699582|10927461|FG000|Overall Study|Lack of Efficacy|1
6904816|NCT00699582|10927462|FG001|Overall Study|Lack of Efficacy|0
6904817|NCT00699582|10927463|FG002|Overall Study|Lack of Efficacy|1
6904818|NCT00699582|10927461|FG000|Overall Study|Progressive Disease|1
6904819|NCT00699582|10927462|FG001|Overall Study|Progressive Disease|0
6904820|NCT00699582|10927463|FG002|Overall Study|Progressive Disease|0
6904821|NCT00699582|10927461|FG000|Overall Study|Administrative/Other|4
6904822|NCT00699582|10927462|FG001|Overall Study|Administrative/Other|3
6904823|NCT00699582|10927463|FG002|Overall Study|Administrative/Other|0
6904824|NCT00699582|10927461|FG000|Overall Study|Randomized, Not Treated|2
6904825|NCT00699582|10927462|FG001|Overall Study|Randomized, Not Treated|1
6904826|NCT00699582|10927463|FG002|Overall Study|Randomized, Not Treated|0
6904827|NCT00699608|10927471|FG000|First Intervention|Withdrawal by Subject|0
6904828|NCT00699608|10927472|FG001|First Intervention|Withdrawal by Subject|0
6904829|NCT00699608|10927473|FG002|First Intervention|Withdrawal by Subject|1
6904830|NCT00699608|10927474|FG003|First Intervention|Withdrawal by Subject|0
6904831|NCT00699608|10927475|FG004|First Intervention|Withdrawal by Subject|0
6904832|NCT00699608|10927476|FG005|First Intervention|Withdrawal by Subject|0
6904833|NCT00699608|10927471|FG000|First Intervention|Protocol Violation|0
6904834|NCT00699608|10927472|FG001|First Intervention|Protocol Violation|0
6904835|NCT00699608|10927473|FG002|First Intervention|Protocol Violation|0
6904836|NCT00699608|10927474|FG003|First Intervention|Protocol Violation|0
6904837|NCT00699608|10927475|FG004|First Intervention|Protocol Violation|1
6904838|NCT00699608|10927476|FG005|First Intervention|Protocol Violation|0
6904839|NCT00699608|10927471|FG000|Second Intervention|Adverse Event|0
6904840|NCT00699608|10927472|FG001|Second Intervention|Adverse Event|0
6904841|NCT00699608|10927473|FG002|Second Intervention|Adverse Event|1
6904842|NCT00699608|10927474|FG003|Second Intervention|Adverse Event|0
6904843|NCT00699608|10927475|FG004|Second Intervention|Adverse Event|0
6904844|NCT00699608|10927476|FG005|Second Intervention|Adverse Event|0
6904845|NCT00699608|10927471|FG000|Second Intervention|Withdrawal by Subject|0
6904846|NCT00699608|10927472|FG001|Second Intervention|Withdrawal by Subject|0
6904847|NCT00699608|10927473|FG002|Second Intervention|Withdrawal by Subject|0
6904848|NCT00699608|10927474|FG003|Second Intervention|Withdrawal by Subject|1
6904849|NCT00699608|10927475|FG004|Second Intervention|Withdrawal by Subject|0
6904850|NCT00699608|10927476|FG005|Second Intervention|Withdrawal by Subject|0
6904851|NCT00699660|10927486|FG000|Overall Study|Lost to Follow-up|4
6904852|NCT00699660|10927487|FG001|Overall Study|Lost to Follow-up|2
6904853|NCT00699660|10927486|FG000|Overall Study|missing reports and recording failures|10
6904854|NCT00699660|10927487|FG001|Overall Study|missing reports and recording failures|6
6904855|NCT00699699|10927493|FG000|Overall Study|Adverse Event|36
6904856|NCT00699699|10927493|FG000|Overall Study|Individual different reasons|21
6904857|NCT00699751|10927499|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27
6904858|NCT00699751|10927500|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27
6904859|NCT00699751|10927499|FG000|Period 1: Without/Before Drug Switch|Death|28
6904860|NCT00699751|10927500|FG001|Period 1: Without/Before Drug Switch|Death|29
6904861|NCT00699751|10927499|FG000|Period 1: Without/Before Drug Switch|Subject Request|43
6904862|NCT00699751|10927500|FG001|Period 1: Without/Before Drug Switch|Subject Request|23
6904863|NCT00699751|10927499|FG000|Period 1: Without/Before Drug Switch|Other|30
6904864|NCT00699751|10927500|FG001|Period 1: Without/Before Drug Switch|Other|20
6904865|NCT00699751|10927499|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97
6904866|NCT00699751|10927500|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63
6904867|NCT00699751|10927499|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0
6904868|NCT00699751|10927500|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4
6904869|NCT00699751|10927499|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0
6904870|NCT00699751|10927500|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1
6904871|NCT00699751|10927499|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0
6904872|NCT00699751|10927500|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4
6904873|NCT00699816|10927518|FG000|Overall Study|Protocol Violation|1
6904874|NCT00699816|10927519|FG001|Overall Study|Protocol Violation|3
6904875|NCT00699907|10927528|FG000|Overall Study|Withdrawal by Subject|2
6904876|NCT00699907|10927529|FG001|Overall Study|Withdrawal by Subject|1
6904877|NCT00699907|10927530|FG002|Overall Study|Withdrawal by Subject|0
6904878|NCT00699907|10927528|FG000|Overall Study|No usable sample|0
6904879|NCT00699907|10927529|FG001|Overall Study|No usable sample|9
6904880|NCT00699907|10927530|FG002|Overall Study|No usable sample|8
6904881|NCT00699972|10927541|FG000|Overall Study|Adverse Event|7
6904882|NCT00699972|10927542|FG001|Overall Study|Adverse Event|9
6904883|NCT00699972|10927543|FG002|Overall Study|Adverse Event|24
6904884|NCT00699972|10927541|FG000|Overall Study|Lost to Follow-up|0
6904885|NCT00699972|10927542|FG001|Overall Study|Lost to Follow-up|2
6904886|NCT00699972|10927543|FG002|Overall Study|Lost to Follow-up|0
6904887|NCT00699972|10927541|FG000|Overall Study|Withdrawal by Subject|3
6904888|NCT00699972|10927542|FG001|Overall Study|Withdrawal by Subject|7
6904889|NCT00699972|10927543|FG002|Overall Study|Withdrawal by Subject|4
6904890|NCT00699972|10927541|FG000|Overall Study|Lack of Efficacy|2
6904891|NCT00699972|10927542|FG001|Overall Study|Lack of Efficacy|0
6904892|NCT00699972|10927543|FG002|Overall Study|Lack of Efficacy|2
6904893|NCT00699972|10927541|FG000|Overall Study|Administrative/Other|3
6904894|NCT00699972|10927542|FG001|Overall Study|Administrative/Other|1
6904895|NCT00699972|10927543|FG002|Overall Study|Administrative/Other|4
6904896|NCT00699972|10927541|FG000|Overall Study|Randomized, Not Treated|1
6904897|NCT00699972|10927542|FG001|Overall Study|Randomized, Not Treated|0
6904898|NCT00699972|10927543|FG002|Overall Study|Randomized, Not Treated|1
6904899|NCT00699998|10927555|FG000|Overall Study|Withdrawal by Subject|194
6904900|NCT00699998|10927556|FG001|Overall Study|Withdrawal by Subject|83
6904901|NCT00699998|10927557|FG002|Overall Study|Withdrawal by Subject|202
6904902|NCT00699998|10927558|FG003|Overall Study|Withdrawal by Subject|80
6904903|NCT00699998|10927555|FG000|Overall Study|Physician Decision|3
6904904|NCT00699998|10927556|FG001|Overall Study|Physician Decision|2
6904905|NCT00699998|10927557|FG002|Overall Study|Physician Decision|1
6904906|NCT00699998|10927558|FG003|Overall Study|Physician Decision|1
6904907|NCT00699998|10927555|FG000|Overall Study|Lost to Follow-up|2
6904908|NCT00699998|10927556|FG001|Overall Study|Lost to Follow-up|1
6904909|NCT00699998|10927557|FG002|Overall Study|Lost to Follow-up|3
6904910|NCT00699998|10927558|FG003|Overall Study|Lost to Follow-up|1
6904911|NCT00700011|10927575|FG000|Overall Study|Death|0
6904912|NCT00700011|10927576|FG001|Overall Study|Death|1
6904913|NCT00700102|10927617|FG000|Overall Study|Died|394
6904914|NCT00700102|10927618|FG001|Overall Study|Died|385
6904915|NCT00700102|10927617|FG000|Overall Study|Lost to Follow-up|8
6904916|NCT00700102|10927618|FG001|Overall Study|Lost to Follow-up|10
6904917|NCT00700115|10927626|FG000|Overall Study|Withdrawal by Subject|1
6904918|NCT00700115|10927627|FG001|Overall Study|Withdrawal by Subject|0
6904919|NCT00700115|10927626|FG000|Overall Study|Lost to Follow-up|0
6904920|NCT00700115|10927627|FG001|Overall Study|Lost to Follow-up|1
6904921|NCT00700180|10927639|FG000|Overall Study|Death|99
6904922|NCT00700180|10927640|FG001|Overall Study|Death|114
6904923|NCT00700180|10927639|FG000|Overall Study|Alive on treatment|5
6904924|NCT00700180|10927640|FG001|Overall Study|Alive on treatment|3
6904925|NCT00700180|10927639|FG000|Overall Study|Alive in follow-up|46
6904926|NCT00700180|10927640|FG001|Overall Study|Alive in follow-up|27
6904927|NCT00700180|10927639|FG000|Overall Study|Lost to Follow-up|4
6904928|NCT00700180|10927640|FG001|Overall Study|Lost to Follow-up|5
6904929|NCT00700271|10927648|FG000|Overall Study|Adverse Event|4
6904930|NCT00700271|10927649|FG001|Overall Study|Adverse Event|6
6978726|NCT01214642|11032236|FG004|Overall Study|Withdrawal by Subject|0
6978727|NCT01214642|11032237|FG005|Overall Study|Withdrawal by Subject|0
6904931|NCT00700271|10927648|FG000|Overall Study|Protocol Violation|1
6904932|NCT00700271|10927649|FG001|Overall Study|Protocol Violation|0
6904933|NCT00700271|10927648|FG000|Overall Study|Administrative Reasons|1
6904934|NCT00700271|10927649|FG001|Overall Study|Administrative Reasons|0
6904935|NCT00700271|10927648|FG000|Overall Study|Withdrawal by Subject|6
6904936|NCT00700271|10927649|FG001|Overall Study|Withdrawal by Subject|4
6904937|NCT00700271|10927648|FG000|Overall Study|Lost to Follow-up|2
6904938|NCT00700271|10927649|FG001|Overall Study|Lost to Follow-up|2
6904939|NCT00700310|10927659|FG000|Overall Study|Adverse Event|6
6904940|NCT00700310|10927660|FG001|Overall Study|Adverse Event|10
6904941|NCT00700310|10927661|FG002|Overall Study|Adverse Event|5
6904942|NCT00700310|10927662|FG003|Overall Study|Adverse Event|11
6904943|NCT00700310|10927659|FG000|Overall Study|Lost to Follow-up|4
6904944|NCT00700310|10927660|FG001|Overall Study|Lost to Follow-up|1
6904945|NCT00700310|10927661|FG002|Overall Study|Lost to Follow-up|0
6904946|NCT00700310|10927662|FG003|Overall Study|Lost to Follow-up|1
6904947|NCT00700310|10927659|FG000|Overall Study|Withdrawal by Subject|8
6904948|NCT00700310|10927660|FG001|Overall Study|Withdrawal by Subject|9
6904949|NCT00700310|10927661|FG002|Overall Study|Withdrawal by Subject|8
6904950|NCT00700310|10927662|FG003|Overall Study|Withdrawal by Subject|8
6904951|NCT00700310|10927659|FG000|Overall Study|Lack of Efficacy|0
6904952|NCT00700310|10927660|FG001|Overall Study|Lack of Efficacy|3
6904953|NCT00700310|10927661|FG002|Overall Study|Lack of Efficacy|0
6904954|NCT00700310|10927662|FG003|Overall Study|Lack of Efficacy|1
6904955|NCT00700310|10927659|FG000|Overall Study|Administrative/Other|1
6904956|NCT00700310|10927660|FG001|Overall Study|Administrative/Other|3
6904957|NCT00700310|10927661|FG002|Overall Study|Administrative/Other|1
6904958|NCT00700310|10927662|FG003|Overall Study|Administrative/Other|3
6904959|NCT00700310|10927659|FG000|Overall Study|Randomized, Not Treated|2
6904960|NCT00700310|10927660|FG001|Overall Study|Randomized, Not Treated|0
6904961|NCT00700310|10927661|FG002|Overall Study|Randomized, Not Treated|2
6904962|NCT00700310|10927662|FG003|Overall Study|Randomized, Not Treated|2
6904963|NCT00700401|10927693|FG000|Overall Study|Detectable HCV RNA after Week 4|82
6904964|NCT00700401|10927693|FG000|Overall Study|Adverse Event|5
6904965|NCT00700401|10927693|FG000|Overall Study|Refused Treatment|2
6904966|NCT00700401|10927693|FG000|Overall Study|Lost to Follow-up|1
6904967|NCT00700401|10927693|FG000|Overall Study|Treatment never started|1
6904968|NCT00700401|10927693|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1
6904969|NCT00700401|10927693|FG000|Overall Study|Withdrawal by Subject|2
6904970|NCT00700427|10927697|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298
6904971|NCT00700427|10927698|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
6904972|NCT00700427|10927699|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
6904973|NCT00700427|10927700|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
6904974|NCT00700427|10927701|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
6904975|NCT00700427|10927697|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173
6904976|NCT00700427|10927698|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
6904977|NCT00700427|10927699|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
6904978|NCT00700427|10927700|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
6904979|NCT00700427|10927701|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
6904980|NCT00700427|10927697|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164
6904981|NCT00700427|10927698|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
6904982|NCT00700427|10927699|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
6904983|NCT00700427|10927700|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
6904984|NCT00700427|10927701|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
6904985|NCT00700427|10927697|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161
6904986|NCT00700427|10927698|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
6904987|NCT00700427|10927699|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
6904988|NCT00700427|10927700|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
6904989|NCT00700427|10927701|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
6904990|NCT00700427|10927697|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108
6904991|NCT00700427|10927698|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
6904992|NCT00700427|10927699|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
6904993|NCT00700427|10927700|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
6904994|NCT00700427|10927701|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
6904995|NCT00700427|10927697|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90
6904996|NCT00700427|10927698|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
6904997|NCT00700427|10927699|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
6904998|NCT00700427|10927700|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
6904999|NCT00700427|10927701|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
6905000|NCT00700427|10927697|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8
6905001|NCT00700427|10927698|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
6905002|NCT00700427|10927699|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
6905003|NCT00700427|10927700|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
6905004|NCT00700427|10927701|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
6905005|NCT00700427|10927697|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7
6905006|NCT00700427|10927698|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
6905007|NCT00700427|10927699|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
6905008|NCT00700427|10927700|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
6905009|NCT00700427|10927701|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
6905010|NCT00700427|10927697|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2
6905011|NCT00700427|10927698|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
6905012|NCT00700427|10927699|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
6905013|NCT00700427|10927700|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
6905014|NCT00700427|10927701|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
6905015|NCT00700427|10927697|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0
6905016|NCT00700427|10927698|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50
6905017|NCT00700427|10927699|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0
6905018|NCT00700427|10927700|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0
6905019|NCT00700427|10927701|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0
6905020|NCT00700427|10927697|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
6905021|NCT00700427|10927698|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162
6905022|NCT00700427|10927699|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
6905023|NCT00700427|10927700|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
6905024|NCT00700427|10927701|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
6905025|NCT00700427|10927697|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
6905026|NCT00700427|10927698|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81
6905027|NCT00700427|10927699|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
6905028|NCT00700427|10927700|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
6905029|NCT00700427|10927701|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
6905030|NCT00700427|10927697|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
6905031|NCT00700427|10927698|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56
6905032|NCT00700427|10927699|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
6905033|NCT00700427|10927700|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
6905034|NCT00700427|10927701|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
6905035|NCT00700427|10927697|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
6978728|NCT01214642|11032238|FG006|Overall Study|Withdrawal by Subject|0
6978729|NCT01214642|11032239|FG007|Overall Study|Withdrawal by Subject|0
6978730|NCT01214642|11032240|FG008|Overall Study|Withdrawal by Subject|3
6905036|NCT00700427|10927698|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49
6905037|NCT00700427|10927699|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
6905038|NCT00700427|10927700|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
6905039|NCT00700427|10927701|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
6905040|NCT00700427|10927697|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
6905041|NCT00700427|10927698|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41
6905042|NCT00700427|10927699|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
6905043|NCT00700427|10927700|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
6905044|NCT00700427|10927701|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
6905045|NCT00700427|10927697|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
6905046|NCT00700427|10927698|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32
6905047|NCT00700427|10927699|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
6905048|NCT00700427|10927700|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
6905049|NCT00700427|10927701|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
6905050|NCT00700427|10927697|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
6905051|NCT00700427|10927698|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3
6905052|NCT00700427|10927699|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
6905053|NCT00700427|10927700|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
6905054|NCT00700427|10927701|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
6905055|NCT00700427|10927697|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0
6905056|NCT00700427|10927698|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2
6905057|NCT00700427|10927699|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0
6905058|NCT00700427|10927700|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0
6905059|NCT00700427|10927701|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0
6905060|NCT00700427|10927697|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
6905061|NCT00700427|10927698|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5
6905062|NCT00700427|10927699|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
6905063|NCT00700427|10927700|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
6905064|NCT00700427|10927701|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
6905065|NCT00700427|10927697|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
6905066|NCT00700427|10927698|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
6905067|NCT00700427|10927699|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8
6905068|NCT00700427|10927700|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5
6905069|NCT00700427|10927701|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
6905070|NCT00700427|10927697|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
6905071|NCT00700427|10927698|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
6905072|NCT00700427|10927699|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25
6905073|NCT00700427|10927700|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34
6905074|NCT00700427|10927701|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
6905075|NCT00700427|10927697|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
6905076|NCT00700427|10927698|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
6905077|NCT00700427|10927699|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23
6905078|NCT00700427|10927700|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25
6905079|NCT00700427|10927701|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
6905080|NCT00700427|10927697|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
6905081|NCT00700427|10927698|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
6905082|NCT00700427|10927699|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19
6905083|NCT00700427|10927700|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9
6905084|NCT00700427|10927701|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
6905085|NCT00700427|10927697|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
6905086|NCT00700427|10927698|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
6905087|NCT00700427|10927699|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3
6905088|NCT00700427|10927700|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11
6905089|NCT00700427|10927701|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
6905090|NCT00700427|10927697|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
6905091|NCT00700427|10927698|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
6905092|NCT00700427|10927699|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
6905093|NCT00700427|10927700|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5
6905094|NCT00700427|10927701|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
6905095|NCT00700427|10927697|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
6905096|NCT00700427|10927698|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
6905097|NCT00700427|10927699|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
6905098|NCT00700427|10927700|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3
6905099|NCT00700427|10927701|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
6905100|NCT00700427|10927697|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0
6905101|NCT00700427|10927698|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0
6905102|NCT00700427|10927699|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1
6905103|NCT00700427|10927700|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1
6905104|NCT00700427|10927701|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0
6905105|NCT00700427|10927697|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
6905106|NCT00700427|10927698|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
6905107|NCT00700427|10927699|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2
6905108|NCT00700427|10927700|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
6905109|NCT00700427|10927701|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
6905110|NCT00700427|10927697|FG000|Study Period 3B (Randomized Withdrawal)|Death|0
6905111|NCT00700427|10927698|FG001|Study Period 3B (Randomized Withdrawal)|Death|0
6905112|NCT00700427|10927699|FG002|Study Period 3B (Randomized Withdrawal)|Death|1
6905113|NCT00700427|10927700|FG003|Study Period 3B (Randomized Withdrawal)|Death|0
6905114|NCT00700427|10927701|FG004|Study Period 3B (Randomized Withdrawal)|Death|0
6905115|NCT00700427|10927697|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0
6905116|NCT00700427|10927698|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0
6905117|NCT00700427|10927699|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0
6905118|NCT00700427|10927700|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0
6905119|NCT00700427|10927701|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16
6905120|NCT00700427|10927697|FG000|Study Period 4 (Open-Label Extension)|Death|0
6905121|NCT00700427|10927698|FG001|Study Period 4 (Open-Label Extension)|Death|0
6905122|NCT00700427|10927699|FG002|Study Period 4 (Open-Label Extension)|Death|0
6905123|NCT00700427|10927700|FG003|Study Period 4 (Open-Label Extension)|Death|0
6905124|NCT00700427|10927701|FG004|Study Period 4 (Open-Label Extension)|Death|1
6905125|NCT00700427|10927697|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0
6905126|NCT00700427|10927698|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0
6905127|NCT00700427|10927699|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0
6905128|NCT00700427|10927700|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0
6905129|NCT00700427|10927701|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12
6905130|NCT00700427|10927697|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
6905131|NCT00700427|10927698|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
6905132|NCT00700427|10927699|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
6905133|NCT00700427|10927700|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
6905134|NCT00700427|10927701|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38
6905135|NCT00700427|10927697|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0
6905136|NCT00700427|10927698|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0
6905137|NCT00700427|10927699|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0
6905138|NCT00700427|10927700|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0
6905139|NCT00700427|10927701|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2
6905140|NCT00700427|10927697|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
6905141|NCT00700427|10927698|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
6905142|NCT00700427|10927699|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
6905143|NCT00700427|10927700|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
6905144|NCT00700427|10927701|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2
6905145|NCT00700427|10927697|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
6905146|NCT00700427|10927698|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
6905147|NCT00700427|10927699|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
6905148|NCT00700427|10927700|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
6905149|NCT00700427|10927701|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1
6905150|NCT00700427|10927697|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
6905151|NCT00700427|10927698|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
6905152|NCT00700427|10927699|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
6905153|NCT00700427|10927700|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
6905154|NCT00700427|10927701|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11
6905155|NCT00700427|10927697|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
6905156|NCT00700427|10927698|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
6905157|NCT00700427|10927699|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
6905158|NCT00700427|10927700|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
6905159|NCT00700427|10927701|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1
6905160|NCT00700570|10927715|FG000|Overall Study|Adverse Event|2
6905161|NCT00700570|10927716|FG001|Overall Study|Adverse Event|6
6905162|NCT00700570|10927715|FG000|Overall Study|Discretion of Investigator or Sponsor|0
6905163|NCT00700570|10927716|FG001|Overall Study|Discretion of Investigator or Sponsor|3
6905164|NCT00700570|10927715|FG000|Overall Study|Disease Progression|8
6905165|NCT00700570|10927716|FG001|Overall Study|Disease Progression|11
6905166|NCT00700570|10927715|FG000|Overall Study|Withdrawal by Subject|1
6905167|NCT00700570|10927716|FG001|Overall Study|Withdrawal by Subject|6
6905168|NCT00700622|10927724|FG000|Overall Study|Adverse Event|4
6905169|NCT00700622|10927725|FG001|Overall Study|Adverse Event|0
6905170|NCT00700622|10927724|FG000|Overall Study|Lost to Follow-up|0
6905171|NCT00700622|10927725|FG001|Overall Study|Lost to Follow-up|1
6905172|NCT00700622|10927724|FG000|Overall Study|Physician Decision|2
6905173|NCT00700622|10927725|FG001|Overall Study|Physician Decision|1
6905174|NCT00700622|10927724|FG000|Overall Study|Protocol Violation|0
6905175|NCT00700622|10927725|FG001|Overall Study|Protocol Violation|1
6905176|NCT00700622|10927724|FG000|Overall Study|Withdrawal by Subject|4
6905177|NCT00700622|10927725|FG001|Overall Study|Withdrawal by Subject|1
6905178|NCT00700622|10927724|FG000|Overall Study|Other|3
6905179|NCT00700622|10927725|FG001|Overall Study|Other|1
6905180|NCT00700635|10927734|FG000|Overall Study|Adverse Event|1
6905181|NCT00700635|10927735|FG001|Overall Study|Adverse Event|0
6905182|NCT00700635|10927736|FG002|Overall Study|Adverse Event|0
6905183|NCT00700635|10927734|FG000|Overall Study|Lost to Follow-up|1
6905184|NCT00700635|10927735|FG001|Overall Study|Lost to Follow-up|3
6905185|NCT00700635|10927736|FG002|Overall Study|Lost to Follow-up|0
6905186|NCT00700635|10927734|FG000|Overall Study|Protocol Violation|2
6905187|NCT00700635|10927735|FG001|Overall Study|Protocol Violation|2
6905188|NCT00700635|10927736|FG002|Overall Study|Protocol Violation|0
6905189|NCT00700635|10927734|FG000|Overall Study|Withdrawal by Subject|7
6905190|NCT00700635|10927735|FG001|Overall Study|Withdrawal by Subject|3
6905191|NCT00700635|10927736|FG002|Overall Study|Withdrawal by Subject|1
6905192|NCT00700713|10927747|FG000|Overall Study|Protocol Violation|1
6905193|NCT00700713|10927748|FG001|Overall Study|Protocol Violation|0
6905194|NCT00700713|10927749|FG002|Overall Study|Protocol Violation|1
6905195|NCT00700713|10927747|FG000|Overall Study|Withdrawal by Subject|0
6905196|NCT00700713|10927748|FG001|Overall Study|Withdrawal by Subject|0
6905197|NCT00700713|10927749|FG002|Overall Study|Withdrawal by Subject|1
6905198|NCT00700739|10927759|FG000|Overall Study|Lost to Follow-up|4
6905199|NCT00700739|10927760|FG001|Overall Study|Lost to Follow-up|4
6905200|NCT00700752|10927767|FG000|First Intervention|Withdrawal by Subject|0
6905201|NCT00700752|10927768|FG001|First Intervention|Withdrawal by Subject|2
6905202|NCT00700804|10927776|FG000|Overall Study|Withdrawal by Subject|1
6905203|NCT00700804|10927777|FG001|Overall Study|Withdrawal by Subject|2
6905204|NCT00700804|10927776|FG000|Overall Study|Protocol Violation|1
6905205|NCT00700804|10927777|FG001|Overall Study|Protocol Violation|1
6905206|NCT00700804|10927776|FG000|Overall Study|Loose Stools|1
6905207|NCT00700804|10927777|FG001|Overall Study|Loose Stools|1
6905208|NCT00700817|10927788|FG000|Week 0-26 (Main Period)|Adverse Event|14
6905209|NCT00700817|10927789|FG001|Week 0-26 (Main Period)|Adverse Event|15
6905210|NCT00700817|10927790|FG002|Week 0-26 (Main Period)|Adverse Event|4
6905211|NCT00700817|10927791|FG003|Week 0-26 (Main Period)|Adverse Event|0
6905212|NCT00700817|10927792|FG004|Week 0-26 (Main Period)|Adverse Event|0
6905213|NCT00700817|10927788|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4
6905214|NCT00700817|10927789|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0
6905215|NCT00700817|10927790|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4
6905216|NCT00700817|10927791|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0
6905217|NCT00700817|10927792|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0
6905218|NCT00700817|10927788|FG000|Week 0-26 (Main Period)|Protocol Violation|14
6905219|NCT00700817|10927789|FG001|Week 0-26 (Main Period)|Protocol Violation|4
6905220|NCT00700817|10927790|FG002|Week 0-26 (Main Period)|Protocol Violation|4
6905221|NCT00700817|10927791|FG003|Week 0-26 (Main Period)|Protocol Violation|0
6905222|NCT00700817|10927792|FG004|Week 0-26 (Main Period)|Protocol Violation|0
6905223|NCT00700817|10927788|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10
6905224|NCT00700817|10927789|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7
6905225|NCT00700817|10927790|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5
6905226|NCT00700817|10927791|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0
6905227|NCT00700817|10927792|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0
6905228|NCT00700817|10927788|FG000|Week 0-26 (Main Period)|Unclassified|14
6905229|NCT00700817|10927789|FG001|Week 0-26 (Main Period)|Unclassified|4
6905230|NCT00700817|10927790|FG002|Week 0-26 (Main Period)|Unclassified|8
6905231|NCT00700817|10927791|FG003|Week 0-26 (Main Period)|Unclassified|0
6905232|NCT00700817|10927792|FG004|Week 0-26 (Main Period)|Unclassified|0
6905233|NCT00700817|10927788|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5
6905234|NCT00700817|10927789|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10
6905235|NCT00700817|10927790|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3
6905236|NCT00700817|10927791|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0
6905237|NCT00700817|10927792|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0
6905238|NCT00700817|10927788|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3
6905239|NCT00700817|10927789|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2
6905240|NCT00700817|10927790|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2
6905241|NCT00700817|10927791|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0
6905242|NCT00700817|10927792|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0
6905243|NCT00700817|10927788|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2
6905244|NCT00700817|10927789|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3
6905245|NCT00700817|10927790|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7
6905246|NCT00700817|10927791|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
6905247|NCT00700817|10927792|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
6905248|NCT00700817|10927788|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6
6905249|NCT00700817|10927789|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8
6905250|NCT00700817|10927790|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2
6905251|NCT00700817|10927791|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
6905252|NCT00700817|10927792|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
6905253|NCT00700817|10927788|FG000|Week 26-52 (Extension Period 1)|Unclassified|4
6905254|NCT00700817|10927789|FG001|Week 26-52 (Extension Period 1)|Unclassified|3
6905255|NCT00700817|10927790|FG002|Week 26-52 (Extension Period 1)|Unclassified|1
6905256|NCT00700817|10927791|FG003|Week 26-52 (Extension Period 1)|Unclassified|0
6905257|NCT00700817|10927792|FG004|Week 26-52 (Extension Period 1)|Unclassified|0
6905258|NCT00700817|10927788|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0
6905259|NCT00700817|10927789|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3
6905260|NCT00700817|10927790|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0
6905261|NCT00700817|10927791|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6
6905262|NCT00700817|10927792|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0
6905263|NCT00700817|10927788|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1
6905264|NCT00700817|10927789|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2
6905265|NCT00700817|10927790|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0
6905266|NCT00700817|10927791|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1
6905267|NCT00700817|10927792|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1
6905268|NCT00700817|10927788|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
6905269|NCT00700817|10927789|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
6905270|NCT00700817|10927790|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
6905271|NCT00700817|10927791|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
6905272|NCT00700817|10927792|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
6905273|NCT00700817|10927788|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4
6905274|NCT00700817|10927789|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
6905275|NCT00700817|10927790|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0
6905276|NCT00700817|10927791|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1
6905277|NCT00700817|10927792|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
6905278|NCT00700817|10927788|FG000|Week 52-78 (Extension Period 2)|Unclassified|2
6905279|NCT00700817|10927789|FG001|Week 52-78 (Extension Period 2)|Unclassified|4
6905280|NCT00700817|10927790|FG002|Week 52-78 (Extension Period 2)|Unclassified|0
6905281|NCT00700817|10927791|FG003|Week 52-78 (Extension Period 2)|Unclassified|0
6905282|NCT00700817|10927792|FG004|Week 52-78 (Extension Period 2)|Unclassified|1
6905286|NCT00700999|10927817|FG000|Overall Study|Lost to Follow-up|7
6905287|NCT00700999|10927818|FG001|Overall Study|Lost to Follow-up|7
6905288|NCT00700999|10927817|FG000|Overall Study|Excluded - did not meet study criteria|0
6905289|NCT00700999|10927818|FG001|Overall Study|Excluded - did not meet study criteria|1
6905290|NCT00700999|10927817|FG000|Overall Study|Withdrawal by Subject|8
6905291|NCT00700999|10927818|FG001|Overall Study|Withdrawal by Subject|1
6905292|NCT00701038|10927826|FG000|Overall Study|study amended pilot group of patients|4
6905293|NCT00701038|10927827|FG001|Overall Study|study amended pilot group of patients|4
6905294|NCT00701051|10927835|FG000|Screening|Failed Screening|40
6905295|NCT00701051|10927836|FG001|Screening|Failed Screening|0
6905296|NCT00701051|10927837|FG002|Screening|Failed Screening|0
6905297|NCT00701051|10927835|FG000|Screening|Time conflicts|19
6905298|NCT00701051|10927836|FG001|Screening|Time conflicts|0
6905299|NCT00701051|10927837|FG002|Screening|Time conflicts|0
6905300|NCT00701051|10927835|FG000|Exercise Intervention|time conflict; non-study related illness|0
6905301|NCT00701051|10927836|FG001|Exercise Intervention|time conflict; non-study related illness|5
6905302|NCT00701051|10927837|FG002|Exercise Intervention|time conflict; non-study related illness|3
6905303|NCT00701064|10927845|FG000|Overall Study|Protocol Violation|1
6905304|NCT00701064|10927846|FG001|Overall Study|Protocol Violation|1
6905305|NCT00701064|10927845|FG000|Overall Study|Withdrawal by Subject|1
6905306|NCT00701064|10927846|FG001|Overall Study|Withdrawal by Subject|1
6905307|NCT00701064|10927845|FG000|Overall Study|initiated other PTSD treatment|2
6905308|NCT00701064|10927846|FG001|Overall Study|initiated other PTSD treatment|2
6905309|NCT00701090|10927854|FG000|Overall Study|Adverse Event|11
6905310|NCT00701090|10927855|FG001|Overall Study|Adverse Event|2
6905311|NCT00701090|10927854|FG000|Overall Study|Death|0
6905312|NCT00701090|10927855|FG001|Overall Study|Death|1
6905313|NCT00701090|10927854|FG000|Overall Study|Lack of Efficacy|5
6905314|NCT00701090|10927855|FG001|Overall Study|Lack of Efficacy|4
6905315|NCT00701090|10927854|FG000|Overall Study|Lost to Follow-up|9
6905316|NCT00701090|10927855|FG001|Overall Study|Lost to Follow-up|9
6905317|NCT00701090|10927854|FG000|Overall Study|Physician Decision|3
6905318|NCT00701090|10927855|FG001|Overall Study|Physician Decision|4
6905319|NCT00701090|10927854|FG000|Overall Study|Protocol Violation|2
6905320|NCT00701090|10927855|FG001|Overall Study|Protocol Violation|3
6905321|NCT00701090|10927854|FG000|Overall Study|Withdrawal by Subject|11
6905322|NCT00701090|10927855|FG001|Overall Study|Withdrawal by Subject|16
6905323|NCT00701090|10927854|FG000|Overall Study|Other|7
6905324|NCT00701090|10927855|FG001|Overall Study|Other|12
6905325|NCT00701103|10927872|FG000|Overall Study|Adverse Event|0
6905326|NCT00701103|10927873|FG001|Overall Study|Adverse Event|0
6905327|NCT00701103|10927874|FG002|Overall Study|Adverse Event|1
6905328|NCT00701103|10927875|FG003|Overall Study|Adverse Event|1
6905329|NCT00701103|10927876|FG004|Overall Study|Adverse Event|0
6905330|NCT00701103|10927877|FG005|Overall Study|Adverse Event|1
6905331|NCT00701103|10927878|FG006|Overall Study|Adverse Event|1
6905332|NCT00701103|10927879|FG007|Overall Study|Adverse Event|0
6905333|NCT00701103|10927880|FG008|Overall Study|Adverse Event|0
6905334|NCT00701103|10927881|FG009|Overall Study|Adverse Event|2
6905335|NCT00701103|10927882|FG010|Overall Study|Adverse Event|0
6905336|NCT00701103|10927872|FG000|Overall Study|Progressive Disease|5
6905337|NCT00701103|10927873|FG001|Overall Study|Progressive Disease|2
6905338|NCT00701103|10927874|FG002|Overall Study|Progressive Disease|6
6905339|NCT00701103|10927875|FG003|Overall Study|Progressive Disease|5
6905340|NCT00701103|10927876|FG004|Overall Study|Progressive Disease|6
6905341|NCT00701103|10927877|FG005|Overall Study|Progressive Disease|5
6905342|NCT00701103|10927878|FG006|Overall Study|Progressive Disease|7
6905343|NCT00701103|10927879|FG007|Overall Study|Progressive Disease|7
6905344|NCT00701103|10927880|FG008|Overall Study|Progressive Disease|8
6905345|NCT00701103|10927881|FG009|Overall Study|Progressive Disease|8
6905346|NCT00701103|10927882|FG010|Overall Study|Progressive Disease|11
6905347|NCT00701103|10927872|FG000|Overall Study|Withdrawal by Subject|0
6905348|NCT00701103|10927873|FG001|Overall Study|Withdrawal by Subject|1
6905349|NCT00701103|10927874|FG002|Overall Study|Withdrawal by Subject|1
6905350|NCT00701103|10927875|FG003|Overall Study|Withdrawal by Subject|0
6905351|NCT00701103|10927876|FG004|Overall Study|Withdrawal by Subject|0
6905352|NCT00701103|10927877|FG005|Overall Study|Withdrawal by Subject|0
6905353|NCT00701103|10927878|FG006|Overall Study|Withdrawal by Subject|0
6905354|NCT00701103|10927879|FG007|Overall Study|Withdrawal by Subject|0
6905355|NCT00701103|10927880|FG008|Overall Study|Withdrawal by Subject|0
6905356|NCT00701103|10927881|FG009|Overall Study|Withdrawal by Subject|0
6905357|NCT00701103|10927882|FG010|Overall Study|Withdrawal by Subject|0
6905358|NCT00701103|10927872|FG000|Overall Study|Other|0
6905359|NCT00701103|10927873|FG001|Overall Study|Other|0
6905360|NCT00701103|10927874|FG002|Overall Study|Other|0
6905361|NCT00701103|10927875|FG003|Overall Study|Other|0
6905362|NCT00701103|10927876|FG004|Overall Study|Other|0
6905363|NCT00701103|10927877|FG005|Overall Study|Other|0
6905364|NCT00701103|10927878|FG006|Overall Study|Other|0
6905365|NCT00701103|10927879|FG007|Overall Study|Other|0
6905366|NCT00701103|10927880|FG008|Overall Study|Other|1
6905367|NCT00701103|10927881|FG009|Overall Study|Other|1
6905368|NCT00701103|10927882|FG010|Overall Study|Other|0
6905369|NCT00701129|10927910|FG000|Overall Study|Death|2
6905370|NCT00701311|10927914|FG000|Overall Study|Lack of Efficacy|3
6905371|NCT00701311|10927914|FG000|Overall Study|Adverse Event|3
6905372|NCT00701311|10927914|FG000|Overall Study|Withdrawal by Subject|2
6905373|NCT00701363|10927922|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4
6905374|NCT00701363|10927923|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
6905375|NCT00701363|10927924|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
6905376|NCT00701363|10927925|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
6905377|NCT00701363|10927922|FG000|Treatment Phase 1|Does not meet entry Criteria|1
6905378|NCT00701363|10927923|FG001|Treatment Phase 1|Does not meet entry Criteria|0
6905379|NCT00701363|10927924|FG002|Treatment Phase 1|Does not meet entry Criteria|0
6905380|NCT00701363|10927925|FG003|Treatment Phase 1|Does not meet entry Criteria|0
6905381|NCT00701363|10927922|FG000|Treatment Phase 1|Adverse Event|7
6905382|NCT00701363|10927923|FG001|Treatment Phase 1|Adverse Event|0
6905383|NCT00701363|10927924|FG002|Treatment Phase 1|Adverse Event|0
6905384|NCT00701363|10927925|FG003|Treatment Phase 1|Adverse Event|0
6905385|NCT00701363|10927922|FG000|Treatment Phase 1|Protocol Violation|1
6905386|NCT00701363|10927923|FG001|Treatment Phase 1|Protocol Violation|0
6905387|NCT00701363|10927924|FG002|Treatment Phase 1|Protocol Violation|0
6905388|NCT00701363|10927925|FG003|Treatment Phase 1|Protocol Violation|0
6905389|NCT00701363|10927922|FG000|Treatment Phase 1|Withdrawal by Subject|5
6905390|NCT00701363|10927923|FG001|Treatment Phase 1|Withdrawal by Subject|0
6905391|NCT00701363|10927924|FG002|Treatment Phase 1|Withdrawal by Subject|0
6905392|NCT00701363|10927925|FG003|Treatment Phase 1|Withdrawal by Subject|0
6905393|NCT00701363|10927922|FG000|Treatment Phase 1|Lack of Efficacy|1
6905394|NCT00701363|10927923|FG001|Treatment Phase 1|Lack of Efficacy|0
6905395|NCT00701363|10927924|FG002|Treatment Phase 1|Lack of Efficacy|0
6905396|NCT00701363|10927925|FG003|Treatment Phase 1|Lack of Efficacy|0
6905397|NCT00701363|10927922|FG000|Treatment Phase 2|Adverse Event|0
6905398|NCT00701363|10927923|FG001|Treatment Phase 2|Adverse Event|0
6905399|NCT00701363|10927924|FG002|Treatment Phase 2|Adverse Event|1
6905400|NCT00701363|10927925|FG003|Treatment Phase 2|Adverse Event|0
6905401|NCT00701363|10927922|FG000|Treatment Phase 2|Withdrawal by Subject|0
6905402|NCT00701363|10927923|FG001|Treatment Phase 2|Withdrawal by Subject|0
6905403|NCT00701363|10927924|FG002|Treatment Phase 2|Withdrawal by Subject|1
6905404|NCT00701363|10927925|FG003|Treatment Phase 2|Withdrawal by Subject|0
6905405|NCT00701415|10927969|FG000|Overall Study|Adverse Event|0
6905406|NCT00701415|10927970|FG001|Overall Study|Adverse Event|1
6905407|NCT00701415|10927969|FG000|Overall Study|Social/family issues and needle phobia|1
6905408|NCT00701415|10927970|FG001|Overall Study|Social/family issues and needle phobia|0
6905409|NCT00701441|10927978|FG000|Overall Study|failure in cpap compliance|0
6905410|NCT00701441|10927979|FG001|Overall Study|failure in cpap compliance|4
6905411|NCT00701558|10927989|FG000|Overall Study|Death|7
6905412|NCT00701558|10927989|FG000|Overall Study|Lost to Follow-up|8
6905413|NCT00701662|10928001|FG000|Overall Study|Lack of Efficacy|1
6905414|NCT00701701|10928020|FG000|Overall Study|Withdrawal by Subject|0
6905415|NCT00701701|10928021|FG001|Overall Study|Withdrawal by Subject|1
6905416|NCT00701701|10928020|FG000|Overall Study|Adverse Event|0
6905417|NCT00701701|10928021|FG001|Overall Study|Adverse Event|1
6905418|NCT00701727|10928041|FG000|First Treatment Period|Adverse Event|0
6905419|NCT00701727|10928042|FG001|First Treatment Period|Adverse Event|0
6905420|NCT00701727|10928041|FG000|First Treatment Period|Withdrawal by Subject|1
6905421|NCT00701727|10928042|FG001|First Treatment Period|Withdrawal by Subject|0
6905422|NCT00701727|10928041|FG000|First Treatment Period|sponsor decision|0
6905423|NCT00701727|10928042|FG001|First Treatment Period|sponsor decision|1
6905424|NCT00701727|10928041|FG000|First Treatment Period|Lost to Follow-up|0
6905425|NCT00701727|10928042|FG001|First Treatment Period|Lost to Follow-up|1
6905426|NCT00701727|10928041|FG000|Second Treatment Period|Withdrawal by Subject|2
6905427|NCT00701727|10928042|FG001|Second Treatment Period|Withdrawal by Subject|0
6905428|NCT00701779|10928048|FG000|Overall Study|Adverse Event|6
6905429|NCT00701779|10928048|FG000|Overall Study|Lost to Follow-up|1
6905430|NCT00701779|10928048|FG000|Overall Study|Withdrawal by Subject|2
6905431|NCT00701805|10928056|FG000|Overall Study|Withdrawal by Subject|3
6905432|NCT00701805|10928057|FG001|Overall Study|Withdrawal by Subject|1
6905433|NCT00701805|10928058|FG002|Overall Study|Withdrawal by Subject|4
6905434|NCT00701805|10928059|FG003|Overall Study|Withdrawal by Subject|3
6905435|NCT00701805|10928056|FG000|Overall Study|Adverse Event|0
6905436|NCT00701805|10928057|FG001|Overall Study|Adverse Event|1
6905437|NCT00701805|10928058|FG002|Overall Study|Adverse Event|1
6905438|NCT00701805|10928059|FG003|Overall Study|Adverse Event|0
6905439|NCT00701805|10928056|FG000|Overall Study|Missed 7 consecutive doses|0
6905440|NCT00701805|10928057|FG001|Overall Study|Missed 7 consecutive doses|1
6905441|NCT00701805|10928058|FG002|Overall Study|Missed 7 consecutive doses|0
6905442|NCT00701805|10928059|FG003|Overall Study|Missed 7 consecutive doses|0
6905443|NCT00701805|10928056|FG000|Overall Study|Admitted to hospital for 2 weeks|0
6905444|NCT00701805|10928057|FG001|Overall Study|Admitted to hospital for 2 weeks|0
6905445|NCT00701805|10928058|FG002|Overall Study|Admitted to hospital for 2 weeks|1
6905446|NCT00701805|10928059|FG003|Overall Study|Admitted to hospital for 2 weeks|0
6905447|NCT00701805|10928056|FG000|Overall Study|Physician decision, change of therapy|0
6905448|NCT00701805|10928057|FG001|Overall Study|Physician decision, change of therapy|0
6905449|NCT00701805|10928058|FG002|Overall Study|Physician decision, change of therapy|0
6905450|NCT00701805|10928059|FG003|Overall Study|Physician decision, change of therapy|1
6905451|NCT00701805|10928056|FG000|Overall Study|Difficult to travel to dialysis site|0
6905452|NCT00701805|10928057|FG001|Overall Study|Difficult to travel to dialysis site|0
6905453|NCT00701805|10928058|FG002|Overall Study|Difficult to travel to dialysis site|1
6905454|NCT00701805|10928059|FG003|Overall Study|Difficult to travel to dialysis site|0
6905455|NCT00701805|10928056|FG000|Overall Study|Resumption criteria were not met|0
6905456|NCT00701805|10928057|FG001|Overall Study|Resumption criteria were not met|1
6905457|NCT00701805|10928058|FG002|Overall Study|Resumption criteria were not met|0
6905458|NCT00701805|10928059|FG003|Overall Study|Resumption criteria were not met|0
6905459|NCT00702052|10928087|FG000|Overall Study|Adverse Event|23
6905460|NCT00702052|10928087|FG000|Overall Study|Disease Progression|30
6905461|NCT00702052|10928087|FG000|Overall Study|Withdrawal by Subject|5
6905462|NCT00702143|10928094|FG000|Overall Study|Lost to Follow-up|0
6905463|NCT00702143|10928095|FG001|Overall Study|Lost to Follow-up|0
6905464|NCT00702143|10928096|FG002|Overall Study|Lost to Follow-up|1
6905465|NCT00702208|10928102|FG000|Overall Study|Lost to Follow-up|28
6905466|NCT00702208|10928102|FG000|Overall Study|Did not self-lavage|1
6905467|NCT00702208|10928102|FG000|Overall Study|Unsatisfactory colposcopy|2
6905468|NCT00702221|10928109|FG000|Overall Study|Adverse Event|4
6905469|NCT00702221|10928110|FG001|Overall Study|Adverse Event|3
6905470|NCT00702325|10928125|FG000|Overall Study|Adverse Event|1
6905471|NCT00702325|10928126|FG001|Overall Study|Adverse Event|0
6905472|NCT00702325|10928125|FG000|Overall Study|Withdrawal by Subject|7
6905473|NCT00702325|10928126|FG001|Overall Study|Withdrawal by Subject|7
6905474|NCT00702325|10928125|FG000|Overall Study|Lost to Follow-up|3
6905475|NCT00702325|10928126|FG001|Overall Study|Lost to Follow-up|4
6905476|NCT00702325|10928125|FG000|Overall Study|Incorrect enrollment|5
6905477|NCT00702325|10928126|FG001|Overall Study|Incorrect enrollment|7
6905478|NCT00702325|10928125|FG000|Overall Study|Developed study discontinuation criteria|18
6905479|NCT00702325|10928126|FG001|Overall Study|Developed study discontinuation criteria|28
6905480|NCT00702325|10928125|FG000|Overall Study|Severe noncompliance to protocol|3
6905481|NCT00702325|10928126|FG001|Overall Study|Severe noncompliance to protocol|3
6905482|NCT00702325|10928125|FG000|Overall Study|Termination due to lab results|1
6905483|NCT00702325|10928126|FG001|Overall Study|Termination due to lab results|0
6905484|NCT00702325|10928125|FG000|Overall Study|Didn't follow study medication dosage|0
6905485|NCT00702325|10928126|FG001|Overall Study|Didn't follow study medication dosage|2
6905486|NCT00702325|10928125|FG000|Overall Study|Withdrew consent|0
6905487|NCT00702325|10928126|FG001|Overall Study|Withdrew consent|1
6905488|NCT00702325|10928125|FG000|Overall Study|Incorrectly Discontinued|0
6905489|NCT00702325|10928126|FG001|Overall Study|Incorrectly Discontinued|1
6905490|NCT00702403|10928150|FG000|From Consent to Engraftment|Progressive leukemia|6
6905491|NCT00702403|10928150|FG000|From Consent to Engraftment|Critically ill|2
6905492|NCT00702403|10928150|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2
6905493|NCT00702403|10928150|FG000|From Consent to Engraftment|Myocardial infarction|1
6905494|NCT00702403|10928150|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4
6905495|NCT00702403|10928150|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2
6905496|NCT00702403|10928150|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11
6905497|NCT00702403|10928150|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4
6905498|NCT00702403|10928150|FG000|From Engraftment to Study Completion|Non-compliance|2
6905499|NCT00702403|10928150|FG000|From Engraftment to Study Completion|Adenocarcinoma|1
6905500|NCT00702403|10928150|FG000|From Engraftment to Study Completion|Liver GVHD|1
6905501|NCT00702403|10928150|FG000|From Engraftment to Study Completion|Suicide|1
6905502|NCT00702403|10928150|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1
6905503|NCT00702403|10928150|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1
6905504|NCT00702403|10928150|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5
6905505|NCT00702507|10928166|FG000|Initial Treatment Phase|Adverse Event|2
6905506|NCT00702507|10928166|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3
6905507|NCT00702507|10928166|FG000|Initial Treatment Phase|Lost to Follow-up|2
6905508|NCT00702507|10928166|FG000|Initial Treatment Phase|Negative Candida Culture|34
6905509|NCT00702507|10928166|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1
6905510|NCT00702507|10928166|FG000|Follow-up Phase|Protocol Violation|2
6905511|NCT00702507|10928166|FG000|Follow-up Phase|Lost to Follow-up|23
6905512|NCT00702507|10928166|FG000|Follow-up Phase|Late Enrollment|1
6905513|NCT00702650|10928171|FG000|Overall Study|Withdrawal by Subject|9
6905514|NCT00702650|10928171|FG000|Overall Study|Non-Compliance of Study Drug|3
6905515|NCT00702650|10928171|FG000|Overall Study|Lost to Follow-up|2
6905516|NCT00702650|10928171|FG000|Overall Study|Non-Compliance with Site Directives|1
6905517|NCT00702650|10928171|FG000|Overall Study|Sponsor Request|1
6905518|NCT00702650|10928171|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1
6905519|NCT00702650|10928171|FG000|Overall Study|Adverse Event|3
6905520|NCT00702689|10928175|FG000|Overall Study|Withdrawal by Subject|4
6905521|NCT00702689|10928175|FG000|Overall Study|Recurrent malignancy|1
6905522|NCT00702689|10928175|FG000|Overall Study|Adverse Event|1
6905523|NCT00702715|10928181|FG000|Overall Study|Lost to Follow-up|1
6905524|NCT00702715|10928182|FG001|Overall Study|Lost to Follow-up|0
6905525|NCT00702923|10928208|FG000|Overall Study|Adverse Event|1
6905526|NCT00702949|10928216|FG000|Overall Study|Refusal|3
6905527|NCT00702949|10928217|FG001|Overall Study|Refusal|2
6905528|NCT00702949|10928218|FG002|Overall Study|Refusal|2
6905529|NCT00702949|10928216|FG000|Overall Study|Adverse Event|1
6905530|NCT00702949|10928217|FG001|Overall Study|Adverse Event|6
6905531|NCT00702949|10928218|FG002|Overall Study|Adverse Event|3
6905532|NCT00702949|10928216|FG000|Overall Study|Other Medical Reason/unknown|1
6905533|NCT00702949|10928217|FG001|Overall Study|Other Medical Reason/unknown|1
6905534|NCT00702949|10928218|FG002|Overall Study|Other Medical Reason/unknown|3
6905535|NCT00703118|10928270|FG000|Overall Study|Adverse Event|1
6905536|NCT00703118|10928271|FG001|Overall Study|Adverse Event|2
6905537|NCT00703118|10928272|FG002|Overall Study|Adverse Event|2
6905538|NCT00703118|10928270|FG000|Overall Study|Subject Ineligible To Continue The Trial|6
6905539|NCT00703118|10928271|FG001|Overall Study|Subject Ineligible To Continue The Trial|3
6905540|NCT00703118|10928272|FG002|Overall Study|Subject Ineligible To Continue The Trial|2
6905541|NCT00703118|10928270|FG000|Overall Study|Lost to Follow-up|6
6905542|NCT00703118|10928271|FG001|Overall Study|Lost to Follow-up|4
6905543|NCT00703118|10928272|FG002|Overall Study|Lost to Follow-up|4
6905544|NCT00703118|10928270|FG000|Overall Study|Withdrawal by Subject|8
6905545|NCT00703118|10928271|FG001|Overall Study|Withdrawal by Subject|7
6905546|NCT00703118|10928272|FG002|Overall Study|Withdrawal by Subject|13
6905547|NCT00703118|10928270|FG000|Overall Study|Other|0
6905548|NCT00703118|10928271|FG001|Overall Study|Other|0
6905549|NCT00703118|10928272|FG002|Overall Study|Other|1
6905550|NCT00703157|10928285|FG000|Overall Study|Lost to Follow-up|0
6905551|NCT00703157|10928286|FG001|Overall Study|Lost to Follow-up|1
6905552|NCT00703157|10928285|FG000|Overall Study|source data permanently lost/ other|4
6905553|NCT00703157|10928286|FG001|Overall Study|source data permanently lost/ other|1
6905554|NCT00703677|10928332|FG000|Overall Study|Dropout-withdrawal not related to drug|3
6905555|NCT00703781|10928347|FG000|Overall Study|Withdrawal by Subject|1
6905556|NCT00703781|10928348|FG001|Overall Study|Withdrawal by Subject|2
6905557|NCT00703781|10928347|FG000|Overall Study|Cancelled surgery|1
6905558|NCT00703781|10928348|FG001|Overall Study|Cancelled surgery|0
6905559|NCT00703820|10928356|FG000|Overall Study|Adverse Event|12
6905560|NCT00703820|10928357|FG001|Overall Study|Adverse Event|17
6905561|NCT00703820|10928356|FG000|Overall Study|Death|5
6905562|NCT00703820|10928357|FG001|Overall Study|Death|0
6905563|NCT00703820|10928356|FG000|Overall Study|Lack of Efficacy|11
6905564|NCT00703820|10928357|FG001|Overall Study|Lack of Efficacy|11
6905565|NCT00703820|10928356|FG000|Overall Study|Received non-protocol therapy|1
6905566|NCT00703820|10928357|FG001|Overall Study|Received non-protocol therapy|0
6905567|NCT00703820|10928356|FG000|Overall Study|Physician Decision|4
6905568|NCT00703820|10928357|FG001|Overall Study|Physician Decision|5
6905569|NCT00703820|10928356|FG000|Overall Study|Withdrawal by Subject|2
6905570|NCT00703820|10928357|FG001|Overall Study|Withdrawal by Subject|1
6905571|NCT00703846|10928365|FG000|Overall Study|Adverse Event|8
6905572|NCT00703846|10928365|FG000|Overall Study|Lost to Follow-up|55
6905573|NCT00703846|10928365|FG000|Overall Study|Lack of Efficacy|15
6905574|NCT00703846|10928365|FG000|Overall Study|Noncompliance with Study Treatment|2
6905575|NCT00703846|10928365|FG000|Overall Study|Withdrawal by Subject|40
6905576|NCT00703846|10928365|FG000|Overall Study|Death|1
6905577|NCT00703846|10928365|FG000|Overall Study|Other|14
6905578|NCT00703846|10928365|FG000|Overall Study|Did Not Receive Study Drug|2
6905579|NCT00703911|10928369|FG000|Overall Study|Death|1
6905580|NCT00703911|10928369|FG000|Overall Study|Physician Decision|6
6905581|NCT00703911|10928369|FG000|Overall Study|Lost to Follow-up|1
6905582|NCT00703911|10928369|FG000|Overall Study|Withdrawal by Subject|2
6905583|NCT00703924|10928375|FG000|Overall Study|Withdrawal by Subject|1
6905584|NCT00703924|10928376|FG001|Overall Study|Withdrawal by Subject|1
6905585|NCT00703963|10928397|FG000|Overall Study|Withdrawal by Subject|7
6905586|NCT00703963|10928398|FG001|Overall Study|Withdrawal by Subject|13
6905587|NCT00703963|10928397|FG000|Overall Study|Physician Decision|0
6905588|NCT00703963|10928398|FG001|Overall Study|Physician Decision|1
6905589|NCT00704132|10928426|FG000|Overall Study|Clinical Adverse Experience|1
6905590|NCT00704132|10928427|FG001|Overall Study|Clinical Adverse Experience|0
6905591|NCT00704132|10928426|FG000|Overall Study|Lack of Efficacy|0
6905592|NCT00704132|10928427|FG001|Overall Study|Lack of Efficacy|1
6905593|NCT00704132|10928426|FG000|Overall Study|Withdrawal by Subject|0
6905594|NCT00704132|10928427|FG001|Overall Study|Withdrawal by Subject|1
6905595|NCT00704171|10928435|FG000|Overall Study|Withdrawal by Subject|1
6905596|NCT00704171|10928436|FG001|Overall Study|Withdrawal by Subject|0
6905597|NCT00704184|10928447|FG000|Double-Blind Treatment|Withdrawal by Subject|1
6905598|NCT00704184|10928448|FG001|Double-Blind Treatment|Withdrawal by Subject|0
6905599|NCT00704184|10928449|FG002|Double-Blind Treatment|Withdrawal by Subject|0
6905600|NCT00704184|10928450|FG003|Double-Blind Treatment|Withdrawal by Subject|0
6905601|NCT00704184|10928451|FG004|Double-Blind Treatment|Withdrawal by Subject|0
6905602|NCT00704184|10928447|FG000|Open-Label Treatment|Adverse Event|0
6905603|NCT00704184|10928448|FG001|Open-Label Treatment|Adverse Event|0
6905604|NCT00704184|10928449|FG002|Open-Label Treatment|Adverse Event|2
6905605|NCT00704184|10928450|FG003|Open-Label Treatment|Adverse Event|0
6905606|NCT00704184|10928451|FG004|Open-Label Treatment|Adverse Event|1
6905607|NCT00704184|10928447|FG000|Open-Label Treatment|Lack of Efficacy|0
6905608|NCT00704184|10928448|FG001|Open-Label Treatment|Lack of Efficacy|2
6905609|NCT00704184|10928449|FG002|Open-Label Treatment|Lack of Efficacy|2
6905610|NCT00704184|10928450|FG003|Open-Label Treatment|Lack of Efficacy|2
6905611|NCT00704184|10928451|FG004|Open-Label Treatment|Lack of Efficacy|1
6905612|NCT00704184|10928447|FG000|Open-Label Treatment|Physician Decision|0
6905613|NCT00704184|10928448|FG001|Open-Label Treatment|Physician Decision|0
6905614|NCT00704184|10928449|FG002|Open-Label Treatment|Physician Decision|0
6905615|NCT00704184|10928450|FG003|Open-Label Treatment|Physician Decision|0
6905616|NCT00704184|10928451|FG004|Open-Label Treatment|Physician Decision|1
6905617|NCT00704184|10928447|FG000|Open-Label Treatment|Withdrawal by Subject|1
6905618|NCT00704184|10928448|FG001|Open-Label Treatment|Withdrawal by Subject|0
6905619|NCT00704184|10928449|FG002|Open-Label Treatment|Withdrawal by Subject|0
6905620|NCT00704184|10928450|FG003|Open-Label Treatment|Withdrawal by Subject|3
6905621|NCT00704184|10928451|FG004|Open-Label Treatment|Withdrawal by Subject|0
6905622|NCT00704340|10928469|FG000|Overall Study|Lost to Follow-up|2
6905623|NCT00704340|10928470|FG001|Overall Study|Lost to Follow-up|1
6905624|NCT00704340|10928469|FG000|Overall Study|Death|0
6905625|NCT00704340|10928470|FG001|Overall Study|Death|1
6973908|NCT01185340|11025968|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
6973909|NCT01185340|11025965|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
6973910|NCT01185340|11025966|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4
6973911|NCT01185340|11025967|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
6973912|NCT01185340|11025968|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7
6973913|NCT01185340|11025965|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
6973914|NCT01185340|11025966|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
6973915|NCT01185340|11025967|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
6973916|NCT01185340|11025968|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
6973917|NCT01185340|11025965|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
6973918|NCT01185340|11025966|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
6973919|NCT01185340|11025967|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2
6973920|NCT01185340|11025968|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
6973921|NCT01185340|11025965|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
6973922|NCT01185340|11025966|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
6973923|NCT01185340|11025967|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
6973924|NCT01185340|11025968|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
6973925|NCT01185340|11025965|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
6973926|NCT01185340|11025966|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
6973927|NCT01185340|11025967|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3
6973928|NCT01185340|11025968|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
6973929|NCT01185353|11025985|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1
6973930|NCT01185353|11025986|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1
6973931|NCT01185353|11025987|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1
6973932|NCT01185353|11025988|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1
6973933|NCT01185353|11025989|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5
6905626|NCT00704405|10928501|FG000|Overall Study (NC Population)|Adverse Event|1
6905627|NCT00704405|10928502|FG001|Overall Study (NC Population)|Adverse Event|0
6905628|NCT00704405|10928503|FG002|Overall Study (NC Population)|Adverse Event|0
6905629|NCT00704405|10928504|FG003|Overall Study (NC Population)|Adverse Event|0
6905630|NCT00704405|10928505|FG004|Overall Study (NC Population)|Adverse Event|0
6905631|NCT00704405|10928501|FG000|Overall Study (NC Population)|Lost to Follow-up|2
6905632|NCT00704405|10928502|FG001|Overall Study (NC Population)|Lost to Follow-up|1
6905633|NCT00704405|10928503|FG002|Overall Study (NC Population)|Lost to Follow-up|1
6905634|NCT00704405|10928504|FG003|Overall Study (NC Population)|Lost to Follow-up|2
6905635|NCT00704405|10928505|FG004|Overall Study (NC Population)|Lost to Follow-up|2
6905636|NCT00704405|10928501|FG000|Overall Study (NC Population)|Withdrawal by Subject|2
6905637|NCT00704405|10928502|FG001|Overall Study (NC Population)|Withdrawal by Subject|3
6905638|NCT00704405|10928503|FG002|Overall Study (NC Population)|Withdrawal by Subject|2
6905639|NCT00704405|10928504|FG003|Overall Study (NC Population)|Withdrawal by Subject|2
6905640|NCT00704405|10928505|FG004|Overall Study (NC Population)|Withdrawal by Subject|2
6905641|NCT00704405|10928501|FG000|Overall Study (NC Population)|Other|0
6905642|NCT00704405|10928502|FG001|Overall Study (NC Population)|Other|0
6905643|NCT00704405|10928503|FG002|Overall Study (NC Population)|Other|0
6905644|NCT00704405|10928504|FG003|Overall Study (NC Population)|Other|0
6905645|NCT00704405|10928505|FG004|Overall Study (NC Population)|Other|1
6905646|NCT00704405|10928501|FG000|Overall Study (C Population)|Withdrawal by Subject|1
6905647|NCT00704405|10928502|FG001|Overall Study (C Population)|Withdrawal by Subject|1
6905648|NCT00704405|10928503|FG002|Overall Study (C Population)|Withdrawal by Subject|1
6905649|NCT00704405|10928504|FG003|Overall Study (C Population)|Withdrawal by Subject|1
6905650|NCT00704405|10928505|FG004|Overall Study (C Population)|Withdrawal by Subject|0
6905651|NCT00704405|10928501|FG000|Overall Study (C Population)|Lost to Follow-up|0
6905652|NCT00704405|10928502|FG001|Overall Study (C Population)|Lost to Follow-up|2
6905653|NCT00704405|10928503|FG002|Overall Study (C Population)|Lost to Follow-up|0
6905654|NCT00704405|10928504|FG003|Overall Study (C Population)|Lost to Follow-up|0
6905655|NCT00704405|10928505|FG004|Overall Study (C Population)|Lost to Follow-up|0
6905656|NCT00704418|10928525|FG000|Overall Study|Withdrawal by Subject|2
6905657|NCT00704418|10928526|FG001|Overall Study|Withdrawal by Subject|0
6905658|NCT00704418|10928525|FG000|Overall Study|Over-enrolled/surgery postponed|3
6905659|NCT00704418|10928526|FG001|Overall Study|Over-enrolled/surgery postponed|6
6905660|NCT00704522|10928534|FG000|Overall Study|Lack of Efficacy|65
6905661|NCT00704522|10928535|FG001|Overall Study|Lack of Efficacy|17
6905662|NCT00704522|10928534|FG000|Overall Study|Failure to appear again at hospital|56
6905663|NCT00704522|10928535|FG001|Overall Study|Failure to appear again at hospital|10
6905664|NCT00704522|10928534|FG000|Overall Study|Withdrawal by Subject|17
6905665|NCT00704522|10928535|FG001|Overall Study|Withdrawal by Subject|8
6905666|NCT00704522|10928534|FG000|Overall Study|Adverse Event|9
6905667|NCT00704522|10928535|FG001|Overall Study|Adverse Event|1
6905668|NCT00704522|10928534|FG000|Overall Study|Undefined causes|9
6905669|NCT00704522|10928535|FG001|Overall Study|Undefined causes|7
6905670|NCT00704522|10928534|FG000|Overall Study|No information on therapy end|27
6905671|NCT00704522|10928535|FG001|Overall Study|No information on therapy end|2
6905672|NCT00704730|10928546|FG000|Overall Study|Adverse Event|35
6905673|NCT00704730|10928547|FG001|Overall Study|Adverse Event|9
6905674|NCT00704730|10928546|FG000|Overall Study|Death|11
6905675|NCT00704730|10928547|FG001|Overall Study|Death|5
6905676|NCT00704730|10928546|FG000|Overall Study|Physician Decision|2
6905677|NCT00704730|10928547|FG001|Overall Study|Physician Decision|0
6905678|NCT00704730|10928546|FG000|Overall Study|Did not receive drug|5
6905679|NCT00704730|10928547|FG001|Overall Study|Did not receive drug|2
6905680|NCT00704730|10928546|FG000|Overall Study|Disease progression per PI|58
6905681|NCT00704730|10928547|FG001|Overall Study|Disease progression per PI|67
6905682|NCT00704730|10928546|FG000|Overall Study|data unavailable|1
6905683|NCT00704730|10928547|FG001|Overall Study|data unavailable|0
6905684|NCT00704730|10928546|FG000|Overall Study|Withdrawal by Subject|9
6905685|NCT00704730|10928547|FG001|Overall Study|Withdrawal by Subject|13
6905686|NCT00704808|10928554|FG000|Overall Study|Discontinued prior to starting treatment|14
6905687|NCT00704808|10928554|FG000|Overall Study|Death|7
6905688|NCT00704808|10928554|FG000|Overall Study|Tumor progression|80
6905689|NCT00704808|10928554|FG000|Overall Study|Patient's decision|11
6905690|NCT00704808|10928554|FG000|Overall Study|Early therapy discontinuation|16
6905691|NCT00704808|10928554|FG000|Overall Study|Adverse Event|1
6905692|NCT00704808|10928554|FG000|Overall Study|Lost to Follow-up|1
6905693|NCT00704808|10928554|FG000|Overall Study|Treatment change|1
6905694|NCT00704964|10928589|FG000|Overall Study|Not completed on time|328
6905695|NCT00705016|10928610|FG000|Overall Study|Adverse Event|6
6905696|NCT00705016|10928611|FG001|Overall Study|Adverse Event|11
6905697|NCT00705016|10928612|FG002|Overall Study|Adverse Event|10
6905698|NCT00705016|10928610|FG000|Overall Study|Death|5
6905699|NCT00705016|10928611|FG001|Overall Study|Death|7
6905700|NCT00705016|10928612|FG002|Overall Study|Death|5
6905701|NCT00705016|10928610|FG000|Overall Study|Protocol Violation|0
6905702|NCT00705016|10928611|FG001|Overall Study|Protocol Violation|1
6905703|NCT00705016|10928612|FG002|Overall Study|Protocol Violation|1
6905704|NCT00705016|10928610|FG000|Overall Study|Withdrawal by Subject|4
6905705|NCT00705016|10928611|FG001|Overall Study|Withdrawal by Subject|3
6905706|NCT00705016|10928612|FG002|Overall Study|Withdrawal by Subject|2
6905707|NCT00705016|10928610|FG000|Overall Study|Progressive Disease|33
6905708|NCT00705016|10928611|FG001|Overall Study|Progressive Disease|29
6905709|NCT00705016|10928612|FG002|Overall Study|Progressive Disease|33
6905710|NCT00705016|10928610|FG000|Overall Study|Symptomatic Deterioration|3
6905711|NCT00705016|10928611|FG001|Overall Study|Symptomatic Deterioration|1
6905712|NCT00705016|10928612|FG002|Overall Study|Symptomatic Deterioration|1
6905713|NCT00705016|10928610|FG000|Overall Study|Other|9
6905714|NCT00705016|10928611|FG001|Overall Study|Other|6
6905715|NCT00705016|10928612|FG002|Overall Study|Other|6
6905716|NCT00705146|10928630|FG000|Overall Study|Lost to Follow-up|1
6905717|NCT00705146|10928631|FG001|Overall Study|Lost to Follow-up|1
6905718|NCT00705159|10928641|FG000|Overall Study|Withdrawal by Subject|0
6905719|NCT00705159|10928642|FG001|Overall Study|Withdrawal by Subject|1
6905720|NCT00705159|10928643|FG002|Overall Study|Withdrawal by Subject|1
6905721|NCT00705159|10928644|FG003|Overall Study|Withdrawal by Subject|1
6905722|NCT00705159|10928641|FG000|Overall Study|Protocol Violation|0
6905723|NCT00705159|10928642|FG001|Overall Study|Protocol Violation|1
6905724|NCT00705159|10928643|FG002|Overall Study|Protocol Violation|0
6905725|NCT00705159|10928644|FG003|Overall Study|Protocol Violation|0
6905726|NCT00705159|10928641|FG000|Overall Study|Adverse Event|0
6905727|NCT00705159|10928642|FG001|Overall Study|Adverse Event|0
6905728|NCT00705159|10928643|FG002|Overall Study|Adverse Event|1
6905729|NCT00705159|10928644|FG003|Overall Study|Adverse Event|0
6905730|NCT00705159|10928641|FG000|Overall Study|Lost to Follow-up|0
6905731|NCT00705159|10928642|FG001|Overall Study|Lost to Follow-up|0
6905732|NCT00705159|10928643|FG002|Overall Study|Lost to Follow-up|3
6905733|NCT00705159|10928644|FG003|Overall Study|Lost to Follow-up|2
6905734|NCT00705159|10928641|FG000|Overall Study|Screen Failure|0
6905735|NCT00705159|10928642|FG001|Overall Study|Screen Failure|0
6905736|NCT00705159|10928643|FG002|Overall Study|Screen Failure|0
6905737|NCT00705159|10928644|FG003|Overall Study|Screen Failure|1
6905738|NCT00705224|10928654|FG000|Overall Study|Adverse Event|1
6905739|NCT00705224|10928654|FG000|Overall Study|Lack of Efficacy|2
6905740|NCT00705224|10928654|FG000|Overall Study|Withdrawal by Subject|3
6905741|NCT00705224|10928654|FG000|Overall Study|Lost to Follow-up|5
6905742|NCT00705250|10928661|FG000|Overall Study|Withdrawal by Subject|1
6905743|NCT00705250|10928661|FG000|Overall Study|Patient died in car accident|1
6905744|NCT00705263|10928665|FG000|Overall Study|Withdrawal by Subject|2
6905745|NCT00705289|10928669|FG000|Overall Study|Subject or treating physician's choice|131
6905746|NCT00705341|10928692|FG000|Phase 2: Trial|Withdrawal by Subject|0
6905747|NCT00705341|10928693|FG001|Phase 2: Trial|Withdrawal by Subject|0
6905748|NCT00705341|10928694|FG002|Phase 2: Trial|Withdrawal by Subject|6
6905749|NCT00705341|10928695|FG003|Phase 2: Trial|Withdrawal by Subject|4
6905750|NCT00705341|10928692|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0
6905751|NCT00705341|10928693|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0
6905752|NCT00705341|10928694|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1
6905753|NCT00705341|10928695|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0
6905754|NCT00705367|10928705|FG000|Long-term Extension Period|Adverse Event|2
6905755|NCT00705367|10928706|FG001|Long-term Extension Period|Adverse Event|0
6905756|NCT00705367|10928705|FG000|Long-term Extension Period|Withdrawal by Subject|2
6905757|NCT00705367|10928706|FG001|Long-term Extension Period|Withdrawal by Subject|0
6905758|NCT00705367|10928705|FG000|Long-term Extension Period|Lack of Efficacy|1
6905759|NCT00705367|10928706|FG001|Long-term Extension Period|Lack of Efficacy|0
6905760|NCT00705367|10928705|FG000|Long-term Extension Period|No longer met study criteria|1
6905761|NCT00705367|10928706|FG001|Long-term Extension Period|No longer met study criteria|0
6905762|NCT00705367|10928705|FG000|Long-term Extension Period|Administrative reason by sponsor|3
6905763|NCT00705367|10928706|FG001|Long-term Extension Period|Administrative reason by sponsor|0
6905764|NCT00705406|10928716|FG000|Overall Study|Lost to Follow-up|3
6905765|NCT00705406|10928717|FG001|Overall Study|Lost to Follow-up|3
6905766|NCT00705406|10928716|FG000|Overall Study|Did not receive study drug|1
6905767|NCT00705406|10928717|FG001|Overall Study|Did not receive study drug|2
6905768|NCT00705432|10928730|FG000|Treatment Period|Adverse Event|45
6905769|NCT00705432|10928731|FG001|Treatment Period|Adverse Event|37
6905770|NCT00705432|10928732|FG002|Treatment Period|Adverse Event|51
6905771|NCT00705432|10928733|FG003|Treatment Period|Adverse Event|12
6905772|NCT00705432|10928734|FG004|Treatment Period|Adverse Event|8
6905773|NCT00705432|10928735|FG005|Treatment Period|Adverse Event|9
6905774|NCT00705432|10928730|FG000|Treatment Period|Treatment failure|92
6905775|NCT00705432|10928731|FG001|Treatment Period|Treatment failure|42
6905776|NCT00705432|10928732|FG002|Treatment Period|Treatment failure|33
6905777|NCT00705432|10928733|FG003|Treatment Period|Treatment failure|25
6905778|NCT00705432|10928734|FG004|Treatment Period|Treatment failure|13
6905779|NCT00705432|10928735|FG005|Treatment Period|Treatment failure|14
6905780|NCT00705432|10928730|FG000|Treatment Period|Non medical reason|26
6905781|NCT00705432|10928731|FG001|Treatment Period|Non medical reason|32
6905782|NCT00705432|10928732|FG002|Treatment Period|Non medical reason|37
6905783|NCT00705432|10928733|FG003|Treatment Period|Non medical reason|4
6905784|NCT00705432|10928734|FG004|Treatment Period|Non medical reason|7
6905785|NCT00705432|10928735|FG005|Treatment Period|Non medical reason|7
6905786|NCT00705432|10928730|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2
6905787|NCT00705432|10928731|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1
6905788|NCT00705432|10928732|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1
6905789|NCT00705432|10928733|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0
6905790|NCT00705432|10928734|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0
6905791|NCT00705432|10928735|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0
6905792|NCT00705432|10928730|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69
6905793|NCT00705432|10928731|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42
6905794|NCT00705432|10928732|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24
6905795|NCT00705432|10928733|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14
6905796|NCT00705432|10928734|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6
6905797|NCT00705432|10928735|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7
6905798|NCT00705484|10928748|FG000|Overall Study|Adverse Event|28
6905799|NCT00705484|10928749|FG001|Overall Study|Adverse Event|27
6905800|NCT00705484|10928748|FG000|Overall Study|Lost to Follow-up|169
6905801|NCT00705484|10928749|FG001|Overall Study|Lost to Follow-up|250
6905802|NCT00705484|10928748|FG000|Overall Study|Withdrawal by Subject|96
6905803|NCT00705484|10928749|FG001|Overall Study|Withdrawal by Subject|72
6905804|NCT00705484|10928748|FG000|Overall Study|Administrative|89
6905805|NCT00705484|10928749|FG001|Overall Study|Administrative|59
6905806|NCT00705523|10928759|FG000|Overall Study|Lost to Follow-up|2
6905807|NCT00705523|10928760|FG001|Overall Study|Lost to Follow-up|3
6905808|NCT00705536|10928768|FG000|Start Period 1|Withdrawal by Subject|0
6905809|NCT00705536|10928769|FG001|Start Period 1|Withdrawal by Subject|0
6905810|NCT00705536|10928770|FG002|Start Period 1|Withdrawal by Subject|0
6905811|NCT00705536|10928771|FG003|Start Period 1|Withdrawal by Subject|1
6905812|NCT00705575|10928792|FG000|Overall Study|Abnormal laboratory value(s)|0
6905813|NCT00705575|10928793|FG001|Overall Study|Abnormal laboratory value(s)|3
6905814|NCT00705575|10928792|FG000|Overall Study|Abnormal test procedure result(s)|2
6905815|NCT00705575|10928793|FG001|Overall Study|Abnormal test procedure result(s)|12
6905816|NCT00705575|10928792|FG000|Overall Study|Adverse Event|11
6905817|NCT00705575|10928793|FG001|Overall Study|Adverse Event|15
6905818|NCT00705575|10928792|FG000|Overall Study|Lost to Follow-up|3
6905819|NCT00705575|10928793|FG001|Overall Study|Lost to Follow-up|4
6905820|NCT00705575|10928792|FG000|Overall Study|Protocol Violation|2
6905821|NCT00705575|10928793|FG001|Overall Study|Protocol Violation|2
6905822|NCT00705575|10928792|FG000|Overall Study|Withdrawal by Subject|5
6905823|NCT00705575|10928793|FG001|Overall Study|Withdrawal by Subject|10
6905824|NCT00705614|10928801|FG000|Initial Intervention|Adverse Event|40
6905825|NCT00705614|10928802|FG001|Initial Intervention|Adverse Event|21
6905826|NCT00705614|10928801|FG000|Initial Intervention|Lost to Follow-up|310
6905827|NCT00705614|10928802|FG001|Initial Intervention|Lost to Follow-up|191
6905828|NCT00705614|10928801|FG000|Initial Intervention|Withdrawal by Subject|114
6905829|NCT00705614|10928802|FG001|Initial Intervention|Withdrawal by Subject|71
6905830|NCT00705614|10928801|FG000|Initial Intervention|Administrative Reason|51
6905831|NCT00705614|10928802|FG001|Initial Intervention|Administrative Reason|38
6905832|NCT00705614|10928801|FG000|Initial Intervention|Status completion unknown|3
6905833|NCT00705614|10928802|FG001|Initial Intervention|Status completion unknown|0
6905834|NCT00705614|10928801|FG000|Switch to Remicade|Adverse Event|0
6905835|NCT00705614|10928802|FG001|Switch to Remicade|Adverse Event|5
6905836|NCT00705614|10928801|FG000|Switch to Remicade|Lost to Follow-up|0
6905837|NCT00705614|10928802|FG001|Switch to Remicade|Lost to Follow-up|23
6905838|NCT00705614|10928801|FG000|Switch to Remicade|Withdrawal by Subject|0
6905839|NCT00705614|10928802|FG001|Switch to Remicade|Withdrawal by Subject|12
6905840|NCT00705614|10928801|FG000|Switch to Remicade|Administrative Reason|0
6905841|NCT00705614|10928802|FG001|Switch to Remicade|Administrative Reason|9
6905842|NCT00705666|10928814|FG000|Overall Study|No post-treatment questionnaire|279
6905843|NCT00705666|10928814|FG000|Overall Study|Withdrawal by Subject|21
6905844|NCT00705666|10928814|FG000|Overall Study|Physician Decision|7
6905845|NCT00705666|10928814|FG000|Overall Study|Lost to Follow-up|5
6905846|NCT00705666|10928814|FG000|Overall Study|Death|1
6905847|NCT00705666|10928814|FG000|Overall Study|Adverse Event|4
6905848|NCT00705666|10928814|FG000|Overall Study|Other|12
6905849|NCT00705666|10928814|FG000|Overall Study|Other|2
6905850|NCT00705666|10928814|FG000|Overall Study|Lack of data|3
6905851|NCT00705666|10928814|FG000|Overall Study|Untreated|5
6905852|NCT00705679|10928823|FG000|Overall Study|Adverse Event|1
6905853|NCT00705679|10928824|FG001|Overall Study|Adverse Event|1
6905854|NCT00705679|10928825|FG002|Overall Study|Adverse Event|0
6905855|NCT00705679|10928826|FG003|Overall Study|Adverse Event|0
6905856|NCT00705679|10928827|FG004|Overall Study|Adverse Event|0
6905857|NCT00705679|10928823|FG000|Overall Study|Death|0
6905858|NCT00705679|10928824|FG001|Overall Study|Death|0
6905859|NCT00705679|10928825|FG002|Overall Study|Death|3
6905860|NCT00705679|10928826|FG003|Overall Study|Death|2
6905861|NCT00705679|10928827|FG004|Overall Study|Death|1
6905862|NCT00705679|10928823|FG000|Overall Study|Lost to Follow-up|32
6905863|NCT00705679|10928824|FG001|Overall Study|Lost to Follow-up|60
6905864|NCT00705679|10928825|FG002|Overall Study|Lost to Follow-up|44
6905865|NCT00705679|10928826|FG003|Overall Study|Lost to Follow-up|30
6905866|NCT00705679|10928827|FG004|Overall Study|Lost to Follow-up|35
6905867|NCT00705679|10928823|FG000|Overall Study|Physician Decision|0
6905868|NCT00705679|10928824|FG001|Overall Study|Physician Decision|1
6905869|NCT00705679|10928825|FG002|Overall Study|Physician Decision|0
6905870|NCT00705679|10928826|FG003|Overall Study|Physician Decision|1
6905871|NCT00705679|10928827|FG004|Overall Study|Physician Decision|0
6905872|NCT00705679|10928823|FG000|Overall Study|Withdrawal by Subject|32
6905873|NCT00705679|10928824|FG001|Overall Study|Withdrawal by Subject|77
6905874|NCT00705679|10928825|FG002|Overall Study|Withdrawal by Subject|68
6905875|NCT00705679|10928826|FG003|Overall Study|Withdrawal by Subject|47
6905876|NCT00705679|10928827|FG004|Overall Study|Withdrawal by Subject|33
6905877|NCT00705718|10928846|FG000|Overall Study|Death|6
6905878|NCT00705718|10928847|FG001|Overall Study|Death|6
6905879|NCT00705718|10928846|FG000|Overall Study|Not due for Visit|0
6905880|NCT00705718|10928847|FG001|Overall Study|Not due for Visit|12
6905881|NCT00705718|10928846|FG000|Overall Study|Follow up not done|1
6905882|NCT00705718|10928847|FG001|Overall Study|Follow up not done|4
6905883|NCT00705757|10928856|FG000|Overall Study|Lack of Efficacy|5
6905884|NCT00705757|10928857|FG001|Overall Study|Lack of Efficacy|1
6905885|NCT00705757|10928858|FG002|Overall Study|Lack of Efficacy|3
6905886|NCT00705757|10928856|FG000|Overall Study|Lost to Follow-up|7
6905887|NCT00705757|10928857|FG001|Overall Study|Lost to Follow-up|6
6905888|NCT00705757|10928858|FG002|Overall Study|Lost to Follow-up|6
6905889|NCT00705757|10928856|FG000|Overall Study|Withdrawal by Subject|1
6905890|NCT00705757|10928857|FG001|Overall Study|Withdrawal by Subject|1
6905891|NCT00705757|10928858|FG002|Overall Study|Withdrawal by Subject|2
6905892|NCT00705783|10928868|FG000|Conversion Phase|Sponsor Discontinued Study|54
6905893|NCT00705783|10928869|FG001|Conversion Phase|Sponsor Discontinued Study|0
6905894|NCT00705783|10928870|FG002|Conversion Phase|Sponsor Discontinued Study|0
6905895|NCT00705783|10928868|FG000|Conversion Phase|Lost to Follow-up|13
6905896|NCT00705783|10928869|FG001|Conversion Phase|Lost to Follow-up|0
6905897|NCT00705783|10928870|FG002|Conversion Phase|Lost to Follow-up|0
6905898|NCT00705783|10928868|FG000|Conversion Phase|Met Withdrawal Criteria|4
6905899|NCT00705783|10928869|FG001|Conversion Phase|Met Withdrawal Criteria|0
6905900|NCT00705783|10928870|FG002|Conversion Phase|Met Withdrawal Criteria|0
6905901|NCT00705783|10928868|FG000|Conversion Phase|Withdrawn by Investigator|4
6905902|NCT00705783|10928869|FG001|Conversion Phase|Withdrawn by Investigator|0
6905903|NCT00705783|10928870|FG002|Conversion Phase|Withdrawn by Investigator|0
6905904|NCT00705783|10928868|FG000|Conversion Phase|Withdrew Consent|24
6905905|NCT00705783|10928869|FG001|Conversion Phase|Withdrew Consent|0
6905906|NCT00705783|10928870|FG002|Conversion Phase|Withdrew Consent|0
6905907|NCT00705783|10928868|FG000|Conversion Phase|Protocol Deviation|2
6905908|NCT00705783|10928869|FG001|Conversion Phase|Protocol Deviation|0
6905909|NCT00705783|10928870|FG002|Conversion Phase|Protocol Deviation|0
6905910|NCT00705783|10928868|FG000|Conversion Phase|Adverse Event|11
6905911|NCT00705783|10928869|FG001|Conversion Phase|Adverse Event|0
6905912|NCT00705783|10928870|FG002|Conversion Phase|Adverse Event|0
6905913|NCT00705783|10928868|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13
6905914|NCT00705783|10928869|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0
6905915|NCT00705783|10928870|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0
6905916|NCT00705783|10928868|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8
6905917|NCT00705783|10928869|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0
6905918|NCT00705783|10928870|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0
6905919|NCT00705783|10928868|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42
6905920|NCT00705783|10928869|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0
6905921|NCT00705783|10928870|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0
6905922|NCT00705783|10928868|FG000|Oral Stabilization Phase|Lost to Follow-up|7
6905923|NCT00705783|10928869|FG001|Oral Stabilization Phase|Lost to Follow-up|0
6905924|NCT00705783|10928870|FG002|Oral Stabilization Phase|Lost to Follow-up|0
6905925|NCT00705783|10928868|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19
6905926|NCT00705783|10928869|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0
6905927|NCT00705783|10928870|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0
6905928|NCT00705783|10928868|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12
6905929|NCT00705783|10928869|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0
6905930|NCT00705783|10928870|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0
6905931|NCT00705783|10928868|FG000|Oral Stabilization Phase|Withdrew Consent|29
6905932|NCT00705783|10928869|FG001|Oral Stabilization Phase|Withdrew Consent|0
6905933|NCT00705783|10928870|FG002|Oral Stabilization Phase|Withdrew Consent|0
6905934|NCT00705783|10928868|FG000|Oral Stabilization Phase|Adverse Event|14
6905935|NCT00705783|10928869|FG001|Oral Stabilization Phase|Adverse Event|0
6905936|NCT00705783|10928870|FG002|Oral Stabilization Phase|Adverse Event|0
6905937|NCT00705783|10928868|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7
6905938|NCT00705783|10928869|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
6905939|NCT00705783|10928870|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
6905940|NCT00705783|10928868|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4
6905941|NCT00705783|10928869|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
6905942|NCT00705783|10928870|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
6905943|NCT00705783|10928868|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86
6905944|NCT00705783|10928869|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0
6905945|NCT00705783|10928870|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0
6905946|NCT00705783|10928868|FG000|Depot Stabilization Phase|Lost to Follow-up|11
6905947|NCT00705783|10928869|FG001|Depot Stabilization Phase|Lost to Follow-up|0
6905948|NCT00705783|10928870|FG002|Depot Stabilization Phase|Lost to Follow-up|0
6905949|NCT00705783|10928868|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8
6905950|NCT00705783|10928869|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0
6905951|NCT00705783|10928870|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0
6905952|NCT00705783|10928868|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9
6905953|NCT00705783|10928869|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0
6905954|NCT00705783|10928870|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0
6905955|NCT00705783|10928868|FG000|Depot Stabilization Phase|Withdrew Consent|29
6905956|NCT00705783|10928869|FG001|Depot Stabilization Phase|Withdrew Consent|0
6905957|NCT00705783|10928870|FG002|Depot Stabilization Phase|Withdrew Consent|0
6905958|NCT00705783|10928868|FG000|Depot Stabilization Phase|Adverse Event|17
6905959|NCT00705783|10928869|FG001|Depot Stabilization Phase|Adverse Event|0
6905960|NCT00705783|10928870|FG002|Depot Stabilization Phase|Adverse Event|0
6905961|NCT00705783|10928868|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12
6905962|NCT00705783|10928869|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
6905963|NCT00705783|10928870|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
6905964|NCT00705783|10928868|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1
6905965|NCT00705783|10928869|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
6905966|NCT00705783|10928870|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
6905967|NCT00705783|10928868|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0
6905968|NCT00705783|10928869|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179
6905969|NCT00705783|10928870|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58
6905970|NCT00705783|10928868|FG000|Depot Maintenance Phase|Lost to Follow-up|0
6905971|NCT00705783|10928869|FG001|Depot Maintenance Phase|Lost to Follow-up|5
6905972|NCT00705783|10928870|FG002|Depot Maintenance Phase|Lost to Follow-up|3
6905973|NCT00705783|10928868|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0
6905974|NCT00705783|10928869|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2
6905975|NCT00705783|10928870|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2
6905976|NCT00705783|10928868|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0
6905977|NCT00705783|10928869|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8
6905978|NCT00705783|10928870|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6
6905979|NCT00705783|10928868|FG000|Depot Maintenance Phase|Withdrew Consent|0
6905980|NCT00705783|10928869|FG001|Depot Maintenance Phase|Withdrew Consent|14
6905981|NCT00705783|10928870|FG002|Depot Maintenance Phase|Withdrew Consent|4
6905982|NCT00705783|10928868|FG000|Depot Maintenance Phase|Protocol Deviation|0
6905983|NCT00705783|10928869|FG001|Depot Maintenance Phase|Protocol Deviation|2
6905984|NCT00705783|10928870|FG002|Depot Maintenance Phase|Protocol Deviation|0
6905985|NCT00705783|10928868|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
6905986|NCT00705783|10928869|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9
6905987|NCT00705783|10928870|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5
6905988|NCT00705783|10928868|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
6905989|NCT00705783|10928869|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11
6905990|NCT00705783|10928870|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
6905991|NCT00705783|10928868|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
6905992|NCT00705783|10928869|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16
6905993|NCT00705783|10928870|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40
6905994|NCT00705939|10928911|FG000|Overall Study|Protocol Violation|0
6905995|NCT00705939|10928912|FG001|Overall Study|Protocol Violation|0
6905996|NCT00705939|10928913|FG002|Overall Study|Protocol Violation|1
6905997|NCT00705939|10928911|FG000|Overall Study|Withdrawal by Subject|0
6905998|NCT00705939|10928912|FG001|Overall Study|Withdrawal by Subject|1
6905999|NCT00705939|10928913|FG002|Overall Study|Withdrawal by Subject|3
6906000|NCT00705939|10928911|FG000|Overall Study|Physician Decision|0
6906001|NCT00705939|10928912|FG001|Overall Study|Physician Decision|1
6906002|NCT00705939|10928913|FG002|Overall Study|Physician Decision|0
6906003|NCT00706004|10928922|FG000|Overall Study|Did not meet eligibility criteria|2
6906004|NCT00706030|10928931|FG000|Overall Study|Disease Progression|4
6906005|NCT00706030|10928932|FG001|Overall Study|Disease Progression|6
6906006|NCT00706030|10928933|FG002|Overall Study|Disease Progression|46
6906007|NCT00706030|10928934|FG003|Overall Study|Disease Progression|12
6906008|NCT00706030|10928931|FG000|Overall Study|Adverse Event|1
6906009|NCT00706030|10928932|FG001|Overall Study|Adverse Event|0
6906010|NCT00706030|10928933|FG002|Overall Study|Adverse Event|4
6906011|NCT00706030|10928934|FG003|Overall Study|Adverse Event|2
6906012|NCT00706030|10928931|FG000|Overall Study|Withdrawal by Subject|1
6906013|NCT00706030|10928932|FG001|Overall Study|Withdrawal by Subject|0
6906014|NCT00706030|10928933|FG002|Overall Study|Withdrawal by Subject|2
6906015|NCT00706030|10928934|FG003|Overall Study|Withdrawal by Subject|0
6906016|NCT00706030|10928931|FG000|Overall Study|Physician Decision|0
6906017|NCT00706030|10928932|FG001|Overall Study|Physician Decision|0
6906018|NCT00706030|10928933|FG002|Overall Study|Physician Decision|2
6906019|NCT00706030|10928934|FG003|Overall Study|Physician Decision|0
6906020|NCT00706030|10928931|FG000|Overall Study|Not recorded|0
6906021|NCT00706030|10928932|FG001|Overall Study|Not recorded|0
6906022|NCT00706030|10928933|FG002|Overall Study|Not recorded|2
6906023|NCT00706030|10928934|FG003|Overall Study|Not recorded|0
6906024|NCT00706030|10928931|FG000|Overall Study|Protocol Violation|0
6906025|NCT00706030|10928932|FG001|Overall Study|Protocol Violation|0
6906026|NCT00706030|10928933|FG002|Overall Study|Protocol Violation|1
6906027|NCT00706030|10928934|FG003|Overall Study|Protocol Violation|1
6906028|NCT00706030|10928931|FG000|Overall Study|Failed to return|0
6906029|NCT00706030|10928932|FG001|Overall Study|Failed to return|0
6906030|NCT00706030|10928933|FG002|Overall Study|Failed to return|1
6906031|NCT00706030|10928934|FG003|Overall Study|Failed to return|0
6906032|NCT00706030|10928931|FG000|Overall Study|Symptomatic Deterioration|0
6978731|NCT01214642|11032241|FG009|Overall Study|Withdrawal by Subject|1
6978732|NCT01214642|11032242|FG010|Overall Study|Withdrawal by Subject|1
6978733|NCT01214642|11032243|FG011|Overall Study|Withdrawal by Subject|0
6978734|NCT01214642|11032232|FG000|Overall Study|Physician Decision|0
6978735|NCT01214642|11032233|FG001|Overall Study|Physician Decision|0
6978736|NCT01214642|11032234|FG002|Overall Study|Physician Decision|1
6978737|NCT01214642|11032235|FG003|Overall Study|Physician Decision|1
6978738|NCT01214642|11032236|FG004|Overall Study|Physician Decision|1
6906033|NCT00706030|10928932|FG001|Overall Study|Symptomatic Deterioration|0
6906034|NCT00706030|10928933|FG002|Overall Study|Symptomatic Deterioration|1
6906035|NCT00706030|10928934|FG003|Overall Study|Symptomatic Deterioration|0
6906036|NCT00706030|10928931|FG000|Overall Study|No treatment received|0
6906037|NCT00706030|10928932|FG001|Overall Study|No treatment received|0
6906038|NCT00706030|10928933|FG002|Overall Study|No treatment received|0
6906039|NCT00706030|10928934|FG003|Overall Study|No treatment received|1
6906040|NCT00706030|10928931|FG000|Overall Study|Death|0
6906041|NCT00706030|10928932|FG001|Overall Study|Death|0
6906042|NCT00706030|10928933|FG002|Overall Study|Death|1
6906043|NCT00706030|10928934|FG003|Overall Study|Death|0
6906044|NCT00706095|10928948|FG000|Overall Study|Progressive Disease|4
6906045|NCT00706095|10928949|FG001|Overall Study|Progressive Disease|5
6906046|NCT00706095|10928950|FG002|Overall Study|Progressive Disease|3
6906047|NCT00706095|10928948|FG000|Overall Study|Clinical Progression|1
6906048|NCT00706095|10928949|FG001|Overall Study|Clinical Progression|2
6906049|NCT00706095|10928950|FG002|Overall Study|Clinical Progression|2
6906050|NCT00706095|10928948|FG000|Overall Study|Withdrawal by Subject|1
6906051|NCT00706095|10928949|FG001|Overall Study|Withdrawal by Subject|0
6906052|NCT00706095|10928950|FG002|Overall Study|Withdrawal by Subject|0
6906053|NCT00706134|10928987|FG000|Overall Study|Adverse Event|8
6906054|NCT00706134|10928988|FG001|Overall Study|Adverse Event|7
6906055|NCT00706134|10928989|FG002|Overall Study|Adverse Event|2
6906056|NCT00706134|10928990|FG003|Overall Study|Adverse Event|3
6906057|NCT00706134|10928987|FG000|Overall Study|Lost to Follow-up|0
6906058|NCT00706134|10928988|FG001|Overall Study|Lost to Follow-up|1
6906059|NCT00706134|10928989|FG002|Overall Study|Lost to Follow-up|0
6906060|NCT00706134|10928990|FG003|Overall Study|Lost to Follow-up|0
6906061|NCT00706134|10928987|FG000|Overall Study|Protocol Violation|0
6906062|NCT00706134|10928988|FG001|Overall Study|Protocol Violation|6
6906063|NCT00706134|10928989|FG002|Overall Study|Protocol Violation|0
6906064|NCT00706134|10928990|FG003|Overall Study|Protocol Violation|3
6906065|NCT00706134|10928987|FG000|Overall Study|Withdrawal by Subject|1
6906066|NCT00706134|10928988|FG001|Overall Study|Withdrawal by Subject|2
6906067|NCT00706134|10928989|FG002|Overall Study|Withdrawal by Subject|1
6906068|NCT00706134|10928990|FG003|Overall Study|Withdrawal by Subject|0
6906069|NCT00706134|10928987|FG000|Overall Study|Unsatisfactory therapeutic effect|9
6906070|NCT00706134|10928988|FG001|Overall Study|Unsatisfactory therapeutic effect|3
6906071|NCT00706134|10928989|FG002|Overall Study|Unsatisfactory therapeutic effect|3
6906072|NCT00706134|10928990|FG003|Overall Study|Unsatisfactory therapeutic effect|5
6906073|NCT00706134|10928987|FG000|Overall Study|Did not meet study criteria|2
6906074|NCT00706134|10928988|FG001|Overall Study|Did not meet study criteria|0
6906075|NCT00706134|10928989|FG002|Overall Study|Did not meet study criteria|0
6906076|NCT00706134|10928990|FG003|Overall Study|Did not meet study criteria|0
6906077|NCT00706238|10929000|FG000|Overall Study|Disease progression|4
6906078|NCT00706238|10929000|FG000|Overall Study|Other|1
6906079|NCT00706342|10929015|FG000|Overall Study|Adverse Event|3
6906080|NCT00706342|10929015|FG000|Overall Study|Not responding to treatment|2
6906081|NCT00706342|10929015|FG000|Overall Study|Withdrawn due to failure to respond|1
6906082|NCT00706342|10929015|FG000|Overall Study|Death|1
6906083|NCT00706342|10929015|FG000|Overall Study|Withdrew from the study on his own.|1
6906084|NCT00706342|10929015|FG000|Overall Study|Investigator discretion|2
6906085|NCT00706342|10929015|FG000|Overall Study|Non-responder Week 12|1
6906086|NCT00706342|10929015|FG000|Overall Study|Ongoing|6
6906087|NCT00706342|10929015|FG000|Overall Study|WIthdrawal of consent|1
6906088|NCT00706355|10929023|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1
6906089|NCT00706355|10929024|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
6906090|NCT00706355|10929025|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
6906091|NCT00706355|10929026|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
6906092|NCT00706355|10929023|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2
6906093|NCT00706355|10929024|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
6906094|NCT00706355|10929025|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
6906095|NCT00706355|10929026|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
6906096|NCT00706355|10929023|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
6978739|NCT01214642|11032237|FG005|Overall Study|Physician Decision|0
7082203|NCT02139644|11192564|FG002|Treatment Period|Withdrawal by Subject|2
6906097|NCT00706355|10929024|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1
6906098|NCT00706355|10929025|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
6906099|NCT00706355|10929026|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
6906100|NCT00706355|10929023|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
6906101|NCT00706355|10929024|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1
6906102|NCT00706355|10929025|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
6906103|NCT00706355|10929026|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
6906104|NCT00706355|10929023|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
6906105|NCT00706355|10929024|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5
6906106|NCT00706355|10929025|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
6906107|NCT00706355|10929026|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
6906108|NCT00706355|10929023|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0
6906109|NCT00706355|10929024|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0
6906110|NCT00706355|10929025|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1
6906111|NCT00706355|10929026|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0
6906112|NCT00706355|10929023|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
6906113|NCT00706355|10929024|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
6906114|NCT00706355|10929025|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1
6906115|NCT00706355|10929026|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
6906116|NCT00706355|10929023|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0
6906117|NCT00706355|10929024|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0
6906118|NCT00706355|10929025|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0
6906119|NCT00706355|10929026|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2
6906120|NCT00706355|10929023|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
6906121|NCT00706355|10929024|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
6906122|NCT00706355|10929025|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
6906123|NCT00706355|10929026|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2
6906124|NCT00706381|10929042|FG000|Overall Study|Lost to Follow-up|0
6906125|NCT00706381|10929043|FG001|Overall Study|Lost to Follow-up|1
6906126|NCT00706381|10929044|FG002|Overall Study|Lost to Follow-up|1
6906127|NCT00706381|10929045|FG003|Overall Study|Lost to Follow-up|0
6906128|NCT00706433|10929075|FG000|Overall Study|Lost to Follow-up|3
6906129|NCT00706433|10929076|FG001|Overall Study|Lost to Follow-up|1
6906130|NCT00706433|10929077|FG002|Overall Study|Lost to Follow-up|6
6906131|NCT00706433|10929078|FG003|Overall Study|Lost to Follow-up|0
6906132|NCT00706433|10929075|FG000|Overall Study|Withdrawal by Subject|1
6906133|NCT00706433|10929076|FG001|Overall Study|Withdrawal by Subject|2
6906134|NCT00706433|10929077|FG002|Overall Study|Withdrawal by Subject|3
6906135|NCT00706433|10929078|FG003|Overall Study|Withdrawal by Subject|1
6906136|NCT00706433|10929075|FG000|Overall Study|Adverse Event|0
6906137|NCT00706433|10929076|FG001|Overall Study|Adverse Event|0
6906138|NCT00706433|10929077|FG002|Overall Study|Adverse Event|1
6906139|NCT00706433|10929078|FG003|Overall Study|Adverse Event|0
6906140|NCT00706433|10929075|FG000|Overall Study|Protocol Violation|1
6906141|NCT00706433|10929076|FG001|Overall Study|Protocol Violation|0
6906142|NCT00706433|10929077|FG002|Overall Study|Protocol Violation|0
6906143|NCT00706433|10929078|FG003|Overall Study|Protocol Violation|0
6906144|NCT00706433|10929075|FG000|Overall Study|new job|0
6906145|NCT00706433|10929076|FG001|Overall Study|new job|0
6906146|NCT00706433|10929077|FG002|Overall Study|new job|0
6906147|NCT00706433|10929078|FG003|Overall Study|new job|1
6906148|NCT00706511|10929121|FG000|Overall Study|Withdrawal by Subject|1
6906149|NCT00706511|10929122|FG001|Overall Study|Withdrawal by Subject|0
6906150|NCT00706511|10929123|FG002|Overall Study|Withdrawal by Subject|0
6906151|NCT00706511|10929124|FG003|Overall Study|Withdrawal by Subject|0
6906152|NCT00706628|10929164|FG000|Overall Study|Other Adverse Event|16
6906153|NCT00706628|10929165|FG001|Overall Study|Other Adverse Event|5
6906154|NCT00706628|10929166|FG002|Overall Study|Other Adverse Event|5
6906155|NCT00706628|10929167|FG003|Overall Study|Other Adverse Event|2
6906156|NCT00706628|10929164|FG000|Overall Study|Non compliant with protocol|0
6906157|NCT00706628|10929165|FG001|Overall Study|Non compliant with protocol|1
6906158|NCT00706628|10929166|FG002|Overall Study|Non compliant with protocol|0
6906159|NCT00706628|10929167|FG003|Overall Study|Non compliant with protocol|0
6906160|NCT00706628|10929164|FG000|Overall Study|Consent withdrawn|6
6906161|NCT00706628|10929165|FG001|Overall Study|Consent withdrawn|1
6906162|NCT00706628|10929166|FG002|Overall Study|Consent withdrawn|3
6906163|NCT00706628|10929167|FG003|Overall Study|Consent withdrawn|0
6906164|NCT00706628|10929164|FG000|Overall Study|Progressive disease|20
6906165|NCT00706628|10929165|FG001|Overall Study|Progressive disease|13
6906166|NCT00706628|10929166|FG002|Overall Study|Progressive disease|8
6906167|NCT00706628|10929167|FG003|Overall Study|Progressive disease|1
6906168|NCT00706628|10929164|FG000|Overall Study|Other than those stated above|4
6906169|NCT00706628|10929165|FG001|Overall Study|Other than those stated above|0
6906170|NCT00706628|10929166|FG002|Overall Study|Other than those stated above|0
6906171|NCT00706628|10929167|FG003|Overall Study|Other than those stated above|0
6906172|NCT00706628|10929164|FG000|Overall Study|Not treated|1
6906173|NCT00706628|10929165|FG001|Overall Study|Not treated|1
6906174|NCT00706628|10929166|FG002|Overall Study|Not treated|0
6906175|NCT00706628|10929167|FG003|Overall Study|Not treated|0
6906176|NCT00706641|10929180|FG000|Dasatinib Administration|Withdrawal by Subject|1
6906177|NCT00706641|10929180|FG000|Dasatinib Administration|Ineligible after start of therapy|1
6906178|NCT00706641|10929180|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1
6906179|NCT00706654|10929187|FG000|Conversion Phase|Lost to Follow-up|4
6906180|NCT00706654|10929188|FG001|Conversion Phase|Lost to Follow-up|0
6906181|NCT00706654|10929189|FG002|Conversion Phase|Lost to Follow-up|0
6906182|NCT00706654|10929190|FG003|Conversion Phase|Lost to Follow-up|0
6906183|NCT00706654|10929187|FG000|Conversion Phase|Sponsor Discontinued Trial|8
6906184|NCT00706654|10929188|FG001|Conversion Phase|Sponsor Discontinued Trial|0
6906185|NCT00706654|10929189|FG002|Conversion Phase|Sponsor Discontinued Trial|0
6906186|NCT00706654|10929190|FG003|Conversion Phase|Sponsor Discontinued Trial|0
6906187|NCT00706654|10929187|FG000|Conversion Phase|Met Withdrawal Criteria|2
6906188|NCT00706654|10929188|FG001|Conversion Phase|Met Withdrawal Criteria|0
6906189|NCT00706654|10929189|FG002|Conversion Phase|Met Withdrawal Criteria|0
6906190|NCT00706654|10929190|FG003|Conversion Phase|Met Withdrawal Criteria|0
6906191|NCT00706654|10929187|FG000|Conversion Phase|Withdrawn by Investigator|14
6906192|NCT00706654|10929188|FG001|Conversion Phase|Withdrawn by Investigator|0
6906193|NCT00706654|10929189|FG002|Conversion Phase|Withdrawn by Investigator|0
6906194|NCT00706654|10929190|FG003|Conversion Phase|Withdrawn by Investigator|0
6906195|NCT00706654|10929187|FG000|Conversion Phase|Withdrew Consent|38
6906196|NCT00706654|10929188|FG001|Conversion Phase|Withdrew Consent|0
6906197|NCT00706654|10929189|FG002|Conversion Phase|Withdrew Consent|0
6906198|NCT00706654|10929190|FG003|Conversion Phase|Withdrew Consent|0
6906199|NCT00706654|10929187|FG000|Conversion Phase|Adverse Event|18
6906200|NCT00706654|10929188|FG001|Conversion Phase|Adverse Event|0
6906201|NCT00706654|10929189|FG002|Conversion Phase|Adverse Event|0
6906202|NCT00706654|10929190|FG003|Conversion Phase|Adverse Event|0
6906203|NCT00706654|10929187|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9
6906204|NCT00706654|10929188|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0
6906205|NCT00706654|10929189|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0
6906206|NCT00706654|10929190|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0
6906207|NCT00706654|10929187|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2
6906208|NCT00706654|10929188|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0
6906209|NCT00706654|10929189|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0
6906210|NCT00706654|10929190|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0
6906211|NCT00706654|10929187|FG000|Oral Stabilization Phase|Lost to Follow-up|17
6906212|NCT00706654|10929188|FG001|Oral Stabilization Phase|Lost to Follow-up|0
6906213|NCT00706654|10929189|FG002|Oral Stabilization Phase|Lost to Follow-up|0
6906214|NCT00706654|10929190|FG003|Oral Stabilization Phase|Lost to Follow-up|0
6906215|NCT00706654|10929187|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19
6906216|NCT00706654|10929188|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0
6906217|NCT00706654|10929189|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0
6906218|NCT00706654|10929190|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0
6906219|NCT00706654|10929187|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15
6906220|NCT00706654|10929188|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0
6906221|NCT00706654|10929189|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0
6906222|NCT00706654|10929190|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0
6906223|NCT00706654|10929187|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21
6906224|NCT00706654|10929188|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0
6906225|NCT00706654|10929189|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0
6906226|NCT00706654|10929190|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0
6906227|NCT00706654|10929187|FG000|Oral Stabilization Phase|Withdrew consent|55
6906228|NCT00706654|10929188|FG001|Oral Stabilization Phase|Withdrew consent|0
6906229|NCT00706654|10929189|FG002|Oral Stabilization Phase|Withdrew consent|0
6906230|NCT00706654|10929190|FG003|Oral Stabilization Phase|Withdrew consent|0
6906231|NCT00706654|10929187|FG000|Oral Stabilization Phase|Protocol Deviation|2
6906232|NCT00706654|10929188|FG001|Oral Stabilization Phase|Protocol Deviation|0
6906233|NCT00706654|10929189|FG002|Oral Stabilization Phase|Protocol Deviation|0
6906234|NCT00706654|10929190|FG003|Oral Stabilization Phase|Protocol Deviation|0
6906235|NCT00706654|10929187|FG000|Oral Stabilization Phase|Adverse Event|21
6906236|NCT00706654|10929188|FG001|Oral Stabilization Phase|Adverse Event|0
6906237|NCT00706654|10929189|FG002|Oral Stabilization Phase|Adverse Event|0
6906238|NCT00706654|10929190|FG003|Oral Stabilization Phase|Adverse Event|0
6906239|NCT00706654|10929187|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20
6906240|NCT00706654|10929188|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
6906241|NCT00706654|10929189|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
6906242|NCT00706654|10929190|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
6906243|NCT00706654|10929187|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10
6906244|NCT00706654|10929188|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
6906245|NCT00706654|10929189|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
6906246|NCT00706654|10929190|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
6906247|NCT00706654|10929187|FG000|Depot Maintenance Phase|Lost to Follow-up|0
6906248|NCT00706654|10929188|FG001|Depot Maintenance Phase|Lost to Follow-up|4
6906249|NCT00706654|10929189|FG002|Depot Maintenance Phase|Lost to Follow-up|10
6906250|NCT00706654|10929190|FG003|Depot Maintenance Phase|Lost to Follow-up|6
6906251|NCT00706654|10929187|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0
6906252|NCT00706654|10929188|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4
6906253|NCT00706654|10929189|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6
6906254|NCT00706654|10929190|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5
6906255|NCT00706654|10929187|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0
6906256|NCT00706654|10929188|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8
6906257|NCT00706654|10929189|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12
6906258|NCT00706654|10929190|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8
6906259|NCT00706654|10929187|FG000|Depot Maintenance Phase|Withdrew Consent|0
6906260|NCT00706654|10929188|FG001|Depot Maintenance Phase|Withdrew Consent|21
6906261|NCT00706654|10929189|FG002|Depot Maintenance Phase|Withdrew Consent|29
6906262|NCT00706654|10929190|FG003|Depot Maintenance Phase|Withdrew Consent|14
6906263|NCT00706654|10929187|FG000|Depot Maintenance Phase|Protocol Deviation|0
6906264|NCT00706654|10929188|FG001|Depot Maintenance Phase|Protocol Deviation|2
6906265|NCT00706654|10929189|FG002|Depot Maintenance Phase|Protocol Deviation|3
6906266|NCT00706654|10929190|FG003|Depot Maintenance Phase|Protocol Deviation|1
6906267|NCT00706654|10929187|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
6906268|NCT00706654|10929188|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8
6906269|NCT00706654|10929189|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
6906270|NCT00706654|10929190|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
6906271|NCT00706654|10929187|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
6906272|NCT00706654|10929188|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
6906273|NCT00706654|10929189|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12
6906274|NCT00706654|10929190|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17
6906275|NCT00706654|10929187|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
6906276|NCT00706654|10929188|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
6906277|NCT00706654|10929189|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
6906278|NCT00706654|10929190|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12
6906279|NCT00706706|10929200|FG000|Overall Study|Death|53
6906280|NCT00706706|10929200|FG000|Overall Study|Lost to Follow-up|7
6906281|NCT00706706|10929200|FG000|Overall Study|Study endpoint had reached|45
6906282|NCT00706849|10929249|FG000|Treatment Period|Adverse Event|0
6906283|NCT00706849|10929250|FG001|Treatment Period|Adverse Event|9
6906284|NCT00706849|10929249|FG000|Treatment Period|Other|0
6906285|NCT00706849|10929250|FG001|Treatment Period|Other|1
6906286|NCT00706849|10929249|FG000|Follow-up Period|Withdrawal by Subject|0
6906287|NCT00706849|10929250|FG001|Follow-up Period|Withdrawal by Subject|2
6906288|NCT00706849|10929249|FG000|Follow-up Period|Protocol non-compliance|0
6906289|NCT00706849|10929250|FG001|Follow-up Period|Protocol non-compliance|1
6906290|NCT00706901|10929259|FG000|Overall Study|Lost to Follow-up|2
6906291|NCT00706901|10929260|FG001|Overall Study|Lost to Follow-up|3
6906292|NCT00706901|10929261|FG002|Overall Study|Lost to Follow-up|2
6906293|NCT00706901|10929259|FG000|Overall Study|Withdrawal by Subject|4
6906294|NCT00706901|10929260|FG001|Overall Study|Withdrawal by Subject|2
6906295|NCT00706901|10929261|FG002|Overall Study|Withdrawal by Subject|5
6906296|NCT00706901|10929259|FG000|Overall Study|In Jail|1
6906297|NCT00706901|10929260|FG001|Overall Study|In Jail|0
6906298|NCT00706901|10929261|FG002|Overall Study|In Jail|1
6906299|NCT00706901|10929259|FG000|Overall Study|Death|1
6906300|NCT00706901|10929260|FG001|Overall Study|Death|0
6906301|NCT00706901|10929261|FG002|Overall Study|Death|0
6906302|NCT00706914|10929273|FG000|Overall Study|Lack of Efficacy|0
6906303|NCT00706914|10929274|FG001|Overall Study|Lack of Efficacy|1
6906304|NCT00706914|10929275|FG002|Overall Study|Lack of Efficacy|0
6906305|NCT00706914|10929273|FG000|Overall Study|Lost to Follow-up|1
6906306|NCT00706914|10929274|FG001|Overall Study|Lost to Follow-up|0
6906307|NCT00706914|10929275|FG002|Overall Study|Lost to Follow-up|0
6906308|NCT00706914|10929273|FG000|Overall Study|Adverse Event|2
6906309|NCT00706914|10929274|FG001|Overall Study|Adverse Event|2
6906310|NCT00706914|10929275|FG002|Overall Study|Adverse Event|0
6906311|NCT00706914|10929273|FG000|Overall Study|Protocol Violation|3
6906312|NCT00706914|10929274|FG001|Overall Study|Protocol Violation|1
6906313|NCT00706914|10929275|FG002|Overall Study|Protocol Violation|1
6906314|NCT00706966|10929283|FG000|Overall Study|Adverse Event|1
6906315|NCT00706992|10929331|FG000|Overall Study|Study termination|5
6906316|NCT00706992|10929332|FG001|Overall Study|Study termination|5
6906317|NCT00706992|10929333|FG002|Overall Study|Study termination|6
6906318|NCT00706992|10929334|FG003|Overall Study|Study termination|2
6906319|NCT00706992|10929335|FG004|Overall Study|Study termination|3
6906320|NCT00706992|10929336|FG005|Overall Study|Study termination|2
6906321|NCT00706992|10929337|FG006|Overall Study|Study termination|3
6906322|NCT00706992|10929331|FG000|Overall Study|Disease progression before treatment|0
6906323|NCT00706992|10929332|FG001|Overall Study|Disease progression before treatment|0
6906324|NCT00706992|10929333|FG002|Overall Study|Disease progression before treatment|0
6906325|NCT00706992|10929334|FG003|Overall Study|Disease progression before treatment|0
6906326|NCT00706992|10929335|FG004|Overall Study|Disease progression before treatment|1
6906327|NCT00706992|10929336|FG005|Overall Study|Disease progression before treatment|0
6906328|NCT00706992|10929337|FG006|Overall Study|Disease progression before treatment|0
6906329|NCT00707031|10929356|FG000|Overall Study|Adverse Event|45
6906330|NCT00707031|10929357|FG001|Overall Study|Adverse Event|45
6906331|NCT00707031|10929356|FG000|Overall Study|Lack of Efficacy|19
6906332|NCT00707031|10929357|FG001|Overall Study|Lack of Efficacy|6
6906333|NCT00707031|10929356|FG000|Overall Study|Lost to Follow-up|2
6906334|NCT00707031|10929357|FG001|Overall Study|Lost to Follow-up|1
6906335|NCT00707031|10929356|FG000|Overall Study|Protocol Violation|1
6906336|NCT00707031|10929357|FG001|Overall Study|Protocol Violation|0
6906337|NCT00707031|10929356|FG000|Overall Study|Withdrawal by Subject|7
6906338|NCT00707031|10929357|FG001|Overall Study|Withdrawal by Subject|8
6906339|NCT00707031|10929356|FG000|Overall Study|Poor Compliance to Protocol|7
6906340|NCT00707031|10929357|FG001|Overall Study|Poor Compliance to Protocol|13
6906341|NCT00707031|10929356|FG000|Overall Study|Familial or Personal Reasons|12
6906342|NCT00707031|10929357|FG001|Overall Study|Familial or Personal Reasons|15
6906343|NCT00707031|10929356|FG000|Overall Study|Serious Noncompliance|2
6906344|NCT00707031|10929357|FG001|Overall Study|Serious Noncompliance|3
6906345|NCT00707031|10929356|FG000|Overall Study|Sponsor Decision|9
6906346|NCT00707031|10929357|FG001|Overall Study|Sponsor Decision|8
6906347|NCT00707057|10929366|FG000|Overall Study|Withdrawal by Subject|8
6906348|NCT00707057|10929367|FG001|Overall Study|Withdrawal by Subject|3
6906349|NCT00707057|10929366|FG000|Overall Study|Dosed incorrectly|0
6906350|NCT00707057|10929367|FG001|Overall Study|Dosed incorrectly|1
6906351|NCT00707174|10929375|FG000|Overall Study|Adverse Event|1
6906352|NCT00707174|10929376|FG001|Overall Study|Adverse Event|6
6906353|NCT00707174|10929375|FG000|Overall Study|Withdrawal by Subject|4
6906354|NCT00707174|10929376|FG001|Overall Study|Withdrawal by Subject|1
6906355|NCT00707239|10929385|FG000|Overall Study|Adverse Event|5
6906356|NCT00707239|10929386|FG001|Overall Study|Adverse Event|3
6906357|NCT00707239|10929387|FG002|Overall Study|Adverse Event|2
6906358|NCT00707239|10929385|FG000|Overall Study|Death|3
6906359|NCT00707239|10929386|FG001|Overall Study|Death|1
6906360|NCT00707239|10929387|FG002|Overall Study|Death|3
6906361|NCT00707239|10929385|FG000|Overall Study|Physician Decision|1
6906362|NCT00707239|10929386|FG001|Overall Study|Physician Decision|1
6906363|NCT00707239|10929387|FG002|Overall Study|Physician Decision|2
6906364|NCT00707239|10929385|FG000|Overall Study|Protocol Violation|0
6906365|NCT00707239|10929386|FG001|Overall Study|Protocol Violation|0
6906366|NCT00707239|10929387|FG002|Overall Study|Protocol Violation|1
6906367|NCT00707239|10929385|FG000|Overall Study|Lack of Efficacy|1
6906368|NCT00707239|10929386|FG001|Overall Study|Lack of Efficacy|2
6906369|NCT00707239|10929387|FG002|Overall Study|Lack of Efficacy|0
6906370|NCT00707239|10929385|FG000|Overall Study|Randomized, but not treated|1
6906371|NCT00707239|10929386|FG001|Overall Study|Randomized, but not treated|1
6906372|NCT00707239|10929387|FG002|Overall Study|Randomized, but not treated|1
6906373|NCT00707239|10929385|FG000|Overall Study|Other|8
6906374|NCT00707239|10929386|FG001|Overall Study|Other|3
6906375|NCT00707239|10929387|FG002|Overall Study|Other|5
6906376|NCT00707486|10929411|FG000|Overall Study|Withdrawal by Subject|1
6906377|NCT00707577|10929419|FG000|Overall Study|Withdrawal by Subject|3
6906378|NCT00707577|10929420|FG001|Overall Study|Withdrawal by Subject|2
6906379|NCT00707577|10929419|FG000|Overall Study|Lost to Follow-up|34
6906380|NCT00707577|10929420|FG001|Overall Study|Lost to Follow-up|25
6906381|NCT00707577|10929419|FG000|Overall Study|Left employment|13
6906382|NCT00707577|10929420|FG001|Overall Study|Left employment|10
6906383|NCT00707577|10929419|FG000|Overall Study|Pregnancy|4
6906384|NCT00707577|10929420|FG001|Overall Study|Pregnancy|1
6906385|NCT00707746|10929439|FG000|Treatment Period|Adverse Event|2
6906386|NCT00707746|10929440|FG001|Treatment Period|Adverse Event|4
6906387|NCT00707746|10929439|FG000|Treatment Period|Ineligibility|0
6906388|NCT00707746|10929440|FG001|Treatment Period|Ineligibility|1
6906389|NCT00707954|10929473|FG000|Overall Study|Physician Decision|0
6906390|NCT00707954|10929474|FG001|Overall Study|Physician Decision|0
6906391|NCT00707954|10929475|FG002|Overall Study|Physician Decision|0
6906392|NCT00707954|10929476|FG003|Overall Study|Physician Decision|0
6906393|NCT00707954|10929477|FG004|Overall Study|Physician Decision|1
6906394|NCT00707980|10929502|FG000|Overall Study|Adverse Event|49
6906395|NCT00707980|10929502|FG000|Overall Study|Lack of Efficacy|35
6906396|NCT00707980|10929502|FG000|Overall Study|Non-Compliance with Study Drug|28
6906397|NCT00707980|10929502|FG000|Overall Study|Protocol Deviations|19
6906398|NCT00707980|10929502|FG000|Overall Study|Withdrawal of Consent|81
6906399|NCT00707980|10929502|FG000|Overall Study|Lost to Follow-up|59
6906400|NCT00707980|10929502|FG000|Overall Study|Other|39
6906401|NCT00707993|10929508|FG000|Overall Study|Adverse Event|16
6906402|NCT00707993|10929509|FG001|Overall Study|Adverse Event|20
6906403|NCT00707993|10929508|FG000|Overall Study|Protocol Violation|4
6906404|NCT00707993|10929509|FG001|Overall Study|Protocol Violation|7
6906405|NCT00707993|10929508|FG000|Overall Study|Lost to Follow-up|0
6906406|NCT00707993|10929509|FG001|Overall Study|Lost to Follow-up|4
6906407|NCT00707993|10929508|FG000|Overall Study|Withdrawal by Subject|12
6906408|NCT00707993|10929509|FG001|Overall Study|Withdrawal by Subject|16
6906409|NCT00707993|10929508|FG000|Overall Study|Hyperglycemic Rescue|55
6906410|NCT00707993|10929509|FG001|Overall Study|Hyperglycemic Rescue|47
6906411|NCT00707993|10929508|FG000|Overall Study|Other|2
6906412|NCT00707993|10929509|FG001|Overall Study|Other|0
6906413|NCT00708032|10929526|FG000|Overall Study|Adverse Event|0
6906414|NCT00708032|10929527|FG001|Overall Study|Adverse Event|2
6906415|NCT00708032|10929526|FG000|Overall Study|Lost to Follow-up|1
6906416|NCT00708032|10929527|FG001|Overall Study|Lost to Follow-up|2
6906417|NCT00708032|10929526|FG000|Overall Study|Pregnancy|0
6906418|NCT00708032|10929527|FG001|Overall Study|Pregnancy|1
6906419|NCT00708032|10929526|FG000|Overall Study|Poor vision|0
6906420|NCT00708032|10929527|FG001|Overall Study|Poor vision|6
6906421|NCT00708032|10929526|FG000|Overall Study|Visit out of range at month 12|4
6906422|NCT00708032|10929527|FG001|Overall Study|Visit out of range at month 12|1
6906423|NCT00708032|10929526|FG000|Overall Study|Did not meet protocol criteria|1
6906424|NCT00708032|10929527|FG001|Overall Study|Did not meet protocol criteria|2
6906425|NCT00708032|10929526|FG000|Overall Study|Protocol Violation|4
6906426|NCT00708032|10929527|FG001|Overall Study|Protocol Violation|1
6906427|NCT00708032|10929526|FG000|Overall Study|Withdrawal by Subject|0
6906428|NCT00708032|10929527|FG001|Overall Study|Withdrawal by Subject|1
6906429|NCT00708097|10929567|FG000|Period 1|Protocol Violation|0
6906430|NCT00708097|10929568|FG001|Period 1|Protocol Violation|1
6906431|NCT00708097|10929569|FG002|Period 1|Protocol Violation|0
6906432|NCT00708097|10929570|FG003|Period 1|Protocol Violation|2
6906433|NCT00708097|10929571|FG004|Period 1|Protocol Violation|0
6906434|NCT00708097|10929567|FG000|Period 1|Other Reason|0
6906435|NCT00708097|10929568|FG001|Period 1|Other Reason|0
6906436|NCT00708097|10929569|FG002|Period 1|Other Reason|0
6906437|NCT00708097|10929570|FG003|Period 1|Other Reason|0
6906438|NCT00708097|10929571|FG004|Period 1|Other Reason|1
6906439|NCT00708097|10929567|FG000|Period 2|Protocol Violation|0
6906440|NCT00708097|10929568|FG001|Period 2|Protocol Violation|1
6906441|NCT00708097|10929569|FG002|Period 2|Protocol Violation|1
6906442|NCT00708097|10929570|FG003|Period 2|Protocol Violation|1
6906443|NCT00708097|10929571|FG004|Period 2|Protocol Violation|0
6906444|NCT00708123|10929605|FG000|Period 1|Protocol Violation|0
6906445|NCT00708123|10929606|FG001|Period 1|Protocol Violation|1
6906446|NCT00708123|10929607|FG002|Period 1|Protocol Violation|0
6906447|NCT00708123|10929608|FG003|Period 1|Protocol Violation|1
6906448|NCT00708123|10929609|FG004|Period 1|Protocol Violation|0
6906449|NCT00708123|10929605|FG000|Period 1|Adverse Event|0
6906450|NCT00708123|10929606|FG001|Period 1|Adverse Event|0
6906451|NCT00708123|10929607|FG002|Period 1|Adverse Event|1
6906452|NCT00708123|10929608|FG003|Period 1|Adverse Event|0
6906453|NCT00708123|10929609|FG004|Period 1|Adverse Event|0
6906454|NCT00708123|10929605|FG000|Period 2|Protocol Violation|0
6906455|NCT00708123|10929606|FG001|Period 2|Protocol Violation|0
6906456|NCT00708123|10929607|FG002|Period 2|Protocol Violation|0
6906457|NCT00708123|10929608|FG003|Period 2|Protocol Violation|1
6906458|NCT00708123|10929609|FG004|Period 2|Protocol Violation|0
6906459|NCT00708123|10929605|FG000|Period 2|Other Reason|1
6906460|NCT00708123|10929606|FG001|Period 2|Other Reason|0
6906461|NCT00708123|10929607|FG002|Period 2|Other Reason|0
6906462|NCT00708123|10929608|FG003|Period 2|Other Reason|0
6906463|NCT00708123|10929609|FG004|Period 2|Other Reason|0
6906464|NCT00708123|10929605|FG000|Period 3|Lost to Follow-up|0
6906465|NCT00708123|10929606|FG001|Period 3|Lost to Follow-up|0
6906466|NCT00708123|10929607|FG002|Period 3|Lost to Follow-up|1
6906467|NCT00708123|10929608|FG003|Period 3|Lost to Follow-up|1
6906468|NCT00708123|10929609|FG004|Period 3|Lost to Follow-up|0
6906469|NCT00708123|10929605|FG000|Period 4|Protocol Violation|0
6906470|NCT00708123|10929606|FG001|Period 4|Protocol Violation|1
6906471|NCT00708123|10929607|FG002|Period 4|Protocol Violation|0
6906472|NCT00708123|10929608|FG003|Period 4|Protocol Violation|0
6906473|NCT00708123|10929609|FG004|Period 4|Protocol Violation|0
6906474|NCT00708162|10929627|FG000|Randomized Phase|Randomized but Not Treated|7
6906475|NCT00708162|10929628|FG001|Randomized Phase|Randomized but Not Treated|5
6906476|NCT00708162|10929627|FG000|Randomized Phase|Participant Noncompliance|40
6906477|NCT00708162|10929628|FG001|Randomized Phase|Participant Noncompliance|32
6906478|NCT00708162|10929627|FG000|Randomized Phase|Lost to Follow-up|34
6906479|NCT00708162|10929628|FG001|Randomized Phase|Lost to Follow-up|34
6906480|NCT00708162|10929627|FG000|Randomized Phase|Withdrew Consent|31
6906481|NCT00708162|10929628|FG001|Randomized Phase|Withdrew Consent|22
6906482|NCT00708162|10929627|FG000|Randomized Phase|Lack of Efficacy|14
6906483|NCT00708162|10929628|FG001|Randomized Phase|Lack of Efficacy|19
6906484|NCT00708162|10929627|FG000|Randomized Phase|Protocol Violation|10
6906485|NCT00708162|10929628|FG001|Randomized Phase|Protocol Violation|11
6906486|NCT00708162|10929627|FG000|Randomized Phase|Adverse Event|8
6906487|NCT00708162|10929628|FG001|Randomized Phase|Adverse Event|12
6906488|NCT00708162|10929627|FG000|Randomized Phase|Investigator's Discretion|7
6906489|NCT00708162|10929628|FG001|Randomized Phase|Investigator's Discretion|10
6906490|NCT00708162|10929627|FG000|Randomized Phase|Death|2
6906491|NCT00708162|10929628|FG001|Randomized Phase|Death|9
6906492|NCT00708162|10929627|FG000|Randomized Phase|Pregnancy|3
6906493|NCT00708162|10929628|FG001|Randomized Phase|Pregnancy|0
6906494|NCT00708162|10929627|FG000|Open-Label Phase|Lost to Follow-up|10
6906495|NCT00708162|10929628|FG001|Open-Label Phase|Lost to Follow-up|8
6906496|NCT00708162|10929627|FG000|Open-Label Phase|Withdrew Consent|12
6906497|NCT00708162|10929628|FG001|Open-Label Phase|Withdrew Consent|6
6906498|NCT00708162|10929627|FG000|Open-Label Phase|Participant Noncompliance|7
6906499|NCT00708162|10929628|FG001|Open-Label Phase|Participant Noncompliance|7
6906500|NCT00708162|10929627|FG000|Open-Label Phase|Lack of Efficacy|7
6906501|NCT00708162|10929628|FG001|Open-Label Phase|Lack of Efficacy|4
6906502|NCT00708162|10929627|FG000|Open-Label Phase|Investigator's Discretion|3
6906503|NCT00708162|10929628|FG001|Open-Label Phase|Investigator's Discretion|2
6906504|NCT00708162|10929627|FG000|Open-Label Phase|Death|3
6906505|NCT00708162|10929628|FG001|Open-Label Phase|Death|1
6978740|NCT01214642|11032238|FG006|Overall Study|Physician Decision|0
6978741|NCT01214642|11032239|FG007|Overall Study|Physician Decision|0
6906506|NCT00708162|10929627|FG000|Open-Label Phase|Adverse Event|1
6906507|NCT00708162|10929628|FG001|Open-Label Phase|Adverse Event|2
6906508|NCT00708162|10929627|FG000|Open-Label Phase|Other|1
6906509|NCT00708162|10929628|FG001|Open-Label Phase|Other|0
6906510|NCT00708175|10929637|FG000|Overall Study|Adverse Event|4
6906511|NCT00708175|10929638|FG001|Overall Study|Adverse Event|5
6906512|NCT00708175|10929637|FG000|Overall Study|Protocol Violation|2
6906513|NCT00708175|10929638|FG001|Overall Study|Protocol Violation|3
6906514|NCT00708175|10929637|FG000|Overall Study|Lost to Follow-up|5
6906515|NCT00708175|10929638|FG001|Overall Study|Lost to Follow-up|3
6906516|NCT00708175|10929637|FG000|Overall Study|Withdrawal by Subject|5
6906517|NCT00708175|10929638|FG001|Overall Study|Withdrawal by Subject|7
6906518|NCT00708175|10929637|FG000|Overall Study|BMD loss >7%|2
6906519|NCT00708175|10929638|FG001|Overall Study|BMD loss >7%|3
6906520|NCT00708201|10929646|FG000|Overall Study|Adverse Event|4
6906521|NCT00708201|10929647|FG001|Overall Study|Adverse Event|4
6906522|NCT00708201|10929646|FG000|Overall Study|Withdrawal by Subject|1
6906523|NCT00708201|10929647|FG001|Overall Study|Withdrawal by Subject|1
6906524|NCT00708201|10929646|FG000|Overall Study|Lost to Follow-up|2
6906525|NCT00708201|10929647|FG001|Overall Study|Lost to Follow-up|0
6906526|NCT00708201|10929646|FG000|Overall Study|Protocol Violation|0
6906527|NCT00708201|10929647|FG001|Overall Study|Protocol Violation|1
6906528|NCT00708214|10929656|FG000|Overall Study|Other Adverse Event|3
6906529|NCT00708214|10929657|FG001|Overall Study|Other Adverse Event|6
6906530|NCT00708214|10929658|FG002|Overall Study|Other Adverse Event|2
6906531|NCT00708214|10929656|FG000|Overall Study|Other|0
6906532|NCT00708214|10929657|FG001|Overall Study|Other|1
6906533|NCT00708214|10929658|FG002|Overall Study|Other|1
6906534|NCT00708214|10929656|FG000|Overall Study|Progressive Disease|4
6906535|NCT00708214|10929657|FG001|Overall Study|Progressive Disease|6
6906536|NCT00708214|10929658|FG002|Overall Study|Progressive Disease|5
6906537|NCT00708227|10929675|FG000|Overall Study|Physician Decision|0
6906538|NCT00708227|10929676|FG001|Overall Study|Physician Decision|3
6906539|NCT00708227|10929677|FG002|Overall Study|Physician Decision|1
6906540|NCT00708227|10929678|FG003|Overall Study|Physician Decision|2
6906541|NCT00708227|10929675|FG000|Overall Study|Withdrawal by Subject|1
6906542|NCT00708227|10929676|FG001|Overall Study|Withdrawal by Subject|2
6906543|NCT00708227|10929677|FG002|Overall Study|Withdrawal by Subject|0
6906544|NCT00708227|10929678|FG003|Overall Study|Withdrawal by Subject|1
6973934|NCT01185353|11025990|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0
6978742|NCT01214642|11032240|FG008|Overall Study|Physician Decision|0
6978743|NCT01214642|11032241|FG009|Overall Study|Physician Decision|0
6978744|NCT01214642|11032242|FG010|Overall Study|Physician Decision|0
6978745|NCT01214642|11032243|FG011|Overall Study|Physician Decision|2
6978746|NCT01214655|11032289|FG000|Part A|Progressive Disease|7
6978747|NCT01214655|11032290|FG001|Part A|Progressive Disease|0
6978748|NCT01214655|11032291|FG002|Part A|Progressive Disease|0
6978749|NCT01214655|11032289|FG000|Part A|Physician Decision|1
6978750|NCT01214655|11032290|FG001|Part A|Physician Decision|0
6978751|NCT01214655|11032291|FG002|Part A|Physician Decision|0
6978752|NCT01214655|11032289|FG000|Part B|Progressive disease|0
7060162|NCT01914926|11156154|FG001|Overall Study|uncooperative, agitated and removed|1
7060163|NCT01915095|11156167|FG000|Overall Study|Some subjects were unable to commit to the training study.|0
7060164|NCT01915095|11156168|FG001|Overall Study|Some subjects were unable to commit to the training study.|0
7082204|NCT02139644|11192565|FG003|Treatment Period|Withdrawal by Subject|2
6973935|NCT01185353|11025991|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0
6973936|NCT01185353|11025992|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0
6973937|NCT01185353|11025993|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0
6973938|NCT01185353|11025994|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0
6973939|NCT01185353|11025985|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
6973940|NCT01185353|11025986|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
6973941|NCT01185353|11025987|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
6973942|NCT01185353|11025988|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
6973943|NCT01185353|11025989|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4
6973944|NCT01185353|11025990|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
6973945|NCT01185353|11025991|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
6973946|NCT01185353|11025992|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
6973947|NCT01185353|11025993|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
6973948|NCT01185353|11025994|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
6973949|NCT01185353|11025985|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2
6973950|NCT01185353|11025986|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
6973951|NCT01185353|11025987|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
6973952|NCT01185353|11025988|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
6973953|NCT01185353|11025989|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1
6973954|NCT01185353|11025990|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
6973955|NCT01185353|11025991|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
6978753|NCT01214655|11032290|FG001|Part B|Progressive disease|10
6978754|NCT01214655|11032291|FG002|Part B|Progressive disease|0
6906545|NCT00708305|10929708|FG000|Period 1|Protocol Violation|1
6906546|NCT00708305|10929709|FG001|Period 1|Protocol Violation|0
6906547|NCT00708305|10929710|FG002|Period 1|Protocol Violation|1
6906548|NCT00708305|10929711|FG003|Period 1|Protocol Violation|0
6906549|NCT00708305|10929708|FG000|Period 1|Other Reason|0
6906550|NCT00708305|10929709|FG001|Period 1|Other Reason|0
6906551|NCT00708305|10929710|FG002|Period 1|Other Reason|0
6906552|NCT00708305|10929711|FG003|Period 1|Other Reason|2
6906553|NCT00708305|10929708|FG000|Period 2|Lost to Follow-up|0
6906554|NCT00708305|10929709|FG001|Period 2|Lost to Follow-up|1
6906555|NCT00708305|10929710|FG002|Period 2|Lost to Follow-up|0
6906556|NCT00708305|10929711|FG003|Period 2|Lost to Follow-up|0
6906557|NCT00708305|10929708|FG000|Period 2|Protocol Violation|0
6906558|NCT00708305|10929709|FG001|Period 2|Protocol Violation|1
6906559|NCT00708305|10929710|FG002|Period 2|Protocol Violation|0
6906560|NCT00708305|10929711|FG003|Period 2|Protocol Violation|0
6906561|NCT00708305|10929708|FG000|Period 2|Other Reason|1
6906562|NCT00708305|10929709|FG001|Period 2|Other Reason|0
6906563|NCT00708305|10929710|FG002|Period 2|Other Reason|0
6906564|NCT00708305|10929711|FG003|Period 2|Other Reason|1
6906565|NCT00708305|10929708|FG000|Period 3|Protocol Violation|0
6906566|NCT00708305|10929709|FG001|Period 3|Protocol Violation|2
6906567|NCT00708305|10929710|FG002|Period 3|Protocol Violation|0
6906568|NCT00708305|10929711|FG003|Period 3|Protocol Violation|0
6906569|NCT00708305|10929708|FG000|Period 3|Other Reason|1
6906570|NCT00708305|10929709|FG001|Period 3|Other Reason|0
6906571|NCT00708305|10929710|FG002|Period 3|Other Reason|0
6906572|NCT00708305|10929711|FG003|Period 3|Other Reason|0
6906573|NCT00708422|10929726|FG000|Overall Study|Adverse Event|3
6906574|NCT00708422|10929727|FG001|Overall Study|Adverse Event|1
6906575|NCT00708422|10929726|FG000|Overall Study|Withdrawal by Subject|1
6906576|NCT00708422|10929727|FG001|Overall Study|Withdrawal by Subject|0
6906577|NCT00708435|10929735|FG000|Overall Study|Death / Serious Adverse Event|10
6906578|NCT00708435|10929736|FG001|Overall Study|Death / Serious Adverse Event|5
6906579|NCT00708435|10929735|FG000|Overall Study|Lost to Follow-up|9
6906580|NCT00708435|10929736|FG001|Overall Study|Lost to Follow-up|4
6906581|NCT00708435|10929735|FG000|Overall Study|Withdrawal by Subject|3
6906582|NCT00708435|10929736|FG001|Overall Study|Withdrawal by Subject|7
6906583|NCT00708435|10929735|FG000|Overall Study|Adverse Event|1
6906584|NCT00708435|10929736|FG001|Overall Study|Adverse Event|0
6906585|NCT00708435|10929735|FG000|Overall Study|Protocol Violation|0
6906586|NCT00708435|10929736|FG001|Overall Study|Protocol Violation|1
6906587|NCT00708435|10929735|FG000|Overall Study|Intervention by primary care physician|1
6906588|NCT00708435|10929736|FG001|Overall Study|Intervention by primary care physician|0
6906589|NCT00708435|10929735|FG000|Overall Study|Refused hospitalization|1
6906590|NCT00708435|10929736|FG001|Overall Study|Refused hospitalization|0
6906591|NCT00708461|10929746|FG000|Overall Study|Lost to Follow-up|18
6906592|NCT00708461|10929747|FG001|Overall Study|Lost to Follow-up|11
6906593|NCT00708461|10929746|FG000|Overall Study|Withdrawal by Subject|8
6906594|NCT00708461|10929747|FG001|Overall Study|Withdrawal by Subject|9
6906595|NCT00708461|10929746|FG000|Overall Study|left workforce|115
6906596|NCT00708461|10929747|FG001|Overall Study|left workforce|180
6906597|NCT00708500|10929756|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
6906598|NCT00708500|10929757|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3
6906599|NCT00708500|10929758|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
6906600|NCT00708500|10929756|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1
6906601|NCT00708500|10929757|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
6906602|NCT00708500|10929758|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
6906603|NCT00708500|10929756|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
6906604|NCT00708500|10929757|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1
6906605|NCT00708500|10929758|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
6906606|NCT00708500|10929756|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
6906607|NCT00708500|10929757|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2
6906608|NCT00708500|10929758|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
6906609|NCT00708500|10929756|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
6906610|NCT00708500|10929757|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
6906611|NCT00708500|10929758|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1
6906612|NCT00708500|10929756|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1
6906613|NCT00708500|10929757|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10
6906614|NCT00708500|10929758|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19
6906615|NCT00708500|10929756|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49
6906616|NCT00708500|10929757|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36
6906617|NCT00708500|10929758|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29
6906618|NCT00708500|10929756|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
6906619|NCT00708500|10929757|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1
6906620|NCT00708500|10929758|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
6906621|NCT00708500|10929756|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3
6906622|NCT00708500|10929757|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1
6977138|NCT01205126|11030145|FG000|Maintenance Phase|Prohibited drugs used|1
6906623|NCT00708500|10929758|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4
6906624|NCT00708500|10929756|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2
6906625|NCT00708500|10929757|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0
6906626|NCT00708500|10929758|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1
6906627|NCT00708500|10929756|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0
6906628|NCT00708500|10929757|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2
6906629|NCT00708500|10929758|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1
6906630|NCT00708500|10929756|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0
6906631|NCT00708500|10929757|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
6906632|NCT00708500|10929758|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
6906633|NCT00708500|10929756|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
6906634|NCT00708500|10929757|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1
6906635|NCT00708500|10929758|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
6906636|NCT00708500|10929756|FG000|FOLLOWUP|Adverse Event|0
6906637|NCT00708500|10929757|FG001|FOLLOWUP|Adverse Event|1
6906638|NCT00708500|10929758|FG002|FOLLOWUP|Adverse Event|0
6906639|NCT00708500|10929756|FG000|FOLLOWUP|Lost to Follow-up|1
6906640|NCT00708500|10929757|FG001|FOLLOWUP|Lost to Follow-up|6
6906641|NCT00708500|10929758|FG002|FOLLOWUP|Lost to Follow-up|4
6906642|NCT00708500|10929756|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3
6906643|NCT00708500|10929757|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4
6906644|NCT00708500|10929758|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5
6906645|NCT00708500|10929756|FG000|FOLLOWUP|Subject withdrew consent|31
6906646|NCT00708500|10929757|FG001|FOLLOWUP|Subject withdrew consent|4
6906647|NCT00708500|10929758|FG002|FOLLOWUP|Subject withdrew consent|5
6906648|NCT00708500|10929756|FG000|FOLLOWUP|Non-compliance with protocol|5
6906649|NCT00708500|10929757|FG001|FOLLOWUP|Non-compliance with protocol|0
6906650|NCT00708500|10929758|FG002|FOLLOWUP|Non-compliance with protocol|1
6906651|NCT00708552|10929779|FG000|Overall Study|Adverse Event|10
6906652|NCT00708552|10929780|FG001|Overall Study|Adverse Event|3
6906653|NCT00708552|10929781|FG002|Overall Study|Adverse Event|4
6906654|NCT00708552|10929782|FG003|Overall Study|Adverse Event|6
6906655|NCT00708552|10929779|FG000|Overall Study|Lack of Efficacy|0
6906656|NCT00708552|10929780|FG001|Overall Study|Lack of Efficacy|4
6906657|NCT00708552|10929781|FG002|Overall Study|Lack of Efficacy|1
6906658|NCT00708552|10929782|FG003|Overall Study|Lack of Efficacy|0
6906659|NCT00708552|10929779|FG000|Overall Study|Protocol Violation|0
6906660|NCT00708552|10929780|FG001|Overall Study|Protocol Violation|0
6906661|NCT00708552|10929781|FG002|Overall Study|Protocol Violation|2
6906662|NCT00708552|10929782|FG003|Overall Study|Protocol Violation|4
6906663|NCT00708552|10929779|FG000|Overall Study|Lost to Follow-up|4
6906664|NCT00708552|10929780|FG001|Overall Study|Lost to Follow-up|2
6906665|NCT00708552|10929781|FG002|Overall Study|Lost to Follow-up|0
6906666|NCT00708552|10929782|FG003|Overall Study|Lost to Follow-up|1
6906667|NCT00708552|10929779|FG000|Overall Study|Physician Decision|1
6906668|NCT00708552|10929780|FG001|Overall Study|Physician Decision|2
6906669|NCT00708552|10929781|FG002|Overall Study|Physician Decision|0
6906670|NCT00708552|10929782|FG003|Overall Study|Physician Decision|0
6906671|NCT00708552|10929779|FG000|Overall Study|Withdrawal by Subject|12
6906672|NCT00708552|10929780|FG001|Overall Study|Withdrawal by Subject|7
6906673|NCT00708552|10929781|FG002|Overall Study|Withdrawal by Subject|8
6906674|NCT00708552|10929782|FG003|Overall Study|Withdrawal by Subject|10
6906675|NCT00708643|10929798|FG000|Overall Study|Adverse Event|0
6906676|NCT00708643|10929799|FG001|Overall Study|Adverse Event|1
6906677|NCT00708682|10929805|FG000|Infant Series|Adverse Event|1
6906678|NCT00708682|10929805|FG000|Infant Series|Lost to Follow-up|4
6906679|NCT00708682|10929805|FG000|Infant Series|Protocol Violation|1
6906680|NCT00708682|10929805|FG000|Infant Series|Parent/legal guardian request|6
6906681|NCT00708682|10929805|FG000|Infant Series|Failed to return|2
6906682|NCT00708682|10929805|FG000|Infant Series|Other|19
6906683|NCT00708682|10929805|FG000|After Infant Series|Parent/Legal Guardian Request|1
6906684|NCT00708682|10929805|FG000|Toddler Dose|Parent/Legal Guardian Request|1
6906685|NCT00708682|10929805|FG000|Toddler Dose|Lost to Follow-up|3
6906686|NCT00708682|10929805|FG000|Toddler Dose|Failed to Return|4
6906687|NCT00708708|10929811|FG000|Overall Study|Another therapy instead of Enbrel|141
6906688|NCT00708708|10929811|FG000|Overall Study|Lost to Follow-up|52
6906689|NCT00708708|10929811|FG000|Overall Study|Withdrawal by Subject|51
6906690|NCT00708708|10929811|FG000|Overall Study|Intolerance|42
6906691|NCT00708708|10929811|FG000|Overall Study|Another therapy along with Enbrel|15
6906692|NCT00708708|10929811|FG000|Overall Study|Other unspecified|11
6906693|NCT00708708|10929811|FG000|Overall Study|Good effectiveness|9
6906694|NCT00708708|10929811|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9
6906695|NCT00708708|10929811|FG000|Overall Study|Administrative reasons|7
6906696|NCT00708708|10929811|FG000|Overall Study|Lack of effectiveness|4
6906697|NCT00708708|10929811|FG000|Overall Study|Lack of compliance|3
6906698|NCT00708708|10929811|FG000|Overall Study|Pregnancy|3
6906699|NCT00708708|10929811|FG000|Overall Study|Adverse Event|3
6906700|NCT00708708|10929811|FG000|Overall Study|Missing values|392
6906701|NCT00709059|10929863|FG000|Overall Study|Lost to Follow-up|34
6906702|NCT00709059|10929863|FG000|Overall Study|Withdrawal by Subject|19
6906703|NCT00709059|10929863|FG000|Overall Study|Physician Decision|7
6906704|NCT00709059|10929863|FG000|Overall Study|Disease complication|3
6906705|NCT00709059|10929863|FG000|Overall Study|Side effects|20
6906706|NCT00709059|10929863|FG000|Overall Study|Serious side effects|11
6906707|NCT00709098|10929870|FG000|Double-blind Period|Withdrawal of consent|3
6906708|NCT00709098|10929871|FG001|Double-blind Period|Withdrawal of consent|3
6906709|NCT00709098|10929872|FG002|Double-blind Period|Withdrawal of consent|0
6906710|NCT00709098|10929870|FG000|Double-blind Period|Administrative reason|1
6906711|NCT00709098|10929871|FG001|Double-blind Period|Administrative reason|3
6906712|NCT00709098|10929872|FG002|Double-blind Period|Administrative reason|0
6906713|NCT00709098|10929870|FG000|Double-blind Period|Death|1
6906714|NCT00709098|10929871|FG001|Double-blind Period|Death|1
6906715|NCT00709098|10929872|FG002|Double-blind Period|Death|0
6906716|NCT00709098|10929870|FG000|Double-blind Period|Lost to Follow-up|1
6906717|NCT00709098|10929871|FG001|Double-blind Period|Lost to Follow-up|1
6906718|NCT00709098|10929872|FG002|Double-blind Period|Lost to Follow-up|0
6906719|NCT00709098|10929870|FG000|Open-label Period|Withdrawal of consent|0
6906720|NCT00709098|10929871|FG001|Open-label Period|Withdrawal of consent|0
6906721|NCT00709098|10929872|FG002|Open-label Period|Withdrawal of consent|7
6906722|NCT00709098|10929870|FG000|Open-label Period|Administrative reason|0
6906723|NCT00709098|10929871|FG001|Open-label Period|Administrative reason|0
6906724|NCT00709098|10929872|FG002|Open-label Period|Administrative reason|5
6906725|NCT00709098|10929870|FG000|Open-label Period|Death|0
6906726|NCT00709098|10929871|FG001|Open-label Period|Death|0
6906727|NCT00709098|10929872|FG002|Open-label Period|Death|1
6906728|NCT00709098|10929870|FG000|Open-label Period|Lost to Follow-up|0
6906729|NCT00709098|10929871|FG001|Open-label Period|Lost to Follow-up|0
6906730|NCT00709098|10929872|FG002|Open-label Period|Lost to Follow-up|1
6906731|NCT00709111|10929881|FG000|Overall Study|Withdrawal by Subject|1
6906732|NCT00709111|10929881|FG000|Overall Study|Unable to attend clinic visits|1
6906733|NCT00709124|10929887|FG000|Overall Study|Death|3
6906734|NCT00709124|10929888|FG001|Overall Study|Death|1
6906735|NCT00709124|10929887|FG000|Overall Study|encephalopathy; can't do assessment|1
6906736|NCT00709124|10929888|FG001|Overall Study|encephalopathy; can't do assessment|0
6906737|NCT00709202|10929900|FG000|Overall Study|Withdrawal by Subject|6
6906738|NCT00709202|10929901|FG001|Overall Study|Withdrawal by Subject|6
6906739|NCT00709228|10929908|FG000|Overall Study|Not treated|14
6906740|NCT00709228|10929908|FG000|Overall Study|Eligibility criteria not met|281
6906741|NCT00709228|10929908|FG000|Overall Study|Adverse events|2
6906742|NCT00709228|10929908|FG000|Overall Study|Discontinued treatment|14
6906743|NCT00709228|10929908|FG000|Overall Study|Did not enter follow-up|4
6906744|NCT00709228|10929908|FG000|Overall Study|Discontinued follow-up|5
6906745|NCT00709228|10929908|FG000|Overall Study|Disease progression|1
6906746|NCT00709228|10929908|FG000|Overall Study|Lost to Follow-up|6
6906747|NCT00709228|10929908|FG000|Overall Study|Non-compliance|5
6906748|NCT00709319|10929929|FG000|Overall Study|Death|4
6906749|NCT00709319|10929929|FG000|Overall Study|Withdrawal by Subject|2
6906750|NCT00709592|10929935|FG000|Overall Study|Unable to proceed to transplant|0
6906751|NCT00709592|10929936|FG001|Overall Study|Unable to proceed to transplant|1
6906752|NCT00709618|10929942|FG000|Overall Study|Withdrawal by Subject|4
6906753|NCT00709618|10929942|FG000|Overall Study|Lost to Follow-up|1
6906754|NCT00709618|10929942|FG000|Overall Study|Study Closed/Terminated|25
6906755|NCT00709722|10929955|FG000|Overall Study|Adverse Event|1
6906756|NCT00709735|10929961|FG000|Overall Study|Lost to Follow-up|1
6906757|NCT00709735|10929962|FG001|Overall Study|Lost to Follow-up|1
6906758|NCT00709735|10929961|FG000|Overall Study|Relapse into Opioid Abuse|0
6906759|NCT00709735|10929962|FG001|Overall Study|Relapse into Opioid Abuse|1
6906760|NCT00709735|10929961|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2
6906761|NCT00709735|10929962|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0
6906762|NCT00709761|10929968|FG000|Overall Study|Withdrawal by Subject|8
6906763|NCT00709761|10929968|FG000|Overall Study|study closed/terminated|17
6906764|NCT00709761|10929968|FG000|Overall Study|Lost to Follow-up|2
6906765|NCT00709852|10929981|FG000|Period 1|Adverse Event|2
6906766|NCT00709852|10929982|FG001|Period 1|Adverse Event|0
6906767|NCT00709852|10929981|FG000|Period 1|Withdrawal by Subject|4
6906768|NCT00709852|10929982|FG001|Period 1|Withdrawal by Subject|2
6906769|NCT00709852|10929981|FG000|Period 1|Protocol Violation|1
6906770|NCT00709852|10929982|FG001|Period 1|Protocol Violation|0
6906771|NCT00709852|10929981|FG000|Period 1|Defective scanner|0
6906772|NCT00709852|10929982|FG001|Period 1|Defective scanner|1
6906773|NCT00709852|10929981|FG000|Period 1|Lost to Follow-up|1
6906774|NCT00709852|10929982|FG001|Period 1|Lost to Follow-up|0
6906775|NCT00709852|10929981|FG000|Period 2|Protocol Violation|4
6906776|NCT00709852|10929982|FG001|Period 2|Protocol Violation|1
6906777|NCT00709852|10929981|FG000|Period 2|Adverse Event|1
6906778|NCT00709852|10929982|FG001|Period 2|Adverse Event|1
6906779|NCT00709852|10929981|FG000|Period 2|Lost to Follow-up|1
6906780|NCT00709852|10929982|FG001|Period 2|Lost to Follow-up|0
6906781|NCT00709852|10929981|FG000|Period 2|No 72-hour follow-up|3
6906782|NCT00709852|10929982|FG001|Period 2|No 72-hour follow-up|0
6906783|NCT00709956|10930020|FG000|Overall Study|Withdrawal by Subject|1
6906784|NCT00709956|10930021|FG001|Overall Study|Withdrawal by Subject|1
6906785|NCT00709956|10930020|FG000|Overall Study|Inclusion/exclusion criteria violation|2
6906786|NCT00709956|10930021|FG001|Overall Study|Inclusion/exclusion criteria violation|3
6906787|NCT00709995|10930031|FG000|Overall Study|Adverse Event|4
6906788|NCT00709995|10930032|FG001|Overall Study|Adverse Event|2
6906789|NCT00709995|10930031|FG000|Overall Study|Withdrawal by Subject|1
6906790|NCT00709995|10930032|FG001|Overall Study|Withdrawal by Subject|3
6906791|NCT00710021|10930044|FG000|Overall Study|Lost to Follow-up|1
6906792|NCT00710021|10930045|FG001|Overall Study|Lost to Follow-up|0
6906793|NCT00710021|10930046|FG002|Overall Study|Lost to Follow-up|0
6906794|NCT00710021|10930044|FG000|Overall Study|Subject's Decision|0
6906795|NCT00710021|10930045|FG001|Overall Study|Subject's Decision|1
6906796|NCT00710021|10930046|FG002|Overall Study|Subject's Decision|0
6906797|NCT00710021|10930044|FG000|Overall Study|Subject misrandomized|0
6906798|NCT00710021|10930045|FG001|Overall Study|Subject misrandomized|1
6906799|NCT00710021|10930046|FG002|Overall Study|Subject misrandomized|1
6906800|NCT00710021|10930044|FG000|Overall Study|Physician Decision|0
6906801|NCT00710021|10930045|FG001|Overall Study|Physician Decision|1
6906802|NCT00710021|10930046|FG002|Overall Study|Physician Decision|0
6906803|NCT00710034|10930057|FG000|Completed 6 Weeks of Treatment|Adverse Event|5
6906804|NCT00710034|10930058|FG001|Completed 6 Weeks of Treatment|Adverse Event|12
6906805|NCT00710034|10930057|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12
6906806|NCT00710034|10930058|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8
6906807|NCT00710034|10930057|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15
6906808|NCT00710034|10930058|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17
6906809|NCT00710034|10930057|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2
6906810|NCT00710034|10930058|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6
6906811|NCT00710034|10930057|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6
6906812|NCT00710034|10930058|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4
6906813|NCT00710034|10930057|FG000|Completed 6 Weeks of Treatment|Physician Decision|1
6906814|NCT00710034|10930058|FG001|Completed 6 Weeks of Treatment|Physician Decision|0
6906815|NCT00710034|10930057|FG000|Completed 12 Weeks of Treatment|Adverse Event|0
6906816|NCT00710034|10930058|FG001|Completed 12 Weeks of Treatment|Adverse Event|1
6906817|NCT00710034|10930057|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0
6906818|NCT00710034|10930058|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2
6906819|NCT00710034|10930057|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5
6906820|NCT00710034|10930058|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5
6906821|NCT00710034|10930057|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0
6906822|NCT00710034|10930058|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1
6906823|NCT00710034|10930057|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8
6906824|NCT00710034|10930058|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2
6906825|NCT00710385|10930074|FG000|Overall Study|Did not qualify|1
6906826|NCT00710385|10930074|FG000|Overall Study|Withdrawal by Subject|1
6906827|NCT00710385|10930074|FG000|Overall Study|Undisclosed back pain|1
6906828|NCT00710385|10930074|FG000|Overall Study|Physician Decision|1
6906829|NCT00710385|10930074|FG000|Overall Study|Undisclosed excessive methadone use|1
6906830|NCT00710424|10930086|FG000|Overall Study|Adverse Event|30
6906831|NCT00710424|10930087|FG001|Overall Study|Adverse Event|12
6906832|NCT00710424|10930086|FG000|Overall Study|Lack of Efficacy|4
6906833|NCT00710424|10930087|FG001|Overall Study|Lack of Efficacy|5
6906834|NCT00710424|10930086|FG000|Overall Study|Withdrawal by Subject|5
6906835|NCT00710424|10930087|FG001|Overall Study|Withdrawal by Subject|3
6906836|NCT00710424|10930086|FG000|Overall Study|Lost to Follow-up|0
6906837|NCT00710424|10930087|FG001|Overall Study|Lost to Follow-up|1
6906838|NCT00710424|10930086|FG000|Overall Study|Refused medication, no side effects|1
6906839|NCT00710424|10930087|FG001|Overall Study|Refused medication, no side effects|0
6906840|NCT00710424|10930086|FG000|Overall Study|Non-compliance with stable analgesia|1
6906841|NCT00710424|10930087|FG001|Overall Study|Non-compliance with stable analgesia|0
6906842|NCT00710424|10930086|FG000|Overall Study|Did not meet entry criteria at visit 1|1
6906843|NCT00710424|10930087|FG001|Overall Study|Did not meet entry criteria at visit 1|0
6906844|NCT00710424|10930086|FG000|Overall Study|Subject thought medication changed|1
6906845|NCT00710424|10930087|FG001|Overall Study|Subject thought medication changed|0
6906846|NCT00710424|10930086|FG000|Overall Study|Ceased treatment due to travel|1
6906847|NCT00710424|10930087|FG001|Overall Study|Ceased treatment due to travel|0
6906848|NCT00710424|10930086|FG000|Overall Study|Subject preferred paracetamol|0
6906849|NCT00710424|10930087|FG001|Overall Study|Subject preferred paracetamol|1
6906850|NCT00710424|10930086|FG000|Overall Study|Felt good so stopped treatment|0
6906851|NCT00710424|10930087|FG001|Overall Study|Felt good so stopped treatment|1
6906852|NCT00710554|10930095|FG000|Overall Study|Adverse Event|24
6906853|NCT00710554|10930096|FG001|Overall Study|Adverse Event|7
6906854|NCT00710554|10930095|FG000|Overall Study|Withdrawal by Subject|7
6906855|NCT00710554|10930096|FG001|Overall Study|Withdrawal by Subject|3
6906856|NCT00710554|10930095|FG000|Overall Study|Lost to Follow-up|7
6906857|NCT00710554|10930096|FG001|Overall Study|Lost to Follow-up|1
6906858|NCT00710554|10930095|FG000|Overall Study|Lack of Efficacy|11
6906859|NCT00710554|10930096|FG001|Overall Study|Lack of Efficacy|12
6906860|NCT00710554|10930095|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0
6906861|NCT00710554|10930096|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1
6906862|NCT00710593|10930104|FG000|Overall Study|Incarceration|1
6906863|NCT00710593|10930105|FG001|Overall Study|Incarceration|0
6906864|NCT00710593|10930104|FG000|Overall Study|Unable to complete Wk 48 within window|2
6906865|NCT00710593|10930105|FG001|Overall Study|Unable to complete Wk 48 within window|0
6906866|NCT00710593|10930104|FG000|Overall Study|Lost to Follow-up|3
6906867|NCT00710593|10930105|FG001|Overall Study|Lost to Follow-up|1
6906868|NCT00710593|10930104|FG000|Overall Study|Moved out of area|1
6906869|NCT00710593|10930105|FG001|Overall Study|Moved out of area|0
6906870|NCT00710593|10930104|FG000|Overall Study|Failure to adhere or complete study eval|1
6906871|NCT00710593|10930105|FG001|Overall Study|Failure to adhere or complete study eval|1
6906872|NCT00710593|10930104|FG000|Overall Study|Protocol Violation|1
6906873|NCT00710593|10930105|FG001|Overall Study|Protocol Violation|1
6906874|NCT00710593|10930104|FG000|Overall Study|Prem disc vaccine, completed all visits|6
6906875|NCT00710593|10930105|FG001|Overall Study|Prem disc vaccine, completed all visits|2
6906876|NCT00710606|10930129|FG000|Overall Study|Adverse Event|0
6906877|NCT00710606|10930130|FG001|Overall Study|Adverse Event|2
6906878|NCT00710684|10930141|FG000|Overall Study|Adverse Event|11
6906879|NCT00710684|10930142|FG001|Overall Study|Adverse Event|19
6906880|NCT00710684|10930143|FG002|Overall Study|Adverse Event|16
6906881|NCT00710684|10930141|FG000|Overall Study|Lack of Efficacy|4
6906882|NCT00710684|10930142|FG001|Overall Study|Lack of Efficacy|3
6906883|NCT00710684|10930143|FG002|Overall Study|Lack of Efficacy|5
6906884|NCT00710684|10930141|FG000|Overall Study|Protocol Violation|5
6906885|NCT00710684|10930142|FG001|Overall Study|Protocol Violation|5
6906886|NCT00710684|10930143|FG002|Overall Study|Protocol Violation|5
6906887|NCT00710684|10930141|FG000|Overall Study|Lost to Follow-up|4
6906888|NCT00710684|10930142|FG001|Overall Study|Lost to Follow-up|6
6906889|NCT00710684|10930143|FG002|Overall Study|Lost to Follow-up|7
6906890|NCT00710684|10930141|FG000|Overall Study|Physician Decision|0
6906891|NCT00710684|10930142|FG001|Overall Study|Physician Decision|2
6906892|NCT00710684|10930143|FG002|Overall Study|Physician Decision|4
6906893|NCT00710684|10930141|FG000|Overall Study|Withdrawal by Subject|24
6906894|NCT00710684|10930142|FG001|Overall Study|Withdrawal by Subject|18
6906895|NCT00710684|10930143|FG002|Overall Study|Withdrawal by Subject|11
6906896|NCT00710684|10930141|FG000|Overall Study|Missing|1
6906897|NCT00710684|10930142|FG001|Overall Study|Missing|0
6906898|NCT00710684|10930143|FG002|Overall Study|Missing|0
6906899|NCT00710684|10930141|FG000|Overall Study|Did not continue after week 24|25
6906900|NCT00710684|10930142|FG001|Overall Study|Did not continue after week 24|21
6906901|NCT00710684|10930143|FG002|Overall Study|Did not continue after week 24|16
6906902|NCT00710749|10930157|FG000|First Intervention|Withdrawal by Subject|1
6906903|NCT00710749|10930158|FG001|First Intervention|Withdrawal by Subject|0
6906904|NCT00710762|10930168|FG000|Overall Study|Progressive disease|27
6906905|NCT00710762|10930169|FG001|Overall Study|Progressive disease|30
6906906|NCT00710762|10930168|FG000|Overall Study|Adverse Event other disease worsening|2
6906907|NCT00710762|10930169|FG001|Overall Study|Adverse Event other disease worsening|1
6906908|NCT00710762|10930168|FG000|Overall Study|Other Adverse Event|7
6906909|NCT00710762|10930169|FG001|Overall Study|Other Adverse Event|7
6906910|NCT00710762|10930168|FG000|Overall Study|Lost to Follow-up|1
6906911|NCT00710762|10930169|FG001|Overall Study|Lost to Follow-up|0
6906912|NCT00710762|10930168|FG000|Overall Study|Reason other than listed above|2
6906913|NCT00710762|10930169|FG001|Overall Study|Reason other than listed above|2
6906914|NCT00710866|10930195|FG000|Overall Study|Protocol Violation|5
6906915|NCT00710866|10930196|FG001|Overall Study|Protocol Violation|4
6906916|NCT00710866|10930195|FG000|Overall Study|Withdrawal by Subject|2
6906917|NCT00710866|10930196|FG001|Overall Study|Withdrawal by Subject|1
6906918|NCT00710866|10930195|FG000|Overall Study|Lost to Follow-up|1
6906919|NCT00710866|10930196|FG001|Overall Study|Lost to Follow-up|0
6906920|NCT00710866|10930195|FG000|Overall Study|Failed to meet eligibility|1
6906921|NCT00710866|10930196|FG001|Overall Study|Failed to meet eligibility|1
6906922|NCT00710879|10930204|FG000|Overall Study|Lost to Follow-up|2
6906923|NCT00710879|10930205|FG001|Overall Study|Lost to Follow-up|1
6906924|NCT00710879|10930204|FG000|Overall Study|Protocol Violation|0
6906925|NCT00710879|10930205|FG001|Overall Study|Protocol Violation|3
6906926|NCT00711009|10930247|FG000|Overall Study|Adverse Event/HIV-Related Event|4
6906927|NCT00711009|10930248|FG001|Overall Study|Adverse Event/HIV-Related Event|5
6906928|NCT00711009|10930247|FG000|Overall Study|Withdrawal by Subject|4
6906929|NCT00711009|10930248|FG001|Overall Study|Withdrawal by Subject|2
6906930|NCT00711009|10930247|FG000|Overall Study|Lost to Follow-up|3
6906931|NCT00711009|10930248|FG001|Overall Study|Lost to Follow-up|9
6906932|NCT00711009|10930247|FG000|Overall Study|Participant Noncompliant|0
6906933|NCT00711009|10930248|FG001|Overall Study|Participant Noncompliant|1
6906934|NCT00711009|10930247|FG000|Overall Study|Virologic Failure|2
6906935|NCT00711009|10930248|FG001|Overall Study|Virologic Failure|1
6906936|NCT00711009|10930247|FG000|Overall Study|Pregnancy|1
6906937|NCT00711009|10930248|FG001|Overall Study|Pregnancy|0
6906938|NCT00711009|10930247|FG000|Overall Study|Site closing|0
6906939|NCT00711009|10930248|FG001|Overall Study|Site closing|1
6906940|NCT00711009|10930247|FG000|Overall Study|Dose adjustment|1
6906941|NCT00711009|10930248|FG001|Overall Study|Dose adjustment|0
6906942|NCT00711100|10930258|FG000|Overall Study|Lack of Efficacy|5
6906943|NCT00711100|10930258|FG000|Overall Study|Withdrawal by Subject|8
6906944|NCT00711113|10930274|FG000|Overall Study|Lost to Follow-up|9
6906945|NCT00711113|10930274|FG000|Overall Study|Implant lost|2
6906946|NCT00711191|10930281|FG000|Overall Study|Adverse Event|1
6906947|NCT00711191|10930282|FG001|Overall Study|Adverse Event|1
6906948|NCT00711191|10930283|FG002|Overall Study|Adverse Event|2
6906949|NCT00711191|10930281|FG000|Overall Study|Objective progression or relapse|2
6906950|NCT00711191|10930282|FG001|Overall Study|Objective progression or relapse|3
6906951|NCT00711191|10930283|FG002|Overall Study|Objective progression or relapse|7
6906952|NCT00711191|10930281|FG000|Overall Study|Withdrawal by Subject|0
6906953|NCT00711191|10930282|FG001|Overall Study|Withdrawal by Subject|1
6906954|NCT00711191|10930283|FG002|Overall Study|Withdrawal by Subject|3
6906955|NCT00711243|10930300|FG000|Registed and Started Treatment|Withdrawal by Subject|0
6906956|NCT00711243|10930301|FG001|Registed and Started Treatment|Withdrawal by Subject|0
6906957|NCT00711243|10930302|FG002|Registed and Started Treatment|Withdrawal by Subject|0
6906958|NCT00711243|10930303|FG003|Registed and Started Treatment|Withdrawal by Subject|0
6906959|NCT00711243|10930304|FG004|Registed and Started Treatment|Withdrawal by Subject|0
6906960|NCT00711243|10930305|FG005|Registed and Started Treatment|Withdrawal by Subject|1
6906961|NCT00711243|10930300|FG000|Reached First Response/4 Cycles|Death|0
6906962|NCT00711243|10930301|FG001|Reached First Response/4 Cycles|Death|0
6906963|NCT00711243|10930302|FG002|Reached First Response/4 Cycles|Death|0
6906964|NCT00711243|10930303|FG003|Reached First Response/4 Cycles|Death|0
6906965|NCT00711243|10930304|FG004|Reached First Response/4 Cycles|Death|0
6906966|NCT00711243|10930305|FG005|Reached First Response/4 Cycles|Death|2
6906967|NCT00711243|10930300|FG000|Reached First Response/4 Cycles|Progressive disease|0
6906968|NCT00711243|10930301|FG001|Reached First Response/4 Cycles|Progressive disease|0
6906969|NCT00711243|10930302|FG002|Reached First Response/4 Cycles|Progressive disease|0
6906970|NCT00711243|10930303|FG003|Reached First Response/4 Cycles|Progressive disease|1
6906971|NCT00711243|10930304|FG004|Reached First Response/4 Cycles|Progressive disease|0
6906972|NCT00711243|10930305|FG005|Reached First Response/4 Cycles|Progressive disease|0
6906973|NCT00711243|10930300|FG000|Treated Cycle 5 After First Response|Progressive disease|1
6906974|NCT00711243|10930301|FG001|Treated Cycle 5 After First Response|Progressive disease|2
6906975|NCT00711243|10930302|FG002|Treated Cycle 5 After First Response|Progressive disease|0
6906976|NCT00711243|10930303|FG003|Treated Cycle 5 After First Response|Progressive disease|0
6906977|NCT00711243|10930304|FG004|Treated Cycle 5 After First Response|Progressive disease|1
6906978|NCT00711243|10930305|FG005|Treated Cycle 5 After First Response|Progressive disease|1
6906979|NCT00711243|10930300|FG000|Treated Cycle 5 After First Response|Death|0
6906980|NCT00711243|10930301|FG001|Treated Cycle 5 After First Response|Death|0
6906981|NCT00711243|10930302|FG002|Treated Cycle 5 After First Response|Death|0
6906982|NCT00711243|10930303|FG003|Treated Cycle 5 After First Response|Death|0
6906983|NCT00711243|10930304|FG004|Treated Cycle 5 After First Response|Death|0
6906984|NCT00711243|10930305|FG005|Treated Cycle 5 After First Response|Death|2
6906985|NCT00711243|10930300|FG000|Treated Cycle 5 After First Response|Decline in performance status|0
6906986|NCT00711243|10930301|FG001|Treated Cycle 5 After First Response|Decline in performance status|0
6906987|NCT00711243|10930302|FG002|Treated Cycle 5 After First Response|Decline in performance status|0
6906988|NCT00711243|10930303|FG003|Treated Cycle 5 After First Response|Decline in performance status|0
6906989|NCT00711243|10930304|FG004|Treated Cycle 5 After First Response|Decline in performance status|0
6906990|NCT00711243|10930305|FG005|Treated Cycle 5 After First Response|Decline in performance status|1
6906991|NCT00711243|10930300|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0
6906992|NCT00711243|10930301|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0
6906993|NCT00711243|10930302|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0
6906994|NCT00711243|10930303|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0
6906995|NCT00711243|10930304|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0
6906996|NCT00711243|10930305|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2
6906997|NCT00711412|10930330|FG000|Induction Treatment|Death|2
6906998|NCT00711412|10930330|FG000|Induction Treatment|Adverse Event|1
6906999|NCT00711412|10930330|FG000|Induction Treatment|Other|1
6907000|NCT00711412|10930330|FG000|Evaluated for Combination Treatment|Adverse Event|2
6907001|NCT00711412|10930330|FG000|Evaluated for Combination Treatment|Death|1
6907002|NCT00711412|10930330|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1
6907003|NCT00711412|10930330|FG000|Evaluated for Combination Treatment|Progressive disease|2
6907004|NCT00711412|10930330|FG000|Combination Treatment|Progressive Disease|1
6907005|NCT00711412|10930330|FG000|Evaluation for Response and Surgery|Progressive Disease|2
6907006|NCT00711412|10930330|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2
6907007|NCT00711412|10930330|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1
6907008|NCT00711412|10930330|FG000|Evaluation for Response and Surgery|Death|1
6907009|NCT00711412|10930330|FG000|Survival Follow up Until Death|Other|12
6907010|NCT00711425|10930335|FG000|Overall Study|Protocol Violation|1
6907011|NCT00711425|10930335|FG000|Overall Study|Death|2
6907012|NCT00711425|10930335|FG000|Overall Study|Lost to Follow-up|1
6907013|NCT00711477|10930351|FG000|Overall Study|Adverse Event|3
6907014|NCT00711477|10930352|FG001|Overall Study|Adverse Event|1
6907015|NCT00711477|10930351|FG000|Overall Study|Lost to Follow-up|0
6907016|NCT00711477|10930352|FG001|Overall Study|Lost to Follow-up|1
6907017|NCT00711477|10930351|FG000|Overall Study|Noncompliance|0
6907018|NCT00711477|10930352|FG001|Overall Study|Noncompliance|1
6907019|NCT00711516|10930367|FG000|Overall Study|Adverse Event|1
6907020|NCT00711516|10930368|FG001|Overall Study|Adverse Event|1
6907021|NCT00711516|10930367|FG000|Overall Study|Withdrawal by Subject|0
6907022|NCT00711516|10930368|FG001|Overall Study|Withdrawal by Subject|1
6907023|NCT00711516|10930367|FG000|Overall Study|Protocol Violation|0
6907024|NCT00711516|10930368|FG001|Overall Study|Protocol Violation|1
6907025|NCT00711529|10930376|FG000|Overall Study|Protocol Violation|2
6907026|NCT00711529|10930377|FG001|Overall Study|Protocol Violation|0
6907027|NCT00711529|10930376|FG000|Overall Study|Withdrawal by Subject|2
6907028|NCT00711529|10930377|FG001|Overall Study|Withdrawal by Subject|6
6907029|NCT00711594|10930387|FG000|Overall Study|Progressive disease|2
6907030|NCT00711594|10930388|FG001|Overall Study|Progressive disease|2
6907031|NCT00711594|10930389|FG002|Overall Study|Progressive disease|6
6907032|NCT00711594|10930390|FG003|Overall Study|Progressive disease|44
6907033|NCT00711594|10930387|FG000|Overall Study|Other Adverse Event|1
6907034|NCT00711594|10930388|FG001|Overall Study|Other Adverse Event|0
6907035|NCT00711594|10930389|FG002|Overall Study|Other Adverse Event|0
6907036|NCT00711594|10930390|FG003|Overall Study|Other Adverse Event|16
6907037|NCT00711594|10930387|FG000|Overall Study|Withdrawal by Subject|0
6907038|NCT00711594|10930388|FG001|Overall Study|Withdrawal by Subject|1
6907039|NCT00711594|10930389|FG002|Overall Study|Withdrawal by Subject|0
6907040|NCT00711594|10930390|FG003|Overall Study|Withdrawal by Subject|2
6907041|NCT00711646|10930404|FG000|Overall Study|Adverse Event|6
6907042|NCT00711646|10930405|FG001|Overall Study|Adverse Event|1
6907043|NCT00711646|10930404|FG000|Overall Study|Withdrawal by Subject|4
6907044|NCT00711646|10930405|FG001|Overall Study|Withdrawal by Subject|0
6907045|NCT00711646|10930404|FG000|Overall Study|Protocol Violation|0
6907046|NCT00711646|10930405|FG001|Overall Study|Protocol Violation|1
6907047|NCT00711646|10930404|FG000|Overall Study|Lost to Follow-up|1
6907048|NCT00711646|10930405|FG001|Overall Study|Lost to Follow-up|0
6907049|NCT00711646|10930404|FG000|Overall Study|administrative decision|0
6907050|NCT00711646|10930405|FG001|Overall Study|administrative decision|1
6907051|NCT00711646|10930404|FG000|Overall Study|patient non-compliance|1
6907052|NCT00711646|10930405|FG001|Overall Study|patient non-compliance|0
6907053|NCT00711802|10930430|FG000|Overall Study|Not treated (no further detail)|2
6907054|NCT00711802|10930431|FG001|Overall Study|Not treated (no further detail)|1
6907055|NCT00711802|10930432|FG002|Overall Study|Not treated (no further detail)|2
6907056|NCT00711802|10930433|FG003|Overall Study|Not treated (no further detail)|0
6907057|NCT00711802|10930434|FG004|Overall Study|Not treated (no further detail)|2
6907058|NCT00711802|10930435|FG005|Overall Study|Not treated (no further detail)|0
6907059|NCT00711802|10930436|FG006|Overall Study|Not treated (no further detail)|0
6907060|NCT00711802|10930437|FG007|Overall Study|Not treated (no further detail)|0
6907061|NCT00711802|10930430|FG000|Overall Study|Adverse Event|0
6907062|NCT00711802|10930431|FG001|Overall Study|Adverse Event|0
6907063|NCT00711802|10930432|FG002|Overall Study|Adverse Event|0
6907064|NCT00711802|10930433|FG003|Overall Study|Adverse Event|0
6907065|NCT00711802|10930434|FG004|Overall Study|Adverse Event|1
6907066|NCT00711802|10930435|FG005|Overall Study|Adverse Event|1
6907067|NCT00711802|10930436|FG006|Overall Study|Adverse Event|0
6907068|NCT00711802|10930437|FG007|Overall Study|Adverse Event|0
6907069|NCT00711802|10930430|FG000|Overall Study|Microbiological failure|0
6907070|NCT00711802|10930431|FG001|Overall Study|Microbiological failure|1
6907071|NCT00711802|10930432|FG002|Overall Study|Microbiological failure|0
6907072|NCT00711802|10930433|FG003|Overall Study|Microbiological failure|0
6907073|NCT00711802|10930434|FG004|Overall Study|Microbiological failure|0
6907074|NCT00711802|10930435|FG005|Overall Study|Microbiological failure|1
6907075|NCT00711802|10930436|FG006|Overall Study|Microbiological failure|0
6907076|NCT00711802|10930437|FG007|Overall Study|Microbiological failure|0
6907077|NCT00711802|10930430|FG000|Overall Study|Protocol Violation|0
6907078|NCT00711802|10930431|FG001|Overall Study|Protocol Violation|0
6907079|NCT00711802|10930432|FG002|Overall Study|Protocol Violation|0
6907080|NCT00711802|10930433|FG003|Overall Study|Protocol Violation|1
6907081|NCT00711802|10930434|FG004|Overall Study|Protocol Violation|0
6907082|NCT00711802|10930435|FG005|Overall Study|Protocol Violation|0
6907083|NCT00711802|10930436|FG006|Overall Study|Protocol Violation|0
6907084|NCT00711802|10930437|FG007|Overall Study|Protocol Violation|0
6907085|NCT00711802|10930430|FG000|Overall Study|Physician Decision|0
6907086|NCT00711802|10930431|FG001|Overall Study|Physician Decision|2
6907087|NCT00711802|10930432|FG002|Overall Study|Physician Decision|0
6907088|NCT00711802|10930433|FG003|Overall Study|Physician Decision|0
6907089|NCT00711802|10930434|FG004|Overall Study|Physician Decision|0
6907090|NCT00711802|10930435|FG005|Overall Study|Physician Decision|0
6907091|NCT00711802|10930436|FG006|Overall Study|Physician Decision|0
6907092|NCT00711802|10930437|FG007|Overall Study|Physician Decision|0
6907093|NCT00711802|10930430|FG000|Overall Study|Withdrawal by Subject|0
6907094|NCT00711802|10930431|FG001|Overall Study|Withdrawal by Subject|1
6907095|NCT00711802|10930432|FG002|Overall Study|Withdrawal by Subject|0
6907096|NCT00711802|10930433|FG003|Overall Study|Withdrawal by Subject|1
6907097|NCT00711802|10930434|FG004|Overall Study|Withdrawal by Subject|0
6907098|NCT00711802|10930435|FG005|Overall Study|Withdrawal by Subject|0
6907099|NCT00711802|10930436|FG006|Overall Study|Withdrawal by Subject|0
6907100|NCT00711802|10930437|FG007|Overall Study|Withdrawal by Subject|0
6907101|NCT00711802|10930430|FG000|Overall Study|Lost to Follow-up|0
6907102|NCT00711802|10930431|FG001|Overall Study|Lost to Follow-up|0
6907103|NCT00711802|10930432|FG002|Overall Study|Lost to Follow-up|3
6907104|NCT00711802|10930433|FG003|Overall Study|Lost to Follow-up|1
6907105|NCT00711802|10930434|FG004|Overall Study|Lost to Follow-up|10
6907106|NCT00711802|10930435|FG005|Overall Study|Lost to Follow-up|6
6907107|NCT00711802|10930436|FG006|Overall Study|Lost to Follow-up|4
6907108|NCT00711802|10930437|FG007|Overall Study|Lost to Follow-up|2
6907109|NCT00711802|10930430|FG000|Overall Study|Reason not reported|0
6907110|NCT00711802|10930431|FG001|Overall Study|Reason not reported|1
6907111|NCT00711802|10930432|FG002|Overall Study|Reason not reported|1
6907112|NCT00711802|10930433|FG003|Overall Study|Reason not reported|0
6907113|NCT00711802|10930434|FG004|Overall Study|Reason not reported|1
6907114|NCT00711802|10930435|FG005|Overall Study|Reason not reported|0
6907115|NCT00711802|10930436|FG006|Overall Study|Reason not reported|1
6907116|NCT00711802|10930437|FG007|Overall Study|Reason not reported|0
6907117|NCT00711880|10930473|FG000|Overall Study|Adverse Event|11
6907118|NCT00711880|10930474|FG001|Overall Study|Adverse Event|2
6907119|NCT00711880|10930473|FG000|Overall Study|Patient non-compliance|1
6907120|NCT00711880|10930474|FG001|Overall Study|Patient non-compliance|0
6907121|NCT00711880|10930473|FG000|Overall Study|Lack of Efficacy|1
6907122|NCT00711880|10930474|FG001|Overall Study|Lack of Efficacy|5
6907123|NCT00711958|10930482|FG000|Overall Study|Withdrawal by Subject|6
6907124|NCT00711958|10930483|FG001|Overall Study|Withdrawal by Subject|8
6907125|NCT00711958|10930482|FG000|Overall Study|Lack of Efficacy|3
6907126|NCT00711958|10930483|FG001|Overall Study|Lack of Efficacy|1
6907127|NCT00711958|10930482|FG000|Overall Study|Clinical deterioration|1
6907128|NCT00711958|10930483|FG001|Overall Study|Clinical deterioration|0
6907129|NCT00711958|10930482|FG000|Overall Study|Adverse Event|9
6907130|NCT00711958|10930483|FG001|Overall Study|Adverse Event|7
6907131|NCT00711958|10930482|FG000|Overall Study|Protocol Violation|1
6907132|NCT00711958|10930483|FG001|Overall Study|Protocol Violation|0
6907133|NCT00711958|10930482|FG000|Overall Study|Lost to Follow-up|2
6907134|NCT00711958|10930483|FG001|Overall Study|Lost to Follow-up|2
6907135|NCT00711958|10930482|FG000|Overall Study|Death|10
6907136|NCT00711958|10930483|FG001|Overall Study|Death|5
6907137|NCT00711958|10930482|FG000|Overall Study|Progression of disease|1
6907138|NCT00711958|10930483|FG001|Overall Study|Progression of disease|0
6907139|NCT00711971|10930492|FG000|Overall Study|Lost to Follow-up|3
6907140|NCT00711971|10930493|FG001|Overall Study|Lost to Follow-up|4
6907141|NCT00711971|10930494|FG002|Overall Study|Lost to Follow-up|1
6907142|NCT00712010|10930517|FG000|Washout (7 Days)|Withdrawal by Subject|1
6907143|NCT00712166|10930548|FG000|Overall Study|Noncompliance|0
6907144|NCT00712166|10930549|FG001|Overall Study|Noncompliance|1
6907145|NCT00712270|10930581|FG000|Overall Study|Withdrawal by Subject|11
6907146|NCT00712270|10930581|FG000|Overall Study|Screen Failure|3
6907147|NCT00712335|10930635|FG000|Overall Study|Withdrawal by Subject|0
6907148|NCT00712335|10930636|FG001|Overall Study|Withdrawal by Subject|7
6907149|NCT00712335|10930637|FG002|Overall Study|Withdrawal by Subject|2
6907150|NCT00712335|10930638|FG003|Overall Study|Withdrawal by Subject|3
6907151|NCT00712335|10930639|FG004|Overall Study|Withdrawal by Subject|0
6907152|NCT00712335|10930635|FG000|Overall Study|Lost to Follow-up|2
6907153|NCT00712335|10930636|FG001|Overall Study|Lost to Follow-up|5
6907154|NCT00712335|10930637|FG002|Overall Study|Lost to Follow-up|0
6907155|NCT00712335|10930638|FG003|Overall Study|Lost to Follow-up|1
6907156|NCT00712335|10930639|FG004|Overall Study|Lost to Follow-up|0
6907157|NCT00712335|10930635|FG000|Overall Study|Protocol Violation|1
6907158|NCT00712335|10930636|FG001|Overall Study|Protocol Violation|2
6907159|NCT00712335|10930637|FG002|Overall Study|Protocol Violation|1
6907160|NCT00712335|10930638|FG003|Overall Study|Protocol Violation|0
6907161|NCT00712335|10930639|FG004|Overall Study|Protocol Violation|0
6907162|NCT00712335|10930635|FG000|Overall Study|Lack of Efficacy|0
6907163|NCT00712335|10930636|FG001|Overall Study|Lack of Efficacy|0
6907164|NCT00712335|10930637|FG002|Overall Study|Lack of Efficacy|1
6907165|NCT00712335|10930638|FG003|Overall Study|Lack of Efficacy|1
6907166|NCT00712335|10930639|FG004|Overall Study|Lack of Efficacy|0
6907167|NCT00712335|10930635|FG000|Overall Study|Other Reason|0
6907168|NCT00712335|10930636|FG001|Overall Study|Other Reason|3
6907169|NCT00712335|10930637|FG002|Overall Study|Other Reason|1
6907170|NCT00712335|10930638|FG003|Overall Study|Other Reason|0
6907171|NCT00712335|10930639|FG004|Overall Study|Other Reason|0
6907172|NCT00712348|10930651|FG000|Overall Study|Withdrawal by Subject|1
6907173|NCT00712543|10930670|FG000|Day 8-14|Lost to Follow-up|0
6907174|NCT00712543|10930671|FG001|Day 8-14|Lost to Follow-up|2
6907175|NCT00712673|10930680|FG000|Overall Study|Adverse Event|3
6907176|NCT00712673|10930681|FG001|Overall Study|Adverse Event|3
6907177|NCT00712673|10930682|FG002|Overall Study|Adverse Event|21
6907178|NCT00712673|10930683|FG003|Overall Study|Adverse Event|26
6907179|NCT00712673|10930680|FG000|Overall Study|Lack of Efficacy|2
6907180|NCT00712673|10930681|FG001|Overall Study|Lack of Efficacy|8
6907181|NCT00712673|10930682|FG002|Overall Study|Lack of Efficacy|8
6907182|NCT00712673|10930683|FG003|Overall Study|Lack of Efficacy|6
6907183|NCT00712673|10930680|FG000|Overall Study|Poor Compliance to Protocol|3
6907184|NCT00712673|10930681|FG001|Overall Study|Poor Compliance to Protocol|3
6907185|NCT00712673|10930682|FG002|Overall Study|Poor Compliance to Protocol|4
6907186|NCT00712673|10930683|FG003|Overall Study|Poor Compliance to Protocol|16
6907187|NCT00712673|10930680|FG000|Overall Study|Lost to Follow-up|1
6907188|NCT00712673|10930681|FG001|Overall Study|Lost to Follow-up|0
6907189|NCT00712673|10930682|FG002|Overall Study|Lost to Follow-up|2
6907190|NCT00712673|10930683|FG003|Overall Study|Lost to Follow-up|0
6907191|NCT00712673|10930680|FG000|Overall Study|Withdrawal by Subject|6
6907192|NCT00712673|10930681|FG001|Overall Study|Withdrawal by Subject|7
6907193|NCT00712673|10930682|FG002|Overall Study|Withdrawal by Subject|15
6907194|NCT00712673|10930683|FG003|Overall Study|Withdrawal by Subject|20
6907195|NCT00712673|10930680|FG000|Overall Study|Familial and Personal Reasons|5
6907196|NCT00712673|10930681|FG001|Overall Study|Familial and Personal Reasons|0
6907197|NCT00712673|10930682|FG002|Overall Study|Familial and Personal Reasons|5
6907198|NCT00712673|10930683|FG003|Overall Study|Familial and Personal Reasons|2
6907199|NCT00712673|10930680|FG000|Overall Study|Investigator's Decision|1
6907200|NCT00712673|10930681|FG001|Overall Study|Investigator's Decision|0
6907201|NCT00712673|10930682|FG002|Overall Study|Investigator's Decision|0
6907202|NCT00712673|10930683|FG003|Overall Study|Investigator's Decision|0
6907203|NCT00712673|10930680|FG000|Overall Study|Protocol Violation|0
6907204|NCT00712673|10930681|FG001|Overall Study|Protocol Violation|0
6907205|NCT00712673|10930682|FG002|Overall Study|Protocol Violation|2
6907206|NCT00712673|10930683|FG003|Overall Study|Protocol Violation|0
6907207|NCT00712712|10930702|FG000|Overall Study|Protocol Violation|11
6907208|NCT00712712|10930702|FG000|Overall Study|Radiofrequency not done|3
6907209|NCT00712712|10930702|FG000|Overall Study|Death|8
6907210|NCT00712712|10930702|FG000|Overall Study|Withdrawal by Subject|1
6907211|NCT00712725|10930714|FG000|Overall Study|Adverse Event|1
6907212|NCT00712725|10930715|FG001|Overall Study|Adverse Event|0
6907213|NCT00712725|10930716|FG002|Overall Study|Adverse Event|0
6907214|NCT00712725|10930717|FG003|Overall Study|Adverse Event|1
6907215|NCT00712725|10930718|FG004|Overall Study|Adverse Event|0
6907216|NCT00712725|10930719|FG005|Overall Study|Adverse Event|0
6907217|NCT00712725|10930720|FG006|Overall Study|Adverse Event|0
6907218|NCT00712725|10930721|FG007|Overall Study|Adverse Event|0
6907219|NCT00712725|10930714|FG000|Overall Study|Lost to Follow-up|3
6907220|NCT00712725|10930715|FG001|Overall Study|Lost to Follow-up|2
6907221|NCT00712725|10930716|FG002|Overall Study|Lost to Follow-up|1
6907222|NCT00712725|10930717|FG003|Overall Study|Lost to Follow-up|1
6907223|NCT00712725|10930718|FG004|Overall Study|Lost to Follow-up|2
6907224|NCT00712725|10930719|FG005|Overall Study|Lost to Follow-up|2
6907225|NCT00712725|10930720|FG006|Overall Study|Lost to Follow-up|3
6907226|NCT00712725|10930721|FG007|Overall Study|Lost to Follow-up|1
6907227|NCT00712725|10930714|FG000|Overall Study|Physician Decision|2
6907228|NCT00712725|10930715|FG001|Overall Study|Physician Decision|0
6907229|NCT00712725|10930716|FG002|Overall Study|Physician Decision|0
6907230|NCT00712725|10930717|FG003|Overall Study|Physician Decision|0
6907231|NCT00712725|10930718|FG004|Overall Study|Physician Decision|1
6907232|NCT00712725|10930719|FG005|Overall Study|Physician Decision|0
6907233|NCT00712725|10930720|FG006|Overall Study|Physician Decision|2
6907234|NCT00712725|10930721|FG007|Overall Study|Physician Decision|0
6907235|NCT00712725|10930714|FG000|Overall Study|Pregnancy|0
6907236|NCT00712725|10930715|FG001|Overall Study|Pregnancy|1
6907237|NCT00712725|10930716|FG002|Overall Study|Pregnancy|0
6907238|NCT00712725|10930717|FG003|Overall Study|Pregnancy|0
6907239|NCT00712725|10930718|FG004|Overall Study|Pregnancy|1
6907240|NCT00712725|10930719|FG005|Overall Study|Pregnancy|0
6907241|NCT00712725|10930720|FG006|Overall Study|Pregnancy|2
6907242|NCT00712725|10930721|FG007|Overall Study|Pregnancy|0
6907243|NCT00712725|10930714|FG000|Overall Study|Protocol Violation|2
6907244|NCT00712725|10930715|FG001|Overall Study|Protocol Violation|0
6907245|NCT00712725|10930716|FG002|Overall Study|Protocol Violation|1
6907246|NCT00712725|10930717|FG003|Overall Study|Protocol Violation|3
6907247|NCT00712725|10930718|FG004|Overall Study|Protocol Violation|2
6907248|NCT00712725|10930719|FG005|Overall Study|Protocol Violation|0
6907249|NCT00712725|10930720|FG006|Overall Study|Protocol Violation|1
6907250|NCT00712725|10930721|FG007|Overall Study|Protocol Violation|1
6907251|NCT00712725|10930714|FG000|Overall Study|Withdrawal by Subject|2
6907252|NCT00712725|10930715|FG001|Overall Study|Withdrawal by Subject|1
6907253|NCT00712725|10930716|FG002|Overall Study|Withdrawal by Subject|1
6907254|NCT00712725|10930717|FG003|Overall Study|Withdrawal by Subject|2
6907255|NCT00712725|10930718|FG004|Overall Study|Withdrawal by Subject|1
6907256|NCT00712725|10930719|FG005|Overall Study|Withdrawal by Subject|1
6907257|NCT00712725|10930720|FG006|Overall Study|Withdrawal by Subject|1
6907258|NCT00712725|10930721|FG007|Overall Study|Withdrawal by Subject|2
6907259|NCT00712725|10930714|FG000|Overall Study|Lack of Qualifying Event|16
6907260|NCT00712725|10930715|FG001|Overall Study|Lack of Qualifying Event|2
6907261|NCT00712725|10930716|FG002|Overall Study|Lack of Qualifying Event|6
6907262|NCT00712725|10930717|FG003|Overall Study|Lack of Qualifying Event|8
6907263|NCT00712725|10930718|FG004|Overall Study|Lack of Qualifying Event|11
6907264|NCT00712725|10930719|FG005|Overall Study|Lack of Qualifying Event|13
6907265|NCT00712725|10930720|FG006|Overall Study|Lack of Qualifying Event|11
6907266|NCT00712725|10930721|FG007|Overall Study|Lack of Qualifying Event|6
6907267|NCT00712725|10930714|FG000|Overall Study|Protocol Specified Criteria|3
6907268|NCT00712725|10930715|FG001|Overall Study|Protocol Specified Criteria|0
6907269|NCT00712725|10930716|FG002|Overall Study|Protocol Specified Criteria|1
6907270|NCT00712725|10930717|FG003|Overall Study|Protocol Specified Criteria|2
6907271|NCT00712725|10930718|FG004|Overall Study|Protocol Specified Criteria|1
6907272|NCT00712725|10930719|FG005|Overall Study|Protocol Specified Criteria|0
6907273|NCT00712725|10930720|FG006|Overall Study|Protocol Specified Criteria|2
6907274|NCT00712725|10930721|FG007|Overall Study|Protocol Specified Criteria|1
6907275|NCT00712920|10930742|FG000|Overall Study|Adverse Event|3
6907276|NCT00712920|10930743|FG001|Overall Study|Adverse Event|4
6907277|NCT00712920|10930744|FG002|Overall Study|Adverse Event|7
6907278|NCT00712920|10930742|FG000|Overall Study|Withdrawal by Subject|4
6907279|NCT00712920|10930743|FG001|Overall Study|Withdrawal by Subject|2
6907280|NCT00712920|10930744|FG002|Overall Study|Withdrawal by Subject|1
6907281|NCT00712920|10930742|FG000|Overall Study|Lost to Follow-up|1
6907282|NCT00712920|10930743|FG001|Overall Study|Lost to Follow-up|4
6907283|NCT00712920|10930744|FG002|Overall Study|Lost to Follow-up|0
6907284|NCT00712920|10930742|FG000|Overall Study|Lack of Efficacy|1
6907285|NCT00712920|10930743|FG001|Overall Study|Lack of Efficacy|0
6907286|NCT00712920|10930744|FG002|Overall Study|Lack of Efficacy|1
6907287|NCT00712920|10930742|FG000|Overall Study|Other|5
6907288|NCT00712920|10930743|FG001|Overall Study|Other|7
6907289|NCT00712920|10930744|FG002|Overall Study|Other|3
6907290|NCT00712920|10930742|FG000|Overall Study|Non-compliance|3
6907291|NCT00712920|10930743|FG001|Overall Study|Non-compliance|0
6907292|NCT00712920|10930744|FG002|Overall Study|Non-compliance|0
6907293|NCT00712959|10930754|FG000|Overall Study|Protocol Violation|3
6907294|NCT00712959|10930755|FG001|Overall Study|Protocol Violation|1
6907295|NCT00712959|10930754|FG000|Overall Study|Lost to Follow-up|13
6907296|NCT00712959|10930755|FG001|Overall Study|Lost to Follow-up|2
6907297|NCT00712959|10930754|FG000|Overall Study|Withdrawal by Subject|3
6907298|NCT00712959|10930755|FG001|Overall Study|Withdrawal by Subject|0
6907299|NCT00712985|10930761|FG000|Overall Study|1 withdrew prior to start of drug|1
6907300|NCT00712985|10930761|FG000|Overall Study|1 patient moved out of state|1
6907301|NCT00712985|10930761|FG000|Overall Study|Lack of Efficacy|3
6907302|NCT00713219|10930765|FG000|Overall Study|Death|1
6907303|NCT00713219|10930765|FG000|Overall Study|Protocol Violation|1
6907304|NCT00713310|10930775|FG000|Overall Study|Adverse Event|5
6907305|NCT00713310|10930776|FG001|Overall Study|Adverse Event|2
6907306|NCT00713310|10930775|FG000|Overall Study|Lack of Efficacy|0
6907307|NCT00713310|10930776|FG001|Overall Study|Lack of Efficacy|2
6907308|NCT00713310|10930775|FG000|Overall Study|Withdrawal by Subject|0
6907309|NCT00713310|10930776|FG001|Overall Study|Withdrawal by Subject|2
6907310|NCT00713323|10930782|FG000|Overall Study|Adverse Event|75
6907311|NCT00713323|10930782|FG000|Overall Study|Withdrawal by Subject|15
6907312|NCT00713323|10930782|FG000|Overall Study|Lost to Follow-up|11
6907313|NCT00713323|10930782|FG000|Overall Study|Lack of Efficacy|36
6907314|NCT00713323|10930782|FG000|Overall Study|Low creatine clearance at screening|1
6907315|NCT00713323|10930782|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1
6907316|NCT00713323|10930782|FG000|Overall Study|Surgery cured allodynic pain|1
6907317|NCT00713323|10930782|FG000|Overall Study|Pain free|1
6907318|NCT00713323|10930782|FG000|Overall Study|Non-compliance|1
6907319|NCT00713323|10930782|FG000|Overall Study|Pain resolved|1
6907320|NCT00713323|10930782|FG000|Overall Study|Subject travelling to USA|1
6907321|NCT00713323|10930782|FG000|Overall Study|Subject travelling to Dominica Republic|1
6907322|NCT00713323|10930782|FG000|Overall Study|Treatment that may interact with Sativex|1
6907323|NCT00713349|10930786|FG000|Overall Study|Protocol Violation|1
6973956|NCT01185353|11025992|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
6973957|NCT01185353|11025993|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
6973958|NCT01185353|11025994|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
6973959|NCT01185353|11025985|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0
6973960|NCT01185353|11025986|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0
6973961|NCT01185353|11025987|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1
6973962|NCT01185353|11025988|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0
6973963|NCT01185353|11025989|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2
6973964|NCT01185353|11025990|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0
6973965|NCT01185353|11025991|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0
6973966|NCT01185353|11025992|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0
6973967|NCT01185353|11025993|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0
6973968|NCT01185353|11025994|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0
6973969|NCT01185353|11025985|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0
6973970|NCT01185353|11025986|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0
6973971|NCT01185353|11025987|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0
6973972|NCT01185353|11025988|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0
6973973|NCT01185353|11025989|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1
6973974|NCT01185353|11025990|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0
6973975|NCT01185353|11025991|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0
6973976|NCT01185353|11025992|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0
6973977|NCT01185353|11025993|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0
6973978|NCT01185353|11025994|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0
6973979|NCT01185353|11025985|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2
6973980|NCT01185353|11025986|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
6973981|NCT01185353|11025987|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
6973982|NCT01185353|11025988|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
6973983|NCT01185353|11025989|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3
6973984|NCT01185353|11025990|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
6973985|NCT01185353|11025991|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
6973986|NCT01185353|11025992|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
6973987|NCT01185353|11025993|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
6973988|NCT01185353|11025994|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
6973989|NCT01185353|11025985|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0
6973990|NCT01185353|11025986|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0
6973991|NCT01185353|11025987|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1
6973992|NCT01185353|11025988|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0
6907324|NCT00713544|10930811|FG000|Overall Study|Adverse Event|5
6907325|NCT00713544|10930812|FG001|Overall Study|Adverse Event|3
6907326|NCT00713544|10930813|FG002|Overall Study|Adverse Event|7
6907327|NCT00713544|10930814|FG003|Overall Study|Adverse Event|7
6907328|NCT00713544|10930815|FG004|Overall Study|Adverse Event|3
6907329|NCT00713544|10930816|FG005|Overall Study|Adverse Event|5
6907330|NCT00713544|10930811|FG000|Overall Study|Withdrawal by Subject|2
6907331|NCT00713544|10930812|FG001|Overall Study|Withdrawal by Subject|0
6907332|NCT00713544|10930813|FG002|Overall Study|Withdrawal by Subject|3
6907333|NCT00713544|10930814|FG003|Overall Study|Withdrawal by Subject|2
6907334|NCT00713544|10930815|FG004|Overall Study|Withdrawal by Subject|3
6907335|NCT00713544|10930816|FG005|Overall Study|Withdrawal by Subject|1
6907336|NCT00713544|10930811|FG000|Overall Study|Protocol Violation|0
6907337|NCT00713544|10930812|FG001|Overall Study|Protocol Violation|0
6907338|NCT00713544|10930813|FG002|Overall Study|Protocol Violation|0
6907339|NCT00713544|10930814|FG003|Overall Study|Protocol Violation|0
6907340|NCT00713544|10930815|FG004|Overall Study|Protocol Violation|0
6907341|NCT00713544|10930816|FG005|Overall Study|Protocol Violation|1
6907342|NCT00713544|10930811|FG000|Overall Study|Physician Decision|0
6907343|NCT00713544|10930812|FG001|Overall Study|Physician Decision|0
6907344|NCT00713544|10930813|FG002|Overall Study|Physician Decision|0
6907345|NCT00713544|10930814|FG003|Overall Study|Physician Decision|0
6907346|NCT00713544|10930815|FG004|Overall Study|Physician Decision|0
6907347|NCT00713544|10930816|FG005|Overall Study|Physician Decision|2
6907348|NCT00713544|10930811|FG000|Overall Study|Lack of Efficacy|0
6907349|NCT00713544|10930812|FG001|Overall Study|Lack of Efficacy|1
6907350|NCT00713544|10930813|FG002|Overall Study|Lack of Efficacy|0
6907351|NCT00713544|10930814|FG003|Overall Study|Lack of Efficacy|1
6907352|NCT00713544|10930815|FG004|Overall Study|Lack of Efficacy|1
6907353|NCT00713544|10930816|FG005|Overall Study|Lack of Efficacy|0
6907354|NCT00713544|10930811|FG000|Overall Study|Lost to Follow-up|0
6907355|NCT00713544|10930812|FG001|Overall Study|Lost to Follow-up|0
6907356|NCT00713544|10930813|FG002|Overall Study|Lost to Follow-up|1
6907357|NCT00713544|10930814|FG003|Overall Study|Lost to Follow-up|0
6907358|NCT00713544|10930815|FG004|Overall Study|Lost to Follow-up|0
6907359|NCT00713544|10930816|FG005|Overall Study|Lost to Follow-up|0
6907360|NCT00713544|10930811|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0
6907361|NCT00713544|10930812|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1
6907362|NCT00713544|10930813|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0
6907363|NCT00713544|10930814|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0
6907364|NCT00713544|10930815|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0
6907365|NCT00713544|10930816|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0
6907366|NCT00713544|10930811|FG000|Overall Study|Incorrect enrollment|0
6907367|NCT00713544|10930812|FG001|Overall Study|Incorrect enrollment|1
6907368|NCT00713544|10930813|FG002|Overall Study|Incorrect enrollment|0
6907369|NCT00713544|10930814|FG003|Overall Study|Incorrect enrollment|0
6907370|NCT00713544|10930815|FG004|Overall Study|Incorrect enrollment|0
6907371|NCT00713544|10930816|FG005|Overall Study|Incorrect enrollment|0
6907372|NCT00713544|10930811|FG000|Overall Study|Hepatotoxicity - not an AE|0
6907373|NCT00713544|10930812|FG001|Overall Study|Hepatotoxicity - not an AE|0
6907374|NCT00713544|10930813|FG002|Overall Study|Hepatotoxicity - not an AE|0
6907375|NCT00713544|10930814|FG003|Overall Study|Hepatotoxicity - not an AE|0
6907376|NCT00713544|10930815|FG004|Overall Study|Hepatotoxicity - not an AE|1
6907377|NCT00713544|10930816|FG005|Overall Study|Hepatotoxicity - not an AE|0
6907378|NCT00713609|10930845|FG000|Overall Study|Adverse Event|2
6907379|NCT00713609|10930846|FG001|Overall Study|Adverse Event|0
6907380|NCT00713609|10930847|FG002|Overall Study|Adverse Event|2
6907381|NCT00713609|10930848|FG003|Overall Study|Adverse Event|2
6907382|NCT00713609|10930849|FG004|Overall Study|Adverse Event|3
6907383|NCT00713609|10930850|FG005|Overall Study|Adverse Event|1
6907384|NCT00713609|10930845|FG000|Overall Study|Lost to Follow-up|5
6907385|NCT00713609|10930846|FG001|Overall Study|Lost to Follow-up|7
6907386|NCT00713609|10930847|FG002|Overall Study|Lost to Follow-up|5
6907387|NCT00713609|10930848|FG003|Overall Study|Lost to Follow-up|5
6907388|NCT00713609|10930849|FG004|Overall Study|Lost to Follow-up|7
6907389|NCT00713609|10930850|FG005|Overall Study|Lost to Follow-up|0
6907390|NCT00713609|10930845|FG000|Overall Study|Lack of Efficacy|1
6907391|NCT00713609|10930846|FG001|Overall Study|Lack of Efficacy|3
6907392|NCT00713609|10930847|FG002|Overall Study|Lack of Efficacy|0
6907393|NCT00713609|10930848|FG003|Overall Study|Lack of Efficacy|0
6907394|NCT00713609|10930849|FG004|Overall Study|Lack of Efficacy|1
6907395|NCT00713609|10930850|FG005|Overall Study|Lack of Efficacy|0
6907396|NCT00713609|10930845|FG000|Overall Study|Non-Compliance with Study Treatment|1
6907397|NCT00713609|10930846|FG001|Overall Study|Non-Compliance with Study Treatment|1
6907398|NCT00713609|10930847|FG002|Overall Study|Non-Compliance with Study Treatment|2
6907399|NCT00713609|10930848|FG003|Overall Study|Non-Compliance with Study Treatment|0
6907400|NCT00713609|10930849|FG004|Overall Study|Non-Compliance with Study Treatment|1
6907401|NCT00713609|10930850|FG005|Overall Study|Non-Compliance with Study Treatment|0
6907402|NCT00713609|10930845|FG000|Overall Study|Withdrawal by Subject|6
6907403|NCT00713609|10930846|FG001|Overall Study|Withdrawal by Subject|1
6907404|NCT00713609|10930847|FG002|Overall Study|Withdrawal by Subject|5
6907405|NCT00713609|10930848|FG003|Overall Study|Withdrawal by Subject|1
6907406|NCT00713609|10930849|FG004|Overall Study|Withdrawal by Subject|5
6907407|NCT00713609|10930850|FG005|Overall Study|Withdrawal by Subject|7
6907408|NCT00713609|10930845|FG000|Overall Study|Protocol Violation|6
6907409|NCT00713609|10930846|FG001|Overall Study|Protocol Violation|3
6907410|NCT00713609|10930847|FG002|Overall Study|Protocol Violation|1
6907411|NCT00713609|10930848|FG003|Overall Study|Protocol Violation|1
6907412|NCT00713609|10930849|FG004|Overall Study|Protocol Violation|2
6907413|NCT00713609|10930850|FG005|Overall Study|Protocol Violation|0
6907414|NCT00713648|10930864|FG000|Overall Study|Adverse Event|1
6907415|NCT00713648|10930864|FG000|Overall Study|Unclassified|2
6907416|NCT00713648|10930864|FG000|Overall Study|According to Protocol|2
6907417|NCT00713648|10930864|FG000|Overall Study|Development of antibodies|3
6907418|NCT00713700|10930885|FG000|Overall Study|Lost to Follow-up|3
6907419|NCT00713700|10930885|FG000|Overall Study|Withdrawal by Subject|1
6907420|NCT00713830|10930900|FG000|Overall Study|Adverse Event|23
6907421|NCT00713830|10930901|FG001|Overall Study|Adverse Event|71
6907422|NCT00713830|10930900|FG000|Overall Study|Lack of Efficacy|24
6907423|NCT00713830|10930901|FG001|Overall Study|Lack of Efficacy|16
6907424|NCT00713830|10930900|FG000|Overall Study|Lost to Follow-up|2
6907425|NCT00713830|10930901|FG001|Overall Study|Lost to Follow-up|9
6907426|NCT00713830|10930900|FG000|Overall Study|Withdrawal by Subject|13
6907427|NCT00713830|10930901|FG001|Overall Study|Withdrawal by Subject|23
6907428|NCT00713830|10930900|FG000|Overall Study|Poor Compliance to Protocol|7
6907429|NCT00713830|10930901|FG001|Overall Study|Poor Compliance to Protocol|14
6907430|NCT00713830|10930900|FG000|Overall Study|Familial and Personal Reasons|9
6907431|NCT00713830|10930901|FG001|Overall Study|Familial and Personal Reasons|34
6907432|NCT00713830|10930900|FG000|Overall Study|Sponsor Decision|4
6907433|NCT00713830|10930901|FG001|Overall Study|Sponsor Decision|10
6907434|NCT00714051|10930909|FG000|Overall Study|Withdrawal by Subject|1
6907435|NCT00714051|10930910|FG001|Overall Study|Withdrawal by Subject|0
6907436|NCT00714051|10930909|FG000|Overall Study|Death|0
6907437|NCT00714051|10930910|FG001|Overall Study|Death|1
6907438|NCT00714168|10930918|FG000|Overall Study|Pregnancy|5
6907439|NCT00714168|10930919|FG001|Overall Study|Pregnancy|4
6907440|NCT00714168|10930918|FG000|Overall Study|Lost to Follow-up|32
6907441|NCT00714168|10930919|FG001|Overall Study|Lost to Follow-up|50
6907442|NCT00714168|10930918|FG000|Overall Study|Relocation|4
6907443|NCT00714168|10930919|FG001|Overall Study|Relocation|3
6907444|NCT00714168|10930918|FG000|Overall Study|Non-study medical condition|3
6907445|NCT00714168|10930919|FG001|Overall Study|Non-study medical condition|2
6907446|NCT00714259|10930947|FG000|Overall Study|Death|2
6907447|NCT00714285|10930964|FG000|Overall Study|Lost to Follow-up|0
6907448|NCT00714285|10930965|FG001|Overall Study|Lost to Follow-up|2
6907449|NCT00714285|10930966|FG002|Overall Study|Lost to Follow-up|0
6907450|NCT00714285|10930967|FG003|Overall Study|Lost to Follow-up|1
6907451|NCT00714285|10930964|FG000|Overall Study|Migrated/moved from study area|0
6907452|NCT00714285|10930965|FG001|Overall Study|Migrated/moved from study area|1
6907453|NCT00714285|10930966|FG002|Overall Study|Migrated/moved from study area|0
6907454|NCT00714285|10930967|FG003|Overall Study|Migrated/moved from study area|0
6907455|NCT00714415|10930994|FG000|Overall Study|Lack of Efficacy|1
6907456|NCT00714415|10930995|FG001|Overall Study|Lack of Efficacy|0
6907457|NCT00714415|10930994|FG000|Overall Study|Death|1
6907458|NCT00714415|10930995|FG001|Overall Study|Death|0
6907459|NCT00714493|10931001|FG000|Overall Study|Adverse Event|11
6907460|NCT00714493|10931001|FG000|Overall Study|Death|3
6907461|NCT00714493|10931001|FG000|Overall Study|Lack of Efficacy|10
6907462|NCT00714493|10931001|FG000|Overall Study|Lost to Follow-up|3
6907463|NCT00714493|10931001|FG000|Overall Study|Protocol Violation|12
6907464|NCT00714493|10931001|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8
6907465|NCT00714493|10931001|FG000|Overall Study|OTHER|2
6907466|NCT00714688|10931033|FG000|Overall Study|Lack of Efficacy|14
6907467|NCT00714688|10931034|FG001|Overall Study|Lack of Efficacy|1
6907468|NCT00714688|10931035|FG002|Overall Study|Lack of Efficacy|4
6907469|NCT00714688|10931033|FG000|Overall Study|Withdrawal by Subject|4
6907470|NCT00714688|10931034|FG001|Overall Study|Withdrawal by Subject|3
6907471|NCT00714688|10931035|FG002|Overall Study|Withdrawal by Subject|3
6907472|NCT00714688|10931033|FG000|Overall Study|Lost to Follow-up|5
6907473|NCT00714688|10931034|FG001|Overall Study|Lost to Follow-up|2
6907474|NCT00714688|10931035|FG002|Overall Study|Lost to Follow-up|0
6907475|NCT00714688|10931033|FG000|Overall Study|Adverse Event|2
6907476|NCT00714688|10931034|FG001|Overall Study|Adverse Event|15
6907477|NCT00714688|10931035|FG002|Overall Study|Adverse Event|19
6907478|NCT00714688|10931033|FG000|Overall Study|Subject Non-compliant|3
6907479|NCT00714688|10931034|FG001|Overall Study|Subject Non-compliant|5
6907480|NCT00714688|10931035|FG002|Overall Study|Subject Non-compliant|5
6907481|NCT00714688|10931033|FG000|Overall Study|Ineligible to Continue the Study|0
6907482|NCT00714688|10931034|FG001|Overall Study|Ineligible to Continue the Study|1
6907483|NCT00714688|10931035|FG002|Overall Study|Ineligible to Continue the Study|1
6907484|NCT00714688|10931033|FG000|Overall Study|Sponsor's Decision|0
6907485|NCT00714688|10931034|FG001|Overall Study|Sponsor's Decision|2
6907486|NCT00714688|10931035|FG002|Overall Study|Sponsor's Decision|0
6907487|NCT00714688|10931033|FG000|Overall Study|Other|1
6907488|NCT00714688|10931034|FG001|Overall Study|Other|6
6907489|NCT00714688|10931035|FG002|Overall Study|Other|5
6907490|NCT00714714|10931043|FG000|Overall Study|Adverse Event|1
6907491|NCT00714870|10931064|FG000|Overall Study|Lost to Follow-up|22
6907492|NCT00714870|10931065|FG001|Overall Study|Lost to Follow-up|5
6907493|NCT00714870|10931064|FG000|Overall Study|patient unable to come b/c back pain|1
6907494|NCT00714870|10931065|FG001|Overall Study|patient unable to come b/c back pain|0
6907495|NCT00714870|10931064|FG000|Overall Study|did not attend minimum of 4 sessions|4
6907496|NCT00714870|10931065|FG001|Overall Study|did not attend minimum of 4 sessions|0
6907497|NCT00715026|10931071|FG000|Overall Study|Withdrawal by Subject|5
6907498|NCT00715026|10931071|FG000|Overall Study|Lost to Follow-up|3
6907499|NCT00715026|10931071|FG000|Overall Study|Protocol Violation|1
6907500|NCT00715026|10931071|FG000|Overall Study|Surgery done on non-study consented hip|1
6907501|NCT00715078|10931078|FG000|Overall Study|Death|29
6907502|NCT00715078|10931079|FG001|Overall Study|Death|36
6907503|NCT00715078|10931080|FG002|Overall Study|Death|36
6907504|NCT00715078|10931078|FG000|Overall Study|Withdrawal by Subject|1
6907505|NCT00715078|10931079|FG001|Overall Study|Withdrawal by Subject|0
6907506|NCT00715078|10931080|FG002|Overall Study|Withdrawal by Subject|1
6907507|NCT00715078|10931078|FG000|Overall Study|Unable to start due to disease prog.|0
6907508|NCT00715078|10931079|FG001|Overall Study|Unable to start due to disease prog.|0
6907509|NCT00715078|10931080|FG002|Overall Study|Unable to start due to disease prog.|1
6907510|NCT00715117|10931137|FG000|Overall Study|Crohn's flare and rescue with steroids|0
6907511|NCT00715117|10931138|FG001|Overall Study|Crohn's flare and rescue with steroids|1
6907512|NCT00715208|10931151|FG000|Overall Study|Withdrawal by Subject|1
6907513|NCT00715208|10931152|FG001|Overall Study|Withdrawal by Subject|1
6907514|NCT00715208|10931151|FG000|Overall Study|Adverse Event|0
6907515|NCT00715208|10931152|FG001|Overall Study|Adverse Event|6
6907516|NCT00715208|10931151|FG000|Overall Study|Lack of Efficacy|0
6907517|NCT00715208|10931152|FG001|Overall Study|Lack of Efficacy|2
6907518|NCT00715299|10931158|FG000|Overall Study|Withdrawal by Subject|1
6907519|NCT00715299|10931158|FG000|Overall Study|Adverse Event|3
6907520|NCT00715299|10931158|FG000|Overall Study|failed the pre-screen exercise test|2
6907521|NCT00715403|10931173|FG000|Overall Study|Progressive disease|0
6907522|NCT00715403|10931174|FG001|Overall Study|Progressive disease|1
6907523|NCT00715403|10931175|FG002|Overall Study|Progressive disease|3
6907524|NCT00715403|10931176|FG003|Overall Study|Progressive disease|9
6907525|NCT00715403|10931177|FG004|Overall Study|Progressive disease|5
6907526|NCT00715403|10931178|FG005|Overall Study|Progressive disease|14
6907527|NCT00715403|10931179|FG006|Overall Study|Progressive disease|1
6907528|NCT00715403|10931173|FG000|Overall Study|Dose limiting Toxicity (DLT)|0
6907529|NCT00715403|10931174|FG001|Overall Study|Dose limiting Toxicity (DLT)|0
6907530|NCT00715403|10931175|FG002|Overall Study|Dose limiting Toxicity (DLT)|0
6907531|NCT00715403|10931176|FG003|Overall Study|Dose limiting Toxicity (DLT)|0
6907532|NCT00715403|10931177|FG004|Overall Study|Dose limiting Toxicity (DLT)|0
6907533|NCT00715403|10931178|FG005|Overall Study|Dose limiting Toxicity (DLT)|1
6907534|NCT00715403|10931179|FG006|Overall Study|Dose limiting Toxicity (DLT)|0
6907535|NCT00715403|10931173|FG000|Overall Study|Other Adverse Event than DLT|1
6907536|NCT00715403|10931174|FG001|Overall Study|Other Adverse Event than DLT|0
6907537|NCT00715403|10931175|FG002|Overall Study|Other Adverse Event than DLT|0
6907538|NCT00715403|10931176|FG003|Overall Study|Other Adverse Event than DLT|0
6907539|NCT00715403|10931177|FG004|Overall Study|Other Adverse Event than DLT|0
6907540|NCT00715403|10931178|FG005|Overall Study|Other Adverse Event than DLT|2
6907541|NCT00715403|10931179|FG006|Overall Study|Other Adverse Event than DLT|0
6907542|NCT00715403|10931173|FG000|Overall Study|Protocol Violation|0
6907543|NCT00715403|10931174|FG001|Overall Study|Protocol Violation|0
6907544|NCT00715403|10931175|FG002|Overall Study|Protocol Violation|0
6907545|NCT00715403|10931176|FG003|Overall Study|Protocol Violation|0
6907546|NCT00715403|10931177|FG004|Overall Study|Protocol Violation|0
6907547|NCT00715403|10931178|FG005|Overall Study|Protocol Violation|1
6907548|NCT00715403|10931179|FG006|Overall Study|Protocol Violation|0
6907549|NCT00715403|10931173|FG000|Overall Study|Other reason not defined above|0
6907550|NCT00715403|10931174|FG001|Overall Study|Other reason not defined above|0
6907551|NCT00715403|10931175|FG002|Overall Study|Other reason not defined above|1
6907552|NCT00715403|10931176|FG003|Overall Study|Other reason not defined above|0
6907553|NCT00715403|10931177|FG004|Overall Study|Other reason not defined above|1
6907554|NCT00715403|10931178|FG005|Overall Study|Other reason not defined above|1
6907555|NCT00715403|10931179|FG006|Overall Study|Other reason not defined above|0
6907556|NCT00715429|10931197|FG000|Overall Study|Did not complete the study diary|0
6907557|NCT00715429|10931198|FG001|Overall Study|Did not complete the study diary|1
6907558|NCT00715520|10931207|FG000|Overall Study|Screen failure|8
6907559|NCT00715520|10931208|FG001|Overall Study|Screen failure|1
6907560|NCT00715520|10931209|FG002|Overall Study|Screen failure|1
6907561|NCT00715520|10931207|FG000|Overall Study|Withdrawal by Subject|2
6907562|NCT00715520|10931208|FG001|Overall Study|Withdrawal by Subject|0
6907563|NCT00715520|10931209|FG002|Overall Study|Withdrawal by Subject|1
6907564|NCT00715559|10931217|FG000|Overall Study|medication not tolerated - nausea|1
6907565|NCT00715624|10931223|FG000|Overall Study|Adverse Event|12
6907566|NCT00715624|10931224|FG001|Overall Study|Adverse Event|37
6907567|NCT00715624|10931223|FG000|Overall Study|Lack of Efficacy|11
6907568|NCT00715624|10931224|FG001|Overall Study|Lack of Efficacy|11
6907569|NCT00715624|10931223|FG000|Overall Study|Lost to Follow-up|1
6907570|NCT00715624|10931224|FG001|Overall Study|Lost to Follow-up|2
6907571|NCT00715624|10931223|FG000|Overall Study|Protocol Violation|1
6907572|NCT00715624|10931224|FG001|Overall Study|Protocol Violation|0
6907573|NCT00715624|10931223|FG000|Overall Study|Withdrawal by Subject|11
6907574|NCT00715624|10931224|FG001|Overall Study|Withdrawal by Subject|25
6907575|NCT00715624|10931223|FG000|Overall Study|Familial and personal reasons|10
6907576|NCT00715624|10931224|FG001|Overall Study|Familial and personal reasons|22
6907577|NCT00715624|10931223|FG000|Overall Study|Poor compliance|6
6907578|NCT00715624|10931224|FG001|Overall Study|Poor compliance|13
6907579|NCT00715624|10931223|FG000|Overall Study|Sponsor decision|0
6907580|NCT00715624|10931224|FG001|Overall Study|Sponsor decision|4
6907581|NCT00715624|10931223|FG000|Overall Study|Incorrect randomization (not treated)|0
6907582|NCT00715624|10931224|FG001|Overall Study|Incorrect randomization (not treated)|1
6907583|NCT00715624|10931223|FG000|Overall Study|Other|0
6907584|NCT00715624|10931224|FG001|Overall Study|Other|1
6907585|NCT00715676|10931242|FG000|Overall Study|Adverse Event|3
6907586|NCT00715676|10931243|FG001|Overall Study|Adverse Event|5
6907587|NCT00715676|10931244|FG002|Overall Study|Adverse Event|21
6907588|NCT00715676|10931242|FG000|Overall Study|Withdrawal by Subject|1
6907589|NCT00715676|10931243|FG001|Overall Study|Withdrawal by Subject|3
6907590|NCT00715676|10931244|FG002|Overall Study|Withdrawal by Subject|8
6907591|NCT00715676|10931242|FG000|Overall Study|Lost to Follow-up|1
6907592|NCT00715676|10931243|FG001|Overall Study|Lost to Follow-up|2
6907593|NCT00715676|10931244|FG002|Overall Study|Lost to Follow-up|1
6907594|NCT00715676|10931242|FG000|Overall Study|Terminated by Sponsor|1
6907595|NCT00715676|10931243|FG001|Overall Study|Terminated by Sponsor|0
6907596|NCT00715676|10931244|FG002|Overall Study|Terminated by Sponsor|0
6907597|NCT00715676|10931242|FG000|Overall Study|Did Not Meet Entry Criteria|0
6907598|NCT00715676|10931243|FG001|Overall Study|Did Not Meet Entry Criteria|0
6907599|NCT00715676|10931244|FG002|Overall Study|Did Not Meet Entry Criteria|1
6907600|NCT00715676|10931242|FG000|Overall Study|Use of Exclusionary Medication|0
6907601|NCT00715676|10931243|FG001|Overall Study|Use of Exclusionary Medication|0
6907602|NCT00715676|10931244|FG002|Overall Study|Use of Exclusionary Medication|1
6907603|NCT00715676|10931242|FG000|Overall Study|Elevated Blood Glucose|0
6907604|NCT00715676|10931243|FG001|Overall Study|Elevated Blood Glucose|1
6907605|NCT00715676|10931244|FG002|Overall Study|Elevated Blood Glucose|0
6907606|NCT00715793|10931284|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1
6907607|NCT00715793|10931285|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0
6907608|NCT00715793|10931284|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0
6907609|NCT00715793|10931285|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2
6907610|NCT00715910|10931305|FG000|Booster and ESFU Phase|Lost to Follow-up|0
6907611|NCT00715910|10931306|FG001|Booster and ESFU Phase|Lost to Follow-up|0
6907612|NCT00715910|10931307|FG002|Booster and ESFU Phase|Lost to Follow-up|0
6907613|NCT00715910|10931308|FG003|Booster and ESFU Phase|Lost to Follow-up|6
6907614|NCT00715910|10931309|FG004|Booster and ESFU Phase|Lost to Follow-up|1
6907615|NCT00715910|10931310|FG005|Booster and ESFU Phase|Lost to Follow-up|13
6907616|NCT00715910|10931305|FG000|Booster and ESFU Phase|Other|0
6907617|NCT00715910|10931306|FG001|Booster and ESFU Phase|Other|0
6907618|NCT00715910|10931307|FG002|Booster and ESFU Phase|Other|0
6907619|NCT00715910|10931308|FG003|Booster and ESFU Phase|Other|5
6907620|NCT00715910|10931309|FG004|Booster and ESFU Phase|Other|1
6907621|NCT00715910|10931310|FG005|Booster and ESFU Phase|Other|0
6907622|NCT00715949|10931326|FG000|Overall Study|could not finish first test|4
6907623|NCT00716092|10931352|FG000|Overall Study|Other incl. Lack of Efficacy|2
6907624|NCT00716092|10931353|FG001|Overall Study|Other incl. Lack of Efficacy|1
6907625|NCT00716092|10931354|FG002|Overall Study|Other incl. Lack of Efficacy|0
6907626|NCT00716144|10931366|FG000|Overall Study|Withdrawal by Subject|4
6907627|NCT00716144|10931367|FG001|Overall Study|Withdrawal by Subject|2
6907628|NCT00716144|10931368|FG002|Overall Study|Withdrawal by Subject|6
6907629|NCT00716144|10931369|FG003|Overall Study|Withdrawal by Subject|6
6907630|NCT00716144|10931366|FG000|Overall Study|Lost to Follow-up|2
6907631|NCT00716144|10931367|FG001|Overall Study|Lost to Follow-up|2
6907632|NCT00716144|10931368|FG002|Overall Study|Lost to Follow-up|1
6907633|NCT00716144|10931369|FG003|Overall Study|Lost to Follow-up|2
6907634|NCT00716144|10931366|FG000|Overall Study|Adverse Event|0
6907635|NCT00716144|10931367|FG001|Overall Study|Adverse Event|0
6907636|NCT00716144|10931368|FG002|Overall Study|Adverse Event|0
6907637|NCT00716144|10931369|FG003|Overall Study|Adverse Event|2
6907638|NCT00716144|10931366|FG000|Overall Study|Non-compliance|1
6907639|NCT00716144|10931367|FG001|Overall Study|Non-compliance|0
6907640|NCT00716144|10931368|FG002|Overall Study|Non-compliance|0
6907641|NCT00716144|10931369|FG003|Overall Study|Non-compliance|0
6907642|NCT00716144|10931366|FG000|Overall Study|Protocol Violation|2
6907643|NCT00716144|10931367|FG001|Overall Study|Protocol Violation|0
6907644|NCT00716144|10931368|FG002|Overall Study|Protocol Violation|1
6907645|NCT00716144|10931369|FG003|Overall Study|Protocol Violation|0
6907646|NCT00716144|10931366|FG000|Overall Study|Physician Decision|0
6907647|NCT00716144|10931367|FG001|Overall Study|Physician Decision|1
6907648|NCT00716144|10931368|FG002|Overall Study|Physician Decision|2
6907649|NCT00716144|10931369|FG003|Overall Study|Physician Decision|2
6907650|NCT00716144|10931366|FG000|Overall Study|Intercurrent illness|0
6907651|NCT00716144|10931367|FG001|Overall Study|Intercurrent illness|0
6907652|NCT00716144|10931368|FG002|Overall Study|Intercurrent illness|1
6907653|NCT00716144|10931369|FG003|Overall Study|Intercurrent illness|0
6907654|NCT00716144|10931366|FG000|Overall Study|Withdrew consent, allowed use of data|0
6907655|NCT00716144|10931367|FG001|Overall Study|Withdrew consent, allowed use of data|0
6907656|NCT00716144|10931368|FG002|Overall Study|Withdrew consent, allowed use of data|1
6907657|NCT00716144|10931369|FG003|Overall Study|Withdrew consent, allowed use of data|0
6907658|NCT00716144|10931366|FG000|Overall Study|Adverse event: left foot pain|0
6907659|NCT00716144|10931367|FG001|Overall Study|Adverse event: left foot pain|1
6907660|NCT00716144|10931368|FG002|Overall Study|Adverse event: left foot pain|0
6907661|NCT00716144|10931369|FG003|Overall Study|Adverse event: left foot pain|0
6907662|NCT00716144|10931366|FG000|Overall Study|Clinical Depression|0
6907663|NCT00716144|10931367|FG001|Overall Study|Clinical Depression|1
6907664|NCT00716144|10931368|FG002|Overall Study|Clinical Depression|0
6907665|NCT00716144|10931369|FG003|Overall Study|Clinical Depression|0
6907666|NCT00716274|10931382|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2
6907667|NCT00716274|10931383|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0
6907668|NCT00716274|10931384|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0
6907669|NCT00716274|10931385|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0
6907670|NCT00716274|10931386|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0
6907671|NCT00716274|10931387|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0
6907672|NCT00716274|10931382|FG000|Study Period II (16-Weeks)|Protocol Violation|0
6907673|NCT00716274|10931383|FG001|Study Period II (16-Weeks)|Protocol Violation|3
6907674|NCT00716274|10931384|FG002|Study Period II (16-Weeks)|Protocol Violation|0
6907675|NCT00716274|10931385|FG003|Study Period II (16-Weeks)|Protocol Violation|0
6907676|NCT00716274|10931386|FG004|Study Period II (16-Weeks)|Protocol Violation|0
6907677|NCT00716274|10931387|FG005|Study Period II (16-Weeks)|Protocol Violation|1
6907678|NCT00716274|10931382|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1
6907679|NCT00716274|10931383|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0
6907680|NCT00716274|10931384|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0
6907681|NCT00716274|10931385|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0
6907682|NCT00716274|10931386|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0
6907683|NCT00716274|10931387|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0
6907684|NCT00716274|10931382|FG000|Study Period II (16-Weeks)|Physician Decision|3
6907685|NCT00716274|10931383|FG001|Study Period II (16-Weeks)|Physician Decision|1
6907686|NCT00716274|10931384|FG002|Study Period II (16-Weeks)|Physician Decision|0
6907687|NCT00716274|10931385|FG003|Study Period II (16-Weeks)|Physician Decision|0
6907688|NCT00716274|10931386|FG004|Study Period II (16-Weeks)|Physician Decision|0
6907689|NCT00716274|10931387|FG005|Study Period II (16-Weeks)|Physician Decision|1
6907690|NCT00716274|10931382|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
6907691|NCT00716274|10931383|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
6907692|NCT00716274|10931384|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
6907693|NCT00716274|10931385|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
6907694|NCT00716274|10931386|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
6907695|NCT00716274|10931387|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
6907696|NCT00716274|10931382|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0
6907697|NCT00716274|10931383|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2
6907698|NCT00716274|10931384|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0
6907699|NCT00716274|10931385|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0
6907700|NCT00716274|10931386|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0
6907701|NCT00716274|10931387|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0
6907702|NCT00716274|10931382|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0
6907703|NCT00716274|10931383|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0
6907704|NCT00716274|10931384|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2
6907705|NCT00716274|10931385|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0
6907706|NCT00716274|10931386|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0
6907707|NCT00716274|10931387|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0
6907708|NCT00716274|10931382|FG000|Study Period III (16-Weeks)|Physician Decision|0
6907709|NCT00716274|10931383|FG001|Study Period III (16-Weeks)|Physician Decision|0
6907710|NCT00716274|10931384|FG002|Study Period III (16-Weeks)|Physician Decision|0
6907711|NCT00716274|10931385|FG003|Study Period III (16-Weeks)|Physician Decision|0
6907712|NCT00716274|10931386|FG004|Study Period III (16-Weeks)|Physician Decision|1
6907713|NCT00716274|10931387|FG005|Study Period III (16-Weeks)|Physician Decision|0
6907714|NCT00716274|10931382|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0
6907715|NCT00716274|10931383|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0
6907716|NCT00716274|10931384|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0
6907717|NCT00716274|10931385|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1
6907718|NCT00716274|10931386|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1
6907719|NCT00716274|10931387|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0
6907720|NCT00716274|10931382|FG000|Study Period III (16-Weeks)|Adverse Event|0
6907721|NCT00716274|10931383|FG001|Study Period III (16-Weeks)|Adverse Event|0
6907722|NCT00716274|10931384|FG002|Study Period III (16-Weeks)|Adverse Event|0
6907723|NCT00716274|10931385|FG003|Study Period III (16-Weeks)|Adverse Event|0
6907724|NCT00716274|10931386|FG004|Study Period III (16-Weeks)|Adverse Event|1
6907725|NCT00716274|10931387|FG005|Study Period III (16-Weeks)|Adverse Event|0
6907726|NCT00716417|10931414|FG000|Overall Study|Adverse Event|0
6907727|NCT00716417|10931415|FG001|Overall Study|Adverse Event|0
6907728|NCT00716417|10931416|FG002|Overall Study|Adverse Event|2
6907729|NCT00716417|10931417|FG003|Overall Study|Adverse Event|1
6907730|NCT00716417|10931418|FG004|Overall Study|Adverse Event|0
6907731|NCT00716417|10931419|FG005|Overall Study|Adverse Event|0
6907732|NCT00716417|10931420|FG006|Overall Study|Adverse Event|3
6907733|NCT00716417|10931421|FG007|Overall Study|Adverse Event|1
6907734|NCT00716417|10931422|FG008|Overall Study|Adverse Event|0
6907735|NCT00716417|10931423|FG009|Overall Study|Adverse Event|3
6907736|NCT00716417|10931414|FG000|Overall Study|Withdrawal by Subject|0
6907737|NCT00716417|10931415|FG001|Overall Study|Withdrawal by Subject|1
6907738|NCT00716417|10931416|FG002|Overall Study|Withdrawal by Subject|0
6907739|NCT00716417|10931417|FG003|Overall Study|Withdrawal by Subject|2
6907740|NCT00716417|10931418|FG004|Overall Study|Withdrawal by Subject|0
6907741|NCT00716417|10931419|FG005|Overall Study|Withdrawal by Subject|0
6907742|NCT00716417|10931420|FG006|Overall Study|Withdrawal by Subject|1
6907743|NCT00716417|10931421|FG007|Overall Study|Withdrawal by Subject|0
6907744|NCT00716417|10931422|FG008|Overall Study|Withdrawal by Subject|0
6907745|NCT00716417|10931423|FG009|Overall Study|Withdrawal by Subject|0
6907746|NCT00716417|10931414|FG000|Overall Study|Progressive disease|3
6907747|NCT00716417|10931415|FG001|Overall Study|Progressive disease|5
6907748|NCT00716417|10931416|FG002|Overall Study|Progressive disease|3
6907749|NCT00716417|10931417|FG003|Overall Study|Progressive disease|8
6907750|NCT00716417|10931418|FG004|Overall Study|Progressive disease|0
6907751|NCT00716417|10931419|FG005|Overall Study|Progressive disease|3
6907752|NCT00716417|10931420|FG006|Overall Study|Progressive disease|3
6907753|NCT00716417|10931421|FG007|Overall Study|Progressive disease|1
6907754|NCT00716417|10931422|FG008|Overall Study|Progressive disease|5
6907755|NCT00716417|10931423|FG009|Overall Study|Progressive disease|0
6907756|NCT00716417|10931414|FG000|Overall Study|Dose limiting toxicity (DLT)|0
6907757|NCT00716417|10931415|FG001|Overall Study|Dose limiting toxicity (DLT)|0
6907758|NCT00716417|10931416|FG002|Overall Study|Dose limiting toxicity (DLT)|0
6907759|NCT00716417|10931417|FG003|Overall Study|Dose limiting toxicity (DLT)|0
6907760|NCT00716417|10931418|FG004|Overall Study|Dose limiting toxicity (DLT)|1
6907761|NCT00716417|10931419|FG005|Overall Study|Dose limiting toxicity (DLT)|0
6907762|NCT00716417|10931420|FG006|Overall Study|Dose limiting toxicity (DLT)|0
6907763|NCT00716417|10931421|FG007|Overall Study|Dose limiting toxicity (DLT)|0
6907764|NCT00716417|10931422|FG008|Overall Study|Dose limiting toxicity (DLT)|0
6907765|NCT00716417|10931423|FG009|Overall Study|Dose limiting toxicity (DLT)|0
6907766|NCT00716417|10931414|FG000|Overall Study|On patient request due to toxicities|0
6907767|NCT00716417|10931415|FG001|Overall Study|On patient request due to toxicities|0
6907768|NCT00716417|10931416|FG002|Overall Study|On patient request due to toxicities|0
6907769|NCT00716417|10931417|FG003|Overall Study|On patient request due to toxicities|0
6907770|NCT00716417|10931418|FG004|Overall Study|On patient request due to toxicities|0
6907771|NCT00716417|10931419|FG005|Overall Study|On patient request due to toxicities|0
6907772|NCT00716417|10931420|FG006|Overall Study|On patient request due to toxicities|0
6907773|NCT00716417|10931421|FG007|Overall Study|On patient request due to toxicities|1
6907774|NCT00716417|10931422|FG008|Overall Study|On patient request due to toxicities|0
6907775|NCT00716417|10931423|FG009|Overall Study|On patient request due to toxicities|0
6907776|NCT00716456|10931455|FG000|Overall Study|Adverse Event|0
6907777|NCT00716456|10931456|FG001|Overall Study|Adverse Event|2
6907778|NCT00716456|10931457|FG002|Overall Study|Adverse Event|0
6907779|NCT00716482|10931465|FG000|Overall Study|Lost to Follow-up|6
6907780|NCT00716482|10931465|FG000|Overall Study|Inadequate acquisition or analysis|50
6907781|NCT00716482|10931465|FG000|Overall Study|no pathology obtained|10
6907782|NCT00716482|10931465|FG000|Overall Study|technical/machine error|28
6907783|NCT00716482|10931465|FG000|Overall Study|inclusion/exclusion criteria not met|25
6907784|NCT00716625|10931480|FG000|Overall Study|Safety was not Assessable|1
6907785|NCT00716859|10931538|FG000|Overall Study|Adverse Event|4
6907786|NCT00716859|10931539|FG001|Overall Study|Adverse Event|1
6907787|NCT00716859|10931538|FG000|Overall Study|Lack of Efficacy|3
6907788|NCT00716859|10931539|FG001|Overall Study|Lack of Efficacy|0
6907789|NCT00716859|10931538|FG000|Overall Study|Withdrawal by Subject|1
6907790|NCT00716859|10931539|FG001|Overall Study|Withdrawal by Subject|3
6907791|NCT00716859|10931538|FG000|Overall Study|Not treated|1
6907792|NCT00716859|10931539|FG001|Overall Study|Not treated|1
6907793|NCT00716976|10931560|FG000|Overall Study|Adverse Event|2
6907794|NCT00716976|10931561|FG001|Overall Study|Adverse Event|0
6907795|NCT00716976|10931560|FG000|Overall Study|Death|1
6907796|NCT00716976|10931561|FG001|Overall Study|Death|0
6907797|NCT00716976|10931560|FG000|Overall Study|Physician Decision|2
6907798|NCT00716976|10931561|FG001|Overall Study|Physician Decision|2
6907799|NCT00716976|10931560|FG000|Overall Study|Withdrawal by Subject|5
6907800|NCT00716976|10931561|FG001|Overall Study|Withdrawal by Subject|1
6907801|NCT00716976|10931560|FG000|Overall Study|Premature discontinuation cisplatin|5
6907802|NCT00716976|10931561|FG001|Overall Study|Premature discontinuation cisplatin|4
6907803|NCT00716976|10931560|FG000|Overall Study|Radiation during protocol|1
6907804|NCT00716976|10931561|FG001|Overall Study|Radiation during protocol|0
6907805|NCT00716976|10931560|FG000|Overall Study|Ineligibles|4
6907806|NCT00716976|10931561|FG001|Overall Study|Ineligibles|2
6907807|NCT00717067|10931590|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
6907808|NCT00717067|10931591|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
6907809|NCT00717067|10931592|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1
6907810|NCT00717067|10931593|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
6907811|NCT00717067|10931594|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
6907812|NCT00717093|10931618|FG000|Overall Study|Adverse Event|19
6907813|NCT00717093|10931619|FG001|Overall Study|Adverse Event|9
6907814|NCT00717093|10931618|FG000|Overall Study|Lack of Efficacy|3
6907815|NCT00717093|10931619|FG001|Overall Study|Lack of Efficacy|13
6907816|NCT00717093|10931618|FG000|Overall Study|Lost to Follow-up|9
6907817|NCT00717093|10931619|FG001|Overall Study|Lost to Follow-up|6
6907818|NCT00717093|10931618|FG000|Overall Study|Withdrawal by Subject|12
6907819|NCT00717093|10931619|FG001|Overall Study|Withdrawal by Subject|19
6907820|NCT00717093|10931618|FG000|Overall Study|Other|0
6907821|NCT00717093|10931619|FG001|Overall Study|Other|1
6907822|NCT00717093|10931618|FG000|Overall Study|Randomized but not treated|1
6907823|NCT00717093|10931619|FG001|Overall Study|Randomized but not treated|0
7060165|NCT01915095|11156169|FG002|Overall Study|Some subjects were unable to commit to the training study.|0
7060166|NCT01915095|11156170|FG003|Overall Study|Some subjects were unable to commit to the training study.|4
7060167|NCT01915095|11156171|FG004|Overall Study|Some subjects were unable to commit to the training study.|6
7060168|NCT01915303|11156226|FG000|Core Phase|Adverse Event|7
7060169|NCT01915303|11156226|FG000|Core Phase|Unsatisfactory therapeutic effect|3
7060170|NCT01915303|11156226|FG000|Core Phase|Death|2
7060171|NCT01915303|11156226|FG000|Core Phase|Protocol Violation|2
7060172|NCT01915303|11156226|FG000|Core Phase|Abnormal lab value|1
7060173|NCT01915303|11156226|FG000|Core Phase|Withdrawal by Subject|1
7060174|NCT01915303|11156226|FG000|Extension Phase|Unsatisfactory therapeutic effect|8
7060175|NCT01915303|11156226|FG000|Extension Phase|Withdrawal by Subject|4
7060176|NCT01915303|11156226|FG000|Extension Phase|Adverse Event|3
7060177|NCT01915303|11156226|FG000|Extension Phase|Death|1
7060178|NCT01915303|11156226|FG000|Extension Phase|Protocol Violation|1
7060179|NCT01915732|11156241|FG000|Overall Study|Withdrawal by Subject|18
7060180|NCT01915732|11156242|FG001|Overall Study|Withdrawal by Subject|18
6907824|NCT00717197|10931625|FG000|Overall Study|Unable to purchase study drug|5
6907825|NCT00717197|10931625|FG000|Overall Study|Tumor Progression|1
6907826|NCT00717197|10931625|FG000|Overall Study|Physician Decision|1
6907827|NCT00717236|10931631|FG000|Double-Blind Period|Adverse Event|33
6907828|NCT00717236|10931632|FG001|Double-Blind Period|Adverse Event|6
6907829|NCT00717236|10931631|FG000|Double-Blind Period|Lack of Efficacy|6
6907830|NCT00717236|10931632|FG001|Double-Blind Period|Lack of Efficacy|6
6907831|NCT00717236|10931631|FG000|Double-Blind Period|Lost to Follow-up|3
6907832|NCT00717236|10931632|FG001|Double-Blind Period|Lost to Follow-up|5
6907833|NCT00717236|10931631|FG000|Double-Blind Period|Withdrawal by Subject|10
6907834|NCT00717236|10931632|FG001|Double-Blind Period|Withdrawal by Subject|2
6907835|NCT00717236|10931631|FG000|Double-Blind Period|Loss of efficacy|3
6907836|NCT00717236|10931632|FG001|Double-Blind Period|Loss of efficacy|0
6907837|NCT00717236|10931631|FG000|Double-Blind Period|Other: Death|1
6907838|NCT00717236|10931632|FG001|Double-Blind Period|Other: Death|0
6907839|NCT00717236|10931631|FG000|Double-Blind Period|Other: Pregnancy|1
6907840|NCT00717236|10931632|FG001|Double-Blind Period|Other: Pregnancy|0
6907841|NCT00717236|10931631|FG000|Double-Blind Period|Other: Protocol Violation|2
6907842|NCT00717236|10931632|FG001|Double-Blind Period|Other: Protocol Violation|0
6907843|NCT00717236|10931631|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6
6907844|NCT00717236|10931632|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2
6907845|NCT00717236|10931631|FG000|Double-Blind Period|Other: Site withdrew|2
6907846|NCT00717236|10931632|FG001|Double-Blind Period|Other: Site withdrew|0
6907847|NCT00717236|10931631|FG000|Double-Blind Period|Other: Screening failure|1
6907848|NCT00717236|10931632|FG001|Double-Blind Period|Other: Screening failure|0
6907849|NCT00717236|10931631|FG000|Double-Blind Period|Other: subject withdrew consent|1
6907850|NCT00717236|10931632|FG001|Double-Blind Period|Other: subject withdrew consent|1
6907851|NCT00717236|10931631|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2
6907852|NCT00717236|10931632|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1
6907853|NCT00717236|10931631|FG000|Double-Blind Period|Other: History of adenoid grown|1
6907854|NCT00717236|10931632|FG001|Double-Blind Period|Other: History of adenoid grown|0
6907855|NCT00717236|10931631|FG000|Double-Blind Period|Other: History of cancer|1
6907856|NCT00717236|10931632|FG001|Double-Blind Period|Other: History of cancer|0
6907857|NCT00717236|10931631|FG000|Double-Blind Period|Other: Sponsor request|1
6907858|NCT00717236|10931632|FG001|Double-Blind Period|Other: Sponsor request|0
6907859|NCT00717236|10931631|FG000|Double-Blind Period|Other: Inappropriate randomization|1
6907860|NCT00717236|10931632|FG001|Double-Blind Period|Other: Inappropriate randomization|0
6907861|NCT00717236|10931631|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1
6907862|NCT00717236|10931632|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0
6907863|NCT00717236|10931631|FG000|Double-Blind Period|Other: Subject moved|1
6907864|NCT00717236|10931632|FG001|Double-Blind Period|Other: Subject moved|1
6907865|NCT00717236|10931631|FG000|Double-Blind Period|Other: Stopped taking DMARD|1
6907866|NCT00717236|10931632|FG001|Double-Blind Period|Other: Stopped taking DMARD|0
6907867|NCT00717236|10931631|FG000|Double-Blind Period|Other: Prohibited medication taken|2
6907868|NCT00717236|10931632|FG001|Double-Blind Period|Other: Prohibited medication taken|2
6907869|NCT00717236|10931631|FG000|Double-Blind Period|Other: Transportation problems|0
6907870|NCT00717236|10931632|FG001|Double-Blind Period|Other: Transportation problems|1
6907871|NCT00717236|10931631|FG000|Double-Blind Period|Other: Investigator Decision|0
6977139|NCT01205126|11030146|FG001|Maintenance Phase|Prohibited drugs used|0
6907872|NCT00717236|10931632|FG001|Double-Blind Period|Other: Investigator Decision|1
6907873|NCT00717236|10931631|FG000|Open-Label Period|Adverse Event|29
6907874|NCT00717236|10931632|FG001|Open-Label Period|Adverse Event|4
6907875|NCT00717236|10931631|FG000|Open-Label Period|Lack of Efficacy|30
6907876|NCT00717236|10931632|FG001|Open-Label Period|Lack of Efficacy|8
6907877|NCT00717236|10931631|FG000|Open-Label Period|Lost to Follow-up|28
6907878|NCT00717236|10931632|FG001|Open-Label Period|Lost to Follow-up|4
6907879|NCT00717236|10931631|FG000|Open-Label Period|Withdrawal by Subject|20
6907880|NCT00717236|10931632|FG001|Open-Label Period|Withdrawal by Subject|2
6907881|NCT00717236|10931631|FG000|Open-Label Period|Loss of Efficacy|6
6907882|NCT00717236|10931632|FG001|Open-Label Period|Loss of Efficacy|1
6907883|NCT00717236|10931631|FG000|Open-Label Period|Other: Peripheral Neuropathy|0
6907884|NCT00717236|10931632|FG001|Open-Label Period|Other: Peripheral Neuropathy|1
6907885|NCT00717236|10931631|FG000|Open-Label Period|Other: Lack of Compliance|1
6907886|NCT00717236|10931632|FG001|Open-Label Period|Other: Lack of Compliance|1
6907887|NCT00717236|10931631|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1
6907888|NCT00717236|10931632|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0
6907889|NCT00717236|10931631|FG000|Open-Label Period|Other: Moved|1
6907890|NCT00717236|10931632|FG001|Open-Label Period|Other: Moved|0
6907891|NCT00717236|10931631|FG000|Open-Label Period|Other: Investigator Decision|1
6907892|NCT00717236|10931632|FG001|Open-Label Period|Other: Investigator Decision|0
6907893|NCT00717236|10931631|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1
6907894|NCT00717236|10931632|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0
6907895|NCT00717236|10931631|FG000|Open-Label Period|Other: Sponsor Request|3
6907896|NCT00717236|10931632|FG001|Open-Label Period|Other: Sponsor Request|0
6907897|NCT00717236|10931631|FG000|Open-Label Period|Other: Cataract Surgery|1
6907898|NCT00717236|10931632|FG001|Open-Label Period|Other: Cataract Surgery|0
6907899|NCT00717236|10931631|FG000|Open-Label Period|Other: Administration of Golimumab|1
6907900|NCT00717236|10931632|FG001|Open-Label Period|Other: Administration of Golimumab|0
6907901|NCT00717236|10931631|FG000|Open-Label Period|Other: Completion Accidently Performed|1
6907902|NCT00717236|10931632|FG001|Open-Label Period|Other: Completion Accidently Performed|0
6907903|NCT00717236|10931631|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1
6907904|NCT00717236|10931632|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0
6907905|NCT00717249|10931642|FG000|Overall Study|Lens Discomfort|4
6907906|NCT00717249|10931643|FG001|Overall Study|Lens Discomfort|1
6907907|NCT00717249|10931642|FG000|Overall Study|Unsatisfactory visual Response|0
6907908|NCT00717249|10931643|FG001|Overall Study|Unsatisfactory visual Response|2
6907909|NCT00717249|10931642|FG000|Overall Study|Adverse Event|4
6907910|NCT00717249|10931643|FG001|Overall Study|Adverse Event|2
6907911|NCT00717249|10931642|FG000|Overall Study|Lost to Follow-up|2
6907912|NCT00717249|10931643|FG001|Overall Study|Lost to Follow-up|0
6907913|NCT00717249|10931642|FG000|Overall Study|Withdrawal by Subject|1
6907914|NCT00717249|10931643|FG001|Overall Study|Withdrawal by Subject|2
6907915|NCT00717249|10931642|FG000|Overall Study|Pregnancy|6
6907916|NCT00717249|10931643|FG001|Overall Study|Pregnancy|3
6907917|NCT00717249|10931642|FG000|Overall Study|Protocol Violation|0
6907918|NCT00717249|10931643|FG001|Overall Study|Protocol Violation|2
6907919|NCT00717249|10931642|FG000|Overall Study|Subject became Ineligible|1
6907920|NCT00717249|10931643|FG001|Overall Study|Subject became Ineligible|1
6907921|NCT00717249|10931642|FG000|Overall Study|Unsatisfactory Physiological Response|0
6907922|NCT00717249|10931643|FG001|Overall Study|Unsatisfactory Physiological Response|1
6907923|NCT00717249|10931642|FG000|Overall Study|Gastric Surgery|0
6907924|NCT00717249|10931643|FG001|Overall Study|Gastric Surgery|1
6907925|NCT00717249|10931642|FG000|Overall Study|Diagnosed with Diabetes|1
6907926|NCT00717249|10931643|FG001|Overall Study|Diagnosed with Diabetes|0
6907927|NCT00717249|10931642|FG000|Overall Study|Diagnosed with Multiple Scletosis|1
6907928|NCT00717249|10931643|FG001|Overall Study|Diagnosed with Multiple Scletosis|0
6907929|NCT00717249|10931642|FG000|Overall Study|Subject relocated|1
6907930|NCT00717249|10931643|FG001|Overall Study|Subject relocated|0
6907931|NCT00717249|10931642|FG000|Overall Study|Headaches|1
6907932|NCT00717249|10931643|FG001|Overall Study|Headaches|0
6907933|NCT00717314|10931670|FG000|Overall Study|Adverse Event|3
6907934|NCT00717314|10931671|FG001|Overall Study|Adverse Event|2
6907935|NCT00717314|10931670|FG000|Overall Study|Protocol Violation|1
6907936|NCT00717314|10931671|FG001|Overall Study|Protocol Violation|0
6907937|NCT00717314|10931670|FG000|Overall Study|Lost to Follow-up|1
6907938|NCT00717314|10931671|FG001|Overall Study|Lost to Follow-up|5
6907939|NCT00717314|10931670|FG000|Overall Study|Withdrawal by Subject|1
6907940|NCT00717314|10931671|FG001|Overall Study|Withdrawal by Subject|3
6907941|NCT00717366|10931679|FG000|Core Study Period (20 Weeks)|Renal transplant|4
6907942|NCT00717366|10931680|FG001|Core Study Period (20 Weeks)|Renal transplant|9
6907943|NCT00717366|10931679|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0
6907944|NCT00717366|10931680|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2
6907945|NCT00717366|10931679|FG000|Core Study Period (20 Weeks)|Death|0
6907946|NCT00717366|10931680|FG001|Core Study Period (20 Weeks)|Death|1
6907947|NCT00717366|10931679|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0
6907948|NCT00717366|10931680|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1
6907949|NCT00717366|10931679|FG000|Extension Period (52 Weeks)|Renal transplant|3
6907950|NCT00717366|10931680|FG001|Extension Period (52 Weeks)|Renal transplant|13
6907951|NCT00717366|10931679|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0
6907952|NCT00717366|10931680|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2
6907953|NCT00717366|10931679|FG000|Extension Period (52 Weeks)|Withdrew consent|1
6907954|NCT00717366|10931680|FG001|Extension Period (52 Weeks)|Withdrew consent|1
6907955|NCT00717522|10931701|FG000|Overall Study|Disease Progression|5
6907956|NCT00717522|10931701|FG000|Overall Study|Adverse Event|1
6907957|NCT00717522|10931701|FG000|Overall Study|Death|1
6907958|NCT00717756|10931718|FG000|Overall Study|Withdrawal by Subject|1
6907959|NCT00717769|10931725|FG000|Overall Study|Adverse Event|9
6907960|NCT00717769|10931726|FG001|Overall Study|Adverse Event|6
6907961|NCT00717769|10931727|FG002|Overall Study|Adverse Event|1
6907962|NCT00717769|10931725|FG000|Overall Study|Lack of compliance|0
6907963|NCT00717769|10931726|FG001|Overall Study|Lack of compliance|2
6907964|NCT00717769|10931727|FG002|Overall Study|Lack of compliance|0
6907965|NCT00717769|10931725|FG000|Overall Study|Lost to Follow-up|3
6907966|NCT00717769|10931726|FG001|Overall Study|Lost to Follow-up|4
6907967|NCT00717769|10931727|FG002|Overall Study|Lost to Follow-up|0
6907968|NCT00717769|10931725|FG000|Overall Study|Lack of Efficacy|1
6907969|NCT00717769|10931726|FG001|Overall Study|Lack of Efficacy|2
6907970|NCT00717769|10931727|FG002|Overall Study|Lack of Efficacy|0
6907971|NCT00717769|10931725|FG000|Overall Study|Protocol Violation|0
6907972|NCT00717769|10931726|FG001|Overall Study|Protocol Violation|2
6907973|NCT00717769|10931727|FG002|Overall Study|Protocol Violation|0
6907974|NCT00717769|10931725|FG000|Overall Study|Sponsor decision|1
6907975|NCT00717769|10931726|FG001|Overall Study|Sponsor decision|0
6907976|NCT00717769|10931727|FG002|Overall Study|Sponsor decision|10
6907977|NCT00717769|10931725|FG000|Overall Study|Withdrew consent|2
6907978|NCT00717769|10931726|FG001|Overall Study|Withdrew consent|2
6907979|NCT00717769|10931727|FG002|Overall Study|Withdrew consent|0
6907980|NCT00717860|10931739|FG000|Overall Study|Clinical adverse experience|5
6907981|NCT00717860|10931740|FG001|Overall Study|Clinical adverse experience|9
6907982|NCT00717860|10931739|FG000|Overall Study|Laboratory adverse experience|2
6907983|NCT00717860|10931740|FG001|Overall Study|Laboratory adverse experience|2
6907984|NCT00717860|10931739|FG000|Overall Study|Lack of Efficacy|7
6907985|NCT00717860|10931740|FG001|Overall Study|Lack of Efficacy|13
6907986|NCT00717860|10931739|FG000|Overall Study|Discontinued for other reason|6
6907987|NCT00717860|10931740|FG001|Overall Study|Discontinued for other reason|1
6907988|NCT00717860|10931739|FG000|Overall Study|Withdrew consent|7
6907989|NCT00717860|10931740|FG001|Overall Study|Withdrew consent|3
6907990|NCT00717886|10931755|FG000|Overall Study|Withdrawal by Subject|3
6907991|NCT00717886|10931755|FG000|Overall Study|Treatment Failure|1
6907992|NCT00718042|10931783|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
6907993|NCT00718042|10931784|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
6907994|NCT00718042|10931785|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
6907995|NCT00718042|10931786|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
6907996|NCT00718042|10931787|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2
6907997|NCT00718042|10931788|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
6907998|NCT00718042|10931783|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64
6907999|NCT00718042|10931784|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0
6908000|NCT00718042|10931785|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0
6908001|NCT00718042|10931786|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0
6908002|NCT00718042|10931787|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36
6908003|NCT00718042|10931788|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0
6908004|NCT00718042|10931783|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0
6908005|NCT00718042|10931784|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1
6908006|NCT00718042|10931785|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1
6908007|NCT00718042|10931786|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0
6908008|NCT00718042|10931787|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0
6908009|NCT00718042|10931788|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0
6908010|NCT00718042|10931783|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
6908011|NCT00718042|10931784|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1
6908012|NCT00718042|10931785|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
6908013|NCT00718042|10931786|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
6908014|NCT00718042|10931787|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
6908015|NCT00718042|10931788|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
6908016|NCT00718042|10931783|FG000|Donor Follow-up|Lost to Follow-up|13
6908017|NCT00718042|10931784|FG001|Donor Follow-up|Lost to Follow-up|0
6908018|NCT00718042|10931785|FG002|Donor Follow-up|Lost to Follow-up|0
6908019|NCT00718042|10931786|FG003|Donor Follow-up|Lost to Follow-up|0
6908020|NCT00718042|10931787|FG004|Donor Follow-up|Lost to Follow-up|19
6908021|NCT00718042|10931788|FG005|Donor Follow-up|Lost to Follow-up|0
6908022|NCT00718081|10931803|FG000|Overall Study|Adverse Event|0
6908023|NCT00718081|10931804|FG001|Overall Study|Adverse Event|1
6908024|NCT00718081|10931805|FG002|Overall Study|Adverse Event|0
6908025|NCT00718081|10931803|FG000|Overall Study|Lack of Efficacy|7
6908026|NCT00718081|10931804|FG001|Overall Study|Lack of Efficacy|3
6908027|NCT00718081|10931805|FG002|Overall Study|Lack of Efficacy|21
6908028|NCT00718159|10931838|FG000|Overall Study|Progressive Disease|3
6908029|NCT00718159|10931839|FG001|Overall Study|Progressive Disease|3
6908030|NCT00718159|10931840|FG002|Overall Study|Progressive Disease|2
6908031|NCT00718159|10931841|FG003|Overall Study|Progressive Disease|0
6908032|NCT00718159|10931842|FG004|Overall Study|Progressive Disease|6
6908033|NCT00718159|10931843|FG005|Overall Study|Progressive Disease|0
6908034|NCT00718159|10931844|FG006|Overall Study|Progressive Disease|0
6908035|NCT00718159|10931838|FG000|Overall Study|Death due to Adverse Event|0
6908036|NCT00718159|10931839|FG001|Overall Study|Death due to Adverse Event|0
6908037|NCT00718159|10931840|FG002|Overall Study|Death due to Adverse Event|0
6908038|NCT00718159|10931841|FG003|Overall Study|Death due to Adverse Event|2
6908039|NCT00718159|10931842|FG004|Overall Study|Death due to Adverse Event|2
6908040|NCT00718159|10931843|FG005|Overall Study|Death due to Adverse Event|0
6908041|NCT00718159|10931844|FG006|Overall Study|Death due to Adverse Event|0
6908042|NCT00718159|10931838|FG000|Overall Study|Death due to Study Drug Toxicity|0
6908043|NCT00718159|10931839|FG001|Overall Study|Death due to Study Drug Toxicity|0
6908044|NCT00718159|10931840|FG002|Overall Study|Death due to Study Drug Toxicity|1
6908045|NCT00718159|10931841|FG003|Overall Study|Death due to Study Drug Toxicity|2
6908046|NCT00718159|10931842|FG004|Overall Study|Death due to Study Drug Toxicity|0
6908047|NCT00718159|10931843|FG005|Overall Study|Death due to Study Drug Toxicity|0
6908048|NCT00718159|10931844|FG006|Overall Study|Death due to Study Drug Toxicity|0
6908049|NCT00718159|10931838|FG000|Overall Study|Investigator Decision|0
6908050|NCT00718159|10931839|FG001|Overall Study|Investigator Decision|0
6908051|NCT00718159|10931840|FG002|Overall Study|Investigator Decision|0
6908052|NCT00718159|10931841|FG003|Overall Study|Investigator Decision|0
6908053|NCT00718159|10931842|FG004|Overall Study|Investigator Decision|0
6908054|NCT00718159|10931843|FG005|Overall Study|Investigator Decision|1
6908055|NCT00718159|10931844|FG006|Overall Study|Investigator Decision|1
6908056|NCT00718237|10931862|FG000|Overall Study|Adverse Event|1
6908057|NCT00718237|10931863|FG001|Overall Study|Adverse Event|3
6908058|NCT00718237|10931862|FG000|Overall Study|Lost to Follow-up|2
6908059|NCT00718237|10931863|FG001|Overall Study|Lost to Follow-up|2
6908060|NCT00718237|10931862|FG000|Overall Study|Physician Decision|1
6908061|NCT00718237|10931863|FG001|Overall Study|Physician Decision|0
6908062|NCT00718237|10931862|FG000|Overall Study|Withdrawal by Subject|9
6908063|NCT00718237|10931863|FG001|Overall Study|Withdrawal by Subject|10
6908064|NCT00718315|10931885|FG000|Overall Study|Adverse Event|1
6908065|NCT00718315|10931886|FG001|Overall Study|Adverse Event|2
6908066|NCT00718315|10931887|FG002|Overall Study|Adverse Event|3
6908067|NCT00718315|10931885|FG000|Overall Study|Death|6
6908068|NCT00718315|10931886|FG001|Overall Study|Death|6
6908069|NCT00718315|10931887|FG002|Overall Study|Death|5
6908070|NCT00718315|10931885|FG000|Overall Study|Lost to Follow-up|2
6908071|NCT00718315|10931886|FG001|Overall Study|Lost to Follow-up|3
6908072|NCT00718315|10931887|FG002|Overall Study|Lost to Follow-up|4
6908073|NCT00718315|10931885|FG000|Overall Study|Protocol Violation|5
6908074|NCT00718315|10931886|FG001|Overall Study|Protocol Violation|5
6908075|NCT00718315|10931887|FG002|Overall Study|Protocol Violation|3
6908076|NCT00718315|10931885|FG000|Overall Study|Erlotinib dose decreased|4
6908077|NCT00718315|10931886|FG001|Overall Study|Erlotinib dose decreased|3
6908078|NCT00718315|10931887|FG002|Overall Study|Erlotinib dose decreased|1
6908079|NCT00718315|10931885|FG000|Overall Study|Use of Minocyclin|1
6908080|NCT00718315|10931886|FG001|Overall Study|Use of Minocyclin|1
6908081|NCT00718315|10931887|FG002|Overall Study|Use of Minocyclin|1
6908082|NCT00718315|10931885|FG000|Overall Study|Disease progression|0
6908083|NCT00718315|10931886|FG001|Overall Study|Disease progression|1
6908084|NCT00718315|10931887|FG002|Overall Study|Disease progression|1
6908085|NCT00718315|10931885|FG000|Overall Study|Other|0
6908086|NCT00718315|10931886|FG001|Overall Study|Other|0
6908087|NCT00718315|10931887|FG002|Overall Study|Other|1
6908088|NCT00718315|10931885|FG000|Overall Study|Use of ATB and Corticoids|0
6908089|NCT00718315|10931886|FG001|Overall Study|Use of ATB and Corticoids|1
6908090|NCT00718315|10931887|FG002|Overall Study|Use of ATB and Corticoids|2
6908091|NCT00718328|10931897|FG000|Overall Study|Lost to Follow-up|1
6908092|NCT00718328|10931898|FG001|Overall Study|Lost to Follow-up|0
6908093|NCT00718419|10931906|FG000|Overall Study|Adverse Event|2
6908094|NCT00718419|10931907|FG001|Overall Study|Adverse Event|1
6908095|NCT00718419|10931906|FG000|Overall Study|Physician Decision|1
6908096|NCT00718419|10931907|FG001|Overall Study|Physician Decision|6
6908097|NCT00718419|10931906|FG000|Overall Study|Sponsor decision|0
6908098|NCT00718419|10931907|FG001|Overall Study|Sponsor decision|1
6908099|NCT00718419|10931906|FG000|Overall Study|Withdrawal by Subject|0
6908100|NCT00718419|10931907|FG001|Overall Study|Withdrawal by Subject|5
6908101|NCT00718419|10931906|FG000|Overall Study|Progressive Disease|7
6908102|NCT00718419|10931907|FG001|Overall Study|Progressive Disease|25
6908103|NCT00718419|10931906|FG000|Overall Study|Death Due to Progressive Disease|2
6908104|NCT00718419|10931907|FG001|Overall Study|Death Due to Progressive Disease|0
6908105|NCT00718419|10931906|FG000|Overall Study|Death Due to Study Drug Related|0
6908106|NCT00718419|10931907|FG001|Overall Study|Death Due to Study Drug Related|1
6908107|NCT00718419|10931906|FG000|Overall Study|Death Due to Adverse Events|1
6908108|NCT00718419|10931907|FG001|Overall Study|Death Due to Adverse Events|0
6908109|NCT00718510|10931915|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0
6908110|NCT00718510|10931916|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1
6908111|NCT00718510|10931915|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1
6908112|NCT00718510|10931916|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0
6908113|NCT00718523|10931924|FG000|Overall Study|Withdrawal by Subject|5
6908114|NCT00718523|10931925|FG001|Overall Study|Withdrawal by Subject|7
6908115|NCT00718523|10931924|FG000|Overall Study|Death|13
6908116|NCT00718523|10931925|FG001|Overall Study|Death|17
6908117|NCT00718549|10931931|FG000|Induction Phase|Disease Progression|1
6908118|NCT00718549|10931932|FG001|Induction Phase|Disease Progression|0
6908119|NCT00718549|10931933|FG002|Induction Phase|Disease Progression|0
6908120|NCT00718549|10931931|FG000|Induction Phase|Eligibility Criteria Violation|2
6908121|NCT00718549|10931932|FG001|Induction Phase|Eligibility Criteria Violation|0
6908122|NCT00718549|10931933|FG002|Induction Phase|Eligibility Criteria Violation|0
6908123|NCT00718549|10931931|FG000|Induction Phase|Early Termination - No Additional Info|59
6908124|NCT00718549|10931932|FG001|Induction Phase|Early Termination - No Additional Info|0
6908125|NCT00718549|10931933|FG002|Induction Phase|Early Termination - No Additional Info|0
6908126|NCT00718549|10931931|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0
6908127|NCT00718549|10931932|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15
6908128|NCT00718549|10931933|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8
6908129|NCT00718549|10931931|FG000|Maintenance/ Observation Phase|Death|0
6908130|NCT00718549|10931932|FG001|Maintenance/ Observation Phase|Death|1
6908131|NCT00718549|10931933|FG002|Maintenance/ Observation Phase|Death|2
6908132|NCT00718549|10931931|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0
6908133|NCT00718549|10931932|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4
6908134|NCT00718549|10931933|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4
6908135|NCT00718549|10931931|FG000|Maintenance/ Observation Phase|Progression|0
6908136|NCT00718549|10931932|FG001|Maintenance/ Observation Phase|Progression|5
6908137|NCT00718549|10931933|FG002|Maintenance/ Observation Phase|Progression|14
6908138|NCT00718549|10931931|FG000|Maintenance/ Observation Phase|Relapse|0
6908139|NCT00718549|10931932|FG001|Maintenance/ Observation Phase|Relapse|3
6908140|NCT00718549|10931933|FG002|Maintenance/ Observation Phase|Relapse|2
6908141|NCT00718666|10931949|FG000|Booster Phase Year 5|No active participation request|0
6908142|NCT00718666|10931950|FG001|Booster Phase Year 5|No active participation request|0
6908143|NCT00718666|10931951|FG002|Booster Phase Year 5|No active participation request|1
6908144|NCT00718666|10931949|FG000|Booster Phase Year 5|Declined v-4 serology|1
6908145|NCT00718666|10931950|FG001|Booster Phase Year 5|Declined v-4 serology|0
6908146|NCT00718666|10931951|FG002|Booster Phase Year 5|Declined v-4 serology|0
6908147|NCT00718666|10931949|FG000|Booster Phase Year 5|Withdrawal by Subject|0
6908148|NCT00718666|10931950|FG001|Booster Phase Year 5|Withdrawal by Subject|0
6908149|NCT00718666|10931951|FG002|Booster Phase Year 5|Withdrawal by Subject|1
6908150|NCT00718666|10931949|FG000|Booster Phase Year 5|Lost to Follow-up|1
6908151|NCT00718666|10931950|FG001|Booster Phase Year 5|Lost to Follow-up|0
6908152|NCT00718666|10931951|FG002|Booster Phase Year 5|Lost to Follow-up|4
6908153|NCT00718718|10931976|FG000|Prior to Week 12|Adverse Event|0
6908154|NCT00718718|10931977|FG001|Prior to Week 12|Adverse Event|0
6908155|NCT00718718|10931978|FG002|Prior to Week 12|Adverse Event|0
6908156|NCT00718718|10931979|FG003|Prior to Week 12|Adverse Event|0
6908157|NCT00718718|10931980|FG004|Prior to Week 12|Adverse Event|0
6908158|NCT00718718|10931981|FG005|Prior to Week 12|Adverse Event|0
6908159|NCT00718718|10931982|FG006|Prior to Week 12|Adverse Event|0
6908160|NCT00718718|10931983|FG007|Prior to Week 12|Adverse Event|1
6908161|NCT00718718|10931984|FG008|Prior to Week 12|Adverse Event|1
6908162|NCT00718718|10931985|FG009|Prior to Week 12|Adverse Event|0
6908163|NCT00718718|10931976|FG000|Prior to Week 12|Withdrawal by Subject|0
6908164|NCT00718718|10931977|FG001|Prior to Week 12|Withdrawal by Subject|0
6908165|NCT00718718|10931978|FG002|Prior to Week 12|Withdrawal by Subject|0
6908166|NCT00718718|10931979|FG003|Prior to Week 12|Withdrawal by Subject|0
6908167|NCT00718718|10931980|FG004|Prior to Week 12|Withdrawal by Subject|3
6908168|NCT00718718|10931981|FG005|Prior to Week 12|Withdrawal by Subject|0
6908169|NCT00718718|10931982|FG006|Prior to Week 12|Withdrawal by Subject|1
6908170|NCT00718718|10931983|FG007|Prior to Week 12|Withdrawal by Subject|1
6908171|NCT00718718|10931984|FG008|Prior to Week 12|Withdrawal by Subject|1
6908172|NCT00718718|10931985|FG009|Prior to Week 12|Withdrawal by Subject|0
6908173|NCT00718718|10931976|FG000|Prior to Week 12|Other|1
6908174|NCT00718718|10931977|FG001|Prior to Week 12|Other|0
6908175|NCT00718718|10931978|FG002|Prior to Week 12|Other|1
6908176|NCT00718718|10931979|FG003|Prior to Week 12|Other|0
6908177|NCT00718718|10931980|FG004|Prior to Week 12|Other|0
6908178|NCT00718718|10931981|FG005|Prior to Week 12|Other|0
6908179|NCT00718718|10931982|FG006|Prior to Week 12|Other|0
6908180|NCT00718718|10931983|FG007|Prior to Week 12|Other|0
6908181|NCT00718718|10931984|FG008|Prior to Week 12|Other|0
6908182|NCT00718718|10931985|FG009|Prior to Week 12|Other|0
6908183|NCT00718718|10931976|FG000|Week 12 to End of Study|Adverse Event|0
6908184|NCT00718718|10931977|FG001|Week 12 to End of Study|Adverse Event|0
6908185|NCT00718718|10931978|FG002|Week 12 to End of Study|Adverse Event|0
6908186|NCT00718718|10931979|FG003|Week 12 to End of Study|Adverse Event|0
6908187|NCT00718718|10931980|FG004|Week 12 to End of Study|Adverse Event|0
6908188|NCT00718718|10931981|FG005|Week 12 to End of Study|Adverse Event|0
6908189|NCT00718718|10931982|FG006|Week 12 to End of Study|Adverse Event|0
6908190|NCT00718718|10931983|FG007|Week 12 to End of Study|Adverse Event|1
6908191|NCT00718718|10931984|FG008|Week 12 to End of Study|Adverse Event|0
6908192|NCT00718718|10931985|FG009|Week 12 to End of Study|Adverse Event|0
6908193|NCT00718718|10931976|FG000|Week 12 to End of Study|Death|0
6908194|NCT00718718|10931977|FG001|Week 12 to End of Study|Death|0
6908195|NCT00718718|10931978|FG002|Week 12 to End of Study|Death|0
6908196|NCT00718718|10931979|FG003|Week 12 to End of Study|Death|0
6908197|NCT00718718|10931980|FG004|Week 12 to End of Study|Death|0
6908198|NCT00718718|10931981|FG005|Week 12 to End of Study|Death|1
6908199|NCT00718718|10931982|FG006|Week 12 to End of Study|Death|0
6908200|NCT00718718|10931983|FG007|Week 12 to End of Study|Death|0
6908201|NCT00718718|10931984|FG008|Week 12 to End of Study|Death|0
6908202|NCT00718718|10931985|FG009|Week 12 to End of Study|Death|0
6908203|NCT00718718|10931976|FG000|Week 12 to End of Study|Withdrawal by Subject|0
6908204|NCT00718718|10931977|FG001|Week 12 to End of Study|Withdrawal by Subject|0
6908205|NCT00718718|10931978|FG002|Week 12 to End of Study|Withdrawal by Subject|0
6908206|NCT00718718|10931979|FG003|Week 12 to End of Study|Withdrawal by Subject|0
6908207|NCT00718718|10931980|FG004|Week 12 to End of Study|Withdrawal by Subject|0
6908208|NCT00718718|10931981|FG005|Week 12 to End of Study|Withdrawal by Subject|2
6908209|NCT00718718|10931982|FG006|Week 12 to End of Study|Withdrawal by Subject|1
6908210|NCT00718718|10931983|FG007|Week 12 to End of Study|Withdrawal by Subject|0
6908211|NCT00718718|10931984|FG008|Week 12 to End of Study|Withdrawal by Subject|0
6908212|NCT00718718|10931985|FG009|Week 12 to End of Study|Withdrawal by Subject|0
6908213|NCT00718718|10931976|FG000|Week 12 to End of Study|Lost to Follow-up|0
6908214|NCT00718718|10931977|FG001|Week 12 to End of Study|Lost to Follow-up|0
6908215|NCT00718718|10931978|FG002|Week 12 to End of Study|Lost to Follow-up|0
6908216|NCT00718718|10931979|FG003|Week 12 to End of Study|Lost to Follow-up|0
6908217|NCT00718718|10931980|FG004|Week 12 to End of Study|Lost to Follow-up|0
6908218|NCT00718718|10931981|FG005|Week 12 to End of Study|Lost to Follow-up|0
6908219|NCT00718718|10931982|FG006|Week 12 to End of Study|Lost to Follow-up|0
6908220|NCT00718718|10931983|FG007|Week 12 to End of Study|Lost to Follow-up|0
6908221|NCT00718718|10931984|FG008|Week 12 to End of Study|Lost to Follow-up|1
6908222|NCT00718718|10931985|FG009|Week 12 to End of Study|Lost to Follow-up|0
6908223|NCT00718718|10931976|FG000|Week 12 to End of Study|Other|0
6908224|NCT00718718|10931977|FG001|Week 12 to End of Study|Other|1
6908225|NCT00718718|10931978|FG002|Week 12 to End of Study|Other|0
6908226|NCT00718718|10931979|FG003|Week 12 to End of Study|Other|1
6908227|NCT00718718|10931980|FG004|Week 12 to End of Study|Other|0
6908228|NCT00718718|10931981|FG005|Week 12 to End of Study|Other|0
6908229|NCT00718718|10931982|FG006|Week 12 to End of Study|Other|1
6908230|NCT00718718|10931983|FG007|Week 12 to End of Study|Other|0
6908231|NCT00718718|10931984|FG008|Week 12 to End of Study|Other|0
6908232|NCT00718718|10931985|FG009|Week 12 to End of Study|Other|0
6908233|NCT00718770|10932011|FG000|Overall Study|Adverse Event|1
6908234|NCT00718770|10932011|FG000|Overall Study|Lack of Efficacy|1
6908235|NCT00718770|10932011|FG000|Overall Study|Lack of Efficacy|1
6908236|NCT00718770|10932011|FG000|Overall Study|Adverse Event|1
6908237|NCT00718770|10932011|FG000|Overall Study|Lack of Efficacy|1
6908238|NCT00718770|10932011|FG000|Overall Study|Adverse Event|1
6908239|NCT00718770|10932011|FG000|Overall Study|Lack of Efficacy|1
6908240|NCT00718770|10932011|FG000|Overall Study|Adverse Event|1
6973993|NCT01185353|11025989|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0
6973994|NCT01185353|11025990|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1
6973995|NCT01185353|11025991|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0
6973996|NCT01185353|11025992|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0
6973997|NCT01185353|11025993|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0
6973998|NCT01185353|11025994|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0
6973999|NCT01185353|11025985|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
6974000|NCT01185353|11025986|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
6974001|NCT01185353|11025987|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
6974002|NCT01185353|11025988|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
6974003|NCT01185353|11025989|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
6974004|NCT01185353|11025990|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
6974005|NCT01185353|11025991|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
6974006|NCT01185353|11025992|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
6974007|NCT01185353|11025993|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
6974008|NCT01185353|11025994|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
6974009|NCT01185353|11025985|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
6974010|NCT01185353|11025986|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
6974011|NCT01185353|11025987|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
6974012|NCT01185353|11025988|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
6974013|NCT01185353|11025989|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
6974014|NCT01185353|11025990|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
6974015|NCT01185353|11025991|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
6974016|NCT01185353|11025992|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
6974017|NCT01185353|11025993|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
6974018|NCT01185353|11025994|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
6974019|NCT01185353|11025985|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
6974020|NCT01185353|11025986|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
6974021|NCT01185353|11025987|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1
6974022|NCT01185353|11025988|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2
6974023|NCT01185353|11025989|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
6974024|NCT01185353|11025990|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3
6974025|NCT01185353|11025991|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4
6974026|NCT01185353|11025992|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
6908241|NCT00718809|10932017|FG000|Overall Study|Disease progression|9
6908242|NCT00718809|10932018|FG001|Overall Study|Disease progression|7
6908243|NCT00718809|10932017|FG000|Overall Study|Adverse Event|1
6908244|NCT00718809|10932018|FG001|Overall Study|Adverse Event|1
6908245|NCT00718809|10932017|FG000|Overall Study|Withdrawal by Subject|0
6908246|NCT00718809|10932018|FG001|Overall Study|Withdrawal by Subject|1
6908247|NCT00718809|10932017|FG000|Overall Study|Lost to Follow-up|1
6908248|NCT00718809|10932018|FG001|Overall Study|Lost to Follow-up|0
6908249|NCT00718809|10932017|FG000|Overall Study|Noncompliance|1
6908250|NCT00718809|10932018|FG001|Overall Study|Noncompliance|0
6908251|NCT00718861|10932026|FG000|Overall Study|Withdrawal by Subject|15
6908252|NCT00718861|10932027|FG001|Overall Study|Withdrawal by Subject|10
6908253|NCT00718861|10932026|FG000|Overall Study|Adverse Event|2
6908254|NCT00718861|10932027|FG001|Overall Study|Adverse Event|1
6908255|NCT00718861|10932026|FG000|Overall Study|Lost to Follow-up|2
6908256|NCT00718861|10932027|FG001|Overall Study|Lost to Follow-up|1
6908257|NCT00718861|10932026|FG000|Overall Study|Administrative Problems|1
6908258|NCT00718861|10932027|FG001|Overall Study|Administrative Problems|1
6908259|NCT00718861|10932026|FG000|Overall Study|Death|1
6908260|NCT00718861|10932027|FG001|Overall Study|Death|5
6908261|NCT00718887|10932035|FG000|Overall Study|Withdrawal by Subject|3
6908262|NCT00718887|10932036|FG001|Overall Study|Withdrawal by Subject|2
6908263|NCT00718887|10932035|FG000|Overall Study|Not identified|2
6908264|NCT00718887|10932036|FG001|Overall Study|Not identified|7
6908265|NCT00719043|10932055|FG000|Overall Study|Adverse Event|5
6908266|NCT00719043|10932056|FG001|Overall Study|Adverse Event|1
6908267|NCT00719043|10932057|FG002|Overall Study|Adverse Event|2
6908268|NCT00719043|10932058|FG003|Overall Study|Adverse Event|2
6908269|NCT00719043|10932059|FG004|Overall Study|Adverse Event|1
6908270|NCT00719043|10932060|FG005|Overall Study|Adverse Event|4
6908271|NCT00719043|10932061|FG006|Overall Study|Adverse Event|4
6908272|NCT00719043|10932055|FG000|Overall Study|Lost to Follow-up|14
6908273|NCT00719043|10932056|FG001|Overall Study|Lost to Follow-up|10
6908274|NCT00719043|10932057|FG002|Overall Study|Lost to Follow-up|8
6908275|NCT00719043|10932058|FG003|Overall Study|Lost to Follow-up|9
6908276|NCT00719043|10932059|FG004|Overall Study|Lost to Follow-up|10
6908277|NCT00719043|10932060|FG005|Overall Study|Lost to Follow-up|9
6908278|NCT00719043|10932061|FG006|Overall Study|Lost to Follow-up|9
6908279|NCT00719043|10932055|FG000|Overall Study|Protocol Violation|0
6908280|NCT00719043|10932056|FG001|Overall Study|Protocol Violation|0
6908281|NCT00719043|10932057|FG002|Overall Study|Protocol Violation|0
6908282|NCT00719043|10932058|FG003|Overall Study|Protocol Violation|0
6908283|NCT00719043|10932059|FG004|Overall Study|Protocol Violation|0
6908284|NCT00719043|10932060|FG005|Overall Study|Protocol Violation|1
6908285|NCT00719043|10932061|FG006|Overall Study|Protocol Violation|0
6908286|NCT00719043|10932055|FG000|Overall Study|Other|1
6908287|NCT00719043|10932056|FG001|Overall Study|Other|0
6908288|NCT00719043|10932057|FG002|Overall Study|Other|1
6908289|NCT00719043|10932058|FG003|Overall Study|Other|2
6908290|NCT00719043|10932059|FG004|Overall Study|Other|0
6908291|NCT00719043|10932060|FG005|Overall Study|Other|2
6908292|NCT00719043|10932061|FG006|Overall Study|Other|1
6908293|NCT00719043|10932055|FG000|Overall Study|Withdrawal by Subject|12
6908294|NCT00719043|10932056|FG001|Overall Study|Withdrawal by Subject|14
6908295|NCT00719043|10932057|FG002|Overall Study|Withdrawal by Subject|9
6908296|NCT00719043|10932058|FG003|Overall Study|Withdrawal by Subject|10
6908297|NCT00719043|10932059|FG004|Overall Study|Withdrawal by Subject|16
6908298|NCT00719043|10932060|FG005|Overall Study|Withdrawal by Subject|18
6908299|NCT00719043|10932061|FG006|Overall Study|Withdrawal by Subject|14
6908300|NCT00719212|10932111|FG000|Overall Study|Death|41
6908301|NCT00719212|10932111|FG000|Overall Study|Lost to Follow-up|2
6908302|NCT00719212|10932111|FG000|Overall Study|Withdrawal by Subject|1
6908303|NCT00719264|10932117|FG000|Overall Study|Adverse Event|41
6908304|NCT00719264|10932118|FG001|Overall Study|Adverse Event|49
6908305|NCT00719264|10932117|FG000|Overall Study|Death|13
6908306|NCT00719264|10932118|FG001|Overall Study|Death|10
6908307|NCT00719264|10932117|FG000|Overall Study|Administrative Problems|6
6908308|NCT00719264|10932118|FG001|Overall Study|Administrative Problems|4
6908309|NCT00719264|10932117|FG000|Overall Study|Lost to Follow-up|1
6908310|NCT00719264|10932118|FG001|Overall Study|Lost to Follow-up|1
6908311|NCT00719264|10932117|FG000|Overall Study|Withdrawal by Subject|12
6908312|NCT00719264|10932118|FG001|Overall Study|Withdrawal by Subject|7
6908313|NCT00719264|10932117|FG000|Overall Study|Protocol Deviation|1
6908314|NCT00719264|10932118|FG001|Overall Study|Protocol Deviation|3
6908315|NCT00719264|10932117|FG000|Overall Study|New Cancer Therapy|4
6908316|NCT00719264|10932118|FG001|Overall Study|New Cancer Therapy|2
6908317|NCT00719264|10932117|FG000|Overall Study|Disease Progression|104
6908318|NCT00719264|10932118|FG001|Overall Study|Disease Progression|107
6908319|NCT00719355|10932142|FG000|Overall Study|Death|0
6908320|NCT00719355|10932143|FG001|Overall Study|Death|1
6908321|NCT00719355|10932142|FG000|Overall Study|Medical|14
6908322|NCT00719355|10932143|FG001|Overall Study|Medical|5
6908323|NCT00719355|10932142|FG000|Overall Study|Compliance|4
6908324|NCT00719355|10932143|FG001|Overall Study|Compliance|6
6908325|NCT00719355|10932142|FG000|Overall Study|Moved|0
6908326|NCT00719355|10932143|FG001|Overall Study|Moved|1
6908327|NCT00719472|10932149|FG000|Enrolled in Study|Physician decision to withdraw patient|1
6908328|NCT00719472|10932149|FG000|Enrolled in Study|Subject decision to withdraw|8
6908329|NCT00719472|10932149|FG000|Enrolled in Study|Various Reasons|17
6908330|NCT00719472|10932149|FG000|Received Cycle 1 Treatment|Adverse Event|8
6908331|NCT00719472|10932149|FG000|Received Cycle 1 Treatment|Death|5
6908332|NCT00719472|10932149|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11
6908333|NCT00719472|10932149|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7
6908334|NCT00719472|10932149|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9
6908335|NCT00719472|10932149|FG000|Received Cycle 1 Treatment|Various Reasons|13
6908336|NCT00719472|10932149|FG000|Received Cycle 2 Treatment|Adverse Event|12
6908337|NCT00719472|10932149|FG000|Received Cycle 2 Treatment|Death|6
6908338|NCT00719472|10932149|FG000|Received Cycle 2 Treatment|Disease progression|3
6908339|NCT00719472|10932149|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3
6908340|NCT00719472|10932149|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13
6908341|NCT00719472|10932149|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6
6908342|NCT00719472|10932149|FG000|Received Cycle 2 Treatment|Various Reasons|25
6908343|NCT00719537|10932155|FG000|Overall Study|Withdrawal by Subject|1
6908344|NCT00719537|10932156|FG001|Overall Study|Withdrawal by Subject|0
6908345|NCT00719537|10932155|FG000|Overall Study|Lost to Follow-up|0
6908346|NCT00719537|10932156|FG001|Overall Study|Lost to Follow-up|1
6908347|NCT00719563|10932164|FG000|Overall Study|Adverse Event|16
6908348|NCT00719563|10932165|FG001|Overall Study|Adverse Event|13
6908349|NCT00719563|10932164|FG000|Overall Study|Medical condition changed|3
6908350|NCT00719563|10932165|FG001|Overall Study|Medical condition changed|5
6908351|NCT00719563|10932164|FG000|Overall Study|Lack of Efficacy|3
6908352|NCT00719563|10932165|FG001|Overall Study|Lack of Efficacy|7
6908353|NCT00719563|10932164|FG000|Overall Study|Personal reasons|6
6908354|NCT00719563|10932165|FG001|Overall Study|Personal reasons|7
6908355|NCT00719563|10932164|FG000|Overall Study|Unknown reasons|4
6908356|NCT00719563|10932165|FG001|Overall Study|Unknown reasons|6
6908357|NCT00719563|10932164|FG000|Overall Study|Noncompliant|1
6908358|NCT00719563|10932165|FG001|Overall Study|Noncompliant|1
6908359|NCT00719563|10932164|FG000|Overall Study|Lost to Follow-up|5
6908360|NCT00719563|10932165|FG001|Overall Study|Lost to Follow-up|3
6908361|NCT00719680|10932196|FG000|Overall Study|Adverse Event|1
6908362|NCT00719680|10932196|FG000|Overall Study|Lost to Follow-up|1
6908363|NCT00719680|10932196|FG000|Overall Study|Withdrawal by Subject|3
6908364|NCT00719706|10932202|FG000|Overall Study|Adverse Event|5
6908365|NCT00719706|10932203|FG001|Overall Study|Adverse Event|4
6908366|NCT00719706|10932202|FG000|Overall Study|Withdrawal by Subject|1
6908367|NCT00719706|10932203|FG001|Overall Study|Withdrawal by Subject|2
6908368|NCT00719706|10932202|FG000|Overall Study|Protocol Violation|3
6908369|NCT00719706|10932203|FG001|Overall Study|Protocol Violation|0
6908370|NCT00719732|10932209|FG000|Overall Study|Lost to Follow-up|20
6908371|NCT00719732|10932209|FG000|Overall Study|Unilateral (not bilateral) implantation|1
6908372|NCT00719732|10932209|FG000|Overall Study|Illness not associated with device|1
6908373|NCT00719810|10932216|FG000|Overall Study|Adverse Event|0
6908374|NCT00719810|10932217|FG001|Overall Study|Adverse Event|2
6908375|NCT00719810|10932218|FG002|Overall Study|Adverse Event|3
6908376|NCT00719810|10932216|FG000|Overall Study|Lost to Follow-up|2
6908377|NCT00719810|10932217|FG001|Overall Study|Lost to Follow-up|0
6908378|NCT00719810|10932218|FG002|Overall Study|Lost to Follow-up|3
6908379|NCT00719810|10932216|FG000|Overall Study|Physician Decision|0
6908380|NCT00719810|10932217|FG001|Overall Study|Physician Decision|1
6908381|NCT00719810|10932218|FG002|Overall Study|Physician Decision|0
6908382|NCT00719810|10932216|FG000|Overall Study|Withdrawal by Subject|1
6908383|NCT00719810|10932217|FG001|Overall Study|Withdrawal by Subject|1
6908384|NCT00719810|10932218|FG002|Overall Study|Withdrawal by Subject|2
6908385|NCT00719849|10932228|FG000|Overall Study|Death|0
6908386|NCT00719849|10932229|FG001|Overall Study|Death|1
6908387|NCT00719862|10932237|FG000|Overall Study|Adverse Event|1
6908388|NCT00719862|10932238|FG001|Overall Study|Adverse Event|2
6908389|NCT00719862|10932237|FG000|Overall Study|Lack of Efficacy|3
6908390|NCT00719862|10932238|FG001|Overall Study|Lack of Efficacy|0
6908391|NCT00719862|10932237|FG000|Overall Study|Non-Compliance|1
6908392|NCT00719862|10932238|FG001|Overall Study|Non-Compliance|0
6908393|NCT00719862|10932237|FG000|Overall Study|Withdrawal by Subject|1
6908394|NCT00719862|10932238|FG001|Overall Study|Withdrawal by Subject|0
6908395|NCT00719862|10932237|FG000|Overall Study|Lost to Follow-up|0
6908396|NCT00719862|10932238|FG001|Overall Study|Lost to Follow-up|1
6908397|NCT00719862|10932237|FG000|Overall Study|Other|2
6908398|NCT00719862|10932238|FG001|Overall Study|Other|3
6908399|NCT00719901|10932244|FG000|Overall Study|Adverse Event|5
6908400|NCT00719901|10932244|FG000|Overall Study|Withdrawal by Subject|1
6908401|NCT00719901|10932244|FG000|Overall Study|Alternate Treatment|1
6908402|NCT00719901|10932244|FG000|Overall Study|Disease Progression|3
6908403|NCT00719901|10932244|FG000|Overall Study|Availability of Study Drug|1
6908404|NCT00719953|10932248|FG000|Overall Study|Adverse Event|4
6908405|NCT00720057|10932254|FG000|Overall Study|Lost to Follow-up|0
6908406|NCT00720057|10932255|FG001|Overall Study|Lost to Follow-up|2
6908407|NCT00720057|10932254|FG000|Overall Study|Protocol Violation|1
6908408|NCT00720057|10932255|FG001|Overall Study|Protocol Violation|0
6908409|NCT00720057|10932254|FG000|Overall Study|Withdrawal by Subject|0
6908410|NCT00720057|10932255|FG001|Overall Study|Withdrawal by Subject|1
6908411|NCT00720096|10932263|FG000|Overall Study|Withdrawal by Subject|0
6908412|NCT00720096|10932264|FG001|Overall Study|Withdrawal by Subject|2
6908413|NCT00720109|10932270|FG000|Induction Period|Did not meet eligibility criteria|3
6908414|NCT00720109|10932271|FG001|Induction Period|Did not meet eligibility criteria|0
6908415|NCT00720109|10932272|FG002|Induction Period|Did not meet eligibility criteria|0
6908416|NCT00720109|10932270|FG000|Induction Period|Bone Marrow Transplant|2
6908417|NCT00720109|10932271|FG001|Induction Period|Bone Marrow Transplant|0
6908418|NCT00720109|10932272|FG002|Induction Period|Bone Marrow Transplant|0
6908419|NCT00720109|10932270|FG000|Induction Period|Physician Decision|1
6908420|NCT00720109|10932271|FG001|Induction Period|Physician Decision|0
6908421|NCT00720109|10932272|FG002|Induction Period|Physician Decision|0
6908422|NCT00720109|10932270|FG000|Risk Stratification Period|Adverse Event|0
6908423|NCT00720109|10932271|FG001|Risk Stratification Period|Adverse Event|1
6908424|NCT00720109|10932272|FG002|Risk Stratification Period|Adverse Event|0
6908425|NCT00720109|10932270|FG000|Risk Stratification Period|Physician Decision|0
6908426|NCT00720109|10932271|FG001|Risk Stratification Period|Physician Decision|2
6908427|NCT00720109|10932272|FG002|Risk Stratification Period|Physician Decision|1
6908428|NCT00720109|10932270|FG000|Risk Stratification Period|Bone marrow transplant|0
6908429|NCT00720109|10932271|FG001|Risk Stratification Period|Bone marrow transplant|9
6908430|NCT00720109|10932272|FG002|Risk Stratification Period|Bone marrow transplant|7
6908431|NCT00720109|10932270|FG000|Risk Stratification Period|Disease progression or relapse|0
6908432|NCT00720109|10932271|FG001|Risk Stratification Period|Disease progression or relapse|2
6908433|NCT00720109|10932272|FG002|Risk Stratification Period|Disease progression or relapse|0
6908434|NCT00720109|10932270|FG000|Risk Stratification Period|Development of second malignant neoplasm|0
6908435|NCT00720109|10932271|FG001|Risk Stratification Period|Development of second malignant neoplasm|1
6908436|NCT00720109|10932272|FG002|Risk Stratification Period|Development of second malignant neoplasm|0
6908437|NCT00720122|10932281|FG000|Overall Study|Lost to Follow-up|1
6908438|NCT00720122|10932281|FG000|Overall Study|Physician Decision|1
6908439|NCT00720122|10932281|FG000|Overall Study|Withdrawal by Subject|7
6908440|NCT00720213|10932285|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7
6908441|NCT00720213|10932286|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0
6908442|NCT00720213|10932287|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0
6908443|NCT00720226|10932297|FG000|Overall Study|Withdrawal by Subject|7
6908444|NCT00720226|10932298|FG001|Overall Study|Withdrawal by Subject|4
6908445|NCT00720278|10932307|FG000|Overall Study|Adverse Event|5
6908446|NCT00720278|10932308|FG001|Overall Study|Adverse Event|3
6908447|NCT00720278|10932309|FG002|Overall Study|Adverse Event|4
6908448|NCT00720278|10932307|FG000|Overall Study|Withdrawal by Subject|0
6908449|NCT00720278|10932308|FG001|Overall Study|Withdrawal by Subject|1
6908450|NCT00720278|10932309|FG002|Overall Study|Withdrawal by Subject|0
6908451|NCT00720278|10932307|FG000|Overall Study|Lost to Follow-up|0
6908452|NCT00720278|10932308|FG001|Overall Study|Lost to Follow-up|0
6908453|NCT00720278|10932309|FG002|Overall Study|Lost to Follow-up|1
6908454|NCT00720278|10932307|FG000|Overall Study|Non-compliance|1
6908455|NCT00720278|10932308|FG001|Overall Study|Non-compliance|0
6908456|NCT00720278|10932309|FG002|Overall Study|Non-compliance|0
6908457|NCT00720278|10932307|FG000|Overall Study|eligibility criteria violation|1
6908458|NCT00720278|10932308|FG001|Overall Study|eligibility criteria violation|0
6908459|NCT00720278|10932309|FG002|Overall Study|eligibility criteria violation|1
6908460|NCT00720356|10932330|FG000|Registration to Study|Determined to have methylated MGMT|67
6908461|NCT00720356|10932330|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1
6908462|NCT00720356|10932330|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1
6908463|NCT00720356|10932330|FG000|Went on to be Treated Cycle 3|Adverse Event|1
6908464|NCT00720356|10932330|FG000|Went on to be Treated Cycle 3|Physician Decision|1
6908465|NCT00720356|10932330|FG000|Follow up Until Death|Withdrawal by Subject|1
6908466|NCT00720356|10932330|FG000|Follow up Until Death|Alive at last data collection|4
6908467|NCT00720382|10932347|FG000|Overall Study|Adverse Event|54
6908468|NCT00720382|10932348|FG001|Overall Study|Adverse Event|17
6908469|NCT00720382|10932347|FG000|Overall Study|Lack of Efficacy|18
6908470|NCT00720382|10932348|FG001|Overall Study|Lack of Efficacy|7
6908471|NCT00720382|10932347|FG000|Overall Study|Non-Compliance|15
6908472|NCT00720382|10932348|FG001|Overall Study|Non-Compliance|5
6908473|NCT00720382|10932347|FG000|Overall Study|Withdrawal by Subject|47
6908474|NCT00720382|10932348|FG001|Overall Study|Withdrawal by Subject|11
6908475|NCT00720382|10932347|FG000|Overall Study|Lost to Follow-up|28
6908476|NCT00720382|10932348|FG001|Overall Study|Lost to Follow-up|14
6908477|NCT00720382|10932347|FG000|Overall Study|administrative|14
6908478|NCT00720382|10932348|FG001|Overall Study|administrative|5
6908479|NCT00720434|10932358|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
6908480|NCT00720434|10932359|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1
6908481|NCT00720434|10932360|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
6908482|NCT00720434|10932361|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
6908483|NCT00720434|10932358|FG000|Open-Label Period (Week 5-72)|Adverse Event|0
6908484|NCT00720434|10932359|FG001|Open-Label Period (Week 5-72)|Adverse Event|0
6908485|NCT00720434|10932360|FG002|Open-Label Period (Week 5-72)|Adverse Event|0
6908486|NCT00720434|10932361|FG003|Open-Label Period (Week 5-72)|Adverse Event|2
6908487|NCT00720434|10932358|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1
6908488|NCT00720434|10932359|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0
6908489|NCT00720434|10932360|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0
6908490|NCT00720434|10932361|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0
6908491|NCT00720434|10932358|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
6908492|NCT00720434|10932359|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
6908493|NCT00720434|10932360|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
6908494|NCT00720434|10932361|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
6908495|NCT00720434|10932358|FG000|Open-Label Period (Week 5-72)|Other|4
6908496|NCT00720434|10932359|FG001|Open-Label Period (Week 5-72)|Other|3
6908497|NCT00720434|10932360|FG002|Open-Label Period (Week 5-72)|Other|3
6908498|NCT00720434|10932361|FG003|Open-Label Period (Week 5-72)|Other|2
6908499|NCT00720499|10932381|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2
6908500|NCT00720499|10932382|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0
6908501|NCT00720499|10932381|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1
6908502|NCT00720499|10932382|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2
6908503|NCT00720499|10932381|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2
6908504|NCT00720499|10932382|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3
6908505|NCT00720759|10932399|FG000|Overall Study|Lost to Follow-up|0
6908506|NCT00720759|10932400|FG001|Overall Study|Lost to Follow-up|1
6908507|NCT00720759|10932401|FG002|Overall Study|Lost to Follow-up|1
6908508|NCT00720759|10932402|FG003|Overall Study|Lost to Follow-up|0
6908509|NCT00720798|10932412|FG000|Overall Study|Adverse Event|304
6908510|NCT00720798|10932412|FG000|Overall Study|Death|39
6908511|NCT00720798|10932412|FG000|Overall Study|Insufficient Therapeutic Response|129
6908512|NCT00720798|10932412|FG000|Overall Study|Protocol Violation|4
6908513|NCT00720798|10932412|FG000|Overall Study|Refused Treatment|151
6908514|NCT00720798|10932412|FG000|Overall Study|Failure to Return|46
6908515|NCT00720798|10932412|FG000|Overall Study|Reason not Specified|83
6908516|NCT00720876|10932416|FG000|Overall Study|found to be ineligible after starting tx|2
6908517|NCT00720941|10932422|FG000|Overall Study|Death|334
6908518|NCT00720941|10932423|FG001|Overall Study|Death|335
6908519|NCT00720941|10932422|FG000|Overall Study|Protocol Violation|0
6908520|NCT00720941|10932423|FG001|Overall Study|Protocol Violation|2
6908521|NCT00720941|10932422|FG000|Overall Study|Lost to Follow-up|17
6908522|NCT00720941|10932423|FG001|Overall Study|Lost to Follow-up|15
6908523|NCT00720941|10932422|FG000|Overall Study|Physician Decision|1
6908524|NCT00720941|10932423|FG001|Overall Study|Physician Decision|5
6908525|NCT00720941|10932422|FG000|Overall Study|Withdrawal by Subject|27
6908526|NCT00720941|10932423|FG001|Overall Study|Withdrawal by Subject|35
6908527|NCT00720941|10932422|FG000|Overall Study|Ongoing|34
6978755|NCT01214655|11032289|FG000|Part B|Death|0
6978756|NCT01214655|11032290|FG001|Part B|Death|1
6978757|NCT01214655|11032291|FG002|Part B|Death|0
6978758|NCT01214655|11032289|FG000|Part B|Withdrawal by Subject|0
6978759|NCT01214655|11032290|FG001|Part B|Withdrawal by Subject|2
6978760|NCT01214655|11032291|FG002|Part B|Withdrawal by Subject|0
6978761|NCT01214655|11032289|FG000|Part C|Progressive Disease|0
6978762|NCT01214655|11032290|FG001|Part C|Progressive Disease|0
6978763|NCT01214655|11032291|FG002|Part C|Progressive Disease|5
6978764|NCT01214655|11032289|FG000|Part C|Death|0
6978765|NCT01214655|11032290|FG001|Part C|Death|0
6978766|NCT01214655|11032291|FG002|Part C|Death|1
6978767|NCT01214655|11032289|FG000|Part C|Physician Decision|0
6978768|NCT01214655|11032290|FG001|Part C|Physician Decision|0
6978769|NCT01214655|11032291|FG002|Part C|Physician Decision|1
6978770|NCT01214668|11032343|FG000|Overall Study|Adverse Event|0
6978771|NCT01214668|11032344|FG001|Overall Study|Adverse Event|1
6978772|NCT01214668|11032345|FG002|Overall Study|Adverse Event|0
6978773|NCT01214668|11032346|FG003|Overall Study|Adverse Event|2
6978774|NCT01214668|11032347|FG004|Overall Study|Adverse Event|1
6978775|NCT01214668|11032348|FG005|Overall Study|Adverse Event|1
6978776|NCT01214668|11032343|FG000|Overall Study|Death|0
6978777|NCT01214668|11032344|FG001|Overall Study|Death|0
6978778|NCT01214668|11032345|FG002|Overall Study|Death|1
6978779|NCT01214668|11032346|FG003|Overall Study|Death|0
6978780|NCT01214668|11032347|FG004|Overall Study|Death|0
6978781|NCT01214668|11032348|FG005|Overall Study|Death|0
6908528|NCT00720941|10932423|FG001|Overall Study|Ongoing|23
6978782|NCT01214668|11032343|FG000|Overall Study|Progressive Disease|4
6978783|NCT01214668|11032344|FG001|Overall Study|Progressive Disease|2
6978784|NCT01214668|11032345|FG002|Overall Study|Progressive Disease|5
6978785|NCT01214668|11032346|FG003|Overall Study|Progressive Disease|4
6978786|NCT01214668|11032347|FG004|Overall Study|Progressive Disease|4
6978787|NCT01214668|11032348|FG005|Overall Study|Progressive Disease|5
6978788|NCT01214668|11032343|FG000|Overall Study|Withdrawal by Subject|0
6978789|NCT01214668|11032344|FG001|Overall Study|Withdrawal by Subject|0
6978790|NCT01214668|11032345|FG002|Overall Study|Withdrawal by Subject|0
6908529|NCT00721110|10932433|FG000|Overall Study|Ultram use|1
6908530|NCT00721110|10932434|FG001|Overall Study|Ultram use|0
6908531|NCT00721110|10932435|FG002|Overall Study|Ultram use|0
6908532|NCT00721110|10932436|FG003|Overall Study|Ultram use|0
6908533|NCT00721110|10932433|FG000|Overall Study|vertical incision|0
6908534|NCT00721110|10932434|FG001|Overall Study|vertical incision|0
6908535|NCT00721110|10932435|FG002|Overall Study|vertical incision|1
6908536|NCT00721110|10932436|FG003|Overall Study|vertical incision|0
6908537|NCT00721123|10932446|FG000|Overall Study|Adverse Event|96
6978791|NCT01214668|11032346|FG003|Overall Study|Withdrawal by Subject|0
6978792|NCT01214668|11032347|FG004|Overall Study|Withdrawal by Subject|1
6978793|NCT01214668|11032348|FG005|Overall Study|Withdrawal by Subject|0
6908538|NCT00721123|10932446|FG000|Overall Study|Death|10
6908539|NCT00721123|10932446|FG000|Overall Study|Insufficient Therapeutic Response|21
6908540|NCT00721123|10932446|FG000|Overall Study|Protocol Violation|1
6908541|NCT00721123|10932446|FG000|Overall Study|Refused Treatment|41
6908542|NCT00721123|10932446|FG000|Overall Study|Failure to Return|9
6908543|NCT00721123|10932446|FG000|Overall Study|Withdrawal by Subject|5
6908544|NCT00721149|10932487|FG000|Overall Study|Physician Decision|1
6908545|NCT00721214|10932508|FG000|Overall Study|Chose another center for transplant|1
6908546|NCT00721214|10932508|FG000|Overall Study|Death|3
6908547|NCT00721227|10932514|FG000|Overall Study|Lost to Follow-up|3
6908548|NCT00721227|10932515|FG001|Overall Study|Lost to Follow-up|0
6908549|NCT00721227|10932514|FG000|Overall Study|Noncompliance with scheduled visits.|1
6908550|NCT00721227|10932515|FG001|Overall Study|Noncompliance with scheduled visits.|0
6908551|NCT00721279|10932533|FG000|Overall Study|Lack of Efficacy|6
6908552|NCT00721279|10932534|FG001|Overall Study|Lack of Efficacy|3
6908553|NCT00721279|10932533|FG000|Overall Study|Tolerability insufficient|5
6908554|NCT00721279|10932534|FG001|Overall Study|Tolerability insufficient|2
6908555|NCT00721279|10932533|FG000|Overall Study|Withdrawal by Subject|13
6908556|NCT00721279|10932534|FG001|Overall Study|Withdrawal by Subject|3
6908557|NCT00721279|10932533|FG000|Overall Study|Other|12
6908558|NCT00721279|10932534|FG001|Overall Study|Other|16
6908559|NCT00721396|10932556|FG000|Overall Study|Adverse Event|4
6908560|NCT00721396|10932557|FG001|Overall Study|Adverse Event|7
6908561|NCT00721396|10932558|FG002|Overall Study|Adverse Event|2
6908562|NCT00721396|10932559|FG003|Overall Study|Adverse Event|0
6908563|NCT00721396|10932556|FG000|Overall Study|Withdrawal by Subject|12
6908564|NCT00721396|10932557|FG001|Overall Study|Withdrawal by Subject|15
6908565|NCT00721396|10932558|FG002|Overall Study|Withdrawal by Subject|3
6908566|NCT00721396|10932559|FG003|Overall Study|Withdrawal by Subject|7
6908567|NCT00721396|10932556|FG000|Overall Study|Lost to Follow-up|7
6908568|NCT00721396|10932557|FG001|Overall Study|Lost to Follow-up|9
6908569|NCT00721396|10932558|FG002|Overall Study|Lost to Follow-up|3
6908570|NCT00721396|10932559|FG003|Overall Study|Lost to Follow-up|3
6908571|NCT00721396|10932556|FG000|Overall Study|Protocol Violation|4
6908572|NCT00721396|10932557|FG001|Overall Study|Protocol Violation|3
6908573|NCT00721396|10932558|FG002|Overall Study|Protocol Violation|1
6908574|NCT00721396|10932559|FG003|Overall Study|Protocol Violation|0
6908575|NCT00721396|10932556|FG000|Overall Study|Inappropriate enrollment|0
6908576|NCT00721396|10932557|FG001|Overall Study|Inappropriate enrollment|2
6908577|NCT00721396|10932558|FG002|Overall Study|Inappropriate enrollment|0
6908578|NCT00721396|10932559|FG003|Overall Study|Inappropriate enrollment|0
6908579|NCT00721396|10932556|FG000|Overall Study|Administrative reason|3
6908580|NCT00721396|10932557|FG001|Overall Study|Administrative reason|0
6908581|NCT00721396|10932558|FG002|Overall Study|Administrative reason|1
6908582|NCT00721396|10932559|FG003|Overall Study|Administrative reason|0
6908583|NCT00721409|10932577|FG000|Overall Study|Global deterioration of health status|2
6908584|NCT00721409|10932578|FG001|Overall Study|Global deterioration of health status|6
6908585|NCT00721409|10932579|FG002|Overall Study|Global deterioration of health status|3
6908586|NCT00721409|10932577|FG000|Overall Study|Death|0
6908587|NCT00721409|10932578|FG001|Overall Study|Death|1
6908588|NCT00721409|10932579|FG002|Overall Study|Death|0
6908589|NCT00721409|10932577|FG000|Overall Study|Randomized not Treated|0
6908590|NCT00721409|10932578|FG001|Overall Study|Randomized not Treated|1
6908591|NCT00721409|10932579|FG002|Overall Study|Randomized not Treated|4
6908592|NCT00721409|10932577|FG000|Overall Study|Reason not specified|1
6908593|NCT00721409|10932578|FG001|Overall Study|Reason not specified|0
6908594|NCT00721409|10932579|FG002|Overall Study|Reason not specified|2
6908595|NCT00721409|10932577|FG000|Overall Study|Adverse Event|0
6908596|NCT00721409|10932578|FG001|Overall Study|Adverse Event|13
6908597|NCT00721409|10932579|FG002|Overall Study|Adverse Event|2
6908598|NCT00721409|10932577|FG000|Overall Study|Lost to Follow-up|0
6908599|NCT00721409|10932578|FG001|Overall Study|Lost to Follow-up|0
6908600|NCT00721409|10932579|FG002|Overall Study|Lost to Follow-up|1
6908601|NCT00721409|10932577|FG000|Overall Study|Withdrawal by Subject|1
6908602|NCT00721409|10932578|FG001|Overall Study|Withdrawal by Subject|6
6908603|NCT00721409|10932579|FG002|Overall Study|Withdrawal by Subject|5
6908604|NCT00721409|10932577|FG000|Overall Study|Objective progression or relapse|8
6908605|NCT00721409|10932578|FG001|Overall Study|Objective progression or relapse|55
6908606|NCT00721409|10932579|FG002|Overall Study|Objective progression or relapse|62
6908607|NCT00721578|10932626|FG000|Overall Study|Death|1
6908608|NCT00721578|10932627|FG001|Overall Study|Death|1
6908609|NCT00721578|10932626|FG000|Overall Study|Withdrawal by Subject|1
6908610|NCT00721578|10932627|FG001|Overall Study|Withdrawal by Subject|1
6908611|NCT00721630|10932638|FG000|Overall Study|Participant found to be ineligible|1
6908612|NCT00721734|10932647|FG000|Overall Study|Progressive Disease|3
6908613|NCT00721734|10932648|FG001|Overall Study|Progressive Disease|10
6908614|NCT00721734|10932649|FG002|Overall Study|Progressive Disease|4
6908615|NCT00721734|10932650|FG003|Overall Study|Progressive Disease|5
6908616|NCT00721734|10932651|FG004|Overall Study|Progressive Disease|2
6908617|NCT00721734|10932647|FG000|Overall Study|Adverse Event|3
6908618|NCT00721734|10932648|FG001|Overall Study|Adverse Event|1
6908619|NCT00721734|10932649|FG002|Overall Study|Adverse Event|4
6908620|NCT00721734|10932650|FG003|Overall Study|Adverse Event|0
6908621|NCT00721734|10932651|FG004|Overall Study|Adverse Event|3
6908622|NCT00721734|10932647|FG000|Overall Study|Withdrawal by Subject|2
6908623|NCT00721734|10932648|FG001|Overall Study|Withdrawal by Subject|1
6908624|NCT00721734|10932649|FG002|Overall Study|Withdrawal by Subject|0
6908625|NCT00721734|10932650|FG003|Overall Study|Withdrawal by Subject|0
6908626|NCT00721734|10932651|FG004|Overall Study|Withdrawal by Subject|1
6908627|NCT00721734|10932647|FG000|Overall Study|Other|0
6908628|NCT00721734|10932648|FG001|Overall Study|Other|0
6908629|NCT00721734|10932649|FG002|Overall Study|Other|0
6908630|NCT00721734|10932650|FG003|Overall Study|Other|1
6908631|NCT00721734|10932651|FG004|Overall Study|Other|0
6908632|NCT00721799|10932663|FG000|Overall Study|Withdrawal by Subject|7
6908633|NCT00721799|10932663|FG000|Overall Study|withdraw by subject after scan 1|1
6908634|NCT00721955|10932670|FG000|Overall Study|Adverse Event|0
6908635|NCT00721955|10932671|FG001|Overall Study|Adverse Event|0
6908636|NCT00721955|10932672|FG002|Overall Study|Adverse Event|2
6908637|NCT00721968|10932682|FG000|Overall Study|Lost to Follow-up|2
6908638|NCT00721968|10932683|FG001|Overall Study|Lost to Follow-up|0
6908639|NCT00722137|10932733|FG000|Overall Study|Overt Disease Progression|5
6908640|NCT00722137|10932734|FG001|Overall Study|Overt Disease Progression|4
6908641|NCT00722137|10932733|FG000|Overall Study|Adverse Event|17
6908642|NCT00722137|10932734|FG001|Overall Study|Adverse Event|21
6908643|NCT00722137|10932733|FG000|Overall Study|Death|12
6908644|NCT00722137|10932734|FG001|Overall Study|Death|7
6908645|NCT00722137|10932733|FG000|Overall Study|Withdrawal by Subject|6
6908646|NCT00722137|10932734|FG001|Overall Study|Withdrawal by Subject|9
6908647|NCT00722137|10932733|FG000|Overall Study|Other Reason Unknown|3
6908648|NCT00722137|10932734|FG001|Overall Study|Other Reason Unknown|4
6908649|NCT00722137|10932733|FG000|Overall Study|Randomized But Not Treated|2
6908650|NCT00722137|10932734|FG001|Overall Study|Randomized But Not Treated|3
6908651|NCT00722371|10932747|FG000|Overall Study|Adverse Event|6
6908652|NCT00722371|10932748|FG001|Overall Study|Adverse Event|13
6908653|NCT00722371|10932749|FG002|Overall Study|Adverse Event|9
6908654|NCT00722371|10932750|FG003|Overall Study|Adverse Event|10
6908655|NCT00722371|10932751|FG004|Overall Study|Adverse Event|6
6908656|NCT00722371|10932752|FG005|Overall Study|Adverse Event|8
6908657|NCT00722371|10932753|FG006|Overall Study|Adverse Event|4
6908658|NCT00722371|10932747|FG000|Overall Study|Contraindication|0
6908659|NCT00722371|10932748|FG001|Overall Study|Contraindication|0
6908660|NCT00722371|10932749|FG002|Overall Study|Contraindication|1
6908661|NCT00722371|10932750|FG003|Overall Study|Contraindication|0
6908662|NCT00722371|10932751|FG004|Overall Study|Contraindication|0
6908663|NCT00722371|10932752|FG005|Overall Study|Contraindication|0
6908664|NCT00722371|10932753|FG006|Overall Study|Contraindication|0
6908665|NCT00722371|10932747|FG000|Overall Study|Creatinine / Creatinine clearance|2
6908666|NCT00722371|10932748|FG001|Overall Study|Creatinine / Creatinine clearance|1
6908667|NCT00722371|10932749|FG002|Overall Study|Creatinine / Creatinine clearance|2
6908668|NCT00722371|10932750|FG003|Overall Study|Creatinine / Creatinine clearance|3
6908669|NCT00722371|10932751|FG004|Overall Study|Creatinine / Creatinine clearance|2
6908670|NCT00722371|10932752|FG005|Overall Study|Creatinine / Creatinine clearance|1
6908671|NCT00722371|10932753|FG006|Overall Study|Creatinine / Creatinine clearance|1
6908672|NCT00722371|10932747|FG000|Overall Study|Excluded medication|0
6908673|NCT00722371|10932748|FG001|Overall Study|Excluded medication|1
6908674|NCT00722371|10932749|FG002|Overall Study|Excluded medication|1
6908675|NCT00722371|10932750|FG003|Overall Study|Excluded medication|0
6908676|NCT00722371|10932751|FG004|Overall Study|Excluded medication|0
6908677|NCT00722371|10932752|FG005|Overall Study|Excluded medication|0
6908678|NCT00722371|10932753|FG006|Overall Study|Excluded medication|1
6908679|NCT00722371|10932747|FG000|Overall Study|Hyperglycemia|2
6908680|NCT00722371|10932748|FG001|Overall Study|Hyperglycemia|6
6908681|NCT00722371|10932749|FG002|Overall Study|Hyperglycemia|4
6908682|NCT00722371|10932750|FG003|Overall Study|Hyperglycemia|2
6908683|NCT00722371|10932751|FG004|Overall Study|Hyperglycemia|5
6908684|NCT00722371|10932752|FG005|Overall Study|Hyperglycemia|1
6908685|NCT00722371|10932753|FG006|Overall Study|Hyperglycemia|1
6908686|NCT00722371|10932747|FG000|Overall Study|Hypoglycemia|1
6908687|NCT00722371|10932748|FG001|Overall Study|Hypoglycemia|0
6908688|NCT00722371|10932749|FG002|Overall Study|Hypoglycemia|0
6908689|NCT00722371|10932750|FG003|Overall Study|Hypoglycemia|0
6908690|NCT00722371|10932751|FG004|Overall Study|Hypoglycemia|0
6908691|NCT00722371|10932752|FG005|Overall Study|Hypoglycemia|0
6908692|NCT00722371|10932753|FG006|Overall Study|Hypoglycemia|0
6908693|NCT00722371|10932747|FG000|Overall Study|Lack of Efficacy|4
6908694|NCT00722371|10932748|FG001|Overall Study|Lack of Efficacy|6
6908695|NCT00722371|10932749|FG002|Overall Study|Lack of Efficacy|6
6908696|NCT00722371|10932750|FG003|Overall Study|Lack of Efficacy|6
6908697|NCT00722371|10932751|FG004|Overall Study|Lack of Efficacy|2
6908698|NCT00722371|10932752|FG005|Overall Study|Lack of Efficacy|3
6908699|NCT00722371|10932753|FG006|Overall Study|Lack of Efficacy|0
6908700|NCT00722371|10932747|FG000|Overall Study|Lost to Follow-up|11
6908701|NCT00722371|10932748|FG001|Overall Study|Lost to Follow-up|14
6908702|NCT00722371|10932749|FG002|Overall Study|Lost to Follow-up|21
6908703|NCT00722371|10932750|FG003|Overall Study|Lost to Follow-up|13
6908704|NCT00722371|10932751|FG004|Overall Study|Lost to Follow-up|8
6908705|NCT00722371|10932752|FG005|Overall Study|Lost to Follow-up|16
6908706|NCT00722371|10932753|FG006|Overall Study|Lost to Follow-up|13
6908707|NCT00722371|10932747|FG000|Overall Study|Physician Decision|5
6908708|NCT00722371|10932748|FG001|Overall Study|Physician Decision|2
6908709|NCT00722371|10932749|FG002|Overall Study|Physician Decision|2
6908710|NCT00722371|10932750|FG003|Overall Study|Physician Decision|5
6908711|NCT00722371|10932751|FG004|Overall Study|Physician Decision|2
6908712|NCT00722371|10932752|FG005|Overall Study|Physician Decision|3
6908713|NCT00722371|10932753|FG006|Overall Study|Physician Decision|4
6908714|NCT00722371|10932747|FG000|Overall Study|Pregnancy|1
6908715|NCT00722371|10932748|FG001|Overall Study|Pregnancy|1
6908716|NCT00722371|10932749|FG002|Overall Study|Pregnancy|0
6908717|NCT00722371|10932750|FG003|Overall Study|Pregnancy|0
6908718|NCT00722371|10932751|FG004|Overall Study|Pregnancy|0
6908719|NCT00722371|10932752|FG005|Overall Study|Pregnancy|1
6908720|NCT00722371|10932753|FG006|Overall Study|Pregnancy|0
6908721|NCT00722371|10932747|FG000|Overall Study|Protocol Violation|6
6908722|NCT00722371|10932748|FG001|Overall Study|Protocol Violation|1
6908723|NCT00722371|10932749|FG002|Overall Study|Protocol Violation|0
6908724|NCT00722371|10932750|FG003|Overall Study|Protocol Violation|1
6908725|NCT00722371|10932751|FG004|Overall Study|Protocol Violation|4
6908726|NCT00722371|10932752|FG005|Overall Study|Protocol Violation|2
6908727|NCT00722371|10932753|FG006|Overall Study|Protocol Violation|1
6908728|NCT00722371|10932747|FG000|Overall Study|Withdrawal by Subject|18
6908729|NCT00722371|10932748|FG001|Overall Study|Withdrawal by Subject|27
6908730|NCT00722371|10932749|FG002|Overall Study|Withdrawal by Subject|19
6908731|NCT00722371|10932750|FG003|Overall Study|Withdrawal by Subject|23
6908732|NCT00722371|10932751|FG004|Overall Study|Withdrawal by Subject|19
6908733|NCT00722371|10932752|FG005|Overall Study|Withdrawal by Subject|18
6908734|NCT00722371|10932753|FG006|Overall Study|Withdrawal by Subject|26
6908735|NCT00722423|10932771|FG000|Overall Study|Protocol Violation|0
6908736|NCT00722423|10932772|FG001|Overall Study|Protocol Violation|1
6908737|NCT00722761|10932821|FG000|Overall Study|Lost to Follow-up|1
6908738|NCT00722761|10932822|FG001|Overall Study|Lost to Follow-up|4
6908739|NCT00722761|10932821|FG000|Overall Study|Withdrawal by Subject|5
6908740|NCT00722761|10932822|FG001|Overall Study|Withdrawal by Subject|2
6908741|NCT00722800|10932830|FG000|Overall Study|Withdrawal by Subject|1
6908742|NCT00722800|10932831|FG001|Overall Study|Withdrawal by Subject|0
6908743|NCT00722800|10932830|FG000|Overall Study|Physician Decision|1
6908744|NCT00722800|10932831|FG001|Overall Study|Physician Decision|0
6908745|NCT00723008|10932843|FG000|Enrollment|Lost to Follow-up|1
6908746|NCT00723008|10932844|FG001|Enrollment|Lost to Follow-up|0
6908747|NCT00723008|10932843|FG000|4-Week Double Blinded|Lack of Efficacy|0
6908748|NCT00723008|10932844|FG001|4-Week Double Blinded|Lack of Efficacy|1
6908749|NCT00723008|10932843|FG000|4-Week Double Blinded|Withdrawal by Subject|1
6908750|NCT00723008|10932844|FG001|4-Week Double Blinded|Withdrawal by Subject|1
6908751|NCT00723008|10932843|FG000|4-Week Double Blinded|Lost to Follow-up|4
6908752|NCT00723008|10932844|FG001|4-Week Double Blinded|Lost to Follow-up|3
6908753|NCT00723008|10932843|FG000|4-Week Unblinded Treatment|Adverse Event|1
6908754|NCT00723008|10932844|FG001|4-Week Unblinded Treatment|Adverse Event|0
6908755|NCT00723008|10932843|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0
6908756|NCT00723008|10932844|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1
6908757|NCT00723021|10932858|FG000|Intervention Period 4|Adverse Event|0
6908758|NCT00723021|10932859|FG001|Intervention Period 4|Adverse Event|0
6908759|NCT00723021|10932860|FG002|Intervention Period 4|Adverse Event|0
6908760|NCT00723021|10932861|FG003|Intervention Period 4|Adverse Event|0
6908761|NCT00723021|10932862|FG004|Intervention Period 4|Adverse Event|1
6908762|NCT00723125|10932897|FG000|Overall Study|Met Dx|1
6908763|NCT00723125|10932898|FG001|Overall Study|Met Dx|0
6908764|NCT00723125|10932897|FG000|Overall Study|Withdrawal by Subject|15
7060181|NCT01915732|11156241|FG000|Overall Study|Failure to Meet Randomization Criteria|1
7060182|NCT01915732|11156242|FG001|Overall Study|Failure to Meet Randomization Criteria|0
7060183|NCT01915732|11156241|FG000|Overall Study|Adverse Event|12
7060184|NCT01915732|11156242|FG001|Overall Study|Adverse Event|4
7060185|NCT01915732|11156241|FG000|Overall Study|Protocol Violation|5
7060186|NCT01915732|11156242|FG001|Overall Study|Protocol Violation|5
7060187|NCT01915732|11156241|FG000|Overall Study|Lack of Efficacy|6
7060188|NCT01915732|11156242|FG001|Overall Study|Lack of Efficacy|11
7060189|NCT01915732|11156241|FG000|Overall Study|Lost to Follow-up|22
7060190|NCT01915732|11156242|FG001|Overall Study|Lost to Follow-up|26
7060191|NCT01915732|11156241|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1
7060192|NCT01915732|11156242|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0
7060193|NCT01915732|11156241|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1
7060194|NCT01915732|11156242|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0
7060195|NCT01915732|11156241|FG000|Overall Study|Drug Release Error|1
7060196|NCT01915732|11156242|FG001|Overall Study|Drug Release Error|0
6908765|NCT00723125|10932898|FG001|Overall Study|Withdrawal by Subject|6
6908766|NCT00723125|10932897|FG000|Overall Study|Adverse Event|2
6908767|NCT00723125|10932898|FG001|Overall Study|Adverse Event|0
6908768|NCT00723190|10932923|FG000|Overall Study|Withdrawal by Subject|45
6908769|NCT00723190|10932923|FG000|Overall Study|Lost to Follow-up|37
6908770|NCT00723190|10932923|FG000|Overall Study|Adverse Event|18
6908771|NCT00723190|10932923|FG000|Overall Study|Lack of Efficacy|16
6908772|NCT00723190|10932923|FG000|Overall Study|Protocol Violation|15
7060197|NCT01915732|11156241|FG000|Overall Study|Recovered|1
7060198|NCT01915732|11156242|FG001|Overall Study|Recovered|0
7060199|NCT01915732|11156241|FG000|Overall Study|Pregnancy|1
7060200|NCT01915732|11156242|FG001|Overall Study|Pregnancy|0
6908773|NCT00723190|10932923|FG000|Overall Study|Other-Premature Discontinuation|9
6908774|NCT00723190|10932923|FG000|Overall Study|Other-Not included in safety population|2
6908775|NCT00723203|10932927|FG000|Overall Study|Withdrawal by Subject|3
6908776|NCT00723229|10932933|FG000|First Intervention|Lost to Follow-up|7
6908777|NCT00723229|10932934|FG001|First Intervention|Lost to Follow-up|3
6908778|NCT00723255|10932940|FG000|Overall Study|Ineligible: Inadequate pathology|1
6908779|NCT00723255|10932940|FG000|Overall Study|Ineligible: Second primary|1
6908780|NCT00723255|10932940|FG000|Overall Study|Ineligible: Wrong Primary|2
6908781|NCT00723294|10932956|FG000|Overall Study|Lobular histology|2
6908782|NCT00723294|10932956|FG000|Overall Study|>25% intraductal component|1
6908783|NCT00723294|10932956|FG000|Overall Study|No MRI tumor enhancement|1
6908784|NCT00723294|10932956|FG000|Overall Study|1.0-Tesla MRI|1
6908785|NCT00723294|10932956|FG000|Overall Study|No cryoabalation|2
6908786|NCT00723294|10932956|FG000|Overall Study|Did not undergo surgery|1
6908787|NCT00723294|10932956|FG000|Overall Study|Treated prior to registration|1
6908788|NCT00723294|10932956|FG000|Overall Study|Treated by non-credentialed surgeon|1
6908789|NCT00723294|10932956|FG000|Overall Study|Benign lesion|1
6908790|NCT00723294|10932956|FG000|Overall Study|Withdrawal by Subject|1
6908791|NCT00723294|10932956|FG000|Overall Study|No treatment due to probe failure|1
6908792|NCT00723398|10932965|FG000|Overall Study|Withdrawal by Subject|2
6908793|NCT00723398|10932966|FG001|Overall Study|Withdrawal by Subject|6
6908794|NCT00723398|10932967|FG002|Overall Study|Withdrawal by Subject|4
6908795|NCT00723398|10932968|FG003|Overall Study|Withdrawal by Subject|4
6908796|NCT00723398|10932969|FG004|Overall Study|Withdrawal by Subject|4
6908797|NCT00723398|10932965|FG000|Overall Study|Protocol Violation|2
6908798|NCT00723398|10932966|FG001|Overall Study|Protocol Violation|1
6908799|NCT00723398|10932967|FG002|Overall Study|Protocol Violation|5
6908800|NCT00723398|10932968|FG003|Overall Study|Protocol Violation|0
6908801|NCT00723398|10932969|FG004|Overall Study|Protocol Violation|0
6908802|NCT00723398|10932965|FG000|Overall Study|Physician Decision|2
6908803|NCT00723398|10932966|FG001|Overall Study|Physician Decision|2
6908804|NCT00723398|10932967|FG002|Overall Study|Physician Decision|5
6908805|NCT00723398|10932968|FG003|Overall Study|Physician Decision|0
6908806|NCT00723398|10932969|FG004|Overall Study|Physician Decision|1
6908807|NCT00723398|10932965|FG000|Overall Study|Adverse Event|0
6908808|NCT00723398|10932966|FG001|Overall Study|Adverse Event|5
6908809|NCT00723398|10932967|FG002|Overall Study|Adverse Event|3
6908810|NCT00723398|10932968|FG003|Overall Study|Adverse Event|1
6908811|NCT00723398|10932969|FG004|Overall Study|Adverse Event|4
6908812|NCT00723398|10932965|FG000|Overall Study|Lost to Follow-up|0
6908813|NCT00723398|10932966|FG001|Overall Study|Lost to Follow-up|1
6908814|NCT00723398|10932967|FG002|Overall Study|Lost to Follow-up|0
6908815|NCT00723398|10932968|FG003|Overall Study|Lost to Follow-up|0
6908816|NCT00723398|10932969|FG004|Overall Study|Lost to Follow-up|0
6908817|NCT00723450|10932983|FG000|Open-Label Phase|Adverse Event|26
6908818|NCT00723450|10932984|FG001|Open-Label Phase|Adverse Event|0
6908819|NCT00723450|10932985|FG002|Open-Label Phase|Adverse Event|0
6908820|NCT00723450|10932983|FG000|Open-Label Phase|Lack of Efficacy|18
6908821|NCT00723450|10932984|FG001|Open-Label Phase|Lack of Efficacy|0
6908822|NCT00723450|10932985|FG002|Open-Label Phase|Lack of Efficacy|0
6908823|NCT00723450|10932983|FG000|Open-Label Phase|Protocol Violation|35
6908824|NCT00723450|10932984|FG001|Open-Label Phase|Protocol Violation|0
6908825|NCT00723450|10932985|FG002|Open-Label Phase|Protocol Violation|0
6908826|NCT00723450|10932983|FG000|Open-Label Phase|Lost to Follow-up|7
6908827|NCT00723450|10932984|FG001|Open-Label Phase|Lost to Follow-up|0
6908828|NCT00723450|10932985|FG002|Open-Label Phase|Lost to Follow-up|0
6908829|NCT00723450|10932983|FG000|Open-Label Phase|Physician Decision|2
6908830|NCT00723450|10932984|FG001|Open-Label Phase|Physician Decision|0
6908831|NCT00723450|10932985|FG002|Open-Label Phase|Physician Decision|0
6908832|NCT00723450|10932983|FG000|Open-Label Phase|Withdrawal by Subject|37
6908833|NCT00723450|10932984|FG001|Open-Label Phase|Withdrawal by Subject|0
6908834|NCT00723450|10932985|FG002|Open-Label Phase|Withdrawal by Subject|0
6908835|NCT00723450|10932983|FG000|Randomized Phase|Adverse Event|0
6908836|NCT00723450|10932984|FG001|Randomized Phase|Adverse Event|26
6908837|NCT00723450|10932985|FG002|Randomized Phase|Adverse Event|17
6908838|NCT00723450|10932983|FG000|Randomized Phase|Lack of Efficacy|0
6908839|NCT00723450|10932984|FG001|Randomized Phase|Lack of Efficacy|11
6908840|NCT00723450|10932985|FG002|Randomized Phase|Lack of Efficacy|11
6908841|NCT00723450|10932983|FG000|Randomized Phase|Protocol Violation|0
6908842|NCT00723450|10932984|FG001|Randomized Phase|Protocol Violation|9
6908843|NCT00723450|10932985|FG002|Randomized Phase|Protocol Violation|13
6908844|NCT00723450|10932983|FG000|Randomized Phase|Lost to Follow-up|0
6908845|NCT00723450|10932984|FG001|Randomized Phase|Lost to Follow-up|2
6908846|NCT00723450|10932985|FG002|Randomized Phase|Lost to Follow-up|3
6908847|NCT00723450|10932983|FG000|Randomized Phase|Physician Decision|0
6908848|NCT00723450|10932984|FG001|Randomized Phase|Physician Decision|3
6908849|NCT00723450|10932985|FG002|Randomized Phase|Physician Decision|1
6908850|NCT00723450|10932983|FG000|Randomized Phase|Withdrawal by Subject|0
6908851|NCT00723450|10932984|FG001|Randomized Phase|Withdrawal by Subject|14
6908852|NCT00723450|10932985|FG002|Randomized Phase|Withdrawal by Subject|22
6908853|NCT00723489|10932998|FG000|Overall Study|Physician Decision|0
6908854|NCT00723489|10932999|FG001|Overall Study|Physician Decision|1
6908855|NCT00723489|10933000|FG002|Overall Study|Physician Decision|0
6908856|NCT00723489|10933001|FG003|Overall Study|Physician Decision|0
6908857|NCT00723489|10932998|FG000|Overall Study|Pregnancy|0
6908858|NCT00723489|10932999|FG001|Overall Study|Pregnancy|0
6908859|NCT00723489|10933000|FG002|Overall Study|Pregnancy|0
6908860|NCT00723489|10933001|FG003|Overall Study|Pregnancy|1
6908861|NCT00723489|10932998|FG000|Overall Study|Withdrawal by Subject|0
6908862|NCT00723489|10932999|FG001|Overall Study|Withdrawal by Subject|0
6908863|NCT00723489|10933000|FG002|Overall Study|Withdrawal by Subject|0
6908864|NCT00723489|10933001|FG003|Overall Study|Withdrawal by Subject|1
6908865|NCT00723489|10932998|FG000|Overall Study|Seropositive at baseline|1
6908866|NCT00723489|10932999|FG001|Overall Study|Seropositive at baseline|0
6908867|NCT00723489|10933000|FG002|Overall Study|Seropositive at baseline|0
6908868|NCT00723489|10933001|FG003|Overall Study|Seropositive at baseline|0
6908869|NCT00723489|10932998|FG000|Overall Study|Prohibited Medication|0
6908870|NCT00723489|10932999|FG001|Overall Study|Prohibited Medication|0
6908871|NCT00723489|10933000|FG002|Overall Study|Prohibited Medication|0
6908872|NCT00723489|10933001|FG003|Overall Study|Prohibited Medication|1
6908873|NCT00723489|10932998|FG000|Overall Study|Samples Collected Out of Window|0
6908874|NCT00723489|10932999|FG001|Overall Study|Samples Collected Out of Window|3
6908875|NCT00723489|10933000|FG002|Overall Study|Samples Collected Out of Window|0
6908876|NCT00723489|10933001|FG003|Overall Study|Samples Collected Out of Window|0
6908877|NCT00723528|10933014|FG000|Period 1: Controlled Period (CP)|Adverse Event|0
6908878|NCT00723528|10933015|FG001|Period 1: Controlled Period (CP)|Adverse Event|0
6908879|NCT00723528|10933016|FG002|Period 1: Controlled Period (CP)|Adverse Event|1
6908880|NCT00723528|10933017|FG003|Period 1: Controlled Period (CP)|Adverse Event|0
6908881|NCT00723528|10933018|FG004|Period 1: Controlled Period (CP)|Adverse Event|0
6908882|NCT00723528|10933019|FG005|Period 1: Controlled Period (CP)|Adverse Event|0
6908883|NCT00723528|10933020|FG006|Period 1: Controlled Period (CP)|Adverse Event|0
6908884|NCT00723528|10933014|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2
6908885|NCT00723528|10933015|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
6908886|NCT00723528|10933016|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
6908887|NCT00723528|10933017|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
6908888|NCT00723528|10933018|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
6908889|NCT00723528|10933019|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
6908890|NCT00723528|10933020|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
6908891|NCT00723528|10933014|FG000|Period 1: Controlled Period (CP)|Physician Decision|0
6908892|NCT00723528|10933015|FG001|Period 1: Controlled Period (CP)|Physician Decision|0
6908893|NCT00723528|10933016|FG002|Period 1: Controlled Period (CP)|Physician Decision|1
6908894|NCT00723528|10933017|FG003|Period 1: Controlled Period (CP)|Physician Decision|0
6908895|NCT00723528|10933018|FG004|Period 1: Controlled Period (CP)|Physician Decision|0
6908896|NCT00723528|10933019|FG005|Period 1: Controlled Period (CP)|Physician Decision|0
6908897|NCT00723528|10933020|FG006|Period 1: Controlled Period (CP)|Physician Decision|0
6908898|NCT00723528|10933014|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
6908899|NCT00723528|10933015|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
6908900|NCT00723528|10933016|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1
6908901|NCT00723528|10933017|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
6908902|NCT00723528|10933018|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
6908903|NCT00723528|10933019|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
6908904|NCT00723528|10933020|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
6908905|NCT00723528|10933014|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2
6908906|NCT00723528|10933015|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
6908907|NCT00723528|10933016|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1
6908908|NCT00723528|10933017|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
6908909|NCT00723528|10933018|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
6908910|NCT00723528|10933019|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
6908911|NCT00723528|10933020|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
6908912|NCT00723528|10933014|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0
6908913|NCT00723528|10933015|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0
6908914|NCT00723528|10933016|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0
6908915|NCT00723528|10933017|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1
6908916|NCT00723528|10933018|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0
6908917|NCT00723528|10933019|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1
6908918|NCT00723528|10933020|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1
6908919|NCT00723528|10933014|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0
6908920|NCT00723528|10933015|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0
6908921|NCT00723528|10933016|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0
6978794|NCT01214720|11032365|FG000|Overall Study|Alive and still on treatment|34
6908922|NCT00723528|10933017|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0
6908923|NCT00723528|10933018|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0
6908924|NCT00723528|10933019|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1
6908925|NCT00723528|10933020|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0
6908926|NCT00723528|10933014|FG000|Period 2: After Controlled Period|Other|0
6908927|NCT00723528|10933015|FG001|Period 2: After Controlled Period|Other|0
6908928|NCT00723528|10933016|FG002|Period 2: After Controlled Period|Other|0
6908929|NCT00723528|10933017|FG003|Period 2: After Controlled Period|Other|0
6908930|NCT00723528|10933018|FG004|Period 2: After Controlled Period|Other|1
6908931|NCT00723528|10933019|FG005|Period 2: After Controlled Period|Other|4
6908932|NCT00723528|10933020|FG006|Period 2: After Controlled Period|Other|0
6908933|NCT00723528|10933014|FG000|Period 2: After Controlled Period|Adverse Event|0
6908934|NCT00723528|10933015|FG001|Period 2: After Controlled Period|Adverse Event|0
6908935|NCT00723528|10933016|FG002|Period 2: After Controlled Period|Adverse Event|0
6908936|NCT00723528|10933017|FG003|Period 2: After Controlled Period|Adverse Event|0
6908937|NCT00723528|10933018|FG004|Period 2: After Controlled Period|Adverse Event|1
6908938|NCT00723528|10933019|FG005|Period 2: After Controlled Period|Adverse Event|0
6908939|NCT00723528|10933020|FG006|Period 2: After Controlled Period|Adverse Event|1
6908940|NCT00723528|10933014|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
6908941|NCT00723528|10933015|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
6908942|NCT00723528|10933016|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
6908943|NCT00723528|10933017|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
6908944|NCT00723528|10933018|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
6908945|NCT00723528|10933019|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
6908946|NCT00723528|10933020|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1
6908947|NCT00723528|10933014|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
6908948|NCT00723528|10933015|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
6908949|NCT00723528|10933016|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
6908950|NCT00723528|10933017|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
6908951|NCT00723528|10933018|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
6908952|NCT00723528|10933019|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
6908953|NCT00723528|10933020|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1
6908954|NCT00723554|10933036|FG000|Overall Study|Adverse Event|12
6908955|NCT00723554|10933036|FG000|Overall Study|Investigator's judgement|5
6908956|NCT00723554|10933036|FG000|Overall Study|Inhaled medication other than iloprost|4
6908957|NCT00723554|10933036|FG000|Overall Study|Withdrawal of consent|3
6908958|NCT00723554|10933036|FG000|Overall Study|Other|3
6908959|NCT00723554|10933036|FG000|Overall Study|Lost to Follow-up|1
6908960|NCT00723554|10933036|FG000|Overall Study|Non-compliance|1
6908961|NCT00723606|10933048|FG000|Overall Study|Adverse Event|2
6908962|NCT00723606|10933049|FG001|Overall Study|Adverse Event|5
6908963|NCT00723606|10933048|FG000|Overall Study|Other|2
6908964|NCT00723606|10933049|FG001|Overall Study|Other|0
6908965|NCT00723606|10933048|FG000|Overall Study|Withdrawal by Subject|0
6908966|NCT00723606|10933049|FG001|Overall Study|Withdrawal by Subject|2
6974027|NCT01185353|11025993|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
6974028|NCT01185353|11025994|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
6974029|NCT01185353|11025985|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
6974030|NCT01185353|11025986|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
6974031|NCT01185353|11025987|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
6974032|NCT01185353|11025988|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
6974033|NCT01185353|11025989|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
6974034|NCT01185353|11025990|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
6974035|NCT01185353|11025991|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1
6974036|NCT01185353|11025992|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
6974037|NCT01185353|11025993|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
6974038|NCT01185353|11025994|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
6974039|NCT01185353|11025985|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0
6974040|NCT01185353|11025986|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0
6974041|NCT01185353|11025987|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0
6974042|NCT01185353|11025988|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0
6974043|NCT01185353|11025989|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0
6974044|NCT01185353|11025990|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0
6974045|NCT01185353|11025991|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0
6974046|NCT01185353|11025992|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8
6974047|NCT01185353|11025993|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2
6974048|NCT01185353|11025994|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2
6974049|NCT01185353|11025985|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
6974050|NCT01185353|11025986|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
6974051|NCT01185353|11025987|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
6974052|NCT01185353|11025988|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
6974053|NCT01185353|11025989|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
6974054|NCT01185353|11025990|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
6974055|NCT01185353|11025991|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
6974056|NCT01185353|11025992|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6
6974057|NCT01185353|11025993|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
6908967|NCT00723697|10933063|FG000|Overall Study|Physician questionnaires not received|2
6908968|NCT00723697|10933063|FG000|Overall Study|Missing Informed Consent Form|10
6908969|NCT00723697|10933063|FG000|Overall Study|Other exclusion criteria applied|6
6908970|NCT00723710|10933070|FG000|Overall Study|Disease progression|48
6908971|NCT00723710|10933070|FG000|Overall Study|Adverse Event|88
6908972|NCT00723710|10933070|FG000|Overall Study|Withdrawal by Subject|36
6908973|NCT00723710|10933070|FG000|Overall Study|Physician Decision|2
6908974|NCT00723801|10933086|FG000|Overall Study|Lost to Follow-up|1
6908975|NCT00723801|10933087|FG001|Overall Study|Lost to Follow-up|2
6908976|NCT00723801|10933086|FG000|Overall Study|Protocol Violation|2
6908977|NCT00723801|10933087|FG001|Overall Study|Protocol Violation|1
6908978|NCT00723840|10933097|FG000|Overall Study|Lost to Follow-up|2
6908979|NCT00723840|10933097|FG000|Overall Study|Failure to return|18
6908980|NCT00723840|10933097|FG000|Overall Study|Withdrawal by Subject|55
6908981|NCT00723840|10933097|FG000|Overall Study|Serious Adverse Events|3
6908982|NCT00723840|10933097|FG000|Overall Study|Other Medical Event|2
6908983|NCT00723840|10933097|FG000|Overall Study|Unspecified reason|2
6908984|NCT00723892|10933110|FG000|Overall Study|Participant not tracked|33
6908985|NCT00723892|10933111|FG001|Overall Study|Participant not tracked|35
6908986|NCT00723892|10933110|FG000|Overall Study|Virological criterion|24
6908987|NCT00723892|10933111|FG001|Overall Study|Virological criterion|9
6908988|NCT00723892|10933110|FG000|Overall Study|Withdrawal by Subject|6
6908989|NCT00723892|10933111|FG001|Overall Study|Withdrawal by Subject|9
6908990|NCT00723892|10933110|FG000|Overall Study|End planned|11
6908991|NCT00723892|10933111|FG001|Overall Study|End planned|7
6908992|NCT00723892|10933110|FG000|Overall Study|Bad tolerance|5
6908993|NCT00723892|10933111|FG001|Overall Study|Bad tolerance|5
6908994|NCT00723892|10933110|FG000|Overall Study|Multiple reasons|17
6908995|NCT00723892|10933111|FG001|Overall Study|Multiple reasons|12
6908996|NCT00723892|10933110|FG000|Overall Study|Other|6
6908997|NCT00723892|10933111|FG001|Overall Study|Other|3
6908998|NCT00723892|10933110|FG000|Overall Study|Study end|1
6908999|NCT00723892|10933111|FG001|Overall Study|Study end|3
6909000|NCT00723892|10933110|FG000|Overall Study|Weight loss|1
6909001|NCT00723892|10933111|FG001|Overall Study|Weight loss|3
6909002|NCT00723892|10933110|FG000|Overall Study|Alcohol abuse|0
6909003|NCT00723892|10933111|FG001|Overall Study|Alcohol abuse|1
6909004|NCT00723892|10933110|FG000|Overall Study|Intercurrent infection|2
6909005|NCT00723892|10933111|FG001|Overall Study|Intercurrent infection|0
6909006|NCT00723892|10933110|FG000|Overall Study|Drug addiction|1
6909007|NCT00723892|10933111|FG001|Overall Study|Drug addiction|0
6909008|NCT00723957|10933123|FG000|Overall Study|Adverse event unrelated to study drug|1
6909009|NCT00723957|10933124|FG001|Overall Study|Adverse event unrelated to study drug|4
6909010|NCT00723957|10933123|FG000|Overall Study|Death|3
6909011|NCT00723957|10933124|FG001|Overall Study|Death|4
6909012|NCT00723957|10933123|FG000|Overall Study|Disease progression|27
6909013|NCT00723957|10933124|FG001|Overall Study|Disease progression|25
6909014|NCT00723957|10933123|FG000|Overall Study|Maximum clinical benefit|4
6909015|NCT00723957|10933124|FG001|Overall Study|Maximum clinical benefit|5
6909016|NCT00723957|10933123|FG000|Overall Study|Investigator decision|1
6909017|NCT00723957|10933124|FG001|Overall Study|Investigator decision|1
6909018|NCT00723957|10933123|FG000|Overall Study|Study drug toxicity|4
6909019|NCT00723957|10933124|FG001|Overall Study|Study drug toxicity|6
6909020|NCT00723957|10933123|FG000|Overall Study|Withdrawal by Subject|7
6909021|NCT00723957|10933124|FG001|Overall Study|Withdrawal by Subject|5
6909022|NCT00723957|10933123|FG000|Overall Study|Reason not analyzed|1
6909023|NCT00723957|10933124|FG001|Overall Study|Reason not analyzed|0
6909024|NCT00723957|10933123|FG000|Overall Study|Never received treatment|3
6909025|NCT00723957|10933124|FG001|Overall Study|Never received treatment|3
6909026|NCT00724061|10933134|FG000|Dose Escalation Phase|Adverse Event|2
6909027|NCT00724061|10933134|FG000|Dose Escalation Phase|Disease Progression|3
6909028|NCT00724126|10933140|FG000|Overall Study|Adverse Event|2
6909029|NCT00724126|10933141|FG001|Overall Study|Adverse Event|0
6909030|NCT00724126|10933140|FG000|Overall Study|Withdrawal by Subject|8
6909031|NCT00724126|10933141|FG001|Overall Study|Withdrawal by Subject|6
6909032|NCT00724126|10933140|FG000|Overall Study|Lost to Follow-up|6
6909033|NCT00724126|10933141|FG001|Overall Study|Lost to Follow-up|6
6909034|NCT00724126|10933140|FG000|Overall Study|Noncompliance|2
6909035|NCT00724126|10933141|FG001|Overall Study|Noncompliance|1
6909036|NCT00724126|10933140|FG000|Overall Study|Subject randomized although ineligible|1
6909037|NCT00724126|10933141|FG001|Overall Study|Subject randomized although ineligible|1
6909038|NCT00724126|10933140|FG000|Overall Study|Subject had to leave vicinity of site|0
6909039|NCT00724126|10933141|FG001|Overall Study|Subject had to leave vicinity of site|1
6909040|NCT00724152|10933152|FG000|Two-arm Study Period|Withdrawal by Subject|3
6909041|NCT00724152|10933153|FG001|Two-arm Study Period|Withdrawal by Subject|2
6909042|NCT00724152|10933154|FG002|Two-arm Study Period|Withdrawal by Subject|0
6909043|NCT00724152|10933152|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
6909044|NCT00724152|10933153|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2
6909045|NCT00724152|10933154|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
6909046|NCT00724243|10933164|FG000|Overall Study|Lack of Efficacy|10
6909047|NCT00724243|10933164|FG000|Overall Study|Adverse Event|5
6909048|NCT00724373|10933181|FG000|Overall Study|Adverse Event|41
6909049|NCT00724373|10933181|FG000|Overall Study|Lack of Efficacy|82
6909050|NCT00724373|10933181|FG000|Overall Study|Lost to Follow-up|7
6909051|NCT00724373|10933181|FG000|Overall Study|Non-compliance|2
6909052|NCT00724373|10933181|FG000|Overall Study|HCV RNA negative after 4 weeks|9
6909053|NCT00724373|10933181|FG000|Overall Study|Participant moved away|1
6909054|NCT00724373|10933181|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2
6909055|NCT00724373|10933181|FG000|Overall Study|Only to have 24 week regimen|1
6909056|NCT00724373|10933181|FG000|Overall Study|Viral Relapse|1
6909057|NCT00724373|10933181|FG000|Overall Study|Acute HCV infection|1
6909058|NCT00724373|10933181|FG000|Overall Study|Drug Relapse|1
6909059|NCT00724373|10933181|FG000|Overall Study|Tolerability|23
6909060|NCT00724451|10933185|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7
6909061|NCT00724451|10933185|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3
6909062|NCT00724451|10933185|FG000|Overall Study|Not Eligible for Treatment|431
6909063|NCT00724451|10933185|FG000|Overall Study|Participant Refused Treatment|89
6909064|NCT00724451|10933185|FG000|Overall Study|Never Started Treatment|89
6909065|NCT00724451|10933185|FG000|Overall Study|Unknown; No Data Sources Available|9
6909066|NCT00724451|10933185|FG000|Overall Study|Physician Decision|116
6909067|NCT00724451|10933185|FG000|Overall Study|Withdrawal by Subject|45
6909068|NCT00724451|10933185|FG000|Overall Study|Investigator + Participant Decision|13
6909069|NCT00724503|10933196|FG000|Overall Study|Lost to Follow-up|4
6909070|NCT00724503|10933197|FG001|Overall Study|Lost to Follow-up|8
6909071|NCT00724503|10933196|FG000|Overall Study|Withdrawal by Subject|11
6909072|NCT00724503|10933197|FG001|Overall Study|Withdrawal by Subject|23
6909073|NCT00724503|10933196|FG000|Overall Study|Death|190
6909074|NCT00724503|10933197|FG001|Overall Study|Death|182
6909075|NCT00724503|10933196|FG000|Overall Study|Adverse Event|1
6909076|NCT00724503|10933197|FG001|Overall Study|Adverse Event|0
6909077|NCT00724503|10933196|FG000|Overall Study|Not otherwise specified|4
6909078|NCT00724503|10933197|FG001|Overall Study|Not otherwise specified|7
6909079|NCT00724711|10933244|FG000|Overall Study|Adverse Event|7
6909080|NCT00724711|10933245|FG001|Overall Study|Adverse Event|3
6909081|NCT00724711|10933244|FG000|Overall Study|Pregnancy|0
6909082|NCT00724711|10933245|FG001|Overall Study|Pregnancy|1
6909083|NCT00724711|10933244|FG000|Overall Study|Lack of Efficacy|0
6909084|NCT00724711|10933245|FG001|Overall Study|Lack of Efficacy|1
6909085|NCT00724711|10933244|FG000|Overall Study|Physician Decision|0
6909086|NCT00724711|10933245|FG001|Overall Study|Physician Decision|3
6909087|NCT00724711|10933244|FG000|Overall Study|Withdrawal by Subject|5
6909088|NCT00724711|10933245|FG001|Overall Study|Withdrawal by Subject|4
6909089|NCT00724711|10933244|FG000|Overall Study|Lost to Follow-up|4
6909090|NCT00724711|10933245|FG001|Overall Study|Lost to Follow-up|5
6909091|NCT00724711|10933244|FG000|Overall Study|Protocol Violation|1
6909092|NCT00724711|10933245|FG001|Overall Study|Protocol Violation|0
6909093|NCT00724815|10933262|FG000|Overall Study|Randomized, not treated|31
6909094|NCT00724815|10933263|FG001|Overall Study|Randomized, not treated|30
6909095|NCT00724815|10933262|FG000|Overall Study|Adverse Event|5
6909096|NCT00724815|10933263|FG001|Overall Study|Adverse Event|3
6909097|NCT00724815|10933262|FG000|Overall Study|Lost to Follow-up|4
6909098|NCT00724815|10933263|FG001|Overall Study|Lost to Follow-up|1
6909099|NCT00724815|10933262|FG000|Overall Study|Other Various|3
6909100|NCT00724815|10933263|FG001|Overall Study|Other Various|5
6909101|NCT00724854|10933271|FG000|Overall Study|Lack of Efficacy|187
6909102|NCT00724854|10933272|FG001|Overall Study|Lack of Efficacy|13
6909103|NCT00724854|10933271|FG000|Overall Study|Lost to Follow-up|87
6909104|NCT00724854|10933272|FG001|Overall Study|Lost to Follow-up|10
6909105|NCT00724854|10933271|FG000|Overall Study|Adverse Event|62
6909106|NCT00724854|10933272|FG001|Overall Study|Adverse Event|4
6909107|NCT00724854|10933271|FG000|Overall Study|Other|42
6909108|NCT00724854|10933272|FG001|Overall Study|Other|3
6909109|NCT00724854|10933271|FG000|Overall Study|Death|11
6909110|NCT00724854|10933272|FG001|Overall Study|Death|0
6909111|NCT00724854|10933271|FG000|Overall Study|Change of treatment|7
6909112|NCT00724854|10933272|FG001|Overall Study|Change of treatment|0
6909113|NCT00724854|10933271|FG000|Overall Study|Withdrawal by Subject|5
6909114|NCT00724854|10933272|FG001|Overall Study|Withdrawal by Subject|0
6909115|NCT00724854|10933271|FG000|Overall Study|Adverse event + lack of efficacy|2
6909116|NCT00724854|10933272|FG001|Overall Study|Adverse event + lack of efficacy|1
6909117|NCT00724867|10933279|FG000|Overall Study|Adverse Event|25
6909118|NCT00724867|10933279|FG000|Overall Study|Lack of Efficacy|14
6909119|NCT00724867|10933279|FG000|Overall Study|Lost to Follow-up|12
6909120|NCT00724867|10933279|FG000|Overall Study|Non-compliance with study drug|6
6909121|NCT00724867|10933279|FG000|Overall Study|Physician Decision|17
6909122|NCT00724867|10933279|FG000|Overall Study|Protocol Violation|1
6909123|NCT00724867|10933279|FG000|Overall Study|Withdrawal by Subject|31
6909124|NCT00724867|10933279|FG000|Overall Study|Sponsor decision to end study|14
6909125|NCT00724867|10933279|FG000|Overall Study|Subject incarcerated|1
6909126|NCT00724867|10933279|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4
6909127|NCT00724867|10933279|FG000|Overall Study|Subject moved out of state|1
6909128|NCT00724867|10933279|FG000|Overall Study|Elected to exit due to site closure|2
6909129|NCT00724893|10933288|FG000|Overall Study|Adverse Event|76
6909130|NCT00724893|10933289|FG001|Overall Study|Adverse Event|142
6909131|NCT00724893|10933288|FG000|Overall Study|Withdrawal by Subject|0
6909132|NCT00724893|10933289|FG001|Overall Study|Withdrawal by Subject|1
6909133|NCT00724893|10933288|FG000|Overall Study|Lack of virologic response|94
6909134|NCT00724893|10933289|FG001|Overall Study|Lack of virologic response|202
6909135|NCT00724893|10933288|FG000|Overall Study|Reason not specified|193
6909136|NCT00724893|10933289|FG001|Overall Study|Reason not specified|7
6909137|NCT00724893|10933288|FG000|Overall Study|Patient choice|0
6909138|NCT00724893|10933289|FG001|Overall Study|Patient choice|26
6909139|NCT00724893|10933288|FG000|Overall Study|Geographic reasons|0
6909140|NCT00724893|10933289|FG001|Overall Study|Geographic reasons|11
6909141|NCT00724893|10933288|FG000|Overall Study|Incarceration|0
6909142|NCT00724893|10933289|FG001|Overall Study|Incarceration|9
6909143|NCT00724893|10933288|FG000|Overall Study|Substance abuse|0
6909144|NCT00724893|10933289|FG001|Overall Study|Substance abuse|3
6909145|NCT00724893|10933288|FG000|Overall Study|Financial reasons|0
6909146|NCT00724893|10933289|FG001|Overall Study|Financial reasons|2
6909147|NCT00724893|10933288|FG000|Overall Study|Assigned shorter treatment|0
6909148|NCT00724893|10933289|FG001|Overall Study|Assigned shorter treatment|2
6909149|NCT00724893|10933288|FG000|Overall Study|Lost to Follow-up|0
6909150|NCT00724893|10933289|FG001|Overall Study|Lost to Follow-up|52
6909151|NCT00724893|10933288|FG000|Overall Study|Unknown, missing data|1
6909152|NCT00724893|10933289|FG001|Overall Study|Unknown, missing data|1
6909153|NCT00724932|10933312|FG000|Overall Study|Lost to Follow-up|1
6909154|NCT00724932|10933313|FG001|Overall Study|Lost to Follow-up|0
6909155|NCT00724932|10933312|FG000|Overall Study|Not treated|4
6909156|NCT00724932|10933313|FG001|Overall Study|Not treated|3
6909157|NCT00724945|10933321|FG000|Period 1|non-compliance|1
6909158|NCT00724945|10933322|FG001|Period 1|non-compliance|0
6909159|NCT00724945|10933321|FG000|Period 1|Adverse Event|1
6909160|NCT00724945|10933322|FG001|Period 1|Adverse Event|1
6909161|NCT00724945|10933321|FG000|Period 1|Lost to Follow-up|1
6909162|NCT00724945|10933322|FG001|Period 1|Lost to Follow-up|0
6909163|NCT00724945|10933321|FG000|Period 2|lens comfort issue|3
6909164|NCT00724945|10933322|FG001|Period 2|lens comfort issue|0
6909165|NCT00724945|10933321|FG000|Period 2|lens physiology issue|1
6909166|NCT00724945|10933322|FG001|Period 2|lens physiology issue|0
6909167|NCT00724958|10933328|FG000|Overall Study|Adverse Event|28
6909168|NCT00724958|10933328|FG000|Overall Study|Loss of Response|40
6909169|NCT00724958|10933328|FG000|Overall Study|No Response|18
6909170|NCT00724958|10933328|FG000|Overall Study|Remission|7
6909171|NCT00724958|10933328|FG000|Overall Study|Other Reason|76
6909172|NCT00724958|10933328|FG000|Overall Study|No documentation for end of therapy|13
6909173|NCT00724971|10933332|FG000|Overall Study|Adverse Event|5
6909174|NCT00724971|10933332|FG000|Overall Study|Withdrawal by Subject|1
6909175|NCT00725010|10933361|FG000|Overall Study|Toxicity|9
6909176|NCT00725010|10933361|FG000|Overall Study|Tumor Progression|7
6909177|NCT00725010|10933361|FG000|Overall Study|Withdrawal by Subject|2
6909178|NCT00725010|10933361|FG000|Overall Study|Death|1
6909179|NCT00725010|10933361|FG000|Overall Study|Lost to Follow-up|1
6909180|NCT00725010|10933361|FG000|Overall Study|Hepatopathy probably not Temodal-related|1
6909181|NCT00725010|10933361|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1
6909182|NCT00725010|10933361|FG000|Overall Study|No further documentation|1
6909183|NCT00725010|10933361|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2
6909184|NCT00725075|10933370|FG000|Overall Study|Use of Excluded Medication|0
6909185|NCT00725075|10933371|FG001|Overall Study|Use of Excluded Medication|1
6909186|NCT00725075|10933372|FG002|Overall Study|Use of Excluded Medication|0
6909187|NCT00725075|10933370|FG000|Overall Study|Protocol Violation|0
6909188|NCT00725075|10933371|FG001|Overall Study|Protocol Violation|0
6909189|NCT00725075|10933372|FG002|Overall Study|Protocol Violation|1
6909190|NCT00725075|10933370|FG000|Overall Study|Lost to Follow-up|1
6909191|NCT00725075|10933371|FG001|Overall Study|Lost to Follow-up|0
6909192|NCT00725075|10933372|FG002|Overall Study|Lost to Follow-up|0
6909193|NCT00725075|10933370|FG000|Overall Study|Withdrawal by Subject|4
6909194|NCT00725075|10933371|FG001|Overall Study|Withdrawal by Subject|5
6909195|NCT00725075|10933372|FG002|Overall Study|Withdrawal by Subject|4
6909196|NCT00725075|10933370|FG000|Overall Study|Adverse Event|2
6909197|NCT00725075|10933371|FG001|Overall Study|Adverse Event|1
6909198|NCT00725075|10933372|FG002|Overall Study|Adverse Event|1
6909199|NCT00725075|10933370|FG000|Overall Study|Worsening of Disease|2
6909200|NCT00725075|10933371|FG001|Overall Study|Worsening of Disease|1
6909201|NCT00725075|10933372|FG002|Overall Study|Worsening of Disease|2
6909202|NCT00725075|10933370|FG000|Overall Study|Inclusion/Exclusion Criteria|1
6909203|NCT00725075|10933371|FG001|Overall Study|Inclusion/Exclusion Criteria|0
6909204|NCT00725075|10933372|FG002|Overall Study|Inclusion/Exclusion Criteria|1
6909205|NCT00725075|10933370|FG000|Overall Study|Other|1
6909206|NCT00725075|10933371|FG001|Overall Study|Other|0
6909207|NCT00725075|10933372|FG002|Overall Study|Other|0
6909208|NCT00725101|10933380|FG000|Overall Study|Death|3
6909209|NCT00725101|10933380|FG000|Overall Study|Lost to Follow-up|353
6909210|NCT00725101|10933380|FG000|Overall Study|Protocol Violation|1
6909211|NCT00725101|10933380|FG000|Overall Study|Withdrawal by Subject|127
6909212|NCT00725101|10933380|FG000|Overall Study|not specified/no reason given|11
6909213|NCT00725205|10933391|FG000|Overall Study|Adverse Event|22
6909214|NCT00725205|10933391|FG000|Overall Study|Investigator Discontinued|1
6909215|NCT00725205|10933391|FG000|Overall Study|Non-compliance With Protocol|14
6909216|NCT00725205|10933391|FG000|Overall Study|Other|8
6909217|NCT00725205|10933391|FG000|Overall Study|Protocol Defined Clinical Event|1
6909218|NCT00725205|10933391|FG000|Overall Study|Treatment Failure|41
6909219|NCT00725283|10933404|FG000|Overall Study|Missing Code|3
6909220|NCT00725283|10933404|FG000|Overall Study|Death|5
6909221|NCT00725283|10933404|FG000|Overall Study|Other|6
6909222|NCT00725283|10933404|FG000|Overall Study|Withdrawal by Subject|10
6909223|NCT00725296|10933408|FG000|Overall Study|Adverse Event|11
6909224|NCT00725296|10933408|FG000|Overall Study|Lack of Efficacy|7
6909225|NCT00725296|10933408|FG000|Overall Study|Withdrawal by Subject|3
6909226|NCT00725296|10933408|FG000|Overall Study|Non-Compliance|2
6909227|NCT00725296|10933408|FG000|Overall Study|Lost to Follow-up|1
6909228|NCT00725296|10933408|FG000|Overall Study|Other|38
6909229|NCT00725322|10933415|FG000|Washout (28 Days)|Withdrawal by Subject|2
6909230|NCT00725322|10933416|FG001|Washout (28 Days)|Withdrawal by Subject|0
6909231|NCT00725322|10933415|FG000|Washout (28 Days)|Protocol Violation|0
6909232|NCT00725322|10933416|FG001|Washout (28 Days)|Protocol Violation|1
6909233|NCT00725452|10933426|FG000|Overall Study|Adverse Event|3
6909234|NCT00725452|10933426|FG000|Overall Study|Lack of Efficacy|2
6909235|NCT00725452|10933426|FG000|Overall Study|Reason not specified|1
6909236|NCT00725452|10933426|FG000|Overall Study|Physician Decision|1
6909237|NCT00725452|10933426|FG000|Overall Study|Withdrawal by Subject|3
6909238|NCT00725452|10933426|FG000|Overall Study|Lost to Follow-up|1
6909239|NCT00725543|10933444|FG000|Overall Study|Adverse Event|10
6909240|NCT00725543|10933444|FG000|Overall Study|Lack of Efficacy|3
6909241|NCT00725543|10933444|FG000|Overall Study|Withdrawal by Subject|10
6909242|NCT00725543|10933444|FG000|Overall Study|Physician Decision|5
6909243|NCT00725543|10933444|FG000|Overall Study|Lost to Follow-up|4
6909244|NCT00725543|10933444|FG000|Overall Study|Non-compliance|2
6909245|NCT00725543|10933444|FG000|Overall Study|Other|119
6909246|NCT00725608|10933448|FG000|Overall Study|Lost to Follow-up|60
6909247|NCT00725608|10933448|FG000|Overall Study|Adverse Event|14
6909248|NCT00725608|10933448|FG000|Overall Study|Individual reasons|86
6909249|NCT00725608|10933448|FG000|Overall Study|Other|7
6909250|NCT00725621|10933452|FG000|Overall Study|Adverse Event|25
6909251|NCT00725621|10933452|FG000|Overall Study|Lack of Efficacy|46
6909252|NCT00725621|10933452|FG000|Overall Study|Withdrawal by Subject|57
6909253|NCT00725621|10933452|FG000|Overall Study|Physician Decision|19
6909254|NCT00725621|10933452|FG000|Overall Study|Lost to Follow-up|52
6909255|NCT00725621|10933452|FG000|Overall Study|Non-compliance|8
6909256|NCT00725621|10933452|FG000|Overall Study|Continued treatment by other physician|6
6909257|NCT00725621|10933452|FG000|Overall Study|Switched to other study|1
6909258|NCT00725621|10933452|FG000|Overall Study|Switched to other drug|1
6909259|NCT00725621|10933452|FG000|Overall Study|Prepared for elective surgery|1
6909260|NCT00725621|10933452|FG000|Overall Study|Reason not specified|55
6909261|NCT00725712|10933462|FG000|Overall Study|Withdrawal by Subject|2
6909262|NCT00725712|10933463|FG001|Overall Study|Withdrawal by Subject|1
6909263|NCT00725712|10933462|FG000|Overall Study|Protocol Violation|1
6909264|NCT00725712|10933463|FG001|Overall Study|Protocol Violation|0
6909265|NCT00725712|10933462|FG000|Overall Study|Progressive disease|37
6909266|NCT00725712|10933463|FG001|Overall Study|Progressive disease|16
6909267|NCT00725712|10933462|FG000|Overall Study|Clinical progression not based on RECIST|0
6909268|NCT00725712|10933463|FG001|Overall Study|Clinical progression not based on RECIST|3
6909269|NCT00725712|10933462|FG000|Overall Study|Adverse Event|5
6909270|NCT00725712|10933463|FG001|Overall Study|Adverse Event|5
6909271|NCT00725712|10933462|FG000|Overall Study|Death|2
6909272|NCT00725712|10933463|FG001|Overall Study|Death|0
6909273|NCT00725712|10933462|FG000|Overall Study|Other: Death|1
6909274|NCT00725712|10933463|FG001|Overall Study|Other: Death|0
6978795|NCT01214720|11032366|FG001|Overall Study|Alive and still on treatment|18
6978796|NCT01214720|11032365|FG000|Overall Study|Alive and in follow-up|45
6978797|NCT01214720|11032366|FG001|Overall Study|Alive and in follow-up|48
6978798|NCT01214720|11032365|FG000|Overall Study|Lost to Follow-up|6
6978799|NCT01214720|11032366|FG001|Overall Study|Lost to Follow-up|2
6978800|NCT01214837|11032388|FG000|Overall Study|Death|0
6978801|NCT01214837|11032389|FG001|Overall Study|Death|0
6978802|NCT01214837|11032390|FG002|Overall Study|Death|1
6978803|NCT01214837|11032388|FG000|Overall Study|Adverse Event|1
6978804|NCT01214837|11032389|FG001|Overall Study|Adverse Event|2
6978805|NCT01214837|11032390|FG002|Overall Study|Adverse Event|1
6978806|NCT01214837|11032388|FG000|Overall Study|Withdrawal by Subject|27
6978807|NCT01214837|11032389|FG001|Overall Study|Withdrawal by Subject|36
6978808|NCT01214837|11032390|FG002|Overall Study|Withdrawal by Subject|28
6978809|NCT01214837|11032388|FG000|Overall Study|Lost to Follow-up|20
6978810|NCT01214837|11032389|FG001|Overall Study|Lost to Follow-up|15
6978811|NCT01214837|11032390|FG002|Overall Study|Lost to Follow-up|21
6978812|NCT01214837|11032388|FG000|Overall Study|Inappropriate Enrolment|0
6978813|NCT01214837|11032389|FG001|Overall Study|Inappropriate Enrolment|1
6978814|NCT01214837|11032390|FG002|Overall Study|Inappropriate Enrolment|2
6978815|NCT01214837|11032388|FG000|Overall Study|Administrative Reason|2
6978816|NCT01214837|11032389|FG001|Overall Study|Administrative Reason|6
6978817|NCT01214837|11032390|FG002|Overall Study|Administrative Reason|4
6909275|NCT00725712|10933462|FG000|Overall Study|Hospitalized, unable to continue|0
6978818|NCT01214837|11032388|FG000|Overall Study|Protocol Violation|3
6978819|NCT01214837|11032389|FG001|Overall Study|Protocol Violation|1
6978820|NCT01214837|11032390|FG002|Overall Study|Protocol Violation|5
6978821|NCT01214837|11032388|FG000|Overall Study|Unable to Classify|1
6909276|NCT00725712|10933463|FG001|Overall Study|Hospitalized, unable to continue|1
6909277|NCT00725725|10933476|FG000|Overall Study|Adverse Event|1
6909278|NCT00725725|10933477|FG001|Overall Study|Adverse Event|3
6909279|NCT00725725|10933478|FG002|Overall Study|Adverse Event|2
6909280|NCT00725725|10933476|FG000|Overall Study|Lost to Follow-up|2
6909281|NCT00725725|10933477|FG001|Overall Study|Lost to Follow-up|0
6909282|NCT00725725|10933478|FG002|Overall Study|Lost to Follow-up|2
6909283|NCT00725725|10933476|FG000|Overall Study|Withdrawal by Subject|1
6909284|NCT00725725|10933477|FG001|Overall Study|Withdrawal by Subject|0
6909285|NCT00725725|10933478|FG002|Overall Study|Withdrawal by Subject|1
6909286|NCT00725725|10933476|FG000|Overall Study|Protocol Violation|0
6909287|NCT00725725|10933477|FG001|Overall Study|Protocol Violation|1
6909288|NCT00725725|10933478|FG002|Overall Study|Protocol Violation|0
6909289|NCT00725764|10933496|FG000|Overall Study|Withdrawal by Subject|2
6909290|NCT00725764|10933496|FG000|Overall Study|Physician Decision|1
6909291|NCT00725764|10933496|FG000|Overall Study|Progressive Disease|7
6909292|NCT00725764|10933496|FG000|Overall Study|Lost to Follow-up|1
6909293|NCT00725764|10933496|FG000|Overall Study|Death|1
6909294|NCT00725764|10933496|FG000|Overall Study|Participant non compliant with protocol|1
6909295|NCT00725764|10933496|FG000|Overall Study|Decline in performance status|1
6909296|NCT00725842|10933501|FG000|Overall Study|Lost to Follow-up|19
6909297|NCT00725842|10933501|FG000|Overall Study|Death|1
6909298|NCT00725842|10933501|FG000|Overall Study|Positive HCV-RNA at Visit 2|13
6909299|NCT00725842|10933501|FG000|Overall Study|Consent date prior to study start date|5
6909300|NCT00725842|10933501|FG000|Overall Study|Inclusion criterion not met|1
6909301|NCT00725842|10933501|FG000|Overall Study|No Visit 1 data|1
6909302|NCT00725920|10933507|FG000|Overall Study|Lack of Efficacy|3
6909303|NCT00725920|10933508|FG001|Overall Study|Lack of Efficacy|6
6909304|NCT00726232|10933529|FG000|Initial Phase (Dose-finding)|Death|0
6909305|NCT00726232|10933530|FG001|Initial Phase (Dose-finding)|Death|0
6909306|NCT00726232|10933531|FG002|Initial Phase (Dose-finding)|Death|0
6909307|NCT00726232|10933532|FG003|Initial Phase (Dose-finding)|Death|0
6909308|NCT00726232|10933533|FG004|Initial Phase (Dose-finding)|Death|1
6909309|NCT00726232|10933534|FG005|Initial Phase (Dose-finding)|Death|0
6909310|NCT00726232|10933535|FG006|Initial Phase (Dose-finding)|Death|0
6909311|NCT00726232|10933536|FG007|Initial Phase (Dose-finding)|Death|0
6909312|NCT00726232|10933529|FG000|Initial Phase (Dose-finding)|Adverse Event|2
6909313|NCT00726232|10933530|FG001|Initial Phase (Dose-finding)|Adverse Event|2
6909314|NCT00726232|10933531|FG002|Initial Phase (Dose-finding)|Adverse Event|2
6909315|NCT00726232|10933532|FG003|Initial Phase (Dose-finding)|Adverse Event|1
6909316|NCT00726232|10933533|FG004|Initial Phase (Dose-finding)|Adverse Event|7
6909317|NCT00726232|10933534|FG005|Initial Phase (Dose-finding)|Adverse Event|3
6909318|NCT00726232|10933535|FG006|Initial Phase (Dose-finding)|Adverse Event|0
6909319|NCT00726232|10933536|FG007|Initial Phase (Dose-finding)|Adverse Event|0
6909320|NCT00726232|10933529|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2
6909321|NCT00726232|10933530|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0
6909322|NCT00726232|10933531|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0
6909323|NCT00726232|10933532|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1
6909324|NCT00726232|10933533|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0
6909325|NCT00726232|10933534|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2
6909326|NCT00726232|10933535|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0
6909327|NCT00726232|10933536|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0
6909328|NCT00726232|10933529|FG000|Initial Phase (Dose-finding)|Disease progression|3
6909329|NCT00726232|10933530|FG001|Initial Phase (Dose-finding)|Disease progression|1
6909330|NCT00726232|10933531|FG002|Initial Phase (Dose-finding)|Disease progression|0
6909331|NCT00726232|10933532|FG003|Initial Phase (Dose-finding)|Disease progression|0
6909332|NCT00726232|10933533|FG004|Initial Phase (Dose-finding)|Disease progression|0
6909333|NCT00726232|10933534|FG005|Initial Phase (Dose-finding)|Disease progression|0
6909334|NCT00726232|10933535|FG006|Initial Phase (Dose-finding)|Disease progression|0
6909335|NCT00726232|10933536|FG007|Initial Phase (Dose-finding)|Disease progression|0
6909336|NCT00726232|10933529|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4
6909337|NCT00726232|10933530|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
6909338|NCT00726232|10933531|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
6909339|NCT00726232|10933532|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4
6909340|NCT00726232|10933533|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9
6909341|NCT00726232|10933534|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
6909342|NCT00726232|10933535|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0
6909343|NCT00726232|10933536|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0
6909344|NCT00726232|10933529|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1
6909345|NCT00726232|10933530|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
6909346|NCT00726232|10933531|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
6909347|NCT00726232|10933532|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2
6909348|NCT00726232|10933533|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4
6909349|NCT00726232|10933534|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1
6909350|NCT00726232|10933535|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
6977140|NCT01205126|11030145|FG000|Maintenance Phase|Other|11
6909351|NCT00726232|10933536|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
6909352|NCT00726232|10933529|FG000|Initial Phase (Dose-finding)|Unspecified reason|1
6909353|NCT00726232|10933530|FG001|Initial Phase (Dose-finding)|Unspecified reason|0
6909354|NCT00726232|10933531|FG002|Initial Phase (Dose-finding)|Unspecified reason|0
6909355|NCT00726232|10933532|FG003|Initial Phase (Dose-finding)|Unspecified reason|0
6909356|NCT00726232|10933533|FG004|Initial Phase (Dose-finding)|Unspecified reason|0
6909357|NCT00726232|10933534|FG005|Initial Phase (Dose-finding)|Unspecified reason|0
6909358|NCT00726232|10933535|FG006|Initial Phase (Dose-finding)|Unspecified reason|0
6909359|NCT00726232|10933536|FG007|Initial Phase (Dose-finding)|Unspecified reason|0
6909360|NCT00726232|10933529|FG000|Expansion Phase|Death|0
6909361|NCT00726232|10933530|FG001|Expansion Phase|Death|0
6909362|NCT00726232|10933531|FG002|Expansion Phase|Death|0
6909363|NCT00726232|10933532|FG003|Expansion Phase|Death|0
6909364|NCT00726232|10933533|FG004|Expansion Phase|Death|0
6909365|NCT00726232|10933534|FG005|Expansion Phase|Death|0
6909366|NCT00726232|10933535|FG006|Expansion Phase|Death|0
6909367|NCT00726232|10933536|FG007|Expansion Phase|Death|1
6909368|NCT00726232|10933529|FG000|Expansion Phase|Adverse Event|0
6909369|NCT00726232|10933530|FG001|Expansion Phase|Adverse Event|0
6909370|NCT00726232|10933531|FG002|Expansion Phase|Adverse Event|0
6909371|NCT00726232|10933532|FG003|Expansion Phase|Adverse Event|0
6909372|NCT00726232|10933533|FG004|Expansion Phase|Adverse Event|0
6909373|NCT00726232|10933534|FG005|Expansion Phase|Adverse Event|0
6909374|NCT00726232|10933535|FG006|Expansion Phase|Adverse Event|6
6909375|NCT00726232|10933536|FG007|Expansion Phase|Adverse Event|11
6909376|NCT00726232|10933529|FG000|Expansion Phase|Withdrawal by Subject|0
6909377|NCT00726232|10933530|FG001|Expansion Phase|Withdrawal by Subject|0
6909378|NCT00726232|10933531|FG002|Expansion Phase|Withdrawal by Subject|0
6909379|NCT00726232|10933532|FG003|Expansion Phase|Withdrawal by Subject|0
6909380|NCT00726232|10933533|FG004|Expansion Phase|Withdrawal by Subject|0
6909381|NCT00726232|10933534|FG005|Expansion Phase|Withdrawal by Subject|0
6909382|NCT00726232|10933535|FG006|Expansion Phase|Withdrawal by Subject|2
6909383|NCT00726232|10933536|FG007|Expansion Phase|Withdrawal by Subject|3
6909384|NCT00726232|10933529|FG000|Expansion Phase|Disease progression|0
6909385|NCT00726232|10933530|FG001|Expansion Phase|Disease progression|0
6909386|NCT00726232|10933531|FG002|Expansion Phase|Disease progression|0
6909387|NCT00726232|10933532|FG003|Expansion Phase|Disease progression|0
6909388|NCT00726232|10933533|FG004|Expansion Phase|Disease progression|0
6909389|NCT00726232|10933534|FG005|Expansion Phase|Disease progression|0
6909390|NCT00726232|10933535|FG006|Expansion Phase|Disease progression|4
6909391|NCT00726232|10933536|FG007|Expansion Phase|Disease progression|0
6909392|NCT00726232|10933529|FG000|Expansion Phase|Termination of the trial by sponsor|0
6909393|NCT00726232|10933530|FG001|Expansion Phase|Termination of the trial by sponsor|0
6909394|NCT00726232|10933531|FG002|Expansion Phase|Termination of the trial by sponsor|0
6909395|NCT00726232|10933532|FG003|Expansion Phase|Termination of the trial by sponsor|0
6909396|NCT00726232|10933533|FG004|Expansion Phase|Termination of the trial by sponsor|0
6909397|NCT00726232|10933534|FG005|Expansion Phase|Termination of the trial by sponsor|0
6909398|NCT00726232|10933535|FG006|Expansion Phase|Termination of the trial by sponsor|10
6909399|NCT00726232|10933536|FG007|Expansion Phase|Termination of the trial by sponsor|16
6909400|NCT00726232|10933529|FG000|Expansion Phase|Per Investigator: lack of response|0
6909401|NCT00726232|10933530|FG001|Expansion Phase|Per Investigator: lack of response|0
6909402|NCT00726232|10933531|FG002|Expansion Phase|Per Investigator: lack of response|0
6909403|NCT00726232|10933532|FG003|Expansion Phase|Per Investigator: lack of response|0
6909404|NCT00726232|10933533|FG004|Expansion Phase|Per Investigator: lack of response|0
6909405|NCT00726232|10933534|FG005|Expansion Phase|Per Investigator: lack of response|0
6909406|NCT00726232|10933535|FG006|Expansion Phase|Per Investigator: lack of response|1
6909407|NCT00726232|10933536|FG007|Expansion Phase|Per Investigator: lack of response|7
6909408|NCT00726232|10933529|FG000|Expansion Phase|Unspecified reason|0
6909409|NCT00726232|10933530|FG001|Expansion Phase|Unspecified reason|0
6909410|NCT00726232|10933531|FG002|Expansion Phase|Unspecified reason|0
6909411|NCT00726232|10933532|FG003|Expansion Phase|Unspecified reason|0
6909412|NCT00726232|10933533|FG004|Expansion Phase|Unspecified reason|0
6909413|NCT00726232|10933534|FG005|Expansion Phase|Unspecified reason|0
6909414|NCT00726232|10933535|FG006|Expansion Phase|Unspecified reason|1
6909415|NCT00726232|10933536|FG007|Expansion Phase|Unspecified reason|0
6909416|NCT00726323|10933557|FG000|Overall Study|Withdrawal by Subject|3
6909417|NCT00726323|10933558|FG001|Overall Study|Withdrawal by Subject|1
6909418|NCT00726323|10933557|FG000|Overall Study|Physician Decision|1
6909419|NCT00726323|10933558|FG001|Overall Study|Physician Decision|0
6909420|NCT00726323|10933557|FG000|Overall Study|Progressive disease|23
6909421|NCT00726323|10933558|FG001|Overall Study|Progressive disease|16
6909422|NCT00726323|10933557|FG000|Overall Study|Clinical progression|0
6909423|NCT00726323|10933558|FG001|Overall Study|Clinical progression|3
6909424|NCT00726323|10933557|FG000|Overall Study|Adverse Event|9
6909425|NCT00726323|10933558|FG001|Overall Study|Adverse Event|9
6909426|NCT00726323|10933557|FG000|Overall Study|Death|1
6909427|NCT00726323|10933558|FG001|Overall Study|Death|0
6909428|NCT00726323|10933557|FG000|Overall Study|Participant wished to discontinue|0
6909429|NCT00726323|10933558|FG001|Overall Study|Participant wished to discontinue|1
6909430|NCT00726323|10933557|FG000|Overall Study|Metastatic lesions inferred cyst|0
6909431|NCT00726323|10933558|FG001|Overall Study|Metastatic lesions inferred cyst|1
6909432|NCT00726388|10933568|FG000|Overall Study|Withdrawal by Subject|5
6909433|NCT00726388|10933568|FG000|Overall Study|Adverse Event|3
6909434|NCT00726388|10933568|FG000|Overall Study|Lost to Follow-up|10
6909435|NCT00726388|10933568|FG000|Overall Study|Participants Non-compliant With Study Procedures|5
6909436|NCT00726388|10933568|FG000|Overall Study|Other|5
6909437|NCT00726388|10933568|FG000|Overall Study|Enrolled, Not Treated|79
6909438|NCT00726453|10933581|FG000|Primary Enrollment Group|Death|18
6909439|NCT00726453|10933582|FG001|Primary Enrollment Group|Death|0
6909440|NCT00726453|10933581|FG000|Primary Enrollment Group|Withdrawal by Subject|13
6909441|NCT00726453|10933582|FG001|Primary Enrollment Group|Withdrawal by Subject|0
6909442|NCT00726453|10933581|FG000|38 mm Length Group|Death|0
6909443|NCT00726453|10933582|FG001|38 mm Length Group|Death|3
6909444|NCT00726557|10933587|FG000|Overall Study|Screening failure|4
6909445|NCT00726557|10933587|FG000|Overall Study|No end of treatment documentation|37
6909446|NCT00726557|10933587|FG000|Overall Study|No follow-up documentation available|55
6909447|NCT00726557|10933587|FG000|Overall Study|Treatment less than 3 months|17
6909448|NCT00726557|10933587|FG000|Overall Study|Inclusion criteria not met|15
6909449|NCT00726609|10933592|FG000|Overall Study|Adverse Event|10
6909450|NCT00726609|10933592|FG000|Overall Study|Withdrawal by Subject|2
6909451|NCT00726609|10933592|FG000|Overall Study|Lack of Efficacy|25
6909452|NCT00726609|10933592|FG000|Overall Study|Other|16
6909453|NCT00726609|10933592|FG000|Overall Study|Missing|42
6909454|NCT00726609|10933592|FG000|Overall Study|Other|3
6909455|NCT00726622|10933598|FG000|Overall Study|Withdrawal by Subject|16
6909456|NCT00726622|10933599|FG001|Overall Study|Withdrawal by Subject|2
6909457|NCT00726622|10933598|FG000|Overall Study|Physician Decision|0
6909458|NCT00726622|10933599|FG001|Overall Study|Physician Decision|1
6909459|NCT00726622|10933598|FG000|Overall Study|Metastasis|2
6909460|NCT00726622|10933599|FG001|Overall Study|Metastasis|0
6909461|NCT00726661|10933607|FG000|Overall Study|Lost to Follow-up|36
6909462|NCT00726661|10933608|FG001|Overall Study|Lost to Follow-up|11
6909463|NCT00726661|10933607|FG000|Overall Study|Withdrawal by Subject|17
6909464|NCT00726661|10933608|FG001|Overall Study|Withdrawal by Subject|13
6909465|NCT00726661|10933607|FG000|Overall Study|Trial terminated by sponsor|214
6909466|NCT00726661|10933608|FG001|Overall Study|Trial terminated by sponsor|187
6909467|NCT00726661|10933607|FG000|Overall Study|Death|475
6909468|NCT00726661|10933608|FG001|Overall Study|Death|159
6909469|NCT00726661|10933607|FG000|Overall Study|Physician Decision|25
6909470|NCT00726661|10933608|FG001|Overall Study|Physician Decision|13
6909471|NCT00726661|10933607|FG000|Overall Study|Other|47
6909472|NCT00726661|10933608|FG001|Overall Study|Other|35
6909473|NCT00726752|10933635|FG000|Overall Study|Lack of Efficacy|6
6909474|NCT00726882|10933639|FG000|Overall Study|Withdrawal by Subject|5
6909475|NCT00726882|10933639|FG000|Overall Study|Lost to Follow-up|7
6909476|NCT00726882|10933639|FG000|Overall Study|Other|10
6909477|NCT00726895|10933645|FG000|Washout Period of 7 Days|Withdrawal by Subject|0
6909478|NCT00726895|10933646|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
6909479|NCT00726986|10933653|FG000|Induction Phase|Adverse Event|4
6909480|NCT00726986|10933653|FG000|Induction Phase|Withdrawal by Subject|2
6909481|NCT00726986|10933653|FG000|Induction Phase|Death|2
6909482|NCT00726986|10933653|FG000|Induction Phase|Lack of Efficacy|5
6909483|NCT00726986|10933653|FG000|Induction Phase|Secondary Disease|2
6909484|NCT00726986|10933653|FG000|Maintenance Phase|Adverse Event|1
6909485|NCT00726986|10933653|FG000|Maintenance Phase|Lack of Efficacy|2
6909486|NCT00726999|10933659|FG000|Overall Study|Physician Decision|0
6909487|NCT00726999|10933660|FG001|Overall Study|Physician Decision|1
6909488|NCT00726999|10933659|FG000|Overall Study|Withdrawal by Subject|2
6909489|NCT00726999|10933660|FG001|Overall Study|Withdrawal by Subject|0
6909490|NCT00726999|10933659|FG000|Overall Study|Protocol Violation|1
6909491|NCT00726999|10933660|FG001|Overall Study|Protocol Violation|0
6909492|NCT00727025|10933668|FG000|Overall Study|Physician Decision|23
6909493|NCT00727194|10933685|FG000|Screening Period|Low QMG scores|0
6909494|NCT00727194|10933686|FG001|Screening Period|Low QMG scores|0
6909495|NCT00727194|10933687|FG002|Screening Period|Low QMG scores|6
6909496|NCT00727194|10933685|FG000|Screening Period|Lacked AChR antibodies|0
6909497|NCT00727194|10933686|FG001|Screening Period|Lacked AChR antibodies|0
6909498|NCT00727194|10933687|FG002|Screening Period|Lacked AChR antibodies|5
6909499|NCT00727194|10933685|FG000|Screening Period|Not stable on concomitant MG therapy|0
6909500|NCT00727194|10933686|FG001|Screening Period|Not stable on concomitant MG therapy|0
6909501|NCT00727194|10933687|FG002|Screening Period|Not stable on concomitant MG therapy|2
6909502|NCT00727194|10933685|FG000|Screening Period|Severe infections|0
6909503|NCT00727194|10933686|FG001|Screening Period|Severe infections|0
6909504|NCT00727194|10933687|FG002|Screening Period|Severe infections|2
6909505|NCT00727194|10933685|FG000|Screening Period|History of thymoma|0
6909506|NCT00727194|10933686|FG001|Screening Period|History of thymoma|0
6909507|NCT00727194|10933687|FG002|Screening Period|History of thymoma|1
6909508|NCT00727194|10933685|FG000|Treatment Period 2|Lack of Efficacy|0
6909509|NCT00727194|10933686|FG001|Treatment Period 2|Lack of Efficacy|1
6909510|NCT00727194|10933687|FG002|Treatment Period 2|Lack of Efficacy|0
6909511|NCT00727246|10933714|FG000|Overall Study|could not complete MRI|0
6909512|NCT00727246|10933715|FG001|Overall Study|could not complete MRI|1
6909513|NCT00727246|10933716|FG002|Overall Study|could not complete MRI|0
6909514|NCT00727246|10933717|FG003|Overall Study|could not complete MRI|1
6909515|NCT00727246|10933714|FG000|Overall Study|incidental finding|0
6909516|NCT00727246|10933715|FG001|Overall Study|incidental finding|0
6909517|NCT00727246|10933716|FG002|Overall Study|incidental finding|0
6909518|NCT00727246|10933717|FG003|Overall Study|incidental finding|1
6909519|NCT00727246|10933714|FG000|Overall Study|withdrawn|0
6909520|NCT00727246|10933715|FG001|Overall Study|withdrawn|0
6909521|NCT00727246|10933716|FG002|Overall Study|withdrawn|1
6909522|NCT00727246|10933717|FG003|Overall Study|withdrawn|0
6909523|NCT00727259|10933727|FG000|Overall Study|Not all questionnaires completed|1055
6909524|NCT00727272|10933732|FG000|Washout Period A|Adverse Event|0
6909525|NCT00727272|10933733|FG001|Washout Period A|Adverse Event|0
6909526|NCT00727272|10933734|FG002|Washout Period A|Adverse Event|1
6909527|NCT00727272|10933732|FG000|Washout Period B|Withdrawal by Subject|0
6909528|NCT00727272|10933733|FG001|Washout Period B|Withdrawal by Subject|0
6909529|NCT00727272|10933734|FG002|Washout Period B|Withdrawal by Subject|1
6909530|NCT00727311|10933748|FG000|Overall Study|Did not receive drug|316
6909531|NCT00727311|10933748|FG000|Overall Study|Missing end of therapy data|205
6909532|NCT00727311|10933748|FG000|Overall Study|Adverse Event|58
6909533|NCT00727311|10933748|FG000|Overall Study|Lack of Efficacy|242
6909534|NCT00727311|10933748|FG000|Overall Study|Lost to Follow-up|73
6909535|NCT00727311|10933748|FG000|Overall Study|Withdrawal by Subject|77
6909536|NCT00727311|10933748|FG000|Overall Study|Other|97
6909537|NCT00727311|10933748|FG000|Overall Study|Multiple reasons|39
6909538|NCT00727402|10933774|FG000|Overall Study|Physician Decision|116
6909539|NCT00727415|10933778|FG000|Phase I|Dose Limiting Toxicity|2
6909540|NCT00727441|10933785|FG000|Overall Study|Disease Progression|11
6909541|NCT00727441|10933786|FG001|Overall Study|Disease Progression|14
6909542|NCT00727441|10933787|FG002|Overall Study|Disease Progression|17
6909543|NCT00727441|10933785|FG000|Overall Study|Eligibility|7
6909544|NCT00727441|10933786|FG001|Overall Study|Eligibility|5
6909545|NCT00727441|10933787|FG002|Overall Study|Eligibility|7
6909546|NCT00727441|10933785|FG000|Overall Study|Death|0
6909547|NCT00727441|10933786|FG001|Overall Study|Death|1
6909548|NCT00727441|10933787|FG002|Overall Study|Death|1
6909549|NCT00727441|10933785|FG000|Overall Study|Physician Decision|0
6909550|NCT00727441|10933786|FG001|Overall Study|Physician Decision|1
6909551|NCT00727441|10933787|FG002|Overall Study|Physician Decision|0
6909552|NCT00727441|10933785|FG000|Overall Study|Withdrawal by Subject|0
6909553|NCT00727441|10933786|FG001|Overall Study|Withdrawal by Subject|1
6909554|NCT00727441|10933787|FG002|Overall Study|Withdrawal by Subject|0
6909555|NCT00727506|10933804|FG000|Overall Study|Adverse Event|0
6909556|NCT00727506|10933805|FG001|Overall Study|Adverse Event|0
6909557|NCT00727506|10933806|FG002|Overall Study|Adverse Event|4
6909558|NCT00727506|10933807|FG003|Overall Study|Adverse Event|4
6909559|NCT00727506|10933808|FG004|Overall Study|Adverse Event|1
6909560|NCT00727506|10933809|FG005|Overall Study|Adverse Event|8
6909561|NCT00727506|10933804|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2
6909562|NCT00727506|10933805|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0
6909563|NCT00727506|10933806|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2
6909564|NCT00727506|10933807|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0
6909565|NCT00727506|10933808|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0
6909566|NCT00727506|10933809|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0
6909567|NCT00727506|10933804|FG000|Overall Study|Progressive disease|4
6909568|NCT00727506|10933805|FG001|Overall Study|Progressive disease|7
6909569|NCT00727506|10933806|FG002|Overall Study|Progressive disease|9
6909570|NCT00727506|10933807|FG003|Overall Study|Progressive disease|28
6909571|NCT00727506|10933808|FG004|Overall Study|Progressive disease|38
6909572|NCT00727506|10933809|FG005|Overall Study|Progressive disease|28
6909573|NCT00727506|10933804|FG000|Overall Study|Refused to continue medication|0
6909574|NCT00727506|10933805|FG001|Overall Study|Refused to continue medication|1
6909575|NCT00727506|10933806|FG002|Overall Study|Refused to continue medication|2
6909576|NCT00727506|10933807|FG003|Overall Study|Refused to continue medication|3
6909577|NCT00727506|10933808|FG004|Overall Study|Refused to continue medication|1
6909578|NCT00727506|10933809|FG005|Overall Study|Refused to continue medication|2
6909579|NCT00727506|10933804|FG000|Overall Study|Other reason not described above|0
6909580|NCT00727506|10933805|FG001|Overall Study|Other reason not described above|0
6909581|NCT00727506|10933806|FG002|Overall Study|Other reason not described above|1
6909582|NCT00727506|10933807|FG003|Overall Study|Other reason not described above|4
6909583|NCT00727506|10933808|FG004|Overall Study|Other reason not described above|1
6909584|NCT00727506|10933809|FG005|Overall Study|Other reason not described above|1
6909585|NCT00727532|10933829|FG000|Overall Study|Adverse Event|1
6909586|NCT00727532|10933829|FG000|Overall Study|Withdrawal by Subject|1
6909587|NCT00727558|10933835|FG000|Overall Study|Lens issue|0
6909588|NCT00727558|10933836|FG001|Overall Study|Lens issue|1
6909589|NCT00727558|10933835|FG000|Overall Study|Adverse Event|0
6909590|NCT00727558|10933836|FG001|Overall Study|Adverse Event|1
6909591|NCT00727558|10933835|FG000|Overall Study|Subject unable to return for follow-up|1
6909592|NCT00727558|10933836|FG001|Overall Study|Subject unable to return for follow-up|1
6909593|NCT00727558|10933835|FG000|Overall Study|Lost to Follow-up|1
6909594|NCT00727558|10933836|FG001|Overall Study|Lost to Follow-up|0
6909595|NCT00727571|10933846|FG000|Overall Study|Ineligibility determined|1
6909596|NCT00727571|10933847|FG001|Overall Study|Ineligibility determined|1
6909597|NCT00727571|10933848|FG002|Overall Study|Ineligibility determined|1
6909598|NCT00727571|10933849|FG003|Overall Study|Ineligibility determined|0
6909599|NCT00727571|10933846|FG000|Overall Study|Death|0
6909600|NCT00727571|10933847|FG001|Overall Study|Death|19
6909601|NCT00727571|10933848|FG002|Overall Study|Death|5
6909602|NCT00727571|10933849|FG003|Overall Study|Death|1
6909603|NCT00727571|10933846|FG000|Overall Study|Physician Decision|0
6909604|NCT00727571|10933847|FG001|Overall Study|Physician Decision|5
6909605|NCT00727571|10933848|FG002|Overall Study|Physician Decision|0
6909606|NCT00727571|10933849|FG003|Overall Study|Physician Decision|0
6909607|NCT00727571|10933846|FG000|Overall Study|Withdrawal by Subject|0
6909608|NCT00727571|10933847|FG001|Overall Study|Withdrawal by Subject|10
6909609|NCT00727571|10933848|FG002|Overall Study|Withdrawal by Subject|11
6909610|NCT00727571|10933849|FG003|Overall Study|Withdrawal by Subject|0
6909611|NCT00727571|10933846|FG000|Overall Study|Subject Non Compliance|0
6909612|NCT00727571|10933847|FG001|Overall Study|Subject Non Compliance|6
6909613|NCT00727571|10933848|FG002|Overall Study|Subject Non Compliance|0
6909614|NCT00727571|10933849|FG003|Overall Study|Subject Non Compliance|4
6909615|NCT00727571|10933846|FG000|Overall Study|Dismissed from nursing home|0
6909616|NCT00727571|10933847|FG001|Overall Study|Dismissed from nursing home|9
6909617|NCT00727571|10933848|FG002|Overall Study|Dismissed from nursing home|5
6909618|NCT00727571|10933849|FG003|Overall Study|Dismissed from nursing home|0
6909619|NCT00727571|10933846|FG000|Overall Study|Hospitalization|0
6909620|NCT00727571|10933847|FG001|Overall Study|Hospitalization|1
6909621|NCT00727571|10933848|FG002|Overall Study|Hospitalization|0
6909622|NCT00727571|10933849|FG003|Overall Study|Hospitalization|1
6909623|NCT00727571|10933846|FG000|Overall Study|AE not leading to hospitalization|0
6909624|NCT00727571|10933847|FG001|Overall Study|AE not leading to hospitalization|0
6909625|NCT00727571|10933848|FG002|Overall Study|AE not leading to hospitalization|2
6909626|NCT00727571|10933849|FG003|Overall Study|AE not leading to hospitalization|0
6909627|NCT00727571|10933846|FG000|Overall Study|Other|0
6909628|NCT00727571|10933847|FG001|Overall Study|Other|4
6909629|NCT00727571|10933848|FG002|Overall Study|Other|6
6909630|NCT00727571|10933849|FG003|Overall Study|Other|0
6909631|NCT00727649|10933879|FG000|First Intervention (4-weeks)|Lost to Follow-up|1
6909632|NCT00727649|10933880|FG001|First Intervention (4-weeks)|Lost to Follow-up|2
6909633|NCT00727649|10933879|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2
6909634|NCT00727649|10933880|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1
6909635|NCT00727649|10933879|FG000|Wash-out (2-weeks)|Lost to Follow-up|3
6909636|NCT00727649|10933880|FG001|Wash-out (2-weeks)|Lost to Follow-up|1
6909637|NCT00727649|10933879|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1
6909638|NCT00727649|10933880|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2
6909639|NCT00727649|10933879|FG000|Second Intervention (4-weeks)|Death|1
6909640|NCT00727649|10933880|FG001|Second Intervention (4-weeks)|Death|0
6909641|NCT00727649|10933879|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0
6909642|NCT00727649|10933880|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1
6909643|NCT00727649|10933879|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0
6909644|NCT00727649|10933880|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2
6909645|NCT00727714|10933888|FG000|Overall Study|Lost to Follow-up|2
6909646|NCT00727844|10933903|FG000|Initial Randomization|Physician Decision|2
6909647|NCT00727844|10933904|FG001|Initial Randomization|Physician Decision|0
6909648|NCT00727844|10933905|FG002|Initial Randomization|Physician Decision|0
6909649|NCT00727844|10933906|FG003|Initial Randomization|Physician Decision|0
6974058|NCT01185353|11025994|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
6974059|NCT01185353|11025985|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
6974060|NCT01185353|11025986|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
6974061|NCT01185353|11025987|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
6974062|NCT01185353|11025988|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
6974063|NCT01185353|11025989|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
6974064|NCT01185353|11025990|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
6974065|NCT01185353|11025991|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
6974066|NCT01185353|11025992|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2
6974067|NCT01185353|11025993|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
6974068|NCT01185353|11025994|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
6974069|NCT01185353|11025985|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
6974070|NCT01185353|11025986|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
6974071|NCT01185353|11025987|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
6974072|NCT01185353|11025988|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
6974073|NCT01185353|11025989|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
6974074|NCT01185353|11025990|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
6974075|NCT01185353|11025991|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
6974076|NCT01185353|11025992|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
6974077|NCT01185353|11025993|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2
6974078|NCT01185353|11025994|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
6974079|NCT01185353|11025985|FG000|Part C (Weeks 24 Through 76)|Death|0
6974080|NCT01185353|11025986|FG001|Part C (Weeks 24 Through 76)|Death|0
6974081|NCT01185353|11025987|FG002|Part C (Weeks 24 Through 76)|Death|0
6974082|NCT01185353|11025988|FG003|Part C (Weeks 24 Through 76)|Death|0
6974083|NCT01185353|11025989|FG004|Part C (Weeks 24 Through 76)|Death|0
6974084|NCT01185353|11025990|FG005|Part C (Weeks 24 Through 76)|Death|0
6974085|NCT01185353|11025991|FG006|Part C (Weeks 24 Through 76)|Death|0
6974086|NCT01185353|11025992|FG007|Part C (Weeks 24 Through 76)|Death|0
6909650|NCT00727909|10933925|FG000|Overall Study|Withdrawal by Subject|5
6909651|NCT00727909|10933926|FG001|Overall Study|Withdrawal by Subject|11
6909652|NCT00727909|10933927|FG002|Overall Study|Withdrawal by Subject|8
6909653|NCT00727909|10933928|FG003|Overall Study|Withdrawal by Subject|5
6909654|NCT00727909|10933925|FG000|Overall Study|Death|0
6909655|NCT00727909|10933926|FG001|Overall Study|Death|0
6909656|NCT00727909|10933927|FG002|Overall Study|Death|1
6909657|NCT00727909|10933928|FG003|Overall Study|Death|0
6909658|NCT00727961|10933932|FG000|Overall Study|Lost to Follow-up|1
6909659|NCT00727961|10933932|FG000|Overall Study|Adverse Event|4
6909660|NCT00727961|10933932|FG000|Overall Study|Patient's refusal|2
6909661|NCT00727961|10933932|FG000|Overall Study|Progression|30
6909662|NCT00728130|10933936|FG000|Overall Study|Withdrawal by Subject|1
6909663|NCT00728130|10933936|FG000|Overall Study|Paperwork not completed in time|1
6909664|NCT00728130|10933936|FG000|Overall Study|Physician Decision|1
6909665|NCT00728182|10933942|FG000|Overall Study|Adverse Event|1
6909666|NCT00728182|10933943|FG001|Overall Study|Adverse Event|0
6909667|NCT00728182|10933942|FG000|Overall Study|Lost to Follow-up|2
6909668|NCT00728182|10933943|FG001|Overall Study|Lost to Follow-up|0
6909669|NCT00728182|10933942|FG000|Overall Study|Death|0
6909670|NCT00728182|10933943|FG001|Overall Study|Death|2
6909671|NCT00728182|10933942|FG000|Overall Study|Protocol Noncompliance|0
6909672|NCT00728182|10933943|FG001|Overall Study|Protocol Noncompliance|1
6909673|NCT00728468|10933955|FG000|Overall Study|Enrolled but not treated|1
6909674|NCT00728468|10933955|FG000|Overall Study|Death|1
6909675|NCT00728468|10933955|FG000|Overall Study|Protocol Violation|4
6909676|NCT00728468|10933955|FG000|Overall Study|Objective progression or relapse|9
6909677|NCT00728468|10933955|FG000|Overall Study|Study terminated by sponsor|1
6909678|NCT00728481|10933961|FG000|Overall Study|Withdrawal by Subject|0
6909679|NCT00728481|10933962|FG001|Overall Study|Withdrawal by Subject|1
6909680|NCT00728481|10933961|FG000|Overall Study|Adverse Event|0
6909681|NCT00728481|10933962|FG001|Overall Study|Adverse Event|1
6909682|NCT00728481|10933961|FG000|Overall Study|Study medication non-compliance|0
6909683|NCT00728481|10933962|FG001|Overall Study|Study medication non-compliance|2
6909684|NCT00728481|10933961|FG000|Overall Study|Incorrectly assigned to opposite arm|1
6909685|NCT00728481|10933962|FG001|Overall Study|Incorrectly assigned to opposite arm|0
6909686|NCT00728494|10933970|FG000|Overall Study|Adverse Event|7
6909687|NCT00728494|10933971|FG001|Overall Study|Adverse Event|0
6909688|NCT00728494|10933970|FG000|Overall Study|Withdrawal by Subject|0
6909689|NCT00728494|10933971|FG001|Overall Study|Withdrawal by Subject|2
6909690|NCT00728494|10933970|FG000|Overall Study|Lack of Efficacy|2
6909691|NCT00728494|10933971|FG001|Overall Study|Lack of Efficacy|4
6909692|NCT00728494|10933970|FG000|Overall Study|No data available|0
6909693|NCT00728494|10933971|FG001|Overall Study|No data available|1
6909694|NCT00728689|10933988|FG000|Washout Period (Days 4 - 10)|Death in family|1
6909695|NCT00728689|10933989|FG001|Washout Period (Days 4 - 10)|Death in family|0
6909696|NCT00728936|10934036|FG000|Overall Study|Withdrawal by Subject|0
6909697|NCT00728936|10934037|FG001|Overall Study|Withdrawal by Subject|0
6909698|NCT00728936|10934038|FG002|Overall Study|Withdrawal by Subject|0
6909699|NCT00728936|10934039|FG003|Overall Study|Withdrawal by Subject|0
6909700|NCT00728936|10934040|FG004|Overall Study|Withdrawal by Subject|0
6909701|NCT00728936|10934041|FG005|Overall Study|Withdrawal by Subject|1
6909702|NCT00728936|10934042|FG006|Overall Study|Withdrawal by Subject|0
6978822|NCT01214837|11032389|FG001|Overall Study|Unable to Classify|3
6978823|NCT01214837|11032390|FG002|Overall Study|Unable to Classify|0
6978824|NCT01214850|11032402|FG000|Overall Study|Withdrawal by Subject|38
6978825|NCT01214850|11032403|FG001|Overall Study|Withdrawal by Subject|31
6978826|NCT01214850|11032404|FG002|Overall Study|Withdrawal by Subject|28
6978827|NCT01214850|11032402|FG000|Overall Study|Lost to Follow-up|124
6978828|NCT01214850|11032403|FG001|Overall Study|Lost to Follow-up|98
6978829|NCT01214850|11032404|FG002|Overall Study|Lost to Follow-up|123
6978830|NCT01214850|11032402|FG000|Overall Study|Protocol Violation|5
6978831|NCT01214850|11032403|FG001|Overall Study|Protocol Violation|5
6978832|NCT01214850|11032404|FG002|Overall Study|Protocol Violation|6
6978833|NCT01214850|11032402|FG000|Overall Study|Adverse event or death|11
6978834|NCT01214850|11032403|FG001|Overall Study|Adverse event or death|8
6978835|NCT01214850|11032404|FG002|Overall Study|Adverse event or death|3
6978836|NCT01214850|11032402|FG000|Overall Study|Inappropriate enrollment|2
6978837|NCT01214850|11032403|FG001|Overall Study|Inappropriate enrollment|1
6978838|NCT01214850|11032404|FG002|Overall Study|Inappropriate enrollment|0
6978839|NCT01214850|11032402|FG000|Overall Study|Administrative reason|1
6978840|NCT01214850|11032403|FG001|Overall Study|Administrative reason|0
6978841|NCT01214850|11032404|FG002|Overall Study|Administrative reason|0
6978842|NCT01214850|11032402|FG000|Overall Study|Unable to classify|2
6909703|NCT00728949|10934060|FG000|Overall Study|Adverse Event|8
6909704|NCT00728949|10934061|FG001|Overall Study|Adverse Event|0
6909705|NCT00728949|10934060|FG000|Overall Study|Withdrawal by Subject|2
6909706|NCT00728949|10934061|FG001|Overall Study|Withdrawal by Subject|2
6978843|NCT01214850|11032403|FG001|Overall Study|Unable to classify|1
6978844|NCT01214850|11032404|FG002|Overall Study|Unable to classify|1
6978845|NCT01214915|11032415|FG000|Overall Study|Adverse Event|8
6978846|NCT01214915|11032415|FG000|Overall Study|Lack of Efficacy|3
7041773|NCT01730040|11125599|FG000|Overall Study|Poor compliance to protocol|2
7041774|NCT01730040|11125600|FG001|Overall Study|Poor compliance to protocol|4
6909707|NCT00728949|10934060|FG000|Overall Study|Abnormal Lab Results|0
6909708|NCT00728949|10934061|FG001|Overall Study|Abnormal Lab Results|2
6909709|NCT00728949|10934060|FG000|Overall Study|On treatment at cutoff date|1
6909710|NCT00728949|10934061|FG001|Overall Study|On treatment at cutoff date|0
6909711|NCT00728988|10934069|FG000|Overall Study|Not Treated|2
6909712|NCT00728988|10934070|FG001|Overall Study|Not Treated|2
6909713|NCT00728988|10934069|FG000|Overall Study|Death|1
6909714|NCT00728988|10934070|FG001|Overall Study|Death|1
6909715|NCT00728988|10934069|FG000|Overall Study|Adverse Event|3
6909716|NCT00728988|10934070|FG001|Overall Study|Adverse Event|2
6909717|NCT00728988|10934069|FG000|Overall Study|Other|85
6909718|NCT00728988|10934070|FG001|Overall Study|Other|77
6909719|NCT00728988|10934069|FG000|Overall Study|Withdrawal by Subject|2
6909720|NCT00728988|10934070|FG001|Overall Study|Withdrawal by Subject|6
6909721|NCT00729157|10934094|FG000|Overall Study|Withdrawal by Subject|1
6909722|NCT00729183|10934100|FG000|Overall Study|Adverse Event|11
6909723|NCT00729183|10934101|FG001|Overall Study|Adverse Event|5
6909724|NCT00729183|10934100|FG000|Overall Study|Lack of Efficacy|0
6909725|NCT00729183|10934101|FG001|Overall Study|Lack of Efficacy|1
6909726|NCT00729183|10934100|FG000|Overall Study|Lost to Follow-up|3
6909727|NCT00729183|10934101|FG001|Overall Study|Lost to Follow-up|1
6909728|NCT00729183|10934100|FG000|Overall Study|Physician Decision|1
6909729|NCT00729183|10934101|FG001|Overall Study|Physician Decision|1
6909730|NCT00729183|10934100|FG000|Overall Study|Protocol Violation|1
6909731|NCT00729183|10934101|FG001|Overall Study|Protocol Violation|0
6909732|NCT00729183|10934100|FG000|Overall Study|Withdrawal by Subject|9
6909733|NCT00729183|10934101|FG001|Overall Study|Withdrawal by Subject|7
6909734|NCT00729248|10934107|FG000|Overall Study|Physician Decision|2
6909735|NCT00729326|10934114|FG000|Overall Study|Lost to Follow-up|2
6909736|NCT00729326|10934115|FG001|Overall Study|Lost to Follow-up|0
6909737|NCT00729326|10934114|FG000|Overall Study|Physician Decision|0
6909738|NCT00729326|10934115|FG001|Overall Study|Physician Decision|1
6909739|NCT00729326|10934114|FG000|Overall Study|Protocol Violation|3
6909740|NCT00729326|10934115|FG001|Overall Study|Protocol Violation|2
6909741|NCT00729326|10934114|FG000|Overall Study|Subject Decision|4
6909742|NCT00729326|10934115|FG001|Overall Study|Subject Decision|4
6909743|NCT00729326|10934114|FG000|Overall Study|Sponsor Decision|1
6909744|NCT00729326|10934115|FG001|Overall Study|Sponsor Decision|2
6909745|NCT00729378|10934123|FG000|Baseline|Did not complete study measurements|72
6909746|NCT00729378|10934124|FG001|Baseline|Did not complete study measurements|33
6909747|NCT00729378|10934123|FG000|Baseline|Withdrawal by Subject|66
6909748|NCT00729378|10934124|FG001|Baseline|Withdrawal by Subject|59
6909749|NCT00729378|10934123|FG000|12-months|Lost to Follow-up|100
6909750|NCT00729378|10934124|FG001|12-months|Lost to Follow-up|65
6909751|NCT00729378|10934123|FG000|24-months|Lost to Follow-up|72
6909752|NCT00729378|10934124|FG001|24-months|Lost to Follow-up|51
6909753|NCT00729378|10934123|FG000|36-months|Lost to Follow-up|15
6909754|NCT00729378|10934124|FG001|36-months|Lost to Follow-up|6
6909755|NCT00729469|10934145|FG000|Overall Study|Adverse Event|14
6909756|NCT00729469|10934146|FG001|Overall Study|Adverse Event|25
6909757|NCT00729469|10934145|FG000|Overall Study|Lost to Follow-up|9
6909758|NCT00729469|10934146|FG001|Overall Study|Lost to Follow-up|9
6909759|NCT00729469|10934145|FG000|Overall Study|Protocol Violation|2
6909760|NCT00729469|10934146|FG001|Overall Study|Protocol Violation|1
6909761|NCT00729469|10934145|FG000|Overall Study|Withdrawal by Subject|19
6909762|NCT00729469|10934146|FG001|Overall Study|Withdrawal by Subject|8
6909763|NCT00729469|10934145|FG000|Overall Study|Other-Not mentioned|9
6909764|NCT00729469|10934146|FG001|Overall Study|Other-Not mentioned|4
6909765|NCT00729586|10934171|FG000|Overall Study|Ineligible|0
6909766|NCT00729586|10934172|FG001|Overall Study|Ineligible|1
6909767|NCT00729586|10934171|FG000|Overall Study|never treated|1
6909768|NCT00729586|10934172|FG001|Overall Study|never treated|0
6909769|NCT00729612|10934179|FG000|Overall Study|Non evaluable for response|10
6909770|NCT00729690|10934197|FG000|Overall Study|IT Catheter Malfunction|0
6909771|NCT00729690|10934198|FG001|Overall Study|IT Catheter Malfunction|2
6909772|NCT00729690|10934199|FG002|Overall Study|IT Catheter Malfunction|2
6909773|NCT00729833|10934215|FG000|Overall Study|Death|5
6909774|NCT00729833|10934216|FG001|Overall Study|Death|1
6909775|NCT00729833|10934217|FG002|Overall Study|Death|3
6909776|NCT00729833|10934218|FG003|Overall Study|Death|5
6909777|NCT00729833|10934215|FG000|Overall Study|Study Terminated by Sponsor|0
6909778|NCT00729833|10934216|FG001|Overall Study|Study Terminated by Sponsor|0
6909779|NCT00729833|10934217|FG002|Overall Study|Study Terminated by Sponsor|1
6909780|NCT00729833|10934218|FG003|Overall Study|Study Terminated by Sponsor|0
6909781|NCT00729833|10934215|FG000|Overall Study|Lost to Follow-up|1
6909782|NCT00729833|10934216|FG001|Overall Study|Lost to Follow-up|0
6909783|NCT00729833|10934217|FG002|Overall Study|Lost to Follow-up|0
6909784|NCT00729833|10934218|FG003|Overall Study|Lost to Follow-up|0
6909785|NCT00729833|10934215|FG000|Overall Study|Withdrawal by Subject|3
6909786|NCT00729833|10934216|FG001|Overall Study|Withdrawal by Subject|1
6909787|NCT00729833|10934217|FG002|Overall Study|Withdrawal by Subject|3
6909788|NCT00729833|10934218|FG003|Overall Study|Withdrawal by Subject|0
6909789|NCT00729833|10934215|FG000|Overall Study|Unspecified Reasons|11
6909790|NCT00729833|10934216|FG001|Overall Study|Unspecified Reasons|5
6909791|NCT00729833|10934217|FG002|Overall Study|Unspecified Reasons|5
6909792|NCT00729833|10934218|FG003|Overall Study|Unspecified Reasons|1
6909793|NCT00729859|10934241|FG000|Overall Study|Adverse Event|0
6909794|NCT00729859|10934242|FG001|Overall Study|Adverse Event|1
6909795|NCT00729859|10934243|FG002|Overall Study|Adverse Event|0
6909796|NCT00729859|10934241|FG000|Overall Study|Withdrawal by Subject|0
6909797|NCT00729859|10934242|FG001|Overall Study|Withdrawal by Subject|1
6909798|NCT00729859|10934243|FG002|Overall Study|Withdrawal by Subject|0
6909799|NCT00729937|10934272|FG000|Overall Study|Lost to Follow-up|49
6909800|NCT00729937|10934273|FG001|Overall Study|Lost to Follow-up|58
6909801|NCT00729937|10934274|FG002|Overall Study|Lost to Follow-up|18
6909802|NCT00729937|10934275|FG003|Overall Study|Lost to Follow-up|33
6909803|NCT00729937|10934276|FG004|Overall Study|Lost to Follow-up|18
6909804|NCT00729937|10934277|FG005|Overall Study|Lost to Follow-up|23
6909805|NCT00729937|10934272|FG000|Overall Study|Physician Decision|7
6909806|NCT00729937|10934273|FG001|Overall Study|Physician Decision|16
6909807|NCT00729937|10934274|FG002|Overall Study|Physician Decision|2
6909808|NCT00729937|10934275|FG003|Overall Study|Physician Decision|0
6909809|NCT00729937|10934276|FG004|Overall Study|Physician Decision|5
6909810|NCT00729937|10934277|FG005|Overall Study|Physician Decision|8
6909811|NCT00729937|10934272|FG000|Overall Study|Death|1
6909812|NCT00729937|10934273|FG001|Overall Study|Death|0
6909813|NCT00729937|10934274|FG002|Overall Study|Death|1
6909814|NCT00729937|10934275|FG003|Overall Study|Death|0
6909815|NCT00729937|10934276|FG004|Overall Study|Death|0
6909816|NCT00729937|10934277|FG005|Overall Study|Death|1
6909817|NCT00729937|10934272|FG000|Overall Study|Withdrawal by Subject|3
6909818|NCT00729937|10934273|FG001|Overall Study|Withdrawal by Subject|5
6909819|NCT00729937|10934274|FG002|Overall Study|Withdrawal by Subject|6
6909820|NCT00729937|10934275|FG003|Overall Study|Withdrawal by Subject|0
6909821|NCT00729937|10934276|FG004|Overall Study|Withdrawal by Subject|4
6909822|NCT00729937|10934277|FG005|Overall Study|Withdrawal by Subject|2
6909823|NCT00729937|10934272|FG000|Overall Study|Randomized but not treated|12
6909824|NCT00729937|10934273|FG001|Overall Study|Randomized but not treated|6
6909825|NCT00729937|10934274|FG002|Overall Study|Randomized but not treated|1
6909826|NCT00729937|10934275|FG003|Overall Study|Randomized but not treated|0
6909827|NCT00729937|10934276|FG004|Overall Study|Randomized but not treated|1
6909828|NCT00729937|10934277|FG005|Overall Study|Randomized but not treated|3
6909829|NCT00729937|10934272|FG000|Overall Study|Did not meet eligibility criteria|2
6909830|NCT00729937|10934273|FG001|Overall Study|Did not meet eligibility criteria|1
6909831|NCT00729937|10934274|FG002|Overall Study|Did not meet eligibility criteria|0
6909832|NCT00729937|10934275|FG003|Overall Study|Did not meet eligibility criteria|0
6909833|NCT00729937|10934276|FG004|Overall Study|Did not meet eligibility criteria|0
6909834|NCT00729937|10934277|FG005|Overall Study|Did not meet eligibility criteria|0
6909835|NCT00729937|10934272|FG000|Overall Study|Incarcerated|0
6909836|NCT00729937|10934273|FG001|Overall Study|Incarcerated|2
6909837|NCT00729937|10934274|FG002|Overall Study|Incarcerated|1
6909838|NCT00729937|10934275|FG003|Overall Study|Incarcerated|1
6909839|NCT00729937|10934276|FG004|Overall Study|Incarcerated|0
6909840|NCT00729937|10934277|FG005|Overall Study|Incarcerated|0
6909841|NCT00730015|10934294|FG000|Overall Study|Adverse Event|11
6909842|NCT00730015|10934295|FG001|Overall Study|Adverse Event|10
6909843|NCT00730015|10934296|FG002|Overall Study|Adverse Event|8
6909844|NCT00730015|10934294|FG000|Overall Study|Protocol Violation|2
6909845|NCT00730015|10934295|FG001|Overall Study|Protocol Violation|6
6909846|NCT00730015|10934296|FG002|Overall Study|Protocol Violation|4
6909847|NCT00730015|10934294|FG000|Overall Study|Withdrawal by Subject|12
6909848|NCT00730015|10934295|FG001|Overall Study|Withdrawal by Subject|12
6909849|NCT00730015|10934296|FG002|Overall Study|Withdrawal by Subject|8
6909850|NCT00730015|10934294|FG000|Overall Study|Lost to Follow-up|4
6909851|NCT00730015|10934295|FG001|Overall Study|Lost to Follow-up|10
6909852|NCT00730015|10934296|FG002|Overall Study|Lost to Follow-up|3
6909853|NCT00730015|10934294|FG000|Overall Study|Lack of Efficacy|1
6909854|NCT00730015|10934295|FG001|Overall Study|Lack of Efficacy|2
6909855|NCT00730015|10934296|FG002|Overall Study|Lack of Efficacy|8
6909856|NCT00730015|10934294|FG000|Overall Study|Other Reason|1
6909857|NCT00730015|10934295|FG001|Overall Study|Other Reason|0
6909858|NCT00730015|10934296|FG002|Overall Study|Other Reason|1
6909859|NCT00730028|10934314|FG000|Overall Study|Adverse Event|23
6909860|NCT00730028|10934315|FG001|Overall Study|Adverse Event|26
6909861|NCT00730028|10934316|FG002|Overall Study|Adverse Event|16
6909862|NCT00730028|10934317|FG003|Overall Study|Adverse Event|20
6909863|NCT00730028|10934318|FG004|Overall Study|Adverse Event|43
6909864|NCT00730028|10934314|FG000|Overall Study|Lost to Follow-up|13
6909865|NCT00730028|10934315|FG001|Overall Study|Lost to Follow-up|26
6909866|NCT00730028|10934316|FG002|Overall Study|Lost to Follow-up|22
6909867|NCT00730028|10934317|FG003|Overall Study|Lost to Follow-up|26
6909868|NCT00730028|10934318|FG004|Overall Study|Lost to Follow-up|25
6909869|NCT00730028|10934314|FG000|Overall Study|Protocol Violation|6
6909870|NCT00730028|10934315|FG001|Overall Study|Protocol Violation|1
6909871|NCT00730028|10934316|FG002|Overall Study|Protocol Violation|1
6909872|NCT00730028|10934317|FG003|Overall Study|Protocol Violation|2
6909873|NCT00730028|10934318|FG004|Overall Study|Protocol Violation|0
6909874|NCT00730028|10934314|FG000|Overall Study|Withdrawal by Subject|9
6909875|NCT00730028|10934315|FG001|Overall Study|Withdrawal by Subject|5
6909876|NCT00730028|10934316|FG002|Overall Study|Withdrawal by Subject|4
6909877|NCT00730028|10934317|FG003|Overall Study|Withdrawal by Subject|5
6909878|NCT00730028|10934318|FG004|Overall Study|Withdrawal by Subject|9
6909879|NCT00730028|10934314|FG000|Overall Study|Physician Decision|3
6909880|NCT00730028|10934315|FG001|Overall Study|Physician Decision|3
6909881|NCT00730028|10934316|FG002|Overall Study|Physician Decision|2
6909882|NCT00730028|10934317|FG003|Overall Study|Physician Decision|3
6909883|NCT00730028|10934318|FG004|Overall Study|Physician Decision|2
6909884|NCT00730028|10934314|FG000|Overall Study|Treatment Failure|5
6909885|NCT00730028|10934315|FG001|Overall Study|Treatment Failure|5
6909886|NCT00730028|10934316|FG002|Overall Study|Treatment Failure|0
6978847|NCT01215032|11032428|FG000|Overall Study|Adverse Event|3
6978848|NCT01215032|11032428|FG000|Overall Study|Lack of Efficacy|17
6978849|NCT01215097|11032436|FG000|Overall Study|Adverse Event|1
6978850|NCT01215097|11032437|FG001|Overall Study|Adverse Event|3
6978851|NCT01215097|11032436|FG000|Overall Study|Protocol Violation|0
6978852|NCT01215097|11032437|FG001|Overall Study|Protocol Violation|2
6978853|NCT01215097|11032436|FG000|Overall Study|Lost to Follow-up|2
6978854|NCT01215097|11032437|FG001|Overall Study|Lost to Follow-up|0
6978855|NCT01215097|11032436|FG000|Overall Study|Withdrawal by Subject|6
6978856|NCT01215097|11032437|FG001|Overall Study|Withdrawal by Subject|3
6978857|NCT01215097|11032436|FG000|Overall Study|Lack of Efficacy|0
6978858|NCT01215097|11032437|FG001|Overall Study|Lack of Efficacy|3
6978859|NCT01215097|11032436|FG000|Overall Study|patient's refusal to come|2
6978860|NCT01215097|11032437|FG001|Overall Study|patient's refusal to come|2
6978861|NCT01215097|11032436|FG000|Overall Study|patient's private reason|1
6978862|NCT01215097|11032437|FG001|Overall Study|patient's private reason|1
6978863|NCT01215175|11032477|FG000|Overall Study|Lost to Follow-up|0
6978864|NCT01215175|11032478|FG001|Overall Study|Lost to Follow-up|1
6978865|NCT01215175|11032479|FG002|Overall Study|Lost to Follow-up|0
6978866|NCT01215175|11032480|FG003|Overall Study|Lost to Follow-up|1
6978867|NCT01215175|11032481|FG004|Overall Study|Lost to Follow-up|0
6978868|NCT01215188|11032496|FG000|Overall Study|Lost to Follow-up|22
6978869|NCT01215188|11032497|FG001|Overall Study|Lost to Follow-up|22
6978870|NCT01215188|11032498|FG002|Overall Study|Lost to Follow-up|16
6978871|NCT01215188|11032496|FG000|Overall Study|Adverse Event|1
6978872|NCT01215188|11032497|FG001|Overall Study|Adverse Event|1
6978873|NCT01215188|11032498|FG002|Overall Study|Adverse Event|3
6978874|NCT01215188|11032496|FG000|Overall Study|Physician Decision|2
6978875|NCT01215188|11032497|FG001|Overall Study|Physician Decision|1
6978876|NCT01215188|11032498|FG002|Overall Study|Physician Decision|0
6978877|NCT01215188|11032496|FG000|Overall Study|Lack of Efficacy|0
6978878|NCT01215188|11032497|FG001|Overall Study|Lack of Efficacy|0
6978879|NCT01215188|11032498|FG002|Overall Study|Lack of Efficacy|1
6978880|NCT01215188|11032496|FG000|Overall Study|Protocol Violation|1
6978881|NCT01215188|11032497|FG001|Overall Study|Protocol Violation|1
6978882|NCT01215188|11032498|FG002|Overall Study|Protocol Violation|1
6978883|NCT01215188|11032496|FG000|Overall Study|Withdrawal by Subject|32
6978884|NCT01215188|11032497|FG001|Overall Study|Withdrawal by Subject|34
6978885|NCT01215188|11032498|FG002|Overall Study|Withdrawal by Subject|31
6978886|NCT01215227|11032512|FG000|Overall Study|Adverse Event|11
6978887|NCT01215227|11032513|FG001|Overall Study|Adverse Event|11
6978888|NCT01215227|11032514|FG002|Overall Study|Adverse Event|4
6978889|NCT01215227|11032515|FG003|Overall Study|Adverse Event|8
6978890|NCT01215227|11032516|FG004|Overall Study|Adverse Event|7
6978891|NCT01215227|11032517|FG005|Overall Study|Adverse Event|6
6978892|NCT01215227|11032512|FG000|Overall Study|Treatment Failure|8
6978893|NCT01215227|11032513|FG001|Overall Study|Treatment Failure|4
6978894|NCT01215227|11032514|FG002|Overall Study|Treatment Failure|1
6978895|NCT01215227|11032515|FG003|Overall Study|Treatment Failure|5
6978896|NCT01215227|11032516|FG004|Overall Study|Treatment Failure|1
6978897|NCT01215227|11032517|FG005|Overall Study|Treatment Failure|1
6978898|NCT01215227|11032512|FG000|Overall Study|Lost to Follow-up|1
6978899|NCT01215227|11032513|FG001|Overall Study|Lost to Follow-up|4
6978900|NCT01215227|11032514|FG002|Overall Study|Lost to Follow-up|1
6978901|NCT01215227|11032515|FG003|Overall Study|Lost to Follow-up|1
6978902|NCT01215227|11032516|FG004|Overall Study|Lost to Follow-up|1
6978903|NCT01215227|11032517|FG005|Overall Study|Lost to Follow-up|2
6978904|NCT01215227|11032512|FG000|Overall Study|Subject Withdrew Consent|16
6978905|NCT01215227|11032513|FG001|Overall Study|Subject Withdrew Consent|20
6909887|NCT00730028|10934317|FG003|Overall Study|Treatment Failure|0
6978906|NCT01215227|11032514|FG002|Overall Study|Subject Withdrew Consent|7
6978907|NCT01215227|11032515|FG003|Overall Study|Subject Withdrew Consent|10
6978908|NCT01215227|11032516|FG004|Overall Study|Subject Withdrew Consent|11
6978909|NCT01215227|11032517|FG005|Overall Study|Subject Withdrew Consent|8
6978910|NCT01215227|11032512|FG000|Overall Study|Non-Compliance With Protocol|2
6978911|NCT01215227|11032513|FG001|Overall Study|Non-Compliance With Protocol|6
6978912|NCT01215227|11032514|FG002|Overall Study|Non-Compliance With Protocol|1
6978913|NCT01215227|11032515|FG003|Overall Study|Non-Compliance With Protocol|0
6909888|NCT00730028|10934318|FG004|Overall Study|Treatment Failure|1
6909889|NCT00730028|10934314|FG000|Overall Study|Randomization Error|1
6978914|NCT01215227|11032516|FG004|Overall Study|Non-Compliance With Protocol|0
6978915|NCT01215227|11032517|FG005|Overall Study|Non-Compliance With Protocol|0
6978916|NCT01215227|11032512|FG000|Overall Study|Administrative|83
6978917|NCT01215227|11032513|FG001|Overall Study|Administrative|73
6978918|NCT01215227|11032514|FG002|Overall Study|Administrative|42
6978919|NCT01215227|11032515|FG003|Overall Study|Administrative|24
6978920|NCT01215227|11032516|FG004|Overall Study|Administrative|28
6909890|NCT00730028|10934315|FG001|Overall Study|Randomization Error|0
6909891|NCT00730028|10934316|FG002|Overall Study|Randomization Error|0
6909892|NCT00730028|10934317|FG003|Overall Study|Randomization Error|0
6909893|NCT00730028|10934318|FG004|Overall Study|Randomization Error|2
6909894|NCT00730041|10934332|FG000|Overall Study|Lost to Follow-up|0
6909895|NCT00730041|10934333|FG001|Overall Study|Lost to Follow-up|2
6909896|NCT00730158|10934341|FG000|Overall Study|Withdrawal by Subject|1
6909897|NCT00730158|10934342|FG001|Overall Study|Withdrawal by Subject|1
6909898|NCT00730171|10934352|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5
6909899|NCT00730171|10934352|FG000|Overall Study|Adverse Event|193
6909900|NCT00730171|10934352|FG000|Overall Study|Protocol Violation|48
6909901|NCT00730171|10934352|FG000|Overall Study|Withdrawal by Subject|202
6909902|NCT00730171|10934352|FG000|Overall Study|Lost to Follow-up|121
6909903|NCT00730171|10934352|FG000|Overall Study|Insufficient Therapeutic Response|141
6909904|NCT00730171|10934352|FG000|Overall Study|Other|61
6909905|NCT00730236|10934360|FG000|Overall Study|Adverse Event|4
6909906|NCT00730236|10934360|FG000|Overall Study|Withdrawal by Subject|1
6909907|NCT00730236|10934360|FG000|Overall Study|Non-compliance|1
6909908|NCT00730275|10934368|FG000|Overall Study|Withdrawal by Subject|0
6909909|NCT00730275|10934369|FG001|Overall Study|Withdrawal by Subject|0
6909910|NCT00730275|10934370|FG002|Overall Study|Withdrawal by Subject|0
6909911|NCT00730275|10934371|FG003|Overall Study|Withdrawal by Subject|1
6909912|NCT00730327|10934384|FG000|Overall Study|Lost to Follow-up|14
6909913|NCT00730327|10934385|FG001|Overall Study|Lost to Follow-up|16
6909914|NCT00730327|10934384|FG000|Overall Study|Adverse Event|8
6909915|NCT00730327|10934385|FG001|Overall Study|Adverse Event|1
6909916|NCT00730327|10934384|FG000|Overall Study|Withdrawal by Subject|3
6909917|NCT00730327|10934385|FG001|Overall Study|Withdrawal by Subject|13
6909918|NCT00730327|10934384|FG000|Overall Study|Subject withdrew (reason not specified)|2
6909919|NCT00730327|10934385|FG001|Overall Study|Subject withdrew (reason not specified)|7
6909920|NCT00730405|10934400|FG000|Overall Study-Treatment Phase|Adverse Event|5
6909921|NCT00730405|10934401|FG001|Overall Study-Treatment Phase|Adverse Event|10
6909922|NCT00730405|10934402|FG002|Overall Study-Treatment Phase|Adverse Event|4
6909923|NCT00730405|10934403|FG003|Overall Study-Treatment Phase|Adverse Event|8
6909924|NCT00730405|10934404|FG004|Overall Study-Treatment Phase|Adverse Event|4
6909925|NCT00730405|10934400|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4
6909926|NCT00730405|10934401|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5
6909927|NCT00730405|10934402|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6
6909928|NCT00730405|10934403|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4
6909929|NCT00730405|10934404|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4
6909930|NCT00730405|10934400|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
6909931|NCT00730405|10934401|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
6909932|NCT00730405|10934402|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5
6909933|NCT00730405|10934403|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
6909934|NCT00730405|10934404|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
6909935|NCT00730405|10934400|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7
6909936|NCT00730405|10934401|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1
6909937|NCT00730405|10934402|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2
6909938|NCT00730405|10934403|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5
6909939|NCT00730405|10934404|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8
6909940|NCT00730405|10934400|FG000|Overall Study-Treatment Phase|Did not met eligibility|0
6909941|NCT00730405|10934401|FG001|Overall Study-Treatment Phase|Did not met eligibility|0
6909942|NCT00730405|10934402|FG002|Overall Study-Treatment Phase|Did not met eligibility|1
6909943|NCT00730405|10934403|FG003|Overall Study-Treatment Phase|Did not met eligibility|0
6909944|NCT00730405|10934404|FG004|Overall Study-Treatment Phase|Did not met eligibility|0
6909945|NCT00730405|10934400|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0
6909946|NCT00730405|10934401|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0
6909947|NCT00730405|10934402|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1
6909948|NCT00730405|10934403|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0
6909949|NCT00730405|10934404|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0
6909950|NCT00730405|10934400|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1
6909951|NCT00730405|10934401|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0
6909952|NCT00730405|10934402|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0
6909953|NCT00730405|10934403|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0
6909954|NCT00730405|10934404|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0
6909955|NCT00730405|10934400|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0
6909956|NCT00730405|10934401|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1
6909957|NCT00730405|10934402|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0
6909958|NCT00730405|10934403|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0
6909959|NCT00730405|10934404|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0
6909960|NCT00730405|10934400|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0
6909961|NCT00730405|10934401|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1
6909962|NCT00730405|10934402|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0
6909963|NCT00730405|10934403|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0
6909964|NCT00730405|10934404|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2
6909965|NCT00730405|10934400|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
6909966|NCT00730405|10934401|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
6909967|NCT00730405|10934402|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1
6909968|NCT00730405|10934403|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
6909969|NCT00730405|10934404|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
6909970|NCT00730405|10934400|FG000|Overall Study-Treatment Phase|Misrandomized|0
6909971|NCT00730405|10934401|FG001|Overall Study-Treatment Phase|Misrandomized|1
6909972|NCT00730405|10934402|FG002|Overall Study-Treatment Phase|Misrandomized|0
6909973|NCT00730405|10934403|FG003|Overall Study-Treatment Phase|Misrandomized|0
6909974|NCT00730405|10934404|FG004|Overall Study-Treatment Phase|Misrandomized|0
6909975|NCT00730405|10934400|FG000|Overall Study-Treatment Phase|Study drug interrupted|0
6909976|NCT00730405|10934401|FG001|Overall Study-Treatment Phase|Study drug interrupted|1
6909977|NCT00730405|10934402|FG002|Overall Study-Treatment Phase|Study drug interrupted|0
6909978|NCT00730405|10934403|FG003|Overall Study-Treatment Phase|Study drug interrupted|0
6909979|NCT00730405|10934404|FG004|Overall Study-Treatment Phase|Study drug interrupted|0
6909980|NCT00730405|10934400|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
6909981|NCT00730405|10934401|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
6909982|NCT00730405|10934402|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
6909983|NCT00730405|10934403|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1
6909984|NCT00730405|10934404|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
6909985|NCT00730405|10934400|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
6909986|NCT00730405|10934401|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
6909987|NCT00730405|10934402|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1
6909988|NCT00730405|10934403|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
6909989|NCT00730405|10934404|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
6909990|NCT00730405|10934400|FG000|Overall Study-Treatment Phase|Change of location|0
6974087|NCT01185353|11025993|FG008|Part C (Weeks 24 Through 76)|Death|0
6978921|NCT01215227|11032517|FG005|Overall Study|Administrative|40
6978922|NCT01215227|11032512|FG000|Overall Study|Missing Status|0
6978923|NCT01215227|11032513|FG001|Overall Study|Missing Status|1
6978924|NCT01215227|11032514|FG002|Overall Study|Missing Status|0
6978925|NCT01215227|11032515|FG003|Overall Study|Missing Status|0
7060201|NCT01915732|11156241|FG000|Overall Study|Poor Perceived Efficacy|1
7060202|NCT01915732|11156242|FG001|Overall Study|Poor Perceived Efficacy|0
7060203|NCT01915732|11156241|FG000|Overall Study|Par. Unable to Come to the Hospital|0
7060204|NCT01915732|11156242|FG001|Overall Study|Par. Unable to Come to the Hospital|1
7060205|NCT01915732|11156241|FG000|Overall Study|Got Well|0
7060206|NCT01915732|11156242|FG001|Overall Study|Got Well|1
7060207|NCT01915732|11156241|FG000|Overall Study|Par. not Willing to Continue Treatment|0
7060208|NCT01915732|11156242|FG001|Overall Study|Par. not Willing to Continue Treatment|1
7060209|NCT01915732|11156241|FG000|Overall Study|Par. Refused to Hospital Visits|0
7060210|NCT01915732|11156242|FG001|Overall Study|Par. Refused to Hospital Visits|1
7060211|NCT01915732|11156241|FG000|Overall Study|Job Transfer|0
7060212|NCT01915732|11156242|FG001|Overall Study|Job Transfer|1
7060213|NCT01915732|11156241|FG000|Overall Study|Improper Facial Procedure|0
7060214|NCT01915732|11156242|FG001|Overall Study|Improper Facial Procedure|1
7060215|NCT01915732|11156241|FG000|Overall Study|Poor Conscious Effect|0
7060216|NCT01915732|11156242|FG001|Overall Study|Poor Conscious Effect|1
7060217|NCT01915771|11156248|FG000|Day 1|Withdrawal by Subject|1
7060218|NCT01915771|11156248|FG000|Day 15|Withdrawal by Subject|1
7060219|NCT01915849|11156269|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1
7060220|NCT01915849|11156270|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0
7060221|NCT01915849|11156271|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0
7060222|NCT01915849|11156272|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0
7060223|NCT01915849|11156269|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
7060224|NCT01915849|11156270|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
7060225|NCT01915849|11156271|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
7060226|NCT01915849|11156272|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
7060227|NCT01915914|11156282|FG000|Acute Phase|Withdrawal by Subject|4
7060228|NCT01915914|11156283|FG001|Acute Phase|Withdrawal by Subject|0
7060229|NCT01915914|11156284|FG002|Acute Phase|Withdrawal by Subject|0
7060230|NCT01915914|11156285|FG003|Acute Phase|Withdrawal by Subject|0
7060231|NCT01915914|11156282|FG000|Acute Phase|Lost to Follow-up|4
7060232|NCT01915914|11156283|FG001|Acute Phase|Lost to Follow-up|0
7060233|NCT01915914|11156284|FG002|Acute Phase|Lost to Follow-up|0
7060234|NCT01915914|11156285|FG003|Acute Phase|Lost to Follow-up|0
7060235|NCT01915914|11156282|FG000|Acute Phase|Physician Decision|1
7060236|NCT01915914|11156283|FG001|Acute Phase|Physician Decision|0
7060237|NCT01915914|11156284|FG002|Acute Phase|Physician Decision|0
7060238|NCT01915914|11156285|FG003|Acute Phase|Physician Decision|0
7060239|NCT01915914|11156282|FG000|Acute Phase|Accepted Other Topic Therapies|1
7060240|NCT01915914|11156283|FG001|Acute Phase|Accepted Other Topic Therapies|0
7060241|NCT01915914|11156284|FG002|Acute Phase|Accepted Other Topic Therapies|0
7060242|NCT01915914|11156285|FG003|Acute Phase|Accepted Other Topic Therapies|0
7060243|NCT01915914|11156282|FG000|Acute Phase|"Not Achieved treatment success"|1
6909991|NCT00730405|10934401|FG001|Overall Study-Treatment Phase|Change of location|0
6909992|NCT00730405|10934402|FG002|Overall Study-Treatment Phase|Change of location|0
6909993|NCT00730405|10934403|FG003|Overall Study-Treatment Phase|Change of location|1
6909994|NCT00730405|10934404|FG004|Overall Study-Treatment Phase|Change of location|0
6909995|NCT00730405|10934400|FG000|Overall Study-Treatment Phase|Pregnancy|0
6909996|NCT00730405|10934401|FG001|Overall Study-Treatment Phase|Pregnancy|1
6909997|NCT00730405|10934402|FG002|Overall Study-Treatment Phase|Pregnancy|0
6909998|NCT00730405|10934403|FG003|Overall Study-Treatment Phase|Pregnancy|0
6909999|NCT00730405|10934404|FG004|Overall Study-Treatment Phase|Pregnancy|0
6910000|NCT00730405|10934400|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
6910001|NCT00730405|10934401|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
6910002|NCT00730405|10934402|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
6910003|NCT00730405|10934403|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
6910004|NCT00730405|10934404|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1
6910005|NCT00730405|10934400|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1
6910006|NCT00730405|10934401|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0
6910007|NCT00730405|10934402|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0
6910008|NCT00730405|10934403|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0
6910009|NCT00730405|10934404|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0
6910010|NCT00730405|10934400|FG000|Overall Study-follow-up Phase|Adverse Event|2
6910011|NCT00730405|10934401|FG001|Overall Study-follow-up Phase|Adverse Event|6
6910012|NCT00730405|10934402|FG002|Overall Study-follow-up Phase|Adverse Event|2
6910013|NCT00730405|10934403|FG003|Overall Study-follow-up Phase|Adverse Event|3
6910014|NCT00730405|10934404|FG004|Overall Study-follow-up Phase|Adverse Event|4
6910015|NCT00730405|10934400|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7
6910016|NCT00730405|10934401|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6
6910017|NCT00730405|10934402|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8
6910018|NCT00730405|10934403|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4
6910019|NCT00730405|10934404|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6
6910020|NCT00730405|10934400|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7
6910021|NCT00730405|10934401|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3
6910022|NCT00730405|10934402|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3
6910023|NCT00730405|10934403|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6
6910024|NCT00730405|10934404|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10
6910025|NCT00730405|10934400|FG000|Overall Study-follow-up Phase|Death|0
6910026|NCT00730405|10934401|FG001|Overall Study-follow-up Phase|Death|1
6910027|NCT00730405|10934402|FG002|Overall Study-follow-up Phase|Death|0
6910028|NCT00730405|10934403|FG003|Overall Study-follow-up Phase|Death|1
6910029|NCT00730405|10934404|FG004|Overall Study-follow-up Phase|Death|0
6910030|NCT00730405|10934400|FG000|Overall Study-follow-up Phase|Change of location|1
6910031|NCT00730405|10934401|FG001|Overall Study-follow-up Phase|Change of location|1
6910032|NCT00730405|10934402|FG002|Overall Study-follow-up Phase|Change of location|0
6910033|NCT00730405|10934403|FG003|Overall Study-follow-up Phase|Change of location|1
6910034|NCT00730405|10934404|FG004|Overall Study-follow-up Phase|Change of location|0
6910035|NCT00730405|10934400|FG000|Overall Study-follow-up Phase|Did not met eligibility|0
6910036|NCT00730405|10934401|FG001|Overall Study-follow-up Phase|Did not met eligibility|0
6910037|NCT00730405|10934402|FG002|Overall Study-follow-up Phase|Did not met eligibility|1
6910038|NCT00730405|10934403|FG003|Overall Study-follow-up Phase|Did not met eligibility|0
6910039|NCT00730405|10934404|FG004|Overall Study-follow-up Phase|Did not met eligibility|0
6910040|NCT00730405|10934400|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0
6910041|NCT00730405|10934401|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0
6910042|NCT00730405|10934402|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1
6910043|NCT00730405|10934403|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0
6910044|NCT00730405|10934404|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0
6910045|NCT00730405|10934400|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
6910046|NCT00730405|10934401|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
6910047|NCT00730405|10934402|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1
6910048|NCT00730405|10934403|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
6910049|NCT00730405|10934404|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
6910050|NCT00730405|10934400|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
6910051|NCT00730405|10934401|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
6910052|NCT00730405|10934402|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
6910053|NCT00730405|10934403|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
6910054|NCT00730405|10934404|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1
6910055|NCT00730405|10934400|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1
6910056|NCT00730405|10934401|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0
6910057|NCT00730405|10934402|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0
6910058|NCT00730405|10934403|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0
6910059|NCT00730405|10934404|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0
6910060|NCT00730405|10934400|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0
6910061|NCT00730405|10934401|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0
6910062|NCT00730405|10934402|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0
6910063|NCT00730405|10934403|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1
6910064|NCT00730405|10934404|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0
6910065|NCT00730405|10934400|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
6910066|NCT00730405|10934401|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
6910067|NCT00730405|10934402|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
6910068|NCT00730405|10934403|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
6910069|NCT00730405|10934404|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
6910070|NCT00730405|10934400|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1
6910071|NCT00730405|10934401|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1
6910072|NCT00730405|10934402|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0
6910073|NCT00730405|10934403|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0
6910074|NCT00730405|10934404|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0
7142964|NCT03022422|11299103|FG005|Overall Study|3 subjects consented but not vaccinated|0
7142965|NCT03022630|11299158|FG000|Overall Study|Death|9
7142966|NCT03022630|11299159|FG001|Overall Study|Death|7
7142967|NCT03022630|11299158|FG000|Overall Study|Withdrawal by Subject|0
7142968|NCT03022630|11299159|FG001|Overall Study|Withdrawal by Subject|5
7142969|NCT03022799|11299183|FG000|Overall Study|Adverse Event|0
7142970|NCT03022799|11299184|FG001|Overall Study|Adverse Event|0
7142971|NCT03022799|11299185|FG002|Overall Study|Adverse Event|0
6910075|NCT00730405|10934400|FG000|Overall Study-follow-up Phase|Use of restricted medication|0
6910076|NCT00730405|10934401|FG001|Overall Study-follow-up Phase|Use of restricted medication|1
7142972|NCT03022799|11299186|FG003|Overall Study|Adverse Event|0
7142973|NCT03022799|11299187|FG004|Overall Study|Adverse Event|0
7142974|NCT03022799|11299188|FG005|Overall Study|Adverse Event|0
7142975|NCT03022799|11299189|FG006|Overall Study|Adverse Event|0
7142976|NCT03022799|11299190|FG007|Overall Study|Adverse Event|0
7142977|NCT03022799|11299191|FG008|Overall Study|Adverse Event|0
7142978|NCT03022799|11299192|FG009|Overall Study|Adverse Event|1
7142979|NCT03022799|11299193|FG010|Overall Study|Adverse Event|1
7142980|NCT03022799|11299194|FG011|Overall Study|Adverse Event|0
7142981|NCT03022799|11299195|FG012|Overall Study|Adverse Event|0
7142982|NCT03022981|11299253|FG000|Overall Study|Adverse Event|0
7142983|NCT03022981|11299254|FG001|Overall Study|Adverse Event|1
7142984|NCT03022981|11299255|FG002|Overall Study|Adverse Event|0
6910077|NCT00730405|10934402|FG002|Overall Study-follow-up Phase|Use of restricted medication|0
6910078|NCT00730405|10934403|FG003|Overall Study-follow-up Phase|Use of restricted medication|0
6910079|NCT00730405|10934404|FG004|Overall Study-follow-up Phase|Use of restricted medication|0
6910080|NCT00730405|10934400|FG000|Overall Study-follow-up Phase|Non-compliance|1
6910081|NCT00730405|10934401|FG001|Overall Study-follow-up Phase|Non-compliance|0
6910082|NCT00730405|10934402|FG002|Overall Study-follow-up Phase|Non-compliance|2
6910083|NCT00730405|10934403|FG003|Overall Study-follow-up Phase|Non-compliance|0
6910084|NCT00730405|10934404|FG004|Overall Study-follow-up Phase|Non-compliance|0
6910085|NCT00730405|10934400|FG000|Overall Study-follow-up Phase|Missing|0
6910086|NCT00730405|10934401|FG001|Overall Study-follow-up Phase|Missing|0
6910087|NCT00730405|10934402|FG002|Overall Study-follow-up Phase|Missing|2
6910088|NCT00730405|10934403|FG003|Overall Study-follow-up Phase|Missing|0
6910089|NCT00730405|10934404|FG004|Overall Study-follow-up Phase|Missing|0
6910090|NCT00730405|10934400|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0
6910091|NCT00730405|10934401|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0
6910092|NCT00730405|10934402|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0
6910093|NCT00730405|10934403|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0
6910094|NCT00730405|10934404|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1
6910095|NCT00730405|10934400|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
6910096|NCT00730405|10934401|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
6910097|NCT00730405|10934402|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1
6910098|NCT00730405|10934403|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
6910099|NCT00730405|10934404|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
6910100|NCT00730405|10934400|FG000|Overall Study-follow-up Phase|Mis-randomized|0
6910101|NCT00730405|10934401|FG001|Overall Study-follow-up Phase|Mis-randomized|1
6910102|NCT00730405|10934402|FG002|Overall Study-follow-up Phase|Mis-randomized|0
6910103|NCT00730405|10934403|FG003|Overall Study-follow-up Phase|Mis-randomized|0
6910104|NCT00730405|10934404|FG004|Overall Study-follow-up Phase|Mis-randomized|0
6910105|NCT00730405|10934400|FG000|Overall Study-follow-up Phase|Other Protocol violation|0
6910106|NCT00730405|10934401|FG001|Overall Study-follow-up Phase|Other Protocol violation|0
6910107|NCT00730405|10934402|FG002|Overall Study-follow-up Phase|Other Protocol violation|1
6910108|NCT00730405|10934403|FG003|Overall Study-follow-up Phase|Other Protocol violation|0
6910109|NCT00730405|10934404|FG004|Overall Study-follow-up Phase|Other Protocol violation|0
7142985|NCT03022981|11299253|FG000|Overall Study|Investigator's Discretion|0
6910110|NCT00730405|10934400|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
6910111|NCT00730405|10934401|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
6910112|NCT00730405|10934402|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
6910113|NCT00730405|10934403|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1
6910114|NCT00730405|10934404|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
6910115|NCT00730405|10934400|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1
6910116|NCT00730405|10934401|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0
6910117|NCT00730405|10934402|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0
6910118|NCT00730405|10934403|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0
6910119|NCT00730405|10934404|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0
6910120|NCT00730691|10934439|FG000|Overall Study|Adverse Event|4
6910121|NCT00730691|10934440|FG001|Overall Study|Adverse Event|8
6910122|NCT00730691|10934441|FG002|Overall Study|Adverse Event|11
6910123|NCT00730691|10934442|FG003|Overall Study|Adverse Event|11
6910124|NCT00730691|10934443|FG004|Overall Study|Adverse Event|23
6910125|NCT00730691|10934439|FG000|Overall Study|Lack of Efficacy|4
6910126|NCT00730691|10934440|FG001|Overall Study|Lack of Efficacy|4
6910127|NCT00730691|10934441|FG002|Overall Study|Lack of Efficacy|2
6910128|NCT00730691|10934442|FG003|Overall Study|Lack of Efficacy|1
6910129|NCT00730691|10934443|FG004|Overall Study|Lack of Efficacy|1
6910130|NCT00730691|10934439|FG000|Overall Study|Non-compliance with Study Drug|6
6910131|NCT00730691|10934440|FG001|Overall Study|Non-compliance with Study Drug|1
6910132|NCT00730691|10934441|FG002|Overall Study|Non-compliance with Study Drug|6
6910133|NCT00730691|10934442|FG003|Overall Study|Non-compliance with Study Drug|3
6910134|NCT00730691|10934443|FG004|Overall Study|Non-compliance with Study Drug|3
6910135|NCT00730691|10934439|FG000|Overall Study|Protocol Deviations|3
6910136|NCT00730691|10934440|FG001|Overall Study|Protocol Deviations|5
6910137|NCT00730691|10934441|FG002|Overall Study|Protocol Deviations|3
6910138|NCT00730691|10934442|FG003|Overall Study|Protocol Deviations|7
6910139|NCT00730691|10934443|FG004|Overall Study|Protocol Deviations|5
6910140|NCT00730691|10934439|FG000|Overall Study|Withdrawal of Consent|7
6910141|NCT00730691|10934440|FG001|Overall Study|Withdrawal of Consent|9
6910142|NCT00730691|10934441|FG002|Overall Study|Withdrawal of Consent|3
6910143|NCT00730691|10934442|FG003|Overall Study|Withdrawal of Consent|6
6910144|NCT00730691|10934443|FG004|Overall Study|Withdrawal of Consent|3
6910145|NCT00730691|10934439|FG000|Overall Study|Lost to Follow-up|11
6910146|NCT00730691|10934440|FG001|Overall Study|Lost to Follow-up|8
6910147|NCT00730691|10934441|FG002|Overall Study|Lost to Follow-up|13
6910148|NCT00730691|10934442|FG003|Overall Study|Lost to Follow-up|15
6910149|NCT00730691|10934443|FG004|Overall Study|Lost to Follow-up|13
6910150|NCT00730691|10934439|FG000|Overall Study|Other|1
6910151|NCT00730691|10934440|FG001|Overall Study|Other|1
6910152|NCT00730691|10934441|FG002|Overall Study|Other|1
6910153|NCT00730691|10934442|FG003|Overall Study|Other|2
6910154|NCT00730691|10934443|FG004|Overall Study|Other|2
6910155|NCT00730756|10934461|FG000|Overall Study|Adverse Event|2
6910156|NCT00730756|10934462|FG001|Overall Study|Adverse Event|0
6910157|NCT00730756|10934461|FG000|Overall Study|Lack of Efficacy|1
6910158|NCT00730756|10934462|FG001|Overall Study|Lack of Efficacy|1
6910159|NCT00730756|10934461|FG000|Overall Study|Protocol Deviation|1
6910160|NCT00730756|10934462|FG001|Overall Study|Protocol Deviation|2
6910161|NCT00730756|10934461|FG000|Overall Study|Lost to Follow-up|0
6910162|NCT00730756|10934462|FG001|Overall Study|Lost to Follow-up|1
6910163|NCT00730756|10934461|FG000|Overall Study|Withdrew Consent|0
6910164|NCT00730756|10934462|FG001|Overall Study|Withdrew Consent|1
6910165|NCT00730847|10934468|FG000|Overall Study|Adverse Event|1
6910166|NCT00730847|10934468|FG000|Overall Study|Protocol Violation|2
6910167|NCT00730847|10934468|FG000|Overall Study|Withdrawal by Subject|16
6827043|NCT00121667|10829460|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3
6827044|NCT00121667|10829457|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3
6827045|NCT00121667|10829458|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6
6827046|NCT00121667|10829459|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5
6827047|NCT00121667|10829460|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9
6827048|NCT00121667|10829457|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3
6910168|NCT00730847|10934468|FG000|Overall Study|Lost to Follow-up|67
6910169|NCT00730847|10934468|FG000|Overall Study|Unknown completion status|21
6910170|NCT00730847|10934468|FG000|Overall Study|Other|24
6910171|NCT00730912|10934475|FG000|Overall Study|Discontinued|0
6910172|NCT00730912|10934476|FG001|Overall Study|Discontinued|0
6910173|NCT00730912|10934477|FG002|Overall Study|Discontinued|1
6910174|NCT00730925|10934485|FG000|Overall Study|Progressive Disease|21
6910175|NCT00730925|10934485|FG000|Overall Study|Dose reducing Event|2
6910176|NCT00730925|10934485|FG000|Overall Study|Other Averse Event|7
6827049|NCT00121667|10829458|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5
6827050|NCT00121667|10829459|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8
6827051|NCT00121667|10829460|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4
6827052|NCT00121667|10829457|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
6827053|NCT00121667|10829458|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
6827054|NCT00121667|10829459|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0
6910177|NCT00730925|10934485|FG000|Overall Study|Protocol Violation|1
6910178|NCT00730925|10934485|FG000|Overall Study|Withdrawal by Subject|1
6910179|NCT00730925|10934485|FG000|Overall Study|Switch to combination therapy|8
6910180|NCT00730925|10934485|FG000|Overall Study|Other|1
6910181|NCT00731042|10934496|FG000|Second Intervention|Did not meet inclusion criteria|0
6910182|NCT00731042|10934497|FG001|Second Intervention|Did not meet inclusion criteria|2
6910183|NCT00731120|10934522|FG000|Overall Study|Adverse Event|7
6910184|NCT00731120|10934523|FG001|Overall Study|Adverse Event|6
6910185|NCT00731120|10934524|FG002|Overall Study|Adverse Event|8
6910186|NCT00731120|10934522|FG000|Overall Study|Lack of Efficacy|4
6910187|NCT00731120|10934523|FG001|Overall Study|Lack of Efficacy|5
6910188|NCT00731120|10934524|FG002|Overall Study|Lack of Efficacy|4
6910189|NCT00731120|10934522|FG000|Overall Study|Noncompliance with Study Drug|3
6910190|NCT00731120|10934523|FG001|Overall Study|Noncompliance with Study Drug|3
6910191|NCT00731120|10934524|FG002|Overall Study|Noncompliance with Study Drug|1
6910192|NCT00731120|10934522|FG000|Overall Study|Protocol Deviations|1
6910193|NCT00731120|10934523|FG001|Overall Study|Protocol Deviations|6
6910194|NCT00731120|10934524|FG002|Overall Study|Protocol Deviations|1
6910195|NCT00731120|10934522|FG000|Overall Study|Withdrawal of Consent|13
6910196|NCT00731120|10934523|FG001|Overall Study|Withdrawal of Consent|8
6910197|NCT00731120|10934524|FG002|Overall Study|Withdrawal of Consent|4
6910198|NCT00731120|10934522|FG000|Overall Study|Lost to Follow-up|10
6910199|NCT00731120|10934523|FG001|Overall Study|Lost to Follow-up|15
6910200|NCT00731120|10934524|FG002|Overall Study|Lost to Follow-up|17
6910201|NCT00731120|10934522|FG000|Overall Study|Other|4
6910202|NCT00731120|10934523|FG001|Overall Study|Other|0
6910203|NCT00731120|10934524|FG002|Overall Study|Other|1
6910204|NCT00731133|10934532|FG000|Overall Study|Withdrawal by Subject|10
6910205|NCT00731549|10934557|FG000|Overall Study|Lost to Follow-up|19
6910206|NCT00731549|10934557|FG000|Overall Study|Met withdrawal criteria|24
6910207|NCT00731549|10934557|FG000|Overall Study|Physician Decision|16
6910208|NCT00731549|10934557|FG000|Overall Study|Withdrawal by Subject|89
6910209|NCT00731549|10934557|FG000|Overall Study|Protocol deviation|1
6910210|NCT00731549|10934557|FG000|Overall Study|Adverse Event|31
6910211|NCT00731549|10934557|FG000|Overall Study|Lack of efficacy with AE|37
6910212|NCT00731549|10934557|FG000|Overall Study|Lack of efficacy without AE|6
6910213|NCT00731666|10934593|FG000|Overall Study|Adverse Event|2
6910214|NCT00731666|10934593|FG000|Overall Study|Lost to Follow-up|8
6910215|NCT00731666|10934593|FG000|Overall Study|Withdrawal by Subject|2
6910216|NCT00731679|10934599|FG000|Overall Study|Adverse Event|7
6910217|NCT00731679|10934600|FG001|Overall Study|Adverse Event|8
6910218|NCT00731679|10934599|FG000|Overall Study|Withdrawal by Subject|8
6910219|NCT00731679|10934600|FG001|Overall Study|Withdrawal by Subject|8
6910220|NCT00731679|10934599|FG000|Overall Study|Lost to Follow-up|7
6910221|NCT00731679|10934600|FG001|Overall Study|Lost to Follow-up|8
6910222|NCT00731679|10934599|FG000|Overall Study|Noncompliance|0
6910223|NCT00731679|10934600|FG001|Overall Study|Noncompliance|1
6910224|NCT00731679|10934599|FG000|Overall Study|Pregnancy|0
6910225|NCT00731679|10934600|FG001|Overall Study|Pregnancy|1
6910226|NCT00731692|10934609|FG000|Core Study (36 Months)|Lack of Efficacy|11
6910227|NCT00731692|10934610|FG001|Core Study (36 Months)|Lack of Efficacy|23
6910228|NCT00731692|10934611|FG002|Core Study (36 Months)|Lack of Efficacy|64
6910229|NCT00731692|10934609|FG000|Core Study (36 Months)|Physician Decision|1
6910230|NCT00731692|10934610|FG001|Core Study (36 Months)|Physician Decision|0
6910231|NCT00731692|10934611|FG002|Core Study (36 Months)|Physician Decision|2
6910232|NCT00731692|10934609|FG000|Core Study (36 Months)|Death|2
6910233|NCT00731692|10934610|FG001|Core Study (36 Months)|Death|1
6910234|NCT00731692|10934611|FG002|Core Study (36 Months)|Death|2
6910235|NCT00731692|10934609|FG000|Core Study (36 Months)|Lost to Follow-up|1
6910236|NCT00731692|10934610|FG001|Core Study (36 Months)|Lost to Follow-up|3
6910237|NCT00731692|10934611|FG002|Core Study (36 Months)|Lost to Follow-up|3
6910238|NCT00731692|10934609|FG000|Core Study (36 Months)|Administrative|2
6910239|NCT00731692|10934610|FG001|Core Study (36 Months)|Administrative|2
6910240|NCT00731692|10934611|FG002|Core Study (36 Months)|Administrative|6
6910241|NCT00731692|10934609|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4
6910242|NCT00731692|10934610|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3
6910243|NCT00731692|10934611|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5
6910244|NCT00731692|10934609|FG000|Core Study (36 Months)|Protocol Violation|4
6910245|NCT00731692|10934610|FG001|Core Study (36 Months)|Protocol Violation|5
6910246|NCT00731692|10934611|FG002|Core Study (36 Months)|Protocol Violation|8
6910247|NCT00731692|10934609|FG000|Core Study (36 Months)|Abnormal Lab values|6
6910248|NCT00731692|10934610|FG001|Core Study (36 Months)|Abnormal Lab values|19
6910249|NCT00731692|10934611|FG002|Core Study (36 Months)|Abnormal Lab values|5
6910250|NCT00731692|10934609|FG000|Core Study (36 Months)|Adverse Event|25
6910251|NCT00731692|10934610|FG001|Core Study (36 Months)|Adverse Event|28
6910252|NCT00731692|10934611|FG002|Core Study (36 Months)|Adverse Event|29
6910253|NCT00731692|10934609|FG000|Core Study (36 Months)|Withdrawal by Subject|12
6910254|NCT00731692|10934610|FG001|Core Study (36 Months)|Withdrawal by Subject|32
6910255|NCT00731692|10934611|FG002|Core Study (36 Months)|Withdrawal by Subject|46
6910256|NCT00731692|10934609|FG000|Extension Phase|Admin Problems: Terminated # patients|69
6910257|NCT00731692|10934610|FG001|Extension Phase|Admin Problems: Terminated # patients|189
6910258|NCT00731692|10934611|FG002|Extension Phase|Admin Problems: Terminated # patients|277
6910259|NCT00731692|10934609|FG000|Extension Phase|Abnormal test procedure|0
6910260|NCT00731692|10934610|FG001|Extension Phase|Abnormal test procedure|0
6910261|NCT00731692|10934611|FG002|Extension Phase|Abnormal test procedure|1
6910262|NCT00731692|10934609|FG000|Extension Phase|Abnormal lab values|0
6910263|NCT00731692|10934610|FG001|Extension Phase|Abnormal lab values|0
6910264|NCT00731692|10934611|FG002|Extension Phase|Abnormal lab values|1
6910265|NCT00731692|10934609|FG000|Extension Phase|Lost to Follow-up|0
6910266|NCT00731692|10934610|FG001|Extension Phase|Lost to Follow-up|1
6910267|NCT00731692|10934611|FG002|Extension Phase|Lost to Follow-up|4
6910268|NCT00731692|10934609|FG000|Extension Phase|Withdrawal by Subject|4
6910269|NCT00731692|10934610|FG001|Extension Phase|Withdrawal by Subject|5
6910270|NCT00731692|10934611|FG002|Extension Phase|Withdrawal by Subject|3
6910271|NCT00731692|10934609|FG000|Extension Phase|Adverse Event|1
6910272|NCT00731692|10934610|FG001|Extension Phase|Adverse Event|1
6910273|NCT00731692|10934611|FG002|Extension Phase|Adverse Event|15
6910274|NCT00731783|10934629|FG000|One Month Follow-Up Visit|Lost to Follow-up|14
6910275|NCT00731783|10934630|FG001|One Month Follow-Up Visit|Lost to Follow-up|22
6910276|NCT00731783|10934629|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7
6910277|NCT00731783|10934630|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16
6910278|NCT00731783|10934629|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6
6910279|NCT00731783|10934630|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3
6910280|NCT00731783|10934629|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6
6910281|NCT00731783|10934630|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7
6910282|NCT00731822|10934638|FG000|Overall Study|Adverse Event|2
6910283|NCT00731822|10934639|FG001|Overall Study|Adverse Event|1
6910284|NCT00731822|10934638|FG000|Overall Study|Protocol Violation|1
6910285|NCT00731822|10934639|FG001|Overall Study|Protocol Violation|0
6910286|NCT00731822|10934638|FG000|Overall Study|Lost to Follow-up|1
6910287|NCT00731822|10934639|FG001|Overall Study|Lost to Follow-up|0
6910288|NCT00731939|10934654|FG000|Overall Study|Adverse Event|6
6910289|NCT00731939|10934654|FG000|Overall Study|Lost to Follow-up|15
6910290|NCT00731939|10934654|FG000|Overall Study|Not implanted with study device|9
6910291|NCT00731939|10934654|FG000|Overall Study|Withdrawal by Subject|2
6910292|NCT00731939|10934654|FG000|Overall Study|Did not meet enrollment criteria|2
6910293|NCT00732069|10934662|FG000|Washout After First Study Drug|Adverse Event|1
6910294|NCT00732069|10934663|FG001|Washout After First Study Drug|Adverse Event|0
6910295|NCT00732069|10934664|FG002|Washout After First Study Drug|Adverse Event|0
6910296|NCT00732069|10934665|FG003|Washout After First Study Drug|Adverse Event|0
6910297|NCT00732069|10934666|FG004|Washout After First Study Drug|Adverse Event|0
6910298|NCT00732069|10934667|FG005|Washout After First Study Drug|Adverse Event|0
6910299|NCT00732160|10934679|FG000|Overall Study|Adverse Event|1
6910300|NCT00732160|10934680|FG001|Overall Study|Adverse Event|0
6910301|NCT00732160|10934681|FG002|Overall Study|Adverse Event|1
6910302|NCT00732160|10934682|FG003|Overall Study|Adverse Event|1
6910303|NCT00732160|10934679|FG000|Overall Study|scheduling|4
6910304|NCT00732160|10934680|FG001|Overall Study|scheduling|4
6910305|NCT00732160|10934681|FG002|Overall Study|scheduling|2
6910306|NCT00732160|10934682|FG003|Overall Study|scheduling|1
6910307|NCT00732199|10934694|FG000|Overall Study|Withdrawal by Subject|25
6910308|NCT00732199|10934695|FG001|Overall Study|Withdrawal by Subject|18
6910309|NCT00732199|10934694|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9
6910310|NCT00732199|10934695|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8
6910311|NCT00732238|10934727|FG000|Overall Study|Bacteremia|4
6910312|NCT00732238|10934728|FG001|Overall Study|Bacteremia|1
6910313|NCT00732238|10934727|FG000|Overall Study|Asymptomatic bacteriuria|1
6910314|NCT00732238|10934728|FG001|Overall Study|Asymptomatic bacteriuria|0
6910315|NCT00732251|10934736|FG000|Overall Study|Lost to Follow-up|3
6910316|NCT00732251|10934736|FG000|Overall Study|Withdrawal by Subject|3
6910317|NCT00732251|10934736|FG000|Overall Study|Early Term due to Site Closure|1
6910318|NCT00732303|10934740|FG000|Overall Study|Study Terminated|2
6910319|NCT00732472|10934748|FG000|Overall Study|Adverse Event|0
6910320|NCT00732472|10934749|FG001|Overall Study|Adverse Event|1
6910321|NCT00732472|10934750|FG002|Overall Study|Adverse Event|1
6910322|NCT00732472|10934751|FG003|Overall Study|Adverse Event|1
6910323|NCT00732472|10934748|FG000|Overall Study|Protocol Violation|0
6910324|NCT00732472|10934749|FG001|Overall Study|Protocol Violation|0
6910325|NCT00732472|10934750|FG002|Overall Study|Protocol Violation|0
6910326|NCT00732472|10934751|FG003|Overall Study|Protocol Violation|1
6910327|NCT00732472|10934748|FG000|Overall Study|Withdrawal by Subject|0
6910328|NCT00732472|10934749|FG001|Overall Study|Withdrawal by Subject|2
6910329|NCT00732472|10934750|FG002|Overall Study|Withdrawal by Subject|0
6910330|NCT00732472|10934751|FG003|Overall Study|Withdrawal by Subject|1
6910331|NCT00732498|10934762|FG000|Overall Study|Ineligible|1
6910332|NCT00732498|10934762|FG000|Overall Study|Adverse Event|2
6910333|NCT00732498|10934762|FG000|Overall Study|Physician Decision|3
6910334|NCT00732615|10934768|FG000|Overall Study|Withdrawal by Subject|3
6910335|NCT00732615|10934769|FG001|Overall Study|Withdrawal by Subject|1
6910336|NCT00732615|10934768|FG000|Overall Study|Lost to Follow-up|0
6910337|NCT00732615|10934769|FG001|Overall Study|Lost to Follow-up|1
6910338|NCT00732615|10934768|FG000|Overall Study|Adverse Event|0
6910339|NCT00732615|10934769|FG001|Overall Study|Adverse Event|2
6910340|NCT00732615|10934768|FG000|Overall Study|Physician Decision|3
6910341|NCT00732615|10934769|FG001|Overall Study|Physician Decision|0
6910342|NCT00732615|10934768|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1
6910343|NCT00732615|10934769|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1
6910344|NCT00732641|10934778|FG000|Overall Study|Relapse or Progressive Disease|65
6910345|NCT00732641|10934779|FG001|Overall Study|Relapse or Progressive Disease|101
6910346|NCT00732641|10934778|FG000|Overall Study|Serious Adverse Events|12
6910347|NCT00732641|10934779|FG001|Overall Study|Serious Adverse Events|3
6910348|NCT00732641|10934778|FG000|Overall Study|Physician Decision|6
6910349|NCT00732641|10934779|FG001|Overall Study|Physician Decision|0
6910350|NCT00732641|10934778|FG000|Overall Study|Withdrawal by Subject|4
6910351|NCT00732641|10934779|FG001|Overall Study|Withdrawal by Subject|2
6910352|NCT00732641|10934778|FG000|Overall Study|Unable to Complete|1
6910353|NCT00732641|10934779|FG001|Overall Study|Unable to Complete|1
6910354|NCT00732641|10934778|FG000|Overall Study|Other|18
6910355|NCT00732641|10934779|FG001|Overall Study|Other|5
6910356|NCT00732758|10934800|FG000|Overall Study|Lost to Follow-up|8
6910357|NCT00732758|10934801|FG001|Overall Study|Lost to Follow-up|16
6910358|NCT00732875|10934807|FG000|Overall Study|Adverse Event|16
6910359|NCT00732875|10934807|FG000|Overall Study|Withdrawal by Subject|6
6910360|NCT00732875|10934807|FG000|Overall Study|Lack of Efficacy|13
6910361|NCT00732940|10934822|FG000|Overall Study|Withdrawal by Subject|1
6910362|NCT00732940|10934823|FG001|Overall Study|Withdrawal by Subject|2
6910363|NCT00732940|10934822|FG000|Overall Study|Adverse Event|0
6910364|NCT00732940|10934823|FG001|Overall Study|Adverse Event|1
6910365|NCT00732940|10934822|FG000|Overall Study|Lost to Follow-up|1
6910366|NCT00732940|10934823|FG001|Overall Study|Lost to Follow-up|0
6910367|NCT00732992|10934831|FG000|Overall Study|Adverse Event|1
6910368|NCT00732992|10934832|FG001|Overall Study|Adverse Event|1
6910369|NCT00732992|10934831|FG000|Overall Study|Objective Progression or Relapse|3
6910370|NCT00732992|10934832|FG001|Overall Study|Objective Progression or Relapse|5
6910371|NCT00732992|10934831|FG000|Overall Study|Global Deterioration of Health Status|1
6910372|NCT00732992|10934832|FG001|Overall Study|Global Deterioration of Health Status|0
6910373|NCT00732992|10934831|FG000|Overall Study|Withdrawal by Subject|1
6910374|NCT00732992|10934832|FG001|Overall Study|Withdrawal by Subject|0
6910375|NCT00733226|10934860|FG000|Overall Study|Withdrawal by Subject|1
6910376|NCT00733226|10934861|FG001|Overall Study|Withdrawal by Subject|0
6910377|NCT00733226|10934860|FG000|Overall Study|Lost to Follow-up|2
6910378|NCT00733226|10934861|FG001|Overall Study|Lost to Follow-up|0
6910379|NCT00733226|10934860|FG000|Overall Study|moved to another place|2
6910380|NCT00733226|10934861|FG001|Overall Study|moved to another place|0
6974088|NCT01185353|11025994|FG009|Part C (Weeks 24 Through 76)|Death|1
6974089|NCT01185353|11025985|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
6974090|NCT01185353|11025986|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
6974091|NCT01185353|11025987|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
6974092|NCT01185353|11025988|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
6974093|NCT01185353|11025989|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
6974094|NCT01185353|11025990|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
6974095|NCT01185353|11025991|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
6974096|NCT01185353|11025992|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
6974097|NCT01185353|11025993|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
6974098|NCT01185353|11025994|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1
6974099|NCT01185353|11025985|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0
6974100|NCT01185353|11025986|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0
6974101|NCT01185353|11025987|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0
6974102|NCT01185353|11025988|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0
6974103|NCT01185353|11025989|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0
6974104|NCT01185353|11025990|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0
6974105|NCT01185353|11025991|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0
6974106|NCT01185353|11025992|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0
6974107|NCT01185353|11025993|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0
6974108|NCT01185353|11025994|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1
6974109|NCT01185353|11025985|FG000|Part C (Weeks 24 Through 76)|Reason missing|0
6974110|NCT01185353|11025986|FG001|Part C (Weeks 24 Through 76)|Reason missing|0
6974111|NCT01185353|11025987|FG002|Part C (Weeks 24 Through 76)|Reason missing|0
6974112|NCT01185353|11025988|FG003|Part C (Weeks 24 Through 76)|Reason missing|0
6974113|NCT01185353|11025989|FG004|Part C (Weeks 24 Through 76)|Reason missing|0
6974114|NCT01185353|11025990|FG005|Part C (Weeks 24 Through 76)|Reason missing|0
6978926|NCT01215227|11032516|FG004|Overall Study|Missing Status|0
6978927|NCT01215227|11032517|FG005|Overall Study|Missing Status|0
6978928|NCT01215227|11032512|FG000|Overall Study|Randomized but not treated|0
6978929|NCT01215227|11032513|FG001|Overall Study|Randomized but not treated|0
6978930|NCT01215227|11032514|FG002|Overall Study|Randomized but not treated|1
6978931|NCT01215227|11032515|FG003|Overall Study|Randomized but not treated|1
6974115|NCT01185353|11025991|FG006|Part C (Weeks 24 Through 76)|Reason missing|0
6974116|NCT01185353|11025992|FG007|Part C (Weeks 24 Through 76)|Reason missing|0
6974117|NCT01185353|11025993|FG008|Part C (Weeks 24 Through 76)|Reason missing|1
6974118|NCT01185353|11025994|FG009|Part C (Weeks 24 Through 76)|Reason missing|0
6974119|NCT01185353|11025985|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
6974120|NCT01185353|11025986|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
6910381|NCT00733291|10934874|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1
6910382|NCT00733291|10934875|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
6910383|NCT00733291|10934876|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
6910384|NCT00733291|10934877|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
6910385|NCT00733304|10934891|FG000|Overall Study|Adverse Event|3
6910386|NCT00733304|10934892|FG001|Overall Study|Adverse Event|0
6910387|NCT00733304|10934893|FG002|Overall Study|Adverse Event|0
6910388|NCT00733304|10934891|FG000|Overall Study|Lack of Efficacy|0
6910389|NCT00733304|10934892|FG001|Overall Study|Lack of Efficacy|0
6910390|NCT00733304|10934893|FG002|Overall Study|Lack of Efficacy|2
6910391|NCT00733304|10934891|FG000|Overall Study|Lost to Follow-up|0
6910392|NCT00733304|10934892|FG001|Overall Study|Lost to Follow-up|1
6910393|NCT00733304|10934893|FG002|Overall Study|Lost to Follow-up|0
6910394|NCT00733304|10934891|FG000|Overall Study|Physician Decision|3
6910395|NCT00733304|10934892|FG001|Overall Study|Physician Decision|1
6910396|NCT00733304|10934893|FG002|Overall Study|Physician Decision|3
6910397|NCT00733304|10934891|FG000|Overall Study|Withdrawal by Subject|1
6910398|NCT00733304|10934892|FG001|Overall Study|Withdrawal by Subject|1
6910399|NCT00733304|10934893|FG002|Overall Study|Withdrawal by Subject|0
6910400|NCT00733369|10934928|FG000|Overall Study|Lost to Follow-up|2
6910401|NCT00733369|10934929|FG001|Overall Study|Lost to Follow-up|1
6910402|NCT00733369|10934928|FG000|Overall Study|Adverse Event|4
6910403|NCT00733369|10934929|FG001|Overall Study|Adverse Event|4
6910404|NCT00733369|10934928|FG000|Overall Study|Protocol Violation|4
6910405|NCT00733369|10934929|FG001|Overall Study|Protocol Violation|4
6910406|NCT00733408|10934935|FG000|Overall Study|Adverse Event|4
6910407|NCT00733421|10934941|FG000|Overall Study|Withdrawal by Subject|1
6910408|NCT00733421|10934942|FG001|Overall Study|Withdrawal by Subject|1
6910409|NCT00733499|10934950|FG000|Pre-operative|Protocol Violation|0
6910410|NCT00733499|10934951|FG001|Pre-operative|Protocol Violation|1
6910411|NCT00733499|10934950|FG000|3 Months Follow-up|Death|1
6910412|NCT00733499|10934951|FG001|3 Months Follow-up|Death|2
6910413|NCT00733499|10934950|FG000|6 Months Follow-up|Death|0
6910414|NCT00733499|10934951|FG001|6 Months Follow-up|Death|2
6910415|NCT00733499|10934950|FG000|6 Months Follow-up|Adverse Event|0
6910416|NCT00733499|10934951|FG001|6 Months Follow-up|Adverse Event|1
6910417|NCT00733499|10934950|FG000|12 Months Follow-up|Death|2
6910418|NCT00733499|10934951|FG001|12 Months Follow-up|Death|1
6910419|NCT00733499|10934950|FG000|24 Months Follow-up|Death|0
6910420|NCT00733499|10934951|FG001|24 Months Follow-up|Death|1
6910421|NCT00733499|10934950|FG000|5 Year Followup|Adverse Event|2
6910422|NCT00733499|10934951|FG001|5 Year Followup|Adverse Event|2
6910423|NCT00733499|10934950|FG000|5 Year Followup|Non device related AE|0
6910424|NCT00733499|10934951|FG001|5 Year Followup|Non device related AE|1
6910425|NCT00733499|10934950|FG000|5 Year Followup|Revision of Study Implant|0
6910426|NCT00733499|10934951|FG001|5 Year Followup|Revision of Study Implant|1
6910427|NCT00733499|10934950|FG000|5 Year Followup|Lost to Follow-up|2
6910428|NCT00733499|10934951|FG001|5 Year Followup|Lost to Follow-up|0
6910429|NCT00733499|10934950|FG000|5 Year Followup|Death|13
6910430|NCT00733499|10934951|FG001|5 Year Followup|Death|19
6910431|NCT00733499|10934950|FG000|5 Year Followup|missing, unable to locate|0
6910432|NCT00733499|10934951|FG001|5 Year Followup|missing, unable to locate|1
6910433|NCT00733499|10934950|FG000|5 Year Followup|Withdrawal by Subject|4
6910434|NCT00733499|10934951|FG001|5 Year Followup|Withdrawal by Subject|1
6978932|NCT01215227|11032516|FG004|Overall Study|Randomized but not treated|0
6978933|NCT01215227|11032517|FG005|Overall Study|Randomized but not treated|1
6978934|NCT01215253|11032542|FG000|Overall Study|Withdrawal by Subject|57
6978935|NCT01215253|11032543|FG001|Overall Study|Withdrawal by Subject|35
6978936|NCT01215253|11032542|FG000|Overall Study|Physician Decision|9
6978937|NCT01215253|11032543|FG001|Overall Study|Physician Decision|12
6978938|NCT01215253|11032542|FG000|Overall Study|Lost to Follow-up|6
6978939|NCT01215253|11032543|FG001|Overall Study|Lost to Follow-up|4
6978940|NCT01215253|11032542|FG000|Overall Study|Other|14
6978941|NCT01215253|11032543|FG001|Overall Study|Other|12
6978942|NCT01215357|11032610|FG000|Overall Study|Withdrawal by Subject|3
6978943|NCT01215357|11032610|FG000|Overall Study|Protocol Violation|9
6978944|NCT01215422|11032618|FG000|Overall Study|Relocation|1
6978945|NCT01215422|11032619|FG001|Overall Study|Relocation|0
6978946|NCT01215422|11032620|FG002|Overall Study|Relocation|0
6978947|NCT01215422|11032621|FG003|Overall Study|Relocation|0
6978948|NCT01215422|11032618|FG000|Overall Study|Failed intubations|0
6978949|NCT01215422|11032619|FG001|Overall Study|Failed intubations|0
6978950|NCT01215422|11032620|FG002|Overall Study|Failed intubations|3
6978951|NCT01215422|11032621|FG003|Overall Study|Failed intubations|8
6978952|NCT01215422|11032618|FG000|Overall Study|Did not complete all intubations|7
6978953|NCT01215422|11032619|FG001|Overall Study|Did not complete all intubations|0
6978954|NCT01215422|11032620|FG002|Overall Study|Did not complete all intubations|0
6978955|NCT01215422|11032621|FG003|Overall Study|Did not complete all intubations|0
6978956|NCT01215435|11032645|FG000|Overall Study|Adverse Event|1
6910435|NCT00733499|10934950|FG000|10 Year Followup|Death|9
6978957|NCT01215435|11032646|FG001|Overall Study|Adverse Event|0
6978958|NCT01215435|11032645|FG000|Overall Study|Protocol Violation|2
6978959|NCT01215435|11032646|FG001|Overall Study|Protocol Violation|0
6978960|NCT01215435|11032645|FG000|Overall Study|Withdrawal Criteria|8
6910436|NCT00733499|10934951|FG001|10 Year Followup|Death|7
6910437|NCT00733499|10934950|FG000|10 Year Followup|Adverse Event|3
6910438|NCT00733499|10934951|FG001|10 Year Followup|Adverse Event|3
6910439|NCT00733499|10934950|FG000|10 Year Followup|Lost to Follow-up|3
6910440|NCT00733499|10934951|FG001|10 Year Followup|Lost to Follow-up|2
6910441|NCT00733499|10934950|FG000|10 Year Followup|Withdrawal by Subject|5
6910442|NCT00733499|10934951|FG001|10 Year Followup|Withdrawal by Subject|5
6910443|NCT00733499|10934950|FG000|10 Year Followup|missing, unable to locate|0
6910444|NCT00733499|10934951|FG001|10 Year Followup|missing, unable to locate|2
6910445|NCT00733746|10934961|FG000|Overall Study|Ineligible|5
6910446|NCT00733824|10934970|FG000|Phase I|Withdrawal by Subject|1
6910447|NCT00733824|10934971|FG001|Phase I|Withdrawal by Subject|0
6910448|NCT00733824|10934972|FG002|Phase I|Withdrawal by Subject|0
6910449|NCT00733824|10934973|FG003|Phase I|Withdrawal by Subject|0
6910450|NCT00733824|10934974|FG004|Phase I|Withdrawal by Subject|0
6910451|NCT00733902|10934992|FG000|Overall Study|Death|0
6910452|NCT00733902|10934993|FG001|Overall Study|Death|0
6910453|NCT00733902|10934994|FG002|Overall Study|Death|0
6910454|NCT00733902|10934995|FG003|Overall Study|Death|1
6910455|NCT00733902|10934992|FG000|Overall Study|Adverse Event|3
6910456|NCT00733902|10934993|FG001|Overall Study|Adverse Event|4
6910457|NCT00733902|10934994|FG002|Overall Study|Adverse Event|7
6910458|NCT00733902|10934995|FG003|Overall Study|Adverse Event|11
6910459|NCT00733902|10934992|FG000|Overall Study|Lack of Efficacy|56
6910460|NCT00733902|10934993|FG001|Overall Study|Lack of Efficacy|21
6910461|NCT00733902|10934994|FG002|Overall Study|Lack of Efficacy|34
6910462|NCT00733902|10934995|FG003|Overall Study|Lack of Efficacy|23
6910463|NCT00733902|10934992|FG000|Overall Study|Protocol Violation|4
6910464|NCT00733902|10934993|FG001|Overall Study|Protocol Violation|6
6910465|NCT00733902|10934994|FG002|Overall Study|Protocol Violation|3
6910466|NCT00733902|10934995|FG003|Overall Study|Protocol Violation|3
6910467|NCT00733902|10934992|FG000|Overall Study|Withdrawal by Subject|10
6910468|NCT00733902|10934993|FG001|Overall Study|Withdrawal by Subject|5
6910469|NCT00733902|10934994|FG002|Overall Study|Withdrawal by Subject|4
6910470|NCT00733902|10934995|FG003|Overall Study|Withdrawal by Subject|16
6910471|NCT00733902|10934992|FG000|Overall Study|Entered extension study|89
6910472|NCT00733902|10934993|FG001|Overall Study|Entered extension study|124
6910473|NCT00733902|10934994|FG002|Overall Study|Entered extension study|111
6910474|NCT00733902|10934995|FG003|Overall Study|Entered extension study|109
6910475|NCT00733902|10934992|FG000|Overall Study|Randomized but not treated|2
6910476|NCT00733902|10934993|FG001|Overall Study|Randomized but not treated|2
6910477|NCT00733902|10934994|FG002|Overall Study|Randomized but not treated|2
6910478|NCT00733902|10934995|FG003|Overall Study|Randomized but not treated|1
6910479|NCT00733954|10935007|FG000|Overall Study|Lost to Follow-up|5
6910480|NCT00733954|10935008|FG001|Overall Study|Lost to Follow-up|2
6910481|NCT00733954|10935007|FG000|Overall Study|Protocol Violation|1
6910482|NCT00733954|10935008|FG001|Overall Study|Protocol Violation|0
6910483|NCT00733954|10935007|FG000|Overall Study|Withdrawal by Subject|2
6910484|NCT00733954|10935008|FG001|Overall Study|Withdrawal by Subject|0
6910485|NCT00733980|10935016|FG000|Overall Study|Adverse Event|5
6910486|NCT00733980|10935017|FG001|Overall Study|Adverse Event|2
6910487|NCT00733980|10935016|FG000|Overall Study|Lack of Efficacy|0
6910488|NCT00733980|10935017|FG001|Overall Study|Lack of Efficacy|1
6910489|NCT00733980|10935016|FG000|Overall Study|Protocol Violation|2
6910490|NCT00733980|10935017|FG001|Overall Study|Protocol Violation|1
6910491|NCT00733980|10935016|FG000|Overall Study|Protocol defined stopping criteria reach|1
6910492|NCT00733980|10935017|FG001|Overall Study|Protocol defined stopping criteria reach|1
6910493|NCT00733980|10935016|FG000|Overall Study|Lost to Follow-up|6
6910494|NCT00733980|10935017|FG001|Overall Study|Lost to Follow-up|11
6910495|NCT00733980|10935016|FG000|Overall Study|Physician Decision|2
6910496|NCT00733980|10935017|FG001|Overall Study|Physician Decision|3
6910497|NCT00733980|10935016|FG000|Overall Study|Withdrawal by Subject|6
6910498|NCT00733980|10935017|FG001|Overall Study|Withdrawal by Subject|2
6910499|NCT00734032|10935042|FG000|Overall Study|Adverse Event|0
6910500|NCT00734032|10935043|FG001|Overall Study|Adverse Event|1
6910501|NCT00734032|10935044|FG002|Overall Study|Adverse Event|0
6910502|NCT00734032|10935045|FG003|Overall Study|Adverse Event|0
6910503|NCT00734071|10935057|FG000|Overall Study|Adverse Event|4
6910504|NCT00734071|10935058|FG001|Overall Study|Adverse Event|3
6910505|NCT00734071|10935057|FG000|Overall Study|Lack of Efficacy|3
6910506|NCT00734071|10935058|FG001|Overall Study|Lack of Efficacy|1
6910507|NCT00734071|10935057|FG000|Overall Study|Noncompliance|2
6910508|NCT00734071|10935058|FG001|Overall Study|Noncompliance|2
6910509|NCT00734071|10935057|FG000|Overall Study|Protocol Deviations|3
6910510|NCT00734071|10935058|FG001|Overall Study|Protocol Deviations|4
6910511|NCT00734071|10935057|FG000|Overall Study|Voluntary Withdrawal|9
6910512|NCT00734071|10935058|FG001|Overall Study|Voluntary Withdrawal|7
6910513|NCT00734071|10935057|FG000|Overall Study|Lost to Follow-up|16
6910514|NCT00734071|10935058|FG001|Overall Study|Lost to Follow-up|8
6910515|NCT00734071|10935057|FG000|Overall Study|Other|1
6910516|NCT00734071|10935058|FG001|Overall Study|Other|2
6910517|NCT00734097|10935064|FG000|Screening|Protocol Violation|12
6910518|NCT00734097|10935064|FG000|Screening|Withdrawal by Subject|5
6910519|NCT00734097|10935064|FG000|Screening|Lost to Follow-up|2
6910520|NCT00734097|10935064|FG000|Screening|Unconfirmed pregnancy|1
6910521|NCT00734097|10935064|FG000|Open Label|Lost to Follow-up|7
6910522|NCT00734097|10935064|FG000|Open Label|Withdrawal by Subject|5
6910523|NCT00734097|10935064|FG000|Open Label|Protocol Violation|4
6910524|NCT00734149|10935068|FG000|Overall Study|Withdrawal by Subject|1
6910525|NCT00734162|10935078|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0
6910526|NCT00734162|10935079|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1
6910527|NCT00734162|10935080|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0
6910528|NCT00734162|10935081|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2
6910529|NCT00734162|10935078|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
6910530|NCT00734162|10935079|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
6910531|NCT00734162|10935080|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
6910532|NCT00734162|10935081|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2
6910533|NCT00734162|10935078|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1
6910534|NCT00734162|10935079|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
6910535|NCT00734162|10935080|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
6910536|NCT00734162|10935081|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
6910537|NCT00734162|10935078|FG000|Open-Label Phase|Withdrew Consent|1
6910538|NCT00734162|10935079|FG001|Open-Label Phase|Withdrew Consent|0
6910539|NCT00734162|10935080|FG002|Open-Label Phase|Withdrew Consent|1
6910540|NCT00734162|10935081|FG003|Open-Label Phase|Withdrew Consent|1
6910541|NCT00734162|10935078|FG000|Open-Label Phase|Lost to Follow-up|1
6910542|NCT00734162|10935079|FG001|Open-Label Phase|Lost to Follow-up|2
6910543|NCT00734162|10935080|FG002|Open-Label Phase|Lost to Follow-up|0
6910544|NCT00734162|10935081|FG003|Open-Label Phase|Lost to Follow-up|1
6910545|NCT00734162|10935078|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0
6910546|NCT00734162|10935079|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0
6910547|NCT00734162|10935080|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0
6910548|NCT00734162|10935081|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1
6910549|NCT00734214|10935097|FG000|Overall Study|Withdrawal by Subject|3
6910550|NCT00734214|10935098|FG001|Overall Study|Withdrawal by Subject|4
6910551|NCT00734214|10935097|FG000|Overall Study|MD withdrawal|1
6910552|NCT00734214|10935098|FG001|Overall Study|MD withdrawal|0
6910553|NCT00734474|10935159|FG000|Overall Study|Entry Criteria Not Met|0
6910554|NCT00734474|10935160|FG001|Overall Study|Entry Criteria Not Met|0
6910555|NCT00734474|10935161|FG002|Overall Study|Entry Criteria Not Met|5
6910556|NCT00734474|10935162|FG003|Overall Study|Entry Criteria Not Met|0
6910557|NCT00734474|10935163|FG004|Overall Study|Entry Criteria Not Met|3
6910558|NCT00734474|10935164|FG005|Overall Study|Entry Criteria Not Met|1
6910559|NCT00734474|10935165|FG006|Overall Study|Entry Criteria Not Met|0
6910560|NCT00734474|10935166|FG007|Overall Study|Entry Criteria Not Met|1
6910561|NCT00734474|10935167|FG008|Overall Study|Entry Criteria Not Met|1
6910562|NCT00734474|10935159|FG000|Overall Study|Lost to Follow-up|1
6910563|NCT00734474|10935160|FG001|Overall Study|Lost to Follow-up|0
6910564|NCT00734474|10935161|FG002|Overall Study|Lost to Follow-up|13
6910565|NCT00734474|10935162|FG003|Overall Study|Lost to Follow-up|0
6910566|NCT00734474|10935163|FG004|Overall Study|Lost to Follow-up|11
6910567|NCT00734474|10935164|FG005|Overall Study|Lost to Follow-up|1
6910568|NCT00734474|10935165|FG006|Overall Study|Lost to Follow-up|0
6910569|NCT00734474|10935166|FG007|Overall Study|Lost to Follow-up|9
6910570|NCT00734474|10935167|FG008|Overall Study|Lost to Follow-up|4
6910571|NCT00734474|10935159|FG000|Overall Study|Withdrawal by Subject|2
6910572|NCT00734474|10935160|FG001|Overall Study|Withdrawal by Subject|1
6910573|NCT00734474|10935161|FG002|Overall Study|Withdrawal by Subject|18
6910574|NCT00734474|10935162|FG003|Overall Study|Withdrawal by Subject|0
6910575|NCT00734474|10935163|FG004|Overall Study|Withdrawal by Subject|24
6910576|NCT00734474|10935164|FG005|Overall Study|Withdrawal by Subject|2
6910577|NCT00734474|10935165|FG006|Overall Study|Withdrawal by Subject|0
6910578|NCT00734474|10935166|FG007|Overall Study|Withdrawal by Subject|36
6910579|NCT00734474|10935167|FG008|Overall Study|Withdrawal by Subject|21
6910580|NCT00734474|10935159|FG000|Overall Study|Physician Decision|0
6910581|NCT00734474|10935160|FG001|Overall Study|Physician Decision|0
6910582|NCT00734474|10935161|FG002|Overall Study|Physician Decision|4
6910583|NCT00734474|10935162|FG003|Overall Study|Physician Decision|1
6910584|NCT00734474|10935163|FG004|Overall Study|Physician Decision|11
6910585|NCT00734474|10935164|FG005|Overall Study|Physician Decision|0
6910586|NCT00734474|10935165|FG006|Overall Study|Physician Decision|0
6910587|NCT00734474|10935166|FG007|Overall Study|Physician Decision|9
6910588|NCT00734474|10935167|FG008|Overall Study|Physician Decision|9
6910589|NCT00734474|10935159|FG000|Overall Study|Adverse Event|4
6910590|NCT00734474|10935160|FG001|Overall Study|Adverse Event|4
6910591|NCT00734474|10935161|FG002|Overall Study|Adverse Event|63
6910592|NCT00734474|10935162|FG003|Overall Study|Adverse Event|1
6910593|NCT00734474|10935163|FG004|Overall Study|Adverse Event|64
6910594|NCT00734474|10935164|FG005|Overall Study|Adverse Event|0
6910595|NCT00734474|10935165|FG006|Overall Study|Adverse Event|1
6910596|NCT00734474|10935166|FG007|Overall Study|Adverse Event|65
6910597|NCT00734474|10935167|FG008|Overall Study|Adverse Event|39
6910598|NCT00734474|10935159|FG000|Overall Study|Protocol Violation|0
6910599|NCT00734474|10935160|FG001|Overall Study|Protocol Violation|0
6910600|NCT00734474|10935161|FG002|Overall Study|Protocol Violation|4
6910601|NCT00734474|10935162|FG003|Overall Study|Protocol Violation|0
6910602|NCT00734474|10935163|FG004|Overall Study|Protocol Violation|3
6910603|NCT00734474|10935164|FG005|Overall Study|Protocol Violation|0
6910604|NCT00734474|10935165|FG006|Overall Study|Protocol Violation|0
6910605|NCT00734474|10935166|FG007|Overall Study|Protocol Violation|3
6910606|NCT00734474|10935167|FG008|Overall Study|Protocol Violation|1
6910607|NCT00734474|10935159|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8
6910608|NCT00734474|10935160|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25
6910609|NCT00734474|10935161|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0
6910610|NCT00734474|10935162|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8
6910611|NCT00734474|10935163|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0
6910612|NCT00734474|10935164|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21
6910613|NCT00734474|10935165|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23
6910614|NCT00734474|10935166|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0
6910615|NCT00734474|10935167|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0
6910616|NCT00734474|10935159|FG000|Overall Study|Sponsor Decision|0
6910617|NCT00734474|10935160|FG001|Overall Study|Sponsor Decision|0
6910618|NCT00734474|10935161|FG002|Overall Study|Sponsor Decision|0
6910619|NCT00734474|10935162|FG003|Overall Study|Sponsor Decision|0
6910620|NCT00734474|10935163|FG004|Overall Study|Sponsor Decision|2
6910621|NCT00734474|10935164|FG005|Overall Study|Sponsor Decision|0
6910622|NCT00734474|10935165|FG006|Overall Study|Sponsor Decision|0
6910623|NCT00734474|10935166|FG007|Overall Study|Sponsor Decision|0
6910624|NCT00734474|10935167|FG008|Overall Study|Sponsor Decision|0
6910625|NCT00734474|10935159|FG000|Overall Study|Death|0
6910626|NCT00734474|10935160|FG001|Overall Study|Death|0
6910627|NCT00734474|10935161|FG002|Overall Study|Death|1
6910628|NCT00734474|10935162|FG003|Overall Study|Death|0
6910629|NCT00734474|10935163|FG004|Overall Study|Death|0
6910630|NCT00734474|10935164|FG005|Overall Study|Death|0
6910631|NCT00734474|10935165|FG006|Overall Study|Death|0
6910632|NCT00734474|10935166|FG007|Overall Study|Death|2
6910633|NCT00734474|10935167|FG008|Overall Study|Death|1
6910634|NCT00734474|10935159|FG000|Overall Study|Lack of Efficacy|0
6910635|NCT00734474|10935160|FG001|Overall Study|Lack of Efficacy|0
6910636|NCT00734474|10935161|FG002|Overall Study|Lack of Efficacy|4
6910637|NCT00734474|10935162|FG003|Overall Study|Lack of Efficacy|0
6910638|NCT00734474|10935163|FG004|Overall Study|Lack of Efficacy|0
6910639|NCT00734474|10935164|FG005|Overall Study|Lack of Efficacy|0
6910640|NCT00734474|10935165|FG006|Overall Study|Lack of Efficacy|0
6910641|NCT00734474|10935166|FG007|Overall Study|Lack of Efficacy|4
6910642|NCT00734474|10935167|FG008|Overall Study|Lack of Efficacy|6
6910643|NCT00734539|10935199|FG000|Main Study|Death|33
6910644|NCT00734539|10935200|FG001|Main Study|Death|32
6910645|NCT00734539|10935199|FG000|Main Study|Physician Decision|2
6910646|NCT00734539|10935200|FG001|Main Study|Physician Decision|0
6910647|NCT00734539|10935199|FG000|Main Study|Withdrawal by Subject|1
6910648|NCT00734539|10935200|FG001|Main Study|Withdrawal by Subject|3
6910649|NCT00734539|10935199|FG000|Main Study|Enrolled in error; ineligible|1
6910650|NCT00734539|10935200|FG001|Main Study|Enrolled in error; ineligible|0
6910651|NCT00734578|10935212|FG000|Overall Study|Adverse Event|4
6910652|NCT00734578|10935213|FG001|Overall Study|Adverse Event|6
6910653|NCT00734578|10935214|FG002|Overall Study|Adverse Event|1
6910654|NCT00734578|10935212|FG000|Overall Study|Protocol Violation|8
6910655|NCT00734578|10935213|FG001|Overall Study|Protocol Violation|6
6910656|NCT00734578|10935214|FG002|Overall Study|Protocol Violation|3
6910657|NCT00734578|10935212|FG000|Overall Study|Withdrawal by Subject|7
6910658|NCT00734578|10935213|FG001|Overall Study|Withdrawal by Subject|8
6910659|NCT00734578|10935214|FG002|Overall Study|Withdrawal by Subject|11
6910660|NCT00734578|10935212|FG000|Overall Study|Lost to Follow-up|9
6910661|NCT00734578|10935213|FG001|Overall Study|Lost to Follow-up|3
6910662|NCT00734578|10935214|FG002|Overall Study|Lost to Follow-up|5
6910663|NCT00734578|10935212|FG000|Overall Study|Lack of Efficacy|3
6910664|NCT00734578|10935213|FG001|Overall Study|Lack of Efficacy|2
6910665|NCT00734578|10935214|FG002|Overall Study|Lack of Efficacy|5
6910666|NCT00734578|10935212|FG000|Overall Study|Randomized in error|1
6910667|NCT00734578|10935213|FG001|Overall Study|Randomized in error|0
6910668|NCT00734578|10935214|FG002|Overall Study|Randomized in error|0
6910669|NCT00734578|10935212|FG000|Overall Study|Exclusion criteria|1
6910670|NCT00734578|10935213|FG001|Overall Study|Exclusion criteria|0
6910671|NCT00734578|10935214|FG002|Overall Study|Exclusion criteria|0
6910672|NCT00734591|10935224|FG000|Screening for Prospective Period|Site did not participate|1604
6910673|NCT00734591|10935225|FG001|Screening for Prospective Period|Site did not participate|1488
6910674|NCT00734591|10935224|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913
6910675|NCT00734591|10935225|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803
6910676|NCT00734591|10935224|FG000|Prospective Period|Withdrawal by Subject|11
6910677|NCT00734591|10935225|FG001|Prospective Period|Withdrawal by Subject|9
6910678|NCT00734591|10935224|FG000|Prospective Period|Lost to Follow-up|37
6910679|NCT00734591|10935225|FG001|Prospective Period|Lost to Follow-up|33
6910680|NCT00734591|10935224|FG000|Prospective Period|Study Terminated|1
6910681|NCT00734591|10935225|FG001|Prospective Period|Study Terminated|0
6910682|NCT00734591|10935224|FG000|Prospective Period|Other|2
6910683|NCT00734591|10935225|FG001|Prospective Period|Other|2
6910684|NCT00734604|10935237|FG000|Overall Study|Adverse Event|0
6910685|NCT00734604|10935238|FG001|Overall Study|Adverse Event|2
6910686|NCT00734604|10935239|FG002|Overall Study|Adverse Event|0
6910687|NCT00734604|10935240|FG003|Overall Study|Adverse Event|2
6910688|NCT00734604|10935241|FG004|Overall Study|Adverse Event|1
6910689|NCT00734604|10935242|FG005|Overall Study|Adverse Event|1
6910690|NCT00734604|10935237|FG000|Overall Study|Serious Adverse Event|1
6910691|NCT00734604|10935238|FG001|Overall Study|Serious Adverse Event|0
6910692|NCT00734604|10935239|FG002|Overall Study|Serious Adverse Event|1
6910693|NCT00734604|10935240|FG003|Overall Study|Serious Adverse Event|2
6910694|NCT00734604|10935241|FG004|Overall Study|Serious Adverse Event|0
6910695|NCT00734604|10935242|FG005|Overall Study|Serious Adverse Event|1
6910696|NCT00734604|10935237|FG000|Overall Study|Lost to Follow-up|1
6910697|NCT00734604|10935238|FG001|Overall Study|Lost to Follow-up|2
6910698|NCT00734604|10935239|FG002|Overall Study|Lost to Follow-up|2
6910699|NCT00734604|10935240|FG003|Overall Study|Lost to Follow-up|4
6910700|NCT00734604|10935241|FG004|Overall Study|Lost to Follow-up|2
6910701|NCT00734604|10935242|FG005|Overall Study|Lost to Follow-up|3
6910702|NCT00734604|10935237|FG000|Overall Study|Physician Decision|0
6910703|NCT00734604|10935238|FG001|Overall Study|Physician Decision|1
6910704|NCT00734604|10935239|FG002|Overall Study|Physician Decision|1
6910705|NCT00734604|10935240|FG003|Overall Study|Physician Decision|0
6910706|NCT00734604|10935241|FG004|Overall Study|Physician Decision|0
6910707|NCT00734604|10935242|FG005|Overall Study|Physician Decision|0
6910708|NCT00734604|10935237|FG000|Overall Study|Protocol Violation|0
6910709|NCT00734604|10935238|FG001|Overall Study|Protocol Violation|2
6910710|NCT00734604|10935239|FG002|Overall Study|Protocol Violation|0
6910711|NCT00734604|10935240|FG003|Overall Study|Protocol Violation|0
6910712|NCT00734604|10935241|FG004|Overall Study|Protocol Violation|1
6910713|NCT00734604|10935242|FG005|Overall Study|Protocol Violation|0
6910714|NCT00734604|10935237|FG000|Overall Study|Sponsor Decision|1
6910715|NCT00734604|10935238|FG001|Overall Study|Sponsor Decision|2
6910716|NCT00734604|10935239|FG002|Overall Study|Sponsor Decision|1
6910717|NCT00734604|10935240|FG003|Overall Study|Sponsor Decision|0
6910718|NCT00734604|10935241|FG004|Overall Study|Sponsor Decision|2
6910719|NCT00734604|10935242|FG005|Overall Study|Sponsor Decision|0
6910720|NCT00734604|10935237|FG000|Overall Study|Withdrawal by Subject|0
6910721|NCT00734604|10935238|FG001|Overall Study|Withdrawal by Subject|2
6910722|NCT00734604|10935239|FG002|Overall Study|Withdrawal by Subject|0
6910723|NCT00734604|10935240|FG003|Overall Study|Withdrawal by Subject|1
6910724|NCT00734604|10935241|FG004|Overall Study|Withdrawal by Subject|2
6910725|NCT00734604|10935242|FG005|Overall Study|Withdrawal by Subject|1
6910726|NCT00734604|10935237|FG000|Overall Study|Lack of Efficacy|0
6910727|NCT00734604|10935238|FG001|Overall Study|Lack of Efficacy|1
6910728|NCT00734604|10935239|FG002|Overall Study|Lack of Efficacy|1
6910729|NCT00734604|10935240|FG003|Overall Study|Lack of Efficacy|0
6910730|NCT00734604|10935241|FG004|Overall Study|Lack of Efficacy|0
6910731|NCT00734604|10935242|FG005|Overall Study|Lack of Efficacy|0
6910732|NCT00734617|10935255|FG000|Overall Study|Adverse Event|4
6910733|NCT00734617|10935256|FG001|Overall Study|Adverse Event|7
6910734|NCT00734617|10935255|FG000|Overall Study|Withdrawal by Subject|103
6910735|NCT00734617|10935256|FG001|Overall Study|Withdrawal by Subject|95
6910736|NCT00734630|10935264|FG000|Overall Study|Lack of Efficacy|4
6910737|NCT00734630|10935265|FG001|Overall Study|Lack of Efficacy|4
6910738|NCT00734630|10935264|FG000|Overall Study|Withdrawal by Subject|7
6910739|NCT00734630|10935265|FG001|Overall Study|Withdrawal by Subject|9
6910740|NCT00734630|10935264|FG000|Overall Study|Lost to Follow-up|13
6910741|NCT00734630|10935265|FG001|Overall Study|Lost to Follow-up|7
6910742|NCT00734630|10935264|FG000|Overall Study|Protocol Violation|0
6910743|NCT00734630|10935265|FG001|Overall Study|Protocol Violation|3
6910744|NCT00734630|10935264|FG000|Overall Study|Inclusion/Exclusion criteria not met|0
6910745|NCT00734630|10935265|FG001|Overall Study|Inclusion/Exclusion criteria not met|1
6910746|NCT00734630|10935264|FG000|Overall Study|Adverse Event|3
6910747|NCT00734630|10935265|FG001|Overall Study|Adverse Event|6
6910748|NCT00734630|10935264|FG000|Overall Study|Randomized in Error|0
6910749|NCT00734630|10935265|FG001|Overall Study|Randomized in Error|1
6910750|NCT00734630|10935264|FG000|Overall Study|Tested Positive for Illegal Drug Use|1
6910751|NCT00734630|10935265|FG001|Overall Study|Tested Positive for Illegal Drug Use|1
6910752|NCT00734630|10935264|FG000|Overall Study|Poor Compliance|1
6910753|NCT00734630|10935265|FG001|Overall Study|Poor Compliance|1
6910754|NCT00734656|10935271|FG000|Lab Session 1|Withdrawal by Subject|2
6910755|NCT00734656|10935272|FG001|Lab Session 1|Withdrawal by Subject|0
6910756|NCT00734656|10935273|FG002|Lab Session 1|Withdrawal by Subject|0
6910757|NCT00734656|10935274|FG003|Lab Session 1|Withdrawal by Subject|0
6910758|NCT00734656|10935271|FG000|Washout 1|Withdrawal by Subject|1
6910759|NCT00734656|10935272|FG001|Washout 1|Withdrawal by Subject|5
6910760|NCT00734656|10935273|FG002|Washout 1|Withdrawal by Subject|2
6910761|NCT00734656|10935274|FG003|Washout 1|Withdrawal by Subject|3
6910762|NCT00734656|10935271|FG000|Lab Session 2|Withdrawal by Subject|1
6910763|NCT00734656|10935272|FG001|Lab Session 2|Withdrawal by Subject|0
6910764|NCT00734656|10935273|FG002|Lab Session 2|Withdrawal by Subject|0
6910765|NCT00734656|10935274|FG003|Lab Session 2|Withdrawal by Subject|1
6910766|NCT00734656|10935271|FG000|Washout 2|Withdrawal by Subject|1
6910767|NCT00734656|10935272|FG001|Washout 2|Withdrawal by Subject|1
6910768|NCT00734656|10935273|FG002|Washout 2|Withdrawal by Subject|1
6910769|NCT00734656|10935274|FG003|Washout 2|Withdrawal by Subject|0
6910770|NCT00734656|10935271|FG000|Washout 3|Withdrawal by Subject|1
6910771|NCT00734656|10935272|FG001|Washout 3|Withdrawal by Subject|0
6910772|NCT00734656|10935273|FG002|Washout 3|Withdrawal by Subject|0
6910773|NCT00734656|10935274|FG003|Washout 3|Withdrawal by Subject|1
6910774|NCT00734656|10935271|FG000|Lab Session 4|Withdrawal by Subject|0
6910775|NCT00734656|10935272|FG001|Lab Session 4|Withdrawal by Subject|0
6910776|NCT00734656|10935273|FG002|Lab Session 4|Withdrawal by Subject|0
6910777|NCT00734656|10935274|FG003|Lab Session 4|Withdrawal by Subject|1
6910778|NCT00734747|10935289|FG000|SRS Procedure|No staples placed|3
6910779|NCT00734747|10935289|FG000|6 Month Follow-up|Did not meet inclusion criteria|3
6910780|NCT00734851|10935302|FG000|Overall Study|Withdrawal by Subject|2
6910781|NCT00734851|10935302|FG000|Overall Study|Lost to Follow-up|1
6910782|NCT00734851|10935302|FG000|Overall Study|Physician Decision|18
6910783|NCT00734929|10935317|FG000|Overall Study|Lost to Follow-up|1
6910784|NCT00734929|10935318|FG001|Overall Study|Lost to Follow-up|2
6910785|NCT00734929|10935317|FG000|Overall Study|No intervention/ screen fail|5
6910786|NCT00734929|10935318|FG001|Overall Study|No intervention/ screen fail|3
6910787|NCT00734994|10935335|FG000|Overall Study|Withdrawal by Subject|1
6910788|NCT00735007|10935340|FG000|Overall Study|Adverse Event|4
6910789|NCT00735007|10935340|FG000|Overall Study|Protocol Violation|1
6910790|NCT00735072|10935346|FG000|Overall Study|interrupted study med during ARV change|1
6910791|NCT00735072|10935347|FG001|Overall Study|interrupted study med during ARV change|0
6910792|NCT00735072|10935346|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0
6910793|NCT00735072|10935347|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1
6910794|NCT00735371|10935364|FG000|Overall Study|Adverse Event|3
6910795|NCT00735371|10935365|FG001|Overall Study|Adverse Event|3
6910796|NCT00735371|10935366|FG002|Overall Study|Adverse Event|4
6910797|NCT00735371|10935367|FG003|Overall Study|Adverse Event|1
6910798|NCT00735371|10935364|FG000|Overall Study|Protocol Violation|2
6910799|NCT00735371|10935365|FG001|Overall Study|Protocol Violation|2
6910800|NCT00735371|10935366|FG002|Overall Study|Protocol Violation|0
6910801|NCT00735371|10935367|FG003|Overall Study|Protocol Violation|3
6910802|NCT00735371|10935364|FG000|Overall Study|Withdrawal by Subject|0
6910803|NCT00735371|10935365|FG001|Overall Study|Withdrawal by Subject|2
6910804|NCT00735371|10935366|FG002|Overall Study|Withdrawal by Subject|2
6910805|NCT00735371|10935367|FG003|Overall Study|Withdrawal by Subject|0
6910806|NCT00735371|10935364|FG000|Overall Study|Lost to Follow-up|1
6910807|NCT00735371|10935365|FG001|Overall Study|Lost to Follow-up|1
6910808|NCT00735371|10935366|FG002|Overall Study|Lost to Follow-up|3
6910809|NCT00735371|10935367|FG003|Overall Study|Lost to Follow-up|1
6910810|NCT00735371|10935364|FG000|Overall Study|Lack of Efficacy|4
6910811|NCT00735371|10935365|FG001|Overall Study|Lack of Efficacy|2
6910812|NCT00735371|10935366|FG002|Overall Study|Lack of Efficacy|0
6910813|NCT00735371|10935367|FG003|Overall Study|Lack of Efficacy|4
6910814|NCT00735371|10935364|FG000|Overall Study|Sponsor Decision|3
6910815|NCT00735371|10935365|FG001|Overall Study|Sponsor Decision|1
6910816|NCT00735371|10935366|FG002|Overall Study|Sponsor Decision|0
6910817|NCT00735371|10935367|FG003|Overall Study|Sponsor Decision|1
6910818|NCT00735371|10935364|FG000|Overall Study|Protocol Violation|0
6910819|NCT00735371|10935365|FG001|Overall Study|Protocol Violation|1
6910820|NCT00735371|10935366|FG002|Overall Study|Protocol Violation|2
6910821|NCT00735371|10935367|FG003|Overall Study|Protocol Violation|0
6910822|NCT00735371|10935364|FG000|Overall Study|Prior Vyvanse Exposure|1
6910823|NCT00735371|10935365|FG001|Overall Study|Prior Vyvanse Exposure|1
6910824|NCT00735371|10935366|FG002|Overall Study|Prior Vyvanse Exposure|0
6910825|NCT00735371|10935367|FG003|Overall Study|Prior Vyvanse Exposure|0
6910826|NCT00735371|10935364|FG000|Overall Study|Exclusion criteria|1
6910827|NCT00735371|10935365|FG001|Overall Study|Exclusion criteria|0
6910828|NCT00735371|10935366|FG002|Overall Study|Exclusion criteria|0
6910829|NCT00735371|10935367|FG003|Overall Study|Exclusion criteria|0
6910830|NCT00735397|10935377|FG000|Overall Study|Adverse Event|194
6910831|NCT00735397|10935377|FG000|Overall Study|Lost to Follow-up|33
6910832|NCT00735397|10935377|FG000|Overall Study|Participant choice|252
6910833|NCT00735397|10935377|FG000|Overall Study|Inadequate therapeutic effect|202
6910834|NCT00735397|10935377|FG000|Overall Study|Administrative/Other|502
6910835|NCT00735475|10935413|FG000|Overall Study|Adverse Event|0
6910836|NCT00735475|10935414|FG001|Overall Study|Adverse Event|1
6910837|NCT00735475|10935413|FG000|Overall Study|Death|1
6910838|NCT00735475|10935414|FG001|Overall Study|Death|1
6910839|NCT00735475|10935413|FG000|Overall Study|Lost to Follow-up|3
6910840|NCT00735475|10935414|FG001|Overall Study|Lost to Follow-up|3
6910841|NCT00735475|10935413|FG000|Overall Study|Physician Decision|0
6910842|NCT00735475|10935414|FG001|Overall Study|Physician Decision|1
6910843|NCT00735475|10935413|FG000|Overall Study|Withdrawal by Subject|4
6910844|NCT00735475|10935414|FG001|Overall Study|Withdrawal by Subject|5
6910845|NCT00735644|10935429|FG000|Overall Study|Did not receive study vaccine|0
6910846|NCT00735644|10935430|FG001|Overall Study|Did not receive study vaccine|1
6910847|NCT00735644|10935431|FG002|Overall Study|Did not receive study vaccine|0
6910848|NCT00735644|10935432|FG003|Overall Study|Did not receive study vaccine|0
6910849|NCT00735644|10935433|FG004|Overall Study|Did not receive study vaccine|0
6910850|NCT00735644|10935429|FG000|Overall Study|Withdrawal by Subject|0
6910851|NCT00735644|10935430|FG001|Overall Study|Withdrawal by Subject|1
6910852|NCT00735644|10935431|FG002|Overall Study|Withdrawal by Subject|1
6910853|NCT00735644|10935432|FG003|Overall Study|Withdrawal by Subject|1
6910854|NCT00735644|10935433|FG004|Overall Study|Withdrawal by Subject|0
6910855|NCT00735696|10935461|FG000|Overall Study|Withdrawal by Subject|1
6910856|NCT00735696|10935461|FG000|Overall Study|Enrolled but never Treated|1
6910857|NCT00735709|10935469|FG000|Overall Study|Adverse Event|2
6910858|NCT00735709|10935470|FG001|Overall Study|Adverse Event|3
6910859|NCT00735709|10935471|FG002|Overall Study|Adverse Event|1
6910860|NCT00735709|10935472|FG003|Overall Study|Adverse Event|5
6910861|NCT00735709|10935469|FG000|Overall Study|Lack of Efficacy|8
6910862|NCT00735709|10935470|FG001|Overall Study|Lack of Efficacy|4
6910863|NCT00735709|10935471|FG002|Overall Study|Lack of Efficacy|2
6910864|NCT00735709|10935472|FG003|Overall Study|Lack of Efficacy|3
6910865|NCT00735709|10935469|FG000|Overall Study|Noncompliance|0
6910866|NCT00735709|10935470|FG001|Overall Study|Noncompliance|0
6910867|NCT00735709|10935471|FG002|Overall Study|Noncompliance|1
6910868|NCT00735709|10935472|FG003|Overall Study|Noncompliance|0
6910869|NCT00735709|10935469|FG000|Overall Study|Protocol deviations|1
6910870|NCT00735709|10935470|FG001|Overall Study|Protocol deviations|2
6910871|NCT00735709|10935471|FG002|Overall Study|Protocol deviations|1
6910872|NCT00735709|10935472|FG003|Overall Study|Protocol deviations|1
6910873|NCT00735709|10935469|FG000|Overall Study|Voluntary Withdrawal|1
6910874|NCT00735709|10935470|FG001|Overall Study|Voluntary Withdrawal|3
6910875|NCT00735709|10935471|FG002|Overall Study|Voluntary Withdrawal|5
6910876|NCT00735709|10935472|FG003|Overall Study|Voluntary Withdrawal|7
6910877|NCT00735709|10935469|FG000|Overall Study|Lost to Follow-up|0
6910878|NCT00735709|10935470|FG001|Overall Study|Lost to Follow-up|1
6910879|NCT00735709|10935471|FG002|Overall Study|Lost to Follow-up|1
6910880|NCT00735709|10935472|FG003|Overall Study|Lost to Follow-up|1
6910881|NCT00735709|10935469|FG000|Overall Study|Excluded medication|1
6910882|NCT00735709|10935470|FG001|Overall Study|Excluded medication|0
6910883|NCT00735709|10935471|FG002|Overall Study|Excluded medication|0
6910884|NCT00735709|10935472|FG003|Overall Study|Excluded medication|1
6910885|NCT00735878|10935509|FG000|Phase I- Dose Determination|Withdrawal by Subject|0
6910886|NCT00735878|10935510|FG001|Phase I- Dose Determination|Withdrawal by Subject|0
6910887|NCT00735878|10935511|FG002|Phase I- Dose Determination|Withdrawal by Subject|1
6910888|NCT00735904|10935522|FG000|Overall Study|Adverse Event|3
6910889|NCT00735904|10935522|FG000|Overall Study|Death|20
6910890|NCT00735904|10935522|FG000|Overall Study|Protocol Violation|1
6910891|NCT00735904|10935522|FG000|Overall Study|Withdrawal by Subject|1
6910892|NCT00735904|10935522|FG000|Overall Study|Study Terminated by Sponsor|5
6910893|NCT00735904|10935522|FG000|Overall Study|Other|8
6910894|NCT00735943|10935530|FG000|Overall Study|Lost to Follow-up|1
6910895|NCT00735943|10935530|FG000|Overall Study|Adverse Event|1
6910896|NCT00736034|10935538|FG000|Overall Study|Adverse Event|2
6910897|NCT00736099|10935554|FG000|Overall Study|Adverse Event|61
6910898|NCT00736099|10935555|FG001|Overall Study|Adverse Event|18
6910899|NCT00736099|10935554|FG000|Overall Study|Protocol Violation|10
6910900|NCT00736099|10935555|FG001|Overall Study|Protocol Violation|4
6910901|NCT00736099|10935554|FG000|Overall Study|Lost to Follow-up|12
6910902|NCT00736099|10935555|FG001|Overall Study|Lost to Follow-up|5
6910903|NCT00736099|10935554|FG000|Overall Study|Withdrawal by Subject|42
6910904|NCT00736099|10935555|FG001|Overall Study|Withdrawal by Subject|13
6910905|NCT00736099|10935554|FG000|Overall Study|Lack of Efficacy|15
6910906|NCT00736099|10935555|FG001|Overall Study|Lack of Efficacy|8
6910907|NCT00736099|10935554|FG000|Overall Study|Other reason|43
6910908|NCT00736099|10935555|FG001|Overall Study|Other reason|10
6910909|NCT00736190|10935570|FG000|Overall Study|Pregnancy|1
6910910|NCT00736190|10935570|FG000|Overall Study|Withdrawal by Subject|1
6910911|NCT00736190|10935570|FG000|Overall Study|Adverse Event|1
6910912|NCT00736255|10935594|FG000|Overall Study|Adverse Event|1
6910913|NCT00736255|10935595|FG001|Overall Study|Adverse Event|0
6910914|NCT00736255|10935594|FG000|Overall Study|Physician Decision|1
6910915|NCT00736255|10935595|FG001|Overall Study|Physician Decision|0
6910916|NCT00736255|10935594|FG000|Overall Study|Non-compliance|1
6910917|NCT00736255|10935595|FG001|Overall Study|Non-compliance|1
6910918|NCT00736333|10935601|FG000|Overall Study|Did Not Receive Drug or Not Documented|7
6910919|NCT00736333|10935601|FG000|Overall Study|Data Missing|2
6910920|NCT00736333|10935601|FG000|Overall Study|Tumor Progression|75
6910921|NCT00736333|10935601|FG000|Overall Study|Toxicity|6
6910922|NCT00736333|10935601|FG000|Overall Study|Withdrawal by Subject|10
6910923|NCT00736333|10935601|FG000|Overall Study|Death|7
6910924|NCT00736333|10935601|FG000|Overall Study|Other|4
6910925|NCT00736450|10935605|FG000|Overall Study|Not ABC gene eligible|19
6910926|NCT00736450|10935605|FG000|Overall Study|Withdrawal by Subject|5
6910927|NCT00736450|10935605|FG000|Overall Study|Physician Decision|1
6910928|NCT00736476|10935611|FG000|Overall Study|Adverse Event|1
6910929|NCT00736476|10935612|FG001|Overall Study|Adverse Event|0
6910930|NCT00736489|10935624|FG000|Period 1|Lost to Follow-up|1
6910931|NCT00736489|10935625|FG001|Period 1|Lost to Follow-up|0
6910932|NCT00736489|10935626|FG002|Period 1|Lost to Follow-up|0
6910933|NCT00736489|10935627|FG003|Period 1|Lost to Follow-up|0
6910934|NCT00736489|10935628|FG004|Period 1|Lost to Follow-up|0
6910935|NCT00736489|10935629|FG005|Period 1|Lost to Follow-up|0
6910936|NCT00736489|10935624|FG000|Period 1|Withdrawal by Subject|0
6910937|NCT00736489|10935625|FG001|Period 1|Withdrawal by Subject|0
6910938|NCT00736489|10935626|FG002|Period 1|Withdrawal by Subject|0
6910939|NCT00736489|10935627|FG003|Period 1|Withdrawal by Subject|0
6910940|NCT00736489|10935628|FG004|Period 1|Withdrawal by Subject|0
6910941|NCT00736489|10935629|FG005|Period 1|Withdrawal by Subject|1
6910942|NCT00736502|10935643|FG000|Overall Study|Adverse Event|22
6910943|NCT00736502|10935643|FG000|Overall Study|Lack of Efficacy|16
6910944|NCT00736502|10935643|FG000|Overall Study|Lost to Follow-up|27
6910945|NCT00736645|10935671|FG000|Overall Study|Adverse Event|0
6910946|NCT00736645|10935672|FG001|Overall Study|Adverse Event|2
6910947|NCT00736645|10935673|FG002|Overall Study|Adverse Event|0
6910948|NCT00736645|10935674|FG003|Overall Study|Adverse Event|0
6910949|NCT00736723|10935686|FG000|Overall Study|Withdrawal by Subject|4
6910950|NCT00736723|10935687|FG001|Overall Study|Withdrawal by Subject|3
6910951|NCT00736840|10935693|FG000|Overall Study|Lost to Follow-up|13
6910952|NCT00736853|10935697|FG000|Open-Label Period|Physician Decision|2
6910953|NCT00736853|10935698|FG001|Open-Label Period|Physician Decision|0
6910954|NCT00736853|10935699|FG002|Open-Label Period|Physician Decision|0
6910955|NCT00736853|10935697|FG000|Open-Label Period|Adverse Event|31
6910956|NCT00736853|10935698|FG001|Open-Label Period|Adverse Event|0
6910957|NCT00736853|10935699|FG002|Open-Label Period|Adverse Event|0
6910958|NCT00736853|10935697|FG000|Open-Label Period|Withdrawal by Subject|16
6910959|NCT00736853|10935698|FG001|Open-Label Period|Withdrawal by Subject|0
6910960|NCT00736853|10935699|FG002|Open-Label Period|Withdrawal by Subject|0
6910961|NCT00736853|10935697|FG000|Open-Label Period|Started but not treated|42
6910962|NCT00736853|10935698|FG001|Open-Label Period|Started but not treated|0
6910963|NCT00736853|10935699|FG002|Open-Label Period|Started but not treated|0
6910964|NCT00736853|10935697|FG000|Open-Label Period|Failed to meet the transfer criteria|40
6910965|NCT00736853|10935698|FG001|Open-Label Period|Failed to meet the transfer criteria|0
6910966|NCT00736853|10935699|FG002|Open-Label Period|Failed to meet the transfer criteria|0
6910967|NCT00736853|10935697|FG000|Open-Label Period|Unable to attend hospital appointments|1
6910968|NCT00736853|10935698|FG001|Open-Label Period|Unable to attend hospital appointments|0
6910969|NCT00736853|10935699|FG002|Open-Label Period|Unable to attend hospital appointments|0
6910970|NCT00736853|10935697|FG000|Double-Blind Period|Lack of Efficacy|0
6910971|NCT00736853|10935698|FG001|Double-Blind Period|Lack of Efficacy|19
6910972|NCT00736853|10935699|FG002|Double-Blind Period|Lack of Efficacy|42
6910973|NCT00736853|10935697|FG000|Double-Blind Period|Adverse Event|0
6910974|NCT00736853|10935698|FG001|Double-Blind Period|Adverse Event|3
6910975|NCT00736853|10935699|FG002|Double-Blind Period|Adverse Event|2
6910976|NCT00736853|10935697|FG000|Double-Blind Period|Withdrawal by Subject|0
6910977|NCT00736853|10935698|FG001|Double-Blind Period|Withdrawal by Subject|1
6910978|NCT00736853|10935699|FG002|Double-Blind Period|Withdrawal by Subject|4
6910979|NCT00736853|10935697|FG000|Double-Blind Period|Ineligible to participate the study|0
6910980|NCT00736853|10935698|FG001|Double-Blind Period|Ineligible to participate the study|1
6910981|NCT00736853|10935699|FG002|Double-Blind Period|Ineligible to participate the study|0
6910982|NCT00736879|10935712|FG000|Double Blind Treatment Period|Lack of Efficacy|1
6910983|NCT00736879|10935713|FG001|Double Blind Treatment Period|Lack of Efficacy|0
6910984|NCT00736879|10935714|FG002|Double Blind Treatment Period|Lack of Efficacy|0
6910985|NCT00736879|10935715|FG003|Double Blind Treatment Period|Lack of Efficacy|0
6910986|NCT00736879|10935712|FG000|Double Blind Treatment Period|Adverse Event|0
6910987|NCT00736879|10935713|FG001|Double Blind Treatment Period|Adverse Event|1
6910988|NCT00736879|10935714|FG002|Double Blind Treatment Period|Adverse Event|1
6910989|NCT00736879|10935715|FG003|Double Blind Treatment Period|Adverse Event|0
6910990|NCT00736879|10935712|FG000|Double Blind Treatment Period|Withdrawal by Subject|2
6910991|NCT00736879|10935713|FG001|Double Blind Treatment Period|Withdrawal by Subject|1
6910992|NCT00736879|10935714|FG002|Double Blind Treatment Period|Withdrawal by Subject|3
6910993|NCT00736879|10935715|FG003|Double Blind Treatment Period|Withdrawal by Subject|3
6910994|NCT00736879|10935712|FG000|Double Blind Treatment Period|Lost to Follow-up|0
6910995|NCT00736879|10935713|FG001|Double Blind Treatment Period|Lost to Follow-up|0
6910996|NCT00736879|10935714|FG002|Double Blind Treatment Period|Lost to Follow-up|2
6910997|NCT00736879|10935715|FG003|Double Blind Treatment Period|Lost to Follow-up|1
6910998|NCT00736879|10935712|FG000|Double Blind Treatment Period|Poor non-compliance|0
6910999|NCT00736879|10935713|FG001|Double Blind Treatment Period|Poor non-compliance|0
6911000|NCT00736879|10935714|FG002|Double Blind Treatment Period|Poor non-compliance|1
6911001|NCT00736879|10935715|FG003|Double Blind Treatment Period|Poor non-compliance|1
6911002|NCT00736879|10935712|FG000|Double Blind Treatment Period|No longer met criteria|0
6911003|NCT00736879|10935713|FG001|Double Blind Treatment Period|No longer met criteria|1
6911004|NCT00736879|10935714|FG002|Double Blind Treatment Period|No longer met criteria|0
6911005|NCT00736879|10935715|FG003|Double Blind Treatment Period|No longer met criteria|0
6911006|NCT00736879|10935712|FG000|Double Blind Treatment Period|non-specified|0
6911007|NCT00736879|10935713|FG001|Double Blind Treatment Period|non-specified|1
6911008|NCT00736879|10935714|FG002|Double Blind Treatment Period|non-specified|0
6911009|NCT00736879|10935715|FG003|Double Blind Treatment Period|non-specified|0
6911010|NCT00736879|10935712|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
6911011|NCT00736879|10935713|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1
6911012|NCT00736879|10935714|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
6911013|NCT00736879|10935715|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
6911014|NCT00736879|10935712|FG000|Follow up Period - No Drug Treatment|non-specified|1
6911015|NCT00736879|10935713|FG001|Follow up Period - No Drug Treatment|non-specified|2
6911016|NCT00736879|10935714|FG002|Follow up Period - No Drug Treatment|non-specified|0
6911017|NCT00736879|10935715|FG003|Follow up Period - No Drug Treatment|non-specified|0
6911018|NCT00736944|10935728|FG000|Induction|Death|1
6911019|NCT00736944|10935728|FG000|Definitive Treatment|Physician Decision|1
6911020|NCT00736957|10935735|FG000|Overall Study|Adverse Event|43
6911021|NCT00736957|10935735|FG000|Overall Study|Withdrawal by Subject|49
6911022|NCT00736957|10935735|FG000|Overall Study|violation of eligibility criteria|2
6911023|NCT00736957|10935735|FG000|Overall Study|did not attend hospital appointments|1
6911024|NCT00736957|10935735|FG000|Overall Study|not eligible for Treatment Period I|22
6911025|NCT00736957|10935735|FG000|Overall Study|Physician Decision|5
6911026|NCT00736996|10935742|FG000|Overall Study|Lost to Follow-up|1
6911027|NCT00736996|10935743|FG001|Overall Study|Lost to Follow-up|9
6911028|NCT00736996|10935744|FG002|Overall Study|Lost to Follow-up|2
6911029|NCT00737048|10935755|FG000|Overall Study|Physician Decision|0
6911030|NCT00737048|10935756|FG001|Overall Study|Physician Decision|0
6911031|NCT00737048|10935757|FG002|Overall Study|Physician Decision|1
6911032|NCT00737048|10935755|FG000|Overall Study|Adverse Event|0
6911033|NCT00737048|10935756|FG001|Overall Study|Adverse Event|1
6911034|NCT00737048|10935757|FG002|Overall Study|Adverse Event|0
6911035|NCT00737048|10935755|FG000|Overall Study|Worsening of the symptoms|3
6911036|NCT00737048|10935756|FG001|Overall Study|Worsening of the symptoms|5
6911037|NCT00737048|10935757|FG002|Overall Study|Worsening of the symptoms|3
6911038|NCT00737061|10935765|FG000|Waiting Period|Lost to Follow-up|6
6911039|NCT00737061|10935765|FG000|Waiting Period|Withdrawal by Subject|1
6911040|NCT00737061|10935765|FG000|Waiting Period|Bilateral placement failure|34
6911041|NCT00737061|10935765|FG000|Waiting Period|Deemed patent following HSG|26
6911042|NCT00737061|10935765|FG000|Waiting Period|Alternative contraception failure|3
6911043|NCT00737061|10935765|FG000|Waiting Period|Elected surgical tubal ligation|5
6911044|NCT00737061|10935765|FG000|1 Year Wearing Period|Lost to Follow-up|11
6911045|NCT00737061|10935765|FG000|1 Year Wearing Period|Withdrawal by Subject|2
6911046|NCT00737061|10935765|FG000|1 Year Wearing Period|Discontinued reilance|3
6911047|NCT00737061|10935765|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1
6911048|NCT00737100|10935772|FG000|Overall Study|Adverse Event|6
6911049|NCT00737100|10935773|FG001|Overall Study|Adverse Event|5
6911050|NCT00737100|10935774|FG002|Overall Study|Adverse Event|3
6911051|NCT00737100|10935772|FG000|Overall Study|Lost to Follow-up|0
6911052|NCT00737100|10935773|FG001|Overall Study|Lost to Follow-up|1
6911053|NCT00737100|10935774|FG002|Overall Study|Lost to Follow-up|0
6911054|NCT00737100|10935772|FG000|Overall Study|Withdrawal by Subject|0
6911055|NCT00737100|10935773|FG001|Overall Study|Withdrawal by Subject|0
6911056|NCT00737100|10935774|FG002|Overall Study|Withdrawal by Subject|3
6911057|NCT00737100|10935772|FG000|Overall Study|Reason discontinued not explained above|1
6911058|NCT00737100|10935773|FG001|Overall Study|Reason discontinued not explained above|1
6911059|NCT00737100|10935774|FG002|Overall Study|Reason discontinued not explained above|1
6911060|NCT00737438|10935812|FG000|Overall Study|Withdrawal by Subject|2
6911061|NCT00737438|10935812|FG000|Overall Study|Patient ineligible|1
6911062|NCT00737464|10935816|FG000|Overall Study|Adverse Event|1
6911063|NCT00737464|10935816|FG000|Overall Study|Death|6
6911064|NCT00737464|10935816|FG000|Overall Study|Other - Failure to Return|1
6911065|NCT00737464|10935816|FG000|Overall Study|Refused Treatment / Withdrew Consent|6
6911066|NCT00737464|10935816|FG000|Overall Study|Other reasons|4
6911067|NCT00737477|10935820|FG000|Overall Study|Adverse Event|9
6911068|NCT00737477|10935820|FG000|Overall Study|Death|9
6911069|NCT00737477|10935820|FG000|Overall Study|Treatment Refusal|1
6911070|NCT00737477|10935820|FG000|Overall Study|Withdrawal by Subject|1
6911071|NCT00737477|10935820|FG000|Overall Study|Renal Transplantation|10
6911072|NCT00737477|10935820|FG000|Overall Study|Other|4
6911073|NCT00737529|10935824|FG000|Overall Study|Disease Progression|95
6911074|NCT00737529|10935824|FG000|Overall Study|Adverse Event|24
6911075|NCT00737529|10935824|FG000|Overall Study|Withdrawal by Subject|5
6911076|NCT00737529|10935824|FG000|Overall Study|Death|4
6911077|NCT00737529|10935824|FG000|Overall Study|Protocol Violation|1
6911078|NCT00737529|10935824|FG000|Overall Study|Other|4
6911079|NCT00737568|10935830|FG000|Treatment Period Through Week 240|Investigator's Discretion|6
6911080|NCT00737568|10935831|FG001|Treatment Period Through Week 240|Investigator's Discretion|5
6911081|NCT00737568|10935830|FG000|Treatment Period Through Week 240|Withdrew Consent|5
6911082|NCT00737568|10935831|FG001|Treatment Period Through Week 240|Withdrew Consent|6
6911083|NCT00737568|10935830|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3
6911084|NCT00737568|10935831|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4
6911085|NCT00737568|10935830|FG000|Treatment Period Through Week 240|Lost to Follow-up|3
6911086|NCT00737568|10935831|FG001|Treatment Period Through Week 240|Lost to Follow-up|3
6911087|NCT00737568|10935830|FG000|Treatment Period Through Week 240|Protocol Violation|2
6911088|NCT00737568|10935831|FG001|Treatment Period Through Week 240|Protocol Violation|3
6911089|NCT00737568|10935830|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1
6911090|NCT00737568|10935831|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0
6911091|NCT00737568|10935830|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25
6911092|NCT00737568|10935831|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17
6911093|NCT00737568|10935830|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0
6911094|NCT00737568|10935831|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1
6911095|NCT00737568|10935830|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1
6911096|NCT00737568|10935831|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0
6911097|NCT00737633|10935839|FG000|Overall Study|Study terminated by sponsor|44
6911098|NCT00737633|10935840|FG001|Overall Study|Study terminated by sponsor|55
6911099|NCT00737633|10935839|FG000|Overall Study|Lost to Follow-up|0
6911100|NCT00737633|10935840|FG001|Overall Study|Lost to Follow-up|1
6911101|NCT00737633|10935839|FG000|Overall Study|protocol non-compliance|0
6911102|NCT00737633|10935840|FG001|Overall Study|protocol non-compliance|1
6974121|NCT01185353|11025987|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
6974122|NCT01185353|11025988|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
6974123|NCT01185353|11025989|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
6974124|NCT01185353|11025990|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
6974125|NCT01185353|11025991|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
6974126|NCT01185353|11025992|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1
6974127|NCT01185353|11025993|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3
6974128|NCT01185353|11025994|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
6974129|NCT01185353|11025985|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
6974130|NCT01185353|11025986|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
6974131|NCT01185353|11025987|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
6974132|NCT01185353|11025988|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
6974133|NCT01185353|11025989|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
6974134|NCT01185353|11025990|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
6974135|NCT01185353|11025991|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
6974136|NCT01185353|11025992|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
6974137|NCT01185353|11025993|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2
6974138|NCT01185353|11025994|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
6974139|NCT01185353|11025985|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0
6974140|NCT01185353|11025986|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0
6974141|NCT01185353|11025987|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0
6974142|NCT01185353|11025988|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0
6974143|NCT01185353|11025989|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0
6974144|NCT01185353|11025990|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0
6974145|NCT01185353|11025991|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0
6974146|NCT01185353|11025992|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1
6974147|NCT01185353|11025993|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2
6974148|NCT01185353|11025994|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0
6974149|NCT01185366|11026035|FG000|First Line Therapy|Insurance Coverage Denied|1
6974150|NCT01185366|11026036|FG001|First Line Therapy|Insurance Coverage Denied|1
6974151|NCT01185366|11026035|FG000|First Line Therapy|Withdrawal by Subject|1
6974152|NCT01185366|11026036|FG001|First Line Therapy|Withdrawal by Subject|0
6974153|NCT01185366|11026035|FG000|First Line Therapy|Lack of Metastatic Site|1
6974154|NCT01185366|11026036|FG001|First Line Therapy|Lack of Metastatic Site|0
6974155|NCT01185366|11026035|FG000|Crossover to Second Line Therapy|Adverse Event|3
6974156|NCT01185366|11026036|FG001|Crossover to Second Line Therapy|Adverse Event|6
6974157|NCT01185366|11026035|FG000|Crossover to Second Line Therapy|Physician Decision|5
6974158|NCT01185366|11026036|FG001|Crossover to Second Line Therapy|Physician Decision|1
6974159|NCT01185366|11026035|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1
6974160|NCT01185366|11026036|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0
6974161|NCT01185366|11026035|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5
6974162|NCT01185366|11026036|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3
6974163|NCT01185509|11026046|FG000|Overall Study|Progression/Relapse|9
6974164|NCT01185509|11026047|FG001|Overall Study|Progression/Relapse|15
6974165|NCT01185509|11026046|FG000|Overall Study|Physician Decision|2
6974166|NCT01185509|11026047|FG001|Overall Study|Physician Decision|2
6974167|NCT01185509|11026046|FG000|Overall Study|Withdrawal by Subject|0
6974168|NCT01185509|11026047|FG001|Overall Study|Withdrawal by Subject|1
6974169|NCT01185509|11026046|FG000|Overall Study|Death|0
6974170|NCT01185509|11026047|FG001|Overall Study|Death|1
6974171|NCT01185509|11026046|FG000|Overall Study|Intercurrent Illness|0
6974172|NCT01185509|11026047|FG001|Overall Study|Intercurrent Illness|1
6974173|NCT01185522|11026054|FG000|Overall Study|Lack of Efficacy|28
6974174|NCT01185522|11026054|FG000|Overall Study|Lost to Follow-up|19
6974175|NCT01185522|11026054|FG000|Overall Study|Withdrawal by Subject|10
6974176|NCT01185522|11026054|FG000|Overall Study|Poor tolerance|39
6974177|NCT01185522|11026054|FG000|Overall Study|Other reasons|12
6974178|NCT01185548|11026059|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2
6974179|NCT01185561|11026074|FG000|Overall Study|Lost to Follow-up|0
6974180|NCT01185561|11026075|FG001|Overall Study|Lost to Follow-up|4
6974181|NCT01185561|11026074|FG000|Overall Study|Withdrawal by Subject|2
6974182|NCT01185561|11026075|FG001|Overall Study|Withdrawal by Subject|8
6974183|NCT01185600|11026083|FG000|Overall Study|Adverse Event|1
6974184|NCT01185600|11026084|FG001|Overall Study|Adverse Event|1
6974185|NCT01185600|11026083|FG000|Overall Study|Death|0
6974186|NCT01185600|11026084|FG001|Overall Study|Death|1
6974187|NCT01185600|11026083|FG000|Overall Study|Lost to Follow-up|0
6974188|NCT01185600|11026084|FG001|Overall Study|Lost to Follow-up|5
6974189|NCT01185600|11026083|FG000|Overall Study|Physician Decision|29
6974190|NCT01185600|11026084|FG001|Overall Study|Physician Decision|35
6974191|NCT01185600|11026083|FG000|Overall Study|Withdrawal by Subject|1
6974192|NCT01185600|11026084|FG001|Overall Study|Withdrawal by Subject|1
6974193|NCT01185600|11026083|FG000|Overall Study|Hold by DSMB|1
6911103|NCT00737672|10935848|FG000|Overall Study|Graft Abandonment|48
6911104|NCT00737672|10935849|FG001|Overall Study|Graft Abandonment|56
6911105|NCT00737672|10935848|FG000|Overall Study|Death|23
6911106|NCT00737672|10935849|FG001|Overall Study|Death|22
6911107|NCT00737672|10935848|FG000|Overall Study|Withdrawal by Subject|1
6911108|NCT00737672|10935849|FG001|Overall Study|Withdrawal by Subject|2
6911109|NCT00737672|10935848|FG000|Overall Study|Lost to Follow-up|1
6911110|NCT00737672|10935849|FG001|Overall Study|Lost to Follow-up|0
6911111|NCT00737672|10935848|FG000|Overall Study|Miscellaneous|7
6911112|NCT00737672|10935849|FG001|Overall Study|Miscellaneous|1
6911113|NCT00737672|10935848|FG000|Overall Study|Physician Decision|0
6911114|NCT00737672|10935849|FG001|Overall Study|Physician Decision|2
6911115|NCT00737698|10935858|FG000|Overall Study|Withdrawal by Subject|6
6911116|NCT00737698|10935859|FG001|Overall Study|Withdrawal by Subject|5
6911117|NCT00737698|10935860|FG002|Overall Study|Withdrawal by Subject|3
6911118|NCT00737698|10935858|FG000|Overall Study|Death|0
6911119|NCT00737698|10935859|FG001|Overall Study|Death|0
6911120|NCT00737698|10935860|FG002|Overall Study|Death|1
6911121|NCT00737711|10935868|FG000|Overall Study|Adverse Event|2
6911122|NCT00737711|10935868|FG000|Overall Study|Death|8
6911123|NCT00737711|10935868|FG000|Overall Study|Failure to return|4
6911124|NCT00737711|10935868|FG000|Overall Study|Protocol Violation|1
6911125|NCT00737711|10935868|FG000|Overall Study|Withdrawal by Subject|5
6911126|NCT00737711|10935868|FG000|Overall Study|Blood transfusion|6
6911127|NCT00737711|10935868|FG000|Overall Study|Other|5
6911128|NCT00738062|10935918|FG000|Open Label Treatment|Lack of Efficacy|5
6911129|NCT00738062|10935919|FG001|Open Label Treatment|Lack of Efficacy|0
6911130|NCT00738062|10935920|FG002|Open Label Treatment|Lack of Efficacy|0
6911131|NCT00738062|10935918|FG000|Open Label Treatment|Adverse Event|11
6911132|NCT00738062|10935919|FG001|Open Label Treatment|Adverse Event|0
6911133|NCT00738062|10935920|FG002|Open Label Treatment|Adverse Event|0
6911134|NCT00738062|10935918|FG000|Open Label Treatment|Protocol Violation|2
6911135|NCT00738062|10935919|FG001|Open Label Treatment|Protocol Violation|0
6911136|NCT00738062|10935920|FG002|Open Label Treatment|Protocol Violation|0
6911137|NCT00738062|10935918|FG000|Open Label Treatment|Withdrawal by Subject|9
6911138|NCT00738062|10935919|FG001|Open Label Treatment|Withdrawal by Subject|0
6911139|NCT00738062|10935920|FG002|Open Label Treatment|Withdrawal by Subject|0
6911140|NCT00738062|10935918|FG000|Open Label Treatment|Investigator Decision|1
6911141|NCT00738062|10935919|FG001|Open Label Treatment|Investigator Decision|0
6911142|NCT00738062|10935920|FG002|Open Label Treatment|Investigator Decision|0
6911143|NCT00738062|10935918|FG000|Open-Label Extension|Adverse Event|5
6911144|NCT00738062|10935919|FG001|Open-Label Extension|Adverse Event|0
6911145|NCT00738062|10935920|FG002|Open-Label Extension|Adverse Event|0
6911146|NCT00738062|10935918|FG000|Open-Label Extension|Physician Decision|1
6911147|NCT00738062|10935919|FG001|Open-Label Extension|Physician Decision|0
6911148|NCT00738062|10935920|FG002|Open-Label Extension|Physician Decision|0
6911149|NCT00738062|10935918|FG000|Open-Label Extension|Lack of Efficacy|2
6911150|NCT00738062|10935919|FG001|Open-Label Extension|Lack of Efficacy|0
6911151|NCT00738062|10935920|FG002|Open-Label Extension|Lack of Efficacy|0
6911152|NCT00738062|10935918|FG000|Open-Label Extension|Withdrawal by Subject|6
6911153|NCT00738062|10935919|FG001|Open-Label Extension|Withdrawal by Subject|0
6911154|NCT00738062|10935920|FG002|Open-Label Extension|Withdrawal by Subject|0
6911155|NCT00738062|10935918|FG000|Open-Label Extension|Protocol Violation|1
6911156|NCT00738062|10935919|FG001|Open-Label Extension|Protocol Violation|0
6911157|NCT00738062|10935920|FG002|Open-Label Extension|Protocol Violation|0
6911158|NCT00738062|10935918|FG000|Open-Label Extension|Study Terminated|2
6911159|NCT00738062|10935919|FG001|Open-Label Extension|Study Terminated|0
6911160|NCT00738062|10935920|FG002|Open-Label Extension|Study Terminated|0
6911161|NCT00738101|10935929|FG000|Overall Study|Physician Decision|5
6911162|NCT00738101|10935929|FG000|Overall Study|Death|1
6911163|NCT00738101|10935929|FG000|Overall Study|Repeat enrollment|1
6911164|NCT00738283|10935933|FG000|Overall Study|Death|1
6911165|NCT00738283|10935933|FG000|Overall Study|Transfer to another facility|2
6911166|NCT00738283|10935933|FG000|Overall Study|Discharge home prior to end of study|1
6911167|NCT00738374|10935945|FG000|Induction Treatment Phase|Adverse Event|14
6911168|NCT00738374|10935946|FG001|Induction Treatment Phase|Adverse Event|0
6911169|NCT00738374|10935947|FG002|Induction Treatment Phase|Adverse Event|0
6911170|NCT00738374|10935948|FG003|Induction Treatment Phase|Adverse Event|0
6911171|NCT00738374|10935945|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4
6911172|NCT00738374|10935946|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0
6911173|NCT00738374|10935947|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0
6911174|NCT00738374|10935948|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0
6911175|NCT00738374|10935945|FG000|Induction Treatment Phase|Physician Decision|2
6911176|NCT00738374|10935946|FG001|Induction Treatment Phase|Physician Decision|0
6911177|NCT00738374|10935947|FG002|Induction Treatment Phase|Physician Decision|0
6911178|NCT00738374|10935948|FG003|Induction Treatment Phase|Physician Decision|0
6911179|NCT00738374|10935945|FG000|Induction Treatment Phase|Protocol Violation|2
6911180|NCT00738374|10935946|FG001|Induction Treatment Phase|Protocol Violation|0
6911181|NCT00738374|10935947|FG002|Induction Treatment Phase|Protocol Violation|0
6911182|NCT00738374|10935948|FG003|Induction Treatment Phase|Protocol Violation|0
6911183|NCT00738374|10935945|FG000|Induction Treatment Phase|Non-compliance|1
6911184|NCT00738374|10935946|FG001|Induction Treatment Phase|Non-compliance|0
6911185|NCT00738374|10935947|FG002|Induction Treatment Phase|Non-compliance|0
6911186|NCT00738374|10935948|FG003|Induction Treatment Phase|Non-compliance|0
6911187|NCT00738374|10935945|FG000|Induction Treatment Phase|Withdrawal by Subject|1
6911188|NCT00738374|10935946|FG001|Induction Treatment Phase|Withdrawal by Subject|0
6911189|NCT00738374|10935947|FG002|Induction Treatment Phase|Withdrawal by Subject|0
6911190|NCT00738374|10935948|FG003|Induction Treatment Phase|Withdrawal by Subject|0
6911191|NCT00738374|10935945|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0
6911192|NCT00738374|10935946|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1
6911193|NCT00738374|10935947|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2
6911194|NCT00738374|10935948|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0
6911195|NCT00738374|10935945|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0
6911196|NCT00738374|10935946|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4
6911197|NCT00738374|10935947|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5
6911198|NCT00738374|10935948|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11
6911199|NCT00738374|10935945|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
6911200|NCT00738374|10935946|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
6911201|NCT00738374|10935947|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
6911202|NCT00738374|10935948|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1
6911203|NCT00738374|10935945|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0
6911204|NCT00738374|10935946|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1
6911205|NCT00738374|10935947|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0
6911206|NCT00738374|10935948|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0
6911207|NCT00738374|10935945|FG000|Maintenance Treatment/Observation Phase|Other|0
6911208|NCT00738374|10935946|FG001|Maintenance Treatment/Observation Phase|Other|1
6911209|NCT00738374|10935947|FG002|Maintenance Treatment/Observation Phase|Other|0
6911210|NCT00738374|10935948|FG003|Maintenance Treatment/Observation Phase|Other|0
6911211|NCT00738400|10935959|FG000|Overall Study|Adverse Event|3
6911212|NCT00738400|10935960|FG001|Overall Study|Adverse Event|1
6911213|NCT00738400|10935959|FG000|Overall Study|Withdrawal by Subject|0
6911214|NCT00738400|10935960|FG001|Overall Study|Withdrawal by Subject|1
6911215|NCT00738400|10935959|FG000|Overall Study|Lack of Efficacy|0
6911216|NCT00738400|10935960|FG001|Overall Study|Lack of Efficacy|1
6911217|NCT00738400|10935959|FG000|Overall Study|Lost to Follow-up|0
6911218|NCT00738400|10935960|FG001|Overall Study|Lost to Follow-up|3
6911219|NCT00738400|10935959|FG000|Overall Study|Protocol Violation|1
6911220|NCT00738400|10935960|FG001|Overall Study|Protocol Violation|0
6911221|NCT00738400|10935959|FG000|Overall Study|Non-compliant with study medication|0
6911222|NCT00738400|10935960|FG001|Overall Study|Non-compliant with study medication|1
6911223|NCT00738530|10935977|FG000|Overall Study|Death|220
6911224|NCT00738530|10935978|FG001|Overall Study|Death|224
6911225|NCT00738530|10935977|FG000|Overall Study|Lost to Follow-up|8
6911226|NCT00738530|10935978|FG001|Overall Study|Lost to Follow-up|6
6911227|NCT00738530|10935977|FG000|Overall Study|Withdrawal by Subject|6
6911228|NCT00738530|10935978|FG001|Overall Study|Withdrawal by Subject|8
6911229|NCT00738673|10935990|FG000|Overall Study|Adverse Event|1
6911230|NCT00738673|10935991|FG001|Overall Study|Adverse Event|0
6911231|NCT00738673|10935990|FG000|Overall Study|Lack of Efficacy|19
6911232|NCT00738673|10935991|FG001|Overall Study|Lack of Efficacy|8
6911233|NCT00738673|10935990|FG000|Overall Study|Protocol Violation|1
6911234|NCT00738673|10935991|FG001|Overall Study|Protocol Violation|2
6911235|NCT00738673|10935990|FG000|Overall Study|Withdrawal by Subject|3
6911236|NCT00738673|10935991|FG001|Overall Study|Withdrawal by Subject|1
6911237|NCT00738699|10935999|FG000|Overall Study|Withdrawal by Subject|5
6911238|NCT00738699|10936000|FG001|Overall Study|Withdrawal by Subject|0
6911239|NCT00738699|10935999|FG000|Overall Study|Lost to Follow-up|1
6911240|NCT00738699|10936000|FG001|Overall Study|Lost to Follow-up|0
6911241|NCT00738699|10935999|FG000|Overall Study|Death|144
6911242|NCT00738699|10936000|FG001|Overall Study|Death|68
6911243|NCT00738699|10935999|FG000|Overall Study|Discontinuation of study by Sponsor|123
6911244|NCT00738699|10936000|FG001|Overall Study|Discontinuation of study by Sponsor|72
6911245|NCT00738699|10935999|FG000|Overall Study|Other|2
6911246|NCT00738699|10936000|FG001|Overall Study|Other|0
6911247|NCT00738881|10936008|FG000|Overall Study|Withdrawal by Subject|0
6911248|NCT00738881|10936009|FG001|Overall Study|Withdrawal by Subject|2
6911249|NCT00738894|10936017|FG000|Overall Study|Lost to Follow-up|23
6911250|NCT00738894|10936018|FG001|Overall Study|Lost to Follow-up|13
6911251|NCT00738894|10936017|FG000|Overall Study|Withdrawal by Subject|10
6911252|NCT00738894|10936018|FG001|Overall Study|Withdrawal by Subject|15
6911253|NCT00738894|10936017|FG000|Overall Study|Physician Decision|4
6911254|NCT00738894|10936018|FG001|Overall Study|Physician Decision|5
6911255|NCT00738894|10936017|FG000|Overall Study|Death|2
6911256|NCT00738894|10936018|FG001|Overall Study|Death|0
6911257|NCT00739102|10936024|FG000|Overall Study|Death|5
6911258|NCT00739102|10936024|FG000|Overall Study|Withdrawal by Subject|10
6911259|NCT00739297|10936028|FG000|First Washout Period of 4-7 Days|Adverse Event|0
6911260|NCT00739297|10936029|FG001|First Washout Period of 4-7 Days|Adverse Event|0
6911261|NCT00739297|10936030|FG002|First Washout Period of 4-7 Days|Adverse Event|0
6911262|NCT00739297|10936031|FG003|First Washout Period of 4-7 Days|Adverse Event|2
6911263|NCT00739297|10936032|FG004|First Washout Period of 4-7 Days|Adverse Event|0
6911264|NCT00739297|10936033|FG005|First Washout Period of 4-7 Days|Adverse Event|0
6911265|NCT00739297|10936034|FG006|First Washout Period of 4-7 Days|Adverse Event|2
6911266|NCT00739297|10936028|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
6911267|NCT00739297|10936029|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
6911268|NCT00739297|10936030|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
6911269|NCT00739297|10936031|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
6911270|NCT00739297|10936032|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
6911271|NCT00739297|10936033|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
6911272|NCT00739297|10936034|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
6911273|NCT00739310|10936050|FG000|Overall Study|Poor adherance to prescribed therapy|4
6911274|NCT00739310|10936050|FG000|Overall Study|Withdrawal by Subject|1
6911275|NCT00739310|10936050|FG000|Overall Study|Lost to Follow-up|2
6911276|NCT00739596|10936075|FG000|Overall Study|Adverse Event|12
6911277|NCT00739596|10936076|FG001|Overall Study|Adverse Event|6
6911278|NCT00739596|10936075|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4
6911279|NCT00739596|10936076|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0
6911280|NCT00739596|10936075|FG000|Overall Study|Patient Withdrew Consent|8
6911281|NCT00739596|10936076|FG001|Overall Study|Patient Withdrew Consent|8
6911282|NCT00739596|10936075|FG000|Overall Study|Lost to Follow-up|0
6911283|NCT00739596|10936076|FG001|Overall Study|Lost to Follow-up|2
6911284|NCT00739596|10936075|FG000|Overall Study|Protocol Deviation|1
6911285|NCT00739596|10936076|FG001|Overall Study|Protocol Deviation|1
6911286|NCT00739648|10936084|FG000|Overall Study|Adverse Event|3
6911287|NCT00739648|10936085|FG001|Overall Study|Adverse Event|15
6911288|NCT00739648|10936084|FG000|Overall Study|Withdrawal by Subject|13
6911289|NCT00739648|10936085|FG001|Overall Study|Withdrawal by Subject|25
6911290|NCT00739648|10936084|FG000|Overall Study|Lost to Follow-up|4
6911291|NCT00739648|10936085|FG001|Overall Study|Lost to Follow-up|7
6911292|NCT00739648|10936084|FG000|Overall Study|Death|2
6911293|NCT00739648|10936085|FG001|Overall Study|Death|0
6911294|NCT00739648|10936084|FG000|Overall Study|Do not know|4
6911295|NCT00739648|10936085|FG001|Overall Study|Do not know|6
6911296|NCT00739661|10936097|FG000|Overall Study|Adverse Event|2
6911297|NCT00739661|10936098|FG001|Overall Study|Adverse Event|0
6911298|NCT00739661|10936097|FG000|Overall Study|Physician decision to withdraw patient|1
6911299|NCT00739661|10936098|FG001|Overall Study|Physician decision to withdraw patient|0
6911300|NCT00739661|10936097|FG000|Overall Study|Patient decision to withdraw|9
6911301|NCT00739661|10936098|FG001|Overall Study|Patient decision to withdraw|4
6911302|NCT00739661|10936097|FG000|Overall Study|Disease progression, radiographic|33
6911303|NCT00739661|10936098|FG001|Overall Study|Disease progression, radiographic|37
6911304|NCT00739661|10936097|FG000|Overall Study|Reason for discontinuation not available|1
6911305|NCT00739661|10936098|FG001|Overall Study|Reason for discontinuation not available|1
6911306|NCT00739908|10936144|FG000|Overall Study|Adverse Event|5
6911307|NCT00739908|10936145|FG001|Overall Study|Adverse Event|6
6911308|NCT00739908|10936144|FG000|Overall Study|Withdrawal by Subject|4
6911309|NCT00739908|10936145|FG001|Overall Study|Withdrawal by Subject|2
6911310|NCT00739908|10936144|FG000|Overall Study|Lost to Follow-up|14
6911311|NCT00739908|10936145|FG001|Overall Study|Lost to Follow-up|9
6911312|NCT00739908|10936144|FG000|Overall Study|Non-Compliance With Study Procedures|2
6911313|NCT00739908|10936145|FG001|Overall Study|Non-Compliance With Study Procedures|3
6911314|NCT00739908|10936144|FG000|Overall Study|Non-Compliance With Study Medication|0
6911315|NCT00739908|10936145|FG001|Overall Study|Non-Compliance With Study Medication|3
6911316|NCT00739908|10936144|FG000|Overall Study|Lack of Efficacy|0
6911317|NCT00739908|10936145|FG001|Overall Study|Lack of Efficacy|1
6911318|NCT00739908|10936144|FG000|Overall Study|Relocation|0
6911319|NCT00739908|10936145|FG001|Overall Study|Relocation|1
6911320|NCT00739934|10936153|FG000|Voriconazole IV|Adverse Event|6
6911321|NCT00739934|10936153|FG000|Voriconazole Oral|Other|3
6911322|NCT00739973|10936175|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35
6911323|NCT00739973|10936176|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
6911324|NCT00739973|10936177|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
6911325|NCT00739973|10936178|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
6911326|NCT00739973|10936179|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
6911327|NCT00739973|10936180|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
6911328|NCT00739973|10936181|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
6911329|NCT00739973|10936182|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
6911330|NCT00739973|10936183|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
6911331|NCT00739973|10936175|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38
6911332|NCT00739973|10936176|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
6911333|NCT00739973|10936177|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
6911334|NCT00739973|10936178|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
6911335|NCT00739973|10936179|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
6911336|NCT00739973|10936180|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
6911337|NCT00739973|10936181|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
6911338|NCT00739973|10936182|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
6911339|NCT00739973|10936183|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
6911340|NCT00739973|10936175|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810
6911341|NCT00739973|10936176|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
6911342|NCT00739973|10936177|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
6911343|NCT00739973|10936178|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
6911344|NCT00739973|10936179|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
6911345|NCT00739973|10936180|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
6911346|NCT00739973|10936181|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
6911347|NCT00739973|10936182|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
6911348|NCT00739973|10936183|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
6911349|NCT00739973|10936175|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86
6911350|NCT00739973|10936176|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
6911351|NCT00739973|10936177|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
6911352|NCT00739973|10936178|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
6911353|NCT00739973|10936179|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
6911354|NCT00739973|10936180|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
6911355|NCT00739973|10936181|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
6911356|NCT00739973|10936182|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
6911357|NCT00739973|10936183|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
6978961|NCT01215435|11032646|FG001|Overall Study|Withdrawal Criteria|11
6911358|NCT00739973|10936175|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17
6911359|NCT00739973|10936176|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
6911360|NCT00739973|10936177|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
6911361|NCT00739973|10936178|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
6911362|NCT00739973|10936179|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
6911363|NCT00739973|10936180|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
6911364|NCT00739973|10936181|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
6911365|NCT00739973|10936182|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
6911366|NCT00739973|10936183|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
6911367|NCT00739973|10936175|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12
6911368|NCT00739973|10936176|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
6911369|NCT00739973|10936177|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
6911370|NCT00739973|10936178|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
6911371|NCT00739973|10936179|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
6911372|NCT00739973|10936180|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
6911373|NCT00739973|10936181|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
6911374|NCT00739973|10936182|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
6911375|NCT00739973|10936183|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
6911376|NCT00739973|10936175|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11
6911377|NCT00739973|10936176|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
6911378|NCT00739973|10936177|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
6911379|NCT00739973|10936178|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
6911380|NCT00739973|10936179|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
6911381|NCT00739973|10936180|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
6911382|NCT00739973|10936181|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
6911383|NCT00739973|10936182|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
6911384|NCT00739973|10936183|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
6911385|NCT00739973|10936175|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
6911386|NCT00739973|10936176|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
6911387|NCT00739973|10936177|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
6911388|NCT00739973|10936178|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2
6911389|NCT00739973|10936179|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7
6911390|NCT00739973|10936180|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
6911391|NCT00739973|10936181|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
6911392|NCT00739973|10936182|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
6911393|NCT00739973|10936183|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
6911394|NCT00739973|10936175|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
6911395|NCT00739973|10936176|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
6911396|NCT00739973|10936177|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
6911397|NCT00739973|10936178|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
6911398|NCT00739973|10936179|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
6911399|NCT00739973|10936180|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
6911400|NCT00739973|10936181|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
6911401|NCT00739973|10936182|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
6911402|NCT00739973|10936183|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
6911403|NCT00739973|10936175|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
6911404|NCT00739973|10936176|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
6911405|NCT00739973|10936177|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
6911406|NCT00739973|10936178|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
6911407|NCT00739973|10936179|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
6911408|NCT00739973|10936180|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
6911409|NCT00739973|10936181|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
6911410|NCT00739973|10936182|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
6911411|NCT00739973|10936183|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
6911412|NCT00739973|10936175|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17
6911413|NCT00739973|10936176|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
6911414|NCT00739973|10936177|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
6911415|NCT00739973|10936178|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4
6911416|NCT00739973|10936179|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
6911417|NCT00739973|10936180|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
6911418|NCT00739973|10936181|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
6911419|NCT00739973|10936182|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
6911420|NCT00739973|10936183|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
6911421|NCT00739973|10936175|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
6911422|NCT00739973|10936176|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
6911423|NCT00739973|10936177|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1
6911424|NCT00739973|10936178|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
6911425|NCT00739973|10936179|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
6911426|NCT00739973|10936180|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
6978962|NCT01215435|11032645|FG000|Overall Study|Lost to Follow-up|3
6911427|NCT00739973|10936181|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
6911428|NCT00739973|10936182|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
6911429|NCT00739973|10936183|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
6911430|NCT00739973|10936175|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
6911431|NCT00739973|10936176|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
6911432|NCT00739973|10936177|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
6911433|NCT00739973|10936178|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
6911434|NCT00739973|10936179|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
6911435|NCT00739973|10936180|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
6911436|NCT00739973|10936181|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
6911437|NCT00739973|10936182|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
6911438|NCT00739973|10936183|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
6911439|NCT00739973|10936175|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
6911440|NCT00739973|10936176|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
6911441|NCT00739973|10936177|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4
6911442|NCT00739973|10936178|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
6911443|NCT00739973|10936179|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
6911444|NCT00739973|10936180|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
6911445|NCT00739973|10936181|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
6911446|NCT00739973|10936182|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3
6911447|NCT00739973|10936183|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
6911448|NCT00739973|10936175|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
6911449|NCT00739973|10936176|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
6911450|NCT00739973|10936177|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
6911451|NCT00739973|10936178|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
6911452|NCT00739973|10936179|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
6911453|NCT00739973|10936180|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
6911454|NCT00739973|10936181|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1
6911455|NCT00739973|10936182|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
6911456|NCT00739973|10936183|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
6911457|NCT00739973|10936175|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5
6911458|NCT00739973|10936176|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
6911459|NCT00739973|10936177|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
6978963|NCT01215435|11032646|FG001|Overall Study|Lost to Follow-up|0
6911460|NCT00739973|10936178|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
6911461|NCT00739973|10936179|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
6911462|NCT00739973|10936180|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
6911463|NCT00739973|10936181|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
6911464|NCT00739973|10936182|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
6911465|NCT00739973|10936183|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
6911466|NCT00739973|10936175|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
6911467|NCT00739973|10936176|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1
6911468|NCT00739973|10936177|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
6911469|NCT00739973|10936178|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
6911470|NCT00739973|10936179|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
6911471|NCT00739973|10936180|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
6911472|NCT00739973|10936181|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2
6911473|NCT00739973|10936182|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
6911474|NCT00739973|10936183|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
6911475|NCT00740051|10936227|FG000|Overall Study|Lack of Efficacy|2
6911476|NCT00740051|10936228|FG001|Overall Study|Lack of Efficacy|5
6911477|NCT00740051|10936227|FG000|Overall Study|Adverse Event|1
6911478|NCT00740051|10936228|FG001|Overall Study|Adverse Event|4
6911479|NCT00740051|10936227|FG000|Overall Study|Protocol Violation|2
6911480|NCT00740051|10936228|FG001|Overall Study|Protocol Violation|6
6911481|NCT00740051|10936227|FG000|Overall Study|Lost to Follow-up|3
6911482|NCT00740051|10936228|FG001|Overall Study|Lost to Follow-up|8
6911483|NCT00740051|10936227|FG000|Overall Study|Withdrawal by Subject|6
6911484|NCT00740051|10936228|FG001|Overall Study|Withdrawal by Subject|8
6911485|NCT00740051|10936227|FG000|Overall Study|Other reason (not specified)|4
6911486|NCT00740051|10936228|FG001|Overall Study|Other reason (not specified)|1
6911487|NCT00740220|10936253|FG000|Overall Study|screen failures (non-COPD patients)|9
6911488|NCT00740584|10936266|FG000|Overall Study|Withdrawal by Subject|1
6911489|NCT00740636|10936273|FG000|Overall Study|Adverse Event|0
6911490|NCT00740636|10936274|FG001|Overall Study|Adverse Event|2
6911491|NCT00740636|10936273|FG000|Overall Study|Patient Ineligible|0
6911492|NCT00740636|10936274|FG001|Overall Study|Patient Ineligible|1
6911493|NCT00740636|10936273|FG000|Overall Study|Patient Not Treated|0
6911494|NCT00740636|10936274|FG001|Overall Study|Patient Not Treated|1
6911495|NCT00740636|10936273|FG000|Overall Study|Progressive Disease|1
6911496|NCT00740636|10936274|FG001|Overall Study|Progressive Disease|0
6911497|NCT00740636|10936273|FG000|Overall Study|Death|1
6911498|NCT00740636|10936274|FG001|Overall Study|Death|0
6911499|NCT00740714|10936283|FG000|Overall Study|Withdrawal by Subject|17
6911500|NCT00740714|10936284|FG001|Overall Study|Withdrawal by Subject|19
6911501|NCT00740714|10936285|FG002|Overall Study|Withdrawal by Subject|29
6911502|NCT00740779|10936296|FG000|Overall Study|Adverse Event|4
6911503|NCT00740779|10936297|FG001|Overall Study|Adverse Event|6
6911504|NCT00740779|10936298|FG002|Overall Study|Adverse Event|3
6911505|NCT00740779|10936296|FG000|Overall Study|Protocol Violation|1
6911506|NCT00740779|10936297|FG001|Overall Study|Protocol Violation|1
6911507|NCT00740779|10936298|FG002|Overall Study|Protocol Violation|1
6911508|NCT00740779|10936296|FG000|Overall Study|Lack of Efficacy|0
6911509|NCT00740779|10936297|FG001|Overall Study|Lack of Efficacy|0
6911510|NCT00740779|10936298|FG002|Overall Study|Lack of Efficacy|2
6911511|NCT00740779|10936296|FG000|Overall Study|Withdrawal by Subject|2
6911512|NCT00740779|10936297|FG001|Overall Study|Withdrawal by Subject|4
6911513|NCT00740779|10936298|FG002|Overall Study|Withdrawal by Subject|2
6911514|NCT00740779|10936296|FG000|Overall Study|Lost to Follow-up|2
6911515|NCT00740779|10936297|FG001|Overall Study|Lost to Follow-up|3
6911516|NCT00740779|10936298|FG002|Overall Study|Lost to Follow-up|5
6911517|NCT00740792|10936310|FG000|Overall Study|Adverse Event|3
6911518|NCT00740792|10936311|FG001|Overall Study|Adverse Event|1
6911519|NCT00740792|10936312|FG002|Overall Study|Adverse Event|1
6911520|NCT00740792|10936313|FG003|Overall Study|Adverse Event|3
6911521|NCT00740792|10936310|FG000|Overall Study|Lack of Efficacy|1
6911522|NCT00740792|10936311|FG001|Overall Study|Lack of Efficacy|1
6911523|NCT00740792|10936312|FG002|Overall Study|Lack of Efficacy|0
6911524|NCT00740792|10936313|FG003|Overall Study|Lack of Efficacy|3
6911525|NCT00740792|10936310|FG000|Overall Study|Lost to Follow-up|2
6911526|NCT00740792|10936311|FG001|Overall Study|Lost to Follow-up|1
6911527|NCT00740792|10936312|FG002|Overall Study|Lost to Follow-up|0
6911528|NCT00740792|10936313|FG003|Overall Study|Lost to Follow-up|0
6911529|NCT00740792|10936310|FG000|Overall Study|Protocol Violation|0
6911530|NCT00740792|10936311|FG001|Overall Study|Protocol Violation|1
6911531|NCT00740792|10936312|FG002|Overall Study|Protocol Violation|0
6911532|NCT00740792|10936313|FG003|Overall Study|Protocol Violation|2
6911533|NCT00740792|10936310|FG000|Overall Study|Withdrawal by Subject|1
6911534|NCT00740792|10936311|FG001|Overall Study|Withdrawal by Subject|1
6911535|NCT00740792|10936312|FG002|Overall Study|Withdrawal by Subject|0
6911536|NCT00740792|10936313|FG003|Overall Study|Withdrawal by Subject|0
6911537|NCT00740792|10936310|FG000|Overall Study|administrative|3
6911538|NCT00740792|10936311|FG001|Overall Study|administrative|3
6911539|NCT00740792|10936312|FG002|Overall Study|administrative|8
6911540|NCT00740792|10936313|FG003|Overall Study|administrative|2
6911541|NCT00740857|10936339|FG000|Overall Study|Withdrawal by Subject|1
6911542|NCT00740857|10936340|FG001|Overall Study|Withdrawal by Subject|0
6911543|NCT00740857|10936341|FG002|Overall Study|Withdrawal by Subject|0
6911544|NCT00740870|10936349|FG000|Overall Study|Not Catheterized|4
6911545|NCT00740870|10936349|FG000|Overall Study|Further testing contraindicated implant|17
6911546|NCT00741013|10936359|FG000|Overall Study|Adverse Event|1
6911547|NCT00741013|10936360|FG001|Overall Study|Adverse Event|0
6911548|NCT00741013|10936361|FG002|Overall Study|Adverse Event|0
6911549|NCT00741013|10936359|FG000|Overall Study|Withdrawal by Subject|0
6911550|NCT00741013|10936360|FG001|Overall Study|Withdrawal by Subject|0
6911551|NCT00741013|10936361|FG002|Overall Study|Withdrawal by Subject|1
6911552|NCT00741013|10936359|FG000|Overall Study|Discovered failed screen after enrolled|0
6911553|NCT00741013|10936360|FG001|Overall Study|Discovered failed screen after enrolled|2
6911554|NCT00741013|10936361|FG002|Overall Study|Discovered failed screen after enrolled|0
6911555|NCT00741039|10936377|FG000|Overall Study|Patient non-compliance|2
6911556|NCT00741039|10936378|FG001|Overall Study|Patient non-compliance|0
6911557|NCT00741091|10936384|FG000|Overall Study|Death|13
6911558|NCT00741091|10936384|FG000|Overall Study|Lost to Follow-up|16
6911559|NCT00741091|10936384|FG000|Overall Study|Withdrawal by Subject|6
6911560|NCT00741091|10936384|FG000|Overall Study|Missed Visit|22
6911561|NCT00741260|10936414|FG000|Overall Study|Disease Progression|3
6911562|NCT00741260|10936415|FG001|Overall Study|Disease Progression|5
6911563|NCT00741260|10936416|FG002|Overall Study|Disease Progression|3
6911564|NCT00741260|10936417|FG003|Overall Study|Disease Progression|3
6911565|NCT00741260|10936418|FG004|Overall Study|Disease Progression|5
6911566|NCT00741260|10936419|FG005|Overall Study|Disease Progression|37
6911567|NCT00741260|10936420|FG006|Overall Study|Disease Progression|4
6911568|NCT00741260|10936414|FG000|Overall Study|Death|0
6911569|NCT00741260|10936415|FG001|Overall Study|Death|1
6911570|NCT00741260|10936416|FG002|Overall Study|Death|0
6911571|NCT00741260|10936417|FG003|Overall Study|Death|1
6911572|NCT00741260|10936418|FG004|Overall Study|Death|2
6911573|NCT00741260|10936419|FG005|Overall Study|Death|2
6911574|NCT00741260|10936420|FG006|Overall Study|Death|1
6911575|NCT00741260|10936414|FG000|Overall Study|Withdrawal by Subject|0
6911576|NCT00741260|10936415|FG001|Overall Study|Withdrawal by Subject|0
6911577|NCT00741260|10936416|FG002|Overall Study|Withdrawal by Subject|0
6911578|NCT00741260|10936417|FG003|Overall Study|Withdrawal by Subject|0
6911579|NCT00741260|10936418|FG004|Overall Study|Withdrawal by Subject|1
6911580|NCT00741260|10936419|FG005|Overall Study|Withdrawal by Subject|3
6911581|NCT00741260|10936420|FG006|Overall Study|Withdrawal by Subject|1
6911582|NCT00741260|10936414|FG000|Overall Study|Physician Decision|1
6911583|NCT00741260|10936415|FG001|Overall Study|Physician Decision|1
6911584|NCT00741260|10936416|FG002|Overall Study|Physician Decision|0
6911585|NCT00741260|10936417|FG003|Overall Study|Physician Decision|0
6911586|NCT00741260|10936418|FG004|Overall Study|Physician Decision|0
6911587|NCT00741260|10936419|FG005|Overall Study|Physician Decision|0
6911588|NCT00741260|10936420|FG006|Overall Study|Physician Decision|0
6911589|NCT00741260|10936414|FG000|Overall Study|Other|2
6911590|NCT00741260|10936415|FG001|Overall Study|Other|1
6911591|NCT00741260|10936416|FG002|Overall Study|Other|1
6911592|NCT00741260|10936417|FG003|Overall Study|Other|2
6911593|NCT00741260|10936418|FG004|Overall Study|Other|1
6911594|NCT00741260|10936419|FG005|Overall Study|Other|3
6911595|NCT00741260|10936420|FG006|Overall Study|Other|1
6911596|NCT00741286|10936456|FG000|Overall Study|Lost to Follow-up|15
6911597|NCT00741286|10936457|FG001|Overall Study|Lost to Follow-up|10
6911598|NCT00741286|10936456|FG000|Overall Study|Adverse Event|1
6911599|NCT00741286|10936457|FG001|Overall Study|Adverse Event|6
6911600|NCT00741286|10936456|FG000|Overall Study|Protocol Violation|3
6911601|NCT00741286|10936457|FG001|Overall Study|Protocol Violation|2
6911602|NCT00741286|10936456|FG000|Overall Study|Primary Outcome|1
6911603|NCT00741286|10936457|FG001|Overall Study|Primary Outcome|1
6911604|NCT00741338|10936465|FG000|Overall Study|Adverse Event|0
6911605|NCT00741338|10936466|FG001|Overall Study|Adverse Event|1
6911606|NCT00741598|10936508|FG000|Overall Study|Lost to Follow-up|3
6911607|NCT00741598|10936509|FG001|Overall Study|Lost to Follow-up|4
6911608|NCT00741598|10936508|FG000|Overall Study|Lack of Efficacy|1
6911609|NCT00741598|10936509|FG001|Overall Study|Lack of Efficacy|2
6911610|NCT00741598|10936508|FG000|Overall Study|Physician Decision|1
6911611|NCT00741598|10936509|FG001|Overall Study|Physician Decision|1
6911612|NCT00741598|10936508|FG000|Overall Study|Pregnancy|1
6911613|NCT00741598|10936509|FG001|Overall Study|Pregnancy|0
6911614|NCT00741598|10936508|FG000|Overall Study|Withdrawal by Subject|3
6911615|NCT00741598|10936509|FG001|Overall Study|Withdrawal by Subject|2
6911616|NCT00741611|10936519|FG000|Overall Study|Death|0
6911617|NCT00741611|10936520|FG001|Overall Study|Death|0
6911618|NCT00741611|10936521|FG002|Overall Study|Death|1
6911619|NCT00741611|10936519|FG000|Overall Study|Withdrawal by Subject|0
6911620|NCT00741611|10936520|FG001|Overall Study|Withdrawal by Subject|2
6911621|NCT00741611|10936521|FG002|Overall Study|Withdrawal by Subject|2
6911622|NCT00741819|10936530|FG000|Overall Study|Adverse Event|3
6911623|NCT00741819|10936530|FG000|Overall Study|Withdrawal by Subject|3
6911624|NCT00741819|10936530|FG000|Overall Study|Death|1
6911625|NCT00741819|10936530|FG000|Overall Study|Disease progression|1
6911626|NCT00741936|10936547|FG000|Overall Study|Lost to Follow-up|1
6911627|NCT00741936|10936548|FG001|Overall Study|Lost to Follow-up|1
6911628|NCT00741936|10936547|FG000|Overall Study|Adverse Event|3
6911629|NCT00741936|10936548|FG001|Overall Study|Adverse Event|4
6911630|NCT00741936|10936547|FG000|Overall Study|Pregnancy|0
6911631|NCT00741936|10936548|FG001|Overall Study|Pregnancy|1
6911632|NCT00741936|10936547|FG000|Overall Study|Protocol Violation|2
6911633|NCT00741936|10936548|FG001|Overall Study|Protocol Violation|0
6911634|NCT00741936|10936547|FG000|Overall Study|Lack of Efficacy|0
6911635|NCT00741936|10936548|FG001|Overall Study|Lack of Efficacy|2
6911636|NCT00741936|10936547|FG000|Overall Study|Low compliance|3
6911637|NCT00741936|10936548|FG001|Overall Study|Low compliance|0
6911638|NCT00742001|10936557|FG000|Overall Study|Withdrawn; health exclusion (flu)|0
6911639|NCT00742001|10936558|FG001|Overall Study|Withdrawn; health exclusion (flu)|0
6911640|NCT00742001|10936559|FG002|Overall Study|Withdrawn; health exclusion (flu)|1
6911641|NCT00742027|10936570|FG000|Overall Study|Disease Progression|76
6911642|NCT00742027|10936570|FG000|Overall Study|New Cancer Therapy|19
6911643|NCT00742027|10936570|FG000|Overall Study|Withdrawal by Subject|18
6911644|NCT00742027|10936570|FG000|Overall Study|Death|7
6911645|NCT00742027|10936570|FG000|Overall Study|Lost to Follow-up|4
6911646|NCT00742027|10936570|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2
6911647|NCT00742027|10936570|FG000|Overall Study|Missing|2
6911648|NCT00742027|10936570|FG000|Overall Study|Administrative Problems|1
6911649|NCT00742079|10936580|FG000|Overall Study|Lost to Follow-up|0
6911650|NCT00742079|10936581|FG001|Overall Study|Lost to Follow-up|1
6911651|NCT00742183|10936598|FG000|Overall Study|Adverse Event|2
6911652|NCT00742183|10936599|FG001|Overall Study|Adverse Event|2
6911653|NCT00742183|10936598|FG000|Overall Study|Death|1
6911654|NCT00742183|10936599|FG001|Overall Study|Death|0
6911655|NCT00742183|10936598|FG000|Overall Study|Physician Decision|0
6911656|NCT00742183|10936599|FG001|Overall Study|Physician Decision|2
6911657|NCT00742183|10936598|FG000|Overall Study|Lost to Follow-up|4
6911658|NCT00742183|10936599|FG001|Overall Study|Lost to Follow-up|4
6911659|NCT00742183|10936598|FG000|Overall Study|Required skin-graft|1
6911660|NCT00742183|10936599|FG001|Overall Study|Required skin-graft|1
6911661|NCT00742183|10936598|FG000|Overall Study|Withdrawal by Subject|1
6911662|NCT00742183|10936599|FG001|Overall Study|Withdrawal by Subject|0
6911663|NCT00742183|10936598|FG000|Overall Study|Lack of Efficacy|0
6911664|NCT00742183|10936599|FG001|Overall Study|Lack of Efficacy|3
6911665|NCT00742209|10936610|FG000|Overall Study|Adverse Event|11
6911666|NCT00742209|10936611|FG001|Overall Study|Adverse Event|4
6911667|NCT00742209|10936612|FG002|Overall Study|Adverse Event|17
6911668|NCT00742209|10936613|FG003|Overall Study|Adverse Event|16
6911669|NCT00742209|10936614|FG004|Overall Study|Adverse Event|13
6911670|NCT00742209|10936610|FG000|Overall Study|Participant Withdrew Consent|8
6911671|NCT00742209|10936611|FG001|Overall Study|Participant Withdrew Consent|4
6911672|NCT00742209|10936612|FG002|Overall Study|Participant Withdrew Consent|14
6911673|NCT00742209|10936613|FG003|Overall Study|Participant Withdrew Consent|7
6911674|NCT00742209|10936614|FG004|Overall Study|Participant Withdrew Consent|4
6911675|NCT00742209|10936610|FG000|Overall Study|Protocol Violation|6
6911676|NCT00742209|10936611|FG001|Overall Study|Protocol Violation|5
6911677|NCT00742209|10936612|FG002|Overall Study|Protocol Violation|4
6911678|NCT00742209|10936613|FG003|Overall Study|Protocol Violation|5
6911679|NCT00742209|10936614|FG004|Overall Study|Protocol Violation|3
6911680|NCT00742209|10936610|FG000|Overall Study|Lost to Follow-up|3
6911681|NCT00742209|10936611|FG001|Overall Study|Lost to Follow-up|4
6911682|NCT00742209|10936612|FG002|Overall Study|Lost to Follow-up|5
6911683|NCT00742209|10936613|FG003|Overall Study|Lost to Follow-up|5
6911684|NCT00742209|10936614|FG004|Overall Study|Lost to Follow-up|3
6911685|NCT00742209|10936610|FG000|Overall Study|Lack of Efficacy|6
6911686|NCT00742209|10936611|FG001|Overall Study|Lack of Efficacy|1
6911687|NCT00742209|10936612|FG002|Overall Study|Lack of Efficacy|1
6911688|NCT00742209|10936613|FG003|Overall Study|Lack of Efficacy|3
6911689|NCT00742209|10936614|FG004|Overall Study|Lack of Efficacy|1
6911690|NCT00742209|10936610|FG000|Overall Study|Investigator Discretion|0
6911691|NCT00742209|10936611|FG001|Overall Study|Investigator Discretion|0
6911692|NCT00742209|10936612|FG002|Overall Study|Investigator Discretion|5
6911693|NCT00742209|10936613|FG003|Overall Study|Investigator Discretion|1
6911694|NCT00742209|10936614|FG004|Overall Study|Investigator Discretion|1
6911695|NCT00742235|10936629|FG000|Overall Study|Lost to Follow-up|0
6911696|NCT00742235|10936630|FG001|Overall Study|Lost to Follow-up|31
6911697|NCT00742274|10936638|FG000|Overall Study|Death|1
6911698|NCT00742274|10936639|FG001|Overall Study|Death|0
6911699|NCT00742274|10936638|FG000|Overall Study|Withdrawal by Subject|1
6911700|NCT00742274|10936639|FG001|Overall Study|Withdrawal by Subject|2
6911701|NCT00742274|10936638|FG000|Overall Study|Removed for medical reasons|1
6911702|NCT00742274|10936639|FG001|Overall Study|Removed for medical reasons|1
6911703|NCT00742326|10936656|FG000|Overall Study|Physician Decision|0
6911704|NCT00742326|10936657|FG001|Overall Study|Physician Decision|1
6911705|NCT00742391|10936665|FG000|Overall Study|Adverse Event|2
6911706|NCT00742391|10936666|FG001|Overall Study|Adverse Event|1
6911707|NCT00742391|10936665|FG000|Overall Study|Lost to Follow-up|1
6911708|NCT00742391|10936666|FG001|Overall Study|Lost to Follow-up|0
6911709|NCT00742391|10936665|FG000|Overall Study|Protocol Violation|1
6911710|NCT00742391|10936666|FG001|Overall Study|Protocol Violation|0
6911711|NCT00742417|10936674|FG000|Randomized|Withdrawal by legal representative|0
6911712|NCT00742417|10936675|FG001|Randomized|Withdrawal by legal representative|1
6911713|NCT00742417|10936674|FG000|Randomized|Withdrawal by Subject|1
6911714|NCT00742417|10936675|FG001|Randomized|Withdrawal by Subject|0
6911715|NCT00742417|10936674|FG000|Randomized|Physician Decision|1
6911716|NCT00742417|10936675|FG001|Randomized|Physician Decision|0
6911717|NCT00742417|10936674|FG000|Intensive Period|Withdrawal by Subject|1
6911718|NCT00742417|10936675|FG001|Intensive Period|Withdrawal by Subject|1
6911719|NCT00742417|10936674|FG000|Intensive Period|Adverse Event|2
6911720|NCT00742417|10936675|FG001|Intensive Period|Adverse Event|0
6911721|NCT00742508|10936694|FG000|8-Week Primary Evaluation Period|Adverse Event|2
6911722|NCT00742508|10936695|FG001|8-Week Primary Evaluation Period|Adverse Event|4
6911723|NCT00742508|10936694|FG000|8-Week Primary Evaluation Period|Protocol Violation|1
6911724|NCT00742508|10936695|FG001|8-Week Primary Evaluation Period|Protocol Violation|0
6911725|NCT00742508|10936694|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8
6911726|NCT00742508|10936695|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5
6911727|NCT00742508|10936694|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0
6911728|NCT00742508|10936695|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2
6911729|NCT00742508|10936694|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0
6911730|NCT00742508|10936695|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1
6911731|NCT00742560|10936706|FG000|Overall Study|Adverse Event|0
6911732|NCT00742560|10936707|FG001|Overall Study|Adverse Event|0
6911733|NCT00742560|10936708|FG002|Overall Study|Adverse Event|1
6911734|NCT00742560|10936709|FG003|Overall Study|Adverse Event|1
6911735|NCT00742560|10936710|FG004|Overall Study|Adverse Event|1
6911736|NCT00742560|10936706|FG000|Overall Study|Death|0
6911737|NCT00742560|10936707|FG001|Overall Study|Death|2
6911738|NCT00742560|10936708|FG002|Overall Study|Death|0
6911739|NCT00742560|10936709|FG003|Overall Study|Death|2
6911740|NCT00742560|10936710|FG004|Overall Study|Death|3
7142986|NCT03022981|11299254|FG001|Overall Study|Investigator's Discretion|1
7142987|NCT03022981|11299255|FG002|Overall Study|Investigator's Discretion|2
7142988|NCT03022981|11299253|FG000|Overall Study|Lost to Follow-up|6
7142989|NCT03022981|11299254|FG001|Overall Study|Lost to Follow-up|2
7142990|NCT03022981|11299255|FG002|Overall Study|Lost to Follow-up|1
6911741|NCT00742560|10936706|FG000|Overall Study|Subject's Decision|1
6911742|NCT00742560|10936707|FG001|Overall Study|Subject's Decision|0
6911743|NCT00742560|10936708|FG002|Overall Study|Subject's Decision|2
6911744|NCT00742560|10936709|FG003|Overall Study|Subject's Decision|3
6911745|NCT00742560|10936710|FG004|Overall Study|Subject's Decision|3
6911746|NCT00742560|10936706|FG000|Overall Study|Investigator's Decision|0
6911747|NCT00742560|10936707|FG001|Overall Study|Investigator's Decision|0
6911748|NCT00742560|10936708|FG002|Overall Study|Investigator's Decision|4
6911749|NCT00742560|10936709|FG003|Overall Study|Investigator's Decision|1
6911750|NCT00742560|10936710|FG004|Overall Study|Investigator's Decision|0
6911751|NCT00742560|10936706|FG000|Overall Study|Disease Progression|1
6911752|NCT00742560|10936707|FG001|Overall Study|Disease Progression|0
6911753|NCT00742560|10936708|FG002|Overall Study|Disease Progression|5
6911754|NCT00742560|10936709|FG003|Overall Study|Disease Progression|17
6911755|NCT00742560|10936710|FG004|Overall Study|Disease Progression|16
6911756|NCT00742560|10936706|FG000|Overall Study|New Multiple Myeloma Therapy|1
6911757|NCT00742560|10936707|FG001|Overall Study|New Multiple Myeloma Therapy|0
6911758|NCT00742560|10936708|FG002|Overall Study|New Multiple Myeloma Therapy|2
6911759|NCT00742560|10936709|FG003|Overall Study|New Multiple Myeloma Therapy|3
6911760|NCT00742560|10936710|FG004|Overall Study|New Multiple Myeloma Therapy|4
6911761|NCT00742560|10936706|FG000|Overall Study|Other|0
6911762|NCT00742560|10936707|FG001|Overall Study|Other|1
6911763|NCT00742560|10936708|FG002|Overall Study|Other|8
6911764|NCT00742560|10936709|FG003|Overall Study|Other|9
6911765|NCT00742560|10936710|FG004|Overall Study|Other|9
6911766|NCT00742560|10936706|FG000|Overall Study|MIssing|0
6911767|NCT00742560|10936707|FG001|Overall Study|MIssing|0
6911768|NCT00742560|10936708|FG002|Overall Study|MIssing|0
6911769|NCT00742560|10936709|FG003|Overall Study|MIssing|0
6911770|NCT00742560|10936710|FG004|Overall Study|MIssing|1
6911771|NCT00742625|10936750|FG000|Remission Induction|Progression|6
6911772|NCT00742625|10936750|FG000|Remission Induction|Failed induction|8
6911773|NCT00742625|10936750|FG000|Remission Induction|Adverse Event|3
6911774|NCT00742625|10936750|FG000|Remission Induction|Death|10
6911775|NCT00742625|10936750|FG000|Remission Induction|Refusal|5
6911776|NCT00742625|10936750|FG000|Remission Induction|Non protocol treatment|17
6911777|NCT00742625|10936750|FG000|Remission Induction|Other, not specified|5
6911778|NCT00742625|10936750|FG000|Consolidation|Progression|5
6911779|NCT00742625|10936750|FG000|Consolidation|Adverse Event|1
6911780|NCT00742625|10936750|FG000|Consolidation|Death|1
6911781|NCT00742625|10936750|FG000|Consolidation|Refused|1
6911782|NCT00742625|10936750|FG000|Consolidation|Non protocol therapy|13
6911783|NCT00742781|10936757|FG000|Overall Study|Withdrawal by Subject|3
7142991|NCT03022981|11299253|FG000|Overall Study|Non-Compliance With Study Drug|0
6911784|NCT00742859|10936766|FG000|Overall Study|Adverse Event|5
6911785|NCT00742859|10936767|FG001|Overall Study|Adverse Event|6
6911786|NCT00742859|10936768|FG002|Overall Study|Adverse Event|3
6911787|NCT00742859|10936769|FG003|Overall Study|Adverse Event|1
6911788|NCT00742859|10936766|FG000|Overall Study|Death|1
6911789|NCT00742859|10936767|FG001|Overall Study|Death|0
6911790|NCT00742859|10936768|FG002|Overall Study|Death|0
6911791|NCT00742859|10936769|FG003|Overall Study|Death|1
6911792|NCT00742859|10936766|FG000|Overall Study|Physician Decision|1
6911793|NCT00742859|10936767|FG001|Overall Study|Physician Decision|2
6911794|NCT00742859|10936768|FG002|Overall Study|Physician Decision|0
6911795|NCT00742859|10936769|FG003|Overall Study|Physician Decision|0
6911796|NCT00742859|10936766|FG000|Overall Study|Withdrawal by Subject|4
6911797|NCT00742859|10936767|FG001|Overall Study|Withdrawal by Subject|2
6911798|NCT00742859|10936768|FG002|Overall Study|Withdrawal by Subject|4
6911799|NCT00742859|10936769|FG003|Overall Study|Withdrawal by Subject|1
6911800|NCT00742859|10936766|FG000|Overall Study|Endpoint|0
6911801|NCT00742859|10936767|FG001|Overall Study|Endpoint|1
6911802|NCT00742859|10936768|FG002|Overall Study|Endpoint|1
6911803|NCT00742859|10936769|FG003|Overall Study|Endpoint|2
6911804|NCT00742859|10936766|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0
6911805|NCT00742859|10936767|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1
6911806|NCT00742859|10936768|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1
6911807|NCT00742859|10936769|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0
6911808|NCT00742859|10936766|FG000|Overall Study|Sponsor req visit schedule noncompliance|0
6911809|NCT00742859|10936767|FG001|Overall Study|Sponsor req visit schedule noncompliance|0
6911810|NCT00742859|10936768|FG002|Overall Study|Sponsor req visit schedule noncompliance|0
6911811|NCT00742859|10936769|FG003|Overall Study|Sponsor req visit schedule noncompliance|1
6911812|NCT00742859|10936766|FG000|Overall Study|Sponsor request patient out of town|0
6911813|NCT00742859|10936767|FG001|Overall Study|Sponsor request patient out of town|0
6911814|NCT00742859|10936768|FG002|Overall Study|Sponsor request patient out of town|1
6911815|NCT00742859|10936769|FG003|Overall Study|Sponsor request patient out of town|1
6911816|NCT00742859|10936766|FG000|Overall Study|Site error|0
6911817|NCT00742859|10936767|FG001|Overall Study|Site error|0
6911818|NCT00742859|10936768|FG002|Overall Study|Site error|1
6911819|NCT00742859|10936769|FG003|Overall Study|Site error|1
6911820|NCT00742885|10936790|FG000|Overall Study|Lost to Follow-up|1
6911821|NCT00742885|10936791|FG001|Overall Study|Lost to Follow-up|0
6911822|NCT00742924|10936804|FG000|Overall Study|Adverse Event|0
6911823|NCT00742924|10936805|FG001|Overall Study|Adverse Event|0
6911824|NCT00742924|10936806|FG002|Overall Study|Adverse Event|1
6911825|NCT00742924|10936807|FG003|Overall Study|Adverse Event|1
6911826|NCT00742924|10936804|FG000|Overall Study|Lack of Efficacy|5
6911827|NCT00742924|10936805|FG001|Overall Study|Lack of Efficacy|1
6911828|NCT00742924|10936806|FG002|Overall Study|Lack of Efficacy|2
6911829|NCT00742924|10936807|FG003|Overall Study|Lack of Efficacy|4
6911830|NCT00742924|10936804|FG000|Overall Study|Physician Decision|0
6911831|NCT00742924|10936805|FG001|Overall Study|Physician Decision|0
6911832|NCT00742924|10936806|FG002|Overall Study|Physician Decision|0
6911833|NCT00742924|10936807|FG003|Overall Study|Physician Decision|1
6911834|NCT00742924|10936804|FG000|Overall Study|Withdrawal by Subject|0
6911835|NCT00742924|10936805|FG001|Overall Study|Withdrawal by Subject|1
6911836|NCT00742924|10936806|FG002|Overall Study|Withdrawal by Subject|1
6911837|NCT00742924|10936807|FG003|Overall Study|Withdrawal by Subject|0
6911838|NCT00743106|10936832|FG000|Overall Study|Met intraoperative exclusion criterion|8
6911839|NCT00743106|10936833|FG001|Overall Study|Met intraoperative exclusion criterion|5
6911840|NCT00743119|10936839|FG000|Overall Study|unreliable|3
6911841|NCT00743119|10936839|FG000|Overall Study|Withdrawal by Subject|1
6911842|NCT00743145|10936851|FG000|Overall Study|Withdrawal by Subject|1
6911843|NCT00743145|10936851|FG000|Overall Study|Adverse Event|2
6911844|NCT00743145|10936851|FG000|Overall Study|Pregnancy|1
6911845|NCT00743249|10936867|FG000|Overall Study|Adverse Event|0
6911846|NCT00743249|10936868|FG001|Overall Study|Adverse Event|4
6911847|NCT00743249|10936867|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0
6911848|NCT00743249|10936868|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1
6911849|NCT00743249|10936867|FG000|Overall Study|Unsuccessful insertion of stent|2
6911850|NCT00743249|10936868|FG001|Overall Study|Unsuccessful insertion of stent|1
6911851|NCT00743275|10936880|FG000|Overall Study|Protocol Violation|0
6911852|NCT00743275|10936881|FG001|Overall Study|Protocol Violation|1
6911853|NCT00743288|10936887|FG000|Overall Study|Adverse Event|1
6911854|NCT00743288|10936888|FG001|Overall Study|Adverse Event|1
6911855|NCT00743288|10936889|FG002|Overall Study|Adverse Event|2
6911856|NCT00743288|10936890|FG003|Overall Study|Adverse Event|2
6911857|NCT00743288|10936891|FG004|Overall Study|Adverse Event|1
6911858|NCT00743288|10936892|FG005|Overall Study|Adverse Event|1
6911859|NCT00743288|10936893|FG006|Overall Study|Adverse Event|2
6911860|NCT00743288|10936887|FG000|Overall Study|Withdrawal by Subject|0
6911861|NCT00743288|10936888|FG001|Overall Study|Withdrawal by Subject|0
6911862|NCT00743288|10936889|FG002|Overall Study|Withdrawal by Subject|1
6911863|NCT00743288|10936890|FG003|Overall Study|Withdrawal by Subject|0
6911864|NCT00743288|10936891|FG004|Overall Study|Withdrawal by Subject|0
6911865|NCT00743288|10936892|FG005|Overall Study|Withdrawal by Subject|1
6911866|NCT00743288|10936893|FG006|Overall Study|Withdrawal by Subject|1
6911867|NCT00743288|10936887|FG000|Overall Study|Progressive disease (PD)|2
6911868|NCT00743288|10936888|FG001|Overall Study|Progressive disease (PD)|0
6911869|NCT00743288|10936889|FG002|Overall Study|Progressive disease (PD)|1
6911870|NCT00743288|10936890|FG003|Overall Study|Progressive disease (PD)|4
6911871|NCT00743288|10936891|FG004|Overall Study|Progressive disease (PD)|5
6911872|NCT00743288|10936892|FG005|Overall Study|Progressive disease (PD)|3
6911873|NCT00743288|10936893|FG006|Overall Study|Progressive disease (PD)|6
6911874|NCT00743288|10936887|FG000|Overall Study|Worsening of condition (Not PD)|0
6911875|NCT00743288|10936888|FG001|Overall Study|Worsening of condition (Not PD)|2
6911876|NCT00743288|10936889|FG002|Overall Study|Worsening of condition (Not PD)|1
6911877|NCT00743288|10936890|FG003|Overall Study|Worsening of condition (Not PD)|1
6911878|NCT00743288|10936891|FG004|Overall Study|Worsening of condition (Not PD)|0
6911879|NCT00743288|10936892|FG005|Overall Study|Worsening of condition (Not PD)|0
6911880|NCT00743288|10936893|FG006|Overall Study|Worsening of condition (Not PD)|0
6978964|NCT01215435|11032645|FG000|Overall Study|Unclassified|5
6978965|NCT01215435|11032646|FG001|Overall Study|Unclassified|5
6978966|NCT01215513|11032652|FG000|Overall Study|Not completed CS42|9
6978967|NCT01215513|11032652|FG000|Overall Study|Not enrolled from CS42 to CS42A|21
6911881|NCT00743340|10936904|FG000|Overall Study|Study medication non-compliance|1
6911882|NCT00743340|10936904|FG000|Overall Study|Lost to Follow-up|1
6911883|NCT00743340|10936904|FG000|Overall Study|Withdrawal from the Study|5
6978968|NCT01215513|11032652|FG000|Overall Study|Adverse event (CS42A)|2
6978969|NCT01215513|11032652|FG000|Overall Study|Physician decision (CS42A)|6
6978970|NCT01215513|11032652|FG000|Overall Study|Withdrawal by subject (CS42A)|5
6978971|NCT01215513|11032652|FG000|Overall Study|Miscellaneous reasons (CS42A)|2
6978972|NCT01215721|11032692|FG000|Overall Study|Adverse Event|2
6978973|NCT01215734|11032698|FG000|Overall Study|Death|0
6978974|NCT01215734|11032699|FG001|Overall Study|Death|1
6978975|NCT01215851|11032724|FG000|Treatment Period|Adverse Event|1
6978976|NCT01215851|11032725|FG001|Treatment Period|Adverse Event|1
6978977|NCT01215851|11032726|FG002|Treatment Period|Adverse Event|1
6978978|NCT01215851|11032727|FG003|Treatment Period|Adverse Event|3
6978979|NCT01215851|11032728|FG004|Treatment Period|Adverse Event|0
6978980|NCT01215851|11032729|FG005|Treatment Period|Adverse Event|1
6978981|NCT01215851|11032724|FG000|Follow up Period|Lost to Follow-up|0
6978982|NCT01215851|11032725|FG001|Follow up Period|Lost to Follow-up|0
6978983|NCT01215851|11032726|FG002|Follow up Period|Lost to Follow-up|0
6978984|NCT01215851|11032727|FG003|Follow up Period|Lost to Follow-up|0
6978985|NCT01215851|11032728|FG004|Follow up Period|Lost to Follow-up|0
6978986|NCT01215851|11032729|FG005|Follow up Period|Lost to Follow-up|1
6978987|NCT01215916|11032753|FG000|Overall Study|Progressive Disease|0
6978988|NCT01215916|11032754|FG001|Overall Study|Progressive Disease|2
6978989|NCT01215916|11032755|FG002|Overall Study|Progressive Disease|1
6978990|NCT01215916|11032756|FG003|Overall Study|Progressive Disease|2
6978991|NCT01215916|11032757|FG004|Overall Study|Progressive Disease|5
6978992|NCT01215916|11032758|FG005|Overall Study|Progressive Disease|4
6978993|NCT01215916|11032759|FG006|Overall Study|Progressive Disease|5
6978994|NCT01215916|11032760|FG007|Overall Study|Progressive Disease|3
6978995|NCT01215916|11032761|FG008|Overall Study|Progressive Disease|1
6978996|NCT01215916|11032753|FG000|Overall Study|Adverse Event|1
6978997|NCT01215916|11032754|FG001|Overall Study|Adverse Event|1
6978998|NCT01215916|11032755|FG002|Overall Study|Adverse Event|0
6978999|NCT01215916|11032756|FG003|Overall Study|Adverse Event|1
6979000|NCT01215916|11032757|FG004|Overall Study|Adverse Event|0
6979001|NCT01215916|11032758|FG005|Overall Study|Adverse Event|0
6979002|NCT01215916|11032759|FG006|Overall Study|Adverse Event|3
6979003|NCT01215916|11032760|FG007|Overall Study|Adverse Event|0
6979004|NCT01215916|11032761|FG008|Overall Study|Adverse Event|0
6979005|NCT01215916|11032753|FG000|Overall Study|Withdrawal by Subject|0
6979006|NCT01215916|11032754|FG001|Overall Study|Withdrawal by Subject|1
6979007|NCT01215916|11032755|FG002|Overall Study|Withdrawal by Subject|1
6979008|NCT01215916|11032756|FG003|Overall Study|Withdrawal by Subject|2
6911884|NCT00743340|10936904|FG000|Overall Study|Protocol Violation|1
6911885|NCT00743340|10936904|FG000|Overall Study|Virologic failure|8
6911886|NCT00743340|10936904|FG000|Overall Study|Pregnancy|1
6911887|NCT00743340|10936904|FG000|Overall Study|Rolled over to other Gilead Study|23
6911888|NCT00743340|10936904|FG000|Overall Study|Participant Relocated|1
6911889|NCT00743366|10936908|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3
6911890|NCT00743366|10936909|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3
6974194|NCT01185600|11026084|FG001|Overall Study|Hold by DSMB|2
6974195|NCT01185639|11026093|FG000|Overall Study|Progressed and didn't receive therapy|2
6974196|NCT01185704|11026099|FG000|Overall Study|Randomized but not treated|3
6974197|NCT01185704|11026100|FG001|Overall Study|Randomized but not treated|3
6974198|NCT01185704|11026099|FG000|Overall Study|Lack of ovarian response|5
6974199|NCT01185704|11026100|FG001|Overall Study|Lack of ovarian response|1
6974200|NCT01185704|11026099|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5
6974201|NCT01185704|11026100|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3
6974202|NCT01185704|11026099|FG000|Overall Study|Ectopic pregnancy|0
6974203|NCT01185704|11026100|FG001|Overall Study|Ectopic pregnancy|1
6974204|NCT01185782|11026108|FG000|Overall Study|Adverse Event|0
6974205|NCT01185782|11026109|FG001|Overall Study|Adverse Event|1
6974206|NCT01185782|11026108|FG000|Overall Study|Protocol Violation|1
6974207|NCT01185782|11026109|FG001|Overall Study|Protocol Violation|0
6974208|NCT01185782|11026108|FG000|Overall Study|Poor Response to Treatment|3
6974209|NCT01185782|11026109|FG001|Overall Study|Poor Response to Treatment|1
6979009|NCT01215916|11032757|FG004|Overall Study|Withdrawal by Subject|0
6979010|NCT01215916|11032758|FG005|Overall Study|Withdrawal by Subject|0
6911891|NCT00743431|10936915|FG000|Overall Study|Toxicity|6
6911892|NCT00743431|10936915|FG000|Overall Study|Tumor progression|56
6911893|NCT00743431|10936915|FG000|Overall Study|Withdrawal by Subject|13
6979011|NCT01215916|11032759|FG006|Overall Study|Withdrawal by Subject|1
6979012|NCT01215916|11032760|FG007|Overall Study|Withdrawal by Subject|0
6979013|NCT01215916|11032761|FG008|Overall Study|Withdrawal by Subject|0
6911894|NCT00743431|10936915|FG000|Overall Study|Death|9
6911895|NCT00743431|10936915|FG000|Overall Study|Reason for discontinuation not specified|29
6911896|NCT00743431|10936915|FG000|Overall Study|No documentation available|13
6911897|NCT00743444|10936919|FG000|First Intervention|Catheter placement problems|0
6911898|NCT00743444|10936920|FG001|First Intervention|Catheter placement problems|1
6911899|NCT00743444|10936919|FG000|Washout Period|Adverse Event|0
6911900|NCT00743444|10936920|FG001|Washout Period|Adverse Event|1
6911901|NCT00743483|10936926|FG000|Baseline Period|Physician Decision|1
6911902|NCT00743483|10936926|FG000|Treatment Period|Adverse Event|1
6911903|NCT00743509|10936930|FG000|Overall Study|Withdrawal by Subject|2
6911904|NCT00743652|10936943|FG000|Overall Study|Parent/Legal Guardian Request|3
6911905|NCT00743652|10936944|FG001|Overall Study|Parent/Legal Guardian Request|2
6911906|NCT00743652|10936945|FG002|Overall Study|Parent/Legal Guardian Request|2
6911907|NCT00743652|10936946|FG003|Overall Study|Parent/Legal Guardian Request|2
6911908|NCT00743652|10936947|FG004|Overall Study|Parent/Legal Guardian Request|0
6911909|NCT00743652|10936943|FG000|Overall Study|Adverse Event|3
6911910|NCT00743652|10936944|FG001|Overall Study|Adverse Event|0
6911911|NCT00743652|10936945|FG002|Overall Study|Adverse Event|0
6911912|NCT00743652|10936946|FG003|Overall Study|Adverse Event|0
6911913|NCT00743652|10936947|FG004|Overall Study|Adverse Event|0
6911914|NCT00743652|10936943|FG000|Overall Study|Death|2
6911915|NCT00743652|10936944|FG001|Overall Study|Death|0
6911916|NCT00743652|10936945|FG002|Overall Study|Death|0
6911917|NCT00743652|10936946|FG003|Overall Study|Death|0
6911918|NCT00743652|10936947|FG004|Overall Study|Death|0
6911919|NCT00743652|10936943|FG000|Overall Study|Investigator Request|0
6911920|NCT00743652|10936944|FG001|Overall Study|Investigator Request|0
6911921|NCT00743652|10936945|FG002|Overall Study|Investigator Request|0
6911922|NCT00743652|10936946|FG003|Overall Study|Investigator Request|2
6911923|NCT00743652|10936947|FG004|Overall Study|Investigator Request|0
6911924|NCT00743652|10936943|FG000|Overall Study|Other|1
6911925|NCT00743652|10936944|FG001|Overall Study|Other|1
6911926|NCT00743652|10936945|FG002|Overall Study|Other|0
6911927|NCT00743652|10936946|FG003|Overall Study|Other|0
6911928|NCT00743652|10936947|FG004|Overall Study|Other|0
6911929|NCT00743652|10936943|FG000|Overall Study|Lost to Follow-up|1
6911930|NCT00743652|10936944|FG001|Overall Study|Lost to Follow-up|0
6911931|NCT00743652|10936945|FG002|Overall Study|Lost to Follow-up|0
6911932|NCT00743652|10936946|FG003|Overall Study|Lost to Follow-up|0
6911933|NCT00743652|10936947|FG004|Overall Study|Lost to Follow-up|0
6911934|NCT00744042|10936989|FG000|Overall Study|Withdrawal by Subject|1
6911935|NCT00744055|10937001|FG000|Overall Study|Withdrawal by Subject|6
6911936|NCT00744055|10937002|FG001|Overall Study|Withdrawal by Subject|9
6911937|NCT00744055|10937001|FG000|Overall Study|Lack of Efficacy|0
6911938|NCT00744055|10937002|FG001|Overall Study|Lack of Efficacy|1
6911939|NCT00744055|10937001|FG000|Overall Study|Physician Decision|0
6911940|NCT00744055|10937002|FG001|Overall Study|Physician Decision|2
6911941|NCT00744055|10937001|FG000|Overall Study|Protocol Violation|1
6911942|NCT00744055|10937002|FG001|Overall Study|Protocol Violation|1
6911943|NCT00744055|10937001|FG000|Overall Study|Lost to Follow-up|0
6911944|NCT00744055|10937002|FG001|Overall Study|Lost to Follow-up|1
6911945|NCT00744237|10937027|FG000|Overall Study|Lack of Efficacy|1
6911946|NCT00744237|10937028|FG001|Overall Study|Lack of Efficacy|1
6911947|NCT00744237|10937029|FG002|Overall Study|Lack of Efficacy|0
6911948|NCT00744237|10937027|FG000|Overall Study|Withdrawal by Subject|9
6911949|NCT00744237|10937028|FG001|Overall Study|Withdrawal by Subject|5
6911950|NCT00744237|10937029|FG002|Overall Study|Withdrawal by Subject|3
6911951|NCT00744237|10937027|FG000|Overall Study|Lost to Follow-up|1
6911952|NCT00744237|10937028|FG001|Overall Study|Lost to Follow-up|1
6911953|NCT00744237|10937029|FG002|Overall Study|Lost to Follow-up|1
6911954|NCT00744237|10937027|FG000|Overall Study|Protocol Violation|3
6911955|NCT00744237|10937028|FG001|Overall Study|Protocol Violation|4
6911956|NCT00744237|10937029|FG002|Overall Study|Protocol Violation|3
6911957|NCT00744237|10937027|FG000|Overall Study|Inclusion/Exclusion criteria not met|1
6911958|NCT00744237|10937028|FG001|Overall Study|Inclusion/Exclusion criteria not met|0
6911959|NCT00744237|10937029|FG002|Overall Study|Inclusion/Exclusion criteria not met|0
6911960|NCT00744237|10937027|FG000|Overall Study|Dosing Error|1
6911961|NCT00744237|10937028|FG001|Overall Study|Dosing Error|0
6911962|NCT00744237|10937029|FG002|Overall Study|Dosing Error|1
6911963|NCT00744237|10937027|FG000|Overall Study|Study Drug Error|1
6911964|NCT00744237|10937028|FG001|Overall Study|Study Drug Error|0
6911965|NCT00744237|10937029|FG002|Overall Study|Study Drug Error|0
6911966|NCT00744237|10937027|FG000|Overall Study|Prohibited Concomitant Medication|0
6911967|NCT00744237|10937028|FG001|Overall Study|Prohibited Concomitant Medication|0
6911968|NCT00744237|10937029|FG002|Overall Study|Prohibited Concomitant Medication|1
6911969|NCT00744237|10937027|FG000|Overall Study|Poor Compliance|0
6911970|NCT00744237|10937028|FG001|Overall Study|Poor Compliance|2
6911971|NCT00744237|10937029|FG002|Overall Study|Poor Compliance|0
6911972|NCT00744237|10937027|FG000|Overall Study|Administrative. Site Closed|1
6911973|NCT00744237|10937028|FG001|Overall Study|Administrative. Site Closed|1
6911974|NCT00744237|10937029|FG002|Overall Study|Administrative. Site Closed|1
6911975|NCT00744237|10937027|FG000|Overall Study|Adverse Event|9
6911976|NCT00744237|10937028|FG001|Overall Study|Adverse Event|13
6911977|NCT00744237|10937029|FG002|Overall Study|Adverse Event|5
6911978|NCT00744263|10937039|FG000|Overall Study|Death|3006
6911979|NCT00744263|10937040|FG001|Overall Study|Death|3005
6911980|NCT00744263|10937039|FG000|Overall Study|Lost to Follow-up|2038
6911981|NCT00744263|10937040|FG001|Overall Study|Lost to Follow-up|2135
6911982|NCT00744263|10937039|FG000|Overall Study|Withdrawal by Subject|166
6911983|NCT00744263|10937040|FG001|Overall Study|Withdrawal by Subject|150
6911984|NCT00744263|10937039|FG000|Overall Study|Physician Decision|20
6911985|NCT00744263|10937040|FG001|Overall Study|Physician Decision|23
6911986|NCT00744263|10937039|FG000|Overall Study|Protocol Violation|3
6911987|NCT00744263|10937040|FG001|Overall Study|Protocol Violation|5
6911988|NCT00744263|10937039|FG000|Overall Study|Adverse Event|1
6911989|NCT00744263|10937040|FG001|Overall Study|Adverse Event|0
6911990|NCT00744263|10937039|FG000|Overall Study|Other|2
6911991|NCT00744263|10937040|FG001|Overall Study|Other|2
6911992|NCT00744328|10937051|FG000|Overall Study|Lost to Follow-up|2
6911993|NCT00744328|10937052|FG001|Overall Study|Lost to Follow-up|5
6911994|NCT00744328|10937053|FG002|Overall Study|Lost to Follow-up|3
6911995|NCT00744328|10937051|FG000|Overall Study|Withdrawal by Subject|5
6911996|NCT00744328|10937052|FG001|Overall Study|Withdrawal by Subject|3
6911997|NCT00744328|10937053|FG002|Overall Study|Withdrawal by Subject|4
6911998|NCT00744328|10937051|FG000|Overall Study|Found ineligible after randomization|0
6911999|NCT00744328|10937052|FG001|Overall Study|Found ineligible after randomization|0
6912000|NCT00744328|10937053|FG002|Overall Study|Found ineligible after randomization|1
6912001|NCT00744471|10937075|FG000|Overall Study|Randomized but not treated|1
6912002|NCT00744471|10937076|FG001|Overall Study|Randomized but not treated|1
6912003|NCT00744471|10937077|FG002|Overall Study|Randomized but not treated|4
6912004|NCT00744471|10937078|FG003|Overall Study|Randomized but not treated|0
6912005|NCT00744471|10937075|FG000|Overall Study|Death|0
6912006|NCT00744471|10937076|FG001|Overall Study|Death|0
6912007|NCT00744471|10937077|FG002|Overall Study|Death|0
6912008|NCT00744471|10937078|FG003|Overall Study|Death|1
6912009|NCT00744471|10937075|FG000|Overall Study|Adverse Event|6
6912010|NCT00744471|10937076|FG001|Overall Study|Adverse Event|7
6912011|NCT00744471|10937077|FG002|Overall Study|Adverse Event|5
6912012|NCT00744471|10937078|FG003|Overall Study|Adverse Event|9
6912013|NCT00744471|10937075|FG000|Overall Study|Withdrawal by Subject|9
6912014|NCT00744471|10937076|FG001|Overall Study|Withdrawal by Subject|9
6912015|NCT00744471|10937077|FG002|Overall Study|Withdrawal by Subject|15
6912016|NCT00744471|10937078|FG003|Overall Study|Withdrawal by Subject|12
6912017|NCT00744471|10937075|FG000|Overall Study|Protocol Violation|1
6912018|NCT00744471|10937076|FG001|Overall Study|Protocol Violation|4
6912019|NCT00744471|10937077|FG002|Overall Study|Protocol Violation|1
6912020|NCT00744471|10937078|FG003|Overall Study|Protocol Violation|2
6912021|NCT00744471|10937075|FG000|Overall Study|Entered extension study|41
6912022|NCT00744471|10937076|FG001|Overall Study|Entered extension study|84
6912023|NCT00744471|10937077|FG002|Overall Study|Entered extension study|100
6912024|NCT00744471|10937078|FG003|Overall Study|Entered extension study|91
6912025|NCT00744471|10937075|FG000|Overall Study|Other|2
6912026|NCT00744471|10937076|FG001|Overall Study|Other|3
6912027|NCT00744471|10937077|FG002|Overall Study|Other|6
6912028|NCT00744471|10937078|FG003|Overall Study|Other|2
6912029|NCT00744471|10937075|FG000|Overall Study|Lack of Efficacy|83
6912030|NCT00744471|10937076|FG001|Overall Study|Lack of Efficacy|37
6912031|NCT00744471|10937077|FG002|Overall Study|Lack of Efficacy|19
6912032|NCT00744471|10937078|FG003|Overall Study|Lack of Efficacy|31
6912033|NCT00744471|10937075|FG000|Overall Study|Lost to Follow-up|0
6912034|NCT00744471|10937076|FG001|Overall Study|Lost to Follow-up|0
6912035|NCT00744471|10937077|FG002|Overall Study|Lost to Follow-up|2
6912036|NCT00744471|10937078|FG003|Overall Study|Lost to Follow-up|0
6912037|NCT00744497|10937090|FG000|Overall Study|Withdrawal by Subject|21
6912038|NCT00744497|10937091|FG001|Overall Study|Withdrawal by Subject|18
6912039|NCT00744497|10937090|FG000|Overall Study|Death|11
6912040|NCT00744497|10937091|FG001|Overall Study|Death|9
6912041|NCT00744497|10937090|FG000|Overall Study|Lost to Follow-up|4
6912042|NCT00744497|10937091|FG001|Overall Study|Lost to Follow-up|2
6912043|NCT00744497|10937090|FG000|Overall Study|Poor compliance/noncompliance|9
6912044|NCT00744497|10937091|FG001|Overall Study|Poor compliance/noncompliance|5
6912045|NCT00744497|10937090|FG000|Overall Study|No longer meets study criteria|7
6912046|NCT00744497|10937091|FG001|Overall Study|No longer meets study criteria|3
6912047|NCT00744497|10937090|FG000|Overall Study|Administrative Reason By Sponsor|25
6912048|NCT00744497|10937091|FG001|Overall Study|Administrative Reason By Sponsor|8
6912049|NCT00744497|10937090|FG000|Overall Study|Disease progression|312
6912050|NCT00744497|10937091|FG001|Overall Study|Disease progression|219
6912051|NCT00744497|10937090|FG000|Overall Study|Study drug toxicity|68
6912052|NCT00744497|10937091|FG001|Overall Study|Study drug toxicity|141
6912053|NCT00744497|10937090|FG000|Overall Study|Adverse event unrelated to study drug|78
6912054|NCT00744497|10937091|FG001|Overall Study|Adverse event unrelated to study drug|122
6912055|NCT00744497|10937090|FG000|Overall Study|Patient requested to stop study drug|65
6912056|NCT00744497|10937091|FG001|Overall Study|Patient requested to stop study drug|80
6912057|NCT00744497|10937090|FG000|Overall Study|Maximum clinical benefit|141
6912058|NCT00744497|10937091|FG001|Overall Study|Maximum clinical benefit|142
6912059|NCT00744497|10937090|FG000|Overall Study|Not defined|19
6912060|NCT00744497|10937091|FG001|Overall Study|Not defined|13
6912061|NCT00744523|10937099|FG000|30 Days After the Procedure|Insufficient follow-up|0
6912062|NCT00744523|10937100|FG001|30 Days After the Procedure|Insufficient follow-up|5
6912063|NCT00744627|10937110|FG000|Overall Study|Adverse Event|6
6912064|NCT00744627|10937111|FG001|Overall Study|Adverse Event|9
6912065|NCT00744627|10937110|FG000|Overall Study|Lack of Efficacy|7
6912066|NCT00744627|10937111|FG001|Overall Study|Lack of Efficacy|3
6912067|NCT00744627|10937110|FG000|Overall Study|Noncompliance|0
6912068|NCT00744627|10937111|FG001|Overall Study|Noncompliance|1
6912069|NCT00744627|10937110|FG000|Overall Study|Protocol Deviations|0
6912070|NCT00744627|10937111|FG001|Overall Study|Protocol Deviations|2
6912071|NCT00744627|10937110|FG000|Overall Study|Voluntary Withdrawal|9
6912072|NCT00744627|10937111|FG001|Overall Study|Voluntary Withdrawal|6
6912073|NCT00744627|10937110|FG000|Overall Study|Lost to Follow-up|2
6912074|NCT00744627|10937111|FG001|Overall Study|Lost to Follow-up|1
6912075|NCT00744627|10937110|FG000|Overall Study|Other|1
6912076|NCT00744627|10937111|FG001|Overall Study|Other|0
6912077|NCT00744653|10937117|FG000|Overall Study|antineoplastic treatment|11
6912078|NCT00744653|10937117|FG000|Overall Study|Death|1
6912079|NCT00744653|10937117|FG000|Overall Study|Lost to Follow-up|1
6912080|NCT00744653|10937117|FG000|Overall Study|Physician Decision|3
6912081|NCT00744757|10937126|FG000|Overall Study|Objective disease progression|7
6912082|NCT00744757|10937126|FG000|Overall Study|Physician Decision|5
6912083|NCT00744757|10937126|FG000|Overall Study|Withdrawal by Subject|1
6912084|NCT00744757|10937126|FG000|Overall Study|Death|6
6912085|NCT00744757|10937126|FG000|Overall Study|Adverse Event|2
6912086|NCT00744796|10937130|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12
6912087|NCT00744861|10937147|FG000|Feasibility Stage 1|Withdrawal by Subject|1
6912088|NCT00744861|10937148|FG001|Feasibility Stage 1|Withdrawal by Subject|1
6912089|NCT00744861|10937149|FG002|Feasibility Stage 1|Withdrawal by Subject|0
6912090|NCT00744861|10937150|FG003|Feasibility Stage 1|Withdrawal by Subject|0
6912091|NCT00744861|10937147|FG000|Feasibility Stage 1|Pregnancy|0
6912092|NCT00744861|10937148|FG001|Feasibility Stage 1|Pregnancy|1
6912093|NCT00744861|10937149|FG002|Feasibility Stage 1|Pregnancy|0
6912094|NCT00744861|10937150|FG003|Feasibility Stage 1|Pregnancy|0
6912095|NCT00744861|10937147|FG000|Pivotal Stage 2|Adverse Event|0
6912096|NCT00744861|10937148|FG001|Pivotal Stage 2|Adverse Event|0
6912097|NCT00744861|10937149|FG002|Pivotal Stage 2|Adverse Event|6
6912098|NCT00744861|10937150|FG003|Pivotal Stage 2|Adverse Event|11
6912099|NCT00744861|10937147|FG000|Pivotal Stage 2|Death|0
6912100|NCT00744861|10937148|FG001|Pivotal Stage 2|Death|0
6912101|NCT00744861|10937149|FG002|Pivotal Stage 2|Death|0
6912102|NCT00744861|10937150|FG003|Pivotal Stage 2|Death|1
6912103|NCT00744861|10937147|FG000|Pivotal Stage 2|Lost to Follow-up|0
6912104|NCT00744861|10937148|FG001|Pivotal Stage 2|Lost to Follow-up|0
6912105|NCT00744861|10937149|FG002|Pivotal Stage 2|Lost to Follow-up|13
6912106|NCT00744861|10937150|FG003|Pivotal Stage 2|Lost to Follow-up|14
6912107|NCT00744861|10937147|FG000|Pivotal Stage 2|Physician Decision|0
6912108|NCT00744861|10937148|FG001|Pivotal Stage 2|Physician Decision|0
6912109|NCT00744861|10937149|FG002|Pivotal Stage 2|Physician Decision|3
6912110|NCT00744861|10937150|FG003|Pivotal Stage 2|Physician Decision|1
6912111|NCT00744861|10937147|FG000|Pivotal Stage 2|Protocol Violation|0
6912112|NCT00744861|10937148|FG001|Pivotal Stage 2|Protocol Violation|0
6912113|NCT00744861|10937149|FG002|Pivotal Stage 2|Protocol Violation|0
6912114|NCT00744861|10937150|FG003|Pivotal Stage 2|Protocol Violation|1
6912115|NCT00744861|10937147|FG000|Pivotal Stage 2|Withdrawal by Subject|0
6912116|NCT00744861|10937148|FG001|Pivotal Stage 2|Withdrawal by Subject|0
6912117|NCT00744861|10937149|FG002|Pivotal Stage 2|Withdrawal by Subject|20
6912118|NCT00744861|10937150|FG003|Pivotal Stage 2|Withdrawal by Subject|14
6912119|NCT00744861|10937147|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0
6912120|NCT00744861|10937148|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0
6912121|NCT00744861|10937149|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60
6912122|NCT00744861|10937150|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63
6912123|NCT00744874|10937158|FG000|Overall Study|Lost to Follow-up|1
6912124|NCT00744874|10937158|FG000|Overall Study|Withdrawal by Subject|1
6912125|NCT00744874|10937158|FG000|Overall Study|Study Device not available at procedure|1
6912126|NCT00744874|10937158|FG000|Overall Study|Unable to accomodate schedule|1
6912127|NCT00744939|10937173|FG000|Overall Study|Withdrawal by Subject|9
6912128|NCT00744939|10937173|FG000|Overall Study|Protocol Violation|13
6912129|NCT00744939|10937173|FG000|Overall Study|Death|24
6912130|NCT00744939|10937173|FG000|Overall Study|distance|4
6912131|NCT00744939|10937173|FG000|Overall Study|Lost to Follow-up|12
6912132|NCT00744939|10937173|FG000|Overall Study|Medical history exclusionary|1
6912133|NCT00744939|10937173|FG000|Overall Study|Did not receive Magnevist|7
6912134|NCT00744939|10937173|FG000|Overall Study|Failed inclusion/exclusion criteria|19
6912135|NCT00744939|10937173|FG000|Overall Study|coma|1
6912136|NCT00744939|10937173|FG000|Overall Study|incorrect race|1
6912137|NCT00744978|10937196|FG000|Period 1|Lost to Follow-up|1
6912138|NCT00744978|10937197|FG001|Period 1|Lost to Follow-up|0
6912139|NCT00744978|10937196|FG000|Period 1|Withdrawal by Subject|0
6912140|NCT00744978|10937197|FG001|Period 1|Withdrawal by Subject|2
6912141|NCT00744978|10937196|FG000|Period 1|Other|0
6912142|NCT00744978|10937197|FG001|Period 1|Other|2
6912143|NCT00744978|10937196|FG000|Period 1|Adverse Event|4
6912144|NCT00744978|10937197|FG001|Period 1|Adverse Event|0
6912145|NCT00744978|10937196|FG000|Period 1|Randomized but not Treated|1
6912146|NCT00744978|10937197|FG001|Period 1|Randomized but not Treated|1
6912147|NCT00744978|10937196|FG000|Period 2|Adverse Event|0
6912148|NCT00744978|10937197|FG001|Period 2|Adverse Event|1
6912149|NCT00744991|10937203|FG000|Overall Study|Progressive Disease|11
6912150|NCT00744991|10937203|FG000|Overall Study|Withdrawal by Subject|8
6912151|NCT00744991|10937203|FG000|Overall Study|Physician Decision|3
6912152|NCT00744991|10937203|FG000|Overall Study|Adverse Event|2
6912153|NCT00744991|10937203|FG000|Overall Study|Protocol Entry Criteria Unmet|1
6912154|NCT00745095|10937216|FG000|Overall Study|Declined to participate|1
6912155|NCT00745095|10937217|FG001|Overall Study|Declined to participate|0
6912156|NCT00745095|10937218|FG002|Overall Study|Declined to participate|0
6912157|NCT00745095|10937219|FG003|Overall Study|Declined to participate|0
6912158|NCT00745095|10937220|FG004|Overall Study|Declined to participate|92
6912159|NCT00745095|10937221|FG005|Overall Study|Declined to participate|95
6912160|NCT00745095|10937216|FG000|Overall Study|Ineligible due to GFR criteria|0
6912161|NCT00745095|10937217|FG001|Overall Study|Ineligible due to GFR criteria|2
6912162|NCT00745095|10937218|FG002|Overall Study|Ineligible due to GFR criteria|3
6912163|NCT00745095|10937219|FG003|Overall Study|Ineligible due to GFR criteria|3
6912164|NCT00745095|10937220|FG004|Overall Study|Ineligible due to GFR criteria|30
6912165|NCT00745095|10937221|FG005|Overall Study|Ineligible due to GFR criteria|28
6912166|NCT00745121|10937240|FG000|Overall Study|Death|3
6912167|NCT00745121|10937241|FG001|Overall Study|Death|0
6912168|NCT00745121|10937240|FG000|Overall Study|Adverse Event|1
6912169|NCT00745121|10937241|FG001|Overall Study|Adverse Event|0
6912170|NCT00745121|10937240|FG000|Overall Study|Lost to Follow-up|1
6912171|NCT00745121|10937241|FG001|Overall Study|Lost to Follow-up|0
6912172|NCT00745121|10937240|FG000|Overall Study|Withdrawal by Subject|4
6912173|NCT00745121|10937241|FG001|Overall Study|Withdrawal by Subject|2
6912174|NCT00745251|10937249|FG000|Overall Study|Adverse Event|1
6912175|NCT00745251|10937250|FG001|Overall Study|Adverse Event|2
6912176|NCT00745251|10937249|FG000|Overall Study|Withdrawal by Subject|1
6912177|NCT00745251|10937250|FG001|Overall Study|Withdrawal by Subject|1
6912178|NCT00745368|10937265|FG000|Overall Study|Unable to provide sample|3
6912179|NCT00745420|10937269|FG000|Overall Study|Ineligible|1
6912180|NCT00745498|10937276|FG000|Overall Study|Lost to Follow-up|1
6912181|NCT00745498|10937277|FG001|Overall Study|Lost to Follow-up|1
6912182|NCT00745498|10937278|FG002|Overall Study|Lost to Follow-up|3
6912183|NCT00745498|10937276|FG000|Overall Study|Injection of intravitreal silicone oil o|3
6912184|NCT00745498|10937277|FG001|Overall Study|Injection of intravitreal silicone oil o|4
6912185|NCT00745498|10937278|FG002|Overall Study|Injection of intravitreal silicone oil o|4
6912186|NCT00745498|10937276|FG000|Overall Study|Non-PDR related VH|0
6912187|NCT00745498|10937277|FG001|Overall Study|Non-PDR related VH|1
6912188|NCT00745498|10937278|FG002|Overall Study|Non-PDR related VH|1
6912189|NCT00745498|10937276|FG000|Overall Study|Edophthalmitis after preoperative IVB|1
6912190|NCT00745498|10937277|FG001|Overall Study|Edophthalmitis after preoperative IVB|0
6912191|NCT00745498|10937278|FG002|Overall Study|Edophthalmitis after preoperative IVB|0
6912192|NCT00745615|10937290|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3
6912193|NCT00745615|10937291|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1
6912194|NCT00745615|10937292|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
6912195|NCT00745615|10937293|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4
6912196|NCT00745615|10937294|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
6912197|NCT00745615|10937295|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
6912198|NCT00745615|10937290|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0
6912199|NCT00745615|10937291|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1
6912200|NCT00745615|10937292|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0
6912201|NCT00745615|10937293|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0
6912202|NCT00745615|10937294|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0
6912203|NCT00745615|10937295|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0
6912204|NCT00745615|10937290|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2
6912205|NCT00745615|10937291|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3
6912206|NCT00745615|10937292|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1
6912207|NCT00745615|10937293|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1
6912208|NCT00745615|10937294|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0
6912209|NCT00745615|10937295|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0
6912210|NCT00745615|10937290|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0
6912211|NCT00745615|10937291|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1
6912212|NCT00745615|10937292|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0
6912213|NCT00745615|10937293|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0
6912214|NCT00745615|10937294|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0
6912215|NCT00745615|10937295|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0
6912216|NCT00745615|10937290|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0
6912217|NCT00745615|10937291|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1
6912218|NCT00745615|10937292|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0
6912219|NCT00745615|10937293|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0
6912220|NCT00745615|10937294|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0
6912221|NCT00745615|10937295|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0
6912222|NCT00745615|10937290|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
6912223|NCT00745615|10937291|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
6912224|NCT00745615|10937292|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
6912225|NCT00745615|10937293|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
6912226|NCT00745615|10937294|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50
6912227|NCT00745615|10937295|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50
6912228|NCT00745615|10937290|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
6912229|NCT00745615|10937291|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
6912230|NCT00745615|10937292|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
6912231|NCT00745615|10937293|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
6912232|NCT00745615|10937294|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19
6912233|NCT00745615|10937295|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19
6912234|NCT00745615|10937290|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
6912235|NCT00745615|10937291|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
6912236|NCT00745615|10937292|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
6912237|NCT00745615|10937293|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
6912238|NCT00745615|10937294|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9
6912239|NCT00745615|10937295|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11
6912240|NCT00745615|10937290|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
6912241|NCT00745615|10937291|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
6912242|NCT00745615|10937292|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
6912243|NCT00745615|10937293|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
6912244|NCT00745615|10937294|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2
6912245|NCT00745615|10937295|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8
6912246|NCT00745615|10937290|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
6912247|NCT00745615|10937291|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
6912248|NCT00745615|10937292|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
6912249|NCT00745615|10937293|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
6912250|NCT00745615|10937294|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2
6912251|NCT00745615|10937295|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5
6912252|NCT00745615|10937290|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
6912253|NCT00745615|10937291|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
6912254|NCT00745615|10937292|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
6912255|NCT00745615|10937293|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
6912256|NCT00745615|10937294|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1
6912257|NCT00745615|10937295|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3
6912258|NCT00745615|10937290|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
6912259|NCT00745615|10937291|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
6912260|NCT00745615|10937292|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
6912261|NCT00745615|10937293|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
6912262|NCT00745615|10937294|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
6912263|NCT00745615|10937295|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1
6912264|NCT00745615|10937290|FG000|Open-Label (up to Approx 10.5 Years)|Death|0
6912265|NCT00745615|10937291|FG001|Open-Label (up to Approx 10.5 Years)|Death|0
6912266|NCT00745615|10937292|FG002|Open-Label (up to Approx 10.5 Years)|Death|0
6912267|NCT00745615|10937293|FG003|Open-Label (up to Approx 10.5 Years)|Death|0
6912268|NCT00745615|10937294|FG004|Open-Label (up to Approx 10.5 Years)|Death|0
6912269|NCT00745615|10937295|FG005|Open-Label (up to Approx 10.5 Years)|Death|1
6912270|NCT00745615|10937290|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
6912271|NCT00745615|10937291|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
6912272|NCT00745615|10937292|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
6912273|NCT00745615|10937293|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
6912274|NCT00745615|10937294|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8
6912275|NCT00745615|10937295|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10
6912276|NCT00745823|10937309|FG000|Overall Study|Adverse Event|5
6912277|NCT00745823|10937310|FG001|Overall Study|Adverse Event|3
6912278|NCT00745823|10937309|FG000|Overall Study|Lack of Efficacy|20
6912279|NCT00745823|10937310|FG001|Overall Study|Lack of Efficacy|6
6912280|NCT00745823|10937309|FG000|Overall Study|Lost to Follow-up|10
6912281|NCT00745823|10937310|FG001|Overall Study|Lost to Follow-up|11
6912282|NCT00745823|10937309|FG000|Overall Study|Physician Decision|10
6912283|NCT00745823|10937310|FG001|Overall Study|Physician Decision|5
6912284|NCT00745823|10937309|FG000|Overall Study|Pregnancy|0
6912285|NCT00745823|10937310|FG001|Overall Study|Pregnancy|4
6912286|NCT00745823|10937309|FG000|Overall Study|Withdrawal by Subject|14
6912287|NCT00745823|10937310|FG001|Overall Study|Withdrawal by Subject|8
6912288|NCT00745823|10937309|FG000|Overall Study|Study Terminated by Sponsor|326
6912289|NCT00745823|10937310|FG001|Overall Study|Study Terminated by Sponsor|349
6912290|NCT00745849|10937318|FG000|First Intervention|Withdrawal by Subject|0
6912291|NCT00745849|10937319|FG001|First Intervention|Withdrawal by Subject|1
6912292|NCT00745849|10937318|FG000|First Intervention|Lost to Follow-up|1
6912293|NCT00745849|10937319|FG001|First Intervention|Lost to Follow-up|1
6912294|NCT00745849|10937318|FG000|Second Intervention|Lost to Follow-up|2
6912295|NCT00745849|10937319|FG001|Second Intervention|Lost to Follow-up|1
6912296|NCT00745875|10937327|FG000|Overall Study|Continuing study treatment|4
6912297|NCT00745875|10937328|FG001|Overall Study|Continuing study treatment|4
6912298|NCT00745901|10937336|FG000|Overall Study|Adverse Event|3
6912299|NCT00745901|10937337|FG001|Overall Study|Adverse Event|4
6912300|NCT00745901|10937336|FG000|Overall Study|Protocol Violation|0
6912301|NCT00745901|10937337|FG001|Overall Study|Protocol Violation|1
6912302|NCT00745901|10937336|FG000|Overall Study|Withdrawal by Subject|1
6912303|NCT00745901|10937337|FG001|Overall Study|Withdrawal by Subject|0
6912304|NCT00745901|10937336|FG000|Overall Study|Lost to Follow-up|7
6912305|NCT00745901|10937337|FG001|Overall Study|Lost to Follow-up|4
6912306|NCT00745901|10937336|FG000|Overall Study|Pregnancy|2
6912307|NCT00745901|10937337|FG001|Overall Study|Pregnancy|4
6912308|NCT00745901|10937336|FG000|Overall Study|Lack of compliance|2
6912309|NCT00745901|10937337|FG001|Overall Study|Lack of compliance|2
6912310|NCT00745901|10937336|FG000|Overall Study|Patient's next menses did not start with|1
6912311|NCT00745901|10937337|FG001|Overall Study|Patient's next menses did not start with|0
6912312|NCT00745901|10937336|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0
6912313|NCT00745901|10937337|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2
6912314|NCT00745901|10937336|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1
6912315|NCT00745901|10937337|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1
6912316|NCT00745901|10937336|FG000|Overall Study|Patient didn't take any study medication|7
6912317|NCT00745901|10937337|FG001|Overall Study|Patient didn't take any study medication|3
6912318|NCT00746096|10937354|FG000|Overall Study|Adverse Event|1
6912319|NCT00746096|10937355|FG001|Overall Study|Adverse Event|0
6912320|NCT00746096|10937354|FG000|Overall Study|Withdrawal by Subject|5
6912321|NCT00746096|10937355|FG001|Overall Study|Withdrawal by Subject|1
6912322|NCT00746096|10937354|FG000|Overall Study|Lost to Follow-up|2
6912323|NCT00746096|10937355|FG001|Overall Study|Lost to Follow-up|1
6912324|NCT00746096|10937354|FG000|Overall Study|Protocol Violation|1
6912325|NCT00746096|10937355|FG001|Overall Study|Protocol Violation|0
6912326|NCT00746096|10937354|FG000|Overall Study|No study drug treatment|1
6912327|NCT00746096|10937355|FG001|Overall Study|No study drug treatment|1
6912328|NCT00746252|10937381|FG000|Overall Study|weight gain >7.5 %|1
6912329|NCT00746252|10937382|FG001|Overall Study|weight gain >7.5 %|2
6912330|NCT00746330|10937392|FG000|Period 1|Abnormal test procedure result|0
6912331|NCT00746330|10937393|FG001|Period 1|Abnormal test procedure result|0
6912332|NCT00746330|10937394|FG002|Period 1|Abnormal test procedure result|1
6912333|NCT00746330|10937395|FG003|Period 1|Abnormal test procedure result|0
6912334|NCT00746356|10937406|FG000|Overall Study|Withdrawal by Subject|2
6912335|NCT00746356|10937407|FG001|Overall Study|Withdrawal by Subject|3
6912336|NCT00746356|10937406|FG000|Overall Study|Death|7
6912337|NCT00746356|10937407|FG001|Overall Study|Death|3
6912338|NCT00746356|10937406|FG000|Overall Study|Lost to Follow-up|1
6912339|NCT00746356|10937407|FG001|Overall Study|Lost to Follow-up|0
6912340|NCT00746356|10937406|FG000|Overall Study|Removal of Device|0
6912341|NCT00746356|10937407|FG001|Overall Study|Removal of Device|1
6912342|NCT00746356|10937406|FG000|Overall Study|Patient relocated|1
6912343|NCT00746356|10937407|FG001|Overall Study|Patient relocated|0
6912344|NCT00746551|10937452|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2
6912345|NCT00746551|10937453|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4
6912346|NCT00746551|10937452|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9
6912347|NCT00746551|10937453|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7
6912348|NCT00746551|10937452|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6
6912349|NCT00746551|10937453|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8
6912350|NCT00746564|10937459|FG000|Overall Study|Required Pacemaker/ICD Implant|2
6912351|NCT00746733|10937488|FG000|Second Intervention|Adverse Event|1
6912352|NCT00746733|10937489|FG001|Second Intervention|Adverse Event|0
6912353|NCT00746733|10937488|FG000|Third Intervention|Withdrawal by Subject|1
6912354|NCT00746733|10937489|FG001|Third Intervention|Withdrawal by Subject|1
6912355|NCT00746785|10937505|FG000|Overall Study|Lost to Follow-up|29
6912356|NCT00746785|10937506|FG001|Overall Study|Lost to Follow-up|25
6912357|NCT00746785|10937507|FG002|Overall Study|Lost to Follow-up|27
6912358|NCT00746798|10937519|FG000|Overall Study|Protocol Violation|0
6912359|NCT00746798|10937520|FG001|Overall Study|Protocol Violation|1
6912360|NCT00746798|10937521|FG002|Overall Study|Protocol Violation|0
6912361|NCT00746798|10937522|FG003|Overall Study|Protocol Violation|0
6912362|NCT00746798|10937519|FG000|Overall Study|Withdrawal by Subject|0
6912363|NCT00746798|10937520|FG001|Overall Study|Withdrawal by Subject|1
6912364|NCT00746798|10937521|FG002|Overall Study|Withdrawal by Subject|1
6912365|NCT00746798|10937522|FG003|Overall Study|Withdrawal by Subject|0
6912366|NCT00746798|10937519|FG000|Overall Study|Death|0
6912367|NCT00746798|10937520|FG001|Overall Study|Death|0
6912368|NCT00746798|10937521|FG002|Overall Study|Death|2
6912369|NCT00746798|10937522|FG003|Overall Study|Death|0
6912370|NCT00746798|10937519|FG000|Overall Study|Participant unable to return for visit|1
6912371|NCT00746798|10937520|FG001|Overall Study|Participant unable to return for visit|0
6912372|NCT00746798|10937521|FG002|Overall Study|Participant unable to return for visit|0
6912373|NCT00746798|10937522|FG003|Overall Study|Participant unable to return for visit|0
6912374|NCT00746941|10937556|FG000|Overall Study|Death|2
6912375|NCT00746941|10937557|FG001|Overall Study|Death|0
6912376|NCT00746941|10937558|FG002|Overall Study|Death|0
6912377|NCT00746941|10937559|FG003|Overall Study|Death|6
6912378|NCT00746941|10937556|FG000|Overall Study|Physician Decision|0
6912379|NCT00746941|10937557|FG001|Overall Study|Physician Decision|0
6912380|NCT00746941|10937558|FG002|Overall Study|Physician Decision|2
6912381|NCT00746941|10937559|FG003|Overall Study|Physician Decision|0
6912382|NCT00746941|10937556|FG000|Overall Study|Withdrawal by Subject|3
6912383|NCT00746941|10937557|FG001|Overall Study|Withdrawal by Subject|0
6912384|NCT00746941|10937558|FG002|Overall Study|Withdrawal by Subject|0
6912385|NCT00746941|10937559|FG003|Overall Study|Withdrawal by Subject|2
6912386|NCT00746941|10937556|FG000|Overall Study|Other, reason not provided|2
6912387|NCT00746941|10937557|FG001|Overall Study|Other, reason not provided|4
6912388|NCT00746941|10937558|FG002|Overall Study|Other, reason not provided|0
6912389|NCT00746941|10937559|FG003|Overall Study|Other, reason not provided|4
6912390|NCT00746941|10937556|FG000|Overall Study|Adverse Event|0
6912391|NCT00746941|10937557|FG001|Overall Study|Adverse Event|0
6912392|NCT00746941|10937558|FG002|Overall Study|Adverse Event|0
6912393|NCT00746941|10937559|FG003|Overall Study|Adverse Event|1
6912394|NCT00747006|10937579|FG000|Overall Study|Adverse Event|1
6912395|NCT00747006|10937580|FG001|Overall Study|Adverse Event|0
6912396|NCT00747006|10937581|FG002|Overall Study|Adverse Event|0
6912397|NCT00747006|10937579|FG000|Overall Study|Lost to Follow-up|0
6912398|NCT00747006|10937580|FG001|Overall Study|Lost to Follow-up|1
6912399|NCT00747006|10937581|FG002|Overall Study|Lost to Follow-up|0
6912400|NCT00747006|10937579|FG000|Overall Study|Physician Decision|2
6912401|NCT00747006|10937580|FG001|Overall Study|Physician Decision|0
6912402|NCT00747006|10937581|FG002|Overall Study|Physician Decision|1
6912403|NCT00747149|10937594|FG000|Overall Study|Adverse Event|0
6912404|NCT00747149|10937595|FG001|Overall Study|Adverse Event|15
6912405|NCT00747149|10937594|FG000|Overall Study|Lost to Follow-up|0
6912406|NCT00747149|10937595|FG001|Overall Study|Lost to Follow-up|10
6912407|NCT00747149|10937594|FG000|Overall Study|Withdrawal by Subject|0
6912408|NCT00747149|10937595|FG001|Overall Study|Withdrawal by Subject|6
6912409|NCT00747149|10937594|FG000|Overall Study|Did not receive treatment|0
6912410|NCT00747149|10937595|FG001|Overall Study|Did not receive treatment|1
6912411|NCT00747149|10937594|FG000|Overall Study|Incorrect enrollment|0
6912412|NCT00747149|10937595|FG001|Overall Study|Incorrect enrollment|6
6912413|NCT00747149|10937594|FG000|Overall Study|Severe non-compliance to protocol|0
6912414|NCT00747149|10937595|FG001|Overall Study|Severe non-compliance to protocol|1
6912415|NCT00747149|10937594|FG000|Overall Study|Not reported|1
6912416|NCT00747149|10937595|FG001|Overall Study|Not reported|4
6912417|NCT00747227|10937618|FG000|Overall Study|Death|3
6912418|NCT00747227|10937619|FG001|Overall Study|Death|1
6912419|NCT00747227|10937618|FG000|Overall Study|Withdrawal by Subject|1
6912420|NCT00747227|10937619|FG001|Overall Study|Withdrawal by Subject|0
6912421|NCT00747227|10937618|FG000|Overall Study|Lost to Follow-up|1
6912422|NCT00747227|10937619|FG001|Overall Study|Lost to Follow-up|2
6912423|NCT00747227|10937618|FG000|Overall Study|Illness|1
6912424|NCT00747227|10937619|FG001|Overall Study|Illness|1
6912425|NCT00747344|10937627|FG000|Controlled Period|Adverse Event|3
6912426|NCT00747344|10937628|FG001|Controlled Period|Adverse Event|0
6912427|NCT00747344|10937629|FG002|Controlled Period|Adverse Event|0
6912428|NCT00747344|10937630|FG003|Controlled Period|Adverse Event|0
6912429|NCT00747344|10937627|FG000|Controlled Period|Lack of Efficacy|2
6912430|NCT00747344|10937628|FG001|Controlled Period|Lack of Efficacy|1
6912431|NCT00747344|10937629|FG002|Controlled Period|Lack of Efficacy|0
6912432|NCT00747344|10937630|FG003|Controlled Period|Lack of Efficacy|0
6912433|NCT00747344|10937627|FG000|Controlled Period|Other|0
6912434|NCT00747344|10937628|FG001|Controlled Period|Other|3
6912435|NCT00747344|10937629|FG002|Controlled Period|Other|0
6912436|NCT00747344|10937630|FG003|Controlled Period|Other|0
6912437|NCT00747344|10937627|FG000|After Controlled Period|Adverse Event|0
6912438|NCT00747344|10937628|FG001|After Controlled Period|Adverse Event|0
6912439|NCT00747344|10937629|FG002|After Controlled Period|Adverse Event|0
6912440|NCT00747344|10937630|FG003|After Controlled Period|Adverse Event|1
6912441|NCT00747435|10937638|FG000|Overall Study|Lost to Follow-up|2
6912442|NCT00747435|10937638|FG000|Overall Study|Withdrawal by Subject|3
6912443|NCT00747435|10937638|FG000|Overall Study|Still undergoing follow up|1
6912444|NCT00747474|10937642|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
6912445|NCT00747474|10937643|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
6912446|NCT00747474|10937644|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
6912447|NCT00747474|10937645|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
6912448|NCT00747474|10937646|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
6912449|NCT00747474|10937647|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
6912450|NCT00747474|10937648|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
6912451|NCT00747474|10937649|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1
6912452|NCT00747474|10937650|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
6912453|NCT00747474|10937651|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
6912454|NCT00747474|10937652|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
6912455|NCT00747474|10937653|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
6912456|NCT00747565|10937664|FG000|Overall Study|Withdrawal by Subject|10
6912457|NCT00747565|10937665|FG001|Overall Study|Withdrawal by Subject|6
6912458|NCT00747565|10937664|FG000|Overall Study|Lost to Follow-up|4
6912459|NCT00747565|10937665|FG001|Overall Study|Lost to Follow-up|1
6912460|NCT00747617|10937673|FG000|Overall Study|Lost to Follow-up|3
6912461|NCT00747617|10937674|FG001|Overall Study|Lost to Follow-up|1
6912462|NCT00747643|10937682|FG000|Overall Study|Withdrawal by Subject|36
6912463|NCT00747643|10937683|FG001|Overall Study|Withdrawal by Subject|27
6912464|NCT00747812|10937704|FG000|Overall Study|Research Site Staff Relocation|5
6912465|NCT00747812|10937705|FG001|Overall Study|Research Site Staff Relocation|3
6912466|NCT00748033|10937713|FG000|Overall Study|Adverse Event|0
6912467|NCT00748033|10937714|FG001|Overall Study|Adverse Event|1
6912468|NCT00748098|10937737|FG000|First Treatment Intervention Period|Adverse Event|1
6912469|NCT00748098|10937738|FG001|First Treatment Intervention Period|Adverse Event|1
6912470|NCT00748098|10937737|FG000|First Treatment Intervention Period|Protocol Violation|1
6912471|NCT00748098|10937738|FG001|First Treatment Intervention Period|Protocol Violation|0
6912472|NCT00748098|10937737|FG000|First Treatment Intervention Period|Lost to Follow-up|1
6912473|NCT00748098|10937738|FG001|First Treatment Intervention Period|Lost to Follow-up|0
6912474|NCT00748098|10937737|FG000|First Treatment Intervention Period|Withdrawal by Subject|2
6912475|NCT00748098|10937738|FG001|First Treatment Intervention Period|Withdrawal by Subject|0
6912476|NCT00748098|10937737|FG000|First Taper Period|Protocol Violation|1
6912477|NCT00748098|10937738|FG001|First Taper Period|Protocol Violation|0
6912478|NCT00748098|10937737|FG000|First Taper Period|Withdrawal by Subject|2
6912479|NCT00748098|10937738|FG001|First Taper Period|Withdrawal by Subject|0
6912480|NCT00748098|10937737|FG000|First Taper Period|Protocol Stopping Criteria Met|0
6912481|NCT00748098|10937738|FG001|First Taper Period|Protocol Stopping Criteria Met|1
6912482|NCT00748098|10937737|FG000|1-Week Washout Period|Adverse Event|0
6912483|NCT00748098|10937738|FG001|1-Week Washout Period|Adverse Event|1
6912484|NCT00748098|10937737|FG000|1-Week Washout Period|Withdrawal by Subject|2
6912485|NCT00748098|10937738|FG001|1-Week Washout Period|Withdrawal by Subject|0
6912486|NCT00748098|10937737|FG000|Second Treatment Intervention Period|Adverse Event|4
6912487|NCT00748098|10937738|FG001|Second Treatment Intervention Period|Adverse Event|1
6912488|NCT00748098|10937737|FG000|Second Treatment Intervention Period|Lost to Follow-up|1
6912489|NCT00748098|10937738|FG001|Second Treatment Intervention Period|Lost to Follow-up|1
6912490|NCT00748098|10937737|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1
6912491|NCT00748098|10937738|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1
6912492|NCT00748189|10937747|FG000|Overall Study|Death|99
6912493|NCT00748189|10937748|FG001|Overall Study|Death|84
6912494|NCT00748189|10937747|FG000|Overall Study|Withdrawal by Subject|23
6912495|NCT00748189|10937748|FG001|Overall Study|Withdrawal by Subject|29
6912496|NCT00748189|10937747|FG000|Overall Study|Physician Decision|16
6912497|NCT00748189|10937748|FG001|Overall Study|Physician Decision|5
6912498|NCT00748189|10937747|FG000|Overall Study|Lost to Follow-up|8
6912499|NCT00748189|10937748|FG001|Overall Study|Lost to Follow-up|15
6912500|NCT00748189|10937747|FG000|Overall Study|Study terminated by Sponsor|70
6912501|NCT00748189|10937748|FG001|Overall Study|Study terminated by Sponsor|79
6912502|NCT00748215|10937761|FG000|Overall Study|Withdrawal by Subject|7
6912503|NCT00748215|10937762|FG001|Overall Study|Withdrawal by Subject|7
6912504|NCT00748215|10937761|FG000|Overall Study|Treatment change|2
6912505|NCT00748215|10937762|FG001|Overall Study|Treatment change|1
6912506|NCT00748215|10937761|FG000|Overall Study|Change in patient condition|0
6912507|NCT00748215|10937762|FG001|Overall Study|Change in patient condition|3
6912508|NCT00748215|10937761|FG000|Overall Study|Non-compliant|0
6912509|NCT00748215|10937762|FG001|Overall Study|Non-compliant|2
6912510|NCT00748215|10937761|FG000|Overall Study|Adverse Event|0
6912511|NCT00748215|10937762|FG001|Overall Study|Adverse Event|5
6912512|NCT00748241|10937768|FG000|Overall Study|Implant failure|1
6912513|NCT00748241|10937768|FG000|Overall Study|Lost to Follow-up|5
6912514|NCT00748241|10937768|FG000|Overall Study|Death|2
6912515|NCT00748540|10937781|FG000|Overall Study|Physician Decision|1
6912516|NCT00748553|10937787|FG000|Overall Study|Adverse Event|0
6912517|NCT00748553|10937788|FG001|Overall Study|Adverse Event|1
6912518|NCT00748553|10937787|FG000|Overall Study|disease progression|2
6912519|NCT00748553|10937788|FG001|Overall Study|disease progression|0
6912520|NCT00748553|10937787|FG000|Overall Study|noncompliance|1
6912521|NCT00748553|10937788|FG001|Overall Study|noncompliance|0
6912522|NCT00748566|10937793|FG000|Overall Study|Adverse Event|49
6912523|NCT00748566|10937793|FG000|Overall Study|Death|1
6912524|NCT00748566|10937793|FG000|Overall Study|Lack of Efficacy|12
6912525|NCT00748566|10937793|FG000|Overall Study|Lost to Follow-up|1
6912526|NCT00748566|10937793|FG000|Overall Study|Protocol Violation|13
6912527|NCT00748566|10937793|FG000|Overall Study|Withdrawal by Subject|22
6912528|NCT00748566|10937793|FG000|Overall Study|Study terminated by sponsor|5
6912529|NCT00748566|10937793|FG000|Overall Study|Other|9
6912530|NCT00748709|10937807|FG000|Overall Study|Progressive disease|15
6912531|NCT00748709|10937807|FG000|Overall Study|Drug reducing Toxity|2
6912532|NCT00748709|10937807|FG000|Overall Study|Other Adverse Event|1
6912533|NCT00748709|10937807|FG000|Overall Study|Withdrawal by Subject|1
6912534|NCT00748709|10937807|FG000|Overall Study|Other Reasons|1
6912535|NCT00748969|10937837|FG000|Overall Study|Withdrawal by Subject|1
6912536|NCT00748969|10937838|FG001|Overall Study|Withdrawal by Subject|0
6912537|NCT00748969|10937837|FG000|Overall Study|Withdrawal by Subject|0
6912538|NCT00748969|10937838|FG001|Overall Study|Withdrawal by Subject|1
6912539|NCT00749190|10937874|FG000|Overall Study|Adverse Event|0
6912540|NCT00749190|10937875|FG001|Overall Study|Adverse Event|2
6912541|NCT00749190|10937876|FG002|Overall Study|Adverse Event|0
6912542|NCT00749190|10937877|FG003|Overall Study|Adverse Event|4
6912543|NCT00749190|10937878|FG004|Overall Study|Adverse Event|0
6912544|NCT00749190|10937879|FG005|Overall Study|Adverse Event|3
6912545|NCT00749190|10937880|FG006|Overall Study|Adverse Event|0
6912546|NCT00749190|10937874|FG000|Overall Study|Lack of Efficacy|3
6912547|NCT00749190|10937875|FG001|Overall Study|Lack of Efficacy|1
6912548|NCT00749190|10937876|FG002|Overall Study|Lack of Efficacy|1
6912549|NCT00749190|10937877|FG003|Overall Study|Lack of Efficacy|0
6912550|NCT00749190|10937878|FG004|Overall Study|Lack of Efficacy|0
6912551|NCT00749190|10937879|FG005|Overall Study|Lack of Efficacy|1
6912552|NCT00749190|10937880|FG006|Overall Study|Lack of Efficacy|0
6912553|NCT00749190|10937874|FG000|Overall Study|Withdrawal by Subject|2
6912554|NCT00749190|10937875|FG001|Overall Study|Withdrawal by Subject|1
6912555|NCT00749190|10937876|FG002|Overall Study|Withdrawal by Subject|0
6912556|NCT00749190|10937877|FG003|Overall Study|Withdrawal by Subject|0
6912557|NCT00749190|10937878|FG004|Overall Study|Withdrawal by Subject|0
6912558|NCT00749190|10937879|FG005|Overall Study|Withdrawal by Subject|1
6912559|NCT00749190|10937880|FG006|Overall Study|Withdrawal by Subject|0
6912560|NCT00749190|10937874|FG000|Overall Study|Protocol Violation|0
6912561|NCT00749190|10937875|FG001|Overall Study|Protocol Violation|1
6912562|NCT00749190|10937876|FG002|Overall Study|Protocol Violation|0
6912563|NCT00749190|10937877|FG003|Overall Study|Protocol Violation|0
6912564|NCT00749190|10937878|FG004|Overall Study|Protocol Violation|0
6912565|NCT00749190|10937879|FG005|Overall Study|Protocol Violation|0
6912566|NCT00749190|10937880|FG006|Overall Study|Protocol Violation|1
6912567|NCT00749190|10937874|FG000|Overall Study|Other reason not defined above|0
6912568|NCT00749190|10937875|FG001|Overall Study|Other reason not defined above|0
6912569|NCT00749190|10937876|FG002|Overall Study|Other reason not defined above|0
6912570|NCT00749190|10937877|FG003|Overall Study|Other reason not defined above|1
6912571|NCT00749190|10937878|FG004|Overall Study|Other reason not defined above|0
6912572|NCT00749190|10937879|FG005|Overall Study|Other reason not defined above|0
6912573|NCT00749190|10937880|FG006|Overall Study|Other reason not defined above|0
6912574|NCT00749203|10937903|FG000|no Infusion at Week 1|Lost to Follow-up|0
6912575|NCT00749203|10937904|FG001|no Infusion at Week 1|Lost to Follow-up|1
6912576|NCT00749203|10937903|FG000|no Infusion at Week 1|Withdrawal by Subject|0
6912577|NCT00749203|10937904|FG001|no Infusion at Week 1|Withdrawal by Subject|1
6912578|NCT00749203|10937903|FG000|no Infusion at Week 1|delayed-onset sedation|0
6912579|NCT00749203|10937904|FG001|no Infusion at Week 1|delayed-onset sedation|1
6912580|NCT00749203|10937903|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0
6912581|NCT00749203|10937904|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1
6912582|NCT00749203|10937903|FG000|Second Infusion at 2 Weeks|Protocol Violation|0
6912583|NCT00749203|10937904|FG001|Second Infusion at 2 Weeks|Protocol Violation|1
6912584|NCT00749203|10937903|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0
6912585|NCT00749203|10937904|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1
6912586|NCT00749398|10937925|FG000|Overall Study|Lack of Efficacy|7
6912587|NCT00749398|10937925|FG000|Overall Study|Adverse Event|4
6912588|NCT00749398|10937925|FG000|Overall Study|Serious adverse event|11
6912589|NCT00749398|10937925|FG000|Overall Study|Withdrawal by Subject|17
6912590|NCT00749398|10937925|FG000|Overall Study|Lost to Follow-up|11
6912591|NCT00749398|10937925|FG000|Overall Study|Reason not specified|2
6912592|NCT00749398|10937925|FG000|Overall Study|Unknown reason|1
6912593|NCT00749411|10937931|FG000|Overall Study|Adverse Event|0
6912594|NCT00749411|10937932|FG001|Overall Study|Adverse Event|2
6912595|NCT00749411|10937931|FG000|Overall Study|Lack of Efficacy|0
6912596|NCT00749411|10937932|FG001|Overall Study|Lack of Efficacy|1
6912597|NCT00749411|10937931|FG000|Overall Study|Protocol Violation|1
6912598|NCT00749411|10937932|FG001|Overall Study|Protocol Violation|1
6912599|NCT00749411|10937931|FG000|Overall Study|Protocol-defined stopping criteria|0
6912600|NCT00749411|10937932|FG001|Overall Study|Protocol-defined stopping criteria|1
6974210|NCT01185782|11026108|FG000|Overall Study|Other|2
6974211|NCT01185782|11026109|FG001|Overall Study|Other|5
6974212|NCT01185782|11026108|FG000|Overall Study|Randomized but not treated|0
6974213|NCT01185782|11026109|FG001|Overall Study|Randomized but not treated|4
6974214|NCT01185821|11026120|FG000|Overall Study|Abnormal laboratory value(s)|1
6974215|NCT01185821|11026121|FG001|Overall Study|Abnormal laboratory value(s)|2
6974216|NCT01185821|11026122|FG002|Overall Study|Abnormal laboratory value(s)|1
6974217|NCT01185821|11026123|FG003|Overall Study|Abnormal laboratory value(s)|0
6974218|NCT01185821|11026124|FG004|Overall Study|Abnormal laboratory value(s)|0
6974219|NCT01185821|11026120|FG000|Overall Study|Protocol Violation|0
6974220|NCT01185821|11026121|FG001|Overall Study|Protocol Violation|0
6974221|NCT01185821|11026122|FG002|Overall Study|Protocol Violation|0
6974222|NCT01185821|11026123|FG003|Overall Study|Protocol Violation|1
6974223|NCT01185821|11026124|FG004|Overall Study|Protocol Violation|1
6974224|NCT01185821|11026120|FG000|Overall Study|Abnormal test procedure result|0
6974225|NCT01185821|11026121|FG001|Overall Study|Abnormal test procedure result|0
6974226|NCT01185821|11026122|FG002|Overall Study|Abnormal test procedure result|0
6974227|NCT01185821|11026123|FG003|Overall Study|Abnormal test procedure result|0
6974228|NCT01185821|11026124|FG004|Overall Study|Abnormal test procedure result|1
6974229|NCT01185821|11026120|FG000|Overall Study|Death|0
6974230|NCT01185821|11026121|FG001|Overall Study|Death|1
6912601|NCT00749463|10937941|FG000|Overall Study|Adverse Event|0
6979014|NCT01215916|11032753|FG000|Overall Study|Death|0
6979015|NCT01215916|11032754|FG001|Overall Study|Death|1
6979016|NCT01215916|11032755|FG002|Overall Study|Death|0
6979017|NCT01215916|11032756|FG003|Overall Study|Death|0
6979018|NCT01215916|11032757|FG004|Overall Study|Death|1
6979019|NCT01215916|11032758|FG005|Overall Study|Death|0
6979020|NCT01215916|11032759|FG006|Overall Study|Death|0
6979021|NCT01215916|11032760|FG007|Overall Study|Death|0
6979022|NCT01215916|11032761|FG008|Overall Study|Death|1
6979023|NCT01215916|11032753|FG000|Overall Study|Physician Decision|0
6912602|NCT00749463|10937942|FG001|Overall Study|Adverse Event|4
6912603|NCT00749463|10937943|FG002|Overall Study|Adverse Event|1
6912604|NCT00749463|10937941|FG000|Overall Study|Withdrawal by Subject|1
6912605|NCT00749463|10937942|FG001|Overall Study|Withdrawal by Subject|0
6912606|NCT00749463|10937943|FG002|Overall Study|Withdrawal by Subject|0
6912607|NCT00749580|10937962|FG000|Overall Study|Lost to Follow-up|4
6912608|NCT00749580|10937963|FG001|Overall Study|Lost to Follow-up|8
6912609|NCT00749580|10937962|FG000|Overall Study|Adverse Event|0
6912610|NCT00749580|10937963|FG001|Overall Study|Adverse Event|1
6912611|NCT00749684|10937991|FG000|Overall Study|Death|1
6912612|NCT00749684|10937991|FG000|Overall Study|Adverse Event|27
6912613|NCT00749684|10937991|FG000|Overall Study|Participant's Wish|10
6912614|NCT00749684|10937991|FG000|Overall Study|Not Documented|1
6912615|NCT00749684|10937991|FG000|Overall Study|Progressive Desease|31
6912616|NCT00749684|10937991|FG000|Overall Study|Therapy according to protocol + AE|2
6979024|NCT01215916|11032754|FG001|Overall Study|Physician Decision|0
6979025|NCT01215916|11032755|FG002|Overall Study|Physician Decision|1
6979026|NCT01215916|11032756|FG003|Overall Study|Physician Decision|1
6979027|NCT01215916|11032757|FG004|Overall Study|Physician Decision|0
6979028|NCT01215916|11032758|FG005|Overall Study|Physician Decision|0
6979029|NCT01215916|11032759|FG006|Overall Study|Physician Decision|0
6979030|NCT01215916|11032760|FG007|Overall Study|Physician Decision|0
6979031|NCT01215916|11032761|FG008|Overall Study|Physician Decision|0
6979032|NCT01215942|11032796|FG000|Treatment Period|Adverse Event|15
6979033|NCT01215942|11032797|FG001|Treatment Period|Adverse Event|26
6979034|NCT01215942|11032796|FG000|Treatment Period|Death|2
7060244|NCT01915914|11156283|FG001|Acute Phase|"Not Achieved treatment success"|0
6912617|NCT00749684|10937991|FG000|Overall Study|AE+discontinuation on participants wish|1
6912618|NCT00749684|10937991|FG000|Overall Study|Missing|9
6912619|NCT00749775|10938004|FG000|Overall Study|Protocol Violation|24
6912620|NCT00749775|10938004|FG000|Overall Study|Lost to Follow-up|36
6912621|NCT00749775|10938004|FG000|Overall Study|No visit after first day of treatment|44
6912622|NCT00749775|10938004|FG000|Overall Study|No drug administration|3
6912623|NCT00749892|10938030|FG000|Overall Study|Withdrawal by Subject|3
6912624|NCT00749944|10938047|FG000|Overall Study|Lost to Follow-up|2
6912625|NCT00749944|10938048|FG001|Overall Study|Lost to Follow-up|1
6912626|NCT00749944|10938047|FG000|Overall Study|Other|1
6912627|NCT00749944|10938048|FG001|Overall Study|Other|0
6912628|NCT00749944|10938047|FG000|Overall Study|Withdrawal by Subject|2
6912629|NCT00749944|10938048|FG001|Overall Study|Withdrawal by Subject|0
6912630|NCT00749996|10938067|FG000|Overall Study|Lost to Follow-up|7
6912631|NCT00749996|10938068|FG001|Overall Study|Lost to Follow-up|4
6912632|NCT00749996|10938067|FG000|Overall Study|Withdrawal by Subject|5
6912633|NCT00749996|10938068|FG001|Overall Study|Withdrawal by Subject|4
6912634|NCT00749996|10938067|FG000|Overall Study|Protocol Violation|2
6912635|NCT00749996|10938068|FG001|Overall Study|Protocol Violation|3
6912636|NCT00749996|10938067|FG000|Overall Study|Physician Decision|2
6912637|NCT00749996|10938068|FG001|Overall Study|Physician Decision|0
6912638|NCT00749996|10938067|FG000|Overall Study|Pregnancy|0
6912639|NCT00749996|10938068|FG001|Overall Study|Pregnancy|2
6912640|NCT00749996|10938067|FG000|Overall Study|Adverse Event|1
6912641|NCT00749996|10938068|FG001|Overall Study|Adverse Event|0
6912642|NCT00749996|10938067|FG000|Overall Study|Death|1
6912643|NCT00749996|10938068|FG001|Overall Study|Death|0
6912644|NCT00750061|10938076|FG000|Overall Study|Adverse Event|2
6912645|NCT00750061|10938077|FG001|Overall Study|Adverse Event|0
6912646|NCT00750061|10938076|FG000|Overall Study|Withdrawal by Subject|0
6912647|NCT00750061|10938077|FG001|Overall Study|Withdrawal by Subject|1
6912648|NCT00750061|10938076|FG000|Overall Study|Physician Decision|0
6912649|NCT00750061|10938077|FG001|Overall Study|Physician Decision|1
6912650|NCT00750139|10938087|FG000|Overall Study|Adverse Event|1
6912651|NCT00750139|10938088|FG001|Overall Study|Adverse Event|2
6912652|NCT00750139|10938089|FG002|Overall Study|Adverse Event|0
6912653|NCT00750139|10938090|FG003|Overall Study|Adverse Event|1
6912654|NCT00750139|10938087|FG000|Overall Study|Lost to Follow-up|17
6912655|NCT00750139|10938088|FG001|Overall Study|Lost to Follow-up|12
6912656|NCT00750139|10938089|FG002|Overall Study|Lost to Follow-up|15
6912657|NCT00750139|10938090|FG003|Overall Study|Lost to Follow-up|6
6912658|NCT00750139|10938087|FG000|Overall Study|Withdrawal by Subject|3
6912659|NCT00750139|10938088|FG001|Overall Study|Withdrawal by Subject|2
6979035|NCT01215942|11032797|FG001|Treatment Period|Death|4
6979036|NCT01215942|11032796|FG000|Treatment Period|Lack of Efficacy|23
6979037|NCT01215942|11032797|FG001|Treatment Period|Lack of Efficacy|62
6979038|NCT01215942|11032796|FG000|Treatment Period|Lost to Follow-up|3
6979039|NCT01215942|11032797|FG001|Treatment Period|Lost to Follow-up|4
6912660|NCT00750139|10938089|FG002|Overall Study|Withdrawal by Subject|6
6912661|NCT00750139|10938090|FG003|Overall Study|Withdrawal by Subject|2
6912662|NCT00750139|10938087|FG000|Overall Study|Physician Decision|1
6912663|NCT00750139|10938088|FG001|Overall Study|Physician Decision|1
6912664|NCT00750139|10938089|FG002|Overall Study|Physician Decision|0
6912665|NCT00750139|10938090|FG003|Overall Study|Physician Decision|0
6912666|NCT00750139|10938087|FG000|Overall Study|Non-compliance|1
6912667|NCT00750139|10938088|FG001|Overall Study|Non-compliance|0
6912668|NCT00750139|10938089|FG002|Overall Study|Non-compliance|1
6912669|NCT00750139|10938090|FG003|Overall Study|Non-compliance|3
6912670|NCT00750139|10938087|FG000|Overall Study|Termination by sponsor|4
6912671|NCT00750139|10938088|FG001|Overall Study|Termination by sponsor|0
6912672|NCT00750139|10938089|FG002|Overall Study|Termination by sponsor|0
6912673|NCT00750139|10938090|FG003|Overall Study|Termination by sponsor|1
6912674|NCT00750139|10938087|FG000|Overall Study|Non-specific|62
6912675|NCT00750139|10938088|FG001|Overall Study|Non-specific|42
6912676|NCT00750139|10938089|FG002|Overall Study|Non-specific|79
6912677|NCT00750139|10938090|FG003|Overall Study|Non-specific|33
6912678|NCT00750152|10938104|FG000|Overall Study|Adverse Event|2
6912679|NCT00750152|10938105|FG001|Overall Study|Adverse Event|1
6912680|NCT00750152|10938104|FG000|Overall Study|Lost to Follow-up|8
6912681|NCT00750152|10938105|FG001|Overall Study|Lost to Follow-up|13
6912682|NCT00750152|10938104|FG000|Overall Study|Withdrawal by Subject|3
6912683|NCT00750152|10938105|FG001|Overall Study|Withdrawal by Subject|3
6912684|NCT00750152|10938104|FG000|Overall Study|Physician Decision|1
6912685|NCT00750152|10938105|FG001|Overall Study|Physician Decision|1
6912686|NCT00750152|10938104|FG000|Overall Study|Non-compliance|0
6912687|NCT00750152|10938105|FG001|Overall Study|Non-compliance|1
6912688|NCT00750152|10938104|FG000|Overall Study|Termination by sponsor|1
6912689|NCT00750152|10938105|FG001|Overall Study|Termination by sponsor|0
6912690|NCT00750152|10938104|FG000|Overall Study|Other|7
6912691|NCT00750152|10938105|FG001|Overall Study|Other|8
6912692|NCT00750308|10938155|FG000|First Treatment|Adverse Event|0
6912693|NCT00750308|10938156|FG001|First Treatment|Adverse Event|1
6912694|NCT00750308|10938157|FG002|First Treatment|Adverse Event|0
6912695|NCT00750308|10938158|FG003|First Treatment|Adverse Event|0
6912696|NCT00750308|10938159|FG004|First Treatment|Adverse Event|0
6912697|NCT00750308|10938160|FG005|First Treatment|Adverse Event|0
6912698|NCT00750308|10938161|FG006|First Treatment|Adverse Event|0
6912699|NCT00750308|10938162|FG007|First Treatment|Adverse Event|0
6912700|NCT00750308|10938163|FG008|First Treatment|Adverse Event|0
6912701|NCT00750308|10938164|FG009|First Treatment|Adverse Event|0
6912702|NCT00750308|10938165|FG010|First Treatment|Adverse Event|1
6912703|NCT00750308|10938166|FG011|First Treatment|Adverse Event|1
6912704|NCT00750308|10938155|FG000|First Treatment|Withdrawal by Subject|0
6912705|NCT00750308|10938156|FG001|First Treatment|Withdrawal by Subject|0
6912706|NCT00750308|10938157|FG002|First Treatment|Withdrawal by Subject|0
6912707|NCT00750308|10938158|FG003|First Treatment|Withdrawal by Subject|1
6912708|NCT00750308|10938159|FG004|First Treatment|Withdrawal by Subject|0
6912709|NCT00750308|10938160|FG005|First Treatment|Withdrawal by Subject|0
6912710|NCT00750308|10938161|FG006|First Treatment|Withdrawal by Subject|0
6912711|NCT00750308|10938162|FG007|First Treatment|Withdrawal by Subject|1
6912712|NCT00750308|10938163|FG008|First Treatment|Withdrawal by Subject|0
6912713|NCT00750308|10938164|FG009|First Treatment|Withdrawal by Subject|0
6912714|NCT00750308|10938165|FG010|First Treatment|Withdrawal by Subject|0
6912715|NCT00750308|10938166|FG011|First Treatment|Withdrawal by Subject|0
6912716|NCT00750308|10938155|FG000|Second Treatment|Adverse Event|0
6912717|NCT00750308|10938156|FG001|Second Treatment|Adverse Event|0
6912718|NCT00750308|10938157|FG002|Second Treatment|Adverse Event|0
6912719|NCT00750308|10938158|FG003|Second Treatment|Adverse Event|0
6912720|NCT00750308|10938159|FG004|Second Treatment|Adverse Event|0
6912721|NCT00750308|10938160|FG005|Second Treatment|Adverse Event|1
6912722|NCT00750308|10938161|FG006|Second Treatment|Adverse Event|0
6912723|NCT00750308|10938162|FG007|Second Treatment|Adverse Event|0
6912724|NCT00750308|10938163|FG008|Second Treatment|Adverse Event|1
6912725|NCT00750308|10938164|FG009|Second Treatment|Adverse Event|0
6912726|NCT00750308|10938165|FG010|Second Treatment|Adverse Event|0
6912727|NCT00750308|10938166|FG011|Second Treatment|Adverse Event|0
6912728|NCT00750308|10938155|FG000|Second Treatment|Withdrawal by Subject|0
6912729|NCT00750308|10938156|FG001|Second Treatment|Withdrawal by Subject|0
6912730|NCT00750308|10938157|FG002|Second Treatment|Withdrawal by Subject|0
6912731|NCT00750308|10938158|FG003|Second Treatment|Withdrawal by Subject|0
6912732|NCT00750308|10938159|FG004|Second Treatment|Withdrawal by Subject|1
6912733|NCT00750308|10938160|FG005|Second Treatment|Withdrawal by Subject|0
6912734|NCT00750308|10938161|FG006|Second Treatment|Withdrawal by Subject|0
6912735|NCT00750308|10938162|FG007|Second Treatment|Withdrawal by Subject|0
6912736|NCT00750308|10938163|FG008|Second Treatment|Withdrawal by Subject|0
6912737|NCT00750308|10938164|FG009|Second Treatment|Withdrawal by Subject|0
6912738|NCT00750308|10938165|FG010|Second Treatment|Withdrawal by Subject|0
6912739|NCT00750308|10938166|FG011|Second Treatment|Withdrawal by Subject|0
6912740|NCT00750308|10938155|FG000|Third Treatment|Withdrawal by Subject|0
6912741|NCT00750308|10938156|FG001|Third Treatment|Withdrawal by Subject|1
6912742|NCT00750308|10938157|FG002|Third Treatment|Withdrawal by Subject|0
6912743|NCT00750308|10938158|FG003|Third Treatment|Withdrawal by Subject|0
6912744|NCT00750308|10938159|FG004|Third Treatment|Withdrawal by Subject|0
6912745|NCT00750308|10938160|FG005|Third Treatment|Withdrawal by Subject|0
6912746|NCT00750308|10938161|FG006|Third Treatment|Withdrawal by Subject|0
6912747|NCT00750308|10938162|FG007|Third Treatment|Withdrawal by Subject|0
6912748|NCT00750308|10938163|FG008|Third Treatment|Withdrawal by Subject|0
6912749|NCT00750308|10938164|FG009|Third Treatment|Withdrawal by Subject|0
6912750|NCT00750308|10938165|FG010|Third Treatment|Withdrawal by Subject|0
6912751|NCT00750308|10938166|FG011|Third Treatment|Withdrawal by Subject|0
6912752|NCT00750438|10938222|FG000|Overall Study|Protocol Violation|4
6912753|NCT00750438|10938223|FG001|Overall Study|Protocol Violation|1
6912754|NCT00750438|10938222|FG000|Overall Study|Physician Decision|2
6912755|NCT00750438|10938223|FG001|Overall Study|Physician Decision|2
6912756|NCT00750438|10938222|FG000|Overall Study|Withdrawal by Subject|1
6912757|NCT00750438|10938223|FG001|Overall Study|Withdrawal by Subject|1
6912758|NCT00750737|10938231|FG000|Overall Study|Withdrawal by Subject|3
6912759|NCT00750737|10938232|FG001|Overall Study|Withdrawal by Subject|3
6912760|NCT00750867|10938251|FG000|Overall Study|Adverse Event|2
6912761|NCT00750880|10938255|FG000|Overall Study|Adverse Event|76
6912762|NCT00750880|10938255|FG000|Overall Study|Death|4
6912763|NCT00750880|10938255|FG000|Overall Study|Lack of Efficacy|46
6912764|NCT00750880|10938255|FG000|Overall Study|Lost to Follow-up|10
6912765|NCT00750880|10938255|FG000|Overall Study|Protocol Violation|15
6912766|NCT00750880|10938255|FG000|Overall Study|Withdrawal by Subject|33
6912767|NCT00750880|10938255|FG000|Overall Study|Physician Decision|20
6912768|NCT00750880|10938255|FG000|Overall Study|Administrative|11
6912769|NCT00750893|10938260|FG000|Overall Study|Adverse Event|5
6912770|NCT00750893|10938260|FG000|Overall Study|Withdrawal by Subject|10
6912771|NCT00750893|10938260|FG000|Overall Study|Lost to Follow-up|510
6912772|NCT00750893|10938260|FG000|Overall Study|Other|17
6912773|NCT00750919|10938264|FG000|Overall Study|Adverse Event|9
6912774|NCT00750919|10938264|FG000|Overall Study|Withdrawal by Subject|1
6912775|NCT00750919|10938264|FG000|Overall Study|Lack of Efficacy|8
6912776|NCT00750919|10938264|FG000|Overall Study|Could not cooperate, unrelated to trial|4
6912777|NCT00750919|10938264|FG000|Overall Study|Other|36
6912778|NCT00751023|10938270|FG000|Overall Study|Lost to Follow-up|11
6912779|NCT00751023|10938271|FG001|Overall Study|Lost to Follow-up|7
6912780|NCT00751036|10938279|FG000|Overall Study|Disease Progression|28
6912781|NCT00751036|10938280|FG001|Overall Study|Disease Progression|29
6912782|NCT00751036|10938279|FG000|Overall Study|Adverse Event|6
6912783|NCT00751036|10938280|FG001|Overall Study|Adverse Event|4
6912784|NCT00751036|10938279|FG000|Overall Study|Administrative Problems|3
6912785|NCT00751036|10938280|FG001|Overall Study|Administrative Problems|4
6912786|NCT00751036|10938279|FG000|Overall Study|Withdrawal by Subject|5
6912787|NCT00751036|10938280|FG001|Overall Study|Withdrawal by Subject|2
6912788|NCT00751036|10938279|FG000|Overall Study|Death|3
6912789|NCT00751036|10938280|FG001|Overall Study|Death|3
6912790|NCT00751036|10938279|FG000|Overall Study|Lost to Follow-up|0
6912791|NCT00751036|10938280|FG001|Overall Study|Lost to Follow-up|1
6912792|NCT00751036|10938279|FG000|Overall Study|Protocol Violation|1
6912793|NCT00751036|10938280|FG001|Overall Study|Protocol Violation|0
6912794|NCT00751036|10938279|FG000|Overall Study|Missing end of Treatment Page|2
6912795|NCT00751036|10938280|FG001|Overall Study|Missing end of Treatment Page|3
6912796|NCT00751101|10938288|FG000|Overall Study|Withdrawal by Subject|1
6912797|NCT00751101|10938289|FG001|Overall Study|Withdrawal by Subject|0
6912798|NCT00751101|10938288|FG000|Overall Study|No HFS / Never Started Patch/|0
6912799|NCT00751101|10938289|FG001|Overall Study|No HFS / Never Started Patch/|4
6912800|NCT00751101|10938288|FG000|Overall Study|Never began capecitabine|1
6912801|NCT00751101|10938289|FG001|Overall Study|Never began capecitabine|0
6912802|NCT00751101|10938288|FG000|Overall Study|Physician Decision|0
6912803|NCT00751101|10938289|FG001|Overall Study|Physician Decision|1
6912804|NCT00751114|10938301|FG000|Overall Study|Adverse Event|2
6912805|NCT00751114|10938302|FG001|Overall Study|Adverse Event|4
6912806|NCT00751114|10938301|FG000|Overall Study|Protocol Violation|8
6912807|NCT00751114|10938302|FG001|Overall Study|Protocol Violation|9
6912808|NCT00751114|10938301|FG000|Overall Study|Withdrawal by Subject|9
6912809|NCT00751114|10938302|FG001|Overall Study|Withdrawal by Subject|4
6912810|NCT00751114|10938301|FG000|Overall Study|Lost to Follow-up|4
6912811|NCT00751114|10938302|FG001|Overall Study|Lost to Follow-up|7
6912812|NCT00751114|10938301|FG000|Overall Study|Lack of Efficacy|0
6912813|NCT00751114|10938302|FG001|Overall Study|Lack of Efficacy|7
6912814|NCT00751114|10938301|FG000|Overall Study|Not Treated|13
6912815|NCT00751114|10938302|FG001|Overall Study|Not Treated|1
6912816|NCT00751114|10938301|FG000|Overall Study|Out of country for 2 months|1
6912817|NCT00751114|10938302|FG001|Overall Study|Out of country for 2 months|0
6912818|NCT00751114|10938301|FG000|Overall Study|Move to another city|1
6912819|NCT00751114|10938302|FG001|Overall Study|Move to another city|0
6912820|NCT00751140|10938308|FG000|Overall Study|benign angioma excluded from analysis|1
6912821|NCT00751296|10938326|FG000|Overall Study|Adverse Event|2
6912822|NCT00751348|10938332|FG000|Overall Study|Withdrawal by Subject|5
6912823|NCT00751348|10938333|FG001|Overall Study|Withdrawal by Subject|2
6912824|NCT00751348|10938332|FG000|Overall Study|Migration from study area|1
6912825|NCT00751348|10938333|FG001|Overall Study|Migration from study area|0
6912826|NCT00751400|10938339|FG000|Overall Study|Lost to Follow-up|10
6912827|NCT00751621|10938352|FG000|Overall Study|Adverse Event|1
6912828|NCT00751621|10938352|FG000|Overall Study|Withdrawal by Subject|1
6974231|NCT01185821|11026122|FG002|Overall Study|Death|0
6912829|NCT00751621|10938352|FG000|Overall Study|Subject moved to another country|1
6912830|NCT00751621|10938352|FG000|Overall Study|Poor adherence to asthma treatment|1
6912831|NCT00751790|10938372|FG000|Overall Study|Lost to Follow-up|1
6912832|NCT00751790|10938372|FG000|Overall Study|Death|3
6912833|NCT00751790|10938372|FG000|Overall Study|Withdrawal by Subject|1
6912834|NCT00751881|10938379|FG000|Core Treatment Period|Not treated|1
6912835|NCT00751881|10938380|FG001|Core Treatment Period|Not treated|1
6912836|NCT00751881|10938381|FG002|Core Treatment Period|Not treated|2
6912837|NCT00751881|10938379|FG000|Core Treatment Period|Adverse Event|26
6912838|NCT00751881|10938380|FG001|Core Treatment Period|Adverse Event|54
6912839|NCT00751881|10938381|FG002|Core Treatment Period|Adverse Event|58
6912840|NCT00751881|10938379|FG000|Core Treatment Period|Lack of Efficacy|37
6912841|NCT00751881|10938380|FG001|Core Treatment Period|Lack of Efficacy|30
6912842|NCT00751881|10938381|FG002|Core Treatment Period|Lack of Efficacy|20
6912843|NCT00751881|10938379|FG000|Core Treatment Period|Poor compliance to protocol|15
6912844|NCT00751881|10938380|FG001|Core Treatment Period|Poor compliance to protocol|3
6912845|NCT00751881|10938381|FG002|Core Treatment Period|Poor compliance to protocol|4
6912846|NCT00751881|10938379|FG000|Core Treatment Period|Lost to Follow-up|6
6912847|NCT00751881|10938380|FG001|Core Treatment Period|Lost to Follow-up|4
6912848|NCT00751881|10938381|FG002|Core Treatment Period|Lost to Follow-up|3
6912849|NCT00751881|10938379|FG000|Core Treatment Period|Other: protocol deviation|3
6912850|NCT00751881|10938380|FG001|Core Treatment Period|Other: protocol deviation|3
6912851|NCT00751881|10938381|FG002|Core Treatment Period|Other: protocol deviation|7
6912852|NCT00751881|10938379|FG000|Core Treatment Period|Other: wish to parent|5
6912853|NCT00751881|10938380|FG001|Core Treatment Period|Other: wish to parent|7
6912854|NCT00751881|10938381|FG002|Core Treatment Period|Other: wish to parent|4
6912855|NCT00751881|10938379|FG000|Core Treatment Period|Other: personal/family constraints|6
6912856|NCT00751881|10938380|FG001|Core Treatment Period|Other: personal/family constraints|7
6912857|NCT00751881|10938381|FG002|Core Treatment Period|Other: personal/family constraints|10
6912858|NCT00751881|10938379|FG000|Core Treatment Period|Other: MS treatment change|6
6912859|NCT00751881|10938380|FG001|Core Treatment Period|Other: MS treatment change|4
6912860|NCT00751881|10938381|FG002|Core Treatment Period|Other: MS treatment change|4
6912861|NCT00751881|10938379|FG000|Core Treatment Period|Other: tolerability complaints|2
6912862|NCT00751881|10938380|FG001|Core Treatment Period|Other: tolerability complaints|0
6912863|NCT00751881|10938381|FG002|Core Treatment Period|Other: tolerability complaints|0
6912864|NCT00751881|10938379|FG000|Core Treatment Period|Other:participant's decision/unspecified|19
6912865|NCT00751881|10938380|FG001|Core Treatment Period|Other:participant's decision/unspecified|22
6912866|NCT00751881|10938381|FG002|Core Treatment Period|Other:participant's decision/unspecified|16
6912867|NCT00751881|10938379|FG000|Extension Study Period|Adverse Event|18
6912868|NCT00751881|10938380|FG001|Extension Study Period|Adverse Event|20
6912869|NCT00751881|10938381|FG002|Extension Study Period|Adverse Event|21
6912870|NCT00751881|10938379|FG000|Extension Study Period|Lack of Efficacy|14
6912871|NCT00751881|10938380|FG001|Extension Study Period|Lack of Efficacy|10
6912872|NCT00751881|10938381|FG002|Extension Study Period|Lack of Efficacy|20
6912873|NCT00751881|10938379|FG000|Extension Study Period|Lost to Follow-up|4
6912874|NCT00751881|10938380|FG001|Extension Study Period|Lost to Follow-up|9
6912875|NCT00751881|10938381|FG002|Extension Study Period|Lost to Follow-up|6
6912876|NCT00751881|10938379|FG000|Extension Study Period|Poor Compliance to Protocol|3
6912877|NCT00751881|10938380|FG001|Extension Study Period|Poor Compliance to Protocol|2
6912878|NCT00751881|10938381|FG002|Extension Study Period|Poor Compliance to Protocol|1
6912879|NCT00751881|10938379|FG000|Extension Study Period|Other than specified above|26
6912880|NCT00751881|10938380|FG001|Extension Study Period|Other than specified above|30
6912881|NCT00751881|10938381|FG002|Extension Study Period|Other than specified above|18
6912882|NCT00751998|10938403|FG000|Overall Study|Lost to Follow-up|7
6912883|NCT00751998|10938403|FG000|Overall Study|Death|11
6912884|NCT00751998|10938403|FG000|Overall Study|Withdrawal by Subject|2
6912885|NCT00752089|10938407|FG000|Overall Study|Adverse Event|1
6912886|NCT00752089|10938407|FG000|Overall Study|Protocol Deviation|2
6912887|NCT00752089|10938407|FG000|Overall Study|Could not attend visit 9|1
6912888|NCT00752089|10938407|FG000|Overall Study|Not capable of wearing partial denture|1
6912889|NCT00752089|10938407|FG000|Overall Study|Cannot continue the study|1
6912890|NCT00752128|10938427|FG000|Overall Study|Withdrawal by Subject|4
6912891|NCT00752206|10938434|FG000|Overall Study|Disease progression|8
6912892|NCT00752206|10938435|FG001|Overall Study|Disease progression|11
6912893|NCT00752206|10938434|FG000|Overall Study|Pregnancy|1
6912894|NCT00752206|10938435|FG001|Overall Study|Pregnancy|0
6912895|NCT00752219|10938443|FG000|Overall Study|Clinical failure|0
6912896|NCT00752219|10938444|FG001|Overall Study|Clinical failure|1
6912897|NCT00752219|10938443|FG000|Overall Study|Adverse Event|5
6912898|NCT00752219|10938444|FG001|Overall Study|Adverse Event|3
6912899|NCT00752219|10938443|FG000|Overall Study|Protocol deviation|1
6912900|NCT00752219|10938444|FG001|Overall Study|Protocol deviation|0
6912901|NCT00752219|10938443|FG000|Overall Study|Lost to Follow-up|1
6912902|NCT00752219|10938444|FG001|Overall Study|Lost to Follow-up|2
6912903|NCT00752219|10938443|FG000|Overall Study|Randomized but not treated|1
6912904|NCT00752219|10938444|FG001|Overall Study|Randomized but not treated|0
6912905|NCT00752219|10938443|FG000|Overall Study|Other|3
6912906|NCT00752219|10938444|FG001|Overall Study|Other|0
6912907|NCT00752232|10938457|FG000|Overall Study|Protocol Violation|0
6912908|NCT00752232|10938458|FG001|Overall Study|Protocol Violation|0
6912909|NCT00752232|10938459|FG002|Overall Study|Protocol Violation|0
6912910|NCT00752232|10938460|FG003|Overall Study|Protocol Violation|0
6912911|NCT00752232|10938461|FG004|Overall Study|Protocol Violation|0
6912912|NCT00752232|10938462|FG005|Overall Study|Protocol Violation|1
6912913|NCT00752232|10938463|FG006|Overall Study|Protocol Violation|0
6912914|NCT00752232|10938457|FG000|Overall Study|Caregiver request|2
6912915|NCT00752232|10938458|FG001|Overall Study|Caregiver request|0
6912916|NCT00752232|10938459|FG002|Overall Study|Caregiver request|0
6912917|NCT00752232|10938460|FG003|Overall Study|Caregiver request|0
6912918|NCT00752232|10938461|FG004|Overall Study|Caregiver request|1
6912919|NCT00752232|10938462|FG005|Overall Study|Caregiver request|0
6912920|NCT00752232|10938463|FG006|Overall Study|Caregiver request|0
6912921|NCT00752232|10938457|FG000|Overall Study|Investigator request|0
6912922|NCT00752232|10938458|FG001|Overall Study|Investigator request|0
6912923|NCT00752232|10938459|FG002|Overall Study|Investigator request|0
6912924|NCT00752232|10938460|FG003|Overall Study|Investigator request|0
6912925|NCT00752232|10938461|FG004|Overall Study|Investigator request|1
6912926|NCT00752232|10938462|FG005|Overall Study|Investigator request|0
6912927|NCT00752232|10938463|FG006|Overall Study|Investigator request|0
6912928|NCT00752232|10938457|FG000|Overall Study|Subject request|0
6912929|NCT00752232|10938458|FG001|Overall Study|Subject request|0
6912930|NCT00752232|10938459|FG002|Overall Study|Subject request|1
6912931|NCT00752232|10938460|FG003|Overall Study|Subject request|0
6912932|NCT00752232|10938461|FG004|Overall Study|Subject request|0
6912933|NCT00752232|10938462|FG005|Overall Study|Subject request|0
6912934|NCT00752232|10938463|FG006|Overall Study|Subject request|0
6912935|NCT00752232|10938457|FG000|Overall Study|Group home admission|0
6912936|NCT00752232|10938458|FG001|Overall Study|Group home admission|0
6912937|NCT00752232|10938459|FG002|Overall Study|Group home admission|0
6912938|NCT00752232|10938460|FG003|Overall Study|Group home admission|1
6912939|NCT00752232|10938461|FG004|Overall Study|Group home admission|0
6912940|NCT00752232|10938462|FG005|Overall Study|Group home admission|0
6912941|NCT00752232|10938463|FG006|Overall Study|Group home admission|0
6912942|NCT00752232|10938457|FG000|Overall Study|Caregiver could not attend the subject|0
6912943|NCT00752232|10938458|FG001|Overall Study|Caregiver could not attend the subject|0
6912944|NCT00752232|10938459|FG002|Overall Study|Caregiver could not attend the subject|0
6912945|NCT00752232|10938460|FG003|Overall Study|Caregiver could not attend the subject|0
6912946|NCT00752232|10938461|FG004|Overall Study|Caregiver could not attend the subject|1
6912947|NCT00752232|10938462|FG005|Overall Study|Caregiver could not attend the subject|0
6912948|NCT00752232|10938463|FG006|Overall Study|Caregiver could not attend the subject|0
6912949|NCT00752557|10938483|FG000|Overall Study|Withdrawal by Subject|4
6912950|NCT00752557|10938484|FG001|Overall Study|Withdrawal by Subject|3
6912951|NCT00752557|10938485|FG002|Overall Study|Withdrawal by Subject|3
6912952|NCT00752557|10938483|FG000|Overall Study|Unspecified resaons|0
6912953|NCT00752557|10938484|FG001|Overall Study|Unspecified resaons|2
6912954|NCT00752557|10938485|FG002|Overall Study|Unspecified resaons|2
6979040|NCT01215942|11032796|FG000|Treatment Period|Withdrawal by Subject|17
6979041|NCT01215942|11032797|FG001|Treatment Period|Withdrawal by Subject|40
6979042|NCT01215942|11032796|FG000|Treatment Period|Physician Decision|5
6979043|NCT01215942|11032797|FG001|Treatment Period|Physician Decision|5
6979044|NCT01215942|11032796|FG000|Treatment Period|Protocol Violation|0
6979045|NCT01215942|11032797|FG001|Treatment Period|Protocol Violation|1
6979046|NCT01215942|11032796|FG000|Treatment Period|Sponsor Decision|349
6979047|NCT01215942|11032797|FG001|Treatment Period|Sponsor Decision|530
6979048|NCT01215942|11032796|FG000|Post-Treatment Follow-Up Period|Death|0
6979049|NCT01215942|11032797|FG001|Post-Treatment Follow-Up Period|Death|1
6979050|NCT01215942|11032796|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13
6979051|NCT01215942|11032797|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13
6979052|NCT01215942|11032796|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43
6979053|NCT01215942|11032797|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69
6979054|NCT01215942|11032796|FG000|Post-Treatment Follow-Up Period|Physician Decision|1
6979055|NCT01215942|11032797|FG001|Post-Treatment Follow-Up Period|Physician Decision|2
6979056|NCT01215942|11032796|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28
6979057|NCT01215942|11032797|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61
6979058|NCT01215955|11032818|FG000|Overall Study|Adverse Event|1
6979059|NCT01215955|11032819|FG001|Overall Study|Adverse Event|4
6979060|NCT01215955|11032820|FG002|Overall Study|Adverse Event|2
6912955|NCT00752557|10938483|FG000|Overall Study|Lost to Follow-up|1
6912956|NCT00752557|10938484|FG001|Overall Study|Lost to Follow-up|0
6912957|NCT00752557|10938485|FG002|Overall Study|Lost to Follow-up|1
6979061|NCT01215955|11032821|FG003|Overall Study|Adverse Event|3
6979062|NCT01215955|11032818|FG000|Overall Study|Death|2
6979063|NCT01215955|11032819|FG001|Overall Study|Death|0
6979064|NCT01215955|11032820|FG002|Overall Study|Death|1
6979065|NCT01215955|11032821|FG003|Overall Study|Death|3
6979066|NCT01215955|11032818|FG000|Overall Study|Entry Criteria Not Met|1
6979067|NCT01215955|11032819|FG001|Overall Study|Entry Criteria Not Met|3
6979068|NCT01215955|11032820|FG002|Overall Study|Entry Criteria Not Met|4
6912958|NCT00752609|10938497|FG000|Overall Study|Adverse Event|2
6912959|NCT00752609|10938498|FG001|Overall Study|Adverse Event|2
6912960|NCT00752609|10938497|FG000|Overall Study|Withdrawal by Subject|3
6912961|NCT00752609|10938498|FG001|Overall Study|Withdrawal by Subject|0
6912962|NCT00752609|10938497|FG000|Overall Study|Physician Decision|1
6912963|NCT00752609|10938498|FG001|Overall Study|Physician Decision|0
6912964|NCT00752609|10938497|FG000|Overall Study|Death|1
6912965|NCT00752609|10938498|FG001|Overall Study|Death|0
6912966|NCT00752609|10938497|FG000|Overall Study|Met exclusion criteria|1
6912967|NCT00752609|10938498|FG001|Overall Study|Met exclusion criteria|0
6912968|NCT00752609|10938497|FG000|Overall Study|Received Aranesp in error|1
6912969|NCT00752609|10938498|FG001|Overall Study|Received Aranesp in error|0
6912970|NCT00752622|10938507|FG000|Induction Phase|Adverse Event|3
6912971|NCT00752622|10938507|FG000|Induction Phase|Other|3
6912972|NCT00752622|10938507|FG000|Induction Phase|Non-responder|14
6912973|NCT00752622|10938507|FG000|Induction Phase|Withdrawal by Subject|1
6912974|NCT00752622|10938507|FG000|Induction Phase|Premature study termination|14
6912975|NCT00752622|10938507|FG000|Observational Phase|Premature Study Termination|36
6912976|NCT00752622|10938507|FG000|Observational Phase|Non-responder|2
6912977|NCT00752622|10938507|FG000|Observational Phase|Withdrawal by Subject|2
6912978|NCT00752622|10938507|FG000|Observational Phase|Adverse Event|1
6912979|NCT00752622|10938507|FG000|Observational Phase|Other|2
6912980|NCT00752622|10938507|FG000|Interventional Phase|Non-responder|2
6912981|NCT00752622|10938507|FG000|Interventional Phase|Physician Decision|1
6912982|NCT00752622|10938507|FG000|Interventional Phase|Premature Study Termination|5
6912983|NCT00752726|10938514|FG000|Overall Study|Lost to Follow-up|2
6912984|NCT00752726|10938515|FG001|Overall Study|Lost to Follow-up|1
6912985|NCT00752726|10938514|FG000|Overall Study|Adverse Event|3
6912986|NCT00752726|10938515|FG001|Overall Study|Adverse Event|0
6912987|NCT00752726|10938514|FG000|Overall Study|Withdrawal by Subject|5
6912988|NCT00752726|10938515|FG001|Overall Study|Withdrawal by Subject|10
6912989|NCT00752726|10938514|FG000|Overall Study|Other Reason|1
6912990|NCT00752726|10938515|FG001|Overall Study|Other Reason|2
6912991|NCT00752791|10938521|FG000|Overall Study|Adverse Event|7
6912992|NCT00752791|10938521|FG000|Overall Study|Withdrawal by Subject|1
6912993|NCT00752791|10938521|FG000|Overall Study|Physician Decision|1
6912994|NCT00752791|10938521|FG000|Overall Study|Death|1
6912995|NCT00752791|10938521|FG000|Overall Study|Renal transplant|3
6912996|NCT00752791|10938521|FG000|Overall Study|Switched to hemodialysis|2
6912997|NCT00752791|10938521|FG000|Overall Study|Protocol deviation|1
6912998|NCT00752856|10938527|FG000|Overall Study|randomized but did not do viral kinetics|0
6912999|NCT00752856|10938528|FG001|Overall Study|randomized but did not do viral kinetics|1
6913000|NCT00752895|10938536|FG000|Overall Study|Withdrawal by Subject|8
6913001|NCT00752895|10938537|FG001|Overall Study|Withdrawal by Subject|3
6913002|NCT00753012|10938560|FG000|Overall Study|Ineligible, abnormal cardiac histo|1
6913003|NCT00753012|10938561|FG001|Overall Study|Ineligible, abnormal cardiac histo|0
6913004|NCT00753012|10938560|FG000|Overall Study|Adverse Event|2
6913005|NCT00753012|10938561|FG001|Overall Study|Adverse Event|0
6913006|NCT00753012|10938560|FG000|Overall Study|Withdrawal by Subject|0
6913007|NCT00753012|10938561|FG001|Overall Study|Withdrawal by Subject|1
6913008|NCT00753012|10938560|FG000|Overall Study|Lost to Follow-up|4
6913009|NCT00753012|10938561|FG001|Overall Study|Lost to Follow-up|0
6913010|NCT00753012|10938560|FG000|Overall Study|Confounded endpoint data|1
6913011|NCT00753012|10938561|FG001|Overall Study|Confounded endpoint data|0
6913012|NCT00753272|10938587|FG000|Overall Study|Adverse Event|878
6913013|NCT00753272|10938588|FG001|Overall Study|Adverse Event|869
6913014|NCT00753272|10938587|FG000|Overall Study|Protocol Violation|28
6913015|NCT00753272|10938588|FG001|Overall Study|Protocol Violation|46
6913016|NCT00753272|10938587|FG000|Overall Study|Withdrawal by Subject|2481
6913017|NCT00753272|10938588|FG001|Overall Study|Withdrawal by Subject|2407
6913018|NCT00753272|10938587|FG000|Overall Study|Lost to Follow-up|491
6913019|NCT00753272|10938588|FG001|Overall Study|Lost to Follow-up|497
6913020|NCT00753272|10938587|FG000|Overall Study|Other|1104
6913021|NCT00753272|10938588|FG001|Overall Study|Other|1088
6913022|NCT00753415|10938625|FG000|Part A|Disease progression|1
6913023|NCT00753415|10938626|FG001|Part A|Disease progression|0
6913024|NCT00753415|10938627|FG002|Part A|Disease progression|1
6913025|NCT00753415|10938628|FG003|Part A|Disease progression|2
6913026|NCT00753415|10938629|FG004|Part A|Disease progression|0
6913027|NCT00753415|10938630|FG005|Part A|Disease progression|0
6913028|NCT00753415|10938631|FG006|Part A|Disease progression|0
6913029|NCT00753415|10938632|FG007|Part A|Disease progression|0
6913030|NCT00753415|10938633|FG008|Part A|Disease progression|0
6913031|NCT00753415|10938634|FG009|Part A|Disease progression|0
6913032|NCT00753415|10938625|FG000|Part A|Withdrawal by Subject|0
6913033|NCT00753415|10938626|FG001|Part A|Withdrawal by Subject|0
6913034|NCT00753415|10938627|FG002|Part A|Withdrawal by Subject|1
6913035|NCT00753415|10938628|FG003|Part A|Withdrawal by Subject|0
6913036|NCT00753415|10938629|FG004|Part A|Withdrawal by Subject|0
6913037|NCT00753415|10938630|FG005|Part A|Withdrawal by Subject|0
6913038|NCT00753415|10938631|FG006|Part A|Withdrawal by Subject|0
6913039|NCT00753415|10938632|FG007|Part A|Withdrawal by Subject|0
6913040|NCT00753415|10938633|FG008|Part A|Withdrawal by Subject|0
6913041|NCT00753415|10938634|FG009|Part A|Withdrawal by Subject|0
6913042|NCT00753415|10938625|FG000|Part B|Lost to Follow-up|0
6913043|NCT00753415|10938626|FG001|Part B|Lost to Follow-up|0
6913044|NCT00753415|10938627|FG002|Part B|Lost to Follow-up|0
6913045|NCT00753415|10938628|FG003|Part B|Lost to Follow-up|0
6913046|NCT00753415|10938629|FG004|Part B|Lost to Follow-up|0
6913047|NCT00753415|10938630|FG005|Part B|Lost to Follow-up|0
6913048|NCT00753415|10938631|FG006|Part B|Lost to Follow-up|0
6913049|NCT00753415|10938632|FG007|Part B|Lost to Follow-up|1
6913050|NCT00753415|10938633|FG008|Part B|Lost to Follow-up|1
6913051|NCT00753415|10938634|FG009|Part B|Lost to Follow-up|0
6913052|NCT00753415|10938625|FG000|Part B|Disease progression|0
6913053|NCT00753415|10938626|FG001|Part B|Disease progression|0
6913054|NCT00753415|10938627|FG002|Part B|Disease progression|0
6913055|NCT00753415|10938628|FG003|Part B|Disease progression|0
6913056|NCT00753415|10938629|FG004|Part B|Disease progression|0
6913057|NCT00753415|10938630|FG005|Part B|Disease progression|0
6913058|NCT00753415|10938631|FG006|Part B|Disease progression|0
6913059|NCT00753415|10938632|FG007|Part B|Disease progression|0
6913060|NCT00753415|10938633|FG008|Part B|Disease progression|2
6913061|NCT00753415|10938634|FG009|Part B|Disease progression|1
6913062|NCT00753454|10938658|FG000|Overall Study|Adverse Event|4
6913063|NCT00753454|10938658|FG000|Overall Study|Lack of Efficacy|1
6913064|NCT00753454|10938658|FG000|Overall Study|Lost to Follow-up|3
6913065|NCT00753454|10938658|FG000|Overall Study|Withdrawal by Subject|5
6913066|NCT00753454|10938658|FG000|Overall Study|Investigator Decision|1
6913067|NCT00753506|10938664|FG000|Overall Study|Withdrawal by Subject|4
6913068|NCT00753506|10938665|FG001|Overall Study|Withdrawal by Subject|1
6913069|NCT00753506|10938664|FG000|Overall Study|Lost to Follow-up|2
6913070|NCT00753506|10938665|FG001|Overall Study|Lost to Follow-up|0
6913071|NCT00753506|10938664|FG000|Overall Study|Other reason|1
6913072|NCT00753506|10938665|FG001|Overall Study|Other reason|1
6913073|NCT00753519|10938673|FG000|Overall Study|Withdrawal by Subject|0
6913074|NCT00753519|10938674|FG001|Overall Study|Withdrawal by Subject|2
6913075|NCT00753623|10938684|FG000|Phase I (14 Days)|Withdrawal by Subject|1
6913076|NCT00753623|10938685|FG001|Phase I (14 Days)|Withdrawal by Subject|1
6913077|NCT00753623|10938684|FG000|Phase I (14 Days)|Physician Decision|1
6913078|NCT00753623|10938685|FG001|Phase I (14 Days)|Physician Decision|2
6913079|NCT00753623|10938684|FG000|Phase I (14 Days)|Adverse Event|0
6913080|NCT00753623|10938685|FG001|Phase I (14 Days)|Adverse Event|1
6913081|NCT00753623|10938684|FG000|Washout (7 Days)|Physician Decision|1
6913082|NCT00753623|10938685|FG001|Washout (7 Days)|Physician Decision|0
6913083|NCT00753623|10938684|FG000|Phase II (14 Days)|Physician Decision|0
6913084|NCT00753623|10938685|FG001|Phase II (14 Days)|Physician Decision|1
6913085|NCT00753649|10938697|FG000|Overall Study|Migrated/moved from study area|1
6913086|NCT00753649|10938698|FG001|Overall Study|Migrated/moved from study area|0
6913087|NCT00753649|10938697|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3
6913088|NCT00753649|10938698|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0
6913089|NCT00753649|10938697|FG000|Overall Study|Lost to follow-up-complete vaccination|1
6913090|NCT00753649|10938698|FG001|Overall Study|Lost to follow-up-complete vaccination|0
6913091|NCT00753649|10938697|FG000|Overall Study|Protocol Violation|2
6913092|NCT00753649|10938698|FG001|Overall Study|Protocol Violation|0
6913093|NCT00753675|10938707|FG000|Overall Study|other reason|11
6913094|NCT00753675|10938708|FG001|Overall Study|other reason|12
6913095|NCT00753675|10938709|FG002|Overall Study|other reason|13
6913096|NCT00753675|10938707|FG000|Overall Study|Death|1
6913097|NCT00753675|10938708|FG001|Overall Study|Death|2
6913098|NCT00753675|10938709|FG002|Overall Study|Death|4
6913099|NCT00753675|10938707|FG000|Overall Study|Adverse Event|11
6913100|NCT00753675|10938708|FG001|Overall Study|Adverse Event|9
6913101|NCT00753675|10938709|FG002|Overall Study|Adverse Event|4
6913102|NCT00753675|10938707|FG000|Overall Study|Objective progression of disease|35
6913103|NCT00753675|10938708|FG001|Overall Study|Objective progression of disease|35
6913104|NCT00753675|10938709|FG002|Overall Study|Objective progression of disease|35
6913105|NCT00753675|10938707|FG000|Overall Study|Withdrawal by Subject|0
6913106|NCT00753675|10938708|FG001|Overall Study|Withdrawal by Subject|1
6913107|NCT00753675|10938709|FG002|Overall Study|Withdrawal by Subject|0
6913108|NCT00753675|10938707|FG000|Overall Study|Lost to Follow-up|1
6913109|NCT00753675|10938708|FG001|Overall Study|Lost to Follow-up|0
6913110|NCT00753675|10938709|FG002|Overall Study|Lost to Follow-up|0
6913111|NCT00753688|10938719|FG000|Overall Study|Death|102
6913112|NCT00753688|10938720|FG001|Overall Study|Death|203
6913113|NCT00753688|10938719|FG000|Overall Study|Missing|4
6913114|NCT00753688|10938720|FG001|Overall Study|Missing|9
6913115|NCT00753688|10938719|FG000|Overall Study|Participant Withdrew Consent|2
6913116|NCT00753688|10938720|FG001|Overall Study|Participant Withdrew Consent|2
6913117|NCT00753688|10938719|FG000|Overall Study|Ongoing - in Follow-up|15
6913118|NCT00753688|10938720|FG001|Overall Study|Ongoing - in Follow-up|31
6913119|NCT00753688|10938719|FG000|Overall Study|Adverse Event|0
6913120|NCT00753688|10938720|FG001|Overall Study|Adverse Event|1
6913121|NCT00753714|10938728|FG000|Overall Study|Lack of Efficacy|21
6913122|NCT00753714|10938729|FG001|Overall Study|Lack of Efficacy|34
6913123|NCT00753714|10938728|FG000|Overall Study|Adverse Event|26
6913124|NCT00753714|10938729|FG001|Overall Study|Adverse Event|18
6913125|NCT00753714|10938728|FG000|Overall Study|Protocol Violation|1
6913126|NCT00753714|10938729|FG001|Overall Study|Protocol Violation|0
6913127|NCT00753714|10938728|FG000|Overall Study|Lost to Follow-up|0
6913128|NCT00753714|10938729|FG001|Overall Study|Lost to Follow-up|1
6913129|NCT00753714|10938728|FG000|Overall Study|Withdrawal by Subject|2
6913130|NCT00753714|10938729|FG001|Overall Study|Withdrawal by Subject|1
6913131|NCT00753714|10938728|FG000|Overall Study|Death|3
6913132|NCT00753714|10938729|FG001|Overall Study|Death|3
6913133|NCT00753714|10938728|FG000|Overall Study|Other|7
6913134|NCT00753714|10938729|FG001|Overall Study|Other|5
6913135|NCT00753766|10938740|FG000|Overall Study|Physician Decision|1
6913136|NCT00753766|10938741|FG001|Overall Study|Physician Decision|0
6913137|NCT00753896|10938748|FG000|Overall Study|Adverse Event|4
6913138|NCT00753896|10938748|FG000|Overall Study|Death|1
6913139|NCT00753896|10938748|FG000|Overall Study|Lost to Follow-up|2
6913140|NCT00753896|10938748|FG000|Overall Study|Protocol Violation|1
6913141|NCT00753896|10938748|FG000|Overall Study|Withdrawal by Subject|4
6913142|NCT00753896|10938748|FG000|Overall Study|Entry Criteria Not Met|4
6913143|NCT00753922|10938756|FG000|Overall Study|Lost to Follow-up|155
6913144|NCT00753922|10938757|FG001|Overall Study|Lost to Follow-up|24
6913145|NCT00753922|10938758|FG002|Overall Study|Lost to Follow-up|28
6913146|NCT00753922|10938759|FG003|Overall Study|Lost to Follow-up|5
6913147|NCT00753922|10938756|FG000|Overall Study|Withdrawal by Subject|9
6913148|NCT00753922|10938757|FG001|Overall Study|Withdrawal by Subject|11
6913149|NCT00753922|10938758|FG002|Overall Study|Withdrawal by Subject|4
6913150|NCT00753922|10938759|FG003|Overall Study|Withdrawal by Subject|2
6913151|NCT00753922|10938756|FG000|Overall Study|Patient Non-compliance|55
6913152|NCT00753922|10938757|FG001|Overall Study|Patient Non-compliance|22
6913153|NCT00753922|10938758|FG002|Overall Study|Patient Non-compliance|14
6913154|NCT00753922|10938759|FG003|Overall Study|Patient Non-compliance|11
6913155|NCT00753922|10938756|FG000|Overall Study|Patients Not Completing Visit|11
6913156|NCT00753922|10938757|FG001|Overall Study|Patients Not Completing Visit|0
6913157|NCT00753922|10938758|FG002|Overall Study|Patients Not Completing Visit|1
6913158|NCT00753922|10938759|FG003|Overall Study|Patients Not Completing Visit|0
6913159|NCT00753922|10938756|FG000|Overall Study|Death|2
6913160|NCT00753922|10938757|FG001|Overall Study|Death|23
6913161|NCT00753922|10938758|FG002|Overall Study|Death|2
6913162|NCT00753922|10938759|FG003|Overall Study|Death|1
6913163|NCT00753922|10938756|FG000|Overall Study|Discontinuation Due to Explantation|14
6913164|NCT00753922|10938757|FG001|Overall Study|Discontinuation Due to Explantation|14
6913165|NCT00753922|10938758|FG002|Overall Study|Discontinuation Due to Explantation|14
6913166|NCT00753922|10938759|FG003|Overall Study|Discontinuation Due to Explantation|4
6913167|NCT00754065|10938793|FG000|Overall Study|Never received treatment|12
6913168|NCT00754065|10938794|FG001|Overall Study|Never received treatment|2
6913169|NCT00754065|10938793|FG000|Overall Study|Adverse Event|19
6913170|NCT00754065|10938794|FG001|Overall Study|Adverse Event|25
6913171|NCT00754065|10938793|FG000|Overall Study|Lost to Follow-up|7
6913172|NCT00754065|10938794|FG001|Overall Study|Lost to Follow-up|11
6913173|NCT00754065|10938793|FG000|Overall Study|Protocol Violation|12
6913174|NCT00754065|10938794|FG001|Overall Study|Protocol Violation|10
6913175|NCT00754065|10938793|FG000|Overall Study|Withdrawal by Subject|4
6913176|NCT00754065|10938794|FG001|Overall Study|Withdrawal by Subject|5
6913177|NCT00754065|10938793|FG000|Overall Study|Pregnancy|6
6913178|NCT00754065|10938794|FG001|Overall Study|Pregnancy|0
6913179|NCT00754065|10938793|FG000|Overall Study|Reason not specified or unknown, etc.|21
6913180|NCT00754065|10938794|FG001|Overall Study|Reason not specified or unknown, etc.|27
6913181|NCT00754234|10938847|FG000|Overall Study|Withdrawal by Subject|3
6913182|NCT00754325|10938866|FG000|Initial Treatment|Continuing Active Treatment|4
6913183|NCT00754325|10938867|FG001|Initial Treatment|Continuing Active Treatment|5
6913184|NCT00754325|10938866|FG000|Initial Treatment|Adverse Event|7
6913185|NCT00754325|10938867|FG001|Initial Treatment|Adverse Event|6
6913186|NCT00754325|10938866|FG000|Initial Treatment|Withdrawal by Subject|2
6913187|NCT00754325|10938867|FG001|Initial Treatment|Withdrawal by Subject|2
6913188|NCT00754325|10938866|FG000|Initial Treatment|Physician Decision|2
6913189|NCT00754325|10938867|FG001|Initial Treatment|Physician Decision|0
6913190|NCT00754325|10938866|FG000|Initial Treatment|Sponsor Request|0
6913191|NCT00754325|10938867|FG001|Initial Treatment|Sponsor Request|1
6913192|NCT00754325|10938866|FG000|Initial Treatment|Disease Progression|35
6913193|NCT00754325|10938867|FG001|Initial Treatment|Disease Progression|35
6913194|NCT00754338|10938878|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
6913195|NCT00754338|10938879|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
6913196|NCT00754338|10938880|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
6913197|NCT00754338|10938881|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
6913198|NCT00754338|10938878|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
6913199|NCT00754338|10938879|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
6913200|NCT00754338|10938880|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
6913201|NCT00754338|10938881|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
6913202|NCT00754390|10938904|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3
6913203|NCT00754390|10938904|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2
6913204|NCT00754390|10938904|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1
6913205|NCT00754390|10938904|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1
6913206|NCT00754442|10938913|FG000|Overall Study|Withdrawal by Subject|5
6913207|NCT00754442|10938914|FG001|Overall Study|Withdrawal by Subject|3
6913208|NCT00754559|10938955|FG000|Overall Study|Adverse Event|15
6913209|NCT00754559|10938955|FG000|Overall Study|Protocol Violation|11
6913210|NCT00754559|10938955|FG000|Overall Study|Lack of Efficacy|10
6913211|NCT00754559|10938955|FG000|Overall Study|Lost to Follow-up|2
6913212|NCT00754559|10938955|FG000|Overall Study|Administrative reason|1
6913213|NCT00754559|10938955|FG000|Overall Study|Other|5
6913214|NCT00754559|10938955|FG000|Overall Study|Withdrawal by Subject|3
6913215|NCT00754572|10938962|FG000|Overall Study|Adverse Event|19
6913216|NCT00754572|10938962|FG000|Overall Study|Other|39
6913217|NCT00754572|10938962|FG000|Overall Study|Protocol Violation|3
6913218|NCT00754572|10938962|FG000|Overall Study|Withdrawal by Subject|3
6913219|NCT00754572|10938962|FG000|Overall Study|Lack of Efficacy|2
6913220|NCT00754572|10938962|FG000|Overall Study|Death|1
6913221|NCT00754572|10938962|FG000|Overall Study|Administrative Reason|3
6913222|NCT00754572|10938962|FG000|Overall Study|Lost to Follow-up|1
6974232|NCT01185821|11026123|FG003|Overall Study|Death|0
6974233|NCT01185821|11026124|FG004|Overall Study|Death|0
6974234|NCT01185821|11026120|FG000|Overall Study|Condition no longer required study drug|0
6974235|NCT01185821|11026121|FG001|Overall Study|Condition no longer required study drug|0
6974236|NCT01185821|11026122|FG002|Overall Study|Condition no longer required study drug|0
6974237|NCT01185821|11026123|FG003|Overall Study|Condition no longer required study drug|0
6974238|NCT01185821|11026124|FG004|Overall Study|Condition no longer required study drug|1
6974239|NCT01185821|11026120|FG000|Overall Study|Adverse Event|2
6974240|NCT01185821|11026121|FG001|Overall Study|Adverse Event|3
6974241|NCT01185821|11026122|FG002|Overall Study|Adverse Event|1
6974242|NCT01185821|11026123|FG003|Overall Study|Adverse Event|2
6974243|NCT01185821|11026124|FG004|Overall Study|Adverse Event|5
6974244|NCT01185821|11026120|FG000|Overall Study|Lack of Efficacy|0
6974245|NCT01185821|11026121|FG001|Overall Study|Lack of Efficacy|0
6974246|NCT01185821|11026122|FG002|Overall Study|Lack of Efficacy|3
6974247|NCT01185821|11026123|FG003|Overall Study|Lack of Efficacy|0
6974248|NCT01185821|11026124|FG004|Overall Study|Lack of Efficacy|9
6974249|NCT01185821|11026120|FG000|Overall Study|Withdrawal by Subject|3
6974250|NCT01185821|11026121|FG001|Overall Study|Withdrawal by Subject|2
6974251|NCT01185821|11026122|FG002|Overall Study|Withdrawal by Subject|2
6974252|NCT01185821|11026123|FG003|Overall Study|Withdrawal by Subject|1
6974253|NCT01185821|11026124|FG004|Overall Study|Withdrawal by Subject|3
6974254|NCT01185821|11026120|FG000|Overall Study|Lost to Follow-up|1
6974255|NCT01185821|11026121|FG001|Overall Study|Lost to Follow-up|1
6974256|NCT01185821|11026122|FG002|Overall Study|Lost to Follow-up|2
6974257|NCT01185821|11026123|FG003|Overall Study|Lost to Follow-up|1
6974258|NCT01185821|11026124|FG004|Overall Study|Lost to Follow-up|2
6974259|NCT01185821|11026120|FG000|Overall Study|Administrative problems|0
6974260|NCT01185821|11026121|FG001|Overall Study|Administrative problems|0
6974261|NCT01185821|11026122|FG002|Overall Study|Administrative problems|1
6974262|NCT01185821|11026123|FG003|Overall Study|Administrative problems|1
6974263|NCT01185821|11026124|FG004|Overall Study|Administrative problems|2
6974264|NCT01185834|11026138|FG000|Overall Study|Lost to Follow-up|2
6974265|NCT01185834|11026138|FG000|Overall Study|Discomfort|4
6974266|NCT01185834|11026138|FG000|Overall Study|Biomicroscopy|4
6974267|NCT01185834|11026138|FG000|Overall Study|Time/Job Conflict|2
6974268|NCT01185834|11026138|FG000|Overall Study|Early exit - Site error|2
6979069|NCT01215955|11032821|FG003|Overall Study|Entry Criteria Not Met|7
6979070|NCT01215955|11032818|FG000|Overall Study|Lack of Efficacy|1
7142992|NCT03022981|11299254|FG001|Overall Study|Non-Compliance With Study Drug|0
7142993|NCT03022981|11299255|FG002|Overall Study|Non-Compliance With Study Drug|2
7142994|NCT03022981|11299253|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0
7142995|NCT03022981|11299254|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0
7142996|NCT03022981|11299255|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1
7142997|NCT03023137|11299275|FG000|Overall Study|Multiple pregnancy|2
6896994|NCT00636168|10915635|FG000|Treated With Study Drug|Death|3
6896995|NCT00636168|10915636|FG001|Treated With Study Drug|Death|0
6896996|NCT00636168|10915635|FG000|Treated With Study Drug|Pregnancy|1
6896997|NCT00636168|10915636|FG001|Treated With Study Drug|Pregnancy|0
6896998|NCT00636168|10915635|FG000|Treated With Study Drug|No longer meets study criteria|1
6896999|NCT00636168|10915636|FG001|Treated With Study Drug|No longer meets study criteria|0
6897000|NCT00636168|10915635|FG000|Treated With Study Drug|Other reason|1
6897001|NCT00636168|10915636|FG001|Treated With Study Drug|Other reason|3
6897002|NCT00636168|10915635|FG000|Long Term Follow-Up|Lost to Follow-up|3
6897003|NCT00636168|10915636|FG001|Long Term Follow-Up|Lost to Follow-up|3
6897004|NCT00636168|10915635|FG000|Long Term Follow-Up|Participant withdrew consent|0
6897005|NCT00636168|10915636|FG001|Long Term Follow-Up|Participant withdrew consent|2
6897006|NCT00636168|10915635|FG000|Long Term Follow-Up|Death|8
6897007|NCT00636168|10915636|FG001|Long Term Follow-Up|Death|9
6897008|NCT00636181|10915645|FG000|Overall Study|Withdrawal by Subject|8
6897009|NCT00636181|10915646|FG001|Overall Study|Withdrawal by Subject|6
6897010|NCT00636181|10915647|FG002|Overall Study|Withdrawal by Subject|10
6897011|NCT00636194|10915657|FG000|Overall Study|Study related symptoms and complaints|1
6897012|NCT00636194|10915658|FG001|Overall Study|Study related symptoms and complaints|0
6897013|NCT00636194|10915657|FG000|Overall Study|Protocol Violation|2
6897014|NCT00636194|10915658|FG001|Overall Study|Protocol Violation|0
6897015|NCT00636207|10915667|FG000|Overall Study|Adverse Event|1
6897016|NCT00636207|10915668|FG001|Overall Study|Adverse Event|0
6897017|NCT00636207|10915669|FG002|Overall Study|Adverse Event|0
6897018|NCT00636207|10915670|FG003|Overall Study|Adverse Event|0
6897019|NCT00636207|10915671|FG004|Overall Study|Adverse Event|0
6913223|NCT00754624|10938966|FG000|Overall Study|Adverse Event|16
6913224|NCT00754624|10938966|FG000|Overall Study|Death|1
6913225|NCT00754624|10938966|FG000|Overall Study|Physician Decision|8
6913226|NCT00754624|10938966|FG000|Overall Study|Protocol Violation|1
6913227|NCT00754624|10938966|FG000|Overall Study|Withdrawal by Subject|28
7142998|NCT03023137|11299276|FG001|Overall Study|Multiple pregnancy|4
7142999|NCT03023137|11299275|FG000|Overall Study|Lost to Follow-up|1
7143000|NCT03023137|11299276|FG001|Overall Study|Lost to Follow-up|1
7143001|NCT03023137|11299275|FG000|Overall Study|Protocol Violation|0
6913228|NCT00754624|10938966|FG000|Overall Study|Various|12
6913229|NCT00754624|10938966|FG000|Overall Study|Lost to Follow-up|3
6913230|NCT00754650|10938970|FG000|Overall Study|Disease Progression|2
6913231|NCT00754741|10938977|FG000|Overall Study|Died or disenrolled|57
6913232|NCT00754741|10938978|FG001|Overall Study|Died or disenrolled|69
6913233|NCT00754741|10938979|FG002|Overall Study|Died or disenrolled|54
6913234|NCT00754936|10939009|FG000|Overall Study|Lost to Follow-up|3
6913235|NCT00754936|10939009|FG000|Overall Study|Physician Decision|1
6913236|NCT00754936|10939009|FG000|Overall Study|Withdrawal by Subject|2
6913237|NCT00754936|10939009|FG000|Overall Study|Side Effects|3
6913238|NCT00754936|10939009|FG000|Overall Study|Inter-current medical events|3
6913239|NCT00755079|10939024|FG000|Overall Study|Lost to Follow-up|1
6913240|NCT00755079|10939025|FG001|Overall Study|Lost to Follow-up|3
6913241|NCT00755079|10939024|FG000|Overall Study|Adverse Event|0
6913242|NCT00755079|10939025|FG001|Overall Study|Adverse Event|1
6913243|NCT00755079|10939024|FG000|Overall Study|Withdrawal by Subject|0
6913244|NCT00755079|10939025|FG001|Overall Study|Withdrawal by Subject|2
6913245|NCT00755105|10939034|FG000|Overall Study|Withdrawal by Subject|9
6913246|NCT00755105|10939035|FG001|Overall Study|Withdrawal by Subject|11
6913247|NCT00755105|10939036|FG002|Overall Study|Withdrawal by Subject|4
6913248|NCT00755183|10939055|FG000|Overall Study|Adverse Event|5
6913249|NCT00755183|10939056|FG001|Overall Study|Adverse Event|2
6913250|NCT00755183|10939055|FG000|Overall Study|Protocol Violation|0
6913251|NCT00755183|10939056|FG001|Overall Study|Protocol Violation|1
6913252|NCT00755183|10939055|FG000|Overall Study|Withdrawal by Subject|0
6913253|NCT00755183|10939056|FG001|Overall Study|Withdrawal by Subject|2
6913254|NCT00755183|10939055|FG000|Overall Study|Administrative|2
6913255|NCT00755183|10939056|FG001|Overall Study|Administrative|1
6913256|NCT00755196|10939064|FG000|Overall Study|Lost to Follow-up|1
6913257|NCT00755196|10939064|FG000|Overall Study|Lack of Efficiency|1
6913258|NCT00755222|10939071|FG000|Overall Study|Withdrawal by Subject|4
6913259|NCT00755222|10939072|FG001|Overall Study|Withdrawal by Subject|2
6913260|NCT00755222|10939071|FG000|Overall Study|Adverse Event|2
6913261|NCT00755222|10939072|FG001|Overall Study|Adverse Event|0
6913262|NCT00755222|10939071|FG000|Overall Study|Protocol Violation|2
6913263|NCT00755222|10939072|FG001|Overall Study|Protocol Violation|0
6913264|NCT00755326|10939098|FG000|Overall Study|Lost to Follow-up|2
6913265|NCT00755326|10939099|FG001|Overall Study|Lost to Follow-up|3
6913266|NCT00755417|10939109|FG000|Overall Study|Adverse Event|28
6913267|NCT00755417|10939110|FG001|Overall Study|Adverse Event|20
6913268|NCT00755417|10939111|FG002|Overall Study|Adverse Event|7
6913269|NCT00755417|10939109|FG000|Overall Study|Lack of Efficacy|8
6913270|NCT00755417|10939110|FG001|Overall Study|Lack of Efficacy|4
6913271|NCT00755417|10939111|FG002|Overall Study|Lack of Efficacy|9
6913272|NCT00755417|10939109|FG000|Overall Study|Protocol Violation|2
6913273|NCT00755417|10939110|FG001|Overall Study|Protocol Violation|1
6913274|NCT00755417|10939111|FG002|Overall Study|Protocol Violation|1
6913275|NCT00755417|10939109|FG000|Overall Study|Lost to Follow-up|3
6913276|NCT00755417|10939110|FG001|Overall Study|Lost to Follow-up|0
6913277|NCT00755417|10939111|FG002|Overall Study|Lost to Follow-up|1
6913278|NCT00755417|10939109|FG000|Overall Study|Withdrawal by Subject|12
6913279|NCT00755417|10939110|FG001|Overall Study|Withdrawal by Subject|12
6913280|NCT00755417|10939111|FG002|Overall Study|Withdrawal by Subject|12
6913281|NCT00755417|10939109|FG000|Overall Study|Not specified or missing data|9
6913282|NCT00755417|10939110|FG001|Overall Study|Not specified or missing data|18
6913283|NCT00755417|10939111|FG002|Overall Study|Not specified or missing data|12
6913284|NCT00755716|10939122|FG000|Overall Study|Adverse Event|1
6913285|NCT00755716|10939123|FG001|Overall Study|Adverse Event|4
6913286|NCT00755716|10939124|FG002|Overall Study|Adverse Event|1
6913287|NCT00755716|10939122|FG000|Overall Study|Lack of Efficacy|2
6913288|NCT00755716|10939123|FG001|Overall Study|Lack of Efficacy|0
6913289|NCT00755716|10939124|FG002|Overall Study|Lack of Efficacy|0
6913290|NCT00755716|10939122|FG000|Overall Study|Lost to Follow-up|5
6913291|NCT00755716|10939123|FG001|Overall Study|Lost to Follow-up|3
6913292|NCT00755716|10939124|FG002|Overall Study|Lost to Follow-up|1
6913293|NCT00755716|10939122|FG000|Overall Study|work schedule issues|0
6913294|NCT00755716|10939123|FG001|Overall Study|work schedule issues|1
7143002|NCT03023137|11299276|FG001|Overall Study|Protocol Violation|4
6913295|NCT00755716|10939124|FG002|Overall Study|work schedule issues|1
6913296|NCT00755807|10939147|FG000|Acute Phase|Adverse Event|16
6913297|NCT00755807|10939148|FG001|Acute Phase|Adverse Event|5
6913298|NCT00755807|10939147|FG000|Acute Phase|Protocol Violation|1
6913299|NCT00755807|10939148|FG001|Acute Phase|Protocol Violation|3
6913300|NCT00755807|10939147|FG000|Acute Phase|Withdrawal by Subject|1
6913301|NCT00755807|10939148|FG001|Acute Phase|Withdrawal by Subject|2
6913302|NCT00755807|10939147|FG000|Acute Phase|Lack of Efficacy|0
6913303|NCT00755807|10939148|FG001|Acute Phase|Lack of Efficacy|1
6913304|NCT00755807|10939147|FG000|Acute Phase|Physician Decision|0
6913305|NCT00755807|10939148|FG001|Acute Phase|Physician Decision|1
6913306|NCT00755807|10939147|FG000|Open-label Extension Phase|Adverse Event|7
6913307|NCT00755807|10939148|FG001|Open-label Extension Phase|Adverse Event|7
6913308|NCT00755807|10939147|FG000|Open-label Extension Phase|Protocol Violation|5
6913309|NCT00755807|10939148|FG001|Open-label Extension Phase|Protocol Violation|2
6913310|NCT00755807|10939147|FG000|Open-label Extension Phase|Lack of Efficacy|3
6913311|NCT00755807|10939148|FG001|Open-label Extension Phase|Lack of Efficacy|3
6913312|NCT00755807|10939147|FG000|Open-label Extension Phase|Withdrawal by Subject|1
6913313|NCT00755807|10939148|FG001|Open-label Extension Phase|Withdrawal by Subject|3
6913314|NCT00755807|10939147|FG000|Open-label Extension Phase|Lost to Follow-up|2
6913315|NCT00755807|10939148|FG001|Open-label Extension Phase|Lost to Follow-up|0
6913316|NCT00755807|10939147|FG000|Open-label Extension Phase|Sponsor Decision|0
6913317|NCT00755807|10939148|FG001|Open-label Extension Phase|Sponsor Decision|1
6913318|NCT00755846|10939164|FG000|Overall Study|Adverse Event|0
6913319|NCT00755846|10939165|FG001|Overall Study|Adverse Event|0
6913320|NCT00755846|10939166|FG002|Overall Study|Adverse Event|0
6913321|NCT00755846|10939167|FG003|Overall Study|Adverse Event|1
6913322|NCT00755846|10939168|FG004|Overall Study|Adverse Event|3
6913323|NCT00755846|10939169|FG005|Overall Study|Adverse Event|2
6913324|NCT00755846|10939164|FG000|Overall Study|Protocol Violation|1
6913325|NCT00755846|10939165|FG001|Overall Study|Protocol Violation|1
6913326|NCT00755846|10939166|FG002|Overall Study|Protocol Violation|1
6913327|NCT00755846|10939167|FG003|Overall Study|Protocol Violation|1
6913328|NCT00755846|10939168|FG004|Overall Study|Protocol Violation|1
6913329|NCT00755846|10939169|FG005|Overall Study|Protocol Violation|1
6913330|NCT00755846|10939164|FG000|Overall Study|Lost to Follow-up|0
6913331|NCT00755846|10939165|FG001|Overall Study|Lost to Follow-up|2
6913332|NCT00755846|10939166|FG002|Overall Study|Lost to Follow-up|1
6913333|NCT00755846|10939167|FG003|Overall Study|Lost to Follow-up|0
6913334|NCT00755846|10939168|FG004|Overall Study|Lost to Follow-up|4
6913335|NCT00755846|10939169|FG005|Overall Study|Lost to Follow-up|2
6913336|NCT00755846|10939164|FG000|Overall Study|Withdrawal by Subject|2
6913337|NCT00755846|10939165|FG001|Overall Study|Withdrawal by Subject|3
6913338|NCT00755846|10939166|FG002|Overall Study|Withdrawal by Subject|5
6913339|NCT00755846|10939167|FG003|Overall Study|Withdrawal by Subject|2
6913340|NCT00755846|10939168|FG004|Overall Study|Withdrawal by Subject|0
6913341|NCT00755846|10939169|FG005|Overall Study|Withdrawal by Subject|1
6913342|NCT00755846|10939164|FG000|Overall Study|Hyperglycemic Rescue|21
6913343|NCT00755846|10939165|FG001|Overall Study|Hyperglycemic Rescue|7
6913344|NCT00755846|10939166|FG002|Overall Study|Hyperglycemic Rescue|5
6913345|NCT00755846|10939167|FG003|Overall Study|Hyperglycemic Rescue|8
6913346|NCT00755846|10939168|FG004|Overall Study|Hyperglycemic Rescue|8
6913347|NCT00755846|10939169|FG005|Overall Study|Hyperglycemic Rescue|7
6913348|NCT00755846|10939164|FG000|Overall Study|Physician Decision|1
6913349|NCT00755846|10939165|FG001|Overall Study|Physician Decision|3
6913350|NCT00755846|10939166|FG002|Overall Study|Physician Decision|0
6913351|NCT00755846|10939167|FG003|Overall Study|Physician Decision|1
6913352|NCT00755846|10939168|FG004|Overall Study|Physician Decision|0
6913353|NCT00755846|10939169|FG005|Overall Study|Physician Decision|1
6913354|NCT00755846|10939164|FG000|Overall Study|Administrative Error|0
6913355|NCT00755846|10939165|FG001|Overall Study|Administrative Error|1
6913356|NCT00755846|10939166|FG002|Overall Study|Administrative Error|0
6913357|NCT00755846|10939167|FG003|Overall Study|Administrative Error|0
6913358|NCT00755846|10939168|FG004|Overall Study|Administrative Error|0
6913359|NCT00755846|10939169|FG005|Overall Study|Administrative Error|0
6913360|NCT00755846|10939164|FG000|Overall Study|Participant Non-compliance|0
6913361|NCT00755846|10939165|FG001|Overall Study|Participant Non-compliance|0
6913362|NCT00755846|10939166|FG002|Overall Study|Participant Non-compliance|0
6913363|NCT00755846|10939167|FG003|Overall Study|Participant Non-compliance|0
6913364|NCT00755846|10939168|FG004|Overall Study|Participant Non-compliance|1
6913365|NCT00755846|10939169|FG005|Overall Study|Participant Non-compliance|0
6913366|NCT00755937|10939192|FG000|Recruitment|Unknown if infliximab received|164
6913367|NCT00755937|10939192|FG000|Observational Follow-up|Lost to Follow-up|148
6913368|NCT00756002|10939198|FG000|Double-Blind Treatment Period|Lack of Efficacy|1
6913369|NCT00756002|10939199|FG001|Double-Blind Treatment Period|Lack of Efficacy|1
6913370|NCT00756002|10939198|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
6913371|NCT00756002|10939199|FG001|Double-Blind Treatment Period|Lost to Follow-up|1
6913372|NCT00756002|10939198|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6
6913373|NCT00756002|10939199|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6
6913374|NCT00756002|10939198|FG000|Double-Blind Treatment Period|Protocol Violation|6
6913375|NCT00756002|10939199|FG001|Double-Blind Treatment Period|Protocol Violation|5
6913376|NCT00756002|10939198|FG000|Double-Blind Treatment Period|Other|2
6913377|NCT00756002|10939199|FG001|Double-Blind Treatment Period|Other|2
6913378|NCT00756275|10939237|FG000|Overall Study|Lost to Follow-up|25
6913379|NCT00756275|10939238|FG001|Overall Study|Lost to Follow-up|21
6913380|NCT00756275|10939237|FG000|Overall Study|Withdrawal by Subject|4
6913381|NCT00756275|10939238|FG001|Overall Study|Withdrawal by Subject|7
6913382|NCT00756314|10939246|FG000|Overall Study|Lost to Follow-up|2
6913383|NCT00756314|10939247|FG001|Overall Study|Lost to Follow-up|59
6913384|NCT00756444|10939255|FG000|Overall Study|Adverse Event|1
6913385|NCT00756444|10939256|FG001|Overall Study|Adverse Event|1
6913386|NCT00756444|10939255|FG000|Overall Study|Withdrawal by Subject|6
6913387|NCT00756444|10939256|FG001|Overall Study|Withdrawal by Subject|8
6913388|NCT00756444|10939255|FG000|Overall Study|Lost to Follow-up|0
6913389|NCT00756444|10939256|FG001|Overall Study|Lost to Follow-up|1
6913390|NCT00756444|10939255|FG000|Overall Study|Death|5
6913391|NCT00756444|10939256|FG001|Overall Study|Death|4
6913392|NCT00756444|10939255|FG000|Overall Study|Disease Progression|2
6913393|NCT00756444|10939256|FG001|Overall Study|Disease Progression|7
6913394|NCT00756444|10939255|FG000|Overall Study|Ineligibility Determined|1
6913395|NCT00756444|10939256|FG001|Overall Study|Ineligibility Determined|0
6913396|NCT00756457|10939265|FG000|Overall Study|Lost to Follow-up|1
6913397|NCT00756457|10939266|FG001|Overall Study|Lost to Follow-up|2
6913398|NCT00756470|10939288|FG000|Overall Study|Withdrawal by Subject|1
6913399|NCT00756470|10939288|FG000|Overall Study|Adverse Event|4
6913400|NCT00756652|10939335|FG000|Original Phase|Withdrawal by Subject|864
6913401|NCT00756652|10939336|FG001|Original Phase|Withdrawal by Subject|23
6913402|NCT00756652|10939335|FG000|Original Phase|Lost to Follow-up|601
6913403|NCT00756652|10939336|FG001|Original Phase|Lost to Follow-up|0
6913404|NCT00756652|10939335|FG000|Original Phase|Other Discontinuation|797
6913405|NCT00756652|10939336|FG001|Original Phase|Other Discontinuation|5
6913406|NCT00756652|10939335|FG000|Original Phase|Participant Noncompliance|18622
6913407|NCT00756652|10939336|FG001|Original Phase|Participant Noncompliance|424
6913408|NCT00756652|10939335|FG000|Original Phase|Unknown Discontinuation Reason|2
6913409|NCT00756652|10939336|FG001|Original Phase|Unknown Discontinuation Reason|0
6913410|NCT00756652|10939335|FG000|Original Phase|Participants without data|3259
6913411|NCT00756652|10939336|FG001|Original Phase|Participants without data|466
6913412|NCT00756652|10939335|FG000|Original Phase|Death|168
6913413|NCT00756652|10939336|FG001|Original Phase|Death|1
6913414|NCT00756652|10939335|FG000|Original Phase|Not due for F/U at Phase One closure|11076
6913415|NCT00756652|10939336|FG001|Original Phase|Not due for F/U at Phase One closure|2
6913416|NCT00756652|10939335|FG000|Re-Op Phase|Withdrawal by Subject|62
6913417|NCT00756652|10939336|FG001|Re-Op Phase|Withdrawal by Subject|0
6913418|NCT00756652|10939335|FG000|Re-Op Phase|Death|6
6913419|NCT00756652|10939336|FG001|Re-Op Phase|Death|0
6913420|NCT00756652|10939335|FG000|Re-Op Phase|Lost to Follow-up|340
6913421|NCT00756652|10939336|FG001|Re-Op Phase|Lost to Follow-up|0
6913422|NCT00756652|10939335|FG000|Re-Op Phase|Site Closed|2454
6913423|NCT00756652|10939336|FG001|Re-Op Phase|Site Closed|0
6913424|NCT00756652|10939335|FG000|Re-Op Phase|Withdrawn after explant|14
6913425|NCT00756652|10939336|FG001|Re-Op Phase|Withdrawn after explant|0
6913426|NCT00756717|10939345|FG000|Overall Study|Withdrawal by Subject|2
6913427|NCT00756730|10939351|FG000|Overall Study|discontinued due to rash prior to week 4|0
6913428|NCT00756730|10939352|FG001|Overall Study|discontinued due to rash prior to week 4|1
6913429|NCT00756730|10939351|FG000|Overall Study|persistent low-level viremmia|0
6913430|NCT00756730|10939352|FG001|Overall Study|persistent low-level viremmia|1
6913431|NCT00756886|10939360|FG000|Overall Study|Lost to Follow-up|1
6913432|NCT00756886|10939361|FG001|Overall Study|Lost to Follow-up|0
6913433|NCT00756886|10939360|FG000|Overall Study|Adverse Event|0
6913434|NCT00756886|10939361|FG001|Overall Study|Adverse Event|3
6913435|NCT00756886|10939360|FG000|Overall Study|Lack of Efficacy|1
6913436|NCT00756886|10939361|FG001|Overall Study|Lack of Efficacy|0
6913437|NCT00756886|10939360|FG000|Overall Study|Ineligible|9
6913438|NCT00756886|10939361|FG001|Overall Study|Ineligible|4
6913439|NCT00757003|10939385|FG000|Overall Study|Death|33
6913440|NCT00757003|10939385|FG000|Overall Study|Lost to Follow-up|9
6913441|NCT00757003|10939385|FG000|Overall Study|Withdrawal by Subject|4
6913442|NCT00757003|10939385|FG000|Overall Study|Surgically explanted|2
6913443|NCT00757003|10939385|FG000|Overall Study|Not implanted|1
6913444|NCT00757172|10939390|FG000|Overall Study|Withdrawal by Subject|4
6913445|NCT00757172|10939390|FG000|Overall Study|Physician Decision|3
6913446|NCT00757172|10939390|FG000|Overall Study|Progression|4
6913447|NCT00757237|10939396|FG000|Overall Study|Lost to Follow-up|0
6913448|NCT00757237|10939397|FG001|Overall Study|Lost to Follow-up|1
6913449|NCT00757237|10939396|FG000|Overall Study|Protocol Violation|0
6913450|NCT00757237|10939397|FG001|Overall Study|Protocol Violation|2
6913451|NCT00757237|10939396|FG000|Overall Study|Physician Decision|2
6913452|NCT00757237|10939397|FG001|Overall Study|Physician Decision|3
6913453|NCT00757237|10939396|FG000|Overall Study|Withdrawal by Subject|8
6913454|NCT00757237|10939397|FG001|Overall Study|Withdrawal by Subject|12
6913455|NCT00757237|10939396|FG000|Overall Study|Safety or Tolerability|3
6913456|NCT00757237|10939397|FG001|Overall Study|Safety or Tolerability|5
6913457|NCT00757237|10939396|FG000|Overall Study|Other|0
6913458|NCT00757237|10939397|FG001|Overall Study|Other|2
6913459|NCT00757588|10939411|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3
6913460|NCT00757588|10939412|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2
6913461|NCT00757588|10939411|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6
6913462|NCT00757588|10939412|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3
6913463|NCT00757588|10939411|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13
6913464|NCT00757588|10939412|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5
6913465|NCT00757588|10939411|FG000|Period 1: Short-term (24-week) Phase|Death|1
6913466|NCT00757588|10939412|FG001|Period 1: Short-term (24-week) Phase|Death|0
6913467|NCT00757588|10939411|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3
6913468|NCT00757588|10939412|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5
6913469|NCT00757588|10939411|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5
6913470|NCT00757588|10939412|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1
6913471|NCT00757588|10939411|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5
6913472|NCT00757588|10939412|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0
6913473|NCT00757588|10939411|FG000|Period 1: Short-term (24-week) Phase|Other|0
6913474|NCT00757588|10939412|FG001|Period 1: Short-term (24-week) Phase|Other|1
6913475|NCT00757588|10939411|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1
6913476|NCT00757588|10939412|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0
6913477|NCT00757588|10939411|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4
6913478|NCT00757588|10939412|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0
6913479|NCT00757588|10939411|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4
6913480|NCT00757588|10939412|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2
6913481|NCT00757588|10939411|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
6913482|NCT00757588|10939412|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
6913483|NCT00757588|10939411|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5
6913484|NCT00757588|10939412|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2
6913485|NCT00757588|10939411|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1
6913486|NCT00757588|10939412|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0
6913487|NCT00757588|10939411|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5
6913488|NCT00757588|10939412|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4
6913489|NCT00757588|10939411|FG000|Period 2: Long-term (52-week) Phase|Other|1
6913490|NCT00757588|10939412|FG001|Period 2: Long-term (52-week) Phase|Other|0
6913491|NCT00757705|10939472|FG000|Overall Study|Adverse Event|19
6913492|NCT00757705|10939472|FG000|Overall Study|Lost to Follow-up|16
6913493|NCT00757705|10939472|FG000|Overall Study|Withdrawal by Subject|25
6913494|NCT00757705|10939472|FG000|Overall Study|Insufficient Response|26
6913495|NCT00757705|10939472|FG000|Overall Study|Ineligible to continue|8
6913496|NCT00757705|10939472|FG000|Overall Study|Non-compliant|9
6913497|NCT00757705|10939472|FG000|Overall Study|Other|18
6913498|NCT00757783|10939478|FG000|Overall Study|Adverse Event|0
6913499|NCT00757783|10939479|FG001|Overall Study|Adverse Event|2
6913500|NCT00757783|10939478|FG000|Overall Study|Lost to Follow-up|1
6913501|NCT00757783|10939479|FG001|Overall Study|Lost to Follow-up|1
6913502|NCT00757783|10939478|FG000|Overall Study|Protocol Violation|1
6913503|NCT00757783|10939479|FG001|Overall Study|Protocol Violation|0
6913504|NCT00757783|10939478|FG000|Overall Study|Withdrawal by Subject|2
6913505|NCT00757783|10939479|FG001|Overall Study|Withdrawal by Subject|1
6913506|NCT00757783|10939478|FG000|Overall Study|Other|1
6913507|NCT00757783|10939479|FG001|Overall Study|Other|2
6913508|NCT00757848|10939499|FG000|Overall Study|Voluntary discontinuation|1
6913509|NCT00757848|10939500|FG001|Overall Study|Voluntary discontinuation|0
6913510|NCT00757848|10939499|FG000|Overall Study|Adverse Event|1
6913511|NCT00757848|10939500|FG001|Overall Study|Adverse Event|2
6913512|NCT00757848|10939499|FG000|Overall Study|Incorrect enrolment|1
6913513|NCT00757848|10939500|FG001|Overall Study|Incorrect enrolment|0
6913514|NCT00758043|10939510|FG000|Overall Study|Adverse Event|1
6913515|NCT00758043|10939511|FG001|Overall Study|Adverse Event|20
6913516|NCT00758043|10939512|FG002|Overall Study|Adverse Event|12
6913517|NCT00758043|10939513|FG003|Overall Study|Adverse Event|62
6913518|NCT00758043|10939510|FG000|Overall Study|Lack of Efficacy|0
6913519|NCT00758043|10939511|FG001|Overall Study|Lack of Efficacy|6
6913520|NCT00758043|10939512|FG002|Overall Study|Lack of Efficacy|18
6913521|NCT00758043|10939513|FG003|Overall Study|Lack of Efficacy|12
6913522|NCT00758043|10939510|FG000|Overall Study|Refused Further Treatment|0
6913523|NCT00758043|10939511|FG001|Overall Study|Refused Further Treatment|11
6913524|NCT00758043|10939512|FG002|Overall Study|Refused Further Treatment|5
6913525|NCT00758043|10939513|FG003|Overall Study|Refused Further Treatment|8
6913526|NCT00758043|10939510|FG000|Overall Study|Lost to Follow-up|0
6913527|NCT00758043|10939511|FG001|Overall Study|Lost to Follow-up|2
6913528|NCT00758043|10939512|FG002|Overall Study|Lost to Follow-up|2
6913529|NCT00758043|10939513|FG003|Overall Study|Lost to Follow-up|5
6913530|NCT00758043|10939510|FG000|Overall Study|Withdrawal by Subject|0
6913531|NCT00758043|10939511|FG001|Overall Study|Withdrawal by Subject|1
6913532|NCT00758043|10939512|FG002|Overall Study|Withdrawal by Subject|1
6913533|NCT00758043|10939513|FG003|Overall Study|Withdrawal by Subject|4
6913534|NCT00758043|10939510|FG000|Overall Study|Required Prohibited Medication|0
6913535|NCT00758043|10939511|FG001|Overall Study|Required Prohibited Medication|0
6913536|NCT00758043|10939512|FG002|Overall Study|Required Prohibited Medication|1
6913537|NCT00758043|10939513|FG003|Overall Study|Required Prohibited Medication|3
6913538|NCT00758043|10939510|FG000|Overall Study|Non-Compliant With study Drug|0
6913539|NCT00758043|10939511|FG001|Overall Study|Non-Compliant With study Drug|0
6913540|NCT00758043|10939512|FG002|Overall Study|Non-Compliant With study Drug|0
6913541|NCT00758043|10939513|FG003|Overall Study|Non-Compliant With study Drug|1
6913542|NCT00758043|10939510|FG000|Overall Study|Other Reasons|0
6913543|NCT00758043|10939511|FG001|Overall Study|Other Reasons|1
6913544|NCT00758043|10939512|FG002|Overall Study|Other Reasons|0
6913545|NCT00758043|10939513|FG003|Overall Study|Other Reasons|5
6913546|NCT00758069|10939532|FG000|Overall Study|Lack of Efficacy|0
6913547|NCT00758069|10939533|FG001|Overall Study|Lack of Efficacy|0
6913548|NCT00758069|10939534|FG002|Overall Study|Lack of Efficacy|1
6913549|NCT00758069|10939532|FG000|Overall Study|Incorrect Study Drug|1
6913550|NCT00758069|10939533|FG001|Overall Study|Incorrect Study Drug|0
6913551|NCT00758069|10939534|FG002|Overall Study|Incorrect Study Drug|0
6913552|NCT00758160|10939542|FG000|Overall Study|No Longer Requires Study Medication|4
6913553|NCT00758160|10939542|FG000|Overall Study|Administration Problems|3
6913554|NCT00758160|10939542|FG000|Overall Study|Adverse Event|15
6913555|NCT00758160|10939542|FG000|Overall Study|Lack of Efficacy|10
6913556|NCT00758160|10939542|FG000|Overall Study|Lost to Follow-up|14
6913557|NCT00758160|10939542|FG000|Overall Study|Protocol Violation|12
6913558|NCT00758160|10939542|FG000|Overall Study|Withdrawal by Subject|8
6913559|NCT00758264|10939553|FG000|Active Phase|Withdrawal by Subject|0
6913560|NCT00758264|10939554|FG001|Active Phase|Withdrawal by Subject|0
6913561|NCT00758264|10939555|FG002|Active Phase|Withdrawal by Subject|1
6913562|NCT00758264|10939553|FG000|Active Phase|Lost to Follow-up|1
6913563|NCT00758264|10939554|FG001|Active Phase|Lost to Follow-up|0
6913564|NCT00758264|10939555|FG002|Active Phase|Lost to Follow-up|0
6913565|NCT00758264|10939553|FG000|Active Phase|Other|0
6913566|NCT00758264|10939554|FG001|Active Phase|Other|0
6913567|NCT00758264|10939555|FG002|Active Phase|Other|4
6913568|NCT00758394|10939576|FG000|2nd Intervention Order|Lost to Follow-up|0
6913569|NCT00758394|10939577|FG001|2nd Intervention Order|Lost to Follow-up|1
6913570|NCT00758394|10939578|FG002|2nd Intervention Order|Lost to Follow-up|0
6913571|NCT00758394|10939579|FG003|2nd Intervention Order|Lost to Follow-up|0
6913572|NCT00758394|10939576|FG000|3rd Intervention|Lost to Follow-up|1
6913573|NCT00758394|10939577|FG001|3rd Intervention|Lost to Follow-up|0
6913574|NCT00758394|10939578|FG002|3rd Intervention|Lost to Follow-up|0
6913575|NCT00758394|10939579|FG003|3rd Intervention|Lost to Follow-up|1
6913576|NCT00758459|10939600|FG000|Overall Study|Adverse Event|3
6913577|NCT00758459|10939601|FG001|Overall Study|Adverse Event|2
6913578|NCT00758459|10939600|FG000|Overall Study|Protocol Violation|0
6913579|NCT00758459|10939601|FG001|Overall Study|Protocol Violation|1
6913580|NCT00758459|10939600|FG000|Overall Study|Withdrawal by Subject|0
6913581|NCT00758459|10939601|FG001|Overall Study|Withdrawal by Subject|1
6913582|NCT00758485|10939609|FG000|Overall Study|Lost to Follow-up|0
6913583|NCT00758485|10939610|FG001|Overall Study|Lost to Follow-up|1
6913584|NCT00758485|10939609|FG000|Overall Study|Not Treated|1
6913585|NCT00758485|10939610|FG001|Overall Study|Not Treated|2
6913586|NCT00758498|10939620|FG000|Overall Study|Adverse Event|2
6913587|NCT00758498|10939621|FG001|Overall Study|Adverse Event|2
6913588|NCT00758498|10939622|FG002|Overall Study|Adverse Event|3
6913589|NCT00758498|10939620|FG000|Overall Study|Subject legally detained out of state|1
6913590|NCT00758498|10939621|FG001|Overall Study|Subject legally detained out of state|0
7187151|NCT02561962|11387637|FG006|Overall Study|Withdrawal by Subject|2
6913591|NCT00758498|10939622|FG002|Overall Study|Subject legally detained out of state|0
6913592|NCT00758498|10939620|FG000|Overall Study|Withdrawal by Subject|0
6913593|NCT00758498|10939621|FG001|Overall Study|Withdrawal by Subject|0
6913594|NCT00758498|10939622|FG002|Overall Study|Withdrawal by Subject|1
6913595|NCT00758498|10939620|FG000|Overall Study|Noncompliance to study procedures|0
6913596|NCT00758498|10939621|FG001|Overall Study|Noncompliance to study procedures|0
6913597|NCT00758498|10939622|FG002|Overall Study|Noncompliance to study procedures|1
6913598|NCT00758524|10939636|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3
6913599|NCT00758524|10939637|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2
6913600|NCT00758524|10939638|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4
6913601|NCT00758524|10939639|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
6913602|NCT00758524|10939640|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3
6913603|NCT00758524|10939641|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5
6913604|NCT00758524|10939642|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
6913605|NCT00758524|10939643|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
6913606|NCT00758524|10939644|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
6913607|NCT00758524|10939645|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
6913608|NCT00758524|10939646|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
6913609|NCT00758524|10939647|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
6913610|NCT00758524|10939648|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
6913611|NCT00758524|10939649|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
6913612|NCT00758524|10939650|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
6913613|NCT00758524|10939651|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
6913614|NCT00758524|10939652|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
6913615|NCT00758524|10939636|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3
6913616|NCT00758524|10939637|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
6913617|NCT00758524|10939638|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2
6913618|NCT00758524|10939639|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3
6913619|NCT00758524|10939640|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1
6913620|NCT00758524|10939641|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3
6913621|NCT00758524|10939642|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
6913622|NCT00758524|10939643|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
6913623|NCT00758524|10939644|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
6913624|NCT00758524|10939645|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
6913625|NCT00758524|10939646|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
6913626|NCT00758524|10939647|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
6913627|NCT00758524|10939648|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
6913628|NCT00758524|10939649|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
6913629|NCT00758524|10939650|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
6913630|NCT00758524|10939651|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
6913631|NCT00758524|10939652|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
6913632|NCT00758524|10939636|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2
6913633|NCT00758524|10939637|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1
6913634|NCT00758524|10939638|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1
6913635|NCT00758524|10939639|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3
6913636|NCT00758524|10939640|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2
6913637|NCT00758524|10939641|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1
6913638|NCT00758524|10939642|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0
6913639|NCT00758524|10939643|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0
6913640|NCT00758524|10939644|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0
6913641|NCT00758524|10939645|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0
6913642|NCT00758524|10939646|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0
6913643|NCT00758524|10939647|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0
6913644|NCT00758524|10939648|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0
6913645|NCT00758524|10939649|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0
6913646|NCT00758524|10939650|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0
6913647|NCT00758524|10939651|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0
6913648|NCT00758524|10939652|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0
6913649|NCT00758524|10939636|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
6913650|NCT00758524|10939637|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2
6913651|NCT00758524|10939638|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1
6913652|NCT00758524|10939639|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
6913653|NCT00758524|10939640|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2
6913654|NCT00758524|10939641|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1
6913655|NCT00758524|10939642|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
6913656|NCT00758524|10939643|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
6913657|NCT00758524|10939644|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
6913658|NCT00758524|10939645|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
6913659|NCT00758524|10939646|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
6913660|NCT00758524|10939647|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
6913661|NCT00758524|10939648|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
6913662|NCT00758524|10939649|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
6913663|NCT00758524|10939650|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
6913664|NCT00758524|10939651|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
6913665|NCT00758524|10939652|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
6913666|NCT00758524|10939636|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0
6913667|NCT00758524|10939637|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0
6913668|NCT00758524|10939638|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1
6913669|NCT00758524|10939639|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1
6913670|NCT00758524|10939640|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0
6913671|NCT00758524|10939641|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0
6913672|NCT00758524|10939642|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0
6913673|NCT00758524|10939643|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0
6913674|NCT00758524|10939644|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0
6913675|NCT00758524|10939645|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0
6913676|NCT00758524|10939646|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0
6913677|NCT00758524|10939647|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0
6913678|NCT00758524|10939648|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0
6913679|NCT00758524|10939649|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0
6913680|NCT00758524|10939650|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0
6913681|NCT00758524|10939651|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0
6913682|NCT00758524|10939652|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0
6913683|NCT00758524|10939636|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
6913684|NCT00758524|10939637|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
6913685|NCT00758524|10939638|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
6913686|NCT00758524|10939639|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
6913687|NCT00758524|10939640|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1
6913688|NCT00758524|10939641|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
6913689|NCT00758524|10939642|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
6913690|NCT00758524|10939643|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
6913691|NCT00758524|10939644|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
6913692|NCT00758524|10939645|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
6913693|NCT00758524|10939646|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
6913694|NCT00758524|10939647|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
6913695|NCT00758524|10939648|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
6913696|NCT00758524|10939649|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
6913697|NCT00758524|10939650|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
6913698|NCT00758524|10939651|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
6913699|NCT00758524|10939652|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
6913700|NCT00758524|10939636|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
6913701|NCT00758524|10939637|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1
6913702|NCT00758524|10939638|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
6913703|NCT00758524|10939639|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
6913704|NCT00758524|10939640|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
6913705|NCT00758524|10939641|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
6913706|NCT00758524|10939642|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
6913707|NCT00758524|10939643|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
6913708|NCT00758524|10939644|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
6913709|NCT00758524|10939645|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
6913710|NCT00758524|10939646|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
6913711|NCT00758524|10939647|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
6913712|NCT00758524|10939648|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
6913713|NCT00758524|10939649|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
6913714|NCT00758524|10939650|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
6913715|NCT00758524|10939651|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
6913716|NCT00758524|10939652|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
6913717|NCT00758524|10939636|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0
6913718|NCT00758524|10939637|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1
6913719|NCT00758524|10939638|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0
6913720|NCT00758524|10939639|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0
6913721|NCT00758524|10939640|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0
6913722|NCT00758524|10939641|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0
6913723|NCT00758524|10939642|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0
6913724|NCT00758524|10939643|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0
6913725|NCT00758524|10939644|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0
6913726|NCT00758524|10939645|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0
6913727|NCT00758524|10939646|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0
6913728|NCT00758524|10939647|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0
6913729|NCT00758524|10939648|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0
6913730|NCT00758524|10939649|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0
6913731|NCT00758524|10939650|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0
6913732|NCT00758524|10939651|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0
6913733|NCT00758524|10939652|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0
6913734|NCT00758524|10939636|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
6913735|NCT00758524|10939637|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
6913736|NCT00758524|10939638|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
6913737|NCT00758524|10939639|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
6913738|NCT00758524|10939640|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
6913739|NCT00758524|10939641|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
6913740|NCT00758524|10939642|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
6913741|NCT00758524|10939643|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
6913742|NCT00758524|10939644|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2
6913743|NCT00758524|10939645|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
6913744|NCT00758524|10939646|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
6913745|NCT00758524|10939647|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
6913746|NCT00758524|10939648|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
6913747|NCT00758524|10939649|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
6913748|NCT00758524|10939650|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
6913749|NCT00758524|10939651|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
6913750|NCT00758524|10939652|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
6913751|NCT00758524|10939636|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
6913752|NCT00758524|10939637|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
6913753|NCT00758524|10939638|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
6913754|NCT00758524|10939639|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
6913755|NCT00758524|10939640|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
6913756|NCT00758524|10939641|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
6913757|NCT00758524|10939642|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1
6913758|NCT00758524|10939643|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
6913759|NCT00758524|10939644|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
6913760|NCT00758524|10939645|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
6913761|NCT00758524|10939646|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
6913762|NCT00758524|10939647|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
6913763|NCT00758524|10939648|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
6977141|NCT01205126|11030146|FG001|Maintenance Phase|Other|8
6913764|NCT00758524|10939649|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
6913765|NCT00758524|10939650|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
6913766|NCT00758524|10939651|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
6913767|NCT00758524|10939652|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
6913768|NCT00758589|10939707|FG000|Overall Study|Adverse Event|3
6913769|NCT00758589|10939708|FG001|Overall Study|Adverse Event|2
6913770|NCT00758589|10939709|FG002|Overall Study|Adverse Event|5
6913771|NCT00758589|10939710|FG003|Overall Study|Adverse Event|4
6913772|NCT00758589|10939707|FG000|Overall Study|Withdrawal by Subject|0
6913773|NCT00758589|10939708|FG001|Overall Study|Withdrawal by Subject|1
6913774|NCT00758589|10939709|FG002|Overall Study|Withdrawal by Subject|1
6913775|NCT00758589|10939710|FG003|Overall Study|Withdrawal by Subject|1
6913776|NCT00758589|10939707|FG000|Overall Study|Palm stopped to work|0
6913777|NCT00758589|10939708|FG001|Overall Study|Palm stopped to work|0
6913778|NCT00758589|10939709|FG002|Overall Study|Palm stopped to work|0
6913779|NCT00758589|10939710|FG003|Overall Study|Palm stopped to work|1
6913780|NCT00758602|10939722|FG000|Overall Study|Adverse Event|11
6913781|NCT00758602|10939723|FG001|Overall Study|Adverse Event|10
6913782|NCT00758602|10939722|FG000|Overall Study|Lost to Follow-up|4
6913783|NCT00758602|10939723|FG001|Overall Study|Lost to Follow-up|3
6913784|NCT00758602|10939722|FG000|Overall Study|Withdrawal by Subject|1
6913785|NCT00758602|10939723|FG001|Overall Study|Withdrawal by Subject|3
6913786|NCT00758602|10939722|FG000|Overall Study|Protocol Violation|0
6913787|NCT00758602|10939723|FG001|Overall Study|Protocol Violation|2
6913788|NCT00758602|10939722|FG000|Overall Study|Death|0
6913789|NCT00758602|10939723|FG001|Overall Study|Death|1
6913790|NCT00758602|10939722|FG000|Overall Study|Reason not specified|3
6913791|NCT00758602|10939723|FG001|Overall Study|Reason not specified|3
6913792|NCT00758680|10939740|FG000|Overall Study|Adverse Event|0
6913793|NCT00758680|10939741|FG001|Overall Study|Adverse Event|0
6913794|NCT00758680|10939742|FG002|Overall Study|Adverse Event|0
6913795|NCT00758680|10939743|FG003|Overall Study|Adverse Event|0
6913796|NCT00758680|10939744|FG004|Overall Study|Adverse Event|0
6913797|NCT00758680|10939745|FG005|Overall Study|Adverse Event|0
6913798|NCT00758680|10939746|FG006|Overall Study|Adverse Event|0
6913799|NCT00758680|10939747|FG007|Overall Study|Adverse Event|1
6913800|NCT00758680|10939748|FG008|Overall Study|Adverse Event|0
6913801|NCT00758680|10939749|FG009|Overall Study|Adverse Event|1
6913802|NCT00758680|10939740|FG000|Overall Study|Laboratory Adverse Event|0
6913803|NCT00758680|10939741|FG001|Overall Study|Laboratory Adverse Event|0
6913804|NCT00758680|10939742|FG002|Overall Study|Laboratory Adverse Event|0
6913805|NCT00758680|10939743|FG003|Overall Study|Laboratory Adverse Event|0
6913806|NCT00758680|10939744|FG004|Overall Study|Laboratory Adverse Event|0
6913807|NCT00758680|10939745|FG005|Overall Study|Laboratory Adverse Event|0
6913808|NCT00758680|10939746|FG006|Overall Study|Laboratory Adverse Event|0
6913809|NCT00758680|10939747|FG007|Overall Study|Laboratory Adverse Event|0
6913810|NCT00758680|10939748|FG008|Overall Study|Laboratory Adverse Event|1
6913811|NCT00758680|10939749|FG009|Overall Study|Laboratory Adverse Event|0
6913812|NCT00758680|10939740|FG000|Overall Study|Withdrawal by Subject|0
6913813|NCT00758680|10939741|FG001|Overall Study|Withdrawal by Subject|0
6913814|NCT00758680|10939742|FG002|Overall Study|Withdrawal by Subject|0
6913815|NCT00758680|10939743|FG003|Overall Study|Withdrawal by Subject|0
6913816|NCT00758680|10939744|FG004|Overall Study|Withdrawal by Subject|0
6913817|NCT00758680|10939745|FG005|Overall Study|Withdrawal by Subject|0
6913818|NCT00758680|10939746|FG006|Overall Study|Withdrawal by Subject|1
6913819|NCT00758680|10939747|FG007|Overall Study|Withdrawal by Subject|0
6913820|NCT00758680|10939748|FG008|Overall Study|Withdrawal by Subject|1
6913821|NCT00758680|10939749|FG009|Overall Study|Withdrawal by Subject|0
6913822|NCT00758706|10939774|FG000|Overall Study|Adverse Event|4
6913823|NCT00758706|10939775|FG001|Overall Study|Adverse Event|4
6913824|NCT00758771|10939833|FG000|Overall Study|Withdrawal by Subject|1
6913825|NCT00758771|10939834|FG001|Overall Study|Withdrawal by Subject|1
6913826|NCT00758771|10939833|FG000|Overall Study|Did not meet eligibility criteria|2
6913827|NCT00758771|10939834|FG001|Overall Study|Did not meet eligibility criteria|4
6913828|NCT00759031|10939867|FG000|First Intervention (1 Day)|Physician Decision|1
6913829|NCT00759031|10939868|FG001|First Intervention (1 Day)|Physician Decision|0
6913830|NCT00759031|10939867|FG000|First Intervention (1 Day)|Withdrawal by Subject|0
6913831|NCT00759031|10939868|FG001|First Intervention (1 Day)|Withdrawal by Subject|1
6913832|NCT00759031|10939867|FG000|First Intervention (1 Day)|Screening failure|1
6913833|NCT00759031|10939868|FG001|First Intervention (1 Day)|Screening failure|0
6913834|NCT00759109|10939880|FG000|Overall Study|Adverse Event|17
6913835|NCT00759109|10939881|FG001|Overall Study|Adverse Event|12
6913836|NCT00759109|10939880|FG000|Overall Study|Inability to comply|1
6913837|NCT00759109|10939881|FG001|Overall Study|Inability to comply|1
6913838|NCT00759109|10939880|FG000|Overall Study|Withdrawal by Subject|9
6913839|NCT00759109|10939881|FG001|Overall Study|Withdrawal by Subject|5
6913840|NCT00759109|10939880|FG000|Overall Study|Death|4
6913841|NCT00759109|10939881|FG001|Overall Study|Death|3
6913842|NCT00759109|10939880|FG000|Overall Study|Lost to Follow-up|4
6913843|NCT00759109|10939881|FG001|Overall Study|Lost to Follow-up|6
6913844|NCT00759109|10939880|FG000|Overall Study|Started new therapy|2
6913845|NCT00759109|10939881|FG001|Overall Study|Started new therapy|6
6913846|NCT00759109|10939880|FG000|Overall Study|HCV RNA negative|1
6913847|NCT00759109|10939881|FG001|Overall Study|HCV RNA negative|0
6913848|NCT00759109|10939880|FG000|Overall Study|Participant moved to a different city|0
6913849|NCT00759109|10939881|FG001|Overall Study|Participant moved to a different city|1
6913850|NCT00759109|10939880|FG000|Overall Study|Participant had a liver transplant|0
6913851|NCT00759109|10939881|FG001|Overall Study|Participant had a liver transplant|1
6913852|NCT00759109|10939880|FG000|Overall Study|Lost during study|1
6913853|NCT00759109|10939881|FG001|Overall Study|Lost during study|0
6913854|NCT00759148|10939889|FG000|Overall Study|Adverse Event|1
6913855|NCT00759148|10939890|FG001|Overall Study|Adverse Event|6
6913856|NCT00759148|10939889|FG000|Overall Study|Withdrawal by Subject|3
6913857|NCT00759148|10939890|FG001|Overall Study|Withdrawal by Subject|7
6913858|NCT00759148|10939889|FG000|Overall Study|Lost to Follow-up|3
6913859|NCT00759148|10939890|FG001|Overall Study|Lost to Follow-up|9
6913860|NCT00759148|10939889|FG000|Overall Study|Treatment Failure|6
6913861|NCT00759148|10939890|FG001|Overall Study|Treatment Failure|10
6913862|NCT00759148|10939889|FG000|Overall Study|Reason not given|1
6913863|NCT00759148|10939890|FG001|Overall Study|Reason not given|0
6913864|NCT00759174|10939905|FG000|Overall Study|Other|0
6913865|NCT00759174|10939906|FG001|Overall Study|Other|2
6913866|NCT00759356|10939946|FG000|Overall Study|Adverse Event|0
6913867|NCT00759356|10939947|FG001|Overall Study|Adverse Event|1
6913868|NCT00759356|10939946|FG000|Overall Study|Withdrawal by Subject|0
6913869|NCT00759356|10939947|FG001|Overall Study|Withdrawal by Subject|2
6913870|NCT00759356|10939946|FG000|Overall Study|Subject was unable to return|1
6913871|NCT00759356|10939947|FG001|Overall Study|Subject was unable to return|0
6913872|NCT00759395|10939955|FG000|Overall Study|Adverse Event|1
6913873|NCT00759395|10939956|FG001|Overall Study|Adverse Event|0
6913874|NCT00759395|10939955|FG000|Overall Study|Withdrawal by Subject|1
6913875|NCT00759395|10939956|FG001|Overall Study|Withdrawal by Subject|0
6913876|NCT00759395|10939955|FG000|Overall Study|Lack of Efficacy|0
6913877|NCT00759395|10939956|FG001|Overall Study|Lack of Efficacy|2
6913878|NCT00759564|10939999|FG000|Washout Period (at Least 14 Days)|Adverse Event|0
6913879|NCT00759564|10940000|FG001|Washout Period (at Least 14 Days)|Adverse Event|0
6913880|NCT00759564|10940001|FG002|Washout Period (at Least 14 Days)|Adverse Event|0
6913881|NCT00759564|10940002|FG003|Washout Period (at Least 14 Days)|Adverse Event|0
6913882|NCT00759564|10940003|FG004|Washout Period (at Least 14 Days)|Adverse Event|1
6913883|NCT00759681|10940054|FG000|Overall Study|Death|2
6913884|NCT00759681|10940055|FG001|Overall Study|Death|5
6913885|NCT00759681|10940054|FG000|Overall Study|Lost to Follow-up|8
6913886|NCT00759681|10940055|FG001|Overall Study|Lost to Follow-up|5
6913887|NCT00759759|10940068|FG000|Overall Study|didn't return for period 2|1
6913888|NCT00759759|10940069|FG001|Overall Study|didn't return for period 2|0
6913889|NCT00759759|10940068|FG000|Overall Study|Didn't receive drug in period 2|1
6913890|NCT00759759|10940069|FG001|Overall Study|Didn't receive drug in period 2|0
6913891|NCT00759759|10940068|FG000|Overall Study|Withdrawal by Subject|2
6913892|NCT00759759|10940069|FG001|Overall Study|Withdrawal by Subject|1
6974269|NCT01185964|11026145|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1
6974270|NCT01185964|11026146|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6
6974271|NCT01185964|11026147|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2
6974272|NCT01185964|11026148|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0
6974273|NCT01185964|11026145|FG000|Phase 1b and Phase 2|Other Therapy Started|0
6974274|NCT01185964|11026146|FG001|Phase 1b and Phase 2|Other Therapy Started|3
6974275|NCT01185964|11026147|FG002|Phase 1b and Phase 2|Other Therapy Started|3
6974276|NCT01185964|11026148|FG003|Phase 1b and Phase 2|Other Therapy Started|0
6974277|NCT01185964|11026145|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0
6974278|NCT01185964|11026146|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0
6974279|NCT01185964|11026147|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1
6974280|NCT01185964|11026148|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0
6974281|NCT01185964|11026145|FG000|Phase 1b and Phase 2|Adverse Event|1
6974282|NCT01185964|11026146|FG001|Phase 1b and Phase 2|Adverse Event|0
6974283|NCT01185964|11026147|FG002|Phase 1b and Phase 2|Adverse Event|2
6974284|NCT01185964|11026148|FG003|Phase 1b and Phase 2|Adverse Event|0
6974285|NCT01185964|11026145|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0
6974286|NCT01185964|11026146|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1
6974287|NCT01185964|11026147|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1
6974288|NCT01185964|11026148|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0
6974289|NCT01185964|11026145|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
6974290|NCT01185964|11026146|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
6974291|NCT01185964|11026147|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
6974292|NCT01185964|11026148|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2
6974293|NCT01185964|11026145|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
6974294|NCT01185964|11026146|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
6974295|NCT01185964|11026147|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
6974296|NCT01185964|11026148|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1
6974297|NCT01185964|11026145|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
6974298|NCT01185964|11026146|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
6977142|NCT01205126|11030145|FG000|Maintenance Phase|Lost to Follow-up|5
6913893|NCT00759785|10940086|FG000|Overall Study|Participant sample not evaluable|11
6913894|NCT00759785|10940087|FG001|Overall Study|Participant sample not evaluable|2
6913895|NCT00759785|10940086|FG000|Overall Study|Participant sample lost|0
6913896|NCT00759785|10940087|FG001|Overall Study|Participant sample lost|1
6913897|NCT00759785|10940086|FG000|Overall Study|Protocol Violation|1
6913898|NCT00759785|10940087|FG001|Overall Study|Protocol Violation|0
6913899|NCT00759785|10940086|FG000|Overall Study|Physician Decision|0
6913900|NCT00759785|10940087|FG001|Overall Study|Physician Decision|1
6913901|NCT00759785|10940086|FG000|Overall Study|Withdrawal by Subject|0
6913902|NCT00759785|10940087|FG001|Overall Study|Withdrawal by Subject|1
6913903|NCT00759863|10940108|FG000|Overall Study|Death, moved, or lost contact|20
6913904|NCT00759863|10940109|FG001|Overall Study|Death, moved, or lost contact|18
6913905|NCT00759876|10940115|FG000|Overall Study|Sponsor terminated study early|36
6913906|NCT00759902|10940121|FG000|Overall Study|Adverse Event|0
6913907|NCT00759902|10940122|FG001|Overall Study|Adverse Event|1
6913908|NCT00759915|10940130|FG000|Overall Study|Withdrawal by Subject|1
6913909|NCT00759915|10940131|FG001|Overall Study|Withdrawal by Subject|0
6913910|NCT00759915|10940130|FG000|Overall Study|Adverse Event|0
6913911|NCT00759915|10940131|FG001|Overall Study|Adverse Event|1
6913912|NCT00759941|10940139|FG000|Overall Study|Use of medication|1
6913913|NCT00759941|10940140|FG001|Overall Study|Use of medication|0
6913914|NCT00759941|10940139|FG000|Overall Study|Adverse Event|1
6913915|NCT00759941|10940140|FG001|Overall Study|Adverse Event|0
6913916|NCT00759941|10940139|FG000|Overall Study|Exited in error by site|1
6913917|NCT00759941|10940140|FG001|Overall Study|Exited in error by site|1
6913918|NCT00759954|10940148|FG000|Overall Study|Personal reason|1
6913919|NCT00759954|10940149|FG001|Overall Study|Personal reason|0
6913920|NCT00759954|10940148|FG000|Overall Study|Adverse Event|1
6913921|NCT00759954|10940149|FG001|Overall Study|Adverse Event|2
6913922|NCT00760084|10940186|FG000|Overall Study|Physician Decision|5
6913923|NCT00760084|10940186|FG000|Overall Study|Withdrawal by Subject|2
6913924|NCT00760084|10940186|FG000|Overall Study|Progressive Disease|3
6913925|NCT00760214|10940193|FG000|Overall Study|Adverse Event|8
6913926|NCT00760214|10940194|FG001|Overall Study|Adverse Event|9
6913927|NCT00760214|10940195|FG002|Overall Study|Adverse Event|12
6913928|NCT00760214|10940193|FG000|Overall Study|Protocol Violation|3
6913929|NCT00760214|10940194|FG001|Overall Study|Protocol Violation|0
6913930|NCT00760214|10940195|FG002|Overall Study|Protocol Violation|3
6913931|NCT00760214|10940193|FG000|Overall Study|Lost to Follow-up|0
6913932|NCT00760214|10940194|FG001|Overall Study|Lost to Follow-up|0
6913933|NCT00760214|10940195|FG002|Overall Study|Lost to Follow-up|1
6913934|NCT00760214|10940193|FG000|Overall Study|Withdrawal by Subject|12
6913935|NCT00760214|10940194|FG001|Overall Study|Withdrawal by Subject|14
6913936|NCT00760214|10940195|FG002|Overall Study|Withdrawal by Subject|13
6913937|NCT00760214|10940193|FG000|Overall Study|Lack of Efficacy|3
6913938|NCT00760214|10940194|FG001|Overall Study|Lack of Efficacy|2
6913939|NCT00760214|10940195|FG002|Overall Study|Lack of Efficacy|4
6913940|NCT00760214|10940193|FG000|Overall Study|Pregnancy|0
6913941|NCT00760214|10940194|FG001|Overall Study|Pregnancy|0
6913942|NCT00760214|10940195|FG002|Overall Study|Pregnancy|1
6913943|NCT00760214|10940193|FG000|Overall Study|Physician Decision|1
6913944|NCT00760214|10940194|FG001|Overall Study|Physician Decision|1
6913945|NCT00760214|10940195|FG002|Overall Study|Physician Decision|1
6913946|NCT00760214|10940193|FG000|Overall Study|Other|3
6913947|NCT00760214|10940194|FG001|Overall Study|Other|4
6913948|NCT00760214|10940195|FG002|Overall Study|Other|6
6913949|NCT00760266|10940205|FG000|Overall Study|Adverse Event|13
6913950|NCT00760266|10940206|FG001|Overall Study|Adverse Event|7
6913951|NCT00760266|10940205|FG000|Overall Study|Abnormal laboratory value(s)|1
6913952|NCT00760266|10940206|FG001|Overall Study|Abnormal laboratory value(s)|0
6913953|NCT00760266|10940205|FG000|Overall Study|Abnormal test procedure result(s)|1
6913954|NCT00760266|10940206|FG001|Overall Study|Abnormal test procedure result(s)|0
6913955|NCT00760266|10940205|FG000|Overall Study|Lack of Efficacy|2
6913956|NCT00760266|10940206|FG001|Overall Study|Lack of Efficacy|2
6913957|NCT00760266|10940205|FG000|Overall Study|Protocol deviation|2
6913958|NCT00760266|10940206|FG001|Overall Study|Protocol deviation|4
6913959|NCT00760266|10940205|FG000|Overall Study|Patient withdrew consent|3
6913960|NCT00760266|10940206|FG001|Overall Study|Patient withdrew consent|3
6913961|NCT00760266|10940205|FG000|Overall Study|Lost to Follow-up|2
6913962|NCT00760266|10940206|FG001|Overall Study|Lost to Follow-up|1
6913963|NCT00760266|10940205|FG000|Overall Study|Administrative Problems|0
6913964|NCT00760266|10940206|FG001|Overall Study|Administrative Problems|1
6913965|NCT00760383|10940214|FG000|Overall Study|moved away; withdrew; medical reasons|5
6913966|NCT00760383|10940215|FG001|Overall Study|moved away; withdrew; medical reasons|7
6913967|NCT00760474|10940230|FG000|Period 1 (P1)|Discontinued then re-entered|1
6913968|NCT00760474|10940231|FG001|Period 1 (P1)|Discontinued then re-entered|1
6913969|NCT00760474|10940230|FG000|Placebo Washout Period|Other|0
6913970|NCT00760474|10940231|FG001|Placebo Washout Period|Other|1
6913971|NCT00760474|10940230|FG000|Period 2 (P2)|Lost to Follow-up|1
6913972|NCT00760474|10940231|FG001|Period 2 (P2)|Lost to Follow-up|0
6913973|NCT00760474|10940230|FG000|Period 2 (P2)|Adverse Event|0
6913974|NCT00760474|10940231|FG001|Period 2 (P2)|Adverse Event|1
6913975|NCT00760487|10940238|FG000|Overall Study|Unilateral implantation|3
6913976|NCT00760513|10940244|FG000|Overall Study|Withdrawal by Subject|5
6913977|NCT00760513|10940245|FG001|Overall Study|Withdrawal by Subject|7
6913978|NCT00760552|10940271|FG000|Overall Study|Death|2
6913979|NCT00760552|10940272|FG001|Overall Study|Death|0
6913980|NCT00760552|10940271|FG000|Overall Study|Lost to Follow-up|11
6913981|NCT00760552|10940272|FG001|Overall Study|Lost to Follow-up|10
6913982|NCT00760617|10940303|FG000|Overall Study|Adverse Event|5
6913983|NCT00760617|10940304|FG001|Overall Study|Adverse Event|2
6913984|NCT00760617|10940305|FG002|Overall Study|Adverse Event|0
6913985|NCT00760617|10940303|FG000|Overall Study|Lost to Follow-up|0
6913986|NCT00760617|10940304|FG001|Overall Study|Lost to Follow-up|0
6913987|NCT00760617|10940305|FG002|Overall Study|Lost to Follow-up|5
6913988|NCT00760669|10940313|FG000|Overall Study|Not assessed for overall improvement|18
6913989|NCT00760669|10940313|FG000|Overall Study|Participants missing efficacy assessment|6
6913990|NCT00760669|10940313|FG000|Overall Study|Participants with overlapping cases|1
6913991|NCT00760669|10940313|FG000|Overall Study|Took drug before entering in contract|5
6913992|NCT00760747|10940319|FG000|Study Period II|Adverse Event|3
6913993|NCT00760747|10940320|FG001|Study Period II|Adverse Event|4
6913994|NCT00760747|10940319|FG000|Study Period II|Lack of Efficacy|0
6913995|NCT00760747|10940320|FG001|Study Period II|Lack of Efficacy|6
6913996|NCT00760747|10940319|FG000|Study Period II|Parent/Caregiver Decision|3
6913997|NCT00760747|10940320|FG001|Study Period II|Parent/Caregiver Decision|0
6913998|NCT00760747|10940319|FG000|Study Period II|Protocol Violation|6
6913999|NCT00760747|10940320|FG001|Study Period II|Protocol Violation|3
6914000|NCT00760747|10940319|FG000|Study Period II|Withdrawal by Subject|1
6914001|NCT00760747|10940320|FG001|Study Period II|Withdrawal by Subject|0
6914002|NCT00760747|10940319|FG000|Study Period II|No drug administered|0
6914003|NCT00760747|10940320|FG001|Study Period II|No drug administered|1
6914004|NCT00760747|10940319|FG000|Study Period III|Adverse Event|1
6914005|NCT00760747|10940320|FG001|Study Period III|Adverse Event|0
6914006|NCT00760747|10940319|FG000|Study Period III|Lack of Efficacy|1
6914007|NCT00760747|10940320|FG001|Study Period III|Lack of Efficacy|0
6914008|NCT00760747|10940319|FG000|Study Period III|Parent/Caregiver Decision|0
6914009|NCT00760747|10940320|FG001|Study Period III|Parent/Caregiver Decision|1
6914010|NCT00760747|10940319|FG000|Study Period III|Protocol Violation|1
6914011|NCT00760747|10940320|FG001|Study Period III|Protocol Violation|1
6914012|NCT00760747|10940319|FG000|Study Period III|Physician Decision|0
6914013|NCT00760747|10940320|FG001|Study Period III|Physician Decision|1
6914014|NCT00760838|10940328|FG000|Overall Study|Adverse Event|1
6914015|NCT00760838|10940329|FG001|Overall Study|Adverse Event|1
6914016|NCT00760838|10940328|FG000|Overall Study|Lack of Efficacy|1
6914017|NCT00760838|10940329|FG001|Overall Study|Lack of Efficacy|0
6914018|NCT00760838|10940328|FG000|Overall Study|Lost to Follow-up|2
6914019|NCT00760838|10940329|FG001|Overall Study|Lost to Follow-up|0
6914020|NCT00760838|10940328|FG000|Overall Study|Withdrawal by Subject|1
6914021|NCT00760838|10940329|FG001|Overall Study|Withdrawal by Subject|1
6914022|NCT00760877|10940337|FG000|Overall Study|Protocol Violation|1
6914023|NCT00760877|10940338|FG001|Overall Study|Protocol Violation|0
6914024|NCT00760877|10940337|FG000|Overall Study|Non-compliance with protocol treatment|2
6914025|NCT00760877|10940338|FG001|Overall Study|Non-compliance with protocol treatment|1
6914026|NCT00760877|10940337|FG000|Overall Study|Pregnancy|1
6914027|NCT00760877|10940338|FG001|Overall Study|Pregnancy|4
6914028|NCT00760877|10940337|FG000|Overall Study|Death|2
6914029|NCT00760877|10940338|FG001|Overall Study|Death|1
6914030|NCT00760877|10940337|FG000|Overall Study|Withdrawal by Subject|7
6914031|NCT00760877|10940338|FG001|Overall Study|Withdrawal by Subject|3
6914032|NCT00760877|10940337|FG000|Overall Study|Adverse Event|19
6914033|NCT00760877|10940338|FG001|Overall Study|Adverse Event|12
6914034|NCT00760877|10940337|FG000|Overall Study|Participant diagnosed with AML|0
6914035|NCT00760877|10940338|FG001|Overall Study|Participant diagnosed with AML|1
6914036|NCT00760877|10940337|FG000|Overall Study|Participant not eligible to cross-over|0
6914037|NCT00760877|10940338|FG001|Overall Study|Participant not eligible to cross-over|1
6914038|NCT00760877|10940337|FG000|Overall Study|Physician Decision|1
6914039|NCT00760877|10940338|FG001|Overall Study|Physician Decision|2
6914040|NCT00760877|10940337|FG000|Overall Study|Participants transferred to AMN107A2408|11
6914041|NCT00760877|10940338|FG001|Overall Study|Participants transferred to AMN107A2408|1
6914042|NCT00760877|10940337|FG000|Overall Study|Treatment failure|1
6914043|NCT00760877|10940338|FG001|Overall Study|Treatment failure|0
6914044|NCT00760929|10940349|FG000|Overall Study|Adverse Event|2
6914045|NCT00760929|10940350|FG001|Overall Study|Adverse Event|0
6914046|NCT00760929|10940351|FG002|Overall Study|Adverse Event|6
6914047|NCT00760929|10940352|FG003|Overall Study|Adverse Event|10
6914048|NCT00760929|10940349|FG000|Overall Study|Lack of Efficacy|0
6914049|NCT00760929|10940350|FG001|Overall Study|Lack of Efficacy|2
6914050|NCT00760929|10940351|FG002|Overall Study|Lack of Efficacy|1
6914051|NCT00760929|10940352|FG003|Overall Study|Lack of Efficacy|0
6914052|NCT00760929|10940349|FG000|Overall Study|Withdrawal by Subject|1
6914053|NCT00760929|10940350|FG001|Overall Study|Withdrawal by Subject|0
6914054|NCT00760929|10940351|FG002|Overall Study|Withdrawal by Subject|9
6914055|NCT00760929|10940352|FG003|Overall Study|Withdrawal by Subject|1
6914056|NCT00760929|10940349|FG000|Overall Study|Lost to Follow-up|0
6914057|NCT00760929|10940350|FG001|Overall Study|Lost to Follow-up|0
6914058|NCT00760929|10940351|FG002|Overall Study|Lost to Follow-up|1
6914059|NCT00760929|10940352|FG003|Overall Study|Lost to Follow-up|0
6914060|NCT00760929|10940349|FG000|Overall Study|Progression of Disease|21
6914061|NCT00760929|10940350|FG001|Overall Study|Progression of Disease|26
6914062|NCT00760929|10940351|FG002|Overall Study|Progression of Disease|38
6914063|NCT00760929|10940352|FG003|Overall Study|Progression of Disease|42
6914064|NCT00760929|10940349|FG000|Overall Study|Other|2
6914065|NCT00760929|10940350|FG001|Overall Study|Other|0
6914066|NCT00760929|10940351|FG002|Overall Study|Other|2
6914067|NCT00760929|10940352|FG003|Overall Study|Other|1
6914068|NCT00760929|10940349|FG000|Overall Study|Death|0
6914069|NCT00760929|10940350|FG001|Overall Study|Death|0
6914070|NCT00760929|10940351|FG002|Overall Study|Death|1
6914071|NCT00760929|10940352|FG003|Overall Study|Death|0
6914072|NCT00760929|10940349|FG000|Overall Study|Violation of Selection Criteria at Entry|0
6914073|NCT00760929|10940350|FG001|Overall Study|Violation of Selection Criteria at Entry|0
6914074|NCT00760929|10940351|FG002|Overall Study|Violation of Selection Criteria at Entry|0
6914075|NCT00760929|10940352|FG003|Overall Study|Violation of Selection Criteria at Entry|1
6914076|NCT00760994|10940364|FG000|Overall Study|Lost to Follow-up|4
6914077|NCT00760994|10940365|FG001|Overall Study|Lost to Follow-up|4
6914078|NCT00760994|10940366|FG002|Overall Study|Lost to Follow-up|3
6914079|NCT00761150|10940420|FG000|Open-label Period|Adverse Event|36
6914080|NCT00761150|10940421|FG001|Open-label Period|Adverse Event|0
6914081|NCT00761150|10940422|FG002|Open-label Period|Adverse Event|0
6914082|NCT00761150|10940420|FG000|Open-label Period|Did not meet DB randomization criteria|11
6914083|NCT00761150|10940421|FG001|Open-label Period|Did not meet DB randomization criteria|0
6914084|NCT00761150|10940422|FG002|Open-label Period|Did not meet DB randomization criteria|0
6914085|NCT00761150|10940420|FG000|Open-label Period|Lost to Follow-up|7
6914086|NCT00761150|10940421|FG001|Open-label Period|Lost to Follow-up|0
6914087|NCT00761150|10940422|FG002|Open-label Period|Lost to Follow-up|0
6914088|NCT00761150|10940420|FG000|Open-label Period|Lack of Efficacy|4
6914089|NCT00761150|10940421|FG001|Open-label Period|Lack of Efficacy|0
6914090|NCT00761150|10940422|FG002|Open-label Period|Lack of Efficacy|0
6914091|NCT00761150|10940420|FG000|Open-label Period|Withdrawal by Subject|5
6914092|NCT00761150|10940421|FG001|Open-label Period|Withdrawal by Subject|0
6914093|NCT00761150|10940422|FG002|Open-label Period|Withdrawal by Subject|0
6914094|NCT00761150|10940420|FG000|Open-label Period|Noncompliance|2
6914095|NCT00761150|10940421|FG001|Open-label Period|Noncompliance|0
6914096|NCT00761150|10940422|FG002|Open-label Period|Noncompliance|0
6914097|NCT00761150|10940420|FG000|Open-label Period|Other|5
6914098|NCT00761150|10940421|FG001|Open-label Period|Other|0
6914099|NCT00761150|10940422|FG002|Open-label Period|Other|0
6914100|NCT00761150|10940420|FG000|Double-blind Period|Lack of Efficacy|0
6914101|NCT00761150|10940421|FG001|Double-blind Period|Lack of Efficacy|2
6914102|NCT00761150|10940422|FG002|Double-blind Period|Lack of Efficacy|19
6914103|NCT00761150|10940420|FG000|Double-blind Period|Adverse Event|0
6914104|NCT00761150|10940421|FG001|Double-blind Period|Adverse Event|3
6914105|NCT00761150|10940422|FG002|Double-blind Period|Adverse Event|3
6914106|NCT00761150|10940420|FG000|Double-blind Period|Withdrawal by Subject|0
6914107|NCT00761150|10940421|FG001|Double-blind Period|Withdrawal by Subject|3
6914108|NCT00761150|10940422|FG002|Double-blind Period|Withdrawal by Subject|2
6914109|NCT00761150|10940420|FG000|Double-blind Period|Lost to Follow-up|0
6914110|NCT00761150|10940421|FG001|Double-blind Period|Lost to Follow-up|2
6914111|NCT00761150|10940422|FG002|Double-blind Period|Lost to Follow-up|1
6914112|NCT00761150|10940420|FG000|Double-blind Period|Did not meet DB randomization criteria|0
6914113|NCT00761150|10940421|FG001|Double-blind Period|Did not meet DB randomization criteria|0
6914114|NCT00761150|10940422|FG002|Double-blind Period|Did not meet DB randomization criteria|1
6914115|NCT00761150|10940420|FG000|Double-blind Period|Noncompliance|0
6914116|NCT00761150|10940421|FG001|Double-blind Period|Noncompliance|1
6914117|NCT00761150|10940422|FG002|Double-blind Period|Noncompliance|0
6914118|NCT00761150|10940420|FG000|Double-blind Period|Other|0
6914119|NCT00761150|10940421|FG001|Double-blind Period|Other|3
6914120|NCT00761150|10940422|FG002|Double-blind Period|Other|3
6914121|NCT00761189|10940429|FG000|Overall Study|Adverse Event|42
6914122|NCT00761189|10940429|FG000|Overall Study|Lack of Efficacy|45
6914123|NCT00761189|10940429|FG000|Overall Study|Lost to Follow-up|36
6914124|NCT00761189|10940429|FG000|Overall Study|Withdrawal by Subject|49
6914125|NCT00761189|10940429|FG000|Overall Study|Other|13
6914126|NCT00761215|10940445|FG000|Overall Study|Randomized but didn't receive drug|1
6914127|NCT00761215|10940446|FG001|Overall Study|Randomized but didn't receive drug|1
6914128|NCT00761215|10940447|FG002|Overall Study|Randomized but didn't receive drug|2
6979071|NCT01215955|11032819|FG001|Overall Study|Lack of Efficacy|2
6914129|NCT00761215|10940445|FG000|Overall Study|Lost to Follow-up|6
6914130|NCT00761215|10940446|FG001|Overall Study|Lost to Follow-up|3
6914131|NCT00761215|10940447|FG002|Overall Study|Lost to Follow-up|6
6914132|NCT00761215|10940445|FG000|Overall Study|Withdrawal by Subject|1
6914133|NCT00761215|10940446|FG001|Overall Study|Withdrawal by Subject|0
6914134|NCT00761215|10940447|FG002|Overall Study|Withdrawal by Subject|0
6914135|NCT00761215|10940445|FG000|Overall Study|Bacteremia|1
6914136|NCT00761215|10940446|FG001|Overall Study|Bacteremia|0
6914137|NCT00761215|10940447|FG002|Overall Study|Bacteremia|0
6914138|NCT00761267|10940461|FG000|Overall Study|Death|1
6914139|NCT00761267|10940462|FG001|Overall Study|Death|2
6914140|NCT00761267|10940463|FG002|Overall Study|Death|5
6914141|NCT00761267|10940461|FG000|Overall Study|Lost to Follow-up|0
6914142|NCT00761267|10940462|FG001|Overall Study|Lost to Follow-up|0
6914143|NCT00761267|10940463|FG002|Overall Study|Lost to Follow-up|1
6914144|NCT00761267|10940461|FG000|Overall Study|Randomized but not treated|1
6914145|NCT00761267|10940462|FG001|Overall Study|Randomized but not treated|1
6914146|NCT00761267|10940463|FG002|Overall Study|Randomized but not treated|0
6914147|NCT00761267|10940461|FG000|Overall Study|Withdrawal by Subject|0
6914148|NCT00761267|10940462|FG001|Overall Study|Withdrawal by Subject|1
6914149|NCT00761267|10940463|FG002|Overall Study|Withdrawal by Subject|0
6914150|NCT00761280|10940484|FG000|Randomization to First Dose|Withdrawal by Subject|0
6914151|NCT00761280|10940485|FG001|Randomization to First Dose|Withdrawal by Subject|2
6914152|NCT00761280|10940484|FG000|Randomization to First Dose|Sponsor decision|1
6914153|NCT00761280|10940485|FG001|Randomization to First Dose|Sponsor decision|0
6914154|NCT00761280|10940484|FG000|Randomization to First Dose|Other|1
6914155|NCT00761280|10940485|FG001|Randomization to First Dose|Other|0
6914156|NCT00761280|10940484|FG000|First Dose to End of Study|End of trial|5
6914157|NCT00761280|10940485|FG001|First Dose to End of Study|End of trial|5
6914158|NCT00761280|10940484|FG000|First Dose to End of Study|Progressive disease|5
6914159|NCT00761280|10940485|FG001|First Dose to End of Study|Progressive disease|3
6914160|NCT00761280|10940484|FG000|First Dose to End of Study|Sponsor decision|1
6914161|NCT00761280|10940485|FG001|First Dose to End of Study|Sponsor decision|2
6914162|NCT00761280|10940484|FG000|First Dose to End of Study|Death|1
6914163|NCT00761280|10940485|FG001|First Dose to End of Study|Death|0
6914164|NCT00761280|10940484|FG000|First Dose to End of Study|Lost to Follow-up|0
6914165|NCT00761280|10940485|FG001|First Dose to End of Study|Lost to Follow-up|1
6914166|NCT00761306|10940491|FG000|Overall Study|Adverse Event|5
6914167|NCT00761306|10940491|FG000|Overall Study|Lack of Efficacy|4
6914168|NCT00761306|10940491|FG000|Overall Study|Protocol Violation|2
6914169|NCT00761306|10940491|FG000|Overall Study|Withdrawal of Consent|3
6914170|NCT00761306|10940491|FG000|Overall Study|Lost to Follow-up|1
6914171|NCT00761306|10940491|FG000|Overall Study|Administrative or Other Reasons|5
6914172|NCT00761319|10940497|FG000|Overall Study|Protocol Violation|21
6914173|NCT00761319|10940498|FG001|Overall Study|Protocol Violation|14
6914174|NCT00761319|10940497|FG000|Overall Study|Adverse Event|11
6914175|NCT00761319|10940498|FG001|Overall Study|Adverse Event|7
6914176|NCT00761319|10940497|FG000|Overall Study|Withdrawal by Subject|8
6914177|NCT00761319|10940498|FG001|Overall Study|Withdrawal by Subject|7
6914178|NCT00761319|10940497|FG000|Overall Study|Noncompliance|4
6914179|NCT00761319|10940498|FG001|Overall Study|Noncompliance|3
6914180|NCT00761319|10940497|FG000|Overall Study|Lost to Follow-up|1
6914181|NCT00761319|10940498|FG001|Overall Study|Lost to Follow-up|1
6914182|NCT00761319|10940497|FG000|Overall Study|Nonspecified|2
6914183|NCT00761319|10940498|FG001|Overall Study|Nonspecified|2
6914184|NCT00761319|10940497|FG000|Overall Study|Missing|1
6914185|NCT00761319|10940498|FG001|Overall Study|Missing|0
6914186|NCT00761462|10940510|FG000|Treatment|Subjects never received study medication|23
6914187|NCT00761462|10940511|FG001|Treatment|Subjects never received study medication|12
6914188|NCT00761462|10940510|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4
6914189|NCT00761462|10940511|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0
6914190|NCT00761462|10940510|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75
6914191|NCT00761462|10940511|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30
6914192|NCT00761462|10940510|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75
6914193|NCT00761462|10940511|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21
6914194|NCT00761514|10940517|FG000|Overall Study|Adverse Event|1
6914195|NCT00761514|10940517|FG000|Overall Study|Withdrawal by Subject|2
6914196|NCT00761514|10940517|FG000|Overall Study|Lost to Follow-up|1
6914197|NCT00761514|10940517|FG000|Overall Study|Health insurance didn't cover study drug|1
6914198|NCT00761514|10940517|FG000|Overall Study|Problem complying with study visit|1
6914199|NCT00761514|10940517|FG000|Overall Study|Unable to pay for medications|1
6914200|NCT00761579|10940521|FG000|Overall Study|Adverse Event|10
6914201|NCT00761579|10940521|FG000|Overall Study|Death|2
6914202|NCT00761579|10940521|FG000|Overall Study|Lack of Efficacy|21
6914203|NCT00761579|10940521|FG000|Overall Study|Lost to Follow-up|16
6914204|NCT00761579|10940521|FG000|Overall Study|Pregnancy|1
6914205|NCT00761579|10940521|FG000|Overall Study|Withdrawal by Subject|34
6914206|NCT00761579|10940521|FG000|Overall Study|Lack of compliance|2
6914207|NCT00761579|10940521|FG000|Overall Study|Protocol deviation|1
6914208|NCT00761579|10940521|FG000|Overall Study|Drug overdose|1
6914209|NCT00761579|10940521|FG000|Overall Study|Aggravation of depression|1
6914210|NCT00761579|10940521|FG000|Overall Study|Aggravation of symptoms by changing drug|1
6914211|NCT00761579|10940521|FG000|Overall Study|Lost survey form|1
6914212|NCT00761579|10940521|FG000|Overall Study|Intake of prohibited concomitant drug|1
6914213|NCT00761605|10940536|FG000|Overall Study|Adverse Event|26
6914214|NCT00761605|10940536|FG000|Overall Study|Death|2
6914215|NCT00761605|10940536|FG000|Overall Study|Lack of Efficacy|26
6914216|NCT00761605|10940536|FG000|Overall Study|Lost to Follow-up|29
6914217|NCT00761605|10940536|FG000|Overall Study|Withdrawal by Subject|37
6914218|NCT00761605|10940536|FG000|Overall Study|Other|21
6914219|NCT00761631|10940548|FG000|Overall Study|Parent/legal guardian request|8
6914220|NCT00761631|10940549|FG001|Overall Study|Parent/legal guardian request|3
6914221|NCT00761631|10940550|FG002|Overall Study|Parent/legal guardian request|8
6914222|NCT00761631|10940551|FG003|Overall Study|Parent/legal guardian request|0
6914223|NCT00761631|10940552|FG004|Overall Study|Parent/legal guardian request|5
6914224|NCT00761631|10940553|FG005|Overall Study|Parent/legal guardian request|0
6914225|NCT00761631|10940548|FG000|Overall Study|Lost to Follow-up|2
6914226|NCT00761631|10940549|FG001|Overall Study|Lost to Follow-up|4
6914227|NCT00761631|10940550|FG002|Overall Study|Lost to Follow-up|7
6914228|NCT00761631|10940551|FG003|Overall Study|Lost to Follow-up|1
6914229|NCT00761631|10940552|FG004|Overall Study|Lost to Follow-up|6
6914230|NCT00761631|10940553|FG005|Overall Study|Lost to Follow-up|1
6914231|NCT00761631|10940548|FG000|Overall Study|Protocol Violation|2
6914232|NCT00761631|10940549|FG001|Overall Study|Protocol Violation|0
6914233|NCT00761631|10940550|FG002|Overall Study|Protocol Violation|0
6914234|NCT00761631|10940551|FG003|Overall Study|Protocol Violation|1
6914235|NCT00761631|10940552|FG004|Overall Study|Protocol Violation|5
6914236|NCT00761631|10940553|FG005|Overall Study|Protocol Violation|1
6914237|NCT00761631|10940548|FG000|Overall Study|Randomized, not treated|1
6914238|NCT00761631|10940549|FG001|Overall Study|Randomized, not treated|0
6914239|NCT00761631|10940550|FG002|Overall Study|Randomized, not treated|0
6914240|NCT00761631|10940551|FG003|Overall Study|Randomized, not treated|0
6914241|NCT00761631|10940552|FG004|Overall Study|Randomized, not treated|0
6914242|NCT00761631|10940553|FG005|Overall Study|Randomized, not treated|0
6914243|NCT00761631|10940548|FG000|Overall Study|Failed to return|1
6914244|NCT00761631|10940549|FG001|Overall Study|Failed to return|0
6914245|NCT00761631|10940550|FG002|Overall Study|Failed to return|1
6914246|NCT00761631|10940551|FG003|Overall Study|Failed to return|1
6914247|NCT00761631|10940552|FG004|Overall Study|Failed to return|5
6914248|NCT00761631|10940553|FG005|Overall Study|Failed to return|2
6914249|NCT00761631|10940548|FG000|Overall Study|Physician Decision|1
6914250|NCT00761631|10940549|FG001|Overall Study|Physician Decision|0
6914251|NCT00761631|10940550|FG002|Overall Study|Physician Decision|0
6914252|NCT00761631|10940551|FG003|Overall Study|Physician Decision|0
6914253|NCT00761631|10940552|FG004|Overall Study|Physician Decision|0
6914254|NCT00761631|10940553|FG005|Overall Study|Physician Decision|0
6914255|NCT00761631|10940548|FG000|Overall Study|Other|0
6914256|NCT00761631|10940549|FG001|Overall Study|Other|0
6914257|NCT00761631|10940550|FG002|Overall Study|Other|0
6914258|NCT00761631|10940551|FG003|Overall Study|Other|0
6914259|NCT00761631|10940552|FG004|Overall Study|Other|1
6914260|NCT00761631|10940553|FG005|Overall Study|Other|1
6914261|NCT00761657|10940585|FG000|Part 1 (up to Day 57)|Adverse Event|0
6914262|NCT00761657|10940586|FG001|Part 1 (up to Day 57)|Adverse Event|0
6914263|NCT00761657|10940587|FG002|Part 1 (up to Day 57)|Adverse Event|0
6914264|NCT00761657|10940588|FG003|Part 1 (up to Day 57)|Adverse Event|1
6914265|NCT00761657|10940589|FG004|Part 1 (up to Day 57)|Adverse Event|0
6914266|NCT00761657|10940590|FG005|Part 1 (up to Day 57)|Adverse Event|0
6914267|NCT00761657|10940591|FG006|Part 1 (up to Day 57)|Adverse Event|0
6914268|NCT00761657|10940592|FG007|Part 1 (up to Day 57)|Adverse Event|0
6914269|NCT00761657|10940593|FG008|Part 1 (up to Day 57)|Adverse Event|0
6914270|NCT00761657|10940585|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0
6914271|NCT00761657|10940586|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0
6914272|NCT00761657|10940587|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1
6914273|NCT00761657|10940588|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1
6914274|NCT00761657|10940589|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0
6914275|NCT00761657|10940590|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0
6914276|NCT00761657|10940591|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0
6914277|NCT00761657|10940592|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0
6914278|NCT00761657|10940593|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0
6914279|NCT00761657|10940585|FG000|Part 1 (up to Day 57)|Sponsor Decision|0
6914280|NCT00761657|10940586|FG001|Part 1 (up to Day 57)|Sponsor Decision|0
6914281|NCT00761657|10940587|FG002|Part 1 (up to Day 57)|Sponsor Decision|3
6914282|NCT00761657|10940588|FG003|Part 1 (up to Day 57)|Sponsor Decision|4
6914283|NCT00761657|10940589|FG004|Part 1 (up to Day 57)|Sponsor Decision|0
6914284|NCT00761657|10940590|FG005|Part 1 (up to Day 57)|Sponsor Decision|0
6914285|NCT00761657|10940591|FG006|Part 1 (up to Day 57)|Sponsor Decision|1
6914286|NCT00761657|10940592|FG007|Part 1 (up to Day 57)|Sponsor Decision|1
6914287|NCT00761657|10940593|FG008|Part 1 (up to Day 57)|Sponsor Decision|1
6914288|NCT00761657|10940585|FG000|Part 2 (up to Day 114)|Adverse Event|0
6914289|NCT00761657|10940586|FG001|Part 2 (up to Day 114)|Adverse Event|0
6914290|NCT00761657|10940587|FG002|Part 2 (up to Day 114)|Adverse Event|0
6914291|NCT00761657|10940588|FG003|Part 2 (up to Day 114)|Adverse Event|0
6914292|NCT00761657|10940589|FG004|Part 2 (up to Day 114)|Adverse Event|0
6914293|NCT00761657|10940590|FG005|Part 2 (up to Day 114)|Adverse Event|0
6914294|NCT00761657|10940591|FG006|Part 2 (up to Day 114)|Adverse Event|0
6914295|NCT00761657|10940592|FG007|Part 2 (up to Day 114)|Adverse Event|0
6914296|NCT00761657|10940593|FG008|Part 2 (up to Day 114)|Adverse Event|1
6914297|NCT00761735|10940623|FG000|Overall Study|Lost to Follow-up|6
6914298|NCT00761735|10940623|FG000|Overall Study|Withdrawal by Subject|6
6979072|NCT01215955|11032820|FG002|Overall Study|Lack of Efficacy|1
6914299|NCT00761735|10940623|FG000|Overall Study|Non-compliance with protocol|1
6914300|NCT00761735|10940623|FG000|Overall Study|Administrative|1
6914301|NCT00761748|10940631|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3
6914302|NCT00761748|10940632|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0
6914303|NCT00761748|10940631|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0
6914304|NCT00761748|10940632|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3
6914305|NCT00761761|10940640|FG000|Overall Study|Lost to Follow-up|3
6914306|NCT00761761|10940641|FG001|Overall Study|Lost to Follow-up|1
6914307|NCT00761761|10940640|FG000|Overall Study|Withdrawal by Subject|3
6914308|NCT00761761|10940641|FG001|Overall Study|Withdrawal by Subject|0
6914309|NCT00761774|10940649|FG000|Overall Study|Adverse Event|17
6914310|NCT00761774|10940649|FG000|Overall Study|Lack of Efficacy|37
6914311|NCT00761774|10940649|FG000|Overall Study|Lost to Follow-up|2
6914312|NCT00761774|10940649|FG000|Overall Study|Withdrawal by Subject|9
6914313|NCT00761774|10940649|FG000|Overall Study|Non-compliance|4
6914314|NCT00761774|10940649|FG000|Overall Study|End of study|2
6914315|NCT00761774|10940649|FG000|Overall Study|Reclassification of seizures|1
6914316|NCT00761774|10940649|FG000|Overall Study|Medical decision to read SUSAR reports|1
6914317|NCT00761774|10940649|FG000|Overall Study|Sponsor decision|1
6914318|NCT00761774|10940649|FG000|Overall Study|Investigator clinical judgement|1
6914319|NCT00761774|10940649|FG000|Overall Study|Patient moved out of study area|1
6914320|NCT00761774|10940649|FG000|Overall Study|Coordinator leaving site|1
6914321|NCT00761774|10940649|FG000|Overall Study|Subject IP non-compliance|1
6914322|NCT00761774|10940649|FG000|Overall Study|IP stopped by hospital physician|1
6914323|NCT00761865|10940666|FG000|Overall Study|Lost to Follow-up|8
6914324|NCT00761865|10940667|FG001|Overall Study|Lost to Follow-up|7
6914325|NCT00761891|10940673|FG000|Overall Study|Withdrawal by Subject|10
6914326|NCT00761956|10940693|FG000|Overall Study|Lost to Follow-up|6
6914327|NCT00761956|10940694|FG001|Overall Study|Lost to Follow-up|11
6914328|NCT00761956|10940693|FG000|Overall Study|Withdrawal by Subject|3
6914329|NCT00761956|10940694|FG001|Overall Study|Withdrawal by Subject|8
6914330|NCT00761956|10940693|FG000|Overall Study|Death|0
6914331|NCT00761956|10940694|FG001|Overall Study|Death|1
6914332|NCT00761956|10940693|FG000|Overall Study|Adverse Event|26
6914333|NCT00761956|10940694|FG001|Overall Study|Adverse Event|34
6914334|NCT00761969|10940702|FG000|Overall Study|Death|112
6914335|NCT00761969|10940703|FG001|Overall Study|Death|47
6914336|NCT00761969|10940702|FG000|Overall Study|Lost to Follow-up|88
6914337|NCT00761969|10940703|FG001|Overall Study|Lost to Follow-up|93
6914338|NCT00762034|10940720|FG000|Induction Period|Protocol Violation|1
6914339|NCT00762034|10940721|FG001|Induction Period|Protocol Violation|2
6914340|NCT00762034|10940720|FG000|Induction Period|Entry Criterion Not Met|12
6914341|NCT00762034|10940721|FG001|Induction Period|Entry Criterion Not Met|11
6914342|NCT00762034|10940720|FG000|Induction Period|Adverse Event|27
6914343|NCT00762034|10940721|FG001|Induction Period|Adverse Event|38
6914344|NCT00762034|10940720|FG000|Induction Period|Lost to Follow-up|1
6914345|NCT00762034|10940721|FG001|Induction Period|Lost to Follow-up|1
6914346|NCT00762034|10940720|FG000|Induction Period|Progressive Disease|73
6914347|NCT00762034|10940721|FG001|Induction Period|Progressive Disease|55
6914348|NCT00762034|10940720|FG000|Induction Period|Physician Decision|21
6914349|NCT00762034|10940721|FG001|Induction Period|Physician Decision|20
6914350|NCT00762034|10940720|FG000|Induction Period|Withdrawal by Subject|15
6914351|NCT00762034|10940721|FG001|Induction Period|Withdrawal by Subject|19
6914352|NCT00762034|10940720|FG000|Induction Period|Deaths Not Due to Study Disease|19
6914353|NCT00762034|10940721|FG001|Induction Period|Deaths Not Due to Study Disease|14
6914354|NCT00762034|10940720|FG000|Induction Period|Deaths Due to Study Disease|9
6914355|NCT00762034|10940721|FG001|Induction Period|Deaths Due to Study Disease|9
6914356|NCT00762034|10940720|FG000|Maintenance Period|Protocol Violation|1
6914357|NCT00762034|10940721|FG001|Maintenance Period|Protocol Violation|3
6914358|NCT00762034|10940720|FG000|Maintenance Period|Entry Criterion Not Met|0
6914359|NCT00762034|10940721|FG001|Maintenance Period|Entry Criterion Not Met|2
6914360|NCT00762034|10940720|FG000|Maintenance Period|Adverse Event|42
6914361|NCT00762034|10940721|FG001|Maintenance Period|Adverse Event|26
6914362|NCT00762034|10940720|FG000|Maintenance Period|Progressive Disease|186
6914363|NCT00762034|10940721|FG001|Maintenance Period|Progressive Disease|224
6914364|NCT00762034|10940720|FG000|Maintenance Period|Physician Decision|25
6914365|NCT00762034|10940721|FG001|Maintenance Period|Physician Decision|20
6914366|NCT00762034|10940720|FG000|Maintenance Period|Withdrawal by Subject|34
6914367|NCT00762034|10940721|FG001|Maintenance Period|Withdrawal by Subject|14
6914368|NCT00762034|10940720|FG000|Maintenance Period|Death not due to study disease|2
6914369|NCT00762034|10940721|FG001|Maintenance Period|Death not due to study disease|5
6914370|NCT00762034|10940720|FG000|Maintenance Period|Death due to study disease|3
6914371|NCT00762034|10940721|FG001|Maintenance Period|Death due to study disease|3
6914372|NCT00762034|10940720|FG000|Maintenance Period|Other|1
6914373|NCT00762034|10940721|FG001|Maintenance Period|Other|1
6914374|NCT00762073|10940739|FG000|Overall Study|Lack of Efficacy|1
6914375|NCT00762073|10940740|FG001|Overall Study|Lack of Efficacy|1
6914376|NCT00762073|10940741|FG002|Overall Study|Lack of Efficacy|0
6914377|NCT00762073|10940742|FG003|Overall Study|Lack of Efficacy|0
6914378|NCT00762073|10940739|FG000|Overall Study|Adverse Event|1
6914379|NCT00762073|10940740|FG001|Overall Study|Adverse Event|0
6914380|NCT00762073|10940741|FG002|Overall Study|Adverse Event|1
6914381|NCT00762073|10940742|FG003|Overall Study|Adverse Event|1
6914382|NCT00762073|10940739|FG000|Overall Study|Significant Subject Noncompliance|0
6914383|NCT00762073|10940740|FG001|Overall Study|Significant Subject Noncompliance|1
6914384|NCT00762073|10940741|FG002|Overall Study|Significant Subject Noncompliance|0
6914385|NCT00762073|10940742|FG003|Overall Study|Significant Subject Noncompliance|1
6914386|NCT00762073|10940739|FG000|Overall Study|Withdrawal by Subject|1
6914387|NCT00762073|10940740|FG001|Overall Study|Withdrawal by Subject|2
6914388|NCT00762073|10940741|FG002|Overall Study|Withdrawal by Subject|1
6914389|NCT00762073|10940742|FG003|Overall Study|Withdrawal by Subject|1
6914390|NCT00762073|10940739|FG000|Overall Study|Not on treatment for >/= 77 days|1
6914391|NCT00762073|10940740|FG001|Overall Study|Not on treatment for >/= 77 days|0
6914392|NCT00762073|10940741|FG002|Overall Study|Not on treatment for >/= 77 days|0
6914393|NCT00762073|10940742|FG003|Overall Study|Not on treatment for >/= 77 days|0
6914394|NCT00762086|10940761|FG000|Overall Study|Adverse Event|2
6914395|NCT00762086|10940762|FG001|Overall Study|Adverse Event|0
6914396|NCT00762086|10940761|FG000|Overall Study|Lost to Follow-up|0
6914397|NCT00762086|10940762|FG001|Overall Study|Lost to Follow-up|2
6914398|NCT00762086|10940761|FG000|Overall Study|Non compliance|1
6914399|NCT00762086|10940762|FG001|Overall Study|Non compliance|0
6914400|NCT00762086|10940761|FG000|Overall Study|Withdrawal by Subject|2
6914401|NCT00762086|10940762|FG001|Overall Study|Withdrawal by Subject|2
6914402|NCT00762086|10940761|FG000|Overall Study|Ineligible to participate in the study|1
6914403|NCT00762086|10940762|FG001|Overall Study|Ineligible to participate in the study|0
6914404|NCT00762164|10940770|FG000|Overall Study|Lost to Follow-up|1
6914405|NCT00762164|10940771|FG001|Overall Study|Lost to Follow-up|1
6914406|NCT00762164|10940770|FG000|Overall Study|Discontinued medication|2
6914407|NCT00762164|10940771|FG001|Overall Study|Discontinued medication|0
6914408|NCT00762164|10940770|FG000|Overall Study|Withdrawal by Subject|0
6914409|NCT00762164|10940771|FG001|Overall Study|Withdrawal by Subject|1
6914410|NCT00762229|10940799|FG000|Overall Study|Lost to Follow-up|1
6914411|NCT00762229|10940800|FG001|Overall Study|Lost to Follow-up|1
6914412|NCT00762229|10940799|FG000|Overall Study|did not recveive intervention|0
6914413|NCT00762229|10940800|FG001|Overall Study|did not recveive intervention|1
6914414|NCT00762268|10940808|FG000|Overall Study|Withdrawal by Subject|3
6914415|NCT00762268|10940809|FG001|Overall Study|Withdrawal by Subject|3
6914416|NCT00762359|10940854|FG000|Overall Study|Adverse Event|20
6914417|NCT00762359|10940855|FG001|Overall Study|Adverse Event|23
6914418|NCT00762359|10940854|FG000|Overall Study|Protocol Violation|21
6914419|NCT00762359|10940855|FG001|Overall Study|Protocol Violation|13
6914420|NCT00762359|10940854|FG000|Overall Study|Withdrawal by Subject|13
6914421|NCT00762359|10940855|FG001|Overall Study|Withdrawal by Subject|10
6914422|NCT00762359|10940854|FG000|Overall Study|Lack of Efficacy|0
6914423|NCT00762359|10940855|FG001|Overall Study|Lack of Efficacy|4
6914424|NCT00762359|10940854|FG000|Overall Study|Institution closed|2
6914425|NCT00762359|10940855|FG001|Overall Study|Institution closed|3
6914426|NCT00762359|10940854|FG000|Overall Study|Physician Decision|2
6914427|NCT00762359|10940855|FG001|Overall Study|Physician Decision|3
6914428|NCT00762359|10940854|FG000|Overall Study|Removal|0
6914429|NCT00762359|10940855|FG001|Overall Study|Removal|1
6914430|NCT00762359|10940854|FG000|Overall Study|Withdrew consent|1
6914431|NCT00762359|10940855|FG001|Overall Study|Withdrew consent|0
6914432|NCT00762372|10940864|FG000|Overall Study|Adverse Event|1
6914433|NCT00762372|10940865|FG001|Overall Study|Adverse Event|0
6914434|NCT00762372|10940866|FG002|Overall Study|Adverse Event|0
6914435|NCT00762385|10940880|FG000|First Intervention|Lens Issue|1
6914436|NCT00762385|10940881|FG001|First Intervention|Lens Issue|1
6914437|NCT00762385|10940880|FG000|First Intervention|Lost to Follow-up|0
6914438|NCT00762385|10940881|FG001|First Intervention|Lost to Follow-up|2
6914439|NCT00762385|10940880|FG000|First Intervention|Ineligible|1
6914440|NCT00762385|10940881|FG001|First Intervention|Ineligible|0
6914441|NCT00762385|10940880|FG000|First Intervention|Protocol Violation|0
6914442|NCT00762385|10940881|FG001|First Intervention|Protocol Violation|1
6914443|NCT00762385|10940880|FG000|Second Intervention|Protocol Violation|3
6914444|NCT00762385|10940881|FG001|Second Intervention|Protocol Violation|3
6914445|NCT00762411|10940892|FG000|Initial Treatment|Death|7
6914446|NCT00762411|10940893|FG001|Initial Treatment|Death|6
6914447|NCT00762411|10940892|FG000|Initial Treatment|Adverse Event|132
6914448|NCT00762411|10940893|FG001|Initial Treatment|Adverse Event|40
6914449|NCT00762411|10940892|FG000|Initial Treatment|Protocol Violation|4
6914450|NCT00762411|10940893|FG001|Initial Treatment|Protocol Violation|1
6914451|NCT00762411|10940892|FG000|Initial Treatment|Withdrawal by Subject|65
6914452|NCT00762411|10940893|FG001|Initial Treatment|Withdrawal by Subject|52
6914453|NCT00762411|10940892|FG000|Initial Treatment|Physician Decision|1
6914454|NCT00762411|10940893|FG001|Initial Treatment|Physician Decision|0
6914455|NCT00762411|10940892|FG000|Initial Treatment|Sponsor Decision|293
6914456|NCT00762411|10940893|FG001|Initial Treatment|Sponsor Decision|401
6914457|NCT00762411|10940892|FG000|Initial Treatment|Lost to Follow-up|5
6914458|NCT00762411|10940893|FG001|Initial Treatment|Lost to Follow-up|0
6914459|NCT00762411|10940892|FG000|Initial Treatment|Caregiver Decision|21
6914460|NCT00762411|10940893|FG001|Initial Treatment|Caregiver Decision|16
6914461|NCT00762411|10940892|FG000|Initial Treatment|Abnormal Lab/ECG Result|6
6914462|NCT00762411|10940893|FG001|Initial Treatment|Abnormal Lab/ECG Result|4
6914463|NCT00762411|10940892|FG000|Initial Treatment|Entry Criteria Exclusion|0
6914464|NCT00762411|10940893|FG001|Initial Treatment|Entry Criteria Exclusion|1
6914465|NCT00762411|10940892|FG000|Delayed Start|Adverse Event|0
6914466|NCT00762411|10940893|FG001|Delayed Start|Adverse Event|4
6914467|NCT00762411|10940892|FG000|Delayed Start|Protocol Violation|0
6914468|NCT00762411|10940893|FG001|Delayed Start|Protocol Violation|1
6914469|NCT00762411|10940892|FG000|Delayed Start|Sponsor Decision|16
6914470|NCT00762411|10940893|FG001|Delayed Start|Sponsor Decision|20
6914471|NCT00762411|10940892|FG000|Delayed Start|Caregiver Decision|1
6914472|NCT00762411|10940893|FG001|Delayed Start|Caregiver Decision|1
6914473|NCT00762411|10940892|FG000|Safety Follow Up (SFU)-Optional|Death|1
6914474|NCT00762411|10940893|FG001|Safety Follow Up (SFU)-Optional|Death|8
6914475|NCT00762411|10940892|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0
6914476|NCT00762411|10940893|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1
6914477|NCT00762411|10940892|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21
6914478|NCT00762411|10940893|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46
6914479|NCT00762411|10940892|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6
6914480|NCT00762411|10940893|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
6914481|NCT00762411|10940892|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
6914482|NCT00762411|10940893|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
6914483|NCT00762411|10940892|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48
6914484|NCT00762411|10940893|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54
6914485|NCT00762463|10940927|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
6914486|NCT00762463|10940928|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
6914487|NCT00762463|10940929|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
6914488|NCT00762463|10940930|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
6914489|NCT00762463|10940927|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3
6914490|NCT00762463|10940928|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4
6914491|NCT00762463|10940929|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
6914492|NCT00762463|10940930|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
6914493|NCT00762463|10940927|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2
6914494|NCT00762463|10940928|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4
6914495|NCT00762463|10940929|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
6914496|NCT00762463|10940930|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
6914497|NCT00762463|10940927|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4
6914498|NCT00762463|10940928|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1
6914499|NCT00762463|10940929|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
6914500|NCT00762463|10940930|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
6914501|NCT00762463|10940927|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
6914502|NCT00762463|10940928|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
6914503|NCT00762463|10940929|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
6914504|NCT00762463|10940930|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
6914505|NCT00762463|10940927|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
6914506|NCT00762463|10940928|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
6914507|NCT00762463|10940929|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0
6914508|NCT00762463|10940930|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
6914509|NCT00762463|10940927|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1
6914510|NCT00762463|10940928|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
6914511|NCT00762463|10940929|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3
6914512|NCT00762463|10940930|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
6914513|NCT00762463|10940927|FG000|Extension Phase (Week 6 to Week 12)|Other|0
6914514|NCT00762463|10940928|FG001|Extension Phase (Week 6 to Week 12)|Other|0
6914515|NCT00762463|10940929|FG002|Extension Phase (Week 6 to Week 12)|Other|0
6914516|NCT00762463|10940930|FG003|Extension Phase (Week 6 to Week 12)|Other|1
6914517|NCT00762476|10940945|FG000|Overall Study|Adverse Event|7
6914518|NCT00762476|10940946|FG001|Overall Study|Adverse Event|1
6914519|NCT00762476|10940945|FG000|Overall Study|Lost to Follow-up|2
6914520|NCT00762476|10940946|FG001|Overall Study|Lost to Follow-up|0
6914521|NCT00762476|10940945|FG000|Overall Study|Protocol Violation|5
6914522|NCT00762476|10940946|FG001|Overall Study|Protocol Violation|6
6914523|NCT00762476|10940945|FG000|Overall Study|Physician Decision|2
6914524|NCT00762476|10940946|FG001|Overall Study|Physician Decision|14
6914525|NCT00762476|10940945|FG000|Overall Study|Withdrawal by Subject|6
6914526|NCT00762476|10940946|FG001|Overall Study|Withdrawal by Subject|12
6914527|NCT00762476|10940945|FG000|Overall Study|antibiotic use|0
6914528|NCT00762476|10940946|FG001|Overall Study|antibiotic use|1
6914529|NCT00762476|10940945|FG000|Overall Study|non-compliance with study visits|0
6914530|NCT00762476|10940946|FG001|Overall Study|non-compliance with study visits|2
6914531|NCT00762476|10940945|FG000|Overall Study|Seasonal allergies|1
6914532|NCT00762476|10940946|FG001|Overall Study|Seasonal allergies|0
6914533|NCT00762502|10940956|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4
6914534|NCT00762502|10940957|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3
6914535|NCT00762502|10940958|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6
6914536|NCT00762502|10940956|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6
6914537|NCT00762502|10940957|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3
6914538|NCT00762502|10940958|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13
6914539|NCT00762502|10940956|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0
6914540|NCT00762502|10940957|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1
6979073|NCT01215955|11032821|FG003|Overall Study|Lack of Efficacy|0
6914541|NCT00762502|10940958|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0
6914542|NCT00762606|10940984|FG000|Overall Study|Lost to Follow-up|18
6914543|NCT00762606|10940985|FG001|Overall Study|Lost to Follow-up|13
6914544|NCT00762762|10941022|FG000|Overall Study|Did not report for appointments|8
6914545|NCT00762762|10941023|FG001|Overall Study|Did not report for appointments|10
6914546|NCT00762788|10941035|FG000|Overall Study|Lost to Follow-up|26
6914547|NCT00762788|10941036|FG001|Overall Study|Lost to Follow-up|37
6914548|NCT00762788|10941037|FG002|Overall Study|Lost to Follow-up|21
6914549|NCT00762788|10941038|FG003|Overall Study|Lost to Follow-up|26
6914550|NCT00762788|10941039|FG004|Overall Study|Lost to Follow-up|13
6914551|NCT00762788|10941040|FG005|Overall Study|Lost to Follow-up|21
6914552|NCT00762892|10941065|FG000|Overall Study|Lost to Follow-up|2
6914553|NCT00762892|10941066|FG001|Overall Study|Lost to Follow-up|5
6914554|NCT00762892|10941065|FG000|Overall Study|Withdrawal by Subject|0
6914555|NCT00762892|10941066|FG001|Overall Study|Withdrawal by Subject|1
6914556|NCT00762892|10941065|FG000|Overall Study|Death|1
6914557|NCT00762892|10941066|FG001|Overall Study|Death|0
6914558|NCT00762892|10941065|FG000|Overall Study|Pregnancy|1
6914559|NCT00762892|10941066|FG001|Overall Study|Pregnancy|0
6914560|NCT00762892|10941065|FG000|Overall Study|Incarceration|1
6914561|NCT00762892|10941066|FG001|Overall Study|Incarceration|0
6914562|NCT00762970|10941079|FG000|Overall Study|Withdrawal by Subject|7
6914563|NCT00762970|10941080|FG001|Overall Study|Withdrawal by Subject|4
6914564|NCT00762970|10941081|FG002|Overall Study|Withdrawal by Subject|0
6914565|NCT00762970|10941079|FG000|Overall Study|Protocol Violation|3
6914566|NCT00762970|10941080|FG001|Overall Study|Protocol Violation|1
6914567|NCT00762970|10941081|FG002|Overall Study|Protocol Violation|1
6914568|NCT00762970|10941079|FG000|Overall Study|Lost to Follow-up|1
6914569|NCT00762970|10941080|FG001|Overall Study|Lost to Follow-up|2
6914570|NCT00762970|10941081|FG002|Overall Study|Lost to Follow-up|0
6914571|NCT00762970|10941079|FG000|Overall Study|Difficulty of handling lens|1
6914572|NCT00762970|10941080|FG001|Overall Study|Difficulty of handling lens|2
6914573|NCT00762970|10941081|FG002|Overall Study|Difficulty of handling lens|0
6914574|NCT00762996|10941089|FG000|Period One|Protocol Violation|0
6914575|NCT00762996|10941090|FG001|Period One|Protocol Violation|0
6914576|NCT00762996|10941091|FG002|Period One|Protocol Violation|1
6914577|NCT00762996|10941092|FG003|Period One|Protocol Violation|0
6914578|NCT00762996|10941089|FG000|Period One|ineligible|0
6914579|NCT00762996|10941090|FG001|Period One|ineligible|0
6914580|NCT00762996|10941091|FG002|Period One|ineligible|1
6914581|NCT00762996|10941092|FG003|Period One|ineligible|1
6914582|NCT00762996|10941089|FG000|Period One|Adverse Event|0
6914583|NCT00762996|10941090|FG001|Period One|Adverse Event|0
6914584|NCT00762996|10941091|FG002|Period One|Adverse Event|1
6914585|NCT00762996|10941092|FG003|Period One|Adverse Event|0
6914586|NCT00762996|10941089|FG000|Period One|Withdrawal by Subject|0
6914587|NCT00762996|10941090|FG001|Period One|Withdrawal by Subject|0
6914588|NCT00762996|10941091|FG002|Period One|Withdrawal by Subject|1
6914589|NCT00762996|10941092|FG003|Period One|Withdrawal by Subject|0
6914590|NCT00763035|10941100|FG000|First Intervention|Did not meeting inclusion/exclusion|1
6914591|NCT00763035|10941101|FG001|First Intervention|Did not meeting inclusion/exclusion|0
6914592|NCT00763035|10941100|FG000|First Intervention|Adverse Event|0
6914593|NCT00763035|10941101|FG001|First Intervention|Adverse Event|1
6914594|NCT00763035|10941100|FG000|Second Intervention|Adverse Event|1
6914595|NCT00763035|10941101|FG001|Second Intervention|Adverse Event|0
6914596|NCT00763035|10941100|FG000|Second Intervention|Physician Decision|2
6914597|NCT00763035|10941101|FG001|Second Intervention|Physician Decision|0
6914598|NCT00763139|10941125|FG000|Overall Study|Adverse Event|4
6914599|NCT00763139|10941126|FG001|Overall Study|Adverse Event|2
6914600|NCT00763139|10941125|FG000|Overall Study|Withdrawal by Subject|0
6914601|NCT00763139|10941126|FG001|Overall Study|Withdrawal by Subject|1
6914602|NCT00763139|10941125|FG000|Overall Study|med change not allowed by protocol|1
6914603|NCT00763139|10941126|FG001|Overall Study|med change not allowed by protocol|0
6914604|NCT00763256|10941151|FG000|Overall Study|Didn't return for appointments|7
6914605|NCT00763256|10941152|FG001|Overall Study|Didn't return for appointments|10
6914606|NCT00763269|10941160|FG000|Overall Study|Lost to Follow-up|12
6914607|NCT00763269|10941161|FG001|Overall Study|Lost to Follow-up|13
6974299|NCT01185964|11026147|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
6974300|NCT01185964|11026148|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2
6974301|NCT01186328|11026173|FG000|Overall Study|Death|1
6974302|NCT01186328|11026174|FG001|Overall Study|Death|0
6974303|NCT01186328|11026175|FG002|Overall Study|Death|0
6974304|NCT01186419|11026186|FG000|Overall Study|Withdrawal by Subject|5
6974305|NCT01186419|11026187|FG001|Overall Study|Withdrawal by Subject|3
6974306|NCT01186419|11026186|FG000|Overall Study|Adverse Event|1
6974307|NCT01186419|11026187|FG001|Overall Study|Adverse Event|2
6974308|NCT01186419|11026186|FG000|Overall Study|Physician Decision|0
6974309|NCT01186419|11026187|FG001|Overall Study|Physician Decision|3
6974310|NCT01186419|11026186|FG000|Overall Study|Other|1
6974311|NCT01186419|11026187|FG001|Overall Study|Other|1
6974312|NCT01186458|11026192|FG000|Overall Study|Adverse Event|1
6974313|NCT01186692|11026205|FG000|Overall Study|Not Catheterized|11
6974314|NCT01186692|11026205|FG000|Overall Study|Futher testing contraindicated implant|19
6974315|NCT01186692|11026205|FG000|Overall Study|Adverse Event|2
6974316|NCT01186744|11026223|FG000|Overall Study|Lack of Efficacy|156
6974317|NCT01186744|11026224|FG001|Overall Study|Lack of Efficacy|99
6914608|NCT00763282|10941169|FG000|Overall Study|Withdrawal by Subject|6
6914609|NCT00763282|10941170|FG001|Overall Study|Withdrawal by Subject|5
6914610|NCT00763282|10941169|FG000|Overall Study|Death|4
6914611|NCT00763282|10941170|FG001|Overall Study|Death|3
6914612|NCT00763282|10941169|FG000|Overall Study|Lost to Follow-up|22
6914613|NCT00763282|10941170|FG001|Overall Study|Lost to Follow-up|26
6914614|NCT00763321|10941181|FG000|Open-label Period|Adverse Event|24
6914615|NCT00763321|10941182|FG001|Open-label Period|Adverse Event|0
6914616|NCT00763321|10941183|FG002|Open-label Period|Adverse Event|0
6914617|NCT00763321|10941181|FG000|Open-label Period|Lost to Follow-up|14
6914618|NCT00763321|10941182|FG001|Open-label Period|Lost to Follow-up|0
6914619|NCT00763321|10941183|FG002|Open-label Period|Lost to Follow-up|0
6914620|NCT00763321|10941181|FG000|Open-label Period|Withdrawal by Subject|7
6914621|NCT00763321|10941182|FG001|Open-label Period|Withdrawal by Subject|0
6914622|NCT00763321|10941183|FG002|Open-label Period|Withdrawal by Subject|0
6914623|NCT00763321|10941181|FG000|Open-label Period|Subject noncompliant|7
6914624|NCT00763321|10941182|FG001|Open-label Period|Subject noncompliant|0
6914625|NCT00763321|10941183|FG002|Open-label Period|Subject noncompliant|0
6914626|NCT00763321|10941181|FG000|Open-label Period|Did not meet DB randomization criteria|5
6914627|NCT00763321|10941182|FG001|Open-label Period|Did not meet DB randomization criteria|0
6914628|NCT00763321|10941183|FG002|Open-label Period|Did not meet DB randomization criteria|0
6914629|NCT00763321|10941181|FG000|Open-label Period|Lack of Efficacy|2
6914630|NCT00763321|10941182|FG001|Open-label Period|Lack of Efficacy|0
6914631|NCT00763321|10941183|FG002|Open-label Period|Lack of Efficacy|0
6914632|NCT00763321|10941181|FG000|Open-label Period|Other|4
6914633|NCT00763321|10941182|FG001|Open-label Period|Other|0
6914634|NCT00763321|10941183|FG002|Open-label Period|Other|0
6914635|NCT00763321|10941181|FG000|Double-blind Period|Lack of Efficacy|0
6914636|NCT00763321|10941182|FG001|Double-blind Period|Lack of Efficacy|9
6914637|NCT00763321|10941183|FG002|Double-blind Period|Lack of Efficacy|17
6914638|NCT00763321|10941181|FG000|Double-blind Period|Adverse Event|0
6914639|NCT00763321|10941182|FG001|Double-blind Period|Adverse Event|4
6914640|NCT00763321|10941183|FG002|Double-blind Period|Adverse Event|4
6914641|NCT00763321|10941181|FG000|Double-blind Period|Lost to Follow-up|0
6914642|NCT00763321|10941182|FG001|Double-blind Period|Lost to Follow-up|4
6914643|NCT00763321|10941183|FG002|Double-blind Period|Lost to Follow-up|2
6914644|NCT00763321|10941181|FG000|Double-blind Period|Withdrawal by Subject|0
6914645|NCT00763321|10941182|FG001|Double-blind Period|Withdrawal by Subject|2
6914646|NCT00763321|10941183|FG002|Double-blind Period|Withdrawal by Subject|3
6914647|NCT00763321|10941181|FG000|Double-blind Period|Other|0
6914648|NCT00763321|10941182|FG001|Double-blind Period|Other|2
6914649|NCT00763321|10941183|FG002|Double-blind Period|Other|3
6914650|NCT00763386|10941205|FG000|Overall Study|Adverse Event|43
6914651|NCT00763386|10941206|FG001|Overall Study|Adverse Event|33
6914652|NCT00763386|10941205|FG000|Overall Study|Death|1
6914653|NCT00763386|10941206|FG001|Overall Study|Death|2
6914654|NCT00763386|10941205|FG000|Overall Study|Lost to Follow-up|3
6914655|NCT00763386|10941206|FG001|Overall Study|Lost to Follow-up|3
6914656|NCT00763386|10941205|FG000|Overall Study|Withdrawal by Subject|0
6914657|NCT00763386|10941206|FG001|Overall Study|Withdrawal by Subject|1
6914658|NCT00763386|10941205|FG000|Overall Study|CRF missing|0
6914659|NCT00763386|10941206|FG001|Overall Study|CRF missing|1
6914660|NCT00763386|10941205|FG000|Overall Study|Study Prosthesis Removed|1
6914661|NCT00763386|10941206|FG001|Overall Study|Study Prosthesis Removed|0
6914662|NCT00763451|10941225|FG000|Overall Study|Adverse Event|4
6914663|NCT00763451|10941226|FG001|Overall Study|Adverse Event|6
6914664|NCT00763451|10941227|FG002|Overall Study|Adverse Event|19
6914665|NCT00763451|10941228|FG003|Overall Study|Adverse Event|14
6914666|NCT00763451|10941225|FG000|Overall Study|Lack of Efficacy|1
6914667|NCT00763451|10941226|FG001|Overall Study|Lack of Efficacy|4
6914668|NCT00763451|10941227|FG002|Overall Study|Lack of Efficacy|3
6914669|NCT00763451|10941228|FG003|Overall Study|Lack of Efficacy|2
6914670|NCT00763451|10941225|FG000|Overall Study|Withdrawal by Subject|1
6914671|NCT00763451|10941226|FG001|Overall Study|Withdrawal by Subject|6
6914672|NCT00763451|10941227|FG002|Overall Study|Withdrawal by Subject|9
6914673|NCT00763451|10941228|FG003|Overall Study|Withdrawal by Subject|7
6914674|NCT00763451|10941225|FG000|Overall Study|Protocol Violation|0
6914675|NCT00763451|10941226|FG001|Overall Study|Protocol Violation|0
6914676|NCT00763451|10941227|FG002|Overall Study|Protocol Violation|1
6914677|NCT00763451|10941228|FG003|Overall Study|Protocol Violation|0
6914678|NCT00763451|10941225|FG000|Overall Study|Poor Compliance to Protocol|1
6914679|NCT00763451|10941226|FG001|Overall Study|Poor Compliance to Protocol|1
6914680|NCT00763451|10941227|FG002|Overall Study|Poor Compliance to Protocol|2
6914681|NCT00763451|10941228|FG003|Overall Study|Poor Compliance to Protocol|2
6914682|NCT00763451|10941225|FG000|Overall Study|Familial and Personal Reasons|5
6914683|NCT00763451|10941226|FG001|Overall Study|Familial and Personal Reasons|3
6914684|NCT00763451|10941227|FG002|Overall Study|Familial and Personal Reasons|5
6914685|NCT00763451|10941228|FG003|Overall Study|Familial and Personal Reasons|4
6914686|NCT00763451|10941225|FG000|Overall Study|Randomized but not Treated|1
6914687|NCT00763451|10941226|FG001|Overall Study|Randomized but not Treated|1
6914688|NCT00763451|10941227|FG002|Overall Study|Randomized but not Treated|0
6914689|NCT00763451|10941228|FG003|Overall Study|Randomized but not Treated|0
6914690|NCT00763451|10941225|FG000|Overall Study|Study Site Reason|0
6914691|NCT00763451|10941226|FG001|Overall Study|Study Site Reason|1
6914692|NCT00763451|10941227|FG002|Overall Study|Study Site Reason|1
6914693|NCT00763451|10941228|FG003|Overall Study|Study Site Reason|1
6914694|NCT00763698|10941243|FG000|Overall Study|Unsuccessful Implant|5
6914695|NCT00763698|10941243|FG000|Overall Study|Death|4
6914696|NCT00763698|10941243|FG000|Overall Study|Withdrawal by Subject|1
6914697|NCT00763815|10941254|FG000|Overall Study|Adverse Event|14
6914698|NCT00763815|10941255|FG001|Overall Study|Adverse Event|29
6914699|NCT00763815|10941254|FG000|Overall Study|Lack of Efficacy|10
6914700|NCT00763815|10941255|FG001|Overall Study|Lack of Efficacy|11
6914701|NCT00763815|10941254|FG000|Overall Study|Poor Compliance to Protocol|6
6914702|NCT00763815|10941255|FG001|Overall Study|Poor Compliance to Protocol|6
6914703|NCT00763815|10941254|FG000|Overall Study|Lost to Follow-up|2
6914704|NCT00763815|10941255|FG001|Overall Study|Lost to Follow-up|4
6914705|NCT00763815|10941254|FG000|Overall Study|Early Termination|1
6914706|NCT00763815|10941255|FG001|Overall Study|Early Termination|0
6914707|NCT00763815|10941254|FG000|Overall Study|Familial and Personal Reasons|9
6914708|NCT00763815|10941255|FG001|Overall Study|Familial and Personal Reasons|16
6914709|NCT00763815|10941254|FG000|Overall Study|Physician Decision|1
6914710|NCT00763815|10941255|FG001|Overall Study|Physician Decision|0
6914711|NCT00763815|10941254|FG000|Overall Study|Withdrawal by Subject|7
6914712|NCT00763815|10941255|FG001|Overall Study|Withdrawal by Subject|12
6914713|NCT00763815|10941254|FG000|Overall Study|Protocol Violation|2
6914714|NCT00763815|10941255|FG001|Overall Study|Protocol Violation|5
6914715|NCT00763815|10941254|FG000|Overall Study|Sponsor's Decision|0
6914716|NCT00763815|10941255|FG001|Overall Study|Sponsor's Decision|1
6914717|NCT00763958|10941276|FG000|Overall Study|did not meet final criteria|4
6914718|NCT00763958|10941277|FG001|Overall Study|did not meet final criteria|4
6914719|NCT00763958|10941276|FG000|Overall Study|Lost to Follow-up|10
6914720|NCT00763958|10941277|FG001|Overall Study|Lost to Follow-up|2
6914721|NCT00763958|10941276|FG000|Overall Study|Believed they were receiving placebo|0
6914722|NCT00763958|10941277|FG001|Overall Study|Believed they were receiving placebo|5
6914723|NCT00763971|10941287|FG000|Overall Study|Adverse Event|5
6914724|NCT00763971|10941288|FG001|Overall Study|Adverse Event|2
6914725|NCT00763971|10941289|FG002|Overall Study|Adverse Event|4
6897020|NCT00636207|10915672|FG005|Overall Study|Adverse Event|0
6914726|NCT00763971|10941287|FG000|Overall Study|Protocol Violation|3
6914727|NCT00763971|10941288|FG001|Overall Study|Protocol Violation|3
6914728|NCT00763971|10941289|FG002|Overall Study|Protocol Violation|2
6914729|NCT00763971|10941287|FG000|Overall Study|Withdrawal by Subject|4
6914730|NCT00763971|10941288|FG001|Overall Study|Withdrawal by Subject|5
6914731|NCT00763971|10941289|FG002|Overall Study|Withdrawal by Subject|5
6914732|NCT00763971|10941287|FG000|Overall Study|Lost to Follow-up|0
6914733|NCT00763971|10941288|FG001|Overall Study|Lost to Follow-up|1
6914734|NCT00763971|10941289|FG002|Overall Study|Lost to Follow-up|0
6914735|NCT00763971|10941287|FG000|Overall Study|Lack of Efficacy|11
6897021|NCT00636207|10915673|FG006|Overall Study|Adverse Event|0
6897022|NCT00636207|10915667|FG000|Overall Study|Withdrawal by Subject|0
6897023|NCT00636207|10915668|FG001|Overall Study|Withdrawal by Subject|1
6897024|NCT00636207|10915669|FG002|Overall Study|Withdrawal by Subject|0
6897025|NCT00636207|10915670|FG003|Overall Study|Withdrawal by Subject|0
6897026|NCT00636207|10915671|FG004|Overall Study|Withdrawal by Subject|1
6897027|NCT00636207|10915672|FG005|Overall Study|Withdrawal by Subject|0
6897028|NCT00636207|10915673|FG006|Overall Study|Withdrawal by Subject|0
6897029|NCT00636363|10915701|FG000|Overall Study|Conjunctivitis|0
6897030|NCT00636363|10915702|FG001|Overall Study|Conjunctivitis|0
6897031|NCT00636363|10915703|FG002|Overall Study|Conjunctivitis|1
6897032|NCT00636363|10915701|FG000|Overall Study|Adverse Event|0
6897033|NCT00636363|10915702|FG001|Overall Study|Adverse Event|0
6897034|NCT00636363|10915703|FG002|Overall Study|Adverse Event|1
6897035|NCT00636363|10915701|FG000|Overall Study|Positive slit lamp finding|0
6897036|NCT00636363|10915702|FG001|Overall Study|Positive slit lamp finding|2
6897037|NCT00636363|10915703|FG002|Overall Study|Positive slit lamp finding|1
6897038|NCT00636363|10915701|FG000|Overall Study|Study related symptoms/complaints|8
6897039|NCT00636363|10915702|FG001|Overall Study|Study related symptoms/complaints|7
6897040|NCT00636363|10915703|FG002|Overall Study|Study related symptoms/complaints|4
6897041|NCT00636363|10915701|FG000|Overall Study|Met ineligibility criteria|0
6897042|NCT00636363|10915702|FG001|Overall Study|Met ineligibility criteria|0
6897043|NCT00636363|10915703|FG002|Overall Study|Met ineligibility criteria|3
6897044|NCT00636363|10915701|FG000|Overall Study|Missed > 1 visit|0
6897045|NCT00636363|10915702|FG001|Overall Study|Missed > 1 visit|1
6897046|NCT00636363|10915703|FG002|Overall Study|Missed > 1 visit|3
6897047|NCT00636363|10915701|FG000|Overall Study|Lack of motivation|1
6897048|NCT00636363|10915702|FG001|Overall Study|Lack of motivation|0
6897049|NCT00636363|10915703|FG002|Overall Study|Lack of motivation|1
6897050|NCT00636363|10915701|FG000|Overall Study|Protocol Violation|0
6897051|NCT00636363|10915702|FG001|Overall Study|Protocol Violation|3
6897052|NCT00636363|10915703|FG002|Overall Study|Protocol Violation|0
6897053|NCT00636363|10915701|FG000|Overall Study|Lost to Follow-up|3
6897054|NCT00636363|10915702|FG001|Overall Study|Lost to Follow-up|4
6897055|NCT00636363|10915703|FG002|Overall Study|Lost to Follow-up|2
6897056|NCT00636363|10915701|FG000|Overall Study|Withdrawal by Subject|1
6897057|NCT00636363|10915702|FG001|Overall Study|Withdrawal by Subject|3
6897058|NCT00636363|10915703|FG002|Overall Study|Withdrawal by Subject|2
6914736|NCT00763971|10941288|FG001|Overall Study|Lack of Efficacy|22
6914737|NCT00763971|10941289|FG002|Overall Study|Lack of Efficacy|54
6914738|NCT00763971|10941287|FG000|Overall Study|Unable to swallow capsule|2
6914739|NCT00763971|10941288|FG001|Overall Study|Unable to swallow capsule|1
6914740|NCT00763971|10941289|FG002|Overall Study|Unable to swallow capsule|1
6914741|NCT00763971|10941287|FG000|Overall Study|Personal reason|3
6914742|NCT00763971|10941288|FG001|Overall Study|Personal reason|0
6914743|NCT00763971|10941289|FG002|Overall Study|Personal reason|0
6914744|NCT00763971|10941287|FG000|Overall Study|Exclusion criteria met|1
6914745|NCT00763971|10941288|FG001|Overall Study|Exclusion criteria met|0
6914746|NCT00763971|10941289|FG002|Overall Study|Exclusion criteria met|0
6914747|NCT00763971|10941287|FG000|Overall Study|Sponsor decision|1
6914748|NCT00763971|10941288|FG001|Overall Study|Sponsor decision|0
6914749|NCT00763971|10941289|FG002|Overall Study|Sponsor decision|0
6914750|NCT00763971|10941287|FG000|Overall Study|Due to holiday season|2
6914751|NCT00763971|10941288|FG001|Overall Study|Due to holiday season|0
6914752|NCT00763971|10941289|FG002|Overall Study|Due to holiday season|1
6914753|NCT00763971|10941287|FG000|Overall Study|Randomization error|0
6914754|NCT00763971|10941288|FG001|Overall Study|Randomization error|0
6914755|NCT00763971|10941289|FG002|Overall Study|Randomization error|1
6914756|NCT00763971|10941287|FG000|Overall Study|Medical monitor decision|0
6914757|NCT00763971|10941288|FG001|Overall Study|Medical monitor decision|0
6914758|NCT00763971|10941289|FG002|Overall Study|Medical monitor decision|1
6914759|NCT00763971|10941287|FG000|Overall Study|Moved to another country|0
6914760|NCT00763971|10941288|FG001|Overall Study|Moved to another country|1
6914761|NCT00763971|10941289|FG002|Overall Study|Moved to another country|0
6914762|NCT00763971|10941287|FG000|Overall Study|Subject wanted dose reduction|0
6914763|NCT00763971|10941288|FG001|Overall Study|Subject wanted dose reduction|1
6914764|NCT00763971|10941289|FG002|Overall Study|Subject wanted dose reduction|0
6914765|NCT00763971|10941287|FG000|Overall Study|Lack of availability|0
6914766|NCT00763971|10941288|FG001|Overall Study|Lack of availability|1
6914767|NCT00763971|10941289|FG002|Overall Study|Lack of availability|0
6914768|NCT00763971|10941287|FG000|Overall Study|Performed final visit on phone|0
6914769|NCT00763971|10941288|FG001|Overall Study|Performed final visit on phone|1
6914770|NCT00763971|10941289|FG002|Overall Study|Performed final visit on phone|0
6914771|NCT00763971|10941287|FG000|Overall Study|Participation in 489-326 required|1
6914772|NCT00763971|10941288|FG001|Overall Study|Participation in 489-326 required|0
6914773|NCT00763971|10941289|FG002|Overall Study|Participation in 489-326 required|0
6914774|NCT00764322|10941303|FG000|Overall Study|Withdrawal by Subject|11
6914775|NCT00764322|10941303|FG000|Overall Study|No CYP2D6 genotyping|9
6914776|NCT00764361|10941322|FG000|Overall Study|Withdrawal by Subject|2
6914777|NCT00764361|10941323|FG001|Overall Study|Withdrawal by Subject|3
6914778|NCT00764361|10941322|FG000|Overall Study|Adverse Event|0
6914779|NCT00764361|10941323|FG001|Overall Study|Adverse Event|1
6914780|NCT00764465|10941335|FG000|Overall Study|Adverse Event|2
6914781|NCT00764465|10941336|FG001|Overall Study|Adverse Event|0
6914782|NCT00764465|10941337|FG002|Overall Study|Adverse Event|0
6914783|NCT00764465|10941338|FG003|Overall Study|Adverse Event|1
6914784|NCT00764465|10941339|FG004|Overall Study|Adverse Event|1
6914785|NCT00764465|10941340|FG005|Overall Study|Adverse Event|1
6914786|NCT00764465|10941335|FG000|Overall Study|Withdrawal by Subject|0
6914787|NCT00764465|10941336|FG001|Overall Study|Withdrawal by Subject|1
6914788|NCT00764465|10941337|FG002|Overall Study|Withdrawal by Subject|1
6914789|NCT00764465|10941338|FG003|Overall Study|Withdrawal by Subject|0
6914790|NCT00764465|10941339|FG004|Overall Study|Withdrawal by Subject|0
6914791|NCT00764465|10941340|FG005|Overall Study|Withdrawal by Subject|0
6914792|NCT00764491|10941359|FG000|Overall Study|Lost to Follow-up|35
6914793|NCT00764491|10941360|FG001|Overall Study|Lost to Follow-up|17
6914794|NCT00764504|10941369|FG000|Overall Study|Death|12
6914795|NCT00764504|10941370|FG001|Overall Study|Death|6
6914796|NCT00764504|10941371|FG002|Overall Study|Death|13
6914797|NCT00764504|10941369|FG000|Overall Study|Revision of Device|12
6914798|NCT00764504|10941370|FG001|Overall Study|Revision of Device|23
6914799|NCT00764504|10941371|FG002|Overall Study|Revision of Device|14
6914800|NCT00764504|10941369|FG000|Overall Study|Physician Decision|1
6914801|NCT00764504|10941370|FG001|Overall Study|Physician Decision|0
6914802|NCT00764504|10941371|FG002|Overall Study|Physician Decision|0
6914803|NCT00764504|10941369|FG000|Overall Study|Withdrawal by Subject|1
6914804|NCT00764504|10941370|FG001|Overall Study|Withdrawal by Subject|7
6914805|NCT00764504|10941371|FG002|Overall Study|Withdrawal by Subject|4
6914806|NCT00764504|10941369|FG000|Overall Study|Lost to Follow-up|40
6914807|NCT00764504|10941370|FG001|Overall Study|Lost to Follow-up|34
6914808|NCT00764504|10941371|FG002|Overall Study|Lost to Follow-up|72
6914809|NCT00764517|10941381|FG000|Overall Study|Adverse Event|9
6914810|NCT00764517|10941382|FG001|Overall Study|Adverse Event|3
6914811|NCT00764517|10941381|FG000|Overall Study|Death|3
6914812|NCT00764517|10941382|FG001|Overall Study|Death|11
6914813|NCT00764517|10941381|FG000|Overall Study|Physician Decision|3
6914814|NCT00764517|10941382|FG001|Overall Study|Physician Decision|0
6914815|NCT00764660|10941390|FG000|Overall Study|Adverse Event|6
6914816|NCT00764660|10941391|FG001|Overall Study|Adverse Event|3
6914817|NCT00764660|10941390|FG000|Overall Study|Lost to Follow-up|3
6914818|NCT00764660|10941391|FG001|Overall Study|Lost to Follow-up|4
6914819|NCT00764660|10941390|FG000|Overall Study|Withdrawal by Subject|7
6914820|NCT00764660|10941391|FG001|Overall Study|Withdrawal by Subject|3
6914821|NCT00764660|10941390|FG000|Overall Study|Noncompliance With Protocol|5
6914822|NCT00764660|10941391|FG001|Overall Study|Noncompliance With Protocol|1
6914823|NCT00764660|10941390|FG000|Overall Study|Did Not Meet Protocol Eligibility|1
6914824|NCT00764660|10941391|FG001|Overall Study|Did Not Meet Protocol Eligibility|0
6914825|NCT00764673|10941397|FG000|Overall Study|Death|1
6914826|NCT00764673|10941397|FG000|Overall Study|Lost to Follow-up|3
6914827|NCT00764673|10941397|FG000|Overall Study|Withdrawal by Subject|6
6914828|NCT00764673|10941397|FG000|Overall Study|Revision of Device|2
6914829|NCT00764751|10941420|FG000|Overall Study|Adverse Event|1
6914830|NCT00764751|10941421|FG001|Overall Study|Adverse Event|1
6914831|NCT00764751|10941420|FG000|Overall Study|Psoriasis flare up on the scalp|1
6914832|NCT00764751|10941421|FG001|Overall Study|Psoriasis flare up on the scalp|0
6914833|NCT00764790|10941435|FG000|Overall Study|Protocol Violation|0
6914834|NCT00764790|10941436|FG001|Overall Study|Protocol Violation|0
6914835|NCT00764790|10941437|FG002|Overall Study|Protocol Violation|1
6914836|NCT00764790|10941435|FG000|Overall Study|Withdrawal by Subject|10
6914837|NCT00764790|10941436|FG001|Overall Study|Withdrawal by Subject|12
6914838|NCT00764790|10941437|FG002|Overall Study|Withdrawal by Subject|6
6914839|NCT00764790|10941435|FG000|Overall Study|Lost to Follow-up|28
6914840|NCT00764790|10941436|FG001|Overall Study|Lost to Follow-up|29
6914841|NCT00764790|10941437|FG002|Overall Study|Lost to Follow-up|23
6914842|NCT00764868|10941445|FG000|Overall Study|Adverse Event|18
6914843|NCT00764868|10941445|FG000|Overall Study|Withdrawal by Subject|31
6914844|NCT00764868|10941445|FG000|Overall Study|Non-compliance|16
6914845|NCT00764868|10941445|FG000|Overall Study|Lost to Follow-up|25
6914846|NCT00764868|10941445|FG000|Overall Study|Lack of Efficacy|5
6914847|NCT00764868|10941445|FG000|Overall Study|Subject moved|7
6914848|NCT00764868|10941445|FG000|Overall Study|Pregnancy|3
6914849|NCT00764868|10941445|FG000|Overall Study|Prohibited medication|1
6914850|NCT00764868|10941445|FG000|Overall Study|Out of town|1
6914851|NCT00764868|10941445|FG000|Overall Study|Misuse and compliance of study drug|1
6914852|NCT00764868|10941445|FG000|Overall Study|Subject sent to boarding school|1
6914853|NCT00764868|10941445|FG000|Overall Study|Met an exclusion criteria|1
6914854|NCT00764868|10941445|FG000|Overall Study|Positive drug screen|2
6914855|NCT00764868|10941445|FG000|Overall Study|Sponsor requested withdrawal|1
6914856|NCT00764881|10941451|FG000|Overall Study|Adverse Event|5
6914857|NCT00764881|10941452|FG001|Overall Study|Adverse Event|1
6914858|NCT00764881|10941451|FG000|Overall Study|Withdrawal by Subject|1
6914859|NCT00764881|10941452|FG001|Overall Study|Withdrawal by Subject|3
6914860|NCT00764881|10941451|FG000|Overall Study|Protocol Violation|2
6914861|NCT00764881|10941452|FG001|Overall Study|Protocol Violation|2
6914862|NCT00764881|10941451|FG000|Overall Study|Lost to Follow-up|2
6914863|NCT00764881|10941452|FG001|Overall Study|Lost to Follow-up|0
6914864|NCT00764881|10941451|FG000|Overall Study|Noncompliant|1
6914865|NCT00764881|10941452|FG001|Overall Study|Noncompliant|0
6914866|NCT00764881|10941451|FG000|Overall Study|Accidentally discontinued study drug|1
6914867|NCT00764881|10941452|FG001|Overall Study|Accidentally discontinued study drug|0
6914868|NCT00764881|10941451|FG000|Overall Study|Wished to become pregnant|1
6914869|NCT00764881|10941452|FG001|Overall Study|Wished to become pregnant|0
6914870|NCT00764881|10941451|FG000|Overall Study|Carcinoma detected|1
6914871|NCT00764881|10941452|FG001|Overall Study|Carcinoma detected|0
6914872|NCT00764881|10941451|FG000|Overall Study|Possibly noncompliant (study drug)|0
6914873|NCT00764881|10941452|FG001|Overall Study|Possibly noncompliant (study drug)|2
6914874|NCT00764881|10941451|FG000|Overall Study|no treatment or no observation|2
6914875|NCT00764881|10941452|FG001|Overall Study|no treatment or no observation|2
6914876|NCT00764946|10941461|FG000|Overall Study|Lack of Efficacy|1
6914877|NCT00764946|10941462|FG001|Overall Study|Lack of Efficacy|0
6914878|NCT00764946|10941463|FG002|Overall Study|Lack of Efficacy|0
6914879|NCT00764946|10941461|FG000|Overall Study|Lost to Follow-up|3
6914880|NCT00764946|10941462|FG001|Overall Study|Lost to Follow-up|4
6914881|NCT00764946|10941463|FG002|Overall Study|Lost to Follow-up|0
6914882|NCT00764946|10941461|FG000|Overall Study|Physician Decision|2
6914883|NCT00764946|10941462|FG001|Overall Study|Physician Decision|4
6914884|NCT00764946|10941463|FG002|Overall Study|Physician Decision|0
6914885|NCT00764946|10941461|FG000|Overall Study|Adverse Event|3
6914886|NCT00764946|10941462|FG001|Overall Study|Adverse Event|2
6914887|NCT00764946|10941463|FG002|Overall Study|Adverse Event|1
6914888|NCT00764946|10941461|FG000|Overall Study|Withdrawal by Subject|3
6914889|NCT00764946|10941462|FG001|Overall Study|Withdrawal by Subject|6
6914890|NCT00764946|10941463|FG002|Overall Study|Withdrawal by Subject|2
6914891|NCT00764946|10941461|FG000|Overall Study|Never Treated|1
6914892|NCT00764946|10941462|FG001|Overall Study|Never Treated|1
6914893|NCT00764946|10941463|FG002|Overall Study|Never Treated|1
6914894|NCT00765037|10941477|FG000|Overall Study|Lost to Follow-up|5
6914895|NCT00765037|10941477|FG000|Overall Study|Adverse Event|1
6914896|NCT00765063|10941481|FG000|Overall Study|Lack of Efficacy|5
6914897|NCT00765063|10941481|FG000|Overall Study|Withdrawal by Subject|1
6914898|NCT00765063|10941481|FG000|Overall Study|Other|16
6914899|NCT00765063|10941481|FG000|Overall Study|Protocol Violation|6
6914900|NCT00765063|10941481|FG000|Overall Study|Adverse Event|4
6914901|NCT00765076|10941488|FG000|Overall Study|Adverse Event|1
6914902|NCT00765076|10941489|FG001|Overall Study|Adverse Event|0
6914903|NCT00765076|10941490|FG002|Overall Study|Adverse Event|0
6914904|NCT00765076|10941488|FG000|Overall Study|Withdrawal by Subject|0
6914905|NCT00765076|10941489|FG001|Overall Study|Withdrawal by Subject|0
6914906|NCT00765076|10941490|FG002|Overall Study|Withdrawal by Subject|1
6914907|NCT00765102|10941498|FG000|Overall Study|Progressive disease|18
6914908|NCT00765102|10941498|FG000|Overall Study|Adverse Event|6
6914909|NCT00765102|10941498|FG000|Overall Study|Physician Decision|4
6914910|NCT00765102|10941498|FG000|Overall Study|Withdrawal by Subject|2
6914911|NCT00765102|10941498|FG000|Overall Study|Protocol Violation|1
6914912|NCT00765245|10941538|FG000|Overall Study|disease progression|3
6914913|NCT00765245|10941539|FG001|Overall Study|disease progression|2
6914914|NCT00765245|10941538|FG000|Overall Study|Withdrawal by Subject|3
6914915|NCT00765245|10941539|FG001|Overall Study|Withdrawal by Subject|0
6914916|NCT00765245|10941538|FG000|Overall Study|Adverse Event|5
6914917|NCT00765245|10941539|FG001|Overall Study|Adverse Event|0
6914918|NCT00765245|10941538|FG000|Overall Study|Physician Decision|1
6914919|NCT00765245|10941539|FG001|Overall Study|Physician Decision|0
6914920|NCT00765245|10941538|FG000|Overall Study|Death|1
6914921|NCT00765245|10941539|FG001|Overall Study|Death|0
6914922|NCT00765336|10941547|FG000|Overall Study|Protocol Violation|4
6914923|NCT00765336|10941548|FG001|Overall Study|Protocol Violation|2
6914924|NCT00765336|10941547|FG000|Overall Study|Withdrawal by Subject|6
6914925|NCT00765336|10941548|FG001|Overall Study|Withdrawal by Subject|4
6914926|NCT00765336|10941547|FG000|Overall Study|Lost to Follow-up|7
6914927|NCT00765336|10941548|FG001|Overall Study|Lost to Follow-up|9
6914928|NCT00765336|10941547|FG000|Overall Study|Adverse Event|2
6914929|NCT00765336|10941548|FG001|Overall Study|Adverse Event|1
6914930|NCT00765362|10941554|FG000|Overall Study|Death|9
6914931|NCT00765362|10941554|FG000|Overall Study|Adverse Event|2
6914932|NCT00765362|10941554|FG000|Overall Study|Protocol Violation|18
6914933|NCT00765362|10941554|FG000|Overall Study|Withdrawal by Subject|13
6914934|NCT00765362|10941554|FG000|Overall Study|Lost to Follow-up|95
6914935|NCT00765388|10941564|FG000|Period 1|Lack of Efficacy|1
6914936|NCT00765388|10941565|FG001|Period 1|Lack of Efficacy|2
6914937|NCT00765388|10941564|FG000|Period 1|Lost to Follow-up|0
6914938|NCT00765388|10941565|FG001|Period 1|Lost to Follow-up|1
6914939|NCT00765388|10941564|FG000|Period 1|Herpes Zoster|0
6914940|NCT00765388|10941565|FG001|Period 1|Herpes Zoster|1
6914941|NCT00765388|10941564|FG000|Period 1|Hip operation|0
6914942|NCT00765388|10941565|FG001|Period 1|Hip operation|1
6914943|NCT00765674|10941602|FG000|Overall Study|Adverse Event|7
6914944|NCT00765674|10941603|FG001|Overall Study|Adverse Event|2
6914945|NCT00765674|10941604|FG002|Overall Study|Adverse Event|8
6914946|NCT00765674|10941605|FG003|Overall Study|Adverse Event|11
6914947|NCT00765674|10941602|FG000|Overall Study|Abnormal Laboratory Value(s)|0
6914948|NCT00765674|10941603|FG001|Overall Study|Abnormal Laboratory Value(s)|0
6914949|NCT00765674|10941604|FG002|Overall Study|Abnormal Laboratory Value(s)|1
6914950|NCT00765674|10941605|FG003|Overall Study|Abnormal Laboratory Value(s)|0
6914951|NCT00765674|10941602|FG000|Overall Study|Abnormal Test Procedure Result(s)|1
6914952|NCT00765674|10941603|FG001|Overall Study|Abnormal Test Procedure Result(s)|3
6914953|NCT00765674|10941604|FG002|Overall Study|Abnormal Test Procedure Result(s)|1
6914954|NCT00765674|10941605|FG003|Overall Study|Abnormal Test Procedure Result(s)|2
6914955|NCT00765674|10941602|FG000|Overall Study|Lack of Efficacy|2
6914956|NCT00765674|10941603|FG001|Overall Study|Lack of Efficacy|3
6914957|NCT00765674|10941604|FG002|Overall Study|Lack of Efficacy|1
6914958|NCT00765674|10941605|FG003|Overall Study|Lack of Efficacy|2
6914959|NCT00765674|10941602|FG000|Overall Study|Protocol Violation|2
6914960|NCT00765674|10941603|FG001|Overall Study|Protocol Violation|0
6914961|NCT00765674|10941604|FG002|Overall Study|Protocol Violation|1
6914962|NCT00765674|10941605|FG003|Overall Study|Protocol Violation|0
6914963|NCT00765674|10941602|FG000|Overall Study|Withdrawal by Subject|5
6914964|NCT00765674|10941603|FG001|Overall Study|Withdrawal by Subject|7
6914965|NCT00765674|10941604|FG002|Overall Study|Withdrawal by Subject|3
6914966|NCT00765674|10941605|FG003|Overall Study|Withdrawal by Subject|8
6914967|NCT00765674|10941602|FG000|Overall Study|Lost to Follow-up|4
6914968|NCT00765674|10941603|FG001|Overall Study|Lost to Follow-up|6
6914969|NCT00765674|10941604|FG002|Overall Study|Lost to Follow-up|2
6914970|NCT00765674|10941605|FG003|Overall Study|Lost to Follow-up|1
6914971|NCT00765674|10941602|FG000|Overall Study|Randomized in Error - No Study Drug|0
6914972|NCT00765674|10941603|FG001|Overall Study|Randomized in Error - No Study Drug|1
6914973|NCT00765674|10941604|FG002|Overall Study|Randomized in Error - No Study Drug|0
6914974|NCT00765674|10941605|FG003|Overall Study|Randomized in Error - No Study Drug|1
6914975|NCT00765726|10941615|FG000|Overall Study|Withdrawal by Subject|1
6914976|NCT00765726|10941615|FG000|Overall Study|Discontinuation of study by sponsor|8
6914977|NCT00765817|10941621|FG000|Overall Study|Adverse Event|13
6914978|NCT00765817|10941622|FG001|Overall Study|Adverse Event|1
6914979|NCT00765817|10941621|FG000|Overall Study|Death|0
6914980|NCT00765817|10941622|FG001|Overall Study|Death|1
6914981|NCT00765817|10941621|FG000|Overall Study|Entry criteria not met|2
6914982|NCT00765817|10941622|FG001|Overall Study|Entry criteria not met|2
6914983|NCT00765817|10941621|FG000|Overall Study|Loss of glucose control|0
6914984|NCT00765817|10941622|FG001|Overall Study|Loss of glucose control|2
6914985|NCT00765817|10941621|FG000|Overall Study|Lost to Follow-up|1
6914986|NCT00765817|10941622|FG001|Overall Study|Lost to Follow-up|3
6914987|NCT00765817|10941621|FG000|Overall Study|Physician Decision|2
6914988|NCT00765817|10941622|FG001|Overall Study|Physician Decision|1
6914989|NCT00765817|10941621|FG000|Overall Study|Protocol Violation|1
6914990|NCT00765817|10941622|FG001|Overall Study|Protocol Violation|1
6914991|NCT00765817|10941621|FG000|Overall Study|Subject decision|7
6914992|NCT00765817|10941622|FG001|Overall Study|Subject decision|11
6914993|NCT00765843|10941631|FG000|Overall Study|Lost to Follow-up|1
6914994|NCT00765843|10941632|FG001|Overall Study|Lost to Follow-up|3
6914995|NCT00765843|10941633|FG002|Overall Study|Lost to Follow-up|2
6914996|NCT00765843|10941631|FG000|Overall Study|did not return to receive intervention|0
6914997|NCT00765843|10941632|FG001|Overall Study|did not return to receive intervention|1
6914998|NCT00765843|10941633|FG002|Overall Study|did not return to receive intervention|0
6914999|NCT00765843|10941631|FG000|Overall Study|Adverse Event|0
6915000|NCT00765843|10941632|FG001|Overall Study|Adverse Event|0
6915001|NCT00765843|10941633|FG002|Overall Study|Adverse Event|1
6915002|NCT00765882|10941651|FG000|Overall Study|Adverse Event|10
6915003|NCT00765882|10941652|FG001|Overall Study|Adverse Event|21
6915004|NCT00765882|10941653|FG002|Overall Study|Adverse Event|20
6915005|NCT00765882|10941651|FG000|Overall Study|Lack of Efficacy|4
6915006|NCT00765882|10941652|FG001|Overall Study|Lack of Efficacy|0
6915007|NCT00765882|10941653|FG002|Overall Study|Lack of Efficacy|1
6915008|NCT00765882|10941651|FG000|Overall Study|Protocol Violation|4
6915009|NCT00765882|10941652|FG001|Overall Study|Protocol Violation|3
6915010|NCT00765882|10941653|FG002|Overall Study|Protocol Violation|1
6915011|NCT00765882|10941651|FG000|Overall Study|Withdrawal by Subject|2
6915012|NCT00765882|10941652|FG001|Overall Study|Withdrawal by Subject|6
6915013|NCT00765882|10941653|FG002|Overall Study|Withdrawal by Subject|6
6915014|NCT00765882|10941651|FG000|Overall Study|Lost to Follow-up|1
6915015|NCT00765882|10941652|FG001|Overall Study|Lost to Follow-up|9
6915016|NCT00765882|10941653|FG002|Overall Study|Lost to Follow-up|6
6915017|NCT00765882|10941651|FG000|Overall Study|Other Reason|3
6915018|NCT00765882|10941652|FG001|Overall Study|Other Reason|1
6915019|NCT00765882|10941653|FG002|Overall Study|Other Reason|2
6915020|NCT00765999|10941676|FG000|Overall Study|Adverse Event|203
6915021|NCT00765999|10941676|FG000|Overall Study|Insufficient Therapeutic Response|100
6915022|NCT00765999|10941676|FG000|Overall Study|Protocol Violation|95
6915023|NCT00765999|10941676|FG000|Overall Study|Consent Withdrawn|202
6915024|NCT00765999|10941676|FG000|Overall Study|Lost to Follow-up|131
6915025|NCT00765999|10941676|FG000|Overall Study|Study Terminated by Sponsor|2
6915026|NCT00765999|10941676|FG000|Overall Study|Other Miscellaneous Reasons|51
6915027|NCT00766038|10941684|FG000|Overall Study|Lost to Follow-up|15
6915028|NCT00766038|10941685|FG001|Overall Study|Lost to Follow-up|14
6915029|NCT00766051|10941695|FG000|Overall Study|Withdrawal by Subject|2
6915030|NCT00766051|10941696|FG001|Overall Study|Withdrawal by Subject|0
6915031|NCT00766090|10941706|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0
6915032|NCT00766090|10941707|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0
6915033|NCT00766090|10941708|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0
6915034|NCT00766090|10941709|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0
6915035|NCT00766090|10941710|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0
6915036|NCT00766090|10941711|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0
6915037|NCT00766090|10941712|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0
6915038|NCT00766090|10941713|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0
6915039|NCT00766090|10941714|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1
6915040|NCT00766090|10941715|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0
6915041|NCT00766090|10941716|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0
6915042|NCT00766090|10941717|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0
6915043|NCT00766090|10941706|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2
6915044|NCT00766090|10941707|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0
6915045|NCT00766090|10941708|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0
6915046|NCT00766090|10941709|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0
6915047|NCT00766090|10941710|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0
6915048|NCT00766090|10941711|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0
6915049|NCT00766090|10941712|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0
6915050|NCT00766090|10941713|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0
6915051|NCT00766090|10941714|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0
6915052|NCT00766090|10941715|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0
6915053|NCT00766090|10941716|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0
6915054|NCT00766090|10941717|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0
6915055|NCT00766090|10941706|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
6915056|NCT00766090|10941707|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
6915057|NCT00766090|10941708|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
6915058|NCT00766090|10941709|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
6915059|NCT00766090|10941710|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
6915060|NCT00766090|10941711|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
6915061|NCT00766090|10941712|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
6915062|NCT00766090|10941713|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
6915063|NCT00766090|10941714|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
6915064|NCT00766090|10941715|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
6915065|NCT00766090|10941716|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
6915066|NCT00766090|10941717|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
6915067|NCT00766090|10941706|FG000|Washout Period 1 (14 Days)|Protocol Violation|0
6915068|NCT00766090|10941707|FG001|Washout Period 1 (14 Days)|Protocol Violation|0
6915069|NCT00766090|10941708|FG002|Washout Period 1 (14 Days)|Protocol Violation|1
6915070|NCT00766090|10941709|FG003|Washout Period 1 (14 Days)|Protocol Violation|0
6915071|NCT00766090|10941710|FG004|Washout Period 1 (14 Days)|Protocol Violation|0
6915072|NCT00766090|10941711|FG005|Washout Period 1 (14 Days)|Protocol Violation|0
6915073|NCT00766090|10941712|FG006|Washout Period 1 (14 Days)|Protocol Violation|0
6915074|NCT00766090|10941713|FG007|Washout Period 1 (14 Days)|Protocol Violation|0
6915075|NCT00766090|10941714|FG008|Washout Period 1 (14 Days)|Protocol Violation|0
6915076|NCT00766090|10941715|FG009|Washout Period 1 (14 Days)|Protocol Violation|0
6915077|NCT00766090|10941716|FG010|Washout Period 1 (14 Days)|Protocol Violation|0
6915078|NCT00766090|10941717|FG011|Washout Period 1 (14 Days)|Protocol Violation|0
6915079|NCT00766090|10941706|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0
6915080|NCT00766090|10941707|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0
6915081|NCT00766090|10941708|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0
6915082|NCT00766090|10941709|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0
6915083|NCT00766090|10941710|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2
6915084|NCT00766090|10941711|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0
6915085|NCT00766090|10941712|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0
6915086|NCT00766090|10941713|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0
6915087|NCT00766090|10941714|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0
6915088|NCT00766090|10941715|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0
6915089|NCT00766090|10941716|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0
6915090|NCT00766090|10941717|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0
6915091|NCT00766090|10941706|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0
6915092|NCT00766090|10941707|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0
6915093|NCT00766090|10941708|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1
6915094|NCT00766090|10941709|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0
6915095|NCT00766090|10941710|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0
6915096|NCT00766090|10941711|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0
6915097|NCT00766090|10941712|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0
6915098|NCT00766090|10941713|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0
6915099|NCT00766090|10941714|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0
6915100|NCT00766090|10941715|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0
6915101|NCT00766090|10941716|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0
6915102|NCT00766090|10941717|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0
6915103|NCT00766090|10941706|FG000|Washout Period 2 (14 Days)|Physician Decision|0
6915104|NCT00766090|10941707|FG001|Washout Period 2 (14 Days)|Physician Decision|0
6915105|NCT00766090|10941708|FG002|Washout Period 2 (14 Days)|Physician Decision|1
6915106|NCT00766090|10941709|FG003|Washout Period 2 (14 Days)|Physician Decision|0
6915107|NCT00766090|10941710|FG004|Washout Period 2 (14 Days)|Physician Decision|0
6915108|NCT00766090|10941711|FG005|Washout Period 2 (14 Days)|Physician Decision|0
6915109|NCT00766090|10941712|FG006|Washout Period 2 (14 Days)|Physician Decision|0
6915110|NCT00766090|10941713|FG007|Washout Period 2 (14 Days)|Physician Decision|0
6915111|NCT00766090|10941714|FG008|Washout Period 2 (14 Days)|Physician Decision|0
6915112|NCT00766090|10941715|FG009|Washout Period 2 (14 Days)|Physician Decision|0
6915113|NCT00766090|10941716|FG010|Washout Period 2 (14 Days)|Physician Decision|0
6915114|NCT00766090|10941717|FG011|Washout Period 2 (14 Days)|Physician Decision|0
6915115|NCT00766090|10941706|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0
6915116|NCT00766090|10941707|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0
6915117|NCT00766090|10941708|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0
6915118|NCT00766090|10941709|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0
6915119|NCT00766090|10941710|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0
6915120|NCT00766090|10941711|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1
6915121|NCT00766090|10941712|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0
6915122|NCT00766090|10941713|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0
6915123|NCT00766090|10941714|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0
6915124|NCT00766090|10941715|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0
6915125|NCT00766090|10941716|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0
6915126|NCT00766090|10941717|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0
6915127|NCT00766090|10941706|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0
6915128|NCT00766090|10941707|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1
6915129|NCT00766090|10941708|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0
6915130|NCT00766090|10941709|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1
6915131|NCT00766090|10941710|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0
6915132|NCT00766090|10941711|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0
6915133|NCT00766090|10941712|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0
6915134|NCT00766090|10941713|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0
6915135|NCT00766090|10941714|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0
6915136|NCT00766090|10941715|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0
6915137|NCT00766090|10941716|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0
6915138|NCT00766090|10941717|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1
6915139|NCT00766090|10941706|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0
6915140|NCT00766090|10941707|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0
6915141|NCT00766090|10941708|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0
6915142|NCT00766090|10941709|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0
6915143|NCT00766090|10941710|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1
6915144|NCT00766090|10941711|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0
6915145|NCT00766090|10941712|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0
6915146|NCT00766090|10941713|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0
6915147|NCT00766090|10941714|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0
6915148|NCT00766090|10941715|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0
6915149|NCT00766090|10941716|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0
6915150|NCT00766090|10941717|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0
6915151|NCT00766142|10941738|FG000|Overall Study|Protocol Violation|4
6915152|NCT00766363|10941746|FG000|Overall Study|Withdrawal by Subject|1
6915153|NCT00766363|10941747|FG001|Overall Study|Withdrawal by Subject|0
6915154|NCT00766363|10941748|FG002|Overall Study|Withdrawal by Subject|0
6915155|NCT00766363|10941749|FG003|Overall Study|Withdrawal by Subject|0
6915156|NCT00766363|10941746|FG000|Overall Study|Adverse Event Prior to Randomization|0
6915157|NCT00766363|10941747|FG001|Overall Study|Adverse Event Prior to Randomization|1
6915158|NCT00766363|10941748|FG002|Overall Study|Adverse Event Prior to Randomization|0
6915159|NCT00766363|10941749|FG003|Overall Study|Adverse Event Prior to Randomization|0
6915160|NCT00766376|10941760|FG000|Overall Study|Withdrawal by Subject|27
6915161|NCT00766415|10941766|FG000|Overall Study|Withdrawal by Subject|0
6915162|NCT00766415|10941767|FG001|Overall Study|Withdrawal by Subject|1
6915163|NCT00766467|10941775|FG000|Overall Study|Withdrawal by Subject|7
6915164|NCT00766467|10941776|FG001|Overall Study|Withdrawal by Subject|2
6915165|NCT00766467|10941775|FG000|Overall Study|Adverse Event|1
6915166|NCT00766467|10941776|FG001|Overall Study|Adverse Event|1
6915167|NCT00766467|10941775|FG000|Overall Study|Protocol Violation|2
6915168|NCT00766467|10941776|FG001|Overall Study|Protocol Violation|4
6915169|NCT00766467|10941775|FG000|Overall Study|Tumor Progression on Study|0
6915170|NCT00766467|10941776|FG001|Overall Study|Tumor Progression on Study|1
6915171|NCT00766467|10941775|FG000|Overall Study|Physician Decision|1
6915172|NCT00766467|10941776|FG001|Overall Study|Physician Decision|0
6915173|NCT00766493|10941782|FG000|30 Days Post-Procedure|Discontinued|7
6915174|NCT00766493|10941782|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4
6915175|NCT00766493|10941782|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1
6915176|NCT00766506|10941788|FG000|Overall Study|Use rescue medication after 3 hours|3
6915177|NCT00766506|10941789|FG001|Overall Study|Use rescue medication after 3 hours|0
6915178|NCT00766506|10941788|FG000|Overall Study|Other|2
6915179|NCT00766506|10941789|FG001|Overall Study|Other|2
6915180|NCT00766532|10941795|FG000|Overall Study|Protocol Violation|2
6915181|NCT00766597|10941799|FG000|Overall Study|Unexpected closure of study|4
6915182|NCT00766597|10941799|FG000|Overall Study|Without CCR5-tropic virus|5
6915183|NCT00766675|10941809|FG000|Overall Study|Adverse Event|16
6915184|NCT00766675|10941809|FG000|Overall Study|Lost to Follow-up|2
6915185|NCT00766675|10941809|FG000|Overall Study|Withdrawal by Subject|11
6915186|NCT00766675|10941809|FG000|Overall Study|Protocol Violation|8
6915187|NCT00766675|10941809|FG000|Overall Study|Participant took prohibited medication|1
6915188|NCT00766675|10941809|FG000|Overall Study|Receive other anti-neoplastic treatment|1
6915189|NCT00766675|10941809|FG000|Overall Study|Insufficient therapy|1
6915190|NCT00766831|10941829|FG000|Overall Study|Withdrawal by Subject|4
6915191|NCT00766831|10941829|FG000|Overall Study|Lost to Follow-up|3
6915192|NCT00766831|10941829|FG000|Overall Study|Adverse Event|20
6915193|NCT00766831|10941829|FG000|Overall Study|Protocol Violation|15
6915194|NCT00766831|10941829|FG000|Overall Study|Physician Decision|5
6915195|NCT00766831|10941829|FG000|Overall Study|Withdrawal of consent|26
6915196|NCT00766831|10941829|FG000|Overall Study|Non cooperation by participants|14
6915197|NCT00766831|10941829|FG000|Overall Study|Other|28
6915198|NCT00767000|10941838|FG000|54-week Study|Adverse Event|4
6915199|NCT00767000|10941839|FG001|54-week Study|Adverse Event|6
6915200|NCT00767000|10941840|FG002|54-week Study|Adverse Event|6
6915201|NCT00767000|10941841|FG003|54-week Study|Adverse Event|8
6915202|NCT00767000|10941842|FG004|54-week Study|Adverse Event|4
6915203|NCT00767000|10941838|FG000|54-week Study|Creaninine/creatinine clearance|2
6915204|NCT00767000|10941839|FG001|54-week Study|Creaninine/creatinine clearance|1
6915205|NCT00767000|10941840|FG002|54-week Study|Creaninine/creatinine clearance|2
6915206|NCT00767000|10941841|FG003|54-week Study|Creaninine/creatinine clearance|2
6915207|NCT00767000|10941842|FG004|54-week Study|Creaninine/creatinine clearance|4
6915208|NCT00767000|10941838|FG000|54-week Study|Hyperglycemia|0
6915209|NCT00767000|10941839|FG001|54-week Study|Hyperglycemia|0
6915210|NCT00767000|10941840|FG002|54-week Study|Hyperglycemia|1
6915211|NCT00767000|10941841|FG003|54-week Study|Hyperglycemia|0
6915212|NCT00767000|10941842|FG004|54-week Study|Hyperglycemia|1
6915213|NCT00767000|10941838|FG000|54-week Study|Hypoglycemia|0
6915214|NCT00767000|10941839|FG001|54-week Study|Hypoglycemia|1
6915215|NCT00767000|10941840|FG002|54-week Study|Hypoglycemia|0
6915216|NCT00767000|10941841|FG003|54-week Study|Hypoglycemia|0
6915217|NCT00767000|10941842|FG004|54-week Study|Hypoglycemia|0
6915218|NCT00767000|10941838|FG000|54-week Study|Interruption of study medication|0
6979074|NCT01215955|11032818|FG000|Overall Study|Lost to Follow-up|4
6915219|NCT00767000|10941839|FG001|54-week Study|Interruption of study medication|0
6915220|NCT00767000|10941840|FG002|54-week Study|Interruption of study medication|1
6915221|NCT00767000|10941841|FG003|54-week Study|Interruption of study medication|0
6915222|NCT00767000|10941842|FG004|54-week Study|Interruption of study medication|0
6915223|NCT00767000|10941838|FG000|54-week Study|Lack of Efficacy|2
6915224|NCT00767000|10941839|FG001|54-week Study|Lack of Efficacy|0
6915225|NCT00767000|10941840|FG002|54-week Study|Lack of Efficacy|1
6915226|NCT00767000|10941841|FG003|54-week Study|Lack of Efficacy|0
6915227|NCT00767000|10941842|FG004|54-week Study|Lack of Efficacy|5
6915228|NCT00767000|10941838|FG000|54-week Study|Lost to Follow-up|4
6915229|NCT00767000|10941839|FG001|54-week Study|Lost to Follow-up|0
6915230|NCT00767000|10941840|FG002|54-week Study|Lost to Follow-up|1
6915231|NCT00767000|10941841|FG003|54-week Study|Lost to Follow-up|4
6915232|NCT00767000|10941842|FG004|54-week Study|Lost to Follow-up|2
6915233|NCT00767000|10941838|FG000|54-week Study|Physician Decision|4
6915234|NCT00767000|10941839|FG001|54-week Study|Physician Decision|0
6915235|NCT00767000|10941840|FG002|54-week Study|Physician Decision|1
6915236|NCT00767000|10941841|FG003|54-week Study|Physician Decision|1
6915237|NCT00767000|10941842|FG004|54-week Study|Physician Decision|1
6915238|NCT00767000|10941838|FG000|54-week Study|Progressive disease|0
6915239|NCT00767000|10941839|FG001|54-week Study|Progressive disease|0
6915240|NCT00767000|10941840|FG002|54-week Study|Progressive disease|1
6915241|NCT00767000|10941841|FG003|54-week Study|Progressive disease|0
6915242|NCT00767000|10941842|FG004|54-week Study|Progressive disease|0
6915243|NCT00767000|10941838|FG000|54-week Study|Protocol Violation|0
6915244|NCT00767000|10941839|FG001|54-week Study|Protocol Violation|0
6915245|NCT00767000|10941840|FG002|54-week Study|Protocol Violation|1
6915246|NCT00767000|10941841|FG003|54-week Study|Protocol Violation|2
6915247|NCT00767000|10941842|FG004|54-week Study|Protocol Violation|0
6915248|NCT00767000|10941838|FG000|54-week Study|Withdrawal by Subject|2
6915249|NCT00767000|10941839|FG001|54-week Study|Withdrawal by Subject|3
6915250|NCT00767000|10941840|FG002|54-week Study|Withdrawal by Subject|5
6915251|NCT00767000|10941841|FG003|54-week Study|Withdrawal by Subject|11
6915252|NCT00767000|10941842|FG004|54-week Study|Withdrawal by Subject|13
6915253|NCT00767000|10941838|FG000|54-week Study|Study terminated by sponsor|90
6915254|NCT00767000|10941839|FG001|54-week Study|Study terminated by sponsor|102
6915255|NCT00767000|10941840|FG002|54-week Study|Study terminated by sponsor|89
6915256|NCT00767000|10941841|FG003|54-week Study|Study terminated by sponsor|196
6915257|NCT00767000|10941842|FG004|54-week Study|Study terminated by sponsor|194
6915258|NCT00767000|10941838|FG000|54-week Study|Reason not reported|0
6915259|NCT00767000|10941839|FG001|54-week Study|Reason not reported|0
6915260|NCT00767000|10941840|FG002|54-week Study|Reason not reported|0
6915261|NCT00767000|10941841|FG003|54-week Study|Reason not reported|1
6915262|NCT00767000|10941842|FG004|54-week Study|Reason not reported|0
6915263|NCT00767000|10941838|FG000|Optional 104-week Extension|Study terminated by sponsor|7
6915264|NCT00767000|10941839|FG001|Optional 104-week Extension|Study terminated by sponsor|3
6915265|NCT00767000|10941840|FG002|Optional 104-week Extension|Study terminated by sponsor|7
6915266|NCT00767000|10941841|FG003|Optional 104-week Extension|Study terminated by sponsor|2
6915267|NCT00767000|10941842|FG004|Optional 104-week Extension|Study terminated by sponsor|4
6915268|NCT00767039|10941856|FG000|Overall Study|Death|5
6915269|NCT00767039|10941857|FG001|Overall Study|Death|2
6915270|NCT00767104|10941865|FG000|Overall Study|Lost to Follow-up|1
6915271|NCT00767104|10941866|FG001|Overall Study|Lost to Follow-up|2
6915272|NCT00767325|10941874|FG000|Overall Study|Lack of Efficacy|2
6915273|NCT00767325|10941874|FG000|Overall Study|Adverse Event|7
6915274|NCT00767325|10941874|FG000|Overall Study|Lost to Follow-up|3
6915275|NCT00767325|10941874|FG000|Overall Study|No longer met study criteria|2
6915276|NCT00767325|10941874|FG000|Overall Study|Missed visit due to family reasons|1
6915277|NCT00767455|10941904|FG000|Overall Study|Investigator error|19
6915278|NCT00767520|10941936|FG000|Overall Study|Participants still on treatment|11
6915279|NCT00767520|10941937|FG001|Overall Study|Participants still on treatment|15
6915280|NCT00767520|10941936|FG000|Overall Study|Randomized in error and Never treated|0
6915281|NCT00767520|10941937|FG001|Overall Study|Randomized in error and Never treated|2
6915282|NCT00767676|10941958|FG000|Overall Study|Investigator error|54
6915283|NCT00767806|10941985|FG000|Overall Study|Adverse Event|30
6915284|NCT00767806|10941986|FG001|Overall Study|Adverse Event|11
6915285|NCT00767806|10941985|FG000|Overall Study|Withdrawal by Subject|8
6915286|NCT00767806|10941986|FG001|Overall Study|Withdrawal by Subject|13
6915287|NCT00767806|10941985|FG000|Overall Study|Protocol Violation|6
6915288|NCT00767806|10941986|FG001|Overall Study|Protocol Violation|5
6915289|NCT00767806|10941985|FG000|Overall Study|Lack of Efficacy|1
6915290|NCT00767806|10941986|FG001|Overall Study|Lack of Efficacy|9
6915291|NCT00767806|10941985|FG000|Overall Study|Physician Decision|4
6915292|NCT00767806|10941986|FG001|Overall Study|Physician Decision|3
6915293|NCT00767806|10941985|FG000|Overall Study|Lost to Follow-up|1
6915294|NCT00767806|10941986|FG001|Overall Study|Lost to Follow-up|4
6915295|NCT00767806|10941985|FG000|Overall Study|Entry Criteria Not Met|1
6915296|NCT00767806|10941986|FG001|Overall Study|Entry Criteria Not Met|1
6915297|NCT00767806|10941985|FG000|Overall Study|Sponsor Decision|0
6915298|NCT00767806|10941986|FG001|Overall Study|Sponsor Decision|1
6915299|NCT00767819|10941995|FG000|Overall Study|Unsatisfactory therapeutic effect|18
6915300|NCT00767819|10941996|FG001|Overall Study|Unsatisfactory therapeutic effect|14
6915301|NCT00767819|10941997|FG002|Overall Study|Unsatisfactory therapeutic effect|0
6915302|NCT00767819|10941995|FG000|Overall Study|Withdrawal by Subject|1
6915303|NCT00767819|10941996|FG001|Overall Study|Withdrawal by Subject|1
6915304|NCT00767819|10941997|FG002|Overall Study|Withdrawal by Subject|0
6915305|NCT00767819|10941995|FG000|Overall Study|Administrative problems|0
6915306|NCT00767819|10941996|FG001|Overall Study|Administrative problems|1
6915307|NCT00767819|10941997|FG002|Overall Study|Administrative problems|0
6915308|NCT00767819|10941995|FG000|Overall Study|Death|2
6915309|NCT00767819|10941996|FG001|Overall Study|Death|3
6915310|NCT00767819|10941997|FG002|Overall Study|Death|0
6915311|NCT00767819|10941995|FG000|Overall Study|Adverse Event|2
6915312|NCT00767819|10941996|FG001|Overall Study|Adverse Event|0
6915313|NCT00767819|10941997|FG002|Overall Study|Adverse Event|0
6915314|NCT00767819|10941995|FG000|Overall Study|Abnormal lab values|1
6915315|NCT00767819|10941996|FG001|Overall Study|Abnormal lab values|0
6915316|NCT00767819|10941997|FG002|Overall Study|Abnormal lab values|0
6915317|NCT00767819|10941995|FG000|Overall Study|Lost to Follow-up|1
6915318|NCT00767819|10941996|FG001|Overall Study|Lost to Follow-up|0
6915319|NCT00767819|10941997|FG002|Overall Study|Lost to Follow-up|0
6915320|NCT00768053|10942005|FG000|Overall Study|Adverse Event|10
6915321|NCT00768053|10942005|FG000|Overall Study|Lost to Follow-up|1
6915322|NCT00768066|10942012|FG000|Overall Study|Did not receive study product injection.|3
6915323|NCT00768066|10942013|FG001|Overall Study|Did not receive study product injection.|3
6915324|NCT00768066|10942014|FG002|Overall Study|Did not receive study product injection.|0
6915325|NCT00768079|10942025|FG000|Overall Study|Lost to Follow-up|2
6915326|NCT00768079|10942026|FG001|Overall Study|Lost to Follow-up|0
6915327|NCT00768079|10942027|FG002|Overall Study|Lost to Follow-up|4
6915328|NCT00768079|10942025|FG000|Overall Study|Participant incarcerated|0
6915329|NCT00768079|10942026|FG001|Overall Study|Participant incarcerated|1
6915330|NCT00768079|10942027|FG002|Overall Study|Participant incarcerated|0
6915331|NCT00768144|10942041|FG000|Overall Study|Adverse Event|13
6915332|NCT00768144|10942041|FG000|Overall Study|Progressive Disease|21
6915333|NCT00768144|10942041|FG000|Overall Study|Patient or MD Decision to End Treatment|1
6915334|NCT00768144|10942041|FG000|Overall Study|Pt Withdrew Consent|1
6915335|NCT00768222|10942047|FG000|Overall Study|Lost to Follow-up|1
6915336|NCT00768222|10942048|FG001|Overall Study|Lost to Follow-up|1
6915337|NCT00768222|10942047|FG000|Overall Study|Withdrawal by Subject|3
6915338|NCT00768222|10942048|FG001|Overall Study|Withdrawal by Subject|1
6915339|NCT00768222|10942047|FG000|Overall Study|Protocol Violation|0
6915340|NCT00768222|10942048|FG001|Overall Study|Protocol Violation|2
6915341|NCT00768300|10942093|FG000|Overall Study|Randomized but not treated|1
6915342|NCT00768300|10942094|FG001|Overall Study|Randomized but not treated|1
6915343|NCT00768300|10942093|FG000|Overall Study|Adverse Event|10
6915344|NCT00768300|10942094|FG001|Overall Study|Adverse Event|2
6915345|NCT00768300|10942093|FG000|Overall Study|Protocol Violation|6
6915346|NCT00768300|10942094|FG001|Overall Study|Protocol Violation|1
6915347|NCT00768300|10942093|FG000|Overall Study|Withdrawal by Subject|13
6915348|NCT00768300|10942094|FG001|Overall Study|Withdrawal by Subject|7
6915349|NCT00768300|10942093|FG000|Overall Study|Physician Decision|2
6915350|NCT00768300|10942094|FG001|Overall Study|Physician Decision|3
6915351|NCT00768300|10942093|FG000|Overall Study|Study discontinued by Sponsor|271
6915352|NCT00768300|10942094|FG001|Overall Study|Study discontinued by Sponsor|140
6915353|NCT00768300|10942093|FG000|Overall Study|Death|21
6915354|NCT00768300|10942094|FG001|Overall Study|Death|5
6915355|NCT00768300|10942093|FG000|Overall Study|Subject moved to pursue lung transplant|1
6915356|NCT00768300|10942094|FG001|Overall Study|Subject moved to pursue lung transplant|1
6915357|NCT00768300|10942093|FG000|Overall Study|Screen failure following randomization|1
6915358|NCT00768300|10942094|FG001|Overall Study|Screen failure following randomization|0
6915359|NCT00768300|10942093|FG000|Overall Study|Received lung transplant|1
6915360|NCT00768300|10942094|FG001|Overall Study|Received lung transplant|1
6979075|NCT01215955|11032819|FG001|Overall Study|Lost to Follow-up|4
6979076|NCT01215955|11032820|FG002|Overall Study|Lost to Follow-up|8
6979077|NCT01215955|11032821|FG003|Overall Study|Lost to Follow-up|9
6979078|NCT01215955|11032818|FG000|Overall Study|Physician Decision|4
6979079|NCT01215955|11032819|FG001|Overall Study|Physician Decision|10
6979080|NCT01215955|11032820|FG002|Overall Study|Physician Decision|8
6979081|NCT01215955|11032821|FG003|Overall Study|Physician Decision|11
6979082|NCT01215955|11032818|FG000|Overall Study|Protocol Violation|17
6979083|NCT01215955|11032819|FG001|Overall Study|Protocol Violation|13
6979084|NCT01215955|11032820|FG002|Overall Study|Protocol Violation|8
6979085|NCT01215955|11032821|FG003|Overall Study|Protocol Violation|8
6979086|NCT01215955|11032818|FG000|Overall Study|Sponsor Decision|1
6979087|NCT01215955|11032819|FG001|Overall Study|Sponsor Decision|2
6979088|NCT01215955|11032820|FG002|Overall Study|Sponsor Decision|0
6979089|NCT01215955|11032821|FG003|Overall Study|Sponsor Decision|1
6979090|NCT01215955|11032818|FG000|Overall Study|Withdrawal by Subject|14
6979091|NCT01215955|11032819|FG001|Overall Study|Withdrawal by Subject|15
6979092|NCT01215955|11032820|FG002|Overall Study|Withdrawal by Subject|13
6979093|NCT01215955|11032821|FG003|Overall Study|Withdrawal by Subject|9
6979094|NCT01215955|11032818|FG000|Overall Study|Quality Issues|0
6915361|NCT00768300|10942093|FG000|Overall Study|Lost to Follow-up|0
6979095|NCT01215955|11032819|FG001|Overall Study|Quality Issues|0
6979096|NCT01215955|11032820|FG002|Overall Study|Quality Issues|3
6979097|NCT01215955|11032821|FG003|Overall Study|Quality Issues|2
6979098|NCT01215968|11032836|FG000|Overall Study|Adverse Event|0
6979099|NCT01215968|11032837|FG001|Overall Study|Adverse Event|2
6979100|NCT01215968|11032836|FG000|Overall Study|Protocol Violation|2
6979101|NCT01215968|11032837|FG001|Overall Study|Protocol Violation|4
6915362|NCT00768300|10942094|FG001|Overall Study|Lost to Follow-up|1
6915363|NCT00768300|10942093|FG000|Overall Study|Began prohibited concomitant medication|0
6915364|NCT00768300|10942094|FG001|Overall Study|Began prohibited concomitant medication|1
6915365|NCT00768300|10942093|FG000|Overall Study|Treated but never dosed with Study drug|1
6915366|NCT00768300|10942094|FG001|Overall Study|Treated but never dosed with Study drug|0
6915367|NCT00768300|10942093|FG000|Overall Study|Missing data|1
6915368|NCT00768300|10942094|FG001|Overall Study|Missing data|0
6915369|NCT00768430|10942102|FG000|7 Day Endpoint|Withdrawal by Subject|2
6915370|NCT00768430|10942103|FG001|7 Day Endpoint|Withdrawal by Subject|3
6915371|NCT00768469|10942111|FG000|Overall Study|Adverse Event|0
6915372|NCT00768469|10942112|FG001|Overall Study|Adverse Event|2
6915373|NCT00768469|10942111|FG000|Overall Study|Disease Progression|3
6915374|NCT00768469|10942112|FG001|Overall Study|Disease Progression|4
6915375|NCT00768469|10942111|FG000|Overall Study|Withdrawal by Subject|0
6915376|NCT00768469|10942112|FG001|Overall Study|Withdrawal by Subject|1
6915377|NCT00768560|10942132|FG000|Intervention Set 1|Adverse Event|0
6915378|NCT00768560|10942133|FG001|Intervention Set 1|Adverse Event|1
6915379|NCT00768560|10942134|FG002|Intervention Set 1|Adverse Event|0
6915380|NCT00768560|10942135|FG003|Intervention Set 1|Adverse Event|0
6915381|NCT00768560|10942136|FG004|Intervention Set 1|Adverse Event|0
6915382|NCT00768560|10942137|FG005|Intervention Set 1|Adverse Event|0
6974318|NCT01186744|11026225|FG002|Overall Study|Lack of Efficacy|0
6974319|NCT01186744|11026226|FG003|Overall Study|Lack of Efficacy|2
6974320|NCT01186744|11026227|FG004|Overall Study|Lack of Efficacy|2
6974321|NCT01186744|11026228|FG005|Overall Study|Lack of Efficacy|5
6974322|NCT01186744|11026223|FG000|Overall Study|Protocol Violation|1
6974323|NCT01186744|11026224|FG001|Overall Study|Protocol Violation|2
6974324|NCT01186744|11026225|FG002|Overall Study|Protocol Violation|0
6974325|NCT01186744|11026226|FG003|Overall Study|Protocol Violation|1
6974326|NCT01186744|11026227|FG004|Overall Study|Protocol Violation|1
6974327|NCT01186744|11026228|FG005|Overall Study|Protocol Violation|2
6974328|NCT01186744|11026223|FG000|Overall Study|Lost to Follow-up|15
6974329|NCT01186744|11026224|FG001|Overall Study|Lost to Follow-up|16
6974330|NCT01186744|11026225|FG002|Overall Study|Lost to Follow-up|2
6974331|NCT01186744|11026226|FG003|Overall Study|Lost to Follow-up|1
6974332|NCT01186744|11026227|FG004|Overall Study|Lost to Follow-up|1
6974333|NCT01186744|11026228|FG005|Overall Study|Lost to Follow-up|4
6974334|NCT01186744|11026223|FG000|Overall Study|Screen failure|1
6974335|NCT01186744|11026224|FG001|Overall Study|Screen failure|1
6974336|NCT01186744|11026225|FG002|Overall Study|Screen failure|0
6974337|NCT01186744|11026226|FG003|Overall Study|Screen failure|1
6974338|NCT01186744|11026227|FG004|Overall Study|Screen failure|0
6974339|NCT01186744|11026228|FG005|Overall Study|Screen failure|0
6974340|NCT01186744|11026223|FG000|Overall Study|Withdrawal by Subject|14
6974341|NCT01186744|11026224|FG001|Overall Study|Withdrawal by Subject|10
6974342|NCT01186744|11026225|FG002|Overall Study|Withdrawal by Subject|2
6974343|NCT01186744|11026226|FG003|Overall Study|Withdrawal by Subject|5
6974344|NCT01186744|11026227|FG004|Overall Study|Withdrawal by Subject|0
6974345|NCT01186744|11026228|FG005|Overall Study|Withdrawal by Subject|6
6974346|NCT01186744|11026223|FG000|Overall Study|Study terminated by Sponsor|1
6974347|NCT01186744|11026224|FG001|Overall Study|Study terminated by Sponsor|0
6974348|NCT01186744|11026225|FG002|Overall Study|Study terminated by Sponsor|0
6974349|NCT01186744|11026226|FG003|Overall Study|Study terminated by Sponsor|0
6974350|NCT01186744|11026227|FG004|Overall Study|Study terminated by Sponsor|0
6974351|NCT01186744|11026228|FG005|Overall Study|Study terminated by Sponsor|0
6974352|NCT01186744|11026223|FG000|Overall Study|Other|9
6974353|NCT01186744|11026224|FG001|Overall Study|Other|10
6974354|NCT01186744|11026225|FG002|Overall Study|Other|1
6974355|NCT01186744|11026226|FG003|Overall Study|Other|2
6974356|NCT01186744|11026227|FG004|Overall Study|Other|1
6974357|NCT01186744|11026228|FG005|Overall Study|Other|5
6974358|NCT01186744|11026223|FG000|Overall Study|Adverse Event|10
6974359|NCT01186744|11026224|FG001|Overall Study|Adverse Event|14
6974360|NCT01186744|11026225|FG002|Overall Study|Adverse Event|1
6974361|NCT01186744|11026226|FG003|Overall Study|Adverse Event|0
6974362|NCT01186744|11026227|FG004|Overall Study|Adverse Event|1
6974363|NCT01186744|11026228|FG005|Overall Study|Adverse Event|4
6974364|NCT01186744|11026223|FG000|Overall Study|Death|1
6974365|NCT01186744|11026224|FG001|Overall Study|Death|0
6974366|NCT01186744|11026225|FG002|Overall Study|Death|0
6974367|NCT01186744|11026226|FG003|Overall Study|Death|0
6974368|NCT01186744|11026227|FG004|Overall Study|Death|0
6974369|NCT01186744|11026228|FG005|Overall Study|Death|0
6974370|NCT01186770|11026267|FG000|Overall Study|Ineligibility|0
6974371|NCT01186770|11026268|FG001|Overall Study|Ineligibility|0
6974372|NCT01186770|11026269|FG002|Overall Study|Ineligibility|2
6974373|NCT01186770|11026270|FG003|Overall Study|Ineligibility|0
6974374|NCT01186770|11026267|FG000|Overall Study|Protocol Violation|7
6974375|NCT01186770|11026268|FG001|Overall Study|Protocol Violation|9
6974376|NCT01186770|11026269|FG002|Overall Study|Protocol Violation|12
6974377|NCT01186770|11026270|FG003|Overall Study|Protocol Violation|14
6974378|NCT01186770|11026267|FG000|Overall Study|Adverse Event|2
6974379|NCT01186770|11026268|FG001|Overall Study|Adverse Event|9
6974380|NCT01186770|11026269|FG002|Overall Study|Adverse Event|7
6974381|NCT01186770|11026270|FG003|Overall Study|Adverse Event|9
6974382|NCT01186770|11026267|FG000|Overall Study|Withdrawal by Subject|15
6974383|NCT01186770|11026268|FG001|Overall Study|Withdrawal by Subject|13
6974384|NCT01186770|11026269|FG002|Overall Study|Withdrawal by Subject|11
6915383|NCT00768651|10942158|FG000|Overall Study|Withdrawal by Subject|1
6915384|NCT00768664|10942163|FG000|Overall Study|Death|57
6915385|NCT00768664|10942163|FG000|Overall Study|Lost to Follow-up|2
6915386|NCT00768664|10942163|FG000|Overall Study|Other|9
6915387|NCT00768664|10942163|FG000|Overall Study|Participant refused|1
6915388|NCT00768755|10942183|FG000|Phase 1|Death|6
6915389|NCT00768755|10942184|FG001|Phase 1|Death|0
6915390|NCT00768755|10942185|FG002|Phase 1|Death|0
6915391|NCT00768755|10942186|FG003|Phase 1|Death|0
6915392|NCT00768755|10942183|FG000|Phase 1|Other|4
6915393|NCT00768755|10942184|FG001|Phase 1|Other|0
6915394|NCT00768755|10942185|FG002|Phase 1|Other|0
6915395|NCT00768755|10942186|FG003|Phase 1|Other|0
6915396|NCT00768755|10942183|FG000|Phase 2|Death|0
6915397|NCT00768755|10942184|FG001|Phase 2|Death|37
6915398|NCT00768755|10942185|FG002|Phase 2|Death|48
6915399|NCT00768755|10942186|FG003|Phase 2|Death|31
6915400|NCT00768755|10942183|FG000|Phase 2|Protocol Violation|0
6915401|NCT00768755|10942184|FG001|Phase 2|Protocol Violation|2
6915402|NCT00768755|10942185|FG002|Phase 2|Protocol Violation|0
6915403|NCT00768755|10942186|FG003|Phase 2|Protocol Violation|1
6915404|NCT00768755|10942183|FG000|Phase 2|Lost to Follow-up|0
6915405|NCT00768755|10942184|FG001|Phase 2|Lost to Follow-up|1
6915406|NCT00768755|10942185|FG002|Phase 2|Lost to Follow-up|1
6915407|NCT00768755|10942186|FG003|Phase 2|Lost to Follow-up|4
6915408|NCT00768755|10942183|FG000|Phase 2|Withdrawal by Subject|0
6915409|NCT00768755|10942184|FG001|Phase 2|Withdrawal by Subject|1
6915410|NCT00768755|10942185|FG002|Phase 2|Withdrawal by Subject|0
6915411|NCT00768755|10942186|FG003|Phase 2|Withdrawal by Subject|1
6915412|NCT00768755|10942183|FG000|Phase 2|Other|0
6915413|NCT00768755|10942184|FG001|Phase 2|Other|1
6915414|NCT00768755|10942185|FG002|Phase 2|Other|2
6915415|NCT00768755|10942186|FG003|Phase 2|Other|4
6915416|NCT00768755|10942183|FG000|Phase 2|Study Terminated by Sponsor|0
6915417|NCT00768755|10942184|FG001|Phase 2|Study Terminated by Sponsor|13
6915418|NCT00768755|10942185|FG002|Phase 2|Study Terminated by Sponsor|7
6915419|NCT00768755|10942186|FG003|Phase 2|Study Terminated by Sponsor|14
6915420|NCT00768755|10942183|FG000|Phase 2|Randomized but not treated|0
6915421|NCT00768755|10942184|FG001|Phase 2|Randomized but not treated|0
6915422|NCT00768755|10942185|FG002|Phase 2|Randomized but not treated|0
6915423|NCT00768755|10942186|FG003|Phase 2|Randomized but not treated|2
6915424|NCT00768898|10942195|FG000|Overall Study|Unrelated injury|1
6915425|NCT00768898|10942195|FG000|Overall Study|Headache|1
6915426|NCT00768989|10942206|FG000|Prior to Week 24|Withdrawal by Subject|1
6915427|NCT00768989|10942207|FG001|Prior to Week 24|Withdrawal by Subject|0
6915428|NCT00768989|10942206|FG000|Prior to Week 24|Adverse Event|3
6915429|NCT00768989|10942207|FG001|Prior to Week 24|Adverse Event|0
6915430|NCT00768989|10942206|FG000|Prior to Week 24|Lost to Follow-up|0
6915431|NCT00768989|10942207|FG001|Prior to Week 24|Lost to Follow-up|1
6915432|NCT00768989|10942206|FG000|Prior to Week 24|Protocol Violation|0
6915433|NCT00768989|10942207|FG001|Prior to Week 24|Protocol Violation|2
6915434|NCT00768989|10942206|FG000|Week 24 to Prior to Week 36|Adverse Event|1
6915435|NCT00768989|10942207|FG001|Week 24 to Prior to Week 36|Adverse Event|0
6915436|NCT00768989|10942206|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6
6915437|NCT00768989|10942207|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0
6915438|NCT00768989|10942206|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1
6915439|NCT00768989|10942207|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0
6915440|NCT00768989|10942206|FG000|On or After Week 36|Lack of Efficacy|1
6915441|NCT00768989|10942207|FG001|On or After Week 36|Lack of Efficacy|0
6915442|NCT00768989|10942206|FG000|On or After Week 36|Adverse Event|0
6915443|NCT00768989|10942207|FG001|On or After Week 36|Adverse Event|1
6915444|NCT00768989|10942206|FG000|On or After Week 36|Lost to Follow-up|1
6915445|NCT00768989|10942207|FG001|On or After Week 36|Lost to Follow-up|0
6915446|NCT00768989|10942206|FG000|On or After Week 36|Poor Compliance|1
6915447|NCT00768989|10942207|FG001|On or After Week 36|Poor Compliance|0
6915448|NCT00768989|10942206|FG000|On or After Week 36|Protocol Violation|1
6915449|NCT00768989|10942207|FG001|On or After Week 36|Protocol Violation|0
6915450|NCT00768989|10942206|FG000|On or After Week 36|Did not attend termination visit|2
6915451|NCT00768989|10942207|FG001|On or After Week 36|Did not attend termination visit|0
6915452|NCT00768989|10942206|FG000|On or After Week 36|Sponsor Termination|45
6915453|NCT00768989|10942207|FG001|On or After Week 36|Sponsor Termination|26
6915454|NCT00769067|10942226|FG000|Overall Study|Death|89
6915455|NCT00769067|10942227|FG001|Overall Study|Death|86
6915456|NCT00769067|10942226|FG000|Overall Study|Lost to Follow-up|3
6915457|NCT00769067|10942227|FG001|Overall Study|Lost to Follow-up|1
6915458|NCT00769067|10942226|FG000|Overall Study|Study terminated by sponsor|1
6915459|NCT00769067|10942227|FG001|Overall Study|Study terminated by sponsor|3
6915460|NCT00769067|10942226|FG000|Overall Study|Other|1
6915461|NCT00769067|10942227|FG001|Overall Study|Other|3
6915462|NCT00769067|10942226|FG000|Overall Study|Withdrawal by Subject|0
6915463|NCT00769067|10942227|FG001|Overall Study|Withdrawal by Subject|1
6915464|NCT00769119|10942236|FG000|Overall Study|Voluntary discontinuation|0
6915465|NCT00769119|10942237|FG001|Overall Study|Voluntary discontinuation|2
6915466|NCT00769119|10942236|FG000|Overall Study|Adverse Event|1
6915467|NCT00769119|10942237|FG001|Overall Study|Adverse Event|1
6915468|NCT00769119|10942236|FG000|Overall Study|Disallowed medication|1
6915469|NCT00769119|10942237|FG001|Overall Study|Disallowed medication|0
6915470|NCT00769132|10942243|FG000|Period 1|Adverse Event|1
6915471|NCT00769132|10942244|FG001|Period 1|Adverse Event|0
6915472|NCT00769132|10942245|FG002|Period 1|Adverse Event|0
6915473|NCT00769132|10942246|FG003|Period 1|Adverse Event|1
6915474|NCT00769132|10942243|FG000|Period 2|Withdrawal by Subject|0
6915475|NCT00769132|10942244|FG001|Period 2|Withdrawal by Subject|0
6915476|NCT00769132|10942245|FG002|Period 2|Withdrawal by Subject|0
6915477|NCT00769132|10942246|FG003|Period 2|Withdrawal by Subject|1
6915478|NCT00769132|10942243|FG000|Period 3|Withdrawal by Subject|1
6915479|NCT00769132|10942244|FG001|Period 3|Withdrawal by Subject|0
6915480|NCT00769132|10942245|FG002|Period 3|Withdrawal by Subject|0
6915481|NCT00769132|10942246|FG003|Period 3|Withdrawal by Subject|0
6915482|NCT00769132|10942243|FG000|Period 4|Withdrawal by Subject|0
6915483|NCT00769132|10942244|FG001|Period 4|Withdrawal by Subject|1
6915484|NCT00769132|10942245|FG002|Period 4|Withdrawal by Subject|0
6915485|NCT00769132|10942246|FG003|Period 4|Withdrawal by Subject|0
6915486|NCT00769184|10942256|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1
6915487|NCT00769184|10942257|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0
6915488|NCT00769184|10942256|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0
6915489|NCT00769184|10942257|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1
6915490|NCT00769184|10942256|FG000|No Treatment (6 Weeks)|Adverse Event|1
6915491|NCT00769184|10942257|FG001|No Treatment (6 Weeks)|Adverse Event|1
6915492|NCT00769483|10942284|FG000|Overall Study|Withdrawal by Subject|0
6915493|NCT00769483|10942285|FG001|Overall Study|Withdrawal by Subject|1
6915494|NCT00769483|10942286|FG002|Overall Study|Withdrawal by Subject|0
6915495|NCT00769483|10942287|FG003|Overall Study|Withdrawal by Subject|0
6915496|NCT00769483|10942288|FG004|Overall Study|Withdrawal by Subject|1
6915497|NCT00769483|10942289|FG005|Overall Study|Withdrawal by Subject|0
6915498|NCT00769561|10942307|FG000|Overall Study|Withdrawal by Subject|2
6915499|NCT00769561|10942308|FG001|Overall Study|Withdrawal by Subject|2
6915500|NCT00769561|10942307|FG000|Overall Study|Lost to Follow-up|1
6915501|NCT00769561|10942308|FG001|Overall Study|Lost to Follow-up|3
6915502|NCT00769704|10942328|FG000|Overall Study|Lost to Follow-up|3
6915503|NCT00769704|10942329|FG001|Overall Study|Lost to Follow-up|2
6915504|NCT00769704|10942328|FG000|Overall Study|Death|95
6915505|NCT00769704|10942329|FG001|Overall Study|Death|190
6915506|NCT00769704|10942328|FG000|Overall Study|Withdrawal by Subject|12
6915507|NCT00769704|10942329|FG001|Overall Study|Withdrawal by Subject|5
6915508|NCT00769704|10942328|FG000|Overall Study|Other|1
6915509|NCT00769704|10942329|FG001|Overall Study|Other|2
6915510|NCT00769860|10942342|FG000|Overall Study|Withdrawal by Subject|2
6915511|NCT00769860|10942343|FG001|Overall Study|Withdrawal by Subject|0
6915512|NCT00770029|10942368|FG000|Overall Study|Lost to Follow-up|2
6915513|NCT00770029|10942369|FG001|Overall Study|Lost to Follow-up|0
6915514|NCT00770029|10942368|FG000|Overall Study|Withdrawal by Subject|3
6915515|NCT00770029|10942369|FG001|Overall Study|Withdrawal by Subject|3
6915516|NCT00770029|10942368|FG000|Overall Study|Adverse Event|1
6915517|NCT00770029|10942369|FG001|Overall Study|Adverse Event|0
6915518|NCT00770120|10942375|FG000|Overall Study|Progression|31
6915519|NCT00770120|10942375|FG000|Overall Study|Adverse Event|11
6915520|NCT00770120|10942375|FG000|Overall Study|Not Protocol Specified|11
6915521|NCT00770120|10942375|FG000|Overall Study|Death|3
6915522|NCT00770120|10942375|FG000|Overall Study|Withdrawal by Subject|2
6915523|NCT00770120|10942375|FG000|Overall Study|Ineligible|1
6915524|NCT00770120|10942375|FG000|Overall Study|Never Received Treatment/Not Analyzable|1
6915525|NCT00770120|10942375|FG000|Overall Study|Reason under Review|1
6915526|NCT00770146|10942399|FG000|Treatment Period|Withdrawal by Subject|6
6915527|NCT00770146|10942400|FG001|Treatment Period|Withdrawal by Subject|13
6915528|NCT00770146|10942399|FG000|Treatment Period|Adverse Event|2
6915529|NCT00770146|10942400|FG001|Treatment Period|Adverse Event|26
6915530|NCT00770146|10942399|FG000|Treatment Period|Other|1
6915531|NCT00770146|10942400|FG001|Treatment Period|Other|5
6915532|NCT00770146|10942399|FG000|Treatment Period|Protocol non-compliance|0
6915533|NCT00770146|10942400|FG001|Treatment Period|Protocol non-compliance|1
6915534|NCT00770146|10942399|FG000|Follow-up Period|Withdrawal by Subject|7
6915535|NCT00770146|10942400|FG001|Follow-up Period|Withdrawal by Subject|13
6915536|NCT00770146|10942399|FG000|Follow-up Period|Adverse Event|0
6915537|NCT00770146|10942400|FG001|Follow-up Period|Adverse Event|2
6915538|NCT00770146|10942399|FG000|Follow-up Period|Other|4
6915539|NCT00770146|10942400|FG001|Follow-up Period|Other|5
6915540|NCT00770211|10942408|FG000|Overall Study|Lost to Follow-up|1
6915541|NCT00770211|10942409|FG001|Overall Study|Lost to Follow-up|0
6915542|NCT00770211|10942408|FG000|Overall Study|Withdrawal by Subject|0
6915543|NCT00770211|10942409|FG001|Overall Study|Withdrawal by Subject|2
6915544|NCT00770224|10942415|FG000|Step 1: Induction|Adverse Event|3
6915545|NCT00770224|10942416|FG001|Step 1: Induction|Adverse Event|0
6915546|NCT00770224|10942415|FG000|Step 1: Induction|Refusal unrelated to adverse event|6
6915547|NCT00770224|10942416|FG001|Step 1: Induction|Refusal unrelated to adverse event|0
6915548|NCT00770224|10942415|FG000|Step 1: Induction|Other reason not protocol specified|2
6915549|NCT00770224|10942416|FG001|Step 1: Induction|Other reason not protocol specified|0
6915550|NCT00770224|10942415|FG000|Step 1: Induction|Ineligible|2
6915551|NCT00770224|10942416|FG001|Step 1: Induction|Ineligible|0
6915552|NCT00770224|10942415|FG000|Step 1: Induction|No protocol treatment given|1
6915553|NCT00770224|10942416|FG001|Step 1: Induction|No protocol treatment given|0
6915554|NCT00770224|10942415|FG000|Step 2: Maintenance|Adverse Event|0
6915555|NCT00770224|10942416|FG001|Step 2: Maintenance|Adverse Event|10
6915556|NCT00770224|10942415|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0
6915557|NCT00770224|10942416|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8
6915558|NCT00770224|10942415|FG000|Step 2: Maintenance|Progression/relapse|0
6915559|NCT00770224|10942416|FG001|Step 2: Maintenance|Progression/relapse|1
6915560|NCT00770224|10942415|FG000|Step 2: Maintenance|Death|0
6915561|NCT00770224|10942416|FG001|Step 2: Maintenance|Death|2
6915562|NCT00770224|10942415|FG000|Step 2: Maintenance|Other reason not protocol specified|0
6915563|NCT00770224|10942416|FG001|Step 2: Maintenance|Other reason not protocol specified|7
6915564|NCT00770224|10942415|FG000|Step 2: Maintenance|Ineligible|0
6915565|NCT00770224|10942416|FG001|Step 2: Maintenance|Ineligible|2
6915566|NCT00770289|10942423|FG000|Overall Study|Other|6
6915567|NCT00770315|10942436|FG000|Overall Study|Adverse Event|11
6915568|NCT00770315|10942437|FG001|Overall Study|Adverse Event|17
6915569|NCT00770315|10942438|FG002|Overall Study|Adverse Event|16
6915570|NCT00770315|10942439|FG003|Overall Study|Adverse Event|6
6915571|NCT00770315|10942436|FG000|Overall Study|Lost to Follow-up|9
6915572|NCT00770315|10942437|FG001|Overall Study|Lost to Follow-up|5
6915573|NCT00770315|10942438|FG002|Overall Study|Lost to Follow-up|10
6915574|NCT00770315|10942439|FG003|Overall Study|Lost to Follow-up|3
6915575|NCT00770315|10942436|FG000|Overall Study|Withdrawal by Subject|13
6915576|NCT00770315|10942437|FG001|Overall Study|Withdrawal by Subject|17
6915577|NCT00770315|10942438|FG002|Overall Study|Withdrawal by Subject|24
6915578|NCT00770315|10942439|FG003|Overall Study|Withdrawal by Subject|20
6915579|NCT00770315|10942436|FG000|Overall Study|Noncompliance with Protocol|7
6915580|NCT00770315|10942437|FG001|Overall Study|Noncompliance with Protocol|4
6915581|NCT00770315|10942438|FG002|Overall Study|Noncompliance with Protocol|7
6915582|NCT00770315|10942439|FG003|Overall Study|Noncompliance with Protocol|9
6915583|NCT00770328|10942451|FG000|Overall Study|Adverse Event|11
6915584|NCT00770328|10942452|FG001|Overall Study|Adverse Event|2
6915585|NCT00770328|10942451|FG000|Overall Study|Lost to Follow-up|2
6915586|NCT00770328|10942452|FG001|Overall Study|Lost to Follow-up|2
6915587|NCT00770341|10942461|FG000|Overall Study|Did not meet eligibility criteria|1
6915588|NCT00770341|10942462|FG001|Overall Study|Did not meet eligibility criteria|0
6915589|NCT00770341|10942463|FG002|Overall Study|Did not meet eligibility criteria|0
6915590|NCT00770341|10942461|FG000|Overall Study|Withdrawal by Subject|0
6915591|NCT00770341|10942462|FG001|Overall Study|Withdrawal by Subject|1
6915592|NCT00770341|10942463|FG002|Overall Study|Withdrawal by Subject|0
6915593|NCT00770341|10942461|FG000|Overall Study|Clinical Adverse Event|3
6915594|NCT00770341|10942462|FG001|Overall Study|Clinical Adverse Event|1
6915595|NCT00770341|10942463|FG002|Overall Study|Clinical Adverse Event|2
6915596|NCT00770341|10942461|FG000|Overall Study|Laboratory adverse event|3
6915597|NCT00770341|10942462|FG001|Overall Study|Laboratory adverse event|3
6915598|NCT00770341|10942463|FG002|Overall Study|Laboratory adverse event|0
6915599|NCT00770341|10942461|FG000|Overall Study|Lack of Efficacy|3
6915600|NCT00770341|10942462|FG001|Overall Study|Lack of Efficacy|0
6915601|NCT00770341|10942463|FG002|Overall Study|Lack of Efficacy|1
6915602|NCT00770341|10942461|FG000|Overall Study|Other|1
6915603|NCT00770341|10942462|FG001|Overall Study|Other|0
6915604|NCT00770341|10942463|FG002|Overall Study|Other|0
6915605|NCT00770341|10942461|FG000|Overall Study|Not treated|1
6915606|NCT00770341|10942462|FG001|Overall Study|Not treated|0
6915607|NCT00770341|10942463|FG002|Overall Study|Not treated|0
6915608|NCT00770367|10942474|FG000|First Intervention|Withdrawal by Subject|0
6915609|NCT00770367|10942475|FG001|First Intervention|Withdrawal by Subject|2
6915610|NCT00770367|10942474|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0
6915611|NCT00770367|10942475|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1
6915612|NCT00770367|10942474|FG000|Second Intervention|Lost to Follow-up|2
6915613|NCT00770367|10942475|FG001|Second Intervention|Lost to Follow-up|0
6915614|NCT00770432|10942485|FG000|Overall Study|Other|4
6915615|NCT00770432|10942486|FG001|Overall Study|Other|6
6915616|NCT00770432|10942485|FG000|Overall Study|Non-compliance|0
6915617|NCT00770432|10942486|FG001|Overall Study|Non-compliance|1
6915618|NCT00770484|10942494|FG000|Overall Study|Withdrawal by Subject|1
6915619|NCT00770484|10942495|FG001|Overall Study|Withdrawal by Subject|0
6915620|NCT00770510|10942501|FG000|Overall Study|Lost to Follow-up|2
6915621|NCT00770510|10942501|FG000|Overall Study|Pregnancy|1
6915622|NCT00770510|10942501|FG000|Overall Study|Withdrawal by Subject|2
6915623|NCT00770562|10942515|FG000|Overall Study|Did not take treatment|1
6915624|NCT00770562|10942516|FG001|Overall Study|Did not take treatment|1
6915625|NCT00770588|10942525|FG000|Overall Study|Adverse Event|9
6915626|NCT00770588|10942526|FG001|Overall Study|Adverse Event|2
6915627|NCT00770588|10942525|FG000|Overall Study|Death caused by progression of disease|70
6915628|NCT00770588|10942526|FG001|Overall Study|Death caused by progression of disease|91
6915629|NCT00770588|10942525|FG000|Overall Study|Lost to Follow-up|1
6915630|NCT00770588|10942526|FG001|Overall Study|Lost to Follow-up|1
6915631|NCT00770588|10942525|FG000|Overall Study|Withdrawal by Subject|1
6915632|NCT00770588|10942526|FG001|Overall Study|Withdrawal by Subject|1
6915633|NCT00770601|10942533|FG000|Overall Study|Withdrawal by Subject|1
6915634|NCT00770653|10942539|FG000|Overall Study|Adverse Event|13
6915635|NCT00770653|10942540|FG001|Overall Study|Adverse Event|5
6915636|NCT00770653|10942539|FG000|Overall Study|Protocol Violation|8
6915637|NCT00770653|10942540|FG001|Overall Study|Protocol Violation|6
6915638|NCT00770653|10942539|FG000|Overall Study|Withdrawal by Subject|4
6915639|NCT00770653|10942540|FG001|Overall Study|Withdrawal by Subject|7
6915640|NCT00770653|10942539|FG000|Overall Study|Lack of Compliance|1
6915641|NCT00770653|10942540|FG001|Overall Study|Lack of Compliance|4
6915642|NCT00770653|10942539|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2
6915643|NCT00770653|10942540|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2
6915644|NCT00770653|10942539|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2
6915645|NCT00770653|10942540|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1
6915646|NCT00770653|10942539|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0
6915647|NCT00770653|10942540|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2
6915648|NCT00770653|10942539|FG000|Overall Study|Lost to Follow-up|1
6915649|NCT00770653|10942540|FG001|Overall Study|Lost to Follow-up|2
6915650|NCT00770653|10942539|FG000|Overall Study|Physician Decision|1
6915651|NCT00770653|10942540|FG001|Overall Study|Physician Decision|0
6915652|NCT00770679|10942546|FG000|Overall Study|Lost to Follow-up|3
6915653|NCT00770679|10942546|FG000|Overall Study|Follow-up LDL measurement not collected|3
6915654|NCT00770692|10942554|FG000|Overall Study|Withdrawal by Subject|7
6915655|NCT00770692|10942555|FG001|Overall Study|Withdrawal by Subject|9
6915656|NCT00770692|10942556|FG002|Overall Study|Withdrawal by Subject|9
6915657|NCT00770692|10942557|FG003|Overall Study|Withdrawal by Subject|6
6915658|NCT00770692|10942554|FG000|Overall Study|Adverse Event|3
6915659|NCT00770692|10942555|FG001|Overall Study|Adverse Event|0
6915660|NCT00770692|10942556|FG002|Overall Study|Adverse Event|4
6915661|NCT00770692|10942557|FG003|Overall Study|Adverse Event|4
6915662|NCT00770692|10942554|FG000|Overall Study|Investigator judgment|2
6915663|NCT00770692|10942555|FG001|Overall Study|Investigator judgment|0
6915664|NCT00770692|10942556|FG002|Overall Study|Investigator judgment|1
6915665|NCT00770692|10942557|FG003|Overall Study|Investigator judgment|1
6915666|NCT00770770|10942573|FG000|Overall Study|Lost to Follow-up|1
6915667|NCT00770770|10942574|FG001|Overall Study|Lost to Follow-up|0
6915668|NCT00770770|10942573|FG000|Overall Study|Withdrawal by Subject|1
6915669|NCT00770770|10942574|FG001|Overall Study|Withdrawal by Subject|0
6915670|NCT00770770|10942573|FG000|Overall Study|Death|0
6915671|NCT00770770|10942574|FG001|Overall Study|Death|1
6915672|NCT00770770|10942573|FG000|Overall Study|Study Terminated|8
6915673|NCT00770770|10942574|FG001|Overall Study|Study Terminated|0
6915674|NCT00770913|10942601|FG000|Overall Study|Adverse Event|1
6915675|NCT00770913|10942602|FG001|Overall Study|Adverse Event|3
6915676|NCT00770913|10942603|FG002|Overall Study|Adverse Event|6
6915677|NCT00770913|10942601|FG000|Overall Study|Refusal to continue participation|6
6915678|NCT00770913|10942602|FG001|Overall Study|Refusal to continue participation|4
6915679|NCT00770913|10942603|FG002|Overall Study|Refusal to continue participation|5
6915680|NCT00770913|10942601|FG000|Overall Study|Physician Decision|0
6915681|NCT00770913|10942602|FG001|Overall Study|Physician Decision|1
6915682|NCT00770913|10942603|FG002|Overall Study|Physician Decision|1
6915683|NCT00770913|10942601|FG000|Overall Study|Protocol Violation|3
6915684|NCT00770913|10942602|FG001|Overall Study|Protocol Violation|0
6915685|NCT00770913|10942603|FG002|Overall Study|Protocol Violation|1
6915686|NCT00770913|10942601|FG000|Overall Study|Incorrect drug was allocated|1
6915687|NCT00770913|10942602|FG001|Overall Study|Incorrect drug was allocated|0
6915688|NCT00770913|10942603|FG002|Overall Study|Incorrect drug was allocated|0
6915689|NCT00770991|10942613|FG000|Overall Study|Physician Decision|2
6915690|NCT00770991|10942614|FG001|Overall Study|Physician Decision|0
6915691|NCT00770991|10942613|FG000|Overall Study|Withdrawal by Subject|1
6915692|NCT00770991|10942614|FG001|Overall Study|Withdrawal by Subject|0
6915693|NCT00770991|10942613|FG000|Overall Study|Adverse Event|1
6915694|NCT00770991|10942614|FG001|Overall Study|Adverse Event|5
6915695|NCT00770991|10942613|FG000|Overall Study|Pregnancy|1
6915696|NCT00770991|10942614|FG001|Overall Study|Pregnancy|0
6915697|NCT00771030|10942632|FG000|Overall Study|Adverse Event|0
6915698|NCT00771030|10942633|FG001|Overall Study|Adverse Event|1
6915699|NCT00771030|10942634|FG002|Overall Study|Adverse Event|0
6915700|NCT00771030|10942635|FG003|Overall Study|Adverse Event|0
6915701|NCT00771030|10942636|FG004|Overall Study|Adverse Event|0
6915702|NCT00771030|10942637|FG005|Overall Study|Adverse Event|0
6915703|NCT00771030|10942638|FG006|Overall Study|Adverse Event|0
6915704|NCT00771472|10942703|FG000|Overall Study|Physician Decision|2
6915705|NCT00771472|10942704|FG001|Overall Study|Physician Decision|3
6915706|NCT00771472|10942703|FG000|Overall Study|Progressive Disease|3
6915707|NCT00771472|10942704|FG001|Overall Study|Progressive Disease|1
6915708|NCT00771472|10942703|FG000|Overall Study|Protocol Violation|1
6915709|NCT00771472|10942704|FG001|Overall Study|Protocol Violation|0
6915710|NCT00771615|10942775|FG000|Overall Study|Withdrawal by Subject|0
6915711|NCT00771615|10942776|FG001|Overall Study|Withdrawal by Subject|1
6915712|NCT00771615|10942777|FG002|Overall Study|Withdrawal by Subject|0
6915713|NCT00771615|10942778|FG003|Overall Study|Withdrawal by Subject|0
6915714|NCT00771615|10942779|FG004|Overall Study|Withdrawal by Subject|0
6915715|NCT00771615|10942780|FG005|Overall Study|Withdrawal by Subject|0
6915716|NCT00771615|10942781|FG006|Overall Study|Withdrawal by Subject|0
6915717|NCT00771615|10942782|FG007|Overall Study|Withdrawal by Subject|1
6915718|NCT00771615|10942783|FG008|Overall Study|Withdrawal by Subject|0
6915719|NCT00771615|10942775|FG000|Overall Study|Lost to Follow-up|1
6915720|NCT00771615|10942776|FG001|Overall Study|Lost to Follow-up|1
6915721|NCT00771615|10942777|FG002|Overall Study|Lost to Follow-up|1
6915722|NCT00771615|10942778|FG003|Overall Study|Lost to Follow-up|1
6915723|NCT00771615|10942779|FG004|Overall Study|Lost to Follow-up|0
6915724|NCT00771615|10942780|FG005|Overall Study|Lost to Follow-up|1
6915725|NCT00771615|10942781|FG006|Overall Study|Lost to Follow-up|1
6915726|NCT00771615|10942782|FG007|Overall Study|Lost to Follow-up|0
6915727|NCT00771615|10942783|FG008|Overall Study|Lost to Follow-up|0
6915728|NCT00771667|10942816|FG000|Induction Phase|Adverse Event|5
6915729|NCT00771667|10942817|FG001|Induction Phase|Adverse Event|2
6915730|NCT00771667|10942818|FG002|Induction Phase|Adverse Event|4
6915731|NCT00771667|10942819|FG003|Induction Phase|Adverse Event|1
6915732|NCT00771667|10942820|FG004|Induction Phase|Adverse Event|0
6915733|NCT00771667|10942821|FG005|Induction Phase|Adverse Event|0
6915734|NCT00771667|10942822|FG006|Induction Phase|Adverse Event|0
6915735|NCT00771667|10942823|FG007|Induction Phase|Adverse Event|0
6915736|NCT00771667|10942824|FG008|Induction Phase|Adverse Event|0
6915737|NCT00771667|10942825|FG009|Induction Phase|Adverse Event|0
6915738|NCT00771667|10942816|FG000|Induction Phase|Lack of Efficacy|9
6915739|NCT00771667|10942817|FG001|Induction Phase|Lack of Efficacy|2
6915740|NCT00771667|10942818|FG002|Induction Phase|Lack of Efficacy|4
6915741|NCT00771667|10942819|FG003|Induction Phase|Lack of Efficacy|3
6915742|NCT00771667|10942820|FG004|Induction Phase|Lack of Efficacy|0
6915743|NCT00771667|10942821|FG005|Induction Phase|Lack of Efficacy|0
6915744|NCT00771667|10942822|FG006|Induction Phase|Lack of Efficacy|0
6915745|NCT00771667|10942823|FG007|Induction Phase|Lack of Efficacy|0
6915746|NCT00771667|10942824|FG008|Induction Phase|Lack of Efficacy|0
6915747|NCT00771667|10942825|FG009|Induction Phase|Lack of Efficacy|0
6915748|NCT00771667|10942816|FG000|Induction Phase|Lost to Follow-up|1
6915749|NCT00771667|10942817|FG001|Induction Phase|Lost to Follow-up|0
6915750|NCT00771667|10942818|FG002|Induction Phase|Lost to Follow-up|1
6915751|NCT00771667|10942819|FG003|Induction Phase|Lost to Follow-up|0
6915752|NCT00771667|10942820|FG004|Induction Phase|Lost to Follow-up|0
6915753|NCT00771667|10942821|FG005|Induction Phase|Lost to Follow-up|0
6915754|NCT00771667|10942822|FG006|Induction Phase|Lost to Follow-up|0
6915755|NCT00771667|10942823|FG007|Induction Phase|Lost to Follow-up|0
6915756|NCT00771667|10942824|FG008|Induction Phase|Lost to Follow-up|0
6915757|NCT00771667|10942825|FG009|Induction Phase|Lost to Follow-up|0
6915758|NCT00771667|10942816|FG000|Induction Phase|Other|4
6915759|NCT00771667|10942817|FG001|Induction Phase|Other|6
6915760|NCT00771667|10942818|FG002|Induction Phase|Other|3
6915761|NCT00771667|10942819|FG003|Induction Phase|Other|4
6915762|NCT00771667|10942820|FG004|Induction Phase|Other|0
6915763|NCT00771667|10942821|FG005|Induction Phase|Other|0
6915764|NCT00771667|10942822|FG006|Induction Phase|Other|0
6915765|NCT00771667|10942823|FG007|Induction Phase|Other|0
6915766|NCT00771667|10942824|FG008|Induction Phase|Other|0
6915767|NCT00771667|10942825|FG009|Induction Phase|Other|0
6915768|NCT00771667|10942816|FG000|Maintenance Phase|Adverse Event|0
6915769|NCT00771667|10942817|FG001|Maintenance Phase|Adverse Event|0
6915770|NCT00771667|10942818|FG002|Maintenance Phase|Adverse Event|0
6915771|NCT00771667|10942819|FG003|Maintenance Phase|Adverse Event|0
6915772|NCT00771667|10942820|FG004|Maintenance Phase|Adverse Event|1
6915773|NCT00771667|10942821|FG005|Maintenance Phase|Adverse Event|3
6915774|NCT00771667|10942822|FG006|Maintenance Phase|Adverse Event|5
6915775|NCT00771667|10942823|FG007|Maintenance Phase|Adverse Event|1
6915776|NCT00771667|10942824|FG008|Maintenance Phase|Adverse Event|8
6915777|NCT00771667|10942825|FG009|Maintenance Phase|Adverse Event|7
6915778|NCT00771667|10942816|FG000|Maintenance Phase|Lack of Efficacy|0
6915779|NCT00771667|10942817|FG001|Maintenance Phase|Lack of Efficacy|0
6915780|NCT00771667|10942818|FG002|Maintenance Phase|Lack of Efficacy|0
6915781|NCT00771667|10942819|FG003|Maintenance Phase|Lack of Efficacy|0
6915782|NCT00771667|10942820|FG004|Maintenance Phase|Lack of Efficacy|1
6915783|NCT00771667|10942821|FG005|Maintenance Phase|Lack of Efficacy|3
6915784|NCT00771667|10942822|FG006|Maintenance Phase|Lack of Efficacy|3
6915785|NCT00771667|10942823|FG007|Maintenance Phase|Lack of Efficacy|2
6915786|NCT00771667|10942824|FG008|Maintenance Phase|Lack of Efficacy|11
6915787|NCT00771667|10942825|FG009|Maintenance Phase|Lack of Efficacy|7
6915788|NCT00771667|10942816|FG000|Maintenance Phase|Other|0
6915789|NCT00771667|10942817|FG001|Maintenance Phase|Other|0
6915790|NCT00771667|10942818|FG002|Maintenance Phase|Other|0
6915791|NCT00771667|10942819|FG003|Maintenance Phase|Other|0
6915792|NCT00771667|10942820|FG004|Maintenance Phase|Other|0
6915793|NCT00771667|10942821|FG005|Maintenance Phase|Other|1
6915794|NCT00771667|10942822|FG006|Maintenance Phase|Other|2
6915795|NCT00771667|10942823|FG007|Maintenance Phase|Other|2
6915796|NCT00771667|10942824|FG008|Maintenance Phase|Other|3
6915797|NCT00771667|10942825|FG009|Maintenance Phase|Other|3
6915798|NCT00771758|10942855|FG000|Overall Study|Adverse Event|2
6915799|NCT00771758|10942856|FG001|Overall Study|Adverse Event|8
6915800|NCT00771758|10942857|FG002|Overall Study|Adverse Event|1
6915801|NCT00771758|10942855|FG000|Overall Study|Lack of Efficacy|0
6915802|NCT00771758|10942856|FG001|Overall Study|Lack of Efficacy|2
6915803|NCT00771758|10942857|FG002|Overall Study|Lack of Efficacy|1
6915804|NCT00771758|10942855|FG000|Overall Study|Lost to Follow-up|1
6915805|NCT00771758|10942856|FG001|Overall Study|Lost to Follow-up|0
6915806|NCT00771758|10942857|FG002|Overall Study|Lost to Follow-up|0
6915807|NCT00771758|10942855|FG000|Overall Study|Protocol Violation|1
6915808|NCT00771758|10942856|FG001|Overall Study|Protocol Violation|0
6915809|NCT00771758|10942857|FG002|Overall Study|Protocol Violation|0
6915810|NCT00771758|10942855|FG000|Overall Study|Withdrawal by Subject|1
6915811|NCT00771758|10942856|FG001|Overall Study|Withdrawal by Subject|0
6915812|NCT00771758|10942857|FG002|Overall Study|Withdrawal by Subject|0
6915813|NCT00771758|10942855|FG000|Overall Study|Other|3
6915814|NCT00771758|10942856|FG001|Overall Study|Other|2
6915815|NCT00771758|10942857|FG002|Overall Study|Other|0
6915816|NCT00771810|10942885|FG000|Overall Study|Adverse Event|3
6915817|NCT00771810|10942886|FG001|Overall Study|Adverse Event|0
6915818|NCT00771810|10942887|FG002|Overall Study|Adverse Event|2
6915819|NCT00771810|10942885|FG000|Overall Study|Lost to Follow-up|0
6915820|NCT00771810|10942886|FG001|Overall Study|Lost to Follow-up|0
6915821|NCT00771810|10942887|FG002|Overall Study|Lost to Follow-up|1
6915822|NCT00771810|10942885|FG000|Overall Study|Physician Decision|1
6915823|NCT00771810|10942886|FG001|Overall Study|Physician Decision|2
6915824|NCT00771810|10942887|FG002|Overall Study|Physician Decision|2
6915825|NCT00771810|10942885|FG000|Overall Study|Protocol Violation|0
6915826|NCT00771810|10942886|FG001|Overall Study|Protocol Violation|1
6915827|NCT00771810|10942887|FG002|Overall Study|Protocol Violation|1
6915828|NCT00771810|10942885|FG000|Overall Study|Withdrawal by Subject|1
6915829|NCT00771810|10942886|FG001|Overall Study|Withdrawal by Subject|2
6915830|NCT00771810|10942887|FG002|Overall Study|Withdrawal by Subject|0
6915831|NCT00771810|10942885|FG000|Overall Study|Other|0
6915832|NCT00771810|10942886|FG001|Overall Study|Other|0
6915833|NCT00771810|10942887|FG002|Overall Study|Other|1
6915834|NCT00771849|10942898|FG000|Overall Study|Lost to Follow-up|1
6915835|NCT00771849|10942899|FG001|Overall Study|Lost to Follow-up|2
6915836|NCT00771849|10942898|FG000|Overall Study|Withdrawal by Subject|1
6915837|NCT00771849|10942899|FG001|Overall Study|Withdrawal by Subject|1
6915838|NCT00771849|10942898|FG000|Overall Study|Not vaccinated|0
6915839|NCT00771849|10942899|FG001|Overall Study|Not vaccinated|1
6915840|NCT00771901|10942921|FG000|Overall Study|Dissat w/# of study medication (40/day)|0
6915841|NCT00771901|10942922|FG001|Overall Study|Dissat w/# of study medication (40/day)|0
6915842|NCT00771901|10942923|FG002|Overall Study|Dissat w/# of study medication (40/day)|4
6915843|NCT00771914|10942935|FG000|Overall Study|Physician Decision|0
6915844|NCT00771914|10942936|FG001|Overall Study|Physician Decision|0
6915845|NCT00771914|10942937|FG002|Overall Study|Physician Decision|0
6915846|NCT00771914|10942938|FG003|Overall Study|Physician Decision|1
6915847|NCT00771914|10942935|FG000|Overall Study|Lost to Follow-up|0
6915848|NCT00771914|10942936|FG001|Overall Study|Lost to Follow-up|0
6915849|NCT00771914|10942937|FG002|Overall Study|Lost to Follow-up|0
6915850|NCT00771914|10942938|FG003|Overall Study|Lost to Follow-up|1
6915851|NCT00771927|10942950|FG000|Overall Study|Adverse Event|100
6915852|NCT00771927|10942951|FG001|Overall Study|Adverse Event|105
6915853|NCT00771927|10942950|FG000|Overall Study|Lack of Efficacy|70
6915854|NCT00771927|10942951|FG001|Overall Study|Lack of Efficacy|42
6915855|NCT00771927|10942950|FG000|Overall Study|Lost to Follow-up|46
6915856|NCT00771927|10942951|FG001|Overall Study|Lost to Follow-up|46
6915857|NCT00771927|10942950|FG000|Overall Study|Withdrawal by Subject|16
6915858|NCT00771927|10942951|FG001|Overall Study|Withdrawal by Subject|17
6915859|NCT00771927|10942950|FG000|Overall Study|Other reason|23
6915860|NCT00771927|10942951|FG001|Overall Study|Other reason|27
6915861|NCT00771953|10942959|FG000|Overall Study|Adverse Event|5
6915862|NCT00771953|10942960|FG001|Overall Study|Adverse Event|3
6915863|NCT00771953|10942959|FG000|Overall Study|Death|2
6915864|NCT00771953|10942960|FG001|Overall Study|Death|2
6915865|NCT00771953|10942959|FG000|Overall Study|Progression before active Tx|1
6915866|NCT00771953|10942960|FG001|Overall Study|Progression before active Tx|2
6915867|NCT00771953|10942959|FG000|Overall Study|Sponsor decision|1
6915868|NCT00771953|10942960|FG001|Overall Study|Sponsor decision|0
6915869|NCT00771953|10942959|FG000|Overall Study|Other complicating disease|1
6915870|NCT00771953|10942960|FG001|Overall Study|Other complicating disease|0
6915871|NCT00771953|10942959|FG000|Overall Study|Withdrawal by Subject|0
6915872|NCT00771953|10942960|FG001|Overall Study|Withdrawal by Subject|3
6915873|NCT00772005|10942972|FG000|Overall Study|Adverse Event|9
6915874|NCT00772005|10942973|FG001|Overall Study|Adverse Event|14
6915875|NCT00772005|10942974|FG002|Overall Study|Adverse Event|10
6915876|NCT00772005|10942975|FG003|Overall Study|Adverse Event|13
6915877|NCT00772005|10942972|FG000|Overall Study|Lack of Efficacy|0
6915878|NCT00772005|10942973|FG001|Overall Study|Lack of Efficacy|1
6915879|NCT00772005|10942974|FG002|Overall Study|Lack of Efficacy|0
6915880|NCT00772005|10942975|FG003|Overall Study|Lack of Efficacy|0
6915881|NCT00772005|10942972|FG000|Overall Study|Withdrawal by Subject|3
6915882|NCT00772005|10942973|FG001|Overall Study|Withdrawal by Subject|7
6915883|NCT00772005|10942974|FG002|Overall Study|Withdrawal by Subject|10
6915884|NCT00772005|10942975|FG003|Overall Study|Withdrawal by Subject|2
6915885|NCT00772005|10942972|FG000|Overall Study|Protocol Violation|2
6915886|NCT00772005|10942973|FG001|Overall Study|Protocol Violation|4
6915887|NCT00772005|10942974|FG002|Overall Study|Protocol Violation|1
6915888|NCT00772005|10942975|FG003|Overall Study|Protocol Violation|6
6915889|NCT00772005|10942972|FG000|Overall Study|Lost to Follow-up|7
6915890|NCT00772005|10942973|FG001|Overall Study|Lost to Follow-up|3
6915891|NCT00772005|10942974|FG002|Overall Study|Lost to Follow-up|6
6915892|NCT00772005|10942975|FG003|Overall Study|Lost to Follow-up|3
6915893|NCT00772005|10942972|FG000|Overall Study|Non-compliance with study procedures|1
6915894|NCT00772005|10942973|FG001|Overall Study|Non-compliance with study procedures|1
6915895|NCT00772005|10942974|FG002|Overall Study|Non-compliance with study procedures|0
6915896|NCT00772005|10942975|FG003|Overall Study|Non-compliance with study procedures|1
6915897|NCT00772005|10942972|FG000|Overall Study|Non-compliance with drug administration|3
6915898|NCT00772005|10942973|FG001|Overall Study|Non-compliance with drug administration|0
6915899|NCT00772005|10942974|FG002|Overall Study|Non-compliance with drug administration|1
6915900|NCT00772005|10942975|FG003|Overall Study|Non-compliance with drug administration|1
6915901|NCT00772031|10942987|FG000|Overall Study|Early termination of trial|12
6915902|NCT00772031|10942988|FG001|Overall Study|Early termination of trial|10
6915903|NCT00772031|10942987|FG000|Overall Study|Lost to Follow-up|20
6915904|NCT00772031|10942988|FG001|Overall Study|Lost to Follow-up|33
6915905|NCT00772070|10943002|FG000|Overall Study|Lost to Follow-up|0
6915906|NCT00772070|10943003|FG001|Overall Study|Lost to Follow-up|8
6915907|NCT00772070|10943002|FG000|Overall Study|Withdrawal by Subject|0
6915908|NCT00772070|10943003|FG001|Overall Study|Withdrawal by Subject|2
6915909|NCT00772070|10943002|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2
6915910|NCT00772070|10943003|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0
6915911|NCT00772109|10943013|FG000|Overall Study|Serious adverse event|1
6915912|NCT00772109|10943014|FG001|Overall Study|Serious adverse event|0
6915913|NCT00772109|10943015|FG002|Overall Study|Serious adverse event|1
6915914|NCT00772109|10943016|FG003|Overall Study|Serious adverse event|0
6915915|NCT00772109|10943013|FG000|Overall Study|Protocol Violation|5
6915916|NCT00772109|10943014|FG001|Overall Study|Protocol Violation|8
6915917|NCT00772109|10943015|FG002|Overall Study|Protocol Violation|7
6915918|NCT00772109|10943016|FG003|Overall Study|Protocol Violation|6
6915919|NCT00772109|10943013|FG000|Overall Study|Lost to Follow-up|7
6915920|NCT00772109|10943014|FG001|Overall Study|Lost to Follow-up|3
6915921|NCT00772109|10943015|FG002|Overall Study|Lost to Follow-up|5
6915922|NCT00772109|10943016|FG003|Overall Study|Lost to Follow-up|9
6915923|NCT00772109|10943013|FG000|Overall Study|Withdrawal by Subject|8
6915924|NCT00772109|10943014|FG001|Overall Study|Withdrawal by Subject|8
6915925|NCT00772109|10943015|FG002|Overall Study|Withdrawal by Subject|6
6915926|NCT00772109|10943016|FG003|Overall Study|Withdrawal by Subject|16
6915927|NCT00772148|10943028|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3
6915928|NCT00772148|10943029|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1
6915929|NCT00772148|10943028|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3
6915930|NCT00772148|10943029|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5
6915931|NCT00772148|10943028|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2
6915932|NCT00772148|10943029|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0
6915933|NCT00772148|10943028|FG000|Maintenance Phase (Week 52)|Death|2
6915934|NCT00772148|10943029|FG001|Maintenance Phase (Week 52)|Death|2
6915935|NCT00772148|10943028|FG000|Maintenance Phase (Week 52)|Adverse Event|1
6915936|NCT00772148|10943029|FG001|Maintenance Phase (Week 52)|Adverse Event|0
6915937|NCT00772148|10943028|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0
6915938|NCT00772148|10943029|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1
6915939|NCT00772148|10943028|FG000|Maintenance Phase (Week 52)|Administrative/other|1
6915940|NCT00772148|10943029|FG001|Maintenance Phase (Week 52)|Administrative/other|2
6915941|NCT00772330|10943039|FG000|Overall Study|Lost to Follow-up|3
6915942|NCT00772369|10943046|FG000|Overall Study|Did not return record release form|1
6915943|NCT00772382|10943050|FG000|Overall Study|Adverse Event|19
6915944|NCT00772382|10943050|FG000|Overall Study|Death|6
6915945|NCT00772382|10943050|FG000|Overall Study|Lack of Efficacy|4
6915946|NCT00772382|10943050|FG000|Overall Study|Physician Decision|5
6915947|NCT00772382|10943050|FG000|Overall Study|Protocol Violation|1
6915948|NCT00772382|10943050|FG000|Overall Study|Withdrawal by Subject|10
6915949|NCT00772382|10943050|FG000|Overall Study|Other Reasons|10
6915950|NCT00772447|10943056|FG000|Overall Study|Withdrawal by Subject|9
6915951|NCT00772447|10943057|FG001|Overall Study|Withdrawal by Subject|5
6915952|NCT00772447|10943056|FG000|Overall Study|Physician Decision|4
6915953|NCT00772447|10943057|FG001|Overall Study|Physician Decision|8
6915954|NCT00772447|10943056|FG000|Overall Study|Lost to Follow-up|2
6915955|NCT00772447|10943057|FG001|Overall Study|Lost to Follow-up|4
6915956|NCT00772447|10943056|FG000|Overall Study|incorrect enrolment|3
6915957|NCT00772447|10943057|FG001|Overall Study|incorrect enrolment|4
6915958|NCT00772447|10943056|FG000|Overall Study|Protocol Violation|0
6915959|NCT00772447|10943057|FG001|Overall Study|Protocol Violation|1
6915960|NCT00772447|10943056|FG000|Overall Study|all others|2
6915961|NCT00772447|10943057|FG001|Overall Study|all others|2
6915962|NCT00772538|10943066|FG000|Overall Study|Adverse Event|6
6915963|NCT00772538|10943067|FG001|Overall Study|Adverse Event|6
6915964|NCT00772538|10943066|FG000|Overall Study|Protocol Violation|3
6915965|NCT00772538|10943067|FG001|Overall Study|Protocol Violation|3
6915966|NCT00772538|10943066|FG000|Overall Study|Lost to Follow-up|1
6915967|NCT00772538|10943067|FG001|Overall Study|Lost to Follow-up|1
6915968|NCT00772538|10943066|FG000|Overall Study|Withdrawal by Subject|3
6915969|NCT00772538|10943067|FG001|Overall Study|Withdrawal by Subject|8
6915970|NCT00772538|10943066|FG000|Overall Study|Lack of Efficacy|0
6915971|NCT00772538|10943067|FG001|Overall Study|Lack of Efficacy|1
6915972|NCT00772538|10943066|FG000|Overall Study|Other|7
6915973|NCT00772538|10943067|FG001|Overall Study|Other|7
6915974|NCT00772577|10943075|FG000|Overall Study|Adverse Event|6
6915975|NCT00772577|10943076|FG001|Overall Study|Adverse Event|3
6915976|NCT00772577|10943075|FG000|Overall Study|Abnormal laboratory values|0
6915977|NCT00772577|10943076|FG001|Overall Study|Abnormal laboratory values|1
6915978|NCT00772577|10943075|FG000|Overall Study|Unsatisfactory therapeutic effect|0
6915979|NCT00772577|10943076|FG001|Overall Study|Unsatisfactory therapeutic effect|8
6915980|NCT00772577|10943075|FG000|Overall Study|Patient withdrew consent|8
6915981|NCT00772577|10943076|FG001|Overall Study|Patient withdrew consent|5
6915982|NCT00772577|10943075|FG000|Overall Study|Lost to Follow-up|4
6915983|NCT00772577|10943076|FG001|Overall Study|Lost to Follow-up|3
6915984|NCT00772577|10943075|FG000|Overall Study|Administrative problems|2
6915985|NCT00772577|10943076|FG001|Overall Study|Administrative problems|1
6915986|NCT00772577|10943075|FG000|Overall Study|Protocol Deviation|3
6915987|NCT00772577|10943076|FG001|Overall Study|Protocol Deviation|2
6915988|NCT00772603|10943102|FG000|Overall Study|Withdrawal by Subject|11
6915989|NCT00772603|10943103|FG001|Overall Study|Withdrawal by Subject|10
6915990|NCT00772603|10943104|FG002|Overall Study|Withdrawal by Subject|6
6915991|NCT00772603|10943102|FG000|Overall Study|Adverse Event|37
6915992|NCT00772603|10943103|FG001|Overall Study|Adverse Event|18
6915993|NCT00772603|10943104|FG002|Overall Study|Adverse Event|10
6915994|NCT00772603|10943102|FG000|Overall Study|Subject Non-compliance|1
6915995|NCT00772603|10943103|FG001|Overall Study|Subject Non-compliance|6
6915996|NCT00772603|10943104|FG002|Overall Study|Subject Non-compliance|4
6915997|NCT00772603|10943102|FG000|Overall Study|Protocol Violation|0
6915998|NCT00772603|10943103|FG001|Overall Study|Protocol Violation|1
6915999|NCT00772603|10943104|FG002|Overall Study|Protocol Violation|1
6916000|NCT00772603|10943102|FG000|Overall Study|Lost to Follow-up|1
6916001|NCT00772603|10943103|FG001|Overall Study|Lost to Follow-up|5
6916002|NCT00772603|10943104|FG002|Overall Study|Lost to Follow-up|2
6916003|NCT00772603|10943102|FG000|Overall Study|Physician Decision|0
6979102|NCT01215968|11032836|FG000|Overall Study|Not received study drug|0
6979103|NCT01215968|11032837|FG001|Overall Study|Not received study drug|1
6979104|NCT01215981|11032848|FG000|Overall Study|Physician Decision|0
6979105|NCT01215981|11032849|FG001|Overall Study|Physician Decision|1
6979106|NCT01215981|11032848|FG000|Overall Study|Protocol Violation|1
6979107|NCT01215981|11032849|FG001|Overall Study|Protocol Violation|0
6916004|NCT00772603|10943103|FG001|Overall Study|Physician Decision|0
6916005|NCT00772603|10943104|FG002|Overall Study|Physician Decision|1
6916006|NCT00772603|10943102|FG000|Overall Study|Other|2
6916007|NCT00772603|10943103|FG001|Overall Study|Other|0
6916008|NCT00772603|10943104|FG002|Overall Study|Other|2
6916009|NCT00772629|10943117|FG000|Overall Study|Subject was not vaccinated|1
6916010|NCT00772629|10943118|FG001|Overall Study|Subject was not vaccinated|0
6916011|NCT00772668|10943124|FG000|Overall Study|Physician Decision|3
6916012|NCT00772707|10943129|FG000|Overall Study|Withdrawn|3
6916013|NCT00772889|10943141|FG000|Overall Study|Adverse Event|7
6916014|NCT00772889|10943142|FG001|Overall Study|Adverse Event|4
6916015|NCT00772889|10943143|FG002|Overall Study|Adverse Event|0
6916016|NCT00772889|10943141|FG000|Overall Study|Withdrawal by Subject|9
6916017|NCT00772889|10943142|FG001|Overall Study|Withdrawal by Subject|8
6916018|NCT00772889|10943143|FG002|Overall Study|Withdrawal by Subject|9
6916019|NCT00772889|10943141|FG000|Overall Study|Lost to Follow-up|6
6916020|NCT00772889|10943142|FG001|Overall Study|Lost to Follow-up|6
6916021|NCT00772889|10943143|FG002|Overall Study|Lost to Follow-up|7
6916022|NCT00772928|10943157|FG000|Overall Study|Lost to Follow-up|9
6916023|NCT00772928|10943158|FG001|Overall Study|Lost to Follow-up|6
6916024|NCT00772928|10943157|FG000|Overall Study|Protocol Violation|10
6916025|NCT00772928|10943158|FG001|Overall Study|Protocol Violation|12
6916026|NCT00772928|10943157|FG000|Overall Study|Withdrawal by Subject|25
6916027|NCT00772928|10943158|FG001|Overall Study|Withdrawal by Subject|22
6916028|NCT00772928|10943157|FG000|Overall Study|Did not receive vaccine|0
6916029|NCT00772928|10943158|FG001|Overall Study|Did not receive vaccine|1
6916030|NCT00772941|10943164|FG000|Overall Study|CRFs not available|195
6916031|NCT00772941|10943164|FG000|Overall Study|Study not completed|16
6916032|NCT00772941|10943164|FG000|Overall Study|Missed Visits|374
6916033|NCT00772941|10943164|FG000|Overall Study|Poor Compliance|7
6916034|NCT00772941|10943164|FG000|Overall Study|GPSP Violation|90
6916035|NCT00772954|10943194|FG000|Overall Study|Adverse Event|0
6916036|NCT00772954|10943195|FG001|Overall Study|Adverse Event|0
6916037|NCT00772954|10943196|FG002|Overall Study|Adverse Event|1
6916038|NCT00772967|10943204|FG000|Crossover Treatment 1|Adverse Event (Pain)|0
6916039|NCT00772967|10943205|FG001|Crossover Treatment 1|Adverse Event (Pain)|0
6916040|NCT00772967|10943206|FG002|Crossover Treatment 1|Adverse Event (Pain)|0
6979108|NCT01215981|11032848|FG000|Overall Study|Withdrawal by Subject|1
6979109|NCT01215981|11032849|FG001|Overall Study|Withdrawal by Subject|0
6979110|NCT01216072|11032857|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40
6979111|NCT01216072|11032858|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4
6979112|NCT01216072|11032857|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2
6916041|NCT00772967|10943207|FG003|Crossover Treatment 1|Adverse Event (Pain)|1
6916042|NCT00772967|10943208|FG004|Crossover Treatment 1|Adverse Event (Pain)|0
6916043|NCT00772967|10943209|FG005|Crossover Treatment 1|Adverse Event (Pain)|0
6916044|NCT00772967|10943204|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0
6916045|NCT00772967|10943205|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1
6916046|NCT00772967|10943206|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0
6916047|NCT00772967|10943207|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0
6979113|NCT01216072|11032858|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0
6916048|NCT00772967|10943208|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0
6916049|NCT00772967|10943209|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0
6916050|NCT00772967|10943204|FG000|Crossover Treatment 3|Adverse Event|0
6916051|NCT00772967|10943205|FG001|Crossover Treatment 3|Adverse Event|0
6916052|NCT00772967|10943206|FG002|Crossover Treatment 3|Adverse Event|0
6916053|NCT00772967|10943207|FG003|Crossover Treatment 3|Adverse Event|0
6916054|NCT00772967|10943208|FG004|Crossover Treatment 3|Adverse Event|1
6916055|NCT00772967|10943209|FG005|Crossover Treatment 3|Adverse Event|0
6916056|NCT00773097|10943217|FG000|Overall Study|Withdrawal by Subject|1
6916057|NCT00773097|10943217|FG000|Overall Study|Physician Decision|6
6916058|NCT00773136|10943221|FG000|Overall Study|Physician Decision|2
6916059|NCT00773175|10943228|FG000|Overall Study|Adverse Event|2
6916060|NCT00773175|10943229|FG001|Overall Study|Adverse Event|0
6916061|NCT00773175|10943228|FG000|Overall Study|Consent Withdrawn|0
6916062|NCT00773175|10943229|FG001|Overall Study|Consent Withdrawn|2
6916063|NCT00773253|10943242|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0
6916064|NCT00773253|10943243|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1
6916065|NCT00773279|10943251|FG000|Period 1|Adverse Event|2
6916066|NCT00773279|10943252|FG001|Period 1|Adverse Event|1
6916067|NCT00773279|10943251|FG000|Period 1|Lack of Efficacy|0
6916068|NCT00773279|10943252|FG001|Period 1|Lack of Efficacy|2
6916069|NCT00773279|10943251|FG000|Period 1|Unclassified|5
6916070|NCT00773279|10943252|FG001|Period 1|Unclassified|1
6916071|NCT00773279|10943251|FG000|Period 2|Adverse Event|0
6916072|NCT00773279|10943252|FG001|Period 2|Adverse Event|1
6916073|NCT00773279|10943251|FG000|Period 2|Lack of Efficacy|1
6916074|NCT00773279|10943252|FG001|Period 2|Lack of Efficacy|0
6916075|NCT00773279|10943251|FG000|Period 2|Protocol Violation|0
6916076|NCT00773279|10943252|FG001|Period 2|Protocol Violation|3
6916077|NCT00773279|10943251|FG000|Period 2|Unclassified|2
6916078|NCT00773279|10943252|FG001|Period 2|Unclassified|2
6916079|NCT00773292|10943259|FG000|Treatment 48 Weeks|Adverse Event|1
6916080|NCT00773292|10943259|FG000|Treatment 48 Weeks|Lack of Efficacy|1
6916081|NCT00773383|10943272|FG000|Overall Study|Adverse Event|4
6916082|NCT00773383|10943272|FG000|Overall Study|Death|1
6916083|NCT00773383|10943272|FG000|Overall Study|Progression of Disease|23
6916084|NCT00773383|10943272|FG000|Overall Study|Other|2
6916085|NCT00773383|10943272|FG000|Overall Study|No study dose received|1
6974385|NCT01186770|11026270|FG003|Overall Study|Withdrawal by Subject|17
6974386|NCT01186770|11026267|FG000|Overall Study|Lost to Follow-up|10
6974387|NCT01186770|11026268|FG001|Overall Study|Lost to Follow-up|6
6974388|NCT01186770|11026269|FG002|Overall Study|Lost to Follow-up|14
6974389|NCT01186770|11026270|FG003|Overall Study|Lost to Follow-up|9
6974390|NCT01186770|11026267|FG000|Overall Study|Insufficient response to treatment|7
6974391|NCT01186770|11026268|FG001|Overall Study|Insufficient response to treatment|8
6974392|NCT01186770|11026269|FG002|Overall Study|Insufficient response to treatment|5
6974393|NCT01186770|11026270|FG003|Overall Study|Insufficient response to treatment|7
6974394|NCT01186770|11026267|FG000|Overall Study|Other than specified|0
6974395|NCT01186770|11026268|FG001|Overall Study|Other than specified|1
6974396|NCT01186770|11026269|FG002|Overall Study|Other than specified|1
6974397|NCT01186770|11026270|FG003|Overall Study|Other than specified|2
6974398|NCT01186796|11026282|FG000|Overall Study|Adverse Event|3
6974399|NCT01186796|11026283|FG001|Overall Study|Adverse Event|0
6974400|NCT01186796|11026282|FG000|Overall Study|Withdrawal by Subject|1
6974401|NCT01186796|11026283|FG001|Overall Study|Withdrawal by Subject|1
6974402|NCT01186796|11026282|FG000|Overall Study|Protocol Violation|0
6974403|NCT01186796|11026283|FG001|Overall Study|Protocol Violation|1
6974404|NCT01186809|11026289|FG000|Overall Study|Death|30
6974405|NCT01186939|11026293|FG000|Overall Study|Death|7
6974406|NCT01186939|11026293|FG000|Overall Study|Withdrawal by Subject|2
6974407|NCT01186939|11026293|FG000|Overall Study|No longer receiving clinical benefit|17
6974408|NCT01186939|11026293|FG000|Overall Study|Program closed|5
6974409|NCT01186939|11026293|FG000|Overall Study|Sponsor decision|4
6974410|NCT01186939|11026293|FG000|Overall Study|Started additional treatment|1
6974411|NCT01186939|11026293|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1
6974412|NCT01186939|11026293|FG000|Overall Study|Myocardial infarction|1
6974413|NCT01186939|11026293|FG000|Overall Study|Bone marrow transplant|1
6974414|NCT01186939|11026293|FG000|Overall Study|Transformation to AML|1
6974415|NCT01186978|11026297|FG000|Overall Study|Withdrawal by Subject|1
6974416|NCT01187043|11026322|FG000|Overall Study|Adverse Event|0
6974417|NCT01187043|11026323|FG001|Overall Study|Adverse Event|0
6974418|NCT01187043|11026324|FG002|Overall Study|Adverse Event|0
6974419|NCT01187043|11026325|FG003|Overall Study|Adverse Event|0
6974420|NCT01187043|11026326|FG004|Overall Study|Adverse Event|1
6974421|NCT01187043|11026322|FG000|Overall Study|Unable to make scheduled visits|1
6974422|NCT01187043|11026323|FG001|Overall Study|Unable to make scheduled visits|0
6974423|NCT01187043|11026324|FG002|Overall Study|Unable to make scheduled visits|4
6974424|NCT01187043|11026325|FG003|Overall Study|Unable to make scheduled visits|0
6974425|NCT01187043|11026326|FG004|Overall Study|Unable to make scheduled visits|1
6974426|NCT01187407|11026373|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29
6974427|NCT01187407|11026374|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
6974428|NCT01187407|11026375|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
6974429|NCT01187407|11026376|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
6916086|NCT00773461|10943295|FG000|Overall Study|Adverse Event|1
6916087|NCT00773461|10943296|FG001|Overall Study|Adverse Event|3
6916088|NCT00773461|10943295|FG000|Overall Study|Withdrawal by Subject|4
6916089|NCT00773461|10943296|FG001|Overall Study|Withdrawal by Subject|1
6916090|NCT00773513|10943309|FG000|Overall Study|Renal Transplant|254
6916091|NCT00773513|10943310|FG001|Overall Study|Renal Transplant|263
6916092|NCT00773513|10943309|FG000|Overall Study|Adverse Event / Intercurrent Illness|40
6916093|NCT00773513|10943310|FG001|Overall Study|Adverse Event / Intercurrent Illness|48
6916094|NCT00773513|10943309|FG000|Overall Study|Withdrew Consent|68
6916095|NCT00773513|10943310|FG001|Overall Study|Withdrew Consent|69
6916096|NCT00773513|10943309|FG000|Overall Study|Refused Treatment / Did not Cooperate|26
6916097|NCT00773513|10943310|FG001|Overall Study|Refused Treatment / Did not Cooperate|32
6916098|NCT00773513|10943309|FG000|Overall Study|Failure to Return|22
6916099|NCT00773513|10943310|FG001|Overall Study|Failure to Return|8
6916100|NCT00773513|10943309|FG000|Overall Study|Insufficient Therapeutic Response|1
6916101|NCT00773513|10943310|FG001|Overall Study|Insufficient Therapeutic Response|18
6916102|NCT00773513|10943309|FG000|Overall Study|Reason Not Specified|159
6916103|NCT00773513|10943310|FG001|Overall Study|Reason Not Specified|126
6916104|NCT00773513|10943309|FG000|Overall Study|Death|531
6916105|NCT00773513|10943310|FG001|Overall Study|Death|545
6916106|NCT00773734|10943324|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5
6916107|NCT00773734|10943325|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1
6916108|NCT00773734|10943326|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8
6916109|NCT00773734|10943327|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10
6916110|NCT00773734|10943328|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
6916111|NCT00773734|10943329|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
6916112|NCT00773734|10943324|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4
6916113|NCT00773734|10943325|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3
6916114|NCT00773734|10943326|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
6916115|NCT00773734|10943327|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
6916116|NCT00773734|10943328|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
6916117|NCT00773734|10943329|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
6916118|NCT00773734|10943324|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
6916119|NCT00773734|10943325|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
6916120|NCT00773734|10943326|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6
6916121|NCT00773734|10943327|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4
6916122|NCT00773734|10943328|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
6916123|NCT00773734|10943329|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
6916124|NCT00773734|10943324|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1
6916125|NCT00773734|10943325|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0
6916126|NCT00773734|10943326|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0
6916127|NCT00773734|10943327|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0
6916128|NCT00773734|10943328|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0
6916129|NCT00773734|10943329|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0
6916130|NCT00773734|10943324|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2
6916131|NCT00773734|10943325|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
6916132|NCT00773734|10943326|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
6916133|NCT00773734|10943327|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1
6916134|NCT00773734|10943328|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
6916135|NCT00773734|10943329|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
6916136|NCT00773734|10943324|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1
6916137|NCT00773734|10943325|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3
6916138|NCT00773734|10943326|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4
6916139|NCT00773734|10943327|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
6916140|NCT00773734|10943328|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
6916141|NCT00773734|10943329|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
6916142|NCT00773734|10943324|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1
6916143|NCT00773734|10943325|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1
6916144|NCT00773734|10943326|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1
6916145|NCT00773734|10943327|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1
6916146|NCT00773734|10943328|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0
6916147|NCT00773734|10943329|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0
6916148|NCT00773734|10943324|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0
6916149|NCT00773734|10943325|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4
6916150|NCT00773734|10943326|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0
6916151|NCT00773734|10943327|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0
6916152|NCT00773734|10943328|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1
6916153|NCT00773734|10943329|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2
6916154|NCT00773734|10943324|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
6916155|NCT00773734|10943325|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
6916156|NCT00773734|10943326|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
6916157|NCT00773734|10943327|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1
6916158|NCT00773734|10943328|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
6916159|NCT00773734|10943329|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
6916160|NCT00773734|10943324|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
6916161|NCT00773734|10943325|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
6916162|NCT00773734|10943326|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
6916163|NCT00773734|10943327|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
6916164|NCT00773734|10943328|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
6916165|NCT00773734|10943329|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2
6916166|NCT00773734|10943324|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
6916167|NCT00773734|10943325|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
6916168|NCT00773734|10943326|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
6916169|NCT00773734|10943327|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
6916170|NCT00773734|10943328|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
6916171|NCT00773734|10943329|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
6916172|NCT00773734|10943324|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
6916173|NCT00773734|10943325|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
6916174|NCT00773734|10943326|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
6916175|NCT00773734|10943327|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
6916176|NCT00773734|10943328|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
6916177|NCT00773734|10943329|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
6916178|NCT00773734|10943324|FG000|Core: Active Treatment Phase Week 16-24|Other|0
6916179|NCT00773734|10943325|FG001|Core: Active Treatment Phase Week 16-24|Other|1
6916180|NCT00773734|10943326|FG002|Core: Active Treatment Phase Week 16-24|Other|0
6916181|NCT00773734|10943327|FG003|Core: Active Treatment Phase Week 16-24|Other|0
6916182|NCT00773734|10943328|FG004|Core: Active Treatment Phase Week 16-24|Other|0
6916183|NCT00773734|10943329|FG005|Core: Active Treatment Phase Week 16-24|Other|0
6916184|NCT00773734|10943324|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0
6916185|NCT00773734|10943325|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0
6916186|NCT00773734|10943326|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0
6916187|NCT00773734|10943327|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0
6916188|NCT00773734|10943328|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2
6916189|NCT00773734|10943329|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1
6916190|NCT00773734|10943324|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0
6916191|NCT00773734|10943325|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8
6916192|NCT00773734|10943326|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10
6916193|NCT00773734|10943327|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3
6916194|NCT00773734|10943328|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1
6916195|NCT00773734|10943329|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2
6916196|NCT00773734|10943324|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0
6916197|NCT00773734|10943325|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
6916198|NCT00773734|10943326|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1
6916199|NCT00773734|10943327|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
6916200|NCT00773734|10943328|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
6916201|NCT00773734|10943329|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
6916202|NCT00773734|10943324|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
6916203|NCT00773734|10943325|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2
6916204|NCT00773734|10943326|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5
6916205|NCT00773734|10943327|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3
6916206|NCT00773734|10943328|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
6916207|NCT00773734|10943329|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1
6916208|NCT00773734|10943324|FG000|Extension: Active Treatment Week 24-52|Other|0
6916209|NCT00773734|10943325|FG001|Extension: Active Treatment Week 24-52|Other|0
6916210|NCT00773734|10943326|FG002|Extension: Active Treatment Week 24-52|Other|1
6916211|NCT00773734|10943327|FG003|Extension: Active Treatment Week 24-52|Other|2
6916212|NCT00773734|10943328|FG004|Extension: Active Treatment Week 24-52|Other|0
6916213|NCT00773734|10943329|FG005|Extension: Active Treatment Week 24-52|Other|1
6916214|NCT00773734|10943324|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0
6916215|NCT00773734|10943325|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0
6916216|NCT00773734|10943326|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0
6916217|NCT00773734|10943327|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1
6916218|NCT00773734|10943328|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0
6916219|NCT00773734|10943329|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0
6916220|NCT00773734|10943324|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
6916221|NCT00773734|10943325|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
6916222|NCT00773734|10943326|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2
6916223|NCT00773734|10943327|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4
6916224|NCT00773734|10943328|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
6916225|NCT00773734|10943329|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
6916226|NCT00773734|10943324|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
6916227|NCT00773734|10943325|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
6916228|NCT00773734|10943326|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6
6916229|NCT00773734|10943327|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3
6916230|NCT00773734|10943328|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
6916231|NCT00773734|10943329|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
6916232|NCT00773734|10943324|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
6916233|NCT00773734|10943325|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
6916234|NCT00773734|10943326|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
6916235|NCT00773734|10943327|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
6916236|NCT00773734|10943328|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
6916237|NCT00773734|10943329|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
6916238|NCT00773747|10943388|FG000|Overall Study|Lack of Efficacy|112
6916239|NCT00773747|10943389|FG001|Overall Study|Lack of Efficacy|144
6916240|NCT00773747|10943388|FG000|Overall Study|Physician Decision|26
6916241|NCT00773747|10943389|FG001|Overall Study|Physician Decision|18
6916242|NCT00773747|10943388|FG000|Overall Study|Lost to Follow-up|0
6916243|NCT00773747|10943389|FG001|Overall Study|Lost to Follow-up|1
6916244|NCT00773747|10943388|FG000|Overall Study|Protocol Violation|2
6916245|NCT00773747|10943389|FG001|Overall Study|Protocol Violation|2
6916246|NCT00773747|10943388|FG000|Overall Study|Withdrawal by Subject|89
6916247|NCT00773747|10943389|FG001|Overall Study|Withdrawal by Subject|61
6916248|NCT00773747|10943388|FG000|Overall Study|Adverse Event|61
6916249|NCT00773747|10943389|FG001|Overall Study|Adverse Event|62
6916250|NCT00773747|10943388|FG000|Overall Study|Death|5
6916251|NCT00773747|10943389|FG001|Overall Study|Death|8
6916252|NCT00773747|10943388|FG000|Overall Study|Not Treated|2
6916253|NCT00773747|10943389|FG001|Overall Study|Not Treated|0
6916254|NCT00773838|10943403|FG000|Overall Study|Adverse Event|29
6916255|NCT00773838|10943403|FG000|Overall Study|Lost to Follow-up|1
6916256|NCT00773838|10943403|FG000|Overall Study|Physician Decision|8
6916257|NCT00773838|10943403|FG000|Overall Study|Progressive Disease|82
6916258|NCT00773838|10943403|FG000|Overall Study|Protocol Violation|2
6916259|NCT00773838|10943403|FG000|Overall Study|Withdrawal by Subject|21
6916260|NCT00773968|10943411|FG000|Overall Study|Adverse Event|2
6916261|NCT00773968|10943411|FG000|Overall Study|Death|1
6916262|NCT00773968|10943411|FG000|Overall Study|Failure to Return|2
6916263|NCT00773968|10943411|FG000|Overall Study|Lack of Efficacy|3
6916264|NCT00773968|10943411|FG000|Overall Study|Protocol Violation|1
6916265|NCT00773968|10943411|FG000|Overall Study|Withdrawal by Subject|11
6916266|NCT00773968|10943411|FG000|Overall Study|Screen Failure|17
6916267|NCT00773968|10943411|FG000|Overall Study|Other|8
6916268|NCT00774046|10943415|FG000|Screening|Not eligible|56
6916269|NCT00774046|10943415|FG000|Enrollment|Desired other therapy/refused|28
6916270|NCT00774046|10943415|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3
6916271|NCT00774397|10943465|FG000|Overall Study|Adverse Event|1
6916272|NCT00774397|10943466|FG001|Overall Study|Adverse Event|3
6916273|NCT00774397|10943467|FG002|Overall Study|Adverse Event|16
6916274|NCT00774397|10943468|FG003|Overall Study|Adverse Event|8
6916275|NCT00774397|10943469|FG004|Overall Study|Adverse Event|8
6916276|NCT00774397|10943470|FG005|Overall Study|Adverse Event|3
6916277|NCT00774397|10943471|FG006|Overall Study|Adverse Event|16
6916278|NCT00774397|10943465|FG000|Overall Study|Lack of Efficacy|11
6916279|NCT00774397|10943466|FG001|Overall Study|Lack of Efficacy|4
6916280|NCT00774397|10943467|FG002|Overall Study|Lack of Efficacy|5
6916281|NCT00774397|10943468|FG003|Overall Study|Lack of Efficacy|3
6916282|NCT00774397|10943469|FG004|Overall Study|Lack of Efficacy|27
6916283|NCT00774397|10943470|FG005|Overall Study|Lack of Efficacy|15
6916284|NCT00774397|10943471|FG006|Overall Study|Lack of Efficacy|9
6916285|NCT00774397|10943465|FG000|Overall Study|Protocol Violation|0
6916286|NCT00774397|10943466|FG001|Overall Study|Protocol Violation|1
6916287|NCT00774397|10943467|FG002|Overall Study|Protocol Violation|3
6916288|NCT00774397|10943468|FG003|Overall Study|Protocol Violation|1
6916289|NCT00774397|10943469|FG004|Overall Study|Protocol Violation|2
6916290|NCT00774397|10943470|FG005|Overall Study|Protocol Violation|1
6916291|NCT00774397|10943471|FG006|Overall Study|Protocol Violation|0
6916292|NCT00774397|10943465|FG000|Overall Study|Lost to Follow-up|0
6916293|NCT00774397|10943466|FG001|Overall Study|Lost to Follow-up|1
6916294|NCT00774397|10943467|FG002|Overall Study|Lost to Follow-up|1
6916295|NCT00774397|10943468|FG003|Overall Study|Lost to Follow-up|1
6916296|NCT00774397|10943469|FG004|Overall Study|Lost to Follow-up|0
6916297|NCT00774397|10943470|FG005|Overall Study|Lost to Follow-up|1
6916298|NCT00774397|10943471|FG006|Overall Study|Lost to Follow-up|0
6916299|NCT00774397|10943465|FG000|Overall Study|Refused to continue trial medication|1
6916300|NCT00774397|10943466|FG001|Overall Study|Refused to continue trial medication|3
6916301|NCT00774397|10943467|FG002|Overall Study|Refused to continue trial medication|2
6916302|NCT00774397|10943468|FG003|Overall Study|Refused to continue trial medication|2
6916303|NCT00774397|10943469|FG004|Overall Study|Refused to continue trial medication|6
6916304|NCT00774397|10943470|FG005|Overall Study|Refused to continue trial medication|2
6916305|NCT00774397|10943471|FG006|Overall Study|Refused to continue trial medication|3
6916306|NCT00774397|10943465|FG000|Overall Study|Not treated|0
6916307|NCT00774397|10943466|FG001|Overall Study|Not treated|0
6916308|NCT00774397|10943467|FG002|Overall Study|Not treated|0
6916309|NCT00774397|10943468|FG003|Overall Study|Not treated|0
6916310|NCT00774397|10943469|FG004|Overall Study|Not treated|1
6916311|NCT00774397|10943470|FG005|Overall Study|Not treated|0
6916312|NCT00774397|10943471|FG006|Overall Study|Not treated|1
6916313|NCT00774397|10943465|FG000|Overall Study|Other than those stated above|1
6916314|NCT00774397|10943466|FG001|Overall Study|Other than those stated above|1
6916315|NCT00774397|10943467|FG002|Overall Study|Other than those stated above|3
6916316|NCT00774397|10943468|FG003|Overall Study|Other than those stated above|2
6916317|NCT00774397|10943469|FG004|Overall Study|Other than those stated above|2
6916318|NCT00774397|10943470|FG005|Overall Study|Other than those stated above|0
6916319|NCT00774397|10943471|FG006|Overall Study|Other than those stated above|1
6916320|NCT00774566|10943496|FG000|Overall Study|Protocol Violation|18
6916321|NCT00774566|10943497|FG001|Overall Study|Protocol Violation|15
6916322|NCT00774748|10943512|FG000|Overall Study|Lost to Follow-up|3
6916323|NCT00774787|10943520|FG000|Overall Study|Lost to Follow-up|1
6916324|NCT00774800|10943524|FG000|Intervention 4|Withdrawal by Subject|1
6916325|NCT00774852|10943536|FG000|Overall Study|Adverse Event|9
6916326|NCT00774852|10943537|FG001|Overall Study|Adverse Event|6
6916327|NCT00774852|10943536|FG000|Overall Study|Death|2
6916328|NCT00774852|10943537|FG001|Overall Study|Death|1
6916329|NCT00774852|10943536|FG000|Overall Study|Lack of Efficacy|3
6916330|NCT00774852|10943537|FG001|Overall Study|Lack of Efficacy|7
6916331|NCT00774852|10943536|FG000|Overall Study|Lost to Follow-up|9
6916332|NCT00774852|10943537|FG001|Overall Study|Lost to Follow-up|5
6916333|NCT00774852|10943536|FG000|Overall Study|Physician Decision|2
6916334|NCT00774852|10943537|FG001|Overall Study|Physician Decision|6
6916335|NCT00774852|10943536|FG000|Overall Study|Pregnancy|1
6916336|NCT00774852|10943537|FG001|Overall Study|Pregnancy|2
6916337|NCT00774852|10943536|FG000|Overall Study|Withdrawal by Subject|2
6916338|NCT00774852|10943537|FG001|Overall Study|Withdrawal by Subject|2
6916339|NCT00774852|10943536|FG000|Overall Study|Non-responder|15
6916340|NCT00774852|10943537|FG001|Overall Study|Non-responder|11
6916341|NCT00774852|10943536|FG000|Overall Study|Subject non-compliance|0
6916342|NCT00774852|10943537|FG001|Overall Study|Subject non-compliance|1
6916343|NCT00774852|10943536|FG000|Overall Study|Protocol Violation|1
6916344|NCT00774852|10943537|FG001|Overall Study|Protocol Violation|0
6916345|NCT00774852|10943536|FG000|Overall Study|Subject received prohibited medication|1
6916346|NCT00774852|10943537|FG001|Overall Study|Subject received prohibited medication|0
6916347|NCT00774930|10943555|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11
6916348|NCT00774930|10943556|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12
6916349|NCT00774930|10943555|FG000|DB Phase|Adverse Event|1
6916350|NCT00774930|10943556|FG001|DB Phase|Adverse Event|2
6916351|NCT00774930|10943555|FG000|DB Phase|Subject Decision|1
6916352|NCT00774930|10943556|FG001|DB Phase|Subject Decision|5
6916353|NCT00774930|10943555|FG000|DB Phase|Sponsor Decision|0
6916354|NCT00774930|10943556|FG001|DB Phase|Sponsor Decision|1
6916355|NCT00774930|10943555|FG000|DB Phase|Disease Progression|1
6916356|NCT00774930|10943556|FG001|DB Phase|Disease Progression|1
6916357|NCT00774930|10943555|FG000|DB Phase|Started Nonprotocol Radiation therapy|0
6916358|NCT00774930|10943556|FG001|DB Phase|Started Nonprotocol Radiation therapy|1
6916359|NCT00774930|10943555|FG000|IOL Phase|Adverse Event|1
6916360|NCT00774930|10943556|FG001|IOL Phase|Adverse Event|1
6916361|NCT00774930|10943555|FG000|IOL Phase|Subject Decision|4
6916362|NCT00774930|10943556|FG001|IOL Phase|Subject Decision|3
6916363|NCT00774930|10943555|FG000|IOL Phase|Physician Decision|3
6916364|NCT00774930|10943556|FG001|IOL Phase|Physician Decision|2
6916365|NCT00774930|10943555|FG000|IOL Phase|Sponsor Decision|1
6916366|NCT00774930|10943556|FG001|IOL Phase|Sponsor Decision|0
6916367|NCT00774930|10943555|FG000|IOL Phase|Disease Progression|2
6916368|NCT00774930|10943556|FG001|IOL Phase|Disease Progression|1
6916369|NCT00774930|10943555|FG000|IOL Phase|Subject Consumed Prohibited Medication|1
6916370|NCT00774930|10943556|FG001|IOL Phase|Subject Consumed Prohibited Medication|0
6916371|NCT00774930|10943555|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0
6916372|NCT00774930|10943556|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1
6916373|NCT00774930|10943555|FG000|IOL Phase|Other|1
6916374|NCT00774930|10943556|FG001|IOL Phase|Other|0
6916375|NCT00774930|10943555|FG000|IOL Phase|Brain radiation|0
6916376|NCT00774930|10943556|FG001|IOL Phase|Brain radiation|1
6916377|NCT00774930|10943555|FG000|LTOLE Phase|Adverse Event|7
6916378|NCT00774930|10943556|FG001|LTOLE Phase|Adverse Event|3
6916379|NCT00774930|10943555|FG000|LTOLE Phase|Subject decision|0
6916380|NCT00774930|10943556|FG001|LTOLE Phase|Subject decision|5
6916381|NCT00774930|10943555|FG000|LTOLE Phase|Physician Decision|4
6916382|NCT00774930|10943556|FG001|LTOLE Phase|Physician Decision|1
6916383|NCT00774930|10943555|FG000|LTOLE Phase|Sponsor decision|2
6916384|NCT00774930|10943556|FG001|LTOLE Phase|Sponsor decision|1
6916385|NCT00774930|10943555|FG000|LTOLE Phase|Disease Progression|2
6916386|NCT00774930|10943556|FG001|LTOLE Phase|Disease Progression|5
6916387|NCT00774930|10943555|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0
6916388|NCT00774930|10943556|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1
6916389|NCT00774930|10943555|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0
6916390|NCT00774930|10943556|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1
6916391|NCT00774995|10943568|FG000|Overall Study|Protocol Violation|0
6916392|NCT00774995|10943569|FG001|Overall Study|Protocol Violation|0
6916393|NCT00774995|10943570|FG002|Overall Study|Protocol Violation|1
6916394|NCT00774995|10943571|FG003|Overall Study|Protocol Violation|0
6916395|NCT00775021|10943581|FG000|First Intervention|Lost to Follow-up|1
6916396|NCT00775021|10943582|FG001|First Intervention|Lost to Follow-up|0
6916397|NCT00775021|10943581|FG000|Second Intervention|Adverse Event|0
6916398|NCT00775021|10943582|FG001|Second Intervention|Adverse Event|1
6916399|NCT00775138|10943592|FG000|Overall Study|Withdrawal by Subject|0
6916400|NCT00775138|10943593|FG001|Overall Study|Withdrawal by Subject|0
6916401|NCT00775138|10943594|FG002|Overall Study|Withdrawal by Subject|2
6916402|NCT00775138|10943595|FG003|Overall Study|Withdrawal by Subject|2
6916403|NCT00775138|10943592|FG000|Overall Study|Adverse Event|0
6916404|NCT00775138|10943593|FG001|Overall Study|Adverse Event|0
6916405|NCT00775138|10943594|FG002|Overall Study|Adverse Event|1
6916406|NCT00775138|10943595|FG003|Overall Study|Adverse Event|0
6916407|NCT00775203|10943609|FG000|Overall Study|Adverse Event|25
6916408|NCT00775203|10943610|FG001|Overall Study|Adverse Event|6
6916409|NCT00775203|10943609|FG000|Overall Study|Lack of Efficacy|8
6916410|NCT00775203|10943610|FG001|Overall Study|Lack of Efficacy|9
6916411|NCT00775203|10943609|FG000|Overall Study|Withdrawal by Subject|11
6916412|NCT00775203|10943610|FG001|Overall Study|Withdrawal by Subject|9
6916413|NCT00775203|10943609|FG000|Overall Study|Lost to Follow-up|11
6916414|NCT00775203|10943610|FG001|Overall Study|Lost to Follow-up|15
6916415|NCT00775203|10943609|FG000|Overall Study|Administrative reason|2
6916416|NCT00775203|10943610|FG001|Overall Study|Administrative reason|0
6916417|NCT00775203|10943609|FG000|Overall Study|Noncompliance|4
6916418|NCT00775203|10943610|FG001|Overall Study|Noncompliance|2
6916419|NCT00775203|10943609|FG000|Overall Study|Protocol Violation|0
6916420|NCT00775203|10943610|FG001|Overall Study|Protocol Violation|1
6916421|NCT00775203|10943609|FG000|Overall Study|Entered other study|1
6916422|NCT00775203|10943610|FG001|Overall Study|Entered other study|0
6916423|NCT00775203|10943609|FG000|Overall Study|Physician Decision|0
6916424|NCT00775203|10943610|FG001|Overall Study|Physician Decision|1
6916425|NCT00775268|10943627|FG000|Baseline|Drug not synthesize dose|1
6916426|NCT00775268|10943628|FG001|Baseline|Drug not synthesize dose|0
6916427|NCT00775268|10943627|FG000|Baseline|Not treated-ineligible per CT|0
6916428|NCT00775268|10943628|FG001|Baseline|Not treated-ineligible per CT|1
6916429|NCT00775268|10943627|FG000|After 2 Cycles|Participant refused to be scanned further|1
6916430|NCT00775268|10943628|FG001|After 2 Cycles|Participant refused to be scanned further|0
6916431|NCT00775268|10943627|FG000|After Completion|Participant missed scan appointment|1
6916432|NCT00775268|10943628|FG001|After Completion|Participant missed scan appointment|0
6916433|NCT00775437|10943653|FG000|Overall Study|Loss of efficacy|2
6916434|NCT00775437|10943653|FG000|Overall Study|Withdrawal by Subject|3
6916435|NCT00775437|10943653|FG000|Overall Study|Lost to Follow-up|1
6916436|NCT00775450|10943662|FG000|Overall Study|Serious Adverse Event|2
6916437|NCT00775450|10943663|FG001|Overall Study|Serious Adverse Event|0
6916438|NCT00775450|10943664|FG002|Overall Study|Serious Adverse Event|0
6916439|NCT00775450|10943665|FG003|Overall Study|Serious Adverse Event|0
6916440|NCT00775450|10943666|FG004|Overall Study|Serious Adverse Event|0
6916441|NCT00775450|10943662|FG000|Overall Study|Protocol Violation|0
6916442|NCT00775450|10943663|FG001|Overall Study|Protocol Violation|0
6916443|NCT00775450|10943664|FG002|Overall Study|Protocol Violation|0
6916444|NCT00775450|10943665|FG003|Overall Study|Protocol Violation|0
6916445|NCT00775450|10943666|FG004|Overall Study|Protocol Violation|1
6916446|NCT00775450|10943662|FG000|Overall Study|Withdrawal by Subject|1
6916447|NCT00775450|10943663|FG001|Overall Study|Withdrawal by Subject|0
6916448|NCT00775450|10943664|FG002|Overall Study|Withdrawal by Subject|0
6916449|NCT00775450|10943665|FG003|Overall Study|Withdrawal by Subject|0
6916450|NCT00775450|10943666|FG004|Overall Study|Withdrawal by Subject|1
6916451|NCT00775463|10943680|FG000|Overall Study|Withdrawal by Subject|0
6916452|NCT00775463|10943681|FG001|Overall Study|Withdrawal by Subject|1
6916453|NCT00775463|10943680|FG000|Overall Study|Adverse Event|7
6916454|NCT00775463|10943681|FG001|Overall Study|Adverse Event|9
6916455|NCT00775463|10943680|FG000|Overall Study|Protocol Violation|2
6916456|NCT00775463|10943681|FG001|Overall Study|Protocol Violation|2
6916457|NCT00775463|10943680|FG000|Overall Study|Lost to Follow-up|1
6916458|NCT00775463|10943681|FG001|Overall Study|Lost to Follow-up|0
6916459|NCT00775463|10943680|FG000|Overall Study|Lack of Efficacy|1
6916460|NCT00775463|10943681|FG001|Overall Study|Lack of Efficacy|1
6916461|NCT00775528|10943694|FG000|Overall Study|Protocol Violation|1
6916462|NCT00775593|10943698|FG000|Overall Study|Unmet eligibility criteria|6
6916463|NCT00775593|10943698|FG000|Overall Study|Death|1
6916464|NCT00775606|10943704|FG000|Overall Study|Study sponsor terminated funding|3
6916465|NCT00775606|10943705|FG001|Overall Study|Study sponsor terminated funding|0
6916466|NCT00775983|10943766|FG000|Overall Study|Protocol Violation|1
6916467|NCT00775983|10943767|FG001|Overall Study|Protocol Violation|2
6916468|NCT00776009|10943779|FG000|Period 1: First Intervention|Withdrawal by Subject|0
6916469|NCT00776009|10943780|FG001|Period 1: First Intervention|Withdrawal by Subject|0
6916470|NCT00776009|10943781|FG002|Period 1: First Intervention|Withdrawal by Subject|1
6916471|NCT00776009|10943782|FG003|Period 1: First Intervention|Withdrawal by Subject|0
6916472|NCT00776009|10943783|FG004|Period 1: First Intervention|Withdrawal by Subject|1
6916473|NCT00776009|10943784|FG005|Period 1: First Intervention|Withdrawal by Subject|0
6916474|NCT00776009|10943779|FG000|Period 1: First Intervention|Protocol Violation|0
6916475|NCT00776009|10943780|FG001|Period 1: First Intervention|Protocol Violation|1
6916476|NCT00776009|10943781|FG002|Period 1: First Intervention|Protocol Violation|0
6916477|NCT00776009|10943782|FG003|Period 1: First Intervention|Protocol Violation|0
6916478|NCT00776009|10943783|FG004|Period 1: First Intervention|Protocol Violation|1
6916479|NCT00776009|10943784|FG005|Period 1: First Intervention|Protocol Violation|0
6916480|NCT00776009|10943779|FG000|Period 2: Second Intervention|Withdrawal by Subject|0
6916481|NCT00776009|10943780|FG001|Period 2: Second Intervention|Withdrawal by Subject|0
6916482|NCT00776009|10943781|FG002|Period 2: Second Intervention|Withdrawal by Subject|0
6916483|NCT00776009|10943782|FG003|Period 2: Second Intervention|Withdrawal by Subject|0
6916484|NCT00776009|10943783|FG004|Period 2: Second Intervention|Withdrawal by Subject|0
6916485|NCT00776009|10943784|FG005|Period 2: Second Intervention|Withdrawal by Subject|1
6916486|NCT00776009|10943779|FG000|Period 2: Second Intervention|Protocol Violation|1
6916487|NCT00776009|10943780|FG001|Period 2: Second Intervention|Protocol Violation|0
6916488|NCT00776009|10943781|FG002|Period 2: Second Intervention|Protocol Violation|1
6916489|NCT00776009|10943782|FG003|Period 2: Second Intervention|Protocol Violation|0
6916490|NCT00776009|10943783|FG004|Period 2: Second Intervention|Protocol Violation|0
6916491|NCT00776009|10943784|FG005|Period 2: Second Intervention|Protocol Violation|0
6916492|NCT00776009|10943779|FG000|Period 3: Third Intervention|Withdrawal by Subject|1
6916493|NCT00776009|10943780|FG001|Period 3: Third Intervention|Withdrawal by Subject|0
6916494|NCT00776009|10943781|FG002|Period 3: Third Intervention|Withdrawal by Subject|0
6916495|NCT00776009|10943782|FG003|Period 3: Third Intervention|Withdrawal by Subject|0
6916496|NCT00776009|10943783|FG004|Period 3: Third Intervention|Withdrawal by Subject|0
6916497|NCT00776009|10943784|FG005|Period 3: Third Intervention|Withdrawal by Subject|0
6916498|NCT00776230|10943795|FG000|Overall Study|Lost to Follow-up|2
6916499|NCT00776230|10943796|FG001|Overall Study|Lost to Follow-up|1
6916500|NCT00776230|10943797|FG002|Overall Study|Lost to Follow-up|5
6916501|NCT00776230|10943795|FG000|Overall Study|Not vaccinated at Day 0|1
6916502|NCT00776230|10943796|FG001|Overall Study|Not vaccinated at Day 0|0
6916503|NCT00776230|10943797|FG002|Overall Study|Not vaccinated at Day 0|0
6916504|NCT00776230|10943795|FG000|Overall Study|Withdrawal by Subject|0
6916505|NCT00776230|10943796|FG001|Overall Study|Withdrawal by Subject|1
6916506|NCT00776230|10943797|FG002|Overall Study|Withdrawal by Subject|0
6916507|NCT00776230|10943795|FG000|Overall Study|Subject missed Visit 4|0
6916508|NCT00776230|10943796|FG001|Overall Study|Subject missed Visit 4|1
6916509|NCT00776230|10943797|FG002|Overall Study|Subject missed Visit 4|0
6916510|NCT00776659|10943820|FG000|Overall Study|Lost to Follow-up|15
6916511|NCT00776659|10943820|FG000|Overall Study|Withdrawal by Subject|10
6916512|NCT00776659|10943820|FG000|Overall Study|Study Terminated by Sponsor|1
6916513|NCT00776789|10943826|FG000|Overall Study|Consent refusal|2
6916514|NCT00776789|10943827|FG001|Overall Study|Consent refusal|2
6916515|NCT00776789|10943826|FG000|Overall Study|Poor quality video|1
6916516|NCT00776789|10943827|FG001|Overall Study|Poor quality video|1
6916517|NCT00776919|10943839|FG000|Overall Study|Withdrawal by Subject|16
6916518|NCT00776919|10943840|FG001|Overall Study|Withdrawal by Subject|14
6916519|NCT00776919|10943841|FG002|Overall Study|Withdrawal by Subject|15
6916520|NCT00776919|10943842|FG003|Overall Study|Withdrawal by Subject|26
6916521|NCT00776919|10943839|FG000|Overall Study|Lost to Follow-up|8
6916522|NCT00776919|10943840|FG001|Overall Study|Lost to Follow-up|12
6916523|NCT00776919|10943841|FG002|Overall Study|Lost to Follow-up|11
6916524|NCT00776919|10943842|FG003|Overall Study|Lost to Follow-up|8
6916525|NCT00776919|10943839|FG000|Overall Study|Adverse Event|1
6916526|NCT00776919|10943840|FG001|Overall Study|Adverse Event|0
6916527|NCT00776919|10943841|FG002|Overall Study|Adverse Event|2
6916528|NCT00776919|10943842|FG003|Overall Study|Adverse Event|2
6916529|NCT00776919|10943839|FG000|Overall Study|Protocol Violation|1
6916530|NCT00776919|10943840|FG001|Overall Study|Protocol Violation|2
6916531|NCT00776919|10943841|FG002|Overall Study|Protocol Violation|0
6916532|NCT00776919|10943842|FG003|Overall Study|Protocol Violation|1
6916533|NCT00776919|10943839|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1
6916534|NCT00776919|10943840|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5
6979114|NCT01216072|11032857|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3
6979115|NCT01216072|11032858|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0
6979116|NCT01216072|11032857|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3
6979117|NCT01216072|11032858|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4
6979118|NCT01216072|11032857|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12
6916535|NCT00776919|10943841|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4
6916536|NCT00776919|10943842|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2
6916537|NCT00776984|10943854|FG000|Overall Study|Adverse Event|8
6916538|NCT00776984|10943855|FG001|Overall Study|Adverse Event|2
6916539|NCT00776984|10943854|FG000|Overall Study|Protocol Violation|4
6916540|NCT00776984|10943855|FG001|Overall Study|Protocol Violation|2
6916541|NCT00776984|10943854|FG000|Overall Study|Lost to Follow-up|2
6916542|NCT00776984|10943855|FG001|Overall Study|Lost to Follow-up|0
6916543|NCT00776984|10943854|FG000|Overall Study|Withdrawal by Subject|12
6916544|NCT00776984|10943855|FG001|Overall Study|Withdrawal by Subject|7
6916545|NCT00776984|10943854|FG000|Overall Study|Lack of Efficacy|0
6916546|NCT00776984|10943855|FG001|Overall Study|Lack of Efficacy|1
6916547|NCT00776984|10943854|FG000|Overall Study|Other|5
6916548|NCT00776984|10943855|FG001|Overall Study|Other|9
6916549|NCT00776997|10943861|FG000|Overall Study|Adverse Event|2
6916550|NCT00777023|10943868|FG000|Overall Study|Adverse Event|15
6916551|NCT00777023|10943869|FG001|Overall Study|Adverse Event|21
6979119|NCT01216072|11032858|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22
6979120|NCT01216072|11032857|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5
6916552|NCT00777023|10943870|FG002|Overall Study|Adverse Event|8
6916553|NCT00777023|10943868|FG000|Overall Study|Lack of Efficacy|1
6916554|NCT00777023|10943869|FG001|Overall Study|Lack of Efficacy|0
6916555|NCT00777023|10943870|FG002|Overall Study|Lack of Efficacy|14
6916556|NCT00777023|10943868|FG000|Overall Study|Protocol Violation|2
6916557|NCT00777023|10943869|FG001|Overall Study|Protocol Violation|1
6916558|NCT00777023|10943870|FG002|Overall Study|Protocol Violation|1
6916559|NCT00777023|10943868|FG000|Overall Study|Lost to Follow-up|2
6916560|NCT00777023|10943869|FG001|Overall Study|Lost to Follow-up|3
6916561|NCT00777023|10943870|FG002|Overall Study|Lost to Follow-up|3
6916562|NCT00777023|10943868|FG000|Overall Study|Death|0
6916563|NCT00777023|10943869|FG001|Overall Study|Death|1
6916564|NCT00777023|10943870|FG002|Overall Study|Death|0
6916565|NCT00777023|10943868|FG000|Overall Study|Withdrawal by Subject|7
6916566|NCT00777023|10943869|FG001|Overall Study|Withdrawal by Subject|7
6916567|NCT00777023|10943870|FG002|Overall Study|Withdrawal by Subject|8
6916568|NCT00777023|10943868|FG000|Overall Study|Missing data|1
6916569|NCT00777023|10943869|FG001|Overall Study|Missing data|1
6916570|NCT00777023|10943870|FG002|Overall Study|Missing data|0
6916571|NCT00777023|10943868|FG000|Overall Study|Reasons not specified|4
6916572|NCT00777023|10943869|FG001|Overall Study|Reasons not specified|4
6916573|NCT00777023|10943870|FG002|Overall Study|Reasons not specified|2
6916574|NCT00777023|10943868|FG000|Overall Study|Last dose date unknown|3
6916575|NCT00777023|10943869|FG001|Overall Study|Last dose date unknown|3
6916576|NCT00777023|10943870|FG002|Overall Study|Last dose date unknown|1
6916577|NCT00777049|10943880|FG000|Overall Study|Withdrawal by Subject|1
6916578|NCT00777049|10943881|FG001|Overall Study|Withdrawal by Subject|0
6916579|NCT00777049|10943880|FG000|Overall Study|No treatment (elevated liver enzymes)|0
6916580|NCT00777049|10943881|FG001|Overall Study|No treatment (elevated liver enzymes)|1
6916581|NCT00777088|10943896|FG000|Overall Study|PED Treatment not attempted|1
6916582|NCT00777101|10943903|FG000|Overall Study|Death|48
6916583|NCT00777101|10943904|FG001|Overall Study|Death|43
6916584|NCT00777101|10943903|FG000|Overall Study|Withdrawal by Subject|11
6916585|NCT00777101|10943904|FG001|Overall Study|Withdrawal by Subject|6
6916586|NCT00777101|10943903|FG000|Overall Study|Lost to Follow-up|2
6916587|NCT00777101|10943904|FG001|Overall Study|Lost to Follow-up|1
6916588|NCT00777101|10943903|FG000|Overall Study|Discontinuation of Study by Sponsor|1
6916589|NCT00777101|10943904|FG001|Overall Study|Discontinuation of Study by Sponsor|0
6916590|NCT00777101|10943903|FG000|Overall Study|Failed to Return|0
6916591|NCT00777101|10943904|FG001|Overall Study|Failed to Return|1
6916592|NCT00777153|10943914|FG000|Overall Study|Lost to Follow-up|1
6916593|NCT00777153|10943915|FG001|Overall Study|Lost to Follow-up|1
6916594|NCT00777153|10943916|FG002|Overall Study|Lost to Follow-up|0
6916595|NCT00777153|10943914|FG000|Overall Study|Death|85
6916596|NCT00777153|10943915|FG001|Overall Study|Death|73
6916597|NCT00777153|10943916|FG002|Overall Study|Death|33
6916598|NCT00777153|10943914|FG000|Overall Study|Withdrawal by Subject|3
6916599|NCT00777153|10943915|FG001|Overall Study|Withdrawal by Subject|4
6916600|NCT00777153|10943916|FG002|Overall Study|Withdrawal by Subject|3
6916601|NCT00777153|10943914|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1
6916602|NCT00777153|10943915|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5
6916603|NCT00777153|10943916|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1
6916604|NCT00777205|10943939|FG000|Overall Study|Lost to Follow-up|25
6916605|NCT00777205|10943940|FG001|Overall Study|Lost to Follow-up|9
6916606|NCT00777205|10943939|FG000|Overall Study|Withdrawal by Subject|6
6916607|NCT00777205|10943940|FG001|Overall Study|Withdrawal by Subject|4
6916608|NCT00777205|10943939|FG000|Overall Study|Death|0
6916609|NCT00777205|10943940|FG001|Overall Study|Death|2
6916610|NCT00777205|10943939|FG000|Overall Study|Protocol Violation|0
6916611|NCT00777205|10943940|FG001|Overall Study|Protocol Violation|56
6916612|NCT00777257|10943951|FG000|Overall Study|Adverse Event|3
6916613|NCT00777257|10943952|FG001|Overall Study|Adverse Event|1
6916614|NCT00777257|10943953|FG002|Overall Study|Adverse Event|0
6916615|NCT00777257|10943951|FG000|Overall Study|Lost to Follow-up|3
6916616|NCT00777257|10943952|FG001|Overall Study|Lost to Follow-up|3
6916617|NCT00777257|10943953|FG002|Overall Study|Lost to Follow-up|2
6916618|NCT00777257|10943951|FG000|Overall Study|Protocol Violation|2
6916619|NCT00777257|10943952|FG001|Overall Study|Protocol Violation|2
6916620|NCT00777257|10943953|FG002|Overall Study|Protocol Violation|2
6916621|NCT00777257|10943951|FG000|Overall Study|Withdrawal by Subject|3
6916622|NCT00777257|10943952|FG001|Overall Study|Withdrawal by Subject|6
6916623|NCT00777257|10943953|FG002|Overall Study|Withdrawal by Subject|5
6916624|NCT00777296|10943965|FG000|Overall Study|Adverse Event|0
6916625|NCT00777296|10943966|FG001|Overall Study|Adverse Event|1
6916626|NCT00777296|10943967|FG002|Overall Study|Adverse Event|0
6916627|NCT00777296|10943968|FG003|Overall Study|Adverse Event|1
6916628|NCT00777296|10943965|FG000|Overall Study|Withdrawal by Subject|1
6916629|NCT00777296|10943966|FG001|Overall Study|Withdrawal by Subject|0
6916630|NCT00777296|10943967|FG002|Overall Study|Withdrawal by Subject|0
6916631|NCT00777296|10943968|FG003|Overall Study|Withdrawal by Subject|0
6916632|NCT00777296|10943965|FG000|Overall Study|CRF form not completed|0
6916633|NCT00777296|10943966|FG001|Overall Study|CRF form not completed|0
6916634|NCT00777296|10943967|FG002|Overall Study|CRF form not completed|2
6916635|NCT00777296|10943968|FG003|Overall Study|CRF form not completed|0
6916636|NCT00777556|10943999|FG000|Overall Study|Inappropriate self-selection|34
6916637|NCT00777556|10943999|FG000|Overall Study|Dispensed but did not use product|12
6916638|NCT00777556|10943999|FG000|Overall Study|Did not complete all 3 follow-up visits|20
6916639|NCT00777608|10944005|FG000|Overall Study|Lost to Follow-up|1
6916640|NCT00777608|10944006|FG001|Overall Study|Lost to Follow-up|1
6916641|NCT00777608|10944005|FG000|Overall Study|Withdrawal by Subject|1
6916642|NCT00777608|10944006|FG001|Overall Study|Withdrawal by Subject|3
6916643|NCT00777608|10944005|FG000|Overall Study|Protocol Violation|1
6916644|NCT00777608|10944006|FG001|Overall Study|Protocol Violation|0
6916645|NCT00777608|10944005|FG000|Overall Study|Investigator Decision|1
6916646|NCT00777608|10944006|FG001|Overall Study|Investigator Decision|2
6916647|NCT00777803|10944047|FG000|Overall Study|Lost to Follow-up|12
6916648|NCT00777803|10944048|FG001|Overall Study|Lost to Follow-up|5
6916649|NCT00777803|10944047|FG000|Overall Study|Adverse Event|1
6916650|NCT00777803|10944048|FG001|Overall Study|Adverse Event|0
6916651|NCT00777803|10944047|FG000|Overall Study|Non-compliance|2
6916652|NCT00777803|10944048|FG001|Overall Study|Non-compliance|2
6916653|NCT00777829|10944054|FG000|Overall Study|Withdrawal by Subject|0
6916654|NCT00777829|10944055|FG001|Overall Study|Withdrawal by Subject|2
6916655|NCT00777920|10944069|FG000|Overall Study|Adverse Event|39
6916656|NCT00777920|10944069|FG000|Overall Study|Withdrawal of Consent|4
6916657|NCT00777920|10944069|FG000|Overall Study|Lost to Follow-up|1
6916658|NCT00777920|10944069|FG000|Overall Study|Investigator's discretion|1
6916659|NCT00777920|10944069|FG000|Overall Study|Clinical status did not improve|1
6916660|NCT00777920|10944069|FG000|Overall Study|Other, not specified|4
6916661|NCT00777946|10944076|FG000|Overall Study|Adverse Event|11
6916662|NCT00777946|10944077|FG001|Overall Study|Adverse Event|1
6916663|NCT00777946|10944078|FG002|Overall Study|Adverse Event|3
6916664|NCT00777946|10944076|FG000|Overall Study|Lack of Efficacy|0
6916665|NCT00777946|10944077|FG001|Overall Study|Lack of Efficacy|0
6916666|NCT00777946|10944078|FG002|Overall Study|Lack of Efficacy|9
6916667|NCT00777946|10944076|FG000|Overall Study|Condition no longer required study drug|1
6916668|NCT00777946|10944077|FG001|Overall Study|Condition no longer required study drug|0
6916669|NCT00777946|10944078|FG002|Overall Study|Condition no longer required study drug|0
6916670|NCT00777946|10944076|FG000|Overall Study|Patient withdrew consent|3
6916671|NCT00777946|10944077|FG001|Overall Study|Patient withdrew consent|2
6916672|NCT00777946|10944078|FG002|Overall Study|Patient withdrew consent|3
6916673|NCT00777946|10944076|FG000|Overall Study|Lost to Follow-up|3
6916674|NCT00777946|10944077|FG001|Overall Study|Lost to Follow-up|1
6916675|NCT00777946|10944078|FG002|Overall Study|Lost to Follow-up|0
6916676|NCT00777946|10944076|FG000|Overall Study|Protocol deviation|2
6916677|NCT00777946|10944077|FG001|Overall Study|Protocol deviation|1
6916678|NCT00777946|10944078|FG002|Overall Study|Protocol deviation|1
6916679|NCT00777946|10944076|FG000|Overall Study|Randomized in error|1
6916680|NCT00777946|10944077|FG001|Overall Study|Randomized in error|1
6916681|NCT00777946|10944078|FG002|Overall Study|Randomized in error|0
6916682|NCT00778102|10944088|FG000|Overall Study|Adverse Event|8
6916683|NCT00778102|10944089|FG001|Overall Study|Adverse Event|5
6916684|NCT00778102|10944088|FG000|Overall Study|Death|1
6916685|NCT00778102|10944089|FG001|Overall Study|Death|1
6916686|NCT00778102|10944088|FG000|Overall Study|Lost to Follow-up|1
6916687|NCT00778102|10944089|FG001|Overall Study|Lost to Follow-up|0
6916688|NCT00778102|10944088|FG000|Overall Study|Violation of Selection Criteria|1
6916689|NCT00778102|10944089|FG001|Overall Study|Violation of Selection Criteria|1
6916690|NCT00778102|10944088|FG000|Overall Study|Protocol Violation|0
6916691|NCT00778102|10944089|FG001|Overall Study|Protocol Violation|1
6916692|NCT00778102|10944088|FG000|Overall Study|Refused Treatment|2
6916693|NCT00778102|10944089|FG001|Overall Study|Refused Treatment|3
6916694|NCT00778102|10944088|FG000|Overall Study|Withdrawal by Subject|1
6916695|NCT00778102|10944089|FG001|Overall Study|Withdrawal by Subject|1
6916696|NCT00778102|10944088|FG000|Overall Study|Administrative Reason|7
6916697|NCT00778102|10944089|FG001|Overall Study|Administrative Reason|10
6916698|NCT00778258|10944117|FG000|Overall Study|Adverse Event|1
6916699|NCT00778258|10944118|FG001|Overall Study|Adverse Event|0
6916700|NCT00778258|10944119|FG002|Overall Study|Adverse Event|0
6916701|NCT00778258|10944120|FG003|Overall Study|Adverse Event|0
6916702|NCT00778258|10944121|FG004|Overall Study|Adverse Event|0
6916703|NCT00778258|10944122|FG005|Overall Study|Adverse Event|1
6916704|NCT00778258|10944123|FG006|Overall Study|Adverse Event|0
6916705|NCT00778258|10944124|FG007|Overall Study|Adverse Event|0
6916706|NCT00778258|10944125|FG008|Overall Study|Adverse Event|0
6916707|NCT00778258|10944117|FG000|Overall Study|Lost to Follow-up|0
6916708|NCT00778258|10944118|FG001|Overall Study|Lost to Follow-up|0
6916709|NCT00778258|10944119|FG002|Overall Study|Lost to Follow-up|2
6916710|NCT00778258|10944120|FG003|Overall Study|Lost to Follow-up|0
6916711|NCT00778258|10944121|FG004|Overall Study|Lost to Follow-up|0
6916712|NCT00778258|10944122|FG005|Overall Study|Lost to Follow-up|3
6916713|NCT00778258|10944123|FG006|Overall Study|Lost to Follow-up|2
6916714|NCT00778258|10944124|FG007|Overall Study|Lost to Follow-up|2
6916715|NCT00778258|10944125|FG008|Overall Study|Lost to Follow-up|0
6916716|NCT00778258|10944117|FG000|Overall Study|Withdrawal by Subject|6
6916717|NCT00778258|10944118|FG001|Overall Study|Withdrawal by Subject|2
6916718|NCT00778258|10944119|FG002|Overall Study|Withdrawal by Subject|8
6916719|NCT00778258|10944120|FG003|Overall Study|Withdrawal by Subject|2
6916720|NCT00778258|10944121|FG004|Overall Study|Withdrawal by Subject|0
6916721|NCT00778258|10944122|FG005|Overall Study|Withdrawal by Subject|6
6916722|NCT00778258|10944123|FG006|Overall Study|Withdrawal by Subject|12
6916723|NCT00778258|10944124|FG007|Overall Study|Withdrawal by Subject|12
6916724|NCT00778258|10944125|FG008|Overall Study|Withdrawal by Subject|4
6916725|NCT00778258|10944117|FG000|Overall Study|New Contraindication|0
6916726|NCT00778258|10944118|FG001|Overall Study|New Contraindication|0
6916727|NCT00778258|10944119|FG002|Overall Study|New Contraindication|0
6916728|NCT00778258|10944120|FG003|Overall Study|New Contraindication|0
6916729|NCT00778258|10944121|FG004|Overall Study|New Contraindication|0
6916730|NCT00778258|10944122|FG005|Overall Study|New Contraindication|0
6916731|NCT00778258|10944123|FG006|Overall Study|New Contraindication|0
6916732|NCT00778258|10944124|FG007|Overall Study|New Contraindication|1
6916733|NCT00778258|10944125|FG008|Overall Study|New Contraindication|0
6916734|NCT00778258|10944117|FG000|Overall Study|Non-compliance|0
6916735|NCT00778258|10944118|FG001|Overall Study|Non-compliance|0
6916736|NCT00778258|10944119|FG002|Overall Study|Non-compliance|0
6916737|NCT00778258|10944120|FG003|Overall Study|Non-compliance|1
6916738|NCT00778258|10944121|FG004|Overall Study|Non-compliance|0
6916739|NCT00778258|10944122|FG005|Overall Study|Non-compliance|0
6916740|NCT00778258|10944123|FG006|Overall Study|Non-compliance|0
6916741|NCT00778258|10944124|FG007|Overall Study|Non-compliance|0
6916742|NCT00778258|10944125|FG008|Overall Study|Non-compliance|0
6916743|NCT00778258|10944117|FG000|Overall Study|Other|0
6916744|NCT00778258|10944118|FG001|Overall Study|Other|0
6916745|NCT00778258|10944119|FG002|Overall Study|Other|0
6916746|NCT00778258|10944120|FG003|Overall Study|Other|0
6916747|NCT00778258|10944121|FG004|Overall Study|Other|0
6916748|NCT00778258|10944122|FG005|Overall Study|Other|0
6916749|NCT00778258|10944123|FG006|Overall Study|Other|1
6916750|NCT00778258|10944124|FG007|Overall Study|Other|0
6916751|NCT00778258|10944125|FG008|Overall Study|Other|0
6916752|NCT00778336|10944166|FG000|Index Procedure-Discharge|Death|6
6916753|NCT00778336|10944167|FG001|Index Procedure-Discharge|Death|3
6916754|NCT00778336|10944168|FG002|Index Procedure-Discharge|Death|2
6916755|NCT00778336|10944169|FG003|Index Procedure-Discharge|Death|0
6916756|NCT00778336|10944166|FG000|3 Month Follow Up|Lost to Follow-up|15
6916757|NCT00778336|10944167|FG001|3 Month Follow Up|Lost to Follow-up|20
6916758|NCT00778336|10944168|FG002|3 Month Follow Up|Lost to Follow-up|3
6916759|NCT00778336|10944169|FG003|3 Month Follow Up|Lost to Follow-up|0
6916760|NCT00778336|10944166|FG000|3 Month Follow Up|Death|8
6916761|NCT00778336|10944167|FG001|3 Month Follow Up|Death|3
6916762|NCT00778336|10944168|FG002|3 Month Follow Up|Death|2
6916763|NCT00778336|10944169|FG003|3 Month Follow Up|Death|0
6916764|NCT00778375|10944179|FG000|Overall Study|Ineligible|3
6916765|NCT00778622|10944188|FG000|Overall Study|Adverse Event|5
6916766|NCT00778622|10944189|FG001|Overall Study|Adverse Event|4
6916767|NCT00778622|10944190|FG002|Overall Study|Adverse Event|7
6916768|NCT00778622|10944188|FG000|Overall Study|Withdrawal by Subject|4
6916769|NCT00778622|10944189|FG001|Overall Study|Withdrawal by Subject|5
6916770|NCT00778622|10944190|FG002|Overall Study|Withdrawal by Subject|5
6916771|NCT00778622|10944188|FG000|Overall Study|Lost to Follow-up|3
6916772|NCT00778622|10944189|FG001|Overall Study|Lost to Follow-up|3
6916773|NCT00778622|10944190|FG002|Overall Study|Lost to Follow-up|2
6916774|NCT00778622|10944188|FG000|Overall Study|Protocol Violation|0
6916775|NCT00778622|10944189|FG001|Overall Study|Protocol Violation|3
6916776|NCT00778622|10944190|FG002|Overall Study|Protocol Violation|0
6916777|NCT00778622|10944188|FG000|Overall Study|Lack of Efficacy|2
6916778|NCT00778622|10944189|FG001|Overall Study|Lack of Efficacy|0
6916779|NCT00778622|10944190|FG002|Overall Study|Lack of Efficacy|0
6916780|NCT00778622|10944188|FG000|Overall Study|immigration|1
6916781|NCT00778622|10944189|FG001|Overall Study|immigration|0
6916782|NCT00778622|10944190|FG002|Overall Study|immigration|0
6916783|NCT00778622|10944188|FG000|Overall Study|Other|1
6916784|NCT00778622|10944189|FG001|Overall Study|Other|0
6916785|NCT00778622|10944190|FG002|Overall Study|Other|1
6916786|NCT00778817|10944211|FG000|Overall Study|Adverse Event|2
6916787|NCT00778817|10944211|FG000|Overall Study|Withdrawal by Subject|2
6916788|NCT00778830|10944217|FG000|Overall Study|Ongoing at data cut-off|0
6916789|NCT00778830|10944218|FG001|Overall Study|Ongoing at data cut-off|1
6916790|NCT00778895|10944231|FG000|Active Phase|Adverse Event|3
6916791|NCT00778895|10944232|FG001|Active Phase|Adverse Event|1
6916792|NCT00778895|10944233|FG002|Active Phase|Adverse Event|0
6916793|NCT00778895|10944231|FG000|Active Phase|Withdrawal by Subject|1
6916794|NCT00778895|10944232|FG001|Active Phase|Withdrawal by Subject|4
6916795|NCT00778895|10944233|FG002|Active Phase|Withdrawal by Subject|0
6916796|NCT00778895|10944231|FG000|Active Phase|Lost to Follow-up|1
6916797|NCT00778895|10944232|FG001|Active Phase|Lost to Follow-up|1
6916798|NCT00778895|10944233|FG002|Active Phase|Lost to Follow-up|0
6916799|NCT00778895|10944231|FG000|Active Phase|Other|2
6916800|NCT00778895|10944232|FG001|Active Phase|Other|0
6916801|NCT00778895|10944233|FG002|Active Phase|Other|0
6916802|NCT00778895|10944231|FG000|ESFU Phase|Adverse Event|2
6916803|NCT00778895|10944232|FG001|ESFU Phase|Adverse Event|1
6916804|NCT00778895|10944233|FG002|ESFU Phase|Adverse Event|0
6916805|NCT00778895|10944231|FG000|ESFU Phase|Withdrawal by Subject|1
6916806|NCT00778895|10944232|FG001|ESFU Phase|Withdrawal by Subject|4
6916807|NCT00778895|10944233|FG002|ESFU Phase|Withdrawal by Subject|0
6916808|NCT00778895|10944231|FG000|ESFU Phase|Lost to Follow-up|6
6916809|NCT00778895|10944232|FG001|ESFU Phase|Lost to Follow-up|7
6916810|NCT00778895|10944233|FG002|ESFU Phase|Lost to Follow-up|2
6916811|NCT00778895|10944231|FG000|ESFU Phase|Other|2
6916812|NCT00778895|10944232|FG001|ESFU Phase|Other|0
6916813|NCT00778895|10944233|FG002|ESFU Phase|Other|0
6916814|NCT00778921|10944245|FG000|Overall Study|Adverse Event|9
6916815|NCT00778921|10944246|FG001|Overall Study|Adverse Event|10
6916816|NCT00778921|10944247|FG002|Overall Study|Adverse Event|14
6916817|NCT00778921|10944245|FG000|Overall Study|Abnormal Laboratory Value(s)|1
6916818|NCT00778921|10944246|FG001|Overall Study|Abnormal Laboratory Value(s)|0
6916819|NCT00778921|10944247|FG002|Overall Study|Abnormal Laboratory Value(s)|0
6916820|NCT00778921|10944245|FG000|Overall Study|Abnormal Test Procedure Result(s)|0
6916821|NCT00778921|10944246|FG001|Overall Study|Abnormal Test Procedure Result(s)|0
6916822|NCT00778921|10944247|FG002|Overall Study|Abnormal Test Procedure Result(s)|2
6916823|NCT00778921|10944245|FG000|Overall Study|Unsatisfactory therapeutic response|1
6916824|NCT00778921|10944246|FG001|Overall Study|Unsatisfactory therapeutic response|1
6916825|NCT00778921|10944247|FG002|Overall Study|Unsatisfactory therapeutic response|1
6916826|NCT00778921|10944245|FG000|Overall Study|Patient No Longer Requires Study Drug|0
6916827|NCT00778921|10944246|FG001|Overall Study|Patient No Longer Requires Study Drug|1
6916828|NCT00778921|10944247|FG002|Overall Study|Patient No Longer Requires Study Drug|0
6916829|NCT00778921|10944245|FG000|Overall Study|Patient withdrew request|3
6916830|NCT00778921|10944246|FG001|Overall Study|Patient withdrew request|1
6916831|NCT00778921|10944247|FG002|Overall Study|Patient withdrew request|6
6916832|NCT00778921|10944245|FG000|Overall Study|Lost to Follow-up|0
6916833|NCT00778921|10944246|FG001|Overall Study|Lost to Follow-up|2
6916834|NCT00778921|10944247|FG002|Overall Study|Lost to Follow-up|1
6916835|NCT00778921|10944245|FG000|Overall Study|Administrative Problems|1
6916836|NCT00778921|10944246|FG001|Overall Study|Administrative Problems|2
6916837|NCT00778921|10944247|FG002|Overall Study|Administrative Problems|0
6916838|NCT00778921|10944245|FG000|Overall Study|Protocol Violation|3
6916839|NCT00778921|10944246|FG001|Overall Study|Protocol Violation|0
6916840|NCT00778921|10944247|FG002|Overall Study|Protocol Violation|2
6916841|NCT00778921|10944245|FG000|Overall Study|Not treated|0
6916842|NCT00778921|10944246|FG001|Overall Study|Not treated|2
6916843|NCT00778921|10944247|FG002|Overall Study|Not treated|2
6916844|NCT00779025|10944255|FG000|Overall Study|Withdrawal by Subject|1
6916845|NCT00779142|10944268|FG000|Overall Study|Screen Failures|3
6916846|NCT00779246|10944284|FG000|Overall Study|Missing sufficient data for analysis|33
6916847|NCT00779246|10944285|FG001|Overall Study|Missing sufficient data for analysis|53
6916848|NCT00779259|10944291|FG000|Quinine Alone|Adverse Event|2
6916849|NCT00779324|10944336|FG000|Overall Study|Lost to Follow-up|2
6916850|NCT00779324|10944337|FG001|Overall Study|Lost to Follow-up|1
6916851|NCT00779324|10944336|FG000|Overall Study|Withdrawal by Subject|4
6916852|NCT00779324|10944337|FG001|Overall Study|Withdrawal by Subject|2
6916853|NCT00779324|10944336|FG000|Overall Study|Missed visit|1
6916854|NCT00779324|10944337|FG001|Overall Study|Missed visit|1
6916855|NCT00779402|10944345|FG000|Treatment Phase 1|Disease Progression|1
6916856|NCT00779402|10944346|FG001|Treatment Phase 1|Disease Progression|0
6916857|NCT00779402|10944345|FG000|Treatment Phase 1|Adverse Event|2
6916858|NCT00779402|10944346|FG001|Treatment Phase 1|Adverse Event|0
6916859|NCT00779402|10944345|FG000|Treatment Phase 1|Protocol Violation|1
6916860|NCT00779402|10944346|FG001|Treatment Phase 1|Protocol Violation|0
6916861|NCT00779402|10944345|FG000|Treatment Phase 1|Patient Refused to Continue|17
6916862|NCT00779402|10944346|FG001|Treatment Phase 1|Patient Refused to Continue|2
6916863|NCT00779402|10944345|FG000|Treatment Phase 1|Lost to Follow-up|0
6916864|NCT00779402|10944346|FG001|Treatment Phase 1|Lost to Follow-up|1
6916865|NCT00779402|10944345|FG000|Treatment Phase 1|Death|0
6916866|NCT00779402|10944346|FG001|Treatment Phase 1|Death|1
6916867|NCT00779402|10944345|FG000|Treatment Phase 1|Intercurrent Illness|1
6916868|NCT00779402|10944346|FG001|Treatment Phase 1|Intercurrent Illness|1
6916869|NCT00779402|10944345|FG000|Treatment Phase 1|Withdrawal by Subject|1
6916870|NCT00779402|10944346|FG001|Treatment Phase 1|Withdrawal by Subject|0
6916871|NCT00779402|10944345|FG000|Treatment Phase 1|Other|4
6916872|NCT00779402|10944346|FG001|Treatment Phase 1|Other|2
6916873|NCT00779402|10944345|FG000|Treatment Phase 1|Closure of Study|3
6916874|NCT00779402|10944346|FG001|Treatment Phase 1|Closure of Study|2
6916875|NCT00779402|10944345|FG000|Treatment Phase 1|Completed Protocol Visits|3
6916876|NCT00779402|10944346|FG001|Treatment Phase 1|Completed Protocol Visits|6
6916877|NCT00779402|10944345|FG000|Surveillance Phase|Protocol Violation|0
6916878|NCT00779402|10944346|FG001|Surveillance Phase|Protocol Violation|1
6916879|NCT00779402|10944345|FG000|Surveillance Phase|Patient refused to continue|22
6916880|NCT00779402|10944346|FG001|Surveillance Phase|Patient refused to continue|14
6916881|NCT00779402|10944345|FG000|Surveillance Phase|Lost to Follow-up|2
6916882|NCT00779402|10944346|FG001|Surveillance Phase|Lost to Follow-up|1
6916883|NCT00779402|10944345|FG000|Surveillance Phase|Death|0
6916884|NCT00779402|10944346|FG001|Surveillance Phase|Death|1
6916885|NCT00779402|10944345|FG000|Surveillance Phase|Intercurrent Illness|2
6916886|NCT00779402|10944346|FG001|Surveillance Phase|Intercurrent Illness|0
6916887|NCT00779402|10944345|FG000|Surveillance Phase|Other|5
6916888|NCT00779402|10944346|FG001|Surveillance Phase|Other|5
6916889|NCT00779402|10944345|FG000|Surveillance Phase|Withdrawal by Subject|4
6916890|NCT00779402|10944346|FG001|Surveillance Phase|Withdrawal by Subject|1
6916891|NCT00779402|10944345|FG000|Surveillance Phase|Closure of study|5
6916892|NCT00779402|10944346|FG001|Surveillance Phase|Closure of study|6
6916893|NCT00779402|10944345|FG000|Surveillance Phase|Completed Protocol Visits|3
6916894|NCT00779402|10944346|FG001|Surveillance Phase|Completed Protocol Visits|2
6916895|NCT00779402|10944345|FG000|Long-term Follow-up|Patient refused to continue|2
6916896|NCT00779402|10944346|FG001|Long-term Follow-up|Patient refused to continue|0
6916897|NCT00779402|10944345|FG000|Long-term Follow-up|Other|5
6916898|NCT00779402|10944346|FG001|Long-term Follow-up|Other|0
6916899|NCT00779402|10944345|FG000|Long-term Follow-up|Closure of Study|8
6916900|NCT00779402|10944346|FG001|Long-term Follow-up|Closure of Study|4
6916901|NCT00779402|10944345|FG000|Long-term Follow-up|Completed Protocol Visits|6
6916902|NCT00779402|10944346|FG001|Long-term Follow-up|Completed Protocol Visits|2
6916903|NCT00779467|10944356|FG000|Overall Study|Lack of Efficacy|11
6916904|NCT00779467|10944357|FG001|Overall Study|Lack of Efficacy|2
6916905|NCT00779467|10944358|FG002|Overall Study|Lack of Efficacy|6
6916906|NCT00779467|10944359|FG003|Overall Study|Lack of Efficacy|11
6916907|NCT00779467|10944356|FG000|Overall Study|failed inclusion criteria|3
6916908|NCT00779467|10944357|FG001|Overall Study|failed inclusion criteria|3
6916909|NCT00779467|10944358|FG002|Overall Study|failed inclusion criteria|1
6916910|NCT00779467|10944359|FG003|Overall Study|failed inclusion criteria|2
6916911|NCT00779467|10944356|FG000|Overall Study|missing data|1
6916912|NCT00779467|10944357|FG001|Overall Study|missing data|0
6916913|NCT00779467|10944358|FG002|Overall Study|missing data|1
6916914|NCT00779467|10944359|FG003|Overall Study|missing data|4
6916915|NCT00779467|10944356|FG000|Overall Study|technical issue|0
6916916|NCT00779467|10944357|FG001|Overall Study|technical issue|0
6916917|NCT00779467|10944358|FG002|Overall Study|technical issue|2
6916918|NCT00779467|10944359|FG003|Overall Study|technical issue|1
6916919|NCT00779467|10944356|FG000|Overall Study|unavailable research staff|0
6916920|NCT00779467|10944357|FG001|Overall Study|unavailable research staff|0
6916921|NCT00779467|10944358|FG002|Overall Study|unavailable research staff|0
6916922|NCT00779467|10944359|FG003|Overall Study|unavailable research staff|1
6916923|NCT00779506|10944369|FG000|Overall Study|Screening Failed|2
6916924|NCT00779506|10944369|FG000|Overall Study|Adverse Event|4
6916925|NCT00779506|10944369|FG000|Overall Study|Lack of Efficacy|11
6916926|NCT00779506|10944369|FG000|Overall Study|Protocol Violation|5
6916927|NCT00779506|10944369|FG000|Overall Study|Withdrawal by Subject|6
6916928|NCT00779506|10944369|FG000|Overall Study|Lost to Follow-up|1
6916929|NCT00779584|10944391|FG000|Overall Study|Protocol Violation|0
6916930|NCT00779584|10944392|FG001|Overall Study|Protocol Violation|0
6916931|NCT00779584|10944393|FG002|Overall Study|Protocol Violation|0
6916932|NCT00779584|10944394|FG003|Overall Study|Protocol Violation|0
6916933|NCT00779584|10944395|FG004|Overall Study|Protocol Violation|0
6916934|NCT00779584|10944396|FG005|Overall Study|Protocol Violation|1
6916935|NCT00779584|10944397|FG006|Overall Study|Protocol Violation|0
6916936|NCT00779584|10944398|FG007|Overall Study|Protocol Violation|0
6916937|NCT00779584|10944399|FG008|Overall Study|Protocol Violation|0
6916938|NCT00779584|10944391|FG000|Overall Study|Withdrawal by Subject|1
6916939|NCT00779584|10944392|FG001|Overall Study|Withdrawal by Subject|1
6916940|NCT00779584|10944393|FG002|Overall Study|Withdrawal by Subject|2
6916941|NCT00779584|10944394|FG003|Overall Study|Withdrawal by Subject|0
6916942|NCT00779584|10944395|FG004|Overall Study|Withdrawal by Subject|0
6916943|NCT00779584|10944396|FG005|Overall Study|Withdrawal by Subject|2
6916944|NCT00779584|10944397|FG006|Overall Study|Withdrawal by Subject|1
6916945|NCT00779584|10944398|FG007|Overall Study|Withdrawal by Subject|0
6916946|NCT00779584|10944399|FG008|Overall Study|Withdrawal by Subject|0
6916947|NCT00779584|10944391|FG000|Overall Study|Lost to Follow-up|0
6916948|NCT00779584|10944392|FG001|Overall Study|Lost to Follow-up|0
6916949|NCT00779584|10944393|FG002|Overall Study|Lost to Follow-up|0
6916950|NCT00779584|10944394|FG003|Overall Study|Lost to Follow-up|0
6916951|NCT00779584|10944395|FG004|Overall Study|Lost to Follow-up|1
6916952|NCT00779584|10944396|FG005|Overall Study|Lost to Follow-up|0
6916953|NCT00779584|10944397|FG006|Overall Study|Lost to Follow-up|0
6916954|NCT00779584|10944398|FG007|Overall Study|Lost to Follow-up|0
6916955|NCT00779584|10944399|FG008|Overall Study|Lost to Follow-up|0
6916956|NCT00779584|10944391|FG000|Overall Study|Progression of Disease|0
6916957|NCT00779584|10944392|FG001|Overall Study|Progression of Disease|1
6916958|NCT00779584|10944393|FG002|Overall Study|Progression of Disease|2
6916959|NCT00779584|10944394|FG003|Overall Study|Progression of Disease|6
6916960|NCT00779584|10944395|FG004|Overall Study|Progression of Disease|5
6916961|NCT00779584|10944396|FG005|Overall Study|Progression of Disease|1
6916962|NCT00779584|10944397|FG006|Overall Study|Progression of Disease|4
6979121|NCT01216072|11032858|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0
6916963|NCT00779584|10944398|FG007|Overall Study|Progression of Disease|2
6916964|NCT00779584|10944399|FG008|Overall Study|Progression of Disease|1
6916965|NCT00779584|10944391|FG000|Overall Study|Adverse Event|1
6916966|NCT00779584|10944392|FG001|Overall Study|Adverse Event|0
6916967|NCT00779584|10944393|FG002|Overall Study|Adverse Event|2
6916968|NCT00779584|10944394|FG003|Overall Study|Adverse Event|0
6916969|NCT00779584|10944395|FG004|Overall Study|Adverse Event|0
6916970|NCT00779584|10944396|FG005|Overall Study|Adverse Event|0
6916971|NCT00779584|10944397|FG006|Overall Study|Adverse Event|2
6916972|NCT00779584|10944398|FG007|Overall Study|Adverse Event|1
6916973|NCT00779584|10944399|FG008|Overall Study|Adverse Event|1
6916974|NCT00779584|10944391|FG000|Overall Study|Symptomatic Deterioration|1
6916975|NCT00779584|10944392|FG001|Overall Study|Symptomatic Deterioration|1
6916976|NCT00779584|10944393|FG002|Overall Study|Symptomatic Deterioration|1
6916977|NCT00779584|10944394|FG003|Overall Study|Symptomatic Deterioration|0
6916978|NCT00779584|10944395|FG004|Overall Study|Symptomatic Deterioration|0
6916979|NCT00779584|10944396|FG005|Overall Study|Symptomatic Deterioration|1
6916980|NCT00779584|10944397|FG006|Overall Study|Symptomatic Deterioration|1
6916981|NCT00779584|10944398|FG007|Overall Study|Symptomatic Deterioration|0
6916982|NCT00779584|10944399|FG008|Overall Study|Symptomatic Deterioration|0
6916983|NCT00779584|10944391|FG000|Overall Study|Ongoing in Study|0
6916984|NCT00779584|10944392|FG001|Overall Study|Ongoing in Study|0
6916985|NCT00779584|10944393|FG002|Overall Study|Ongoing in Study|0
6916986|NCT00779584|10944394|FG003|Overall Study|Ongoing in Study|0
6916987|NCT00779584|10944395|FG004|Overall Study|Ongoing in Study|1
6916988|NCT00779584|10944396|FG005|Overall Study|Ongoing in Study|1
6916989|NCT00779584|10944397|FG006|Overall Study|Ongoing in Study|0
7143003|NCT03023137|11299275|FG000|Overall Study|Lost the baby in a car accident|1
7143004|NCT03023137|11299276|FG001|Overall Study|Lost the baby in a car accident|0
7143005|NCT03023397|11299290|FG000|Run-In|Failed screening allergen challenge|1
7143006|NCT03023397|11299291|FG001|Run-In|Failed screening allergen challenge|0
6916990|NCT00779584|10944398|FG007|Overall Study|Ongoing in Study|0
6916991|NCT00779584|10944399|FG008|Overall Study|Ongoing in Study|0
6916992|NCT00779675|10944419|FG000|Treatment Period|Adverse Event|87
6916993|NCT00779675|10944419|FG000|Treatment Period|Treatment Failure|80
6916994|NCT00779675|10944419|FG000|Treatment Period|Transferred to Another Study|38
6916995|NCT00779675|10944419|FG000|Treatment Period|Lost to Follow-up|23
6916996|NCT00779675|10944419|FG000|Treatment Period|Withdrawal by Subject|46
6916997|NCT00779675|10944419|FG000|Treatment Period|Protocol Violation|54
6916998|NCT00779675|10944419|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1
6916999|NCT00779675|10944419|FG000|Treatment Period|Administrative|3
6917000|NCT00779675|10944419|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9
6917001|NCT00779675|10944419|FG000|Extended Treatment Period|Protocol Violation|13
6917002|NCT00779675|10944419|FG000|Extended Treatment Period|Adverse Event|6
6917003|NCT00779675|10944419|FG000|Extended Treatment Period|Treatment Failure|11
6917004|NCT00779675|10944419|FG000|Extended Treatment Period|Protocol defined clinical event|1
6917005|NCT00779675|10944419|FG000|Extended Treatment Period|Lost to Follow-up|6
6974430|NCT01187407|11026377|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
6974431|NCT01187407|11026373|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4
6974432|NCT01187407|11026374|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
6974433|NCT01187407|11026375|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
6974434|NCT01187407|11026376|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
6974435|NCT01187407|11026377|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
6974436|NCT01187407|11026373|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9
6974437|NCT01187407|11026374|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
6974438|NCT01187407|11026375|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
6974439|NCT01187407|11026376|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
6974440|NCT01187407|11026377|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
6974441|NCT01187407|11026373|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
6974442|NCT01187407|11026374|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
6974443|NCT01187407|11026375|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
6974444|NCT01187407|11026376|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
6974445|NCT01187407|11026377|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
6974446|NCT01187407|11026373|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13
6974447|NCT01187407|11026374|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
6974448|NCT01187407|11026375|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
6974449|NCT01187407|11026376|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
6974450|NCT01187407|11026377|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
6974451|NCT01187407|11026373|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29
6974452|NCT01187407|11026374|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
6974453|NCT01187407|11026375|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
6974454|NCT01187407|11026376|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
6974455|NCT01187407|11026377|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
6974456|NCT01187407|11026373|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4
6974457|NCT01187407|11026374|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
6974458|NCT01187407|11026375|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
6974459|NCT01187407|11026376|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
6974460|NCT01187407|11026377|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
6974461|NCT01187407|11026373|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
6974462|NCT01187407|11026374|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
6974463|NCT01187407|11026375|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6
6974464|NCT01187407|11026376|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5
6974465|NCT01187407|11026377|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12
6974466|NCT01187407|11026373|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
6974467|NCT01187407|11026374|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3
6974468|NCT01187407|11026375|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
6974469|NCT01187407|11026376|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5
6917006|NCT00779766|10944433|FG000|Month 24|Serious Adverse Event|2
6917007|NCT00779766|10944434|FG001|Month 24|Serious Adverse Event|3
6917008|NCT00779766|10944433|FG000|Month 24|Adverse Event|3
6917009|NCT00779766|10944434|FG001|Month 24|Adverse Event|3
6917010|NCT00779766|10944433|FG000|Month 24|Protocol Violation|3
6917011|NCT00779766|10944434|FG001|Month 24|Protocol Violation|1
6917012|NCT00779766|10944433|FG000|Month 24|Withdrawal by Subject|159
6917013|NCT00779766|10944434|FG001|Month 24|Withdrawal by Subject|127
6917014|NCT00779766|10944433|FG000|Month 24|Migrated/moved from study area|138
6917015|NCT00779766|10944434|FG001|Month 24|Migrated/moved from study area|162
6917016|NCT00779766|10944433|FG000|Month 24|Lost to Follow-up|9
6917017|NCT00779766|10944434|FG001|Month 24|Lost to Follow-up|9
6917018|NCT00779766|10944433|FG000|Month 24|Other|18
6917019|NCT00779766|10944434|FG001|Month 24|Other|27
6917020|NCT00779766|10944433|FG000|Month 48|Withdrawal by Subject|68
6917021|NCT00779766|10944434|FG001|Month 48|Withdrawal by Subject|63
6917022|NCT00779766|10944433|FG000|Month 48|Migrated/moved from study area|76
6917023|NCT00779766|10944434|FG001|Month 48|Migrated/moved from study area|75
6917024|NCT00779766|10944433|FG000|Month 48|Lost to Follow-up|29
6917025|NCT00779766|10944434|FG001|Month 48|Lost to Follow-up|30
6917026|NCT00779766|10944433|FG000|Month 48|Other|1
6917027|NCT00779766|10944434|FG001|Month 48|Other|0
6917028|NCT00779766|10944433|FG000|Month 72|Withdrawal by Subject|55
6917029|NCT00779766|10944434|FG001|Month 72|Withdrawal by Subject|71
6917030|NCT00779766|10944433|FG000|Month 72|Migrated/moved from study area|124
6917031|NCT00779766|10944434|FG001|Month 72|Migrated/moved from study area|109
6917032|NCT00779766|10944433|FG000|Month 72|Lost to Follow-up|6
6917033|NCT00779766|10944434|FG001|Month 72|Lost to Follow-up|8
6917034|NCT00779766|10944433|FG000|Month 72|Other|0
6917035|NCT00779766|10944434|FG001|Month 72|Other|1
6917036|NCT00779779|10944441|FG000|Overall Study|Adverse Event|1
6917037|NCT00779779|10944441|FG000|Overall Study|Protocol Violation|14
6917038|NCT00779779|10944441|FG000|Overall Study|Withdrawal by Subject|4
6917039|NCT00779779|10944441|FG000|Overall Study|Lost to Follow-up|5
6917040|NCT00779857|10944445|FG000|Overall Study|Death|1
6917041|NCT00779857|10944445|FG000|Overall Study|Withdrawal by Subject|3
6917042|NCT00779857|10944445|FG000|Overall Study|Missed Visit|2
6917043|NCT00779909|10944466|FG000|Overall Study|Lost to Follow-up|1
6917044|NCT00779909|10944467|FG001|Overall Study|Lost to Follow-up|0
6917045|NCT00779909|10944468|FG002|Overall Study|Lost to Follow-up|0
6917046|NCT00779909|10944469|FG003|Overall Study|Lost to Follow-up|1
6917047|NCT00779909|10944466|FG000|Overall Study|Withdrawal by Subject|0
6917048|NCT00779909|10944467|FG001|Overall Study|Withdrawal by Subject|1
6917049|NCT00779909|10944468|FG002|Overall Study|Withdrawal by Subject|0
6917050|NCT00779909|10944469|FG003|Overall Study|Withdrawal by Subject|0
6917051|NCT00780143|10944495|FG000|Overall Study|Progressive disease|1
6917052|NCT00780143|10944495|FG000|Overall Study|Toxicity|1
6917053|NCT00780143|10944495|FG000|Overall Study|Adverse Event|1
6917054|NCT00780273|10944512|FG000|Overall Study|Death|1
6917055|NCT00780273|10944512|FG000|Overall Study|Lost to Follow-up|1
6917056|NCT00780416|10944532|FG000|Overall Study|Physician Decision|3
6917057|NCT00780416|10944533|FG001|Overall Study|Physician Decision|3
6917058|NCT00780416|10944532|FG000|Overall Study|Protocol Violation|1
6917059|NCT00780416|10944533|FG001|Overall Study|Protocol Violation|0
6917060|NCT00780416|10944532|FG000|Overall Study|Withdrawal by Subject|8
6917061|NCT00780416|10944533|FG001|Overall Study|Withdrawal by Subject|6
6917062|NCT00780559|10944554|FG000|Overall Study|Lost to Follow-up|2
6917063|NCT00780559|10944555|FG001|Overall Study|Lost to Follow-up|7
6917064|NCT00780559|10944554|FG000|Overall Study|Death|1
6917065|NCT00780559|10944555|FG001|Overall Study|Death|0
6917066|NCT00780910|10944614|FG000|Overall Study|Adverse Event|2
6917067|NCT00780975|10944627|FG000|Overall Study|Progressive disease|3
6917068|NCT00780975|10944627|FG000|Overall Study|Toxicity|5
6917069|NCT00781274|10944640|FG000|Overall Study|Withdrawal by Subject|2
6917070|NCT00781326|10944644|FG000|Phase I|Adverse Event|1
6917071|NCT00781326|10944644|FG000|Phase I|Withdrawal by Subject|1
6917072|NCT00781326|10944644|FG000|Phase I|Physician Decision|2
6917073|NCT00781365|10944650|FG000|Overall Study|Withdrawal by Subject|13
6917074|NCT00781365|10944651|FG001|Overall Study|Withdrawal by Subject|8
6917075|NCT00781365|10944650|FG000|Overall Study|Did Not Attend Visit|20
6917076|NCT00781365|10944651|FG001|Overall Study|Did Not Attend Visit|28
6917077|NCT00781365|10944650|FG000|Overall Study|Language barrier|1
6917078|NCT00781365|10944651|FG001|Overall Study|Language barrier|0
6917079|NCT00781391|10944660|FG000|Overall Study|never received study drug|24
6917080|NCT00781391|10944661|FG001|Overall Study|never received study drug|23
6917081|NCT00781391|10944662|FG002|Overall Study|never received study drug|32
6917082|NCT00781391|10944660|FG000|Overall Study|Protocol Violation|19
6917083|NCT00781391|10944661|FG001|Overall Study|Protocol Violation|17
6917084|NCT00781391|10944662|FG002|Overall Study|Protocol Violation|20
6917085|NCT00781391|10944660|FG000|Overall Study|Death|789
6917086|NCT00781391|10944661|FG001|Overall Study|Death|730
6917087|NCT00781391|10944662|FG002|Overall Study|Death|706
6917088|NCT00781391|10944660|FG000|Overall Study|Withdrawal by Subject|47
6917089|NCT00781391|10944661|FG001|Overall Study|Withdrawal by Subject|37
6917090|NCT00781391|10944662|FG002|Overall Study|Withdrawal by Subject|25
6917091|NCT00781391|10944660|FG000|Overall Study|Lost to Follow-up|0
6917092|NCT00781391|10944661|FG001|Overall Study|Lost to Follow-up|0
6917093|NCT00781391|10944662|FG002|Overall Study|Lost to Follow-up|1
6917094|NCT00781456|10944672|FG000|Overall Study|Adverse Event|3
6917095|NCT00781456|10944673|FG001|Overall Study|Adverse Event|3
6917096|NCT00781456|10944672|FG000|Overall Study|Withdrawal by Subject|3
6917097|NCT00781456|10944673|FG001|Overall Study|Withdrawal by Subject|5
6917098|NCT00781456|10944672|FG000|Overall Study|Protocol Violation|4
6917099|NCT00781456|10944673|FG001|Overall Study|Protocol Violation|1
6917100|NCT00781456|10944672|FG000|Overall Study|Noncompliance With Protocol|1
6917101|NCT00781456|10944673|FG001|Overall Study|Noncompliance With Protocol|1
6917102|NCT00781456|10944672|FG000|Overall Study|Lost to Follow-up|10
6917103|NCT00781456|10944673|FG001|Overall Study|Lost to Follow-up|5
6917104|NCT00781456|10944672|FG000|Overall Study|Other Reason, Unknown|0
6917105|NCT00781456|10944673|FG001|Overall Study|Other Reason, Unknown|1
6917106|NCT00781599|10944692|FG000|Overall Study|Lost to Follow-up|7
6917107|NCT00781599|10944693|FG001|Overall Study|Lost to Follow-up|4
6917108|NCT00781768|10944701|FG000|Overall Study|Not transplanted.|0
6917109|NCT00781768|10944702|FG001|Overall Study|Not transplanted.|2
6917110|NCT00781859|10944710|FG000|Overall Study|Adverse Event|2
6917111|NCT00781859|10944711|FG001|Overall Study|Adverse Event|2
6917112|NCT00781859|10944710|FG000|Overall Study|Withdrawal by Subject|8
6917113|NCT00781859|10944711|FG001|Overall Study|Withdrawal by Subject|4
6917114|NCT00781859|10944710|FG000|Overall Study|Lost to Follow-up|6
6917115|NCT00781859|10944711|FG001|Overall Study|Lost to Follow-up|3
6917116|NCT00781859|10944710|FG000|Overall Study|Death|3
6917117|NCT00781859|10944711|FG001|Overall Study|Death|0
6917118|NCT00781885|10944717|FG000|Overall Study|Physician Decision|1
6917119|NCT00781911|10944732|FG000|Overall Study|Adverse Event|4
6917120|NCT00781911|10944733|FG001|Overall Study|Adverse Event|4
6917121|NCT00781911|10944732|FG000|Overall Study|Withdrawal by Subject|1
6917122|NCT00781911|10944733|FG001|Overall Study|Withdrawal by Subject|2
6917123|NCT00781911|10944732|FG000|Overall Study|Physician Decision|0
6917124|NCT00781911|10944733|FG001|Overall Study|Physician Decision|2
6917125|NCT00781911|10944732|FG000|Overall Study|Sponsor Decision|1
6917126|NCT00781911|10944733|FG001|Overall Study|Sponsor Decision|0
6917127|NCT00781937|10944743|FG000|Main Trial Period Through Week 56|Adverse Event|18
6917128|NCT00781937|10944744|FG001|Main Trial Period Through Week 56|Adverse Event|18
6917129|NCT00781937|10944743|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0
6917130|NCT00781937|10944744|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2
6917131|NCT00781937|10944743|FG000|Main Trial Period Through Week 56|Protocol Violation|8
6917132|NCT00781937|10944744|FG001|Main Trial Period Through Week 56|Protocol Violation|5
6917133|NCT00781937|10944743|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17
6917134|NCT00781937|10944744|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24
6917135|NCT00781937|10944743|FG000|Main Trial Period Through Week 56|Unclassified|10
6917136|NCT00781937|10944744|FG001|Main Trial Period Through Week 56|Unclassified|15
6917137|NCT00781937|10944743|FG000|Follow up Period (Week 56-68)|Protocol Violation|1
6917138|NCT00781937|10944744|FG001|Follow up Period (Week 56-68)|Protocol Violation|1
6917139|NCT00781937|10944743|FG000|Follow up Period (Week 56-68)|Unclassified|5
6917140|NCT00781937|10944744|FG001|Follow up Period (Week 56-68)|Unclassified|4
6917141|NCT00781963|10944762|FG000|Overall Study|Death|3
6917142|NCT00781963|10944763|FG001|Overall Study|Death|0
6917143|NCT00781963|10944762|FG000|Overall Study|Lost to Follow-up|2
6917144|NCT00781963|10944763|FG001|Overall Study|Lost to Follow-up|1
6917145|NCT00781963|10944762|FG000|Overall Study|Withdrawal by Subject|3
6917146|NCT00781963|10944763|FG001|Overall Study|Withdrawal by Subject|1
6917147|NCT00781963|10944762|FG000|Overall Study|Refused follow-up|9
6917148|NCT00781963|10944763|FG001|Overall Study|Refused follow-up|0
6917149|NCT00782067|10944769|FG000|Overall Study|Adverse Event|35
6917150|NCT00782067|10944769|FG000|Overall Study|Subject withdrew consent|11
6917151|NCT00782067|10944769|FG000|Overall Study|Lost to Follow-up|2
6917152|NCT00782067|10944769|FG000|Overall Study|Administrative problems|14
6917153|NCT00782067|10944769|FG000|Overall Study|Death|9
6917154|NCT00782067|10944769|FG000|Overall Study|Disease progression|43
6917155|NCT00782067|10944769|FG000|Overall Study|Protocol deviation|2
6917156|NCT00782171|10944775|FG000|Overall Study|Lost to Follow-up|2
6917157|NCT00782171|10944776|FG001|Overall Study|Lost to Follow-up|2
6917158|NCT00782171|10944775|FG000|Overall Study|Withdrawal by Subject|2
6917159|NCT00782171|10944776|FG001|Overall Study|Withdrawal by Subject|1
6917160|NCT00782171|10944775|FG000|Overall Study|complications|3
6917161|NCT00782171|10944776|FG001|Overall Study|complications|1
6917162|NCT00782171|10944775|FG000|Overall Study|others|7
6917163|NCT00782171|10944776|FG001|Overall Study|others|9
6917164|NCT00782171|10944775|FG000|Overall Study|not eligible|8
6917165|NCT00782171|10944776|FG001|Overall Study|not eligible|6
6917166|NCT00782210|10944785|FG000|Overall Study|Adverse Event|21
6917167|NCT00782210|10944786|FG001|Overall Study|Adverse Event|17
6917168|NCT00782210|10944787|FG002|Overall Study|Adverse Event|16
6917169|NCT00782210|10944785|FG000|Overall Study|Lost to Follow-up|2
6917170|NCT00782210|10944786|FG001|Overall Study|Lost to Follow-up|1
6917171|NCT00782210|10944787|FG002|Overall Study|Lost to Follow-up|2
6917172|NCT00782210|10944785|FG000|Overall Study|Withdrawal by Subject|11
6917173|NCT00782210|10944786|FG001|Overall Study|Withdrawal by Subject|8
6917174|NCT00782210|10944787|FG002|Overall Study|Withdrawal by Subject|11
6917175|NCT00782210|10944785|FG000|Overall Study|Non compliance with protocol|0
6917176|NCT00782210|10944786|FG001|Overall Study|Non compliance with protocol|3
6977143|NCT01205126|11030146|FG001|Maintenance Phase|Lost to Follow-up|5
6917177|NCT00782210|10944787|FG002|Overall Study|Non compliance with protocol|2
6917178|NCT00782210|10944785|FG000|Overall Study|Lack of Efficacy|13
6917179|NCT00782210|10944786|FG001|Overall Study|Lack of Efficacy|4
6917180|NCT00782210|10944787|FG002|Overall Study|Lack of Efficacy|1
6917181|NCT00782210|10944785|FG000|Overall Study|Other reason not described above|3
6917182|NCT00782210|10944786|FG001|Overall Study|Other reason not described above|2
6917183|NCT00782210|10944787|FG002|Overall Study|Other reason not described above|3
6917184|NCT00782275|10944804|FG000|Overall Study|Adverse Event|11
6917185|NCT00782275|10944804|FG000|Overall Study|Withdrawal by Subject|1
6917186|NCT00782275|10944804|FG000|Overall Study|Progressive Disease|21
6917187|NCT00782275|10944804|FG000|Overall Study|Physician Decision|4
6917188|NCT00782275|10944804|FG000|Overall Study|Not started treatment|1
6917189|NCT00782275|10944804|FG000|Overall Study|Other|3
6917190|NCT00782340|10944811|FG000|Open Label Titration|Adverse Event|12
6917191|NCT00782340|10944812|FG001|Open Label Titration|Adverse Event|0
6917192|NCT00782340|10944813|FG002|Open Label Titration|Adverse Event|0
6917193|NCT00782340|10944811|FG000|Open Label Titration|Treatment failure|50
6917194|NCT00782340|10944812|FG001|Open Label Titration|Treatment failure|0
6917195|NCT00782340|10944813|FG002|Open Label Titration|Treatment failure|0
6917196|NCT00782340|10944811|FG000|Open Label Titration|Protocol Violation|5
6917197|NCT00782340|10944812|FG001|Open Label Titration|Protocol Violation|0
6917198|NCT00782340|10944813|FG002|Open Label Titration|Protocol Violation|0
6917199|NCT00782340|10944811|FG000|Open Label Titration|Withdrawal by Subject|5
6917200|NCT00782340|10944812|FG001|Open Label Titration|Withdrawal by Subject|0
6917201|NCT00782340|10944813|FG002|Open Label Titration|Withdrawal by Subject|0
6917202|NCT00782340|10944811|FG000|Open Label Titration|Enrollment capped|16
6917203|NCT00782340|10944812|FG001|Open Label Titration|Enrollment capped|0
6917204|NCT00782340|10944813|FG002|Open Label Titration|Enrollment capped|0
6917205|NCT00782340|10944811|FG000|Open Label Titration|Did not meet responder criteria|2
6917206|NCT00782340|10944812|FG001|Open Label Titration|Did not meet responder criteria|0
6917207|NCT00782340|10944813|FG002|Open Label Titration|Did not meet responder criteria|0
6917208|NCT00782340|10944811|FG000|Open Label Titration|Lost to Follow-up|5
6917209|NCT00782340|10944812|FG001|Open Label Titration|Lost to Follow-up|0
6917210|NCT00782340|10944813|FG002|Open Label Titration|Lost to Follow-up|0
6917211|NCT00782340|10944811|FG000|Open Label Titration|Randomized in error|6
6917212|NCT00782340|10944812|FG001|Open Label Titration|Randomized in error|0
6917213|NCT00782340|10944813|FG002|Open Label Titration|Randomized in error|0
6917214|NCT00782418|10944824|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1
6917215|NCT00782418|10944825|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0
6917216|NCT00782418|10944826|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0
6917217|NCT00782418|10944827|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0
6917218|NCT00782418|10944828|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0
6917219|NCT00782418|10944829|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0
6917220|NCT00782418|10944830|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0
6917221|NCT00782418|10944824|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
6917222|NCT00782418|10944825|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
6917223|NCT00782418|10944826|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
6917224|NCT00782418|10944827|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
6917225|NCT00782418|10944828|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
6917226|NCT00782418|10944829|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
6917227|NCT00782418|10944830|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
6917228|NCT00782496|10944846|FG000|Overall Study|Lost to Follow-up|14
6917229|NCT00782496|10944847|FG001|Overall Study|Lost to Follow-up|15
6917230|NCT00782509|10944857|FG000|Overall Study|Adverse Event|20
6917231|NCT00782509|10944858|FG001|Overall Study|Adverse Event|10
6917232|NCT00782509|10944859|FG002|Overall Study|Adverse Event|20
6917233|NCT00782509|10944857|FG000|Overall Study|Lost to Follow-up|1
6917234|NCT00782509|10944858|FG001|Overall Study|Lost to Follow-up|2
6917235|NCT00782509|10944859|FG002|Overall Study|Lost to Follow-up|3
6917236|NCT00782509|10944857|FG000|Overall Study|Withdrawal by Subject|3
6917237|NCT00782509|10944858|FG001|Overall Study|Withdrawal by Subject|5
6917238|NCT00782509|10944859|FG002|Overall Study|Withdrawal by Subject|8
6917239|NCT00782509|10944857|FG000|Overall Study|Non compliance with protocol|2
6917240|NCT00782509|10944858|FG001|Overall Study|Non compliance with protocol|0
6917241|NCT00782509|10944859|FG002|Overall Study|Non compliance with protocol|0
6917242|NCT00782509|10944857|FG000|Overall Study|Other reasons not stated above|5
6917243|NCT00782509|10944858|FG001|Overall Study|Other reasons not stated above|2
6917244|NCT00782509|10944859|FG002|Overall Study|Other reasons not stated above|3
6917245|NCT00782509|10944857|FG000|Overall Study|Lack of Efficacy|10
6917246|NCT00782509|10944858|FG001|Overall Study|Lack of Efficacy|5
6917247|NCT00782509|10944859|FG002|Overall Study|Lack of Efficacy|2
6917248|NCT00782626|10944874|FG000|Overall Study|Adverse Event|1
6917249|NCT00782626|10944874|FG000|Overall Study|Progressive Disease|5
6917250|NCT00782626|10944874|FG000|Overall Study|Other Complicating Disease|1
6917251|NCT00782717|10944891|FG000|Overall Study|Adverse Event|2
6917252|NCT00782717|10944892|FG001|Overall Study|Adverse Event|5
6917253|NCT00782717|10944891|FG000|Overall Study|Patient decision unrelated to AE|6
6917254|NCT00782717|10944892|FG001|Overall Study|Patient decision unrelated to AE|3
6917255|NCT00782717|10944891|FG000|Overall Study|Noncompliance|2
6917256|NCT00782717|10944892|FG001|Overall Study|Noncompliance|1
6917257|NCT00782717|10944891|FG000|Overall Study|Treatment failure|3
6917258|NCT00782717|10944892|FG001|Overall Study|Treatment failure|14
6917259|NCT00782717|10944891|FG000|Overall Study|Enrollment close prior to surgery|1
6917260|NCT00782717|10944892|FG001|Overall Study|Enrollment close prior to surgery|0
6917261|NCT00782717|10944891|FG000|Overall Study|Did not meet entrance criteria|1
6917262|NCT00782717|10944892|FG001|Overall Study|Did not meet entrance criteria|3
6917263|NCT00782717|10944891|FG000|Overall Study|Exited in error|0
6917264|NCT00782717|10944892|FG001|Overall Study|Exited in error|2
6917265|NCT00782795|10944904|FG000|Overall Study|Withdrawal by Subject|1
6917266|NCT00782795|10944905|FG001|Overall Study|Withdrawal by Subject|2
6917267|NCT00782834|10944935|FG000|Treatment Phase|fibrous tumor not GIST|1
6917268|NCT00783094|10944942|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4
6917269|NCT00783094|10944943|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5
6917270|NCT00783094|10944944|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5
6917271|NCT00783094|10944942|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0
6917272|NCT00783094|10944943|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2
6917273|NCT00783094|10944944|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1
6917274|NCT00783094|10944942|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0
6917275|NCT00783094|10944943|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2
6917276|NCT00783094|10944944|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0
6917277|NCT00783094|10944942|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1
6917278|NCT00783094|10944943|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2
6917279|NCT00783094|10944944|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1
6917280|NCT00783094|10944942|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
6917281|NCT00783094|10944943|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1
6917282|NCT00783094|10944944|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
6917283|NCT00783094|10944942|FG000|Open-Label Extension Period|Adverse Event|12
6917284|NCT00783094|10944943|FG001|Open-Label Extension Period|Adverse Event|7
6917285|NCT00783094|10944944|FG002|Open-Label Extension Period|Adverse Event|16
6917286|NCT00783094|10944942|FG000|Open-Label Extension Period|Death|0
6917287|NCT00783094|10944943|FG001|Open-Label Extension Period|Death|0
6917288|NCT00783094|10944944|FG002|Open-Label Extension Period|Death|1
6917289|NCT00783094|10944942|FG000|Open-Label Extension Period|Protocol Violation|4
6917290|NCT00783094|10944943|FG001|Open-Label Extension Period|Protocol Violation|5
6917291|NCT00783094|10944944|FG002|Open-Label Extension Period|Protocol Violation|7
6917292|NCT00783094|10944942|FG000|Open-Label Extension Period|Withdrawal by Subject|1
6917293|NCT00783094|10944943|FG001|Open-Label Extension Period|Withdrawal by Subject|1
6917294|NCT00783094|10944944|FG002|Open-Label Extension Period|Withdrawal by Subject|3
6917295|NCT00783094|10944942|FG000|Open-Label Extension Period|Physician Decision|4
6917296|NCT00783094|10944943|FG001|Open-Label Extension Period|Physician Decision|2
6917297|NCT00783094|10944944|FG002|Open-Label Extension Period|Physician Decision|3
6917298|NCT00783094|10944942|FG000|Open-Label Extension Period|Lack of Efficacy|1
6917299|NCT00783094|10944943|FG001|Open-Label Extension Period|Lack of Efficacy|4
6917300|NCT00783094|10944944|FG002|Open-Label Extension Period|Lack of Efficacy|0
6917301|NCT00783198|10944958|FG000|Overall Study|Adverse Event|15
6917302|NCT00783198|10944959|FG001|Overall Study|Adverse Event|19
6917303|NCT00783198|10944960|FG002|Overall Study|Adverse Event|3
6917304|NCT00783198|10944958|FG000|Overall Study|Lost to Follow-up|11
6917305|NCT00783198|10944959|FG001|Overall Study|Lost to Follow-up|1
6917306|NCT00783198|10944960|FG002|Overall Study|Lost to Follow-up|7
6917307|NCT00783198|10944958|FG000|Overall Study|Withdrawal by Subject|22
6917308|NCT00783198|10944959|FG001|Overall Study|Withdrawal by Subject|14
6917309|NCT00783198|10944960|FG002|Overall Study|Withdrawal by Subject|20
6917310|NCT00783198|10944958|FG000|Overall Study|Noncompliance with protocol|7
6917311|NCT00783198|10944959|FG001|Overall Study|Noncompliance with protocol|7
6917312|NCT00783198|10944960|FG002|Overall Study|Noncompliance with protocol|10
6917313|NCT00783198|10944958|FG000|Overall Study|Did not meet protocol eligibility|0
6917314|NCT00783198|10944959|FG001|Overall Study|Did not meet protocol eligibility|1
6917315|NCT00783198|10944960|FG002|Overall Study|Did not meet protocol eligibility|0
6917316|NCT00783198|10944958|FG000|Overall Study|Administrative|2
6917317|NCT00783198|10944959|FG001|Overall Study|Administrative|1
6917318|NCT00783198|10944960|FG002|Overall Study|Administrative|2
6917319|NCT00783289|10944972|FG000|Overall Study|Protocol Violation|0
6917320|NCT00783289|10944973|FG001|Overall Study|Protocol Violation|1
6917321|NCT00783289|10944974|FG002|Overall Study|Protocol Violation|0
6917322|NCT00783289|10944975|FG003|Overall Study|Protocol Violation|0
6917323|NCT00783302|10944988|FG000|Overall Study|Lost to Follow-up|17
6917324|NCT00783302|10944988|FG000|Overall Study|Technical Problems|11
6917325|NCT00783302|10944988|FG000|Overall Study|Protocol Violation|3
6917326|NCT00783302|10944988|FG000|Overall Study|Physician Decision|1
6917327|NCT00783302|10944988|FG000|Overall Study|Withdrawal by Subject|3
6917328|NCT00783432|10945008|FG000|Overall Study|Adverse Event|22
6917329|NCT00783432|10945009|FG001|Overall Study|Adverse Event|17
6917330|NCT00783432|10945008|FG000|Overall Study|Lack of Efficacy|20
6917331|NCT00783432|10945009|FG001|Overall Study|Lack of Efficacy|21
6917332|NCT00783432|10945008|FG000|Overall Study|Lost to Follow-up|11
6917333|NCT00783432|10945009|FG001|Overall Study|Lost to Follow-up|6
6917334|NCT00783432|10945008|FG000|Overall Study|Withdrawal by Subject|23
6917335|NCT00783432|10945009|FG001|Overall Study|Withdrawal by Subject|20
6917336|NCT00783432|10945008|FG000|Overall Study|subject moved|3
6917337|NCT00783432|10945009|FG001|Overall Study|subject moved|5
6917338|NCT00783432|10945008|FG000|Overall Study|Protocol Violation|6
6917339|NCT00783432|10945009|FG001|Overall Study|Protocol Violation|9
6917340|NCT00783692|10945035|FG000|Induction Phase|Adverse Event|7
6917341|NCT00783692|10945036|FG001|Induction Phase|Adverse Event|9
6917342|NCT00783692|10945037|FG002|Induction Phase|Adverse Event|24
6917343|NCT00783692|10945038|FG003|Induction Phase|Adverse Event|0
6917344|NCT00783692|10945039|FG004|Induction Phase|Adverse Event|0
6917345|NCT00783692|10945040|FG005|Induction Phase|Adverse Event|0
6917346|NCT00783692|10945041|FG006|Induction Phase|Adverse Event|0
6917347|NCT00783692|10945035|FG000|Induction Phase|Protocol Violation|0
6917348|NCT00783692|10945036|FG001|Induction Phase|Protocol Violation|0
6917349|NCT00783692|10945037|FG002|Induction Phase|Protocol Violation|1
6917350|NCT00783692|10945038|FG003|Induction Phase|Protocol Violation|0
6917351|NCT00783692|10945039|FG004|Induction Phase|Protocol Violation|0
6917352|NCT00783692|10945040|FG005|Induction Phase|Protocol Violation|0
6917353|NCT00783692|10945041|FG006|Induction Phase|Protocol Violation|0
6917354|NCT00783692|10945035|FG000|Induction Phase|Lack of Efficacy|1
6917355|NCT00783692|10945036|FG001|Induction Phase|Lack of Efficacy|3
6917356|NCT00783692|10945037|FG002|Induction Phase|Lack of Efficacy|28
6917357|NCT00783692|10945038|FG003|Induction Phase|Lack of Efficacy|0
6917358|NCT00783692|10945039|FG004|Induction Phase|Lack of Efficacy|0
6917359|NCT00783692|10945040|FG005|Induction Phase|Lack of Efficacy|0
6917360|NCT00783692|10945041|FG006|Induction Phase|Lack of Efficacy|0
6917361|NCT00783692|10945035|FG000|Induction Phase|Withdrawal by Subject|3
6917362|NCT00783692|10945036|FG001|Induction Phase|Withdrawal by Subject|9
6917363|NCT00783692|10945037|FG002|Induction Phase|Withdrawal by Subject|16
6917364|NCT00783692|10945038|FG003|Induction Phase|Withdrawal by Subject|0
6917365|NCT00783692|10945039|FG004|Induction Phase|Withdrawal by Subject|0
6917366|NCT00783692|10945040|FG005|Induction Phase|Withdrawal by Subject|0
6917367|NCT00783692|10945041|FG006|Induction Phase|Withdrawal by Subject|0
6917368|NCT00783692|10945035|FG000|Induction Phase|Lost to Follow-up|0
6917369|NCT00783692|10945036|FG001|Induction Phase|Lost to Follow-up|0
6917370|NCT00783692|10945037|FG002|Induction Phase|Lost to Follow-up|3
6917371|NCT00783692|10945038|FG003|Induction Phase|Lost to Follow-up|0
6917372|NCT00783692|10945039|FG004|Induction Phase|Lost to Follow-up|0
6917373|NCT00783692|10945040|FG005|Induction Phase|Lost to Follow-up|0
6917374|NCT00783692|10945041|FG006|Induction Phase|Lost to Follow-up|0
6917375|NCT00783692|10945035|FG000|Induction Phase|Other|0
6917376|NCT00783692|10945036|FG001|Induction Phase|Other|0
6917377|NCT00783692|10945037|FG002|Induction Phase|Other|2
6917378|NCT00783692|10945038|FG003|Induction Phase|Other|0
6917379|NCT00783692|10945039|FG004|Induction Phase|Other|0
6917380|NCT00783692|10945040|FG005|Induction Phase|Other|0
6917381|NCT00783692|10945041|FG006|Induction Phase|Other|0
6917382|NCT00783692|10945035|FG000|Maintenance Phase|Adverse Event|7
6917383|NCT00783692|10945036|FG001|Maintenance Phase|Adverse Event|0
6917384|NCT00783692|10945037|FG002|Maintenance Phase|Adverse Event|0
6917385|NCT00783692|10945038|FG003|Maintenance Phase|Adverse Event|15
6917386|NCT00783692|10945039|FG004|Maintenance Phase|Adverse Event|12
6917387|NCT00783692|10945040|FG005|Maintenance Phase|Adverse Event|9
6917388|NCT00783692|10945041|FG006|Maintenance Phase|Adverse Event|38
6917389|NCT00783692|10945035|FG000|Maintenance Phase|Protocol Violation|0
6917390|NCT00783692|10945036|FG001|Maintenance Phase|Protocol Violation|0
6917391|NCT00783692|10945037|FG002|Maintenance Phase|Protocol Violation|0
6917392|NCT00783692|10945038|FG003|Maintenance Phase|Protocol Violation|1
6917393|NCT00783692|10945039|FG004|Maintenance Phase|Protocol Violation|2
6917394|NCT00783692|10945040|FG005|Maintenance Phase|Protocol Violation|3
6917395|NCT00783692|10945041|FG006|Maintenance Phase|Protocol Violation|4
6917396|NCT00783692|10945035|FG000|Maintenance Phase|Lack of Efficacy|79
6917397|NCT00783692|10945036|FG001|Maintenance Phase|Lack of Efficacy|0
6917398|NCT00783692|10945037|FG002|Maintenance Phase|Lack of Efficacy|0
6917399|NCT00783692|10945038|FG003|Maintenance Phase|Lack of Efficacy|64
6917400|NCT00783692|10945039|FG004|Maintenance Phase|Lack of Efficacy|58
6917401|NCT00783692|10945040|FG005|Maintenance Phase|Lack of Efficacy|48
6917402|NCT00783692|10945041|FG006|Maintenance Phase|Lack of Efficacy|177
6917403|NCT00783692|10945035|FG000|Maintenance Phase|Withdrawal by Subject|7
6917404|NCT00783692|10945036|FG001|Maintenance Phase|Withdrawal by Subject|0
6917405|NCT00783692|10945037|FG002|Maintenance Phase|Withdrawal by Subject|0
6917406|NCT00783692|10945038|FG003|Maintenance Phase|Withdrawal by Subject|7
6917407|NCT00783692|10945039|FG004|Maintenance Phase|Withdrawal by Subject|6
6917408|NCT00783692|10945040|FG005|Maintenance Phase|Withdrawal by Subject|9
6917409|NCT00783692|10945041|FG006|Maintenance Phase|Withdrawal by Subject|24
6917410|NCT00783692|10945035|FG000|Maintenance Phase|Lost to Follow-up|2
6917411|NCT00783692|10945036|FG001|Maintenance Phase|Lost to Follow-up|0
6917412|NCT00783692|10945037|FG002|Maintenance Phase|Lost to Follow-up|0
6917413|NCT00783692|10945038|FG003|Maintenance Phase|Lost to Follow-up|1
6917414|NCT00783692|10945039|FG004|Maintenance Phase|Lost to Follow-up|3
6917415|NCT00783692|10945040|FG005|Maintenance Phase|Lost to Follow-up|2
6917416|NCT00783692|10945041|FG006|Maintenance Phase|Lost to Follow-up|5
6917417|NCT00783692|10945035|FG000|Maintenance Phase|Other|0
6917418|NCT00783692|10945036|FG001|Maintenance Phase|Other|0
6917419|NCT00783692|10945037|FG002|Maintenance Phase|Other|0
6917420|NCT00783692|10945038|FG003|Maintenance Phase|Other|1
6917421|NCT00783692|10945039|FG004|Maintenance Phase|Other|0
6917422|NCT00783692|10945040|FG005|Maintenance Phase|Other|1
6917423|NCT00783692|10945041|FG006|Maintenance Phase|Other|1
6917424|NCT00783705|10945056|FG000|Overall Study|Adverse Event|2
6917425|NCT00783705|10945057|FG001|Overall Study|Adverse Event|0
6917426|NCT00783705|10945056|FG000|Overall Study|Withdrawal by Subject|3
6917427|NCT00783705|10945057|FG001|Overall Study|Withdrawal by Subject|2
6917428|NCT00783705|10945056|FG000|Overall Study|Lost to Follow-up|1
6917429|NCT00783705|10945057|FG001|Overall Study|Lost to Follow-up|3
6917430|NCT00783718|10945066|FG000|Induction Phase|Adverse Event|4
6917431|NCT00783718|10945067|FG001|Induction Phase|Adverse Event|0
6917432|NCT00783718|10945068|FG002|Induction Phase|Adverse Event|7
6917433|NCT00783718|10945069|FG003|Induction Phase|Adverse Event|0
6917434|NCT00783718|10945070|FG004|Induction Phase|Adverse Event|0
6917435|NCT00783718|10945071|FG005|Induction Phase|Adverse Event|0
6917436|NCT00783718|10945072|FG006|Induction Phase|Adverse Event|0
6917437|NCT00783718|10945066|FG000|Induction Phase|Protocol Violation|1
6917438|NCT00783718|10945067|FG001|Induction Phase|Protocol Violation|1
6917439|NCT00783718|10945068|FG002|Induction Phase|Protocol Violation|6
6917440|NCT00783718|10945069|FG003|Induction Phase|Protocol Violation|0
6917441|NCT00783718|10945070|FG004|Induction Phase|Protocol Violation|0
6917442|NCT00783718|10945071|FG005|Induction Phase|Protocol Violation|0
6917443|NCT00783718|10945072|FG006|Induction Phase|Protocol Violation|0
6917444|NCT00783718|10945066|FG000|Induction Phase|Lack of Efficacy|5
6917445|NCT00783718|10945067|FG001|Induction Phase|Lack of Efficacy|2
6917446|NCT00783718|10945068|FG002|Induction Phase|Lack of Efficacy|14
6917447|NCT00783718|10945069|FG003|Induction Phase|Lack of Efficacy|0
6917448|NCT00783718|10945070|FG004|Induction Phase|Lack of Efficacy|0
6917449|NCT00783718|10945071|FG005|Induction Phase|Lack of Efficacy|0
6917450|NCT00783718|10945072|FG006|Induction Phase|Lack of Efficacy|0
6917451|NCT00783718|10945066|FG000|Induction Phase|Withdrawal by Subject|3
6917452|NCT00783718|10945067|FG001|Induction Phase|Withdrawal by Subject|4
6917453|NCT00783718|10945068|FG002|Induction Phase|Withdrawal by Subject|8
6917454|NCT00783718|10945069|FG003|Induction Phase|Withdrawal by Subject|0
6917455|NCT00783718|10945070|FG004|Induction Phase|Withdrawal by Subject|0
6917456|NCT00783718|10945071|FG005|Induction Phase|Withdrawal by Subject|0
6917457|NCT00783718|10945072|FG006|Induction Phase|Withdrawal by Subject|0
6917458|NCT00783718|10945066|FG000|Induction Phase|Lost to Follow-up|1
6917459|NCT00783718|10945067|FG001|Induction Phase|Lost to Follow-up|0
6917460|NCT00783718|10945068|FG002|Induction Phase|Lost to Follow-up|1
6917461|NCT00783718|10945069|FG003|Induction Phase|Lost to Follow-up|0
6917462|NCT00783718|10945070|FG004|Induction Phase|Lost to Follow-up|0
6917463|NCT00783718|10945071|FG005|Induction Phase|Lost to Follow-up|0
6917464|NCT00783718|10945072|FG006|Induction Phase|Lost to Follow-up|0
6917465|NCT00783718|10945066|FG000|Maintenance Phase|Adverse Event|12
6917466|NCT00783718|10945067|FG001|Maintenance Phase|Adverse Event|0
6917467|NCT00783718|10945068|FG002|Maintenance Phase|Adverse Event|0
6917468|NCT00783718|10945069|FG003|Maintenance Phase|Adverse Event|15
6917469|NCT00783718|10945070|FG004|Maintenance Phase|Adverse Event|7
6917470|NCT00783718|10945071|FG005|Maintenance Phase|Adverse Event|6
6917471|NCT00783718|10945072|FG006|Maintenance Phase|Adverse Event|16
6917472|NCT00783718|10945066|FG000|Maintenance Phase|Protocol Violation|1
6917473|NCT00783718|10945067|FG001|Maintenance Phase|Protocol Violation|0
6917474|NCT00783718|10945068|FG002|Maintenance Phase|Protocol Violation|0
6917475|NCT00783718|10945069|FG003|Maintenance Phase|Protocol Violation|0
6917476|NCT00783718|10945070|FG004|Maintenance Phase|Protocol Violation|0
6917477|NCT00783718|10945071|FG005|Maintenance Phase|Protocol Violation|0
6917478|NCT00783718|10945072|FG006|Maintenance Phase|Protocol Violation|2
6917479|NCT00783718|10945066|FG000|Maintenance Phase|Lack of Efficacy|83
6917480|NCT00783718|10945067|FG001|Maintenance Phase|Lack of Efficacy|0
6917481|NCT00783718|10945068|FG002|Maintenance Phase|Lack of Efficacy|0
6917482|NCT00783718|10945069|FG003|Maintenance Phase|Lack of Efficacy|61
6917483|NCT00783718|10945070|FG004|Maintenance Phase|Lack of Efficacy|31
6917484|NCT00783718|10945071|FG005|Maintenance Phase|Lack of Efficacy|33
6917485|NCT00783718|10945072|FG006|Maintenance Phase|Lack of Efficacy|155
6917486|NCT00783718|10945066|FG000|Maintenance Phase|Withdrawal by Subject|6
6917487|NCT00783718|10945067|FG001|Maintenance Phase|Withdrawal by Subject|0
6917488|NCT00783718|10945068|FG002|Maintenance Phase|Withdrawal by Subject|0
6917489|NCT00783718|10945069|FG003|Maintenance Phase|Withdrawal by Subject|2
6917490|NCT00783718|10945070|FG004|Maintenance Phase|Withdrawal by Subject|5
6917491|NCT00783718|10945071|FG005|Maintenance Phase|Withdrawal by Subject|2
6917492|NCT00783718|10945072|FG006|Maintenance Phase|Withdrawal by Subject|20
6917493|NCT00783718|10945066|FG000|Maintenance Phase|Lost to Follow-up|3
6917494|NCT00783718|10945067|FG001|Maintenance Phase|Lost to Follow-up|0
6917495|NCT00783718|10945068|FG002|Maintenance Phase|Lost to Follow-up|0
6917496|NCT00783718|10945069|FG003|Maintenance Phase|Lost to Follow-up|0
6917497|NCT00783718|10945070|FG004|Maintenance Phase|Lost to Follow-up|2
6917498|NCT00783718|10945071|FG005|Maintenance Phase|Lost to Follow-up|0
6917499|NCT00783718|10945072|FG006|Maintenance Phase|Lost to Follow-up|2
6917500|NCT00783796|10945082|FG000|Overall Study|Did not receive any stent|4
6917501|NCT00783796|10945082|FG000|Overall Study|Received non-XIENCE V stent|1
6917502|NCT00783796|10945082|FG000|Overall Study|Received commercial XIENCE V stent|1
6917503|NCT00783835|10945088|FG000|Overall Study|Adverse Event|3
6917504|NCT00783835|10945088|FG000|Overall Study|Medical Criteria|1
6917505|NCT00783835|10945088|FG000|Overall Study|Withdrawal by Subject|2
6917506|NCT00783835|10945088|FG000|Overall Study|Lost to Follow-up|1
6917507|NCT00783835|10945088|FG000|Overall Study|Participant not Adherent|3
6917508|NCT00784134|10945133|FG000|Overall Study|Lost to Follow-up|3
6917509|NCT00784134|10945134|FG001|Overall Study|Lost to Follow-up|6
6917510|NCT00784147|10945142|FG000|Overall Study|Lost to Follow-up|2
6917511|NCT00784147|10945143|FG001|Overall Study|Lost to Follow-up|4
6917512|NCT00784147|10945142|FG000|Overall Study|Withdrawal by Subject|1
6917513|NCT00784147|10945143|FG001|Overall Study|Withdrawal by Subject|3
6917514|NCT00784147|10945142|FG000|Overall Study|Physician Decision|2
6917515|NCT00784147|10945143|FG001|Overall Study|Physician Decision|1
6917516|NCT00784147|10945142|FG000|Overall Study|Protocol Violation|1
6917517|NCT00784147|10945143|FG001|Overall Study|Protocol Violation|1
6917518|NCT00784147|10945142|FG000|Overall Study|Death|2
6917519|NCT00784147|10945143|FG001|Overall Study|Death|0
6917520|NCT00784238|10945170|FG000|Overall Study|Adverse Event|14
6917521|NCT00784238|10945170|FG000|Overall Study|Death|2
6917522|NCT00784238|10945170|FG000|Overall Study|Lack of Efficacy|33
6917523|NCT00784238|10945170|FG000|Overall Study|Lost to Follow-up|29
6917524|NCT00784238|10945170|FG000|Overall Study|Pregnancy|1
6917525|NCT00784238|10945170|FG000|Overall Study|Withdrawal by Subject|26
6917526|NCT00784238|10945170|FG000|Overall Study|Other|14
6917527|NCT00784277|10945181|FG000|IR Treatment|Adverse Event|4
6917528|NCT00784277|10945182|FG001|IR Treatment|Adverse Event|8
6917529|NCT00784277|10945183|FG002|IR Treatment|Adverse Event|19
6917530|NCT00784277|10945184|FG003|IR Treatment|Adverse Event|35
6917531|NCT00784277|10945185|FG004|IR Treatment|Adverse Event|0
6917532|NCT00784277|10945186|FG005|IR Treatment|Adverse Event|0
6917533|NCT00784277|10945187|FG006|IR Treatment|Adverse Event|0
6917534|NCT00784277|10945181|FG000|IR Treatment|Lack of Efficacy|4
6917535|NCT00784277|10945182|FG001|IR Treatment|Lack of Efficacy|4
6917536|NCT00784277|10945183|FG002|IR Treatment|Lack of Efficacy|1
6917537|NCT00784277|10945184|FG003|IR Treatment|Lack of Efficacy|0
6917538|NCT00784277|10945185|FG004|IR Treatment|Lack of Efficacy|0
6917539|NCT00784277|10945186|FG005|IR Treatment|Lack of Efficacy|0
6917540|NCT00784277|10945187|FG006|IR Treatment|Lack of Efficacy|0
6917541|NCT00784277|10945181|FG000|IR Treatment|Lost to Follow-up|1
6917542|NCT00784277|10945182|FG001|IR Treatment|Lost to Follow-up|0
6917543|NCT00784277|10945183|FG002|IR Treatment|Lost to Follow-up|1
6917544|NCT00784277|10945184|FG003|IR Treatment|Lost to Follow-up|0
6917545|NCT00784277|10945185|FG004|IR Treatment|Lost to Follow-up|0
6917546|NCT00784277|10945186|FG005|IR Treatment|Lost to Follow-up|0
6917547|NCT00784277|10945187|FG006|IR Treatment|Lost to Follow-up|0
6917548|NCT00784277|10945181|FG000|IR Treatment|Withdrawal by Subject|5
6917549|NCT00784277|10945182|FG001|IR Treatment|Withdrawal by Subject|1
6917550|NCT00784277|10945183|FG002|IR Treatment|Withdrawal by Subject|4
6917551|NCT00784277|10945184|FG003|IR Treatment|Withdrawal by Subject|6
6917552|NCT00784277|10945185|FG004|IR Treatment|Withdrawal by Subject|0
6917553|NCT00784277|10945186|FG005|IR Treatment|Withdrawal by Subject|0
6917554|NCT00784277|10945187|FG006|IR Treatment|Withdrawal by Subject|0
6917555|NCT00784277|10945181|FG000|IR Treatment|Resolution Of Pain|0
6917556|NCT00784277|10945182|FG001|IR Treatment|Resolution Of Pain|1
6917557|NCT00784277|10945183|FG002|IR Treatment|Resolution Of Pain|0
6917558|NCT00784277|10945184|FG003|IR Treatment|Resolution Of Pain|0
6917559|NCT00784277|10945185|FG004|IR Treatment|Resolution Of Pain|0
6917560|NCT00784277|10945186|FG005|IR Treatment|Resolution Of Pain|0
6917561|NCT00784277|10945187|FG006|IR Treatment|Resolution Of Pain|0
6917562|NCT00784277|10945181|FG000|IR Treatment|Other|2
6917563|NCT00784277|10945182|FG001|IR Treatment|Other|3
6917564|NCT00784277|10945183|FG002|IR Treatment|Other|3
6917565|NCT00784277|10945184|FG003|IR Treatment|Other|2
6917566|NCT00784277|10945185|FG004|IR Treatment|Other|0
6917567|NCT00784277|10945186|FG005|IR Treatment|Other|0
6917568|NCT00784277|10945187|FG006|IR Treatment|Other|0
6917569|NCT00784277|10945181|FG000|ER Treatment|Adverse Event|0
6917570|NCT00784277|10945182|FG001|ER Treatment|Adverse Event|0
6917571|NCT00784277|10945183|FG002|ER Treatment|Adverse Event|0
6917572|NCT00784277|10945184|FG003|ER Treatment|Adverse Event|0
6917573|NCT00784277|10945185|FG004|ER Treatment|Adverse Event|1
6917574|NCT00784277|10945186|FG005|ER Treatment|Adverse Event|7
6917575|NCT00784277|10945187|FG006|ER Treatment|Adverse Event|7
6917576|NCT00784277|10945181|FG000|ER Treatment|Lack of Efficacy|0
6917577|NCT00784277|10945182|FG001|ER Treatment|Lack of Efficacy|0
6917578|NCT00784277|10945183|FG002|ER Treatment|Lack of Efficacy|0
6917579|NCT00784277|10945184|FG003|ER Treatment|Lack of Efficacy|0
6917580|NCT00784277|10945185|FG004|ER Treatment|Lack of Efficacy|3
6917581|NCT00784277|10945186|FG005|ER Treatment|Lack of Efficacy|4
6917582|NCT00784277|10945187|FG006|ER Treatment|Lack of Efficacy|0
6917583|NCT00784277|10945181|FG000|ER Treatment|Lost to Follow-up|0
6917584|NCT00784277|10945182|FG001|ER Treatment|Lost to Follow-up|0
6917585|NCT00784277|10945183|FG002|ER Treatment|Lost to Follow-up|0
6917586|NCT00784277|10945184|FG003|ER Treatment|Lost to Follow-up|0
6917587|NCT00784277|10945185|FG004|ER Treatment|Lost to Follow-up|0
6917588|NCT00784277|10945186|FG005|ER Treatment|Lost to Follow-up|2
6917589|NCT00784277|10945187|FG006|ER Treatment|Lost to Follow-up|0
6917590|NCT00784277|10945181|FG000|ER Treatment|Withdrawal by Subject|0
6917591|NCT00784277|10945182|FG001|ER Treatment|Withdrawal by Subject|0
6917592|NCT00784277|10945183|FG002|ER Treatment|Withdrawal by Subject|0
6917593|NCT00784277|10945184|FG003|ER Treatment|Withdrawal by Subject|0
6917594|NCT00784277|10945185|FG004|ER Treatment|Withdrawal by Subject|2
6917595|NCT00784277|10945186|FG005|ER Treatment|Withdrawal by Subject|5
6917596|NCT00784277|10945187|FG006|ER Treatment|Withdrawal by Subject|3
6917597|NCT00784277|10945181|FG000|ER Treatment|Study Medication Non-Compliant|0
6917598|NCT00784277|10945182|FG001|ER Treatment|Study Medication Non-Compliant|0
6917599|NCT00784277|10945183|FG002|ER Treatment|Study Medication Non-Compliant|0
6917600|NCT00784277|10945184|FG003|ER Treatment|Study Medication Non-Compliant|0
6917601|NCT00784277|10945185|FG004|ER Treatment|Study Medication Non-Compliant|2
6917602|NCT00784277|10945186|FG005|ER Treatment|Study Medication Non-Compliant|3
6917603|NCT00784277|10945187|FG006|ER Treatment|Study Medication Non-Compliant|3
6917604|NCT00784277|10945181|FG000|ER Treatment|Other|0
6917605|NCT00784277|10945182|FG001|ER Treatment|Other|0
6917606|NCT00784277|10945183|FG002|ER Treatment|Other|0
6917607|NCT00784277|10945184|FG003|ER Treatment|Other|0
6917608|NCT00784277|10945185|FG004|ER Treatment|Other|1
6917609|NCT00784277|10945186|FG005|ER Treatment|Other|3
6917610|NCT00784277|10945187|FG006|ER Treatment|Other|2
6917611|NCT00784368|10945213|FG000|Overall Study|Physician Decision|0
6917612|NCT00784368|10945214|FG001|Overall Study|Physician Decision|0
6917613|NCT00784368|10945215|FG002|Overall Study|Physician Decision|6
6917614|NCT00784368|10945213|FG000|Overall Study|Lack of Efficacy|2
6917615|NCT00784368|10945214|FG001|Overall Study|Lack of Efficacy|0
6917616|NCT00784368|10945215|FG002|Overall Study|Lack of Efficacy|1
6917617|NCT00784368|10945213|FG000|Overall Study|Adverse Event|6
6917618|NCT00784368|10945214|FG001|Overall Study|Adverse Event|9
6917619|NCT00784368|10945215|FG002|Overall Study|Adverse Event|2
6917620|NCT00784368|10945213|FG000|Overall Study|Diagnosis of fever|0
6917621|NCT00784368|10945214|FG001|Overall Study|Diagnosis of fever|0
6917622|NCT00784368|10945215|FG002|Overall Study|Diagnosis of fever|1
6917623|NCT00784368|10945213|FG000|Overall Study|Worsening of complications|0
6917624|NCT00784368|10945214|FG001|Overall Study|Worsening of complications|0
6917625|NCT00784368|10945215|FG002|Overall Study|Worsening of complications|1
6917626|NCT00784368|10945213|FG000|Overall Study|Worsening of symptoms|0
6917627|NCT00784368|10945214|FG001|Overall Study|Worsening of symptoms|1
6917628|NCT00784368|10945215|FG002|Overall Study|Worsening of symptoms|0
6917629|NCT00784368|10945213|FG000|Overall Study|Withdrawal of informed consent|0
6917630|NCT00784368|10945214|FG001|Overall Study|Withdrawal of informed consent|1
6917631|NCT00784368|10945215|FG002|Overall Study|Withdrawal of informed consent|0
6917632|NCT00784459|10945228|FG000|Overall Study|Adverse Event|0
6917633|NCT00784459|10945229|FG001|Overall Study|Adverse Event|2
6917634|NCT00784550|10945241|FG000|Overall Study|Adverse Event|12
6917635|NCT00784550|10945242|FG001|Overall Study|Adverse Event|10
6917636|NCT00784550|10945241|FG000|Overall Study|Lack of Efficacy|0
6917637|NCT00784550|10945242|FG001|Overall Study|Lack of Efficacy|1
6917638|NCT00784550|10945241|FG000|Overall Study|Protocol Violation|10
6917639|NCT00784550|10945242|FG001|Overall Study|Protocol Violation|10
6917640|NCT00784550|10945241|FG000|Overall Study|Lost to Follow-up|8
6917641|NCT00784550|10945242|FG001|Overall Study|Lost to Follow-up|5
6917642|NCT00784550|10945241|FG000|Overall Study|Physician Decision|2
6917643|NCT00784550|10945242|FG001|Overall Study|Physician Decision|3
6917644|NCT00784550|10945241|FG000|Overall Study|Withdrawal by Subject|4
6917645|NCT00784550|10945242|FG001|Overall Study|Withdrawal by Subject|13
6917646|NCT00784563|10945251|FG000|Years 1 & 2|Withdrawal by Subject|3
6917647|NCT00784563|10945252|FG001|Years 1 & 2|Withdrawal by Subject|2
6917648|NCT00784563|10945253|FG002|Years 1 & 2|Withdrawal by Subject|0
6917649|NCT00784563|10945251|FG000|Years 1 & 2|Adverse Event|0
6917650|NCT00784563|10945252|FG001|Years 1 & 2|Adverse Event|3
6917651|NCT00784563|10945253|FG002|Years 1 & 2|Adverse Event|0
6917652|NCT00784563|10945251|FG000|Year 3|Withdrawal by Subject|0
6917653|NCT00784563|10945252|FG001|Year 3|Withdrawal by Subject|0
6917654|NCT00784563|10945253|FG002|Year 3|Withdrawal by Subject|2
6917655|NCT00784563|10945251|FG000|Year 3|Adverse Event|0
6917656|NCT00784563|10945252|FG001|Year 3|Adverse Event|0
6917657|NCT00784563|10945253|FG002|Year 3|Adverse Event|1
6917658|NCT00784654|10945272|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44
6917659|NCT00784654|10945273|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0
6917660|NCT00784654|10945274|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0
6917661|NCT00784654|10945272|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22
6917662|NCT00784654|10945273|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
6917663|NCT00784654|10945274|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
6917664|NCT00784654|10945272|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21
6917665|NCT00784654|10945273|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
6917666|NCT00784654|10945274|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
6917667|NCT00784654|10945272|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11
6917668|NCT00784654|10945273|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
6917669|NCT00784654|10945274|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
6917670|NCT00784654|10945272|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7
6917671|NCT00784654|10945273|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0
6917672|NCT00784654|10945274|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0
6917673|NCT00784654|10945272|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1
6917674|NCT00784654|10945273|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
6917675|NCT00784654|10945274|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
6917676|NCT00784654|10945272|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1
6917677|NCT00784654|10945273|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
6917678|NCT00784654|10945274|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
6917679|NCT00784654|10945272|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1
6917680|NCT00784654|10945273|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0
6917681|NCT00784654|10945274|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0
6917682|NCT00784654|10945272|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1
6917683|NCT00784654|10945273|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
6917684|NCT00784654|10945274|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
6917685|NCT00784654|10945272|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1
7143007|NCT03023397|11299292|FG002|Run-In|Failed screening allergen challenge|0
6917686|NCT00784654|10945273|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
6917687|NCT00784654|10945274|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
6917688|NCT00784654|10945272|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1
6917689|NCT00784654|10945273|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
6917690|NCT00784654|10945274|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
6917691|NCT00784654|10945272|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0
6917692|NCT00784654|10945273|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8
6917693|NCT00784654|10945274|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35
6917694|NCT00784654|10945272|FG000|Randomized Withdrawal Period|Lack of Efficacy|0
6917695|NCT00784654|10945273|FG001|Randomized Withdrawal Period|Lack of Efficacy|5
6917696|NCT00784654|10945274|FG002|Randomized Withdrawal Period|Lack of Efficacy|18
6917697|NCT00784654|10945272|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0
6917698|NCT00784654|10945273|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1
6917699|NCT00784654|10945274|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7
6917700|NCT00784654|10945272|FG000|Randomized Withdrawal Period|Protocol Violation|0
6917701|NCT00784654|10945273|FG001|Randomized Withdrawal Period|Protocol Violation|2
6917702|NCT00784654|10945274|FG002|Randomized Withdrawal Period|Protocol Violation|1
6917703|NCT00784654|10945272|FG000|Randomized Withdrawal Period|Adverse Event|0
6917704|NCT00784654|10945273|FG001|Randomized Withdrawal Period|Adverse Event|1
6917705|NCT00784654|10945274|FG002|Randomized Withdrawal Period|Adverse Event|1
6917706|NCT00784654|10945272|FG000|Randomized Withdrawal Period|Did not complete a visit|0
6917707|NCT00784654|10945273|FG001|Randomized Withdrawal Period|Did not complete a visit|1
6917708|NCT00784654|10945274|FG002|Randomized Withdrawal Period|Did not complete a visit|0
6917709|NCT00784654|10945272|FG000|Randomized Withdrawal Period|Family reasons|0
6917710|NCT00784654|10945273|FG001|Randomized Withdrawal Period|Family reasons|0
6917711|NCT00784654|10945274|FG002|Randomized Withdrawal Period|Family reasons|1
6917712|NCT00784693|10945287|FG000|Overall Study|Lost to Follow-up|0
6917713|NCT00784693|10945288|FG001|Overall Study|Lost to Follow-up|1
6917714|NCT00784693|10945287|FG000|Overall Study|Lack of Efficacy|1
6917715|NCT00784693|10945288|FG001|Overall Study|Lack of Efficacy|1
6917716|NCT00784693|10945287|FG000|Overall Study|Withdrawal by Subject|0
6917717|NCT00784693|10945288|FG001|Overall Study|Withdrawal by Subject|4
6917718|NCT00784693|10945287|FG000|Overall Study|Randomized but not Treated|1
6917719|NCT00784693|10945288|FG001|Overall Study|Randomized but not Treated|0
6917720|NCT00784693|10945287|FG000|Overall Study|Other|1
6917721|NCT00784693|10945288|FG001|Overall Study|Other|0
6917722|NCT00784719|10945301|FG000|Overall Study|Adverse Event|0
6917723|NCT00784719|10945302|FG001|Overall Study|Adverse Event|2
6917724|NCT00784719|10945303|FG002|Overall Study|Adverse Event|0
6917725|NCT00784719|10945304|FG003|Overall Study|Adverse Event|0
6917726|NCT00784719|10945305|FG004|Overall Study|Adverse Event|1
6917727|NCT00784719|10945306|FG005|Overall Study|Adverse Event|1
6917728|NCT00784719|10945307|FG006|Overall Study|Adverse Event|1
6917729|NCT00784719|10945301|FG000|Overall Study|Lost to Follow-up|0
7143008|NCT03023397|11299290|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1
7143009|NCT03023397|11299291|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0
7143010|NCT03023397|11299292|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0
6917730|NCT00784719|10945302|FG001|Overall Study|Lost to Follow-up|0
6917731|NCT00784719|10945303|FG002|Overall Study|Lost to Follow-up|0
6917732|NCT00784719|10945304|FG003|Overall Study|Lost to Follow-up|0
6917733|NCT00784719|10945305|FG004|Overall Study|Lost to Follow-up|1
6917734|NCT00784719|10945306|FG005|Overall Study|Lost to Follow-up|1
6917735|NCT00784719|10945307|FG006|Overall Study|Lost to Follow-up|0
6917736|NCT00784719|10945301|FG000|Overall Study|Other|2
6917737|NCT00784719|10945302|FG001|Overall Study|Other|1
6917738|NCT00784719|10945303|FG002|Overall Study|Other|1
6917739|NCT00784719|10945304|FG003|Overall Study|Other|0
6917740|NCT00784719|10945305|FG004|Overall Study|Other|2
6917741|NCT00784719|10945306|FG005|Overall Study|Other|1
6917742|NCT00784719|10945307|FG006|Overall Study|Other|3
6917743|NCT00784719|10945301|FG000|Overall Study|Withdrawal by Subject|1
6917744|NCT00784719|10945302|FG001|Overall Study|Withdrawal by Subject|0
6917745|NCT00784719|10945303|FG002|Overall Study|Withdrawal by Subject|0
6917746|NCT00784719|10945304|FG003|Overall Study|Withdrawal by Subject|0
6917747|NCT00784719|10945305|FG004|Overall Study|Withdrawal by Subject|2
6917748|NCT00784719|10945306|FG005|Overall Study|Withdrawal by Subject|0
6917749|NCT00784719|10945307|FG006|Overall Study|Withdrawal by Subject|1
6917750|NCT00784758|10945325|FG000|Overall Study|Withdrawal by Subject|3
6917751|NCT00784758|10945326|FG001|Overall Study|Withdrawal by Subject|0
6917752|NCT00784758|10945325|FG000|Overall Study|Adverse Event|1
6917753|NCT00784758|10945326|FG001|Overall Study|Adverse Event|0
6917754|NCT00784784|10945336|FG000|Overall Study|Withdrawal by Subject|2
6917755|NCT00784784|10945337|FG001|Overall Study|Withdrawal by Subject|2
6917756|NCT00784810|10945345|FG000|Overall Study|Adverse Event|32
6917757|NCT00784810|10945346|FG001|Overall Study|Adverse Event|20
6917758|NCT00784810|10945345|FG000|Overall Study|Lack of Efficacy|14
6917759|NCT00784810|10945346|FG001|Overall Study|Lack of Efficacy|11
6917760|NCT00784810|10945345|FG000|Overall Study|Withdrawal by Subject|11
6917761|NCT00784810|10945346|FG001|Overall Study|Withdrawal by Subject|9
6917762|NCT00784810|10945345|FG000|Overall Study|Administrative|5
6917763|NCT00784810|10945346|FG001|Overall Study|Administrative|8
6917764|NCT00784810|10945345|FG000|Overall Study|Lost to Follow-up|1
6917765|NCT00784810|10945346|FG001|Overall Study|Lost to Follow-up|1
6917766|NCT00784836|10945352|FG000|Overall Study|Early Study Termination|3
6917767|NCT00784875|10945364|FG000|Period A - Baseline|Entry Criteria Not Met|0
6917768|NCT00784875|10945365|FG001|Period A - Baseline|Entry Criteria Not Met|0
6917769|NCT00784875|10945366|FG002|Period A - Baseline|Entry Criteria Not Met|0
6917770|NCT00784875|10945367|FG003|Period A - Baseline|Entry Criteria Not Met|5
6917771|NCT00784875|10945364|FG000|Period A - Baseline|Adverse Event|0
6917772|NCT00784875|10945365|FG001|Period A - Baseline|Adverse Event|0
6917773|NCT00784875|10945366|FG002|Period A - Baseline|Adverse Event|0
6917774|NCT00784875|10945367|FG003|Period A - Baseline|Adverse Event|8
6917775|NCT00784875|10945364|FG000|Period A - Baseline|Protocol Violation|0
6917776|NCT00784875|10945365|FG001|Period A - Baseline|Protocol Violation|0
6917777|NCT00784875|10945366|FG002|Period A - Baseline|Protocol Violation|0
6917778|NCT00784875|10945367|FG003|Period A - Baseline|Protocol Violation|25
6917779|NCT00784875|10945364|FG000|Period A - Baseline|Withdrawal by Subject|0
6917780|NCT00784875|10945365|FG001|Period A - Baseline|Withdrawal by Subject|0
6917781|NCT00784875|10945366|FG002|Period A - Baseline|Withdrawal by Subject|0
6917782|NCT00784875|10945367|FG003|Period A - Baseline|Withdrawal by Subject|27
6917783|NCT00784875|10945364|FG000|Period A - Baseline|Physician Decision|0
6917784|NCT00784875|10945365|FG001|Period A - Baseline|Physician Decision|0
6917785|NCT00784875|10945366|FG002|Period A - Baseline|Physician Decision|0
6917786|NCT00784875|10945367|FG003|Period A - Baseline|Physician Decision|2
6917787|NCT00784875|10945364|FG000|Period A - Baseline|Sponsor Decision|0
6917788|NCT00784875|10945365|FG001|Period A - Baseline|Sponsor Decision|0
6917789|NCT00784875|10945366|FG002|Period A - Baseline|Sponsor Decision|0
6917790|NCT00784875|10945367|FG003|Period A - Baseline|Sponsor Decision|113
6917791|NCT00784875|10945364|FG000|Period A - Baseline|Lost to Follow-up|0
6917792|NCT00784875|10945365|FG001|Period A - Baseline|Lost to Follow-up|0
6917793|NCT00784875|10945366|FG002|Period A - Baseline|Lost to Follow-up|0
6917794|NCT00784875|10945367|FG003|Period A - Baseline|Lost to Follow-up|2
6917795|NCT00784875|10945364|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
6917796|NCT00784875|10945365|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
6917797|NCT00784875|10945366|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2
6917798|NCT00784875|10945367|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1
6917799|NCT00784875|10945364|FG000|Period B - Efficacy Endpoint|Adverse Event|0
6917800|NCT00784875|10945365|FG001|Period B - Efficacy Endpoint|Adverse Event|3
6917801|NCT00784875|10945366|FG002|Period B - Efficacy Endpoint|Adverse Event|2
6917802|NCT00784875|10945367|FG003|Period B - Efficacy Endpoint|Adverse Event|1
6917803|NCT00784875|10945364|FG000|Period B - Efficacy Endpoint|Protocol Violation|1
6917804|NCT00784875|10945365|FG001|Period B - Efficacy Endpoint|Protocol Violation|1
6917805|NCT00784875|10945366|FG002|Period B - Efficacy Endpoint|Protocol Violation|2
6917806|NCT00784875|10945367|FG003|Period B - Efficacy Endpoint|Protocol Violation|3
6917807|NCT00784875|10945364|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0
6917808|NCT00784875|10945365|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1
6917809|NCT00784875|10945366|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0
6917810|NCT00784875|10945367|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0
6917811|NCT00784875|10945364|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4
6917812|NCT00784875|10945365|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1
6917813|NCT00784875|10945366|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1
6917814|NCT00784875|10945367|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2
6917815|NCT00784875|10945364|FG000|Period B - Efficacy Endpoint|Physician Decision|0
6917816|NCT00784875|10945365|FG001|Period B - Efficacy Endpoint|Physician Decision|0
6917817|NCT00784875|10945366|FG002|Period B - Efficacy Endpoint|Physician Decision|1
6917818|NCT00784875|10945367|FG003|Period B - Efficacy Endpoint|Physician Decision|0
6917819|NCT00784875|10945364|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9
6917820|NCT00784875|10945365|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6
6917821|NCT00784875|10945366|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12
6917822|NCT00784875|10945367|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12
6917823|NCT00784875|10945364|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0
6917824|NCT00784875|10945365|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0
6917825|NCT00784875|10945366|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1
6917826|NCT00784875|10945367|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0
6917827|NCT00784875|10945364|FG000|Period C|Adverse Event|1
6917828|NCT00784875|10945365|FG001|Period C|Adverse Event|0
6917829|NCT00784875|10945366|FG002|Period C|Adverse Event|4
6917830|NCT00784875|10945367|FG003|Period C|Adverse Event|2
6917831|NCT00784875|10945364|FG000|Period C|Protocol Violation|0
6917832|NCT00784875|10945365|FG001|Period C|Protocol Violation|0
6917833|NCT00784875|10945366|FG002|Period C|Protocol Violation|1
6917834|NCT00784875|10945367|FG003|Period C|Protocol Violation|2
6917835|NCT00784875|10945364|FG000|Period C|Lack of Efficacy|0
6917836|NCT00784875|10945365|FG001|Period C|Lack of Efficacy|0
6917837|NCT00784875|10945366|FG002|Period C|Lack of Efficacy|1
6917838|NCT00784875|10945367|FG003|Period C|Lack of Efficacy|0
6917839|NCT00784875|10945364|FG000|Period C|Withdrawal by Subject|1
6917840|NCT00784875|10945365|FG001|Period C|Withdrawal by Subject|1
6917841|NCT00784875|10945366|FG002|Period C|Withdrawal by Subject|2
6917842|NCT00784875|10945367|FG003|Period C|Withdrawal by Subject|0
6917843|NCT00784875|10945364|FG000|Period C|Physician Decision|0
6917844|NCT00784875|10945365|FG001|Period C|Physician Decision|0
6917845|NCT00784875|10945366|FG002|Period C|Physician Decision|1
6917846|NCT00784875|10945367|FG003|Period C|Physician Decision|1
6917847|NCT00784875|10945364|FG000|Period C|Sponsor Decision|5
6917848|NCT00784875|10945365|FG001|Period C|Sponsor Decision|5
6917849|NCT00784875|10945366|FG002|Period C|Sponsor Decision|4
6917850|NCT00784875|10945367|FG003|Period C|Sponsor Decision|2
6917851|NCT00784875|10945364|FG000|Period D|Adverse Event|0
6917852|NCT00784875|10945365|FG001|Period D|Adverse Event|2
6917853|NCT00784875|10945366|FG002|Period D|Adverse Event|2
6917854|NCT00784875|10945367|FG003|Period D|Adverse Event|0
6917855|NCT00784875|10945364|FG000|Period D|Protocol Violation|1
6917856|NCT00784875|10945365|FG001|Period D|Protocol Violation|0
6917857|NCT00784875|10945366|FG002|Period D|Protocol Violation|0
6917858|NCT00784875|10945367|FG003|Period D|Protocol Violation|0
6917859|NCT00784875|10945364|FG000|Period D|Withdrawal by Subject|2
6917860|NCT00784875|10945365|FG001|Period D|Withdrawal by Subject|0
6917861|NCT00784875|10945366|FG002|Period D|Withdrawal by Subject|2
6917862|NCT00784875|10945367|FG003|Period D|Withdrawal by Subject|0
6917863|NCT00784875|10945364|FG000|Period D|Physician Decision|0
6917864|NCT00784875|10945365|FG001|Period D|Physician Decision|1
6917865|NCT00784875|10945366|FG002|Period D|Physician Decision|0
6917866|NCT00784875|10945367|FG003|Period D|Physician Decision|0
6917867|NCT00784875|10945364|FG000|Period D|Sponsor Decision|1
6917868|NCT00784875|10945365|FG001|Period D|Sponsor Decision|1
6917869|NCT00784875|10945366|FG002|Period D|Sponsor Decision|1
6917870|NCT00784875|10945367|FG003|Period D|Sponsor Decision|0
6917871|NCT00784875|10945364|FG000|Period D|Lost to Follow-up|1
6917872|NCT00784875|10945365|FG001|Period D|Lost to Follow-up|0
6917873|NCT00784875|10945366|FG002|Period D|Lost to Follow-up|1
6917874|NCT00784875|10945367|FG003|Period D|Lost to Follow-up|1
6917875|NCT00784927|10945390|FG000|Overall Study|Cancel Prior to Initiating Treatment|1
6917876|NCT00784927|10945390|FG000|Overall Study|Protocol Violation|1
6917877|NCT00784927|10945390|FG000|Overall Study|Ineligible|1
6917878|NCT00784979|10945395|FG000|Overall Study|incomplete data|6
6917879|NCT00785044|10945399|FG000|Overall Study|Dosed at non-participating sites|152
6917880|NCT00785044|10945399|FG000|Overall Study|Death|77
6917881|NCT00785044|10945399|FG000|Overall Study|Lost to Follow-up|266
6917882|NCT00785044|10945399|FG000|Overall Study|Withdrawal by Subject|1
6917883|NCT00785213|10945404|FG000|Quinine Sulfate Alone|Adverse Event|4
6917884|NCT00785213|10945404|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1
6917885|NCT00785486|10945411|FG000|Midazolam Alone|Withdrawal by Subject|1
6917886|NCT00785512|10945434|FG000|Overall Study|Inclusion/Exclusion not meet|0
6917887|NCT00785512|10945435|FG001|Overall Study|Inclusion/Exclusion not meet|0
6917888|NCT00785512|10945434|FG000|Overall Study|Adverse Event|0
6917889|NCT00785512|10945435|FG001|Overall Study|Adverse Event|0
6917890|NCT00785512|10945434|FG000|Overall Study|Lack of Efficacy|0
6917891|NCT00785512|10945435|FG001|Overall Study|Lack of Efficacy|2
6917892|NCT00785512|10945434|FG000|Overall Study|Withdrawal by Subject|0
6917893|NCT00785512|10945435|FG001|Overall Study|Withdrawal by Subject|1
6917894|NCT00785512|10945434|FG000|Overall Study|Lost to Follow-up|3
6917895|NCT00785512|10945435|FG001|Overall Study|Lost to Follow-up|0
6917896|NCT00785512|10945434|FG000|Overall Study|Precedure Refused|0
6917897|NCT00785512|10945435|FG001|Overall Study|Precedure Refused|0
6917898|NCT00785512|10945434|FG000|Overall Study|IVRS Programing Error|0
6917899|NCT00785512|10945435|FG001|Overall Study|IVRS Programing Error|0
6917900|NCT00785512|10945434|FG000|Overall Study|Physician Decision|0
6917901|NCT00785512|10945435|FG001|Overall Study|Physician Decision|0
6917902|NCT00785512|10945434|FG000|Overall Study|Lack of compliance|0
6917903|NCT00785512|10945435|FG001|Overall Study|Lack of compliance|1
6917904|NCT00785538|10945446|FG000|Treatment Period|Adverse Event|1
6917905|NCT00785538|10945447|FG001|Treatment Period|Adverse Event|2
6917906|NCT00785538|10945448|FG002|Treatment Period|Adverse Event|2
6917907|NCT00785538|10945449|FG003|Treatment Period|Adverse Event|0
6917908|NCT00785538|10945446|FG000|Treatment Period|Withdrawal by Subject|0
6917909|NCT00785538|10945447|FG001|Treatment Period|Withdrawal by Subject|0
6917910|NCT00785538|10945448|FG002|Treatment Period|Withdrawal by Subject|0
6917911|NCT00785538|10945449|FG003|Treatment Period|Withdrawal by Subject|1
6917912|NCT00785577|10945465|FG000|Study Period 2: Therapy Phase|Adverse Event|5
6917913|NCT00785577|10945466|FG001|Study Period 2: Therapy Phase|Adverse Event|7
6917914|NCT00785577|10945467|FG002|Study Period 2: Therapy Phase|Adverse Event|14
6917915|NCT00785577|10945468|FG003|Study Period 2: Therapy Phase|Adverse Event|10
6917916|NCT00785577|10945469|FG004|Study Period 2: Therapy Phase|Adverse Event|17
6917917|NCT00785577|10945465|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0
6917918|NCT00785577|10945466|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0
6917919|NCT00785577|10945467|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0
6917920|NCT00785577|10945468|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0
6917921|NCT00785577|10945469|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1
6917922|NCT00785577|10945465|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0
6917923|NCT00785577|10945466|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0
6917924|NCT00785577|10945467|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0
6917925|NCT00785577|10945468|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1
6917926|NCT00785577|10945469|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0
6917927|NCT00785577|10945465|FG000|Study Period 2: Therapy Phase|Physician Decision|1
6917928|NCT00785577|10945466|FG001|Study Period 2: Therapy Phase|Physician Decision|0
6917929|NCT00785577|10945467|FG002|Study Period 2: Therapy Phase|Physician Decision|0
6917930|NCT00785577|10945468|FG003|Study Period 2: Therapy Phase|Physician Decision|0
6917931|NCT00785577|10945469|FG004|Study Period 2: Therapy Phase|Physician Decision|0
6917932|NCT00785577|10945465|FG000|Study Period 2: Therapy Phase|Protocol Violation|1
6917933|NCT00785577|10945466|FG001|Study Period 2: Therapy Phase|Protocol Violation|1
6917934|NCT00785577|10945467|FG002|Study Period 2: Therapy Phase|Protocol Violation|1
6917935|NCT00785577|10945468|FG003|Study Period 2: Therapy Phase|Protocol Violation|0
6917936|NCT00785577|10945469|FG004|Study Period 2: Therapy Phase|Protocol Violation|1
6917937|NCT00785577|10945465|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2
6917938|NCT00785577|10945466|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1
6917939|NCT00785577|10945467|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1
6917940|NCT00785577|10945468|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0
6917941|NCT00785577|10945469|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1
6917942|NCT00785577|10945465|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
6917943|NCT00785577|10945466|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
6917944|NCT00785577|10945467|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
6917945|NCT00785577|10945468|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
6917946|NCT00785577|10945469|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
6917947|NCT00785577|10945465|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1
6917948|NCT00785577|10945466|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0
6917949|NCT00785577|10945467|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1
6917950|NCT00785577|10945468|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1
6917951|NCT00785577|10945469|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0
6917952|NCT00785577|10945465|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0
6917953|NCT00785577|10945466|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0
6917954|NCT00785577|10945467|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0
6917955|NCT00785577|10945468|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1
6917956|NCT00785577|10945469|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0
6917957|NCT00785577|10945465|FG000|Study Period 3: 1-Week Washout Phase|Death|0
6917958|NCT00785577|10945466|FG001|Study Period 3: 1-Week Washout Phase|Death|0
6917959|NCT00785577|10945467|FG002|Study Period 3: 1-Week Washout Phase|Death|0
6917960|NCT00785577|10945468|FG003|Study Period 3: 1-Week Washout Phase|Death|0
6917961|NCT00785577|10945469|FG004|Study Period 3: 1-Week Washout Phase|Death|1
6917962|NCT00785629|10945495|FG000|Overall Study|Adverse Event|2
6917963|NCT00785629|10945496|FG001|Overall Study|Adverse Event|1
6917964|NCT00785629|10945497|FG002|Overall Study|Adverse Event|1
6917965|NCT00785629|10945498|FG003|Overall Study|Adverse Event|5
6917966|NCT00785629|10945495|FG000|Overall Study|Protocol Violation|1
6917967|NCT00785629|10945496|FG001|Overall Study|Protocol Violation|2
6917968|NCT00785629|10945497|FG002|Overall Study|Protocol Violation|4
6917969|NCT00785629|10945498|FG003|Overall Study|Protocol Violation|5
6917970|NCT00785629|10945495|FG000|Overall Study|administrative decision|5
6917971|NCT00785629|10945496|FG001|Overall Study|administrative decision|1
6917972|NCT00785629|10945497|FG002|Overall Study|administrative decision|3
6917973|NCT00785629|10945498|FG003|Overall Study|administrative decision|4
6917974|NCT00785629|10945495|FG000|Overall Study|Withdrawal by Subject|0
6917975|NCT00785629|10945496|FG001|Overall Study|Withdrawal by Subject|1
6917976|NCT00785629|10945497|FG002|Overall Study|Withdrawal by Subject|2
6917977|NCT00785629|10945498|FG003|Overall Study|Withdrawal by Subject|2
6974470|NCT01187407|11026377|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13
6974471|NCT01187407|11026373|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
6974472|NCT01187407|11026374|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
6974473|NCT01187407|11026375|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
6974474|NCT01187407|11026376|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
6974475|NCT01187407|11026377|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
6974476|NCT01187407|11026373|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
6917978|NCT00785707|10945506|FG000|Overall Study|Lost to Follow-up|7
6917979|NCT00785785|10945516|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3
6917980|NCT00785785|10945517|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4
6917981|NCT00785785|10945516|FG000|Core Phase up to 36 Months|Adverse Event|31
6917982|NCT00785785|10945517|FG001|Core Phase up to 36 Months|Adverse Event|21
6917983|NCT00785785|10945516|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1
6917984|NCT00785785|10945517|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0
6917985|NCT00785785|10945516|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2
6917986|NCT00785785|10945517|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2
6917987|NCT00785785|10945516|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16
6917988|NCT00785785|10945517|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17
6917989|NCT00785785|10945516|FG000|Core Phase up to 36 Months|Lost to Follow-up|3
6917990|NCT00785785|10945517|FG001|Core Phase up to 36 Months|Lost to Follow-up|7
6917991|NCT00785785|10945516|FG000|Core Phase up to 36 Months|Administrative problems|3
6917992|NCT00785785|10945517|FG001|Core Phase up to 36 Months|Administrative problems|3
6917993|NCT00785785|10945516|FG000|Core Phase up to 36 Months|Death|5
6917994|NCT00785785|10945517|FG001|Core Phase up to 36 Months|Death|8
6917995|NCT00785785|10945516|FG000|Core Phase up to 36 Months|Disease progression|139
6917996|NCT00785785|10945517|FG001|Core Phase up to 36 Months|Disease progression|119
6917997|NCT00785785|10945516|FG000|Core Phase up to 36 Months|Protocol deviation|5
6917998|NCT00785785|10945517|FG001|Core Phase up to 36 Months|Protocol deviation|6
6917999|NCT00785785|10945516|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116
6918000|NCT00785785|10945517|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133
6918001|NCT00785785|10945516|FG000|Optional Extension Phase|Adverse Event|4
6918002|NCT00785785|10945517|FG001|Optional Extension Phase|Adverse Event|5
6918003|NCT00785785|10945516|FG000|Optional Extension Phase|Withdrawal by Subject|6
6918004|NCT00785785|10945517|FG001|Optional Extension Phase|Withdrawal by Subject|6
6918005|NCT00785785|10945516|FG000|Optional Extension Phase|Lost to Follow-up|1
6918006|NCT00785785|10945517|FG001|Optional Extension Phase|Lost to Follow-up|0
6918007|NCT00785785|10945516|FG000|Optional Extension Phase|Administrative problems|2
6918008|NCT00785785|10945517|FG001|Optional Extension Phase|Administrative problems|0
6918009|NCT00785785|10945516|FG000|Optional Extension Phase|Death|1
6918010|NCT00785785|10945517|FG001|Optional Extension Phase|Death|5
6918011|NCT00785785|10945516|FG000|Optional Extension Phase|Disease progression|22
6918012|NCT00785785|10945517|FG001|Optional Extension Phase|Disease progression|70
6918013|NCT00785785|10945516|FG000|Optional Extension Phase|Protocol deviation|0
6918014|NCT00785785|10945517|FG001|Optional Extension Phase|Protocol deviation|2
6918015|NCT00785785|10945516|FG000|Optional Extension Phase|Study terminated by sponsor|3
6918016|NCT00785785|10945517|FG001|Optional Extension Phase|Study terminated by sponsor|37
6918017|NCT00785928|10945532|FG000|Treatment Phase|Adverse Event|1
6918018|NCT00785928|10945533|FG001|Treatment Phase|Adverse Event|1
6918019|NCT00785928|10945534|FG002|Treatment Phase|Adverse Event|2
6918020|NCT00785928|10945535|FG003|Treatment Phase|Adverse Event|0
6918021|NCT00785928|10945536|FG004|Treatment Phase|Adverse Event|0
6918022|NCT00785928|10945537|FG005|Treatment Phase|Adverse Event|0
6918023|NCT00785928|10945538|FG006|Treatment Phase|Adverse Event|2
6918024|NCT00785928|10945532|FG000|Treatment Phase|Inadequate Response|0
6918025|NCT00785928|10945533|FG001|Treatment Phase|Inadequate Response|1
6918026|NCT00785928|10945534|FG002|Treatment Phase|Inadequate Response|0
6918027|NCT00785928|10945535|FG003|Treatment Phase|Inadequate Response|0
6918028|NCT00785928|10945536|FG004|Treatment Phase|Inadequate Response|0
6918029|NCT00785928|10945537|FG005|Treatment Phase|Inadequate Response|0
6918030|NCT00785928|10945538|FG006|Treatment Phase|Inadequate Response|0
6918031|NCT00785928|10945532|FG000|Treatment Phase|Lack of Efficacy|0
6918032|NCT00785928|10945533|FG001|Treatment Phase|Lack of Efficacy|1
6918033|NCT00785928|10945534|FG002|Treatment Phase|Lack of Efficacy|1
6918034|NCT00785928|10945535|FG003|Treatment Phase|Lack of Efficacy|0
6918035|NCT00785928|10945536|FG004|Treatment Phase|Lack of Efficacy|0
6918036|NCT00785928|10945537|FG005|Treatment Phase|Lack of Efficacy|0
6918037|NCT00785928|10945538|FG006|Treatment Phase|Lack of Efficacy|0
6918038|NCT00785928|10945532|FG000|Treatment Phase|Physician Decision|0
6918039|NCT00785928|10945533|FG001|Treatment Phase|Physician Decision|0
6918040|NCT00785928|10945534|FG002|Treatment Phase|Physician Decision|0
6918041|NCT00785928|10945535|FG003|Treatment Phase|Physician Decision|0
6918042|NCT00785928|10945536|FG004|Treatment Phase|Physician Decision|1
6918043|NCT00785928|10945537|FG005|Treatment Phase|Physician Decision|0
6918044|NCT00785928|10945538|FG006|Treatment Phase|Physician Decision|0
6918045|NCT00785928|10945532|FG000|Treatment Phase|Sponsor Decision|1
6918046|NCT00785928|10945533|FG001|Treatment Phase|Sponsor Decision|0
6918047|NCT00785928|10945534|FG002|Treatment Phase|Sponsor Decision|0
6918048|NCT00785928|10945535|FG003|Treatment Phase|Sponsor Decision|0
6918049|NCT00785928|10945536|FG004|Treatment Phase|Sponsor Decision|0
6918050|NCT00785928|10945537|FG005|Treatment Phase|Sponsor Decision|0
6918051|NCT00785928|10945538|FG006|Treatment Phase|Sponsor Decision|1
6918052|NCT00785928|10945532|FG000|Treatment Phase|Withdrawal by Subject|1
6918053|NCT00785928|10945533|FG001|Treatment Phase|Withdrawal by Subject|2
6918054|NCT00785928|10945534|FG002|Treatment Phase|Withdrawal by Subject|0
6918055|NCT00785928|10945535|FG003|Treatment Phase|Withdrawal by Subject|0
6918056|NCT00785928|10945536|FG004|Treatment Phase|Withdrawal by Subject|1
7143011|NCT03023423|11299304|FG000|Overall Study|Death|5
7143012|NCT03023423|11299305|FG001|Overall Study|Death|12
6918057|NCT00785928|10945537|FG005|Treatment Phase|Withdrawal by Subject|0
6918058|NCT00785928|10945538|FG006|Treatment Phase|Withdrawal by Subject|0
6918059|NCT00785980|10945576|FG000|7 Day Washout Period|Protocol Violation|3
6918060|NCT00786032|10945594|FG000|Overall Study|Death|4
6918061|NCT00786032|10945594|FG000|Overall Study|Withdrawal by Subject|14
6918062|NCT00786032|10945594|FG000|Overall Study|Did not complete in the timeframe|6
6918063|NCT00786188|10945602|FG000|Overall Study|Adverse Event|3
6918064|NCT00786188|10945603|FG001|Overall Study|Adverse Event|1
6918065|NCT00786188|10945602|FG000|Overall Study|Withdrawal by Subject|2
6918066|NCT00786188|10945603|FG001|Overall Study|Withdrawal by Subject|0
6918067|NCT00786409|10945611|FG000|Overall Study|Withdrawal by Subject|2
6918068|NCT00786409|10945611|FG000|Overall Study|Adverse Event|2
6918069|NCT00786409|10945611|FG000|Overall Study|Pregnancy|2
6918070|NCT00786409|10945611|FG000|Overall Study|Lost to Follow-up|1
6918071|NCT00786422|10945615|FG000|Rivaroxaban Treatment|Death|2
6918072|NCT00786422|10945615|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3
6918073|NCT00786422|10945615|FG000|Rivaroxaban Treatment|Lack of Efficacy|1
6918074|NCT00786422|10945615|FG000|Rivaroxaban Treatment|Physician Decision|1
6918075|NCT00786422|10945615|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1
6918076|NCT00786422|10945615|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1
6918077|NCT00786422|10945615|FG000|Rivaroxaban Treatment|Adverse Event|2
6918078|NCT00786422|10945615|FG000|Follow-up Period|Death|1
6918079|NCT00786422|10945615|FG000|Follow-up Period|End-of-study done up to 4 days early|2
6918080|NCT00786474|10945623|FG000|Overall Study|Death|5
6918081|NCT00786474|10945624|FG001|Overall Study|Death|4
6918082|NCT00786474|10945623|FG000|Overall Study|Withdrawal by Subject|23
6918083|NCT00786474|10945624|FG001|Overall Study|Withdrawal by Subject|31
6918084|NCT00786474|10945623|FG000|Overall Study|Lost to Follow-up|3
6918085|NCT00786474|10945624|FG001|Overall Study|Lost to Follow-up|3
6918086|NCT00786474|10945623|FG000|Overall Study|Physician Decision|2
6918087|NCT00786474|10945624|FG001|Overall Study|Physician Decision|1
6918088|NCT00786474|10945623|FG000|Overall Study|Other|4
6918089|NCT00786474|10945624|FG001|Overall Study|Other|4
6918090|NCT00786565|10945647|FG000|Enrollment Prior to Surgery|Site Closed|3
6918091|NCT00786565|10945647|FG000|Enrollment Prior to Surgery|Protocol Violation|3
6918092|NCT00786565|10945647|FG000|Post Surgery|Abnormal macular pucker|1
6918093|NCT00786565|10945647|FG000|Post Surgery|Adapt AO implanted posterior side up|1
6918094|NCT00786799|10945664|FG000|Overall Study|Lost to Follow-up|1
6918095|NCT00786799|10945665|FG001|Overall Study|Lost to Follow-up|1
6918096|NCT00786838|10945685|FG000|Overall Study|Physician Decision|4
6918097|NCT00786838|10945685|FG000|Overall Study|Death|4
6918098|NCT00786838|10945685|FG000|Overall Study|Adverse Event|6
6918099|NCT00786838|10945685|FG000|Overall Study|Progressive disease|31
6918100|NCT00786838|10945685|FG000|Overall Study|Withdrawal by Subject|4
6918101|NCT00786864|10945696|FG000|Overall Study|Lost to Follow-up|0
6918102|NCT00786864|10945697|FG001|Overall Study|Lost to Follow-up|1
6918103|NCT00786864|10945696|FG000|Overall Study|Sustained serious back injury|1
6918104|NCT00786864|10945697|FG001|Overall Study|Sustained serious back injury|0
6918105|NCT00787137|10945744|FG000|Overall Study|Study Termination|0
6918106|NCT00787137|10945745|FG001|Overall Study|Study Termination|0
6918107|NCT00787137|10945746|FG002|Overall Study|Study Termination|1
6918108|NCT00787150|10945757|FG000|Overall Study|Adverse Event|4
6918109|NCT00787150|10945758|FG001|Overall Study|Adverse Event|4
6918110|NCT00787150|10945759|FG002|Overall Study|Adverse Event|4
6918111|NCT00787150|10945757|FG000|Overall Study|Physician Decision|1
6918112|NCT00787150|10945758|FG001|Overall Study|Physician Decision|2
6918113|NCT00787150|10945759|FG002|Overall Study|Physician Decision|1
6918114|NCT00787150|10945757|FG000|Overall Study|Withdrawal by Subject|2
6918115|NCT00787150|10945758|FG001|Overall Study|Withdrawal by Subject|1
6918116|NCT00787150|10945759|FG002|Overall Study|Withdrawal by Subject|0
6918117|NCT00787150|10945757|FG000|Overall Study|Dosing incorrect study durg|2
6918118|NCT00787150|10945758|FG001|Overall Study|Dosing incorrect study durg|0
6918119|NCT00787150|10945759|FG002|Overall Study|Dosing incorrect study durg|0
6918120|NCT00787189|10945771|FG000|Overall Study|Lost to Follow-up|2
6918121|NCT00787189|10945772|FG001|Overall Study|Lost to Follow-up|2
6918122|NCT00787202|10945783|FG000|Overall Study|Adverse Event|3
6918123|NCT00787202|10945784|FG001|Overall Study|Adverse Event|2
6918124|NCT00787202|10945785|FG002|Overall Study|Adverse Event|0
6918125|NCT00787202|10945786|FG003|Overall Study|Adverse Event|0
6918126|NCT00787202|10945787|FG004|Overall Study|Adverse Event|2
6918127|NCT00787202|10945783|FG000|Overall Study|Lack of Efficacy|5
6918128|NCT00787202|10945784|FG001|Overall Study|Lack of Efficacy|6
6918129|NCT00787202|10945785|FG002|Overall Study|Lack of Efficacy|5
6918130|NCT00787202|10945786|FG003|Overall Study|Lack of Efficacy|2
6918131|NCT00787202|10945787|FG004|Overall Study|Lack of Efficacy|1
6918132|NCT00787202|10945783|FG000|Overall Study|Lost to Follow-up|1
6918133|NCT00787202|10945784|FG001|Overall Study|Lost to Follow-up|0
6918134|NCT00787202|10945785|FG002|Overall Study|Lost to Follow-up|0
6918135|NCT00787202|10945786|FG003|Overall Study|Lost to Follow-up|0
6918136|NCT00787202|10945787|FG004|Overall Study|Lost to Follow-up|0
6918137|NCT00787202|10945783|FG000|Overall Study|Withdrawal by Subject|2
6918138|NCT00787202|10945784|FG001|Overall Study|Withdrawal by Subject|2
7143013|NCT03023423|11299306|FG002|Overall Study|Death|20
6918139|NCT00787202|10945785|FG002|Overall Study|Withdrawal by Subject|2
6918140|NCT00787202|10945786|FG003|Overall Study|Withdrawal by Subject|0
6918141|NCT00787202|10945787|FG004|Overall Study|Withdrawal by Subject|0
6918142|NCT00787202|10945783|FG000|Overall Study|Protocol Violation|2
6918143|NCT00787202|10945784|FG001|Overall Study|Protocol Violation|1
6918144|NCT00787202|10945785|FG002|Overall Study|Protocol Violation|0
6918145|NCT00787202|10945786|FG003|Overall Study|Protocol Violation|0
6918146|NCT00787202|10945787|FG004|Overall Study|Protocol Violation|1
6918147|NCT00787202|10945783|FG000|Overall Study|Randomized, not treated|1
6918148|NCT00787202|10945784|FG001|Overall Study|Randomized, not treated|0
6918149|NCT00787202|10945785|FG002|Overall Study|Randomized, not treated|0
6918150|NCT00787202|10945786|FG003|Overall Study|Randomized, not treated|0
6918151|NCT00787202|10945787|FG004|Overall Study|Randomized, not treated|0
6918152|NCT00787254|10945818|FG000|Overall Study|Adverse Event|24
6918153|NCT00787254|10945819|FG001|Overall Study|Adverse Event|23
6918154|NCT00787254|10945818|FG000|Overall Study|Protocol Violation|26
6918155|NCT00787254|10945819|FG001|Overall Study|Protocol Violation|23
6918156|NCT00787254|10945818|FG000|Overall Study|Withdrawal by Subject|16
6918157|NCT00787254|10945819|FG001|Overall Study|Withdrawal by Subject|11
6918158|NCT00787254|10945818|FG000|Overall Study|Lack of Efficacy|4
6918159|NCT00787254|10945819|FG001|Overall Study|Lack of Efficacy|15
6918160|NCT00787254|10945818|FG000|Overall Study|NSAIDs discontinuation|1
7143014|NCT03023423|11299304|FG000|Overall Study|Other|0
7143015|NCT03023423|11299305|FG001|Overall Study|Other|2
7143016|NCT03023423|11299306|FG002|Overall Study|Other|2
7143017|NCT03023423|11299304|FG000|Overall Study|Ongoing|2
7143018|NCT03023423|11299305|FG001|Overall Study|Ongoing|32
7143019|NCT03023423|11299306|FG002|Overall Study|Ongoing|24
7143020|NCT03023722|11299357|FG000|Overall Study|No follow-up assessment|4
7143021|NCT03023826|11299361|FG000|Period 1|Withdrawal by Subject|0
7143022|NCT03023826|11299362|FG001|Period 1|Withdrawal by Subject|0
7143023|NCT03023826|11299363|FG002|Period 1|Withdrawal by Subject|0
7143024|NCT03023826|11299364|FG003|Period 1|Withdrawal by Subject|0
7143025|NCT03023826|11299365|FG004|Period 1|Withdrawal by Subject|1
7143026|NCT03023826|11299366|FG005|Period 1|Withdrawal by Subject|0
6918161|NCT00787254|10945819|FG001|Overall Study|NSAIDs discontinuation|2
6918162|NCT00787254|10945818|FG000|Overall Study|Institution closed|1
6918163|NCT00787254|10945819|FG001|Overall Study|Institution closed|0
6918164|NCT00787254|10945818|FG000|Overall Study|Physician Decision|4
6918165|NCT00787254|10945819|FG001|Overall Study|Physician Decision|8
6918166|NCT00787267|10945825|FG000|Overall Study|Screen failure/Ineligible|10
6979122|NCT01216072|11032857|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11
6979123|NCT01216072|11032858|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4
6979124|NCT01216072|11032857|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0
6979125|NCT01216072|11032858|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10
6979126|NCT01216072|11032857|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0
6979127|NCT01216072|11032858|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1
6979128|NCT01216072|11032857|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0
6979129|NCT01216072|11032858|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3
6979130|NCT01216163|11032870|FG000|Overall Study|Withdrawal by Subject|1
6979131|NCT01216163|11032871|FG001|Overall Study|Withdrawal by Subject|1
6979132|NCT01216163|11032872|FG002|Overall Study|Withdrawal by Subject|0
6979133|NCT01216176|11032883|FG000|Overall Study|Adverse Event|0
6979134|NCT01216176|11032884|FG001|Overall Study|Adverse Event|8
6979135|NCT01216176|11032885|FG002|Overall Study|Adverse Event|0
6979136|NCT01216176|11032883|FG000|Overall Study|Physician Decision|0
6979137|NCT01216176|11032884|FG001|Overall Study|Physician Decision|0
6979138|NCT01216176|11032885|FG002|Overall Study|Physician Decision|1
6979139|NCT01216189|11032896|FG000|Overall Study|Lost to Follow-up|21
6979140|NCT01216189|11032897|FG001|Overall Study|Lost to Follow-up|3
6979141|NCT01216189|11032896|FG000|Overall Study|Death|4
6979142|NCT01216189|11032897|FG001|Overall Study|Death|2
6979143|NCT01216202|11032905|FG000|Overall Study|Withdrawal by Subject|8
6979144|NCT01216202|11032906|FG001|Overall Study|Withdrawal by Subject|0
6979145|NCT01216202|11032905|FG000|Overall Study|Death|0
6979146|NCT01216202|11032906|FG001|Overall Study|Death|2
6979147|NCT01216202|11032905|FG000|Overall Study|Lost to Follow-up|14
6979148|NCT01216202|11032906|FG001|Overall Study|Lost to Follow-up|0
6979149|NCT01216319|11032923|FG000|Overall Study|Lost to Follow-up|2
6979150|NCT01216319|11032923|FG000|Overall Study|Unanticipated chemo for breast cancer|2
7143027|NCT03023878|11299374|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11
6918167|NCT00787267|10945825|FG000|Overall Study|No Reason Provided|1
6918168|NCT00787267|10945825|FG000|Overall Study|Withdrawal by Subject|1
6918169|NCT00787319|10945829|FG000|Overall Study|Lost to Follow-up|2
6918170|NCT00787319|10945829|FG000|Overall Study|Withdrawal by Subject|15
6918171|NCT00787319|10945829|FG000|Overall Study|Adverse Event|3
6918172|NCT00787319|10945829|FG000|Overall Study|Objective progression or relapse|30
6918173|NCT00787319|10945829|FG000|Overall Study|Lack of Efficacy|1
6979151|NCT01216332|11032929|FG000|Overall Study|Withdrawal by Subject|4
6979152|NCT01216332|11032930|FG001|Overall Study|Withdrawal by Subject|0
7143028|NCT03023878|11299374|FG000|Pre-Study Run-In Period|Death|1
7143029|NCT03023878|11299374|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5
6918174|NCT00787319|10945829|FG000|Overall Study|Budget exhausted/exceeded|1
6918175|NCT00787319|10945829|FG000|Overall Study|Unresponsiveness to visit invitation|1
6918176|NCT00787319|10945829|FG000|Overall Study|No health insurance reimbursement|2
6918177|NCT00787319|10945829|FG000|Overall Study|Stabilized disease findings|3
6918178|NCT00787319|10945829|FG000|Overall Study|Inactive disease|5
6918179|NCT00787527|10945842|FG000|Overall Study|Toxicity|3
6918180|NCT00787566|10945853|FG000|Overall Study|AE related to chemotherapy|0
6918181|NCT00787566|10945854|FG001|Overall Study|AE related to chemotherapy|1
6918182|NCT00787566|10945855|FG002|Overall Study|AE related to chemotherapy|0
6918183|NCT00787605|10945865|FG000|Overall Study|Administrative Problems|3
6918184|NCT00787605|10945866|FG001|Overall Study|Administrative Problems|0
6918185|NCT00787605|10945865|FG000|Overall Study|Adverse Event|14
6918186|NCT00787605|10945866|FG001|Overall Study|Adverse Event|25
6918187|NCT00787605|10945865|FG000|Overall Study|Lost to Follow-up|3
6918188|NCT00787605|10945866|FG001|Overall Study|Lost to Follow-up|6
6918189|NCT00787605|10945865|FG000|Overall Study|Protocol Violation|7
6918190|NCT00787605|10945866|FG001|Overall Study|Protocol Violation|3
6918191|NCT00787605|10945865|FG000|Overall Study|Withdrawal by Subject|6
6918192|NCT00787605|10945866|FG001|Overall Study|Withdrawal by Subject|13
6918193|NCT00787605|10945865|FG000|Overall Study|Lack of Efficacy|13
6918194|NCT00787605|10945866|FG001|Overall Study|Lack of Efficacy|9
6918195|NCT00787644|10945874|FG000|Overall Study|Lost to Follow-up|1
6918196|NCT00787644|10945875|FG001|Overall Study|Lost to Follow-up|1
6918197|NCT00787644|10945874|FG000|Overall Study|Withdrawal by Subject|1
6918198|NCT00787644|10945875|FG001|Overall Study|Withdrawal by Subject|1
6918199|NCT00787787|10945892|FG000|Overall Study|Lack of Efficacy|4
6918200|NCT00787787|10945892|FG000|Overall Study|Adverse Event|3
6918201|NCT00787800|10945898|FG000|Overall Study|Withdrawal by Subject|3
6918202|NCT00787800|10945899|FG001|Overall Study|Withdrawal by Subject|5
6918203|NCT00787800|10945898|FG000|Overall Study|Death|0
6918204|NCT00787800|10945899|FG001|Overall Study|Death|2
6918205|NCT00787839|10945906|FG000|Overall Study|Failure to have the OGTT was most common|404
6918206|NCT00787891|10945938|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1
6918207|NCT00787891|10945939|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2
6918208|NCT00787891|10945938|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
6918209|NCT00787891|10945939|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
6918210|NCT00787891|10945938|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0
6918211|NCT00787891|10945939|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1
6918212|NCT00787891|10945938|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1
6918213|NCT00787891|10945939|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0
6918214|NCT00787891|10945938|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6
6918215|NCT00787891|10945939|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2
6918216|NCT00787891|10945938|FG000|Short-term Double-blind Phase (Part 1)|Other|0
6918217|NCT00787891|10945939|FG001|Short-term Double-blind Phase (Part 1)|Other|2
6918218|NCT00787891|10945938|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0
6918219|NCT00787891|10945939|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1
6918220|NCT00787891|10945938|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
6918221|NCT00787891|10945939|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
6918222|NCT00787891|10945938|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1
6918223|NCT00787891|10945939|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3
6918224|NCT00787891|10945938|FG000|Maintenance Double-blind Phase (Part 2)|Other|5
6918225|NCT00787891|10945939|FG001|Maintenance Double-blind Phase (Part 2)|Other|2
6918226|NCT00787930|10945956|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3
6918227|NCT00788073|10945985|FG000|STX209 Then Placebo|Adverse Event|1
6918228|NCT00788073|10945986|FG001|STX209 Then Placebo|Adverse Event|0
6918229|NCT00788073|10945985|FG000|STX209 Then Placebo|Lost to Follow-up|0
6918230|NCT00788073|10945986|FG001|STX209 Then Placebo|Lost to Follow-up|1
6918231|NCT00788073|10945985|FG000|STX209 Then Placebo|Withdrawal by Subject|0
6918232|NCT00788073|10945986|FG001|STX209 Then Placebo|Withdrawal by Subject|1
6918233|NCT00788073|10945985|FG000|STX209 Then Placebo|unable to return due to travel|0
6918234|NCT00788073|10945986|FG001|STX209 Then Placebo|unable to return due to travel|1
6918235|NCT00788073|10945985|FG000|Placebo Then STX209|Adverse Event|2
6918236|NCT00788073|10945986|FG001|Placebo Then STX209|Adverse Event|0
6918237|NCT00788073|10945985|FG000|Placebo Then STX209|Protocol Violation|0
6918238|NCT00788073|10945986|FG001|Placebo Then STX209|Protocol Violation|1
6918239|NCT00788372|10945999|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18
6918240|NCT00788372|10945999|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9
6918241|NCT00788372|10945999|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4
6918242|NCT00788372|10945999|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13
6918243|NCT00788372|10945999|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9
6918244|NCT00788372|10945999|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9
6918245|NCT00788372|10945999|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1
6918246|NCT00788593|10946003|FG000|Placebo Run-in Phase|Adverse Event|2
6918247|NCT00788593|10946004|FG001|Placebo Run-in Phase|Adverse Event|0
6918248|NCT00788593|10946005|FG002|Placebo Run-in Phase|Adverse Event|0
6918249|NCT00788593|10946003|FG000|Placebo Run-in Phase|Withdrawal by Subject|2
6918250|NCT00788593|10946004|FG001|Placebo Run-in Phase|Withdrawal by Subject|0
6918251|NCT00788593|10946005|FG002|Placebo Run-in Phase|Withdrawal by Subject|0
6918252|NCT00788593|10946003|FG000|Placebo Run-in Phase|Protocol Violation|2
6918253|NCT00788593|10946004|FG001|Placebo Run-in Phase|Protocol Violation|0
6918254|NCT00788593|10946005|FG002|Placebo Run-in Phase|Protocol Violation|0
6918255|NCT00788593|10946003|FG000|First Intervention Period|Adverse Event|0
6918256|NCT00788593|10946004|FG001|First Intervention Period|Adverse Event|1
6918257|NCT00788593|10946005|FG002|First Intervention Period|Adverse Event|0
6918258|NCT00788593|10946003|FG000|Second Intervention Period|Lost to Follow-up|0
6918259|NCT00788593|10946004|FG001|Second Intervention Period|Lost to Follow-up|1
6918260|NCT00788593|10946005|FG002|Second Intervention Period|Lost to Follow-up|0
6918261|NCT00788593|10946003|FG000|Second Intervention Period|Other|0
6918262|NCT00788593|10946004|FG001|Second Intervention Period|Other|0
6918263|NCT00788593|10946005|FG002|Second Intervention Period|Other|1
6918264|NCT00788697|10946015|FG000|Overall Study|No study drug administered|12
6918265|NCT00788697|10946015|FG000|Overall Study|Training Patients|74
6918266|NCT00788697|10946015|FG000|Overall Study|no truth standard procedure available|5
6918267|NCT00788697|10946015|FG000|Overall Study|Technically inadequate truth standard|1
6918268|NCT00788697|10946015|FG000|Overall Study|Indeterminate diagnosis from truth stand|17
6918269|NCT00788775|10946029|FG000|Overall Study|Progressive Disease|8
6918270|NCT00788775|10946030|FG001|Overall Study|Progressive Disease|6
6918271|NCT00788775|10946029|FG000|Overall Study|Withdrawal by Subject|0
6918272|NCT00788775|10946030|FG001|Overall Study|Withdrawal by Subject|2
6918273|NCT00788775|10946029|FG000|Overall Study|Patient Non-Compliance|1
6918274|NCT00788775|10946030|FG001|Overall Study|Patient Non-Compliance|0
6918275|NCT00788775|10946029|FG000|Overall Study|Patient's measurable disease resected.|1
6918276|NCT00788775|10946030|FG001|Overall Study|Patient's measurable disease resected.|0
6918277|NCT00788827|10946036|FG000|Overall Study|Lack of Efficacy|2
6918278|NCT00788957|10946055|FG000|Part 1|Death|8
6918279|NCT00788957|10946056|FG001|Part 1|Death|0
6918280|NCT00788957|10946057|FG002|Part 1|Death|0
6918281|NCT00788957|10946058|FG003|Part 1|Death|0
6918282|NCT00788957|10946059|FG004|Part 1|Death|0
6918283|NCT00788957|10946060|FG005|Part 1|Death|0
6918284|NCT00788957|10946055|FG000|Part 1|Lost to Follow-up|1
6918285|NCT00788957|10946056|FG001|Part 1|Lost to Follow-up|0
6918286|NCT00788957|10946057|FG002|Part 1|Lost to Follow-up|0
6918287|NCT00788957|10946058|FG003|Part 1|Lost to Follow-up|0
6918288|NCT00788957|10946059|FG004|Part 1|Lost to Follow-up|0
6918289|NCT00788957|10946060|FG005|Part 1|Lost to Follow-up|0
6918290|NCT00788957|10946055|FG000|Part 2|Withdrawal by Subject|0
6918291|NCT00788957|10946056|FG001|Part 2|Withdrawal by Subject|9
6918292|NCT00788957|10946057|FG002|Part 2|Withdrawal by Subject|5
6918293|NCT00788957|10946058|FG003|Part 2|Withdrawal by Subject|3
6918294|NCT00788957|10946059|FG004|Part 2|Withdrawal by Subject|0
6918295|NCT00788957|10946060|FG005|Part 2|Withdrawal by Subject|0
6918296|NCT00788957|10946055|FG000|Part 2|Death|0
6918297|NCT00788957|10946056|FG001|Part 2|Death|32
6918298|NCT00788957|10946057|FG002|Part 2|Death|35
6918299|NCT00788957|10946058|FG003|Part 2|Death|37
6918300|NCT00788957|10946059|FG004|Part 2|Death|0
6918301|NCT00788957|10946060|FG005|Part 2|Death|0
6918302|NCT00788957|10946055|FG000|Part 2|Lost to Follow-up|0
6918303|NCT00788957|10946056|FG001|Part 2|Lost to Follow-up|0
6918304|NCT00788957|10946057|FG002|Part 2|Lost to Follow-up|3
6918305|NCT00788957|10946058|FG003|Part 2|Lost to Follow-up|0
6918306|NCT00788957|10946059|FG004|Part 2|Lost to Follow-up|0
6918307|NCT00788957|10946060|FG005|Part 2|Lost to Follow-up|0
6918308|NCT00788957|10946055|FG000|Part 2|On-study at time of data cut-off|0
6918309|NCT00788957|10946056|FG001|Part 2|On-study at time of data cut-off|1
6918310|NCT00788957|10946057|FG002|Part 2|On-study at time of data cut-off|1
6918311|NCT00788957|10946058|FG003|Part 2|On-study at time of data cut-off|1
6918312|NCT00788957|10946059|FG004|Part 2|On-study at time of data cut-off|0
6918313|NCT00788957|10946060|FG005|Part 2|On-study at time of data cut-off|0
6918314|NCT00788957|10946055|FG000|Part 3|Withdrawal by Subject|0
6918315|NCT00788957|10946056|FG001|Part 3|Withdrawal by Subject|0
6918316|NCT00788957|10946057|FG002|Part 3|Withdrawal by Subject|0
6918317|NCT00788957|10946058|FG003|Part 3|Withdrawal by Subject|0
6918318|NCT00788957|10946059|FG004|Part 3|Withdrawal by Subject|0
6918319|NCT00788957|10946060|FG005|Part 3|Withdrawal by Subject|2
6918320|NCT00788957|10946055|FG000|Part 3|Death|0
6918321|NCT00788957|10946056|FG001|Part 3|Death|0
6918322|NCT00788957|10946057|FG002|Part 3|Death|0
6918323|NCT00788957|10946058|FG003|Part 3|Death|0
6918324|NCT00788957|10946059|FG004|Part 3|Death|8
6918325|NCT00788957|10946060|FG005|Part 3|Death|9
6918326|NCT00788957|10946055|FG000|Part 3|On-study at time of data cut-off|0
6918327|NCT00788957|10946056|FG001|Part 3|On-study at time of data cut-off|0
6918328|NCT00788957|10946057|FG002|Part 3|On-study at time of data cut-off|0
6918329|NCT00788957|10946058|FG003|Part 3|On-study at time of data cut-off|0
6918330|NCT00788957|10946059|FG004|Part 3|On-study at time of data cut-off|1
6918331|NCT00788957|10946060|FG005|Part 3|On-study at time of data cut-off|0
6918332|NCT00789035|10946082|FG000|Overall Study|Adverse Event|0
6918333|NCT00789035|10946083|FG001|Overall Study|Adverse Event|2
6918334|NCT00789035|10946084|FG002|Overall Study|Adverse Event|0
6918335|NCT00789035|10946085|FG003|Overall Study|Adverse Event|1
6918336|NCT00789035|10946086|FG004|Overall Study|Adverse Event|3
6918337|NCT00789035|10946082|FG000|Overall Study|Lack of Efficacy|3
6918338|NCT00789035|10946083|FG001|Overall Study|Lack of Efficacy|0
6918339|NCT00789035|10946084|FG002|Overall Study|Lack of Efficacy|0
6918340|NCT00789035|10946085|FG003|Overall Study|Lack of Efficacy|0
6918341|NCT00789035|10946086|FG004|Overall Study|Lack of Efficacy|2
6918342|NCT00789035|10946082|FG000|Overall Study|Protocol Violation|1
6918343|NCT00789035|10946083|FG001|Overall Study|Protocol Violation|0
6918344|NCT00789035|10946084|FG002|Overall Study|Protocol Violation|0
6918345|NCT00789035|10946085|FG003|Overall Study|Protocol Violation|0
6918346|NCT00789035|10946086|FG004|Overall Study|Protocol Violation|0
6918347|NCT00789035|10946082|FG000|Overall Study|Withdrawal by Subject|0
6918348|NCT00789035|10946083|FG001|Overall Study|Withdrawal by Subject|2
6918349|NCT00789035|10946084|FG002|Overall Study|Withdrawal by Subject|0
6918350|NCT00789035|10946085|FG003|Overall Study|Withdrawal by Subject|0
6918351|NCT00789035|10946086|FG004|Overall Study|Withdrawal by Subject|0
6918352|NCT00789035|10946082|FG000|Overall Study|Other reason not defined above|2
6918353|NCT00789035|10946083|FG001|Overall Study|Other reason not defined above|3
6918354|NCT00789035|10946084|FG002|Overall Study|Other reason not defined above|1
6918355|NCT00789035|10946085|FG003|Overall Study|Other reason not defined above|0
6918356|NCT00789035|10946086|FG004|Overall Study|Other reason not defined above|1
6918357|NCT00789191|10946120|FG000|Overall Study|Adverse Event|2
6918358|NCT00789191|10946121|FG001|Overall Study|Adverse Event|4
6918359|NCT00789191|10946120|FG000|Overall Study|Lack of Efficacy|0
6918360|NCT00789191|10946121|FG001|Overall Study|Lack of Efficacy|5
6918361|NCT00789191|10946120|FG000|Overall Study|Protocol Violation|5
6918362|NCT00789191|10946121|FG001|Overall Study|Protocol Violation|3
6918363|NCT00789191|10946120|FG000|Overall Study|Withdrawal Criteria|2
6918364|NCT00789191|10946121|FG001|Overall Study|Withdrawal Criteria|4
6918365|NCT00789191|10946120|FG000|Overall Study|Unclassified|5
6918366|NCT00789191|10946121|FG001|Overall Study|Unclassified|3
6918367|NCT00789321|10946141|FG000|Overall Study|Adverse Event|0
6918368|NCT00789321|10946142|FG001|Overall Study|Adverse Event|1
6918369|NCT00789360|10946150|FG000|Overall Study|Protocol Violation|3
6918370|NCT00789360|10946151|FG001|Overall Study|Protocol Violation|1
6918371|NCT00789373|10946158|FG000|Induction|Adverse Event|64
6918372|NCT00789373|10946159|FG001|Induction|Adverse Event|0
6918373|NCT00789373|10946160|FG002|Induction|Adverse Event|0
6918374|NCT00789373|10946158|FG000|Induction|Death Due to study disease|24
6918375|NCT00789373|10946159|FG001|Induction|Death Due to study disease|0
6918376|NCT00789373|10946160|FG002|Induction|Death Due to study disease|0
6918377|NCT00789373|10946158|FG000|Induction|Death due to adverse event|19
6918378|NCT00789373|10946159|FG001|Induction|Death due to adverse event|0
6918379|NCT00789373|10946160|FG002|Induction|Death due to adverse event|0
6918380|NCT00789373|10946158|FG000|Induction|Death due to toxicity|11
6918381|NCT00789373|10946159|FG001|Induction|Death due to toxicity|0
6918382|NCT00789373|10946160|FG002|Induction|Death due to toxicity|0
6918383|NCT00789373|10946158|FG000|Induction|Death due to procedure|1
6918384|NCT00789373|10946159|FG001|Induction|Death due to procedure|0
6918385|NCT00789373|10946160|FG002|Induction|Death due to procedure|0
6918386|NCT00789373|10946158|FG000|Induction|Investigator decision|7
6918387|NCT00789373|10946159|FG001|Induction|Investigator decision|0
6918388|NCT00789373|10946160|FG002|Induction|Investigator decision|0
6918389|NCT00789373|10946158|FG000|Induction|Protocol entry criteria not met|9
6918390|NCT00789373|10946159|FG001|Induction|Protocol entry criteria not met|0
6918391|NCT00789373|10946160|FG002|Induction|Protocol entry criteria not met|0
6918392|NCT00789373|10946158|FG000|Induction|Lost to Follow-up|6
6918393|NCT00789373|10946159|FG001|Induction|Lost to Follow-up|0
6918394|NCT00789373|10946160|FG002|Induction|Lost to Follow-up|0
6918395|NCT00789373|10946158|FG000|Induction|Protocol Violation|1
6918396|NCT00789373|10946159|FG001|Induction|Protocol Violation|0
6918397|NCT00789373|10946160|FG002|Induction|Protocol Violation|0
6918398|NCT00789373|10946158|FG000|Induction|Progressive Disease|220
6918399|NCT00789373|10946159|FG001|Induction|Progressive Disease|0
6918400|NCT00789373|10946160|FG002|Induction|Progressive Disease|0
6918401|NCT00789373|10946158|FG000|Induction|Withdrawal by Subject|37
6918402|NCT00789373|10946159|FG001|Induction|Withdrawal by Subject|0
6918403|NCT00789373|10946160|FG002|Induction|Withdrawal by Subject|0
6918404|NCT00789373|10946158|FG000|Maintenance|Adverse Event|0
6918405|NCT00789373|10946159|FG001|Maintenance|Adverse Event|65
6918406|NCT00789373|10946160|FG002|Maintenance|Adverse Event|12
6918407|NCT00789373|10946158|FG000|Maintenance|Death due to study disease|0
6918408|NCT00789373|10946159|FG001|Maintenance|Death due to study disease|3
6918409|NCT00789373|10946160|FG002|Maintenance|Death due to study disease|1
6918410|NCT00789373|10946158|FG000|Maintenance|Death due to adverse event|0
6918411|NCT00789373|10946159|FG001|Maintenance|Death due to adverse event|4
6918412|NCT00789373|10946160|FG002|Maintenance|Death due to adverse event|1
6918413|NCT00789373|10946158|FG000|Maintenance|Death due to toxicity|0
6918414|NCT00789373|10946159|FG001|Maintenance|Death due to toxicity|1
6918415|NCT00789373|10946160|FG002|Maintenance|Death due to toxicity|2
6918416|NCT00789373|10946158|FG000|Maintenance|Investigator Decision|0
6918417|NCT00789373|10946159|FG001|Maintenance|Investigator Decision|4
6918418|NCT00789373|10946160|FG002|Maintenance|Investigator Decision|2
6918419|NCT00789373|10946158|FG000|Maintenance|Protocol entry criteria not met|0
6918420|NCT00789373|10946159|FG001|Maintenance|Protocol entry criteria not met|2
6918421|NCT00789373|10946160|FG002|Maintenance|Protocol entry criteria not met|0
6918422|NCT00789373|10946158|FG000|Maintenance|Lost to Follow-up|0
6918423|NCT00789373|10946159|FG001|Maintenance|Lost to Follow-up|2
6918424|NCT00789373|10946160|FG002|Maintenance|Lost to Follow-up|0
6918425|NCT00789373|10946158|FG000|Maintenance|Progressive Disease|0
6918426|NCT00789373|10946159|FG001|Maintenance|Progressive Disease|253
6918427|NCT00789373|10946160|FG002|Maintenance|Progressive Disease|152
6918428|NCT00789373|10946158|FG000|Maintenance|Withdrawal by Subject|0
6918429|NCT00789373|10946159|FG001|Maintenance|Withdrawal by Subject|21
6918430|NCT00789373|10946160|FG002|Maintenance|Withdrawal by Subject|8
6918431|NCT00789373|10946158|FG000|Maintenance|Sponsor Decision|0
6918432|NCT00789373|10946159|FG001|Maintenance|Sponsor Decision|0
6918433|NCT00789373|10946160|FG002|Maintenance|Sponsor Decision|2
6918434|NCT00789373|10946158|FG000|Maintenance|Participants On-Going at Data Cut-Off|0
6918435|NCT00789373|10946159|FG001|Maintenance|Participants On-Going at Data Cut-Off|4
6918436|NCT00789373|10946160|FG002|Maintenance|Participants On-Going at Data Cut-Off|0
6918437|NCT00789477|10946189|FG000|Overall Study|Withdrawal by Subject|2
6918438|NCT00789477|10946190|FG001|Overall Study|Withdrawal by Subject|1
6918439|NCT00789477|10946191|FG002|Overall Study|Withdrawal by Subject|3
6918440|NCT00789477|10946192|FG003|Overall Study|Withdrawal by Subject|2
6918441|NCT00789477|10946193|FG004|Overall Study|Withdrawal by Subject|3
6918442|NCT00789477|10946189|FG000|Overall Study|Protocol Violation|1
6918443|NCT00789477|10946190|FG001|Overall Study|Protocol Violation|0
6918444|NCT00789477|10946191|FG002|Overall Study|Protocol Violation|0
6918445|NCT00789477|10946192|FG003|Overall Study|Protocol Violation|1
6918446|NCT00789477|10946193|FG004|Overall Study|Protocol Violation|0
6918447|NCT00789477|10946189|FG000|Overall Study|Adverse Event|3
6918448|NCT00789477|10946190|FG001|Overall Study|Adverse Event|3
6918449|NCT00789477|10946191|FG002|Overall Study|Adverse Event|1
6918450|NCT00789477|10946192|FG003|Overall Study|Adverse Event|0
6918451|NCT00789477|10946193|FG004|Overall Study|Adverse Event|0
6918452|NCT00789477|10946189|FG000|Overall Study|Death|1
6918453|NCT00789477|10946190|FG001|Overall Study|Death|1
6918454|NCT00789477|10946191|FG002|Overall Study|Death|2
6918455|NCT00789477|10946192|FG003|Overall Study|Death|2
6918456|NCT00789477|10946193|FG004|Overall Study|Death|0
6918457|NCT00789477|10946189|FG000|Overall Study|Lost to Follow-up|0
6918458|NCT00789477|10946190|FG001|Overall Study|Lost to Follow-up|1
6918459|NCT00789477|10946191|FG002|Overall Study|Lost to Follow-up|4
6918460|NCT00789477|10946192|FG003|Overall Study|Lost to Follow-up|2
6918461|NCT00789477|10946193|FG004|Overall Study|Lost to Follow-up|4
6918462|NCT00789477|10946189|FG000|Overall Study|Lack of Efficacy|2
6979153|NCT01217073|11032989|FG000|Base Period|Adverse Event|1
6979154|NCT01217073|11032990|FG001|Base Period|Adverse Event|0
6979155|NCT01217073|11032991|FG002|Base Period|Adverse Event|1
6979156|NCT01217073|11032992|FG003|Base Period|Adverse Event|0
6979157|NCT01217073|11032993|FG004|Base Period|Adverse Event|4
6979158|NCT01217073|11032994|FG005|Base Period|Adverse Event|1
6979159|NCT01217073|11032995|FG006|Base Period|Adverse Event|0
6979160|NCT01217073|11032996|FG007|Base Period|Adverse Event|0
6979161|NCT01217073|11032989|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1
6979162|NCT01217073|11032990|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0
6979163|NCT01217073|11032991|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0
6979164|NCT01217073|11032992|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0
6979165|NCT01217073|11032993|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0
6979166|NCT01217073|11032994|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0
6979167|NCT01217073|11032995|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0
6979168|NCT01217073|11032996|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0
6979169|NCT01217073|11032989|FG000|Base Period|Excluded medication|0
6979170|NCT01217073|11032990|FG001|Base Period|Excluded medication|0
6979171|NCT01217073|11032991|FG002|Base Period|Excluded medication|0
6979172|NCT01217073|11032992|FG003|Base Period|Excluded medication|0
6979173|NCT01217073|11032993|FG004|Base Period|Excluded medication|1
6979174|NCT01217073|11032994|FG005|Base Period|Excluded medication|0
6979175|NCT01217073|11032995|FG006|Base Period|Excluded medication|0
6979176|NCT01217073|11032996|FG007|Base Period|Excluded medication|0
6979177|NCT01217073|11032989|FG000|Base Period|Lack of Efficacy|0
6979178|NCT01217073|11032990|FG001|Base Period|Lack of Efficacy|0
6979179|NCT01217073|11032991|FG002|Base Period|Lack of Efficacy|0
6979180|NCT01217073|11032992|FG003|Base Period|Lack of Efficacy|0
6979181|NCT01217073|11032993|FG004|Base Period|Lack of Efficacy|0
6979182|NCT01217073|11032994|FG005|Base Period|Lack of Efficacy|1
6979183|NCT01217073|11032995|FG006|Base Period|Lack of Efficacy|0
6918463|NCT00789477|10946190|FG001|Overall Study|Lack of Efficacy|0
6979184|NCT01217073|11032996|FG007|Base Period|Lack of Efficacy|0
6979185|NCT01217073|11032989|FG000|Base Period|Lost to Follow-up|0
6979186|NCT01217073|11032990|FG001|Base Period|Lost to Follow-up|0
6979187|NCT01217073|11032991|FG002|Base Period|Lost to Follow-up|1
6979188|NCT01217073|11032992|FG003|Base Period|Lost to Follow-up|1
6979189|NCT01217073|11032993|FG004|Base Period|Lost to Follow-up|3
6979190|NCT01217073|11032994|FG005|Base Period|Lost to Follow-up|0
6979191|NCT01217073|11032995|FG006|Base Period|Lost to Follow-up|0
6918464|NCT00789477|10946191|FG002|Overall Study|Lack of Efficacy|0
6918465|NCT00789477|10946192|FG003|Overall Study|Lack of Efficacy|0
6918466|NCT00789477|10946193|FG004|Overall Study|Lack of Efficacy|0
6918467|NCT00789477|10946189|FG000|Overall Study|Other|2
6918468|NCT00789477|10946190|FG001|Overall Study|Other|0
6979192|NCT01217073|11032996|FG007|Base Period|Lost to Follow-up|0
6979193|NCT01217073|11032989|FG000|Base Period|Physician Decision|0
6979194|NCT01217073|11032990|FG001|Base Period|Physician Decision|0
6979195|NCT01217073|11032991|FG002|Base Period|Physician Decision|0
6979196|NCT01217073|11032992|FG003|Base Period|Physician Decision|0
6979197|NCT01217073|11032993|FG004|Base Period|Physician Decision|1
6918469|NCT00789477|10946191|FG002|Overall Study|Other|1
6918470|NCT00789477|10946192|FG003|Overall Study|Other|3
6918471|NCT00789477|10946193|FG004|Overall Study|Other|0
6918472|NCT00789529|10946209|FG000|Overall Study|Withdrawal by Subject|0
6918473|NCT00789529|10946210|FG001|Overall Study|Withdrawal by Subject|1
6918474|NCT00789529|10946209|FG000|Overall Study|Other Reason|1
6918475|NCT00789529|10946210|FG001|Overall Study|Other Reason|0
6918476|NCT00789555|10946219|FG000|Overall Study|Protocol Amendment|78
6918477|NCT00789555|10946220|FG001|Overall Study|Protocol Amendment|76
6918478|NCT00789555|10946221|FG002|Overall Study|Protocol Amendment|80
6918479|NCT00789555|10946219|FG000|Overall Study|Adverse Event|17
6918480|NCT00789555|10946220|FG001|Overall Study|Adverse Event|7
6918481|NCT00789555|10946221|FG002|Overall Study|Adverse Event|10
6918482|NCT00789555|10946219|FG000|Overall Study|Lost to Follow-up|9
6918483|NCT00789555|10946220|FG001|Overall Study|Lost to Follow-up|10
6918484|NCT00789555|10946221|FG002|Overall Study|Lost to Follow-up|18
6918485|NCT00789555|10946219|FG000|Overall Study|Patient decision unnrelated to adv event|38
6918486|NCT00789555|10946220|FG001|Overall Study|Patient decision unnrelated to adv event|29
6918487|NCT00789555|10946221|FG002|Overall Study|Patient decision unnrelated to adv event|26
6918488|NCT00789555|10946219|FG000|Overall Study|Treatment failure|11
6918489|NCT00789555|10946220|FG001|Overall Study|Treatment failure|8
6827055|NCT00121667|10829460|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
6827056|NCT00121667|10829457|FG000|Short Term (ST) + Long Term (LT) Period|Death|1
6827057|NCT00121667|10829458|FG001|Short Term (ST) + Long Term (LT) Period|Death|0
6897059|NCT00636441|10915725|FG000|Overall Study|Adverse Event|0
6918490|NCT00789555|10946221|FG002|Overall Study|Treatment failure|12
6918491|NCT00789555|10946219|FG000|Overall Study|Protocol Violation|6
6918492|NCT00789555|10946220|FG001|Overall Study|Protocol Violation|9
6918493|NCT00789555|10946221|FG002|Overall Study|Protocol Violation|13
6918494|NCT00789581|10946231|FG000|AC Therapy|Adverse Event|2
6918495|NCT00789581|10946232|FG001|AC Therapy|Adverse Event|3
6918496|NCT00789581|10946231|FG000|AC Therapy|Withdrawal by Subject|4
6918497|NCT00789581|10946232|FG001|AC Therapy|Withdrawal by Subject|7
6918498|NCT00789581|10946231|FG000|AC Therapy|Disease recurrence|3
6918499|NCT00789581|10946232|FG001|AC Therapy|Disease recurrence|1
6918500|NCT00789581|10946231|FG000|AC Therapy|Intercurrent Illness|1
6918501|NCT00789581|10946232|FG001|AC Therapy|Intercurrent Illness|0
6918502|NCT00789581|10946231|FG000|AC Therapy|Never Treated|1
6918503|NCT00789581|10946232|FG001|AC Therapy|Never Treated|4
6918504|NCT00789581|10946231|FG000|AC Therapy|Other|0
6918505|NCT00789581|10946232|FG001|AC Therapy|Other|2
6918506|NCT00789581|10946231|FG000|Adjuvant Therapy|Never treated|2
6918507|NCT00789581|10946232|FG001|Adjuvant Therapy|Never treated|2
6918508|NCT00789581|10946231|FG000|Adjuvant Therapy|Adverse Event|20
6918509|NCT00789581|10946232|FG001|Adjuvant Therapy|Adverse Event|44
6918510|NCT00789581|10946231|FG000|Adjuvant Therapy|Withdrawal by Subject|14
6918511|NCT00789581|10946232|FG001|Adjuvant Therapy|Withdrawal by Subject|5
6918512|NCT00789581|10946231|FG000|Adjuvant Therapy|Disease recurrence|2
6918513|NCT00789581|10946232|FG001|Adjuvant Therapy|Disease recurrence|1
6918514|NCT00789581|10946231|FG000|Adjuvant Therapy|Intercurrent Illness|1
6918515|NCT00789581|10946232|FG001|Adjuvant Therapy|Intercurrent Illness|3
6918516|NCT00789581|10946231|FG000|Adjuvant Therapy|Protocol Violation|1
6918517|NCT00789581|10946232|FG001|Adjuvant Therapy|Protocol Violation|1
6918518|NCT00789581|10946231|FG000|Adjuvant Therapy|Other|0
6918519|NCT00789581|10946232|FG001|Adjuvant Therapy|Other|1
6918520|NCT00789698|10946256|FG000|Overall Study|Lack of Efficacy|10
6918521|NCT00789698|10946257|FG001|Overall Study|Lack of Efficacy|4
6918522|NCT00789698|10946258|FG002|Overall Study|Lack of Efficacy|5
6918523|NCT00789698|10946259|FG003|Overall Study|Lack of Efficacy|18
6918524|NCT00789698|10946256|FG000|Overall Study|Adverse Event|5
6918525|NCT00789698|10946257|FG001|Overall Study|Adverse Event|5
6918526|NCT00789698|10946258|FG002|Overall Study|Adverse Event|3
6918527|NCT00789698|10946259|FG003|Overall Study|Adverse Event|4
6918528|NCT00789698|10946256|FG000|Overall Study|Lost to Follow-up|5
6918529|NCT00789698|10946257|FG001|Overall Study|Lost to Follow-up|5
6918530|NCT00789698|10946258|FG002|Overall Study|Lost to Follow-up|2
6918531|NCT00789698|10946259|FG003|Overall Study|Lost to Follow-up|9
6918532|NCT00789698|10946256|FG000|Overall Study|Protocol Violation|6
6918533|NCT00789698|10946257|FG001|Overall Study|Protocol Violation|1
6918534|NCT00789698|10946258|FG002|Overall Study|Protocol Violation|2
6918535|NCT00789698|10946259|FG003|Overall Study|Protocol Violation|1
6918536|NCT00789698|10946256|FG000|Overall Study|Withdrawal by Subject|14
6918537|NCT00789698|10946257|FG001|Overall Study|Withdrawal by Subject|15
6918538|NCT00789698|10946258|FG002|Overall Study|Withdrawal by Subject|12
6918539|NCT00789698|10946259|FG003|Overall Study|Withdrawal by Subject|19
6918540|NCT00789698|10946256|FG000|Overall Study|Administrative|0
6918541|NCT00789698|10946257|FG001|Overall Study|Administrative|3
6897060|NCT00636441|10915726|FG001|Overall Study|Adverse Event|1
6897061|NCT00636441|10915727|FG002|Overall Study|Adverse Event|1
6897062|NCT00636441|10915728|FG003|Overall Study|Adverse Event|0
6897063|NCT00636441|10915729|FG004|Overall Study|Adverse Event|0
6897064|NCT00636441|10915730|FG005|Overall Study|Adverse Event|1
6897065|NCT00636441|10915731|FG006|Overall Study|Adverse Event|0
6897066|NCT00636441|10915725|FG000|Overall Study|Late, ineligible|0
6897067|NCT00636441|10915726|FG001|Overall Study|Late, ineligible|0
6897068|NCT00636441|10915727|FG002|Overall Study|Late, ineligible|0
6918542|NCT00789698|10946258|FG002|Overall Study|Administrative|3
6918543|NCT00789698|10946259|FG003|Overall Study|Administrative|1
6918544|NCT00789737|10946279|FG000|Overall Study|Withdrawal by Subject|13
6918545|NCT00789737|10946280|FG001|Overall Study|Withdrawal by Subject|22
6918546|NCT00789737|10946279|FG000|Overall Study|Lost to Follow-up|10
6918547|NCT00789737|10946280|FG001|Overall Study|Lost to Follow-up|14
6918548|NCT00789737|10946279|FG000|Overall Study|Adverse Event|8
6918549|NCT00789737|10946280|FG001|Overall Study|Adverse Event|8
6918550|NCT00789737|10946279|FG000|Overall Study|Protocol Violation|3
6918551|NCT00789737|10946280|FG001|Overall Study|Protocol Violation|0
6918552|NCT00789737|10946279|FG000|Overall Study|Lack of Efficacy|3
6918553|NCT00789737|10946280|FG001|Overall Study|Lack of Efficacy|0
6918554|NCT00789737|10946279|FG000|Overall Study|hyperglycemia that met protocol-specifie|0
6918555|NCT00789737|10946280|FG001|Overall Study|hyperglycemia that met protocol-specifie|4
6918556|NCT00789737|10946279|FG000|Overall Study|Other|11
6918557|NCT00789737|10946280|FG001|Overall Study|Other|7
6918558|NCT00789815|10946322|FG000|Overall Study|Protocol Violation|6
6918559|NCT00789815|10946323|FG001|Overall Study|Protocol Violation|1
6918560|NCT00789815|10946322|FG000|Overall Study|Intubation due to massive bleeding|1
6918561|NCT00789815|10946323|FG001|Overall Study|Intubation due to massive bleeding|0
6918562|NCT00789828|10946331|FG000|Core Period (48 Weeks)|Administrative problems|0
6918563|NCT00789828|10946332|FG001|Core Period (48 Weeks)|Administrative problems|1
6918564|NCT00789828|10946331|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0
6918565|NCT00789828|10946332|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4
6918566|NCT00789828|10946331|FG000|Core Period (48 Weeks)|Lost to Follow-up|0
6918567|NCT00789828|10946332|FG001|Core Period (48 Weeks)|Lost to Follow-up|1
6918568|NCT00789828|10946331|FG000|Open-label Extension Period (4 Years)|Adverse Event|10
6918569|NCT00789828|10946332|FG001|Open-label Extension Period (4 Years)|Adverse Event|0
6918570|NCT00789828|10946331|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6
6918571|NCT00789828|10946332|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0
6918572|NCT00789828|10946331|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3
6918573|NCT00789828|10946332|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0
6918574|NCT00789828|10946331|FG000|Open-label Extension Period (4 Years)|Administrative problems|7
6918575|NCT00789828|10946332|FG001|Open-label Extension Period (4 Years)|Administrative problems|0
6918576|NCT00789828|10946331|FG000|Open-label Extension Period (4 Years)|Death|1
6918577|NCT00789828|10946332|FG001|Open-label Extension Period (4 Years)|Death|0
6918578|NCT00789828|10946331|FG000|Open-label Extension Period (4 Years)|Disease progression|1
6918579|NCT00789828|10946332|FG001|Open-label Extension Period (4 Years)|Disease progression|0
6918580|NCT00789828|10946331|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1
6918581|NCT00789828|10946332|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0
6918582|NCT00789854|10946344|FG000|Overall Study|Adverse Event|28
6918583|NCT00789854|10946345|FG001|Overall Study|Adverse Event|23
6918584|NCT00789854|10946346|FG002|Overall Study|Adverse Event|18
6918585|NCT00789854|10946344|FG000|Overall Study|Lost to Follow-up|1
6918586|NCT00789854|10946345|FG001|Overall Study|Lost to Follow-up|1
6918587|NCT00789854|10946346|FG002|Overall Study|Lost to Follow-up|4
6918588|NCT00789854|10946344|FG000|Overall Study|Withdrawal by Subject|9
6918589|NCT00789854|10946345|FG001|Overall Study|Withdrawal by Subject|6
6918590|NCT00789854|10946346|FG002|Overall Study|Withdrawal by Subject|17
6918591|NCT00789854|10946344|FG000|Overall Study|Eligibility criteria not fulfilled|2
6918592|NCT00789854|10946345|FG001|Overall Study|Eligibility criteria not fulfilled|5
6918593|NCT00789854|10946346|FG002|Overall Study|Eligibility criteria not fulfilled|1
6918594|NCT00789854|10946344|FG000|Overall Study|Severe non-compliance to the protocol|3
6918595|NCT00789854|10946345|FG001|Overall Study|Severe non-compliance to the protocol|0
6918596|NCT00789854|10946346|FG002|Overall Study|Severe non-compliance to the protocol|0
6918597|NCT00789854|10946344|FG000|Overall Study|Safety reasons|0
6918598|NCT00789854|10946345|FG001|Overall Study|Safety reasons|0
6918599|NCT00789854|10946346|FG002|Overall Study|Safety reasons|2
6918600|NCT00789854|10946344|FG000|Overall Study|Other|6
6918601|NCT00789854|10946345|FG001|Overall Study|Other|0
6918602|NCT00789854|10946346|FG002|Overall Study|Other|5
6918603|NCT00789880|10946374|FG000|Overall Study|Adverse Event|0
6918604|NCT00789880|10946375|FG001|Overall Study|Adverse Event|0
6918605|NCT00789880|10946376|FG002|Overall Study|Adverse Event|0
6918606|NCT00789880|10946377|FG003|Overall Study|Adverse Event|0
6918607|NCT00789880|10946378|FG004|Overall Study|Adverse Event|1
6918608|NCT00789880|10946379|FG005|Overall Study|Adverse Event|0
6918609|NCT00789880|10946374|FG000|Overall Study|Protocol Violation|0
6918610|NCT00789880|10946375|FG001|Overall Study|Protocol Violation|1
6918611|NCT00789880|10946376|FG002|Overall Study|Protocol Violation|0
6918612|NCT00789880|10946377|FG003|Overall Study|Protocol Violation|1
6918613|NCT00789880|10946378|FG004|Overall Study|Protocol Violation|0
6918614|NCT00789880|10946379|FG005|Overall Study|Protocol Violation|0
6918615|NCT00789880|10946374|FG000|Overall Study|Withdrawal by Subject|1
6918616|NCT00789880|10946375|FG001|Overall Study|Withdrawal by Subject|0
6918617|NCT00789880|10946376|FG002|Overall Study|Withdrawal by Subject|0
6918618|NCT00789880|10946377|FG003|Overall Study|Withdrawal by Subject|0
6918619|NCT00789880|10946378|FG004|Overall Study|Withdrawal by Subject|2
6918620|NCT00789880|10946379|FG005|Overall Study|Withdrawal by Subject|0
6918621|NCT00789958|10946393|FG000|Overall Study|Adverse Event|3
6918622|NCT00789958|10946393|FG000|Overall Study|Withdrawal by Subject|4
6918623|NCT00789958|10946393|FG000|Overall Study|Progression|3
6918624|NCT00789958|10946393|FG000|Overall Study|not protocol specified|1
6918625|NCT00789958|10946393|FG000|Overall Study|Not eligible/not analyzable|26
6918626|NCT00790023|10946411|FG000|Overall Study|Adverse Event|2
6918627|NCT00790023|10946412|FG001|Overall Study|Adverse Event|1
6918628|NCT00790023|10946413|FG002|Overall Study|Adverse Event|4
6918629|NCT00790023|10946411|FG000|Overall Study|Protocol Violation|2
6918630|NCT00790023|10946412|FG001|Overall Study|Protocol Violation|4
6918631|NCT00790023|10946413|FG002|Overall Study|Protocol Violation|2
6918632|NCT00790023|10946411|FG000|Overall Study|Withdrawal by Subject|2
6918633|NCT00790023|10946412|FG001|Overall Study|Withdrawal by Subject|0
6918634|NCT00790023|10946413|FG002|Overall Study|Withdrawal by Subject|6
6918635|NCT00790023|10946411|FG000|Overall Study|Lost to Follow-up|0
6918636|NCT00790023|10946412|FG001|Overall Study|Lost to Follow-up|0
6918637|NCT00790023|10946413|FG002|Overall Study|Lost to Follow-up|1
6918638|NCT00790023|10946411|FG000|Overall Study|Other|5
6918639|NCT00790023|10946412|FG001|Overall Study|Other|5
6918640|NCT00790023|10946413|FG002|Overall Study|Other|8
6918641|NCT00790036|10946424|FG000|Overall Study|Abnormal lab values|3
6918642|NCT00790036|10946425|FG001|Overall Study|Abnormal lab values|2
6918643|NCT00790036|10946424|FG000|Overall Study|Administrative problems|5
6918644|NCT00790036|10946425|FG001|Overall Study|Administrative problems|9
6918645|NCT00790036|10946424|FG000|Overall Study|Adverse Event|113
6918646|NCT00790036|10946425|FG001|Overall Study|Adverse Event|44
6918647|NCT00790036|10946424|FG000|Overall Study|Death|1
6918648|NCT00790036|10946425|FG001|Overall Study|Death|0
6918649|NCT00790036|10946424|FG000|Overall Study|Disease progression|24
6918650|NCT00790036|10946425|FG001|Overall Study|Disease progression|48
6918651|NCT00790036|10946424|FG000|Overall Study|Lost to Follow-up|1
6918652|NCT00790036|10946425|FG001|Overall Study|Lost to Follow-up|2
6918653|NCT00790036|10946424|FG000|Overall Study|Protocol Violation|10
6918654|NCT00790036|10946425|FG001|Overall Study|Protocol Violation|2
6918655|NCT00790036|10946424|FG000|Overall Study|Withdrawal by Subject|18
6918656|NCT00790036|10946425|FG001|Overall Study|Withdrawal by Subject|7
6918657|NCT00790036|10946424|FG000|Overall Study|Subject/guardian decision|20
6918658|NCT00790036|10946425|FG001|Overall Study|Subject/guardian decision|7
6918659|NCT00790088|10946454|FG000|Overall Study|Protocol Violation|11
6918660|NCT00790088|10946454|FG000|Overall Study|Withdrawal by Subject|17
6918661|NCT00790088|10946454|FG000|Overall Study|Lost to Follow-up|7
6918662|NCT00790088|10946454|FG000|Overall Study|Physician Decision|4
6918663|NCT00790205|10946479|FG000|Overall Study|Lost to Follow-up|61
6918664|NCT00790205|10946480|FG001|Overall Study|Lost to Follow-up|71
6918665|NCT00790205|10946479|FG000|Overall Study|Withdrawal by Subject|299
6918666|NCT00790205|10946480|FG001|Overall Study|Withdrawal by Subject|363
6918667|NCT00790296|10946501|FG000|Overall Study|Did not meet study eligibility criteria|1
6918668|NCT00790296|10946502|FG001|Overall Study|Did not meet study eligibility criteria|1
6918669|NCT00790296|10946501|FG000|Overall Study|Adverse Event|0
6918670|NCT00790296|10946502|FG001|Overall Study|Adverse Event|1
6974477|NCT01187407|11026374|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
6974478|NCT01187407|11026375|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
6974479|NCT01187407|11026376|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
6974480|NCT01187407|11026377|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
6974481|NCT01187407|11026373|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
6974482|NCT01187407|11026374|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6
6974483|NCT01187407|11026375|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
6974484|NCT01187407|11026376|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3
6974485|NCT01187407|11026377|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10
6974486|NCT01187407|11026373|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
6974487|NCT01187407|11026374|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
6974488|NCT01187407|11026375|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
6974489|NCT01187407|11026376|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11
6974490|NCT01187407|11026377|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22
6974491|NCT01187407|11026373|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
6974492|NCT01187407|11026374|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
6974493|NCT01187407|11026375|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
6974494|NCT01187407|11026376|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
6974495|NCT01187407|11026377|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
6974496|NCT01187446|11026396|FG000|Overall Study|Patient started non-protocol therapy|0
6974497|NCT01187446|11026397|FG001|Overall Study|Patient started non-protocol therapy|1
6974498|NCT01187550|11026423|FG000|Overall Study|Protocol Violation|3
6974499|NCT01187550|11026424|FG001|Overall Study|Protocol Violation|1
6974500|NCT01187550|11026423|FG000|Overall Study|Other|3
6974501|NCT01187550|11026424|FG001|Overall Study|Other|0
6974502|NCT01187550|11026423|FG000|Overall Study|Randomized but not treated|8
6974503|NCT01187550|11026424|FG001|Overall Study|Randomized but not treated|0
6974504|NCT01187901|11026443|FG000|Overall Study|Protocol Violation|1
6974505|NCT01187901|11026444|FG001|Overall Study|Protocol Violation|0
6974506|NCT01187901|11026443|FG000|Overall Study|Lost to Follow-up|1
6918671|NCT00790400|10946519|FG000|Double-blind Period (Core Phase)|Protocol Violation|1
6918672|NCT00790400|10946520|FG001|Double-blind Period (Core Phase)|Protocol Violation|0
6918673|NCT00790400|10946519|FG000|Double-blind Period (Core Phase)|Progressive disease|0
6918674|NCT00790400|10946520|FG001|Double-blind Period (Core Phase)|Progressive disease|9
6918675|NCT00790400|10946519|FG000|Double-blind Period (Core Phase)|Adverse Event|2
6918676|NCT00790400|10946520|FG001|Double-blind Period (Core Phase)|Adverse Event|4
6918677|NCT00790400|10946519|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1
6918678|NCT00790400|10946520|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0
6918679|NCT00790400|10946519|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1
6918680|NCT00790400|10946520|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0
6918681|NCT00790400|10946519|FG000|Double-blind Period (Core Phase)|Administrative problems|1
6918682|NCT00790400|10946520|FG001|Double-blind Period (Core Phase)|Administrative problems|0
6918683|NCT00790400|10946519|FG000|Double-blind Period (Core Phase)|Death|1
6918684|NCT00790400|10946520|FG001|Double-blind Period (Core Phase)|Death|0
6918685|NCT00790400|10946519|FG000|Everolimus Period (Core or Extension)|Adverse Event|9
6918686|NCT00790400|10946520|FG001|Everolimus Period (Core or Extension)|Adverse Event|0
6918687|NCT00790400|10946519|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1
6918688|NCT00790400|10946520|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0
6918689|NCT00790400|10946519|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7
6918690|NCT00790400|10946520|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0
6918691|NCT00790400|10946519|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1
6918692|NCT00790400|10946520|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0
6918693|NCT00790400|10946519|FG000|Everolimus Period (Core or Extension)|Administrative problems|2
6918694|NCT00790400|10946520|FG001|Everolimus Period (Core or Extension)|Administrative problems|0
6918695|NCT00790400|10946519|FG000|Everolimus Period (Core or Extension)|Death|1
6918696|NCT00790400|10946520|FG001|Everolimus Period (Core or Extension)|Death|0
6918697|NCT00790400|10946519|FG000|Everolimus Period (Core or Extension)|Disease progression|5
6918698|NCT00790400|10946520|FG001|Everolimus Period (Core or Extension)|Disease progression|0
6918699|NCT00790400|10946519|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1
6918700|NCT00790400|10946520|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0
6918701|NCT00790400|10946519|FG000|Everolimus Period (Core or Extension)|New treatment|2
6918702|NCT00790400|10946520|FG001|Everolimus Period (Core or Extension)|New treatment|0
6918703|NCT00790556|10946529|FG000|Treatment Period 1|Physician Decision|1
6918704|NCT00790556|10946530|FG001|Treatment Period 1|Physician Decision|0
6918705|NCT00790556|10946529|FG000|Treatment Period 1|Withdrawal by Subject|1
6918706|NCT00790556|10946530|FG001|Treatment Period 1|Withdrawal by Subject|0
6918707|NCT00790569|10946539|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20
6918708|NCT00790569|10946540|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8
6918709|NCT00790569|10946541|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20
6918710|NCT00790569|10946539|FG000|End of Treatment (6 Month Interview)|Death|0
6918711|NCT00790569|10946540|FG001|End of Treatment (6 Month Interview)|Death|2
6918712|NCT00790569|10946541|FG002|End of Treatment (6 Month Interview)|Death|1
6918713|NCT00790569|10946539|FG000|End of Treatment (6 Month Interview)|Hospitalized|2
6918714|NCT00790569|10946540|FG001|End of Treatment (6 Month Interview)|Hospitalized|0
6918715|NCT00790569|10946541|FG002|End of Treatment (6 Month Interview)|Hospitalized|0
6918716|NCT00790569|10946539|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0
6918717|NCT00790569|10946540|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0
6918718|NCT00790569|10946541|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2
6918719|NCT00790569|10946539|FG000|End of Treatment (6 Month Interview)|Incarcerated|0
6918720|NCT00790569|10946540|FG001|End of Treatment (6 Month Interview)|Incarcerated|0
6918721|NCT00790569|10946541|FG002|End of Treatment (6 Month Interview)|Incarcerated|3
6918722|NCT00790569|10946539|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66
6918723|NCT00790569|10946540|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19
6918724|NCT00790569|10946541|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50
6918725|NCT00790582|10946551|FG000|Overall Study|Death|14
6918726|NCT00790582|10946552|FG001|Overall Study|Death|32
6918727|NCT00790582|10946551|FG000|Overall Study|Physician Decision|7
6918728|NCT00790582|10946552|FG001|Overall Study|Physician Decision|1
6918729|NCT00790582|10946551|FG000|Overall Study|Lost to Follow-up|3
6918730|NCT00790582|10946552|FG001|Overall Study|Lost to Follow-up|3
6918731|NCT00790582|10946551|FG000|Overall Study|Withdrawal by Subject|7
6918732|NCT00790582|10946552|FG001|Overall Study|Withdrawal by Subject|51
6918733|NCT00790647|10946560|FG000|Overall Study|Adverse Event|1
6918734|NCT00790751|10946607|FG000|Overall Study|Protocol non-compliance|16
6918735|NCT00790751|10946608|FG001|Overall Study|Protocol non-compliance|16
6918736|NCT00790751|10946609|FG002|Overall Study|Protocol non-compliance|10
6918737|NCT00790751|10946610|FG003|Overall Study|Protocol non-compliance|11
6918738|NCT00790751|10946607|FG000|Overall Study|Lost to Follow-up|4
6918739|NCT00790751|10946608|FG001|Overall Study|Lost to Follow-up|9
6918740|NCT00790751|10946609|FG002|Overall Study|Lost to Follow-up|4
6918741|NCT00790751|10946610|FG003|Overall Study|Lost to Follow-up|5
6918742|NCT00790751|10946607|FG000|Overall Study|Adverse Event|5
6918743|NCT00790751|10946608|FG001|Overall Study|Adverse Event|3
6918744|NCT00790751|10946609|FG002|Overall Study|Adverse Event|5
6918745|NCT00790751|10946610|FG003|Overall Study|Adverse Event|4
6918746|NCT00790751|10946607|FG000|Overall Study|Requirement for restricted medication|0
6918747|NCT00790751|10946608|FG001|Overall Study|Requirement for restricted medication|2
6918748|NCT00790751|10946609|FG002|Overall Study|Requirement for restricted medication|0
6918749|NCT00790751|10946610|FG003|Overall Study|Requirement for restricted medication|0
6918750|NCT00790751|10946607|FG000|Overall Study|Death|0
6918751|NCT00790751|10946608|FG001|Overall Study|Death|0
6918752|NCT00790751|10946609|FG002|Overall Study|Death|1
6918753|NCT00790751|10946610|FG003|Overall Study|Death|0
6918754|NCT00790751|10946607|FG000|Overall Study|Physician Decision|0
6918755|NCT00790751|10946608|FG001|Overall Study|Physician Decision|0
6918756|NCT00790751|10946609|FG002|Overall Study|Physician Decision|0
6918757|NCT00790751|10946610|FG003|Overall Study|Physician Decision|1
6974507|NCT01187901|11026444|FG001|Overall Study|Lost to Follow-up|2
6974508|NCT01187901|11026443|FG000|Overall Study|Unrelated Health Reasons|1
6974509|NCT01187901|11026444|FG001|Overall Study|Unrelated Health Reasons|2
6974510|NCT01187901|11026443|FG000|Overall Study|Suspected Allergic Reaction|1
6974511|NCT01187901|11026444|FG001|Overall Study|Suspected Allergic Reaction|1
6974512|NCT01187901|11026443|FG000|Overall Study|Adverse Event|3
6974513|NCT01187901|11026444|FG001|Overall Study|Adverse Event|0
6974514|NCT01187901|11026443|FG000|Overall Study|No Endpoint due to Early Study Halt|2
6974515|NCT01187901|11026444|FG001|Overall Study|No Endpoint due to Early Study Halt|3
6974516|NCT01187901|11026443|FG000|Overall Study|Pregnancy|0
6974517|NCT01187901|11026444|FG001|Overall Study|Pregnancy|2
6977144|NCT01205126|11030145|FG000|Maintenance Phase|Withdrawal by Subject|8
6977145|NCT01205126|11030146|FG001|Maintenance Phase|Withdrawal by Subject|11
6977146|NCT01205152|11030152|FG000|Overall Study|Death|1
6977147|NCT01205165|11030158|FG000|Overall Study|Lost to Follow-up|2
6977148|NCT01205230|11030165|FG000|Overall Study|Adverse Event|4
6977149|NCT01205230|11030166|FG001|Overall Study|Adverse Event|0
6977150|NCT01205230|11030165|FG000|Overall Study|Physician Decision|1
6977151|NCT01205230|11030166|FG001|Overall Study|Physician Decision|0
6977152|NCT01205269|11030177|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0
6977153|NCT01205269|11030178|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0
6977154|NCT01205269|11030179|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0
6977155|NCT01205269|11030180|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1
6977156|NCT01205269|11030181|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0
6977157|NCT01205269|11030182|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0
6977158|NCT01205438|11030197|FG000|Overall Study|Adverse Event|19
6977159|NCT01205438|11030198|FG001|Overall Study|Adverse Event|17
6977160|NCT01205438|11030199|FG002|Overall Study|Adverse Event|24
6977161|NCT01205438|11030197|FG000|Overall Study|Death|1
6977162|NCT01205438|11030198|FG001|Overall Study|Death|1
6977163|NCT01205438|11030199|FG002|Overall Study|Death|3
6977164|NCT01205438|11030197|FG000|Overall Study|Entry Criteria Not Met|16
6977165|NCT01205438|11030198|FG001|Overall Study|Entry Criteria Not Met|15
6977166|NCT01205438|11030199|FG002|Overall Study|Entry Criteria Not Met|13
6977167|NCT01205438|11030197|FG000|Overall Study|Lack of Efficacy|14
6977168|NCT01205438|11030198|FG001|Overall Study|Lack of Efficacy|11
6977169|NCT01205438|11030199|FG002|Overall Study|Lack of Efficacy|14
6977170|NCT01205438|11030197|FG000|Overall Study|Lost to Follow-up|6
6977171|NCT01205438|11030198|FG001|Overall Study|Lost to Follow-up|7
6977172|NCT01205438|11030199|FG002|Overall Study|Lost to Follow-up|8
6977173|NCT01205438|11030197|FG000|Overall Study|Withdrawal by Subject|19
6977174|NCT01205438|11030198|FG001|Overall Study|Withdrawal by Subject|25
6977175|NCT01205438|11030199|FG002|Overall Study|Withdrawal by Subject|19
6977176|NCT01205438|11030197|FG000|Overall Study|Physician Decision|0
6977177|NCT01205438|11030198|FG001|Overall Study|Physician Decision|3
6977178|NCT01205438|11030199|FG002|Overall Study|Physician Decision|2
6977179|NCT01205438|11030197|FG000|Overall Study|Protocol Violation|2
6977180|NCT01205438|11030198|FG001|Overall Study|Protocol Violation|7
6977181|NCT01205438|11030199|FG002|Overall Study|Protocol Violation|4
6977182|NCT01205438|11030197|FG000|Overall Study|Sponsor Decision|0
6977183|NCT01205438|11030198|FG001|Overall Study|Sponsor Decision|1
6977184|NCT01205438|11030199|FG002|Overall Study|Sponsor Decision|1
6977185|NCT01205451|11030212|FG000|Overall Study|Lost to Follow-up|1
6977186|NCT01205451|11030213|FG001|Overall Study|Lost to Follow-up|1
6977187|NCT01205451|11030212|FG000|Overall Study|Withdrawal by Subject|5
6977188|NCT01205451|11030213|FG001|Overall Study|Withdrawal by Subject|9
6977189|NCT01205529|11030228|FG000|Overall Study|Procedure Cancelled|4
6977190|NCT01205529|11030228|FG000|Overall Study|Withdrawal by Subject|2
6977191|NCT01205529|11030228|FG000|Overall Study|Physician Decision|4
6977192|NCT01205529|11030228|FG000|Overall Study|Unstable post op|15
6977193|NCT01205529|11030228|FG000|Overall Study|No longer met criteria|30
6977194|NCT01205581|11030243|FG000|Overall Study|Withdrawal by Subject|1
6977195|NCT01205581|11030244|FG001|Overall Study|Withdrawal by Subject|0
6977196|NCT01205581|11030245|FG002|Overall Study|Withdrawal by Subject|0
6977197|NCT01205581|11030246|FG003|Overall Study|Withdrawal by Subject|0
6977198|NCT01205581|11030247|FG004|Overall Study|Withdrawal by Subject|0
6977199|NCT01205581|11030248|FG005|Overall Study|Withdrawal by Subject|0
6977200|NCT01205685|11030283|FG000|Overall Study|Disease Progression|10
6977201|NCT01205685|11030283|FG000|Overall Study|Withdrawal by Subject|1
6977202|NCT01205776|11030289|FG000|Overall Study|Lost to Follow-up|53
6977203|NCT01205776|11030290|FG001|Overall Study|Lost to Follow-up|61
6918758|NCT00790790|10946623|FG000|Study Period 2: Therapy Phase|Adverse Event|3
6918759|NCT00790790|10946624|FG001|Study Period 2: Therapy Phase|Adverse Event|16
6918760|NCT00790790|10946625|FG002|Study Period 2: Therapy Phase|Adverse Event|16
6918761|NCT00790790|10946623|FG000|Study Period 2: Therapy Phase|Protocol Violation|1
6918762|NCT00790790|10946624|FG001|Study Period 2: Therapy Phase|Protocol Violation|1
6918763|NCT00790790|10946625|FG002|Study Period 2: Therapy Phase|Protocol Violation|0
6918764|NCT00790790|10946623|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7
6918765|NCT00790790|10946624|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0
6918766|NCT00790790|10946625|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2
6918767|NCT00790790|10946623|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1
6918768|NCT00790790|10946624|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0
6918769|NCT00790790|10946625|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3
6918770|NCT00790790|10946623|FG000|Study Period 2: Therapy Phase|Physician Decision|0
6918771|NCT00790790|10946624|FG001|Study Period 2: Therapy Phase|Physician Decision|1
6918772|NCT00790790|10946625|FG002|Study Period 2: Therapy Phase|Physician Decision|0
6918773|NCT00790842|10946641|FG000|Dose Level 1|Adverse Event|1
6918774|NCT00790842|10946642|FG001|Dose Level 1|Adverse Event|0
6918775|NCT00790842|10946643|FG002|Dose Level 1|Adverse Event|0
6918776|NCT00790842|10946644|FG003|Dose Level 1|Adverse Event|2
6918777|NCT00790842|10946645|FG004|Dose Level 1|Adverse Event|0
6918778|NCT00790842|10946646|FG005|Dose Level 1|Adverse Event|0
6918779|NCT00790842|10946647|FG006|Dose Level 1|Adverse Event|0
6918780|NCT00790842|10946648|FG007|Dose Level 1|Adverse Event|1
6918781|NCT00790842|10946649|FG008|Dose Level 1|Adverse Event|0
6918782|NCT00790842|10946650|FG009|Dose Level 1|Adverse Event|0
6918783|NCT00790842|10946651|FG010|Dose Level 1|Adverse Event|0
6918784|NCT00790842|10946641|FG000|Dose Level 1|Physician Decision|1
6918785|NCT00790842|10946642|FG001|Dose Level 1|Physician Decision|0
6918786|NCT00790842|10946643|FG002|Dose Level 1|Physician Decision|0
6918787|NCT00790842|10946644|FG003|Dose Level 1|Physician Decision|0
6918788|NCT00790842|10946645|FG004|Dose Level 1|Physician Decision|0
6918789|NCT00790842|10946646|FG005|Dose Level 1|Physician Decision|0
6918790|NCT00790842|10946647|FG006|Dose Level 1|Physician Decision|0
6918791|NCT00790842|10946648|FG007|Dose Level 1|Physician Decision|1
6918792|NCT00790842|10946649|FG008|Dose Level 1|Physician Decision|0
6918793|NCT00790842|10946650|FG009|Dose Level 1|Physician Decision|0
6918794|NCT00790842|10946651|FG010|Dose Level 1|Physician Decision|0
6918795|NCT00790842|10946641|FG000|Dose Level 1|Withdrawal by Subject|1
6918796|NCT00790842|10946642|FG001|Dose Level 1|Withdrawal by Subject|0
6918797|NCT00790842|10946643|FG002|Dose Level 1|Withdrawal by Subject|0
6918798|NCT00790842|10946644|FG003|Dose Level 1|Withdrawal by Subject|0
6918799|NCT00790842|10946645|FG004|Dose Level 1|Withdrawal by Subject|0
6918800|NCT00790842|10946646|FG005|Dose Level 1|Withdrawal by Subject|0
6918801|NCT00790842|10946647|FG006|Dose Level 1|Withdrawal by Subject|0
6918802|NCT00790842|10946648|FG007|Dose Level 1|Withdrawal by Subject|0
6918803|NCT00790842|10946649|FG008|Dose Level 1|Withdrawal by Subject|0
6918804|NCT00790842|10946650|FG009|Dose Level 1|Withdrawal by Subject|0
6918805|NCT00790842|10946651|FG010|Dose Level 1|Withdrawal by Subject|0
6918806|NCT00790842|10946641|FG000|Dose Level 2|Death|0
6918807|NCT00790842|10946642|FG001|Dose Level 2|Death|1
6918808|NCT00790842|10946643|FG002|Dose Level 2|Death|0
6918809|NCT00790842|10946644|FG003|Dose Level 2|Death|0
6918810|NCT00790842|10946645|FG004|Dose Level 2|Death|1
6918811|NCT00790842|10946646|FG005|Dose Level 2|Death|0
6918812|NCT00790842|10946647|FG006|Dose Level 2|Death|0
6918813|NCT00790842|10946648|FG007|Dose Level 2|Death|0
6918814|NCT00790842|10946649|FG008|Dose Level 2|Death|0
6918815|NCT00790842|10946650|FG009|Dose Level 2|Death|0
6918816|NCT00790842|10946651|FG010|Dose Level 2|Death|0
6918817|NCT00790842|10946641|FG000|Dose Level 2|Physician Decision|0
6918818|NCT00790842|10946642|FG001|Dose Level 2|Physician Decision|1
6918819|NCT00790842|10946643|FG002|Dose Level 2|Physician Decision|0
6918820|NCT00790842|10946644|FG003|Dose Level 2|Physician Decision|0
6918821|NCT00790842|10946645|FG004|Dose Level 2|Physician Decision|0
6918822|NCT00790842|10946646|FG005|Dose Level 2|Physician Decision|0
6918823|NCT00790842|10946647|FG006|Dose Level 2|Physician Decision|0
6918824|NCT00790842|10946648|FG007|Dose Level 2|Physician Decision|0
6918825|NCT00790842|10946649|FG008|Dose Level 2|Physician Decision|0
6918826|NCT00790842|10946650|FG009|Dose Level 2|Physician Decision|0
6918827|NCT00790842|10946651|FG010|Dose Level 2|Physician Decision|0
6918828|NCT00790842|10946641|FG000|Dose Level 2|Withdrawal by Subject|0
6918829|NCT00790842|10946642|FG001|Dose Level 2|Withdrawal by Subject|1
6918830|NCT00790842|10946643|FG002|Dose Level 2|Withdrawal by Subject|0
6918831|NCT00790842|10946644|FG003|Dose Level 2|Withdrawal by Subject|0
6918832|NCT00790842|10946645|FG004|Dose Level 2|Withdrawal by Subject|0
6918833|NCT00790842|10946646|FG005|Dose Level 2|Withdrawal by Subject|0
6918834|NCT00790842|10946647|FG006|Dose Level 2|Withdrawal by Subject|0
6918835|NCT00790842|10946648|FG007|Dose Level 2|Withdrawal by Subject|0
6918836|NCT00790842|10946649|FG008|Dose Level 2|Withdrawal by Subject|0
6918837|NCT00790842|10946650|FG009|Dose Level 2|Withdrawal by Subject|0
6918838|NCT00790842|10946651|FG010|Dose Level 2|Withdrawal by Subject|0
6918839|NCT00790842|10946641|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0
6918840|NCT00790842|10946642|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0
6918841|NCT00790842|10946643|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0
6918842|NCT00790842|10946644|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0
6918843|NCT00790842|10946645|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0
6918844|NCT00790842|10946646|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0
6918845|NCT00790842|10946647|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0
6918846|NCT00790842|10946648|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0
6918847|NCT00790842|10946649|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2
6918848|NCT00790842|10946650|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0
6918849|NCT00790842|10946651|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0
6918850|NCT00790842|10946641|FG000|Dose Level 3|Adverse Event|0
6918851|NCT00790842|10946642|FG001|Dose Level 3|Adverse Event|0
6918852|NCT00790842|10946643|FG002|Dose Level 3|Adverse Event|1
6918853|NCT00790842|10946644|FG003|Dose Level 3|Adverse Event|0
6918854|NCT00790842|10946645|FG004|Dose Level 3|Adverse Event|0
6918855|NCT00790842|10946646|FG005|Dose Level 3|Adverse Event|0
6918856|NCT00790842|10946647|FG006|Dose Level 3|Adverse Event|0
6918857|NCT00790842|10946648|FG007|Dose Level 3|Adverse Event|0
6918858|NCT00790842|10946649|FG008|Dose Level 3|Adverse Event|0
6918859|NCT00790842|10946650|FG009|Dose Level 3|Adverse Event|0
6918860|NCT00790842|10946651|FG010|Dose Level 3|Adverse Event|0
6918861|NCT00790842|10946641|FG000|Dose Level 3|Withdrawal by Subject|0
6918862|NCT00790842|10946642|FG001|Dose Level 3|Withdrawal by Subject|0
6918863|NCT00790842|10946643|FG002|Dose Level 3|Withdrawal by Subject|3
6918864|NCT00790842|10946644|FG003|Dose Level 3|Withdrawal by Subject|0
6918865|NCT00790842|10946645|FG004|Dose Level 3|Withdrawal by Subject|0
6918866|NCT00790842|10946646|FG005|Dose Level 3|Withdrawal by Subject|0
6918867|NCT00790842|10946647|FG006|Dose Level 3|Withdrawal by Subject|0
6918868|NCT00790842|10946648|FG007|Dose Level 3|Withdrawal by Subject|0
6918869|NCT00790842|10946649|FG008|Dose Level 3|Withdrawal by Subject|0
6918870|NCT00790842|10946650|FG009|Dose Level 3|Withdrawal by Subject|2
6918871|NCT00790842|10946651|FG010|Dose Level 3|Withdrawal by Subject|0
6918872|NCT00790842|10946641|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
6918873|NCT00790842|10946642|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
6918874|NCT00790842|10946643|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
6918875|NCT00790842|10946644|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
6918876|NCT00790842|10946645|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
6918877|NCT00790842|10946646|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1
6918878|NCT00790842|10946647|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
6918879|NCT00790842|10946648|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
6918880|NCT00790842|10946649|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
6918881|NCT00790842|10946650|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
6918882|NCT00790842|10946651|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
6918883|NCT00790842|10946641|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0
6918884|NCT00790842|10946642|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0
6918885|NCT00790842|10946643|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1
6918886|NCT00790842|10946644|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0
6918887|NCT00790842|10946645|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0
6918888|NCT00790842|10946646|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0
6918889|NCT00790842|10946647|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0
6918890|NCT00790842|10946648|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0
6918891|NCT00790842|10946649|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0
6918892|NCT00790842|10946650|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0
6918893|NCT00790842|10946651|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0
6918894|NCT00790842|10946641|FG000|Dose Level 4|Adverse Event|0
6918895|NCT00790842|10946642|FG001|Dose Level 4|Adverse Event|0
6918896|NCT00790842|10946643|FG002|Dose Level 4|Adverse Event|0
6918897|NCT00790842|10946644|FG003|Dose Level 4|Adverse Event|0
6918898|NCT00790842|10946645|FG004|Dose Level 4|Adverse Event|0
6918899|NCT00790842|10946646|FG005|Dose Level 4|Adverse Event|0
6918900|NCT00790842|10946647|FG006|Dose Level 4|Adverse Event|1
6918901|NCT00790842|10946648|FG007|Dose Level 4|Adverse Event|0
6918902|NCT00790842|10946649|FG008|Dose Level 4|Adverse Event|0
6918903|NCT00790842|10946650|FG009|Dose Level 4|Adverse Event|0
6918904|NCT00790842|10946651|FG010|Dose Level 4|Adverse Event|0
6918905|NCT00790842|10946641|FG000|Dose Level 4|Physician Decision|0
6918906|NCT00790842|10946642|FG001|Dose Level 4|Physician Decision|0
7143030|NCT03023878|11299374|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2
7143031|NCT03023878|11299374|FG000|Treatment Period|Disease Progression|1
6918907|NCT00790842|10946643|FG002|Dose Level 4|Physician Decision|0
6918908|NCT00790842|10946644|FG003|Dose Level 4|Physician Decision|0
6918909|NCT00790842|10946645|FG004|Dose Level 4|Physician Decision|0
6918910|NCT00790842|10946646|FG005|Dose Level 4|Physician Decision|0
6918911|NCT00790842|10946647|FG006|Dose Level 4|Physician Decision|1
6918912|NCT00790842|10946648|FG007|Dose Level 4|Physician Decision|0
6918913|NCT00790842|10946649|FG008|Dose Level 4|Physician Decision|0
6918914|NCT00790842|10946650|FG009|Dose Level 4|Physician Decision|0
6918915|NCT00790842|10946651|FG010|Dose Level 4|Physician Decision|1
6918916|NCT00790842|10946641|FG000|Dose Level 4|Withdrawal by Subject|0
6918917|NCT00790842|10946642|FG001|Dose Level 4|Withdrawal by Subject|0
7143032|NCT03023878|11299374|FG000|Treatment Period|Withdrawal by Subject|1
7143033|NCT03023878|11299374|FG000|Treatment Period|Adverse Event|1
6918918|NCT00790842|10946643|FG002|Dose Level 4|Withdrawal by Subject|0
6918919|NCT00790842|10946644|FG003|Dose Level 4|Withdrawal by Subject|0
6918920|NCT00790842|10946645|FG004|Dose Level 4|Withdrawal by Subject|0
6918921|NCT00790842|10946646|FG005|Dose Level 4|Withdrawal by Subject|0
6918922|NCT00790842|10946647|FG006|Dose Level 4|Withdrawal by Subject|0
6918923|NCT00790842|10946648|FG007|Dose Level 4|Withdrawal by Subject|0
6918924|NCT00790842|10946649|FG008|Dose Level 4|Withdrawal by Subject|0
6918925|NCT00790842|10946650|FG009|Dose Level 4|Withdrawal by Subject|0
6918926|NCT00790842|10946651|FG010|Dose Level 4|Withdrawal by Subject|1
6918927|NCT00790842|10946641|FG000|Expansion Cohort|Adverse Event|0
6918928|NCT00790842|10946642|FG001|Expansion Cohort|Adverse Event|0
6918929|NCT00790842|10946643|FG002|Expansion Cohort|Adverse Event|0
6918930|NCT00790842|10946644|FG003|Expansion Cohort|Adverse Event|0
6918931|NCT00790842|10946645|FG004|Expansion Cohort|Adverse Event|0
6918932|NCT00790842|10946646|FG005|Expansion Cohort|Adverse Event|0
6918933|NCT00790842|10946647|FG006|Expansion Cohort|Adverse Event|1
6918934|NCT00790842|10946648|FG007|Expansion Cohort|Adverse Event|0
6918935|NCT00790842|10946649|FG008|Expansion Cohort|Adverse Event|0
6918936|NCT00790842|10946650|FG009|Expansion Cohort|Adverse Event|0
6918937|NCT00790842|10946651|FG010|Expansion Cohort|Adverse Event|0
6918938|NCT00790842|10946641|FG000|Expansion Cohort|Death|0
6918939|NCT00790842|10946642|FG001|Expansion Cohort|Death|0
6918940|NCT00790842|10946643|FG002|Expansion Cohort|Death|2
6918941|NCT00790842|10946644|FG003|Expansion Cohort|Death|0
6918942|NCT00790842|10946645|FG004|Expansion Cohort|Death|0
6918943|NCT00790842|10946646|FG005|Expansion Cohort|Death|0
6918944|NCT00790842|10946647|FG006|Expansion Cohort|Death|0
6918945|NCT00790842|10946648|FG007|Expansion Cohort|Death|0
6918946|NCT00790842|10946649|FG008|Expansion Cohort|Death|0
6918947|NCT00790842|10946650|FG009|Expansion Cohort|Death|0
6918948|NCT00790842|10946651|FG010|Expansion Cohort|Death|0
6918949|NCT00790842|10946641|FG000|Expansion Cohort|Physician Decision|0
6918950|NCT00790842|10946642|FG001|Expansion Cohort|Physician Decision|0
6918951|NCT00790842|10946643|FG002|Expansion Cohort|Physician Decision|1
6918952|NCT00790842|10946644|FG003|Expansion Cohort|Physician Decision|0
6918953|NCT00790842|10946645|FG004|Expansion Cohort|Physician Decision|0
6918954|NCT00790842|10946646|FG005|Expansion Cohort|Physician Decision|0
6918955|NCT00790842|10946647|FG006|Expansion Cohort|Physician Decision|0
6918956|NCT00790842|10946648|FG007|Expansion Cohort|Physician Decision|0
6918957|NCT00790842|10946649|FG008|Expansion Cohort|Physician Decision|0
6918958|NCT00790842|10946650|FG009|Expansion Cohort|Physician Decision|0
6918959|NCT00790842|10946651|FG010|Expansion Cohort|Physician Decision|0
6918960|NCT00790842|10946641|FG000|Expansion Cohort|Withdrawal by Subject|0
6918961|NCT00790842|10946642|FG001|Expansion Cohort|Withdrawal by Subject|0
6918962|NCT00790842|10946643|FG002|Expansion Cohort|Withdrawal by Subject|3
6918963|NCT00790842|10946644|FG003|Expansion Cohort|Withdrawal by Subject|0
6918964|NCT00790842|10946645|FG004|Expansion Cohort|Withdrawal by Subject|0
6918965|NCT00790842|10946646|FG005|Expansion Cohort|Withdrawal by Subject|0
6918966|NCT00790842|10946647|FG006|Expansion Cohort|Withdrawal by Subject|0
6918967|NCT00790842|10946648|FG007|Expansion Cohort|Withdrawal by Subject|0
6918968|NCT00790842|10946649|FG008|Expansion Cohort|Withdrawal by Subject|0
6918969|NCT00790842|10946650|FG009|Expansion Cohort|Withdrawal by Subject|0
6918970|NCT00790842|10946651|FG010|Expansion Cohort|Withdrawal by Subject|0
6918971|NCT00790842|10946641|FG000|Expansion Cohort|Study Closure|0
6918972|NCT00790842|10946642|FG001|Expansion Cohort|Study Closure|0
6918973|NCT00790842|10946643|FG002|Expansion Cohort|Study Closure|1
6918974|NCT00790842|10946644|FG003|Expansion Cohort|Study Closure|0
6918975|NCT00790842|10946645|FG004|Expansion Cohort|Study Closure|0
6918976|NCT00790842|10946646|FG005|Expansion Cohort|Study Closure|0
6918977|NCT00790842|10946647|FG006|Expansion Cohort|Study Closure|0
6918978|NCT00790842|10946648|FG007|Expansion Cohort|Study Closure|0
6918979|NCT00790842|10946649|FG008|Expansion Cohort|Study Closure|0
6918980|NCT00790842|10946650|FG009|Expansion Cohort|Study Closure|0
6918981|NCT00790842|10946651|FG010|Expansion Cohort|Study Closure|0
6918982|NCT00790868|10946706|FG000|Overall Study|Withdrawal by Subject|4
6918983|NCT00790868|10946707|FG001|Overall Study|Withdrawal by Subject|5
6918984|NCT00790868|10946706|FG000|Overall Study|Lost to Follow-up|2
6918985|NCT00790868|10946707|FG001|Overall Study|Lost to Follow-up|12
6918986|NCT00790907|10946718|FG000|Overall Study|Adverse Event|9
6918987|NCT00790907|10946719|FG001|Overall Study|Adverse Event|7
6918988|NCT00790907|10946720|FG002|Overall Study|Adverse Event|6
6918989|NCT00790907|10946718|FG000|Overall Study|Physician Decision|304
6918990|NCT00790907|10946719|FG001|Overall Study|Physician Decision|271
6918991|NCT00790907|10946720|FG002|Overall Study|Physician Decision|255
6918992|NCT00790907|10946718|FG000|Overall Study|Withdrawal by Subject|1
6918993|NCT00790907|10946719|FG001|Overall Study|Withdrawal by Subject|7
6918994|NCT00790907|10946720|FG002|Overall Study|Withdrawal by Subject|5
6918995|NCT00790907|10946718|FG000|Overall Study|Bleeding Event|11
6918996|NCT00790907|10946719|FG001|Overall Study|Bleeding Event|16
6918997|NCT00790907|10946720|FG002|Overall Study|Bleeding Event|21
6918998|NCT00790907|10946718|FG000|Overall Study|Required Protocol-prohibited Therapy|17
6918999|NCT00790907|10946719|FG001|Overall Study|Required Protocol-prohibited Therapy|5
6919000|NCT00790907|10946720|FG002|Overall Study|Required Protocol-prohibited Therapy|7
6919001|NCT00790907|10946718|FG000|Overall Study|Qualifying Condition Not Present|29
6919002|NCT00790907|10946719|FG001|Overall Study|Qualifying Condition Not Present|14
6919003|NCT00790907|10946720|FG002|Overall Study|Qualifying Condition Not Present|16
6919004|NCT00790907|10946718|FG000|Overall Study|Verbatim Reason on the Case Report Form|74
6919005|NCT00790907|10946719|FG001|Overall Study|Verbatim Reason on the Case Report Form|20
6919006|NCT00790907|10946720|FG002|Overall Study|Verbatim Reason on the Case Report Form|29
6919007|NCT00790907|10946718|FG000|Overall Study|Did Not Receive Study Drug|10
6919008|NCT00790907|10946719|FG001|Overall Study|Did Not Receive Study Drug|0
6919009|NCT00790907|10946720|FG002|Overall Study|Did Not Receive Study Drug|0
6919010|NCT00791128|10946749|FG000|Overall Study|Adverse Event|4
6919011|NCT00791128|10946749|FG000|Overall Study|Device migration|2
6919012|NCT00791128|10946749|FG000|Overall Study|non-compliance by subject|2
6919013|NCT00791128|10946749|FG000|Overall Study|abdominal tumor, unrelated to device|1
6919014|NCT00791258|10946766|FG000|Overall Study|Adverse Event|87
6919015|NCT00791258|10946766|FG000|Overall Study|Lost to Follow-up|18
6919016|NCT00791258|10946766|FG000|Overall Study|Protocol Violation|109
6919017|NCT00791258|10946766|FG000|Overall Study|Withdrawal by Subject|40
6919018|NCT00791258|10946766|FG000|Overall Study|Did not take medication for >3 days|1
6919019|NCT00791258|10946766|FG000|Overall Study|subject left area|2
6919020|NCT00791258|10946766|FG000|Overall Study|non-compliance|3
6919021|NCT00791258|10946766|FG000|Overall Study|Subject incarcerated|1
6919022|NCT00791258|10946766|FG000|Overall Study|Subject required restricted medication|1
6919023|NCT00791258|10946766|FG000|Overall Study|Lack of Efficacy|1
6919024|NCT00791388|10946784|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
6919025|NCT00791388|10946785|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1
6919026|NCT00791388|10946786|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
6919027|NCT00791388|10946787|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
6919028|NCT00791388|10946788|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
6919029|NCT00791388|10946784|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1
6919030|NCT00791388|10946785|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
6919031|NCT00791388|10946786|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
6919032|NCT00791388|10946787|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
6919033|NCT00791388|10946788|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
6919034|NCT00791388|10946784|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0
6919035|NCT00791388|10946785|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0
6919036|NCT00791388|10946786|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0
6919037|NCT00791388|10946787|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0
6919038|NCT00791388|10946788|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4
6919039|NCT00791479|10946806|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0
6919040|NCT00791479|10946807|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0
6919041|NCT00791479|10946808|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0
6919042|NCT00791479|10946809|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0
6919043|NCT00791479|10946810|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3
6919044|NCT00791479|10946811|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0
6919045|NCT00791479|10946806|FG000|Overall Study|Adverse Event|0
6919046|NCT00791479|10946807|FG001|Overall Study|Adverse Event|1
6919047|NCT00791479|10946808|FG002|Overall Study|Adverse Event|0
6919048|NCT00791479|10946809|FG003|Overall Study|Adverse Event|2
6919049|NCT00791479|10946810|FG004|Overall Study|Adverse Event|0
6919050|NCT00791479|10946811|FG005|Overall Study|Adverse Event|1
6919051|NCT00791479|10946806|FG000|Overall Study|Lost to Follow-up|0
6919052|NCT00791479|10946807|FG001|Overall Study|Lost to Follow-up|1
6919053|NCT00791479|10946808|FG002|Overall Study|Lost to Follow-up|0
6919054|NCT00791479|10946809|FG003|Overall Study|Lost to Follow-up|0
6919055|NCT00791479|10946810|FG004|Overall Study|Lost to Follow-up|0
6919056|NCT00791479|10946811|FG005|Overall Study|Lost to Follow-up|1
6919057|NCT00791479|10946806|FG000|Overall Study|Protocol Violation|2
6919058|NCT00791479|10946807|FG001|Overall Study|Protocol Violation|1
6919059|NCT00791479|10946808|FG002|Overall Study|Protocol Violation|0
6919060|NCT00791479|10946809|FG003|Overall Study|Protocol Violation|1
6919061|NCT00791479|10946810|FG004|Overall Study|Protocol Violation|0
6919062|NCT00791479|10946811|FG005|Overall Study|Protocol Violation|0
6919063|NCT00791479|10946806|FG000|Overall Study|Withdrawal by Subject|0
6919064|NCT00791479|10946807|FG001|Overall Study|Withdrawal by Subject|0
6919065|NCT00791479|10946808|FG002|Overall Study|Withdrawal by Subject|0
6919066|NCT00791479|10946809|FG003|Overall Study|Withdrawal by Subject|1
6919067|NCT00791479|10946810|FG004|Overall Study|Withdrawal by Subject|0
6919068|NCT00791479|10946811|FG005|Overall Study|Withdrawal by Subject|1
6919069|NCT00791492|10946834|FG000|Overall Study|Withdrawal by Subject|1
6919070|NCT00791492|10946835|FG001|Overall Study|Withdrawal by Subject|2
6919071|NCT00791492|10946834|FG000|Overall Study|Liver transplantation|5
6919072|NCT00791492|10946835|FG001|Overall Study|Liver transplantation|1
6919073|NCT00791518|10946841|FG000|Overall Study|Protocol Violation|93
6919074|NCT00791557|10946860|FG000|Overall Study|Adverse Event|1
6919075|NCT00791648|10946866|FG000|Overall Study|Physician Decision|0
6919076|NCT00791648|10946867|FG001|Overall Study|Physician Decision|1
6919077|NCT00791648|10946866|FG000|Overall Study|Withdrawal by Subject|0
6919078|NCT00791648|10946867|FG001|Overall Study|Withdrawal by Subject|1
6919079|NCT00791661|10946876|FG000|7 Day Wash-out|Adverse Event|0
6919080|NCT00791661|10946877|FG001|7 Day Wash-out|Adverse Event|0
6919081|NCT00791661|10946878|FG002|7 Day Wash-out|Adverse Event|1
6919082|NCT00791661|10946876|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
6919083|NCT00791661|10946877|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
6919084|NCT00791661|10946878|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1
6919085|NCT00791700|10946906|FG000|Overall Study|Insufficient clinical response|1
6919086|NCT00791700|10946907|FG001|Overall Study|Insufficient clinical response|4
6919087|NCT00791700|10946908|FG002|Overall Study|Insufficient clinical response|1
6919088|NCT00791700|10946909|FG003|Overall Study|Insufficient clinical response|8
6919089|NCT00791700|10946906|FG000|Overall Study|No longer willing to participate|1
6919090|NCT00791700|10946907|FG001|Overall Study|No longer willing to participate|1
6919091|NCT00791700|10946908|FG002|Overall Study|No longer willing to participate|0
6919092|NCT00791700|10946909|FG003|Overall Study|No longer willing to participate|8
6919093|NCT00791700|10946906|FG000|Overall Study|Non-compliance with study treatment|0
6919094|NCT00791700|10946907|FG001|Overall Study|Non-compliance with study treatment|2
6919095|NCT00791700|10946908|FG002|Overall Study|Non-compliance with study treatment|0
6919096|NCT00791700|10946909|FG003|Overall Study|Non-compliance with study treatment|4
6919097|NCT00791700|10946906|FG000|Overall Study|Withdrawn due to pregnancy|0
6919098|NCT00791700|10946907|FG001|Overall Study|Withdrawn due to pregnancy|0
6919099|NCT00791700|10946908|FG002|Overall Study|Withdrawn due to pregnancy|0
6919100|NCT00791700|10946909|FG003|Overall Study|Withdrawn due to pregnancy|1
6919101|NCT00791700|10946906|FG000|Overall Study|Other|0
6919102|NCT00791700|10946907|FG001|Overall Study|Other|1
6919103|NCT00791700|10946908|FG002|Overall Study|Other|0
6919104|NCT00791700|10946909|FG003|Overall Study|Other|1
6919105|NCT00791700|10946906|FG000|Overall Study|Death|0
6919106|NCT00791700|10946907|FG001|Overall Study|Death|0
6919107|NCT00791700|10946908|FG002|Overall Study|Death|0
6919108|NCT00791700|10946909|FG003|Overall Study|Death|1
6919109|NCT00791700|10946906|FG000|Overall Study|Lost to Follow-up|4
6919110|NCT00791700|10946907|FG001|Overall Study|Lost to Follow-up|3
6919111|NCT00791700|10946908|FG002|Overall Study|Lost to Follow-up|4
6919112|NCT00791700|10946909|FG003|Overall Study|Lost to Follow-up|6
6919113|NCT00791700|10946906|FG000|Overall Study|Adverse Event|0
6919114|NCT00791700|10946907|FG001|Overall Study|Adverse Event|0
6919115|NCT00791700|10946908|FG002|Overall Study|Adverse Event|1
6919116|NCT00791700|10946909|FG003|Overall Study|Adverse Event|1
6919117|NCT00791765|10946932|FG000|Weeks 1 to 12|Adverse Event|0
6919118|NCT00791765|10946933|FG001|Weeks 1 to 12|Adverse Event|1
6919119|NCT00791765|10946932|FG000|Weeks 1 to 12|Lost to Follow-up|1
6919120|NCT00791765|10946933|FG001|Weeks 1 to 12|Lost to Follow-up|0
6919121|NCT00791765|10946932|FG000|Weeks 1 to 12|Withdrawal by Subject|3
6919122|NCT00791765|10946933|FG001|Weeks 1 to 12|Withdrawal by Subject|0
6919123|NCT00791765|10946932|FG000|Weeks 1 to 12|Physician Decision|1
6919124|NCT00791765|10946933|FG001|Weeks 1 to 12|Physician Decision|0
6919125|NCT00791765|10946932|FG000|Weeks 1 to 12|Disease progression|3
6919126|NCT00791765|10946933|FG001|Weeks 1 to 12|Disease progression|0
6919127|NCT00791765|10946932|FG000|Weeks 1 to 12|Ineligibility determined|0
6919128|NCT00791765|10946933|FG001|Weeks 1 to 12|Ineligibility determined|3
6919129|NCT00791765|10946932|FG000|Weeks 13 to 24|Protocol deviation|2
6979198|NCT01217073|11032994|FG005|Base Period|Physician Decision|0
6979199|NCT01217073|11032995|FG006|Base Period|Physician Decision|0
6979200|NCT01217073|11032996|FG007|Base Period|Physician Decision|0
6979201|NCT01217073|11032989|FG000|Base Period|Protocol Violation|1
6979202|NCT01217073|11032990|FG001|Base Period|Protocol Violation|0
6979203|NCT01217073|11032991|FG002|Base Period|Protocol Violation|0
7082205|NCT02139644|11192566|FG004|Treatment Period|Withdrawal by Subject|3
6919130|NCT00791765|10946933|FG001|Weeks 13 to 24|Protocol deviation|0
6919131|NCT00791765|10946932|FG000|Weeks 13 to 24|Adverse Event|0
6919132|NCT00791765|10946933|FG001|Weeks 13 to 24|Adverse Event|3
6919133|NCT00791765|10946932|FG000|Weeks 13 to 24|Withdrawal by Subject|2
6919134|NCT00791765|10946933|FG001|Weeks 13 to 24|Withdrawal by Subject|1
6919135|NCT00791765|10946932|FG000|Weeks 13 to 24|Disease progression|0
6919136|NCT00791765|10946933|FG001|Weeks 13 to 24|Disease progression|1
6919137|NCT00791765|10946932|FG000|Weeks 13 to 24|Lost to Follow-up|1
6919138|NCT00791765|10946933|FG001|Weeks 13 to 24|Lost to Follow-up|2
6919139|NCT00791765|10946932|FG000|Weeks 13 to 24|Other|0
6919140|NCT00791765|10946933|FG001|Weeks 13 to 24|Other|1
6919141|NCT00791778|10946941|FG000|Double-blind Treatment|Adverse Event|49
6919142|NCT00791778|10946942|FG001|Double-blind Treatment|Adverse Event|9
6919143|NCT00791778|10946941|FG000|Double-blind Treatment|Physician Decision|6
6919144|NCT00791778|10946942|FG001|Double-blind Treatment|Physician Decision|26
6919145|NCT00791778|10946941|FG000|Double-blind Treatment|Protocol Violation|0
6919146|NCT00791778|10946942|FG001|Double-blind Treatment|Protocol Violation|4
6919147|NCT00791778|10946941|FG000|Double-blind Treatment|Withdrawal by Subject|20
6919148|NCT00791778|10946942|FG001|Double-blind Treatment|Withdrawal by Subject|9
6919149|NCT00791778|10946941|FG000|Double-blind Treatment|Non-compliant with study medication|2
6919150|NCT00791778|10946942|FG001|Double-blind Treatment|Non-compliant with study medication|0
6919151|NCT00791778|10946941|FG000|Follow-up|Withdrawal by Subject|3
6919152|NCT00791778|10946942|FG001|Follow-up|Withdrawal by Subject|0
6919153|NCT00791778|10946941|FG000|Follow-up|Lost to Follow-up|2
6919154|NCT00791778|10946942|FG001|Follow-up|Lost to Follow-up|1
6919155|NCT00791921|10946967|FG000|Overall Study|Protocol planed|24
6919156|NCT00791921|10946968|FG001|Overall Study|Protocol planed|88
6919157|NCT00791921|10946967|FG000|Overall Study|Withdrawal by Subject|1
6979204|NCT01217073|11032992|FG003|Base Period|Protocol Violation|0
6979205|NCT01217073|11032993|FG004|Base Period|Protocol Violation|1
6919158|NCT00791921|10946968|FG001|Overall Study|Withdrawal by Subject|2
6919159|NCT00791921|10946967|FG000|Overall Study|Adverse Event|8
6919160|NCT00791921|10946968|FG001|Overall Study|Adverse Event|2
6919161|NCT00791921|10946967|FG000|Overall Study|Lack of Efficacy|0
6919162|NCT00791921|10946968|FG001|Overall Study|Lack of Efficacy|2
6919163|NCT00791921|10946967|FG000|Overall Study|Lack of study drug administration|1
6919164|NCT00791921|10946968|FG001|Overall Study|Lack of study drug administration|1
6919165|NCT00791921|10946967|FG000|Overall Study|Reason other than those above|0
6919166|NCT00791921|10946968|FG001|Overall Study|Reason other than those above|1
6919167|NCT00791934|10946974|FG000|Overall Study|Withdrawal by Subject|2
6919168|NCT00791934|10946974|FG000|Overall Study|Did not consent for extended follow-up|13
6919169|NCT00791999|10946991|FG000|Overall Study|Protocol planed withdrawal|14
6919170|NCT00791999|10946992|FG001|Overall Study|Protocol planed withdrawal|11
6919171|NCT00791999|10946993|FG002|Overall Study|Protocol planed withdrawal|11
6919172|NCT00791999|10946994|FG003|Overall Study|Protocol planed withdrawal|45
6919173|NCT00791999|10946991|FG000|Overall Study|Withdrawal by Subject|0
6919174|NCT00791999|10946992|FG001|Overall Study|Withdrawal by Subject|1
6919175|NCT00791999|10946993|FG002|Overall Study|Withdrawal by Subject|0
6919176|NCT00791999|10946994|FG003|Overall Study|Withdrawal by Subject|2
6919177|NCT00791999|10946991|FG000|Overall Study|Protocol Violation|3
6919178|NCT00791999|10946992|FG001|Overall Study|Protocol Violation|0
6919179|NCT00791999|10946993|FG002|Overall Study|Protocol Violation|1
6919180|NCT00791999|10946994|FG003|Overall Study|Protocol Violation|0
6919181|NCT00791999|10946991|FG000|Overall Study|Adverse Event|3
6919182|NCT00791999|10946992|FG001|Overall Study|Adverse Event|3
6919183|NCT00791999|10946993|FG002|Overall Study|Adverse Event|7
6919184|NCT00791999|10946994|FG003|Overall Study|Adverse Event|3
6919185|NCT00791999|10946991|FG000|Overall Study|Lack of Efficacy|0
6919186|NCT00791999|10946992|FG001|Overall Study|Lack of Efficacy|1
6919187|NCT00791999|10946993|FG002|Overall Study|Lack of Efficacy|0
6919188|NCT00791999|10946994|FG003|Overall Study|Lack of Efficacy|2
6919189|NCT00791999|10946991|FG000|Overall Study|Reason other than those above|1
6919190|NCT00791999|10946992|FG001|Overall Study|Reason other than those above|0
6919191|NCT00791999|10946993|FG002|Overall Study|Reason other than those above|1
6919192|NCT00791999|10946994|FG003|Overall Study|Reason other than those above|0
6919193|NCT00792103|10947008|FG000|Overall Study|Enrolled, not treated|15
6919194|NCT00792103|10947008|FG000|Overall Study|Lost to Follow-up|17
6919195|NCT00792103|10947008|FG000|Overall Study|Adverse Event|25
6919196|NCT00792103|10947008|FG000|Overall Study|Withdrawal by Subject|52
6919197|NCT00792103|10947008|FG000|Overall Study|Protocol Violation|10
6919198|NCT00792103|10947008|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14
6919199|NCT00792298|10947016|FG000|Treatment Period 1|Adverse Event|0
6919200|NCT00792298|10947017|FG001|Treatment Period 1|Adverse Event|1
6919201|NCT00792298|10947018|FG002|Treatment Period 1|Adverse Event|0
6919202|NCT00792298|10947019|FG003|Treatment Period 1|Adverse Event|1
6919203|NCT00792298|10947020|FG004|Treatment Period 1|Adverse Event|0
6919204|NCT00792298|10947021|FG005|Treatment Period 1|Adverse Event|1
6919205|NCT00792298|10947022|FG006|Treatment Period 1|Adverse Event|1
6919206|NCT00792298|10947023|FG007|Treatment Period 1|Adverse Event|0
6919207|NCT00792298|10947016|FG000|Treatment Period 1|Lack of Efficacy|0
6919208|NCT00792298|10947017|FG001|Treatment Period 1|Lack of Efficacy|0
6919209|NCT00792298|10947018|FG002|Treatment Period 1|Lack of Efficacy|1
6919210|NCT00792298|10947019|FG003|Treatment Period 1|Lack of Efficacy|0
6919211|NCT00792298|10947020|FG004|Treatment Period 1|Lack of Efficacy|0
6919212|NCT00792298|10947021|FG005|Treatment Period 1|Lack of Efficacy|0
6919213|NCT00792298|10947022|FG006|Treatment Period 1|Lack of Efficacy|0
6919214|NCT00792298|10947023|FG007|Treatment Period 1|Lack of Efficacy|0
6919215|NCT00792298|10947016|FG000|Treatment Period 1|Withdrawal by Subject|1
6919216|NCT00792298|10947017|FG001|Treatment Period 1|Withdrawal by Subject|0
6919217|NCT00792298|10947018|FG002|Treatment Period 1|Withdrawal by Subject|1
6919218|NCT00792298|10947019|FG003|Treatment Period 1|Withdrawal by Subject|2
6919219|NCT00792298|10947020|FG004|Treatment Period 1|Withdrawal by Subject|0
6919220|NCT00792298|10947021|FG005|Treatment Period 1|Withdrawal by Subject|2
6919221|NCT00792298|10947022|FG006|Treatment Period 1|Withdrawal by Subject|1
6919222|NCT00792298|10947023|FG007|Treatment Period 1|Withdrawal by Subject|0
6919223|NCT00792298|10947016|FG000|Treatment Period 1|Lost to Follow-up|0
6919224|NCT00792298|10947017|FG001|Treatment Period 1|Lost to Follow-up|0
6919225|NCT00792298|10947018|FG002|Treatment Period 1|Lost to Follow-up|0
6919226|NCT00792298|10947019|FG003|Treatment Period 1|Lost to Follow-up|0
6919227|NCT00792298|10947020|FG004|Treatment Period 1|Lost to Follow-up|0
6919228|NCT00792298|10947021|FG005|Treatment Period 1|Lost to Follow-up|0
6919229|NCT00792298|10947022|FG006|Treatment Period 1|Lost to Follow-up|1
6919230|NCT00792298|10947023|FG007|Treatment Period 1|Lost to Follow-up|0
6919231|NCT00792298|10947016|FG000|Treatment Period 1|Physician Decision|0
6919232|NCT00792298|10947017|FG001|Treatment Period 1|Physician Decision|0
6919233|NCT00792298|10947018|FG002|Treatment Period 1|Physician Decision|0
6919234|NCT00792298|10947019|FG003|Treatment Period 1|Physician Decision|1
6919235|NCT00792298|10947020|FG004|Treatment Period 1|Physician Decision|0
6919236|NCT00792298|10947021|FG005|Treatment Period 1|Physician Decision|0
6919237|NCT00792298|10947022|FG006|Treatment Period 1|Physician Decision|1
6919238|NCT00792298|10947023|FG007|Treatment Period 1|Physician Decision|0
6919239|NCT00792298|10947016|FG000|Treatment Period 1|Protocol Violation|0
6919240|NCT00792298|10947017|FG001|Treatment Period 1|Protocol Violation|0
6919241|NCT00792298|10947018|FG002|Treatment Period 1|Protocol Violation|0
6919242|NCT00792298|10947019|FG003|Treatment Period 1|Protocol Violation|0
6919243|NCT00792298|10947020|FG004|Treatment Period 1|Protocol Violation|0
6919244|NCT00792298|10947021|FG005|Treatment Period 1|Protocol Violation|0
6919245|NCT00792298|10947022|FG006|Treatment Period 1|Protocol Violation|0
6919246|NCT00792298|10947023|FG007|Treatment Period 1|Protocol Violation|1
6919247|NCT00792298|10947016|FG000|Washout|Adverse Event|0
6919248|NCT00792298|10947017|FG001|Washout|Adverse Event|0
6919249|NCT00792298|10947018|FG002|Washout|Adverse Event|0
6919250|NCT00792298|10947019|FG003|Washout|Adverse Event|0
6919251|NCT00792298|10947020|FG004|Washout|Adverse Event|0
6919252|NCT00792298|10947021|FG005|Washout|Adverse Event|1
6919253|NCT00792298|10947022|FG006|Washout|Adverse Event|0
6919254|NCT00792298|10947023|FG007|Washout|Adverse Event|0
6919255|NCT00792298|10947016|FG000|Washout|Withdrawal by Subject|0
6919256|NCT00792298|10947017|FG001|Washout|Withdrawal by Subject|0
6919257|NCT00792298|10947018|FG002|Washout|Withdrawal by Subject|1
6919258|NCT00792298|10947019|FG003|Washout|Withdrawal by Subject|0
6919259|NCT00792298|10947020|FG004|Washout|Withdrawal by Subject|0
6919260|NCT00792298|10947021|FG005|Washout|Withdrawal by Subject|1
6919261|NCT00792298|10947022|FG006|Washout|Withdrawal by Subject|0
6919262|NCT00792298|10947023|FG007|Washout|Withdrawal by Subject|0
6919263|NCT00792298|10947016|FG000|Treatment Period 2|Lack of Efficacy|0
6919264|NCT00792298|10947017|FG001|Treatment Period 2|Lack of Efficacy|0
6919265|NCT00792298|10947018|FG002|Treatment Period 2|Lack of Efficacy|0
6919266|NCT00792298|10947019|FG003|Treatment Period 2|Lack of Efficacy|0
6919267|NCT00792298|10947020|FG004|Treatment Period 2|Lack of Efficacy|1
6919268|NCT00792298|10947021|FG005|Treatment Period 2|Lack of Efficacy|0
6919269|NCT00792298|10947022|FG006|Treatment Period 2|Lack of Efficacy|0
6919270|NCT00792298|10947023|FG007|Treatment Period 2|Lack of Efficacy|0
6919271|NCT00792298|10947016|FG000|Treatment Period 2|Physician Decision|0
6919272|NCT00792298|10947017|FG001|Treatment Period 2|Physician Decision|0
6919273|NCT00792298|10947018|FG002|Treatment Period 2|Physician Decision|0
6919274|NCT00792298|10947019|FG003|Treatment Period 2|Physician Decision|0
6919275|NCT00792298|10947020|FG004|Treatment Period 2|Physician Decision|0
6919276|NCT00792298|10947021|FG005|Treatment Period 2|Physician Decision|0
6919277|NCT00792298|10947022|FG006|Treatment Period 2|Physician Decision|1
6919278|NCT00792298|10947023|FG007|Treatment Period 2|Physician Decision|0
6919279|NCT00792298|10947016|FG000|Treatment Period 2|Pregnancy|0
6919280|NCT00792298|10947017|FG001|Treatment Period 2|Pregnancy|0
6919281|NCT00792298|10947018|FG002|Treatment Period 2|Pregnancy|1
6919282|NCT00792298|10947019|FG003|Treatment Period 2|Pregnancy|0
6919283|NCT00792298|10947020|FG004|Treatment Period 2|Pregnancy|0
6919284|NCT00792298|10947021|FG005|Treatment Period 2|Pregnancy|0
6919285|NCT00792298|10947022|FG006|Treatment Period 2|Pregnancy|0
6919286|NCT00792298|10947023|FG007|Treatment Period 2|Pregnancy|0
6919287|NCT00792298|10947016|FG000|Treatment Period 2|Withdrawal by Subject|1
6919288|NCT00792298|10947017|FG001|Treatment Period 2|Withdrawal by Subject|1
6919289|NCT00792298|10947018|FG002|Treatment Period 2|Withdrawal by Subject|0
6919290|NCT00792298|10947019|FG003|Treatment Period 2|Withdrawal by Subject|2
6919291|NCT00792298|10947020|FG004|Treatment Period 2|Withdrawal by Subject|1
6919292|NCT00792298|10947021|FG005|Treatment Period 2|Withdrawal by Subject|0
6919293|NCT00792298|10947022|FG006|Treatment Period 2|Withdrawal by Subject|0
6919294|NCT00792298|10947023|FG007|Treatment Period 2|Withdrawal by Subject|2
6919295|NCT00792467|10947049|FG000|Overall Study|progression of disease|17
6919296|NCT00792467|10947049|FG000|Overall Study|Adverse Event|1
6919297|NCT00792467|10947049|FG000|Overall Study|patient request|1
6919298|NCT00792467|10947049|FG000|Overall Study|Lost to Follow-up|1
6919299|NCT00792467|10947049|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1
6919300|NCT00792467|10947049|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1
6919301|NCT00792571|10947054|FG000|Overall Study|Death|1
6919302|NCT00792571|10947054|FG000|Overall Study|Adverse Event|4
6919303|NCT00792571|10947054|FG000|Overall Study|Withdrawal by Subject|1
6919304|NCT00792571|10947054|FG000|Overall Study|Other|4
6919305|NCT00792623|10947062|FG000|Overall Study|Adverse Event|2
6919306|NCT00792623|10947062|FG000|Overall Study|Withdrawal by Subject|5
6919307|NCT00792636|10947070|FG000|Overall Study|Protocol Violation|17
6919308|NCT00792636|10947071|FG001|Overall Study|Protocol Violation|23
6919309|NCT00792636|10947072|FG002|Overall Study|Protocol Violation|20
6919310|NCT00792636|10947070|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19
6919311|NCT00792636|10947071|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20
6919312|NCT00792636|10947072|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20
6919313|NCT00792636|10947070|FG000|Overall Study|Lost to Follow-up|13
6919314|NCT00792636|10947071|FG001|Overall Study|Lost to Follow-up|19
6919315|NCT00792636|10947072|FG002|Overall Study|Lost to Follow-up|14
6919316|NCT00792636|10947070|FG000|Overall Study|Withdrew Consent|10
6919317|NCT00792636|10947071|FG001|Overall Study|Withdrew Consent|13
6919318|NCT00792636|10947072|FG002|Overall Study|Withdrew Consent|9
6919319|NCT00792636|10947070|FG000|Overall Study|Lack of Efficacy|3
6919320|NCT00792636|10947071|FG001|Overall Study|Lack of Efficacy|4
6919321|NCT00792636|10947072|FG002|Overall Study|Lack of Efficacy|13
6919322|NCT00792636|10947070|FG000|Overall Study|Adverse Event|4
6919323|NCT00792636|10947071|FG001|Overall Study|Adverse Event|2
6919324|NCT00792636|10947072|FG002|Overall Study|Adverse Event|3
6919325|NCT00792636|10947070|FG000|Overall Study|Investigator Discretion|2
6919326|NCT00792636|10947071|FG001|Overall Study|Investigator Discretion|0
6919327|NCT00792636|10947072|FG002|Overall Study|Investigator Discretion|2
6919328|NCT00792701|10947097|FG000|Overall Study|Adverse Event|0
6919329|NCT00792701|10947098|FG001|Overall Study|Adverse Event|22
6919330|NCT00792701|10947097|FG000|Overall Study|Ineligible|1
6919331|NCT00792701|10947098|FG001|Overall Study|Ineligible|3
6919332|NCT00792701|10947097|FG000|Overall Study|Withdrawal by Subject|1
6919333|NCT00792701|10947098|FG001|Overall Study|Withdrawal by Subject|19
6919334|NCT00792701|10947097|FG000|Overall Study|Not protocol specified|17
6919335|NCT00792701|10947098|FG001|Overall Study|Not protocol specified|0
6919336|NCT00792805|10947109|FG000|Overall Study|Adverse Event|12
6919337|NCT00792805|10947110|FG001|Overall Study|Adverse Event|10
6919338|NCT00792805|10947111|FG002|Overall Study|Adverse Event|10
6919339|NCT00792805|10947109|FG000|Overall Study|Subject withdrew consent|5
6919340|NCT00792805|10947110|FG001|Overall Study|Subject withdrew consent|6
6919341|NCT00792805|10947111|FG002|Overall Study|Subject withdrew consent|5
6919342|NCT00792805|10947109|FG000|Overall Study|Administrative problems|2
6919343|NCT00792805|10947110|FG001|Overall Study|Administrative problems|0
6919344|NCT00792805|10947111|FG002|Overall Study|Administrative problems|4
6919345|NCT00792805|10947109|FG000|Overall Study|Abnormal test procedure result(s)|1
6919346|NCT00792805|10947110|FG001|Overall Study|Abnormal test procedure result(s)|2
6919347|NCT00792805|10947111|FG002|Overall Study|Abnormal test procedure result(s)|0
6919348|NCT00792805|10947109|FG000|Overall Study|Unsatisfactory therapeutic effect|1
6919349|NCT00792805|10947110|FG001|Overall Study|Unsatisfactory therapeutic effect|6
6919350|NCT00792805|10947111|FG002|Overall Study|Unsatisfactory therapeutic effect|6
6919351|NCT00792805|10947109|FG000|Overall Study|Lost to Follow-up|1
6919352|NCT00792805|10947110|FG001|Overall Study|Lost to Follow-up|1
6919353|NCT00792805|10947111|FG002|Overall Study|Lost to Follow-up|6
6919354|NCT00792805|10947109|FG000|Overall Study|Abnormal laboratory value(s)|0
6919355|NCT00792805|10947110|FG001|Overall Study|Abnormal laboratory value(s)|0
6919356|NCT00792805|10947111|FG002|Overall Study|Abnormal laboratory value(s)|1
6919357|NCT00792805|10947109|FG000|Overall Study|Protocol deviation|0
6919358|NCT00792805|10947110|FG001|Overall Study|Protocol deviation|1
6919359|NCT00792805|10947111|FG002|Overall Study|Protocol deviation|1
6919360|NCT00792909|10947122|FG000|Overall Study|Withdrawal by Subject|0
6919361|NCT00792909|10947123|FG001|Overall Study|Withdrawal by Subject|1
6919362|NCT00792909|10947124|FG002|Overall Study|Withdrawal by Subject|0
6919363|NCT00792935|10947156|FG000|Overall Study|Adverse Event|2
6919364|NCT00792935|10947157|FG001|Overall Study|Adverse Event|1
6919365|NCT00792935|10947156|FG000|Overall Study|Lost to Follow-up|0
6919366|NCT00792935|10947157|FG001|Overall Study|Lost to Follow-up|1
6919367|NCT00792935|10947156|FG000|Overall Study|Protocol Violation|2
6919368|NCT00792935|10947157|FG001|Overall Study|Protocol Violation|0
6919369|NCT00792935|10947156|FG000|Overall Study|Withdrawal by Subject|0
6919370|NCT00792935|10947157|FG001|Overall Study|Withdrawal by Subject|1
6919371|NCT00793104|10947163|FG000|Overall Study|Lost to Follow-up|1
6919372|NCT00793182|10947169|FG000|Overall Study|Adverse Event|0
6919373|NCT00793182|10947170|FG001|Overall Study|Adverse Event|1
6919374|NCT00793325|10947176|FG000|Overall Study|Protocol Violation|18
6919375|NCT00793325|10947176|FG000|Overall Study|Lost to Follow-up|1
6919376|NCT00793403|10947199|FG000|Overall Study|Other|73
6919377|NCT00793546|10947215|FG000|Overall Study|Death|3
6919378|NCT00793546|10947216|FG001|Overall Study|Death|0
6919379|NCT00793546|10947215|FG000|Overall Study|Lost to Follow-up|1
6919380|NCT00793546|10947216|FG001|Overall Study|Lost to Follow-up|0
6919381|NCT00793546|10947215|FG000|Overall Study|Withdrawal by Subject|1
6919382|NCT00793546|10947216|FG001|Overall Study|Withdrawal by Subject|1
6919383|NCT00793546|10947215|FG000|Overall Study|Study Terminated by Sponsor|8
6919384|NCT00793546|10947216|FG001|Overall Study|Study Terminated by Sponsor|27
6919385|NCT00793546|10947215|FG000|Overall Study|Other|1
6919386|NCT00793546|10947216|FG001|Overall Study|Other|0
6919387|NCT00793585|10947230|FG000|Overall Study|Adverse Event|1
6919388|NCT00793585|10947231|FG001|Overall Study|Adverse Event|1
6919389|NCT00793585|10947230|FG000|Overall Study|Protocol Violation|1
6919390|NCT00793585|10947231|FG001|Overall Study|Protocol Violation|2
6919391|NCT00793598|10947242|FG000|Overall Study|Patient Request|0
6919392|NCT00793598|10947243|FG001|Overall Study|Patient Request|1
6919393|NCT00793598|10947244|FG002|Overall Study|Patient Request|0
6919394|NCT00793598|10947245|FG003|Overall Study|Patient Request|0
6919395|NCT00793598|10947246|FG004|Overall Study|Patient Request|0
6919396|NCT00793598|10947247|FG005|Overall Study|Patient Request|0
6919397|NCT00793598|10947248|FG006|Overall Study|Patient Request|0
6919398|NCT00793598|10947249|FG007|Overall Study|Patient Request|0
6919399|NCT00793598|10947242|FG000|Overall Study|Protocol Violation|0
6919400|NCT00793598|10947243|FG001|Overall Study|Protocol Violation|0
6919401|NCT00793598|10947244|FG002|Overall Study|Protocol Violation|0
6919402|NCT00793598|10947245|FG003|Overall Study|Protocol Violation|0
6919403|NCT00793598|10947246|FG004|Overall Study|Protocol Violation|0
6919404|NCT00793598|10947247|FG005|Overall Study|Protocol Violation|0
6919405|NCT00793598|10947248|FG006|Overall Study|Protocol Violation|0
6919406|NCT00793598|10947249|FG007|Overall Study|Protocol Violation|1
6919407|NCT00793598|10947242|FG000|Overall Study|Subject not dosed|0
6919408|NCT00793598|10947243|FG001|Overall Study|Subject not dosed|0
6919409|NCT00793598|10947244|FG002|Overall Study|Subject not dosed|0
6919410|NCT00793598|10947245|FG003|Overall Study|Subject not dosed|0
6919411|NCT00793598|10947246|FG004|Overall Study|Subject not dosed|0
6919412|NCT00793598|10947247|FG005|Overall Study|Subject not dosed|1
6919413|NCT00793598|10947248|FG006|Overall Study|Subject not dosed|0
6919414|NCT00793598|10947249|FG007|Overall Study|Subject not dosed|0
6919415|NCT00793624|10947284|FG000|Overall Study|Adverse Event|18
6919416|NCT00793624|10947285|FG001|Overall Study|Adverse Event|16
6919417|NCT00793624|10947286|FG002|Overall Study|Adverse Event|15
6919418|NCT00793624|10947287|FG003|Overall Study|Adverse Event|20
6919419|NCT00793624|10947284|FG000|Overall Study|Lost to Follow-up|2
6919420|NCT00793624|10947285|FG001|Overall Study|Lost to Follow-up|2
6919421|NCT00793624|10947286|FG002|Overall Study|Lost to Follow-up|4
6919422|NCT00793624|10947287|FG003|Overall Study|Lost to Follow-up|0
6919423|NCT00793624|10947284|FG000|Overall Study|Withdrawal by Subject|20
6919424|NCT00793624|10947285|FG001|Overall Study|Withdrawal by Subject|9
6919425|NCT00793624|10947286|FG002|Overall Study|Withdrawal by Subject|11
6919426|NCT00793624|10947287|FG003|Overall Study|Withdrawal by Subject|14
6919427|NCT00793624|10947284|FG000|Overall Study|Lack of Efficacy|9
6919428|NCT00793624|10947285|FG001|Overall Study|Lack of Efficacy|2
6919429|NCT00793624|10947286|FG002|Overall Study|Lack of Efficacy|1
6919430|NCT00793624|10947287|FG003|Overall Study|Lack of Efficacy|3
6919431|NCT00793624|10947284|FG000|Overall Study|Non compliance with protocol|2
6919432|NCT00793624|10947285|FG001|Overall Study|Non compliance with protocol|3
6919433|NCT00793624|10947286|FG002|Overall Study|Non compliance with protocol|2
6919434|NCT00793624|10947287|FG003|Overall Study|Non compliance with protocol|3
6919435|NCT00793624|10947284|FG000|Overall Study|Other reason not described above|6
6919436|NCT00793624|10947285|FG001|Overall Study|Other reason not described above|4
6919437|NCT00793624|10947286|FG002|Overall Study|Other reason not described above|6
6919438|NCT00793624|10947287|FG003|Overall Study|Other reason not described above|3
6919439|NCT00793780|10947318|FG000|Overall Study|Withdrawal by Subject|2
6919440|NCT00793780|10947319|FG001|Overall Study|Withdrawal by Subject|1
6919441|NCT00793793|10947337|FG000|Overall Study|Adverse Event|0
6919442|NCT00793793|10947338|FG001|Overall Study|Adverse Event|0
6919443|NCT00793793|10947339|FG002|Overall Study|Adverse Event|1
6919444|NCT00793793|10947340|FG003|Overall Study|Adverse Event|1
6919445|NCT00793793|10947341|FG004|Overall Study|Adverse Event|0
6919446|NCT00793793|10947342|FG005|Overall Study|Adverse Event|1
6919447|NCT00793793|10947343|FG006|Overall Study|Adverse Event|2
6919448|NCT00793793|10947344|FG007|Overall Study|Adverse Event|0
6919449|NCT00793793|10947345|FG008|Overall Study|Adverse Event|0
6919450|NCT00793793|10947346|FG009|Overall Study|Adverse Event|0
6919451|NCT00793793|10947347|FG010|Overall Study|Adverse Event|0
6919452|NCT00793793|10947348|FG011|Overall Study|Adverse Event|2
6919453|NCT00793793|10947337|FG000|Overall Study|Protocol Violation|0
6919454|NCT00793793|10947338|FG001|Overall Study|Protocol Violation|0
6919455|NCT00793793|10947339|FG002|Overall Study|Protocol Violation|0
6919456|NCT00793793|10947340|FG003|Overall Study|Protocol Violation|1
6919457|NCT00793793|10947341|FG004|Overall Study|Protocol Violation|0
6919458|NCT00793793|10947342|FG005|Overall Study|Protocol Violation|0
6919459|NCT00793793|10947343|FG006|Overall Study|Protocol Violation|0
6919460|NCT00793793|10947344|FG007|Overall Study|Protocol Violation|0
6919461|NCT00793793|10947345|FG008|Overall Study|Protocol Violation|0
6919462|NCT00793793|10947346|FG009|Overall Study|Protocol Violation|0
6919463|NCT00793793|10947347|FG010|Overall Study|Protocol Violation|0
6919464|NCT00793793|10947348|FG011|Overall Study|Protocol Violation|0
6919465|NCT00793793|10947337|FG000|Overall Study|Lost to Follow-up|0
6919466|NCT00793793|10947338|FG001|Overall Study|Lost to Follow-up|0
6919467|NCT00793793|10947339|FG002|Overall Study|Lost to Follow-up|1
6919468|NCT00793793|10947340|FG003|Overall Study|Lost to Follow-up|0
6919469|NCT00793793|10947341|FG004|Overall Study|Lost to Follow-up|0
6919470|NCT00793793|10947342|FG005|Overall Study|Lost to Follow-up|0
6919471|NCT00793793|10947343|FG006|Overall Study|Lost to Follow-up|0
6919472|NCT00793793|10947344|FG007|Overall Study|Lost to Follow-up|0
6919473|NCT00793793|10947345|FG008|Overall Study|Lost to Follow-up|1
6919474|NCT00793793|10947346|FG009|Overall Study|Lost to Follow-up|3
6919475|NCT00793793|10947347|FG010|Overall Study|Lost to Follow-up|1
6919476|NCT00793793|10947348|FG011|Overall Study|Lost to Follow-up|0
6919477|NCT00793793|10947337|FG000|Overall Study|Withdrawal by Subject|0
6919478|NCT00793793|10947338|FG001|Overall Study|Withdrawal by Subject|0
6919479|NCT00793793|10947339|FG002|Overall Study|Withdrawal by Subject|0
6919480|NCT00793793|10947340|FG003|Overall Study|Withdrawal by Subject|0
6919481|NCT00793793|10947341|FG004|Overall Study|Withdrawal by Subject|1
6919482|NCT00793793|10947342|FG005|Overall Study|Withdrawal by Subject|0
6919483|NCT00793793|10947343|FG006|Overall Study|Withdrawal by Subject|0
6919484|NCT00793793|10947344|FG007|Overall Study|Withdrawal by Subject|0
6919485|NCT00793793|10947345|FG008|Overall Study|Withdrawal by Subject|1
6919486|NCT00793793|10947346|FG009|Overall Study|Withdrawal by Subject|0
6919487|NCT00793793|10947347|FG010|Overall Study|Withdrawal by Subject|0
6919488|NCT00793793|10947348|FG011|Overall Study|Withdrawal by Subject|0
6919489|NCT00793793|10947337|FG000|Overall Study|reason not specified|0
6919490|NCT00793793|10947338|FG001|Overall Study|reason not specified|1
6919491|NCT00793793|10947339|FG002|Overall Study|reason not specified|0
6919492|NCT00793793|10947340|FG003|Overall Study|reason not specified|1
6919493|NCT00793793|10947341|FG004|Overall Study|reason not specified|1
6919494|NCT00793793|10947342|FG005|Overall Study|reason not specified|1
6919495|NCT00793793|10947343|FG006|Overall Study|reason not specified|2
6919496|NCT00793793|10947344|FG007|Overall Study|reason not specified|0
6919497|NCT00793793|10947345|FG008|Overall Study|reason not specified|7
6919498|NCT00793793|10947346|FG009|Overall Study|reason not specified|6
6919499|NCT00793793|10947347|FG010|Overall Study|reason not specified|2
6919500|NCT00793793|10947348|FG011|Overall Study|reason not specified|4
6919501|NCT00793819|10947396|FG000|Overall Study|Adverse Event|8
6919502|NCT00793819|10947397|FG001|Overall Study|Adverse Event|4
6919503|NCT00793819|10947396|FG000|Overall Study|Lack of Efficacy|1
6919504|NCT00793819|10947397|FG001|Overall Study|Lack of Efficacy|1
6919505|NCT00793819|10947396|FG000|Overall Study|Withdrawal by Subject|4
6919506|NCT00793819|10947397|FG001|Overall Study|Withdrawal by Subject|3
6919507|NCT00793819|10947396|FG000|Overall Study|Lost to Follow-up|1
6919508|NCT00793819|10947397|FG001|Overall Study|Lost to Follow-up|1
6919509|NCT00793871|10947403|FG000|Overall Study|Death|50
6919510|NCT00793871|10947403|FG000|Overall Study|Lost to Follow-up|3
6919511|NCT00793871|10947403|FG000|Overall Study|Study terminated by the Sponsor|7
6919512|NCT00793910|10947409|FG000|Overall Study|discarded study pills|0
6919513|NCT00793910|10947410|FG001|Overall Study|discarded study pills|1
6919514|NCT00793910|10947409|FG000|Overall Study|did not pick up medications|1
6919515|NCT00793910|10947410|FG001|Overall Study|did not pick up medications|1
6919516|NCT00793910|10947409|FG000|Overall Study|ineligible based on entry criteria|2
6919517|NCT00793910|10947410|FG001|Overall Study|ineligible based on entry criteria|3
6919518|NCT00793910|10947409|FG000|Overall Study|decided to undergo LASIK instead of PRK|2
6919519|NCT00793910|10947410|FG001|Overall Study|decided to undergo LASIK instead of PRK|1
6919520|NCT00793910|10947409|FG000|Overall Study|Withdrawal by Subject|0
6919521|NCT00793910|10947410|FG001|Overall Study|Withdrawal by Subject|1
6919522|NCT00794040|10947418|FG000|Overall Study|Withdrawal by Subject|3
6919523|NCT00794040|10947419|FG001|Overall Study|Withdrawal by Subject|4
6919524|NCT00794040|10947418|FG000|Overall Study|Physician Decision|0
6919525|NCT00794040|10947419|FG001|Overall Study|Physician Decision|1
6919526|NCT00794118|10947425|FG000|Overall Study|Lost to Follow-up|16
6919527|NCT00794118|10947425|FG000|Overall Study|Withdrawal by Subject|9
6919528|NCT00794118|10947425|FG000|Overall Study|Changed hospital center|2
6919529|NCT00794157|10947441|FG000|Overall Study|Adverse Event|4
6919530|NCT00794157|10947442|FG001|Overall Study|Adverse Event|1
6919531|NCT00794157|10947443|FG002|Overall Study|Adverse Event|8
6919532|NCT00794157|10947441|FG000|Overall Study|Subject withdrew consent|2
6919533|NCT00794157|10947442|FG001|Overall Study|Subject withdrew consent|0
6919534|NCT00794157|10947443|FG002|Overall Study|Subject withdrew consent|3
6919535|NCT00794157|10947441|FG000|Overall Study|Lost to Follow-up|2
6919536|NCT00794157|10947442|FG001|Overall Study|Lost to Follow-up|0
6919537|NCT00794157|10947443|FG002|Overall Study|Lost to Follow-up|1
6919538|NCT00794157|10947441|FG000|Overall Study|Unsatisfactory therapeutic effect|1
6919539|NCT00794157|10947442|FG001|Overall Study|Unsatisfactory therapeutic effect|0
6919540|NCT00794157|10947443|FG002|Overall Study|Unsatisfactory therapeutic effect|2
6919541|NCT00794157|10947441|FG000|Overall Study|Administrative problems|1
6919542|NCT00794157|10947442|FG001|Overall Study|Administrative problems|7
6919543|NCT00794157|10947443|FG002|Overall Study|Administrative problems|4
6919544|NCT00794157|10947441|FG000|Overall Study|Abnormal test procedure result(s)|0
6919545|NCT00794157|10947442|FG001|Overall Study|Abnormal test procedure result(s)|1
6919546|NCT00794157|10947443|FG002|Overall Study|Abnormal test procedure result(s)|0
6919547|NCT00794157|10947441|FG000|Overall Study|Protocol deviation|0
6919548|NCT00794157|10947442|FG001|Overall Study|Protocol deviation|1
6919549|NCT00794157|10947443|FG002|Overall Study|Protocol deviation|1
6919550|NCT00794196|10947462|FG000|Overall Study|Lost to Follow-up|5
6919551|NCT00794196|10947463|FG001|Overall Study|Lost to Follow-up|23
6919552|NCT00794339|10947482|FG000|Overall Study|Withdrawal by Subject|3
6919553|NCT00794339|10947482|FG000|Overall Study|Ineligible|4
6919554|NCT00794339|10947482|FG000|Overall Study|Tx prior to ATSM|3
6919555|NCT00794339|10947482|FG000|Overall Study|ATSM imaging not complete or inadequate|3
6919556|NCT00794339|10947482|FG000|Overall Study|Tx not per protocol|1
6919557|NCT00794365|10947503|FG000|Overall Study|Lost to Follow-up|38
6919558|NCT00794365|10947503|FG000|Overall Study|Other|17
6919559|NCT00794365|10947503|FG000|Overall Study|Poor Compliance|11
6919560|NCT00794365|10947503|FG000|Overall Study|Adverse Event|10
6919561|NCT00794365|10947503|FG000|Overall Study|Lack of Efficacy|3
6919562|NCT00794417|10947511|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0
6919563|NCT00794417|10947512|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0
6919564|NCT00794417|10947513|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2
6919565|NCT00794417|10947514|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0
6919566|NCT00794417|10947511|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3
6919567|NCT00794417|10947512|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3
6919568|NCT00794417|10947513|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1
6919569|NCT00794417|10947514|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0
6919570|NCT00794417|10947511|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0
6919571|NCT00794417|10947512|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0
6919572|NCT00794417|10947513|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0
6919573|NCT00794417|10947514|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7
6919574|NCT00794417|10947511|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0
6919575|NCT00794417|10947512|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0
6919576|NCT00794417|10947513|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0
6919577|NCT00794417|10947514|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11
6919578|NCT00794417|10947511|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0
6919579|NCT00794417|10947512|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0
6919580|NCT00794417|10947513|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0
6919581|NCT00794417|10947514|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4
6919582|NCT00794417|10947511|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0
6919583|NCT00794417|10947512|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0
6919584|NCT00794417|10947513|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0
6919585|NCT00794417|10947514|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13
6919586|NCT00794573|10947558|FG000|Overall Study|Death|3
6919587|NCT00794573|10947559|FG001|Overall Study|Death|0
6919588|NCT00794573|10947558|FG000|Overall Study|Withdrawal by Subject|9
6919589|NCT00794573|10947559|FG001|Overall Study|Withdrawal by Subject|12
6919590|NCT00794573|10947558|FG000|Overall Study|Lost to Follow-up|26
6919591|NCT00794573|10947559|FG001|Overall Study|Lost to Follow-up|33
6919592|NCT00794664|10947567|FG000|Treatment Period|Withdrawal by Subject|0
6919593|NCT00794664|10947568|FG001|Treatment Period|Withdrawal by Subject|2
6919594|NCT00794664|10947567|FG000|Treatment Period|Protocol non-compliance|0
6919595|NCT00794664|10947568|FG001|Treatment Period|Protocol non-compliance|1
6919596|NCT00794664|10947567|FG000|Treatment Period|Other|0
6919597|NCT00794664|10947568|FG001|Treatment Period|Other|1
6919598|NCT00794664|10947567|FG000|Treatment Period|Adverse Event|1
6919599|NCT00794664|10947568|FG001|Treatment Period|Adverse Event|8
6919600|NCT00794664|10947567|FG000|Follow-up Period|Other|1
6919601|NCT00794664|10947568|FG001|Follow-up Period|Other|2
6919602|NCT00794664|10947567|FG000|Follow-up Period|Withdrawal by Subject|0
6919603|NCT00794664|10947568|FG001|Follow-up Period|Withdrawal by Subject|2
6919604|NCT00794664|10947567|FG000|Follow-up Period|Protocol non-compliance|0
6919605|NCT00794664|10947568|FG001|Follow-up Period|Protocol non-compliance|1
6919606|NCT00794820|10947574|FG000|Overall Study|Adverse Event|11
6919607|NCT00794820|10947574|FG000|Overall Study|Secondary Malignancies|2
6919608|NCT00794820|10947574|FG000|Overall Study|Resistant Disease|2
6919609|NCT00794820|10947574|FG000|Overall Study|Ineligible/Screen Failure|1
6919610|NCT00794950|10947578|FG000|BCG Induction|Withdrawal by Subject|2
6919611|NCT00794950|10947578|FG000|BCG Induction|ineligible|3
6919612|NCT00794950|10947578|FG000|BCG Induction|noncompliant w. BCG|1
6919613|NCT00794950|10947578|FG000|BCG Induction|Adverse Event|1
6919614|NCT00794950|10947578|FG000|Beginning Sunitinib Treatment|cystectomy|5
6919615|NCT00794950|10947578|FG000|Beginning Sunitinib Treatment|Physician Decision|5
6919616|NCT00794950|10947578|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1
6919617|NCT00794950|10947578|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1
6919618|NCT00794963|10947585|FG000|Overall Study|Withdrawal by Subject|1
6919619|NCT00794963|10947586|FG001|Overall Study|Withdrawal by Subject|4
6919620|NCT00795132|10947601|FG000|Overall Study|Death|1
6919621|NCT00795132|10947601|FG000|Overall Study|Relapse|2
6919622|NCT00795184|10947648|FG000|Overall Study|Tissue sampling incomplete/conclusive|8
6919623|NCT00795184|10947649|FG001|Overall Study|Tissue sampling incomplete/conclusive|13
6919624|NCT00795509|10947711|FG000|Overall Study|Protocol Violation|31
6919625|NCT00795535|10947715|FG000|Overall Study|incomplete data and technical problems|20
6919626|NCT00795600|10947721|FG000|Overall Study|Adverse Event|1
6919627|NCT00795600|10947722|FG001|Overall Study|Adverse Event|1
6919628|NCT00795600|10947721|FG000|Overall Study|Protocol Violation|1
6919629|NCT00795600|10947722|FG001|Overall Study|Protocol Violation|2
6919630|NCT00795600|10947721|FG000|Overall Study|Withdrawal by Subject|1
6919631|NCT00795600|10947722|FG001|Overall Study|Withdrawal by Subject|0
6919632|NCT00795600|10947721|FG000|Overall Study|Unclassified|1
6919633|NCT00795600|10947722|FG001|Overall Study|Unclassified|1
6919634|NCT00795639|10947730|FG000|Overall Study|Death|1
6919635|NCT00795639|10947731|FG001|Overall Study|Death|6
6919636|NCT00795639|10947730|FG000|Overall Study|Withdrawal by Subject|1
6919637|NCT00795639|10947731|FG001|Overall Study|Withdrawal by Subject|3
6919638|NCT00795639|10947730|FG000|Overall Study|Pregnancy|1
6919639|NCT00795639|10947731|FG001|Overall Study|Pregnancy|0
6919640|NCT00795639|10947730|FG000|Overall Study|Adverse Event|5
6919641|NCT00795639|10947731|FG001|Overall Study|Adverse Event|2
6919642|NCT00795639|10947730|FG000|Overall Study|Other|0
6919643|NCT00795639|10947731|FG001|Overall Study|Other|2
6919644|NCT00795639|10947730|FG000|Overall Study|Terminated by sponsor|13
6919645|NCT00795639|10947731|FG001|Overall Study|Terminated by sponsor|12
6919646|NCT00795639|10947730|FG000|Overall Study|Randomized and not treated|0
6919647|NCT00795639|10947731|FG001|Overall Study|Randomized and not treated|1
6919648|NCT00795704|10947739|FG000|Overall Study|Withdrawal by Subject|3
6919649|NCT00795704|10947740|FG001|Overall Study|Withdrawal by Subject|2
6979206|NCT01217073|11032994|FG005|Base Period|Protocol Violation|2
6919650|NCT00795704|10947739|FG000|Overall Study|Adverse Event|1
6919651|NCT00795704|10947740|FG001|Overall Study|Adverse Event|1
6919652|NCT00795717|10947748|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1
6919653|NCT00795717|10947749|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0
6919654|NCT00795717|10947748|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
6919655|NCT00795717|10947749|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
6919656|NCT00795717|10947748|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0
6919657|NCT00795717|10947749|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1
6919658|NCT00795717|10947748|FG000|Phase II|too busy|0
6919659|NCT00795717|10947749|FG001|Phase II|too busy|1
6919660|NCT00795821|10947762|FG000|Acute Treatment Phase|Adverse Event|23
6919661|NCT00795821|10947763|FG001|Acute Treatment Phase|Adverse Event|4
6919662|NCT00795821|10947762|FG000|Acute Treatment Phase|Death|1
6919663|NCT00795821|10947763|FG001|Acute Treatment Phase|Death|0
6919664|NCT00795821|10947762|FG000|Acute Treatment Phase|Lack of Efficacy|5
6919665|NCT00795821|10947763|FG001|Acute Treatment Phase|Lack of Efficacy|2
6919666|NCT00795821|10947762|FG000|Acute Treatment Phase|Lost to Follow-up|9
6919667|NCT00795821|10947763|FG001|Acute Treatment Phase|Lost to Follow-up|12
6919668|NCT00795821|10947762|FG000|Acute Treatment Phase|Physician Decision|1
6919669|NCT00795821|10947763|FG001|Acute Treatment Phase|Physician Decision|1
6919670|NCT00795821|10947762|FG000|Acute Treatment Phase|Protocol Violation|1
6919671|NCT00795821|10947763|FG001|Acute Treatment Phase|Protocol Violation|2
6919672|NCT00795821|10947762|FG000|Acute Treatment Phase|Withdrawal by Subject|16
6919673|NCT00795821|10947763|FG001|Acute Treatment Phase|Withdrawal by Subject|10
6919674|NCT00795821|10947762|FG000|Long-term Extension Phase|Adverse Event|25
6919675|NCT00795821|10947763|FG001|Long-term Extension Phase|Adverse Event|32
6919676|NCT00795821|10947762|FG000|Long-term Extension Phase|Lack of Efficacy|16
6919677|NCT00795821|10947763|FG001|Long-term Extension Phase|Lack of Efficacy|12
6919678|NCT00795821|10947762|FG000|Long-term Extension Phase|Lost to Follow-up|20
6919679|NCT00795821|10947763|FG001|Long-term Extension Phase|Lost to Follow-up|16
6919680|NCT00795821|10947762|FG000|Long-term Extension Phase|Physician Decision|1
6919681|NCT00795821|10947763|FG001|Long-term Extension Phase|Physician Decision|2
6919682|NCT00795821|10947762|FG000|Long-term Extension Phase|Protocol Violation|3
6919683|NCT00795821|10947763|FG001|Long-term Extension Phase|Protocol Violation|5
6919684|NCT00795821|10947762|FG000|Long-term Extension Phase|Withdrawal by Subject|25
6919685|NCT00795821|10947763|FG001|Long-term Extension Phase|Withdrawal by Subject|25
6919686|NCT00795821|10947762|FG000|Taper Phase|Adverse Event|2
6919687|NCT00795821|10947763|FG001|Taper Phase|Adverse Event|0
6919688|NCT00795821|10947762|FG000|Taper Phase|Lost to Follow-up|1
6919689|NCT00795821|10947763|FG001|Taper Phase|Lost to Follow-up|0
6919690|NCT00795821|10947762|FG000|Taper Phase|Physician Decision|2
6919691|NCT00795821|10947763|FG001|Taper Phase|Physician Decision|0
6919692|NCT00795821|10947762|FG000|Taper Phase|Withdrawal by Subject|4
6919693|NCT00795821|10947763|FG001|Taper Phase|Withdrawal by Subject|0
6919694|NCT00795886|10947779|FG000|Overall Study|Death|10
6919695|NCT00795951|10947784|FG000|Overall Study|Lost to Follow-up|1
6919696|NCT00795951|10947784|FG000|Overall Study|Withdrawal by Subject|1
6919697|NCT00796003|10947791|FG000|Overall Study|Disease Progression|2
6919698|NCT00796003|10947792|FG001|Overall Study|Disease Progression|13
6919699|NCT00796003|10947791|FG000|Overall Study|Adverse Event|1
6919700|NCT00796003|10947792|FG001|Overall Study|Adverse Event|7
6919701|NCT00796003|10947791|FG000|Overall Study|Specified organ function not met|0
6919702|NCT00796003|10947792|FG001|Overall Study|Specified organ function not met|1
6979207|NCT01217073|11032995|FG006|Base Period|Protocol Violation|0
6979208|NCT01217073|11032996|FG007|Base Period|Protocol Violation|0
7060245|NCT01915914|11156284|FG002|Acute Phase|"Not Achieved treatment success"|0
6919703|NCT00796003|10947791|FG000|Overall Study|Physician Decision|0
6919704|NCT00796003|10947792|FG001|Overall Study|Physician Decision|4
6919705|NCT00796003|10947791|FG000|Overall Study|Withdrawal by Subject|0
6919706|NCT00796003|10947792|FG001|Overall Study|Withdrawal by Subject|1
6919707|NCT00796003|10947791|FG000|Overall Study|Other|0
6919708|NCT00796003|10947792|FG001|Overall Study|Other|1
6919709|NCT00796003|10947791|FG000|Overall Study|Participants Not treated|0
6919710|NCT00796003|10947792|FG001|Overall Study|Participants Not treated|2
6974518|NCT01187953|11026456|FG000|Overall Study|Death|11
6974519|NCT01187953|11026457|FG001|Overall Study|Death|13
6974520|NCT01187953|11026456|FG000|Overall Study|Adverse Event|1
6974521|NCT01187953|11026457|FG001|Overall Study|Adverse Event|2
6974522|NCT01187953|11026456|FG000|Overall Study|Lost to Follow-up|0
6974523|NCT01187953|11026457|FG001|Overall Study|Lost to Follow-up|3
6974524|NCT01187953|11026456|FG000|Overall Study|Withdrawal by Subject|3
6974525|NCT01187953|11026457|FG001|Overall Study|Withdrawal by Subject|3
6974526|NCT01188226|11026467|FG000|Overall Study|Withdrawal by Subject|4
6974527|NCT01188343|11026484|FG000|Overall Study|Not vaccinated|0
6974528|NCT01188343|11026485|FG001|Overall Study|Not vaccinated|2
6974529|NCT01188343|11026486|FG002|Overall Study|Not vaccinated|1
6974530|NCT01188343|11026484|FG000|Overall Study|Withdrawal by Subject|1
6974531|NCT01188343|11026485|FG001|Overall Study|Withdrawal by Subject|24
6974532|NCT01188343|11026486|FG002|Overall Study|Withdrawal by Subject|0
6974533|NCT01188538|11026556|FG000|Overall Study|Lost to Follow-up|0
6974534|NCT01188538|11026557|FG001|Overall Study|Lost to Follow-up|1
6974535|NCT01188551|11026569|FG000|Overall Study|Pharmacy issues|1
6974536|NCT01188551|11026570|FG001|Overall Study|Pharmacy issues|0
6974537|NCT01188551|11026571|FG002|Overall Study|Pharmacy issues|0
6974538|NCT01188551|11026572|FG003|Overall Study|Pharmacy issues|0
6974539|NCT01188564|11026584|FG000|Double-blind Phase|randomized not treated|1
6979209|NCT01217073|11032989|FG000|Base Period|Withdrawal by Subject|4
6919711|NCT00796120|10947803|FG000|Overall Study|Death|3
6919712|NCT00796120|10947804|FG001|Overall Study|Death|0
6919713|NCT00796120|10947803|FG000|Overall Study|Adverse Event|11
6919714|NCT00796120|10947804|FG001|Overall Study|Adverse Event|6
6919715|NCT00796120|10947803|FG000|Overall Study|Progressive disease|22
6919716|NCT00796120|10947804|FG001|Overall Study|Progressive disease|13
6919717|NCT00796120|10947803|FG000|Overall Study|Participant refusal|3
6919718|NCT00796120|10947804|FG001|Overall Study|Participant refusal|4
6919719|NCT00796120|10947803|FG000|Overall Study|Other|6
6919720|NCT00796120|10947804|FG001|Overall Study|Other|17
6919721|NCT00796120|10947803|FG000|Overall Study|Physician Decision|16
6919722|NCT00796120|10947804|FG001|Overall Study|Physician Decision|17
6919723|NCT00796120|10947803|FG000|Overall Study|Randomized but not treated|0
6919724|NCT00796120|10947804|FG001|Overall Study|Randomized but not treated|3
6919725|NCT00796224|10947812|FG000|Overall Study|Adverse Event|1
6919726|NCT00796224|10947813|FG001|Overall Study|Adverse Event|0
6919727|NCT00796224|10947812|FG000|Overall Study|Protocol Violation|0
6919728|NCT00796224|10947813|FG001|Overall Study|Protocol Violation|1
6919729|NCT00796315|10947831|FG000|Overall Study|Protocol Violation|0
6919730|NCT00796315|10947832|FG001|Overall Study|Protocol Violation|1
6919731|NCT00796315|10947833|FG002|Overall Study|Protocol Violation|0
6919732|NCT00796328|10947844|FG000|Overall Study|experienced hypotension requiring tx|6
6919733|NCT00796367|10947851|FG000|Overall Study|Adverse Event|6
6919734|NCT00796367|10947852|FG001|Overall Study|Adverse Event|4
6919735|NCT00796367|10947853|FG002|Overall Study|Adverse Event|7
6919736|NCT00796367|10947851|FG000|Overall Study|Lost to Follow-up|5
6919737|NCT00796367|10947852|FG001|Overall Study|Lost to Follow-up|4
6919738|NCT00796367|10947853|FG002|Overall Study|Lost to Follow-up|21
6919739|NCT00796367|10947851|FG000|Overall Study|Withdrawal by Subject|9
6919740|NCT00796367|10947852|FG001|Overall Study|Withdrawal by Subject|11
6919741|NCT00796367|10947853|FG002|Overall Study|Withdrawal by Subject|12
6919742|NCT00796367|10947851|FG000|Overall Study|Lack of Efficacy|2
6919743|NCT00796367|10947852|FG001|Overall Study|Lack of Efficacy|1
6919744|NCT00796367|10947853|FG002|Overall Study|Lack of Efficacy|0
6919745|NCT00796367|10947851|FG000|Overall Study|non compliance|3
6919746|NCT00796367|10947852|FG001|Overall Study|non compliance|1
6919747|NCT00796367|10947853|FG002|Overall Study|non compliance|1
6919748|NCT00796367|10947851|FG000|Overall Study|Pregnancy|1
6919749|NCT00796367|10947852|FG001|Overall Study|Pregnancy|0
6919750|NCT00796367|10947853|FG002|Overall Study|Pregnancy|1
6919751|NCT00796367|10947851|FG000|Overall Study|Requirement for restricted medication|2
6979210|NCT01217073|11032990|FG001|Base Period|Withdrawal by Subject|5
6919752|NCT00796367|10947852|FG001|Overall Study|Requirement for restricted medication|0
6919753|NCT00796367|10947853|FG002|Overall Study|Requirement for restricted medication|2
6919754|NCT00796367|10947851|FG000|Overall Study|other|2
6919755|NCT00796367|10947852|FG001|Overall Study|other|4
6919756|NCT00796367|10947853|FG002|Overall Study|other|3
6919757|NCT00796419|10947863|FG000|Overall Study|Death|0
6919758|NCT00796419|10947864|FG001|Overall Study|Death|1
6919759|NCT00796445|10947872|FG000|Overall Study|Protocol Violation|5
6919760|NCT00796445|10947873|FG001|Overall Study|Protocol Violation|3
6919761|NCT00796445|10947872|FG000|Overall Study|Adverse event, serious fatal|10
6919762|NCT00796445|10947873|FG001|Overall Study|Adverse event, serious fatal|5
6919763|NCT00796445|10947872|FG000|Overall Study|Adverse event, non-fatal|4
6919764|NCT00796445|10947873|FG001|Overall Study|Adverse event, non-fatal|0
6919765|NCT00796445|10947872|FG000|Overall Study|Disease progression/recurrence|537
6919766|NCT00796445|10947873|FG001|Overall Study|Disease progression/recurrence|268
6919767|NCT00796445|10947872|FG000|Overall Study|Other|10
6919768|NCT00796445|10947873|FG001|Overall Study|Other|7
6919769|NCT00796445|10947872|FG000|Overall Study|Withdrawal by Subject|18
6919770|NCT00796445|10947873|FG001|Overall Study|Withdrawal by Subject|9
6919771|NCT00796445|10947872|FG000|Overall Study|Invalid Informed Consent Form|1
6979211|NCT01217073|11032991|FG002|Base Period|Withdrawal by Subject|5
6979212|NCT01217073|11032992|FG003|Base Period|Withdrawal by Subject|1
6979213|NCT01217073|11032993|FG004|Base Period|Withdrawal by Subject|5
6979214|NCT01217073|11032994|FG005|Base Period|Withdrawal by Subject|5
6979215|NCT01217073|11032995|FG006|Base Period|Withdrawal by Subject|0
6979216|NCT01217073|11032996|FG007|Base Period|Withdrawal by Subject|0
6979217|NCT01217073|11032989|FG000|Extension Period|Adverse Event|0
6979218|NCT01217073|11032990|FG001|Extension Period|Adverse Event|0
6979219|NCT01217073|11032991|FG002|Extension Period|Adverse Event|0
6979220|NCT01217073|11032992|FG003|Extension Period|Adverse Event|0
6979221|NCT01217073|11032993|FG004|Extension Period|Adverse Event|0
6979222|NCT01217073|11032994|FG005|Extension Period|Adverse Event|0
6919772|NCT00796445|10947873|FG001|Overall Study|Invalid Informed Consent Form|0
6919773|NCT00796549|10947887|FG000|Overall Study|Adverse Event|11
6919774|NCT00796549|10947887|FG000|Overall Study|not entered|149
6919775|NCT00796549|10947887|FG000|Overall Study|Other|2
6919776|NCT00796549|10947887|FG000|Overall Study|Progressive disease|56
6919777|NCT00796562|10947893|FG000|Overall Study|Death|49
6919778|NCT00796614|10947901|FG000|Overall Study|Adverse Event|1
6919779|NCT00796614|10947902|FG001|Overall Study|Adverse Event|2
6919780|NCT00796614|10947903|FG002|Overall Study|Adverse Event|0
6919781|NCT00796614|10947904|FG003|Overall Study|Adverse Event|0
6919782|NCT00796614|10947901|FG000|Overall Study|Protocol Violation|0
6919783|NCT00796614|10947902|FG001|Overall Study|Protocol Violation|0
6979223|NCT01217073|11032995|FG006|Extension Period|Adverse Event|19
6919784|NCT00796614|10947903|FG002|Overall Study|Protocol Violation|2
6919785|NCT00796614|10947904|FG003|Overall Study|Protocol Violation|0
6919786|NCT00796614|10947901|FG000|Overall Study|Lost to Follow-up|2
6919787|NCT00796614|10947902|FG001|Overall Study|Lost to Follow-up|2
6919788|NCT00796614|10947903|FG002|Overall Study|Lost to Follow-up|1
6919789|NCT00796614|10947904|FG003|Overall Study|Lost to Follow-up|0
6919790|NCT00796614|10947901|FG000|Overall Study|Withdrawal by Subject|1
6919791|NCT00796614|10947902|FG001|Overall Study|Withdrawal by Subject|0
6919792|NCT00796614|10947903|FG002|Overall Study|Withdrawal by Subject|0
6919793|NCT00796614|10947904|FG003|Overall Study|Withdrawal by Subject|1
6919794|NCT00796614|10947901|FG000|Overall Study|Other than stated|1
6919795|NCT00796614|10947902|FG001|Overall Study|Other than stated|0
6919796|NCT00796614|10947903|FG002|Overall Study|Other than stated|0
6919797|NCT00796614|10947904|FG003|Overall Study|Other than stated|0
6919798|NCT00796653|10947927|FG000|Overall Study|Adverse Event|19
6919799|NCT00796653|10947928|FG001|Overall Study|Adverse Event|16
6919800|NCT00796653|10947929|FG002|Overall Study|Adverse Event|16
6919801|NCT00796653|10947930|FG003|Overall Study|Adverse Event|16
6919802|NCT00796653|10947927|FG000|Overall Study|Lost to Follow-up|2
6919803|NCT00796653|10947928|FG001|Overall Study|Lost to Follow-up|1
6919804|NCT00796653|10947929|FG002|Overall Study|Lost to Follow-up|2
6919805|NCT00796653|10947930|FG003|Overall Study|Lost to Follow-up|3
6919806|NCT00796653|10947927|FG000|Overall Study|Withdrawal by Subject|16
6919807|NCT00796653|10947928|FG001|Overall Study|Withdrawal by Subject|8
6919808|NCT00796653|10947929|FG002|Overall Study|Withdrawal by Subject|8
6919809|NCT00796653|10947930|FG003|Overall Study|Withdrawal by Subject|13
6919810|NCT00796653|10947927|FG000|Overall Study|Lack of Efficacy|8
6919811|NCT00796653|10947928|FG001|Overall Study|Lack of Efficacy|1
6919812|NCT00796653|10947929|FG002|Overall Study|Lack of Efficacy|3
6919813|NCT00796653|10947930|FG003|Overall Study|Lack of Efficacy|2
6919814|NCT00796653|10947927|FG000|Overall Study|Non compliance with protocol|2
6919815|NCT00796653|10947928|FG001|Overall Study|Non compliance with protocol|2
6919816|NCT00796653|10947929|FG002|Overall Study|Non compliance with protocol|0
6919817|NCT00796653|10947930|FG003|Overall Study|Non compliance with protocol|2
6919818|NCT00796653|10947927|FG000|Overall Study|Other reason not described above|4
6919819|NCT00796653|10947928|FG001|Overall Study|Other reason not described above|9
6919820|NCT00796653|10947929|FG002|Overall Study|Other reason not described above|7
6919821|NCT00796653|10947930|FG003|Overall Study|Other reason not described above|4
6919822|NCT00796666|10947950|FG000|Overall Study|Death|2
6919823|NCT00796666|10947951|FG001|Overall Study|Death|4
6919824|NCT00796666|10947950|FG000|Overall Study|Withdrawal by Subject|2
6919825|NCT00796666|10947951|FG001|Overall Study|Withdrawal by Subject|0
6919826|NCT00796666|10947950|FG000|Overall Study|Adverse Event|7
6919827|NCT00796666|10947951|FG001|Overall Study|Adverse Event|5
6919828|NCT00796666|10947950|FG000|Overall Study|Protocol Violation|1
6919829|NCT00796666|10947951|FG001|Overall Study|Protocol Violation|0
6919830|NCT00796666|10947950|FG000|Overall Study|Other|1
6919831|NCT00796666|10947951|FG001|Overall Study|Other|0
6919832|NCT00796666|10947950|FG000|Overall Study|Terminated by sponsor|53
6919833|NCT00796666|10947951|FG001|Overall Study|Terminated by sponsor|55
6919834|NCT00796666|10947950|FG000|Overall Study|Randomized and not treated|1
6919835|NCT00796666|10947951|FG001|Overall Study|Randomized and not treated|0
6919836|NCT00796718|10947976|FG000|Overall Study|Adverse Event|2
6919837|NCT00796718|10947976|FG000|Overall Study|Exclusion Criteria|1
6919838|NCT00796718|10947976|FG000|Overall Study|Lost to Follow-up|5
6919839|NCT00796718|10947976|FG000|Overall Study|Withdrawal by Informed Consent|1
6919840|NCT00796757|10947995|FG000|Overall Study|Withdrawal by Subject|14
6919841|NCT00796757|10947995|FG000|Overall Study|Death|61
6919842|NCT00796757|10947995|FG000|Overall Study|Protocol Violation|1
6919843|NCT00796757|10947995|FG000|Overall Study|Participant noncompliance|1
6919844|NCT00796757|10947995|FG000|Overall Study|Investigator's decision|2
6919845|NCT00796757|10947995|FG000|Overall Study|Other|7
6919846|NCT00796822|10948001|FG000|Overall Study|Lost to Follow-up|2
6919847|NCT00796822|10948002|FG001|Overall Study|Lost to Follow-up|0
6919848|NCT00796822|10948001|FG000|Overall Study|Adverse Event|1
6919849|NCT00796822|10948002|FG001|Overall Study|Adverse Event|0
6919850|NCT00796978|10948017|FG000|Overall Study|Cardiac adverse event|5
6919851|NCT00796978|10948017|FG000|Overall Study|Adverse Event|4
6919852|NCT00796978|10948017|FG000|Overall Study|Withdrawal by Subject|3
6919853|NCT00796991|10948024|FG000|Overall Study|Adverse Event|0
6919854|NCT00796991|10948025|FG001|Overall Study|Adverse Event|0
6919855|NCT00796991|10948026|FG002|Overall Study|Adverse Event|1
6919856|NCT00796991|10948024|FG000|Overall Study|Death|2
6919857|NCT00796991|10948025|FG001|Overall Study|Death|0
6919858|NCT00796991|10948026|FG002|Overall Study|Death|0
6919859|NCT00796991|10948024|FG000|Overall Study|Disease Progression|10
6919860|NCT00796991|10948025|FG001|Overall Study|Disease Progression|9
6919861|NCT00796991|10948026|FG002|Overall Study|Disease Progression|7
6919862|NCT00796991|10948024|FG000|Overall Study|Study Drug Toxicity|3
6919863|NCT00796991|10948025|FG001|Overall Study|Study Drug Toxicity|3
6919864|NCT00796991|10948026|FG002|Overall Study|Study Drug Toxicity|5
6919865|NCT00796991|10948024|FG000|Overall Study|Withdrawal by Subject|0
6919866|NCT00796991|10948025|FG001|Overall Study|Withdrawal by Subject|0
6919867|NCT00796991|10948026|FG002|Overall Study|Withdrawal by Subject|1
6919868|NCT00797108|10948037|FG000|Overall Study|Adverse Event|1
6919869|NCT00797108|10948038|FG001|Overall Study|Adverse Event|0
6919870|NCT00797108|10948039|FG002|Overall Study|Adverse Event|3
6919871|NCT00797108|10948037|FG000|Overall Study|Did Not Meet Entrance Criteria|0
6919872|NCT00797108|10948038|FG001|Overall Study|Did Not Meet Entrance Criteria|1
6919873|NCT00797108|10948039|FG002|Overall Study|Did Not Meet Entrance Criteria|0
6919874|NCT00797108|10948037|FG000|Overall Study|Global Deterioration of Health Status|0
6919875|NCT00797108|10948038|FG001|Overall Study|Global Deterioration of Health Status|1
6919876|NCT00797108|10948039|FG002|Overall Study|Global Deterioration of Health Status|0
6919877|NCT00797108|10948037|FG000|Overall Study|Lack of Efficacy|1
6919878|NCT00797108|10948038|FG001|Overall Study|Lack of Efficacy|0
6919879|NCT00797108|10948039|FG002|Overall Study|Lack of Efficacy|1
6919880|NCT00797108|10948037|FG000|Overall Study|Other|0
6919881|NCT00797108|10948038|FG001|Overall Study|Other|0
6919882|NCT00797108|10948039|FG002|Overall Study|Other|2
6919883|NCT00797108|10948037|FG000|Overall Study|Randomized but not Treated|2
6919884|NCT00797108|10948038|FG001|Overall Study|Randomized but not Treated|0
6919885|NCT00797108|10948039|FG002|Overall Study|Randomized but not Treated|0
6919886|NCT00797225|10948055|FG000|Weeks 1 to 12|Adverse Event|0
6919887|NCT00797225|10948056|FG001|Weeks 1 to 12|Adverse Event|0
6919888|NCT00797225|10948057|FG002|Weeks 1 to 12|Adverse Event|1
6919889|NCT00797225|10948058|FG003|Weeks 1 to 12|Adverse Event|0
6919890|NCT00797225|10948059|FG004|Weeks 1 to 12|Adverse Event|0
6919891|NCT00797225|10948060|FG005|Weeks 1 to 12|Adverse Event|0
6919892|NCT00797225|10948061|FG006|Weeks 1 to 12|Adverse Event|0
6919893|NCT00797225|10948062|FG007|Weeks 1 to 12|Adverse Event|0
6919894|NCT00797225|10948055|FG000|Weeks 1 to 12|Non-compliance|0
6919895|NCT00797225|10948056|FG001|Weeks 1 to 12|Non-compliance|1
6919896|NCT00797225|10948057|FG002|Weeks 1 to 12|Non-compliance|0
6919897|NCT00797225|10948058|FG003|Weeks 1 to 12|Non-compliance|0
6919898|NCT00797225|10948059|FG004|Weeks 1 to 12|Non-compliance|0
6919899|NCT00797225|10948060|FG005|Weeks 1 to 12|Non-compliance|0
6919900|NCT00797225|10948061|FG006|Weeks 1 to 12|Non-compliance|0
6919901|NCT00797225|10948062|FG007|Weeks 1 to 12|Non-compliance|0
6919902|NCT00797225|10948055|FG000|Weeks 1 to 12|Lack of Efficacy|1
6919903|NCT00797225|10948056|FG001|Weeks 1 to 12|Lack of Efficacy|0
6919904|NCT00797225|10948057|FG002|Weeks 1 to 12|Lack of Efficacy|0
6919905|NCT00797225|10948058|FG003|Weeks 1 to 12|Lack of Efficacy|0
6919906|NCT00797225|10948059|FG004|Weeks 1 to 12|Lack of Efficacy|0
6919907|NCT00797225|10948060|FG005|Weeks 1 to 12|Lack of Efficacy|0
6919908|NCT00797225|10948061|FG006|Weeks 1 to 12|Lack of Efficacy|0
6919909|NCT00797225|10948062|FG007|Weeks 1 to 12|Lack of Efficacy|0
6919910|NCT00797225|10948055|FG000|Weeks 1 to 12|Sponsor Decision|1
6919911|NCT00797225|10948056|FG001|Weeks 1 to 12|Sponsor Decision|0
6919912|NCT00797225|10948057|FG002|Weeks 1 to 12|Sponsor Decision|0
6919913|NCT00797225|10948058|FG003|Weeks 1 to 12|Sponsor Decision|0
6919914|NCT00797225|10948059|FG004|Weeks 1 to 12|Sponsor Decision|0
6919915|NCT00797225|10948060|FG005|Weeks 1 to 12|Sponsor Decision|0
6919916|NCT00797225|10948061|FG006|Weeks 1 to 12|Sponsor Decision|0
6919917|NCT00797225|10948062|FG007|Weeks 1 to 12|Sponsor Decision|0
6919918|NCT00797225|10948055|FG000|Weeks 13 to 24|Non-compliance|0
6919919|NCT00797225|10948056|FG001|Weeks 13 to 24|Non-compliance|2
6919920|NCT00797225|10948057|FG002|Weeks 13 to 24|Non-compliance|0
6919921|NCT00797225|10948058|FG003|Weeks 13 to 24|Non-compliance|0
6919922|NCT00797225|10948059|FG004|Weeks 13 to 24|Non-compliance|0
6919923|NCT00797225|10948060|FG005|Weeks 13 to 24|Non-compliance|0
6919924|NCT00797225|10948061|FG006|Weeks 13 to 24|Non-compliance|0
6919925|NCT00797225|10948062|FG007|Weeks 13 to 24|Non-compliance|0
6919926|NCT00797225|10948055|FG000|Weeks 13 to 24|Withdrawal by Subject|0
6919927|NCT00797225|10948056|FG001|Weeks 13 to 24|Withdrawal by Subject|1
6919928|NCT00797225|10948057|FG002|Weeks 13 to 24|Withdrawal by Subject|1
6919929|NCT00797225|10948058|FG003|Weeks 13 to 24|Withdrawal by Subject|0
6919930|NCT00797225|10948059|FG004|Weeks 13 to 24|Withdrawal by Subject|0
6919931|NCT00797225|10948060|FG005|Weeks 13 to 24|Withdrawal by Subject|0
6919932|NCT00797225|10948061|FG006|Weeks 13 to 24|Withdrawal by Subject|0
6919933|NCT00797225|10948062|FG007|Weeks 13 to 24|Withdrawal by Subject|0
6919934|NCT00797225|10948055|FG000|Weeks 13 to 24|Lost to Follow-up|0
6919935|NCT00797225|10948056|FG001|Weeks 13 to 24|Lost to Follow-up|0
6919936|NCT00797225|10948057|FG002|Weeks 13 to 24|Lost to Follow-up|1
6919937|NCT00797225|10948058|FG003|Weeks 13 to 24|Lost to Follow-up|0
6919938|NCT00797225|10948059|FG004|Weeks 13 to 24|Lost to Follow-up|1
6919939|NCT00797225|10948060|FG005|Weeks 13 to 24|Lost to Follow-up|0
6919940|NCT00797225|10948061|FG006|Weeks 13 to 24|Lost to Follow-up|0
6919941|NCT00797225|10948062|FG007|Weeks 13 to 24|Lost to Follow-up|0
6919942|NCT00797225|10948055|FG000|Weeks 13 to 24|Adverse Event|0
6919943|NCT00797225|10948056|FG001|Weeks 13 to 24|Adverse Event|1
6919944|NCT00797225|10948057|FG002|Weeks 13 to 24|Adverse Event|0
6919945|NCT00797225|10948058|FG003|Weeks 13 to 24|Adverse Event|0
6919946|NCT00797225|10948059|FG004|Weeks 13 to 24|Adverse Event|0
6919947|NCT00797225|10948060|FG005|Weeks 13 to 24|Adverse Event|0
6919948|NCT00797225|10948061|FG006|Weeks 13 to 24|Adverse Event|1
6919949|NCT00797225|10948062|FG007|Weeks 13 to 24|Adverse Event|0
6919950|NCT00797225|10948055|FG000|Weeks 13 to 24|Sponsor Decision|0
6919951|NCT00797225|10948056|FG001|Weeks 13 to 24|Sponsor Decision|0
6919952|NCT00797225|10948057|FG002|Weeks 13 to 24|Sponsor Decision|0
6919953|NCT00797225|10948058|FG003|Weeks 13 to 24|Sponsor Decision|0
6919954|NCT00797225|10948059|FG004|Weeks 13 to 24|Sponsor Decision|0
6919955|NCT00797225|10948060|FG005|Weeks 13 to 24|Sponsor Decision|0
6919956|NCT00797225|10948061|FG006|Weeks 13 to 24|Sponsor Decision|1
6919957|NCT00797225|10948062|FG007|Weeks 13 to 24|Sponsor Decision|0
6979224|NCT01217073|11032996|FG007|Extension Period|Adverse Event|5
6979225|NCT01217073|11032989|FG000|Extension Period|ALT/AST|0
6979226|NCT01217073|11032990|FG001|Extension Period|ALT/AST|0
6979227|NCT01217073|11032991|FG002|Extension Period|ALT/AST|0
6979228|NCT01217073|11032992|FG003|Extension Period|ALT/AST|0
6979229|NCT01217073|11032993|FG004|Extension Period|ALT/AST|0
6979230|NCT01217073|11032994|FG005|Extension Period|ALT/AST|0
6979231|NCT01217073|11032995|FG006|Extension Period|ALT/AST|2
6979232|NCT01217073|11032996|FG007|Extension Period|ALT/AST|0
6979233|NCT01217073|11032989|FG000|Extension Period|Contraindication to study medication|0
6979234|NCT01217073|11032990|FG001|Extension Period|Contraindication to study medication|0
6979235|NCT01217073|11032991|FG002|Extension Period|Contraindication to study medication|0
6979236|NCT01217073|11032992|FG003|Extension Period|Contraindication to study medication|0
6979237|NCT01217073|11032993|FG004|Extension Period|Contraindication to study medication|0
6979238|NCT01217073|11032994|FG005|Extension Period|Contraindication to study medication|0
7082206|NCT02139644|11192567|FG005|Treatment Period|Withdrawal by Subject|2
6919958|NCT00797316|10948090|FG000|Overall Study|Administrative problems|1
6919959|NCT00797316|10948091|FG001|Overall Study|Administrative problems|0
6919960|NCT00797316|10948090|FG000|Overall Study|Adverse Event|5
6919961|NCT00797316|10948091|FG001|Overall Study|Adverse Event|3
6919962|NCT00797316|10948090|FG000|Overall Study|Lost to Follow-up|4
6919963|NCT00797316|10948091|FG001|Overall Study|Lost to Follow-up|8
6919964|NCT00797316|10948090|FG000|Overall Study|Protocol Deviation|1
6919965|NCT00797316|10948091|FG001|Overall Study|Protocol Deviation|2
6919966|NCT00797316|10948090|FG000|Overall Study|Patient withdrew consent|12
6919967|NCT00797316|10948091|FG001|Overall Study|Patient withdrew consent|6
6919968|NCT00797316|10948090|FG000|Overall Study|Unsatisfactory therapeutic effect|0
6919969|NCT00797316|10948091|FG001|Overall Study|Unsatisfactory therapeutic effect|13
6919970|NCT00797511|10948105|FG000|Overall Study|Withdrawal by Subject|1
6919971|NCT00797563|10948110|FG000|Overall Study|Adverse Event|1
6919972|NCT00797667|10948117|FG000|Overall Study|Lack of Efficacy|0
6919973|NCT00797667|10948118|FG001|Overall Study|Lack of Efficacy|1
6919974|NCT00797667|10948119|FG002|Overall Study|Lack of Efficacy|0
6919975|NCT00797667|10948117|FG000|Overall Study|Lost to Follow-up|8
6919976|NCT00797667|10948118|FG001|Overall Study|Lost to Follow-up|12
6919977|NCT00797667|10948119|FG002|Overall Study|Lost to Follow-up|2
6919978|NCT00797667|10948117|FG000|Overall Study|Physician Decision|3
6919979|NCT00797667|10948118|FG001|Overall Study|Physician Decision|1
6919980|NCT00797667|10948119|FG002|Overall Study|Physician Decision|0
6919981|NCT00797667|10948117|FG000|Overall Study|Pregnancy|2
6919982|NCT00797667|10948118|FG001|Overall Study|Pregnancy|0
6919983|NCT00797667|10948119|FG002|Overall Study|Pregnancy|0
6919984|NCT00797667|10948117|FG000|Overall Study|Protocol Violation|2
6919985|NCT00797667|10948118|FG001|Overall Study|Protocol Violation|7
6919986|NCT00797667|10948119|FG002|Overall Study|Protocol Violation|0
6919987|NCT00797667|10948117|FG000|Overall Study|Study Terminated by Sponsor|217
6919988|NCT00797667|10948118|FG001|Overall Study|Study Terminated by Sponsor|216
6919989|NCT00797667|10948119|FG002|Overall Study|Study Terminated by Sponsor|115
6919990|NCT00797667|10948117|FG000|Overall Study|Withdrawal by Subject|9
6919991|NCT00797667|10948118|FG001|Overall Study|Withdrawal by Subject|14
6919992|NCT00797667|10948119|FG002|Overall Study|Withdrawal by Subject|2
6919993|NCT00797667|10948117|FG000|Overall Study|Adverse Event|19
6919994|NCT00797667|10948118|FG001|Overall Study|Adverse Event|8
6919995|NCT00797667|10948119|FG002|Overall Study|Adverse Event|8
6919996|NCT00797732|10948129|FG000|Overall Study|Withdrawal by Subject|3
6919997|NCT00797732|10948130|FG001|Overall Study|Withdrawal by Subject|3
6919998|NCT00797732|10948131|FG002|Overall Study|Withdrawal by Subject|0
6919999|NCT00797732|10948129|FG000|Overall Study|Lost to Follow-up|1
6920000|NCT00797732|10948130|FG001|Overall Study|Lost to Follow-up|0
6920001|NCT00797732|10948131|FG002|Overall Study|Lost to Follow-up|0
6920002|NCT00797732|10948129|FG000|Overall Study|Death|1
6920003|NCT00797732|10948130|FG001|Overall Study|Death|0
6920004|NCT00797732|10948131|FG002|Overall Study|Death|0
6920005|NCT00797732|10948129|FG000|Overall Study|Not meet inclusion criteria|0
6920006|NCT00797732|10948130|FG001|Overall Study|Not meet inclusion criteria|0
6920007|NCT00797732|10948131|FG002|Overall Study|Not meet inclusion criteria|7
6920008|NCT00797732|10948129|FG000|Overall Study|Excluded due to time constraints|0
6920009|NCT00797732|10948130|FG001|Overall Study|Excluded due to time constraints|0
6920010|NCT00797732|10948131|FG002|Overall Study|Excluded due to time constraints|24
6920011|NCT00797732|10948129|FG000|Overall Study|Refused to Participate|0
6920012|NCT00797732|10948130|FG001|Overall Study|Refused to Participate|0
6920013|NCT00797732|10948131|FG002|Overall Study|Refused to Participate|123
6920014|NCT00797823|10948149|FG000|First Period (Initial Randomization)|Physician Decision|1
6979239|NCT01217073|11032995|FG006|Extension Period|Contraindication to study medication|1
6920015|NCT00797823|10948150|FG001|First Period (Initial Randomization)|Physician Decision|0
6920016|NCT00797823|10948151|FG002|First Period (Initial Randomization)|Physician Decision|0
6979240|NCT01217073|11032996|FG007|Extension Period|Contraindication to study medication|0
6979241|NCT01217073|11032989|FG000|Extension Period|Creatinine/eGFR|0
6979242|NCT01217073|11032990|FG001|Extension Period|Creatinine/eGFR|0
6979243|NCT01217073|11032991|FG002|Extension Period|Creatinine/eGFR|0
6920017|NCT00797862|10948161|FG000|Overall Study|Adverse Event|86
6920018|NCT00797862|10948162|FG001|Overall Study|Adverse Event|44
6920019|NCT00797862|10948163|FG002|Overall Study|Adverse Event|58
6920020|NCT00797862|10948161|FG000|Overall Study|Abnormal Test Procedure Result|0
6920021|NCT00797862|10948162|FG001|Overall Study|Abnormal Test Procedure Result|1
6920022|NCT00797862|10948163|FG002|Overall Study|Abnormal Test Procedure Result|1
6920023|NCT00797862|10948161|FG000|Overall Study|Lack of Efficacy|1
6920024|NCT00797862|10948162|FG001|Overall Study|Lack of Efficacy|7
6920025|NCT00797862|10948163|FG002|Overall Study|Lack of Efficacy|6
6920026|NCT00797862|10948161|FG000|Overall Study|No longer required study medication|1
6920027|NCT00797862|10948162|FG001|Overall Study|No longer required study medication|0
6920028|NCT00797862|10948163|FG002|Overall Study|No longer required study medication|0
6920029|NCT00797862|10948161|FG000|Overall Study|Withdrawal by Subject|14
6920030|NCT00797862|10948162|FG001|Overall Study|Withdrawal by Subject|7
6920031|NCT00797862|10948163|FG002|Overall Study|Withdrawal by Subject|7
6920032|NCT00797862|10948161|FG000|Overall Study|Lost to Follow-up|11
6920033|NCT00797862|10948162|FG001|Overall Study|Lost to Follow-up|0
6920034|NCT00797862|10948163|FG002|Overall Study|Lost to Follow-up|5
6920035|NCT00797862|10948161|FG000|Overall Study|Administrative Problem|4
6920036|NCT00797862|10948162|FG001|Overall Study|Administrative Problem|0
6920037|NCT00797862|10948163|FG002|Overall Study|Administrative Problem|0
6920038|NCT00797862|10948161|FG000|Overall Study|Protocol Violation|4
6920039|NCT00797862|10948162|FG001|Overall Study|Protocol Violation|6
6920040|NCT00797862|10948163|FG002|Overall Study|Protocol Violation|8
6920041|NCT00797862|10948161|FG000|Overall Study|Mis-randomized|3
6920042|NCT00797862|10948162|FG001|Overall Study|Mis-randomized|3
6920043|NCT00797862|10948163|FG002|Overall Study|Mis-randomized|1
6920044|NCT00797966|10948175|FG000|Phase A|Lost to Follow-up|0
6920045|NCT00797966|10948176|FG001|Phase A|Lost to Follow-up|0
6920046|NCT00797966|10948177|FG002|Phase A|Lost to Follow-up|0
6920047|NCT00797966|10948178|FG003|Phase A|Lost to Follow-up|0
6920048|NCT00797966|10948179|FG004|Phase A|Lost to Follow-up|33
6920049|NCT00797966|10948180|FG005|Phase A|Lost to Follow-up|0
6920050|NCT00797966|10948175|FG000|Phase A|Adverse Event|0
6920051|NCT00797966|10948176|FG001|Phase A|Adverse Event|0
6920052|NCT00797966|10948177|FG002|Phase A|Adverse Event|0
6920053|NCT00797966|10948178|FG003|Phase A|Adverse Event|0
6920054|NCT00797966|10948179|FG004|Phase A|Adverse Event|46
6920055|NCT00797966|10948180|FG005|Phase A|Adverse Event|0
6920056|NCT00797966|10948175|FG000|Phase A|Met withdrawal criteria|0
6920057|NCT00797966|10948176|FG001|Phase A|Met withdrawal criteria|0
6920058|NCT00797966|10948177|FG002|Phase A|Met withdrawal criteria|0
6920059|NCT00797966|10948178|FG003|Phase A|Met withdrawal criteria|0
6920060|NCT00797966|10948179|FG004|Phase A|Met withdrawal criteria|4
6920061|NCT00797966|10948180|FG005|Phase A|Met withdrawal criteria|0
6920062|NCT00797966|10948175|FG000|Phase A|Physician Decision|0
6920063|NCT00797966|10948176|FG001|Phase A|Physician Decision|0
6920064|NCT00797966|10948177|FG002|Phase A|Physician Decision|0
6920065|NCT00797966|10948178|FG003|Phase A|Physician Decision|0
6920066|NCT00797966|10948179|FG004|Phase A|Physician Decision|13
6920067|NCT00797966|10948180|FG005|Phase A|Physician Decision|0
6920068|NCT00797966|10948175|FG000|Phase A|Withdrawal by Subject|0
6920069|NCT00797966|10948176|FG001|Phase A|Withdrawal by Subject|0
6920070|NCT00797966|10948177|FG002|Phase A|Withdrawal by Subject|0
6920071|NCT00797966|10948178|FG003|Phase A|Withdrawal by Subject|0
6920072|NCT00797966|10948179|FG004|Phase A|Withdrawal by Subject|33
6920073|NCT00797966|10948180|FG005|Phase A|Withdrawal by Subject|0
6920074|NCT00797966|10948175|FG000|Phase A|Protocol deviation|0
6920075|NCT00797966|10948176|FG001|Phase A|Protocol deviation|0
6920076|NCT00797966|10948177|FG002|Phase A|Protocol deviation|0
6920077|NCT00797966|10948178|FG003|Phase A|Protocol deviation|0
6920078|NCT00797966|10948179|FG004|Phase A|Protocol deviation|56
6920079|NCT00797966|10948180|FG005|Phase A|Protocol deviation|0
6920080|NCT00797966|10948175|FG000|Phase B|Lost to Follow-up|0
6920081|NCT00797966|10948176|FG001|Phase B|Lost to Follow-up|1
6920082|NCT00797966|10948177|FG002|Phase B|Lost to Follow-up|3
6920083|NCT00797966|10948178|FG003|Phase B|Lost to Follow-up|0
6920084|NCT00797966|10948179|FG004|Phase B|Lost to Follow-up|0
6920085|NCT00797966|10948180|FG005|Phase B|Lost to Follow-up|0
6920086|NCT00797966|10948175|FG000|Phase B|Adverse Event|2
6920087|NCT00797966|10948176|FG001|Phase B|Adverse Event|1
6920088|NCT00797966|10948177|FG002|Phase B|Adverse Event|3
7082207|NCT02139644|11192562|FG000|Treatment Period|Non-compliance|0
6920089|NCT00797966|10948178|FG003|Phase B|Adverse Event|1
6920090|NCT00797966|10948179|FG004|Phase B|Adverse Event|0
6920091|NCT00797966|10948180|FG005|Phase B|Adverse Event|0
6920092|NCT00797966|10948175|FG000|Phase B|Met Withdrawal Criteria|3
6920093|NCT00797966|10948176|FG001|Phase B|Met Withdrawal Criteria|3
6920094|NCT00797966|10948177|FG002|Phase B|Met Withdrawal Criteria|6
6920095|NCT00797966|10948178|FG003|Phase B|Met Withdrawal Criteria|1
6920096|NCT00797966|10948179|FG004|Phase B|Met Withdrawal Criteria|0
6920097|NCT00797966|10948180|FG005|Phase B|Met Withdrawal Criteria|0
6920098|NCT00797966|10948175|FG000|Phase B|Physician Decision|1
6920099|NCT00797966|10948176|FG001|Phase B|Physician Decision|0
6920100|NCT00797966|10948177|FG002|Phase B|Physician Decision|3
6920101|NCT00797966|10948178|FG003|Phase B|Physician Decision|1
6920102|NCT00797966|10948179|FG004|Phase B|Physician Decision|0
6920103|NCT00797966|10948180|FG005|Phase B|Physician Decision|0
6920104|NCT00797966|10948175|FG000|Phase B|Withdrawal by Subject|1
6920105|NCT00797966|10948176|FG001|Phase B|Withdrawal by Subject|4
6920106|NCT00797966|10948177|FG002|Phase B|Withdrawal by Subject|3
6920107|NCT00797966|10948178|FG003|Phase B|Withdrawal by Subject|3
6920108|NCT00797966|10948179|FG004|Phase B|Withdrawal by Subject|0
6920109|NCT00797966|10948180|FG005|Phase B|Withdrawal by Subject|0
6920110|NCT00797966|10948175|FG000|Phase B|Protocol Deviation|4
6920111|NCT00797966|10948176|FG001|Phase B|Protocol Deviation|8
6920112|NCT00797966|10948177|FG002|Phase B|Protocol Deviation|2
6920113|NCT00797966|10948178|FG003|Phase B|Protocol Deviation|6
6920114|NCT00797966|10948179|FG004|Phase B|Protocol Deviation|0
6920115|NCT00797966|10948180|FG005|Phase B|Protocol Deviation|0
6920116|NCT00797966|10948175|FG000|Phase B|Lack of Efficacy|0
6920117|NCT00797966|10948176|FG001|Phase B|Lack of Efficacy|1
6920118|NCT00797966|10948177|FG002|Phase B|Lack of Efficacy|1
6920119|NCT00797966|10948178|FG003|Phase B|Lack of Efficacy|4
6920120|NCT00797966|10948179|FG004|Phase B|Lack of Efficacy|0
6920121|NCT00797966|10948180|FG005|Phase B|Lack of Efficacy|0
6920122|NCT00797966|10948175|FG000|Phase A+|Lost to Follow-up|0
6920123|NCT00797966|10948176|FG001|Phase A+|Lost to Follow-up|0
6920124|NCT00797966|10948177|FG002|Phase A+|Lost to Follow-up|0
6920125|NCT00797966|10948178|FG003|Phase A+|Lost to Follow-up|0
6920126|NCT00797966|10948179|FG004|Phase A+|Lost to Follow-up|0
6920127|NCT00797966|10948180|FG005|Phase A+|Lost to Follow-up|9
6920128|NCT00797966|10948175|FG000|Phase A+|Met withdrawal criteria|0
6920129|NCT00797966|10948176|FG001|Phase A+|Met withdrawal criteria|0
6920130|NCT00797966|10948177|FG002|Phase A+|Met withdrawal criteria|0
6920131|NCT00797966|10948178|FG003|Phase A+|Met withdrawal criteria|0
6920132|NCT00797966|10948179|FG004|Phase A+|Met withdrawal criteria|0
6920133|NCT00797966|10948180|FG005|Phase A+|Met withdrawal criteria|5
6920134|NCT00797966|10948175|FG000|Phase A+|Withdrawal by Subject|0
6920135|NCT00797966|10948176|FG001|Phase A+|Withdrawal by Subject|0
6920136|NCT00797966|10948177|FG002|Phase A+|Withdrawal by Subject|0
6920137|NCT00797966|10948178|FG003|Phase A+|Withdrawal by Subject|0
6920138|NCT00797966|10948179|FG004|Phase A+|Withdrawal by Subject|0
6920139|NCT00797966|10948180|FG005|Phase A+|Withdrawal by Subject|6
6920140|NCT00797966|10948175|FG000|Phase A+|Adverse Event|0
6920141|NCT00797966|10948176|FG001|Phase A+|Adverse Event|0
6920142|NCT00797966|10948177|FG002|Phase A+|Adverse Event|0
6920143|NCT00797966|10948178|FG003|Phase A+|Adverse Event|0
6920144|NCT00797966|10948179|FG004|Phase A+|Adverse Event|0
6920145|NCT00797966|10948180|FG005|Phase A+|Adverse Event|4
6920146|NCT00797966|10948175|FG000|Phase A+|Protocol deviation|0
6920147|NCT00797966|10948176|FG001|Phase A+|Protocol deviation|0
6920148|NCT00797966|10948177|FG002|Phase A+|Protocol deviation|0
6920149|NCT00797966|10948178|FG003|Phase A+|Protocol deviation|0
6920150|NCT00797966|10948179|FG004|Phase A+|Protocol deviation|0
6920151|NCT00797966|10948180|FG005|Phase A+|Protocol deviation|4
6920152|NCT00798096|10948209|FG000|Overall Study|Ongoing|2
6920153|NCT00798135|10948213|FG000|Overall Study|Disease progression, relapse|11
6920154|NCT00798135|10948213|FG000|Overall Study|Disease progression, refractory|1
6920155|NCT00798135|10948213|FG000|Overall Study|Physician Decision|1
6920156|NCT00798161|10948224|FG000|Overall Study|Adverse Event|3
6920157|NCT00798161|10948225|FG001|Overall Study|Adverse Event|4
6920158|NCT00798161|10948226|FG002|Overall Study|Adverse Event|6
6920159|NCT00798161|10948227|FG003|Overall Study|Adverse Event|6
6920160|NCT00798161|10948228|FG004|Overall Study|Adverse Event|5
6920161|NCT00798161|10948229|FG005|Overall Study|Adverse Event|2
6920162|NCT00798161|10948230|FG006|Overall Study|Adverse Event|4
6920163|NCT00798161|10948224|FG000|Overall Study|Protocol Violation|2
6920164|NCT00798161|10948225|FG001|Overall Study|Protocol Violation|1
6920165|NCT00798161|10948226|FG002|Overall Study|Protocol Violation|3
6920166|NCT00798161|10948227|FG003|Overall Study|Protocol Violation|3
6920167|NCT00798161|10948228|FG004|Overall Study|Protocol Violation|3
6920168|NCT00798161|10948229|FG005|Overall Study|Protocol Violation|2
6920169|NCT00798161|10948230|FG006|Overall Study|Protocol Violation|0
6920170|NCT00798161|10948224|FG000|Overall Study|Lost to Follow-up|1
6920171|NCT00798161|10948225|FG001|Overall Study|Lost to Follow-up|3
6920172|NCT00798161|10948226|FG002|Overall Study|Lost to Follow-up|4
6920173|NCT00798161|10948227|FG003|Overall Study|Lost to Follow-up|3
6920174|NCT00798161|10948228|FG004|Overall Study|Lost to Follow-up|4
6920175|NCT00798161|10948229|FG005|Overall Study|Lost to Follow-up|0
6920176|NCT00798161|10948230|FG006|Overall Study|Lost to Follow-up|0
6920177|NCT00798161|10948224|FG000|Overall Study|Withdrawal by Subject|5
6920178|NCT00798161|10948225|FG001|Overall Study|Withdrawal by Subject|4
6920179|NCT00798161|10948226|FG002|Overall Study|Withdrawal by Subject|5
6920180|NCT00798161|10948227|FG003|Overall Study|Withdrawal by Subject|4
6920181|NCT00798161|10948228|FG004|Overall Study|Withdrawal by Subject|2
6920182|NCT00798161|10948229|FG005|Overall Study|Withdrawal by Subject|3
6920183|NCT00798161|10948230|FG006|Overall Study|Withdrawal by Subject|1
6920184|NCT00798161|10948224|FG000|Overall Study|Other reason (incl. lack of efficacy)|7
6920185|NCT00798161|10948225|FG001|Overall Study|Other reason (incl. lack of efficacy)|5
6920186|NCT00798161|10948226|FG002|Overall Study|Other reason (incl. lack of efficacy)|3
6920187|NCT00798161|10948227|FG003|Overall Study|Other reason (incl. lack of efficacy)|5
6920188|NCT00798161|10948228|FG004|Overall Study|Other reason (incl. lack of efficacy)|2
6920189|NCT00798161|10948229|FG005|Overall Study|Other reason (incl. lack of efficacy)|4
6920190|NCT00798161|10948230|FG006|Overall Study|Other reason (incl. lack of efficacy)|5
6974540|NCT01188564|11026585|FG001|Double-blind Phase|randomized not treated|0
6920191|NCT00798174|10948246|FG000|Overall Study|inability to implant azygos coil|3
6920192|NCT00798174|10948247|FG001|Overall Study|inability to implant azygos coil|3
6920193|NCT00798174|10948246|FG000|Overall Study|Inability to sedate for DFT testing|1
6920194|NCT00798174|10948247|FG001|Overall Study|Inability to sedate for DFT testing|0
6920195|NCT00798304|10948254|FG000|Overall Study|Adverse Event|0
6920196|NCT00798304|10948255|FG001|Overall Study|Adverse Event|1
6920197|NCT00798304|10948256|FG002|Overall Study|Adverse Event|1
6920198|NCT00798304|10948254|FG000|Overall Study|Discontinuation by Sponsor|14
6920199|NCT00798304|10948255|FG001|Overall Study|Discontinuation by Sponsor|21
6920200|NCT00798304|10948256|FG002|Overall Study|Discontinuation by Sponsor|9
6920201|NCT00798317|10948266|FG000|Overall Study|Physician Decision|0
6920202|NCT00798317|10948267|FG001|Overall Study|Physician Decision|1
6920203|NCT00798317|10948266|FG000|Overall Study|Withdrawal by Subject|5
6920204|NCT00798317|10948267|FG001|Overall Study|Withdrawal by Subject|4
6920205|NCT00798317|10948266|FG000|Overall Study|Lost to Follow-up|2
6920206|NCT00798317|10948267|FG001|Overall Study|Lost to Follow-up|2
6920207|NCT00798317|10948266|FG000|Overall Study|Adverse Event|2
6920208|NCT00798317|10948267|FG001|Overall Study|Adverse Event|0
6920209|NCT00798317|10948266|FG000|Overall Study|Death|1
6920210|NCT00798317|10948267|FG001|Overall Study|Death|0
6920211|NCT00798369|10948279|FG000|Overall Study|Subject withdrew consent|0
6920212|NCT00798369|10948280|FG001|Overall Study|Subject withdrew consent|0
6920213|NCT00798369|10948281|FG002|Overall Study|Subject withdrew consent|1
6920214|NCT00798369|10948282|FG003|Overall Study|Subject withdrew consent|1
6920215|NCT00798369|10948283|FG004|Overall Study|Subject withdrew consent|0
6920216|NCT00798369|10948284|FG005|Overall Study|Subject withdrew consent|2
6920217|NCT00798369|10948279|FG000|Overall Study|Lost to Follow-up|1
6920218|NCT00798369|10948280|FG001|Overall Study|Lost to Follow-up|1
6920219|NCT00798369|10948281|FG002|Overall Study|Lost to Follow-up|1
6920220|NCT00798369|10948282|FG003|Overall Study|Lost to Follow-up|0
6920221|NCT00798369|10948283|FG004|Overall Study|Lost to Follow-up|1
6920222|NCT00798369|10948284|FG005|Overall Study|Lost to Follow-up|0
6920223|NCT00798369|10948279|FG000|Overall Study|Adminstrative problems|0
6920224|NCT00798369|10948280|FG001|Overall Study|Adminstrative problems|0
6920225|NCT00798369|10948281|FG002|Overall Study|Adminstrative problems|0
6920226|NCT00798369|10948282|FG003|Overall Study|Adminstrative problems|0
6920227|NCT00798369|10948283|FG004|Overall Study|Adminstrative problems|0
6920228|NCT00798369|10948284|FG005|Overall Study|Adminstrative problems|1
6920229|NCT00798434|10948301|FG000|Double-Blind|Adverse Event|22
6920230|NCT00798434|10948302|FG001|Double-Blind|Adverse Event|46
6920231|NCT00798434|10948301|FG000|Double-Blind|Death|0
6920232|NCT00798434|10948302|FG001|Double-Blind|Death|1
6920233|NCT00798434|10948301|FG000|Double-Blind|Lost to Follow-up|1
6920234|NCT00798434|10948302|FG001|Double-Blind|Lost to Follow-up|0
6920235|NCT00798434|10948301|FG000|Double-Blind|Lack of Efficacy|8
6920236|NCT00798434|10948302|FG001|Double-Blind|Lack of Efficacy|12
6920237|NCT00798434|10948301|FG000|Double-Blind|Withdrawal by Subject|17
6920238|NCT00798434|10948302|FG001|Double-Blind|Withdrawal by Subject|14
6920239|NCT00798434|10948301|FG000|Double-Blind|Protocol Violation|1
6920240|NCT00798434|10948302|FG001|Double-Blind|Protocol Violation|4
6920241|NCT00798434|10948301|FG000|Double-Blind|Did Not Meet Entrance Criteria|2
6920242|NCT00798434|10948302|FG001|Double-Blind|Did Not Meet Entrance Criteria|1
6920243|NCT00798434|10948301|FG000|Double-Blind|Other|1
6920244|NCT00798434|10948302|FG001|Double-Blind|Other|0
6920245|NCT00798434|10948301|FG000|Double-Blind|Not Treated|3
6920246|NCT00798434|10948302|FG001|Double-Blind|Not Treated|6
6920247|NCT00798434|10948301|FG000|Open-Label|Adverse Event|33
6920248|NCT00798434|10948302|FG001|Open-Label|Adverse Event|11
6920249|NCT00798434|10948301|FG000|Open-Label|Lack of Efficacy|5
6920250|NCT00798434|10948302|FG001|Open-Label|Lack of Efficacy|11
6920251|NCT00798434|10948301|FG000|Open-Label|Withdrawal by Subject|2
6920252|NCT00798434|10948302|FG001|Open-Label|Withdrawal by Subject|7
6920253|NCT00798434|10948301|FG000|Open-Label|Protocol Violation|1
6920254|NCT00798434|10948302|FG001|Open-Label|Protocol Violation|0
6920255|NCT00798434|10948301|FG000|Open-Label|Other|1
6920256|NCT00798434|10948302|FG001|Open-Label|Other|2
6920257|NCT00798434|10948301|FG000|Open-Label|Not Treated|0
6920258|NCT00798434|10948302|FG001|Open-Label|Not Treated|1
6920259|NCT00798603|10948326|FG000|Overall Study|Still on treatment as of 11/6/2012|1
6920260|NCT00798603|10948326|FG000|Overall Study|Withdrawal by Subject|10
6920261|NCT00798603|10948326|FG000|Overall Study|Adverse Event|22
6920262|NCT00798603|10948326|FG000|Overall Study|Physician Decision|1
6920263|NCT00798603|10948326|FG000|Overall Study|Lack of insurance coverage|1
6920264|NCT00798655|10948330|FG000|Overall Study|Did not receive at least one dose of pan|2
6920265|NCT00798694|10948336|FG000|Overall Study|Lost to Follow-up|1
6920266|NCT00798694|10948337|FG001|Overall Study|Lost to Follow-up|1
6920267|NCT00798694|10948336|FG000|Overall Study|Physician Decision|1
6920268|NCT00798694|10948337|FG001|Overall Study|Physician Decision|0
6920269|NCT00798707|10948352|FG000|Overall Study|Adverse Event|6
6920270|NCT00798707|10948353|FG001|Overall Study|Adverse Event|8
6920271|NCT00798707|10948354|FG002|Overall Study|Adverse Event|8
6920272|NCT00798707|10948352|FG000|Overall Study|Failed to return|2
6920273|NCT00798707|10948353|FG001|Overall Study|Failed to return|2
6920274|NCT00798707|10948354|FG002|Overall Study|Failed to return|0
6920275|NCT00798707|10948352|FG000|Overall Study|Investigator|0
6920276|NCT00798707|10948353|FG001|Overall Study|Investigator|1
6920277|NCT00798707|10948354|FG002|Overall Study|Investigator|2
6920278|NCT00798707|10948352|FG000|Overall Study|Lack of Efficacy|2
6920279|NCT00798707|10948353|FG001|Overall Study|Lack of Efficacy|2
6920280|NCT00798707|10948354|FG002|Overall Study|Lack of Efficacy|1
6920281|NCT00798707|10948352|FG000|Overall Study|Lost to Follow-up|5
6920282|NCT00798707|10948353|FG001|Overall Study|Lost to Follow-up|6
6920283|NCT00798707|10948354|FG002|Overall Study|Lost to Follow-up|6
6920284|NCT00798707|10948352|FG000|Overall Study|Other|0
6920285|NCT00798707|10948353|FG001|Overall Study|Other|1
6920286|NCT00798707|10948354|FG002|Overall Study|Other|0
6920287|NCT00798707|10948352|FG000|Overall Study|Protocol Violation|4
6920288|NCT00798707|10948353|FG001|Overall Study|Protocol Violation|0
6920289|NCT00798707|10948354|FG002|Overall Study|Protocol Violation|2
6920290|NCT00798707|10948352|FG000|Overall Study|Withdrawal by Subject|3
6920291|NCT00798707|10948353|FG001|Overall Study|Withdrawal by Subject|8
6920292|NCT00798707|10948354|FG002|Overall Study|Withdrawal by Subject|2
6920293|NCT00798707|10948352|FG000|Overall Study|Randomized not treated|4
6920294|NCT00798707|10948353|FG001|Overall Study|Randomized not treated|5
6920295|NCT00798707|10948354|FG002|Overall Study|Randomized not treated|1
6920296|NCT00798759|10948368|FG000|Overall Study|Adverse Event|3
6920297|NCT00798759|10948369|FG001|Overall Study|Adverse Event|3
6920298|NCT00798759|10948368|FG000|Overall Study|Lost to Follow-up|1
6920299|NCT00798759|10948369|FG001|Overall Study|Lost to Follow-up|1
6920300|NCT00798759|10948368|FG000|Overall Study|Protocol Violation|4
6920301|NCT00798759|10948369|FG001|Overall Study|Protocol Violation|8
6920302|NCT00798759|10948368|FG000|Overall Study|Other|0
6920303|NCT00798759|10948369|FG001|Overall Study|Other|1
6920304|NCT00798889|10948375|FG000|Overall Study|Adverse Event|53
6920305|NCT00798889|10948375|FG000|Overall Study|Protocol Violation|2
6920306|NCT00798889|10948375|FG000|Overall Study|Withdrawal by Subject|31
6920307|NCT00798889|10948375|FG000|Overall Study|Lost to Follow-up|1
6920308|NCT00798889|10948375|FG000|Overall Study|Lack of Efficacy|213
6920309|NCT00798889|10948375|FG000|Overall Study|Decision of Sponsor|11
6920310|NCT00798889|10948375|FG000|Overall Study|Enrolled, Not treated|3
6920311|NCT00798967|10948381|FG000|Overall Study|Adverse Event|2
6920312|NCT00798967|10948382|FG001|Overall Study|Adverse Event|3
6920313|NCT00798967|10948381|FG000|Overall Study|Withdrawal by Subject|0
6920314|NCT00798967|10948382|FG001|Overall Study|Withdrawal by Subject|1
6920315|NCT00798967|10948381|FG000|Overall Study|Physician Decision|1
6920316|NCT00798967|10948382|FG001|Overall Study|Physician Decision|0
6920317|NCT00798967|10948381|FG000|Overall Study|Randomized in error by site|1
6920318|NCT00798967|10948382|FG001|Overall Study|Randomized in error by site|0
6920319|NCT00799383|10948395|FG000|Overall Study|Protocol Violation|1
6920320|NCT00799383|10948396|FG001|Overall Study|Protocol Violation|1
6920321|NCT00799383|10948395|FG000|Overall Study|Adverse Event|0
6920322|NCT00799383|10948396|FG001|Overall Study|Adverse Event|1
6920323|NCT00799383|10948395|FG000|Overall Study|Lost to Follow-up|1
6920324|NCT00799383|10948396|FG001|Overall Study|Lost to Follow-up|2
6920325|NCT00799383|10948395|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1
6920326|NCT00799383|10948396|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1
6920327|NCT00799383|10948395|FG000|Overall Study|Withdrawal by Subject|0
6920328|NCT00799383|10948396|FG001|Overall Study|Withdrawal by Subject|1
6920329|NCT00799409|10948405|FG000|Overall Study|Withdrawal by Subject|1
6920330|NCT00799409|10948406|FG001|Overall Study|Withdrawal by Subject|0
6920331|NCT00799409|10948407|FG002|Overall Study|Withdrawal by Subject|0
6920332|NCT00799409|10948405|FG000|Overall Study|Lost to Follow-up|1
6920333|NCT00799409|10948406|FG001|Overall Study|Lost to Follow-up|0
6920334|NCT00799409|10948407|FG002|Overall Study|Lost to Follow-up|0
6920335|NCT00799409|10948405|FG000|Overall Study|Optimal Dose Not Achieved|2
6920336|NCT00799409|10948406|FG001|Overall Study|Optimal Dose Not Achieved|0
6920337|NCT00799409|10948407|FG002|Overall Study|Optimal Dose Not Achieved|0
6920338|NCT00799409|10948405|FG000|Overall Study|Failure to follow study protocol)|1
6920339|NCT00799409|10948406|FG001|Overall Study|Failure to follow study protocol)|0
6920340|NCT00799409|10948407|FG002|Overall Study|Failure to follow study protocol)|0
6920341|NCT00799409|10948405|FG000|Overall Study|Did not attend lab school day 1|1
6920342|NCT00799409|10948406|FG001|Overall Study|Did not attend lab school day 1|0
6920343|NCT00799409|10948407|FG002|Overall Study|Did not attend lab school day 1|0
6920344|NCT00799409|10948405|FG000|Overall Study|medication compliance|1
6920345|NCT00799409|10948406|FG001|Overall Study|medication compliance|0
6920346|NCT00799409|10948407|FG002|Overall Study|medication compliance|0
6920347|NCT00799422|10948415|FG000|First Week of Wear|Lost to Follow-up|0
6920348|NCT00799422|10948416|FG001|First Week of Wear|Lost to Follow-up|0
6920349|NCT00799422|10948417|FG002|First Week of Wear|Lost to Follow-up|1
6920350|NCT00799422|10948418|FG003|First Week of Wear|Lost to Follow-up|0
6920351|NCT00799422|10948419|FG004|First Week of Wear|Lost to Follow-up|0
6920352|NCT00799422|10948420|FG005|First Week of Wear|Lost to Follow-up|0
6920353|NCT00799422|10948415|FG000|First Week of Wear|Adverse Event|0
6920354|NCT00799422|10948416|FG001|First Week of Wear|Adverse Event|0
6920355|NCT00799422|10948417|FG002|First Week of Wear|Adverse Event|0
6920356|NCT00799422|10948418|FG003|First Week of Wear|Adverse Event|1
6920357|NCT00799422|10948419|FG004|First Week of Wear|Adverse Event|0
6920358|NCT00799422|10948420|FG005|First Week of Wear|Adverse Event|0
6920359|NCT00799487|10948444|FG000|Dose Adjustment Period|Lost to Follow-up|1
6920360|NCT00799487|10948445|FG001|Dose Adjustment Period|Lost to Follow-up|0
6920361|NCT00799487|10948446|FG002|Dose Adjustment Period|Lost to Follow-up|0
6920362|NCT00799487|10948444|FG000|Dose Adjustment Period|Adverse Event|2
6920363|NCT00799487|10948445|FG001|Dose Adjustment Period|Adverse Event|0
6920364|NCT00799487|10948446|FG002|Dose Adjustment Period|Adverse Event|0
6920365|NCT00799487|10948444|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8
6920366|NCT00799487|10948445|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0
6920367|NCT00799487|10948446|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0
6920368|NCT00799487|10948444|FG000|Dose Adjustment Period|Investigator Discretion|2
6920369|NCT00799487|10948445|FG001|Dose Adjustment Period|Investigator Discretion|0
6920370|NCT00799487|10948446|FG002|Dose Adjustment Period|Investigator Discretion|0
6920371|NCT00799487|10948444|FG000|Dose Adjustment Period|Withdrawal by Subject|3
6920372|NCT00799487|10948445|FG001|Dose Adjustment Period|Withdrawal by Subject|0
6920373|NCT00799487|10948446|FG002|Dose Adjustment Period|Withdrawal by Subject|0
6920374|NCT00799487|10948444|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1
6920375|NCT00799487|10948445|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0
6920376|NCT00799487|10948446|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0
6920377|NCT00799487|10948444|FG000|Dose Adjustment Period|Child too young (exclusion)|1
6920378|NCT00799487|10948445|FG001|Dose Adjustment Period|Child too young (exclusion)|0
6920379|NCT00799487|10948446|FG002|Dose Adjustment Period|Child too young (exclusion)|0
6920380|NCT00799487|10948444|FG000|Dose Adjustment Period|Missed laboratory day 1|1
6920381|NCT00799487|10948445|FG001|Dose Adjustment Period|Missed laboratory day 1|0
6920382|NCT00799487|10948446|FG002|Dose Adjustment Period|Missed laboratory day 1|0
6920383|NCT00799487|10948444|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2
6920384|NCT00799487|10948445|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
6920385|NCT00799487|10948446|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
6920386|NCT00799487|10948444|FG000|Double-Blind Assessment Period|Lost to Follow-up|0
6920387|NCT00799487|10948445|FG001|Double-Blind Assessment Period|Lost to Follow-up|0
6920388|NCT00799487|10948446|FG002|Double-Blind Assessment Period|Lost to Follow-up|1
6920389|NCT00799487|10948444|FG000|Double-Blind Assessment Period|Subject was out of the state|0
6920390|NCT00799487|10948445|FG001|Double-Blind Assessment Period|Subject was out of the state|0
6920391|NCT00799487|10948446|FG002|Double-Blind Assessment Period|Subject was out of the state|1
6920392|NCT00799487|10948444|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0
6920393|NCT00799487|10948445|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1
6920394|NCT00799487|10948446|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0
6920395|NCT00799591|10948461|FG000|Overall Study|De-escalation of doses|20
6920396|NCT00799591|10948461|FG000|Overall Study|Death|14
6920397|NCT00799591|10948461|FG000|Overall Study|Technical failure|12
6920398|NCT00799591|10948461|FG000|Overall Study|Resistant germ|11
6920399|NCT00799591|10948461|FG000|Overall Study|New infection|4
6920400|NCT00799591|10948461|FG000|Overall Study|Resistance germ and technical failure|2
6920401|NCT00799591|10948461|FG000|Overall Study|Persistance of fever undetermined origin|1
6920402|NCT00799591|10948461|FG000|Overall Study|Antibiotic changed, no apparent reason|1
6920403|NCT00799591|10948461|FG000|Overall Study|Infectious origin not probable|1
6920404|NCT00799617|10948480|FG000|Main Testosterone Trial|Randomized in error|1
6920405|NCT00799617|10948481|FG001|Main Testosterone Trial|Randomized in error|1
6920406|NCT00799617|10948480|FG000|Main Testosterone Trial|Lost to Follow-up|18
6920407|NCT00799617|10948481|FG001|Main Testosterone Trial|Lost to Follow-up|20
6920408|NCT00799617|10948480|FG000|Sexual Funtion Trial|Lost to Follow-up|12
6920409|NCT00799617|10948481|FG001|Sexual Funtion Trial|Lost to Follow-up|14
6920410|NCT00799617|10948480|FG000|Sexual Funtion Trial|No Baseline Data|4
6920411|NCT00799617|10948481|FG001|Sexual Funtion Trial|No Baseline Data|7
6920412|NCT00799617|10948480|FG000|Physical Function Trial|Lost to Follow-up|6
6920413|NCT00799617|10948481|FG001|Physical Function Trial|Lost to Follow-up|11
6920414|NCT00799617|10948480|FG000|Vitality Trial|Lost to Follow-up|7
6920415|NCT00799617|10948481|FG001|Vitality Trial|Lost to Follow-up|22
6920416|NCT00799617|10948480|FG000|Cardiovascular Trial|Month 12 scan not available|15
6920417|NCT00799617|10948481|FG001|Cardiovascular Trial|Month 12 scan not available|15
6920418|NCT00799617|10948480|FG000|Cardiovascular Trial|Baseline scan not analyzable|0
6920419|NCT00799617|10948481|FG001|Cardiovascular Trial|Baseline scan not analyzable|2
6920420|NCT00799617|10948480|FG000|Bone Trial|Month 12 scan not available|6
6920421|NCT00799617|10948481|FG001|Bone Trial|Month 12 scan not available|16
6920422|NCT00799617|10948480|FG000|Cognitive Function Trial|Lost to Follow-up|0
6920423|NCT00799617|10948481|FG001|Cognitive Function Trial|Lost to Follow-up|1
6920424|NCT00799617|10948480|FG000|Anemia Trial|Withdrawal by Subject|3
6920425|NCT00799617|10948481|FG001|Anemia Trial|Withdrawal by Subject|3
6920426|NCT00799708|10948500|FG000|Overall Study|non-compliance|1
6920427|NCT00799708|10948501|FG001|Overall Study|non-compliance|0
6920428|NCT00799708|10948502|FG002|Overall Study|non-compliance|0
6920429|NCT00799825|10948524|FG000|Overall Study|Adverse Event|1
6920430|NCT00799825|10948524|FG000|Overall Study|Withdrawal by Subject|6
6920431|NCT00799825|10948524|FG000|Overall Study|Lost to Follow-up|38
6920432|NCT00799825|10948524|FG000|Overall Study|Pregnancy|3
6920433|NCT00799903|10948530|FG000|Overall Study|Investigator Site Closed|25
6920434|NCT00799903|10948531|FG001|Overall Study|Investigator Site Closed|23
6920435|NCT00799903|10948530|FG000|Overall Study|Withdrawal by Subject|179
6920436|NCT00799903|10948531|FG001|Overall Study|Withdrawal by Subject|175
6920437|NCT00799903|10948530|FG000|Overall Study|Lost to Follow-up|69
6920438|NCT00799903|10948531|FG001|Overall Study|Lost to Follow-up|80
6920439|NCT00800176|10948557|FG000|Overall Study|Adverse Event|2
6920440|NCT00800176|10948558|FG001|Overall Study|Adverse Event|1
6920441|NCT00800176|10948559|FG002|Overall Study|Adverse Event|0
6920442|NCT00800176|10948560|FG003|Overall Study|Adverse Event|2
6920443|NCT00800176|10948561|FG004|Overall Study|Adverse Event|1
6920444|NCT00800176|10948562|FG005|Overall Study|Adverse Event|1
6920445|NCT00800176|10948557|FG000|Overall Study|Refused treatment|3
6920446|NCT00800176|10948558|FG001|Overall Study|Refused treatment|2
6920447|NCT00800176|10948559|FG002|Overall Study|Refused treatment|0
6920448|NCT00800176|10948560|FG003|Overall Study|Refused treatment|0
6920449|NCT00800176|10948561|FG004|Overall Study|Refused treatment|1
6920450|NCT00800176|10948562|FG005|Overall Study|Refused treatment|4
6920451|NCT00800176|10948557|FG000|Overall Study|Failure to return|3
6920452|NCT00800176|10948558|FG001|Overall Study|Failure to return|3
6920453|NCT00800176|10948559|FG002|Overall Study|Failure to return|0
6920454|NCT00800176|10948560|FG003|Overall Study|Failure to return|2
6920455|NCT00800176|10948561|FG004|Overall Study|Failure to return|0
6920456|NCT00800176|10948562|FG005|Overall Study|Failure to return|0
6920457|NCT00800176|10948557|FG000|Overall Study|Other|1
6920458|NCT00800176|10948558|FG001|Overall Study|Other|0
6920459|NCT00800176|10948559|FG002|Overall Study|Other|0
6920460|NCT00800176|10948560|FG003|Overall Study|Other|0
6920461|NCT00800176|10948561|FG004|Overall Study|Other|2
6920462|NCT00800176|10948562|FG005|Overall Study|Other|0
6920463|NCT00800202|10948578|FG000|Overall Study|Adverse Event|7
6920464|NCT00800202|10948579|FG001|Overall Study|Adverse Event|6
6920465|NCT00800202|10948578|FG000|Overall Study|Death|1
6920466|NCT00800202|10948579|FG001|Overall Study|Death|0
6920467|NCT00800202|10948578|FG000|Overall Study|Other|5
6920468|NCT00800202|10948579|FG001|Overall Study|Other|0
6920469|NCT00800202|10948578|FG000|Overall Study|Disease Progression|54
6920470|NCT00800202|10948579|FG001|Overall Study|Disease Progression|18
6920471|NCT00800384|10948600|FG000|Overall Study|Withdrawal by Subject|24
6920472|NCT00800384|10948601|FG001|Overall Study|Withdrawal by Subject|17
6920473|NCT00800384|10948600|FG000|Overall Study|Lost to Follow-up|17
6920474|NCT00800384|10948601|FG001|Overall Study|Lost to Follow-up|26
6920475|NCT00800436|10948615|FG000|Overall Study|Withdrawal by Subject|0
6920476|NCT00800436|10948616|FG001|Overall Study|Withdrawal by Subject|0
6920477|NCT00800436|10948617|FG002|Overall Study|Withdrawal by Subject|1
6920478|NCT00800436|10948618|FG003|Overall Study|Withdrawal by Subject|1
6920479|NCT00800436|10948619|FG004|Overall Study|Withdrawal by Subject|0
6920480|NCT00800436|10948620|FG005|Overall Study|Withdrawal by Subject|0
6920481|NCT00800436|10948621|FG006|Overall Study|Withdrawal by Subject|0
6920482|NCT00800540|10948637|FG000|Period One: 6 Weeks|Noncompliance|1
6920483|NCT00800540|10948638|FG001|Period One: 6 Weeks|Noncompliance|0
6920484|NCT00800540|10948637|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0
6920485|NCT00800540|10948638|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1
6920486|NCT00800540|10948637|FG000|Period 2: 6 Weeks|Adverse Event|0
6920487|NCT00800540|10948638|FG001|Period 2: 6 Weeks|Adverse Event|1
6920488|NCT00800683|10948646|FG000|Overall Study|Adverse Event|11
6920489|NCT00800683|10948647|FG001|Overall Study|Adverse Event|8
6920490|NCT00800683|10948646|FG000|Overall Study|Lost to Follow-up|3
6920491|NCT00800683|10948647|FG001|Overall Study|Lost to Follow-up|1
6920492|NCT00800683|10948646|FG000|Overall Study|Withdrawal by Subject|1
6920493|NCT00800683|10948647|FG001|Overall Study|Withdrawal by Subject|7
6920494|NCT00800683|10948646|FG000|Overall Study|Lack of Efficacy|1
6920495|NCT00800683|10948647|FG001|Overall Study|Lack of Efficacy|1
6920496|NCT00800683|10948646|FG000|Overall Study|Other|1
6920497|NCT00800683|10948647|FG001|Overall Study|Other|2
6920498|NCT00800735|10948653|FG000|Overall Study|Administrative/Other|2
6920499|NCT00800735|10948653|FG000|Overall Study|Insufficient Therapeutic Response|2
6920500|NCT00800735|10948653|FG000|Overall Study|Violation of Selection Criteria at Entry|7
6920501|NCT00800735|10948653|FG000|Overall Study|Withdrew Consent|3
6920502|NCT00800982|10948672|FG000|Overall Study|Lost to Follow-up|1
6920503|NCT00800982|10948673|FG001|Overall Study|Lost to Follow-up|2
6920504|NCT00800982|10948672|FG000|Overall Study|Withdrawal by Subject|0
6920505|NCT00800982|10948673|FG001|Overall Study|Withdrawal by Subject|1
6920506|NCT00800982|10948672|FG000|Overall Study|Patient moved out of state|1
6920507|NCT00800982|10948673|FG001|Overall Study|Patient moved out of state|0
6920508|NCT00801099|10948679|FG000|Overall Study|Lost to Follow-up|101
6920509|NCT00801229|10948702|FG000|Signed Consent|Withdrawal by Subject|2
6920510|NCT00801229|10948703|FG001|Signed Consent|Withdrawal by Subject|2
6920511|NCT00801229|10948702|FG000|Signed Consent|Found Ineligible|1
6920512|NCT00801229|10948703|FG001|Signed Consent|Found Ineligible|1
6920513|NCT00801229|10948702|FG000|Received Study Drug/Placebo|Elevated SGOT level|1
6920514|NCT00801229|10948703|FG001|Received Study Drug/Placebo|Elevated SGOT level|0
6920515|NCT00801229|10948702|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0
6920516|NCT00801229|10948703|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1
6920517|NCT00801229|10948702|FG000|Received Study Drug/Placebo|Simulator sickness|1
6920518|NCT00801229|10948703|FG001|Received Study Drug/Placebo|Simulator sickness|1
6920519|NCT00801229|10948702|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1
6920520|NCT00801229|10948703|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0
6920521|NCT00801229|10948702|FG000|Received Study Drug/Placebo|Lost to Follow-up|0
6920522|NCT00801229|10948703|FG001|Received Study Drug/Placebo|Lost to Follow-up|1
6920523|NCT00801229|10948702|FG000|Received Study Drug/Placebo|Adverse Event|1
6920524|NCT00801229|10948703|FG001|Received Study Drug/Placebo|Adverse Event|1
6920525|NCT00801242|10948709|FG000|Overall Study|Adverse Event|10
6920526|NCT00801242|10948709|FG000|Overall Study|Withdrawal by Subject|13
6920527|NCT00801242|10948709|FG000|Overall Study|Protocol Violation|5
6920528|NCT00801242|10948709|FG000|Overall Study|Physician Decision|3
6920529|NCT00801242|10948709|FG000|Overall Study|Lost to Follow-up|1
6920530|NCT00801242|10948709|FG000|Overall Study|Miscellaneous reasons|20
6920531|NCT00801632|10948752|FG000|Overall Study|Re-transplant|1
6920532|NCT00801892|10948793|FG000|Main Study Period|Withdrawal by Subject|0
6920533|NCT00801892|10948794|FG001|Main Study Period|Withdrawal by Subject|1
6920534|NCT00801892|10948793|FG000|Sham Crossover Period|Lost to Follow-up|0
6920535|NCT00801892|10948794|FG001|Sham Crossover Period|Lost to Follow-up|2
6920536|NCT00801983|10948804|FG000|Period 1|Lost to Follow-up|2
6920537|NCT00801983|10948805|FG001|Period 1|Lost to Follow-up|0
6920538|NCT00801983|10948804|FG000|Period 1|Withdrawal by Subject|2
6920539|NCT00801983|10948805|FG001|Period 1|Withdrawal by Subject|8
6920540|NCT00801983|10948804|FG000|Period 2|Withdrawal by Subject|2
6920541|NCT00801983|10948805|FG001|Period 2|Withdrawal by Subject|1
6920542|NCT00802074|10948817|FG000|Overall Study|Adverse Event|1
6920543|NCT00802074|10948818|FG001|Overall Study|Adverse Event|1
6920544|NCT00802074|10948819|FG002|Overall Study|Adverse Event|1
6920545|NCT00802074|10948820|FG003|Overall Study|Adverse Event|0
6920546|NCT00802074|10948821|FG004|Overall Study|Adverse Event|0
6920547|NCT00802074|10948822|FG005|Overall Study|Adverse Event|0
6920548|NCT00802074|10948817|FG000|Overall Study|Withdrawal by Subject|1
6920549|NCT00802074|10948818|FG001|Overall Study|Withdrawal by Subject|0
6920550|NCT00802074|10948819|FG002|Overall Study|Withdrawal by Subject|0
6920551|NCT00802074|10948820|FG003|Overall Study|Withdrawal by Subject|0
6920552|NCT00802074|10948821|FG004|Overall Study|Withdrawal by Subject|0
6920553|NCT00802074|10948822|FG005|Overall Study|Withdrawal by Subject|0
6920554|NCT00802178|10948862|FG000|Overall Study|Lack of Efficacy|36
6920555|NCT00802178|10948862|FG000|Overall Study|Insufficient tolerability (IT)|17
6920556|NCT00802178|10948862|FG000|Overall Study|Withdrawal by Subject|18
6920557|NCT00802178|10948862|FG000|Overall Study|Other|32
6920558|NCT00802178|10948862|FG000|Overall Study|Lack of efficacy and patient wish|1
6920559|NCT00802178|10948862|FG000|Overall Study|IT and patient wish|8
6920560|NCT00802178|10948862|FG000|Overall Study|Patients wish and other reason|1
6974541|NCT01188655|11026604|FG000|Overall Study|Lack of Efficacy|1
6974542|NCT01188655|11026604|FG000|Overall Study|Lost to Follow-up|1
6974543|NCT01188655|11026604|FG000|Overall Study|Other|11
6974544|NCT01188668|11026608|FG000|Period 1: ARIP Alone|Protocol Violation|2
6974545|NCT01188668|11026608|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2
6974546|NCT01188668|11026608|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1
6974547|NCT01188681|11026619|FG000|Overall Study|bladder cancer|0
6974548|NCT01188681|11026620|FG001|Overall Study|bladder cancer|0
6974549|NCT01188681|11026621|FG002|Overall Study|bladder cancer|1
6974550|NCT01188681|11026622|FG003|Overall Study|bladder cancer|0
6974551|NCT01188681|11026619|FG000|Overall Study|Withdrawal by Subject|0
6974552|NCT01188681|11026620|FG001|Overall Study|Withdrawal by Subject|0
6974553|NCT01188681|11026621|FG002|Overall Study|Withdrawal by Subject|0
6974554|NCT01188681|11026622|FG003|Overall Study|Withdrawal by Subject|1
6974555|NCT01188772|11026653|FG000|Overall Study|Randomized but Not Treated|0
6974556|NCT01188772|11026654|FG001|Overall Study|Randomized but Not Treated|1
6974557|NCT01188772|11026655|FG002|Overall Study|Randomized but Not Treated|0
6974558|NCT01188772|11026656|FG003|Overall Study|Randomized but Not Treated|0
6974559|NCT01188772|11026653|FG000|Overall Study|Adverse Event|0
6974560|NCT01188772|11026654|FG001|Overall Study|Adverse Event|1
6974561|NCT01188772|11026655|FG002|Overall Study|Adverse Event|2
6974562|NCT01188772|11026656|FG003|Overall Study|Adverse Event|0
6974563|NCT01188772|11026653|FG000|Overall Study|Lost to Follow-up|4
6974564|NCT01188772|11026654|FG001|Overall Study|Lost to Follow-up|1
6974565|NCT01188772|11026655|FG002|Overall Study|Lost to Follow-up|1
6974566|NCT01188772|11026656|FG003|Overall Study|Lost to Follow-up|1
6974567|NCT01188772|11026653|FG000|Overall Study|Non-responder|0
6974568|NCT01188772|11026654|FG001|Overall Study|Non-responder|0
6974569|NCT01188772|11026655|FG002|Overall Study|Non-responder|3
6974570|NCT01188772|11026656|FG003|Overall Study|Non-responder|0
6974571|NCT01188772|11026653|FG000|Overall Study|Physician Decision|0
6974572|NCT01188772|11026654|FG001|Overall Study|Physician Decision|0
6974573|NCT01188772|11026655|FG002|Overall Study|Physician Decision|1
6974574|NCT01188772|11026656|FG003|Overall Study|Physician Decision|0
6974575|NCT01188772|11026653|FG000|Overall Study|Terminated by Sponsor|0
6974576|NCT01188772|11026654|FG001|Overall Study|Terminated by Sponsor|0
6974577|NCT01188772|11026655|FG002|Overall Study|Terminated by Sponsor|1
6974578|NCT01188772|11026656|FG003|Overall Study|Terminated by Sponsor|0
6974579|NCT01188772|11026653|FG000|Overall Study|Treatment Failure|0
6974580|NCT01188772|11026654|FG001|Overall Study|Treatment Failure|0
6974581|NCT01188772|11026655|FG002|Overall Study|Treatment Failure|1
6974582|NCT01188772|11026656|FG003|Overall Study|Treatment Failure|0
6974583|NCT01188772|11026653|FG000|Overall Study|Virologic Failure|1
6974584|NCT01188772|11026654|FG001|Overall Study|Virologic Failure|0
6920561|NCT00802360|10948882|FG000|Overall Study|Stimulation failure|4
6920562|NCT00802360|10948883|FG001|Overall Study|Stimulation failure|0
6920563|NCT00802360|10948884|FG002|Overall Study|Stimulation failure|3
6920564|NCT00802360|10948885|FG003|Overall Study|Stimulation failure|3
6920565|NCT00802360|10948882|FG000|Overall Study|Inadequate number of oocytes retrieved|0
6920566|NCT00802360|10948883|FG001|Overall Study|Inadequate number of oocytes retrieved|0
6920567|NCT00802360|10948884|FG002|Overall Study|Inadequate number of oocytes retrieved|0
6920568|NCT00802360|10948885|FG003|Overall Study|Inadequate number of oocytes retrieved|1
6920569|NCT00802360|10948882|FG000|Overall Study|Cycle cancelled|0
6920570|NCT00802360|10948883|FG001|Overall Study|Cycle cancelled|1
6920571|NCT00802360|10948884|FG002|Overall Study|Cycle cancelled|1
6920572|NCT00802360|10948885|FG003|Overall Study|Cycle cancelled|1
6920573|NCT00802360|10948882|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0
6920574|NCT00802360|10948883|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0
6920575|NCT00802360|10948884|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0
6920576|NCT00802360|10948885|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1
6920577|NCT00802360|10948882|FG000|Overall Study|No positive serum pregnancy|17
6920578|NCT00802360|10948883|FG001|Overall Study|No positive serum pregnancy|20
6920579|NCT00802360|10948884|FG002|Overall Study|No positive serum pregnancy|14
6920580|NCT00802360|10948885|FG003|Overall Study|No positive serum pregnancy|10
6920581|NCT00802360|10948882|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1
6920582|NCT00802360|10948883|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0
6920583|NCT00802360|10948884|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1
6920584|NCT00802360|10948885|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0
6920585|NCT00802360|10948882|FG000|Overall Study|Pregnancy loss/miscarriage|0
6920586|NCT00802360|10948883|FG001|Overall Study|Pregnancy loss/miscarriage|2
6920587|NCT00802360|10948884|FG002|Overall Study|Pregnancy loss/miscarriage|0
6920588|NCT00802360|10948885|FG003|Overall Study|Pregnancy loss/miscarriage|3
6920589|NCT00802360|10948882|FG000|Overall Study|Other|2
6920590|NCT00802360|10948883|FG001|Overall Study|Other|3
6920591|NCT00802360|10948884|FG002|Overall Study|Other|6
6920592|NCT00802360|10948885|FG003|Overall Study|Other|3
6920593|NCT00802438|10948906|FG000|Overall Study|Screen Failure|20
6920594|NCT00802438|10948906|FG000|Overall Study|Withdrawal by Subject|7
6920595|NCT00802438|10948906|FG000|Overall Study|Physician Decision|1
6920596|NCT00802464|10948914|FG000|Month 0 - Month 8|Adverse Event|0
6920597|NCT00802464|10948915|FG001|Month 0 - Month 8|Adverse Event|1
6920598|NCT00802464|10948916|FG002|Month 0 - Month 8|Adverse Event|1
6920599|NCT00802464|10948917|FG003|Month 0 - Month 8|Adverse Event|2
6920600|NCT00802464|10948914|FG000|Month 0 - Month 8|Protocol Violation|0
6920601|NCT00802464|10948915|FG001|Month 0 - Month 8|Protocol Violation|0
6920602|NCT00802464|10948916|FG002|Month 0 - Month 8|Protocol Violation|1
6920603|NCT00802464|10948917|FG003|Month 0 - Month 8|Protocol Violation|0
6920604|NCT00802464|10948914|FG000|Month 0 - Month 8|Withdrawal by Subject|0
6920605|NCT00802464|10948915|FG001|Month 0 - Month 8|Withdrawal by Subject|1
6920606|NCT00802464|10948916|FG002|Month 0 - Month 8|Withdrawal by Subject|2
6920607|NCT00802464|10948917|FG003|Month 0 - Month 8|Withdrawal by Subject|5
6920608|NCT00802464|10948914|FG000|Month 0 - Month 8|Lost to Follow-up|0
6920609|NCT00802464|10948915|FG001|Month 0 - Month 8|Lost to Follow-up|1
6920610|NCT00802464|10948916|FG002|Month 0 - Month 8|Lost to Follow-up|2
6920611|NCT00802464|10948917|FG003|Month 0 - Month 8|Lost to Follow-up|2
6920612|NCT00802464|10948914|FG000|Month 0 - Month 8|Other|0
6920613|NCT00802464|10948915|FG001|Month 0 - Month 8|Other|0
6920614|NCT00802464|10948916|FG002|Month 0 - Month 8|Other|1
6920615|NCT00802464|10948917|FG003|Month 0 - Month 8|Other|0
6920616|NCT00802464|10948914|FG000|Month 8 - Month 14|Adverse Event|0
6920617|NCT00802464|10948915|FG001|Month 8 - Month 14|Adverse Event|1
6920618|NCT00802464|10948916|FG002|Month 8 - Month 14|Adverse Event|0
6920619|NCT00802464|10948917|FG003|Month 8 - Month 14|Adverse Event|0
6920620|NCT00802464|10948914|FG000|Month 8 - Month 14|Withdrawal by Subject|1
6920621|NCT00802464|10948915|FG001|Month 8 - Month 14|Withdrawal by Subject|1
6920622|NCT00802464|10948916|FG002|Month 8 - Month 14|Withdrawal by Subject|0
6920623|NCT00802464|10948917|FG003|Month 8 - Month 14|Withdrawal by Subject|0
6920624|NCT00802464|10948914|FG000|Month 8 - Month 14|Lost to Follow-up|0
6920625|NCT00802464|10948915|FG001|Month 8 - Month 14|Lost to Follow-up|0
6920626|NCT00802464|10948916|FG002|Month 8 - Month 14|Lost to Follow-up|1
6920627|NCT00802464|10948917|FG003|Month 8 - Month 14|Lost to Follow-up|0
6920628|NCT00802529|10948944|FG000|Overall Study|Lost to Follow-up|0
6920629|NCT00802529|10948945|FG001|Overall Study|Lost to Follow-up|1
6920630|NCT00802672|10948963|FG000|Overall Study|Lack of fungal pathogen at baseline|56
6920631|NCT00802672|10948964|FG001|Overall Study|Lack of fungal pathogen at baseline|43
6920632|NCT00802672|10948965|FG002|Overall Study|Lack of fungal pathogen at baseline|25
6920633|NCT00802672|10948963|FG000|Overall Study|Adverse Event|1
6920634|NCT00802672|10948964|FG001|Overall Study|Adverse Event|1
6920635|NCT00802672|10948965|FG002|Overall Study|Adverse Event|1
6920636|NCT00802672|10948963|FG000|Overall Study|Protocol Violation|2
6920637|NCT00802672|10948964|FG001|Overall Study|Protocol Violation|1
6920638|NCT00802672|10948965|FG002|Overall Study|Protocol Violation|1
6920639|NCT00802672|10948963|FG000|Overall Study|Lost to Follow-up|5
6920640|NCT00802672|10948964|FG001|Overall Study|Lost to Follow-up|5
6920641|NCT00802672|10948965|FG002|Overall Study|Lost to Follow-up|3
6920642|NCT00802672|10948963|FG000|Overall Study|Withdrawal by Subject|1
6920643|NCT00802672|10948964|FG001|Overall Study|Withdrawal by Subject|1
6920644|NCT00802672|10948965|FG002|Overall Study|Withdrawal by Subject|2
6920645|NCT00802672|10948963|FG000|Overall Study|other|3
6920646|NCT00802672|10948964|FG001|Overall Study|other|1
6920647|NCT00802672|10948965|FG002|Overall Study|other|2
6920648|NCT00802737|10948985|FG000|Overall Study|Withdrawn due to Disease Progression|9
6920649|NCT00802737|10948986|FG001|Overall Study|Withdrawn due to Disease Progression|3
6920650|NCT00802737|10948987|FG002|Overall Study|Withdrawn due to Disease Progression|0
6920651|NCT00802737|10948985|FG000|Overall Study|Death|6
6920652|NCT00802737|10948986|FG001|Overall Study|Death|5
6920653|NCT00802737|10948987|FG002|Overall Study|Death|1
6920654|NCT00802737|10948985|FG000|Overall Study|Adverse Event|1
6920655|NCT00802737|10948986|FG001|Overall Study|Adverse Event|0
6920656|NCT00802737|10948987|FG002|Overall Study|Adverse Event|0
6920657|NCT00802737|10948985|FG000|Overall Study|Received Prohibited Therapy|1
6920658|NCT00802737|10948986|FG001|Overall Study|Received Prohibited Therapy|0
6920659|NCT00802737|10948987|FG002|Overall Study|Received Prohibited Therapy|0
6920660|NCT00802737|10948985|FG000|Overall Study|Ongoing CLL-Treatment|0
6920661|NCT00802737|10948986|FG001|Overall Study|Ongoing CLL-Treatment|1
6920662|NCT00802737|10948987|FG002|Overall Study|Ongoing CLL-Treatment|0
6920663|NCT00802737|10948985|FG000|Overall Study|Participant too Unwell|0
6920664|NCT00802737|10948986|FG001|Overall Study|Participant too Unwell|2
6920665|NCT00802737|10948987|FG002|Overall Study|Participant too Unwell|0
6920666|NCT00802841|10948998|FG000|Overall Study|Administrative problems|1
6920667|NCT00802841|10948999|FG001|Overall Study|Administrative problems|0
6920668|NCT00802841|10948998|FG000|Overall Study|Lost to Follow-up|2
6920669|NCT00802841|10948999|FG001|Overall Study|Lost to Follow-up|1
6920670|NCT00802841|10948998|FG000|Overall Study|Death|1
6920671|NCT00802841|10948999|FG001|Overall Study|Death|2
6920672|NCT00802841|10948998|FG000|Overall Study|Adverse Event|8
6920673|NCT00802841|10948999|FG001|Overall Study|Adverse Event|2
6920674|NCT00802841|10948998|FG000|Overall Study|Disease progression|7
6920675|NCT00802841|10948999|FG001|Overall Study|Disease progression|3
6920676|NCT00802841|10948998|FG000|Overall Study|Withdrawal by Subject|9
6920677|NCT00802841|10948999|FG001|Overall Study|Withdrawal by Subject|5
6920678|NCT00802841|10948998|FG000|Overall Study|Protocol deviation|2
7143034|NCT03023878|11299374|FG000|Long Term Follow-Up Period|Death|2
7143035|NCT03024606|11299393|FG000|Overall Study|Withdrawal by Subject|9
7143036|NCT03024606|11299394|FG001|Overall Study|Withdrawal by Subject|10
7143037|NCT03024970|11299400|FG000|First Intervention|Adverse Event|1
7143038|NCT03024970|11299401|FG001|First Intervention|Adverse Event|0
7143039|NCT03024970|11299400|FG000|Second Intervention|Lost to Follow-up|1
6920679|NCT00802841|10948999|FG001|Overall Study|Protocol deviation|6
6920680|NCT00802841|10948998|FG000|Overall Study|Treatment duration completed|66
6920681|NCT00802841|10948999|FG001|Overall Study|Treatment duration completed|76
6920682|NCT00802867|10949011|FG000|Overall Study|Lost to Follow-up|6
6920683|NCT00802867|10949011|FG000|Overall Study|Protocol Violation|6
6920684|NCT00802867|10949011|FG000|Overall Study|Withdrawal by Subject|1
6920685|NCT00802945|10949035|FG000|Overall Study|Death|27
6920686|NCT00802945|10949036|FG001|Overall Study|Death|23
6920687|NCT00802945|10949035|FG000|Overall Study|Terminated by sponsor|8
6920688|NCT00802945|10949036|FG001|Overall Study|Terminated by sponsor|12
6920689|NCT00803023|10949066|FG000|Overall Study|Adverse Event|5
6920690|NCT00803023|10949067|FG001|Overall Study|Adverse Event|4
6920691|NCT00803023|10949068|FG002|Overall Study|Adverse Event|8
6920692|NCT00803023|10949069|FG003|Overall Study|Adverse Event|6
6920693|NCT00803023|10949066|FG000|Overall Study|Withdrawal by Subject|0
6920694|NCT00803023|10949067|FG001|Overall Study|Withdrawal by Subject|2
6920695|NCT00803023|10949068|FG002|Overall Study|Withdrawal by Subject|0
6920696|NCT00803023|10949069|FG003|Overall Study|Withdrawal by Subject|0
6920697|NCT00803023|10949066|FG000|Overall Study|Lost to Follow-up|0
6920698|NCT00803023|10949067|FG001|Overall Study|Lost to Follow-up|1
6920699|NCT00803023|10949068|FG002|Overall Study|Lost to Follow-up|2
6920700|NCT00803023|10949069|FG003|Overall Study|Lost to Follow-up|1
6920701|NCT00803023|10949066|FG000|Overall Study|Lack of Efficacy|0
6920702|NCT00803023|10949067|FG001|Overall Study|Lack of Efficacy|1
6920703|NCT00803023|10949068|FG002|Overall Study|Lack of Efficacy|1
6920704|NCT00803023|10949069|FG003|Overall Study|Lack of Efficacy|1
6920705|NCT00803049|10949083|FG000|Overall Study|Adverse Event|21
6920706|NCT00803049|10949084|FG001|Overall Study|Adverse Event|33
6920707|NCT00803049|10949085|FG002|Overall Study|Adverse Event|13
6920708|NCT00803049|10949086|FG003|Overall Study|Adverse Event|27
6920709|NCT00803049|10949083|FG000|Overall Study|Lack of Efficacy|10
6920710|NCT00803049|10949084|FG001|Overall Study|Lack of Efficacy|19
6920711|NCT00803049|10949085|FG002|Overall Study|Lack of Efficacy|6
6920712|NCT00803049|10949086|FG003|Overall Study|Lack of Efficacy|13
6979244|NCT01217073|11032992|FG003|Extension Period|Creatinine/eGFR|0
7143040|NCT03024970|11299401|FG001|Second Intervention|Lost to Follow-up|0
7143041|NCT03025217|11299407|FG000|Overall Study|Pregnancy|1
6920713|NCT00803049|10949083|FG000|Overall Study|Lost to Follow-up|0
6920714|NCT00803049|10949084|FG001|Overall Study|Lost to Follow-up|2
6920715|NCT00803049|10949085|FG002|Overall Study|Lost to Follow-up|0
6920716|NCT00803049|10949086|FG003|Overall Study|Lost to Follow-up|3
6920717|NCT00803049|10949083|FG000|Overall Study|Death|2
6979245|NCT01217073|11032993|FG004|Extension Period|Creatinine/eGFR|0
6920718|NCT00803049|10949084|FG001|Overall Study|Death|1
6920719|NCT00803049|10949085|FG002|Overall Study|Death|0
6920720|NCT00803049|10949086|FG003|Overall Study|Death|2
6920721|NCT00803049|10949083|FG000|Overall Study|Progressive Disease|6
6920722|NCT00803049|10949084|FG001|Overall Study|Progressive Disease|10
6920723|NCT00803049|10949085|FG002|Overall Study|Progressive Disease|6
6920724|NCT00803049|10949086|FG003|Overall Study|Progressive Disease|6
6920725|NCT00803049|10949083|FG000|Overall Study|Withdrawal by Subject|19
6920726|NCT00803049|10949084|FG001|Overall Study|Withdrawal by Subject|43
6920727|NCT00803049|10949085|FG002|Overall Study|Withdrawal by Subject|16
6920728|NCT00803049|10949086|FG003|Overall Study|Withdrawal by Subject|44
6920729|NCT00803049|10949083|FG000|Overall Study|Protocol Violation|0
6920730|NCT00803049|10949084|FG001|Overall Study|Protocol Violation|1
6920731|NCT00803049|10949085|FG002|Overall Study|Protocol Violation|1
6920732|NCT00803049|10949086|FG003|Overall Study|Protocol Violation|0
6920733|NCT00803049|10949083|FG000|Overall Study|Randomized and Not Treated|0
6920734|NCT00803049|10949084|FG001|Overall Study|Randomized and Not Treated|0
6920735|NCT00803049|10949085|FG002|Overall Study|Randomized and Not Treated|0
6920736|NCT00803049|10949086|FG003|Overall Study|Randomized and Not Treated|2
6920737|NCT00803049|10949083|FG000|Overall Study|Other than Specified Above|3
6920738|NCT00803049|10949084|FG001|Overall Study|Other than Specified Above|9
6920739|NCT00803049|10949085|FG002|Overall Study|Other than Specified Above|2
6920740|NCT00803049|10949086|FG003|Overall Study|Other than Specified Above|5
6920741|NCT00803101|10949115|FG000|Overall Study|Death / Serious Adverse Event|4
6920742|NCT00803101|10949116|FG001|Overall Study|Death / Serious Adverse Event|6
6920743|NCT00803101|10949115|FG000|Overall Study|Withdrawal by Subject|6
6920744|NCT00803101|10949116|FG001|Overall Study|Withdrawal by Subject|4
6920745|NCT00803101|10949115|FG000|Overall Study|Lost to Follow-up|2
6920746|NCT00803101|10949116|FG001|Overall Study|Lost to Follow-up|2
6920747|NCT00803101|10949115|FG000|Overall Study|Protocol Violation|1
6920748|NCT00803101|10949116|FG001|Overall Study|Protocol Violation|7
6920749|NCT00803101|10949115|FG000|Overall Study|Surgery finished outside protocol window|1
6920750|NCT00803101|10949116|FG001|Overall Study|Surgery finished outside protocol window|1
6920751|NCT00803101|10949115|FG000|Overall Study|Patient died outside SAE report period|1
6920752|NCT00803101|10949116|FG001|Overall Study|Patient died outside SAE report period|0
6920753|NCT00803101|10949115|FG000|Overall Study|Patient did not attend scheduled visit|2
6920754|NCT00803101|10949116|FG001|Overall Study|Patient did not attend scheduled visit|1
6920755|NCT00803101|10949115|FG000|Overall Study|Patient did not have surgery|1
6920756|NCT00803101|10949116|FG001|Overall Study|Patient did not have surgery|1
6920757|NCT00803205|10949124|FG000|Overall Study|Adverse Event|7
6979246|NCT01217073|11032994|FG005|Extension Period|Creatinine/eGFR|0
6979247|NCT01217073|11032995|FG006|Extension Period|Creatinine/eGFR|11
6979248|NCT01217073|11032996|FG007|Extension Period|Creatinine/eGFR|1
6979249|NCT01217073|11032989|FG000|Extension Period|Death|0
6979250|NCT01217073|11032990|FG001|Extension Period|Death|0
6979251|NCT01217073|11032991|FG002|Extension Period|Death|0
6979252|NCT01217073|11032992|FG003|Extension Period|Death|0
6979253|NCT01217073|11032993|FG004|Extension Period|Death|0
6979254|NCT01217073|11032994|FG005|Extension Period|Death|0
6979255|NCT01217073|11032995|FG006|Extension Period|Death|1
6979256|NCT01217073|11032996|FG007|Extension Period|Death|0
6979257|NCT01217073|11032989|FG000|Extension Period|Excluded medication|0
6979258|NCT01217073|11032990|FG001|Extension Period|Excluded medication|0
6979259|NCT01217073|11032991|FG002|Extension Period|Excluded medication|0
6979260|NCT01217073|11032992|FG003|Extension Period|Excluded medication|0
6979261|NCT01217073|11032993|FG004|Extension Period|Excluded medication|0
6979262|NCT01217073|11032994|FG005|Extension Period|Excluded medication|0
6979263|NCT01217073|11032995|FG006|Extension Period|Excluded medication|2
6979264|NCT01217073|11032996|FG007|Extension Period|Excluded medication|0
6979265|NCT01217073|11032989|FG000|Extension Period|Lack of Efficacy|0
6979266|NCT01217073|11032990|FG001|Extension Period|Lack of Efficacy|0
6979267|NCT01217073|11032991|FG002|Extension Period|Lack of Efficacy|0
6979268|NCT01217073|11032992|FG003|Extension Period|Lack of Efficacy|0
6979269|NCT01217073|11032993|FG004|Extension Period|Lack of Efficacy|0
6979270|NCT01217073|11032994|FG005|Extension Period|Lack of Efficacy|0
6979271|NCT01217073|11032995|FG006|Extension Period|Lack of Efficacy|3
6979272|NCT01217073|11032996|FG007|Extension Period|Lack of Efficacy|0
6979273|NCT01217073|11032989|FG000|Extension Period|Lost to Follow-up|0
6920758|NCT00803205|10949125|FG001|Overall Study|Adverse Event|2
6920759|NCT00803205|10949124|FG000|Overall Study|Lost to Follow-up|1
6920760|NCT00803205|10949125|FG001|Overall Study|Lost to Follow-up|0
6920761|NCT00803205|10949124|FG000|Overall Study|Withdrawal by Subject|9
6920762|NCT00803205|10949125|FG001|Overall Study|Withdrawal by Subject|9
6920763|NCT00803205|10949124|FG000|Overall Study|Physician Decision|1
6920764|NCT00803205|10949125|FG001|Overall Study|Physician Decision|0
6920765|NCT00803205|10949124|FG000|Overall Study|Protocol Violation|1
6920766|NCT00803205|10949125|FG001|Overall Study|Protocol Violation|1
6979274|NCT01217073|11032990|FG001|Extension Period|Lost to Follow-up|0
6979275|NCT01217073|11032991|FG002|Extension Period|Lost to Follow-up|0
6979276|NCT01217073|11032992|FG003|Extension Period|Lost to Follow-up|0
6979277|NCT01217073|11032993|FG004|Extension Period|Lost to Follow-up|0
6979278|NCT01217073|11032994|FG005|Extension Period|Lost to Follow-up|0
6979279|NCT01217073|11032995|FG006|Extension Period|Lost to Follow-up|9
6979280|NCT01217073|11032996|FG007|Extension Period|Lost to Follow-up|1
6920767|NCT00803205|10949124|FG000|Overall Study|Medical Monitor Decision|1
6920768|NCT00803205|10949125|FG001|Overall Study|Medical Monitor Decision|0
6920769|NCT00803205|10949124|FG000|Overall Study|Acquired a Lung Infection|0
6920770|NCT00803205|10949125|FG001|Overall Study|Acquired a Lung Infection|1
6920771|NCT00803205|10949124|FG000|Overall Study|Sponsor Decision|0
6920772|NCT00803205|10949125|FG001|Overall Study|Sponsor Decision|1
6920773|NCT00803244|10949133|FG000|Overall Study|Adverse Event|1
6920774|NCT00803244|10949134|FG001|Overall Study|Adverse Event|2
6920775|NCT00803244|10949133|FG000|Overall Study|Withdrawal by Subject|2
6920776|NCT00803244|10949134|FG001|Overall Study|Withdrawal by Subject|3
6920777|NCT00803244|10949133|FG000|Overall Study|Any other reason not above-mentioned|4
6920778|NCT00803244|10949134|FG001|Overall Study|Any other reason not above-mentioned|10
6920779|NCT00803270|10949142|FG000|Overall Study|Lost to Follow-up|1
6920780|NCT00803270|10949143|FG001|Overall Study|Lost to Follow-up|2
6920781|NCT00803361|10949151|FG000|Overall Study|Adverse Event|13
6920782|NCT00803361|10949152|FG001|Overall Study|Adverse Event|3
6920783|NCT00803361|10949151|FG000|Overall Study|Lack of Efficacy|4
6920784|NCT00803361|10949152|FG001|Overall Study|Lack of Efficacy|13
6920785|NCT00803361|10949151|FG000|Overall Study|Lost to Follow-up|1
6920786|NCT00803361|10949152|FG001|Overall Study|Lost to Follow-up|2
6920787|NCT00803361|10949151|FG000|Overall Study|Physician Decision|1
6920788|NCT00803361|10949152|FG001|Overall Study|Physician Decision|0
6920789|NCT00803361|10949151|FG000|Overall Study|Protocol Violation|2
6920790|NCT00803361|10949152|FG001|Overall Study|Protocol Violation|4
6920791|NCT00803361|10949151|FG000|Overall Study|Withdrawal by Subject|5
6920792|NCT00803361|10949152|FG001|Overall Study|Withdrawal by Subject|6
6920793|NCT00803452|10949170|FG000|Overall Study|Adverse Event|0
6920794|NCT00803452|10949171|FG001|Overall Study|Adverse Event|2
6920795|NCT00803452|10949170|FG000|Overall Study|Lost to Follow-up|0
6920796|NCT00803452|10949171|FG001|Overall Study|Lost to Follow-up|3
6920797|NCT00803569|10949186|FG000|Overall Study|Progressive Disease|3
6920798|NCT00803569|10949186|FG000|Overall Study|Noncompliance|1
6920799|NCT00803595|10949193|FG000|Overall Study|Adverse Event|3
6920800|NCT00803595|10949194|FG001|Overall Study|Adverse Event|4
6920801|NCT00803595|10949195|FG002|Overall Study|Adverse Event|1
6920802|NCT00803595|10949193|FG000|Overall Study|Protocol Violation|7
6920803|NCT00803595|10949194|FG001|Overall Study|Protocol Violation|2
6920804|NCT00803595|10949195|FG002|Overall Study|Protocol Violation|12
6920805|NCT00803595|10949193|FG000|Overall Study|Withdrawal by Subject|5
6920806|NCT00803595|10949194|FG001|Overall Study|Withdrawal by Subject|2
6920807|NCT00803595|10949195|FG002|Overall Study|Withdrawal by Subject|3
6920808|NCT00803634|10949205|FG000|Overall Study|Withdrew Consent|1
6920809|NCT00803634|10949206|FG001|Overall Study|Withdrew Consent|0
6920810|NCT00803634|10949205|FG000|Overall Study|Lost to Follow-up|2
6920811|NCT00803634|10949206|FG001|Overall Study|Lost to Follow-up|3
6920812|NCT00803634|10949205|FG000|Overall Study|Death|3
6920813|NCT00803634|10949206|FG001|Overall Study|Death|2
6920814|NCT00803712|10949238|FG000|Overall Study|Noncompliance|3
6920815|NCT00803712|10949239|FG001|Overall Study|Noncompliance|0
6920816|NCT00803712|10949238|FG000|Overall Study|Adverse Event|5
6920817|NCT00803712|10949239|FG001|Overall Study|Adverse Event|0
6920818|NCT00803712|10949238|FG000|Overall Study|Death|8
6920819|NCT00803712|10949239|FG001|Overall Study|Death|7
6920820|NCT00803712|10949238|FG000|Overall Study|Lost to Follow-up|3
6920821|NCT00803712|10949239|FG001|Overall Study|Lost to Follow-up|1
6920822|NCT00803712|10949238|FG000|Overall Study|Withdrawal by Subject|2
6920823|NCT00803712|10949239|FG001|Overall Study|Withdrawal by Subject|4
6920824|NCT00803712|10949238|FG000|Overall Study|"Other in electronic Case Report Form"|0
6920825|NCT00803712|10949239|FG001|Overall Study|"Other in electronic Case Report Form"|1
6920826|NCT00803712|10949238|FG000|Overall Study|Protocol criteria (other)|0
6920827|NCT00803712|10949239|FG001|Overall Study|Protocol criteria (other)|2
6920828|NCT00803712|10949238|FG000|Overall Study|Protocol criteria (renal transplant)|12
6920829|NCT00803712|10949239|FG001|Overall Study|Protocol criteria (renal transplant)|8
6920830|NCT00803712|10949238|FG000|Overall Study|Administrative decision|2
6920831|NCT00803712|10949239|FG001|Overall Study|Administrative decision|3
6920832|NCT00803712|10949238|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1
6920833|NCT00803712|10949239|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1
6920834|NCT00803738|10949247|FG000|Overall Study|Adverse Event|3
6920835|NCT00803738|10949248|FG001|Overall Study|Adverse Event|5
6920836|NCT00803738|10949247|FG000|Overall Study|Lost to Follow-up|4
6920837|NCT00803738|10949248|FG001|Overall Study|Lost to Follow-up|4
6920838|NCT00803738|10949247|FG000|Overall Study|Protocol Violation|18
6920839|NCT00803738|10949248|FG001|Overall Study|Protocol Violation|10
6920840|NCT00803738|10949247|FG000|Overall Study|Withdrawal by Subject|1
6920841|NCT00803738|10949248|FG001|Overall Study|Withdrawal by Subject|4
6920842|NCT00803738|10949247|FG000|Overall Study|Lack of Efficacy|10
6920843|NCT00803738|10949248|FG001|Overall Study|Lack of Efficacy|16
6920844|NCT00803738|10949247|FG000|Overall Study|Negative Baseline Culture of Candida|56
6920845|NCT00803738|10949248|FG001|Overall Study|Negative Baseline Culture of Candida|63
6920846|NCT00803738|10949247|FG000|Overall Study|Positive Results for STD or abnormal PAP|2
6920847|NCT00803738|10949248|FG001|Overall Study|Positive Results for STD or abnormal PAP|8
6920848|NCT00804141|10949276|FG000|Overall Study|Adverse Event|157
6920849|NCT00804141|10949276|FG000|Overall Study|Death|4
6920850|NCT00804141|10949276|FG000|Overall Study|Failed to return|96
6920851|NCT00804141|10949276|FG000|Overall Study|Investigator request|8
6920852|NCT00804141|10949276|FG000|Overall Study|Protocol Violation|85
6920853|NCT00804141|10949276|FG000|Overall Study|Withdrawal by Subject|131
6920854|NCT00804141|10949276|FG000|Overall Study|Lack of Efficacy|46
6920855|NCT00804141|10949276|FG000|Overall Study|Other than specified|30
6920856|NCT00804141|10949276|FG000|Overall Study|Enrolled but not treated|6
6920857|NCT00804193|10949283|FG000|Overall Study|Lack of baseline fungus|32
6920858|NCT00804193|10949284|FG001|Overall Study|Lack of baseline fungus|31
6920859|NCT00804193|10949285|FG002|Overall Study|Lack of baseline fungus|19
6920860|NCT00804193|10949283|FG000|Overall Study|Adverse Event|0
6920861|NCT00804193|10949284|FG001|Overall Study|Adverse Event|0
6920862|NCT00804193|10949285|FG002|Overall Study|Adverse Event|2
6920863|NCT00804193|10949283|FG000|Overall Study|Lack of Efficacy|1
6920864|NCT00804193|10949284|FG001|Overall Study|Lack of Efficacy|1
6920865|NCT00804193|10949285|FG002|Overall Study|Lack of Efficacy|3
6920866|NCT00804193|10949283|FG000|Overall Study|Protocol Violation|0
6920867|NCT00804193|10949284|FG001|Overall Study|Protocol Violation|8
6920868|NCT00804193|10949285|FG002|Overall Study|Protocol Violation|2
6920869|NCT00804193|10949283|FG000|Overall Study|Lost to Follow-up|3
6920870|NCT00804193|10949284|FG001|Overall Study|Lost to Follow-up|3
6920871|NCT00804193|10949285|FG002|Overall Study|Lost to Follow-up|4
6920872|NCT00804193|10949283|FG000|Overall Study|Withdrawal by Subject|3
6920873|NCT00804193|10949284|FG001|Overall Study|Withdrawal by Subject|1
6920874|NCT00804193|10949285|FG002|Overall Study|Withdrawal by Subject|2
6920875|NCT00804570|10949295|FG000|Overall Study|Adverse Event|14
6920876|NCT00804570|10949296|FG001|Overall Study|Adverse Event|7
6920877|NCT00804570|10949295|FG000|Overall Study|Lack of Efficacy|0
6920878|NCT00804570|10949296|FG001|Overall Study|Lack of Efficacy|1
6920879|NCT00804570|10949295|FG000|Overall Study|Lost to Follow-up|18
6920880|NCT00804570|10949296|FG001|Overall Study|Lost to Follow-up|21
6920881|NCT00804570|10949295|FG000|Overall Study|Entry criteria not met|5
6920882|NCT00804570|10949296|FG001|Overall Study|Entry criteria not met|5
6920883|NCT00804570|10949295|FG000|Overall Study|Protocol Violation|12
6920884|NCT00804570|10949296|FG001|Overall Study|Protocol Violation|16
6920885|NCT00804570|10949295|FG000|Overall Study|Physician Decision|1
6920886|NCT00804570|10949296|FG001|Overall Study|Physician Decision|2
6920887|NCT00804570|10949295|FG000|Overall Study|Sponsor decision|1
6920888|NCT00804570|10949296|FG001|Overall Study|Sponsor decision|4
6920889|NCT00804570|10949295|FG000|Overall Study|Withdrawal by Subject|21
6920890|NCT00804570|10949296|FG001|Overall Study|Withdrawal by Subject|38
6920891|NCT00804687|10949329|FG000|Period 3: Treatment Period|Positive Drug screen|0
6920892|NCT00804687|10949330|FG001|Period 3: Treatment Period|Positive Drug screen|0
6920893|NCT00804687|10949331|FG002|Period 3: Treatment Period|Positive Drug screen|0
6920894|NCT00804687|10949332|FG003|Period 3: Treatment Period|Positive Drug screen|1
6920895|NCT00804687|10949333|FG004|Period 3: Treatment Period|Positive Drug screen|0
6920896|NCT00804687|10949334|FG005|Period 3: Treatment Period|Positive Drug screen|0
6920897|NCT00804687|10949329|FG000|Period 5: Treatment Period|Withdrawal by Subject|0
6920898|NCT00804687|10949330|FG001|Period 5: Treatment Period|Withdrawal by Subject|0
6920899|NCT00804687|10949331|FG002|Period 5: Treatment Period|Withdrawal by Subject|0
6920900|NCT00804687|10949332|FG003|Period 5: Treatment Period|Withdrawal by Subject|0
6920901|NCT00804687|10949333|FG004|Period 5: Treatment Period|Withdrawal by Subject|1
6920902|NCT00804687|10949334|FG005|Period 5: Treatment Period|Withdrawal by Subject|0
6920903|NCT00804687|10949329|FG000|Period 5: Treatment Period|Positive drugs of abuse|0
6920904|NCT00804687|10949330|FG001|Period 5: Treatment Period|Positive drugs of abuse|0
6920905|NCT00804687|10949331|FG002|Period 5: Treatment Period|Positive drugs of abuse|1
6920906|NCT00804687|10949332|FG003|Period 5: Treatment Period|Positive drugs of abuse|0
6920907|NCT00804687|10949333|FG004|Period 5: Treatment Period|Positive drugs of abuse|0
6920908|NCT00804687|10949334|FG005|Period 5: Treatment Period|Positive drugs of abuse|0
6920909|NCT00804687|10949329|FG000|Period 5: Treatment Period|Positive drug test|1
6920910|NCT00804687|10949330|FG001|Period 5: Treatment Period|Positive drug test|0
6920911|NCT00804687|10949331|FG002|Period 5: Treatment Period|Positive drug test|0
6920912|NCT00804687|10949332|FG003|Period 5: Treatment Period|Positive drug test|0
6920913|NCT00804687|10949333|FG004|Period 5: Treatment Period|Positive drug test|0
6920914|NCT00804687|10949334|FG005|Period 5: Treatment Period|Positive drug test|0
6920915|NCT00804843|10949344|FG000|Overall Study|Protocol Violation|1
6920916|NCT00804843|10949345|FG001|Overall Study|Protocol Violation|0
6920917|NCT00804843|10949344|FG000|Overall Study|Adverse Event|8
6920918|NCT00804843|10949345|FG001|Overall Study|Adverse Event|5
6920919|NCT00804843|10949344|FG000|Overall Study|Withdrawal by Subject|1
6920920|NCT00804843|10949345|FG001|Overall Study|Withdrawal by Subject|2
6920921|NCT00804908|10949355|FG000|Overall Study|Other|115
6920922|NCT00804908|10949356|FG001|Overall Study|Other|116
6920923|NCT00804908|10949357|FG002|Overall Study|Other|114
6920924|NCT00804986|10949384|FG000|Overall Study|Adverse Event|0
6920925|NCT00804986|10949385|FG001|Overall Study|Adverse Event|1
6920926|NCT00804986|10949386|FG002|Overall Study|Adverse Event|2
6920927|NCT00804986|10949387|FG003|Overall Study|Adverse Event|1
6920928|NCT00804986|10949388|FG004|Overall Study|Adverse Event|3
6920929|NCT00804986|10949389|FG005|Overall Study|Adverse Event|0
6920930|NCT00804986|10949384|FG000|Overall Study|Lack of Efficacy|0
6920931|NCT00804986|10949385|FG001|Overall Study|Lack of Efficacy|0
6920932|NCT00804986|10949386|FG002|Overall Study|Lack of Efficacy|0
6920933|NCT00804986|10949387|FG003|Overall Study|Lack of Efficacy|1
6920934|NCT00804986|10949388|FG004|Overall Study|Lack of Efficacy|0
6920935|NCT00804986|10949389|FG005|Overall Study|Lack of Efficacy|3
6920936|NCT00804986|10949384|FG000|Overall Study|Lost to Follow-up|0
6920937|NCT00804986|10949385|FG001|Overall Study|Lost to Follow-up|0
6920938|NCT00804986|10949386|FG002|Overall Study|Lost to Follow-up|0
6920939|NCT00804986|10949387|FG003|Overall Study|Lost to Follow-up|1
6920940|NCT00804986|10949388|FG004|Overall Study|Lost to Follow-up|1
6920941|NCT00804986|10949389|FG005|Overall Study|Lost to Follow-up|3
6920942|NCT00804986|10949384|FG000|Overall Study|Protocol Violation|0
6920943|NCT00804986|10949385|FG001|Overall Study|Protocol Violation|1
6920944|NCT00804986|10949386|FG002|Overall Study|Protocol Violation|0
6920945|NCT00804986|10949387|FG003|Overall Study|Protocol Violation|1
6920946|NCT00804986|10949388|FG004|Overall Study|Protocol Violation|0
6920947|NCT00804986|10949389|FG005|Overall Study|Protocol Violation|0
6920948|NCT00804986|10949384|FG000|Overall Study|Withdrawal by Subject|0
6920949|NCT00804986|10949385|FG001|Overall Study|Withdrawal by Subject|3
6920950|NCT00804986|10949386|FG002|Overall Study|Withdrawal by Subject|0
6920951|NCT00804986|10949387|FG003|Overall Study|Withdrawal by Subject|3
6920952|NCT00804986|10949388|FG004|Overall Study|Withdrawal by Subject|5
6920953|NCT00804986|10949389|FG005|Overall Study|Withdrawal by Subject|3
6920954|NCT00804986|10949384|FG000|Overall Study|Inclusion/Exclusion criteria not met|0
6920955|NCT00804986|10949385|FG001|Overall Study|Inclusion/Exclusion criteria not met|2
6920956|NCT00804986|10949386|FG002|Overall Study|Inclusion/Exclusion criteria not met|0
6920957|NCT00804986|10949387|FG003|Overall Study|Inclusion/Exclusion criteria not met|1
6920958|NCT00804986|10949388|FG004|Overall Study|Inclusion/Exclusion criteria not met|0
6920959|NCT00804986|10949389|FG005|Overall Study|Inclusion/Exclusion criteria not met|1
6920960|NCT00804986|10949384|FG000|Overall Study|Sponsor Decision|0
6920961|NCT00804986|10949385|FG001|Overall Study|Sponsor Decision|1
6920962|NCT00804986|10949386|FG002|Overall Study|Sponsor Decision|0
6920963|NCT00804986|10949387|FG003|Overall Study|Sponsor Decision|0
6920964|NCT00804986|10949388|FG004|Overall Study|Sponsor Decision|0
6920965|NCT00804986|10949389|FG005|Overall Study|Sponsor Decision|0
6920966|NCT00804986|10949384|FG000|Overall Study|Physician Decision|1
6920967|NCT00804986|10949385|FG001|Overall Study|Physician Decision|0
6920968|NCT00804986|10949386|FG002|Overall Study|Physician Decision|0
6920969|NCT00804986|10949387|FG003|Overall Study|Physician Decision|0
6920970|NCT00804986|10949388|FG004|Overall Study|Physician Decision|0
6920971|NCT00804986|10949389|FG005|Overall Study|Physician Decision|0
6920972|NCT00805025|10949420|FG000|Overall Study|Screened but not enrolled/treated|42
6920973|NCT00805025|10949420|FG000|Overall Study|Adverse Event|4
6920974|NCT00805025|10949420|FG000|Overall Study|Withdrawal by Subject|2
6920975|NCT00805025|10949420|FG000|Overall Study|Physician Decision|1
6920976|NCT00805142|10949435|FG000|Titration Period|Adverse Event|3
6920977|NCT00805142|10949436|FG001|Titration Period|Adverse Event|3
6920978|NCT00805142|10949435|FG000|Titration Period|Lack of Efficacy|1
6920979|NCT00805142|10949436|FG001|Titration Period|Lack of Efficacy|1
6920980|NCT00805142|10949435|FG000|Titration Period|Lost to Follow-up|0
6920981|NCT00805142|10949436|FG001|Titration Period|Lost to Follow-up|1
6920982|NCT00805142|10949435|FG000|Titration Period|Disease Progression|2
6920983|NCT00805142|10949436|FG001|Titration Period|Disease Progression|1
6920984|NCT00805142|10949435|FG000|Titration Period|Withdrawal of consent|0
6920985|NCT00805142|10949436|FG001|Titration Period|Withdrawal of consent|1
6920986|NCT00805142|10949435|FG000|Titration Period|Other|0
6920987|NCT00805142|10949436|FG001|Titration Period|Other|3
6920988|NCT00805142|10949435|FG000|Maintenance Period|Adverse Event|0
6920989|NCT00805142|10949436|FG001|Maintenance Period|Adverse Event|1
6920990|NCT00805142|10949435|FG000|Maintenance Period|Other|0
6920991|NCT00805142|10949436|FG001|Maintenance Period|Other|1
6920992|NCT00805194|10949451|FG000|Overall Study|Progressive disease (modified RECIST)|404
6920993|NCT00805194|10949452|FG001|Overall Study|Progressive disease (modified RECIST)|435
6920994|NCT00805194|10949451|FG000|Overall Study|Worsening or AE of underlying disease|64
6920995|NCT00805194|10949452|FG001|Overall Study|Worsening or AE of underlying disease|70
6920996|NCT00805194|10949451|FG000|Overall Study|Other AE|84
6920997|NCT00805194|10949452|FG001|Overall Study|Other AE|73
6920998|NCT00805194|10949451|FG000|Overall Study|Protocol Violation|9
6920999|NCT00805194|10949452|FG001|Overall Study|Protocol Violation|9
6921000|NCT00805194|10949451|FG000|Overall Study|Lost to Follow-up|5
6921001|NCT00805194|10949452|FG001|Overall Study|Lost to Follow-up|5
6921002|NCT00805194|10949451|FG000|Overall Study|Withdrawal by Subject|60
6921003|NCT00805194|10949452|FG001|Overall Study|Withdrawal by Subject|42
6921004|NCT00805194|10949451|FG000|Overall Study|Not treated|3
6921005|NCT00805194|10949452|FG001|Overall Study|Not treated|4
6921006|NCT00805194|10949451|FG000|Overall Study|Reasons other than stated above|20
6921007|NCT00805194|10949452|FG001|Overall Study|Reasons other than stated above|16
6921008|NCT00805207|10949472|FG000|Overall Study|Protocol Violation|0
6921009|NCT00805207|10949473|FG001|Overall Study|Protocol Violation|0
6921010|NCT00805207|10949474|FG002|Overall Study|Protocol Violation|1
6921011|NCT00805207|10949475|FG003|Overall Study|Protocol Violation|0
6921012|NCT00805207|10949476|FG004|Overall Study|Protocol Violation|0
6921013|NCT00805207|10949477|FG005|Overall Study|Protocol Violation|0
6921014|NCT00805207|10949478|FG006|Overall Study|Protocol Violation|0
6921015|NCT00805207|10949479|FG007|Overall Study|Protocol Violation|0
6921016|NCT00805207|10949480|FG008|Overall Study|Protocol Violation|0
6921017|NCT00805207|10949472|FG000|Overall Study|Physician Decision|0
6921018|NCT00805207|10949473|FG001|Overall Study|Physician Decision|1
6921019|NCT00805207|10949474|FG002|Overall Study|Physician Decision|0
6921020|NCT00805207|10949475|FG003|Overall Study|Physician Decision|0
6921021|NCT00805207|10949476|FG004|Overall Study|Physician Decision|0
6921022|NCT00805207|10949477|FG005|Overall Study|Physician Decision|1
6921023|NCT00805207|10949478|FG006|Overall Study|Physician Decision|0
6921024|NCT00805207|10949479|FG007|Overall Study|Physician Decision|0
6921025|NCT00805207|10949480|FG008|Overall Study|Physician Decision|0
6921026|NCT00805207|10949472|FG000|Overall Study|Withdrawal by Subject|0
6921027|NCT00805207|10949473|FG001|Overall Study|Withdrawal by Subject|1
6921028|NCT00805207|10949474|FG002|Overall Study|Withdrawal by Subject|0
6921029|NCT00805207|10949475|FG003|Overall Study|Withdrawal by Subject|0
6921030|NCT00805207|10949476|FG004|Overall Study|Withdrawal by Subject|1
6921031|NCT00805207|10949477|FG005|Overall Study|Withdrawal by Subject|2
6921032|NCT00805207|10949478|FG006|Overall Study|Withdrawal by Subject|0
6921033|NCT00805207|10949479|FG007|Overall Study|Withdrawal by Subject|0
6921034|NCT00805207|10949480|FG008|Overall Study|Withdrawal by Subject|0
6921035|NCT00805285|10949504|FG000|Overall Study|Lack of Efficacy|1
6921036|NCT00805389|10949513|FG000|Overall Study|Adverse Event|0
6921037|NCT00805389|10949514|FG001|Overall Study|Adverse Event|0
6921038|NCT00805389|10949515|FG002|Overall Study|Adverse Event|1
6921039|NCT00805389|10949516|FG003|Overall Study|Adverse Event|2
6921040|NCT00805389|10949517|FG004|Overall Study|Adverse Event|0
6921041|NCT00805389|10949513|FG000|Overall Study|Lost to Follow-up|4
6921042|NCT00805389|10949514|FG001|Overall Study|Lost to Follow-up|3
6921043|NCT00805389|10949515|FG002|Overall Study|Lost to Follow-up|6
6921044|NCT00805389|10949516|FG003|Overall Study|Lost to Follow-up|10
6921045|NCT00805389|10949517|FG004|Overall Study|Lost to Follow-up|9
6921046|NCT00805389|10949513|FG000|Overall Study|Protocol Violation|0
6921047|NCT00805389|10949514|FG001|Overall Study|Protocol Violation|0
6921048|NCT00805389|10949515|FG002|Overall Study|Protocol Violation|1
6921049|NCT00805389|10949516|FG003|Overall Study|Protocol Violation|0
6921050|NCT00805389|10949517|FG004|Overall Study|Protocol Violation|0
6921051|NCT00805389|10949513|FG000|Overall Study|Withdrawal by Subject|3
6921052|NCT00805389|10949514|FG001|Overall Study|Withdrawal by Subject|2
6921053|NCT00805389|10949515|FG002|Overall Study|Withdrawal by Subject|4
6921054|NCT00805389|10949516|FG003|Overall Study|Withdrawal by Subject|5
6921055|NCT00805389|10949517|FG004|Overall Study|Withdrawal by Subject|4
6921056|NCT00805441|10949541|FG000|Overall Study|Adverse Event|5
6921057|NCT00805441|10949542|FG001|Overall Study|Adverse Event|2
6921058|NCT00805441|10949541|FG000|Overall Study|Lack of Efficacy|0
6921059|NCT00805441|10949542|FG001|Overall Study|Lack of Efficacy|2
6921060|NCT00805441|10949541|FG000|Overall Study|Protocol Violation|4
6921061|NCT00805441|10949542|FG001|Overall Study|Protocol Violation|8
6921062|NCT00805441|10949541|FG000|Overall Study|Lost to Follow-up|10
6921063|NCT00805441|10949542|FG001|Overall Study|Lost to Follow-up|13
6921064|NCT00805441|10949541|FG000|Overall Study|Withdrawal by Subject|15
6921065|NCT00805441|10949542|FG001|Overall Study|Withdrawal by Subject|9
6921066|NCT00805441|10949541|FG000|Overall Study|Physician Decision|0
6921067|NCT00805441|10949542|FG001|Overall Study|Physician Decision|1
6921068|NCT00805441|10949541|FG000|Overall Study|Acute Alcohol Withdrawal|0
6921069|NCT00805441|10949542|FG001|Overall Study|Acute Alcohol Withdrawal|1
6921070|NCT00805467|10949552|FG000|Overall Study|Lack of Efficacy|0
6921071|NCT00805467|10949553|FG001|Overall Study|Lack of Efficacy|8
6921072|NCT00805467|10949554|FG002|Overall Study|Lack of Efficacy|13
6921073|NCT00805467|10949555|FG003|Overall Study|Lack of Efficacy|86
6921074|NCT00805467|10949552|FG000|Overall Study|Lost to Follow-up|0
6921075|NCT00805467|10949553|FG001|Overall Study|Lost to Follow-up|1
6921076|NCT00805467|10949554|FG002|Overall Study|Lost to Follow-up|7
6921077|NCT00805467|10949555|FG003|Overall Study|Lost to Follow-up|21
6921078|NCT00805467|10949552|FG000|Overall Study|Withdrawal by Subject|0
6921079|NCT00805467|10949553|FG001|Overall Study|Withdrawal by Subject|6
6921080|NCT00805467|10949554|FG002|Overall Study|Withdrawal by Subject|45
6921081|NCT00805467|10949555|FG003|Overall Study|Withdrawal by Subject|50
6921082|NCT00805467|10949552|FG000|Overall Study|Protocol Violation|0
6921083|NCT00805467|10949553|FG001|Overall Study|Protocol Violation|3
6921084|NCT00805467|10949554|FG002|Overall Study|Protocol Violation|0
6921085|NCT00805467|10949555|FG003|Overall Study|Protocol Violation|5
6921086|NCT00805467|10949552|FG000|Overall Study|Adverse Event|0
6921087|NCT00805467|10949553|FG001|Overall Study|Adverse Event|13
6921088|NCT00805467|10949554|FG002|Overall Study|Adverse Event|26
6921089|NCT00805467|10949555|FG003|Overall Study|Adverse Event|57
6921090|NCT00805467|10949552|FG000|Overall Study|Death|0
6921091|NCT00805467|10949553|FG001|Overall Study|Death|2
6921092|NCT00805467|10949554|FG002|Overall Study|Death|7
6921093|NCT00805467|10949555|FG003|Overall Study|Death|5
6921094|NCT00805467|10949552|FG000|Overall Study|Physician Decision|0
6921095|NCT00805467|10949553|FG001|Overall Study|Physician Decision|1
6921096|NCT00805467|10949554|FG002|Overall Study|Physician Decision|2
6921097|NCT00805467|10949555|FG003|Overall Study|Physician Decision|6
6921098|NCT00805467|10949552|FG000|Overall Study|Not reported|0
6921099|NCT00805467|10949553|FG001|Overall Study|Not reported|0
6921100|NCT00805467|10949554|FG002|Overall Study|Not reported|3
6921101|NCT00805467|10949555|FG003|Overall Study|Not reported|7
6921102|NCT00805480|10949569|FG000|Overall Study|Withdrawal by Subject|13
6921103|NCT00805480|10949570|FG001|Overall Study|Withdrawal by Subject|5
6921104|NCT00805480|10949571|FG002|Overall Study|Withdrawal by Subject|11
6921105|NCT00805480|10949572|FG003|Overall Study|Withdrawal by Subject|5
6921106|NCT00805480|10949569|FG000|Overall Study|Lost to Follow-up|1
6921107|NCT00805480|10949570|FG001|Overall Study|Lost to Follow-up|2
6921108|NCT00805480|10949571|FG002|Overall Study|Lost to Follow-up|0
6921109|NCT00805480|10949572|FG003|Overall Study|Lost to Follow-up|0
6921110|NCT00805480|10949569|FG000|Overall Study|Adverse Event|0
6921111|NCT00805480|10949570|FG001|Overall Study|Adverse Event|0
6921112|NCT00805480|10949571|FG002|Overall Study|Adverse Event|1
6921113|NCT00805480|10949572|FG003|Overall Study|Adverse Event|0
6921114|NCT00805532|10949600|FG000|Overall Study|invalid data|0
6921115|NCT00805532|10949601|FG001|Overall Study|invalid data|1
6921116|NCT00805545|10949611|FG000|Overall Study|Protocol Violation|3
6921117|NCT00805545|10949612|FG001|Overall Study|Protocol Violation|2
6921118|NCT00805545|10949611|FG000|Overall Study|Protocol Violation|3
6921119|NCT00805545|10949612|FG001|Overall Study|Protocol Violation|1
6921120|NCT00805675|10949621|FG000|Overall Study|Adverse Event|0
6921121|NCT00805675|10949622|FG001|Overall Study|Adverse Event|0
6921122|NCT00805675|10949623|FG002|Overall Study|Adverse Event|1
6921123|NCT00805740|10949633|FG000|Overall Study|Death|7
6921124|NCT00805740|10949634|FG001|Overall Study|Death|4
6921125|NCT00805740|10949633|FG000|Overall Study|Withdrawal by Subject|1
6979281|NCT01217073|11032989|FG000|Extension Period|Non-compliance with study drug|0
6979282|NCT01217073|11032990|FG001|Extension Period|Non-compliance with study drug|0
6979283|NCT01217073|11032991|FG002|Extension Period|Non-compliance with study drug|0
6979284|NCT01217073|11032992|FG003|Extension Period|Non-compliance with study drug|0
6979285|NCT01217073|11032993|FG004|Extension Period|Non-compliance with study drug|0
6979286|NCT01217073|11032994|FG005|Extension Period|Non-compliance with study drug|0
6979287|NCT01217073|11032995|FG006|Extension Period|Non-compliance with study drug|0
6979288|NCT01217073|11032996|FG007|Extension Period|Non-compliance with study drug|1
6979289|NCT01217073|11032989|FG000|Extension Period|Physician Decision|0
6979290|NCT01217073|11032990|FG001|Extension Period|Physician Decision|0
6979291|NCT01217073|11032991|FG002|Extension Period|Physician Decision|0
6979292|NCT01217073|11032992|FG003|Extension Period|Physician Decision|0
6979293|NCT01217073|11032993|FG004|Extension Period|Physician Decision|0
6979294|NCT01217073|11032994|FG005|Extension Period|Physician Decision|0
6979295|NCT01217073|11032995|FG006|Extension Period|Physician Decision|4
6979296|NCT01217073|11032996|FG007|Extension Period|Physician Decision|1
6979297|NCT01217073|11032989|FG000|Extension Period|Protocol Violation|0
6979298|NCT01217073|11032990|FG001|Extension Period|Protocol Violation|0
6979299|NCT01217073|11032991|FG002|Extension Period|Protocol Violation|0
6979300|NCT01217073|11032992|FG003|Extension Period|Protocol Violation|0
6979301|NCT01217073|11032993|FG004|Extension Period|Protocol Violation|0
6979302|NCT01217073|11032994|FG005|Extension Period|Protocol Violation|0
6979303|NCT01217073|11032995|FG006|Extension Period|Protocol Violation|2
6979304|NCT01217073|11032996|FG007|Extension Period|Protocol Violation|1
6979305|NCT01217073|11032989|FG000|Extension Period|Site discontinued study participation|0
6979306|NCT01217073|11032990|FG001|Extension Period|Site discontinued study participation|0
6979307|NCT01217073|11032991|FG002|Extension Period|Site discontinued study participation|0
6979308|NCT01217073|11032992|FG003|Extension Period|Site discontinued study participation|0
6979309|NCT01217073|11032993|FG004|Extension Period|Site discontinued study participation|0
6979310|NCT01217073|11032994|FG005|Extension Period|Site discontinued study participation|0
6979311|NCT01217073|11032995|FG006|Extension Period|Site discontinued study participation|7
6979312|NCT01217073|11032996|FG007|Extension Period|Site discontinued study participation|2
6979313|NCT01217073|11032989|FG000|Extension Period|Withdrawal by Subject|0
6979314|NCT01217073|11032990|FG001|Extension Period|Withdrawal by Subject|0
6979315|NCT01217073|11032991|FG002|Extension Period|Withdrawal by Subject|0
6979316|NCT01217073|11032992|FG003|Extension Period|Withdrawal by Subject|0
6979317|NCT01217073|11032993|FG004|Extension Period|Withdrawal by Subject|0
6979318|NCT01217073|11032994|FG005|Extension Period|Withdrawal by Subject|0
6979319|NCT01217073|11032995|FG006|Extension Period|Withdrawal by Subject|30
6979320|NCT01217073|11032996|FG007|Extension Period|Withdrawal by Subject|8
6979321|NCT01217112|11033025|FG000|Overall Study|Adverse Event|0
6979322|NCT01217112|11033026|FG001|Overall Study|Adverse Event|2
6979323|NCT01217112|11033027|FG002|Overall Study|Adverse Event|0
6979324|NCT01217112|11033028|FG003|Overall Study|Adverse Event|2
6979325|NCT01217112|11033029|FG004|Overall Study|Adverse Event|0
6979326|NCT01217112|11033025|FG000|Overall Study|Withdrawal by Subject|0
6979327|NCT01217112|11033026|FG001|Overall Study|Withdrawal by Subject|0
6979328|NCT01217112|11033027|FG002|Overall Study|Withdrawal by Subject|1
6979329|NCT01217112|11033028|FG003|Overall Study|Withdrawal by Subject|0
6979330|NCT01217112|11033029|FG004|Overall Study|Withdrawal by Subject|0
6979331|NCT01217112|11033025|FG000|Overall Study|Physician Decision|0
6979332|NCT01217112|11033026|FG001|Overall Study|Physician Decision|0
6921126|NCT00805740|10949634|FG001|Overall Study|Withdrawal by Subject|0
6921127|NCT00805740|10949633|FG000|Overall Study|Lost to Follow-up|1
6979333|NCT01217112|11033027|FG002|Overall Study|Physician Decision|0
6979334|NCT01217112|11033028|FG003|Overall Study|Physician Decision|0
6979335|NCT01217112|11033029|FG004|Overall Study|Physician Decision|1
6979336|NCT01217190|11033043|FG000|Second Dosing|Withdrawal by Subject|0
6921128|NCT00805740|10949634|FG001|Overall Study|Lost to Follow-up|0
6921129|NCT00805740|10949633|FG000|Overall Study|Randomized, but not treated|2
6921130|NCT00805740|10949634|FG001|Overall Study|Randomized, but not treated|0
6921131|NCT00805766|10949640|FG000|Screening Period|Adverse Event|1
6921132|NCT00805766|10949640|FG000|Screening Period|Lack of Efficacy|2
6921133|NCT00805766|10949640|FG000|Screening Period|Pregnancy|1
6921134|NCT00805766|10949640|FG000|Screening Period|Responder|2
6921135|NCT00805766|10949640|FG000|Increased Dose Period|Adverse Event|4
6921136|NCT00805766|10949640|FG000|Increased Dose Period|Lack of Efficacy|7
6921137|NCT00805766|10949640|FG000|Increased Dose Period|Pregnancy|1
6921138|NCT00805766|10949640|FG000|Increased Dose Period|Withdrawal by Subject|1
6921139|NCT00805792|10949648|FG000|Overall Study|Death|3
6921140|NCT00805792|10949648|FG000|Overall Study|Lost to Follow-up|2
6921141|NCT00805935|10949665|FG000|Overall Study|Stimulation Failure|1
6921142|NCT00805935|10949666|FG001|Overall Study|Stimulation Failure|5
6921143|NCT00805935|10949667|FG002|Overall Study|Stimulation Failure|2
6921144|NCT00805935|10949668|FG003|Overall Study|Stimulation Failure|2
6921145|NCT00805935|10949665|FG000|Overall Study|Cycle cancelled|0
6921146|NCT00805935|10949666|FG001|Overall Study|Cycle cancelled|0
6921147|NCT00805935|10949667|FG002|Overall Study|Cycle cancelled|2
6921148|NCT00805935|10949668|FG003|Overall Study|Cycle cancelled|0
6921149|NCT00805935|10949665|FG000|Overall Study|Cycle cancellation for risk of OHSS|1
6921150|NCT00805935|10949666|FG001|Overall Study|Cycle cancellation for risk of OHSS|0
6921151|NCT00805935|10949667|FG002|Overall Study|Cycle cancellation for risk of OHSS|1
6921152|NCT00805935|10949668|FG003|Overall Study|Cycle cancellation for risk of OHSS|0
6921153|NCT00805935|10949665|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
6921154|NCT00805935|10949666|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
6921155|NCT00805935|10949667|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
6921156|NCT00805935|10949668|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1
6921157|NCT00805935|10949665|FG000|Overall Study|Lost to Follow-up|1
6921158|NCT00805935|10949666|FG001|Overall Study|Lost to Follow-up|0
6921159|NCT00805935|10949667|FG002|Overall Study|Lost to Follow-up|0
6921160|NCT00805935|10949668|FG003|Overall Study|Lost to Follow-up|0
6921161|NCT00805935|10949665|FG000|Overall Study|No positive serum pregnancy|8
6921162|NCT00805935|10949666|FG001|Overall Study|No positive serum pregnancy|7
6921163|NCT00805935|10949667|FG002|Overall Study|No positive serum pregnancy|6
6921164|NCT00805935|10949668|FG003|Overall Study|No positive serum pregnancy|5
6921165|NCT00805935|10949665|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0
6921166|NCT00805935|10949666|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0
6921167|NCT00805935|10949667|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0
6921168|NCT00805935|10949668|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1
6921169|NCT00805935|10949665|FG000|Overall Study|Pregnancy loss/miscarriage|2
6921170|NCT00805935|10949666|FG001|Overall Study|Pregnancy loss/miscarriage|0
6921171|NCT00805935|10949667|FG002|Overall Study|Pregnancy loss/miscarriage|0
6921172|NCT00805935|10949668|FG003|Overall Study|Pregnancy loss/miscarriage|0
6921173|NCT00805935|10949665|FG000|Overall Study|Biochemical pregnancy|0
6921174|NCT00805935|10949666|FG001|Overall Study|Biochemical pregnancy|1
6921175|NCT00805935|10949667|FG002|Overall Study|Biochemical pregnancy|0
6921176|NCT00805935|10949668|FG003|Overall Study|Biochemical pregnancy|0
6921177|NCT00805935|10949665|FG000|Overall Study|Chemical pregnancy|0
6921178|NCT00805935|10949666|FG001|Overall Study|Chemical pregnancy|5
6921179|NCT00805935|10949667|FG002|Overall Study|Chemical pregnancy|3
6921180|NCT00805935|10949668|FG003|Overall Study|Chemical pregnancy|2
6921181|NCT00805935|10949665|FG000|Overall Study|Ectopic pregnancy|0
6921182|NCT00805935|10949666|FG001|Overall Study|Ectopic pregnancy|0
6921183|NCT00805935|10949667|FG002|Overall Study|Ectopic pregnancy|1
6921184|NCT00805935|10949668|FG003|Overall Study|Ectopic pregnancy|0
6921185|NCT00805935|10949665|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0
6921186|NCT00805935|10949666|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1
6921187|NCT00805935|10949667|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0
6921188|NCT00805935|10949668|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0
6921189|NCT00806026|10949696|FG000|Overall Study|Death|0
6921190|NCT00806026|10949697|FG001|Overall Study|Death|0
6921191|NCT00806026|10949698|FG002|Overall Study|Death|0
6921192|NCT00806026|10949699|FG003|Overall Study|Death|1
6921193|NCT00806026|10949700|FG004|Overall Study|Death|0
6921194|NCT00806026|10949701|FG005|Overall Study|Death|0
6921195|NCT00806026|10949696|FG000|Overall Study|Did not meet entrance criteria|4
6921196|NCT00806026|10949697|FG001|Overall Study|Did not meet entrance criteria|1
6921197|NCT00806026|10949698|FG002|Overall Study|Did not meet entrance criteria|2
6921198|NCT00806026|10949699|FG003|Overall Study|Did not meet entrance criteria|1
6921199|NCT00806026|10949700|FG004|Overall Study|Did not meet entrance criteria|0
6921200|NCT00806026|10949701|FG005|Overall Study|Did not meet entrance criteria|0
6921201|NCT00806026|10949696|FG000|Overall Study|Lack of Efficacy|5
6921202|NCT00806026|10949697|FG001|Overall Study|Lack of Efficacy|18
6921203|NCT00806026|10949698|FG002|Overall Study|Lack of Efficacy|13
6921204|NCT00806026|10949699|FG003|Overall Study|Lack of Efficacy|4
6921205|NCT00806026|10949700|FG004|Overall Study|Lack of Efficacy|8
6921206|NCT00806026|10949701|FG005|Overall Study|Lack of Efficacy|7
6921207|NCT00806026|10949696|FG000|Overall Study|Lost to Follow-up|8
6921208|NCT00806026|10949697|FG001|Overall Study|Lost to Follow-up|15
6921209|NCT00806026|10949698|FG002|Overall Study|Lost to Follow-up|8
6921210|NCT00806026|10949699|FG003|Overall Study|Lost to Follow-up|2
6921211|NCT00806026|10949700|FG004|Overall Study|Lost to Follow-up|6
6921212|NCT00806026|10949701|FG005|Overall Study|Lost to Follow-up|6
6921213|NCT00806026|10949696|FG000|Overall Study|Withdrawal by Subject|14
6921214|NCT00806026|10949697|FG001|Overall Study|Withdrawal by Subject|17
6921215|NCT00806026|10949698|FG002|Overall Study|Withdrawal by Subject|9
6921216|NCT00806026|10949699|FG003|Overall Study|Withdrawal by Subject|2
6921217|NCT00806026|10949700|FG004|Overall Study|Withdrawal by Subject|5
6921218|NCT00806026|10949701|FG005|Overall Study|Withdrawal by Subject|3
6921219|NCT00806026|10949696|FG000|Overall Study|Other|3
6921220|NCT00806026|10949697|FG001|Overall Study|Other|6
6921221|NCT00806026|10949698|FG002|Overall Study|Other|8
6921222|NCT00806026|10949699|FG003|Overall Study|Other|2
6921223|NCT00806026|10949700|FG004|Overall Study|Other|0
6921224|NCT00806026|10949701|FG005|Overall Study|Other|4
6921225|NCT00806026|10949696|FG000|Overall Study|Protocol Violation|6
6921226|NCT00806026|10949697|FG001|Overall Study|Protocol Violation|9
6921227|NCT00806026|10949698|FG002|Overall Study|Protocol Violation|9
6921228|NCT00806026|10949699|FG003|Overall Study|Protocol Violation|0
6921229|NCT00806026|10949700|FG004|Overall Study|Protocol Violation|2
6921230|NCT00806026|10949701|FG005|Overall Study|Protocol Violation|3
6921231|NCT00806026|10949696|FG000|Overall Study|Adverse Event|52
6921232|NCT00806026|10949697|FG001|Overall Study|Adverse Event|35
6921233|NCT00806026|10949698|FG002|Overall Study|Adverse Event|44
6921234|NCT00806026|10949699|FG003|Overall Study|Adverse Event|17
6921235|NCT00806026|10949700|FG004|Overall Study|Adverse Event|9
6921236|NCT00806026|10949701|FG005|Overall Study|Adverse Event|9
6921237|NCT00806156|10949724|FG000|Overall Study|Death|35
6921238|NCT00806156|10949725|FG001|Overall Study|Death|95
6921239|NCT00806156|10949724|FG000|Overall Study|Did not meet eligibility criteria|1
6921240|NCT00806156|10949725|FG001|Overall Study|Did not meet eligibility criteria|0
6921241|NCT00806156|10949724|FG000|Overall Study|Study terminated by Sponsor|2
6921242|NCT00806156|10949725|FG001|Overall Study|Study terminated by Sponsor|40
6921243|NCT00806156|10949724|FG000|Overall Study|Consent withdrawn by subject|1
6921244|NCT00806156|10949725|FG001|Overall Study|Consent withdrawn by subject|3
6921245|NCT00806156|10949724|FG000|Overall Study|Lost to Follow-up|0
6921246|NCT00806156|10949725|FG001|Overall Study|Lost to Follow-up|1
6921247|NCT00806195|10949747|FG000|Overall Study|Death|6
6921248|NCT00806195|10949748|FG001|Overall Study|Death|0
6921249|NCT00806195|10949749|FG002|Overall Study|Death|1
6921250|NCT00806195|10949750|FG003|Overall Study|Death|0
6921251|NCT00806195|10949747|FG000|Overall Study|Adverse Event|25
6921252|NCT00806195|10949748|FG001|Overall Study|Adverse Event|5
6921253|NCT00806195|10949749|FG002|Overall Study|Adverse Event|11
6921254|NCT00806195|10949750|FG003|Overall Study|Adverse Event|2
6921255|NCT00806195|10949747|FG000|Overall Study|Withdrawal by Subject|119
6921256|NCT00806195|10949748|FG001|Overall Study|Withdrawal by Subject|31
6921257|NCT00806195|10949749|FG002|Overall Study|Withdrawal by Subject|76
6921258|NCT00806195|10949750|FG003|Overall Study|Withdrawal by Subject|35
6921259|NCT00806195|10949747|FG000|Overall Study|Lost to Follow-up|217
6921260|NCT00806195|10949748|FG001|Overall Study|Lost to Follow-up|66
6921261|NCT00806195|10949749|FG002|Overall Study|Lost to Follow-up|90
6921262|NCT00806195|10949750|FG003|Overall Study|Lost to Follow-up|34
6921263|NCT00806195|10949747|FG000|Overall Study|Inappropriate Enrollment|0
6921264|NCT00806195|10949748|FG001|Overall Study|Inappropriate Enrollment|1
6921265|NCT00806195|10949749|FG002|Overall Study|Inappropriate Enrollment|0
6921266|NCT00806195|10949750|FG003|Overall Study|Inappropriate Enrollment|0
6921267|NCT00806195|10949747|FG000|Overall Study|Administrative Reason|113
6921268|NCT00806195|10949748|FG001|Overall Study|Administrative Reason|35
6921269|NCT00806195|10949749|FG002|Overall Study|Administrative Reason|66
6921270|NCT00806195|10949750|FG003|Overall Study|Administrative Reason|26
6921271|NCT00806195|10949747|FG000|Overall Study|Protocol Violation|34
6921272|NCT00806195|10949748|FG001|Overall Study|Protocol Violation|24
6921273|NCT00806195|10949749|FG002|Overall Study|Protocol Violation|26
6921274|NCT00806195|10949750|FG003|Overall Study|Protocol Violation|9
6921275|NCT00806260|10949785|FG000|Period 1 (1 Day)|Adverse Event|0
6921276|NCT00806260|10949786|FG001|Period 1 (1 Day)|Adverse Event|0
6921277|NCT00806260|10949787|FG002|Period 1 (1 Day)|Adverse Event|0
6921278|NCT00806260|10949788|FG003|Period 1 (1 Day)|Adverse Event|0
6921279|NCT00806260|10949789|FG004|Period 1 (1 Day)|Adverse Event|3
6921280|NCT00806260|10949790|FG005|Period 1 (1 Day)|Adverse Event|0
6921281|NCT00806260|10949785|FG000|Period 2|Adverse Event|0
6921282|NCT00806260|10949786|FG001|Period 2|Adverse Event|0
6921283|NCT00806260|10949787|FG002|Period 2|Adverse Event|0
6921284|NCT00806260|10949788|FG003|Period 2|Adverse Event|1
6921285|NCT00806260|10949789|FG004|Period 2|Adverse Event|0
6921286|NCT00806260|10949790|FG005|Period 2|Adverse Event|0
6921287|NCT00806260|10949785|FG000|Period 2|Protocol Violation|1
6921288|NCT00806260|10949786|FG001|Period 2|Protocol Violation|0
6921289|NCT00806260|10949787|FG002|Period 2|Protocol Violation|1
6921290|NCT00806260|10949788|FG003|Period 2|Protocol Violation|0
6921291|NCT00806260|10949789|FG004|Period 2|Protocol Violation|0
6921292|NCT00806260|10949790|FG005|Period 2|Protocol Violation|0
6921293|NCT00806260|10949785|FG000|Period 2|Need to take concomitant medication|1
6921294|NCT00806260|10949786|FG001|Period 2|Need to take concomitant medication|0
6921295|NCT00806260|10949787|FG002|Period 2|Need to take concomitant medication|0
6921296|NCT00806260|10949788|FG003|Period 2|Need to take concomitant medication|0
6921297|NCT00806260|10949789|FG004|Period 2|Need to take concomitant medication|0
6921298|NCT00806260|10949790|FG005|Period 2|Need to take concomitant medication|0
6921299|NCT00806260|10949785|FG000|Period 2|sponsor request|0
6921300|NCT00806260|10949786|FG001|Period 2|sponsor request|0
6921301|NCT00806260|10949787|FG002|Period 2|sponsor request|1
6921302|NCT00806260|10949788|FG003|Period 2|sponsor request|1
6921303|NCT00806260|10949789|FG004|Period 2|sponsor request|0
6921304|NCT00806260|10949790|FG005|Period 2|sponsor request|0
6921305|NCT00806260|10949785|FG000|Period 3|Protocol Violation|0
6921306|NCT00806260|10949786|FG001|Period 3|Protocol Violation|1
6921307|NCT00806260|10949787|FG002|Period 3|Protocol Violation|1
6921308|NCT00806260|10949788|FG003|Period 3|Protocol Violation|0
6921309|NCT00806260|10949789|FG004|Period 3|Protocol Violation|0
6921310|NCT00806260|10949790|FG005|Period 3|Protocol Violation|0
6921311|NCT00806260|10949785|FG000|Period 3|Pregnancy|1
6921312|NCT00806260|10949786|FG001|Period 3|Pregnancy|0
6921313|NCT00806260|10949787|FG002|Period 3|Pregnancy|0
6921314|NCT00806260|10949788|FG003|Period 3|Pregnancy|0
6921315|NCT00806260|10949789|FG004|Period 3|Pregnancy|0
6921316|NCT00806260|10949790|FG005|Period 3|Pregnancy|0
6921317|NCT00806286|10949805|FG000|Overall Study|Adverse Event|5
6921318|NCT00806286|10949806|FG001|Overall Study|Adverse Event|2
6921319|NCT00806286|10949807|FG002|Overall Study|Adverse Event|0
6921320|NCT00806286|10949805|FG000|Overall Study|Disease progression|31
6921321|NCT00806286|10949806|FG001|Overall Study|Disease progression|38
6921322|NCT00806286|10949807|FG002|Overall Study|Disease progression|1
6921323|NCT00806286|10949805|FG000|Overall Study|Death|1
6921324|NCT00806286|10949806|FG001|Overall Study|Death|6
6921325|NCT00806286|10949807|FG002|Overall Study|Death|0
6921326|NCT00806286|10949805|FG000|Overall Study|Lost to Follow-up|0
6921327|NCT00806286|10949806|FG001|Overall Study|Lost to Follow-up|1
6921328|NCT00806286|10949807|FG002|Overall Study|Lost to Follow-up|0
6921329|NCT00806286|10949805|FG000|Overall Study|Withdrawal by Subject|8
6921330|NCT00806286|10949806|FG001|Overall Study|Withdrawal by Subject|3
6921331|NCT00806286|10949807|FG002|Overall Study|Withdrawal by Subject|1
6921332|NCT00806286|10949805|FG000|Overall Study|Physician Decision|2
6921333|NCT00806286|10949806|FG001|Overall Study|Physician Decision|2
6921334|NCT00806286|10949807|FG002|Overall Study|Physician Decision|0
6921335|NCT00806286|10949805|FG000|Overall Study|Due to a variety of reasons|7
6921336|NCT00806286|10949806|FG001|Overall Study|Due to a variety of reasons|2
6921337|NCT00806286|10949807|FG002|Overall Study|Due to a variety of reasons|1
6921338|NCT00806351|10949817|FG000|Overall Study|Death|5
6921339|NCT00806351|10949818|FG001|Overall Study|Death|4
6921340|NCT00806442|10949824|FG000|Overall Study|Lost to Follow-up|3
6921341|NCT00806442|10949825|FG001|Overall Study|Lost to Follow-up|2
6921342|NCT00806442|10949824|FG000|Overall Study|Withdrawal by Subject|1
6921343|NCT00806442|10949825|FG001|Overall Study|Withdrawal by Subject|5
6921344|NCT00806494|10949833|FG000|Overall Study|Adverse Event|29
6921345|NCT00806494|10949833|FG000|Overall Study|Lack of Efficacy|6
6921346|NCT00806494|10949833|FG000|Overall Study|Lost to Follow-up|10
6921347|NCT00806494|10949833|FG000|Overall Study|Other|30
6921348|NCT00806494|10949833|FG000|Overall Study|Withdrawal by Subject|5
6921349|NCT00806546|10949838|FG000|Overall Study|Enrolled, not treated|35
6921350|NCT00806546|10949838|FG000|Overall Study|Lost to Follow-up|32
6921351|NCT00806546|10949838|FG000|Overall Study|Adverse Event|74
6921352|NCT00806546|10949838|FG000|Overall Study|Withdrawal by Subject|75
6921353|NCT00806546|10949838|FG000|Overall Study|Protocol Violation|49
6921354|NCT00806546|10949838|FG000|Overall Study|Various|42
6921355|NCT00806585|10949847|FG000|Overall Study|Study terminated by Sponsor|0
6921356|NCT00806585|10949848|FG001|Overall Study|Study terminated by Sponsor|0
6921357|NCT00806585|10949849|FG002|Overall Study|Study terminated by Sponsor|1
6921358|NCT00806585|10949850|FG003|Overall Study|Study terminated by Sponsor|2
6921359|NCT00806585|10949851|FG004|Overall Study|Study terminated by Sponsor|0
6921360|NCT00806585|10949847|FG000|Overall Study|Protocol Violation|3
6921361|NCT00806585|10949848|FG001|Overall Study|Protocol Violation|1
6921362|NCT00806585|10949849|FG002|Overall Study|Protocol Violation|2
6921363|NCT00806585|10949850|FG003|Overall Study|Protocol Violation|0
6921364|NCT00806585|10949851|FG004|Overall Study|Protocol Violation|0
6921365|NCT00806585|10949847|FG000|Overall Study|Physician Decision|0
6921366|NCT00806585|10949848|FG001|Overall Study|Physician Decision|2
6921367|NCT00806585|10949849|FG002|Overall Study|Physician Decision|3
6921368|NCT00806585|10949850|FG003|Overall Study|Physician Decision|0
6921369|NCT00806585|10949851|FG004|Overall Study|Physician Decision|1
6921370|NCT00806585|10949847|FG000|Overall Study|Lost to Follow-up|2
6921371|NCT00806585|10949848|FG001|Overall Study|Lost to Follow-up|1
6921372|NCT00806585|10949849|FG002|Overall Study|Lost to Follow-up|2
6921373|NCT00806585|10949850|FG003|Overall Study|Lost to Follow-up|2
6921374|NCT00806585|10949851|FG004|Overall Study|Lost to Follow-up|5
6921375|NCT00806585|10949847|FG000|Overall Study|Lack of Efficacy|1
6921376|NCT00806585|10949848|FG001|Overall Study|Lack of Efficacy|0
6921377|NCT00806585|10949849|FG002|Overall Study|Lack of Efficacy|0
6921378|NCT00806585|10949850|FG003|Overall Study|Lack of Efficacy|0
6921379|NCT00806585|10949851|FG004|Overall Study|Lack of Efficacy|0
6921380|NCT00806585|10949847|FG000|Overall Study|Adverse Event|1
6921381|NCT00806585|10949848|FG001|Overall Study|Adverse Event|5
6921382|NCT00806585|10949849|FG002|Overall Study|Adverse Event|3
6921383|NCT00806585|10949850|FG003|Overall Study|Adverse Event|4
6921384|NCT00806585|10949851|FG004|Overall Study|Adverse Event|2
6921385|NCT00806585|10949847|FG000|Overall Study|Withdrawal by Subject|10
6921386|NCT00806585|10949848|FG001|Overall Study|Withdrawal by Subject|8
6921387|NCT00806585|10949849|FG002|Overall Study|Withdrawal by Subject|9
6921388|NCT00806585|10949850|FG003|Overall Study|Withdrawal by Subject|3
6921389|NCT00806585|10949851|FG004|Overall Study|Withdrawal by Subject|11
6921390|NCT00806585|10949847|FG000|Overall Study|Completion status unknown|15
6921391|NCT00806585|10949848|FG001|Overall Study|Completion status unknown|14
6921392|NCT00806585|10949849|FG002|Overall Study|Completion status unknown|12
6921393|NCT00806585|10949850|FG003|Overall Study|Completion status unknown|4
6921394|NCT00806585|10949851|FG004|Overall Study|Completion status unknown|12
6921395|NCT00806624|10949870|FG000|Overall Study|Adverse Event|2
6921396|NCT00806624|10949871|FG001|Overall Study|Adverse Event|8
6921397|NCT00806624|10949872|FG002|Overall Study|Adverse Event|0
6921398|NCT00806624|10949870|FG000|Overall Study|Death|0
6921399|NCT00806624|10949871|FG001|Overall Study|Death|1
6921400|NCT00806624|10949872|FG002|Overall Study|Death|1
6921401|NCT00806624|10949870|FG000|Overall Study|Lost to Follow-up|1
6921402|NCT00806624|10949871|FG001|Overall Study|Lost to Follow-up|0
6921403|NCT00806624|10949872|FG002|Overall Study|Lost to Follow-up|1
6921404|NCT00806624|10949870|FG000|Overall Study|Withdrawal by Subject|6
6921405|NCT00806624|10949871|FG001|Overall Study|Withdrawal by Subject|3
6921406|NCT00806624|10949872|FG002|Overall Study|Withdrawal by Subject|3
6921407|NCT00806624|10949870|FG000|Overall Study|discontinued before start of treatment|0
6921408|NCT00806624|10949871|FG001|Overall Study|discontinued before start of treatment|0
6921409|NCT00806624|10949872|FG002|Overall Study|discontinued before start of treatment|1
6921410|NCT00806819|10949896|FG000|Overall Study|progressive disease (modified RECIST )|217
6921411|NCT00806819|10949897|FG001|Overall Study|progressive disease (modified RECIST )|216
6921412|NCT00806819|10949896|FG000|Overall Study|Worsening or AE of underlying disease|18
6921413|NCT00806819|10949897|FG001|Overall Study|Worsening or AE of underlying disease|25
6921414|NCT00806819|10949896|FG000|Overall Study|Other AE|38
6921415|NCT00806819|10949897|FG001|Overall Study|Other AE|40
6921416|NCT00806819|10949896|FG000|Overall Study|Protocol Violation|9
6921417|NCT00806819|10949897|FG001|Overall Study|Protocol Violation|4
6921418|NCT00806819|10949896|FG000|Overall Study|Lost to Follow-up|1
6921419|NCT00806819|10949897|FG001|Overall Study|Lost to Follow-up|0
6921420|NCT00806819|10949896|FG000|Overall Study|Withdrawal by Subject|32
6921421|NCT00806819|10949897|FG001|Overall Study|Withdrawal by Subject|29
6921422|NCT00806819|10949896|FG000|Overall Study|Not treated|6
6921423|NCT00806819|10949897|FG001|Overall Study|Not treated|3
6921424|NCT00806819|10949896|FG000|Overall Study|Reasons other than stated above|25
6921425|NCT00806819|10949897|FG001|Overall Study|Reasons other than stated above|41
6921426|NCT00806988|10949906|FG000|Overall Study|Death|15
6921427|NCT00806988|10949907|FG001|Overall Study|Death|16
6921428|NCT00806988|10949906|FG000|Overall Study|Withdrawal by Subject|8
6921429|NCT00806988|10949907|FG001|Overall Study|Withdrawal by Subject|8
6921430|NCT00806988|10949906|FG000|Overall Study|Lost to Follow-up|4
6921431|NCT00806988|10949907|FG001|Overall Study|Lost to Follow-up|19
6921432|NCT00807001|10949918|FG000|Overall Study|Non-compliance|0
6921433|NCT00807001|10949919|FG001|Overall Study|Non-compliance|1
6921434|NCT00807001|10949920|FG002|Overall Study|Non-compliance|0
6921435|NCT00807001|10949921|FG003|Overall Study|Non-compliance|0
6921436|NCT00807001|10949922|FG004|Overall Study|Non-compliance|0
6921437|NCT00807014|10949936|FG000|Overall Study|Participant Considered Disease Cured|13
6921438|NCT00807014|10949937|FG001|Overall Study|Participant Considered Disease Cured|2
6921439|NCT00807014|10949936|FG000|Overall Study|Participant Considered Disease Not Cured|2
6921440|NCT00807014|10949937|FG001|Overall Study|Participant Considered Disease Not Cured|7
6921441|NCT00807014|10949936|FG000|Overall Study|Protocol Violation|2
6921442|NCT00807014|10949937|FG001|Overall Study|Protocol Violation|8
6921443|NCT00807014|10949936|FG000|Overall Study|Adverse Event|0
6921444|NCT00807014|10949937|FG001|Overall Study|Adverse Event|2
6921445|NCT00807014|10949936|FG000|Overall Study|Lost to Follow-up|9
6921446|NCT00807014|10949937|FG001|Overall Study|Lost to Follow-up|7
6921447|NCT00807014|10949936|FG000|Overall Study|Recovery|1
6921448|NCT00807014|10949937|FG001|Overall Study|Recovery|0
6921449|NCT00807014|10949936|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0
6921450|NCT00807014|10949937|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1
6921451|NCT00807040|10949945|FG000|Overall Study|Death|24
6921452|NCT00807040|10949946|FG001|Overall Study|Death|29
6921453|NCT00807040|10949945|FG000|Overall Study|Withdrawal by Subject|8
6921454|NCT00807040|10949946|FG001|Overall Study|Withdrawal by Subject|6
6921455|NCT00807040|10949945|FG000|Overall Study|Lost to Follow-up|4
6921456|NCT00807040|10949946|FG001|Overall Study|Lost to Follow-up|6
6921457|NCT00807092|10949954|FG000|Overall Study|Adverse Event|0
6921458|NCT00807092|10949955|FG001|Overall Study|Adverse Event|1
6921459|NCT00807092|10949954|FG000|Overall Study|Protocol Violation|0
6921460|NCT00807092|10949955|FG001|Overall Study|Protocol Violation|2
6921461|NCT00807092|10949954|FG000|Overall Study|Withdrawal by Subject|1
6921462|NCT00807092|10949955|FG001|Overall Study|Withdrawal by Subject|0
6921463|NCT00807092|10949954|FG000|Overall Study|CGMS data collection failed|0
6921464|NCT00807092|10949955|FG001|Overall Study|CGMS data collection failed|1
6921465|NCT00807144|10949963|FG000|Overall Study|Lost to Follow-up|0
6921466|NCT00807144|10949964|FG001|Overall Study|Lost to Follow-up|1
6921467|NCT00807235|10949985|FG000|Overall Study|Adverse Event|1
6921468|NCT00807235|10949986|FG001|Overall Study|Adverse Event|0
6921469|NCT00807248|10949996|FG000|Overall Study|Adverse Event|1
6921470|NCT00807248|10949997|FG001|Overall Study|Adverse Event|2
6921471|NCT00807248|10949998|FG002|Overall Study|Adverse Event|2
6921472|NCT00807248|10949999|FG003|Overall Study|Adverse Event|6
6921473|NCT00807248|10949996|FG000|Overall Study|Lack of Efficacy|14
6921474|NCT00807248|10949997|FG001|Overall Study|Lack of Efficacy|4
6921475|NCT00807248|10949998|FG002|Overall Study|Lack of Efficacy|8
6921476|NCT00807248|10949999|FG003|Overall Study|Lack of Efficacy|3
6921477|NCT00807248|10949996|FG000|Overall Study|Protocol Violation|0
6921478|NCT00807248|10949997|FG001|Overall Study|Protocol Violation|1
6921479|NCT00807248|10949998|FG002|Overall Study|Protocol Violation|1
6921480|NCT00807248|10949999|FG003|Overall Study|Protocol Violation|0
6921481|NCT00807248|10949996|FG000|Overall Study|Withdrawal of Consent|5
6921482|NCT00807248|10949997|FG001|Overall Study|Withdrawal of Consent|5
6921483|NCT00807248|10949998|FG002|Overall Study|Withdrawal of Consent|5
6921484|NCT00807248|10949999|FG003|Overall Study|Withdrawal of Consent|5
6921485|NCT00807248|10949996|FG000|Overall Study|Lost to Follow-up|1
6921486|NCT00807248|10949997|FG001|Overall Study|Lost to Follow-up|0
6921487|NCT00807248|10949998|FG002|Overall Study|Lost to Follow-up|0
6921488|NCT00807248|10949999|FG003|Overall Study|Lost to Follow-up|0
6921489|NCT00807248|10949996|FG000|Overall Study|Other Reason|0
6921490|NCT00807248|10949997|FG001|Overall Study|Other Reason|0
6921491|NCT00807248|10949998|FG002|Overall Study|Other Reason|2
6921492|NCT00807248|10949999|FG003|Overall Study|Other Reason|0
6921493|NCT00807495|10950018|FG000|Overall Study|Adverse Event|6
6921494|NCT00807495|10950019|FG001|Overall Study|Adverse Event|3
6921495|NCT00807495|10950020|FG002|Overall Study|Adverse Event|1
6921496|NCT00807495|10950021|FG003|Overall Study|Adverse Event|1
6921497|NCT00807495|10950022|FG004|Overall Study|Adverse Event|2
6921498|NCT00807495|10950018|FG000|Overall Study|Withdrawal by Patient|2
6921499|NCT00807495|10950019|FG001|Overall Study|Withdrawal by Patient|0
6921500|NCT00807495|10950020|FG002|Overall Study|Withdrawal by Patient|1
6921501|NCT00807495|10950021|FG003|Overall Study|Withdrawal by Patient|0
6921502|NCT00807495|10950022|FG004|Overall Study|Withdrawal by Patient|0
6921503|NCT00807495|10950018|FG000|Overall Study|Reason Not Specified|0
6921504|NCT00807495|10950019|FG001|Overall Study|Reason Not Specified|3
6921505|NCT00807495|10950020|FG002|Overall Study|Reason Not Specified|2
6921506|NCT00807495|10950021|FG003|Overall Study|Reason Not Specified|0
6921507|NCT00807495|10950022|FG004|Overall Study|Reason Not Specified|3
6974585|NCT01188772|11026655|FG002|Overall Study|Virologic Failure|0
6974586|NCT01188772|11026656|FG003|Overall Study|Virologic Failure|0
6974587|NCT01188772|11026653|FG000|Overall Study|Withdrawal by Subject|0
6974588|NCT01188772|11026654|FG001|Overall Study|Withdrawal by Subject|0
6974589|NCT01188772|11026655|FG002|Overall Study|Withdrawal by Subject|2
6974590|NCT01188772|11026656|FG003|Overall Study|Withdrawal by Subject|0
6974591|NCT01188811|11026671|FG000|Overall Study|Withdrawal by Subject|0
6974592|NCT01188811|11026672|FG001|Overall Study|Withdrawal by Subject|2
6974593|NCT01188811|11026671|FG000|Overall Study|Adverse Event|6
6974594|NCT01188811|11026672|FG001|Overall Study|Adverse Event|0
6974595|NCT01188967|11026701|FG000|Overall Study|Withdrawal by Subject|1
6974596|NCT01188967|11026702|FG001|Overall Study|Withdrawal by Subject|1
6974597|NCT01188967|11026701|FG000|Overall Study|Physician Decision|1
6974598|NCT01188967|11026702|FG001|Overall Study|Physician Decision|1
6974599|NCT01188967|11026701|FG000|Overall Study|Lost to Follow-up|3
6974600|NCT01188967|11026702|FG001|Overall Study|Lost to Follow-up|2
6974601|NCT01189032|11026713|FG000|Overall Study|Adverse Event|1
6974602|NCT01189032|11026714|FG001|Overall Study|Adverse Event|3
6974603|NCT01189032|11026715|FG002|Overall Study|Adverse Event|4
6974604|NCT01189032|11026713|FG000|Overall Study|Lack of Efficacy|2
6974605|NCT01189032|11026714|FG001|Overall Study|Lack of Efficacy|3
6974606|NCT01189032|11026715|FG002|Overall Study|Lack of Efficacy|0
6974607|NCT01189032|11026713|FG000|Overall Study|Withdrawal by Subject|1
6974608|NCT01189032|11026714|FG001|Overall Study|Withdrawal by Subject|0
6974609|NCT01189032|11026715|FG002|Overall Study|Withdrawal by Subject|1
6974610|NCT01189032|11026713|FG000|Overall Study|Protocol Violation|1
6974611|NCT01189032|11026714|FG001|Overall Study|Protocol Violation|1
6974612|NCT01189032|11026715|FG002|Overall Study|Protocol Violation|1
6974613|NCT01189201|11026750|FG000|Overall Study|Adverse Event|1
6974614|NCT01189266|11026780|FG000|Overall Study|Adverse Event|1
6974615|NCT01189266|11026781|FG001|Overall Study|Adverse Event|0
6974616|NCT01189266|11026782|FG002|Overall Study|Adverse Event|5
6974617|NCT01189266|11026780|FG000|Overall Study|Death|0
6974618|NCT01189266|11026781|FG001|Overall Study|Death|0
6974619|NCT01189266|11026782|FG002|Overall Study|Death|5
6974620|NCT01189266|11026780|FG000|Overall Study|Lack of Efficacy|4
6974621|NCT01189266|11026781|FG001|Overall Study|Lack of Efficacy|5
6974622|NCT01189266|11026782|FG002|Overall Study|Lack of Efficacy|44
6974623|NCT01189266|11026780|FG000|Overall Study|Physician Decision|0
6974624|NCT01189266|11026781|FG001|Overall Study|Physician Decision|0
6974625|NCT01189266|11026782|FG002|Overall Study|Physician Decision|1
6974626|NCT01189266|11026780|FG000|Overall Study|Protocol Violation|0
6974627|NCT01189266|11026781|FG001|Overall Study|Protocol Violation|1
6974628|NCT01189266|11026782|FG002|Overall Study|Protocol Violation|1
6974629|NCT01189266|11026780|FG000|Overall Study|Withdrawal by Subject|0
6921508|NCT00807573|10950043|FG000|Overall Study|Withdrawal by Subject|1
6921509|NCT00807573|10950043|FG000|Overall Study|Adverse Event|1
6921510|NCT00807599|10950058|FG000|Overall Study|Not treated on protocol study|0
6921511|NCT00807599|10950059|FG001|Overall Study|Not treated on protocol study|0
6921512|NCT00807599|10950060|FG002|Overall Study|Not treated on protocol study|2
6921513|NCT00807599|10950058|FG000|Overall Study|Adverse Event|0
6921514|NCT00807599|10950059|FG001|Overall Study|Adverse Event|0
6921515|NCT00807599|10950060|FG002|Overall Study|Adverse Event|5
6921516|NCT00807599|10950058|FG000|Overall Study|Inadequate response to induction|0
6921517|NCT00807599|10950059|FG001|Overall Study|Inadequate response to induction|0
6921518|NCT00807599|10950060|FG002|Overall Study|Inadequate response to induction|9
6921519|NCT00807599|10950058|FG000|Overall Study|Withdrawal by Subject|0
6921520|NCT00807599|10950059|FG001|Overall Study|Withdrawal by Subject|0
6921521|NCT00807599|10950060|FG002|Overall Study|Withdrawal by Subject|1
6921522|NCT00807742|10950078|FG000|Overall Study|Death|9
6921523|NCT00807742|10950079|FG001|Overall Study|Death|2
6921524|NCT00807742|10950078|FG000|Overall Study|Withdrawal by Subject|2
6921525|NCT00807742|10950079|FG001|Overall Study|Withdrawal by Subject|1
6921526|NCT00807742|10950078|FG000|Overall Study|Lost to Follow-up|35
6921527|NCT00807742|10950079|FG001|Overall Study|Lost to Follow-up|51
6921528|NCT00807846|10950096|FG000|Overall Study|Adverse Event|5
6921529|NCT00807846|10950097|FG001|Overall Study|Adverse Event|0
6921530|NCT00807846|10950096|FG000|Overall Study|Lack of Efficacy|2
6921531|NCT00807846|10950097|FG001|Overall Study|Lack of Efficacy|0
6921532|NCT00807846|10950096|FG000|Overall Study|Protocol Violation|2
6921533|NCT00807846|10950097|FG001|Overall Study|Protocol Violation|1
6921534|NCT00807846|10950096|FG000|Overall Study|Withdrawal by Subject|2
6921535|NCT00807846|10950097|FG001|Overall Study|Withdrawal by Subject|1
6921536|NCT00807846|10950096|FG000|Overall Study|Other|1
6921537|NCT00807846|10950097|FG001|Overall Study|Other|2
6921538|NCT00807885|10950112|FG000|Overall Study|Lost to Follow-up|0
6921539|NCT00807885|10950113|FG001|Overall Study|Lost to Follow-up|0
6921540|NCT00807885|10950114|FG002|Overall Study|Lost to Follow-up|0
6921541|NCT00807885|10950115|FG003|Overall Study|Lost to Follow-up|0
6921542|NCT00807885|10950116|FG004|Overall Study|Lost to Follow-up|0
6921543|NCT00807885|10950117|FG005|Overall Study|Lost to Follow-up|1
6921544|NCT00807885|10950118|FG006|Overall Study|Lost to Follow-up|0
6921545|NCT00807885|10950119|FG007|Overall Study|Lost to Follow-up|0
6921546|NCT00807885|10950120|FG008|Overall Study|Lost to Follow-up|0
6921547|NCT00807937|10950144|FG000|Overall Study|Adverse Event|12
6921548|NCT00807937|10950145|FG001|Overall Study|Adverse Event|12
6921549|NCT00807937|10950146|FG002|Overall Study|Adverse Event|5
6921550|NCT00807937|10950147|FG003|Overall Study|Adverse Event|4
6921551|NCT00807937|10950144|FG000|Overall Study|Protocol Violation|4
6921552|NCT00807937|10950145|FG001|Overall Study|Protocol Violation|5
6921553|NCT00807937|10950146|FG002|Overall Study|Protocol Violation|3
6921554|NCT00807937|10950147|FG003|Overall Study|Protocol Violation|3
6921555|NCT00807937|10950144|FG000|Overall Study|Withdrawal by Subject|5
6921556|NCT00807937|10950145|FG001|Overall Study|Withdrawal by Subject|4
6921557|NCT00807937|10950146|FG002|Overall Study|Withdrawal by Subject|1
6921558|NCT00807937|10950147|FG003|Overall Study|Withdrawal by Subject|4
6921559|NCT00807937|10950144|FG000|Overall Study|Lost to Follow-up|4
6921560|NCT00807937|10950145|FG001|Overall Study|Lost to Follow-up|0
6921561|NCT00807937|10950146|FG002|Overall Study|Lost to Follow-up|2
6921562|NCT00807937|10950147|FG003|Overall Study|Lost to Follow-up|1
6921563|NCT00807937|10950144|FG000|Overall Study|Lack of Efficacy|0
6921564|NCT00807937|10950145|FG001|Overall Study|Lack of Efficacy|0
6921565|NCT00807937|10950146|FG002|Overall Study|Lack of Efficacy|1
6921566|NCT00807937|10950147|FG003|Overall Study|Lack of Efficacy|2
6921567|NCT00807937|10950144|FG000|Overall Study|Intake of prohibited medicine|0
6921568|NCT00807937|10950145|FG001|Overall Study|Intake of prohibited medicine|0
6921569|NCT00807937|10950146|FG002|Overall Study|Intake of prohibited medicine|2
6921570|NCT00807937|10950147|FG003|Overall Study|Intake of prohibited medicine|0
6921571|NCT00807937|10950144|FG000|Overall Study|All other reasons (not provided)|2
6921572|NCT00807937|10950145|FG001|Overall Study|All other reasons (not provided)|4
6921573|NCT00807937|10950146|FG002|Overall Study|All other reasons (not provided)|0
6921574|NCT00807937|10950147|FG003|Overall Study|All other reasons (not provided)|1
6921575|NCT00808015|10950166|FG000|Overall Study|Death|1
6921576|NCT00808015|10950166|FG000|Overall Study|Lack of Efficacy|58
6921577|NCT00808015|10950166|FG000|Overall Study|Lost to Follow-up|76
6921578|NCT00808015|10950166|FG000|Overall Study|Participants not willing to participate|158
6921579|NCT00808015|10950166|FG000|Overall Study|Adverse Event|22
6921580|NCT00808015|10950166|FG000|Overall Study|Other|25
6921581|NCT00808015|10950166|FG000|Overall Study|Enrolled but not treated|4
6921582|NCT00808028|10950174|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3
6921583|NCT00808028|10950175|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0
6921584|NCT00808028|10950176|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2
6921585|NCT00808028|10950177|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5
6921586|NCT00808028|10950174|FG000|Stage 1 (6 Months)|Other|1
6921587|NCT00808028|10950175|FG001|Stage 1 (6 Months)|Other|0
6921588|NCT00808028|10950176|FG002|Stage 1 (6 Months)|Other|2
6921589|NCT00808028|10950177|FG003|Stage 1 (6 Months)|Other|4
6921590|NCT00808028|10950174|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0
6921591|NCT00808028|10950175|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1
6921592|NCT00808028|10950176|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1
6921593|NCT00808028|10950177|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3
6921594|NCT00808028|10950174|FG000|Stage 1 (6 Months)|Adverse Event|0
6921595|NCT00808028|10950175|FG001|Stage 1 (6 Months)|Adverse Event|0
6921596|NCT00808028|10950176|FG002|Stage 1 (6 Months)|Adverse Event|1
6921597|NCT00808028|10950177|FG003|Stage 1 (6 Months)|Adverse Event|2
6921598|NCT00808028|10950174|FG000|Stage 1 (6 Months)|Lost to Follow-up|1
6921599|NCT00808028|10950175|FG001|Stage 1 (6 Months)|Lost to Follow-up|0
6921600|NCT00808028|10950176|FG002|Stage 1 (6 Months)|Lost to Follow-up|1
6921601|NCT00808028|10950177|FG003|Stage 1 (6 Months)|Lost to Follow-up|0
6921602|NCT00808028|10950174|FG000|Stage 1 (6 Months)|Protocol Violation|0
6921603|NCT00808028|10950175|FG001|Stage 1 (6 Months)|Protocol Violation|0
6921604|NCT00808028|10950176|FG002|Stage 1 (6 Months)|Protocol Violation|0
6921605|NCT00808028|10950177|FG003|Stage 1 (6 Months)|Protocol Violation|1
6921606|NCT00808028|10950174|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6
6921607|NCT00808028|10950175|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0
6921608|NCT00808028|10950176|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9
6921609|NCT00808028|10950177|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11
6921610|NCT00808028|10950174|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
6921611|NCT00808028|10950175|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
6921612|NCT00808028|10950176|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1
6921613|NCT00808028|10950177|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
6921614|NCT00808028|10950174|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2
6921615|NCT00808028|10950175|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0
6921616|NCT00808028|10950176|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8
6921617|NCT00808028|10950177|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7
6921618|NCT00808028|10950174|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2
6921619|NCT00808028|10950175|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0
6921620|NCT00808028|10950176|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5
6921621|NCT00808028|10950177|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4
6921622|NCT00808028|10950174|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1
6921623|NCT00808028|10950175|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0
6921624|NCT00808028|10950176|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1
6921625|NCT00808028|10950177|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0
6921626|NCT00808028|10950174|FG000|Stage 2 (Followed up to 48 Months )|Other|0
6921627|NCT00808028|10950175|FG001|Stage 2 (Followed up to 48 Months )|Other|0
6921628|NCT00808028|10950176|FG002|Stage 2 (Followed up to 48 Months )|Other|1
6921629|NCT00808028|10950177|FG003|Stage 2 (Followed up to 48 Months )|Other|1
6921630|NCT00808028|10950174|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
6921631|NCT00808028|10950175|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
6921632|NCT00808028|10950176|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2
6921633|NCT00808028|10950177|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
6921634|NCT00808028|10950174|FG000|Stage 2 (Followed up to 48 Months )|Death|0
6921635|NCT00808028|10950175|FG001|Stage 2 (Followed up to 48 Months )|Death|0
6921636|NCT00808028|10950176|FG002|Stage 2 (Followed up to 48 Months )|Death|1
6921637|NCT00808028|10950177|FG003|Stage 2 (Followed up to 48 Months )|Death|0
6921638|NCT00808028|10950174|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0
6921639|NCT00808028|10950175|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0
6921640|NCT00808028|10950176|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1
6921641|NCT00808028|10950177|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0
6921642|NCT00808067|10950199|FG000|Overall Study|Major/minor bleed|30
6921643|NCT00808067|10950200|FG001|Overall Study|Major/minor bleed|44
6921644|NCT00808067|10950199|FG000|Overall Study|Outcome event - other|33
6921645|NCT00808067|10950200|FG001|Overall Study|Outcome event - other|25
6921646|NCT00808067|10950199|FG000|Overall Study|Adverse Event|111
6921647|NCT00808067|10950200|FG001|Overall Study|Adverse Event|121
6921648|NCT00808067|10950199|FG000|Overall Study|Hospitalization (not including surgery)|18
6921649|NCT00808067|10950200|FG001|Overall Study|Hospitalization (not including surgery)|17
6921650|NCT00808067|10950199|FG000|Overall Study|Hospitalization due to surgery|37
6921651|NCT00808067|10950200|FG001|Overall Study|Hospitalization due to surgery|40
6921652|NCT00808067|10950199|FG000|Overall Study|Reduced creatinine clearance|53
6921653|NCT00808067|10950200|FG001|Overall Study|Reduced creatinine clearance|55
6921654|NCT00808067|10950199|FG000|Overall Study|Elevated LFT results|7
6921655|NCT00808067|10950200|FG001|Overall Study|Elevated LFT results|3
6921656|NCT00808067|10950199|FG000|Overall Study|Patient refused to take study medication|65
6921657|NCT00808067|10950200|FG001|Overall Study|Patient refused to take study medication|76
6921658|NCT00808067|10950199|FG000|Overall Study|Missing|1
6921659|NCT00808067|10950200|FG001|Overall Study|Missing|0
6921660|NCT00808067|10950199|FG000|Overall Study|Death|1
6921661|NCT00808067|10950200|FG001|Overall Study|Death|1
6921662|NCT00808067|10950199|FG000|Overall Study|Procedure|6
6921663|NCT00808067|10950200|FG001|Overall Study|Procedure|7
6921664|NCT00808067|10950199|FG000|Overall Study|Withdrawal by Subject|21
6921665|NCT00808067|10950200|FG001|Overall Study|Withdrawal by Subject|25
6921666|NCT00808067|10950199|FG000|Overall Study|Site closed|4
6921667|NCT00808067|10950200|FG001|Overall Study|Site closed|3
6921668|NCT00808067|10950199|FG000|Overall Study|Physician Decision|47
6921669|NCT00808067|10950200|FG001|Overall Study|Physician Decision|38
6921670|NCT00808067|10950199|FG000|Overall Study|Protocol Violation|3
6921671|NCT00808067|10950200|FG001|Overall Study|Protocol Violation|11
6921672|NCT00808067|10950199|FG000|Overall Study|Patient elected|7
6921673|NCT00808067|10950200|FG001|Overall Study|Patient elected|9
6921674|NCT00808067|10950199|FG000|Overall Study|Site closed for cause|19
6921675|NCT00808067|10950200|FG001|Overall Study|Site closed for cause|19
6921676|NCT00808067|10950199|FG000|Overall Study|Other reason not defined above|5
6921677|NCT00808067|10950200|FG001|Overall Study|Other reason not defined above|5
6921678|NCT00808067|10950199|FG000|Overall Study|Excluded from analysis|13
6921679|NCT00808067|10950200|FG001|Overall Study|Excluded from analysis|19
6921680|NCT00808132|10950211|FG000|Overall Study|Adverse Event|34
6921681|NCT00808132|10950212|FG001|Overall Study|Adverse Event|33
6921682|NCT00808132|10950213|FG002|Overall Study|Adverse Event|16
6921683|NCT00808132|10950214|FG003|Overall Study|Adverse Event|31
6921684|NCT00808132|10950215|FG004|Overall Study|Adverse Event|33
6921685|NCT00808132|10950211|FG000|Overall Study|Death|0
6921686|NCT00808132|10950212|FG001|Overall Study|Death|0
6921687|NCT00808132|10950213|FG002|Overall Study|Death|0
6921688|NCT00808132|10950214|FG003|Overall Study|Death|0
6921689|NCT00808132|10950215|FG004|Overall Study|Death|1
6921690|NCT00808132|10950211|FG000|Overall Study|Physician Decision|0
6921691|NCT00808132|10950212|FG001|Overall Study|Physician Decision|1
6921692|NCT00808132|10950213|FG002|Overall Study|Physician Decision|0
6921693|NCT00808132|10950214|FG003|Overall Study|Physician Decision|0
6921694|NCT00808132|10950215|FG004|Overall Study|Physician Decision|0
6921695|NCT00808132|10950211|FG000|Overall Study|Lost to Follow-up|8
6921696|NCT00808132|10950212|FG001|Overall Study|Lost to Follow-up|10
6921697|NCT00808132|10950213|FG002|Overall Study|Lost to Follow-up|11
6921698|NCT00808132|10950214|FG003|Overall Study|Lost to Follow-up|8
6921699|NCT00808132|10950215|FG004|Overall Study|Lost to Follow-up|9
6921700|NCT00808132|10950211|FG000|Overall Study|Protocol Violation|8
6921701|NCT00808132|10950212|FG001|Overall Study|Protocol Violation|9
6921702|NCT00808132|10950213|FG002|Overall Study|Protocol Violation|4
6921703|NCT00808132|10950214|FG003|Overall Study|Protocol Violation|9
6921704|NCT00808132|10950215|FG004|Overall Study|Protocol Violation|5
6921705|NCT00808132|10950211|FG000|Overall Study|Withdrawal by Subject|27
6921706|NCT00808132|10950212|FG001|Overall Study|Withdrawal by Subject|18
6921707|NCT00808132|10950213|FG002|Overall Study|Withdrawal by Subject|2
6921708|NCT00808132|10950214|FG003|Overall Study|Withdrawal by Subject|7
6921709|NCT00808132|10950215|FG004|Overall Study|Withdrawal by Subject|16
6921710|NCT00808132|10950211|FG000|Overall Study|Other|6
6921711|NCT00808132|10950212|FG001|Overall Study|Other|4
6921712|NCT00808132|10950213|FG002|Overall Study|Other|6
6921713|NCT00808132|10950214|FG003|Overall Study|Other|2
6921714|NCT00808132|10950215|FG004|Overall Study|Other|15
6921715|NCT00808132|10950211|FG000|Overall Study|Randomized, but not treated|10
6921716|NCT00808132|10950212|FG001|Overall Study|Randomized, but not treated|7
6921717|NCT00808132|10950213|FG002|Overall Study|Randomized, but not treated|9
6921718|NCT00808132|10950214|FG003|Overall Study|Randomized, but not treated|8
6921719|NCT00808132|10950215|FG004|Overall Study|Randomized, but not treated|9
6921720|NCT00808132|10950211|FG000|Overall Study|Unsatisfactory response|5
6921721|NCT00808132|10950212|FG001|Overall Study|Unsatisfactory response|6
6921722|NCT00808132|10950213|FG002|Overall Study|Unsatisfactory response|6
6921723|NCT00808132|10950214|FG003|Overall Study|Unsatisfactory response|4
6921724|NCT00808132|10950215|FG004|Overall Study|Unsatisfactory response|12
6921725|NCT00808210|10950229|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3
6921726|NCT00808210|10950230|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7
6921727|NCT00808210|10950229|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6
6921728|NCT00808210|10950230|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2
6921729|NCT00808210|10950229|FG000|Double-Blind TX Period|Adverse Event|0
6921730|NCT00808210|10950230|FG001|Double-Blind TX Period|Adverse Event|1
6921731|NCT00808210|10950229|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1
6921732|NCT00808210|10950230|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1
6921733|NCT00808210|10950229|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1
6921734|NCT00808210|10950230|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1
6921735|NCT00808210|10950229|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9
6921736|NCT00808210|10950230|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4
6921737|NCT00808236|10950238|FG000|Overall Study|Was not resuscitated|50
6921738|NCT00808236|10950239|FG001|Overall Study|Was not resuscitated|56
6921739|NCT00808236|10950238|FG000|Overall Study|Pre-defined exclusion|13
6921740|NCT00808236|10950239|FG001|Overall Study|Pre-defined exclusion|3
6921741|NCT00808236|10950238|FG000|Overall Study|Lost to Follow-up|1
6921742|NCT00808236|10950239|FG001|Overall Study|Lost to Follow-up|1
6921743|NCT00808236|10950238|FG000|Overall Study|Physician Decision|0
6921744|NCT00808236|10950239|FG001|Overall Study|Physician Decision|1
6921745|NCT00808236|10950238|FG000|Overall Study|Death|18
6921746|NCT00808236|10950239|FG001|Overall Study|Death|30
6921747|NCT00808249|10950249|FG000|Overall Study|Adverse Event|4
6921748|NCT00808249|10950250|FG001|Overall Study|Adverse Event|7
6921749|NCT00808249|10950251|FG002|Overall Study|Adverse Event|10
6921750|NCT00808249|10950252|FG003|Overall Study|Adverse Event|6
6921751|NCT00808249|10950249|FG000|Overall Study|Lost to Follow-up|2
6921752|NCT00808249|10950250|FG001|Overall Study|Lost to Follow-up|3
6921753|NCT00808249|10950251|FG002|Overall Study|Lost to Follow-up|3
6921754|NCT00808249|10950252|FG003|Overall Study|Lost to Follow-up|5
6921755|NCT00808249|10950249|FG000|Overall Study|Withdrawal by Subject|4
6921756|NCT00808249|10950250|FG001|Overall Study|Withdrawal by Subject|0
6921757|NCT00808249|10950251|FG002|Overall Study|Withdrawal by Subject|2
6921758|NCT00808249|10950252|FG003|Overall Study|Withdrawal by Subject|4
6921759|NCT00808249|10950249|FG000|Overall Study|Protocol Violation|3
6921760|NCT00808249|10950250|FG001|Overall Study|Protocol Violation|3
6921761|NCT00808249|10950251|FG002|Overall Study|Protocol Violation|3
6921762|NCT00808249|10950252|FG003|Overall Study|Protocol Violation|0
6921763|NCT00808249|10950249|FG000|Overall Study|Lack of Efficacy|1
6921764|NCT00808249|10950250|FG001|Overall Study|Lack of Efficacy|1
6921765|NCT00808249|10950251|FG002|Overall Study|Lack of Efficacy|0
6921766|NCT00808249|10950252|FG003|Overall Study|Lack of Efficacy|0
6921767|NCT00808249|10950249|FG000|Overall Study|study specific discontinuation criteria|1
6921768|NCT00808249|10950250|FG001|Overall Study|study specific discontinuation criteria|0
6921769|NCT00808249|10950251|FG002|Overall Study|study specific discontinuation criteria|1
6921770|NCT00808249|10950252|FG003|Overall Study|study specific discontinuation criteria|0
6921771|NCT00808249|10950249|FG000|Overall Study|All other reasons|2
6921772|NCT00808249|10950250|FG001|Overall Study|All other reasons|1
6921773|NCT00808249|10950251|FG002|Overall Study|All other reasons|3
6921774|NCT00808249|10950252|FG003|Overall Study|All other reasons|1
6921775|NCT00808444|10950286|FG000|Overall Study|Withdrawal by Subject|1
6921776|NCT00808444|10950287|FG001|Overall Study|Withdrawal by Subject|0
6921777|NCT00808444|10950286|FG000|Overall Study|Lost to Follow-up|0
6921778|NCT00808444|10950287|FG001|Overall Study|Lost to Follow-up|1
6921779|NCT00808483|10950308|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
6921780|NCT00808483|10950309|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
6921781|NCT00808483|10950308|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1
6921782|NCT00808483|10950309|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0
6921783|NCT00808483|10950308|FG000|From 5 Months to 12 Months|Lack of Efficacy|1
6921784|NCT00808483|10950309|FG001|From 5 Months to 12 Months|Lack of Efficacy|0
6921785|NCT00808509|10950324|FG000|Randomized Phase|Did not meet eligibility criteria|1
6921786|NCT00808509|10950325|FG001|Randomized Phase|Did not meet eligibility criteria|0
6921787|NCT00808509|10950324|FG000|Randomized Phase|Reduced methotrexate dose|1
6921788|NCT00808509|10950325|FG001|Randomized Phase|Reduced methotrexate dose|2
6921789|NCT00808509|10950324|FG000|Randomized Phase|Patient refused rescue therapy|0
6921790|NCT00808509|10950325|FG001|Randomized Phase|Patient refused rescue therapy|3
6921791|NCT00808639|10950333|FG000|Overall Study|Disease progression before surgery.|1
6921792|NCT00808665|10950339|FG000|Overall Study|Withdrawal by Subject|1
6921793|NCT00808665|10950340|FG001|Overall Study|Withdrawal by Subject|0
6921794|NCT00808665|10950339|FG000|Overall Study|only required minimally invasive surgery|1
6921795|NCT00808665|10950340|FG001|Overall Study|only required minimally invasive surgery|0
6921796|NCT00808665|10950339|FG000|Overall Study|surgery cancelled|1
6921797|NCT00808665|10950340|FG001|Overall Study|surgery cancelled|0
6921798|NCT00808665|10950339|FG000|Overall Study|required an additional procedure|0
6921799|NCT00808665|10950340|FG001|Overall Study|required an additional procedure|1
6921800|NCT00808665|10950339|FG000|Overall Study|Physician Decision|3
6921801|NCT00808665|10950340|FG001|Overall Study|Physician Decision|1
6921802|NCT00808665|10950339|FG000|Overall Study|Medication stopped by resident|0
6921803|NCT00808665|10950340|FG001|Overall Study|Medication stopped by resident|1
6921804|NCT00808808|10950349|FG000|Overall Study|Vaccinated; survey not completed|131
6921805|NCT00808808|10950350|FG001|Overall Study|Vaccinated; survey not completed|169
6921806|NCT00808808|10950351|FG002|Overall Study|Vaccinated; survey not completed|302
6921807|NCT00808808|10950349|FG000|Overall Study|Employee was not vaccinated.|2686
6921808|NCT00808808|10950350|FG001|Overall Study|Employee was not vaccinated.|2268
6921809|NCT00808808|10950351|FG002|Overall Study|Employee was not vaccinated.|2255
6921810|NCT00809094|10950383|FG000|Overall Study|Lost to Follow-up|0
6921811|NCT00809094|10950384|FG001|Overall Study|Lost to Follow-up|1
6921812|NCT00809133|10950404|FG000|Overall Study|Progressive disease|2
6921813|NCT00809133|10950405|FG001|Overall Study|Progressive disease|5
6921814|NCT00809133|10950406|FG002|Overall Study|Progressive disease|5
6921815|NCT00809133|10950407|FG003|Overall Study|Progressive disease|3
6921816|NCT00809133|10950408|FG004|Overall Study|Progressive disease|4
6921817|NCT00809133|10950409|FG005|Overall Study|Progressive disease|1
6921818|NCT00809133|10950410|FG006|Overall Study|Progressive disease|3
6921819|NCT00809133|10950411|FG007|Overall Study|Progressive disease|3
6921820|NCT00809133|10950412|FG008|Overall Study|Progressive disease|3
6921821|NCT00809133|10950413|FG009|Overall Study|Progressive disease|9
6921822|NCT00809133|10950414|FG010|Overall Study|Progressive disease|5
6921823|NCT00809133|10950415|FG011|Overall Study|Progressive disease|7
6921824|NCT00809133|10950416|FG012|Overall Study|Progressive disease|5
6921825|NCT00809133|10950417|FG013|Overall Study|Progressive disease|4
6921826|NCT00809133|10950404|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0
6979337|NCT01217190|11033044|FG001|Second Dosing|Withdrawal by Subject|2
6979338|NCT01217229|11033053|FG000|Overall Study|Adverse Event|1
6979339|NCT01217229|11033053|FG000|Overall Study|Disease progression, deterioration|2
6979340|NCT01217229|11033053|FG000|Overall Study|Disease progression, Cheson criteria|14
6979341|NCT01217229|11033053|FG000|Overall Study|Protocol Violation|1
6921827|NCT00809133|10950405|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0
6921828|NCT00809133|10950406|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0
6921829|NCT00809133|10950407|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0
6921830|NCT00809133|10950408|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0
6921831|NCT00809133|10950409|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1
6921832|NCT00809133|10950410|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1
6921833|NCT00809133|10950411|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1
6921834|NCT00809133|10950412|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0
6921835|NCT00809133|10950413|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0
6921836|NCT00809133|10950414|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0
6921837|NCT00809133|10950415|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0
6921838|NCT00809133|10950416|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0
6921839|NCT00809133|10950417|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2
6921840|NCT00809133|10950404|FG000|Overall Study|Other adverse event|1
6921841|NCT00809133|10950405|FG001|Overall Study|Other adverse event|1
6921842|NCT00809133|10950406|FG002|Overall Study|Other adverse event|1
6921843|NCT00809133|10950407|FG003|Overall Study|Other adverse event|0
6921844|NCT00809133|10950408|FG004|Overall Study|Other adverse event|0
6921845|NCT00809133|10950409|FG005|Overall Study|Other adverse event|3
6921846|NCT00809133|10950410|FG006|Overall Study|Other adverse event|2
6921847|NCT00809133|10950411|FG007|Overall Study|Other adverse event|4
6921848|NCT00809133|10950412|FG008|Overall Study|Other adverse event|0
6921849|NCT00809133|10950413|FG009|Overall Study|Other adverse event|0
6921850|NCT00809133|10950414|FG010|Overall Study|Other adverse event|1
6921851|NCT00809133|10950415|FG011|Overall Study|Other adverse event|1
6921852|NCT00809133|10950416|FG012|Overall Study|Other adverse event|0
6921853|NCT00809133|10950417|FG013|Overall Study|Other adverse event|1
6921854|NCT00809133|10950404|FG000|Overall Study|Lost to Follow-up|0
6921855|NCT00809133|10950405|FG001|Overall Study|Lost to Follow-up|0
6921856|NCT00809133|10950406|FG002|Overall Study|Lost to Follow-up|0
6921857|NCT00809133|10950407|FG003|Overall Study|Lost to Follow-up|0
6921858|NCT00809133|10950408|FG004|Overall Study|Lost to Follow-up|0
6921859|NCT00809133|10950409|FG005|Overall Study|Lost to Follow-up|1
6921860|NCT00809133|10950410|FG006|Overall Study|Lost to Follow-up|0
6921861|NCT00809133|10950411|FG007|Overall Study|Lost to Follow-up|0
6921862|NCT00809133|10950412|FG008|Overall Study|Lost to Follow-up|0
6921863|NCT00809133|10950413|FG009|Overall Study|Lost to Follow-up|0
6921864|NCT00809133|10950414|FG010|Overall Study|Lost to Follow-up|0
6921865|NCT00809133|10950415|FG011|Overall Study|Lost to Follow-up|0
6921866|NCT00809133|10950416|FG012|Overall Study|Lost to Follow-up|0
6921867|NCT00809133|10950417|FG013|Overall Study|Lost to Follow-up|0
6921868|NCT00809133|10950404|FG000|Overall Study|Consent withdrawn|0
6921869|NCT00809133|10950405|FG001|Overall Study|Consent withdrawn|0
6921870|NCT00809133|10950406|FG002|Overall Study|Consent withdrawn|0
6921871|NCT00809133|10950407|FG003|Overall Study|Consent withdrawn|0
6921872|NCT00809133|10950408|FG004|Overall Study|Consent withdrawn|1
6921873|NCT00809133|10950409|FG005|Overall Study|Consent withdrawn|0
6921874|NCT00809133|10950410|FG006|Overall Study|Consent withdrawn|0
6921875|NCT00809133|10950411|FG007|Overall Study|Consent withdrawn|0
6921876|NCT00809133|10950412|FG008|Overall Study|Consent withdrawn|0
6921877|NCT00809133|10950413|FG009|Overall Study|Consent withdrawn|0
6921878|NCT00809133|10950414|FG010|Overall Study|Consent withdrawn|0
6921879|NCT00809133|10950415|FG011|Overall Study|Consent withdrawn|0
6921880|NCT00809133|10950416|FG012|Overall Study|Consent withdrawn|0
6921881|NCT00809133|10950417|FG013|Overall Study|Consent withdrawn|0
6921882|NCT00809133|10950404|FG000|Overall Study|Other not mentioned above|0
6921883|NCT00809133|10950405|FG001|Overall Study|Other not mentioned above|1
6921884|NCT00809133|10950406|FG002|Overall Study|Other not mentioned above|0
6921885|NCT00809133|10950407|FG003|Overall Study|Other not mentioned above|0
6921886|NCT00809133|10950408|FG004|Overall Study|Other not mentioned above|0
6921887|NCT00809133|10950409|FG005|Overall Study|Other not mentioned above|1
6921888|NCT00809133|10950410|FG006|Overall Study|Other not mentioned above|0
6921889|NCT00809133|10950411|FG007|Overall Study|Other not mentioned above|0
6921890|NCT00809133|10950412|FG008|Overall Study|Other not mentioned above|0
6921891|NCT00809133|10950413|FG009|Overall Study|Other not mentioned above|0
6921892|NCT00809133|10950414|FG010|Overall Study|Other not mentioned above|0
6921893|NCT00809133|10950415|FG011|Overall Study|Other not mentioned above|0
6921894|NCT00809133|10950416|FG012|Overall Study|Other not mentioned above|0
6921895|NCT00809133|10950417|FG013|Overall Study|Other not mentioned above|0
6921896|NCT00809159|10950473|FG000|Part 1|Adverse Event|1
6921897|NCT00809159|10950474|FG001|Part 1|Adverse Event|1
6921898|NCT00809159|10950475|FG002|Part 1|Adverse Event|0
6921899|NCT00809159|10950476|FG003|Part 1|Adverse Event|0
6921900|NCT00809159|10950477|FG004|Part 1|Adverse Event|0
6921901|NCT00809159|10950478|FG005|Part 1|Adverse Event|0
6921902|NCT00809159|10950473|FG000|Part 1|Lost to Follow-up|1
6921903|NCT00809159|10950474|FG001|Part 1|Lost to Follow-up|0
6921904|NCT00809159|10950475|FG002|Part 1|Lost to Follow-up|0
6921905|NCT00809159|10950476|FG003|Part 1|Lost to Follow-up|0
6921906|NCT00809159|10950477|FG004|Part 1|Lost to Follow-up|0
6921907|NCT00809159|10950478|FG005|Part 1|Lost to Follow-up|0
6921908|NCT00809159|10950473|FG000|Part 1|Withdrawal by Subject|3
6921909|NCT00809159|10950474|FG001|Part 1|Withdrawal by Subject|1
6921910|NCT00809159|10950475|FG002|Part 1|Withdrawal by Subject|0
6921911|NCT00809159|10950476|FG003|Part 1|Withdrawal by Subject|0
6921912|NCT00809159|10950477|FG004|Part 1|Withdrawal by Subject|0
6921913|NCT00809159|10950478|FG005|Part 1|Withdrawal by Subject|0
6921914|NCT00809159|10950473|FG000|Part 1|Unsatisfactory therapeutic effect|3
6921915|NCT00809159|10950474|FG001|Part 1|Unsatisfactory therapeutic effect|1
6921916|NCT00809159|10950475|FG002|Part 1|Unsatisfactory therapeutic effect|0
6921917|NCT00809159|10950476|FG003|Part 1|Unsatisfactory therapeutic effect|0
6921918|NCT00809159|10950477|FG004|Part 1|Unsatisfactory therapeutic effect|0
6921919|NCT00809159|10950478|FG005|Part 1|Unsatisfactory therapeutic effect|0
6921920|NCT00809159|10950473|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0
6921921|NCT00809159|10950474|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0
6921922|NCT00809159|10950475|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4
6921923|NCT00809159|10950476|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3
6921924|NCT00809159|10950477|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5
6921925|NCT00809159|10950478|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1
6921926|NCT00809159|10950473|FG000|Part 1 and 2|Administrative problems|0
6921927|NCT00809159|10950474|FG001|Part 1 and 2|Administrative problems|0
6921928|NCT00809159|10950475|FG002|Part 1 and 2|Administrative problems|0
6921929|NCT00809159|10950476|FG003|Part 1 and 2|Administrative problems|1
6921930|NCT00809159|10950477|FG004|Part 1 and 2|Administrative problems|0
6921931|NCT00809159|10950478|FG005|Part 1 and 2|Administrative problems|0
6921932|NCT00809159|10950473|FG000|Part 1 and 2|Adverse Event|0
6921933|NCT00809159|10950474|FG001|Part 1 and 2|Adverse Event|0
6921934|NCT00809159|10950475|FG002|Part 1 and 2|Adverse Event|1
6921935|NCT00809159|10950476|FG003|Part 1 and 2|Adverse Event|0
6921936|NCT00809159|10950477|FG004|Part 1 and 2|Adverse Event|1
6921937|NCT00809159|10950478|FG005|Part 1 and 2|Adverse Event|1
6921938|NCT00809159|10950473|FG000|Part 1 and 2|Lost to Follow-up|0
6921939|NCT00809159|10950474|FG001|Part 1 and 2|Lost to Follow-up|0
6921940|NCT00809159|10950475|FG002|Part 1 and 2|Lost to Follow-up|1
6921941|NCT00809159|10950476|FG003|Part 1 and 2|Lost to Follow-up|1
6921942|NCT00809159|10950477|FG004|Part 1 and 2|Lost to Follow-up|0
6921943|NCT00809159|10950478|FG005|Part 1 and 2|Lost to Follow-up|0
6921944|NCT00809159|10950473|FG000|Part 1 and 2|Withdrawal by Subject|0
6921945|NCT00809159|10950474|FG001|Part 1 and 2|Withdrawal by Subject|0
6921946|NCT00809159|10950475|FG002|Part 1 and 2|Withdrawal by Subject|4
6921947|NCT00809159|10950476|FG003|Part 1 and 2|Withdrawal by Subject|0
6921948|NCT00809159|10950477|FG004|Part 1 and 2|Withdrawal by Subject|0
6921949|NCT00809159|10950478|FG005|Part 1 and 2|Withdrawal by Subject|1
6921950|NCT00809328|10950501|FG000|Overall Study|Lack of Efficacy|18
6921951|NCT00809328|10950501|FG000|Overall Study|Adverse Event|6
6921952|NCT00809328|10950501|FG000|Overall Study|Protocol Violation|3
6921953|NCT00809328|10950501|FG000|Overall Study|Withdrawal by Subject|2
6921954|NCT00809354|10950515|FG000|Overall Study|Adverse Event|32
6921955|NCT00809354|10950516|FG001|Overall Study|Adverse Event|45
6921956|NCT00809354|10950517|FG002|Overall Study|Adverse Event|37
6921957|NCT00809354|10950518|FG003|Overall Study|Adverse Event|53
6921958|NCT00809354|10950519|FG004|Overall Study|Adverse Event|26
6921959|NCT00809354|10950520|FG005|Overall Study|Adverse Event|33
6921960|NCT00809354|10950521|FG006|Overall Study|Adverse Event|44
6921961|NCT00809354|10950522|FG007|Overall Study|Adverse Event|40
6921962|NCT00809354|10950523|FG008|Overall Study|Adverse Event|46
6921963|NCT00809354|10950524|FG009|Overall Study|Adverse Event|26
6921964|NCT00809354|10950515|FG000|Overall Study|Lack of Efficacy|23
6921965|NCT00809354|10950516|FG001|Overall Study|Lack of Efficacy|23
6921966|NCT00809354|10950517|FG002|Overall Study|Lack of Efficacy|22
6921967|NCT00809354|10950518|FG003|Overall Study|Lack of Efficacy|15
6921968|NCT00809354|10950519|FG004|Overall Study|Lack of Efficacy|40
6921969|NCT00809354|10950520|FG005|Overall Study|Lack of Efficacy|19
6921970|NCT00809354|10950521|FG006|Overall Study|Lack of Efficacy|21
6921971|NCT00809354|10950522|FG007|Overall Study|Lack of Efficacy|15
6921972|NCT00809354|10950523|FG008|Overall Study|Lack of Efficacy|18
6921973|NCT00809354|10950524|FG009|Overall Study|Lack of Efficacy|38
6921974|NCT00809354|10950515|FG000|Overall Study|Lost to Follow-up|10
6921975|NCT00809354|10950516|FG001|Overall Study|Lost to Follow-up|11
6921976|NCT00809354|10950517|FG002|Overall Study|Lost to Follow-up|8
7143042|NCT03025217|11299407|FG000|Overall Study|Lost to Follow-up|1
6921977|NCT00809354|10950518|FG003|Overall Study|Lost to Follow-up|13
6921978|NCT00809354|10950519|FG004|Overall Study|Lost to Follow-up|6
6921979|NCT00809354|10950520|FG005|Overall Study|Lost to Follow-up|2
6921980|NCT00809354|10950521|FG006|Overall Study|Lost to Follow-up|0
6921981|NCT00809354|10950522|FG007|Overall Study|Lost to Follow-up|5
6921982|NCT00809354|10950523|FG008|Overall Study|Lost to Follow-up|4
6921983|NCT00809354|10950524|FG009|Overall Study|Lost to Follow-up|0
6921984|NCT00809354|10950515|FG000|Overall Study|Protocol Violation|7
6921985|NCT00809354|10950516|FG001|Overall Study|Protocol Violation|14
6921986|NCT00809354|10950517|FG002|Overall Study|Protocol Violation|14
6921987|NCT00809354|10950518|FG003|Overall Study|Protocol Violation|12
6921988|NCT00809354|10950519|FG004|Overall Study|Protocol Violation|14
6921989|NCT00809354|10950520|FG005|Overall Study|Protocol Violation|6
6921990|NCT00809354|10950521|FG006|Overall Study|Protocol Violation|4
6921991|NCT00809354|10950522|FG007|Overall Study|Protocol Violation|6
6921992|NCT00809354|10950523|FG008|Overall Study|Protocol Violation|9
6921993|NCT00809354|10950524|FG009|Overall Study|Protocol Violation|3
6921994|NCT00809354|10950515|FG000|Overall Study|Withdrawal by Subject|32
6921995|NCT00809354|10950516|FG001|Overall Study|Withdrawal by Subject|27
7143043|NCT03025217|11299407|FG000|Overall Study|Not eligible, poor English|2
7143044|NCT03026075|11299420|FG000|Overall Study|Physician Decision|1
7143045|NCT03026088|11299424|FG000|Overall Study|Study termination|20
7143046|NCT03026166|11299430|FG000|Overall Study|Death|22
6921996|NCT00809354|10950517|FG002|Overall Study|Withdrawal by Subject|31
6921997|NCT00809354|10950518|FG003|Overall Study|Withdrawal by Subject|33
6921998|NCT00809354|10950519|FG004|Overall Study|Withdrawal by Subject|34
6921999|NCT00809354|10950520|FG005|Overall Study|Withdrawal by Subject|29
6922000|NCT00809354|10950521|FG006|Overall Study|Withdrawal by Subject|27
6922001|NCT00809354|10950522|FG007|Overall Study|Withdrawal by Subject|19
6922002|NCT00809354|10950523|FG008|Overall Study|Withdrawal by Subject|18
6922003|NCT00809354|10950524|FG009|Overall Study|Withdrawal by Subject|20
6922004|NCT00809354|10950515|FG000|Overall Study|Other|10
6922005|NCT00809354|10950516|FG001|Overall Study|Other|2
6922006|NCT00809354|10950517|FG002|Overall Study|Other|7
6922007|NCT00809354|10950518|FG003|Overall Study|Other|10
6922008|NCT00809354|10950519|FG004|Overall Study|Other|5
6922009|NCT00809354|10950520|FG005|Overall Study|Other|3
7143047|NCT03026166|11299431|FG001|Overall Study|Death|7
6922010|NCT00809354|10950521|FG006|Overall Study|Other|2
6922011|NCT00809354|10950522|FG007|Overall Study|Other|3
6922012|NCT00809354|10950523|FG008|Overall Study|Other|4
6922013|NCT00809354|10950524|FG009|Overall Study|Other|3
6922014|NCT00809354|10950515|FG000|Overall Study|Study terminated by sponsor|138
6922015|NCT00809354|10950516|FG001|Overall Study|Study terminated by sponsor|134
6922016|NCT00809354|10950517|FG002|Overall Study|Study terminated by sponsor|129
6922017|NCT00809354|10950518|FG003|Overall Study|Study terminated by sponsor|120
6922018|NCT00809354|10950519|FG004|Overall Study|Study terminated by sponsor|126
6922019|NCT00809354|10950520|FG005|Overall Study|Study terminated by sponsor|133
6922020|NCT00809354|10950521|FG006|Overall Study|Study terminated by sponsor|124
6922021|NCT00809354|10950522|FG007|Overall Study|Study terminated by sponsor|148
6922022|NCT00809354|10950523|FG008|Overall Study|Study terminated by sponsor|127
6922023|NCT00809354|10950524|FG009|Overall Study|Study terminated by sponsor|135
6922024|NCT00809354|10950515|FG000|Overall Study|Withdrawn due to pregnancy|0
6922025|NCT00809354|10950516|FG001|Overall Study|Withdrawn due to pregnancy|1
6922026|NCT00809354|10950517|FG002|Overall Study|Withdrawn due to pregnancy|0
6922027|NCT00809354|10950518|FG003|Overall Study|Withdrawn due to pregnancy|0
6922028|NCT00809354|10950519|FG004|Overall Study|Withdrawn due to pregnancy|0
6922029|NCT00809354|10950520|FG005|Overall Study|Withdrawn due to pregnancy|0
6922030|NCT00809354|10950521|FG006|Overall Study|Withdrawn due to pregnancy|0
6922031|NCT00809354|10950522|FG007|Overall Study|Withdrawn due to pregnancy|0
6922032|NCT00809354|10950523|FG008|Overall Study|Withdrawn due to pregnancy|0
6922033|NCT00809354|10950524|FG009|Overall Study|Withdrawn due to pregnancy|0
6922034|NCT00809354|10950515|FG000|Overall Study|Randomized but not Treated|3
6922035|NCT00809354|10950516|FG001|Overall Study|Randomized but not Treated|1
6922036|NCT00809354|10950517|FG002|Overall Study|Randomized but not Treated|6
6922037|NCT00809354|10950518|FG003|Overall Study|Randomized but not Treated|0
6922038|NCT00809354|10950519|FG004|Overall Study|Randomized but not Treated|5
6922039|NCT00809354|10950520|FG005|Overall Study|Randomized but not Treated|0
6922040|NCT00809354|10950521|FG006|Overall Study|Randomized but not Treated|1
6922041|NCT00809354|10950522|FG007|Overall Study|Randomized but not Treated|1
6922042|NCT00809354|10950523|FG008|Overall Study|Randomized but not Treated|2
6922043|NCT00809354|10950524|FG009|Overall Study|Randomized but not Treated|1
6922044|NCT00809354|10950515|FG000|Overall Study|Death|0
6922045|NCT00809354|10950516|FG001|Overall Study|Death|0
6922046|NCT00809354|10950517|FG002|Overall Study|Death|0
6922047|NCT00809354|10950518|FG003|Overall Study|Death|0
6922048|NCT00809354|10950519|FG004|Overall Study|Death|0
6922049|NCT00809354|10950520|FG005|Overall Study|Death|0
6922050|NCT00809354|10950521|FG006|Overall Study|Death|0
6922051|NCT00809354|10950522|FG007|Overall Study|Death|1
6922052|NCT00809354|10950523|FG008|Overall Study|Death|0
6922053|NCT00809354|10950524|FG009|Overall Study|Death|0
6922054|NCT00809445|10950554|FG000|1 Month Follow-up|Lost contact|1
6922055|NCT00809445|10950555|FG001|1 Month Follow-up|Lost contact|2
6922056|NCT00809445|10950556|FG002|1 Month Follow-up|Lost contact|1
6922057|NCT00809445|10950554|FG000|1 Month Follow-up|Withdrew consent|1
6922058|NCT00809445|10950555|FG001|1 Month Follow-up|Withdrew consent|1
6922059|NCT00809445|10950556|FG002|1 Month Follow-up|Withdrew consent|1
6922060|NCT00809445|10950554|FG000|1 Month Follow-up|Death|0
6922061|NCT00809445|10950555|FG001|1 Month Follow-up|Death|1
6922062|NCT00809445|10950556|FG002|1 Month Follow-up|Death|1
6922063|NCT00809445|10950554|FG000|1 Month Follow-up|Incarcerated|0
6922064|NCT00809445|10950555|FG001|1 Month Follow-up|Incarcerated|0
6922065|NCT00809445|10950556|FG002|1 Month Follow-up|Incarcerated|1
6922066|NCT00809445|10950554|FG000|6 Month Follow-up|Lost contact|16
6922067|NCT00809445|10950555|FG001|6 Month Follow-up|Lost contact|14
6922068|NCT00809445|10950556|FG002|6 Month Follow-up|Lost contact|14
6922069|NCT00809445|10950554|FG000|6 Month Follow-up|Death|2
6922070|NCT00809445|10950555|FG001|6 Month Follow-up|Death|1
6922071|NCT00809445|10950556|FG002|6 Month Follow-up|Death|1
6922072|NCT00809445|10950554|FG000|6 Month Follow-up|Incarcerated|6
6922073|NCT00809445|10950555|FG001|6 Month Follow-up|Incarcerated|8
6922074|NCT00809445|10950556|FG002|6 Month Follow-up|Incarcerated|8
6922075|NCT00809445|10950554|FG000|6 Month Follow-up|Withdrew consent|0
6922076|NCT00809445|10950555|FG001|6 Month Follow-up|Withdrew consent|0
6922077|NCT00809445|10950556|FG002|6 Month Follow-up|Withdrew consent|1
6922078|NCT00809471|10950567|FG000|Overall Study|Protocol non-compliance|15
6922079|NCT00809471|10950568|FG001|Overall Study|Protocol non-compliance|15
6922080|NCT00809471|10950569|FG002|Overall Study|Protocol non-compliance|6
6922081|NCT00809471|10950567|FG000|Overall Study|Lost to Follow-up|4
6922082|NCT00809471|10950568|FG001|Overall Study|Lost to Follow-up|2
6922083|NCT00809471|10950569|FG002|Overall Study|Lost to Follow-up|9
6922084|NCT00809471|10950567|FG000|Overall Study|Adverse Event|0
6922085|NCT00809471|10950568|FG001|Overall Study|Adverse Event|2
6922086|NCT00809471|10950569|FG002|Overall Study|Adverse Event|2
6922087|NCT00809471|10950567|FG000|Overall Study|Requirement for restricted medication|1
6922088|NCT00809471|10950568|FG001|Overall Study|Requirement for restricted medication|1
6922089|NCT00809471|10950569|FG002|Overall Study|Requirement for restricted medication|0
6922090|NCT00809614|10950588|FG000|Overall Study|Lack of Efficacy|2
6922091|NCT00809614|10950589|FG001|Overall Study|Lack of Efficacy|3
6922092|NCT00809614|10950588|FG000|Overall Study|Withdrawal by Subject|1
6922093|NCT00809614|10950589|FG001|Overall Study|Withdrawal by Subject|1
6922094|NCT00809757|10950598|FG000|Overall Study|Adverse Event|2
6922095|NCT00809757|10950599|FG001|Overall Study|Adverse Event|3
6922096|NCT00809757|10950600|FG002|Overall Study|Adverse Event|3
6922097|NCT00809757|10950598|FG000|Overall Study|Lost to Follow-up|0
6922098|NCT00809757|10950599|FG001|Overall Study|Lost to Follow-up|0
6922099|NCT00809757|10950600|FG002|Overall Study|Lost to Follow-up|1
6922100|NCT00809757|10950598|FG000|Overall Study|Protocol Violation|1
6922101|NCT00809757|10950599|FG001|Overall Study|Protocol Violation|1
6922102|NCT00809757|10950600|FG002|Overall Study|Protocol Violation|1
6922103|NCT00809757|10950598|FG000|Overall Study|Withdrawal by Subject|2
6922104|NCT00809757|10950599|FG001|Overall Study|Withdrawal by Subject|1
6922105|NCT00809757|10950600|FG002|Overall Study|Withdrawal by Subject|3
6922106|NCT00809757|10950598|FG000|Overall Study|Subject Uncooperative|1
6922107|NCT00809757|10950599|FG001|Overall Study|Subject Uncooperative|0
6922108|NCT00809757|10950600|FG002|Overall Study|Subject Uncooperative|2
6922109|NCT00809757|10950598|FG000|Overall Study|Noncompliance with Medication|0
6922110|NCT00809757|10950599|FG001|Overall Study|Noncompliance with Medication|0
6922111|NCT00809757|10950600|FG002|Overall Study|Noncompliance with Medication|1
6922112|NCT00809783|10950617|FG000|Overall Study|Death|1
6922113|NCT00809783|10950618|FG001|Overall Study|Death|0
6922114|NCT00809783|10950619|FG002|Overall Study|Death|0
6922115|NCT00809783|10950617|FG000|Overall Study|Adverse Event|34
6922116|NCT00809783|10950618|FG001|Overall Study|Adverse Event|52
6922117|NCT00809783|10950619|FG002|Overall Study|Adverse Event|71
6922118|NCT00809783|10950617|FG000|Overall Study|Lack of Efficacy|39
6922119|NCT00809783|10950618|FG001|Overall Study|Lack of Efficacy|52
6922120|NCT00809783|10950619|FG002|Overall Study|Lack of Efficacy|63
6922121|NCT00809783|10950617|FG000|Overall Study|Lost to Follow-up|0
6922122|NCT00809783|10950618|FG001|Overall Study|Lost to Follow-up|3
6922123|NCT00809783|10950619|FG002|Overall Study|Lost to Follow-up|4
6922124|NCT00809783|10950617|FG000|Overall Study|Withdrawal by Subject|47
6922125|NCT00809783|10950618|FG001|Overall Study|Withdrawal by Subject|72
6922126|NCT00809783|10950619|FG002|Overall Study|Withdrawal by Subject|64
6922127|NCT00809783|10950617|FG000|Overall Study|Protocol Violation|2
6922128|NCT00809783|10950618|FG001|Overall Study|Protocol Violation|6
6922129|NCT00809783|10950619|FG002|Overall Study|Protocol Violation|5
6922130|NCT00809783|10950617|FG000|Overall Study|Randomized, but not treated|3
6922131|NCT00809783|10950618|FG001|Overall Study|Randomized, but not treated|0
6922132|NCT00809783|10950619|FG002|Overall Study|Randomized, but not treated|2
6922133|NCT00809783|10950617|FG000|Overall Study|Study Terminated by Sponsor|378
6922134|NCT00809783|10950618|FG001|Overall Study|Study Terminated by Sponsor|626
6922135|NCT00809783|10950619|FG002|Overall Study|Study Terminated by Sponsor|565
6922136|NCT00809783|10950617|FG000|Overall Study|Other|21
6922137|NCT00809783|10950618|FG001|Overall Study|Other|21
6922138|NCT00809783|10950619|FG002|Overall Study|Other|16
6922139|NCT00809835|10950640|FG000|Overall Study|Lost to Follow-up|7
6922140|NCT00809835|10950641|FG001|Overall Study|Lost to Follow-up|6
6922141|NCT00809835|10950642|FG002|Overall Study|Lost to Follow-up|10
6922142|NCT00809835|10950643|FG003|Overall Study|Lost to Follow-up|2
6922143|NCT00809835|10950640|FG000|Overall Study|Withdrawal by Subject|1
6922144|NCT00809835|10950641|FG001|Overall Study|Withdrawal by Subject|1
6922145|NCT00809835|10950642|FG002|Overall Study|Withdrawal by Subject|1
6922146|NCT00809835|10950643|FG003|Overall Study|Withdrawal by Subject|0
6922147|NCT00809926|10950677|FG000|Overall Study|Adverse Event|18
6922148|NCT00809926|10950678|FG001|Overall Study|Adverse Event|10
6922149|NCT00809926|10950677|FG000|Overall Study|Unsatisfactory therapeutic effect|3
6979342|NCT01217229|11033053|FG000|Overall Study|Disease progression not confirmed|2
6979343|NCT01217307|11033059|FG000|Overall Study|Withdrawal by Subject|0
6979344|NCT01217307|11033060|FG001|Overall Study|Withdrawal by Subject|1
6979345|NCT01217385|11033066|FG000|Overall Study|Withdrawal by Subject|3
6979346|NCT01217385|11033066|FG000|Overall Study|DOSI not performed/not eval|12
6979347|NCT01217385|11033066|FG000|Overall Study|Central Path not Available|1
6979348|NCT01217385|11033066|FG000|Overall Study|Normal Breast TOI not available|10
7041775|NCT01730040|11125601|FG002|Overall Study|Poor compliance to protocol|0
6922150|NCT00809926|10950678|FG001|Overall Study|Unsatisfactory therapeutic effect|3
6922151|NCT00809926|10950677|FG000|Overall Study|Patient withdrew consent|8
7041776|NCT01730040|11125602|FG003|Overall Study|Poor compliance to protocol|0
6979349|NCT01217437|11033089|FG000|Overall Study|Adverse Event|0
6979350|NCT01217437|11033090|FG001|Overall Study|Adverse Event|8
6979351|NCT01217437|11033089|FG000|Overall Study|Death|5
6979352|NCT01217437|11033090|FG001|Overall Study|Death|0
6979353|NCT01217437|11033089|FG000|Overall Study|Lack of Efficacy|29
6979354|NCT01217437|11033090|FG001|Overall Study|Lack of Efficacy|25
6979355|NCT01217437|11033089|FG000|Overall Study|Physician Decision|8
6979356|NCT01217437|11033090|FG001|Overall Study|Physician Decision|5
6979357|NCT01217437|11033089|FG000|Overall Study|Withdrawal by Subject|0
6979358|NCT01217437|11033090|FG001|Overall Study|Withdrawal by Subject|2
6979359|NCT01217437|11033089|FG000|Overall Study|Ineligible|1
6979360|NCT01217437|11033090|FG001|Overall Study|Ineligible|1
6979361|NCT01217463|11033098|FG000|Overall Study|Adverse Event|8
6979362|NCT01217463|11033099|FG001|Overall Study|Adverse Event|5
6979363|NCT01217463|11033098|FG000|Overall Study|Physician Decision|0
6979364|NCT01217463|11033099|FG001|Overall Study|Physician Decision|1
6979365|NCT01217463|11033098|FG000|Overall Study|Withdrawal by Subject|3
6979366|NCT01217463|11033099|FG001|Overall Study|Withdrawal by Subject|0
6979367|NCT01217463|11033098|FG000|Overall Study|Surgery on the Target Limb|0
6979368|NCT01217463|11033099|FG001|Overall Study|Surgery on the Target Limb|1
6979369|NCT01217463|11033098|FG000|Overall Study|Patient Non-compliant|1
6979370|NCT01217463|11033099|FG001|Overall Study|Patient Non-compliant|0
6979371|NCT01217463|11033098|FG000|Overall Study|Other|1
6979372|NCT01217463|11033099|FG001|Overall Study|Other|1
6979373|NCT01217476|11033109|FG000|Overall Study|Adverse Event|6
6979374|NCT01217476|11033110|FG001|Overall Study|Adverse Event|1
6979375|NCT01217476|11033109|FG000|Overall Study|Physician Decision|0
6979376|NCT01217476|11033110|FG001|Overall Study|Physician Decision|1
6979377|NCT01217476|11033109|FG000|Overall Study|Withdrawal by Subject|3
6979378|NCT01217476|11033110|FG001|Overall Study|Withdrawal by Subject|3
6979379|NCT01217476|11033109|FG000|Overall Study|Surgery on the Target Limb|0
6979380|NCT01217476|11033110|FG001|Overall Study|Surgery on the Target Limb|2
6979381|NCT01217476|11033109|FG000|Overall Study|Protocol Deviation|1
6979382|NCT01217476|11033110|FG001|Overall Study|Protocol Deviation|0
6979383|NCT01217476|11033109|FG000|Overall Study|Other|2
6979384|NCT01217476|11033110|FG001|Overall Study|Other|0
6979385|NCT01217606|11033131|FG000|Initial Treatment Phase|Other Reasons|0
6979386|NCT01217606|11033132|FG001|Initial Treatment Phase|Other Reasons|2
6979387|NCT01217606|11033131|FG000|Initial Treatment Phase|Protocol Violation|3
6979388|NCT01217606|11033132|FG001|Initial Treatment Phase|Protocol Violation|2
6979389|NCT01217606|11033131|FG000|Initial Treatment Phase|Personal Reasons|0
6979390|NCT01217606|11033132|FG001|Initial Treatment Phase|Personal Reasons|2
6979391|NCT01217606|11033131|FG000|Initial Treatment Phase|Lack of Efficacy|1
6979392|NCT01217606|11033132|FG001|Initial Treatment Phase|Lack of Efficacy|0
6979393|NCT01217606|11033131|FG000|Initial Treatment Phase|Adverse Event|10
6979394|NCT01217606|11033132|FG001|Initial Treatment Phase|Adverse Event|6
6979395|NCT01217606|11033131|FG000|9-Month Masked Extension|Adverse Event|3
6979396|NCT01217606|11033132|FG001|9-Month Masked Extension|Adverse Event|6
6979397|NCT01217606|11033131|FG000|9-Month Masked Extension|Other Reasons|4
6979398|NCT01217606|11033132|FG001|9-Month Masked Extension|Other Reasons|4
6979399|NCT01217606|11033131|FG000|9-Month Masked Extension|Personal Reasons|2
6979400|NCT01217606|11033132|FG001|9-Month Masked Extension|Personal Reasons|1
6979401|NCT01217606|11033131|FG000|9-Month Masked Extension|Lost to Follow-up|1
6979402|NCT01217606|11033132|FG001|9-Month Masked Extension|Lost to Follow-up|0
6979403|NCT01217606|11033131|FG000|9-Month Masked Extension|Pregnancy|1
6979404|NCT01217606|11033132|FG001|9-Month Masked Extension|Pregnancy|0
6979405|NCT01217606|11033131|FG000|9-Month Masked Extension|Lack of Efficacy|2
6979406|NCT01217606|11033132|FG001|9-Month Masked Extension|Lack of Efficacy|0
6979407|NCT01217801|11033155|FG000|Period 1|Protocol Violation|1
6979408|NCT01217801|11033156|FG001|Period 1|Protocol Violation|1
6979409|NCT01217801|11033155|FG000|Period 1|Withdrawal by Subject|0
6979410|NCT01217801|11033156|FG001|Period 1|Withdrawal by Subject|1
6979411|NCT01217814|11033165|FG000|Overall Study|Adverse Event|1
6979412|NCT01217814|11033166|FG001|Overall Study|Adverse Event|1
6979413|NCT01217814|11033167|FG002|Overall Study|Adverse Event|0
6979414|NCT01217814|11033165|FG000|Overall Study|Lack of Efficacy|0
6979415|NCT01217814|11033166|FG001|Overall Study|Lack of Efficacy|0
6979416|NCT01217814|11033167|FG002|Overall Study|Lack of Efficacy|1
6979417|NCT01217892|11033199|FG000|Overall Study|Adverse Event|1
6979418|NCT01217892|11033200|FG001|Overall Study|Adverse Event|1
6979419|NCT01217892|11033201|FG002|Overall Study|Adverse Event|1
6979420|NCT01217892|11033202|FG003|Overall Study|Adverse Event|0
6979421|NCT01217892|11033199|FG000|Overall Study|Withdrawal by Subject|0
6979422|NCT01217892|11033200|FG001|Overall Study|Withdrawal by Subject|2
6979423|NCT01217892|11033201|FG002|Overall Study|Withdrawal by Subject|1
6979424|NCT01217892|11033202|FG003|Overall Study|Withdrawal by Subject|0
6979425|NCT01217892|11033199|FG000|Overall Study|Lab value|1
6979426|NCT01217892|11033200|FG001|Overall Study|Lab value|0
6979427|NCT01217892|11033201|FG002|Overall Study|Lab value|1
6979428|NCT01217892|11033202|FG003|Overall Study|Lab value|0
6979429|NCT01217892|11033199|FG000|Overall Study|Subject no longer meets study criteria|5
6979430|NCT01217892|11033200|FG001|Overall Study|Subject no longer meets study criteria|2
6979431|NCT01217892|11033201|FG002|Overall Study|Subject no longer meets study criteria|4
6979432|NCT01217892|11033202|FG003|Overall Study|Subject no longer meets study criteria|8
6979433|NCT01217892|11033199|FG000|Overall Study|Incorrect enrollment|0
6979434|NCT01217892|11033200|FG001|Overall Study|Incorrect enrollment|1
6979435|NCT01217892|11033201|FG002|Overall Study|Incorrect enrollment|1
6979436|NCT01217892|11033202|FG003|Overall Study|Incorrect enrollment|0
6979437|NCT01217892|11033199|FG000|Overall Study|Poor/Non-Compliance|0
6979438|NCT01217892|11033200|FG001|Overall Study|Poor/Non-Compliance|0
6979439|NCT01217892|11033201|FG002|Overall Study|Poor/Non-Compliance|1
6979440|NCT01217892|11033202|FG003|Overall Study|Poor/Non-Compliance|0
6979441|NCT01217944|11033215|FG000|Overall Study|Protocol Violation|1
6979442|NCT01217944|11033216|FG001|Overall Study|Protocol Violation|1
6979443|NCT01217944|11033217|FG002|Overall Study|Protocol Violation|0
6979444|NCT01217944|11033215|FG000|Overall Study|Lost to Follow-up|3
6979445|NCT01217944|11033216|FG001|Overall Study|Lost to Follow-up|1
6979446|NCT01217944|11033217|FG002|Overall Study|Lost to Follow-up|0
6979447|NCT01217944|11033215|FG000|Overall Study|Withdrawal by Subject|1
6979448|NCT01217944|11033216|FG001|Overall Study|Withdrawal by Subject|2
6979449|NCT01217944|11033217|FG002|Overall Study|Withdrawal by Subject|0
6979450|NCT01217944|11033215|FG000|Overall Study|Lack of Efficacy|1
6979451|NCT01217944|11033216|FG001|Overall Study|Lack of Efficacy|0
6979452|NCT01217944|11033217|FG002|Overall Study|Lack of Efficacy|0
6979453|NCT01217957|11033232|FG000|Phase 1|Withdrawal by Patient|1
6979454|NCT01217957|11033233|FG001|Phase 1|Withdrawal by Patient|0
6979455|NCT01217957|11033234|FG002|Phase 1|Withdrawal by Patient|1
6979456|NCT01217957|11033235|FG003|Phase 1|Withdrawal by Patient|1
6979457|NCT01217957|11033236|FG004|Phase 1|Withdrawal by Patient|0
6979458|NCT01217957|11033232|FG000|Phase 2|Withdrawal by Patient|0
6979459|NCT01217957|11033233|FG001|Phase 2|Withdrawal by Patient|0
6979460|NCT01217957|11033234|FG002|Phase 2|Withdrawal by Patient|0
6979461|NCT01217957|11033235|FG003|Phase 2|Withdrawal by Patient|0
6979462|NCT01217957|11033236|FG004|Phase 2|Withdrawal by Patient|1
6979463|NCT01218009|11033259|FG000|Overall Study|Protocol Violation|2
6979464|NCT01218009|11033260|FG001|Overall Study|Protocol Violation|1
6979465|NCT01218009|11033259|FG000|Overall Study|Withdrawal by Subject|3
6979466|NCT01218009|11033260|FG001|Overall Study|Withdrawal by Subject|1
6979467|NCT01218009|11033259|FG000|Overall Study|Sponsor terminated study|161
6979468|NCT01218009|11033260|FG001|Overall Study|Sponsor terminated study|163
6979469|NCT01218087|11033273|FG000|Overall Study|Death|2
6979470|NCT01218087|11033274|FG001|Overall Study|Death|1
6979471|NCT01218087|11033273|FG000|Overall Study|Withdrawal by Subject|5
6979472|NCT01218087|11033274|FG001|Overall Study|Withdrawal by Subject|0
6979473|NCT01218087|11033273|FG000|Overall Study|Transferred|8
6979474|NCT01218087|11033274|FG001|Overall Study|Transferred|5
6979475|NCT01218100|11033284|FG000|Overall Study|Did not meet InclusionExclusion criteria|1
6979476|NCT01218100|11033285|FG001|Overall Study|Did not meet InclusionExclusion criteria|1
6979477|NCT01218100|11033286|FG002|Overall Study|Did not meet InclusionExclusion criteria|1
6979478|NCT01218100|11033287|FG003|Overall Study|Did not meet InclusionExclusion criteria|2
6979479|NCT01218100|11033284|FG000|Overall Study|Adverse Event|4
6979480|NCT01218100|11033285|FG001|Overall Study|Adverse Event|6
6979481|NCT01218100|11033286|FG002|Overall Study|Adverse Event|6
6979482|NCT01218100|11033287|FG003|Overall Study|Adverse Event|7
6979483|NCT01218100|11033284|FG000|Overall Study|Lack of Efficacy|9
6979484|NCT01218100|11033285|FG001|Overall Study|Lack of Efficacy|6
6979485|NCT01218100|11033286|FG002|Overall Study|Lack of Efficacy|5
6979486|NCT01218100|11033287|FG003|Overall Study|Lack of Efficacy|12
6979487|NCT01218100|11033284|FG000|Overall Study|Protocol Violation|0
6979488|NCT01218100|11033285|FG001|Overall Study|Protocol Violation|0
6979489|NCT01218100|11033286|FG002|Overall Study|Protocol Violation|1
6979490|NCT01218100|11033287|FG003|Overall Study|Protocol Violation|1
6979491|NCT01218100|11033284|FG000|Overall Study|Withdrawal by Subject|5
6979492|NCT01218100|11033285|FG001|Overall Study|Withdrawal by Subject|2
6979493|NCT01218100|11033286|FG002|Overall Study|Withdrawal by Subject|6
6979494|NCT01218100|11033287|FG003|Overall Study|Withdrawal by Subject|7
6979495|NCT01218100|11033284|FG000|Overall Study|Lost to Follow-up|3
6979496|NCT01218100|11033285|FG001|Overall Study|Lost to Follow-up|8
6979497|NCT01218100|11033286|FG002|Overall Study|Lost to Follow-up|2
6979498|NCT01218100|11033287|FG003|Overall Study|Lost to Follow-up|1
6979499|NCT01218100|11033284|FG000|Overall Study|Other Reason|2
6979500|NCT01218100|11033285|FG001|Overall Study|Other Reason|2
6979501|NCT01218100|11033286|FG002|Overall Study|Other Reason|6
6979502|NCT01218100|11033287|FG003|Overall Study|Other Reason|4
6979503|NCT01218113|11033300|FG000|Overall Study|Withdrawal by Subject|1
6979504|NCT01218113|11033301|FG001|Overall Study|Withdrawal by Subject|0
6979505|NCT01218113|11033302|FG002|Overall Study|Withdrawal by Subject|1
6979506|NCT01218113|11033300|FG000|Overall Study|Lost to Follow-up|4
6979507|NCT01218113|11033301|FG001|Overall Study|Lost to Follow-up|1
6979508|NCT01218113|11033302|FG002|Overall Study|Lost to Follow-up|4
6979509|NCT01218113|11033300|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0
6979510|NCT01218113|11033301|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0
6979511|NCT01218113|11033302|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1
6979512|NCT01218126|11033321|FG000|Overall Study|Adverse Event|8
6979513|NCT01218126|11033322|FG001|Overall Study|Adverse Event|10
6979514|NCT01218126|11033323|FG002|Overall Study|Adverse Event|12
6979515|NCT01218126|11033324|FG003|Overall Study|Adverse Event|16
6979516|NCT01218126|11033321|FG000|Overall Study|Lack of Efficacy|7
6979517|NCT01218126|11033322|FG001|Overall Study|Lack of Efficacy|2
6979518|NCT01218126|11033323|FG002|Overall Study|Lack of Efficacy|2
6979519|NCT01218126|11033324|FG003|Overall Study|Lack of Efficacy|6
6979520|NCT01218126|11033321|FG000|Overall Study|Protocol Violation|5
6979521|NCT01218126|11033322|FG001|Overall Study|Protocol Violation|2
6979522|NCT01218126|11033323|FG002|Overall Study|Protocol Violation|2
6979523|NCT01218126|11033324|FG003|Overall Study|Protocol Violation|3
6979524|NCT01218126|11033321|FG000|Overall Study|Protocol-defined stopping criteria|1
6979525|NCT01218126|11033322|FG001|Overall Study|Protocol-defined stopping criteria|1
6979526|NCT01218126|11033323|FG002|Overall Study|Protocol-defined stopping criteria|0
6979527|NCT01218126|11033324|FG003|Overall Study|Protocol-defined stopping criteria|0
6979528|NCT01218126|11033321|FG000|Overall Study|Lost to Follow-up|0
6979529|NCT01218126|11033322|FG001|Overall Study|Lost to Follow-up|0
6979530|NCT01218126|11033323|FG002|Overall Study|Lost to Follow-up|0
6979531|NCT01218126|11033324|FG003|Overall Study|Lost to Follow-up|2
6979532|NCT01218126|11033321|FG000|Overall Study|Physician Decision|1
6979533|NCT01218126|11033322|FG001|Overall Study|Physician Decision|2
6979534|NCT01218126|11033323|FG002|Overall Study|Physician Decision|4
6979535|NCT01218126|11033324|FG003|Overall Study|Physician Decision|2
6979536|NCT01218126|11033321|FG000|Overall Study|Withdrawal by Subject|2
6979537|NCT01218126|11033322|FG001|Overall Study|Withdrawal by Subject|5
6979538|NCT01218126|11033323|FG002|Overall Study|Withdrawal by Subject|4
6979539|NCT01218126|11033324|FG003|Overall Study|Withdrawal by Subject|6
6979540|NCT01218204|11033336|FG000|Part B Washout|Adverse Event|0
6979541|NCT01218204|11033337|FG001|Part B Washout|Adverse Event|1
6979542|NCT01218204|11033338|FG002|Part B Washout|Adverse Event|0
6979543|NCT01218204|11033339|FG003|Part B Washout|Adverse Event|0
6979544|NCT01218204|11033336|FG000|Part B Washout|Lost to Follow-up|0
6979545|NCT01218204|11033337|FG001|Part B Washout|Lost to Follow-up|2
6979546|NCT01218204|11033338|FG002|Part B Washout|Lost to Follow-up|0
6979547|NCT01218204|11033339|FG003|Part B Washout|Lost to Follow-up|0
6979548|NCT01218204|11033336|FG000|Part B Washout|Physician Decision|0
6979549|NCT01218204|11033337|FG001|Part B Washout|Physician Decision|14
6979550|NCT01218204|11033338|FG002|Part B Washout|Physician Decision|0
6979551|NCT01218204|11033339|FG003|Part B Washout|Physician Decision|0
6979552|NCT01218204|11033336|FG000|Part B Washout|Withdrawal by Subject|0
6979553|NCT01218204|11033337|FG001|Part B Washout|Withdrawal by Subject|14
6979554|NCT01218204|11033338|FG002|Part B Washout|Withdrawal by Subject|0
6979555|NCT01218204|11033339|FG003|Part B Washout|Withdrawal by Subject|0
6979556|NCT01218204|11033336|FG000|Part B Washout|Reached defined stopping criteria|0
6979557|NCT01218204|11033337|FG001|Part B Washout|Reached defined stopping criteria|2
6979558|NCT01218204|11033338|FG002|Part B Washout|Reached defined stopping criteria|0
6979559|NCT01218204|11033339|FG003|Part B Washout|Reached defined stopping criteria|0
6979560|NCT01218204|11033336|FG000|Part B Washout|Did not meet continuation criteria|0
6979561|NCT01218204|11033337|FG001|Part B Washout|Did not meet continuation criteria|112
6979562|NCT01218204|11033338|FG002|Part B Washout|Did not meet continuation criteria|0
6979563|NCT01218204|11033339|FG003|Part B Washout|Did not meet continuation criteria|0
6979564|NCT01218204|11033336|FG000|Part B Run-in|Adverse Event|0
6979565|NCT01218204|11033337|FG001|Part B Run-in|Adverse Event|0
6979566|NCT01218204|11033338|FG002|Part B Run-in|Adverse Event|1
6979567|NCT01218204|11033339|FG003|Part B Run-in|Adverse Event|0
6979568|NCT01218204|11033336|FG000|Part B Run-in|Protocol Violation|0
6979569|NCT01218204|11033337|FG001|Part B Run-in|Protocol Violation|0
6979570|NCT01218204|11033338|FG002|Part B Run-in|Protocol Violation|2
6979571|NCT01218204|11033339|FG003|Part B Run-in|Protocol Violation|0
6979572|NCT01218204|11033336|FG000|Part B Run-in|Withdrawal by Subject|0
6979573|NCT01218204|11033337|FG001|Part B Run-in|Withdrawal by Subject|0
6979574|NCT01218204|11033338|FG002|Part B Run-in|Withdrawal by Subject|3
6979575|NCT01218204|11033339|FG003|Part B Run-in|Withdrawal by Subject|0
6979576|NCT01218204|11033336|FG000|Part B Pooled Treatment Arm|Adverse Event|0
6979577|NCT01218204|11033337|FG001|Part B Pooled Treatment Arm|Adverse Event|0
6979578|NCT01218204|11033338|FG002|Part B Pooled Treatment Arm|Adverse Event|0
6979579|NCT01218204|11033339|FG003|Part B Pooled Treatment Arm|Adverse Event|2
6979580|NCT01218204|11033336|FG000|Part B Pooled Treatment Arm|Protocol Violation|0
6979581|NCT01218204|11033337|FG001|Part B Pooled Treatment Arm|Protocol Violation|0
6979582|NCT01218204|11033338|FG002|Part B Pooled Treatment Arm|Protocol Violation|0
6979583|NCT01218204|11033339|FG003|Part B Pooled Treatment Arm|Protocol Violation|1
6979584|NCT01218243|11033388|FG000|Overall Study|Lack of Efficacy|1
6979585|NCT01218243|11033389|FG001|Overall Study|Lack of Efficacy|1
6979586|NCT01218243|11033388|FG000|Overall Study|Lost to Follow-up|3
6979587|NCT01218243|11033389|FG001|Overall Study|Lost to Follow-up|3
6979588|NCT01218243|11033388|FG000|Overall Study|Protocol Violation|5
6979589|NCT01218243|11033389|FG001|Overall Study|Protocol Violation|10
6979590|NCT01218308|11033397|FG000|Overall Study|Adverse Event|1
6979591|NCT01218308|11033398|FG001|Overall Study|Adverse Event|2
6979592|NCT01218308|11033397|FG000|Overall Study|Protocol Violation|0
6979593|NCT01218308|11033398|FG001|Overall Study|Protocol Violation|2
6979594|NCT01218308|11033397|FG000|Overall Study|Withdrawal by Subject|61
6979595|NCT01218308|11033398|FG001|Overall Study|Withdrawal by Subject|64
6979596|NCT01218308|11033397|FG000|Overall Study|Lost to Follow-up|27
6979597|NCT01218308|11033398|FG001|Overall Study|Lost to Follow-up|31
6979598|NCT01218308|11033397|FG000|Overall Study|Other|14
6979599|NCT01218308|11033398|FG001|Overall Study|Other|21
6979600|NCT01218438|11033413|FG000|Epoch 1|Physician Decision|2
6979601|NCT01218438|11033413|FG000|Epoch 1|Adverse Event|1
6979602|NCT01218438|11033413|FG000|Epoch 3|Withdrawal by Subject|3
6979603|NCT01218438|11033413|FG000|Epoch 3|Adverse Event|1
6979604|NCT01218438|11033413|FG000|Epoch 4|Physician Decision|1
6979605|NCT01218438|11033413|FG000|Epoch 4|Withdrawal by Subject|2
6979606|NCT01218477|11033491|FG000|Overall Study|Disease progression|2
6979607|NCT01218477|11033492|FG001|Overall Study|Disease progression|3
6979608|NCT01218477|11033493|FG002|Overall Study|Disease progression|6
6979609|NCT01218477|11033494|FG003|Overall Study|Disease progression|2
6979610|NCT01218477|11033491|FG000|Overall Study|Study drug toxicity|0
6979611|NCT01218477|11033492|FG001|Overall Study|Study drug toxicity|2
6979612|NCT01218477|11033493|FG002|Overall Study|Study drug toxicity|5
6979613|NCT01218477|11033494|FG003|Overall Study|Study drug toxicity|0
6979614|NCT01218477|11033491|FG000|Overall Study|No longer meets study criteria|1
6979615|NCT01218477|11033492|FG001|Overall Study|No longer meets study criteria|0
6979616|NCT01218477|11033493|FG002|Overall Study|No longer meets study criteria|0
6979617|NCT01218477|11033494|FG003|Overall Study|No longer meets study criteria|0
6979618|NCT01218477|11033491|FG000|Overall Study|Withdrawal by Subject|0
6979619|NCT01218477|11033492|FG001|Overall Study|Withdrawal by Subject|0
6979620|NCT01218477|11033493|FG002|Overall Study|Withdrawal by Subject|1
6979621|NCT01218477|11033494|FG003|Overall Study|Withdrawal by Subject|0
6979622|NCT01218477|11033491|FG000|Overall Study|Prepared for cell transplantation|0
6979623|NCT01218477|11033492|FG001|Overall Study|Prepared for cell transplantation|1
6979624|NCT01218477|11033493|FG002|Overall Study|Prepared for cell transplantation|1
6979625|NCT01218477|11033494|FG003|Overall Study|Prepared for cell transplantation|0
6979626|NCT01218477|11033491|FG000|Overall Study|Administrative reason by sponsor|0
6979627|NCT01218477|11033492|FG001|Overall Study|Administrative reason by sponsor|0
6979628|NCT01218477|11033493|FG002|Overall Study|Administrative reason by sponsor|1
6979629|NCT01218477|11033494|FG003|Overall Study|Administrative reason by sponsor|0
6979630|NCT01218477|11033491|FG000|Overall Study|Maximum clinical benefit|0
6979631|NCT01218477|11033492|FG001|Overall Study|Maximum clinical benefit|2
6979632|NCT01218477|11033493|FG002|Overall Study|Maximum clinical benefit|0
6979633|NCT01218477|11033494|FG003|Overall Study|Maximum clinical benefit|0
6979634|NCT01218516|11033510|FG000|Combination Therapy (up to 4.5 Months)|Death|2
6979635|NCT01218516|11033511|FG001|Combination Therapy (up to 4.5 Months)|Death|1
6979636|NCT01218516|11033512|FG002|Combination Therapy (up to 4.5 Months)|Death|0
6979637|NCT01218516|11033513|FG003|Combination Therapy (up to 4.5 Months)|Death|0
6979638|NCT01218516|11033510|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0
6979639|NCT01218516|11033511|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3
6979640|NCT01218516|11033512|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0
6979641|NCT01218516|11033513|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0
6979642|NCT01218516|11033510|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2
6979643|NCT01218516|11033511|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2
6979644|NCT01218516|11033512|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0
6979645|NCT01218516|11033513|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0
6979646|NCT01218516|11033510|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2
6979647|NCT01218516|11033511|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0
6979648|NCT01218516|11033512|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0
6979649|NCT01218516|11033513|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0
6979650|NCT01218516|11033510|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17
6979651|NCT01218516|11033511|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15
6979652|NCT01218516|11033512|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0
6979653|NCT01218516|11033513|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0
6979654|NCT01218516|11033510|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0
6979655|NCT01218516|11033511|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1
6979656|NCT01218516|11033512|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0
6979657|NCT01218516|11033513|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0
6979658|NCT01218516|11033510|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0
6979659|NCT01218516|11033511|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1
6979660|NCT01218516|11033512|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0
6979661|NCT01218516|11033513|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0
6979662|NCT01218516|11033510|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0
6979663|NCT01218516|11033511|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3
6979664|NCT01218516|11033512|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0
7060246|NCT01915914|11156285|FG003|Acute Phase|"Not Achieved treatment success"|0
6979665|NCT01218516|11033513|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0
6979666|NCT01218516|11033510|FG000|Combination Therapy (up to 4.5 Months)|Other|3
7060247|NCT01915914|11156282|FG000|Acute Phase|Missing|1
7060248|NCT01915914|11156283|FG001|Acute Phase|Missing|0
7060249|NCT01915914|11156284|FG002|Acute Phase|Missing|0
7060250|NCT01915914|11156285|FG003|Acute Phase|Missing|0
7060251|NCT01915914|11156282|FG000|Maintenance Phase|Withdrawal by Subject|0
7060252|NCT01915914|11156283|FG001|Maintenance Phase|Withdrawal by Subject|1
7060253|NCT01915914|11156284|FG002|Maintenance Phase|Withdrawal by Subject|1
6979667|NCT01218516|11033511|FG001|Combination Therapy (up to 4.5 Months)|Other|4
6979668|NCT01218516|11033512|FG002|Combination Therapy (up to 4.5 Months)|Other|0
6979669|NCT01218516|11033513|FG003|Combination Therapy (up to 4.5 Months)|Other|0
6979670|NCT01218516|11033510|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0
6979671|NCT01218516|11033511|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1
6979672|NCT01218516|11033512|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0
6979673|NCT01218516|11033513|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0
6979674|NCT01218516|11033510|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2
6979675|NCT01218516|11033511|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3
6979676|NCT01218516|11033512|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0
6979677|NCT01218516|11033513|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0
6979678|NCT01218516|11033510|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1
6979679|NCT01218516|11033511|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1
6979680|NCT01218516|11033512|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0
6979681|NCT01218516|11033513|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0
6979682|NCT01218594|11033528|FG000|Overall Study|Death|1
6979683|NCT01218594|11033528|FG000|Overall Study|Withdrawal by Subject|3
6979684|NCT01218594|11033528|FG000|Overall Study|Adverse Event|2
6979685|NCT01218594|11033528|FG000|Overall Study|Physician Decision|6
6979686|NCT01218646|11033536|FG000|Overall Study|Adverse Event|0
6979687|NCT01218646|11033537|FG001|Overall Study|Adverse Event|0
6979688|NCT01218646|11033538|FG002|Overall Study|Adverse Event|1
6979689|NCT01218646|11033539|FG003|Overall Study|Adverse Event|0
6979690|NCT01218646|11033536|FG000|Overall Study|Lost to Follow-up|1
6979691|NCT01218646|11033537|FG001|Overall Study|Lost to Follow-up|0
6979692|NCT01218646|11033538|FG002|Overall Study|Lost to Follow-up|0
6979693|NCT01218646|11033539|FG003|Overall Study|Lost to Follow-up|0
6979694|NCT01218646|11033536|FG000|Overall Study|Protocol Violation|0
6979695|NCT01218646|11033537|FG001|Overall Study|Protocol Violation|0
6979696|NCT01218646|11033538|FG002|Overall Study|Protocol Violation|1
6979697|NCT01218646|11033539|FG003|Overall Study|Protocol Violation|1
6979698|NCT01218659|11033551|FG000|18-Month Randomized Period|Withdrawal by Subject|2
6979699|NCT01218659|11033552|FG001|18-Month Randomized Period|Withdrawal by Subject|3
6979700|NCT01218659|11033553|FG002|18-Month Randomized Period|Withdrawal by Subject|0
6979701|NCT01218659|11033551|FG000|18-Month Randomized Period|Did not receive study drug|0
6979702|NCT01218659|11033552|FG001|18-Month Randomized Period|Did not receive study drug|3
6979703|NCT01218659|11033553|FG002|18-Month Randomized Period|Did not receive study drug|0
6979704|NCT01218659|11033551|FG000|12-Month OLE|Withdrawal by Subject|0
6979705|NCT01218659|11033552|FG001|12-Month OLE|Withdrawal by Subject|0
6979706|NCT01218659|11033553|FG002|12-Month OLE|Withdrawal by Subject|2
6979707|NCT01218659|11033551|FG000|12-Month OLE|Physician Decision|0
6979708|NCT01218659|11033552|FG001|12-Month OLE|Physician Decision|0
6979709|NCT01218659|11033553|FG002|12-Month OLE|Physician Decision|1
6979710|NCT01218659|11033551|FG000|12-Month OLE|Lost to Follow-up|0
6979711|NCT01218659|11033552|FG001|12-Month OLE|Lost to Follow-up|0
6979712|NCT01218659|11033553|FG002|12-Month OLE|Lost to Follow-up|1
6979713|NCT01218659|11033551|FG000|12-Month OLE|Pregnancy|0
6827058|NCT00121667|10829459|FG002|Short Term (ST) + Long Term (LT) Period|Death|0
6827059|NCT00121667|10829460|FG003|Short Term (ST) + Long Term (LT) Period|Death|2
6979714|NCT01218659|11033552|FG001|12-Month OLE|Pregnancy|0
6979715|NCT01218659|11033553|FG002|12-Month OLE|Pregnancy|1
6979716|NCT01218659|11033551|FG000|12-Month OLE|Lack of Efficacy|0
6979717|NCT01218659|11033552|FG001|12-Month OLE|Lack of Efficacy|0
6979718|NCT01218659|11033553|FG002|12-Month OLE|Lack of Efficacy|1
6979719|NCT01218659|11033551|FG000|12-Month OLE|Declined to participate in the OLE|0
6979720|NCT01218659|11033552|FG001|12-Month OLE|Declined to participate in the OLE|0
6979721|NCT01218659|11033553|FG002|12-Month OLE|Declined to participate in the OLE|4
6979722|NCT01218802|11033573|FG000|Overall Study|Lost to Follow-up|5
6979723|NCT01218802|11033574|FG001|Overall Study|Lost to Follow-up|6
6979724|NCT01218802|11033573|FG000|Overall Study|Withdrawal by Subject|3
6979725|NCT01218802|11033574|FG001|Overall Study|Withdrawal by Subject|10
6979726|NCT01218802|11033573|FG000|Overall Study|Adverse Event|0
6979727|NCT01218802|11033574|FG001|Overall Study|Adverse Event|2
6979728|NCT01218802|11033573|FG000|Overall Study|Incarcerated|2
6979729|NCT01218802|11033574|FG001|Overall Study|Incarcerated|0
6979730|NCT01218867|11033591|FG000|Overall Study|Death during treatment|0
6979731|NCT01218867|11033592|FG001|Overall Study|Death during treatment|0
6979732|NCT01218867|11033593|FG002|Overall Study|Death during treatment|0
6979733|NCT01218867|11033594|FG003|Overall Study|Death during treatment|0
6979734|NCT01218867|11033595|FG004|Overall Study|Death during treatment|0
6979735|NCT01218867|11033596|FG005|Overall Study|Death during treatment|0
6979736|NCT01218867|11033597|FG006|Overall Study|Death during treatment|1
6979737|NCT01218867|11033598|FG007|Overall Study|Death during treatment|0
6979738|NCT01218867|11033599|FG008|Overall Study|Death during treatment|0
6979739|NCT01218867|11033600|FG009|Overall Study|Death during treatment|0
6979740|NCT01218867|11033601|FG010|Overall Study|Death during treatment|0
6979741|NCT01219933|11033731|FG000|Overall Study|Adverse Event|8
6979742|NCT01219933|11033731|FG000|Overall Study|No LDA reached|5
6979743|NCT01219933|11033731|FG000|Overall Study|No LDA maintained|7
6979744|NCT01219933|11033731|FG000|Overall Study|Lost to Follow-up|3
6979745|NCT01219933|11033731|FG000|Overall Study|GC free|1
6979746|NCT01219933|11033731|FG000|Overall Study|Withdrawal by Subject|5
6979747|NCT01219933|11033731|FG000|Overall Study|Protocol Violation|8
6979748|NCT01219933|11033731|FG000|Overall Study|Lack of Efficacy|1
6979749|NCT01219959|11033738|FG000|Overall Study|Adverse Event|6
6979750|NCT01219959|11033739|FG001|Overall Study|Adverse Event|14
6979751|NCT01219959|11033738|FG000|Overall Study|Physician Decision|0
6979752|NCT01219959|11033739|FG001|Overall Study|Physician Decision|4
6979753|NCT01219959|11033738|FG000|Overall Study|Withdrawal by Subject|0
6979754|NCT01219959|11033739|FG001|Overall Study|Withdrawal by Subject|2
6979755|NCT01219959|11033738|FG000|Overall Study|Renal Transplantation|0
6979756|NCT01219959|11033739|FG001|Overall Study|Renal Transplantation|3
6979757|NCT01219959|11033738|FG000|Overall Study|Other|1
6979758|NCT01219959|11033739|FG001|Overall Study|Other|0
6979759|NCT01219985|11033745|FG000|Overall Study|Physician Decision|20
6979760|NCT01220024|11033753|FG000|Overall Study|Lost to Follow-up|1
6979761|NCT01220024|11033754|FG001|Overall Study|Lost to Follow-up|1
6979762|NCT01220128|11033767|FG000|Overall Study|Progressive disease|0
6979763|NCT01220128|11033768|FG001|Overall Study|Progressive disease|0
6979764|NCT01220128|11033769|FG002|Overall Study|Progressive disease|2
6979765|NCT01220128|11033770|FG003|Overall Study|Progressive disease|0
6979766|NCT01220128|11033771|FG004|Overall Study|Progressive disease|0
6979767|NCT01220128|11033772|FG005|Overall Study|Progressive disease|0
6979768|NCT01220128|11033773|FG006|Overall Study|Progressive disease|0
6979769|NCT01220128|11033767|FG000|Overall Study|Sponsor study termination|0
6979770|NCT01220128|11033768|FG001|Overall Study|Sponsor study termination|1
6979771|NCT01220128|11033769|FG002|Overall Study|Sponsor study termination|0
6979772|NCT01220128|11033770|FG003|Overall Study|Sponsor study termination|0
6979773|NCT01220128|11033771|FG004|Overall Study|Sponsor study termination|0
6979774|NCT01220128|11033772|FG005|Overall Study|Sponsor study termination|0
6979775|NCT01220128|11033773|FG006|Overall Study|Sponsor study termination|1
6979776|NCT01220128|11033767|FG000|Overall Study|Adverse event, serious fatal|2
6979777|NCT01220128|11033768|FG001|Overall Study|Adverse event, serious fatal|0
6979778|NCT01220128|11033769|FG002|Overall Study|Adverse event, serious fatal|0
6979779|NCT01220128|11033770|FG003|Overall Study|Adverse event, serious fatal|0
6979780|NCT01220128|11033771|FG004|Overall Study|Adverse event, serious fatal|0
6979781|NCT01220128|11033772|FG005|Overall Study|Adverse event, serious fatal|0
6979782|NCT01220128|11033773|FG006|Overall Study|Adverse event, serious fatal|1
6979783|NCT01220128|11033767|FG000|Overall Study|Adverse event, non-fatal|1
6979784|NCT01220128|11033768|FG001|Overall Study|Adverse event, non-fatal|0
6979785|NCT01220128|11033769|FG002|Overall Study|Adverse event, non-fatal|0
6979786|NCT01220128|11033770|FG003|Overall Study|Adverse event, non-fatal|0
6979787|NCT01220128|11033771|FG004|Overall Study|Adverse event, non-fatal|0
6979788|NCT01220128|11033772|FG005|Overall Study|Adverse event, non-fatal|0
6979789|NCT01220128|11033773|FG006|Overall Study|Adverse event, non-fatal|3
6979790|NCT01220128|11033767|FG000|Overall Study|Other|0
6979791|NCT01220128|11033768|FG001|Overall Study|Other|0
6979792|NCT01220128|11033769|FG002|Overall Study|Other|1
6979793|NCT01220128|11033770|FG003|Overall Study|Other|0
6979794|NCT01220128|11033771|FG004|Overall Study|Other|0
6979795|NCT01220128|11033772|FG005|Overall Study|Other|0
6979796|NCT01220128|11033773|FG006|Overall Study|Other|0
6979797|NCT01220128|11033767|FG000|Overall Study|Consent withdrawn by subject|1
6979798|NCT01220128|11033768|FG001|Overall Study|Consent withdrawn by subject|0
6979799|NCT01220128|11033769|FG002|Overall Study|Consent withdrawn by subject|0
6979800|NCT01220128|11033770|FG003|Overall Study|Consent withdrawn by subject|0
6979801|NCT01220128|11033771|FG004|Overall Study|Consent withdrawn by subject|0
6979802|NCT01220128|11033772|FG005|Overall Study|Consent withdrawn by subject|0
6979803|NCT01220128|11033773|FG006|Overall Study|Consent withdrawn by subject|0
6979804|NCT01220167|11033793|FG000|Period 3|Urine positive for substance abuse|0
6979805|NCT01220167|11033794|FG001|Period 3|Urine positive for substance abuse|1
6979806|NCT01220167|11033795|FG002|Period 3|Urine positive for substance abuse|0
6979807|NCT01220180|11033804|FG000|Overall Study|Lost to Follow-up|76
6979808|NCT01220180|11033804|FG000|Overall Study|Other|72
6979809|NCT01220180|11033804|FG000|Overall Study|Adverse Event|35
6979810|NCT01220180|11033804|FG000|Overall Study|Lack of Efficacy|22
6979811|NCT01220180|11033804|FG000|Overall Study|Death|1
6979812|NCT01220180|11033804|FG000|Overall Study|Randomized but not treated|1
6979813|NCT01220297|11033810|FG000|Overall Study|Death|2
6979814|NCT01220297|11033810|FG000|Overall Study|Lost to Follow-up|1
6979815|NCT01220401|11033816|FG000|Overall Study|Withdrawal by Subject|2
6979816|NCT01220401|11033816|FG000|Overall Study|Protocol Violation|1
7041777|NCT01730040|11125603|FG004|Overall Study|Poor compliance to protocol|0
7041778|NCT01730040|11125604|FG005|Overall Study|Poor compliance to protocol|0
7041779|NCT01730040|11125605|FG006|Overall Study|Poor compliance to protocol|1
7041780|NCT01730053|11125627|FG000|Overall Study|Participant moved|0
7041781|NCT01730053|11125628|FG001|Overall Study|Participant moved|0
7041782|NCT01730053|11125629|FG002|Overall Study|Participant moved|1
7041783|NCT01730053|11125630|FG003|Overall Study|Participant moved|0
7041784|NCT01730053|11125631|FG004|Overall Study|Participant moved|0
7041785|NCT01730053|11125632|FG005|Overall Study|Participant moved|0
7041786|NCT01730053|11125627|FG000|Overall Study|Physician Decision|0
7041787|NCT01730053|11125628|FG001|Overall Study|Physician Decision|0
6979817|NCT01220414|11033822|FG000|Overall Study|Withdrawal by Subject|1
6979818|NCT01220414|11033823|FG001|Overall Study|Withdrawal by Subject|0
6979819|NCT01220414|11033824|FG002|Overall Study|Withdrawal by Subject|0
6979820|NCT01220414|11033825|FG003|Overall Study|Withdrawal by Subject|1
6979821|NCT01220557|11033847|FG000|Overall Study|Lost to Follow-up|5
6979822|NCT01220557|11033848|FG001|Overall Study|Lost to Follow-up|3
6979823|NCT01220557|11033847|FG000|Overall Study|attended less than 6 lessons|1
6979824|NCT01220557|11033848|FG001|Overall Study|attended less than 6 lessons|2
6979825|NCT01220609|11033854|FG000|Overall Study|Ineligible-Wrong primary cancer site|1
6979826|NCT01220609|11033854|FG000|Overall Study|Ineligible- Wrong cell type|1
6979827|NCT01220609|11033854|FG000|Overall Study|Ineligible-Never treated|1
6979828|NCT01220856|11033893|FG000|Overall Study|graft loss|3
6979829|NCT01220856|11033894|FG001|Overall Study|graft loss|3
6979830|NCT01220856|11033893|FG000|Overall Study|Lost to Follow-up|1
6979831|NCT01220856|11033894|FG001|Overall Study|Lost to Follow-up|0
6979832|NCT01220999|11033916|FG000|Overall Study|Progressive disease|0
6979833|NCT01220999|11033917|FG001|Overall Study|Progressive disease|0
6979834|NCT01220999|11033918|FG002|Overall Study|Progressive disease|1
6979835|NCT01220999|11033919|FG003|Overall Study|Progressive disease|0
6979836|NCT01220999|11033920|FG004|Overall Study|Progressive disease|0
6979837|NCT01221090|11033936|FG000|Overall Study|Non-Compliant or Unable to Contact|15
6979838|NCT01221090|11033937|FG001|Overall Study|Non-Compliant or Unable to Contact|12
6979839|NCT01221090|11033938|FG002|Overall Study|Non-Compliant or Unable to Contact|15
6979840|NCT01221090|11033939|FG003|Overall Study|Non-Compliant or Unable to Contact|20
6979841|NCT01221090|11033936|FG000|Overall Study|Withdrawal by Subject|0
6979842|NCT01221090|11033937|FG001|Overall Study|Withdrawal by Subject|22
6979843|NCT01221090|11033938|FG002|Overall Study|Withdrawal by Subject|27
6979844|NCT01221090|11033939|FG003|Overall Study|Withdrawal by Subject|2
6979845|NCT01221181|11033949|FG000|Overall Study|Lost to Follow-up|1
6979846|NCT01221233|11033977|FG000|Overall Study|Withdrawal by Subject|3
6979847|NCT01221233|11033978|FG001|Overall Study|Withdrawal by Subject|1
6979848|NCT01221272|11033984|FG000|Period 1|Adverse Event|2
6979849|NCT01221272|11033985|FG001|Period 1|Adverse Event|0
6979850|NCT01221272|11033984|FG000|Period 1|Consent Withdrawal|0
6979851|NCT01221272|11033985|FG001|Period 1|Consent Withdrawal|1
6979852|NCT01221272|11033984|FG000|Period 1|Significant Dosing Noncompliance|0
6979853|NCT01221272|11033985|FG001|Period 1|Significant Dosing Noncompliance|1
6979854|NCT01221272|11033984|FG000|Period 2|Adverse Event|0
6979855|NCT01221272|11033985|FG001|Period 2|Adverse Event|2
6979856|NCT01221285|11033994|FG000|Overall Study|Withdrawal by Subject|1
6979857|NCT01221350|11034013|FG000|Overall Study|Discontinued intervention (GERD)|1
6979858|NCT01221350|11034014|FG001|Overall Study|Discontinued intervention (GERD)|0
6979859|NCT01221350|11034013|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0
6979860|NCT01221350|11034014|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1
6979861|NCT01221350|11034013|FG000|Overall Study|Withdrawal by Subject|4
6979862|NCT01221350|11034014|FG001|Overall Study|Withdrawal by Subject|2
6979863|NCT01221363|11034024|FG000|Overall Study|Pregnancy|1
6979864|NCT01221363|11034025|FG001|Overall Study|Pregnancy|0
6979865|NCT01221363|11034024|FG000|Overall Study|Withdrawal by Subject|11
6979866|NCT01221363|11034025|FG001|Overall Study|Withdrawal by Subject|5
6979867|NCT01221597|11034042|FG000|Overall Study|Adverse Event|4
6979868|NCT01221597|11034043|FG001|Overall Study|Adverse Event|1
6979869|NCT01221597|11034042|FG000|Overall Study|Withdrawal by Subject|20
6979870|NCT01221597|11034043|FG001|Overall Study|Withdrawal by Subject|6
6979871|NCT01221597|11034042|FG000|Overall Study|Lost to Follow-up|6
6979872|NCT01221597|11034043|FG001|Overall Study|Lost to Follow-up|5
6979873|NCT01221597|11034042|FG000|Overall Study|Protocol Violation|1
6979874|NCT01221597|11034043|FG001|Overall Study|Protocol Violation|0
6979875|NCT01221597|11034042|FG000|Overall Study|Other|3
6979876|NCT01221597|11034043|FG001|Overall Study|Other|4
6979877|NCT01221597|11034042|FG000|Overall Study|Death|2
6979878|NCT01221597|11034043|FG001|Overall Study|Death|0
6979879|NCT01221623|11034052|FG000|Overall Study|Withdrawal by Subject|19
6979880|NCT01221623|11034053|FG001|Overall Study|Withdrawal by Subject|8
6979881|NCT01221623|11034052|FG000|Overall Study|Lost to Follow-up|7
6979882|NCT01221623|11034053|FG001|Overall Study|Lost to Follow-up|1
6979883|NCT01221623|11034052|FG000|Overall Study|Adverse Event|6
6979884|NCT01221623|11034053|FG001|Overall Study|Adverse Event|3
6979885|NCT01221623|11034052|FG000|Overall Study|Death|1
6979886|NCT01221623|11034053|FG001|Overall Study|Death|0
6979887|NCT01221623|11034052|FG000|Overall Study|Other|5
6979888|NCT01221623|11034053|FG001|Overall Study|Other|2
6979889|NCT01221727|11034061|FG000|Overall Study|Physician Decision|2
6979890|NCT01221727|11034062|FG001|Overall Study|Physician Decision|0
6979891|NCT01221727|11034061|FG000|Overall Study|Withdrawal by Subject|1
6979892|NCT01221727|11034062|FG001|Overall Study|Withdrawal by Subject|1
6979893|NCT01221753|11034074|FG000|Overall Study|Adverse Event|1
6979894|NCT01221948|11034086|FG000|Overall Study|Physician Decision|5
6979895|NCT01221948|11034086|FG000|Overall Study|Withdrawal by Subject|2
6979896|NCT01221948|11034086|FG000|Overall Study|not disclosed|2
6979897|NCT01221948|11034086|FG000|Overall Study|Death|1
6979898|NCT01221948|11034086|FG000|Overall Study|Protocol Violation|4
6979899|NCT01222078|11034090|FG000|Overall Study|Early termination of the study|1
6979900|NCT01222104|11034102|FG000|Overall Study|Lost to Follow-up|37
6979901|NCT01222104|11034102|FG000|Overall Study|Death|10
6979902|NCT01222403|11034215|FG000|Overall Study|Inappropriate enrollment|0
6979903|NCT01222403|11034216|FG001|Overall Study|Inappropriate enrollment|2
6979904|NCT01222416|11034224|FG000|Overall Study|ineligible;metastasis|3
6979905|NCT01222416|11034225|FG001|Overall Study|ineligible;metastasis|0
6979906|NCT01222416|11034224|FG000|Overall Study|Adverse Event|4
6979907|NCT01222416|11034225|FG001|Overall Study|Adverse Event|0
6979908|NCT01222416|11034224|FG000|Overall Study|Withdrawal by Subject|5
6979909|NCT01222416|11034225|FG001|Overall Study|Withdrawal by Subject|0
6979910|NCT01222416|11034224|FG000|Overall Study|scheduling|6
6979911|NCT01222416|11034225|FG001|Overall Study|scheduling|0
6979912|NCT01222416|11034224|FG000|Overall Study|missed view/scan|1
6979913|NCT01222416|11034225|FG001|Overall Study|missed view/scan|0
6979914|NCT01222416|11034224|FG000|Overall Study|Death|1
6979915|NCT01222416|11034225|FG001|Overall Study|Death|0
6979916|NCT01222507|11034244|FG000|Overall Study|Physician Decision|1
6979917|NCT01222507|11034244|FG000|Overall Study|Withdrawal by Subject|1
6979918|NCT01222520|11034250|FG000|Open-label run-in Period|Withdrawal by Subject|0
6979919|NCT01222520|11034251|FG001|Open-label run-in Period|Withdrawal by Subject|2
6979920|NCT01222520|11034250|FG000|Open-label run-in Period|Blood pressure criteria not met|0
6979921|NCT01222520|11034251|FG001|Open-label run-in Period|Blood pressure criteria not met|18
6979922|NCT01222520|11034250|FG000|Open-label run-in Period|Number of patients fulfilled|0
6979923|NCT01222520|11034251|FG001|Open-label run-in Period|Number of patients fulfilled|3
6979924|NCT01222520|11034250|FG000|Double-blind Period|Adverse Event|0
6979925|NCT01222520|11034251|FG001|Double-blind Period|Adverse Event|1
6979926|NCT01222520|11034250|FG000|Double-blind Period|Lack of Efficacy|0
6979927|NCT01222520|11034251|FG001|Double-blind Period|Lack of Efficacy|1
6979928|NCT01222520|11034250|FG000|Double-blind Period|Study medication stolen|1
6979929|NCT01222520|11034251|FG001|Double-blind Period|Study medication stolen|0
6979930|NCT01222533|11034257|FG000|Overall Study|Adverse Event|5
6979931|NCT01222533|11034257|FG000|Overall Study|Withdrawal by Subject|5
6979932|NCT01222533|11034257|FG000|Overall Study|Other|4
6979933|NCT01222715|11034285|FG000|Overall Study|Adverse Event|0
6979934|NCT01222715|11034286|FG001|Overall Study|Adverse Event|4
6979935|NCT01222715|11034285|FG000|Overall Study|Death|0
6979936|NCT01222715|11034286|FG001|Overall Study|Death|1
6979937|NCT01222715|11034285|FG000|Overall Study|Lack of Efficacy|22
6979938|NCT01222715|11034286|FG001|Overall Study|Lack of Efficacy|14
6979939|NCT01222715|11034285|FG000|Overall Study|Physician Decision|12
6979940|NCT01222715|11034286|FG001|Overall Study|Physician Decision|2
6979941|NCT01222715|11034285|FG000|Overall Study|Refusal of further protocol therapy|0
6979942|NCT01222715|11034286|FG001|Overall Study|Refusal of further protocol therapy|4
6979943|NCT01222715|11034285|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1
6979944|NCT01222715|11034286|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1
6979945|NCT01222715|11034285|FG000|Overall Study|Ineligible|0
6979946|NCT01222715|11034286|FG001|Overall Study|Ineligible|1
6979947|NCT01222715|11034285|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1
6979948|NCT01222715|11034286|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0
6979949|NCT01222767|11034292|FG000|Overall Study|Progressive disease|13
6979950|NCT01222767|11034292|FG000|Overall Study|Adverse Event|2
6979951|NCT01222767|11034292|FG000|Overall Study|Surgical resection|1
6979952|NCT01222767|11034292|FG000|Overall Study|Never treated|1
6979953|NCT01223027|11034316|FG000|Overall Study|Adverse Event|20
6979954|NCT01223027|11034317|FG001|Overall Study|Adverse Event|10
6979955|NCT01223027|11034316|FG000|Overall Study|Death|42
6979956|NCT01223027|11034317|FG001|Overall Study|Death|42
6979957|NCT01223027|11034316|FG000|Overall Study|Lost to Follow-up|2
6979958|NCT01223027|11034317|FG001|Overall Study|Lost to Follow-up|1
6979959|NCT01223027|11034316|FG000|Overall Study|Physician Decision|4
6979960|NCT01223027|11034317|FG001|Overall Study|Physician Decision|8
6979961|NCT01223027|11034316|FG000|Overall Study|Progressive Disease|167
6979962|NCT01223027|11034317|FG001|Overall Study|Progressive Disease|183
6979963|NCT01223027|11034316|FG000|Overall Study|Protocol Violation|2
6979964|NCT01223027|11034317|FG001|Overall Study|Protocol Violation|1
6979965|NCT01223027|11034316|FG000|Overall Study|Subject/guardian decicion|18
6979966|NCT01223027|11034317|FG001|Overall Study|Subject/guardian decicion|16
6979967|NCT01223027|11034316|FG000|Overall Study|New therapy for study indication|17
6979968|NCT01223027|11034317|FG001|Overall Study|New therapy for study indication|8
6979969|NCT01223027|11034316|FG000|Overall Study|Study terminated by sponsor|2
6979970|NCT01223027|11034317|FG001|Overall Study|Study terminated by sponsor|8
6979971|NCT01223183|11034325|FG000|Imaging Day 1|Physician Decision|0
6979972|NCT01223183|11034326|FG001|Imaging Day 1|Physician Decision|1
6979973|NCT01223183|11034325|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1
6979974|NCT01223183|11034326|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0
6979975|NCT01223183|11034325|FG000|Washout Period (5-24 Days)|Physician Decision|1
6979976|NCT01223183|11034326|FG001|Washout Period (5-24 Days)|Physician Decision|0
6979977|NCT01223196|11034335|FG000|Overall Study|Lost to Follow-up|2
6979978|NCT01223196|11034336|FG001|Overall Study|Lost to Follow-up|0
6979979|NCT01223196|11034335|FG000|Overall Study|Physician Decision|1
6979980|NCT01223196|11034336|FG001|Overall Study|Physician Decision|0
6979981|NCT01223196|11034335|FG000|Overall Study|Withdrawal by Subject|1
6979982|NCT01223196|11034336|FG001|Overall Study|Withdrawal by Subject|0
6979983|NCT01223235|11034344|FG000|Overall Study|Withdrawal by Subject|1
6979984|NCT01223365|11034363|FG000|Open-label Titration Period|Enrolled but not treated|1
6979985|NCT01223365|11034363|FG000|Open-label Titration Period|Adverse Event|23
6979986|NCT01223365|11034363|FG000|Open-label Titration Period|Lack of Efficacy|3
6979987|NCT01223365|11034363|FG000|Open-label Titration Period|Withdrawal by Subject|5
6979988|NCT01223365|11034363|FG000|Open-label Titration Period|Protocol Violation|1
6979989|NCT01223365|11034363|FG000|Open-label Titration Period|Lost to Follow-up|2
6979990|NCT01223365|11034363|FG000|Open-label Titration Period|Noncompliance with study drug admin|1
6979991|NCT01223365|11034363|FG000|Open-label Titration Period|Noncompliance with study procedures|2
6979992|NCT01223365|11034363|FG000|Open-label Titration Period|Starting physical therapy|1
6979993|NCT01223365|11034363|FG000|Open-label Treatment Period|Adverse Event|39
6979994|NCT01223365|11034363|FG000|Open-label Treatment Period|Lack of Efficacy|2
6979995|NCT01223365|11034363|FG000|Open-label Treatment Period|Withdrawal by Subject|19
6979996|NCT01223365|11034363|FG000|Open-label Treatment Period|Protocol Violation|15
6979997|NCT01223365|11034363|FG000|Open-label Treatment Period|Lost to Follow-up|7
6979998|NCT01223365|11034363|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7
6979999|NCT01223365|11034363|FG000|Open-label Treatment Period|Noncompliance with study procedures|6
6980000|NCT01223365|11034363|FG000|Open-label Treatment Period|Moved out of area|2
6980001|NCT01223365|11034363|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1
6980002|NCT01223365|11034363|FG000|Open-label Treatment Period|"Out of window"|1
6980003|NCT01223365|11034363|FG000|Open-label Treatment Period|Starting physical therapy|1
6980004|NCT01223365|11034363|FG000|Open-label Treatment Period|Physician Decision|2
6980005|NCT01223404|11034393|FG000|First Intervention (1 Day)|Adverse Event|0
6980006|NCT01223404|11034394|FG001|First Intervention (1 Day)|Adverse Event|0
6980007|NCT01223404|11034395|FG002|First Intervention (1 Day)|Adverse Event|0
6980008|NCT01223404|11034396|FG003|First Intervention (1 Day)|Adverse Event|1
6980009|NCT01223404|11034397|FG004|First Intervention (1 Day)|Adverse Event|0
6980010|NCT01223404|11034398|FG005|First Intervention (1 Day)|Adverse Event|0
6980011|NCT01223404|11034393|FG000|Second Intervention (1 Day)|Adverse Event|1
6980012|NCT01223404|11034394|FG001|Second Intervention (1 Day)|Adverse Event|0
6980013|NCT01223404|11034395|FG002|Second Intervention (1 Day)|Adverse Event|0
6980014|NCT01223404|11034396|FG003|Second Intervention (1 Day)|Adverse Event|0
6980015|NCT01223404|11034397|FG004|Second Intervention (1 Day)|Adverse Event|0
6980016|NCT01223404|11034398|FG005|Second Intervention (1 Day)|Adverse Event|0
6980017|NCT01223404|11034393|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0
6980018|NCT01223404|11034394|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0
6980019|NCT01223404|11034395|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0
6980020|NCT01223404|11034396|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1
6980021|NCT01223404|11034397|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0
6980022|NCT01223404|11034398|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0
6980023|NCT01223937|11034434|FG000|Overall Study|Withdrawal by Subject|3
6980024|NCT01223937|11034435|FG001|Overall Study|Withdrawal by Subject|2
6980025|NCT01223937|11034434|FG000|Overall Study|Lost to Follow-up|1
6980026|NCT01223937|11034435|FG001|Overall Study|Lost to Follow-up|4
6980027|NCT01223937|11034434|FG000|Overall Study|Adverse Event|1
6980028|NCT01223937|11034435|FG001|Overall Study|Adverse Event|4
6980029|NCT01223937|11034434|FG000|Overall Study|Protocol Violation|8
6980030|NCT01223937|11034435|FG001|Overall Study|Protocol Violation|7
6980031|NCT01223937|11034434|FG000|Overall Study|Other|4
6980032|NCT01223937|11034435|FG001|Overall Study|Other|1
6980033|NCT01224158|11034466|FG000|Overall Study|Withdrawal by Subject|1
6980034|NCT01224158|11034467|FG001|Overall Study|Withdrawal by Subject|0
6980035|NCT01224171|11034475|FG000|Overall Study|Adverse Event|8
6980036|NCT01224171|11034476|FG001|Overall Study|Adverse Event|4
6980037|NCT01224171|11034475|FG000|Overall Study|Protocol Violation|0
6980038|NCT01224171|11034476|FG001|Overall Study|Protocol Violation|1
6980039|NCT01224171|11034475|FG000|Overall Study|Lack of Efficacy|5
6980040|NCT01224171|11034476|FG001|Overall Study|Lack of Efficacy|1
6980041|NCT01224171|11034475|FG000|Overall Study|Withdrawal of Consent|2
6980042|NCT01224171|11034476|FG001|Overall Study|Withdrawal of Consent|4
6980043|NCT01224171|11034475|FG000|Overall Study|Lost to Follow-up|0
6980044|NCT01224171|11034476|FG001|Overall Study|Lost to Follow-up|3
6980045|NCT01224431|11034498|FG000|Overall Study|not randomized|0
6980046|NCT01224431|11034499|FG001|Overall Study|not randomized|4
6980047|NCT01224431|11034498|FG000|Overall Study|no video record|0
6980048|NCT01224431|11034499|FG001|Overall Study|no video record|1
6980049|NCT01224639|11034523|FG000|Overall Study|Withdrawal by Subject|0
6980050|NCT01224639|11034524|FG001|Overall Study|Withdrawal by Subject|0
6980051|NCT01224639|11034525|FG002|Overall Study|Withdrawal by Subject|0
6980052|NCT01224639|11034526|FG003|Overall Study|Withdrawal by Subject|0
6980053|NCT01224639|11034527|FG004|Overall Study|Withdrawal by Subject|2
6980054|NCT01224639|11034528|FG005|Overall Study|Withdrawal by Subject|0
6980055|NCT01224639|11034529|FG006|Overall Study|Withdrawal by Subject|1
6980056|NCT01224639|11034530|FG007|Overall Study|Withdrawal by Subject|1
6980057|NCT01224639|11034523|FG000|Overall Study|Adverse Event|0
6980058|NCT01224639|11034524|FG001|Overall Study|Adverse Event|0
6980059|NCT01224639|11034525|FG002|Overall Study|Adverse Event|0
6980060|NCT01224639|11034526|FG003|Overall Study|Adverse Event|0
6980061|NCT01224639|11034527|FG004|Overall Study|Adverse Event|0
6980062|NCT01224639|11034528|FG005|Overall Study|Adverse Event|0
6980063|NCT01224639|11034529|FG006|Overall Study|Adverse Event|0
6980064|NCT01224639|11034530|FG007|Overall Study|Adverse Event|1
6980065|NCT01224782|11034557|FG000|Overall Study|Lost to Follow-up|177
6980066|NCT01224782|11034557|FG000|Overall Study|Withdrawal by Subject|16
6980067|NCT01224782|11034557|FG000|Overall Study|Death|14
6980068|NCT01224782|11034557|FG000|Overall Study|Improvement|13
6980069|NCT01224782|11034557|FG000|Overall Study|Adverse Event|12
6980070|NCT01224782|11034557|FG000|Overall Study|Adverse Reaction|11
6980071|NCT01224782|11034557|FG000|Overall Study|Noncompliance|10
6980072|NCT01224782|11034557|FG000|Overall Study|Other|4
6980073|NCT01224782|11034557|FG000|Overall Study|Start of Dialysis|3
6980074|NCT01224782|11034557|FG000|Overall Study|Change of Treatment|1
6980075|NCT01224782|11034557|FG000|Overall Study|Financial Reasons|1
6980076|NCT01224782|11034557|FG000|Overall Study|Deterioration|1
6980077|NCT01224782|11034557|FG000|Overall Study|Transplantation|1
6980078|NCT01224821|11034561|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1
6980079|NCT01224821|11034561|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38
6980080|NCT01224821|11034561|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3
6980081|NCT01224821|11034561|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
6980082|NCT01224821|11034561|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1
6980083|NCT01224821|11034561|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1
6980084|NCT01224821|11034561|FG000|Long-Term Follow-Up|Death|2
6980085|NCT01224821|11034561|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9
6980086|NCT01224925|11034567|FG000|Overall Study|Lost to Follow-up|3
6980087|NCT01224925|11034568|FG001|Overall Study|Lost to Follow-up|2
6980088|NCT01225146|11034609|FG000|Overall Study|Sponsor discontinued making 2mg drug|0
6980089|NCT01225146|11034610|FG001|Overall Study|Sponsor discontinued making 2mg drug|2
6980090|NCT01225159|11034620|FG000|Overall Study|Change operation|1
6980091|NCT01225159|11034621|FG001|Overall Study|Change operation|0
6980092|NCT01225172|11034629|FG000|Overall Study|Subject decision to stop|1
6980093|NCT01225172|11034630|FG001|Overall Study|Subject decision to stop|0
6980094|NCT01225172|11034629|FG000|Overall Study|Subject request to discontinue treatment|3
6980095|NCT01225172|11034630|FG001|Overall Study|Subject request to discontinue treatment|1
6980096|NCT01225172|11034629|FG000|Overall Study|Subject no longer meets study criteria|1
6980097|NCT01225172|11034630|FG001|Overall Study|Subject no longer meets study criteria|0
6980098|NCT01225172|11034629|FG000|Overall Study|Withdrawal by Subject|1
6980099|NCT01225172|11034630|FG001|Overall Study|Withdrawal by Subject|0
6980100|NCT01225211|11034646|FG000|Overall Study|Adverse Event|0
6980101|NCT01225211|11034647|FG001|Overall Study|Adverse Event|0
6980102|NCT01225211|11034648|FG002|Overall Study|Adverse Event|1
6980103|NCT01225211|11034649|FG003|Overall Study|Adverse Event|0
6980104|NCT01225211|11034650|FG004|Overall Study|Adverse Event|0
6980105|NCT01225211|11034651|FG005|Overall Study|Adverse Event|0
6980106|NCT01225211|11034652|FG006|Overall Study|Adverse Event|0
6980107|NCT01225211|11034653|FG007|Overall Study|Adverse Event|0
6980108|NCT01225211|11034654|FG008|Overall Study|Adverse Event|0
6980109|NCT01225211|11034655|FG009|Overall Study|Adverse Event|1
6980110|NCT01225211|11034646|FG000|Overall Study|Withdrawal by Subject|0
6980111|NCT01225211|11034647|FG001|Overall Study|Withdrawal by Subject|0
6980112|NCT01225211|11034648|FG002|Overall Study|Withdrawal by Subject|0
6980113|NCT01225211|11034649|FG003|Overall Study|Withdrawal by Subject|0
6980114|NCT01225211|11034650|FG004|Overall Study|Withdrawal by Subject|0
6980115|NCT01225211|11034651|FG005|Overall Study|Withdrawal by Subject|0
6980116|NCT01225211|11034652|FG006|Overall Study|Withdrawal by Subject|1
6980117|NCT01225211|11034653|FG007|Overall Study|Withdrawal by Subject|0
6980118|NCT01225211|11034654|FG008|Overall Study|Withdrawal by Subject|1
6980119|NCT01225211|11034655|FG009|Overall Study|Withdrawal by Subject|3
6980120|NCT01225211|11034646|FG000|Overall Study|Other|0
6980121|NCT01225211|11034647|FG001|Overall Study|Other|0
6980122|NCT01225211|11034648|FG002|Overall Study|Other|0
6980123|NCT01225211|11034649|FG003|Overall Study|Other|0
6980124|NCT01225211|11034650|FG004|Overall Study|Other|0
6980125|NCT01225211|11034651|FG005|Overall Study|Other|0
6980126|NCT01225211|11034652|FG006|Overall Study|Other|0
6980127|NCT01225211|11034653|FG007|Overall Study|Other|0
6980128|NCT01225211|11034654|FG008|Overall Study|Other|0
6980129|NCT01225211|11034655|FG009|Overall Study|Other|1
6980130|NCT01225549|11034745|FG000|Period 4 - Washout|Disallowed medication|0
6980131|NCT01225549|11034746|FG001|Period 4 - Washout|Disallowed medication|1
6980132|NCT01225549|11034747|FG002|Period 4 - Washout|Disallowed medication|0
6980133|NCT01225549|11034748|FG003|Period 4 - Washout|Disallowed medication|0
6980134|NCT01225549|11034749|FG004|Period 4 - Washout|Disallowed medication|0
6980135|NCT01225549|11034750|FG005|Period 4 - Washout|Disallowed medication|0
6980136|NCT01225549|11034751|FG006|Period 4 - Washout|Disallowed medication|0
6980137|NCT01225549|11034752|FG007|Period 4 - Washout|Disallowed medication|0
6980138|NCT01225549|11034753|FG008|Period 4 - Washout|Disallowed medication|0
6980139|NCT01225549|11034754|FG009|Period 4 - Washout|Disallowed medication|0
6980140|NCT01225549|11034745|FG000|Period 6 - Washout|Disallowed medication|0
6980141|NCT01225549|11034746|FG001|Period 6 - Washout|Disallowed medication|0
6980142|NCT01225549|11034747|FG002|Period 6 - Washout|Disallowed medication|0
6980143|NCT01225549|11034748|FG003|Period 6 - Washout|Disallowed medication|1
6980144|NCT01225549|11034749|FG004|Period 6 - Washout|Disallowed medication|0
6980145|NCT01225549|11034750|FG005|Period 6 - Washout|Disallowed medication|0
6980146|NCT01225549|11034751|FG006|Period 6 - Washout|Disallowed medication|0
6980147|NCT01225549|11034752|FG007|Period 6 - Washout|Disallowed medication|0
6980148|NCT01225549|11034753|FG008|Period 6 - Washout|Disallowed medication|0
6980149|NCT01225549|11034754|FG009|Period 6 - Washout|Disallowed medication|0
6980150|NCT01225562|11034767|FG000|Overall Study|Withdrawal by Subject|52
6980151|NCT01225562|11034768|FG001|Overall Study|Withdrawal by Subject|50
6980152|NCT01225562|11034769|FG002|Overall Study|Withdrawal by Subject|52
6980153|NCT01225562|11034767|FG000|Overall Study|Lost to Follow-up|3
6980154|NCT01225562|11034768|FG001|Overall Study|Lost to Follow-up|6
6980155|NCT01225562|11034769|FG002|Overall Study|Lost to Follow-up|1
6980156|NCT01225731|11034782|FG000|Part 1|Did not meet eligibility criteria|1
6980157|NCT01225731|11034783|FG001|Part 1|Did not meet eligibility criteria|0
6980158|NCT01225731|11034784|FG002|Part 1|Did not meet eligibility criteria|0
6980159|NCT01225731|11034785|FG003|Part 1|Did not meet eligibility criteria|0
6980160|NCT01225731|11034786|FG004|Part 1|Did not meet eligibility criteria|1
6980161|NCT01225731|11034787|FG005|Part 1|Did not meet eligibility criteria|0
6980162|NCT01225731|11034788|FG006|Part 1|Did not meet eligibility criteria|0
6980163|NCT01225731|11034789|FG007|Part 1|Did not meet eligibility criteria|0
6922152|NCT00809926|10950678|FG001|Overall Study|Patient withdrew consent|6
6922153|NCT00809926|10950677|FG000|Overall Study|Lost to Follow-up|2
6922154|NCT00809926|10950678|FG001|Overall Study|Lost to Follow-up|1
6922155|NCT00809926|10950677|FG000|Overall Study|Administrative Problems|0
6922156|NCT00809926|10950678|FG001|Overall Study|Administrative Problems|1
6922157|NCT00809926|10950677|FG000|Overall Study|Protocol deviation|0
6922158|NCT00809926|10950678|FG001|Overall Study|Protocol deviation|2
6922159|NCT00809965|10950687|FG000|Overall Study|Death|194
6922160|NCT00809965|10950688|FG001|Overall Study|Death|147
6922161|NCT00809965|10950689|FG002|Overall Study|Death|196
6980164|NCT01225731|11034790|FG008|Part 1|Did not meet eligibility criteria|0
6980165|NCT01225731|11034791|FG009|Part 1|Did not meet eligibility criteria|0
6980166|NCT01225731|11034792|FG010|Part 1|Did not meet eligibility criteria|0
6980167|NCT01225731|11034793|FG011|Part 1|Did not meet eligibility criteria|0
6980168|NCT01225731|11034794|FG012|Part 1|Did not meet eligibility criteria|0
6980169|NCT01225731|11034782|FG000|Part 1|Adverse Event|1
6980170|NCT01225731|11034783|FG001|Part 1|Adverse Event|2
6980171|NCT01225731|11034784|FG002|Part 1|Adverse Event|1
6980172|NCT01225731|11034785|FG003|Part 1|Adverse Event|1
6980173|NCT01225731|11034786|FG004|Part 1|Adverse Event|1
6980174|NCT01225731|11034787|FG005|Part 1|Adverse Event|0
6980175|NCT01225731|11034788|FG006|Part 1|Adverse Event|0
6980176|NCT01225731|11034789|FG007|Part 1|Adverse Event|0
6980177|NCT01225731|11034790|FG008|Part 1|Adverse Event|0
6980178|NCT01225731|11034791|FG009|Part 1|Adverse Event|0
6980179|NCT01225731|11034792|FG010|Part 1|Adverse Event|0
6980180|NCT01225731|11034793|FG011|Part 1|Adverse Event|0
6980181|NCT01225731|11034794|FG012|Part 1|Adverse Event|0
6980182|NCT01225731|11034782|FG000|Part 1|Withdrawal by Subject|0
6980183|NCT01225731|11034783|FG001|Part 1|Withdrawal by Subject|3
6980184|NCT01225731|11034784|FG002|Part 1|Withdrawal by Subject|0
6980185|NCT01225731|11034785|FG003|Part 1|Withdrawal by Subject|0
6980186|NCT01225731|11034786|FG004|Part 1|Withdrawal by Subject|4
6980187|NCT01225731|11034787|FG005|Part 1|Withdrawal by Subject|0
6980188|NCT01225731|11034788|FG006|Part 1|Withdrawal by Subject|0
6980189|NCT01225731|11034789|FG007|Part 1|Withdrawal by Subject|0
6980190|NCT01225731|11034790|FG008|Part 1|Withdrawal by Subject|0
6980191|NCT01225731|11034791|FG009|Part 1|Withdrawal by Subject|0
6980192|NCT01225731|11034792|FG010|Part 1|Withdrawal by Subject|0
6980193|NCT01225731|11034793|FG011|Part 1|Withdrawal by Subject|0
6980194|NCT01225731|11034794|FG012|Part 1|Withdrawal by Subject|0
6980195|NCT01225731|11034782|FG000|Part 1|Protocol Violation|0
6980196|NCT01225731|11034783|FG001|Part 1|Protocol Violation|0
6980197|NCT01225731|11034784|FG002|Part 1|Protocol Violation|0
6980198|NCT01225731|11034785|FG003|Part 1|Protocol Violation|1
6980199|NCT01225731|11034786|FG004|Part 1|Protocol Violation|0
6980200|NCT01225731|11034787|FG005|Part 1|Protocol Violation|0
6980201|NCT01225731|11034788|FG006|Part 1|Protocol Violation|0
6980202|NCT01225731|11034789|FG007|Part 1|Protocol Violation|0
6980203|NCT01225731|11034790|FG008|Part 1|Protocol Violation|0
6980204|NCT01225731|11034791|FG009|Part 1|Protocol Violation|0
6980205|NCT01225731|11034792|FG010|Part 1|Protocol Violation|0
6980206|NCT01225731|11034793|FG011|Part 1|Protocol Violation|0
6980207|NCT01225731|11034794|FG012|Part 1|Protocol Violation|0
6980208|NCT01225731|11034782|FG000|Part 2|Protocol Violation|0
6980209|NCT01225731|11034783|FG001|Part 2|Protocol Violation|0
6980210|NCT01225731|11034784|FG002|Part 2|Protocol Violation|0
6980211|NCT01225731|11034785|FG003|Part 2|Protocol Violation|0
6980212|NCT01225731|11034786|FG004|Part 2|Protocol Violation|0
6980213|NCT01225731|11034787|FG005|Part 2|Protocol Violation|1
6980214|NCT01225731|11034788|FG006|Part 2|Protocol Violation|0
6980215|NCT01225731|11034789|FG007|Part 2|Protocol Violation|0
6980216|NCT01225731|11034790|FG008|Part 2|Protocol Violation|1
6922162|NCT00809965|10950687|FG000|Overall Study|Lost to Follow-up|17
6980217|NCT01225731|11034791|FG009|Part 2|Protocol Violation|0
6980218|NCT01225731|11034792|FG010|Part 2|Protocol Violation|0
6980219|NCT01225731|11034793|FG011|Part 2|Protocol Violation|0
6980220|NCT01225731|11034794|FG012|Part 2|Protocol Violation|0
6980221|NCT01225731|11034782|FG000|Part 2|Adverse Event|0
6980222|NCT01225731|11034783|FG001|Part 2|Adverse Event|0
6980223|NCT01225731|11034784|FG002|Part 2|Adverse Event|0
6980224|NCT01225731|11034785|FG003|Part 2|Adverse Event|0
6980225|NCT01225731|11034786|FG004|Part 2|Adverse Event|0
6980226|NCT01225731|11034787|FG005|Part 2|Adverse Event|0
6980227|NCT01225731|11034788|FG006|Part 2|Adverse Event|4
6980228|NCT01225731|11034789|FG007|Part 2|Adverse Event|4
6980229|NCT01225731|11034790|FG008|Part 2|Adverse Event|2
6980230|NCT01225731|11034791|FG009|Part 2|Adverse Event|0
6980231|NCT01225731|11034792|FG010|Part 2|Adverse Event|0
6980232|NCT01225731|11034793|FG011|Part 2|Adverse Event|0
6980233|NCT01225731|11034794|FG012|Part 2|Adverse Event|0
6980234|NCT01225731|11034782|FG000|Part 2|Lack of Efficacy|0
6980235|NCT01225731|11034783|FG001|Part 2|Lack of Efficacy|0
6980236|NCT01225731|11034784|FG002|Part 2|Lack of Efficacy|0
6980237|NCT01225731|11034785|FG003|Part 2|Lack of Efficacy|0
6980238|NCT01225731|11034786|FG004|Part 2|Lack of Efficacy|0
6980239|NCT01225731|11034787|FG005|Part 2|Lack of Efficacy|1
6980240|NCT01225731|11034788|FG006|Part 2|Lack of Efficacy|0
6980241|NCT01225731|11034789|FG007|Part 2|Lack of Efficacy|12
6980242|NCT01225731|11034790|FG008|Part 2|Lack of Efficacy|3
6980243|NCT01225731|11034791|FG009|Part 2|Lack of Efficacy|0
6980244|NCT01225731|11034792|FG010|Part 2|Lack of Efficacy|0
6980245|NCT01225731|11034793|FG011|Part 2|Lack of Efficacy|0
6980246|NCT01225731|11034794|FG012|Part 2|Lack of Efficacy|0
6980247|NCT01225731|11034782|FG000|Part 2|Pregnancy|0
6980248|NCT01225731|11034783|FG001|Part 2|Pregnancy|0
6980249|NCT01225731|11034784|FG002|Part 2|Pregnancy|0
6980250|NCT01225731|11034785|FG003|Part 2|Pregnancy|0
6980251|NCT01225731|11034786|FG004|Part 2|Pregnancy|0
6980252|NCT01225731|11034787|FG005|Part 2|Pregnancy|0
6980253|NCT01225731|11034788|FG006|Part 2|Pregnancy|1
6980254|NCT01225731|11034789|FG007|Part 2|Pregnancy|0
6980255|NCT01225731|11034790|FG008|Part 2|Pregnancy|1
6980256|NCT01225731|11034791|FG009|Part 2|Pregnancy|0
6980257|NCT01225731|11034792|FG010|Part 2|Pregnancy|0
6980258|NCT01225731|11034793|FG011|Part 2|Pregnancy|0
6980259|NCT01225731|11034794|FG012|Part 2|Pregnancy|0
6980260|NCT01225731|11034782|FG000|Part 2|Lost to Follow-up|0
6980261|NCT01225731|11034783|FG001|Part 2|Lost to Follow-up|0
6980262|NCT01225731|11034784|FG002|Part 2|Lost to Follow-up|0
6980263|NCT01225731|11034785|FG003|Part 2|Lost to Follow-up|0
6980264|NCT01225731|11034786|FG004|Part 2|Lost to Follow-up|0
6980265|NCT01225731|11034787|FG005|Part 2|Lost to Follow-up|0
6980266|NCT01225731|11034788|FG006|Part 2|Lost to Follow-up|0
6980267|NCT01225731|11034789|FG007|Part 2|Lost to Follow-up|3
6980268|NCT01225731|11034790|FG008|Part 2|Lost to Follow-up|1
6980269|NCT01225731|11034791|FG009|Part 2|Lost to Follow-up|0
6980270|NCT01225731|11034792|FG010|Part 2|Lost to Follow-up|0
6980271|NCT01225731|11034793|FG011|Part 2|Lost to Follow-up|0
6980272|NCT01225731|11034794|FG012|Part 2|Lost to Follow-up|0
6980273|NCT01225731|11034782|FG000|Part 2|Physician Decision|0
6980274|NCT01225731|11034783|FG001|Part 2|Physician Decision|0
6980275|NCT01225731|11034784|FG002|Part 2|Physician Decision|0
6980276|NCT01225731|11034785|FG003|Part 2|Physician Decision|0
6980277|NCT01225731|11034786|FG004|Part 2|Physician Decision|0
6980278|NCT01225731|11034787|FG005|Part 2|Physician Decision|0
6980279|NCT01225731|11034788|FG006|Part 2|Physician Decision|0
6980280|NCT01225731|11034789|FG007|Part 2|Physician Decision|2
6980281|NCT01225731|11034790|FG008|Part 2|Physician Decision|2
6980282|NCT01225731|11034791|FG009|Part 2|Physician Decision|0
6980283|NCT01225731|11034792|FG010|Part 2|Physician Decision|0
6980284|NCT01225731|11034793|FG011|Part 2|Physician Decision|0
6980285|NCT01225731|11034794|FG012|Part 2|Physician Decision|0
6980286|NCT01225731|11034782|FG000|Part 2|Withdrawal by Subject|0
6980287|NCT01225731|11034783|FG001|Part 2|Withdrawal by Subject|0
6980288|NCT01225731|11034784|FG002|Part 2|Withdrawal by Subject|0
6980289|NCT01225731|11034785|FG003|Part 2|Withdrawal by Subject|0
6980290|NCT01225731|11034786|FG004|Part 2|Withdrawal by Subject|0
6980291|NCT01225731|11034787|FG005|Part 2|Withdrawal by Subject|1
6980292|NCT01225731|11034788|FG006|Part 2|Withdrawal by Subject|3
6980293|NCT01225731|11034789|FG007|Part 2|Withdrawal by Subject|4
6980294|NCT01225731|11034790|FG008|Part 2|Withdrawal by Subject|1
6980295|NCT01225731|11034791|FG009|Part 2|Withdrawal by Subject|0
6980296|NCT01225731|11034792|FG010|Part 2|Withdrawal by Subject|0
6980297|NCT01225731|11034793|FG011|Part 2|Withdrawal by Subject|0
6980298|NCT01225731|11034794|FG012|Part 2|Withdrawal by Subject|0
6980299|NCT01225731|11034782|FG000|Part 3|Adverse Event|0
6980300|NCT01225731|11034783|FG001|Part 3|Adverse Event|0
6980301|NCT01225731|11034784|FG002|Part 3|Adverse Event|0
6980302|NCT01225731|11034785|FG003|Part 3|Adverse Event|0
6980303|NCT01225731|11034786|FG004|Part 3|Adverse Event|0
6980304|NCT01225731|11034787|FG005|Part 3|Adverse Event|0
6980305|NCT01225731|11034788|FG006|Part 3|Adverse Event|0
6980306|NCT01225731|11034789|FG007|Part 3|Adverse Event|0
6980307|NCT01225731|11034790|FG008|Part 3|Adverse Event|0
6980308|NCT01225731|11034791|FG009|Part 3|Adverse Event|0
6980309|NCT01225731|11034792|FG010|Part 3|Adverse Event|1
6980310|NCT01225731|11034793|FG011|Part 3|Adverse Event|1
6980311|NCT01225731|11034794|FG012|Part 3|Adverse Event|0
6980312|NCT01225731|11034782|FG000|Part 3|Lost to Follow-up|0
6980313|NCT01225731|11034783|FG001|Part 3|Lost to Follow-up|0
6980314|NCT01225731|11034784|FG002|Part 3|Lost to Follow-up|0
6980315|NCT01225731|11034785|FG003|Part 3|Lost to Follow-up|0
6980316|NCT01225731|11034786|FG004|Part 3|Lost to Follow-up|0
6980317|NCT01225731|11034787|FG005|Part 3|Lost to Follow-up|0
6980318|NCT01225731|11034788|FG006|Part 3|Lost to Follow-up|0
6980319|NCT01225731|11034789|FG007|Part 3|Lost to Follow-up|0
6980320|NCT01225731|11034790|FG008|Part 3|Lost to Follow-up|0
6980321|NCT01225731|11034791|FG009|Part 3|Lost to Follow-up|0
6980322|NCT01225731|11034792|FG010|Part 3|Lost to Follow-up|1
6980323|NCT01225731|11034793|FG011|Part 3|Lost to Follow-up|2
6980324|NCT01225731|11034794|FG012|Part 3|Lost to Follow-up|1
6980325|NCT01225731|11034782|FG000|Part 3|Physician Decision|0
6980326|NCT01225731|11034783|FG001|Part 3|Physician Decision|0
6980327|NCT01225731|11034784|FG002|Part 3|Physician Decision|0
6980328|NCT01225731|11034785|FG003|Part 3|Physician Decision|0
6980329|NCT01225731|11034786|FG004|Part 3|Physician Decision|0
6980330|NCT01225731|11034787|FG005|Part 3|Physician Decision|0
6980331|NCT01225731|11034788|FG006|Part 3|Physician Decision|0
6980332|NCT01225731|11034789|FG007|Part 3|Physician Decision|0
6980333|NCT01225731|11034790|FG008|Part 3|Physician Decision|0
6980334|NCT01225731|11034791|FG009|Part 3|Physician Decision|0
6980335|NCT01225731|11034792|FG010|Part 3|Physician Decision|0
6980336|NCT01225731|11034793|FG011|Part 3|Physician Decision|1
6980337|NCT01225731|11034794|FG012|Part 3|Physician Decision|2
6980338|NCT01225731|11034782|FG000|Part 3|Withdrawal by Subject|0
6980339|NCT01225731|11034783|FG001|Part 3|Withdrawal by Subject|0
6980340|NCT01225731|11034784|FG002|Part 3|Withdrawal by Subject|0
6980341|NCT01225731|11034785|FG003|Part 3|Withdrawal by Subject|0
6980342|NCT01225731|11034786|FG004|Part 3|Withdrawal by Subject|0
6980343|NCT01225731|11034787|FG005|Part 3|Withdrawal by Subject|0
6980344|NCT01225731|11034788|FG006|Part 3|Withdrawal by Subject|0
6980345|NCT01225731|11034789|FG007|Part 3|Withdrawal by Subject|0
6980346|NCT01225731|11034790|FG008|Part 3|Withdrawal by Subject|0
6980347|NCT01225731|11034791|FG009|Part 3|Withdrawal by Subject|0
6980348|NCT01225731|11034792|FG010|Part 3|Withdrawal by Subject|4
6980349|NCT01225731|11034793|FG011|Part 3|Withdrawal by Subject|6
6980350|NCT01225731|11034794|FG012|Part 3|Withdrawal by Subject|4
6980351|NCT01225822|11034828|FG000|Overall Study|Adverse Event|13
6980352|NCT01225822|11034829|FG001|Overall Study|Adverse Event|31
6980353|NCT01225822|11034830|FG002|Overall Study|Adverse Event|18
6980354|NCT01225822|11034831|FG003|Overall Study|Adverse Event|23
6980355|NCT01225822|11034832|FG004|Overall Study|Adverse Event|14
6980356|NCT01225822|11034828|FG000|Overall Study|Protocol Violation|6
6980357|NCT01225822|11034829|FG001|Overall Study|Protocol Violation|8
6980358|NCT01225822|11034830|FG002|Overall Study|Protocol Violation|6
6980359|NCT01225822|11034831|FG003|Overall Study|Protocol Violation|7
6980360|NCT01225822|11034832|FG004|Overall Study|Protocol Violation|4
6980361|NCT01225822|11034828|FG000|Overall Study|Lost to Follow-up|0
6980362|NCT01225822|11034829|FG001|Overall Study|Lost to Follow-up|0
6980363|NCT01225822|11034830|FG002|Overall Study|Lost to Follow-up|0
6980364|NCT01225822|11034831|FG003|Overall Study|Lost to Follow-up|1
6980365|NCT01225822|11034832|FG004|Overall Study|Lost to Follow-up|0
6980366|NCT01225822|11034828|FG000|Overall Study|Withdrawal by Subject|6
6980367|NCT01225822|11034829|FG001|Overall Study|Withdrawal by Subject|7
6980368|NCT01225822|11034830|FG002|Overall Study|Withdrawal by Subject|7
6980369|NCT01225822|11034831|FG003|Overall Study|Withdrawal by Subject|11
6980370|NCT01225822|11034832|FG004|Overall Study|Withdrawal by Subject|6
6980371|NCT01225822|11034828|FG000|Overall Study|Other|13
6980372|NCT01225822|11034829|FG001|Overall Study|Other|10
6980373|NCT01225822|11034830|FG002|Overall Study|Other|7
6980374|NCT01225822|11034831|FG003|Overall Study|Other|10
6980375|NCT01225822|11034832|FG004|Overall Study|Other|7
6980376|NCT01225835|11034849|FG000|Overall Study|Completed protocol|2
6980377|NCT01225835|11034850|FG001|Overall Study|Completed protocol|1
6980378|NCT01225835|11034849|FG000|Overall Study|Did not meet hCG criterion|2
6980379|NCT01225835|11034850|FG001|Overall Study|Did not meet hCG criterion|0
6980380|NCT01225835|11034849|FG000|Overall Study|Adverse Event|2
6980381|NCT01225835|11034850|FG001|Overall Study|Adverse Event|1
6980382|NCT01225835|11034849|FG000|Overall Study|Other|1
6980383|NCT01225835|11034850|FG001|Overall Study|Other|1
6980384|NCT01225887|11034862|FG000|Overall Study|Ineligible:required test not done|2
6980385|NCT01225887|11034862|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1
6980386|NCT01225887|11034862|FG000|Overall Study|Ineligible:inadequate pathology|2
6980387|NCT01225952|11034878|FG000|Overall Study|Lost to Follow-up|1
6980388|NCT01225952|11034879|FG001|Overall Study|Lost to Follow-up|0
6980389|NCT01225952|11034880|FG002|Overall Study|Lost to Follow-up|0
6980390|NCT01225952|11034878|FG000|Overall Study|Study Eye Explanted|0
6980391|NCT01225952|11034879|FG001|Overall Study|Study Eye Explanted|0
6980392|NCT01225952|11034880|FG002|Overall Study|Study Eye Explanted|1
6980393|NCT01225952|11034878|FG000|Overall Study|Withdrawal by Subject|4
6980394|NCT01225952|11034879|FG001|Overall Study|Withdrawal by Subject|4
6980395|NCT01225952|11034880|FG002|Overall Study|Withdrawal by Subject|5
6980396|NCT01225952|11034878|FG000|Overall Study|Surgical complications|1
6980397|NCT01225952|11034879|FG001|Overall Study|Surgical complications|0
6980398|NCT01225952|11034880|FG002|Overall Study|Surgical complications|0
6980399|NCT01225991|11034888|FG000|Overall Study|Withdrawal by Subject|6
6980400|NCT01226043|11034894|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1
6980401|NCT01226043|11034895|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2
6980402|NCT01226043|11034896|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0
6980403|NCT01226043|11034897|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0
6980404|NCT01226043|11034894|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0
6980405|NCT01226043|11034895|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1
6980406|NCT01226043|11034896|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0
6980407|NCT01226043|11034897|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0
6980408|NCT01226043|11034894|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2
6980409|NCT01226043|11034895|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
6980410|NCT01226043|11034896|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
6980411|NCT01226043|11034897|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
6980412|NCT01226043|11034894|FG000|4-week Crossover Phase - Period 1|Physician Decision|0
6980413|NCT01226043|11034895|FG001|4-week Crossover Phase - Period 1|Physician Decision|6
6980414|NCT01226043|11034896|FG002|4-week Crossover Phase - Period 1|Physician Decision|0
6980415|NCT01226043|11034897|FG003|4-week Crossover Phase - Period 1|Physician Decision|0
6980416|NCT01226043|11034894|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
6980417|NCT01226043|11034895|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1
6980418|NCT01226043|11034896|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
6980419|NCT01226043|11034897|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
6980420|NCT01226043|11034894|FG000|4-week Crossover Phase - Period 2|Physician Decision|4
6980421|NCT01226043|11034895|FG001|4-week Crossover Phase - Period 2|Physician Decision|5
6980422|NCT01226043|11034896|FG002|4-week Crossover Phase - Period 2|Physician Decision|0
6980423|NCT01226043|11034897|FG003|4-week Crossover Phase - Period 2|Physician Decision|0
6980424|NCT01226043|11034894|FG000|6-week Re-randomization Phase|Adverse Event|0
6980425|NCT01226043|11034895|FG001|6-week Re-randomization Phase|Adverse Event|0
6980426|NCT01226043|11034896|FG002|6-week Re-randomization Phase|Adverse Event|1
6980427|NCT01226043|11034897|FG003|6-week Re-randomization Phase|Adverse Event|1
6980428|NCT01226043|11034894|FG000|6-week Re-randomization Phase|Protocol Violation|0
6980429|NCT01226043|11034895|FG001|6-week Re-randomization Phase|Protocol Violation|0
6980430|NCT01226043|11034896|FG002|6-week Re-randomization Phase|Protocol Violation|1
6980431|NCT01226043|11034897|FG003|6-week Re-randomization Phase|Protocol Violation|1
6980432|NCT01226043|11034894|FG000|6-week Re-randomization Phase|Lost to Follow-up|0
6980433|NCT01226043|11034895|FG001|6-week Re-randomization Phase|Lost to Follow-up|0
6980434|NCT01226043|11034896|FG002|6-week Re-randomization Phase|Lost to Follow-up|1
6980435|NCT01226043|11034897|FG003|6-week Re-randomization Phase|Lost to Follow-up|3
6980436|NCT01226043|11034894|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0
6980437|NCT01226043|11034895|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0
6980438|NCT01226043|11034896|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1
6980439|NCT01226043|11034897|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3
6980440|NCT01226043|11034894|FG000|6-week Re-randomization Phase|Physician Decision|0
6980441|NCT01226043|11034895|FG001|6-week Re-randomization Phase|Physician Decision|0
6980442|NCT01226043|11034896|FG002|6-week Re-randomization Phase|Physician Decision|3
6980443|NCT01226043|11034897|FG003|6-week Re-randomization Phase|Physician Decision|2
6980444|NCT01226043|11034894|FG000|6-week Re-randomization Phase|completed in error|0
6980445|NCT01226043|11034895|FG001|6-week Re-randomization Phase|completed in error|0
6980446|NCT01226043|11034896|FG002|6-week Re-randomization Phase|completed in error|0
6980447|NCT01226043|11034897|FG003|6-week Re-randomization Phase|completed in error|1
6980448|NCT01226043|11034894|FG000|30-week Observational Phase|Adverse Event|0
6980449|NCT01226043|11034895|FG001|30-week Observational Phase|Adverse Event|0
6980450|NCT01226043|11034896|FG002|30-week Observational Phase|Adverse Event|1
6980451|NCT01226043|11034897|FG003|30-week Observational Phase|Adverse Event|1
6980452|NCT01226043|11034894|FG000|30-week Observational Phase|Protocol Violation|0
6980453|NCT01226043|11034895|FG001|30-week Observational Phase|Protocol Violation|0
6980454|NCT01226043|11034896|FG002|30-week Observational Phase|Protocol Violation|0
6980455|NCT01226043|11034897|FG003|30-week Observational Phase|Protocol Violation|1
6980456|NCT01226043|11034894|FG000|30-week Observational Phase|Lost to Follow-up|0
6980457|NCT01226043|11034895|FG001|30-week Observational Phase|Lost to Follow-up|0
6980458|NCT01226043|11034896|FG002|30-week Observational Phase|Lost to Follow-up|2
6980459|NCT01226043|11034897|FG003|30-week Observational Phase|Lost to Follow-up|2
6980460|NCT01226043|11034894|FG000|30-week Observational Phase|Withdrawal by Subject|0
6980461|NCT01226043|11034895|FG001|30-week Observational Phase|Withdrawal by Subject|0
6980462|NCT01226043|11034896|FG002|30-week Observational Phase|Withdrawal by Subject|1
6980463|NCT01226043|11034897|FG003|30-week Observational Phase|Withdrawal by Subject|7
6980464|NCT01226043|11034894|FG000|30-week Observational Phase|Physician Decision|0
6980465|NCT01226043|11034895|FG001|30-week Observational Phase|Physician Decision|0
6980466|NCT01226043|11034896|FG002|30-week Observational Phase|Physician Decision|2
6980467|NCT01226043|11034897|FG003|30-week Observational Phase|Physician Decision|2
7041788|NCT01730053|11125629|FG002|Overall Study|Physician Decision|0
7041789|NCT01730053|11125630|FG003|Overall Study|Physician Decision|1
7041790|NCT01730053|11125631|FG004|Overall Study|Physician Decision|0
7041791|NCT01730053|11125632|FG005|Overall Study|Physician Decision|0
7041792|NCT01730053|11125627|FG000|Overall Study|Adverse Event|2
7041793|NCT01730053|11125628|FG001|Overall Study|Adverse Event|6
7041794|NCT01730053|11125629|FG002|Overall Study|Adverse Event|3
7041795|NCT01730053|11125630|FG003|Overall Study|Adverse Event|3
7041796|NCT01730053|11125631|FG004|Overall Study|Adverse Event|2
7041797|NCT01730053|11125632|FG005|Overall Study|Adverse Event|2
7041798|NCT01730053|11125627|FG000|Overall Study|Poor compliance to protocol|1
7041799|NCT01730053|11125628|FG001|Overall Study|Poor compliance to protocol|2
7041800|NCT01730053|11125629|FG002|Overall Study|Poor compliance to protocol|2
7041801|NCT01730053|11125630|FG003|Overall Study|Poor compliance to protocol|0
7041802|NCT01730053|11125631|FG004|Overall Study|Poor compliance to protocol|0
7041803|NCT01730053|11125632|FG005|Overall Study|Poor compliance to protocol|2
7041804|NCT01730053|11125627|FG000|Overall Study|Other than specified|2
7041805|NCT01730053|11125628|FG001|Overall Study|Other than specified|6
7041806|NCT01730053|11125629|FG002|Overall Study|Other than specified|5
6980468|NCT01226095|11034927|FG000|Overall Study|Poor compliance|1
6980469|NCT01226121|11034941|FG000|Overall Study|Lost to Follow-up|2
6980470|NCT01226121|11034942|FG001|Overall Study|Lost to Follow-up|0
6980471|NCT01226121|11034943|FG002|Overall Study|Lost to Follow-up|1
6980472|NCT01226459|11034957|FG000|Overall Study|Adverse Event|2
6980473|NCT01226459|11034958|FG001|Overall Study|Adverse Event|8
6980474|NCT01226459|11034957|FG000|Overall Study|Protocol Violation|4
6980475|NCT01226459|11034958|FG001|Overall Study|Protocol Violation|3
6980476|NCT01226459|11034957|FG000|Overall Study|Withdrawal by Subject|10
6980477|NCT01226459|11034958|FG001|Overall Study|Withdrawal by Subject|13
6980478|NCT01226459|11034957|FG000|Overall Study|Lost to Follow-up|4
6980479|NCT01226459|11034958|FG001|Overall Study|Lost to Follow-up|8
6980480|NCT01226459|11034957|FG000|Overall Study|Pregnancy|1
6980481|NCT01226459|11034958|FG001|Overall Study|Pregnancy|0
6980482|NCT01226472|11034964|FG000|Overall Study|Progressive Disease|1
6980483|NCT01226511|11035007|FG000|Acute Treatment Period|Adverse Event|7
6980484|NCT01226511|11035008|FG001|Acute Treatment Period|Adverse Event|6
6980485|NCT01226511|11035007|FG000|Acute Treatment Period|Lack of Efficacy|2
6980486|NCT01226511|11035008|FG001|Acute Treatment Period|Lack of Efficacy|1
6980487|NCT01226511|11035007|FG000|Acute Treatment Period|Lost to Follow-up|3
6980488|NCT01226511|11035008|FG001|Acute Treatment Period|Lost to Follow-up|6
6980489|NCT01226511|11035007|FG000|Acute Treatment Period|Parent/caregiver decision|5
6980490|NCT01226511|11035008|FG001|Acute Treatment Period|Parent/caregiver decision|7
6980491|NCT01226511|11035007|FG000|Acute Treatment Period|Protocol Violation|5
6980492|NCT01226511|11035008|FG001|Acute Treatment Period|Protocol Violation|5
6980493|NCT01226511|11035007|FG000|Acute Treatment Period|Withdrawal by Subject|10
6980494|NCT01226511|11035008|FG001|Acute Treatment Period|Withdrawal by Subject|6
6980495|NCT01226511|11035007|FG000|Extension Treatment Period|Adverse Event|8
6980496|NCT01226511|11035008|FG001|Extension Treatment Period|Adverse Event|8
6980497|NCT01226511|11035007|FG000|Extension Treatment Period|Lack of Efficacy|3
6980498|NCT01226511|11035008|FG001|Extension Treatment Period|Lack of Efficacy|2
6980499|NCT01226511|11035007|FG000|Extension Treatment Period|Lost to Follow-up|4
6980500|NCT01226511|11035008|FG001|Extension Treatment Period|Lost to Follow-up|3
6980501|NCT01226511|11035007|FG000|Extension Treatment Period|Protocol Violation|2
6980502|NCT01226511|11035008|FG001|Extension Treatment Period|Protocol Violation|2
6980503|NCT01226511|11035007|FG000|Extension Treatment Period|Withdrawal by Subject|1
6980504|NCT01226511|11035008|FG001|Extension Treatment Period|Withdrawal by Subject|3
6980505|NCT01226511|11035007|FG000|Extension Treatment Period|Parent/Caregiver Decision|8
6980506|NCT01226511|11035008|FG001|Extension Treatment Period|Parent/Caregiver Decision|8
6980507|NCT01226511|11035007|FG000|Extension Treatment Period|Sponsor Decision|1
6980508|NCT01226511|11035008|FG001|Extension Treatment Period|Sponsor Decision|1
6980509|NCT01226511|11035007|FG000|Taper Period|Adverse Event|1
6980510|NCT01226511|11035008|FG001|Taper Period|Adverse Event|0
6980511|NCT01226511|11035007|FG000|Taper Period|Lost to Follow-up|2
6980512|NCT01226511|11035008|FG001|Taper Period|Lost to Follow-up|2
6980513|NCT01226511|11035007|FG000|Taper Period|Protocol Violation|1
6980514|NCT01226511|11035008|FG001|Taper Period|Protocol Violation|0
6980515|NCT01226511|11035007|FG000|Taper Period|Parent/Caregiver Decision|1
6980516|NCT01226511|11035008|FG001|Taper Period|Parent/Caregiver Decision|1
6980517|NCT01226745|11035041|FG000|Overall Study|Did not complete schedule of assessments|8
6980518|NCT01226745|11035042|FG001|Overall Study|Did not complete schedule of assessments|3
6980519|NCT01226745|11035043|FG002|Overall Study|Did not complete schedule of assessments|6
6980520|NCT01226745|11035044|FG003|Overall Study|Did not complete schedule of assessments|0
6980521|NCT01226745|11035045|FG004|Overall Study|Did not complete schedule of assessments|0
6980522|NCT01226745|11035046|FG005|Overall Study|Did not complete schedule of assessments|1
6980523|NCT01226745|11035041|FG000|Overall Study|Lost to Follow-up|2
6980524|NCT01226745|11035042|FG001|Overall Study|Lost to Follow-up|6
6980525|NCT01226745|11035043|FG002|Overall Study|Lost to Follow-up|6
6980526|NCT01226745|11035044|FG003|Overall Study|Lost to Follow-up|1
6980527|NCT01226745|11035045|FG004|Overall Study|Lost to Follow-up|1
6980528|NCT01226745|11035046|FG005|Overall Study|Lost to Follow-up|2
6980529|NCT01226745|11035041|FG000|Overall Study|Death|1
6980530|NCT01226745|11035042|FG001|Overall Study|Death|0
6980531|NCT01226745|11035043|FG002|Overall Study|Death|0
6980532|NCT01226745|11035044|FG003|Overall Study|Death|0
6980533|NCT01226745|11035045|FG004|Overall Study|Death|0
6980534|NCT01226745|11035046|FG005|Overall Study|Death|1
6980535|NCT01226745|11035041|FG000|Overall Study|Other|6
6980536|NCT01226745|11035042|FG001|Overall Study|Other|7
6980537|NCT01226745|11035043|FG002|Overall Study|Other|8
6980538|NCT01226745|11035044|FG003|Overall Study|Other|4
6980539|NCT01226745|11035045|FG004|Overall Study|Other|3
6980540|NCT01226745|11035046|FG005|Overall Study|Other|1
6980541|NCT01227018|11035084|FG000|Overall Study|Disease progression|9
6980542|NCT01227018|11035084|FG000|Overall Study|Toxicity|2
6980543|NCT01227018|11035084|FG000|Overall Study|Withdrew after beginning treatment|4
6980544|NCT01227044|11035090|FG000|Overall Study|Lost to Follow-up|5
6980545|NCT01227044|11035091|FG001|Overall Study|Lost to Follow-up|7
6980546|NCT01227044|11035090|FG000|Overall Study|Discontinued Intervention|1
6980547|NCT01227044|11035091|FG001|Overall Study|Discontinued Intervention|2
6980548|NCT01227252|11035111|FG000|Overall Study|Sponsor Decision|0
6980549|NCT01227252|11035112|FG001|Overall Study|Sponsor Decision|1
6980550|NCT01227252|11035113|FG002|Overall Study|Sponsor Decision|0
6980551|NCT01227252|11035114|FG003|Overall Study|Sponsor Decision|0
6980552|NCT01227252|11035111|FG000|Overall Study|Lost to Follow-up|0
6980553|NCT01227252|11035112|FG001|Overall Study|Lost to Follow-up|1
6980554|NCT01227252|11035113|FG002|Overall Study|Lost to Follow-up|0
6980555|NCT01227252|11035114|FG003|Overall Study|Lost to Follow-up|0
6980556|NCT01227252|11035111|FG000|Overall Study|Withdrawal by Subject|0
6980557|NCT01227252|11035112|FG001|Overall Study|Withdrawal by Subject|1
6980558|NCT01227252|11035113|FG002|Overall Study|Withdrawal by Subject|0
6980559|NCT01227252|11035114|FG003|Overall Study|Withdrawal by Subject|0
6980560|NCT01227265|11035130|FG000|Overall Study|Did Not Receive Treatment|1
6980561|NCT01227265|11035131|FG001|Overall Study|Did Not Receive Treatment|2
6980562|NCT01227265|11035132|FG002|Overall Study|Did Not Receive Treatment|0
6980563|NCT01227265|11035130|FG000|Overall Study|Administrative|1
6980564|NCT01227265|11035131|FG001|Overall Study|Administrative|0
6980565|NCT01227265|11035132|FG002|Overall Study|Administrative|2
6980566|NCT01227265|11035130|FG000|Overall Study|Did Not Meet Protocol Eligibility|0
6980567|NCT01227265|11035131|FG001|Overall Study|Did Not Meet Protocol Eligibility|0
6980568|NCT01227265|11035132|FG002|Overall Study|Did Not Meet Protocol Eligibility|1
6980569|NCT01227265|11035130|FG000|Overall Study|Protocol Violation|2
6980570|NCT01227265|11035131|FG001|Overall Study|Protocol Violation|1
6980571|NCT01227265|11035132|FG002|Overall Study|Protocol Violation|0
6980572|NCT01227265|11035130|FG000|Overall Study|Withdrawal by Subject|7
6980573|NCT01227265|11035131|FG001|Overall Study|Withdrawal by Subject|7
6980574|NCT01227265|11035132|FG002|Overall Study|Withdrawal by Subject|3
6980575|NCT01227265|11035130|FG000|Overall Study|Lost to Follow-up|2
6980576|NCT01227265|11035131|FG001|Overall Study|Lost to Follow-up|0
6980577|NCT01227265|11035132|FG002|Overall Study|Lost to Follow-up|3
6980578|NCT01227265|11035130|FG000|Overall Study|Adverse Event|6
6980579|NCT01227265|11035131|FG001|Overall Study|Adverse Event|10
6980580|NCT01227265|11035132|FG002|Overall Study|Adverse Event|5
6980581|NCT01227278|11035142|FG000|Overall Study|Withdrawal by Subject|4
6980582|NCT01227278|11035143|FG001|Overall Study|Withdrawal by Subject|4
6980583|NCT01227278|11035142|FG000|Overall Study|Death|0
6980584|NCT01227278|11035143|FG001|Overall Study|Death|2
6980585|NCT01227278|11035142|FG000|Overall Study|Other|1
6980586|NCT01227278|11035143|FG001|Overall Study|Other|2
6980587|NCT01227395|11035157|FG000|Overall Study|Protocol Violation|0
6980588|NCT01227395|11035158|FG001|Overall Study|Protocol Violation|1
6980589|NCT01227421|11035186|FG000|Overall Study|Lost to Follow-up|6
6980590|NCT01227421|11035187|FG001|Overall Study|Lost to Follow-up|7
7143048|NCT03026166|11299430|FG000|Overall Study|Physician Decision|2
7143049|NCT03026166|11299431|FG001|Overall Study|Physician Decision|0
7143050|NCT03026166|11299430|FG000|Overall Study|Withdrawal by Subject|1
7143051|NCT03026166|11299431|FG001|Overall Study|Withdrawal by Subject|2
7143052|NCT03026166|11299430|FG000|Overall Study|Lost to Follow-up|1
7143053|NCT03026166|11299431|FG001|Overall Study|Lost to Follow-up|0
7143054|NCT03026166|11299430|FG000|Overall Study|Study Terminated by Sponsor|3
7143055|NCT03026166|11299431|FG001|Overall Study|Study Terminated by Sponsor|3
7143056|NCT03026166|11299430|FG000|Overall Study|Other|1
7143057|NCT03026166|11299431|FG001|Overall Study|Other|0
7143058|NCT03026257|11299443|FG000|Overall Study|Adverse Event|3
7143059|NCT03026257|11299444|FG001|Overall Study|Adverse Event|0
7143060|NCT03026257|11299445|FG002|Overall Study|Adverse Event|0
7143061|NCT03026257|11299446|FG003|Overall Study|Adverse Event|0
7143062|NCT03026257|11299447|FG004|Overall Study|Adverse Event|0
7143063|NCT03026257|11299448|FG005|Overall Study|Adverse Event|0
7143064|NCT03026257|11299443|FG000|Overall Study|Lost to Follow-up|1
7143065|NCT03026257|11299444|FG001|Overall Study|Lost to Follow-up|0
6980591|NCT01227421|11035188|FG002|Overall Study|Lost to Follow-up|5
6980592|NCT01227421|11035186|FG000|Overall Study|Adverse Event|2
6980593|NCT01227421|11035187|FG001|Overall Study|Adverse Event|7
6980594|NCT01227421|11035188|FG002|Overall Study|Adverse Event|2
6980595|NCT01227421|11035186|FG000|Overall Study|Withdrawal by Subject|1
6980596|NCT01227421|11035187|FG001|Overall Study|Withdrawal by Subject|2
6980597|NCT01227421|11035188|FG002|Overall Study|Withdrawal by Subject|1
6980598|NCT01227421|11035186|FG000|Overall Study|Protocol Violation|1
6980599|NCT01227421|11035187|FG001|Overall Study|Protocol Violation|1
6980600|NCT01227421|11035188|FG002|Overall Study|Protocol Violation|2
6980601|NCT01227421|11035186|FG000|Overall Study|Randomized in error|1
6980602|NCT01227421|11035187|FG001|Overall Study|Randomized in error|1
6980603|NCT01227421|11035188|FG002|Overall Study|Randomized in error|0
6980604|NCT01227512|11035208|FG000|Overall Study|Physician Decision|6
6980605|NCT01227512|11035209|FG001|Overall Study|Physician Decision|6
6980606|NCT01227512|11035208|FG000|Overall Study|Adverse Event|4
6980607|NCT01227512|11035209|FG001|Overall Study|Adverse Event|3
6980608|NCT01227512|11035208|FG000|Overall Study|Withdrawal by Subject|3
6980609|NCT01227512|11035209|FG001|Overall Study|Withdrawal by Subject|0
6980610|NCT01227512|11035208|FG000|Overall Study|Participant met withdrawal criteria|0
7143066|NCT03026257|11299445|FG002|Overall Study|Lost to Follow-up|0
7143067|NCT03026257|11299446|FG003|Overall Study|Lost to Follow-up|0
7143068|NCT03026257|11299447|FG004|Overall Study|Lost to Follow-up|0
7143069|NCT03026257|11299448|FG005|Overall Study|Lost to Follow-up|0
7143070|NCT03026257|11299443|FG000|Overall Study|Protocol Violation|1
7143071|NCT03026257|11299444|FG001|Overall Study|Protocol Violation|0
7143072|NCT03026257|11299445|FG002|Overall Study|Protocol Violation|0
6980611|NCT01227512|11035209|FG001|Overall Study|Participant met withdrawal criteria|1
6980612|NCT01227564|11035224|FG000|Overall Study|No Longer Willing to Participate|4
6980613|NCT01227564|11035225|FG001|Overall Study|No Longer Willing to Participate|2
6980614|NCT01227564|11035226|FG002|Overall Study|No Longer Willing to Participate|5
6980615|NCT01227564|11035224|FG000|Overall Study|Participant moved to another town|0
6980616|NCT01227564|11035225|FG001|Overall Study|Participant moved to another town|0
6980617|NCT01227564|11035226|FG002|Overall Study|Participant moved to another town|1
6980618|NCT01227577|11035236|FG000|Overall Study|Protocol deviation|3
6980619|NCT01227577|11035236|FG000|Overall Study|Death|3
6980620|NCT01227577|11035236|FG000|Overall Study|Administrative problems|2
6980621|NCT01227577|11035236|FG000|Overall Study|Lost to Follow-up|1
6980622|NCT01227577|11035236|FG000|Overall Study|Withdrawal by Subject|4
6980623|NCT01227577|11035236|FG000|Overall Study|Lack of Efficacy|5
6980624|NCT01227577|11035236|FG000|Overall Study|Adverse Event|17
6980625|NCT01227629|11035250|FG000|Overall Study|Adverse Event|2
6980626|NCT01227629|11035251|FG001|Overall Study|Adverse Event|2
6980627|NCT01227629|11035252|FG002|Overall Study|Adverse Event|1
6980628|NCT01227629|11035253|FG003|Overall Study|Adverse Event|6
6980629|NCT01227629|11035254|FG004|Overall Study|Adverse Event|1
6980630|NCT01227629|11035255|FG005|Overall Study|Adverse Event|1
6980631|NCT01227629|11035256|FG006|Overall Study|Adverse Event|6
6980632|NCT01227629|11035257|FG007|Overall Study|Adverse Event|6
6980633|NCT01227629|11035258|FG008|Overall Study|Adverse Event|4
6980634|NCT01227629|11035259|FG009|Overall Study|Adverse Event|0
6980635|NCT01227629|11035250|FG000|Overall Study|Protocol Violation|0
6980636|NCT01227629|11035251|FG001|Overall Study|Protocol Violation|0
6980637|NCT01227629|11035252|FG002|Overall Study|Protocol Violation|0
6980638|NCT01227629|11035253|FG003|Overall Study|Protocol Violation|1
6980639|NCT01227629|11035254|FG004|Overall Study|Protocol Violation|0
6980640|NCT01227629|11035255|FG005|Overall Study|Protocol Violation|0
6980641|NCT01227629|11035256|FG006|Overall Study|Protocol Violation|0
6980642|NCT01227629|11035257|FG007|Overall Study|Protocol Violation|0
6980643|NCT01227629|11035258|FG008|Overall Study|Protocol Violation|0
6980644|NCT01227629|11035259|FG009|Overall Study|Protocol Violation|0
6980645|NCT01227629|11035250|FG000|Overall Study|Lost to Follow-up|0
7143073|NCT03026257|11299446|FG003|Overall Study|Protocol Violation|1
7143074|NCT03026257|11299447|FG004|Overall Study|Protocol Violation|1
7143075|NCT03026257|11299448|FG005|Overall Study|Protocol Violation|0
6980646|NCT01227629|11035251|FG001|Overall Study|Lost to Follow-up|0
6980647|NCT01227629|11035252|FG002|Overall Study|Lost to Follow-up|0
6980648|NCT01227629|11035253|FG003|Overall Study|Lost to Follow-up|0
6980649|NCT01227629|11035254|FG004|Overall Study|Lost to Follow-up|1
6980650|NCT01227629|11035255|FG005|Overall Study|Lost to Follow-up|0
6980651|NCT01227629|11035256|FG006|Overall Study|Lost to Follow-up|0
7143076|NCT03026257|11299443|FG000|Overall Study|Withdrawal by Subject|1
7143077|NCT03026257|11299444|FG001|Overall Study|Withdrawal by Subject|1
7143078|NCT03026257|11299445|FG002|Overall Study|Withdrawal by Subject|0
7143079|NCT03026257|11299446|FG003|Overall Study|Withdrawal by Subject|0
7143080|NCT03026257|11299447|FG004|Overall Study|Withdrawal by Subject|0
7143081|NCT03026257|11299448|FG005|Overall Study|Withdrawal by Subject|0
7143082|NCT03026283|11299462|FG000|CCTA Diagnosis|CCTA not performed as planned|9
7143083|NCT03026283|11299463|FG001|CCTA Diagnosis|CCTA not performed as planned|0
7143084|NCT03026283|11299464|FG002|CCTA Diagnosis|CCTA not performed as planned|0
7143085|NCT03026283|11299465|FG003|CCTA Diagnosis|CCTA not performed as planned|0
7143086|NCT03026283|11299466|FG004|CCTA Diagnosis|CCTA not performed as planned|0
7143087|NCT03026283|11299467|FG005|CCTA Diagnosis|CCTA not performed as planned|0
7143088|NCT03026283|11299468|FG006|CCTA Diagnosis|CCTA not performed as planned|0
7143089|NCT03026283|11299469|FG007|CCTA Diagnosis|CCTA not performed as planned|0
7143090|NCT03026283|11299462|FG000|CCTA Diagnosis|Withdrawal by Subject|5
7143091|NCT03026283|11299463|FG001|CCTA Diagnosis|Withdrawal by Subject|0
7143092|NCT03026283|11299464|FG002|CCTA Diagnosis|Withdrawal by Subject|0
7143093|NCT03026283|11299465|FG003|CCTA Diagnosis|Withdrawal by Subject|0
7143094|NCT03026283|11299466|FG004|CCTA Diagnosis|Withdrawal by Subject|0
7143095|NCT03026283|11299467|FG005|CCTA Diagnosis|Withdrawal by Subject|0
7143096|NCT03026283|11299468|FG006|CCTA Diagnosis|Withdrawal by Subject|0
7143097|NCT03026283|11299469|FG007|CCTA Diagnosis|Withdrawal by Subject|0
7143098|NCT03026283|11299462|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
7143099|NCT03026283|11299463|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3
6980652|NCT01227629|11035257|FG007|Overall Study|Lost to Follow-up|0
6980653|NCT01227629|11035258|FG008|Overall Study|Lost to Follow-up|0
6980654|NCT01227629|11035259|FG009|Overall Study|Lost to Follow-up|0
6980655|NCT01227629|11035250|FG000|Overall Study|Withdrawal by Subject|0
6980656|NCT01227629|11035251|FG001|Overall Study|Withdrawal by Subject|0
6980657|NCT01227629|11035252|FG002|Overall Study|Withdrawal by Subject|0
6980658|NCT01227629|11035253|FG003|Overall Study|Withdrawal by Subject|0
6980659|NCT01227629|11035254|FG004|Overall Study|Withdrawal by Subject|0
6980660|NCT01227629|11035255|FG005|Overall Study|Withdrawal by Subject|0
6980661|NCT01227629|11035256|FG006|Overall Study|Withdrawal by Subject|2
6980662|NCT01227629|11035257|FG007|Overall Study|Withdrawal by Subject|0
6980663|NCT01227629|11035258|FG008|Overall Study|Withdrawal by Subject|0
6980664|NCT01227629|11035259|FG009|Overall Study|Withdrawal by Subject|1
6980665|NCT01227629|11035250|FG000|Overall Study|Other|0
6980666|NCT01227629|11035251|FG001|Overall Study|Other|0
6980667|NCT01227629|11035252|FG002|Overall Study|Other|0
6980668|NCT01227629|11035253|FG003|Overall Study|Other|1
6980669|NCT01227629|11035254|FG004|Overall Study|Other|0
6980670|NCT01227629|11035255|FG005|Overall Study|Other|0
6980671|NCT01227629|11035256|FG006|Overall Study|Other|0
6980672|NCT01227629|11035257|FG007|Overall Study|Other|0
6980673|NCT01227629|11035258|FG008|Overall Study|Other|2
6980674|NCT01227629|11035259|FG009|Overall Study|Other|1
6980675|NCT01227668|11035320|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12
6980676|NCT01227668|11035321|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0
6980677|NCT01227668|11035320|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7
6980678|NCT01227668|11035321|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0
6980679|NCT01227668|11035320|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8
6980680|NCT01227668|11035321|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0
6980681|NCT01227668|11035320|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11
6980682|NCT01227668|11035321|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0
6980683|NCT01227668|11035320|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7
6980684|NCT01227668|11035321|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0
6980685|NCT01227668|11035320|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25
6980686|NCT01227668|11035321|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0
6980687|NCT01227668|11035320|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2
6980688|NCT01227668|11035321|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0
6980689|NCT01227668|11035320|FG000|Phase 2 (Randomization Phase)|Adverse Event|0
6980690|NCT01227668|11035321|FG001|Phase 2 (Randomization Phase)|Adverse Event|1
6980691|NCT01227668|11035320|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5
6980692|NCT01227668|11035321|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0
6980693|NCT01227668|11035320|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1
6980694|NCT01227668|11035321|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0
6980695|NCT01227668|11035320|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13
6980696|NCT01227668|11035321|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23
6980697|NCT01227668|11035320|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0
6980698|NCT01227668|11035321|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1
6980699|NCT01227707|11035340|FG000|Overall Study|Adverse Event|10
6980700|NCT01227707|11035340|FG000|Overall Study|Progression of disease|3
6980701|NCT01227707|11035340|FG000|Overall Study|Withdrawal by Subject|1
6980702|NCT01227707|11035340|FG000|Overall Study|Patient non-compliance|3
6980703|NCT01227707|11035340|FG000|Overall Study|Medical decision|6
6980704|NCT01227707|11035340|FG000|Overall Study|Death|1
6980705|NCT01227824|11035357|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12
6980706|NCT01227824|11035358|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7
6980707|NCT01227824|11035359|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0
6980708|NCT01227824|11035357|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22
6980709|NCT01227824|11035358|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25
6980710|NCT01227824|11035359|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0
6980711|NCT01227824|11035357|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18
6980712|NCT01227824|11035358|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16
6980713|NCT01227824|11035359|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0
6980714|NCT01227824|11035357|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6
6980715|NCT01227824|11035358|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3
6980716|NCT01227824|11035359|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0
6980717|NCT01227824|11035357|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6
6980718|NCT01227824|11035358|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4
6980719|NCT01227824|11035359|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0
6980720|NCT01227824|11035357|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22
6980721|NCT01227824|11035358|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10
6980722|NCT01227824|11035359|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0
6980723|NCT01227824|11035357|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18
6980724|NCT01227824|11035358|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14
6980725|NCT01227824|11035359|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0
6980726|NCT01227824|11035357|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3
6980727|NCT01227824|11035358|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
6980728|NCT01227824|11035359|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
6980729|NCT01227824|11035357|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0
6980730|NCT01227824|11035358|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0
6980731|NCT01227824|11035359|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4
6980732|NCT01227824|11035357|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
6980733|NCT01227824|11035358|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
6980734|NCT01227824|11035359|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5
6980735|NCT01227824|11035357|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0
6980736|NCT01227824|11035358|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0
6980737|NCT01227824|11035359|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5
6980738|NCT01227824|11035357|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
6980739|NCT01227824|11035358|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
6980740|NCT01227824|11035359|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4
6980741|NCT01227824|11035357|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
6980742|NCT01227824|11035358|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
6980743|NCT01227824|11035359|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15
6980744|NCT01227824|11035357|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
6980745|NCT01227824|11035358|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
6980746|NCT01227824|11035359|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8
6980747|NCT01227824|11035357|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0
6980748|NCT01227824|11035358|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0
6980749|NCT01227824|11035359|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3
6980750|NCT01227889|11035368|FG000|Randomized Phase (RP)|Adverse Event|13
6980751|NCT01227889|11035369|FG001|Randomized Phase (RP)|Adverse Event|0
6980752|NCT01227889|11035368|FG000|Randomized Phase (RP)|Physician Decision|13
6980753|NCT01227889|11035369|FG001|Randomized Phase (RP)|Physician Decision|5
6980754|NCT01227889|11035368|FG000|Randomized Phase (RP)|Progressive Disease|135
6980755|NCT01227889|11035369|FG001|Randomized Phase (RP)|Progressive Disease|52
6980756|NCT01227889|11035368|FG000|Randomized Phase (RP)|Study terminated by sponsor|10
6980757|NCT01227889|11035369|FG001|Randomized Phase (RP)|Study terminated by sponsor|0
6980758|NCT01227889|11035368|FG000|Randomized Phase (RP)|Missing|1
6980759|NCT01227889|11035369|FG001|Randomized Phase (RP)|Missing|3
6980760|NCT01227889|11035368|FG000|Randomized Phase (RP)|Withdrawal by Subject|15
6980761|NCT01227889|11035369|FG001|Randomized Phase (RP)|Withdrawal by Subject|3
6980762|NCT01227889|11035368|FG000|Crossover Phase|Adverse Event|0
6980763|NCT01227889|11035369|FG001|Crossover Phase|Adverse Event|1
6980764|NCT01227889|11035368|FG000|Crossover Phase|Physician Decision|0
6980765|NCT01227889|11035369|FG001|Crossover Phase|Physician Decision|3
6980766|NCT01227889|11035368|FG000|Crossover Phase|Progressive Disease|0
6980767|NCT01227889|11035369|FG001|Crossover Phase|Progressive Disease|31
6980768|NCT01227889|11035368|FG000|Crossover Phase|Study Terminated By Sponsor|0
6980769|NCT01227889|11035369|FG001|Crossover Phase|Study Terminated By Sponsor|1
6980770|NCT01227889|11035368|FG000|Crossover Phase|Withdrawal by Subject|0
6980771|NCT01227889|11035369|FG001|Crossover Phase|Withdrawal by Subject|1
6980772|NCT01227902|11035387|FG000|Overall Study|Adverse Event|12
6980773|NCT01227902|11035388|FG001|Overall Study|Adverse Event|8
6980774|NCT01227902|11035389|FG002|Overall Study|Adverse Event|11
6980775|NCT01227902|11035390|FG003|Overall Study|Adverse Event|4
6980776|NCT01227902|11035387|FG000|Overall Study|Lack of Efficacy|1
6980777|NCT01227902|11035388|FG001|Overall Study|Lack of Efficacy|2
6980778|NCT01227902|11035389|FG002|Overall Study|Lack of Efficacy|2
6980779|NCT01227902|11035390|FG003|Overall Study|Lack of Efficacy|1
6980780|NCT01227902|11035387|FG000|Overall Study|Protocol Violation|1
6980781|NCT01227902|11035388|FG001|Overall Study|Protocol Violation|0
6980782|NCT01227902|11035389|FG002|Overall Study|Protocol Violation|0
6980783|NCT01227902|11035390|FG003|Overall Study|Protocol Violation|0
6980784|NCT01227902|11035387|FG000|Overall Study|Lost to Follow-up|0
6980785|NCT01227902|11035388|FG001|Overall Study|Lost to Follow-up|0
6980786|NCT01227902|11035389|FG002|Overall Study|Lost to Follow-up|1
6980787|NCT01227902|11035390|FG003|Overall Study|Lost to Follow-up|2
6980788|NCT01227902|11035387|FG000|Overall Study|Physician Decision|0
6980789|NCT01227902|11035388|FG001|Overall Study|Physician Decision|1
6980790|NCT01227902|11035389|FG002|Overall Study|Physician Decision|1
6980791|NCT01227902|11035390|FG003|Overall Study|Physician Decision|0
6980792|NCT01227902|11035387|FG000|Overall Study|Withdrawal by Subject|4
6980793|NCT01227902|11035388|FG001|Overall Study|Withdrawal by Subject|2
6980794|NCT01227902|11035389|FG002|Overall Study|Withdrawal by Subject|4
6980795|NCT01227902|11035390|FG003|Overall Study|Withdrawal by Subject|3
6980796|NCT01227928|11035403|FG000|Overall Study|Lost to Follow-up|4
6980797|NCT01227928|11035404|FG001|Overall Study|Lost to Follow-up|2
6980798|NCT01227928|11035403|FG000|Overall Study|Withdrawal by Subject|4
6980799|NCT01227928|11035404|FG001|Overall Study|Withdrawal by Subject|3
6980800|NCT01227928|11035403|FG000|Overall Study|Death|14
6980801|NCT01227928|11035404|FG001|Overall Study|Death|12
6980802|NCT01227954|11035410|FG000|Overall Study|Protocol Violation|6
6980803|NCT01227954|11035410|FG000|Overall Study|No protocol treatment|7
6980804|NCT01227967|11035416|FG000|Overall Study|Protocol Violation|3
6980805|NCT01227967|11035417|FG001|Overall Study|Protocol Violation|1
6980806|NCT01227967|11035416|FG000|Overall Study|Death|0
6980807|NCT01227967|11035417|FG001|Overall Study|Death|1
6980808|NCT01227967|11035416|FG000|Overall Study|Lost to Follow-up|8
6980809|NCT01227967|11035417|FG001|Overall Study|Lost to Follow-up|3
6980810|NCT01227967|11035416|FG000|Overall Study|Withdrawal by Subject|4
6980811|NCT01227967|11035417|FG001|Overall Study|Withdrawal by Subject|3
6980812|NCT01227967|11035416|FG000|Overall Study|Physician Decision|0
6980813|NCT01227967|11035417|FG001|Overall Study|Physician Decision|1
6980814|NCT01227967|11035416|FG000|Overall Study|Never Started Treatment|0
6980815|NCT01227967|11035417|FG001|Overall Study|Never Started Treatment|4
6980816|NCT01227967|11035416|FG000|Overall Study|Taking Additional Antiviral Drug|1
6980817|NCT01227967|11035417|FG001|Overall Study|Taking Additional Antiviral Drug|0
6980818|NCT01228019|11035436|FG000|Overall Study|Dose Violation|70
6980819|NCT01228019|11035436|FG000|Overall Study|Duplicate enrollment|1
6980820|NCT01228019|11035436|FG000|Overall Study|Missing pre-treatment data|72
6980821|NCT01228019|11035436|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152
6980822|NCT01228019|11035436|FG000|Overall Study|Violation of Entry Criterion|9
6980823|NCT01228071|11035440|FG000|Overall Study|Protocol Violation|1
6980824|NCT01228071|11035440|FG000|Overall Study|Withdrawal by Subject|1
6980825|NCT01228175|11035462|FG000|Overall Study|Lost to Follow-up|64
6980826|NCT01228175|11035463|FG001|Overall Study|Lost to Follow-up|50
6980827|NCT01228175|11035462|FG000|Overall Study|Withdrawal by Subject|1
6980828|NCT01228175|11035463|FG001|Overall Study|Withdrawal by Subject|2
6980829|NCT01228175|11035462|FG000|Overall Study|Physician Decision|1
6980830|NCT01228175|11035463|FG001|Overall Study|Physician Decision|1
6980831|NCT01228318|11035471|FG000|Overall Study|Clinic no show to receive intervention|1
6980832|NCT01228318|11035472|FG001|Overall Study|Clinic no show to receive intervention|0
6980833|NCT01228318|11035471|FG000|Overall Study|Unable to contact|2
6980834|NCT01228318|11035472|FG001|Overall Study|Unable to contact|5
6980835|NCT01228318|11035471|FG000|Overall Study|Moved|0
6980836|NCT01228318|11035472|FG001|Overall Study|Moved|2
6980837|NCT01228318|11035471|FG000|Overall Study|Incarcerated|1
6980838|NCT01228318|11035472|FG001|Overall Study|Incarcerated|0
6980839|NCT01228591|11035487|FG000|Baseline|Lack of Efficacy|1
6980840|NCT01228591|11035488|FG001|Baseline|Lack of Efficacy|2
6980841|NCT01228734|11035500|FG000|Overall Study|Randomized, but not treated|0
6980842|NCT01228734|11035501|FG001|Overall Study|Randomized, but not treated|4
6980843|NCT01228747|11035509|FG000|Overall Study|Adverse Event|8
6980844|NCT01228747|11035510|FG001|Overall Study|Adverse Event|4
6980845|NCT01228747|11035509|FG000|Overall Study|Lack of Efficacy|40
6980846|NCT01228747|11035510|FG001|Overall Study|Lack of Efficacy|27
6980847|NCT01228747|11035509|FG000|Overall Study|Protocol Violation|6
6980848|NCT01228747|11035510|FG001|Overall Study|Protocol Violation|5
6980849|NCT01228747|11035509|FG000|Overall Study|Lost to Follow-up|4
6980850|NCT01228747|11035510|FG001|Overall Study|Lost to Follow-up|3
6980851|NCT01228747|11035509|FG000|Overall Study|Withdrawal by Subject|5
6980852|NCT01228747|11035510|FG001|Overall Study|Withdrawal by Subject|1
6980853|NCT01228747|11035509|FG000|Overall Study|Other Reason|2
6980854|NCT01228747|11035510|FG001|Overall Study|Other Reason|5
6980855|NCT01229111|11035542|FG000|Overall Study|Death|1
6980856|NCT01229150|11035550|FG000|Overall Study|Toxicity|2
6980857|NCT01229150|11035551|FG001|Overall Study|Toxicity|2
6980858|NCT01229150|11035552|FG002|Overall Study|Toxicity|0
6980859|NCT01229150|11035553|FG003|Overall Study|Toxicity|0
6980860|NCT01229176|11035575|FG000|Overall Study|Withdrawal by Subject|0
6980861|NCT01229176|11035576|FG001|Overall Study|Withdrawal by Subject|0
6980862|NCT01229176|11035577|FG002|Overall Study|Withdrawal by Subject|0
6980863|NCT01229176|11035578|FG003|Overall Study|Withdrawal by Subject|1
6980864|NCT01229176|11035579|FG004|Overall Study|Withdrawal by Subject|1
6980865|NCT01229176|11035580|FG005|Overall Study|Withdrawal by Subject|1
6980866|NCT01229176|11035581|FG006|Overall Study|Withdrawal by Subject|0
6980867|NCT01229176|11035582|FG007|Overall Study|Withdrawal by Subject|1
6980868|NCT01229176|11035575|FG000|Overall Study|Lost to Follow-up|0
6980869|NCT01229176|11035576|FG001|Overall Study|Lost to Follow-up|3
6980870|NCT01229176|11035577|FG002|Overall Study|Lost to Follow-up|0
6980871|NCT01229176|11035578|FG003|Overall Study|Lost to Follow-up|0
6980872|NCT01229176|11035579|FG004|Overall Study|Lost to Follow-up|1
6980873|NCT01229176|11035580|FG005|Overall Study|Lost to Follow-up|1
6980874|NCT01229176|11035581|FG006|Overall Study|Lost to Follow-up|0
6980875|NCT01229176|11035582|FG007|Overall Study|Lost to Follow-up|2
6980876|NCT01229254|11035624|FG000|Overall Study|Not Continuing Into Safety Extension|3
6980877|NCT01229254|11035625|FG001|Overall Study|Not Continuing Into Safety Extension|1
6980878|NCT01229254|11035626|FG002|Overall Study|Not Continuing Into Safety Extension|1
6980879|NCT01229254|11035624|FG000|Overall Study|Adverse Event|4
6980880|NCT01229254|11035625|FG001|Overall Study|Adverse Event|5
6980881|NCT01229254|11035626|FG002|Overall Study|Adverse Event|3
6980882|NCT01229254|11035624|FG000|Overall Study|Lost to Follow-up|3
6980883|NCT01229254|11035625|FG001|Overall Study|Lost to Follow-up|0
6980884|NCT01229254|11035626|FG002|Overall Study|Lost to Follow-up|1
6980885|NCT01229254|11035624|FG000|Overall Study|Physician Decision|0
6980886|NCT01229254|11035625|FG001|Overall Study|Physician Decision|3
6980887|NCT01229254|11035626|FG002|Overall Study|Physician Decision|0
6980888|NCT01229254|11035624|FG000|Overall Study|Protocol Violation|4
6980889|NCT01229254|11035625|FG001|Overall Study|Protocol Violation|6
6980890|NCT01229254|11035626|FG002|Overall Study|Protocol Violation|5
6980891|NCT01229254|11035624|FG000|Overall Study|Withdrawal by Subject|1
6980892|NCT01229254|11035625|FG001|Overall Study|Withdrawal by Subject|0
6980893|NCT01229254|11035626|FG002|Overall Study|Withdrawal by Subject|1
6980894|NCT01229254|11035624|FG000|Overall Study|Non-compliance with Study Drug|0
6980895|NCT01229254|11035625|FG001|Overall Study|Non-compliance with Study Drug|1
6980896|NCT01229254|11035626|FG002|Overall Study|Non-compliance with Study Drug|1
6980897|NCT01229267|11035640|FG000|Overall Study|Adverse Event|4
6980898|NCT01229267|11035641|FG001|Overall Study|Adverse Event|6
6980899|NCT01229267|11035642|FG002|Overall Study|Adverse Event|3
6980900|NCT01229267|11035643|FG003|Overall Study|Adverse Event|2
6980901|NCT01229267|11035644|FG004|Overall Study|Adverse Event|10
6980902|NCT01229267|11035640|FG000|Overall Study|Death|40
6980903|NCT01229267|11035641|FG001|Overall Study|Death|37
6980904|NCT01229267|11035642|FG002|Overall Study|Death|35
6980905|NCT01229267|11035643|FG003|Overall Study|Death|13
6980906|NCT01229267|11035644|FG004|Overall Study|Death|103
6980907|NCT01229267|11035640|FG000|Overall Study|Withdrawal by Subject|23
6980908|NCT01229267|11035641|FG001|Overall Study|Withdrawal by Subject|22
6980909|NCT01229267|11035642|FG002|Overall Study|Withdrawal by Subject|32
6980910|NCT01229267|11035643|FG003|Overall Study|Withdrawal by Subject|14
6980911|NCT01229267|11035644|FG004|Overall Study|Withdrawal by Subject|59
6980912|NCT01229267|11035640|FG000|Overall Study|Protocol Violation|0
6980913|NCT01229267|11035641|FG001|Overall Study|Protocol Violation|1
6980914|NCT01229267|11035642|FG002|Overall Study|Protocol Violation|0
6980915|NCT01229267|11035643|FG003|Overall Study|Protocol Violation|0
6980916|NCT01229267|11035644|FG004|Overall Study|Protocol Violation|0
6980917|NCT01229267|11035640|FG000|Overall Study|Progressive disease|0
6980918|NCT01229267|11035641|FG001|Overall Study|Progressive disease|0
6980919|NCT01229267|11035642|FG002|Overall Study|Progressive disease|0
6980920|NCT01229267|11035643|FG003|Overall Study|Progressive disease|0
6980921|NCT01229267|11035644|FG004|Overall Study|Progressive disease|1
6980922|NCT01229267|11035640|FG000|Overall Study|Physician Decision|8
6980923|NCT01229267|11035641|FG001|Overall Study|Physician Decision|11
6980924|NCT01229267|11035642|FG002|Overall Study|Physician Decision|8
6980925|NCT01229267|11035643|FG003|Overall Study|Physician Decision|3
6980926|NCT01229267|11035644|FG004|Overall Study|Physician Decision|25
6980927|NCT01229267|11035640|FG000|Overall Study|Lost to Follow-up|6
6980928|NCT01229267|11035641|FG001|Overall Study|Lost to Follow-up|5
6980929|NCT01229267|11035642|FG002|Overall Study|Lost to Follow-up|8
6980930|NCT01229267|11035643|FG003|Overall Study|Lost to Follow-up|3
6980931|NCT01229267|11035644|FG004|Overall Study|Lost to Follow-up|22
6980932|NCT01229371|11035655|FG000|Overall Study|Withdrawal by Subject|0
6980933|NCT01229371|11035656|FG001|Overall Study|Withdrawal by Subject|1
6980934|NCT01229371|11035657|FG002|Overall Study|Withdrawal by Subject|0
6980935|NCT01229371|11035658|FG003|Overall Study|Withdrawal by Subject|0
6980936|NCT01229397|11035670|FG000|Overall Study|Withdrawal by Subject|3
6980937|NCT01229397|11035671|FG001|Overall Study|Withdrawal by Subject|3
6980938|NCT01229397|11035670|FG000|Overall Study|Lost to Follow-up|7
6980939|NCT01229397|11035671|FG001|Overall Study|Lost to Follow-up|6
6980940|NCT01229397|11035670|FG000|Overall Study|Migrated/moved from study area|1
6980941|NCT01229397|11035671|FG001|Overall Study|Migrated/moved from study area|0
6980942|NCT01229436|11035694|FG000|Overall Study|Withdrawal by Subject|2
6980943|NCT01229436|11035694|FG000|Overall Study|Lost to Follow-up|3
6980944|NCT01229449|11035703|FG000|Overall Study|Withdrawal by Subject|0
6980945|NCT01229449|11035704|FG001|Overall Study|Withdrawal by Subject|3
6980946|NCT01229449|11035705|FG002|Overall Study|Withdrawal by Subject|0
6980947|NCT01229449|11035706|FG003|Overall Study|Withdrawal by Subject|1
6980948|NCT01229449|11035707|FG004|Overall Study|Withdrawal by Subject|1
6980949|NCT01229449|11035703|FG000|Overall Study|Lost to Follow-up|1
6980950|NCT01229449|11035704|FG001|Overall Study|Lost to Follow-up|1
6980951|NCT01229449|11035705|FG002|Overall Study|Lost to Follow-up|1
6980952|NCT01229449|11035706|FG003|Overall Study|Lost to Follow-up|0
6980953|NCT01229449|11035707|FG004|Overall Study|Lost to Follow-up|0
6980954|NCT01229449|11035703|FG000|Overall Study|Physician Decision|0
6980955|NCT01229449|11035704|FG001|Overall Study|Physician Decision|0
6980956|NCT01229449|11035705|FG002|Overall Study|Physician Decision|1
6980957|NCT01229449|11035706|FG003|Overall Study|Physician Decision|0
6980958|NCT01229449|11035707|FG004|Overall Study|Physician Decision|0
6980959|NCT01229735|11035756|FG000|Overall Study|Lack of Efficacy|8
6980960|NCT01229735|11035757|FG001|Overall Study|Lack of Efficacy|8
6980961|NCT01229735|11035756|FG000|Overall Study|Protocol Violation|13
6980962|NCT01229735|11035757|FG001|Overall Study|Protocol Violation|8
6980963|NCT01229735|11035756|FG000|Overall Study|Lost to Follow-up|0
6980964|NCT01229735|11035757|FG001|Overall Study|Lost to Follow-up|2
6980965|NCT01229735|11035756|FG000|Overall Study|Withdrawal by Subject|18
6980966|NCT01229735|11035757|FG001|Overall Study|Withdrawal by Subject|17
6980967|NCT01229735|11035756|FG000|Overall Study|Other Reason|13
6980968|NCT01229735|11035757|FG001|Overall Study|Other Reason|10
6980969|NCT01229735|11035756|FG000|Overall Study|SAE, non-fatal|0
6980970|NCT01229735|11035757|FG001|Overall Study|SAE, non-fatal|4
6980971|NCT01229735|11035756|FG000|Overall Study|AE, non-serious non-fatal|13
6980972|NCT01229735|11035757|FG001|Overall Study|AE, non-serious non-fatal|17
6980973|NCT01229735|11035756|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
6980974|NCT01229735|11035757|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
6980975|NCT01230060|11035782|FG000|Overall Study|Withdrawal by Subject|1
6980976|NCT01230554|11035827|FG000|Overall Study|Lost to Follow-up|2
6980977|NCT01230554|11035827|FG000|Overall Study|Inability to maintain visit schedule|1
6980978|NCT01230710|11035844|FG000|Overall Study|Disease Progression|41
6980979|NCT01230710|11035844|FG000|Overall Study|Lost to Follow-up|3
6980980|NCT01230710|11035844|FG000|Overall Study|Death|4
6980981|NCT01230710|11035844|FG000|Overall Study|Withdrawal of Consent|1
6980982|NCT01230749|11035852|FG000|Overall Study|Adverse Event|0
6980983|NCT01230749|11035853|FG001|Overall Study|Adverse Event|0
6980984|NCT01230749|11035854|FG002|Overall Study|Adverse Event|0
6980985|NCT01230749|11035855|FG003|Overall Study|Adverse Event|1
6980986|NCT01230749|11035852|FG000|Overall Study|Physician Decision|0
6980987|NCT01230749|11035853|FG001|Overall Study|Physician Decision|0
6980988|NCT01230749|11035854|FG002|Overall Study|Physician Decision|1
6980989|NCT01230749|11035855|FG003|Overall Study|Physician Decision|0
6980990|NCT01230749|11035852|FG000|Overall Study|Withdrawal by Subject|0
6980991|NCT01230749|11035853|FG001|Overall Study|Withdrawal by Subject|1
6980992|NCT01230749|11035854|FG002|Overall Study|Withdrawal by Subject|0
6980993|NCT01230749|11035855|FG003|Overall Study|Withdrawal by Subject|0
6980994|NCT01230749|11035852|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0
6980995|NCT01230749|11035853|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1
6980996|NCT01230749|11035854|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1
6980997|NCT01230749|11035855|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1
6980998|NCT01230814|11035886|FG000|Overall Study|Lost to Follow-up|11
6980999|NCT01230814|11035887|FG001|Overall Study|Lost to Follow-up|3
6981000|NCT01230814|11035886|FG000|Overall Study|Discontinued (not due to adverse event)|2
6981001|NCT01230814|11035887|FG001|Overall Study|Discontinued (not due to adverse event)|1
6981002|NCT01230827|11035897|FG000|Overall Study|Lost to Follow-up|0
6981003|NCT01230827|11035898|FG001|Overall Study|Lost to Follow-up|0
6981004|NCT01230827|11035899|FG002|Overall Study|Lost to Follow-up|1
6981005|NCT01230827|11035900|FG003|Overall Study|Lost to Follow-up|3
6981006|NCT01230827|11035897|FG000|Overall Study|Withdrawal by Subject|1
6981007|NCT01230827|11035898|FG001|Overall Study|Withdrawal by Subject|0
6981008|NCT01230827|11035899|FG002|Overall Study|Withdrawal by Subject|3
6981009|NCT01230827|11035900|FG003|Overall Study|Withdrawal by Subject|2
6981010|NCT01230827|11035897|FG000|Overall Study|Lack of Efficacy|14
6981011|NCT01230827|11035898|FG001|Overall Study|Lack of Efficacy|1
6981012|NCT01230827|11035899|FG002|Overall Study|Lack of Efficacy|2
6981013|NCT01230827|11035900|FG003|Overall Study|Lack of Efficacy|3
6981014|NCT01230827|11035897|FG000|Overall Study|Adverse Event|4
6981015|NCT01230827|11035898|FG001|Overall Study|Adverse Event|2
6981016|NCT01230827|11035899|FG002|Overall Study|Adverse Event|3
6981017|NCT01230827|11035900|FG003|Overall Study|Adverse Event|7
6981018|NCT01230827|11035897|FG000|Overall Study|Recovery|0
6981019|NCT01230827|11035898|FG001|Overall Study|Recovery|6
6981020|NCT01230827|11035899|FG002|Overall Study|Recovery|0
6981021|NCT01230827|11035900|FG003|Overall Study|Recovery|0
6981022|NCT01230827|11035897|FG000|Overall Study|Study terminated by Sponsor|0
6981023|NCT01230827|11035898|FG001|Overall Study|Study terminated by Sponsor|2
6981024|NCT01230827|11035899|FG002|Overall Study|Study terminated by Sponsor|56
6981025|NCT01230827|11035900|FG003|Overall Study|Study terminated by Sponsor|63
6981026|NCT01230892|11035910|FG000|Overall Study|Withdrawal by Subject|1
6981027|NCT01230892|11035911|FG001|Overall Study|Withdrawal by Subject|1
6981028|NCT01230892|11035910|FG000|Overall Study|Lost to Follow-up|2
6981029|NCT01230892|11035911|FG001|Overall Study|Lost to Follow-up|0
6981030|NCT01231321|11035937|FG000|Overall Study|Adverse Event|3
6981031|NCT01231321|11035937|FG000|Overall Study|Lack of Efficacy|2
6981032|NCT01231373|11035960|FG000|Overall Study|Withdrew consent prior to randomization|2
6981033|NCT01231373|11035961|FG001|Overall Study|Withdrew consent prior to randomization|1
6981034|NCT01231373|11035962|FG002|Overall Study|Withdrew consent prior to randomization|0
6981035|NCT01231373|11035963|FG003|Overall Study|Withdrew consent prior to randomization|0
6981036|NCT01231373|11035960|FG000|Overall Study|Lost to Follow-up|0
6981037|NCT01231373|11035961|FG001|Overall Study|Lost to Follow-up|0
6981038|NCT01231373|11035962|FG002|Overall Study|Lost to Follow-up|0
6981039|NCT01231373|11035963|FG003|Overall Study|Lost to Follow-up|1
6981040|NCT01231373|11035960|FG000|Overall Study|Withdrew Consent|1
6981041|NCT01231373|11035961|FG001|Overall Study|Withdrew Consent|0
6981042|NCT01231373|11035962|FG002|Overall Study|Withdrew Consent|0
6981043|NCT01231373|11035963|FG003|Overall Study|Withdrew Consent|0
6981044|NCT01231464|11035995|FG000|Overall Study|Adverse Event|0
6981045|NCT01231464|11035996|FG001|Overall Study|Adverse Event|1
6981046|NCT01231464|11035995|FG000|Overall Study|Protocol Violation|1
6981047|NCT01231464|11035996|FG001|Overall Study|Protocol Violation|2
6981048|NCT01231464|11035995|FG000|Overall Study|Lost to Follow-up|1
6981049|NCT01231464|11035996|FG001|Overall Study|Lost to Follow-up|2
6981050|NCT01231464|11035995|FG000|Overall Study|Withdrawal by Subject|3
6981051|NCT01231464|11035996|FG001|Overall Study|Withdrawal by Subject|2
6981052|NCT01231503|11036012|FG000|Overall Study|Adverse Event|0
6981053|NCT01231503|11036013|FG001|Overall Study|Adverse Event|0
6981054|NCT01231503|11036014|FG002|Overall Study|Adverse Event|0
6981055|NCT01231503|11036015|FG003|Overall Study|Adverse Event|0
6981056|NCT01231503|11036016|FG004|Overall Study|Adverse Event|0
6981057|NCT01231503|11036017|FG005|Overall Study|Adverse Event|1
6981058|NCT01231503|11036018|FG006|Overall Study|Adverse Event|0
6981059|NCT01231503|11036019|FG007|Overall Study|Adverse Event|0
6981060|NCT01231503|11036012|FG000|Overall Study|Adverse event, serious fatal|0
6981061|NCT01231503|11036013|FG001|Overall Study|Adverse event, serious fatal|0
6981062|NCT01231503|11036014|FG002|Overall Study|Adverse event, serious fatal|1
6981063|NCT01231503|11036015|FG003|Overall Study|Adverse event, serious fatal|1
6981064|NCT01231503|11036016|FG004|Overall Study|Adverse event, serious fatal|0
6981065|NCT01231503|11036017|FG005|Overall Study|Adverse event, serious fatal|1
6981066|NCT01231503|11036018|FG006|Overall Study|Adverse event, serious fatal|0
6981067|NCT01231503|11036019|FG007|Overall Study|Adverse event, serious fatal|0
6981068|NCT01231503|11036012|FG000|Overall Study|Withdrawal by Subject|6
6981069|NCT01231503|11036013|FG001|Overall Study|Withdrawal by Subject|3
6981070|NCT01231503|11036014|FG002|Overall Study|Withdrawal by Subject|3
6981071|NCT01231503|11036015|FG003|Overall Study|Withdrawal by Subject|1
6981072|NCT01231503|11036016|FG004|Overall Study|Withdrawal by Subject|3
6981073|NCT01231503|11036017|FG005|Overall Study|Withdrawal by Subject|5
6981074|NCT01231503|11036018|FG006|Overall Study|Withdrawal by Subject|1
6981075|NCT01231503|11036019|FG007|Overall Study|Withdrawal by Subject|2
6981076|NCT01231503|11036012|FG000|Overall Study|Lost to Follow-up|8
6981077|NCT01231503|11036013|FG001|Overall Study|Lost to Follow-up|10
6981078|NCT01231503|11036014|FG002|Overall Study|Lost to Follow-up|8
6981079|NCT01231503|11036015|FG003|Overall Study|Lost to Follow-up|5
6981080|NCT01231503|11036016|FG004|Overall Study|Lost to Follow-up|7
6981081|NCT01231503|11036017|FG005|Overall Study|Lost to Follow-up|9
6981082|NCT01231503|11036018|FG006|Overall Study|Lost to Follow-up|6
6981083|NCT01231503|11036019|FG007|Overall Study|Lost to Follow-up|6
6981084|NCT01231503|11036012|FG000|Overall Study|Protocol Violation|0
6981085|NCT01231503|11036013|FG001|Overall Study|Protocol Violation|0
6981086|NCT01231503|11036014|FG002|Overall Study|Protocol Violation|0
6981087|NCT01231503|11036015|FG003|Overall Study|Protocol Violation|1
6981088|NCT01231503|11036016|FG004|Overall Study|Protocol Violation|0
6981089|NCT01231503|11036017|FG005|Overall Study|Protocol Violation|0
6981090|NCT01231503|11036018|FG006|Overall Study|Protocol Violation|0
6981091|NCT01231503|11036019|FG007|Overall Study|Protocol Violation|0
6981092|NCT01231555|11036050|FG000|Overall Study|Study terminated|8
6981093|NCT01231555|11036051|FG001|Overall Study|Study terminated|5
6981094|NCT01231555|11036052|FG002|Overall Study|Study terminated|8
6981095|NCT01231555|11036050|FG000|Overall Study|Withdrawal by Subject|0
6981096|NCT01231555|11036051|FG001|Overall Study|Withdrawal by Subject|2
6981097|NCT01231555|11036052|FG002|Overall Study|Withdrawal by Subject|0
6981098|NCT01231581|11036062|FG000|Overall Study|Lost to Follow-up|2
6981099|NCT01231581|11036063|FG001|Overall Study|Lost to Follow-up|2
6981100|NCT01231581|11036062|FG000|Overall Study|Withdrawal by Subject|6
6981101|NCT01231581|11036063|FG001|Overall Study|Withdrawal by Subject|9
6981102|NCT01231581|11036062|FG000|Overall Study|Study Closed/Terminated|6
6981103|NCT01231581|11036063|FG001|Overall Study|Study Closed/Terminated|5
6981104|NCT01231581|11036062|FG000|Overall Study|Death|65
6981105|NCT01231581|11036063|FG001|Overall Study|Death|64
6981106|NCT01231581|11036062|FG000|Overall Study|Ongoing|1
6981107|NCT01231581|11036063|FG001|Overall Study|Ongoing|0
6981108|NCT01231607|11036074|FG000|Overall Study|Adverse Event|0
6981109|NCT01231607|11036075|FG001|Overall Study|Adverse Event|8
6981110|NCT01231607|11036076|FG002|Overall Study|Adverse Event|4
6981111|NCT01231607|11036077|FG003|Overall Study|Adverse Event|4
6981112|NCT01231607|11036078|FG004|Overall Study|Adverse Event|5
6981113|NCT01231607|11036074|FG000|Overall Study|Lost to Follow-up|13
6981114|NCT01231607|11036075|FG001|Overall Study|Lost to Follow-up|11
6981115|NCT01231607|11036076|FG002|Overall Study|Lost to Follow-up|10
6981116|NCT01231607|11036077|FG003|Overall Study|Lost to Follow-up|10
6981117|NCT01231607|11036078|FG004|Overall Study|Lost to Follow-up|4
6981118|NCT01231607|11036074|FG000|Overall Study|Physician Decision|4
6981119|NCT01231607|11036075|FG001|Overall Study|Physician Decision|4
6981120|NCT01231607|11036076|FG002|Overall Study|Physician Decision|3
6981121|NCT01231607|11036077|FG003|Overall Study|Physician Decision|5
6981122|NCT01231607|11036078|FG004|Overall Study|Physician Decision|4
6981123|NCT01231607|11036074|FG000|Overall Study|Protocol Violation|3
6981124|NCT01231607|11036075|FG001|Overall Study|Protocol Violation|2
6981125|NCT01231607|11036076|FG002|Overall Study|Protocol Violation|0
6981126|NCT01231607|11036077|FG003|Overall Study|Protocol Violation|2
6981127|NCT01231607|11036078|FG004|Overall Study|Protocol Violation|2
6981128|NCT01231607|11036074|FG000|Overall Study|Withdrawal by Subject|9
6981129|NCT01231607|11036075|FG001|Overall Study|Withdrawal by Subject|9
6981130|NCT01231607|11036076|FG002|Overall Study|Withdrawal by Subject|14
6981131|NCT01231607|11036077|FG003|Overall Study|Withdrawal by Subject|17
6981132|NCT01231607|11036078|FG004|Overall Study|Withdrawal by Subject|9
6981133|NCT01231620|11036096|FG000|Overall Study|Physician Decision|3
6981134|NCT01231620|11036097|FG001|Overall Study|Physician Decision|5
6981135|NCT01231620|11036098|FG002|Overall Study|Physician Decision|10
6981136|NCT01231620|11036096|FG000|Overall Study|Death|12
6981137|NCT01231620|11036097|FG001|Overall Study|Death|14
6981138|NCT01231620|11036098|FG002|Overall Study|Death|11
6981139|NCT01231620|11036096|FG000|Overall Study|Adverse Event|2
6981140|NCT01231620|11036097|FG001|Overall Study|Adverse Event|2
6981141|NCT01231620|11036098|FG002|Overall Study|Adverse Event|1
6981142|NCT01231620|11036096|FG000|Overall Study|Withdrawal by Subject|6
6981143|NCT01231620|11036097|FG001|Overall Study|Withdrawal by Subject|6
6981144|NCT01231620|11036098|FG002|Overall Study|Withdrawal by Subject|8
6981145|NCT01231620|11036096|FG000|Overall Study|Lost to Follow-up|3
6981146|NCT01231620|11036097|FG001|Overall Study|Lost to Follow-up|4
6981147|NCT01231620|11036098|FG002|Overall Study|Lost to Follow-up|9
7041807|NCT01730053|11125630|FG003|Overall Study|Other than specified|4
7041808|NCT01730053|11125631|FG004|Overall Study|Other than specified|7
7041809|NCT01730053|11125632|FG005|Overall Study|Other than specified|9
7041810|NCT01730339|11125649|FG000|Overall Study|Withdrawal by Subject|3
7041811|NCT01730339|11125650|FG001|Overall Study|Withdrawal by Subject|2
7041812|NCT01730339|11125649|FG000|Overall Study|Lost to Follow-up|1
6981148|NCT01231659|11036126|FG000|Overall Study|Adverse Event|9
6981149|NCT01231659|11036126|FG000|Overall Study|Disease Progression|48
6981150|NCT01231659|11036126|FG000|Overall Study|Death|2
6981151|NCT01231659|11036126|FG000|Overall Study|Patient refused to complete study visit|1
6981152|NCT01231659|11036126|FG000|Overall Study|Other protocol defined criteria|12
6981153|NCT01231984|11036136|FG000|Study Period 1|Withdrawal by Subject|0
6981154|NCT01231984|11036137|FG001|Study Period 1|Withdrawal by Subject|0
6981155|NCT01231984|11036138|FG002|Study Period 1|Withdrawal by Subject|0
6981156|NCT01231984|11036139|FG003|Study Period 1|Withdrawal by Subject|1
6981157|NCT01231984|11036136|FG000|Study Period 1|Lost to Follow-up|1
6981158|NCT01231984|11036137|FG001|Study Period 1|Lost to Follow-up|1
6981159|NCT01231984|11036138|FG002|Study Period 1|Lost to Follow-up|1
6981160|NCT01231984|11036139|FG003|Study Period 1|Lost to Follow-up|0
6981161|NCT01231984|11036136|FG000|Study Period 1|Did not continue to meet I/E Criteria|2
6981162|NCT01231984|11036137|FG001|Study Period 1|Did not continue to meet I/E Criteria|2
6981163|NCT01231984|11036138|FG002|Study Period 1|Did not continue to meet I/E Criteria|2
6981164|NCT01231984|11036139|FG003|Study Period 1|Did not continue to meet I/E Criteria|2
6981165|NCT01231984|11036136|FG000|Study Period 1|Screen Failure|0
6981166|NCT01231984|11036137|FG001|Study Period 1|Screen Failure|0
6981167|NCT01231984|11036138|FG002|Study Period 1|Screen Failure|0
6981168|NCT01231984|11036139|FG003|Study Period 1|Screen Failure|1
6981169|NCT01231984|11036136|FG000|Study Period 1|Non-compliance with study requirements|5
6981170|NCT01231984|11036137|FG001|Study Period 1|Non-compliance with study requirements|0
6981171|NCT01231984|11036138|FG002|Study Period 1|Non-compliance with study requirements|2
6981172|NCT01231984|11036139|FG003|Study Period 1|Non-compliance with study requirements|1
6981173|NCT01231984|11036136|FG000|Study Period 1|Protocol Violation|3
6981174|NCT01231984|11036137|FG001|Study Period 1|Protocol Violation|4
6981175|NCT01231984|11036138|FG002|Study Period 1|Protocol Violation|2
6981176|NCT01231984|11036139|FG003|Study Period 1|Protocol Violation|3
6981177|NCT01231984|11036136|FG000|Study Period 1|Adverse Event|1
6981178|NCT01231984|11036137|FG001|Study Period 1|Adverse Event|0
6981179|NCT01231984|11036138|FG002|Study Period 1|Adverse Event|0
6981180|NCT01231984|11036139|FG003|Study Period 1|Adverse Event|0
6981181|NCT01231984|11036136|FG000|Study Period 1|Other|0
6981182|NCT01231984|11036137|FG001|Study Period 1|Other|0
6981183|NCT01231984|11036138|FG002|Study Period 1|Other|0
6981184|NCT01231984|11036139|FG003|Study Period 1|Other|1
6981185|NCT01231984|11036136|FG000|Study Period 2|Withdrawal by Subject|1
6981186|NCT01231984|11036137|FG001|Study Period 2|Withdrawal by Subject|1
6981187|NCT01231984|11036138|FG002|Study Period 2|Withdrawal by Subject|0
6981188|NCT01231984|11036139|FG003|Study Period 2|Withdrawal by Subject|0
6981189|NCT01231984|11036136|FG000|Study Period 2|Lost to Follow-up|1
6981190|NCT01231984|11036137|FG001|Study Period 2|Lost to Follow-up|0
6981191|NCT01231984|11036138|FG002|Study Period 2|Lost to Follow-up|0
6981192|NCT01231984|11036139|FG003|Study Period 2|Lost to Follow-up|3
6981193|NCT01231984|11036136|FG000|Study Period 2|Did not continue to meet I/E Criteria|1
6981194|NCT01231984|11036137|FG001|Study Period 2|Did not continue to meet I/E Criteria|1
6981195|NCT01231984|11036138|FG002|Study Period 2|Did not continue to meet I/E Criteria|0
6981196|NCT01231984|11036139|FG003|Study Period 2|Did not continue to meet I/E Criteria|1
6981197|NCT01232127|11036157|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1
6981198|NCT01232127|11036158|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0
6981199|NCT01232127|11036159|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0
6981200|NCT01232296|11036182|FG000|Overall Study|Adverse Event|24
6981201|NCT01232296|11036183|FG001|Overall Study|Adverse Event|12
6981202|NCT01232296|11036182|FG000|Overall Study|Physician Decision|1
6981203|NCT01232296|11036183|FG001|Overall Study|Physician Decision|1
6981204|NCT01232296|11036182|FG000|Overall Study|Progressive disease|43
6981205|NCT01232296|11036183|FG001|Overall Study|Progressive disease|61
6981206|NCT01232296|11036182|FG000|Overall Study|Study terminated by sponsor|0
6981207|NCT01232296|11036183|FG001|Overall Study|Study terminated by sponsor|1
6981208|NCT01232296|11036182|FG000|Overall Study|Technical problems|3
6981209|NCT01232296|11036183|FG001|Overall Study|Technical problems|0
6981210|NCT01232296|11036182|FG000|Overall Study|Subject/guardian decision|10
6981211|NCT01232296|11036183|FG001|Overall Study|Subject/guardian decision|2
6981212|NCT01232296|11036182|FG000|Overall Study|Death|1
6981213|NCT01232296|11036183|FG001|Overall Study|Death|6
6981214|NCT01232452|11036191|FG000|Overall Study|Adverse Event|17
6981215|NCT01232452|11036192|FG001|Overall Study|Adverse Event|15
6981216|NCT01232452|11036191|FG000|Overall Study|Withdrawal by Subject|11
6981217|NCT01232452|11036192|FG001|Overall Study|Withdrawal by Subject|8
6981218|NCT01232452|11036191|FG000|Overall Study|Physician Decision|8
6981219|NCT01232452|11036192|FG001|Overall Study|Physician Decision|12
6981220|NCT01232452|11036191|FG000|Overall Study|Protocol entry criterion not met|0
6981221|NCT01232452|11036192|FG001|Overall Study|Protocol entry criterion not met|2
6981222|NCT01232452|11036191|FG000|Overall Study|Sponsor Decision|3
6981223|NCT01232452|11036192|FG001|Overall Study|Sponsor Decision|1
6981224|NCT01232452|11036191|FG000|Overall Study|Protocol Violation|0
6981225|NCT01232452|11036192|FG001|Overall Study|Protocol Violation|1
6981226|NCT01232491|11036209|FG000|Overall Study|Adverse Event|13
6981227|NCT01232491|11036210|FG001|Overall Study|Adverse Event|8
6981228|NCT01232491|11036209|FG000|Overall Study|Lack of Efficacy|1
6981229|NCT01232491|11036210|FG001|Overall Study|Lack of Efficacy|5
6981230|NCT01232491|11036209|FG000|Overall Study|Protocol Violation|13
6981231|NCT01232491|11036210|FG001|Overall Study|Protocol Violation|11
6981232|NCT01232491|11036209|FG000|Overall Study|Withdrawal Criteria|12
6981233|NCT01232491|11036210|FG001|Overall Study|Withdrawal Criteria|21
6981234|NCT01232491|11036209|FG000|Overall Study|Other|21
6981235|NCT01232491|11036210|FG001|Overall Study|Other|18
6981236|NCT01232556|11036239|FG000|Overall Study|Withdrawal by Subject|21
6981237|NCT01232556|11036240|FG001|Overall Study|Withdrawal by Subject|17
6981238|NCT01232556|11036239|FG000|Overall Study|Death|97
6981239|NCT01232556|11036240|FG001|Overall Study|Death|97
6981240|NCT01232556|11036239|FG000|Overall Study|Lost to Follow-up|0
6981241|NCT01232556|11036240|FG001|Overall Study|Lost to Follow-up|2
6981242|NCT01232556|11036239|FG000|Overall Study|Terminated by Sponsor|35
6981243|NCT01232556|11036240|FG001|Overall Study|Terminated by Sponsor|51
6981244|NCT01232556|11036239|FG000|Overall Study|Other|6
6981245|NCT01232556|11036240|FG001|Overall Study|Other|4
6981246|NCT01232569|11036248|FG000|Double-blind Treatment Period|Withdrawal by Subject|9
6981247|NCT01232569|11036249|FG001|Double-blind Treatment Period|Withdrawal by Subject|2
6981248|NCT01232569|11036250|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
6981249|NCT01232569|11036251|FG003|Double-blind Treatment Period|Withdrawal by Subject|0
6981250|NCT01232569|11036248|FG000|Double-blind Treatment Period|Escape|2
6981251|NCT01232569|11036249|FG001|Double-blind Treatment Period|Escape|2
6981252|NCT01232569|11036250|FG002|Double-blind Treatment Period|Escape|0
6981253|NCT01232569|11036251|FG003|Double-blind Treatment Period|Escape|0
6981254|NCT01232569|11036248|FG000|Double-blind Treatment Period|Lost to Follow-up|4
6981255|NCT01232569|11036249|FG001|Double-blind Treatment Period|Lost to Follow-up|0
6981256|NCT01232569|11036250|FG002|Double-blind Treatment Period|Lost to Follow-up|0
6981257|NCT01232569|11036251|FG003|Double-blind Treatment Period|Lost to Follow-up|0
6981258|NCT01232569|11036248|FG000|Double-blind Treatment Period|Lack of Efficacy|1
6981259|NCT01232569|11036249|FG001|Double-blind Treatment Period|Lack of Efficacy|2
6981260|NCT01232569|11036250|FG002|Double-blind Treatment Period|Lack of Efficacy|0
6981261|NCT01232569|11036251|FG003|Double-blind Treatment Period|Lack of Efficacy|0
6981262|NCT01232569|11036248|FG000|Double-blind Treatment Period|Physician Decision|1
6981263|NCT01232569|11036249|FG001|Double-blind Treatment Period|Physician Decision|0
6981264|NCT01232569|11036250|FG002|Double-blind Treatment Period|Physician Decision|0
6981265|NCT01232569|11036251|FG003|Double-blind Treatment Period|Physician Decision|0
6981266|NCT01232569|11036248|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9
6981267|NCT01232569|11036249|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3
6981268|NCT01232569|11036250|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
6981269|NCT01232569|11036251|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
6981270|NCT01232569|11036248|FG000|Double-blind Treatment Period|Death|2
6981271|NCT01232569|11036249|FG001|Double-blind Treatment Period|Death|0
6981272|NCT01232569|11036250|FG002|Double-blind Treatment Period|Death|0
6981273|NCT01232569|11036251|FG003|Double-blind Treatment Period|Death|0
6981274|NCT01232738|11036260|FG000|Overall Study|Death|3
6981275|NCT01232738|11036260|FG000|Overall Study|Physician Decision|2
6981276|NCT01232738|11036260|FG000|Overall Study|Lost to Follow-up|1
6981277|NCT01232738|11036260|FG000|Overall Study|Withdrawal by Subject|2
6981278|NCT01232738|11036260|FG000|Overall Study|Adverse Event|5
6981279|NCT01232790|11036268|FG000|Randomization|Withdrawal by Subject|2
6981280|NCT01232790|11036269|FG001|Randomization|Withdrawal by Subject|0
6981281|NCT01232790|11036268|FG000|Randomization|Protocol Violation|0
6981282|NCT01232790|11036269|FG001|Randomization|Protocol Violation|1
6981283|NCT01232790|11036268|FG000|Randomization|Physician Decision|0
6981284|NCT01232790|11036269|FG001|Randomization|Physician Decision|1
6981285|NCT01232790|11036268|FG000|Initial Assessment|Withdrawal by Subject|0
6981286|NCT01232790|11036269|FG001|Initial Assessment|Withdrawal by Subject|1
6981287|NCT01232790|11036268|FG000|First Crossover|Withdrawal by Subject|1
6981288|NCT01232790|11036269|FG001|First Crossover|Withdrawal by Subject|0
6981289|NCT01232790|11036268|FG000|Second Crossover|Withdrawal by Subject|1
6981290|NCT01232790|11036269|FG001|Second Crossover|Withdrawal by Subject|2
6981291|NCT01232868|11036291|FG000|Overall Study|Lost to Follow-up|2
6981292|NCT01232868|11036292|FG001|Overall Study|Lost to Follow-up|4
6981293|NCT01232894|11036300|FG000|Overall Study|Lost to Follow-up|0
6981294|NCT01232894|11036301|FG001|Overall Study|Lost to Follow-up|1
6981295|NCT01232894|11036300|FG000|Overall Study|Death|1
6981296|NCT01232894|11036301|FG001|Overall Study|Death|0
6981297|NCT01232894|11036300|FG000|Overall Study|Protocol Violation|1
6981298|NCT01232894|11036301|FG001|Overall Study|Protocol Violation|1
6981299|NCT01232894|11036300|FG000|Overall Study|Withdrawal by Subject|8
6981300|NCT01232894|11036301|FG001|Overall Study|Withdrawal by Subject|5
6981301|NCT01232894|11036300|FG000|Overall Study|Physician Decision|2
6981302|NCT01232894|11036301|FG001|Overall Study|Physician Decision|1
6981303|NCT01233050|11036331|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8
6981304|NCT01233050|11036332|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6
6981305|NCT01233076|11036338|FG000|Period 2, One Week|Lost to Follow-up|1
6981306|NCT01233076|11036339|FG001|Period 2, One Week|Lost to Follow-up|0
6981307|NCT01233232|11036348|FG000|Overall Study|Voluntary Discontinuation by Subject|1
6981308|NCT01233232|11036349|FG001|Overall Study|Voluntary Discontinuation by Subject|0
6981309|NCT01233232|11036350|FG002|Overall Study|Voluntary Discontinuation by Subject|0
6981310|NCT01233258|11036363|FG000|First Intervention (6 Months)|Withdrawal by Subject|0
6981311|NCT01233258|11036364|FG001|First Intervention (6 Months)|Withdrawal by Subject|0
6981312|NCT01233258|11036365|FG002|First Intervention (6 Months)|Withdrawal by Subject|0
6981313|NCT01233258|11036366|FG003|First Intervention (6 Months)|Withdrawal by Subject|1
6981314|NCT01233258|11036367|FG004|First Intervention (6 Months)|Withdrawal by Subject|0
6981315|NCT01233258|11036368|FG005|First Intervention (6 Months)|Withdrawal by Subject|1
6981316|NCT01233258|11036363|FG000|First Intervention (6 Months)|Protocol Violation|0
6981317|NCT01233258|11036364|FG001|First Intervention (6 Months)|Protocol Violation|0
6981318|NCT01233258|11036365|FG002|First Intervention (6 Months)|Protocol Violation|1
6981319|NCT01233258|11036366|FG003|First Intervention (6 Months)|Protocol Violation|0
6981320|NCT01233258|11036367|FG004|First Intervention (6 Months)|Protocol Violation|0
6981321|NCT01233258|11036368|FG005|First Intervention (6 Months)|Protocol Violation|0
6981322|NCT01233258|11036363|FG000|First Intervention (6 Months)|Non-compliance with study medication|1
6981323|NCT01233258|11036364|FG001|First Intervention (6 Months)|Non-compliance with study medication|0
6981324|NCT01233258|11036365|FG002|First Intervention (6 Months)|Non-compliance with study medication|0
6981325|NCT01233258|11036366|FG003|First Intervention (6 Months)|Non-compliance with study medication|0
6981326|NCT01233258|11036367|FG004|First Intervention (6 Months)|Non-compliance with study medication|0
6981327|NCT01233258|11036368|FG005|First Intervention (6 Months)|Non-compliance with study medication|0
6981328|NCT01233284|11036383|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1
6981329|NCT01233284|11036384|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0
6981330|NCT01233284|11036385|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0
6981331|NCT01233284|11036386|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0
6981332|NCT01233284|11036387|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0
6981333|NCT01233284|11036383|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0
6981334|NCT01233284|11036384|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1
6981335|NCT01233284|11036385|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0
6981336|NCT01233284|11036386|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0
6981337|NCT01233284|11036387|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0
6981338|NCT01233284|11036383|FG000|Period 1 (4 Weeks)|Other|0
6981339|NCT01233284|11036384|FG001|Period 1 (4 Weeks)|Other|0
6981340|NCT01233284|11036385|FG002|Period 1 (4 Weeks)|Other|1
6981341|NCT01233284|11036386|FG003|Period 1 (4 Weeks)|Other|0
6981342|NCT01233284|11036387|FG004|Period 1 (4 Weeks)|Other|0
6981343|NCT01233284|11036383|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0
6981344|NCT01233284|11036384|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0
6981345|NCT01233284|11036385|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1
6981346|NCT01233284|11036386|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0
6981347|NCT01233284|11036387|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0
6981348|NCT01233284|11036383|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0
6981349|NCT01233284|11036384|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0
6981350|NCT01233284|11036385|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1
6981351|NCT01233284|11036386|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0
6981352|NCT01233284|11036387|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0
6981353|NCT01233284|11036383|FG000|Period 3 (4 Weeks)|Other|0
6981354|NCT01233284|11036384|FG001|Period 3 (4 Weeks)|Other|0
6981355|NCT01233284|11036385|FG002|Period 3 (4 Weeks)|Other|0
6981356|NCT01233284|11036386|FG003|Period 3 (4 Weeks)|Other|1
6981357|NCT01233284|11036387|FG004|Period 3 (4 Weeks)|Other|0
6981358|NCT01233284|11036383|FG000|Period 4 (4 Weeks)|Adverse Event|0
6981359|NCT01233284|11036384|FG001|Period 4 (4 Weeks)|Adverse Event|1
6981360|NCT01233284|11036385|FG002|Period 4 (4 Weeks)|Adverse Event|0
6981361|NCT01233284|11036386|FG003|Period 4 (4 Weeks)|Adverse Event|0
6981362|NCT01233284|11036387|FG004|Period 4 (4 Weeks)|Adverse Event|0
6981363|NCT01233284|11036383|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0
6981364|NCT01233284|11036384|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0
6981365|NCT01233284|11036385|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0
6981366|NCT01233284|11036386|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1
6981367|NCT01233284|11036387|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0
6981368|NCT01233609|11036404|FG000|Overall Study|Death|1
6981369|NCT01233609|11036405|FG001|Overall Study|Death|0
6981370|NCT01233609|11036404|FG000|Overall Study|Lost to Follow-up|3
6981371|NCT01233609|11036405|FG001|Overall Study|Lost to Follow-up|1
6981372|NCT01233609|11036404|FG000|Overall Study|Adverse Event|2
6981373|NCT01233609|11036405|FG001|Overall Study|Adverse Event|1
6981374|NCT01233609|11036404|FG000|Overall Study|Withdrawal by Subject|3
6981375|NCT01233609|11036405|FG001|Overall Study|Withdrawal by Subject|0
6981376|NCT01233687|11036419|FG000|Phase II AMG 102 + Erlotinib|Death|1
6981377|NCT01233687|11036419|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2
6981378|NCT01233687|11036419|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1
6981379|NCT01233817|11036439|FG000|Overall Study|Lost to Follow-up|1
6981380|NCT01233817|11036439|FG000|Overall Study|Withdrawal by Subject|2
6981381|NCT01233869|11036447|FG000|Initial Treatment Period (24 Months)|Death|1
6981382|NCT01233869|11036448|FG001|Initial Treatment Period (24 Months)|Death|0
6981383|NCT01233869|11036449|FG002|Initial Treatment Period (24 Months)|Death|0
6981384|NCT01233869|11036450|FG003|Initial Treatment Period (24 Months)|Death|0
6981385|NCT01233869|11036447|FG000|Initial Treatment Period (24 Months)|Adverse Event|9
6981386|NCT01233869|11036448|FG001|Initial Treatment Period (24 Months)|Adverse Event|17
6981387|NCT01233869|11036449|FG002|Initial Treatment Period (24 Months)|Adverse Event|0
6981388|NCT01233869|11036450|FG003|Initial Treatment Period (24 Months)|Adverse Event|3
6981389|NCT01233869|11036447|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14
6981390|NCT01233869|11036448|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11
6981391|NCT01233869|11036449|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2
6981392|NCT01233869|11036450|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19
6981393|NCT01233869|11036447|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0
6981394|NCT01233869|11036448|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0
6981395|NCT01233869|11036449|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0
6981396|NCT01233869|11036450|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1
6981397|NCT01233869|11036447|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10
6981398|NCT01233869|11036448|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3
6981399|NCT01233869|11036449|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5
6981400|NCT01233869|11036450|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11
6981401|NCT01233869|11036447|FG000|Extended Treatment Period (46 Months)|Other|3
6981402|NCT01233869|11036448|FG001|Extended Treatment Period (46 Months)|Other|0
6981403|NCT01233869|11036449|FG002|Extended Treatment Period (46 Months)|Other|0
6981404|NCT01233869|11036450|FG003|Extended Treatment Period (46 Months)|Other|3
6981405|NCT01233869|11036447|FG000|Extended Treatment Period (46 Months)|Adverse Event|1
6981406|NCT01233869|11036448|FG001|Extended Treatment Period (46 Months)|Adverse Event|0
6981407|NCT01233869|11036449|FG002|Extended Treatment Period (46 Months)|Adverse Event|0
6981408|NCT01233869|11036450|FG003|Extended Treatment Period (46 Months)|Adverse Event|1
6981409|NCT01233999|11036469|FG000|Overall Study|Withdrawal by Subject|1
6981410|NCT01233999|11036469|FG000|Overall Study|Lost to Follow-up|1
6981411|NCT01234337|11036484|FG000|Overall Study|Adverse Event|58
6981412|NCT01234337|11036485|FG001|Overall Study|Adverse Event|21
6981413|NCT01234337|11036484|FG000|Overall Study|Disease progression/recurrence/relapse|181
6981414|NCT01234337|11036485|FG001|Overall Study|Disease progression/recurrence/relapse|223
6981415|NCT01234337|11036484|FG000|Overall Study|Investi. decision not protocol driven|5
6981416|NCT01234337|11036485|FG001|Overall Study|Investi. decision not protocol driven|6
6981417|NCT01234337|11036484|FG000|Overall Study|Non-compliant with study medication|3
6981418|NCT01234337|11036485|FG001|Overall Study|Non-compliant with study medication|2
6981419|NCT01234337|11036484|FG000|Overall Study|Randomized but not treated|6
6981420|NCT01234337|11036485|FG001|Overall Study|Randomized but not treated|4
6981421|NCT01234337|11036484|FG000|Overall Study|Lost to Follow-up|0
6981422|NCT01234337|11036485|FG001|Overall Study|Lost to Follow-up|1
6981423|NCT01234337|11036484|FG000|Overall Study|Protocol Violation|2
6981424|NCT01234337|11036485|FG001|Overall Study|Protocol Violation|3
6981425|NCT01234337|11036484|FG000|Overall Study|Withdrawal by Subject|11
6981426|NCT01234337|11036485|FG001|Overall Study|Withdrawal by Subject|9
6981427|NCT01234337|11036484|FG000|Overall Study|Death|0
6981428|NCT01234337|11036485|FG001|Overall Study|Death|1
6981429|NCT01234337|11036484|FG000|Overall Study|Switch to commercial drug|0
6981430|NCT01234337|11036485|FG001|Overall Study|Switch to commercial drug|1
6981431|NCT01234350|11036493|FG000|Overall Study|Adverse Event|277
6981432|NCT01234350|11036494|FG001|Overall Study|Adverse Event|92
6981433|NCT01234350|11036493|FG000|Overall Study|Withdrawal by Subject|61
6981434|NCT01234350|11036494|FG001|Overall Study|Withdrawal by Subject|36
6981435|NCT01234350|11036493|FG000|Overall Study|Lost to Follow-up|115
6981436|NCT01234350|11036494|FG001|Overall Study|Lost to Follow-up|47
6981437|NCT01234350|11036493|FG000|Overall Study|Covers a diverse set of reasons|234
6981438|NCT01234350|11036494|FG001|Overall Study|Covers a diverse set of reasons|92
6981439|NCT01234402|11036505|FG000|Overall Study|Lost to Follow-up|0
6981440|NCT01234402|11036506|FG001|Overall Study|Lost to Follow-up|1
6981441|NCT01234402|11036507|FG002|Overall Study|Lost to Follow-up|3
6981442|NCT01234402|11036505|FG000|Overall Study|Withdrawal by Subject|1
6981443|NCT01234402|11036506|FG001|Overall Study|Withdrawal by Subject|3
6981444|NCT01234402|11036507|FG002|Overall Study|Withdrawal by Subject|4
6981445|NCT01234402|11036505|FG000|Overall Study|Never treated: Death|0
6981446|NCT01234402|11036506|FG001|Overall Study|Never treated: Death|0
6981447|NCT01234402|11036507|FG002|Overall Study|Never treated: Death|1
6981448|NCT01234402|11036505|FG000|Overall Study|Never treated: Withdrawal By Subject|0
6981449|NCT01234402|11036506|FG001|Overall Study|Never treated: Withdrawal By Subject|1
6981450|NCT01234402|11036507|FG002|Overall Study|Never treated: Withdrawal By Subject|0
6981451|NCT01234402|11036505|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0
6981452|NCT01234402|11036506|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1
6981453|NCT01234402|11036507|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0
6981454|NCT01234467|11036517|FG000|Overall Study|Adverse Event|3
6981455|NCT01234467|11036517|FG000|Overall Study|Death|2
6981456|NCT01234467|11036517|FG000|Overall Study|Withdrawal by Subject|2
6981457|NCT01234467|11036517|FG000|Overall Study|Disease Progression|2
6981458|NCT01234467|11036517|FG000|Overall Study|Clinical deterioration|1
6981459|NCT01234467|11036517|FG000|Overall Study|Physician Decision|1
6981460|NCT01234467|11036517|FG000|Overall Study|Other complicating disease (stroke)|1
6981461|NCT01234480|11036521|FG000|Overall Study|Pregnancy|88
6981462|NCT01234480|11036521|FG000|Overall Study|>36/Normal History|50
6981463|NCT01234480|11036521|FG000|Overall Study|Age|3
6981464|NCT01234480|11036521|FG000|Overall Study|HPV Vaccine History|28
6981465|NCT01234480|11036521|FG000|Overall Study|HPV Vaccine after Enrollment|17
6981466|NCT01234480|11036521|FG000|Overall Study|Hysterectomy|2
6981467|NCT01234480|11036521|FG000|Overall Study|Hysterectomy post enrollment|1
6981468|NCT01234480|11036521|FG000|Overall Study|Inclusion/Exclusion Violation|3
6981469|NCT01234480|11036521|FG000|Overall Study|Informed Consent Form Violation|30
6981470|NCT01234480|11036521|FG000|Overall Study|Incorrect Visit|3
6981471|NCT01234480|11036521|FG000|Overall Study|No Florida Lab License|20
6981472|NCT01234480|11036521|FG000|Overall Study|Out of Window|42
6981473|NCT01234480|11036521|FG000|Overall Study|Sample Processing/Storage|92
6981474|NCT01234480|11036521|FG000|Overall Study|Site Amendment prohibited colposcopy|11
6981475|NCT01234480|11036521|FG000|Overall Study|Site/Subject non-compliance|44
6981476|NCT01234480|11036521|FG000|Overall Study|Missing Sample|9
6981477|NCT01234649|11036530|FG000|Overall Study|Withdrawal by Subject|32
6981478|NCT01234649|11036531|FG001|Overall Study|Withdrawal by Subject|26
6981479|NCT01234649|11036530|FG000|Overall Study|Pregnancy|6
6981480|NCT01234649|11036531|FG001|Overall Study|Pregnancy|6
6981481|NCT01234649|11036530|FG000|Overall Study|intolerant to side effects|4
6981482|NCT01234649|11036531|FG001|Overall Study|intolerant to side effects|3
6981483|NCT01234649|11036530|FG000|Overall Study|Allergic reaction|1
6981484|NCT01234649|11036531|FG001|Overall Study|Allergic reaction|0
6981485|NCT01234649|11036530|FG000|Overall Study|Lack of Efficacy|0
6981486|NCT01234649|11036531|FG001|Overall Study|Lack of Efficacy|3
6981487|NCT01234675|11036537|FG000|First Intervention (6 Weeks)|Adverse Event|0
6981488|NCT01234675|11036538|FG001|First Intervention (6 Weeks)|Adverse Event|1
6981489|NCT01234675|11036537|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1
6981490|NCT01234675|11036538|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0
6981491|NCT01234883|11036572|FG000|Overall Study|Early treatment release|8
6981492|NCT01234883|11036573|FG001|Overall Study|Early treatment release|10
6981493|NCT01234883|11036572|FG000|Overall Study|Parent/guardian withdrew consent|1
6981494|NCT01234883|11036573|FG001|Overall Study|Parent/guardian withdrew consent|2
6981495|NCT01234883|11036572|FG000|Overall Study|Technical difficulties with IV infusion|0
6981496|NCT01234883|11036573|FG001|Overall Study|Technical difficulties with IV infusion|1
6981497|NCT01234883|11036572|FG000|Overall Study|Inclusion/exclusion failure|1
6981498|NCT01234883|11036573|FG001|Overall Study|Inclusion/exclusion failure|0
6922163|NCT00809965|10950688|FG001|Overall Study|Lost to Follow-up|10
6922164|NCT00809965|10950689|FG002|Overall Study|Lost to Follow-up|18
6922165|NCT00809965|10950687|FG000|Overall Study|Withdrawal by Subject|405
6922166|NCT00809965|10950688|FG001|Overall Study|Withdrawal by Subject|448
6922167|NCT00809965|10950689|FG002|Overall Study|Withdrawal by Subject|441
6922168|NCT00809965|10950687|FG000|Overall Study|Other Reason|167
6922169|NCT00809965|10950688|FG001|Overall Study|Other Reason|170
6922170|NCT00809965|10950689|FG002|Overall Study|Other Reason|189
6922171|NCT00810043|10950699|FG000|Overall Study|Withdrawal by Subject|1
6922172|NCT00810043|10950700|FG001|Overall Study|Withdrawal by Subject|0
6922173|NCT00810043|10950701|FG002|Overall Study|Withdrawal by Subject|2
6922174|NCT00810043|10950699|FG000|Overall Study|Lost to Follow-up|1
6922175|NCT00810043|10950700|FG001|Overall Study|Lost to Follow-up|0
6922176|NCT00810043|10950701|FG002|Overall Study|Lost to Follow-up|0
6922177|NCT00810043|10950699|FG000|Overall Study|Physician Decision|0
6981502|NCT01235338|11036618|FG000|Overall Study|Adverse Event|3
6981503|NCT01235338|11036619|FG001|Overall Study|Adverse Event|2
6981504|NCT01235338|11036618|FG000|Overall Study|Protocol Violation|1
6981505|NCT01235338|11036619|FG001|Overall Study|Protocol Violation|1
6981506|NCT01235338|11036618|FG000|Overall Study|Withdrawal by Subject|5
6981507|NCT01235338|11036619|FG001|Overall Study|Withdrawal by Subject|0
6981508|NCT01235338|11036618|FG000|Overall Study|Exclusion criteria violations|1
6981509|NCT01235338|11036619|FG001|Overall Study|Exclusion criteria violations|1
6981510|NCT01235338|11036618|FG000|Overall Study|Positive drug screen|0
6981511|NCT01235338|11036619|FG001|Overall Study|Positive drug screen|1
6981512|NCT01235338|11036618|FG000|Overall Study|Prohibited meds|1
6981513|NCT01235338|11036619|FG001|Overall Study|Prohibited meds|0
6981514|NCT01235351|11036629|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10
6981515|NCT01235351|11036630|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4
6981516|NCT01235403|11036649|FG000|Overall Study|Adverse Event|14
6981517|NCT01235403|11036649|FG000|Overall Study|Lost to Follow-up|2
6981518|NCT01235403|11036649|FG000|Overall Study|Withdrawal by Subject|4
6981519|NCT01235403|11036649|FG000|Overall Study|Lack of Efficacy|2
6981520|NCT01235403|11036649|FG000|Overall Study|Other reasons for premature termination|4
6981521|NCT01235442|11036655|FG000|Overall Study|Lost to Follow-up|12
6981522|NCT01235442|11036656|FG001|Overall Study|Lost to Follow-up|10
6981523|NCT01235442|11036655|FG000|Overall Study|Death|0
6981524|NCT01235442|11036656|FG001|Overall Study|Death|2
6981525|NCT01235442|11036655|FG000|Overall Study|Pregnancy|1
6981526|NCT01235442|11036656|FG001|Overall Study|Pregnancy|1
6981527|NCT01235442|11036655|FG000|Overall Study|Ineligibility determined|5
6981528|NCT01235442|11036656|FG001|Overall Study|Ineligibility determined|4
6981529|NCT01235442|11036655|FG000|Overall Study|Protocol Violation|3
6981530|NCT01235442|11036656|FG001|Overall Study|Protocol Violation|3
6981531|NCT01235442|11036655|FG000|Overall Study|Adverse Event|4
6981532|NCT01235442|11036656|FG001|Overall Study|Adverse Event|6
6981533|NCT01235442|11036655|FG000|Overall Study|Withdrawal by Subject|15
6981534|NCT01235442|11036656|FG001|Overall Study|Withdrawal by Subject|9
6981535|NCT01235442|11036655|FG000|Overall Study|Lack of Efficacy|1
6981536|NCT01235442|11036656|FG001|Overall Study|Lack of Efficacy|3
6981537|NCT01235442|11036655|FG000|Overall Study|Noncompliance|1
6981538|NCT01235442|11036656|FG001|Overall Study|Noncompliance|2
6981539|NCT01235442|11036655|FG000|Overall Study|Administrative decision|1
6981540|NCT01235442|11036656|FG001|Overall Study|Administrative decision|2
6981541|NCT01235442|11036655|FG000|Overall Study|Other unspecified|1
6981542|NCT01235442|11036656|FG001|Overall Study|Other unspecified|2
6981543|NCT01235507|11036662|FG000|Overall Study|Adverse Event|1
6981544|NCT01235507|11036662|FG000|Overall Study|Withdrawal by Subject|1
6981545|NCT01235546|11036668|FG000|Overall Study|Staff error, medication not administered|1
6981546|NCT01235546|11036669|FG001|Overall Study|Staff error, medication not administered|0
6981547|NCT01235546|11036668|FG000|Overall Study|Protocol Violation|1
6981548|NCT01235546|11036669|FG001|Overall Study|Protocol Violation|1
6981549|NCT01235598|11036686|FG000|Overall Study|Adverse Event|0
6981550|NCT01235598|11036687|FG001|Overall Study|Adverse Event|3
6981551|NCT01235598|11036686|FG000|Overall Study|Lack of Efficacy|0
6981552|NCT01235598|11036687|FG001|Overall Study|Lack of Efficacy|1
6981553|NCT01235598|11036686|FG000|Overall Study|Withdrawal by Subject|1
6981554|NCT01235598|11036687|FG001|Overall Study|Withdrawal by Subject|0
6981555|NCT01235689|11036696|FG000|Overall Study|Adverse Event|12
6981556|NCT01235689|11036697|FG001|Overall Study|Adverse Event|16
6981557|NCT01235689|11036696|FG000|Overall Study|Lack of Efficacy|12
6981558|NCT01235689|11036697|FG001|Overall Study|Lack of Efficacy|5
6981559|NCT01235689|11036696|FG000|Overall Study|Withdrawal by Subject|3
6981560|NCT01235689|11036697|FG001|Overall Study|Withdrawal by Subject|4
6981561|NCT01235689|11036696|FG000|Overall Study|Lost to Follow-up|1
6981562|NCT01235689|11036697|FG001|Overall Study|Lost to Follow-up|2
6981563|NCT01235689|11036696|FG000|Overall Study|Miscellaneous|1
6981564|NCT01235689|11036697|FG001|Overall Study|Miscellaneous|5
6981565|NCT01235715|11036705|FG000|Overall Study|Physician Decision|0
6981566|NCT01235715|11036706|FG001|Overall Study|Physician Decision|2
6981567|NCT01235728|11036713|FG000|Overall Study|Protocol Violation|0
6981568|NCT01235728|11036714|FG001|Overall Study|Protocol Violation|0
6981569|NCT01235728|11036715|FG002|Overall Study|Protocol Violation|0
6981570|NCT01235728|11036716|FG003|Overall Study|Protocol Violation|1
6981571|NCT01235728|11036717|FG004|Overall Study|Protocol Violation|0
6981572|NCT01235728|11036718|FG005|Overall Study|Protocol Violation|0
6981573|NCT01235728|11036719|FG006|Overall Study|Protocol Violation|0
6981574|NCT01235728|11036720|FG007|Overall Study|Protocol Violation|0
6981575|NCT01235741|11036731|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9
6981576|NCT01235741|11036732|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
6981577|NCT01235741|11036733|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
6981578|NCT01235741|11036731|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121
6981579|NCT01235741|11036732|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
6981580|NCT01235741|11036733|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
6981581|NCT01235741|11036731|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1
6981582|NCT01235741|11036732|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
6981583|NCT01235741|11036733|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
6981584|NCT01235741|11036731|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1
6981585|NCT01235741|11036732|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
6981586|NCT01235741|11036733|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
6981587|NCT01235741|11036731|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5
6981588|NCT01235741|11036732|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
6981589|NCT01235741|11036733|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
6981590|NCT01235741|11036731|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4
6981591|NCT01235741|11036732|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
6981592|NCT01235741|11036733|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
6981593|NCT01235741|11036731|FG000|Randomized to Treatment|Withdrawal by Subject|0
6981594|NCT01235741|11036732|FG001|Randomized to Treatment|Withdrawal by Subject|0
6981595|NCT01235741|11036733|FG002|Randomized to Treatment|Withdrawal by Subject|1
6981596|NCT01235741|11036731|FG000|Randomized to Treatment|Adverse Event|0
6981597|NCT01235741|11036732|FG001|Randomized to Treatment|Adverse Event|1
6981598|NCT01235741|11036733|FG002|Randomized to Treatment|Adverse Event|1
6981599|NCT01235741|11036731|FG000|Randomized to Treatment|Sponsor terminated study|0
6981600|NCT01235741|11036732|FG001|Randomized to Treatment|Sponsor terminated study|35
6981601|NCT01235741|11036733|FG002|Randomized to Treatment|Sponsor terminated study|34
6981602|NCT01235741|11036731|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0
6981603|NCT01235741|11036732|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3
6981604|NCT01235741|11036733|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6
6981605|NCT01235741|11036731|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0
6981606|NCT01235741|11036732|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5
6981607|NCT01235741|11036733|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1
6981608|NCT01235741|11036731|FG000|Follow-Up Post Treatment up to Month 6|Other|0
6981609|NCT01235741|11036732|FG001|Follow-Up Post Treatment up to Month 6|Other|1
6981610|NCT01235741|11036733|FG002|Follow-Up Post Treatment up to Month 6|Other|0
6981611|NCT01235793|11036745|FG000|Overall Study|Death|6
7041813|NCT01730339|11125650|FG001|Overall Study|Lost to Follow-up|1
6981612|NCT01235949|11036777|FG000|Primary Phase|Migrated/moved from study area|1
6981613|NCT01235949|11036778|FG001|Primary Phase|Migrated/moved from study area|1
6981614|NCT01235949|11036779|FG002|Primary Phase|Migrated/moved from study area|0
6981615|NCT01235949|11036780|FG003|Primary Phase|Migrated/moved from study area|0
6981616|NCT01235949|11036781|FG004|Primary Phase|Migrated/moved from study area|1
6981617|NCT01235949|11036782|FG005|Primary Phase|Migrated/moved from study area|2
6981618|NCT01235949|11036783|FG006|Primary Phase|Migrated/moved from study area|0
6981619|NCT01235949|11036784|FG007|Primary Phase|Migrated/moved from study area|0
6981620|NCT01235949|11036785|FG008|Primary Phase|Migrated/moved from study area|0
6981621|NCT01235949|11036786|FG009|Primary Phase|Migrated/moved from study area|0
6981622|NCT01235949|11036787|FG010|Primary Phase|Migrated/moved from study area|0
6981623|NCT01235949|11036788|FG011|Primary Phase|Migrated/moved from study area|0
6981624|NCT01235949|11036789|FG012|Primary Phase|Migrated/moved from study area|0
6981625|NCT01235949|11036790|FG013|Primary Phase|Migrated/moved from study area|0
6981626|NCT01235949|11036791|FG014|Primary Phase|Migrated/moved from study area|0
6981627|NCT01235949|11036792|FG015|Primary Phase|Migrated/moved from study area|0
6981628|NCT01235949|11036793|FG016|Primary Phase|Migrated/moved from study area|0
6981629|NCT01235949|11036794|FG017|Primary Phase|Migrated/moved from study area|0
6981630|NCT01235949|11036777|FG000|Primary Phase|Adverse Event|0
6981631|NCT01235949|11036778|FG001|Primary Phase|Adverse Event|0
6981632|NCT01235949|11036779|FG002|Primary Phase|Adverse Event|0
6981633|NCT01235949|11036780|FG003|Primary Phase|Adverse Event|1
6981634|NCT01235949|11036781|FG004|Primary Phase|Adverse Event|0
6981635|NCT01235949|11036782|FG005|Primary Phase|Adverse Event|0
6981636|NCT01235949|11036783|FG006|Primary Phase|Adverse Event|0
6981637|NCT01235949|11036784|FG007|Primary Phase|Adverse Event|0
6981638|NCT01235949|11036785|FG008|Primary Phase|Adverse Event|0
6981639|NCT01235949|11036786|FG009|Primary Phase|Adverse Event|0
6981640|NCT01235949|11036787|FG010|Primary Phase|Adverse Event|0
6981641|NCT01235949|11036788|FG011|Primary Phase|Adverse Event|0
6981642|NCT01235949|11036789|FG012|Primary Phase|Adverse Event|0
6981643|NCT01235949|11036790|FG013|Primary Phase|Adverse Event|0
6981644|NCT01235949|11036791|FG014|Primary Phase|Adverse Event|0
6981645|NCT01235949|11036792|FG015|Primary Phase|Adverse Event|0
6981646|NCT01235949|11036793|FG016|Primary Phase|Adverse Event|0
6981647|NCT01235949|11036794|FG017|Primary Phase|Adverse Event|0
6981648|NCT01235949|11036777|FG000|Primary Phase|Withdrawal by Subject|3
6981649|NCT01235949|11036778|FG001|Primary Phase|Withdrawal by Subject|2
6981650|NCT01235949|11036779|FG002|Primary Phase|Withdrawal by Subject|2
6981651|NCT01235949|11036780|FG003|Primary Phase|Withdrawal by Subject|0
6981652|NCT01235949|11036781|FG004|Primary Phase|Withdrawal by Subject|0
6981653|NCT01235949|11036782|FG005|Primary Phase|Withdrawal by Subject|3
6981654|NCT01235949|11036783|FG006|Primary Phase|Withdrawal by Subject|0
6981655|NCT01235949|11036784|FG007|Primary Phase|Withdrawal by Subject|0
6981656|NCT01235949|11036785|FG008|Primary Phase|Withdrawal by Subject|0
6981657|NCT01235949|11036786|FG009|Primary Phase|Withdrawal by Subject|0
6981658|NCT01235949|11036787|FG010|Primary Phase|Withdrawal by Subject|0
6981659|NCT01235949|11036788|FG011|Primary Phase|Withdrawal by Subject|0
6981660|NCT01235949|11036789|FG012|Primary Phase|Withdrawal by Subject|0
6981661|NCT01235949|11036790|FG013|Primary Phase|Withdrawal by Subject|0
6981662|NCT01235949|11036791|FG014|Primary Phase|Withdrawal by Subject|0
6981663|NCT01235949|11036792|FG015|Primary Phase|Withdrawal by Subject|0
6981664|NCT01235949|11036793|FG016|Primary Phase|Withdrawal by Subject|0
6981665|NCT01235949|11036794|FG017|Primary Phase|Withdrawal by Subject|0
6981666|NCT01235949|11036777|FG000|Primary Phase|Lost to Follow-up|0
6981667|NCT01235949|11036778|FG001|Primary Phase|Lost to Follow-up|0
6981668|NCT01235949|11036779|FG002|Primary Phase|Lost to Follow-up|1
6981669|NCT01235949|11036780|FG003|Primary Phase|Lost to Follow-up|1
6981670|NCT01235949|11036781|FG004|Primary Phase|Lost to Follow-up|0
6981671|NCT01235949|11036782|FG005|Primary Phase|Lost to Follow-up|2
6981672|NCT01235949|11036783|FG006|Primary Phase|Lost to Follow-up|0
6981673|NCT01235949|11036784|FG007|Primary Phase|Lost to Follow-up|0
6981674|NCT01235949|11036785|FG008|Primary Phase|Lost to Follow-up|0
6981675|NCT01235949|11036786|FG009|Primary Phase|Lost to Follow-up|0
6981676|NCT01235949|11036787|FG010|Primary Phase|Lost to Follow-up|0
6981677|NCT01235949|11036788|FG011|Primary Phase|Lost to Follow-up|0
6981678|NCT01235949|11036789|FG012|Primary Phase|Lost to Follow-up|0
6981679|NCT01235949|11036790|FG013|Primary Phase|Lost to Follow-up|0
6981680|NCT01235949|11036791|FG014|Primary Phase|Lost to Follow-up|0
6981681|NCT01235949|11036792|FG015|Primary Phase|Lost to Follow-up|0
6981682|NCT01235949|11036793|FG016|Primary Phase|Lost to Follow-up|0
6981683|NCT01235949|11036794|FG017|Primary Phase|Lost to Follow-up|0
6981684|NCT01235949|11036777|FG000|Booster Phase|Migrated/moved from study area|0
6981685|NCT01235949|11036778|FG001|Booster Phase|Migrated/moved from study area|0
6981686|NCT01235949|11036779|FG002|Booster Phase|Migrated/moved from study area|0
6981687|NCT01235949|11036780|FG003|Booster Phase|Migrated/moved from study area|0
6981688|NCT01235949|11036781|FG004|Booster Phase|Migrated/moved from study area|0
6981689|NCT01235949|11036782|FG005|Booster Phase|Migrated/moved from study area|0
6981690|NCT01235949|11036783|FG006|Booster Phase|Migrated/moved from study area|0
6981691|NCT01235949|11036784|FG007|Booster Phase|Migrated/moved from study area|0
6981692|NCT01235949|11036785|FG008|Booster Phase|Migrated/moved from study area|0
6981693|NCT01235949|11036786|FG009|Booster Phase|Migrated/moved from study area|0
6981694|NCT01235949|11036787|FG010|Booster Phase|Migrated/moved from study area|0
6981695|NCT01235949|11036788|FG011|Booster Phase|Migrated/moved from study area|1
6981696|NCT01235949|11036789|FG012|Booster Phase|Migrated/moved from study area|1
6981697|NCT01235949|11036790|FG013|Booster Phase|Migrated/moved from study area|0
6981698|NCT01235949|11036791|FG014|Booster Phase|Migrated/moved from study area|0
6981699|NCT01235949|11036792|FG015|Booster Phase|Migrated/moved from study area|0
6981700|NCT01235949|11036793|FG016|Booster Phase|Migrated/moved from study area|0
6981701|NCT01235949|11036794|FG017|Booster Phase|Migrated/moved from study area|1
6981702|NCT01235949|11036777|FG000|Booster Phase|Adverse Event|0
6981703|NCT01235949|11036778|FG001|Booster Phase|Adverse Event|0
6981704|NCT01235949|11036779|FG002|Booster Phase|Adverse Event|0
6981705|NCT01235949|11036780|FG003|Booster Phase|Adverse Event|0
6981706|NCT01235949|11036781|FG004|Booster Phase|Adverse Event|0
6981707|NCT01235949|11036782|FG005|Booster Phase|Adverse Event|0
6981708|NCT01235949|11036783|FG006|Booster Phase|Adverse Event|0
6981709|NCT01235949|11036784|FG007|Booster Phase|Adverse Event|0
6981710|NCT01235949|11036785|FG008|Booster Phase|Adverse Event|0
6981711|NCT01235949|11036786|FG009|Booster Phase|Adverse Event|0
6981712|NCT01235949|11036787|FG010|Booster Phase|Adverse Event|0
6981713|NCT01235949|11036788|FG011|Booster Phase|Adverse Event|0
6981714|NCT01235949|11036789|FG012|Booster Phase|Adverse Event|0
6981715|NCT01235949|11036790|FG013|Booster Phase|Adverse Event|0
6981716|NCT01235949|11036791|FG014|Booster Phase|Adverse Event|0
6981717|NCT01235949|11036792|FG015|Booster Phase|Adverse Event|1
6981718|NCT01235949|11036793|FG016|Booster Phase|Adverse Event|0
6981719|NCT01235949|11036794|FG017|Booster Phase|Adverse Event|0
6981720|NCT01235949|11036777|FG000|Booster Phase|Withdrawal by Subject|0
6981721|NCT01235949|11036778|FG001|Booster Phase|Withdrawal by Subject|0
6981722|NCT01235949|11036779|FG002|Booster Phase|Withdrawal by Subject|0
6981723|NCT01235949|11036780|FG003|Booster Phase|Withdrawal by Subject|0
6981724|NCT01235949|11036781|FG004|Booster Phase|Withdrawal by Subject|0
6981725|NCT01235949|11036782|FG005|Booster Phase|Withdrawal by Subject|0
6981726|NCT01235949|11036783|FG006|Booster Phase|Withdrawal by Subject|0
6981727|NCT01235949|11036784|FG007|Booster Phase|Withdrawal by Subject|1
6981728|NCT01235949|11036785|FG008|Booster Phase|Withdrawal by Subject|1
6981729|NCT01235949|11036786|FG009|Booster Phase|Withdrawal by Subject|0
6981730|NCT01235949|11036787|FG010|Booster Phase|Withdrawal by Subject|1
6981731|NCT01235949|11036788|FG011|Booster Phase|Withdrawal by Subject|1
6981732|NCT01235949|11036789|FG012|Booster Phase|Withdrawal by Subject|2
6981733|NCT01235949|11036790|FG013|Booster Phase|Withdrawal by Subject|0
6981734|NCT01235949|11036791|FG014|Booster Phase|Withdrawal by Subject|2
6981735|NCT01235949|11036792|FG015|Booster Phase|Withdrawal by Subject|0
6981736|NCT01235949|11036793|FG016|Booster Phase|Withdrawal by Subject|0
6981737|NCT01235949|11036794|FG017|Booster Phase|Withdrawal by Subject|0
6981738|NCT01235949|11036777|FG000|Booster Phase|Lost to Follow-up|0
6981739|NCT01235949|11036778|FG001|Booster Phase|Lost to Follow-up|0
6981740|NCT01235949|11036779|FG002|Booster Phase|Lost to Follow-up|0
6981741|NCT01235949|11036780|FG003|Booster Phase|Lost to Follow-up|0
6981742|NCT01235949|11036781|FG004|Booster Phase|Lost to Follow-up|0
6981743|NCT01235949|11036782|FG005|Booster Phase|Lost to Follow-up|0
6981744|NCT01235949|11036783|FG006|Booster Phase|Lost to Follow-up|0
6981745|NCT01235949|11036784|FG007|Booster Phase|Lost to Follow-up|0
6981746|NCT01235949|11036785|FG008|Booster Phase|Lost to Follow-up|1
6981747|NCT01235949|11036786|FG009|Booster Phase|Lost to Follow-up|1
6981748|NCT01235949|11036787|FG010|Booster Phase|Lost to Follow-up|1
6981749|NCT01235949|11036788|FG011|Booster Phase|Lost to Follow-up|1
6981750|NCT01235949|11036789|FG012|Booster Phase|Lost to Follow-up|0
6981751|NCT01235949|11036790|FG013|Booster Phase|Lost to Follow-up|0
6981752|NCT01235949|11036791|FG014|Booster Phase|Lost to Follow-up|0
6981753|NCT01235949|11036792|FG015|Booster Phase|Lost to Follow-up|0
6981754|NCT01235949|11036793|FG016|Booster Phase|Lost to Follow-up|0
6981755|NCT01235949|11036794|FG017|Booster Phase|Lost to Follow-up|1
6981756|NCT01235975|11036834|FG000|Overall Study|Serious Adverse Event|0
6981757|NCT01235975|11036835|FG001|Overall Study|Serious Adverse Event|1
6981758|NCT01235975|11036834|FG000|Overall Study|Withdrawal by Subject|8
6981759|NCT01235975|11036835|FG001|Overall Study|Withdrawal by Subject|2
6981760|NCT01235975|11036834|FG000|Overall Study|Migrated/moved from study area|2
6981761|NCT01235975|11036835|FG001|Overall Study|Migrated/moved from study area|1
6981762|NCT01235975|11036834|FG000|Overall Study|Lost to Follow-up|7
6981763|NCT01235975|11036835|FG001|Overall Study|Lost to Follow-up|3
6981764|NCT01236001|11036843|FG000|Overall Study|Adverse Event|5
6981765|NCT01236001|11036844|FG001|Overall Study|Adverse Event|14
6981766|NCT01236001|11036843|FG000|Overall Study|Lack of Efficacy|6
6981767|NCT01236001|11036844|FG001|Overall Study|Lack of Efficacy|6
6981768|NCT01236001|11036843|FG000|Overall Study|Lost to Follow-up|6
6981769|NCT01236001|11036844|FG001|Overall Study|Lost to Follow-up|1
6981770|NCT01236001|11036843|FG000|Overall Study|Incompliance|1
6981771|NCT01236001|11036844|FG001|Overall Study|Incompliance|0
6981772|NCT01236001|11036843|FG000|Overall Study|Planned Visit After End of Study|0
6981773|NCT01236001|11036844|FG001|Overall Study|Planned Visit After End of Study|1
6981774|NCT01236118|11036954|FG000|Overall Study|Adverse Event|2
6981775|NCT01236118|11036955|FG001|Overall Study|Adverse Event|0
6981776|NCT01236118|11036956|FG002|Overall Study|Adverse Event|2
6981777|NCT01236118|11036954|FG000|Overall Study|Physician Decision|0
6981778|NCT01236118|11036955|FG001|Overall Study|Physician Decision|1
6981779|NCT01236118|11036956|FG002|Overall Study|Physician Decision|0
6981780|NCT01236118|11036954|FG000|Overall Study|Withdrawal by Subject|0
6981781|NCT01236118|11036955|FG001|Overall Study|Withdrawal by Subject|0
6981782|NCT01236118|11036956|FG002|Overall Study|Withdrawal by Subject|1
6981783|NCT01236339|11036993|FG000|Overall Study|Termination of study by sponsor|11
6981784|NCT01236339|11036994|FG001|Overall Study|Termination of study by sponsor|13
6981785|NCT01236352|11037012|FG000|Overall Study|Death|0
6981786|NCT01236352|11037013|FG001|Overall Study|Death|0
6981787|NCT01236352|11037014|FG002|Overall Study|Death|0
6981788|NCT01236352|11037015|FG003|Overall Study|Death|0
6981789|NCT01236352|11037016|FG004|Overall Study|Death|0
6981790|NCT01236352|11037017|FG005|Overall Study|Death|0
6981791|NCT01236352|11037018|FG006|Overall Study|Death|0
6981792|NCT01236352|11037019|FG007|Overall Study|Death|1
6981793|NCT01236352|11037020|FG008|Overall Study|Death|0
6981794|NCT01236352|11037021|FG009|Overall Study|Death|0
6981795|NCT01236352|11037022|FG010|Overall Study|Death|0
6981796|NCT01236352|11037012|FG000|Overall Study|Withdrawal by Subject|0
6981797|NCT01236352|11037013|FG001|Overall Study|Withdrawal by Subject|0
6981798|NCT01236352|11037014|FG002|Overall Study|Withdrawal by Subject|0
6981799|NCT01236352|11037015|FG003|Overall Study|Withdrawal by Subject|0
6981800|NCT01236352|11037016|FG004|Overall Study|Withdrawal by Subject|0
6981801|NCT01236352|11037017|FG005|Overall Study|Withdrawal by Subject|0
6981802|NCT01236352|11037018|FG006|Overall Study|Withdrawal by Subject|0
6981803|NCT01236352|11037019|FG007|Overall Study|Withdrawal by Subject|0
6981804|NCT01236352|11037020|FG008|Overall Study|Withdrawal by Subject|0
6981805|NCT01236352|11037021|FG009|Overall Study|Withdrawal by Subject|2
6981806|NCT01236352|11037022|FG010|Overall Study|Withdrawal by Subject|1
6981807|NCT01236352|11037012|FG000|Overall Study|Adverse Event|0
6981808|NCT01236352|11037013|FG001|Overall Study|Adverse Event|0
6981809|NCT01236352|11037014|FG002|Overall Study|Adverse Event|0
6981810|NCT01236352|11037015|FG003|Overall Study|Adverse Event|0
6981811|NCT01236352|11037016|FG004|Overall Study|Adverse Event|0
6981812|NCT01236352|11037017|FG005|Overall Study|Adverse Event|0
6981813|NCT01236352|11037018|FG006|Overall Study|Adverse Event|2
6981814|NCT01236352|11037019|FG007|Overall Study|Adverse Event|0
6981815|NCT01236352|11037020|FG008|Overall Study|Adverse Event|0
6981816|NCT01236352|11037021|FG009|Overall Study|Adverse Event|4
6981817|NCT01236352|11037022|FG010|Overall Study|Adverse Event|1
6981818|NCT01236352|11037012|FG000|Overall Study|Study drug toxicity|0
6981819|NCT01236352|11037013|FG001|Overall Study|Study drug toxicity|0
6981820|NCT01236352|11037014|FG002|Overall Study|Study drug toxicity|0
6981821|NCT01236352|11037015|FG003|Overall Study|Study drug toxicity|0
6981822|NCT01236352|11037016|FG004|Overall Study|Study drug toxicity|0
6981823|NCT01236352|11037017|FG005|Overall Study|Study drug toxicity|1
6981824|NCT01236352|11037018|FG006|Overall Study|Study drug toxicity|1
6981825|NCT01236352|11037019|FG007|Overall Study|Study drug toxicity|0
6981826|NCT01236352|11037020|FG008|Overall Study|Study drug toxicity|0
6981827|NCT01236352|11037021|FG009|Overall Study|Study drug toxicity|2
6981828|NCT01236352|11037022|FG010|Overall Study|Study drug toxicity|2
6981829|NCT01236352|11037012|FG000|Overall Study|Disease progression|1
6981830|NCT01236352|11037013|FG001|Overall Study|Disease progression|2
6981831|NCT01236352|11037014|FG002|Overall Study|Disease progression|1
6981832|NCT01236352|11037015|FG003|Overall Study|Disease progression|2
6981833|NCT01236352|11037016|FG004|Overall Study|Disease progression|2
6981834|NCT01236352|11037017|FG005|Overall Study|Disease progression|2
6981835|NCT01236352|11037018|FG006|Overall Study|Disease progression|1
6981836|NCT01236352|11037019|FG007|Overall Study|Disease progression|3
6981837|NCT01236352|11037020|FG008|Overall Study|Disease progression|2
6981838|NCT01236352|11037021|FG009|Overall Study|Disease progression|2
6981839|NCT01236352|11037022|FG010|Overall Study|Disease progression|2
6981840|NCT01236352|11037012|FG000|Overall Study|Poor/Non-compliance|1
6981841|NCT01236352|11037013|FG001|Overall Study|Poor/Non-compliance|0
6981842|NCT01236352|11037014|FG002|Overall Study|Poor/Non-compliance|0
6981843|NCT01236352|11037015|FG003|Overall Study|Poor/Non-compliance|0
6981844|NCT01236352|11037016|FG004|Overall Study|Poor/Non-compliance|0
6981845|NCT01236352|11037017|FG005|Overall Study|Poor/Non-compliance|0
6981846|NCT01236352|11037018|FG006|Overall Study|Poor/Non-compliance|0
6981847|NCT01236352|11037019|FG007|Overall Study|Poor/Non-compliance|0
6981848|NCT01236352|11037020|FG008|Overall Study|Poor/Non-compliance|0
6981849|NCT01236352|11037021|FG009|Overall Study|Poor/Non-compliance|0
6981850|NCT01236352|11037022|FG010|Overall Study|Poor/Non-compliance|0
6981851|NCT01236352|11037012|FG000|Overall Study|Maximum clinical benefit|1
6981852|NCT01236352|11037013|FG001|Overall Study|Maximum clinical benefit|1
6981853|NCT01236352|11037014|FG002|Overall Study|Maximum clinical benefit|1
6981854|NCT01236352|11037015|FG003|Overall Study|Maximum clinical benefit|0
6981855|NCT01236352|11037016|FG004|Overall Study|Maximum clinical benefit|2
6981856|NCT01236352|11037017|FG005|Overall Study|Maximum clinical benefit|0
6981857|NCT01236352|11037018|FG006|Overall Study|Maximum clinical benefit|3
6981858|NCT01236352|11037019|FG007|Overall Study|Maximum clinical benefit|1
6981859|NCT01236352|11037020|FG008|Overall Study|Maximum clinical benefit|1
6981860|NCT01236352|11037021|FG009|Overall Study|Maximum clinical benefit|4
6981861|NCT01236352|11037022|FG010|Overall Study|Maximum clinical benefit|2
6981862|NCT01236352|11037012|FG000|Overall Study|Subject request to discontinue treatment|0
6981863|NCT01236352|11037013|FG001|Overall Study|Subject request to discontinue treatment|0
6981864|NCT01236352|11037014|FG002|Overall Study|Subject request to discontinue treatment|1
6981865|NCT01236352|11037015|FG003|Overall Study|Subject request to discontinue treatment|1
6981866|NCT01236352|11037016|FG004|Overall Study|Subject request to discontinue treatment|0
6981867|NCT01236352|11037017|FG005|Overall Study|Subject request to discontinue treatment|1
6981868|NCT01236352|11037018|FG006|Overall Study|Subject request to discontinue treatment|0
6981869|NCT01236352|11037019|FG007|Overall Study|Subject request to discontinue treatment|0
6981870|NCT01236352|11037020|FG008|Overall Study|Subject request to discontinue treatment|0
6981871|NCT01236352|11037021|FG009|Overall Study|Subject request to discontinue treatment|1
6981872|NCT01236352|11037022|FG010|Overall Study|Subject request to discontinue treatment|4
6981873|NCT01236352|11037012|FG000|Overall Study|Subject to receive drug via EAP|1
6981874|NCT01236352|11037013|FG001|Overall Study|Subject to receive drug via EAP|1
6981875|NCT01236352|11037014|FG002|Overall Study|Subject to receive drug via EAP|1
6981876|NCT01236352|11037015|FG003|Overall Study|Subject to receive drug via EAP|0
6981877|NCT01236352|11037016|FG004|Overall Study|Subject to receive drug via EAP|0
6981878|NCT01236352|11037017|FG005|Overall Study|Subject to receive drug via EAP|0
6981879|NCT01236352|11037018|FG006|Overall Study|Subject to receive drug via EAP|0
6981880|NCT01236352|11037019|FG007|Overall Study|Subject to receive drug via EAP|2
6981881|NCT01236352|11037020|FG008|Overall Study|Subject to receive drug via EAP|0
6981882|NCT01236352|11037021|FG009|Overall Study|Subject to receive drug via EAP|4
6981883|NCT01236352|11037022|FG010|Overall Study|Subject to receive drug via EAP|0
6981884|NCT01236352|11037012|FG000|Overall Study|Patient moving to allogeneic transplant|0
6981885|NCT01236352|11037013|FG001|Overall Study|Patient moving to allogeneic transplant|0
6981886|NCT01236352|11037014|FG002|Overall Study|Patient moving to allogeneic transplant|0
6981887|NCT01236352|11037015|FG003|Overall Study|Patient moving to allogeneic transplant|0
6981888|NCT01236352|11037016|FG004|Overall Study|Patient moving to allogeneic transplant|0
6981889|NCT01236352|11037017|FG005|Overall Study|Patient moving to allogeneic transplant|0
6981890|NCT01236352|11037018|FG006|Overall Study|Patient moving to allogeneic transplant|1
6981891|NCT01236352|11037019|FG007|Overall Study|Patient moving to allogeneic transplant|0
6981892|NCT01236352|11037020|FG008|Overall Study|Patient moving to allogeneic transplant|0
6981893|NCT01236352|11037021|FG009|Overall Study|Patient moving to allogeneic transplant|0
6981894|NCT01236352|11037022|FG010|Overall Study|Patient moving to allogeneic transplant|0
6981895|NCT01236352|11037012|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0
6981896|NCT01236352|11037013|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0
6981897|NCT01236352|11037014|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0
6981898|NCT01236352|11037015|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0
6981899|NCT01236352|11037016|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0
6981900|NCT01236352|11037017|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0
6981901|NCT01236352|11037018|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0
6981902|NCT01236352|11037019|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0
6981903|NCT01236352|11037020|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0
6981904|NCT01236352|11037021|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0
6981905|NCT01236352|11037022|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1
6981906|NCT01236352|11037012|FG000|Overall Study|Lack of response to drug|0
6981907|NCT01236352|11037013|FG001|Overall Study|Lack of response to drug|0
6981908|NCT01236352|11037014|FG002|Overall Study|Lack of response to drug|0
6981909|NCT01236352|11037015|FG003|Overall Study|Lack of response to drug|0
6981910|NCT01236352|11037016|FG004|Overall Study|Lack of response to drug|0
6981911|NCT01236352|11037017|FG005|Overall Study|Lack of response to drug|0
6981912|NCT01236352|11037018|FG006|Overall Study|Lack of response to drug|0
6981913|NCT01236352|11037019|FG007|Overall Study|Lack of response to drug|0
6981914|NCT01236352|11037020|FG008|Overall Study|Lack of response to drug|0
6981915|NCT01236352|11037021|FG009|Overall Study|Lack of response to drug|1
6981916|NCT01236352|11037022|FG010|Overall Study|Lack of response to drug|1
6981917|NCT01236352|11037012|FG000|Overall Study|Patient transferred to IST|0
6981918|NCT01236352|11037013|FG001|Overall Study|Patient transferred to IST|0
6981919|NCT01236352|11037014|FG002|Overall Study|Patient transferred to IST|0
6981920|NCT01236352|11037015|FG003|Overall Study|Patient transferred to IST|0
6981921|NCT01236352|11037016|FG004|Overall Study|Patient transferred to IST|0
6981922|NCT01236352|11037017|FG005|Overall Study|Patient transferred to IST|0
6981923|NCT01236352|11037018|FG006|Overall Study|Patient transferred to IST|0
6981924|NCT01236352|11037019|FG007|Overall Study|Patient transferred to IST|0
6981925|NCT01236352|11037020|FG008|Overall Study|Patient transferred to IST|0
6981926|NCT01236352|11037021|FG009|Overall Study|Patient transferred to IST|2
6981927|NCT01236352|11037022|FG010|Overall Study|Patient transferred to IST|6
6981928|NCT01236365|11037048|FG000|Overall Study|Lost to Follow-up|0
6981929|NCT01236365|11037049|FG001|Overall Study|Lost to Follow-up|2
6981930|NCT01236365|11037048|FG000|Overall Study|Moved Out of State|1
6981931|NCT01236365|11037049|FG001|Overall Study|Moved Out of State|0
6981932|NCT01236365|11037048|FG000|Overall Study|Dropped at Randomization due to high LFT|1
6981933|NCT01236365|11037049|FG001|Overall Study|Dropped at Randomization due to high LFT|0
6981934|NCT01236534|11037080|FG000|Overall Study|Adverse Event|3
6981935|NCT01236534|11037081|FG001|Overall Study|Adverse Event|0
7041814|NCT01730339|11125649|FG000|Overall Study|Un-specified|1
6981936|NCT01236573|11037098|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
6981937|NCT01236573|11037099|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
6981938|NCT01236573|11037100|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
6981939|NCT01236573|11037101|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
6981940|NCT01236573|11037102|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
6981941|NCT01236573|11037103|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
6981942|NCT01236573|11037104|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
6981943|NCT01236573|11037105|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
6981944|NCT01236573|11037106|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
6981945|NCT01236573|11037107|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
6981946|NCT01236573|11037108|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
6981947|NCT01236573|11037098|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
6981948|NCT01236573|11037099|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
6981949|NCT01236573|11037100|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
6981950|NCT01236573|11037101|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
6981951|NCT01236573|11037102|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
6981952|NCT01236573|11037103|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
6981953|NCT01236573|11037104|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
6981954|NCT01236573|11037105|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
6981955|NCT01236573|11037106|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1
6981956|NCT01236573|11037107|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
6981957|NCT01236573|11037108|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
6981958|NCT01236573|11037098|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
6981959|NCT01236573|11037099|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
6981960|NCT01236573|11037100|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
6981961|NCT01236573|11037101|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
6981962|NCT01236573|11037102|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
6981963|NCT01236573|11037103|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
6981964|NCT01236573|11037104|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
6981965|NCT01236573|11037105|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
6981966|NCT01236573|11037106|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
6981967|NCT01236573|11037107|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
6981968|NCT01236573|11037108|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1
6981969|NCT01236755|11037146|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8
6981970|NCT01236755|11037146|FG000|Spectacles Wearing Phase|Lost to Follow-up|9
6981971|NCT01236755|11037146|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5
6981972|NCT01236755|11037146|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3
6981973|NCT01237054|11037180|FG000|Overall Study|imaging 10C0096|1
6981974|NCT01237223|11037211|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29
6981975|NCT01237223|11037212|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
6981976|NCT01237223|11037213|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
6981977|NCT01237223|11037214|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
6981978|NCT01237223|11037215|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
6981979|NCT01237223|11037216|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
6981980|NCT01237223|11037211|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25
6981981|NCT01237223|11037212|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
6981982|NCT01237223|11037213|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
6981983|NCT01237223|11037214|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
6981984|NCT01237223|11037215|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
6981985|NCT01237223|11037216|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
6981986|NCT01237223|11037211|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308
6981987|NCT01237223|11037212|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
6981988|NCT01237223|11037213|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
6981989|NCT01237223|11037214|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
6981990|NCT01237223|11037215|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
6981991|NCT01237223|11037216|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
6981992|NCT01237223|11037211|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28
6981993|NCT01237223|11037212|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
6981994|NCT01237223|11037213|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
6981995|NCT01237223|11037214|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
6981996|NCT01237223|11037215|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
6981997|NCT01237223|11037216|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
6981998|NCT01237223|11037211|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8
6981999|NCT01237223|11037212|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
6982000|NCT01237223|11037213|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
6982001|NCT01237223|11037214|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
6982002|NCT01237223|11037215|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
6982003|NCT01237223|11037216|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
6982004|NCT01237223|11037211|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12
6982005|NCT01237223|11037212|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4
6982006|NCT01237223|11037213|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3
6982007|NCT01237223|11037214|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
6982008|NCT01237223|11037215|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
6982009|NCT01237223|11037216|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1
6982010|NCT01237223|11037211|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20
6982011|NCT01237223|11037212|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6
6982012|NCT01237223|11037213|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7
6982013|NCT01237223|11037214|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
6982014|NCT01237223|11037215|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0
6982015|NCT01237223|11037216|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
6982016|NCT01237223|11037211|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
6982017|NCT01237223|11037212|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
6982018|NCT01237223|11037213|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
6982019|NCT01237223|11037214|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0
6982020|NCT01237223|11037215|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
6982021|NCT01237223|11037216|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
6982022|NCT01237223|11037211|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
6982023|NCT01237223|11037212|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
6982024|NCT01237223|11037213|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
6982025|NCT01237223|11037214|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
6982026|NCT01237223|11037215|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
6982027|NCT01237223|11037216|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1
6982028|NCT01237223|11037211|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0
6982029|NCT01237223|11037212|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
6982030|NCT01237223|11037213|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
6982031|NCT01237223|11037214|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2
6982032|NCT01237223|11037215|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
6982033|NCT01237223|11037216|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
6982034|NCT01237327|11037245|FG000|Overall Study|Protocol Violation: Core Study|1
6982035|NCT01237327|11037246|FG001|Overall Study|Protocol Violation: Core Study|0
7143100|NCT03026283|11299464|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
7143101|NCT03026283|11299465|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
7143102|NCT03026283|11299466|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
6982036|NCT01237327|11037245|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3
6982037|NCT01237327|11037246|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2
6982038|NCT01237327|11037245|FG000|Overall Study|Progression of Disease: Core Study|18
6982039|NCT01237327|11037246|FG001|Overall Study|Progression of Disease: Core Study|22
6982040|NCT01237327|11037245|FG000|Overall Study|Progression of Disease: Extension Study|15
6982041|NCT01237327|11037246|FG001|Overall Study|Progression of Disease: Extension Study|13
6982042|NCT01237327|11037245|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1
6982043|NCT01237327|11037246|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0
6982044|NCT01237327|11037245|FG000|Overall Study|Withdrawal by Subject|1
6982045|NCT01237327|11037246|FG001|Overall Study|Withdrawal by Subject|3
6982046|NCT01237327|11037245|FG000|Overall Study|Lost to Follow-up|3
7143103|NCT03026283|11299467|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
7143104|NCT03026283|11299468|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
7143105|NCT03026283|11299469|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
7143106|NCT03026283|11299462|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
7143107|NCT03026283|11299463|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
7143108|NCT03026283|11299464|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15
7143109|NCT03026283|11299465|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
7143110|NCT03026283|11299466|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
7143111|NCT03026283|11299467|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
7143112|NCT03026283|11299468|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
7143113|NCT03026283|11299469|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
7143114|NCT03026283|11299462|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
6982047|NCT01237327|11037246|FG001|Overall Study|Lost to Follow-up|0
6982048|NCT01237340|11037252|FG000|Overall Study|Adverse Event|3
6982049|NCT01237340|11037252|FG000|Overall Study|Withdrawal by Subject|1
6982050|NCT01237340|11037252|FG000|Overall Study|Early termination of the trial|36
6982051|NCT01237587|11037265|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5
6982052|NCT01237587|11037266|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1
6982053|NCT01237587|11037265|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1
6982054|NCT01237587|11037266|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3
6982055|NCT01237587|11037265|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2
6982056|NCT01237587|11037266|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3
6982057|NCT01237587|11037265|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2
6982058|NCT01237587|11037266|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4
6982059|NCT01237587|11037265|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4
6982060|NCT01237587|11037266|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3
6982061|NCT01237587|11037265|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3
6982062|NCT01237587|11037266|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4
6982063|NCT01237587|11037265|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4
6982064|NCT01237587|11037266|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3
6982065|NCT01237587|11037265|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5
6982066|NCT01237587|11037266|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5
6982067|NCT01237587|11037265|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2
6982068|NCT01237587|11037266|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4
6982069|NCT01237587|11037265|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2
6982070|NCT01237587|11037266|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4
6982071|NCT01237587|11037265|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0
6982072|NCT01237587|11037266|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5
6982073|NCT01237587|11037265|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1
6982074|NCT01237587|11037266|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0
6982075|NCT01237587|11037265|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4
6982076|NCT01237587|11037266|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4
6982077|NCT01237587|11037265|FG000|Taper Phase|Adverse Event|0
6982078|NCT01237587|11037266|FG001|Taper Phase|Adverse Event|2
6982079|NCT01237587|11037265|FG000|Taper Phase|Protocol Violation|2
6982080|NCT01237587|11037266|FG001|Taper Phase|Protocol Violation|0
6982081|NCT01237587|11037265|FG000|Taper Phase|Lack of Efficacy|2
6982082|NCT01237587|11037266|FG001|Taper Phase|Lack of Efficacy|5
6982083|NCT01237587|11037265|FG000|Taper Phase|Parent/Guardian Decision|0
6982084|NCT01237587|11037266|FG001|Taper Phase|Parent/Guardian Decision|2
6982085|NCT01237587|11037265|FG000|Taper Phase|Sponsor Decision|1
6982086|NCT01237587|11037266|FG001|Taper Phase|Sponsor Decision|0
6982087|NCT01237587|11037265|FG000|Taper Phase|Withdrawal by Subject|0
6982088|NCT01237587|11037266|FG001|Taper Phase|Withdrawal by Subject|1
6982089|NCT01237678|11037282|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5
6982090|NCT01237678|11037283|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
6982091|NCT01237678|11037284|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
6982092|NCT01237678|11037282|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24
6982093|NCT01237678|11037283|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
6982094|NCT01237678|11037284|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
6982095|NCT01237678|11037282|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3
6982096|NCT01237678|11037283|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
6982097|NCT01237678|11037284|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
6982098|NCT01237678|11037282|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1
6982099|NCT01237678|11037283|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
6982100|NCT01237678|11037284|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
6982101|NCT01237678|11037282|FG000|Phase II|Adverse Event|0
6982102|NCT01237678|11037283|FG001|Phase II|Adverse Event|39
6982103|NCT01237678|11037284|FG002|Phase II|Adverse Event|9
6982104|NCT01237678|11037282|FG000|Phase II|Death|0
6982105|NCT01237678|11037283|FG001|Phase II|Death|0
6982106|NCT01237678|11037284|FG002|Phase II|Death|2
6982107|NCT01237678|11037282|FG000|Phase II|Lack of Efficacy|0
6982108|NCT01237678|11037283|FG001|Phase II|Lack of Efficacy|25
6982109|NCT01237678|11037284|FG002|Phase II|Lack of Efficacy|3
6982110|NCT01237678|11037282|FG000|Phase II|Withdrawal by Subject|0
6982111|NCT01237678|11037283|FG001|Phase II|Withdrawal by Subject|1
6982112|NCT01237678|11037284|FG002|Phase II|Withdrawal by Subject|5
6982113|NCT01237678|11037282|FG000|Phase II|Completed Cycles 4-6|0
6982114|NCT01237678|11037283|FG001|Phase II|Completed Cycles 4-6|11
6982115|NCT01237678|11037284|FG002|Phase II|Completed Cycles 4-6|21
6982116|NCT01237678|11037282|FG000|Phase II|Sponsor Decision/Study Closed|0
6982117|NCT01237678|11037283|FG001|Phase II|Sponsor Decision/Study Closed|18
6982118|NCT01237678|11037284|FG002|Phase II|Sponsor Decision/Study Closed|7
6982119|NCT01237678|11037282|FG000|Phase II|Randomized but were not treated|0
6982120|NCT01237678|11037283|FG001|Phase II|Randomized but were not treated|4
6982121|NCT01237678|11037284|FG002|Phase II|Randomized but were not treated|3
6982122|NCT01237899|11037319|FG000|Washout Period of at Least 7 Days|Adverse Event|0
6982123|NCT01237899|11037320|FG001|Washout Period of at Least 7 Days|Adverse Event|0
6982124|NCT01237899|11037321|FG002|Washout Period of at Least 7 Days|Adverse Event|1
6982125|NCT01237899|11037322|FG003|Washout Period of at Least 7 Days|Adverse Event|0
6982126|NCT01237899|11037323|FG004|Washout Period of at Least 7 Days|Adverse Event|0
6982127|NCT01237899|11037324|FG005|Washout Period of at Least 7 Days|Adverse Event|0
6982128|NCT01237899|11037325|FG006|Washout Period of at Least 7 Days|Adverse Event|0
6982129|NCT01237899|11037326|FG007|Washout Period of at Least 7 Days|Adverse Event|0
6982130|NCT01237899|11037327|FG008|Washout Period of at Least 7 Days|Adverse Event|0
6982131|NCT01237899|11037328|FG009|Washout Period of at Least 7 Days|Adverse Event|0
6982132|NCT01237899|11037329|FG010|Washout Period of at Least 7 Days|Adverse Event|0
6982133|NCT01237951|11037347|FG000|Overall Study|Death|1
6982134|NCT01238120|11037355|FG000|Overall Study|Withdrawal by Subject|4
6982135|NCT01238120|11037356|FG001|Overall Study|Withdrawal by Subject|1
6982136|NCT01238120|11037357|FG002|Overall Study|Withdrawal by Subject|2
6982137|NCT01238120|11037358|FG003|Overall Study|Withdrawal by Subject|5
6982138|NCT01238120|11037355|FG000|Overall Study|Lost to Follow-up|2
6982139|NCT01238120|11037356|FG001|Overall Study|Lost to Follow-up|0
6982140|NCT01238120|11037357|FG002|Overall Study|Lost to Follow-up|1
6982141|NCT01238120|11037358|FG003|Overall Study|Lost to Follow-up|1
6982142|NCT01238120|11037355|FG000|Overall Study|Withdrawn due to Medical Problem|2
6982143|NCT01238120|11037356|FG001|Overall Study|Withdrawn due to Medical Problem|0
6982144|NCT01238120|11037357|FG002|Overall Study|Withdrawn due to Medical Problem|1
6982145|NCT01238120|11037358|FG003|Overall Study|Withdrawn due to Medical Problem|0
6982146|NCT01238172|11037370|FG000|Overall Study|Ineligible: based on Eligibility Review|2
6982147|NCT01238172|11037371|FG001|Overall Study|Ineligible: based on Eligibility Review|5
6982148|NCT01238172|11037370|FG000|Overall Study|Ineligible: based on Central Path Review|9
6982149|NCT01238172|11037371|FG001|Overall Study|Ineligible: based on Central Path Review|19
7041815|NCT01730339|11125650|FG001|Overall Study|Un-specified|0
7041816|NCT01730378|11125668|FG000|Overall Study|Lost to Follow-up|1
7041817|NCT01730378|11125669|FG001|Overall Study|Lost to Follow-up|0
7041818|NCT01730534|11125678|FG000|Overall Study|Withdrawal by Subject|97
7041819|NCT01730534|11125679|FG001|Overall Study|Withdrawal by Subject|127
7041820|NCT01730534|11125678|FG000|Overall Study|Lost to Follow-up|12
7041821|NCT01730534|11125679|FG001|Overall Study|Lost to Follow-up|18
7041822|NCT01730586|11125685|FG000|Overall Study|Progressive Disease|2
7041823|NCT01730586|11125685|FG000|Overall Study|Inadequate Trial|8
7041824|NCT01730586|11125685|FG000|Overall Study|Adverse Event|2
7041825|NCT01730586|11125685|FG000|Overall Study|Hospice|1
7041826|NCT01730729|11125691|FG000|Overall Study|Adverse Event|1
7041827|NCT01730729|11125691|FG000|Overall Study|Death|1
7041828|NCT01730729|11125691|FG000|Overall Study|Progressive Disease|12
7041829|NCT01730950|11125722|FG000|Overall Study|Protocol Violation|6
7041830|NCT01730950|11125723|FG001|Overall Study|Protocol Violation|6
7041831|NCT01731002|11125733|FG000|Overall Study|Adverse Event|0
7041832|NCT01731002|11125734|FG001|Overall Study|Adverse Event|2
7041833|NCT01731002|11125735|FG002|Overall Study|Adverse Event|2
7041834|NCT01731002|11125733|FG000|Overall Study|Non-Compliant|0
7041835|NCT01731002|11125734|FG001|Overall Study|Non-Compliant|1
7041836|NCT01731002|11125735|FG002|Overall Study|Non-Compliant|0
7041837|NCT01731002|11125733|FG000|Overall Study|Lost to Follow-up|1
7041838|NCT01731002|11125734|FG001|Overall Study|Lost to Follow-up|0
7041839|NCT01731002|11125735|FG002|Overall Study|Lost to Follow-up|0
7041840|NCT01731002|11125733|FG000|Overall Study|Test Agent Discontinuation|0
7041841|NCT01731002|11125734|FG001|Overall Study|Test Agent Discontinuation|1
7041842|NCT01731002|11125735|FG002|Overall Study|Test Agent Discontinuation|0
7041843|NCT01731002|11125733|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2
7041844|NCT01731002|11125734|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
7041845|NCT01731002|11125735|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
7041846|NCT01731002|11125733|FG000|Overall Study|Elevated IOP|1
7041847|NCT01731002|11125734|FG001|Overall Study|Elevated IOP|0
7041848|NCT01731002|11125735|FG002|Overall Study|Elevated IOP|0
7041849|NCT01731002|11125733|FG000|Overall Study|Inappropriate use of study medications|0
7041850|NCT01731002|11125734|FG001|Overall Study|Inappropriate use of study medications|0
7041851|NCT01731002|11125735|FG002|Overall Study|Inappropriate use of study medications|1
7041852|NCT01731171|11125758|FG000|Overall Study|Withdrawal by Subject|4
7041853|NCT01731171|11125759|FG001|Overall Study|Withdrawal by Subject|1
7041854|NCT01731171|11125758|FG000|Overall Study|Lost to Follow-up|3
7041855|NCT01731171|11125759|FG001|Overall Study|Lost to Follow-up|2
7041856|NCT01731171|11125758|FG000|Overall Study|Moved out of Area|0
7041857|NCT01731171|11125759|FG001|Overall Study|Moved out of Area|2
7041858|NCT01731171|11125758|FG000|Overall Study|Terminated for Lack of Adherence|0
7041859|NCT01731171|11125759|FG001|Overall Study|Terminated for Lack of Adherence|1
7041860|NCT01731171|11125758|FG000|Overall Study|Terminated for Safety Reasons|0
7041861|NCT01731171|11125759|FG001|Overall Study|Terminated for Safety Reasons|1
7041862|NCT01731470|11125765|FG000|Overall Study|Withdrawal by Subject|1
7041863|NCT01731470|11125765|FG000|Overall Study|Did not meet study criteria|1
7041864|NCT01731600|11125771|FG000|Overall Study|Adverse Event|2
7041865|NCT01731600|11125772|FG001|Overall Study|Adverse Event|0
7041866|NCT01731600|11125771|FG000|Overall Study|Withdrawal criteria|1
7041867|NCT01731600|11125772|FG001|Overall Study|Withdrawal criteria|0
7041868|NCT01731600|11125771|FG000|Overall Study|Other reasons|3
7041869|NCT01731600|11125772|FG001|Overall Study|Other reasons|0
7041870|NCT01731678|11125782|FG000|Overall Study|Withdrawal by Subject|3
7041871|NCT01731678|11125782|FG000|Overall Study|Did not meet inclusion criteria|1
7041872|NCT01731678|11125782|FG000|Overall Study|RMT too high, making TMS difficult|3
7041873|NCT01731886|11125804|FG000|Overall Study|Death|1
7041874|NCT01731886|11125805|FG001|Overall Study|Death|0
6982150|NCT01238575|11037407|FG000|Overall Study|Lack of Efficacy|2
6982151|NCT01238575|11037408|FG001|Overall Study|Lack of Efficacy|4
6982152|NCT01238575|11037407|FG000|Overall Study|Adverse Event|2
6982153|NCT01238575|11037408|FG001|Overall Study|Adverse Event|0
6982154|NCT01238588|11037414|FG000|Overall Study|Withdrawal by Subject|1
6982155|NCT01238588|11037414|FG000|Overall Study|Physician Decision|2
6982156|NCT01238822|11037426|FG000|Overall Study|COULD NOT SWALLOW PILLS|3
6982157|NCT01238835|11037436|FG000|Overall Study|Death|124
6982158|NCT01238835|11037436|FG000|Overall Study|Withdrawal by Subject|9
6982159|NCT01238835|11037436|FG000|Overall Study|Lost to Follow-up|1
6982160|NCT01238835|11037436|FG000|Overall Study|Site early discontinuation|2
6982161|NCT01238848|11037442|FG000|Overall Study|Physician Decision|13
6982162|NCT01238848|11037443|FG001|Overall Study|Physician Decision|5
6982163|NCT01238861|11037455|FG000|Overall Study|Lost to Follow-up|4
6982164|NCT01238861|11037456|FG001|Overall Study|Lost to Follow-up|2
6982165|NCT01238861|11037457|FG002|Overall Study|Lost to Follow-up|3
6982166|NCT01238861|11037458|FG003|Overall Study|Lost to Follow-up|1
6982167|NCT01238861|11037459|FG004|Overall Study|Lost to Follow-up|1
6982168|NCT01238861|11037460|FG005|Overall Study|Lost to Follow-up|2
6982169|NCT01238861|11037455|FG000|Overall Study|Unplanned surgery|1
6982170|NCT01238861|11037456|FG001|Overall Study|Unplanned surgery|0
6982171|NCT01238861|11037457|FG002|Overall Study|Unplanned surgery|0
6982172|NCT01238861|11037458|FG003|Overall Study|Unplanned surgery|0
6982173|NCT01238861|11037459|FG004|Overall Study|Unplanned surgery|0
6982174|NCT01238861|11037460|FG005|Overall Study|Unplanned surgery|0
6982175|NCT01238861|11037455|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0
6982176|NCT01238861|11037456|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0
6982177|NCT01238861|11037457|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1
6982178|NCT01238861|11037458|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0
6982179|NCT01238861|11037459|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1
6982180|NCT01238861|11037460|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1
6982181|NCT01238861|11037455|FG000|Overall Study|Incorrect enrollment/randomization|0
6982182|NCT01238861|11037456|FG001|Overall Study|Incorrect enrollment/randomization|0
6982183|NCT01238861|11037457|FG002|Overall Study|Incorrect enrollment/randomization|1
6982184|NCT01238861|11037458|FG003|Overall Study|Incorrect enrollment/randomization|0
6982185|NCT01238861|11037459|FG004|Overall Study|Incorrect enrollment/randomization|1
6982186|NCT01238861|11037460|FG005|Overall Study|Incorrect enrollment/randomization|0
6982187|NCT01238861|11037455|FG000|Overall Study|Subject traveled to Argentina by 1 year|0
6982188|NCT01238861|11037456|FG001|Overall Study|Subject traveled to Argentina by 1 year|0
6982189|NCT01238861|11037457|FG002|Overall Study|Subject traveled to Argentina by 1 year|1
6982190|NCT01238861|11037458|FG003|Overall Study|Subject traveled to Argentina by 1 year|0
6982191|NCT01238861|11037459|FG004|Overall Study|Subject traveled to Argentina by 1 year|0
6982192|NCT01238861|11037460|FG005|Overall Study|Subject traveled to Argentina by 1 year|0
6982193|NCT01238861|11037455|FG000|Overall Study|Subject moved out of state/area|0
6982194|NCT01238861|11037456|FG001|Overall Study|Subject moved out of state/area|0
6982195|NCT01238861|11037457|FG002|Overall Study|Subject moved out of state/area|1
6982196|NCT01238861|11037458|FG003|Overall Study|Subject moved out of state/area|1
6982197|NCT01238861|11037459|FG004|Overall Study|Subject moved out of state/area|0
6982198|NCT01238861|11037460|FG005|Overall Study|Subject moved out of state/area|0
6982199|NCT01238861|11037455|FG000|Overall Study|Strongyloides stercoralis antibodies +|0
6982200|NCT01238861|11037456|FG001|Overall Study|Strongyloides stercoralis antibodies +|0
6982201|NCT01238861|11037457|FG002|Overall Study|Strongyloides stercoralis antibodies +|0
6982202|NCT01238861|11037458|FG003|Overall Study|Strongyloides stercoralis antibodies +|1
6982203|NCT01238861|11037459|FG004|Overall Study|Strongyloides stercoralis antibodies +|0
6982204|NCT01238861|11037460|FG005|Overall Study|Strongyloides stercoralis antibodies +|0
6982205|NCT01238861|11037455|FG000|Overall Study|Personal problems|0
6982206|NCT01238861|11037456|FG001|Overall Study|Personal problems|0
6982207|NCT01238861|11037457|FG002|Overall Study|Personal problems|0
6982208|NCT01238861|11037458|FG003|Overall Study|Personal problems|1
6982209|NCT01238861|11037459|FG004|Overall Study|Personal problems|0
6982210|NCT01238861|11037460|FG005|Overall Study|Personal problems|0
6982211|NCT01238861|11037455|FG000|Overall Study|Unable to continue visits|0
6982212|NCT01238861|11037456|FG001|Overall Study|Unable to continue visits|0
6982213|NCT01238861|11037457|FG002|Overall Study|Unable to continue visits|0
6982214|NCT01238861|11037458|FG003|Overall Study|Unable to continue visits|1
6982215|NCT01238861|11037459|FG004|Overall Study|Unable to continue visits|0
6982216|NCT01238861|11037460|FG005|Overall Study|Unable to continue visits|1
6982217|NCT01238861|11037455|FG000|Overall Study|Serious adverse event|0
6982218|NCT01238861|11037456|FG001|Overall Study|Serious adverse event|0
6982219|NCT01238861|11037457|FG002|Overall Study|Serious adverse event|0
6982220|NCT01238861|11037458|FG003|Overall Study|Serious adverse event|0
6982221|NCT01238861|11037459|FG004|Overall Study|Serious adverse event|0
6982222|NCT01238861|11037460|FG005|Overall Study|Serious adverse event|1
6982223|NCT01238861|11037455|FG000|Overall Study|Lack of compliance|0
6982224|NCT01238861|11037456|FG001|Overall Study|Lack of compliance|0
6982225|NCT01238861|11037457|FG002|Overall Study|Lack of compliance|0
6982226|NCT01238861|11037458|FG003|Overall Study|Lack of compliance|0
6982227|NCT01238861|11037459|FG004|Overall Study|Lack of compliance|0
6982228|NCT01238861|11037460|FG005|Overall Study|Lack of compliance|1
6982229|NCT01238861|11037455|FG000|Overall Study|Adverse Event|0
6982230|NCT01238861|11037456|FG001|Overall Study|Adverse Event|1
6982231|NCT01238861|11037457|FG002|Overall Study|Adverse Event|0
6982232|NCT01238861|11037458|FG003|Overall Study|Adverse Event|0
6982233|NCT01238861|11037459|FG004|Overall Study|Adverse Event|0
6982234|NCT01238861|11037460|FG005|Overall Study|Adverse Event|0
6982235|NCT01238861|11037455|FG000|Overall Study|Withdrawal by Subject|6
6982236|NCT01238861|11037456|FG001|Overall Study|Withdrawal by Subject|5
6982237|NCT01238861|11037457|FG002|Overall Study|Withdrawal by Subject|4
6982238|NCT01238861|11037458|FG003|Overall Study|Withdrawal by Subject|8
6982239|NCT01238861|11037459|FG004|Overall Study|Withdrawal by Subject|10
6982240|NCT01238861|11037460|FG005|Overall Study|Withdrawal by Subject|9
6982241|NCT01238900|11037481|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4
6982242|NCT01238900|11037481|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1
6982243|NCT01238991|11037496|FG000|Overall Study|Adverse Event|1
6982244|NCT01238991|11037497|FG001|Overall Study|Adverse Event|0
6982245|NCT01238991|11037498|FG002|Overall Study|Adverse Event|3
6982246|NCT01238991|11037499|FG003|Overall Study|Adverse Event|1
6982247|NCT01238991|11037500|FG004|Overall Study|Adverse Event|1
6982248|NCT01238991|11037501|FG005|Overall Study|Adverse Event|0
6982249|NCT01238991|11037502|FG006|Overall Study|Adverse Event|1
6982250|NCT01238991|11037503|FG007|Overall Study|Adverse Event|1
6982251|NCT01238991|11037504|FG008|Overall Study|Adverse Event|0
6982252|NCT01238991|11037505|FG009|Overall Study|Adverse Event|0
6982253|NCT01238991|11037496|FG000|Overall Study|Death|0
6982254|NCT01238991|11037497|FG001|Overall Study|Death|0
6982255|NCT01238991|11037498|FG002|Overall Study|Death|0
6982256|NCT01238991|11037499|FG003|Overall Study|Death|1
6982257|NCT01238991|11037500|FG004|Overall Study|Death|0
6982258|NCT01238991|11037501|FG005|Overall Study|Death|0
6982259|NCT01238991|11037502|FG006|Overall Study|Death|0
6982260|NCT01238991|11037503|FG007|Overall Study|Death|0
6982261|NCT01238991|11037504|FG008|Overall Study|Death|0
6982262|NCT01238991|11037505|FG009|Overall Study|Death|0
6982263|NCT01238991|11037496|FG000|Overall Study|Lack of Efficacy|0
6982264|NCT01238991|11037497|FG001|Overall Study|Lack of Efficacy|0
6982265|NCT01238991|11037498|FG002|Overall Study|Lack of Efficacy|1
6982266|NCT01238991|11037499|FG003|Overall Study|Lack of Efficacy|0
6982267|NCT01238991|11037500|FG004|Overall Study|Lack of Efficacy|0
6982268|NCT01238991|11037501|FG005|Overall Study|Lack of Efficacy|0
6982269|NCT01238991|11037502|FG006|Overall Study|Lack of Efficacy|0
6982270|NCT01238991|11037503|FG007|Overall Study|Lack of Efficacy|0
6982271|NCT01238991|11037504|FG008|Overall Study|Lack of Efficacy|1
6982272|NCT01238991|11037505|FG009|Overall Study|Lack of Efficacy|0
6982273|NCT01238991|11037496|FG000|Overall Study|Withdrawal by Subject|0
6982274|NCT01238991|11037497|FG001|Overall Study|Withdrawal by Subject|0
6982275|NCT01238991|11037498|FG002|Overall Study|Withdrawal by Subject|1
6827060|NCT00121992|10829553|FG000|Overall Study|Treatment not received|2
6827061|NCT00121992|10829554|FG001|Overall Study|Treatment not received|11
6982276|NCT01238991|11037499|FG003|Overall Study|Withdrawal by Subject|0
6982277|NCT01238991|11037500|FG004|Overall Study|Withdrawal by Subject|0
6982278|NCT01238991|11037501|FG005|Overall Study|Withdrawal by Subject|0
6982279|NCT01238991|11037502|FG006|Overall Study|Withdrawal by Subject|0
6982280|NCT01238991|11037503|FG007|Overall Study|Withdrawal by Subject|0
6982281|NCT01238991|11037504|FG008|Overall Study|Withdrawal by Subject|0
6982282|NCT01238991|11037505|FG009|Overall Study|Withdrawal by Subject|0
6982283|NCT01238991|11037496|FG000|Overall Study|Study Terminated by Sponsor|0
6982284|NCT01238991|11037497|FG001|Overall Study|Study Terminated by Sponsor|0
6982285|NCT01238991|11037498|FG002|Overall Study|Study Terminated by Sponsor|0
6982286|NCT01238991|11037499|FG003|Overall Study|Study Terminated by Sponsor|0
6982287|NCT01238991|11037500|FG004|Overall Study|Study Terminated by Sponsor|1
6982288|NCT01238991|11037501|FG005|Overall Study|Study Terminated by Sponsor|0
6982289|NCT01238991|11037502|FG006|Overall Study|Study Terminated by Sponsor|7
6982290|NCT01238991|11037503|FG007|Overall Study|Study Terminated by Sponsor|4
6982291|NCT01238991|11037504|FG008|Overall Study|Study Terminated by Sponsor|2
6982292|NCT01238991|11037505|FG009|Overall Study|Study Terminated by Sponsor|2
6982293|NCT01238991|11037496|FG000|Overall Study|Caregiver's request|0
6982294|NCT01238991|11037497|FG001|Overall Study|Caregiver's request|0
6982295|NCT01238991|11037498|FG002|Overall Study|Caregiver's request|0
6982296|NCT01238991|11037499|FG003|Overall Study|Caregiver's request|0
6982297|NCT01238991|11037500|FG004|Overall Study|Caregiver's request|0
6982298|NCT01238991|11037501|FG005|Overall Study|Caregiver's request|0
6982299|NCT01238991|11037502|FG006|Overall Study|Caregiver's request|0
6982300|NCT01238991|11037503|FG007|Overall Study|Caregiver's request|0
6982301|NCT01238991|11037504|FG008|Overall Study|Caregiver's request|1
6982302|NCT01238991|11037505|FG009|Overall Study|Caregiver's request|0
6982303|NCT01238991|11037496|FG000|Overall Study|Admission to a nursing home|1
6982304|NCT01238991|11037497|FG001|Overall Study|Admission to a nursing home|0
6982305|NCT01238991|11037498|FG002|Overall Study|Admission to a nursing home|1
6982306|NCT01238991|11037499|FG003|Overall Study|Admission to a nursing home|0
6982307|NCT01238991|11037500|FG004|Overall Study|Admission to a nursing home|0
6982308|NCT01238991|11037501|FG005|Overall Study|Admission to a nursing home|0
6982309|NCT01238991|11037502|FG006|Overall Study|Admission to a nursing home|0
6982310|NCT01238991|11037503|FG007|Overall Study|Admission to a nursing home|0
6982311|NCT01238991|11037504|FG008|Overall Study|Admission to a nursing home|0
6982312|NCT01238991|11037505|FG009|Overall Study|Admission to a nursing home|0
6982313|NCT01239043|11037532|FG000|Overall Study|Protocol Violation|2
6982314|NCT01239043|11037533|FG001|Overall Study|Protocol Violation|1
6982315|NCT01239121|11037547|FG000|Overall Study|Withdrawal by Subject|2
6982316|NCT01239121|11037548|FG001|Overall Study|Withdrawal by Subject|4
6982317|NCT01239121|11037549|FG002|Overall Study|Withdrawal by Subject|0
6982318|NCT01239160|11037559|FG000|Overall Study|Lost to Follow-up|3
6982319|NCT01239160|11037560|FG001|Overall Study|Lost to Follow-up|5
6982320|NCT01239160|11037561|FG002|Overall Study|Lost to Follow-up|0
6982321|NCT01239160|11037559|FG000|Overall Study|Withdrawal by Subject|17
6982322|NCT01239160|11037560|FG001|Overall Study|Withdrawal by Subject|6
6982323|NCT01239160|11037561|FG002|Overall Study|Withdrawal by Subject|2
6982324|NCT01239160|11037559|FG000|Overall Study|Physician Decision|5
6982325|NCT01239160|11037560|FG001|Overall Study|Physician Decision|7
6982326|NCT01239160|11037561|FG002|Overall Study|Physician Decision|2
6982327|NCT01239160|11037559|FG000|Overall Study|Early Termination Due to Study Closure|0
6982328|NCT01239160|11037560|FG001|Overall Study|Early Termination Due to Study Closure|1
6982329|NCT01239160|11037561|FG002|Overall Study|Early Termination Due to Study Closure|6
6982330|NCT01239316|11037571|FG000|Overall Study|Progression/Relapse|11
6982331|NCT01239316|11037571|FG000|Overall Study|Adverse Event|1
6982332|NCT01239342|11037577|FG000|Overall Study|Adverse Event|1
6982333|NCT01239342|11037578|FG001|Overall Study|Adverse Event|0
6982334|NCT01239342|11037577|FG000|Overall Study|Withdrawal by Subject|1
6982335|NCT01239342|11037578|FG001|Overall Study|Withdrawal by Subject|5
6982336|NCT01239342|11037577|FG000|Overall Study|Reason Unknown|1
6982337|NCT01239342|11037578|FG001|Overall Study|Reason Unknown|1
6982338|NCT01239381|11037588|FG000|Overall Study|Protocol Violation|1
6982339|NCT01239381|11037588|FG000|Overall Study|Withdrawal by Subject|1
6982340|NCT01239394|11037593|FG000|Overall Study|Adverse Event|1
6982341|NCT01239472|11037599|FG000|Overall Study|Withdrawal by Subject|5
6982342|NCT01239472|11037600|FG001|Overall Study|Withdrawal by Subject|1
6982343|NCT01239472|11037599|FG000|Overall Study|Adverse Event|0
6982344|NCT01239472|11037600|FG001|Overall Study|Adverse Event|1
6982345|NCT01239472|11037599|FG000|Overall Study|Lack of Efficacy|0
6982346|NCT01239472|11037600|FG001|Overall Study|Lack of Efficacy|1
6982347|NCT01239732|11037625|FG000|Overall Study|Termination of study per protocol|667
6982348|NCT01239732|11037625|FG000|Overall Study|Death|226
6982349|NCT01239732|11037625|FG000|Overall Study|Withdrawal by Subject|87
6982350|NCT01239732|11037625|FG000|Overall Study|Adverse Event|6
6982351|NCT01239732|11037625|FG000|Overall Study|Protocol Violation|3
6982352|NCT01239732|11037625|FG000|Overall Study|Participant non compliance|5
6982353|NCT01239732|11037625|FG000|Overall Study|Study termination by sponsor|2
6982354|NCT01239732|11037625|FG000|Overall Study|Investigator's decision|4
6982355|NCT01239732|11037625|FG000|Overall Study|Treatment failure|2
6982356|NCT01239732|11037625|FG000|Overall Study|Other|19
6982357|NCT01239745|11037629|FG000|Overall Study|Study terminated by sponsor|45
6982358|NCT01239745|11037629|FG000|Overall Study|Adverse Event|1
6982359|NCT01239992|11037633|FG000|Overall Study|Withdrawal by Subject|2
6982360|NCT01240135|11037648|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1
6982361|NCT01240135|11037649|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1
6982362|NCT01240135|11037648|FG000|Period Two, 14 Days of Wear|Adverse Event|0
6982363|NCT01240135|11037649|FG001|Period Two, 14 Days of Wear|Adverse Event|1
6982364|NCT01240200|11037657|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2
6982365|NCT01240200|11037658|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1
6982366|NCT01240356|11037673|FG000|Overall Study|Withdrawal by Subject|2
6982367|NCT01240356|11037674|FG001|Overall Study|Withdrawal by Subject|0
6982368|NCT01240356|11037673|FG000|Overall Study|MRI contraindication|1
6982369|NCT01240356|11037674|FG001|Overall Study|MRI contraindication|0
6982370|NCT01240382|11037685|FG000|Overall Study|Adverse Event|2
6982371|NCT01240382|11037686|FG001|Overall Study|Adverse Event|1
6982372|NCT01240382|11037685|FG000|Overall Study|Lack of Efficacy|0
6982373|NCT01240382|11037686|FG001|Overall Study|Lack of Efficacy|2
6982374|NCT01240382|11037685|FG000|Overall Study|Fear of adverse events|0
6982375|NCT01240382|11037686|FG001|Overall Study|Fear of adverse events|1
6982376|NCT01240551|11037694|FG000|Overall Study|Refused further treatment|3
6982377|NCT01240551|11037695|FG001|Overall Study|Refused further treatment|2
6982378|NCT01240551|11037694|FG000|Overall Study|Lost to Follow-up|1
6982379|NCT01240551|11037695|FG001|Overall Study|Lost to Follow-up|1
6982380|NCT01240590|11037706|FG000|Phase I|Refused further treatment|0
6982381|NCT01240590|11037707|FG001|Phase I|Refused further treatment|0
6982382|NCT01240590|11037708|FG002|Phase I|Refused further treatment|3
6982383|NCT01240590|11037709|FG003|Phase I|Refused further treatment|0
6982384|NCT01240590|11037710|FG004|Phase I|Refused further treatment|0
6982385|NCT01240590|11037706|FG000|Phase II|Refused further treatment|0
6982386|NCT01240590|11037707|FG001|Phase II|Refused further treatment|0
6982387|NCT01240590|11037708|FG002|Phase II|Refused further treatment|0
6982388|NCT01240590|11037709|FG003|Phase II|Refused further treatment|2
6982389|NCT01240590|11037710|FG004|Phase II|Refused further treatment|1
6982390|NCT01240746|11037739|FG000|Overall Study|Adverse Event|2
6982391|NCT01240746|11037740|FG001|Overall Study|Adverse Event|0
6982392|NCT01240746|11037741|FG002|Overall Study|Adverse Event|10
6982393|NCT01240746|11037739|FG000|Overall Study|Lost to Follow-up|23
6982394|NCT01240746|11037740|FG001|Overall Study|Lost to Follow-up|20
6982395|NCT01240746|11037741|FG002|Overall Study|Lost to Follow-up|102
6982396|NCT01240746|11037739|FG000|Overall Study|Protocol Violation|24
6982397|NCT01240746|11037740|FG001|Overall Study|Protocol Violation|15
6982398|NCT01240746|11037741|FG002|Overall Study|Protocol Violation|72
6982399|NCT01240746|11037739|FG000|Overall Study|Withdrawal by Subject|10
6982400|NCT01240746|11037740|FG001|Overall Study|Withdrawal by Subject|13
6982401|NCT01240746|11037741|FG002|Overall Study|Withdrawal by Subject|59
6982402|NCT01240785|11037751|FG000|Overall Study|Lost to Follow-up|1
6982403|NCT01240785|11037752|FG001|Overall Study|Lost to Follow-up|0
6982404|NCT01240785|11037751|FG000|Overall Study|Protocol Violation|0
6982405|NCT01240785|11037752|FG001|Overall Study|Protocol Violation|3
6982406|NCT01240811|11037761|FG000|Overall Study|Physician Decision|0
6982407|NCT01240811|11037762|FG001|Overall Study|Physician Decision|1
6982408|NCT01240811|11037763|FG002|Overall Study|Physician Decision|0
6982409|NCT01240811|11037761|FG000|Overall Study|Withdrawal by Subject|0
6982410|NCT01240811|11037762|FG001|Overall Study|Withdrawal by Subject|0
6982411|NCT01240811|11037763|FG002|Overall Study|Withdrawal by Subject|1
6982412|NCT01240863|11037775|FG000|Open-label Titration Period|Adverse Event|47
6982413|NCT01240863|11037776|FG001|Open-label Titration Period|Adverse Event|0
6982414|NCT01240863|11037777|FG002|Open-label Titration Period|Adverse Event|0
6982415|NCT01240863|11037775|FG000|Open-label Titration Period|Lack of Efficacy|19
6982416|NCT01240863|11037776|FG001|Open-label Titration Period|Lack of Efficacy|0
6982417|NCT01240863|11037777|FG002|Open-label Titration Period|Lack of Efficacy|0
6982418|NCT01240863|11037775|FG000|Open-label Titration Period|Withdrawal by Subject|9
6982419|NCT01240863|11037776|FG001|Open-label Titration Period|Withdrawal by Subject|0
6982420|NCT01240863|11037777|FG002|Open-label Titration Period|Withdrawal by Subject|0
6982421|NCT01240863|11037775|FG000|Open-label Titration Period|Protocol Violation|7
6982422|NCT01240863|11037776|FG001|Open-label Titration Period|Protocol Violation|0
6982423|NCT01240863|11037777|FG002|Open-label Titration Period|Protocol Violation|0
6982424|NCT01240863|11037775|FG000|Open-label Titration Period|Noncompliance to study drug admin|3
6982425|NCT01240863|11037776|FG001|Open-label Titration Period|Noncompliance to study drug admin|0
6982426|NCT01240863|11037777|FG002|Open-label Titration Period|Noncompliance to study drug admin|0
6982427|NCT01240863|11037775|FG000|Open-label Titration Period|Noncompliance to study procedures|3
6982428|NCT01240863|11037776|FG001|Open-label Titration Period|Noncompliance to study procedures|0
6982429|NCT01240863|11037777|FG002|Open-label Titration Period|Noncompliance to study procedures|0
6982430|NCT01240863|11037775|FG000|Open-label Titration Period|Dropped out prior to dosing|2
6982431|NCT01240863|11037776|FG001|Open-label Titration Period|Dropped out prior to dosing|0
6982432|NCT01240863|11037777|FG002|Open-label Titration Period|Dropped out prior to dosing|0
6982433|NCT01240863|11037775|FG000|Open-label Titration Period|Other|7
6982434|NCT01240863|11037776|FG001|Open-label Titration Period|Other|0
6982435|NCT01240863|11037777|FG002|Open-label Titration Period|Other|0
6982436|NCT01240863|11037775|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
6982437|NCT01240863|11037776|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4
6982438|NCT01240863|11037777|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10
6982439|NCT01240863|11037775|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
6982440|NCT01240863|11037776|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
6982441|NCT01240863|11037777|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
6982442|NCT01240863|11037775|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
6982443|NCT01240863|11037776|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3
6982444|NCT01240863|11037777|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5
6982445|NCT01240863|11037775|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
6982446|NCT01240863|11037776|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
6982447|NCT01240863|11037777|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14
6982448|NCT01240863|11037775|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
6982449|NCT01240863|11037776|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9
6982450|NCT01240863|11037777|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11
6982451|NCT01240863|11037775|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0
6982452|NCT01240863|11037776|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
6982453|NCT01240863|11037777|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
6982454|NCT01240863|11037775|FG000|Double-blind Treatment Period (12 Weeks)|Other|0
6982455|NCT01240863|11037776|FG001|Double-blind Treatment Period (12 Weeks)|Other|1
6982456|NCT01240863|11037777|FG002|Double-blind Treatment Period (12 Weeks)|Other|5
6982457|NCT01240863|11037775|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
6982458|NCT01240863|11037776|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1
6982459|NCT01240863|11037777|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
6982460|NCT01240915|11037797|FG000|Overall Study|Adverse Event|0
6982461|NCT01240915|11037798|FG001|Overall Study|Adverse Event|0
6982462|NCT01240915|11037799|FG002|Overall Study|Adverse Event|0
6982463|NCT01240915|11037800|FG003|Overall Study|Adverse Event|1
6982464|NCT01240915|11037801|FG004|Overall Study|Adverse Event|0
6982465|NCT01240915|11037802|FG005|Overall Study|Adverse Event|2
6982466|NCT01240915|11037803|FG006|Overall Study|Adverse Event|0
6982467|NCT01240915|11037804|FG007|Overall Study|Adverse Event|0
6982468|NCT01240915|11037805|FG008|Overall Study|Adverse Event|1
6982469|NCT01240915|11037797|FG000|Overall Study|Lost to Follow-up|0
6982470|NCT01240915|11037798|FG001|Overall Study|Lost to Follow-up|0
6982471|NCT01240915|11037799|FG002|Overall Study|Lost to Follow-up|0
6982472|NCT01240915|11037800|FG003|Overall Study|Lost to Follow-up|0
6982473|NCT01240915|11037801|FG004|Overall Study|Lost to Follow-up|1
6982474|NCT01240915|11037802|FG005|Overall Study|Lost to Follow-up|1
6982475|NCT01240915|11037803|FG006|Overall Study|Lost to Follow-up|0
6982476|NCT01240915|11037804|FG007|Overall Study|Lost to Follow-up|1
6982477|NCT01240915|11037805|FG008|Overall Study|Lost to Follow-up|1
6982478|NCT01240915|11037797|FG000|Overall Study|Withdrawal by Subject|2
6982479|NCT01240915|11037798|FG001|Overall Study|Withdrawal by Subject|1
6982480|NCT01240915|11037799|FG002|Overall Study|Withdrawal by Subject|0
6982481|NCT01240915|11037800|FG003|Overall Study|Withdrawal by Subject|2
6982482|NCT01240915|11037801|FG004|Overall Study|Withdrawal by Subject|0
6982483|NCT01240915|11037802|FG005|Overall Study|Withdrawal by Subject|4
6982484|NCT01240915|11037803|FG006|Overall Study|Withdrawal by Subject|2
6982485|NCT01240915|11037804|FG007|Overall Study|Withdrawal by Subject|3
6982486|NCT01240915|11037805|FG008|Overall Study|Withdrawal by Subject|3
6982487|NCT01240915|11037797|FG000|Overall Study|Other|0
6982488|NCT01240915|11037798|FG001|Overall Study|Other|0
6982489|NCT01240915|11037799|FG002|Overall Study|Other|0
6982490|NCT01240915|11037800|FG003|Overall Study|Other|0
6982491|NCT01240915|11037801|FG004|Overall Study|Other|2
6982492|NCT01240915|11037802|FG005|Overall Study|Other|0
6982493|NCT01240915|11037803|FG006|Overall Study|Other|0
6982494|NCT01240915|11037804|FG007|Overall Study|Other|0
6982495|NCT01240915|11037805|FG008|Overall Study|Other|0
6982496|NCT01240915|11037797|FG000|Overall Study|Insufficient Clinical Response|0
6982497|NCT01240915|11037798|FG001|Overall Study|Insufficient Clinical Response|0
6982498|NCT01240915|11037799|FG002|Overall Study|Insufficient Clinical Response|0
6982499|NCT01240915|11037800|FG003|Overall Study|Insufficient Clinical Response|0
6982500|NCT01240915|11037801|FG004|Overall Study|Insufficient Clinical Response|1
6982501|NCT01240915|11037802|FG005|Overall Study|Insufficient Clinical Response|3
6982502|NCT01240915|11037803|FG006|Overall Study|Insufficient Clinical Response|6
6982503|NCT01240915|11037804|FG007|Overall Study|Insufficient Clinical Response|0
6982504|NCT01240915|11037805|FG008|Overall Study|Insufficient Clinical Response|3
6982505|NCT01241240|11037829|FG000|Overall Study|Adverse Event|5
6982506|NCT01241240|11037830|FG001|Overall Study|Adverse Event|4
6982507|NCT01241240|11037829|FG000|Overall Study|Lost to Follow-up|2
6982508|NCT01241240|11037830|FG001|Overall Study|Lost to Follow-up|4
6982509|NCT01241240|11037829|FG000|Overall Study|Personal Reasons|1
6982510|NCT01241240|11037830|FG001|Overall Study|Personal Reasons|1
6982511|NCT01241292|11037838|FG000|Overall Study|Administrative Reason by Sponsor|1
6982512|NCT01241292|11037839|FG001|Overall Study|Administrative Reason by Sponsor|0
6982513|NCT01241292|11037838|FG000|Overall Study|Disease Progression|2
6982514|NCT01241292|11037839|FG001|Overall Study|Disease Progression|0
6982515|NCT01241292|11037838|FG000|Overall Study|Study Drug Toxicity|0
6982516|NCT01241292|11037839|FG001|Overall Study|Study Drug Toxicity|1
6982517|NCT01241292|11037838|FG000|Overall Study|Participant Discontinued Treatment|0
6982518|NCT01241292|11037839|FG001|Overall Study|Participant Discontinued Treatment|2
6982519|NCT01241318|11037851|FG000|Overall Study|Woman: false pregnancies|27
6982520|NCT01241318|11037852|FG001|Overall Study|Woman: false pregnancies|15
6982521|NCT01241318|11037851|FG000|Overall Study|Woman: miscarriage/abortion|46
6982522|NCT01241318|11037852|FG001|Overall Study|Woman: miscarriage/abortion|38
6982523|NCT01241318|11037851|FG000|Overall Study|Withdrawal by Subject|175
6982524|NCT01241318|11037852|FG001|Overall Study|Withdrawal by Subject|46
6982525|NCT01241318|11037851|FG000|Overall Study|Lost to Follow-up|740
6982526|NCT01241318|11037852|FG001|Overall Study|Lost to Follow-up|455
6982527|NCT01241318|11037851|FG000|Overall Study|Death|2
6982528|NCT01241318|11037852|FG001|Overall Study|Death|4
6982529|NCT01241318|11037851|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60
6982530|NCT01241318|11037852|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38
6982531|NCT01241318|11037851|FG000|Overall Study|Woman: Stillborn infant|129
6982532|NCT01241318|11037852|FG001|Overall Study|Woman: Stillborn infant|146
6982533|NCT01241448|11037898|FG000|Overall Study|Adverse Event|1
6982534|NCT01241448|11037899|FG001|Overall Study|Adverse Event|0
6982535|NCT01241448|11037900|FG002|Overall Study|Adverse Event|2
6982536|NCT01241448|11037901|FG003|Overall Study|Adverse Event|2
6982537|NCT01241448|11037898|FG000|Overall Study|Lost to Follow-up|2
6982538|NCT01241448|11037899|FG001|Overall Study|Lost to Follow-up|1
6982539|NCT01241448|11037900|FG002|Overall Study|Lost to Follow-up|1
6982540|NCT01241448|11037901|FG003|Overall Study|Lost to Follow-up|1
6982541|NCT01241448|11037898|FG000|Overall Study|Physician Decision|0
6982542|NCT01241448|11037899|FG001|Overall Study|Physician Decision|2
6982543|NCT01241448|11037900|FG002|Overall Study|Physician Decision|0
6982544|NCT01241448|11037901|FG003|Overall Study|Physician Decision|0
6982545|NCT01241448|11037898|FG000|Overall Study|Protocol Violation|10
6982546|NCT01241448|11037899|FG001|Overall Study|Protocol Violation|5
6982547|NCT01241448|11037900|FG002|Overall Study|Protocol Violation|3
6982548|NCT01241448|11037901|FG003|Overall Study|Protocol Violation|6
6982549|NCT01241448|11037898|FG000|Overall Study|Sponsor Decision|17
6982550|NCT01241448|11037899|FG001|Overall Study|Sponsor Decision|14
6982551|NCT01241448|11037900|FG002|Overall Study|Sponsor Decision|12
6982552|NCT01241448|11037901|FG003|Overall Study|Sponsor Decision|6
6982553|NCT01241448|11037898|FG000|Overall Study|Withdrawal by Subject|4
6982554|NCT01241448|11037899|FG001|Overall Study|Withdrawal by Subject|5
6982555|NCT01241448|11037900|FG002|Overall Study|Withdrawal by Subject|3
6982556|NCT01241448|11037901|FG003|Overall Study|Withdrawal by Subject|6
6982557|NCT01241448|11037898|FG000|Overall Study|Excluded due to data integrity issues|3
6982558|NCT01241448|11037899|FG001|Overall Study|Excluded due to data integrity issues|2
6982559|NCT01241448|11037900|FG002|Overall Study|Excluded due to data integrity issues|2
6982560|NCT01241448|11037901|FG003|Overall Study|Excluded due to data integrity issues|2
6982561|NCT01241461|11037914|FG000|Overall Study|Progressive Disease|3
6982562|NCT01241461|11037915|FG001|Overall Study|Progressive Disease|6
6982563|NCT01241552|11037943|FG000|Overall Study|Lack of Efficacy|1
6982564|NCT01241552|11037944|FG001|Overall Study|Lack of Efficacy|0
6982565|NCT01241552|11037945|FG002|Overall Study|Lack of Efficacy|0
6982566|NCT01241552|11037946|FG003|Overall Study|Lack of Efficacy|0
6982567|NCT01241552|11037943|FG000|Overall Study|Death|26
6982568|NCT01241552|11037944|FG001|Overall Study|Death|30
6982569|NCT01241552|11037945|FG002|Overall Study|Death|20
6982570|NCT01241552|11037946|FG003|Overall Study|Death|25
6982571|NCT01241552|11037943|FG000|Overall Study|Adverse Event|1
6982572|NCT01241552|11037944|FG001|Overall Study|Adverse Event|1
6982573|NCT01241552|11037945|FG002|Overall Study|Adverse Event|0
6982574|NCT01241552|11037946|FG003|Overall Study|Adverse Event|0
6982575|NCT01241552|11037943|FG000|Overall Study|Technical Problems|2
6982576|NCT01241552|11037944|FG001|Overall Study|Technical Problems|0
6982577|NCT01241552|11037945|FG002|Overall Study|Technical Problems|2
6982578|NCT01241552|11037946|FG003|Overall Study|Technical Problems|2
6982579|NCT01241552|11037943|FG000|Overall Study|Progressive Disease|0
6982580|NCT01241552|11037944|FG001|Overall Study|Progressive Disease|0
6982581|NCT01241552|11037945|FG002|Overall Study|Progressive Disease|1
6982582|NCT01241552|11037946|FG003|Overall Study|Progressive Disease|2
6982583|NCT01241552|11037943|FG000|Overall Study|Protocol Violation|0
6982584|NCT01241552|11037944|FG001|Overall Study|Protocol Violation|2
6982585|NCT01241552|11037945|FG002|Overall Study|Protocol Violation|6
6982586|NCT01241552|11037946|FG003|Overall Study|Protocol Violation|1
6982587|NCT01241552|11037943|FG000|Overall Study|Withdrawal by Subject|7
6982588|NCT01241552|11037944|FG001|Overall Study|Withdrawal by Subject|15
6982589|NCT01241552|11037945|FG002|Overall Study|Withdrawal by Subject|14
6982590|NCT01241552|11037946|FG003|Overall Study|Withdrawal by Subject|15
6982591|NCT01241552|11037943|FG000|Overall Study|Physician Decision|2
6982592|NCT01241552|11037944|FG001|Overall Study|Physician Decision|4
6982593|NCT01241552|11037945|FG002|Overall Study|Physician Decision|2
6982594|NCT01241552|11037946|FG003|Overall Study|Physician Decision|3
6982595|NCT01241552|11037943|FG000|Overall Study|Lost to Follow-up|2
6982596|NCT01241552|11037944|FG001|Overall Study|Lost to Follow-up|11
6982597|NCT01241552|11037945|FG002|Overall Study|Lost to Follow-up|15
6982598|NCT01241552|11037946|FG003|Overall Study|Lost to Follow-up|16
6982599|NCT01241591|11037965|FG000|Overall Study|Lack of Efficacy|5
6982600|NCT01241591|11037966|FG001|Overall Study|Lack of Efficacy|2
6982601|NCT01241591|11037967|FG002|Overall Study|Lack of Efficacy|2
6982602|NCT01241591|11037968|FG003|Overall Study|Lack of Efficacy|3
6982603|NCT01241591|11037965|FG000|Overall Study|Protocol Violation|5
6982604|NCT01241591|11037966|FG001|Overall Study|Protocol Violation|2
6982605|NCT01241591|11037967|FG002|Overall Study|Protocol Violation|3
6982606|NCT01241591|11037968|FG003|Overall Study|Protocol Violation|0
6982607|NCT01241591|11037965|FG000|Overall Study|Lost to Follow-up|1
6982608|NCT01241591|11037966|FG001|Overall Study|Lost to Follow-up|2
6982609|NCT01241591|11037967|FG002|Overall Study|Lost to Follow-up|2
6982610|NCT01241591|11037968|FG003|Overall Study|Lost to Follow-up|2
6982611|NCT01241591|11037965|FG000|Overall Study|Screen Failure|3
6982612|NCT01241591|11037966|FG001|Overall Study|Screen Failure|2
6982613|NCT01241591|11037967|FG002|Overall Study|Screen Failure|1
6982614|NCT01241591|11037968|FG003|Overall Study|Screen Failure|0
6982615|NCT01241591|11037965|FG000|Overall Study|Withdrawal by Subject|6
6982616|NCT01241591|11037966|FG001|Overall Study|Withdrawal by Subject|4
6982617|NCT01241591|11037967|FG002|Overall Study|Withdrawal by Subject|2
6982618|NCT01241591|11037968|FG003|Overall Study|Withdrawal by Subject|2
6982619|NCT01241591|11037965|FG000|Overall Study|Other|0
6982620|NCT01241591|11037966|FG001|Overall Study|Other|1
6982621|NCT01241591|11037967|FG002|Overall Study|Other|0
6982622|NCT01241591|11037968|FG003|Overall Study|Other|1
6982623|NCT01241591|11037965|FG000|Overall Study|Adverse Event|3
6982624|NCT01241591|11037966|FG001|Overall Study|Adverse Event|11
6982625|NCT01241591|11037967|FG002|Overall Study|Adverse Event|12
6982626|NCT01241591|11037968|FG003|Overall Study|Adverse Event|4
6982627|NCT01241604|11037978|FG000|Screening Period|Screen Failure|3
6982628|NCT01241604|11037979|FG001|Screening Period|Screen Failure|0
6982629|NCT01241604|11037980|FG002|Screening Period|Screen Failure|0
6982630|NCT01241760|11037989|FG000|Overall Study|Adverse Event|1
6982631|NCT01241760|11037990|FG001|Overall Study|Adverse Event|0
6982632|NCT01241760|11037989|FG000|Overall Study|Lost to Follow-up|18
6982633|NCT01241760|11037990|FG001|Overall Study|Lost to Follow-up|22
6982634|NCT01241760|11037989|FG000|Overall Study|Withdrawal by Subject|13
6982635|NCT01241760|11037990|FG001|Overall Study|Withdrawal by Subject|13
6982636|NCT01241760|11037989|FG000|Overall Study|Switch To Commercially Available Medicat|1
6982637|NCT01241760|11037990|FG001|Overall Study|Switch To Commercially Available Medicat|4
6982638|NCT01241760|11037989|FG000|Overall Study|Other|1
6982639|NCT01241760|11037990|FG001|Overall Study|Other|1
6982640|NCT01242085|11038018|FG000|Overall Study|Withdrawal by Subject|4
6982641|NCT01242085|11038019|FG001|Overall Study|Withdrawal by Subject|2
6982642|NCT01242085|11038020|FG002|Overall Study|Withdrawal by Subject|0
6982643|NCT01242085|11038018|FG000|Overall Study|medically unable to have surgery|4
6982644|NCT01242085|11038019|FG001|Overall Study|medically unable to have surgery|5
6982645|NCT01242085|11038020|FG002|Overall Study|medically unable to have surgery|0
6982646|NCT01242111|11038026|FG000|Overall Study|Adverse Event|1
6982647|NCT01242111|11038026|FG000|Overall Study|Withdrawal by Subject|1
6982648|NCT01242111|11038026|FG000|Overall Study|Did not consent to MOR-100 follow-up|1
6982649|NCT01242176|11038030|FG000|Washout Period of 7 Days|Adverse Event|0
6982650|NCT01242176|11038031|FG001|Washout Period of 7 Days|Adverse Event|2
6982651|NCT01242176|11038030|FG000|Washout Period of 7 Days|Non-compliant with protocol|1
6982652|NCT01242176|11038031|FG001|Washout Period of 7 Days|Non-compliant with protocol|0
6982653|NCT01242371|11038048|FG000|Overall Study|Withdrawal by Subject|2
6982654|NCT01242371|11038049|FG001|Overall Study|Withdrawal by Subject|2
6982655|NCT01242371|11038048|FG000|Overall Study|Protocol Violation|0
6982656|NCT01242371|11038049|FG001|Overall Study|Protocol Violation|3
6982657|NCT01242514|11038058|FG000|Overall Study|e.g., project closure|1042
6982658|NCT01242514|11038059|FG001|Overall Study|e.g., project closure|305
6982659|NCT01242514|11038060|FG002|Overall Study|e.g., project closure|171
6982660|NCT01242514|11038058|FG000|Overall Study|Subject decision|33
6982661|NCT01242514|11038059|FG001|Overall Study|Subject decision|8
6982662|NCT01242514|11038060|FG002|Overall Study|Subject decision|2
6982663|NCT01242514|11038058|FG000|Overall Study|Severe non-compliance to protocol|5
6982664|NCT01242514|11038059|FG001|Overall Study|Severe non-compliance to protocol|2
6982665|NCT01242514|11038060|FG002|Overall Study|Severe non-compliance to protocol|1
6982666|NCT01242514|11038058|FG000|Overall Study|Lack of therapeutic response|99
6982667|NCT01242514|11038059|FG001|Overall Study|Lack of therapeutic response|16
6982668|NCT01242514|11038060|FG002|Overall Study|Lack of therapeutic response|10
6982669|NCT01242514|11038058|FG000|Overall Study|Dev. of study specific discont. criteria|21
6982670|NCT01242514|11038059|FG001|Overall Study|Dev. of study specific discont. criteria|3
6982671|NCT01242514|11038060|FG002|Overall Study|Dev. of study specific discont. criteria|5
6982672|NCT01242514|11038058|FG000|Overall Study|Lost to Follow-up|14
6982673|NCT01242514|11038059|FG001|Overall Study|Lost to Follow-up|5
6982674|NCT01242514|11038060|FG002|Overall Study|Lost to Follow-up|4
6982675|NCT01242514|11038058|FG000|Overall Study|Adverse Event|129
6982676|NCT01242514|11038059|FG001|Overall Study|Adverse Event|18
6982677|NCT01242514|11038060|FG002|Overall Study|Adverse Event|19
6982678|NCT01242748|11038100|FG000|Overall Study|Adverse Event|10
6982679|NCT01242748|11038101|FG001|Overall Study|Adverse Event|5
6982680|NCT01242748|11038100|FG000|Overall Study|Lost to Follow-up|6
6982681|NCT01242748|11038101|FG001|Overall Study|Lost to Follow-up|2
6982682|NCT01242748|11038100|FG000|Overall Study|Physician Decision|3
6982683|NCT01242748|11038101|FG001|Overall Study|Physician Decision|2
6982684|NCT01242748|11038100|FG000|Overall Study|Protocol Violation|1
6982685|NCT01242748|11038101|FG001|Overall Study|Protocol Violation|0
6982686|NCT01242748|11038100|FG000|Overall Study|Withdrawal by Subject|10
6982687|NCT01242748|11038101|FG001|Overall Study|Withdrawal by Subject|2
6982688|NCT01242748|11038100|FG000|Overall Study|Miscellaneous reasons|8
6982689|NCT01242748|11038101|FG001|Overall Study|Miscellaneous reasons|3
6982690|NCT01242813|11038107|FG000|Overall Study|Lost to Follow-up|2
6982691|NCT01243151|11038120|FG000|Overall Study|Adverse Event|0
6982692|NCT01243151|11038121|FG001|Overall Study|Adverse Event|1
6982693|NCT01243151|11038122|FG002|Overall Study|Adverse Event|0
6982694|NCT01243151|11038123|FG003|Overall Study|Adverse Event|0
6982695|NCT01243151|11038124|FG004|Overall Study|Adverse Event|0
6982696|NCT01243151|11038120|FG000|Overall Study|Protocol Violation|0
6982697|NCT01243151|11038121|FG001|Overall Study|Protocol Violation|0
6982698|NCT01243151|11038122|FG002|Overall Study|Protocol Violation|1
6982699|NCT01243151|11038123|FG003|Overall Study|Protocol Violation|0
6982700|NCT01243151|11038124|FG004|Overall Study|Protocol Violation|0
6982701|NCT01243151|11038120|FG000|Overall Study|Other|0
6982702|NCT01243151|11038121|FG001|Overall Study|Other|0
6982703|NCT01243151|11038122|FG002|Overall Study|Other|0
6982704|NCT01243151|11038123|FG003|Overall Study|Other|1
6982705|NCT01243151|11038124|FG004|Overall Study|Other|0
6982706|NCT01243151|11038120|FG000|Overall Study|Randomized but not treated|0
6982707|NCT01243151|11038121|FG001|Overall Study|Randomized but not treated|0
6982708|NCT01243151|11038122|FG002|Overall Study|Randomized but not treated|0
6982709|NCT01243151|11038123|FG003|Overall Study|Randomized but not treated|1
6982710|NCT01243151|11038124|FG004|Overall Study|Randomized but not treated|0
6982711|NCT01243177|11038142|FG000|Overall Study|Lack of Efficacy|47
6982712|NCT01243177|11038143|FG001|Overall Study|Lack of Efficacy|31
6982713|NCT01243177|11038142|FG000|Overall Study|Protocol Violation|11
6982714|NCT01243177|11038143|FG001|Overall Study|Protocol Violation|10
6982715|NCT01243177|11038142|FG000|Overall Study|Lost to Follow-up|15
6982716|NCT01243177|11038143|FG001|Overall Study|Lost to Follow-up|18
6982717|NCT01243177|11038142|FG000|Overall Study|Withdrawal by Subject|46
6982718|NCT01243177|11038143|FG001|Overall Study|Withdrawal by Subject|38
6982719|NCT01243177|11038142|FG000|Overall Study|AE, serious fatal|0
6982720|NCT01243177|11038143|FG001|Overall Study|AE, serious fatal|1
6982721|NCT01243177|11038142|FG000|Overall Study|SAE, non-fatal|7
6982722|NCT01243177|11038143|FG001|Overall Study|SAE, non-fatal|9
6982723|NCT01243177|11038142|FG000|Overall Study|AE, non-serious non-fatal|40
6982724|NCT01243177|11038143|FG001|Overall Study|AE, non-serious non-fatal|58
6982725|NCT01243177|11038142|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1
6982726|NCT01243177|11038143|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0
6982727|NCT01243177|11038142|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
6982728|NCT01243177|11038143|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
6982729|NCT01243177|11038142|FG000|Overall Study|Other Reason|11
6982730|NCT01243177|11038143|FG001|Overall Study|Other Reason|12
6982731|NCT01243242|11038151|FG000|Overall Study|Adverse Event|1
6982732|NCT01243242|11038152|FG001|Overall Study|Adverse Event|1
6982733|NCT01243242|11038151|FG000|Overall Study|Withdrawal by Subject|1
6982734|NCT01243242|11038152|FG001|Overall Study|Withdrawal by Subject|1
6982735|NCT01243242|11038151|FG000|Overall Study|Physician Decision|0
6982736|NCT01243242|11038152|FG001|Overall Study|Physician Decision|1
6982737|NCT01243242|11038151|FG000|Overall Study|sponsor decision|0
6982738|NCT01243242|11038152|FG001|Overall Study|sponsor decision|1
6982739|NCT01243242|11038151|FG000|Overall Study|non compliance|1
6982740|NCT01243242|11038152|FG001|Overall Study|non compliance|0
6982741|NCT01243268|11038158|FG000|Overall Study|Lost to Follow-up|4
6982742|NCT01243268|11038158|FG000|Overall Study|Protocol Violation|51
6982743|NCT01243268|11038158|FG000|Overall Study|Deviation with contract date|7
6982744|NCT01243268|11038158|FG000|Overall Study|Duplicate subject|2
6982745|NCT01243411|11038179|FG000|Overall Study|Withdrawal by Subject|18
6982746|NCT01243411|11038179|FG000|Overall Study|Lost to Follow-up|10
6982747|NCT01243411|11038179|FG000|Overall Study|Adverse Event|5
6982748|NCT01243411|11038179|FG000|Overall Study|Other|8
6982749|NCT01243424|11038185|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49
6982750|NCT01243424|11038186|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37
6982751|NCT01243424|11038185|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14
6982752|NCT01243424|11038186|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12
7143115|NCT03026283|11299463|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
7143116|NCT03026283|11299464|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
7143117|NCT03026283|11299465|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8
7143118|NCT03026283|11299466|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11
7143119|NCT03026283|11299467|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
7143120|NCT03026283|11299468|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
7143121|NCT03026283|11299469|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
6982753|NCT01243424|11038185|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15
6982754|NCT01243424|11038186|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22
6982755|NCT01243424|11038185|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0
6982756|NCT01243424|11038186|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1
6982757|NCT01243424|11038185|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38
6982758|NCT01243424|11038186|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35
6982759|NCT01243424|11038185|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8
6982760|NCT01243424|11038186|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8
6982761|NCT01243424|11038185|FG000|Discontinuation From Study (Treated Set)|Not treated|5
6982762|NCT01243424|11038186|FG001|Discontinuation From Study (Treated Set)|Not treated|4
6982763|NCT01243424|11038185|FG000|Discontinuation From Treatment|Not treated|5
6982764|NCT01243424|11038186|FG001|Discontinuation From Treatment|Not treated|4
6982765|NCT01243424|11038185|FG000|Discontinuation From Treatment|Adverse Event|457
6982766|NCT01243424|11038186|FG001|Discontinuation From Treatment|Adverse Event|523
6982767|NCT01243424|11038185|FG000|Discontinuation From Treatment|Lack of Efficacy|61
6982768|NCT01243424|11038186|FG001|Discontinuation From Treatment|Lack of Efficacy|41
6982769|NCT01243424|11038185|FG000|Discontinuation From Treatment|Protocol Violation|46
6982770|NCT01243424|11038186|FG001|Discontinuation From Treatment|Protocol Violation|47
6982771|NCT01243424|11038185|FG000|Discontinuation From Treatment|Lost to Follow-up|24
6982772|NCT01243424|11038186|FG001|Discontinuation From Treatment|Lost to Follow-up|28
6982773|NCT01243424|11038185|FG000|Discontinuation From Treatment|Withdrawal by Subject|309
6982774|NCT01243424|11038186|FG001|Discontinuation From Treatment|Withdrawal by Subject|328
6982775|NCT01243424|11038185|FG000|Discontinuation From Treatment|Other than listed above|230
6982776|NCT01243424|11038186|FG001|Discontinuation From Treatment|Other than listed above|211
6982777|NCT01243671|11038239|FG000|Overall Study|Adverse Event|3
6982778|NCT01243671|11038239|FG000|Overall Study|Anti-adalimumab antibody positive|1
6982779|NCT01243671|11038239|FG000|Overall Study|Other|1
6982780|NCT01243762|11038250|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0
6982781|NCT01243762|11038251|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2
6982782|NCT01243762|11038252|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0
6982783|NCT01243762|11038253|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0
6982784|NCT01243762|11038254|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1
6982785|NCT01243762|11038255|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1
6982786|NCT01243762|11038256|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0
6982787|NCT01243762|11038250|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0
6982788|NCT01243762|11038251|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1
7041875|NCT01731886|11125804|FG000|Overall Study|Never started treatment|0
6982789|NCT01243762|11038252|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0
6982790|NCT01243762|11038253|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1
6982791|NCT01243762|11038254|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0
6982792|NCT01243762|11038255|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0
6982793|NCT01243762|11038256|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0
6982794|NCT01243762|11038250|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
6982795|NCT01243762|11038251|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
6982796|NCT01243762|11038252|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
6982797|NCT01243762|11038253|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
6982798|NCT01243762|11038254|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
6982799|NCT01243762|11038255|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
6982800|NCT01243762|11038256|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0
6982801|NCT01243762|11038250|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
6982802|NCT01243762|11038251|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3
6982803|NCT01243762|11038252|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
6982804|NCT01243762|11038253|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
6982805|NCT01243762|11038254|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
6982806|NCT01243762|11038255|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
6982807|NCT01243762|11038256|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
6982808|NCT01243762|11038250|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
6982809|NCT01243762|11038251|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1
6982810|NCT01243762|11038252|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
6982811|NCT01243762|11038253|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
6982812|NCT01243762|11038254|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
6982813|NCT01243762|11038255|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
6982814|NCT01243762|11038256|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3
6982815|NCT01243762|11038250|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
6982816|NCT01243762|11038251|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
6982817|NCT01243762|11038252|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
6982818|NCT01243762|11038253|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
6982819|NCT01243762|11038254|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2
6982820|NCT01243762|11038255|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
6982821|NCT01243762|11038256|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
6982822|NCT01243762|11038250|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
6982823|NCT01243762|11038251|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
6982824|NCT01243762|11038252|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
6982825|NCT01243762|11038253|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
6982826|NCT01243762|11038254|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
6982827|NCT01243762|11038255|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
6982828|NCT01243762|11038256|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
6982829|NCT01243762|11038250|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
6982830|NCT01243762|11038251|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
6982831|NCT01243762|11038252|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
6982832|NCT01243762|11038253|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
6982833|NCT01243762|11038254|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
6982834|NCT01243762|11038255|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
6982835|NCT01243762|11038256|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
6982836|NCT01243775|11038275|FG000|Overall Study|Withdrawal by Subject|2
6982837|NCT01243944|11038281|FG000|Overall Study|Adverse Event|15
6982838|NCT01243944|11038282|FG001|Overall Study|Adverse Event|13
6982839|NCT01243944|11038281|FG000|Overall Study|Lost to Follow-up|2
6982840|NCT01243944|11038282|FG001|Overall Study|Lost to Follow-up|1
6982841|NCT01243944|11038281|FG000|Overall Study|Physician Decision|2
6982842|NCT01243944|11038282|FG001|Overall Study|Physician Decision|7
6982843|NCT01243944|11038281|FG000|Overall Study|Disease progression|12
6982844|NCT01243944|11038282|FG001|Overall Study|Disease progression|11
6982845|NCT01243944|11038281|FG000|Overall Study|Protocol deviation|1
6982846|NCT01243944|11038282|FG001|Overall Study|Protocol deviation|1
6982847|NCT01243944|11038281|FG000|Overall Study|Participant decision|10
6982848|NCT01243944|11038282|FG001|Overall Study|Participant decision|15
6982849|NCT01243944|11038281|FG000|Overall Study|Death|2
6982850|NCT01243944|11038282|FG001|Overall Study|Death|3
6982851|NCT01243944|11038281|FG000|Overall Study|Non-compliance with study treatment|1
6982852|NCT01243944|11038282|FG001|Overall Study|Non-compliance with study treatment|0
6982853|NCT01244035|11038295|FG000|Part 1: Period 1|Adverse Event|0
6982854|NCT01244035|11038296|FG001|Part 1: Period 1|Adverse Event|0
6982855|NCT01244035|11038297|FG002|Part 1: Period 1|Adverse Event|0
6982856|NCT01244035|11038298|FG003|Part 1: Period 1|Adverse Event|0
6982857|NCT01244035|11038299|FG004|Part 1: Period 1|Adverse Event|0
6982858|NCT01244035|11038300|FG005|Part 1: Period 1|Adverse Event|1
6982859|NCT01244035|11038295|FG000|Part 1: Period 1|Withdrawal by Subject|0
6982860|NCT01244035|11038296|FG001|Part 1: Period 1|Withdrawal by Subject|2
6982861|NCT01244035|11038297|FG002|Part 1: Period 1|Withdrawal by Subject|0
6982862|NCT01244035|11038298|FG003|Part 1: Period 1|Withdrawal by Subject|0
6982863|NCT01244035|11038299|FG004|Part 1: Period 1|Withdrawal by Subject|0
6982864|NCT01244035|11038300|FG005|Part 1: Period 1|Withdrawal by Subject|0
6982865|NCT01244035|11038295|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1
6982866|NCT01244035|11038296|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0
6982867|NCT01244035|11038297|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2
6982868|NCT01244035|11038298|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0
6982869|NCT01244035|11038299|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1
6982870|NCT01244035|11038300|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1
6982871|NCT01244035|11038295|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0
6982872|NCT01244035|11038296|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0
6982873|NCT01244035|11038297|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1
6982874|NCT01244035|11038298|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0
6982875|NCT01244035|11038299|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0
6982876|NCT01244035|11038300|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0
6982877|NCT01244035|11038295|FG000|Part 1: Period 3|Adverse Event|0
6982878|NCT01244035|11038296|FG001|Part 1: Period 3|Adverse Event|0
6982879|NCT01244035|11038297|FG002|Part 1: Period 3|Adverse Event|0
6982880|NCT01244035|11038298|FG003|Part 1: Period 3|Adverse Event|0
6982881|NCT01244035|11038299|FG004|Part 1: Period 3|Adverse Event|0
6982882|NCT01244035|11038300|FG005|Part 1: Period 3|Adverse Event|1
6982883|NCT01244035|11038295|FG000|Part 1: Period 3|Withdrawal by Subject|0
6982884|NCT01244035|11038296|FG001|Part 1: Period 3|Withdrawal by Subject|0
6982885|NCT01244035|11038297|FG002|Part 1: Period 3|Withdrawal by Subject|0
6982886|NCT01244035|11038298|FG003|Part 1: Period 3|Withdrawal by Subject|0
6982887|NCT01244035|11038299|FG004|Part 1: Period 3|Withdrawal by Subject|1
6982888|NCT01244035|11038300|FG005|Part 1: Period 3|Withdrawal by Subject|0
6982889|NCT01244035|11038295|FG000|Part 1: Period 3|Protocol Deviation|0
6982890|NCT01244035|11038296|FG001|Part 1: Period 3|Protocol Deviation|1
6982891|NCT01244035|11038297|FG002|Part 1: Period 3|Protocol Deviation|0
6982892|NCT01244035|11038298|FG003|Part 1: Period 3|Protocol Deviation|0
6982893|NCT01244035|11038299|FG004|Part 1: Period 3|Protocol Deviation|0
6982894|NCT01244035|11038300|FG005|Part 1: Period 3|Protocol Deviation|0
6982895|NCT01244061|11038322|FG000|Overall Study|Death|1
6982896|NCT01244061|11038323|FG001|Overall Study|Death|0
6982897|NCT01244061|11038322|FG000|Overall Study|Did not meet entrance criteria|1
6922178|NCT00810043|10950700|FG001|Overall Study|Physician Decision|0
6922179|NCT00810043|10950701|FG002|Overall Study|Physician Decision|2
6922180|NCT00810043|10950699|FG000|Overall Study|Death|2
6922181|NCT00810043|10950700|FG001|Overall Study|Death|0
6982898|NCT01244061|11038323|FG001|Overall Study|Did not meet entrance criteria|0
6982899|NCT01244061|11038322|FG000|Overall Study|Lack of Efficacy|1
6982900|NCT01244061|11038323|FG001|Overall Study|Lack of Efficacy|3
6982901|NCT01244061|11038322|FG000|Overall Study|Lost to Follow-up|34
6982902|NCT01244061|11038323|FG001|Overall Study|Lost to Follow-up|30
6982903|NCT01244061|11038322|FG000|Overall Study|Withdrawal by Subject|29
6982904|NCT01244061|11038323|FG001|Overall Study|Withdrawal by Subject|46
6982905|NCT01244061|11038322|FG000|Overall Study|Other|8
6982906|NCT01244061|11038323|FG001|Overall Study|Other|19
6982907|NCT01244061|11038322|FG000|Overall Study|Protocol Violation|1
6982908|NCT01244061|11038323|FG001|Overall Study|Protocol Violation|1
6982909|NCT01244061|11038322|FG000|Overall Study|Adverse Event|5
6982910|NCT01244061|11038323|FG001|Overall Study|Adverse Event|2
6982911|NCT01244061|11038322|FG000|Overall Study|Randomized but not treated|2
6982912|NCT01244061|11038323|FG001|Overall Study|Randomized but not treated|2
6982913|NCT01244126|11038332|FG000|Overall Study|Protocol Violation|3
6982914|NCT01244126|11038333|FG001|Overall Study|Protocol Violation|3
6922182|NCT00810043|10950701|FG002|Overall Study|Death|0
6922183|NCT00810043|10950699|FG000|Overall Study|Unrelated medical problem|0
6982915|NCT01244126|11038334|FG002|Overall Study|Protocol Violation|9
6982916|NCT01244191|11038344|FG000|Overall Study|Progressive disease|295
6982917|NCT01244191|11038345|FG001|Overall Study|Progressive disease|350
6982918|NCT01244191|11038344|FG000|Overall Study|Clinical disease progression|54
6982919|NCT01244191|11038345|FG001|Overall Study|Clinical disease progression|36
6982920|NCT01244191|11038344|FG000|Overall Study|Adverse Event|65
6982921|NCT01244191|11038345|FG001|Overall Study|Adverse Event|48
6982922|NCT01244191|11038344|FG000|Overall Study|Death|22
6982923|NCT01244191|11038345|FG001|Overall Study|Death|29
6982924|NCT01244191|11038344|FG000|Overall Study|Lost to Follow-up|0
6982925|NCT01244191|11038345|FG001|Overall Study|Lost to Follow-up|2
6982926|NCT01244191|11038344|FG000|Overall Study|Protocol Violation|1
6982927|NCT01244191|11038345|FG001|Overall Study|Protocol Violation|2
6982928|NCT01244191|11038344|FG000|Overall Study|Withdrawal by Subject|31
6982929|NCT01244191|11038345|FG001|Overall Study|Withdrawal by Subject|23
6982930|NCT01244191|11038344|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12
6982931|NCT01244191|11038345|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8
6982932|NCT01244425|11038361|FG000|Overall Study|Withdrawal by Subject|2
6982933|NCT01244425|11038362|FG001|Overall Study|Withdrawal by Subject|2
6982934|NCT01244425|11038361|FG000|Overall Study|Adverse Event|1
6982935|NCT01244425|11038362|FG001|Overall Study|Adverse Event|1
6982936|NCT01244490|11038395|FG000|Overall Study|Lack of Efficacy|14
6982937|NCT01244490|11038396|FG001|Overall Study|Lack of Efficacy|5
6982938|NCT01244490|11038397|FG002|Overall Study|Lack of Efficacy|5
6922184|NCT00810043|10950700|FG001|Overall Study|Unrelated medical problem|1
6922185|NCT00810043|10950701|FG002|Overall Study|Unrelated medical problem|0
6922186|NCT00810043|10950699|FG000|Overall Study|Non-medical problem|0
6922187|NCT00810043|10950700|FG001|Overall Study|Non-medical problem|0
6982939|NCT01244490|11038395|FG000|Overall Study|Withdrawal by Subject|4
6982940|NCT01244490|11038396|FG001|Overall Study|Withdrawal by Subject|4
6982941|NCT01244490|11038397|FG002|Overall Study|Withdrawal by Subject|9
6982942|NCT01244490|11038395|FG000|Overall Study|Adverse Event|1
6982943|NCT01244490|11038396|FG001|Overall Study|Adverse Event|9
6982944|NCT01244490|11038397|FG002|Overall Study|Adverse Event|5
6982945|NCT01244490|11038395|FG000|Overall Study|Lost to Follow-up|0
6982946|NCT01244490|11038396|FG001|Overall Study|Lost to Follow-up|6
6982947|NCT01244490|11038397|FG002|Overall Study|Lost to Follow-up|3
6982948|NCT01244490|11038395|FG000|Overall Study|Other|0
6982949|NCT01244490|11038396|FG001|Overall Study|Other|0
6982950|NCT01244490|11038397|FG002|Overall Study|Other|1
6982951|NCT01244516|11038412|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4
6982952|NCT01244516|11038413|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5
6982953|NCT01244516|11038414|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2
6982954|NCT01244516|11038412|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
6982955|NCT01244516|11038413|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1
6982956|NCT01244516|11038414|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
6982957|NCT01244516|11038412|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
6982958|NCT01244516|11038413|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
6982959|NCT01244516|11038414|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1
6982960|NCT01244516|11038412|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2
6982961|NCT01244516|11038413|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0
6982962|NCT01244516|11038414|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0
6982963|NCT01244516|11038412|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
6982964|NCT01244516|11038413|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0
6982965|NCT01244516|11038414|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
6982966|NCT01244516|11038412|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
6982967|NCT01244516|11038413|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1
6982968|NCT01244516|11038414|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
6982969|NCT01244516|11038412|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
6982970|NCT01244516|11038413|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
6982971|NCT01244516|11038414|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1
7041876|NCT01731886|11125805|FG001|Overall Study|Never started treatment|1
7041877|NCT01731886|11125804|FG000|Overall Study|Non-compliant|1
7041878|NCT01731886|11125805|FG001|Overall Study|Non-compliant|0
7041879|NCT01731912|11125812|FG000|Overall Study|noncompliance|2
7041880|NCT01731938|11125820|FG000|Preliminary Part I|Withdrawal by Subject|2
7041881|NCT01731938|11125821|FG001|Preliminary Part I|Withdrawal by Subject|2
7041882|NCT01731938|11125820|FG000|Preliminary Part I|Physician Decision|1
7041883|NCT01731938|11125821|FG001|Preliminary Part I|Physician Decision|0
7041884|NCT01731938|11125820|FG000|Preliminary Part I|Lost to Follow-up|0
7041885|NCT01731938|11125821|FG001|Preliminary Part I|Lost to Follow-up|3
7041886|NCT01731938|11125820|FG000|Preliminary Part I|Missed Week 6 visit|0
7041887|NCT01731938|11125821|FG001|Preliminary Part I|Missed Week 6 visit|3
7041888|NCT01731938|11125820|FG000|Primary Part II|Withdrawal by Subject|5
7041889|NCT01731938|11125821|FG001|Primary Part II|Withdrawal by Subject|4
7041890|NCT01731938|11125820|FG000|Primary Part II|Lost to Follow-up|4
7041891|NCT01731938|11125821|FG001|Primary Part II|Lost to Follow-up|5
7041892|NCT01731938|11125820|FG000|Primary Part II|Death|2
7041893|NCT01731938|11125821|FG001|Primary Part II|Death|1
7041894|NCT01731938|11125820|FG000|Primary Part II|Missed Week 6 visit|2
7041895|NCT01731938|11125821|FG001|Primary Part II|Missed Week 6 visit|3
7041896|NCT01731951|11125834|FG000|Overall Study|Documented Disease Progression|1
7041897|NCT01731951|11125835|FG001|Overall Study|Documented Disease Progression|0
7041898|NCT01731951|11125836|FG002|Overall Study|Documented Disease Progression|0
7041899|NCT01731951|11125837|FG003|Overall Study|Documented Disease Progression|0
7041900|NCT01731951|11125838|FG004|Overall Study|Documented Disease Progression|0
7041901|NCT01731951|11125839|FG005|Overall Study|Documented Disease Progression|0
7041902|NCT01731951|11125834|FG000|Overall Study|Lost to Follow-up|2
7041903|NCT01731951|11125835|FG001|Overall Study|Lost to Follow-up|0
7041904|NCT01731951|11125836|FG002|Overall Study|Lost to Follow-up|0
7041905|NCT01731951|11125837|FG003|Overall Study|Lost to Follow-up|1
7041906|NCT01731951|11125838|FG004|Overall Study|Lost to Follow-up|3
7041907|NCT01731951|11125839|FG005|Overall Study|Lost to Follow-up|1
7041908|NCT01731951|11125834|FG000|Overall Study|Withdrawal of Consent|1
7041909|NCT01731951|11125835|FG001|Overall Study|Withdrawal of Consent|0
7041910|NCT01731951|11125836|FG002|Overall Study|Withdrawal of Consent|0
7041911|NCT01731951|11125837|FG003|Overall Study|Withdrawal of Consent|0
7041912|NCT01731951|11125838|FG004|Overall Study|Withdrawal of Consent|0
7041913|NCT01731951|11125839|FG005|Overall Study|Withdrawal of Consent|2
7041914|NCT01731951|11125834|FG000|Overall Study|Death|13
7041915|NCT01731951|11125835|FG001|Overall Study|Death|15
7041916|NCT01731951|11125836|FG002|Overall Study|Death|9
7041917|NCT01731951|11125837|FG003|Overall Study|Death|8
7041918|NCT01731951|11125838|FG004|Overall Study|Death|9
7041919|NCT01731951|11125839|FG005|Overall Study|Death|6
7041920|NCT01731990|11125859|FG000|Overall Study|Adverse Event|1
7041921|NCT01731990|11125860|FG001|Overall Study|Adverse Event|5
7041922|NCT01731990|11125859|FG000|Overall Study|Withdrawal by Subject|1
7041923|NCT01731990|11125860|FG001|Overall Study|Withdrawal by Subject|1
6982972|NCT01244893|11038451|FG000|Baseline|Protocol Violation|0
6982973|NCT01244893|11038452|FG001|Baseline|Protocol Violation|1
6982974|NCT01244893|11038451|FG000|1-Week Follow Up|Lost to Follow-up|1
6982975|NCT01244893|11038452|FG001|1-Week Follow Up|Lost to Follow-up|0
6982976|NCT01244906|11038463|FG000|Overall Study|Death|2
6982977|NCT01244906|11038463|FG000|Overall Study|Progression of disease post treatment|6
6982978|NCT01244984|11038470|FG000|Overall Study|Adverse Event|2
6982979|NCT01244984|11038471|FG001|Overall Study|Adverse Event|11
6982980|NCT01244984|11038472|FG002|Overall Study|Adverse Event|2
6982981|NCT01244984|11038470|FG000|Overall Study|Protocol Violation|1
6982982|NCT01244984|11038471|FG001|Overall Study|Protocol Violation|0
6982983|NCT01244984|11038472|FG002|Overall Study|Protocol Violation|0
6982984|NCT01244984|11038470|FG000|Overall Study|Protocol Defined Stopping Criteria|1
6982985|NCT01244984|11038471|FG001|Overall Study|Protocol Defined Stopping Criteria|1
6982986|NCT01244984|11038472|FG002|Overall Study|Protocol Defined Stopping Criteria|0
6982987|NCT01244984|11038470|FG000|Overall Study|Withdrawal by Subject|1
6982988|NCT01244984|11038471|FG001|Overall Study|Withdrawal by Subject|2
6982989|NCT01244984|11038472|FG002|Overall Study|Withdrawal by Subject|2
6982990|NCT01245049|11038483|FG000|Overall Study|Migrated/moved from study area|0
6982991|NCT01245049|11038484|FG001|Overall Study|Migrated/moved from study area|1
6982992|NCT01245049|11038483|FG000|Overall Study|Withdrawal by Subject|0
6982993|NCT01245049|11038484|FG001|Overall Study|Withdrawal by Subject|1
6982994|NCT01245049|11038483|FG000|Overall Study|Lost to Follow-up|1
6982995|NCT01245049|11038484|FG001|Overall Study|Lost to Follow-up|2
6982996|NCT01245062|11038492|FG000|Randomization and Crossover Phase|Lost to Follow-up|4
6982997|NCT01245062|11038493|FG001|Randomization and Crossover Phase|Lost to Follow-up|2
6982998|NCT01245062|11038494|FG002|Randomization and Crossover Phase|Lost to Follow-up|0
6982999|NCT01245062|11038492|FG000|Randomization and Crossover Phase|Physician Decision|2
6983000|NCT01245062|11038493|FG001|Randomization and Crossover Phase|Physician Decision|4
6983001|NCT01245062|11038494|FG002|Randomization and Crossover Phase|Physician Decision|0
6983002|NCT01245062|11038492|FG000|Randomization and Crossover Phase|Withdrew Consent|12
6983003|NCT01245062|11038493|FG001|Randomization and Crossover Phase|Withdrew Consent|11
6983004|NCT01245062|11038494|FG002|Randomization and Crossover Phase|Withdrew Consent|0
6983005|NCT01245062|11038492|FG000|Randomization and Crossover Phase|Study closed/ terminated|23
6983006|NCT01245062|11038493|FG001|Randomization and Crossover Phase|Study closed/ terminated|14
6983007|NCT01245062|11038494|FG002|Randomization and Crossover Phase|Study closed/ terminated|0
6983008|NCT01245062|11038492|FG000|Cross-over Phase|Lost to Follow-up|0
6983009|NCT01245062|11038493|FG001|Cross-over Phase|Lost to Follow-up|0
6983010|NCT01245062|11038494|FG002|Cross-over Phase|Lost to Follow-up|1
6983011|NCT01245062|11038492|FG000|Cross-over Phase|Physician Decision|0
6983012|NCT01245062|11038493|FG001|Cross-over Phase|Physician Decision|0
6983013|NCT01245062|11038494|FG002|Cross-over Phase|Physician Decision|1
6983014|NCT01245062|11038492|FG000|Cross-over Phase|Withdrew Consent|0
6983015|NCT01245062|11038493|FG001|Cross-over Phase|Withdrew Consent|0
6983016|NCT01245062|11038494|FG002|Cross-over Phase|Withdrew Consent|4
6983017|NCT01245062|11038492|FG000|Cross-over Phase|Study closed/ terminated|0
6983018|NCT01245062|11038493|FG001|Cross-over Phase|Study closed/ terminated|0
6983019|NCT01245062|11038494|FG002|Cross-over Phase|Study closed/ terminated|11
6983020|NCT01245101|11038504|FG000|Period 1 (Treatment)|Withdrawal by Subject|2
6983021|NCT01245101|11038505|FG001|Period 1 (Treatment)|Withdrawal by Subject|0
6983022|NCT01245101|11038504|FG000|Period 2 (Washout)|Withdrawal by Subject|1
6983023|NCT01245101|11038505|FG001|Period 2 (Washout)|Withdrawal by Subject|0
6983024|NCT01245101|11038504|FG000|Period 3 (Treatment)|Withdrawal by Subject|1
6983025|NCT01245101|11038505|FG001|Period 3 (Treatment)|Withdrawal by Subject|0
6983026|NCT01245140|11038513|FG000|Overall Study|Adverse Event|1
6983027|NCT01245140|11038514|FG001|Overall Study|Adverse Event|3
6983028|NCT01245140|11038513|FG000|Overall Study|Lack of Efficacy|2
6983029|NCT01245140|11038514|FG001|Overall Study|Lack of Efficacy|4
6983030|NCT01245140|11038513|FG000|Overall Study|Protocol Violation|0
6983031|NCT01245140|11038514|FG001|Overall Study|Protocol Violation|1
6983032|NCT01245140|11038513|FG000|Overall Study|Withdrawal by Subject|0
6983033|NCT01245140|11038514|FG001|Overall Study|Withdrawal by Subject|1
6983034|NCT01245140|11038513|FG000|Overall Study|Refused Treatment/Did Not Coopera|0
6983035|NCT01245140|11038514|FG001|Overall Study|Refused Treatment/Did Not Coopera|1
6983036|NCT01245283|11038534|FG000|Overall Study|Lost to Follow-up|14
6983037|NCT01245283|11038535|FG001|Overall Study|Lost to Follow-up|11
6983038|NCT01245283|11038536|FG002|Overall Study|Lost to Follow-up|11
6983039|NCT01245374|11038547|FG000|Overall Study|Protocol Violation|1
6983040|NCT01245374|11038547|FG000|Overall Study|Withdrawal by Subject|3
6983041|NCT01245387|11038552|FG000|Overall Study|Lost to Follow-up|106
6983042|NCT01245387|11038552|FG000|Overall Study|Lack of Efficacy|195
6983043|NCT01245387|11038552|FG000|Overall Study|Adverse Event|9
6983044|NCT01245387|11038552|FG000|Overall Study|Death|3
6983045|NCT01245387|11038552|FG000|Overall Study|Other|131
6983046|NCT01245387|11038552|FG000|Overall Study|Missing discontinuation status|369
6983047|NCT01245673|11038587|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1
6983048|NCT01245751|11038609|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2
6983049|NCT01245751|11038610|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1
6983050|NCT01245751|11038611|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0
6983051|NCT01245751|11038612|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0
6983052|NCT01245751|11038609|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
6983053|NCT01245751|11038610|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
6983054|NCT01245751|11038611|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
6983055|NCT01245751|11038612|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2
6983056|NCT01245751|11038609|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
6983057|NCT01245751|11038610|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4
6983058|NCT01245751|11038611|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
6983059|NCT01245751|11038612|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
6983060|NCT01245764|11038627|FG000|Study Phase A|Other|3
6983061|NCT01245764|11038628|FG001|Study Phase A|Other|2
6983062|NCT01245764|11038629|FG002|Study Phase A|Other|3
6983063|NCT01245764|11038630|FG003|Study Phase A|Other|1
6983064|NCT01245764|11038627|FG000|Study Phase A|Protocol Violation|6
6983065|NCT01245764|11038628|FG001|Study Phase A|Protocol Violation|3
6983066|NCT01245764|11038629|FG002|Study Phase A|Protocol Violation|2
6983067|NCT01245764|11038630|FG003|Study Phase A|Protocol Violation|2
6983068|NCT01245764|11038627|FG000|Study Phase A|Lost to Follow-up|0
6983069|NCT01245764|11038628|FG001|Study Phase A|Lost to Follow-up|0
6983070|NCT01245764|11038629|FG002|Study Phase A|Lost to Follow-up|5
6983071|NCT01245764|11038630|FG003|Study Phase A|Lost to Follow-up|0
6983072|NCT01246206|11038703|FG000|Overall Study|Patient did not receive study regiments.|1
6983073|NCT01246466|11038732|FG000|Overall Study|Death|1
6983074|NCT01246466|11038732|FG000|Overall Study|Withdrawal by Subject|1
6983075|NCT01246583|11038745|FG000|Overall Study|Lost to Follow-up|0
6983076|NCT01246583|11038746|FG001|Overall Study|Lost to Follow-up|0
6983077|NCT01246583|11038747|FG002|Overall Study|Lost to Follow-up|0
6983078|NCT01246583|11038748|FG003|Overall Study|Lost to Follow-up|1
6983079|NCT01246583|11038745|FG000|Overall Study|Protocol Violation|0
6983080|NCT01246583|11038746|FG001|Overall Study|Protocol Violation|0
6983081|NCT01246583|11038747|FG002|Overall Study|Protocol Violation|1
6983082|NCT01246583|11038748|FG003|Overall Study|Protocol Violation|0
6983083|NCT01246583|11038745|FG000|Overall Study|Withdrawal by Subject|1
6983084|NCT01246583|11038746|FG001|Overall Study|Withdrawal by Subject|0
6983085|NCT01246583|11038747|FG002|Overall Study|Withdrawal by Subject|0
6983086|NCT01246583|11038748|FG003|Overall Study|Withdrawal by Subject|0
6983087|NCT01246960|11038783|FG000|Overall Study|Lost to Follow-up|3
6983088|NCT01246960|11038784|FG001|Overall Study|Lost to Follow-up|1
6983089|NCT01246960|11038783|FG000|Overall Study|Withdrawal (by participant or physician)|3
6983090|NCT01246960|11038784|FG001|Overall Study|Withdrawal (by participant or physician)|3
6983091|NCT01246973|11038792|FG000|Overall Study|Other|38
6983092|NCT01246973|11038793|FG001|Overall Study|Other|25
6983093|NCT01246973|11038792|FG000|Overall Study|Adverse Event|16
6983094|NCT01246973|11038793|FG001|Overall Study|Adverse Event|9
6983095|NCT01246973|11038792|FG000|Overall Study|Withdrawal by Subject|7
6983096|NCT01246973|11038793|FG001|Overall Study|Withdrawal by Subject|13
6983097|NCT01246986|11038806|FG000|Overall Study|Lost to Follow-up|0
6983098|NCT01246986|11038807|FG001|Overall Study|Lost to Follow-up|1
6983099|NCT01246986|11038808|FG002|Overall Study|Lost to Follow-up|3
6983100|NCT01246986|11038809|FG003|Overall Study|Lost to Follow-up|0
6983101|NCT01246986|11038810|FG004|Overall Study|Lost to Follow-up|0
6983102|NCT01246986|11038811|FG005|Overall Study|Lost to Follow-up|1
6983103|NCT01246986|11038812|FG006|Overall Study|Lost to Follow-up|0
6983104|NCT01246986|11038806|FG000|Overall Study|Withdrawal by Subject|3
6983105|NCT01246986|11038807|FG001|Overall Study|Withdrawal by Subject|4
6983106|NCT01246986|11038808|FG002|Overall Study|Withdrawal by Subject|3
6983107|NCT01246986|11038809|FG003|Overall Study|Withdrawal by Subject|0
6983108|NCT01246986|11038810|FG004|Overall Study|Withdrawal by Subject|4
6983109|NCT01246986|11038811|FG005|Overall Study|Withdrawal by Subject|0
6983110|NCT01246986|11038812|FG006|Overall Study|Withdrawal by Subject|0
6983111|NCT01246999|11038847|FG000|Overall Study|Lost to Follow-up|0
6983112|NCT01246999|11038848|FG001|Overall Study|Lost to Follow-up|1
6983113|NCT01246999|11038849|FG002|Overall Study|Lost to Follow-up|0
6983114|NCT01246999|11038850|FG003|Overall Study|Lost to Follow-up|0
6983115|NCT01246999|11038847|FG000|Overall Study|Withdrawal by Subject|0
6983116|NCT01246999|11038848|FG001|Overall Study|Withdrawal by Subject|0
6983117|NCT01246999|11038849|FG002|Overall Study|Withdrawal by Subject|0
6983118|NCT01246999|11038850|FG003|Overall Study|Withdrawal by Subject|2
6983119|NCT01247090|11038875|FG000|Overall Study|Physician Decision|1
6983120|NCT01247090|11038876|FG001|Overall Study|Physician Decision|0
6983121|NCT01247090|11038877|FG002|Overall Study|Physician Decision|0
6983122|NCT01247090|11038875|FG000|Overall Study|Withdrawal by Subject|0
6983123|NCT01247090|11038876|FG001|Overall Study|Withdrawal by Subject|1
6983124|NCT01247090|11038877|FG002|Overall Study|Withdrawal by Subject|0
6983125|NCT01247350|11038922|FG000|Overall Study|Adverse Event|0
6983126|NCT01247350|11038923|FG001|Overall Study|Adverse Event|0
6983127|NCT01247350|11038924|FG002|Overall Study|Adverse Event|1
6983128|NCT01247350|11038925|FG003|Overall Study|Adverse Event|0
6983129|NCT01247350|11038926|FG004|Overall Study|Adverse Event|0
6983130|NCT01247350|11038922|FG000|Overall Study|Withdrawal by Subject|0
6983131|NCT01247350|11038923|FG001|Overall Study|Withdrawal by Subject|0
6983132|NCT01247350|11038924|FG002|Overall Study|Withdrawal by Subject|0
6983133|NCT01247350|11038925|FG003|Overall Study|Withdrawal by Subject|1
6983134|NCT01247350|11038926|FG004|Overall Study|Withdrawal by Subject|0
6983135|NCT01247350|11038922|FG000|Overall Study|Entry criteria not met|0
6983136|NCT01247350|11038923|FG001|Overall Study|Entry criteria not met|0
6983137|NCT01247350|11038924|FG002|Overall Study|Entry criteria not met|0
6983138|NCT01247350|11038925|FG003|Overall Study|Entry criteria not met|0
6983139|NCT01247350|11038926|FG004|Overall Study|Entry criteria not met|1
6983140|NCT01247922|11038994|FG000|Overall Study|Disease progression|4
6983141|NCT01248013|11039007|FG000|Overall Study|Withdrawal by Subject|14
6983142|NCT01248065|11039013|FG000|Overall Study|Lost to Follow-up|3
6983143|NCT01248065|11039014|FG001|Overall Study|Lost to Follow-up|5
6983144|NCT01248065|11039013|FG000|Overall Study|Withdrawal by Subject|14
6983145|NCT01248065|11039014|FG001|Overall Study|Withdrawal by Subject|11
6983146|NCT01248065|11039013|FG000|Overall Study|Adverse Event|3
6983147|NCT01248065|11039014|FG001|Overall Study|Adverse Event|0
6983148|NCT01248065|11039013|FG000|Overall Study|Third treatment failure event|3
6983149|NCT01248065|11039014|FG001|Overall Study|Third treatment failure event|1
6983150|NCT01248065|11039013|FG000|Overall Study|Other|3
6983151|NCT01248065|11039014|FG001|Overall Study|Other|5
6983152|NCT01248364|11039044|FG000|Overall Study|Adverse Event|0
6983153|NCT01248364|11039045|FG001|Overall Study|Adverse Event|1
6983154|NCT01248364|11039046|FG002|Overall Study|Adverse Event|0
6983155|NCT01248364|11039047|FG003|Overall Study|Adverse Event|0
6983156|NCT01248455|11039072|FG000|Overall Study|switched to alternate treatment|1
6983157|NCT01248468|11039079|FG000|Overall Study|Administrative problem|1
6983158|NCT01248468|11039080|FG001|Overall Study|Administrative problem|0
6983159|NCT01248468|11039081|FG002|Overall Study|Administrative problem|0
6983160|NCT01248468|11039079|FG000|Overall Study|Lost to Follow-up|9
6983161|NCT01248468|11039080|FG001|Overall Study|Lost to Follow-up|12
6983162|NCT01248468|11039081|FG002|Overall Study|Lost to Follow-up|4
6983163|NCT01248468|11039079|FG000|Overall Study|Pregnancy|1
6983164|NCT01248468|11039080|FG001|Overall Study|Pregnancy|0
6983165|NCT01248468|11039081|FG002|Overall Study|Pregnancy|0
6983166|NCT01248468|11039079|FG000|Overall Study|Withdrawal by Subject|4
6983167|NCT01248468|11039080|FG001|Overall Study|Withdrawal by Subject|2
6983168|NCT01248468|11039081|FG002|Overall Study|Withdrawal by Subject|0
6983169|NCT01248715|11039100|FG000|Overall Study|Not influenza positive|501
6983170|NCT01248715|11039101|FG001|Overall Study|Not influenza positive|510
6983171|NCT01248728|11039109|FG000|Overall Study|Adverse Event|1
6983172|NCT01248728|11039110|FG001|Overall Study|Adverse Event|1
6983173|NCT01248728|11039109|FG000|Overall Study|Withdrawal by Subject|2
6983174|NCT01248728|11039110|FG001|Overall Study|Withdrawal by Subject|1
6983175|NCT01248728|11039109|FG000|Overall Study|Lack of Efficacy|1
6983176|NCT01248728|11039110|FG001|Overall Study|Lack of Efficacy|0
6983177|NCT01248780|11039124|FG000|Overall Study|Lack of Efficacy|2
6983178|NCT01248780|11039125|FG001|Overall Study|Lack of Efficacy|0
6983179|NCT01248780|11039124|FG000|Overall Study|Lost to Follow-up|0
6983180|NCT01248780|11039125|FG001|Overall Study|Lost to Follow-up|1
6983181|NCT01248780|11039124|FG000|Overall Study|Death|0
6983182|NCT01248780|11039125|FG001|Overall Study|Death|1
6983183|NCT01248780|11039124|FG000|Overall Study|Adverse Event|2
6983184|NCT01248780|11039125|FG001|Overall Study|Adverse Event|7
6983185|NCT01248780|11039124|FG000|Overall Study|Protocol Violation|1
6983186|NCT01248780|11039125|FG001|Overall Study|Protocol Violation|1
6983187|NCT01248780|11039124|FG000|Overall Study|Withdrawal by Subject|4
6983188|NCT01248780|11039125|FG001|Overall Study|Withdrawal by Subject|4
6983189|NCT01248780|11039124|FG000|Overall Study|Not treated|0
6983190|NCT01248780|11039125|FG001|Overall Study|Not treated|1
6983191|NCT01248793|11039133|FG000|Overall Study|Lost to Follow-up|0
6983192|NCT01248793|11039134|FG001|Overall Study|Lost to Follow-up|1
6983193|NCT01248793|11039133|FG000|Overall Study|Adverse Event|1
6983194|NCT01248793|11039134|FG001|Overall Study|Adverse Event|1
6983195|NCT01248793|11039133|FG000|Overall Study|Protocol Violation|0
6983196|NCT01248793|11039134|FG001|Overall Study|Protocol Violation|1
6983197|NCT01248793|11039133|FG000|Overall Study|Withdrawal by Subject|3
6983198|NCT01248793|11039134|FG001|Overall Study|Withdrawal by Subject|3
6983199|NCT01248884|11039143|FG000|Overall Study|Withdrawal by Subject|1
6983200|NCT01248884|11039144|FG001|Overall Study|Withdrawal by Subject|3
6983201|NCT01248884|11039145|FG002|Overall Study|Withdrawal by Subject|1
6983202|NCT01248884|11039143|FG000|Overall Study|Adverse Event|1
6983203|NCT01248884|11039144|FG001|Overall Study|Adverse Event|0
6983204|NCT01248884|11039145|FG002|Overall Study|Adverse Event|0
6983205|NCT01248936|11039155|FG000|Overall Study|Sponsor Decision|259
6983206|NCT01248936|11039155|FG000|Overall Study|Progression of Disease|50
6983207|NCT01248936|11039155|FG000|Overall Study|Death|26
6983208|NCT01248936|11039155|FG000|Overall Study|Withdrawal of Consent|20
6983209|NCT01248936|11039155|FG000|Overall Study|Adverse Event|8
6983210|NCT01248936|11039155|FG000|Overall Study|Lost to Follow-up|7
6983211|NCT01248936|11039155|FG000|Overall Study|Refused Treatment|1
6983212|NCT01248936|11039155|FG000|Overall Study|Other reason|3
6983213|NCT01248949|11039165|FG000|Overall Study|Lost to Follow-up|2
6983214|NCT01248949|11039166|FG001|Overall Study|Lost to Follow-up|2
6983215|NCT01248949|11039167|FG002|Overall Study|Lost to Follow-up|2
6983216|NCT01248949|11039168|FG003|Overall Study|Lost to Follow-up|1
6983217|NCT01248949|11039169|FG004|Overall Study|Lost to Follow-up|0
6983218|NCT01248949|11039165|FG000|Overall Study|Withdrawal by Subject|5
6983219|NCT01248949|11039166|FG001|Overall Study|Withdrawal by Subject|3
6983220|NCT01248949|11039167|FG002|Overall Study|Withdrawal by Subject|11
6983221|NCT01248949|11039168|FG003|Overall Study|Withdrawal by Subject|3
6983222|NCT01248949|11039169|FG004|Overall Study|Withdrawal by Subject|1
6983223|NCT01248949|11039165|FG000|Overall Study|Death|22
6983224|NCT01248949|11039166|FG001|Overall Study|Death|7
6983225|NCT01248949|11039167|FG002|Overall Study|Death|21
6983226|NCT01248949|11039168|FG003|Overall Study|Death|6
6983227|NCT01248949|11039169|FG004|Overall Study|Death|2
6983228|NCT01248949|11039165|FG000|Overall Study|Alternative Therapy|1
6983229|NCT01248949|11039166|FG001|Overall Study|Alternative Therapy|0
6983230|NCT01248949|11039167|FG002|Overall Study|Alternative Therapy|0
6983231|NCT01248949|11039168|FG003|Overall Study|Alternative Therapy|0
6983232|NCT01248949|11039169|FG004|Overall Study|Alternative Therapy|0
6983233|NCT01248949|11039165|FG000|Overall Study|Alternative Therapy.|1
6983234|NCT01248949|11039166|FG001|Overall Study|Alternative Therapy.|0
6983235|NCT01248949|11039167|FG002|Overall Study|Alternative Therapy.|0
6983236|NCT01248949|11039168|FG003|Overall Study|Alternative Therapy.|0
6983237|NCT01248949|11039169|FG004|Overall Study|Alternative Therapy.|0
6983238|NCT01248949|11039165|FG000|Overall Study|Palliative Radiation To Brain Metastases|1
6983239|NCT01248949|11039166|FG001|Overall Study|Palliative Radiation To Brain Metastases|0
6983240|NCT01248949|11039167|FG002|Overall Study|Palliative Radiation To Brain Metastases|0
6983241|NCT01248949|11039168|FG003|Overall Study|Palliative Radiation To Brain Metastases|0
6983242|NCT01248949|11039169|FG004|Overall Study|Palliative Radiation To Brain Metastases|0
6983243|NCT01248949|11039165|FG000|Overall Study|Entered Hospice And Refused Follow Up|0
6983244|NCT01248949|11039166|FG001|Overall Study|Entered Hospice And Refused Follow Up|0
6983245|NCT01248949|11039167|FG002|Overall Study|Entered Hospice And Refused Follow Up|0
6983246|NCT01248949|11039168|FG003|Overall Study|Entered Hospice And Refused Follow Up|0
6983247|NCT01248949|11039169|FG004|Overall Study|Entered Hospice And Refused Follow Up|1
6983248|NCT01248949|11039165|FG000|Overall Study|Participant Went To Hospice|0
6983249|NCT01248949|11039166|FG001|Overall Study|Participant Went To Hospice|0
6983250|NCT01248949|11039167|FG002|Overall Study|Participant Went To Hospice|1
6983251|NCT01248949|11039168|FG003|Overall Study|Participant Went To Hospice|0
6983252|NCT01248949|11039169|FG004|Overall Study|Participant Went To Hospice|0
6983253|NCT01248949|11039165|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1
6983254|NCT01248949|11039166|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0
6983255|NCT01248949|11039167|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0
6983256|NCT01248949|11039168|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0
6983257|NCT01248949|11039169|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0
6983258|NCT01248949|11039165|FG000|Overall Study|Pi Decision Due To Declining Status|0
6983259|NCT01248949|11039166|FG001|Overall Study|Pi Decision Due To Declining Status|0
6983260|NCT01248949|11039167|FG002|Overall Study|Pi Decision Due To Declining Status|1
6983261|NCT01248949|11039168|FG003|Overall Study|Pi Decision Due To Declining Status|0
6983262|NCT01248949|11039169|FG004|Overall Study|Pi Decision Due To Declining Status|0
6983263|NCT01248949|11039165|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0
6983264|NCT01248949|11039166|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1
6983265|NCT01248949|11039167|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0
6983266|NCT01248949|11039168|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0
6983267|NCT01248949|11039169|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0
6983268|NCT01248949|11039165|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
6983269|NCT01248949|11039166|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
6983270|NCT01248949|11039167|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1
6983271|NCT01248949|11039168|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
6983272|NCT01248949|11039169|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
6983273|NCT01248962|11039183|FG000|Overall Study|Withdrawal by Subject|1
6983274|NCT01248962|11039184|FG001|Overall Study|Withdrawal by Subject|1
6983275|NCT01248962|11039183|FG000|Overall Study|Adverse Event|2
6983276|NCT01248962|11039184|FG001|Overall Study|Adverse Event|1
6983277|NCT01248962|11039183|FG000|Overall Study|Complete Response after 4 Cycles|1
6983278|NCT01248962|11039184|FG001|Overall Study|Complete Response after 4 Cycles|0
6983279|NCT01248962|11039183|FG000|Overall Study|Complete Response after 3 Cycles|0
6983280|NCT01248962|11039184|FG001|Overall Study|Complete Response after 3 Cycles|1
6983281|NCT01248962|11039183|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12
6983282|NCT01248962|11039184|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13
6983283|NCT01249092|11039195|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1
6983284|NCT01249092|11039195|FG000|Overall Study|Unable to tolerate expected SE -nausea|1
6983285|NCT01249118|11039201|FG000|First Washout Period|Physician Decision|0
6983286|NCT01249118|11039202|FG001|First Washout Period|Physician Decision|1
6983287|NCT01249118|11039203|FG002|First Washout Period|Physician Decision|0
6983288|NCT01249131|11039210|FG000|Washout Period of 10 Days|Adverse Event|0
6983289|NCT01249131|11039211|FG001|Washout Period of 10 Days|Adverse Event|0
6983290|NCT01249131|11039212|FG002|Washout Period of 10 Days|Adverse Event|0
6983291|NCT01249131|11039213|FG003|Washout Period of 10 Days|Adverse Event|0
6983292|NCT01249131|11039214|FG004|Washout Period of 10 Days|Adverse Event|1
6983293|NCT01249131|11039215|FG005|Washout Period of 10 Days|Adverse Event|0
6983294|NCT01249261|11039225|FG000|Overall Study|Withdrawal by Subject|1
6983295|NCT01249261|11039226|FG001|Overall Study|Withdrawal by Subject|0
6983296|NCT01249274|11039234|FG000|Overall Study|Lost to Follow-up|3
6983297|NCT01249274|11039235|FG001|Overall Study|Lost to Follow-up|4
6983298|NCT01249274|11039234|FG000|Overall Study|Received inpatient substance treatment|1
6983299|NCT01249274|11039235|FG001|Overall Study|Received inpatient substance treatment|2
6983300|NCT01249365|11039243|FG000|Overall Study|Lost to Follow-up|1
6983301|NCT01249404|11039250|FG000|Overall Study|Study treatment not received|0
6983302|NCT01249404|11039251|FG001|Overall Study|Study treatment not received|1
6983303|NCT01249404|11039252|FG002|Overall Study|Study treatment not received|2
6983304|NCT01249404|11039250|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2
6983305|NCT01249404|11039251|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0
6983306|NCT01249404|11039252|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2
6983307|NCT01249404|11039250|FG000|Overall Study|Adverse Event|2
6983308|NCT01249404|11039251|FG001|Overall Study|Adverse Event|2
6983309|NCT01249404|11039252|FG002|Overall Study|Adverse Event|2
6983310|NCT01249404|11039250|FG000|Overall Study|Withdrawal by Subject|2
6983311|NCT01249404|11039251|FG001|Overall Study|Withdrawal by Subject|2
6983312|NCT01249404|11039252|FG002|Overall Study|Withdrawal by Subject|0
6983313|NCT01249404|11039250|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1
6983314|NCT01249404|11039251|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2
6983315|NCT01249404|11039252|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1
6983316|NCT01249404|11039250|FG000|Overall Study|Non compliance to visit schedule|0
6983317|NCT01249404|11039251|FG001|Overall Study|Non compliance to visit schedule|1
6983318|NCT01249404|11039252|FG002|Overall Study|Non compliance to visit schedule|0
6983319|NCT01249417|11039263|FG000|Randomised Population|Study treatment not received|0
6983320|NCT01249417|11039264|FG001|Randomised Population|Study treatment not received|0
6983321|NCT01249417|11039265|FG002|Randomised Population|Study treatment not received|2
6983322|NCT01249417|11039263|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1
6983323|NCT01249417|11039264|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1
6983324|NCT01249417|11039265|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2
6983325|NCT01249417|11039263|FG000|Treatment Phase - ITT Population|Other|0
6983326|NCT01249417|11039264|FG001|Treatment Phase - ITT Population|Other|0
6983327|NCT01249417|11039265|FG002|Treatment Phase - ITT Population|Other|1
6983328|NCT01249417|11039263|FG000|Treatment Phase - ITT Population|Adverse Event|0
6983329|NCT01249417|11039264|FG001|Treatment Phase - ITT Population|Adverse Event|0
6983330|NCT01249417|11039265|FG002|Treatment Phase - ITT Population|Adverse Event|1
6983331|NCT01249417|11039263|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1
6983332|NCT01249417|11039264|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3
6983333|NCT01249417|11039265|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1
6983334|NCT01249417|11039263|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0
6983335|NCT01249417|11039264|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1
6983336|NCT01249417|11039265|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1
6983337|NCT01249651|11039282|FG000|Overall Study|Withdrawal by Subject|4
6983338|NCT01249651|11039282|FG000|Overall Study|Adverse Event|1
6983339|NCT01249651|11039282|FG000|Overall Study|Protocol Violation|1
6983340|NCT01249651|11039282|FG000|Overall Study|Sponsor Decision|1
6983341|NCT01249664|11039288|FG000|Overall Study|Withdrawal by Subject|5
6983342|NCT01249664|11039289|FG001|Overall Study|Withdrawal by Subject|0
6983343|NCT01249664|11039288|FG000|Overall Study|Adverse Event|1
6983344|NCT01249664|11039289|FG001|Overall Study|Adverse Event|0
6983345|NCT01249833|11039299|FG000|Overall Study|Lost to Follow-up|0
6983346|NCT01249833|11039300|FG001|Overall Study|Lost to Follow-up|1
6983347|NCT01250002|11039341|FG000|Overall Study|Change to open surgical procedure|4
6983348|NCT01250002|11039342|FG001|Overall Study|Change to open surgical procedure|3
6983349|NCT01250054|11039348|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1
6983350|NCT01250054|11039349|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0
6983351|NCT01250119|11039355|FG000|Diagnostic Phase|Failed to Produce a Test Results|69
6983352|NCT01250119|11039356|FG001|Diagnostic Phase|Failed to Produce a Test Results|0
6983353|NCT01250119|11039355|FG000|Diagnostic Phase|Participants Not Tested|44
6983354|NCT01250119|11039356|FG001|Diagnostic Phase|Participants Not Tested|0
6983355|NCT01250119|11039355|FG000|Treatment Phase|Progressive Disease|0
6983356|NCT01250119|11039356|FG001|Treatment Phase|Progressive Disease|32
6983357|NCT01250119|11039355|FG000|Treatment Phase|Death|0
6983358|NCT01250119|11039356|FG001|Treatment Phase|Death|2
6983359|NCT01250119|11039355|FG000|Treatment Phase|Withdrawal by Subject|0
6983360|NCT01250119|11039356|FG001|Treatment Phase|Withdrawal by Subject|1
6983361|NCT01250119|11039355|FG000|Treatment Phase|Adverse Event|0
6983362|NCT01250119|11039356|FG001|Treatment Phase|Adverse Event|2
6983363|NCT01250119|11039355|FG000|Treatment Phase|Unknown reason|0
6983364|NCT01250119|11039356|FG001|Treatment Phase|Unknown reason|4
6983365|NCT01250145|11039365|FG000|Overall Study|Adverse Event|2
6983366|NCT01250145|11039366|FG001|Overall Study|Adverse Event|1
6983367|NCT01250145|11039365|FG000|Overall Study|Withdrawal by Subject|0
6983368|NCT01250145|11039366|FG001|Overall Study|Withdrawal by Subject|4
6983369|NCT01250171|11039389|FG000|Overall Study|Administrative reasons|1
6983370|NCT01250171|11039390|FG001|Overall Study|Administrative reasons|0
6983371|NCT01250171|11039391|FG002|Overall Study|Administrative reasons|0
6983372|NCT01250379|11039427|FG000|Overall Study|Death|141
6983373|NCT01250379|11039428|FG001|Overall Study|Death|148
6983374|NCT01250379|11039427|FG000|Overall Study|Withdrawal by Subject|32
6983375|NCT01250379|11039428|FG001|Overall Study|Withdrawal by Subject|20
6983376|NCT01250379|11039427|FG000|Overall Study|Physician Decision|11
6983377|NCT01250379|11039428|FG001|Overall Study|Physician Decision|3
6983378|NCT01250379|11039427|FG000|Overall Study|Protocol Violation|2
6983379|NCT01250379|11039428|FG001|Overall Study|Protocol Violation|8
6983380|NCT01250379|11039427|FG000|Overall Study|Lost to Follow-up|9
6983381|NCT01250379|11039428|FG001|Overall Study|Lost to Follow-up|6
6983382|NCT01250379|11039427|FG000|Overall Study|Adverse Event|5
6983383|NCT01250379|11039428|FG001|Overall Study|Adverse Event|4
6983384|NCT01250379|11039427|FG000|Overall Study|Other|0
6983385|NCT01250379|11039428|FG001|Overall Study|Other|4
6983386|NCT01250379|11039427|FG000|Overall Study|Participant noncompliance|2
6983387|NCT01250379|11039428|FG001|Overall Study|Participant noncompliance|0
6983388|NCT01250418|11039436|FG000|Overall Study|monitor data failure|1
6983389|NCT01250418|11039437|FG001|Overall Study|monitor data failure|1
6983390|NCT01250509|11039445|FG000|Overall Study|Lost to Follow-up|5
6983391|NCT01250509|11039446|FG001|Overall Study|Lost to Follow-up|2
6983392|NCT01250756|11039473|FG000|Infant Series|Withdrawal by Subject|4
6983393|NCT01250756|11039474|FG001|Infant Series|Withdrawal by Subject|5
6983394|NCT01250756|11039473|FG000|Infant Series|Randomized, Not Vaccinated|2
6983395|NCT01250756|11039474|FG001|Infant Series|Randomized, Not Vaccinated|2
6983396|NCT01250756|11039473|FG000|Infant Series|Other|22
6983397|NCT01250756|11039474|FG001|Infant Series|Other|0
6983398|NCT01250756|11039473|FG000|After Infant Series|Adverse Event|5
6983399|NCT01250756|11039474|FG001|After Infant Series|Adverse Event|2
6983400|NCT01250756|11039473|FG000|After Infant Series|Withdrawal by Subject|4
6983401|NCT01250756|11039474|FG001|After Infant Series|Withdrawal by Subject|1
6983402|NCT01250756|11039473|FG000|After Infant Series|Other|2
6983403|NCT01250756|11039474|FG001|After Infant Series|Other|1
6983404|NCT01250756|11039473|FG000|Toddler Dose|Adverse Event|0
6983405|NCT01250756|11039474|FG001|Toddler Dose|Adverse Event|1
6983406|NCT01250756|11039473|FG000|After Toddler Dose|Adverse Event|0
6983407|NCT01250756|11039474|FG001|After Toddler Dose|Adverse Event|1
6983408|NCT01250769|11039490|FG000|Overall Study|Withdrawal by Subject|0
6983409|NCT01250769|11039491|FG001|Overall Study|Withdrawal by Subject|1
6983410|NCT01250769|11039492|FG002|Overall Study|Withdrawal by Subject|1
6983411|NCT01250769|11039493|FG003|Overall Study|Withdrawal by Subject|0
6983412|NCT01250769|11039490|FG000|Overall Study|Adverse Event|0
6983413|NCT01250769|11039491|FG001|Overall Study|Adverse Event|0
6983414|NCT01250769|11039492|FG002|Overall Study|Adverse Event|1
6983415|NCT01250769|11039493|FG003|Overall Study|Adverse Event|0
7041924|NCT01731990|11125859|FG000|Overall Study|Protocol deviation|1
7041925|NCT01731990|11125860|FG001|Overall Study|Protocol deviation|2
7041926|NCT01731990|11125859|FG000|Overall Study|Death|1
7041927|NCT01731990|11125860|FG001|Overall Study|Death|0
7041928|NCT01732107|11125866|FG000|Overall Study|Adverse Event|2
7041929|NCT01732107|11125866|FG000|Overall Study|Disease Progression|8
7041930|NCT01732107|11125866|FG000|Overall Study|Physician Decision|1
7041931|NCT01732107|11125866|FG000|Overall Study|Withdrawal by Subject|2
7041932|NCT01732458|11125917|FG000|Overall Study|Lost to Follow-up|0
7041933|NCT01732458|11125918|FG001|Overall Study|Lost to Follow-up|2
7041934|NCT01732458|11125919|FG002|Overall Study|Lost to Follow-up|0
7041935|NCT01732458|11125920|FG003|Overall Study|Lost to Follow-up|0
7041936|NCT01732458|11125917|FG000|Overall Study|Non-Compliance With Study Drug|0
7041937|NCT01732458|11125918|FG001|Overall Study|Non-Compliance With Study Drug|0
7041938|NCT01732458|11125919|FG002|Overall Study|Non-Compliance With Study Drug|1
7041939|NCT01732458|11125920|FG003|Overall Study|Non-Compliance With Study Drug|0
7041940|NCT01732458|11125917|FG000|Overall Study|Physician Decision|1
7041941|NCT01732458|11125918|FG001|Overall Study|Physician Decision|2
7041942|NCT01732458|11125919|FG002|Overall Study|Physician Decision|2
7041943|NCT01732458|11125920|FG003|Overall Study|Physician Decision|0
7041944|NCT01732458|11125917|FG000|Overall Study|Protocol Violation|2
7041945|NCT01732458|11125918|FG001|Overall Study|Protocol Violation|0
7041946|NCT01732458|11125919|FG002|Overall Study|Protocol Violation|0
7041947|NCT01732458|11125920|FG003|Overall Study|Protocol Violation|2
7041948|NCT01732458|11125917|FG000|Overall Study|Screen Failure|0
7041949|NCT01732458|11125918|FG001|Overall Study|Screen Failure|1
7041950|NCT01732458|11125919|FG002|Overall Study|Screen Failure|0
7041951|NCT01732458|11125920|FG003|Overall Study|Screen Failure|0
7041952|NCT01732471|11125942|FG000|Overall Study|Withdrawal by Subject|1
7041953|NCT01732484|11125946|FG000|Overall Study|Death|7
7041954|NCT01732484|11125946|FG000|Overall Study|Lost to Follow-up|14
7041955|NCT01732484|11125946|FG000|Overall Study|chronical illness|5
7041956|NCT01732510|11125959|FG000|Overall Study|Adverse Event|0
7041957|NCT01732510|11125960|FG001|Overall Study|Adverse Event|1
7041958|NCT01732510|11125961|FG002|Overall Study|Adverse Event|1
7041959|NCT01732510|11125962|FG003|Overall Study|Adverse Event|0
7041960|NCT01732510|11125963|FG004|Overall Study|Adverse Event|0
7041961|NCT01732510|11125964|FG005|Overall Study|Adverse Event|0
7041962|NCT01732510|11125965|FG006|Overall Study|Adverse Event|1
7041963|NCT01732510|11125959|FG000|Overall Study|Protocol Violation|0
7041964|NCT01732510|11125960|FG001|Overall Study|Protocol Violation|0
7041965|NCT01732510|11125961|FG002|Overall Study|Protocol Violation|0
7041966|NCT01732510|11125962|FG003|Overall Study|Protocol Violation|1
7041967|NCT01732510|11125963|FG004|Overall Study|Protocol Violation|0
7041968|NCT01732510|11125964|FG005|Overall Study|Protocol Violation|0
7041969|NCT01732510|11125965|FG006|Overall Study|Protocol Violation|0
7041970|NCT01732510|11125959|FG000|Overall Study|Withdrawal by Subject|1
7041971|NCT01732510|11125960|FG001|Overall Study|Withdrawal by Subject|3
6983416|NCT01250873|11039510|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2
6983417|NCT01250873|11039510|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1
6983418|NCT01250925|11039526|FG000|Overall Study|Lost to Follow-up|1
6983419|NCT01250925|11039527|FG001|Overall Study|Lost to Follow-up|1
6983420|NCT01250925|11039528|FG002|Overall Study|Lost to Follow-up|0
6983421|NCT01250925|11039526|FG000|Overall Study|Withdrawal by Subject|2
6983422|NCT01250925|11039527|FG001|Overall Study|Withdrawal by Subject|0
6983423|NCT01250925|11039528|FG002|Overall Study|Withdrawal by Subject|0
6983424|NCT01250925|11039526|FG000|Overall Study|Protocol Violation|2
6983425|NCT01250925|11039527|FG001|Overall Study|Protocol Violation|0
6983426|NCT01250925|11039528|FG002|Overall Study|Protocol Violation|0
6983427|NCT01250925|11039526|FG000|Overall Study|Physician Decision|0
6983428|NCT01250925|11039527|FG001|Overall Study|Physician Decision|2
6983429|NCT01250925|11039528|FG002|Overall Study|Physician Decision|1
6983430|NCT01250925|11039526|FG000|Overall Study|Adverse Event|0
6983431|NCT01250925|11039527|FG001|Overall Study|Adverse Event|0
6983432|NCT01250925|11039528|FG002|Overall Study|Adverse Event|1
6983433|NCT01251146|11039565|FG000|Overall Study|Lost to Follow-up|3
6983434|NCT01251146|11039566|FG001|Overall Study|Lost to Follow-up|10
6983435|NCT01251276|11039574|FG000|Overall Study|Protocol Violation|1
6983436|NCT01251276|11039575|FG001|Overall Study|Protocol Violation|0
6983437|NCT01251276|11039574|FG000|Overall Study|Lost to Follow-up|0
6983438|NCT01251276|11039575|FG001|Overall Study|Lost to Follow-up|1
6983439|NCT01251354|11039610|FG000|Overall Study|Adverse Event|1
6983440|NCT01251354|11039610|FG000|Overall Study|Investigator's Decision|1
6983441|NCT01251354|11039610|FG000|Overall Study|Disease Progression|4
6983442|NCT01251367|11039614|FG000|Overall Study|Protocol Violation|1
6983443|NCT01251367|11039614|FG000|Overall Study|Lack of Efficacy|2
6983444|NCT01251367|11039614|FG000|Overall Study|Adverse Event|19
6983445|NCT01251367|11039614|FG000|Overall Study|Withdrawal by Subject|36
6983446|NCT01251367|11039614|FG000|Overall Study|Lost to Follow-up|5
6983447|NCT01251367|11039614|FG000|Overall Study|Subject Required Alternative Treatment|7
6983448|NCT01251367|11039614|FG000|Overall Study|No Study Drug Available|1
6983449|NCT01251367|11039614|FG000|Overall Study|Subject had Personal or Medical Issues|4
6983450|NCT01251367|11039614|FG000|Overall Study|End of Study Visit Performed in Error|1
6983451|NCT01251380|11039618|FG000|Overall Study|Other (Not otherwise specified)|12
6983452|NCT01251380|11039618|FG000|Overall Study|Withdrawal by Subject|6
6983453|NCT01251380|11039618|FG000|Overall Study|Lack of Efficacy|1
6983454|NCT01251380|11039618|FG000|Overall Study|Adverse Event|1
6983455|NCT01251380|11039618|FG000|Overall Study|Lost to Follow-up|2
6983456|NCT01251614|11039671|FG000|Overall Study|Adverse Event|1
6983457|NCT01251614|11039672|FG001|Overall Study|Adverse Event|0
6983458|NCT01251614|11039673|FG002|Overall Study|Adverse Event|1
6983459|NCT01251614|11039671|FG000|Overall Study|Lack of Efficacy|1
6983460|NCT01251614|11039672|FG001|Overall Study|Lack of Efficacy|9
6983461|NCT01251614|11039673|FG002|Overall Study|Lack of Efficacy|4
6983462|NCT01251614|11039671|FG000|Overall Study|Clearing of Psoriatic Lesions|1
6983463|NCT01251614|11039672|FG001|Overall Study|Clearing of Psoriatic Lesions|0
6983464|NCT01251614|11039673|FG002|Overall Study|Clearing of Psoriatic Lesions|0
6983465|NCT01251614|11039671|FG000|Overall Study|Pregnancy|0
6983466|NCT01251614|11039672|FG001|Overall Study|Pregnancy|0
6983467|NCT01251614|11039673|FG002|Overall Study|Pregnancy|2
6983468|NCT01251614|11039671|FG000|Overall Study|Loss of Disease Control|0
6983469|NCT01251614|11039672|FG001|Overall Study|Loss of Disease Control|1
6983470|NCT01251614|11039673|FG002|Overall Study|Loss of Disease Control|0
6983471|NCT01251614|11039671|FG000|Overall Study|Withdrawal by Subject|0
6983472|NCT01251614|11039672|FG001|Overall Study|Withdrawal by Subject|2
6983473|NCT01251614|11039673|FG002|Overall Study|Withdrawal by Subject|1
6983474|NCT01251614|11039671|FG000|Overall Study|Lost to Follow-up|0
6983475|NCT01251614|11039672|FG001|Overall Study|Lost to Follow-up|1
6983476|NCT01251614|11039673|FG002|Overall Study|Lost to Follow-up|0
6983477|NCT01251653|11039700|FG000|Overall Study|Progressive Disease|1
6983478|NCT01251653|11039701|FG001|Overall Study|Progressive Disease|7
6983479|NCT01251653|11039702|FG002|Overall Study|Progressive Disease|16
6983480|NCT01251653|11039703|FG003|Overall Study|Progressive Disease|4
6983481|NCT01251653|11039704|FG004|Overall Study|Progressive Disease|0
6983482|NCT01251653|11039705|FG005|Overall Study|Progressive Disease|17
6983483|NCT01251653|11039706|FG006|Overall Study|Progressive Disease|14
6983484|NCT01251653|11039707|FG007|Overall Study|Progressive Disease|7
6983485|NCT01251653|11039708|FG008|Overall Study|Progressive Disease|5
6983486|NCT01251653|11039700|FG000|Overall Study|Dose-limiting toxicity|0
6983487|NCT01251653|11039701|FG001|Overall Study|Dose-limiting toxicity|1
6983488|NCT01251653|11039702|FG002|Overall Study|Dose-limiting toxicity|1
6983489|NCT01251653|11039703|FG003|Overall Study|Dose-limiting toxicity|1
6983490|NCT01251653|11039704|FG004|Overall Study|Dose-limiting toxicity|0
6983491|NCT01251653|11039705|FG005|Overall Study|Dose-limiting toxicity|0
6983492|NCT01251653|11039706|FG006|Overall Study|Dose-limiting toxicity|2
6983493|NCT01251653|11039707|FG007|Overall Study|Dose-limiting toxicity|0
6983494|NCT01251653|11039708|FG008|Overall Study|Dose-limiting toxicity|0
6983495|NCT01251653|11039700|FG000|Overall Study|Adverse Event|1
6983496|NCT01251653|11039701|FG001|Overall Study|Adverse Event|0
6983497|NCT01251653|11039702|FG002|Overall Study|Adverse Event|2
6983498|NCT01251653|11039703|FG003|Overall Study|Adverse Event|1
6983499|NCT01251653|11039704|FG004|Overall Study|Adverse Event|1
6983500|NCT01251653|11039705|FG005|Overall Study|Adverse Event|0
6983501|NCT01251653|11039706|FG006|Overall Study|Adverse Event|2
6983502|NCT01251653|11039707|FG007|Overall Study|Adverse Event|2
6983503|NCT01251653|11039708|FG008|Overall Study|Adverse Event|1
6983504|NCT01251653|11039700|FG000|Overall Study|Withdrawal by Subject|1
6983505|NCT01251653|11039701|FG001|Overall Study|Withdrawal by Subject|0
6983506|NCT01251653|11039702|FG002|Overall Study|Withdrawal by Subject|1
6983507|NCT01251653|11039703|FG003|Overall Study|Withdrawal by Subject|0
6983508|NCT01251653|11039704|FG004|Overall Study|Withdrawal by Subject|1
6983509|NCT01251653|11039705|FG005|Overall Study|Withdrawal by Subject|1
6983510|NCT01251653|11039706|FG006|Overall Study|Withdrawal by Subject|0
6983511|NCT01251653|11039707|FG007|Overall Study|Withdrawal by Subject|1
6983512|NCT01251653|11039708|FG008|Overall Study|Withdrawal by Subject|0
6983513|NCT01251653|11039700|FG000|Overall Study|Other reason not mentioned above|0
6983514|NCT01251653|11039701|FG001|Overall Study|Other reason not mentioned above|0
6983515|NCT01251653|11039702|FG002|Overall Study|Other reason not mentioned above|0
6983516|NCT01251653|11039703|FG003|Overall Study|Other reason not mentioned above|0
6983517|NCT01251653|11039704|FG004|Overall Study|Other reason not mentioned above|0
6983518|NCT01251653|11039705|FG005|Overall Study|Other reason not mentioned above|0
6983519|NCT01251653|11039706|FG006|Overall Study|Other reason not mentioned above|0
6983520|NCT01251653|11039707|FG007|Overall Study|Other reason not mentioned above|2
6983521|NCT01251653|11039708|FG008|Overall Study|Other reason not mentioned above|0
6983522|NCT01251744|11039746|FG000|Overall Study|Lost to Follow-up|1
6983523|NCT01251744|11039747|FG001|Overall Study|Lost to Follow-up|0
6983524|NCT01251770|11039779|FG000|Overall Study|Protocol Violation|13
6983525|NCT01251770|11039780|FG001|Overall Study|Protocol Violation|7
6983526|NCT01251887|11039789|FG000|Overall Study|Scheduling conflict|1
6983527|NCT01251887|11039790|FG001|Overall Study|Scheduling conflict|2
6983528|NCT01251887|11039791|FG002|Overall Study|Scheduling conflict|2
6983529|NCT01251887|11039789|FG000|Overall Study|Physician Decision|0
6983530|NCT01251887|11039790|FG001|Overall Study|Physician Decision|1
6983531|NCT01251887|11039791|FG002|Overall Study|Physician Decision|0
6983532|NCT01251965|11039802|FG000|Overall Study|Participant/physician decision|1
6983533|NCT01251965|11039803|FG001|Overall Study|Participant/physician decision|2
6983534|NCT01251965|11039804|FG002|Overall Study|Participant/physician decision|0
6983535|NCT01251965|11039802|FG000|Overall Study|Death|0
6983536|NCT01251965|11039803|FG001|Overall Study|Death|0
6983537|NCT01251965|11039804|FG002|Overall Study|Death|11
6983538|NCT01252095|11039824|FG000|Overall Study|Disease progression|1
6983539|NCT01252095|11039825|FG001|Overall Study|Disease progression|0
6983540|NCT01252134|11039831|FG000|Period 1, 8 Hours|Personal Reasons|0
6983541|NCT01252134|11039832|FG001|Period 1, 8 Hours|Personal Reasons|1
6983542|NCT01252134|11039833|FG002|Period 1, 8 Hours|Personal Reasons|1
6983543|NCT01252134|11039834|FG003|Period 1, 8 Hours|Personal Reasons|0
6983544|NCT01252134|11039835|FG004|Period 1, 8 Hours|Personal Reasons|0
6983545|NCT01252134|11039836|FG005|Period 1, 8 Hours|Personal Reasons|0
6983546|NCT01252186|11039851|FG000|Overall Study|Adverse Event|9
6983547|NCT01252186|11039852|FG001|Overall Study|Adverse Event|6
6983548|NCT01252186|11039853|FG002|Overall Study|Adverse Event|8
6983549|NCT01252186|11039851|FG000|Overall Study|Withdrawal by Subject|2
6983550|NCT01252186|11039852|FG001|Overall Study|Withdrawal by Subject|5
6983551|NCT01252186|11039853|FG002|Overall Study|Withdrawal by Subject|2
6983552|NCT01252186|11039851|FG000|Overall Study|Physician Decision|0
6983553|NCT01252186|11039852|FG001|Overall Study|Physician Decision|0
6983554|NCT01252186|11039853|FG002|Overall Study|Physician Decision|1
6983555|NCT01252186|11039851|FG000|Overall Study|Non-compliance|0
6983556|NCT01252186|11039852|FG001|Overall Study|Non-compliance|3
6983557|NCT01252186|11039853|FG002|Overall Study|Non-compliance|4
6983558|NCT01252186|11039851|FG000|Overall Study|Protocol Violation|0
6983559|NCT01252186|11039852|FG001|Overall Study|Protocol Violation|0
6983560|NCT01252186|11039853|FG002|Overall Study|Protocol Violation|1
6983561|NCT01252186|11039851|FG000|Overall Study|Pregnancy|2
6983562|NCT01252186|11039852|FG001|Overall Study|Pregnancy|2
6983563|NCT01252186|11039853|FG002|Overall Study|Pregnancy|0
6983564|NCT01252186|11039851|FG000|Overall Study|Sponsor Request|2
6983565|NCT01252186|11039852|FG001|Overall Study|Sponsor Request|1
6983566|NCT01252186|11039853|FG002|Overall Study|Sponsor Request|0
6983567|NCT01252186|11039851|FG000|Overall Study|Lost to Follow-up|10
6983568|NCT01252186|11039852|FG001|Overall Study|Lost to Follow-up|10
6983569|NCT01252186|11039853|FG002|Overall Study|Lost to Follow-up|11
6983570|NCT01252186|11039851|FG000|Overall Study|Other - Miscellaneous Reasons|5
6983571|NCT01252186|11039852|FG001|Overall Study|Other - Miscellaneous Reasons|5
6983572|NCT01252186|11039853|FG002|Overall Study|Other - Miscellaneous Reasons|7
6983573|NCT01252238|11039864|FG000|Overall Study|Sponsor terminated study|4
6983574|NCT01252238|11039865|FG001|Overall Study|Sponsor terminated study|4
6983575|NCT01252238|11039866|FG002|Overall Study|Sponsor terminated study|4
6983576|NCT01252251|11039877|FG000|Overall Study|Withdrawal by Subject|1
6983577|NCT01252290|11039886|FG000|Overall Study|Withdrawal by Subject|1
6983578|NCT01252355|11039893|FG000|Overall Study|Adverse Event|9
6983579|NCT01252355|11039894|FG001|Overall Study|Adverse Event|17
6983580|NCT01252355|11039895|FG002|Overall Study|Adverse Event|22
6983581|NCT01252355|11039893|FG000|Overall Study|Lack of Efficacy|6
6983582|NCT01252355|11039894|FG001|Overall Study|Lack of Efficacy|4
6983583|NCT01252355|11039895|FG002|Overall Study|Lack of Efficacy|2
6983584|NCT01252355|11039893|FG000|Overall Study|Lost to Follow-up|0
6983585|NCT01252355|11039894|FG001|Overall Study|Lost to Follow-up|0
6983586|NCT01252355|11039895|FG002|Overall Study|Lost to Follow-up|1
6983587|NCT01252355|11039893|FG000|Overall Study|Poor Compliance to Protocol|1
6983588|NCT01252355|11039894|FG001|Overall Study|Poor Compliance to Protocol|1
6983589|NCT01252355|11039895|FG002|Overall Study|Poor Compliance to Protocol|1
6983590|NCT01252355|11039893|FG000|Overall Study|Progressive Disease|2
6983591|NCT01252355|11039894|FG001|Overall Study|Progressive Disease|0
6983592|NCT01252355|11039895|FG002|Overall Study|Progressive Disease|0
6983593|NCT01252355|11039893|FG000|Overall Study|Sponsor Early Termination of Study|149
6983594|NCT01252355|11039894|FG001|Overall Study|Sponsor Early Termination of Study|149
6983595|NCT01252355|11039895|FG002|Overall Study|Sponsor Early Termination of Study|146
6983596|NCT01252355|11039893|FG000|Overall Study|Randomized but not Treated|2
6983597|NCT01252355|11039894|FG001|Overall Study|Randomized but not Treated|0
6983598|NCT01252355|11039895|FG002|Overall Study|Randomized but not Treated|0
6983599|NCT01252355|11039893|FG000|Overall Study|Other Than Above|8
6983600|NCT01252355|11039894|FG001|Overall Study|Other Than Above|7
6983601|NCT01252355|11039895|FG002|Overall Study|Other Than Above|7
6983602|NCT01252563|11039903|FG000|Overall Study|Contract Deviation|41
6983603|NCT01252563|11039903|FG000|Overall Study|Centralized Registration Deviation|30
6983604|NCT01252563|11039903|FG000|Overall Study|Lost to Follow-up|161
6983605|NCT01252563|11039903|FG000|Overall Study|No visit after first day of treatment|194
6983606|NCT01252563|11039903|FG000|Overall Study|No drug administration|6
6983607|NCT01252667|11039944|FG000|Overall Study|Transplant aborted post-conditioning|0
6983608|NCT01252667|11039945|FG001|Overall Study|Transplant aborted post-conditioning|0
6983609|NCT01252667|11039946|FG002|Overall Study|Transplant aborted post-conditioning|0
6983610|NCT01252667|11039947|FG003|Overall Study|Transplant aborted post-conditioning|0
6983611|NCT01252667|11039948|FG004|Overall Study|Transplant aborted post-conditioning|0
6983612|NCT01252667|11039949|FG005|Overall Study|Transplant aborted post-conditioning|1
6983613|NCT01252810|11039990|FG000|Overall Study|Withdrawal by Subject|4
6983614|NCT01252810|11039991|FG001|Overall Study|Withdrawal by Subject|1
6983615|NCT01252810|11039990|FG000|Overall Study|Lost to Follow-up|0
6983616|NCT01252810|11039991|FG001|Overall Study|Lost to Follow-up|1
6983617|NCT01252810|11039990|FG000|Overall Study|Physician Decision|2
6983618|NCT01252810|11039991|FG001|Overall Study|Physician Decision|1
6983619|NCT01252810|11039990|FG000|Overall Study|Various reasons|8
6983620|NCT01252810|11039991|FG001|Overall Study|Various reasons|0
6983621|NCT01252940|11039999|FG000|Main Study Phase|Randomized but not treated|4
6983622|NCT01252940|11040000|FG001|Main Study Phase|Randomized but not treated|2
6983623|NCT01252940|11039999|FG000|Main Study Phase|Adverse Event|3
6983624|NCT01252940|11040000|FG001|Main Study Phase|Adverse Event|1
6983625|NCT01252940|11039999|FG000|Main Study Phase|Lack of Efficacy|1
6983626|NCT01252940|11040000|FG001|Main Study Phase|Lack of Efficacy|0
6983627|NCT01252940|11039999|FG000|Main Study Phase|Lost to Follow-up|6
6983628|NCT01252940|11040000|FG001|Main Study Phase|Lost to Follow-up|1
6983629|NCT01252940|11039999|FG000|Main Study Phase|Physician Decision|1
6983630|NCT01252940|11040000|FG001|Main Study Phase|Physician Decision|0
6983631|NCT01252940|11039999|FG000|Main Study Phase|Protocol Violation|4
6983632|NCT01252940|11040000|FG001|Main Study Phase|Protocol Violation|2
6983633|NCT01252940|11039999|FG000|Main Study Phase|Withdrawal by Subject|6
6983634|NCT01252940|11040000|FG001|Main Study Phase|Withdrawal by Subject|5
6983635|NCT01252940|11039999|FG000|Main Study Phase|Subject Non-compliance|1
6983636|NCT01252940|11040000|FG001|Main Study Phase|Subject Non-compliance|1
6983637|NCT01252940|11039999|FG000|Extension Phase|Adverse Event|2
6983638|NCT01252940|11040000|FG001|Extension Phase|Adverse Event|1
6983639|NCT01252940|11039999|FG000|Extension Phase|Lack of Efficacy|1
6983640|NCT01252940|11040000|FG001|Extension Phase|Lack of Efficacy|0
6983641|NCT01252940|11039999|FG000|Extension Phase|Lost to Follow-up|5
6983642|NCT01252940|11040000|FG001|Extension Phase|Lost to Follow-up|0
6983643|NCT01252940|11039999|FG000|Extension Phase|Physician Decision|0
6983644|NCT01252940|11040000|FG001|Extension Phase|Physician Decision|1
6983645|NCT01252940|11039999|FG000|Extension Phase|Subject Non-compliance|1
6983646|NCT01252940|11040000|FG001|Extension Phase|Subject Non-compliance|0
6983647|NCT01252940|11039999|FG000|Extension Phase|Withdrawal by Subject|1
6983648|NCT01252940|11040000|FG001|Extension Phase|Withdrawal by Subject|1
6983649|NCT01252966|11040009|FG000|Overall Study|Lost to Follow-up|16
6983650|NCT01252966|11040010|FG001|Overall Study|Lost to Follow-up|10
6983651|NCT01252966|11040009|FG000|Overall Study|Withdrawal by Subject|7
6983652|NCT01252966|11040010|FG001|Overall Study|Withdrawal by Subject|3
6983653|NCT01253018|11040020|FG000|Overall Study|Lost to Follow-up|1
6983654|NCT01253018|11040021|FG001|Overall Study|Lost to Follow-up|1
6983655|NCT01253018|11040020|FG000|Overall Study|Robot Repair Issues|2
6983656|NCT01253018|11040021|FG001|Overall Study|Robot Repair Issues|0
6983657|NCT01253018|11040020|FG000|Overall Study|Withdrawal by Subject|1
6983658|NCT01253018|11040021|FG001|Overall Study|Withdrawal by Subject|1
6983659|NCT01253044|11040030|FG000|Overall Study|Lost to Follow-up|38
6983660|NCT01253044|11040031|FG001|Overall Study|Lost to Follow-up|29
6983661|NCT01253135|11040037|FG000|Original Protocol|Protocol Amendment|15
6983662|NCT01253135|11040037|FG000|Amended Protocol|Non-compliance|1
6983663|NCT01253174|11040049|FG000|Period 1|Randomized but not treated|0
6983664|NCT01253174|11040050|FG001|Period 1|Randomized but not treated|1
6983665|NCT01253174|11040051|FG002|Period 1|Randomized but not treated|1
6983666|NCT01253174|11040052|FG003|Period 1|Randomized but not treated|0
6983667|NCT01253174|11040053|FG004|Period 1|Randomized but not treated|1
6983668|NCT01253174|11040054|FG005|Period 1|Randomized but not treated|0
6983669|NCT01253174|11040049|FG000|Period 2|Adverse Event|0
6983670|NCT01253174|11040050|FG001|Period 2|Adverse Event|0
6983671|NCT01253174|11040051|FG002|Period 2|Adverse Event|1
6983672|NCT01253174|11040052|FG003|Period 2|Adverse Event|0
6983673|NCT01253174|11040053|FG004|Period 2|Adverse Event|0
6983674|NCT01253174|11040054|FG005|Period 2|Adverse Event|0
6983675|NCT01253174|11040049|FG000|Period 3|Withdrawal by Subject|0
6983676|NCT01253174|11040050|FG001|Period 3|Withdrawal by Subject|1
6983677|NCT01253174|11040051|FG002|Period 3|Withdrawal by Subject|0
6983678|NCT01253174|11040052|FG003|Period 3|Withdrawal by Subject|0
6983679|NCT01253174|11040053|FG004|Period 3|Withdrawal by Subject|1
6983680|NCT01253174|11040054|FG005|Period 3|Withdrawal by Subject|0
6983681|NCT01253174|11040049|FG000|Period 3|Pregnancy|0
6983682|NCT01253174|11040050|FG001|Period 3|Pregnancy|0
6983683|NCT01253174|11040051|FG002|Period 3|Pregnancy|1
6983684|NCT01253174|11040052|FG003|Period 3|Pregnancy|0
6983685|NCT01253174|11040053|FG004|Period 3|Pregnancy|0
6983686|NCT01253174|11040054|FG005|Period 3|Pregnancy|0
6983687|NCT01253187|11040063|FG000|Period 2|Withdrawal by Subject|0
6983688|NCT01253187|11040064|FG001|Period 2|Withdrawal by Subject|0
6983689|NCT01253187|11040065|FG002|Period 2|Withdrawal by Subject|0
6983690|NCT01253187|11040066|FG003|Period 2|Withdrawal by Subject|0
6983691|NCT01253187|11040067|FG004|Period 2|Withdrawal by Subject|1
6983692|NCT01253187|11040068|FG005|Period 2|Withdrawal by Subject|0
6983693|NCT01253187|11040063|FG000|Period 3|Pregnancy|1
6983694|NCT01253187|11040064|FG001|Period 3|Pregnancy|0
6983695|NCT01253187|11040065|FG002|Period 3|Pregnancy|0
6983696|NCT01253187|11040066|FG003|Period 3|Pregnancy|0
6983697|NCT01253187|11040067|FG004|Period 3|Pregnancy|0
6983698|NCT01253187|11040068|FG005|Period 3|Pregnancy|0
6983699|NCT01253187|11040063|FG000|Period 3|difficulty with blood sampling|0
6983700|NCT01253187|11040064|FG001|Period 3|difficulty with blood sampling|1
6983701|NCT01253187|11040065|FG002|Period 3|difficulty with blood sampling|0
6983702|NCT01253187|11040066|FG003|Period 3|difficulty with blood sampling|0
6983703|NCT01253187|11040067|FG004|Period 3|difficulty with blood sampling|0
6983704|NCT01253187|11040068|FG005|Period 3|difficulty with blood sampling|0
6983705|NCT01253187|11040063|FG000|Period 3|non-compliance|0
6983706|NCT01253187|11040064|FG001|Period 3|non-compliance|0
6983707|NCT01253187|11040065|FG002|Period 3|non-compliance|0
6983708|NCT01253187|11040066|FG003|Period 3|non-compliance|0
6983709|NCT01253187|11040067|FG004|Period 3|non-compliance|1
6983710|NCT01253187|11040068|FG005|Period 3|non-compliance|0
6983711|NCT01253200|11040084|FG000|Overall Study|Death|1
6983712|NCT01253200|11040085|FG001|Overall Study|Death|0
6983713|NCT01253200|11040086|FG002|Overall Study|Death|0
6983714|NCT01253200|11040087|FG003|Overall Study|Death|0
6983715|NCT01253200|11040088|FG004|Overall Study|Death|0
6983716|NCT01253200|11040084|FG000|Overall Study|Lost to Follow-up|1
6983717|NCT01253200|11040085|FG001|Overall Study|Lost to Follow-up|1
6983718|NCT01253200|11040086|FG002|Overall Study|Lost to Follow-up|0
6983719|NCT01253200|11040087|FG003|Overall Study|Lost to Follow-up|0
6983720|NCT01253200|11040088|FG004|Overall Study|Lost to Follow-up|0
6983721|NCT01253200|11040084|FG000|Overall Study|Withdrawal by Subject|2
6983722|NCT01253200|11040085|FG001|Overall Study|Withdrawal by Subject|0
6983723|NCT01253200|11040086|FG002|Overall Study|Withdrawal by Subject|0
6983724|NCT01253200|11040087|FG003|Overall Study|Withdrawal by Subject|0
6983725|NCT01253200|11040088|FG004|Overall Study|Withdrawal by Subject|0
6983726|NCT01253200|11040084|FG000|Overall Study|Protocol Violation|1
6983727|NCT01253200|11040085|FG001|Overall Study|Protocol Violation|4
6983728|NCT01253200|11040086|FG002|Overall Study|Protocol Violation|0
6983729|NCT01253200|11040087|FG003|Overall Study|Protocol Violation|0
6983730|NCT01253200|11040088|FG004|Overall Study|Protocol Violation|5
6983731|NCT01253200|11040084|FG000|Overall Study|intents|10
6983732|NCT01253200|11040085|FG001|Overall Study|intents|10
6983733|NCT01253200|11040086|FG002|Overall Study|intents|1
6983734|NCT01253200|11040087|FG003|Overall Study|intents|3
6983735|NCT01253200|11040088|FG004|Overall Study|intents|0
6983736|NCT01253200|11040084|FG000|Overall Study|Attempts|6
6983737|NCT01253200|11040085|FG001|Overall Study|Attempts|4
6983738|NCT01253200|11040086|FG002|Overall Study|Attempts|1
6983739|NCT01253200|11040087|FG003|Overall Study|Attempts|2
6983740|NCT01253200|11040088|FG004|Overall Study|Attempts|0
6983741|NCT01253226|11040102|FG000|Overall Study|Adverse Event|0
6983742|NCT01253226|11040103|FG001|Overall Study|Adverse Event|0
6983743|NCT01253226|11040104|FG002|Overall Study|Adverse Event|1
6983744|NCT01253226|11040105|FG003|Overall Study|Adverse Event|0
6983745|NCT01253226|11040106|FG004|Overall Study|Adverse Event|0
6983746|NCT01253226|11040102|FG000|Overall Study|Death|0
6983747|NCT01253226|11040103|FG001|Overall Study|Death|1
6983748|NCT01253226|11040104|FG002|Overall Study|Death|0
6983749|NCT01253226|11040105|FG003|Overall Study|Death|0
6983750|NCT01253226|11040106|FG004|Overall Study|Death|0
6983751|NCT01253226|11040102|FG000|Overall Study|Physician Decision|0
6983752|NCT01253226|11040103|FG001|Overall Study|Physician Decision|0
6983753|NCT01253226|11040104|FG002|Overall Study|Physician Decision|0
6983754|NCT01253226|11040105|FG003|Overall Study|Physician Decision|0
6983755|NCT01253226|11040106|FG004|Overall Study|Physician Decision|2
6983756|NCT01253226|11040102|FG000|Overall Study|Withdrawal by Subject|0
6983757|NCT01253226|11040103|FG001|Overall Study|Withdrawal by Subject|0
6983758|NCT01253226|11040104|FG002|Overall Study|Withdrawal by Subject|0
6983759|NCT01253226|11040105|FG003|Overall Study|Withdrawal by Subject|1
6983760|NCT01253226|11040106|FG004|Overall Study|Withdrawal by Subject|0
6983761|NCT01253265|11040123|FG000|Overall Study|Met Predefined Discontinuation Criteria|1
6983762|NCT01253265|11040124|FG001|Overall Study|Met Predefined Discontinuation Criteria|0
6983763|NCT01253265|11040125|FG002|Overall Study|Met Predefined Discontinuation Criteria|0
6983764|NCT01253265|11040126|FG003|Overall Study|Met Predefined Discontinuation Criteria|0
6983765|NCT01253265|11040127|FG004|Overall Study|Met Predefined Discontinuation Criteria|0
6983766|NCT01253265|11040123|FG000|Overall Study|Withdrawal by Subject|0
6983767|NCT01253265|11040124|FG001|Overall Study|Withdrawal by Subject|0
6983768|NCT01253265|11040125|FG002|Overall Study|Withdrawal by Subject|0
6983769|NCT01253265|11040126|FG003|Overall Study|Withdrawal by Subject|0
6983770|NCT01253265|11040127|FG004|Overall Study|Withdrawal by Subject|1
6983771|NCT01253291|11040144|FG000|Overall Study|Withdrawal by Subject|1
6983772|NCT01253291|11040145|FG001|Overall Study|Withdrawal by Subject|1
6983773|NCT01253291|11040146|FG002|Overall Study|Withdrawal by Subject|0
6983774|NCT01253291|11040147|FG003|Overall Study|Withdrawal by Subject|0
6983775|NCT01253291|11040148|FG004|Overall Study|Withdrawal by Subject|0
6983776|NCT01253291|11040144|FG000|Overall Study|Adverse Event|0
6983777|NCT01253291|11040145|FG001|Overall Study|Adverse Event|1
6983778|NCT01253291|11040146|FG002|Overall Study|Adverse Event|0
6983779|NCT01253291|11040147|FG003|Overall Study|Adverse Event|0
6983780|NCT01253291|11040148|FG004|Overall Study|Adverse Event|0
6983781|NCT01253291|11040144|FG000|Overall Study|Lack of Efficacy|1
6983782|NCT01253291|11040145|FG001|Overall Study|Lack of Efficacy|0
6983783|NCT01253291|11040146|FG002|Overall Study|Lack of Efficacy|0
6983784|NCT01253291|11040147|FG003|Overall Study|Lack of Efficacy|0
6983785|NCT01253291|11040148|FG004|Overall Study|Lack of Efficacy|0
6983786|NCT01253291|11040144|FG000|Overall Study|Physician Decision|2
6983787|NCT01253291|11040145|FG001|Overall Study|Physician Decision|0
6983788|NCT01253291|11040146|FG002|Overall Study|Physician Decision|0
6983789|NCT01253291|11040147|FG003|Overall Study|Physician Decision|0
6983790|NCT01253291|11040148|FG004|Overall Study|Physician Decision|2
6983791|NCT01253304|11040165|FG000|Overall Study|Adverse Event|0
6983792|NCT01253304|11040166|FG001|Overall Study|Adverse Event|0
6983793|NCT01253304|11040167|FG002|Overall Study|Adverse Event|0
6983794|NCT01253304|11040168|FG003|Overall Study|Adverse Event|1
6983795|NCT01253317|11040178|FG000|Overall Study|Adverse Event|2
6983796|NCT01253369|11040211|FG000|Overall Study|Adverse Event|4
6983797|NCT01253369|11040211|FG000|Overall Study|Withdrawal by Subject|2
6983798|NCT01253369|11040211|FG000|Overall Study|Death|1
6983799|NCT01253369|11040211|FG000|Overall Study|Progressive disease|23
6983800|NCT01253369|11040211|FG000|Overall Study|Not Evaluable|3
6983801|NCT01253408|11040218|FG000|Overall Study|Adverse Event|0
6983802|NCT01253408|11040219|FG001|Overall Study|Adverse Event|1
6983803|NCT01253408|11040220|FG002|Overall Study|Adverse Event|0
6983804|NCT01253421|11040232|FG000|Assessment and Scheduling|Found to be Ineligible|74
6983805|NCT01253421|11040233|FG001|Assessment and Scheduling|Found to be Ineligible|0
6983806|NCT01253421|11040234|FG002|Assessment and Scheduling|Found to be Ineligible|0
6983807|NCT01253421|11040235|FG003|Assessment and Scheduling|Found to be Ineligible|0
6983808|NCT01253421|11040236|FG004|Assessment and Scheduling|Found to be Ineligible|0
6983809|NCT01253421|11040232|FG000|Assessment and Scheduling|Lost to Follow-up|17
6983810|NCT01253421|11040233|FG001|Assessment and Scheduling|Lost to Follow-up|0
6983811|NCT01253421|11040234|FG002|Assessment and Scheduling|Lost to Follow-up|0
6983812|NCT01253421|11040235|FG003|Assessment and Scheduling|Lost to Follow-up|0
6983813|NCT01253421|11040236|FG004|Assessment and Scheduling|Lost to Follow-up|0
6983814|NCT01253421|11040232|FG000|Assessment and Scheduling|Withdrawal by Subject|7
6983815|NCT01253421|11040233|FG001|Assessment and Scheduling|Withdrawal by Subject|0
6983816|NCT01253421|11040234|FG002|Assessment and Scheduling|Withdrawal by Subject|0
6983817|NCT01253421|11040235|FG003|Assessment and Scheduling|Withdrawal by Subject|0
6983818|NCT01253421|11040236|FG004|Assessment and Scheduling|Withdrawal by Subject|0
6983819|NCT01253421|11040232|FG000|Assessment and Scheduling|Physician Decision|1
6983820|NCT01253421|11040233|FG001|Assessment and Scheduling|Physician Decision|0
6983821|NCT01253421|11040234|FG002|Assessment and Scheduling|Physician Decision|0
6983822|NCT01253421|11040235|FG003|Assessment and Scheduling|Physician Decision|0
6983823|NCT01253421|11040236|FG004|Assessment and Scheduling|Physician Decision|0
6983824|NCT01253421|11040232|FG000|Drug+Scanning Visit|Physician Decision|0
6983825|NCT01253421|11040233|FG001|Drug+Scanning Visit|Physician Decision|0
6983826|NCT01253421|11040234|FG002|Drug+Scanning Visit|Physician Decision|0
6983827|NCT01253421|11040235|FG003|Drug+Scanning Visit|Physician Decision|0
6983828|NCT01253421|11040236|FG004|Drug+Scanning Visit|Physician Decision|1
6983829|NCT01253447|11040246|FG000|Overall Study|Adverse Event|2
6983830|NCT01253564|11040259|FG000|Overall Study|Disease Progression|22
6983831|NCT01253564|11040259|FG000|Overall Study|Withdrawal by Subject|1
6983832|NCT01253564|11040259|FG000|Overall Study|Serious Adverse Event|1
6983833|NCT01253577|11040263|FG000|Overall Study|Lost to Follow-up|3
6983834|NCT01253811|11040274|FG000|Overall Study|Withdrawal criteria|1
6983835|NCT01254019|11040311|FG000|Overall Study|Adverse Event|0
6983836|NCT01254019|11040312|FG001|Overall Study|Adverse Event|2
6983837|NCT01254019|11040311|FG000|Overall Study|Protocol Violation|1
6983838|NCT01254019|11040312|FG001|Overall Study|Protocol Violation|0
6983839|NCT01254019|11040311|FG000|Overall Study|Withdrawal by Subject|0
6983840|NCT01254019|11040312|FG001|Overall Study|Withdrawal by Subject|2
6983841|NCT01254045|11040321|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1
6983842|NCT01254045|11040322|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
6983843|NCT01254045|11040323|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
6983844|NCT01254045|11040324|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
6983845|NCT01254045|11040325|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
6983846|NCT01254045|11040326|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
6983847|NCT01254188|11040336|FG000|Overall Study|Disease Progression|6
6983848|NCT01254188|11040336|FG000|Overall Study|Protocol Violation|6
6983849|NCT01254188|11040336|FG000|Overall Study|Pregnancy|2
6983850|NCT01254188|11040336|FG000|Overall Study|Death|4
6983851|NCT01254188|11040336|FG000|Overall Study|Lost to Follow-up|5
6983852|NCT01254188|11040336|FG000|Overall Study|Withdrawal by Subject|7
6983853|NCT01254188|11040336|FG000|Overall Study|Adverse Event|43
6983854|NCT01254188|11040336|FG000|Overall Study|per investigator discretion|20
6983855|NCT01254227|11040349|FG000|Overall Study|Withdrawal by Subject|6
6983856|NCT01254227|11040349|FG000|Overall Study|Lost to Follow-up|6
6983857|NCT01254227|11040349|FG000|Overall Study|Adverse Event|5
6983858|NCT01254227|11040349|FG000|Overall Study|Abnormal test procedure result|5
6983859|NCT01254227|11040349|FG000|Overall Study|Administrative problems|2
6983860|NCT01254227|11040349|FG000|Overall Study|Death|1
6983861|NCT01254227|11040349|FG000|Overall Study|Protocol deviation|1
6983862|NCT01254292|11040355|FG000|Comparative Phase|Adverse Event|25
6983863|NCT01254292|11040356|FG001|Comparative Phase|Adverse Event|25
6983864|NCT01254292|11040355|FG000|Comparative Phase|Lost to Follow-up|3
6983865|NCT01254292|11040356|FG001|Comparative Phase|Lost to Follow-up|21
6983866|NCT01254292|11040355|FG000|Comparative Phase|Pregnancy|2
6983867|NCT01254292|11040356|FG001|Comparative Phase|Pregnancy|6
6983868|NCT01254292|11040355|FG000|Comparative Phase|Withdrawal by Subject|20
6983869|NCT01254292|11040356|FG001|Comparative Phase|Withdrawal by Subject|21
6983870|NCT01254292|11040355|FG000|Comparative Phase|Protocol Violation|1
6983871|NCT01254292|11040356|FG001|Comparative Phase|Protocol Violation|2
6983872|NCT01254292|11040355|FG000|Comparative Phase|Wish for pregnancy|4
6983873|NCT01254292|11040356|FG001|Comparative Phase|Wish for pregnancy|6
6983874|NCT01254292|11040355|FG000|LCS12 Extension Phase|Wish for pregnancy|14
6983875|NCT01254292|11040356|FG001|LCS12 Extension Phase|Wish for pregnancy|0
6983876|NCT01254292|11040355|FG000|LCS12 Extension Phase|Adverse Event|9
6983877|NCT01254292|11040356|FG001|LCS12 Extension Phase|Adverse Event|0
6983878|NCT01254292|11040355|FG000|LCS12 Extension Phase|Withdrawal by Subject|7
6983879|NCT01254292|11040356|FG001|LCS12 Extension Phase|Withdrawal by Subject|0
6983880|NCT01254292|11040355|FG000|LCS12 Extension Phase|Other unknown|4
6983881|NCT01254292|11040356|FG001|LCS12 Extension Phase|Other unknown|0
6983882|NCT01254292|11040355|FG000|LCS12 Extension Phase|Pregnancy|2
6983883|NCT01254292|11040356|FG001|LCS12 Extension Phase|Pregnancy|0
6983884|NCT01254292|11040355|FG000|LCS12 Extension Phase|Lost to Follow-up|1
6983885|NCT01254292|11040356|FG001|LCS12 Extension Phase|Lost to Follow-up|0
6983886|NCT01254305|11040366|FG000|Overall Study|Adverse Event|6
6983887|NCT01254305|11040367|FG001|Overall Study|Adverse Event|3
6983888|NCT01254305|11040368|FG002|Overall Study|Adverse Event|2
6983889|NCT01254305|11040366|FG000|Overall Study|Lack of Efficacy|1
6983890|NCT01254305|11040367|FG001|Overall Study|Lack of Efficacy|0
6983891|NCT01254305|11040368|FG002|Overall Study|Lack of Efficacy|1
6983892|NCT01254305|11040366|FG000|Overall Study|Protocol Violation|1
6983893|NCT01254305|11040367|FG001|Overall Study|Protocol Violation|7
6983894|NCT01254305|11040368|FG002|Overall Study|Protocol Violation|3
6983895|NCT01254305|11040366|FG000|Overall Study|Withdrawal by Subject|4
6983896|NCT01254305|11040367|FG001|Overall Study|Withdrawal by Subject|2
6983897|NCT01254305|11040368|FG002|Overall Study|Withdrawal by Subject|4
6983898|NCT01254305|11040366|FG000|Overall Study|Lost to Follow-up|10
6983899|NCT01254305|11040367|FG001|Overall Study|Lost to Follow-up|6
6983900|NCT01254305|11040368|FG002|Overall Study|Lost to Follow-up|5
6983901|NCT01254305|11040366|FG000|Overall Study|Other Reasons|0
6983902|NCT01254305|11040367|FG001|Overall Study|Other Reasons|0
6983903|NCT01254305|11040368|FG002|Overall Study|Other Reasons|2
6983904|NCT01254318|11040379|FG000|Overall Study|Lost to Follow-up|5
6983905|NCT01254318|11040379|FG000|Overall Study|Death|47
6983906|NCT01254331|11040383|FG000|Initial Phase|Adverse Event|3
6983907|NCT01254331|11040383|FG000|Initial Phase|Withdrawal by Subject|1
6983908|NCT01254331|11040383|FG000|Initial Phase|Pregnancy|1
6983909|NCT01254331|11040383|FG000|Extension Phase|Lack of Efficacy|1
6983910|NCT01254331|11040383|FG000|Extension Phase|Lost to Follow-up|3
6983911|NCT01254344|11040389|FG000|Overall Study|Adverse Event|2
6983912|NCT01254344|11040390|FG001|Overall Study|Adverse Event|5
6983913|NCT01254344|11040389|FG000|Overall Study|Physician Decision|7
6983914|NCT01254344|11040390|FG001|Overall Study|Physician Decision|4
6983915|NCT01254344|11040389|FG000|Overall Study|Protocol Violation|1
6983916|NCT01254344|11040390|FG001|Overall Study|Protocol Violation|4
6983917|NCT01254344|11040389|FG000|Overall Study|Withdrawal by Subject|3
6983918|NCT01254344|11040390|FG001|Overall Study|Withdrawal by Subject|6
6983919|NCT01254565|11040417|FG000|Overall Study|Non-compliance to Study Procedures|0
6983920|NCT01254565|11040418|FG001|Overall Study|Non-compliance to Study Procedures|0
6983921|NCT01254565|11040419|FG002|Overall Study|Non-compliance to Study Procedures|0
6983922|NCT01254565|11040420|FG003|Overall Study|Non-compliance to Study Procedures|0
6983923|NCT01254565|11040421|FG004|Overall Study|Non-compliance to Study Procedures|1
6983924|NCT01254565|11040422|FG005|Overall Study|Non-compliance to Study Procedures|0
6983925|NCT01254565|11040417|FG000|Overall Study|Did not Receive Treatment|1
6983926|NCT01254565|11040418|FG001|Overall Study|Did not Receive Treatment|1
6983927|NCT01254565|11040419|FG002|Overall Study|Did not Receive Treatment|0
6983928|NCT01254565|11040420|FG003|Overall Study|Did not Receive Treatment|0
6983929|NCT01254565|11040421|FG004|Overall Study|Did not Receive Treatment|3
6983930|NCT01254565|11040422|FG005|Overall Study|Did not Receive Treatment|4
6983931|NCT01254565|11040417|FG000|Overall Study|Other|0
6983932|NCT01254565|11040418|FG001|Overall Study|Other|0
6983933|NCT01254565|11040419|FG002|Overall Study|Other|0
6983934|NCT01254565|11040420|FG003|Overall Study|Other|1
6983935|NCT01254565|11040421|FG004|Overall Study|Other|0
6983936|NCT01254565|11040422|FG005|Overall Study|Other|0
6983937|NCT01254604|11040438|FG000|Overall Study|Lost to Follow-up|1
6983938|NCT01254604|11040439|FG001|Overall Study|Lost to Follow-up|1
6983939|NCT01254604|11040438|FG000|Overall Study|Protocol Violation|2
6983940|NCT01254604|11040439|FG001|Overall Study|Protocol Violation|2
6983941|NCT01254604|11040438|FG000|Overall Study|Withdrawal by Subject|2
6983942|NCT01254604|11040439|FG001|Overall Study|Withdrawal by Subject|4
6983943|NCT01254604|11040438|FG000|Overall Study|Adverse Event|3
6983944|NCT01254604|11040439|FG001|Overall Study|Adverse Event|2
6983945|NCT01254630|11040449|FG000|Overall Study|Adverse Event|36
6983946|NCT01254630|11040450|FG001|Overall Study|Adverse Event|15
6983947|NCT01254630|11040451|FG002|Overall Study|Adverse Event|40
6983948|NCT01254630|11040452|FG003|Overall Study|Adverse Event|8
6983949|NCT01254630|11040449|FG000|Overall Study|Death|461
6983950|NCT01254630|11040450|FG001|Overall Study|Death|151
6983951|NCT01254630|11040451|FG002|Overall Study|Death|478
6983952|NCT01254630|11040452|FG003|Overall Study|Death|139
6983953|NCT01254630|11040449|FG000|Overall Study|Lost to Follow-up|80
6983954|NCT01254630|11040450|FG001|Overall Study|Lost to Follow-up|26
6983955|NCT01254630|11040451|FG002|Overall Study|Lost to Follow-up|89
6983956|NCT01254630|11040452|FG003|Overall Study|Lost to Follow-up|32
6983957|NCT01254630|11040449|FG000|Overall Study|Physician Decision|24
6983958|NCT01254630|11040450|FG001|Overall Study|Physician Decision|8
6983959|NCT01254630|11040451|FG002|Overall Study|Physician Decision|16
6983960|NCT01254630|11040452|FG003|Overall Study|Physician Decision|7
6983961|NCT01254630|11040449|FG000|Overall Study|Withdrawal by Subject|201
6983962|NCT01254630|11040450|FG001|Overall Study|Withdrawal by Subject|94
6983963|NCT01254630|11040451|FG002|Overall Study|Withdrawal by Subject|188
6983964|NCT01254630|11040452|FG003|Overall Study|Withdrawal by Subject|89
6983965|NCT01254630|11040449|FG000|Overall Study|Study terminated by sponsor|0
6983966|NCT01254630|11040450|FG001|Overall Study|Study terminated by sponsor|994
6983967|NCT01254630|11040451|FG002|Overall Study|Study terminated by sponsor|0
6983968|NCT01254630|11040452|FG003|Overall Study|Study terminated by sponsor|1010
6983969|NCT01254630|11040449|FG000|Overall Study|Status not recorded|0
6983970|NCT01254630|11040450|FG001|Overall Study|Status not recorded|0
6983971|NCT01254630|11040451|FG002|Overall Study|Status not recorded|1
6983972|NCT01254630|11040452|FG003|Overall Study|Status not recorded|0
6983973|NCT01254643|11040460|FG000|Overall Study|Withdrawal by Subject|1
6983974|NCT01254656|11040467|FG000|Overall Study|Discontinued due to termination of study|40
6983975|NCT01254656|11040468|FG001|Overall Study|Discontinued due to termination of study|39
6983976|NCT01254656|11040469|FG002|Overall Study|Discontinued due to termination of study|13
6983977|NCT01254656|11040467|FG000|Overall Study|Lack of Efficacy|3
6983978|NCT01254656|11040468|FG001|Overall Study|Lack of Efficacy|0
6983979|NCT01254656|11040469|FG002|Overall Study|Lack of Efficacy|0
6983980|NCT01254656|11040467|FG000|Overall Study|Lost to Follow-up|1
6983981|NCT01254656|11040468|FG001|Overall Study|Lost to Follow-up|0
6983982|NCT01254656|11040469|FG002|Overall Study|Lost to Follow-up|2
6983983|NCT01254656|11040467|FG000|Overall Study|Withdrawal by Subject|2
6983984|NCT01254656|11040468|FG001|Overall Study|Withdrawal by Subject|2
6983985|NCT01254656|11040469|FG002|Overall Study|Withdrawal by Subject|1
6983986|NCT01254656|11040467|FG000|Overall Study|Pregnancy|0
6983987|NCT01254656|11040468|FG001|Overall Study|Pregnancy|0
6983988|NCT01254656|11040469|FG002|Overall Study|Pregnancy|2
6983989|NCT01254656|11040467|FG000|Overall Study|Adverse Event|1
6983990|NCT01254656|11040468|FG001|Overall Study|Adverse Event|1
6983991|NCT01254656|11040469|FG002|Overall Study|Adverse Event|0
6983992|NCT01254656|11040467|FG000|Overall Study|Death|0
6983993|NCT01254656|11040468|FG001|Overall Study|Death|1
6983994|NCT01254656|11040469|FG002|Overall Study|Death|0
6983995|NCT01254669|11040479|FG000|Overall Study|Withdrawal by Subject|0
6983996|NCT01254669|11040480|FG001|Overall Study|Withdrawal by Subject|1
6983997|NCT01254669|11040479|FG000|Overall Study|time constraint|2
6983998|NCT01254669|11040480|FG001|Overall Study|time constraint|2
6983999|NCT01254669|11040479|FG000|Overall Study|called to clinic during intervention|1
6984000|NCT01254669|11040480|FG001|Overall Study|called to clinic during intervention|1
6984001|NCT01254721|11040490|FG000|Overall Study|Lost to Follow-up|0
6984002|NCT01254721|11040491|FG001|Overall Study|Lost to Follow-up|4
6984003|NCT01254721|11040490|FG000|Overall Study|Lack of Efficacy|4
6984004|NCT01254721|11040491|FG001|Overall Study|Lack of Efficacy|2
6984005|NCT01254721|11040490|FG000|Overall Study|Death|0
6984006|NCT01254721|11040491|FG001|Overall Study|Death|1
6984007|NCT01254721|11040490|FG000|Overall Study|technical problum|1
6984008|NCT01254721|11040491|FG001|Overall Study|technical problum|0
6984009|NCT01254721|11040490|FG000|Overall Study|Adverse Event|2
6984010|NCT01254721|11040491|FG001|Overall Study|Adverse Event|3
6984011|NCT01254721|11040490|FG000|Overall Study|Withdrawal by Subject|8
6984012|NCT01254721|11040491|FG001|Overall Study|Withdrawal by Subject|11
6984013|NCT01254721|11040490|FG000|Overall Study|Wrongly randomization|0
6984014|NCT01254721|11040491|FG001|Overall Study|Wrongly randomization|1
6984015|NCT01254747|11040501|FG000|Overall Study|Unacceptable subjective vision|0
6984016|NCT01254747|11040502|FG001|Overall Study|Unacceptable subjective vision|0
6984017|NCT01254747|11040503|FG002|Overall Study|Unacceptable subjective vision|0
6984018|NCT01254747|11040504|FG003|Overall Study|Unacceptable subjective vision|2
6984019|NCT01254747|11040501|FG000|Overall Study|Difficult removal handling|0
6984020|NCT01254747|11040502|FG001|Overall Study|Difficult removal handling|0
6984021|NCT01254747|11040503|FG002|Overall Study|Difficult removal handling|1
6984022|NCT01254747|11040504|FG003|Overall Study|Difficult removal handling|0
6984023|NCT01254747|11040501|FG000|Overall Study|Symptoms and problems|0
6984024|NCT01254747|11040502|FG001|Overall Study|Symptoms and problems|2
6984025|NCT01254747|11040503|FG002|Overall Study|Symptoms and problems|1
6984026|NCT01254747|11040504|FG003|Overall Study|Symptoms and problems|0
6984027|NCT01254747|11040501|FG000|Overall Study|Lost to Follow-up|0
6984028|NCT01254747|11040502|FG001|Overall Study|Lost to Follow-up|0
6984029|NCT01254747|11040503|FG002|Overall Study|Lost to Follow-up|1
6984030|NCT01254747|11040504|FG003|Overall Study|Lost to Follow-up|0
6984031|NCT01254747|11040501|FG000|Overall Study|Biomicroscopy|0
6984032|NCT01254747|11040502|FG001|Overall Study|Biomicroscopy|0
6984033|NCT01254747|11040503|FG002|Overall Study|Biomicroscopy|1
6984034|NCT01254747|11040504|FG003|Overall Study|Biomicroscopy|0
6984035|NCT01254747|11040501|FG000|Overall Study|Discomfort|0
6984036|NCT01254747|11040502|FG001|Overall Study|Discomfort|4
6984037|NCT01254747|11040503|FG002|Overall Study|Discomfort|0
6984038|NCT01254747|11040504|FG003|Overall Study|Discomfort|0
6984039|NCT01254890|11040546|FG000|Overall Study|Ineligible|0
6984040|NCT01254890|11040547|FG001|Overall Study|Ineligible|3
6984041|NCT01254890|11040546|FG000|Overall Study|Withdrawal by Subject|1
6984042|NCT01254890|11040547|FG001|Overall Study|Withdrawal by Subject|2
6984043|NCT01254890|11040546|FG000|Overall Study|Disease Progression|0
6984044|NCT01254890|11040547|FG001|Overall Study|Disease Progression|5
6984045|NCT01255163|11040558|FG000|Overall Study|Withdrawal by Subject|1
6984046|NCT01255163|11040559|FG001|Overall Study|Withdrawal by Subject|0
6984047|NCT01255163|11040558|FG000|Overall Study|Lost to Follow-up|2
6984048|NCT01255163|11040559|FG001|Overall Study|Lost to Follow-up|0
6984049|NCT01255163|11040558|FG000|Overall Study|Adverse Event|0
6984050|NCT01255163|11040559|FG001|Overall Study|Adverse Event|2
6984051|NCT01255163|11040558|FG000|Overall Study|AstraZeneca stopped support of the study|1
6984052|NCT01255163|11040559|FG001|Overall Study|AstraZeneca stopped support of the study|3
6984053|NCT01255306|11040569|FG000|Overall Study|Physician Decision|1
6984054|NCT01255306|11040570|FG001|Overall Study|Physician Decision|1
6984055|NCT01255423|11040581|FG000|Overall Study|Abnormal Laboratory value|3
6984056|NCT01255423|11040582|FG001|Overall Study|Abnormal Laboratory value|2
6984057|NCT01255423|11040581|FG000|Overall Study|Use of prohibited medications|0
6984058|NCT01255423|11040582|FG001|Overall Study|Use of prohibited medications|1
6984059|NCT01255436|11040590|FG000|Overall Study|Lost to Follow-up|178
6984060|NCT01255436|11040591|FG001|Overall Study|Lost to Follow-up|191
6984061|NCT01255436|11040590|FG000|Overall Study|Death, stroke, or MI|4
6984062|NCT01255436|11040591|FG001|Overall Study|Death, stroke, or MI|3
6984063|NCT01255592|11040604|FG000|Overall Study|Adverse Event|5
6984064|NCT01255592|11040605|FG001|Overall Study|Adverse Event|0
6984065|NCT01255592|11040604|FG000|Overall Study|Withdrawal by Subject|1
6984066|NCT01255592|11040605|FG001|Overall Study|Withdrawal by Subject|0
6984067|NCT01255592|11040604|FG000|Overall Study|Other|0
6984068|NCT01255592|11040605|FG001|Overall Study|Other|1
6984069|NCT01255631|11040614|FG000|Overall Study|poor enrollment, no data analyzed|9
6984070|NCT01255631|11040615|FG001|Overall Study|poor enrollment, no data analyzed|6
6984071|NCT01255670|11040623|FG000|Overall Study|Adverse Event|10
6984072|NCT01255670|11040624|FG001|Overall Study|Adverse Event|10
6984073|NCT01255670|11040623|FG000|Overall Study|Lost to Follow-up|16
6984074|NCT01255670|11040624|FG001|Overall Study|Lost to Follow-up|10
6984075|NCT01255722|11040633|FG000|Overall Study|Adverse Event|0
6984076|NCT01255722|11040634|FG001|Overall Study|Adverse Event|1
6984077|NCT01255722|11040635|FG002|Overall Study|Adverse Event|1
6984078|NCT01255722|11040633|FG000|Overall Study|asymptomatic patient|1
6984079|NCT01255722|11040634|FG001|Overall Study|asymptomatic patient|0
6984080|NCT01255722|11040635|FG002|Overall Study|asymptomatic patient|0
6984081|NCT01255722|11040633|FG000|Overall Study|beta-blocker contraindicated|2
6984082|NCT01255722|11040634|FG001|Overall Study|beta-blocker contraindicated|0
6984083|NCT01255722|11040635|FG002|Overall Study|beta-blocker contraindicated|0
7041972|NCT01732510|11125961|FG002|Overall Study|Withdrawal by Subject|2
7041973|NCT01732510|11125962|FG003|Overall Study|Withdrawal by Subject|1
7041974|NCT01732510|11125963|FG004|Overall Study|Withdrawal by Subject|5
7041975|NCT01732510|11125964|FG005|Overall Study|Withdrawal by Subject|0
7041976|NCT01732510|11125965|FG006|Overall Study|Withdrawal by Subject|1
7041977|NCT01732510|11125959|FG000|Overall Study|Lost to Follow-up|0
7041978|NCT01732510|11125960|FG001|Overall Study|Lost to Follow-up|0
7041979|NCT01732510|11125961|FG002|Overall Study|Lost to Follow-up|1
6984084|NCT01255761|11040646|FG000|Overall Study|Adverse Event|29
6984085|NCT01255761|11040647|FG001|Overall Study|Adverse Event|43
6984086|NCT01255761|11040646|FG000|Overall Study|Lack of Efficacy|86
6984087|NCT01255761|11040647|FG001|Overall Study|Lack of Efficacy|74
6984088|NCT01255761|11040646|FG000|Overall Study|Protocol Violation|9
6984089|NCT01255761|11040647|FG001|Overall Study|Protocol Violation|5
6984090|NCT01255761|11040646|FG000|Overall Study|Lost to Follow-up|10
6984091|NCT01255761|11040647|FG001|Overall Study|Lost to Follow-up|8
6984092|NCT01255761|11040646|FG000|Overall Study|Withdrawal by Subject|11
6984093|NCT01255761|11040647|FG001|Overall Study|Withdrawal by Subject|27
6984094|NCT01255761|11040646|FG000|Overall Study|Other Reasons|37
6984095|NCT01255761|11040647|FG001|Overall Study|Other Reasons|18
6984096|NCT01255787|11040657|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6
6984097|NCT01255787|11040658|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2
6984098|NCT01255787|11040659|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9
6984099|NCT01255787|11040660|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9
6984100|NCT01255787|11040657|FG000|Overall Study|Major Protocol Deviation|1
6984101|NCT01255787|11040658|FG001|Overall Study|Major Protocol Deviation|1
6984102|NCT01255787|11040659|FG002|Overall Study|Major Protocol Deviation|0
6984103|NCT01255787|11040660|FG003|Overall Study|Major Protocol Deviation|4
6984104|NCT01255787|11040657|FG000|Overall Study|Lost to Follow-up|1
6984105|NCT01255787|11040658|FG001|Overall Study|Lost to Follow-up|2
6984106|NCT01255787|11040659|FG002|Overall Study|Lost to Follow-up|4
6984107|NCT01255787|11040660|FG003|Overall Study|Lost to Follow-up|2
6984108|NCT01255787|11040657|FG000|Overall Study|Withdrawal of Consent|3
6984109|NCT01255787|11040658|FG001|Overall Study|Withdrawal of Consent|9
6984110|NCT01255787|11040659|FG002|Overall Study|Withdrawal of Consent|3
6984111|NCT01255787|11040660|FG003|Overall Study|Withdrawal of Consent|4
6984112|NCT01255787|11040657|FG000|Overall Study|Pregnancy|0
6984113|NCT01255787|11040658|FG001|Overall Study|Pregnancy|0
6984114|NCT01255787|11040659|FG002|Overall Study|Pregnancy|0
6984115|NCT01255787|11040660|FG003|Overall Study|Pregnancy|1
6984116|NCT01255787|11040657|FG000|Overall Study|Lack of Efficacy|2
6984117|NCT01255787|11040658|FG001|Overall Study|Lack of Efficacy|2
6984118|NCT01255787|11040659|FG002|Overall Study|Lack of Efficacy|2
6984119|NCT01255787|11040660|FG003|Overall Study|Lack of Efficacy|2
6984120|NCT01255787|11040657|FG000|Overall Study|Noncompliance with Study Drug|3
6984121|NCT01255787|11040658|FG001|Overall Study|Noncompliance with Study Drug|1
6984122|NCT01255787|11040659|FG002|Overall Study|Noncompliance with Study Drug|0
6984123|NCT01255787|11040660|FG003|Overall Study|Noncompliance with Study Drug|0
6984124|NCT01255904|11040701|FG000|Overall Study|Physician Decision|1
6984125|NCT01255904|11040702|FG001|Overall Study|Physician Decision|4
6984126|NCT01256008|11040711|FG000|Overall Study|Lost to Follow-up|6
6984127|NCT01256008|11040712|FG001|Overall Study|Lost to Follow-up|4
6984128|NCT01256008|11040713|FG002|Overall Study|Lost to Follow-up|11
6984129|NCT01256008|11040711|FG000|Overall Study|Withdrawal by Subject|2
6984130|NCT01256008|11040712|FG001|Overall Study|Withdrawal by Subject|3
6984131|NCT01256008|11040713|FG002|Overall Study|Withdrawal by Subject|10
6984132|NCT01256060|11040732|FG000|Overall Study|Lost to Follow-up|0
6984133|NCT01256060|11040733|FG001|Overall Study|Lost to Follow-up|1
6984134|NCT01256060|11040734|FG002|Overall Study|Lost to Follow-up|0
6984135|NCT01256060|11040735|FG003|Overall Study|Lost to Follow-up|0
6984136|NCT01256177|11040752|FG000|Overall Study|Withdrawal by Subject|23
6984137|NCT01256177|11040753|FG001|Overall Study|Withdrawal by Subject|22
6984138|NCT01256177|11040752|FG000|Overall Study|Lost to Follow-up|2
6984139|NCT01256177|11040753|FG001|Overall Study|Lost to Follow-up|2
6984140|NCT01256177|11040752|FG000|Overall Study|Adverse Event|8
6984141|NCT01256177|11040753|FG001|Overall Study|Adverse Event|9
6984142|NCT01256177|11040752|FG000|Overall Study|Severe Non-Compliance to Protocol|4
6984143|NCT01256177|11040753|FG001|Overall Study|Severe Non-Compliance to Protocol|2
6984144|NCT01256177|11040752|FG000|Overall Study|Condition under Investigation Worsened|1
6984145|NCT01256177|11040753|FG001|Overall Study|Condition under Investigation Worsened|0
6984146|NCT01256177|11040752|FG000|Overall Study|Lack of Efficacy|11
6984147|NCT01256177|11040753|FG001|Overall Study|Lack of Efficacy|2
6984148|NCT01256177|11040752|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1
6984149|NCT01256177|11040753|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0
6984150|NCT01256190|11040761|FG000|Overall Study|Lost to Follow-up|2
6984151|NCT01256190|11040762|FG001|Overall Study|Lost to Follow-up|0
6984152|NCT01256294|11040768|FG000|Overall Study|Adverse Event|1
6984153|NCT01256294|11040769|FG001|Overall Study|Adverse Event|0
6984154|NCT01256294|11040768|FG000|Overall Study|Withdrawal by Subject|1
6984155|NCT01256294|11040769|FG001|Overall Study|Withdrawal by Subject|1
6984156|NCT01256294|11040768|FG000|Overall Study|Protocol deviation|2
6984157|NCT01256294|11040769|FG001|Overall Study|Protocol deviation|1
6984158|NCT01256385|11040777|FG000|Overall Study|Physician Decision|1
6984159|NCT01256385|11040778|FG001|Overall Study|Physician Decision|1
6984160|NCT01256385|11040777|FG000|Overall Study|Withdrawal by Subject|2
6984161|NCT01256385|11040778|FG001|Overall Study|Withdrawal by Subject|2
6984162|NCT01256411|11040788|FG000|Extension by Maximum Treatment|Protocol deviation|0
6984163|NCT01256411|11040789|FG001|Extension by Maximum Treatment|Protocol deviation|0
6984164|NCT01256411|11040790|FG002|Extension by Maximum Treatment|Protocol deviation|1
6984165|NCT01256411|11040791|FG003|Extension by Maximum Treatment|Protocol deviation|0
6984166|NCT01256411|11040792|FG004|Extension by Maximum Treatment|Protocol deviation|0
6984167|NCT01256411|11040793|FG005|Extension by Maximum Treatment|Protocol deviation|0
6984168|NCT01256411|11040788|FG000|Extension by Maximum Treatment|Lost to Follow-up|1
6984169|NCT01256411|11040789|FG001|Extension by Maximum Treatment|Lost to Follow-up|2
6984170|NCT01256411|11040790|FG002|Extension by Maximum Treatment|Lost to Follow-up|0
6984171|NCT01256411|11040791|FG003|Extension by Maximum Treatment|Lost to Follow-up|0
6984172|NCT01256411|11040792|FG004|Extension by Maximum Treatment|Lost to Follow-up|0
6984173|NCT01256411|11040793|FG005|Extension by Maximum Treatment|Lost to Follow-up|0
6984174|NCT01256411|11040788|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1
6984175|NCT01256411|11040789|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6
6984176|NCT01256411|11040790|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1
6984177|NCT01256411|11040791|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0
6984178|NCT01256411|11040792|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0
6984179|NCT01256411|11040793|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0
6984180|NCT01256411|11040788|FG000|Extension by Maximum Treatment|Lack of Efficacy|1
6984181|NCT01256411|11040789|FG001|Extension by Maximum Treatment|Lack of Efficacy|0
6984182|NCT01256411|11040790|FG002|Extension by Maximum Treatment|Lack of Efficacy|1
6984183|NCT01256411|11040791|FG003|Extension by Maximum Treatment|Lack of Efficacy|0
6984184|NCT01256411|11040792|FG004|Extension by Maximum Treatment|Lack of Efficacy|0
6984185|NCT01256411|11040793|FG005|Extension by Maximum Treatment|Lack of Efficacy|0
6984186|NCT01256411|11040788|FG000|Extension by Maximum Treatment|Adverse Event|4
6984187|NCT01256411|11040789|FG001|Extension by Maximum Treatment|Adverse Event|2
6984188|NCT01256411|11040790|FG002|Extension by Maximum Treatment|Adverse Event|1
6984189|NCT01256411|11040791|FG003|Extension by Maximum Treatment|Adverse Event|0
6984190|NCT01256411|11040792|FG004|Extension by Maximum Treatment|Adverse Event|0
6984191|NCT01256411|11040793|FG005|Extension by Maximum Treatment|Adverse Event|0
6984192|NCT01256411|11040788|FG000|Extension by Mono or Combination Therapy|Adverse Event|0
6984193|NCT01256411|11040789|FG001|Extension by Mono or Combination Therapy|Adverse Event|0
6984194|NCT01256411|11040790|FG002|Extension by Mono or Combination Therapy|Adverse Event|0
6984195|NCT01256411|11040791|FG003|Extension by Mono or Combination Therapy|Adverse Event|0
6984196|NCT01256411|11040792|FG004|Extension by Mono or Combination Therapy|Adverse Event|6
6984197|NCT01256411|11040793|FG005|Extension by Mono or Combination Therapy|Adverse Event|1
6984198|NCT01256411|11040788|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0
6984199|NCT01256411|11040789|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0
6984200|NCT01256411|11040790|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0
6984201|NCT01256411|11040791|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0
6984202|NCT01256411|11040792|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0
6984203|NCT01256411|11040793|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1
6984204|NCT01256411|11040788|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0
6984205|NCT01256411|11040789|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0
6984206|NCT01256411|11040790|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0
6984207|NCT01256411|11040791|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0
6984208|NCT01256411|11040792|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3
6984209|NCT01256411|11040793|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0
6984210|NCT01256411|11040788|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
6984211|NCT01256411|11040789|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
6984212|NCT01256411|11040790|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
6984213|NCT01256411|11040791|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
6984214|NCT01256411|11040792|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7
6984215|NCT01256411|11040793|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1
6984216|NCT01256411|11040788|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0
6984217|NCT01256411|11040789|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0
6984218|NCT01256411|11040790|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0
6984219|NCT01256411|11040791|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0
6984220|NCT01256411|11040792|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1
6984221|NCT01256411|11040793|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1
6984222|NCT01256450|11040827|FG000|Open-label Titration|Adverse Event|39
6984223|NCT01256450|11040828|FG001|Open-label Titration|Adverse Event|0
6984224|NCT01256450|11040829|FG002|Open-label Titration|Adverse Event|0
6984225|NCT01256450|11040827|FG000|Open-label Titration|Lost to Follow-up|7
6984226|NCT01256450|11040828|FG001|Open-label Titration|Lost to Follow-up|0
6984227|NCT01256450|11040829|FG002|Open-label Titration|Lost to Follow-up|0
6984228|NCT01256450|11040827|FG000|Open-label Titration|Lack of analgesic effect|30
6984229|NCT01256450|11040828|FG001|Open-label Titration|Lack of analgesic effect|0
6984230|NCT01256450|11040829|FG002|Open-label Titration|Lack of analgesic effect|0
6984231|NCT01256450|11040827|FG000|Open-label Titration|Non-compliance|9
6984232|NCT01256450|11040828|FG001|Open-label Titration|Non-compliance|0
6984233|NCT01256450|11040829|FG002|Open-label Titration|Non-compliance|0
6984234|NCT01256450|11040827|FG000|Open-label Titration|Screen failure|1
6984235|NCT01256450|11040828|FG001|Open-label Titration|Screen failure|0
6984236|NCT01256450|11040829|FG002|Open-label Titration|Screen failure|0
6984237|NCT01256450|11040827|FG000|Open-label Titration|Other|13
6984238|NCT01256450|11040828|FG001|Open-label Titration|Other|0
6984239|NCT01256450|11040829|FG002|Open-label Titration|Other|0
6984240|NCT01256450|11040827|FG000|Double-blind Treatment|Adverse Event|0
6984241|NCT01256450|11040828|FG001|Double-blind Treatment|Adverse Event|8
6984242|NCT01256450|11040829|FG002|Double-blind Treatment|Adverse Event|6
6984243|NCT01256450|11040827|FG000|Double-blind Treatment|Lost to Follow-up|0
6984244|NCT01256450|11040828|FG001|Double-blind Treatment|Lost to Follow-up|1
6984245|NCT01256450|11040829|FG002|Double-blind Treatment|Lost to Follow-up|7
6984246|NCT01256450|11040827|FG000|Double-blind Treatment|Withdrawal by Subject|0
6984247|NCT01256450|11040828|FG001|Double-blind Treatment|Withdrawal by Subject|0
6984248|NCT01256450|11040829|FG002|Double-blind Treatment|Withdrawal by Subject|1
6984249|NCT01256450|11040827|FG000|Double-blind Treatment|Lack of analgesic effect|0
6984250|NCT01256450|11040828|FG001|Double-blind Treatment|Lack of analgesic effect|5
6984251|NCT01256450|11040829|FG002|Double-blind Treatment|Lack of analgesic effect|6
6984252|NCT01256450|11040827|FG000|Double-blind Treatment|Non-compliance|0
6984253|NCT01256450|11040828|FG001|Double-blind Treatment|Non-compliance|5
6984254|NCT01256450|11040829|FG002|Double-blind Treatment|Non-compliance|4
6984255|NCT01256450|11040827|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0
6984256|NCT01256450|11040828|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0
6984257|NCT01256450|11040829|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1
6984258|NCT01256450|11040827|FG000|Double-blind Treatment|Other|0
6984259|NCT01256450|11040828|FG001|Double-blind Treatment|Other|9
6984260|NCT01256450|11040829|FG002|Double-blind Treatment|Other|12
6984261|NCT01256476|11040838|FG000|Overall Study|Adverse Event|2
6984262|NCT01256476|11040839|FG001|Overall Study|Adverse Event|1
6984263|NCT01256476|11040838|FG000|Overall Study|Withdrawal by Subject|2
6984264|NCT01256476|11040839|FG001|Overall Study|Withdrawal by Subject|1
6984265|NCT01256476|11040838|FG000|Overall Study|Lost to Follow-up|1
6984266|NCT01256476|11040839|FG001|Overall Study|Lost to Follow-up|2
6984267|NCT01256476|11040838|FG000|Overall Study|Persistent ALT or AST elevation|1
6984268|NCT01256476|11040839|FG001|Overall Study|Persistent ALT or AST elevation|0
6984269|NCT01256476|11040838|FG000|Overall Study|Physician Decision|0
6984270|NCT01256476|11040839|FG001|Overall Study|Physician Decision|1
6984271|NCT01256476|11040838|FG000|Overall Study|Subject non-compliance|0
6984272|NCT01256476|11040839|FG001|Overall Study|Subject non-compliance|1
6984273|NCT01256476|11040838|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0
6984274|NCT01256476|11040839|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1
6984275|NCT01256502|11040845|FG000|Overall Study|Had scaffold removed|4
6984276|NCT01256502|11040845|FG000|Overall Study|Personal reasons|5
6984277|NCT01256502|11040845|FG000|Overall Study|Protocol deviation|1
6984278|NCT01256567|11040854|FG000|Overall Study|Withdrawal by Subject|1
6984279|NCT01256593|11040859|FG000|Overall Study|Protocol Violation|26
6984280|NCT01256593|11040859|FG000|Overall Study|No Drug Administration Information|2
6984281|NCT01256593|11040859|FG000|Overall Study|No Visit After Treatment|186
6984282|NCT01256658|11040865|FG000|Period 1|Lost to Follow-up|837
6984283|NCT01256658|11040866|FG001|Period 1|Lost to Follow-up|661
6984284|NCT01256658|11040865|FG000|Period 1|Withdrawal by Subject|35
6984285|NCT01256658|11040866|FG001|Period 1|Withdrawal by Subject|43
6984286|NCT01256658|11040865|FG000|Period 1|Death|48
6984287|NCT01256658|11040866|FG001|Period 1|Death|44
6984288|NCT01256671|11040875|FG000|Overall Study|Adverse Event|29
6984289|NCT01256671|11040875|FG000|Overall Study|Lost to Follow-up|16
6984290|NCT01256671|11040875|FG000|Overall Study|Withdrawal by Subject|31
6984291|NCT01256671|11040875|FG000|Overall Study|Physician Decision|3
6984292|NCT01256671|11040875|FG000|Overall Study|Lack of Efficacy|4
6984293|NCT01256671|11040875|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12
6984294|NCT01256684|11040882|FG000|Overall Study|Adverse Event|1
6984295|NCT01256684|11040883|FG001|Overall Study|Adverse Event|4
6984296|NCT01256684|11040884|FG002|Overall Study|Adverse Event|2
6984297|NCT01256684|11040882|FG000|Overall Study|Withdrawal by Subject|4
6984298|NCT01256684|11040883|FG001|Overall Study|Withdrawal by Subject|0
6984299|NCT01256684|11040884|FG002|Overall Study|Withdrawal by Subject|2
6984300|NCT01256684|11040882|FG000|Overall Study|Physician Decision|0
6984301|NCT01256684|11040883|FG001|Overall Study|Physician Decision|1
6984302|NCT01256684|11040884|FG002|Overall Study|Physician Decision|0
6984303|NCT01256684|11040882|FG000|Overall Study|Lack of Efficacy|0
6984304|NCT01256684|11040883|FG001|Overall Study|Lack of Efficacy|1
6984305|NCT01256684|11040884|FG002|Overall Study|Lack of Efficacy|1
6984306|NCT01256684|11040882|FG000|Overall Study|Entry criteria not met/non-compliance|4
6984307|NCT01256684|11040883|FG001|Overall Study|Entry criteria not met/non-compliance|7
6984308|NCT01256684|11040884|FG002|Overall Study|Entry criteria not met/non-compliance|6
6984309|NCT01256788|11040895|FG000|Overall Study|Lost to Follow-up|5
6984310|NCT01256788|11040896|FG001|Overall Study|Lost to Follow-up|8
6984311|NCT01256788|11040897|FG002|Overall Study|Lost to Follow-up|3
6984312|NCT01256879|11040918|FG000|Overall Study|Withdrawal by Subject|1
6984313|NCT01257204|11040973|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0
6984314|NCT01257204|11040974|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1
6984315|NCT01257204|11040975|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3
6984316|NCT01257204|11040973|FG000|Treatment Period (up to Week 24)|Adverse Event|3
6984317|NCT01257204|11040974|FG001|Treatment Period (up to Week 24)|Adverse Event|1
6984318|NCT01257204|11040975|FG002|Treatment Period (up to Week 24)|Adverse Event|2
6984319|NCT01257204|11040973|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1
7041980|NCT01732510|11125962|FG003|Overall Study|Lost to Follow-up|1
6984320|NCT01257204|11040974|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0
6984321|NCT01257204|11040975|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1
6984322|NCT01257204|11040973|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0
6984323|NCT01257204|11040974|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2
6984324|NCT01257204|11040975|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0
6984325|NCT01257204|11040973|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
6984326|NCT01257204|11040974|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
6984327|NCT01257204|11040975|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1
6984328|NCT01257204|11040973|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1
6984329|NCT01257204|11040974|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2
6984330|NCT01257204|11040975|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2
6984331|NCT01257204|11040973|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0
6984332|NCT01257204|11040974|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2
6984333|NCT01257204|11040975|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1
6984334|NCT01257204|11040973|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1
6984335|NCT01257204|11040974|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4
6984336|NCT01257204|11040975|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4
6984337|NCT01257204|11040973|FG000|Follow-up Period (up to Week 48)|Other|0
6984338|NCT01257204|11040974|FG001|Follow-up Period (up to Week 48)|Other|0
6984339|NCT01257204|11040975|FG002|Follow-up Period (up to Week 48)|Other|5
6984340|NCT01257230|11041011|FG000|Overall Study|Not Treated|0
6984341|NCT01257230|11041012|FG001|Overall Study|Not Treated|0
6984342|NCT01257230|11041013|FG002|Overall Study|Not Treated|1
6984343|NCT01257230|11041011|FG000|Overall Study|Adverse Event|2
6984344|NCT01257230|11041012|FG001|Overall Study|Adverse Event|0
6984345|NCT01257230|11041013|FG002|Overall Study|Adverse Event|0
6984346|NCT01257230|11041011|FG000|Overall Study|Lack of Efficacy|0
6984347|NCT01257230|11041012|FG001|Overall Study|Lack of Efficacy|1
6984348|NCT01257230|11041013|FG002|Overall Study|Lack of Efficacy|0
6984349|NCT01257230|11041011|FG000|Overall Study|Protocol Violation|3
6984350|NCT01257230|11041012|FG001|Overall Study|Protocol Violation|0
6984351|NCT01257230|11041013|FG002|Overall Study|Protocol Violation|1
6984352|NCT01257230|11041011|FG000|Overall Study|Withdrawal by Subject|0
6984353|NCT01257230|11041012|FG001|Overall Study|Withdrawal by Subject|4
6984354|NCT01257230|11041013|FG002|Overall Study|Withdrawal by Subject|1
6984355|NCT01257230|11041011|FG000|Overall Study|Other reason not defined above|1
6984356|NCT01257230|11041012|FG001|Overall Study|Other reason not defined above|5
6984357|NCT01257230|11041013|FG002|Overall Study|Other reason not defined above|3
6984358|NCT01257425|11041044|FG000|Overall Study|Lack of Efficacy|3
6984359|NCT01257425|11041045|FG001|Overall Study|Lack of Efficacy|3
6984360|NCT01257425|11041044|FG000|Overall Study|Adverse Event|1
6984361|NCT01257425|11041045|FG001|Overall Study|Adverse Event|1
6984362|NCT01257425|11041044|FG000|Overall Study|Protocol Violation|1
6984363|NCT01257425|11041045|FG001|Overall Study|Protocol Violation|1
6984364|NCT01257425|11041044|FG000|Overall Study|Withdrawal by Subject|0
6984365|NCT01257425|11041045|FG001|Overall Study|Withdrawal by Subject|1
6984366|NCT01257425|11041044|FG000|Overall Study|Death|1
6984367|NCT01257425|11041045|FG001|Overall Study|Death|0
6984368|NCT01257503|11041062|FG000|Overall Study|Lost to Follow-up|7
6984369|NCT01257503|11041063|FG001|Overall Study|Lost to Follow-up|10
6984370|NCT01257503|11041062|FG000|Overall Study|Over 5 years old at enrollment|0
6984371|NCT01257503|11041063|FG001|Overall Study|Over 5 years old at enrollment|1
6984372|NCT01257503|11041062|FG000|Overall Study|strep culture positive at enrollment|1
6984373|NCT01257503|11041063|FG001|Overall Study|strep culture positive at enrollment|0
6984374|NCT01257542|11041071|FG000|Overall Study|Protocol Violation|3
6984375|NCT01257542|11041072|FG001|Overall Study|Protocol Violation|5
6984376|NCT01257542|11041071|FG000|Overall Study|Withdrawal by Subject|0
6984377|NCT01257542|11041072|FG001|Overall Study|Withdrawal by Subject|2
6984378|NCT01257581|11041081|FG000|Overall Study|Early Termination|3
6984379|NCT01257581|11041082|FG001|Overall Study|Early Termination|1
6984380|NCT01257581|11041083|FG002|Overall Study|Early Termination|2
6984381|NCT01257581|11041081|FG000|Overall Study|Death|2
6984382|NCT01257581|11041082|FG001|Overall Study|Death|2
6984383|NCT01257581|11041083|FG002|Overall Study|Death|4
6984384|NCT01257698|11041093|FG000|Overall Study|Protocol Violation|4
6984385|NCT01257698|11041094|FG001|Overall Study|Protocol Violation|0
6984386|NCT01257737|11041102|FG000|Overall Study|Lost to Follow-up|1
6984387|NCT01257737|11041103|FG001|Overall Study|Lost to Follow-up|2
6984388|NCT01257737|11041102|FG000|Overall Study|Liver transplant|1
6984389|NCT01257737|11041103|FG001|Overall Study|Liver transplant|0
6984390|NCT01257737|11041102|FG000|Overall Study|Relocation out of the country|0
6984391|NCT01257737|11041103|FG001|Overall Study|Relocation out of the country|1
6984392|NCT01257737|11041102|FG000|Overall Study|Withdrew from study|0
6984393|NCT01257737|11041103|FG001|Overall Study|Withdrew from study|1
6984394|NCT01258075|11041145|FG000|Overall Study|Adverse Event|8
6984395|NCT01258075|11041146|FG001|Overall Study|Adverse Event|3
6984396|NCT01258075|11041145|FG000|Overall Study|Lost to Follow-up|11
6984397|NCT01258075|11041146|FG001|Overall Study|Lost to Follow-up|6
6984398|NCT01258075|11041145|FG000|Overall Study|Withdrawal by Subject|10
6984399|NCT01258075|11041146|FG001|Overall Study|Withdrawal by Subject|7
6984400|NCT01258075|11041145|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1
6984401|NCT01258075|11041146|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2
6984402|NCT01258075|11041145|FG000|Overall Study|Other|12
6984403|NCT01258075|11041146|FG001|Overall Study|Other|5
6984404|NCT01258101|11041156|FG000|Overall Study|Adverse Event|5
6984405|NCT01258101|11041157|FG001|Overall Study|Adverse Event|6
6984406|NCT01258101|11041158|FG002|Overall Study|Adverse Event|0
6984407|NCT01258101|11041159|FG003|Overall Study|Adverse Event|0
6984408|NCT01258101|11041156|FG000|Overall Study|Extra exclusion criterion amended|2
6984409|NCT01258101|11041157|FG001|Overall Study|Extra exclusion criterion amended|1
6984410|NCT01258101|11041158|FG002|Overall Study|Extra exclusion criterion amended|1
6984411|NCT01258101|11041159|FG003|Overall Study|Extra exclusion criterion amended|1
6984412|NCT01258101|11041156|FG000|Overall Study|Informed consent has been withdrawn|2
6984413|NCT01258101|11041157|FG001|Overall Study|Informed consent has been withdrawn|2
6984414|NCT01258101|11041158|FG002|Overall Study|Informed consent has been withdrawn|1
6984415|NCT01258101|11041159|FG003|Overall Study|Informed consent has been withdrawn|1
6984416|NCT01258101|11041156|FG000|Overall Study|Patient is not able to attend visits|8
6984417|NCT01258101|11041157|FG001|Overall Study|Patient is not able to attend visits|9
6984418|NCT01258101|11041158|FG002|Overall Study|Patient is not able to attend visits|7
6984419|NCT01258101|11041159|FG003|Overall Study|Patient is not able to attend visits|6
6984420|NCT01258101|11041156|FG000|Overall Study|Patient´s compliance|4
6984421|NCT01258101|11041157|FG001|Overall Study|Patient´s compliance|3
6984422|NCT01258101|11041158|FG002|Overall Study|Patient´s compliance|1
6984423|NCT01258101|11041159|FG003|Overall Study|Patient´s compliance|2
6984424|NCT01258101|11041156|FG000|Overall Study|Lost to Follow-up|5
6984425|NCT01258101|11041157|FG001|Overall Study|Lost to Follow-up|5
6984426|NCT01258101|11041158|FG002|Overall Study|Lost to Follow-up|0
6984427|NCT01258101|11041159|FG003|Overall Study|Lost to Follow-up|6
6984428|NCT01258101|11041156|FG000|Overall Study|PCR positive at week 24|0
6984429|NCT01258101|11041157|FG001|Overall Study|PCR positive at week 24|0
6984430|NCT01258101|11041158|FG002|Overall Study|PCR positive at week 24|0
6984431|NCT01258101|11041159|FG003|Overall Study|PCR positive at week 24|1
6984432|NCT01258101|11041156|FG000|Overall Study|Other reason|7
6984433|NCT01258101|11041157|FG001|Overall Study|Other reason|8
6984434|NCT01258101|11041158|FG002|Overall Study|Other reason|1
6984435|NCT01258101|11041159|FG003|Overall Study|Other reason|8
6984436|NCT01258348|11041184|FG000|Overall Study|Adverse Event|1
6984437|NCT01258348|11041185|FG001|Overall Study|Adverse Event|1
6984438|NCT01258348|11041186|FG002|Overall Study|Adverse Event|3
6984439|NCT01258348|11041187|FG003|Overall Study|Adverse Event|2
6984440|NCT01258348|11041188|FG004|Overall Study|Adverse Event|4
6984441|NCT01258348|11041184|FG000|Overall Study|Progressive Disease|0
6984442|NCT01258348|11041185|FG001|Overall Study|Progressive Disease|3
6984443|NCT01258348|11041186|FG002|Overall Study|Progressive Disease|0
6984444|NCT01258348|11041187|FG003|Overall Study|Progressive Disease|2
6984445|NCT01258348|11041188|FG004|Overall Study|Progressive Disease|2
6984446|NCT01258348|11041184|FG000|Overall Study|Physician Decision|0
6984447|NCT01258348|11041185|FG001|Overall Study|Physician Decision|0
6984448|NCT01258348|11041186|FG002|Overall Study|Physician Decision|0
6984449|NCT01258348|11041187|FG003|Overall Study|Physician Decision|2
6984450|NCT01258348|11041188|FG004|Overall Study|Physician Decision|0
6984451|NCT01258348|11041184|FG000|Overall Study|Withdrawal by Subject|0
6984452|NCT01258348|11041185|FG001|Overall Study|Withdrawal by Subject|1
6984453|NCT01258348|11041186|FG002|Overall Study|Withdrawal by Subject|0
6984454|NCT01258348|11041187|FG003|Overall Study|Withdrawal by Subject|0
6984455|NCT01258348|11041188|FG004|Overall Study|Withdrawal by Subject|0
6984456|NCT01258595|11041259|FG000|Overall Study|Lost to Follow-up|1
6984457|NCT01258595|11041260|FG001|Overall Study|Lost to Follow-up|0
6984458|NCT01258595|11041259|FG000|Overall Study|Withdrawal by Subject|0
6984459|NCT01258595|11041260|FG001|Overall Study|Withdrawal by Subject|1
6984460|NCT01258608|11041268|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1
6984461|NCT01258608|11041269|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0
6984462|NCT01258608|11041268|FG000|Overall Study|Clinical progression|1
6984463|NCT01258608|11041269|FG001|Overall Study|Clinical progression|0
6984464|NCT01258608|11041268|FG000|Overall Study|Sponsor decision|0
6984465|NCT01258608|11041269|FG001|Overall Study|Sponsor decision|1
6984466|NCT01258608|11041268|FG000|Overall Study|Physician Decision|6
6984467|NCT01258608|11041269|FG001|Overall Study|Physician Decision|1
6984468|NCT01258608|11041268|FG000|Overall Study|Lost to Follow-up|0
6984469|NCT01258608|11041269|FG001|Overall Study|Lost to Follow-up|1
6984470|NCT01258608|11041268|FG000|Overall Study|Lack of compliance|1
6984471|NCT01258608|11041269|FG001|Overall Study|Lack of compliance|0
6984472|NCT01258608|11041268|FG000|Overall Study|Lack of Efficacy|0
6984473|NCT01258608|11041269|FG001|Overall Study|Lack of Efficacy|1
6984474|NCT01258608|11041268|FG000|Overall Study|Adverse Event|6
6984475|NCT01258608|11041269|FG001|Overall Study|Adverse Event|10
6984476|NCT01258608|11041268|FG000|Overall Study|Withdrawal by Subject|6
6984477|NCT01258608|11041269|FG001|Overall Study|Withdrawal by Subject|5
6984478|NCT01258660|11041278|FG000|Overall Study|Adverse Event|2
6984479|NCT01258660|11041279|FG001|Overall Study|Adverse Event|4
6984480|NCT01258660|11041278|FG000|Overall Study|Withdrawal by Subject|3
6984481|NCT01258660|11041279|FG001|Overall Study|Withdrawal by Subject|0
6984482|NCT01258660|11041278|FG000|Overall Study|due to relocation|2
6984483|NCT01258660|11041279|FG001|Overall Study|due to relocation|0
6984484|NCT01258660|11041278|FG000|Overall Study|Protocol Violation|0
6984485|NCT01258660|11041279|FG001|Overall Study|Protocol Violation|1
6984486|NCT01258660|11041278|FG000|Overall Study|Invalid for primary analysis data set|4
6984487|NCT01258660|11041279|FG001|Overall Study|Invalid for primary analysis data set|6
6984488|NCT01258738|11041288|FG000|Double-blind Period|Did not meet inclusion criteria|3
6984489|NCT01258738|11041289|FG001|Double-blind Period|Did not meet inclusion criteria|3
6984490|NCT01258738|11041288|FG000|Double-blind Period|Withdrawal by Subject|2
6984491|NCT01258738|11041289|FG001|Double-blind Period|Withdrawal by Subject|2
6984492|NCT01258738|11041288|FG000|Double-blind Period|Protocol Violation|1
6984493|NCT01258738|11041289|FG001|Double-blind Period|Protocol Violation|1
6984494|NCT01258738|11041288|FG000|Double-blind Period|Adverse Event|3
6984495|NCT01258738|11041289|FG001|Double-blind Period|Adverse Event|1
6984496|NCT01258738|11041288|FG000|Open-label Period|Did not meet inclusion criteria|0
6984497|NCT01258738|11041289|FG001|Open-label Period|Did not meet inclusion criteria|1
6984498|NCT01258738|11041288|FG000|Open-label Period|Insufficient clinical response|5
6984499|NCT01258738|11041289|FG001|Open-label Period|Insufficient clinical response|3
6984500|NCT01258738|11041288|FG000|Open-label Period|Lost to Follow-up|0
6984501|NCT01258738|11041289|FG001|Open-label Period|Lost to Follow-up|2
6984502|NCT01258738|11041288|FG000|Open-label Period|Withdrawal by Subject|5
6984503|NCT01258738|11041289|FG001|Open-label Period|Withdrawal by Subject|6
6984504|NCT01258738|11041288|FG000|Open-label Period|Protocol Violation|2
6984505|NCT01258738|11041289|FG001|Open-label Period|Protocol Violation|2
6984506|NCT01258738|11041288|FG000|Open-label Period|Adverse Event|4
6984507|NCT01258738|11041289|FG001|Open-label Period|Adverse Event|5
6984508|NCT01258738|11041288|FG000|Open-label Period|Other Reasons|0
6984509|NCT01258738|11041289|FG001|Open-label Period|Other Reasons|1
6984510|NCT01258738|11041288|FG000|Open-label Period|Withdrawn due to pregnancy|1
6984511|NCT01258738|11041289|FG001|Open-label Period|Withdrawn due to pregnancy|1
6984512|NCT01258998|11041322|FG000|Overall Study|Ineligible|1
6984513|NCT01259089|11041341|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0
6984514|NCT01259089|11041342|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0
6984515|NCT01259089|11041343|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0
6984516|NCT01259089|11041344|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0
6984517|NCT01259089|11041345|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0
6984518|NCT01259089|11041346|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1
6984519|NCT01259089|11041341|FG000|Reached First Response at 4 Weeks|Adverse Event|0
6984520|NCT01259089|11041342|FG001|Reached First Response at 4 Weeks|Adverse Event|0
6984521|NCT01259089|11041343|FG002|Reached First Response at 4 Weeks|Adverse Event|0
6984522|NCT01259089|11041344|FG003|Reached First Response at 4 Weeks|Adverse Event|0
6984523|NCT01259089|11041345|FG004|Reached First Response at 4 Weeks|Adverse Event|0
6984524|NCT01259089|11041346|FG005|Reached First Response at 4 Weeks|Adverse Event|1
6984525|NCT01259089|11041341|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
6984526|NCT01259089|11041342|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
6984527|NCT01259089|11041343|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
6984528|NCT01259089|11041344|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
6984529|NCT01259089|11041345|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
6984530|NCT01259089|11041346|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1
6984531|NCT01259089|11041341|FG000|Confirmed Response at 8 Weeks|Adverse Event|0
6984532|NCT01259089|11041342|FG001|Confirmed Response at 8 Weeks|Adverse Event|0
6984533|NCT01259089|11041343|FG002|Confirmed Response at 8 Weeks|Adverse Event|0
6984534|NCT01259089|11041344|FG003|Confirmed Response at 8 Weeks|Adverse Event|0
6984535|NCT01259089|11041345|FG004|Confirmed Response at 8 Weeks|Adverse Event|1
6984536|NCT01259089|11041346|FG005|Confirmed Response at 8 Weeks|Adverse Event|2
6984537|NCT01259089|11041341|FG000|Confirmed Response at 8 Weeks|Progressive disease|0
6984538|NCT01259089|11041342|FG001|Confirmed Response at 8 Weeks|Progressive disease|0
6984539|NCT01259089|11041343|FG002|Confirmed Response at 8 Weeks|Progressive disease|1
6984540|NCT01259089|11041344|FG003|Confirmed Response at 8 Weeks|Progressive disease|1
6984541|NCT01259089|11041345|FG004|Confirmed Response at 8 Weeks|Progressive disease|3
6984542|NCT01259089|11041346|FG005|Confirmed Response at 8 Weeks|Progressive disease|7
6984543|NCT01259089|11041341|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1
6984544|NCT01259089|11041342|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
6984545|NCT01259089|11041343|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
6984546|NCT01259089|11041344|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
6984547|NCT01259089|11041345|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
6984548|NCT01259089|11041346|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
6984549|NCT01259089|11041341|FG000|Continued Treatment After 8 Weeks|Adverse Event|0
6984550|NCT01259089|11041342|FG001|Continued Treatment After 8 Weeks|Adverse Event|0
6984551|NCT01259089|11041343|FG002|Continued Treatment After 8 Weeks|Adverse Event|0
6984552|NCT01259089|11041344|FG003|Continued Treatment After 8 Weeks|Adverse Event|0
6984553|NCT01259089|11041345|FG004|Continued Treatment After 8 Weeks|Adverse Event|2
6984554|NCT01259089|11041346|FG005|Continued Treatment After 8 Weeks|Adverse Event|1
6984555|NCT01259089|11041341|FG000|Continued Treatment After 8 Weeks|Progressive disease|1
6984556|NCT01259089|11041342|FG001|Continued Treatment After 8 Weeks|Progressive disease|1
6984557|NCT01259089|11041343|FG002|Continued Treatment After 8 Weeks|Progressive disease|1
6984558|NCT01259089|11041344|FG003|Continued Treatment After 8 Weeks|Progressive disease|1
6984559|NCT01259089|11041345|FG004|Continued Treatment After 8 Weeks|Progressive disease|0
6984560|NCT01259089|11041346|FG005|Continued Treatment After 8 Weeks|Progressive disease|0
6984561|NCT01259089|11041341|FG000|Survival Follow up for Two Years|Death|3
6984562|NCT01259089|11041342|FG001|Survival Follow up for Two Years|Death|2
6984563|NCT01259089|11041343|FG002|Survival Follow up for Two Years|Death|2
6984564|NCT01259089|11041344|FG003|Survival Follow up for Two Years|Death|3
6984565|NCT01259089|11041345|FG004|Survival Follow up for Two Years|Death|6
6984566|NCT01259089|11041346|FG005|Survival Follow up for Two Years|Death|13
6984567|NCT01259089|11041341|FG000|Survival Follow up for Two Years|Lost to Follow-up|0
6984568|NCT01259089|11041342|FG001|Survival Follow up for Two Years|Lost to Follow-up|0
6984569|NCT01259089|11041343|FG002|Survival Follow up for Two Years|Lost to Follow-up|0
6984570|NCT01259089|11041344|FG003|Survival Follow up for Two Years|Lost to Follow-up|0
6984571|NCT01259089|11041345|FG004|Survival Follow up for Two Years|Lost to Follow-up|0
6984572|NCT01259089|11041346|FG005|Survival Follow up for Two Years|Lost to Follow-up|2
6984573|NCT01259089|11041341|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0
6984574|NCT01259089|11041342|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0
6984575|NCT01259089|11041343|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0
6984576|NCT01259089|11041344|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0
6984577|NCT01259089|11041345|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0
6984578|NCT01259089|11041346|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4
6984579|NCT01259102|11041365|FG000|Overall Study|Adverse Event|1
6984580|NCT01259102|11041366|FG001|Overall Study|Adverse Event|0
6984581|NCT01259102|11041367|FG002|Overall Study|Adverse Event|1
6984582|NCT01259102|11041368|FG003|Overall Study|Adverse Event|1
6984583|NCT01259102|11041369|FG004|Overall Study|Adverse Event|0
6984584|NCT01259102|11041365|FG000|Overall Study|Other|0
6984585|NCT01259102|11041366|FG001|Overall Study|Other|0
6984586|NCT01259102|11041367|FG002|Overall Study|Other|1
6984587|NCT01259102|11041368|FG003|Overall Study|Other|1
6984588|NCT01259102|11041369|FG004|Overall Study|Other|1
6984589|NCT01259115|11041381|FG000|Period 1|Adverse Event|1
6984590|NCT01259115|11041382|FG001|Period 1|Adverse Event|0
6984591|NCT01259115|11041381|FG000|Period 1|Protocol Violation|2
6984592|NCT01259115|11041382|FG001|Period 1|Protocol Violation|0
6984593|NCT01259115|11041381|FG000|Period 1|Lost to Follow-up|0
6984594|NCT01259115|11041382|FG001|Period 1|Lost to Follow-up|1
6984595|NCT01259115|11041381|FG000|Period 2|Adverse Event|1
6984596|NCT01259115|11041382|FG001|Period 2|Adverse Event|0
6984597|NCT01259245|11041404|FG000|Overall Study|Withdrawal by Subject|27
6984598|NCT01259245|11041405|FG001|Overall Study|Withdrawal by Subject|24
6984599|NCT01259245|11041404|FG000|Overall Study|Death|1
6984600|NCT01259245|11041405|FG001|Overall Study|Death|2
6984601|NCT01259297|11041421|FG000|Double Blind Randomized Period|Death|1
6984602|NCT01259297|11041422|FG001|Double Blind Randomized Period|Death|1
6984603|NCT01259297|11041423|FG002|Double Blind Randomized Period|Death|1
6984604|NCT01259297|11041424|FG003|Double Blind Randomized Period|Death|2
6984605|NCT01259297|11041425|FG004|Double Blind Randomized Period|Death|1
6984606|NCT01259297|11041426|FG005|Double Blind Randomized Period|Death|5
6984607|NCT01259297|11041427|FG006|Double Blind Randomized Period|Death|2
6984608|NCT01259297|11041428|FG007|Double Blind Randomized Period|Death|1
6984609|NCT01259297|11041421|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
6984610|NCT01259297|11041422|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
6984611|NCT01259297|11041423|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0
6984612|NCT01259297|11041424|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
6984613|NCT01259297|11041425|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
6984614|NCT01259297|11041426|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
6984615|NCT01259297|11041427|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
6984616|NCT01259297|11041428|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
6984617|NCT01259297|11041421|FG000|Double Blind Randomized Period|Other reasons|0
6984618|NCT01259297|11041422|FG001|Double Blind Randomized Period|Other reasons|1
6984619|NCT01259297|11041423|FG002|Double Blind Randomized Period|Other reasons|0
6984620|NCT01259297|11041424|FG003|Double Blind Randomized Period|Other reasons|0
6984621|NCT01259297|11041425|FG004|Double Blind Randomized Period|Other reasons|1
6984622|NCT01259297|11041426|FG005|Double Blind Randomized Period|Other reasons|2
6984623|NCT01259297|11041427|FG006|Double Blind Randomized Period|Other reasons|3
6984624|NCT01259297|11041428|FG007|Double Blind Randomized Period|Other reasons|1
6984625|NCT01259375|11041445|FG000|Overall Study|Adverse Event|1
6984626|NCT01259388|11041453|FG000|Overall Study|Adverse Event|3
6984627|NCT01259388|11041454|FG001|Overall Study|Adverse Event|0
6984628|NCT01259388|11041453|FG000|Overall Study|Withdrawal by Subject|1
6984629|NCT01259388|11041454|FG001|Overall Study|Withdrawal by Subject|1
6984630|NCT01259388|11041453|FG000|Overall Study|Physician Decision|1
6984631|NCT01259388|11041454|FG001|Overall Study|Physician Decision|0
6984632|NCT01259401|11041462|FG000|4-month Follow-up|Death|0
6984633|NCT01259401|11041463|FG001|4-month Follow-up|Death|1
6984634|NCT01259401|11041462|FG000|4-month Follow-up|Lost to Follow-up|0
6984635|NCT01259401|11041463|FG001|4-month Follow-up|Lost to Follow-up|1
6984636|NCT01259466|11041490|FG000|Overall Study|Withdrawal by Subject|1
6984637|NCT01259466|11041491|FG001|Overall Study|Withdrawal by Subject|9
6984638|NCT01259492|11041501|FG000|Period 1 (9 Weeks)|Adverse Event|13
6984639|NCT01259492|11041502|FG001|Period 1 (9 Weeks)|Adverse Event|18
6984640|NCT01259492|11041503|FG002|Period 1 (9 Weeks)|Adverse Event|26
6984641|NCT01259492|11041504|FG003|Period 1 (9 Weeks)|Adverse Event|3
6984642|NCT01259492|11041501|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2
6984643|NCT01259492|11041502|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2
6984644|NCT01259492|11041503|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4
6984645|NCT01259492|11041504|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11
6984646|NCT01259492|11041501|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5
6984647|NCT01259492|11041502|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8
6984648|NCT01259492|11041503|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6
6984649|NCT01259492|11041504|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7
6984650|NCT01259492|11041501|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4
6984651|NCT01259492|11041502|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6
6984652|NCT01259492|11041503|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3
6984653|NCT01259492|11041504|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4
6984654|NCT01259492|11041501|FG000|Period 1 (9 Weeks)|Administrative Problems|0
6984655|NCT01259492|11041502|FG001|Period 1 (9 Weeks)|Administrative Problems|1
6984656|NCT01259492|11041503|FG002|Period 1 (9 Weeks)|Administrative Problems|1
6984657|NCT01259492|11041504|FG003|Period 1 (9 Weeks)|Administrative Problems|2
6984658|NCT01259492|11041501|FG000|Period 1 (9 Weeks)|Protocol Violation|5
6984659|NCT01259492|11041502|FG001|Period 1 (9 Weeks)|Protocol Violation|6
6984660|NCT01259492|11041503|FG002|Period 1 (9 Weeks)|Protocol Violation|3
6984661|NCT01259492|11041504|FG003|Period 1 (9 Weeks)|Protocol Violation|1
6984662|NCT01259492|11041501|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3
6984663|NCT01259492|11041502|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4
6984664|NCT01259492|11041503|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7
6984665|NCT01259492|11041504|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8
6984666|NCT01259492|11041501|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
6984667|NCT01259492|11041502|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
6984668|NCT01259492|11041503|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
6984669|NCT01259492|11041504|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
6984670|NCT01259492|11041501|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6
6984671|NCT01259492|11041502|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2
6984672|NCT01259492|11041503|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8
6984673|NCT01259492|11041504|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4
6984674|NCT01259492|11041501|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
6984675|NCT01259492|11041502|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
6984676|NCT01259492|11041503|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1
6984677|NCT01259492|11041504|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
6984678|NCT01259492|11041501|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0
6984679|NCT01259492|11041502|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2
6984680|NCT01259492|11041503|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1
6984681|NCT01259492|11041504|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0
6984682|NCT01259492|11041501|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
6984683|NCT01259492|11041502|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11
6984684|NCT01259492|11041503|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6
6984685|NCT01259492|11041504|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
6984686|NCT01259492|11041501|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
6984687|NCT01259492|11041502|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
6984688|NCT01259492|11041503|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
6984689|NCT01259492|11041504|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1
6984690|NCT01259492|11041501|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
6984691|NCT01259492|11041502|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
6984692|NCT01259492|11041503|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1
6984693|NCT01259492|11041504|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
6984694|NCT01259492|11041501|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28
6984695|NCT01259492|11041502|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42
6984696|NCT01259492|11041503|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29
6984697|NCT01259492|11041504|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62
6984698|NCT01259492|11041501|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1
6984699|NCT01259492|11041502|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
6984700|NCT01259492|11041503|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
6984701|NCT01259492|11041504|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
6984702|NCT01259492|11041501|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12
6984703|NCT01259492|11041502|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6
6984704|NCT01259492|11041503|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4
6984705|NCT01259492|11041504|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3
7041981|NCT01732510|11125963|FG004|Overall Study|Lost to Follow-up|0
6984706|NCT01259492|11041501|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
6984707|NCT01259492|11041502|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4
6984708|NCT01259492|11041503|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6
6984709|NCT01259492|11041504|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
6984710|NCT01259492|11041501|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
6984711|NCT01259492|11041502|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
6984712|NCT01259492|11041503|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1
6984713|NCT01259492|11041504|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
6984714|NCT01259492|11041501|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5
6984715|NCT01259492|11041502|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6
6984716|NCT01259492|11041503|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3
6984717|NCT01259492|11041504|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7
6984718|NCT01259713|11041526|FG000|Overall Study|Adverse Event|54
6984719|NCT01259713|11041527|FG001|Overall Study|Adverse Event|23
6984720|NCT01259713|11041526|FG000|Overall Study|Death Not Related to IFI|8
6984721|NCT01259713|11041527|FG001|Overall Study|Death Not Related to IFI|1
6984722|NCT01259713|11041526|FG000|Overall Study|Investigators Discretion|14
6984723|NCT01259713|11041527|FG001|Overall Study|Investigators Discretion|6
6984724|NCT01259713|11041526|FG000|Overall Study|Lack of Efficacy|2
6984725|NCT01259713|11041527|FG001|Overall Study|Lack of Efficacy|0
6984726|NCT01259713|11041526|FG000|Overall Study|Protocol Violation|5
6984727|NCT01259713|11041527|FG001|Overall Study|Protocol Violation|4
6984728|NCT01259713|11041526|FG000|Overall Study|Subject Withdrew Consent|12
6984729|NCT01259713|11041527|FG001|Overall Study|Subject Withdrew Consent|7
6984730|NCT01259726|11041537|FG000|Overall Study|Death|1
6984731|NCT01259726|11041538|FG001|Overall Study|Death|0
6984732|NCT01259726|11041539|FG002|Overall Study|Death|0
6984733|NCT01259726|11041540|FG003|Overall Study|Death|0
6984734|NCT01259726|11041537|FG000|Overall Study|Physician Decision|2
6984735|NCT01259726|11041538|FG001|Overall Study|Physician Decision|0
6984736|NCT01259726|11041539|FG002|Overall Study|Physician Decision|1
6984737|NCT01259726|11041540|FG003|Overall Study|Physician Decision|1
6984738|NCT01259726|11041537|FG000|Overall Study|Withdrawal by Subject|1
6984739|NCT01259726|11041538|FG001|Overall Study|Withdrawal by Subject|3
6984740|NCT01259726|11041539|FG002|Overall Study|Withdrawal by Subject|2
6984741|NCT01259726|11041540|FG003|Overall Study|Withdrawal by Subject|1
6984742|NCT01259726|11041537|FG000|Overall Study|Lost to Follow-up|1
6984743|NCT01259726|11041538|FG001|Overall Study|Lost to Follow-up|1
6984744|NCT01259726|11041539|FG002|Overall Study|Lost to Follow-up|1
6984745|NCT01259726|11041540|FG003|Overall Study|Lost to Follow-up|3
6984746|NCT01259856|11041552|FG000|Overall Study|Adverse Event|12
6984747|NCT01259856|11041553|FG001|Overall Study|Adverse Event|9
6984748|NCT01259856|11041552|FG000|Overall Study|Death|0
6984749|NCT01259856|11041553|FG001|Overall Study|Death|1
6984750|NCT01259856|11041552|FG000|Overall Study|Lack of Efficacy|3
6984751|NCT01259856|11041553|FG001|Overall Study|Lack of Efficacy|1
6984752|NCT01259856|11041552|FG000|Overall Study|Lost to Follow-up|1
6984753|NCT01259856|11041553|FG001|Overall Study|Lost to Follow-up|1
6984754|NCT01259856|11041552|FG000|Overall Study|Physician Decision|2
6984755|NCT01259856|11041553|FG001|Overall Study|Physician Decision|1
6984756|NCT01259856|11041552|FG000|Overall Study|Withdrawal by Subject|9
6984757|NCT01259856|11041553|FG001|Overall Study|Withdrawal by Subject|10
6984758|NCT01259856|11041552|FG000|Overall Study|Treatment never started|0
6984759|NCT01259856|11041553|FG001|Overall Study|Treatment never started|6
6984760|NCT01259856|11041552|FG000|Overall Study|Study closure by sponsor|40
6984761|NCT01259856|11041553|FG001|Overall Study|Study closure by sponsor|41
6984762|NCT01259856|11041552|FG000|Overall Study|Patient developed other disease|0
6984763|NCT01259856|11041553|FG001|Overall Study|Patient developed other disease|1
6984764|NCT01259856|11041552|FG000|Overall Study|Transfer to another study|0
6984765|NCT01259856|11041553|FG001|Overall Study|Transfer to another study|1
6984766|NCT01259856|11041552|FG000|Overall Study|Unknown/missing|2
6984767|NCT01259856|11041553|FG001|Overall Study|Unknown/missing|2
6984768|NCT01259869|11041559|FG000|Overall Study|Duplicated registration|1
6984769|NCT01260142|11041569|FG000|Treatment Period 1|Study on hold|1
6984770|NCT01260142|11041570|FG001|Treatment Period 1|Study on hold|1
6984771|NCT01260142|11041571|FG002|Treatment Period 1|Study on hold|0
6984772|NCT01260142|11041572|FG003|Treatment Period 1|Study on hold|0
6984773|NCT01260142|11041573|FG004|Treatment Period 1|Study on hold|1
6984774|NCT01260142|11041574|FG005|Treatment Period 1|Study on hold|2
6984775|NCT01260142|11041569|FG000|Treatment Period 1|Unexplained elevated sys. BP|0
6984776|NCT01260142|11041570|FG001|Treatment Period 1|Unexplained elevated sys. BP|0
6984777|NCT01260142|11041571|FG002|Treatment Period 1|Unexplained elevated sys. BP|0
6984778|NCT01260142|11041572|FG003|Treatment Period 1|Unexplained elevated sys. BP|0
6984779|NCT01260142|11041573|FG004|Treatment Period 1|Unexplained elevated sys. BP|1
6984780|NCT01260142|11041574|FG005|Treatment Period 1|Unexplained elevated sys. BP|0
6984781|NCT01260142|11041569|FG000|Treatment Period 1|Withdrawal by Subject|0
6984782|NCT01260142|11041570|FG001|Treatment Period 1|Withdrawal by Subject|0
6984783|NCT01260142|11041571|FG002|Treatment Period 1|Withdrawal by Subject|0
6984784|NCT01260142|11041572|FG003|Treatment Period 1|Withdrawal by Subject|0
6984785|NCT01260142|11041573|FG004|Treatment Period 1|Withdrawal by Subject|0
6984786|NCT01260142|11041574|FG005|Treatment Period 1|Withdrawal by Subject|1
6984787|NCT01260181|11041594|FG000|Overall Study|Decision of Investigator|1
6984788|NCT01260194|11041598|FG000|Overall Study|Withdrawal of Consent|1
6984789|NCT01260311|11041613|FG000|Overall Study|Adverse Event|11
6984790|NCT01260311|11041613|FG000|Overall Study|Lack of Efficacy|4
6984791|NCT01260311|11041613|FG000|Overall Study|Lost to Follow-up|25
6984792|NCT01260311|11041613|FG000|Overall Study|Withdrawal by Subject|6
6984793|NCT01260311|11041613|FG000|Overall Study|Financial Constraints|77
6984794|NCT01260311|11041613|FG000|Overall Study|Gone to Province|2
6984795|NCT01260311|11041613|FG000|Overall Study|Medication Stopped|1
6984796|NCT01260311|11041613|FG000|Overall Study|Fesoterodine Started Before Enrollment|1
6984797|NCT01260350|11041646|FG000|Overall Study|Lack of Efficacy|0
6984798|NCT01260350|11041647|FG001|Overall Study|Lack of Efficacy|0
6984799|NCT01260350|11041648|FG002|Overall Study|Lack of Efficacy|0
6984800|NCT01260350|11041649|FG003|Overall Study|Lack of Efficacy|0
6984801|NCT01260350|11041650|FG004|Overall Study|Lack of Efficacy|0
6984802|NCT01260350|11041651|FG005|Overall Study|Lack of Efficacy|0
6984803|NCT01260350|11041652|FG006|Overall Study|Lack of Efficacy|0
6984804|NCT01260350|11041653|FG007|Overall Study|Lack of Efficacy|0
6984805|NCT01260350|11041654|FG008|Overall Study|Lack of Efficacy|0
6984806|NCT01260350|11041655|FG009|Overall Study|Lack of Efficacy|0
6984807|NCT01260350|11041656|FG010|Overall Study|Lack of Efficacy|0
6984808|NCT01260350|11041657|FG011|Overall Study|Lack of Efficacy|0
6984809|NCT01260350|11041658|FG012|Overall Study|Lack of Efficacy|0
6984810|NCT01260350|11041659|FG013|Overall Study|Lack of Efficacy|0
6984811|NCT01260350|11041660|FG014|Overall Study|Lack of Efficacy|0
6984812|NCT01260350|11041661|FG015|Overall Study|Lack of Efficacy|0
6984813|NCT01260350|11041662|FG016|Overall Study|Lack of Efficacy|0
6984814|NCT01260350|11041663|FG017|Overall Study|Lack of Efficacy|1
6984815|NCT01260350|11041664|FG018|Overall Study|Lack of Efficacy|0
6984816|NCT01260350|11041665|FG019|Overall Study|Lack of Efficacy|0
6984817|NCT01260350|11041666|FG020|Overall Study|Lack of Efficacy|3
6984818|NCT01260350|11041667|FG021|Overall Study|Lack of Efficacy|0
6984819|NCT01260350|11041646|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0
6984820|NCT01260350|11041647|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0
6984821|NCT01260350|11041648|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0
6984822|NCT01260350|11041649|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0
6984823|NCT01260350|11041650|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0
6984824|NCT01260350|11041651|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0
6984825|NCT01260350|11041652|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0
6984826|NCT01260350|11041653|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0
6984827|NCT01260350|11041654|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1
6984828|NCT01260350|11041655|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0
6984829|NCT01260350|11041656|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0
6984830|NCT01260350|11041657|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0
6984831|NCT01260350|11041658|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0
6984832|NCT01260350|11041659|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0
6984833|NCT01260350|11041660|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0
6984834|NCT01260350|11041661|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0
6984835|NCT01260350|11041662|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0
6984836|NCT01260350|11041663|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0
6984837|NCT01260350|11041664|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0
6984838|NCT01260350|11041665|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0
6984839|NCT01260350|11041666|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0
6984840|NCT01260350|11041667|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0
6984841|NCT01260467|11041725|FG000|Overall Study|Withdrawal by Subject|2
6984842|NCT01260584|11041744|FG000|Period 1|Protocol Violation|0
6984843|NCT01260584|11041745|FG001|Period 1|Protocol Violation|0
6984844|NCT01260584|11041746|FG002|Period 1|Protocol Violation|1
6984845|NCT01260584|11041747|FG003|Period 1|Protocol Violation|1
6984846|NCT01260584|11041744|FG000|Period 1|Adverse Event|0
6984847|NCT01260584|11041745|FG001|Period 1|Adverse Event|0
6984848|NCT01260584|11041746|FG002|Period 1|Adverse Event|1
6984849|NCT01260584|11041747|FG003|Period 1|Adverse Event|0
6984850|NCT01260584|11041744|FG000|Period 2|Protocol Violation|0
6984851|NCT01260584|11041745|FG001|Period 2|Protocol Violation|2
6984852|NCT01260584|11041746|FG002|Period 2|Protocol Violation|3
6984853|NCT01260584|11041747|FG003|Period 2|Protocol Violation|1
6984854|NCT01260584|11041744|FG000|Period 2|Adverse Event|1
6984855|NCT01260584|11041745|FG001|Period 2|Adverse Event|0
6984856|NCT01260584|11041746|FG002|Period 2|Adverse Event|2
6984857|NCT01260584|11041747|FG003|Period 2|Adverse Event|0
6984858|NCT01260584|11041744|FG000|Period 2|Withdrawal by Subject|0
6984859|NCT01260584|11041745|FG001|Period 2|Withdrawal by Subject|1
6984860|NCT01260584|11041746|FG002|Period 2|Withdrawal by Subject|0
6984861|NCT01260584|11041747|FG003|Period 2|Withdrawal by Subject|0
6984862|NCT01260701|11041791|FG000|Overall Study|Adverse Event|9
6984863|NCT01260701|11041791|FG000|Overall Study|Withdrawal by Subject|2
6984864|NCT01260701|11041791|FG000|Overall Study|Progression|53
6984865|NCT01260701|11041791|FG000|Overall Study|Death|2
6984866|NCT01260701|11041791|FG000|Overall Study|Not protocol specified|3
6984867|NCT01260701|11041791|FG000|Overall Study|Under review|1
6984868|NCT01260701|11041791|FG000|Overall Study|Ineligible|4
6984869|NCT01260701|11041791|FG000|Overall Study|Did not begin protocol therapy|1
6984870|NCT01260896|11041831|FG000|First Intervention|Withdrawn Due to Emesis|2
6984871|NCT01260896|11041832|FG001|First Intervention|Withdrawn Due to Emesis|0
6984872|NCT01260922|11041840|FG000|First Intervention|Withdrawal by Subject|0
6984873|NCT01260922|11041841|FG001|First Intervention|Withdrawal by Subject|1
6984874|NCT01260922|11041840|FG000|Washout of 28 Days|Withdrawal by Subject|4
6984875|NCT01260922|11041841|FG001|Washout of 28 Days|Withdrawal by Subject|2
6984876|NCT01260922|11041840|FG000|Second Intervention|Emesis|0
6984877|NCT01260922|11041841|FG001|Second Intervention|Emesis|2
6984878|NCT01260948|11041849|FG000|Washout of 28 Days|Withdrawal by Subject|1
6984879|NCT01260948|11041850|FG001|Washout of 28 Days|Withdrawal by Subject|3
6984880|NCT01260948|11041849|FG000|Second Intervention|Emesis|0
6984881|NCT01260948|11041850|FG001|Second Intervention|Emesis|1
6984882|NCT01261000|11041856|FG000|Overall Study|Screen failure|1
7041982|NCT01732510|11125964|FG005|Overall Study|Lost to Follow-up|1
7041983|NCT01732510|11125965|FG006|Overall Study|Lost to Follow-up|0
7041984|NCT01732510|11125959|FG000|Overall Study|Physician Decision|0
7041985|NCT01732510|11125960|FG001|Overall Study|Physician Decision|1
7041986|NCT01732510|11125961|FG002|Overall Study|Physician Decision|0
7041987|NCT01732510|11125962|FG003|Overall Study|Physician Decision|0
7041988|NCT01732510|11125963|FG004|Overall Study|Physician Decision|0
7041989|NCT01732510|11125964|FG005|Overall Study|Physician Decision|0
7041990|NCT01732510|11125965|FG006|Overall Study|Physician Decision|0
7041991|NCT01732510|11125959|FG000|Overall Study|Pregnancy|0
7041992|NCT01732510|11125960|FG001|Overall Study|Pregnancy|0
7041993|NCT01732510|11125961|FG002|Overall Study|Pregnancy|0
7041994|NCT01732510|11125962|FG003|Overall Study|Pregnancy|1
7041995|NCT01732510|11125963|FG004|Overall Study|Pregnancy|0
7041996|NCT01732510|11125964|FG005|Overall Study|Pregnancy|0
7041997|NCT01732510|11125965|FG006|Overall Study|Pregnancy|0
7041998|NCT01732510|11125959|FG000|Overall Study|Study Terminated By Sponsor|0
7041999|NCT01732510|11125960|FG001|Overall Study|Study Terminated By Sponsor|0
7042000|NCT01732510|11125961|FG002|Overall Study|Study Terminated By Sponsor|0
7042001|NCT01732510|11125962|FG003|Overall Study|Study Terminated By Sponsor|1
7042002|NCT01732510|11125963|FG004|Overall Study|Study Terminated By Sponsor|0
7042003|NCT01732510|11125964|FG005|Overall Study|Study Terminated By Sponsor|12
7042004|NCT01732510|11125965|FG006|Overall Study|Study Terminated By Sponsor|6
7042005|NCT01732536|11125986|FG000|Overall Study|Withdrawal by Subject|1
7042006|NCT01732536|11125987|FG001|Overall Study|Withdrawal by Subject|1
7042007|NCT01732549|11125998|FG000|Overall Study|Adverse Event|13
7042008|NCT01732549|11125999|FG001|Overall Study|Adverse Event|3
7042009|NCT01732549|11125998|FG000|Overall Study|Consent withdrawn|13
7042010|NCT01732549|11125999|FG001|Overall Study|Consent withdrawn|6
7042011|NCT01732549|11125998|FG000|Overall Study|Disease progression|37
7042012|NCT01732549|11125999|FG001|Overall Study|Disease progression|50
7042013|NCT01732549|11125998|FG000|Overall Study|Other|8
7042014|NCT01732549|11125999|FG001|Overall Study|Other|14
7042015|NCT01732588|11126009|FG000|First Intervention (7 Days)|Adverse Event|0
7042016|NCT01732588|11126010|FG001|First Intervention (7 Days)|Adverse Event|1
7042017|NCT01732588|11126011|FG002|First Intervention (7 Days)|Adverse Event|0
7042018|NCT01732640|11126019|FG000|Overall Study|Adverse Event|0
7042019|NCT01732640|11126020|FG001|Overall Study|Adverse Event|1
7042020|NCT01732640|11126019|FG000|Overall Study|Death|0
7042021|NCT01732640|11126020|FG001|Overall Study|Death|1
7042022|NCT01732692|11126032|FG000|Overall Study|Adverse Event|0
7042023|NCT01732692|11126033|FG001|Overall Study|Adverse Event|1
7042024|NCT01732757|11126055|FG000|Overall Study|Lost to Follow-up|1
7042025|NCT01732757|11126056|FG001|Overall Study|Lost to Follow-up|0
7042026|NCT01732757|11126057|FG002|Overall Study|Lost to Follow-up|0
7042027|NCT01732770|11126067|FG000|Overall Study|Lost to Follow-up|2
7042028|NCT01732770|11126068|FG001|Overall Study|Lost to Follow-up|3
7042029|NCT01732770|11126067|FG000|Overall Study|Withdrawal by Subject|5
7042030|NCT01732770|11126068|FG001|Overall Study|Withdrawal by Subject|3
7042031|NCT01732770|11126067|FG000|Overall Study|Decision by Sponsor|2
7042032|NCT01732770|11126068|FG001|Overall Study|Decision by Sponsor|2
7042033|NCT01732770|11126067|FG000|Overall Study|Death|1
7042034|NCT01732770|11126068|FG001|Overall Study|Death|0
7042035|NCT01732783|11126077|FG000|Overall Study|Discontinued Panitumumab Treatment|106
7042036|NCT01732783|11126078|FG001|Overall Study|Discontinued Panitumumab Treatment|25
7042037|NCT01732783|11126079|FG002|Overall Study|Discontinued Panitumumab Treatment|7
7042038|NCT01732783|11126077|FG000|Overall Study|Death|13
7042039|NCT01732783|11126078|FG001|Overall Study|Death|4
7042040|NCT01732783|11126079|FG002|Overall Study|Death|1
7042041|NCT01732783|11126077|FG000|Overall Study|Lost to Follow-up|7
7042042|NCT01732783|11126078|FG001|Overall Study|Lost to Follow-up|1
7042043|NCT01732783|11126079|FG002|Overall Study|Lost to Follow-up|1
7042044|NCT01732783|11126077|FG000|Overall Study|Administrative Decision|8
7042045|NCT01732783|11126078|FG001|Overall Study|Administrative Decision|2
7042046|NCT01732783|11126079|FG002|Overall Study|Administrative Decision|1
7042047|NCT01732783|11126077|FG000|Overall Study|Withdrawal by Subject|1
7042048|NCT01732783|11126078|FG001|Overall Study|Withdrawal by Subject|0
7042049|NCT01732783|11126079|FG002|Overall Study|Withdrawal by Subject|0
7042050|NCT01732796|11126090|FG000|Overall Study|Adverse Event|16
7042051|NCT01732796|11126091|FG001|Overall Study|Adverse Event|16
7042052|NCT01732796|11126092|FG002|Overall Study|Adverse Event|4
7042053|NCT01732796|11126090|FG000|Overall Study|Lack of Efficacy|21
7042054|NCT01732796|11126091|FG001|Overall Study|Lack of Efficacy|18
7042055|NCT01732796|11126092|FG002|Overall Study|Lack of Efficacy|5
6984883|NCT01261325|11041868|FG000|Overall Study|Lack of Efficacy|1
6984884|NCT01261325|11041869|FG001|Overall Study|Lack of Efficacy|1
6984885|NCT01261325|11041870|FG002|Overall Study|Lack of Efficacy|0
6984886|NCT01261325|11041868|FG000|Overall Study|Withdrawal by Subject|2
6984887|NCT01261325|11041869|FG001|Overall Study|Withdrawal by Subject|2
6984888|NCT01261325|11041870|FG002|Overall Study|Withdrawal by Subject|4
6984889|NCT01261325|11041868|FG000|Overall Study|SAE, non-fatal|1
6984890|NCT01261325|11041869|FG001|Overall Study|SAE, non-fatal|5
6984891|NCT01261325|11041870|FG002|Overall Study|SAE, non-fatal|1
6984892|NCT01261325|11041868|FG000|Overall Study|AE, non-serious non-fatal|9
6984893|NCT01261325|11041869|FG001|Overall Study|AE, non-serious non-fatal|15
6984894|NCT01261325|11041870|FG002|Overall Study|AE, non-serious non-fatal|13
6984895|NCT01261325|11041868|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
6984896|NCT01261325|11041869|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
6984897|NCT01261325|11041870|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
6984898|NCT01261325|11041868|FG000|Overall Study|Non Compliance|2
6984899|NCT01261325|11041869|FG001|Overall Study|Non Compliance|0
6984900|NCT01261325|11041870|FG002|Overall Study|Non Compliance|0
6984901|NCT01261325|11041868|FG000|Overall Study|Patient Randomized by Mistake|0
6984902|NCT01261325|11041869|FG001|Overall Study|Patient Randomized by Mistake|1
6984903|NCT01261325|11041870|FG002|Overall Study|Patient Randomized by Mistake|0
6984904|NCT01261325|11041868|FG000|Overall Study|Erroneously Randomized|1
6984905|NCT01261325|11041869|FG001|Overall Study|Erroneously Randomized|0
6984906|NCT01261325|11041870|FG002|Overall Study|Erroneously Randomized|0
6984907|NCT01261325|11041868|FG000|Overall Study|Screen Failure|1
6984908|NCT01261325|11041869|FG001|Overall Study|Screen Failure|0
6984909|NCT01261325|11041870|FG002|Overall Study|Screen Failure|0
6984910|NCT01261325|11041868|FG000|Overall Study|Randomized in Error|0
6984911|NCT01261325|11041869|FG001|Overall Study|Randomized in Error|0
6984912|NCT01261325|11041870|FG002|Overall Study|Randomized in Error|1
6984913|NCT01261325|11041868|FG000|Overall Study|Protocol Violation|0
6984914|NCT01261325|11041869|FG001|Overall Study|Protocol Violation|3
6984915|NCT01261325|11041870|FG002|Overall Study|Protocol Violation|1
6984916|NCT01261325|11041868|FG000|Overall Study|Lost to Follow-up|0
6984917|NCT01261325|11041869|FG001|Overall Study|Lost to Follow-up|1
6984918|NCT01261325|11041870|FG002|Overall Study|Lost to Follow-up|3
6984919|NCT01261325|11041868|FG000|Overall Study|AE, serious fatal|0
6984920|NCT01261325|11041869|FG001|Overall Study|AE, serious fatal|0
6984921|NCT01261325|11041870|FG002|Overall Study|AE, serious fatal|2
6984922|NCT01261338|11041883|FG000|Overall Study|Withdrawal by Subject|3
6984923|NCT01261338|11041884|FG001|Overall Study|Withdrawal by Subject|2
6984924|NCT01261390|11041894|FG000|Overall Study|Significant Concurrent Illness|1
6984925|NCT01261390|11041895|FG001|Overall Study|Significant Concurrent Illness|0
6984926|NCT01261390|11041896|FG002|Overall Study|Significant Concurrent Illness|1
6984927|NCT01261390|11041897|FG003|Overall Study|Significant Concurrent Illness|0
6984928|NCT01261390|11041894|FG000|Overall Study|Dissatisfaction with Treatment|2
6984929|NCT01261390|11041895|FG001|Overall Study|Dissatisfaction with Treatment|1
6984930|NCT01261390|11041896|FG002|Overall Study|Dissatisfaction with Treatment|1
6984931|NCT01261390|11041897|FG003|Overall Study|Dissatisfaction with Treatment|2
6984932|NCT01261390|11041894|FG000|Overall Study|Relocation|0
6984933|NCT01261390|11041895|FG001|Overall Study|Relocation|1
6984934|NCT01261390|11041896|FG002|Overall Study|Relocation|0
6984935|NCT01261390|11041897|FG003|Overall Study|Relocation|0
6984936|NCT01261390|11041894|FG000|Overall Study|Loss of Interest in the Study|3
6984937|NCT01261390|11041895|FG001|Overall Study|Loss of Interest in the Study|1
6984938|NCT01261390|11041896|FG002|Overall Study|Loss of Interest in the Study|0
6984939|NCT01261390|11041897|FG003|Overall Study|Loss of Interest in the Study|0
6984940|NCT01261390|11041894|FG000|Overall Study|Lost to Follow-up|1
6984941|NCT01261390|11041895|FG001|Overall Study|Lost to Follow-up|6
6984942|NCT01261390|11041896|FG002|Overall Study|Lost to Follow-up|5
6984943|NCT01261390|11041897|FG003|Overall Study|Lost to Follow-up|6
6984944|NCT01261611|11041932|FG000|Treatment Cycle 1|Withdrawal by Subject|3
6984945|NCT01261611|11041933|FG001|Treatment Cycle 1|Withdrawal by Subject|2
6984946|NCT01261611|11041934|FG002|Treatment Cycle 1|Withdrawal by Subject|0
6984947|NCT01261611|11041932|FG000|Treatment Cycle 1|Lost to Follow-up|1
6984948|NCT01261611|11041933|FG001|Treatment Cycle 1|Lost to Follow-up|0
6984949|NCT01261611|11041934|FG002|Treatment Cycle 1|Lost to Follow-up|0
6984950|NCT01261611|11041932|FG000|Treatment Cycle 1|Adverse Event|0
6984951|NCT01261611|11041933|FG001|Treatment Cycle 1|Adverse Event|1
6984952|NCT01261611|11041934|FG002|Treatment Cycle 1|Adverse Event|0
6984953|NCT01261611|11041932|FG000|Treatment Cycle 1|Protocol Violation|0
6984954|NCT01261611|11041933|FG001|Treatment Cycle 1|Protocol Violation|0
6984955|NCT01261611|11041934|FG002|Treatment Cycle 1|Protocol Violation|2
6984956|NCT01261611|11041932|FG000|Treatment Cycle 2|Completed study|4
6984957|NCT01261611|11041933|FG001|Treatment Cycle 2|Completed study|0
6984958|NCT01261611|11041934|FG002|Treatment Cycle 2|Completed study|0
6984959|NCT01261611|11041932|FG000|Treatment Cycle 2|Withdrawal by Subject|4
6984960|NCT01261611|11041933|FG001|Treatment Cycle 2|Withdrawal by Subject|0
6984961|NCT01261611|11041934|FG002|Treatment Cycle 2|Withdrawal by Subject|0
6984962|NCT01261611|11041932|FG000|Treatment Cycle 2|Adverse Event|1
6984963|NCT01261611|11041933|FG001|Treatment Cycle 2|Adverse Event|0
6984964|NCT01261611|11041934|FG002|Treatment Cycle 2|Adverse Event|0
6984965|NCT01261611|11041932|FG000|Treatment Cycle 2|Protocol Violation|2
6984966|NCT01261611|11041933|FG001|Treatment Cycle 2|Protocol Violation|0
6984967|NCT01261611|11041934|FG002|Treatment Cycle 2|Protocol Violation|0
6984968|NCT01261611|11041932|FG000|Treatment Cycle 2|Not otherwise specified|2
6984969|NCT01261611|11041933|FG001|Treatment Cycle 2|Not otherwise specified|0
6984970|NCT01261611|11041934|FG002|Treatment Cycle 2|Not otherwise specified|0
6984971|NCT01261611|11041932|FG000|Treatment Cycle 3|Completed study|24
6984972|NCT01261611|11041933|FG001|Treatment Cycle 3|Completed study|0
6984973|NCT01261611|11041934|FG002|Treatment Cycle 3|Completed study|0
6984974|NCT01261611|11041932|FG000|Treatment Cycle 3|Withdrawal by Subject|4
6984975|NCT01261611|11041933|FG001|Treatment Cycle 3|Withdrawal by Subject|0
6984976|NCT01261611|11041934|FG002|Treatment Cycle 3|Withdrawal by Subject|0
6984977|NCT01261611|11041932|FG000|Treatment Cycle 3|Adverse Event|1
6984978|NCT01261611|11041933|FG001|Treatment Cycle 3|Adverse Event|0
6984979|NCT01261611|11041934|FG002|Treatment Cycle 3|Adverse Event|0
6984980|NCT01261611|11041932|FG000|Treatment Cycle 3|Lost to Follow-up|1
6984981|NCT01261611|11041933|FG001|Treatment Cycle 3|Lost to Follow-up|0
6984982|NCT01261611|11041934|FG002|Treatment Cycle 3|Lost to Follow-up|0
6984983|NCT01261611|11041932|FG000|Treatment Cycle 4|Completed study|87
6984984|NCT01261611|11041933|FG001|Treatment Cycle 4|Completed study|0
6984985|NCT01261611|11041934|FG002|Treatment Cycle 4|Completed study|0
6984986|NCT01261611|11041932|FG000|Treatment Cycle 4|Withdrawal by Subject|3
6984987|NCT01261611|11041933|FG001|Treatment Cycle 4|Withdrawal by Subject|0
6984988|NCT01261611|11041934|FG002|Treatment Cycle 4|Withdrawal by Subject|0
6984989|NCT01261611|11041932|FG000|Treatment Cycle 4|Adverse Event|1
6984990|NCT01261611|11041933|FG001|Treatment Cycle 4|Adverse Event|0
6984991|NCT01261611|11041934|FG002|Treatment Cycle 4|Adverse Event|0
6984992|NCT01261611|11041932|FG000|Treatment Cycle 4|Lost to Follow-up|2
6984993|NCT01261611|11041933|FG001|Treatment Cycle 4|Lost to Follow-up|0
6984994|NCT01261611|11041934|FG002|Treatment Cycle 4|Lost to Follow-up|0
6984995|NCT01261611|11041932|FG000|Treatment Cycle 4|Not otherwise specified|3
6984996|NCT01261611|11041933|FG001|Treatment Cycle 4|Not otherwise specified|0
6984997|NCT01261611|11041934|FG002|Treatment Cycle 4|Not otherwise specified|0
6984998|NCT01261611|11041932|FG000|Treatment Cycle 5|Withdrawal by Subject|1
6984999|NCT01261611|11041933|FG001|Treatment Cycle 5|Withdrawal by Subject|0
6985000|NCT01261611|11041934|FG002|Treatment Cycle 5|Withdrawal by Subject|0
6985001|NCT01261611|11041932|FG000|Treatment Cycle 5|Adverse Event|1
6985002|NCT01261611|11041933|FG001|Treatment Cycle 5|Adverse Event|0
6985003|NCT01261611|11041934|FG002|Treatment Cycle 5|Adverse Event|0
6985004|NCT01261611|11041932|FG000|Treatment Cycle 5|Lost to Follow-up|1
6985005|NCT01261611|11041933|FG001|Treatment Cycle 5|Lost to Follow-up|0
6985006|NCT01261611|11041934|FG002|Treatment Cycle 5|Lost to Follow-up|0
6985007|NCT01261624|11041948|FG000|Week 0 to Week 12|Disease Progression|1
6985008|NCT01261624|11041949|FG001|Week 0 to Week 12|Disease Progression|1
6985009|NCT01261624|11041948|FG000|Week 0 to Week 12|Insufficient Response|0
6985010|NCT01261624|11041949|FG001|Week 0 to Week 12|Insufficient Response|2
6985011|NCT01261624|11041948|FG000|Week 13 to Week 24|Insufficient Response|0
6985012|NCT01261624|11041949|FG001|Week 13 to Week 24|Insufficient Response|1
6985013|NCT01261780|11041963|FG000|Overall Study|Withdrawal by Subject|1
6985014|NCT01261780|11041964|FG001|Overall Study|Withdrawal by Subject|0
6985015|NCT01261780|11041963|FG000|Overall Study|Event not related to subject|1
6985016|NCT01261780|11041964|FG001|Overall Study|Event not related to subject|2
6985017|NCT01261793|11041973|FG000|Overall Study|Lack of Efficacy|44
6985018|NCT01261793|11041974|FG001|Overall Study|Lack of Efficacy|37
6985019|NCT01261793|11041975|FG002|Overall Study|Lack of Efficacy|32
6985020|NCT01261793|11041973|FG000|Overall Study|Protocol Violation|3
6985021|NCT01261793|11041974|FG001|Overall Study|Protocol Violation|5
6985022|NCT01261793|11041975|FG002|Overall Study|Protocol Violation|6
6985023|NCT01261793|11041973|FG000|Overall Study|Lost to Follow-up|10
6985024|NCT01261793|11041974|FG001|Overall Study|Lost to Follow-up|3
6985025|NCT01261793|11041975|FG002|Overall Study|Lost to Follow-up|7
6985026|NCT01261793|11041973|FG000|Overall Study|Withdrawal by Subject|12
6985027|NCT01261793|11041974|FG001|Overall Study|Withdrawal by Subject|14
6985028|NCT01261793|11041975|FG002|Overall Study|Withdrawal by Subject|14
6985029|NCT01261793|11041973|FG000|Overall Study|Death|3
6985030|NCT01261793|11041974|FG001|Overall Study|Death|1
6985031|NCT01261793|11041975|FG002|Overall Study|Death|0
6985032|NCT01261793|11041973|FG000|Overall Study|Adverse Event|9
6985033|NCT01261793|11041974|FG001|Overall Study|Adverse Event|24
6985034|NCT01261793|11041975|FG002|Overall Study|Adverse Event|19
6985035|NCT01261793|11041973|FG000|Overall Study|Patient non-availability|1
6985036|NCT01261793|11041974|FG001|Overall Study|Patient non-availability|1
6985037|NCT01261793|11041975|FG002|Overall Study|Patient non-availability|1
6985038|NCT01261793|11041973|FG000|Overall Study|Suspected pregnancy|1
6985039|NCT01261793|11041974|FG001|Overall Study|Suspected pregnancy|1
6985040|NCT01261793|11041975|FG002|Overall Study|Suspected pregnancy|0
6985041|NCT01261793|11041973|FG000|Overall Study|Patient non-compliance|1
6985042|NCT01261793|11041974|FG001|Overall Study|Patient non-compliance|0
6985043|NCT01261793|11041975|FG002|Overall Study|Patient non-compliance|1
6985044|NCT01261793|11041973|FG000|Overall Study|Patient pregnant|1
6985045|NCT01261793|11041974|FG001|Overall Study|Patient pregnant|0
6985046|NCT01261793|11041975|FG002|Overall Study|Patient pregnant|0
6985047|NCT01261793|11041973|FG000|Overall Study|Outside the study area|0
6985048|NCT01261793|11041974|FG001|Overall Study|Outside the study area|2
6985049|NCT01261793|11041975|FG002|Overall Study|Outside the study area|1
6985050|NCT01261793|11041973|FG000|Overall Study|Lack of efficacy & patient not available|0
6985051|NCT01261793|11041974|FG001|Overall Study|Lack of efficacy & patient not available|1
6985052|NCT01261793|11041975|FG002|Overall Study|Lack of efficacy & patient not available|0
6985053|NCT01261793|11041973|FG000|Overall Study|Patient withdrew after cardiology visit|0
6985054|NCT01261793|11041974|FG001|Overall Study|Patient withdrew after cardiology visit|1
6985055|NCT01261793|11041975|FG002|Overall Study|Patient withdrew after cardiology visit|0
6985056|NCT01261793|11041973|FG000|Overall Study|Randomization error|0
6985057|NCT01261793|11041974|FG001|Overall Study|Randomization error|1
6985058|NCT01261793|11041975|FG002|Overall Study|Randomization error|0
6985059|NCT01261793|11041973|FG000|Overall Study|Patient unable to start IV line|0
6985060|NCT01261793|11041974|FG001|Overall Study|Patient unable to start IV line|0
6985061|NCT01261793|11041975|FG002|Overall Study|Patient unable to start IV line|1
6985062|NCT01261975|11041992|FG000|Overall Study|Surgical complication|1
6985063|NCT01262027|11041999|FG000|Overall Study|Adverse Event|1
6985064|NCT01262027|11041999|FG000|Overall Study|Withdrawal by Subject|3
6985065|NCT01262027|11041999|FG000|Overall Study|Protocol Violation|1
6985066|NCT01262092|11042005|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2
6985067|NCT01262092|11042006|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1
6985068|NCT01262092|11042005|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1
6985069|NCT01262092|11042006|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0
6985070|NCT01262092|11042005|FG000|Buprenorphine Taper|noncompliance - missed medication|1
6985071|NCT01262092|11042006|FG001|Buprenorphine Taper|noncompliance - missed medication|1
6985072|NCT01262092|11042005|FG000|Gabapentin Taper|noncompliance - missed medications|1
6985073|NCT01262092|11042006|FG001|Gabapentin Taper|noncompliance - missed medications|0
6985074|NCT01262287|11042045|FG000|Overall Study|Lost to Follow-up|2
6985075|NCT01262287|11042046|FG001|Overall Study|Lost to Follow-up|1
6985076|NCT01262352|11042058|FG000|Period 1|Illness after randomization|1
6985077|NCT01262352|11042059|FG001|Period 1|Illness after randomization|0
6985078|NCT01262352|11042058|FG000|Washout|Adverse Event|1
6985079|NCT01262352|11042059|FG001|Washout|Adverse Event|1
6985080|NCT01262352|11042058|FG000|Washout|Extended Washout|0
6985081|NCT01262352|11042059|FG001|Washout|Extended Washout|1
6985082|NCT01262365|11042068|FG000|Overall Study|Lack of Efficacy|35
6985083|NCT01262365|11042069|FG001|Overall Study|Lack of Efficacy|30
6985084|NCT01262365|11042070|FG002|Overall Study|Lack of Efficacy|47
6985085|NCT01262365|11042068|FG000|Overall Study|Protocol Violation|3
6985086|NCT01262365|11042069|FG001|Overall Study|Protocol Violation|1
6985087|NCT01262365|11042070|FG002|Overall Study|Protocol Violation|1
6985088|NCT01262365|11042068|FG000|Overall Study|Lost to Follow-up|3
6985089|NCT01262365|11042069|FG001|Overall Study|Lost to Follow-up|7
6985090|NCT01262365|11042070|FG002|Overall Study|Lost to Follow-up|6
6985091|NCT01262365|11042068|FG000|Overall Study|Withdrawal by Subject|17
6985092|NCT01262365|11042069|FG001|Overall Study|Withdrawal by Subject|22
6985093|NCT01262365|11042070|FG002|Overall Study|Withdrawal by Subject|22
6985094|NCT01262365|11042068|FG000|Overall Study|Death|1
6985095|NCT01262365|11042069|FG001|Overall Study|Death|2
6985096|NCT01262365|11042070|FG002|Overall Study|Death|1
6985097|NCT01262365|11042068|FG000|Overall Study|Adverse Event|26
6985098|NCT01262365|11042069|FG001|Overall Study|Adverse Event|16
6985099|NCT01262365|11042070|FG002|Overall Study|Adverse Event|11
6985100|NCT01262365|11042068|FG000|Overall Study|sponsor decision|1
6985101|NCT01262365|11042069|FG001|Overall Study|sponsor decision|1
6985102|NCT01262365|11042070|FG002|Overall Study|sponsor decision|0
6985103|NCT01262365|11042068|FG000|Overall Study|Randomization error|1
6985104|NCT01262365|11042069|FG001|Overall Study|Randomization error|0
6985105|NCT01262365|11042070|FG002|Overall Study|Randomization error|2
6985106|NCT01262365|11042068|FG000|Overall Study|Non-compliance|1
6985107|NCT01262365|11042069|FG001|Overall Study|Non-compliance|0
6985108|NCT01262365|11042070|FG002|Overall Study|Non-compliance|2
6985109|NCT01262365|11042068|FG000|Overall Study|Suspected pregnancy|1
6985110|NCT01262365|11042069|FG001|Overall Study|Suspected pregnancy|0
6985111|NCT01262365|11042070|FG002|Overall Study|Suspected pregnancy|0
6985112|NCT01262365|11042068|FG000|Overall Study|Patient pregnant|1
6985113|NCT01262365|11042069|FG001|Overall Study|Patient pregnant|0
6985114|NCT01262365|11042070|FG002|Overall Study|Patient pregnant|1
6985115|NCT01262365|11042068|FG000|Overall Study|Toxicity related to study drug|0
6985116|NCT01262365|11042069|FG001|Overall Study|Toxicity related to study drug|1
6985117|NCT01262365|11042070|FG002|Overall Study|Toxicity related to study drug|0
6985118|NCT01262365|11042068|FG000|Overall Study|Cannot tolerate the protocol|0
6985119|NCT01262365|11042069|FG001|Overall Study|Cannot tolerate the protocol|1
6985120|NCT01262365|11042070|FG002|Overall Study|Cannot tolerate the protocol|0
6985121|NCT01262365|11042068|FG000|Overall Study|Patient unavailable|0
6985122|NCT01262365|11042069|FG001|Overall Study|Patient unavailable|0
6985123|NCT01262365|11042070|FG002|Overall Study|Patient unavailable|1
6985124|NCT01262456|11042081|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6
6985125|NCT01262456|11042082|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8
6985126|NCT01262456|11042083|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9
6985127|NCT01262456|11042081|FG000|3-Month Double-Blind Period|Lost to Follow-up|4
6985128|NCT01262456|11042082|FG001|3-Month Double-Blind Period|Lost to Follow-up|5
6985129|NCT01262456|11042083|FG002|3-Month Double-Blind Period|Lost to Follow-up|3
6985130|NCT01262456|11042081|FG000|3-Month Double-Blind Period|Adverse Event|6
6985131|NCT01262456|11042082|FG001|3-Month Double-Blind Period|Adverse Event|4
6985132|NCT01262456|11042083|FG002|3-Month Double-Blind Period|Adverse Event|8
6985133|NCT01262456|11042081|FG000|3-Month Double-Blind Period|Protocol Violation|3
6985134|NCT01262456|11042082|FG001|3-Month Double-Blind Period|Protocol Violation|6
6985135|NCT01262456|11042083|FG002|3-Month Double-Blind Period|Protocol Violation|6
6985136|NCT01262456|11042081|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1
6985137|NCT01262456|11042082|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1
6985138|NCT01262456|11042083|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1
6985139|NCT01262456|11042081|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0
6985140|NCT01262456|11042082|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1
6985141|NCT01262456|11042083|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0
6985142|NCT01262456|11042081|FG000|1-Month Open-Label Extension Period|Adverse Event|2
6985143|NCT01262456|11042082|FG001|1-Month Open-Label Extension Period|Adverse Event|0
6985144|NCT01262456|11042083|FG002|1-Month Open-Label Extension Period|Adverse Event|2
6985145|NCT01262456|11042081|FG000|1-Month Open-Label Extension Period|Protocol Violation|1
6985146|NCT01262456|11042082|FG001|1-Month Open-Label Extension Period|Protocol Violation|0
6985147|NCT01262456|11042083|FG002|1-Month Open-Label Extension Period|Protocol Violation|2
6985148|NCT01262456|11042081|FG000|1-Month Open-Label Extension Period|Other Reason|0
6985149|NCT01262456|11042082|FG001|1-Month Open-Label Extension Period|Other Reason|1
6985150|NCT01262456|11042083|FG002|1-Month Open-Label Extension Period|Other Reason|0
6985151|NCT01262560|11042111|FG000|Overall Study|Protocol Violation|0
6985152|NCT01262560|11042112|FG001|Overall Study|Protocol Violation|1
6985153|NCT01262560|11042113|FG002|Overall Study|Protocol Violation|2
6985154|NCT01262573|11042123|FG000|Overall Study|Withdrawal by Subject|0
6985155|NCT01262573|11042124|FG001|Overall Study|Withdrawal by Subject|1
6985156|NCT01262638|11042145|FG000|Overall Study|Adverse Event|3
6985157|NCT01262638|11042146|FG001|Overall Study|Adverse Event|4
6985158|NCT01262638|11042147|FG002|Overall Study|Adverse Event|3
6985159|NCT01262638|11042148|FG003|Overall Study|Adverse Event|4
6985160|NCT01262638|11042145|FG000|Overall Study|Protocol Violation|1
6985161|NCT01262638|11042146|FG001|Overall Study|Protocol Violation|0
6985162|NCT01262638|11042147|FG002|Overall Study|Protocol Violation|0
6985163|NCT01262638|11042148|FG003|Overall Study|Protocol Violation|1
6985164|NCT01262638|11042145|FG000|Overall Study|Withdrawal by Subject|2
6985165|NCT01262638|11042146|FG001|Overall Study|Withdrawal by Subject|1
6985166|NCT01262638|11042147|FG002|Overall Study|Withdrawal by Subject|0
6985167|NCT01262638|11042148|FG003|Overall Study|Withdrawal by Subject|1
6985168|NCT01262638|11042145|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0
6985169|NCT01262638|11042146|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0
6985170|NCT01262638|11042147|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1
6985171|NCT01262638|11042148|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0
6985172|NCT01262638|11042145|FG000|Overall Study|Lost to Follow-up|1
6985173|NCT01262638|11042146|FG001|Overall Study|Lost to Follow-up|1
6985174|NCT01262638|11042147|FG002|Overall Study|Lost to Follow-up|1
6985175|NCT01262638|11042148|FG003|Overall Study|Lost to Follow-up|1
6985176|NCT01262638|11042145|FG000|Overall Study|Participant Went Out of Town|0
6985177|NCT01262638|11042146|FG001|Overall Study|Participant Went Out of Town|0
6985178|NCT01262638|11042147|FG002|Overall Study|Participant Went Out of Town|1
6985179|NCT01262638|11042148|FG003|Overall Study|Participant Went Out of Town|0
6985180|NCT01262651|11042163|FG000|Overall Study|Adverse Event|40
6985181|NCT01262651|11042164|FG001|Overall Study|Adverse Event|35
6985182|NCT01262651|11042163|FG000|Overall Study|Withdrawal by Subject|15
6985183|NCT01262651|11042164|FG001|Overall Study|Withdrawal by Subject|11
6985184|NCT01262651|11042163|FG000|Overall Study|Withdrawal by Investigator|2
6985185|NCT01262651|11042164|FG001|Overall Study|Withdrawal by Investigator|2
6985186|NCT01262651|11042163|FG000|Overall Study|Met Withdrawal Criteria|1
6985187|NCT01262651|11042164|FG001|Overall Study|Met Withdrawal Criteria|0
6985188|NCT01262677|11042173|FG000|Overall Study|Does not meet entrance criteria|0
6985189|NCT01262677|11042174|FG001|Overall Study|Does not meet entrance criteria|2
6985190|NCT01262677|11042175|FG002|Overall Study|Does not meet entrance criteria|0
6985191|NCT01262677|11042173|FG000|Overall Study|Insufficient clinical response|0
6985192|NCT01262677|11042174|FG001|Overall Study|Insufficient clinical response|0
6985193|NCT01262677|11042175|FG002|Overall Study|Insufficient clinical response|1
6985194|NCT01262677|11042173|FG000|Overall Study|Lost to Follow-up|1
6985195|NCT01262677|11042174|FG001|Overall Study|Lost to Follow-up|0
6985196|NCT01262677|11042175|FG002|Overall Study|Lost to Follow-up|2
6985197|NCT01262677|11042173|FG000|Overall Study|No longer willing to participate|3
6985198|NCT01262677|11042174|FG001|Overall Study|No longer willing to participate|3
6985199|NCT01262677|11042175|FG002|Overall Study|No longer willing to participate|2
6985200|NCT01262677|11042173|FG000|Overall Study|Reason not provided|2
6985201|NCT01262677|11042174|FG001|Overall Study|Reason not provided|1
6985202|NCT01262677|11042175|FG002|Overall Study|Reason not provided|3
6985203|NCT01262677|11042173|FG000|Overall Study|Protocol Violation|0
6985204|NCT01262677|11042174|FG001|Overall Study|Protocol Violation|1
6985205|NCT01262677|11042175|FG002|Overall Study|Protocol Violation|1
6985206|NCT01262677|11042173|FG000|Overall Study|Adverse Event (AE) related to study drug|3
6985207|NCT01262677|11042174|FG001|Overall Study|Adverse Event (AE) related to study drug|8
6985208|NCT01262677|11042175|FG002|Overall Study|Adverse Event (AE) related to study drug|3
6985209|NCT01262820|11042187|FG000|Overall Study|Adverse Event|5
6985210|NCT01262820|11042187|FG000|Overall Study|Lack of Efficacy|9
6985211|NCT01262820|11042187|FG000|Overall Study|Drug held for 21+ days|1
6985212|NCT01262872|11042208|FG000|Step 2|Death|0
6985213|NCT01262872|11042209|FG001|Step 2|Death|0
6985214|NCT01262872|11042210|FG002|Step 2|Death|0
6985215|NCT01262872|11042211|FG003|Step 2|Death|1
6985216|NCT01262872|11042212|FG004|Step 2|Death|0
6985217|NCT01262872|11042213|FG005|Step 2|Death|2
6985218|NCT01262872|11042214|FG006|Step 2|Death|2
6985219|NCT01262872|11042215|FG007|Step 2|Death|1
6985220|NCT01262872|11042208|FG000|Step 2|Protocol Violation|0
6985221|NCT01262872|11042209|FG001|Step 2|Protocol Violation|0
6985222|NCT01262872|11042210|FG002|Step 2|Protocol Violation|1
6985223|NCT01262872|11042211|FG003|Step 2|Protocol Violation|0
6985224|NCT01262872|11042212|FG004|Step 2|Protocol Violation|0
6985225|NCT01262872|11042213|FG005|Step 2|Protocol Violation|0
6985226|NCT01262872|11042214|FG006|Step 2|Protocol Violation|3
6985227|NCT01262872|11042215|FG007|Step 2|Protocol Violation|1
6985228|NCT01262872|11042208|FG000|Step 2|Withdrawal by Subject|0
6985229|NCT01262872|11042209|FG001|Step 2|Withdrawal by Subject|0
6985230|NCT01262872|11042210|FG002|Step 2|Withdrawal by Subject|4
6985231|NCT01262872|11042211|FG003|Step 2|Withdrawal by Subject|6
6985232|NCT01262872|11042212|FG004|Step 2|Withdrawal by Subject|3
6985233|NCT01262872|11042213|FG005|Step 2|Withdrawal by Subject|1
6985234|NCT01262872|11042214|FG006|Step 2|Withdrawal by Subject|2
6985235|NCT01262872|11042215|FG007|Step 2|Withdrawal by Subject|1
6985236|NCT01262872|11042208|FG000|Step 2|Migrated/moved from study area|0
6985237|NCT01262872|11042209|FG001|Step 2|Migrated/moved from study area|0
6985238|NCT01262872|11042210|FG002|Step 2|Migrated/moved from study area|4
6985239|NCT01262872|11042211|FG003|Step 2|Migrated/moved from study area|3
6985240|NCT01262872|11042212|FG004|Step 2|Migrated/moved from study area|2
6985241|NCT01262872|11042213|FG005|Step 2|Migrated/moved from study area|6
6985242|NCT01262872|11042214|FG006|Step 2|Migrated/moved from study area|2
6985243|NCT01262872|11042215|FG007|Step 2|Migrated/moved from study area|3
6985244|NCT01262898|11042253|FG000|Overall Study|Protocol Violation|1
6985245|NCT01262898|11042254|FG001|Overall Study|Protocol Violation|1
6985246|NCT01262898|11042255|FG002|Overall Study|Protocol Violation|0
6985247|NCT01262898|11042256|FG003|Overall Study|Protocol Violation|0
6985248|NCT01262898|11042253|FG000|Overall Study|Lost to Follow-up|1
6985249|NCT01262898|11042254|FG001|Overall Study|Lost to Follow-up|0
6985250|NCT01262898|11042255|FG002|Overall Study|Lost to Follow-up|0
6985251|NCT01262898|11042256|FG003|Overall Study|Lost to Follow-up|0
6985252|NCT01262898|11042253|FG000|Overall Study|Withdrawal by Subject|1
6985253|NCT01262898|11042254|FG001|Overall Study|Withdrawal by Subject|1
6985254|NCT01262898|11042255|FG002|Overall Study|Withdrawal by Subject|0
6985255|NCT01262898|11042256|FG003|Overall Study|Withdrawal by Subject|0
6985256|NCT01262976|11042275|FG000|Up to Month 2|Serious Adverse Event|0
6985257|NCT01262976|11042276|FG001|Up to Month 2|Serious Adverse Event|0
6985258|NCT01262976|11042277|FG002|Up to Month 2|Serious Adverse Event|1
6985259|NCT01262976|11042278|FG003|Up to Month 2|Serious Adverse Event|0
6985260|NCT01262976|11042279|FG004|Up to Month 2|Serious Adverse Event|0
6985261|NCT01262976|11042280|FG005|Up to Month 2|Serious Adverse Event|0
6985262|NCT01262976|11042275|FG000|Up to Month 2|Withdrawal by Subject|1
6985263|NCT01262976|11042276|FG001|Up to Month 2|Withdrawal by Subject|0
6985264|NCT01262976|11042277|FG002|Up to Month 2|Withdrawal by Subject|0
6985265|NCT01262976|11042278|FG003|Up to Month 2|Withdrawal by Subject|0
6985266|NCT01262976|11042279|FG004|Up to Month 2|Withdrawal by Subject|0
6985267|NCT01262976|11042280|FG005|Up to Month 2|Withdrawal by Subject|0
6985268|NCT01262976|11042275|FG000|Up to Month 2|Migrated/moved from study area|0
6985269|NCT01262976|11042276|FG001|Up to Month 2|Migrated/moved from study area|1
6985270|NCT01262976|11042277|FG002|Up to Month 2|Migrated/moved from study area|0
6985271|NCT01262976|11042278|FG003|Up to Month 2|Migrated/moved from study area|0
6985272|NCT01262976|11042279|FG004|Up to Month 2|Migrated/moved from study area|1
6985273|NCT01262976|11042280|FG005|Up to Month 2|Migrated/moved from study area|1
6985274|NCT01262976|11042275|FG000|Up to Month 2|Lost to Follow-up|1
6985275|NCT01262976|11042276|FG001|Up to Month 2|Lost to Follow-up|0
6985276|NCT01262976|11042277|FG002|Up to Month 2|Lost to Follow-up|0
6985277|NCT01262976|11042278|FG003|Up to Month 2|Lost to Follow-up|1
6985278|NCT01262976|11042279|FG004|Up to Month 2|Lost to Follow-up|1
6985279|NCT01262976|11042280|FG005|Up to Month 2|Lost to Follow-up|1
6985280|NCT01262976|11042275|FG000|Up to Month 2|Other|1
6985281|NCT01262976|11042276|FG001|Up to Month 2|Other|0
6985282|NCT01262976|11042277|FG002|Up to Month 2|Other|0
6985283|NCT01262976|11042278|FG003|Up to Month 2|Other|1
6985284|NCT01262976|11042279|FG004|Up to Month 2|Other|0
6985285|NCT01262976|11042280|FG005|Up to Month 2|Other|2
6985286|NCT01262976|11042275|FG000|Up to Month 7|Serious Adverse Event|0
6985287|NCT01262976|11042276|FG001|Up to Month 7|Serious Adverse Event|0
6985288|NCT01262976|11042277|FG002|Up to Month 7|Serious Adverse Event|2
6985289|NCT01262976|11042278|FG003|Up to Month 7|Serious Adverse Event|0
6985290|NCT01262976|11042279|FG004|Up to Month 7|Serious Adverse Event|0
6985291|NCT01262976|11042280|FG005|Up to Month 7|Serious Adverse Event|0
6985292|NCT01262976|11042275|FG000|Up to Month 7|Withdrawal by Subject|1
6985293|NCT01262976|11042276|FG001|Up to Month 7|Withdrawal by Subject|0
6985294|NCT01262976|11042277|FG002|Up to Month 7|Withdrawal by Subject|0
6985295|NCT01262976|11042278|FG003|Up to Month 7|Withdrawal by Subject|0
6985296|NCT01262976|11042279|FG004|Up to Month 7|Withdrawal by Subject|0
7143122|NCT03026283|11299462|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
7143123|NCT03026283|11299463|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
6985297|NCT01262976|11042280|FG005|Up to Month 7|Withdrawal by Subject|0
6985298|NCT01262976|11042275|FG000|Up to Month 7|Migrated/moved from study area|0
6985299|NCT01262976|11042276|FG001|Up to Month 7|Migrated/moved from study area|0
6985300|NCT01262976|11042277|FG002|Up to Month 7|Migrated/moved from study area|1
6985301|NCT01262976|11042278|FG003|Up to Month 7|Migrated/moved from study area|3
6985302|NCT01262976|11042279|FG004|Up to Month 7|Migrated/moved from study area|1
6985303|NCT01262976|11042280|FG005|Up to Month 7|Migrated/moved from study area|1
6985304|NCT01262976|11042275|FG000|Up to Month 7|Lost to Follow-up|1
6985305|NCT01262976|11042276|FG001|Up to Month 7|Lost to Follow-up|0
6985306|NCT01262976|11042277|FG002|Up to Month 7|Lost to Follow-up|1
6985307|NCT01262976|11042278|FG003|Up to Month 7|Lost to Follow-up|3
6985308|NCT01262976|11042279|FG004|Up to Month 7|Lost to Follow-up|1
6985309|NCT01262976|11042280|FG005|Up to Month 7|Lost to Follow-up|3
6985310|NCT01262976|11042275|FG000|Up to Month 7|Other|3
6985311|NCT01262976|11042276|FG001|Up to Month 7|Other|0
6985312|NCT01262976|11042277|FG002|Up to Month 7|Other|2
6985313|NCT01262976|11042278|FG003|Up to Month 7|Other|0
6985314|NCT01262976|11042279|FG004|Up to Month 7|Other|0
6985315|NCT01262976|11042280|FG005|Up to Month 7|Other|0
6985316|NCT01262976|11042275|FG000|Up to Year 1|Serious Adverse Event|0
6985317|NCT01262976|11042276|FG001|Up to Year 1|Serious Adverse Event|0
6985318|NCT01262976|11042277|FG002|Up to Year 1|Serious Adverse Event|2
6985319|NCT01262976|11042278|FG003|Up to Year 1|Serious Adverse Event|0
6985320|NCT01262976|11042279|FG004|Up to Year 1|Serious Adverse Event|0
6985321|NCT01262976|11042280|FG005|Up to Year 1|Serious Adverse Event|0
6985322|NCT01262976|11042275|FG000|Up to Year 1|Withdrawal by Subject|1
6985323|NCT01262976|11042276|FG001|Up to Year 1|Withdrawal by Subject|0
6985324|NCT01262976|11042277|FG002|Up to Year 1|Withdrawal by Subject|0
6985325|NCT01262976|11042278|FG003|Up to Year 1|Withdrawal by Subject|0
6985326|NCT01262976|11042279|FG004|Up to Year 1|Withdrawal by Subject|0
6985327|NCT01262976|11042280|FG005|Up to Year 1|Withdrawal by Subject|0
6985328|NCT01262976|11042275|FG000|Up to Year 1|Migrated/moved from study area|1
6985329|NCT01262976|11042276|FG001|Up to Year 1|Migrated/moved from study area|0
6985330|NCT01262976|11042277|FG002|Up to Year 1|Migrated/moved from study area|0
6985331|NCT01262976|11042278|FG003|Up to Year 1|Migrated/moved from study area|3
6985332|NCT01262976|11042279|FG004|Up to Year 1|Migrated/moved from study area|3
6985333|NCT01262976|11042280|FG005|Up to Year 1|Migrated/moved from study area|2
6985334|NCT01262976|11042275|FG000|Up to Year 1|Lost to Follow-up|4
6985335|NCT01262976|11042276|FG001|Up to Year 1|Lost to Follow-up|0
6985336|NCT01262976|11042277|FG002|Up to Year 1|Lost to Follow-up|0
6985337|NCT01262976|11042278|FG003|Up to Year 1|Lost to Follow-up|1
6985338|NCT01262976|11042279|FG004|Up to Year 1|Lost to Follow-up|6
6985339|NCT01262976|11042280|FG005|Up to Year 1|Lost to Follow-up|5
6985340|NCT01262976|11042275|FG000|Up to Year 1|Other|3
6985341|NCT01262976|11042276|FG001|Up to Year 1|Other|1
6985342|NCT01262976|11042277|FG002|Up to Year 1|Other|0
6985343|NCT01262976|11042278|FG003|Up to Year 1|Other|0
6985344|NCT01262976|11042279|FG004|Up to Year 1|Other|2
6985345|NCT01262976|11042280|FG005|Up to Year 1|Other|1
6985346|NCT01262976|11042275|FG000|Up to Year 1|Subjects with unknown completion status|0
6985347|NCT01262976|11042276|FG001|Up to Year 1|Subjects with unknown completion status|0
6985348|NCT01262976|11042277|FG002|Up to Year 1|Subjects with unknown completion status|1
6985349|NCT01262976|11042278|FG003|Up to Year 1|Subjects with unknown completion status|0
6985350|NCT01262976|11042279|FG004|Up to Year 1|Subjects with unknown completion status|0
6985351|NCT01262976|11042280|FG005|Up to Year 1|Subjects with unknown completion status|1
6985352|NCT01262976|11042275|FG000|Up to Year 2|Serious Adverse Event|0
6985353|NCT01262976|11042276|FG001|Up to Year 2|Serious Adverse Event|0
6985354|NCT01262976|11042277|FG002|Up to Year 2|Serious Adverse Event|2
6985355|NCT01262976|11042278|FG003|Up to Year 2|Serious Adverse Event|0
6985356|NCT01262976|11042279|FG004|Up to Year 2|Serious Adverse Event|0
6985357|NCT01262976|11042280|FG005|Up to Year 2|Serious Adverse Event|0
6985358|NCT01262976|11042275|FG000|Up to Year 2|Withdrawal by Subject|1
6985359|NCT01262976|11042276|FG001|Up to Year 2|Withdrawal by Subject|0
6985360|NCT01262976|11042277|FG002|Up to Year 2|Withdrawal by Subject|0
6985361|NCT01262976|11042278|FG003|Up to Year 2|Withdrawal by Subject|0
6985362|NCT01262976|11042279|FG004|Up to Year 2|Withdrawal by Subject|0
6985363|NCT01262976|11042280|FG005|Up to Year 2|Withdrawal by Subject|0
6985364|NCT01262976|11042275|FG000|Up to Year 2|Migrated/moved from study area|0
6985365|NCT01262976|11042276|FG001|Up to Year 2|Migrated/moved from study area|0
6985366|NCT01262976|11042277|FG002|Up to Year 2|Migrated/moved from study area|0
6985367|NCT01262976|11042278|FG003|Up to Year 2|Migrated/moved from study area|2
6985368|NCT01262976|11042279|FG004|Up to Year 2|Migrated/moved from study area|1
6985369|NCT01262976|11042280|FG005|Up to Year 2|Migrated/moved from study area|2
6985370|NCT01262976|11042275|FG000|Up to Year 2|Lost to Follow-up|1
6985371|NCT01262976|11042276|FG001|Up to Year 2|Lost to Follow-up|1
6985372|NCT01262976|11042277|FG002|Up to Year 2|Lost to Follow-up|2
7143124|NCT03026283|11299464|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
7143125|NCT03026283|11299465|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9
7143126|NCT03026283|11299466|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2
7143127|NCT03026283|11299467|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2
7143128|NCT03026283|11299468|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
7143129|NCT03026283|11299469|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
7143130|NCT03026283|11299462|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
7143131|NCT03026283|11299463|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
7143132|NCT03026283|11299464|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
7143133|NCT03026283|11299465|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2
7143134|NCT03026283|11299466|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
7143135|NCT03026283|11299467|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7
7143136|NCT03026283|11299468|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
7143137|NCT03026283|11299469|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
7143138|NCT03026283|11299462|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
6985373|NCT01262976|11042278|FG003|Up to Year 2|Lost to Follow-up|2
6985374|NCT01262976|11042279|FG004|Up to Year 2|Lost to Follow-up|3
6985375|NCT01262976|11042280|FG005|Up to Year 2|Lost to Follow-up|3
6985376|NCT01262976|11042275|FG000|Up to Year 2|Subjects with unknown completion status|0
6985377|NCT01262976|11042276|FG001|Up to Year 2|Subjects with unknown completion status|0
6985378|NCT01262976|11042277|FG002|Up to Year 2|Subjects with unknown completion status|1
6985379|NCT01262976|11042278|FG003|Up to Year 2|Subjects with unknown completion status|0
6985380|NCT01262976|11042279|FG004|Up to Year 2|Subjects with unknown completion status|0
6985381|NCT01262976|11042280|FG005|Up to Year 2|Subjects with unknown completion status|0
6985382|NCT01262976|11042275|FG000|Up to Year 2|Other|3
6985383|NCT01262976|11042276|FG001|Up to Year 2|Other|0
6985384|NCT01262976|11042277|FG002|Up to Year 2|Other|0
6985385|NCT01262976|11042278|FG003|Up to Year 2|Other|0
6985386|NCT01262976|11042279|FG004|Up to Year 2|Other|0
6985387|NCT01262976|11042280|FG005|Up to Year 2|Other|0
6985388|NCT01262976|11042275|FG000|Up to Year 3|Serious Adverse Event|0
6985389|NCT01262976|11042276|FG001|Up to Year 3|Serious Adverse Event|0
6985390|NCT01262976|11042277|FG002|Up to Year 3|Serious Adverse Event|2
6985391|NCT01262976|11042278|FG003|Up to Year 3|Serious Adverse Event|0
6985392|NCT01262976|11042279|FG004|Up to Year 3|Serious Adverse Event|0
6985393|NCT01262976|11042280|FG005|Up to Year 3|Serious Adverse Event|0
6985394|NCT01262976|11042275|FG000|Up to Year 3|Withdrawal by Subject|1
6985395|NCT01262976|11042276|FG001|Up to Year 3|Withdrawal by Subject|0
6985396|NCT01262976|11042277|FG002|Up to Year 3|Withdrawal by Subject|0
6985397|NCT01262976|11042278|FG003|Up to Year 3|Withdrawal by Subject|0
6985398|NCT01262976|11042279|FG004|Up to Year 3|Withdrawal by Subject|0
6985399|NCT01262976|11042280|FG005|Up to Year 3|Withdrawal by Subject|0
6985400|NCT01262976|11042275|FG000|Up to Year 3|Migrated/moved from study area|0
6985401|NCT01262976|11042276|FG001|Up to Year 3|Migrated/moved from study area|0
6985402|NCT01262976|11042277|FG002|Up to Year 3|Migrated/moved from study area|0
6985403|NCT01262976|11042278|FG003|Up to Year 3|Migrated/moved from study area|2
6985404|NCT01262976|11042279|FG004|Up to Year 3|Migrated/moved from study area|1
6985405|NCT01262976|11042280|FG005|Up to Year 3|Migrated/moved from study area|1
6985406|NCT01262976|11042275|FG000|Up to Year 3|Lost to Follow-up|2
6985407|NCT01262976|11042276|FG001|Up to Year 3|Lost to Follow-up|2
6985408|NCT01262976|11042277|FG002|Up to Year 3|Lost to Follow-up|4
6985409|NCT01262976|11042278|FG003|Up to Year 3|Lost to Follow-up|3
6985410|NCT01262976|11042279|FG004|Up to Year 3|Lost to Follow-up|1
6985411|NCT01262976|11042280|FG005|Up to Year 3|Lost to Follow-up|3
6985412|NCT01262976|11042275|FG000|Up to Year 3|Subjects with unknown completion status|0
6985413|NCT01262976|11042276|FG001|Up to Year 3|Subjects with unknown completion status|0
6985414|NCT01262976|11042277|FG002|Up to Year 3|Subjects with unknown completion status|1
6985415|NCT01262976|11042278|FG003|Up to Year 3|Subjects with unknown completion status|0
6985416|NCT01262976|11042279|FG004|Up to Year 3|Subjects with unknown completion status|0
6985417|NCT01262976|11042280|FG005|Up to Year 3|Subjects with unknown completion status|0
6985418|NCT01262976|11042275|FG000|Up to Year 3|Other|3
6985419|NCT01262976|11042276|FG001|Up to Year 3|Other|0
6985420|NCT01262976|11042277|FG002|Up to Year 3|Other|0
6985421|NCT01262976|11042278|FG003|Up to Year 3|Other|0
6985422|NCT01262976|11042279|FG004|Up to Year 3|Other|0
6985423|NCT01262976|11042280|FG005|Up to Year 3|Other|0
6985424|NCT01262989|11042295|FG000|Period 1|Lost to Follow-up|1
6985425|NCT01262989|11042296|FG001|Period 1|Lost to Follow-up|1
6985426|NCT01262989|11042295|FG000|Period 1|Intercurrent disease|0
6985427|NCT01262989|11042296|FG001|Period 1|Intercurrent disease|1
6985428|NCT01262989|11042295|FG000|Period 1|Positive answer for exclusion criteria|0
6985429|NCT01262989|11042296|FG001|Period 1|Positive answer for exclusion criteria|1
6985430|NCT01262989|11042295|FG000|Period 2|Intercurrent disease|0
6985431|NCT01262989|11042296|FG001|Period 2|Intercurrent disease|1
6985432|NCT01263015|11042304|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13
6985433|NCT01263015|11042305|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48
6985434|NCT01263015|11042304|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18
6985435|NCT01263015|11042305|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14
6985436|NCT01263015|11042304|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14
6985437|NCT01263015|11042305|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12
6985438|NCT01263015|11042304|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17
6985439|NCT01263015|11042305|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18
6985440|NCT01263015|11042304|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9
6985441|NCT01263015|11042305|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15
6985442|NCT01263015|11042304|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1
6985443|NCT01263015|11042305|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2
6985444|NCT01263015|11042304|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3
6985445|NCT01263015|11042305|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10
6985446|NCT01263015|11042304|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7
6985447|NCT01263015|11042305|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2
6985448|NCT01263015|11042304|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3
6985449|NCT01263015|11042305|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2
6985450|NCT01263015|11042304|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
6985451|NCT01263015|11042305|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
6985452|NCT01263015|11042304|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0
6985453|NCT01263015|11042305|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2
6985454|NCT01263015|11042304|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3
6985455|NCT01263015|11042305|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7
6985456|NCT01263054|11042313|FG000|Overall Study|Death|1
6985457|NCT01263054|11042314|FG001|Overall Study|Death|0
6985458|NCT01263054|11042313|FG000|Overall Study|Lost to Follow-up|2
6985459|NCT01263054|11042314|FG001|Overall Study|Lost to Follow-up|2
6985460|NCT01263054|11042313|FG000|Overall Study|Withdrawal by Subject|1
6985461|NCT01263054|11042314|FG001|Overall Study|Withdrawal by Subject|3
6985462|NCT01263054|11042313|FG000|Overall Study|Qualification Violation|1
6985463|NCT01263054|11042314|FG001|Overall Study|Qualification Violation|0
6985464|NCT01263054|11042313|FG000|Overall Study|Other|0
6985465|NCT01263054|11042314|FG001|Overall Study|Other|1
6985466|NCT01263093|11042322|FG000|Washout|Physician Decision|1
6985467|NCT01263093|11042323|FG001|Washout|Physician Decision|0
6985468|NCT01263093|11042322|FG000|Period 2|Adverse Event|1
6985469|NCT01263093|11042323|FG001|Period 2|Adverse Event|0
6985470|NCT01263106|11042330|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1
6985471|NCT01263106|11042331|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1
6985472|NCT01263119|11042340|FG000|Period 1|Protocol Violation|2
6985473|NCT01263119|11042340|FG000|Period 2|Adverse Event|2
6985474|NCT01263197|11042359|FG000|First Intervention (Period 1)|Adverse Event|0
6985475|NCT01263197|11042360|FG001|First Intervention (Period 1)|Adverse Event|0
6985476|NCT01263197|11042361|FG002|First Intervention (Period 1)|Adverse Event|0
6985477|NCT01263197|11042362|FG003|First Intervention (Period 1)|Adverse Event|0
6985478|NCT01263197|11042363|FG004|First Intervention (Period 1)|Adverse Event|0
6985479|NCT01263197|11042364|FG005|First Intervention (Period 1)|Adverse Event|1
6985480|NCT01263197|11042359|FG000|Washout Period 1|Protocol Violation|0
6985481|NCT01263197|11042360|FG001|Washout Period 1|Protocol Violation|0
6985482|NCT01263197|11042361|FG002|Washout Period 1|Protocol Violation|0
6985483|NCT01263197|11042362|FG003|Washout Period 1|Protocol Violation|0
6985484|NCT01263197|11042363|FG004|Washout Period 1|Protocol Violation|1
6985485|NCT01263197|11042364|FG005|Washout Period 1|Protocol Violation|0
6985486|NCT01263197|11042359|FG000|Washout Period 2|Physician Decision|0
6985487|NCT01263197|11042360|FG001|Washout Period 2|Physician Decision|0
6985488|NCT01263197|11042361|FG002|Washout Period 2|Physician Decision|0
6985489|NCT01263197|11042362|FG003|Washout Period 2|Physician Decision|0
6985490|NCT01263197|11042363|FG004|Washout Period 2|Physician Decision|0
6985491|NCT01263197|11042364|FG005|Washout Period 2|Physician Decision|1
6985492|NCT01263197|11042359|FG000|Washout Period 2|Protocol Violation|0
6985493|NCT01263197|11042360|FG001|Washout Period 2|Protocol Violation|0
6985494|NCT01263197|11042361|FG002|Washout Period 2|Protocol Violation|0
6985495|NCT01263197|11042362|FG003|Washout Period 2|Protocol Violation|1
6985496|NCT01263197|11042363|FG004|Washout Period 2|Protocol Violation|0
6985497|NCT01263197|11042364|FG005|Washout Period 2|Protocol Violation|0
6985498|NCT01263197|11042359|FG000|Third Intervention (Period 3)|Adverse Event|0
6985499|NCT01263197|11042360|FG001|Third Intervention (Period 3)|Adverse Event|1
6985500|NCT01263197|11042361|FG002|Third Intervention (Period 3)|Adverse Event|0
6985501|NCT01263197|11042362|FG003|Third Intervention (Period 3)|Adverse Event|0
6985502|NCT01263197|11042363|FG004|Third Intervention (Period 3)|Adverse Event|0
6985503|NCT01263197|11042364|FG005|Third Intervention (Period 3)|Adverse Event|0
6985504|NCT01263223|11042378|FG000|Period 2|Withdrawal by Subject|0
6985505|NCT01263223|11042379|FG001|Period 2|Withdrawal by Subject|1
6985506|NCT01263223|11042378|FG000|7-day Follow-up|Withdrawal by Subject|0
6985507|NCT01263223|11042379|FG001|7-day Follow-up|Withdrawal by Subject|1
6985508|NCT01263223|11042378|FG000|7-day Follow-up|Lost to Follow-up|1
6985509|NCT01263223|11042379|FG001|7-day Follow-up|Lost to Follow-up|0
6985510|NCT01263444|11042436|FG000|Overall Study|Adverse Event|8
6985511|NCT01263444|11042436|FG000|Overall Study|Withdrawal by Subject|1
6985512|NCT01263444|11042436|FG000|Overall Study|Protocol Violation|1
6985513|NCT01263470|11042446|FG000|Overall Study|Adverse Event|2
6985514|NCT01263470|11042447|FG001|Overall Study|Adverse Event|2
6985515|NCT01263470|11042448|FG002|Overall Study|Adverse Event|1
6985516|NCT01263470|11042449|FG003|Overall Study|Adverse Event|1
6985517|NCT01263470|11042450|FG004|Overall Study|Adverse Event|2
6985518|NCT01263470|11042451|FG005|Overall Study|Adverse Event|2
6985519|NCT01263470|11042446|FG000|Overall Study|Protocol Violation|0
6985520|NCT01263470|11042447|FG001|Overall Study|Protocol Violation|1
6985521|NCT01263470|11042448|FG002|Overall Study|Protocol Violation|0
6985522|NCT01263470|11042449|FG003|Overall Study|Protocol Violation|0
6985523|NCT01263470|11042450|FG004|Overall Study|Protocol Violation|0
6985524|NCT01263470|11042451|FG005|Overall Study|Protocol Violation|1
6985525|NCT01263470|11042446|FG000|Overall Study|Withdrawal by Subject|0
6985526|NCT01263470|11042447|FG001|Overall Study|Withdrawal by Subject|1
6985527|NCT01263470|11042448|FG002|Overall Study|Withdrawal by Subject|1
6985528|NCT01263470|11042449|FG003|Overall Study|Withdrawal by Subject|2
6985529|NCT01263470|11042450|FG004|Overall Study|Withdrawal by Subject|0
6985530|NCT01263470|11042451|FG005|Overall Study|Withdrawal by Subject|2
6985531|NCT01263470|11042446|FG000|Overall Study|Lack of Efficacy|0
6985532|NCT01263470|11042447|FG001|Overall Study|Lack of Efficacy|0
6985533|NCT01263470|11042448|FG002|Overall Study|Lack of Efficacy|2
6985534|NCT01263470|11042449|FG003|Overall Study|Lack of Efficacy|0
6985535|NCT01263470|11042450|FG004|Overall Study|Lack of Efficacy|0
6985536|NCT01263470|11042451|FG005|Overall Study|Lack of Efficacy|0
6985537|NCT01263470|11042446|FG000|Overall Study|Participant Unavailability|0
6985538|NCT01263470|11042447|FG001|Overall Study|Participant Unavailability|1
6985539|NCT01263470|11042448|FG002|Overall Study|Participant Unavailability|0
6985540|NCT01263470|11042449|FG003|Overall Study|Participant Unavailability|0
6985541|NCT01263470|11042450|FG004|Overall Study|Participant Unavailability|0
6985542|NCT01263470|11042451|FG005|Overall Study|Participant Unavailability|0
6985543|NCT01263470|11042446|FG000|Overall Study|Study Drug Non-compliance|0
6985544|NCT01263470|11042447|FG001|Overall Study|Study Drug Non-compliance|0
6985545|NCT01263470|11042448|FG002|Overall Study|Study Drug Non-compliance|0
6985546|NCT01263470|11042449|FG003|Overall Study|Study Drug Non-compliance|0
6985547|NCT01263470|11042450|FG004|Overall Study|Study Drug Non-compliance|1
6985548|NCT01263470|11042451|FG005|Overall Study|Study Drug Non-compliance|0
6985549|NCT01263483|11042468|FG000|Overall Study|Adverse Event|4
6985550|NCT01263483|11042469|FG001|Overall Study|Adverse Event|0
6985551|NCT01263483|11042470|FG002|Overall Study|Adverse Event|3
6985552|NCT01263483|11042468|FG000|Overall Study|Withdrawal by Subject|1
6985553|NCT01263483|11042469|FG001|Overall Study|Withdrawal by Subject|0
6985554|NCT01263483|11042470|FG002|Overall Study|Withdrawal by Subject|0
6985555|NCT01263483|11042468|FG000|Overall Study|Lack of Efficacy|2
6985556|NCT01263483|11042469|FG001|Overall Study|Lack of Efficacy|0
6985557|NCT01263483|11042470|FG002|Overall Study|Lack of Efficacy|0
6985558|NCT01263483|11042468|FG000|Overall Study|Protocol Violation|0
6985559|NCT01263483|11042469|FG001|Overall Study|Protocol Violation|1
6985560|NCT01263483|11042470|FG002|Overall Study|Protocol Violation|1
6985561|NCT01263483|11042468|FG000|Overall Study|Participant Unavailability|0
6985562|NCT01263483|11042469|FG001|Overall Study|Participant Unavailability|1
6985563|NCT01263483|11042470|FG002|Overall Study|Participant Unavailability|1
6985564|NCT01263496|11042483|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1
6985565|NCT01263496|11042484|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0
6985566|NCT01263496|11042485|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0
6985567|NCT01263496|11042486|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0
6985568|NCT01263496|11042487|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0
6985569|NCT01263496|11042488|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0
6985570|NCT01263496|11042489|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0
6985571|NCT01263496|11042490|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0
6985572|NCT01263496|11042491|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0
6985573|NCT01263496|11042483|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0
6985574|NCT01263496|11042484|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0
6985575|NCT01263496|11042485|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0
6985576|NCT01263496|11042486|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1
6985577|NCT01263496|11042487|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2
6985578|NCT01263496|11042488|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0
6985579|NCT01263496|11042489|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0
6985580|NCT01263496|11042490|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0
6985581|NCT01263496|11042491|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0
6985582|NCT01263496|11042483|FG000|Entered - Long-Term Extension Study|Adverse Event|0
6985583|NCT01263496|11042484|FG001|Entered - Long-Term Extension Study|Adverse Event|5
6985584|NCT01263496|11042485|FG002|Entered - Long-Term Extension Study|Adverse Event|6
6985585|NCT01263496|11042486|FG003|Entered - Long-Term Extension Study|Adverse Event|3
6985586|NCT01263496|11042487|FG004|Entered - Long-Term Extension Study|Adverse Event|1
6985587|NCT01263496|11042488|FG005|Entered - Long-Term Extension Study|Adverse Event|0
6985588|NCT01263496|11042489|FG006|Entered - Long-Term Extension Study|Adverse Event|0
6985589|NCT01263496|11042490|FG007|Entered - Long-Term Extension Study|Adverse Event|0
6985590|NCT01263496|11042491|FG008|Entered - Long-Term Extension Study|Adverse Event|1
6985591|NCT01263496|11042483|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0
6985592|NCT01263496|11042484|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2
6985593|NCT01263496|11042485|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0
6985594|NCT01263496|11042486|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0
6985595|NCT01263496|11042487|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0
6985596|NCT01263496|11042488|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0
6985597|NCT01263496|11042489|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0
6985598|NCT01263496|11042490|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0
6985599|NCT01263496|11042491|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0
6985600|NCT01263496|11042483|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1
6985601|NCT01263496|11042484|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2
6985602|NCT01263496|11042485|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0
6985603|NCT01263496|11042486|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2
6985604|NCT01263496|11042487|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4
6985605|NCT01263496|11042488|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1
6985606|NCT01263496|11042489|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1
6985607|NCT01263496|11042490|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0
6985608|NCT01263496|11042491|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1
6985609|NCT01263496|11042483|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8
6985610|NCT01263496|11042484|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4
6985611|NCT01263496|11042485|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4
6985612|NCT01263496|11042486|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1
6985613|NCT01263496|11042487|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5
6985614|NCT01263496|11042488|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0
6985615|NCT01263496|11042489|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0
6985616|NCT01263496|11042490|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0
6985617|NCT01263496|11042491|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1
6985618|NCT01263496|11042483|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0
6985619|NCT01263496|11042484|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0
6985620|NCT01263496|11042485|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0
6985621|NCT01263496|11042486|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0
6985622|NCT01263496|11042487|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0
6985623|NCT01263496|11042488|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0
6985624|NCT01263496|11042489|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0
6985625|NCT01263496|11042490|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1
6985626|NCT01263496|11042491|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0
6985627|NCT01263509|11042505|FG000|Entered - Long-Term Extension Study|Adverse Event|5
6985628|NCT01263509|11042506|FG001|Entered - Long-Term Extension Study|Adverse Event|5
6985629|NCT01263509|11042507|FG002|Entered - Long-Term Extension Study|Adverse Event|4
6985630|NCT01263509|11042508|FG003|Entered - Long-Term Extension Study|Adverse Event|1
6985631|NCT01263509|11042505|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1
6985632|NCT01263509|11042506|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4
6985633|NCT01263509|11042507|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1
6985634|NCT01263509|11042508|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0
6985635|NCT01263509|11042505|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1
6985636|NCT01263509|11042506|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2
6985637|NCT01263509|11042507|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0
6985638|NCT01263509|11042508|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0
6985639|NCT01263509|11042505|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1
6985640|NCT01263509|11042506|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1
6985641|NCT01263509|11042507|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0
6985642|NCT01263509|11042508|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0
6985643|NCT01263509|11042505|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
6985644|NCT01263509|11042506|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
6985645|NCT01263509|11042507|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
6985646|NCT01263509|11042508|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1
6985647|NCT01263561|11042516|FG000|Overall Study|Death|1
6985648|NCT01263561|11042517|FG001|Overall Study|Death|2
6985649|NCT01263639|11042525|FG000|Overall Study|Lost to Follow-up|66
6985650|NCT01263639|11042526|FG001|Overall Study|Lost to Follow-up|70
6985651|NCT01263639|11042525|FG000|Overall Study|Exclusion =Admission greater than 7 days|7
6985652|NCT01263639|11042526|FG001|Overall Study|Exclusion =Admission greater than 7 days|9
6985653|NCT01263665|11042532|FG000|Overall Study|Withdrew Consent|1
6985654|NCT01263665|11042532|FG000|Overall Study|Lost to Follow-up|3
6985655|NCT01263665|11042532|FG000|Overall Study|Death|2
6985656|NCT01263665|11042532|FG000|Overall Study|Amputation above the ankle|1
6985657|NCT01263665|11042532|FG000|Overall Study|Surgical Bypass|2
6985658|NCT01263691|11042542|FG000|Overall Study|Lost to Follow-up|1
6985659|NCT01263691|11042543|FG001|Overall Study|Lost to Follow-up|0
6985660|NCT01263691|11042544|FG002|Overall Study|Lost to Follow-up|1
6985661|NCT01263691|11042545|FG003|Overall Study|Lost to Follow-up|1
6985662|NCT01263691|11042546|FG004|Overall Study|Lost to Follow-up|0
6985663|NCT01263691|11042547|FG005|Overall Study|Lost to Follow-up|0
6985664|NCT01263691|11042542|FG000|Overall Study|Withdrawal by Subject|1
6985665|NCT01263691|11042543|FG001|Overall Study|Withdrawal by Subject|0
6985666|NCT01263691|11042544|FG002|Overall Study|Withdrawal by Subject|0
6985667|NCT01263691|11042545|FG003|Overall Study|Withdrawal by Subject|0
6985668|NCT01263691|11042546|FG004|Overall Study|Withdrawal by Subject|0
6985669|NCT01263691|11042547|FG005|Overall Study|Withdrawal by Subject|0
6985670|NCT01263691|11042542|FG000|Overall Study|Adverse Event|1
6985671|NCT01263691|11042543|FG001|Overall Study|Adverse Event|0
6985672|NCT01263691|11042544|FG002|Overall Study|Adverse Event|0
6985673|NCT01263691|11042545|FG003|Overall Study|Adverse Event|0
6985674|NCT01263691|11042546|FG004|Overall Study|Adverse Event|0
6985675|NCT01263691|11042547|FG005|Overall Study|Adverse Event|0
6985676|NCT01263704|11042582|FG000|Overall Study|Progressive disease|18
6985677|NCT01263704|11042582|FG000|Overall Study|Adverse Event|3
6985678|NCT01263704|11042582|FG000|Overall Study|Death|2
6985679|NCT01263704|11042582|FG000|Overall Study|Patient withdrew consent|2
6985680|NCT01263704|11042582|FG000|Overall Study|Eligibility criteria not fulfilled|1
6985681|NCT01263704|11042582|FG000|Overall Study|Lost to Follow-up|1
6985682|NCT01263704|11042582|FG000|Overall Study|Colon metastases|1
6985683|NCT01263704|11042582|FG000|Overall Study|Principal Investigator (PI) decision|1
6985684|NCT01263782|11042599|FG000|Overall Study|Death|0
6985685|NCT01263782|11042600|FG001|Overall Study|Death|0
6985686|NCT01263782|11042601|FG002|Overall Study|Death|1
6985687|NCT01263782|11042602|FG003|Overall Study|Death|0
6985688|NCT01263782|11042599|FG000|Overall Study|Progressive disease|0
6985689|NCT01263782|11042600|FG001|Overall Study|Progressive disease|0
6985690|NCT01263782|11042601|FG002|Overall Study|Progressive disease|0
6985691|NCT01263782|11042602|FG003|Overall Study|Progressive disease|1
6985692|NCT01263782|11042599|FG000|Overall Study|Too early|0
6985693|NCT01263782|11042600|FG001|Overall Study|Too early|0
6985694|NCT01263782|11042601|FG002|Overall Study|Too early|1
6985695|NCT01263782|11042602|FG003|Overall Study|Too early|0
6985696|NCT01263782|11042599|FG000|Overall Study|Inevaluable|0
6985697|NCT01263782|11042600|FG001|Overall Study|Inevaluable|0
6985698|NCT01263782|11042601|FG002|Overall Study|Inevaluable|1
6985699|NCT01263782|11042602|FG003|Overall Study|Inevaluable|0
6985700|NCT01263873|11042614|FG000|Overall Study|One provider unable to complete numbers|1
6985701|NCT01263873|11042615|FG001|Overall Study|One provider unable to complete numbers|1
6985702|NCT01263925|11042623|FG000|Overall Study|Protocol Violation|1
6985703|NCT01263925|11042624|FG001|Overall Study|Protocol Violation|0
6985704|NCT01263925|11042623|FG000|Overall Study|Lack of Efficacy|0
6985705|NCT01263925|11042624|FG001|Overall Study|Lack of Efficacy|1
6985706|NCT01263925|11042623|FG000|Overall Study|Adverse Event|23
6985707|NCT01263925|11042624|FG001|Overall Study|Adverse Event|22
6985708|NCT01263925|11042623|FG000|Overall Study|Unsatisfactory Compliance of Subject|8
6985709|NCT01263925|11042624|FG001|Overall Study|Unsatisfactory Compliance of Subject|5
6985710|NCT01263925|11042623|FG000|Overall Study|Withdrawal by Subject|6
6985711|NCT01263925|11042624|FG001|Overall Study|Withdrawal by Subject|8
6985712|NCT01263925|11042623|FG000|Overall Study|Other|4
6985713|NCT01263925|11042624|FG001|Overall Study|Other|4
6985714|NCT01263925|11042623|FG000|Overall Study|Lost to Follow-up|3
6985715|NCT01263925|11042624|FG001|Overall Study|Lost to Follow-up|1
6985716|NCT01263925|11042623|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
6985717|NCT01263925|11042624|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
6985718|NCT01263925|11042623|FG000|Overall Study|AE/ Unsatisfactory Compliance|2
6985719|NCT01263925|11042624|FG001|Overall Study|AE/ Unsatisfactory Compliance|2
6985720|NCT01263925|11042623|FG000|Overall Study|AE/ Withdrawal|1
6985721|NCT01263925|11042624|FG001|Overall Study|AE/ Withdrawal|4
6985722|NCT01263925|11042623|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
6985723|NCT01263925|11042624|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
6985724|NCT01263925|11042623|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1
6985725|NCT01263925|11042624|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2
6985726|NCT01263925|11042623|FG000|Overall Study|Withdrawal/ Not specified|0
6985727|NCT01263925|11042624|FG001|Overall Study|Withdrawal/ Not specified|1
6985728|NCT01264016|11042635|FG000|Overall Study|Withdrawal by Subject|1
6985729|NCT01264016|11042635|FG000|Overall Study|Felt faint at sight of blood|1
6985730|NCT01264081|11042640|FG000|Participants Screened|Screening failures|30
6985731|NCT01264081|11042640|FG000|Started Treatment|Withdrawal by Subject|1
6985732|NCT01264081|11042640|FG000|Started Treatment|Not complete cycle 1 due to death|1
6985733|NCT01264380|11042644|FG000|Period C|Disease Progression|0
6985734|NCT01264380|11042645|FG001|Period C|Disease Progression|0
6985735|NCT01264380|11042646|FG002|Period C|Disease Progression|4
6985736|NCT01264380|11042644|FG000|Period C|Death|0
6985737|NCT01264380|11042645|FG001|Period C|Death|0
6985738|NCT01264380|11042646|FG002|Period C|Death|2
6985739|NCT01264380|11042644|FG000|Period C|Follow-up for survival status|0
6985740|NCT01264380|11042645|FG001|Period C|Follow-up for survival status|0
6985741|NCT01264380|11042646|FG002|Period C|Follow-up for survival status|6
6985742|NCT01264380|11042644|FG000|Period C|Withdrawal by Subject|0
6985743|NCT01264380|11042645|FG001|Period C|Withdrawal by Subject|0
6985744|NCT01264380|11042646|FG002|Period C|Withdrawal by Subject|1
6985745|NCT01264380|11042644|FG000|Period C|Adverse Event|0
6985746|NCT01264380|11042645|FG001|Period C|Adverse Event|0
6985747|NCT01264380|11042646|FG002|Period C|Adverse Event|1
6985748|NCT01264419|11042654|FG000|Overall Study|Lost to Follow-up|3
6985749|NCT01264718|11042694|FG000|Overall Study|Lost to Follow-up|3
6985750|NCT01264718|11042695|FG001|Overall Study|Lost to Follow-up|2
6985751|NCT01264718|11042694|FG000|Overall Study|Withdrawal by Subject|9
6985752|NCT01264718|11042695|FG001|Overall Study|Withdrawal by Subject|15
6985753|NCT01264718|11042694|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37
6985754|NCT01264718|11042695|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26
6985755|NCT01264770|11042707|FG000|Overall Study|Not reported|0
6985756|NCT01264770|11042708|FG001|Overall Study|Not reported|0
6985757|NCT01264770|11042709|FG002|Overall Study|Not reported|1
6985758|NCT01264770|11042710|FG003|Overall Study|Not reported|0
6985759|NCT01264770|11042711|FG004|Overall Study|Not reported|0
6985760|NCT01264770|11042712|FG005|Overall Study|Not reported|0
6985761|NCT01264770|11042707|FG000|Overall Study|e.g., change in circumstances|8
6985762|NCT01264770|11042708|FG001|Overall Study|e.g., change in circumstances|3
6985763|NCT01264770|11042709|FG002|Overall Study|e.g., change in circumstances|3
6985764|NCT01264770|11042710|FG003|Overall Study|e.g., change in circumstances|3
6985765|NCT01264770|11042711|FG004|Overall Study|e.g., change in circumstances|4
6985766|NCT01264770|11042712|FG005|Overall Study|e.g., change in circumstances|4
6985767|NCT01264770|11042707|FG000|Overall Study|Severe non-compliance to protocol|0
6985768|NCT01264770|11042708|FG001|Overall Study|Severe non-compliance to protocol|0
6985769|NCT01264770|11042709|FG002|Overall Study|Severe non-compliance to protocol|1
6985770|NCT01264770|11042710|FG003|Overall Study|Severe non-compliance to protocol|1
6985771|NCT01264770|11042711|FG004|Overall Study|Severe non-compliance to protocol|0
6985772|NCT01264770|11042712|FG005|Overall Study|Severe non-compliance to protocol|0
6985773|NCT01264770|11042707|FG000|Overall Study|Lack of therapeutic response|1
6985774|NCT01264770|11042708|FG001|Overall Study|Lack of therapeutic response|0
6985775|NCT01264770|11042709|FG002|Overall Study|Lack of therapeutic response|2
6985776|NCT01264770|11042710|FG003|Overall Study|Lack of therapeutic response|1
6985777|NCT01264770|11042711|FG004|Overall Study|Lack of therapeutic response|1
6985778|NCT01264770|11042712|FG005|Overall Study|Lack of therapeutic response|0
6985779|NCT01264770|11042707|FG000|Overall Study|Dev. of study specific discont. criteria|2
6985780|NCT01264770|11042708|FG001|Overall Study|Dev. of study specific discont. criteria|0
6985781|NCT01264770|11042709|FG002|Overall Study|Dev. of study specific discont. criteria|0
6985782|NCT01264770|11042710|FG003|Overall Study|Dev. of study specific discont. criteria|0
6985783|NCT01264770|11042711|FG004|Overall Study|Dev. of study specific discont. criteria|1
6985784|NCT01264770|11042712|FG005|Overall Study|Dev. of study specific discont. criteria|1
6985785|NCT01264770|11042707|FG000|Overall Study|Lost to Follow-up|0
6985786|NCT01264770|11042708|FG001|Overall Study|Lost to Follow-up|0
6985787|NCT01264770|11042709|FG002|Overall Study|Lost to Follow-up|1
6985788|NCT01264770|11042710|FG003|Overall Study|Lost to Follow-up|1
6985789|NCT01264770|11042711|FG004|Overall Study|Lost to Follow-up|0
6985790|NCT01264770|11042712|FG005|Overall Study|Lost to Follow-up|0
6985791|NCT01264770|11042707|FG000|Overall Study|Adverse Event|7
6985792|NCT01264770|11042708|FG001|Overall Study|Adverse Event|7
6985793|NCT01264770|11042709|FG002|Overall Study|Adverse Event|8
6985794|NCT01264770|11042710|FG003|Overall Study|Adverse Event|0
6985795|NCT01264770|11042711|FG004|Overall Study|Adverse Event|2
6985796|NCT01264770|11042712|FG005|Overall Study|Adverse Event|1
6985797|NCT01264887|11042732|FG000|Overall Study|Adverse Event|5
6985798|NCT01264887|11042732|FG000|Overall Study|Death|7
6985799|NCT01264887|11042732|FG000|Overall Study|Lack of Efficacy|5
6985800|NCT01264887|11042732|FG000|Overall Study|Physician Decision|4
6985801|NCT01264887|11042732|FG000|Overall Study|Withdrawal by Subject|6
6985802|NCT01264887|11042732|FG000|Overall Study|Sponsor Decision Administrative Reasons|2
6985803|NCT01264887|11042732|FG000|Overall Study|Other|2
6985804|NCT01264939|11042740|FG000|Overall Study|Adverse Event|1
6985805|NCT01264939|11042741|FG001|Overall Study|Adverse Event|3
6985806|NCT01264939|11042740|FG000|Overall Study|Lost to Follow-up|0
6985807|NCT01264939|11042741|FG001|Overall Study|Lost to Follow-up|3
6985808|NCT01264939|11042740|FG000|Overall Study|Physician Decision|1
6985809|NCT01264939|11042741|FG001|Overall Study|Physician Decision|1
6985810|NCT01264939|11042740|FG000|Overall Study|Patient/Guardian Decision|8
6985811|NCT01264939|11042741|FG001|Overall Study|Patient/Guardian Decision|10
6985812|NCT01264939|11042740|FG000|Overall Study|Disease Progression|8
6985813|NCT01264939|11042741|FG001|Overall Study|Disease Progression|11
6985814|NCT01265056|11042762|FG000|Initial Study Period|Withdrawal by Subject|1
6985815|NCT01265056|11042763|FG001|Initial Study Period|Withdrawal by Subject|1
6985816|NCT01265056|11042762|FG000|Initial Study Period|Withdrawal by Subject|1
6985817|NCT01265056|11042763|FG001|Initial Study Period|Withdrawal by Subject|1
6985818|NCT01265056|11042762|FG000|Follow up|Lost to Follow-up|7
6985819|NCT01265056|11042763|FG001|Follow up|Lost to Follow-up|3
6985820|NCT01265394|11042769|FG000|Overall Study|Subjects withdrawn|37
6985821|NCT01265420|11042774|FG000|Overall Study|Lost to Follow-up|1
6985822|NCT01265498|11042814|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31
6985823|NCT01265498|11042815|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33
6985824|NCT01265511|11042823|FG000|Overall Study|Lack of Efficacy|2
6985825|NCT01265511|11042824|FG001|Overall Study|Lack of Efficacy|1
6985826|NCT01265511|11042823|FG000|Overall Study|Met stopping rules|0
6985827|NCT01265511|11042824|FG001|Overall Study|Met stopping rules|2
6985828|NCT01265537|11042841|FG000|Overall Study|Adverse Event|2
6985829|NCT01265537|11042842|FG001|Overall Study|Adverse Event|1
6985830|NCT01265537|11042841|FG000|Overall Study|Physician Decision|0
6985831|NCT01265537|11042842|FG001|Overall Study|Physician Decision|1
6985832|NCT01265550|11042852|FG000|Pre Randomization|Withdrawal by Subject|0
6985833|NCT01265550|11042853|FG001|Pre Randomization|Withdrawal by Subject|0
6985834|NCT01265550|11042854|FG002|Pre Randomization|Withdrawal by Subject|0
6985835|NCT01265550|11042855|FG003|Pre Randomization|Withdrawal by Subject|70
6985836|NCT01265550|11042852|FG000|Pre Randomization|Technical Exclusions|0
6985837|NCT01265550|11042853|FG001|Pre Randomization|Technical Exclusions|0
6985838|NCT01265550|11042854|FG002|Pre Randomization|Technical Exclusions|0
6985839|NCT01265550|11042855|FG003|Pre Randomization|Technical Exclusions|54
6985840|NCT01265550|11042852|FG000|Pre Randomization|GERD, PPI-Responsive|0
6985841|NCT01265550|11042853|FG001|Pre Randomization|GERD, PPI-Responsive|0
6985842|NCT01265550|11042854|FG002|Pre Randomization|GERD, PPI-Responsive|0
6985843|NCT01265550|11042855|FG003|Pre Randomization|GERD, PPI-Responsive|42
6985844|NCT01265550|11042852|FG000|Pre Randomization|Non-GERD organic disorders|0
6985845|NCT01265550|11042853|FG001|Pre Randomization|Non-GERD organic disorders|0
6985846|NCT01265550|11042854|FG002|Pre Randomization|Non-GERD organic disorders|0
6985847|NCT01265550|11042855|FG003|Pre Randomization|Non-GERD organic disorders|23
6985848|NCT01265550|11042852|FG000|Pre Randomization|Functional heartburn|0
6985849|NCT01265550|11042853|FG001|Pre Randomization|Functional heartburn|0
6985850|NCT01265550|11042854|FG002|Pre Randomization|Functional heartburn|0
6985851|NCT01265550|11042855|FG003|Pre Randomization|Functional heartburn|99
6985852|NCT01265563|11042874|FG000|Overall Study|Withdrawal by Subject|0
6985853|NCT01265563|11042875|FG001|Overall Study|Withdrawal by Subject|1
6985854|NCT01265563|11042876|FG002|Overall Study|Withdrawal by Subject|1
6985855|NCT01265563|11042877|FG003|Overall Study|Withdrawal by Subject|0
6985856|NCT01265563|11042878|FG004|Overall Study|Withdrawal by Subject|2
6985857|NCT01265615|11042899|FG000|Overall Study|Protocol Violation|2
6985858|NCT01265615|11042900|FG001|Overall Study|Protocol Violation|2
6985859|NCT01265615|11042901|FG002|Overall Study|Protocol Violation|4
6985860|NCT01265615|11042902|FG003|Overall Study|Protocol Violation|3
6985861|NCT01265719|11042923|FG000|Overall Study|Does not meet entrance criteria|0
6985862|NCT01265719|11042924|FG001|Overall Study|Does not meet entrance criteria|3
6985863|NCT01265719|11042923|FG000|Overall Study|Other reasons|2
6985864|NCT01265719|11042924|FG001|Overall Study|Other reasons|0
6985865|NCT01265719|11042923|FG000|Overall Study|Withdrawal by Subject|8
6985866|NCT01265719|11042924|FG001|Overall Study|Withdrawal by Subject|3
6985867|NCT01265719|11042923|FG000|Overall Study|Lost to Follow-up|2
6985868|NCT01265719|11042924|FG001|Overall Study|Lost to Follow-up|7
6985869|NCT01265719|11042923|FG000|Overall Study|Adverse Event|2
6985870|NCT01265719|11042924|FG001|Overall Study|Adverse Event|0
6985871|NCT01265797|11042932|FG000|Run-in Month|Withdrawal by Subject|0
6985872|NCT01265797|11042933|FG001|Run-in Month|Withdrawal by Subject|4
6985873|NCT01265797|11042932|FG000|Run-in Month|1st seizure during run-in month|0
6985874|NCT01265797|11042933|FG001|Run-in Month|1st seizure during run-in month|1
6985875|NCT01265797|11042932|FG000|Blinded Month|Lack of Efficacy|5
6985876|NCT01265797|11042933|FG001|Blinded Month|Lack of Efficacy|0
6985877|NCT01265797|11042932|FG000|Blinded Month|Lost to Follow-up|1
6985878|NCT01265797|11042933|FG001|Blinded Month|Lost to Follow-up|0
6985879|NCT01265797|11042932|FG000|Blinded Month|Protocol Violation|2
6985880|NCT01265797|11042933|FG001|Blinded Month|Protocol Violation|1
6985881|NCT01265797|11042932|FG000|Blinded Month|Adverse Event|2
6985882|NCT01265797|11042933|FG001|Blinded Month|Adverse Event|0
6985883|NCT01265797|11042932|FG000|Blinded Month|Diary data incomplete|0
6985884|NCT01265797|11042933|FG001|Blinded Month|Diary data incomplete|1
6985885|NCT01265797|11042932|FG000|Open Label Month|Lost to Follow-up|0
6985886|NCT01265797|11042933|FG001|Open Label Month|Lost to Follow-up|1
6985887|NCT01265823|11042941|FG000|Overall Study|Unsatisfactory Response Efficacy|1
6985888|NCT01265823|11042941|FG000|Overall Study|Failure to Return|4
6985889|NCT01265823|11042941|FG000|Overall Study|Protocol Violation|1
6985890|NCT01265823|11042941|FG000|Overall Study|Participant Request|1
6985891|NCT01265875|11042949|FG000|Overall Study|Uncooperative/unreliable|1
6985892|NCT01265953|11042956|FG000|Overall Study|Non compliance|5
6985893|NCT01265953|11042957|FG001|Overall Study|Non compliance|3
6985894|NCT01265992|11042976|FG000|Overall Study|Lost to Follow-up|1
6985895|NCT01265992|11042976|FG000|Overall Study|Withdrawal by Subject|1
6985896|NCT01265992|11042976|FG000|Overall Study|Adverse Event|1
6985897|NCT01265992|11042976|FG000|Overall Study|Administrative reasons|2
6985898|NCT01265992|11042976|FG000|Overall Study|Stopped treatment|3
6985899|NCT01265992|11042976|FG000|Overall Study|Did not receive treatment|1
6985900|NCT01266018|11042980|FG000|Overall Study|Physician Decision|1
6985901|NCT01266018|11042981|FG001|Overall Study|Physician Decision|0
6985902|NCT01266018|11042980|FG000|Overall Study|Progressive disease|0
6985903|NCT01266018|11042981|FG001|Overall Study|Progressive disease|1
6985904|NCT01266070|11042987|FG000|Overall Study|Adverse Event|3
6985905|NCT01266070|11042987|FG000|Overall Study|Protocol Violation|1
6985906|NCT01266122|11042993|FG000|Overall Study|Lost to Follow-up|6
6985907|NCT01266122|11042994|FG001|Overall Study|Lost to Follow-up|6
6985908|NCT01266148|11043002|FG000|Overall Study|Adverse Event|2
6985909|NCT01266148|11043003|FG001|Overall Study|Adverse Event|0
6985910|NCT01266148|11043002|FG000|Overall Study|Ongoing rejection|1
6985911|NCT01266148|11043003|FG001|Overall Study|Ongoing rejection|0
6985912|NCT01266148|11043002|FG000|Overall Study|2 2R rejections|1
6985913|NCT01266148|11043003|FG001|Overall Study|2 2R rejections|0
6985914|NCT01266148|11043002|FG000|Overall Study|Death|2
6985915|NCT01266148|11043003|FG001|Overall Study|Death|3
6985916|NCT01266148|11043002|FG000|Overall Study|missing mGFR value + AE|1
6985917|NCT01266148|11043003|FG001|Overall Study|missing mGFR value + AE|0
6985918|NCT01266161|11043011|FG000|Overall Study|Ineligible|1
6985919|NCT01266161|11043012|FG001|Overall Study|Ineligible|0
6985920|NCT01266161|11043011|FG000|Overall Study|Lack of Efficacy|0
6985921|NCT01266161|11043012|FG001|Overall Study|Lack of Efficacy|1
6985922|NCT01266161|11043011|FG000|Overall Study|Vomited within 4 hours of dosing|3
6985923|NCT01266161|11043012|FG001|Overall Study|Vomited within 4 hours of dosing|0
6985924|NCT01266265|11043020|FG000|Overall Study|Death|95
6985925|NCT01266265|11043021|FG001|Overall Study|Death|73
6985926|NCT01266265|11043020|FG000|Overall Study|Lost to Follow-up|23
6985927|NCT01266265|11043021|FG001|Overall Study|Lost to Follow-up|28
6985928|NCT01266265|11043020|FG000|Overall Study|Withdrawal by Subject|13
6985929|NCT01266265|11043021|FG001|Overall Study|Withdrawal by Subject|11
6985930|NCT01266265|11043020|FG000|Overall Study|Respiratory-related adverse event|2
6985931|NCT01266265|11043021|FG001|Overall Study|Respiratory-related adverse event|1
6985932|NCT01266265|11043020|FG000|Overall Study|Transferred care to another provider|22
6985933|NCT01266265|11043021|FG001|Overall Study|Transferred care to another provider|28
6985934|NCT01266265|11043020|FG000|Overall Study|Stopped/changed PAH medication(s)|16
6985935|NCT01266265|11043021|FG001|Overall Study|Stopped/changed PAH medication(s)|9
6985936|NCT01266265|11043020|FG000|Overall Study|Enrolled in another clinical study|15
6985937|NCT01266265|11043021|FG001|Overall Study|Enrolled in another clinical study|26
6985938|NCT01266265|11043020|FG000|Overall Study|Non-compliance|8
6985939|NCT01266265|11043021|FG001|Overall Study|Non-compliance|5
6985940|NCT01266265|11043020|FG000|Overall Study|Lung transplant|6
6985941|NCT01266265|11043021|FG001|Overall Study|Lung transplant|5
6985942|NCT01266265|11043020|FG000|Overall Study|Site closed early|4
6985943|NCT01266265|11043021|FG001|Overall Study|Site closed early|3
6985944|NCT01266265|11043020|FG000|Overall Study|Clinical worsening|1
6985945|NCT01266265|11043021|FG001|Overall Study|Clinical worsening|1
6985946|NCT01266291|11043027|FG000|Overall Study|Adverse Event|1
6985947|NCT01266317|11043031|FG000|Overall Study|Withdrawal by Subject|2
7042056|NCT01732796|11126090|FG000|Overall Study|Lost to Follow-up|2
7042057|NCT01732796|11126091|FG001|Overall Study|Lost to Follow-up|0
7042058|NCT01732796|11126092|FG002|Overall Study|Lost to Follow-up|0
7042059|NCT01732796|11126090|FG000|Overall Study|Withdrawal by Subject|6
7042060|NCT01732796|11126091|FG001|Overall Study|Withdrawal by Subject|8
7042061|NCT01732796|11126092|FG002|Overall Study|Withdrawal by Subject|2
7042062|NCT01732796|11126090|FG000|Overall Study|Other reason not defined above|1
7042063|NCT01732796|11126091|FG001|Overall Study|Other reason not defined above|0
7042064|NCT01732796|11126092|FG002|Overall Study|Other reason not defined above|2
7044868|NCT01759420|11131031|FG000|Overall Study|Screen failure|5
7044869|NCT01759420|11131031|FG000|Overall Study|Inaccurate EKG machine readings|1
7044870|NCT01759446|11131040|FG000|Overall Study|Protocol Violation|1
7044871|NCT01759446|11131041|FG001|Overall Study|Protocol Violation|0
7044872|NCT01759446|11131042|FG002|Overall Study|Protocol Violation|1
7060254|NCT01915914|11156285|FG003|Maintenance Phase|Withdrawal by Subject|0
7060255|NCT01915914|11156282|FG000|Maintenance Phase|Lost to Follow-up|0
7060256|NCT01915914|11156283|FG001|Maintenance Phase|Lost to Follow-up|4
7060257|NCT01915914|11156284|FG002|Maintenance Phase|Lost to Follow-up|1
7060258|NCT01915914|11156285|FG003|Maintenance Phase|Lost to Follow-up|0
7060259|NCT01915914|11156282|FG000|Maintenance Phase|Missing|0
7060260|NCT01915914|11156283|FG001|Maintenance Phase|Missing|1
7060261|NCT01915914|11156284|FG002|Maintenance Phase|Missing|0
7060262|NCT01915914|11156285|FG003|Maintenance Phase|Missing|0
7060263|NCT01915914|11156282|FG000|Follow-up Phase|Withdrawal by Subject|0
7060264|NCT01915914|11156283|FG001|Follow-up Phase|Withdrawal by Subject|0
7060265|NCT01915914|11156284|FG002|Follow-up Phase|Withdrawal by Subject|0
7060266|NCT01915914|11156285|FG003|Follow-up Phase|Withdrawal by Subject|1
7060267|NCT01915914|11156282|FG000|Follow-up Phase|Physician Decision|0
7060268|NCT01915914|11156283|FG001|Follow-up Phase|Physician Decision|0
7044873|NCT01759446|11131043|FG003|Overall Study|Protocol Violation|0
7044874|NCT01759446|11131044|FG004|Overall Study|Protocol Violation|0
7044875|NCT01759446|11131040|FG000|Overall Study|Withdrawal by Subject|0
7044876|NCT01759446|11131041|FG001|Overall Study|Withdrawal by Subject|1
7044877|NCT01759446|11131042|FG002|Overall Study|Withdrawal by Subject|0
7044878|NCT01759446|11131043|FG003|Overall Study|Withdrawal by Subject|1
7044879|NCT01759446|11131044|FG004|Overall Study|Withdrawal by Subject|0
7060269|NCT01915914|11156284|FG002|Follow-up Phase|Physician Decision|0
7044880|NCT01759511|11131056|FG000|Overall Study|Adverse Event|4
7044881|NCT01759511|11131056|FG000|Overall Study|Death|2
7044882|NCT01759511|11131056|FG000|Overall Study|Lack of Efficacy|2
7044883|NCT01759511|11131056|FG000|Overall Study|Physician Decision|1
7044884|NCT01759511|11131056|FG000|Overall Study|Progressive Disease|5
7060270|NCT01915914|11156285|FG003|Follow-up Phase|Physician Decision|1
7060271|NCT01915940|11156305|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39
7060272|NCT01915940|11156306|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0
7060273|NCT01915940|11156307|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0
7060274|NCT01915940|11156305|FG000|Treatment Period|Decision of Participant|0
7060275|NCT01915940|11156306|FG001|Treatment Period|Decision of Participant|1
7060276|NCT01915940|11156307|FG002|Treatment Period|Decision of Participant|3
7060277|NCT01915940|11156305|FG000|Treatment Period|Adverse Event|0
6985948|NCT01266460|11043039|FG000|Overall Study|Adverse Event|3
6985949|NCT01266460|11043039|FG000|Overall Study|Withdrawal by Subject|5
6985950|NCT01266460|11043039|FG000|Overall Study|Disease Progression|18
6985951|NCT01266460|11043039|FG000|Overall Study|Not otherwise specified|8
6985952|NCT01266590|11043043|FG000|Overall Study|Adverse Event|3
6985953|NCT01266590|11043043|FG000|Overall Study|Lost to Follow-up|1
6985954|NCT01266590|11043043|FG000|Overall Study|Withdrawal by Subject|1
6985955|NCT01266590|11043043|FG000|Overall Study|Physician Decision|1
6985956|NCT01266603|11043050|FG000|Overall Study|Adverse Event|1
6985957|NCT01266603|11043050|FG000|Overall Study|Lack of Efficacy|14
6985958|NCT01266603|11043050|FG000|Overall Study|Withdrawal by Subject|1
6985959|NCT01266603|11043050|FG000|Overall Study|Failed screening; MAGE-A3 negative|26
6985960|NCT01266642|11043056|FG000|Overall Study|Protocol Violation|0
6985961|NCT01266642|11043057|FG001|Overall Study|Protocol Violation|1
6985962|NCT01266850|11043068|FG000|Overall Study|Lost to Follow-up|19
6985963|NCT01266850|11043069|FG001|Overall Study|Lost to Follow-up|19
6985964|NCT01266850|11043070|FG002|Overall Study|Lost to Follow-up|13
6985965|NCT01266850|11043071|FG003|Overall Study|Lost to Follow-up|13
6985966|NCT01266850|11043072|FG004|Overall Study|Lost to Follow-up|12
6985967|NCT01266850|11043068|FG000|Overall Study|Withdrawal by Subject|8
6985968|NCT01266850|11043069|FG001|Overall Study|Withdrawal by Subject|9
6985969|NCT01266850|11043070|FG002|Overall Study|Withdrawal by Subject|6
6985970|NCT01266850|11043071|FG003|Overall Study|Withdrawal by Subject|9
6985971|NCT01266850|11043072|FG004|Overall Study|Withdrawal by Subject|12
6985972|NCT01266850|11043068|FG000|Overall Study|Physician Decision|3
6985973|NCT01266850|11043069|FG001|Overall Study|Physician Decision|6
6985974|NCT01266850|11043070|FG002|Overall Study|Physician Decision|4
6985975|NCT01266850|11043071|FG003|Overall Study|Physician Decision|4
6985976|NCT01266850|11043072|FG004|Overall Study|Physician Decision|3
6985977|NCT01266850|11043068|FG000|Overall Study|Protocol Violation|0
6985978|NCT01266850|11043069|FG001|Overall Study|Protocol Violation|1
6985979|NCT01266850|11043070|FG002|Overall Study|Protocol Violation|0
6985980|NCT01266850|11043071|FG003|Overall Study|Protocol Violation|1
6985981|NCT01266850|11043072|FG004|Overall Study|Protocol Violation|2
6985982|NCT01266850|11043068|FG000|Overall Study|Adverse Event|0
6985983|NCT01266850|11043069|FG001|Overall Study|Adverse Event|0
6985984|NCT01266850|11043070|FG002|Overall Study|Adverse Event|0
6985985|NCT01266850|11043071|FG003|Overall Study|Adverse Event|0
6985986|NCT01266850|11043072|FG004|Overall Study|Adverse Event|1
6985987|NCT01266850|11043068|FG000|Overall Study|Site Closure|0
6985988|NCT01266850|11043069|FG001|Overall Study|Site Closure|1
6985989|NCT01266850|11043070|FG002|Overall Study|Site Closure|1
6985990|NCT01266850|11043071|FG003|Overall Study|Site Closure|1
6985991|NCT01266850|11043072|FG004|Overall Study|Site Closure|0
6985992|NCT01266876|11043089|FG000|Overall Study|Adverse Event|0
6985993|NCT01266876|11043090|FG001|Overall Study|Adverse Event|0
6985994|NCT01266876|11043091|FG002|Overall Study|Adverse Event|0
6985995|NCT01266876|11043092|FG003|Overall Study|Adverse Event|1
6985996|NCT01266876|11043093|FG004|Overall Study|Adverse Event|0
6985997|NCT01266902|11043107|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2
6985998|NCT01266902|11043108|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3
6985999|NCT01266902|11043109|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0
6986000|NCT01266902|11043107|FG000|Period 1 (Main Study)|Lost to Follow-up|5
6986001|NCT01266902|11043108|FG001|Period 1 (Main Study)|Lost to Follow-up|12
6986002|NCT01266902|11043109|FG002|Period 1 (Main Study)|Lost to Follow-up|0
6986003|NCT01266902|11043107|FG000|Period 1 (Main Study)|Lack of Efficacy|4
6986004|NCT01266902|11043108|FG001|Period 1 (Main Study)|Lack of Efficacy|2
6986005|NCT01266902|11043109|FG002|Period 1 (Main Study)|Lack of Efficacy|0
6986006|NCT01266902|11043107|FG000|Period 1 (Main Study)|Adverse Event|3
6986007|NCT01266902|11043108|FG001|Period 1 (Main Study)|Adverse Event|11
6986008|NCT01266902|11043109|FG002|Period 1 (Main Study)|Adverse Event|0
6986009|NCT01266902|11043107|FG000|Period 1 (Main Study)|Withdrawal by Subject|2
6986010|NCT01266902|11043108|FG001|Period 1 (Main Study)|Withdrawal by Subject|12
6986011|NCT01266902|11043109|FG002|Period 1 (Main Study)|Withdrawal by Subject|0
6986012|NCT01266902|11043107|FG000|Period 1 (Main Study)|Subject non-compliant|3
6986013|NCT01266902|11043108|FG001|Period 1 (Main Study)|Subject non-compliant|7
6986014|NCT01266902|11043109|FG002|Period 1 (Main Study)|Subject non-compliant|0
6986015|NCT01266902|11043107|FG000|Period 1 (Main Study)|Continued RPV treatment|11
6986016|NCT01266902|11043108|FG001|Period 1 (Main Study)|Continued RPV treatment|34
6986017|NCT01266902|11043109|FG002|Period 1 (Main Study)|Continued RPV treatment|0
6986018|NCT01266902|11043107|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0
6986019|NCT01266902|11043108|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0
6986020|NCT01266902|11043109|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1
6986021|NCT01266902|11043107|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0
6986022|NCT01266902|11043108|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0
6986023|NCT01266902|11043109|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1
6986024|NCT01266902|11043107|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0
6986025|NCT01266902|11043108|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0
6986026|NCT01266902|11043109|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6
6986027|NCT01266967|11043119|FG000|Overall Study|Death|69
6986028|NCT01266967|11043120|FG001|Overall Study|Death|61
6986029|NCT01266967|11043119|FG000|Overall Study|Study Closed/Terminated|15
6986030|NCT01266967|11043120|FG001|Overall Study|Study Closed/Terminated|17
6986031|NCT01266967|11043119|FG000|Overall Study|Lost to Follow-up|2
6986032|NCT01266967|11043120|FG001|Overall Study|Lost to Follow-up|1
6986033|NCT01266967|11043119|FG000|Overall Study|Physician Decision|0
6986034|NCT01266967|11043120|FG001|Overall Study|Physician Decision|1
6986035|NCT01266967|11043119|FG000|Overall Study|Withdrawal by Subject|3
6986036|NCT01266967|11043120|FG001|Overall Study|Withdrawal by Subject|3
6986037|NCT01266993|11043131|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5
6986038|NCT01266993|11043132|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1
6986039|NCT01266993|11043131|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0
6986040|NCT01266993|11043132|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1
6986041|NCT01267175|11043172|FG000|Overall Study|Withdrawal by Subject|1
6986042|NCT01267175|11043172|FG000|Overall Study|Lost to Follow-up|1
6986043|NCT01267201|11043176|FG000|First Intervention Period|Withdrawal by Subject|1
6986044|NCT01267201|11043177|FG001|First Intervention Period|Withdrawal by Subject|0
6986045|NCT01267201|11043178|FG002|First Intervention Period|Withdrawal by Subject|0
6986046|NCT01267201|11043179|FG003|First Intervention Period|Withdrawal by Subject|0
6986047|NCT01267201|11043180|FG004|First Intervention Period|Withdrawal by Subject|0
6986048|NCT01267201|11043181|FG005|First Intervention Period|Withdrawal by Subject|0
6986049|NCT01267201|11043176|FG000|Second Intervention Period|Withdrawal by Subject|0
6986050|NCT01267201|11043177|FG001|Second Intervention Period|Withdrawal by Subject|1
6986051|NCT01267201|11043178|FG002|Second Intervention Period|Withdrawal by Subject|0
6986052|NCT01267201|11043179|FG003|Second Intervention Period|Withdrawal by Subject|0
6986053|NCT01267201|11043180|FG004|Second Intervention Period|Withdrawal by Subject|0
6986054|NCT01267201|11043181|FG005|Second Intervention Period|Withdrawal by Subject|0
6986055|NCT01267253|11043214|FG000|Overall Study|Ineligible - required test not done|1
6986056|NCT01267253|11043214|FG000|Overall Study|Inevaluable-never received study treatme|2
6986057|NCT01267266|11043218|FG000|Enrollment Phase|Withdrawal by Subject|2
6986058|NCT01267266|11043219|FG001|Enrollment Phase|Withdrawal by Subject|0
6986059|NCT01267266|11043218|FG000|Lead-in Phase|Lack of Efficacy|20
6986060|NCT01267266|11043219|FG001|Lead-in Phase|Lack of Efficacy|0
6986061|NCT01267266|11043218|FG000|Lead-in Phase|Adverse Event|2
6986062|NCT01267266|11043219|FG001|Lead-in Phase|Adverse Event|0
6986063|NCT01267266|11043218|FG000|Lead-in Phase|Withdrawal by Subject|1
6986064|NCT01267266|11043219|FG001|Lead-in Phase|Withdrawal by Subject|0
6986065|NCT01267994|11043294|FG000|Overall Study|Adverse Event|2
6986066|NCT01268046|11043303|FG000|Overall Study|Withdrawal by Subject|1
6986067|NCT01268046|11043304|FG001|Overall Study|Withdrawal by Subject|0
6986068|NCT01268046|11043305|FG002|Overall Study|Withdrawal by Subject|0
6986069|NCT01268046|11043306|FG003|Overall Study|Withdrawal by Subject|1
6986070|NCT01268046|11043303|FG000|Overall Study|Lost to Follow-up|0
6986071|NCT01268046|11043304|FG001|Overall Study|Lost to Follow-up|0
6986072|NCT01268046|11043305|FG002|Overall Study|Lost to Follow-up|1
6986073|NCT01268046|11043306|FG003|Overall Study|Lost to Follow-up|0
6986074|NCT01268059|11043320|FG000|Overall Study|Lost to Follow-up|0
6986075|NCT01268059|11043321|FG001|Overall Study|Lost to Follow-up|1
6986076|NCT01268059|11043322|FG002|Overall Study|Lost to Follow-up|0
6986077|NCT01268059|11043323|FG003|Overall Study|Lost to Follow-up|0
6986078|NCT01268059|11043320|FG000|Overall Study|Withdrawal by Subject|7
6986079|NCT01268059|11043321|FG001|Overall Study|Withdrawal by Subject|4
6986080|NCT01268059|11043322|FG002|Overall Study|Withdrawal by Subject|0
6986081|NCT01268059|11043323|FG003|Overall Study|Withdrawal by Subject|0
6986082|NCT01268059|11043320|FG000|Overall Study|Death|20
6986083|NCT01268059|11043321|FG001|Overall Study|Death|30
6986084|NCT01268059|11043322|FG002|Overall Study|Death|3
6986085|NCT01268059|11043323|FG003|Overall Study|Death|5
6986086|NCT01268059|11043320|FG000|Overall Study|Progression of disease|1
6986087|NCT01268059|11043321|FG001|Overall Study|Progression of disease|0
6986088|NCT01268059|11043322|FG002|Overall Study|Progression of disease|0
6986089|NCT01268059|11043323|FG003|Overall Study|Progression of disease|0
6986090|NCT01268098|11043338|FG000|Overall Study|Adverse Event|1
6986091|NCT01268098|11043339|FG001|Overall Study|Adverse Event|0
6986092|NCT01268150|11043354|FG000|Treatment Phase|Progression of disease|18
6986093|NCT01268150|11043354|FG000|Treatment Phase|Adverse Event|3
6986094|NCT01268150|11043354|FG000|Treatment Phase|Withdrawal by Subject|3
6986095|NCT01268150|11043354|FG000|Treatment Phase|Other|4
6986096|NCT01268150|11043354|FG000|Extension Phase|Adverse Event|3
6986097|NCT01268150|11043354|FG000|Extension Phase|Disease progression|18
6986098|NCT01268150|11043354|FG000|Extension Phase|Other|6
6986099|NCT01268267|11043364|FG000|Overall Study|Protocol Violation|1
6986100|NCT01268293|11043369|FG000|Overall Study|Disease progression|7
6986101|NCT01268293|11043369|FG000|Overall Study|Adverse Event|1
6986102|NCT01268293|11043369|FG000|Overall Study|Subject choice|1
6986103|NCT01268306|11043373|FG000|Overall Study|Lost to Follow-up|1
6986104|NCT01268488|11043377|FG000|Overall Study|Adverse Event|3
6986105|NCT01268488|11043377|FG000|Overall Study|Physician Decision|2
6986106|NCT01268501|11043382|FG000|Overall Study|Lost to Follow-up|1
6986107|NCT01268501|11043382|FG000|Overall Study|Withdrawal by Subject|3
6986108|NCT01268501|11043382|FG000|Overall Study|Unacceptable Subjective Vision|3
6986109|NCT01268501|11043382|FG000|Overall Study|Handling Difficulties|2
6986110|NCT01268514|11043386|FG000|Overall Study|Adverse Event|20
6986111|NCT01268514|11043386|FG000|Overall Study|Death|8
6986112|NCT01268514|11043386|FG000|Overall Study|Lost to Follow-up|5
6986113|NCT01268514|11043386|FG000|Overall Study|Withdrawal by Subject|3
6986114|NCT01268514|11043386|FG000|Overall Study|Withdrawal by Surgeon|5
6986115|NCT01268566|11043418|FG000|Overall Study|Lost to Follow-up|1
6986116|NCT01268566|11043418|FG000|Overall Study|Withdrawal by Subject|12
6986117|NCT01268566|11043418|FG000|Overall Study|Death|30
6986118|NCT01268683|11043429|FG000|Overall Study|Lost to Follow-up|1
6986119|NCT01268683|11043429|FG000|Overall Study|Death|1
6986120|NCT01268891|11043435|FG000|Overall Study|Adverse Event|3
6986121|NCT01268891|11043436|FG001|Overall Study|Adverse Event|7
6986122|NCT01268891|11043435|FG000|Overall Study|Lack of Efficacy|1
6986123|NCT01268891|11043436|FG001|Overall Study|Lack of Efficacy|0
6986124|NCT01268891|11043435|FG000|Overall Study|Withdrawal of Consent|3
6986125|NCT01268891|11043436|FG001|Overall Study|Withdrawal of Consent|1
6986126|NCT01268891|11043435|FG000|Overall Study|Administrative or other reason(s)|1
6986127|NCT01268891|11043436|FG001|Overall Study|Administrative or other reason(s)|0
6986128|NCT01269125|11043477|FG000|Overall Study|Adverse Event|3
6986129|NCT01269125|11043478|FG001|Overall Study|Adverse Event|5
6986130|NCT01269125|11043479|FG002|Overall Study|Adverse Event|0
6986131|NCT01269125|11043477|FG000|Overall Study|Lost to Follow-up|4
6986132|NCT01269125|11043478|FG001|Overall Study|Lost to Follow-up|0
6986133|NCT01269125|11043479|FG002|Overall Study|Lost to Follow-up|0
6986134|NCT01269346|11043487|FG000|Treatment Phase|Disease progression|3
6986135|NCT01269346|11043487|FG000|Treatment Phase|Adverse Event|3
6986136|NCT01269346|11043487|FG000|Treatment Phase|Withdrawal by Subject|1
6986137|NCT01269346|11043487|FG000|Treatment Phase|Other|2
6986138|NCT01269346|11043487|FG000|Extension Phase|Adverse Event|6
6986139|NCT01269346|11043487|FG000|Extension Phase|Withdrawal by Subject|4
6986140|NCT01269346|11043487|FG000|Extension Phase|Disease progression|22
6986141|NCT01269346|11043487|FG000|Extension Phase|Physician decision or participant choice|9
6986142|NCT01269346|11043487|FG000|Extension Phase|Clinical progression|1
6986143|NCT01269346|11043487|FG000|Extension Phase|Started a prohibited con med|1
6986144|NCT01269385|11043501|FG000|Overall Study|Adverse Event|1
6986145|NCT01269385|11043502|FG001|Overall Study|Adverse Event|1
6986146|NCT01269385|11043503|FG002|Overall Study|Adverse Event|0
6986147|NCT01269385|11043504|FG003|Overall Study|Adverse Event|0
6986148|NCT01269918|11043540|FG000|Overall Study|Did not receive study drug|0
6986149|NCT01269918|11043541|FG001|Overall Study|Did not receive study drug|3
6986150|NCT01270139|11043559|FG000|Overall Study|Adverse Event|8
6986151|NCT01270139|11043560|FG001|Overall Study|Adverse Event|17
6986152|NCT01270139|11043561|FG002|Overall Study|Adverse Event|18
6986153|NCT01270139|11043559|FG000|Overall Study|Lost to Follow-up|10
6986154|NCT01270139|11043560|FG001|Overall Study|Lost to Follow-up|9
6986155|NCT01270139|11043561|FG002|Overall Study|Lost to Follow-up|2
6986156|NCT01270256|11043578|FG000|Overall Study|Withdrawal by Subject|1
6986157|NCT01270256|11043579|FG001|Overall Study|Withdrawal by Subject|0
6986158|NCT01270321|11043588|FG000|Overall Study|Death|3
6986159|NCT01270321|11043589|FG001|Overall Study|Death|1
6986160|NCT01270321|11043590|FG002|Overall Study|Death|4
6986161|NCT01270321|11043588|FG000|Overall Study|Adverse Event|7
6986162|NCT01270321|11043589|FG001|Overall Study|Adverse Event|9
6986163|NCT01270321|11043590|FG002|Overall Study|Adverse Event|5
6986164|NCT01270464|11043601|FG000|Overall Study|Protocol Violation|4
6986165|NCT01270464|11043602|FG001|Overall Study|Protocol Violation|3
6986166|NCT01270464|11043603|FG002|Overall Study|Protocol Violation|2
6986167|NCT01270464|11043601|FG000|Overall Study|Lack of Efficacy|2
6986168|NCT01270464|11043602|FG001|Overall Study|Lack of Efficacy|3
6986169|NCT01270464|11043603|FG002|Overall Study|Lack of Efficacy|1
6986170|NCT01270464|11043601|FG000|Overall Study|Adverse Event|9
6986171|NCT01270464|11043602|FG001|Overall Study|Adverse Event|1
6986172|NCT01270464|11043603|FG002|Overall Study|Adverse Event|7
6986173|NCT01270464|11043601|FG000|Overall Study|Withdrawal by Subject|2
6986174|NCT01270464|11043602|FG001|Overall Study|Withdrawal by Subject|1
6986175|NCT01270464|11043603|FG002|Overall Study|Withdrawal by Subject|4
6986176|NCT01270464|11043601|FG000|Overall Study|Lost to Follow-up|2
6986177|NCT01270464|11043602|FG001|Overall Study|Lost to Follow-up|3
6986178|NCT01270464|11043603|FG002|Overall Study|Lost to Follow-up|1
6986179|NCT01270464|11043601|FG000|Overall Study|Other|1
6986180|NCT01270464|11043602|FG001|Overall Study|Other|1
6986181|NCT01270464|11043603|FG002|Overall Study|Other|3
6986182|NCT01270503|11043611|FG000|Overall Study|Lost to Follow-up|1
6986183|NCT01270620|11043661|FG000|Overall Study|Withdrawal by Subject|1
6986184|NCT01270620|11043662|FG001|Overall Study|Withdrawal by Subject|3
6986185|NCT01270802|11043727|FG000|Overall Study|Withdrawal by Subject|1
6986186|NCT01270802|11043728|FG001|Overall Study|Withdrawal by Subject|0
6986187|NCT01270802|11043727|FG000|Overall Study|Adverse Event|1
6986188|NCT01270802|11043728|FG001|Overall Study|Adverse Event|0
6986189|NCT01270802|11043727|FG000|Overall Study|Lost to Follow-up|0
6986190|NCT01270802|11043728|FG001|Overall Study|Lost to Follow-up|1
6986191|NCT01270828|11043737|FG000|Pregabalin CR SB|Reason Unspecified|0
6986192|NCT01270828|11043738|FG001|Pregabalin CR SB|Reason Unspecified|0
6986193|NCT01270828|11043739|FG002|Pregabalin CR SB|Reason Unspecified|8
6986194|NCT01270828|11043737|FG000|Pregabalin CR SB|Enrolled but not treated|0
6986195|NCT01270828|11043738|FG001|Pregabalin CR SB|Enrolled but not treated|0
6986196|NCT01270828|11043739|FG002|Pregabalin CR SB|Enrolled but not treated|5
6986197|NCT01270828|11043737|FG000|Pregabalin CR SB|Related adverse event|0
6986198|NCT01270828|11043738|FG001|Pregabalin CR SB|Related adverse event|0
6986199|NCT01270828|11043739|FG002|Pregabalin CR SB|Related adverse event|46
6986200|NCT01270828|11043737|FG000|Pregabalin CR SB|Lack of Efficacy|0
6986201|NCT01270828|11043738|FG001|Pregabalin CR SB|Lack of Efficacy|0
6986202|NCT01270828|11043739|FG002|Pregabalin CR SB|Lack of Efficacy|32
6986203|NCT01270828|11043737|FG000|Pregabalin CR SB|Withdrawal by Subject|0
6986204|NCT01270828|11043738|FG001|Pregabalin CR SB|Withdrawal by Subject|0
6986205|NCT01270828|11043739|FG002|Pregabalin CR SB|Withdrawal by Subject|29
6986206|NCT01270828|11043737|FG000|Pregabalin CR SB|Lost to Follow-up|0
6986207|NCT01270828|11043738|FG001|Pregabalin CR SB|Lost to Follow-up|0
6986208|NCT01270828|11043739|FG002|Pregabalin CR SB|Lost to Follow-up|10
6986209|NCT01270828|11043737|FG000|Pregabalin CR SB|Unrelated AE|0
6986210|NCT01270828|11043738|FG001|Pregabalin CR SB|Unrelated AE|0
6986211|NCT01270828|11043739|FG002|Pregabalin CR SB|Unrelated AE|8
6986212|NCT01270828|11043737|FG000|Pregabalin CR SB|Protocol Violation|0
6986213|NCT01270828|11043738|FG001|Pregabalin CR SB|Protocol Violation|0
6986214|NCT01270828|11043739|FG002|Pregabalin CR SB|Protocol Violation|8
6986215|NCT01270828|11043737|FG000|Double Blind Phase|Death|0
6986216|NCT01270828|11043738|FG001|Double Blind Phase|Death|1
6986217|NCT01270828|11043739|FG002|Double Blind Phase|Death|0
6986218|NCT01270828|11043737|FG000|Double Blind Phase|Protocol Violation|0
6986219|NCT01270828|11043738|FG001|Double Blind Phase|Protocol Violation|1
6986220|NCT01270828|11043739|FG002|Double Blind Phase|Protocol Violation|0
6986221|NCT01270828|11043737|FG000|Double Blind Phase|Protocol and GCP non-compliance|4
6986222|NCT01270828|11043738|FG001|Double Blind Phase|Protocol and GCP non-compliance|3
6986223|NCT01270828|11043739|FG002|Double Blind Phase|Protocol and GCP non-compliance|0
6986224|NCT01270828|11043737|FG000|Double Blind Phase|Reason Unspecified|7
6986225|NCT01270828|11043738|FG001|Double Blind Phase|Reason Unspecified|4
6986226|NCT01270828|11043739|FG002|Double Blind Phase|Reason Unspecified|0
6986227|NCT01270828|11043737|FG000|Double Blind Phase|Withdrawal by Subject|6
6986228|NCT01270828|11043738|FG001|Double Blind Phase|Withdrawal by Subject|15
6986229|NCT01270828|11043739|FG002|Double Blind Phase|Withdrawal by Subject|0
6986230|NCT01270828|11043737|FG000|Double Blind Phase|Lost to Follow-up|1
6986231|NCT01270828|11043738|FG001|Double Blind Phase|Lost to Follow-up|2
6986232|NCT01270828|11043739|FG002|Double Blind Phase|Lost to Follow-up|0
6986233|NCT01270828|11043737|FG000|Double Blind Phase|Lack of Efficacy|2
6986234|NCT01270828|11043738|FG001|Double Blind Phase|Lack of Efficacy|11
6986235|NCT01270828|11043739|FG002|Double Blind Phase|Lack of Efficacy|0
6986236|NCT01270828|11043737|FG000|Double Blind Phase|Adverse event not related to study drug|1
6986237|NCT01270828|11043738|FG001|Double Blind Phase|Adverse event not related to study drug|1
6986238|NCT01270828|11043739|FG002|Double Blind Phase|Adverse event not related to study drug|0
6986239|NCT01270828|11043737|FG000|Double Blind Phase|Adverse event related to study drug|5
6986240|NCT01270828|11043738|FG001|Double Blind Phase|Adverse event related to study drug|7
6986241|NCT01270828|11043739|FG002|Double Blind Phase|Adverse event related to study drug|0
6986242|NCT01270841|11043751|FG000|Overall Study|Adverse Event|0
6986243|NCT01270841|11043752|FG001|Overall Study|Adverse Event|1
6986244|NCT01270841|11043753|FG002|Overall Study|Adverse Event|0
6986245|NCT01270841|11043754|FG003|Overall Study|Adverse Event|3
6986246|NCT01270841|11043751|FG000|Overall Study|Withdrawal by Subject|3
6986247|NCT01270841|11043752|FG001|Overall Study|Withdrawal by Subject|2
6986248|NCT01270841|11043753|FG002|Overall Study|Withdrawal by Subject|3
6986249|NCT01270841|11043754|FG003|Overall Study|Withdrawal by Subject|3
6986250|NCT01270841|11043751|FG000|Overall Study|Lost to Follow-up|3
6986251|NCT01270841|11043752|FG001|Overall Study|Lost to Follow-up|1
6986252|NCT01270841|11043753|FG002|Overall Study|Lost to Follow-up|4
6986253|NCT01270841|11043754|FG003|Overall Study|Lost to Follow-up|2
6986254|NCT01270841|11043751|FG000|Overall Study|Physician Decision|0
6986255|NCT01270841|11043752|FG001|Overall Study|Physician Decision|1
6986256|NCT01270841|11043753|FG002|Overall Study|Physician Decision|0
6986257|NCT01270841|11043754|FG003|Overall Study|Physician Decision|0
6986258|NCT01270841|11043751|FG000|Overall Study|Did not qualify|6
6986259|NCT01270841|11043752|FG001|Overall Study|Did not qualify|3
6986260|NCT01270841|11043753|FG002|Overall Study|Did not qualify|4
6986261|NCT01270841|11043754|FG003|Overall Study|Did not qualify|5
6986262|NCT01270841|11043751|FG000|Overall Study|Protocol Violation|1
6986263|NCT01270841|11043752|FG001|Overall Study|Protocol Violation|5
6986264|NCT01270841|11043753|FG002|Overall Study|Protocol Violation|0
6986265|NCT01270841|11043754|FG003|Overall Study|Protocol Violation|0
6986266|NCT01270841|11043751|FG000|Overall Study|Enrolled in error|0
6986267|NCT01270841|11043752|FG001|Overall Study|Enrolled in error|1
6986268|NCT01270841|11043753|FG002|Overall Study|Enrolled in error|0
6986269|NCT01270841|11043754|FG003|Overall Study|Enrolled in error|0
6986270|NCT01270880|11043773|FG000|Overall Study|Never rec'd treatment, but registered.|1
6986271|NCT01270958|11043777|FG000|Overall Study|Lost to Follow-up|2
6986272|NCT01270958|11043777|FG000|Overall Study|Did not meet inclusion criteria for age|2
6986273|NCT01270971|11043783|FG000|Overall Study|Withdrawal by Subject|24
6986274|NCT01270971|11043784|FG001|Overall Study|Withdrawal by Subject|11
6986275|NCT01270971|11043783|FG000|Overall Study|Lost to Follow-up|18
6986276|NCT01270971|11043784|FG001|Overall Study|Lost to Follow-up|5
6986277|NCT01270971|11043783|FG000|Overall Study|Adverse Event|1
6986278|NCT01270971|11043784|FG001|Overall Study|Adverse Event|2
6986279|NCT01270971|11043783|FG000|Overall Study|Non compliance|2
6986280|NCT01270971|11043784|FG001|Overall Study|Non compliance|2
6986281|NCT01270971|11043783|FG000|Overall Study|Non-specific|7
6986282|NCT01270971|11043784|FG001|Overall Study|Non-specific|3
6986283|NCT01271010|11043790|FG000|Overall Study|Reason not specified|11
6986284|NCT01271010|11043790|FG000|Overall Study|Start of new CLL therapy|1
6986285|NCT01271010|11043790|FG000|Overall Study|Protocol Violation|1
6986286|NCT01271010|11043790|FG000|Overall Study|Death|2
6986287|NCT01271010|11043790|FG000|Overall Study|Progression and relapse of disease|1
6986288|NCT01271010|11043790|FG000|Overall Study|Withdrawal by Subject|18
6986289|NCT01271010|11043790|FG000|Overall Study|Disease progression|27
6986290|NCT01271504|11043834|FG000|Overall Study|Death|7
6986291|NCT01271504|11043835|FG001|Overall Study|Death|6
6986292|NCT01271504|11043836|FG002|Overall Study|Death|32
6986293|NCT01271504|11043837|FG003|Overall Study|Death|32
6986294|NCT01271504|11043834|FG000|Overall Study|Lost to Follow-up|0
6986295|NCT01271504|11043835|FG001|Overall Study|Lost to Follow-up|1
6986296|NCT01271504|11043836|FG002|Overall Study|Lost to Follow-up|3
6986297|NCT01271504|11043837|FG003|Overall Study|Lost to Follow-up|1
6986298|NCT01271504|11043834|FG000|Overall Study|Protocol Violation|0
6986299|NCT01271504|11043835|FG001|Overall Study|Protocol Violation|0
6986300|NCT01271504|11043836|FG002|Overall Study|Protocol Violation|0
6986301|NCT01271504|11043837|FG003|Overall Study|Protocol Violation|2
6986302|NCT01271504|11043834|FG000|Overall Study|Administrative Reasons|0
6986303|NCT01271504|11043835|FG001|Overall Study|Administrative Reasons|0
6986304|NCT01271504|11043836|FG002|Overall Study|Administrative Reasons|6
6986305|NCT01271504|11043837|FG003|Overall Study|Administrative Reasons|5
6986306|NCT01271504|11043834|FG000|Overall Study|Withdrawal by Subject|0
6986307|NCT01271504|11043835|FG001|Overall Study|Withdrawal by Subject|0
6986308|NCT01271504|11043836|FG002|Overall Study|Withdrawal by Subject|1
6986309|NCT01271504|11043837|FG003|Overall Study|Withdrawal by Subject|3
6986310|NCT01271504|11043834|FG000|Overall Study|Other|0
6986311|NCT01271504|11043835|FG001|Overall Study|Other|1
6986312|NCT01271504|11043836|FG002|Overall Study|Other|2
6986313|NCT01271504|11043837|FG003|Overall Study|Other|0
6986314|NCT01271712|11043873|FG000|Double Blind Treatment|Death|2
6986315|NCT01271712|11043874|FG001|Double Blind Treatment|Death|0
6986316|NCT01271712|11043873|FG000|Double Blind Treatment|Lack of Efficacy|1
6986317|NCT01271712|11043874|FG001|Double Blind Treatment|Lack of Efficacy|0
6986318|NCT01271712|11043873|FG000|Double Blind Treatment|Adverse Event|9
6986319|NCT01271712|11043874|FG001|Double Blind Treatment|Adverse Event|4
6986320|NCT01271712|11043873|FG000|Double Blind Treatment|Progressive disease|23
6986321|NCT01271712|11043874|FG001|Double Blind Treatment|Progressive disease|3
6986322|NCT01271712|11043873|FG000|Double Blind Treatment|Withdrawal by Subject|4
6986323|NCT01271712|11043874|FG001|Double Blind Treatment|Withdrawal by Subject|1
6986324|NCT01271712|11043873|FG000|Double Blind Treatment|Non compliance with study drug|2
6986325|NCT01271712|11043874|FG001|Double Blind Treatment|Non compliance with study drug|0
6986326|NCT01271712|11043873|FG000|Double Blind Treatment|receive no study drug|1
6986327|NCT01271712|11043874|FG001|Double Blind Treatment|receive no study drug|0
6986328|NCT01271712|11043873|FG000|Open Label Treatment|Death|6
6986329|NCT01271712|11043874|FG001|Open Label Treatment|Death|5
6986330|NCT01271712|11043873|FG000|Open Label Treatment|Withdrawal by Subject|6
6986331|NCT01271712|11043874|FG001|Open Label Treatment|Withdrawal by Subject|11
6986332|NCT01271712|11043873|FG000|Open Label Treatment|Physician Decision|2
6986333|NCT01271712|11043874|FG001|Open Label Treatment|Physician Decision|0
6986334|NCT01271712|11043873|FG000|Open Label Treatment|Adverse Event|14
6986335|NCT01271712|11043874|FG001|Open Label Treatment|Adverse Event|8
6986336|NCT01271712|11043873|FG000|Open Label Treatment|Progressive disease|59
6986337|NCT01271712|11043874|FG001|Open Label Treatment|Progressive disease|32
6986338|NCT01271712|11043873|FG000|Open Label Treatment|transferred to rollover study|1
6986339|NCT01271712|11043874|FG001|Open Label Treatment|transferred to rollover study|0
6986340|NCT01271712|11043873|FG000|Open Label Treatment|Non-compliance with study drug|1
6986341|NCT01271712|11043874|FG001|Open Label Treatment|Non-compliance with study drug|0
6986342|NCT01271712|11043873|FG000|Open Label Treatment|Protocol Violation|0
6986343|NCT01271712|11043874|FG001|Open Label Treatment|Protocol Violation|1
6986344|NCT01271712|11043873|FG000|Open Label Treatment|Switching to other therapy|2
6986345|NCT01271712|11043874|FG001|Open Label Treatment|Switching to other therapy|1
6986346|NCT01271712|11043873|FG000|Safety Follow-up|Death|11
6986347|NCT01271712|11043874|FG001|Safety Follow-up|Death|7
6986348|NCT01271712|11043873|FG000|Safety Follow-up|Withdrawal by Subject|4
6986349|NCT01271712|11043874|FG001|Safety Follow-up|Withdrawal by Subject|2
6986350|NCT01271712|11043873|FG000|Safety Follow-up|Protocol Violation|1
6986351|NCT01271712|11043874|FG001|Safety Follow-up|Protocol Violation|1
6986352|NCT01271712|11043873|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3
6986353|NCT01271712|11043874|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4
6986354|NCT01271712|11043873|FG000|Safety Follow-up|No follow-up|1
6986355|NCT01271712|11043874|FG001|Safety Follow-up|No follow-up|1
6986356|NCT01271712|11043873|FG000|Safety Follow-up|Progressive disease|1
6986357|NCT01271712|11043874|FG001|Safety Follow-up|Progressive disease|0
6986358|NCT01271712|11043873|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15
6986359|NCT01271712|11043874|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6
6986360|NCT01271725|11043883|FG000|Part A|Progressive disease according to RECIST|8
6986361|NCT01271725|11043884|FG001|Part A|Progressive disease according to RECIST|0
6986362|NCT01271725|11043883|FG000|Part A|Clinical signs/symptoms of progression|2
6986363|NCT01271725|11043884|FG001|Part A|Clinical signs/symptoms of progression|0
6986364|NCT01271725|11043883|FG000|Part A|Other Adverse Event|8
6986365|NCT01271725|11043884|FG001|Part A|Other Adverse Event|0
6986366|NCT01271725|11043883|FG000|Part A|Lost to Follow-up|1
6986367|NCT01271725|11043884|FG001|Part A|Lost to Follow-up|0
6986368|NCT01271725|11043883|FG000|Part A|Withdrawal by Subject|12
6986369|NCT01271725|11043884|FG001|Part A|Withdrawal by Subject|0
6986370|NCT01271725|11043883|FG000|Part A|Other than specified|3
6986371|NCT01271725|11043884|FG001|Part A|Other than specified|0
6986372|NCT01271725|11043883|FG000|Part A|Protocol Violation|1
6986373|NCT01271725|11043884|FG001|Part A|Protocol Violation|0
6986374|NCT01271725|11043883|FG000|Part B|Other than specified|0
6986375|NCT01271725|11043884|FG001|Part B|Other than specified|2
6986376|NCT01271725|11043883|FG000|Part B|Clinical signs/symptoms of progression|0
6986377|NCT01271725|11043884|FG001|Part B|Clinical signs/symptoms of progression|2
6986378|NCT01271725|11043883|FG000|Part B|Other Adverse Event|0
6986379|NCT01271725|11043884|FG001|Part B|Other Adverse Event|1
6986380|NCT01271725|11043883|FG000|Part B|Protocol Violation|0
6986381|NCT01271725|11043884|FG001|Part B|Protocol Violation|1
6986382|NCT01271725|11043883|FG000|Part B|Withdrawal by Subject|0
6986383|NCT01271725|11043884|FG001|Part B|Withdrawal by Subject|6
6986384|NCT01271803|11043896|FG000|Overall Study|Progressive disease|0
6986385|NCT01271803|11043897|FG001|Overall Study|Progressive disease|0
6986386|NCT01271803|11043898|FG002|Overall Study|Progressive disease|2
6986387|NCT01271803|11043896|FG000|Overall Study|Death|53
6986388|NCT01271803|11043897|FG001|Overall Study|Death|34
6986389|NCT01271803|11043898|FG002|Overall Study|Death|0
6986390|NCT01271803|11043896|FG000|Overall Study|Withdrawal by Subject|1
6986391|NCT01271803|11043897|FG001|Overall Study|Withdrawal by Subject|5
6986392|NCT01271803|11043898|FG002|Overall Study|Withdrawal by Subject|0
6986393|NCT01271803|11043896|FG000|Overall Study|Lost to Follow-up|1
6986394|NCT01271803|11043897|FG001|Overall Study|Lost to Follow-up|0
6986395|NCT01271803|11043898|FG002|Overall Study|Lost to Follow-up|0
6986396|NCT01271933|11043971|FG000|Single-Blind Phase|Lack of Efficacy|37
6986397|NCT01271933|11043972|FG001|Single-Blind Phase|Lack of Efficacy|0
6986398|NCT01271933|11043973|FG002|Single-Blind Phase|Lack of Efficacy|0
6986399|NCT01271933|11043971|FG000|Single-Blind Phase|Lost to Follow-up|10
6986400|NCT01271933|11043972|FG001|Single-Blind Phase|Lost to Follow-up|0
6986401|NCT01271933|11043973|FG002|Single-Blind Phase|Lost to Follow-up|0
6986402|NCT01271933|11043971|FG000|Single-Blind Phase|Withdrawal by Subject|15
6986403|NCT01271933|11043972|FG001|Single-Blind Phase|Withdrawal by Subject|0
6986404|NCT01271933|11043973|FG002|Single-Blind Phase|Withdrawal by Subject|0
6986405|NCT01271933|11043971|FG000|Single-Blind Phase|Protocol Violation|3
6986406|NCT01271933|11043972|FG001|Single-Blind Phase|Protocol Violation|0
6986407|NCT01271933|11043973|FG002|Single-Blind Phase|Protocol Violation|0
6986408|NCT01271933|11043971|FG000|Single-Blind Phase|Adverse Event|52
6986409|NCT01271933|11043972|FG001|Single-Blind Phase|Adverse Event|0
6986410|NCT01271933|11043973|FG002|Single-Blind Phase|Adverse Event|0
6986411|NCT01271933|11043971|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1
6986412|NCT01271933|11043972|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0
6986413|NCT01271933|11043973|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0
6986414|NCT01271933|11043971|FG000|Single-Blind Phase|(Protocol non-compliance)|2
6986415|NCT01271933|11043972|FG001|Single-Blind Phase|(Protocol non-compliance)|0
6986416|NCT01271933|11043973|FG002|Single-Blind Phase|(Protocol non-compliance)|0
6986417|NCT01271933|11043971|FG000|Single-Blind Phase|(Participant request-personal reason)|1
6986418|NCT01271933|11043972|FG001|Single-Blind Phase|(Participant request-personal reason)|0
6986419|NCT01271933|11043973|FG002|Single-Blind Phase|(Participant request-personal reason)|0
6986420|NCT01271933|11043971|FG000|Double-Blind Phase|Randomized but not treated|0
6986421|NCT01271933|11043972|FG001|Double-Blind Phase|Randomized but not treated|0
6986422|NCT01271933|11043973|FG002|Double-Blind Phase|Randomized but not treated|1
6986423|NCT01271933|11043971|FG000|Double-Blind Phase|Lack of Efficacy|0
6986424|NCT01271933|11043972|FG001|Double-Blind Phase|Lack of Efficacy|6
6986425|NCT01271933|11043973|FG002|Double-Blind Phase|Lack of Efficacy|9
6986426|NCT01271933|11043971|FG000|Double-Blind Phase|Lost to Follow-up|0
6986427|NCT01271933|11043972|FG001|Double-Blind Phase|Lost to Follow-up|1
6986428|NCT01271933|11043973|FG002|Double-Blind Phase|Lost to Follow-up|1
6986429|NCT01271933|11043971|FG000|Double-Blind Phase|Withdrawal by Subject|0
6986430|NCT01271933|11043972|FG001|Double-Blind Phase|Withdrawal by Subject|6
6986431|NCT01271933|11043973|FG002|Double-Blind Phase|Withdrawal by Subject|1
6986432|NCT01271933|11043971|FG000|Double-Blind Phase|Adverse Event|0
6986433|NCT01271933|11043972|FG001|Double-Blind Phase|Adverse Event|3
6986434|NCT01271933|11043973|FG002|Double-Blind Phase|Adverse Event|0
6986435|NCT01271933|11043971|FG000|Double-Blind Phase|Participant request-personal reason|0
6986436|NCT01271933|11043972|FG001|Double-Blind Phase|Participant request-personal reason|1
6986437|NCT01271933|11043973|FG002|Double-Blind Phase|Participant request-personal reason|0
6986438|NCT01272011|11044009|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0
6986439|NCT01272011|11044010|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2
6986440|NCT01272011|11044011|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0
6986441|NCT01272180|11044027|FG000|Overall Study|Adverse Event|0
6986442|NCT01272180|11044028|FG001|Overall Study|Adverse Event|0
6986443|NCT01272180|11044029|FG002|Overall Study|Adverse Event|1
6986444|NCT01272180|11044030|FG003|Overall Study|Adverse Event|0
6986445|NCT01272180|11044027|FG000|Overall Study|Withdrawal by Subject|2
6986446|NCT01272180|11044028|FG001|Overall Study|Withdrawal by Subject|6
6986447|NCT01272180|11044029|FG002|Overall Study|Withdrawal by Subject|3
6986448|NCT01272180|11044030|FG003|Overall Study|Withdrawal by Subject|2
6986449|NCT01272180|11044027|FG000|Overall Study|Lost to Follow-up|15
6986450|NCT01272180|11044028|FG001|Overall Study|Lost to Follow-up|14
6986451|NCT01272180|11044029|FG002|Overall Study|Lost to Follow-up|8
6986452|NCT01272180|11044030|FG003|Overall Study|Lost to Follow-up|10
6986453|NCT01272180|11044027|FG000|Overall Study|Inappropriate enrollment|0
6986454|NCT01272180|11044028|FG001|Overall Study|Inappropriate enrollment|0
6986455|NCT01272180|11044029|FG002|Overall Study|Inappropriate enrollment|1
6986456|NCT01272180|11044030|FG003|Overall Study|Inappropriate enrollment|1
6986457|NCT01272180|11044027|FG000|Overall Study|Protocol Violation|0
6986458|NCT01272180|11044028|FG001|Overall Study|Protocol Violation|1
6986459|NCT01272180|11044029|FG002|Overall Study|Protocol Violation|0
6986460|NCT01272180|11044030|FG003|Overall Study|Protocol Violation|1
6986461|NCT01272193|11044046|FG000|Overall Study|Adverse Event|1
6986462|NCT01272193|11044047|FG001|Overall Study|Adverse Event|1
6986463|NCT01272193|11044046|FG000|Overall Study|Lack of Efficacy|0
6986464|NCT01272193|11044047|FG001|Overall Study|Lack of Efficacy|3
6986465|NCT01272193|11044046|FG000|Overall Study|Withdrawal Criteria|1
6986466|NCT01272193|11044047|FG001|Overall Study|Withdrawal Criteria|1
6986467|NCT01272193|11044046|FG000|Overall Study|Unclassified|8
6986468|NCT01272193|11044047|FG001|Overall Study|Unclassified|7
6986469|NCT01272219|11044057|FG000|Main Period: Week 0 to Week 56|Adverse Event|86
6986470|NCT01272219|11044058|FG001|Main Period: Week 0 to Week 56|Adverse Event|0
6986471|NCT01272219|11044059|FG002|Main Period: Week 0 to Week 56|Adverse Event|0
6986472|NCT01272219|11044060|FG003|Main Period: Week 0 to Week 56|Adverse Event|16
6986473|NCT01272219|11044061|FG004|Main Period: Week 0 to Week 56|Adverse Event|152
6986474|NCT01272219|11044062|FG005|Main Period: Week 0 to Week 56|Adverse Event|29
6986475|NCT01272219|11044057|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11
6986476|NCT01272219|11044058|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0
6986477|NCT01272219|11044059|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0
6986478|NCT01272219|11044060|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14
6986479|NCT01272219|11044061|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12
6986480|NCT01272219|11044062|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22
6986481|NCT01272219|11044057|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25
6986482|NCT01272219|11044058|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0
6986483|NCT01272219|11044059|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0
6986484|NCT01272219|11044060|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18
6986485|NCT01272219|11044061|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40
6986486|NCT01272219|11044062|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20
6986487|NCT01272219|11044057|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122
6986488|NCT01272219|11044058|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0
6986489|NCT01272219|11044059|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0
6986490|NCT01272219|11044060|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114
6986491|NCT01272219|11044061|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172
6986492|NCT01272219|11044062|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147
6986493|NCT01272219|11044057|FG000|Main Period: Week 0 to Week 56|Unclassified|36
6986494|NCT01272219|11044058|FG001|Main Period: Week 0 to Week 56|Unclassified|0
6986495|NCT01272219|11044059|FG002|Main Period: Week 0 to Week 56|Unclassified|0
6986496|NCT01272219|11044060|FG003|Main Period: Week 0 to Week 56|Unclassified|29
6986497|NCT01272219|11044061|FG004|Main Period: Week 0 to Week 56|Unclassified|42
6986498|NCT01272219|11044062|FG005|Main Period: Week 0 to Week 56|Unclassified|34
6986499|NCT01272219|11044057|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
6986500|NCT01272219|11044058|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
6986501|NCT01272219|11044059|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
6986502|NCT01272219|11044060|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2
6986503|NCT01272219|11044061|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
6986504|NCT01272219|11044062|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
6986505|NCT01272219|11044057|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
6986506|NCT01272219|11044058|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
6986507|NCT01272219|11044059|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
6986508|NCT01272219|11044060|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1
6986509|NCT01272219|11044061|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
6986510|NCT01272219|11044062|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
6986511|NCT01272219|11044057|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
6986512|NCT01272219|11044058|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1
6986513|NCT01272219|11044059|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
6986514|NCT01272219|11044060|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3
6986515|NCT01272219|11044061|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
6986516|NCT01272219|11044062|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
6986517|NCT01272219|11044057|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
6986518|NCT01272219|11044058|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6
6986519|NCT01272219|11044059|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4
6986520|NCT01272219|11044060|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7
6986521|NCT01272219|11044061|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
6986522|NCT01272219|11044062|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
6986523|NCT01272219|11044057|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0
6986524|NCT01272219|11044058|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1
6986525|NCT01272219|11044059|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2
6986526|NCT01272219|11044060|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2
6986527|NCT01272219|11044061|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0
6986528|NCT01272219|11044062|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0
6986529|NCT01272219|11044057|FG000|Main + Extension Period: Week 0-172|Adverse Event|0
6986530|NCT01272219|11044058|FG001|Main + Extension Period: Week 0-172|Adverse Event|0
6986531|NCT01272219|11044059|FG002|Main + Extension Period: Week 0-172|Adverse Event|0
6986532|NCT01272219|11044060|FG003|Main + Extension Period: Week 0-172|Adverse Event|0
6986533|NCT01272219|11044061|FG004|Main + Extension Period: Week 0-172|Adverse Event|191
6986534|NCT01272219|11044062|FG005|Main + Extension Period: Week 0-172|Adverse Event|43
6986535|NCT01272219|11044057|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0
6986536|NCT01272219|11044058|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0
6986537|NCT01272219|11044059|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0
6986538|NCT01272219|11044060|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0
6986539|NCT01272219|11044061|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29
6986540|NCT01272219|11044062|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36
6986541|NCT01272219|11044057|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0
6986542|NCT01272219|11044058|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0
6986543|NCT01272219|11044059|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0
6986544|NCT01272219|11044060|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0
6986545|NCT01272219|11044061|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76
6986546|NCT01272219|11044062|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36
6986547|NCT01272219|11044057|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0
6986548|NCT01272219|11044058|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0
6986549|NCT01272219|11044059|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0
6986550|NCT01272219|11044060|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0
6986551|NCT01272219|11044061|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364
6986552|NCT01272219|11044062|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256
6986553|NCT01272219|11044057|FG000|Main + Extension Period: Week 0-172|Missing reason|0
6986554|NCT01272219|11044058|FG001|Main + Extension Period: Week 0-172|Missing reason|0
6986555|NCT01272219|11044059|FG002|Main + Extension Period: Week 0-172|Missing reason|0
6986556|NCT01272219|11044060|FG003|Main + Extension Period: Week 0-172|Missing reason|0
6986557|NCT01272219|11044061|FG004|Main + Extension Period: Week 0-172|Missing reason|1
6986558|NCT01272219|11044062|FG005|Main + Extension Period: Week 0-172|Missing reason|0
6986559|NCT01272219|11044057|FG000|Main + Extension Period: Week 0-172|Unclassified|0
6986560|NCT01272219|11044058|FG001|Main + Extension Period: Week 0-172|Unclassified|0
6986561|NCT01272219|11044059|FG002|Main + Extension Period: Week 0-172|Unclassified|0
6986562|NCT01272219|11044060|FG003|Main + Extension Period: Week 0-172|Unclassified|0
6986563|NCT01272219|11044061|FG004|Main + Extension Period: Week 0-172|Unclassified|61
6986564|NCT01272219|11044062|FG005|Main + Extension Period: Week 0-172|Unclassified|51
6986565|NCT01272232|11044078|FG000|Weeks 0-56|Adverse Event|39
6986566|NCT01272232|11044079|FG001|Weeks 0-56|Adverse Event|18
6986567|NCT01272232|11044080|FG002|Weeks 0-56|Adverse Event|7
6986568|NCT01272232|11044078|FG000|Weeks 0-56|Lack of Efficacy|0
6986569|NCT01272232|11044079|FG001|Weeks 0-56|Lack of Efficacy|0
6986570|NCT01272232|11044080|FG002|Weeks 0-56|Lack of Efficacy|3
6986571|NCT01272232|11044078|FG000|Weeks 0-56|Protocol Violation|12
6986572|NCT01272232|11044079|FG001|Weeks 0-56|Protocol Violation|8
6986573|NCT01272232|11044080|FG002|Weeks 0-56|Protocol Violation|13
6986574|NCT01272232|11044078|FG000|Weeks 0-56|Withdrawal criteria|32
6986575|NCT01272232|11044079|FG001|Weeks 0-56|Withdrawal criteria|14
6986576|NCT01272232|11044080|FG002|Weeks 0-56|Withdrawal criteria|37
6986577|NCT01272232|11044078|FG000|Weeks 0-56|Unclassified|16
6986578|NCT01272232|11044079|FG001|Weeks 0-56|Unclassified|7
6986579|NCT01272232|11044080|FG002|Weeks 0-56|Unclassified|12
6986580|NCT01272232|11044078|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
6986581|NCT01272232|11044079|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
6986582|NCT01272232|11044080|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0
6986583|NCT01272232|11044078|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1
6986584|NCT01272232|11044079|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
6986585|NCT01272232|11044080|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
6986586|NCT01272232|11044078|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
6986587|NCT01272232|11044079|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0
6986588|NCT01272232|11044080|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
6986589|NCT01272232|11044078|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9
6986590|NCT01272232|11044079|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7
6986591|NCT01272232|11044080|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4
6986592|NCT01272232|11044078|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
6986593|NCT01272232|11044079|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
6986594|NCT01272232|11044080|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0
7042065|NCT04537234|11126104|FG000|Overall Study|Withdrawal by Subject|2
7042066|NCT04537234|11126105|FG001|Overall Study|Withdrawal by Subject|0
7042067|NCT03478956|11126141|FG000|Overall Study|Adverse Event|1
7042068|NCT03478956|11126142|FG001|Overall Study|Adverse Event|0
7042069|NCT03478956|11126141|FG000|Overall Study|Withdrawal by Subject|0
7042070|NCT03478956|11126142|FG001|Overall Study|Withdrawal by Subject|1
7042071|NCT03478956|11126141|FG000|Overall Study|Ongoing in the Study|11
7042072|NCT03478956|11126142|FG001|Overall Study|Ongoing in the Study|11
7042073|NCT03348930|11126148|FG000|Washout (1 Week)|Lost to Follow-up|1
7042074|NCT03348930|11126149|FG001|Washout (1 Week)|Lost to Follow-up|1
7042075|NCT03282240|11126158|FG000|Overall Study|Adverse Event|2
7042076|NCT03282240|11126159|FG001|Overall Study|Adverse Event|2
7042077|NCT03282240|11126160|FG002|Overall Study|Adverse Event|0
7042078|NCT03282240|11126158|FG000|Overall Study|Lost to Follow-up|3
7042079|NCT03282240|11126159|FG001|Overall Study|Lost to Follow-up|0
7042080|NCT03282240|11126160|FG002|Overall Study|Lost to Follow-up|0
7042081|NCT03282240|11126158|FG000|Overall Study|Protocol Deviation|4
7042082|NCT03282240|11126159|FG001|Overall Study|Protocol Deviation|1
7042083|NCT03282240|11126160|FG002|Overall Study|Protocol Deviation|2
7042084|NCT03282240|11126158|FG000|Overall Study|Withdrawal by Subject|1
7042085|NCT03282240|11126159|FG001|Overall Study|Withdrawal by Subject|0
7042086|NCT03282240|11126160|FG002|Overall Study|Withdrawal by Subject|1
7042087|NCT03260868|11126173|FG000|Overall Study|Poor Compliance to Protocol|0
7042088|NCT03260868|11126174|FG001|Overall Study|Poor Compliance to Protocol|2
7042089|NCT03260868|11126173|FG000|Overall Study|Study Terminated By Sponsor|2
7042090|NCT03260868|11126174|FG001|Overall Study|Study Terminated By Sponsor|1
7042091|NCT03260868|11126173|FG000|Overall Study|Other than specified above|1
7042092|NCT03260868|11126174|FG001|Overall Study|Other than specified above|0
7042093|NCT03157037|11126189|FG000|Overall Study|Death|1
7042094|NCT03128931|11126213|FG000|Overall Study|Physician Decision|1
7042095|NCT03128931|11126213|FG000|Overall Study|Equipment Issues|3
7042096|NCT02498392|11126219|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7
7042097|NCT02498392|11126220|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0
7042098|NCT02498392|11126219|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3
7042099|NCT02498392|11126220|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0
7042100|NCT02498392|11126219|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0
7042101|NCT02498392|11126220|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2
7042102|NCT02498392|11126219|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0
7042103|NCT02498392|11126220|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2
7042104|NCT02498392|11126219|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2
7042105|NCT02498392|11126220|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3
7042106|NCT02498392|11126219|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1
7042107|NCT02498392|11126220|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3
7042108|NCT01899729|11126245|FG000|Overall Study|Adverse Event|1
7042109|NCT01899729|11126246|FG001|Overall Study|Adverse Event|0
7042110|NCT01899729|11126247|FG002|Overall Study|Adverse Event|0
7042111|NCT01899729|11126248|FG003|Overall Study|Adverse Event|0
7042112|NCT01899729|11126249|FG004|Overall Study|Adverse Event|1
7042113|NCT01899729|11126245|FG000|Overall Study|Withdrawal by Subject|1
7042114|NCT01899729|11126246|FG001|Overall Study|Withdrawal by Subject|2
7042115|NCT01899729|11126247|FG002|Overall Study|Withdrawal by Subject|0
7042116|NCT01899729|11126248|FG003|Overall Study|Withdrawal by Subject|0
7042117|NCT01899729|11126249|FG004|Overall Study|Withdrawal by Subject|0
7042118|NCT01899729|11126245|FG000|Overall Study|Lack of Efficacy|0
7042119|NCT01899729|11126246|FG001|Overall Study|Lack of Efficacy|0
7042120|NCT01899729|11126247|FG002|Overall Study|Lack of Efficacy|2
7042121|NCT01899729|11126248|FG003|Overall Study|Lack of Efficacy|0
7042122|NCT01899729|11126249|FG004|Overall Study|Lack of Efficacy|1
7042123|NCT01648205|11126270|FG000|Placebo|Pregnancy|1
7042124|NCT01648205|11126270|FG000|Placebo|Withdrawal by Subject|1
7042125|NCT01648205|11126270|FG000|Placebo|Protocol Violation|2
7042126|NCT01648205|11126270|FG000|Ranolazine|Death|1
7042127|NCT01648205|11126270|FG000|Ranolazine|Withdrawal by Subject|1
7042128|NCT01648205|11126270|FG000|Ranolazine|Protocol Violation|3
6986595|NCT01272635|11044119|FG000|Overall Study|Lost to Follow-up|31
6986596|NCT01272635|11044120|FG001|Overall Study|Lost to Follow-up|20
6986597|NCT01272635|11044121|FG002|Overall Study|Lost to Follow-up|31
6986598|NCT01272635|11044122|FG003|Overall Study|Lost to Follow-up|23
6986599|NCT01272661|11044133|FG000|Overall Study|lost to followup/case closed/ no birth|126
6986600|NCT01272661|11044134|FG001|Overall Study|lost to followup/case closed/ no birth|209
6986601|NCT01272661|11044135|FG002|Overall Study|lost to followup/case closed/ no birth|72
6986602|NCT01272804|11044149|FG000|Overall Study|Adverse Event|1
6986603|NCT01272804|11044150|FG001|Overall Study|Adverse Event|0
6986604|NCT01272804|11044151|FG002|Overall Study|Adverse Event|0
6986605|NCT01272804|11044152|FG003|Overall Study|Adverse Event|0
6986606|NCT01272804|11044153|FG004|Overall Study|Adverse Event|2
6986607|NCT01272804|11044154|FG005|Overall Study|Adverse Event|1
6986608|NCT01272869|11044179|FG000|Period 2 (14 Days)|Adverse Event|1
6986609|NCT01272869|11044180|FG001|Period 2 (14 Days)|Adverse Event|0
6986610|NCT01272908|11044190|FG000|Initial Treatment Period|Adverse Event|1
6986611|NCT01272908|11044190|FG000|Initial Treatment Period|Lack of Efficacy|5
6986612|NCT01272908|11044190|FG000|Initial Treatment Period|Protocol Violation|1
6986613|NCT01272908|11044190|FG000|Initial Treatment Period|Withdrawal by Subject|1
6986614|NCT01272908|11044190|FG000|Re-Treatment Period|Adverse Event|2
6986615|NCT01272908|11044190|FG000|Re-Treatment Period|Lack of Efficacy|3
6986616|NCT01272908|11044190|FG000|Re-Treatment Period|Withdrawal by Subject|1
6986617|NCT01272921|11044198|FG000|Overall Study|Protocol Violation|2
6986618|NCT01272921|11044199|FG001|Overall Study|Protocol Violation|1
6986619|NCT01272934|11044209|FG000|Overall Study|Adverse Event|0
6986620|NCT01272934|11044210|FG001|Overall Study|Adverse Event|1
6986621|NCT01272934|11044209|FG000|Overall Study|Abnormal Laboratory Value|0
6986622|NCT01272934|11044210|FG001|Overall Study|Abnormal Laboratory Value|1
6986623|NCT01272947|11044219|FG000|Overall Study|Abnormal Laboratory Value|2
6986624|NCT01272947|11044220|FG001|Overall Study|Abnormal Laboratory Value|2
6986625|NCT01273038|11044249|FG000|Second Intervention (14 Days)|Adverse Event|0
6986626|NCT01273038|11044250|FG001|Second Intervention (14 Days)|Adverse Event|1
6986627|NCT01273038|11044249|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0
6986628|NCT01273038|11044250|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1
6986629|NCT01273155|11044260|FG000|Overall Study|Off study trmt prior to end of C1/PD|2
6986630|NCT01273155|11044261|FG001|Overall Study|Off study trmt prior to end of C1/PD|3
6986631|NCT01273155|11044262|FG002|Overall Study|Off study trmt prior to end of C1/PD|8
6986632|NCT01273155|11044263|FG003|Overall Study|Off study trmt prior to end of C1/PD|0
6986633|NCT01273155|11044264|FG004|Overall Study|Off study trmt prior to end of C1/PD|0
6986634|NCT01273155|11044265|FG005|Overall Study|Off study trmt prior to end of C1/PD|2
6986635|NCT01273155|11044266|FG006|Overall Study|Off study trmt prior to end of C1/PD|3
6986636|NCT01273155|11044260|FG000|Overall Study|Change in liver function/no longer eval.|0
6986637|NCT01273155|11044261|FG001|Overall Study|Change in liver function/no longer eval.|1
6986638|NCT01273155|11044262|FG002|Overall Study|Change in liver function/no longer eval.|0
6986639|NCT01273155|11044263|FG003|Overall Study|Change in liver function/no longer eval.|0
6986640|NCT01273155|11044264|FG004|Overall Study|Change in liver function/no longer eval.|1
6986641|NCT01273155|11044265|FG005|Overall Study|Change in liver function/no longer eval.|0
6986642|NCT01273155|11044266|FG006|Overall Study|Change in liver function/no longer eval.|0
6986643|NCT01273155|11044260|FG000|Overall Study|Off study prior to C1/due to toxicity|0
6986644|NCT01273155|11044261|FG001|Overall Study|Off study prior to C1/due to toxicity|0
6986645|NCT01273155|11044262|FG002|Overall Study|Off study prior to C1/due to toxicity|2
6986646|NCT01273155|11044263|FG003|Overall Study|Off study prior to C1/due to toxicity|0
6986647|NCT01273155|11044264|FG004|Overall Study|Off study prior to C1/due to toxicity|0
6986648|NCT01273155|11044265|FG005|Overall Study|Off study prior to C1/due to toxicity|0
6986649|NCT01273155|11044266|FG006|Overall Study|Off study prior to C1/due to toxicity|1
6986650|NCT01273155|11044260|FG000|Overall Study|Died during Cycle 1|0
6986651|NCT01273155|11044261|FG001|Overall Study|Died during Cycle 1|0
6986652|NCT01273155|11044262|FG002|Overall Study|Died during Cycle 1|1
6986653|NCT01273155|11044263|FG003|Overall Study|Died during Cycle 1|1
6986654|NCT01273155|11044264|FG004|Overall Study|Died during Cycle 1|0
6986655|NCT01273155|11044265|FG005|Overall Study|Died during Cycle 1|2
6986656|NCT01273155|11044266|FG006|Overall Study|Died during Cycle 1|2
6986657|NCT01273155|11044260|FG000|Overall Study|Withdrew during C1/refused further trmt|0
6986658|NCT01273155|11044261|FG001|Overall Study|Withdrew during C1/refused further trmt|0
6986659|NCT01273155|11044262|FG002|Overall Study|Withdrew during C1/refused further trmt|1
6986660|NCT01273155|11044263|FG003|Overall Study|Withdrew during C1/refused further trmt|0
6986661|NCT01273155|11044264|FG004|Overall Study|Withdrew during C1/refused further trmt|1
6986662|NCT01273155|11044265|FG005|Overall Study|Withdrew during C1/refused further trmt|1
6986663|NCT01273155|11044266|FG006|Overall Study|Withdrew during C1/refused further trmt|0
6986664|NCT01273181|11044293|FG000|Phase I, Dose 1|Study termination|1
6986665|NCT01273181|11044294|FG001|Phase I, Dose 1|Study termination|0
6986666|NCT01273181|11044295|FG002|Phase I, Dose 1|Study termination|0
6986667|NCT01273181|11044296|FG003|Phase I, Dose 1|Study termination|0
6986668|NCT01273181|11044293|FG000|Phase I, Dose 2|Death during treatment|0
6986669|NCT01273181|11044294|FG001|Phase I, Dose 2|Death during treatment|1
6986670|NCT01273181|11044295|FG002|Phase I, Dose 2|Death during treatment|0
6986671|NCT01273181|11044296|FG003|Phase I, Dose 2|Death during treatment|0
6986672|NCT01273181|11044293|FG000|Phase 2, Dose 1|Study termination|0
6986673|NCT01273181|11044294|FG001|Phase 2, Dose 1|Study termination|0
6986674|NCT01273181|11044295|FG002|Phase 2, Dose 1|Study termination|1
6986675|NCT01273181|11044296|FG003|Phase 2, Dose 1|Study termination|0
6986676|NCT01273181|11044293|FG000|Phase 2, Dose 2|Death during treatment|0
6986677|NCT01273181|11044294|FG001|Phase 2, Dose 2|Death during treatment|0
6986678|NCT01273181|11044295|FG002|Phase 2, Dose 2|Death during treatment|0
6986679|NCT01273181|11044296|FG003|Phase 2, Dose 2|Death during treatment|1
6986680|NCT01273519|11044317|FG000|Overall Study|Adverse Event|3
6986681|NCT01273519|11044318|FG001|Overall Study|Adverse Event|0
6986682|NCT01273519|11044319|FG002|Overall Study|Adverse Event|0
6986683|NCT01273519|11044317|FG000|Overall Study|Lost to Follow-up|2
6986684|NCT01273519|11044318|FG001|Overall Study|Lost to Follow-up|1
6986685|NCT01273519|11044319|FG002|Overall Study|Lost to Follow-up|3
6986686|NCT01273519|11044317|FG000|Overall Study|Lack of Efficacy|8
6986687|NCT01273519|11044318|FG001|Overall Study|Lack of Efficacy|3
6986688|NCT01273519|11044319|FG002|Overall Study|Lack of Efficacy|4
6986689|NCT01273519|11044317|FG000|Overall Study|Other|6
6986690|NCT01273519|11044318|FG001|Overall Study|Other|1
6986691|NCT01273519|11044319|FG002|Overall Study|Other|1
6986692|NCT01273597|11044330|FG000|Overall Study|Adverse Event|5
6986693|NCT01273597|11044330|FG000|Overall Study|Underwent Kidney Transplantation|2
6986694|NCT01273597|11044330|FG000|Overall Study|Reason Not Reported|1
6986695|NCT01273623|11044334|FG000|Overall Study|did not meet IVUS criteria|29
6986696|NCT01273805|11044354|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10
6986697|NCT01273805|11044355|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10
6986698|NCT01273818|11044364|FG000|Overall Study|Physician Decision|13
6986699|NCT01273818|11044365|FG001|Overall Study|Physician Decision|2
6986700|NCT01273818|11044366|FG002|Overall Study|Physician Decision|9
6986701|NCT01273883|11044383|FG000|First Intervention|Adverse Event|2
6986702|NCT01273883|11044384|FG001|First Intervention|Adverse Event|1
6986703|NCT01273883|11044383|FG000|Second Intervention|Lost to Follow-up|1
6986704|NCT01273883|11044384|FG001|Second Intervention|Lost to Follow-up|1
6986705|NCT01273883|11044383|FG000|Second Intervention|Lack of Efficacy|1
6986706|NCT01273883|11044384|FG001|Second Intervention|Lack of Efficacy|0
6986707|NCT01274182|11044397|FG000|Overall Study|Unsatisfactory therapeutic effect|6
6986708|NCT01274182|11044398|FG001|Overall Study|Unsatisfactory therapeutic effect|3
6986709|NCT01274182|11044399|FG002|Overall Study|Unsatisfactory therapeutic effect|4
6986710|NCT01274182|11044397|FG000|Overall Study|Adverse Event|4
6986711|NCT01274182|11044398|FG001|Overall Study|Adverse Event|5
6986712|NCT01274182|11044399|FG002|Overall Study|Adverse Event|3
6986713|NCT01274182|11044397|FG000|Overall Study|Withdrawal by Subject|5
6986714|NCT01274182|11044398|FG001|Overall Study|Withdrawal by Subject|5
6986715|NCT01274182|11044399|FG002|Overall Study|Withdrawal by Subject|3
6986716|NCT01274182|11044397|FG000|Overall Study|Lost to Follow-up|2
6986717|NCT01274182|11044398|FG001|Overall Study|Lost to Follow-up|3
6986718|NCT01274182|11044399|FG002|Overall Study|Lost to Follow-up|1
6986719|NCT01274182|11044397|FG000|Overall Study|Protocol Violation|3
6986720|NCT01274182|11044398|FG001|Overall Study|Protocol Violation|2
6986721|NCT01274182|11044399|FG002|Overall Study|Protocol Violation|0
6986722|NCT01274182|11044397|FG000|Overall Study|Death|1
6986723|NCT01274182|11044398|FG001|Overall Study|Death|0
6986724|NCT01274182|11044399|FG002|Overall Study|Death|1
6986725|NCT01274338|11044417|FG000|Overall Study|Lack of Efficacy|72
6986726|NCT01274338|11044418|FG001|Overall Study|Lack of Efficacy|108
6986727|NCT01274338|11044419|FG002|Overall Study|Lack of Efficacy|116
6986728|NCT01274338|11044420|FG003|Overall Study|Lack of Efficacy|0
6986729|NCT01274338|11044421|FG004|Overall Study|Lack of Efficacy|0
6986730|NCT01274338|11044422|FG005|Overall Study|Lack of Efficacy|0
6986731|NCT01274338|11044417|FG000|Overall Study|Adverse Event|272
6986732|NCT01274338|11044418|FG001|Overall Study|Adverse Event|105
6986733|NCT01274338|11044419|FG002|Overall Study|Adverse Event|180
6986734|NCT01274338|11044420|FG003|Overall Study|Adverse Event|1
6986735|NCT01274338|11044421|FG004|Overall Study|Adverse Event|0
6986736|NCT01274338|11044422|FG005|Overall Study|Adverse Event|0
6986737|NCT01274338|11044417|FG000|Overall Study|Death|8
6986738|NCT01274338|11044418|FG001|Overall Study|Death|1
6986739|NCT01274338|11044419|FG002|Overall Study|Death|0
6986740|NCT01274338|11044420|FG003|Overall Study|Death|0
6986741|NCT01274338|11044421|FG004|Overall Study|Death|0
6986742|NCT01274338|11044422|FG005|Overall Study|Death|0
6986743|NCT01274338|11044417|FG000|Overall Study|Withdrawal by Subject|27
6986744|NCT01274338|11044418|FG001|Overall Study|Withdrawal by Subject|99
6986745|NCT01274338|11044419|FG002|Overall Study|Withdrawal by Subject|17
6986746|NCT01274338|11044420|FG003|Overall Study|Withdrawal by Subject|0
6986747|NCT01274338|11044421|FG004|Overall Study|Withdrawal by Subject|0
6986748|NCT01274338|11044422|FG005|Overall Study|Withdrawal by Subject|0
6986749|NCT01274338|11044417|FG000|Overall Study|Did not start treatment|8
6986750|NCT01274338|11044418|FG001|Overall Study|Did not start treatment|116
6986751|NCT01274338|11044419|FG002|Overall Study|Did not start treatment|7
6986752|NCT01274338|11044420|FG003|Overall Study|Did not start treatment|0
6986753|NCT01274338|11044421|FG004|Overall Study|Did not start treatment|0
6986754|NCT01274338|11044422|FG005|Overall Study|Did not start treatment|0
6986755|NCT01274338|11044417|FG000|Overall Study|Alternative therapy|0
6986756|NCT01274338|11044418|FG001|Overall Study|Alternative therapy|1
6986757|NCT01274338|11044419|FG002|Overall Study|Alternative therapy|0
6986758|NCT01274338|11044420|FG003|Overall Study|Alternative therapy|0
6986759|NCT01274338|11044421|FG004|Overall Study|Alternative therapy|0
6986760|NCT01274338|11044422|FG005|Overall Study|Alternative therapy|0
6986761|NCT01274338|11044417|FG000|Overall Study|Other complicating diseases|0
6986762|NCT01274338|11044418|FG001|Overall Study|Other complicating diseases|3
6986763|NCT01274338|11044419|FG002|Overall Study|Other complicating diseases|1
6986764|NCT01274338|11044420|FG003|Overall Study|Other complicating diseases|0
6986765|NCT01274338|11044421|FG004|Overall Study|Other complicating diseases|0
6986766|NCT01274338|11044422|FG005|Overall Study|Other complicating diseases|0
6986767|NCT01274338|11044417|FG000|Overall Study|Treatment arm was suspended due to toxicity|4
6986768|NCT01274338|11044418|FG001|Overall Study|Treatment arm was suspended due to toxicity|0
6986769|NCT01274338|11044419|FG002|Overall Study|Treatment arm was suspended due to toxicity|0
6986770|NCT01274338|11044420|FG003|Overall Study|Treatment arm was suspended due to toxicity|0
6986771|NCT01274338|11044421|FG004|Overall Study|Treatment arm was suspended due to toxicity|0
6986772|NCT01274338|11044422|FG005|Overall Study|Treatment arm was suspended due to toxicity|0
6986773|NCT01274338|11044417|FG000|Overall Study|Pregnancy|0
6986774|NCT01274338|11044418|FG001|Overall Study|Pregnancy|0
6986775|NCT01274338|11044419|FG002|Overall Study|Pregnancy|1
6986776|NCT01274338|11044420|FG003|Overall Study|Pregnancy|0
6986777|NCT01274338|11044421|FG004|Overall Study|Pregnancy|0
6986778|NCT01274338|11044422|FG005|Overall Study|Pregnancy|0
6986779|NCT01274338|11044417|FG000|Overall Study|Reason not reported|12
6986780|NCT01274338|11044418|FG001|Overall Study|Reason not reported|21
6986781|NCT01274338|11044419|FG002|Overall Study|Reason not reported|3
6986782|NCT01274338|11044420|FG003|Overall Study|Reason not reported|0
6986783|NCT01274338|11044421|FG004|Overall Study|Reason not reported|1
6986784|NCT01274338|11044422|FG005|Overall Study|Reason not reported|0
6986785|NCT01274351|11044435|FG000|Overall Study|Lost to Follow-up|1
6986786|NCT01274351|11044435|FG000|Overall Study|patient not compliant with the protocol|1
6986787|NCT01274351|11044435|FG000|Overall Study|Pregnancy|1
6986788|NCT01274351|11044435|FG000|Overall Study|Death|2
6986789|NCT01274351|11044435|FG000|Overall Study|Withdrawal by Subject|3
6986790|NCT01274351|11044435|FG000|Overall Study|Adverse Event|8
6986791|NCT01274351|11044435|FG000|Overall Study|progression of disease|3
6986792|NCT01274351|11044435|FG000|Overall Study|hospitalization|1
6986793|NCT01274637|11044462|FG000|Overall Study|Withdrawal by Subject|0
6986794|NCT01274637|11044463|FG001|Overall Study|Withdrawal by Subject|1
6986795|NCT01274637|11044462|FG000|Overall Study|Lost to Follow-up|0
6986796|NCT01274637|11044463|FG001|Overall Study|Lost to Follow-up|1
6986797|NCT01274715|11044469|FG000|Overall Study|Lost to Follow-up|1
6986798|NCT01274715|11044469|FG000|Overall Study|After consent, met exclusion criteria.|1
6986799|NCT01274715|11044469|FG000|Overall Study|After consent, met exclusion criteria.|1
6986800|NCT01274715|11044469|FG000|Overall Study|After consent, met exclusion criteria.|1
6986801|NCT01275066|11044489|FG000|Overall Study|Withdrawal by Subject|0
6986802|NCT01275066|11044490|FG001|Overall Study|Withdrawal by Subject|0
6986803|NCT01275066|11044491|FG002|Overall Study|Withdrawal by Subject|1
6986804|NCT01275066|11044489|FG000|Overall Study|Not Diagnosed w/ Disease|1
6986805|NCT01275066|11044490|FG001|Overall Study|Not Diagnosed w/ Disease|0
6986806|NCT01275066|11044491|FG002|Overall Study|Not Diagnosed w/ Disease|0
6986807|NCT01275131|11044507|FG000|Period 1|Withdrawal by Subject|1
6986808|NCT01275131|11044508|FG001|Period 1|Withdrawal by Subject|0
6986809|NCT01275131|11044509|FG002|Period 1|Withdrawal by Subject|3
6986810|NCT01275131|11044510|FG003|Period 1|Withdrawal by Subject|2
6986811|NCT01275131|11044507|FG000|Period 1|Physician Decision|1
6986812|NCT01275131|11044508|FG001|Period 1|Physician Decision|0
6986813|NCT01275131|11044509|FG002|Period 1|Physician Decision|0
6986814|NCT01275131|11044510|FG003|Period 1|Physician Decision|0
6986815|NCT01275131|11044507|FG000|Period 2 (Crossover)|Adverse Event|0
6986816|NCT01275131|11044508|FG001|Period 2 (Crossover)|Adverse Event|1
6986817|NCT01275131|11044509|FG002|Period 2 (Crossover)|Adverse Event|0
6986818|NCT01275131|11044510|FG003|Period 2 (Crossover)|Adverse Event|0
6986819|NCT01275131|11044507|FG000|Period 2 (Crossover)|Withdrawal by Subject|1
6986820|NCT01275131|11044508|FG001|Period 2 (Crossover)|Withdrawal by Subject|0
6986821|NCT01275131|11044509|FG002|Period 2 (Crossover)|Withdrawal by Subject|1
6986822|NCT01275131|11044510|FG003|Period 2 (Crossover)|Withdrawal by Subject|2
6986823|NCT01275144|11044528|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1
6986824|NCT01275144|11044529|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0
6986825|NCT01275170|11044545|FG000|Part 1: Period 1|Equipment malfunction before study drug|1
6986826|NCT01275170|11044546|FG001|Part 1: Period 1|Equipment malfunction before study drug|0
6986827|NCT01275170|11044547|FG002|Part 1: Period 1|Equipment malfunction before study drug|0
6986828|NCT01275170|11044548|FG003|Part 1: Period 1|Equipment malfunction before study drug|0
6986829|NCT01275170|11044549|FG004|Part 1: Period 1|Equipment malfunction before study drug|0
6986830|NCT01275170|11044550|FG005|Part 1: Period 1|Equipment malfunction before study drug|0
6986831|NCT01275170|11044551|FG006|Part 1: Period 1|Equipment malfunction before study drug|0
6986832|NCT01275170|11044552|FG007|Part 1: Period 1|Equipment malfunction before study drug|0
6986833|NCT01275196|11044587|FG000|Overall Study|Adverse Event|3
6986834|NCT01275196|11044588|FG001|Overall Study|Adverse Event|5
6986835|NCT01275196|11044587|FG000|Overall Study|Withdrawal by Subject|4
6986836|NCT01275196|11044588|FG001|Overall Study|Withdrawal by Subject|5
6986837|NCT01275196|11044587|FG000|Overall Study|Lost to Follow-up|1
6986838|NCT01275196|11044588|FG001|Overall Study|Lost to Follow-up|0
6986839|NCT01275196|11044587|FG000|Overall Study|Disease Progression|6
6986840|NCT01275196|11044588|FG001|Overall Study|Disease Progression|5
6986841|NCT01275196|11044587|FG000|Overall Study|Protocol Violation|1
6986842|NCT01275196|11044588|FG001|Overall Study|Protocol Violation|0
6986843|NCT01275196|11044587|FG000|Overall Study|Suboptimal response/treatment failure|5
6986844|NCT01275196|11044588|FG001|Overall Study|Suboptimal response/treatment failure|6
6986845|NCT01275222|11044602|FG000|Phase l by Treatment|Adverse Event|1
6986846|NCT01275222|11044603|FG001|Phase l by Treatment|Adverse Event|4
6986847|NCT01275222|11044604|FG002|Phase l by Treatment|Adverse Event|2
6986848|NCT01275222|11044605|FG003|Phase l by Treatment|Adverse Event|3
6986849|NCT01275222|11044606|FG004|Phase l by Treatment|Adverse Event|0
6986850|NCT01275222|11044607|FG005|Phase l by Treatment|Adverse Event|0
6986851|NCT01275222|11044602|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0
6986852|NCT01275222|11044603|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0
6986853|NCT01275222|11044604|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1
6986854|NCT01275222|11044605|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0
6986855|NCT01275222|11044606|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0
6986856|NCT01275222|11044607|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0
6986857|NCT01275222|11044602|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0
6986858|NCT01275222|11044603|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0
6986859|NCT01275222|11044604|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0
6986860|NCT01275222|11044605|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1
6986861|NCT01275222|11044606|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0
6986862|NCT01275222|11044607|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0
6986863|NCT01275222|11044602|FG000|Phase l by Treatment|Disease progression|12
6986864|NCT01275222|11044603|FG001|Phase l by Treatment|Disease progression|8
6986865|NCT01275222|11044604|FG002|Phase l by Treatment|Disease progression|2
6986866|NCT01275222|11044605|FG003|Phase l by Treatment|Disease progression|5
6986867|NCT01275222|11044606|FG004|Phase l by Treatment|Disease progression|0
6986868|NCT01275222|11044607|FG005|Phase l by Treatment|Disease progression|0
6986869|NCT01275222|11044602|FG000|Phase l by Treatment|Withdrawal by Subject|0
6986870|NCT01275222|11044603|FG001|Phase l by Treatment|Withdrawal by Subject|0
6986871|NCT01275222|11044604|FG002|Phase l by Treatment|Withdrawal by Subject|0
6986872|NCT01275222|11044605|FG003|Phase l by Treatment|Withdrawal by Subject|1
6986873|NCT01275222|11044606|FG004|Phase l by Treatment|Withdrawal by Subject|0
6986874|NCT01275222|11044607|FG005|Phase l by Treatment|Withdrawal by Subject|0
6986875|NCT01275222|11044602|FG000|Phase l by Treatment|Death|0
6986876|NCT01275222|11044603|FG001|Phase l by Treatment|Death|1
6986877|NCT01275222|11044604|FG002|Phase l by Treatment|Death|0
6986878|NCT01275222|11044605|FG003|Phase l by Treatment|Death|1
6986879|NCT01275222|11044606|FG004|Phase l by Treatment|Death|0
6986880|NCT01275222|11044607|FG005|Phase l by Treatment|Death|0
6986881|NCT01275222|11044602|FG000|Phase ll by Stratum|Adverse Event|0
6986882|NCT01275222|11044603|FG001|Phase ll by Stratum|Adverse Event|0
6986883|NCT01275222|11044604|FG002|Phase ll by Stratum|Adverse Event|0
6986884|NCT01275222|11044605|FG003|Phase ll by Stratum|Adverse Event|0
6986885|NCT01275222|11044606|FG004|Phase ll by Stratum|Adverse Event|2
6986886|NCT01275222|11044607|FG005|Phase ll by Stratum|Adverse Event|10
6986887|NCT01275222|11044602|FG000|Phase ll by Stratum|Abnormal laboratory values|0
6986888|NCT01275222|11044603|FG001|Phase ll by Stratum|Abnormal laboratory values|0
6986889|NCT01275222|11044604|FG002|Phase ll by Stratum|Abnormal laboratory values|0
6986890|NCT01275222|11044605|FG003|Phase ll by Stratum|Abnormal laboratory values|0
6986891|NCT01275222|11044606|FG004|Phase ll by Stratum|Abnormal laboratory values|0
6986892|NCT01275222|11044607|FG005|Phase ll by Stratum|Abnormal laboratory values|1
6986893|NCT01275222|11044602|FG000|Phase ll by Stratum|Disease progression|0
6986894|NCT01275222|11044603|FG001|Phase ll by Stratum|Disease progression|0
6986895|NCT01275222|11044604|FG002|Phase ll by Stratum|Disease progression|0
6986896|NCT01275222|11044605|FG003|Phase ll by Stratum|Disease progression|0
6986897|NCT01275222|11044606|FG004|Phase ll by Stratum|Disease progression|23
6986898|NCT01275222|11044607|FG005|Phase ll by Stratum|Disease progression|31
6986899|NCT01275222|11044602|FG000|Phase ll by Stratum|Withdrawal by Subject|0
6986900|NCT01275222|11044603|FG001|Phase ll by Stratum|Withdrawal by Subject|0
6986901|NCT01275222|11044604|FG002|Phase ll by Stratum|Withdrawal by Subject|0
6986902|NCT01275222|11044605|FG003|Phase ll by Stratum|Withdrawal by Subject|0
6986903|NCT01275222|11044606|FG004|Phase ll by Stratum|Withdrawal by Subject|2
6986904|NCT01275222|11044607|FG005|Phase ll by Stratum|Withdrawal by Subject|3
6986905|NCT01275222|11044602|FG000|Phase ll by Stratum|Death|0
6986906|NCT01275222|11044603|FG001|Phase ll by Stratum|Death|0
6986907|NCT01275222|11044604|FG002|Phase ll by Stratum|Death|0
6986908|NCT01275222|11044605|FG003|Phase ll by Stratum|Death|0
6986909|NCT01275222|11044606|FG004|Phase ll by Stratum|Death|1
6986910|NCT01275222|11044607|FG005|Phase ll by Stratum|Death|1
6986911|NCT01275339|11044645|FG000|Overall Study|Referred for surgery for AS symptoms|1
6986912|NCT01275339|11044646|FG001|Overall Study|Referred for surgery for AS symptoms|0
6986913|NCT01275339|11044647|FG002|Overall Study|Referred for surgery for AS symptoms|0
6986914|NCT01275339|11044648|FG003|Overall Study|Referred for surgery for AS symptoms|0
6986915|NCT01275339|11044645|FG000|Overall Study|Withdrawal by Subject|0
6986916|NCT01275339|11044646|FG001|Overall Study|Withdrawal by Subject|0
6986917|NCT01275339|11044647|FG002|Overall Study|Withdrawal by Subject|1
6986918|NCT01275339|11044648|FG003|Overall Study|Withdrawal by Subject|0
6986919|NCT01275430|11044675|FG000|Overall Study|Adverse Event|1
6986920|NCT01275430|11044675|FG000|Overall Study|No Contrast Injection|6
6986921|NCT01275430|11044675|FG000|Overall Study|Device Malfunction|1
6986922|NCT01275430|11044675|FG000|Overall Study|Inability to achieve maximum p-wave|1
6986923|NCT01275625|11044684|FG000|Overall Study|Death|1
6986924|NCT01275625|11044684|FG000|Overall Study|Lack of Efficacy|2
6986925|NCT01275625|11044684|FG000|Overall Study|Lost to Follow-up|1
6986926|NCT01275625|11044684|FG000|Overall Study|Withdrawal by Subject|3
6986927|NCT01275625|11044684|FG000|Overall Study|Protocol Violation|1
6986928|NCT01275625|11044684|FG000|Overall Study|Adverse Event|4
6986929|NCT01275625|11044684|FG000|Overall Study|Other|1
6986930|NCT01275755|11044694|FG000|Double-blind Treatment Period|Adverse Event|0
6986931|NCT01275755|11044695|FG001|Double-blind Treatment Period|Adverse Event|2
6986932|NCT01275755|11044694|FG000|Double-blind Treatment Period|Lost to Follow-up|1
6986933|NCT01275755|11044695|FG001|Double-blind Treatment Period|Lost to Follow-up|1
6986934|NCT01275755|11044694|FG000|Double-blind Treatment Period|Withdrawal by Subject|1
6986935|NCT01275755|11044695|FG001|Double-blind Treatment Period|Withdrawal by Subject|0
6986936|NCT01275755|11044694|FG000|Run-out Placebo Period|Lost to Follow-up|1
6986937|NCT01275755|11044695|FG001|Run-out Placebo Period|Lost to Follow-up|0
6986938|NCT01275833|11044703|FG000|Overall Study|Study terminated|1
6986939|NCT01275833|11044704|FG001|Overall Study|Study terminated|1
6986940|NCT01276041|11044710|FG000|Overall Study|Adverse Event|2
6986941|NCT01276041|11044710|FG000|Overall Study|Protocol Violation|1
6986942|NCT01276106|11044718|FG000|Overall Study|Adverse Event|3
6986943|NCT01276106|11044719|FG001|Overall Study|Adverse Event|3
6986944|NCT01276106|11044720|FG002|Overall Study|Adverse Event|11
6986945|NCT01276106|11044721|FG003|Overall Study|Adverse Event|3
6986946|NCT01276106|11044718|FG000|Overall Study|Withdrawal by Subject|6
6986947|NCT01276106|11044719|FG001|Overall Study|Withdrawal by Subject|3
6986948|NCT01276106|11044720|FG002|Overall Study|Withdrawal by Subject|1
6986949|NCT01276106|11044721|FG003|Overall Study|Withdrawal by Subject|6
6986950|NCT01276106|11044718|FG000|Overall Study|Lack of Efficacy|0
6986951|NCT01276106|11044719|FG001|Overall Study|Lack of Efficacy|1
6986952|NCT01276106|11044720|FG002|Overall Study|Lack of Efficacy|0
6986953|NCT01276106|11044721|FG003|Overall Study|Lack of Efficacy|1
6986954|NCT01276106|11044718|FG000|Overall Study|Lost to Follow-up|2
6986955|NCT01276106|11044719|FG001|Overall Study|Lost to Follow-up|1
6986956|NCT01276106|11044720|FG002|Overall Study|Lost to Follow-up|1
6986957|NCT01276106|11044721|FG003|Overall Study|Lost to Follow-up|0
6986958|NCT01276106|11044718|FG000|Overall Study|Physician Decision|0
6986959|NCT01276106|11044719|FG001|Overall Study|Physician Decision|0
6986960|NCT01276106|11044720|FG002|Overall Study|Physician Decision|1
6986961|NCT01276106|11044721|FG003|Overall Study|Physician Decision|1
6986962|NCT01276106|11044718|FG000|Overall Study|Protocol Violation|1
6986963|NCT01276106|11044719|FG001|Overall Study|Protocol Violation|1
6986964|NCT01276106|11044720|FG002|Overall Study|Protocol Violation|0
6986965|NCT01276106|11044721|FG003|Overall Study|Protocol Violation|2
6986966|NCT01276106|11044718|FG000|Overall Study|Insufficient therapeutic effects|0
6986967|NCT01276106|11044719|FG001|Overall Study|Insufficient therapeutic effects|0
6986968|NCT01276106|11044720|FG002|Overall Study|Insufficient therapeutic effects|2
6986969|NCT01276106|11044721|FG003|Overall Study|Insufficient therapeutic effects|0
6986970|NCT01276223|11044765|FG000|Overall Study|Adverse Event|7
6986971|NCT01276223|11044766|FG001|Overall Study|Adverse Event|4
6986972|NCT01276223|11044767|FG002|Overall Study|Adverse Event|1
6986973|NCT01276223|11044765|FG000|Overall Study|Lost to Follow-up|0
6986974|NCT01276223|11044766|FG001|Overall Study|Lost to Follow-up|0
6986975|NCT01276223|11044767|FG002|Overall Study|Lost to Follow-up|1
6986976|NCT01276223|11044765|FG000|Overall Study|Other|0
6986977|NCT01276223|11044766|FG001|Overall Study|Other|0
6986978|NCT01276223|11044767|FG002|Overall Study|Other|1
6986979|NCT01276223|11044765|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3
6986980|NCT01276223|11044766|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0
6986981|NCT01276223|11044767|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0
6986982|NCT01276223|11044765|FG000|Overall Study|Protocol Violation|1
6986983|NCT01276223|11044766|FG001|Overall Study|Protocol Violation|0
6986984|NCT01276223|11044767|FG002|Overall Study|Protocol Violation|0
6986985|NCT01276236|11044774|FG000|Overall Study|Lack of Efficacy|2
6986986|NCT01276236|11044774|FG000|Overall Study|Withdrawal by Subject|4
6986987|NCT01276288|11044778|FG000|Overall Study|Adverse Event|1
6986988|NCT01276288|11044779|FG001|Overall Study|Adverse Event|1
6986989|NCT01276288|11044780|FG002|Overall Study|Adverse Event|0
6986990|NCT01276288|11044781|FG003|Overall Study|Adverse Event|0
6986991|NCT01276288|11044778|FG000|Overall Study|not treated|1
6986992|NCT01276288|11044779|FG001|Overall Study|not treated|0
6986993|NCT01276288|11044780|FG002|Overall Study|not treated|0
6986994|NCT01276288|11044781|FG003|Overall Study|not treated|0
6986995|NCT01276327|11044830|FG000|Overall Study|Adverse Event|1
6986996|NCT01276327|11044831|FG001|Overall Study|Adverse Event|3
6986997|NCT01276327|11044830|FG000|Overall Study|Withdrawal by Subject|1
6986998|NCT01276327|11044831|FG001|Overall Study|Withdrawal by Subject|0
6986999|NCT01276353|11044839|FG000|Double-blind|Adverse Event|2
6987000|NCT01276353|11044840|FG001|Double-blind|Adverse Event|0
6987001|NCT01276353|11044839|FG000|Double-blind|Withdrawal by Subject|1
6987002|NCT01276353|11044840|FG001|Double-blind|Withdrawal by Subject|0
6987003|NCT01276353|11044839|FG000|Extension|Adverse Event|2
6987004|NCT01276353|11044840|FG001|Extension|Adverse Event|5
6987005|NCT01276353|11044839|FG000|Extension|Withdrawal by Subject|1
6987006|NCT01276353|11044840|FG001|Extension|Withdrawal by Subject|2
6987007|NCT01276353|11044839|FG000|Extension|Withdrawal of study drug 4 days in a row|3
6987008|NCT01276353|11044840|FG001|Extension|Withdrawal of study drug 4 days in a row|1
6987009|NCT01276353|11044839|FG000|Extension|Physician Decision|1
6987010|NCT01276353|11044840|FG001|Extension|Physician Decision|0
6987011|NCT01276353|11044839|FG000|Extension|Prohibited concomitant medications|0
6987012|NCT01276353|11044840|FG001|Extension|Prohibited concomitant medications|1
6987013|NCT01276379|11044852|FG000|Overall Study|Screening failure|40
6987014|NCT01276457|11044860|FG000|Core Study|Adverse Event|6
6987015|NCT01276457|11044861|FG001|Core Study|Adverse Event|3
6987016|NCT01276457|11044860|FG000|Core Study|Lost to Follow-up|1
6987017|NCT01276457|11044861|FG001|Core Study|Lost to Follow-up|2
6987018|NCT01276457|11044860|FG000|Core Study|Administrative problems|1
6987019|NCT01276457|11044861|FG001|Core Study|Administrative problems|1
6987020|NCT01276457|11044860|FG000|Core Study|Death|2
6987021|NCT01276457|11044861|FG001|Core Study|Death|2
6987022|NCT01276457|11044860|FG000|Core Study|Lack of Efficacy|3
6987023|NCT01276457|11044861|FG001|Core Study|Lack of Efficacy|12
6987024|NCT01276457|11044860|FG000|Extension Study|Lost to Follow-up|3
6987025|NCT01276457|11044861|FG001|Extension Study|Lost to Follow-up|0
6987026|NCT01276457|11044860|FG000|Extension Study|Death|0
6987027|NCT01276457|11044861|FG001|Extension Study|Death|1
6987028|NCT01276457|11044860|FG000|Extension Study|Lack of Efficacy|3
6987029|NCT01276457|11044861|FG001|Extension Study|Lack of Efficacy|1
6987030|NCT01276509|11044871|FG000|Overall Study|Adverse Event|9
6987031|NCT01276509|11044872|FG001|Overall Study|Adverse Event|8
6987032|NCT01276509|11044873|FG002|Overall Study|Adverse Event|4
6987033|NCT01276509|11044874|FG003|Overall Study|Adverse Event|3
6987034|NCT01276509|11044871|FG000|Overall Study|Lack of Efficacy|2
6987035|NCT01276509|11044872|FG001|Overall Study|Lack of Efficacy|1
6987036|NCT01276509|11044873|FG002|Overall Study|Lack of Efficacy|1
6987037|NCT01276509|11044874|FG003|Overall Study|Lack of Efficacy|2
6987038|NCT01276509|11044871|FG000|Overall Study|Pregnancy|1
6987039|NCT01276509|11044872|FG001|Overall Study|Pregnancy|0
6987040|NCT01276509|11044873|FG002|Overall Study|Pregnancy|0
6987041|NCT01276509|11044874|FG003|Overall Study|Pregnancy|0
6987042|NCT01276509|11044871|FG000|Overall Study|Withdrawal by Subject|1
6987043|NCT01276509|11044872|FG001|Overall Study|Withdrawal by Subject|2
6987044|NCT01276509|11044873|FG002|Overall Study|Withdrawal by Subject|0
6987045|NCT01276509|11044874|FG003|Overall Study|Withdrawal by Subject|0
6987046|NCT01276509|11044871|FG000|Overall Study|Other|0
6987047|NCT01276509|11044872|FG001|Overall Study|Other|1
6987048|NCT01276509|11044873|FG002|Overall Study|Other|0
6987049|NCT01276509|11044874|FG003|Overall Study|Other|0
6987050|NCT01276639|11044891|FG000|Week 0 to 16|Death|1
6987051|NCT01276639|11044892|FG001|Week 0 to 16|Death|0
6987052|NCT01276639|11044893|FG002|Week 0 to 16|Death|0
6987053|NCT01276639|11044894|FG003|Week 0 to 16|Death|0
6987054|NCT01276639|11044895|FG004|Week 0 to 16|Death|0
6987055|NCT01276639|11044891|FG000|Week 0 to 16|Adverse Event|11
6987056|NCT01276639|11044892|FG001|Week 0 to 16|Adverse Event|8
6987057|NCT01276639|11044893|FG002|Week 0 to 16|Adverse Event|11
6987058|NCT01276639|11044894|FG003|Week 0 to 16|Adverse Event|0
6987059|NCT01276639|11044895|FG004|Week 0 to 16|Adverse Event|0
6987060|NCT01276639|11044891|FG000|Week 0 to 16|Lack of Efficacy|20
6987061|NCT01276639|11044892|FG001|Week 0 to 16|Lack of Efficacy|15
6987062|NCT01276639|11044893|FG002|Week 0 to 16|Lack of Efficacy|25
6987063|NCT01276639|11044894|FG003|Week 0 to 16|Lack of Efficacy|0
6987064|NCT01276639|11044895|FG004|Week 0 to 16|Lack of Efficacy|0
6987065|NCT01276639|11044891|FG000|Week 0 to 16|Lost to Follow-up|3
6987066|NCT01276639|11044892|FG001|Week 0 to 16|Lost to Follow-up|5
6987067|NCT01276639|11044893|FG002|Week 0 to 16|Lost to Follow-up|3
6987068|NCT01276639|11044894|FG003|Week 0 to 16|Lost to Follow-up|0
6987069|NCT01276639|11044895|FG004|Week 0 to 16|Lost to Follow-up|0
6987070|NCT01276639|11044891|FG000|Week 0 to 16|Withdrawal by Subject|8
6987071|NCT01276639|11044892|FG001|Week 0 to 16|Withdrawal by Subject|5
6987072|NCT01276639|11044893|FG002|Week 0 to 16|Withdrawal by Subject|4
6987073|NCT01276639|11044894|FG003|Week 0 to 16|Withdrawal by Subject|0
6987074|NCT01276639|11044895|FG004|Week 0 to 16|Withdrawal by Subject|0
6987075|NCT01276639|11044891|FG000|Week 0 to 16|Other|7
6987076|NCT01276639|11044892|FG001|Week 0 to 16|Other|7
6987077|NCT01276639|11044893|FG002|Week 0 to 16|Other|2
6987078|NCT01276639|11044894|FG003|Week 0 to 16|Other|0
6987079|NCT01276639|11044895|FG004|Week 0 to 16|Other|0
6987080|NCT01276639|11044891|FG000|Week 0 to 16|Randomized, But Not Treated|0
6987081|NCT01276639|11044892|FG001|Week 0 to 16|Randomized, But Not Treated|1
6987082|NCT01276639|11044893|FG002|Week 0 to 16|Randomized, But Not Treated|0
6987083|NCT01276639|11044894|FG003|Week 0 to 16|Randomized, But Not Treated|0
6987084|NCT01276639|11044895|FG004|Week 0 to 16|Randomized, But Not Treated|0
6987085|NCT01276639|11044891|FG000|Week 16 to 52|Death|1
6987086|NCT01276639|11044892|FG001|Week 16 to 52|Death|0
6987087|NCT01276639|11044893|FG002|Week 16 to 52|Death|0
6987088|NCT01276639|11044894|FG003|Week 16 to 52|Death|0
6987089|NCT01276639|11044895|FG004|Week 16 to 52|Death|0
6987090|NCT01276639|11044891|FG000|Week 16 to 52|Adverse Event|10
6987091|NCT01276639|11044892|FG001|Week 16 to 52|Adverse Event|13
6987092|NCT01276639|11044893|FG002|Week 16 to 52|Adverse Event|0
6987093|NCT01276639|11044894|FG003|Week 16 to 52|Adverse Event|1
6987094|NCT01276639|11044895|FG004|Week 16 to 52|Adverse Event|3
6987095|NCT01276639|11044891|FG000|Week 16 to 52|Lack of Efficacy|99
6987096|NCT01276639|11044892|FG001|Week 16 to 52|Lack of Efficacy|71
6987097|NCT01276639|11044893|FG002|Week 16 to 52|Lack of Efficacy|0
6987098|NCT01276639|11044894|FG003|Week 16 to 52|Lack of Efficacy|14
6987099|NCT01276639|11044895|FG004|Week 16 to 52|Lack of Efficacy|13
6987100|NCT01276639|11044891|FG000|Week 16 to 52|Lost to Follow-up|3
6987101|NCT01276639|11044892|FG001|Week 16 to 52|Lost to Follow-up|1
6987102|NCT01276639|11044893|FG002|Week 16 to 52|Lost to Follow-up|0
6987103|NCT01276639|11044894|FG003|Week 16 to 52|Lost to Follow-up|0
6987104|NCT01276639|11044895|FG004|Week 16 to 52|Lost to Follow-up|1
6987105|NCT01276639|11044891|FG000|Week 16 to 52|Withdrawal by Subject|4
6987106|NCT01276639|11044892|FG001|Week 16 to 52|Withdrawal by Subject|4
6987107|NCT01276639|11044893|FG002|Week 16 to 52|Withdrawal by Subject|0
6987108|NCT01276639|11044894|FG003|Week 16 to 52|Withdrawal by Subject|0
6987109|NCT01276639|11044895|FG004|Week 16 to 52|Withdrawal by Subject|1
6987110|NCT01276639|11044891|FG000|Week 16 to 52|Other|10
6987111|NCT01276639|11044892|FG001|Week 16 to 52|Other|12
6987112|NCT01276639|11044893|FG002|Week 16 to 52|Other|0
6987113|NCT01276639|11044894|FG003|Week 16 to 52|Other|1
6987114|NCT01276639|11044895|FG004|Week 16 to 52|Other|3
6987115|NCT01276756|11044930|FG000|Overall Study|Lost to Follow-up|2
6987116|NCT01276756|11044931|FG001|Overall Study|Lost to Follow-up|0
6987117|NCT01276756|11044930|FG000|Overall Study|Adverse Event|3
6987118|NCT01276756|11044931|FG001|Overall Study|Adverse Event|2
6987119|NCT01276821|11044939|FG000|Overall Study|Protocol Violation|0
6987120|NCT01276821|11044940|FG001|Overall Study|Protocol Violation|1
6987121|NCT01276847|11044949|FG000|Overall Study|Withdrawal by Subject|1
6987122|NCT01276847|11044950|FG001|Overall Study|Withdrawal by Subject|0
6987123|NCT01276847|11044951|FG002|Overall Study|Withdrawal by Subject|0
6987124|NCT01277042|11044969|FG000|Overall Study|Adverse Event|4
6987125|NCT01277042|11044970|FG001|Overall Study|Adverse Event|3
6987126|NCT01277042|11044969|FG000|Overall Study|Lost to Follow-up|2
6987127|NCT01277042|11044970|FG001|Overall Study|Lost to Follow-up|2
6987128|NCT01277042|11044969|FG000|Overall Study|Withdrawal by Subject|2
6987129|NCT01277042|11044970|FG001|Overall Study|Withdrawal by Subject|0
6987130|NCT01277302|11045010|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
6987131|NCT01277302|11045011|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
6987132|NCT01277302|11045012|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8
6987133|NCT01277302|11045010|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0
6987134|NCT01277302|11045011|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0
6987135|NCT01277302|11045012|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2
6987136|NCT01277302|11045010|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
6987137|NCT01277302|11045011|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
6987138|NCT01277302|11045012|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1
6987139|NCT01277302|11045010|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0
6987140|NCT01277302|11045011|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0
6987141|NCT01277302|11045012|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1
6987142|NCT01277302|11045010|FG000|8-Month Alternate Dose Regimen Period|Death|0
6987143|NCT01277302|11045011|FG001|8-Month Alternate Dose Regimen Period|Death|1
6987144|NCT01277302|11045012|FG002|8-Month Alternate Dose Regimen Period|Death|0
6987145|NCT01277302|11045010|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
6987146|NCT01277302|11045011|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
6987147|NCT01277302|11045012|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3
6987148|NCT01277302|11045010|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3
6987149|NCT01277302|11045011|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0
6987150|NCT01277302|11045012|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1
6987151|NCT01277302|11045010|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0
6987152|NCT01277302|11045011|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2
6987153|NCT01277302|11045012|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1
6987154|NCT01277302|11045010|FG000|8-Month Alternate Dose Regimen Period|Relocation|1
6987155|NCT01277302|11045011|FG001|8-Month Alternate Dose Regimen Period|Relocation|0
6987156|NCT01277302|11045012|FG002|8-Month Alternate Dose Regimen Period|Relocation|1
6987157|NCT01277510|11045048|FG000|Double-blind Phase|Non-compliance|0
6987158|NCT01277510|11045049|FG001|Double-blind Phase|Non-compliance|1
6987159|NCT01277510|11045048|FG000|Double-blind Phase|Adverse Event|1
6987160|NCT01277510|11045049|FG001|Double-blind Phase|Adverse Event|0
6987161|NCT01277510|11045048|FG000|Double-blind Phase|Withdrawal by Subject|2
6987162|NCT01277510|11045049|FG001|Double-blind Phase|Withdrawal by Subject|0
6987163|NCT01277510|11045048|FG000|Double-blind Phase|Administrative decision|7
6987164|NCT01277510|11045049|FG001|Double-blind Phase|Administrative decision|9
6987165|NCT01277510|11045048|FG000|Double-blind Phase|Death|0
6987166|NCT01277510|11045049|FG001|Double-blind Phase|Death|1
6987167|NCT01277510|11045048|FG000|Double-blind Phase|Protocol-specified criteria|2
6987168|NCT01277510|11045049|FG001|Double-blind Phase|Protocol-specified criteria|6
6987169|NCT01277510|11045048|FG000|Double-blind Phase|Other|1
6987170|NCT01277510|11045049|FG001|Double-blind Phase|Other|1
6987171|NCT01277510|11045048|FG000|Open-label Phase|Administrative decision|4
6987172|NCT01277510|11045049|FG001|Open-label Phase|Administrative decision|3
6987173|NCT01277510|11045048|FG000|Open-label Phase|Protocol-specified criteria|1
6987174|NCT01277510|11045049|FG001|Open-label Phase|Protocol-specified criteria|0
6987175|NCT01277510|11045048|FG000|Open-label Phase|Never received investigational product|2
6987176|NCT01277510|11045049|FG001|Open-label Phase|Never received investigational product|0
6987177|NCT01277523|11045060|FG000|Overall Study|Adverse Event|1
6987178|NCT01277523|11045061|FG001|Overall Study|Adverse Event|0
6987179|NCT01277523|11045062|FG002|Overall Study|Adverse Event|0
6987180|NCT01277523|11045060|FG000|Overall Study|Protocol Violation|2
6987181|NCT01277523|11045061|FG001|Overall Study|Protocol Violation|0
6987182|NCT01277523|11045062|FG002|Overall Study|Protocol Violation|0
6987183|NCT01277523|11045060|FG000|Overall Study|Other Reason not Defined|0
6987184|NCT01277523|11045061|FG001|Overall Study|Other Reason not Defined|1
6987185|NCT01277523|11045062|FG002|Overall Study|Other Reason not Defined|0
6987186|NCT01277549|11045072|FG000|Overall Study|Failed to meet eligibility criteria|13
6987187|NCT01277549|11045073|FG001|Overall Study|Failed to meet eligibility criteria|9
6987188|NCT01277549|11045072|FG000|Overall Study|Withdrawal by Subject|1
6987189|NCT01277549|11045073|FG001|Overall Study|Withdrawal by Subject|3
6987190|NCT01277549|11045072|FG000|Overall Study|Protocol Violation|10
6987191|NCT01277549|11045073|FG001|Overall Study|Protocol Violation|1
6987192|NCT01277549|11045072|FG000|Overall Study|Physician Decision|2
6987193|NCT01277549|11045073|FG001|Overall Study|Physician Decision|1
6987194|NCT01277601|11045086|FG000|Overall Study|Adverse Event|5
6987195|NCT01277601|11045087|FG001|Overall Study|Adverse Event|3
6987196|NCT01277601|11045088|FG002|Overall Study|Adverse Event|0
6987197|NCT01277601|11045089|FG003|Overall Study|Adverse Event|7
6987198|NCT01277601|11045086|FG000|Overall Study|Withdrawal by Subject|18
6987199|NCT01277601|11045087|FG001|Overall Study|Withdrawal by Subject|21
6987200|NCT01277601|11045088|FG002|Overall Study|Withdrawal by Subject|8
6987201|NCT01277601|11045089|FG003|Overall Study|Withdrawal by Subject|17
6987202|NCT01277601|11045086|FG000|Overall Study|Lost to Follow-up|7
6987203|NCT01277601|11045087|FG001|Overall Study|Lost to Follow-up|9
6987204|NCT01277601|11045088|FG002|Overall Study|Lost to Follow-up|4
6987205|NCT01277601|11045089|FG003|Overall Study|Lost to Follow-up|2
6987206|NCT01277601|11045086|FG000|Overall Study|Physician Decision|3
6987207|NCT01277601|11045087|FG001|Overall Study|Physician Decision|5
6987208|NCT01277601|11045088|FG002|Overall Study|Physician Decision|1
6987209|NCT01277601|11045089|FG003|Overall Study|Physician Decision|6
6987210|NCT01277601|11045086|FG000|Overall Study|Pregnancy|2
6987211|NCT01277601|11045087|FG001|Overall Study|Pregnancy|2
6987212|NCT01277601|11045088|FG002|Overall Study|Pregnancy|4
6987213|NCT01277601|11045089|FG003|Overall Study|Pregnancy|1
6987214|NCT01277601|11045086|FG000|Overall Study|Noncompliance with Study Drug|1
6987215|NCT01277601|11045087|FG001|Overall Study|Noncompliance with Study Drug|3
6987216|NCT01277601|11045088|FG002|Overall Study|Noncompliance with Study Drug|2
6987217|NCT01277601|11045089|FG003|Overall Study|Noncompliance with Study Drug|0
6987218|NCT01277601|11045086|FG000|Overall Study|Subject Never Dosed with Study Drug|1
6987219|NCT01277601|11045087|FG001|Overall Study|Subject Never Dosed with Study Drug|2
6987220|NCT01277601|11045088|FG002|Overall Study|Subject Never Dosed with Study Drug|3
6987221|NCT01277601|11045089|FG003|Overall Study|Subject Never Dosed with Study Drug|1
6987222|NCT01277601|11045086|FG000|Overall Study|Protocol Violation|0
6987223|NCT01277601|11045087|FG001|Overall Study|Protocol Violation|2
6987224|NCT01277601|11045088|FG002|Overall Study|Protocol Violation|5
6987225|NCT01277601|11045089|FG003|Overall Study|Protocol Violation|0
6987226|NCT01277601|11045086|FG000|Overall Study|Subject Terminated from Study by Sponsor|0
6987227|NCT01277601|11045087|FG001|Overall Study|Subject Terminated from Study by Sponsor|1
6987228|NCT01277601|11045088|FG002|Overall Study|Subject Terminated from Study by Sponsor|0
6987229|NCT01277601|11045089|FG003|Overall Study|Subject Terminated from Study by Sponsor|2
6987230|NCT01277666|11045119|FG000|Overall Study|Adverse Event|26
6987231|NCT01277666|11045120|FG001|Overall Study|Adverse Event|25
6987232|NCT01277666|11045121|FG002|Overall Study|Adverse Event|20
6987233|NCT01277666|11045119|FG000|Overall Study|Lack of Efficacy|8
6987234|NCT01277666|11045120|FG001|Overall Study|Lack of Efficacy|20
6987235|NCT01277666|11045121|FG002|Overall Study|Lack of Efficacy|12
6987236|NCT01277666|11045119|FG000|Overall Study|Protocol Violation|2
6987237|NCT01277666|11045120|FG001|Overall Study|Protocol Violation|3
6987238|NCT01277666|11045121|FG002|Overall Study|Protocol Violation|2
6987239|NCT01277666|11045119|FG000|Overall Study|Protocol Defined Stopping criteria|1
6987240|NCT01277666|11045120|FG001|Overall Study|Protocol Defined Stopping criteria|2
6987241|NCT01277666|11045121|FG002|Overall Study|Protocol Defined Stopping criteria|6
6987242|NCT01277666|11045119|FG000|Overall Study|Lost to Follow-up|1
6987243|NCT01277666|11045120|FG001|Overall Study|Lost to Follow-up|1
6987244|NCT01277666|11045121|FG002|Overall Study|Lost to Follow-up|2
6987245|NCT01277666|11045119|FG000|Overall Study|Withdrawal by Subject|7
6987246|NCT01277666|11045120|FG001|Overall Study|Withdrawal by Subject|8
6987247|NCT01277666|11045121|FG002|Overall Study|Withdrawal by Subject|6
6987248|NCT01277666|11045119|FG000|Overall Study|Death|0
6987249|NCT01277666|11045120|FG001|Overall Study|Death|0
6987250|NCT01277666|11045121|FG002|Overall Study|Death|1
6987251|NCT01277718|11045129|FG000|Period 2 - Second Intervention|Protocol Violation|0
6987252|NCT01277718|11045130|FG001|Period 2 - Second Intervention|Protocol Violation|1
6987253|NCT01277718|11045129|FG000|Period 2 - Second Intervention|Physician Decision|0
6987254|NCT01277718|11045130|FG001|Period 2 - Second Intervention|Physician Decision|2
6987255|NCT01277744|11045138|FG000|Overall Study|Physician Decision|2
6987256|NCT01277757|11045142|FG000|Overall Study|Disease Progression|1
6987257|NCT01277757|11045142|FG000|Overall Study|Withdrawal by Subject|1
6987258|NCT01277861|11045153|FG000|Overall Study|Physician Decision|2
6987259|NCT01277861|11045154|FG001|Overall Study|Physician Decision|2
6987260|NCT01277887|11045164|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1
6987261|NCT01277887|11045165|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0
6987262|NCT01277887|11045164|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2
6987263|NCT01277887|11045165|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0
6987264|NCT01277887|11045164|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3
6987265|NCT01277887|11045165|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5
6987266|NCT01278030|11045173|FG000|Overall Study|Withdrawal by Subject|8
6987267|NCT01278030|11045174|FG001|Overall Study|Withdrawal by Subject|4
6987268|NCT01278160|11045182|FG000|Overall Study|Adverse Event|1
6987269|NCT01278160|11045183|FG001|Overall Study|Adverse Event|1
6987270|NCT01278160|11045182|FG000|Overall Study|Lost to Follow-up|0
6987271|NCT01278160|11045183|FG001|Overall Study|Lost to Follow-up|1
6987272|NCT01278160|11045182|FG000|Overall Study|Withdrawal by Subject|3
6987273|NCT01278160|11045183|FG001|Overall Study|Withdrawal by Subject|2
6987274|NCT01278160|11045182|FG000|Overall Study|Unclassified|1
6987275|NCT01278160|11045183|FG001|Overall Study|Unclassified|2
6987276|NCT01278173|11045189|FG000|Overall Study|Lack of Efficacy|13
6987277|NCT01278173|11045189|FG000|Overall Study|Adverse Event|8
6987278|NCT01278173|11045189|FG000|Overall Study|Administrative or other reason|4
6987279|NCT01278173|11045189|FG000|Overall Study|Protocol Violation|1
6987280|NCT01278173|11045189|FG000|Overall Study|Withdrawal by Subject|1
6987281|NCT01278342|11045200|FG000|Overall Study|Physician Decision|0
6987282|NCT01278342|11045201|FG001|Overall Study|Physician Decision|1
6987283|NCT01278342|11045202|FG002|Overall Study|Physician Decision|0
6987284|NCT01278342|11045200|FG000|Overall Study|Lost to Follow-up|1
6987285|NCT01278342|11045201|FG001|Overall Study|Lost to Follow-up|0
6987286|NCT01278342|11045202|FG002|Overall Study|Lost to Follow-up|0
6987287|NCT01278342|11045200|FG000|Overall Study|Administrative problems|2
6987288|NCT01278342|11045201|FG001|Overall Study|Administrative problems|0
6987289|NCT01278342|11045202|FG002|Overall Study|Administrative problems|0
6987290|NCT01278342|11045200|FG000|Overall Study|Other|1
6987291|NCT01278342|11045201|FG001|Overall Study|Other|0
6987292|NCT01278342|11045202|FG002|Overall Study|Other|0
6987293|NCT01278394|11045210|FG000|Overall Study|Lost to Follow-up|1
6987294|NCT01278407|11045217|FG000|Confirmatory Phase|Adverse Event|5
6987295|NCT01278407|11045218|FG001|Confirmatory Phase|Adverse Event|10
6987296|NCT01278407|11045219|FG002|Confirmatory Phase|Adverse Event|1
6987297|NCT01278407|11045220|FG003|Confirmatory Phase|Adverse Event|0
6987298|NCT01278407|11045221|FG004|Confirmatory Phase|Adverse Event|0
6987299|NCT01278407|11045217|FG000|Confirmatory Phase|Participant's Choice|3
6987300|NCT01278407|11045218|FG001|Confirmatory Phase|Participant's Choice|5
6987301|NCT01278407|11045219|FG002|Confirmatory Phase|Participant's Choice|3
6987302|NCT01278407|11045220|FG003|Confirmatory Phase|Participant's Choice|0
6987303|NCT01278407|11045221|FG004|Confirmatory Phase|Participant's Choice|0
6987304|NCT01278407|11045217|FG000|Confirmatory Phase|Other|1
6987305|NCT01278407|11045218|FG001|Confirmatory Phase|Other|1
6987306|NCT01278407|11045219|FG002|Confirmatory Phase|Other|2
6987307|NCT01278407|11045220|FG003|Confirmatory Phase|Other|0
6987308|NCT01278407|11045221|FG004|Confirmatory Phase|Other|0
6987309|NCT01278407|11045217|FG000|Extension Phase|Adverse Event|0
6987310|NCT01278407|11045218|FG001|Extension Phase|Adverse Event|0
6987311|NCT01278407|11045219|FG002|Extension Phase|Adverse Event|0
6987312|NCT01278407|11045220|FG003|Extension Phase|Adverse Event|7
6987313|NCT01278407|11045221|FG004|Extension Phase|Adverse Event|16
6987314|NCT01278407|11045217|FG000|Extension Phase|Participant's Choice|0
6987315|NCT01278407|11045218|FG001|Extension Phase|Participant's Choice|0
6987316|NCT01278407|11045219|FG002|Extension Phase|Participant's Choice|0
6987317|NCT01278407|11045220|FG003|Extension Phase|Participant's Choice|4
6987318|NCT01278407|11045221|FG004|Extension Phase|Participant's Choice|11
6987319|NCT01278407|11045217|FG000|Extension Phase|Other|0
6987320|NCT01278407|11045218|FG001|Extension Phase|Other|0
6987321|NCT01278407|11045219|FG002|Extension Phase|Other|0
6987322|NCT01278407|11045220|FG003|Extension Phase|Other|1
6987323|NCT01278407|11045221|FG004|Extension Phase|Other|3
6987324|NCT01278615|11045235|FG000|Overall Study|Withdrawal by Subject|2
6987325|NCT01278745|11045241|FG000|Overall Study|Death|2
6987326|NCT01278745|11045242|FG001|Overall Study|Death|5
6987327|NCT01278745|11045243|FG002|Overall Study|Death|7
6987328|NCT01278745|11045244|FG003|Overall Study|Death|0
6987329|NCT01278745|11045241|FG000|Overall Study|Physician Decision|1
6987330|NCT01278745|11045242|FG001|Overall Study|Physician Decision|0
6987331|NCT01278745|11045243|FG002|Overall Study|Physician Decision|0
6987332|NCT01278745|11045244|FG003|Overall Study|Physician Decision|9
6987333|NCT01278745|11045241|FG000|Overall Study|Withdrawal by Subject|1
6987334|NCT01278745|11045242|FG001|Overall Study|Withdrawal by Subject|1
6987335|NCT01278745|11045243|FG002|Overall Study|Withdrawal by Subject|5
6987336|NCT01278745|11045244|FG003|Overall Study|Withdrawal by Subject|1
6987337|NCT01278745|11045241|FG000|Overall Study|Sponsor Decision|1
6987338|NCT01278745|11045242|FG001|Overall Study|Sponsor Decision|0
6987339|NCT01278745|11045243|FG002|Overall Study|Sponsor Decision|62
6987340|NCT01278745|11045244|FG003|Overall Study|Sponsor Decision|6
6987341|NCT01278745|11045241|FG000|Overall Study|Ineligible|0
6987342|NCT01278745|11045242|FG001|Overall Study|Ineligible|0
6987343|NCT01278745|11045243|FG002|Overall Study|Ineligible|42
6987344|NCT01278745|11045244|FG003|Overall Study|Ineligible|61
6987345|NCT01278745|11045241|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0
6987346|NCT01278745|11045242|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0
6987347|NCT01278745|11045243|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5
6987348|NCT01278745|11045244|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1
7042139|NCT00915681|11126300|FG000|Overall Study|Screening failures|46
7042140|NCT00145158|11126306|FG000|Overall Study|premature withdrawal|2
7042141|NCT00145158|11126307|FG001|Overall Study|premature withdrawal|3
7042142|NCT01732822|11126325|FG000|Overall Study|Withdrawal by Subject|123
7042143|NCT01732822|11126326|FG001|Overall Study|Withdrawal by Subject|113
7042144|NCT01732835|11126354|FG000|6-month Primary Endpoint|Did not receive device|19
7042145|NCT01732835|11126354|FG000|6-month Primary Endpoint|Withdrawal by Subject|2
7042146|NCT01732835|11126354|FG000|6-month Primary Endpoint|Adverse Event|3
7042147|NCT01732835|11126354|FG000|2-year Extended Follow-up|Withdrawal by Subject|1
7042148|NCT01732835|11126354|FG000|2-year Extended Follow-up|Adverse Event|3
7042149|NCT01732835|11126354|FG000|2-year Extended Follow-up|Death|1
7042150|NCT01732874|11126360|FG000|Overall Study|Withdrawal by Subject|5
7042151|NCT01732874|11126361|FG001|Overall Study|Withdrawal by Subject|1
7042152|NCT01732874|11126360|FG000|Overall Study|Death of Infant|3
7042153|NCT01732874|11126361|FG001|Overall Study|Death of Infant|2
7042154|NCT01733121|11126394|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2
7042155|NCT01733121|11126395|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0
7042156|NCT01733121|11126394|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3
7042157|NCT01733121|11126395|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2
7042158|NCT01733121|11126394|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
7042159|NCT01733121|11126395|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3
7042160|NCT01733121|11126394|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
7042161|NCT01733121|11126395|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
7042162|NCT01733316|11126434|FG000|RP103 Phase|Non-compliance|1
7042163|NCT01733316|11126434|FG000|Long Term Extension Phase|Adverse Event|1
7042164|NCT01733316|11126434|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2
7042165|NCT01733316|11126434|FG000|Long Term Extension Phase|Sponsor Decision|2
7042166|NCT01733329|11126447|FG000|Overall Study|Protocol Violation|1
7042167|NCT01733329|11126448|FG001|Overall Study|Protocol Violation|1
7042168|NCT01733329|11126447|FG000|Overall Study|Uterine artery injury|1
7042169|NCT01733329|11126448|FG001|Overall Study|Uterine artery injury|0
7042170|NCT01733680|11126485|FG000|Overall Study|Withdrawal by Subject|0
7042171|NCT01733680|11126486|FG001|Overall Study|Withdrawal by Subject|1
7042172|NCT01733732|11126498|FG000|Overall Study|Adverse Event|1
7042173|NCT01733732|11126499|FG001|Overall Study|Adverse Event|0
7042174|NCT01733732|11126498|FG000|Overall Study|Did not attend all study visits|1
7042175|NCT01733732|11126499|FG001|Overall Study|Did not attend all study visits|0
7042176|NCT01733758|11126528|FG000|Overall Study|Adverse Event|5
7042177|NCT01733758|11126529|FG001|Overall Study|Adverse Event|7
7042178|NCT01733758|11126530|FG002|Overall Study|Adverse Event|8
7042179|NCT01733758|11126531|FG003|Overall Study|Adverse Event|1
7042180|NCT01733758|11126528|FG000|Overall Study|Withdrawal by Subject|1
7042181|NCT01733758|11126529|FG001|Overall Study|Withdrawal by Subject|1
7042182|NCT01733758|11126530|FG002|Overall Study|Withdrawal by Subject|5
7042183|NCT01733758|11126531|FG003|Overall Study|Withdrawal by Subject|3
7042184|NCT01733758|11126528|FG000|Overall Study|Persistent Hyperglycemia|3
7042185|NCT01733758|11126529|FG001|Overall Study|Persistent Hyperglycemia|2
7042186|NCT01733758|11126530|FG002|Overall Study|Persistent Hyperglycemia|0
7042187|NCT01733758|11126531|FG003|Overall Study|Persistent Hyperglycemia|0
7042188|NCT01733758|11126528|FG000|Overall Study|Protocol Violation|0
7042189|NCT01733758|11126529|FG001|Overall Study|Protocol Violation|1
7042190|NCT01733758|11126530|FG002|Overall Study|Protocol Violation|2
7042191|NCT01733758|11126531|FG003|Overall Study|Protocol Violation|2
7042192|NCT01733758|11126528|FG000|Overall Study|Non-compliance|1
7042193|NCT01733758|11126529|FG001|Overall Study|Non-compliance|0
7042194|NCT01733758|11126530|FG002|Overall Study|Non-compliance|0
7042195|NCT01733758|11126531|FG003|Overall Study|Non-compliance|0
7042196|NCT01733758|11126528|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4
7042197|NCT01733758|11126529|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0
7042198|NCT01733758|11126530|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0
7042199|NCT01733758|11126531|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1
7042200|NCT01733758|11126528|FG000|Overall Study|Inv Decision, HbA1c not controlled|1
7042201|NCT01733758|11126529|FG001|Overall Study|Inv Decision, HbA1c not controlled|1
7042202|NCT01733758|11126530|FG002|Overall Study|Inv Decision, HbA1c not controlled|0
7042203|NCT01733758|11126531|FG003|Overall Study|Inv Decision, HbA1c not controlled|1
7042204|NCT01734382|11126577|FG000|Part 1|Adverse Event|2
7042205|NCT01734382|11126578|FG001|Part 1|Adverse Event|0
7042206|NCT01734382|11126579|FG002|Part 1|Adverse Event|0
7042207|NCT01734382|11126577|FG000|Part 2|Adverse Event|0
7042208|NCT01734382|11126578|FG001|Part 2|Adverse Event|0
7060278|NCT01915940|11156306|FG001|Treatment Period|Adverse Event|9
6987349|NCT01278797|11045252|FG000|Period 1|Adverse Event|0
6987350|NCT01278797|11045253|FG001|Period 1|Adverse Event|1
6987351|NCT01278797|11045252|FG000|Period 1|Protocol Violation|1
6987352|NCT01278797|11045253|FG001|Period 1|Protocol Violation|0
6987353|NCT01278862|11045261|FG000|Overall Study|Lost to Follow-up|1
6987354|NCT01278862|11045262|FG001|Overall Study|Lost to Follow-up|1
6987355|NCT01279044|11045298|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0
6987356|NCT01279044|11045299|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3
6987357|NCT01279044|11045300|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2
6987358|NCT01279044|11045298|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
6987359|NCT01279044|11045299|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8
6987360|NCT01279044|11045300|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
6987361|NCT01279044|11045298|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0
6987362|NCT01279044|11045299|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0
6987363|NCT01279044|11045300|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1
6987364|NCT01279057|11045309|FG000|Overall Study|Adverse Event|1
6987365|NCT01279057|11045310|FG001|Overall Study|Adverse Event|0
6987366|NCT01279057|11045311|FG002|Overall Study|Adverse Event|1
6987367|NCT01279057|11045309|FG000|Overall Study|Insufficient therapeutic response|0
6987368|NCT01279057|11045310|FG001|Overall Study|Insufficient therapeutic response|0
6987369|NCT01279057|11045311|FG002|Overall Study|Insufficient therapeutic response|1
6987370|NCT01279057|11045309|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0
6987371|NCT01279057|11045310|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1
6987372|NCT01279057|11045311|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0
6987373|NCT01279057|11045309|FG000|Overall Study|Withdrew consent|2
6987374|NCT01279057|11045310|FG001|Overall Study|Withdrew consent|0
6987375|NCT01279057|11045311|FG002|Overall Study|Withdrew consent|1
6987376|NCT01279057|11045309|FG000|Overall Study|Pregnancy|0
6987377|NCT01279057|11045310|FG001|Overall Study|Pregnancy|1
6987378|NCT01279057|11045311|FG002|Overall Study|Pregnancy|0
6987379|NCT01279057|11045309|FG000|Overall Study|Other|3
6987380|NCT01279057|11045310|FG001|Overall Study|Other|3
6987381|NCT01279057|11045311|FG002|Overall Study|Other|0
6987382|NCT01279070|11045321|FG000|Overall Study|Withdrawal by Subject|2
6987383|NCT01279070|11045322|FG001|Overall Study|Withdrawal by Subject|3
6987384|NCT01279070|11045321|FG000|Overall Study|Acute exacerbation|3
6987385|NCT01279070|11045322|FG001|Overall Study|Acute exacerbation|1
6987386|NCT01279200|11045352|FG000|Overall Study|Withdrawal by Subject|1
6987387|NCT01279200|11045353|FG001|Overall Study|Withdrawal by Subject|3
6987388|NCT01279200|11045352|FG000|Overall Study|Patient withdrawal due to high cost|0
6987389|NCT01279200|11045353|FG001|Overall Study|Patient withdrawal due to high cost|1
6987390|NCT01279200|11045352|FG000|Overall Study|Inconvenience of ultrasound visit|0
6987391|NCT01279200|11045353|FG001|Overall Study|Inconvenience of ultrasound visit|1
6987392|NCT01279200|11045352|FG000|Overall Study|ultrasound screening failure|0
6987393|NCT01279200|11045353|FG001|Overall Study|ultrasound screening failure|1
6987394|NCT01279200|11045352|FG000|Overall Study|Lost to Follow-up|0
6987395|NCT01279200|11045353|FG001|Overall Study|Lost to Follow-up|1
6987396|NCT01279200|11045352|FG000|Overall Study|Adverse Event|1
6987397|NCT01279200|11045353|FG001|Overall Study|Adverse Event|0
6987398|NCT01279343|11045378|FG000|Overall Study|Did not receive treatment|2
6987399|NCT01279343|11045379|FG001|Overall Study|Did not receive treatment|6
6987400|NCT01279447|11045387|FG000|Overall Study|Lost to Follow-up|3
6987401|NCT01279447|11045388|FG001|Overall Study|Lost to Follow-up|1
6987402|NCT01279486|11045394|FG000|Overall Study|Lost to Follow-up|1
6987403|NCT01279681|11045409|FG000|Overall Study|Disease Progression|9
6987404|NCT01279681|11045410|FG001|Overall Study|Disease Progression|6
6987405|NCT01279681|11045409|FG000|Overall Study|Withdrawal by Subject|3
6987406|NCT01279681|11045410|FG001|Overall Study|Withdrawal by Subject|4
6987407|NCT01279681|11045409|FG000|Overall Study|Adverse Event|2
6987408|NCT01279681|11045410|FG001|Overall Study|Adverse Event|3
6987409|NCT01279681|11045409|FG000|Overall Study|Death|0
6987410|NCT01279681|11045410|FG001|Overall Study|Death|1
6987411|NCT01279681|11045409|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0
6987412|NCT01279681|11045410|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1
6987413|NCT01279681|11045409|FG000|Overall Study|Physician Decision|1
6987414|NCT01279681|11045410|FG001|Overall Study|Physician Decision|0
6987415|NCT01279681|11045409|FG000|Overall Study|Other Reason|0
6987416|NCT01279681|11045410|FG001|Overall Study|Other Reason|2
6987417|NCT01279850|11045416|FG000|Overall Study|Protocol Violation|50
6987418|NCT01279850|11045416|FG000|Overall Study|No Drug Administration Information|7
6987419|NCT01279850|11045416|FG000|Overall Study|No Visit After Treatment|34
6987420|NCT01279954|11045422|FG000|Overall Study|Lack of Efficacy|3
6987421|NCT01279954|11045423|FG001|Overall Study|Lack of Efficacy|4
6987422|NCT01280266|11045473|FG000|First Intervention (Week 1-4)|Adverse Event|1
6987423|NCT01280266|11045474|FG001|First Intervention (Week 1-4)|Adverse Event|0
7060279|NCT01915940|11156307|FG002|Treatment Period|Adverse Event|1
6987424|NCT01280266|11045473|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0
6987425|NCT01280266|11045474|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2
6987426|NCT01280357|11045484|FG000|Overall Study|Excluded no internal monitoring|14
6987427|NCT01280357|11045484|FG000|Overall Study|IInsufficient data/No data supplied|12
6987428|NCT01280591|11045516|FG000|Overall Study|Withdrawal by Subject|0
6987429|NCT01280591|11045517|FG001|Overall Study|Withdrawal by Subject|0
6987430|NCT01280591|11045518|FG002|Overall Study|Withdrawal by Subject|0
6987431|NCT01280591|11045519|FG003|Overall Study|Withdrawal by Subject|2
6987432|NCT01280591|11045516|FG000|Overall Study|Does not meet exclusion #27 criteria|0
6987433|NCT01280591|11045517|FG001|Overall Study|Does not meet exclusion #27 criteria|0
6987434|NCT01280591|11045518|FG002|Overall Study|Does not meet exclusion #27 criteria|0
6987435|NCT01280591|11045519|FG003|Overall Study|Does not meet exclusion #27 criteria|1
6987436|NCT01280617|11045540|FG000|Overall Study|Adverse Event|0
6987437|NCT01280617|11045541|FG001|Overall Study|Adverse Event|1
6987438|NCT01280656|11045550|FG000|Overall Study|Adverse Event|1
6987439|NCT01280656|11045551|FG001|Overall Study|Adverse Event|14
6987440|NCT01280656|11045552|FG002|Overall Study|Adverse Event|13
6987441|NCT01280656|11045550|FG000|Overall Study|Lack of Efficacy|1
6987442|NCT01280656|11045551|FG001|Overall Study|Lack of Efficacy|22
6987443|NCT01280656|11045552|FG002|Overall Study|Lack of Efficacy|38
6987444|NCT01280656|11045550|FG000|Overall Study|Treatment shortening (RGT)|0
6987445|NCT01280656|11045551|FG001|Overall Study|Treatment shortening (RGT)|4
6987446|NCT01280656|11045552|FG002|Overall Study|Treatment shortening (RGT)|5
6987447|NCT01280656|11045550|FG000|Overall Study|Other|1
6987448|NCT01280656|11045551|FG001|Overall Study|Other|7
6987449|NCT01280656|11045552|FG002|Overall Study|Other|7
6987450|NCT01280721|11045581|FG000|Overall Study|Adverse Event|4
6987451|NCT01280721|11045581|FG000|Overall Study|Physician Decision|3
6987452|NCT01280721|11045581|FG000|Overall Study|Withdrawal by Subject|6
6987453|NCT01280721|11045581|FG000|Overall Study|eGFR under the withdrawal criteria|7
6987454|NCT01280721|11045581|FG000|Overall Study|No tolerability for the lowest dose|2
6987455|NCT01280812|11045599|FG000|Overall Study|Withdrawal by Subject|2
6987456|NCT01280812|11045600|FG001|Overall Study|Withdrawal by Subject|1
6987457|NCT01280812|11045601|FG002|Overall Study|Withdrawal by Subject|0
6987458|NCT01280812|11045599|FG000|Overall Study|Lost to Follow-up|1
6987459|NCT01280812|11045600|FG001|Overall Study|Lost to Follow-up|1
6987460|NCT01280812|11045601|FG002|Overall Study|Lost to Follow-up|1
6987461|NCT01280903|11045612|FG000|Overall Study|Lost to Follow-up|23
6987462|NCT01280903|11045613|FG001|Overall Study|Lost to Follow-up|16
6987463|NCT01280955|11045628|FG000|Overall Study|Death|2
6987464|NCT01280955|11045628|FG000|Overall Study|Withdrawal by Subject|1
6987465|NCT01280968|11045636|FG000|Overall Study|Lost to Follow-up|8
6987466|NCT01280968|11045637|FG001|Overall Study|Lost to Follow-up|2
6987467|NCT01280968|11045636|FG000|Overall Study|Unable to Follow Experimental Protocol|2
6987468|NCT01280968|11045637|FG001|Overall Study|Unable to Follow Experimental Protocol|0
6987469|NCT01280968|11045636|FG000|Overall Study|Commuting Problems|2
6987470|NCT01280968|11045637|FG001|Overall Study|Commuting Problems|0
6987471|NCT01280968|11045636|FG000|Overall Study|Anxiety|2
6987472|NCT01280968|11045637|FG001|Overall Study|Anxiety|0
6987473|NCT01280968|11045636|FG000|Overall Study|Adverse Event|1
6987474|NCT01280968|11045637|FG001|Overall Study|Adverse Event|0
6987475|NCT01280968|11045636|FG000|Overall Study|Scheduling Conflicts|1
6987476|NCT01280968|11045637|FG001|Overall Study|Scheduling Conflicts|1
6987477|NCT01280968|11045636|FG000|Overall Study|Pre-existing Neurological Condition|1
6987478|NCT01280968|11045637|FG001|Overall Study|Pre-existing Neurological Condition|0
6987479|NCT01280968|11045636|FG000|Overall Study|Unable to Smoke in Supine Position|1
6987480|NCT01280968|11045637|FG001|Overall Study|Unable to Smoke in Supine Position|0
6987481|NCT01280981|11045644|FG000|Overall Study|Withdrawal by Subject|11
6987482|NCT01280981|11045644|FG000|Overall Study|Protocol Violation|2
6987483|NCT01280981|11045644|FG000|Overall Study|Lack of Efficacy|13
6987484|NCT01280981|11045644|FG000|Overall Study|Lost to Follow-up|3
6987485|NCT01280981|11045644|FG000|Overall Study|Adverse Event|6
6987486|NCT01280981|11045644|FG000|Overall Study|Irregular or discontinued menses|3
6987487|NCT01280981|11045644|FG000|Overall Study|Failed to return|45
6987488|NCT01280981|11045644|FG000|Overall Study|Non-compliance with protocol|3
6987489|NCT01280981|11045644|FG000|Overall Study|Withdrawal of consent|3
6987490|NCT01280981|11045644|FG000|Overall Study|Elective surgery|2
6987491|NCT01280981|11045644|FG000|Overall Study|Study site closure|1
6987492|NCT01281137|11045659|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0
6987493|NCT01281137|11045660|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1
6987494|NCT01281137|11045659|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4
6987495|NCT01281137|11045660|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9
6987496|NCT01281137|11045659|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0
6987497|NCT01281137|11045660|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5
6987498|NCT01281137|11045659|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1
6987499|NCT01281137|11045660|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0
6987500|NCT01281137|11045659|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1
6987501|NCT01281137|11045660|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2
6987502|NCT01281189|11045686|FG000|Overall Study|Adverse Event|7
6987503|NCT01281189|11045687|FG001|Overall Study|Adverse Event|9
6987504|NCT01281189|11045686|FG000|Overall Study|Lost to Follow-up|6
6987505|NCT01281189|11045687|FG001|Overall Study|Lost to Follow-up|4
6987506|NCT01281189|11045686|FG000|Overall Study|Withdrawal by Subject|21
6987507|NCT01281189|11045687|FG001|Overall Study|Withdrawal by Subject|24
6987508|NCT01281189|11045686|FG000|Overall Study|Physician Decision|2
6987509|NCT01281189|11045687|FG001|Overall Study|Physician Decision|3
6987510|NCT01281189|11045686|FG000|Overall Study|Death|103
6987511|NCT01281189|11045687|FG001|Overall Study|Death|91
6987512|NCT01281189|11045686|FG000|Overall Study|Other|8
6987513|NCT01281189|11045687|FG001|Overall Study|Other|12
6987514|NCT01281202|11045695|FG000|Overall Study|Adverse Event|2
6987515|NCT01281202|11045696|FG001|Overall Study|Adverse Event|0
6987516|NCT01281202|11045695|FG000|Overall Study|Withdrawal by Subject|2
6987517|NCT01281202|11045696|FG001|Overall Study|Withdrawal by Subject|2
6987518|NCT01281202|11045695|FG000|Overall Study|Protocol Violation|11
6987519|NCT01281202|11045696|FG001|Overall Study|Protocol Violation|10
6987520|NCT01281202|11045695|FG000|Overall Study|Administrative|2
6987521|NCT01281202|11045696|FG001|Overall Study|Administrative|8
7143139|NCT03026283|11299463|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
7143140|NCT03026283|11299464|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
6987522|NCT01281202|11045695|FG000|Overall Study|Lost to Follow-up|11
6987523|NCT01281202|11045696|FG001|Overall Study|Lost to Follow-up|13
6987524|NCT01281202|11045695|FG000|Overall Study|Incarceration|0
6987525|NCT01281202|11045696|FG001|Overall Study|Incarceration|3
6987526|NCT01281306|11045711|FG000|Overall Study|Lack of Efficacy|0
6987527|NCT01281306|11045712|FG001|Overall Study|Lack of Efficacy|1
6987528|NCT01281306|11045713|FG002|Overall Study|Lack of Efficacy|3
6987529|NCT01281306|11045714|FG003|Overall Study|Lack of Efficacy|0
6987530|NCT01281306|11045715|FG004|Overall Study|Lack of Efficacy|2
6987531|NCT01281306|11045716|FG005|Overall Study|Lack of Efficacy|0
6987532|NCT01281306|11045717|FG006|Overall Study|Lack of Efficacy|1
6987533|NCT01281306|11045711|FG000|Overall Study|Withdrawal by Subject|1
6987534|NCT01281306|11045712|FG001|Overall Study|Withdrawal by Subject|0
6987535|NCT01281306|11045713|FG002|Overall Study|Withdrawal by Subject|2
6987536|NCT01281306|11045714|FG003|Overall Study|Withdrawal by Subject|4
6987537|NCT01281306|11045715|FG004|Overall Study|Withdrawal by Subject|1
6987538|NCT01281306|11045716|FG005|Overall Study|Withdrawal by Subject|3
6987539|NCT01281306|11045717|FG006|Overall Study|Withdrawal by Subject|1
6987540|NCT01281306|11045711|FG000|Overall Study|Protocol deviation|0
6987541|NCT01281306|11045712|FG001|Overall Study|Protocol deviation|1
6987542|NCT01281306|11045713|FG002|Overall Study|Protocol deviation|1
6987543|NCT01281306|11045714|FG003|Overall Study|Protocol deviation|1
6987544|NCT01281306|11045715|FG004|Overall Study|Protocol deviation|1
6987545|NCT01281306|11045716|FG005|Overall Study|Protocol deviation|0
6987546|NCT01281306|11045717|FG006|Overall Study|Protocol deviation|0
6987547|NCT01281306|11045711|FG000|Overall Study|Condition no longer requires study drug|1
6987548|NCT01281306|11045712|FG001|Overall Study|Condition no longer requires study drug|0
6987549|NCT01281306|11045713|FG002|Overall Study|Condition no longer requires study drug|0
6987550|NCT01281306|11045714|FG003|Overall Study|Condition no longer requires study drug|0
6987551|NCT01281306|11045715|FG004|Overall Study|Condition no longer requires study drug|0
6987552|NCT01281306|11045716|FG005|Overall Study|Condition no longer requires study drug|1
6987553|NCT01281306|11045717|FG006|Overall Study|Condition no longer requires study drug|1
6987554|NCT01281306|11045711|FG000|Overall Study|Lost to Follow-up|1
6987555|NCT01281306|11045712|FG001|Overall Study|Lost to Follow-up|0
6987556|NCT01281306|11045713|FG002|Overall Study|Lost to Follow-up|0
6987557|NCT01281306|11045714|FG003|Overall Study|Lost to Follow-up|2
6987558|NCT01281306|11045715|FG004|Overall Study|Lost to Follow-up|0
6987559|NCT01281306|11045716|FG005|Overall Study|Lost to Follow-up|0
6987560|NCT01281306|11045717|FG006|Overall Study|Lost to Follow-up|1
6987561|NCT01281306|11045711|FG000|Overall Study|Death|1
6987562|NCT01281306|11045712|FG001|Overall Study|Death|0
6987563|NCT01281306|11045713|FG002|Overall Study|Death|0
6987564|NCT01281306|11045714|FG003|Overall Study|Death|0
6987565|NCT01281306|11045715|FG004|Overall Study|Death|0
6987566|NCT01281306|11045716|FG005|Overall Study|Death|0
6987567|NCT01281306|11045717|FG006|Overall Study|Death|0
6987568|NCT01281306|11045711|FG000|Overall Study|Adverse Event|3
6987569|NCT01281306|11045712|FG001|Overall Study|Adverse Event|2
6987570|NCT01281306|11045713|FG002|Overall Study|Adverse Event|2
6987571|NCT01281306|11045714|FG003|Overall Study|Adverse Event|3
6987572|NCT01281306|11045715|FG004|Overall Study|Adverse Event|5
6987573|NCT01281306|11045716|FG005|Overall Study|Adverse Event|3
6987574|NCT01281306|11045717|FG006|Overall Study|Adverse Event|3
6987575|NCT01281306|11045711|FG000|Overall Study|Randomized in error|1
6987576|NCT01281306|11045712|FG001|Overall Study|Randomized in error|0
6987577|NCT01281306|11045713|FG002|Overall Study|Randomized in error|0
6987578|NCT01281306|11045714|FG003|Overall Study|Randomized in error|1
6987579|NCT01281306|11045715|FG004|Overall Study|Randomized in error|0
6987580|NCT01281306|11045716|FG005|Overall Study|Randomized in error|0
6987581|NCT01281306|11045717|FG006|Overall Study|Randomized in error|0
6987582|NCT01281839|11045755|FG000|Overall Study|Lost to Follow-up|6
6987583|NCT01281839|11045756|FG001|Overall Study|Lost to Follow-up|3
6987584|NCT01281839|11045755|FG000|Overall Study|Withdrawal by Subject|4
6987585|NCT01281839|11045756|FG001|Overall Study|Withdrawal by Subject|10
6987586|NCT01281839|11045755|FG000|Overall Study|Reason not specified|0
6987587|NCT01281839|11045756|FG001|Overall Study|Reason not specified|1
6987588|NCT01281865|11045764|FG000|Overall Study|Adverse Event|1
6987589|NCT01281865|11045765|FG001|Overall Study|Adverse Event|1
6987590|NCT01281865|11045764|FG000|Overall Study|Withdrawal by Subject|1
6987591|NCT01281865|11045765|FG001|Overall Study|Withdrawal by Subject|0
6987592|NCT01281865|11045764|FG000|Overall Study|Lack of Efficacy|1
6987593|NCT01281865|11045765|FG001|Overall Study|Lack of Efficacy|0
6987594|NCT01281917|11045771|FG000|Overall Study|Withdrawal by Subject|1
6987595|NCT01281956|11045775|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1
6987596|NCT01281956|11045776|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0
6987597|NCT01281969|11045787|FG000|Overall Study|not randomized didn't meet criteria|0
6987598|NCT01281969|11045788|FG001|Overall Study|not randomized didn't meet criteria|0
6987599|NCT01281969|11045789|FG002|Overall Study|not randomized didn't meet criteria|7
6987600|NCT01281969|11045787|FG000|Overall Study|AE during LP prior to IVIG admin|1
6987601|NCT01281969|11045788|FG001|Overall Study|AE during LP prior to IVIG admin|0
6987602|NCT01281969|11045789|FG002|Overall Study|AE during LP prior to IVIG admin|3
6987603|NCT01281969|11045787|FG000|Overall Study|not randomized, child consent not given|0
6987604|NCT01281969|11045788|FG001|Overall Study|not randomized, child consent not given|0
6987605|NCT01281969|11045789|FG002|Overall Study|not randomized, child consent not given|2
6987606|NCT01282164|11045813|FG000|Overall Study|Lack of hypoglycemia during ITT|1
6987607|NCT01282164|11045814|FG001|Overall Study|Lack of hypoglycemia during ITT|0
6987608|NCT01282203|11045828|FG000|Overall Study|Adverse Event|1
6987609|NCT01282229|11045835|FG000|Overall Study|Protocol Violation|2
6987610|NCT01282294|11045862|FG000|Overall Study|Lost to Follow-up|14
6987611|NCT01282294|11045862|FG000|Overall Study|Screening failure|1
6987612|NCT01282294|11045862|FG000|Overall Study|Adverse Event|1
6987613|NCT01282294|11045862|FG000|Overall Study|Patient non-compliance|2
6987614|NCT01282294|11045862|FG000|Overall Study|Physician Decision|1
6987615|NCT01282372|11045866|FG000|Overall Study|Lack of Efficacy / Exacerbation|25
6987616|NCT01282372|11045866|FG000|Overall Study|Lost to Follow-up|23
6987617|NCT01282372|11045866|FG000|Overall Study|Withdrawal by Subject|11
6987618|NCT01282372|11045866|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4
6987619|NCT01282372|11045866|FG000|Overall Study|Death|1
6987620|NCT01282372|11045866|FG000|Overall Study|Presence of AE, Lack of Efficacy|1
6987621|NCT01282372|11045866|FG000|Overall Study|Presence of AE, Regression of Symptoms|1
6987622|NCT01282372|11045866|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1
6987623|NCT01282372|11045866|FG000|Overall Study|Adverse Event|12
6987624|NCT01282424|11045877|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30
6987625|NCT01282424|11045877|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6
6987626|NCT01282424|11045877|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7
6987627|NCT01282424|11045877|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3
6987628|NCT01282424|11045877|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2
6987629|NCT01282424|11045877|FG000|Long-term Follow-up Period (5 Years)|Death|40
6987630|NCT01282424|11045877|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1
6987631|NCT01282424|11045877|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21
6987632|NCT01282463|11045884|FG000|Overall Study|Lost to Follow-up|1
6987633|NCT01282463|11045885|FG001|Overall Study|Lost to Follow-up|0
6987634|NCT01282463|11045886|FG002|Overall Study|Lost to Follow-up|0
6987635|NCT01282463|11045884|FG000|Overall Study|Withdrawal by Subject|6
6987636|NCT01282463|11045885|FG001|Overall Study|Withdrawal by Subject|2
6987637|NCT01282463|11045886|FG002|Overall Study|Withdrawal by Subject|3
6987638|NCT01282463|11045884|FG000|Overall Study|"Never Treated Death"|0
6987639|NCT01282463|11045885|FG001|Overall Study|"Never Treated Death"|1
6987640|NCT01282463|11045886|FG002|Overall Study|"Never Treated Death"|0
6987641|NCT01282463|11045884|FG000|Overall Study|"Never Treated PD"|0
6987642|NCT01282463|11045885|FG001|Overall Study|"Never Treated PD"|1
6987643|NCT01282463|11045886|FG002|Overall Study|"Never Treated PD"|0
6987644|NCT01282463|11045884|FG000|Overall Study|Protocol Violation|0
6987645|NCT01282463|11045885|FG001|Overall Study|Protocol Violation|0
6987646|NCT01282463|11045886|FG002|Overall Study|Protocol Violation|1
6987647|NCT01282463|11045884|FG000|Overall Study|Physician Decision|1
6987648|NCT01282463|11045885|FG001|Overall Study|Physician Decision|0
6987649|NCT01282463|11045886|FG002|Overall Study|Physician Decision|0
6987650|NCT01282476|11045902|FG000|Overall Study|Death|11
6987651|NCT01282801|11045916|FG000|Second Intervention|Emesis During Critical Breakfast|0
6987652|NCT01282801|11045917|FG001|Second Intervention|Emesis During Critical Breakfast|1
6987653|NCT01282814|11045925|FG000|First Intervention|Emesis During Dosing Interval|0
6987654|NCT01282814|11045926|FG001|First Intervention|Emesis During Dosing Interval|3
6987655|NCT01282814|11045925|FG000|Washout of 7 Days|Withdrawal by Subject|2
6987656|NCT01282814|11045926|FG001|Washout of 7 Days|Withdrawal by Subject|0
6987657|NCT01282866|11045932|FG000|Overall Study|Adverse Event|1
6987658|NCT01283009|11045938|FG000|Overall Study|Death|83
6987659|NCT01283009|11045939|FG001|Overall Study|Death|78
6987660|NCT01283009|11045938|FG000|Overall Study|Study ended early|23
6987661|NCT01283009|11045939|FG001|Overall Study|Study ended early|26
6987662|NCT01283009|11045938|FG000|Overall Study|Withdrawal by Subject|10
6987663|NCT01283009|11045939|FG001|Overall Study|Withdrawal by Subject|8
6987664|NCT01283009|11045938|FG000|Overall Study|Physician Decision|1
6987665|NCT01283009|11045939|FG001|Overall Study|Physician Decision|1
6987666|NCT01283009|11045938|FG000|Overall Study|Lost to Follow-up|1
6987667|NCT01283009|11045939|FG001|Overall Study|Lost to Follow-up|0
6987668|NCT01283009|11045938|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0
6987669|NCT01283009|11045939|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4
6987670|NCT01283035|11045950|FG000|Overall Study|Subject later found ineligible|1
6987671|NCT01283139|11045958|FG000|Overall Study|Lost to Follow-up|5
6987672|NCT01283139|11045959|FG001|Overall Study|Lost to Follow-up|2
6987673|NCT01283139|11045960|FG002|Overall Study|Lost to Follow-up|3
6987674|NCT01283139|11045961|FG003|Overall Study|Lost to Follow-up|1
6987675|NCT01283139|11045958|FG000|Overall Study|Withdrawal by Subject|8
6987676|NCT01283139|11045959|FG001|Overall Study|Withdrawal by Subject|8
6987677|NCT01283139|11045960|FG002|Overall Study|Withdrawal by Subject|6
6987678|NCT01283139|11045961|FG003|Overall Study|Withdrawal by Subject|8
6987679|NCT01283139|11045958|FG000|Overall Study|Death|2
6987680|NCT01283139|11045959|FG001|Overall Study|Death|0
6987681|NCT01283139|11045960|FG002|Overall Study|Death|2
6987682|NCT01283139|11045961|FG003|Overall Study|Death|2
6987683|NCT01283139|11045958|FG000|Overall Study|Lack of Efficacy|1
6987684|NCT01283139|11045959|FG001|Overall Study|Lack of Efficacy|2
6987685|NCT01283139|11045960|FG002|Overall Study|Lack of Efficacy|2
6987686|NCT01283139|11045961|FG003|Overall Study|Lack of Efficacy|1
6987687|NCT01283139|11045958|FG000|Overall Study|Early termination due to AE/SAE|1
6987688|NCT01283139|11045959|FG001|Overall Study|Early termination due to AE/SAE|1
6987689|NCT01283139|11045960|FG002|Overall Study|Early termination due to AE/SAE|0
6987690|NCT01283139|11045961|FG003|Overall Study|Early termination due to AE/SAE|0
6987691|NCT01283139|11045958|FG000|Overall Study|Participant's refusal to continue|0
6987692|NCT01283139|11045959|FG001|Overall Study|Participant's refusal to continue|3
6987693|NCT01283139|11045960|FG002|Overall Study|Participant's refusal to continue|1
6987694|NCT01283139|11045961|FG003|Overall Study|Participant's refusal to continue|1
6987695|NCT01283139|11045958|FG000|Overall Study|Pregnancy|0
6987696|NCT01283139|11045959|FG001|Overall Study|Pregnancy|1
6987697|NCT01283139|11045960|FG002|Overall Study|Pregnancy|1
6987698|NCT01283139|11045961|FG003|Overall Study|Pregnancy|0
6987699|NCT01283139|11045958|FG000|Overall Study|Missed follow-up visit|0
6987700|NCT01283139|11045959|FG001|Overall Study|Missed follow-up visit|1
6987701|NCT01283139|11045960|FG002|Overall Study|Missed follow-up visit|2
6987702|NCT01283139|11045961|FG003|Overall Study|Missed follow-up visit|2
6987703|NCT01283139|11045958|FG000|Overall Study|Participant randomized in error|0
6987704|NCT01283139|11045959|FG001|Overall Study|Participant randomized in error|0
6987705|NCT01283139|11045960|FG002|Overall Study|Participant randomized in error|1
6987706|NCT01283139|11045961|FG003|Overall Study|Participant randomized in error|0
6987707|NCT01283152|11045973|FG000|Overall Study|Discharged prior to 24 hr assessment|1
6987708|NCT01283152|11045974|FG001|Overall Study|Discharged prior to 24 hr assessment|0
6987709|NCT01283152|11045973|FG000|Overall Study|Refused HESA|1
6987710|NCT01283152|11045974|FG001|Overall Study|Refused HESA|0
6987711|NCT01283282|11045980|FG000|First Intervention (6 Weeks)|Physician Decision|0
6987712|NCT01283282|11045981|FG001|First Intervention (6 Weeks)|Physician Decision|1
6987713|NCT01283282|11045980|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2
6987714|NCT01283282|11045981|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3
6987715|NCT01283282|11045980|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1
6987716|NCT01283282|11045981|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0
6987717|NCT01283334|11045999|FG000|Overall Study|Withdrawal by Subject|1
6987718|NCT01283334|11045999|FG000|Overall Study|Inability to Swallow Everolimus Pills|1
6987719|NCT01283334|11045999|FG000|Overall Study|Adverse Event|4
6987720|NCT01283334|11045999|FG000|Overall Study|Physician Decision|1
6987721|NCT01283386|11046007|FG000|Overall Study|Death|2
6987722|NCT01283386|11046008|FG001|Overall Study|Death|0
6987723|NCT01283386|11046007|FG000|Overall Study|Withdrawal by Subject|2
6987724|NCT01283386|11046008|FG001|Overall Study|Withdrawal by Subject|1
6987725|NCT01283386|11046007|FG000|Overall Study|Relapse of underlying disease|1
6987726|NCT01283386|11046008|FG001|Overall Study|Relapse of underlying disease|3
6987727|NCT01283386|11046007|FG000|Overall Study|Progression of underlying disease|2
6987728|NCT01283386|11046008|FG001|Overall Study|Progression of underlying disease|7
6987729|NCT01283386|11046007|FG000|Overall Study|Reason not specified|1
6987730|NCT01283386|11046008|FG001|Overall Study|Reason not specified|0
6987731|NCT01283386|11046007|FG000|Overall Study|Protocol Violation|0
6987732|NCT01283386|11046008|FG001|Overall Study|Protocol Violation|1
6987733|NCT01283464|11046016|FG000|Overall Study|Lost to Follow-up|0
6987734|NCT01283464|11046017|FG001|Overall Study|Lost to Follow-up|1
6987735|NCT01283464|11046016|FG000|Overall Study|Withdrawal by Subject|1
6987736|NCT01283464|11046017|FG001|Overall Study|Withdrawal by Subject|0
6987737|NCT01283464|11046016|FG000|Overall Study|Physician Decision|1
6987738|NCT01283464|11046017|FG001|Overall Study|Physician Decision|0
6987739|NCT01283516|11046032|FG000|Overall Study|Adverse Event|0
6987740|NCT01283516|11046033|FG001|Overall Study|Adverse Event|0
6987741|NCT01283516|11046034|FG002|Overall Study|Adverse Event|0
6987742|NCT01283516|11046035|FG003|Overall Study|Adverse Event|0
6987743|NCT01283516|11046036|FG004|Overall Study|Adverse Event|0
6987744|NCT01283516|11046037|FG005|Overall Study|Adverse Event|0
6987745|NCT01283516|11046038|FG006|Overall Study|Adverse Event|2
6987746|NCT01283516|11046039|FG007|Overall Study|Adverse Event|0
6987747|NCT01283516|11046040|FG008|Overall Study|Adverse Event|28
6987748|NCT01283516|11046032|FG000|Overall Study|Death|0
6987749|NCT01283516|11046033|FG001|Overall Study|Death|0
6987750|NCT01283516|11046034|FG002|Overall Study|Death|0
6987751|NCT01283516|11046035|FG003|Overall Study|Death|0
6987752|NCT01283516|11046036|FG004|Overall Study|Death|0
6987753|NCT01283516|11046037|FG005|Overall Study|Death|1
6987754|NCT01283516|11046038|FG006|Overall Study|Death|0
6987755|NCT01283516|11046039|FG007|Overall Study|Death|1
6987756|NCT01283516|11046040|FG008|Overall Study|Death|12
6987757|NCT01283516|11046032|FG000|Overall Study|Disease Progression|2
6987758|NCT01283516|11046033|FG001|Overall Study|Disease Progression|2
6987759|NCT01283516|11046034|FG002|Overall Study|Disease Progression|3
6987760|NCT01283516|11046035|FG003|Overall Study|Disease Progression|3
6987761|NCT01283516|11046036|FG004|Overall Study|Disease Progression|13
6987762|NCT01283516|11046037|FG005|Overall Study|Disease Progression|8
6987763|NCT01283516|11046038|FG006|Overall Study|Disease Progression|6
6987764|NCT01283516|11046039|FG007|Overall Study|Disease Progression|3
6987765|NCT01283516|11046040|FG008|Overall Study|Disease Progression|139
6987766|NCT01283516|11046032|FG000|Overall Study|Withdrawal by Subject|0
6987767|NCT01283516|11046033|FG001|Overall Study|Withdrawal by Subject|0
6987768|NCT01283516|11046034|FG002|Overall Study|Withdrawal by Subject|0
6987769|NCT01283516|11046035|FG003|Overall Study|Withdrawal by Subject|0
6987770|NCT01283516|11046036|FG004|Overall Study|Withdrawal by Subject|1
6987771|NCT01283516|11046037|FG005|Overall Study|Withdrawal by Subject|0
6987772|NCT01283516|11046038|FG006|Overall Study|Withdrawal by Subject|1
6987773|NCT01283516|11046039|FG007|Overall Study|Withdrawal by Subject|0
6987774|NCT01283516|11046040|FG008|Overall Study|Withdrawal by Subject|36
6987775|NCT01283516|11046032|FG000|Overall Study|Administrative problems|0
6987776|NCT01283516|11046033|FG001|Overall Study|Administrative problems|0
6987777|NCT01283516|11046034|FG002|Overall Study|Administrative problems|0
6987778|NCT01283516|11046035|FG003|Overall Study|Administrative problems|0
6987779|NCT01283516|11046036|FG004|Overall Study|Administrative problems|0
6987780|NCT01283516|11046037|FG005|Overall Study|Administrative problems|1
6987781|NCT01283516|11046038|FG006|Overall Study|Administrative problems|1
6987782|NCT01283516|11046039|FG007|Overall Study|Administrative problems|1
6987783|NCT01283516|11046040|FG008|Overall Study|Administrative problems|39
6987784|NCT01283516|11046032|FG000|Overall Study|Lost to Follow-up|0
6987785|NCT01283516|11046033|FG001|Overall Study|Lost to Follow-up|0
6987786|NCT01283516|11046034|FG002|Overall Study|Lost to Follow-up|0
6987787|NCT01283516|11046035|FG003|Overall Study|Lost to Follow-up|0
6987788|NCT01283516|11046036|FG004|Overall Study|Lost to Follow-up|0
6987789|NCT01283516|11046037|FG005|Overall Study|Lost to Follow-up|0
6987790|NCT01283516|11046038|FG006|Overall Study|Lost to Follow-up|0
6987791|NCT01283516|11046039|FG007|Overall Study|Lost to Follow-up|0
6987792|NCT01283516|11046040|FG008|Overall Study|Lost to Follow-up|1
6987793|NCT01283542|11046068|FG000|Main Phase|Acute or progressive vision loss|1
6987794|NCT01283542|11046068|FG000|Main Phase|Uncontrolled diabetes mellitus|1
6987795|NCT01283542|11046068|FG000|Main Phase|abnormal laboratory values|5
6987796|NCT01283542|11046068|FG000|Extension Phase|Physician Decision|1
6987797|NCT01283542|11046068|FG000|Extension Phase|Adverse Event|1
6987798|NCT01283542|11046068|FG000|Extension Phase|Administrative problems|1
6987799|NCT01283581|11046104|FG000|Overall Study|Lost to Follow-up|8
6987800|NCT01283581|11046105|FG001|Overall Study|Lost to Follow-up|6
6987801|NCT01283581|11046106|FG002|Overall Study|Lost to Follow-up|8
6987802|NCT01283581|11046104|FG000|Overall Study|Withdrawal by Subject|2
6987803|NCT01283581|11046105|FG001|Overall Study|Withdrawal by Subject|5
6987804|NCT01283581|11046106|FG002|Overall Study|Withdrawal by Subject|2
6987805|NCT01283581|11046104|FG000|Overall Study|Adverse Event|1
6987806|NCT01283581|11046105|FG001|Overall Study|Adverse Event|1
6987807|NCT01283581|11046106|FG002|Overall Study|Adverse Event|4
6987808|NCT01283581|11046104|FG000|Overall Study|Physician Decision|0
6987809|NCT01283581|11046105|FG001|Overall Study|Physician Decision|1
6987810|NCT01283581|11046106|FG002|Overall Study|Physician Decision|2
6987811|NCT01283581|11046104|FG000|Overall Study|Protocol Violation|0
6987812|NCT01283581|11046105|FG001|Overall Study|Protocol Violation|1
6987813|NCT01283581|11046106|FG002|Overall Study|Protocol Violation|2
6987814|NCT01283581|11046104|FG000|Overall Study|Noncompliance|1
6987815|NCT01283581|11046105|FG001|Overall Study|Noncompliance|0
6987816|NCT01283581|11046106|FG002|Overall Study|Noncompliance|0
6987817|NCT01283581|11046104|FG000|Overall Study|Investigator unblinded|0
6987818|NCT01283581|11046105|FG001|Overall Study|Investigator unblinded|0
6987819|NCT01283581|11046106|FG002|Overall Study|Investigator unblinded|1
6987820|NCT01283581|11046104|FG000|Overall Study|"Early termination"|0
6987821|NCT01283581|11046105|FG001|Overall Study|"Early termination"|0
6987822|NCT01283581|11046106|FG002|Overall Study|"Early termination"|1
6987823|NCT01283971|11046119|FG000|Overall Study|Adverse Event|3
6987824|NCT01283971|11046120|FG001|Overall Study|Adverse Event|5
6987825|NCT01283971|11046119|FG000|Overall Study|Insufficient therapeutic responses|3
6987826|NCT01283971|11046120|FG001|Overall Study|Insufficient therapeutic responses|3
6987827|NCT01283971|11046119|FG000|Overall Study|Protocol Violation|5
6987828|NCT01283971|11046120|FG001|Overall Study|Protocol Violation|1
6987829|NCT01283971|11046119|FG000|Overall Study|Refused treatment|3
6987830|NCT01283971|11046120|FG001|Overall Study|Refused treatment|1
6987831|NCT01283971|11046119|FG000|Overall Study|Failure to return|0
6987832|NCT01283971|11046120|FG001|Overall Study|Failure to return|1
6987833|NCT01283971|11046119|FG000|Overall Study|Administrative reasons|1
6987834|NCT01283971|11046120|FG001|Overall Study|Administrative reasons|1
6987835|NCT01284062|11046130|FG000|Overall Study|Adverse Event|4
6987836|NCT01284062|11046131|FG001|Overall Study|Adverse Event|5
6987837|NCT01284062|11046132|FG002|Overall Study|Adverse Event|0
6987838|NCT01284062|11046133|FG003|Overall Study|Adverse Event|5
6987839|NCT01284062|11046130|FG000|Overall Study|Lack of Efficacy|3
6987840|NCT01284062|11046131|FG001|Overall Study|Lack of Efficacy|2
6987841|NCT01284062|11046132|FG002|Overall Study|Lack of Efficacy|2
6987842|NCT01284062|11046133|FG003|Overall Study|Lack of Efficacy|1
6987843|NCT01284062|11046130|FG000|Overall Study|Medication error without adverse event|0
6987844|NCT01284062|11046131|FG001|Overall Study|Medication error without adverse event|0
6987845|NCT01284062|11046132|FG002|Overall Study|Medication error without adverse event|1
6987846|NCT01284062|11046133|FG003|Overall Study|Medication error without adverse event|0
6987847|NCT01284062|11046130|FG000|Overall Study|Protocol Violation|1
6987848|NCT01284062|11046131|FG001|Overall Study|Protocol Violation|0
6987849|NCT01284062|11046132|FG002|Overall Study|Protocol Violation|0
6987850|NCT01284062|11046133|FG003|Overall Study|Protocol Violation|2
6987851|NCT01284062|11046130|FG000|Overall Study|Withdrawal by Subject|3
6987852|NCT01284062|11046131|FG001|Overall Study|Withdrawal by Subject|1
6987853|NCT01284062|11046132|FG002|Overall Study|Withdrawal by Subject|2
6987854|NCT01284062|11046133|FG003|Overall Study|Withdrawal by Subject|5
6987855|NCT01284062|11046130|FG000|Overall Study|Other|0
6987856|NCT01284062|11046131|FG001|Overall Study|Other|0
6987857|NCT01284062|11046132|FG002|Overall Study|Other|0
6987858|NCT01284062|11046133|FG003|Overall Study|Other|1
6987859|NCT01284062|11046130|FG000|Overall Study|Site Closed|0
6987860|NCT01284062|11046131|FG001|Overall Study|Site Closed|0
6987861|NCT01284062|11046132|FG002|Overall Study|Site Closed|1
6987862|NCT01284062|11046133|FG003|Overall Study|Site Closed|0
6987863|NCT01284114|11046146|FG000|Overall Study|viral infection|1
6987864|NCT01284114|11046146|FG000|Overall Study|From the results of ALLTITUDE study|1
6987865|NCT01284114|11046146|FG000|Overall Study|Symptomatic hypotension|1
6987866|NCT01284114|11046146|FG000|Overall Study|dizziness|1
6987867|NCT01284127|11046151|FG000|Overall Study|Adverse Event|2
6987868|NCT01284127|11046151|FG000|Overall Study|Withdrawal by Subject|4
6987869|NCT01284127|11046151|FG000|Overall Study|Physician Decision|1
6987870|NCT01284140|11046157|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
6987871|NCT01284140|11046158|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
6987872|NCT01284140|11046157|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0
6987873|NCT01284140|11046158|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1
6987874|NCT01284361|11046243|FG000|Overall Study|Withdrawal by Subject|1
6987875|NCT01284361|11046243|FG000|Overall Study|Protocol Violation|5
6987876|NCT01284361|11046243|FG000|Overall Study|Adverse Event|1
6987877|NCT01284361|11046243|FG000|Overall Study|Lost to Follow-up|2
6987878|NCT01284621|11046263|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
6987879|NCT01284621|11046264|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
6987880|NCT01284621|11046265|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
6987881|NCT01284621|11046266|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
6987882|NCT01284621|11046267|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1
6987883|NCT01284621|11046268|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
6987884|NCT01284634|11046282|FG000|Overall Study|Adverse Event|1
6987885|NCT01284634|11046283|FG001|Overall Study|Adverse Event|0
6987886|NCT01284634|11046284|FG002|Overall Study|Adverse Event|2
6987887|NCT01284634|11046285|FG003|Overall Study|Adverse Event|1
6987888|NCT01284959|11046298|FG000|Overall Study|Withdrawal by Subject|1
6987889|NCT01284959|11046299|FG001|Overall Study|Withdrawal by Subject|0
6987890|NCT01284959|11046300|FG002|Overall Study|Withdrawal by Subject|0
6987891|NCT01284959|11046298|FG000|Overall Study|Adverse Event|0
6987892|NCT01284959|11046299|FG001|Overall Study|Adverse Event|0
6987893|NCT01284959|11046300|FG002|Overall Study|Adverse Event|1
6987894|NCT01285310|11046329|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3
6987895|NCT01285310|11046330|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4
6987896|NCT01285310|11046331|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6
6987897|NCT01285310|11046332|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
6987898|NCT01285310|11046333|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
6987899|NCT01285310|11046329|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1
6987900|NCT01285310|11046330|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7
6987901|NCT01285310|11046331|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3
6987902|NCT01285310|11046332|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
6987903|NCT01285310|11046333|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
6987904|NCT01285310|11046329|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1
6987905|NCT01285310|11046330|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
6987906|NCT01285310|11046331|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2
6987907|NCT01285310|11046332|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
6987908|NCT01285310|11046333|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
6987909|NCT01285310|11046329|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
6987910|NCT01285310|11046330|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
6987911|NCT01285310|11046331|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2
7042209|NCT01734382|11126579|FG002|Part 2|Adverse Event|1
6987912|NCT01285310|11046332|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
6987913|NCT01285310|11046333|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
6987914|NCT01285310|11046329|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
6987915|NCT01285310|11046330|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
6987916|NCT01285310|11046331|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
6987917|NCT01285310|11046332|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
6987918|NCT01285310|11046333|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
6987919|NCT01285310|11046329|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1
6987920|NCT01285310|11046330|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0
6987921|NCT01285310|11046331|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1
6987922|NCT01285310|11046332|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0
6987923|NCT01285310|11046333|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0
6987924|NCT01285310|11046329|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0
6987925|NCT01285310|11046330|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2
6987926|NCT01285310|11046331|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3
6987927|NCT01285310|11046332|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0
6987928|NCT01285310|11046333|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2
6987929|NCT01285310|11046329|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
6987930|NCT01285310|11046330|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4
6987931|NCT01285310|11046331|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3
6987932|NCT01285310|11046332|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1
6922188|NCT00810043|10950701|FG002|Overall Study|Non-medical problem|1
6922189|NCT00810043|10950699|FG000|Overall Study|No longer met enrollment criteria|0
6922190|NCT00810043|10950700|FG001|Overall Study|No longer met enrollment criteria|0
6922191|NCT00810043|10950701|FG002|Overall Study|No longer met enrollment criteria|3
6922192|NCT00810069|10950712|FG000|Lead-in Period I|Adverse Event|43
6922193|NCT00810069|10950713|FG001|Lead-in Period I|Adverse Event|0
6922194|NCT00810069|10950714|FG002|Lead-in Period I|Adverse Event|0
6922195|NCT00810069|10950712|FG000|Lead-in Period I|Lack of Efficacy|1
6922196|NCT00810069|10950713|FG001|Lead-in Period I|Lack of Efficacy|0
6922197|NCT00810069|10950714|FG002|Lead-in Period I|Lack of Efficacy|0
6922198|NCT00810069|10950712|FG000|Lead-in Period I|Lost to Follow-up|19
6922199|NCT00810069|10950713|FG001|Lead-in Period I|Lost to Follow-up|0
6922200|NCT00810069|10950714|FG002|Lead-in Period I|Lost to Follow-up|0
6987933|NCT01285310|11046333|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
6987934|NCT01285310|11046329|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
6987935|NCT01285310|11046330|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3
6987936|NCT01285310|11046331|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
6987937|NCT01285310|11046332|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
6987938|NCT01285310|11046333|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
6987939|NCT01285310|11046329|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0
6987940|NCT01285310|11046330|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21
6987941|NCT01285310|11046331|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19
6987942|NCT01285310|11046332|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6
6987943|NCT01285310|11046333|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15
6987944|NCT01285310|11046329|FG000|Active Treatment Phase: Weeks 25-52|Other|0
6987945|NCT01285310|11046330|FG001|Active Treatment Phase: Weeks 25-52|Other|1
6987946|NCT01285310|11046331|FG002|Active Treatment Phase: Weeks 25-52|Other|0
6987947|NCT01285310|11046332|FG003|Active Treatment Phase: Weeks 25-52|Other|0
6987948|NCT01285310|11046333|FG004|Active Treatment Phase: Weeks 25-52|Other|0
6987949|NCT01285310|11046329|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0
6987950|NCT01285310|11046330|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1
6987951|NCT01285310|11046331|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1
6987952|NCT01285310|11046332|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1
6987953|NCT01285310|11046333|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0
6987954|NCT01285323|11046373|FG000|Overall Study|Adverse Event|9
6987955|NCT01285323|11046374|FG001|Overall Study|Adverse Event|8
6987956|NCT01285323|11046373|FG000|Overall Study|Lack of Efficacy|4
6987957|NCT01285323|11046374|FG001|Overall Study|Lack of Efficacy|2
6987958|NCT01285323|11046373|FG000|Overall Study|Withdrawal by Subject|15
6987959|NCT01285323|11046374|FG001|Overall Study|Withdrawal by Subject|11
6987960|NCT01285323|11046373|FG000|Overall Study|Protocol Violation|1
6987961|NCT01285323|11046374|FG001|Overall Study|Protocol Violation|2
6987962|NCT01285323|11046373|FG000|Overall Study|Non-compliance with study procedures|2
6987963|NCT01285323|11046374|FG001|Overall Study|Non-compliance with study procedures|3
6987964|NCT01285323|11046373|FG000|Overall Study|Lost to Follow-up|1
6987965|NCT01285323|11046374|FG001|Overall Study|Lost to Follow-up|1
6987966|NCT01285323|11046373|FG000|Overall Study|Other|1
6987967|NCT01285323|11046374|FG001|Overall Study|Other|3
7042210|NCT01734382|11126577|FG000|Part 2|Lack of Efficacy|0
7042211|NCT01734382|11126578|FG001|Part 2|Lack of Efficacy|1
7042212|NCT01734382|11126579|FG002|Part 2|Lack of Efficacy|1
7042213|NCT01734382|11126577|FG000|Part 2|Other|0
7042214|NCT01734382|11126578|FG001|Part 2|Other|0
7042215|NCT01734382|11126579|FG002|Part 2|Other|1
7042216|NCT01734382|11126577|FG000|Part 2|Physician Decision|0
7042217|NCT01734382|11126578|FG001|Part 2|Physician Decision|0
7042218|NCT01734382|11126579|FG002|Part 2|Physician Decision|3
6987968|NCT01285349|11046383|FG000|Overall Study|Lost to Follow-up|27
6987969|NCT01285349|11046384|FG001|Overall Study|Lost to Follow-up|20
6987970|NCT01285349|11046385|FG002|Overall Study|Lost to Follow-up|27
6987971|NCT01285401|11046396|FG000|Overall Study|Prematurely withdrawn from the study|17
6987972|NCT01285401|11046397|FG001|Overall Study|Prematurely withdrawn from the study|29
6987973|NCT01285492|11046417|FG000|Overall Study|Adverse Event|11
6987974|NCT01285492|11046418|FG001|Overall Study|Adverse Event|0
6987975|NCT01285492|11046417|FG000|Overall Study|Protocol Violation|3
6987976|NCT01285492|11046418|FG001|Overall Study|Protocol Violation|0
6987977|NCT01285492|11046417|FG000|Overall Study|Withdrawal by Subject|2
6987978|NCT01285492|11046418|FG001|Overall Study|Withdrawal by Subject|1
6987979|NCT01285492|11046417|FG000|Overall Study|Death|1
6987980|NCT01285492|11046418|FG001|Overall Study|Death|0
6987981|NCT01285518|11046432|FG000|Overall Study|Lost to Follow-up|0
6987982|NCT01285518|11046433|FG001|Overall Study|Lost to Follow-up|0
6987983|NCT01285518|11046434|FG002|Overall Study|Lost to Follow-up|0
6987984|NCT01285518|11046435|FG003|Overall Study|Lost to Follow-up|0
6987985|NCT01285518|11046436|FG004|Overall Study|Lost to Follow-up|0
6987986|NCT01285518|11046437|FG005|Overall Study|Lost to Follow-up|1
6987987|NCT01285518|11046438|FG006|Overall Study|Lost to Follow-up|0
6987988|NCT01285518|11046439|FG007|Overall Study|Lost to Follow-up|0
6987989|NCT01285609|11046460|FG000|Randomized|Progressive Disease|41
6987990|NCT01285609|11046461|FG001|Randomized|Progressive Disease|61
6987991|NCT01285609|11046460|FG000|Randomized|Adverse Event Unrelated to Study Drug|18
6987992|NCT01285609|11046461|FG001|Randomized|Adverse Event Unrelated to Study Drug|18
6987993|NCT01285609|11046460|FG000|Randomized|Study Drug Toxicity|13
6987994|NCT01285609|11046461|FG001|Randomized|Study Drug Toxicity|14
6987995|NCT01285609|11046460|FG000|Randomized|Death|5
6987996|NCT01285609|11046461|FG001|Randomized|Death|7
6987997|NCT01285609|11046460|FG000|Randomized|Withdrawal by Subject|8
6987998|NCT01285609|11046461|FG001|Randomized|Withdrawal by Subject|11
6987999|NCT01285609|11046460|FG000|Randomized|Subject No Longer Met Study Criteria|1
6988000|NCT01285609|11046461|FG001|Randomized|Subject No Longer Met Study Criteria|1
6988001|NCT01285609|11046460|FG000|Randomized|Undisclosed Reasons|1
6988002|NCT01285609|11046461|FG001|Randomized|Undisclosed Reasons|0
6988003|NCT01285609|11046460|FG000|Randomized|Randomized but not Treated|4
6988004|NCT01285609|11046461|FG001|Randomized|Randomized but not Treated|4
6988005|NCT01285609|11046460|FG000|Treated With Blinded Therapy|Progressive Disease|223
6988006|NCT01285609|11046461|FG001|Treated With Blinded Therapy|Progressive Disease|305
6988007|NCT01285609|11046460|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87
6988008|NCT01285609|11046461|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14
6988009|NCT01285609|11046460|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36
6988010|NCT01285609|11046461|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14
6988011|NCT01285609|11046460|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20
6988012|NCT01285609|11046461|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7
6988013|NCT01285609|11046460|FG000|Treated With Blinded Therapy|Death|11
6988014|NCT01285609|11046461|FG001|Treated With Blinded Therapy|Death|3
6988015|NCT01285609|11046460|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2
6988016|NCT01285609|11046461|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4
6988017|NCT01285609|11046460|FG000|Treated With Blinded Therapy|Not Reported|0
6988018|NCT01285609|11046461|FG001|Treated With Blinded Therapy|Not Reported|2
6988019|NCT01285609|11046460|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1
6988020|NCT01285609|11046461|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2
6988021|NCT01285609|11046460|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1
6988022|NCT01285609|11046461|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0
6988023|NCT01285609|11046460|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1
6988024|NCT01285609|11046461|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3
6988025|NCT01285609|11046460|FG000|Treated With Blinded Therapy|Physician and Patient decision|1
6988026|NCT01285609|11046461|FG001|Treated With Blinded Therapy|Physician and Patient decision|3
6988027|NCT01285609|11046460|FG000|Treated With Blinded Therapy|Participant refused participation|1
6988028|NCT01285609|11046461|FG001|Treated With Blinded Therapy|Participant refused participation|0
6988029|NCT01285609|11046460|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1
6988030|NCT01285609|11046461|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0
6988031|NCT01285609|11046460|FG000|Treated With Blinded Therapy|Participant hospitalized|1
6988032|NCT01285609|11046461|FG001|Treated With Blinded Therapy|Participant hospitalized|0
6988033|NCT01285609|11046460|FG000|Treated With Blinded Therapy|Investigator's assessment|1
6988034|NCT01285609|11046461|FG001|Treated With Blinded Therapy|Investigator's assessment|0
6988035|NCT01285609|11046460|FG000|Treated With Blinded Therapy|PI decision to discontinue|0
6988036|NCT01285609|11046461|FG001|Treated With Blinded Therapy|PI decision to discontinue|1
6988037|NCT01285609|11046460|FG000|Treated With Blinded Therapy|Worsening of general condition|0
6988038|NCT01285609|11046461|FG001|Treated With Blinded Therapy|Worsening of general condition|1
6988039|NCT01285908|11046516|FG000|Baseline Measurement|unable to insert catheter|1
6988040|NCT01285908|11046517|FG001|Baseline Measurement|unable to insert catheter|0
6988041|NCT01285908|11046518|FG002|Baseline Measurement|unable to insert catheter|0
6988042|NCT01285908|11046516|FG000|Baseline Measurement|History of stroke, exclusion criteria|1
6988043|NCT01285908|11046517|FG001|Baseline Measurement|History of stroke, exclusion criteria|0
6988044|NCT01285908|11046518|FG002|Baseline Measurement|History of stroke, exclusion criteria|0
6988045|NCT01285908|11046516|FG000|Baseline Measurement|unable to tolerate procedure|1
6988046|NCT01285908|11046517|FG001|Baseline Measurement|unable to tolerate procedure|0
6988047|NCT01285908|11046518|FG002|Baseline Measurement|unable to tolerate procedure|0
6988048|NCT01285960|11046548|FG000|Overall Study|Withdrawal by Subject|2
6988049|NCT01285960|11046548|FG000|Overall Study|Lost to Follow-up|2
6988050|NCT01285960|11046548|FG000|Overall Study|2 subjects received less 10 sonications|2
6988051|NCT01286012|11046554|FG000|Overall Study|Adverse Event|3
6988052|NCT01286012|11046555|FG001|Overall Study|Adverse Event|3
6988053|NCT01286012|11046554|FG000|Overall Study|Death|2
6988054|NCT01286012|11046555|FG001|Overall Study|Death|3
6988055|NCT01286012|11046554|FG000|Overall Study|Protocol Violation|1
6988056|NCT01286012|11046555|FG001|Overall Study|Protocol Violation|1
6988057|NCT01286012|11046554|FG000|Overall Study|Withdrawal by Subject|4
6988058|NCT01286012|11046555|FG001|Overall Study|Withdrawal by Subject|4
6988059|NCT01286012|11046554|FG000|Overall Study|Physician Decision|2
6988060|NCT01286012|11046555|FG001|Overall Study|Physician Decision|0
6988061|NCT01286012|11046554|FG000|Overall Study|peritoneal dialysis, randomized in error|1
6988062|NCT01286012|11046555|FG001|Overall Study|peritoneal dialysis, randomized in error|3
6988063|NCT01286077|11046564|FG000|Overall Study|Adverse Event|2
6988064|NCT01286077|11046565|FG001|Overall Study|Adverse Event|0
6988065|NCT01286077|11046564|FG000|Overall Study|Death|1
6988066|NCT01286077|11046565|FG001|Overall Study|Death|0
6988067|NCT01286077|11046564|FG000|Overall Study|Protocol Violation|1
6988068|NCT01286077|11046565|FG001|Overall Study|Protocol Violation|1
6988069|NCT01286077|11046564|FG000|Overall Study|Withdrawal by Subject|0
6988070|NCT01286077|11046565|FG001|Overall Study|Withdrawal by Subject|2
6988071|NCT01286077|11046564|FG000|Overall Study|Intercurrent illness|1
6988072|NCT01286077|11046565|FG001|Overall Study|Intercurrent illness|0
6988073|NCT01286077|11046564|FG000|Overall Study|Non-compliance|1
6988074|NCT01286077|11046565|FG001|Overall Study|Non-compliance|0
6988075|NCT01286077|11046564|FG000|Overall Study|The subject starts with alternative MMY|0
6988076|NCT01286077|11046565|FG001|Overall Study|The subject starts with alternative MMY|3
6988077|NCT01286077|11046564|FG000|Overall Study|Patient's decision to stop treatment|3
6988078|NCT01286077|11046565|FG001|Overall Study|Patient's decision to stop treatment|0
6988079|NCT01286077|11046564|FG000|Overall Study|Progression of disease|0
6988080|NCT01286077|11046565|FG001|Overall Study|Progression of disease|1
6988081|NCT01286077|11046564|FG000|Overall Study|refill medication not received in time|1
6988082|NCT01286077|11046565|FG001|Overall Study|refill medication not received in time|0
6988083|NCT01286129|11046573|FG000|Overall Study|Withdrawal by Subject|4
6988084|NCT01286129|11046574|FG001|Overall Study|Withdrawal by Subject|1
6988085|NCT01286129|11046573|FG000|Overall Study|Could not comply with study requirements|4
6988086|NCT01286129|11046574|FG001|Overall Study|Could not comply with study requirements|4
6988087|NCT01286168|11046582|FG000|Overall Study|Withdrawal by Subject|1
6988088|NCT01286168|11046582|FG000|Overall Study|Surgical Drains Fell Out at Home|2
6988089|NCT01286311|11046593|FG000|Overall Study|Physician did not want outreach sent|14
6988090|NCT01286311|11046594|FG001|Overall Study|Physician did not want outreach sent|0
6988091|NCT01286480|11046661|FG000|Overall Study|Withdrawal by Subject|5
6988092|NCT01286480|11046662|FG001|Overall Study|Withdrawal by Subject|3
6988093|NCT01286558|11046674|FG000|Overall Study|Adverse Event|1
6988094|NCT01286558|11046675|FG001|Overall Study|Adverse Event|1
6988095|NCT01286558|11046674|FG000|Overall Study|Withdrawal by Subject|0
6988096|NCT01286558|11046675|FG001|Overall Study|Withdrawal by Subject|1
6988097|NCT01286740|11046681|FG000|Overall Study|Enrolled but not treated|1
6988098|NCT01286740|11046681|FG000|Overall Study|Protocol Violation|1
6988099|NCT01286753|11046687|FG000|Overall Study|Adverse Event|7
6988100|NCT01286753|11046688|FG001|Overall Study|Adverse Event|6
6988101|NCT01286753|11046687|FG000|Overall Study|Progression|11
6988102|NCT01286753|11046688|FG001|Overall Study|Progression|13
6988103|NCT01286753|11046687|FG000|Overall Study|Refused Treatment|1
6988104|NCT01286753|11046688|FG001|Overall Study|Refused Treatment|0
6988105|NCT01286753|11046687|FG000|Overall Study|Withdrawal of Consent|0
6988106|NCT01286753|11046688|FG001|Overall Study|Withdrawal of Consent|2
6988107|NCT01286753|11046687|FG000|Overall Study|Discontinued to Join Extension Study|6
6988108|NCT01286753|11046688|FG001|Overall Study|Discontinued to Join Extension Study|4
6988109|NCT01286753|11046687|FG000|Overall Study|Participant to Receive Radiotherapy|1
6988110|NCT01286753|11046688|FG001|Overall Study|Participant to Receive Radiotherapy|0
6988111|NCT01286779|11046695|FG000|Overall Study|Withdrawal by Subject|9
6988112|NCT01286779|11046695|FG000|Overall Study|Protocol Violation|5
6988113|NCT01286779|11046695|FG000|Overall Study|Physician Decision|2
6988114|NCT01286779|11046695|FG000|Overall Study|Participant had scheduled surgery|1
6988115|NCT01286779|11046695|FG000|Overall Study|Participant moved to another country|1
6988116|NCT01286779|11046695|FG000|Overall Study|Discontinued by sponsor|1
6988117|NCT01286987|11046741|FG000|Part 1: Dose Escalation|Clinical Progression|1
6988118|NCT01286987|11046742|FG001|Part 1: Dose Escalation|Clinical Progression|1
6988119|NCT01286987|11046743|FG002|Part 1: Dose Escalation|Clinical Progression|0
6988120|NCT01286987|11046744|FG003|Part 1: Dose Escalation|Clinical Progression|1
6988121|NCT01286987|11046745|FG004|Part 1: Dose Escalation|Clinical Progression|1
6988122|NCT01286987|11046746|FG005|Part 1: Dose Escalation|Clinical Progression|1
6988123|NCT01286987|11046747|FG006|Part 1: Dose Escalation|Clinical Progression|0
6988124|NCT01286987|11046748|FG007|Part 1: Dose Escalation|Clinical Progression|2
6988125|NCT01286987|11046749|FG008|Part 1: Dose Escalation|Clinical Progression|1
6988126|NCT01286987|11046750|FG009|Part 1: Dose Escalation|Clinical Progression|0
6988127|NCT01286987|11046751|FG010|Part 1: Dose Escalation|Clinical Progression|0
6988128|NCT01286987|11046752|FG011|Part 1: Dose Escalation|Clinical Progression|0
6988129|NCT01286987|11046753|FG012|Part 1: Dose Escalation|Clinical Progression|0
6988130|NCT01286987|11046754|FG013|Part 1: Dose Escalation|Clinical Progression|0
6988131|NCT01286987|11046755|FG014|Part 1: Dose Escalation|Clinical Progression|0
6988132|NCT01286987|11046741|FG000|Part 1: Dose Escalation|Progressive Disease|2
6988133|NCT01286987|11046742|FG001|Part 1: Dose Escalation|Progressive Disease|2
6988134|NCT01286987|11046743|FG002|Part 1: Dose Escalation|Progressive Disease|3
6988135|NCT01286987|11046744|FG003|Part 1: Dose Escalation|Progressive Disease|2
6988136|NCT01286987|11046745|FG004|Part 1: Dose Escalation|Progressive Disease|1
6988137|NCT01286987|11046746|FG005|Part 1: Dose Escalation|Progressive Disease|5
6988138|NCT01286987|11046747|FG006|Part 1: Dose Escalation|Progressive Disease|5
6988139|NCT01286987|11046748|FG007|Part 1: Dose Escalation|Progressive Disease|3
6988140|NCT01286987|11046749|FG008|Part 1: Dose Escalation|Progressive Disease|5
6988141|NCT01286987|11046750|FG009|Part 1: Dose Escalation|Progressive Disease|0
6988142|NCT01286987|11046751|FG010|Part 1: Dose Escalation|Progressive Disease|0
6988143|NCT01286987|11046752|FG011|Part 1: Dose Escalation|Progressive Disease|0
6988144|NCT01286987|11046753|FG012|Part 1: Dose Escalation|Progressive Disease|0
6988145|NCT01286987|11046754|FG013|Part 1: Dose Escalation|Progressive Disease|0
6988146|NCT01286987|11046755|FG014|Part 1: Dose Escalation|Progressive Disease|0
6988147|NCT01286987|11046741|FG000|Part 1: Dose Escalation|Physician Decision|0
6988148|NCT01286987|11046742|FG001|Part 1: Dose Escalation|Physician Decision|0
6988149|NCT01286987|11046743|FG002|Part 1: Dose Escalation|Physician Decision|0
6988150|NCT01286987|11046744|FG003|Part 1: Dose Escalation|Physician Decision|0
6988151|NCT01286987|11046745|FG004|Part 1: Dose Escalation|Physician Decision|1
6988152|NCT01286987|11046746|FG005|Part 1: Dose Escalation|Physician Decision|0
6988153|NCT01286987|11046747|FG006|Part 1: Dose Escalation|Physician Decision|0
6988154|NCT01286987|11046748|FG007|Part 1: Dose Escalation|Physician Decision|0
6988155|NCT01286987|11046749|FG008|Part 1: Dose Escalation|Physician Decision|0
6988156|NCT01286987|11046750|FG009|Part 1: Dose Escalation|Physician Decision|0
6988157|NCT01286987|11046751|FG010|Part 1: Dose Escalation|Physician Decision|0
6988158|NCT01286987|11046752|FG011|Part 1: Dose Escalation|Physician Decision|0
6988159|NCT01286987|11046753|FG012|Part 1: Dose Escalation|Physician Decision|0
6988160|NCT01286987|11046754|FG013|Part 1: Dose Escalation|Physician Decision|0
6988161|NCT01286987|11046755|FG014|Part 1: Dose Escalation|Physician Decision|0
6988162|NCT01286987|11046741|FG000|Part 2: Dose Expansion|Death|0
6988163|NCT01286987|11046742|FG001|Part 2: Dose Expansion|Death|0
6988164|NCT01286987|11046743|FG002|Part 2: Dose Expansion|Death|0
6988165|NCT01286987|11046744|FG003|Part 2: Dose Expansion|Death|0
6988166|NCT01286987|11046745|FG004|Part 2: Dose Expansion|Death|0
6988167|NCT01286987|11046746|FG005|Part 2: Dose Expansion|Death|0
6988168|NCT01286987|11046747|FG006|Part 2: Dose Expansion|Death|0
6988169|NCT01286987|11046748|FG007|Part 2: Dose Expansion|Death|0
6988170|NCT01286987|11046749|FG008|Part 2: Dose Expansion|Death|0
6988171|NCT01286987|11046750|FG009|Part 2: Dose Expansion|Death|0
6988172|NCT01286987|11046751|FG010|Part 2: Dose Expansion|Death|0
6988173|NCT01286987|11046752|FG011|Part 2: Dose Expansion|Death|0
6988174|NCT01286987|11046753|FG012|Part 2: Dose Expansion|Death|1
6988175|NCT01286987|11046754|FG013|Part 2: Dose Expansion|Death|1
6988176|NCT01286987|11046755|FG014|Part 2: Dose Expansion|Death|0
6988177|NCT01286987|11046741|FG000|Part 2: Dose Expansion|Physician Decision|0
6988178|NCT01286987|11046742|FG001|Part 2: Dose Expansion|Physician Decision|0
6988179|NCT01286987|11046743|FG002|Part 2: Dose Expansion|Physician Decision|0
6988180|NCT01286987|11046744|FG003|Part 2: Dose Expansion|Physician Decision|0
6988181|NCT01286987|11046745|FG004|Part 2: Dose Expansion|Physician Decision|0
6988182|NCT01286987|11046746|FG005|Part 2: Dose Expansion|Physician Decision|0
6988183|NCT01286987|11046747|FG006|Part 2: Dose Expansion|Physician Decision|0
6988184|NCT01286987|11046748|FG007|Part 2: Dose Expansion|Physician Decision|0
6988185|NCT01286987|11046749|FG008|Part 2: Dose Expansion|Physician Decision|0
6988186|NCT01286987|11046750|FG009|Part 2: Dose Expansion|Physician Decision|0
6988187|NCT01286987|11046751|FG010|Part 2: Dose Expansion|Physician Decision|1
6988188|NCT01286987|11046752|FG011|Part 2: Dose Expansion|Physician Decision|1
6988189|NCT01286987|11046753|FG012|Part 2: Dose Expansion|Physician Decision|0
6988190|NCT01286987|11046754|FG013|Part 2: Dose Expansion|Physician Decision|1
6988191|NCT01286987|11046755|FG014|Part 2: Dose Expansion|Physician Decision|0
6988192|NCT01286987|11046741|FG000|Part 2: Dose Expansion|Other|0
6988193|NCT01286987|11046742|FG001|Part 2: Dose Expansion|Other|0
6988194|NCT01286987|11046743|FG002|Part 2: Dose Expansion|Other|0
6988195|NCT01286987|11046744|FG003|Part 2: Dose Expansion|Other|0
6988196|NCT01286987|11046745|FG004|Part 2: Dose Expansion|Other|0
6988197|NCT01286987|11046746|FG005|Part 2: Dose Expansion|Other|0
6988198|NCT01286987|11046747|FG006|Part 2: Dose Expansion|Other|0
6988199|NCT01286987|11046748|FG007|Part 2: Dose Expansion|Other|0
6988200|NCT01286987|11046749|FG008|Part 2: Dose Expansion|Other|0
6988201|NCT01286987|11046750|FG009|Part 2: Dose Expansion|Other|0
6988202|NCT01286987|11046751|FG010|Part 2: Dose Expansion|Other|0
6988203|NCT01286987|11046752|FG011|Part 2: Dose Expansion|Other|0
6988204|NCT01286987|11046753|FG012|Part 2: Dose Expansion|Other|0
6988205|NCT01286987|11046754|FG013|Part 2: Dose Expansion|Other|1
6988206|NCT01286987|11046755|FG014|Part 2: Dose Expansion|Other|0
6988207|NCT01286987|11046741|FG000|Part 2: Dose Expansion|Progressive Disease|0
6988208|NCT01286987|11046742|FG001|Part 2: Dose Expansion|Progressive Disease|0
6988209|NCT01286987|11046743|FG002|Part 2: Dose Expansion|Progressive Disease|0
6988210|NCT01286987|11046744|FG003|Part 2: Dose Expansion|Progressive Disease|0
6988211|NCT01286987|11046745|FG004|Part 2: Dose Expansion|Progressive Disease|0
6988212|NCT01286987|11046746|FG005|Part 2: Dose Expansion|Progressive Disease|0
6988213|NCT01286987|11046747|FG006|Part 2: Dose Expansion|Progressive Disease|0
6988214|NCT01286987|11046748|FG007|Part 2: Dose Expansion|Progressive Disease|0
6988215|NCT01286987|11046749|FG008|Part 2: Dose Expansion|Progressive Disease|0
6988216|NCT01286987|11046750|FG009|Part 2: Dose Expansion|Progressive Disease|11
6988217|NCT01286987|11046751|FG010|Part 2: Dose Expansion|Progressive Disease|6
6988218|NCT01286987|11046752|FG011|Part 2: Dose Expansion|Progressive Disease|7
6988219|NCT01286987|11046753|FG012|Part 2: Dose Expansion|Progressive Disease|11
6988220|NCT01286987|11046754|FG013|Part 2: Dose Expansion|Progressive Disease|19
6988221|NCT01286987|11046755|FG014|Part 2: Dose Expansion|Progressive Disease|2
6988222|NCT01286987|11046741|FG000|Part 2: Dose Expansion|Clinical Progression|0
6988223|NCT01286987|11046742|FG001|Part 2: Dose Expansion|Clinical Progression|0
6988224|NCT01286987|11046743|FG002|Part 2: Dose Expansion|Clinical Progression|0
6988225|NCT01286987|11046744|FG003|Part 2: Dose Expansion|Clinical Progression|0
6988226|NCT01286987|11046745|FG004|Part 2: Dose Expansion|Clinical Progression|0
6988227|NCT01286987|11046746|FG005|Part 2: Dose Expansion|Clinical Progression|0
6988228|NCT01286987|11046747|FG006|Part 2: Dose Expansion|Clinical Progression|0
6988229|NCT01286987|11046748|FG007|Part 2: Dose Expansion|Clinical Progression|0
6988230|NCT01286987|11046749|FG008|Part 2: Dose Expansion|Clinical Progression|0
6988231|NCT01286987|11046750|FG009|Part 2: Dose Expansion|Clinical Progression|0
6988232|NCT01286987|11046751|FG010|Part 2: Dose Expansion|Clinical Progression|2
6988233|NCT01286987|11046752|FG011|Part 2: Dose Expansion|Clinical Progression|2
6988234|NCT01286987|11046753|FG012|Part 2: Dose Expansion|Clinical Progression|0
6988235|NCT01286987|11046754|FG013|Part 2: Dose Expansion|Clinical Progression|2
6988236|NCT01286987|11046755|FG014|Part 2: Dose Expansion|Clinical Progression|0
6988237|NCT01286987|11046741|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0
6988238|NCT01286987|11046742|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0
6988239|NCT01286987|11046743|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0
6988240|NCT01286987|11046744|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0
6988241|NCT01286987|11046745|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0
6988242|NCT01286987|11046746|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0
6988243|NCT01286987|11046747|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0
6988244|NCT01286987|11046748|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0
6988245|NCT01286987|11046749|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0
6988246|NCT01286987|11046750|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0
6988247|NCT01286987|11046751|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1
6988248|NCT01286987|11046752|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0
6988249|NCT01286987|11046753|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0
6988250|NCT01286987|11046754|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0
6988251|NCT01286987|11046755|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0
6988252|NCT01287013|11046799|FG000|Overall Study|Non-evaluable|3
6988253|NCT01287013|11046800|FG001|Overall Study|Non-evaluable|5
6988254|NCT01287013|11046801|FG002|Overall Study|Non-evaluable|21
6988255|NCT01287039|11046811|FG000|Overall Study|Noncompliance with study procedures|0
6988256|NCT01287039|11046812|FG001|Overall Study|Noncompliance with study procedures|1
6988257|NCT01287039|11046811|FG000|Overall Study|Change of location/residence|0
6988258|NCT01287039|11046812|FG001|Overall Study|Change of location/residence|3
6988259|NCT01287039|11046811|FG000|Overall Study|Elective surgery|0
6988260|NCT01287039|11046812|FG001|Overall Study|Elective surgery|1
6988261|NCT01287039|11046811|FG000|Overall Study|Protocol Violation|2
6988262|NCT01287039|11046812|FG001|Overall Study|Protocol Violation|3
6988263|NCT01287039|11046811|FG000|Overall Study|Excluded medication taken|1
6988264|NCT01287039|11046812|FG001|Overall Study|Excluded medication taken|0
6988265|NCT01287039|11046811|FG000|Overall Study|Noncompliance with study medication|0
6988266|NCT01287039|11046812|FG001|Overall Study|Noncompliance with study medication|1
6988267|NCT01287039|11046811|FG000|Overall Study|Problem with travel|0
6988268|NCT01287039|11046812|FG001|Overall Study|Problem with travel|1
6988269|NCT01287039|11046811|FG000|Overall Study|Death|1
6988270|NCT01287039|11046812|FG001|Overall Study|Death|0
6988271|NCT01287039|11046811|FG000|Overall Study|Change of residence|1
6988272|NCT01287039|11046812|FG001|Overall Study|Change of residence|0
6988273|NCT01287039|11046811|FG000|Overall Study|Adverse Event|7
6988274|NCT01287039|11046812|FG001|Overall Study|Adverse Event|4
6988275|NCT01287039|11046811|FG000|Overall Study|Withdrawal by Subject|14
6988276|NCT01287039|11046812|FG001|Overall Study|Withdrawal by Subject|11
6988277|NCT01287039|11046811|FG000|Overall Study|Lost to Follow-up|3
6988278|NCT01287039|11046812|FG001|Overall Study|Lost to Follow-up|2
6988279|NCT01287065|11046818|FG000|Treatment Period 1|Adverse Event|0
6988280|NCT01287065|11046819|FG001|Treatment Period 1|Adverse Event|0
6988281|NCT01287065|11046820|FG002|Treatment Period 1|Adverse Event|0
6988282|NCT01287065|11046821|FG003|Treatment Period 1|Adverse Event|0
6988283|NCT01287065|11046822|FG004|Treatment Period 1|Adverse Event|1
6988284|NCT01287065|11046823|FG005|Treatment Period 1|Adverse Event|0
6988285|NCT01287065|11046818|FG000|Treatment Period 1|Withdrawal by Subject|0
6988286|NCT01287065|11046819|FG001|Treatment Period 1|Withdrawal by Subject|0
6988287|NCT01287065|11046820|FG002|Treatment Period 1|Withdrawal by Subject|0
6988288|NCT01287065|11046821|FG003|Treatment Period 1|Withdrawal by Subject|0
6988289|NCT01287065|11046822|FG004|Treatment Period 1|Withdrawal by Subject|0
6988290|NCT01287065|11046823|FG005|Treatment Period 1|Withdrawal by Subject|1
6988291|NCT01287104|11046844|FG000|Overall Study|Patient developed progressive disease|1
6988292|NCT01287104|11046845|FG001|Overall Study|Patient developed progressive disease|1
6988293|NCT01287104|11046846|FG002|Overall Study|Patient developed progressive disease|3
6988294|NCT01287104|11046847|FG003|Overall Study|Patient developed progressive disease|2
6988295|NCT01287104|11046844|FG000|Overall Study|Donor anaphylaxis|0
6988296|NCT01287104|11046845|FG001|Overall Study|Donor anaphylaxis|1
6988297|NCT01287104|11046846|FG002|Overall Study|Donor anaphylaxis|0
6988298|NCT01287104|11046847|FG003|Overall Study|Donor anaphylaxis|1
6988299|NCT01287104|11046844|FG000|Overall Study|Developed GVHD or complications of BMT|0
6988300|NCT01287104|11046845|FG001|Overall Study|Developed GVHD or complications of BMT|1
6988301|NCT01287104|11046846|FG002|Overall Study|Developed GVHD or complications of BMT|4
6988302|NCT01287104|11046847|FG003|Overall Study|Developed GVHD or complications of BMT|0
6988303|NCT01287104|11046844|FG000|Overall Study|Low donor chimerism|0
6988304|NCT01287104|11046845|FG001|Overall Study|Low donor chimerism|1
6988305|NCT01287104|11046846|FG002|Overall Study|Low donor chimerism|0
6988306|NCT01287104|11046847|FG003|Overall Study|Low donor chimerism|0
6988307|NCT01287104|11046844|FG000|Overall Study|NK cells did not meet release criteria|0
6988308|NCT01287104|11046845|FG001|Overall Study|NK cells did not meet release criteria|1
6988309|NCT01287104|11046846|FG002|Overall Study|NK cells did not meet release criteria|0
6988310|NCT01287104|11046847|FG003|Overall Study|NK cells did not meet release criteria|0
6988311|NCT01287117|11046868|FG000|Overall Study|Adverse Event|2
6988312|NCT01287117|11046869|FG001|Overall Study|Adverse Event|1
6988313|NCT01287117|11046870|FG002|Overall Study|Adverse Event|1
6988314|NCT01287117|11046871|FG003|Overall Study|Adverse Event|1
6988315|NCT01287117|11046868|FG000|Overall Study|Lost to Follow-up|1
6988316|NCT01287117|11046869|FG001|Overall Study|Lost to Follow-up|1
6988317|NCT01287117|11046870|FG002|Overall Study|Lost to Follow-up|0
6988318|NCT01287117|11046871|FG003|Overall Study|Lost to Follow-up|0
6988319|NCT01287117|11046868|FG000|Overall Study|Physician Decision|0
6988320|NCT01287117|11046869|FG001|Overall Study|Physician Decision|1
6988321|NCT01287117|11046870|FG002|Overall Study|Physician Decision|1
6988322|NCT01287117|11046871|FG003|Overall Study|Physician Decision|1
6988323|NCT01287117|11046868|FG000|Overall Study|Patient/Legal Guardian's Decision|2
6988324|NCT01287117|11046869|FG001|Overall Study|Patient/Legal Guardian's Decision|6
6988325|NCT01287117|11046870|FG002|Overall Study|Patient/Legal Guardian's Decision|8
6988326|NCT01287117|11046871|FG003|Overall Study|Patient/Legal Guardian's Decision|5
6988327|NCT01287117|11046868|FG000|Overall Study|Disease Progression|10
6988328|NCT01287117|11046869|FG001|Overall Study|Disease Progression|5
6988329|NCT01287117|11046870|FG002|Overall Study|Disease Progression|6
6988330|NCT01287117|11046871|FG003|Overall Study|Disease Progression|5
6988331|NCT01287195|11046881|FG000|Overall Study|Withdrawal by Subject|2
6988332|NCT01287221|11046898|FG000|Overall Study|Lack of Perceived Benefit|1
6988333|NCT01287221|11046899|FG001|Overall Study|Lack of Perceived Benefit|1
6988334|NCT01287221|11046898|FG000|Overall Study|Adverse Event|3
6988335|NCT01287221|11046899|FG001|Overall Study|Adverse Event|3
6988336|NCT01287221|11046898|FG000|Overall Study|Withdrawal by Subject|0
6988337|NCT01287221|11046899|FG001|Overall Study|Withdrawal by Subject|1
6988338|NCT01287364|11046907|FG000|Overall Study|Adverse Event|0
6988339|NCT01287364|11046908|FG001|Overall Study|Adverse Event|3
6988340|NCT01287364|11046907|FG000|Overall Study|Protocol Violation|5
6988341|NCT01287364|11046908|FG001|Overall Study|Protocol Violation|5
6988342|NCT01287364|11046907|FG000|Overall Study|Other Reason|4
6988343|NCT01287364|11046908|FG001|Overall Study|Other Reason|2
6988344|NCT01287403|11046940|FG000|1st Intervention (1 Day)|Adverse Event|1
6988345|NCT01287416|11046956|FG000|Pre-post Training|Withdrawal by Subject|17
6988346|NCT01287416|11046957|FG001|Pre-post Training|Withdrawal by Subject|24
6988347|NCT01287416|11046956|FG000|Pre-post Training|Lost to Follow-up|5
6988348|NCT01287416|11046957|FG001|Pre-post Training|Lost to Follow-up|1
6988349|NCT01287416|11046956|FG000|6 Month Follow-up|Lost to Follow-up|3
6988350|NCT01287416|11046957|FG001|6 Month Follow-up|Lost to Follow-up|2
6988351|NCT01287520|11046972|FG000|Overall Study|Adverse Event|2
6988352|NCT01287520|11046973|FG001|Overall Study|Adverse Event|2
6988353|NCT01287520|11046974|FG002|Overall Study|Adverse Event|2
6988354|NCT01287520|11046975|FG003|Overall Study|Adverse Event|1
6988355|NCT01287520|11046976|FG004|Overall Study|Adverse Event|1
6988356|NCT01287520|11046977|FG005|Overall Study|Adverse Event|2
6988357|NCT01287520|11046978|FG006|Overall Study|Adverse Event|0
6988358|NCT01287520|11046979|FG007|Overall Study|Adverse Event|2
6988359|NCT01287520|11046980|FG008|Overall Study|Adverse Event|0
6988360|NCT01287520|11046972|FG000|Overall Study|Physician Decision|1
6988361|NCT01287520|11046973|FG001|Overall Study|Physician Decision|1
6988362|NCT01287520|11046974|FG002|Overall Study|Physician Decision|2
6988363|NCT01287520|11046975|FG003|Overall Study|Physician Decision|0
6988364|NCT01287520|11046976|FG004|Overall Study|Physician Decision|1
6988365|NCT01287520|11046977|FG005|Overall Study|Physician Decision|1
6988366|NCT01287520|11046978|FG006|Overall Study|Physician Decision|0
6988367|NCT01287520|11046979|FG007|Overall Study|Physician Decision|1
6988368|NCT01287520|11046980|FG008|Overall Study|Physician Decision|0
6988369|NCT01287520|11046972|FG000|Overall Study|Progressive disease|0
6988370|NCT01287520|11046973|FG001|Overall Study|Progressive disease|4
6988371|NCT01287520|11046974|FG002|Overall Study|Progressive disease|1
6988372|NCT01287520|11046975|FG003|Overall Study|Progressive disease|6
6988373|NCT01287520|11046976|FG004|Overall Study|Progressive disease|1
6988374|NCT01287520|11046977|FG005|Overall Study|Progressive disease|0
6988375|NCT01287520|11046978|FG006|Overall Study|Progressive disease|2
6988376|NCT01287520|11046979|FG007|Overall Study|Progressive disease|2
6988377|NCT01287520|11046980|FG008|Overall Study|Progressive disease|4
6988378|NCT01287520|11046972|FG000|Overall Study|Withdrawal by Subject|0
6988379|NCT01287520|11046973|FG001|Overall Study|Withdrawal by Subject|0
6988380|NCT01287520|11046974|FG002|Overall Study|Withdrawal by Subject|0
6988381|NCT01287520|11046975|FG003|Overall Study|Withdrawal by Subject|0
6988382|NCT01287520|11046976|FG004|Overall Study|Withdrawal by Subject|0
6988383|NCT01287520|11046977|FG005|Overall Study|Withdrawal by Subject|1
6988384|NCT01287520|11046978|FG006|Overall Study|Withdrawal by Subject|0
6988385|NCT01287520|11046979|FG007|Overall Study|Withdrawal by Subject|0
6988386|NCT01287520|11046980|FG008|Overall Study|Withdrawal by Subject|1
6988387|NCT01287754|11047031|FG000|Overall Study|Death|2
6988388|NCT01287754|11047032|FG001|Overall Study|Death|12
6988389|NCT01287754|11047031|FG000|Overall Study|Lost to Follow-up|1
6988390|NCT01287754|11047032|FG001|Overall Study|Lost to Follow-up|6
6988391|NCT01287754|11047031|FG000|Overall Study|Protocol Violation|0
6988392|NCT01287754|11047032|FG001|Overall Study|Protocol Violation|3
6988393|NCT01287832|11047040|FG000|Overall Study|Adverse Event|1
6988394|NCT01287832|11047041|FG001|Overall Study|Adverse Event|0
6988395|NCT01287832|11047040|FG000|Overall Study|Death|0
6988396|NCT01287832|11047041|FG001|Overall Study|Death|1
6988397|NCT01287897|11047051|FG000|Overall Study|Adverse Event|5
6988398|NCT01287897|11047052|FG001|Overall Study|Adverse Event|3
6988399|NCT01287897|11047053|FG002|Overall Study|Adverse Event|6
6988400|NCT01287897|11047054|FG003|Overall Study|Adverse Event|4
6988401|NCT01287897|11047051|FG000|Overall Study|Lack of Efficacy|2
6988402|NCT01287897|11047052|FG001|Overall Study|Lack of Efficacy|0
6988403|NCT01287897|11047053|FG002|Overall Study|Lack of Efficacy|0
6988404|NCT01287897|11047054|FG003|Overall Study|Lack of Efficacy|0
6988405|NCT01287897|11047051|FG000|Overall Study|Protocol Violation|1
6988406|NCT01287897|11047052|FG001|Overall Study|Protocol Violation|1
6988407|NCT01287897|11047053|FG002|Overall Study|Protocol Violation|0
6988408|NCT01287897|11047054|FG003|Overall Study|Protocol Violation|1
6988409|NCT01287897|11047051|FG000|Overall Study|Lost to Follow-up|0
6988410|NCT01287897|11047052|FG001|Overall Study|Lost to Follow-up|0
6988411|NCT01287897|11047053|FG002|Overall Study|Lost to Follow-up|2
6988412|NCT01287897|11047054|FG003|Overall Study|Lost to Follow-up|0
6988413|NCT01287897|11047051|FG000|Overall Study|Withdrawal by Subject|1
6988414|NCT01287897|11047052|FG001|Overall Study|Withdrawal by Subject|5
6988415|NCT01287897|11047053|FG002|Overall Study|Withdrawal by Subject|3
6988416|NCT01287897|11047054|FG003|Overall Study|Withdrawal by Subject|2
6988417|NCT01287897|11047051|FG000|Overall Study|Not consented properly|0
6988418|NCT01287897|11047052|FG001|Overall Study|Not consented properly|1
6988419|NCT01287897|11047053|FG002|Overall Study|Not consented properly|0
6988420|NCT01287897|11047054|FG003|Overall Study|Not consented properly|0
6988421|NCT01287897|11047051|FG000|Overall Study|Not meeting entrance criteria|1
6988422|NCT01287897|11047052|FG001|Overall Study|Not meeting entrance criteria|1
6988423|NCT01287897|11047053|FG002|Overall Study|Not meeting entrance criteria|0
6988424|NCT01287897|11047054|FG003|Overall Study|Not meeting entrance criteria|0
6988425|NCT01287897|11047051|FG000|Overall Study|Other|1
6988426|NCT01287897|11047052|FG001|Overall Study|Other|0
6988427|NCT01287897|11047053|FG002|Overall Study|Other|1
6988428|NCT01287897|11047054|FG003|Overall Study|Other|0
6988429|NCT01288053|11047072|FG000|Overall Study|Death|1
6988430|NCT01288079|11047080|FG000|Overall Study|Withdrawal by Subject|2
6988431|NCT01288079|11047081|FG001|Overall Study|Withdrawal by Subject|4
6988432|NCT01288079|11047082|FG002|Overall Study|Withdrawal by Subject|1
6988433|NCT01288079|11047083|FG003|Overall Study|Withdrawal by Subject|0
6988434|NCT01288079|11047080|FG000|Overall Study|Adverse Event|2
6988435|NCT01288079|11047081|FG001|Overall Study|Adverse Event|1
6988436|NCT01288079|11047082|FG002|Overall Study|Adverse Event|2
6988437|NCT01288079|11047083|FG003|Overall Study|Adverse Event|3
6988438|NCT01288079|11047080|FG000|Overall Study|Severe Non-Compliance to Protocol|1
6988439|NCT01288079|11047081|FG001|Overall Study|Severe Non-Compliance to Protocol|3
6988440|NCT01288079|11047082|FG002|Overall Study|Severe Non-Compliance to Protocol|1
6988441|NCT01288079|11047083|FG003|Overall Study|Severe Non-Compliance to Protocol|3
6988442|NCT01288079|11047080|FG000|Overall Study|Condition under Investigation Worsened|0
6988443|NCT01288079|11047081|FG001|Overall Study|Condition under Investigation Worsened|0
6988444|NCT01288079|11047082|FG002|Overall Study|Condition under Investigation Worsened|0
6988445|NCT01288079|11047083|FG003|Overall Study|Condition under Investigation Worsened|1
6988446|NCT01288079|11047080|FG000|Overall Study|Lack of Efficacy|2
6988447|NCT01288079|11047081|FG001|Overall Study|Lack of Efficacy|2
6988448|NCT01288079|11047082|FG002|Overall Study|Lack of Efficacy|0
6988449|NCT01288079|11047083|FG003|Overall Study|Lack of Efficacy|2
6988450|NCT01288079|11047080|FG000|Overall Study|Study-Specific Withdrawal Criteria|1
6988451|NCT01288079|11047081|FG001|Overall Study|Study-Specific Withdrawal Criteria|1
6988452|NCT01288079|11047082|FG002|Overall Study|Study-Specific Withdrawal Criteria|0
6988453|NCT01288079|11047083|FG003|Overall Study|Study-Specific Withdrawal Criteria|0
6988454|NCT01288079|11047080|FG000|Overall Study|Lost to Follow-up|1
6988455|NCT01288079|11047081|FG001|Overall Study|Lost to Follow-up|1
6988456|NCT01288079|11047082|FG002|Overall Study|Lost to Follow-up|1
6988457|NCT01288079|11047083|FG003|Overall Study|Lost to Follow-up|0
6988458|NCT01288079|11047080|FG000|Overall Study|Other or Study Termination|11
6988459|NCT01288079|11047081|FG001|Overall Study|Other or Study Termination|15
6988460|NCT01288079|11047082|FG002|Overall Study|Other or Study Termination|14
6988461|NCT01288079|11047083|FG003|Overall Study|Other or Study Termination|8
6988462|NCT01288209|11047095|FG000|Overall Study|Withdrawal by Subject|1
6988463|NCT01288209|11047096|FG001|Overall Study|Withdrawal by Subject|3
6988464|NCT01288209|11047095|FG000|Overall Study|Other|1
6988465|NCT01288209|11047096|FG001|Overall Study|Other|0
6988466|NCT01288287|11047102|FG000|Overall Study|Lost to Follow-up|8
6988467|NCT01288287|11047102|FG000|Overall Study|Withdrawal by Subject|4
6988468|NCT01288287|11047102|FG000|Overall Study|Lack of Efficacy|13
6988469|NCT01288287|11047102|FG000|Overall Study|Other Reason|13
6988470|NCT01288287|11047102|FG000|Overall Study|Unknown Reason|1
6988471|NCT01288287|11047102|FG000|Overall Study|Unknown Status|7
6988472|NCT01288430|11047117|FG000|Part 1|Progressive disease|2
6988473|NCT01288430|11047118|FG001|Part 1|Progressive disease|1
6988474|NCT01288430|11047119|FG002|Part 1|Progressive disease|1
6988475|NCT01288430|11047120|FG003|Part 1|Progressive disease|6
6988476|NCT01288430|11047121|FG004|Part 1|Progressive disease|2
6988477|NCT01288430|11047122|FG005|Part 1|Progressive disease|4
6988478|NCT01288430|11047123|FG006|Part 1|Progressive disease|2
6988479|NCT01288430|11047124|FG007|Part 1|Progressive disease|0
6988480|NCT01288430|11047125|FG008|Part 1|Progressive disease|0
6988481|NCT01288430|11047126|FG009|Part 1|Progressive disease|0
6988482|NCT01288430|11047117|FG000|Part 1|Clinical disease progression|0
6988483|NCT01288430|11047118|FG001|Part 1|Clinical disease progression|0
6988484|NCT01288430|11047119|FG002|Part 1|Clinical disease progression|1
6988485|NCT01288430|11047120|FG003|Part 1|Clinical disease progression|0
6988486|NCT01288430|11047121|FG004|Part 1|Clinical disease progression|0
6988487|NCT01288430|11047122|FG005|Part 1|Clinical disease progression|2
6988488|NCT01288430|11047123|FG006|Part 1|Clinical disease progression|2
6988489|NCT01288430|11047124|FG007|Part 1|Clinical disease progression|0
6988490|NCT01288430|11047125|FG008|Part 1|Clinical disease progression|0
6988491|NCT01288430|11047126|FG009|Part 1|Clinical disease progression|0
6988492|NCT01288430|11047117|FG000|Part 1|Death due to disease progression|0
6988493|NCT01288430|11047118|FG001|Part 1|Death due to disease progression|0
6988494|NCT01288430|11047119|FG002|Part 1|Death due to disease progression|0
6988495|NCT01288430|11047120|FG003|Part 1|Death due to disease progression|0
6988496|NCT01288430|11047121|FG004|Part 1|Death due to disease progression|1
6988497|NCT01288430|11047122|FG005|Part 1|Death due to disease progression|0
6988498|NCT01288430|11047123|FG006|Part 1|Death due to disease progression|0
6988499|NCT01288430|11047124|FG007|Part 1|Death due to disease progression|0
6988500|NCT01288430|11047125|FG008|Part 1|Death due to disease progression|0
6988501|NCT01288430|11047126|FG009|Part 1|Death due to disease progression|0
6988502|NCT01288430|11047117|FG000|Part 1|Adverse Event|0
6988503|NCT01288430|11047118|FG001|Part 1|Adverse Event|0
6988504|NCT01288430|11047119|FG002|Part 1|Adverse Event|3
6988505|NCT01288430|11047120|FG003|Part 1|Adverse Event|1
6988506|NCT01288430|11047121|FG004|Part 1|Adverse Event|0
6988507|NCT01288430|11047122|FG005|Part 1|Adverse Event|0
6988508|NCT01288430|11047123|FG006|Part 1|Adverse Event|2
6988509|NCT01288430|11047124|FG007|Part 1|Adverse Event|0
6988510|NCT01288430|11047125|FG008|Part 1|Adverse Event|0
6988511|NCT01288430|11047126|FG009|Part 1|Adverse Event|0
6988512|NCT01288430|11047117|FG000|Part 1|Other|0
6988513|NCT01288430|11047118|FG001|Part 1|Other|2
6988514|NCT01288430|11047119|FG002|Part 1|Other|0
6988515|NCT01288430|11047120|FG003|Part 1|Other|0
6988516|NCT01288430|11047121|FG004|Part 1|Other|0
6988517|NCT01288430|11047122|FG005|Part 1|Other|0
6988518|NCT01288430|11047123|FG006|Part 1|Other|1
6988519|NCT01288430|11047124|FG007|Part 1|Other|0
6988520|NCT01288430|11047125|FG008|Part 1|Other|0
6988521|NCT01288430|11047126|FG009|Part 1|Other|0
6988522|NCT01288430|11047117|FG000|Part 2|Progressive disease|0
6988523|NCT01288430|11047118|FG001|Part 2|Progressive disease|0
6988524|NCT01288430|11047119|FG002|Part 2|Progressive disease|0
6988525|NCT01288430|11047120|FG003|Part 2|Progressive disease|0
6988526|NCT01288430|11047121|FG004|Part 2|Progressive disease|0
6988527|NCT01288430|11047122|FG005|Part 2|Progressive disease|0
6988528|NCT01288430|11047123|FG006|Part 2|Progressive disease|0
6988529|NCT01288430|11047124|FG007|Part 2|Progressive disease|8
6988530|NCT01288430|11047125|FG008|Part 2|Progressive disease|7
6988531|NCT01288430|11047126|FG009|Part 2|Progressive disease|2
6988532|NCT01288430|11047117|FG000|Part 2|Clinical disease progression|0
6988533|NCT01288430|11047118|FG001|Part 2|Clinical disease progression|0
6988534|NCT01288430|11047119|FG002|Part 2|Clinical disease progression|0
6988535|NCT01288430|11047120|FG003|Part 2|Clinical disease progression|0
6988536|NCT01288430|11047121|FG004|Part 2|Clinical disease progression|0
6988537|NCT01288430|11047122|FG005|Part 2|Clinical disease progression|0
6988538|NCT01288430|11047123|FG006|Part 2|Clinical disease progression|0
6988539|NCT01288430|11047124|FG007|Part 2|Clinical disease progression|2
6988540|NCT01288430|11047125|FG008|Part 2|Clinical disease progression|0
6988541|NCT01288430|11047126|FG009|Part 2|Clinical disease progression|0
6988542|NCT01288430|11047117|FG000|Part 2|Withdrawal by Subject|0
6988543|NCT01288430|11047118|FG001|Part 2|Withdrawal by Subject|0
6988544|NCT01288430|11047119|FG002|Part 2|Withdrawal by Subject|0
6988545|NCT01288430|11047120|FG003|Part 2|Withdrawal by Subject|0
6988546|NCT01288430|11047121|FG004|Part 2|Withdrawal by Subject|0
6988547|NCT01288430|11047122|FG005|Part 2|Withdrawal by Subject|0
6988548|NCT01288430|11047123|FG006|Part 2|Withdrawal by Subject|0
6988549|NCT01288430|11047124|FG007|Part 2|Withdrawal by Subject|1
6988550|NCT01288430|11047125|FG008|Part 2|Withdrawal by Subject|4
6988551|NCT01288430|11047126|FG009|Part 2|Withdrawal by Subject|0
6988552|NCT01288430|11047117|FG000|Part 2|Adverse Event|0
6988553|NCT01288430|11047118|FG001|Part 2|Adverse Event|0
6988554|NCT01288430|11047119|FG002|Part 2|Adverse Event|0
6988555|NCT01288430|11047120|FG003|Part 2|Adverse Event|0
6988556|NCT01288430|11047121|FG004|Part 2|Adverse Event|0
6988557|NCT01288430|11047122|FG005|Part 2|Adverse Event|0
6988558|NCT01288430|11047123|FG006|Part 2|Adverse Event|0
6988559|NCT01288430|11047124|FG007|Part 2|Adverse Event|1
6988560|NCT01288430|11047125|FG008|Part 2|Adverse Event|1
6988561|NCT01288430|11047126|FG009|Part 2|Adverse Event|0
6988562|NCT01288430|11047117|FG000|Part 2|Other|0
6988563|NCT01288430|11047118|FG001|Part 2|Other|0
6988564|NCT01288430|11047119|FG002|Part 2|Other|0
6988565|NCT01288430|11047120|FG003|Part 2|Other|0
6988566|NCT01288430|11047121|FG004|Part 2|Other|0
6988567|NCT01288430|11047122|FG005|Part 2|Other|0
6988568|NCT01288430|11047123|FG006|Part 2|Other|0
6988569|NCT01288430|11047124|FG007|Part 2|Other|0
6988570|NCT01288430|11047125|FG008|Part 2|Other|0
6988571|NCT01288430|11047126|FG009|Part 2|Other|1
6988572|NCT01288443|11047159|FG000|Overall Study|Adverse Event|0
6988573|NCT01288443|11047160|FG001|Overall Study|Adverse Event|0
6988574|NCT01288443|11047161|FG002|Overall Study|Adverse Event|1
6988575|NCT01288443|11047162|FG003|Overall Study|Adverse Event|1
6988576|NCT01288443|11047163|FG004|Overall Study|Adverse Event|3
6988577|NCT01288443|11047164|FG005|Overall Study|Adverse Event|1
6988578|NCT01288443|11047159|FG000|Overall Study|Poor compliance to protocol|0
6988579|NCT01288443|11047160|FG001|Overall Study|Poor compliance to protocol|0
6988580|NCT01288443|11047161|FG002|Overall Study|Poor compliance to protocol|0
6988581|NCT01288443|11047162|FG003|Overall Study|Poor compliance to protocol|0
6988582|NCT01288443|11047163|FG004|Overall Study|Poor compliance to protocol|0
6988583|NCT01288443|11047164|FG005|Overall Study|Poor compliance to protocol|1
6988584|NCT01288443|11047159|FG000|Overall Study|Participant Moved|0
6988585|NCT01288443|11047160|FG001|Overall Study|Participant Moved|0
6988586|NCT01288443|11047161|FG002|Overall Study|Participant Moved|0
6988587|NCT01288443|11047162|FG003|Overall Study|Participant Moved|1
6988588|NCT01288443|11047163|FG004|Overall Study|Participant Moved|2
6988589|NCT01288443|11047164|FG005|Overall Study|Participant Moved|1
6988590|NCT01288443|11047159|FG000|Overall Study|Consent withdrawn by Participant|0
6988591|NCT01288443|11047160|FG001|Overall Study|Consent withdrawn by Participant|0
6988592|NCT01288443|11047161|FG002|Overall Study|Consent withdrawn by Participant|0
6988593|NCT01288443|11047162|FG003|Overall Study|Consent withdrawn by Participant|0
6988594|NCT01288443|11047163|FG004|Overall Study|Consent withdrawn by Participant|0
6988595|NCT01288443|11047164|FG005|Overall Study|Consent withdrawn by Participant|1
6988596|NCT01288443|11047159|FG000|Overall Study|Lost to Follow-up|0
6988597|NCT01288443|11047160|FG001|Overall Study|Lost to Follow-up|1
6988598|NCT01288443|11047161|FG002|Overall Study|Lost to Follow-up|0
6988599|NCT01288443|11047162|FG003|Overall Study|Lost to Follow-up|0
6988600|NCT01288443|11047163|FG004|Overall Study|Lost to Follow-up|0
6988601|NCT01288443|11047164|FG005|Overall Study|Lost to Follow-up|0
6988602|NCT01288443|11047159|FG000|Overall Study|Study drug auto-injector administration|0
6988603|NCT01288443|11047160|FG001|Overall Study|Study drug auto-injector administration|0
6988604|NCT01288443|11047161|FG002|Overall Study|Study drug auto-injector administration|0
6988605|NCT01288443|11047162|FG003|Overall Study|Study drug auto-injector administration|0
6988606|NCT01288443|11047163|FG004|Overall Study|Study drug auto-injector administration|1
6988607|NCT01288443|11047164|FG005|Overall Study|Study drug auto-injector administration|1
6988608|NCT01288443|11047159|FG000|Overall Study|Other than above|0
6988609|NCT01288443|11047160|FG001|Overall Study|Other than above|0
6988610|NCT01288443|11047161|FG002|Overall Study|Other than above|0
6988611|NCT01288443|11047162|FG003|Overall Study|Other than above|2
6988612|NCT01288443|11047163|FG004|Overall Study|Other than above|1
6988613|NCT01288443|11047164|FG005|Overall Study|Other than above|0
6988614|NCT01288469|11047181|FG000|Overall Study|Adverse Event|4
6988615|NCT01288469|11047182|FG001|Overall Study|Adverse Event|1
6988616|NCT01288469|11047183|FG002|Overall Study|Adverse Event|1
6988617|NCT01288469|11047181|FG000|Overall Study|Poor compliance to protocol|0
6988618|NCT01288469|11047182|FG001|Overall Study|Poor compliance to protocol|1
6988619|NCT01288469|11047183|FG002|Overall Study|Poor compliance to protocol|0
6988620|NCT01288469|11047181|FG000|Overall Study|Participant Moved|1
6988621|NCT01288469|11047182|FG001|Overall Study|Participant Moved|0
6988622|NCT01288469|11047183|FG002|Overall Study|Participant Moved|0
6988623|NCT01288469|11047181|FG000|Overall Study|Consent withdrawn by subject|1
6988624|NCT01288469|11047182|FG001|Overall Study|Consent withdrawn by subject|1
6988625|NCT01288469|11047183|FG002|Overall Study|Consent withdrawn by subject|1
6988626|NCT01288469|11047181|FG000|Overall Study|Exclusion criteria finally met|1
6988627|NCT01288469|11047182|FG001|Overall Study|Exclusion criteria finally met|0
6988628|NCT01288469|11047183|FG002|Overall Study|Exclusion criteria finally met|0
6988629|NCT01288612|11047207|FG000|Overall Study|Unable to contact|11
6988630|NCT01288612|11047208|FG001|Overall Study|Unable to contact|16
6988631|NCT01288612|11047209|FG002|Overall Study|Unable to contact|20
6988632|NCT01288612|11047207|FG000|Overall Study|Declined|78
6988633|NCT01288612|11047208|FG001|Overall Study|Declined|63
6988634|NCT01288612|11047209|FG002|Overall Study|Declined|62
6988635|NCT01288612|11047207|FG000|Overall Study|Unable to intubate|0
6988636|NCT01288612|11047208|FG001|Overall Study|Unable to intubate|3
6988637|NCT01288612|11047209|FG002|Overall Study|Unable to intubate|0
6988638|NCT01288729|11047219|FG000|Overall Study|Withdrawal by Subject|1
6988639|NCT01288729|11047220|FG001|Overall Study|Withdrawal by Subject|0
6988640|NCT01288911|11047275|FG000|Double-blind Period|Death|11
6988641|NCT01288911|11047276|FG001|Double-blind Period|Death|7
6988642|NCT01288911|11047275|FG000|Double-blind Period|Lost to Follow-up|0
6988643|NCT01288911|11047276|FG001|Double-blind Period|Lost to Follow-up|2
6988644|NCT01288911|11047275|FG000|Double-blind Period|Progressive Disease|75
6988645|NCT01288911|11047276|FG001|Double-blind Period|Progressive Disease|103
6988646|NCT01288911|11047275|FG000|Double-blind Period|Protocol Violation|1
6988647|NCT01288911|11047276|FG001|Double-blind Period|Protocol Violation|0
6988648|NCT01288911|11047275|FG000|Double-blind Period|Withdrawal by Subject|25
6988649|NCT01288911|11047276|FG001|Double-blind Period|Withdrawal by Subject|26
6988650|NCT01288911|11047275|FG000|Double-blind Period|Miscellaneous Reason|29
6988651|NCT01288911|11047276|FG001|Double-blind Period|Miscellaneous Reason|42
6988652|NCT01288911|11047275|FG000|Double-blind Period|Randomized but never received study drug|1
6988653|NCT01288911|11047276|FG001|Double-blind Period|Randomized but never received study drug|2
6988654|NCT01288911|11047275|FG000|Open-label Period (All Enzalutamide)|Death|0
6988655|NCT01288911|11047276|FG001|Open-label Period (All Enzalutamide)|Death|1
6988656|NCT01288911|11047275|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1
6988657|NCT01288911|11047276|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0
6988658|NCT01288911|11047275|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18
6988659|NCT01288911|11047276|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3
6988660|NCT01288911|11047275|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1
6988661|NCT01288911|11047276|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0
6988662|NCT01288911|11047275|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5
6988663|NCT01288911|11047276|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0
6988664|NCT01288911|11047275|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17
6988665|NCT01288911|11047276|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5
6988666|NCT01288937|11047287|FG000|Overall Study|Adverse Event|1
6988667|NCT01288937|11047288|FG001|Overall Study|Adverse Event|0
6988668|NCT01288976|11047297|FG000|Overall Study|Withdrawal by Subject|58
6988669|NCT01288976|11047298|FG001|Overall Study|Withdrawal by Subject|12
6988670|NCT01288976|11047299|FG002|Overall Study|Withdrawal by Subject|9
6988671|NCT01288976|11047297|FG000|Overall Study|Death|98
6988672|NCT01288976|11047298|FG001|Overall Study|Death|6
6988673|NCT01288976|11047299|FG002|Overall Study|Death|4
6988674|NCT01288976|11047297|FG000|Overall Study|Data unavailable|22
6988675|NCT01288976|11047298|FG001|Overall Study|Data unavailable|9
6988676|NCT01288976|11047299|FG002|Overall Study|Data unavailable|7
6988677|NCT01288989|11047310|FG000|Overall Study|Death|0
6988678|NCT01288989|11047311|FG001|Overall Study|Death|0
6988679|NCT01288989|11047312|FG002|Overall Study|Death|0
6988680|NCT01288989|11047313|FG003|Overall Study|Death|1
6988681|NCT01288989|11047314|FG004|Overall Study|Death|0
6988682|NCT01288989|11047310|FG000|Overall Study|Dose limiting toxicity|1
6988683|NCT01288989|11047311|FG001|Overall Study|Dose limiting toxicity|0
6988684|NCT01288989|11047312|FG002|Overall Study|Dose limiting toxicity|0
6988685|NCT01288989|11047313|FG003|Overall Study|Dose limiting toxicity|0
6988686|NCT01288989|11047314|FG004|Overall Study|Dose limiting toxicity|0
6988687|NCT01288989|11047310|FG000|Overall Study|Adverse Event|0
6988688|NCT01288989|11047311|FG001|Overall Study|Adverse Event|0
6988689|NCT01288989|11047312|FG002|Overall Study|Adverse Event|0
6988690|NCT01288989|11047313|FG003|Overall Study|Adverse Event|0
6988691|NCT01288989|11047314|FG004|Overall Study|Adverse Event|2
6988692|NCT01288989|11047310|FG000|Overall Study|Physician Decision|0
6988693|NCT01288989|11047311|FG001|Overall Study|Physician Decision|0
6988694|NCT01288989|11047312|FG002|Overall Study|Physician Decision|0
6988695|NCT01288989|11047313|FG003|Overall Study|Physician Decision|0
6988696|NCT01288989|11047314|FG004|Overall Study|Physician Decision|1
6988697|NCT01288989|11047310|FG000|Overall Study|Withdrawal by Subject|0
6988698|NCT01288989|11047311|FG001|Overall Study|Withdrawal by Subject|0
6988699|NCT01288989|11047312|FG002|Overall Study|Withdrawal by Subject|0
6988700|NCT01288989|11047313|FG003|Overall Study|Withdrawal by Subject|0
6988701|NCT01288989|11047314|FG004|Overall Study|Withdrawal by Subject|3
6988702|NCT01289015|11047334|FG000|Overall Study|Protocol Violation|12
6988703|NCT01289015|11047335|FG001|Overall Study|Protocol Violation|9
6988704|NCT01289015|11047334|FG000|Overall Study|Adverse Event|3
6988705|NCT01289015|11047335|FG001|Overall Study|Adverse Event|0
6988706|NCT01289015|11047334|FG000|Overall Study|Lost to Follow-up|33
6988707|NCT01289015|11047335|FG001|Overall Study|Lost to Follow-up|17
6988708|NCT01289015|11047334|FG000|Overall Study|Withdrawal by Subject|17
6988709|NCT01289015|11047335|FG001|Overall Study|Withdrawal by Subject|8
6988710|NCT01289015|11047334|FG000|Overall Study|Disease progression|1
6988711|NCT01289015|11047335|FG001|Overall Study|Disease progression|0
6988712|NCT01289015|11047334|FG000|Overall Study|Negative baseline culture and others|33
6988713|NCT01289015|11047335|FG001|Overall Study|Negative baseline culture and others|20
6988714|NCT01289028|11047341|FG000|Overall Study|Progressive Disease|49
6988715|NCT01289028|11047341|FG000|Overall Study|Adverse Event|14
6988716|NCT01289028|11047341|FG000|Overall Study|Withdrawal by Subject|6
6988717|NCT01289028|11047341|FG000|Overall Study|Death|4
6988718|NCT01289028|11047341|FG000|Overall Study|Lack of Efficacy|2
6988719|NCT01289028|11047341|FG000|Overall Study|No longer required|2
6988720|NCT01289028|11047341|FG000|Overall Study|Lost to Follow-up|2
6988721|NCT01289028|11047341|FG000|Overall Study|New Cancer Therapy|2
6988722|NCT01289028|11047341|FG000|Overall Study|Abnormal Lab Value|1
6988723|NCT01289028|11047341|FG000|Overall Study|Missing reason for discon|1
6988724|NCT01289041|11047347|FG000|Overall Study|Adverse Event|24
6988725|NCT01289041|11047347|FG000|Overall Study|Physician Decision|1
6988726|NCT01289041|11047347|FG000|Overall Study|Progressive Disease|41
6988727|NCT01289041|11047347|FG000|Overall Study|Withdrawal by Subject|3
6988728|NCT01289041|11047347|FG000|Overall Study|Death|1
6988729|NCT01289119|11047373|FG000|Overall Study|Adverse Event|2
6988730|NCT01289119|11047374|FG001|Overall Study|Adverse Event|1
6988731|NCT01289119|11047375|FG002|Overall Study|Adverse Event|0
6988732|NCT01289119|11047376|FG003|Overall Study|Adverse Event|2
6988733|NCT01289119|11047377|FG004|Overall Study|Adverse Event|1
6988734|NCT01289119|11047378|FG005|Overall Study|Adverse Event|0
6988735|NCT01289119|11047373|FG000|Overall Study|Major Protocol Deviation|2
6988736|NCT01289119|11047374|FG001|Overall Study|Major Protocol Deviation|1
6988737|NCT01289119|11047375|FG002|Overall Study|Major Protocol Deviation|3
6988738|NCT01289119|11047376|FG003|Overall Study|Major Protocol Deviation|0
6988739|NCT01289119|11047377|FG004|Overall Study|Major Protocol Deviation|2
6988740|NCT01289119|11047378|FG005|Overall Study|Major Protocol Deviation|1
6988741|NCT01289119|11047373|FG000|Overall Study|Lost to Follow-up|0
6988742|NCT01289119|11047374|FG001|Overall Study|Lost to Follow-up|3
6988743|NCT01289119|11047375|FG002|Overall Study|Lost to Follow-up|0
6988744|NCT01289119|11047376|FG003|Overall Study|Lost to Follow-up|0
6988745|NCT01289119|11047377|FG004|Overall Study|Lost to Follow-up|0
6988746|NCT01289119|11047378|FG005|Overall Study|Lost to Follow-up|1
6988747|NCT01289119|11047373|FG000|Overall Study|Withdrawal by Subject|4
6988748|NCT01289119|11047374|FG001|Overall Study|Withdrawal by Subject|2
6988749|NCT01289119|11047375|FG002|Overall Study|Withdrawal by Subject|4
6988750|NCT01289119|11047376|FG003|Overall Study|Withdrawal by Subject|3
6988751|NCT01289119|11047377|FG004|Overall Study|Withdrawal by Subject|1
6988752|NCT01289119|11047378|FG005|Overall Study|Withdrawal by Subject|1
6988753|NCT01289119|11047373|FG000|Overall Study|Pregnancy|0
6988754|NCT01289119|11047374|FG001|Overall Study|Pregnancy|1
6988755|NCT01289119|11047375|FG002|Overall Study|Pregnancy|0
6988756|NCT01289119|11047376|FG003|Overall Study|Pregnancy|0
6988757|NCT01289119|11047377|FG004|Overall Study|Pregnancy|0
6988758|NCT01289119|11047378|FG005|Overall Study|Pregnancy|0
6988759|NCT01289119|11047373|FG000|Overall Study|Lack of Efficacy|0
6988760|NCT01289119|11047374|FG001|Overall Study|Lack of Efficacy|1
6988761|NCT01289119|11047375|FG002|Overall Study|Lack of Efficacy|1
6988762|NCT01289119|11047376|FG003|Overall Study|Lack of Efficacy|1
6988763|NCT01289119|11047377|FG004|Overall Study|Lack of Efficacy|1
6988764|NCT01289119|11047378|FG005|Overall Study|Lack of Efficacy|1
6988765|NCT01289119|11047373|FG000|Overall Study|Other|1
6988766|NCT01289119|11047374|FG001|Overall Study|Other|0
6988767|NCT01289119|11047375|FG002|Overall Study|Other|1
6988768|NCT01289119|11047376|FG003|Overall Study|Other|0
6988769|NCT01289119|11047377|FG004|Overall Study|Other|0
6988770|NCT01289119|11047378|FG005|Overall Study|Other|0
6988771|NCT01289210|11047392|FG000|Overall Study|Adverse Event|1
6988772|NCT01289353|11047417|FG000|Overall Study|Lost to Follow-up|2
6988773|NCT01289418|11047437|FG000|Day 8 Survey|email address invalid|283
6988774|NCT01289418|11047437|FG000|Day 8 Survey|participants did not complete the survey|1935
6988775|NCT01289418|11047437|FG000|Day 29 Survey|email address invalid|283
6988776|NCT01289418|11047437|FG000|Day 29 Survey|participants did not complete the survey|2185
6988777|NCT01289574|11047505|FG000|Overall Study|Lack of Efficacy|4
6988778|NCT01289574|11047506|FG001|Overall Study|Lack of Efficacy|0
6988779|NCT01289574|11047507|FG002|Overall Study|Lack of Efficacy|1
6988780|NCT01289574|11047505|FG000|Overall Study|Lost to Follow-up|2
6988781|NCT01289574|11047506|FG001|Overall Study|Lost to Follow-up|0
6988782|NCT01289574|11047507|FG002|Overall Study|Lost to Follow-up|1
6988783|NCT01289574|11047505|FG000|Overall Study|Withdrawal by Subject|1
6988784|NCT01289574|11047506|FG001|Overall Study|Withdrawal by Subject|1
6988785|NCT01289574|11047507|FG002|Overall Study|Withdrawal by Subject|1
6988786|NCT01289574|11047505|FG000|Overall Study|Adverse Event|0
6988787|NCT01289574|11047506|FG001|Overall Study|Adverse Event|1
6988788|NCT01289574|11047507|FG002|Overall Study|Adverse Event|0
6988789|NCT01289574|11047505|FG000|Overall Study|Subject wanted alternate treatment|0
6988790|NCT01289574|11047506|FG001|Overall Study|Subject wanted alternate treatment|1
6988791|NCT01289574|11047507|FG002|Overall Study|Subject wanted alternate treatment|0
6988792|NCT01289639|11047519|FG000|Overall Study|Lost to Follow-up|1
6988793|NCT01289639|11047520|FG001|Overall Study|Lost to Follow-up|0
6988794|NCT01289639|11047521|FG002|Overall Study|Lost to Follow-up|0
6988795|NCT01289678|11047538|FG000|Overall Study|Physician Decision|6
6988796|NCT01289782|11047544|FG000|Overall Study|Lost to Follow-up|14
6988797|NCT01289782|11047545|FG001|Overall Study|Lost to Follow-up|7
6988798|NCT01289782|11047544|FG000|Overall Study|Protocol Violation|1
6988799|NCT01289782|11047545|FG001|Overall Study|Protocol Violation|1
6988800|NCT01289782|11047544|FG000|Overall Study|Withdrawal by Subject|8
6988801|NCT01289782|11047545|FG001|Overall Study|Withdrawal by Subject|2
6988802|NCT01289782|11047544|FG000|Overall Study|Sponsor's Decision|1
6988803|NCT01289782|11047545|FG001|Overall Study|Sponsor's Decision|0
6988804|NCT01289782|11047544|FG000|Overall Study|Reason not specified|1
6988805|NCT01289782|11047545|FG001|Overall Study|Reason not specified|2
6988806|NCT01289821|11047551|FG000|Treatment Period|Withdrawal by Subject|1
6988807|NCT01289821|11047551|FG000|Treatment Period|Physician Decision|3
6988808|NCT01289821|11047551|FG000|Treatment Period|Adverse Event|4
6988809|NCT01289821|11047551|FG000|Treatment Period|Radiological Progression|43
6988810|NCT01289821|11047551|FG000|Treatment Period|Clinical Progression|2
6988811|NCT01289821|11047551|FG000|Treatment Period|Therapeutic procedure required|1
6988812|NCT01289821|11047551|FG000|Safety Follow-up Period|Withdrawal by Subject|1
6988813|NCT01289821|11047551|FG000|Safety Follow-up Period|Protocol Violation|3
6988814|NCT01289821|11047551|FG000|Safety Follow-up Period|Unspecified reason|1
6988815|NCT01289821|11047551|FG000|Survival Follow-up Period|Protocol Violation|1
6988816|NCT01289821|11047551|FG000|Survival Follow-up Period|Lost to Follow-up|1
6988817|NCT01289821|11047551|FG000|Survival Follow-up Period|Clinical endpoint reached|16
6988818|NCT01289847|11047555|FG000|Overall Study|Patient could not comply with visits|1
6988819|NCT01289990|11047591|FG000|Overall Study|Death|0
6988820|NCT01289990|11047592|FG001|Overall Study|Death|0
6988821|NCT01289990|11047593|FG002|Overall Study|Death|0
6988822|NCT01289990|11047594|FG003|Overall Study|Death|1
6988823|NCT01289990|11047595|FG004|Overall Study|Death|2
6988824|NCT01289990|11047596|FG005|Overall Study|Death|1
6988825|NCT01289990|11047597|FG006|Overall Study|Death|0
6988826|NCT01289990|11047598|FG007|Overall Study|Death|0
6988827|NCT01289990|11047599|FG008|Overall Study|Death|0
6988828|NCT01289990|11047600|FG009|Overall Study|Death|0
6988829|NCT01289990|11047601|FG010|Overall Study|Death|0
6988830|NCT01289990|11047602|FG011|Overall Study|Death|1
6988831|NCT01289990|11047603|FG012|Overall Study|Death|0
6988832|NCT01289990|11047591|FG000|Overall Study|Lost to Follow-up|3
6988833|NCT01289990|11047592|FG001|Overall Study|Lost to Follow-up|2
6988834|NCT01289990|11047593|FG002|Overall Study|Lost to Follow-up|5
6988835|NCT01289990|11047594|FG003|Overall Study|Lost to Follow-up|5
6988836|NCT01289990|11047595|FG004|Overall Study|Lost to Follow-up|3
6988837|NCT01289990|11047596|FG005|Overall Study|Lost to Follow-up|4
6988838|NCT01289990|11047597|FG006|Overall Study|Lost to Follow-up|2
6988839|NCT01289990|11047598|FG007|Overall Study|Lost to Follow-up|2
6988840|NCT01289990|11047599|FG008|Overall Study|Lost to Follow-up|1
6988841|NCT01289990|11047600|FG009|Overall Study|Lost to Follow-up|4
6988842|NCT01289990|11047601|FG010|Overall Study|Lost to Follow-up|2
6988843|NCT01289990|11047602|FG011|Overall Study|Lost to Follow-up|1
6988844|NCT01289990|11047603|FG012|Overall Study|Lost to Follow-up|2
6988845|NCT01289990|11047591|FG000|Overall Study|Withdrawal by Subject|15
6988846|NCT01289990|11047592|FG001|Overall Study|Withdrawal by Subject|14
6988847|NCT01289990|11047593|FG002|Overall Study|Withdrawal by Subject|12
6988848|NCT01289990|11047594|FG003|Overall Study|Withdrawal by Subject|13
6988849|NCT01289990|11047595|FG004|Overall Study|Withdrawal by Subject|8
6988850|NCT01289990|11047596|FG005|Overall Study|Withdrawal by Subject|7
6988851|NCT01289990|11047597|FG006|Overall Study|Withdrawal by Subject|13
6988852|NCT01289990|11047598|FG007|Overall Study|Withdrawal by Subject|9
6988853|NCT01289990|11047599|FG008|Overall Study|Withdrawal by Subject|12
6988854|NCT01289990|11047600|FG009|Overall Study|Withdrawal by Subject|13
6988855|NCT01289990|11047601|FG010|Overall Study|Withdrawal by Subject|11
6988856|NCT01289990|11047602|FG011|Overall Study|Withdrawal by Subject|13
6988857|NCT01289990|11047603|FG012|Overall Study|Withdrawal by Subject|16
6988858|NCT01289990|11047591|FG000|Overall Study|discontinued in preceding trial|18
6988859|NCT01289990|11047592|FG001|Overall Study|discontinued in preceding trial|20
6988860|NCT01289990|11047593|FG002|Overall Study|discontinued in preceding trial|41
6988861|NCT01289990|11047594|FG003|Overall Study|discontinued in preceding trial|17
6988862|NCT01289990|11047595|FG004|Overall Study|discontinued in preceding trial|11
6988863|NCT01289990|11047596|FG005|Overall Study|discontinued in preceding trial|12
6988864|NCT01289990|11047597|FG006|Overall Study|discontinued in preceding trial|18
6988865|NCT01289990|11047598|FG007|Overall Study|discontinued in preceding trial|8
6988866|NCT01289990|11047599|FG008|Overall Study|discontinued in preceding trial|17
6988867|NCT01289990|11047600|FG009|Overall Study|discontinued in preceding trial|21
6988868|NCT01289990|11047601|FG010|Overall Study|discontinued in preceding trial|17
6988869|NCT01289990|11047602|FG011|Overall Study|discontinued in preceding trial|17
6988870|NCT01289990|11047603|FG012|Overall Study|discontinued in preceding trial|24
6988871|NCT01289990|11047591|FG000|Overall Study|did not continue in extension|41
6988872|NCT01289990|11047592|FG001|Overall Study|did not continue in extension|45
6988873|NCT01289990|11047593|FG002|Overall Study|did not continue in extension|51
6988874|NCT01289990|11047594|FG003|Overall Study|did not continue in extension|51
6988875|NCT01289990|11047595|FG004|Overall Study|did not continue in extension|48
6988876|NCT01289990|11047596|FG005|Overall Study|did not continue in extension|50
6988877|NCT01289990|11047597|FG006|Overall Study|did not continue in extension|54
6988878|NCT01289990|11047598|FG007|Overall Study|did not continue in extension|36
6988879|NCT01289990|11047599|FG008|Overall Study|did not continue in extension|44
6988880|NCT01289990|11047600|FG009|Overall Study|did not continue in extension|48
6988881|NCT01289990|11047601|FG010|Overall Study|did not continue in extension|45
6988882|NCT01289990|11047602|FG011|Overall Study|did not continue in extension|34
6988883|NCT01289990|11047603|FG012|Overall Study|did not continue in extension|56
6988884|NCT01289990|11047591|FG000|Overall Study|Not treated|0
6988885|NCT01289990|11047592|FG001|Overall Study|Not treated|0
6988886|NCT01289990|11047593|FG002|Overall Study|Not treated|0
6988887|NCT01289990|11047594|FG003|Overall Study|Not treated|0
6988888|NCT01289990|11047595|FG004|Overall Study|Not treated|0
6988889|NCT01289990|11047596|FG005|Overall Study|Not treated|0
6988890|NCT01289990|11047597|FG006|Overall Study|Not treated|1
6988891|NCT01289990|11047598|FG007|Overall Study|Not treated|0
6988892|NCT01289990|11047599|FG008|Overall Study|Not treated|1
6988893|NCT01289990|11047600|FG009|Overall Study|Not treated|0
6988894|NCT01289990|11047601|FG010|Overall Study|Not treated|1
6988895|NCT01289990|11047602|FG011|Overall Study|Not treated|2
6988896|NCT01289990|11047603|FG012|Overall Study|Not treated|0
6988897|NCT01290029|11047631|FG000|Overall Study|Other|2
6988898|NCT01290068|11047637|FG000|Overall Study|Adverse Event|1
6988899|NCT01290068|11047638|FG001|Overall Study|Adverse Event|3
6988900|NCT01290068|11047637|FG000|Overall Study|Lost to Follow-up|3
6988901|NCT01290068|11047638|FG001|Overall Study|Lost to Follow-up|0
6988902|NCT01290068|11047637|FG000|Overall Study|Withdrawal by subject prior to implant|0
6988903|NCT01290068|11047638|FG001|Overall Study|Withdrawal by subject prior to implant|2
6988904|NCT01290068|11047637|FG000|Overall Study|Other|3
6988905|NCT01290068|11047638|FG001|Overall Study|Other|1
6988906|NCT01290094|11047644|FG000|Overall Study|Withdrawal by Subject|1
6988907|NCT01290094|11047644|FG000|Overall Study|Lost to Follow-up|5
6988908|NCT01290224|11047648|FG000|Overall Study|Adverse Event|1
6988909|NCT01290224|11047648|FG000|Overall Study|Refused Further Treatment|4
6988910|NCT01290263|11047667|FG000|Overall Study|Adverse Event|0
6988911|NCT01290263|11047668|FG001|Overall Study|Adverse Event|0
6988912|NCT01290263|11047669|FG002|Overall Study|Adverse Event|0
6988913|NCT01290263|11047670|FG003|Overall Study|Adverse Event|1
6988914|NCT01290263|11047671|FG004|Overall Study|Adverse Event|1
6988915|NCT01290263|11047667|FG000|Overall Study|Lack of Efficacy|8
6988916|NCT01290263|11047668|FG001|Overall Study|Lack of Efficacy|2
6988917|NCT01290263|11047669|FG002|Overall Study|Lack of Efficacy|7
6988918|NCT01290263|11047670|FG003|Overall Study|Lack of Efficacy|24
6988919|NCT01290263|11047671|FG004|Overall Study|Lack of Efficacy|33
6988920|NCT01290263|11047667|FG000|Overall Study|Withdrawal by Subject|3
6988921|NCT01290263|11047668|FG001|Overall Study|Withdrawal by Subject|1
6988922|NCT01290263|11047669|FG002|Overall Study|Withdrawal by Subject|0
6988923|NCT01290263|11047670|FG003|Overall Study|Withdrawal by Subject|1
6988924|NCT01290263|11047671|FG004|Overall Study|Withdrawal by Subject|2
6988925|NCT01290263|11047667|FG000|Overall Study|Participant Non-Compliance|0
6988926|NCT01290263|11047668|FG001|Overall Study|Participant Non-Compliance|0
6988927|NCT01290263|11047669|FG002|Overall Study|Participant Non-Compliance|0
6988928|NCT01290263|11047670|FG003|Overall Study|Participant Non-Compliance|1
6988929|NCT01290263|11047671|FG004|Overall Study|Participant Non-Compliance|1
6988930|NCT01290315|11047683|FG000|Overall Study|Adverse Event|0
6988931|NCT01290315|11047684|FG001|Overall Study|Adverse Event|0
6988932|NCT01290315|11047685|FG002|Overall Study|Adverse Event|0
6988933|NCT01290315|11047686|FG003|Overall Study|Adverse Event|3
6988934|NCT01290315|11047683|FG000|Overall Study|Selection criteria/compliance|2
6988935|NCT01290315|11047684|FG001|Overall Study|Selection criteria/compliance|1
6988936|NCT01290315|11047685|FG002|Overall Study|Selection criteria/compliance|0
6988937|NCT01290315|11047686|FG003|Overall Study|Selection criteria/compliance|2
6988938|NCT01290315|11047683|FG000|Overall Study|Lost to Follow-up|0
6988939|NCT01290315|11047684|FG001|Overall Study|Lost to Follow-up|1
6988940|NCT01290315|11047685|FG002|Overall Study|Lost to Follow-up|0
6988941|NCT01290315|11047686|FG003|Overall Study|Lost to Follow-up|0
6988942|NCT01290315|11047683|FG000|Overall Study|Withdrawal by Subject|1
6988943|NCT01290315|11047684|FG001|Overall Study|Withdrawal by Subject|1
6988944|NCT01290315|11047685|FG002|Overall Study|Withdrawal by Subject|0
6988945|NCT01290315|11047686|FG003|Overall Study|Withdrawal by Subject|0
7042219|NCT01734382|11126577|FG000|Part 2|Protocol Violation|0
7042220|NCT01734382|11126578|FG001|Part 2|Protocol Violation|1
7042221|NCT01734382|11126579|FG002|Part 2|Protocol Violation|0
7042222|NCT01734382|11126577|FG000|Part 2|Withdrawal by Subject|0
7042223|NCT01734382|11126578|FG001|Part 2|Withdrawal by Subject|0
7042224|NCT01734382|11126579|FG002|Part 2|Withdrawal by Subject|1
7042225|NCT01734395|11126591|FG000|Overall Study|Other|65
7042226|NCT01734395|11126591|FG000|Overall Study|Lost to Follow-up|287
7042227|NCT01734395|11126591|FG000|Overall Study|Lack of Efficacy|5
7042228|NCT01734395|11126591|FG000|Overall Study|Adverse Event|40
7042229|NCT01734395|11126591|FG000|Overall Study|Withdrawal by Subject|10
7042230|NCT01734395|11126591|FG000|Overall Study|Missing the reasons for not completed|3
7042231|NCT01734434|11126599|FG000|Overall Study|Death Infant|3
7042232|NCT01734434|11126600|FG001|Overall Study|Death Infant|1
6988946|NCT01290341|11047697|FG000|Overall Study|Protocol Violation|7
6988947|NCT01290341|11047698|FG001|Overall Study|Protocol Violation|3
6988948|NCT01290341|11047697|FG000|Overall Study|Adverse Event|1
6988949|NCT01290341|11047698|FG001|Overall Study|Adverse Event|0
6988950|NCT01290341|11047697|FG000|Overall Study|Lost to Follow-up|21
6988951|NCT01290341|11047698|FG001|Overall Study|Lost to Follow-up|10
6988952|NCT01290341|11047697|FG000|Overall Study|Withdrawal by Subject|19
6988953|NCT01290341|11047698|FG001|Overall Study|Withdrawal by Subject|5
6988954|NCT01290341|11047697|FG000|Overall Study|Negative baseline culture and others|44
6988955|NCT01290341|11047698|FG001|Overall Study|Negative baseline culture and others|11
6988956|NCT01290523|11047721|FG000|Overall Study|Death|3
6988957|NCT01290601|11047734|FG000|Overall Study|Adverse Event|0
6988958|NCT01290601|11047735|FG001|Overall Study|Adverse Event|2
6988959|NCT01290601|11047736|FG002|Overall Study|Adverse Event|0
6988960|NCT01290601|11047737|FG003|Overall Study|Adverse Event|0
6988961|NCT01290601|11047734|FG000|Overall Study|Lack of Efficacy|2
6988962|NCT01290601|11047735|FG001|Overall Study|Lack of Efficacy|1
6988963|NCT01290601|11047736|FG002|Overall Study|Lack of Efficacy|0
6988964|NCT01290601|11047737|FG003|Overall Study|Lack of Efficacy|0
6988965|NCT01290601|11047734|FG000|Overall Study|Lost to Follow-up|7
6988966|NCT01290601|11047735|FG001|Overall Study|Lost to Follow-up|2
6988967|NCT01290601|11047736|FG002|Overall Study|Lost to Follow-up|0
6988968|NCT01290601|11047737|FG003|Overall Study|Lost to Follow-up|0
6988969|NCT01290601|11047734|FG000|Overall Study|Other|1
6988970|NCT01290601|11047735|FG001|Overall Study|Other|0
6988971|NCT01290601|11047736|FG002|Overall Study|Other|0
6988972|NCT01290601|11047737|FG003|Overall Study|Other|0
6988973|NCT01290601|11047734|FG000|Overall Study|Protocol Violation|1
6988974|NCT01290601|11047735|FG001|Overall Study|Protocol Violation|0
6988975|NCT01290601|11047736|FG002|Overall Study|Protocol Violation|0
6988976|NCT01290601|11047737|FG003|Overall Study|Protocol Violation|0
6988977|NCT01290666|11047774|FG000|Overall Study|Lost to Follow-up|11
6988978|NCT01290666|11047774|FG000|Overall Study|Withdrawal by Subject|23
6988979|NCT01290666|11047774|FG000|Overall Study|Early Termination of Study|4
6988980|NCT01290679|11047780|FG000|Overall Study|Adverse Event|2
6988981|NCT01290679|11047781|FG001|Overall Study|Adverse Event|0
6988982|NCT01290679|11047780|FG000|Overall Study|Lost to Follow-up|8
6988983|NCT01290679|11047781|FG001|Overall Study|Lost to Follow-up|10
6988984|NCT01290679|11047780|FG000|Overall Study|Protocol Violation|0
6988985|NCT01290679|11047781|FG001|Overall Study|Protocol Violation|1
6988986|NCT01290679|11047780|FG000|Overall Study|Withdrawal by Subject|6
6988987|NCT01290679|11047781|FG001|Overall Study|Withdrawal by Subject|5
6988988|NCT01290679|11047780|FG000|Overall Study|Subject Entered Another Trial|0
6988989|NCT01290679|11047781|FG001|Overall Study|Subject Entered Another Trial|5
6988990|NCT01290731|11047787|FG000|Overall Study|Withdrawal by Subject|1
6988991|NCT01290757|11047793|FG000|Overall Study|Adverse Event|1
6988992|NCT01290757|11047794|FG001|Overall Study|Adverse Event|0
6988993|NCT01290757|11047793|FG000|Overall Study|Protocol Violation|1
6988994|NCT01290757|11047794|FG001|Overall Study|Protocol Violation|1
6988995|NCT01290757|11047793|FG000|Overall Study|Other|0
6988996|NCT01290757|11047794|FG001|Overall Study|Other|1
6988997|NCT01290796|11047800|FG000|Overall Study|Lost to Follow-up|21
6988998|NCT01290796|11047800|FG000|Overall Study|Withdrawal by Subject|4
6988999|NCT01290796|11047800|FG000|Overall Study|Physician Decision|2
6989000|NCT01290796|11047800|FG000|Overall Study|Secondary Surgical Intervention|2
6989001|NCT01290796|11047800|FG000|Overall Study|Withdrawal by Sponsor|1
6989002|NCT01290887|11047816|FG000|Overall Study|Adverse Event|6
6989003|NCT01290887|11047817|FG001|Overall Study|Adverse Event|11
6989004|NCT01290887|11047816|FG000|Overall Study|Lack of Efficacy|4
6989005|NCT01290887|11047817|FG001|Overall Study|Lack of Efficacy|5
6989006|NCT01290887|11047816|FG000|Overall Study|Withdrawal by Subject|26
6989007|NCT01290887|11047817|FG001|Overall Study|Withdrawal by Subject|32
6989008|NCT01290887|11047816|FG000|Overall Study|Protocol Violation|2
6989009|NCT01290887|11047817|FG001|Overall Study|Protocol Violation|1
6989010|NCT01290887|11047816|FG000|Overall Study|Lost to Follow-up|4
6989011|NCT01290887|11047817|FG001|Overall Study|Lost to Follow-up|4
6989012|NCT01290887|11047816|FG000|Overall Study|Non-compliance to study procedures|0
6989013|NCT01290887|11047817|FG001|Overall Study|Non-compliance to study procedures|1
6989014|NCT01290887|11047816|FG000|Overall Study|Non-compliance to study medications|1
6989015|NCT01290887|11047817|FG001|Overall Study|Non-compliance to study medications|0
6989016|NCT01290887|11047816|FG000|Overall Study|Sponsor closure of study|420
6989017|NCT01290887|11047817|FG001|Overall Study|Sponsor closure of study|476
6989018|NCT01290887|11047816|FG000|Overall Study|Other|3
6989019|NCT01290887|11047817|FG001|Overall Study|Other|6
6989020|NCT01291017|11047843|FG000|Overall Study|Lost to Follow-up|2
6989021|NCT01291017|11047843|FG000|Overall Study|Withdrawal by Subject|3
6989022|NCT01291173|11047889|FG000|Overall Study|Adverse Event|0
6989023|NCT01291173|11047890|FG001|Overall Study|Adverse Event|3
6989024|NCT01291173|11047891|FG002|Overall Study|Adverse Event|1
6989025|NCT01291173|11047892|FG003|Overall Study|Adverse Event|3
6989026|NCT01291173|11047889|FG000|Overall Study|Protocol Violation|7
6989027|NCT01291173|11047890|FG001|Overall Study|Protocol Violation|2
6989028|NCT01291173|11047891|FG002|Overall Study|Protocol Violation|2
6989029|NCT01291173|11047892|FG003|Overall Study|Protocol Violation|5
6989030|NCT01291173|11047889|FG000|Overall Study|Withdrawal by Subject|6
6989031|NCT01291173|11047890|FG001|Overall Study|Withdrawal by Subject|4
6989032|NCT01291173|11047891|FG002|Overall Study|Withdrawal by Subject|4
6989033|NCT01291173|11047892|FG003|Overall Study|Withdrawal by Subject|2
6989034|NCT01291173|11047889|FG000|Overall Study|Lost to Follow-up|4
6989035|NCT01291173|11047890|FG001|Overall Study|Lost to Follow-up|6
6989036|NCT01291173|11047891|FG002|Overall Study|Lost to Follow-up|3
6989037|NCT01291173|11047892|FG003|Overall Study|Lost to Follow-up|2
6989038|NCT01291173|11047889|FG000|Overall Study|Unable to meet visit schedule|0
6989039|NCT01291173|11047890|FG001|Overall Study|Unable to meet visit schedule|0
6989040|NCT01291173|11047891|FG002|Overall Study|Unable to meet visit schedule|1
6989041|NCT01291173|11047892|FG003|Overall Study|Unable to meet visit schedule|0
6989042|NCT01291173|11047889|FG000|Overall Study|Lack of compliance|0
6989043|NCT01291173|11047890|FG001|Overall Study|Lack of compliance|0
6989044|NCT01291173|11047891|FG002|Overall Study|Lack of compliance|0
6989045|NCT01291173|11047892|FG003|Overall Study|Lack of compliance|1
6989046|NCT01291173|11047889|FG000|Overall Study|Subject was unblinded|0
6989047|NCT01291173|11047890|FG001|Overall Study|Subject was unblinded|0
6989048|NCT01291173|11047891|FG002|Overall Study|Subject was unblinded|1
6989049|NCT01291173|11047892|FG003|Overall Study|Subject was unblinded|0
6989050|NCT01291173|11047889|FG000|Overall Study|Excluded therapy|0
6989051|NCT01291173|11047890|FG001|Overall Study|Excluded therapy|0
6989052|NCT01291173|11047891|FG002|Overall Study|Excluded therapy|1
6989053|NCT01291173|11047892|FG003|Overall Study|Excluded therapy|0
6989054|NCT01291225|11047904|FG000|Overall Study|Lost to Follow-up|85
6989055|NCT01291225|11047905|FG001|Overall Study|Lost to Follow-up|39
6989056|NCT01291277|11047921|FG000|Overall Study|Death|2
6989057|NCT01291277|11047922|FG001|Overall Study|Death|2
6989058|NCT01291277|11047921|FG000|Overall Study|Lost to Follow-up|3
6989059|NCT01291277|11047922|FG001|Overall Study|Lost to Follow-up|1
6989060|NCT01292057|11047962|FG000|Overall Study|Protocol Violation|1
6989061|NCT01292057|11047963|FG001|Overall Study|Protocol Violation|1
6989062|NCT01292057|11047962|FG000|Overall Study|Lost to Follow-up|1
6989063|NCT01292057|11047963|FG001|Overall Study|Lost to Follow-up|1
6989064|NCT01292187|11047982|FG000|Overall Study|Adverse Event|10
6989065|NCT01292187|11047983|FG001|Overall Study|Adverse Event|5
6989066|NCT01292187|11047982|FG000|Overall Study|Withdrawal by Subject|6
6989067|NCT01292187|11047983|FG001|Overall Study|Withdrawal by Subject|5
6989068|NCT01292187|11047982|FG000|Overall Study|All other reasons|1
6989069|NCT01292187|11047983|FG001|Overall Study|All other reasons|3
6989070|NCT01292226|11047990|FG000|Overall Study|Adverse Event|5
6989071|NCT01292226|11047990|FG000|Overall Study|Death|1
6989072|NCT01292226|11047990|FG000|Overall Study|Graft loss|1
6989073|NCT01292226|11047990|FG000|Overall Study|Protocol Violation|3
6989074|NCT01292226|11047990|FG000|Overall Study|Withdrawal by Subject|1
6989075|NCT01292226|11047990|FG000|Overall Study|Other|2
6989076|NCT01292239|11047996|FG000|Overall Study|Other|1
6989077|NCT01292239|11047997|FG001|Overall Study|Other|1
6989078|NCT01292239|11047996|FG000|Overall Study|Withdrawal by Subject|3
6989079|NCT01292239|11047997|FG001|Overall Study|Withdrawal by Subject|6
6989080|NCT01292473|11048029|FG000|Overall Study|Adverse Event|1
6989081|NCT01292473|11048030|FG001|Overall Study|Adverse Event|0
6989082|NCT01292473|11048031|FG002|Overall Study|Adverse Event|1
6989083|NCT01292473|11048032|FG003|Overall Study|Adverse Event|1
6989084|NCT01292473|11048029|FG000|Overall Study|Lost to Follow-up|1
6989085|NCT01292473|11048030|FG001|Overall Study|Lost to Follow-up|1
6989086|NCT01292473|11048031|FG002|Overall Study|Lost to Follow-up|2
6989087|NCT01292473|11048032|FG003|Overall Study|Lost to Follow-up|2
6989088|NCT01292473|11048029|FG000|Overall Study|Withdrawal by Subject|3
6989089|NCT01292473|11048030|FG001|Overall Study|Withdrawal by Subject|4
6989090|NCT01292473|11048031|FG002|Overall Study|Withdrawal by Subject|3
6989091|NCT01292473|11048032|FG003|Overall Study|Withdrawal by Subject|3
6989092|NCT01292473|11048029|FG000|Overall Study|Physician Decision|0
6989093|NCT01292473|11048030|FG001|Overall Study|Physician Decision|1
6989094|NCT01292473|11048031|FG002|Overall Study|Physician Decision|0
6989095|NCT01292473|11048032|FG003|Overall Study|Physician Decision|0
6989096|NCT01292473|11048029|FG000|Overall Study|Disease Progression|0
6989097|NCT01292473|11048030|FG001|Overall Study|Disease Progression|1
6989098|NCT01292473|11048031|FG002|Overall Study|Disease Progression|3
6989099|NCT01292473|11048032|FG003|Overall Study|Disease Progression|6
6989100|NCT01292486|11048046|FG000|Overall Study|Protocol Violation|2
6989101|NCT01292486|11048046|FG000|Overall Study|Did not meet screening criteria|2
6989102|NCT01292486|11048046|FG000|Overall Study|Adverse Event|1
6989103|NCT01292486|11048046|FG000|Overall Study|Physician Decision|1
6989104|NCT01292603|11048065|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0
6989105|NCT01292603|11048066|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0
6989106|NCT01292603|11048067|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0
6989107|NCT01292603|11048068|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4
6989108|NCT01292603|11048069|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0
6989109|NCT01292603|11048070|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0
6989110|NCT01292603|11048065|FG000|Part 1: Pilot Dose Selection Period|Death|0
6989111|NCT01292603|11048066|FG001|Part 1: Pilot Dose Selection Period|Death|0
6989112|NCT01292603|11048067|FG002|Part 1: Pilot Dose Selection Period|Death|0
6989113|NCT01292603|11048068|FG003|Part 1: Pilot Dose Selection Period|Death|1
6989114|NCT01292603|11048069|FG004|Part 1: Pilot Dose Selection Period|Death|0
6989115|NCT01292603|11048070|FG005|Part 1: Pilot Dose Selection Period|Death|0
6989116|NCT01292603|11048065|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0
6989117|NCT01292603|11048066|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0
6989118|NCT01292603|11048067|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0
6989119|NCT01292603|11048068|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2
6989120|NCT01292603|11048069|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0
6989121|NCT01292603|11048070|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0
6989122|NCT01292603|11048065|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
6989123|NCT01292603|11048066|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
6989124|NCT01292603|11048067|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
6989125|NCT01292603|11048068|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1
6989126|NCT01292603|11048069|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
6989127|NCT01292603|11048070|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
6989128|NCT01292603|11048065|FG000|Part 1: Regular Follow-Up Period|Death|3
6989129|NCT01292603|11048066|FG001|Part 1: Regular Follow-Up Period|Death|1
6989130|NCT01292603|11048067|FG002|Part 1: Regular Follow-Up Period|Death|3
6989131|NCT01292603|11048068|FG003|Part 1: Regular Follow-Up Period|Death|1
6989132|NCT01292603|11048069|FG004|Part 1: Regular Follow-Up Period|Death|0
6989133|NCT01292603|11048070|FG005|Part 1: Regular Follow-Up Period|Death|0
6989134|NCT01292603|11048065|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3
6989135|NCT01292603|11048066|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6
6989136|NCT01292603|11048067|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3
6989137|NCT01292603|11048068|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0
6989138|NCT01292603|11048069|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0
6989139|NCT01292603|11048070|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0
6989140|NCT01292603|11048065|FG000|Part 2: Dose Confirmation Period|Death|0
6989141|NCT01292603|11048066|FG001|Part 2: Dose Confirmation Period|Death|0
6989142|NCT01292603|11048067|FG002|Part 2: Dose Confirmation Period|Death|0
6989143|NCT01292603|11048068|FG003|Part 2: Dose Confirmation Period|Death|0
6989144|NCT01292603|11048069|FG004|Part 2: Dose Confirmation Period|Death|1
6989145|NCT01292603|11048070|FG005|Part 2: Dose Confirmation Period|Death|0
6989146|NCT01292603|11048065|FG000|Part 2: Dose Confirmation Period|Physician Decision|0
6989147|NCT01292603|11048066|FG001|Part 2: Dose Confirmation Period|Physician Decision|0
6989148|NCT01292603|11048067|FG002|Part 2: Dose Confirmation Period|Physician Decision|0
6989149|NCT01292603|11048068|FG003|Part 2: Dose Confirmation Period|Physician Decision|0
6989150|NCT01292603|11048069|FG004|Part 2: Dose Confirmation Period|Physician Decision|2
6989151|NCT01292603|11048070|FG005|Part 2: Dose Confirmation Period|Physician Decision|0
6989152|NCT01292603|11048065|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
6989153|NCT01292603|11048066|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
6989154|NCT01292603|11048067|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
6989155|NCT01292603|11048068|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
6989156|NCT01292603|11048069|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
6989157|NCT01292603|11048070|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
6989158|NCT01292603|11048065|FG000|Part 2: Dose Confirmation Period|Adverse Event|0
6989159|NCT01292603|11048066|FG001|Part 2: Dose Confirmation Period|Adverse Event|0
6989160|NCT01292603|11048067|FG002|Part 2: Dose Confirmation Period|Adverse Event|0
6989161|NCT01292603|11048068|FG003|Part 2: Dose Confirmation Period|Adverse Event|0
6989162|NCT01292603|11048069|FG004|Part 2: Dose Confirmation Period|Adverse Event|7
6989163|NCT01292603|11048070|FG005|Part 2: Dose Confirmation Period|Adverse Event|9
6989164|NCT01292603|11048065|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0
6989165|NCT01292603|11048066|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0
6989166|NCT01292603|11048067|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0
6989167|NCT01292603|11048068|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0
6989168|NCT01292603|11048069|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5
6989169|NCT01292603|11048070|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3
6989170|NCT01292603|11048065|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
6989171|NCT01292603|11048066|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
6989172|NCT01292603|11048067|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
6989173|NCT01292603|11048068|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
6989174|NCT01292603|11048069|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
6989175|NCT01292603|11048070|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2
6989176|NCT01292603|11048065|FG000|Part 2: Regular Follow-Up|Death|0
6989177|NCT01292603|11048066|FG001|Part 2: Regular Follow-Up|Death|0
6989178|NCT01292603|11048067|FG002|Part 2: Regular Follow-Up|Death|0
6989179|NCT01292603|11048068|FG003|Part 2: Regular Follow-Up|Death|0
6989180|NCT01292603|11048069|FG004|Part 2: Regular Follow-Up|Death|6
6989181|NCT01292603|11048070|FG005|Part 2: Regular Follow-Up|Death|3
6989182|NCT01292603|11048065|FG000|Part 2: Regular Follow-Up|Disease Progression|0
6989183|NCT01292603|11048066|FG001|Part 2: Regular Follow-Up|Disease Progression|0
6989184|NCT01292603|11048067|FG002|Part 2: Regular Follow-Up|Disease Progression|0
6989185|NCT01292603|11048068|FG003|Part 2: Regular Follow-Up|Disease Progression|0
6989186|NCT01292603|11048069|FG004|Part 2: Regular Follow-Up|Disease Progression|5
6989187|NCT01292603|11048070|FG005|Part 2: Regular Follow-Up|Disease Progression|5
6989188|NCT01292603|11048065|FG000|Part 2: Regular Follow-Up|Noncompliance|0
6989189|NCT01292603|11048066|FG001|Part 2: Regular Follow-Up|Noncompliance|0
6989190|NCT01292603|11048067|FG002|Part 2: Regular Follow-Up|Noncompliance|0
6989191|NCT01292603|11048068|FG003|Part 2: Regular Follow-Up|Noncompliance|0
6989192|NCT01292603|11048069|FG004|Part 2: Regular Follow-Up|Noncompliance|1
6989193|NCT01292603|11048070|FG005|Part 2: Regular Follow-Up|Noncompliance|0
6989194|NCT01292603|11048065|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0
6989195|NCT01292603|11048066|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0
6989196|NCT01292603|11048067|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0
6989197|NCT01292603|11048068|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0
6989198|NCT01292603|11048069|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0
6989199|NCT01292603|11048070|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1
6989200|NCT01292603|11048065|FG000|Part 2: Regular Follow-Up|Protocol Violation|0
6989201|NCT01292603|11048066|FG001|Part 2: Regular Follow-Up|Protocol Violation|0
6989202|NCT01292603|11048067|FG002|Part 2: Regular Follow-Up|Protocol Violation|0
6989203|NCT01292603|11048068|FG003|Part 2: Regular Follow-Up|Protocol Violation|0
6989204|NCT01292603|11048069|FG004|Part 2: Regular Follow-Up|Protocol Violation|2
6989205|NCT01292603|11048070|FG005|Part 2: Regular Follow-Up|Protocol Violation|0
6989206|NCT01292603|11048065|FG000|Part 2: Regular Follow-Up|Physician Decision|0
6989207|NCT01292603|11048066|FG001|Part 2: Regular Follow-Up|Physician Decision|0
6989208|NCT01292603|11048067|FG002|Part 2: Regular Follow-Up|Physician Decision|0
6989209|NCT01292603|11048068|FG003|Part 2: Regular Follow-Up|Physician Decision|0
6989210|NCT01292603|11048069|FG004|Part 2: Regular Follow-Up|Physician Decision|2
6989211|NCT01292603|11048070|FG005|Part 2: Regular Follow-Up|Physician Decision|0
6989212|NCT01292603|11048065|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0
6989213|NCT01292603|11048066|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0
6989214|NCT01292603|11048067|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0
6989215|NCT01292603|11048068|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0
6989216|NCT01292603|11048069|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1
6989217|NCT01292603|11048070|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1
6989218|NCT01292603|11048065|FG000|Part 2: Regular Follow-Up|Adverse Event|0
6989219|NCT01292603|11048066|FG001|Part 2: Regular Follow-Up|Adverse Event|0
6989220|NCT01292603|11048067|FG002|Part 2: Regular Follow-Up|Adverse Event|0
6989221|NCT01292603|11048068|FG003|Part 2: Regular Follow-Up|Adverse Event|0
6989222|NCT01292603|11048069|FG004|Part 2: Regular Follow-Up|Adverse Event|2
6989223|NCT01292603|11048070|FG005|Part 2: Regular Follow-Up|Adverse Event|2
6989224|NCT01292603|11048065|FG000|Overall Survival Status|Death|3
6989225|NCT01292603|11048066|FG001|Overall Survival Status|Death|1
6989226|NCT01292603|11048067|FG002|Overall Survival Status|Death|3
6989227|NCT01292603|11048068|FG003|Overall Survival Status|Death|1
6989228|NCT01292603|11048069|FG004|Overall Survival Status|Death|16
6989229|NCT01292603|11048070|FG005|Overall Survival Status|Death|10
6989230|NCT01292837|11048112|FG000|Overall Study|Adverse Event|1
6989231|NCT01292837|11048112|FG000|Overall Study|Further treatment determined|1
6989232|NCT01292876|11048116|FG000|Overall Study|Physician Decision|4
6989233|NCT01292928|11048122|FG000|Overall Study|Death|8
6989234|NCT01292928|11048122|FG000|Overall Study|Withdrawal by Subject|8
6989235|NCT01292928|11048122|FG000|Overall Study|Lost to Follow-up|6
6989236|NCT01292928|11048122|FG000|Overall Study|Physician Decision|2
6989237|NCT01293006|11048132|FG000|Period 2|Lost to Follow-up|1
6989238|NCT01293006|11048133|FG001|Period 2|Lost to Follow-up|0
6989239|NCT01293006|11048134|FG002|Period 2|Lost to Follow-up|0
6989240|NCT01293006|11048135|FG003|Period 2|Lost to Follow-up|0
6989241|NCT01293032|11048154|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
6989242|NCT01293032|11048155|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
6989243|NCT01293032|11048156|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5
6989244|NCT01293032|11048157|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
6989245|NCT01293032|11048154|FG000|Treatment|Adverse Event|0
6989246|NCT01293032|11048155|FG001|Treatment|Adverse Event|0
6989247|NCT01293032|11048156|FG002|Treatment|Adverse Event|1
6989248|NCT01293032|11048157|FG003|Treatment|Adverse Event|1
6989249|NCT01293032|11048154|FG000|Treatment|Withdrawal by Subject|2
6989250|NCT01293032|11048155|FG001|Treatment|Withdrawal by Subject|4
6989251|NCT01293032|11048156|FG002|Treatment|Withdrawal by Subject|0
6989252|NCT01293032|11048157|FG003|Treatment|Withdrawal by Subject|0
6989253|NCT01293032|11048154|FG000|Treatment|Disease Progression, relapse|0
6989254|NCT01293032|11048155|FG001|Treatment|Disease Progression, relapse|1
6989255|NCT01293032|11048156|FG002|Treatment|Disease Progression, relapse|0
6989256|NCT01293032|11048157|FG003|Treatment|Disease Progression, relapse|0
6989257|NCT01293084|11048164|FG000|Overall Study|Physician Decision|3
6989258|NCT01293084|11048164|FG000|Overall Study|Withdrawal by Subject|2
6989259|NCT01293240|11048170|FG000|Overall Study|Noncompliance|2
6989260|NCT01293539|11048184|FG000|Overall Study|Physician Decision|1
6989261|NCT01293695|11048190|FG000|Overall Study|Withdrawal by Subject|7
6989262|NCT01293695|11048191|FG001|Overall Study|Withdrawal by Subject|1
6989263|NCT01293695|11048190|FG000|Overall Study|Lost to Follow-up|8
6989264|NCT01293695|11048191|FG001|Overall Study|Lost to Follow-up|6
6989265|NCT01293968|11048206|FG000|Overall Study|non-cooperation|3
6989266|NCT01293968|11048207|FG001|Overall Study|non-cooperation|3
6989267|NCT01294150|11048228|FG000|Overall Study|Physician Decision|2
6989268|NCT01294150|11048229|FG001|Overall Study|Physician Decision|2
6989269|NCT01294358|11048294|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0
6989270|NCT01294358|11048295|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2
6989271|NCT01294358|11048296|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0
6989272|NCT01294358|11048297|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0
6989273|NCT01294358|11048298|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0
6989274|NCT01294358|11048294|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0
6989275|NCT01294358|11048295|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0
6989276|NCT01294358|11048296|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2
6989277|NCT01294358|11048297|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0
6989278|NCT01294358|11048298|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0
6989279|NCT01294358|11048294|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
6989280|NCT01294358|11048295|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
6989281|NCT01294358|11048296|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
6989282|NCT01294358|11048297|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1
6989283|NCT01294358|11048298|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
6989284|NCT01294358|11048294|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
6989285|NCT01294358|11048295|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
6989286|NCT01294358|11048296|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
6989287|NCT01294358|11048297|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
6989288|NCT01294358|11048298|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1
6989289|NCT01294371|11048315|FG000|Overall Study|Adverse Event|1
6989290|NCT01294371|11048315|FG000|Overall Study|Withdrawal by Subject|12
6989291|NCT01294371|11048315|FG000|Overall Study|Lost to Follow-up|6
6989292|NCT01294371|11048315|FG000|Overall Study|Administrative Reason|1
6989293|NCT01294371|11048315|FG000|Overall Study|Other|14
6989294|NCT01294397|11048335|FG000|Overall Study|Withdrawal by Subject|1
6989295|NCT01294397|11048335|FG000|Overall Study|Administrative Decision|1
6989296|NCT01294423|11048344|FG000|Overall Study|Adverse Event|1
6989297|NCT01294423|11048345|FG001|Overall Study|Adverse Event|2
6989298|NCT01294423|11048346|FG002|Overall Study|Adverse Event|3
6989299|NCT01294423|11048344|FG000|Overall Study|Withdrawal by Subject|1
6989300|NCT01294423|11048345|FG001|Overall Study|Withdrawal by Subject|2
6989301|NCT01294423|11048346|FG002|Overall Study|Withdrawal by Subject|2
6989302|NCT01294423|11048344|FG000|Overall Study|subject no longer meets study criteria|2
6989303|NCT01294423|11048345|FG001|Overall Study|subject no longer meets study criteria|5
6989304|NCT01294423|11048346|FG002|Overall Study|subject no longer meets study criteria|2
6989305|NCT01294423|11048344|FG000|Overall Study|poor/non-compliance|1
6989306|NCT01294423|11048345|FG001|Overall Study|poor/non-compliance|0
6989307|NCT01294423|11048346|FG002|Overall Study|poor/non-compliance|1
6989308|NCT01294436|11048356|FG000|Overall Study|Adverse Event|10
6989309|NCT01294436|11048357|FG001|Overall Study|Adverse Event|17
6989310|NCT01294436|11048356|FG000|Overall Study|Withdrawal by Subject|11
6989311|NCT01294436|11048357|FG001|Overall Study|Withdrawal by Subject|28
6989312|NCT01294436|11048356|FG000|Overall Study|subject no longer meets study criteria|5
6989313|NCT01294436|11048357|FG001|Overall Study|subject no longer meets study criteria|20
6989314|NCT01294436|11048356|FG000|Overall Study|poor/non-compliance|2
6989315|NCT01294436|11048357|FG001|Overall Study|poor/non-compliance|5
6989316|NCT01294449|11048365|FG000|Overall Study|Death|11
6989317|NCT01294449|11048366|FG001|Overall Study|Death|12
6989318|NCT01294449|11048365|FG000|Overall Study|Withdrawal by Subject|1
6989319|NCT01294449|11048366|FG001|Overall Study|Withdrawal by Subject|3
6989320|NCT01294462|11048374|FG000|Overall Study|Lost to Follow-up|1
6989321|NCT01294462|11048375|FG001|Overall Study|Lost to Follow-up|0
6989322|NCT01294462|11048374|FG000|Overall Study|Withdrawal by Subject|65
6989323|NCT01294462|11048375|FG001|Overall Study|Withdrawal by Subject|63
6989324|NCT01294514|11048381|FG000|Overall Study|Excluded due to Arrhythmia|1
6989325|NCT01294553|11048389|FG000|Overall Study|Duplicated Participants|1
6989326|NCT01294553|11048389|FG000|Overall Study|Protocol Violation|268
6989327|NCT01294579|11048394|FG000|Overall Study|Disease progression|12
6989328|NCT01294579|11048394|FG000|Overall Study|Adverse Event|11
6989329|NCT01294579|11048394|FG000|Overall Study|Study closed/terminated|3
6989330|NCT01294579|11048394|FG000|Overall Study|Lost to Follow-up|1
6989331|NCT01294579|11048394|FG000|Overall Study|Physician Decision|3
6989332|NCT01294579|11048394|FG000|Overall Study|Withdrawal by Subject|5
6989333|NCT01294592|11048400|FG000|Overall Study|Adverse Event|28
6989334|NCT01294592|11048401|FG001|Overall Study|Adverse Event|13
6989335|NCT01294592|11048400|FG000|Overall Study|Lack of Efficacy|7
6989336|NCT01294592|11048401|FG001|Overall Study|Lack of Efficacy|5
6989337|NCT01294592|11048400|FG000|Overall Study|Protocol Violation|1
6989338|NCT01294592|11048401|FG001|Overall Study|Protocol Violation|7
6989339|NCT01294592|11048400|FG000|Overall Study|Lost to Follow-up|7
6989340|NCT01294592|11048401|FG001|Overall Study|Lost to Follow-up|9
6989341|NCT01294592|11048400|FG000|Overall Study|Physician Decision|6
6989342|NCT01294592|11048401|FG001|Overall Study|Physician Decision|11
6989343|NCT01294592|11048400|FG000|Overall Study|Withdrawal by Subject|28
6989344|NCT01294592|11048401|FG001|Overall Study|Withdrawal by Subject|28
6989345|NCT01294644|11048413|FG000|Overall Study|Adverse Event|2
6989346|NCT01294644|11048414|FG001|Overall Study|Adverse Event|0
6989347|NCT01294644|11048415|FG002|Overall Study|Adverse Event|1
6989348|NCT01294644|11048413|FG000|Overall Study|Withdrawal by Subject|3
6989349|NCT01294644|11048414|FG001|Overall Study|Withdrawal by Subject|7
6989350|NCT01294644|11048415|FG002|Overall Study|Withdrawal by Subject|4
6989351|NCT01294644|11048413|FG000|Overall Study|Lost to Follow-up|3
6989352|NCT01294644|11048414|FG001|Overall Study|Lost to Follow-up|2
6989353|NCT01294644|11048415|FG002|Overall Study|Lost to Follow-up|5
6989354|NCT01294644|11048413|FG000|Overall Study|Miscellaneous Reason|2
6989355|NCT01294644|11048414|FG001|Overall Study|Miscellaneous Reason|1
6989356|NCT01294644|11048415|FG002|Overall Study|Miscellaneous Reason|4
6989357|NCT01294683|11048425|FG000|Precrossover (Periods I/II)|Adverse Event|49
6989358|NCT01294683|11048426|FG001|Precrossover (Periods I/II)|Adverse Event|52
6989359|NCT01294683|11048425|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3
6989360|NCT01294683|11048426|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6
6989361|NCT01294683|11048425|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
6989362|NCT01294683|11048426|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
6989363|NCT01294683|11048425|FG000|Precrossover (Periods I/II)|Physician Decision|1
6989364|NCT01294683|11048426|FG001|Precrossover (Periods I/II)|Physician Decision|0
6989365|NCT01294683|11048425|FG000|Precrossover (Periods I/II)|Protocol Violation|5
6989366|NCT01294683|11048426|FG001|Precrossover (Periods I/II)|Protocol Violation|5
6989367|NCT01294683|11048425|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187
6989368|NCT01294683|11048426|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192
6989369|NCT01294683|11048425|FG000|Precrossover (Periods I/II)|Technical Problems|0
6989370|NCT01294683|11048426|FG001|Precrossover (Periods I/II)|Technical Problems|1
6989371|NCT01294683|11048425|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11
6989372|NCT01294683|11048426|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9
6989373|NCT01294683|11048425|FG000|Post Crossover (Period III)|Adverse Event|6
6989374|NCT01294683|11048426|FG001|Post Crossover (Period III)|Adverse Event|6
6989375|NCT01294683|11048425|FG000|Post Crossover (Period III)|Lost to Follow-up|1
6989376|NCT01294683|11048426|FG001|Post Crossover (Period III)|Lost to Follow-up|3
6989377|NCT01294683|11048425|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23
6989378|NCT01294683|11048426|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21
6989379|NCT01294683|11048425|FG000|Post Crossover (Period III)|Withdrawal by Subject|3
6989380|NCT01294683|11048426|FG001|Post Crossover (Period III)|Withdrawal by Subject|2
6989381|NCT01294787|11048459|FG000|Period 1|Adverse Event|0
6989382|NCT01294787|11048460|FG001|Period 1|Adverse Event|0
6989383|NCT01294787|11048461|FG002|Period 1|Adverse Event|0
6989384|NCT01294787|11048462|FG003|Period 1|Adverse Event|0
6989385|NCT01294787|11048463|FG004|Period 1|Adverse Event|1
6989386|NCT01294787|11048464|FG005|Period 1|Adverse Event|0
6989387|NCT01294787|11048459|FG000|Period 1|Withdrawal by Subject|0
6989388|NCT01294787|11048460|FG001|Period 1|Withdrawal by Subject|0
6989389|NCT01294787|11048461|FG002|Period 1|Withdrawal by Subject|0
6989390|NCT01294787|11048462|FG003|Period 1|Withdrawal by Subject|1
6989391|NCT01294787|11048463|FG004|Period 1|Withdrawal by Subject|1
6989392|NCT01294787|11048464|FG005|Period 1|Withdrawal by Subject|1
6989393|NCT01294787|11048459|FG000|Period 1|Administrative problem|0
6989394|NCT01294787|11048460|FG001|Period 1|Administrative problem|0
6989395|NCT01294787|11048461|FG002|Period 1|Administrative problem|1
6989396|NCT01294787|11048462|FG003|Period 1|Administrative problem|0
6989397|NCT01294787|11048463|FG004|Period 1|Administrative problem|0
6989398|NCT01294787|11048464|FG005|Period 1|Administrative problem|1
6989399|NCT01294787|11048459|FG000|Period 2|Adverse Event|0
6989400|NCT01294787|11048460|FG001|Period 2|Adverse Event|3
6989401|NCT01294787|11048461|FG002|Period 2|Adverse Event|0
6989402|NCT01294787|11048462|FG003|Period 2|Adverse Event|1
6989403|NCT01294787|11048463|FG004|Period 2|Adverse Event|0
6989404|NCT01294787|11048464|FG005|Period 2|Adverse Event|0
6989405|NCT01294787|11048459|FG000|Period 2|No longer needs study drug|0
6989406|NCT01294787|11048460|FG001|Period 2|No longer needs study drug|0
6989407|NCT01294787|11048461|FG002|Period 2|No longer needs study drug|0
6989408|NCT01294787|11048462|FG003|Period 2|No longer needs study drug|1
6989409|NCT01294787|11048463|FG004|Period 2|No longer needs study drug|0
6989410|NCT01294787|11048464|FG005|Period 2|No longer needs study drug|0
6989411|NCT01294787|11048459|FG000|Period 3|Adverse Event|0
6989412|NCT01294787|11048460|FG001|Period 3|Adverse Event|0
6989413|NCT01294787|11048461|FG002|Period 3|Adverse Event|0
6989414|NCT01294787|11048462|FG003|Period 3|Adverse Event|0
6989415|NCT01294787|11048463|FG004|Period 3|Adverse Event|1
6989416|NCT01294787|11048464|FG005|Period 3|Adverse Event|0
6989417|NCT01294800|11048479|FG000|Overall Study|Adverse Event|7
6989418|NCT01294800|11048480|FG001|Overall Study|Adverse Event|6
6989419|NCT01294800|11048481|FG002|Overall Study|Adverse Event|12
6989420|NCT01294800|11048482|FG003|Overall Study|Adverse Event|5
6989421|NCT01294800|11048479|FG000|Overall Study|Subject Withdrew Consent|2
6989422|NCT01294800|11048480|FG001|Overall Study|Subject Withdrew Consent|2
6989423|NCT01294800|11048481|FG002|Overall Study|Subject Withdrew Consent|2
6989424|NCT01294800|11048482|FG003|Overall Study|Subject Withdrew Consent|11
6989425|NCT01294800|11048479|FG000|Overall Study|Lost to Follow-up|0
6989426|NCT01294800|11048480|FG001|Overall Study|Lost to Follow-up|0
6989427|NCT01294800|11048481|FG002|Overall Study|Lost to Follow-up|1
6989428|NCT01294800|11048482|FG003|Overall Study|Lost to Follow-up|0
6989429|NCT01294800|11048479|FG000|Overall Study|Non-compliance With Protocol|0
6989430|NCT01294800|11048480|FG001|Overall Study|Non-compliance With Protocol|1
6989431|NCT01294800|11048481|FG002|Overall Study|Non-compliance With Protocol|1
6989432|NCT01294800|11048482|FG003|Overall Study|Non-compliance With Protocol|0
6989433|NCT01294800|11048479|FG000|Overall Study|Did Not Meet Protocol Eligibility|2
6989434|NCT01294800|11048480|FG001|Overall Study|Did Not Meet Protocol Eligibility|1
6989435|NCT01294800|11048481|FG002|Overall Study|Did Not Meet Protocol Eligibility|1
6989436|NCT01294800|11048482|FG003|Overall Study|Did Not Meet Protocol Eligibility|0
6989437|NCT01294917|11048492|FG000|Overall Study|Relocation|5
6989438|NCT01294917|11048492|FG000|Overall Study|Inconvenience|1
6989439|NCT01295034|11048500|FG000|Overall Study|Lost to Follow-up|5
6989440|NCT01295034|11048501|FG001|Overall Study|Lost to Follow-up|5
6989441|NCT01295281|11048528|FG000|First Intervention (7 Days)|Death|0
6989442|NCT01295281|11048529|FG001|First Intervention (7 Days)|Death|1
6989443|NCT01295320|11048535|FG000|Overall Study|Adverse Event|2
6989444|NCT01295320|11048535|FG000|Overall Study|Lost to Follow-up|4
6989445|NCT01295320|11048535|FG000|Overall Study|Withdrawal by Subject|2
6989446|NCT01295320|11048535|FG000|Overall Study|Subject was bedridden|1
6989447|NCT01295320|11048535|FG000|Overall Study|Unable to travel|1
6989448|NCT01295580|11048545|FG000|Overall Study|Protocol Violation|4
6989449|NCT01295580|11048546|FG001|Overall Study|Protocol Violation|2
6989450|NCT01295580|11048545|FG000|Overall Study|Withdrawal by Subject|1
6989451|NCT01295580|11048546|FG001|Overall Study|Withdrawal by Subject|4
6989452|NCT01295580|11048545|FG000|Overall Study|Adverse Event|2
6989453|NCT01295580|11048546|FG001|Overall Study|Adverse Event|1
6989454|NCT01295580|11048545|FG000|Overall Study|Lost to Follow-up|1
6989455|NCT01295580|11048546|FG001|Overall Study|Lost to Follow-up|0
6989456|NCT01295580|11048545|FG000|Overall Study|Lack of Efficacy|1
6989457|NCT01295580|11048546|FG001|Overall Study|Lack of Efficacy|0
6989458|NCT01295580|11048545|FG000|Overall Study|Other: inconvenience|1
6989459|NCT01295580|11048546|FG001|Overall Study|Other: inconvenience|0
6989460|NCT01295580|11048545|FG000|Overall Study|Other: family objection|0
6989461|NCT01295580|11048546|FG001|Overall Study|Other: family objection|1
6989462|NCT01295671|11048555|FG000|Overall Study|Lost to Follow-up|4
6989463|NCT01295671|11048556|FG001|Overall Study|Lost to Follow-up|6
6989464|NCT01295671|11048557|FG002|Overall Study|Lost to Follow-up|3
6989465|NCT01295671|11048555|FG000|Overall Study|Withdrawal by Subject|3
6989466|NCT01295671|11048556|FG001|Overall Study|Withdrawal by Subject|1
6989467|NCT01295671|11048557|FG002|Overall Study|Withdrawal by Subject|0
6989468|NCT01295814|11048576|FG000|Overall Study|Lack of Efficacy|0
6989469|NCT01295814|11048577|FG001|Overall Study|Lack of Efficacy|2
6989470|NCT01295814|11048576|FG000|Overall Study|Withdrawal by Subject|2
6989471|NCT01295814|11048577|FG001|Overall Study|Withdrawal by Subject|0
6989472|NCT01295827|11048595|FG000|Overall Study|Adverse Event|1
6989473|NCT01295827|11048596|FG001|Overall Study|Adverse Event|2
6989474|NCT01295827|11048597|FG002|Overall Study|Adverse Event|2
6989475|NCT01295827|11048598|FG003|Overall Study|Adverse Event|1
6989476|NCT01295827|11048599|FG004|Overall Study|Adverse Event|1
6989477|NCT01295827|11048600|FG005|Overall Study|Adverse Event|4
6989478|NCT01295827|11048601|FG006|Overall Study|Adverse Event|15
6989479|NCT01295827|11048602|FG007|Overall Study|Adverse Event|49
6989480|NCT01295827|11048603|FG008|Overall Study|Adverse Event|22
6989481|NCT01295827|11048604|FG009|Overall Study|Adverse Event|7
6989482|NCT01295827|11048605|FG010|Overall Study|Adverse Event|50
6989483|NCT01295827|11048606|FG011|Overall Study|Adverse Event|21
6989484|NCT01295827|11048607|FG012|Overall Study|Adverse Event|0
6989485|NCT01295827|11048608|FG013|Overall Study|Adverse Event|0
6989486|NCT01295827|11048609|FG014|Overall Study|Adverse Event|0
6989487|NCT01295827|11048595|FG000|Overall Study|Lost to Follow-up|0
6989488|NCT01295827|11048596|FG001|Overall Study|Lost to Follow-up|0
6989489|NCT01295827|11048597|FG002|Overall Study|Lost to Follow-up|3
6989490|NCT01295827|11048598|FG003|Overall Study|Lost to Follow-up|0
6989491|NCT01295827|11048599|FG004|Overall Study|Lost to Follow-up|1
6989492|NCT01295827|11048600|FG005|Overall Study|Lost to Follow-up|0
6989493|NCT01295827|11048601|FG006|Overall Study|Lost to Follow-up|4
6989494|NCT01295827|11048602|FG007|Overall Study|Lost to Follow-up|8
6989495|NCT01295827|11048603|FG008|Overall Study|Lost to Follow-up|7
6989496|NCT01295827|11048604|FG009|Overall Study|Lost to Follow-up|4
6989497|NCT01295827|11048605|FG010|Overall Study|Lost to Follow-up|7
6989498|NCT01295827|11048606|FG011|Overall Study|Lost to Follow-up|3
6989499|NCT01295827|11048607|FG012|Overall Study|Lost to Follow-up|0
6989500|NCT01295827|11048608|FG013|Overall Study|Lost to Follow-up|0
6989501|NCT01295827|11048609|FG014|Overall Study|Lost to Follow-up|0
6989502|NCT01295827|11048595|FG000|Overall Study|Not Reported|0
6989503|NCT01295827|11048596|FG001|Overall Study|Not Reported|0
6989504|NCT01295827|11048597|FG002|Overall Study|Not Reported|0
6989505|NCT01295827|11048598|FG003|Overall Study|Not Reported|1
6989506|NCT01295827|11048599|FG004|Overall Study|Not Reported|0
6989507|NCT01295827|11048600|FG005|Overall Study|Not Reported|0
6989508|NCT01295827|11048601|FG006|Overall Study|Not Reported|24
6989509|NCT01295827|11048602|FG007|Overall Study|Not Reported|58
6989510|NCT01295827|11048603|FG008|Overall Study|Not Reported|41
6989511|NCT01295827|11048604|FG009|Overall Study|Not Reported|2
6989512|NCT01295827|11048605|FG010|Overall Study|Not Reported|23
6989513|NCT01295827|11048606|FG011|Overall Study|Not Reported|13
6989514|NCT01295827|11048607|FG012|Overall Study|Not Reported|0
6989515|NCT01295827|11048608|FG013|Overall Study|Not Reported|0
6989516|NCT01295827|11048609|FG014|Overall Study|Not Reported|0
6989517|NCT01295827|11048595|FG000|Overall Study|Progressive Disease|2
6989518|NCT01295827|11048596|FG001|Overall Study|Progressive Disease|1
6989519|NCT01295827|11048597|FG002|Overall Study|Progressive Disease|5
6989520|NCT01295827|11048598|FG003|Overall Study|Progressive Disease|2
6989521|NCT01295827|11048599|FG004|Overall Study|Progressive Disease|0
6989522|NCT01295827|11048600|FG005|Overall Study|Progressive Disease|1
6989523|NCT01295827|11048601|FG006|Overall Study|Progressive Disease|87
6989524|NCT01295827|11048602|FG007|Overall Study|Progressive Disease|144
6989525|NCT01295827|11048603|FG008|Overall Study|Progressive Disease|85
6989526|NCT01295827|11048604|FG009|Overall Study|Progressive Disease|40
6989527|NCT01295827|11048605|FG010|Overall Study|Progressive Disease|175
6989528|NCT01295827|11048606|FG011|Overall Study|Progressive Disease|136
6989529|NCT01295827|11048607|FG012|Overall Study|Progressive Disease|0
6989530|NCT01295827|11048608|FG013|Overall Study|Progressive Disease|0
6989531|NCT01295827|11048609|FG014|Overall Study|Progressive Disease|0
6989532|NCT01295827|11048595|FG000|Overall Study|Screen Failure|0
6989533|NCT01295827|11048596|FG001|Overall Study|Screen Failure|0
6989534|NCT01295827|11048597|FG002|Overall Study|Screen Failure|0
6989535|NCT01295827|11048598|FG003|Overall Study|Screen Failure|0
6989536|NCT01295827|11048599|FG004|Overall Study|Screen Failure|0
6989537|NCT01295827|11048600|FG005|Overall Study|Screen Failure|0
6989538|NCT01295827|11048601|FG006|Overall Study|Screen Failure|2
6989539|NCT01295827|11048602|FG007|Overall Study|Screen Failure|2
6989540|NCT01295827|11048603|FG008|Overall Study|Screen Failure|2
6989541|NCT01295827|11048604|FG009|Overall Study|Screen Failure|0
6989542|NCT01295827|11048605|FG010|Overall Study|Screen Failure|1
6989543|NCT01295827|11048606|FG011|Overall Study|Screen Failure|0
6989544|NCT01295827|11048607|FG012|Overall Study|Screen Failure|0
6989545|NCT01295827|11048608|FG013|Overall Study|Screen Failure|0
6989546|NCT01295827|11048609|FG014|Overall Study|Screen Failure|0
6989547|NCT01295827|11048595|FG000|Overall Study|Withdrawal by Subject|1
6989548|NCT01295827|11048596|FG001|Overall Study|Withdrawal by Subject|0
6989549|NCT01295827|11048597|FG002|Overall Study|Withdrawal by Subject|2
6989550|NCT01295827|11048598|FG003|Overall Study|Withdrawal by Subject|0
6989551|NCT01295827|11048599|FG004|Overall Study|Withdrawal by Subject|0
6989552|NCT01295827|11048600|FG005|Overall Study|Withdrawal by Subject|1
6989553|NCT01295827|11048601|FG006|Overall Study|Withdrawal by Subject|13
6989554|NCT01295827|11048602|FG007|Overall Study|Withdrawal by Subject|35
6989555|NCT01295827|11048603|FG008|Overall Study|Withdrawal by Subject|11
6989556|NCT01295827|11048604|FG009|Overall Study|Withdrawal by Subject|2
6989557|NCT01295827|11048605|FG010|Overall Study|Withdrawal by Subject|18
6989558|NCT01295827|11048606|FG011|Overall Study|Withdrawal by Subject|13
6989559|NCT01295827|11048607|FG012|Overall Study|Withdrawal by Subject|0
6989560|NCT01295827|11048608|FG013|Overall Study|Withdrawal by Subject|0
6989561|NCT01295827|11048609|FG014|Overall Study|Withdrawal by Subject|0
6989562|NCT01295827|11048595|FG000|Overall Study|Other|0
6989563|NCT01295827|11048596|FG001|Overall Study|Other|0
6989564|NCT01295827|11048597|FG002|Overall Study|Other|0
6989565|NCT01295827|11048598|FG003|Overall Study|Other|0
6989566|NCT01295827|11048599|FG004|Overall Study|Other|0
6989567|NCT01295827|11048600|FG005|Overall Study|Other|0
6989568|NCT01295827|11048601|FG006|Overall Study|Other|1
6989569|NCT01295827|11048602|FG007|Overall Study|Other|1
6989570|NCT01295827|11048603|FG008|Overall Study|Other|1
6989571|NCT01295827|11048604|FG009|Overall Study|Other|0
6989572|NCT01295827|11048605|FG010|Overall Study|Other|2
6989573|NCT01295827|11048606|FG011|Overall Study|Other|0
6989574|NCT01295827|11048607|FG012|Overall Study|Other|0
6989575|NCT01295827|11048608|FG013|Overall Study|Other|0
6989576|NCT01295827|11048609|FG014|Overall Study|Other|0
6989577|NCT01295905|11048674|FG000|Overall Study|Did not meet inclusion criteria|1
6989578|NCT01295905|11048675|FG001|Overall Study|Did not meet inclusion criteria|0
6989579|NCT01295905|11048674|FG000|Overall Study|Met exclusion criteria|1
6989580|NCT01295905|11048675|FG001|Overall Study|Met exclusion criteria|0
7042233|NCT01734434|11126601|FG002|Overall Study|Death Infant|17
7042234|NCT01734434|11126602|FG003|Overall Study|Death Infant|5
7042235|NCT01734434|11126599|FG000|Overall Study|Lost to Follow-up|2
7042236|NCT01734434|11126600|FG001|Overall Study|Lost to Follow-up|9
7042237|NCT01734434|11126601|FG002|Overall Study|Lost to Follow-up|67
7042238|NCT01734434|11126602|FG003|Overall Study|Lost to Follow-up|11
7042239|NCT01734434|11126599|FG000|Overall Study|No Live Birth|1
7042240|NCT01734434|11126600|FG001|Overall Study|No Live Birth|2
7042241|NCT01734434|11126601|FG002|Overall Study|No Live Birth|32
7042242|NCT01734434|11126602|FG003|Overall Study|No Live Birth|6
7042243|NCT01734434|11126599|FG000|Overall Study|Withdrawal by Subject|4
7042244|NCT01734434|11126600|FG001|Overall Study|Withdrawal by Subject|0
7042245|NCT01734434|11126601|FG002|Overall Study|Withdrawal by Subject|8
7042246|NCT01734434|11126602|FG003|Overall Study|Withdrawal by Subject|1
7042247|NCT01734434|11126599|FG000|Overall Study|Signed Adult Version of Consent Form|0
7042248|NCT01734434|11126600|FG001|Overall Study|Signed Adult Version of Consent Form|0
7042249|NCT01734434|11126601|FG002|Overall Study|Signed Adult Version of Consent Form|1
7042250|NCT01734434|11126602|FG003|Overall Study|Signed Adult Version of Consent Form|0
7042251|NCT01734434|11126599|FG000|Overall Study|Subject Not Reachable|0
7042252|NCT01734434|11126600|FG001|Overall Study|Subject Not Reachable|0
7042253|NCT01734434|11126601|FG002|Overall Study|Subject Not Reachable|1
6989581|NCT01296035|11048681|FG000|Overall Study|Withdrawal by Subject|1
6989582|NCT01296152|11048685|FG000|Overall Study|Unwilling to adhere to study requirement|1
6989583|NCT01296347|11048700|FG000|Allocation|Withdrawal by Subject|1
6989584|NCT01296347|11048701|FG001|Allocation|Withdrawal by Subject|2
6989585|NCT01296347|11048700|FG000|Allocation|Lack of Efficacy|1
6989586|NCT01296347|11048701|FG001|Allocation|Lack of Efficacy|2
6989587|NCT01296347|11048700|FG000|Allocation|not received infusion|1
6989588|NCT01296347|11048701|FG001|Allocation|not received infusion|0
6989589|NCT01296347|11048700|FG000|6 Week Follow up|Death|0
6989590|NCT01296347|11048701|FG001|6 Week Follow up|Death|1
6989591|NCT01296347|11048700|FG000|3 Month Follow up|Death|1
6989592|NCT01296347|11048701|FG001|3 Month Follow up|Death|0
6989593|NCT01296347|11048700|FG000|3 Month Follow up|Lost to Follow-up|0
6989594|NCT01296347|11048701|FG001|3 Month Follow up|Lost to Follow-up|1
6989595|NCT01296347|11048700|FG000|6 Month Follow up|Death|2
6989596|NCT01296347|11048701|FG001|6 Month Follow up|Death|1
6989597|NCT01296347|11048700|FG000|6 Month Follow up|Lost to Follow-up|0
6989598|NCT01296347|11048701|FG001|6 Month Follow up|Lost to Follow-up|1
6989599|NCT01296347|11048700|FG000|12 Month Follow up|Lost to Follow-up|3
6989600|NCT01296347|11048701|FG001|12 Month Follow up|Lost to Follow-up|1
6989601|NCT01296347|11048700|FG000|12 Month Follow up|Death|1
6989602|NCT01296347|11048701|FG001|12 Month Follow up|Death|1
6989603|NCT01296347|11048700|FG000|12 Month Follow up|Withdrawal by Subject|0
6989604|NCT01296347|11048701|FG001|12 Month Follow up|Withdrawal by Subject|1
6989605|NCT01296412|11048721|FG000|Overall Study|Adverse Event|8
6989606|NCT01296412|11048722|FG001|Overall Study|Adverse Event|29
6989607|NCT01296412|11048721|FG000|Overall Study|Lack of Efficacy|1
6989608|NCT01296412|11048722|FG001|Overall Study|Lack of Efficacy|0
6989609|NCT01296412|11048721|FG000|Overall Study|Lost to Follow-up|10
6989610|NCT01296412|11048722|FG001|Overall Study|Lost to Follow-up|7
6989611|NCT01296412|11048721|FG000|Overall Study|Non-compliance with study drug|1
6989612|NCT01296412|11048722|FG001|Overall Study|Non-compliance with study drug|2
6989613|NCT01296412|11048721|FG000|Overall Study|Other reason not specified|20
6989614|NCT01296412|11048722|FG001|Overall Study|Other reason not specified|15
6989615|NCT01296412|11048721|FG000|Overall Study|Physician Decision|1
6989616|NCT01296412|11048722|FG001|Overall Study|Physician Decision|3
6989617|NCT01296412|11048721|FG000|Overall Study|Pregnancy|0
6989618|NCT01296412|11048722|FG001|Overall Study|Pregnancy|1
6989619|NCT01296412|11048721|FG000|Overall Study|Withdrawal by Subject|10
6989620|NCT01296412|11048722|FG001|Overall Study|Withdrawal by Subject|13
6989621|NCT01296568|11048737|FG000|Continued Access Phase|Lost to Follow-up|1
6989622|NCT01296568|11048737|FG000|Continued Access Phase|Withdrawal by Subject|1
6989623|NCT01296568|11048737|FG000|Continued Access Phase|Disease Progression|1
6989624|NCT01296672|11048754|FG000|Overall Study|Lost to Follow-up|73
6989625|NCT01296672|11048755|FG001|Overall Study|Lost to Follow-up|18
6989626|NCT01296698|11048765|FG000|Overall Study|Adverse Event|1
6989627|NCT01296698|11048766|FG001|Overall Study|Adverse Event|0
6989628|NCT01296698|11048765|FG000|Overall Study|Death|1
6989629|NCT01296698|11048766|FG001|Overall Study|Death|0
6989630|NCT01296698|11048765|FG000|Overall Study|Lost to Follow-up|19
6989631|NCT01296698|11048766|FG001|Overall Study|Lost to Follow-up|1
6989632|NCT01296698|11048765|FG000|Overall Study|Withdrawal by Subject|12
6989633|NCT01296698|11048766|FG001|Overall Study|Withdrawal by Subject|0
6989634|NCT01296698|11048765|FG000|Overall Study|Difficulty Contacting Subject|2
6989635|NCT01296698|11048766|FG001|Overall Study|Difficulty Contacting Subject|0
6989636|NCT01296698|11048765|FG000|Overall Study|Study Terminated by Sponsor|209
6989637|NCT01296698|11048766|FG001|Overall Study|Study Terminated by Sponsor|12
6989638|NCT01296932|11048814|FG000|Overall Study|Dose limiting toxicity|0
6989639|NCT01296932|11048815|FG001|Overall Study|Dose limiting toxicity|0
6989640|NCT01296932|11048816|FG002|Overall Study|Dose limiting toxicity|0
6989641|NCT01296932|11048817|FG003|Overall Study|Dose limiting toxicity|0
6989642|NCT01296932|11048818|FG004|Overall Study|Dose limiting toxicity|0
6989643|NCT01296932|11048819|FG005|Overall Study|Dose limiting toxicity|0
6989644|NCT01296932|11048820|FG006|Overall Study|Dose limiting toxicity|1
6989645|NCT01296932|11048821|FG007|Overall Study|Dose limiting toxicity|0
6989646|NCT01296932|11048822|FG008|Overall Study|Dose limiting toxicity|1
6989647|NCT01296932|11048814|FG000|Overall Study|Progressive disease|2
6989648|NCT01296932|11048815|FG001|Overall Study|Progressive disease|0
6989649|NCT01296932|11048816|FG002|Overall Study|Progressive disease|1
6989650|NCT01296932|11048817|FG003|Overall Study|Progressive disease|1
6989651|NCT01296932|11048818|FG004|Overall Study|Progressive disease|2
6989652|NCT01296932|11048819|FG005|Overall Study|Progressive disease|3
6989653|NCT01296932|11048820|FG006|Overall Study|Progressive disease|1
6989654|NCT01296932|11048821|FG007|Overall Study|Progressive disease|0
6989655|NCT01296932|11048822|FG008|Overall Study|Progressive disease|0
6989656|NCT01296932|11048814|FG000|Overall Study|Withdrawal by Subject|0
6989657|NCT01296932|11048815|FG001|Overall Study|Withdrawal by Subject|0
6989658|NCT01296932|11048816|FG002|Overall Study|Withdrawal by Subject|1
6989659|NCT01296932|11048817|FG003|Overall Study|Withdrawal by Subject|1
6989660|NCT01296932|11048818|FG004|Overall Study|Withdrawal by Subject|0
6989661|NCT01296932|11048819|FG005|Overall Study|Withdrawal by Subject|0
6989662|NCT01296932|11048820|FG006|Overall Study|Withdrawal by Subject|3
6989663|NCT01296932|11048821|FG007|Overall Study|Withdrawal by Subject|0
6989664|NCT01296932|11048822|FG008|Overall Study|Withdrawal by Subject|0
6989665|NCT01296932|11048814|FG000|Overall Study|Adverse Event|1
6989666|NCT01296932|11048815|FG001|Overall Study|Adverse Event|1
6989667|NCT01296932|11048816|FG002|Overall Study|Adverse Event|1
6989668|NCT01296932|11048817|FG003|Overall Study|Adverse Event|2
6989669|NCT01296932|11048818|FG004|Overall Study|Adverse Event|1
6989670|NCT01296932|11048819|FG005|Overall Study|Adverse Event|0
6989671|NCT01296932|11048820|FG006|Overall Study|Adverse Event|0
6989672|NCT01296932|11048821|FG007|Overall Study|Adverse Event|0
6989673|NCT01296932|11048822|FG008|Overall Study|Adverse Event|1
6989674|NCT01296932|11048814|FG000|Overall Study|Investigator decision|0
6989675|NCT01296932|11048815|FG001|Overall Study|Investigator decision|1
6989676|NCT01296932|11048816|FG002|Overall Study|Investigator decision|0
6989677|NCT01296932|11048817|FG003|Overall Study|Investigator decision|1
6989678|NCT01296932|11048818|FG004|Overall Study|Investigator decision|0
6989679|NCT01296932|11048819|FG005|Overall Study|Investigator decision|0
6989680|NCT01296932|11048820|FG006|Overall Study|Investigator decision|1
6989681|NCT01296932|11048821|FG007|Overall Study|Investigator decision|0
6989682|NCT01296932|11048822|FG008|Overall Study|Investigator decision|1
6989683|NCT01296932|11048814|FG000|Overall Study|No clinical benefit anymore|0
6989684|NCT01296932|11048815|FG001|Overall Study|No clinical benefit anymore|1
6989685|NCT01296932|11048816|FG002|Overall Study|No clinical benefit anymore|0
6989686|NCT01296932|11048817|FG003|Overall Study|No clinical benefit anymore|0
6989687|NCT01296932|11048818|FG004|Overall Study|No clinical benefit anymore|0
6989688|NCT01296932|11048819|FG005|Overall Study|No clinical benefit anymore|0
6989689|NCT01296932|11048820|FG006|Overall Study|No clinical benefit anymore|0
6989690|NCT01296932|11048821|FG007|Overall Study|No clinical benefit anymore|0
6989691|NCT01296932|11048822|FG008|Overall Study|No clinical benefit anymore|0
6989692|NCT01296932|11048814|FG000|Overall Study|Physician Decision|0
6989693|NCT01296932|11048815|FG001|Overall Study|Physician Decision|0
6989694|NCT01296932|11048816|FG002|Overall Study|Physician Decision|1
6989695|NCT01296932|11048817|FG003|Overall Study|Physician Decision|0
6989696|NCT01296932|11048818|FG004|Overall Study|Physician Decision|0
6989697|NCT01296932|11048819|FG005|Overall Study|Physician Decision|0
6989698|NCT01296932|11048820|FG006|Overall Study|Physician Decision|0
6989699|NCT01296932|11048821|FG007|Overall Study|Physician Decision|0
6989700|NCT01296932|11048822|FG008|Overall Study|Physician Decision|0
6989701|NCT01296932|11048814|FG000|Overall Study|IV problems, administration not possible|0
6989702|NCT01296932|11048815|FG001|Overall Study|IV problems, administration not possible|0
6989703|NCT01296932|11048816|FG002|Overall Study|IV problems, administration not possible|1
6989704|NCT01296932|11048817|FG003|Overall Study|IV problems, administration not possible|0
6989705|NCT01296932|11048818|FG004|Overall Study|IV problems, administration not possible|0
7060280|NCT01915940|11156305|FG000|Treatment Period|Other Miscellaneous Reasons|0
7060281|NCT01915940|11156306|FG001|Treatment Period|Other Miscellaneous Reasons|1
7060282|NCT01915940|11156307|FG002|Treatment Period|Other Miscellaneous Reasons|0
7060283|NCT01916109|11156313|FG000|Overall Study|Withdrawal by Subject|1
7060284|NCT01916226|11156321|FG000|Overall Study|Adverse Event|1
7060285|NCT01916226|11156322|FG001|Overall Study|Adverse Event|0
7060286|NCT01916226|11156323|FG002|Overall Study|Adverse Event|1
7060287|NCT01916226|11156324|FG003|Overall Study|Adverse Event|1
7060288|NCT01916226|11156321|FG000|Overall Study|Lack of Efficacy|0
7060289|NCT01916226|11156322|FG001|Overall Study|Lack of Efficacy|0
7060290|NCT01916226|11156323|FG002|Overall Study|Lack of Efficacy|2
7060291|NCT01916226|11156324|FG003|Overall Study|Lack of Efficacy|1
7060292|NCT01916226|11156321|FG000|Overall Study|Protocol Violation|0
7060293|NCT01916226|11156322|FG001|Overall Study|Protocol Violation|1
7060294|NCT01916226|11156323|FG002|Overall Study|Protocol Violation|0
7060295|NCT01916226|11156324|FG003|Overall Study|Protocol Violation|1
7060296|NCT01916226|11156321|FG000|Overall Study|Physician Decision|0
7060297|NCT01916226|11156322|FG001|Overall Study|Physician Decision|0
7060298|NCT01916226|11156323|FG002|Overall Study|Physician Decision|0
7060299|NCT01916226|11156324|FG003|Overall Study|Physician Decision|1
7060300|NCT01916304|11156335|FG000|Overall Study|Screening failure|17
7060301|NCT01916824|11156381|FG000|Overall Study|Lost to Follow-up|3
7060302|NCT01916824|11156382|FG001|Overall Study|Lost to Follow-up|6
7060303|NCT01916824|11156381|FG000|Overall Study|Physician Decision|2
7060304|NCT01916824|11156382|FG001|Overall Study|Physician Decision|0
7060305|NCT01916824|11156381|FG000|Overall Study|Withdrawal by Subject|2
7060306|NCT01916824|11156382|FG001|Overall Study|Withdrawal by Subject|3
7060307|NCT01917006|11156408|FG000|Randomized-treatment Period|Lost to Follow-up|1
7060308|NCT01917006|11156409|FG001|Randomized-treatment Period|Lost to Follow-up|0
7060309|NCT01917006|11156410|FG002|Randomized-treatment Period|Lost to Follow-up|0
7060310|NCT01917006|11156411|FG003|Randomized-treatment Period|Lost to Follow-up|1
7060311|NCT01917006|11156412|FG004|Randomized-treatment Period|Lost to Follow-up|0
6989706|NCT01296932|11048819|FG005|Overall Study|IV problems, administration not possible|0
6989707|NCT01296932|11048820|FG006|Overall Study|IV problems, administration not possible|0
7060312|NCT01917006|11156413|FG005|Randomized-treatment Period|Lost to Follow-up|0
7060313|NCT01917006|11156414|FG006|Randomized-treatment Period|Lost to Follow-up|0
7060314|NCT01917006|11156415|FG007|Randomized-treatment Period|Lost to Follow-up|0
7060315|NCT01917006|11156408|FG000|Randomized-treatment Period|Personal Reasons|0
7060316|NCT01917006|11156409|FG001|Randomized-treatment Period|Personal Reasons|0
7060317|NCT01917006|11156410|FG002|Randomized-treatment Period|Personal Reasons|0
7060318|NCT01917006|11156411|FG003|Randomized-treatment Period|Personal Reasons|0
7060319|NCT01917006|11156412|FG004|Randomized-treatment Period|Personal Reasons|0
6989708|NCT01296932|11048821|FG007|Overall Study|IV problems, administration not possible|0
6989709|NCT01296932|11048822|FG008|Overall Study|IV problems, administration not possible|0
6989710|NCT01296932|11048814|FG000|Overall Study|per protocol|0
6989711|NCT01296932|11048815|FG001|Overall Study|per protocol|0
6989712|NCT01296932|11048816|FG002|Overall Study|per protocol|1
6989713|NCT01296932|11048817|FG003|Overall Study|per protocol|1
6989714|NCT01296932|11048818|FG004|Overall Study|per protocol|0
6989715|NCT01296932|11048819|FG005|Overall Study|per protocol|0
6989716|NCT01296932|11048820|FG006|Overall Study|per protocol|0
6989717|NCT01296932|11048821|FG007|Overall Study|per protocol|0
6989718|NCT01296932|11048822|FG008|Overall Study|per protocol|0
6989719|NCT01296932|11048814|FG000|Overall Study|Low benefit and too many side effects|0
6989720|NCT01296932|11048815|FG001|Overall Study|Low benefit and too many side effects|0
6989721|NCT01296932|11048816|FG002|Overall Study|Low benefit and too many side effects|0
6989722|NCT01296932|11048817|FG003|Overall Study|Low benefit and too many side effects|0
6989723|NCT01296932|11048818|FG004|Overall Study|Low benefit and too many side effects|0
6989724|NCT01296932|11048819|FG005|Overall Study|Low benefit and too many side effects|0
6989725|NCT01296932|11048820|FG006|Overall Study|Low benefit and too many side effects|0
6989726|NCT01296932|11048821|FG007|Overall Study|Low benefit and too many side effects|1
6989727|NCT01296932|11048822|FG008|Overall Study|Low benefit and too many side effects|0
6989728|NCT01296932|11048814|FG000|Overall Study|No adequate treatment response|0
6989729|NCT01296932|11048815|FG001|Overall Study|No adequate treatment response|0
6989730|NCT01296932|11048816|FG002|Overall Study|No adequate treatment response|0
6989731|NCT01296932|11048817|FG003|Overall Study|No adequate treatment response|0
6989732|NCT01296932|11048818|FG004|Overall Study|No adequate treatment response|0
6989733|NCT01296932|11048819|FG005|Overall Study|No adequate treatment response|0
6989734|NCT01296932|11048820|FG006|Overall Study|No adequate treatment response|0
6989735|NCT01296932|11048821|FG007|Overall Study|No adequate treatment response|1
6989736|NCT01296932|11048822|FG008|Overall Study|No adequate treatment response|0
6989737|NCT01296932|11048814|FG000|Overall Study|Dosage already reduced, AE still present|0
6989738|NCT01296932|11048815|FG001|Overall Study|Dosage already reduced, AE still present|0
6989739|NCT01296932|11048816|FG002|Overall Study|Dosage already reduced, AE still present|0
6989740|NCT01296932|11048817|FG003|Overall Study|Dosage already reduced, AE still present|0
6989741|NCT01296932|11048818|FG004|Overall Study|Dosage already reduced, AE still present|0
6989742|NCT01296932|11048819|FG005|Overall Study|Dosage already reduced, AE still present|0
6989743|NCT01296932|11048820|FG006|Overall Study|Dosage already reduced, AE still present|0
6989744|NCT01296932|11048821|FG007|Overall Study|Dosage already reduced, AE still present|0
6989745|NCT01296932|11048822|FG008|Overall Study|Dosage already reduced, AE still present|1
6989746|NCT01297062|11048849|FG000|Overall Study|Adverse Event|2
6989747|NCT01297062|11048850|FG001|Overall Study|Adverse Event|0
6989748|NCT01297062|11048851|FG002|Overall Study|Adverse Event|1
6989749|NCT01297062|11048852|FG003|Overall Study|Adverse Event|0
6989750|NCT01297062|11048853|FG004|Overall Study|Adverse Event|0
6989751|NCT01297062|11048854|FG005|Overall Study|Adverse Event|0
6989752|NCT01297062|11048855|FG006|Overall Study|Adverse Event|0
6989753|NCT01297062|11048849|FG000|Overall Study|Physician Decision|1
6989754|NCT01297062|11048850|FG001|Overall Study|Physician Decision|0
6989755|NCT01297062|11048851|FG002|Overall Study|Physician Decision|1
6989756|NCT01297062|11048852|FG003|Overall Study|Physician Decision|0
6989757|NCT01297062|11048853|FG004|Overall Study|Physician Decision|0
6989758|NCT01297062|11048854|FG005|Overall Study|Physician Decision|0
6989759|NCT01297062|11048855|FG006|Overall Study|Physician Decision|6
6989760|NCT01297062|11048849|FG000|Overall Study|Protocol Violation|0
6989761|NCT01297062|11048850|FG001|Overall Study|Protocol Violation|0
6989762|NCT01297062|11048851|FG002|Overall Study|Protocol Violation|0
6989763|NCT01297062|11048852|FG003|Overall Study|Protocol Violation|0
6989764|NCT01297062|11048853|FG004|Overall Study|Protocol Violation|1
6989765|NCT01297062|11048854|FG005|Overall Study|Protocol Violation|0
6989766|NCT01297062|11048855|FG006|Overall Study|Protocol Violation|0
6989767|NCT01297062|11048849|FG000|Overall Study|Subject Decision|1
6989768|NCT01297062|11048850|FG001|Overall Study|Subject Decision|1
6989769|NCT01297062|11048851|FG002|Overall Study|Subject Decision|0
6989770|NCT01297062|11048852|FG003|Overall Study|Subject Decision|1
6989771|NCT01297062|11048853|FG004|Overall Study|Subject Decision|1
6989772|NCT01297062|11048854|FG005|Overall Study|Subject Decision|1
6989773|NCT01297062|11048855|FG006|Overall Study|Subject Decision|2
6989774|NCT01297244|11048865|FG000|Overall Study|Progressive disease|22
6989775|NCT01297244|11048866|FG001|Overall Study|Progressive disease|3
6989776|NCT01297244|11048865|FG000|Overall Study|Adverse Event|9
6989777|NCT01297244|11048866|FG001|Overall Study|Adverse Event|1
6989778|NCT01297244|11048865|FG000|Overall Study|Death|1
6989779|NCT01297244|11048866|FG001|Overall Study|Death|1
6989780|NCT01297244|11048865|FG000|Overall Study|Clinical progression|1
6989781|NCT01297244|11048866|FG001|Overall Study|Clinical progression|1
6989782|NCT01297244|11048865|FG000|Overall Study|Withdrawal by Subject|2
6989783|NCT01297244|11048866|FG001|Overall Study|Withdrawal by Subject|0
6989784|NCT01297270|11048881|FG000|Overall Study|Adverse Event|19
6989785|NCT01297270|11048882|FG001|Overall Study|Adverse Event|32
6989786|NCT01297270|11048883|FG002|Overall Study|Adverse Event|5
6989787|NCT01297270|11048881|FG000|Overall Study|Lack of Efficacy|15
6989788|NCT01297270|11048882|FG001|Overall Study|Lack of Efficacy|17
6989789|NCT01297270|11048883|FG002|Overall Study|Lack of Efficacy|15
6989790|NCT01297270|11048881|FG000|Overall Study|Lost to Follow-up|1
6989791|NCT01297270|11048882|FG001|Overall Study|Lost to Follow-up|2
6989792|NCT01297270|11048883|FG002|Overall Study|Lost to Follow-up|1
6989793|NCT01297270|11048881|FG000|Overall Study|Protocol Violation|0
6989794|NCT01297270|11048882|FG001|Overall Study|Protocol Violation|2
6989795|NCT01297270|11048883|FG002|Overall Study|Protocol Violation|0
6989796|NCT01297270|11048881|FG000|Overall Study|Withdrawal by Subject|7
6989797|NCT01297270|11048882|FG001|Overall Study|Withdrawal by Subject|15
6989798|NCT01297270|11048883|FG002|Overall Study|Withdrawal by Subject|7
6989799|NCT01297270|11048881|FG000|Overall Study|Other reason not defined above|3
6989800|NCT01297270|11048882|FG001|Overall Study|Other reason not defined above|3
6989801|NCT01297270|11048883|FG002|Overall Study|Other reason not defined above|1
6989802|NCT01297270|11048881|FG000|Overall Study|Not treated|0
6989803|NCT01297270|11048882|FG001|Overall Study|Not treated|1
6989804|NCT01297270|11048883|FG002|Overall Study|Not treated|0
6989805|NCT01297309|11048895|FG000|Overall Study|Eligibility failure|2
6989806|NCT01297309|11048895|FG000|Overall Study|Screen failure|2
6989807|NCT01297309|11048895|FG000|Overall Study|Withdrawal by Subject|5
6989808|NCT01297309|11048895|FG000|Overall Study|Adverse Event|1
6989809|NCT01297309|11048895|FG000|Overall Study|Investigator Decision|2
6989810|NCT01297309|11048895|FG000|Overall Study|Death|1
6989811|NCT01297309|11048895|FG000|Overall Study|Participant not entering extensionperiod|1
6989812|NCT01297322|11048901|FG000|Overall Study|Lost to Follow-up|1
6989813|NCT01297322|11048902|FG001|Overall Study|Lost to Follow-up|0
6989814|NCT01297322|11048901|FG000|Overall Study|Withdrawal by Subject|0
6989815|NCT01297322|11048902|FG001|Overall Study|Withdrawal by Subject|1
6989816|NCT01297322|11048901|FG000|Overall Study|Protocol Violation|0
6989817|NCT01297322|11048902|FG001|Overall Study|Protocol Violation|3
6989818|NCT01297465|11048927|FG000|Overall Study|Lack of Ovarian Response|1
6989819|NCT01297465|11048928|FG001|Overall Study|Lack of Ovarian Response|1
6989820|NCT01297465|11048927|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0
6989821|NCT01297465|11048928|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1
6989822|NCT01297465|11048927|FG000|Overall Study|No Oocytes Retrieved|1
6989823|NCT01297465|11048928|FG001|Overall Study|No Oocytes Retrieved|1
6989824|NCT01297465|11048927|FG000|Overall Study|Poor oocyte quality|0
6989825|NCT01297465|11048928|FG001|Overall Study|Poor oocyte quality|1
6989826|NCT01297465|11048927|FG000|Overall Study|No Fertilization|6
6989827|NCT01297465|11048928|FG001|Overall Study|No Fertilization|4
6989828|NCT01297465|11048927|FG000|Overall Study|All Embryos Discarded|0
6989829|NCT01297465|11048928|FG001|Overall Study|All Embryos Discarded|1
6989830|NCT01297465|11048927|FG000|Overall Study|Intention to Freeze all Embryos|0
6989831|NCT01297465|11048928|FG001|Overall Study|Intention to Freeze all Embryos|1
6989832|NCT01297491|11048936|FG000|Overall Study|Adverse Event|11
6989833|NCT01297491|11048937|FG001|Overall Study|Adverse Event|6
6989834|NCT01297491|11048936|FG000|Overall Study|Physician Decision|3
6989835|NCT01297491|11048937|FG001|Overall Study|Physician Decision|2
6989836|NCT01297491|11048936|FG000|Overall Study|Progressive disease|11
6989837|NCT01297491|11048937|FG001|Overall Study|Progressive disease|20
6989838|NCT01297491|11048936|FG000|Overall Study|Patient/Guardian decision|3
6989839|NCT01297491|11048937|FG001|Overall Study|Patient/Guardian decision|4
6989840|NCT01297491|11048936|FG000|Overall Study|Death|2
6989841|NCT01297491|11048937|FG001|Overall Study|Death|1
6989842|NCT01297504|11048943|FG000|Overall Study|Invalid Consent|1
6989843|NCT01297504|11048943|FG000|Overall Study|Received Palivizumab in Previous Season|1
6989844|NCT01297504|11048943|FG000|Overall Study|No Study Visits|4
6989845|NCT01297504|11048943|FG000|Overall Study|Death|3
6989846|NCT01297504|11048943|FG000|Overall Study|Lost to Follow-up|43
6989847|NCT01297504|11048943|FG000|Overall Study|Withdrawal by Subject|9
6989848|NCT01297504|11048943|FG000|Overall Study|Site Closure|3
6989849|NCT01297504|11048943|FG000|Overall Study|Protocol Violation|3
6989850|NCT01297517|11048954|FG000|Overall Study|Adverse Event|21
6989851|NCT01297517|11048955|FG001|Overall Study|Adverse Event|7
6989852|NCT01297517|11048956|FG002|Overall Study|Adverse Event|16
6989853|NCT01297517|11048954|FG000|Overall Study|Lost to Follow-up|1
6989854|NCT01297517|11048955|FG001|Overall Study|Lost to Follow-up|0
6989855|NCT01297517|11048956|FG002|Overall Study|Lost to Follow-up|1
6989856|NCT01297517|11048954|FG000|Overall Study|Patient Decision Unrelated to AE|2
6989857|NCT01297517|11048955|FG001|Overall Study|Patient Decision Unrelated to AE|3
6989858|NCT01297517|11048956|FG002|Overall Study|Patient Decision Unrelated to AE|7
6989859|NCT01297517|11048954|FG000|Overall Study|Noncompliance|1
6989860|NCT01297517|11048955|FG001|Overall Study|Noncompliance|0
6989861|NCT01297517|11048956|FG002|Overall Study|Noncompliance|0
6989862|NCT01297517|11048954|FG000|Overall Study|Protocol Violation|1
6989863|NCT01297517|11048955|FG001|Overall Study|Protocol Violation|1
6989864|NCT01297517|11048956|FG002|Overall Study|Protocol Violation|1
6989865|NCT01297517|11048954|FG000|Overall Study|Inadequate Control of IOP|1
6989866|NCT01297517|11048955|FG001|Overall Study|Inadequate Control of IOP|1
6989867|NCT01297517|11048956|FG002|Overall Study|Inadequate Control of IOP|2
6989868|NCT01297920|11048974|FG000|Overall Study|Adverse Event|42
6989869|NCT01297920|11048975|FG001|Overall Study|Adverse Event|10
6989870|NCT01297920|11048976|FG002|Overall Study|Adverse Event|38
6989871|NCT01297920|11048974|FG000|Overall Study|Patient Decision Unrelated to AE|6
6989872|NCT01297920|11048975|FG001|Overall Study|Patient Decision Unrelated to AE|5
6989873|NCT01297920|11048976|FG002|Overall Study|Patient Decision Unrelated to AE|2
6989874|NCT01297920|11048974|FG000|Overall Study|Noncompliance|1
6989875|NCT01297920|11048975|FG001|Overall Study|Noncompliance|0
6989876|NCT01297920|11048976|FG002|Overall Study|Noncompliance|0
6989877|NCT01297920|11048974|FG000|Overall Study|Protocol Violation|1
6989878|NCT01297920|11048975|FG001|Overall Study|Protocol Violation|3
6989879|NCT01297920|11048976|FG002|Overall Study|Protocol Violation|0
6989880|NCT01297920|11048974|FG000|Overall Study|Inadequate Control of IOP|7
6989881|NCT01297920|11048975|FG001|Overall Study|Inadequate Control of IOP|9
6989882|NCT01297920|11048976|FG002|Overall Study|Inadequate Control of IOP|17
6989883|NCT01297920|11048974|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1
6989884|NCT01297920|11048975|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0
6989885|NCT01297920|11048976|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0
6989886|NCT01297959|11048986|FG000|Overall Study|Adverse Event|0
6989887|NCT01297959|11048987|FG001|Overall Study|Adverse Event|1
6989888|NCT01297959|11048986|FG000|Overall Study|Protocol Violation|2
6989889|NCT01297959|11048987|FG001|Overall Study|Protocol Violation|1
6989890|NCT01297959|11048986|FG000|Overall Study|Withdrawal by Subject|5
6989891|NCT01297959|11048987|FG001|Overall Study|Withdrawal by Subject|4
6989892|NCT01297959|11048986|FG000|Overall Study|Physician Decision|0
6989893|NCT01297959|11048987|FG001|Overall Study|Physician Decision|1
6989894|NCT01297959|11048986|FG000|Overall Study|Unrelated medical illness / complication|0
6989895|NCT01297959|11048987|FG001|Overall Study|Unrelated medical illness / complication|2
6989896|NCT01297959|11048986|FG000|Overall Study|Other|13
6989897|NCT01297959|11048987|FG001|Overall Study|Other|7
6989898|NCT01298141|11049033|FG000|Overall Study|Adverse Event|3
6989899|NCT01298141|11049033|FG000|Overall Study|Refusal of Required Study Procedures|1
6989900|NCT01298141|11049033|FG000|Overall Study|Withdrawal by Subject|6
6989901|NCT01298141|11049033|FG000|Overall Study|Termination of Study by the Investigator|5
6989902|NCT01298141|11049033|FG000|Overall Study|Other|5
6989903|NCT01298141|11049033|FG000|Overall Study|Lost to Follow-up|1
6989904|NCT01298141|11049033|FG000|Overall Study|Death|6
6989905|NCT01298141|11049033|FG000|Overall Study|Not treated|4
6989906|NCT01298193|11049046|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2
6989907|NCT01298193|11049046|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16
6989908|NCT01298193|11049046|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9
6989909|NCT01298193|11049046|FG000|Efficacy Phase (Second Cycle)|Death|1
6989910|NCT01298323|11049064|FG000|Overall Study|Adverse Event|2
6989911|NCT01298323|11049065|FG001|Overall Study|Adverse Event|4
6989912|NCT01298323|11049064|FG000|Overall Study|Death|11
6989913|NCT01298323|11049065|FG001|Overall Study|Death|16
6989914|NCT01298323|11049064|FG000|Overall Study|Lost to Follow-up|1
6989915|NCT01298323|11049065|FG001|Overall Study|Lost to Follow-up|0
6989916|NCT01298323|11049064|FG000|Overall Study|Withdrawal by Subject|6
6989917|NCT01298323|11049065|FG001|Overall Study|Withdrawal by Subject|3
6989918|NCT01298323|11049064|FG000|Overall Study|Protocol Violation|1
6989919|NCT01298323|11049065|FG001|Overall Study|Protocol Violation|0
6989920|NCT01298323|11049064|FG000|Overall Study|Other|10
6989921|NCT01298323|11049065|FG001|Overall Study|Other|9
6989922|NCT01298323|11049064|FG000|Overall Study|Ongoing|55
6989923|NCT01298323|11049065|FG001|Overall Study|Ongoing|55
6989924|NCT01298323|11049064|FG000|Overall Study|Eligibility criteria not fulfilled|0
6989925|NCT01298323|11049065|FG001|Overall Study|Eligibility criteria not fulfilled|1
6989926|NCT01298362|11049073|FG000|Overall Study|Did not provide 12month BMD measurements|38
6989927|NCT01298362|11049074|FG001|Overall Study|Did not provide 12month BMD measurements|43
6989928|NCT01298492|11049082|FG000|Overall Study|Death|2
6989929|NCT01298492|11049082|FG000|Overall Study|Insufficient Clinical Response|22
6989930|NCT01298492|11049082|FG000|Overall Study|Lost to Follow-up|12
6989931|NCT01298492|11049082|FG000|Overall Study|Withdrawal by Subject|47
6989932|NCT01298492|11049082|FG000|Overall Study|Other (Unspecified)|7
6989933|NCT01298492|11049082|FG000|Overall Study|Withdrawn Due to Pregnancy|1
6989934|NCT01298492|11049082|FG000|Overall Study|Protocol Violation|2
6989935|NCT01298492|11049082|FG000|Overall Study|Adverse Event(Related to Study Drug)|8
6989936|NCT01298492|11049082|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18
6989937|NCT01298518|11049089|FG000|Overall Study|Withdrawal by Subject|0
6989938|NCT01298518|11049090|FG001|Overall Study|Withdrawal by Subject|0
6989939|NCT01298518|11049091|FG002|Overall Study|Withdrawal by Subject|1
6989940|NCT01298531|11049101|FG000|Overall Study|Lack of Efficacy|0
6989941|NCT01298531|11049102|FG001|Overall Study|Lack of Efficacy|1
6989942|NCT01298531|11049101|FG000|Overall Study|Lost to Follow-up|2
6989943|NCT01298531|11049102|FG001|Overall Study|Lost to Follow-up|0
6989944|NCT01298531|11049101|FG000|Overall Study|Protocol Violation|1
6989945|NCT01298531|11049102|FG001|Overall Study|Protocol Violation|1
6989946|NCT01298531|11049101|FG000|Overall Study|Adverse Event|4
6989947|NCT01298531|11049102|FG001|Overall Study|Adverse Event|3
6989948|NCT01298531|11049101|FG000|Overall Study|Does not meet entrance criteria|0
6989949|NCT01298531|11049102|FG001|Overall Study|Does not meet entrance criteria|1
6989950|NCT01298531|11049101|FG000|Overall Study|Other|2
6989951|NCT01298531|11049102|FG001|Overall Study|Other|1
6989952|NCT01298570|11049117|FG000|Overall Study|Disease progression, relapse during acti|64
6989953|NCT01298570|11049118|FG001|Overall Study|Disease progression, relapse during acti|40
6989954|NCT01298570|11049117|FG000|Overall Study|Adverse Event|20
6989955|NCT01298570|11049118|FG001|Overall Study|Adverse Event|2
6989956|NCT01298570|11049117|FG000|Overall Study|Withdrawal by Subject|21
6989957|NCT01298570|11049118|FG001|Overall Study|Withdrawal by Subject|6
6989958|NCT01298570|11049117|FG000|Overall Study|Treatment delay > 4 weeks|4
6989959|NCT01298570|11049118|FG001|Overall Study|Treatment delay > 4 weeks|5
6989960|NCT01298570|11049117|FG000|Overall Study|Physician Decision|4
6989961|NCT01298570|11049118|FG001|Overall Study|Physician Decision|2
6989962|NCT01298570|11049117|FG000|Overall Study|Other complicating disease|2
6989963|NCT01298570|11049118|FG001|Overall Study|Other complicating disease|1
6989964|NCT01298570|11049117|FG000|Overall Study|Surgery|2
6989965|NCT01298570|11049118|FG001|Overall Study|Surgery|1
6989966|NCT01298570|11049117|FG000|Overall Study|Symptomatic progression/deterioration|3
6989967|NCT01298570|11049118|FG001|Overall Study|Symptomatic progression/deterioration|2
6989968|NCT01298570|11049117|FG000|Overall Study|Death|0
6989969|NCT01298570|11049118|FG001|Overall Study|Death|1
6989970|NCT01298570|11049117|FG000|Overall Study|Ineligibility|0
6989971|NCT01298570|11049118|FG001|Overall Study|Ineligibility|1
6989972|NCT01298596|11049126|FG000|Overall Study|Withdrawal by Subject|1
6989973|NCT01298596|11049127|FG001|Overall Study|Withdrawal by Subject|1
6989974|NCT01298596|11049126|FG000|Overall Study|Death|5
6989975|NCT01298596|11049127|FG001|Overall Study|Death|3
6989976|NCT01298596|11049126|FG000|Overall Study|Lost to Follow-up|6
6989977|NCT01298596|11049127|FG001|Overall Study|Lost to Follow-up|14
6989978|NCT01298596|11049126|FG000|Overall Study|Referred for further management|16
6989979|NCT01298596|11049127|FG001|Overall Study|Referred for further management|15
6989980|NCT01298648|11049133|FG000|Overall Study|Withdrawal by Subject|2
6989981|NCT01298648|11049133|FG000|Overall Study|Lost to Follow-up|21
6989982|NCT01298661|11049140|FG000|Overall Study|Withdrawal by Subject|2
6989983|NCT01298661|11049141|FG001|Overall Study|Withdrawal by Subject|0
6989984|NCT01298661|11049142|FG002|Overall Study|Withdrawal by Subject|2
6989985|NCT01298700|11049153|FG000|Overall Study|Adverse Event|50
6989986|NCT01298700|11049154|FG001|Overall Study|Adverse Event|51
6989987|NCT01298700|11049153|FG000|Overall Study|Lack of Efficacy|9
6989988|NCT01298700|11049154|FG001|Overall Study|Lack of Efficacy|14
6989989|NCT01298700|11049153|FG000|Overall Study|Lost to Follow-up|5
6989990|NCT01298700|11049154|FG001|Overall Study|Lost to Follow-up|2
6989991|NCT01298700|11049153|FG000|Overall Study|Withdrawal by Subject|12
6989992|NCT01298700|11049154|FG001|Overall Study|Withdrawal by Subject|9
6989993|NCT01298700|11049153|FG000|Overall Study|Protocol Violation|6
6989994|NCT01298700|11049154|FG001|Overall Study|Protocol Violation|4
6989995|NCT01298700|11049153|FG000|Overall Study|Other Miscellaneous Reasons|16
6989996|NCT01298700|11049154|FG001|Overall Study|Other Miscellaneous Reasons|15
6989997|NCT01298700|11049153|FG000|Overall Study|Did not Receive Study Drug|3
6989998|NCT01298700|11049154|FG001|Overall Study|Did not Receive Study Drug|5
6989999|NCT01298765|11049169|FG000|Titration Period|Adverse Event|26
6990000|NCT01298765|11049169|FG000|Titration Period|Death|1
6990001|NCT01298765|11049169|FG000|Titration Period|Lack of Efficacy|21
6990002|NCT01298765|11049169|FG000|Titration Period|Lost to Follow-up|9
6990003|NCT01298765|11049169|FG000|Titration Period|Physician Decision|1
6990004|NCT01298765|11049169|FG000|Titration Period|Withdrawal by Subject|10
6990005|NCT01298765|11049169|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8
6990006|NCT01298765|11049169|FG000|Long-Term Treatment Period|Adverse Event|19
6990007|NCT01298765|11049169|FG000|Long-Term Treatment Period|Lack of Efficacy|6
6990008|NCT01298765|11049169|FG000|Long-Term Treatment Period|Lost to Follow-up|8
6990009|NCT01298765|11049169|FG000|Long-Term Treatment Period|Withdrawal by Subject|19
6990010|NCT01298765|11049169|FG000|Long-Term Treatment Period|Physician Decision|1
6990011|NCT01298765|11049169|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46
6990012|NCT01298778|11049175|FG000|Overall Study|Lost to Follow-up|2
6990013|NCT01298778|11049176|FG001|Overall Study|Lost to Follow-up|3
6990014|NCT01298778|11049175|FG000|Overall Study|Incorrect use of VAS|1
6990015|NCT01298778|11049176|FG001|Overall Study|Incorrect use of VAS|0
6990016|NCT01298778|11049175|FG000|Overall Study|Withdrawal by Subject|0
6990017|NCT01298778|11049176|FG001|Overall Study|Withdrawal by Subject|1
6990018|NCT01298778|11049175|FG000|Overall Study|Protocol Violation|0
6990019|NCT01298778|11049176|FG001|Overall Study|Protocol Violation|1
6990020|NCT01298778|11049175|FG000|Overall Study|not meet inclusion/exclusion criteria|0
6990021|NCT01298778|11049176|FG001|Overall Study|not meet inclusion/exclusion criteria|1
6990022|NCT01298999|11049186|FG000|Overall Study|Physician Decision|0
6990023|NCT01298999|11049187|FG001|Overall Study|Physician Decision|1
6990024|NCT01298999|11049186|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3
6990025|NCT01298999|11049187|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0
6990026|NCT01299025|11049195|FG000|Overall Study|Withdrawal by Subject|2
6990027|NCT01299025|11049196|FG001|Overall Study|Withdrawal by Subject|1
6990028|NCT01299025|11049195|FG000|Overall Study|Lost to Follow-up|1
6990029|NCT01299025|11049196|FG001|Overall Study|Lost to Follow-up|0
6990030|NCT01299038|11049204|FG000|Overall Study|Withdrawal by Subject|1
6990031|NCT01299038|11049205|FG001|Overall Study|Withdrawal by Subject|0
6990032|NCT01299116|11049235|FG000|Overall Study|Lost to Follow-up|65
6990033|NCT01299116|11049236|FG001|Overall Study|Lost to Follow-up|9
6990034|NCT01299116|11049237|FG002|Overall Study|Lost to Follow-up|11
6990035|NCT01299272|11049248|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140
6990036|NCT01299272|11049249|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0
6990037|NCT01299272|11049250|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0
6990038|NCT01299272|11049251|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0
6990039|NCT01299272|11049248|FG000|Acute Open-label (OL) Period|Adverse Event|140
6990040|NCT01299272|11049249|FG001|Acute Open-label (OL) Period|Adverse Event|0
6990041|NCT01299272|11049250|FG002|Acute Open-label (OL) Period|Adverse Event|0
6990042|NCT01299272|11049251|FG003|Acute Open-label (OL) Period|Adverse Event|0
6990043|NCT01299272|11049248|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56
6990044|NCT01299272|11049249|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0
6990045|NCT01299272|11049250|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0
6990046|NCT01299272|11049251|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0
6990047|NCT01299272|11049248|FG000|Acute Open-label (OL) Period|Protocol Violation|36
6990048|NCT01299272|11049249|FG001|Acute Open-label (OL) Period|Protocol Violation|0
6990049|NCT01299272|11049250|FG002|Acute Open-label (OL) Period|Protocol Violation|0
6990050|NCT01299272|11049251|FG003|Acute Open-label (OL) Period|Protocol Violation|0
6990051|NCT01299272|11049248|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14
6990052|NCT01299272|11049249|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0
6990053|NCT01299272|11049250|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0
6990054|NCT01299272|11049251|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0
6990055|NCT01299272|11049248|FG000|Acute Open-label (OL) Period|Sponsor Decision|13
6990056|NCT01299272|11049249|FG001|Acute Open-label (OL) Period|Sponsor Decision|0
6990057|NCT01299272|11049250|FG002|Acute Open-label (OL) Period|Sponsor Decision|0
6990058|NCT01299272|11049251|FG003|Acute Open-label (OL) Period|Sponsor Decision|0
6990059|NCT01299272|11049248|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10
6990060|NCT01299272|11049249|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0
6990061|NCT01299272|11049250|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0
6990062|NCT01299272|11049251|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0
6990063|NCT01299272|11049248|FG000|Acute Open-label (OL) Period|Physician Decision|5
6990064|NCT01299272|11049249|FG001|Acute Open-label (OL) Period|Physician Decision|0
6990065|NCT01299272|11049250|FG002|Acute Open-label (OL) Period|Physician Decision|0
6990066|NCT01299272|11049251|FG003|Acute Open-label (OL) Period|Physician Decision|0
6990067|NCT01299272|11049248|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
6990068|NCT01299272|11049249|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80
6990069|NCT01299272|11049250|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
6990070|NCT01299272|11049251|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
6990071|NCT01299272|11049248|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0
6990072|NCT01299272|11049249|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44
6990073|NCT01299272|11049250|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0
6990074|NCT01299272|11049251|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0
6990075|NCT01299272|11049248|FG000|Stabilization Open-label (OL) Period|Adverse Event|0
6990076|NCT01299272|11049249|FG001|Stabilization Open-label (OL) Period|Adverse Event|42
6990077|NCT01299272|11049250|FG002|Stabilization Open-label (OL) Period|Adverse Event|0
6990078|NCT01299272|11049251|FG003|Stabilization Open-label (OL) Period|Adverse Event|0
6990079|NCT01299272|11049248|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
6990080|NCT01299272|11049249|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42
6990081|NCT01299272|11049250|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
6990082|NCT01299272|11049251|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
6990083|NCT01299272|11049248|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0
6990084|NCT01299272|11049249|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12
6990085|NCT01299272|11049250|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0
6990086|NCT01299272|11049251|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0
6990087|NCT01299272|11049248|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0
6990088|NCT01299272|11049249|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11
6990089|NCT01299272|11049250|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0
6990090|NCT01299272|11049251|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0
6990091|NCT01299272|11049248|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0
6990092|NCT01299272|11049249|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9
6990093|NCT01299272|11049250|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0
6990094|NCT01299272|11049251|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0
6990095|NCT01299272|11049248|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
6990096|NCT01299272|11049249|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6
6990097|NCT01299272|11049250|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
6990098|NCT01299272|11049251|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
6990099|NCT01299272|11049248|FG000|Stabilization Open-label (OL) Period|Physician Decision|0
6990100|NCT01299272|11049249|FG001|Stabilization Open-label (OL) Period|Physician Decision|3
6990101|NCT01299272|11049250|FG002|Stabilization Open-label (OL) Period|Physician Decision|0
6990102|NCT01299272|11049251|FG003|Stabilization Open-label (OL) Period|Physician Decision|0
6990103|NCT01299272|11049248|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
6990104|NCT01299272|11049249|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
6990105|NCT01299272|11049250|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22
6990106|NCT01299272|11049251|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15
6990107|NCT01299272|11049248|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0
6990108|NCT01299272|11049249|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0
6990109|NCT01299272|11049250|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20
6990110|NCT01299272|11049251|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10
6990111|NCT01299272|11049248|FG000|Double-blind (DB) Randomized Period|Adverse Event|0
6990112|NCT01299272|11049249|FG001|Double-blind (DB) Randomized Period|Adverse Event|0
6990113|NCT01299272|11049250|FG002|Double-blind (DB) Randomized Period|Adverse Event|8
6990114|NCT01299272|11049251|FG003|Double-blind (DB) Randomized Period|Adverse Event|9
6990115|NCT01299272|11049248|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0
6990116|NCT01299272|11049249|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0
6990117|NCT01299272|11049250|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8
6990118|NCT01299272|11049251|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7
6990119|NCT01299272|11049248|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0
6990120|NCT01299272|11049249|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0
6990121|NCT01299272|11049250|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5
6990122|NCT01299272|11049251|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5
6990123|NCT01299272|11049248|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
6990124|NCT01299272|11049249|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
6990125|NCT01299272|11049250|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4
6990126|NCT01299272|11049251|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10
6990127|NCT01299272|11049248|FG000|Double-blind (DB) Randomized Period|Physician Decision|0
6990128|NCT01299272|11049249|FG001|Double-blind (DB) Randomized Period|Physician Decision|0
6990129|NCT01299272|11049250|FG002|Double-blind (DB) Randomized Period|Physician Decision|2
6990130|NCT01299272|11049251|FG003|Double-blind (DB) Randomized Period|Physician Decision|1
6990131|NCT01299272|11049248|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0
6990132|NCT01299272|11049249|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0
6990133|NCT01299272|11049250|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1
6990134|NCT01299272|11049251|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1
6990135|NCT01299376|11049273|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1
6990136|NCT01299376|11049274|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2
6990137|NCT01299376|11049273|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0
6990138|NCT01299376|11049274|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1
6990139|NCT01299376|11049273|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0
6990140|NCT01299376|11049274|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1
6990141|NCT01299376|11049273|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4
6990142|NCT01299376|11049274|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7
6990143|NCT01299376|11049273|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1
6990144|NCT01299376|11049274|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0
6990145|NCT01299376|11049273|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
6990146|NCT01299376|11049274|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
6990147|NCT01299376|11049273|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2
6990148|NCT01299376|11049274|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1
6990149|NCT01299376|11049273|FG000|Extension (Weeks 9 to 52)|Adverse Event|2
6990150|NCT01299376|11049274|FG001|Extension (Weeks 9 to 52)|Adverse Event|3
6990151|NCT01299376|11049273|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1
6990152|NCT01299376|11049274|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2
6990153|NCT01299376|11049273|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4
6990154|NCT01299376|11049274|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9
6990155|NCT01299376|11049273|FG000|Extension (Weeks 9 to 52)|Physician Decision|1
6990156|NCT01299376|11049274|FG001|Extension (Weeks 9 to 52)|Physician Decision|0
6990157|NCT01299389|11049286|FG000|Double-blind|Adverse Event|45
6990158|NCT01299389|11049287|FG001|Double-blind|Adverse Event|27
6990159|NCT01299389|11049288|FG002|Double-blind|Adverse Event|0
6990160|NCT01299389|11049289|FG003|Double-blind|Adverse Event|0
6990161|NCT01299389|11049286|FG000|Double-blind|Lack of Efficacy|45
6990162|NCT01299389|11049287|FG001|Double-blind|Lack of Efficacy|21
6990163|NCT01299389|11049288|FG002|Double-blind|Lack of Efficacy|0
6990164|NCT01299389|11049289|FG003|Double-blind|Lack of Efficacy|0
6990165|NCT01299389|11049286|FG000|Double-blind|Lost to Follow-up|2
6990166|NCT01299389|11049287|FG001|Double-blind|Lost to Follow-up|1
6990167|NCT01299389|11049288|FG002|Double-blind|Lost to Follow-up|0
6990168|NCT01299389|11049289|FG003|Double-blind|Lost to Follow-up|0
6990169|NCT01299389|11049286|FG000|Double-blind|Withdrawal by Subject|16
6990170|NCT01299389|11049287|FG001|Double-blind|Withdrawal by Subject|13
6990171|NCT01299389|11049288|FG002|Double-blind|Withdrawal by Subject|0
6990172|NCT01299389|11049289|FG003|Double-blind|Withdrawal by Subject|0
6990173|NCT01299389|11049286|FG000|Double-blind|Other|1
6990174|NCT01299389|11049287|FG001|Double-blind|Other|1
6990175|NCT01299389|11049288|FG002|Double-blind|Other|0
6990176|NCT01299389|11049289|FG003|Double-blind|Other|0
6990177|NCT01299389|11049286|FG000|Double-blind|"fail to meet study population criteria"|0
6990178|NCT01299389|11049287|FG001|Double-blind|"fail to meet study population criteria"|1
6990179|NCT01299389|11049288|FG002|Double-blind|"fail to meet study population criteria"|0
6990180|NCT01299389|11049289|FG003|Double-blind|"fail to meet study population criteria"|0
6990181|NCT01299389|11049286|FG000|Post-observational|Other|0
6990182|NCT01299389|11049287|FG001|Post-observational|Other|0
6990183|NCT01299389|11049288|FG002|Post-observational|Other|12
6990184|NCT01299389|11049289|FG003|Post-observational|Other|6
6990185|NCT01299480|11049346|FG000|Overall Study|No longer willing to participate|19
6990186|NCT01299480|11049347|FG001|Overall Study|No longer willing to participate|17
6990187|NCT01299480|11049348|FG002|Overall Study|No longer willing to participate|14
6990188|NCT01299480|11049349|FG003|Overall Study|No longer willing to participate|13
6990189|NCT01299480|11049350|FG004|Overall Study|No longer willing to participate|10
6990190|NCT01299480|11049346|FG000|Overall Study|Protocol Violation|7
6990191|NCT01299480|11049347|FG001|Overall Study|Protocol Violation|5
6990192|NCT01299480|11049348|FG002|Overall Study|Protocol Violation|8
6990193|NCT01299480|11049349|FG003|Overall Study|Protocol Violation|1
6990194|NCT01299480|11049350|FG004|Overall Study|Protocol Violation|1
6990195|NCT01299480|11049346|FG000|Overall Study|Withdrawal by Subject|3
6990196|NCT01299480|11049347|FG001|Overall Study|Withdrawal by Subject|4
6990197|NCT01299480|11049348|FG002|Overall Study|Withdrawal by Subject|7
6990198|NCT01299480|11049349|FG003|Overall Study|Withdrawal by Subject|3
6990199|NCT01299480|11049350|FG004|Overall Study|Withdrawal by Subject|4
6990200|NCT01299480|11049346|FG000|Overall Study|Adverse Event|6
6990201|NCT01299480|11049347|FG001|Overall Study|Adverse Event|4
6990202|NCT01299480|11049348|FG002|Overall Study|Adverse Event|5
6990203|NCT01299480|11049349|FG003|Overall Study|Adverse Event|4
6990204|NCT01299480|11049350|FG004|Overall Study|Adverse Event|0
6990205|NCT01299480|11049346|FG000|Overall Study|Withdrawal due to pregnancy|0
6990206|NCT01299480|11049347|FG001|Overall Study|Withdrawal due to pregnancy|1
6990207|NCT01299480|11049348|FG002|Overall Study|Withdrawal due to pregnancy|1
6990208|NCT01299480|11049349|FG003|Overall Study|Withdrawal due to pregnancy|0
6990209|NCT01299480|11049350|FG004|Overall Study|Withdrawal due to pregnancy|0
6990210|NCT01299480|11049346|FG000|Overall Study|Physician Decision|1
6990211|NCT01299480|11049347|FG001|Overall Study|Physician Decision|1
6990212|NCT01299480|11049348|FG002|Overall Study|Physician Decision|0
6990213|NCT01299480|11049349|FG003|Overall Study|Physician Decision|2
6990214|NCT01299480|11049350|FG004|Overall Study|Physician Decision|0
6990215|NCT01299480|11049346|FG000|Overall Study|Lost to Follow-up|3
6990216|NCT01299480|11049347|FG001|Overall Study|Lost to Follow-up|1
6990217|NCT01299480|11049348|FG002|Overall Study|Lost to Follow-up|2
6990218|NCT01299480|11049349|FG003|Overall Study|Lost to Follow-up|1
6990219|NCT01299480|11049350|FG004|Overall Study|Lost to Follow-up|2
6990220|NCT01299480|11049346|FG000|Overall Study|Other|3
6990221|NCT01299480|11049347|FG001|Overall Study|Other|2
6990222|NCT01299480|11049348|FG002|Overall Study|Other|3
6990223|NCT01299480|11049349|FG003|Overall Study|Other|0
6990224|NCT01299480|11049350|FG004|Overall Study|Other|3
6990225|NCT01299480|11049346|FG000|Overall Study|Started, but not vaccinated|0
6990226|NCT01299480|11049347|FG001|Overall Study|Started, but not vaccinated|0
6990227|NCT01299480|11049348|FG002|Overall Study|Started, but not vaccinated|1
6990228|NCT01299480|11049349|FG003|Overall Study|Started, but not vaccinated|1
6990229|NCT01299480|11049350|FG004|Overall Study|Started, but not vaccinated|0
6990230|NCT01299571|11049363|FG000|Overall Study|Protocol Violation|107
6990231|NCT01299584|11049368|FG000|Overall Study|Protocol Violation|9
6990232|NCT01299727|11049392|FG000|Overall Study|Withdrawal by Subject|1
6990233|NCT01299727|11049393|FG001|Overall Study|Withdrawal by Subject|0
6990234|NCT01299727|11049394|FG002|Overall Study|Withdrawal by Subject|0
6990235|NCT01299727|11049392|FG000|Overall Study|Adverse Event|0
6990236|NCT01299727|11049393|FG001|Overall Study|Adverse Event|0
6990237|NCT01299727|11049394|FG002|Overall Study|Adverse Event|1
6990238|NCT01299727|11049392|FG000|Overall Study|Completed the Treatment Period|3
6990239|NCT01299727|11049393|FG001|Overall Study|Completed the Treatment Period|4
6990240|NCT01299727|11049394|FG002|Overall Study|Completed the Treatment Period|3
6990241|NCT01299766|11049404|FG000|Overall Study|Death|5
6990242|NCT01299766|11049405|FG001|Overall Study|Death|4
6990243|NCT01299766|11049404|FG000|Overall Study|Withdrawal by Subject|29
6990244|NCT01299766|11049405|FG001|Overall Study|Withdrawal by Subject|19
6990245|NCT01299805|11049413|FG000|Overall Study|Adverse Event|2
6990246|NCT01299805|11049414|FG001|Overall Study|Adverse Event|0
6990247|NCT01299896|11049422|FG000|Overall Study|Withdrawal by Subject|1
6990248|NCT01299896|11049423|FG001|Overall Study|Withdrawal by Subject|7
6990249|NCT01299896|11049422|FG000|Overall Study|Lost to Follow-up|0
6990250|NCT01299896|11049423|FG001|Overall Study|Lost to Follow-up|11
6990251|NCT01299909|11049432|FG000|Overall Study|Lost to Follow-up|22
6990252|NCT01299909|11049433|FG001|Overall Study|Lost to Follow-up|18
6990253|NCT01299909|11049434|FG002|Overall Study|Lost to Follow-up|17
6990254|NCT01299961|11049441|FG000|Overall Study|Adverse Event|3
6990255|NCT01299961|11049441|FG000|Overall Study|Lack of Efficacy|2
6990256|NCT01299961|11049441|FG000|Overall Study|Lost to Follow-up|1
6990257|NCT01300052|11049447|FG000|Overall Study|Adverse Event|3
6990258|NCT01300052|11049448|FG001|Overall Study|Adverse Event|0
6990259|NCT01300052|11049447|FG000|Overall Study|Withdrawal by Subject|2
6990260|NCT01300052|11049448|FG001|Overall Study|Withdrawal by Subject|2
6990261|NCT01300052|11049447|FG000|Overall Study|Protocol Violation|1
6990262|NCT01300052|11049448|FG001|Overall Study|Protocol Violation|1
6990263|NCT01300234|11049465|FG000|Overall Study|Adverse Event|1
6990264|NCT01300234|11049466|FG001|Overall Study|Adverse Event|1
6990265|NCT01300234|11049465|FG000|Overall Study|Protocol Violation|2
6990266|NCT01300234|11049466|FG001|Overall Study|Protocol Violation|3
6990267|NCT01300234|11049465|FG000|Overall Study|Withdrawal by Subject|5
6990268|NCT01300234|11049466|FG001|Overall Study|Withdrawal by Subject|9
6990269|NCT01300234|11049465|FG000|Overall Study|Lost to Follow-up|14
6990270|NCT01300234|11049466|FG001|Overall Study|Lost to Follow-up|12
6990271|NCT01300234|11049465|FG000|Overall Study|Pregnancy|2
6990272|NCT01300234|11049466|FG001|Overall Study|Pregnancy|1
6990273|NCT01300234|11049465|FG000|Overall Study|Participant reached stopping critera|2
6990274|NCT01300234|11049466|FG001|Overall Study|Participant reached stopping critera|0
6990275|NCT01300234|11049465|FG000|Overall Study|Participant stopped medication|1
6990276|NCT01300234|11049466|FG001|Overall Study|Participant stopped medication|1
6990277|NCT01300234|11049465|FG000|Overall Study|Participant refused return to hospital|1
6990278|NCT01300234|11049466|FG001|Overall Study|Participant refused return to hospital|0
6990279|NCT01300247|11049485|FG000|Overall Study|Death|1
6990280|NCT01300247|11049486|FG001|Overall Study|Death|1
6990281|NCT01300247|11049485|FG000|Overall Study|Lost to Follow-up|2
6990282|NCT01300247|11049486|FG001|Overall Study|Lost to Follow-up|0
6990283|NCT01300247|11049485|FG000|Overall Study|Withdrawal by Subject|1
6990284|NCT01300247|11049486|FG001|Overall Study|Withdrawal by Subject|0
6990285|NCT01300247|11049485|FG000|Overall Study|Non-Compliance|0
6990286|NCT01300247|11049486|FG001|Overall Study|Non-Compliance|1
6990287|NCT01300260|11049494|FG000|Period 1 of Study: First Intervention|Adverse Event|0
6990288|NCT01300260|11049495|FG001|Period 1 of Study: First Intervention|Adverse Event|1
6990289|NCT01300260|11049494|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1
6990290|NCT01300260|11049495|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0
6990291|NCT01300260|11049494|FG000|Period 2 of Study: Second Intervention|Adverse Event|0
6990292|NCT01300260|11049495|FG001|Period 2 of Study: Second Intervention|Adverse Event|1
6990293|NCT01300286|11049512|FG000|Overall Study|did not get dosed|1
6990294|NCT01300338|11049519|FG000|Overall Study|Lost to Follow-up|5
6990295|NCT01300338|11049520|FG001|Overall Study|Lost to Follow-up|0
6990296|NCT01300351|11049528|FG000|Overall Study|Did not receive treatment|2
6990297|NCT01300351|11049529|FG001|Overall Study|Did not receive treatment|0
6990298|NCT01300351|11049528|FG000|Overall Study|Ongoing treatment at data cut-off|27
6990299|NCT01300351|11049529|FG001|Overall Study|Ongoing treatment at data cut-off|23
6990300|NCT01300351|11049528|FG000|Overall Study|Lost to Follow-up|0
6990301|NCT01300351|11049529|FG001|Overall Study|Lost to Follow-up|1
6990302|NCT01300351|11049528|FG000|Overall Study|Adverse Event|0
6990303|NCT01300351|11049529|FG001|Overall Study|Adverse Event|4
6990304|NCT01300351|11049528|FG000|Overall Study|Withdrawal by Subject|7
6990305|NCT01300351|11049529|FG001|Overall Study|Withdrawal by Subject|10
6990306|NCT01300455|11049537|FG000|Washout|Withdrawal by Subject|1
6990307|NCT01300455|11049538|FG001|Washout|Withdrawal by Subject|0
6990308|NCT01300546|11049546|FG000|Overall Study|Withdrawal by Subject|1
6990309|NCT01300546|11049547|FG001|Overall Study|Withdrawal by Subject|0
6990310|NCT01300546|11049546|FG000|Overall Study|Lost to Follow-up|0
6990311|NCT01300546|11049547|FG001|Overall Study|Lost to Follow-up|2
6990312|NCT01300546|11049546|FG000|Overall Study|Lack of Efficacy|0
6990313|NCT01300546|11049547|FG001|Overall Study|Lack of Efficacy|3
6990314|NCT01300546|11049546|FG000|Overall Study|Adverse Event|0
6990315|NCT01300546|11049547|FG001|Overall Study|Adverse Event|1
6990316|NCT01300572|11049562|FG000|Overall Study|HAMA + post dosimetry|1
6990317|NCT01300650|11049572|FG000|Overall Study|Adverse Event|1
6990318|NCT01300728|11049579|FG000|Overall Study|Withdrawal by Subject|1
6990319|NCT01300728|11049580|FG001|Overall Study|Withdrawal by Subject|1
6990320|NCT01300728|11049579|FG000|Overall Study|Physician Decision|1
6990321|NCT01300728|11049580|FG001|Overall Study|Physician Decision|0
6990322|NCT01300741|11049586|FG000|Overall Study|Lens deposits|1
6990323|NCT01300741|11049586|FG000|Overall Study|Lost to Follow-up|1
6990324|NCT01300741|11049586|FG000|Overall Study|Discomfort|1
6990325|NCT01300767|11049592|FG000|Overall Study|Discomfort|2
6990326|NCT01300767|11049592|FG000|Overall Study|Biomicroscopy|1
6990327|NCT01300767|11049592|FG000|Overall Study|Unacceptable fit|1
6990328|NCT01300819|11049600|FG000|Overall Study|Adverse Event|9
6990329|NCT01300819|11049601|FG001|Overall Study|Adverse Event|27
6990330|NCT01300819|11049600|FG000|Overall Study|Lack of Efficacy|2
6990331|NCT01300819|11049601|FG001|Overall Study|Lack of Efficacy|1
6990332|NCT01300819|11049600|FG000|Overall Study|Withdrawal by Subject|10
6990333|NCT01300819|11049601|FG001|Overall Study|Withdrawal by Subject|12
6990334|NCT01300819|11049600|FG000|Overall Study|Patient was 1 month late for Visit 10|0
6990335|NCT01300819|11049601|FG001|Overall Study|Patient was 1 month late for Visit 10|1
6990336|NCT01300819|11049600|FG000|Overall Study|Refusal to down titrate study drug|0
6990337|NCT01300819|11049601|FG001|Overall Study|Refusal to down titrate study drug|1
6990338|NCT01300819|11049600|FG000|Overall Study|Administrative reason|0
6990339|NCT01300819|11049601|FG001|Overall Study|Administrative reason|1
6990340|NCT01300819|11049600|FG000|Overall Study|Safety follow up not done by mistake|0
6990341|NCT01300819|11049601|FG001|Overall Study|Safety follow up not done by mistake|1
6990342|NCT01300819|11049600|FG000|Overall Study|Follow up call was not done|1
6990343|NCT01300819|11049601|FG001|Overall Study|Follow up call was not done|0
6990344|NCT01300923|11049607|FG000|Overall Study|Physician Decision|0
6990345|NCT01300923|11049608|FG001|Overall Study|Physician Decision|2
6990346|NCT01301001|11049626|FG000|First Intervention|Lost to Follow-up|4
6990347|NCT01301001|11049627|FG001|First Intervention|Lost to Follow-up|4
6990348|NCT01301001|11049626|FG000|First Intervention|Withdrawal by Subject|1
6990349|NCT01301001|11049627|FG001|First Intervention|Withdrawal by Subject|4
6990350|NCT01301001|11049626|FG000|First Intervention|Adverse Event|5
6990351|NCT01301001|11049627|FG001|First Intervention|Adverse Event|0
6990352|NCT01301001|11049626|FG000|First Intervention|Protocol Violation|0
6990353|NCT01301001|11049627|FG001|First Intervention|Protocol Violation|1
6990354|NCT01301001|11049626|FG000|Second Intervention|Adverse Event|2
6990355|NCT01301001|11049627|FG001|Second Intervention|Adverse Event|0
6990356|NCT01301001|11049626|FG000|Second Intervention|Withdrawal by Subject|2
6990357|NCT01301001|11049627|FG001|Second Intervention|Withdrawal by Subject|0
6990358|NCT01301027|11049636|FG000|Overall Study|Physician Decision|2
6990359|NCT01301027|11049637|FG001|Overall Study|Physician Decision|0
6990360|NCT01301027|11049636|FG000|Overall Study|Withdrawal by Subject|2
6990361|NCT01301027|11049637|FG001|Overall Study|Withdrawal by Subject|3
6990362|NCT01301027|11049636|FG000|Overall Study|Adverse Event|0
6990363|NCT01301027|11049637|FG001|Overall Study|Adverse Event|2
6990364|NCT01301027|11049636|FG000|Overall Study|Fracture|1
6990365|NCT01301027|11049637|FG001|Overall Study|Fracture|3
6990366|NCT01301027|11049636|FG000|Overall Study|Transplant|0
6990367|NCT01301027|11049637|FG001|Overall Study|Transplant|2
6990368|NCT01301027|11049636|FG000|Overall Study|Volume Overload|3
6990369|NCT01301027|11049637|FG001|Overall Study|Volume Overload|0
6990370|NCT01301066|11049645|FG000|Overall Study|Lost to Follow-up|5
6990371|NCT01301066|11049646|FG001|Overall Study|Lost to Follow-up|11
6990372|NCT01301066|11049645|FG000|Overall Study|Protocol Violation|8
6990373|NCT01301066|11049646|FG001|Overall Study|Protocol Violation|7
6990374|NCT01301066|11049645|FG000|Overall Study|Withdrawal by Subject|4
6990375|NCT01301066|11049646|FG001|Overall Study|Withdrawal by Subject|9
6990376|NCT01301066|11049645|FG000|Overall Study|Adverse Event|6
6990377|NCT01301066|11049646|FG001|Overall Study|Adverse Event|6
6990378|NCT01301066|11049645|FG000|Overall Study|Sponsor Decision|2
6990379|NCT01301066|11049646|FG001|Overall Study|Sponsor Decision|1
6990380|NCT01301066|11049645|FG000|Overall Study|Physician Decision|0
6990381|NCT01301066|11049646|FG001|Overall Study|Physician Decision|1
6990382|NCT01301066|11049645|FG000|Overall Study|Other|2
6990383|NCT01301066|11049646|FG001|Overall Study|Other|0
6990384|NCT01301079|11049654|FG000|Overall Study|Lost to Follow-up|2
6990385|NCT01301079|11049655|FG001|Overall Study|Lost to Follow-up|2
6990386|NCT01301092|11049668|FG000|Overall Study|Lost to Follow-up|0
6990387|NCT01301092|11049669|FG001|Overall Study|Lost to Follow-up|0
6990388|NCT01301092|11049670|FG002|Overall Study|Lost to Follow-up|1
7042254|NCT01734434|11126602|FG003|Overall Study|Subject Not Reachable|0
7042255|NCT01734434|11126599|FG000|Overall Study|Treatment Defaulter|0
7042256|NCT01734434|11126600|FG001|Overall Study|Treatment Defaulter|0
7042257|NCT01734434|11126601|FG002|Overall Study|Treatment Defaulter|1
7042258|NCT01734434|11126602|FG003|Overall Study|Treatment Defaulter|0
7042259|NCT01734434|11126599|FG000|Overall Study|Wrong Version of Consent Form Signed|0
7042260|NCT01734434|11126600|FG001|Overall Study|Wrong Version of Consent Form Signed|0
7042261|NCT01734434|11126601|FG002|Overall Study|Wrong Version of Consent Form Signed|1
7042262|NCT01734434|11126602|FG003|Overall Study|Wrong Version of Consent Form Signed|0
7042263|NCT01734434|11126599|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0
7042264|NCT01734434|11126600|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0
7042265|NCT01734434|11126601|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1
7042266|NCT01734434|11126602|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0
7042267|NCT01734772|11126651|FG000|Overall Study|Adverse Event|1
7042268|NCT01734772|11126652|FG001|Overall Study|Adverse Event|2
7042269|NCT01734772|11126651|FG000|Overall Study|Withdrawal by Subject|0
7042270|NCT01734772|11126652|FG001|Overall Study|Withdrawal by Subject|1
7042271|NCT01734785|11126667|FG000|Open-Label Period|Adverse Event|0
7042272|NCT01734785|11126668|FG001|Open-Label Period|Adverse Event|0
7042273|NCT01734785|11126669|FG002|Open-Label Period|Adverse Event|0
7042274|NCT01734785|11126670|FG003|Open-Label Period|Adverse Event|9
7042275|NCT01734785|11126667|FG000|Open-Label Period|Lack of Efficacy|0
7042276|NCT01734785|11126668|FG001|Open-Label Period|Lack of Efficacy|0
7042277|NCT01734785|11126669|FG002|Open-Label Period|Lack of Efficacy|0
7042278|NCT01734785|11126670|FG003|Open-Label Period|Lack of Efficacy|1
7042279|NCT01734785|11126667|FG000|Open-Label Period|Protocol Violation|0
7042280|NCT01734785|11126668|FG001|Open-Label Period|Protocol Violation|0
7042281|NCT01734785|11126669|FG002|Open-Label Period|Protocol Violation|0
7042282|NCT01734785|11126670|FG003|Open-Label Period|Protocol Violation|13
7042283|NCT01734785|11126667|FG000|Open-Label Period|Lost to Follow-up|0
7042284|NCT01734785|11126668|FG001|Open-Label Period|Lost to Follow-up|0
7042285|NCT01734785|11126669|FG002|Open-Label Period|Lost to Follow-up|0
7042286|NCT01734785|11126670|FG003|Open-Label Period|Lost to Follow-up|14
7042287|NCT01734785|11126667|FG000|Open-Label Period|Withdrawal by Subject|0
7042288|NCT01734785|11126668|FG001|Open-Label Period|Withdrawal by Subject|0
7042289|NCT01734785|11126669|FG002|Open-Label Period|Withdrawal by Subject|0
7042290|NCT01734785|11126670|FG003|Open-Label Period|Withdrawal by Subject|12
7042291|NCT01734785|11126667|FG000|Open-Label Period|Other Reasons|0
7042292|NCT01734785|11126668|FG001|Open-Label Period|Other Reasons|0
7042293|NCT01734785|11126669|FG002|Open-Label Period|Other Reasons|0
7042294|NCT01734785|11126670|FG003|Open-Label Period|Other Reasons|224
6990389|NCT01301274|11049694|FG000|Overall Study|Physician Decision|2
6990390|NCT01301274|11049695|FG001|Overall Study|Physician Decision|1
6990391|NCT01301391|11049706|FG000|Overall Study|Death|13
6990392|NCT01301391|11049706|FG000|Overall Study|Lost to Follow-up|3
6990393|NCT01301391|11049706|FG000|Overall Study|Physician Decision|2
6990394|NCT01301391|11049706|FG000|Overall Study|Sponsor's decision|8
6990395|NCT01301456|11049722|FG000|Stage 1|Withdrawal by Subject|0
6990396|NCT01301456|11049723|FG001|Stage 1|Withdrawal by Subject|0
6990397|NCT01301456|11049724|FG002|Stage 1|Withdrawal by Subject|1
6990398|NCT01301456|11049725|FG003|Stage 1|Withdrawal by Subject|0
6990399|NCT01301456|11049726|FG004|Stage 1|Withdrawal by Subject|1
6990400|NCT01301456|11049727|FG005|Stage 1|Withdrawal by Subject|0
6990401|NCT01301456|11049728|FG006|Stage 1|Withdrawal by Subject|0
6990402|NCT01301456|11049729|FG007|Stage 1|Withdrawal by Subject|0
6990403|NCT01301456|11049730|FG008|Stage 1|Withdrawal by Subject|0
6990404|NCT01301456|11049731|FG009|Stage 1|Withdrawal by Subject|0
6990405|NCT01301456|11049732|FG010|Stage 1|Withdrawal by Subject|0
6990406|NCT01301456|11049733|FG011|Stage 1|Withdrawal by Subject|0
6990407|NCT01301456|11049722|FG000|Stage 1|Randomized but not treated|0
6990408|NCT01301456|11049723|FG001|Stage 1|Randomized but not treated|0
6990409|NCT01301456|11049724|FG002|Stage 1|Randomized but not treated|0
6990410|NCT01301456|11049725|FG003|Stage 1|Randomized but not treated|0
6990411|NCT01301456|11049726|FG004|Stage 1|Randomized but not treated|0
6990412|NCT01301456|11049727|FG005|Stage 1|Randomized but not treated|0
6990413|NCT01301456|11049728|FG006|Stage 1|Randomized but not treated|1
6990414|NCT01301456|11049729|FG007|Stage 1|Randomized but not treated|0
6990415|NCT01301456|11049730|FG008|Stage 1|Randomized but not treated|0
6990416|NCT01301456|11049731|FG009|Stage 1|Randomized but not treated|0
6990417|NCT01301456|11049732|FG010|Stage 1|Randomized but not treated|0
6990418|NCT01301456|11049733|FG011|Stage 1|Randomized but not treated|0
6990419|NCT01301456|11049722|FG000|Stage 2|Adverse Event|0
6990420|NCT01301456|11049723|FG001|Stage 2|Adverse Event|0
6990421|NCT01301456|11049724|FG002|Stage 2|Adverse Event|0
6990422|NCT01301456|11049725|FG003|Stage 2|Adverse Event|0
6990423|NCT01301456|11049726|FG004|Stage 2|Adverse Event|0
6990424|NCT01301456|11049727|FG005|Stage 2|Adverse Event|0
6990425|NCT01301456|11049728|FG006|Stage 2|Adverse Event|0
6990426|NCT01301456|11049729|FG007|Stage 2|Adverse Event|0
6990427|NCT01301456|11049730|FG008|Stage 2|Adverse Event|0
6990428|NCT01301456|11049731|FG009|Stage 2|Adverse Event|0
6990429|NCT01301456|11049732|FG010|Stage 2|Adverse Event|1
6990430|NCT01301456|11049733|FG011|Stage 2|Adverse Event|0
6990431|NCT01301508|11049779|FG000|Overall Study|Withdrawal by Subject|1
6990432|NCT01301508|11049780|FG001|Overall Study|Withdrawal by Subject|2
6990433|NCT01301508|11049779|FG000|Overall Study|Lost to Follow-up|0
6990434|NCT01301508|11049780|FG001|Overall Study|Lost to Follow-up|1
6990435|NCT01301625|11049786|FG000|Overall Study|Death|5
6990436|NCT01301625|11049786|FG000|Overall Study|Not Due|21
6990437|NCT01301625|11049786|FG000|Overall Study|Expected|8
6990438|NCT01301625|11049786|FG000|Overall Study|Lost to Follow-up|1
6990439|NCT01301729|11049790|FG000|Overall Study|Withdrawal by Subject|2
6990440|NCT01301729|11049790|FG000|Overall Study|Participant did not Return for Treatment|1
6990441|NCT01301729|11049790|FG000|Overall Study|Violated Selection Criteria|1
6990442|NCT01301833|11049807|FG000|Overall Study|Adverse Event|7
6990443|NCT01301833|11049808|FG001|Overall Study|Adverse Event|5
6990444|NCT01301833|11049809|FG002|Overall Study|Adverse Event|5
6990445|NCT01301833|11049810|FG003|Overall Study|Adverse Event|5
6990446|NCT01301833|11049807|FG000|Overall Study|Lack of Efficacy|1
6990447|NCT01301833|11049808|FG001|Overall Study|Lack of Efficacy|1
6990448|NCT01301833|11049809|FG002|Overall Study|Lack of Efficacy|0
6990449|NCT01301833|11049810|FG003|Overall Study|Lack of Efficacy|0
6990450|NCT01301833|11049807|FG000|Overall Study|Physician Decision|3
6990451|NCT01301833|11049808|FG001|Overall Study|Physician Decision|1
6990452|NCT01301833|11049809|FG002|Overall Study|Physician Decision|1
6990453|NCT01301833|11049810|FG003|Overall Study|Physician Decision|0
6990454|NCT01301833|11049807|FG000|Overall Study|Withdrawal by Subject|3
6990455|NCT01301833|11049808|FG001|Overall Study|Withdrawal by Subject|1
6990456|NCT01301833|11049809|FG002|Overall Study|Withdrawal by Subject|1
6990457|NCT01301833|11049810|FG003|Overall Study|Withdrawal by Subject|2
6990458|NCT01301833|11049807|FG000|Overall Study|Personal matter|1
6990459|NCT01301833|11049808|FG001|Overall Study|Personal matter|0
6990460|NCT01301833|11049809|FG002|Overall Study|Personal matter|0
6990461|NCT01301833|11049810|FG003|Overall Study|Personal matter|0
6990462|NCT01301950|11049822|FG000|Overall Study|Surgery was cancelled by patient|0
6990463|NCT01301950|11049823|FG001|Overall Study|Surgery was cancelled by patient|1
6990464|NCT01302041|11049829|FG000|Overall Study|Death|5
6990465|NCT01302041|11049829|FG000|Overall Study|Withdrawal by Subject|4
6990466|NCT01302041|11049829|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29
6990467|NCT01302041|11049829|FG000|Overall Study|Other-Miscellaneous Reason|2
6990468|NCT01302054|11049834|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4
6990469|NCT01302054|11049835|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
6990470|NCT01302054|11049836|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
6990471|NCT01302054|11049834|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17
6990472|NCT01302054|11049835|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
6990473|NCT01302054|11049836|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
6990474|NCT01302054|11049834|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16
6990475|NCT01302054|11049835|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
6990476|NCT01302054|11049836|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
6990477|NCT01302054|11049834|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8
6990478|NCT01302054|11049835|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
6990479|NCT01302054|11049836|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
6990480|NCT01302054|11049834|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13
6990481|NCT01302054|11049835|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0
6990482|NCT01302054|11049836|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0
6990483|NCT01302054|11049834|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314
6990484|NCT01302054|11049835|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
6990485|NCT01302054|11049836|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
6990486|NCT01302054|11049834|FG000|Tolterodine Open-Label Run-In Phase|Other|7
6990487|NCT01302054|11049835|FG001|Tolterodine Open-Label Run-In Phase|Other|0
6990488|NCT01302054|11049836|FG002|Tolterodine Open-Label Run-In Phase|Other|0
6990489|NCT01302054|11049834|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2
6990490|NCT01302054|11049835|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
6990491|NCT01302054|11049836|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
6990492|NCT01302054|11049834|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0
6990493|NCT01302054|11049835|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2
6990494|NCT01302054|11049836|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4
6990495|NCT01302054|11049834|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0
6990496|NCT01302054|11049835|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2
6990497|NCT01302054|11049836|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1
6990498|NCT01302054|11049834|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0
6990499|NCT01302054|11049835|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6
6990500|NCT01302054|11049836|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14
6990501|NCT01302054|11049834|FG000|Double-Blind Treatment Phase|Protocol Violation|0
6990502|NCT01302054|11049835|FG001|Double-Blind Treatment Phase|Protocol Violation|3
6990503|NCT01302054|11049836|FG002|Double-Blind Treatment Phase|Protocol Violation|6
6990504|NCT01302054|11049834|FG000|Double-Blind Treatment Phase|Adverse Event|0
6990505|NCT01302054|11049835|FG001|Double-Blind Treatment Phase|Adverse Event|10
6990506|NCT01302054|11049836|FG002|Double-Blind Treatment Phase|Adverse Event|10
6990507|NCT01302054|11049834|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
6990508|NCT01302054|11049835|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
6990509|NCT01302054|11049836|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2
6990510|NCT01302054|11049834|FG000|Double-Blind Treatment Phase|Other|0
6990511|NCT01302054|11049835|FG001|Double-Blind Treatment Phase|Other|4
6990512|NCT01302054|11049836|FG002|Double-Blind Treatment Phase|Other|9
6990513|NCT01302067|11049848|FG000|Overall Study|Death|0
6990514|NCT01302067|11049849|FG001|Overall Study|Death|0
6990515|NCT01302067|11049850|FG002|Overall Study|Death|1
6990516|NCT01302067|11049848|FG000|Overall Study|Physician Decision|9
6990517|NCT01302067|11049849|FG001|Overall Study|Physician Decision|5
6990518|NCT01302067|11049850|FG002|Overall Study|Physician Decision|14
6990519|NCT01302067|11049848|FG000|Overall Study|Lack of Efficacy|8
6990520|NCT01302067|11049849|FG001|Overall Study|Lack of Efficacy|4
6990521|NCT01302067|11049850|FG002|Overall Study|Lack of Efficacy|2
6990522|NCT01302067|11049848|FG000|Overall Study|Lost to Follow-up|9
6990523|NCT01302067|11049849|FG001|Overall Study|Lost to Follow-up|4
6990524|NCT01302067|11049850|FG002|Overall Study|Lost to Follow-up|15
6990525|NCT01302067|11049848|FG000|Overall Study|Withdrawal by Subject|13
6990526|NCT01302067|11049849|FG001|Overall Study|Withdrawal by Subject|6
6990527|NCT01302067|11049850|FG002|Overall Study|Withdrawal by Subject|10
6990528|NCT01302067|11049848|FG000|Overall Study|Other|1
6990529|NCT01302067|11049849|FG001|Overall Study|Other|1
6990530|NCT01302067|11049850|FG002|Overall Study|Other|3
6990531|NCT01302067|11049848|FG000|Overall Study|Protocol Violation|11
6990532|NCT01302067|11049849|FG001|Overall Study|Protocol Violation|0
6990533|NCT01302067|11049850|FG002|Overall Study|Protocol Violation|8
6990534|NCT01302067|11049848|FG000|Overall Study|Adverse Event|27
6990535|NCT01302067|11049849|FG001|Overall Study|Adverse Event|14
6990536|NCT01302067|11049850|FG002|Overall Study|Adverse Event|45
6990537|NCT01302080|11049861|FG000|Overall Study|Withdrew Consent|92
6990538|NCT01302080|11049862|FG001|Overall Study|Withdrew Consent|39
6990539|NCT01302080|11049861|FG000|Overall Study|Patient/Family Moved|28
6990540|NCT01302080|11049862|FG001|Overall Study|Patient/Family Moved|3
6990541|NCT01302080|11049861|FG000|Overall Study|Lost to Follow-up|192
6990542|NCT01302080|11049862|FG001|Overall Study|Lost to Follow-up|93
6990543|NCT01302080|11049861|FG000|Overall Study|Death|1
6990544|NCT01302080|11049862|FG001|Overall Study|Death|0
6990545|NCT01302080|11049861|FG000|Overall Study|Other|52
6990546|NCT01302080|11049862|FG001|Overall Study|Other|8
6990547|NCT01302080|11049861|FG000|Overall Study|Reason Missing For Discontinuation|1
6990548|NCT01302080|11049862|FG001|Overall Study|Reason Missing For Discontinuation|0
6990549|NCT01302119|11049894|FG000|Overall Study|Withdrawal by Subject|30
6990550|NCT01302119|11049895|FG001|Overall Study|Withdrawal by Subject|20
6990551|NCT01302119|11049894|FG000|Overall Study|Lost to Follow-up|10
6990552|NCT01302119|11049895|FG001|Overall Study|Lost to Follow-up|4
6990553|NCT01302119|11049894|FG000|Overall Study|Adverse Event|2
6990554|NCT01302119|11049895|FG001|Overall Study|Adverse Event|1
6990555|NCT01302119|11049894|FG000|Overall Study|Non-compliance|4
6990556|NCT01302119|11049895|FG001|Overall Study|Non-compliance|2
6990557|NCT01302119|11049894|FG000|Overall Study|Non-specific|4
6990558|NCT01302119|11049895|FG001|Overall Study|Non-specific|1
6990559|NCT01302366|11049901|FG000|Overall Study|patient choice or noncompliance|5
6990560|NCT01302392|11049922|FG000|Overall Study|Lost to Follow-up|1
6990561|NCT01302392|11049923|FG001|Overall Study|Lost to Follow-up|0
6990562|NCT01302392|11049922|FG000|Overall Study|Withdrawal by Subject|6
6990563|NCT01302392|11049923|FG001|Overall Study|Withdrawal by Subject|1
6990564|NCT01302418|11049929|FG000|Overall Study|Protocol Violation|9
6990565|NCT01302418|11049929|FG000|Overall Study|Non-evaluable|9
6990566|NCT01302548|11049950|FG000|Overall Study|Lost to Follow-up|2
6990567|NCT01302548|11049951|FG001|Overall Study|Lost to Follow-up|1
6990568|NCT01302691|11049959|FG000|Overall Study|Adverse Event|2
6990569|NCT01302691|11049960|FG001|Overall Study|Adverse Event|0
6990570|NCT01302691|11049959|FG000|Overall Study|Death|0
6990571|NCT01302691|11049960|FG001|Overall Study|Death|1
6990572|NCT01302691|11049959|FG000|Overall Study|Lost to Follow-up|1
6990573|NCT01302691|11049960|FG001|Overall Study|Lost to Follow-up|0
6990574|NCT01302691|11049959|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6
6990575|NCT01302691|11049960|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4
6990576|NCT01302691|11049959|FG000|Overall Study|Physician Decision|0
6990577|NCT01302691|11049960|FG001|Overall Study|Physician Decision|1
6990578|NCT01302691|11049959|FG000|Overall Study|Protocol Violation|1
6990579|NCT01302691|11049960|FG001|Overall Study|Protocol Violation|0
6990584|NCT01302899|11050013|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1
6990585|NCT01302899|11050014|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0
6990586|NCT01302899|11050013|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0
6990587|NCT01302899|11050014|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1
6990588|NCT01302938|11050026|FG000|Overall Study|Withdrawal by Subject|1
6990589|NCT01302938|11050027|FG001|Overall Study|Withdrawal by Subject|0
6990590|NCT01302938|11050026|FG000|Overall Study|Adverse Event|1
6990591|NCT01302938|11050027|FG001|Overall Study|Adverse Event|0
6990592|NCT01302964|11050036|FG000|Overall Study|Adverse Event|1
6990593|NCT01302964|11050037|FG001|Overall Study|Adverse Event|0
6990594|NCT01303159|11050052|FG000|Overall Study|Death|16
6990595|NCT01303159|11050052|FG000|Overall Study|Study Termination|7
6990596|NCT01303172|11050058|FG000|Overall Study|Physician Decision|9
6990597|NCT01303172|11050059|FG001|Overall Study|Physician Decision|6
6990598|NCT01303172|11050058|FG000|Overall Study|Adverse Event|5
6990599|NCT01303172|11050059|FG001|Overall Study|Adverse Event|2
6990600|NCT01303172|11050058|FG000|Overall Study|Withdrawal by Subject|4
6990601|NCT01303172|11050059|FG001|Overall Study|Withdrawal by Subject|2
6990602|NCT01303172|11050058|FG000|Overall Study|Death|20
6990603|NCT01303172|11050059|FG001|Overall Study|Death|7
6990604|NCT01303172|11050058|FG000|Overall Study|Lack of Efficacy|25
6990605|NCT01303172|11050059|FG001|Overall Study|Lack of Efficacy|17
6990606|NCT01303380|11050083|FG000|Overall Study|Lack of compliance to study procedures|1
6990607|NCT01303419|11050096|FG000|Overall Study|Discontinuation of study|60
6990608|NCT01303419|11050096|FG000|Overall Study|Did not complete both imaging methods|5
6990609|NCT01303419|11050096|FG000|Overall Study|Did not meet all I/E after screening|31
6990610|NCT01303445|11050100|FG000|First Intervention (7 Days)|Withdrawal by Subject|1
6990611|NCT01303445|11050101|FG001|First Intervention (7 Days)|Withdrawal by Subject|0
6990612|NCT01303445|11050100|FG000|Second Intervention (7 Days)|Adverse Event|0
6990613|NCT01303445|11050101|FG001|Second Intervention (7 Days)|Adverse Event|2
6990614|NCT01303445|11050100|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1
6990615|NCT01303445|11050101|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0
6990616|NCT01303445|11050100|FG000|Washout (14 Days)|Protocol Violation|1
6990617|NCT01303445|11050101|FG001|Washout (14 Days)|Protocol Violation|0
6990618|NCT01303445|11050100|FG000|Washout (14 Days)|Lost to Follow-up|0
6990619|NCT01303445|11050101|FG001|Washout (14 Days)|Lost to Follow-up|2
6990620|NCT01303445|11050100|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1
6990621|NCT01303445|11050101|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0
6990622|NCT01303445|11050100|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0
6990623|NCT01303445|11050101|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1
6990624|NCT01303510|11050113|FG000|Overall Study|Lost to Follow-up|1
6990625|NCT01303510|11050114|FG001|Overall Study|Lost to Follow-up|0
6990626|NCT01303627|11050122|FG000|Overall Study|the failure while performing URS|0
6990627|NCT01303627|11050123|FG001|Overall Study|the failure while performing URS|1
6990628|NCT01303861|11050160|FG000|Overall Study|Lost to Follow-up|34
6990629|NCT01303861|11050161|FG001|Overall Study|Lost to Follow-up|14
6990630|NCT01303861|11050162|FG002|Overall Study|Lost to Follow-up|27
7060320|NCT01917006|11156413|FG005|Randomized-treatment Period|Personal Reasons|1
6990631|NCT01303861|11050163|FG003|Overall Study|Lost to Follow-up|31
7060321|NCT01917006|11156414|FG006|Randomized-treatment Period|Personal Reasons|0
7060322|NCT01917006|11156415|FG007|Randomized-treatment Period|Personal Reasons|0
6990632|NCT01303861|11050160|FG000|Overall Study|Lack of Efficacy|3
6990633|NCT01303861|11050161|FG001|Overall Study|Lack of Efficacy|2
6990634|NCT01303861|11050162|FG002|Overall Study|Lack of Efficacy|1
6990635|NCT01303861|11050163|FG003|Overall Study|Lack of Efficacy|0
6990636|NCT01303861|11050160|FG000|Overall Study|Withdrawal by Subject|16
6990637|NCT01303861|11050161|FG001|Overall Study|Withdrawal by Subject|8
6990638|NCT01303861|11050162|FG002|Overall Study|Withdrawal by Subject|8
6990639|NCT01303861|11050163|FG003|Overall Study|Withdrawal by Subject|23
6990640|NCT01303861|11050160|FG000|Overall Study|Adverse Event|4
6990641|NCT01303861|11050161|FG001|Overall Study|Adverse Event|1
6990642|NCT01303861|11050162|FG002|Overall Study|Adverse Event|0
6990643|NCT01303861|11050163|FG003|Overall Study|Adverse Event|5
6990644|NCT01303861|11050160|FG000|Overall Study|Pregnancy|1
6990645|NCT01303861|11050161|FG001|Overall Study|Pregnancy|0
6990646|NCT01303861|11050162|FG002|Overall Study|Pregnancy|0
6990647|NCT01303861|11050163|FG003|Overall Study|Pregnancy|0
6990648|NCT01303965|11050187|FG000|Overall Study|Adverse Event|1
6990649|NCT01303965|11050188|FG001|Overall Study|Adverse Event|1
6990650|NCT01303965|11050187|FG000|Overall Study|Death|0
6990651|NCT01303965|11050188|FG001|Overall Study|Death|3
6990652|NCT01303965|11050187|FG000|Overall Study|Withdrawal by Subject|1
6990653|NCT01303965|11050188|FG001|Overall Study|Withdrawal by Subject|0
6990654|NCT01303965|11050187|FG000|Overall Study|Disease Progression|1
6990655|NCT01303965|11050188|FG001|Overall Study|Disease Progression|6
6990656|NCT01304147|11050206|FG000|Second Intervention (7days)|Withdrawal by Subject|1
6990657|NCT01304147|11050207|FG001|Second Intervention (7days)|Withdrawal by Subject|1
6990658|NCT01304329|11050261|FG000|Third Intervention (3 Days)|Adverse Event|0
6990659|NCT01304329|11050262|FG001|Third Intervention (3 Days)|Adverse Event|1
6990660|NCT01304329|11050263|FG002|Third Intervention (3 Days)|Adverse Event|0
6990661|NCT01304329|11050264|FG003|Third Intervention (3 Days)|Adverse Event|0
6990662|NCT01304329|11050265|FG004|Third Intervention (3 Days)|Adverse Event|0
6990663|NCT01304329|11050266|FG005|Third Intervention (3 Days)|Adverse Event|0
6990664|NCT01304498|11050280|FG000|Overall Study|Adverse Event|1
6990665|NCT01304498|11050281|FG001|Overall Study|Adverse Event|1
6990666|NCT01304498|11050280|FG000|Overall Study|Withdrawal by Subject|2
6990667|NCT01304498|11050281|FG001|Overall Study|Withdrawal by Subject|3
6990668|NCT01304498|11050280|FG000|Overall Study|Protocol Violation|1
6990669|NCT01304498|11050281|FG001|Overall Study|Protocol Violation|0
6990670|NCT01304498|11050280|FG000|Overall Study|Lost to Follow-up|2
6990671|NCT01304498|11050281|FG001|Overall Study|Lost to Follow-up|1
6990672|NCT01304693|11050306|FG000|Overall Study|Adverse Event|0
6990673|NCT01304693|11050307|FG001|Overall Study|Adverse Event|0
6990674|NCT01304693|11050308|FG002|Overall Study|Adverse Event|0
6990675|NCT01304693|11050309|FG003|Overall Study|Adverse Event|0
6990676|NCT01304693|11050310|FG004|Overall Study|Adverse Event|1
6990677|NCT01304693|11050306|FG000|Overall Study|Decision Unrelated to an Adverse Event|0
6990678|NCT01304693|11050307|FG001|Overall Study|Decision Unrelated to an Adverse Event|0
6990679|NCT01304693|11050308|FG002|Overall Study|Decision Unrelated to an Adverse Event|1
6990680|NCT01304693|11050309|FG003|Overall Study|Decision Unrelated to an Adverse Event|1
6990681|NCT01304693|11050310|FG004|Overall Study|Decision Unrelated to an Adverse Event|0
6990682|NCT01304706|11050322|FG000|Overall Study|Adverse Event|2
6990683|NCT01304706|11050322|FG000|Overall Study|Lack of Efficacy|1
6990684|NCT01304706|11050322|FG000|Overall Study|Death|3
6990685|NCT01304706|11050322|FG000|Overall Study|Withdrawal by Subject|3
6990686|NCT01304706|11050322|FG000|Overall Study|Lost to Follow-up|7
6990687|NCT01304706|11050322|FG000|Overall Study|Discontinued due to failed drug admin.|1
6990688|NCT01304940|11050328|FG000|Overall Study|not meet symptom severity requirement|3
6990689|NCT01304940|11050329|FG001|Overall Study|not meet symptom severity requirement|0
6990690|NCT01305044|11050343|FG000|Overall Study|Withdrawal by Subject|3
6990691|NCT01305044|11050344|FG001|Overall Study|Withdrawal by Subject|6
6990692|NCT01305200|11050353|FG000|Overall Study|Physician Decision|4
6990693|NCT01305200|11050354|FG001|Overall Study|Physician Decision|6
6990694|NCT01305200|11050355|FG002|Overall Study|Physician Decision|1
6990695|NCT01305200|11050353|FG000|Overall Study|Withdrawal by Subject|24
6990696|NCT01305200|11050354|FG001|Overall Study|Withdrawal by Subject|21
6990697|NCT01305200|11050355|FG002|Overall Study|Withdrawal by Subject|1
6990698|NCT01305200|11050353|FG000|Overall Study|Ineligible|1
6990699|NCT01305200|11050354|FG001|Overall Study|Ineligible|2
6990700|NCT01305200|11050355|FG002|Overall Study|Ineligible|1
6990701|NCT01305200|11050353|FG000|Overall Study|Death|0
6990702|NCT01305200|11050354|FG001|Overall Study|Death|2
6990703|NCT01305200|11050355|FG002|Overall Study|Death|0
6990704|NCT01305239|11050373|FG000|Overall Study|Adverse Event|22
6990705|NCT01305239|11050373|FG000|Overall Study|Exemestane taken prior to inclusion only|1
6990706|NCT01305408|11050410|FG000|Overall Study|Adverse Event|10
6990707|NCT01305408|11050411|FG001|Overall Study|Adverse Event|7
6990708|NCT01305408|11050410|FG000|Overall Study|Lack of Efficacy|3
6990709|NCT01305408|11050411|FG001|Overall Study|Lack of Efficacy|4
6990710|NCT01305408|11050410|FG000|Overall Study|Withdrawal by Subject|9
6990711|NCT01305408|11050411|FG001|Overall Study|Withdrawal by Subject|9
6990712|NCT01305408|11050410|FG000|Overall Study|Protocol Violation|4
6990713|NCT01305408|11050411|FG001|Overall Study|Protocol Violation|6
6990714|NCT01305408|11050410|FG000|Overall Study|Lost to Follow-up|5
6990715|NCT01305408|11050411|FG001|Overall Study|Lost to Follow-up|3
6990716|NCT01305408|11050410|FG000|Overall Study|Noncompliance with study medication|0
6990717|NCT01305408|11050411|FG001|Overall Study|Noncompliance with study medication|1
6990718|NCT01305408|11050410|FG000|Overall Study|Noncompliance with study procedures|0
6990719|NCT01305408|11050411|FG001|Overall Study|Noncompliance with study procedures|1
6990720|NCT01305408|11050410|FG000|Overall Study|Other|1
6990721|NCT01305408|11050411|FG001|Overall Study|Other|0
6990722|NCT01305564|11050421|FG000|Overall Study|Death|21
6990723|NCT01305564|11050421|FG000|Overall Study|Lost to Follow-up|12
6990724|NCT01305564|11050421|FG000|Overall Study|Withdrawal by Subject|1
6990725|NCT01305564|11050421|FG000|Overall Study|Physician Decision|3
6990726|NCT01305577|11050439|FG000|Overall Study|Adverse Event|2
6990727|NCT01305577|11050440|FG001|Overall Study|Adverse Event|2
6990728|NCT01305577|11050441|FG002|Overall Study|Adverse Event|1
6990729|NCT01305577|11050439|FG000|Overall Study|Withdrawal by Subject|7
6990730|NCT01305577|11050440|FG001|Overall Study|Withdrawal by Subject|5
6990731|NCT01305577|11050441|FG002|Overall Study|Withdrawal by Subject|6
6990732|NCT01305577|11050439|FG000|Overall Study|Lost to Follow-up|4
6990733|NCT01305577|11050440|FG001|Overall Study|Lost to Follow-up|3
6990734|NCT01305577|11050441|FG002|Overall Study|Lost to Follow-up|2
6990735|NCT01305577|11050439|FG000|Overall Study|Protocol Deviation|0
6990736|NCT01305577|11050440|FG001|Overall Study|Protocol Deviation|1
6990737|NCT01305577|11050441|FG002|Overall Study|Protocol Deviation|1
6990738|NCT01305941|11050472|FG000|Overall Study|Adverse Event|6
6990739|NCT01305941|11050472|FG000|Overall Study|Clinical decline|2
6990740|NCT01305941|11050472|FG000|Overall Study|Withdrawal by Subject|1
6990741|NCT01305941|11050472|FG000|Overall Study|Death|1
6990742|NCT01306032|11050482|FG000|First Intervention|Adverse Event|1
6990743|NCT01306032|11050483|FG001|First Intervention|Adverse Event|0
6990744|NCT01306032|11050484|FG002|First Intervention|Adverse Event|1
6990745|NCT01306032|11050485|FG003|First Intervention|Adverse Event|0
6990746|NCT01306032|11050486|FG004|First Intervention|Adverse Event|0
6990747|NCT01306032|11050487|FG005|First Intervention|Adverse Event|1
6990748|NCT01306032|11050482|FG000|First Intervention|Withdrawal by Subject|0
6990749|NCT01306032|11050483|FG001|First Intervention|Withdrawal by Subject|2
6990750|NCT01306032|11050484|FG002|First Intervention|Withdrawal by Subject|0
6990751|NCT01306032|11050485|FG003|First Intervention|Withdrawal by Subject|1
6990752|NCT01306032|11050486|FG004|First Intervention|Withdrawal by Subject|0
6990753|NCT01306032|11050487|FG005|First Intervention|Withdrawal by Subject|0
6990754|NCT01306032|11050482|FG000|First Intervention|Death|0
6990755|NCT01306032|11050483|FG001|First Intervention|Death|0
6990756|NCT01306032|11050484|FG002|First Intervention|Death|1
6990757|NCT01306032|11050485|FG003|First Intervention|Death|0
6990758|NCT01306032|11050486|FG004|First Intervention|Death|0
6990759|NCT01306032|11050487|FG005|First Intervention|Death|0
6990760|NCT01306032|11050482|FG000|First Intervention|Ineligible|0
6990761|NCT01306032|11050483|FG001|First Intervention|Ineligible|0
6990762|NCT01306032|11050484|FG002|First Intervention|Ineligible|0
6990763|NCT01306032|11050485|FG003|First Intervention|Ineligible|0
6990764|NCT01306032|11050486|FG004|First Intervention|Ineligible|0
6990765|NCT01306032|11050487|FG005|First Intervention|Ineligible|1
6990766|NCT01306032|11050482|FG000|First Intervention|Progressive disease|0
6990767|NCT01306032|11050483|FG001|First Intervention|Progressive disease|0
6990768|NCT01306032|11050484|FG002|First Intervention|Progressive disease|0
6990769|NCT01306032|11050485|FG003|First Intervention|Progressive disease|0
6990770|NCT01306032|11050486|FG004|First Intervention|Progressive disease|2
6990771|NCT01306032|11050487|FG005|First Intervention|Progressive disease|0
6990772|NCT01306032|11050482|FG000|Disease Progression/Crossover|Withdrawal by Subject|0
6990773|NCT01306032|11050483|FG001|Disease Progression/Crossover|Withdrawal by Subject|0
6990774|NCT01306032|11050484|FG002|Disease Progression/Crossover|Withdrawal by Subject|0
6990775|NCT01306032|11050485|FG003|Disease Progression/Crossover|Withdrawal by Subject|1
6990776|NCT01306032|11050486|FG004|Disease Progression/Crossover|Withdrawal by Subject|0
6990777|NCT01306032|11050487|FG005|Disease Progression/Crossover|Withdrawal by Subject|0
6990778|NCT01306032|11050482|FG000|Disease Progression/Crossover|other/symptomatic progression|0
6990779|NCT01306032|11050483|FG001|Disease Progression/Crossover|other/symptomatic progression|2
6990780|NCT01306032|11050484|FG002|Disease Progression/Crossover|other/symptomatic progression|0
6990781|NCT01306032|11050485|FG003|Disease Progression/Crossover|other/symptomatic progression|2
6990782|NCT01306032|11050486|FG004|Disease Progression/Crossover|other/symptomatic progression|0
6990783|NCT01306032|11050487|FG005|Disease Progression/Crossover|other/symptomatic progression|0
6990784|NCT01306058|11050513|FG000|Overall Study|Death|1
6990785|NCT01306058|11050513|FG000|Overall Study|Enrolled but did not get treatment|1
6990786|NCT01306162|11050521|FG000|Period 1|Adverse Event|0
6990787|NCT01306162|11050522|FG001|Period 1|Adverse Event|0
6990788|NCT01306162|11050523|FG002|Period 1|Adverse Event|0
6990789|NCT01306162|11050524|FG003|Period 1|Adverse Event|1
6990790|NCT01306162|11050521|FG000|Washout 1|Non-compliance to protocol|0
6990791|NCT01306162|11050522|FG001|Washout 1|Non-compliance to protocol|1
6990792|NCT01306162|11050523|FG002|Washout 1|Non-compliance to protocol|0
6990793|NCT01306162|11050524|FG003|Washout 1|Non-compliance to protocol|0
6990794|NCT01306201|11050543|FG000|Overall Study|Arrhythmia|4
6990795|NCT01306201|11050543|FG000|Overall Study|Files could not be processed|3
6990796|NCT01306201|11050543|FG000|Overall Study|Files unreadable|3
6990797|NCT01306214|11050554|FG000|Overall Study|Death|0
6990798|NCT01306214|11050555|FG001|Overall Study|Death|0
6990799|NCT01306214|11050556|FG002|Overall Study|Death|1
6990800|NCT01306214|11050554|FG000|Overall Study|Lost to Follow-up|3
6990801|NCT01306214|11050555|FG001|Overall Study|Lost to Follow-up|5
6990802|NCT01306214|11050556|FG002|Overall Study|Lost to Follow-up|4
6990803|NCT01306214|11050554|FG000|Overall Study|Withdrawal by Subject|24
6990804|NCT01306214|11050555|FG001|Overall Study|Withdrawal by Subject|22
6990805|NCT01306214|11050556|FG002|Overall Study|Withdrawal by Subject|16
6990806|NCT01306214|11050554|FG000|Overall Study|Not treated|1
6990807|NCT01306214|11050555|FG001|Overall Study|Not treated|1
6990808|NCT01306214|11050556|FG002|Overall Study|Not treated|1
6990809|NCT01306253|11050566|FG000|Overall Study|Lost to Follow-up|1
6990810|NCT01306253|11050567|FG001|Overall Study|Lost to Follow-up|1
6990811|NCT01306305|11050588|FG000|Overall Study|Lost to Follow-up|1
6990812|NCT01306305|11050589|FG001|Overall Study|Lost to Follow-up|0
6990813|NCT01306305|11050588|FG000|Overall Study|Withdrew consent|1
6990814|NCT01306305|11050589|FG001|Overall Study|Withdrew consent|0
6990815|NCT01306331|11050597|FG000|Overall Study|Adverse Event|28
6990816|NCT01306331|11050598|FG001|Overall Study|Adverse Event|25
6990817|NCT01306331|11050597|FG000|Overall Study|Lost to Follow-up|321
6990818|NCT01306331|11050598|FG001|Overall Study|Lost to Follow-up|323
6990819|NCT01306331|11050597|FG000|Overall Study|Physician Decision|26
6990820|NCT01306331|11050598|FG001|Overall Study|Physician Decision|22
6990821|NCT01306331|11050597|FG000|Overall Study|Pregnancy|136
6990822|NCT01306331|11050598|FG001|Overall Study|Pregnancy|151
6990823|NCT01306331|11050597|FG000|Overall Study|Protocol Violation|154
6990824|NCT01306331|11050598|FG001|Overall Study|Protocol Violation|124
6990825|NCT01306331|11050597|FG000|Overall Study|Withdrawal by Subject|163
6990826|NCT01306331|11050598|FG001|Overall Study|Withdrawal by Subject|152
6990827|NCT01306331|11050597|FG000|Overall Study|Not sexually active|29
6990828|NCT01306331|11050598|FG001|Overall Study|Not sexually active|28
6990829|NCT01306331|11050597|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10
6990830|NCT01306331|11050598|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20
6990831|NCT01306331|11050597|FG000|Overall Study|Other|34
6990832|NCT01306331|11050598|FG001|Overall Study|Other|32
6990833|NCT01306617|11050607|FG000|Overall Study|Adverse Event|1
6990834|NCT01306617|11050608|FG001|Overall Study|Adverse Event|0
6990835|NCT01306617|11050609|FG002|Overall Study|Adverse Event|0
6990836|NCT01306617|11050607|FG000|Overall Study|Virologic Failure|0
6990837|NCT01306617|11050608|FG001|Overall Study|Virologic Failure|0
6990838|NCT01306617|11050609|FG002|Overall Study|Virologic Failure|5
6990839|NCT01306617|11050607|FG000|Overall Study|Non-compliance|0
6990840|NCT01306617|11050608|FG001|Overall Study|Non-compliance|1
6990841|NCT01306617|11050609|FG002|Overall Study|Non-compliance|0
6990842|NCT01306643|11050617|FG000|Overall Study|Adverse Event|5
6990843|NCT01306643|11050617|FG000|Overall Study|Disease Progression|7
6990844|NCT01306643|11050617|FG000|Overall Study|Other: Change in Eligibility Status|1
6990845|NCT01306656|11050623|FG000|Overall Study|Lost to Follow-up|1
6990846|NCT01306656|11050624|FG001|Overall Study|Lost to Follow-up|0
6990847|NCT01306877|11050634|FG000|Overall Study|Lost to Follow-up|3
6990848|NCT01306877|11050635|FG001|Overall Study|Lost to Follow-up|3
6990849|NCT01306877|11050634|FG000|Overall Study|Physician Decision|0
6990850|NCT01306877|11050635|FG001|Overall Study|Physician Decision|1
6990851|NCT01306890|11050641|FG000|Overall Study|Adverse Event|2
6990852|NCT01306890|11050641|FG000|Overall Study|Death|1223
6990853|NCT01306890|11050641|FG000|Overall Study|Lost to Follow-up|58
6990854|NCT01306890|11050641|FG000|Overall Study|Withdrawal by Subject|88
6990855|NCT01306890|11050641|FG000|Overall Study|Unspecified reasons|104
6990856|NCT01306890|11050641|FG000|Overall Study|Study Termination|3
6990857|NCT01306890|11050641|FG000|Overall Study|No discontinuation documentation|41
6990858|NCT01306942|11050648|FG000|Phase I|Adverse Event|2
6990859|NCT01306942|11050649|FG001|Phase I|Adverse Event|2
6990860|NCT01306942|11050650|FG002|Phase I|Adverse Event|0
6990861|NCT01306942|11050651|FG003|Phase I|Adverse Event|0
6990862|NCT01306942|11050648|FG000|Phase I|Physician Decision|3
6990863|NCT01306942|11050649|FG001|Phase I|Physician Decision|1
6990864|NCT01306942|11050650|FG002|Phase I|Physician Decision|0
6990865|NCT01306942|11050651|FG003|Phase I|Physician Decision|0
6990866|NCT01306942|11050648|FG000|Phase II|Adverse Event|0
6990867|NCT01306942|11050649|FG001|Phase II|Adverse Event|0
6990868|NCT01306942|11050650|FG002|Phase II|Adverse Event|0
6990869|NCT01306942|11050651|FG003|Phase II|Adverse Event|6
6990870|NCT01306942|11050648|FG000|Phase II|Physician Decision|2
6990871|NCT01306942|11050649|FG001|Phase II|Physician Decision|0
6990872|NCT01306942|11050650|FG002|Phase II|Physician Decision|0
6990873|NCT01306942|11050651|FG003|Phase II|Physician Decision|5
6990874|NCT01306942|11050648|FG000|Phase II|Withdrawal by Subject|0
6990875|NCT01306942|11050649|FG001|Phase II|Withdrawal by Subject|0
6990876|NCT01306942|11050650|FG002|Phase II|Withdrawal by Subject|0
6990877|NCT01306942|11050651|FG003|Phase II|Withdrawal by Subject|2
6990878|NCT01306942|11050648|FG000|Phase II|Death|0
6990879|NCT01306942|11050649|FG001|Phase II|Death|0
6990880|NCT01306942|11050650|FG002|Phase II|Death|0
6990881|NCT01306942|11050651|FG003|Phase II|Death|1
6990882|NCT01306942|11050648|FG000|Phase II|Not finished treatment|0
6990883|NCT01306942|11050649|FG001|Phase II|Not finished treatment|0
6990884|NCT01306942|11050650|FG002|Phase II|Not finished treatment|0
6990885|NCT01306942|11050651|FG003|Phase II|Not finished treatment|1
6990886|NCT01306942|11050648|FG000|Phase II|Protocol Violation|0
6990887|NCT01306942|11050649|FG001|Phase II|Protocol Violation|0
6990888|NCT01306942|11050650|FG002|Phase II|Protocol Violation|0
6990889|NCT01306942|11050651|FG003|Phase II|Protocol Violation|1
6990890|NCT01306968|11050667|FG000|Overall Study|Lost to Follow-up|1
6990891|NCT01306968|11050668|FG001|Overall Study|Lost to Follow-up|1
6990892|NCT01306968|11050669|FG002|Overall Study|Lost to Follow-up|0
6990893|NCT01306968|11050670|FG003|Overall Study|Lost to Follow-up|0
6990894|NCT01306968|11050667|FG000|Overall Study|Physician Decision|0
6990895|NCT01306968|11050668|FG001|Overall Study|Physician Decision|1
6990896|NCT01306968|11050669|FG002|Overall Study|Physician Decision|0
6990897|NCT01306968|11050670|FG003|Overall Study|Physician Decision|0
6990898|NCT01306968|11050667|FG000|Overall Study|Relocated and left active duty|0
6990899|NCT01306968|11050668|FG001|Overall Study|Relocated and left active duty|1
6990900|NCT01306968|11050669|FG002|Overall Study|Relocated and left active duty|1
6990901|NCT01306968|11050670|FG003|Overall Study|Relocated and left active duty|1
6990902|NCT01306968|11050667|FG000|Overall Study|Withdrew - time commitment|0
6990903|NCT01306968|11050668|FG001|Overall Study|Withdrew - time commitment|0
6990904|NCT01306968|11050669|FG002|Overall Study|Withdrew - time commitment|0
6990905|NCT01306968|11050670|FG003|Overall Study|Withdrew - time commitment|2
6990906|NCT01306968|11050667|FG000|Overall Study|Withdrew over privacy concerns|0
6990907|NCT01306968|11050668|FG001|Overall Study|Withdrew over privacy concerns|0
6990908|NCT01306968|11050669|FG002|Overall Study|Withdrew over privacy concerns|0
6990909|NCT01306968|11050670|FG003|Overall Study|Withdrew over privacy concerns|1
6990910|NCT01307020|11050701|FG000|Overall Study|Lost to Follow-up|0
6990911|NCT01307020|11050702|FG001|Overall Study|Lost to Follow-up|0
6990912|NCT01307020|11050703|FG002|Overall Study|Lost to Follow-up|1
6990913|NCT01307020|11050704|FG003|Overall Study|Lost to Follow-up|1
6990914|NCT01307020|11050705|FG004|Overall Study|Lost to Follow-up|0
6990915|NCT01307020|11050706|FG005|Overall Study|Lost to Follow-up|0
6990916|NCT01307020|11050707|FG006|Overall Study|Lost to Follow-up|1
6990917|NCT01307020|11050708|FG007|Overall Study|Lost to Follow-up|0
6990918|NCT01307020|11050709|FG008|Overall Study|Lost to Follow-up|0
6990919|NCT01307020|11050710|FG009|Overall Study|Lost to Follow-up|0
6990920|NCT01307020|11050701|FG000|Overall Study|Electronic data capture failure|0
6990921|NCT01307020|11050702|FG001|Overall Study|Electronic data capture failure|1
6990922|NCT01307020|11050703|FG002|Overall Study|Electronic data capture failure|0
6990923|NCT01307020|11050704|FG003|Overall Study|Electronic data capture failure|0
6990924|NCT01307020|11050705|FG004|Overall Study|Electronic data capture failure|0
6990925|NCT01307020|11050706|FG005|Overall Study|Electronic data capture failure|0
6990926|NCT01307020|11050707|FG006|Overall Study|Electronic data capture failure|0
6990927|NCT01307020|11050708|FG007|Overall Study|Electronic data capture failure|0
6990928|NCT01307020|11050709|FG008|Overall Study|Electronic data capture failure|0
6990929|NCT01307020|11050710|FG009|Overall Study|Electronic data capture failure|0
6990930|NCT01307111|11050748|FG000|IUD Insertion|Lost to Follow-up|2
6990931|NCT01307111|11050749|FG001|IUD Insertion|Lost to Follow-up|0
6990932|NCT01307111|11050748|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2
6990933|NCT01307111|11050749|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2
6990934|NCT01307267|11050778|FG000|Overall Study|Death|4
6990935|NCT01307267|11050779|FG001|Overall Study|Death|3
6990936|NCT01307267|11050780|FG002|Overall Study|Death|5
6990937|NCT01307267|11050781|FG003|Overall Study|Death|3
6990938|NCT01307267|11050782|FG004|Overall Study|Death|1
6990939|NCT01307267|11050783|FG005|Overall Study|Death|26
6990940|NCT01307267|11050784|FG006|Overall Study|Death|2
6990941|NCT01307267|11050785|FG007|Overall Study|Death|2
6990942|NCT01307267|11050786|FG008|Overall Study|Death|21
6990943|NCT01307267|11050787|FG009|Overall Study|Death|2
6990944|NCT01307267|11050788|FG010|Overall Study|Death|3
6990945|NCT01307267|11050789|FG011|Overall Study|Death|9
6990946|NCT01307267|11050790|FG012|Overall Study|Death|0
6990947|NCT01307267|11050791|FG013|Overall Study|Death|0
6990948|NCT01307267|11050792|FG014|Overall Study|Death|0
6990949|NCT01307267|11050793|FG015|Overall Study|Death|0
6990950|NCT01307267|11050794|FG016|Overall Study|Death|1
6990951|NCT01307267|11050795|FG017|Overall Study|Death|1
6990952|NCT01307267|11050796|FG018|Overall Study|Death|2
6990953|NCT01307267|11050797|FG019|Overall Study|Death|8
6990954|NCT01307267|11050798|FG020|Overall Study|Death|1
6990955|NCT01307267|11050799|FG021|Overall Study|Death|2
6990956|NCT01307267|11050800|FG022|Overall Study|Death|2
6990957|NCT01307267|11050778|FG000|Overall Study|Lost to Follow-up|0
6990958|NCT01307267|11050779|FG001|Overall Study|Lost to Follow-up|0
6990959|NCT01307267|11050780|FG002|Overall Study|Lost to Follow-up|0
6990960|NCT01307267|11050781|FG003|Overall Study|Lost to Follow-up|0
6990961|NCT01307267|11050782|FG004|Overall Study|Lost to Follow-up|0
6990962|NCT01307267|11050783|FG005|Overall Study|Lost to Follow-up|7
6990963|NCT01307267|11050784|FG006|Overall Study|Lost to Follow-up|0
6990964|NCT01307267|11050785|FG007|Overall Study|Lost to Follow-up|0
6990965|NCT01307267|11050786|FG008|Overall Study|Lost to Follow-up|1
6990966|NCT01307267|11050787|FG009|Overall Study|Lost to Follow-up|2
6990967|NCT01307267|11050788|FG010|Overall Study|Lost to Follow-up|1
6990968|NCT01307267|11050789|FG011|Overall Study|Lost to Follow-up|0
6990969|NCT01307267|11050790|FG012|Overall Study|Lost to Follow-up|0
6990970|NCT01307267|11050791|FG013|Overall Study|Lost to Follow-up|0
6990971|NCT01307267|11050792|FG014|Overall Study|Lost to Follow-up|0
6990972|NCT01307267|11050793|FG015|Overall Study|Lost to Follow-up|0
6990973|NCT01307267|11050794|FG016|Overall Study|Lost to Follow-up|0
6990974|NCT01307267|11050795|FG017|Overall Study|Lost to Follow-up|0
6990975|NCT01307267|11050796|FG018|Overall Study|Lost to Follow-up|0
6990976|NCT01307267|11050797|FG019|Overall Study|Lost to Follow-up|2
6990977|NCT01307267|11050798|FG020|Overall Study|Lost to Follow-up|0
6990978|NCT01307267|11050799|FG021|Overall Study|Lost to Follow-up|0
6990979|NCT01307267|11050800|FG022|Overall Study|Lost to Follow-up|0
6990980|NCT01307267|11050778|FG000|Overall Study|Withdrawal by Subject|0
6990981|NCT01307267|11050779|FG001|Overall Study|Withdrawal by Subject|0
6990982|NCT01307267|11050780|FG002|Overall Study|Withdrawal by Subject|0
6990983|NCT01307267|11050781|FG003|Overall Study|Withdrawal by Subject|0
6990984|NCT01307267|11050782|FG004|Overall Study|Withdrawal by Subject|0
6990985|NCT01307267|11050783|FG005|Overall Study|Withdrawal by Subject|1
6990986|NCT01307267|11050784|FG006|Overall Study|Withdrawal by Subject|0
6990987|NCT01307267|11050785|FG007|Overall Study|Withdrawal by Subject|1
6990988|NCT01307267|11050786|FG008|Overall Study|Withdrawal by Subject|5
6990989|NCT01307267|11050787|FG009|Overall Study|Withdrawal by Subject|1
6990990|NCT01307267|11050788|FG010|Overall Study|Withdrawal by Subject|1
6990991|NCT01307267|11050789|FG011|Overall Study|Withdrawal by Subject|1
6990992|NCT01307267|11050790|FG012|Overall Study|Withdrawal by Subject|0
6990993|NCT01307267|11050791|FG013|Overall Study|Withdrawal by Subject|0
6990994|NCT01307267|11050792|FG014|Overall Study|Withdrawal by Subject|0
6990995|NCT01307267|11050793|FG015|Overall Study|Withdrawal by Subject|0
6990996|NCT01307267|11050794|FG016|Overall Study|Withdrawal by Subject|0
6990997|NCT01307267|11050795|FG017|Overall Study|Withdrawal by Subject|0
6990998|NCT01307267|11050796|FG018|Overall Study|Withdrawal by Subject|0
6990999|NCT01307267|11050797|FG019|Overall Study|Withdrawal by Subject|3
6991000|NCT01307267|11050798|FG020|Overall Study|Withdrawal by Subject|0
6991001|NCT01307267|11050799|FG021|Overall Study|Withdrawal by Subject|0
6991002|NCT01307267|11050800|FG022|Overall Study|Withdrawal by Subject|0
6991003|NCT01307267|11050778|FG000|Overall Study|Other|0
6991004|NCT01307267|11050779|FG001|Overall Study|Other|0
6991005|NCT01307267|11050780|FG002|Overall Study|Other|0
6991006|NCT01307267|11050781|FG003|Overall Study|Other|0
6991007|NCT01307267|11050782|FG004|Overall Study|Other|0
6991008|NCT01307267|11050783|FG005|Overall Study|Other|7
6991009|NCT01307267|11050784|FG006|Overall Study|Other|0
6991010|NCT01307267|11050785|FG007|Overall Study|Other|1
6991011|NCT01307267|11050786|FG008|Overall Study|Other|3
6991012|NCT01307267|11050787|FG009|Overall Study|Other|0
6991013|NCT01307267|11050788|FG010|Overall Study|Other|1
6991014|NCT01307267|11050789|FG011|Overall Study|Other|1
6991015|NCT01307267|11050790|FG012|Overall Study|Other|1
6991016|NCT01307267|11050791|FG013|Overall Study|Other|0
6991017|NCT01307267|11050792|FG014|Overall Study|Other|2
6991018|NCT01307267|11050793|FG015|Overall Study|Other|1
6991019|NCT01307267|11050794|FG016|Overall Study|Other|0
6991020|NCT01307267|11050795|FG017|Overall Study|Other|0
6991021|NCT01307267|11050796|FG018|Overall Study|Other|0
6991022|NCT01307267|11050797|FG019|Overall Study|Other|19
6991023|NCT01307267|11050798|FG020|Overall Study|Other|2
6991024|NCT01307267|11050799|FG021|Overall Study|Other|3
6991025|NCT01307267|11050800|FG022|Overall Study|Other|2
6991026|NCT01307319|11050862|FG000|Overall Study|Adverse Event|2
6991027|NCT01307319|11050863|FG001|Overall Study|Adverse Event|2
6991028|NCT01307319|11050864|FG002|Overall Study|Adverse Event|1
6991029|NCT01307319|11050862|FG000|Overall Study|Lost to Follow-up|1
6991030|NCT01307319|11050863|FG001|Overall Study|Lost to Follow-up|0
6991031|NCT01307319|11050864|FG002|Overall Study|Lost to Follow-up|1
6991032|NCT01307319|11050862|FG000|Overall Study|Protocol Violation|1
6991033|NCT01307319|11050863|FG001|Overall Study|Protocol Violation|1
6991034|NCT01307319|11050864|FG002|Overall Study|Protocol Violation|0
6991035|NCT01307319|11050862|FG000|Overall Study|Withdrawal by Subject|0
6991036|NCT01307319|11050863|FG001|Overall Study|Withdrawal by Subject|1
6991037|NCT01307319|11050864|FG002|Overall Study|Withdrawal by Subject|2
6991038|NCT01307319|11050862|FG000|Overall Study|Other|0
6991039|NCT01307319|11050863|FG001|Overall Study|Other|4
6991040|NCT01307319|11050864|FG002|Overall Study|Other|3
6991041|NCT01307449|11050880|FG000|Overall Study|Adverse Event|1
6991042|NCT01307449|11050881|FG001|Overall Study|Adverse Event|0
6991043|NCT01307449|11050882|FG002|Overall Study|Adverse Event|0
6991044|NCT01307449|11050883|FG003|Overall Study|Adverse Event|0
6991045|NCT01307501|11050897|FG000|Overall Study|Treatment Failure|1
6991046|NCT01307501|11050897|FG000|Overall Study|Death|20
6991047|NCT01307501|11050897|FG000|Overall Study|Lost to Follow-up|1
6991048|NCT01307501|11050897|FG000|Overall Study|Starting Hospice|1
6991049|NCT01307579|11050903|FG000|Overall Study|Death|3
6991050|NCT01307579|11050904|FG001|Overall Study|Death|6
6991051|NCT01307579|11050903|FG000|Overall Study|Physician Decision|26
6991052|NCT01307579|11050904|FG001|Overall Study|Physician Decision|29
6991053|NCT01307579|11050903|FG000|Overall Study|Withdrawal by Subject|7
6991054|NCT01307579|11050904|FG001|Overall Study|Withdrawal by Subject|3
6991055|NCT01307579|11050903|FG000|Overall Study|Institutional diagnosis of IFD|21
6991056|NCT01307579|11050904|FG001|Overall Study|Institutional diagnosis of IFD|36
6991057|NCT01307579|11050903|FG000|Overall Study|Begin conditioning for HSCT|42
6991058|NCT01307579|11050904|FG001|Overall Study|Begin conditioning for HSCT|44
6991059|NCT01307579|11050903|FG000|Overall Study|Refractory or relapsed AML|38
6991060|NCT01307579|11050904|FG001|Overall Study|Refractory or relapsed AML|23
6991061|NCT01307579|11050903|FG000|Overall Study|Ineligible|3
6991062|NCT01307579|11050904|FG001|Overall Study|Ineligible|4
7042295|NCT01734785|11126667|FG000|Double-Blind Period|Adverse Event|0
7042296|NCT01734785|11126668|FG001|Double-Blind Period|Adverse Event|3
7042297|NCT01734785|11126669|FG002|Double-Blind Period|Adverse Event|2
7042298|NCT01734785|11126670|FG003|Double-Blind Period|Adverse Event|0
7042299|NCT01734785|11126667|FG000|Double-Blind Period|Lack of Efficacy|0
7042300|NCT01734785|11126668|FG001|Double-Blind Period|Lack of Efficacy|1
7042301|NCT01734785|11126669|FG002|Double-Blind Period|Lack of Efficacy|0
7042302|NCT01734785|11126670|FG003|Double-Blind Period|Lack of Efficacy|0
7042303|NCT01734785|11126667|FG000|Double-Blind Period|Protocol Violation|0
7042304|NCT01734785|11126668|FG001|Double-Blind Period|Protocol Violation|1
7042305|NCT01734785|11126669|FG002|Double-Blind Period|Protocol Violation|1
7042306|NCT01734785|11126670|FG003|Double-Blind Period|Protocol Violation|0
7042307|NCT01734785|11126667|FG000|Double-Blind Period|Lost to Follow-up|2
7042308|NCT01734785|11126668|FG001|Double-Blind Period|Lost to Follow-up|4
7042309|NCT01734785|11126669|FG002|Double-Blind Period|Lost to Follow-up|2
7042310|NCT01734785|11126670|FG003|Double-Blind Period|Lost to Follow-up|0
7042311|NCT01734785|11126667|FG000|Double-Blind Period|Withdrawal by Subject|2
7042312|NCT01734785|11126668|FG001|Double-Blind Period|Withdrawal by Subject|0
7042313|NCT01734785|11126669|FG002|Double-Blind Period|Withdrawal by Subject|0
7042314|NCT01734785|11126670|FG003|Double-Blind Period|Withdrawal by Subject|0
7042315|NCT01734785|11126667|FG000|Double-Blind Period|Not treated|1
7042316|NCT01734785|11126668|FG001|Double-Blind Period|Not treated|0
7042317|NCT01734785|11126669|FG002|Double-Blind Period|Not treated|0
7042318|NCT01734785|11126670|FG003|Double-Blind Period|Not treated|0
7042319|NCT01734811|11126681|FG000|Overall Study|Lost to Follow-up|2
7042320|NCT01734811|11126682|FG001|Overall Study|Lost to Follow-up|3
7042321|NCT01734811|11126681|FG000|Overall Study|Withdrawal by Subject|2
7042322|NCT01734811|11126682|FG001|Overall Study|Withdrawal by Subject|0
7042323|NCT01734850|11126691|FG000|Overall Study|Continued to Week 48 but recommenced ART|3
7042324|NCT01734850|11126692|FG001|Overall Study|Continued to Week 48 but recommenced ART|2
7042325|NCT01734850|11126693|FG002|Overall Study|Continued to Week 48 but recommenced ART|3
7042326|NCT01734850|11126691|FG000|Overall Study|Not infused due to manufacturing failure|0
7042327|NCT01734850|11126692|FG001|Overall Study|Not infused due to manufacturing failure|0
7042328|NCT01734850|11126693|FG002|Overall Study|Not infused due to manufacturing failure|1
7042329|NCT01734902|11126711|FG000|Overall Study|Other than listed|0
7042330|NCT01734902|11126712|FG001|Overall Study|Other than listed|2
7042331|NCT01734993|11126718|FG000|Overall Study|Adverse Event|1
7042332|NCT01734993|11126718|FG000|Overall Study|Lack of Efficacy|1
7042333|NCT01735175|11126725|FG000|Overall Study|Withdrawal by Subject|9
7042334|NCT01735175|11126726|FG001|Overall Study|Withdrawal by Subject|2
7042335|NCT01735175|11126725|FG000|Overall Study|Lost to Follow-up|4
7042336|NCT01735175|11126726|FG001|Overall Study|Lost to Follow-up|2
7042337|NCT01735175|11126725|FG000|Overall Study|Death|3
7042338|NCT01735175|11126726|FG001|Overall Study|Death|2
7042339|NCT01735175|11126725|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13
7042340|NCT01735175|11126726|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7
7042341|NCT01735201|11126740|FG000|Overall Study|Adverse Event|1
7042342|NCT01735201|11126741|FG001|Overall Study|Adverse Event|1
7042343|NCT01735201|11126742|FG002|Overall Study|Adverse Event|0
7042344|NCT01735201|11126743|FG003|Overall Study|Adverse Event|1
7042345|NCT01735201|11126744|FG004|Overall Study|Adverse Event|1
7042346|NCT01735201|11126745|FG005|Overall Study|Adverse Event|3
7042347|NCT01735201|11126746|FG006|Overall Study|Adverse Event|2
7042348|NCT01735201|11126747|FG007|Overall Study|Adverse Event|1
7042349|NCT01735201|11126740|FG000|Overall Study|Personal Reasons|1
7042350|NCT01735201|11126741|FG001|Overall Study|Personal Reasons|0
7042351|NCT01735201|11126742|FG002|Overall Study|Personal Reasons|0
7042352|NCT01735201|11126743|FG003|Overall Study|Personal Reasons|0
7042353|NCT01735201|11126744|FG004|Overall Study|Personal Reasons|0
7042354|NCT01735201|11126745|FG005|Overall Study|Personal Reasons|0
7042355|NCT01735201|11126746|FG006|Overall Study|Personal Reasons|0
7042356|NCT01735201|11126747|FG007|Overall Study|Personal Reasons|0
7042357|NCT01735201|11126740|FG000|Overall Study|Protocol Violation|1
7042358|NCT01735201|11126741|FG001|Overall Study|Protocol Violation|0
7042359|NCT01735201|11126742|FG002|Overall Study|Protocol Violation|0
7042360|NCT01735201|11126743|FG003|Overall Study|Protocol Violation|0
7042361|NCT01735201|11126744|FG004|Overall Study|Protocol Violation|0
7042362|NCT01735201|11126745|FG005|Overall Study|Protocol Violation|0
7042363|NCT01735201|11126746|FG006|Overall Study|Protocol Violation|0
7042364|NCT01735201|11126747|FG007|Overall Study|Protocol Violation|0
7042365|NCT01735201|11126740|FG000|Overall Study|Other Miscellaneous Reasons|0
7042366|NCT01735201|11126741|FG001|Overall Study|Other Miscellaneous Reasons|0
7042367|NCT01735201|11126742|FG002|Overall Study|Other Miscellaneous Reasons|0
7042368|NCT01735201|11126743|FG003|Overall Study|Other Miscellaneous Reasons|1
7042369|NCT01735201|11126744|FG004|Overall Study|Other Miscellaneous Reasons|0
7042370|NCT01735201|11126745|FG005|Overall Study|Other Miscellaneous Reasons|2
7042371|NCT01735201|11126746|FG006|Overall Study|Other Miscellaneous Reasons|1
7042372|NCT01735201|11126747|FG007|Overall Study|Other Miscellaneous Reasons|1
7042373|NCT01735279|11126771|FG000|Overall Study|Lost to Follow-up|11
7042374|NCT01735279|11126772|FG001|Overall Study|Lost to Follow-up|8
7042375|NCT01735396|11126778|FG000|Overall Study|not evaluable|1
6991063|NCT01307891|11050940|FG000|Overall Study|Progressive Disease|3
6991064|NCT01307891|11050941|FG001|Overall Study|Progressive Disease|1
6991065|NCT01308008|11050957|FG000|4 Weeks|Illness, disinterest, time|9
6991066|NCT01308008|11050958|FG001|4 Weeks|Illness, disinterest, time|2
6991067|NCT01308424|11050992|FG000|Baseline Eligibility|Screen Failures|71
6991068|NCT01308424|11050993|FG001|Baseline Eligibility|Screen Failures|0
6991069|NCT01308424|11050994|FG002|Baseline Eligibility|Screen Failures|0
6991070|NCT01308424|11050992|FG000|Randomization|Adverse Event|0
6991071|NCT01308424|11050993|FG001|Randomization|Adverse Event|1
6991072|NCT01308424|11050994|FG002|Randomization|Adverse Event|1
6991073|NCT01308424|11050992|FG000|Randomization|Lost to Follow-up|0
6991074|NCT01308424|11050993|FG001|Randomization|Lost to Follow-up|1
6991075|NCT01308424|11050994|FG002|Randomization|Lost to Follow-up|0
6991076|NCT01308424|11050992|FG000|Randomization|Physician Decision|0
6991077|NCT01308424|11050993|FG001|Randomization|Physician Decision|1
6991078|NCT01308424|11050994|FG002|Randomization|Physician Decision|1
6991079|NCT01308463|11051005|FG000|Overall Study|Study Discontinued|23
6991080|NCT01308463|11051005|FG000|Overall Study|Death|4
6991081|NCT01308463|11051005|FG000|Overall Study|Revision|2
6991082|NCT01308476|11051011|FG000|Overall Study|Lost to Follow-up|2
6991083|NCT01308476|11051012|FG001|Overall Study|Lost to Follow-up|2
6991084|NCT01308476|11051011|FG000|Overall Study|Other|1
6991085|NCT01308476|11051012|FG001|Overall Study|Other|0
6991086|NCT01308567|11051021|FG000|Overall Study|Lost to Follow-up|2
6991087|NCT01308567|11051022|FG001|Overall Study|Lost to Follow-up|4
6991088|NCT01308567|11051023|FG002|Overall Study|Lost to Follow-up|4
6991089|NCT01308580|11051033|FG000|Overall Study|Lost to Follow-up|12
6991090|NCT01308580|11051034|FG001|Overall Study|Lost to Follow-up|7
6991091|NCT01308736|11051054|FG000|Overall Study|Did not attend a single session|6
6991092|NCT01308736|11051055|FG001|Overall Study|Did not attend a single session|5
6991093|NCT01308749|11051063|FG000|Period 1: Double Blind Treatment|Adverse Event|1
6991094|NCT01308749|11051064|FG001|Period 1: Double Blind Treatment|Adverse Event|0
6991095|NCT01308749|11051063|FG000|Period 2: Open Label Treatment|Adverse Event|0
6991096|NCT01308749|11051064|FG001|Period 2: Open Label Treatment|Adverse Event|1
6991097|NCT01308749|11051063|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0
6991098|NCT01308749|11051064|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1
6991099|NCT01308762|11051087|FG000|Overall Study|Protocol Violation|0
6991100|NCT01308762|11051088|FG001|Overall Study|Protocol Violation|1
6991101|NCT01308762|11051089|FG002|Overall Study|Protocol Violation|0
6991102|NCT01308788|11051102|FG000|2-year Treatment|medication change by treating physician|4
6991103|NCT01308788|11051103|FG001|2-year Treatment|medication change by treating physician|11
6991104|NCT01308853|11051122|FG000|Overall Study|Adverse Event|1
6991105|NCT01308853|11051122|FG000|Overall Study|Lost to Follow-up|2
6991106|NCT01308853|11051122|FG000|Overall Study|Insertion of permanent implants|1
6991107|NCT01309100|11051130|FG000|Overall Study|Protocol Violation|1
6991108|NCT01309100|11051130|FG000|Overall Study|Positive Slit lamp finding|1
6991109|NCT01309165|11051139|FG000|Overall Study|Lost to Follow-up|4
6991110|NCT01309165|11051140|FG001|Overall Study|Lost to Follow-up|3
6991111|NCT01309165|11051139|FG000|Overall Study|Return to work|1
6991112|NCT01309165|11051140|FG001|Overall Study|Return to work|2
6991113|NCT01309165|11051139|FG000|Overall Study|Left country|0
6991114|NCT01309165|11051140|FG001|Overall Study|Left country|1
6991115|NCT01309165|11051139|FG000|Overall Study|No transportation|0
6991116|NCT01309165|11051140|FG001|Overall Study|No transportation|1
6991117|NCT01309165|11051139|FG000|Overall Study|Admitted to hospital for second stroke|1
6991118|NCT01309165|11051140|FG001|Overall Study|Admitted to hospital for second stroke|0
6991119|NCT01309204|11051149|FG000|Overall Study|Adverse Event|48
6991120|NCT01309204|11051150|FG001|Overall Study|Adverse Event|58
6991121|NCT01309204|11051149|FG000|Overall Study|Lost to Follow-up|2
6991122|NCT01309204|11051150|FG001|Overall Study|Lost to Follow-up|2
6991123|NCT01309204|11051149|FG000|Overall Study|Subject's decision unrelated to an AE|9
6991124|NCT01309204|11051150|FG001|Overall Study|Subject's decision unrelated to an AE|10
6991125|NCT01309204|11051149|FG000|Overall Study|Inadequate control of IOP|4
6991126|NCT01309204|11051150|FG001|Overall Study|Inadequate control of IOP|4
6991127|NCT01309204|11051149|FG000|Overall Study|Other|4
6991128|NCT01309204|11051150|FG001|Overall Study|Other|1
6991129|NCT01309243|11051158|FG000|Randomized Phase Through Week 96|Randomized but not treated|6
6991130|NCT01309243|11051159|FG001|Randomized Phase Through Week 96|Randomized but not treated|7
6991131|NCT01309243|11051158|FG000|Randomized Phase Through Week 96|Adverse Event|12
6991132|NCT01309243|11051159|FG001|Randomized Phase Through Week 96|Adverse Event|43
6991133|NCT01309243|11051158|FG000|Randomized Phase Through Week 96|Death|0
6991134|NCT01309243|11051159|FG001|Randomized Phase Through Week 96|Death|1
6991135|NCT01309243|11051158|FG000|Randomized Phase Through Week 96|Pregnancy|2
6991136|NCT01309243|11051159|FG001|Randomized Phase Through Week 96|Pregnancy|0
6991137|NCT01309243|11051158|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16
6991138|NCT01309243|11051159|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4
6991139|NCT01309243|11051158|FG000|Randomized Phase Through Week 96|Investigators Discretion|3
6991140|NCT01309243|11051159|FG001|Randomized Phase Through Week 96|Investigators Discretion|6
6991141|NCT01309243|11051158|FG000|Randomized Phase Through Week 96|Withdrew Consent|12
6991142|NCT01309243|11051159|FG001|Randomized Phase Through Week 96|Withdrew Consent|18
6991143|NCT01309243|11051158|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23
6991144|NCT01309243|11051159|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22
6991145|NCT01309243|11051158|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9
6991146|NCT01309243|11051159|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7
6991147|NCT01309243|11051158|FG000|Randomized Phase Through Week 96|Protocol Violation|1
6991148|NCT01309243|11051159|FG001|Randomized Phase Through Week 96|Protocol Violation|1
6991149|NCT01309243|11051158|FG000|Extension Phase|Lost to Follow-up|6
6991150|NCT01309243|11051159|FG001|Extension Phase|Lost to Follow-up|0
6991151|NCT01309269|11051165|FG000|Overall Study|Adverse Event|56
6991152|NCT01309269|11051165|FG000|Overall Study|Withdrawal by Subject|25
6991153|NCT01309269|11051165|FG000|Overall Study|Lack of Acceptance|15
6991154|NCT01309269|11051165|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119
6991155|NCT01309269|11051165|FG000|Overall Study|Kidney Transplant|25
6991156|NCT01309269|11051165|FG000|Overall Study|Administrative Problems|141
6991157|NCT01309269|11051165|FG000|Overall Study|Other|256
6991158|NCT01309269|11051165|FG000|Overall Study|Other|1
6991159|NCT01309269|11051165|FG000|Overall Study|Study Completion Data Not Recorded|95
6991160|NCT01309269|11051165|FG000|Overall Study|Enrolled but not Treated|107
6991161|NCT01309282|11051169|FG000|Overall Study|Lost to Follow-up|1
6991162|NCT01309308|11051175|FG000|Overall Study|Lost to Follow-up|6
6991163|NCT01309308|11051176|FG001|Overall Study|Lost to Follow-up|4
6991164|NCT01309386|11051197|FG000|Overall Study|Other|2
6991165|NCT01309386|11051198|FG001|Overall Study|Other|0
6991166|NCT01309386|11051197|FG000|Overall Study|Withdrawal by Subject|2
6991167|NCT01309386|11051198|FG001|Overall Study|Withdrawal by Subject|0
6991168|NCT01309386|11051197|FG000|Overall Study|Progressive disease|9
6991169|NCT01309386|11051198|FG001|Overall Study|Progressive disease|11
6991170|NCT01309386|11051197|FG000|Overall Study|Physician Decision|1
6991171|NCT01309386|11051198|FG001|Overall Study|Physician Decision|1
6991172|NCT01309386|11051197|FG000|Overall Study|Lack of Efficacy|3
6991173|NCT01309386|11051198|FG001|Overall Study|Lack of Efficacy|1
6991174|NCT01309386|11051197|FG000|Overall Study|Adverse Event|5
6991175|NCT01309386|11051198|FG001|Overall Study|Adverse Event|8
6991176|NCT01309659|11051226|FG000|Overall Study|Protocol Violation|0
6991177|NCT01309659|11051227|FG001|Overall Study|Protocol Violation|1
6991178|NCT01309737|11051236|FG000|Week 0 to 16|Death|1
6991179|NCT01309737|11051237|FG001|Week 0 to 16|Death|0
6991180|NCT01309737|11051238|FG002|Week 0 to 16|Death|1
6991181|NCT01309737|11051239|FG003|Week 0 to 16|Death|0
6991182|NCT01309737|11051240|FG004|Week 0 to 16|Death|0
6991183|NCT01309737|11051236|FG000|Week 0 to 16|Adverse Event|11
6991184|NCT01309737|11051237|FG001|Week 0 to 16|Adverse Event|10
6991185|NCT01309737|11051238|FG002|Week 0 to 16|Adverse Event|5
6991186|NCT01309737|11051239|FG003|Week 0 to 16|Adverse Event|0
6991187|NCT01309737|11051240|FG004|Week 0 to 16|Adverse Event|0
6991188|NCT01309737|11051236|FG000|Week 0 to 16|Lack of Efficacy|15
6991189|NCT01309737|11051237|FG001|Week 0 to 16|Lack of Efficacy|2
6991190|NCT01309737|11051238|FG002|Week 0 to 16|Lack of Efficacy|24
6991191|NCT01309737|11051239|FG003|Week 0 to 16|Lack of Efficacy|0
6991192|NCT01309737|11051240|FG004|Week 0 to 16|Lack of Efficacy|0
6991193|NCT01309737|11051236|FG000|Week 0 to 16|Lost to Follow-up|7
6991194|NCT01309737|11051237|FG001|Week 0 to 16|Lost to Follow-up|8
6991195|NCT01309737|11051238|FG002|Week 0 to 16|Lost to Follow-up|3
6991196|NCT01309737|11051239|FG003|Week 0 to 16|Lost to Follow-up|0
6991197|NCT01309737|11051240|FG004|Week 0 to 16|Lost to Follow-up|0
6991198|NCT01309737|11051236|FG000|Week 0 to 16|Withdrawal by Subject|7
6991199|NCT01309737|11051237|FG001|Week 0 to 16|Withdrawal by Subject|6
6991200|NCT01309737|11051238|FG002|Week 0 to 16|Withdrawal by Subject|7
6991201|NCT01309737|11051239|FG003|Week 0 to 16|Withdrawal by Subject|0
6991202|NCT01309737|11051240|FG004|Week 0 to 16|Withdrawal by Subject|0
6991203|NCT01309737|11051236|FG000|Week 0 to 16|Other|10
6991204|NCT01309737|11051237|FG001|Week 0 to 16|Other|14
6991205|NCT01309737|11051238|FG002|Week 0 to 16|Other|4
6991206|NCT01309737|11051239|FG003|Week 0 to 16|Other|0
6991207|NCT01309737|11051240|FG004|Week 0 to 16|Other|0
6991208|NCT01309737|11051236|FG000|Week 0 to 16|Randomized, but not treated|1
6991209|NCT01309737|11051237|FG001|Week 0 to 16|Randomized, but not treated|0
6991210|NCT01309737|11051238|FG002|Week 0 to 16|Randomized, but not treated|0
6991211|NCT01309737|11051239|FG003|Week 0 to 16|Randomized, but not treated|0
6991212|NCT01309737|11051240|FG004|Week 0 to 16|Randomized, but not treated|0
6991213|NCT01309737|11051236|FG000|Week 16 to 52|Death|0
6991214|NCT01309737|11051237|FG001|Week 16 to 52|Death|0
6991215|NCT01309737|11051238|FG002|Week 16 to 52|Death|0
6991216|NCT01309737|11051239|FG003|Week 16 to 52|Death|0
6991217|NCT01309737|11051240|FG004|Week 16 to 52|Death|1
6991218|NCT01309737|11051236|FG000|Week 16 to 52|Adverse Event|7
6991219|NCT01309737|11051237|FG001|Week 16 to 52|Adverse Event|7
6991220|NCT01309737|11051238|FG002|Week 16 to 52|Adverse Event|0
6991221|NCT01309737|11051239|FG003|Week 16 to 52|Adverse Event|6
6991222|NCT01309737|11051240|FG004|Week 16 to 52|Adverse Event|5
6991223|NCT01309737|11051236|FG000|Week 16 to 52|Lack of Efficacy|107
6991224|NCT01309737|11051237|FG001|Week 16 to 52|Lack of Efficacy|76
6991225|NCT01309737|11051238|FG002|Week 16 to 52|Lack of Efficacy|0
6991226|NCT01309737|11051239|FG003|Week 16 to 52|Lack of Efficacy|25
6991227|NCT01309737|11051240|FG004|Week 16 to 52|Lack of Efficacy|21
6991228|NCT01309737|11051236|FG000|Week 16 to 52|Lost to Follow-up|4
6991229|NCT01309737|11051237|FG001|Week 16 to 52|Lost to Follow-up|2
6991230|NCT01309737|11051238|FG002|Week 16 to 52|Lost to Follow-up|0
6991231|NCT01309737|11051239|FG003|Week 16 to 52|Lost to Follow-up|1
6991232|NCT01309737|11051240|FG004|Week 16 to 52|Lost to Follow-up|4
6991233|NCT01309737|11051236|FG000|Week 16 to 52|Withdrawal by Subject|5
6991234|NCT01309737|11051237|FG001|Week 16 to 52|Withdrawal by Subject|6
6991235|NCT01309737|11051238|FG002|Week 16 to 52|Withdrawal by Subject|0
6991236|NCT01309737|11051239|FG003|Week 16 to 52|Withdrawal by Subject|0
6991237|NCT01309737|11051240|FG004|Week 16 to 52|Withdrawal by Subject|2
6991238|NCT01309737|11051236|FG000|Week 16 to 52|Other|10
6991239|NCT01309737|11051237|FG001|Week 16 to 52|Other|12
6991240|NCT01309737|11051238|FG002|Week 16 to 52|Other|0
6991241|NCT01309737|11051239|FG003|Week 16 to 52|Other|2
6991242|NCT01309737|11051240|FG004|Week 16 to 52|Other|0
6991243|NCT01309828|11051274|FG000|Overall Study|Adverse Event|10
6991244|NCT01309828|11051275|FG001|Overall Study|Adverse Event|11
6991245|NCT01309828|11051274|FG000|Overall Study|Voluntary Withdrawal|5
6991246|NCT01309828|11051275|FG001|Overall Study|Voluntary Withdrawal|4
6991247|NCT01309828|11051274|FG000|Overall Study|Major Protocol Deviation|0
6991248|NCT01309828|11051275|FG001|Overall Study|Major Protocol Deviation|1
6991249|NCT01309828|11051274|FG000|Overall Study|Other|1
6991250|NCT01309828|11051275|FG001|Overall Study|Other|0
6991251|NCT01309841|11051284|FG000|Overall Study|Other|0
6991252|NCT01309841|11051285|FG001|Overall Study|Other|1
6991253|NCT01309841|11051286|FG002|Overall Study|Other|1
6991254|NCT01309841|11051284|FG000|Overall Study|Lost to Follow-up|7
6991255|NCT01309841|11051285|FG001|Overall Study|Lost to Follow-up|6
6991256|NCT01309841|11051286|FG002|Overall Study|Lost to Follow-up|4
6991257|NCT01309841|11051284|FG000|Overall Study|Study-Specific Withdrawal Criteria|3
6991258|NCT01309841|11051285|FG001|Overall Study|Study-Specific Withdrawal Criteria|1
6991259|NCT01309841|11051286|FG002|Overall Study|Study-Specific Withdrawal Criteria|2
6991260|NCT01309841|11051284|FG000|Overall Study|Lack of Efficacy|0
6991261|NCT01309841|11051285|FG001|Overall Study|Lack of Efficacy|0
6991262|NCT01309841|11051286|FG002|Overall Study|Lack of Efficacy|2
6991263|NCT01309841|11051284|FG000|Overall Study|Adverse Event|9
6991264|NCT01309841|11051285|FG001|Overall Study|Adverse Event|22
6991265|NCT01309841|11051286|FG002|Overall Study|Adverse Event|11
6991266|NCT01309841|11051284|FG000|Overall Study|Death|1
6991267|NCT01309841|11051285|FG001|Overall Study|Death|0
6991268|NCT01309841|11051286|FG002|Overall Study|Death|0
6991269|NCT01309841|11051284|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0
6991270|NCT01309841|11051285|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0
6991271|NCT01309841|11051286|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1
6991272|NCT01309841|11051284|FG000|Overall Study|Withdrawal by Subject|17
6991273|NCT01309841|11051285|FG001|Overall Study|Withdrawal by Subject|6
6991274|NCT01309841|11051286|FG002|Overall Study|Withdrawal by Subject|13
6991275|NCT01309841|11051284|FG000|Overall Study|Did Not Receive Treatment|2
6991276|NCT01309841|11051285|FG001|Overall Study|Did Not Receive Treatment|0
6991277|NCT01309841|11051286|FG002|Overall Study|Did Not Receive Treatment|1
6991278|NCT01309841|11051284|FG000|Overall Study|Severe non-compliance with protocol|0
6991279|NCT01309841|11051285|FG001|Overall Study|Severe non-compliance with protocol|5
6991280|NCT01309841|11051286|FG002|Overall Study|Severe non-compliance with protocol|2
6991281|NCT01309893|11051308|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1
6991282|NCT01309893|11051309|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0
6991283|NCT01309893|11051308|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0
6991284|NCT01309893|11051309|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1
6991285|NCT01309919|11051324|FG000|Overall Study|Did not receive a postpartum IUD|17
6991286|NCT01309919|11051325|FG001|Overall Study|Did not receive a postpartum IUD|48
6991287|NCT01309997|11051333|FG000|Overall Study|Adverse Event|1
6991288|NCT01309997|11051334|FG001|Overall Study|Adverse Event|0
6991289|NCT01309997|11051333|FG000|Overall Study|Death|1
6991290|NCT01309997|11051334|FG001|Overall Study|Death|3
6991291|NCT01309997|11051333|FG000|Overall Study|Lack of Efficacy|2
6991292|NCT01309997|11051334|FG001|Overall Study|Lack of Efficacy|2
6991293|NCT01309997|11051333|FG000|Overall Study|Withdrawal by Subject|1
6991294|NCT01309997|11051334|FG001|Overall Study|Withdrawal by Subject|1
6991295|NCT01310036|11051351|FG000|Overall Study|Administrative/other|10
6991296|NCT01310036|11051351|FG000|Overall Study|Withdrew Consent|11
6991297|NCT01310036|11051351|FG000|Overall Study|Refused Treatment/Did not Cooperate|4
6991298|NCT01310036|11051351|FG000|Overall Study|Progression of Disease|164
6991299|NCT01310036|11051351|FG000|Overall Study|Death|1
6991300|NCT01310036|11051351|FG000|Overall Study|Adverse event or intercurrent illness|12
6991301|NCT01310075|11051357|FG000|Overall Study|Lost to Follow-up|1
6991302|NCT01310075|11051358|FG001|Overall Study|Lost to Follow-up|0
6991303|NCT01310075|11051357|FG000|Overall Study|Physician Decision|10
6991304|NCT01310075|11051358|FG001|Overall Study|Physician Decision|7
6991305|NCT01310075|11051357|FG000|Overall Study|Protocol Violation|2
6991306|NCT01310075|11051358|FG001|Overall Study|Protocol Violation|2
6991307|NCT01310075|11051357|FG000|Overall Study|Withdrawal by Subject|1
6991308|NCT01310075|11051358|FG001|Overall Study|Withdrawal by Subject|1
6991309|NCT01310127|11051366|FG000|Overall Study|Protocol Violation|1
6991310|NCT01310127|11051367|FG001|Overall Study|Protocol Violation|1
6991311|NCT01310127|11051366|FG000|Overall Study|advanced psc cataract outlier|1
6991312|NCT01310127|11051367|FG001|Overall Study|advanced psc cataract outlier|0
6991313|NCT01310413|11051408|FG000|Day 0 to Day 385|Withdrawal by Subject|5
6991314|NCT01310413|11051409|FG001|Day 0 to Day 385|Withdrawal by Subject|2
6991315|NCT01310413|11051410|FG002|Day 0 to Day 385|Withdrawal by Subject|0
6991316|NCT01310413|11051411|FG003|Day 0 to Day 385|Withdrawal by Subject|2
6991317|NCT01310413|11051412|FG004|Day 0 to Day 385|Withdrawal by Subject|1
6991318|NCT01310413|11051413|FG005|Day 0 to Day 385|Withdrawal by Subject|1
6991319|NCT01310413|11051414|FG006|Day 0 to Day 385|Withdrawal by Subject|0
6991320|NCT01310413|11051408|FG000|Day 0 to Day 385|Lost to Follow-up|18
6991321|NCT01310413|11051409|FG001|Day 0 to Day 385|Lost to Follow-up|3
6991322|NCT01310413|11051410|FG002|Day 0 to Day 385|Lost to Follow-up|3
6991323|NCT01310413|11051411|FG003|Day 0 to Day 385|Lost to Follow-up|5
6991324|NCT01310413|11051412|FG004|Day 0 to Day 385|Lost to Follow-up|1
6991325|NCT01310413|11051413|FG005|Day 0 to Day 385|Lost to Follow-up|2
6991326|NCT01310413|11051414|FG006|Day 0 to Day 385|Lost to Follow-up|0
6991327|NCT01310413|11051408|FG000|Day 0 to Day 385|Migrated/moved from study area|3
6991328|NCT01310413|11051409|FG001|Day 0 to Day 385|Migrated/moved from study area|3
6991329|NCT01310413|11051410|FG002|Day 0 to Day 385|Migrated/moved from study area|1
6991330|NCT01310413|11051411|FG003|Day 0 to Day 385|Migrated/moved from study area|1
6991331|NCT01310413|11051412|FG004|Day 0 to Day 385|Migrated/moved from study area|1
6991332|NCT01310413|11051413|FG005|Day 0 to Day 385|Migrated/moved from study area|0
6991333|NCT01310413|11051414|FG006|Day 0 to Day 385|Migrated/moved from study area|0
6991334|NCT01310413|11051408|FG000|Day 0 to Day 385|Other|1
6991335|NCT01310413|11051409|FG001|Day 0 to Day 385|Other|0
6991336|NCT01310413|11051410|FG002|Day 0 to Day 385|Other|3
6991337|NCT01310413|11051411|FG003|Day 0 to Day 385|Other|0
6991338|NCT01310413|11051412|FG004|Day 0 to Day 385|Other|0
6991339|NCT01310413|11051413|FG005|Day 0 to Day 385|Other|0
6991340|NCT01310413|11051414|FG006|Day 0 to Day 385|Other|0
6991341|NCT01310413|11051408|FG000|From Day U0 to Day U385|Withdrawal by Subject|0
6991342|NCT01310413|11051409|FG001|From Day U0 to Day U385|Withdrawal by Subject|0
6991343|NCT01310413|11051410|FG002|From Day U0 to Day U385|Withdrawal by Subject|0
6991344|NCT01310413|11051411|FG003|From Day U0 to Day U385|Withdrawal by Subject|0
6991345|NCT01310413|11051412|FG004|From Day U0 to Day U385|Withdrawal by Subject|0
6991346|NCT01310413|11051413|FG005|From Day U0 to Day U385|Withdrawal by Subject|0
6991347|NCT01310413|11051414|FG006|From Day U0 to Day U385|Withdrawal by Subject|1
6991348|NCT01310413|11051408|FG000|From Day U0 to Day U385|Lost to Follow-up|0
6991349|NCT01310413|11051409|FG001|From Day U0 to Day U385|Lost to Follow-up|0
6991350|NCT01310413|11051410|FG002|From Day U0 to Day U385|Lost to Follow-up|0
6991351|NCT01310413|11051411|FG003|From Day U0 to Day U385|Lost to Follow-up|0
6991352|NCT01310413|11051412|FG004|From Day U0 to Day U385|Lost to Follow-up|0
6991353|NCT01310413|11051413|FG005|From Day U0 to Day U385|Lost to Follow-up|0
6991354|NCT01310413|11051414|FG006|From Day U0 to Day U385|Lost to Follow-up|2
6991355|NCT01310699|11051454|FG000|Overall Study|Patients did not complete tandem.|4
6991356|NCT01310699|11051455|FG001|Overall Study|Patients did not complete tandem.|6
6991357|NCT01310777|11051466|FG000|Overall Study|Adverse Event|23
6991358|NCT01310777|11051467|FG001|Overall Study|Adverse Event|1
6991359|NCT01310777|11051468|FG002|Overall Study|Adverse Event|15
6991360|NCT01310777|11051466|FG000|Overall Study|Lost to Follow-up|0
6991361|NCT01310777|11051467|FG001|Overall Study|Lost to Follow-up|4
6991362|NCT01310777|11051468|FG002|Overall Study|Lost to Follow-up|1
6991363|NCT01310777|11051466|FG000|Overall Study|Patient's Decision Unrelated to AE|1
6991364|NCT01310777|11051467|FG001|Overall Study|Patient's Decision Unrelated to AE|1
6991365|NCT01310777|11051468|FG002|Overall Study|Patient's Decision Unrelated to AE|2
6991366|NCT01310777|11051466|FG000|Overall Study|Inadequate Control of IOP|5
6991367|NCT01310777|11051467|FG001|Overall Study|Inadequate Control of IOP|7
6991368|NCT01310777|11051468|FG002|Overall Study|Inadequate Control of IOP|10
6991369|NCT01310777|11051466|FG000|Overall Study|Other|4
6991370|NCT01310777|11051467|FG001|Overall Study|Other|1
6991371|NCT01310777|11051468|FG002|Overall Study|Other|2
6991372|NCT01310868|11051485|FG000|Overall Study|Do not have histologically confirmed GBM|13
6991373|NCT01311024|11051491|FG000|Overall Study|Protocol Violation|35
6991374|NCT01311024|11051492|FG001|Overall Study|Protocol Violation|22
6991375|NCT01311505|11051518|FG000|First Intervention Period|Protocol Violation|0
6991376|NCT01311505|11051519|FG001|First Intervention Period|Protocol Violation|1
6991377|NCT01311557|11051530|FG000|Overall Study|Serious adverse event|0
6991378|NCT01311557|11051531|FG001|Overall Study|Serious adverse event|1
6991379|NCT01311557|11051530|FG000|Overall Study|Protocol Violation|4
6991380|NCT01311557|11051531|FG001|Overall Study|Protocol Violation|2
6991381|NCT01311557|11051530|FG000|Overall Study|Lost to Follow-up|0
6991382|NCT01311557|11051531|FG001|Overall Study|Lost to Follow-up|1
6991383|NCT01311557|11051530|FG000|Overall Study|Withdrawal by Subject|1
6991384|NCT01311557|11051531|FG001|Overall Study|Withdrawal by Subject|2
6991385|NCT01311648|11051540|FG000|Main Study|Protocol Violation|0
6991386|NCT01311648|11051541|FG001|Main Study|Protocol Violation|1
6991387|NCT01311648|11051540|FG000|Main Study|Adverse Event|0
6991388|NCT01311648|11051541|FG001|Main Study|Adverse Event|1
6991389|NCT01311648|11051540|FG000|Main Study|Inhibitor management|0
6991390|NCT01311648|11051541|FG001|Main Study|Inhibitor management|17
6991391|NCT01311648|11051540|FG000|Main Study|Withdrawal by Subject|0
6991392|NCT01311648|11051541|FG001|Main Study|Withdrawal by Subject|2
6991393|NCT01311648|11051540|FG000|Extension Study|Physician Decision|0
6991394|NCT01311648|11051541|FG001|Extension Study|Physician Decision|1
6991395|NCT01311648|11051540|FG000|Extension Study|ITI therapy with marketed product|0
6991396|NCT01311648|11051541|FG001|Extension Study|ITI therapy with marketed product|1
6991397|NCT01311648|11051540|FG000|Extension Study|Incorrect visit planning|0
6991398|NCT01311648|11051541|FG001|Extension Study|Incorrect visit planning|1
6991399|NCT01311648|11051540|FG000|Extension Study|Family's decision|0
6991400|NCT01311648|11051541|FG001|Extension Study|Family's decision|1
6991401|NCT01311648|11051540|FG000|Extension Study|Failure of ITI therapy|0
6991402|NCT01311648|11051541|FG001|Extension Study|Failure of ITI therapy|3
6991403|NCT01311648|11051540|FG000|Extension Study|Long travel|0
6991404|NCT01311648|11051541|FG001|Extension Study|Long travel|1
6991405|NCT01311648|11051540|FG000|Extension Study|Diagnosed with von Willebrand disease|1
6991406|NCT01311648|11051541|FG001|Extension Study|Diagnosed with von Willebrand disease|0
6991407|NCT01311648|11051540|FG000|Extension Study|Withdrawal by Subject|0
6991408|NCT01311648|11051541|FG001|Extension Study|Withdrawal by Subject|1
6991409|NCT01311648|11051540|FG000|Extension Study|Inhibitor management|0
6991410|NCT01311648|11051541|FG001|Extension Study|Inhibitor management|2
6991411|NCT01311661|11051554|FG000|Overall Study|Adverse Event|2
6991412|NCT01311661|11051554|FG000|Overall Study|Protocol Violation|3
6991413|NCT01311661|11051554|FG000|Overall Study|Withdrawal by Subject|2
6991414|NCT01312129|11051608|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0
6991415|NCT01312129|11051609|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1
6991416|NCT01312467|11051663|FG000|Overall Study|Adverse Event|4
6991417|NCT01312467|11051663|FG000|Overall Study|Lost to Follow-up|1
6991418|NCT01312467|11051663|FG000|Overall Study|Withdrawal by Subject|2
6991419|NCT01312467|11051663|FG000|Overall Study|Deported to country of origin|1
6991420|NCT01312467|11051663|FG000|Overall Study|Another medical condition|1
6991421|NCT01312467|11051663|FG000|Overall Study|Ineligible|4
6991422|NCT01312779|11051695|FG000|Overall Study|Withdrawal by Subject|2
6991423|NCT01312779|11051695|FG000|Overall Study|Death|3
6991424|NCT01312779|11051695|FG000|Overall Study|Not Implanted with Device|27
6991425|NCT01312909|11051735|FG000|Overall Study|Randomized but not treated|1
6991426|NCT01312909|11051736|FG001|Overall Study|Randomized but not treated|3
7143141|NCT03026283|11299465|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1
7143142|NCT03026283|11299466|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
6991427|NCT01312909|11051737|FG002|Overall Study|Randomized but not treated|1
6991428|NCT01312909|11051735|FG000|Overall Study|Adverse Event|1
6991429|NCT01312909|11051736|FG001|Overall Study|Adverse Event|0
6991430|NCT01312909|11051737|FG002|Overall Study|Adverse Event|3
6991431|NCT01312909|11051735|FG000|Overall Study|Protocol Violation|2
6991432|NCT01312909|11051736|FG001|Overall Study|Protocol Violation|0
6991433|NCT01312909|11051737|FG002|Overall Study|Protocol Violation|2
6991434|NCT01312909|11051735|FG000|Overall Study|Other|9
6991435|NCT01312909|11051736|FG001|Overall Study|Other|6
6991436|NCT01312909|11051737|FG002|Overall Study|Other|11
6991437|NCT01312909|11051735|FG000|Overall Study|Withdrawal by Subject|8
6991438|NCT01312909|11051736|FG001|Overall Study|Withdrawal by Subject|10
6991439|NCT01312909|11051737|FG002|Overall Study|Withdrawal by Subject|7
6991440|NCT01312909|11051735|FG000|Overall Study|Lost to Follow-up|21
6991441|NCT01312909|11051736|FG001|Overall Study|Lost to Follow-up|17
6991442|NCT01312909|11051737|FG002|Overall Study|Lost to Follow-up|20
6991443|NCT01312909|11051735|FG000|Overall Study|Insufficient clinical response|0
6991444|NCT01312909|11051736|FG001|Overall Study|Insufficient clinical response|0
6991445|NCT01312909|11051737|FG002|Overall Study|Insufficient clinical response|1
6991446|NCT01312909|11051735|FG000|Overall Study|Entrance criteria not met|0
6991447|NCT01312909|11051736|FG001|Overall Study|Entrance criteria not met|0
6991448|NCT01312909|11051737|FG002|Overall Study|Entrance criteria not met|2
6991449|NCT01312961|11051754|FG000|Overall Study|Adverse Event|3
6991450|NCT01312961|11051755|FG001|Overall Study|Adverse Event|3
6991451|NCT01312961|11051754|FG000|Overall Study|Lack of Efficacy|11
6991452|NCT01312961|11051755|FG001|Overall Study|Lack of Efficacy|1
6991453|NCT01312961|11051754|FG000|Overall Study|Poor compliance to protocol|1
6991454|NCT01312961|11051755|FG001|Overall Study|Poor compliance to protocol|0
6991455|NCT01312961|11051754|FG000|Overall Study|Other than specified above|2
6991456|NCT01312961|11051755|FG001|Overall Study|Other than specified above|3
6991457|NCT01313039|11051762|FG000|Overall Study|Physician Decision|1
6991458|NCT01313039|11051762|FG000|Overall Study|Adverse Event|1
6991459|NCT01313078|11051766|FG000|Overall Study|Death|1
6991460|NCT01313078|11051766|FG000|Overall Study|Discontinued study drug|1
6991461|NCT01313078|11051766|FG000|Overall Study|Withdrawal by Subject|1
6991462|NCT01313117|11051770|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
6991463|NCT01313117|11051770|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
6991464|NCT01313182|11051777|FG000|Overall Study|Protocol Violation|66
6991465|NCT01313182|11051778|FG001|Overall Study|Protocol Violation|92
6991466|NCT01313208|11051786|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3
6991467|NCT01313208|11051787|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2
6991468|NCT01313208|11051786|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1
6991469|NCT01313208|11051787|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2
6991470|NCT01313208|11051786|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0
6991471|NCT01313208|11051787|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1
6991472|NCT01313208|11051786|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1
6991473|NCT01313208|11051787|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0
6991474|NCT01313208|11051786|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1
6991475|NCT01313208|11051787|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0
6991476|NCT01313208|11051786|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3
6991477|NCT01313208|11051787|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1
6991478|NCT01313208|11051786|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0
6991479|NCT01313208|11051787|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2
6991480|NCT01313208|11051786|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1
6991481|NCT01313208|11051787|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0
6991482|NCT01313208|11051786|FG000|Open-label Phase (Weeks 13 - 24)|Other|2
6991483|NCT01313208|11051787|FG001|Open-label Phase (Weeks 13 - 24)|Other|0
6991484|NCT01313221|11051798|FG000|Overall Study|Protocol Violation|0
6991485|NCT01313221|11051799|FG001|Overall Study|Protocol Violation|1
6991486|NCT01313221|11051800|FG002|Overall Study|Protocol Violation|1
6991487|NCT01313221|11051798|FG000|Overall Study|Non-compliance|3
6991488|NCT01313221|11051799|FG001|Overall Study|Non-compliance|0
6991489|NCT01313221|11051800|FG002|Overall Study|Non-compliance|2
6991490|NCT01313221|11051798|FG000|Overall Study|Withdrawal by Subject|2
6991491|NCT01313221|11051799|FG001|Overall Study|Withdrawal by Subject|3
6991492|NCT01313221|11051800|FG002|Overall Study|Withdrawal by Subject|5
6991493|NCT01313221|11051798|FG000|Overall Study|Requirement for alternative therapy|0
6991494|NCT01313221|11051799|FG001|Overall Study|Requirement for alternative therapy|1
6991495|NCT01313221|11051800|FG002|Overall Study|Requirement for alternative therapy|1
6991496|NCT01313221|11051798|FG000|Overall Study|Lost to Follow-up|6
6991497|NCT01313221|11051799|FG001|Overall Study|Lost to Follow-up|3
6991498|NCT01313221|11051800|FG002|Overall Study|Lost to Follow-up|1
6991499|NCT01313221|11051798|FG000|Overall Study|Other|1
6991500|NCT01313221|11051799|FG001|Overall Study|Other|0
6991501|NCT01313221|11051800|FG002|Overall Study|Other|0
6991502|NCT01313221|11051798|FG000|Overall Study|Adverse Event|0
6991503|NCT01313221|11051799|FG001|Overall Study|Adverse Event|0
6991504|NCT01313221|11051800|FG002|Overall Study|Adverse Event|7
6991505|NCT01313221|11051798|FG000|Overall Study|Disease progression|0
6991506|NCT01313221|11051799|FG001|Overall Study|Disease progression|0
6991507|NCT01313221|11051800|FG002|Overall Study|Disease progression|2
6991508|NCT01313221|11051798|FG000|Overall Study|Physician Decision|0
6991509|NCT01313221|11051799|FG001|Overall Study|Physician Decision|0
6991510|NCT01313221|11051800|FG002|Overall Study|Physician Decision|2
6991511|NCT01313221|11051798|FG000|Overall Study|Pregnancy|0
6991512|NCT01313221|11051799|FG001|Overall Study|Pregnancy|0
6991513|NCT01313221|11051800|FG002|Overall Study|Pregnancy|2
6991514|NCT01313286|11051808|FG000|Period 1|Withdrawal by Subject|2
6991515|NCT01313286|11051809|FG001|Period 1|Withdrawal by Subject|0
6991516|NCT01313299|11051818|FG000|Overall Study|Adverse Event|3
6991517|NCT01313299|11051819|FG001|Overall Study|Adverse Event|1
6991518|NCT01313299|11051820|FG002|Overall Study|Adverse Event|1
6991519|NCT01313299|11051818|FG000|Overall Study|Lost to Follow-up|1
6991520|NCT01313299|11051819|FG001|Overall Study|Lost to Follow-up|0
6991521|NCT01313299|11051820|FG002|Overall Study|Lost to Follow-up|0
6991522|NCT01313299|11051818|FG000|Overall Study|Protocol Violation|2
6991523|NCT01313299|11051819|FG001|Overall Study|Protocol Violation|0
6991524|NCT01313299|11051820|FG002|Overall Study|Protocol Violation|0
6991525|NCT01313299|11051818|FG000|Overall Study|Withdrawal by Subject|1
6991526|NCT01313299|11051819|FG001|Overall Study|Withdrawal by Subject|0
6991527|NCT01313299|11051820|FG002|Overall Study|Withdrawal by Subject|2
6991528|NCT01313299|11051818|FG000|Overall Study|Family reason and moved out of state|0
6991529|NCT01313299|11051819|FG001|Overall Study|Family reason and moved out of state|2
6991530|NCT01313299|11051820|FG002|Overall Study|Family reason and moved out of state|0
6991531|NCT01313299|11051818|FG000|Overall Study|Lack of subject compliance|0
6991532|NCT01313299|11051819|FG001|Overall Study|Lack of subject compliance|0
6991533|NCT01313299|11051820|FG002|Overall Study|Lack of subject compliance|1
6991534|NCT01313312|11051828|FG000|Overall Study|Adverse Event|5
6991535|NCT01313312|11051828|FG000|Overall Study|Withdrawal by Subject|18
6991536|NCT01313312|11051828|FG000|Overall Study|Lack of Efficacy|3
6991537|NCT01313312|11051828|FG000|Overall Study|Investigator Decision|1
6991538|NCT01313312|11051828|FG000|Overall Study|Observational Phase|1
6991539|NCT01313312|11051828|FG000|Overall Study|Subject Withdrawn Early in Error|4
6991540|NCT01313312|11051828|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4
6991541|NCT01313559|11051858|FG000|Overall Study|Withdrawal by Subject|1
6991542|NCT01313559|11051859|FG001|Overall Study|Withdrawal by Subject|2
6991543|NCT01313559|11051858|FG000|Overall Study|Disease progression|1
6991544|NCT01313559|11051859|FG001|Overall Study|Disease progression|0
6991545|NCT01313559|11051858|FG000|Overall Study|Rising PSA|2
6991546|NCT01313559|11051859|FG001|Overall Study|Rising PSA|0
6991547|NCT01313624|11051867|FG000|Double-Blind Phase|Adverse Event|27
6991548|NCT01313624|11051868|FG001|Double-Blind Phase|Adverse Event|4
6991549|NCT01313624|11051867|FG000|Double-Blind Phase|Withdrawal by Subject|9
6991550|NCT01313624|11051868|FG001|Double-Blind Phase|Withdrawal by Subject|4
6991551|NCT01313624|11051867|FG000|Double-Blind Phase|Lost to Follow-up|0
6991552|NCT01313624|11051868|FG001|Double-Blind Phase|Lost to Follow-up|2
6991553|NCT01313624|11051867|FG000|Double-Blind Phase|Physician Decision|1
6991554|NCT01313624|11051868|FG001|Double-Blind Phase|Physician Decision|0
6991555|NCT01313624|11051867|FG000|Double-Blind Phase|Lack of Efficacy|1
6991556|NCT01313624|11051868|FG001|Double-Blind Phase|Lack of Efficacy|0
6991557|NCT01313624|11051867|FG000|Open-Label Phase|Adverse Event|1
6991558|NCT01313624|11051868|FG001|Open-Label Phase|Adverse Event|10
6991559|NCT01313624|11051867|FG000|Open-Label Phase|Withdrawal by Subject|2
6991560|NCT01313624|11051868|FG001|Open-Label Phase|Withdrawal by Subject|2
6991561|NCT01313624|11051867|FG000|Open-Label Phase|Lost to Follow-up|1
6991562|NCT01313624|11051868|FG001|Open-Label Phase|Lost to Follow-up|1
6991563|NCT01313637|11051880|FG000|Overall Study|Adverse Event|17
6991564|NCT01313637|11051881|FG001|Overall Study|Adverse Event|24
6991565|NCT01313637|11051882|FG002|Overall Study|Adverse Event|25
6991566|NCT01313637|11051883|FG003|Overall Study|Adverse Event|18
6991567|NCT01313637|11051880|FG000|Overall Study|Lack of Efficacy|44
6991568|NCT01313637|11051881|FG001|Overall Study|Lack of Efficacy|38
6991569|NCT01313637|11051882|FG002|Overall Study|Lack of Efficacy|37
6991570|NCT01313637|11051883|FG003|Overall Study|Lack of Efficacy|24
6991571|NCT01313637|11051880|FG000|Overall Study|Protocol Violation|4
6991572|NCT01313637|11051881|FG001|Overall Study|Protocol Violation|3
6991573|NCT01313637|11051882|FG002|Overall Study|Protocol Violation|11
6991574|NCT01313637|11051883|FG003|Overall Study|Protocol Violation|5
6991575|NCT01313637|11051880|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16
6991576|NCT01313637|11051881|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15
6991577|NCT01313637|11051882|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14
6991578|NCT01313637|11051883|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13
6991579|NCT01313637|11051880|FG000|Overall Study|Lost to Follow-up|0
6991580|NCT01313637|11051881|FG001|Overall Study|Lost to Follow-up|2
6991581|NCT01313637|11051882|FG002|Overall Study|Lost to Follow-up|1
6991582|NCT01313637|11051883|FG003|Overall Study|Lost to Follow-up|3
6991583|NCT01313637|11051880|FG000|Overall Study|Withdrawal by Subject|11
6991584|NCT01313637|11051881|FG001|Overall Study|Withdrawal by Subject|13
6991585|NCT01313637|11051882|FG002|Overall Study|Withdrawal by Subject|18
6991586|NCT01313637|11051883|FG003|Overall Study|Withdrawal by Subject|15
6991587|NCT01313650|11051897|FG000|Overall Study|Adverse Event|9
6991588|NCT01313650|11051898|FG001|Overall Study|Adverse Event|34
6991589|NCT01313650|11051899|FG002|Overall Study|Adverse Event|24
6991590|NCT01313650|11051900|FG003|Overall Study|Adverse Event|23
6991591|NCT01313650|11051897|FG000|Overall Study|Lack of Efficacy|37
6991592|NCT01313650|11051898|FG001|Overall Study|Lack of Efficacy|20
6991593|NCT01313650|11051899|FG002|Overall Study|Lack of Efficacy|32
6991594|NCT01313650|11051900|FG003|Overall Study|Lack of Efficacy|20
6991595|NCT01313650|11051897|FG000|Overall Study|Lost to Follow-up|1
6991596|NCT01313650|11051898|FG001|Overall Study|Lost to Follow-up|0
6991597|NCT01313650|11051899|FG002|Overall Study|Lost to Follow-up|3
6991598|NCT01313650|11051900|FG003|Overall Study|Lost to Follow-up|2
6991599|NCT01313650|11051897|FG000|Overall Study|Withdrawal by Subject|16
6991600|NCT01313650|11051898|FG001|Overall Study|Withdrawal by Subject|20
6991601|NCT01313650|11051899|FG002|Overall Study|Withdrawal by Subject|15
6991602|NCT01313650|11051900|FG003|Overall Study|Withdrawal by Subject|15
6991603|NCT01313650|11051897|FG000|Overall Study|Protocol Violation|4
6991604|NCT01313650|11051898|FG001|Overall Study|Protocol Violation|7
6991605|NCT01313650|11051899|FG002|Overall Study|Protocol Violation|5
6991606|NCT01313650|11051900|FG003|Overall Study|Protocol Violation|6
6991607|NCT01313650|11051897|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9
6991608|NCT01313650|11051898|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13
6991609|NCT01313650|11051899|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24
6991610|NCT01313650|11051900|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15
6991611|NCT01313663|11051912|FG000|Overall Study|Study Closed/Terminated|2
6991612|NCT01313663|11051913|FG001|Overall Study|Study Closed/Terminated|4
6991613|NCT01313663|11051912|FG000|Overall Study|Lost to Follow-up|0
6991614|NCT01313663|11051913|FG001|Overall Study|Lost to Follow-up|1
6991615|NCT01313663|11051912|FG000|Overall Study|Physician Decision|0
6991616|NCT01313663|11051913|FG001|Overall Study|Physician Decision|2
6991617|NCT01313663|11051912|FG000|Overall Study|Withdrawal by Subject|2
6991618|NCT01313663|11051913|FG001|Overall Study|Withdrawal by Subject|1
7042376|NCT01735630|11126791|FG000|Overall Study|Adverse Event|8
7042377|NCT01735630|11126792|FG001|Overall Study|Adverse Event|7
7042378|NCT01735630|11126791|FG000|Overall Study|Lost to Follow-up|1
7042379|NCT01735630|11126792|FG001|Overall Study|Lost to Follow-up|0
7042380|NCT01735630|11126791|FG000|Overall Study|Physician Decision|0
7042381|NCT01735630|11126792|FG001|Overall Study|Physician Decision|1
7042382|NCT01735630|11126791|FG000|Overall Study|Sponsor Decision|2
7042383|NCT01735630|11126792|FG001|Overall Study|Sponsor Decision|1
7042384|NCT01735630|11126791|FG000|Overall Study|Withdrawal by Subject|7
7042385|NCT01735630|11126792|FG001|Overall Study|Withdrawal by Subject|9
7042386|NCT01735916|11126810|FG000|Overall Study|Subject not eligible to be randomized|11
7042387|NCT01735916|11126811|FG001|Overall Study|Subject not eligible to be randomized|0
7042388|NCT01735916|11126812|FG002|Overall Study|Subject not eligible to be randomized|0
7042389|NCT01735916|11126810|FG000|Overall Study|Early termination of study by sponsor|4
7042390|NCT01735916|11126811|FG001|Overall Study|Early termination of study by sponsor|19
7042391|NCT01735916|11126812|FG002|Overall Study|Early termination of study by sponsor|7
7042392|NCT01735916|11126810|FG000|Overall Study|Withdrawal by Subject|3
7042393|NCT01735916|11126811|FG001|Overall Study|Withdrawal by Subject|0
7042394|NCT01735916|11126812|FG002|Overall Study|Withdrawal by Subject|0
7042395|NCT01735994|11126832|FG000|Overall Study|Withdrawal by Subject|6
7042396|NCT01735994|11126833|FG001|Overall Study|Withdrawal by Subject|4
7042397|NCT01735994|11126832|FG000|Overall Study|Injury|2
7042398|NCT01735994|11126833|FG001|Overall Study|Injury|0
7042399|NCT01735994|11126832|FG000|Overall Study|Kicked off team|5
6991619|NCT01313676|11051923|FG000|Overall Study|Adverse Event|395
6991620|NCT01313676|11051924|FG001|Overall Study|Adverse Event|365
6991621|NCT01313676|11051925|FG002|Overall Study|Adverse Event|372
6991622|NCT01313676|11051926|FG003|Overall Study|Adverse Event|333
6991623|NCT01313676|11051923|FG000|Overall Study|Lack of Efficacy|98
6991624|NCT01313676|11051924|FG001|Overall Study|Lack of Efficacy|90
6991625|NCT01313676|11051925|FG002|Overall Study|Lack of Efficacy|65
6991626|NCT01313676|11051926|FG003|Overall Study|Lack of Efficacy|46
6991627|NCT01313676|11051923|FG000|Overall Study|Protocol Violation|37
6991628|NCT01313676|11051924|FG001|Overall Study|Protocol Violation|44
6991629|NCT01313676|11051925|FG002|Overall Study|Protocol Violation|46
6991630|NCT01313676|11051926|FG003|Overall Study|Protocol Violation|44
6991631|NCT01313676|11051923|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3
6991632|NCT01313676|11051924|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4
6991633|NCT01313676|11051925|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2
6991634|NCT01313676|11051926|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11
6991635|NCT01313676|11051923|FG000|Overall Study|Study Closed/terminated|7
6991636|NCT01313676|11051924|FG001|Overall Study|Study Closed/terminated|6
6991637|NCT01313676|11051925|FG002|Overall Study|Study Closed/terminated|9
6991638|NCT01313676|11051926|FG003|Overall Study|Study Closed/terminated|9
6991639|NCT01313676|11051923|FG000|Overall Study|Lost to Follow-up|0
6991640|NCT01313676|11051924|FG001|Overall Study|Lost to Follow-up|0
6991641|NCT01313676|11051925|FG002|Overall Study|Lost to Follow-up|1
6991642|NCT01313676|11051926|FG003|Overall Study|Lost to Follow-up|0
6991643|NCT01313676|11051923|FG000|Overall Study|Physician Decision|53
6991644|NCT01313676|11051924|FG001|Overall Study|Physician Decision|64
6991645|NCT01313676|11051925|FG002|Overall Study|Physician Decision|62
6991646|NCT01313676|11051926|FG003|Overall Study|Physician Decision|48
6991647|NCT01313676|11051923|FG000|Overall Study|Decision by Participant or Proxy|643
6991648|NCT01313676|11051924|FG001|Overall Study|Decision by Participant or Proxy|527
6991649|NCT01313676|11051925|FG002|Overall Study|Decision by Participant or Proxy|515
6991650|NCT01313676|11051926|FG003|Overall Study|Decision by Participant or Proxy|492
6991651|NCT01313676|11051923|FG000|Overall Study|Sponsor Terminated Study Treatment|1
6991652|NCT01313676|11051924|FG001|Overall Study|Sponsor Terminated Study Treatment|1
6991653|NCT01313676|11051925|FG002|Overall Study|Sponsor Terminated Study Treatment|0
6991654|NCT01313676|11051926|FG003|Overall Study|Sponsor Terminated Study Treatment|1
6991655|NCT01313676|11051923|FG000|Overall Study|Investigator Site Closed|12
6991656|NCT01313676|11051924|FG001|Overall Study|Investigator Site Closed|11
6991657|NCT01313676|11051925|FG002|Overall Study|Investigator Site Closed|15
6991658|NCT01313676|11051926|FG003|Overall Study|Investigator Site Closed|10
6991659|NCT01313676|11051923|FG000|Overall Study|Missing|1
6991660|NCT01313676|11051924|FG001|Overall Study|Missing|1
6991661|NCT01313676|11051925|FG002|Overall Study|Missing|1
6991662|NCT01313676|11051926|FG003|Overall Study|Missing|0
6991663|NCT01313728|11051937|FG000|Informed Consent to Baseline|Withdrawal by Subject|1
6991664|NCT01313767|11051944|FG000|Overall Study|Adverse Event|1
6991665|NCT01313767|11051945|FG001|Overall Study|Adverse Event|0
6991666|NCT01313767|11051944|FG000|Overall Study|Lost to Follow-up|1
6991667|NCT01313767|11051945|FG001|Overall Study|Lost to Follow-up|0
6991668|NCT01313767|11051944|FG000|Overall Study|Withdrawal by Subject|2
6991669|NCT01313767|11051945|FG001|Overall Study|Withdrawal by Subject|1
6991670|NCT01313767|11051944|FG000|Overall Study|Protocol Violation|3
6991671|NCT01313767|11051945|FG001|Overall Study|Protocol Violation|1
6991672|NCT01313780|11051953|FG000|Overall Study|Lack of Efficacy|4
6991673|NCT01313780|11051954|FG001|Overall Study|Lack of Efficacy|2
6991674|NCT01313780|11051953|FG000|Overall Study|Adverse Event|6
6991675|NCT01313780|11051954|FG001|Overall Study|Adverse Event|11
6991676|NCT01313780|11051953|FG000|Overall Study|Withdrawal by Subject|2
6991677|NCT01313780|11051954|FG001|Overall Study|Withdrawal by Subject|8
6991678|NCT01313780|11051953|FG000|Overall Study|Protocol Violation|10
6991679|NCT01313780|11051954|FG001|Overall Study|Protocol Violation|4
6991680|NCT01313780|11051953|FG000|Overall Study|missing data|3
6991681|NCT01313780|11051954|FG001|Overall Study|missing data|3
6991682|NCT01313858|11051963|FG000|Overall Study|Premature Treatment Termination|251
6991683|NCT01313858|11051964|FG001|Overall Study|Premature Treatment Termination|219
6991684|NCT01313858|11051965|FG002|Overall Study|Premature Treatment Termination|191
6991685|NCT01313858|11051963|FG000|Overall Study|Lost to Follow-up|35
6991686|NCT01313858|11051964|FG001|Overall Study|Lost to Follow-up|51
6991687|NCT01313858|11051965|FG002|Overall Study|Lost to Follow-up|47
6991688|NCT01313884|11051971|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1
6991689|NCT01314105|11052026|FG000|Overall Study|Progressive Disease|6
6991690|NCT01314105|11052027|FG001|Overall Study|Progressive Disease|10
6991691|NCT01314105|11052026|FG000|Overall Study|Refused to continue taking medication|0
6991692|NCT01314105|11052027|FG001|Overall Study|Refused to continue taking medication|1
6991693|NCT01314105|11052026|FG000|Overall Study|Other Adverse Event|1
6991694|NCT01314105|11052027|FG001|Overall Study|Other Adverse Event|1
6991695|NCT01314261|11052039|FG000|Overall Study|Adverse Event|1
6991696|NCT01314261|11052040|FG001|Overall Study|Adverse Event|0
6991697|NCT01314261|11052041|FG002|Overall Study|Adverse Event|0
6991698|NCT01314261|11052042|FG003|Overall Study|Adverse Event|0
6991699|NCT01314261|11052039|FG000|Overall Study|Withdrawal by Subject|0
6991700|NCT01314261|11052040|FG001|Overall Study|Withdrawal by Subject|3
6991701|NCT01314261|11052041|FG002|Overall Study|Withdrawal by Subject|1
6991702|NCT01314261|11052042|FG003|Overall Study|Withdrawal by Subject|0
6991703|NCT01314261|11052039|FG000|Overall Study|Lost to Follow-up|1
6991704|NCT01314261|11052040|FG001|Overall Study|Lost to Follow-up|0
6991705|NCT01314261|11052041|FG002|Overall Study|Lost to Follow-up|2
6991706|NCT01314261|11052042|FG003|Overall Study|Lost to Follow-up|2
6991707|NCT01314261|11052039|FG000|Overall Study|Virologic Failure|0
6991708|NCT01314261|11052040|FG001|Overall Study|Virologic Failure|1
6991709|NCT01314261|11052041|FG002|Overall Study|Virologic Failure|0
6991710|NCT01314261|11052042|FG003|Overall Study|Virologic Failure|1
6991711|NCT01314443|11052071|FG000|Overall Study|Withdrawal by Subject|2
6991712|NCT01314443|11052072|FG001|Overall Study|Withdrawal by Subject|1
6991713|NCT01314443|11052073|FG002|Overall Study|Withdrawal by Subject|1
6991714|NCT01314443|11052074|FG003|Overall Study|Withdrawal by Subject|1
6991715|NCT01314443|11052071|FG000|Overall Study|Protocol Violation|2
6991716|NCT01314443|11052072|FG001|Overall Study|Protocol Violation|2
6991717|NCT01314443|11052073|FG002|Overall Study|Protocol Violation|1
6991718|NCT01314443|11052074|FG003|Overall Study|Protocol Violation|1
6991719|NCT01314703|11052084|FG000|Overall Study|screen failure and closed enrollment|8
6991720|NCT01314716|11052091|FG000|Double-Blind Phase|Randomized but not treated|1
6991721|NCT01314716|11052092|FG001|Double-Blind Phase|Randomized but not treated|1
6991722|NCT01314716|11052091|FG000|Double-Blind Phase|Adverse Event|10
6991723|NCT01314716|11052092|FG001|Double-Blind Phase|Adverse Event|4
6991724|NCT01314716|11052091|FG000|Double-Blind Phase|Withdrawal by Subject|5
6991725|NCT01314716|11052092|FG001|Double-Blind Phase|Withdrawal by Subject|6
6991726|NCT01314716|11052091|FG000|Double-Blind Phase|Lost to Follow-up|0
6991727|NCT01314716|11052092|FG001|Double-Blind Phase|Lost to Follow-up|1
6991728|NCT01314716|11052091|FG000|Double-Blind Phase|Sponsor request|1
6991729|NCT01314716|11052092|FG001|Double-Blind Phase|Sponsor request|2
6991730|NCT01314716|11052091|FG000|Double-Blind Phase|Physician Decision|0
6991731|NCT01314716|11052092|FG001|Double-Blind Phase|Physician Decision|1
6991732|NCT01314716|11052091|FG000|Open-Label Phase|Adverse Event|4
6991733|NCT01314716|11052092|FG001|Open-Label Phase|Adverse Event|6
6991734|NCT01314716|11052091|FG000|Open-Label Phase|Withdrawal by Subject|1
6991735|NCT01314716|11052092|FG001|Open-Label Phase|Withdrawal by Subject|2
6991736|NCT01314716|11052091|FG000|Open-Label Phase|Physician Decision|5
6991737|NCT01314716|11052092|FG001|Open-Label Phase|Physician Decision|4
6991738|NCT01314872|11052122|FG000|Treatment Period 1|Protocol Violation|2
6991739|NCT01314872|11052123|FG001|Treatment Period 1|Protocol Violation|1
6991740|NCT01314872|11052124|FG002|Treatment Period 1|Protocol Violation|1
6991741|NCT01314872|11052125|FG003|Treatment Period 1|Protocol Violation|0
6991742|NCT01314872|11052126|FG004|Treatment Period 1|Protocol Violation|1
6991743|NCT01314872|11052127|FG005|Treatment Period 1|Protocol Violation|0
6991744|NCT01314872|11052128|FG006|Treatment Period 1|Protocol Violation|0
6991745|NCT01314872|11052129|FG007|Treatment Period 1|Protocol Violation|0
6991746|NCT01314872|11052130|FG008|Treatment Period 1|Protocol Violation|0
6991747|NCT01314872|11052131|FG009|Treatment Period 1|Protocol Violation|1
6991748|NCT01314872|11052132|FG010|Treatment Period 1|Protocol Violation|1
6991749|NCT01314872|11052133|FG011|Treatment Period 1|Protocol Violation|0
6991750|NCT01314872|11052134|FG012|Treatment Period 1|Protocol Violation|0
6991751|NCT01314872|11052135|FG013|Treatment Period 1|Protocol Violation|0
6991752|NCT01314872|11052136|FG014|Treatment Period 1|Protocol Violation|0
6991753|NCT01314872|11052122|FG000|Treatment Period 1|Physician Decision|0
6991754|NCT01314872|11052123|FG001|Treatment Period 1|Physician Decision|1
6991755|NCT01314872|11052124|FG002|Treatment Period 1|Physician Decision|0
6991756|NCT01314872|11052125|FG003|Treatment Period 1|Physician Decision|1
6991757|NCT01314872|11052126|FG004|Treatment Period 1|Physician Decision|0
6991758|NCT01314872|11052127|FG005|Treatment Period 1|Physician Decision|0
6991759|NCT01314872|11052128|FG006|Treatment Period 1|Physician Decision|0
6991760|NCT01314872|11052129|FG007|Treatment Period 1|Physician Decision|0
6991761|NCT01314872|11052130|FG008|Treatment Period 1|Physician Decision|0
6991762|NCT01314872|11052131|FG009|Treatment Period 1|Physician Decision|1
6991763|NCT01314872|11052132|FG010|Treatment Period 1|Physician Decision|0
6991764|NCT01314872|11052133|FG011|Treatment Period 1|Physician Decision|0
6991765|NCT01314872|11052134|FG012|Treatment Period 1|Physician Decision|0
6991766|NCT01314872|11052135|FG013|Treatment Period 1|Physician Decision|0
6991767|NCT01314872|11052136|FG014|Treatment Period 1|Physician Decision|0
6991768|NCT01314872|11052122|FG000|Treatment Period 1|Lack of Efficacy|1
6991769|NCT01314872|11052123|FG001|Treatment Period 1|Lack of Efficacy|0
6991770|NCT01314872|11052124|FG002|Treatment Period 1|Lack of Efficacy|0
6991771|NCT01314872|11052125|FG003|Treatment Period 1|Lack of Efficacy|0
6991772|NCT01314872|11052126|FG004|Treatment Period 1|Lack of Efficacy|0
6991773|NCT01314872|11052127|FG005|Treatment Period 1|Lack of Efficacy|1
6991774|NCT01314872|11052128|FG006|Treatment Period 1|Lack of Efficacy|0
6991775|NCT01314872|11052129|FG007|Treatment Period 1|Lack of Efficacy|2
6991776|NCT01314872|11052130|FG008|Treatment Period 1|Lack of Efficacy|0
6991777|NCT01314872|11052131|FG009|Treatment Period 1|Lack of Efficacy|0
6991778|NCT01314872|11052132|FG010|Treatment Period 1|Lack of Efficacy|0
6991779|NCT01314872|11052133|FG011|Treatment Period 1|Lack of Efficacy|0
6991780|NCT01314872|11052134|FG012|Treatment Period 1|Lack of Efficacy|0
6991781|NCT01314872|11052135|FG013|Treatment Period 1|Lack of Efficacy|0
6991782|NCT01314872|11052136|FG014|Treatment Period 1|Lack of Efficacy|0
6991783|NCT01314872|11052122|FG000|Treatment Period 1|Adverse event, non-fatal|4
6991784|NCT01314872|11052123|FG001|Treatment Period 1|Adverse event, non-fatal|2
6991785|NCT01314872|11052124|FG002|Treatment Period 1|Adverse event, non-fatal|3
6991786|NCT01314872|11052125|FG003|Treatment Period 1|Adverse event, non-fatal|2
6991787|NCT01314872|11052126|FG004|Treatment Period 1|Adverse event, non-fatal|2
6991788|NCT01314872|11052127|FG005|Treatment Period 1|Adverse event, non-fatal|4
6991789|NCT01314872|11052128|FG006|Treatment Period 1|Adverse event, non-fatal|4
6991790|NCT01314872|11052129|FG007|Treatment Period 1|Adverse event, non-fatal|2
6991791|NCT01314872|11052130|FG008|Treatment Period 1|Adverse event, non-fatal|3
6991792|NCT01314872|11052131|FG009|Treatment Period 1|Adverse event, non-fatal|0
6991793|NCT01314872|11052132|FG010|Treatment Period 1|Adverse event, non-fatal|1
6991794|NCT01314872|11052133|FG011|Treatment Period 1|Adverse event, non-fatal|0
6991795|NCT01314872|11052134|FG012|Treatment Period 1|Adverse event, non-fatal|0
6991796|NCT01314872|11052135|FG013|Treatment Period 1|Adverse event, non-fatal|0
6991797|NCT01314872|11052136|FG014|Treatment Period 1|Adverse event, non-fatal|0
6991798|NCT01314872|11052122|FG000|Treatment Period 1|Withdrawal by Subject|3
6991799|NCT01314872|11052123|FG001|Treatment Period 1|Withdrawal by Subject|1
6991800|NCT01314872|11052124|FG002|Treatment Period 1|Withdrawal by Subject|0
6991801|NCT01314872|11052125|FG003|Treatment Period 1|Withdrawal by Subject|2
6991802|NCT01314872|11052126|FG004|Treatment Period 1|Withdrawal by Subject|3
6991803|NCT01314872|11052127|FG005|Treatment Period 1|Withdrawal by Subject|1
6991804|NCT01314872|11052128|FG006|Treatment Period 1|Withdrawal by Subject|3
6991805|NCT01314872|11052129|FG007|Treatment Period 1|Withdrawal by Subject|2
6991806|NCT01314872|11052130|FG008|Treatment Period 1|Withdrawal by Subject|2
6991807|NCT01314872|11052131|FG009|Treatment Period 1|Withdrawal by Subject|2
6991808|NCT01314872|11052132|FG010|Treatment Period 1|Withdrawal by Subject|1
6991809|NCT01314872|11052133|FG011|Treatment Period 1|Withdrawal by Subject|0
6991810|NCT01314872|11052134|FG012|Treatment Period 1|Withdrawal by Subject|0
6991811|NCT01314872|11052135|FG013|Treatment Period 1|Withdrawal by Subject|0
6991812|NCT01314872|11052136|FG014|Treatment Period 1|Withdrawal by Subject|0
6991813|NCT01314872|11052122|FG000|Treatment Period 1|Lost to Follow-up|0
6991814|NCT01314872|11052123|FG001|Treatment Period 1|Lost to Follow-up|1
6991815|NCT01314872|11052124|FG002|Treatment Period 1|Lost to Follow-up|2
6991816|NCT01314872|11052125|FG003|Treatment Period 1|Lost to Follow-up|2
6991817|NCT01314872|11052126|FG004|Treatment Period 1|Lost to Follow-up|1
6991818|NCT01314872|11052127|FG005|Treatment Period 1|Lost to Follow-up|1
6991819|NCT01314872|11052128|FG006|Treatment Period 1|Lost to Follow-up|1
6991820|NCT01314872|11052129|FG007|Treatment Period 1|Lost to Follow-up|1
6991821|NCT01314872|11052130|FG008|Treatment Period 1|Lost to Follow-up|1
6991822|NCT01314872|11052131|FG009|Treatment Period 1|Lost to Follow-up|0
6991823|NCT01314872|11052132|FG010|Treatment Period 1|Lost to Follow-up|0
6991824|NCT01314872|11052133|FG011|Treatment Period 1|Lost to Follow-up|0
6991825|NCT01314872|11052134|FG012|Treatment Period 1|Lost to Follow-up|0
6991826|NCT01314872|11052135|FG013|Treatment Period 1|Lost to Follow-up|0
6991827|NCT01314872|11052136|FG014|Treatment Period 1|Lost to Follow-up|0
6991828|NCT01314872|11052122|FG000|Period 2|Protocol Violation|0
6991829|NCT01314872|11052123|FG001|Period 2|Protocol Violation|0
6991830|NCT01314872|11052124|FG002|Period 2|Protocol Violation|0
6991831|NCT01314872|11052125|FG003|Period 2|Protocol Violation|0
6991832|NCT01314872|11052126|FG004|Period 2|Protocol Violation|0
6991833|NCT01314872|11052127|FG005|Period 2|Protocol Violation|0
6991834|NCT01314872|11052128|FG006|Period 2|Protocol Violation|0
6991835|NCT01314872|11052129|FG007|Period 2|Protocol Violation|0
6991836|NCT01314872|11052130|FG008|Period 2|Protocol Violation|0
6991837|NCT01314872|11052131|FG009|Period 2|Protocol Violation|0
6991838|NCT01314872|11052132|FG010|Period 2|Protocol Violation|0
6991839|NCT01314872|11052133|FG011|Period 2|Protocol Violation|3
6991840|NCT01314872|11052134|FG012|Period 2|Protocol Violation|3
6991841|NCT01314872|11052135|FG013|Period 2|Protocol Violation|2
6991842|NCT01314872|11052136|FG014|Period 2|Protocol Violation|0
6991843|NCT01314872|11052122|FG000|Period 2|Non-compliance with study drug|0
6991844|NCT01314872|11052123|FG001|Period 2|Non-compliance with study drug|0
6991845|NCT01314872|11052124|FG002|Period 2|Non-compliance with study drug|0
6991846|NCT01314872|11052125|FG003|Period 2|Non-compliance with study drug|0
6991847|NCT01314872|11052126|FG004|Period 2|Non-compliance with study drug|0
6991848|NCT01314872|11052127|FG005|Period 2|Non-compliance with study drug|0
6991849|NCT01314872|11052128|FG006|Period 2|Non-compliance with study drug|0
6991850|NCT01314872|11052129|FG007|Period 2|Non-compliance with study drug|0
6991851|NCT01314872|11052130|FG008|Period 2|Non-compliance with study drug|0
6991852|NCT01314872|11052131|FG009|Period 2|Non-compliance with study drug|0
6991853|NCT01314872|11052132|FG010|Period 2|Non-compliance with study drug|0
6991854|NCT01314872|11052133|FG011|Period 2|Non-compliance with study drug|3
6991855|NCT01314872|11052134|FG012|Period 2|Non-compliance with study drug|3
6991856|NCT01314872|11052135|FG013|Period 2|Non-compliance with study drug|1
6991857|NCT01314872|11052136|FG014|Period 2|Non-compliance with study drug|2
6991858|NCT01314872|11052122|FG000|Period 2|Lack of Efficacy|0
6991859|NCT01314872|11052123|FG001|Period 2|Lack of Efficacy|0
6991860|NCT01314872|11052124|FG002|Period 2|Lack of Efficacy|0
6991861|NCT01314872|11052125|FG003|Period 2|Lack of Efficacy|0
6991862|NCT01314872|11052126|FG004|Period 2|Lack of Efficacy|0
6991863|NCT01314872|11052127|FG005|Period 2|Lack of Efficacy|0
6991864|NCT01314872|11052128|FG006|Period 2|Lack of Efficacy|0
6991865|NCT01314872|11052129|FG007|Period 2|Lack of Efficacy|0
6991866|NCT01314872|11052130|FG008|Period 2|Lack of Efficacy|0
6991867|NCT01314872|11052131|FG009|Period 2|Lack of Efficacy|0
6991868|NCT01314872|11052132|FG010|Period 2|Lack of Efficacy|0
6991869|NCT01314872|11052133|FG011|Period 2|Lack of Efficacy|7
6991870|NCT01314872|11052134|FG012|Period 2|Lack of Efficacy|12
6991871|NCT01314872|11052135|FG013|Period 2|Lack of Efficacy|9
6991872|NCT01314872|11052136|FG014|Period 2|Lack of Efficacy|2
6991873|NCT01314872|11052122|FG000|Period 2|Pregnancy|0
6991874|NCT01314872|11052123|FG001|Period 2|Pregnancy|0
6991875|NCT01314872|11052124|FG002|Period 2|Pregnancy|0
6991876|NCT01314872|11052125|FG003|Period 2|Pregnancy|0
6991877|NCT01314872|11052126|FG004|Period 2|Pregnancy|0
6991878|NCT01314872|11052127|FG005|Period 2|Pregnancy|0
6991879|NCT01314872|11052128|FG006|Period 2|Pregnancy|0
6991880|NCT01314872|11052129|FG007|Period 2|Pregnancy|0
6991881|NCT01314872|11052130|FG008|Period 2|Pregnancy|0
6991882|NCT01314872|11052131|FG009|Period 2|Pregnancy|0
6991883|NCT01314872|11052132|FG010|Period 2|Pregnancy|0
6991884|NCT01314872|11052133|FG011|Period 2|Pregnancy|0
6991885|NCT01314872|11052134|FG012|Period 2|Pregnancy|0
6991886|NCT01314872|11052135|FG013|Period 2|Pregnancy|0
6991887|NCT01314872|11052136|FG014|Period 2|Pregnancy|1
6991888|NCT01314872|11052122|FG000|Period 2|Study terminated by Sponsor|0
6991889|NCT01314872|11052123|FG001|Period 2|Study terminated by Sponsor|0
6991890|NCT01314872|11052124|FG002|Period 2|Study terminated by Sponsor|0
6991891|NCT01314872|11052125|FG003|Period 2|Study terminated by Sponsor|0
6991892|NCT01314872|11052126|FG004|Period 2|Study terminated by Sponsor|0
6991893|NCT01314872|11052127|FG005|Period 2|Study terminated by Sponsor|0
6991894|NCT01314872|11052128|FG006|Period 2|Study terminated by Sponsor|0
6991895|NCT01314872|11052129|FG007|Period 2|Study terminated by Sponsor|0
6991896|NCT01314872|11052130|FG008|Period 2|Study terminated by Sponsor|0
6991897|NCT01314872|11052131|FG009|Period 2|Study terminated by Sponsor|0
6991898|NCT01314872|11052132|FG010|Period 2|Study terminated by Sponsor|0
6991899|NCT01314872|11052133|FG011|Period 2|Study terminated by Sponsor|2
6991900|NCT01314872|11052134|FG012|Period 2|Study terminated by Sponsor|2
6991901|NCT01314872|11052135|FG013|Period 2|Study terminated by Sponsor|3
6991902|NCT01314872|11052136|FG014|Period 2|Study terminated by Sponsor|0
6991903|NCT01314872|11052122|FG000|Period 2|Adverse event, non-fatal|0
6991904|NCT01314872|11052123|FG001|Period 2|Adverse event, non-fatal|0
6991905|NCT01314872|11052124|FG002|Period 2|Adverse event, non-fatal|0
6991906|NCT01314872|11052125|FG003|Period 2|Adverse event, non-fatal|0
6991907|NCT01314872|11052126|FG004|Period 2|Adverse event, non-fatal|0
6991908|NCT01314872|11052127|FG005|Period 2|Adverse event, non-fatal|0
6991909|NCT01314872|11052128|FG006|Period 2|Adverse event, non-fatal|0
6991910|NCT01314872|11052129|FG007|Period 2|Adverse event, non-fatal|0
6991911|NCT01314872|11052130|FG008|Period 2|Adverse event, non-fatal|0
6991912|NCT01314872|11052131|FG009|Period 2|Adverse event, non-fatal|0
6991913|NCT01314872|11052132|FG010|Period 2|Adverse event, non-fatal|0
6991914|NCT01314872|11052133|FG011|Period 2|Adverse event, non-fatal|13
6991915|NCT01314872|11052134|FG012|Period 2|Adverse event, non-fatal|16
6991916|NCT01314872|11052135|FG013|Period 2|Adverse event, non-fatal|24
6991917|NCT01314872|11052136|FG014|Period 2|Adverse event, non-fatal|9
6991918|NCT01314872|11052122|FG000|Period 2|Withdrawal by Subject|0
6991919|NCT01314872|11052123|FG001|Period 2|Withdrawal by Subject|0
6991920|NCT01314872|11052124|FG002|Period 2|Withdrawal by Subject|0
6991921|NCT01314872|11052125|FG003|Period 2|Withdrawal by Subject|0
6991922|NCT01314872|11052126|FG004|Period 2|Withdrawal by Subject|0
6991923|NCT01314872|11052127|FG005|Period 2|Withdrawal by Subject|0
6991924|NCT01314872|11052128|FG006|Period 2|Withdrawal by Subject|0
6991925|NCT01314872|11052129|FG007|Period 2|Withdrawal by Subject|0
6991926|NCT01314872|11052130|FG008|Period 2|Withdrawal by Subject|0
6991927|NCT01314872|11052131|FG009|Period 2|Withdrawal by Subject|0
6991928|NCT01314872|11052132|FG010|Period 2|Withdrawal by Subject|0
6991929|NCT01314872|11052133|FG011|Period 2|Withdrawal by Subject|14
6991930|NCT01314872|11052134|FG012|Period 2|Withdrawal by Subject|17
6991931|NCT01314872|11052135|FG013|Period 2|Withdrawal by Subject|12
6991932|NCT01314872|11052136|FG014|Period 2|Withdrawal by Subject|4
6991933|NCT01314872|11052122|FG000|Period 2|Lost to Follow-up|0
6991934|NCT01314872|11052123|FG001|Period 2|Lost to Follow-up|0
6991935|NCT01314872|11052124|FG002|Period 2|Lost to Follow-up|0
6991936|NCT01314872|11052125|FG003|Period 2|Lost to Follow-up|0
6991937|NCT01314872|11052126|FG004|Period 2|Lost to Follow-up|0
6991938|NCT01314872|11052127|FG005|Period 2|Lost to Follow-up|0
6991939|NCT01314872|11052128|FG006|Period 2|Lost to Follow-up|0
6991940|NCT01314872|11052129|FG007|Period 2|Lost to Follow-up|0
6991941|NCT01314872|11052130|FG008|Period 2|Lost to Follow-up|0
6991942|NCT01314872|11052131|FG009|Period 2|Lost to Follow-up|0
6991943|NCT01314872|11052132|FG010|Period 2|Lost to Follow-up|0
6991944|NCT01314872|11052133|FG011|Period 2|Lost to Follow-up|6
6991945|NCT01314872|11052134|FG012|Period 2|Lost to Follow-up|7
6991946|NCT01314872|11052135|FG013|Period 2|Lost to Follow-up|2
6991947|NCT01314872|11052136|FG014|Period 2|Lost to Follow-up|6
6991948|NCT01314911|11052170|FG000|Overall Study|Lost to Follow-up|3
6991949|NCT01314911|11052171|FG001|Overall Study|Lost to Follow-up|2
7060323|NCT01917006|11156408|FG000|Randomized-treatment Period|Protocol Violation|1
6991950|NCT01314911|11052170|FG000|Overall Study|Withdrawal by Subject|1
6991951|NCT01314911|11052171|FG001|Overall Study|Withdrawal by Subject|3
6991952|NCT01314911|11052170|FG000|Overall Study|Received Non-randomized Study Drug|0
6991953|NCT01314911|11052171|FG001|Overall Study|Received Non-randomized Study Drug|1
6991954|NCT01314911|11052170|FG000|Overall Study|Never Started Treatment|1
6991955|NCT01314911|11052171|FG001|Overall Study|Never Started Treatment|0
6991956|NCT01315028|11052192|FG000|Overall Study|Lost to Follow-up|1
6991957|NCT01315028|11052193|FG001|Overall Study|Lost to Follow-up|0
6991958|NCT01315028|11052192|FG000|Overall Study|Death|0
6991959|NCT01315028|11052193|FG001|Overall Study|Death|1
6991960|NCT01315132|11052199|FG000|Overall Study|not treated due to disease progression|1
6991961|NCT01315236|11052223|FG000|Double-blind Phase|Death|1
6991962|NCT01315236|11052224|FG001|Double-blind Phase|Death|0
6991963|NCT01315236|11052223|FG000|Double-blind Phase|Adverse Event|1
6991964|NCT01315236|11052224|FG001|Double-blind Phase|Adverse Event|0
6991965|NCT01315236|11052223|FG000|Double-blind Phase|Withdrawal of Consent|1
6991966|NCT01315236|11052224|FG001|Double-blind Phase|Withdrawal of Consent|0
6991967|NCT01315236|11052223|FG000|Double-blind Phase|Lost to Follow-up|1
6991968|NCT01315236|11052224|FG001|Double-blind Phase|Lost to Follow-up|0
6991969|NCT01315236|11052223|FG000|Open-label Phase|Death|1
6991970|NCT01315236|11052224|FG001|Open-label Phase|Death|0
6991971|NCT01315236|11052223|FG000|Open-label Phase|Adverse Event|0
6991972|NCT01315236|11052224|FG001|Open-label Phase|Adverse Event|1
6991973|NCT01315236|11052223|FG000|Open-label Phase|Other|0
6991974|NCT01315236|11052224|FG001|Open-label Phase|Other|1
6991975|NCT01315236|11052223|FG000|12-Month Follow-up Period|Death|0
6991976|NCT01315236|11052224|FG001|12-Month Follow-up Period|Death|1
6991977|NCT01315236|11052223|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1
6991978|NCT01315236|11052224|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0
6991979|NCT01315249|11052234|FG000|Overall Study|Adverse Event|22
6991980|NCT01315249|11052235|FG001|Overall Study|Adverse Event|26
6991981|NCT01315249|11052234|FG000|Overall Study|Withdrawal by Subject|11
6991982|NCT01315249|11052235|FG001|Overall Study|Withdrawal by Subject|10
6991983|NCT01315249|11052234|FG000|Overall Study|Protocol Violation|8
6991984|NCT01315249|11052235|FG001|Overall Study|Protocol Violation|5
6991985|NCT01315249|11052234|FG000|Overall Study|Abnormal test results|1
6991986|NCT01315249|11052235|FG001|Overall Study|Abnormal test results|2
6991987|NCT01315249|11052234|FG000|Overall Study|Administrative problems|1
6991988|NCT01315249|11052235|FG001|Overall Study|Administrative problems|0
6991989|NCT01315249|11052234|FG000|Overall Study|inability to use device|1
6991990|NCT01315249|11052235|FG001|Overall Study|inability to use device|0
6991991|NCT01315249|11052234|FG000|Overall Study|Lack of Efficacy|0
6991992|NCT01315249|11052235|FG001|Overall Study|Lack of Efficacy|1
6991993|NCT01315249|11052234|FG000|Overall Study|Lost to Follow-up|0
6991994|NCT01315249|11052235|FG001|Overall Study|Lost to Follow-up|2
6991995|NCT01315249|11052234|FG000|Overall Study|Death|0
6991996|NCT01315249|11052235|FG001|Overall Study|Death|1
6991997|NCT01315678|11052263|FG000|Overall Study|Withdrawal by Subject|7
6991998|NCT01315678|11052264|FG001|Overall Study|Withdrawal by Subject|3
6991999|NCT01315678|11052263|FG000|Overall Study|Adverse Event|3
6992000|NCT01315678|11052264|FG001|Overall Study|Adverse Event|1
6992001|NCT01315678|11052263|FG000|Overall Study|Lost to Follow-up|1
6992002|NCT01315678|11052264|FG001|Overall Study|Lost to Follow-up|0
6992003|NCT01315678|11052263|FG000|Overall Study|similar reason to those listed above|3
6992004|NCT01315678|11052264|FG001|Overall Study|similar reason to those listed above|2
6992005|NCT01315847|11052274|FG000|Part I, Period 1|Reached maximum number of arterial lines|3
6992006|NCT01315847|11052275|FG001|Part I, Period 1|Reached maximum number of arterial lines|0
6992007|NCT01315847|11052274|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0
6992008|NCT01315847|11052275|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1
6992009|NCT01316055|11052293|FG000|Overall Study|Lost to Follow-up|1
6992010|NCT01316055|11052294|FG001|Overall Study|Lost to Follow-up|0
6992011|NCT01316055|11052295|FG002|Overall Study|Lost to Follow-up|0
6992012|NCT01316224|11052315|FG000|Overall Study|Protocol Violation|3
6992013|NCT01316224|11052315|FG000|Overall Study|Adverse Event|3
6992014|NCT01316224|11052315|FG000|Overall Study|Lack of Efficacy|1
6992015|NCT01316224|11052315|FG000|Overall Study|Withdrawal by Subject|1
6992016|NCT01316224|11052315|FG000|Overall Study|Adverse Event With Treatment Failure|1
6992017|NCT01316224|11052315|FG000|Overall Study|Other|1
6992018|NCT01316276|11052330|FG000|Overall Study|Death|1
6992019|NCT01316276|11052330|FG000|Overall Study|Adverse Event|19
6992020|NCT01316276|11052330|FG000|Overall Study|Withdrawal of consent|24
6992021|NCT01316276|11052330|FG000|Overall Study|Lost to Follow-up|1
6992022|NCT01316276|11052330|FG000|Overall Study|Other|22
6992023|NCT01316380|11052382|FG000|Overall Study|Adverse Event|0
6992024|NCT01316380|11052383|FG001|Overall Study|Adverse Event|2
6992025|NCT01316380|11052384|FG002|Overall Study|Adverse Event|1
6992026|NCT01316380|11052382|FG000|Overall Study|Protocol Violation|0
6992027|NCT01316380|11052383|FG001|Overall Study|Protocol Violation|0
6992028|NCT01316380|11052384|FG002|Overall Study|Protocol Violation|1
6992029|NCT01316380|11052382|FG000|Overall Study|Withdrawal by Subject|1
6992030|NCT01316380|11052383|FG001|Overall Study|Withdrawal by Subject|2
6992031|NCT01316380|11052384|FG002|Overall Study|Withdrawal by Subject|0
6992032|NCT01316380|11052382|FG000|Overall Study|Other|0
6992033|NCT01316380|11052383|FG001|Overall Study|Other|1
6992034|NCT01316380|11052384|FG002|Overall Study|Other|1
6992035|NCT01316380|11052382|FG000|Overall Study|Not treated|1
6992036|NCT01316380|11052383|FG001|Overall Study|Not treated|0
6992037|NCT01316380|11052384|FG002|Overall Study|Not treated|0
6992038|NCT01316419|11052392|FG000|Overall Study|Not treated|103
6992039|NCT01316419|11052392|FG000|Overall Study|Violated inclusion/exclusion criterion|143
6992040|NCT01316419|11052392|FG000|Overall Study|Lost to Follow-up|19
6992041|NCT01316575|11052407|FG000|Overall Study|Withdrawal by Subject|2
6992042|NCT01316575|11052408|FG001|Overall Study|Withdrawal by Subject|0
6992043|NCT01316575|11052407|FG000|Overall Study|Required alternate treatment|0
6992044|NCT01316575|11052408|FG001|Overall Study|Required alternate treatment|1
6992045|NCT01316614|11052414|FG000|Overall Study|No solid lesion and FNA not indicated|25
6992046|NCT01316614|11052414|FG000|Overall Study|Cytology slides not available for review|4
6992047|NCT01316614|11052414|FG000|Overall Study|Cystic lesion|5
6992048|NCT01316614|11052414|FG000|Overall Study|Inadequate number of passes|2
6992049|NCT01316614|11052414|FG000|Overall Study|Medically unstable|1
6992050|NCT01316692|11052419|FG000|Overall Study|Adverse Event|5
6992051|NCT01316692|11052419|FG000|Overall Study|Disease Progression|7
6992052|NCT01316887|11052437|FG000|Overall Study|Adverse Event|13
6992053|NCT01316887|11052438|FG001|Overall Study|Adverse Event|21
6992054|NCT01316887|11052439|FG002|Overall Study|Adverse Event|17
6992055|NCT01316887|11052437|FG000|Overall Study|Lack of Efficacy|9
6992056|NCT01316887|11052438|FG001|Overall Study|Lack of Efficacy|3
6992057|NCT01316887|11052439|FG002|Overall Study|Lack of Efficacy|1
6992058|NCT01316887|11052437|FG000|Overall Study|Protocol Violation|2
6992059|NCT01316887|11052438|FG001|Overall Study|Protocol Violation|6
6992060|NCT01316887|11052439|FG002|Overall Study|Protocol Violation|6
6992061|NCT01316887|11052437|FG000|Overall Study|Protocol-defined Stopping Criteria|8
6992062|NCT01316887|11052438|FG001|Overall Study|Protocol-defined Stopping Criteria|37
6992063|NCT01316887|11052439|FG002|Overall Study|Protocol-defined Stopping Criteria|36
6992064|NCT01316887|11052437|FG000|Overall Study|Study Closed/Terminated|2
6992065|NCT01316887|11052438|FG001|Overall Study|Study Closed/Terminated|4
6992066|NCT01316887|11052439|FG002|Overall Study|Study Closed/Terminated|3
6992067|NCT01316887|11052437|FG000|Overall Study|Lost to Follow-up|1
6992068|NCT01316887|11052438|FG001|Overall Study|Lost to Follow-up|7
6992069|NCT01316887|11052439|FG002|Overall Study|Lost to Follow-up|5
6992070|NCT01316887|11052437|FG000|Overall Study|Withdrawal by Subject|8
6992071|NCT01316887|11052438|FG001|Overall Study|Withdrawal by Subject|16
6992072|NCT01316887|11052439|FG002|Overall Study|Withdrawal by Subject|15
6992073|NCT01316900|11052452|FG000|Overall Study|Adverse Event|10
6992074|NCT01316900|11052453|FG001|Overall Study|Adverse Event|10
6992075|NCT01316900|11052454|FG002|Overall Study|Adverse Event|15
6992076|NCT01316900|11052455|FG003|Overall Study|Adverse Event|9
6992077|NCT01316900|11052452|FG000|Overall Study|Lack of Efficacy|17
6992078|NCT01316900|11052453|FG001|Overall Study|Lack of Efficacy|9
6992079|NCT01316900|11052454|FG002|Overall Study|Lack of Efficacy|5
6992080|NCT01316900|11052455|FG003|Overall Study|Lack of Efficacy|7
6992081|NCT01316900|11052452|FG000|Overall Study|Protocol Violation|7
6992082|NCT01316900|11052453|FG001|Overall Study|Protocol Violation|1
6992083|NCT01316900|11052454|FG002|Overall Study|Protocol Violation|4
6992084|NCT01316900|11052455|FG003|Overall Study|Protocol Violation|0
6992085|NCT01316900|11052452|FG000|Overall Study|Protocol-defined Stopping Criteria|2
6992086|NCT01316900|11052453|FG001|Overall Study|Protocol-defined Stopping Criteria|3
6992087|NCT01316900|11052454|FG002|Overall Study|Protocol-defined Stopping Criteria|10
6992088|NCT01316900|11052455|FG003|Overall Study|Protocol-defined Stopping Criteria|5
6992089|NCT01316900|11052452|FG000|Overall Study|Lost to Follow-up|1
6992090|NCT01316900|11052453|FG001|Overall Study|Lost to Follow-up|0
6992091|NCT01316900|11052454|FG002|Overall Study|Lost to Follow-up|1
6992092|NCT01316900|11052455|FG003|Overall Study|Lost to Follow-up|1
6992093|NCT01316900|11052452|FG000|Overall Study|Withdrawal by Subject|7
6992094|NCT01316900|11052453|FG001|Overall Study|Withdrawal by Subject|8
6992095|NCT01316900|11052454|FG002|Overall Study|Withdrawal by Subject|6
6992096|NCT01316900|11052455|FG003|Overall Study|Withdrawal by Subject|9
6992097|NCT01316913|11052469|FG000|Overall Study|Adverse Event|17
6992098|NCT01316913|11052470|FG001|Overall Study|Adverse Event|20
6992099|NCT01316913|11052471|FG002|Overall Study|Adverse Event|15
6992100|NCT01316913|11052472|FG003|Overall Study|Adverse Event|11
6992101|NCT01316913|11052469|FG000|Overall Study|Lack of Efficacy|22
6992102|NCT01316913|11052470|FG001|Overall Study|Lack of Efficacy|12
6992103|NCT01316913|11052471|FG002|Overall Study|Lack of Efficacy|9
6992104|NCT01316913|11052472|FG003|Overall Study|Lack of Efficacy|13
6992105|NCT01316913|11052469|FG000|Overall Study|Protocol Violation|1
6992106|NCT01316913|11052470|FG001|Overall Study|Protocol Violation|4
6992107|NCT01316913|11052471|FG002|Overall Study|Protocol Violation|4
6992108|NCT01316913|11052472|FG003|Overall Study|Protocol Violation|1
6992109|NCT01316913|11052469|FG000|Overall Study|Protocol-defined Stopping Criteria|7
6992110|NCT01316913|11052470|FG001|Overall Study|Protocol-defined Stopping Criteria|8
6992111|NCT01316913|11052471|FG002|Overall Study|Protocol-defined Stopping Criteria|11
6992112|NCT01316913|11052472|FG003|Overall Study|Protocol-defined Stopping Criteria|6
6992113|NCT01316913|11052469|FG000|Overall Study|Lost to Follow-up|0
6992114|NCT01316913|11052470|FG001|Overall Study|Lost to Follow-up|1
6992115|NCT01316913|11052471|FG002|Overall Study|Lost to Follow-up|0
6992116|NCT01316913|11052472|FG003|Overall Study|Lost to Follow-up|2
6992117|NCT01316913|11052469|FG000|Overall Study|Withdrawal by Subject|10
6992118|NCT01316913|11052470|FG001|Overall Study|Withdrawal by Subject|9
6992119|NCT01316913|11052471|FG002|Overall Study|Withdrawal by Subject|10
6992120|NCT01316913|11052472|FG003|Overall Study|Withdrawal by Subject|6
6992121|NCT01316939|11052494|FG000|Overall Study|Study closed/terminated|26
6992122|NCT01316939|11052495|FG001|Overall Study|Study closed/terminated|25
6992123|NCT01316939|11052496|FG002|Overall Study|Study closed/terminated|23
6992124|NCT01316939|11052494|FG000|Overall Study|Lack of Efficacy|24
6992125|NCT01316939|11052495|FG001|Overall Study|Lack of Efficacy|25
6992126|NCT01316939|11052496|FG002|Overall Study|Lack of Efficacy|25
6992127|NCT01316939|11052494|FG000|Overall Study|Adverse Event|9
6992128|NCT01316939|11052495|FG001|Overall Study|Adverse Event|12
6992129|NCT01316939|11052496|FG002|Overall Study|Adverse Event|11
6992130|NCT01316939|11052494|FG000|Overall Study|Withdrawal by Subject|1
6992131|NCT01316939|11052495|FG001|Overall Study|Withdrawal by Subject|3
6992132|NCT01316939|11052496|FG002|Overall Study|Withdrawal by Subject|6
6992133|NCT01316939|11052494|FG000|Overall Study|Physician Decision|2
6992134|NCT01316939|11052495|FG001|Overall Study|Physician Decision|2
6992135|NCT01316939|11052496|FG002|Overall Study|Physician Decision|1
6992136|NCT01316939|11052494|FG000|Overall Study|Lost to Follow-up|0
6992137|NCT01316939|11052495|FG001|Overall Study|Lost to Follow-up|0
6992138|NCT01316939|11052496|FG002|Overall Study|Lost to Follow-up|2
6992139|NCT01316939|11052494|FG000|Overall Study|Met Liver chemistry stopping criteria|1
6992140|NCT01316939|11052495|FG001|Overall Study|Met Liver chemistry stopping criteria|0
6992141|NCT01316939|11052496|FG002|Overall Study|Met Liver chemistry stopping criteria|1
6992142|NCT01316939|11052494|FG000|Overall Study|Protocol Violation|0
6992143|NCT01316939|11052495|FG001|Overall Study|Protocol Violation|1
6992144|NCT01316939|11052496|FG002|Overall Study|Protocol Violation|0
6992145|NCT01317004|11052506|FG000|Overall Study|Withdrawal by Subject|1
6992146|NCT01317004|11052507|FG001|Overall Study|Withdrawal by Subject|4
6992147|NCT01317004|11052506|FG000|Overall Study|Protocol Violation|0
6992148|NCT01317004|11052507|FG001|Overall Study|Protocol Violation|2
6992149|NCT01317004|11052506|FG000|Overall Study|Adverse Event|3
6992150|NCT01317004|11052507|FG001|Overall Study|Adverse Event|3
6992151|NCT01317199|11052535|FG000|Dose-escalation Phase 1|Physician Decision|5
6992152|NCT01317199|11052536|FG001|Dose-escalation Phase 1|Physician Decision|0
6992153|NCT01317199|11052537|FG002|Dose-escalation Phase 1|Physician Decision|0
6992154|NCT01317199|11052538|FG003|Dose-escalation Phase 1|Physician Decision|0
6992155|NCT01317199|11052535|FG000|Dose-escalation Phase 1|Disease progression|1
6992156|NCT01317199|11052536|FG001|Dose-escalation Phase 1|Disease progression|0
6992157|NCT01317199|11052537|FG002|Dose-escalation Phase 1|Disease progression|0
6992158|NCT01317199|11052538|FG003|Dose-escalation Phase 1|Disease progression|0
6992159|NCT01317199|11052535|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1
6992160|NCT01317199|11052536|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
7143143|NCT03026283|11299467|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
6992161|NCT01317199|11052537|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
6992162|NCT01317199|11052538|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
6992163|NCT01317199|11052535|FG000|Randomized Phase 2|Disease progression|0
6992164|NCT01317199|11052536|FG001|Randomized Phase 2|Disease progression|3
6992165|NCT01317199|11052537|FG002|Randomized Phase 2|Disease progression|7
6992166|NCT01317199|11052538|FG003|Randomized Phase 2|Disease progression|5
6992167|NCT01317199|11052535|FG000|Randomized Phase 2|Withdrawal by Subject|0
6992168|NCT01317199|11052536|FG001|Randomized Phase 2|Withdrawal by Subject|3
6992169|NCT01317199|11052537|FG002|Randomized Phase 2|Withdrawal by Subject|5
6992170|NCT01317199|11052538|FG003|Randomized Phase 2|Withdrawal by Subject|4
6992171|NCT01317199|11052535|FG000|Randomized Phase 2|Adverse Event|0
6992172|NCT01317199|11052536|FG001|Randomized Phase 2|Adverse Event|0
6992173|NCT01317199|11052537|FG002|Randomized Phase 2|Adverse Event|0
6992174|NCT01317199|11052538|FG003|Randomized Phase 2|Adverse Event|1
6992175|NCT01317199|11052535|FG000|Randomized Phase 2|Comorbidities|0
6992176|NCT01317199|11052536|FG001|Randomized Phase 2|Comorbidities|2
6992177|NCT01317199|11052537|FG002|Randomized Phase 2|Comorbidities|2
6992178|NCT01317199|11052538|FG003|Randomized Phase 2|Comorbidities|2
6992179|NCT01317199|11052535|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0
6992180|NCT01317199|11052536|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2
6992181|NCT01317199|11052537|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5
6992182|NCT01317199|11052538|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2
6992183|NCT01317199|11052535|FG000|Randomized Phase 2|Disenrolled before treatment|0
6992184|NCT01317199|11052536|FG001|Randomized Phase 2|Disenrolled before treatment|1
6992185|NCT01317199|11052537|FG002|Randomized Phase 2|Disenrolled before treatment|1
6992186|NCT01317199|11052538|FG003|Randomized Phase 2|Disenrolled before treatment|2
6992187|NCT01317199|11052535|FG000|Randomized Phase 2|Patient stopped taking study drug|0
6992188|NCT01317199|11052536|FG001|Randomized Phase 2|Patient stopped taking study drug|0
6992189|NCT01317199|11052537|FG002|Randomized Phase 2|Patient stopped taking study drug|0
6992190|NCT01317199|11052538|FG003|Randomized Phase 2|Patient stopped taking study drug|1
6992191|NCT01317199|11052535|FG000|Randomized Phase 2|Patient transferred to other facility|0
6992192|NCT01317199|11052536|FG001|Randomized Phase 2|Patient transferred to other facility|0
6992193|NCT01317199|11052537|FG002|Randomized Phase 2|Patient transferred to other facility|1
6992194|NCT01317199|11052538|FG003|Randomized Phase 2|Patient transferred to other facility|0
6992195|NCT01317277|11052557|FG000|Overall Study|Lost to Follow-up|3
6992196|NCT01317277|11052558|FG001|Overall Study|Lost to Follow-up|1
6992197|NCT01317277|11052557|FG000|Overall Study|Lost MEMS|1
6992198|NCT01317277|11052558|FG001|Overall Study|Lost MEMS|1
6992199|NCT01317277|11052557|FG000|Overall Study|Unable to comply with intervention|1
6992200|NCT01317277|11052558|FG001|Overall Study|Unable to comply with intervention|0
6992201|NCT01317277|11052557|FG000|Overall Study|Withdrawal by Subject|1
6992202|NCT01317277|11052558|FG001|Overall Study|Withdrawal by Subject|0
6992203|NCT01317277|11052557|FG000|Overall Study|Adverse Event|1
6992204|NCT01317277|11052558|FG001|Overall Study|Adverse Event|0
6992205|NCT01317472|11052566|FG000|Overall Study|Withdrawal by Subject|1
6992206|NCT01317472|11052567|FG001|Overall Study|Withdrawal by Subject|0
6992207|NCT01317472|11052566|FG000|Overall Study|Unrelated hospitalization|1
6992208|NCT01317472|11052567|FG001|Overall Study|Unrelated hospitalization|0
6992209|NCT01317550|11052577|FG000|Overall Study|Withdrawal by Subject|1
6992210|NCT01317550|11052578|FG001|Overall Study|Withdrawal by Subject|0
6992211|NCT01317550|11052579|FG002|Overall Study|Withdrawal by Subject|0
6992212|NCT01317550|11052580|FG003|Overall Study|Withdrawal by Subject|0
6992213|NCT01317550|11052577|FG000|Overall Study|Lack of compliance study med|1
6992214|NCT01317550|11052578|FG001|Overall Study|Lack of compliance study med|0
6992215|NCT01317550|11052579|FG002|Overall Study|Lack of compliance study med|0
6992216|NCT01317550|11052580|FG003|Overall Study|Lack of compliance study med|0
6992217|NCT01317615|11052590|FG000|Overall Study|Disease progression|25
6992218|NCT01317615|11052590|FG000|Overall Study|New cancer therapy|5
6992219|NCT01317615|11052590|FG000|Overall Study|Death|6
6992220|NCT01317615|11052590|FG000|Overall Study|Withdrawal by Subject|5
6992221|NCT01317615|11052590|FG000|Overall Study|Abnormal laboratory value(s)|1
6992222|NCT01317615|11052590|FG000|Overall Study|Adverse Event|7
6992223|NCT01317641|11052603|FG000|Overall Study|Not treated|0
6992224|NCT01317641|11052604|FG001|Overall Study|Not treated|0
6992225|NCT01317641|11052605|FG002|Overall Study|Not treated|0
6992226|NCT01317641|11052606|FG003|Overall Study|Not treated|0
6992227|NCT01317641|11052607|FG004|Overall Study|Not treated|0
6992228|NCT01317641|11052608|FG005|Overall Study|Not treated|0
6992229|NCT01317641|11052609|FG006|Overall Study|Not treated|0
6992230|NCT01317641|11052610|FG007|Overall Study|Not treated|1
6992231|NCT01317641|11052611|FG008|Overall Study|Not treated|1
6992232|NCT01317641|11052603|FG000|Overall Study|Adverse Event|0
6992233|NCT01317641|11052604|FG001|Overall Study|Adverse Event|1
6992234|NCT01317641|11052605|FG002|Overall Study|Adverse Event|0
6992235|NCT01317641|11052606|FG003|Overall Study|Adverse Event|1
6992236|NCT01317641|11052607|FG004|Overall Study|Adverse Event|0
6992237|NCT01317641|11052608|FG005|Overall Study|Adverse Event|0
6992238|NCT01317641|11052609|FG006|Overall Study|Adverse Event|2
6992239|NCT01317641|11052610|FG007|Overall Study|Adverse Event|1
6992240|NCT01317641|11052611|FG008|Overall Study|Adverse Event|0
6992241|NCT01317641|11052603|FG000|Overall Study|Protocol Violation|1
6992242|NCT01317641|11052604|FG001|Overall Study|Protocol Violation|0
6992243|NCT01317641|11052605|FG002|Overall Study|Protocol Violation|0
6992244|NCT01317641|11052606|FG003|Overall Study|Protocol Violation|0
6992245|NCT01317641|11052607|FG004|Overall Study|Protocol Violation|0
6992246|NCT01317641|11052608|FG005|Overall Study|Protocol Violation|0
6992247|NCT01317641|11052609|FG006|Overall Study|Protocol Violation|0
6992248|NCT01317641|11052610|FG007|Overall Study|Protocol Violation|0
6992249|NCT01317641|11052611|FG008|Overall Study|Protocol Violation|0
6992250|NCT01317641|11052603|FG000|Overall Study|Disease progression|0
6992251|NCT01317641|11052604|FG001|Overall Study|Disease progression|0
6992252|NCT01317641|11052605|FG002|Overall Study|Disease progression|0
6992253|NCT01317641|11052606|FG003|Overall Study|Disease progression|0
6992254|NCT01317641|11052607|FG004|Overall Study|Disease progression|0
6992255|NCT01317641|11052608|FG005|Overall Study|Disease progression|0
6992256|NCT01317641|11052609|FG006|Overall Study|Disease progression|0
6992257|NCT01317641|11052610|FG007|Overall Study|Disease progression|3
6992258|NCT01317641|11052611|FG008|Overall Study|Disease progression|4
6992259|NCT01317641|11052603|FG000|Overall Study|Withdrawal by Subject|0
6992260|NCT01317641|11052604|FG001|Overall Study|Withdrawal by Subject|0
6992261|NCT01317641|11052605|FG002|Overall Study|Withdrawal by Subject|0
6992262|NCT01317641|11052606|FG003|Overall Study|Withdrawal by Subject|0
6992263|NCT01317641|11052607|FG004|Overall Study|Withdrawal by Subject|0
6992264|NCT01317641|11052608|FG005|Overall Study|Withdrawal by Subject|0
6992265|NCT01317641|11052609|FG006|Overall Study|Withdrawal by Subject|1
6992266|NCT01317641|11052610|FG007|Overall Study|Withdrawal by Subject|0
6992267|NCT01317641|11052611|FG008|Overall Study|Withdrawal by Subject|0
6992268|NCT01317797|11052663|FG000|Overall Study|Other|0
6992269|NCT01317797|11052664|FG001|Overall Study|Other|1
6992270|NCT01317797|11052665|FG002|Overall Study|Other|0
6992271|NCT01317797|11052663|FG000|Overall Study|Withdrawal of Patient|0
6992272|NCT01317797|11052664|FG001|Overall Study|Withdrawal of Patient|0
6992273|NCT01317797|11052665|FG002|Overall Study|Withdrawal of Patient|1
6992274|NCT01317940|11052688|FG000|Overall Study|Death|1
6992275|NCT01317940|11052689|FG001|Overall Study|Death|0
6992276|NCT01317940|11052690|FG002|Overall Study|Death|1
6992277|NCT01317940|11052691|FG003|Overall Study|Death|0
6992278|NCT01317940|11052692|FG004|Overall Study|Death|0
6992279|NCT01317940|11052693|FG005|Overall Study|Death|0
6992280|NCT01317940|11052688|FG000|Overall Study|Lost to Follow-up|0
6992281|NCT01317940|11052689|FG001|Overall Study|Lost to Follow-up|0
6992282|NCT01317940|11052690|FG002|Overall Study|Lost to Follow-up|1
6992283|NCT01317940|11052691|FG003|Overall Study|Lost to Follow-up|1
6992284|NCT01317940|11052692|FG004|Overall Study|Lost to Follow-up|1
6992285|NCT01317940|11052693|FG005|Overall Study|Lost to Follow-up|0
6992286|NCT01317940|11052688|FG000|Overall Study|Change in therapy plan|0
6992287|NCT01317940|11052689|FG001|Overall Study|Change in therapy plan|0
6992288|NCT01317940|11052690|FG002|Overall Study|Change in therapy plan|3
6992289|NCT01317940|11052691|FG003|Overall Study|Change in therapy plan|0
6992290|NCT01317940|11052692|FG004|Overall Study|Change in therapy plan|0
6992291|NCT01317940|11052693|FG005|Overall Study|Change in therapy plan|0
6992292|NCT01318070|11052720|FG000|Overall Study|Adverse Event|1
6992293|NCT01318070|11052721|FG001|Overall Study|Adverse Event|1
6992294|NCT01318070|11052722|FG002|Overall Study|Adverse Event|5
6992295|NCT01318070|11052720|FG000|Overall Study|Withdrawal by Subject|0
6992296|NCT01318070|11052721|FG001|Overall Study|Withdrawal by Subject|1
6992297|NCT01318070|11052722|FG002|Overall Study|Withdrawal by Subject|1
6992298|NCT01318070|11052720|FG000|Overall Study|Lack of Efficacy|0
6992299|NCT01318070|11052721|FG001|Overall Study|Lack of Efficacy|0
6992300|NCT01318070|11052722|FG002|Overall Study|Lack of Efficacy|1
6992301|NCT01318070|11052720|FG000|Overall Study|Principal Investigator Discretion|1
6992302|NCT01318070|11052721|FG001|Overall Study|Principal Investigator Discretion|0
6992303|NCT01318070|11052722|FG002|Overall Study|Principal Investigator Discretion|0
6992304|NCT01318083|11052733|FG000|Overall Study|Adverse Event|4
6992305|NCT01318083|11052734|FG001|Overall Study|Adverse Event|1
6992306|NCT01318083|11052735|FG002|Overall Study|Adverse Event|2
6992307|NCT01318083|11052733|FG000|Overall Study|Withdrawal by Subject|1
6992308|NCT01318083|11052734|FG001|Overall Study|Withdrawal by Subject|0
6992309|NCT01318083|11052735|FG002|Overall Study|Withdrawal by Subject|2
6992310|NCT01318083|11052733|FG000|Overall Study|Lack of Efficacy|0
6992311|NCT01318083|11052734|FG001|Overall Study|Lack of Efficacy|0
6992312|NCT01318083|11052735|FG002|Overall Study|Lack of Efficacy|1
6992313|NCT01318083|11052733|FG000|Overall Study|Treatment Complications|1
6992314|NCT01318083|11052734|FG001|Overall Study|Treatment Complications|0
6992315|NCT01318083|11052735|FG002|Overall Study|Treatment Complications|0
6992316|NCT01318083|11052733|FG000|Overall Study|Lack of Study Medication Compliance|0
6992317|NCT01318083|11052734|FG001|Overall Study|Lack of Study Medication Compliance|1
6992318|NCT01318083|11052735|FG002|Overall Study|Lack of Study Medication Compliance|0
6992319|NCT01318109|11052746|FG000|Overall Study|Adverse Event|0
6992320|NCT01318109|11052747|FG001|Overall Study|Adverse Event|2
6992321|NCT01318109|11052748|FG002|Overall Study|Adverse Event|0
6992322|NCT01318109|11052746|FG000|Overall Study|Withdrawal by Subject|1
6992323|NCT01318109|11052747|FG001|Overall Study|Withdrawal by Subject|0
6992324|NCT01318109|11052748|FG002|Overall Study|Withdrawal by Subject|0
6992325|NCT01318109|11052746|FG000|Overall Study|Schedule Conflict|0
6992326|NCT01318109|11052747|FG001|Overall Study|Schedule Conflict|1
6992327|NCT01318109|11052748|FG002|Overall Study|Schedule Conflict|0
6992328|NCT01318122|11052758|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0
6992329|NCT01318122|11052759|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0
6992330|NCT01318122|11052760|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2
6992331|NCT01318122|11052761|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1
6992332|NCT01318122|11052758|FG000|Enrolled - Long-Term Extension Study|Other|1
6992333|NCT01318122|11052759|FG001|Enrolled - Long-Term Extension Study|Other|0
6992334|NCT01318122|11052760|FG002|Enrolled - Long-Term Extension Study|Other|0
6992335|NCT01318122|11052761|FG003|Enrolled - Long-Term Extension Study|Other|0
6992336|NCT01318122|11052758|FG000|Entered - Long-Term Extension Study|Adverse Event|6
6992337|NCT01318122|11052759|FG001|Entered - Long-Term Extension Study|Adverse Event|6
6992338|NCT01318122|11052760|FG002|Entered - Long-Term Extension Study|Adverse Event|2
6992339|NCT01318122|11052761|FG003|Entered - Long-Term Extension Study|Adverse Event|4
6992340|NCT01318122|11052758|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1
6992341|NCT01318122|11052759|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0
6992342|NCT01318122|11052760|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0
6992343|NCT01318122|11052761|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0
6992344|NCT01318122|11052758|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2
6992345|NCT01318122|11052759|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3
6992346|NCT01318122|11052760|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1
6992347|NCT01318122|11052761|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0
6992348|NCT01318122|11052758|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0
6992349|NCT01318122|11052759|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2
6992350|NCT01318122|11052760|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3
6992351|NCT01318122|11052761|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0
6992352|NCT01318135|11052771|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1
6992353|NCT01318135|11052772|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0
6992354|NCT01318135|11052773|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0
6992355|NCT01318135|11052774|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0
6992356|NCT01318135|11052775|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0
6992357|NCT01318135|11052776|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0
6992358|NCT01318135|11052777|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0
6992359|NCT01318135|11052778|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0
6992360|NCT01318135|11052771|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1
6992361|NCT01318135|11052772|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0
6992362|NCT01318135|11052773|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0
6992363|NCT01318135|11052774|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0
6992364|NCT01318135|11052775|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0
6992365|NCT01318135|11052776|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0
6992366|NCT01318135|11052777|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0
6992367|NCT01318135|11052778|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0
6992368|NCT01318135|11052771|FG000|Entered - Long-Term Extension Study|Adverse Event|9
6992369|NCT01318135|11052772|FG001|Entered - Long-Term Extension Study|Adverse Event|3
6992370|NCT01318135|11052773|FG002|Entered - Long-Term Extension Study|Adverse Event|4
6992371|NCT01318135|11052774|FG003|Entered - Long-Term Extension Study|Adverse Event|3
6992372|NCT01318135|11052775|FG004|Entered - Long-Term Extension Study|Adverse Event|4
6992373|NCT01318135|11052776|FG005|Entered - Long-Term Extension Study|Adverse Event|2
6992374|NCT01318135|11052777|FG006|Entered - Long-Term Extension Study|Adverse Event|0
6992375|NCT01318135|11052778|FG007|Entered - Long-Term Extension Study|Adverse Event|0
6992376|NCT01318135|11052771|FG000|Entered - Long-Term Extension Study|Protocol Violation|1
6992377|NCT01318135|11052772|FG001|Entered - Long-Term Extension Study|Protocol Violation|1
6992378|NCT01318135|11052773|FG002|Entered - Long-Term Extension Study|Protocol Violation|0
6992379|NCT01318135|11052774|FG003|Entered - Long-Term Extension Study|Protocol Violation|0
6992380|NCT01318135|11052775|FG004|Entered - Long-Term Extension Study|Protocol Violation|1
6992381|NCT01318135|11052776|FG005|Entered - Long-Term Extension Study|Protocol Violation|0
6992382|NCT01318135|11052777|FG006|Entered - Long-Term Extension Study|Protocol Violation|0
6992383|NCT01318135|11052778|FG007|Entered - Long-Term Extension Study|Protocol Violation|0
6992384|NCT01318135|11052771|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2
6992385|NCT01318135|11052772|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2
6992386|NCT01318135|11052773|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2
6992387|NCT01318135|11052774|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1
6992388|NCT01318135|11052775|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2
6992389|NCT01318135|11052776|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0
6992390|NCT01318135|11052777|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0
6992391|NCT01318135|11052778|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1
6992392|NCT01318135|11052771|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5
6992393|NCT01318135|11052772|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7
6992394|NCT01318135|11052773|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2
6992395|NCT01318135|11052774|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3
6992396|NCT01318135|11052775|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2
6992397|NCT01318135|11052776|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2
6992398|NCT01318135|11052777|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1
6992399|NCT01318135|11052778|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1
6992400|NCT01318135|11052771|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0
6992401|NCT01318135|11052772|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0
6992402|NCT01318135|11052773|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0
6992403|NCT01318135|11052774|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0
6992404|NCT01318135|11052775|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0
6992405|NCT01318135|11052776|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0
6992406|NCT01318135|11052777|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0
6992407|NCT01318135|11052778|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1
6992408|NCT01318382|11052815|FG000|Overall Study|Physician Decision|2
6992409|NCT01318382|11052815|FG000|Overall Study|Device Malfunction|10
6992410|NCT01318382|11052815|FG000|Overall Study|Protocol Violation|1
6992411|NCT01318499|11052827|FG000|Overall Study|Adverse Event|16
6992412|NCT01318499|11052828|FG001|Overall Study|Adverse Event|11
6992413|NCT01318499|11052829|FG002|Overall Study|Adverse Event|6
6992414|NCT01318499|11052827|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1
6992415|NCT01318499|11052828|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1
6992416|NCT01318499|11052829|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2
6992417|NCT01318499|11052827|FG000|Overall Study|Noncompliance|2
6992418|NCT01318499|11052828|FG001|Overall Study|Noncompliance|3
6992419|NCT01318499|11052829|FG002|Overall Study|Noncompliance|0
6992420|NCT01318499|11052827|FG000|Overall Study|Treatment Failure|19
6992421|NCT01318499|11052828|FG001|Overall Study|Treatment Failure|19
6992422|NCT01318499|11052829|FG002|Overall Study|Treatment Failure|101
6992423|NCT01318499|11052827|FG000|Overall Study|Protocol Violation|2
6992424|NCT01318499|11052828|FG001|Overall Study|Protocol Violation|4
6992425|NCT01318499|11052829|FG002|Overall Study|Protocol Violation|2
6992426|NCT01318499|11052827|FG000|Overall Study|Patient Did Not Use Study Medication|18
6992427|NCT01318499|11052828|FG001|Overall Study|Patient Did Not Use Study Medication|28
6992428|NCT01318499|11052829|FG002|Overall Study|Patient Did Not Use Study Medication|14
6992429|NCT01318499|11052827|FG000|Overall Study|Other|7
6992430|NCT01318499|11052828|FG001|Overall Study|Other|10
6992431|NCT01318499|11052829|FG002|Overall Study|Other|22
6992432|NCT01318512|11052839|FG000|Maintenance Period (6 Months)|Death|2
6992433|NCT01318512|11052839|FG000|Maintenance Period (6 Months)|Protocol Violation|9
6992434|NCT01318811|11052889|FG000|Overall Study|Physician Decision|1
6992435|NCT01318811|11052890|FG001|Overall Study|Physician Decision|1
6992436|NCT01318811|11052889|FG000|Overall Study|CRRT stopped for head CT|0
6992437|NCT01318811|11052890|FG001|Overall Study|CRRT stopped for head CT|1
6992438|NCT01318811|11052889|FG000|Overall Study|Death|0
6992439|NCT01318811|11052890|FG001|Overall Study|Death|1
6992440|NCT01318811|11052889|FG000|Overall Study|CRRT stopped for head MRI|0
6992441|NCT01318811|11052890|FG001|Overall Study|CRRT stopped for head MRI|1
6992442|NCT01318876|11052896|FG000|Day 8 Survey|email address invalid|96
6992443|NCT01318876|11052896|FG000|Day 8 Survey|survey not completed-don't know why|1724
6992444|NCT01318876|11052896|FG000|Day 29 Survey|survey not completed-don't know why|1825
6992445|NCT01318902|11052904|FG000|Overall Study|Symptomatic Deterioration|0
6992446|NCT01318902|11052905|FG001|Overall Study|Symptomatic Deterioration|1
6992447|NCT01318902|11052906|FG002|Overall Study|Symptomatic Deterioration|1
6992448|NCT01318902|11052907|FG003|Overall Study|Symptomatic Deterioration|2
6992449|NCT01318902|11052904|FG000|Overall Study|Withdrawal by Patient|0
6992450|NCT01318902|11052905|FG001|Overall Study|Withdrawal by Patient|1
6992451|NCT01318902|11052906|FG002|Overall Study|Withdrawal by Patient|0
6992452|NCT01318902|11052907|FG003|Overall Study|Withdrawal by Patient|3
6992453|NCT01318902|11052904|FG000|Overall Study|Unsatisfactory Therapeutic Response|1
6992454|NCT01318902|11052905|FG001|Overall Study|Unsatisfactory Therapeutic Response|0
6992455|NCT01318902|11052906|FG002|Overall Study|Unsatisfactory Therapeutic Response|0
6992456|NCT01318902|11052907|FG003|Overall Study|Unsatisfactory Therapeutic Response|1
6992457|NCT01318902|11052904|FG000|Overall Study|Adverse Event|0
6992458|NCT01318902|11052905|FG001|Overall Study|Adverse Event|1
6992459|NCT01318902|11052906|FG002|Overall Study|Adverse Event|0
6992460|NCT01318902|11052907|FG003|Overall Study|Adverse Event|0
6992461|NCT01318902|11052904|FG000|Overall Study|Terminated by Sponsor|0
6992462|NCT01318902|11052905|FG001|Overall Study|Terminated by Sponsor|0
6992463|NCT01318902|11052906|FG002|Overall Study|Terminated by Sponsor|1
6992464|NCT01318902|11052907|FG003|Overall Study|Terminated by Sponsor|0
6992465|NCT01318915|11052919|FG000|Overall Study|Lost to Follow-up|1
6992466|NCT01319383|11052947|FG000|Overall Study|No ex vivo or in vivo response|4
6992467|NCT01319383|11052948|FG001|Overall Study|No ex vivo or in vivo response|0
6992468|NCT01319383|11052947|FG000|Overall Study|Physician Decision|3
6992469|NCT01319383|11052948|FG001|Overall Study|Physician Decision|0
6992470|NCT01319383|11052947|FG000|Overall Study|Lack of Efficacy|5
6992471|NCT01319383|11052948|FG001|Overall Study|Lack of Efficacy|9
6992472|NCT01319383|11052947|FG000|Overall Study|No in vivo response to interval doses|0
6992473|NCT01319383|11052948|FG001|Overall Study|No in vivo response to interval doses|1
6992474|NCT01319422|11052971|FG000|Overall Study|Withdrawal by Subject|1
6992475|NCT01319422|11052972|FG001|Overall Study|Withdrawal by Subject|0
6992476|NCT01319721|11053009|FG000|Overall Study|Lost to Follow-up|1
6992477|NCT01319721|11053010|FG001|Overall Study|Lost to Follow-up|6
7042400|NCT01735994|11126833|FG001|Overall Study|Kicked off team|0
7042401|NCT01735994|11126832|FG000|Overall Study|Lost to Follow-up|50
7042402|NCT01735994|11126833|FG001|Overall Study|Lost to Follow-up|62
7042403|NCT01736124|11126863|FG000|Post-intervention Assessment|Death|2
7042404|NCT01736124|11126864|FG001|Post-intervention Assessment|Death|2
7042405|NCT01736124|11126863|FG000|Post-intervention Assessment|lost computer access|1
7042406|NCT01736124|11126864|FG001|Post-intervention Assessment|lost computer access|1
7042407|NCT01736124|11126863|FG000|Post-intervention Assessment|Moved away|3
7042408|NCT01736124|11126864|FG001|Post-intervention Assessment|Moved away|1
7042409|NCT01736124|11126863|FG000|Post-intervention Assessment|Withdrawal by Subject|11
7042410|NCT01736124|11126864|FG001|Post-intervention Assessment|Withdrawal by Subject|9
7042411|NCT01736124|11126863|FG000|Post-intervention Assessment|Illness|3
7042412|NCT01736124|11126864|FG001|Post-intervention Assessment|Illness|2
7042413|NCT01736124|11126863|FG000|Post-intervention Assessment|Lost to Follow-up|8
7042414|NCT01736124|11126864|FG001|Post-intervention Assessment|Lost to Follow-up|5
7042415|NCT01736124|11126863|FG000|Post-intervention Assessment|Temporarily away|3
7042416|NCT01736124|11126864|FG001|Post-intervention Assessment|Temporarily away|1
7042417|NCT01736124|11126863|FG000|6 Mo. Post-Intervention Assessment|Death|0
7042418|NCT01736124|11126864|FG001|6 Mo. Post-Intervention Assessment|Death|1
7042419|NCT01736124|11126863|FG000|6 Mo. Post-Intervention Assessment|Moved away|0
7042420|NCT01736124|11126864|FG001|6 Mo. Post-Intervention Assessment|Moved away|2
7042421|NCT01736124|11126863|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3
7042422|NCT01736124|11126864|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3
7042423|NCT01736124|11126863|FG000|6 Mo. Post-Intervention Assessment|Illness|1
7042424|NCT01736124|11126864|FG001|6 Mo. Post-Intervention Assessment|Illness|2
7042425|NCT01736124|11126863|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1
7042426|NCT01736124|11126864|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4
7042427|NCT01736124|11126863|FG000|12 Mo. Post-Intervention Assessment|Death|1
7042428|NCT01736124|11126864|FG001|12 Mo. Post-Intervention Assessment|Death|0
7042429|NCT01736124|11126863|FG000|12 Mo. Post-Intervention Assessment|Moved away|1
7042430|NCT01736124|11126864|FG001|12 Mo. Post-Intervention Assessment|Moved away|0
7042431|NCT01736124|11126863|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0
7042432|NCT01736124|11126864|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2
7042433|NCT01736124|11126863|FG000|12 Mo. Post-Intervention Assessment|End of study|10
7042434|NCT01736124|11126864|FG001|12 Mo. Post-Intervention Assessment|End of study|10
7042435|NCT01736176|11126872|FG000|Overall Study|Adverse Event|3
7042436|NCT01736176|11126872|FG000|Overall Study|Withdrawal by Subject|4
7042437|NCT01736176|11126872|FG000|Overall Study|Lack of Efficacy|3
6992478|NCT01319877|11053061|FG000|Overall Study|Lost to Follow-up|100
6992479|NCT01319877|11053062|FG001|Overall Study|Lost to Follow-up|37
6992480|NCT01319877|11053061|FG000|Overall Study|Physician Decision|2
6992481|NCT01319877|11053062|FG001|Overall Study|Physician Decision|0
6992482|NCT01319877|11053061|FG000|Overall Study|Disease Progression|2
6992483|NCT01319877|11053062|FG001|Overall Study|Disease Progression|2
6992484|NCT01319877|11053061|FG000|Overall Study|Withdrawal by Subject|0
6992485|NCT01319877|11053062|FG001|Overall Study|Withdrawal by Subject|1
6992486|NCT01319877|11053061|FG000|Overall Study|Reason Not Specified|4
6992487|NCT01319877|11053062|FG001|Overall Study|Reason Not Specified|5
6992488|NCT01319929|11053069|FG000|First Treatment Period (4 Weeks)|Adverse Event|2
6992489|NCT01319929|11053070|FG001|First Treatment Period (4 Weeks)|Adverse Event|0
6992490|NCT01319929|11053069|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1
6992491|NCT01319929|11053070|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1
6992492|NCT01319929|11053069|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0
6992493|NCT01319929|11053070|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1
6992494|NCT01319929|11053069|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1
6992495|NCT01319929|11053070|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0
6992496|NCT01319929|11053069|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0
6992497|NCT01319929|11053070|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1
6992498|NCT01319994|11053079|FG000|Overall Study|Protocol Violation|7
6992499|NCT01319994|11053080|FG001|Overall Study|Protocol Violation|6
6992500|NCT01320033|11053089|FG000|Overall Study|Lack of Efficacy|0
6992501|NCT01320033|11053090|FG001|Overall Study|Lack of Efficacy|0
6992502|NCT01320033|11053091|FG002|Overall Study|Lack of Efficacy|1
6992503|NCT01320033|11053089|FG000|Overall Study|Adverse Event|9
6992504|NCT01320033|11053090|FG001|Overall Study|Adverse Event|7
6992505|NCT01320033|11053091|FG002|Overall Study|Adverse Event|8
6992506|NCT01320033|11053089|FG000|Overall Study|Withdrawal by Subject|22
6992507|NCT01320033|11053090|FG001|Overall Study|Withdrawal by Subject|23
6992508|NCT01320033|11053091|FG002|Overall Study|Withdrawal by Subject|23
6992509|NCT01320033|11053089|FG000|Overall Study|Protocol Violation|3
6992510|NCT01320033|11053090|FG001|Overall Study|Protocol Violation|5
6992511|NCT01320033|11053091|FG002|Overall Study|Protocol Violation|3
6992512|NCT01320033|11053089|FG000|Overall Study|Lost to Follow-up|22
6992513|NCT01320033|11053090|FG001|Overall Study|Lost to Follow-up|26
6992514|NCT01320033|11053091|FG002|Overall Study|Lost to Follow-up|17
6992515|NCT01320033|11053089|FG000|Overall Study|Other|2
6992516|NCT01320033|11053090|FG001|Overall Study|Other|3
6992517|NCT01320033|11053091|FG002|Overall Study|Other|1
6992518|NCT01320085|11053102|FG000|Overall Study|Treatment Ongoing|0
6992519|NCT01320085|11053103|FG001|Overall Study|Treatment Ongoing|13
6992520|NCT01320085|11053104|FG002|Overall Study|Treatment Ongoing|2
6992521|NCT01320085|11053102|FG000|Overall Study|Disease Progression|26
6992522|NCT01320085|11053103|FG001|Overall Study|Disease Progression|86
6992523|NCT01320085|11053104|FG002|Overall Study|Disease Progression|16
6992524|NCT01320085|11053102|FG000|Overall Study|Adverse Event|12
6992525|NCT01320085|11053103|FG001|Overall Study|Adverse Event|14
6992526|NCT01320085|11053104|FG002|Overall Study|Adverse Event|5
6992527|NCT01320085|11053102|FG000|Overall Study|Withdrawal by Subject|2
6992528|NCT01320085|11053103|FG001|Overall Study|Withdrawal by Subject|4
6992529|NCT01320085|11053104|FG002|Overall Study|Withdrawal by Subject|1
6992530|NCT01320085|11053102|FG000|Overall Study|Protocol Deviation|1
6992531|NCT01320085|11053103|FG001|Overall Study|Protocol Deviation|0
6992532|NCT01320085|11053104|FG002|Overall Study|Protocol Deviation|1
6992533|NCT01320150|11053123|FG000|Overall Study|Protocol Violation|15
6992534|NCT01320150|11053123|FG000|Overall Study|Withdrawal by Subject|5
6992535|NCT01320150|11053123|FG000|Overall Study|Death|2
6992536|NCT01320150|11053123|FG000|Overall Study|Lost to Follow-up|44
6992537|NCT01320202|11053129|FG000|Overall Study|Adverse Event|5
6992538|NCT01320202|11053130|FG001|Overall Study|Adverse Event|5
6992539|NCT01320202|11053129|FG000|Overall Study|Death|5
6992540|NCT01320202|11053130|FG001|Overall Study|Death|3
6992541|NCT01320202|11053129|FG000|Overall Study|Lost to Follow-up|1
6992542|NCT01320202|11053130|FG001|Overall Study|Lost to Follow-up|0
6992543|NCT01320202|11053129|FG000|Overall Study|Physician Decision|3
6992544|NCT01320202|11053130|FG001|Overall Study|Physician Decision|1
6992545|NCT01320202|11053129|FG000|Overall Study|Protocol Violation|2
6992546|NCT01320202|11053130|FG001|Overall Study|Protocol Violation|1
6992547|NCT01320202|11053129|FG000|Overall Study|Withdrawal by Subject|10
6992548|NCT01320202|11053130|FG001|Overall Study|Withdrawal by Subject|3
6992549|NCT01320202|11053129|FG000|Overall Study|non-protocol change to ESA or IV iron|17
6992550|NCT01320202|11053130|FG001|Overall Study|non-protocol change to ESA or IV iron|20
6992551|NCT01320202|11053129|FG000|Overall Study|kidney transplant|1
6992552|NCT01320202|11053130|FG001|Overall Study|kidney transplant|2
6992553|NCT01320202|11053129|FG000|Overall Study|blood transfusion|1
6992554|NCT01320202|11053130|FG001|Overall Study|blood transfusion|7
6992555|NCT01320202|11053129|FG000|Overall Study|moved/changed dialysis|5
6992556|NCT01320202|11053130|FG001|Overall Study|moved/changed dialysis|2
6992557|NCT01320202|11053129|FG000|Overall Study|sponsor request|2
6992558|NCT01320202|11053130|FG001|Overall Study|sponsor request|0
6992559|NCT01320202|11053129|FG000|Overall Study|ineligible|3
6992560|NCT01320202|11053130|FG001|Overall Study|ineligible|0
6992561|NCT01320202|11053129|FG000|Overall Study|regained renal function|1
6992562|NCT01320202|11053130|FG001|Overall Study|regained renal function|0
6992563|NCT01320293|11053139|FG000|Overall Study|Lack of Efficacy|1
6992564|NCT01320293|11053139|FG000|Overall Study|Adverse Event|1
6992565|NCT01320722|11053165|FG000|Overall Study|Did not Receive Intervention|3
6992566|NCT01320722|11053166|FG001|Overall Study|Did not Receive Intervention|2
6992567|NCT01320722|11053167|FG002|Overall Study|Did not Receive Intervention|1
6992568|NCT01320722|11053168|FG003|Overall Study|Did not Receive Intervention|1
6992569|NCT01320722|11053169|FG004|Overall Study|Did not Receive Intervention|2
6992570|NCT01320722|11053165|FG000|Overall Study|Lost to Follow-up|0
6992571|NCT01320722|11053166|FG001|Overall Study|Lost to Follow-up|1
6992572|NCT01320722|11053167|FG002|Overall Study|Lost to Follow-up|0
6992573|NCT01320722|11053168|FG003|Overall Study|Lost to Follow-up|1
6992574|NCT01320722|11053169|FG004|Overall Study|Lost to Follow-up|3
6992575|NCT01320722|11053165|FG000|Overall Study|Not Available for the 8 Week Visit|0
6992576|NCT01320722|11053166|FG001|Overall Study|Not Available for the 8 Week Visit|3
6992577|NCT01320722|11053167|FG002|Overall Study|Not Available for the 8 Week Visit|0
6992578|NCT01320722|11053168|FG003|Overall Study|Not Available for the 8 Week Visit|0
6992579|NCT01320722|11053169|FG004|Overall Study|Not Available for the 8 Week Visit|0
6992580|NCT01320722|11053165|FG000|Overall Study|Participant Developed a Rash|0
6992581|NCT01320722|11053166|FG001|Overall Study|Participant Developed a Rash|0
6992582|NCT01320722|11053167|FG002|Overall Study|Participant Developed a Rash|2
6992583|NCT01320722|11053168|FG003|Overall Study|Participant Developed a Rash|1
6992584|NCT01320722|11053169|FG004|Overall Study|Participant Developed a Rash|1
6992585|NCT01320722|11053165|FG000|Overall Study|Non-compliant with Medication|0
6992586|NCT01320722|11053166|FG001|Overall Study|Non-compliant with Medication|0
6992587|NCT01320722|11053167|FG002|Overall Study|Non-compliant with Medication|1
6992588|NCT01320722|11053168|FG003|Overall Study|Non-compliant with Medication|0
6992589|NCT01320722|11053169|FG004|Overall Study|Non-compliant with Medication|0
6992590|NCT01320722|11053165|FG000|Overall Study|Adverse Event|0
6992591|NCT01320722|11053166|FG001|Overall Study|Adverse Event|0
6992592|NCT01320722|11053167|FG002|Overall Study|Adverse Event|3
6992593|NCT01320722|11053168|FG003|Overall Study|Adverse Event|6
6992594|NCT01320722|11053169|FG004|Overall Study|Adverse Event|0
6992595|NCT01320722|11053165|FG000|Overall Study|Not Compliant with Study Procedures|0
6992596|NCT01320722|11053166|FG001|Overall Study|Not Compliant with Study Procedures|0
6992597|NCT01320722|11053167|FG002|Overall Study|Not Compliant with Study Procedures|0
6992598|NCT01320722|11053168|FG003|Overall Study|Not Compliant with Study Procedures|4
6992599|NCT01320722|11053169|FG004|Overall Study|Not Compliant with Study Procedures|0
6992600|NCT01320722|11053165|FG000|Overall Study|Pregnancy|0
6992601|NCT01320722|11053166|FG001|Overall Study|Pregnancy|0
6992602|NCT01320722|11053167|FG002|Overall Study|Pregnancy|0
6992603|NCT01320722|11053168|FG003|Overall Study|Pregnancy|1
6992604|NCT01320722|11053169|FG004|Overall Study|Pregnancy|0
6992605|NCT01320722|11053165|FG000|Overall Study|Started an Exclusionary Medication|0
6992606|NCT01320722|11053166|FG001|Overall Study|Started an Exclusionary Medication|0
6992607|NCT01320722|11053167|FG002|Overall Study|Started an Exclusionary Medication|0
6992608|NCT01320722|11053168|FG003|Overall Study|Started an Exclusionary Medication|0
6992609|NCT01320722|11053169|FG004|Overall Study|Started an Exclusionary Medication|1
6992610|NCT01320722|11053165|FG000|Overall Study|Withdrew due to Health Condition|0
6992611|NCT01320722|11053166|FG001|Overall Study|Withdrew due to Health Condition|0
6992612|NCT01320722|11053167|FG002|Overall Study|Withdrew due to Health Condition|0
6992613|NCT01320722|11053168|FG003|Overall Study|Withdrew due to Health Condition|0
6992614|NCT01320722|11053169|FG004|Overall Study|Withdrew due to Health Condition|1
6992615|NCT01320735|11053184|FG000|Overall Study|Adverse Event|3
6992616|NCT01320735|11053184|FG000|Overall Study|Withdrawal by Subject|3
6992617|NCT01320735|11053184|FG000|Overall Study|Lost to Follow-up|13
6992618|NCT01320735|11053184|FG000|Overall Study|Administrative Reason|6
6992619|NCT01320735|11053184|FG000|Overall Study|Progression/Hormone-Refractory Pca|55
6992620|NCT01320735|11053184|FG000|Overall Study|Protocol Violation|1
6992621|NCT01320735|11053184|FG000|Overall Study|Other|1
6992622|NCT01320735|11053184|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7
6992623|NCT01320735|11053184|FG000|Overall Study|Investigator Unable to be Contacted|17
6992624|NCT01320943|11053205|FG000|Overall Study|Lost to Follow-up|1
6992625|NCT01320943|11053206|FG001|Overall Study|Lost to Follow-up|0
6992626|NCT01320943|11053205|FG000|Overall Study|Physician Decision|0
6992627|NCT01320943|11053206|FG001|Overall Study|Physician Decision|1
6992628|NCT01320943|11053205|FG000|Overall Study|Randomized but not Treated|0
6992629|NCT01320943|11053206|FG001|Overall Study|Randomized but not Treated|1
6992630|NCT01321073|11053219|FG000|Overall Study|Did not attempt implant|4
6992631|NCT01321073|11053219|FG000|Overall Study|Death|3
6992632|NCT01321606|11053269|FG000|Overall Study|Lost to Follow-up|0
6992633|NCT01321606|11053270|FG001|Overall Study|Lost to Follow-up|0
6992634|NCT01321606|11053271|FG002|Overall Study|Lost to Follow-up|0
6992635|NCT01321606|11053272|FG003|Overall Study|Lost to Follow-up|1
6992636|NCT01321710|11053285|FG000|Overall Study|Lost to Follow-up|4
6992637|NCT01321710|11053286|FG001|Overall Study|Lost to Follow-up|5
6992638|NCT01321710|11053287|FG002|Overall Study|Lost to Follow-up|0
6992639|NCT01321723|11053300|FG000|Overall Study|Adverse Event|3
6992640|NCT01321723|11053301|FG001|Overall Study|Adverse Event|5
7143144|NCT03026283|11299468|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
6992641|NCT01321723|11053302|FG002|Overall Study|Adverse Event|2
6992642|NCT01321723|11053300|FG000|Overall Study|Withdrawal by Subject|2
6992643|NCT01321723|11053301|FG001|Overall Study|Withdrawal by Subject|0
6992644|NCT01321723|11053302|FG002|Overall Study|Withdrawal by Subject|2
6992645|NCT01321749|11053312|FG000|Overall Study|Lost to Follow-up|4
6992646|NCT01321749|11053313|FG001|Overall Study|Lost to Follow-up|11
6992647|NCT01321749|11053312|FG000|Overall Study|Protocol Violation|4
6992648|NCT01321749|11053313|FG001|Overall Study|Protocol Violation|7
6992649|NCT01321749|11053312|FG000|Overall Study|Withdrawal by Subject|5
6992650|NCT01321749|11053313|FG001|Overall Study|Withdrawal by Subject|4
6992651|NCT01321879|11053319|FG000|Overall Study|Lack of Efficacy|5
6992652|NCT01321879|11053319|FG000|Overall Study|Adverse Event|5
6992653|NCT01321879|11053319|FG000|Overall Study|Death|3
6992654|NCT01321879|11053319|FG000|Overall Study|Withdrawal by Subject|1
6992655|NCT01322009|11053325|FG000|Overall Study|Death|0
6992656|NCT01322009|11053326|FG001|Overall Study|Death|1
6992657|NCT01322009|11053325|FG000|Overall Study|Adverse Event|0
6992658|NCT01322009|11053326|FG001|Overall Study|Adverse Event|1
6992659|NCT01322009|11053325|FG000|Overall Study|ng tube discontinued|0
6992660|NCT01322009|11053326|FG001|Overall Study|ng tube discontinued|1
6992661|NCT01322347|11053352|FG000|Overall Study|Adverse Event|7
6992662|NCT01322347|11053353|FG001|Overall Study|Adverse Event|2
6992663|NCT01322347|11053352|FG000|Overall Study|Death|5
6992664|NCT01322347|11053353|FG001|Overall Study|Death|3
6992665|NCT01322347|11053352|FG000|Overall Study|Physician Decision|2
6992666|NCT01322347|11053353|FG001|Overall Study|Physician Decision|1
6992667|NCT01322347|11053352|FG000|Overall Study|Protocol Violation|5
6992668|NCT01322347|11053353|FG001|Overall Study|Protocol Violation|2
6992669|NCT01322347|11053352|FG000|Overall Study|Withdrawal by Subject|1
6992670|NCT01322347|11053353|FG001|Overall Study|Withdrawal by Subject|4
6992671|NCT01322347|11053352|FG000|Overall Study|non-protocol change to ESA or IV iron|14
6992672|NCT01322347|11053353|FG001|Overall Study|non-protocol change to ESA or IV iron|6
6992673|NCT01322347|11053352|FG000|Overall Study|blood transfusion|5
6992674|NCT01322347|11053353|FG001|Overall Study|blood transfusion|5
6992675|NCT01322347|11053352|FG000|Overall Study|sponsor decision|1
6992676|NCT01322347|11053353|FG001|Overall Study|sponsor decision|3
6992677|NCT01322347|11053352|FG000|Overall Study|ineligible|6
6992678|NCT01322347|11053353|FG001|Overall Study|ineligible|3
6992679|NCT01322347|11053352|FG000|Overall Study|kidney transplant|3
6992680|NCT01322347|11053353|FG001|Overall Study|kidney transplant|1
6992681|NCT01322347|11053352|FG000|Overall Study|study drug withheld > 12 wks|0
6992682|NCT01322347|11053353|FG001|Overall Study|study drug withheld > 12 wks|1
6992683|NCT01322347|11053352|FG000|Overall Study|moved/changed dialysis|2
6992684|NCT01322347|11053353|FG001|Overall Study|moved/changed dialysis|4
6992685|NCT01322386|11053367|FG000|Overall Study|Protocol Violation|0
6992686|NCT01322386|11053368|FG001|Overall Study|Protocol Violation|1
6992687|NCT01322386|11053367|FG000|Overall Study|Physician Decision|0
6992688|NCT01322386|11053368|FG001|Overall Study|Physician Decision|1
6992689|NCT01322490|11053379|FG000|Treatment Period|Adverse Event|12
6992690|NCT01322490|11053380|FG001|Treatment Period|Adverse Event|18
6992691|NCT01322490|11053381|FG002|Treatment Period|Adverse Event|15
6992692|NCT01322490|11053379|FG000|Treatment Period|Death|5
6992693|NCT01322490|11053380|FG001|Treatment Period|Death|7
6992694|NCT01322490|11053381|FG002|Treatment Period|Death|3
6992695|NCT01322490|11053379|FG000|Treatment Period|Lack of Efficacy|89
6992696|NCT01322490|11053380|FG001|Treatment Period|Lack of Efficacy|100
6992697|NCT01322490|11053381|FG002|Treatment Period|Lack of Efficacy|112
6992698|NCT01322490|11053379|FG000|Treatment Period|Physician Decision|0
6992699|NCT01322490|11053380|FG001|Treatment Period|Physician Decision|2
6992700|NCT01322490|11053381|FG002|Treatment Period|Physician Decision|1
6992701|NCT01322490|11053379|FG000|Treatment Period|Protocol Violation|7
6992702|NCT01322490|11053380|FG001|Treatment Period|Protocol Violation|5
6992703|NCT01322490|11053381|FG002|Treatment Period|Protocol Violation|4
6992704|NCT01322490|11053379|FG000|Treatment Period|Withdrawal by Subject|14
6992705|NCT01322490|11053380|FG001|Treatment Period|Withdrawal by Subject|16
6992706|NCT01322490|11053381|FG002|Treatment Period|Withdrawal by Subject|11
6992707|NCT01322490|11053379|FG000|Treatment Period|Non-compliance with study drug|0
6992708|NCT01322490|11053380|FG001|Treatment Period|Non-compliance with study drug|0
6992709|NCT01322490|11053381|FG002|Treatment Period|Non-compliance with study drug|1
6992710|NCT01322490|11053379|FG000|Treatment Period|Other per report|2
6992711|NCT01322490|11053380|FG001|Treatment Period|Other per report|2
6992712|NCT01322490|11053381|FG002|Treatment Period|Other per report|1
6992713|NCT01322490|11053379|FG000|Treatment Period|Randomized but Not Treated|3
6992714|NCT01322490|11053380|FG001|Treatment Period|Randomized but Not Treated|3
6992715|NCT01322490|11053381|FG002|Treatment Period|Randomized but Not Treated|5
6992716|NCT01322490|11053379|FG000|Long Term Follow-up Period|Death|235
6992717|NCT01322490|11053380|FG001|Long Term Follow-up Period|Death|239
6992718|NCT01322490|11053381|FG002|Long Term Follow-up Period|Death|236
6992719|NCT01322490|11053379|FG000|Long Term Follow-up Period|Lost to Follow-up|2
6992720|NCT01322490|11053380|FG001|Long Term Follow-up Period|Lost to Follow-up|2
6992721|NCT01322490|11053381|FG002|Long Term Follow-up Period|Lost to Follow-up|3
6992722|NCT01322490|11053379|FG000|Long Term Follow-up Period|Withdrawal by Subject|9
6992723|NCT01322490|11053380|FG001|Long Term Follow-up Period|Withdrawal by Subject|6
6992724|NCT01322490|11053381|FG002|Long Term Follow-up Period|Withdrawal by Subject|6
6992725|NCT01322490|11053379|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160
6992726|NCT01322490|11053380|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158
6992727|NCT01322490|11053381|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165
6992728|NCT01322490|11053379|FG000|Long Term Follow-up Period|Other per report|3
6992729|NCT01322490|11053380|FG001|Long Term Follow-up Period|Other per report|2
6992730|NCT01322490|11053381|FG002|Long Term Follow-up Period|Other per report|2
6992731|NCT01322490|11053379|FG000|Long Term Follow-up Period|Unknown/Missing|0
6992732|NCT01322490|11053380|FG001|Long Term Follow-up Period|Unknown/Missing|1
6992733|NCT01322490|11053381|FG002|Long Term Follow-up Period|Unknown/Missing|1
6992734|NCT01323192|11053497|FG000|Overall Study|Adverse Event|6
6992735|NCT01323192|11053498|FG001|Overall Study|Adverse Event|1
6992736|NCT01323192|11053497|FG000|Overall Study|Withdrawal by Subject|3
6992737|NCT01323192|11053498|FG001|Overall Study|Withdrawal by Subject|1
6992738|NCT01323192|11053497|FG000|Overall Study|Noncompliance with study medication|0
6992739|NCT01323192|11053498|FG001|Overall Study|Noncompliance with study medication|3
6992740|NCT01323192|11053497|FG000|Overall Study|Nonmedical reasons|0
6992741|NCT01323192|11053498|FG001|Overall Study|Nonmedical reasons|1
6992742|NCT01323270|11053506|FG000|Overall Study|Withdrawal by Subject|19
6992743|NCT01323270|11053507|FG001|Overall Study|Withdrawal by Subject|10
6992744|NCT01323270|11053506|FG000|Overall Study|Protocol Violation|9
6992745|NCT01323270|11053507|FG001|Overall Study|Protocol Violation|7
6992746|NCT01323270|11053506|FG000|Overall Study|Lost to Follow-up|4
6992747|NCT01323270|11053507|FG001|Overall Study|Lost to Follow-up|6
6992748|NCT01323270|11053506|FG000|Overall Study|Adverse Event|8
6992749|NCT01323270|11053507|FG001|Overall Study|Adverse Event|0
6992750|NCT01323270|11053506|FG000|Overall Study|Other|0
6992751|NCT01323270|11053507|FG001|Overall Study|Other|3
6992752|NCT01323270|11053506|FG000|Overall Study|Physician Decision|0
6992753|NCT01323270|11053507|FG001|Overall Study|Physician Decision|2
6992754|NCT01323270|11053506|FG000|Overall Study|Not eligible|1
6992755|NCT01323270|11053507|FG001|Overall Study|Not eligible|1
6992756|NCT01323270|11053506|FG000|Overall Study|Death|1
6992757|NCT01323270|11053507|FG001|Overall Study|Death|0
6992758|NCT01323270|11053506|FG000|Overall Study|Randomized, but not vaccinated|1
6992759|NCT01323270|11053507|FG001|Overall Study|Randomized, but not vaccinated|0
6992760|NCT01323387|11053514|FG000|Overall Study|Withdrawal by Subject|41
6992761|NCT01323387|11053514|FG000|Overall Study|Radiographic Data Unavailable|1
6992762|NCT01323387|11053514|FG000|Overall Study|Revision|14
6992763|NCT01323387|11053514|FG000|Overall Study|Protocol Violation|12
6992764|NCT01323387|11053514|FG000|Overall Study|Randomized but Never Treated|16
6992765|NCT01323478|11053520|FG000|Overall Study|Adverse Event|7
6992766|NCT01323478|11053520|FG000|Overall Study|Lack of Efficacy|4
6992767|NCT01323478|11053520|FG000|Overall Study|Non-compliance With Study Product|3
6992768|NCT01323478|11053520|FG000|Overall Study|Protocol Violation|1
6992769|NCT01323478|11053520|FG000|Overall Study|Withdrawal of Consent|1
6992770|NCT01323478|11053520|FG000|Overall Study|Administrative or Other Reasons|8
6992771|NCT01323530|11053535|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2
6992772|NCT01323530|11053536|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0
6992773|NCT01323530|11053537|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0
6992774|NCT01323530|11053538|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0
6992775|NCT01323530|11053539|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0
6992776|NCT01323530|11053540|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2
6992777|NCT01323530|11053541|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0
6992778|NCT01323530|11053535|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1
6992779|NCT01323530|11053536|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1
6992780|NCT01323530|11053537|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1
6992781|NCT01323530|11053538|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0
6992782|NCT01323530|11053539|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2
6992783|NCT01323530|11053540|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0
6992784|NCT01323530|11053541|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0
6992785|NCT01323530|11053535|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0
6992786|NCT01323530|11053536|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1
6992787|NCT01323530|11053537|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0
6992788|NCT01323530|11053538|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0
6992789|NCT01323530|11053539|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1
6992790|NCT01323530|11053540|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1
6992791|NCT01323530|11053541|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0
6992792|NCT01323530|11053535|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
6992793|NCT01323530|11053536|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
6992794|NCT01323530|11053537|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
6992795|NCT01323530|11053538|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
6992796|NCT01323530|11053539|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
6992797|NCT01323530|11053540|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
6992798|NCT01323530|11053541|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2
6992799|NCT01323530|11053535|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
6992800|NCT01323530|11053536|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
6992801|NCT01323530|11053537|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
6992802|NCT01323530|11053538|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
7082208|NCT02139644|11192563|FG001|Treatment Period|Non-compliance|0
6992803|NCT01323530|11053539|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
6992804|NCT01323530|11053540|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
6992805|NCT01323530|11053541|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3
6992806|NCT01323530|11053535|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
6992807|NCT01323530|11053536|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
6992808|NCT01323530|11053537|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
6992809|NCT01323530|11053538|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
6992810|NCT01323530|11053539|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
6992811|NCT01323530|11053540|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
6992812|NCT01323530|11053541|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8
6992813|NCT01323530|11053535|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
6992814|NCT01323530|11053536|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
6992815|NCT01323530|11053537|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
6992816|NCT01323530|11053538|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
6992817|NCT01323530|11053539|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
6992818|NCT01323530|11053540|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
6992819|NCT01323530|11053541|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3
6992820|NCT01323530|11053535|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
6992821|NCT01323530|11053536|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
6992822|NCT01323530|11053537|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
6992823|NCT01323530|11053538|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
6992824|NCT01323530|11053539|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
6992825|NCT01323530|11053540|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
6992826|NCT01323530|11053541|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1
6992827|NCT01323582|11053560|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2
6992828|NCT01323582|11053561|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2
6992829|NCT01323582|11053560|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0
6992830|NCT01323582|11053561|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1
6992831|NCT01323582|11053560|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0
6992832|NCT01323582|11053561|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1
6992833|NCT01323621|11053582|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121
6992834|NCT01323621|11053583|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
6992835|NCT01323621|11053584|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
6992836|NCT01323621|11053582|FG000|2-week, Single-blind Run In Period|Physician Decision|7
6992837|NCT01323621|11053583|FG001|2-week, Single-blind Run In Period|Physician Decision|0
6992838|NCT01323621|11053584|FG002|2-week, Single-blind Run In Period|Physician Decision|0
6992839|NCT01323621|11053582|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12
6992840|NCT01323621|11053583|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0
6992841|NCT01323621|11053584|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0
6992842|NCT01323621|11053582|FG000|2-week, Single-blind Run In Period|Protocol Violation|1
6992843|NCT01323621|11053583|FG001|2-week, Single-blind Run In Period|Protocol Violation|0
6992844|NCT01323621|11053584|FG002|2-week, Single-blind Run In Period|Protocol Violation|0
6992845|NCT01323621|11053582|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1
6992846|NCT01323621|11053583|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0
6992847|NCT01323621|11053584|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0
6992848|NCT01323621|11053582|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86
6992849|NCT01323621|11053583|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
6992850|NCT01323621|11053584|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
6992851|NCT01323621|11053582|FG000|12-week, Double-blind Treatment Period|Adverse Event|0
6992852|NCT01323621|11053583|FG001|12-week, Double-blind Treatment Period|Adverse Event|1
6992853|NCT01323621|11053584|FG002|12-week, Double-blind Treatment Period|Adverse Event|5
6992854|NCT01323621|11053582|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0
6992855|NCT01323621|11053583|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2
6992856|NCT01323621|11053584|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6
6992857|NCT01323621|11053582|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0
6992858|NCT01323621|11053583|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4
6992859|NCT01323621|11053584|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4
6992860|NCT01323621|11053582|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0
6992861|NCT01323621|11053583|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1
6992862|NCT01323621|11053584|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0
6992863|NCT01323621|11053582|FG000|12-week, Double-blind Treatment Period|Physician Decision|0
6992864|NCT01323621|11053583|FG001|12-week, Double-blind Treatment Period|Physician Decision|2
6992865|NCT01323621|11053584|FG002|12-week, Double-blind Treatment Period|Physician Decision|1
6992866|NCT01323621|11053582|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0
6992867|NCT01323621|11053583|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5
6992868|NCT01323621|11053584|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4
6992869|NCT01323634|11053592|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125
6992870|NCT01323634|11053593|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
6992871|NCT01323634|11053594|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
6992872|NCT01323634|11053592|FG000|2-week Run-in Period|Continuation Criteria not Met|73
6992873|NCT01323634|11053593|FG001|2-week Run-in Period|Continuation Criteria not Met|0
6992874|NCT01323634|11053594|FG002|2-week Run-in Period|Continuation Criteria not Met|0
6992875|NCT01323634|11053592|FG000|2-week Run-in Period|Withdrawal by Subject|7
6992876|NCT01323634|11053593|FG001|2-week Run-in Period|Withdrawal by Subject|0
6992877|NCT01323634|11053594|FG002|2-week Run-in Period|Withdrawal by Subject|0
6992878|NCT01323634|11053592|FG000|2-week Run-in Period|Physician Decision|5
6992879|NCT01323634|11053593|FG001|2-week Run-in Period|Physician Decision|0
6992880|NCT01323634|11053594|FG002|2-week Run-in Period|Physician Decision|0
6992881|NCT01323634|11053592|FG000|2-week Run-in Period|Protocol Violation|1
7143145|NCT03026283|11299469|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
6992882|NCT01323634|11053593|FG001|2-week Run-in Period|Protocol Violation|0
6992883|NCT01323634|11053594|FG002|2-week Run-in Period|Protocol Violation|0
6992884|NCT01323634|11053592|FG000|2-week Run-in Period|Adverse Event|1
6992885|NCT01323634|11053593|FG001|2-week Run-in Period|Adverse Event|0
6992886|NCT01323634|11053594|FG002|2-week Run-in Period|Adverse Event|0
6992887|NCT01323634|11053592|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0
6992888|NCT01323634|11053593|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8
6992889|NCT01323634|11053594|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4
6992890|NCT01323634|11053592|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
6992891|NCT01323634|11053593|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
6992892|NCT01323634|11053594|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2
6992893|NCT01323634|11053592|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0
6992894|NCT01323634|11053593|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6
6992895|NCT01323634|11053594|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7
6992896|NCT01323634|11053592|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
6992897|NCT01323634|11053593|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
6992898|NCT01323634|11053594|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
6992899|NCT01323634|11053592|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0
6992900|NCT01323634|11053593|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2
6992901|NCT01323634|11053594|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3
6992902|NCT01323634|11053592|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
6992903|NCT01323634|11053593|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7
6992904|NCT01323634|11053594|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4
6992905|NCT01323634|11053592|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0
6992906|NCT01323634|11053593|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
6992907|NCT01323634|11053594|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
6992908|NCT01323647|11053602|FG000|Overall Study|Migrated/moved from study area|2
6992909|NCT01323647|11053603|FG001|Overall Study|Migrated/moved from study area|0
6992910|NCT01323647|11053602|FG000|Overall Study|Withdrawal by Subject|5
6992911|NCT01323647|11053603|FG001|Overall Study|Withdrawal by Subject|0
6992912|NCT01323647|11053602|FG000|Overall Study|Lost to Follow-up|2
6992913|NCT01323647|11053603|FG001|Overall Study|Lost to Follow-up|0
6992914|NCT01323660|11053609|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6
6992915|NCT01323660|11053610|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1
6992916|NCT01323660|11053611|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1
6992917|NCT01323660|11053612|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3
6992918|NCT01323660|11053613|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3
6992919|NCT01323660|11053614|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4
6992920|NCT01323660|11053609|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
6992921|NCT01323660|11053610|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
6992922|NCT01323660|11053611|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
6992923|NCT01323660|11053612|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
6992924|NCT01323660|11053613|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
6992925|NCT01323660|11053614|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3
6992926|NCT01323660|11053609|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2
6992927|NCT01323660|11053610|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0
6992928|NCT01323660|11053611|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1
6992929|NCT01323660|11053612|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1
6992930|NCT01323660|11053613|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1
6992931|NCT01323660|11053614|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2
6992932|NCT01323660|11053609|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
6992933|NCT01323660|11053610|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
6992934|NCT01323660|11053611|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
6992935|NCT01323660|11053612|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
6992936|NCT01323660|11053613|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1
6992937|NCT01323660|11053614|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
6992938|NCT01323660|11053609|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
6992939|NCT01323660|11053610|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
6992940|NCT01323660|11053611|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
6992941|NCT01323660|11053612|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
6992942|NCT01323660|11053613|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
6992943|NCT01323660|11053614|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
6992944|NCT01323660|11053609|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5
6992945|NCT01323660|11053610|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
6992946|NCT01323660|11053611|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
6992947|NCT01323660|11053612|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
6992948|NCT01323660|11053613|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3
6992949|NCT01323660|11053614|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
6992950|NCT01323660|11053609|FG000|Washout Period (14 Days)|Adverse Event|0
6992951|NCT01323660|11053610|FG001|Washout Period (14 Days)|Adverse Event|0
6992952|NCT01323660|11053611|FG002|Washout Period (14 Days)|Adverse Event|0
6992953|NCT01323660|11053612|FG003|Washout Period (14 Days)|Adverse Event|0
6992954|NCT01323660|11053613|FG004|Washout Period (14 Days)|Adverse Event|1
6992955|NCT01323660|11053614|FG005|Washout Period (14 Days)|Adverse Event|0
6992956|NCT01323660|11053609|FG000|Washout Period (14 Days)|Lack of Efficacy|0
6992957|NCT01323660|11053610|FG001|Washout Period (14 Days)|Lack of Efficacy|0
6992958|NCT01323660|11053611|FG002|Washout Period (14 Days)|Lack of Efficacy|1
6992959|NCT01323660|11053612|FG003|Washout Period (14 Days)|Lack of Efficacy|3
6992960|NCT01323660|11053613|FG004|Washout Period (14 Days)|Lack of Efficacy|2
6992961|NCT01323660|11053614|FG005|Washout Period (14 Days)|Lack of Efficacy|2
7143146|NCT03026283|11299462|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
6992962|NCT01323660|11053609|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1
6992963|NCT01323660|11053610|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0
6992964|NCT01323660|11053611|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0
6992965|NCT01323660|11053612|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1
6992966|NCT01323660|11053613|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1
6992967|NCT01323660|11053614|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2
6992968|NCT01323660|11053609|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9
6992969|NCT01323660|11053610|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
6992970|NCT01323660|11053611|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
6992971|NCT01323660|11053612|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
6992972|NCT01323660|11053613|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
6992973|NCT01323660|11053614|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
6992974|NCT01323660|11053609|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
6992975|NCT01323660|11053610|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
6992976|NCT01323660|11053611|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
6992977|NCT01323660|11053612|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
6992978|NCT01323660|11053613|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
6992979|NCT01323660|11053614|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1
6992980|NCT01323660|11053609|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
6992981|NCT01323660|11053610|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
6992982|NCT01323660|11053611|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
6992983|NCT01323660|11053612|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
6992984|NCT01323660|11053613|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
6992985|NCT01323660|11053614|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
6992986|NCT01323660|11053609|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
6992987|NCT01323660|11053610|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
6992988|NCT01323660|11053611|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
6992989|NCT01323660|11053612|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
6992990|NCT01323660|11053613|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
6992991|NCT01323660|11053614|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
6992992|NCT01323673|11053630|FG000|Overall Study|Adverse Event|0
6992993|NCT01323673|11053631|FG001|Overall Study|Adverse Event|1
6992994|NCT01323673|11053630|FG000|Overall Study|Lost to Follow-up|0
6992995|NCT01323673|11053631|FG001|Overall Study|Lost to Follow-up|1
6992996|NCT01323673|11053630|FG000|Overall Study|Protocol Violation|1
6992997|NCT01323673|11053631|FG001|Overall Study|Protocol Violation|0
6992998|NCT01323673|11053630|FG000|Overall Study|Withdrawal by Subject|2
6992999|NCT01323673|11053631|FG001|Overall Study|Withdrawal by Subject|3
6993000|NCT01323790|11053651|FG000|Overall Study|Other|3
6993001|NCT01323790|11053652|FG001|Overall Study|Other|2
6993002|NCT01323790|11053653|FG002|Overall Study|Other|1
6993003|NCT01323790|11053651|FG000|Overall Study|Lost to Follow-up|11
6993004|NCT01323790|11053652|FG001|Overall Study|Lost to Follow-up|9
6993005|NCT01323790|11053653|FG002|Overall Study|Lost to Follow-up|9
6993006|NCT01323790|11053651|FG000|Overall Study|Study-Specific Withdrawal Criteria|0
6993007|NCT01323790|11053652|FG001|Overall Study|Study-Specific Withdrawal Criteria|3
6993008|NCT01323790|11053653|FG002|Overall Study|Study-Specific Withdrawal Criteria|3
6993009|NCT01323790|11053651|FG000|Overall Study|Lack of Efficacy|3
6993010|NCT01323790|11053652|FG001|Overall Study|Lack of Efficacy|0
6993011|NCT01323790|11053653|FG002|Overall Study|Lack of Efficacy|3
6993012|NCT01323790|11053651|FG000|Overall Study|Adverse Event|11
6993013|NCT01323790|11053652|FG001|Overall Study|Adverse Event|24
6993014|NCT01323790|11053653|FG002|Overall Study|Adverse Event|12
6993015|NCT01323790|11053651|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0
6993016|NCT01323790|11053652|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0
6993017|NCT01323790|11053653|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1
6993018|NCT01323790|11053651|FG000|Overall Study|Withdrawal by Subject|23
6993019|NCT01323790|11053652|FG001|Overall Study|Withdrawal by Subject|20
6993020|NCT01323790|11053653|FG002|Overall Study|Withdrawal by Subject|13
6993021|NCT01323790|11053651|FG000|Overall Study|Did Not Receive Treatment|2
6993022|NCT01323790|11053652|FG001|Overall Study|Did Not Receive Treatment|0
6993023|NCT01323790|11053653|FG002|Overall Study|Did Not Receive Treatment|1
6993024|NCT01323790|11053651|FG000|Overall Study|Severe non-compliance with protocol|2
6993025|NCT01323790|11053652|FG001|Overall Study|Severe non-compliance with protocol|2
6993026|NCT01323790|11053653|FG002|Overall Study|Severe non-compliance with protocol|2
6993027|NCT01323920|11053682|FG000|Overall Study|Death|5
6993028|NCT01323920|11053682|FG000|Overall Study|Withdrawal by Subject|1
6993029|NCT01323946|11053689|FG000|Overall Study|Lost to Follow-up|0
6993030|NCT01323946|11053690|FG001|Overall Study|Lost to Follow-up|1
6993031|NCT01323946|11053691|FG002|Overall Study|Lost to Follow-up|0
6993032|NCT01323946|11053689|FG000|Overall Study|Parents refused the last blood draw|1
6993033|NCT01323946|11053690|FG001|Overall Study|Parents refused the last blood draw|0
6993034|NCT01323946|11053691|FG002|Overall Study|Parents refused the last blood draw|0
6993035|NCT01323946|11053689|FG000|Overall Study|Withdrawal by Subject|2
6993036|NCT01323946|11053690|FG001|Overall Study|Withdrawal by Subject|2
6993037|NCT01323946|11053691|FG002|Overall Study|Withdrawal by Subject|0
6993038|NCT01323972|11053718|FG000|Overall Study|Withdrawal by Subject|1
6993039|NCT01323972|11053719|FG001|Overall Study|Withdrawal by Subject|0
6993040|NCT01323972|11053720|FG002|Overall Study|Withdrawal by Subject|1
6993041|NCT01323972|11053721|FG003|Overall Study|Withdrawal by Subject|0
6993042|NCT01323972|11053718|FG000|Overall Study|Migrated/moved from study area|1
6993043|NCT01323972|11053719|FG001|Overall Study|Migrated/moved from study area|2
6993044|NCT01323972|11053720|FG002|Overall Study|Migrated/moved from study area|0
6993045|NCT01323972|11053721|FG003|Overall Study|Migrated/moved from study area|0
6993046|NCT01323972|11053718|FG000|Overall Study|Lost to Follow-up|0
6993047|NCT01323972|11053719|FG001|Overall Study|Lost to Follow-up|1
6993048|NCT01323972|11053720|FG002|Overall Study|Lost to Follow-up|1
6993049|NCT01323972|11053721|FG003|Overall Study|Lost to Follow-up|1
6993050|NCT01324024|11053754|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2
6993051|NCT01324024|11053755|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1
6993052|NCT01324102|11053767|FG000|Overall Study|illness|1
6993053|NCT01324102|11053768|FG001|Overall Study|illness|6
6993054|NCT01324141|11053790|FG000|Overall Study|Declined to participate before treatment started|1
6993055|NCT01324141|11053790|FG000|Overall Study|Disease progression on study|1
6993056|NCT01324232|11053808|FG000|Overall Study|Protocol Violation|0
6993057|NCT01324232|11053809|FG001|Overall Study|Protocol Violation|0
6993058|NCT01324232|11053810|FG002|Overall Study|Protocol Violation|0
6993059|NCT01324232|11053811|FG003|Overall Study|Protocol Violation|2
6993060|NCT01324232|11053808|FG000|Overall Study|Missing|0
6993061|NCT01324232|11053809|FG001|Overall Study|Missing|0
6993062|NCT01324232|11053810|FG002|Overall Study|Missing|1
6993063|NCT01324232|11053811|FG003|Overall Study|Missing|0
6993064|NCT01324232|11053808|FG000|Overall Study|Participant's Personal Reason/Decision|0
6993065|NCT01324232|11053809|FG001|Overall Study|Participant's Personal Reason/Decision|1
6993066|NCT01324232|11053810|FG002|Overall Study|Participant's Personal Reason/Decision|0
6993067|NCT01324232|11053811|FG003|Overall Study|Participant's Personal Reason/Decision|0
6993068|NCT01324232|11053808|FG000|Overall Study|Lack of Efficacy|2
6993069|NCT01324232|11053809|FG001|Overall Study|Lack of Efficacy|1
6993070|NCT01324232|11053810|FG002|Overall Study|Lack of Efficacy|2
6993071|NCT01324232|11053811|FG003|Overall Study|Lack of Efficacy|2
6993072|NCT01324232|11053808|FG000|Overall Study|Participant Refused Medication|0
6993073|NCT01324232|11053809|FG001|Overall Study|Participant Refused Medication|1
6993074|NCT01324232|11053810|FG002|Overall Study|Participant Refused Medication|0
6993075|NCT01324232|11053811|FG003|Overall Study|Participant Refused Medication|0
6993076|NCT01324232|11053808|FG000|Overall Study|Intercurrent illness|0
6993077|NCT01324232|11053809|FG001|Overall Study|Intercurrent illness|0
6993078|NCT01324232|11053810|FG002|Overall Study|Intercurrent illness|0
6993079|NCT01324232|11053811|FG003|Overall Study|Intercurrent illness|1
6993080|NCT01324232|11053808|FG000|Overall Study|Adverse Event|2
6993081|NCT01324232|11053809|FG001|Overall Study|Adverse Event|5
6993082|NCT01324232|11053810|FG002|Overall Study|Adverse Event|6
6993083|NCT01324232|11053811|FG003|Overall Study|Adverse Event|6
6993084|NCT01324232|11053808|FG000|Overall Study|Withdrawal by Subject|0
6993085|NCT01324232|11053809|FG001|Overall Study|Withdrawal by Subject|3
6993086|NCT01324232|11053810|FG002|Overall Study|Withdrawal by Subject|4
6993087|NCT01324232|11053811|FG003|Overall Study|Withdrawal by Subject|0
6993088|NCT01324232|11053808|FG000|Overall Study|Lost to Follow-up|1
6993089|NCT01324232|11053809|FG001|Overall Study|Lost to Follow-up|0
6993090|NCT01324232|11053810|FG002|Overall Study|Lost to Follow-up|0
6993091|NCT01324232|11053811|FG003|Overall Study|Lost to Follow-up|0
6993092|NCT01324271|11053826|FG000|Overall Study|Lost to Follow-up|3
6993093|NCT01324271|11053827|FG001|Overall Study|Lost to Follow-up|0
6993094|NCT01324271|11053826|FG000|Overall Study|Physician Decision|1
6993095|NCT01324271|11053827|FG001|Overall Study|Physician Decision|0
6993096|NCT01324310|11053833|FG000|Overall Study|Adverse Event|1
6993097|NCT01324310|11053833|FG000|Overall Study|Disease Progression|1
6993098|NCT01324323|11053839|FG000|Overall Study|Withdrawal by Subject|1
6993099|NCT01324349|11053853|FG000|Overall Study|Death|1
6993100|NCT01324349|11053854|FG001|Overall Study|Death|1
6993101|NCT01324349|11053853|FG000|Overall Study|Withdrawal by Subject|0
6993102|NCT01324349|11053854|FG001|Overall Study|Withdrawal by Subject|1
6993103|NCT01324388|11053863|FG000|Part 1 of Study|Adverse Event|2
6993104|NCT01324388|11053864|FG001|Part 1 of Study|Adverse Event|0
6993105|NCT01324388|11053865|FG002|Part 1 of Study|Adverse Event|0
6993106|NCT01324388|11053866|FG003|Part 1 of Study|Adverse Event|0
6993107|NCT01324388|11053863|FG000|Part 1 of Study|Protocol Violation|1
6993108|NCT01324388|11053864|FG001|Part 1 of Study|Protocol Violation|2
6993109|NCT01324388|11053865|FG002|Part 1 of Study|Protocol Violation|0
6993110|NCT01324388|11053866|FG003|Part 1 of Study|Protocol Violation|0
6993111|NCT01324388|11053863|FG000|Part 1 of Study|Physician Decision|1
6993112|NCT01324388|11053864|FG001|Part 1 of Study|Physician Decision|0
6993113|NCT01324388|11053865|FG002|Part 1 of Study|Physician Decision|0
6993114|NCT01324388|11053866|FG003|Part 1 of Study|Physician Decision|0
6993115|NCT01324388|11053863|FG000|Part 2 of Study: First Intervention|Protocol Violation|0
6993116|NCT01324388|11053864|FG001|Part 2 of Study: First Intervention|Protocol Violation|0
6993117|NCT01324388|11053865|FG002|Part 2 of Study: First Intervention|Protocol Violation|0
6993118|NCT01324388|11053866|FG003|Part 2 of Study: First Intervention|Protocol Violation|1
6993119|NCT01324388|11053863|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
6993120|NCT01324388|11053864|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
6993121|NCT01324388|11053865|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1
6993122|NCT01324388|11053866|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
6993123|NCT01324401|11053880|FG000|Overall Study|Withdrawn before any treatment|0
6993124|NCT01324401|11053881|FG001|Overall Study|Withdrawn before any treatment|3
6993125|NCT01324401|11053880|FG000|Overall Study|Adverse Event|1
6993126|NCT01324401|11053881|FG001|Overall Study|Adverse Event|3
6993127|NCT01324440|11053889|FG000|Overall Study|Subject moved|0
6993128|NCT01324440|11053890|FG001|Overall Study|Subject moved|1
6993129|NCT01324570|11053920|FG000|Overall Study|Adverse Event|4
6993130|NCT01324570|11053921|FG001|Overall Study|Adverse Event|7
6993131|NCT01324570|11053920|FG000|Overall Study|Withdrawal by Subject|0
6993132|NCT01324570|11053921|FG001|Overall Study|Withdrawal by Subject|3
6993133|NCT01324570|11053920|FG000|Overall Study|Lack of Efficacy|0
6993134|NCT01324570|11053921|FG001|Overall Study|Lack of Efficacy|1
6993135|NCT01324570|11053920|FG000|Overall Study|Confirmed or suspected diversion|0
6993136|NCT01324570|11053921|FG001|Overall Study|Confirmed or suspected diversion|1
6993137|NCT01324570|11053920|FG000|Overall Study|Administrative|0
6993138|NCT01324570|11053921|FG001|Overall Study|Administrative|2
6993139|NCT01324622|11053931|FG000|Overall Study|Lost to Follow-up|7
6993140|NCT01324622|11053932|FG001|Overall Study|Lost to Follow-up|7
6993141|NCT01324622|11053931|FG000|Overall Study|Death|1
6993142|NCT01324622|11053932|FG001|Overall Study|Death|0
6993143|NCT01324622|11053931|FG000|Overall Study|Lack of Efficacy|1
6993144|NCT01324622|11053932|FG001|Overall Study|Lack of Efficacy|0
6993145|NCT01324830|11053984|FG000|Overall Study|Progressive Disease|3
6993146|NCT01324830|11053985|FG001|Overall Study|Progressive Disease|2
6993147|NCT01324830|11053986|FG002|Overall Study|Progressive Disease|3
6993148|NCT01324830|11053987|FG003|Overall Study|Progressive Disease|3
6993149|NCT01324830|11053988|FG004|Overall Study|Progressive Disease|6
6993150|NCT01324830|11053989|FG005|Overall Study|Progressive Disease|6
6993151|NCT01324830|11053990|FG006|Overall Study|Progressive Disease|3
6993152|NCT01324830|11053991|FG007|Overall Study|Progressive Disease|3
6993153|NCT01324830|11053992|FG008|Overall Study|Progressive Disease|3
6993154|NCT01324830|11053993|FG009|Overall Study|Progressive Disease|6
6993155|NCT01324830|11053994|FG010|Overall Study|Progressive Disease|2
6993156|NCT01324830|11053995|FG011|Overall Study|Progressive Disease|1
6993157|NCT01324830|11053996|FG012|Overall Study|Progressive Disease|1
6993158|NCT01324830|11053997|FG013|Overall Study|Progressive Disease|1
6993159|NCT01324830|11053998|FG014|Overall Study|Progressive Disease|1
6993160|NCT01324830|11053999|FG015|Overall Study|Progressive Disease|3
6993161|NCT01324830|11054000|FG016|Overall Study|Progressive Disease|2
6993162|NCT01324830|11054001|FG017|Overall Study|Progressive Disease|3
6993163|NCT01324830|11054002|FG018|Overall Study|Progressive Disease|4
6993164|NCT01324830|11053984|FG000|Overall Study|Dose limiting toxicity|0
6993165|NCT01324830|11053985|FG001|Overall Study|Dose limiting toxicity|0
6993166|NCT01324830|11053986|FG002|Overall Study|Dose limiting toxicity|0
6993167|NCT01324830|11053987|FG003|Overall Study|Dose limiting toxicity|0
6993168|NCT01324830|11053988|FG004|Overall Study|Dose limiting toxicity|1
6993169|NCT01324830|11053989|FG005|Overall Study|Dose limiting toxicity|0
6993170|NCT01324830|11053990|FG006|Overall Study|Dose limiting toxicity|0
6993171|NCT01324830|11053991|FG007|Overall Study|Dose limiting toxicity|0
6993172|NCT01324830|11053992|FG008|Overall Study|Dose limiting toxicity|0
6993173|NCT01324830|11053993|FG009|Overall Study|Dose limiting toxicity|0
6993174|NCT01324830|11053994|FG010|Overall Study|Dose limiting toxicity|0
6993175|NCT01324830|11053995|FG011|Overall Study|Dose limiting toxicity|0
6993176|NCT01324830|11053996|FG012|Overall Study|Dose limiting toxicity|0
6993177|NCT01324830|11053997|FG013|Overall Study|Dose limiting toxicity|0
6993178|NCT01324830|11053998|FG014|Overall Study|Dose limiting toxicity|0
6993179|NCT01324830|11053999|FG015|Overall Study|Dose limiting toxicity|0
6993180|NCT01324830|11054000|FG016|Overall Study|Dose limiting toxicity|1
6993181|NCT01324830|11054001|FG017|Overall Study|Dose limiting toxicity|1
6993182|NCT01324830|11054002|FG018|Overall Study|Dose limiting toxicity|1
6993183|NCT01324830|11053984|FG000|Overall Study|Reason not mentioned above|0
6993184|NCT01324830|11053985|FG001|Overall Study|Reason not mentioned above|0
6993185|NCT01324830|11053986|FG002|Overall Study|Reason not mentioned above|0
6993186|NCT01324830|11053987|FG003|Overall Study|Reason not mentioned above|0
6993187|NCT01324830|11053988|FG004|Overall Study|Reason not mentioned above|0
6993188|NCT01324830|11053989|FG005|Overall Study|Reason not mentioned above|0
6993189|NCT01324830|11053990|FG006|Overall Study|Reason not mentioned above|0
6993190|NCT01324830|11053991|FG007|Overall Study|Reason not mentioned above|0
6993191|NCT01324830|11053992|FG008|Overall Study|Reason not mentioned above|0
6993192|NCT01324830|11053993|FG009|Overall Study|Reason not mentioned above|0
6993193|NCT01324830|11053994|FG010|Overall Study|Reason not mentioned above|0
6993194|NCT01324830|11053995|FG011|Overall Study|Reason not mentioned above|0
6993195|NCT01324830|11053996|FG012|Overall Study|Reason not mentioned above|0
6993196|NCT01324830|11053997|FG013|Overall Study|Reason not mentioned above|0
6993197|NCT01324830|11053998|FG014|Overall Study|Reason not mentioned above|0
6993198|NCT01324830|11053999|FG015|Overall Study|Reason not mentioned above|0
6993199|NCT01324830|11054000|FG016|Overall Study|Reason not mentioned above|0
6993200|NCT01324830|11054001|FG017|Overall Study|Reason not mentioned above|1
6993201|NCT01324830|11054002|FG018|Overall Study|Reason not mentioned above|0
6993202|NCT01324830|11053984|FG000|Overall Study|Adverse Event, serious fatal|0
6993203|NCT01324830|11053985|FG001|Overall Study|Adverse Event, serious fatal|1
6993204|NCT01324830|11053986|FG002|Overall Study|Adverse Event, serious fatal|0
6993205|NCT01324830|11053987|FG003|Overall Study|Adverse Event, serious fatal|0
6993206|NCT01324830|11053988|FG004|Overall Study|Adverse Event, serious fatal|0
6993207|NCT01324830|11053989|FG005|Overall Study|Adverse Event, serious fatal|0
6993208|NCT01324830|11053990|FG006|Overall Study|Adverse Event, serious fatal|0
6993209|NCT01324830|11053991|FG007|Overall Study|Adverse Event, serious fatal|0
6993210|NCT01324830|11053992|FG008|Overall Study|Adverse Event, serious fatal|0
6993211|NCT01324830|11053993|FG009|Overall Study|Adverse Event, serious fatal|0
6993212|NCT01324830|11053994|FG010|Overall Study|Adverse Event, serious fatal|0
6993213|NCT01324830|11053995|FG011|Overall Study|Adverse Event, serious fatal|0
6993214|NCT01324830|11053996|FG012|Overall Study|Adverse Event, serious fatal|0
6993215|NCT01324830|11053997|FG013|Overall Study|Adverse Event, serious fatal|0
6993216|NCT01324830|11053998|FG014|Overall Study|Adverse Event, serious fatal|0
6993217|NCT01324830|11053999|FG015|Overall Study|Adverse Event, serious fatal|0
6993218|NCT01324830|11054000|FG016|Overall Study|Adverse Event, serious fatal|0
6993219|NCT01324830|11054001|FG017|Overall Study|Adverse Event, serious fatal|0
6993220|NCT01324830|11054002|FG018|Overall Study|Adverse Event, serious fatal|0
6993221|NCT01324830|11053984|FG000|Overall Study|Adverse Event, non-fatal|0
6993222|NCT01324830|11053985|FG001|Overall Study|Adverse Event, non-fatal|0
6993223|NCT01324830|11053986|FG002|Overall Study|Adverse Event, non-fatal|0
6993224|NCT01324830|11053987|FG003|Overall Study|Adverse Event, non-fatal|0
6993225|NCT01324830|11053988|FG004|Overall Study|Adverse Event, non-fatal|0
6993226|NCT01324830|11053989|FG005|Overall Study|Adverse Event, non-fatal|0
6993227|NCT01324830|11053990|FG006|Overall Study|Adverse Event, non-fatal|0
6993228|NCT01324830|11053991|FG007|Overall Study|Adverse Event, non-fatal|0
6993229|NCT01324830|11053992|FG008|Overall Study|Adverse Event, non-fatal|2
6993230|NCT01324830|11053993|FG009|Overall Study|Adverse Event, non-fatal|0
6993231|NCT01324830|11053994|FG010|Overall Study|Adverse Event, non-fatal|1
6993232|NCT01324830|11053995|FG011|Overall Study|Adverse Event, non-fatal|0
6993233|NCT01324830|11053996|FG012|Overall Study|Adverse Event, non-fatal|0
6993234|NCT01324830|11053997|FG013|Overall Study|Adverse Event, non-fatal|0
6993235|NCT01324830|11053998|FG014|Overall Study|Adverse Event, non-fatal|0
6993236|NCT01324830|11053999|FG015|Overall Study|Adverse Event, non-fatal|0
6993237|NCT01324830|11054000|FG016|Overall Study|Adverse Event, non-fatal|0
6993238|NCT01324830|11054001|FG017|Overall Study|Adverse Event, non-fatal|1
6993239|NCT01324830|11054002|FG018|Overall Study|Adverse Event, non-fatal|0
6993240|NCT01324830|11053984|FG000|Overall Study|Withdrawal by Subject|0
6993241|NCT01324830|11053985|FG001|Overall Study|Withdrawal by Subject|0
6993242|NCT01324830|11053986|FG002|Overall Study|Withdrawal by Subject|0
6993243|NCT01324830|11053987|FG003|Overall Study|Withdrawal by Subject|0
6993244|NCT01324830|11053988|FG004|Overall Study|Withdrawal by Subject|0
6993245|NCT01324830|11053989|FG005|Overall Study|Withdrawal by Subject|1
6993246|NCT01324830|11053990|FG006|Overall Study|Withdrawal by Subject|0
6993247|NCT01324830|11053991|FG007|Overall Study|Withdrawal by Subject|0
6993248|NCT01324830|11053992|FG008|Overall Study|Withdrawal by Subject|0
6993249|NCT01324830|11053993|FG009|Overall Study|Withdrawal by Subject|0
6993250|NCT01324830|11053994|FG010|Overall Study|Withdrawal by Subject|1
6993251|NCT01324830|11053995|FG011|Overall Study|Withdrawal by Subject|0
6993252|NCT01324830|11053996|FG012|Overall Study|Withdrawal by Subject|0
6993253|NCT01324830|11053997|FG013|Overall Study|Withdrawal by Subject|0
6993254|NCT01324830|11053998|FG014|Overall Study|Withdrawal by Subject|0
6993255|NCT01324830|11053999|FG015|Overall Study|Withdrawal by Subject|0
6993256|NCT01324830|11054000|FG016|Overall Study|Withdrawal by Subject|0
6993257|NCT01324830|11054001|FG017|Overall Study|Withdrawal by Subject|0
6993258|NCT01324830|11054002|FG018|Overall Study|Withdrawal by Subject|1
6993259|NCT01324947|11054059|FG000|Overall Study|Adverse Event|7
6993260|NCT01324947|11054059|FG000|Overall Study|Death|10
6993261|NCT01324947|11054059|FG000|Overall Study|Other|3
6993262|NCT01324947|11054059|FG000|Overall Study|Progressive Disease|50
6993263|NCT01324947|11054059|FG000|Overall Study|Withdrawal by Subject|3
6993264|NCT01324947|11054059|FG000|Overall Study|1 discontinued before starting drug|1
6993265|NCT01324999|11054065|FG000|Overall Study|Adverse Event|3
6993266|NCT01324999|11054065|FG000|Overall Study|Withdrawal by Subject|2
6993267|NCT01325207|11054084|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
6993268|NCT01325207|11054085|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
6993269|NCT01325207|11054086|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
6993270|NCT01325207|11054087|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
6993271|NCT01325207|11054088|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2
6993272|NCT01325207|11054089|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
6993273|NCT01325207|11054084|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1
6993274|NCT01325207|11054085|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1
6993275|NCT01325207|11054086|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0
6993276|NCT01325207|11054087|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0
6993277|NCT01325207|11054088|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2
6993278|NCT01325207|11054089|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5
6993279|NCT01325207|11054084|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
6993280|NCT01325207|11054085|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
6993281|NCT01325207|11054086|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
6993282|NCT01325207|11054087|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
6993283|NCT01325207|11054088|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0
6993284|NCT01325207|11054089|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4
6993285|NCT01325207|11054084|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
6993286|NCT01325207|11054085|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1
6993287|NCT01325207|11054086|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
6993288|NCT01325207|11054087|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
6993289|NCT01325207|11054088|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
6993290|NCT01325207|11054089|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
6993291|NCT01325207|11054084|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
6993292|NCT01325207|11054085|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
6993293|NCT01325207|11054086|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
6993294|NCT01325207|11054087|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
6993295|NCT01325207|11054088|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
6993296|NCT01325207|11054089|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1
6993297|NCT01325207|11054084|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
6993298|NCT01325207|11054085|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
6993299|NCT01325207|11054086|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
6993300|NCT01325207|11054087|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
6993301|NCT01325207|11054088|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
6993302|NCT01325207|11054089|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1
6993303|NCT01325207|11054084|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
6993304|NCT01325207|11054085|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
6993305|NCT01325207|11054086|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
6993306|NCT01325207|11054087|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
6993307|NCT01325207|11054088|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1
6993308|NCT01325207|11054089|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
6993309|NCT01325337|11054118|FG000|Overall Study|Adverse Event|0
6993310|NCT01325337|11054119|FG001|Overall Study|Adverse Event|2
6993311|NCT01325337|11054120|FG002|Overall Study|Adverse Event|2
6993312|NCT01325337|11054121|FG003|Overall Study|Adverse Event|1
6993313|NCT01325337|11054122|FG004|Overall Study|Adverse Event|2
6993314|NCT01325337|11054118|FG000|Overall Study|Lost to Follow-up|2
6993315|NCT01325337|11054119|FG001|Overall Study|Lost to Follow-up|2
6993316|NCT01325337|11054120|FG002|Overall Study|Lost to Follow-up|2
6993317|NCT01325337|11054121|FG003|Overall Study|Lost to Follow-up|1
6993318|NCT01325337|11054122|FG004|Overall Study|Lost to Follow-up|2
6993319|NCT01325337|11054118|FG000|Overall Study|Personal Reasons|2
6993320|NCT01325337|11054119|FG001|Overall Study|Personal Reasons|5
6993321|NCT01325337|11054120|FG002|Overall Study|Personal Reasons|4
6993322|NCT01325337|11054121|FG003|Overall Study|Personal Reasons|8
6993323|NCT01325337|11054122|FG004|Overall Study|Personal Reasons|3
6993324|NCT01325337|11054118|FG000|Overall Study|Withdrawal by Subject|1
6993325|NCT01325337|11054119|FG001|Overall Study|Withdrawal by Subject|0
6993326|NCT01325337|11054120|FG002|Overall Study|Withdrawal by Subject|1
6993327|NCT01325337|11054121|FG003|Overall Study|Withdrawal by Subject|0
6993328|NCT01325337|11054122|FG004|Overall Study|Withdrawal by Subject|1
6993329|NCT01325350|11054139|FG000|Overall Study|Adverse Event|3
6993330|NCT01325350|11054140|FG001|Overall Study|Adverse Event|3
6993331|NCT01325350|11054141|FG002|Overall Study|Adverse Event|3
6993332|NCT01325350|11054142|FG003|Overall Study|Adverse Event|1
6993333|NCT01325350|11054143|FG004|Overall Study|Adverse Event|2
6993334|NCT01325350|11054139|FG000|Overall Study|Pregnancy|0
6993335|NCT01325350|11054140|FG001|Overall Study|Pregnancy|0
6993336|NCT01325350|11054141|FG002|Overall Study|Pregnancy|1
6993337|NCT01325350|11054142|FG003|Overall Study|Pregnancy|0
6993338|NCT01325350|11054143|FG004|Overall Study|Pregnancy|1
6993339|NCT01325350|11054139|FG000|Overall Study|Lost to Follow-up|1
6993340|NCT01325350|11054140|FG001|Overall Study|Lost to Follow-up|0
6993341|NCT01325350|11054141|FG002|Overall Study|Lost to Follow-up|5
6993342|NCT01325350|11054142|FG003|Overall Study|Lost to Follow-up|1
6993343|NCT01325350|11054143|FG004|Overall Study|Lost to Follow-up|5
6993344|NCT01325350|11054139|FG000|Overall Study|Personal Reasons|2
6993345|NCT01325350|11054140|FG001|Overall Study|Personal Reasons|1
6993346|NCT01325350|11054141|FG002|Overall Study|Personal Reasons|6
6993347|NCT01325350|11054142|FG003|Overall Study|Personal Reasons|5
6993348|NCT01325350|11054143|FG004|Overall Study|Personal Reasons|3
6993349|NCT01325350|11054139|FG000|Overall Study|Protocol Violation|0
6993350|NCT01325350|11054140|FG001|Overall Study|Protocol Violation|0
6993351|NCT01325350|11054141|FG002|Overall Study|Protocol Violation|0
6993352|NCT01325350|11054142|FG003|Overall Study|Protocol Violation|1
6993353|NCT01325350|11054143|FG004|Overall Study|Protocol Violation|0
6993354|NCT01325350|11054139|FG000|Overall Study|Withdrawal by Subject|0
6993355|NCT01325350|11054140|FG001|Overall Study|Withdrawal by Subject|0
6993356|NCT01325350|11054141|FG002|Overall Study|Withdrawal by Subject|1
6993357|NCT01325350|11054142|FG003|Overall Study|Withdrawal by Subject|1
6993358|NCT01325350|11054143|FG004|Overall Study|Withdrawal by Subject|0
6993359|NCT01325350|11054139|FG000|Overall Study|Did Not Receive Treatment|0
6993360|NCT01325350|11054140|FG001|Overall Study|Did Not Receive Treatment|1
6993361|NCT01325350|11054141|FG002|Overall Study|Did Not Receive Treatment|1
6993362|NCT01325350|11054142|FG003|Overall Study|Did Not Receive Treatment|0
6993363|NCT01325350|11054143|FG004|Overall Study|Did Not Receive Treatment|1
6993364|NCT01325428|11054155|FG000|Part A|Progressive disease according to RECIST|9
6993365|NCT01325428|11054155|FG000|Part A|Clinical signs, symptoms of progression|2
6993366|NCT01325428|11054155|FG000|Part A|Other adverse event|1
6993367|NCT01325428|11054155|FG000|Part A|Refused continue taking trial medication|2
6993368|NCT01325428|11054155|FG000|Part A|Other reason not defined above|2
6993369|NCT01325428|11054155|FG000|Part B|Refused continue taking trial medication|2
6993370|NCT01325428|11054155|FG000|Part B|Other reason not defined above|1
6993371|NCT01325493|11054166|FG000|Overall Study|Protocol Violation|0
6993372|NCT01325493|11054167|FG001|Overall Study|Protocol Violation|1
6993373|NCT01325493|11054166|FG000|Overall Study|loss of neuromonitoring signals|0
6993374|NCT01325493|11054167|FG001|Overall Study|loss of neuromonitoring signals|2
6993375|NCT01325493|11054166|FG000|Overall Study|Allergy|1
6993376|NCT01325493|11054167|FG001|Overall Study|Allergy|0
6993377|NCT01325532|11054175|FG000|Overall Study|Withdrawal by Subject|2
6993378|NCT01325532|11054176|FG001|Overall Study|Withdrawal by Subject|0
6993379|NCT01325584|11054182|FG000|Overall Study|Death|1
6993380|NCT01325623|11054186|FG000|Overall Study|Withdrawal by Subject|3
6993381|NCT01325701|11054225|FG000|Overall Study|Adverse Event|12
6993382|NCT01325701|11054226|FG001|Overall Study|Adverse Event|0
6993383|NCT01325701|11054225|FG000|Overall Study|Protocol Violation|1
6993384|NCT01325701|11054226|FG001|Overall Study|Protocol Violation|0
6993385|NCT01325701|11054225|FG000|Overall Study|Physician Decision|2
6993386|NCT01325701|11054226|FG001|Overall Study|Physician Decision|2
6993387|NCT01325701|11054225|FG000|Overall Study|Withdrawal by Subject|2
6993388|NCT01325701|11054226|FG001|Overall Study|Withdrawal by Subject|1
6993389|NCT01325701|11054225|FG000|Overall Study|Rollerover Extension Study|4
6993390|NCT01325701|11054226|FG001|Overall Study|Rollerover Extension Study|0
7042438|NCT01736176|11126872|FG000|Overall Study|Unable to Complete PEG Placement|1
7042439|NCT01736189|11126880|FG000|Overall Study|Violation of registration criteria|41
7042440|NCT01736189|11126880|FG000|Overall Study|Protocol Violation|4
7042441|NCT01736189|11126880|FG000|Overall Study|Criteria and protocol violations|1
7042442|NCT01736215|11126884|FG000|Overall Study|Early termination of erythropoietin use|1
7042443|NCT01736215|11126884|FG000|Overall Study|Adverse Event|4
7042444|NCT01736215|11126884|FG000|Overall Study|Progressive disease stop chemotherapy|1
7042445|NCT01736215|11126884|FG000|Overall Study|Insufficient data to perform analysis|8
7042446|NCT01736254|11126918|FG000|Period 2 (Days 2 to 12)|Adverse Event|3
7042447|NCT01736254|11126918|FG000|Period 3 (Days 13 to 23)|Adverse Event|1
7042448|NCT01736397|11126941|FG000|Overall Study|Lack of Efficacy|1
7042449|NCT01736397|11126942|FG001|Overall Study|Lack of Efficacy|11
7042450|NCT01736397|11126941|FG000|Overall Study|Withdrawal by Subject|6
7042451|NCT01736397|11126942|FG001|Overall Study|Withdrawal by Subject|5
7042452|NCT01736397|11126941|FG000|Overall Study|Lost to Follow-up|0
7042453|NCT01736397|11126942|FG001|Overall Study|Lost to Follow-up|1
7042454|NCT01736397|11126941|FG000|Overall Study|Adverse Event|6
7042455|NCT01736397|11126942|FG001|Overall Study|Adverse Event|3
7042456|NCT01736397|11126941|FG000|Overall Study|Not stated|1
7042457|NCT01736397|11126942|FG001|Overall Study|Not stated|4
7042458|NCT01736475|11126950|FG000|Overall Study|Adverse Event|4
7042459|NCT01736475|11126951|FG001|Overall Study|Adverse Event|0
7042460|NCT01736475|11126950|FG000|Overall Study|Withdrawal by Subject|2
7042461|NCT01736475|11126951|FG001|Overall Study|Withdrawal by Subject|0
7042462|NCT01736475|11126950|FG000|Overall Study|Protocol Violation|4
7042463|NCT01736475|11126951|FG001|Overall Study|Protocol Violation|0
7042464|NCT01736475|11126950|FG000|Overall Study|Other - Screen failure|1
7042465|NCT01736475|11126951|FG001|Overall Study|Other - Screen failure|0
7042466|NCT01736475|11126950|FG000|Overall Study|Other - Surgical procedure|1
6993391|NCT01326026|11054263|FG000|Overall Study|Adverse Event|4
6993392|NCT01326026|11054264|FG001|Overall Study|Adverse Event|3
6993393|NCT01326026|11054263|FG000|Overall Study|Withdrawal Criteria|5
6993394|NCT01326026|11054264|FG001|Overall Study|Withdrawal Criteria|7
6993395|NCT01326026|11054263|FG000|Overall Study|Other|3
6993396|NCT01326026|11054264|FG001|Overall Study|Other|3
6993397|NCT01326481|11054270|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1
6993398|NCT01326533|11054278|FG000|Overall Study|Lost to Follow-up|2
6993399|NCT01326533|11054279|FG001|Overall Study|Lost to Follow-up|0
6993400|NCT01326533|11054278|FG000|Overall Study|Withdrawal by Subject|1
6993401|NCT01326533|11054279|FG001|Overall Study|Withdrawal by Subject|0
6993402|NCT01326533|11054278|FG000|Overall Study|Adverse Event|1
6993403|NCT01326533|11054279|FG001|Overall Study|Adverse Event|0
6993404|NCT01326546|11054287|FG000|Overall Study|Lost to Follow-up|8
6993405|NCT01326546|11054288|FG001|Overall Study|Lost to Follow-up|7
6993406|NCT01326546|11054287|FG000|Overall Study|Protocol Violation|3
6993407|NCT01326546|11054288|FG001|Overall Study|Protocol Violation|4
6993408|NCT01326546|11054287|FG000|Overall Study|Pregnancy|0
6993409|NCT01326546|11054288|FG001|Overall Study|Pregnancy|1
6993410|NCT01326546|11054287|FG000|Overall Study|Adverse Event|1
6993411|NCT01326546|11054288|FG001|Overall Study|Adverse Event|0
6993412|NCT01326546|11054287|FG000|Overall Study|Withdrawal by Subject|5
6993413|NCT01326546|11054288|FG001|Overall Study|Withdrawal by Subject|1
6993414|NCT01326702|11054301|FG000|Overall Study|Other|1
6993415|NCT01326702|11054302|FG001|Overall Study|Other|0
6993416|NCT01326702|11054303|FG002|Overall Study|Other|0
6993417|NCT01326702|11054304|FG003|Overall Study|Other|0
6993418|NCT01326702|11054305|FG004|Overall Study|Other|0
6993419|NCT01326702|11054306|FG005|Overall Study|Other|1
6993420|NCT01326702|11054307|FG006|Overall Study|Other|0
6993421|NCT01326702|11054301|FG000|Overall Study|progressive disease|1
6993422|NCT01326702|11054302|FG001|Overall Study|progressive disease|1
6993423|NCT01326702|11054303|FG002|Overall Study|progressive disease|3
6993424|NCT01326702|11054304|FG003|Overall Study|progressive disease|1
6993425|NCT01326702|11054305|FG004|Overall Study|progressive disease|3
6993426|NCT01326702|11054306|FG005|Overall Study|progressive disease|2
6993427|NCT01326702|11054307|FG006|Overall Study|progressive disease|3
6993428|NCT01326702|11054301|FG000|Overall Study|Death|0
6993429|NCT01326702|11054302|FG001|Overall Study|Death|1
6993430|NCT01326702|11054303|FG002|Overall Study|Death|0
6993431|NCT01326702|11054304|FG003|Overall Study|Death|0
6993432|NCT01326702|11054305|FG004|Overall Study|Death|0
6993433|NCT01326702|11054306|FG005|Overall Study|Death|0
6993434|NCT01326702|11054307|FG006|Overall Study|Death|0
6993435|NCT01326702|11054301|FG000|Overall Study|Adverse Event|0
6993436|NCT01326702|11054302|FG001|Overall Study|Adverse Event|0
6993437|NCT01326702|11054303|FG002|Overall Study|Adverse Event|1
6993438|NCT01326702|11054304|FG003|Overall Study|Adverse Event|1
6993439|NCT01326702|11054305|FG004|Overall Study|Adverse Event|0
6993440|NCT01326702|11054306|FG005|Overall Study|Adverse Event|3
6993441|NCT01326702|11054307|FG006|Overall Study|Adverse Event|1
6993442|NCT01326702|11054301|FG000|Overall Study|Withdrawal by Subject|0
6993443|NCT01326702|11054302|FG001|Overall Study|Withdrawal by Subject|0
6993444|NCT01326702|11054303|FG002|Overall Study|Withdrawal by Subject|1
6993445|NCT01326702|11054304|FG003|Overall Study|Withdrawal by Subject|0
6993446|NCT01326702|11054305|FG004|Overall Study|Withdrawal by Subject|1
6993447|NCT01326702|11054306|FG005|Overall Study|Withdrawal by Subject|1
6993448|NCT01326702|11054307|FG006|Overall Study|Withdrawal by Subject|3
6993449|NCT01326702|11054301|FG000|Overall Study|Not Treated|0
6993450|NCT01326702|11054302|FG001|Overall Study|Not Treated|0
6993451|NCT01326702|11054303|FG002|Overall Study|Not Treated|0
6993452|NCT01326702|11054304|FG003|Overall Study|Not Treated|1
6993453|NCT01326702|11054305|FG004|Overall Study|Not Treated|0
6993454|NCT01326702|11054306|FG005|Overall Study|Not Treated|1
6993455|NCT01326702|11054307|FG006|Overall Study|Not Treated|0
6993456|NCT01326728|11054328|FG000|Overall Study|Death|13
6993457|NCT01326728|11054329|FG001|Overall Study|Death|0
6993458|NCT01326728|11054328|FG000|Overall Study|Early closure of study|34
6993459|NCT01326728|11054329|FG001|Overall Study|Early closure of study|9
6993460|NCT01326910|11054353|FG000|Overall Study|Withdrawal by Subject|3
6993461|NCT01326910|11054354|FG001|Overall Study|Withdrawal by Subject|2
6993462|NCT01326910|11054353|FG000|Overall Study|Protocol Violation|1
6993463|NCT01326910|11054354|FG001|Overall Study|Protocol Violation|1
6993464|NCT01326962|11054360|FG000|Overall Study|Adverse Event|1
6993465|NCT01326962|11054360|FG000|Overall Study|Withdrawal by Subject|1
6993466|NCT01326962|11054360|FG000|Overall Study|Lost to Follow-up|3
6993467|NCT01326962|11054360|FG000|Overall Study|Other|2
6993468|NCT01327053|11054366|FG000|Overall Study|Adverse Event|23
6993469|NCT01327053|11054367|FG001|Overall Study|Adverse Event|57
6993470|NCT01327053|11054366|FG000|Overall Study|Patient/guardian decision|11
6993471|NCT01327053|11054367|FG001|Overall Study|Patient/guardian decision|35
6993472|NCT01327053|11054366|FG000|Overall Study|Physician Decision|10
6993473|NCT01327053|11054367|FG001|Overall Study|Physician Decision|14
6993474|NCT01327053|11054366|FG000|Overall Study|Death|1
6993475|NCT01327053|11054367|FG001|Overall Study|Death|5
6993476|NCT01327053|11054366|FG000|Overall Study|Lost to Follow-up|2
6993477|NCT01327053|11054367|FG001|Overall Study|Lost to Follow-up|4
6993478|NCT01327053|11054366|FG000|Overall Study|Non-compliance with study treatment|0
6993479|NCT01327053|11054367|FG001|Overall Study|Non-compliance with study treatment|5
6993480|NCT01327053|11054366|FG000|Overall Study|Study terminated by Sponsor|1
6993481|NCT01327053|11054367|FG001|Overall Study|Study terminated by Sponsor|3
6993482|NCT01327053|11054366|FG000|Overall Study|Progressive disease|31
6993483|NCT01327053|11054367|FG001|Overall Study|Progressive disease|26
6993484|NCT01327053|11054366|FG000|Overall Study|Protocol Violation|0
6993485|NCT01327053|11054367|FG001|Overall Study|Protocol Violation|1
6993486|NCT01327053|11054366|FG000|Overall Study|Untreated|0
6993487|NCT01327053|11054367|FG001|Overall Study|Untreated|1
6993488|NCT01327300|11054396|FG000|Washout (3 Weeks)|Withdrawal by Subject|1
6993489|NCT01327300|11054397|FG001|Washout (3 Weeks)|Withdrawal by Subject|0
6993490|NCT01327339|11054430|FG000|Overall Study|Protocol Violation|8
6993491|NCT01327482|11054434|FG000|Overall Study|Adverse Event|1
6993492|NCT01327495|11054444|FG000|Overall Study|Adverse Event|2
6993493|NCT01327495|11054445|FG001|Overall Study|Adverse Event|1
6993494|NCT01327495|11054446|FG002|Overall Study|Adverse Event|1
6993495|NCT01327495|11054447|FG003|Overall Study|Adverse Event|0
6993496|NCT01327495|11054448|FG004|Overall Study|Adverse Event|0
6993497|NCT01327495|11054449|FG005|Overall Study|Adverse Event|2
6993498|NCT01327495|11054444|FG000|Overall Study|Withdrawal by Subject|0
6993499|NCT01327495|11054445|FG001|Overall Study|Withdrawal by Subject|1
6993500|NCT01327495|11054446|FG002|Overall Study|Withdrawal by Subject|1
6993501|NCT01327495|11054447|FG003|Overall Study|Withdrawal by Subject|0
6993502|NCT01327495|11054448|FG004|Overall Study|Withdrawal by Subject|1
6993503|NCT01327495|11054449|FG005|Overall Study|Withdrawal by Subject|0
6993504|NCT01327495|11054444|FG000|Overall Study|Physician Decision|0
6993505|NCT01327495|11054445|FG001|Overall Study|Physician Decision|0
6993506|NCT01327495|11054446|FG002|Overall Study|Physician Decision|0
6993507|NCT01327495|11054447|FG003|Overall Study|Physician Decision|0
6993508|NCT01327495|11054448|FG004|Overall Study|Physician Decision|2
6993509|NCT01327495|11054449|FG005|Overall Study|Physician Decision|0
6993510|NCT01327547|11054480|FG000|Overall Study|Adverse Event|4
6993511|NCT01327547|11054481|FG001|Overall Study|Adverse Event|1
6993512|NCT01327547|11054480|FG000|Overall Study|Death|1
6993513|NCT01327547|11054481|FG001|Overall Study|Death|2
6993514|NCT01327547|11054480|FG000|Overall Study|Lost to Follow-up|6
6993515|NCT01327547|11054481|FG001|Overall Study|Lost to Follow-up|6
6993516|NCT01327547|11054480|FG000|Overall Study|Non-Compliance With Study Treatment|0
6993517|NCT01327547|11054481|FG001|Overall Study|Non-Compliance With Study Treatment|2
6993518|NCT01327547|11054480|FG000|Overall Study|Withdrawal by Subject|3
6993519|NCT01327547|11054481|FG001|Overall Study|Withdrawal by Subject|7
6993520|NCT01327547|11054480|FG000|Overall Study|Does Not Meet Entrance Criteria|2
6993521|NCT01327547|11054481|FG001|Overall Study|Does Not Meet Entrance Criteria|2
6993522|NCT01327547|11054480|FG000|Overall Study|Protocol Violation|1
6993523|NCT01327547|11054481|FG001|Overall Study|Protocol Violation|0
6993524|NCT01327547|11054480|FG000|Overall Study|Non-compliance due to alcohol intake|0
6993525|NCT01327547|11054481|FG001|Overall Study|Non-compliance due to alcohol intake|1
6993526|NCT01327547|11054480|FG000|Overall Study|Required prohibited medication|2
6993527|NCT01327547|11054481|FG001|Overall Study|Required prohibited medication|0
6993528|NCT01327547|11054480|FG000|Overall Study|Non-compliance with study procedures|1
6993529|NCT01327547|11054481|FG001|Overall Study|Non-compliance with study procedures|0
6993530|NCT01327547|11054480|FG000|Overall Study|By investigator in subject's interest|0
6993531|NCT01327547|11054481|FG001|Overall Study|By investigator in subject's interest|1
6993532|NCT01327573|11054498|FG000|Overall Study|Physician Decision|3
6993533|NCT01327573|11054499|FG001|Overall Study|Physician Decision|1
6993534|NCT01327599|11054506|FG000|Overall Study|Adverse Event|1
6993535|NCT01327599|11054506|FG000|Overall Study|Could Not Attend Visit|1
6993536|NCT01327599|11054506|FG000|Overall Study|Withdrawal of Consent|1
6993537|NCT01327612|11054517|FG000|Overall Study|Withdrawal by Subject|0
6993538|NCT01327612|11054518|FG001|Overall Study|Withdrawal by Subject|0
6993539|NCT01327612|11054519|FG002|Overall Study|Withdrawal by Subject|0
6993540|NCT01327612|11054520|FG003|Overall Study|Withdrawal by Subject|0
6993541|NCT01327612|11054521|FG004|Overall Study|Withdrawal by Subject|0
6993542|NCT01327612|11054522|FG005|Overall Study|Withdrawal by Subject|1
6993543|NCT01327612|11054523|FG006|Overall Study|Withdrawal by Subject|0
7060324|NCT01917006|11156409|FG001|Randomized-treatment Period|Protocol Violation|0
7060325|NCT01917006|11156410|FG002|Randomized-treatment Period|Protocol Violation|0
7060326|NCT01917006|11156411|FG003|Randomized-treatment Period|Protocol Violation|0
7060327|NCT01917006|11156412|FG004|Randomized-treatment Period|Protocol Violation|0
7060328|NCT01917006|11156413|FG005|Randomized-treatment Period|Protocol Violation|0
7060329|NCT01917006|11156414|FG006|Randomized-treatment Period|Protocol Violation|0
7060330|NCT01917006|11156415|FG007|Randomized-treatment Period|Protocol Violation|0
7060331|NCT01917006|11156408|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0
7060332|NCT01917006|11156409|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0
7060333|NCT01917006|11156410|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0
7060334|NCT01917006|11156411|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0
7060335|NCT01917006|11156412|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0
7060336|NCT01917006|11156413|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0
7060337|NCT01917006|11156414|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1
7060338|NCT01917006|11156415|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0
7060339|NCT01917006|11156408|FG000|Open-label Period|Adverse Event|0
7060340|NCT01917006|11156409|FG001|Open-label Period|Adverse Event|0
6993544|NCT01327612|11054517|FG000|Overall Study|Disease Progression|1
6993545|NCT01327612|11054518|FG001|Overall Study|Disease Progression|1
6993546|NCT01327612|11054519|FG002|Overall Study|Disease Progression|1
6993547|NCT01327612|11054520|FG003|Overall Study|Disease Progression|0
6993548|NCT01327612|11054521|FG004|Overall Study|Disease Progression|1
6993549|NCT01327612|11054522|FG005|Overall Study|Disease Progression|2
6993550|NCT01327612|11054523|FG006|Overall Study|Disease Progression|2
6993551|NCT01327612|11054517|FG000|Overall Study|Administrative Decision|0
6993552|NCT01327612|11054518|FG001|Overall Study|Administrative Decision|0
6993553|NCT01327612|11054519|FG002|Overall Study|Administrative Decision|0
6993554|NCT01327612|11054520|FG003|Overall Study|Administrative Decision|1
6993555|NCT01327612|11054521|FG004|Overall Study|Administrative Decision|0
6993556|NCT01327612|11054522|FG005|Overall Study|Administrative Decision|0
6993557|NCT01327612|11054523|FG006|Overall Study|Administrative Decision|0
6993558|NCT01327612|11054517|FG000|Overall Study|Death|0
6993559|NCT01327612|11054518|FG001|Overall Study|Death|0
6993560|NCT01327612|11054519|FG002|Overall Study|Death|0
6993561|NCT01327612|11054520|FG003|Overall Study|Death|0
6993562|NCT01327612|11054521|FG004|Overall Study|Death|1
6993563|NCT01327612|11054522|FG005|Overall Study|Death|0
6993564|NCT01327612|11054523|FG006|Overall Study|Death|0
6993565|NCT01327651|11054549|FG000|Self-administered Dosing Period|Lost to Follow-up|3
6993566|NCT01327651|11054550|FG001|Self-administered Dosing Period|Lost to Follow-up|2
6993567|NCT01327651|11054551|FG002|Self-administered Dosing Period|Lost to Follow-up|4
6993568|NCT01327651|11054552|FG003|Self-administered Dosing Period|Lost to Follow-up|2
6993569|NCT01327651|11054553|FG004|Self-administered Dosing Period|Lost to Follow-up|3
6993570|NCT01327651|11054554|FG005|Self-administered Dosing Period|Lost to Follow-up|0
6993571|NCT01327651|11054555|FG006|Self-administered Dosing Period|Lost to Follow-up|8
6993572|NCT01327651|11054556|FG007|Self-administered Dosing Period|Lost to Follow-up|9
6993573|NCT01327651|11054557|FG008|Self-administered Dosing Period|Lost to Follow-up|10
6993574|NCT01327651|11054549|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1
6993575|NCT01327651|11054550|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0
6993576|NCT01327651|11054551|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0
6993577|NCT01327651|11054552|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0
6993578|NCT01327651|11054553|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0
6993579|NCT01327651|11054554|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0
6993580|NCT01327651|11054555|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0
6993581|NCT01327651|11054556|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0
6993582|NCT01327651|11054557|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0
6993583|NCT01327651|11054549|FG000|Self-administered Dosing Period|Withdrawal by Subject|0
6993584|NCT01327651|11054550|FG001|Self-administered Dosing Period|Withdrawal by Subject|1
6993585|NCT01327651|11054551|FG002|Self-administered Dosing Period|Withdrawal by Subject|0
6993586|NCT01327651|11054552|FG003|Self-administered Dosing Period|Withdrawal by Subject|1
6993587|NCT01327651|11054553|FG004|Self-administered Dosing Period|Withdrawal by Subject|0
6993588|NCT01327651|11054554|FG005|Self-administered Dosing Period|Withdrawal by Subject|0
6993589|NCT01327651|11054555|FG006|Self-administered Dosing Period|Withdrawal by Subject|2
6993590|NCT01327651|11054556|FG007|Self-administered Dosing Period|Withdrawal by Subject|1
6993591|NCT01327651|11054557|FG008|Self-administered Dosing Period|Withdrawal by Subject|1
6993592|NCT01327651|11054549|FG000|Post Study Follow-up|Lost to Follow-up|0
6993593|NCT01327651|11054550|FG001|Post Study Follow-up|Lost to Follow-up|1
6993594|NCT01327651|11054551|FG002|Post Study Follow-up|Lost to Follow-up|1
6993595|NCT01327651|11054552|FG003|Post Study Follow-up|Lost to Follow-up|0
6993596|NCT01327651|11054553|FG004|Post Study Follow-up|Lost to Follow-up|0
6993597|NCT01327651|11054554|FG005|Post Study Follow-up|Lost to Follow-up|0
6993598|NCT01327651|11054555|FG006|Post Study Follow-up|Lost to Follow-up|4
6993599|NCT01327651|11054556|FG007|Post Study Follow-up|Lost to Follow-up|1
6993600|NCT01327651|11054557|FG008|Post Study Follow-up|Lost to Follow-up|2
6993601|NCT01327703|11054607|FG000|Second Treatment Period|Adverse Event|1
6993602|NCT01327703|11054608|FG001|Second Treatment Period|Adverse Event|1
6993603|NCT01327703|11054607|FG000|Second Treatment Period|Protocol Violation|0
6993604|NCT01327703|11054608|FG001|Second Treatment Period|Protocol Violation|1
6993605|NCT01327846|11054621|FG000|Core Phase|Subject decision (vital status: missing)|1
6993606|NCT01327846|11054622|FG001|Core Phase|Subject decision (vital status: missing)|2
6993607|NCT01327846|11054623|FG002|Core Phase|Subject decision (vital status: missing)|2
6993608|NCT01327846|11054624|FG003|Core Phase|Subject decision (vital status: missing)|1
6993609|NCT01327846|11054621|FG000|Core Phase|Subject decision (vital stat: unkn)|0
6993610|NCT01327846|11054622|FG001|Core Phase|Subject decision (vital stat: unkn)|0
6993611|NCT01327846|11054623|FG002|Core Phase|Subject decision (vital stat: unkn)|3
6993612|NCT01327846|11054624|FG003|Core Phase|Subject decision (vital stat: unkn)|3
6993613|NCT01327846|11054621|FG000|Core Phase|Subject decision (vital stat: dead)|1
6993614|NCT01327846|11054622|FG001|Core Phase|Subject decision (vital stat: dead)|3
6993615|NCT01327846|11054623|FG002|Core Phase|Subject decision (vital stat: dead)|4
6993616|NCT01327846|11054624|FG003|Core Phase|Subject decision (vital stat: dead)|4
6993617|NCT01327846|11054621|FG000|Core Phase|Subject decision (vital stat: alive)|23
6993618|NCT01327846|11054622|FG001|Core Phase|Subject decision (vital stat: alive)|24
6993619|NCT01327846|11054623|FG002|Core Phase|Subject decision (vital stat: alive)|13
6993620|NCT01327846|11054624|FG003|Core Phase|Subject decision (vital stat: alive)|20
6993621|NCT01327846|11054621|FG000|Core Phase|Lost to Follow-up|3
6993622|NCT01327846|11054622|FG001|Core Phase|Lost to Follow-up|3
6993623|NCT01327846|11054623|FG002|Core Phase|Lost to Follow-up|4
6993624|NCT01327846|11054624|FG003|Core Phase|Lost to Follow-up|5
6993625|NCT01327846|11054621|FG000|Extension Phase|Study terminated by sponsor|1073
6993626|NCT01327846|11054622|FG001|Extension Phase|Study terminated by sponsor|1124
6993627|NCT01327846|11054623|FG002|Extension Phase|Study terminated by sponsor|1067
6993628|NCT01327846|11054624|FG003|Extension Phase|Study terminated by sponsor|1660
6993629|NCT01327846|11054621|FG000|Extension Phase|Withdrawal by Subject|20
6993630|NCT01327846|11054622|FG001|Extension Phase|Withdrawal by Subject|13
6993631|NCT01327846|11054623|FG002|Extension Phase|Withdrawal by Subject|19
6993632|NCT01327846|11054624|FG003|Extension Phase|Withdrawal by Subject|37
6993633|NCT01327846|11054621|FG000|Extension Phase|Lost to Follow-up|4
6993634|NCT01327846|11054622|FG001|Extension Phase|Lost to Follow-up|3
6993635|NCT01327846|11054623|FG002|Extension Phase|Lost to Follow-up|4
6993636|NCT01327846|11054624|FG003|Extension Phase|Lost to Follow-up|7
6993637|NCT01327846|11054621|FG000|Extension Phase|Technical Problems|2
6993638|NCT01327846|11054622|FG001|Extension Phase|Technical Problems|4
6993639|NCT01327846|11054623|FG002|Extension Phase|Technical Problems|2
6993640|NCT01327846|11054624|FG003|Extension Phase|Technical Problems|2
6993641|NCT01327885|11054637|FG000|Overall Study|Disease progression-according to RECIST|173
6993642|NCT01327885|11054638|FG001|Overall Study|Disease progression-according to RECIST|165
6993643|NCT01327885|11054637|FG000|Overall Study|Clinical progression|24
6993644|NCT01327885|11054638|FG001|Overall Study|Clinical progression|27
6993645|NCT01327885|11054637|FG000|Overall Study|Adverse Event|14
6993646|NCT01327885|11054638|FG001|Overall Study|Adverse Event|10
6993647|NCT01327885|11054637|FG000|Overall Study|Subject choice|5
6993648|NCT01327885|11054638|FG001|Overall Study|Subject choice|10
6993649|NCT01327885|11054637|FG000|Overall Study|Other|8
6993650|NCT01327885|11054638|FG001|Overall Study|Other|6
6993651|NCT01327885|11054637|FG000|Overall Study|Withdrawal of consent from study|3
6993652|NCT01327885|11054638|FG001|Overall Study|Withdrawal of consent from study|4
6993653|NCT01327885|11054637|FG000|Overall Study|Not treated|1
6993654|NCT01327885|11054638|FG001|Overall Study|Not treated|1
6993655|NCT01327885|11054637|FG000|Overall Study|Administrative decision|0
6993656|NCT01327885|11054638|FG001|Overall Study|Administrative decision|1
6993657|NCT01328002|11054666|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66
6993658|NCT01328002|11054667|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0
6993659|NCT01328002|11054666|FG000|Open-Label Period|Adverse Event|8
6993660|NCT01328002|11054667|FG001|Open-Label Period|Adverse Event|0
6993661|NCT01328002|11054666|FG000|Open-Label Period|Lack of Efficacy|3
6993662|NCT01328002|11054667|FG001|Open-Label Period|Lack of Efficacy|0
6993663|NCT01328002|11054666|FG000|Open-Label Period|Protocol Violation|2
6993664|NCT01328002|11054667|FG001|Open-Label Period|Protocol Violation|0
6993665|NCT01328002|11054666|FG000|Open-Label Period|Withdrawal by Subject|9
6993666|NCT01328002|11054667|FG001|Open-Label Period|Withdrawal by Subject|0
6993667|NCT01328002|11054666|FG000|Open-Label Period|Lost to Follow-up|6
6993668|NCT01328002|11054667|FG001|Open-Label Period|Lost to Follow-up|0
6993669|NCT01328002|11054666|FG000|Open-Label Period|Other Reason|2
6993670|NCT01328002|11054667|FG001|Open-Label Period|Other Reason|0
6993671|NCT01328002|11054666|FG000|Double-Blind Period|Adverse Event|1
6993672|NCT01328002|11054667|FG001|Double-Blind Period|Adverse Event|0
6993673|NCT01328002|11054666|FG000|Double-Blind Period|Lack of Efficacy|1
6993674|NCT01328002|11054667|FG001|Double-Blind Period|Lack of Efficacy|0
6993675|NCT01328041|11054674|FG000|Overall Study|Adverse Event|7
6993676|NCT01328041|11054674|FG000|Overall Study|Lack of Efficacy|27
6993677|NCT01328041|11054674|FG000|Overall Study|Protocol Violation|7
6993678|NCT01328041|11054674|FG000|Overall Study|Lost to Follow-up|7
6993679|NCT01328041|11054674|FG000|Overall Study|Physician Decision|2
6993680|NCT01328041|11054674|FG000|Overall Study|Withdrawal by Subject|7
6993681|NCT01328054|11054678|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0
7143147|NCT03026283|11299463|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
7143148|NCT03026283|11299464|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
7143149|NCT03026283|11299465|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
7143150|NCT03026283|11299466|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25
7143151|NCT03026283|11299467|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19
7187152|NCT02561962|11387638|FG007|Overall Study|Withdrawal by Subject|1
6993682|NCT01328054|11054679|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2
6993683|NCT01328054|11054678|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0
6993684|NCT01328054|11054679|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1
6993685|NCT01328054|11054678|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0
6993686|NCT01328054|11054679|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2
6993687|NCT01328080|11054691|FG000|Overall Study|Lost to Follow-up|5
6993688|NCT01328249|11054710|FG000|Overall Study|Adverse Event|3
6993689|NCT01328249|11054711|FG001|Overall Study|Adverse Event|0
6993690|NCT01328249|11054710|FG000|Overall Study|Disease progression|1
6993691|NCT01328249|11054711|FG001|Overall Study|Disease progression|0
6993692|NCT01328249|11054710|FG000|Overall Study|Withdrawal by Subject|1
6993693|NCT01328249|11054711|FG001|Overall Study|Withdrawal by Subject|1
6993694|NCT01328249|11054710|FG000|Overall Study|Moved before end of treatment visit|1
6993695|NCT01328249|11054711|FG001|Overall Study|Moved before end of treatment visit|0
6993696|NCT01328249|11054710|FG000|Overall Study|Subject choice|1
6993697|NCT01328249|11054711|FG001|Overall Study|Subject choice|1
6993698|NCT01328249|11054710|FG000|Overall Study|Protocol Violation|0
6993699|NCT01328249|11054711|FG001|Overall Study|Protocol Violation|1
6993700|NCT01328366|11054719|FG000|Overall Study|Death|1
6993701|NCT01328366|11054719|FG000|Overall Study|Withdrawal by Subject|2
6993702|NCT01328366|11054719|FG000|Overall Study|Lost to Follow-up|7
6993703|NCT01328431|11054747|FG000|Baseline|Protocol Violation|0
6993704|NCT01328431|11054748|FG001|Baseline|Protocol Violation|2
6993705|NCT01328431|11054747|FG000|1 Month (1M)|Lost to Follow-up|55
6993706|NCT01328431|11054748|FG001|1 Month (1M)|Lost to Follow-up|58
6993707|NCT01328431|11054747|FG000|3 Month (3M)|Death|2
6993708|NCT01328431|11054748|FG001|3 Month (3M)|Death|2
6993709|NCT01328431|11054747|FG000|3 Month (3M)|Lost to Follow-up|75
6993710|NCT01328431|11054748|FG001|3 Month (3M)|Lost to Follow-up|70
6993711|NCT01328431|11054747|FG000|12 Month (12M)|Death|2
6993712|NCT01328431|11054748|FG001|12 Month (12M)|Death|6
6993713|NCT01328431|11054747|FG000|12 Month (12M)|Lost to Follow-up|82
6993714|NCT01328431|11054748|FG001|12 Month (12M)|Lost to Follow-up|91
6993715|NCT01328444|11054754|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3
6993716|NCT01328444|11054755|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1
6993717|NCT01328444|11054756|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1
6993718|NCT01328444|11054757|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3
6993719|NCT01328444|11054758|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5
6993720|NCT01328444|11054759|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2
6993721|NCT01328444|11054754|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
6993722|NCT01328444|11054755|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
6993723|NCT01328444|11054756|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
6993724|NCT01328444|11054757|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
6993725|NCT01328444|11054758|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
6993726|NCT01328444|11054759|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
6993727|NCT01328444|11054754|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0
6993728|NCT01328444|11054755|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0
6993729|NCT01328444|11054756|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0
6993730|NCT01328444|11054757|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1
6993731|NCT01328444|11054758|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0
6993732|NCT01328444|11054759|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1
6993733|NCT01328444|11054754|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
6993734|NCT01328444|11054755|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1
6993735|NCT01328444|11054756|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
6993736|NCT01328444|11054757|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
6993737|NCT01328444|11054758|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2
6993738|NCT01328444|11054759|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
6993739|NCT01328444|11054754|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2
6993740|NCT01328444|11054755|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
6993741|NCT01328444|11054756|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
6993742|NCT01328444|11054757|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
6993743|NCT01328444|11054758|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
6993744|NCT01328444|11054759|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
6993745|NCT01328444|11054754|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
6993746|NCT01328444|11054755|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
6993747|NCT01328444|11054756|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
6993748|NCT01328444|11054757|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
6993749|NCT01328444|11054758|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
6993750|NCT01328444|11054759|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
6993751|NCT01328444|11054754|FG000|Washout Period (14 Days)|Adverse Event|1
6993752|NCT01328444|11054755|FG001|Washout Period (14 Days)|Adverse Event|1
6993753|NCT01328444|11054756|FG002|Washout Period (14 Days)|Adverse Event|0
6993754|NCT01328444|11054757|FG003|Washout Period (14 Days)|Adverse Event|1
6993755|NCT01328444|11054758|FG004|Washout Period (14 Days)|Adverse Event|1
6993756|NCT01328444|11054759|FG005|Washout Period (14 Days)|Adverse Event|2
6993757|NCT01328444|11054754|FG000|Washout Period (14 Days)|Lack of Efficacy|0
6993758|NCT01328444|11054755|FG001|Washout Period (14 Days)|Lack of Efficacy|0
6993759|NCT01328444|11054756|FG002|Washout Period (14 Days)|Lack of Efficacy|0
6993760|NCT01328444|11054757|FG003|Washout Period (14 Days)|Lack of Efficacy|0
6993761|NCT01328444|11054758|FG004|Washout Period (14 Days)|Lack of Efficacy|0
6993762|NCT01328444|11054759|FG005|Washout Period (14 Days)|Lack of Efficacy|1
6993763|NCT01328444|11054754|FG000|Washout Period (14 Days)|Withdrawal by Subject|0
6993764|NCT01328444|11054755|FG001|Washout Period (14 Days)|Withdrawal by Subject|0
6993765|NCT01328444|11054756|FG002|Washout Period (14 Days)|Withdrawal by Subject|0
6993766|NCT01328444|11054757|FG003|Washout Period (14 Days)|Withdrawal by Subject|0
6993767|NCT01328444|11054758|FG004|Washout Period (14 Days)|Withdrawal by Subject|0
6993768|NCT01328444|11054759|FG005|Washout Period (14 Days)|Withdrawal by Subject|1
6993769|NCT01328444|11054754|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5
6993770|NCT01328444|11054755|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0
6993771|NCT01328444|11054756|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1
6993772|NCT01328444|11054757|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1
6993773|NCT01328444|11054758|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1
6993774|NCT01328444|11054759|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0
6993775|NCT01328444|11054754|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5
6993776|NCT01328444|11054755|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
6993777|NCT01328444|11054756|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
6993778|NCT01328444|11054757|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
6993779|NCT01328444|11054758|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
6993780|NCT01328444|11054759|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4
6993781|NCT01328444|11054754|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1
6993782|NCT01328444|11054755|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0
6993783|NCT01328444|11054756|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0
6993784|NCT01328444|11054757|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0
6993785|NCT01328444|11054758|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1
6993786|NCT01328444|11054759|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0
6993787|NCT01328444|11054754|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
6993788|NCT01328444|11054755|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
6993789|NCT01328444|11054756|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
6993790|NCT01328444|11054757|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
6993791|NCT01328444|11054758|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
6993792|NCT01328444|11054759|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
6993793|NCT01328444|11054754|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
6993794|NCT01328444|11054755|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
6993795|NCT01328444|11054756|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
6993796|NCT01328444|11054757|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
6993797|NCT01328444|11054758|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
6993798|NCT01328444|11054759|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
6993799|NCT01328444|11054754|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
6993800|NCT01328444|11054755|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
6993801|NCT01328444|11054756|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
6993802|NCT01328444|11054757|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
6993803|NCT01328444|11054758|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
6993804|NCT01328444|11054759|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
6993805|NCT01328496|11054775|FG000|Overall Study|Significant Change in Health Status|1
6993806|NCT01328496|11054776|FG001|Overall Study|Significant Change in Health Status|0
6993807|NCT01328535|11054785|FG000|Overall Study|Ineligible|1
6993808|NCT01328548|11054793|FG000|Overall Study|Death|3
6993809|NCT01328548|11054794|FG001|Overall Study|Death|0
6993810|NCT01328548|11054793|FG000|Overall Study|Protocol Violation|1
6993811|NCT01328548|11054794|FG001|Overall Study|Protocol Violation|0
6993812|NCT01328574|11054800|FG000|Overall Study|Refused further treatment|1
6993813|NCT01328717|11054809|FG000|Overall Study|Adverse Event|1
6993814|NCT01328756|11054822|FG000|Overall Study|Protocol Violation|4
6993815|NCT01328756|11054822|FG000|Overall Study|Adverse Event|39
6993816|NCT01328756|11054822|FG000|Overall Study|Lack of Efficacy|5
6993817|NCT01328756|11054822|FG000|Overall Study|Withdrawal by Subject|41
6993818|NCT01328756|11054822|FG000|Overall Study|Lost to Follow-up|5
6993819|NCT01328756|11054822|FG000|Overall Study|Other|29
6993820|NCT01328951|11054856|FG000|Overall Study|Disease Progression|17
6993821|NCT01328951|11054857|FG001|Overall Study|Disease Progression|14
6993822|NCT01328951|11054856|FG000|Overall Study|Adverse Event|2
6993823|NCT01328951|11054857|FG001|Overall Study|Adverse Event|0
6993824|NCT01328951|11054856|FG000|Overall Study|Death|243
6993825|NCT01328951|11054857|FG001|Overall Study|Death|258
6993826|NCT01328951|11054856|FG000|Overall Study|Lost to Follow-up|6
6993827|NCT01328951|11054857|FG001|Overall Study|Lost to Follow-up|7
6993828|NCT01328951|11054856|FG000|Overall Study|Withdrawal by Subject|6
6993829|NCT01328951|11054857|FG001|Overall Study|Withdrawal by Subject|6
6993830|NCT01328951|11054856|FG000|Overall Study|Study Closed by the Sponsor|36
6993831|NCT01328951|11054857|FG001|Overall Study|Study Closed by the Sponsor|31
6993832|NCT01328951|11054856|FG000|Overall Study|Other|11
6993833|NCT01328951|11054857|FG001|Overall Study|Other|6
6993834|NCT01329029|11054882|FG000|Overall Study|Withdrawal by Subject|117
6993835|NCT01329029|11054883|FG001|Overall Study|Withdrawal by Subject|87
6993836|NCT01329029|11054882|FG000|Overall Study|Adverse Event|82
6993837|NCT01329029|11054883|FG001|Overall Study|Adverse Event|29
6993838|NCT01329029|11054882|FG000|Overall Study|Death|16
6993839|NCT01329029|11054883|FG001|Overall Study|Death|19
6993840|NCT01329029|11054882|FG000|Overall Study|Other|14
6993841|NCT01329029|11054883|FG001|Overall Study|Other|20
6993842|NCT01329029|11054882|FG000|Overall Study|COPD Exacerbation|11
6993843|NCT01329029|11054883|FG001|Overall Study|COPD Exacerbation|18
6993844|NCT01329029|11054882|FG000|Overall Study|Physician Decision|16
6993845|NCT01329029|11054883|FG001|Overall Study|Physician Decision|13
6993846|NCT01329029|11054882|FG000|Overall Study|Lost to Follow-up|8
6993847|NCT01329029|11054883|FG001|Overall Study|Lost to Follow-up|5
6993848|NCT01329029|11054882|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5
6993849|NCT01329029|11054883|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1
6993850|NCT01329263|11054914|FG000|Overall Study|Lost to Follow-up|4
6993851|NCT01329263|11054915|FG001|Overall Study|Lost to Follow-up|21
6993852|NCT01329263|11054914|FG000|Overall Study|Withdrawal by Subject|1
6993853|NCT01329263|11054915|FG001|Overall Study|Withdrawal by Subject|2
6993854|NCT01329328|11054926|FG000|Overall Study|Withdrawal by Subject|2
6993855|NCT01329328|11054927|FG001|Overall Study|Withdrawal by Subject|4
6993856|NCT01329328|11054928|FG002|Overall Study|Withdrawal by Subject|3
6993857|NCT01329419|11054940|FG000|Overall Study|Protocol Violation|235
6993858|NCT01329562|11054947|FG000|Overall Study|Protocol Violation|5
6993859|NCT01329562|11054948|FG001|Overall Study|Protocol Violation|3
6993860|NCT01329562|11054947|FG000|Overall Study|Lost to Follow-up|1
6993861|NCT01329562|11054948|FG001|Overall Study|Lost to Follow-up|1
6993862|NCT01329562|11054947|FG000|Overall Study|Subject withdrew due to personal issues.|3
6993863|NCT01329562|11054948|FG001|Overall Study|Subject withdrew due to personal issues.|2
6993864|NCT01329562|11054947|FG000|Overall Study|Physician Decision|0
6993865|NCT01329562|11054948|FG001|Overall Study|Physician Decision|1
6993866|NCT01329900|11054969|FG000|Overall Study|Elevated creatinine/renal function|1
6993867|NCT01329939|11054977|FG000|Overall Study|Lost to Follow-up|3
6993868|NCT01329939|11054978|FG001|Overall Study|Lost to Follow-up|0
6993869|NCT01329939|11054979|FG002|Overall Study|Lost to Follow-up|1
6993870|NCT01329939|11054980|FG003|Overall Study|Lost to Follow-up|2
6993871|NCT01329939|11054977|FG000|Overall Study|Withdrawal by Subject|0
6993872|NCT01329939|11054978|FG001|Overall Study|Withdrawal by Subject|1
6993873|NCT01329939|11054979|FG002|Overall Study|Withdrawal by Subject|0
6993874|NCT01329939|11054980|FG003|Overall Study|Withdrawal by Subject|0
6993875|NCT01329939|11054977|FG000|Overall Study|Adverse Event|0
6993876|NCT01329939|11054978|FG001|Overall Study|Adverse Event|0
6993877|NCT01329939|11054979|FG002|Overall Study|Adverse Event|0
6993878|NCT01329939|11054980|FG003|Overall Study|Adverse Event|3
6993879|NCT01329978|11054993|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1
6993880|NCT01329978|11054994|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2
6993881|NCT01329978|11054995|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
6993882|NCT01329978|11054996|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
6993883|NCT01329978|11054997|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
6993884|NCT01329978|11054993|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
6993885|NCT01329978|11054994|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8
6993886|NCT01329978|11054995|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
6993887|NCT01329978|11054996|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
6993888|NCT01329978|11054997|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
6993889|NCT01329978|11054993|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
6993890|NCT01329978|11054994|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
6993891|NCT01329978|11054995|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3
6993892|NCT01329978|11054996|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
6993893|NCT01329978|11054997|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
6993894|NCT01329978|11054993|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
6993895|NCT01329978|11054994|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1
6993896|NCT01329978|11054995|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
6993897|NCT01329978|11054996|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
6993898|NCT01329978|11054997|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
6993899|NCT01329978|11054993|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
6993900|NCT01329978|11054994|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1
6993901|NCT01329978|11054995|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
6993902|NCT01329978|11054996|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
6993903|NCT01329978|11054997|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
6993904|NCT01329978|11054993|FG000|Rerandomization Treatment Period|Lost to Follow-up|0
6993905|NCT01329978|11054994|FG001|Rerandomization Treatment Period|Lost to Follow-up|0
6993906|NCT01329978|11054995|FG002|Rerandomization Treatment Period|Lost to Follow-up|0
6993907|NCT01329978|11054996|FG003|Rerandomization Treatment Period|Lost to Follow-up|5
6993908|NCT01329978|11054997|FG004|Rerandomization Treatment Period|Lost to Follow-up|3
6993909|NCT01329978|11054993|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0
6993910|NCT01329978|11054994|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0
6993911|NCT01329978|11054995|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0
6993912|NCT01329978|11054996|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0
6993913|NCT01329978|11054997|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1
6993914|NCT01330017|11055014|FG000|Overall Study|Adverse Event|0
6993915|NCT01330017|11055015|FG001|Overall Study|Adverse Event|1
6993916|NCT01330017|11055016|FG002|Overall Study|Adverse Event|1
6993917|NCT01330017|11055017|FG003|Overall Study|Adverse Event|4
6993918|NCT01330017|11055018|FG004|Overall Study|Adverse Event|0
6993919|NCT01330017|11055014|FG000|Overall Study|Withdrawal by Subject|0
6993920|NCT01330017|11055015|FG001|Overall Study|Withdrawal by Subject|0
6993921|NCT01330017|11055016|FG002|Overall Study|Withdrawal by Subject|1
6993922|NCT01330017|11055017|FG003|Overall Study|Withdrawal by Subject|0
6993923|NCT01330017|11055018|FG004|Overall Study|Withdrawal by Subject|1
6993924|NCT01330017|11055014|FG000|Overall Study|Lost to Follow-up|0
6993925|NCT01330017|11055015|FG001|Overall Study|Lost to Follow-up|0
6993926|NCT01330017|11055016|FG002|Overall Study|Lost to Follow-up|1
6993927|NCT01330017|11055017|FG003|Overall Study|Lost to Follow-up|0
6993928|NCT01330017|11055018|FG004|Overall Study|Lost to Follow-up|0
6993929|NCT01330017|11055014|FG000|Overall Study|Protocol Violation|0
6993930|NCT01330017|11055015|FG001|Overall Study|Protocol Violation|0
6993931|NCT01330017|11055016|FG002|Overall Study|Protocol Violation|0
6993932|NCT01330017|11055017|FG003|Overall Study|Protocol Violation|1
6993933|NCT01330017|11055018|FG004|Overall Study|Protocol Violation|0
6993934|NCT01330017|11055014|FG000|Overall Study|Unknown Reason|5
6993935|NCT01330017|11055015|FG001|Overall Study|Unknown Reason|3
6993936|NCT01330017|11055016|FG002|Overall Study|Unknown Reason|5
6993937|NCT01330017|11055017|FG003|Overall Study|Unknown Reason|7
6993938|NCT01330017|11055018|FG004|Overall Study|Unknown Reason|2
6993939|NCT01330030|11055032|FG000|Overall Study|Lost to Follow-up|16
6993940|NCT01330030|11055033|FG001|Overall Study|Lost to Follow-up|17
6993941|NCT01330108|11055048|FG000|Overall Study|Withdrawal by Subject|4
6993942|NCT01330303|11055065|FG000|Period 1|Adverse Event|1
6993943|NCT01330303|11055066|FG001|Period 1|Adverse Event|0
6993944|NCT01330303|11055065|FG000|Period 1|Protocol Violation|0
6993945|NCT01330303|11055066|FG001|Period 1|Protocol Violation|1
6993946|NCT01330303|11055065|FG000|Period 1|Withdrawal by Subject|0
6993947|NCT01330303|11055066|FG001|Period 1|Withdrawal by Subject|1
6993948|NCT01330316|11055075|FG000|Overall Study|Adverse Event|2
6993949|NCT01330316|11055076|FG001|Overall Study|Adverse Event|2
6993950|NCT01330316|11055075|FG000|Overall Study|Lack of Efficacy|0
6993951|NCT01330316|11055076|FG001|Overall Study|Lack of Efficacy|10
6993952|NCT01330316|11055075|FG000|Overall Study|Lost to Follow-up|0
6993953|NCT01330316|11055076|FG001|Overall Study|Lost to Follow-up|1
6993954|NCT01330316|11055075|FG000|Overall Study|Withdrawal by Subject|0
6993955|NCT01330316|11055076|FG001|Overall Study|Withdrawal by Subject|1
6993956|NCT01330316|11055075|FG000|Overall Study|other than above|0
6993957|NCT01330316|11055076|FG001|Overall Study|other than above|1
6993958|NCT01330381|11055093|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5
6993959|NCT01330381|11055094|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4
6993960|NCT01330381|11055095|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0
6993961|NCT01330381|11055093|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2
6993962|NCT01330381|11055094|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1
6993963|NCT01330381|11055095|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0
6993964|NCT01330381|11055093|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
6993965|NCT01330381|11055094|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
6993966|NCT01330381|11055095|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0
6993967|NCT01330381|11055093|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1
6993968|NCT01330381|11055094|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
6993969|NCT01330381|11055095|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
6993970|NCT01330381|11055093|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1
6993971|NCT01330381|11055094|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
6993972|NCT01330381|11055095|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
6993973|NCT01330381|11055093|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
6993974|NCT01330381|11055094|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
6993975|NCT01330381|11055095|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0
6993976|NCT01330381|11055093|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7
6993977|NCT01330381|11055094|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0
6993978|NCT01330381|11055095|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16
6993979|NCT01330381|11055093|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2
6993980|NCT01330381|11055094|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0
6993981|NCT01330381|11055095|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0
6993982|NCT01330381|11055093|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
6993983|NCT01330381|11055094|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0
6993984|NCT01330381|11055095|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
6993985|NCT01330381|11055093|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0
6993986|NCT01330381|11055094|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0
6993987|NCT01330381|11055095|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1
6993988|NCT01330433|11055119|FG000|Overall Study|Death|1
6993989|NCT01330433|11055120|FG001|Overall Study|Death|3
6993990|NCT01330433|11055119|FG000|Overall Study|Lost to Follow-up|1
6993991|NCT01330433|11055120|FG001|Overall Study|Lost to Follow-up|0
6993992|NCT01330459|11055128|FG000|Overall Study|Physician Decision|0
6993993|NCT01330459|11055129|FG001|Overall Study|Physician Decision|2
6993994|NCT01330628|11055139|FG000|Overall Study|Death|2
6993995|NCT01330628|11055140|FG001|Overall Study|Death|3
6993996|NCT01330628|11055139|FG000|Overall Study|Lost to Follow-up|5
6993997|NCT01330628|11055140|FG001|Overall Study|Lost to Follow-up|6
6993998|NCT01330628|11055139|FG000|Overall Study|Adverse Event|44
6993999|NCT01330628|11055140|FG001|Overall Study|Adverse Event|25
6994000|NCT01330628|11055139|FG000|Overall Study|Withdrawn|18
6994001|NCT01330628|11055140|FG001|Overall Study|Withdrawn|6
6994002|NCT01330628|11055139|FG000|Overall Study|Didn't receive study treatment|1
6994003|NCT01330628|11055140|FG001|Overall Study|Didn't receive study treatment|0
6994004|NCT01330914|11055146|FG000|Overall Study|Withdrawal by Subject|4
6994005|NCT01330914|11055146|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3
6994006|NCT01331005|11055182|FG000|Overall Study|Lost to Follow-up|2
6994007|NCT01331005|11055183|FG001|Overall Study|Lost to Follow-up|1
6994008|NCT01331005|11055182|FG000|Overall Study|Withdrawal by Subject|2
6994009|NCT01331005|11055183|FG001|Overall Study|Withdrawal by Subject|3
6994010|NCT01331109|11055198|FG000|Overall Study|Adverse Event|6
6994011|NCT01331109|11055198|FG000|Overall Study|Lack of Efficacy|2
6994012|NCT01331109|11055198|FG000|Overall Study|Protocol Violation|3
6994013|NCT01331109|11055198|FG000|Overall Study|Withdrawal by Subject|7
6994014|NCT01331109|11055198|FG000|Overall Study|Lost to Follow-up|1
6994015|NCT01331109|11055198|FG000|Overall Study|Study Terminated by Sponsor|38
6994016|NCT01331161|11055204|FG000|Overall Study|Physician Decision|1
6994017|NCT01331161|11055205|FG001|Overall Study|Physician Decision|0
6994018|NCT01331161|11055204|FG000|Overall Study|Lost to Follow-up|0
6994019|NCT01331161|11055205|FG001|Overall Study|Lost to Follow-up|1
6994020|NCT01331161|11055204|FG000|Overall Study|Pregnancy|0
6994021|NCT01331161|11055205|FG001|Overall Study|Pregnancy|1
6994022|NCT01331239|11055224|FG000|Part II: Core Study|Adverse Event|0
6994023|NCT01331239|11055225|FG001|Part II: Core Study|Adverse Event|3
6994024|NCT01331239|11055226|FG002|Part II: Core Study|Adverse Event|0
6994025|NCT01331239|11055224|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0
6994026|NCT01331239|11055225|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2
6994027|NCT01331239|11055226|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1
6994028|NCT01331239|11055224|FG000|Part II: Core Study|Withdrawal by Subject|0
6994029|NCT01331239|11055225|FG001|Part II: Core Study|Withdrawal by Subject|2
6994030|NCT01331239|11055226|FG002|Part II: Core Study|Withdrawal by Subject|0
6994031|NCT01331239|11055224|FG000|Part II: Core Study|Administrative problems|0
6994032|NCT01331239|11055225|FG001|Part II: Core Study|Administrative problems|1
6994033|NCT01331239|11055226|FG002|Part II: Core Study|Administrative problems|0
6994034|NCT01331291|11055244|FG000|Overall Study|Lack of Efficacy|2
6994035|NCT01331291|11055245|FG001|Overall Study|Lack of Efficacy|8
6994036|NCT01331291|11055244|FG000|Overall Study|Death|0
6994037|NCT01331291|11055245|FG001|Overall Study|Death|1
6994038|NCT01331681|11055267|FG000|Overall Study|Adverse Event|10
6994039|NCT01331681|11055268|FG001|Overall Study|Adverse Event|13
6994040|NCT01331681|11055269|FG002|Overall Study|Adverse Event|10
6994041|NCT01331681|11055267|FG000|Overall Study|Death|6
6994042|NCT01331681|11055268|FG001|Overall Study|Death|6
6994043|NCT01331681|11055269|FG002|Overall Study|Death|2
6994044|NCT01331681|11055267|FG000|Overall Study|Lack of Efficacy|0
6994045|NCT01331681|11055268|FG001|Overall Study|Lack of Efficacy|1
6994046|NCT01331681|11055269|FG002|Overall Study|Lack of Efficacy|0
6994047|NCT01331681|11055267|FG000|Overall Study|Withdrawal by Subject|12
6994048|NCT01331681|11055268|FG001|Overall Study|Withdrawal by Subject|8
6994049|NCT01331681|11055269|FG002|Overall Study|Withdrawal by Subject|15
6994050|NCT01331681|11055267|FG000|Overall Study|Protocol Violation|1
6994051|NCT01331681|11055268|FG001|Overall Study|Protocol Violation|1
6994052|NCT01331681|11055269|FG002|Overall Study|Protocol Violation|0
6994053|NCT01331681|11055267|FG000|Overall Study|Lost to Follow-up|2
6994054|NCT01331681|11055268|FG001|Overall Study|Lost to Follow-up|4
6994055|NCT01331681|11055269|FG002|Overall Study|Lost to Follow-up|1
6994056|NCT01331681|11055267|FG000|Overall Study|Physician Decision|2
6994057|NCT01331681|11055268|FG001|Overall Study|Physician Decision|0
6994058|NCT01331681|11055269|FG002|Overall Study|Physician Decision|4
6994059|NCT01331681|11055267|FG000|Overall Study|Therapeutic procedure required|1
6994060|NCT01331681|11055268|FG001|Overall Study|Therapeutic procedure required|0
6994061|NCT01331681|11055269|FG002|Overall Study|Therapeutic procedure required|0
6994062|NCT01331681|11055267|FG000|Overall Study|Sponsor decision|1
6994063|NCT01331681|11055268|FG001|Overall Study|Sponsor decision|1
6994064|NCT01331681|11055269|FG002|Overall Study|Sponsor decision|0
6994065|NCT01331681|11055267|FG000|Overall Study|Switching to other therapy|0
6994066|NCT01331681|11055268|FG001|Overall Study|Switching to other therapy|0
6994067|NCT01331681|11055269|FG002|Overall Study|Switching to other therapy|1
6994068|NCT01331681|11055267|FG000|Overall Study|Not Received Study Treatment|0
6994069|NCT01331681|11055268|FG001|Overall Study|Not Received Study Treatment|0
6994070|NCT01331681|11055269|FG002|Overall Study|Not Received Study Treatment|2
6994071|NCT01331824|11055302|FG000|Overall Study|Adverse Event|2
6994072|NCT01331824|11055302|FG000|Overall Study|Death|1
6994073|NCT01331824|11055302|FG000|Overall Study|Disease Progression|9
6994074|NCT01331824|11055302|FG000|Overall Study|Withdrawal by Subject|1
6994075|NCT01331837|11055308|FG000|Overall Study|Death|30
6994076|NCT01331837|11055309|FG001|Overall Study|Death|34
6994077|NCT01331837|11055308|FG000|Overall Study|Lost to Follow-up|3
6994078|NCT01331837|11055309|FG001|Overall Study|Lost to Follow-up|1
6994079|NCT01331837|11055308|FG000|Overall Study|Info not recorded|10
6994080|NCT01331837|11055309|FG001|Overall Study|Info not recorded|16
6994081|NCT01331837|11055308|FG000|Overall Study|Withdrawal by Subject|13
6994082|NCT01331837|11055309|FG001|Overall Study|Withdrawal by Subject|16
6994083|NCT01332019|11055317|FG000|Overall Study|Was Not Dosed|1
6994084|NCT01332019|11055318|FG001|Overall Study|Was Not Dosed|0
6994085|NCT01332019|11055317|FG000|Overall Study|Other|16
6994086|NCT01332019|11055318|FG001|Overall Study|Other|18
6994087|NCT01332019|11055317|FG000|Overall Study|Death|2
6994088|NCT01332019|11055318|FG001|Overall Study|Death|1
6994089|NCT01332019|11055317|FG000|Overall Study|Physician Decision|4
6994090|NCT01332019|11055318|FG001|Overall Study|Physician Decision|3
6994091|NCT01332019|11055317|FG000|Overall Study|Withdrawal by Subject|73
6994092|NCT01332019|11055318|FG001|Overall Study|Withdrawal by Subject|71
6994093|NCT01332019|11055317|FG000|Overall Study|Lost to Follow-up|4
6994094|NCT01332019|11055318|FG001|Overall Study|Lost to Follow-up|7
6994095|NCT01332019|11055317|FG000|Overall Study|Adverse Event|13
6994096|NCT01332019|11055318|FG001|Overall Study|Adverse Event|22
7042467|NCT01736475|11126951|FG001|Overall Study|Other - Surgical procedure|0
7042468|NCT01736540|11126972|FG000|Overall Study|Did not complete scan within 45 days|2
7042469|NCT01736540|11126972|FG000|Overall Study|Death|1
7042470|NCT01736540|11126972|FG000|Overall Study|Abnormal test procedure|1
7042471|NCT01736540|11126972|FG000|Overall Study|Withdrawal by Subject|5
7042472|NCT01736540|11126972|FG000|Overall Study|Protocol Violation|1
7042473|NCT01736540|11126972|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1
7042474|NCT01736540|11126972|FG000|Overall Study|No show for MRI appointment|1
7042475|NCT01736540|11126972|FG000|Overall Study|Unable to make MRI appointment|3
7042476|NCT01736553|11126985|FG000|Overall Study|Death|12
7042477|NCT01736553|11126986|FG001|Overall Study|Death|0
7042478|NCT01736553|11126985|FG000|Overall Study|Withdrawal by Subject|5
7042479|NCT01736553|11126986|FG001|Overall Study|Withdrawal by Subject|2
7042480|NCT01736553|11126985|FG000|Overall Study|Lost to Follow-up|2
7042481|NCT01736553|11126986|FG001|Overall Study|Lost to Follow-up|2
7042482|NCT01736566|11127015|FG000|Long Term Follow-up|Still collecting data|42
7042483|NCT01736566|11127016|FG001|Long Term Follow-up|Still collecting data|0
7042484|NCT01736566|11127017|FG002|Long Term Follow-up|Still collecting data|49
7042485|NCT01736566|11127018|FG003|Long Term Follow-up|Still collecting data|0
7042486|NCT01736566|11127019|FG004|Long Term Follow-up|Still collecting data|1
7042487|NCT01736579|11127046|FG000|Overall Study|Termination of Study by Sponsor|2
7042488|NCT01736579|11127047|FG001|Overall Study|Termination of Study by Sponsor|2
7042489|NCT01736657|11127053|FG000|Overall Study|insufficient vascular access|1
7042490|NCT01736683|11127062|FG000|Overall Study|Disease Relapse|0
7042491|NCT01736683|11127063|FG001|Overall Study|Disease Relapse|0
7042492|NCT01736683|11127064|FG002|Overall Study|Disease Relapse|2
7042493|NCT01736683|11127065|FG003|Overall Study|Disease Relapse|1
7042494|NCT01736683|11127066|FG004|Overall Study|Disease Relapse|0
7042495|NCT01736683|11127062|FG000|Overall Study|Adverse Event|0
7042496|NCT01736683|11127063|FG001|Overall Study|Adverse Event|2
7042497|NCT01736683|11127064|FG002|Overall Study|Adverse Event|2
7042498|NCT01736683|11127065|FG003|Overall Study|Adverse Event|3
7042499|NCT01736683|11127066|FG004|Overall Study|Adverse Event|2
7042500|NCT01736683|11127062|FG000|Overall Study|Withdrawal by Subject|0
7042501|NCT01736683|11127063|FG001|Overall Study|Withdrawal by Subject|0
7042502|NCT01736683|11127064|FG002|Overall Study|Withdrawal by Subject|3
7042503|NCT01736683|11127065|FG003|Overall Study|Withdrawal by Subject|1
7042504|NCT01736683|11127066|FG004|Overall Study|Withdrawal by Subject|1
7042505|NCT01736683|11127062|FG000|Overall Study|Lack of Therapeutic Effect|7
7042506|NCT01736683|11127063|FG001|Overall Study|Lack of Therapeutic Effect|4
7042507|NCT01736683|11127064|FG002|Overall Study|Lack of Therapeutic Effect|13
7042508|NCT01736683|11127065|FG003|Overall Study|Lack of Therapeutic Effect|20
7042509|NCT01736683|11127066|FG004|Overall Study|Lack of Therapeutic Effect|1
7042510|NCT01736683|11127062|FG000|Overall Study|Progressive Disease|0
7042511|NCT01736683|11127063|FG001|Overall Study|Progressive Disease|0
7042512|NCT01736683|11127064|FG002|Overall Study|Progressive Disease|0
7042513|NCT01736683|11127065|FG003|Overall Study|Progressive Disease|1
7042514|NCT01736683|11127066|FG004|Overall Study|Progressive Disease|0
7042515|NCT01736683|11127062|FG000|Overall Study|Other|0
7042516|NCT01736683|11127063|FG001|Overall Study|Other|0
7042517|NCT01736683|11127064|FG002|Overall Study|Other|1
7042518|NCT01736683|11127065|FG003|Overall Study|Other|9
7042519|NCT01736683|11127066|FG004|Overall Study|Other|1
7042520|NCT01736696|11127087|FG000|Overall Study|Withdrawal by Subject|0
7042521|NCT01736696|11127088|FG001|Overall Study|Withdrawal by Subject|0
7042522|NCT01736696|11127089|FG002|Overall Study|Withdrawal by Subject|1
7042523|NCT01736696|11127090|FG003|Overall Study|Withdrawal by Subject|0
7042524|NCT01736696|11127091|FG004|Overall Study|Withdrawal by Subject|0
7042525|NCT01736696|11127092|FG005|Overall Study|Withdrawal by Subject|0
7042526|NCT01736696|11127093|FG006|Overall Study|Withdrawal by Subject|0
7042527|NCT01736917|11127135|FG000|Overall Study|Adverse Event|1
7042528|NCT01736917|11127135|FG000|Overall Study|Protocol Violation|10
7042529|NCT01737268|11127151|FG000|Overall Study|Adverse Event|6
7042530|NCT01737268|11127151|FG000|Overall Study|Worsening of Target Disease|2
7042531|NCT01737268|11127151|FG000|Overall Study|In consideration of the patient's safety|1
7044885|NCT01759511|11131056|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4
7044886|NCT01759511|11131056|FG000|Overall Study|Study Terminated by Sponsor|13
7044887|NCT01759511|11131056|FG000|Overall Study|Withdrawal by Subject|3
7044888|NCT01759862|11131066|FG000|Overall Study|Physician Decision|3
7044889|NCT01759862|11131067|FG001|Overall Study|Physician Decision|1
7044890|NCT01759862|11131066|FG000|Overall Study|Adverse Event|0
7044891|NCT01759862|11131067|FG001|Overall Study|Adverse Event|1
7044892|NCT01760447|11131134|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0
7044893|NCT01760447|11131135|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0
7044894|NCT01760447|11131136|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1
7044895|NCT01760447|11131137|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3
6994097|NCT01332149|11055340|FG000|Overall Study|Adverse Event|11
6994098|NCT01332149|11055341|FG001|Overall Study|Adverse Event|9
6994099|NCT01332149|11055340|FG000|Overall Study|Other unspecified|5
6994100|NCT01332149|11055341|FG001|Overall Study|Other unspecified|7
6994101|NCT01332149|11055340|FG000|Overall Study|Protocol Violation|1
6994102|NCT01332149|11055341|FG001|Overall Study|Protocol Violation|3
6994103|NCT01332149|11055340|FG000|Overall Study|Withdrawal by Subject|4
6994104|NCT01332149|11055341|FG001|Overall Study|Withdrawal by Subject|5
6994105|NCT01332149|11055340|FG000|Overall Study|Lost to Follow-up|1
6994106|NCT01332149|11055341|FG001|Overall Study|Lost to Follow-up|1
6994107|NCT01332149|11055340|FG000|Overall Study|Insufficient clinical response|4
6994108|NCT01332149|11055341|FG001|Overall Study|Insufficient clinical response|7
6994109|NCT01332149|11055340|FG000|Overall Study|Did not meet entrance criteria|3
6994110|NCT01332149|11055341|FG001|Overall Study|Did not meet entrance criteria|4
6994111|NCT01332149|11055340|FG000|Overall Study|Randomized but not treated|1
6994112|NCT01332149|11055341|FG001|Overall Study|Randomized but not treated|2
6994113|NCT01332227|11055366|FG000|Overall Study|Adverse Event|4
6994114|NCT01332227|11055367|FG001|Overall Study|Adverse Event|1
6994115|NCT01332227|11055366|FG000|Overall Study|Withdrawal by Subject|5
6994116|NCT01332227|11055367|FG001|Overall Study|Withdrawal by Subject|1
6994117|NCT01332227|11055366|FG000|Overall Study|Lost to Follow-up|2
6994118|NCT01332227|11055367|FG001|Overall Study|Lost to Follow-up|0
6994119|NCT01332227|11055366|FG000|Overall Study|Lack of Efficacy|3
6994120|NCT01332227|11055367|FG001|Overall Study|Lack of Efficacy|1
6994121|NCT01332227|11055366|FG000|Overall Study|Poor compliance/noncompliance|1
6994122|NCT01332227|11055367|FG001|Overall Study|Poor compliance/noncompliance|1
6994123|NCT01332227|11055366|FG000|Overall Study|Patient moved from area|1
6994124|NCT01332227|11055367|FG001|Overall Study|Patient moved from area|0
6994125|NCT01332227|11055366|FG000|Overall Study|Patient began prohibited medication|0
6994126|NCT01332227|11055367|FG001|Overall Study|Patient began prohibited medication|1
6994127|NCT01332292|11055382|FG000|Treatment Period 1 (14 Days)|Adverse Event|1
6994128|NCT01332292|11055383|FG001|Treatment Period 1 (14 Days)|Adverse Event|0
6994129|NCT01332292|11055382|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1
6994130|NCT01332292|11055383|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1
6994131|NCT01332292|11055382|FG000|Treatment Period 2 (14 Days)|Physician Decision|1
6994132|NCT01332292|11055383|FG001|Treatment Period 2 (14 Days)|Physician Decision|1
6994133|NCT01332305|11055396|FG000|Overall Study|Adverse Event|1
6994134|NCT01332305|11055397|FG001|Overall Study|Adverse Event|4
6994135|NCT01332305|11055398|FG002|Overall Study|Adverse Event|6
6994136|NCT01332305|11055399|FG003|Overall Study|Adverse Event|3
6994137|NCT01332305|11055400|FG004|Overall Study|Adverse Event|5
6994138|NCT01332305|11055396|FG000|Overall Study|Withdrawal by Subject|6
6994139|NCT01332305|11055397|FG001|Overall Study|Withdrawal by Subject|5
6994140|NCT01332305|11055398|FG002|Overall Study|Withdrawal by Subject|4
6994141|NCT01332305|11055399|FG003|Overall Study|Withdrawal by Subject|1
6994142|NCT01332305|11055400|FG004|Overall Study|Withdrawal by Subject|0
6994143|NCT01332305|11055396|FG000|Overall Study|Lost to Follow-up|0
6994144|NCT01332305|11055397|FG001|Overall Study|Lost to Follow-up|2
6994145|NCT01332305|11055398|FG002|Overall Study|Lost to Follow-up|3
6994146|NCT01332305|11055399|FG003|Overall Study|Lost to Follow-up|2
6994147|NCT01332305|11055400|FG004|Overall Study|Lost to Follow-up|3
6994148|NCT01332305|11055396|FG000|Overall Study|Protocol Violation|1
6994149|NCT01332305|11055397|FG001|Overall Study|Protocol Violation|2
6994150|NCT01332305|11055398|FG002|Overall Study|Protocol Violation|1
6994151|NCT01332305|11055399|FG003|Overall Study|Protocol Violation|0
6994152|NCT01332305|11055400|FG004|Overall Study|Protocol Violation|3
6994153|NCT01332305|11055396|FG000|Overall Study|Withdrawal by Sponsor|1
6994154|NCT01332305|11055397|FG001|Overall Study|Withdrawal by Sponsor|0
6994155|NCT01332305|11055398|FG002|Overall Study|Withdrawal by Sponsor|0
6994156|NCT01332305|11055399|FG003|Overall Study|Withdrawal by Sponsor|1
6994157|NCT01332305|11055400|FG004|Overall Study|Withdrawal by Sponsor|1
6994158|NCT01332305|11055396|FG000|Overall Study|Treatment Failure|1
6994159|NCT01332305|11055397|FG001|Overall Study|Treatment Failure|1
6994160|NCT01332305|11055398|FG002|Overall Study|Treatment Failure|0
6994161|NCT01332305|11055399|FG003|Overall Study|Treatment Failure|0
6994162|NCT01332305|11055400|FG004|Overall Study|Treatment Failure|0
6994163|NCT01332305|11055396|FG000|Overall Study|Physician Decision|0
6994164|NCT01332305|11055397|FG001|Overall Study|Physician Decision|0
6994165|NCT01332305|11055398|FG002|Overall Study|Physician Decision|0
6994166|NCT01332305|11055399|FG003|Overall Study|Physician Decision|1
6994167|NCT01332305|11055400|FG004|Overall Study|Physician Decision|0
6994168|NCT01332318|11055416|FG000|Overall Study|Adverse Event|0
6994169|NCT01332318|11055417|FG001|Overall Study|Adverse Event|3
6994170|NCT01332318|11055418|FG002|Overall Study|Adverse Event|0
6994171|NCT01332318|11055419|FG003|Overall Study|Adverse Event|0
6994172|NCT01332318|11055416|FG000|Overall Study|Withdrawal by Subject|1
6994173|NCT01332318|11055417|FG001|Overall Study|Withdrawal by Subject|1
6994174|NCT01332318|11055418|FG002|Overall Study|Withdrawal by Subject|0
6994175|NCT01332318|11055419|FG003|Overall Study|Withdrawal by Subject|1
6994176|NCT01332318|11055416|FG000|Overall Study|Protocol Violation|1
6994177|NCT01332318|11055417|FG001|Overall Study|Protocol Violation|0
6994178|NCT01332318|11055418|FG002|Overall Study|Protocol Violation|1
6994179|NCT01332318|11055419|FG003|Overall Study|Protocol Violation|1
6994180|NCT01332331|11055432|FG000|Overall Study|Lost to Follow-up|0
6994181|NCT01332331|11055433|FG001|Overall Study|Lost to Follow-up|1
6994182|NCT01332331|11055432|FG000|Overall Study|Adverse Event|1
6994183|NCT01332331|11055433|FG001|Overall Study|Adverse Event|1
6994184|NCT01332331|11055432|FG000|Overall Study|Physician Decision|1
6994185|NCT01332331|11055433|FG001|Overall Study|Physician Decision|0
6994186|NCT01332630|11055505|FG000|Overall Study|Withdrawal by Subject|3
6994187|NCT01332851|11055515|FG000|Overall Study|Withdrawal by Subject|4
6994188|NCT01332851|11055516|FG001|Overall Study|Withdrawal by Subject|2
6994189|NCT01332851|11055515|FG000|Overall Study|Lost to Follow-up|7
6994190|NCT01332851|11055516|FG001|Overall Study|Lost to Follow-up|11
6994191|NCT01332994|11055533|FG000|Overall Study|Adverse Event|34
6994192|NCT01332994|11055533|FG000|Overall Study|Death|1
6994193|NCT01332994|11055533|FG000|Overall Study|Lack of Efficacy|1
6994194|NCT01332994|11055533|FG000|Overall Study|Lost to Follow-up|4
6994195|NCT01332994|11055533|FG000|Overall Study|Protocol Violation|6
6994196|NCT01332994|11055533|FG000|Overall Study|Withdrawal by Subject|15
6994197|NCT01332994|11055533|FG000|Overall Study|Administrative Problem|2
6994198|NCT01332994|11055533|FG000|Overall Study|Other|8
6994199|NCT01333033|11055539|FG000|Overall Study|Ineligible|0
6994200|NCT01333033|11055540|FG001|Overall Study|Ineligible|0
6994201|NCT01333033|11055541|FG002|Overall Study|Ineligible|0
6994202|NCT01333033|11055542|FG003|Overall Study|Ineligible|0
6994203|NCT01333033|11055543|FG004|Overall Study|Ineligible|6
6994204|NCT01333033|11055544|FG005|Overall Study|Ineligible|8
6994205|NCT01333033|11055539|FG000|Overall Study|Withdrawal by Subject|0
6994206|NCT01333033|11055540|FG001|Overall Study|Withdrawal by Subject|0
6994207|NCT01333033|11055541|FG002|Overall Study|Withdrawal by Subject|0
6994208|NCT01333033|11055542|FG003|Overall Study|Withdrawal by Subject|0
6994209|NCT01333033|11055543|FG004|Overall Study|Withdrawal by Subject|4
6994210|NCT01333033|11055544|FG005|Overall Study|Withdrawal by Subject|2
6994211|NCT01333033|11055539|FG000|Overall Study|PET inevaluable|0
6994212|NCT01333033|11055540|FG001|Overall Study|PET inevaluable|0
6994213|NCT01333033|11055541|FG002|Overall Study|PET inevaluable|0
6994214|NCT01333033|11055542|FG003|Overall Study|PET inevaluable|0
6994215|NCT01333033|11055543|FG004|Overall Study|PET inevaluable|2
6994216|NCT01333033|11055544|FG005|Overall Study|PET inevaluable|4
6994217|NCT01333033|11055539|FG000|Overall Study|Adverse Event|0
6994218|NCT01333033|11055540|FG001|Overall Study|Adverse Event|0
6994219|NCT01333033|11055541|FG002|Overall Study|Adverse Event|0
6994220|NCT01333033|11055542|FG003|Overall Study|Adverse Event|0
6994221|NCT01333033|11055543|FG004|Overall Study|Adverse Event|2
6994222|NCT01333033|11055544|FG005|Overall Study|Adverse Event|1
6994223|NCT01333033|11055539|FG000|Overall Study|Progression|0
6994224|NCT01333033|11055540|FG001|Overall Study|Progression|0
6994225|NCT01333033|11055541|FG002|Overall Study|Progression|0
6994226|NCT01333033|11055542|FG003|Overall Study|Progression|0
6994227|NCT01333033|11055543|FG004|Overall Study|Progression|0
6994228|NCT01333033|11055544|FG005|Overall Study|Progression|1
6994229|NCT01333033|11055539|FG000|Overall Study|MD Decision|0
6994230|NCT01333033|11055540|FG001|Overall Study|MD Decision|0
6994231|NCT01333033|11055541|FG002|Overall Study|MD Decision|0
6994232|NCT01333033|11055542|FG003|Overall Study|MD Decision|0
6994233|NCT01333033|11055543|FG004|Overall Study|MD Decision|0
6994234|NCT01333033|11055544|FG005|Overall Study|MD Decision|2
6994235|NCT01333059|11055564|FG000|Overall Study|Physician Decision|3
6994236|NCT01333059|11055565|FG001|Overall Study|Physician Decision|3
6994237|NCT01333059|11055564|FG000|Overall Study|Protocol Violation|3
6994238|NCT01333059|11055565|FG001|Overall Study|Protocol Violation|0
6994239|NCT01333072|11055575|FG000|Overall Study|Lost to Follow-up|3
6994240|NCT01333072|11055576|FG001|Overall Study|Lost to Follow-up|0
6994241|NCT01333072|11055575|FG000|Overall Study|Adverse Event|2
6994242|NCT01333072|11055576|FG001|Overall Study|Adverse Event|4
6994243|NCT01333072|11055575|FG000|Overall Study|Physician Decision|1
6994244|NCT01333072|11055576|FG001|Overall Study|Physician Decision|0
6994245|NCT01333111|11055591|FG000|Overall Study|patient undergoing major surgery|0
6994246|NCT01333111|11055592|FG001|Overall Study|patient undergoing major surgery|2
6994247|NCT01333111|11055593|FG002|Overall Study|patient undergoing major surgery|0
6994248|NCT01333111|11055591|FG000|Overall Study|personal reasons|0
6994249|NCT01333111|11055592|FG001|Overall Study|personal reasons|0
6994250|NCT01333111|11055593|FG002|Overall Study|personal reasons|1
6994251|NCT01333111|11055591|FG000|Overall Study|unclassified|1
6994252|NCT01333111|11055592|FG001|Overall Study|unclassified|0
6994253|NCT01333111|11055593|FG002|Overall Study|unclassified|0
6994254|NCT01333111|11055591|FG000|Overall Study|withdrawal criteria|0
6994255|NCT01333111|11055592|FG001|Overall Study|withdrawal criteria|1
6994256|NCT01333111|11055593|FG002|Overall Study|withdrawal criteria|0
6994257|NCT01333111|11055591|FG000|Overall Study|Non-compliance|1
6994258|NCT01333111|11055592|FG001|Overall Study|Non-compliance|0
6994259|NCT01333111|11055593|FG002|Overall Study|Non-compliance|0
6994260|NCT01333111|11055591|FG000|Overall Study|Ineffective therapy|0
6994261|NCT01333111|11055592|FG001|Overall Study|Ineffective therapy|0
6994262|NCT01333111|11055593|FG002|Overall Study|Ineffective therapy|1
6994263|NCT01333189|11055603|FG000|Overall Study|Time constraints|1
6994264|NCT01333189|11055604|FG001|Overall Study|Time constraints|0
6994265|NCT01333189|11055603|FG000|Overall Study|Adverse Event|1
6994266|NCT01333189|11055604|FG001|Overall Study|Adverse Event|0
6994267|NCT01333189|11055603|FG000|Overall Study|Transportation difficulties|0
6994268|NCT01333189|11055604|FG001|Overall Study|Transportation difficulties|1
6994269|NCT01333189|11055603|FG000|Overall Study|Moved from region|0
6994270|NCT01333189|11055604|FG001|Overall Study|Moved from region|1
6994271|NCT01333397|11055615|FG000|Overall Study|Lost to Follow-up|1
6994272|NCT01333397|11055616|FG001|Overall Study|Lost to Follow-up|0
6994273|NCT01333397|11055617|FG002|Overall Study|Lost to Follow-up|0
6994274|NCT01333397|11055618|FG003|Overall Study|Lost to Follow-up|1
6994275|NCT01333397|11055619|FG004|Overall Study|Lost to Follow-up|0
6994276|NCT01333475|11055642|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1
6994277|NCT01333475|11055643|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0
6994278|NCT01333475|11055642|FG000|Overall Study|Toxicity|1
6994279|NCT01333475|11055643|FG001|Overall Study|Toxicity|3
6994280|NCT01333501|11055666|FG000|Overall Study|Adverse Event|3
6994281|NCT01333501|11055667|FG001|Overall Study|Adverse Event|1
6994282|NCT01333501|11055666|FG000|Overall Study|Abnormal laboratory value|2
6994283|NCT01333501|11055667|FG001|Overall Study|Abnormal laboratory value|1
6994284|NCT01333501|11055666|FG000|Overall Study|Unsatisfactory therapeutic effect|1
6994285|NCT01333501|11055667|FG001|Overall Study|Unsatisfactory therapeutic effect|7
6994286|NCT01333501|11055666|FG000|Overall Study|Withdrawn consent|3
6994287|NCT01333501|11055667|FG001|Overall Study|Withdrawn consent|12
6994288|NCT01333722|11055693|FG000|Overall Study|Lack of Efficacy|0
6994289|NCT01333722|11055694|FG001|Overall Study|Lack of Efficacy|2
6994290|NCT01333722|11055693|FG000|Overall Study|Withdrawal by Subject|0
6994291|NCT01333722|11055694|FG001|Overall Study|Withdrawal by Subject|1
6994292|NCT01333865|11055706|FG000|Overall Study|Adverse Event|2
6994293|NCT01333956|11055714|FG000|Overall Study|Lost to Follow-up|1
6994294|NCT01333956|11055715|FG001|Overall Study|Lost to Follow-up|2
6994295|NCT01333956|11055716|FG002|Overall Study|Lost to Follow-up|0
6994296|NCT01333956|11055717|FG003|Overall Study|Lost to Follow-up|1
6994297|NCT01333956|11055714|FG000|Overall Study|Unable to complete study procedure|1
6994298|NCT01333956|11055715|FG001|Overall Study|Unable to complete study procedure|0
6994299|NCT01333956|11055716|FG002|Overall Study|Unable to complete study procedure|0
6994300|NCT01333956|11055717|FG003|Overall Study|Unable to complete study procedure|1
6994301|NCT01333956|11055714|FG000|Overall Study|Withdrawal by Subject|0
6994302|NCT01333956|11055715|FG001|Overall Study|Withdrawal by Subject|2
6994303|NCT01333956|11055716|FG002|Overall Study|Withdrawal by Subject|1
6994304|NCT01333956|11055717|FG003|Overall Study|Withdrawal by Subject|0
6994305|NCT01334125|11055734|FG000|Overall Study|Lost to Follow-up|3
6994306|NCT01334125|11055735|FG001|Overall Study|Lost to Follow-up|3
6994307|NCT01334515|11055762|FG000|Overall Study|Adverse Event|1
6994308|NCT01334515|11055763|FG001|Overall Study|Adverse Event|6
6994309|NCT01334515|11055762|FG000|Overall Study|Death|1
6994310|NCT01334515|11055763|FG001|Overall Study|Death|0
6994311|NCT01334515|11055762|FG000|Overall Study|Lack of Efficacy|8
6994312|NCT01334515|11055763|FG001|Overall Study|Lack of Efficacy|21
6994313|NCT01334515|11055762|FG000|Overall Study|Physician Decision|1
6994314|NCT01334515|11055763|FG001|Overall Study|Physician Decision|1
6994315|NCT01334515|11055762|FG000|Overall Study|Withdrawal by Subject|1
6994316|NCT01334515|11055763|FG001|Overall Study|Withdrawal by Subject|1
6994317|NCT01334554|11055771|FG000|Overall Study|Adverse Event|4
6994318|NCT01334554|11055772|FG001|Overall Study|Adverse Event|2
6994319|NCT01334710|11055780|FG000|Overall Study|Trial was terminated|3
6994320|NCT01334866|11055814|FG000|Overall Study|Withdrawal by Subject|10
6994321|NCT01334866|11055814|FG000|Overall Study|Lost to Follow-up|3
6994322|NCT01334866|11055814|FG000|Overall Study|Physician Decision|3
6994323|NCT01334866|11055814|FG000|Overall Study|medically necessary prior to procedure|2
6994324|NCT01334866|11055814|FG000|Overall Study|medically necessary post-procedure|1
6994325|NCT01334918|11055822|FG000|Overall Study|Did not receive study drug|6
6994326|NCT01334918|11055823|FG001|Overall Study|Did not receive study drug|0
6994327|NCT01334918|11055822|FG000|Overall Study|Adverse Event|2
6994328|NCT01334918|11055823|FG001|Overall Study|Adverse Event|0
6994329|NCT01334918|11055822|FG000|Overall Study|Withdrawal by Subject|0
6994330|NCT01334918|11055823|FG001|Overall Study|Withdrawal by Subject|1
6994331|NCT01335009|11055856|FG000|Overall Study|Too ill to travel to study sites|1
6994332|NCT01335009|11055857|FG001|Overall Study|Too ill to travel to study sites|0
6994333|NCT01335009|11055856|FG000|Overall Study|Death|28
6994334|NCT01335009|11055857|FG001|Overall Study|Death|32
6994335|NCT01335009|11055856|FG000|Overall Study|Withdrawal by Subject|1
6994336|NCT01335009|11055857|FG001|Overall Study|Withdrawal by Subject|1
6994337|NCT01335009|11055856|FG000|Overall Study|Lost to Follow-up|1
6994338|NCT01335009|11055857|FG001|Overall Study|Lost to Follow-up|0
6994339|NCT01335464|11055919|FG000|Overall Study|Adverse Event|15
6994340|NCT01335464|11055920|FG001|Overall Study|Adverse Event|25
6994341|NCT01335464|11055919|FG000|Overall Study|Non compliant with protocol|2
6994342|NCT01335464|11055920|FG001|Overall Study|Non compliant with protocol|0
6994343|NCT01335464|11055919|FG000|Overall Study|Consent withdrawn, not due to AE|12
6994344|NCT01335464|11055920|FG001|Overall Study|Consent withdrawn, not due to AE|23
6994345|NCT01335464|11055919|FG000|Overall Study|Not treated|2
6994346|NCT01335464|11055920|FG001|Overall Study|Not treated|0
6994347|NCT01335464|11055919|FG000|Overall Study|Reason other than those stated above|1
6994348|NCT01335464|11055920|FG001|Overall Study|Reason other than those stated above|1
6994349|NCT01335477|11055928|FG000|Overall Study|Adverse Event|30
6994350|NCT01335477|11055929|FG001|Overall Study|Adverse Event|42
6994351|NCT01335477|11055928|FG000|Overall Study|Non compliant with protocol|0
6994352|NCT01335477|11055929|FG001|Overall Study|Non compliant with protocol|2
6994353|NCT01335477|11055928|FG000|Overall Study|Lost to Follow-up|1
6994354|NCT01335477|11055929|FG001|Overall Study|Lost to Follow-up|2
6994355|NCT01335477|11055928|FG000|Overall Study|Consent withdrawn, not due to AE|7
6994356|NCT01335477|11055929|FG001|Overall Study|Consent withdrawn, not due to AE|9
6994357|NCT01335477|11055928|FG000|Overall Study|Not treated|1
6994358|NCT01335477|11055929|FG001|Overall Study|Not treated|2
6994359|NCT01335477|11055928|FG000|Overall Study|Reason other than those stated above|2
6994360|NCT01335477|11055929|FG001|Overall Study|Reason other than those stated above|2
6994361|NCT01335698|11055953|FG000|Treatment Stage 1|Lack of Efficacy|3
6994362|NCT01335698|11055954|FG001|Treatment Stage 1|Lack of Efficacy|1
6994363|NCT01335698|11055955|FG002|Treatment Stage 1|Lack of Efficacy|3
6994364|NCT01335698|11055956|FG003|Treatment Stage 1|Lack of Efficacy|3
6994365|NCT01335698|11055957|FG004|Treatment Stage 1|Lack of Efficacy|1
6994366|NCT01335698|11055953|FG000|Treatment Stage 1|Adverse Event|1
6994367|NCT01335698|11055954|FG001|Treatment Stage 1|Adverse Event|2
6994368|NCT01335698|11055955|FG002|Treatment Stage 1|Adverse Event|2
6994369|NCT01335698|11055956|FG003|Treatment Stage 1|Adverse Event|1
6994370|NCT01335698|11055957|FG004|Treatment Stage 1|Adverse Event|1
6994371|NCT01335698|11055953|FG000|Treatment Stage 1|Withdrawal by Subject|1
6994372|NCT01335698|11055954|FG001|Treatment Stage 1|Withdrawal by Subject|2
6994373|NCT01335698|11055955|FG002|Treatment Stage 1|Withdrawal by Subject|0
6994374|NCT01335698|11055956|FG003|Treatment Stage 1|Withdrawal by Subject|1
6994375|NCT01335698|11055957|FG004|Treatment Stage 1|Withdrawal by Subject|0
6994376|NCT01335698|11055953|FG000|Treatment Stage 1|Lost to Follow-up|1
6994377|NCT01335698|11055954|FG001|Treatment Stage 1|Lost to Follow-up|1
6994378|NCT01335698|11055955|FG002|Treatment Stage 1|Lost to Follow-up|0
6994379|NCT01335698|11055956|FG003|Treatment Stage 1|Lost to Follow-up|0
6994380|NCT01335698|11055957|FG004|Treatment Stage 1|Lost to Follow-up|0
6994381|NCT01335698|11055953|FG000|Treatment Stage 1|Poor compliance/noncompliance|0
6994382|NCT01335698|11055954|FG001|Treatment Stage 1|Poor compliance/noncompliance|1
6994383|NCT01335698|11055955|FG002|Treatment Stage 1|Poor compliance/noncompliance|0
6994384|NCT01335698|11055956|FG003|Treatment Stage 1|Poor compliance/noncompliance|2
6994385|NCT01335698|11055957|FG004|Treatment Stage 1|Poor compliance/noncompliance|0
6994386|NCT01335698|11055953|FG000|Treatment Stage 1|No longer meets study criteria|1
6994387|NCT01335698|11055954|FG001|Treatment Stage 1|No longer meets study criteria|1
6994388|NCT01335698|11055955|FG002|Treatment Stage 1|No longer meets study criteria|0
6994389|NCT01335698|11055956|FG003|Treatment Stage 1|No longer meets study criteria|1
6994390|NCT01335698|11055957|FG004|Treatment Stage 1|No longer meets study criteria|0
6994391|NCT01335698|11055953|FG000|Treatment Stage 1|Other|1
6994392|NCT01335698|11055954|FG001|Treatment Stage 1|Other|0
6994393|NCT01335698|11055955|FG002|Treatment Stage 1|Other|0
6994394|NCT01335698|11055956|FG003|Treatment Stage 1|Other|1
6994395|NCT01335698|11055957|FG004|Treatment Stage 1|Other|0
6994396|NCT01335698|11055953|FG000|Treatment Stage 2|Lack of Efficacy|2
6994397|NCT01335698|11055954|FG001|Treatment Stage 2|Lack of Efficacy|1
6994398|NCT01335698|11055955|FG002|Treatment Stage 2|Lack of Efficacy|3
6994399|NCT01335698|11055956|FG003|Treatment Stage 2|Lack of Efficacy|1
6994400|NCT01335698|11055957|FG004|Treatment Stage 2|Lack of Efficacy|0
6994401|NCT01335698|11055953|FG000|Treatment Stage 2|Adverse Event|2
6994402|NCT01335698|11055954|FG001|Treatment Stage 2|Adverse Event|0
6994403|NCT01335698|11055955|FG002|Treatment Stage 2|Adverse Event|0
6994404|NCT01335698|11055956|FG003|Treatment Stage 2|Adverse Event|3
6994405|NCT01335698|11055957|FG004|Treatment Stage 2|Adverse Event|0
6994406|NCT01335698|11055953|FG000|Treatment Stage 2|Withdrawal by Subject|3
6994407|NCT01335698|11055954|FG001|Treatment Stage 2|Withdrawal by Subject|1
6994408|NCT01335698|11055955|FG002|Treatment Stage 2|Withdrawal by Subject|1
6994409|NCT01335698|11055956|FG003|Treatment Stage 2|Withdrawal by Subject|0
6994410|NCT01335698|11055957|FG004|Treatment Stage 2|Withdrawal by Subject|0
6994411|NCT01335698|11055953|FG000|Treatment Stage 2|Poor compliance/noncompliance|1
6994412|NCT01335698|11055954|FG001|Treatment Stage 2|Poor compliance/noncompliance|0
6994413|NCT01335698|11055955|FG002|Treatment Stage 2|Poor compliance/noncompliance|1
6994414|NCT01335698|11055956|FG003|Treatment Stage 2|Poor compliance/noncompliance|3
6994415|NCT01335698|11055957|FG004|Treatment Stage 2|Poor compliance/noncompliance|1
6994416|NCT01335698|11055953|FG000|Treatment Stage 2|Lost to Follow-up|1
6994417|NCT01335698|11055954|FG001|Treatment Stage 2|Lost to Follow-up|0
6994418|NCT01335698|11055955|FG002|Treatment Stage 2|Lost to Follow-up|0
6994419|NCT01335698|11055956|FG003|Treatment Stage 2|Lost to Follow-up|0
6994420|NCT01335698|11055957|FG004|Treatment Stage 2|Lost to Follow-up|0
6994421|NCT01335698|11055953|FG000|Treatment Stage 2|Capsules received at state hospital|1
6994422|NCT01335698|11055954|FG001|Treatment Stage 2|Capsules received at state hospital|0
6994423|NCT01335698|11055955|FG002|Treatment Stage 2|Capsules received at state hospital|0
6994424|NCT01335698|11055956|FG003|Treatment Stage 2|Capsules received at state hospital|0
6994425|NCT01335698|11055957|FG004|Treatment Stage 2|Capsules received at state hospital|0
6994426|NCT01335698|11055953|FG000|Treatment Stage 2|Subject no longer meets study criteria|0
6994427|NCT01335698|11055954|FG001|Treatment Stage 2|Subject no longer meets study criteria|0
6994428|NCT01335698|11055955|FG002|Treatment Stage 2|Subject no longer meets study criteria|0
6994429|NCT01335698|11055956|FG003|Treatment Stage 2|Subject no longer meets study criteria|1
6994430|NCT01335698|11055957|FG004|Treatment Stage 2|Subject no longer meets study criteria|0
7042532|NCT01737398|11127167|FG000|Overall Study|Adverse event or SAE|16
6994431|NCT01335698|11055953|FG000|Treatment Stage 2|Switched to another formulation|1
6994432|NCT01335698|11055954|FG001|Treatment Stage 2|Switched to another formulation|1
6994433|NCT01335698|11055955|FG002|Treatment Stage 2|Switched to another formulation|0
6994434|NCT01335698|11055956|FG003|Treatment Stage 2|Switched to another formulation|0
6994435|NCT01335698|11055957|FG004|Treatment Stage 2|Switched to another formulation|0
6994436|NCT01335971|11056029|FG000|Overall Study|Withdrawal by Subject|1
6994437|NCT01335971|11056030|FG001|Overall Study|Withdrawal by Subject|0
6994438|NCT01335971|11056031|FG002|Overall Study|Withdrawal by Subject|0
6994439|NCT01335971|11056029|FG000|Overall Study|Did not complete bronchoscopy|1
6994440|NCT01335971|11056030|FG001|Overall Study|Did not complete bronchoscopy|1
6994441|NCT01335971|11056031|FG002|Overall Study|Did not complete bronchoscopy|1
6994442|NCT01336023|11056042|FG000|Week 0 to Week 26|Adverse Event|8
6994443|NCT01336023|11056043|FG001|Week 0 to Week 26|Adverse Event|10
6994444|NCT01336023|11056044|FG002|Week 0 to Week 26|Adverse Event|24
6994445|NCT01336023|11056042|FG000|Week 0 to Week 26|Lack of Efficacy|0
6994446|NCT01336023|11056043|FG001|Week 0 to Week 26|Lack of Efficacy|1
6994447|NCT01336023|11056044|FG002|Week 0 to Week 26|Lack of Efficacy|0
6994448|NCT01336023|11056042|FG000|Week 0 to Week 26|Protocol Violation|1
6994449|NCT01336023|11056043|FG001|Week 0 to Week 26|Protocol Violation|2
6994450|NCT01336023|11056044|FG002|Week 0 to Week 26|Protocol Violation|0
6994451|NCT01336023|11056042|FG000|Week 0 to Week 26|Withdrawal Criteria|34
6994452|NCT01336023|11056043|FG001|Week 0 to Week 26|Withdrawal Criteria|69
6994453|NCT01336023|11056044|FG002|Week 0 to Week 26|Withdrawal Criteria|40
6994454|NCT01336023|11056042|FG000|Week 0 to Week 26|Unclassified|5
6994455|NCT01336023|11056043|FG001|Week 0 to Week 26|Unclassified|16
6994456|NCT01336023|11056044|FG002|Week 0 to Week 26|Unclassified|9
6994457|NCT01336023|11056042|FG000|Week 27 to 52|Adverse Event|1
6994458|NCT01336023|11056043|FG001|Week 27 to 52|Adverse Event|5
6994459|NCT01336023|11056044|FG002|Week 27 to 52|Adverse Event|2
6994460|NCT01336023|11056042|FG000|Week 27 to 52|Protocol Violation|0
6994461|NCT01336023|11056043|FG001|Week 27 to 52|Protocol Violation|2
6994462|NCT01336023|11056044|FG002|Week 27 to 52|Protocol Violation|1
6994463|NCT01336023|11056042|FG000|Week 27 to 52|Withdrawal Criteria|14
6994464|NCT01336023|11056043|FG001|Week 27 to 52|Withdrawal Criteria|19
6994465|NCT01336023|11056044|FG002|Week 27 to 52|Withdrawal Criteria|16
6994466|NCT01336023|11056042|FG000|Week 27 to 52|Unclassified|13
6994467|NCT01336023|11056043|FG001|Week 27 to 52|Unclassified|18
6994468|NCT01336023|11056044|FG002|Week 27 to 52|Unclassified|9
6994469|NCT01336205|11056063|FG000|Overall Study|Other|22
6994470|NCT01336205|11056064|FG001|Overall Study|Other|9
6994471|NCT01336205|11056063|FG000|Overall Study|Lost to Follow-up|40
6994472|NCT01336205|11056064|FG001|Overall Study|Lost to Follow-up|20
6994473|NCT01336205|11056063|FG000|Overall Study|Study-Specific Withdrawal Criteria|16
6994474|NCT01336205|11056064|FG001|Overall Study|Study-Specific Withdrawal Criteria|7
6994475|NCT01336205|11056063|FG000|Overall Study|Lack of Efficacy|4
6994476|NCT01336205|11056064|FG001|Overall Study|Lack of Efficacy|0
6994477|NCT01336205|11056063|FG000|Overall Study|Severe noncompliance with protocol|9
6994478|NCT01336205|11056064|FG001|Overall Study|Severe noncompliance with protocol|2
6994479|NCT01336205|11056063|FG000|Overall Study|Adverse Event|56
6994480|NCT01336205|11056064|FG001|Overall Study|Adverse Event|6
6994481|NCT01336205|11056063|FG000|Overall Study|Death|1
6994482|NCT01336205|11056064|FG001|Overall Study|Death|1
6994483|NCT01336205|11056063|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9
6994484|NCT01336205|11056064|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6
6994485|NCT01336205|11056063|FG000|Overall Study|Withdrawal by Subject|72
6994486|NCT01336205|11056064|FG001|Overall Study|Withdrawal by Subject|38
6994487|NCT01336205|11056063|FG000|Overall Study|Did not receive treatment|4
6994488|NCT01336205|11056064|FG001|Overall Study|Did not receive treatment|0
6994489|NCT01336569|11056090|FG000|Overall Study|Lost to Follow-up|4
6994490|NCT01336608|11056097|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102
6994491|NCT01336608|11056098|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
6994492|NCT01336608|11056099|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
6994493|NCT01336608|11056100|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
6994494|NCT01336608|11056097|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9
6994495|NCT01336608|11056098|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
6994496|NCT01336608|11056099|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
6994497|NCT01336608|11056100|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
6994498|NCT01336608|11056097|FG000|2-week, Single-blind Run-In Period|Adverse Event|1
6994499|NCT01336608|11056098|FG001|2-week, Single-blind Run-In Period|Adverse Event|0
6994500|NCT01336608|11056099|FG002|2-week, Single-blind Run-In Period|Adverse Event|0
6994501|NCT01336608|11056100|FG003|2-week, Single-blind Run-In Period|Adverse Event|0
6994502|NCT01336608|11056097|FG000|2-week, Single-blind Run-In Period|Physician Decision|1
6994503|NCT01336608|11056098|FG001|2-week, Single-blind Run-In Period|Physician Decision|0
6994504|NCT01336608|11056099|FG002|2-week, Single-blind Run-In Period|Physician Decision|0
6994505|NCT01336608|11056100|FG003|2-week, Single-blind Run-In Period|Physician Decision|0
6994506|NCT01336608|11056097|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2
6994507|NCT01336608|11056098|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0
6994508|NCT01336608|11056099|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0
6994509|NCT01336608|11056100|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0
6994510|NCT01336608|11056097|FG000|24-week, Double-blind Treatment Period|Adverse Event|0
6994511|NCT01336608|11056098|FG001|24-week, Double-blind Treatment Period|Adverse Event|8
6994512|NCT01336608|11056099|FG002|24-week, Double-blind Treatment Period|Adverse Event|6
6994513|NCT01336608|11056100|FG003|24-week, Double-blind Treatment Period|Adverse Event|7
6994514|NCT01336608|11056097|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
6994515|NCT01336608|11056098|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
6994516|NCT01336608|11056099|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
6994517|NCT01336608|11056100|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
6994518|NCT01336608|11056097|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
6994519|NCT01336608|11056098|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
6994520|NCT01336608|11056099|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
6994521|NCT01336608|11056100|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6
6994522|NCT01336608|11056097|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0
6994523|NCT01336608|11056098|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4
6994524|NCT01336608|11056099|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3
6994525|NCT01336608|11056100|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3
6994526|NCT01336608|11056097|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
6994527|NCT01336608|11056098|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
6994528|NCT01336608|11056099|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3
6994529|NCT01336608|11056100|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6
6994530|NCT01336608|11056097|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0
6994531|NCT01336608|11056098|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3
6994532|NCT01336608|11056099|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0
6994533|NCT01336608|11056100|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0
6994534|NCT01336608|11056097|FG000|24-week, Double-blind Treatment Period|Physician Decision|0
6994535|NCT01336608|11056098|FG001|24-week, Double-blind Treatment Period|Physician Decision|3
6994536|NCT01336608|11056099|FG002|24-week, Double-blind Treatment Period|Physician Decision|1
6994537|NCT01336608|11056100|FG003|24-week, Double-blind Treatment Period|Physician Decision|1
6994538|NCT01336608|11056097|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
6994539|NCT01336608|11056098|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
6994540|NCT01336608|11056099|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4
6994541|NCT01336608|11056100|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1
6994542|NCT01336647|11056111|FG000|Overall Study|Lost to Follow-up|4
6994543|NCT01336647|11056112|FG001|Overall Study|Lost to Follow-up|1
6994544|NCT01336647|11056113|FG002|Overall Study|Lost to Follow-up|3
6994545|NCT01336712|11056123|FG000|Overall Study|Death|2
6994546|NCT01336712|11056123|FG000|Overall Study|Lack of Efficacy|1
6994547|NCT01336738|11056132|FG000|Overall Study|Adverse Event|0
6994548|NCT01336738|11056133|FG001|Overall Study|Adverse Event|3
6994549|NCT01336738|11056134|FG002|Overall Study|Adverse Event|2
6994550|NCT01336738|11056135|FG003|Overall Study|Adverse Event|1
6994551|NCT01336738|11056136|FG004|Overall Study|Adverse Event|3
6994552|NCT01336738|11056132|FG000|Overall Study|Lost to Follow-up|2
6994553|NCT01336738|11056133|FG001|Overall Study|Lost to Follow-up|1
6994554|NCT01336738|11056134|FG002|Overall Study|Lost to Follow-up|2
6994555|NCT01336738|11056135|FG003|Overall Study|Lost to Follow-up|2
6994556|NCT01336738|11056136|FG004|Overall Study|Lost to Follow-up|2
6994557|NCT01336738|11056132|FG000|Overall Study|Did not meet entrance criteria|0
6994558|NCT01336738|11056133|FG001|Overall Study|Did not meet entrance criteria|1
6994559|NCT01336738|11056134|FG002|Overall Study|Did not meet entrance criteria|0
6994560|NCT01336738|11056135|FG003|Overall Study|Did not meet entrance criteria|0
6994561|NCT01336738|11056136|FG004|Overall Study|Did not meet entrance criteria|0
6994562|NCT01336738|11056132|FG000|Overall Study|Protocol Violation|0
6994563|NCT01336738|11056133|FG001|Overall Study|Protocol Violation|1
6994564|NCT01336738|11056134|FG002|Overall Study|Protocol Violation|0
6994565|NCT01336738|11056135|FG003|Overall Study|Protocol Violation|0
6994566|NCT01336738|11056136|FG004|Overall Study|Protocol Violation|0
6994567|NCT01336738|11056132|FG000|Overall Study|Withdrawal by Subject|2
6994568|NCT01336738|11056133|FG001|Overall Study|Withdrawal by Subject|0
6994569|NCT01336738|11056134|FG002|Overall Study|Withdrawal by Subject|2
6994570|NCT01336738|11056135|FG003|Overall Study|Withdrawal by Subject|1
6994571|NCT01336738|11056136|FG004|Overall Study|Withdrawal by Subject|1
6994572|NCT01336738|11056132|FG000|Overall Study|Other|3
6994573|NCT01336738|11056133|FG001|Overall Study|Other|3
6994574|NCT01336738|11056134|FG002|Overall Study|Other|2
6994575|NCT01336738|11056135|FG003|Overall Study|Other|3
6994576|NCT01336738|11056136|FG004|Overall Study|Other|4
6994577|NCT01336764|11056150|FG000|Overall Study|Withdrawal by Subject|5
6994578|NCT01336764|11056151|FG001|Overall Study|Withdrawal by Subject|5
6994579|NCT01336894|11056171|FG000|Follow-up|Study terminated prematurely|2
6994580|NCT01336894|11056172|FG001|Follow-up|Study terminated prematurely|7
6994581|NCT01336972|11056202|FG000|Overall Study|Adverse Event|1
6994582|NCT01336972|11056203|FG001|Overall Study|Adverse Event|1
6994583|NCT01336972|11056204|FG002|Overall Study|Adverse Event|0
6994584|NCT01337050|11056216|FG000|Overall Study|Death|0
6994585|NCT01337050|11056217|FG001|Overall Study|Death|0
6994586|NCT01337050|11056218|FG002|Overall Study|Death|4
6994587|NCT01337050|11056216|FG000|Overall Study|Other|4
6994588|NCT01337050|11056217|FG001|Overall Study|Other|6
6994589|NCT01337050|11056218|FG002|Overall Study|Other|8
6994590|NCT01337050|11056216|FG000|Overall Study|Participants refused further follow-up|0
6994591|NCT01337050|11056217|FG001|Overall Study|Participants refused further follow-up|7
6994592|NCT01337050|11056218|FG002|Overall Study|Participants refused further follow-up|7
6994593|NCT01337089|11056231|FG000|Overall Study|Adverse Event|237
6994594|NCT01337089|11056231|FG000|Overall Study|Withdrawal by Subject|129
6994595|NCT01337089|11056231|FG000|Overall Study|Withdrawal by Investigator|33
6994596|NCT01337089|11056231|FG000|Overall Study|Met Withdrawal Criteria|3
6994597|NCT01337089|11056231|FG000|Overall Study|Lost to Follow-up|2
6994598|NCT01337115|11056237|FG000|Overall Study|Protocol Violation|2
6994599|NCT01337115|11056238|FG001|Overall Study|Protocol Violation|0
6994600|NCT01337167|11056248|FG000|Infant Series|Adverse Event|1
6994601|NCT01337167|11056249|FG001|Infant Series|Adverse Event|1
6994602|NCT01337167|11056248|FG000|Infant Series|Death|1
6994603|NCT01337167|11056249|FG001|Infant Series|Death|1
6994604|NCT01337167|11056248|FG000|Infant Series|Lost to Follow-up|13
6994605|NCT01337167|11056249|FG001|Infant Series|Lost to Follow-up|7
6994606|NCT01337167|11056248|FG000|Infant Series|Non-compliance with study drug|2
6994607|NCT01337167|11056249|FG001|Infant Series|Non-compliance with study drug|1
6994608|NCT01337167|11056248|FG000|Infant Series|Physician Decision|3
6994609|NCT01337167|11056249|FG001|Infant Series|Physician Decision|1
6994610|NCT01337167|11056248|FG000|Infant Series|Protocol Violation|22
6994611|NCT01337167|11056249|FG001|Infant Series|Protocol Violation|9
6994612|NCT01337167|11056248|FG000|Infant Series|Withdrawal by Subject|15
6994613|NCT01337167|11056249|FG001|Infant Series|Withdrawal by Subject|4
6994614|NCT01337167|11056248|FG000|Infant Series|Randomized but not vaccinated|5
6994615|NCT01337167|11056249|FG001|Infant Series|Randomized but not vaccinated|3
6994616|NCT01337167|11056248|FG000|Interim Period|Lost to Follow-up|51
6994617|NCT01337167|11056249|FG001|Interim Period|Lost to Follow-up|23
6994618|NCT01337167|11056248|FG000|Interim Period|Non-compliance with study drug|1
6994619|NCT01337167|11056249|FG001|Interim Period|Non-compliance with study drug|0
6994620|NCT01337167|11056248|FG000|Interim Period|Physician Decision|6
6994621|NCT01337167|11056249|FG001|Interim Period|Physician Decision|3
6994622|NCT01337167|11056248|FG000|Interim Period|Protocol Violation|5
6994623|NCT01337167|11056249|FG001|Interim Period|Protocol Violation|3
6994624|NCT01337167|11056248|FG000|Interim Period|Withdrawal by Subject|18
6994625|NCT01337167|11056249|FG001|Interim Period|Withdrawal by Subject|10
6994626|NCT01337167|11056248|FG000|Interim Period|Other protocol criterion not met|0
6994627|NCT01337167|11056249|FG001|Interim Period|Other protocol criterion not met|1
6994628|NCT01337167|11056248|FG000|Toddler Vaccinations|Lost to Follow-up|11
6994629|NCT01337167|11056249|FG001|Toddler Vaccinations|Lost to Follow-up|12
6994630|NCT01337167|11056248|FG000|Toddler Vaccinations|Protocol Violation|0
6994631|NCT01337167|11056249|FG001|Toddler Vaccinations|Protocol Violation|1
6994632|NCT01337167|11056248|FG000|Toddler Vaccinations|Withdrawal by Subject|3
6994633|NCT01337167|11056249|FG001|Toddler Vaccinations|Withdrawal by Subject|0
6994634|NCT01337297|11056257|FG000|Overall Study|They entered to single anodal tDCS|4
6994635|NCT01337297|11056258|FG001|Overall Study|They entered to single anodal tDCS|3
6994636|NCT01337297|11056257|FG000|Overall Study|Lost to Follow-up|1
6994637|NCT01337297|11056258|FG001|Overall Study|Lost to Follow-up|3
6994638|NCT01337596|11056282|FG000|Overall Study|Withdrawal by Subject|0
6994639|NCT01337596|11056283|FG001|Overall Study|Withdrawal by Subject|0
6994640|NCT01337596|11056284|FG002|Overall Study|Withdrawal by Subject|0
6994641|NCT01337596|11056285|FG003|Overall Study|Withdrawal by Subject|0
6994642|NCT01337596|11056286|FG004|Overall Study|Withdrawal by Subject|2
6994643|NCT01337596|11056287|FG005|Overall Study|Withdrawal by Subject|0
6994644|NCT01337596|11056288|FG006|Overall Study|Withdrawal by Subject|0
6994645|NCT01337596|11056289|FG007|Overall Study|Withdrawal by Subject|0
6994646|NCT01337596|11056290|FG008|Overall Study|Withdrawal by Subject|0
6994647|NCT01337635|11056315|FG000|Overall Study|Lost to Follow-up|0
6994648|NCT01337635|11056316|FG001|Overall Study|Lost to Follow-up|1
6994649|NCT01337674|11056324|FG000|Treatment Period 1|Adverse Event|0
6994650|NCT01337674|11056325|FG001|Treatment Period 1|Adverse Event|1
6994651|NCT01337674|11056326|FG002|Treatment Period 1|Adverse Event|0
6994652|NCT01337674|11056327|FG003|Treatment Period 1|Adverse Event|0
6994653|NCT01337674|11056324|FG000|Treatment Period 1|Discontinued due to blood draws|0
6994654|NCT01337674|11056325|FG001|Treatment Period 1|Discontinued due to blood draws|0
6994655|NCT01337674|11056326|FG002|Treatment Period 1|Discontinued due to blood draws|0
6994656|NCT01337674|11056327|FG003|Treatment Period 1|Discontinued due to blood draws|1
6994657|NCT01337674|11056324|FG000|Treatment Period 2|Withdrawal by Subject|0
6994658|NCT01337674|11056325|FG001|Treatment Period 2|Withdrawal by Subject|0
6994659|NCT01337674|11056326|FG002|Treatment Period 2|Withdrawal by Subject|1
6994660|NCT01337674|11056327|FG003|Treatment Period 2|Withdrawal by Subject|0
6994661|NCT01337960|11056370|FG000|Overall Study|Lost to Follow-up|1
6994662|NCT01337960|11056371|FG001|Overall Study|Lost to Follow-up|0
6994663|NCT01337960|11056372|FG002|Overall Study|Lost to Follow-up|0
6994664|NCT01337960|11056370|FG000|Overall Study|Withdrawal by Subject|1
6994665|NCT01337960|11056371|FG001|Overall Study|Withdrawal by Subject|0
6994666|NCT01337960|11056372|FG002|Overall Study|Withdrawal by Subject|0
6994667|NCT01337973|11056383|FG000|Overall Study|Lost to Follow-up|2
6994668|NCT01337973|11056384|FG001|Overall Study|Lost to Follow-up|4
6994669|NCT01337973|11056385|FG002|Overall Study|Lost to Follow-up|3
6994670|NCT01337973|11056383|FG000|Overall Study|Death|1
6994671|NCT01337973|11056384|FG001|Overall Study|Death|2
6994672|NCT01337973|11056385|FG002|Overall Study|Death|1
6994673|NCT01337973|11056383|FG000|Overall Study|Withdrawal by Subject|10
6994674|NCT01337973|11056384|FG001|Overall Study|Withdrawal by Subject|8
6994675|NCT01337973|11056385|FG002|Overall Study|Withdrawal by Subject|4
6994676|NCT01337973|11056383|FG000|Overall Study|missing data on primary outcome|3
6994677|NCT01337973|11056384|FG001|Overall Study|missing data on primary outcome|1
6994678|NCT01337973|11056385|FG002|Overall Study|missing data on primary outcome|3
6994679|NCT01337986|11056395|FG000|Overall Study|Adverse Event|2
6994680|NCT01337986|11056396|FG001|Overall Study|Adverse Event|2
6994681|NCT01337986|11056395|FG000|Overall Study|Lost to Follow-up|1
6994682|NCT01337986|11056396|FG001|Overall Study|Lost to Follow-up|0
6994683|NCT01337986|11056395|FG000|Overall Study|Protocol Violation|0
6994684|NCT01337986|11056396|FG001|Overall Study|Protocol Violation|3
6994685|NCT01338012|11056418|FG000|Overall Study|Death|4
6994686|NCT01338012|11056418|FG000|Overall Study|Study terminated|4
7042533|NCT01737398|11127168|FG001|Overall Study|Adverse event or SAE|1
7042534|NCT01737398|11127167|FG000|Overall Study|Stopping rule met|2
7042535|NCT01737398|11127168|FG001|Overall Study|Stopping rule met|1
7042536|NCT01737398|11127167|FG000|Overall Study|Voluntary withdrawal|2
7042537|NCT01737398|11127168|FG001|Overall Study|Voluntary withdrawal|3
7042538|NCT01737398|11127167|FG000|Overall Study|Ineligibility|1
7042539|NCT01737398|11127168|FG001|Overall Study|Ineligibility|0
7042540|NCT01737398|11127167|FG000|Overall Study|Liver transplant|1
7042541|NCT01737398|11127168|FG001|Overall Study|Liver transplant|0
7042542|NCT01737398|11127167|FG000|Overall Study|Disease progression|2
7042543|NCT01737398|11127168|FG001|Overall Study|Disease progression|3
7042544|NCT01737398|11127167|FG000|Overall Study|Sponsor's decision|2
7042545|NCT01737398|11127168|FG001|Overall Study|Sponsor's decision|0
7042546|NCT01737697|11127208|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0
7042547|NCT01737697|11127209|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1
7042548|NCT01737697|11127210|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0
7042549|NCT01737697|11127211|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1
7042550|NCT01737697|11127212|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1
7042551|NCT01737697|11127213|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0
7042552|NCT01737697|11127214|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0
7042553|NCT01737697|11127215|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0
7042554|NCT01737697|11127216|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0
7042555|NCT01737697|11127217|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0
7042556|NCT01737697|11127218|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0
7042557|NCT01737697|11127219|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0
7042558|NCT01737697|11127220|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0
7042559|NCT01737697|11127221|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0
7042560|NCT01737697|11127222|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0
7042561|NCT01737697|11127208|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1
7042562|NCT01737697|11127209|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1
7042563|NCT01737697|11127210|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3
7042564|NCT01737697|11127211|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7042565|NCT01737697|11127212|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7042566|NCT01737697|11127213|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7042567|NCT01737697|11127214|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7042568|NCT01737697|11127215|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7042569|NCT01737697|11127216|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7042570|NCT01737697|11127217|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7042571|NCT01737697|11127218|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7042572|NCT01737697|11127219|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7042573|NCT01737697|11127220|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7042574|NCT01737697|11127221|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7042575|NCT01737697|11127222|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7042576|NCT01737697|11127208|FG000|Acute Phase-Initial 48 Hours|Family emergency|0
7042577|NCT01737697|11127209|FG001|Acute Phase-Initial 48 Hours|Family emergency|0
7042578|NCT01737697|11127210|FG002|Acute Phase-Initial 48 Hours|Family emergency|0
7042579|NCT01737697|11127211|FG003|Acute Phase-Initial 48 Hours|Family emergency|1
7042580|NCT01737697|11127212|FG004|Acute Phase-Initial 48 Hours|Family emergency|0
7042581|NCT01737697|11127213|FG005|Acute Phase-Initial 48 Hours|Family emergency|0
7042582|NCT01737697|11127214|FG006|Acute Phase-Initial 48 Hours|Family emergency|0
7042583|NCT01737697|11127215|FG007|Acute Phase-Initial 48 Hours|Family emergency|0
7042584|NCT01737697|11127216|FG008|Acute Phase-Initial 48 Hours|Family emergency|0
7042585|NCT01737697|11127217|FG009|Acute Phase-Initial 48 Hours|Family emergency|0
7042586|NCT01737697|11127218|FG010|Acute Phase-Initial 48 Hours|Family emergency|0
7042587|NCT01737697|11127219|FG011|Acute Phase-Initial 48 Hours|Family emergency|0
7042588|NCT01737697|11127220|FG012|Acute Phase-Initial 48 Hours|Family emergency|0
7042589|NCT01737697|11127221|FG013|Acute Phase-Initial 48 Hours|Family emergency|0
7042590|NCT01737697|11127222|FG014|Acute Phase-Initial 48 Hours|Family emergency|0
7042591|NCT01737697|11127208|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7042592|NCT01737697|11127209|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1
6994687|NCT01338025|11056424|FG000|Overall Study|Unexpected closure of study|10
6994688|NCT01338025|11056425|FG001|Overall Study|Unexpected closure of study|9
6994689|NCT01338025|11056424|FG000|Overall Study|Withdrawal by Subject|0
6994690|NCT01338025|11056425|FG001|Overall Study|Withdrawal by Subject|2
6994691|NCT01338025|11056424|FG000|Overall Study|Found ineligible after starting|1
6994692|NCT01338025|11056425|FG001|Overall Study|Found ineligible after starting|0
6994693|NCT01338298|11056433|FG000|Overall Study|Withdrawal by Subject|1
6994694|NCT01338298|11056434|FG001|Overall Study|Withdrawal by Subject|1
6994695|NCT01338298|11056433|FG000|Overall Study|Abdominal Pain and scheduled surgery|0
6994696|NCT01338298|11056434|FG001|Overall Study|Abdominal Pain and scheduled surgery|1
6994697|NCT01338298|11056433|FG000|Overall Study|Administrative error|0
6994698|NCT01338298|11056434|FG001|Overall Study|Administrative error|1
6994699|NCT01338298|11056433|FG000|Overall Study|Positive symptom worsening|1
6994700|NCT01338298|11056434|FG001|Overall Study|Positive symptom worsening|0
6994701|NCT01338298|11056433|FG000|Overall Study|Depressive symptoms and nausea|1
6994702|NCT01338298|11056434|FG001|Overall Study|Depressive symptoms and nausea|0
6994703|NCT01338298|11056433|FG000|Overall Study|Non-adherence|1
6994704|NCT01338298|11056434|FG001|Overall Study|Non-adherence|0
6994705|NCT01338415|11056442|FG000|Core + Extension|Adverse Event|8
6994706|NCT01338415|11056443|FG001|Core + Extension|Adverse Event|6
6994707|NCT01338415|11056444|FG002|Core + Extension|Adverse Event|0
6994708|NCT01338415|11056442|FG000|Core + Extension|Withdrawal by Subject|1
6994709|NCT01338415|11056443|FG001|Core + Extension|Withdrawal by Subject|1
6994710|NCT01338415|11056444|FG002|Core + Extension|Withdrawal by Subject|0
6994711|NCT01338415|11056442|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0
6994712|NCT01338415|11056443|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2
6994713|NCT01338415|11056444|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0
6994714|NCT01338415|11056442|FG000|Core + Extension|Other (administrative reason)|1
6994715|NCT01338415|11056443|FG001|Core + Extension|Other (administrative reason)|0
6994716|NCT01338415|11056444|FG002|Core + Extension|Other (administrative reason)|0
6994717|NCT01338415|11056442|FG000|Exceptional Use Treatment Period|Administrative decision|0
6994718|NCT01338415|11056443|FG001|Exceptional Use Treatment Period|Administrative decision|0
6994719|NCT01338415|11056444|FG002|Exceptional Use Treatment Period|Administrative decision|1
6994720|NCT01338415|11056442|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0
6994721|NCT01338415|11056443|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0
6994722|NCT01338415|11056444|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3
6994723|NCT01338415|11056442|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0
6994724|NCT01338415|11056443|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0
6994725|NCT01338415|11056444|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1
6994726|NCT01338415|11056442|FG000|Exceptional Use Treatment Period|Death|0
6994727|NCT01338415|11056443|FG001|Exceptional Use Treatment Period|Death|0
6994728|NCT01338415|11056444|FG002|Exceptional Use Treatment Period|Death|1
6994729|NCT01338493|11056452|FG000|Enrolled|Withdrawal by Subject|1
6994730|NCT01338493|11056452|FG000|Enrolled|Patient not implanted|4
6994731|NCT01338493|11056452|FG000|Discharge|Death|1
6994732|NCT01338493|11056452|FG000|Discharge|Missed visit|1
6994733|NCT01338493|11056452|FG000|6 Months Follow up|Lost to Follow-up|11
6994734|NCT01338493|11056452|FG000|6 Months Follow up|Missed visit|8
6994735|NCT01338493|11056452|FG000|12 Months Follow up|Lost to Follow-up|9
6994736|NCT01338610|11056472|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1
6994737|NCT01338610|11056473|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1
6994738|NCT01338610|11056474|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0
6994739|NCT01338610|11056472|FG000|Overall Study|Protocol Violation|1
6994740|NCT01338610|11056473|FG001|Overall Study|Protocol Violation|0
6994741|NCT01338610|11056474|FG002|Overall Study|Protocol Violation|1
6994742|NCT01338610|11056472|FG000|Overall Study|Adverse Event|3
6994743|NCT01338610|11056473|FG001|Overall Study|Adverse Event|0
6994744|NCT01338610|11056474|FG002|Overall Study|Adverse Event|0
6994745|NCT01338792|11056490|FG000|Overall Study|Adverse Event|2
6994746|NCT01338792|11056490|FG000|Overall Study|Death|1
6994747|NCT01338792|11056490|FG000|Overall Study|Withdrawal by Subject|1
6994748|NCT01338818|11056494|FG000|Overall Study|Adverse Event|8
6994749|NCT01338818|11056494|FG000|Overall Study|Lack of Efficacy|5
6994750|NCT01338818|11056494|FG000|Overall Study|no longer require study drug|1
6994751|NCT01338818|11056494|FG000|Overall Study|Withdrawal by Subject|11
6994752|NCT01338818|11056494|FG000|Overall Study|Lost to Follow-up|4
6994753|NCT01338818|11056494|FG000|Overall Study|Administrative problems|3
6994754|NCT01338818|11056494|FG000|Overall Study|Protocol Deviation|4
6994755|NCT01338870|11056508|FG000|Overall Study|Lost to Follow-up|0
6994756|NCT01338870|11056509|FG001|Overall Study|Lost to Follow-up|0
6994757|NCT01338870|11056510|FG002|Overall Study|Lost to Follow-up|1
6994758|NCT01338870|11056511|FG003|Overall Study|Lost to Follow-up|0
6994759|NCT01338870|11056512|FG004|Overall Study|Lost to Follow-up|1
6994760|NCT01338870|11056513|FG005|Overall Study|Lost to Follow-up|0
6994761|NCT01338870|11056508|FG000|Overall Study|Withdrawal by Subject|2
6994762|NCT01338870|11056509|FG001|Overall Study|Withdrawal by Subject|3
6994763|NCT01338870|11056510|FG002|Overall Study|Withdrawal by Subject|4
6994764|NCT01338870|11056511|FG003|Overall Study|Withdrawal by Subject|0
6994765|NCT01338870|11056512|FG004|Overall Study|Withdrawal by Subject|0
6994766|NCT01338870|11056513|FG005|Overall Study|Withdrawal by Subject|2
6994767|NCT01338870|11056508|FG000|Overall Study|Other|3
6994768|NCT01338870|11056509|FG001|Overall Study|Other|3
6994769|NCT01338870|11056510|FG002|Overall Study|Other|3
6994770|NCT01338870|11056511|FG003|Overall Study|Other|2
6994771|NCT01338870|11056512|FG004|Overall Study|Other|0
6994772|NCT01338870|11056513|FG005|Overall Study|Other|2
6994773|NCT01338870|11056508|FG000|Overall Study|Protocol Violation|0
6994774|NCT01338870|11056509|FG001|Overall Study|Protocol Violation|2
6994775|NCT01338870|11056510|FG002|Overall Study|Protocol Violation|2
6994776|NCT01338870|11056511|FG003|Overall Study|Protocol Violation|2
6994777|NCT01338870|11056512|FG004|Overall Study|Protocol Violation|1
6994778|NCT01338870|11056513|FG005|Overall Study|Protocol Violation|1
6994779|NCT01338870|11056508|FG000|Overall Study|Adverse Event|4
6994780|NCT01338870|11056509|FG001|Overall Study|Adverse Event|4
6994781|NCT01338870|11056510|FG002|Overall Study|Adverse Event|1
6994782|NCT01338870|11056511|FG003|Overall Study|Adverse Event|5
6994783|NCT01338870|11056512|FG004|Overall Study|Adverse Event|4
6994784|NCT01338870|11056513|FG005|Overall Study|Adverse Event|1
6994785|NCT01338987|11056532|FG000|Overall Study|enrolled on new protocol|0
6994786|NCT01338987|11056533|FG001|Overall Study|enrolled on new protocol|0
6994787|NCT01338987|11056534|FG002|Overall Study|enrolled on new protocol|1
6994788|NCT01338987|11056535|FG003|Overall Study|enrolled on new protocol|0
6994789|NCT01338987|11056536|FG004|Overall Study|enrolled on new protocol|0
6994790|NCT01338987|11056532|FG000|Overall Study|Disease progression on study|2
6994791|NCT01338987|11056533|FG001|Overall Study|Disease progression on study|1
6994792|NCT01338987|11056534|FG002|Overall Study|Disease progression on study|1
6994793|NCT01338987|11056535|FG003|Overall Study|Disease progression on study|0
6994794|NCT01338987|11056536|FG004|Overall Study|Disease progression on study|0
6994795|NCT01339000|11056552|FG000|Overall Study|study closed due to lack of drug supply|1
6994796|NCT01339000|11056553|FG001|Overall Study|study closed due to lack of drug supply|0
6994797|NCT01339052|11056568|FG000|Overall Study|Disease progression|13
6994798|NCT01339052|11056569|FG001|Overall Study|Disease progression|46
6994799|NCT01339052|11056568|FG000|Overall Study|Adverse Event|1
6994800|NCT01339052|11056569|FG001|Overall Study|Adverse Event|1
6994801|NCT01339052|11056568|FG000|Overall Study|Withdrawal by Subject|0
6994802|NCT01339052|11056569|FG001|Overall Study|Withdrawal by Subject|3
6994803|NCT01339052|11056568|FG000|Overall Study|Physician Decision|1
6994804|NCT01339052|11056569|FG001|Overall Study|Physician Decision|0
6994805|NCT01339273|11056607|FG000|Overall Study|Lost to Follow-up|8
6994806|NCT01339273|11056608|FG001|Overall Study|Lost to Follow-up|8
6994807|NCT01339390|11056625|FG000|Overall Study|Death|32
6994808|NCT01339390|11056626|FG001|Overall Study|Death|29
6994809|NCT01339390|11056625|FG000|Overall Study|Lost to Follow-up|125
6994810|NCT01339390|11056626|FG001|Overall Study|Lost to Follow-up|127
6994811|NCT01339429|11056645|FG000|Overall Study|Withdrawal by Subject|1
6994812|NCT01339429|11056645|FG000|Overall Study|Physician Decision|3
6994813|NCT01339559|11056649|FG000|Overall Study|Adverse Event|92
6994814|NCT01339559|11056649|FG000|Overall Study|Death|5
6994815|NCT01339559|11056649|FG000|Overall Study|Lack of Efficacy|164
6994816|NCT01339559|11056649|FG000|Overall Study|Lost to Follow-up|22
6994817|NCT01339559|11056649|FG000|Overall Study|Subject choice|89
6994818|NCT01339559|11056649|FG000|Overall Study|Protocol Violation|15
6994819|NCT01339559|11056649|FG000|Overall Study|Study closure at site|1
6994820|NCT01339559|11056649|FG000|Overall Study|Incarcerated|2
6994821|NCT01339559|11056649|FG000|Overall Study|Epilepsy surgery|1
6994822|NCT01339559|11056649|FG000|Overall Study|Pregnancy planned|2
6994823|NCT01339559|11056649|FG000|Overall Study|Left the country|1
6994824|NCT01339559|11056649|FG000|Overall Study|Investigator decision|2
6994825|NCT01339559|11056649|FG000|Overall Study|Patient didn't wish to continue|1
6994826|NCT01339559|11056649|FG000|Overall Study|PI decision|1
6994827|NCT01339832|11056654|FG000|Overall Study|Lost to Follow-up|3
6994828|NCT01339832|11056654|FG000|Overall Study|Death|11
6994829|NCT01339897|11056673|FG000|Overall Study|Adverse Event|1
6994830|NCT01339897|11056674|FG001|Overall Study|Adverse Event|0
6994831|NCT01339897|11056675|FG002|Overall Study|Adverse Event|0
6994832|NCT01339897|11056676|FG003|Overall Study|Adverse Event|1
6994833|NCT01339910|11056690|FG000|Overall Study|Withdrawal by Subject|1
6994834|NCT01339910|11056691|FG001|Overall Study|Withdrawal by Subject|0
6994835|NCT01339910|11056690|FG000|Overall Study|Physician Decision|1
6994836|NCT01339910|11056691|FG001|Overall Study|Physician Decision|0
6994837|NCT01339910|11056690|FG000|Overall Study|Disease relapse|1
6994838|NCT01339910|11056691|FG001|Overall Study|Disease relapse|4
6994839|NCT01339923|11056704|FG000|Overall Study|Adverse Event|1
6994840|NCT01339923|11056705|FG001|Overall Study|Adverse Event|1
6994841|NCT01339923|11056706|FG002|Overall Study|Adverse Event|1
6994842|NCT01339923|11056707|FG003|Overall Study|Adverse Event|0
6994843|NCT01339923|11056708|FG004|Overall Study|Adverse Event|0
6994844|NCT01339923|11056709|FG005|Overall Study|Adverse Event|0
6994845|NCT01339923|11056710|FG006|Overall Study|Adverse Event|1
6994846|NCT01339923|11056704|FG000|Overall Study|Inappropriate Enrollment|1
6994847|NCT01339923|11056705|FG001|Overall Study|Inappropriate Enrollment|0
6994848|NCT01339923|11056706|FG002|Overall Study|Inappropriate Enrollment|0
6994849|NCT01339923|11056707|FG003|Overall Study|Inappropriate Enrollment|0
6994850|NCT01339923|11056708|FG004|Overall Study|Inappropriate Enrollment|0
6994851|NCT01339923|11056709|FG005|Overall Study|Inappropriate Enrollment|1
6994852|NCT01339923|11056710|FG006|Overall Study|Inappropriate Enrollment|0
6994853|NCT01339923|11056704|FG000|Overall Study|Lost to Follow-up|4
6994854|NCT01339923|11056705|FG001|Overall Study|Lost to Follow-up|4
6994855|NCT01339923|11056706|FG002|Overall Study|Lost to Follow-up|0
6994856|NCT01339923|11056707|FG003|Overall Study|Lost to Follow-up|3
6994857|NCT01339923|11056708|FG004|Overall Study|Lost to Follow-up|1
6994858|NCT01339923|11056709|FG005|Overall Study|Lost to Follow-up|1
6994859|NCT01339923|11056710|FG006|Overall Study|Lost to Follow-up|5
6994860|NCT01339923|11056704|FG000|Overall Study|Protocol Violation|0
6994861|NCT01339923|11056705|FG001|Overall Study|Protocol Violation|0
6994862|NCT01339923|11056706|FG002|Overall Study|Protocol Violation|0
6994863|NCT01339923|11056707|FG003|Overall Study|Protocol Violation|0
6994864|NCT01339923|11056708|FG004|Overall Study|Protocol Violation|0
6994865|NCT01339923|11056709|FG005|Overall Study|Protocol Violation|3
6994866|NCT01339923|11056710|FG006|Overall Study|Protocol Violation|1
6994867|NCT01339923|11056704|FG000|Overall Study|Unable to Classify|1
6994868|NCT01339923|11056705|FG001|Overall Study|Unable to Classify|0
6994869|NCT01339923|11056706|FG002|Overall Study|Unable to Classify|1
6994870|NCT01339923|11056707|FG003|Overall Study|Unable to Classify|0
6994871|NCT01339923|11056708|FG004|Overall Study|Unable to Classify|0
6994872|NCT01339923|11056709|FG005|Overall Study|Unable to Classify|1
6994873|NCT01339923|11056710|FG006|Overall Study|Unable to Classify|5
6994874|NCT01339923|11056704|FG000|Overall Study|Withdrawal by Subject|7
6994875|NCT01339923|11056705|FG001|Overall Study|Withdrawal by Subject|11
6994876|NCT01339923|11056706|FG002|Overall Study|Withdrawal by Subject|6
6994877|NCT01339923|11056707|FG003|Overall Study|Withdrawal by Subject|1
6994878|NCT01339923|11056708|FG004|Overall Study|Withdrawal by Subject|4
6994879|NCT01339923|11056709|FG005|Overall Study|Withdrawal by Subject|3
6994880|NCT01339923|11056710|FG006|Overall Study|Withdrawal by Subject|2
6994881|NCT01340014|11056745|FG000|Period 1, First 7 Days|Adverse Event|1
6994882|NCT01340014|11056746|FG001|Period 1, First 7 Days|Adverse Event|0
6994883|NCT01340014|11056745|FG000|Period 1, First 7 Days|Personal Reasons|1
6994884|NCT01340014|11056746|FG001|Period 1, First 7 Days|Personal Reasons|0
6994885|NCT01340014|11056745|FG000|Period 2, Second 7 Days|Adverse Event|0
6994886|NCT01340014|11056746|FG001|Period 2, Second 7 Days|Adverse Event|1
6994887|NCT01340027|11056764|FG000|Overall Study|Randomized but Never Received Study Drug|0
6994888|NCT01340027|11056765|FG001|Overall Study|Randomized but Never Received Study Drug|0
6994889|NCT01340027|11056766|FG002|Overall Study|Randomized but Never Received Study Drug|1
6994890|NCT01340027|11056767|FG003|Overall Study|Randomized but Never Received Study Drug|0
6994891|NCT01340027|11056768|FG004|Overall Study|Randomized but Never Received Study Drug|0
6994892|NCT01340027|11056769|FG005|Overall Study|Randomized but Never Received Study Drug|0
6994893|NCT01340027|11056770|FG006|Overall Study|Randomized but Never Received Study Drug|0
6994894|NCT01340027|11056771|FG007|Overall Study|Randomized but Never Received Study Drug|0
6994895|NCT01340027|11056772|FG008|Overall Study|Randomized but Never Received Study Drug|0
6994896|NCT01340027|11056773|FG009|Overall Study|Randomized but Never Received Study Drug|0
6994897|NCT01340027|11056774|FG010|Overall Study|Randomized but Never Received Study Drug|0
6994898|NCT01340027|11056775|FG011|Overall Study|Randomized but Never Received Study Drug|0
6994899|NCT01340027|11056764|FG000|Overall Study|Adverse Event|0
6994900|NCT01340027|11056765|FG001|Overall Study|Adverse Event|1
6994901|NCT01340027|11056766|FG002|Overall Study|Adverse Event|2
6994902|NCT01340027|11056767|FG003|Overall Study|Adverse Event|0
6994903|NCT01340027|11056768|FG004|Overall Study|Adverse Event|1
6994904|NCT01340027|11056769|FG005|Overall Study|Adverse Event|2
6994905|NCT01340027|11056770|FG006|Overall Study|Adverse Event|2
6994906|NCT01340027|11056771|FG007|Overall Study|Adverse Event|1
6994907|NCT01340027|11056772|FG008|Overall Study|Adverse Event|4
6994908|NCT01340027|11056773|FG009|Overall Study|Adverse Event|1
6994909|NCT01340027|11056774|FG010|Overall Study|Adverse Event|1
6994910|NCT01340027|11056775|FG011|Overall Study|Adverse Event|3
6994911|NCT01340027|11056764|FG000|Overall Study|Lack of Efficacy|0
6994912|NCT01340027|11056765|FG001|Overall Study|Lack of Efficacy|0
6994913|NCT01340027|11056766|FG002|Overall Study|Lack of Efficacy|0
6994914|NCT01340027|11056767|FG003|Overall Study|Lack of Efficacy|0
6994915|NCT01340027|11056768|FG004|Overall Study|Lack of Efficacy|0
6994916|NCT01340027|11056769|FG005|Overall Study|Lack of Efficacy|0
6994917|NCT01340027|11056770|FG006|Overall Study|Lack of Efficacy|1
6994918|NCT01340027|11056771|FG007|Overall Study|Lack of Efficacy|1
6994919|NCT01340027|11056772|FG008|Overall Study|Lack of Efficacy|1
6994920|NCT01340027|11056773|FG009|Overall Study|Lack of Efficacy|0
6994921|NCT01340027|11056774|FG010|Overall Study|Lack of Efficacy|0
6994922|NCT01340027|11056775|FG011|Overall Study|Lack of Efficacy|0
6994923|NCT01340027|11056764|FG000|Overall Study|Lost to Follow-up|0
6994924|NCT01340027|11056765|FG001|Overall Study|Lost to Follow-up|1
6994925|NCT01340027|11056766|FG002|Overall Study|Lost to Follow-up|0
6994926|NCT01340027|11056767|FG003|Overall Study|Lost to Follow-up|0
6994927|NCT01340027|11056768|FG004|Overall Study|Lost to Follow-up|0
6994928|NCT01340027|11056769|FG005|Overall Study|Lost to Follow-up|0
6994929|NCT01340027|11056770|FG006|Overall Study|Lost to Follow-up|1
6994930|NCT01340027|11056771|FG007|Overall Study|Lost to Follow-up|0
6994931|NCT01340027|11056772|FG008|Overall Study|Lost to Follow-up|0
6994932|NCT01340027|11056773|FG009|Overall Study|Lost to Follow-up|1
6994933|NCT01340027|11056774|FG010|Overall Study|Lost to Follow-up|0
6994934|NCT01340027|11056775|FG011|Overall Study|Lost to Follow-up|0
6994935|NCT01340027|11056764|FG000|Overall Study|Protocol Violation|1
6994936|NCT01340027|11056765|FG001|Overall Study|Protocol Violation|2
6994937|NCT01340027|11056766|FG002|Overall Study|Protocol Violation|0
6994938|NCT01340027|11056767|FG003|Overall Study|Protocol Violation|0
6994939|NCT01340027|11056768|FG004|Overall Study|Protocol Violation|6
6994940|NCT01340027|11056769|FG005|Overall Study|Protocol Violation|0
6994941|NCT01340027|11056770|FG006|Overall Study|Protocol Violation|0
6994942|NCT01340027|11056771|FG007|Overall Study|Protocol Violation|1
6994943|NCT01340027|11056772|FG008|Overall Study|Protocol Violation|2
6994944|NCT01340027|11056773|FG009|Overall Study|Protocol Violation|2
6994945|NCT01340027|11056774|FG010|Overall Study|Protocol Violation|0
6994946|NCT01340027|11056775|FG011|Overall Study|Protocol Violation|0
6994947|NCT01340027|11056764|FG000|Overall Study|Withdrawal by Subject|4
6994948|NCT01340027|11056765|FG001|Overall Study|Withdrawal by Subject|3
6994949|NCT01340027|11056766|FG002|Overall Study|Withdrawal by Subject|1
6994950|NCT01340027|11056767|FG003|Overall Study|Withdrawal by Subject|3
6994951|NCT01340027|11056768|FG004|Overall Study|Withdrawal by Subject|3
6994952|NCT01340027|11056769|FG005|Overall Study|Withdrawal by Subject|2
6994953|NCT01340027|11056770|FG006|Overall Study|Withdrawal by Subject|3
6994954|NCT01340027|11056771|FG007|Overall Study|Withdrawal by Subject|4
6994955|NCT01340027|11056772|FG008|Overall Study|Withdrawal by Subject|1
6994956|NCT01340027|11056773|FG009|Overall Study|Withdrawal by Subject|2
6994957|NCT01340027|11056774|FG010|Overall Study|Withdrawal by Subject|0
6994958|NCT01340027|11056775|FG011|Overall Study|Withdrawal by Subject|1
6994959|NCT01340027|11056764|FG000|Overall Study|Miscellaneous|0
6994960|NCT01340027|11056765|FG001|Overall Study|Miscellaneous|0
6994961|NCT01340027|11056766|FG002|Overall Study|Miscellaneous|0
6994962|NCT01340027|11056767|FG003|Overall Study|Miscellaneous|1
6994963|NCT01340027|11056768|FG004|Overall Study|Miscellaneous|0
6994964|NCT01340027|11056769|FG005|Overall Study|Miscellaneous|0
6994965|NCT01340027|11056770|FG006|Overall Study|Miscellaneous|0
6994966|NCT01340027|11056771|FG007|Overall Study|Miscellaneous|0
6994967|NCT01340027|11056772|FG008|Overall Study|Miscellaneous|0
6994968|NCT01340027|11056773|FG009|Overall Study|Miscellaneous|0
6994969|NCT01340027|11056774|FG010|Overall Study|Miscellaneous|1
6994970|NCT01340027|11056775|FG011|Overall Study|Miscellaneous|0
6994971|NCT01340066|11056820|FG000|Placebo Run in Period|Screen Failures|27
6994972|NCT01340066|11056821|FG001|Placebo Run in Period|Screen Failures|0
6994973|NCT01340066|11056822|FG002|Placebo Run in Period|Screen Failures|0
6994974|NCT01340066|11056820|FG000|5 Week Double Blind Randomization Period|Adverse Event|0
6994975|NCT01340066|11056821|FG001|5 Week Double Blind Randomization Period|Adverse Event|2
6994976|NCT01340066|11056822|FG002|5 Week Double Blind Randomization Period|Adverse Event|2
6994977|NCT01340066|11056820|FG000|5 Week Double Blind Randomization Period|Physician Decision|0
6994978|NCT01340066|11056821|FG001|5 Week Double Blind Randomization Period|Physician Decision|1
6994979|NCT01340066|11056822|FG002|5 Week Double Blind Randomization Period|Physician Decision|0
6994980|NCT01340066|11056820|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0
6994981|NCT01340066|11056821|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2
6994982|NCT01340066|11056822|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1
6994983|NCT01340196|11056838|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2
6994984|NCT01340209|11056850|FG000|Overall Study|Adverse Event|1
6994985|NCT01340209|11056851|FG001|Overall Study|Adverse Event|1
6994986|NCT01340209|11056852|FG002|Overall Study|Adverse Event|2
6994987|NCT01340209|11056850|FG000|Overall Study|Protocol Violation|1
6994988|NCT01340209|11056851|FG001|Overall Study|Protocol Violation|2
6994989|NCT01340209|11056852|FG002|Overall Study|Protocol Violation|1
6994990|NCT01340209|11056850|FG000|Overall Study|Withdrawal by Subject|0
6994991|NCT01340209|11056851|FG001|Overall Study|Withdrawal by Subject|0
6994992|NCT01340209|11056852|FG002|Overall Study|Withdrawal by Subject|1
6994993|NCT01340209|11056850|FG000|Overall Study|Other reason not defined above|3
6994994|NCT01340209|11056851|FG001|Overall Study|Other reason not defined above|5
6994995|NCT01340209|11056852|FG002|Overall Study|Other reason not defined above|4
6994996|NCT01340300|11056864|FG000|Overall Study|Lost to Follow-up|3
6994997|NCT01340300|11056865|FG001|Overall Study|Lost to Follow-up|0
6994998|NCT01340300|11056866|FG002|Overall Study|Lost to Follow-up|5
6994999|NCT01340300|11056867|FG003|Overall Study|Lost to Follow-up|10
6995000|NCT01340300|11056864|FG000|Overall Study|Withdrawal by Subject|5
6995001|NCT01340300|11056865|FG001|Overall Study|Withdrawal by Subject|6
6995002|NCT01340300|11056866|FG002|Overall Study|Withdrawal by Subject|6
6995003|NCT01340300|11056867|FG003|Overall Study|Withdrawal by Subject|3
6995004|NCT01340300|11056864|FG000|Overall Study|Adverse Event|1
6995005|NCT01340300|11056865|FG001|Overall Study|Adverse Event|0
6995006|NCT01340300|11056866|FG002|Overall Study|Adverse Event|4
6995007|NCT01340300|11056867|FG003|Overall Study|Adverse Event|0
6995008|NCT01340300|11056864|FG000|Overall Study|Physician Decision|0
6995009|NCT01340300|11056865|FG001|Overall Study|Physician Decision|1
6995010|NCT01340300|11056866|FG002|Overall Study|Physician Decision|0
6995011|NCT01340300|11056867|FG003|Overall Study|Physician Decision|0
6995012|NCT01340300|11056864|FG000|Overall Study|Unrelated sickness|0
6995013|NCT01340300|11056865|FG001|Overall Study|Unrelated sickness|2
6995014|NCT01340300|11056866|FG002|Overall Study|Unrelated sickness|0
6995015|NCT01340300|11056867|FG003|Overall Study|Unrelated sickness|1
6995016|NCT01340482|11056880|FG000|Overall Study|Adverse Event|2
6995017|NCT01340482|11056881|FG001|Overall Study|Adverse Event|0
6995018|NCT01340482|11056882|FG002|Overall Study|Adverse Event|0
6995019|NCT01340495|11056892|FG000|Overall Study|Withdrawal by Subject|1
6995020|NCT01340625|11056912|FG000|First Intervention|Adverse Event|1
6995021|NCT01340625|11056913|FG001|First Intervention|Adverse Event|0
6995022|NCT01340625|11056912|FG000|Washout Period of 28 Days|Withdrawal by Subject|1
6995023|NCT01340625|11056913|FG001|Washout Period of 28 Days|Withdrawal by Subject|0
6995024|NCT01340651|11056919|FG000|Overall Study|Adverse Event|3
6995025|NCT01340651|11056919|FG000|Overall Study|Consent Withdrawn|2
6995026|NCT01340651|11056919|FG000|Overall Study|Commercial Supply per Sponsor|12
6995027|NCT01340664|11056928|FG000|Overall Study|Adverse Event|0
6995028|NCT01340664|11056929|FG001|Overall Study|Adverse Event|1
6995029|NCT01340664|11056930|FG002|Overall Study|Adverse Event|7
6995030|NCT01340664|11056928|FG000|Overall Study|Lost to Follow-up|2
6995031|NCT01340664|11056929|FG001|Overall Study|Lost to Follow-up|0
6995032|NCT01340664|11056930|FG002|Overall Study|Lost to Follow-up|2
6995033|NCT01340664|11056928|FG000|Overall Study|Withdrawal by Subject|2
6995034|NCT01340664|11056929|FG001|Overall Study|Withdrawal by Subject|4
6995035|NCT01340664|11056930|FG002|Overall Study|Withdrawal by Subject|0
6995036|NCT01340664|11056928|FG000|Overall Study|Glycemic withdrawal criteria|2
6995037|NCT01340664|11056929|FG001|Overall Study|Glycemic withdrawal criteria|0
6995038|NCT01340664|11056930|FG002|Overall Study|Glycemic withdrawal criteria|0
6995039|NCT01340664|11056928|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0
6995040|NCT01340664|11056929|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1
6995041|NCT01340664|11056930|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2
6995042|NCT01340664|11056928|FG000|Overall Study|Other|1
6995043|NCT01340664|11056929|FG001|Overall Study|Other|2
6995044|NCT01340664|11056930|FG002|Overall Study|Other|2
6995045|NCT01340768|11056940|FG000|Overall Study|Lost to Follow-up|10
6995046|NCT01340768|11056941|FG001|Overall Study|Lost to Follow-up|4
6995047|NCT01340768|11056940|FG000|Overall Study|Withdrawal by Subject|5
6995048|NCT01340768|11056941|FG001|Overall Study|Withdrawal by Subject|1
6995049|NCT01340768|11056940|FG000|Overall Study|Other|2
6995050|NCT01340768|11056941|FG001|Overall Study|Other|0
6995051|NCT01340794|11056949|FG000|Overall Study|Withdrawal by Subject|0
6995052|NCT01340794|11056950|FG001|Overall Study|Withdrawal by Subject|1
6995053|NCT01340872|11056960|FG000|Double-blind Phase|Adverse Event|6
6995054|NCT01340872|11056961|FG001|Double-blind Phase|Adverse Event|4
6995055|NCT01340872|11056962|FG002|Double-blind Phase|Adverse Event|0
6995056|NCT01340872|11056963|FG003|Double-blind Phase|Adverse Event|0
6995057|NCT01340872|11056960|FG000|Double-blind Phase|Withdrawal by Subject|3
6995058|NCT01340872|11056961|FG001|Double-blind Phase|Withdrawal by Subject|5
6995059|NCT01340872|11056962|FG002|Double-blind Phase|Withdrawal by Subject|0
6995060|NCT01340872|11056963|FG003|Double-blind Phase|Withdrawal by Subject|0
6995061|NCT01340872|11056960|FG000|Double-blind Phase|Lost to Follow-up|0
6995062|NCT01340872|11056961|FG001|Double-blind Phase|Lost to Follow-up|1
6995063|NCT01340872|11056962|FG002|Double-blind Phase|Lost to Follow-up|0
6995064|NCT01340872|11056963|FG003|Double-blind Phase|Lost to Follow-up|0
6995065|NCT01340872|11056960|FG000|Double-blind Phase|Protocol Violation|0
6995066|NCT01340872|11056961|FG001|Double-blind Phase|Protocol Violation|1
6995067|NCT01340872|11056962|FG002|Double-blind Phase|Protocol Violation|0
6995068|NCT01340872|11056963|FG003|Double-blind Phase|Protocol Violation|0
6995069|NCT01340872|11056960|FG000|Open-label Phase|Physician Decision|0
6995070|NCT01340872|11056961|FG001|Open-label Phase|Physician Decision|0
6995071|NCT01340872|11056962|FG002|Open-label Phase|Physician Decision|2
6995072|NCT01340872|11056963|FG003|Open-label Phase|Physician Decision|1
6995073|NCT01340872|11056960|FG000|Open-label Phase|Pregnancy|0
6995074|NCT01340872|11056961|FG001|Open-label Phase|Pregnancy|0
6995075|NCT01340872|11056962|FG002|Open-label Phase|Pregnancy|1
6995076|NCT01340872|11056963|FG003|Open-label Phase|Pregnancy|0
6995077|NCT01340872|11056960|FG000|Open-label Phase|Adverse Event|0
6995078|NCT01340872|11056961|FG001|Open-label Phase|Adverse Event|0
6995079|NCT01340872|11056962|FG002|Open-label Phase|Adverse Event|8
6995080|NCT01340872|11056963|FG003|Open-label Phase|Adverse Event|4
6995081|NCT01340872|11056960|FG000|Open-label Phase|Withdrawal by Subject|0
6995082|NCT01340872|11056961|FG001|Open-label Phase|Withdrawal by Subject|0
6995083|NCT01340872|11056962|FG002|Open-label Phase|Withdrawal by Subject|1
6995084|NCT01340872|11056963|FG003|Open-label Phase|Withdrawal by Subject|6
6995085|NCT01340872|11056960|FG000|Open-label Phase|Worsening of IBD|0
6995086|NCT01340872|11056961|FG001|Open-label Phase|Worsening of IBD|0
6995087|NCT01340872|11056962|FG002|Open-label Phase|Worsening of IBD|1
6995088|NCT01340872|11056963|FG003|Open-label Phase|Worsening of IBD|0
6995089|NCT01340898|11056978|FG000|Primary Phase|Serious Adverse Events|0
6995090|NCT01340898|11056979|FG001|Primary Phase|Serious Adverse Events|0
6995091|NCT01340898|11056980|FG002|Primary Phase|Serious Adverse Events|1
6995092|NCT01340898|11056978|FG000|Primary Phase|Withdrawal by Subject|8
6995093|NCT01340898|11056979|FG001|Primary Phase|Withdrawal by Subject|7
6995094|NCT01340898|11056980|FG002|Primary Phase|Withdrawal by Subject|5
6995095|NCT01340898|11056978|FG000|Primary Phase|Migrated/moved from study area|4
6995096|NCT01340898|11056979|FG001|Primary Phase|Migrated/moved from study area|1
6995097|NCT01340898|11056980|FG002|Primary Phase|Migrated/moved from study area|0
6995098|NCT01340898|11056978|FG000|Primary Phase|Lost to Follow-up|4
6995099|NCT01340898|11056979|FG001|Primary Phase|Lost to Follow-up|1
6995100|NCT01340898|11056980|FG002|Primary Phase|Lost to Follow-up|0
6995101|NCT01340898|11056978|FG000|Booster Phase|Withdrawal by Subject|3
6995102|NCT01340898|11056979|FG001|Booster Phase|Withdrawal by Subject|0
6995103|NCT01340898|11056980|FG002|Booster Phase|Withdrawal by Subject|4
6995104|NCT01340898|11056978|FG000|Booster Phase|Migrated/moved from study area|3
6995105|NCT01340898|11056979|FG001|Booster Phase|Migrated/moved from study area|0
6995106|NCT01340898|11056980|FG002|Booster Phase|Migrated/moved from study area|0
6995107|NCT01340898|11056978|FG000|Booster Phase|Lost to Follow-up|4
6995108|NCT01340898|11056979|FG001|Booster Phase|Lost to Follow-up|2
6995109|NCT01340898|11056980|FG002|Booster Phase|Lost to Follow-up|3
6995110|NCT01340937|11056994|FG000|Period 1: Infant Series|Other protocol criterion not met|0
6995111|NCT01340937|11056995|FG001|Period 1: Infant Series|Other protocol criterion not met|1
6995112|NCT01340937|11056996|FG002|Period 1: Infant Series|Other protocol criterion not met|1
6995113|NCT01340937|11056997|FG003|Period 1: Infant Series|Other protocol criterion not met|0
6995114|NCT01340937|11056994|FG000|Period 1: Infant Series|Adverse Event|0
6995115|NCT01340937|11056995|FG001|Period 1: Infant Series|Adverse Event|1
6995116|NCT01340937|11056996|FG002|Period 1: Infant Series|Adverse Event|4
6995117|NCT01340937|11056997|FG003|Period 1: Infant Series|Adverse Event|0
6995118|NCT01340937|11056994|FG000|Period 1: Infant Series|Death|2
6995119|NCT01340937|11056995|FG001|Period 1: Infant Series|Death|0
6995120|NCT01340937|11056996|FG002|Period 1: Infant Series|Death|2
6995121|NCT01340937|11056997|FG003|Period 1: Infant Series|Death|0
6995122|NCT01340937|11056994|FG000|Period 1: Infant Series|Lost to Follow-up|20
6995123|NCT01340937|11056995|FG001|Period 1: Infant Series|Lost to Follow-up|14
6995124|NCT01340937|11056996|FG002|Period 1: Infant Series|Lost to Follow-up|12
6995125|NCT01340937|11056997|FG003|Period 1: Infant Series|Lost to Follow-up|13
6995126|NCT01340937|11056994|FG000|Period 1: Infant Series|Physician Decision|2
6995127|NCT01340937|11056995|FG001|Period 1: Infant Series|Physician Decision|3
6995128|NCT01340937|11056996|FG002|Period 1: Infant Series|Physician Decision|1
6995129|NCT01340937|11056997|FG003|Period 1: Infant Series|Physician Decision|0
6995130|NCT01340937|11056994|FG000|Period 1: Infant Series|Protocol Violation|1
6995131|NCT01340937|11056995|FG001|Period 1: Infant Series|Protocol Violation|4
6995132|NCT01340937|11056996|FG002|Period 1: Infant Series|Protocol Violation|4
6995133|NCT01340937|11056997|FG003|Period 1: Infant Series|Protocol Violation|3
6995134|NCT01340937|11056994|FG000|Period 1: Infant Series|Withdrawal by Subject|33
6995135|NCT01340937|11056995|FG001|Period 1: Infant Series|Withdrawal by Subject|32
6995136|NCT01340937|11056996|FG002|Period 1: Infant Series|Withdrawal by Subject|30
6995137|NCT01340937|11056997|FG003|Period 1: Infant Series|Withdrawal by Subject|15
6995138|NCT01340937|11056994|FG000|Period 1: Infant Series|Randomized but not vaccinated|0
6995139|NCT01340937|11056995|FG001|Period 1: Infant Series|Randomized but not vaccinated|5
6995140|NCT01340937|11056996|FG002|Period 1: Infant Series|Randomized but not vaccinated|2
6995141|NCT01340937|11056997|FG003|Period 1: Infant Series|Randomized but not vaccinated|1
6995142|NCT01340937|11056994|FG000|Period 2: Interim Period|Withdrawal by Subject|28
6995143|NCT01340937|11056995|FG001|Period 2: Interim Period|Withdrawal by Subject|23
6995144|NCT01340937|11056996|FG002|Period 2: Interim Period|Withdrawal by Subject|17
6995145|NCT01340937|11056997|FG003|Period 2: Interim Period|Withdrawal by Subject|12
6995146|NCT01340937|11056994|FG000|Period 2: Interim Period|Adverse Event|1
6995147|NCT01340937|11056995|FG001|Period 2: Interim Period|Adverse Event|0
6995148|NCT01340937|11056996|FG002|Period 2: Interim Period|Adverse Event|1
6995149|NCT01340937|11056997|FG003|Period 2: Interim Period|Adverse Event|0
6995150|NCT01340937|11056994|FG000|Period 2: Interim Period|Lost to Follow-up|29
6995151|NCT01340937|11056995|FG001|Period 2: Interim Period|Lost to Follow-up|48
6995152|NCT01340937|11056996|FG002|Period 2: Interim Period|Lost to Follow-up|53
6995153|NCT01340937|11056997|FG003|Period 2: Interim Period|Lost to Follow-up|23
6995154|NCT01340937|11056994|FG000|Period 2: Interim Period|Physician Decision|0
6995155|NCT01340937|11056995|FG001|Period 2: Interim Period|Physician Decision|1
6995156|NCT01340937|11056996|FG002|Period 2: Interim Period|Physician Decision|1
6995157|NCT01340937|11056997|FG003|Period 2: Interim Period|Physician Decision|0
6995158|NCT01340937|11056994|FG000|Period 2: Interim Period|Protocol Violation|5
6995159|NCT01340937|11056995|FG001|Period 2: Interim Period|Protocol Violation|3
6995160|NCT01340937|11056996|FG002|Period 2: Interim Period|Protocol Violation|6
6995161|NCT01340937|11056997|FG003|Period 2: Interim Period|Protocol Violation|3
6995162|NCT01340937|11056994|FG000|Period 2: Interim Period|Technical problems|4
6995163|NCT01340937|11056995|FG001|Period 2: Interim Period|Technical problems|4
6995164|NCT01340937|11056996|FG002|Period 2: Interim Period|Technical problems|6
6995165|NCT01340937|11056997|FG003|Period 2: Interim Period|Technical problems|3
6995166|NCT01340937|11056994|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
6995167|NCT01340937|11056995|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
6995168|NCT01340937|11056996|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
6995169|NCT01340937|11056997|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
6995170|NCT01340937|11056994|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6
6995171|NCT01340937|11056995|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14
6995172|NCT01340937|11056996|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7
6995173|NCT01340937|11056997|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8
6995174|NCT01340937|11056994|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0
6995175|NCT01340937|11056995|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0
6995176|NCT01340937|11056996|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0
6995177|NCT01340937|11056997|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1
6995178|NCT01340937|11056994|FG000|Period 3: Toddler Vaccinations|Technical problem|1
6995179|NCT01340937|11056995|FG001|Period 3: Toddler Vaccinations|Technical problem|1
6995180|NCT01340937|11056996|FG002|Period 3: Toddler Vaccinations|Technical problem|1
6995181|NCT01340937|11056997|FG003|Period 3: Toddler Vaccinations|Technical problem|0
6995182|NCT01340976|11057019|FG000|Overall Study|Physician Decision|2
6995183|NCT01340976|11057020|FG001|Overall Study|Physician Decision|0
6995184|NCT01340976|11057021|FG002|Overall Study|Physician Decision|1
6995185|NCT01340976|11057022|FG003|Overall Study|Physician Decision|1
6995186|NCT01340976|11057023|FG004|Overall Study|Physician Decision|1
6995187|NCT01340976|11057024|FG005|Overall Study|Physician Decision|0
6995188|NCT01340976|11057019|FG000|Overall Study|Death|0
6995189|NCT01340976|11057020|FG001|Overall Study|Death|1
6995190|NCT01340976|11057021|FG002|Overall Study|Death|0
6995191|NCT01340976|11057022|FG003|Overall Study|Death|0
6995192|NCT01340976|11057023|FG004|Overall Study|Death|0
6995193|NCT01340976|11057024|FG005|Overall Study|Death|0
6995194|NCT01340976|11057019|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1
6995195|NCT01340976|11057020|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0
6995196|NCT01340976|11057021|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0
6995197|NCT01340976|11057022|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0
6995198|NCT01340976|11057023|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0
6995199|NCT01340976|11057024|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0
6995200|NCT01340976|11057019|FG000|Overall Study|Withdrawal by Subject|0
6995201|NCT01340976|11057020|FG001|Overall Study|Withdrawal by Subject|0
6995202|NCT01340976|11057021|FG002|Overall Study|Withdrawal by Subject|0
6995203|NCT01340976|11057022|FG003|Overall Study|Withdrawal by Subject|1
6995204|NCT01340976|11057023|FG004|Overall Study|Withdrawal by Subject|1
6995205|NCT01340976|11057024|FG005|Overall Study|Withdrawal by Subject|0
6995206|NCT01340976|11057019|FG000|Overall Study|Other anemia treatment|1
6995207|NCT01340976|11057020|FG001|Overall Study|Other anemia treatment|0
6995208|NCT01340976|11057021|FG002|Overall Study|Other anemia treatment|2
6995209|NCT01340976|11057022|FG003|Overall Study|Other anemia treatment|1
6995210|NCT01340976|11057023|FG004|Overall Study|Other anemia treatment|0
6995211|NCT01340976|11057024|FG005|Overall Study|Other anemia treatment|1
6995212|NCT01340976|11057019|FG000|Overall Study|Adverse Event|0
6995213|NCT01340976|11057020|FG001|Overall Study|Adverse Event|1
6995214|NCT01340976|11057021|FG002|Overall Study|Adverse Event|0
6995215|NCT01340976|11057022|FG003|Overall Study|Adverse Event|0
6995216|NCT01340976|11057023|FG004|Overall Study|Adverse Event|0
6995217|NCT01340976|11057024|FG005|Overall Study|Adverse Event|0
6995218|NCT01341457|11057065|FG000|Overall Study|Adverse Event|2
6995219|NCT01341457|11057066|FG001|Overall Study|Adverse Event|0
6995220|NCT01341470|11057079|FG000|Overall Study|Sponsor decision|0
6995221|NCT01341470|11057080|FG001|Overall Study|Sponsor decision|0
6995222|NCT01341470|11057081|FG002|Overall Study|Sponsor decision|1
6995223|NCT01341470|11057082|FG003|Overall Study|Sponsor decision|1
6995224|NCT01341470|11057083|FG004|Overall Study|Sponsor decision|0
6995225|NCT01341470|11057084|FG005|Overall Study|Sponsor decision|1
6995226|NCT01341639|11057102|FG000|Infant Series|Protocol Violation|1
6995227|NCT01341639|11057103|FG001|Infant Series|Protocol Violation|0
6995228|NCT01341639|11057102|FG000|Infant Series|Not Vaccinated|0
6995229|NCT01341639|11057103|FG001|Infant Series|Not Vaccinated|1
6995230|NCT01341639|11057102|FG000|Infant Series|Adverse Event|0
6995231|NCT01341639|11057103|FG001|Infant Series|Adverse Event|5
6995232|NCT01341639|11057102|FG000|Infant Series|Withdrawal by Subject|11
6995233|NCT01341639|11057103|FG001|Infant Series|Withdrawal by Subject|8
6995234|NCT01341639|11057102|FG000|Infant Series|Lost to Follow-up|0
6995235|NCT01341639|11057103|FG001|Infant Series|Lost to Follow-up|2
6995236|NCT01341639|11057102|FG000|Infant Series|Site 0048 Participants|17
6995237|NCT01341639|11057103|FG001|Infant Series|Site 0048 Participants|16
6995238|NCT01341639|11057102|FG000|Interim Period|Withdrawal by Subject|6
6995239|NCT01341639|11057103|FG001|Interim Period|Withdrawal by Subject|7
6995240|NCT01341639|11057102|FG000|Interim Period|Lost to Follow-up|2
6995241|NCT01341639|11057103|FG001|Interim Period|Lost to Follow-up|0
6995242|NCT01341639|11057102|FG000|Interim Period|Physician Decision|0
6995243|NCT01341639|11057103|FG001|Interim Period|Physician Decision|1
6995244|NCT01341639|11057102|FG000|Interim Period|Protocol Violation|0
6995245|NCT01341639|11057103|FG001|Interim Period|Protocol Violation|1
6995246|NCT01341639|11057102|FG000|Post-Treatment|Withdrawal by Subject|0
6995247|NCT01341639|11057103|FG001|Post-Treatment|Withdrawal by Subject|1
6995248|NCT01341639|11057102|FG000|Post-Treatment|Adverse Event|0
6995249|NCT01341639|11057103|FG001|Post-Treatment|Adverse Event|2
6995250|NCT01341652|11057111|FG000|Overall Study|Incorrect Random Assignment|0
6995251|NCT01341652|11057112|FG001|Overall Study|Incorrect Random Assignment|1
6995252|NCT01341652|11057111|FG000|Overall Study|ineligible; presence metastatic disease|0
6995253|NCT01341652|11057112|FG001|Overall Study|ineligible; presence metastatic disease|1
6995254|NCT01341782|11057131|FG000|Overall Study|Adverse Event|1
6995255|NCT01341782|11057132|FG001|Overall Study|Adverse Event|1
6995256|NCT01341782|11057131|FG000|Overall Study|Withdrawal by Subject|6
6995257|NCT01341782|11057132|FG001|Overall Study|Withdrawal by Subject|5
6995258|NCT01341782|11057131|FG000|Overall Study|Missed 3 consecutive doses|0
6995259|NCT01341782|11057132|FG001|Overall Study|Missed 3 consecutive doses|4
6995260|NCT01341782|11057131|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0
6995261|NCT01341782|11057132|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1
6995262|NCT01341782|11057131|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
6995263|NCT01341782|11057132|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
6995264|NCT01341782|11057131|FG000|Overall Study|Other|5
6995265|NCT01341782|11057132|FG001|Overall Study|Other|0
6995266|NCT01341990|11057153|FG000|Overall Study|Adverse Event|0
6995267|NCT01341990|11057154|FG001|Overall Study|Adverse Event|1
6995268|NCT01341990|11057153|FG000|Overall Study|Torn Study Lens|1
6995269|NCT01341990|11057154|FG001|Overall Study|Torn Study Lens|0
6995270|NCT01341990|11057153|FG000|Overall Study|Withdrawal by Subject|2
6995271|NCT01341990|11057154|FG001|Overall Study|Withdrawal by Subject|0
6995272|NCT01342081|11057172|FG000|Overall Study|Did not receive allocated intervention|0
6995273|NCT01342081|11057173|FG001|Overall Study|Did not receive allocated intervention|0
6995274|NCT01342081|11057174|FG002|Overall Study|Did not receive allocated intervention|1
6995275|NCT01342081|11057172|FG000|Overall Study|Adverse Event|1
6995276|NCT01342081|11057173|FG001|Overall Study|Adverse Event|0
6995277|NCT01342081|11057174|FG002|Overall Study|Adverse Event|0
6995278|NCT01342081|11057172|FG000|Overall Study|Physician Decision|0
6995279|NCT01342081|11057173|FG001|Overall Study|Physician Decision|1
6995280|NCT01342081|11057174|FG002|Overall Study|Physician Decision|0
6995281|NCT01342081|11057172|FG000|Overall Study|Withdrawal by Subject|1
6995282|NCT01342081|11057173|FG001|Overall Study|Withdrawal by Subject|1
6995283|NCT01342081|11057174|FG002|Overall Study|Withdrawal by Subject|0
6995284|NCT01342094|11057184|FG000|Overall Study|Adverse Event|5
6995285|NCT01342094|11057185|FG001|Overall Study|Adverse Event|0
6995286|NCT01342094|11057184|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0
6995287|NCT01342094|11057185|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1
6995288|NCT01342094|11057184|FG000|Overall Study|Withdrawal by Subject|0
6995289|NCT01342094|11057185|FG001|Overall Study|Withdrawal by Subject|2
6995290|NCT01342211|11057210|FG000|Overall Study|Lost to Follow-up|0
6995291|NCT01342211|11057211|FG001|Overall Study|Lost to Follow-up|0
6995292|NCT01342211|11057212|FG002|Overall Study|Lost to Follow-up|0
6995293|NCT01342211|11057213|FG003|Overall Study|Lost to Follow-up|1
6995294|NCT01342211|11057214|FG004|Overall Study|Lost to Follow-up|0
6995295|NCT01342211|11057210|FG000|Overall Study|Adverse Event|0
6995296|NCT01342211|11057211|FG001|Overall Study|Adverse Event|0
6995297|NCT01342211|11057212|FG002|Overall Study|Adverse Event|0
6995298|NCT01342211|11057213|FG003|Overall Study|Adverse Event|0
6995299|NCT01342211|11057214|FG004|Overall Study|Adverse Event|1
6995300|NCT01342211|11057210|FG000|Overall Study|Withdrawal by Subject|0
6995301|NCT01342211|11057211|FG001|Overall Study|Withdrawal by Subject|0
6995302|NCT01342211|11057212|FG002|Overall Study|Withdrawal by Subject|0
6995303|NCT01342211|11057213|FG003|Overall Study|Withdrawal by Subject|1
6995304|NCT01342211|11057214|FG004|Overall Study|Withdrawal by Subject|0
6995305|NCT01342211|11057210|FG000|Overall Study|Randomized, but not Treated|0
6995306|NCT01342211|11057211|FG001|Overall Study|Randomized, but not Treated|2
6995307|NCT01342211|11057212|FG002|Overall Study|Randomized, but not Treated|0
6995308|NCT01342211|11057213|FG003|Overall Study|Randomized, but not Treated|0
6995309|NCT01342211|11057214|FG004|Overall Study|Randomized, but not Treated|1
6995310|NCT01342341|11057232|FG000|Overall Study|Lost to Follow-up|4
6995311|NCT01342341|11057233|FG001|Overall Study|Lost to Follow-up|4
6995312|NCT01342367|11057241|FG000|Overall Study|Death|1
6995313|NCT01342367|11057242|FG001|Overall Study|Death|0
6995314|NCT01342367|11057241|FG000|Overall Study|Withdrawal by Subject|1
6995315|NCT01342367|11057242|FG001|Overall Study|Withdrawal by Subject|2
6995316|NCT01342445|11057250|FG000|Overall Study|Experienced side effects|0
6995317|NCT01342445|11057251|FG001|Overall Study|Experienced side effects|2
6995318|NCT01342484|11057296|FG000|Overall Study|Other Reasons|1
6995319|NCT01342484|11057297|FG001|Overall Study|Other Reasons|0
6995320|NCT01342484|11057298|FG002|Overall Study|Other Reasons|0
6995321|NCT01342484|11057296|FG000|Overall Study|Protocol Violation|0
6995322|NCT01342484|11057297|FG001|Overall Study|Protocol Violation|0
6995323|NCT01342484|11057298|FG002|Overall Study|Protocol Violation|1
6995324|NCT01342484|11057296|FG000|Overall Study|Withdrawal by Subject|1
6995325|NCT01342484|11057297|FG001|Overall Study|Withdrawal by Subject|0
6995326|NCT01342484|11057298|FG002|Overall Study|Withdrawal by Subject|0
6995327|NCT01342510|11057310|FG000|Overall Study|Protocol Violation|12
6995328|NCT01342510|11057311|FG001|Overall Study|Protocol Violation|6
6995329|NCT01342510|11057312|FG002|Overall Study|Protocol Violation|13
6995330|NCT01342510|11057313|FG003|Overall Study|Protocol Violation|11
6995331|NCT01342640|11057412|FG000|Overall Study|Adverse Event|3
6995332|NCT01342640|11057412|FG000|Overall Study|Protocol Violation|16
6995333|NCT01342640|11057412|FG000|Overall Study|Lost to Follow-up|21
6995334|NCT01342640|11057412|FG000|Overall Study|Other|1
6995335|NCT01342796|11057435|FG000|Overall Study|Withdrawal by Subject|2
6995336|NCT01342796|11057436|FG001|Overall Study|Withdrawal by Subject|0
6995337|NCT01342796|11057435|FG000|Overall Study|Lost to Follow-up|0
6995338|NCT01342796|11057436|FG001|Overall Study|Lost to Follow-up|3
6995339|NCT01342796|11057435|FG000|Overall Study|Inappropriate enrollment|1
6995340|NCT01342796|11057436|FG001|Overall Study|Inappropriate enrollment|0
6995341|NCT01342887|11057442|FG000|Overall Study|Death|2
6995342|NCT01342913|11057448|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66
6995343|NCT01342913|11057449|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
7044896|NCT01760447|11131134|FG000|Weeks 0-20|Withdrawal by Subject|2
6995344|NCT01342913|11057450|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
6995345|NCT01342913|11057448|FG000|2-week Run-in Period|Physician Decision|6
6995346|NCT01342913|11057449|FG001|2-week Run-in Period|Physician Decision|0
6995347|NCT01342913|11057450|FG002|2-week Run-in Period|Physician Decision|0
6995348|NCT01342913|11057448|FG000|2-week Run-in Period|Withdrawal by Subject|7
6995349|NCT01342913|11057449|FG001|2-week Run-in Period|Withdrawal by Subject|0
6995350|NCT01342913|11057450|FG002|2-week Run-in Period|Withdrawal by Subject|0
6995351|NCT01342913|11057448|FG000|2-week Run-in Period|Adverse Event|2
6995352|NCT01342913|11057449|FG001|2-week Run-in Period|Adverse Event|0
6995353|NCT01342913|11057450|FG002|2-week Run-in Period|Adverse Event|0
6995354|NCT01342913|11057448|FG000|2-week Run-in Period|Protocol Violation|5
6995355|NCT01342913|11057449|FG001|2-week Run-in Period|Protocol Violation|0
6995356|NCT01342913|11057450|FG002|2-week Run-in Period|Protocol Violation|0
6995357|NCT01342913|11057448|FG000|2-week Run-in Period|Continuation Criteria Not Met|88
6995358|NCT01342913|11057449|FG001|2-week Run-in Period|Continuation Criteria Not Met|0
6995359|NCT01342913|11057450|FG002|2-week Run-in Period|Continuation Criteria Not Met|0
6995360|NCT01342913|11057448|FG000|Double-Blind Treatment Period|Adverse Event|0
6995361|NCT01342913|11057449|FG001|Double-Blind Treatment Period|Adverse Event|3
6995362|NCT01342913|11057450|FG002|Double-Blind Treatment Period|Adverse Event|6
6995363|NCT01342913|11057448|FG000|Double-Blind Treatment Period|Lack of Efficacy|0
6995364|NCT01342913|11057449|FG001|Double-Blind Treatment Period|Lack of Efficacy|2
6995365|NCT01342913|11057450|FG002|Double-Blind Treatment Period|Lack of Efficacy|3
6995366|NCT01342913|11057448|FG000|Double-Blind Treatment Period|Protocol Violation|0
6995367|NCT01342913|11057449|FG001|Double-Blind Treatment Period|Protocol Violation|6
6995368|NCT01342913|11057450|FG002|Double-Blind Treatment Period|Protocol Violation|9
6995369|NCT01342913|11057448|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
6995370|NCT01342913|11057449|FG001|Double-Blind Treatment Period|Lost to Follow-up|1
6995371|NCT01342913|11057450|FG002|Double-Blind Treatment Period|Lost to Follow-up|3
6995372|NCT01342913|11057448|FG000|Double-Blind Treatment Period|Physician Decision|0
6995373|NCT01342913|11057449|FG001|Double-Blind Treatment Period|Physician Decision|2
6995374|NCT01342913|11057450|FG002|Double-Blind Treatment Period|Physician Decision|0
6995375|NCT01342913|11057448|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
6995376|NCT01342913|11057449|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2
6995377|NCT01342913|11057450|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2
6995378|NCT01342926|11057460|FG000|Overall Study|Adverse Event|5
6995379|NCT01342926|11057461|FG001|Overall Study|Adverse Event|8
6995380|NCT01342926|11057462|FG002|Overall Study|Adverse Event|10
6995381|NCT01342926|11057463|FG003|Overall Study|Adverse Event|7
6995382|NCT01342926|11057460|FG000|Overall Study|Lost to Follow-up|0
6995383|NCT01342926|11057461|FG001|Overall Study|Lost to Follow-up|1
6995384|NCT01342926|11057462|FG002|Overall Study|Lost to Follow-up|1
6995385|NCT01342926|11057463|FG003|Overall Study|Lost to Follow-up|0
6995386|NCT01342926|11057460|FG000|Overall Study|Investigator Discretion|2
6995387|NCT01342926|11057461|FG001|Overall Study|Investigator Discretion|2
6995388|NCT01342926|11057462|FG002|Overall Study|Investigator Discretion|0
6995389|NCT01342926|11057463|FG003|Overall Study|Investigator Discretion|0
6995390|NCT01342926|11057460|FG000|Overall Study|Withdrawal by Subject|2
6995391|NCT01342926|11057461|FG001|Overall Study|Withdrawal by Subject|4
6995392|NCT01342926|11057462|FG002|Overall Study|Withdrawal by Subject|3
6995393|NCT01342926|11057463|FG003|Overall Study|Withdrawal by Subject|5
6995394|NCT01342965|11057475|FG000|Overall Study|Death|58
6995395|NCT01342965|11057476|FG001|Overall Study|Death|57
6995396|NCT01342965|11057475|FG000|Overall Study|Lost to Follow-up|5
6995397|NCT01342965|11057476|FG001|Overall Study|Lost to Follow-up|3
6995398|NCT01342965|11057475|FG000|Overall Study|Other Reasons- Unspecified|44
6995399|NCT01342965|11057476|FG001|Overall Study|Other Reasons- Unspecified|38
6995400|NCT01342965|11057475|FG000|Overall Study|Withdrawal by Subject|2
6995401|NCT01342965|11057476|FG001|Overall Study|Withdrawal by Subject|9
6995402|NCT01343043|11057499|FG000|Overall Study|Disease progression before treatment|1
6995403|NCT01343043|11057500|FG001|Overall Study|Disease progression before treatment|0
6995404|NCT01343043|11057501|FG002|Overall Study|Disease progression before treatment|0
6995405|NCT01343043|11057502|FG003|Overall Study|Disease progression before treatment|0
6995406|NCT01343043|11057499|FG000|Overall Study|Withdrawal by Subject|1
6995407|NCT01343043|11057500|FG001|Overall Study|Withdrawal by Subject|0
6995408|NCT01343043|11057501|FG002|Overall Study|Withdrawal by Subject|0
6995409|NCT01343043|11057502|FG003|Overall Study|Withdrawal by Subject|0
6995410|NCT01343043|11057499|FG000|Overall Study|Death|1
6995411|NCT01343043|11057500|FG001|Overall Study|Death|1
6995412|NCT01343043|11057501|FG002|Overall Study|Death|0
6995413|NCT01343043|11057502|FG003|Overall Study|Death|1
6995414|NCT01343056|11057519|FG000|Overall Study|Lost to Follow-up|7
6995415|NCT01343056|11057520|FG001|Overall Study|Lost to Follow-up|5
6995416|NCT01343056|11057521|FG002|Overall Study|Lost to Follow-up|3
6995417|NCT01343056|11057522|FG003|Overall Study|Lost to Follow-up|9
6995418|NCT01343082|11057536|FG000|The run-in Period|Not meeting criteria|3
6995419|NCT01343082|11057537|FG001|The run-in Period|Not meeting criteria|4
6995420|NCT01343082|11057538|FG002|The run-in Period|Not meeting criteria|5
6995421|NCT01343082|11057536|FG000|Treatment Period , Switched to DE-111|Adverse Event|1
6995422|NCT01343082|11057537|FG001|Treatment Period , Switched to DE-111|Adverse Event|4
6995423|NCT01343082|11057538|FG002|Treatment Period , Switched to DE-111|Adverse Event|3
6995424|NCT01343082|11057536|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0
6995425|NCT01343082|11057537|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1
6995426|NCT01343082|11057538|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2
6995427|NCT01343082|11057536|FG000|Treatment Period , Switched to DE-111|Physician Decision|0
6995428|NCT01343082|11057537|FG001|Treatment Period , Switched to DE-111|Physician Decision|2
6995429|NCT01343082|11057538|FG002|Treatment Period , Switched to DE-111|Physician Decision|2
6995430|NCT01343082|11057536|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4
6995431|NCT01343082|11057537|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2
6995432|NCT01343082|11057538|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5
6995433|NCT01343277|11057576|FG000|Overall Study|Other|3
6995434|NCT01343277|11057577|FG001|Overall Study|Other|3
6995435|NCT01343277|11057576|FG000|Overall Study|Withdrawal by Subject|18
6995436|NCT01343277|11057577|FG001|Overall Study|Withdrawal by Subject|13
6995437|NCT01343277|11057576|FG000|Overall Study|Physician Decision|1
6995438|NCT01343277|11057577|FG001|Overall Study|Physician Decision|2
6995439|NCT01343277|11057576|FG000|Overall Study|Death|10
6995440|NCT01343277|11057577|FG001|Overall Study|Death|1
6995441|NCT01343277|11057576|FG000|Overall Study|Adverse Event|67
6995442|NCT01343277|11057577|FG001|Overall Study|Adverse Event|13
6995443|NCT01343277|11057576|FG000|Overall Study|Disease progression|270
6995444|NCT01343277|11057577|FG001|Overall Study|Disease progression|138
6995445|NCT01343277|11057576|FG000|Overall Study|Randomized not treated|6
6995446|NCT01343277|11057577|FG001|Overall Study|Randomized not treated|21
6995447|NCT01343277|11057576|FG000|Overall Study|Treatment ongoing|8
6995448|NCT01343277|11057577|FG001|Overall Study|Treatment ongoing|2
6995449|NCT01343277|11057576|FG000|Overall Study|Subsequent anticancer therapy|1
6995450|NCT01343277|11057577|FG001|Overall Study|Subsequent anticancer therapy|0
6995451|NCT01343368|11057585|FG000|Overall Study|Death|1
6995452|NCT01343368|11057586|FG001|Overall Study|Death|0
6995453|NCT01343368|11057585|FG000|Overall Study|Lost to Follow-up|1
6995454|NCT01343368|11057586|FG001|Overall Study|Lost to Follow-up|0
6995455|NCT01343407|11057592|FG000|Second Treatment Period (Part 2)|Adverse Event|0
6995456|NCT01343407|11057593|FG001|Second Treatment Period (Part 2)|Adverse Event|0
6995457|NCT01343407|11057594|FG002|Second Treatment Period (Part 2)|Adverse Event|1
6995458|NCT01343407|11057595|FG003|Second Treatment Period (Part 2)|Adverse Event|0
6995459|NCT01343407|11057596|FG004|Second Treatment Period (Part 2)|Adverse Event|0
6995460|NCT01343407|11057597|FG005|Second Treatment Period (Part 2)|Adverse Event|0
6995461|NCT01343407|11057592|FG000|Second Washout (Part 2)|Withdrawal by Subject|0
6995462|NCT01343407|11057593|FG001|Second Washout (Part 2)|Withdrawal by Subject|0
6995463|NCT01343407|11057594|FG002|Second Washout (Part 2)|Withdrawal by Subject|1
6995464|NCT01343407|11057595|FG003|Second Washout (Part 2)|Withdrawal by Subject|0
6995465|NCT01343407|11057596|FG004|Second Washout (Part 2)|Withdrawal by Subject|0
6995466|NCT01343407|11057597|FG005|Second Washout (Part 2)|Withdrawal by Subject|0
6995467|NCT01343693|11057623|FG000|Overall Study|Lost to Follow-up|9
7042593|NCT01737697|11127210|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7042594|NCT01737697|11127211|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7042595|NCT01737697|11127212|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7042596|NCT01737697|11127213|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7042597|NCT01737697|11127214|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7042598|NCT01737697|11127215|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7042599|NCT01737697|11127216|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7042600|NCT01737697|11127217|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7042601|NCT01737697|11127218|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7042602|NCT01737697|11127219|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7042603|NCT01737697|11127220|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7042604|NCT01737697|11127221|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7042605|NCT01737697|11127222|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7042606|NCT01737697|11127208|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7042607|NCT01737697|11127209|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7042608|NCT01737697|11127210|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7042609|NCT01737697|11127211|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7042610|NCT01737697|11127212|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1
7042611|NCT01737697|11127213|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7042612|NCT01737697|11127214|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7042613|NCT01737697|11127215|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7042614|NCT01737697|11127216|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7042615|NCT01737697|11127217|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7042616|NCT01737697|11127218|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7042617|NCT01737697|11127219|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7042618|NCT01737697|11127220|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7042619|NCT01737697|11127221|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7042620|NCT01737697|11127222|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7042621|NCT01737697|11127208|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7042622|NCT01737697|11127209|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
7042623|NCT01737697|11127210|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
6995468|NCT01343823|11057631|FG000|Overall Study|Study Terminated|1
6995469|NCT01343823|11057632|FG001|Overall Study|Study Terminated|0
6995470|NCT01343823|11057633|FG002|Overall Study|Study Terminated|0
6995471|NCT01343823|11057634|FG003|Overall Study|Study Terminated|1
6995472|NCT01343823|11057631|FG000|Overall Study|Withdrawal by Subject|1
6995473|NCT01343823|11057632|FG001|Overall Study|Withdrawal by Subject|0
6995474|NCT01343823|11057633|FG002|Overall Study|Withdrawal by Subject|0
6995475|NCT01343823|11057634|FG003|Overall Study|Withdrawal by Subject|0
6995476|NCT01343888|11057647|FG000|Overall Study|Adverse Event|12
6995477|NCT01343888|11057648|FG001|Overall Study|Adverse Event|22
6995478|NCT01343888|11057649|FG002|Overall Study|Adverse Event|5
6995479|NCT01343888|11057647|FG000|Overall Study|Lack of Efficacy|9
6995480|NCT01343888|11057648|FG001|Overall Study|Lack of Efficacy|9
6995481|NCT01343888|11057649|FG002|Overall Study|Lack of Efficacy|13
6995482|NCT01343888|11057647|FG000|Overall Study|Lost to Follow-up|0
6995483|NCT01343888|11057648|FG001|Overall Study|Lost to Follow-up|2
6995484|NCT01343888|11057649|FG002|Overall Study|Lost to Follow-up|1
6995485|NCT01343888|11057647|FG000|Overall Study|Protocol Violation|0
6995486|NCT01343888|11057648|FG001|Overall Study|Protocol Violation|2
6995487|NCT01343888|11057649|FG002|Overall Study|Protocol Violation|0
6995488|NCT01343888|11057647|FG000|Overall Study|Withdrawal by Subject|4
6995489|NCT01343888|11057648|FG001|Overall Study|Withdrawal by Subject|4
6995490|NCT01343888|11057649|FG002|Overall Study|Withdrawal by Subject|2
6995491|NCT01343888|11057647|FG000|Overall Study|other than stated above|0
6995492|NCT01343888|11057648|FG001|Overall Study|other than stated above|0
6995493|NCT01343888|11057649|FG002|Overall Study|other than stated above|1
6995494|NCT01343901|11057657|FG000|Overall Study|Death|85
6995495|NCT01343901|11057657|FG000|Overall Study|Physician Decision|4
6995496|NCT01343901|11057657|FG000|Overall Study|Lost to Follow-up|12
6995497|NCT01343901|11057657|FG000|Overall Study|Management by another medical team|11
6995498|NCT01343901|11057657|FG000|Overall Study|Participant decision|1
6995499|NCT01344057|11057661|FG000|Overall Study|Premature Withdrawal|1
6995500|NCT01344161|11057667|FG000|Overall Study|Lost to Follow-up|4
6995501|NCT01344161|11057668|FG001|Overall Study|Lost to Follow-up|1
6995502|NCT01344161|11057667|FG000|Overall Study|Pregnancy|0
6995503|NCT01344161|11057668|FG001|Overall Study|Pregnancy|1
6995504|NCT01344161|11057667|FG000|Overall Study|Protocol Violation|1
6995505|NCT01344161|11057668|FG001|Overall Study|Protocol Violation|1
6995506|NCT01344226|11057674|FG000|Overall Study|Protocol Violation|2
6995507|NCT01344226|11057674|FG000|Overall Study|Withdrawal by Subject|3
6995508|NCT01344226|11057674|FG000|Overall Study|Lack of Efficacy|3
6995509|NCT01344356|11057680|FG000|Overall Study|Physician Decision|0
6995510|NCT01344356|11057681|FG001|Overall Study|Physician Decision|3
6995511|NCT01344356|11057680|FG000|Overall Study|Lost to Follow-up|0
6995512|NCT01344356|11057681|FG001|Overall Study|Lost to Follow-up|6
6995513|NCT01344369|11057691|FG000|Washout of 28 Days|Withdrawal by Subject|1
6995514|NCT01344369|11057692|FG001|Washout of 28 Days|Withdrawal by Subject|0
6995515|NCT01344369|11057691|FG000|Washout of 28 Days|Physician Decision|0
6995516|NCT01344369|11057692|FG001|Washout of 28 Days|Physician Decision|1
6995517|NCT01344369|11057691|FG000|Second Intervention|Emesis within 2 x Tmax|0
6995518|NCT01344369|11057692|FG001|Second Intervention|Emesis within 2 x Tmax|1
6995519|NCT01344447|11057698|FG000|Overall Study|Adverse Event|1
6995520|NCT01344447|11057698|FG000|Overall Study|Protocol Violation|1
6995521|NCT01344447|11057698|FG000|Overall Study|Withdrawal by Subject|1
6995522|NCT01344447|11057698|FG000|Overall Study|The contrast was not seen|1
6995523|NCT01344447|11057698|FG000|Overall Study|Physician Decision|1
6995524|NCT01344447|11057698|FG000|Overall Study|MRA unsuccessful|1
6995525|NCT01344447|11057698|FG000|Overall Study|Bolus tracking failed|1
6995526|NCT01344447|11057698|FG000|Overall Study|Error of power injector|1
6995527|NCT01344460|11057706|FG000|Overall Study|Withdrawal by Subject|1
6995528|NCT01344460|11057706|FG000|Overall Study|Lost to Follow-up|2
6995529|NCT01344538|11057716|FG000|Overall Study|Adverse Event|1
6995530|NCT01344538|11057717|FG001|Overall Study|Adverse Event|1
6995531|NCT01344538|11057716|FG000|Overall Study|Lost to Follow-up|1
6995532|NCT01344538|11057717|FG001|Overall Study|Lost to Follow-up|0
6995533|NCT01344629|11057734|FG000|Crossover Period 2|Withdrawal by Subject|0
6995534|NCT01344629|11057735|FG001|Crossover Period 2|Withdrawal by Subject|1
6995535|NCT01344759|11057743|FG000|Overall Study|Patients failed to reach sedation level|0
6995536|NCT01344759|11057744|FG001|Overall Study|Patients failed to reach sedation level|2
6995537|NCT01344824|11057756|FG000|Overall Study|Adverse Event|15
6995538|NCT01344824|11057756|FG000|Overall Study|Withdrawal by Subject|6
6995539|NCT01344824|11057756|FG000|Overall Study|Other complicating disease|1
6995540|NCT01344824|11057756|FG000|Overall Study|Progression|15
6995541|NCT01344876|11057761|FG000|Overall Study|Adverse Event|0
6995542|NCT01344876|11057762|FG001|Overall Study|Adverse Event|0
6995543|NCT01344876|11057763|FG002|Overall Study|Adverse Event|0
6995544|NCT01344876|11057764|FG003|Overall Study|Adverse Event|0
6995545|NCT01344876|11057765|FG004|Overall Study|Adverse Event|1
6995546|NCT01344876|11057761|FG000|Overall Study|Withdrawal by Subject|0
6995547|NCT01344876|11057762|FG001|Overall Study|Withdrawal by Subject|0
6995548|NCT01344876|11057763|FG002|Overall Study|Withdrawal by Subject|1
6995549|NCT01344876|11057764|FG003|Overall Study|Withdrawal by Subject|0
6995550|NCT01344876|11057765|FG004|Overall Study|Withdrawal by Subject|0
6995551|NCT01344876|11057761|FG000|Overall Study|Definite progression of primary disease|1
6995552|NCT01344876|11057762|FG001|Overall Study|Definite progression of primary disease|0
6995553|NCT01344876|11057763|FG002|Overall Study|Definite progression of primary disease|0
6995554|NCT01344876|11057764|FG003|Overall Study|Definite progression of primary disease|3
6995555|NCT01344876|11057765|FG004|Overall Study|Definite progression of primary disease|0
6995556|NCT01345019|11057780|FG000|Blinded Treatment Phase|Death|147
6995557|NCT01345019|11057781|FG001|Blinded Treatment Phase|Death|137
6995558|NCT01345019|11057780|FG000|Blinded Treatment Phase|Withdrawal by Subject|103
6995559|NCT01345019|11057781|FG001|Blinded Treatment Phase|Withdrawal by Subject|112
6995560|NCT01345019|11057780|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21
6995561|NCT01345019|11057781|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9
6995562|NCT01345019|11057780|FG000|Blinded Treatment Phase|Disease Progression|12
6995563|NCT01345019|11057781|FG001|Blinded Treatment Phase|Disease Progression|10
6995564|NCT01345019|11057780|FG000|Blinded Treatment Phase|Adverse Event|6
6995565|NCT01345019|11057781|FG001|Blinded Treatment Phase|Adverse Event|13
6995566|NCT01345019|11057780|FG000|Blinded Treatment Phase|Administrative Decision|10
6995567|NCT01345019|11057781|FG001|Blinded Treatment Phase|Administrative Decision|8
6995568|NCT01345019|11057780|FG000|Blinded Treatment Phase|Noncompliance|5
6995569|NCT01345019|11057781|FG001|Blinded Treatment Phase|Noncompliance|3
6995570|NCT01345019|11057780|FG000|Blinded Treatment Phase|Ineligibility Determined|1
6995571|NCT01345019|11057781|FG001|Blinded Treatment Phase|Ineligibility Determined|6
6995572|NCT01345019|11057780|FG000|Blinded Treatment Phase|Protocol Deviation|5
6995573|NCT01345019|11057781|FG001|Blinded Treatment Phase|Protocol Deviation|0
6995574|NCT01345019|11057780|FG000|Blinded Treatment Phase|Other, Not Specified|2
6995575|NCT01345019|11057781|FG001|Blinded Treatment Phase|Other, Not Specified|3
6995576|NCT01345019|11057780|FG000|Blinded Treatment Phase|Lost to Follow-up|6
6995577|NCT01345019|11057781|FG001|Blinded Treatment Phase|Lost to Follow-up|3
6995578|NCT01345019|11057780|FG000|Open Label Treatment Phase|Death|49
6995579|NCT01345019|11057781|FG001|Open Label Treatment Phase|Death|48
6995580|NCT01345019|11057780|FG000|Open Label Treatment Phase|Withdrawal by Subject|49
6995581|NCT01345019|11057781|FG001|Open Label Treatment Phase|Withdrawal by Subject|47
6995582|NCT01345019|11057780|FG000|Open Label Treatment Phase|Adverse Event|30
6995583|NCT01345019|11057781|FG001|Open Label Treatment Phase|Adverse Event|51
6995584|NCT01345019|11057780|FG000|Open Label Treatment Phase|Administrative Decision|30
6995585|NCT01345019|11057781|FG001|Open Label Treatment Phase|Administrative Decision|15
6995586|NCT01345019|11057780|FG000|Open Label Treatment Phase|Disease Progression|17
6995587|NCT01345019|11057781|FG001|Open Label Treatment Phase|Disease Progression|18
6995588|NCT01345019|11057780|FG000|Open Label Treatment Phase|Noncompliance|5
6995589|NCT01345019|11057781|FG001|Open Label Treatment Phase|Noncompliance|4
7060341|NCT01917006|11156410|FG002|Open-label Period|Adverse Event|0
7060342|NCT01917006|11156411|FG003|Open-label Period|Adverse Event|0
7060343|NCT01917006|11156412|FG004|Open-label Period|Adverse Event|0
7060344|NCT01917006|11156413|FG005|Open-label Period|Adverse Event|0
7060345|NCT01917006|11156414|FG006|Open-label Period|Adverse Event|0
7060346|NCT01917006|11156415|FG007|Open-label Period|Adverse Event|1
7060347|NCT01917006|11156408|FG000|Open-label Period|Lost to Follow-up|0
7060348|NCT01917006|11156409|FG001|Open-label Period|Lost to Follow-up|0
7060349|NCT01917006|11156410|FG002|Open-label Period|Lost to Follow-up|0
7060350|NCT01917006|11156411|FG003|Open-label Period|Lost to Follow-up|0
7060351|NCT01917006|11156412|FG004|Open-label Period|Lost to Follow-up|0
7060352|NCT01917006|11156413|FG005|Open-label Period|Lost to Follow-up|0
7060353|NCT01917006|11156414|FG006|Open-label Period|Lost to Follow-up|0
7060354|NCT01917006|11156415|FG007|Open-label Period|Lost to Follow-up|1
7060355|NCT01917084|11156432|FG000|Overall Study|Withdrawal by Subject|1
7060356|NCT01917344|11156458|FG000|Overall Study|Withdrawal by Subject|1
7060357|NCT01917526|11156473|FG000|Overall Study|Protocol Violation|1
7060358|NCT01917526|11156474|FG001|Overall Study|Protocol Violation|1
7060359|NCT01917656|11156482|FG000|Overall Study|Adverse Event|11
7060360|NCT01917656|11156483|FG001|Overall Study|Adverse Event|0
7060361|NCT01917656|11156482|FG000|Overall Study|Withdrawal criteria|8
7060362|NCT01917656|11156483|FG001|Overall Study|Withdrawal criteria|14
7060363|NCT01917656|11156482|FG000|Overall Study|Unclassified|0
7060364|NCT01917656|11156483|FG001|Overall Study|Unclassified|3
7060365|NCT01917656|11156482|FG000|Overall Study|Withdrawal by Subject|4
7060366|NCT01917656|11156483|FG001|Overall Study|Withdrawal by Subject|3
7060367|NCT01917656|11156482|FG000|Overall Study|Lost to Follow-up|3
7060368|NCT01917656|11156483|FG001|Overall Study|Lost to Follow-up|4
7060369|NCT01917747|11156496|FG000|Overall Study|Withdrawal by Subject|1
7060370|NCT01917747|11156497|FG001|Overall Study|Withdrawal by Subject|2
7060371|NCT01917747|11156496|FG000|Overall Study|Lost to Follow-up|18
7060372|NCT01917747|11156497|FG001|Overall Study|Lost to Follow-up|9
7060373|NCT01917968|11156528|FG000|Overall Study|Death|3
7060374|NCT01917968|11156529|FG001|Overall Study|Death|2
7060375|NCT01917968|11156528|FG000|Overall Study|Lost to Follow-up|21
7060376|NCT01917968|11156529|FG001|Overall Study|Lost to Follow-up|39
7060377|NCT01917968|11156528|FG000|Overall Study|Physician Decision|1
7060378|NCT01917968|11156529|FG001|Overall Study|Physician Decision|2
6995590|NCT01345019|11057780|FG000|Open Label Treatment Phase|Lost to Follow-up|1
7060379|NCT01917968|11156528|FG000|Overall Study|Withdrawal by Subject|20
7060380|NCT01917968|11156529|FG001|Overall Study|Withdrawal by Subject|35
7060381|NCT01917968|11156528|FG000|Overall Study|Subject Relocation|5
7060382|NCT01917968|11156529|FG001|Overall Study|Subject Relocation|1
6995591|NCT01345019|11057781|FG001|Open Label Treatment Phase|Lost to Follow-up|2
6995592|NCT01345019|11057780|FG000|Open Label Treatment Phase|Pregnancy|1
6995593|NCT01345019|11057781|FG001|Open Label Treatment Phase|Pregnancy|0
6995594|NCT01345019|11057780|FG000|Open Label Treatment Phase|Other, Not Specified|9
6995595|NCT01345019|11057781|FG001|Open Label Treatment Phase|Other, Not Specified|7
6995596|NCT01345019|11057780|FG000|Open Label Treatment Phase|Protocol Violation|0
6995597|NCT01345019|11057781|FG001|Open Label Treatment Phase|Protocol Violation|1
6995598|NCT01345058|11057791|FG000|Overall Study|Withdrawal by Subject|1
6995599|NCT01345058|11057792|FG001|Overall Study|Withdrawal by Subject|0
6995600|NCT01345058|11057791|FG000|Overall Study|Participant Reported Increase in Events|1
6995601|NCT01345058|11057792|FG001|Overall Study|Participant Reported Increase in Events|0
6995602|NCT01345058|11057791|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1
6995603|NCT01345058|11057792|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0
6995604|NCT01345058|11057791|FG000|Overall Study|Participant Stopped Taking Study Drug|1
6995605|NCT01345058|11057792|FG001|Overall Study|Participant Stopped Taking Study Drug|0
6995606|NCT01345058|11057791|FG000|Overall Study|Participant No-Show at Multiple Visits|1
6995607|NCT01345058|11057792|FG001|Overall Study|Participant No-Show at Multiple Visits|0
6995608|NCT01345123|11057801|FG000|Overall Study|participants no longer with health plan|79
6995609|NCT01345123|11057802|FG001|Overall Study|participants no longer with health plan|85
6995610|NCT01345123|11057803|FG002|Overall Study|participants no longer with health plan|88
6995611|NCT01345162|11057814|FG000|Overall Study|Protocol Violation|2
6995612|NCT01345162|11057815|FG001|Overall Study|Protocol Violation|4
6995613|NCT01345188|11057821|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2
6995614|NCT01345188|11057821|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1
6995615|NCT01345253|11057830|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22
6995616|NCT01345253|11057831|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27
6995617|NCT01345253|11057830|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11
6995618|NCT01345253|11057831|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7
6995619|NCT01345253|11057830|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1
6995620|NCT01345253|11057831|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5
6995621|NCT01345253|11057830|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6
6995622|NCT01345253|11057831|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1
6995623|NCT01345253|11057830|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3
6995624|NCT01345253|11057831|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8
6995625|NCT01345253|11057830|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4
6995626|NCT01345253|11057831|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12
6995627|NCT01345253|11057830|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9
6995628|NCT01345253|11057831|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19
6995629|NCT01345253|11057830|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7
6995630|NCT01345253|11057831|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18
6995631|NCT01345253|11057830|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0
6995632|NCT01345253|11057831|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1
6995633|NCT01345253|11057830|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3
6995634|NCT01345253|11057831|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7
6995635|NCT01345253|11057830|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2
6995636|NCT01345253|11057831|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5
6995637|NCT01345253|11057830|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4
6995638|NCT01345253|11057831|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6
6995639|NCT01345253|11057830|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11
6995640|NCT01345253|11057831|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24
6995641|NCT01345253|11057830|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37
6995642|NCT01345253|11057831|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82
6995643|NCT01345253|11057830|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1
6995644|NCT01345253|11057831|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1
6995645|NCT01345292|11057842|FG000|Overall Study|Withdrawal by Subject|2
6995646|NCT01345292|11057843|FG001|Overall Study|Withdrawal by Subject|0
6995647|NCT01345292|11057844|FG002|Overall Study|Withdrawal by Subject|1
6995648|NCT01345318|11057852|FG000|Overall Study|Adverse Event|16
6995649|NCT01345318|11057852|FG000|Overall Study|Lack of Efficacy|17
6995650|NCT01345318|11057852|FG000|Overall Study|Lost to Follow-up|2
6995651|NCT01345318|11057852|FG000|Overall Study|Protocol Violation|1
6995652|NCT01345318|11057852|FG000|Overall Study|Withdrawal by Subject|41
6995653|NCT01345318|11057852|FG000|Overall Study|Other|3
6995654|NCT01345591|11057861|FG000|Overall Study|Lost to Follow-up|1
6995655|NCT01345630|11057872|FG000|Overall Study|Adverse Event|22
6995656|NCT01345630|11057873|FG001|Overall Study|Adverse Event|23
6995657|NCT01345630|11057872|FG000|Overall Study|Lost to Follow-up|17
6995658|NCT01345630|11057873|FG001|Overall Study|Lost to Follow-up|16
6995659|NCT01345630|11057872|FG000|Overall Study|Protocol Violation|4
6995660|NCT01345630|11057873|FG001|Overall Study|Protocol Violation|1
6995661|NCT01345630|11057872|FG000|Overall Study|Medication error without associated AE|0
6995662|NCT01345630|11057873|FG001|Overall Study|Medication error without associated AE|1
6995663|NCT01345630|11057872|FG000|Overall Study|Study terminated by sponsor|254
6995664|NCT01345630|11057873|FG001|Overall Study|Study terminated by sponsor|285
6995665|NCT01345630|11057872|FG000|Overall Study|Other reasons|6
6995666|NCT01345630|11057873|FG001|Overall Study|Other reasons|8
6995667|NCT01345630|11057872|FG000|Overall Study|Withdrawn due to pregnancy|1
6995668|NCT01345630|11057873|FG001|Overall Study|Withdrawn due to pregnancy|2
6995669|NCT01345630|11057872|FG000|Overall Study|No longer willing to participate|9
6995670|NCT01345630|11057873|FG001|Overall Study|No longer willing to participate|12
6995671|NCT01345630|11057872|FG000|Overall Study|Insufficient clinical response|48
6995672|NCT01345630|11057873|FG001|Overall Study|Insufficient clinical response|11
6995673|NCT01345669|11057885|FG000|Overall Study|Primary tumour recurrence|53
6995674|NCT01345669|11057886|FG001|Overall Study|Primary tumour recurrence|32
6995675|NCT01345669|11057885|FG000|Overall Study|Second primary tumour|4
6995676|NCT01345669|11057886|FG001|Overall Study|Second primary tumour|3
6995677|NCT01345669|11057885|FG000|Overall Study|Adverse Event|63
6995678|NCT01345669|11057886|FG001|Overall Study|Adverse Event|9
6995679|NCT01345669|11057885|FG000|Overall Study|Protocol Violation|3
6995680|NCT01345669|11057886|FG001|Overall Study|Protocol Violation|1
6995681|NCT01345669|11057885|FG000|Overall Study|Lost to Follow-up|1
6995682|NCT01345669|11057886|FG001|Overall Study|Lost to Follow-up|1
6995683|NCT01345669|11057885|FG000|Overall Study|Withdrawal by Subject|52
6995684|NCT01345669|11057886|FG001|Overall Study|Withdrawal by Subject|13
6995685|NCT01345669|11057885|FG000|Overall Study|Other Reasons|111
6995686|NCT01345669|11057886|FG001|Overall Study|Other Reasons|60
6995687|NCT01345682|11057894|FG000|Overall Study|Progressive disease per RECIST|226
6995688|NCT01345682|11057895|FG001|Overall Study|Progressive disease per RECIST|93
6995689|NCT01345682|11057894|FG000|Overall Study|Worsening of underlying cancer disease|23
6995690|NCT01345682|11057895|FG001|Overall Study|Worsening of underlying cancer disease|12
6995691|NCT01345682|11057894|FG000|Overall Study|Adverse Event|51
6995692|NCT01345682|11057895|FG001|Overall Study|Adverse Event|41
6995693|NCT01345682|11057894|FG000|Overall Study|Non-compliance with protocol|0
6995694|NCT01345682|11057895|FG001|Overall Study|Non-compliance with protocol|1
6995695|NCT01345682|11057894|FG000|Overall Study|Lost to Follow-up|0
6995696|NCT01345682|11057895|FG001|Overall Study|Lost to Follow-up|1
6995697|NCT01345682|11057894|FG000|Overall Study|Refused to continue trial medication|16
6995698|NCT01345682|11057895|FG001|Overall Study|Refused to continue trial medication|9
6995699|NCT01345682|11057894|FG000|Overall Study|Not treated|2
6995700|NCT01345682|11057895|FG001|Overall Study|Not treated|1
6995701|NCT01345682|11057894|FG000|Overall Study|Reason other than those specified above|4
6995702|NCT01345682|11057895|FG001|Overall Study|Reason other than those specified above|3
6995703|NCT01345929|11057920|FG000|Overall Study|Withdrawal by Subject|9
6995704|NCT01345929|11057921|FG001|Overall Study|Withdrawal by Subject|8
6995705|NCT01345929|11057920|FG000|Overall Study|Lost to Follow-up|9
6995706|NCT01345929|11057921|FG001|Overall Study|Lost to Follow-up|9
6995707|NCT01345929|11057920|FG000|Overall Study|Adverse Event|0
6995708|NCT01345929|11057921|FG001|Overall Study|Adverse Event|1
6995709|NCT01345929|11057920|FG000|Overall Study|Didn't meet eligibility criteria|2
6995710|NCT01345929|11057921|FG001|Overall Study|Didn't meet eligibility criteria|0
6995711|NCT01345929|11057920|FG000|Overall Study|40,000 CFU/ML|1
6995712|NCT01345929|11057921|FG001|Overall Study|40,000 CFU/ML|0
6995713|NCT01345929|11057920|FG000|Overall Study|Patient withdrawal|0
6995714|NCT01345929|11057921|FG001|Overall Study|Patient withdrawal|1
6995715|NCT01346059|11057929|FG000|Overall Study|Withdrawal by Subject|1
6995716|NCT01346059|11057930|FG001|Overall Study|Withdrawal by Subject|0
6995717|NCT01346176|11057952|FG000|Recruited|Protocol Violation|1
6995718|NCT01346176|11057953|FG001|Recruited|Protocol Violation|0
6995719|NCT01346176|11057954|FG002|Recruited|Protocol Violation|0
6995720|NCT01346176|11057952|FG000|Completed Advance Directive|Death|3
6995721|NCT01346176|11057953|FG001|Completed Advance Directive|Death|2
6995722|NCT01346176|11057954|FG002|Completed Advance Directive|Death|2
6995723|NCT01346176|11057952|FG000|Completed Advance Directive|Became Ineligible|3
6995724|NCT01346176|11057953|FG001|Completed Advance Directive|Became Ineligible|0
6995725|NCT01346176|11057954|FG002|Completed Advance Directive|Became Ineligible|1
6995726|NCT01346176|11057952|FG000|Completed Advance Directive|Other reason did not complete AD|7
6995727|NCT01346176|11057953|FG001|Completed Advance Directive|Other reason did not complete AD|12
6995728|NCT01346176|11057954|FG002|Completed Advance Directive|Other reason did not complete AD|7
6995729|NCT01346176|11057952|FG000|Completed Satisfaction Survey|Death|3
6995730|NCT01346176|11057953|FG001|Completed Satisfaction Survey|Death|0
6995731|NCT01346176|11057954|FG002|Completed Satisfaction Survey|Death|2
6995732|NCT01346176|11057952|FG000|Completed Satisfaction Survey|Lost to Follow-up|3
6995733|NCT01346176|11057953|FG001|Completed Satisfaction Survey|Lost to Follow-up|4
6995734|NCT01346176|11057954|FG002|Completed Satisfaction Survey|Lost to Follow-up|4
6995735|NCT01346189|11057966|FG000|Overall Study|Withdrawal by Subject|7
6995736|NCT01346189|11057967|FG001|Overall Study|Withdrawal by Subject|5
6995737|NCT01346189|11057968|FG002|Overall Study|Withdrawal by Subject|3
6995738|NCT01346189|11057969|FG003|Overall Study|Withdrawal by Subject|5
6995739|NCT01346189|11057966|FG000|Overall Study|Physician Decision|4
6995740|NCT01346189|11057967|FG001|Overall Study|Physician Decision|0
6995741|NCT01346189|11057968|FG002|Overall Study|Physician Decision|0
6995742|NCT01346189|11057969|FG003|Overall Study|Physician Decision|0
6995743|NCT01346189|11057966|FG000|Overall Study|Moved|3
6995744|NCT01346189|11057967|FG001|Overall Study|Moved|0
6995745|NCT01346189|11057968|FG002|Overall Study|Moved|4
6995746|NCT01346189|11057969|FG003|Overall Study|Moved|0
6995747|NCT01346189|11057966|FG000|Overall Study|Other|2
6995748|NCT01346189|11057967|FG001|Overall Study|Other|4
6995749|NCT01346189|11057968|FG002|Overall Study|Other|7
6995750|NCT01346189|11057969|FG003|Overall Study|Other|3
6995751|NCT01346189|11057966|FG000|Overall Study|Death|0
6995752|NCT01346189|11057967|FG001|Overall Study|Death|3
6995753|NCT01346189|11057968|FG002|Overall Study|Death|0
6995754|NCT01346189|11057969|FG003|Overall Study|Death|0
6995755|NCT01346189|11057966|FG000|Overall Study|Non-health system primary care physician|0
6995756|NCT01346189|11057967|FG001|Overall Study|Non-health system primary care physician|5
6995757|NCT01346189|11057968|FG002|Overall Study|Non-health system primary care physician|0
6995758|NCT01346189|11057969|FG003|Overall Study|Non-health system primary care physician|0
6995759|NCT01346189|11057966|FG000|Overall Study|Travel|0
6995760|NCT01346189|11057967|FG001|Overall Study|Travel|0
6995761|NCT01346189|11057968|FG002|Overall Study|Travel|0
6995762|NCT01346189|11057969|FG003|Overall Study|Travel|3
6995763|NCT01346293|11057990|FG000|Overall Study|Protocol Violation|30
6995764|NCT01346293|11057991|FG001|Overall Study|Protocol Violation|9
6995765|NCT01346293|11057990|FG000|Overall Study|Lost to Follow-up|21
6995766|NCT01346293|11057991|FG001|Overall Study|Lost to Follow-up|8
6995767|NCT01346293|11057990|FG000|Overall Study|Withdrawal by Subject|15
6995768|NCT01346293|11057991|FG001|Overall Study|Withdrawal by Subject|4
6995769|NCT01346293|11057990|FG000|Overall Study|Other|1
6995770|NCT01346293|11057991|FG001|Overall Study|Other|0
6995771|NCT01346371|11058001|FG000|Overall Study|Lost to Follow-up|2
6995772|NCT01346371|11058002|FG001|Overall Study|Lost to Follow-up|0
6995773|NCT01346410|11058017|FG000|Overall Study|Death|1
6995774|NCT01346475|11058023|FG000|First Intervention|Lost to Follow-up|4
6995775|NCT01346475|11058024|FG001|First Intervention|Lost to Follow-up|3
6995776|NCT01346501|11058036|FG000|Overall Study|Initiated Other Biological Agents|3
6995777|NCT01346501|11058037|FG001|Overall Study|Initiated Other Biological Agents|1
6995778|NCT01346501|11058036|FG000|Overall Study|Other|8
6995779|NCT01346501|11058037|FG001|Overall Study|Other|12
6995780|NCT01346514|11058047|FG000|Overall Study|Lost to Follow-up|19
6995781|NCT01346514|11058048|FG001|Overall Study|Lost to Follow-up|30
6995782|NCT01346514|11058047|FG000|Overall Study|Withdrawal by Subject|7
6995783|NCT01346514|11058048|FG001|Overall Study|Withdrawal by Subject|3
6995784|NCT01346514|11058047|FG000|Overall Study|Death|3
6995785|NCT01346514|11058048|FG001|Overall Study|Death|4
6995786|NCT01346540|11058058|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3
6995787|NCT01346540|11058059|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8
6995788|NCT01346540|11058058|FG000|Overall Study|Adverse Event|0
6995789|NCT01346540|11058059|FG001|Overall Study|Adverse Event|4
6995790|NCT01346592|11058069|FG000|Overall Study|Lost to Follow-up|62
6995791|NCT01346592|11058070|FG001|Overall Study|Lost to Follow-up|29
6995792|NCT01346592|11058071|FG002|Overall Study|Lost to Follow-up|29
6995793|NCT01346592|11058069|FG000|Overall Study|Protocol Violation|2
6995794|NCT01346592|11058070|FG001|Overall Study|Protocol Violation|1
6995795|NCT01346592|11058071|FG002|Overall Study|Protocol Violation|0
6995796|NCT01346592|11058069|FG000|Overall Study|Death|1
6995797|NCT01346592|11058070|FG001|Overall Study|Death|3
6995798|NCT01346592|11058071|FG002|Overall Study|Death|4
6995799|NCT01346592|11058069|FG000|Overall Study|Adverse Event|0
6995800|NCT01346592|11058070|FG001|Overall Study|Adverse Event|1
6995801|NCT01346592|11058071|FG002|Overall Study|Adverse Event|0
6995802|NCT01346592|11058069|FG000|Overall Study|Withdrawal by Subject|77
6995803|NCT01346592|11058070|FG001|Overall Study|Withdrawal by Subject|51
6995804|NCT01346592|11058071|FG002|Overall Study|Withdrawal by Subject|38
6995805|NCT01346592|11058069|FG000|Overall Study|Inappropriate enrollment|3
6995806|NCT01346592|11058070|FG001|Overall Study|Inappropriate enrollment|1
6995807|NCT01346592|11058071|FG002|Overall Study|Inappropriate enrollment|1
6995808|NCT01346592|11058069|FG000|Overall Study|Administrative reason|1
6995809|NCT01346592|11058070|FG001|Overall Study|Administrative reason|0
6995810|NCT01346592|11058071|FG002|Overall Study|Administrative reason|0
6995811|NCT01346592|11058069|FG000|Overall Study|Unable to Classify|7
6995812|NCT01346592|11058070|FG001|Overall Study|Unable to Classify|3
6995813|NCT01346592|11058071|FG002|Overall Study|Unable to Classify|6
6995814|NCT01346696|11058100|FG000|Overall Study|Death|1
6995815|NCT01346774|11058106|FG000|Overall Study|Did not take a single dose|6
6995816|NCT01346774|11058107|FG001|Overall Study|Did not take a single dose|4
6995817|NCT01346774|11058106|FG000|Overall Study|Lost to Follow-up|3
6995818|NCT01346774|11058107|FG001|Overall Study|Lost to Follow-up|4
6995819|NCT01346774|11058106|FG000|Overall Study|Withdrawal by Subject|1
6995820|NCT01346774|11058107|FG001|Overall Study|Withdrawal by Subject|4
6995821|NCT01346774|11058106|FG000|Overall Study|Protocol Violation|2
6995822|NCT01346774|11058107|FG001|Overall Study|Protocol Violation|3
6995823|NCT01346774|11058106|FG000|Overall Study|Adverse Event|1
6995824|NCT01346774|11058107|FG001|Overall Study|Adverse Event|2
6995825|NCT01346969|11058135|FG000|Overall Study|Withdrawal by Subject|0
6995826|NCT01346969|11058136|FG001|Overall Study|Withdrawal by Subject|0
6995827|NCT01346969|11058137|FG002|Overall Study|Withdrawal by Subject|1
6995828|NCT01346969|11058138|FG003|Overall Study|Withdrawal by Subject|0
6995829|NCT01346969|11058135|FG000|Overall Study|Lost to Follow-up|1
6995830|NCT01346969|11058136|FG001|Overall Study|Lost to Follow-up|0
6995831|NCT01346969|11058137|FG002|Overall Study|Lost to Follow-up|2
6995832|NCT01346969|11058138|FG003|Overall Study|Lost to Follow-up|0
6995833|NCT01346969|11058135|FG000|Overall Study|Physician Decision|0
6995834|NCT01346969|11058136|FG001|Overall Study|Physician Decision|0
6995835|NCT01346969|11058137|FG002|Overall Study|Physician Decision|0
6995836|NCT01346969|11058138|FG003|Overall Study|Physician Decision|1
6995837|NCT01346969|11058135|FG000|Overall Study|Randomized but not treated|1
6995838|NCT01346969|11058136|FG001|Overall Study|Randomized but not treated|0
6995839|NCT01346969|11058137|FG002|Overall Study|Randomized but not treated|0
6995840|NCT01346969|11058138|FG003|Overall Study|Randomized but not treated|0
6995841|NCT01347073|11058175|FG000|Overall Study|Adverse Event|1
6995842|NCT01347073|11058175|FG000|Overall Study|Liver Transplant|1
6995843|NCT01347086|11058195|FG000|Overall Study|failed screening visit|0
6995844|NCT01347086|11058196|FG001|Overall Study|failed screening visit|0
6995845|NCT01347086|11058197|FG002|Overall Study|failed screening visit|1
6995846|NCT01347086|11058198|FG003|Overall Study|failed screening visit|0
6995847|NCT01347086|11058199|FG004|Overall Study|failed screening visit|0
6995848|NCT01347086|11058200|FG005|Overall Study|failed screening visit|0
6995849|NCT01347086|11058201|FG006|Overall Study|failed screening visit|1
6995850|NCT01347086|11058202|FG007|Overall Study|failed screening visit|1
6995851|NCT01347086|11058203|FG008|Overall Study|failed screening visit|0
6995852|NCT01347086|11058204|FG009|Overall Study|failed screening visit|1
6995853|NCT01347112|11058238|FG000|Overall Study|Withdrawal by Subject|1
6995854|NCT01347112|11058239|FG001|Overall Study|Withdrawal by Subject|7
6995855|NCT01347112|11058238|FG000|Overall Study|Lost to Follow-up|3
6995856|NCT01347112|11058239|FG001|Overall Study|Lost to Follow-up|5
6995857|NCT01347307|11058255|FG000|Overall Study|Death|0
6995858|NCT01347307|11058256|FG001|Overall Study|Death|4
6995859|NCT01347307|11058255|FG000|Overall Study|Physician Decision|0
6995860|NCT01347307|11058256|FG001|Overall Study|Physician Decision|1
6995861|NCT01347554|11058282|FG000|Overall Study|Lack of Efficacy|7
6995862|NCT01347554|11058283|FG001|Overall Study|Lack of Efficacy|11
6995863|NCT01347580|11058291|FG000|Overall Study|Withdrawal by Subject|13
6995864|NCT01347580|11058292|FG001|Overall Study|Withdrawal by Subject|23
6995865|NCT01347580|11058291|FG000|Overall Study|Death|30
6995866|NCT01347580|11058292|FG001|Overall Study|Death|19
6995867|NCT01347580|11058291|FG000|Overall Study|Protocol Violation|10
6995868|NCT01347580|11058292|FG001|Overall Study|Protocol Violation|7
6995869|NCT01347580|11058291|FG000|Overall Study|Lost to Follow-up|3
6995870|NCT01347580|11058292|FG001|Overall Study|Lost to Follow-up|1
6995871|NCT01347580|11058291|FG000|Overall Study|Had other reason|9
6995872|NCT01347580|11058292|FG001|Overall Study|Had other reason|6
6995873|NCT01347710|11058298|FG000|Overall Study|Withdrawal by Subject|2
6995874|NCT01347710|11058298|FG000|Overall Study|Adverse Event|4
6995875|NCT01347710|11058298|FG000|Overall Study|Angio or SPECT not completed|18
6995876|NCT01347710|11058298|FG000|Overall Study|issue with vitals prior to dosing|1
6995877|NCT01347710|11058298|FG000|Overall Study|Lost to Follow-up|1
6995878|NCT01347710|11058298|FG000|Overall Study|Physician Decision|2
6995879|NCT01347710|11058298|FG000|Overall Study|Other|3
6995880|NCT01347762|11058310|FG000|Overall Study|Lost to Follow-up|0
6995881|NCT01347762|11058311|FG001|Overall Study|Lost to Follow-up|1
6995882|NCT01347762|11058312|FG002|Overall Study|Lost to Follow-up|6
6995883|NCT01347762|11058313|FG003|Overall Study|Lost to Follow-up|5
6995884|NCT01347762|11058310|FG000|Overall Study|Withdrawal by Subject|4
6995885|NCT01347762|11058311|FG001|Overall Study|Withdrawal by Subject|1
6995886|NCT01347762|11058312|FG002|Overall Study|Withdrawal by Subject|3
6995887|NCT01347762|11058313|FG003|Overall Study|Withdrawal by Subject|3
6995888|NCT01347866|11058350|FG000|Overall Study|Death|0
6995889|NCT01347866|11058351|FG001|Overall Study|Death|0
6995890|NCT01347866|11058352|FG002|Overall Study|Death|0
6995891|NCT01347866|11058353|FG003|Overall Study|Death|1
6995892|NCT01347866|11058354|FG004|Overall Study|Death|2
6995893|NCT01347866|11058355|FG005|Overall Study|Death|2
6995894|NCT01347866|11058356|FG006|Overall Study|Death|1
6995895|NCT01347866|11058357|FG007|Overall Study|Death|0
6995896|NCT01347866|11058358|FG008|Overall Study|Death|4
6995897|NCT01347866|11058359|FG009|Overall Study|Death|1
6995898|NCT01347866|11058360|FG010|Overall Study|Death|3
6995899|NCT01347866|11058361|FG011|Overall Study|Death|1
6995900|NCT01347866|11058362|FG012|Overall Study|Death|2
6995901|NCT01347866|11058363|FG013|Overall Study|Death|0
6995902|NCT01347866|11058364|FG014|Overall Study|Death|0
6995903|NCT01347866|11058365|FG015|Overall Study|Death|1
6995904|NCT01347866|11058366|FG016|Overall Study|Death|0
6995905|NCT01347866|11058350|FG000|Overall Study|Lost to Follow-up|0
6995906|NCT01347866|11058351|FG001|Overall Study|Lost to Follow-up|0
6995907|NCT01347866|11058352|FG002|Overall Study|Lost to Follow-up|0
6995908|NCT01347866|11058353|FG003|Overall Study|Lost to Follow-up|0
6995909|NCT01347866|11058354|FG004|Overall Study|Lost to Follow-up|0
6995910|NCT01347866|11058355|FG005|Overall Study|Lost to Follow-up|0
6995911|NCT01347866|11058356|FG006|Overall Study|Lost to Follow-up|0
6995912|NCT01347866|11058357|FG007|Overall Study|Lost to Follow-up|1
6995913|NCT01347866|11058358|FG008|Overall Study|Lost to Follow-up|1
6995914|NCT01347866|11058359|FG009|Overall Study|Lost to Follow-up|0
6995915|NCT01347866|11058360|FG010|Overall Study|Lost to Follow-up|0
6995916|NCT01347866|11058361|FG011|Overall Study|Lost to Follow-up|0
6995917|NCT01347866|11058362|FG012|Overall Study|Lost to Follow-up|0
6995918|NCT01347866|11058363|FG013|Overall Study|Lost to Follow-up|0
6995919|NCT01347866|11058364|FG014|Overall Study|Lost to Follow-up|0
6995920|NCT01347866|11058365|FG015|Overall Study|Lost to Follow-up|0
6995921|NCT01347866|11058366|FG016|Overall Study|Lost to Follow-up|0
6995922|NCT01347866|11058350|FG000|Overall Study|Other|3
6995923|NCT01347866|11058351|FG001|Overall Study|Other|1
6995924|NCT01347866|11058352|FG002|Overall Study|Other|1
6995925|NCT01347866|11058353|FG003|Overall Study|Other|4
6995926|NCT01347866|11058354|FG004|Overall Study|Other|5
6995927|NCT01347866|11058355|FG005|Overall Study|Other|0
6995928|NCT01347866|11058356|FG006|Overall Study|Other|5
6995929|NCT01347866|11058357|FG007|Overall Study|Other|3
6995930|NCT01347866|11058358|FG008|Overall Study|Other|22
6995931|NCT01347866|11058359|FG009|Overall Study|Other|5
6995932|NCT01347866|11058360|FG010|Overall Study|Other|0
6995933|NCT01347866|11058361|FG011|Overall Study|Other|3
6995934|NCT01347866|11058362|FG012|Overall Study|Other|4
6995935|NCT01347866|11058363|FG013|Overall Study|Other|4
6995936|NCT01347866|11058364|FG014|Overall Study|Other|2
6995937|NCT01347866|11058365|FG015|Overall Study|Other|3
6995938|NCT01347866|11058366|FG016|Overall Study|Other|0
6995939|NCT01347866|11058350|FG000|Overall Study|Subject refused further follow-up|2
6995940|NCT01347866|11058351|FG001|Overall Study|Subject refused further follow-up|0
6995941|NCT01347866|11058352|FG002|Overall Study|Subject refused further follow-up|0
6995942|NCT01347866|11058353|FG003|Overall Study|Subject refused further follow-up|2
6995943|NCT01347866|11058354|FG004|Overall Study|Subject refused further follow-up|0
6995944|NCT01347866|11058355|FG005|Overall Study|Subject refused further follow-up|1
6995945|NCT01347866|11058356|FG006|Overall Study|Subject refused further follow-up|0
6995946|NCT01347866|11058357|FG007|Overall Study|Subject refused further follow-up|0
6995947|NCT01347866|11058358|FG008|Overall Study|Subject refused further follow-up|4
6995948|NCT01347866|11058359|FG009|Overall Study|Subject refused further follow-up|1
6995949|NCT01347866|11058360|FG010|Overall Study|Subject refused further follow-up|0
6995950|NCT01347866|11058361|FG011|Overall Study|Subject refused further follow-up|0
6995951|NCT01347866|11058362|FG012|Overall Study|Subject refused further follow-up|1
6995952|NCT01347866|11058363|FG013|Overall Study|Subject refused further follow-up|3
6995953|NCT01347866|11058364|FG014|Overall Study|Subject refused further follow-up|1
6995954|NCT01347866|11058365|FG015|Overall Study|Subject refused further follow-up|0
6995955|NCT01347866|11058366|FG016|Overall Study|Subject refused further follow-up|2
6995956|NCT01347879|11058439|FG000|Overall Study|Adverse Event|0
6995957|NCT01347879|11058440|FG001|Overall Study|Adverse Event|12
6995958|NCT01347879|11058439|FG000|Overall Study|Lost to Follow-up|2
6995959|NCT01347879|11058440|FG001|Overall Study|Lost to Follow-up|0
6995960|NCT01347879|11058439|FG000|Overall Study|Withdrawal by Subject|3
6995961|NCT01347879|11058440|FG001|Overall Study|Withdrawal by Subject|2
6995962|NCT01347879|11058439|FG000|Overall Study|Other|2
6995963|NCT01347879|11058440|FG001|Overall Study|Other|3
6995964|NCT01347931|11058446|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1
6995965|NCT01348087|11058452|FG000|Overall Study|Unsatisfactory therapeutic effect|35
6995966|NCT01348087|11058452|FG000|Overall Study|Administrative problems|79
6995967|NCT01348087|11058452|FG000|Overall Study|protocol deviation|1
6995968|NCT01348087|11058452|FG000|Overall Study|Lost to Follow-up|1
6995969|NCT01348087|11058452|FG000|Overall Study|Subject withdrew consent|7
6995970|NCT01348087|11058452|FG000|Overall Study|Adverse Event|25
6995971|NCT01348100|11058473|FG000|Overall Study|Subject Withdrew Consent|0
6995972|NCT01348100|11058474|FG001|Overall Study|Subject Withdrew Consent|0
6995973|NCT01348100|11058475|FG002|Overall Study|Subject Withdrew Consent|2
6995974|NCT01348100|11058476|FG003|Overall Study|Subject Withdrew Consent|0
6995975|NCT01348100|11058477|FG004|Overall Study|Subject Withdrew Consent|1
6995976|NCT01348100|11058478|FG005|Overall Study|Subject Withdrew Consent|0
6995977|NCT01348100|11058479|FG006|Overall Study|Subject Withdrew Consent|1
6995978|NCT01348100|11058473|FG000|Overall Study|Protocol Deviation|0
6995979|NCT01348100|11058474|FG001|Overall Study|Protocol Deviation|0
6995980|NCT01348100|11058475|FG002|Overall Study|Protocol Deviation|0
6995981|NCT01348100|11058476|FG003|Overall Study|Protocol Deviation|1
6995982|NCT01348100|11058477|FG004|Overall Study|Protocol Deviation|0
6995983|NCT01348100|11058478|FG005|Overall Study|Protocol Deviation|0
6995984|NCT01348100|11058479|FG006|Overall Study|Protocol Deviation|0
6995985|NCT01348100|11058473|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0
6995986|NCT01348100|11058474|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0
6995987|NCT01348100|11058475|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0
6995988|NCT01348100|11058476|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0
6995989|NCT01348100|11058477|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0
6995990|NCT01348100|11058478|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1
6995991|NCT01348100|11058479|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0
6995992|NCT01348100|11058473|FG000|Overall Study|Lost to Follow-up|0
6995993|NCT01348100|11058474|FG001|Overall Study|Lost to Follow-up|0
6995994|NCT01348100|11058475|FG002|Overall Study|Lost to Follow-up|0
6995995|NCT01348100|11058476|FG003|Overall Study|Lost to Follow-up|0
6995996|NCT01348100|11058477|FG004|Overall Study|Lost to Follow-up|0
6995997|NCT01348100|11058478|FG005|Overall Study|Lost to Follow-up|0
6995998|NCT01348100|11058479|FG006|Overall Study|Lost to Follow-up|1
6995999|NCT01348100|11058473|FG000|Overall Study|Administrative Problems|0
6996000|NCT01348100|11058474|FG001|Overall Study|Administrative Problems|0
6996001|NCT01348100|11058475|FG002|Overall Study|Administrative Problems|0
6996002|NCT01348100|11058476|FG003|Overall Study|Administrative Problems|0
6996003|NCT01348100|11058477|FG004|Overall Study|Administrative Problems|0
6996004|NCT01348100|11058478|FG005|Overall Study|Administrative Problems|1
6996005|NCT01348100|11058479|FG006|Overall Study|Administrative Problems|1
6996006|NCT01348139|11058500|FG000|Period 1|Adverse Event|1
6996007|NCT01348139|11058501|FG001|Period 1|Adverse Event|0
6996008|NCT01348139|11058502|FG002|Period 1|Adverse Event|0
6996009|NCT01348139|11058503|FG003|Period 1|Adverse Event|0
6996010|NCT01348139|11058504|FG004|Period 1|Adverse Event|0
6996011|NCT01348139|11058505|FG005|Period 1|Adverse Event|0
6996012|NCT01348165|11058526|FG000|Overall Study|Adverse Event|0
6996013|NCT01348165|11058527|FG001|Overall Study|Adverse Event|0
6996014|NCT01348165|11058528|FG002|Overall Study|Adverse Event|0
6996015|NCT01348165|11058529|FG003|Overall Study|Adverse Event|0
6996016|NCT01348165|11058530|FG004|Overall Study|Adverse Event|0
6996017|NCT01348165|11058531|FG005|Overall Study|Adverse Event|0
6996018|NCT01348165|11058532|FG006|Overall Study|Adverse Event|1
6996019|NCT01348347|11058555|FG000|Overall Study|Withdrawal by Subject|1
6996020|NCT01348347|11058556|FG001|Overall Study|Withdrawal by Subject|1
6996021|NCT01348347|11058557|FG002|Overall Study|Withdrawal by Subject|1
6996022|NCT01348347|11058555|FG000|Overall Study|Progressive disease|2
6996023|NCT01348347|11058556|FG001|Overall Study|Progressive disease|5
6996024|NCT01348347|11058557|FG002|Overall Study|Progressive disease|5
6996025|NCT01348425|11058568|FG000|Overall Study|Imaging was not taken.|1
6996026|NCT01348425|11058569|FG001|Overall Study|Imaging was not taken.|1
6996027|NCT01348490|11058574|FG000|Overall Study|Death|1
6996028|NCT01348490|11058574|FG000|Overall Study|Adverse Event|3
6996029|NCT01348490|11058574|FG000|Overall Study|Consent withdrawn|7
6996030|NCT01348490|11058574|FG000|Overall Study|Disease progression|3
6996031|NCT01348490|11058574|FG000|Overall Study|Lost to Follow-up|1
6996032|NCT01348490|11058574|FG000|Overall Study|Termination of clinical trial by sponsor|1
6996033|NCT01348490|11058574|FG000|Overall Study|Other Unspecified|8
6996034|NCT01348542|11058597|FG000|Overall Study|Withdrawal by Subject|3
6996035|NCT01348542|11058598|FG001|Overall Study|Withdrawal by Subject|0
6996036|NCT01348698|11058617|FG000|Overall Study|Does not meet lesion size criteria|1
6996037|NCT01348698|11058617|FG000|Overall Study|Death|3
6996038|NCT01348698|11058617|FG000|Overall Study|PI decision to close study|68
6996039|NCT01348763|11058621|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1
6996040|NCT01348763|11058621|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1
6996041|NCT01348776|11058625|FG000|Overall Study|Lost to Follow-up|3
6996042|NCT01348789|11058638|FG000|Overall Study|Protocol Violation|2
6996043|NCT01348789|11058638|FG000|Overall Study|Withdrawal by Subject|2
6996044|NCT01348828|11058649|FG000|Overall Study|Death|20
6996045|NCT01348828|11058649|FG000|Overall Study|Withdrawals/Lost to Follow-up|10
6996046|NCT01348828|11058649|FG000|Overall Study|Conversion|2
6996047|NCT01348828|11058649|FG000|Overall Study|missed visit|1
6996048|NCT01348854|11058655|FG000|Overall Study|Lost to Follow-up|2
6996049|NCT01348854|11058656|FG001|Overall Study|Lost to Follow-up|1
6996050|NCT01348854|11058655|FG000|Overall Study|Withdrawal by Subject|1
6996051|NCT01348854|11058656|FG001|Overall Study|Withdrawal by Subject|0
6996052|NCT01349036|11058664|FG000|Overall Study|Disease progression|13
6996053|NCT01349036|11058665|FG001|Overall Study|Disease progression|22
6996054|NCT01349036|11058664|FG000|Overall Study|Other|1
6996055|NCT01349036|11058665|FG001|Overall Study|Other|0
6996056|NCT01349036|11058664|FG000|Overall Study|Withdrawal by Subject|0
6996057|NCT01349036|11058665|FG001|Overall Study|Withdrawal by Subject|2
6996058|NCT01349049|11058684|FG000|Overall Study|Disease progression|3
6996059|NCT01349049|11058685|FG001|Overall Study|Disease progression|5
6996060|NCT01349049|11058686|FG002|Overall Study|Disease progression|3
6996061|NCT01349049|11058687|FG003|Overall Study|Disease progression|2
6996062|NCT01349049|11058688|FG004|Overall Study|Disease progression|2
6996063|NCT01349049|11058689|FG005|Overall Study|Disease progression|2
6996064|NCT01349049|11058690|FG006|Overall Study|Disease progression|3
6996065|NCT01349049|11058691|FG007|Overall Study|Disease progression|2
6996066|NCT01349049|11058692|FG008|Overall Study|Disease progression|33
6996067|NCT01349049|11058684|FG000|Overall Study|Adverse Event|0
6996068|NCT01349049|11058685|FG001|Overall Study|Adverse Event|1
6996069|NCT01349049|11058686|FG002|Overall Study|Adverse Event|0
6996070|NCT01349049|11058687|FG003|Overall Study|Adverse Event|0
6996071|NCT01349049|11058688|FG004|Overall Study|Adverse Event|0
6996072|NCT01349049|11058689|FG005|Overall Study|Adverse Event|3
6996073|NCT01349049|11058690|FG006|Overall Study|Adverse Event|1
6996074|NCT01349049|11058691|FG007|Overall Study|Adverse Event|0
6996075|NCT01349049|11058692|FG008|Overall Study|Adverse Event|4
6996076|NCT01349049|11058684|FG000|Overall Study|Physician Decision|0
6996077|NCT01349049|11058685|FG001|Overall Study|Physician Decision|1
6996078|NCT01349049|11058686|FG002|Overall Study|Physician Decision|0
6996079|NCT01349049|11058687|FG003|Overall Study|Physician Decision|0
6996080|NCT01349049|11058688|FG004|Overall Study|Physician Decision|0
6996081|NCT01349049|11058689|FG005|Overall Study|Physician Decision|0
6996082|NCT01349049|11058690|FG006|Overall Study|Physician Decision|0
6996083|NCT01349049|11058691|FG007|Overall Study|Physician Decision|0
6996084|NCT01349049|11058692|FG008|Overall Study|Physician Decision|2
6996085|NCT01349049|11058684|FG000|Overall Study|Protocol Violation|0
6996086|NCT01349049|11058685|FG001|Overall Study|Protocol Violation|0
6996087|NCT01349049|11058686|FG002|Overall Study|Protocol Violation|0
6996088|NCT01349049|11058687|FG003|Overall Study|Protocol Violation|0
6996089|NCT01349049|11058688|FG004|Overall Study|Protocol Violation|0
6996090|NCT01349049|11058689|FG005|Overall Study|Protocol Violation|0
6996091|NCT01349049|11058690|FG006|Overall Study|Protocol Violation|0
6996092|NCT01349049|11058691|FG007|Overall Study|Protocol Violation|0
6996093|NCT01349049|11058692|FG008|Overall Study|Protocol Violation|1
6996094|NCT01349049|11058684|FG000|Overall Study|Hematopoietic stem cell transplant|0
6996095|NCT01349049|11058685|FG001|Overall Study|Hematopoietic stem cell transplant|0
6996096|NCT01349049|11058686|FG002|Overall Study|Hematopoietic stem cell transplant|0
6996097|NCT01349049|11058687|FG003|Overall Study|Hematopoietic stem cell transplant|0
6996098|NCT01349049|11058688|FG004|Overall Study|Hematopoietic stem cell transplant|1
6996099|NCT01349049|11058689|FG005|Overall Study|Hematopoietic stem cell transplant|0
6996100|NCT01349049|11058690|FG006|Overall Study|Hematopoietic stem cell transplant|1
6996101|NCT01349049|11058691|FG007|Overall Study|Hematopoietic stem cell transplant|1
6996102|NCT01349049|11058692|FG008|Overall Study|Hematopoietic stem cell transplant|0
6996103|NCT01349049|11058684|FG000|Overall Study|Other|0
6996104|NCT01349049|11058685|FG001|Overall Study|Other|0
6996105|NCT01349049|11058686|FG002|Overall Study|Other|0
6996106|NCT01349049|11058687|FG003|Overall Study|Other|0
6996107|NCT01349049|11058688|FG004|Overall Study|Other|0
6996108|NCT01349049|11058689|FG005|Overall Study|Other|1
6996109|NCT01349049|11058690|FG006|Overall Study|Other|0
6996110|NCT01349049|11058691|FG007|Overall Study|Other|0
6996111|NCT01349049|11058692|FG008|Overall Study|Other|4
6996112|NCT01349049|11058684|FG000|Overall Study|Death|0
6996113|NCT01349049|11058685|FG001|Overall Study|Death|0
6996114|NCT01349049|11058686|FG002|Overall Study|Death|0
6996115|NCT01349049|11058687|FG003|Overall Study|Death|0
6996116|NCT01349049|11058688|FG004|Overall Study|Death|0
6996117|NCT01349049|11058689|FG005|Overall Study|Death|0
6996118|NCT01349049|11058690|FG006|Overall Study|Death|0
6996119|NCT01349049|11058691|FG007|Overall Study|Death|1
6996120|NCT01349049|11058692|FG008|Overall Study|Death|5
6996121|NCT01349049|11058684|FG000|Overall Study|Non-compliance|0
6996122|NCT01349049|11058685|FG001|Overall Study|Non-compliance|0
6996123|NCT01349049|11058686|FG002|Overall Study|Non-compliance|0
6996124|NCT01349049|11058687|FG003|Overall Study|Non-compliance|1
6996125|NCT01349049|11058688|FG004|Overall Study|Non-compliance|0
6996126|NCT01349049|11058689|FG005|Overall Study|Non-compliance|0
6996127|NCT01349049|11058690|FG006|Overall Study|Non-compliance|0
6996128|NCT01349049|11058691|FG007|Overall Study|Non-compliance|0
6996129|NCT01349049|11058692|FG008|Overall Study|Non-compliance|0
6996130|NCT01349049|11058684|FG000|Overall Study|Withdrawal by Subject|0
6996131|NCT01349049|11058685|FG001|Overall Study|Withdrawal by Subject|0
6996132|NCT01349049|11058686|FG002|Overall Study|Withdrawal by Subject|0
6996133|NCT01349049|11058687|FG003|Overall Study|Withdrawal by Subject|0
6996134|NCT01349049|11058688|FG004|Overall Study|Withdrawal by Subject|0
6996135|NCT01349049|11058689|FG005|Overall Study|Withdrawal by Subject|0
6996136|NCT01349049|11058690|FG006|Overall Study|Withdrawal by Subject|0
6996137|NCT01349049|11058691|FG007|Overall Study|Withdrawal by Subject|0
6996138|NCT01349049|11058692|FG008|Overall Study|Withdrawal by Subject|6
6996139|NCT01349192|11058741|FG000|Overall Study|Protocol Violation|0
6996140|NCT01349192|11058742|FG001|Overall Study|Protocol Violation|1
6996141|NCT01349192|11058741|FG000|Overall Study|Withdrawal by Subject|0
6996142|NCT01349192|11058742|FG001|Overall Study|Withdrawal by Subject|2
6996143|NCT01349192|11058741|FG000|Overall Study|Lost to Follow-up|1
6996144|NCT01349192|11058742|FG001|Overall Study|Lost to Follow-up|3
6996145|NCT01349192|11058741|FG000|Overall Study|Failure to adhere to Protocol|2
6996146|NCT01349192|11058742|FG001|Overall Study|Failure to adhere to Protocol|0
6996147|NCT01349465|11058756|FG000|Overall Study|Adverse Event|1
6996148|NCT01349465|11058757|FG001|Overall Study|Adverse Event|0
6996149|NCT01349465|11058756|FG000|Overall Study|Death|3
6996150|NCT01349465|11058757|FG001|Overall Study|Death|0
6996151|NCT01349465|11058756|FG000|Overall Study|Lost to Follow-up|10
6996152|NCT01349465|11058757|FG001|Overall Study|Lost to Follow-up|1
6996153|NCT01349465|11058756|FG000|Overall Study|Withdrawal by Subject|4
6996154|NCT01349465|11058757|FG001|Overall Study|Withdrawal by Subject|2
6996155|NCT01349465|11058756|FG000|Overall Study|Subject Ineligible To Continue The Trial|0
6996156|NCT01349465|11058757|FG001|Overall Study|Subject Ineligible To Continue The Trial|19
6996157|NCT01349569|11058774|FG000|Overall Study|Lack of Efficacy|4
6996158|NCT01349660|11058784|FG000|Overall Study|Still Receiving Study Treatment|0
6996159|NCT01349660|11058785|FG001|Overall Study|Still Receiving Study Treatment|0
6996160|NCT01349660|11058786|FG002|Overall Study|Still Receiving Study Treatment|1
6996161|NCT01349660|11058784|FG000|Overall Study|Disease Progression|2
6996162|NCT01349660|11058785|FG001|Overall Study|Disease Progression|4
6996163|NCT01349660|11058786|FG002|Overall Study|Disease Progression|50
6996164|NCT01349660|11058784|FG000|Overall Study|Adverse Event|1
6996165|NCT01349660|11058785|FG001|Overall Study|Adverse Event|1
6996166|NCT01349660|11058786|FG002|Overall Study|Adverse Event|12
6996167|NCT01349660|11058784|FG000|Overall Study|Withdrawal by Subject|2
6996168|NCT01349660|11058785|FG001|Overall Study|Withdrawal by Subject|0
6996169|NCT01349660|11058786|FG002|Overall Study|Withdrawal by Subject|9
6996170|NCT01349660|11058784|FG000|Overall Study|Death|1
6996171|NCT01349660|11058785|FG001|Overall Study|Death|1
6996172|NCT01349660|11058786|FG002|Overall Study|Death|0
6996173|NCT01349660|11058784|FG000|Overall Study|Non-Permitted Interventions|0
6996174|NCT01349660|11058785|FG001|Overall Study|Non-Permitted Interventions|0
6996175|NCT01349660|11058786|FG002|Overall Study|Non-Permitted Interventions|2
6996176|NCT01349660|11058784|FG000|Overall Study|Study Compliance|0
6996177|NCT01349660|11058785|FG001|Overall Study|Study Compliance|0
6996178|NCT01349660|11058786|FG002|Overall Study|Study Compliance|1
6996179|NCT01349660|11058784|FG000|Overall Study|Declining Performance Status|0
6996180|NCT01349660|11058785|FG001|Overall Study|Declining Performance Status|0
6996181|NCT01349660|11058786|FG002|Overall Study|Declining Performance Status|1
6996182|NCT01349673|11058801|FG000|Overall Study|Progression Of Disease Past 40 cm|1
6996183|NCT01349673|11058801|FG000|Overall Study|No Longer Qualified For Study|1
6996184|NCT01349673|11058801|FG000|Overall Study|Site Closure|10
6996185|NCT01349673|11058801|FG000|Overall Study|Withdrawal by Subject|21
6996186|NCT01349673|11058801|FG000|Overall Study|Lost to Follow-up|6
6996187|NCT01349673|11058801|FG000|Overall Study|Adverse Event|17
6996188|NCT01349673|11058801|FG000|Overall Study|Study Terminated By Sponsor|50
6996189|NCT01349673|11058801|FG000|Overall Study|Lack of Efficacy|8
6996190|NCT01349790|11058805|FG000|Overall Study|Investigator Judgement|3
6996191|NCT01349790|11058805|FG000|Overall Study|Death|2
6996192|NCT01349790|11058805|FG000|Overall Study|Withdrawal by Patient|2
6996193|NCT01349790|11058805|FG000|Overall Study|Adverse Event|1
6996194|NCT01349790|11058805|FG000|Overall Study|Lost to Follow-up|1
6996195|NCT01349803|11058813|FG000|Overall Study|Adverse Event|0
6996196|NCT01349803|11058814|FG001|Overall Study|Adverse Event|0
6996197|NCT01349803|11058815|FG002|Overall Study|Adverse Event|0
6996198|NCT01349803|11058816|FG003|Overall Study|Adverse Event|2
6996199|NCT01349803|11058813|FG000|Overall Study|Withdrawal by Subject|1
6996200|NCT01349803|11058814|FG001|Overall Study|Withdrawal by Subject|0
6996201|NCT01349803|11058815|FG002|Overall Study|Withdrawal by Subject|0
6996202|NCT01349803|11058816|FG003|Overall Study|Withdrawal by Subject|0
6996203|NCT01349803|11058813|FG000|Overall Study|Protocol-specified criteria|0
6996204|NCT01349803|11058814|FG001|Overall Study|Protocol-specified criteria|1
6996205|NCT01349803|11058815|FG002|Overall Study|Protocol-specified criteria|3
6996206|NCT01349803|11058816|FG003|Overall Study|Protocol-specified criteria|0
6996207|NCT01349816|11058834|FG000|Overall Study|Withdrawal by Subject|4
6996208|NCT01349816|11058834|FG000|Overall Study|Physician Decision|1
6996209|NCT01349816|11058834|FG000|Overall Study|Adverse Event|14
6996210|NCT01349816|11058834|FG000|Overall Study|Lost to Follow-up|2
6996211|NCT01349816|11058834|FG000|Overall Study|Protocol Violation|1
6996212|NCT01349816|11058834|FG000|Overall Study|Protocol-specified criteria|8
7042624|NCT01737697|11127211|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4
7042625|NCT01737697|11127212|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
7042626|NCT01737697|11127213|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7042627|NCT01737697|11127214|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7042628|NCT01737697|11127215|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7042629|NCT01737697|11127216|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7042630|NCT01737697|11127217|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7042631|NCT01737697|11127218|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7042632|NCT01737697|11127219|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7042633|NCT01737697|11127220|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7042634|NCT01737697|11127221|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7042635|NCT01737697|11127222|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7042636|NCT01737697|11127208|FG000|Subacute Phase|Adverse Event|0
7042637|NCT01737697|11127209|FG001|Subacute Phase|Adverse Event|0
7042638|NCT01737697|11127210|FG002|Subacute Phase|Adverse Event|0
7042639|NCT01737697|11127211|FG003|Subacute Phase|Adverse Event|0
7042640|NCT01737697|11127212|FG004|Subacute Phase|Adverse Event|0
7042641|NCT01737697|11127213|FG005|Subacute Phase|Adverse Event|1
7042642|NCT01737697|11127214|FG006|Subacute Phase|Adverse Event|1
7042643|NCT01737697|11127215|FG007|Subacute Phase|Adverse Event|1
7042644|NCT01737697|11127216|FG008|Subacute Phase|Adverse Event|1
7042645|NCT01737697|11127217|FG009|Subacute Phase|Adverse Event|1
7042646|NCT01737697|11127218|FG010|Subacute Phase|Adverse Event|4
7042647|NCT01737697|11127219|FG011|Subacute Phase|Adverse Event|1
7042648|NCT01737697|11127220|FG012|Subacute Phase|Adverse Event|1
7042649|NCT01737697|11127221|FG013|Subacute Phase|Adverse Event|0
7042650|NCT01737697|11127222|FG014|Subacute Phase|Adverse Event|0
7042651|NCT01737697|11127208|FG000|Subacute Phase|Withdrawal by Subject|0
7042652|NCT01737697|11127209|FG001|Subacute Phase|Withdrawal by Subject|0
7042653|NCT01737697|11127210|FG002|Subacute Phase|Withdrawal by Subject|0
7042654|NCT01737697|11127211|FG003|Subacute Phase|Withdrawal by Subject|0
7042655|NCT01737697|11127212|FG004|Subacute Phase|Withdrawal by Subject|0
7042656|NCT01737697|11127213|FG005|Subacute Phase|Withdrawal by Subject|1
7042657|NCT01737697|11127214|FG006|Subacute Phase|Withdrawal by Subject|0
7042658|NCT01737697|11127215|FG007|Subacute Phase|Withdrawal by Subject|2
7042659|NCT01737697|11127216|FG008|Subacute Phase|Withdrawal by Subject|0
7042660|NCT01737697|11127217|FG009|Subacute Phase|Withdrawal by Subject|1
7042661|NCT01737697|11127218|FG010|Subacute Phase|Withdrawal by Subject|0
7042662|NCT01737697|11127219|FG011|Subacute Phase|Withdrawal by Subject|1
7042663|NCT01737697|11127220|FG012|Subacute Phase|Withdrawal by Subject|1
7042664|NCT01737697|11127221|FG013|Subacute Phase|Withdrawal by Subject|1
7042665|NCT01737697|11127222|FG014|Subacute Phase|Withdrawal by Subject|0
7042666|NCT01737697|11127208|FG000|Subacute Phase|Lost to Follow-up|0
7042667|NCT01737697|11127209|FG001|Subacute Phase|Lost to Follow-up|0
6996213|NCT01349829|11058850|FG000|Overall Study|Lost to Follow-up|4
6996214|NCT01349829|11058851|FG001|Overall Study|Lost to Follow-up|8
6996215|NCT01349829|11058850|FG000|Overall Study|Consent withdrawal|3
6996216|NCT01349829|11058851|FG001|Overall Study|Consent withdrawal|8
6996217|NCT01349829|11058850|FG000|Overall Study|Migrated/moved|2
6996218|NCT01349829|11058851|FG001|Overall Study|Migrated/moved|7
6996219|NCT01350102|11058882|FG000|Overall Study|Adverse Event|0
6996220|NCT01350102|11058883|FG001|Overall Study|Adverse Event|0
6996221|NCT01350102|11058884|FG002|Overall Study|Adverse Event|1
6996222|NCT01350102|11058885|FG003|Overall Study|Adverse Event|0
6996223|NCT01350115|11058897|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0
6996224|NCT01350115|11058898|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1
6996225|NCT01350115|11058897|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0
6996226|NCT01350115|11058898|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1
6996227|NCT01350115|11058897|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1
6996228|NCT01350115|11058898|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0
6996229|NCT01350128|11058906|FG000|Overall Study|Withdrawal by Subject|3
6996230|NCT01350128|11058906|FG000|Overall Study|Protocol discontinuation criteria|8
6996231|NCT01350128|11058906|FG000|Overall Study|Physician Decision|1
6996232|NCT01350128|11058906|FG000|Overall Study|Lost to Follow-up|2
6996233|NCT01350141|11058923|FG000|Overall Study|Lost to Follow-up|1
6996234|NCT01350141|11058924|FG001|Overall Study|Lost to Follow-up|0
6996235|NCT01350141|11058925|FG002|Overall Study|Lost to Follow-up|1
6996236|NCT01350141|11058923|FG000|Overall Study|Withdrawal by Subject|1
6996237|NCT01350141|11058924|FG001|Overall Study|Withdrawal by Subject|0
6996238|NCT01350141|11058925|FG002|Overall Study|Withdrawal by Subject|0
6996239|NCT01350141|11058923|FG000|Overall Study|Randomized but not treated|1
6996240|NCT01350141|11058924|FG001|Overall Study|Randomized but not treated|0
6996241|NCT01350141|11058925|FG002|Overall Study|Randomized but not treated|0
6996242|NCT01350271|11058942|FG000|Overall Study|Lost to Follow-up|21
6996243|NCT01350271|11058943|FG001|Overall Study|Lost to Follow-up|17
6996244|NCT01350271|11058944|FG002|Overall Study|Lost to Follow-up|26
6996245|NCT01350336|11058955|FG000|Overall Study|Lost to Follow-up|31
6996246|NCT01350336|11058955|FG000|Overall Study|Withdrawal by Subject|14
6996247|NCT01350336|11058955|FG000|Overall Study|Physician Decision|8
6996248|NCT01350336|11058955|FG000|Overall Study|Death|4
6996249|NCT01350414|11059021|FG000|Overall Study|Lost to Follow-up|13
6996250|NCT01350414|11059021|FG000|Overall Study|Withdrawal by Subject|4
6996251|NCT01350414|11059021|FG000|Overall Study|Physician Decision|2
6996252|NCT01350492|11059053|FG000|Intervention|Lost to Follow-up|2
6996253|NCT01350492|11059054|FG001|Intervention|Lost to Follow-up|5
6996254|NCT01350492|11059053|FG000|Intervention|Withdrawal by Subject|3
6996255|NCT01350492|11059054|FG001|Intervention|Withdrawal by Subject|1
6996256|NCT01350492|11059053|FG000|Post Intervention Follow-Up|Lost to Follow-up|6
6996257|NCT01350492|11059054|FG001|Post Intervention Follow-Up|Lost to Follow-up|1
6996258|NCT01350492|11059053|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0
6996259|NCT01350492|11059054|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1
6996260|NCT01350505|11059060|FG000|Overall Study|Lost to Follow-up|4
6996261|NCT01350544|11059066|FG000|Overall Study|Administrative Withdrawal|0
6996262|NCT01350544|11059067|FG001|Overall Study|Administrative Withdrawal|1
6996263|NCT01350544|11059066|FG000|Overall Study|Death|1
6996264|NCT01350544|11059067|FG001|Overall Study|Death|2
6996265|NCT01350544|11059066|FG000|Overall Study|Moved out of LA County|2
6996266|NCT01350544|11059067|FG001|Overall Study|Moved out of LA County|2
6996267|NCT01350544|11059066|FG000|Overall Study|Medical Issues|1
6996268|NCT01350544|11059067|FG001|Overall Study|Medical Issues|1
6996269|NCT01350544|11059066|FG000|Overall Study|Withdrawal by Subject|0
6996270|NCT01350544|11059067|FG001|Overall Study|Withdrawal by Subject|1
6996271|NCT01350544|11059066|FG000|Overall Study|Incarceration|1
6996272|NCT01350544|11059067|FG001|Overall Study|Incarceration|0
6996273|NCT01350544|11059066|FG000|Overall Study|Lost to Follow-up|18
6996274|NCT01350544|11059067|FG001|Overall Study|Lost to Follow-up|15
6996275|NCT01350804|11059077|FG000|Core Study|Withdrawal by Subject|11
6996276|NCT01350804|11059078|FG001|Core Study|Withdrawal by Subject|17
6996277|NCT01350804|11059079|FG002|Core Study|Withdrawal by Subject|16
6996278|NCT01350804|11059080|FG003|Core Study|Withdrawal by Subject|7
6996279|NCT01350804|11059077|FG000|Core Study|Study terminated by Sponsor|0
6996280|NCT01350804|11059078|FG001|Core Study|Study terminated by Sponsor|0
6996281|NCT01350804|11059079|FG002|Core Study|Study terminated by Sponsor|0
6996282|NCT01350804|11059080|FG003|Core Study|Study terminated by Sponsor|2
6996283|NCT01350804|11059077|FG000|Core Study|Protocol deviation|1
6996284|NCT01350804|11059078|FG001|Core Study|Protocol deviation|0
6996285|NCT01350804|11059079|FG002|Core Study|Protocol deviation|1
6996286|NCT01350804|11059080|FG003|Core Study|Protocol deviation|0
6996287|NCT01350804|11059077|FG000|Core Study|Physician Decision|1
6996288|NCT01350804|11059078|FG001|Core Study|Physician Decision|0
6996289|NCT01350804|11059079|FG002|Core Study|Physician Decision|1
6996290|NCT01350804|11059080|FG003|Core Study|Physician Decision|3
6996291|NCT01350804|11059077|FG000|Core Study|Lost to Follow-up|3
6996292|NCT01350804|11059078|FG001|Core Study|Lost to Follow-up|0
6996293|NCT01350804|11059079|FG002|Core Study|Lost to Follow-up|2
6996294|NCT01350804|11059080|FG003|Core Study|Lost to Follow-up|1
6996295|NCT01350804|11059077|FG000|Core Study|Lack of Efficacy|16
6996296|NCT01350804|11059078|FG001|Core Study|Lack of Efficacy|19
6996297|NCT01350804|11059079|FG002|Core Study|Lack of Efficacy|18
6996298|NCT01350804|11059080|FG003|Core Study|Lack of Efficacy|5
6996299|NCT01350804|11059077|FG000|Core Study|Death|1
6996300|NCT01350804|11059078|FG001|Core Study|Death|1
6996301|NCT01350804|11059079|FG002|Core Study|Death|1
6996302|NCT01350804|11059080|FG003|Core Study|Death|0
6996303|NCT01350804|11059077|FG000|Core Study|Adverse Event|8
6996304|NCT01350804|11059078|FG001|Core Study|Adverse Event|10
6996305|NCT01350804|11059079|FG002|Core Study|Adverse Event|8
6996306|NCT01350804|11059080|FG003|Core Study|Adverse Event|8
6996307|NCT01350804|11059077|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5
6996308|NCT01350804|11059078|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6
6996309|NCT01350804|11059079|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4
6996310|NCT01350804|11059080|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3
6996311|NCT01350804|11059077|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
6996312|NCT01350804|11059078|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
6996313|NCT01350804|11059079|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64
6996314|NCT01350804|11059080|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16
6996315|NCT01350804|11059077|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1
6996316|NCT01350804|11059078|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0
6996317|NCT01350804|11059079|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2
6996318|NCT01350804|11059080|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0
6996319|NCT01350804|11059077|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
6996320|NCT01350804|11059078|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1
6996321|NCT01350804|11059079|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
6996322|NCT01350804|11059080|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
6996323|NCT01350804|11059077|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
6996324|NCT01350804|11059078|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
6996325|NCT01350804|11059079|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0
6996326|NCT01350804|11059080|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1
6996327|NCT01350804|11059077|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3
6996328|NCT01350804|11059078|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1
6996329|NCT01350804|11059079|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2
6996330|NCT01350804|11059080|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3
6996331|NCT01350973|11059107|FG000|Overall Study|Adverse Event|4
6996332|NCT01350973|11059108|FG001|Overall Study|Adverse Event|7
6996333|NCT01350973|11059109|FG002|Overall Study|Adverse Event|7
6996334|NCT01350973|11059107|FG000|Overall Study|Voluntary Withdrawal|2
6996335|NCT01350973|11059108|FG001|Overall Study|Voluntary Withdrawal|1
6996336|NCT01350973|11059109|FG002|Overall Study|Voluntary Withdrawal|1
6996337|NCT01350999|11059120|FG000|Overall Study|Adverse Event|4
6996338|NCT01350999|11059121|FG001|Overall Study|Adverse Event|9
6996339|NCT01350999|11059122|FG002|Overall Study|Adverse Event|10
6996340|NCT01350999|11059120|FG000|Overall Study|Voluntary withdrawal|3
6996341|NCT01350999|11059121|FG001|Overall Study|Voluntary withdrawal|4
6996342|NCT01350999|11059122|FG002|Overall Study|Voluntary withdrawal|6
6996343|NCT01350999|11059120|FG000|Overall Study|Difficulty Making it to Study Visit|1
6996344|NCT01350999|11059121|FG001|Overall Study|Difficulty Making it to Study Visit|1
6996345|NCT01350999|11059122|FG002|Overall Study|Difficulty Making it to Study Visit|5
6996346|NCT01351025|11059132|FG000|Week 0 - 20|Lost to Follow-up|2
6996347|NCT01351025|11059133|FG001|Week 0 - 20|Lost to Follow-up|1
6996348|NCT01351025|11059132|FG000|Week 0 - 20|Withdrawal by Subject|1
6996349|NCT01351025|11059133|FG001|Week 0 - 20|Withdrawal by Subject|0
6996350|NCT01351025|11059132|FG000|Week 24 - 44|Lost to Follow-up|0
6996351|NCT01351025|11059133|FG001|Week 24 - 44|Lost to Follow-up|2
6996352|NCT01351025|11059132|FG000|Week 24 - 44|Site closed|0
6996353|NCT01351025|11059133|FG001|Week 24 - 44|Site closed|1
6996354|NCT01351025|11059132|FG000|Week 24 - 44|unable to get to clinic|1
6996355|NCT01351025|11059133|FG001|Week 24 - 44|unable to get to clinic|1
6996356|NCT01351350|11059186|FG000|Overall Study|Disease Progression|5
6996357|NCT01351350|11059187|FG001|Overall Study|Disease Progression|13
6996358|NCT01351350|11059188|FG002|Overall Study|Disease Progression|6
6996359|NCT01351350|11059189|FG003|Overall Study|Disease Progression|8
6996360|NCT01351350|11059190|FG004|Overall Study|Disease Progression|5
6996361|NCT01351350|11059186|FG000|Overall Study|Adverse Event|1
6996362|NCT01351350|11059187|FG001|Overall Study|Adverse Event|10
6996363|NCT01351350|11059188|FG002|Overall Study|Adverse Event|1
6996364|NCT01351350|11059189|FG003|Overall Study|Adverse Event|2
6996365|NCT01351350|11059190|FG004|Overall Study|Adverse Event|0
6996366|NCT01351350|11059186|FG000|Overall Study|Participant Decision|2
6996367|NCT01351350|11059187|FG001|Overall Study|Participant Decision|6
6996368|NCT01351350|11059188|FG002|Overall Study|Participant Decision|3
6996369|NCT01351350|11059189|FG003|Overall Study|Participant Decision|3
6996370|NCT01351350|11059190|FG004|Overall Study|Participant Decision|2
6996371|NCT01351350|11059186|FG000|Overall Study|Enrolled but not Treated|0
6996372|NCT01351350|11059187|FG001|Overall Study|Enrolled but not Treated|0
6996373|NCT01351350|11059188|FG002|Overall Study|Enrolled but not Treated|1
6996374|NCT01351350|11059189|FG003|Overall Study|Enrolled but not Treated|0
6996375|NCT01351350|11059190|FG004|Overall Study|Enrolled but not Treated|0
6996376|NCT01351415|11059226|FG000|Overall Study|Withdrawal by Subject|15
6996377|NCT01351415|11059227|FG001|Overall Study|Withdrawal by Subject|17
6996378|NCT01351415|11059226|FG000|Overall Study|Trial termination by the Sponsor|28
6996379|NCT01351415|11059227|FG001|Overall Study|Trial termination by the Sponsor|19
6996380|NCT01351415|11059226|FG000|Overall Study|Lost to Follow-up|5
6996381|NCT01351415|11059227|FG001|Overall Study|Lost to Follow-up|7
6996382|NCT01351415|11059226|FG000|Overall Study|Death|190
6996383|NCT01351415|11059227|FG001|Overall Study|Death|187
6996384|NCT01351415|11059226|FG000|Overall Study|Physician Decision|2
6996385|NCT01351415|11059227|FG001|Overall Study|Physician Decision|3
6996386|NCT01351415|11059226|FG000|Overall Study|Reason unknown|0
6996387|NCT01351415|11059227|FG001|Overall Study|Reason unknown|2
6996388|NCT01351415|11059226|FG000|Overall Study|Never Started|5
6996389|NCT01351415|11059227|FG001|Overall Study|Never Started|5
6996390|NCT01351623|11059245|FG000|Overall Study|Protocol Violation|2
6996391|NCT01351623|11059245|FG000|Overall Study|Adverse Event|4
6996392|NCT01351623|11059245|FG000|Overall Study|Withdrawal by Subject|1
6996393|NCT01351623|11059245|FG000|Overall Study|Death|2
6996394|NCT01352117|11059309|FG000|Overall Study|Death|15
6996395|NCT01352117|11059310|FG001|Overall Study|Death|16
6996396|NCT01352117|11059309|FG000|Overall Study|Withdrawal by Subject|1
6996397|NCT01352117|11059310|FG001|Overall Study|Withdrawal by Subject|0
6996398|NCT01352117|11059309|FG000|Overall Study|Lost to Follow-up|2
6996399|NCT01352117|11059310|FG001|Overall Study|Lost to Follow-up|7
6996400|NCT01352117|11059309|FG000|Overall Study|Non-adherent to study requirements|1
6996401|NCT01352117|11059310|FG001|Overall Study|Non-adherent to study requirements|1
6996402|NCT01352117|11059309|FG000|Overall Study|Did not initiate study treatment|1
6996403|NCT01352117|11059310|FG001|Overall Study|Did not initiate study treatment|0
6996404|NCT01352117|11059309|FG000|Overall Study|Ineligible (no KS diagnosis)|1
6996405|NCT01352117|11059310|FG001|Overall Study|Ineligible (no KS diagnosis)|0
6996406|NCT01352221|11059332|FG000|Double-blind Phase|Adverse Event|6
6996407|NCT01352221|11059333|FG001|Double-blind Phase|Adverse Event|4
6996408|NCT01352221|11059334|FG002|Double-blind Phase|Adverse Event|0
6996409|NCT01352221|11059335|FG003|Double-blind Phase|Adverse Event|0
6996410|NCT01352221|11059332|FG000|Double-blind Phase|Withdrawal by Subject|3
6996411|NCT01352221|11059333|FG001|Double-blind Phase|Withdrawal by Subject|5
6996412|NCT01352221|11059334|FG002|Double-blind Phase|Withdrawal by Subject|0
6996413|NCT01352221|11059335|FG003|Double-blind Phase|Withdrawal by Subject|0
6996414|NCT01352221|11059332|FG000|Double-blind Phase|Lost to Follow-up|0
6996415|NCT01352221|11059333|FG001|Double-blind Phase|Lost to Follow-up|1
6996416|NCT01352221|11059334|FG002|Double-blind Phase|Lost to Follow-up|0
6996417|NCT01352221|11059335|FG003|Double-blind Phase|Lost to Follow-up|0
6996418|NCT01352221|11059332|FG000|Double-blind Phase|Protocol Violation|0
6996419|NCT01352221|11059333|FG001|Double-blind Phase|Protocol Violation|1
6996420|NCT01352221|11059334|FG002|Double-blind Phase|Protocol Violation|0
6996421|NCT01352221|11059335|FG003|Double-blind Phase|Protocol Violation|0
6996422|NCT01352221|11059332|FG000|Open-label Phase|Physician Decision|0
6996423|NCT01352221|11059333|FG001|Open-label Phase|Physician Decision|0
6996424|NCT01352221|11059334|FG002|Open-label Phase|Physician Decision|2
6996425|NCT01352221|11059335|FG003|Open-label Phase|Physician Decision|1
6996426|NCT01352221|11059332|FG000|Open-label Phase|Pregnancy|0
6996427|NCT01352221|11059333|FG001|Open-label Phase|Pregnancy|0
6996428|NCT01352221|11059334|FG002|Open-label Phase|Pregnancy|1
6996429|NCT01352221|11059335|FG003|Open-label Phase|Pregnancy|0
6996430|NCT01352221|11059332|FG000|Open-label Phase|Adverse Event|0
6996431|NCT01352221|11059333|FG001|Open-label Phase|Adverse Event|0
6996432|NCT01352221|11059334|FG002|Open-label Phase|Adverse Event|8
6996433|NCT01352221|11059335|FG003|Open-label Phase|Adverse Event|4
6996434|NCT01352221|11059332|FG000|Open-label Phase|Withdrawal by Subject|0
6996435|NCT01352221|11059333|FG001|Open-label Phase|Withdrawal by Subject|0
6996436|NCT01352221|11059334|FG002|Open-label Phase|Withdrawal by Subject|1
6996437|NCT01352221|11059335|FG003|Open-label Phase|Withdrawal by Subject|6
6996438|NCT01352221|11059332|FG000|Open-label Phase|Worsening of IBD|0
6996439|NCT01352221|11059333|FG001|Open-label Phase|Worsening of IBD|0
6996440|NCT01352221|11059334|FG002|Open-label Phase|Worsening of IBD|1
6996441|NCT01352221|11059335|FG003|Open-label Phase|Worsening of IBD|0
6996442|NCT01352507|11059367|FG000|Treatment Period 1|Adverse Event|3
6996443|NCT01352507|11059368|FG001|Treatment Period 1|Adverse Event|0
6996444|NCT01352507|11059367|FG000|Treatment Period 1|Lost to Follow-up|3
6996445|NCT01352507|11059368|FG001|Treatment Period 1|Lost to Follow-up|4
6996446|NCT01352507|11059367|FG000|Treatment Period 1|Withdrawal by Subject|7
6996447|NCT01352507|11059368|FG001|Treatment Period 1|Withdrawal by Subject|5
6996448|NCT01352507|11059367|FG000|Treatment Period 1|Physician Decision|1
6996449|NCT01352507|11059368|FG001|Treatment Period 1|Physician Decision|0
6996450|NCT01352507|11059367|FG000|Washout Period|Withdrawal by Subject|0
6996451|NCT01352507|11059368|FG001|Washout Period|Withdrawal by Subject|1
6996452|NCT01352507|11059367|FG000|Treatment Period 2|Entry Criteria Not Met|1
6996453|NCT01352507|11059368|FG001|Treatment Period 2|Entry Criteria Not Met|0
6996454|NCT01352507|11059367|FG000|Treatment Period 2|Withdrawal by Subject|4
6996455|NCT01352507|11059368|FG001|Treatment Period 2|Withdrawal by Subject|3
6996456|NCT01352507|11059367|FG000|Treatment Period 2|Lack of Efficacy|1
6996457|NCT01352507|11059368|FG001|Treatment Period 2|Lack of Efficacy|0
6996458|NCT01352585|11059386|FG000|Overall Study|Adverse Event|2
6996459|NCT01352585|11059387|FG001|Overall Study|Adverse Event|1
6996460|NCT01352585|11059386|FG000|Overall Study|Lost to Follow-up|1
6996461|NCT01352585|11059387|FG001|Overall Study|Lost to Follow-up|0
6996462|NCT01352585|11059386|FG000|Overall Study|Other|5
6996463|NCT01352585|11059387|FG001|Overall Study|Other|2
6996464|NCT01352715|11059417|FG000|Overall Study|Death|3
6996465|NCT01352715|11059418|FG001|Overall Study|Death|3
6996466|NCT01352715|11059417|FG000|Overall Study|Lost to Follow-up|5
6996467|NCT01352715|11059418|FG001|Overall Study|Lost to Follow-up|7
6996468|NCT01352715|11059417|FG000|Overall Study|Withdrawal by Subject|4
6996469|NCT01352715|11059418|FG001|Overall Study|Withdrawal by Subject|8
6996470|NCT01352715|11059417|FG000|Overall Study|site closure|16
6996471|NCT01352715|11059418|FG001|Overall Study|site closure|15
6996472|NCT01352715|11059417|FG000|Overall Study|no final visit in closeout period|15
6996473|NCT01352715|11059418|FG001|Overall Study|no final visit in closeout period|12
6996474|NCT01352715|11059417|FG000|Overall Study|major ineligibility|2
6996475|NCT01352715|11059418|FG001|Overall Study|major ineligibility|1
6996476|NCT01352741|11059424|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4
6996477|NCT01352741|11059425|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0
6996478|NCT01352741|11059424|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19
6996479|NCT01352741|11059425|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0
6996480|NCT01352741|11059424|FG000|Open-label Tapentadol Titration Period|Adverse Event|34
6996481|NCT01352741|11059425|FG001|Open-label Tapentadol Titration Period|Adverse Event|0
6996482|NCT01352741|11059424|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7
6996483|NCT01352741|11059425|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0
6996484|NCT01352741|11059424|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5
6996485|NCT01352741|11059425|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0
6996486|NCT01352741|11059424|FG000|Open-label Tapentadol Titration Period|Other|4
6996487|NCT01352741|11059425|FG001|Open-label Tapentadol Titration Period|Other|0
6996488|NCT01352741|11059424|FG000|Double-blind Comparative Period|Protocol Violation|2
6996489|NCT01352741|11059425|FG001|Double-blind Comparative Period|Protocol Violation|0
6996490|NCT01352741|11059424|FG000|Double-blind Comparative Period|Lack of Efficacy|0
6996491|NCT01352741|11059425|FG001|Double-blind Comparative Period|Lack of Efficacy|3
6996492|NCT01352741|11059424|FG000|Double-blind Comparative Period|Adverse Event|16
6996493|NCT01352741|11059425|FG001|Double-blind Comparative Period|Adverse Event|17
6996494|NCT01352741|11059424|FG000|Double-blind Comparative Period|Lost to Follow-up|1
6996495|NCT01352741|11059425|FG001|Double-blind Comparative Period|Lost to Follow-up|0
6996496|NCT01352741|11059424|FG000|Double-blind Comparative Period|Death|0
6996497|NCT01352741|11059425|FG001|Double-blind Comparative Period|Death|1
6996498|NCT01352741|11059424|FG000|Double-blind Comparative Period|Withdrawal of consent|8
6996499|NCT01352741|11059425|FG001|Double-blind Comparative Period|Withdrawal of consent|3
6996500|NCT01352741|11059424|FG000|Double-blind Comparative Period|Other|1
6996501|NCT01352741|11059425|FG001|Double-blind Comparative Period|Other|2
6996502|NCT01352741|11059424|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4
6996503|NCT01352741|11059425|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0
6996504|NCT01352741|11059424|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1
6996505|NCT01352741|11059425|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0
6996506|NCT01352741|11059424|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2
6996507|NCT01352741|11059425|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0
6996508|NCT01352741|11059424|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1
6996509|NCT01352741|11059425|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0
6996510|NCT01352793|11059447|FG000|Overall Study|Lost to Follow-up|289
6996511|NCT01352793|11059448|FG001|Overall Study|Lost to Follow-up|125
6996512|NCT01352793|11059447|FG000|Overall Study|Withdrawal by Subject|120
6996513|NCT01352793|11059448|FG001|Overall Study|Withdrawal by Subject|55
6996514|NCT01352793|11059447|FG000|Overall Study|Protocol Violation|44
6996515|NCT01352793|11059448|FG001|Overall Study|Protocol Violation|23
6996516|NCT01352793|11059447|FG000|Overall Study|Adverse Event|44
6996517|NCT01352793|11059448|FG001|Overall Study|Adverse Event|10
6996518|NCT01352793|11059447|FG000|Overall Study|Physician Decision|1
6996519|NCT01352793|11059448|FG001|Overall Study|Physician Decision|0
6996520|NCT01352793|11059447|FG000|Overall Study|Pregnancy|26
6996521|NCT01352793|11059448|FG001|Overall Study|Pregnancy|8
6996522|NCT01352793|11059447|FG000|Overall Study|Other|25
6996523|NCT01352793|11059448|FG001|Overall Study|Other|7
6996524|NCT01352793|11059447|FG000|Overall Study|Medication error|2
6996525|NCT01352793|11059448|FG001|Overall Study|Medication error|2
6996526|NCT01352793|11059447|FG000|Overall Study|Death|1
6996527|NCT01352793|11059448|FG001|Overall Study|Death|0
6996528|NCT01352793|11059447|FG000|Overall Study|Randomized but not vaccinated|8
6996529|NCT01352793|11059448|FG001|Overall Study|Randomized but not vaccinated|0
6996530|NCT01352793|11059447|FG000|Overall Study|No longer meets eligibility criteria|25
6996531|NCT01352793|11059448|FG001|Overall Study|No longer meets eligibility criteria|15
6996532|NCT01352845|11059456|FG000|Overall Study|Lost to Follow-up|313
6996533|NCT01352845|11059457|FG001|Overall Study|Lost to Follow-up|92
6996534|NCT01352845|11059456|FG000|Overall Study|No Longer Willing to Participate|205
6996535|NCT01352845|11059457|FG001|Overall Study|No Longer Willing to Participate|58
6996536|NCT01352845|11059456|FG000|Overall Study|Withdrawal by Subject|48
6996537|NCT01352845|11059457|FG001|Overall Study|Withdrawal by Subject|16
6996538|NCT01352845|11059456|FG000|Overall Study|No Longer Meets Eligibility Criteria|24
6996539|NCT01352845|11059457|FG001|Overall Study|No Longer Meets Eligibility Criteria|11
6996540|NCT01352845|11059456|FG000|Overall Study|Pregnancy|27
6996541|NCT01352845|11059457|FG001|Overall Study|Pregnancy|7
6996542|NCT01352845|11059456|FG000|Overall Study|Adverse Event|22
6996543|NCT01352845|11059457|FG001|Overall Study|Adverse Event|6
6996544|NCT01352845|11059456|FG000|Overall Study|Other|17
6996545|NCT01352845|11059457|FG001|Overall Study|Other|7
6996546|NCT01352845|11059456|FG000|Overall Study|Protocol Violation|12
6996547|NCT01352845|11059457|FG001|Overall Study|Protocol Violation|6
6996548|NCT01352845|11059456|FG000|Overall Study|Death|3
6996549|NCT01352845|11059457|FG001|Overall Study|Death|0
6996550|NCT01353222|11059496|FG000|Overall Study|Death|30
6996551|NCT01353222|11059497|FG001|Overall Study|Death|30
6996552|NCT01353222|11059496|FG000|Overall Study|Withdrawal by Subject|8
6996553|NCT01353222|11059497|FG001|Overall Study|Withdrawal by Subject|5
6996554|NCT01353222|11059496|FG000|Overall Study|Study Terminated|31
6996555|NCT01353222|11059497|FG001|Overall Study|Study Terminated|37
6996556|NCT01353222|11059496|FG000|Overall Study|Site closed research department|1
6996557|NCT01353222|11059497|FG001|Overall Study|Site closed research department|0
6996558|NCT01353274|11059503|FG000|Overall Study|No case report form (CRF) collected|28
6996559|NCT01353508|11059520|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0
6996560|NCT01353508|11059521|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0
6996561|NCT01353508|11059522|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0
6996562|NCT01353508|11059523|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1
6996563|NCT01353508|11059520|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1
6996564|NCT01353508|11059521|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
6996565|NCT01353508|11059522|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
6996566|NCT01353508|11059523|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
6996567|NCT01353586|11059535|FG000|Overall Study|Procedure terminated prior to ablation|3
6996568|NCT01353586|11059536|FG001|Overall Study|Procedure terminated prior to ablation|0
6996569|NCT01353586|11059535|FG000|Overall Study|Never had insertion of study catheter|4
6996570|NCT01353586|11059536|FG001|Overall Study|Never had insertion of study catheter|1
6996571|NCT01353586|11059535|FG000|Overall Study|Neurological exam not done|0
6996572|NCT01353586|11059536|FG001|Overall Study|Neurological exam not done|1
6996573|NCT01353664|11059545|FG000|Overall Study|Other|3
6996574|NCT01353664|11059545|FG000|Overall Study|Disease Progression|16
6996575|NCT01353703|11059551|FG000|Overall Study|Migrated/moved from study area|1
6996576|NCT01353703|11059552|FG001|Overall Study|Migrated/moved from study area|0
6996577|NCT01353859|11059560|FG000|Overall Study|Adverse Event|3
6996578|NCT01353859|11059560|FG000|Overall Study|Lack of Efficacy|1
6996579|NCT01353898|11059570|FG000|Overall Study|Study site terminated|0
6996580|NCT01353898|11059571|FG001|Overall Study|Study site terminated|0
6996581|NCT01353898|11059572|FG002|Overall Study|Study site terminated|0
6996582|NCT01353898|11059573|FG003|Overall Study|Study site terminated|0
6996583|NCT01353898|11059574|FG004|Overall Study|Study site terminated|0
6996584|NCT01353898|11059575|FG005|Overall Study|Study site terminated|1
6996585|NCT01353911|11059597|FG000|Overall Study|Lost to Follow-up|2
6996586|NCT01353911|11059598|FG001|Overall Study|Lost to Follow-up|6
6996587|NCT01353911|11059599|FG002|Overall Study|Lost to Follow-up|4
6996588|NCT01353911|11059600|FG003|Overall Study|Lost to Follow-up|0
6996589|NCT01353911|11059601|FG004|Overall Study|Lost to Follow-up|4
6996590|NCT01353911|11059602|FG005|Overall Study|Lost to Follow-up|4
6996591|NCT01353911|11059603|FG006|Overall Study|Lost to Follow-up|3
6996592|NCT01353911|11059604|FG007|Overall Study|Lost to Follow-up|6
6996593|NCT01353911|11059597|FG000|Overall Study|Withdrawal by Subject|2
6996594|NCT01353911|11059598|FG001|Overall Study|Withdrawal by Subject|3
6996595|NCT01353911|11059599|FG002|Overall Study|Withdrawal by Subject|4
6996596|NCT01353911|11059600|FG003|Overall Study|Withdrawal by Subject|2
6996597|NCT01353911|11059601|FG004|Overall Study|Withdrawal by Subject|2
6996598|NCT01353911|11059602|FG005|Overall Study|Withdrawal by Subject|3
6996599|NCT01353911|11059603|FG006|Overall Study|Withdrawal by Subject|3
6996600|NCT01353911|11059604|FG007|Overall Study|Withdrawal by Subject|9
6996601|NCT01353911|11059597|FG000|Overall Study|Status Not Recorded|4
6996602|NCT01353911|11059598|FG001|Overall Study|Status Not Recorded|0
6996603|NCT01353911|11059599|FG002|Overall Study|Status Not Recorded|1
6996604|NCT01353911|11059600|FG003|Overall Study|Status Not Recorded|0
6996605|NCT01353911|11059601|FG004|Overall Study|Status Not Recorded|0
6996606|NCT01353911|11059602|FG005|Overall Study|Status Not Recorded|0
6996607|NCT01353911|11059603|FG006|Overall Study|Status Not Recorded|0
6996608|NCT01353911|11059604|FG007|Overall Study|Status Not Recorded|0
6996609|NCT01353963|11059622|FG000|Overall Study|Adverse Event|2
6996610|NCT01354028|11059644|FG000|Overall Study|Physician Decision|0
6996611|NCT01354028|11059645|FG001|Overall Study|Physician Decision|2
6996612|NCT01354028|11059644|FG000|Overall Study|Discharged before study start|2
6996613|NCT01354028|11059645|FG001|Overall Study|Discharged before study start|2
6996614|NCT01354028|11059644|FG000|Overall Study|No quiet alert state|0
6996615|NCT01354028|11059645|FG001|Overall Study|No quiet alert state|1
6996616|NCT01354106|11059657|FG000|Overall Study|Withdrawal by Subject|2
6996617|NCT01354132|11059665|FG000|Randomization|Physician Decision|1
6996618|NCT01354132|11059666|FG001|Randomization|Physician Decision|0
6996619|NCT01354132|11059665|FG000|Randomization|Withdrawal by Subject|0
6996620|NCT01354132|11059666|FG001|Randomization|Withdrawal by Subject|1
6996621|NCT01354132|11059665|FG000|Double Blind (Visits 1-7)|Adverse Event|1
6996622|NCT01354132|11059666|FG001|Double Blind (Visits 1-7)|Adverse Event|0
6996623|NCT01354132|11059665|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8
6996624|NCT01354132|11059666|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11
6996625|NCT01354132|11059665|FG000|1 Month Post Study Medication|Withdrawal by Subject|1
6996626|NCT01354132|11059666|FG001|1 Month Post Study Medication|Withdrawal by Subject|3
6996627|NCT01354223|11059693|FG000|Overall Study|Withdrawal by Subject|3
6996628|NCT01354223|11059694|FG001|Overall Study|Withdrawal by Subject|1
6996629|NCT01354314|11059704|FG000|Overall Study|Lost to Follow-up|1
6996630|NCT01354314|11059705|FG001|Overall Study|Lost to Follow-up|0
6996631|NCT01354314|11059706|FG002|Overall Study|Lost to Follow-up|1
6996632|NCT01354314|11059707|FG003|Overall Study|Lost to Follow-up|1
6996633|NCT01354314|11059704|FG000|Overall Study|Withdrawal by Subject|0
6996634|NCT01354314|11059705|FG001|Overall Study|Withdrawal by Subject|0
6996635|NCT01354314|11059706|FG002|Overall Study|Withdrawal by Subject|1
6996636|NCT01354314|11059707|FG003|Overall Study|Withdrawal by Subject|0
6996637|NCT01354314|11059704|FG000|Overall Study|Adverse Event|0
6996638|NCT01354314|11059705|FG001|Overall Study|Adverse Event|0
6996639|NCT01354314|11059706|FG002|Overall Study|Adverse Event|0
6996640|NCT01354314|11059707|FG003|Overall Study|Adverse Event|1
6996641|NCT01354314|11059704|FG000|Overall Study|Protocol Violation|1
6996642|NCT01354314|11059705|FG001|Overall Study|Protocol Violation|1
6996643|NCT01354314|11059706|FG002|Overall Study|Protocol Violation|0
6996644|NCT01354314|11059707|FG003|Overall Study|Protocol Violation|0
6996645|NCT01354314|11059704|FG000|Overall Study|Less than 90% Adherence|4
6996646|NCT01354314|11059705|FG001|Overall Study|Less than 90% Adherence|2
6996647|NCT01354314|11059706|FG002|Overall Study|Less than 90% Adherence|6
6996648|NCT01354314|11059707|FG003|Overall Study|Less than 90% Adherence|4
6996649|NCT01354353|11059725|FG000|Overall Study|Adverse Event|1
6996650|NCT01354353|11059726|FG001|Overall Study|Adverse Event|0
6996651|NCT01354353|11059727|FG002|Overall Study|Adverse Event|0
6996652|NCT01354353|11059728|FG003|Overall Study|Adverse Event|4
6996653|NCT01354353|11059729|FG004|Overall Study|Adverse Event|0
6996654|NCT01354353|11059730|FG005|Overall Study|Adverse Event|5
6996655|NCT01354353|11059725|FG000|Overall Study|Entry Criteria Not Met|0
6996656|NCT01354353|11059726|FG001|Overall Study|Entry Criteria Not Met|0
6996657|NCT01354353|11059727|FG002|Overall Study|Entry Criteria Not Met|0
6996658|NCT01354353|11059728|FG003|Overall Study|Entry Criteria Not Met|1
6996659|NCT01354353|11059729|FG004|Overall Study|Entry Criteria Not Met|1
6996660|NCT01354353|11059730|FG005|Overall Study|Entry Criteria Not Met|0
6996661|NCT01354353|11059725|FG000|Overall Study|Physician Decision|0
6996662|NCT01354353|11059726|FG001|Overall Study|Physician Decision|1
6996663|NCT01354353|11059727|FG002|Overall Study|Physician Decision|1
6996664|NCT01354353|11059728|FG003|Overall Study|Physician Decision|0
6996665|NCT01354353|11059729|FG004|Overall Study|Physician Decision|0
6996666|NCT01354353|11059730|FG005|Overall Study|Physician Decision|0
6996667|NCT01354353|11059725|FG000|Overall Study|Withdrawal by Subject|2
6996668|NCT01354353|11059726|FG001|Overall Study|Withdrawal by Subject|0
6996669|NCT01354353|11059727|FG002|Overall Study|Withdrawal by Subject|1
6996670|NCT01354353|11059728|FG003|Overall Study|Withdrawal by Subject|0
6996671|NCT01354353|11059729|FG004|Overall Study|Withdrawal by Subject|0
6996672|NCT01354353|11059730|FG005|Overall Study|Withdrawal by Subject|1
6996673|NCT01354496|11059764|FG000|Period 1|Adverse Event|0
6996674|NCT01354496|11059765|FG001|Period 1|Adverse Event|0
6996675|NCT01354496|11059766|FG002|Period 1|Adverse Event|1
6996676|NCT01354496|11059767|FG003|Period 1|Adverse Event|0
6996677|NCT01354496|11059768|FG004|Period 1|Adverse Event|0
6996678|NCT01354496|11059769|FG005|Period 1|Adverse Event|0
6996679|NCT01354496|11059764|FG000|Period 1|Physician Decision|0
6996680|NCT01354496|11059765|FG001|Period 1|Physician Decision|0
6996681|NCT01354496|11059766|FG002|Period 1|Physician Decision|1
6996682|NCT01354496|11059767|FG003|Period 1|Physician Decision|0
6996683|NCT01354496|11059768|FG004|Period 1|Physician Decision|0
6996684|NCT01354496|11059769|FG005|Period 1|Physician Decision|0
6996685|NCT01354496|11059764|FG000|Period 2|Adverse Event|0
6996686|NCT01354496|11059765|FG001|Period 2|Adverse Event|0
6996687|NCT01354496|11059766|FG002|Period 2|Adverse Event|0
6996688|NCT01354496|11059767|FG003|Period 2|Adverse Event|1
6996689|NCT01354496|11059768|FG004|Period 2|Adverse Event|0
6996690|NCT01354496|11059769|FG005|Period 2|Adverse Event|0
6996691|NCT01354496|11059764|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0
6996692|NCT01354496|11059765|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1
6996693|NCT01354496|11059766|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0
6996694|NCT01354496|11059767|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1
6996695|NCT01354496|11059768|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0
6996696|NCT01354496|11059769|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0
6996697|NCT01354899|11059813|FG000|Overall Study|discharge from the hospital|2
6996698|NCT01354899|11059813|FG000|Overall Study|Protocol Violation|1
6996699|NCT01354938|11059817|FG000|Overall Study|Lost to Follow-up|1
6996700|NCT01354964|11059823|FG000|Overall Study|Lost to Follow-up|2
6996701|NCT01354964|11059824|FG001|Overall Study|Lost to Follow-up|0
6996702|NCT01354964|11059823|FG000|Overall Study|IV access issues|1
6996703|NCT01354964|11059824|FG001|Overall Study|IV access issues|1
6996704|NCT01354964|11059823|FG000|Overall Study|Physician Decision|1
6996705|NCT01354964|11059824|FG001|Overall Study|Physician Decision|0
6996706|NCT01355068|11059836|FG000|First Intervention Period|Adverse Event|0
6996707|NCT01355068|11059837|FG001|First Intervention Period|Adverse Event|1
6996708|NCT01355068|11059836|FG000|First Intervention Period|Withdrawal by Subject|0
6996709|NCT01355068|11059837|FG001|First Intervention Period|Withdrawal by Subject|1
6996710|NCT01355081|11059846|FG000|Overall Study|Pretreatment Event or Adverse Event|3
6996711|NCT01355081|11059847|FG001|Overall Study|Pretreatment Event or Adverse Event|4
6996712|NCT01355081|11059848|FG002|Overall Study|Pretreatment Event or Adverse Event|6
6996713|NCT01355081|11059846|FG000|Overall Study|Major Protocol Deviation|0
6996714|NCT01355081|11059847|FG001|Overall Study|Major Protocol Deviation|1
6996715|NCT01355081|11059848|FG002|Overall Study|Major Protocol Deviation|0
6996716|NCT01355081|11059846|FG000|Overall Study|Lost to Follow-up|0
6996717|NCT01355081|11059847|FG001|Overall Study|Lost to Follow-up|0
6996718|NCT01355081|11059848|FG002|Overall Study|Lost to Follow-up|1
6996719|NCT01355081|11059846|FG000|Overall Study|Withdrawal of Consent|2
6996720|NCT01355081|11059847|FG001|Overall Study|Withdrawal of Consent|3
6996721|NCT01355081|11059848|FG002|Overall Study|Withdrawal of Consent|3
6996722|NCT01355081|11059846|FG000|Overall Study|Lack of Efficacy|2
6996723|NCT01355081|11059847|FG001|Overall Study|Lack of Efficacy|1
6996724|NCT01355081|11059848|FG002|Overall Study|Lack of Efficacy|1
6996725|NCT01355081|11059846|FG000|Overall Study|Non Compliance with Study Medication|0
6996726|NCT01355081|11059847|FG001|Overall Study|Non Compliance with Study Medication|1
6996727|NCT01355081|11059848|FG002|Overall Study|Non Compliance with Study Medication|0
6996728|NCT01355159|11059858|FG000|Overall Study|Withdrew consent|39
6996729|NCT01355159|11059859|FG001|Overall Study|Withdrew consent|47
6996730|NCT01355159|11059858|FG000|Overall Study|No primary outcome data|17
6996731|NCT01355159|11059859|FG001|Overall Study|No primary outcome data|11
6996732|NCT01355159|11059858|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22
6996733|NCT01355159|11059859|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15
6996734|NCT01355159|11059858|FG000|Overall Study|Early intrauterine fetal death|6
6996735|NCT01355159|11059859|FG001|Overall Study|Early intrauterine fetal death|6
6996736|NCT01355289|11059894|FG000|Core Study|Adverse Event, Non-Fatal|1
6996737|NCT01355289|11059895|FG001|Core Study|Adverse Event, Non-Fatal|0
6996738|NCT01355289|11059896|FG002|Core Study|Adverse Event, Non-Fatal|0
6996739|NCT01355289|11059897|FG003|Core Study|Adverse Event, Non-Fatal|0
6996740|NCT01355289|11059898|FG004|Core Study|Adverse Event, Non-Fatal|0
6996741|NCT01355289|11059894|FG000|Core Study|Inadequate Therapeutic Effect|0
6996742|NCT01355289|11059895|FG001|Core Study|Inadequate Therapeutic Effect|0
6996743|NCT01355289|11059896|FG002|Core Study|Inadequate Therapeutic Effect|0
6996744|NCT01355289|11059897|FG003|Core Study|Inadequate Therapeutic Effect|1
6996745|NCT01355289|11059898|FG004|Core Study|Inadequate Therapeutic Effect|0
6996746|NCT01355289|11059894|FG000|Core Study|Other|0
6996747|NCT01355289|11059895|FG001|Core Study|Other|0
6996748|NCT01355289|11059896|FG002|Core Study|Other|0
6996749|NCT01355289|11059897|FG003|Core Study|Other|1
6996750|NCT01355289|11059898|FG004|Core Study|Other|0
6996751|NCT01355289|11059894|FG000|Open Label Extension|Adverse Event, Non-Fatal|0
6996752|NCT01355289|11059895|FG001|Open Label Extension|Adverse Event, Non-Fatal|0
6996753|NCT01355289|11059896|FG002|Open Label Extension|Adverse Event, Non-Fatal|0
6996754|NCT01355289|11059897|FG003|Open Label Extension|Adverse Event, Non-Fatal|0
6996755|NCT01355289|11059898|FG004|Open Label Extension|Adverse Event, Non-Fatal|1
6996756|NCT01355289|11059894|FG000|Open Label Extension|Lost to Follow-up|0
6996757|NCT01355289|11059895|FG001|Open Label Extension|Lost to Follow-up|0
6996758|NCT01355289|11059896|FG002|Open Label Extension|Lost to Follow-up|0
6996759|NCT01355289|11059897|FG003|Open Label Extension|Lost to Follow-up|0
6996760|NCT01355289|11059898|FG004|Open Label Extension|Lost to Follow-up|1
6996761|NCT01355289|11059894|FG000|Open Label Extension|Inadequate Therapeutic Effect|0
6996762|NCT01355289|11059895|FG001|Open Label Extension|Inadequate Therapeutic Effect|0
6996763|NCT01355289|11059896|FG002|Open Label Extension|Inadequate Therapeutic Effect|0
6996764|NCT01355289|11059897|FG003|Open Label Extension|Inadequate Therapeutic Effect|0
6996765|NCT01355289|11059898|FG004|Open Label Extension|Inadequate Therapeutic Effect|29
6996766|NCT01355289|11059894|FG000|Open Label Extension|Other|0
6996767|NCT01355289|11059895|FG001|Open Label Extension|Other|0
6996768|NCT01355289|11059896|FG002|Open Label Extension|Other|0
6996769|NCT01355289|11059897|FG003|Open Label Extension|Other|0
6996770|NCT01355289|11059898|FG004|Open Label Extension|Other|3
6996771|NCT01355302|11059911|FG000|Phase 1b|Death|4
6996772|NCT01355302|11059912|FG001|Phase 1b|Death|0
6996773|NCT01355302|11059913|FG002|Phase 1b|Death|0
6996774|NCT01355302|11059911|FG000|Phase 1b|Study terminated by sponsor|2
6996775|NCT01355302|11059912|FG001|Phase 1b|Study terminated by sponsor|0
6996776|NCT01355302|11059913|FG002|Phase 1b|Study terminated by sponsor|0
6996777|NCT01355497|11059954|FG000|Overall Study|Death|19
6996778|NCT01355497|11059955|FG001|Overall Study|Death|18
6996779|NCT01355497|11059954|FG000|Overall Study|Lost to Follow-up|3
6996780|NCT01355497|11059955|FG001|Overall Study|Lost to Follow-up|0
6996781|NCT01355497|11059954|FG000|Overall Study|Protocol Violation|0
6996782|NCT01355497|11059955|FG001|Overall Study|Protocol Violation|1
6996783|NCT01355497|11059954|FG000|Overall Study|other-not provided|9
6996784|NCT01355497|11059955|FG001|Overall Study|other-not provided|4
6996785|NCT01355497|11059954|FG000|Overall Study|Withdrawal by Subject|12
6996786|NCT01355497|11059955|FG001|Overall Study|Withdrawal by Subject|20
6996787|NCT01355497|11059954|FG000|Overall Study|noncompliance|1
6996788|NCT01355497|11059955|FG001|Overall Study|noncompliance|2
6996789|NCT01355497|11059954|FG000|Overall Study|progressive disease|11
6996790|NCT01355497|11059955|FG001|Overall Study|progressive disease|8
6996791|NCT01355497|11059954|FG000|Overall Study|Adverse Event|11
6996792|NCT01355497|11059955|FG001|Overall Study|Adverse Event|10
6996793|NCT01355523|11059963|FG000|Overall Study|Withdrawal by Subject|1
6996794|NCT01355523|11059964|FG001|Overall Study|Withdrawal by Subject|4
6996795|NCT01355523|11059963|FG000|Overall Study|Lost to Follow-up|0
6996796|NCT01355523|11059964|FG001|Overall Study|Lost to Follow-up|2
6996797|NCT01355523|11059963|FG000|Overall Study|Protocol Violation|0
6996798|NCT01355523|11059964|FG001|Overall Study|Protocol Violation|2
6996799|NCT01355523|11059963|FG000|Overall Study|Adverse Event|0
6996800|NCT01355523|11059964|FG001|Overall Study|Adverse Event|2
6996801|NCT01355575|11059970|FG000|Overall Study|Withdrawal by Subject|2
6996802|NCT01355627|11059997|FG000|Overall Study|Request By the Patient to Discontinue|5
6996803|NCT01355627|11059998|FG001|Overall Study|Request By the Patient to Discontinue|7
6996804|NCT01355627|11059997|FG000|Overall Study|Lost to Follow-up|8
6996805|NCT01355627|11059998|FG001|Overall Study|Lost to Follow-up|7
6996806|NCT01355627|11059997|FG000|Overall Study|Fatal Adverse Event|19
6996807|NCT01355627|11059998|FG001|Overall Study|Fatal Adverse Event|23
6996808|NCT01355627|11059997|FG000|Overall Study|Other|1
6996809|NCT01355627|11059998|FG001|Overall Study|Other|1
7042668|NCT01737697|11127210|FG002|Subacute Phase|Lost to Follow-up|0
7042669|NCT01737697|11127211|FG003|Subacute Phase|Lost to Follow-up|0
7042670|NCT01737697|11127212|FG004|Subacute Phase|Lost to Follow-up|0
7042671|NCT01737697|11127213|FG005|Subacute Phase|Lost to Follow-up|0
7042672|NCT01737697|11127214|FG006|Subacute Phase|Lost to Follow-up|0
7042673|NCT01737697|11127215|FG007|Subacute Phase|Lost to Follow-up|0
7042674|NCT01737697|11127216|FG008|Subacute Phase|Lost to Follow-up|0
7042675|NCT01737697|11127217|FG009|Subacute Phase|Lost to Follow-up|0
7042676|NCT01737697|11127218|FG010|Subacute Phase|Lost to Follow-up|0
7042677|NCT01737697|11127219|FG011|Subacute Phase|Lost to Follow-up|0
7042678|NCT01737697|11127220|FG012|Subacute Phase|Lost to Follow-up|0
7042679|NCT01737697|11127221|FG013|Subacute Phase|Lost to Follow-up|0
7042680|NCT01737697|11127222|FG014|Subacute Phase|Lost to Follow-up|1
7042681|NCT01737697|11127208|FG000|Subacute Phase|Hypo-or hyperkalemia|0
7042682|NCT01737697|11127209|FG001|Subacute Phase|Hypo-or hyperkalemia|0
7042683|NCT01737697|11127210|FG002|Subacute Phase|Hypo-or hyperkalemia|0
7042684|NCT01737697|11127211|FG003|Subacute Phase|Hypo-or hyperkalemia|0
7042685|NCT01737697|11127212|FG004|Subacute Phase|Hypo-or hyperkalemia|0
7042686|NCT01737697|11127213|FG005|Subacute Phase|Hypo-or hyperkalemia|0
7042687|NCT01737697|11127214|FG006|Subacute Phase|Hypo-or hyperkalemia|0
7042688|NCT01737697|11127215|FG007|Subacute Phase|Hypo-or hyperkalemia|0
7042689|NCT01737697|11127216|FG008|Subacute Phase|Hypo-or hyperkalemia|0
7042690|NCT01737697|11127217|FG009|Subacute Phase|Hypo-or hyperkalemia|0
7042691|NCT01737697|11127218|FG010|Subacute Phase|Hypo-or hyperkalemia|0
7042692|NCT01737697|11127219|FG011|Subacute Phase|Hypo-or hyperkalemia|1
7042693|NCT01737697|11127220|FG012|Subacute Phase|Hypo-or hyperkalemia|0
7042694|NCT01737697|11127221|FG013|Subacute Phase|Hypo-or hyperkalemia|1
7042695|NCT01737697|11127222|FG014|Subacute Phase|Hypo-or hyperkalemia|0
7042696|NCT01737697|11127208|FG000|Subacute Phase|Protocol Violation|0
7042697|NCT01737697|11127209|FG001|Subacute Phase|Protocol Violation|0
7042698|NCT01737697|11127210|FG002|Subacute Phase|Protocol Violation|0
7042699|NCT01737697|11127211|FG003|Subacute Phase|Protocol Violation|0
7042700|NCT01737697|11127212|FG004|Subacute Phase|Protocol Violation|0
7042701|NCT01737697|11127213|FG005|Subacute Phase|Protocol Violation|1
7042702|NCT01737697|11127214|FG006|Subacute Phase|Protocol Violation|0
7042703|NCT01737697|11127215|FG007|Subacute Phase|Protocol Violation|0
7042704|NCT01737697|11127216|FG008|Subacute Phase|Protocol Violation|0
7042705|NCT01737697|11127217|FG009|Subacute Phase|Protocol Violation|0
7042706|NCT01737697|11127218|FG010|Subacute Phase|Protocol Violation|1
7042707|NCT01737697|11127219|FG011|Subacute Phase|Protocol Violation|0
7042708|NCT01737697|11127220|FG012|Subacute Phase|Protocol Violation|0
7042709|NCT01737697|11127221|FG013|Subacute Phase|Protocol Violation|0
7042710|NCT01737697|11127222|FG014|Subacute Phase|Protocol Violation|0
7042711|NCT01737697|11127208|FG000|Subacute Phase|Physician Decision|0
7042712|NCT01737697|11127209|FG001|Subacute Phase|Physician Decision|0
7042713|NCT01737697|11127210|FG002|Subacute Phase|Physician Decision|0
7042714|NCT01737697|11127211|FG003|Subacute Phase|Physician Decision|0
7042715|NCT01737697|11127212|FG004|Subacute Phase|Physician Decision|0
7042716|NCT01737697|11127213|FG005|Subacute Phase|Physician Decision|0
7042717|NCT01737697|11127214|FG006|Subacute Phase|Physician Decision|0
7042718|NCT01737697|11127215|FG007|Subacute Phase|Physician Decision|0
7042719|NCT01737697|11127216|FG008|Subacute Phase|Physician Decision|1
7042720|NCT01737697|11127217|FG009|Subacute Phase|Physician Decision|0
7042721|NCT01737697|11127218|FG010|Subacute Phase|Physician Decision|0
7042722|NCT01737697|11127219|FG011|Subacute Phase|Physician Decision|0
7042723|NCT01737697|11127220|FG012|Subacute Phase|Physician Decision|0
7042724|NCT01737697|11127221|FG013|Subacute Phase|Physician Decision|0
7042725|NCT01737697|11127222|FG014|Subacute Phase|Physician Decision|0
7042726|NCT01737697|11127208|FG000|Subacute Phase|Death|0
7042727|NCT01737697|11127209|FG001|Subacute Phase|Death|0
7042728|NCT01737697|11127210|FG002|Subacute Phase|Death|0
7042729|NCT01737697|11127211|FG003|Subacute Phase|Death|0
7042730|NCT01737697|11127212|FG004|Subacute Phase|Death|0
7042731|NCT01737697|11127213|FG005|Subacute Phase|Death|0
7042732|NCT01737697|11127214|FG006|Subacute Phase|Death|0
7042733|NCT01737697|11127215|FG007|Subacute Phase|Death|0
7042734|NCT01737697|11127216|FG008|Subacute Phase|Death|0
6996810|NCT01356407|11060042|FG000|Overall Study|Lost to Follow-up|2
6996811|NCT01356407|11060043|FG001|Overall Study|Lost to Follow-up|0
6996812|NCT01356407|11060042|FG000|Overall Study|Patient Withdrew Consent|2
6996813|NCT01356407|11060043|FG001|Overall Study|Patient Withdrew Consent|1
6996814|NCT01356407|11060042|FG000|Overall Study|Could not afford IMP administration|0
6996815|NCT01356407|11060043|FG001|Overall Study|Could not afford IMP administration|1
6996816|NCT01356407|11060042|FG000|Overall Study|Not complete Endoscopy|2
6996817|NCT01356407|11060043|FG001|Overall Study|Not complete Endoscopy|2
6996818|NCT01356589|11060080|FG000|Overall Study|Enrolled, but not treated|3
6996819|NCT01356589|11060080|FG000|Overall Study|Dose data not recorded|2
6996820|NCT01356602|11060087|FG000|Overall Study|Protocol Deviation|0
6996821|NCT01356602|11060088|FG001|Overall Study|Protocol Deviation|1
6996822|NCT01356602|11060089|FG002|Overall Study|Protocol Deviation|1
6996823|NCT01356602|11060087|FG000|Overall Study|Administrative Problems|1
6996824|NCT01356602|11060088|FG001|Overall Study|Administrative Problems|4
6996825|NCT01356602|11060089|FG002|Overall Study|Administrative Problems|5
6996826|NCT01356602|11060087|FG000|Overall Study|Lost to Follow-up|4
6996827|NCT01356602|11060088|FG001|Overall Study|Lost to Follow-up|5
6996828|NCT01356602|11060089|FG002|Overall Study|Lost to Follow-up|6
6996829|NCT01356602|11060087|FG000|Overall Study|Withdrawal by Subject|4
6996830|NCT01356602|11060088|FG001|Overall Study|Withdrawal by Subject|3
6996831|NCT01356602|11060089|FG002|Overall Study|Withdrawal by Subject|7
6996832|NCT01356602|11060087|FG000|Overall Study|Lack of Efficacy|0
6996833|NCT01356602|11060088|FG001|Overall Study|Lack of Efficacy|1
6996834|NCT01356602|11060089|FG002|Overall Study|Lack of Efficacy|4
6996835|NCT01356602|11060087|FG000|Overall Study|Adverse Event|0
6996836|NCT01356602|11060088|FG001|Overall Study|Adverse Event|1
6996837|NCT01356602|11060089|FG002|Overall Study|Adverse Event|1
6996838|NCT01356940|11060103|FG000|First Intervention (28 Days)|Adverse Event|1
6996839|NCT01356940|11060104|FG001|First Intervention (28 Days)|Adverse Event|0
6996840|NCT01356940|11060103|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1
6996841|NCT01356940|11060104|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0
6996842|NCT01356966|11060114|FG000|Overall Study|Withdrawal by Subject|1
6996843|NCT01356966|11060115|FG001|Overall Study|Withdrawal by Subject|2
6996844|NCT01356966|11060114|FG000|Overall Study|Physician Decision|1
6996845|NCT01356966|11060115|FG001|Overall Study|Physician Decision|0
6996846|NCT01357161|11060141|FG000|Part 1 (Open Label Run-in)|Death|5
6996847|NCT01357161|11060142|FG001|Part 1 (Open Label Run-in)|Death|0
6996848|NCT01357161|11060143|FG002|Part 1 (Open Label Run-in)|Death|0
6996849|NCT01357161|11060141|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3
6996850|NCT01357161|11060142|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0
6996851|NCT01357161|11060143|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0
6996852|NCT01357161|11060141|FG000|Part 1 (Open Label Run-in)|Physician Decision|1
6996853|NCT01357161|11060142|FG001|Part 1 (Open Label Run-in)|Physician Decision|0
6996854|NCT01357161|11060143|FG002|Part 1 (Open Label Run-in)|Physician Decision|0
6996855|NCT01357161|11060141|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5
6996856|NCT01357161|11060142|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
6996857|NCT01357161|11060143|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
6996858|NCT01357161|11060141|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1
6996859|NCT01357161|11060142|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
6996860|NCT01357161|11060143|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
6996861|NCT01357161|11060141|FG000|Part 2 (Double-Blind Comparison)|Death|0
6996862|NCT01357161|11060142|FG001|Part 2 (Double-Blind Comparison)|Death|22
6996863|NCT01357161|11060143|FG002|Part 2 (Double-Blind Comparison)|Death|19
6996864|NCT01357161|11060141|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0
6996865|NCT01357161|11060142|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1
6996866|NCT01357161|11060143|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6
6996867|NCT01357161|11060141|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0
6996868|NCT01357161|11060142|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1
6996869|NCT01357161|11060143|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4
6996870|NCT01357161|11060141|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0
6996871|NCT01357161|11060142|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1
6996872|NCT01357161|11060143|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3
6996873|NCT01357161|11060141|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0
6996874|NCT01357161|11060142|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29
6996875|NCT01357161|11060143|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26
6996876|NCT01357161|11060141|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0
6996877|NCT01357161|11060142|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5
6996878|NCT01357161|11060143|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4
6996879|NCT01357239|11060155|FG000|Stratum: All Patients|Adverse Event|0
6996880|NCT01357239|11060156|FG001|Stratum: All Patients|Adverse Event|0
6996881|NCT01357239|11060157|FG002|Stratum: All Patients|Adverse Event|1
6996882|NCT01357239|11060158|FG003|Stratum: All Patients|Adverse Event|1
6996883|NCT01357239|11060155|FG000|Stratum: All Patients|Subject withdrew consent|0
6996884|NCT01357239|11060156|FG001|Stratum: All Patients|Subject withdrew consent|0
6996885|NCT01357239|11060157|FG002|Stratum: All Patients|Subject withdrew consent|1
6996886|NCT01357239|11060158|FG003|Stratum: All Patients|Subject withdrew consent|1
6996887|NCT01357239|11060155|FG000|Stratum I: Fully-Methylated|Adverse Event|0
6996888|NCT01357239|11060156|FG001|Stratum I: Fully-Methylated|Adverse Event|0
6996889|NCT01357239|11060157|FG002|Stratum I: Fully-Methylated|Adverse Event|1
6996890|NCT01357239|11060158|FG003|Stratum I: Fully-Methylated|Adverse Event|0
6996891|NCT01357239|11060155|FG000|Stratum II: Partially-Methylated|Adverse Event|0
6996892|NCT01357239|11060156|FG001|Stratum II: Partially-Methylated|Adverse Event|0
6996893|NCT01357239|11060157|FG002|Stratum II: Partially-Methylated|Adverse Event|0
6996894|NCT01357239|11060158|FG003|Stratum II: Partially-Methylated|Adverse Event|1
6996895|NCT01357239|11060155|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0
6996896|NCT01357239|11060156|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0
6996897|NCT01357239|11060157|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1
6996898|NCT01357239|11060158|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1
6996899|NCT01357551|11060205|FG000|Overall Study|Withdrawal by Subject|6
6996900|NCT01357551|11060206|FG001|Overall Study|Withdrawal by Subject|4
6996901|NCT01357551|11060205|FG000|Overall Study|Death|0
6996902|NCT01357551|11060206|FG001|Overall Study|Death|1
6996903|NCT01357551|11060205|FG000|Overall Study|Lost to Follow-up|16
6996904|NCT01357551|11060206|FG001|Overall Study|Lost to Follow-up|6
6996905|NCT01357577|11060228|FG000|Overall Study|Lost to Follow-up|20
6996906|NCT01357577|11060229|FG001|Overall Study|Lost to Follow-up|16
6996907|NCT01357577|11060228|FG000|Overall Study|Withdrawal by Subject|16
6996908|NCT01357577|11060229|FG001|Overall Study|Withdrawal by Subject|8
6996909|NCT01357577|11060228|FG000|Overall Study|look at data in database?|1
6996910|NCT01357577|11060229|FG001|Overall Study|look at data in database?|2
6996911|NCT01357616|11060238|FG000|Overall Study|Adverse Event|1
6996912|NCT01357616|11060239|FG001|Overall Study|Adverse Event|1
6996913|NCT01357616|11060238|FG000|Overall Study|Lost to Follow-up|4
6996914|NCT01357616|11060239|FG001|Overall Study|Lost to Follow-up|3
6996915|NCT01357616|11060238|FG000|Overall Study|Protocol Violation|0
6996916|NCT01357616|11060239|FG001|Overall Study|Protocol Violation|2
6996917|NCT01357616|11060238|FG000|Overall Study|Inadequate Control of IOP|1
6996918|NCT01357616|11060239|FG001|Overall Study|Inadequate Control of IOP|2
6996919|NCT01357616|11060238|FG000|Overall Study|Decision Unrelated to Adverse Event|3
6996920|NCT01357616|11060239|FG001|Overall Study|Decision Unrelated to Adverse Event|1
6996921|NCT01357616|11060238|FG000|Overall Study|Withdrawal by Subject|1
6996922|NCT01357616|11060239|FG001|Overall Study|Withdrawal by Subject|0
6996923|NCT01357655|11060247|FG000|Overall Study|Administrative Reason by Sponsor|45
6996924|NCT01357655|11060248|FG001|Overall Study|Administrative Reason by Sponsor|0
6996925|NCT01357655|11060247|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3
6996926|NCT01357655|11060248|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0
6996927|NCT01357655|11060247|FG000|Overall Study|Disease Progression|1
6996928|NCT01357655|11060248|FG001|Overall Study|Disease Progression|0
6996929|NCT01357655|11060247|FG000|Overall Study|Lost to Follow-up|2
6996930|NCT01357655|11060248|FG001|Overall Study|Lost to Follow-up|0
6996931|NCT01357655|11060247|FG000|Overall Study|Maximum Clinical Benefit|2
6996932|NCT01357655|11060248|FG001|Overall Study|Maximum Clinical Benefit|0
6996933|NCT01357655|11060247|FG000|Overall Study|Reason Unspecified|1
6996934|NCT01357655|11060248|FG001|Overall Study|Reason Unspecified|0
6996935|NCT01357655|11060247|FG000|Overall Study|Study Drug Toxicity|11
6996936|NCT01357655|11060248|FG001|Overall Study|Study Drug Toxicity|0
6996937|NCT01357655|11060247|FG000|Overall Study|Subject Withdrew Consent|1
6996938|NCT01357655|11060248|FG001|Overall Study|Subject Withdrew Consent|0
6996939|NCT01357850|11060266|FG000|Overall Study|Lost to Follow-up|1
6996940|NCT01357850|11060267|FG001|Overall Study|Lost to Follow-up|0
6996941|NCT01357850|11060268|FG002|Overall Study|Lost to Follow-up|0
6996942|NCT01357850|11060269|FG003|Overall Study|Lost to Follow-up|0
6996943|NCT01357889|11060282|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2
6996944|NCT01357889|11060283|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1
6996945|NCT01357889|11060282|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
6996946|NCT01357889|11060283|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
6996947|NCT01357889|11060282|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1
6996948|NCT01357889|11060283|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0
6996949|NCT01357889|11060282|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
6996950|NCT01357889|11060283|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
6996951|NCT01357889|11060282|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0
6996952|NCT01357889|11060283|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2
6996953|NCT01357889|11060282|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0
6996954|NCT01357889|11060283|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2
6996955|NCT01357889|11060282|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5
6996956|NCT01357889|11060283|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2
6996957|NCT01357889|11060282|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2
6996958|NCT01357889|11060283|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1
6996959|NCT01357889|11060282|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
6996960|NCT01357889|11060283|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
6996961|NCT01357889|11060282|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1
6996962|NCT01357889|11060283|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0
6996963|NCT01357889|11060282|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0
6996964|NCT01357889|11060283|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4
6996965|NCT01357889|11060282|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1
6996966|NCT01357889|11060283|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0
6996967|NCT01357889|11060282|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1
6996968|NCT01357889|11060283|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0
6996969|NCT01357915|11060293|FG000|Overall Study|Lost to Follow-up|3
6996970|NCT01357915|11060294|FG001|Overall Study|Lost to Follow-up|0
6996971|NCT01357980|11060304|FG000|Overall Study|Lack of Efficacy|0
6996972|NCT01357980|11060305|FG001|Overall Study|Lack of Efficacy|1
6996973|NCT01357980|11060306|FG002|Overall Study|Lack of Efficacy|0
6996974|NCT01357980|11060307|FG003|Overall Study|Lack of Efficacy|0
6996975|NCT01357980|11060304|FG000|Overall Study|Consent withdrawn|0
6996976|NCT01357980|11060305|FG001|Overall Study|Consent withdrawn|0
6996977|NCT01357980|11060306|FG002|Overall Study|Consent withdrawn|1
6996978|NCT01357980|11060307|FG003|Overall Study|Consent withdrawn|0
6996979|NCT01358175|11060320|FG000|Overall Study|Death|1
6996980|NCT01358175|11060321|FG001|Overall Study|Death|0
6996981|NCT01358175|11060322|FG002|Overall Study|Death|1
6996982|NCT01358175|11060320|FG000|Overall Study|Withdrawal by Subject|9
6996983|NCT01358175|11060321|FG001|Overall Study|Withdrawal by Subject|5
6996984|NCT01358175|11060322|FG002|Overall Study|Withdrawal by Subject|10
6996985|NCT01358175|11060320|FG000|Overall Study|Technical issues|0
6996986|NCT01358175|11060321|FG001|Overall Study|Technical issues|1
6996987|NCT01358175|11060322|FG002|Overall Study|Technical issues|0
6996988|NCT01358175|11060320|FG000|Overall Study|Pregnancy|0
6996989|NCT01358175|11060321|FG001|Overall Study|Pregnancy|1
6996990|NCT01358175|11060322|FG002|Overall Study|Pregnancy|0
6996991|NCT01358175|11060320|FG000|Overall Study|Physician Decision|1
6996992|NCT01358175|11060321|FG001|Overall Study|Physician Decision|0
6996993|NCT01358175|11060322|FG002|Overall Study|Physician Decision|0
6996994|NCT01358175|11060320|FG000|Overall Study|Non Compliance with Study Treatment|0
6996995|NCT01358175|11060321|FG001|Overall Study|Non Compliance with Study Treatment|1
6996996|NCT01358175|11060322|FG002|Overall Study|Non Compliance with Study Treatment|1
6996997|NCT01358175|11060320|FG000|Overall Study|Lost to Follow-up|1
6996998|NCT01358175|11060321|FG001|Overall Study|Lost to Follow-up|1
6996999|NCT01358175|11060322|FG002|Overall Study|Lost to Follow-up|3
6997000|NCT01358175|11060320|FG000|Overall Study|Lack of Efficacy|3
6997001|NCT01358175|11060321|FG001|Overall Study|Lack of Efficacy|8
6997002|NCT01358175|11060322|FG002|Overall Study|Lack of Efficacy|6
6997003|NCT01358175|11060320|FG000|Overall Study|Adverse Event|6
6997004|NCT01358175|11060321|FG001|Overall Study|Adverse Event|11
6997005|NCT01358175|11060322|FG002|Overall Study|Adverse Event|11
6997006|NCT01358331|11060354|FG000|Overall Study|Lost to Follow-up|0
6997007|NCT01358331|11060355|FG001|Overall Study|Lost to Follow-up|0
6997008|NCT01358331|11060356|FG002|Overall Study|Lost to Follow-up|0
6997009|NCT01358331|11060357|FG003|Overall Study|Lost to Follow-up|1
6997010|NCT01358331|11060358|FG004|Overall Study|Lost to Follow-up|0
6997011|NCT01358331|11060359|FG005|Overall Study|Lost to Follow-up|0
6997012|NCT01358331|11060354|FG000|Overall Study|Withdrawal by Subject|0
6997013|NCT01358331|11060355|FG001|Overall Study|Withdrawal by Subject|0
6997014|NCT01358331|11060356|FG002|Overall Study|Withdrawal by Subject|0
6997015|NCT01358331|11060357|FG003|Overall Study|Withdrawal by Subject|1
6997016|NCT01358331|11060358|FG004|Overall Study|Withdrawal by Subject|1
6997017|NCT01358331|11060359|FG005|Overall Study|Withdrawal by Subject|1
6997018|NCT01358331|11060354|FG000|Overall Study|Adverse Events|1
6997019|NCT01358331|11060355|FG001|Overall Study|Adverse Events|1
6997020|NCT01358331|11060356|FG002|Overall Study|Adverse Events|1
6997021|NCT01358331|11060357|FG003|Overall Study|Adverse Events|0
6997022|NCT01358331|11060358|FG004|Overall Study|Adverse Events|1
6997023|NCT01358331|11060359|FG005|Overall Study|Adverse Events|5
6997024|NCT01358331|11060354|FG000|Overall Study|Symptomatic Deterioration|0
6997025|NCT01358331|11060355|FG001|Overall Study|Symptomatic Deterioration|0
6997026|NCT01358331|11060356|FG002|Overall Study|Symptomatic Deterioration|0
6997027|NCT01358331|11060357|FG003|Overall Study|Symptomatic Deterioration|0
6997028|NCT01358331|11060358|FG004|Overall Study|Symptomatic Deterioration|1
6997029|NCT01358331|11060359|FG005|Overall Study|Symptomatic Deterioration|0
6997030|NCT01358331|11060354|FG000|Overall Study|Participants did not wish to continue|0
6997031|NCT01358331|11060355|FG001|Overall Study|Participants did not wish to continue|0
6997032|NCT01358331|11060356|FG002|Overall Study|Participants did not wish to continue|0
6997033|NCT01358331|11060357|FG003|Overall Study|Participants did not wish to continue|0
6997034|NCT01358331|11060358|FG004|Overall Study|Participants did not wish to continue|1
6997035|NCT01358331|11060359|FG005|Overall Study|Participants did not wish to continue|0
6997036|NCT01358331|11060354|FG000|Overall Study|Progress of disease under investigation|1
6997037|NCT01358331|11060355|FG001|Overall Study|Progress of disease under investigation|2
6997038|NCT01358331|11060356|FG002|Overall Study|Progress of disease under investigation|3
6997039|NCT01358331|11060357|FG003|Overall Study|Progress of disease under investigation|1
6997040|NCT01358331|11060358|FG004|Overall Study|Progress of disease under investigation|3
6997041|NCT01358331|11060359|FG005|Overall Study|Progress of disease under investigation|0
6997042|NCT01358357|11060375|FG000|Open Label Phase|Adverse Event|0
6997043|NCT01358357|11060376|FG001|Open Label Phase|Adverse Event|0
6997044|NCT01358357|11060377|FG002|Open Label Phase|Adverse Event|59
6997045|NCT01358357|11060375|FG000|Open Label Phase|Lack of Efficacy|0
6997046|NCT01358357|11060376|FG001|Open Label Phase|Lack of Efficacy|0
6997047|NCT01358357|11060377|FG002|Open Label Phase|Lack of Efficacy|107
6997048|NCT01358357|11060375|FG000|Open Label Phase|Lost to Follow-up|0
6997049|NCT01358357|11060376|FG001|Open Label Phase|Lost to Follow-up|0
6997050|NCT01358357|11060377|FG002|Open Label Phase|Lost to Follow-up|76
6997051|NCT01358357|11060375|FG000|Open Label Phase|Protocol Violation|0
6997052|NCT01358357|11060376|FG001|Open Label Phase|Protocol Violation|0
6997053|NCT01358357|11060377|FG002|Open Label Phase|Protocol Violation|45
6997054|NCT01358357|11060375|FG000|Open Label Phase|Withdrawal by Subject|0
6997055|NCT01358357|11060376|FG001|Open Label Phase|Withdrawal by Subject|0
6997056|NCT01358357|11060377|FG002|Open Label Phase|Withdrawal by Subject|112
6997057|NCT01358357|11060375|FG000|Open Label Phase|Did not meet criteria for DB phase|0
6997058|NCT01358357|11060376|FG001|Open Label Phase|Did not meet criteria for DB phase|0
6997059|NCT01358357|11060377|FG002|Open Label Phase|Did not meet criteria for DB phase|16
6997060|NCT01358357|11060375|FG000|Open Label Phase|Terminated at study completion|0
6997061|NCT01358357|11060376|FG001|Open Label Phase|Terminated at study completion|0
6997062|NCT01358357|11060377|FG002|Open Label Phase|Terminated at study completion|5
6997063|NCT01358357|11060375|FG000|Open Label Phase|Mood episode|0
6997064|NCT01358357|11060376|FG001|Open Label Phase|Mood episode|0
6997065|NCT01358357|11060377|FG002|Open Label Phase|Mood episode|42
6997066|NCT01358357|11060375|FG000|Double-Blind Phase|Adverse Event|8
6997067|NCT01358357|11060376|FG001|Double-Blind Phase|Adverse Event|5
6997068|NCT01358357|11060377|FG002|Double-Blind Phase|Adverse Event|0
6997069|NCT01358357|11060375|FG000|Double-Blind Phase|Lost to Follow-up|5
6997070|NCT01358357|11060376|FG001|Double-Blind Phase|Lost to Follow-up|7
6997071|NCT01358357|11060377|FG002|Double-Blind Phase|Lost to Follow-up|0
6997072|NCT01358357|11060375|FG000|Double-Blind Phase|Protocol Violation|1
6997073|NCT01358357|11060376|FG001|Double-Blind Phase|Protocol Violation|11
6997074|NCT01358357|11060377|FG002|Double-Blind Phase|Protocol Violation|0
6997075|NCT01358357|11060375|FG000|Double-Blind Phase|Protocol Violation|16
6997076|NCT01358357|11060376|FG001|Double-Blind Phase|Protocol Violation|12
6997077|NCT01358357|11060377|FG002|Double-Blind Phase|Protocol Violation|0
6997078|NCT01358357|11060375|FG000|Double-Blind Phase|Terminated at study completion|2
6997079|NCT01358357|11060376|FG001|Double-Blind Phase|Terminated at study completion|0
6997080|NCT01358357|11060377|FG002|Double-Blind Phase|Terminated at study completion|0
6997081|NCT01358357|11060375|FG000|Double-Blind Phase|Recurrence of mood event|48
6997082|NCT01358357|11060376|FG001|Double-Blind Phase|Recurrence of mood event|64
6997083|NCT01358357|11060377|FG002|Double-Blind Phase|Recurrence of mood event|0
6997084|NCT01358357|11060375|FG000|Double-Blind Phase|Administrative|0
6997085|NCT01358357|11060376|FG001|Double-Blind Phase|Administrative|1
6997086|NCT01358357|11060377|FG002|Double-Blind Phase|Administrative|0
6997087|NCT01358526|11060386|FG000|Open-label Titration Period|Adverse Event|95
6997088|NCT01358526|11060387|FG001|Open-label Titration Period|Adverse Event|0
6997089|NCT01358526|11060388|FG002|Open-label Titration Period|Adverse Event|0
6997090|NCT01358526|11060386|FG000|Open-label Titration Period|Withdrawal by Subject|65
6997091|NCT01358526|11060387|FG001|Open-label Titration Period|Withdrawal by Subject|0
6997092|NCT01358526|11060388|FG002|Open-label Titration Period|Withdrawal by Subject|0
6997093|NCT01358526|11060386|FG000|Open-label Titration Period|Lost to Follow-up|25
6997094|NCT01358526|11060387|FG001|Open-label Titration Period|Lost to Follow-up|0
6997095|NCT01358526|11060388|FG002|Open-label Titration Period|Lost to Follow-up|0
6997096|NCT01358526|11060386|FG000|Open-label Titration Period|Lack of Efficacy|107
6997097|NCT01358526|11060387|FG001|Open-label Titration Period|Lack of Efficacy|0
6997098|NCT01358526|11060388|FG002|Open-label Titration Period|Lack of Efficacy|0
6997099|NCT01358526|11060386|FG000|Open-label Titration Period|Confirmed or suspected diversion|16
6997100|NCT01358526|11060387|FG001|Open-label Titration Period|Confirmed or suspected diversion|0
6997101|NCT01358526|11060388|FG002|Open-label Titration Period|Confirmed or suspected diversion|0
6997102|NCT01358526|11060386|FG000|Open-label Titration Period|Administrative|8
6997103|NCT01358526|11060387|FG001|Open-label Titration Period|Administrative|0
6997104|NCT01358526|11060388|FG002|Open-label Titration Period|Administrative|0
6997105|NCT01358526|11060386|FG000|Open-label Titration Period|Did not qualify|178
6997106|NCT01358526|11060387|FG001|Open-label Titration Period|Did not qualify|0
6997107|NCT01358526|11060388|FG002|Open-label Titration Period|Did not qualify|0
6997108|NCT01358526|11060386|FG000|Double-blind Phase|Adverse Event|0
6997109|NCT01358526|11060387|FG001|Double-blind Phase|Adverse Event|24
6997110|NCT01358526|11060388|FG002|Double-blind Phase|Adverse Event|23
6997111|NCT01358526|11060386|FG000|Double-blind Phase|Withdrawal by Subject|0
6997112|NCT01358526|11060387|FG001|Double-blind Phase|Withdrawal by Subject|10
6997113|NCT01358526|11060388|FG002|Double-blind Phase|Withdrawal by Subject|8
6997114|NCT01358526|11060386|FG000|Double-blind Phase|Lost to Follow-up|0
6997115|NCT01358526|11060387|FG001|Double-blind Phase|Lost to Follow-up|4
6997116|NCT01358526|11060388|FG002|Double-blind Phase|Lost to Follow-up|1
6997117|NCT01358526|11060386|FG000|Double-blind Phase|Lack of Efficacy|0
6997118|NCT01358526|11060387|FG001|Double-blind Phase|Lack of Efficacy|31
6997119|NCT01358526|11060388|FG002|Double-blind Phase|Lack of Efficacy|73
6997120|NCT01358526|11060386|FG000|Double-blind Phase|Confirmed or suspected diversion|0
6997121|NCT01358526|11060387|FG001|Double-blind Phase|Confirmed or suspected diversion|5
6997122|NCT01358526|11060388|FG002|Double-blind Phase|Confirmed or suspected diversion|6
6997123|NCT01358526|11060386|FG000|Double-blind Phase|Administrative|0
6997124|NCT01358526|11060387|FG001|Double-blind Phase|Administrative|6
6997125|NCT01358526|11060388|FG002|Double-blind Phase|Administrative|10
6997126|NCT01358578|11060399|FG000|Induction Period|Adverse Event|2
6997127|NCT01358578|11060400|FG001|Induction Period|Adverse Event|4
6997128|NCT01358578|11060401|FG002|Induction Period|Adverse Event|2
6997129|NCT01358578|11060402|FG003|Induction Period|Adverse Event|6
6997130|NCT01358578|11060403|FG004|Induction Period|Adverse Event|0
6997131|NCT01358578|11060404|FG005|Induction Period|Adverse Event|0
6997132|NCT01358578|11060399|FG000|Induction Period|Lack of Efficacy|0
6997133|NCT01358578|11060400|FG001|Induction Period|Lack of Efficacy|0
6997134|NCT01358578|11060401|FG002|Induction Period|Lack of Efficacy|9
6997135|NCT01358578|11060402|FG003|Induction Period|Lack of Efficacy|1
6997136|NCT01358578|11060403|FG004|Induction Period|Lack of Efficacy|0
6997137|NCT01358578|11060404|FG005|Induction Period|Lack of Efficacy|0
6997138|NCT01358578|11060399|FG000|Induction Period|Lost to Follow-up|0
6997139|NCT01358578|11060400|FG001|Induction Period|Lost to Follow-up|0
6997140|NCT01358578|11060401|FG002|Induction Period|Lost to Follow-up|1
6997141|NCT01358578|11060402|FG003|Induction Period|Lost to Follow-up|4
6997142|NCT01358578|11060403|FG004|Induction Period|Lost to Follow-up|0
6997143|NCT01358578|11060404|FG005|Induction Period|Lost to Follow-up|0
6997144|NCT01358578|11060399|FG000|Induction Period|Physician Decision|2
6997145|NCT01358578|11060400|FG001|Induction Period|Physician Decision|1
6997146|NCT01358578|11060401|FG002|Induction Period|Physician Decision|2
6997147|NCT01358578|11060402|FG003|Induction Period|Physician Decision|0
6997148|NCT01358578|11060403|FG004|Induction Period|Physician Decision|0
6997149|NCT01358578|11060404|FG005|Induction Period|Physician Decision|0
6997150|NCT01358578|11060399|FG000|Induction Period|Protocol Deviation|3
6997151|NCT01358578|11060400|FG001|Induction Period|Protocol Deviation|5
6997152|NCT01358578|11060401|FG002|Induction Period|Protocol Deviation|0
6997153|NCT01358578|11060402|FG003|Induction Period|Protocol Deviation|3
6997154|NCT01358578|11060403|FG004|Induction Period|Protocol Deviation|0
6997155|NCT01358578|11060404|FG005|Induction Period|Protocol Deviation|0
6997156|NCT01358578|11060399|FG000|Induction Period|technical problems|0
6997157|NCT01358578|11060400|FG001|Induction Period|technical problems|0
6997158|NCT01358578|11060401|FG002|Induction Period|technical problems|1
6997159|NCT01358578|11060402|FG003|Induction Period|technical problems|1
6997160|NCT01358578|11060403|FG004|Induction Period|technical problems|0
6997161|NCT01358578|11060404|FG005|Induction Period|technical problems|0
6997162|NCT01358578|11060399|FG000|Induction Period|Withdrawal by Subject|5
6997163|NCT01358578|11060400|FG001|Induction Period|Withdrawal by Subject|5
6997164|NCT01358578|11060401|FG002|Induction Period|Withdrawal by Subject|10
6997165|NCT01358578|11060402|FG003|Induction Period|Withdrawal by Subject|6
6997166|NCT01358578|11060403|FG004|Induction Period|Withdrawal by Subject|0
6997167|NCT01358578|11060404|FG005|Induction Period|Withdrawal by Subject|0
6997168|NCT01358578|11060399|FG000|Maintenance Period|Adverse Event|2
6997169|NCT01358578|11060400|FG001|Maintenance Period|Adverse Event|7
6997170|NCT01358578|11060401|FG002|Maintenance Period|Adverse Event|0
6997171|NCT01358578|11060402|FG003|Maintenance Period|Adverse Event|6
6997172|NCT01358578|11060403|FG004|Maintenance Period|Adverse Event|4
6997173|NCT01358578|11060404|FG005|Maintenance Period|Adverse Event|3
6997174|NCT01358578|11060399|FG000|Maintenance Period|Lack of Efficacy|10
6997175|NCT01358578|11060400|FG001|Maintenance Period|Lack of Efficacy|2
6997176|NCT01358578|11060401|FG002|Maintenance Period|Lack of Efficacy|0
6997177|NCT01358578|11060402|FG003|Maintenance Period|Lack of Efficacy|11
6997178|NCT01358578|11060403|FG004|Maintenance Period|Lack of Efficacy|3
6997179|NCT01358578|11060404|FG005|Maintenance Period|Lack of Efficacy|0
6997180|NCT01358578|11060399|FG000|Maintenance Period|Lost to Follow-up|4
6997181|NCT01358578|11060400|FG001|Maintenance Period|Lost to Follow-up|0
6997182|NCT01358578|11060401|FG002|Maintenance Period|Lost to Follow-up|0
6997183|NCT01358578|11060402|FG003|Maintenance Period|Lost to Follow-up|5
6997184|NCT01358578|11060403|FG004|Maintenance Period|Lost to Follow-up|1
6997185|NCT01358578|11060404|FG005|Maintenance Period|Lost to Follow-up|1
6997186|NCT01358578|11060399|FG000|Maintenance Period|Non-compliance with study treatment|3
6997187|NCT01358578|11060400|FG001|Maintenance Period|Non-compliance with study treatment|1
6997188|NCT01358578|11060401|FG002|Maintenance Period|Non-compliance with study treatment|0
6997189|NCT01358578|11060402|FG003|Maintenance Period|Non-compliance with study treatment|2
6997190|NCT01358578|11060403|FG004|Maintenance Period|Non-compliance with study treatment|1
6997191|NCT01358578|11060404|FG005|Maintenance Period|Non-compliance with study treatment|2
6997192|NCT01358578|11060399|FG000|Maintenance Period|Physician Decision|0
6997193|NCT01358578|11060400|FG001|Maintenance Period|Physician Decision|1
6997194|NCT01358578|11060401|FG002|Maintenance Period|Physician Decision|0
6997195|NCT01358578|11060402|FG003|Maintenance Period|Physician Decision|1
6997196|NCT01358578|11060403|FG004|Maintenance Period|Physician Decision|0
6997197|NCT01358578|11060404|FG005|Maintenance Period|Physician Decision|0
6997198|NCT01358578|11060399|FG000|Maintenance Period|Pregnancy|1
6997199|NCT01358578|11060400|FG001|Maintenance Period|Pregnancy|0
6997200|NCT01358578|11060401|FG002|Maintenance Period|Pregnancy|0
6997201|NCT01358578|11060402|FG003|Maintenance Period|Pregnancy|0
6997202|NCT01358578|11060403|FG004|Maintenance Period|Pregnancy|0
6997203|NCT01358578|11060404|FG005|Maintenance Period|Pregnancy|0
6997204|NCT01358578|11060399|FG000|Maintenance Period|Protocol deviation|7
6997205|NCT01358578|11060400|FG001|Maintenance Period|Protocol deviation|4
6997206|NCT01358578|11060401|FG002|Maintenance Period|Protocol deviation|0
6997207|NCT01358578|11060402|FG003|Maintenance Period|Protocol deviation|2
6997208|NCT01358578|11060403|FG004|Maintenance Period|Protocol deviation|2
6997209|NCT01358578|11060404|FG005|Maintenance Period|Protocol deviation|2
6997210|NCT01358578|11060399|FG000|Maintenance Period|Withdrawal by Subject|12
6997211|NCT01358578|11060400|FG001|Maintenance Period|Withdrawal by Subject|7
6997212|NCT01358578|11060401|FG002|Maintenance Period|Withdrawal by Subject|2
6997213|NCT01358578|11060402|FG003|Maintenance Period|Withdrawal by Subject|15
6997214|NCT01358578|11060403|FG004|Maintenance Period|Withdrawal by Subject|6
6997215|NCT01358578|11060404|FG005|Maintenance Period|Withdrawal by Subject|3
6997216|NCT01358578|11060399|FG000|Follow-up Period|Adverse Event|1
6997217|NCT01358578|11060400|FG001|Follow-up Period|Adverse Event|1
6997218|NCT01358578|11060401|FG002|Follow-up Period|Adverse Event|0
6997219|NCT01358578|11060402|FG003|Follow-up Period|Adverse Event|0
6997220|NCT01358578|11060403|FG004|Follow-up Period|Adverse Event|0
6997221|NCT01358578|11060404|FG005|Follow-up Period|Adverse Event|0
6997222|NCT01358578|11060399|FG000|Follow-up Period|Lack of Efficacy|3
6997223|NCT01358578|11060400|FG001|Follow-up Period|Lack of Efficacy|0
6997224|NCT01358578|11060401|FG002|Follow-up Period|Lack of Efficacy|4
6997225|NCT01358578|11060402|FG003|Follow-up Period|Lack of Efficacy|1
6997226|NCT01358578|11060403|FG004|Follow-up Period|Lack of Efficacy|0
6997227|NCT01358578|11060404|FG005|Follow-up Period|Lack of Efficacy|0
6997228|NCT01358578|11060399|FG000|Follow-up Period|Lost to Follow-up|0
6997229|NCT01358578|11060400|FG001|Follow-up Period|Lost to Follow-up|1
6997230|NCT01358578|11060401|FG002|Follow-up Period|Lost to Follow-up|0
6997231|NCT01358578|11060402|FG003|Follow-up Period|Lost to Follow-up|4
6997232|NCT01358578|11060403|FG004|Follow-up Period|Lost to Follow-up|0
6997233|NCT01358578|11060404|FG005|Follow-up Period|Lost to Follow-up|0
6997234|NCT01358578|11060399|FG000|Follow-up Period|non- compliance with study treatment|1
6997235|NCT01358578|11060400|FG001|Follow-up Period|non- compliance with study treatment|0
6997236|NCT01358578|11060401|FG002|Follow-up Period|non- compliance with study treatment|0
6997237|NCT01358578|11060402|FG003|Follow-up Period|non- compliance with study treatment|0
6997238|NCT01358578|11060403|FG004|Follow-up Period|non- compliance with study treatment|0
6997239|NCT01358578|11060404|FG005|Follow-up Period|non- compliance with study treatment|0
6997240|NCT01358578|11060399|FG000|Follow-up Period|Pregnancy|1
6997241|NCT01358578|11060400|FG001|Follow-up Period|Pregnancy|0
6997242|NCT01358578|11060401|FG002|Follow-up Period|Pregnancy|0
6997243|NCT01358578|11060402|FG003|Follow-up Period|Pregnancy|0
6997244|NCT01358578|11060403|FG004|Follow-up Period|Pregnancy|0
6997245|NCT01358578|11060404|FG005|Follow-up Period|Pregnancy|0
6997246|NCT01358578|11060399|FG000|Follow-up Period|Withdrawal by Subject|3
6997247|NCT01358578|11060400|FG001|Follow-up Period|Withdrawal by Subject|3
6997248|NCT01358578|11060401|FG002|Follow-up Period|Withdrawal by Subject|1
6997249|NCT01358578|11060402|FG003|Follow-up Period|Withdrawal by Subject|12
6997250|NCT01358578|11060403|FG004|Follow-up Period|Withdrawal by Subject|0
6997251|NCT01358578|11060404|FG005|Follow-up Period|Withdrawal by Subject|0
6997252|NCT01358578|11060399|FG000|Follow-up Period|Physician Decision|1
6997253|NCT01358578|11060400|FG001|Follow-up Period|Physician Decision|1
6997254|NCT01358578|11060401|FG002|Follow-up Period|Physician Decision|0
6997255|NCT01358578|11060402|FG003|Follow-up Period|Physician Decision|2
6997256|NCT01358578|11060403|FG004|Follow-up Period|Physician Decision|0
6997257|NCT01358578|11060404|FG005|Follow-up Period|Physician Decision|0
6997258|NCT01358708|11060434|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2
6997259|NCT01358708|11060435|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0
6997260|NCT01358708|11060434|FG000|Double-Blind Treatment Phase|Protocol Violation|1
6997261|NCT01358708|11060435|FG001|Double-Blind Treatment Phase|Protocol Violation|0
6997262|NCT01358721|11060449|FG000|Overall Study|Withdrawal by Subject|0
6997263|NCT01358721|11060450|FG001|Overall Study|Withdrawal by Subject|0
6997264|NCT01358721|11060451|FG002|Overall Study|Withdrawal by Subject|0
6997265|NCT01358721|11060452|FG003|Overall Study|Withdrawal by Subject|1
6997266|NCT01358721|11060449|FG000|Overall Study|Death|0
6997267|NCT01358721|11060450|FG001|Overall Study|Death|2
6997268|NCT01358721|11060451|FG002|Overall Study|Death|0
6997269|NCT01358721|11060452|FG003|Overall Study|Death|0
6997270|NCT01358721|11060449|FG000|Overall Study|Study Drug Toxicity|1
6997271|NCT01358721|11060450|FG001|Overall Study|Study Drug Toxicity|3
6997272|NCT01358721|11060451|FG002|Overall Study|Study Drug Toxicity|4
6997273|NCT01358721|11060452|FG003|Overall Study|Study Drug Toxicity|5
6997274|NCT01358721|11060449|FG000|Overall Study|SUBJ request to discontinue study TRT|0
6997275|NCT01358721|11060450|FG001|Overall Study|SUBJ request to discontinue study TRT|0
6997276|NCT01358721|11060451|FG002|Overall Study|SUBJ request to discontinue study TRT|0
6997277|NCT01358721|11060452|FG003|Overall Study|SUBJ request to discontinue study TRT|1
6997278|NCT01358721|11060449|FG000|Overall Study|Subject No Longer Meets Study Criteria|0
6997279|NCT01358721|11060450|FG001|Overall Study|Subject No Longer Meets Study Criteria|2
6997280|NCT01358721|11060451|FG002|Overall Study|Subject No Longer Meets Study Criteria|0
6997281|NCT01358721|11060452|FG003|Overall Study|Subject No Longer Meets Study Criteria|1
6997282|NCT01358721|11060449|FG000|Overall Study|Adverse Event related to study drug|1
6997283|NCT01358721|11060450|FG001|Overall Study|Adverse Event related to study drug|0
6997284|NCT01358721|11060451|FG002|Overall Study|Adverse Event related to study drug|0
6997285|NCT01358721|11060452|FG003|Overall Study|Adverse Event related to study drug|1
6997286|NCT01358721|11060449|FG000|Overall Study|Disease Progression|19
6997287|NCT01358721|11060450|FG001|Overall Study|Disease Progression|15
6997288|NCT01358721|11060451|FG002|Overall Study|Disease Progression|17
6997289|NCT01358721|11060452|FG003|Overall Study|Disease Progression|15
6997290|NCT01358721|11060449|FG000|Overall Study|Out of State/Unmet Criteria|0
6997291|NCT01358721|11060450|FG001|Overall Study|Out of State/Unmet Criteria|0
6997292|NCT01358721|11060451|FG002|Overall Study|Out of State/Unmet Criteria|1
6997293|NCT01358721|11060452|FG003|Overall Study|Out of State/Unmet Criteria|0
6997294|NCT01358734|11060465|FG000|Overall Study|Adverse Event|4
6997295|NCT01358734|11060466|FG001|Overall Study|Adverse Event|7
6997296|NCT01358734|11060467|FG002|Overall Study|Adverse Event|3
6997297|NCT01358734|11060465|FG000|Overall Study|Lack of Efficacy|0
6997298|NCT01358734|11060466|FG001|Overall Study|Lack of Efficacy|1
6997299|NCT01358734|11060467|FG002|Overall Study|Lack of Efficacy|3
6997300|NCT01358734|11060465|FG000|Overall Study|Withdrawal by Subject|1
6997301|NCT01358734|11060466|FG001|Overall Study|Withdrawal by Subject|6
6997302|NCT01358734|11060467|FG002|Overall Study|Withdrawal by Subject|3
6997303|NCT01358734|11060465|FG000|Overall Study|Death|3
6997304|NCT01358734|11060466|FG001|Overall Study|Death|7
6997305|NCT01358734|11060467|FG002|Overall Study|Death|2
6997306|NCT01358734|11060465|FG000|Overall Study|Progressive Disease|5
6997307|NCT01358734|11060466|FG001|Overall Study|Progressive Disease|13
6997308|NCT01358734|11060467|FG002|Overall Study|Progressive Disease|16
6997309|NCT01358734|11060465|FG000|Overall Study|Non-compliance with study drug|0
6997310|NCT01358734|11060466|FG001|Overall Study|Non-compliance with study drug|0
6997311|NCT01358734|11060467|FG002|Overall Study|Non-compliance with study drug|1
6997312|NCT01358734|11060465|FG000|Overall Study|Other|2
6997313|NCT01358734|11060466|FG001|Overall Study|Other|5
6997314|NCT01358734|11060467|FG002|Overall Study|Other|4
6997315|NCT01358734|11060465|FG000|Overall Study|Protocol Violation|0
6997316|NCT01358734|11060466|FG001|Overall Study|Protocol Violation|0
6997317|NCT01358734|11060467|FG002|Overall Study|Protocol Violation|2
6997318|NCT01358760|11060478|FG000|Overall Study|Adverse Event|3
6997319|NCT01358760|11060479|FG001|Overall Study|Adverse Event|4
6997320|NCT01358760|11060480|FG002|Overall Study|Adverse Event|3
6997321|NCT01358760|11060478|FG000|Overall Study|Lost to Follow-up|1
6997322|NCT01358760|11060479|FG001|Overall Study|Lost to Follow-up|1
6997323|NCT01358760|11060480|FG002|Overall Study|Lost to Follow-up|3
6997324|NCT01358760|11060478|FG000|Overall Study|Withdrawal by Subject|5
6997325|NCT01358760|11060479|FG001|Overall Study|Withdrawal by Subject|3
6997326|NCT01358760|11060480|FG002|Overall Study|Withdrawal by Subject|2
6997327|NCT01358760|11060478|FG000|Overall Study|Physician Decision|1
6997328|NCT01358760|11060479|FG001|Overall Study|Physician Decision|0
6997329|NCT01358760|11060480|FG002|Overall Study|Physician Decision|1
6997330|NCT01358760|11060478|FG000|Overall Study|Entry criteria not met/Non-compliance|12
6997331|NCT01358760|11060479|FG001|Overall Study|Entry criteria not met/Non-compliance|12
6997332|NCT01358760|11060480|FG002|Overall Study|Entry criteria not met/Non-compliance|16
6997333|NCT01358825|11060490|FG000|Overall Study|Blood sample not drawn|0
6997334|NCT01358825|11060491|FG001|Overall Study|Blood sample not drawn|1
6997335|NCT01358864|11060505|FG000|Overall Study|Adverse Event|0
6997336|NCT01358864|11060506|FG001|Overall Study|Adverse Event|6
6997337|NCT01358864|11060507|FG002|Overall Study|Adverse Event|9
6997338|NCT01358864|11060508|FG003|Overall Study|Adverse Event|0
6997339|NCT01358864|11060509|FG004|Overall Study|Adverse Event|4
6997340|NCT01358864|11060510|FG005|Overall Study|Adverse Event|8
6997341|NCT01358864|11060511|FG006|Overall Study|Adverse Event|12
6997342|NCT01358864|11060512|FG007|Overall Study|Adverse Event|7
6997343|NCT01358864|11060505|FG000|Overall Study|Lack of Efficacy|26
6997344|NCT01358864|11060506|FG001|Overall Study|Lack of Efficacy|3
6997345|NCT01358864|11060507|FG002|Overall Study|Lack of Efficacy|4
6997346|NCT01358864|11060508|FG003|Overall Study|Lack of Efficacy|19
6997347|NCT01358864|11060509|FG004|Overall Study|Lack of Efficacy|7
6997348|NCT01358864|11060510|FG005|Overall Study|Lack of Efficacy|4
6997349|NCT01358864|11060511|FG006|Overall Study|Lack of Efficacy|49
6997350|NCT01358864|11060512|FG007|Overall Study|Lack of Efficacy|44
6997351|NCT01358864|11060505|FG000|Overall Study|Lost to Follow-up|0
6997352|NCT01358864|11060506|FG001|Overall Study|Lost to Follow-up|0
6997353|NCT01358864|11060507|FG002|Overall Study|Lost to Follow-up|1
6997354|NCT01358864|11060508|FG003|Overall Study|Lost to Follow-up|0
6997355|NCT01358864|11060509|FG004|Overall Study|Lost to Follow-up|0
6997356|NCT01358864|11060510|FG005|Overall Study|Lost to Follow-up|0
6997357|NCT01358864|11060511|FG006|Overall Study|Lost to Follow-up|0
6997358|NCT01358864|11060512|FG007|Overall Study|Lost to Follow-up|1
6997359|NCT01358864|11060505|FG000|Overall Study|Withdrawal by Subject|3
6997360|NCT01358864|11060506|FG001|Overall Study|Withdrawal by Subject|4
6997361|NCT01358864|11060507|FG002|Overall Study|Withdrawal by Subject|2
6997362|NCT01358864|11060508|FG003|Overall Study|Withdrawal by Subject|0
7143152|NCT03026283|11299468|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
6997363|NCT01358864|11060509|FG004|Overall Study|Withdrawal by Subject|0
6997364|NCT01358864|11060510|FG005|Overall Study|Withdrawal by Subject|1
6997365|NCT01358864|11060511|FG006|Overall Study|Withdrawal by Subject|1
6997366|NCT01358864|11060512|FG007|Overall Study|Withdrawal by Subject|3
6997367|NCT01358864|11060505|FG000|Overall Study|Other reason not defined above|2
6997368|NCT01358864|11060506|FG001|Overall Study|Other reason not defined above|0
6997369|NCT01358864|11060507|FG002|Overall Study|Other reason not defined above|0
6997370|NCT01358864|11060508|FG003|Overall Study|Other reason not defined above|0
7042735|NCT01737697|11127217|FG009|Subacute Phase|Death|0
6997371|NCT01358864|11060509|FG004|Overall Study|Other reason not defined above|0
6997372|NCT01358864|11060510|FG005|Overall Study|Other reason not defined above|0
6997373|NCT01358864|11060511|FG006|Overall Study|Other reason not defined above|2
6997374|NCT01358864|11060512|FG007|Overall Study|Other reason not defined above|0
6997375|NCT01358864|11060505|FG000|Overall Study|Not treated|0
6997376|NCT01358864|11060506|FG001|Overall Study|Not treated|0
6997377|NCT01358864|11060507|FG002|Overall Study|Not treated|0
6997378|NCT01358864|11060508|FG003|Overall Study|Not treated|0
6997379|NCT01358864|11060509|FG004|Overall Study|Not treated|0
6997380|NCT01358864|11060510|FG005|Overall Study|Not treated|0
6997381|NCT01358864|11060511|FG006|Overall Study|Not treated|1
6997382|NCT01358864|11060512|FG007|Overall Study|Not treated|0
6997383|NCT01358968|11060532|FG000|Period 2|Adverse Event|0
6997384|NCT01358968|11060533|FG001|Period 2|Adverse Event|1
6997385|NCT01358968|11060534|FG002|Period 2|Adverse Event|0
6997386|NCT01358968|11060535|FG003|Period 2|Adverse Event|0
6997387|NCT01358968|11060532|FG000|Continued Access Phase|Progression of Disease|0
6997388|NCT01358968|11060533|FG001|Continued Access Phase|Progression of Disease|0
6997389|NCT01358968|11060534|FG002|Continued Access Phase|Progression of Disease|8
6997390|NCT01358968|11060535|FG003|Continued Access Phase|Progression of Disease|4
6997391|NCT01358968|11060532|FG000|Continued Access Phase|Protocol Violation|0
6997392|NCT01358968|11060533|FG001|Continued Access Phase|Protocol Violation|0
6997393|NCT01358968|11060534|FG002|Continued Access Phase|Protocol Violation|0
6997394|NCT01358968|11060535|FG003|Continued Access Phase|Protocol Violation|2
6997395|NCT01358968|11060532|FG000|Continued Access Phase|Withdrawal by Subject|0
6997396|NCT01358968|11060533|FG001|Continued Access Phase|Withdrawal by Subject|0
6997397|NCT01358968|11060534|FG002|Continued Access Phase|Withdrawal by Subject|3
6997398|NCT01358968|11060535|FG003|Continued Access Phase|Withdrawal by Subject|0
6997399|NCT01358968|11060532|FG000|Continued Access Phase|Death|0
6997400|NCT01358968|11060533|FG001|Continued Access Phase|Death|0
6997401|NCT01358968|11060534|FG002|Continued Access Phase|Death|1
6997402|NCT01358968|11060535|FG003|Continued Access Phase|Death|1
6997403|NCT01358981|11060552|FG000|Period 1|Withdrawal by Subject|0
6997404|NCT01358981|11060553|FG001|Period 1|Withdrawal by Subject|0
6997405|NCT01358981|11060554|FG002|Period 1|Withdrawal by Subject|0
6997406|NCT01358981|11060555|FG003|Period 1|Withdrawal by Subject|1
6997407|NCT01358981|11060556|FG004|Period 1|Withdrawal by Subject|0
6997408|NCT01358981|11060557|FG005|Period 1|Withdrawal by Subject|0
6997409|NCT01358981|11060558|FG006|Period 1|Withdrawal by Subject|0
6997410|NCT01359046|11060590|FG000|Overall Study|Did not receive allocated intervention|6
6997411|NCT01359046|11060591|FG001|Overall Study|Did not receive allocated intervention|6
6997412|NCT01359046|11060590|FG000|Overall Study|Physician Decision|1
6997413|NCT01359046|11060591|FG001|Overall Study|Physician Decision|11
6997414|NCT01359150|11060605|FG000|Overall Study|Lack of Efficacy|1
6997415|NCT01359150|11060606|FG001|Overall Study|Lack of Efficacy|1
6997416|NCT01359150|11060605|FG000|Overall Study|Withdrawal by Subject|1
6997417|NCT01359150|11060606|FG001|Overall Study|Withdrawal by Subject|1
6997418|NCT01359150|11060605|FG000|Overall Study|Adverse Event|4
6997419|NCT01359150|11060606|FG001|Overall Study|Adverse Event|3
6997420|NCT01359150|11060605|FG000|Overall Study|Other|1
6997421|NCT01359150|11060606|FG001|Overall Study|Other|0
6997422|NCT01359449|11060632|FG000|Overall Study|Lost to Follow-up|1
6997423|NCT01359449|11060633|FG001|Overall Study|Lost to Follow-up|0
6997424|NCT01359449|11060632|FG000|Overall Study|Protocol Violation|0
6997425|NCT01359449|11060633|FG001|Overall Study|Protocol Violation|2
6997426|NCT01359449|11060632|FG000|Overall Study|Withdrawal by Subject|3
6997427|NCT01359449|11060633|FG001|Overall Study|Withdrawal by Subject|2
6997428|NCT01359592|11060639|FG000|Initial Registration|Adverse Event|1
6997429|NCT01359592|11060640|FG001|Initial Registration|Adverse Event|0
6997430|NCT01359592|11060641|FG002|Initial Registration|Adverse Event|0
6997431|NCT01359592|11060642|FG003|Initial Registration|Adverse Event|0
6997432|NCT01359592|11060639|FG000|Initial Registration|Death|1
6997433|NCT01359592|11060640|FG001|Initial Registration|Death|0
6997434|NCT01359592|11060641|FG002|Initial Registration|Death|0
6997435|NCT01359592|11060642|FG003|Initial Registration|Death|0
6997436|NCT01359592|11060639|FG000|Initial Registration|Other reason not protocol specified|1
6997437|NCT01359592|11060640|FG001|Initial Registration|Other reason not protocol specified|0
6997438|NCT01359592|11060641|FG002|Initial Registration|Other reason not protocol specified|0
6997439|NCT01359592|11060642|FG003|Initial Registration|Other reason not protocol specified|0
6997440|NCT01359592|11060639|FG000|Initial Registration|Ineligible|26
6997441|NCT01359592|11060640|FG001|Initial Registration|Ineligible|0
6997442|NCT01359592|11060641|FG002|Initial Registration|Ineligible|0
6997443|NCT01359592|11060642|FG003|Initial Registration|Ineligible|0
6997444|NCT01359592|11060639|FG000|PET-Directed Therapy|Adverse Event|0
6997445|NCT01359592|11060640|FG001|PET-Directed Therapy|Adverse Event|0
6997446|NCT01359592|11060641|FG002|PET-Directed Therapy|Adverse Event|1
6997447|NCT01359592|11060642|FG003|PET-Directed Therapy|Adverse Event|0
6997448|NCT01359592|11060639|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0
6997449|NCT01359592|11060640|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0
6997450|NCT01359592|11060641|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1
6997451|NCT01359592|11060642|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0
6997452|NCT01359592|11060639|FG000|PET-Directed Therapy|Ineligible|0
6997453|NCT01359592|11060640|FG001|PET-Directed Therapy|Ineligible|0
6997454|NCT01359592|11060641|FG002|PET-Directed Therapy|Ineligible|24
6997455|NCT01359592|11060642|FG003|PET-Directed Therapy|Ineligible|0
6997456|NCT01359644|11060667|FG000|Treatment Period|Lack of Efficacy|0
6997457|NCT01359644|11060668|FG001|Treatment Period|Lack of Efficacy|1
6997458|NCT01359644|11060669|FG002|Treatment Period|Lack of Efficacy|0
6997459|NCT01359644|11060670|FG003|Treatment Period|Lack of Efficacy|0
6997460|NCT01359644|11060671|FG004|Treatment Period|Lack of Efficacy|0
6997461|NCT01359644|11060672|FG005|Treatment Period|Lack of Efficacy|0
6997462|NCT01359644|11060673|FG006|Treatment Period|Lack of Efficacy|0
6997463|NCT01359644|11060674|FG007|Treatment Period|Lack of Efficacy|0
6997464|NCT01359644|11060675|FG008|Treatment Period|Lack of Efficacy|0
6997465|NCT01359644|11060676|FG009|Treatment Period|Lack of Efficacy|0
6997466|NCT01359644|11060667|FG000|Treatment Period|Adverse Event|0
6997467|NCT01359644|11060668|FG001|Treatment Period|Adverse Event|0
6997468|NCT01359644|11060669|FG002|Treatment Period|Adverse Event|1
6997469|NCT01359644|11060670|FG003|Treatment Period|Adverse Event|0
6997470|NCT01359644|11060671|FG004|Treatment Period|Adverse Event|0
6997471|NCT01359644|11060672|FG005|Treatment Period|Adverse Event|1
6997472|NCT01359644|11060673|FG006|Treatment Period|Adverse Event|0
6997473|NCT01359644|11060674|FG007|Treatment Period|Adverse Event|0
6997474|NCT01359644|11060675|FG008|Treatment Period|Adverse Event|0
6997475|NCT01359644|11060676|FG009|Treatment Period|Adverse Event|0
6997476|NCT01359644|11060667|FG000|Treatment Period|Lost to Follow-up|0
6997477|NCT01359644|11060668|FG001|Treatment Period|Lost to Follow-up|0
6997478|NCT01359644|11060669|FG002|Treatment Period|Lost to Follow-up|0
6997479|NCT01359644|11060670|FG003|Treatment Period|Lost to Follow-up|0
6997480|NCT01359644|11060671|FG004|Treatment Period|Lost to Follow-up|0
6997481|NCT01359644|11060672|FG005|Treatment Period|Lost to Follow-up|1
6997482|NCT01359644|11060673|FG006|Treatment Period|Lost to Follow-up|0
6997483|NCT01359644|11060674|FG007|Treatment Period|Lost to Follow-up|0
6997484|NCT01359644|11060675|FG008|Treatment Period|Lost to Follow-up|0
6997485|NCT01359644|11060676|FG009|Treatment Period|Lost to Follow-up|0
6997486|NCT01359644|11060667|FG000|Follow-up Period|Withdrawal by Subject|0
6997487|NCT01359644|11060668|FG001|Follow-up Period|Withdrawal by Subject|0
6997488|NCT01359644|11060669|FG002|Follow-up Period|Withdrawal by Subject|0
6997489|NCT01359644|11060670|FG003|Follow-up Period|Withdrawal by Subject|0
6997490|NCT01359644|11060671|FG004|Follow-up Period|Withdrawal by Subject|0
6997491|NCT01359644|11060672|FG005|Follow-up Period|Withdrawal by Subject|1
6997492|NCT01359644|11060673|FG006|Follow-up Period|Withdrawal by Subject|0
6997493|NCT01359644|11060674|FG007|Follow-up Period|Withdrawal by Subject|0
6997494|NCT01359644|11060675|FG008|Follow-up Period|Withdrawal by Subject|0
6997495|NCT01359644|11060676|FG009|Follow-up Period|Withdrawal by Subject|0
6997496|NCT01359644|11060667|FG000|Follow-up Period|Lost to Follow-up|0
6997497|NCT01359644|11060668|FG001|Follow-up Period|Lost to Follow-up|0
6997498|NCT01359644|11060669|FG002|Follow-up Period|Lost to Follow-up|0
6997499|NCT01359644|11060670|FG003|Follow-up Period|Lost to Follow-up|0
6997500|NCT01359644|11060671|FG004|Follow-up Period|Lost to Follow-up|0
6997501|NCT01359644|11060672|FG005|Follow-up Period|Lost to Follow-up|0
6997502|NCT01359644|11060673|FG006|Follow-up Period|Lost to Follow-up|1
6997503|NCT01359644|11060674|FG007|Follow-up Period|Lost to Follow-up|2
6997504|NCT01359644|11060675|FG008|Follow-up Period|Lost to Follow-up|0
6997505|NCT01359644|11060676|FG009|Follow-up Period|Lost to Follow-up|0
6997506|NCT01359904|11060735|FG000|Overall Study|Withdrawal by Subject|1
6997507|NCT01359904|11060736|FG001|Overall Study|Withdrawal by Subject|0
6997508|NCT01359943|11060745|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1
6997509|NCT01359943|11060746|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
6997510|NCT01359943|11060747|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
6997511|NCT01359943|11060745|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1
6997512|NCT01359943|11060746|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2
6997513|NCT01359943|11060747|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0
6997514|NCT01359943|11060745|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
6997515|NCT01359943|11060746|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2
6997516|NCT01359943|11060747|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
6997517|NCT01359943|11060745|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1
6997518|NCT01359943|11060746|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
6997519|NCT01359943|11060747|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
6997520|NCT01359943|11060745|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1
6997521|NCT01359943|11060746|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3
6997522|NCT01359943|11060747|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4
6997523|NCT01359943|11060745|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
6997524|NCT01359943|11060746|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1
6997525|NCT01359943|11060747|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
6997526|NCT01359943|11060745|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
6997527|NCT01359943|11060746|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
6997528|NCT01359943|11060747|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
6997529|NCT01359943|11060745|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
6997530|NCT01359943|11060746|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1
6997531|NCT01359943|11060747|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
6997532|NCT01359943|11060745|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3
6997533|NCT01359943|11060746|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5
6997534|NCT01359943|11060747|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1
6997535|NCT01359943|11060745|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1
6997536|NCT01359943|11060746|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5
6997537|NCT01359943|11060747|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4
6997538|NCT01359943|11060745|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1
6997539|NCT01359943|11060746|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0
6997540|NCT01359943|11060747|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0
6997541|NCT01359943|11060745|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0
6997542|NCT01359943|11060746|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1
6997543|NCT01359943|11060747|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0
6997544|NCT01359943|11060745|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
6997545|NCT01359943|11060746|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
6997546|NCT01359943|11060747|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
6997547|NCT01359943|11060745|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
6997548|NCT01359943|11060746|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1
6997549|NCT01359943|11060747|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
6997550|NCT01359943|11060745|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3
6997551|NCT01359943|11060746|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5
6997552|NCT01359943|11060747|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1
6997553|NCT01359956|11060761|FG000|Overall Study|Death|61
6997554|NCT01359956|11060762|FG001|Overall Study|Death|64
6997555|NCT01359956|11060763|FG002|Overall Study|Death|67
6997556|NCT01359956|11060764|FG003|Overall Study|Death|58
6997557|NCT01360021|11060777|FG000|Overall Study|Eligibility criteria + other|2
6997558|NCT01360021|11060778|FG001|Overall Study|Eligibility criteria + other|1
6997559|NCT01360021|11060779|FG002|Overall Study|Eligibility criteria + other|1
6997560|NCT01360021|11060777|FG000|Overall Study|Protocol Violation|0
6997561|NCT01360021|11060778|FG001|Overall Study|Protocol Violation|0
6997562|NCT01360021|11060779|FG002|Overall Study|Protocol Violation|1
6997563|NCT01360021|11060777|FG000|Overall Study|Withdrawal by Subject|4
6997564|NCT01360021|11060778|FG001|Overall Study|Withdrawal by Subject|0
6997565|NCT01360021|11060779|FG002|Overall Study|Withdrawal by Subject|2
6997566|NCT01360021|11060777|FG000|Overall Study|Adverse Event|2
6997567|NCT01360021|11060778|FG001|Overall Study|Adverse Event|3
6997568|NCT01360021|11060779|FG002|Overall Study|Adverse Event|3
6997569|NCT01360398|11060796|FG000|Overall Study|Withdrawal by Subject|14
6997570|NCT01360398|11060796|FG000|Overall Study|Other|7
6997571|NCT01360398|11060796|FG000|Overall Study|Migrated/moved from study area|1
6997572|NCT01360554|11060812|FG000|Overall Study|Death|359
6997573|NCT01360554|11060813|FG001|Overall Study|Death|371
6997574|NCT01360554|11060812|FG000|Overall Study|Lost to Follow-up|4
6997575|NCT01360554|11060813|FG001|Overall Study|Lost to Follow-up|4
6997576|NCT01360554|11060812|FG000|Overall Study|Withdrawal by Subject|23
6997577|NCT01360554|11060813|FG001|Overall Study|Withdrawal by Subject|24
6997578|NCT01360554|11060812|FG000|Overall Study|Study terminated by sponsor|49
6997579|NCT01360554|11060813|FG001|Overall Study|Study terminated by sponsor|37
6997580|NCT01360554|11060812|FG000|Overall Study|Other, not specified|1
6997581|NCT01360554|11060813|FG001|Overall Study|Other, not specified|0
6997582|NCT01360554|11060812|FG000|Overall Study|Randomized but not treated.|3
6997583|NCT01360554|11060813|FG001|Overall Study|Randomized but not treated.|3
6997584|NCT01360632|11060822|FG000|Phase A (8 Weeks)|Lost to Follow-up|27
6997585|NCT01360632|11060823|FG001|Phase A (8 Weeks)|Lost to Follow-up|0
6997586|NCT01360632|11060824|FG002|Phase A (8 Weeks)|Lost to Follow-up|0
6997587|NCT01360632|11060825|FG003|Phase A (8 Weeks)|Lost to Follow-up|0
6997588|NCT01360632|11060826|FG004|Phase A (8 Weeks)|Lost to Follow-up|0
6997589|NCT01360632|11060822|FG000|Phase A (8 Weeks)|Adverse Event|60
6997590|NCT01360632|11060823|FG001|Phase A (8 Weeks)|Adverse Event|0
6997591|NCT01360632|11060824|FG002|Phase A (8 Weeks)|Adverse Event|0
6997592|NCT01360632|11060825|FG003|Phase A (8 Weeks)|Adverse Event|0
6997593|NCT01360632|11060826|FG004|Phase A (8 Weeks)|Adverse Event|0
6997594|NCT01360632|11060822|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45
6997595|NCT01360632|11060823|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0
6997596|NCT01360632|11060824|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0
6997597|NCT01360632|11060825|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0
6997598|NCT01360632|11060826|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0
6997599|NCT01360632|11060822|FG000|Phase A (8 Weeks)|Physician Decision|10
6997600|NCT01360632|11060823|FG001|Phase A (8 Weeks)|Physician Decision|0
6997601|NCT01360632|11060824|FG002|Phase A (8 Weeks)|Physician Decision|0
6997602|NCT01360632|11060825|FG003|Phase A (8 Weeks)|Physician Decision|0
6997603|NCT01360632|11060826|FG004|Phase A (8 Weeks)|Physician Decision|0
6997604|NCT01360632|11060822|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74
6997605|NCT01360632|11060823|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0
6997606|NCT01360632|11060824|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0
6997607|NCT01360632|11060825|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0
6997608|NCT01360632|11060826|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0
6997609|NCT01360632|11060822|FG000|Phase A (8 Weeks)|Protocol Deviation|39
6997610|NCT01360632|11060823|FG001|Phase A (8 Weeks)|Protocol Deviation|0
6997611|NCT01360632|11060824|FG002|Phase A (8 Weeks)|Protocol Deviation|0
6997612|NCT01360632|11060825|FG003|Phase A (8 Weeks)|Protocol Deviation|0
6997613|NCT01360632|11060826|FG004|Phase A (8 Weeks)|Protocol Deviation|0
6997614|NCT01360632|11060822|FG000|Phase B (6 Weeks)|Lost to Follow-up|0
6997615|NCT01360632|11060823|FG001|Phase B (6 Weeks)|Lost to Follow-up|1
6997616|NCT01360632|11060824|FG002|Phase B (6 Weeks)|Lost to Follow-up|1
6997617|NCT01360632|11060825|FG003|Phase B (6 Weeks)|Lost to Follow-up|0
6997618|NCT01360632|11060826|FG004|Phase B (6 Weeks)|Lost to Follow-up|0
6997619|NCT01360632|11060822|FG000|Phase B (6 Weeks)|Adverse Event|0
6997620|NCT01360632|11060823|FG001|Phase B (6 Weeks)|Adverse Event|3
6997621|NCT01360632|11060824|FG002|Phase B (6 Weeks)|Adverse Event|9
6997622|NCT01360632|11060825|FG003|Phase B (6 Weeks)|Adverse Event|3
6997623|NCT01360632|11060826|FG004|Phase B (6 Weeks)|Adverse Event|0
6997624|NCT01360632|11060822|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0
6997625|NCT01360632|11060823|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0
6997626|NCT01360632|11060824|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2
6997627|NCT01360632|11060825|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1
6997628|NCT01360632|11060826|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0
6997629|NCT01360632|11060822|FG000|Phase B (6 Weeks)|Physician Decision|0
6997630|NCT01360632|11060823|FG001|Phase B (6 Weeks)|Physician Decision|0
6997631|NCT01360632|11060824|FG002|Phase B (6 Weeks)|Physician Decision|0
6997632|NCT01360632|11060825|FG003|Phase B (6 Weeks)|Physician Decision|1
6997633|NCT01360632|11060826|FG004|Phase B (6 Weeks)|Physician Decision|0
6997634|NCT01360632|11060822|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0
6997635|NCT01360632|11060823|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4
6997636|NCT01360632|11060824|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4
6997637|NCT01360632|11060825|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7
6997638|NCT01360632|11060826|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0
6997639|NCT01360632|11060822|FG000|Phase B (6 Weeks)|Protocol Deviation|0
6997640|NCT01360632|11060823|FG001|Phase B (6 Weeks)|Protocol Deviation|1
6997641|NCT01360632|11060824|FG002|Phase B (6 Weeks)|Protocol Deviation|4
6997642|NCT01360632|11060825|FG003|Phase B (6 Weeks)|Protocol Deviation|1
6997643|NCT01360632|11060826|FG004|Phase B (6 Weeks)|Protocol Deviation|0
6997644|NCT01360632|11060822|FG000|Phase B (6 Weeks)|Lack of Efficacy|0
6997645|NCT01360632|11060823|FG001|Phase B (6 Weeks)|Lack of Efficacy|1
6997646|NCT01360632|11060824|FG002|Phase B (6 Weeks)|Lack of Efficacy|0
6997647|NCT01360632|11060825|FG003|Phase B (6 Weeks)|Lack of Efficacy|0
6997648|NCT01360632|11060826|FG004|Phase B (6 Weeks)|Lack of Efficacy|0
6997649|NCT01360632|11060822|FG000|Phase A+|Lost to Follow-up|0
6997650|NCT01360632|11060823|FG001|Phase A+|Lost to Follow-up|0
6997651|NCT01360632|11060824|FG002|Phase A+|Lost to Follow-up|0
6997652|NCT01360632|11060825|FG003|Phase A+|Lost to Follow-up|0
6997653|NCT01360632|11060826|FG004|Phase A+|Lost to Follow-up|2
6997654|NCT01360632|11060822|FG000|Phase A+|Adverse Event|0
6997655|NCT01360632|11060823|FG001|Phase A+|Adverse Event|0
6997656|NCT01360632|11060824|FG002|Phase A+|Adverse Event|0
6997657|NCT01360632|11060825|FG003|Phase A+|Adverse Event|0
6997658|NCT01360632|11060826|FG004|Phase A+|Adverse Event|2
6997659|NCT01360632|11060822|FG000|Phase A+|Met Withdrawal Criteria|0
6997660|NCT01360632|11060823|FG001|Phase A+|Met Withdrawal Criteria|0
6997661|NCT01360632|11060824|FG002|Phase A+|Met Withdrawal Criteria|0
6997662|NCT01360632|11060825|FG003|Phase A+|Met Withdrawal Criteria|0
6997663|NCT01360632|11060826|FG004|Phase A+|Met Withdrawal Criteria|7
6997664|NCT01360632|11060822|FG000|Phase A+|Physician Decision|0
6997665|NCT01360632|11060823|FG001|Phase A+|Physician Decision|0
6997666|NCT01360632|11060824|FG002|Phase A+|Physician Decision|0
6997667|NCT01360632|11060825|FG003|Phase A+|Physician Decision|0
6997668|NCT01360632|11060826|FG004|Phase A+|Physician Decision|3
6997669|NCT01360632|11060822|FG000|Phase A+|Withdrawal by Subject|0
6997670|NCT01360632|11060823|FG001|Phase A+|Withdrawal by Subject|0
6997671|NCT01360632|11060824|FG002|Phase A+|Withdrawal by Subject|0
6997672|NCT01360632|11060825|FG003|Phase A+|Withdrawal by Subject|0
6997673|NCT01360632|11060826|FG004|Phase A+|Withdrawal by Subject|8
6997674|NCT01360632|11060822|FG000|Phase A+|Protocol Deviation|0
6997675|NCT01360632|11060823|FG001|Phase A+|Protocol Deviation|0
6997676|NCT01360632|11060824|FG002|Phase A+|Protocol Deviation|0
6997677|NCT01360632|11060825|FG003|Phase A+|Protocol Deviation|0
6997678|NCT01360632|11060826|FG004|Phase A+|Protocol Deviation|3
6997679|NCT01360645|11060836|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16
6997680|NCT01360645|11060837|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
6997681|NCT01360645|11060838|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
6997682|NCT01360645|11060839|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
6997683|NCT01360645|11060836|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19
6997684|NCT01360645|11060837|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
6997685|NCT01360645|11060838|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
6997686|NCT01360645|11060839|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
6997687|NCT01360645|11060836|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16
6997688|NCT01360645|11060837|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
6997689|NCT01360645|11060838|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
6997690|NCT01360645|11060839|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
6997691|NCT01360645|11060836|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34
6997692|NCT01360645|11060837|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
6997693|NCT01360645|11060838|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
6997694|NCT01360645|11060839|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
6997695|NCT01360645|11060836|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24
6997696|NCT01360645|11060837|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
6997697|NCT01360645|11060838|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
6997698|NCT01360645|11060839|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
6997699|NCT01360645|11060836|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5
6997700|NCT01360645|11060837|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
6997701|NCT01360645|11060838|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
6997702|NCT01360645|11060839|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
6997703|NCT01360645|11060836|FG000|Phase B (6 Weeks)|Lost to Follow-up|0
6997704|NCT01360645|11060837|FG001|Phase B (6 Weeks)|Lost to Follow-up|1
6997705|NCT01360645|11060838|FG002|Phase B (6 Weeks)|Lost to Follow-up|0
6997706|NCT01360645|11060839|FG003|Phase B (6 Weeks)|Lost to Follow-up|0
6997707|NCT01360645|11060836|FG000|Phase B (6 Weeks)|Adverse Event|0
6997708|NCT01360645|11060837|FG001|Phase B (6 Weeks)|Adverse Event|6
6997709|NCT01360645|11060838|FG002|Phase B (6 Weeks)|Adverse Event|0
6997710|NCT01360645|11060839|FG003|Phase B (6 Weeks)|Adverse Event|0
6997711|NCT01360645|11060836|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0
6997712|NCT01360645|11060837|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3
6997713|NCT01360645|11060838|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2
6997714|NCT01360645|11060839|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0
6997715|NCT01360645|11060836|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0
6997716|NCT01360645|11060837|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3
6997717|NCT01360645|11060838|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8
6997718|NCT01360645|11060839|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0
6997719|NCT01360645|11060836|FG000|Phase B (6 Weeks)|Protocol Deviation|0
6997720|NCT01360645|11060837|FG001|Phase B (6 Weeks)|Protocol Deviation|1
6997721|NCT01360645|11060838|FG002|Phase B (6 Weeks)|Protocol Deviation|3
6997722|NCT01360645|11060839|FG003|Phase B (6 Weeks)|Protocol Deviation|0
6997723|NCT01360645|11060836|FG000|Phase A+|Lost to Follow-up|0
6997724|NCT01360645|11060837|FG001|Phase A+|Lost to Follow-up|0
6997725|NCT01360645|11060838|FG002|Phase A+|Lost to Follow-up|0
6997726|NCT01360645|11060839|FG003|Phase A+|Lost to Follow-up|7
6997727|NCT01360645|11060836|FG000|Phase A+|Adverse Event|0
6997728|NCT01360645|11060837|FG001|Phase A+|Adverse Event|0
6997729|NCT01360645|11060838|FG002|Phase A+|Adverse Event|0
6997730|NCT01360645|11060839|FG003|Phase A+|Adverse Event|2
6997731|NCT01360645|11060836|FG000|Phase A+|Met Withdrawal Criteria|0
6997732|NCT01360645|11060837|FG001|Phase A+|Met Withdrawal Criteria|0
6997733|NCT01360645|11060838|FG002|Phase A+|Met Withdrawal Criteria|0
6997734|NCT01360645|11060839|FG003|Phase A+|Met Withdrawal Criteria|4
6997735|NCT01360645|11060836|FG000|Phase A+|Physician Decision|0
6997736|NCT01360645|11060837|FG001|Phase A+|Physician Decision|0
6997737|NCT01360645|11060838|FG002|Phase A+|Physician Decision|0
6997738|NCT01360645|11060839|FG003|Phase A+|Physician Decision|2
6997739|NCT01360645|11060836|FG000|Phase A+|Withdrawal by Subject|0
6997740|NCT01360645|11060837|FG001|Phase A+|Withdrawal by Subject|0
6997741|NCT01360645|11060838|FG002|Phase A+|Withdrawal by Subject|0
6997742|NCT01360645|11060839|FG003|Phase A+|Withdrawal by Subject|5
6997743|NCT01360645|11060836|FG000|Phase A+|Protocol Deviation|0
6997744|NCT01360645|11060837|FG001|Phase A+|Protocol Deviation|0
6997745|NCT01360645|11060838|FG002|Phase A+|Protocol Deviation|0
6997746|NCT01360645|11060839|FG003|Phase A+|Protocol Deviation|4
6997747|NCT01360762|11060845|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7
6997748|NCT01360762|11060845|FG000|Main Study Period (12-month Treatment)|Death|5
6997749|NCT01360762|11060845|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1
6997750|NCT01360762|11060845|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15
6997751|NCT01360762|11060845|FG000|Main Study Period (12-month Treatment)|Discontinuation|1
6997752|NCT01360762|11060845|FG000|Whole Study Period|Lost to Follow-up|10
6997753|NCT01360762|11060845|FG000|Whole Study Period|Death|7
6997754|NCT01360762|11060845|FG000|Whole Study Period|Patient relapsed|18
6997755|NCT01360762|11060845|FG000|Whole Study Period|Discontinuation of study drug for safety|1
6997756|NCT01360840|11060852|FG000|Overall Study|Ongoing at data cut-off|10
6997757|NCT01360840|11060853|FG001|Overall Study|Ongoing at data cut-off|10
6997758|NCT01360840|11060854|FG002|Overall Study|Ongoing at data cut-off|9
6997759|NCT01360866|11060868|FG000|Overall Study|Lost to Follow-up|11
6997760|NCT01360866|11060869|FG001|Overall Study|Lost to Follow-up|28
6997761|NCT01360866|11060870|FG002|Overall Study|Lost to Follow-up|41
6997762|NCT01360866|11060871|FG003|Overall Study|Lost to Follow-up|0
6997763|NCT01360866|11060868|FG000|Overall Study|Adverse Event|56
6997764|NCT01360866|11060869|FG001|Overall Study|Adverse Event|61
6997765|NCT01360866|11060870|FG002|Overall Study|Adverse Event|134
6997766|NCT01360866|11060871|FG003|Overall Study|Adverse Event|6
6997767|NCT01360866|11060868|FG000|Overall Study|Paticipant met withdrawal criteria|11
6997768|NCT01360866|11060869|FG001|Overall Study|Paticipant met withdrawal criteria|28
6997769|NCT01360866|11060870|FG002|Overall Study|Paticipant met withdrawal criteria|54
6997770|NCT01360866|11060871|FG003|Overall Study|Paticipant met withdrawal criteria|0
6997771|NCT01360866|11060868|FG000|Overall Study|Withdrawn by Investigator|9
6997772|NCT01360866|11060869|FG001|Overall Study|Withdrawn by Investigator|8
6997773|NCT01360866|11060870|FG002|Overall Study|Withdrawn by Investigator|31
6997774|NCT01360866|11060871|FG003|Overall Study|Withdrawn by Investigator|2
6997775|NCT01360866|11060868|FG000|Overall Study|Withdrawal by participant|79
6997776|NCT01360866|11060869|FG001|Overall Study|Withdrawal by participant|89
6997777|NCT01360866|11060870|FG002|Overall Study|Withdrawal by participant|168
6997778|NCT01360866|11060871|FG003|Overall Study|Withdrawal by participant|8
6997779|NCT01360866|11060868|FG000|Overall Study|Protocol Deviation|25
6997780|NCT01360866|11060869|FG001|Overall Study|Protocol Deviation|33
6997781|NCT01360866|11060870|FG002|Overall Study|Protocol Deviation|61
6997782|NCT01360866|11060871|FG003|Overall Study|Protocol Deviation|2
6997783|NCT01360866|11060868|FG000|Overall Study|Lack of Efficacy|30
6997784|NCT01360866|11060869|FG001|Overall Study|Lack of Efficacy|40
6997785|NCT01360866|11060870|FG002|Overall Study|Lack of Efficacy|30
6997786|NCT01360866|11060871|FG003|Overall Study|Lack of Efficacy|4
6997787|NCT01360996|11060884|FG000|Overall Study|Withdrawal by Subject|4
6997788|NCT01360996|11060885|FG001|Overall Study|Withdrawal by Subject|3
6997789|NCT01360996|11060886|FG002|Overall Study|Withdrawal by Subject|2
6997790|NCT01360996|11060884|FG000|Overall Study|Noncompliant|2
6997791|NCT01360996|11060885|FG001|Overall Study|Noncompliant|0
6997792|NCT01360996|11060886|FG002|Overall Study|Noncompliant|0
6997793|NCT01361009|11060893|FG000|Overall Study|Protocol Violation|116
6997794|NCT01361126|11060921|FG000|Overall Study|Sponsor decision|0
6997795|NCT01361126|11060922|FG001|Overall Study|Sponsor decision|2
6997796|NCT01361178|11060931|FG000|Overall Study|Death|13
6997797|NCT01361178|11060932|FG001|Overall Study|Death|0
6997798|NCT01361308|11060946|FG000|Overall Study|Withdrawal by Subject|9
6997799|NCT01361308|11060947|FG001|Overall Study|Withdrawal by Subject|13
6997800|NCT01361308|11060946|FG000|Overall Study|Physician Decision|3
6997801|NCT01361308|11060947|FG001|Overall Study|Physician Decision|3
6997802|NCT01361308|11060946|FG000|Overall Study|Lack of Efficacy|2
6997803|NCT01361308|11060947|FG001|Overall Study|Lack of Efficacy|0
6997804|NCT01361308|11060946|FG000|Overall Study|Protocol Violation|1
6997805|NCT01361308|11060947|FG001|Overall Study|Protocol Violation|0
6997806|NCT01361308|11060946|FG000|Overall Study|Lost to Follow-up|5
6997807|NCT01361308|11060947|FG001|Overall Study|Lost to Follow-up|4
6997808|NCT01361308|11060946|FG000|Overall Study|Adverse Event|8
6997809|NCT01361308|11060947|FG001|Overall Study|Adverse Event|4
6997810|NCT01361308|11060946|FG000|Overall Study|Eligibility Criteria Not Met|2
6997811|NCT01361308|11060947|FG001|Overall Study|Eligibility Criteria Not Met|3
6997812|NCT01361308|11060946|FG000|Overall Study|Failed C-SSRS|5
6997813|NCT01361308|11060947|FG001|Overall Study|Failed C-SSRS|2
6997814|NCT01361308|11060946|FG000|Overall Study|Other|0
6997815|NCT01361308|11060947|FG001|Overall Study|Other|1
6997816|NCT01361464|11060953|FG000|Overall Study|Death|1
6997817|NCT01361464|11060953|FG000|Overall Study|Withdrawal by Subject|2
6997818|NCT01361568|11060963|FG000|Overall Study|Adverse Event|0
6997819|NCT01361568|11060964|FG001|Overall Study|Adverse Event|0
6997820|NCT01361568|11060965|FG002|Overall Study|Adverse Event|0
6997821|NCT01361568|11060966|FG003|Overall Study|Adverse Event|0
6997822|NCT01361568|11060967|FG004|Overall Study|Adverse Event|1
6997823|NCT01361568|11060968|FG005|Overall Study|Adverse Event|0
6997824|NCT01361568|11060963|FG000|Overall Study|Physician Decision|0
6997825|NCT01361568|11060964|FG001|Overall Study|Physician Decision|0
6997826|NCT01361568|11060965|FG002|Overall Study|Physician Decision|0
6997827|NCT01361568|11060966|FG003|Overall Study|Physician Decision|0
6997828|NCT01361568|11060967|FG004|Overall Study|Physician Decision|0
6997829|NCT01361568|11060968|FG005|Overall Study|Physician Decision|1
6997830|NCT01361568|11060963|FG000|Overall Study|Withdrawal by Subject|2
6997831|NCT01361568|11060964|FG001|Overall Study|Withdrawal by Subject|1
6997832|NCT01361568|11060965|FG002|Overall Study|Withdrawal by Subject|0
6997833|NCT01361568|11060966|FG003|Overall Study|Withdrawal by Subject|0
6997834|NCT01361568|11060967|FG004|Overall Study|Withdrawal by Subject|0
6997835|NCT01361568|11060968|FG005|Overall Study|Withdrawal by Subject|1
6997836|NCT01361594|11060985|FG000|Overall Study|Withdrawal by Subject|1
6997837|NCT01361594|11060986|FG001|Overall Study|Withdrawal by Subject|2
6997838|NCT01361607|11060994|FG000|Overall Study|Adverse Event|38
6997839|NCT01361607|11060995|FG001|Overall Study|Adverse Event|29
6997840|NCT01361607|11060994|FG000|Overall Study|Withdrawal by Subject|19
6997841|NCT01361607|11060995|FG001|Overall Study|Withdrawal by Subject|8
6997842|NCT01361607|11060994|FG000|Overall Study|Withdrawal by Investigator|5
6997843|NCT01361607|11060995|FG001|Overall Study|Withdrawal by Investigator|3
6997844|NCT01361607|11060994|FG000|Overall Study|Lost to Follow-up|1
6997845|NCT01361607|11060995|FG001|Overall Study|Lost to Follow-up|0
6997846|NCT01361607|11060994|FG000|Overall Study|Met Withdrawal Criteria|1
6997847|NCT01361607|11060995|FG001|Overall Study|Met Withdrawal Criteria|1
6997848|NCT01361711|11061017|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1
6997849|NCT01361711|11061017|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1
6997850|NCT01361711|11061017|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7
6997851|NCT01361711|11061017|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2
6997852|NCT01361711|11061017|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1
6997853|NCT01361711|11061017|FG000|Completed Week 18 of Treatment|Complete Remission|2
6997854|NCT01361711|11061017|FG000|Completed Week 18 of Treatment|Other|9
6997855|NCT01361711|11061017|FG000|10 Year Follow-up|Still in follow-up|22
6997856|NCT01361711|11061017|FG000|10 Year Follow-up|Death|7
6997857|NCT01361711|11061017|FG000|10 Year Follow-up|Developed new cancer|1
6997858|NCT01361711|11061017|FG000|10 Year Follow-up|Lost to Follow-up|2
6997859|NCT01361711|11061017|FG000|10 Year Follow-up|New treatment started|6
6997860|NCT01361711|11061017|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11
6997861|NCT01361711|11061017|FG000|10 Year Follow-up|Progressive Disease|1
6997862|NCT01361919|11061035|FG000|Overall Study|technical issues|10
6997863|NCT01361919|11061036|FG001|Overall Study|technical issues|12
6997864|NCT01361919|11061037|FG002|Overall Study|technical issues|10
6997865|NCT01362049|11061049|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3
6997866|NCT01362049|11061050|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3
6997867|NCT01362049|11061051|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2
6997868|NCT01362049|11061052|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1
6997869|NCT01362049|11061049|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5
6997870|NCT01362049|11061050|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
6997871|NCT01362049|11061051|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2
6997872|NCT01362049|11061052|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
6997873|NCT01362062|11061068|FG000|Overall Study|Adverse Event|1
6997874|NCT01362062|11061069|FG001|Overall Study|Adverse Event|0
6997875|NCT01362062|11061068|FG000|Overall Study|Lost to Follow-up|11
6997876|NCT01362062|11061069|FG001|Overall Study|Lost to Follow-up|0
6997877|NCT01362062|11061068|FG000|Overall Study|Withdrawal by Subject|2
6997878|NCT01362062|11061069|FG001|Overall Study|Withdrawal by Subject|0
6997879|NCT01362062|11061068|FG000|Overall Study|Non-compliant participant|2
6997880|NCT01362062|11061069|FG001|Overall Study|Non-compliant participant|0
6997881|NCT01362062|11061068|FG000|Overall Study|Detected with Spondylo-arthritis|1
6997882|NCT01362062|11061069|FG001|Overall Study|Detected with Spondylo-arthritis|0
6997883|NCT01362062|11061068|FG000|Overall Study|Had significant improvement|9
6997884|NCT01362062|11061069|FG001|Overall Study|Had significant improvement|0
6997885|NCT01362140|11061085|FG000|Overall Study|Noncompliance|1
6997886|NCT01362140|11061086|FG001|Overall Study|Noncompliance|0
6997887|NCT01362140|11061085|FG000|Overall Study|Adverse Event|2
6997888|NCT01362140|11061086|FG001|Overall Study|Adverse Event|2
6997889|NCT01362140|11061085|FG000|Overall Study|Withdrawal by Subject|3
6997890|NCT01362140|11061086|FG001|Overall Study|Withdrawal by Subject|3
6997891|NCT01362140|11061085|FG000|Overall Study|Administrative Decision|0
6997892|NCT01362140|11061086|FG001|Overall Study|Administrative Decision|1
6997893|NCT01362140|11061085|FG000|Overall Study|Death|2
6997894|NCT01362140|11061086|FG001|Overall Study|Death|1
6997895|NCT01362140|11061085|FG000|Overall Study|Other|1
6997896|NCT01362140|11061086|FG001|Overall Study|Other|1
6997897|NCT01362140|11061085|FG000|Overall Study|Protocol-specified Criteria|1
6997898|NCT01362140|11061086|FG001|Overall Study|Protocol-specified Criteria|2
6997899|NCT01362140|11061085|FG000|Overall Study|Discontinued Without Receiving Treatment|0
6997900|NCT01362140|11061086|FG001|Overall Study|Discontinued Without Receiving Treatment|1
6997901|NCT01362244|11061107|FG000|Overall Study|Adverse Event|3
6997902|NCT01362244|11061108|FG001|Overall Study|Adverse Event|5
6997903|NCT01362244|11061107|FG000|Overall Study|Lack of Efficacy|5
6997904|NCT01362244|11061108|FG001|Overall Study|Lack of Efficacy|11
6997905|NCT01362244|11061107|FG000|Overall Study|Lost to Follow-up|0
6997906|NCT01362244|11061108|FG001|Overall Study|Lost to Follow-up|2
6997907|NCT01362244|11061107|FG000|Overall Study|Protocol Violation|5
6997908|NCT01362244|11061108|FG001|Overall Study|Protocol Violation|1
6997909|NCT01362244|11061107|FG000|Overall Study|Withdrawal by Subject|2
6997910|NCT01362244|11061108|FG001|Overall Study|Withdrawal by Subject|1
6997911|NCT01362244|11061107|FG000|Overall Study|Did not Meet Continuation Criteria|17
6997912|NCT01362244|11061108|FG001|Overall Study|Did not Meet Continuation Criteria|11
6997913|NCT01362244|11061107|FG000|Overall Study|Protocol Defined Stopping Criteria|0
6997914|NCT01362244|11061108|FG001|Overall Study|Protocol Defined Stopping Criteria|1
6997915|NCT01362270|11061116|FG000|Overall Study|Withdrawal by Subject|1
6997916|NCT01362270|11061117|FG001|Overall Study|Withdrawal by Subject|0
6997917|NCT01362270|11061116|FG000|Overall Study|Met exclusion criteria after 1st session|0
6997918|NCT01362270|11061117|FG001|Overall Study|Met exclusion criteria after 1st session|1
6997919|NCT01362270|11061116|FG000|Overall Study|Met excl. criteria before 1st session|1
6997920|NCT01362270|11061117|FG001|Overall Study|Met excl. criteria before 1st session|1
6997921|NCT01362296|11061125|FG000|Randomized Phase (RP)|PD including Death due to PD|56
6997922|NCT01362296|11061126|FG001|Randomized Phase (RP)|PD including Death due to PD|28
6997923|NCT01362296|11061127|FG002|Randomized Phase (RP)|PD including Death due to PD|0
6997924|NCT01362296|11061128|FG003|Randomized Phase (RP)|PD including Death due to PD|0
6997925|NCT01362296|11061125|FG000|Randomized Phase (RP)|Physician Decision|1
6997926|NCT01362296|11061126|FG001|Randomized Phase (RP)|Physician Decision|9
6997927|NCT01362296|11061127|FG002|Randomized Phase (RP)|Physician Decision|0
6997928|NCT01362296|11061128|FG003|Randomized Phase (RP)|Physician Decision|0
6997929|NCT01362296|11061125|FG000|Randomized Phase (RP)|Withdrawal by Subject|2
6997930|NCT01362296|11061126|FG001|Randomized Phase (RP)|Withdrawal by Subject|1
6997931|NCT01362296|11061127|FG002|Randomized Phase (RP)|Withdrawal by Subject|0
6997932|NCT01362296|11061128|FG003|Randomized Phase (RP)|Withdrawal by Subject|0
6997933|NCT01362296|11061125|FG000|Randomized Phase (RP)|Adverse Event|20
6997934|NCT01362296|11061126|FG001|Randomized Phase (RP)|Adverse Event|4
6997935|NCT01362296|11061127|FG002|Randomized Phase (RP)|Adverse Event|0
6997936|NCT01362296|11061128|FG003|Randomized Phase (RP)|Adverse Event|0
6997937|NCT01362296|11061125|FG000|Randomized Phase (RP)|Study Closed/Terminated|8
6997938|NCT01362296|11061126|FG001|Randomized Phase (RP)|Study Closed/Terminated|1
7042736|NCT01737697|11127218|FG010|Subacute Phase|Death|1
6997939|NCT01362296|11061127|FG002|Randomized Phase (RP)|Study Closed/Terminated|0
6997940|NCT01362296|11061128|FG003|Randomized Phase (RP)|Study Closed/Terminated|0
6997941|NCT01362296|11061125|FG000|Crossover Phase|PD including Death due to PD|0
6997942|NCT01362296|11061126|FG001|Crossover Phase|PD including Death due to PD|0
6997943|NCT01362296|11061127|FG002|Crossover Phase|PD including Death due to PD|16
6997944|NCT01362296|11061128|FG003|Crossover Phase|PD including Death due to PD|1
6997945|NCT01362296|11061125|FG000|Crossover Phase|Withdrawal by Subject|0
6997946|NCT01362296|11061126|FG001|Crossover Phase|Withdrawal by Subject|0
6997947|NCT01362296|11061127|FG002|Crossover Phase|Withdrawal by Subject|2
6997948|NCT01362296|11061128|FG003|Crossover Phase|Withdrawal by Subject|1
6997949|NCT01362296|11061125|FG000|Crossover Phase|Adverse Event|0
6997950|NCT01362296|11061126|FG001|Crossover Phase|Adverse Event|0
6997951|NCT01362296|11061127|FG002|Crossover Phase|Adverse Event|4
6997952|NCT01362296|11061128|FG003|Crossover Phase|Adverse Event|0
6997953|NCT01362296|11061125|FG000|Crossover Phase|Study Closed/Terminated|0
6997954|NCT01362296|11061126|FG001|Crossover Phase|Study Closed/Terminated|0
6997955|NCT01362296|11061127|FG002|Crossover Phase|Study Closed/Terminated|1
6997956|NCT01362296|11061128|FG003|Crossover Phase|Study Closed/Terminated|0
6997957|NCT01362322|11061140|FG000|Overall Study|Withdrawal by Subject|3
6997958|NCT01362322|11061141|FG001|Overall Study|Withdrawal by Subject|1
6997959|NCT01362322|11061140|FG000|Overall Study|Lost to Follow-up|2
6997960|NCT01362322|11061141|FG001|Overall Study|Lost to Follow-up|6
6997961|NCT01362348|11061147|FG000|Overall Study|Protocol-defined stopping criteria|9
6997962|NCT01362348|11061147|FG000|Overall Study|Study closed/terminated|5
6997963|NCT01362439|11061151|FG000|Overall Study|Adverse Event|1
6997964|NCT01362439|11061151|FG000|Overall Study|Lack of Efficacy|3
6997965|NCT01362439|11061151|FG000|Overall Study|Lost to Follow-up|2
6997966|NCT01362439|11061151|FG000|Overall Study|Study medication non-compliant|1
6997967|NCT01362439|11061151|FG000|Overall Study|Participant who withdrew consent|8
6997968|NCT01362491|11061159|FG000|Overall Study|Ineligible|1
6997969|NCT01362491|11061160|FG001|Overall Study|Ineligible|0
6997970|NCT01362491|11061161|FG002|Overall Study|Ineligible|0
6997971|NCT01362517|11061170|FG000|Overall Study|Protocol Violation|1
6997972|NCT01362517|11061170|FG000|Overall Study|Lost to Follow-up|1
6997973|NCT01362530|11061179|FG000|Base Study (Cycle 1)|Adverse Event|2
6997974|NCT01362530|11061180|FG001|Base Study (Cycle 1)|Adverse Event|0
6997975|NCT01362530|11061179|FG000|Base Study (Cycle 1)|Physician Decision|0
6997976|NCT01362530|11061180|FG001|Base Study (Cycle 1)|Physician Decision|1
6997977|NCT01362530|11061179|FG000|Base Study (Cycle 1)|Protocol Violation|2
6997978|NCT01362530|11061180|FG001|Base Study (Cycle 1)|Protocol Violation|0
6997979|NCT01362530|11061179|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1
6997980|NCT01362530|11061180|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2
6997981|NCT01362530|11061179|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2
6997982|NCT01362530|11061180|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0
6997983|NCT01362530|11061179|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51
6997984|NCT01362530|11061180|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0
6997985|NCT01362530|11061179|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25
6997986|NCT01362530|11061180|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0
6997987|NCT01362530|11061179|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4
6997988|NCT01362530|11061180|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0
6997989|NCT01362530|11061179|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1
6997990|NCT01362530|11061180|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0
6997991|NCT01362530|11061179|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1
6997992|NCT01362530|11061180|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0
6997993|NCT01362530|11061179|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19
6997994|NCT01362530|11061180|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0
6997995|NCT01362530|11061179|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4
6997996|NCT01362530|11061180|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0
6997997|NCT01362530|11061179|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18
6997998|NCT01362530|11061180|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0
6997999|NCT01362608|11061189|FG000|Overall Study|Protocol Violation|0
6998000|NCT01362608|11061190|FG001|Overall Study|Protocol Violation|1
6998001|NCT01362608|11061189|FG000|Overall Study|Lost to Follow-up|3
6998002|NCT01362608|11061190|FG001|Overall Study|Lost to Follow-up|1
6998003|NCT01362608|11061189|FG000|Overall Study|Withdrawal by Subject|1
6998004|NCT01362608|11061190|FG001|Overall Study|Withdrawal by Subject|2
6998005|NCT01362608|11061189|FG000|Overall Study|Lack of Efficacy|0
6998006|NCT01362608|11061190|FG001|Overall Study|Lack of Efficacy|2
6998007|NCT01362608|11061189|FG000|Overall Study|Adverse Event|0
6998008|NCT01362608|11061190|FG001|Overall Study|Adverse Event|2
7042737|NCT01737697|11127219|FG011|Subacute Phase|Death|0
7042738|NCT01737697|11127220|FG012|Subacute Phase|Death|0
7042739|NCT01737697|11127221|FG013|Subacute Phase|Death|0
7042740|NCT01737697|11127222|FG014|Subacute Phase|Death|0
7042741|NCT01737710|11127260|FG000|Overall Study|Lost to Follow-up|0
7042742|NCT01737710|11127261|FG001|Overall Study|Lost to Follow-up|2
7042743|NCT01737710|11127262|FG002|Overall Study|Lost to Follow-up|2
7042744|NCT01737710|11127263|FG003|Overall Study|Lost to Follow-up|0
7042745|NCT01737710|11127264|FG004|Overall Study|Lost to Follow-up|0
7042746|NCT01737710|11127260|FG000|Overall Study|Withdrawal by Subject|1
6998009|NCT01362790|11061215|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1
6998010|NCT01362790|11061216|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
6998011|NCT01362790|11061217|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
6998012|NCT01362790|11061218|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
6998013|NCT01362790|11061219|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
6998014|NCT01362790|11061220|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
6998015|NCT01362790|11061221|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
6998016|NCT01362790|11061215|FG000|Pilot Phase & Phase 2|Adverse Event|0
6998017|NCT01362790|11061216|FG001|Pilot Phase & Phase 2|Adverse Event|1
6998018|NCT01362790|11061217|FG002|Pilot Phase & Phase 2|Adverse Event|0
6998019|NCT01362790|11061218|FG003|Pilot Phase & Phase 2|Adverse Event|1
6998020|NCT01362790|11061219|FG004|Pilot Phase & Phase 2|Adverse Event|0
6998021|NCT01362790|11061220|FG005|Pilot Phase & Phase 2|Adverse Event|2
6998022|NCT01362790|11061221|FG006|Pilot Phase & Phase 2|Adverse Event|0
6998023|NCT01362790|11061215|FG000|Pilot Phase & Phase 2|Physician Decision|0
6998024|NCT01362790|11061216|FG001|Pilot Phase & Phase 2|Physician Decision|0
6998025|NCT01362790|11061217|FG002|Pilot Phase & Phase 2|Physician Decision|0
6998026|NCT01362790|11061218|FG003|Pilot Phase & Phase 2|Physician Decision|1
6998027|NCT01362790|11061219|FG004|Pilot Phase & Phase 2|Physician Decision|0
6998028|NCT01362790|11061220|FG005|Pilot Phase & Phase 2|Physician Decision|0
6998029|NCT01362790|11061221|FG006|Pilot Phase & Phase 2|Physician Decision|0
6998030|NCT01362790|11061215|FG000|Pilot Phase & Phase 2|Developed antibodies|7
6998031|NCT01362790|11061216|FG001|Pilot Phase & Phase 2|Developed antibodies|2
6998032|NCT01362790|11061217|FG002|Pilot Phase & Phase 2|Developed antibodies|3
6998033|NCT01362790|11061218|FG003|Pilot Phase & Phase 2|Developed antibodies|8
6998034|NCT01362790|11061219|FG004|Pilot Phase & Phase 2|Developed antibodies|0
6998035|NCT01362790|11061220|FG005|Pilot Phase & Phase 2|Developed antibodies|0
6998036|NCT01362790|11061221|FG006|Pilot Phase & Phase 2|Developed antibodies|0
6998037|NCT01362790|11061215|FG000|Pilot Phase & Phase 2|Refused further treatment|0
6998038|NCT01362790|11061216|FG001|Pilot Phase & Phase 2|Refused further treatment|1
6998039|NCT01362790|11061217|FG002|Pilot Phase & Phase 2|Refused further treatment|0
6998040|NCT01362790|11061218|FG003|Pilot Phase & Phase 2|Refused further treatment|0
6998041|NCT01362790|11061219|FG004|Pilot Phase & Phase 2|Refused further treatment|0
6998042|NCT01362790|11061220|FG005|Pilot Phase & Phase 2|Refused further treatment|0
6998043|NCT01362790|11061221|FG006|Pilot Phase & Phase 2|Refused further treatment|0
6998044|NCT01362790|11061215|FG000|Pilot Phase & Phase 2|Progressive disease|1
6998045|NCT01362790|11061216|FG001|Pilot Phase & Phase 2|Progressive disease|2
6998046|NCT01362790|11061217|FG002|Pilot Phase & Phase 2|Progressive disease|2
6998047|NCT01362790|11061218|FG003|Pilot Phase & Phase 2|Progressive disease|3
6998048|NCT01362790|11061219|FG004|Pilot Phase & Phase 2|Progressive disease|0
6998049|NCT01362790|11061220|FG005|Pilot Phase & Phase 2|Progressive disease|2
6998050|NCT01362790|11061221|FG006|Pilot Phase & Phase 2|Progressive disease|0
6998051|NCT01362790|11061215|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1
6998052|NCT01362790|11061216|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
6998053|NCT01362790|11061217|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
6998054|NCT01362790|11061218|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
6998055|NCT01362790|11061219|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
6998056|NCT01362790|11061220|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
6998057|NCT01362790|11061221|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
6998058|NCT01362790|11061215|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
6998059|NCT01362790|11061216|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2
6998060|NCT01362790|11061217|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
6998061|NCT01362790|11061218|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
6998062|NCT01362790|11061219|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
6998063|NCT01362790|11061220|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
6998064|NCT01362790|11061221|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
6998065|NCT01362790|11061215|FG000|Pilot Phase & Phase 2|Death on study|0
6998066|NCT01362790|11061216|FG001|Pilot Phase & Phase 2|Death on study|0
6998067|NCT01362790|11061217|FG002|Pilot Phase & Phase 2|Death on study|0
6998068|NCT01362790|11061218|FG003|Pilot Phase & Phase 2|Death on study|1
6998069|NCT01362790|11061219|FG004|Pilot Phase & Phase 2|Death on study|0
6998070|NCT01362790|11061220|FG005|Pilot Phase & Phase 2|Death on study|0
6998071|NCT01362790|11061221|FG006|Pilot Phase & Phase 2|Death on study|0
6998072|NCT01362790|11061215|FG000|Dose De-escalation of Regimen A|Adverse Event|0
6998073|NCT01362790|11061216|FG001|Dose De-escalation of Regimen A|Adverse Event|0
6998074|NCT01362790|11061217|FG002|Dose De-escalation of Regimen A|Adverse Event|0
6998075|NCT01362790|11061218|FG003|Dose De-escalation of Regimen A|Adverse Event|0
6998076|NCT01362790|11061219|FG004|Dose De-escalation of Regimen A|Adverse Event|1
6998077|NCT01362790|11061220|FG005|Dose De-escalation of Regimen A|Adverse Event|0
6998078|NCT01362790|11061221|FG006|Dose De-escalation of Regimen A|Adverse Event|0
6998079|NCT01362790|11061215|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0
6998080|NCT01362790|11061216|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0
6998081|NCT01362790|11061217|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0
6998082|NCT01362790|11061218|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0
6998083|NCT01362790|11061219|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3
6998084|NCT01362790|11061220|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0
6998085|NCT01362790|11061221|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0
6998086|NCT01362790|11061215|FG000|Dose De-escalation of Regimen A|Progressive disease|0
6998087|NCT01362790|11061216|FG001|Dose De-escalation of Regimen A|Progressive disease|0
6998088|NCT01362790|11061217|FG002|Dose De-escalation of Regimen A|Progressive disease|0
6998089|NCT01362790|11061218|FG003|Dose De-escalation of Regimen A|Progressive disease|0
6998090|NCT01362790|11061219|FG004|Dose De-escalation of Regimen A|Progressive disease|2
6998091|NCT01362790|11061220|FG005|Dose De-escalation of Regimen A|Progressive disease|0
6998092|NCT01362790|11061221|FG006|Dose De-escalation of Regimen A|Progressive disease|0
6998093|NCT01363011|11061273|FG000|Main Study|Adverse Event|2
6998094|NCT01363011|11061274|FG001|Main Study|Adverse Event|3
6998095|NCT01363011|11061273|FG000|Main Study|Investigator's Discretion|1
6998096|NCT01363011|11061274|FG001|Main Study|Investigator's Discretion|1
6998097|NCT01363011|11061273|FG000|Main Study|Withdrew Consent|1
6998098|NCT01363011|11061274|FG001|Main Study|Withdrew Consent|4
6998099|NCT01363011|11061273|FG000|Main Study|Protocol Violation|0
6998100|NCT01363011|11061274|FG001|Main Study|Protocol Violation|1
6998101|NCT01363011|11061273|FG000|Extension Phase|Adverse Event|1
6998102|NCT01363011|11061274|FG001|Extension Phase|Adverse Event|1
6998103|NCT01363011|11061273|FG000|Extension Phase|Lack of Efficacy|0
6998104|NCT01363011|11061274|FG001|Extension Phase|Lack of Efficacy|1
6998105|NCT01363011|11061273|FG000|Extension Phase|Investigator's Discretion|2
6998106|NCT01363011|11061274|FG001|Extension Phase|Investigator's Discretion|2
6998107|NCT01363011|11061273|FG000|Extension Phase|Withdrew Consent|0
6998108|NCT01363011|11061274|FG001|Extension Phase|Withdrew Consent|1
6998109|NCT01363011|11061273|FG000|Extension Phase|Lost to Follow-up|0
6998110|NCT01363011|11061274|FG001|Extension Phase|Lost to Follow-up|2
6998111|NCT01363011|11061273|FG000|Extension Phase|Rolled Over to Another Gilead Study|2
6998112|NCT01363011|11061274|FG001|Extension Phase|Rolled Over to Another Gilead Study|1
6998113|NCT01363076|11061288|FG000|Overall Study|Withdrawal by Subject|0
6998114|NCT01363076|11061289|FG001|Overall Study|Withdrawal by Subject|1
6998115|NCT01363297|11061313|FG000|Overall Study|Other|0
6998116|NCT01363297|11061314|FG001|Overall Study|Other|0
6998117|NCT01363297|11061315|FG002|Overall Study|Other|0
6998118|NCT01363297|11061316|FG003|Overall Study|Other|0
6998119|NCT01363297|11061317|FG004|Overall Study|Other|1
6998120|NCT01363297|11061313|FG000|Overall Study|Death|3
6998121|NCT01363297|11061314|FG001|Overall Study|Death|6
6998122|NCT01363297|11061315|FG002|Overall Study|Death|6
6998123|NCT01363297|11061316|FG003|Overall Study|Death|10
6998124|NCT01363297|11061317|FG004|Overall Study|Death|30
6998125|NCT01363349|11061336|FG000|Overall Study|Adverse Event|6
6998126|NCT01363349|11061337|FG001|Overall Study|Adverse Event|7
6998127|NCT01363349|11061336|FG000|Overall Study|Lack of Efficacy|3
6998128|NCT01363349|11061337|FG001|Overall Study|Lack of Efficacy|10
6998129|NCT01363349|11061336|FG000|Overall Study|Non compliance/Protocol deviations|2
6998130|NCT01363349|11061337|FG001|Overall Study|Non compliance/Protocol deviations|2
6998131|NCT01363349|11061336|FG000|Overall Study|Withdrawal by Subject|14
6998132|NCT01363349|11061337|FG001|Overall Study|Withdrawal by Subject|6
6998133|NCT01363349|11061336|FG000|Overall Study|Lost to Follow-up|5
6998134|NCT01363349|11061337|FG001|Overall Study|Lost to Follow-up|6
6998135|NCT01363349|11061336|FG000|Overall Study|Not reported|36
6998136|NCT01363349|11061337|FG001|Overall Study|Not reported|37
6998137|NCT01363349|11061336|FG000|Overall Study|missing|1
6998138|NCT01363349|11061337|FG001|Overall Study|missing|2
6998139|NCT01363440|11061359|FG000|Overall Study|Adverse Event|5
6998140|NCT01363440|11061360|FG001|Overall Study|Adverse Event|4
6998141|NCT01363440|11061361|FG002|Overall Study|Adverse Event|4
6998142|NCT01363440|11061359|FG000|Overall Study|Death|3
6998143|NCT01363440|11061360|FG001|Overall Study|Death|7
6998144|NCT01363440|11061361|FG002|Overall Study|Death|5
6998145|NCT01363440|11061359|FG000|Overall Study|Withdrawal by Subject|9
6998146|NCT01363440|11061360|FG001|Overall Study|Withdrawal by Subject|11
6998147|NCT01363440|11061361|FG002|Overall Study|Withdrawal by Subject|11
6998148|NCT01363440|11061359|FG000|Overall Study|Lost to Follow-up|2
6998149|NCT01363440|11061360|FG001|Overall Study|Lost to Follow-up|4
6998150|NCT01363440|11061361|FG002|Overall Study|Lost to Follow-up|5
6998151|NCT01363440|11061359|FG000|Overall Study|Other|4
6998152|NCT01363440|11061360|FG001|Overall Study|Other|5
6998153|NCT01363440|11061361|FG002|Overall Study|Other|2
6998154|NCT01363661|11061389|FG000|Overall Study|Adverse Event|9
6998155|NCT01363661|11061390|FG001|Overall Study|Adverse Event|2
6998156|NCT01363661|11061389|FG000|Overall Study|Withdrawal by Subject|1
6998157|NCT01363661|11061390|FG001|Overall Study|Withdrawal by Subject|1
6998158|NCT01363661|11061389|FG000|Overall Study|Protocol Violation|1
6998159|NCT01363661|11061390|FG001|Overall Study|Protocol Violation|0
6998160|NCT01363661|11061389|FG000|Overall Study|Lost to Follow-up|3
6998161|NCT01363661|11061390|FG001|Overall Study|Lost to Follow-up|1
6998162|NCT01363700|11061399|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0
6998163|NCT01363700|11061400|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1
6998164|NCT01363700|11061401|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0
6998165|NCT01363700|11061402|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0
6998166|NCT01363700|11061403|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0
6998167|NCT01363713|11061414|FG000|Overall Study|Adverse Event|1
6998168|NCT01363713|11061414|FG000|Overall Study|Protocol Violation|3
6998169|NCT01363713|11061414|FG000|Overall Study|Withdrawal by Subject|2
6998170|NCT01363765|11061420|FG000|Overall Study|non-diagnostic|2621
6998171|NCT01363765|11061421|FG001|Overall Study|non-diagnostic|1124
6998172|NCT01363765|11061420|FG000|Overall Study|duplicate records|736
6998173|NCT01363765|11061421|FG001|Overall Study|duplicate records|3177
6998174|NCT01363765|11061420|FG000|Overall Study|non-resident|156
6998175|NCT01363765|11061421|FG001|Overall Study|non-resident|76
6998176|NCT01363765|11061420|FG000|Overall Study|age not recorded (used for cross-linkage|117
6998177|NCT01363765|11061421|FG001|Overall Study|age not recorded (used for cross-linkage|354
6998178|NCT01363765|11061420|FG000|Overall Study|smear during intervention|2170
6998179|NCT01363765|11061421|FG001|Overall Study|smear during intervention|0
6998180|NCT01363908|11061436|FG000|Chronic Dosing (CD) Phase|Adverse Event|1
6998181|NCT01363908|11061437|FG001|Chronic Dosing (CD) Phase|Adverse Event|1
6998182|NCT01363908|11061436|FG000|Chronic Dosing (CD) Phase|Patient decision|0
6998183|NCT01363908|11061437|FG001|Chronic Dosing (CD) Phase|Patient decision|1
6998184|NCT01363908|11061436|FG000|Chronic Dosing (CD) Phase|Physician Decision|0
6998185|NCT01363908|11061437|FG001|Chronic Dosing (CD) Phase|Physician Decision|1
6998186|NCT01363908|11061436|FG000|Chronic Dosing (CD) Phase|Early study termination|9
6998187|NCT01363908|11061437|FG001|Chronic Dosing (CD) Phase|Early study termination|3
6998188|NCT01363986|11061443|FG000|Overall Study|Disease progression|1
6998189|NCT01364233|11061474|FG000|Overall Study|Lost to Follow-up|1
6998190|NCT01364298|11061489|FG000|Overall Study|Adverse Event|3
6998191|NCT01364298|11061490|FG001|Overall Study|Adverse Event|4
6998192|NCT01364298|11061489|FG000|Overall Study|Lack of adherence to treatment|1
6998193|NCT01364298|11061490|FG001|Overall Study|Lack of adherence to treatment|3
6998194|NCT01364298|11061489|FG000|Overall Study|Lack of Efficacy|1
6998195|NCT01364298|11061490|FG001|Overall Study|Lack of Efficacy|0
6998196|NCT01364298|11061489|FG000|Overall Study|Lost to Follow-up|5
6998197|NCT01364298|11061490|FG001|Overall Study|Lost to Follow-up|10
6998198|NCT01364298|11061489|FG000|Overall Study|Withdrawal by Subject|3
6998199|NCT01364298|11061490|FG001|Overall Study|Withdrawal by Subject|3
6998200|NCT01364298|11061489|FG000|Overall Study|Other|1
6998201|NCT01364298|11061490|FG001|Overall Study|Other|3
6998202|NCT01364389|11061499|FG000|Overall Study|Withdrawal by Subject|0
6998203|NCT01364389|11061500|FG001|Overall Study|Withdrawal by Subject|1
6998204|NCT01364389|11061501|FG002|Overall Study|Withdrawal by Subject|0
6998205|NCT01364389|11061499|FG000|Overall Study|Protocol deviation|0
6998206|NCT01364389|11061500|FG001|Overall Study|Protocol deviation|0
6998207|NCT01364389|11061501|FG002|Overall Study|Protocol deviation|1
6998208|NCT01364389|11061499|FG000|Overall Study|Administrative problems|1
6998209|NCT01364389|11061500|FG001|Overall Study|Administrative problems|0
6998210|NCT01364389|11061501|FG002|Overall Study|Administrative problems|0
6998211|NCT01364389|11061499|FG000|Overall Study|Adverse Event|1
6998212|NCT01364389|11061500|FG001|Overall Study|Adverse Event|0
6998213|NCT01364389|11061501|FG002|Overall Study|Adverse Event|0
6998214|NCT01364428|11061511|FG000|Overall Study|Adverse Event|1
6998215|NCT01364428|11061512|FG001|Overall Study|Adverse Event|2
6998216|NCT01364428|11061511|FG000|Overall Study|Protocol Violation|2
6998217|NCT01364428|11061512|FG001|Overall Study|Protocol Violation|0
6998218|NCT01364428|11061511|FG000|Overall Study|Withdrawal Criteria|14
6998219|NCT01364428|11061512|FG001|Overall Study|Withdrawal Criteria|10
6998220|NCT01364428|11061511|FG000|Overall Study|Other|3
6998221|NCT01364428|11061512|FG001|Overall Study|Other|3
6998222|NCT01364467|11061520|FG000|Overall Study|Lost to Follow-up|1
6998223|NCT01364467|11061521|FG001|Overall Study|Lost to Follow-up|2
6998224|NCT01364649|11061571|FG000|Overall Study|Pretreatment Event or Adverse Event|20
6998225|NCT01364649|11061572|FG001|Overall Study|Pretreatment Event or Adverse Event|14
6998226|NCT01364649|11061571|FG000|Overall Study|Lack of Efficacy|6
6998227|NCT01364649|11061572|FG001|Overall Study|Lack of Efficacy|0
6998228|NCT01364649|11061571|FG000|Overall Study|Non-compliance with Investigational Drug|1
6998229|NCT01364649|11061572|FG001|Overall Study|Non-compliance with Investigational Drug|0
6998230|NCT01364649|11061571|FG000|Overall Study|Protocol Deviations|4
6998231|NCT01364649|11061572|FG001|Overall Study|Protocol Deviations|8
6998232|NCT01364649|11061571|FG000|Overall Study|Withdrawal of Consent|9
6998233|NCT01364649|11061572|FG001|Overall Study|Withdrawal of Consent|7
6998234|NCT01364649|11061571|FG000|Overall Study|Lost to Follow-up|12
6998235|NCT01364649|11061572|FG001|Overall Study|Lost to Follow-up|13
6998236|NCT01364649|11061571|FG000|Overall Study|Other|4
6998237|NCT01364649|11061572|FG001|Overall Study|Other|1
6998238|NCT01364727|11061578|FG000|Overall Study|Not Eligible|2
6998239|NCT01364870|11061592|FG000|Overall Study|Withdrawal by Subject|13
6998240|NCT01364870|11061593|FG001|Overall Study|Withdrawal by Subject|24
6998241|NCT01364870|11061594|FG002|Overall Study|Withdrawal by Subject|10
6998242|NCT01364870|11061592|FG000|Overall Study|Adverse Event|8
6998243|NCT01364870|11061593|FG001|Overall Study|Adverse Event|6
6998244|NCT01364870|11061594|FG002|Overall Study|Adverse Event|4
6998245|NCT01364870|11061592|FG000|Overall Study|Protocol Violation|1
6998246|NCT01364870|11061593|FG001|Overall Study|Protocol Violation|0
6998247|NCT01364870|11061594|FG002|Overall Study|Protocol Violation|0
6998248|NCT01364922|11061609|FG000|Open-label (OL) Period|Adverse Event|7
6998249|NCT01364922|11061610|FG001|Open-label (OL) Period|Adverse Event|0
6998250|NCT01364922|11061611|FG002|Open-label (OL) Period|Adverse Event|0
6998251|NCT01364922|11061609|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6
6998252|NCT01364922|11061610|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
6998253|NCT01364922|11061611|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
6998254|NCT01364922|11061609|FG000|Open-label (OL) Period|Withdrawal by Subject|4
6998255|NCT01364922|11061610|FG001|Open-label (OL) Period|Withdrawal by Subject|0
6998256|NCT01364922|11061611|FG002|Open-label (OL) Period|Withdrawal by Subject|0
6998257|NCT01364922|11061609|FG000|Open-label (OL) Period|Lack of Efficacy|3
6998258|NCT01364922|11061610|FG001|Open-label (OL) Period|Lack of Efficacy|0
6998259|NCT01364922|11061611|FG002|Open-label (OL) Period|Lack of Efficacy|0
6998260|NCT01364922|11061609|FG000|Open-label (OL) Period|Lost to Follow-up|1
6998261|NCT01364922|11061610|FG001|Open-label (OL) Period|Lost to Follow-up|0
6998262|NCT01364922|11061611|FG002|Open-label (OL) Period|Lost to Follow-up|0
6998263|NCT01364922|11061609|FG000|Open-label (OL) Period|Other, Unspecified|1
6998264|NCT01364922|11061610|FG001|Open-label (OL) Period|Other, Unspecified|0
6998265|NCT01364922|11061611|FG002|Open-label (OL) Period|Other, Unspecified|0
6998266|NCT01364922|11061609|FG000|Double-Blind (DB) Period|Lack of Efficacy|0
6998267|NCT01364922|11061610|FG001|Double-Blind (DB) Period|Lack of Efficacy|3
6998268|NCT01364922|11061611|FG002|Double-Blind (DB) Period|Lack of Efficacy|4
6998269|NCT01364922|11061609|FG000|Double-Blind (DB) Period|Subject Noncompliant|0
6998270|NCT01364922|11061610|FG001|Double-Blind (DB) Period|Subject Noncompliant|1
6998271|NCT01364922|11061611|FG002|Double-Blind (DB) Period|Subject Noncompliant|0
6998272|NCT01364922|11061609|FG000|Double-Blind (DB) Period|Adverse Event|0
6998273|NCT01364922|11061610|FG001|Double-Blind (DB) Period|Adverse Event|0
6998274|NCT01364922|11061611|FG002|Double-Blind (DB) Period|Adverse Event|1
6998275|NCT01364922|11061609|FG000|Double-Blind (DB) Period|Other, Unspecified|0
6998276|NCT01364922|11061610|FG001|Double-Blind (DB) Period|Other, Unspecified|1
6998277|NCT01364922|11061611|FG002|Double-Blind (DB) Period|Other, Unspecified|0
6998278|NCT01365039|11061620|FG000|Overall Study|Study related symptoms and complaints|1
6998279|NCT01365039|11061621|FG001|Overall Study|Study related symptoms and complaints|0
6998280|NCT01365052|11061630|FG000|Overall Study|Adverse Event|4
6998281|NCT01365052|11061631|FG001|Overall Study|Adverse Event|4
6998282|NCT01365091|11061641|FG000|Period 1|Adverse Event|1
6998283|NCT01365091|11061642|FG001|Period 1|Adverse Event|0
6998284|NCT01365091|11061643|FG002|Period 1|Adverse Event|2
6998285|NCT01365091|11061644|FG003|Period 1|Adverse Event|3
6998286|NCT01365091|11061641|FG000|Period 1|Positive test result for drugs of abuse|1
6998287|NCT01365091|11061642|FG001|Period 1|Positive test result for drugs of abuse|0
6998288|NCT01365091|11061643|FG002|Period 1|Positive test result for drugs of abuse|0
6998289|NCT01365091|11061644|FG003|Period 1|Positive test result for drugs of abuse|0
6998290|NCT01365091|11061641|FG000|Period 1|No longer met study criteria|0
6998291|NCT01365091|11061642|FG001|Period 1|No longer met study criteria|1
6998292|NCT01365091|11061643|FG002|Period 1|No longer met study criteria|0
6998293|NCT01365091|11061644|FG003|Period 1|No longer met study criteria|0
6998294|NCT01365091|11061641|FG000|Period 1|Withdrawal by Subject|0
6998295|NCT01365091|11061642|FG001|Period 1|Withdrawal by Subject|1
6998296|NCT01365091|11061643|FG002|Period 1|Withdrawal by Subject|0
6998297|NCT01365091|11061644|FG003|Period 1|Withdrawal by Subject|0
6998298|NCT01365091|11061641|FG000|Period 1|Personal reasons|0
6998299|NCT01365091|11061642|FG001|Period 1|Personal reasons|0
6998300|NCT01365091|11061643|FG002|Period 1|Personal reasons|1
6998301|NCT01365091|11061644|FG003|Period 1|Personal reasons|0
6998302|NCT01365091|11061641|FG000|Period 2|Withdrawal by Subject|1
6998303|NCT01365091|11061642|FG001|Period 2|Withdrawal by Subject|0
6998304|NCT01365091|11061643|FG002|Period 2|Withdrawal by Subject|0
6998305|NCT01365091|11061644|FG003|Period 2|Withdrawal by Subject|0
6998306|NCT01365091|11061641|FG000|Period 2|Adverse Event|0
6998307|NCT01365091|11061642|FG001|Period 2|Adverse Event|0
6998308|NCT01365091|11061643|FG002|Period 2|Adverse Event|1
6998309|NCT01365091|11061644|FG003|Period 2|Adverse Event|0
6998310|NCT01365130|11061668|FG000|Overall Study|Progression/worsening of Dx prior to txt|2
6998311|NCT01365273|11061674|FG000|Overall Study|Lost to Follow-up|1
6998312|NCT01365273|11061675|FG001|Overall Study|Lost to Follow-up|0
6998313|NCT01365273|11061674|FG000|Overall Study|Protocol Violation|0
6998314|NCT01365273|11061675|FG001|Overall Study|Protocol Violation|1
6998315|NCT01365273|11061674|FG000|Overall Study|Physician Decision|1
6998316|NCT01365273|11061675|FG001|Overall Study|Physician Decision|0
6998317|NCT01365455|11061684|FG000|Induction Period|Adverse Event|5
6998318|NCT01365455|11061685|FG001|Induction Period|Adverse Event|3
7060383|NCT01917968|11156528|FG000|Overall Study|36M Missed Visit|3
6998319|NCT01365455|11061686|FG002|Induction Period|Adverse Event|4
6998320|NCT01365455|11061687|FG003|Induction Period|Adverse Event|0
6998321|NCT01365455|11061688|FG004|Induction Period|Adverse Event|0
6998322|NCT01365455|11061684|FG000|Induction Period|Lack of Efficacy|1
6998323|NCT01365455|11061685|FG001|Induction Period|Lack of Efficacy|1
6998324|NCT01365455|11061686|FG002|Induction Period|Lack of Efficacy|0
6998325|NCT01365455|11061687|FG003|Induction Period|Lack of Efficacy|0
6998326|NCT01365455|11061688|FG004|Induction Period|Lack of Efficacy|0
6998327|NCT01365455|11061684|FG000|Induction Period|Pregnancy|0
6998328|NCT01365455|11061685|FG001|Induction Period|Pregnancy|1
6998329|NCT01365455|11061686|FG002|Induction Period|Pregnancy|0
6998330|NCT01365455|11061687|FG003|Induction Period|Pregnancy|0
6998331|NCT01365455|11061688|FG004|Induction Period|Pregnancy|0
6998332|NCT01365455|11061684|FG000|Induction Period|Protocol deviation|0
6998333|NCT01365455|11061685|FG001|Induction Period|Protocol deviation|1
6998334|NCT01365455|11061686|FG002|Induction Period|Protocol deviation|1
6998335|NCT01365455|11061687|FG003|Induction Period|Protocol deviation|0
6998336|NCT01365455|11061688|FG004|Induction Period|Protocol deviation|0
6998337|NCT01365455|11061684|FG000|Induction Period|Subject/guardian decision|9
6998338|NCT01365455|11061685|FG001|Induction Period|Subject/guardian decision|1
6998339|NCT01365455|11061686|FG002|Induction Period|Subject/guardian decision|8
6998340|NCT01365455|11061687|FG003|Induction Period|Subject/guardian decision|0
6998341|NCT01365455|11061688|FG004|Induction Period|Subject/guardian decision|0
6998342|NCT01365455|11061684|FG000|Induction Period|Lost to Follow-up|0
6998343|NCT01365455|11061685|FG001|Induction Period|Lost to Follow-up|0
6998344|NCT01365455|11061686|FG002|Induction Period|Lost to Follow-up|3
6998345|NCT01365455|11061687|FG003|Induction Period|Lost to Follow-up|0
6998346|NCT01365455|11061688|FG004|Induction Period|Lost to Follow-up|0
6998347|NCT01365455|11061684|FG000|Maintenance Period|Adverse Event|12
6998348|NCT01365455|11061685|FG001|Maintenance Period|Adverse Event|5
6998349|NCT01365455|11061686|FG002|Maintenance Period|Adverse Event|1
6998350|NCT01365455|11061687|FG003|Maintenance Period|Adverse Event|2
6998351|NCT01365455|11061688|FG004|Maintenance Period|Adverse Event|4
6998352|NCT01365455|11061684|FG000|Maintenance Period|Lack of Efficacy|10
6998353|NCT01365455|11061685|FG001|Maintenance Period|Lack of Efficacy|2
6998354|NCT01365455|11061686|FG002|Maintenance Period|Lack of Efficacy|0
6998355|NCT01365455|11061687|FG003|Maintenance Period|Lack of Efficacy|2
6998356|NCT01365455|11061688|FG004|Maintenance Period|Lack of Efficacy|2
6998357|NCT01365455|11061684|FG000|Maintenance Period|Lost to Follow-up|2
6998358|NCT01365455|11061685|FG001|Maintenance Period|Lost to Follow-up|4
6998359|NCT01365455|11061686|FG002|Maintenance Period|Lost to Follow-up|0
6998360|NCT01365455|11061687|FG003|Maintenance Period|Lost to Follow-up|0
6998361|NCT01365455|11061688|FG004|Maintenance Period|Lost to Follow-up|3
6998362|NCT01365455|11061684|FG000|Maintenance Period|Non-compliance with study treatment|0
6998363|NCT01365455|11061685|FG001|Maintenance Period|Non-compliance with study treatment|0
6998364|NCT01365455|11061686|FG002|Maintenance Period|Non-compliance with study treatment|0
6998365|NCT01365455|11061687|FG003|Maintenance Period|Non-compliance with study treatment|1
6998366|NCT01365455|11061688|FG004|Maintenance Period|Non-compliance with study treatment|0
6998367|NCT01365455|11061684|FG000|Maintenance Period|Physician Decision|0
6998368|NCT01365455|11061685|FG001|Maintenance Period|Physician Decision|1
6998369|NCT01365455|11061686|FG002|Maintenance Period|Physician Decision|0
6998370|NCT01365455|11061687|FG003|Maintenance Period|Physician Decision|0
6998371|NCT01365455|11061688|FG004|Maintenance Period|Physician Decision|1
6998372|NCT01365455|11061684|FG000|Maintenance Period|Pregnancy|0
6998373|NCT01365455|11061685|FG001|Maintenance Period|Pregnancy|4
6998374|NCT01365455|11061686|FG002|Maintenance Period|Pregnancy|0
6998375|NCT01365455|11061687|FG003|Maintenance Period|Pregnancy|0
6998376|NCT01365455|11061688|FG004|Maintenance Period|Pregnancy|2
6998377|NCT01365455|11061684|FG000|Maintenance Period|Protocol deviation|1
6998378|NCT01365455|11061685|FG001|Maintenance Period|Protocol deviation|1
6998379|NCT01365455|11061686|FG002|Maintenance Period|Protocol deviation|0
6998380|NCT01365455|11061687|FG003|Maintenance Period|Protocol deviation|0
6998381|NCT01365455|11061688|FG004|Maintenance Period|Protocol deviation|0
6998382|NCT01365455|11061684|FG000|Maintenance Period|Subject/guardian decision|4
6998383|NCT01365455|11061685|FG001|Maintenance Period|Subject/guardian decision|6
6998384|NCT01365455|11061686|FG002|Maintenance Period|Subject/guardian decision|2
6998385|NCT01365455|11061687|FG003|Maintenance Period|Subject/guardian decision|4
6998386|NCT01365455|11061688|FG004|Maintenance Period|Subject/guardian decision|1
6998387|NCT01365468|11061708|FG000|Overall Study|Physician Decision|1
6998388|NCT01365468|11061709|FG001|Overall Study|Physician Decision|0
6998389|NCT01365468|11061708|FG000|Overall Study|Disease progression|1
6998390|NCT01365468|11061709|FG001|Overall Study|Disease progression|0
6998391|NCT01365468|11061708|FG000|Overall Study|Lost to Follow-up|2
6998392|NCT01365468|11061709|FG001|Overall Study|Lost to Follow-up|0
6998393|NCT01365481|11061720|FG000|Overall Study|Adverse Event|6
6998394|NCT01365481|11061721|FG001|Overall Study|Adverse Event|9
6998395|NCT01365481|11061722|FG002|Overall Study|Adverse Event|0
6998396|NCT01365481|11061723|FG003|Overall Study|Adverse Event|2
6998397|NCT01365481|11061720|FG000|Overall Study|Withdrawal by Subject|0
6998398|NCT01365481|11061721|FG001|Overall Study|Withdrawal by Subject|2
6998399|NCT01365481|11061722|FG002|Overall Study|Withdrawal by Subject|1
6998400|NCT01365481|11061723|FG003|Overall Study|Withdrawal by Subject|1
6998401|NCT01365481|11061720|FG000|Overall Study|Lost to Follow-up|1
6998402|NCT01365481|11061721|FG001|Overall Study|Lost to Follow-up|1
6998403|NCT01365481|11061722|FG002|Overall Study|Lost to Follow-up|2
6998404|NCT01365481|11061723|FG003|Overall Study|Lost to Follow-up|3
6998405|NCT01365481|11061720|FG000|Overall Study|Abnormal laboratory value(s)|0
6998406|NCT01365481|11061721|FG001|Overall Study|Abnormal laboratory value(s)|1
6998407|NCT01365481|11061722|FG002|Overall Study|Abnormal laboratory value(s)|0
6998408|NCT01365481|11061723|FG003|Overall Study|Abnormal laboratory value(s)|0
6998409|NCT01365481|11061720|FG000|Overall Study|Administrative problems|0
6998410|NCT01365481|11061721|FG001|Overall Study|Administrative problems|1
6998411|NCT01365481|11061722|FG002|Overall Study|Administrative problems|0
6998412|NCT01365481|11061723|FG003|Overall Study|Administrative problems|0
6998413|NCT01365481|11061720|FG000|Overall Study|Protocol deviation|0
6998414|NCT01365481|11061721|FG001|Overall Study|Protocol deviation|1
6998415|NCT01365481|11061722|FG002|Overall Study|Protocol deviation|0
6998416|NCT01365481|11061723|FG003|Overall Study|Protocol deviation|1
6998417|NCT01365481|11061720|FG000|Overall Study|Unsatisfactory therapeutic effect|0
6998418|NCT01365481|11061721|FG001|Overall Study|Unsatisfactory therapeutic effect|0
6998419|NCT01365481|11061722|FG002|Overall Study|Unsatisfactory therapeutic effect|1
6998420|NCT01365481|11061723|FG003|Overall Study|Unsatisfactory therapeutic effect|0
6998421|NCT01365494|11061735|FG000|Overall Study|Adverse Event|1
6998422|NCT01365494|11061736|FG001|Overall Study|Adverse Event|0
6998423|NCT01365494|11061735|FG000|Overall Study|Withdrawal by Subject|0
6998424|NCT01365494|11061736|FG001|Overall Study|Withdrawal by Subject|1
6998425|NCT01365494|11061735|FG000|Overall Study|Lost to Follow-up|1
6998426|NCT01365494|11061736|FG001|Overall Study|Lost to Follow-up|2
6998427|NCT01365507|11061745|FG000|Overall Study|Withdrawal Criteria|8
6998428|NCT01365507|11061746|FG001|Overall Study|Withdrawal Criteria|5
6998429|NCT01365507|11061745|FG000|Overall Study|Unclassified|1
6998430|NCT01365507|11061746|FG001|Overall Study|Unclassified|4
6998431|NCT01365546|11061752|FG000|Overall Study|Withdrawal by Subject|1
6998432|NCT01365546|11061752|FG000|Overall Study|Screen failure|9
6998433|NCT01365546|11061752|FG000|Overall Study|Study termination|1
6998434|NCT01365910|11061820|FG000|Overall Study|Withdrawal by Subject|7
6998435|NCT01365910|11061820|FG000|Overall Study|disease progression|18
6998436|NCT01365910|11061820|FG000|Overall Study|Adverse Event|3
6998437|NCT01365910|11061820|FG000|Overall Study|other complicating disease|1
6998438|NCT01365910|11061820|FG000|Overall Study|pt did not get tx, nausea/vomiting|1
6998439|NCT01366209|11061835|FG000|Overall Study|Adverse Event|6
6998440|NCT01366209|11061836|FG001|Overall Study|Adverse Event|7
6998441|NCT01366209|11061835|FG000|Overall Study|Withdrawal by Subject|4
6998442|NCT01366209|11061836|FG001|Overall Study|Withdrawal by Subject|4
6998443|NCT01366209|11061835|FG000|Overall Study|Death|12
6998444|NCT01366209|11061836|FG001|Overall Study|Death|19
6998445|NCT01366209|11061835|FG000|Overall Study|Lung transplantation|6
6998446|NCT01366209|11061836|FG001|Overall Study|Lung transplantation|1
6998447|NCT01366209|11061835|FG000|Overall Study|Lost to Follow-up|2
6998448|NCT01366209|11061836|FG001|Overall Study|Lost to Follow-up|1
6998449|NCT01366209|11061835|FG000|Overall Study|Physician Decision|1
6998450|NCT01366209|11061836|FG001|Overall Study|Physician Decision|0
6998451|NCT01366209|11061835|FG000|Overall Study|Sponsors decision|0
6998452|NCT01366209|11061836|FG001|Overall Study|Sponsors decision|1
6998453|NCT01366209|11061835|FG000|Overall Study|Withdrew consent|4
6998454|NCT01366209|11061836|FG001|Overall Study|Withdrew consent|3
6998455|NCT01366443|11061847|FG000|Overall Study|Lost to Follow-up|2
6998456|NCT01366443|11061847|FG000|Overall Study|Under 18 yo|1
6998457|NCT01366521|11061873|FG000|Overall Study|Adverse Event|1
6998458|NCT01366521|11061874|FG001|Overall Study|Adverse Event|0
6998459|NCT01366521|11061875|FG002|Overall Study|Adverse Event|0
6998460|NCT01366521|11061876|FG003|Overall Study|Adverse Event|0
6998461|NCT01366521|11061873|FG000|Overall Study|Protocol Violation|0
6998462|NCT01366521|11061874|FG001|Overall Study|Protocol Violation|0
6998463|NCT01366521|11061875|FG002|Overall Study|Protocol Violation|1
6998464|NCT01366521|11061876|FG003|Overall Study|Protocol Violation|0
6998465|NCT01366521|11061873|FG000|Overall Study|Physician Decision|0
6998466|NCT01366521|11061874|FG001|Overall Study|Physician Decision|0
6998467|NCT01366521|11061875|FG002|Overall Study|Physician Decision|1
6998468|NCT01366521|11061876|FG003|Overall Study|Physician Decision|0
6998469|NCT01366521|11061873|FG000|Overall Study|Withdrawal by Subject|0
6998470|NCT01366521|11061874|FG001|Overall Study|Withdrawal by Subject|1
6998471|NCT01366521|11061875|FG002|Overall Study|Withdrawal by Subject|0
6998472|NCT01366521|11061876|FG003|Overall Study|Withdrawal by Subject|0
6998473|NCT01366534|11061891|FG000|Overall Study|Lost to Follow-up|1
6998474|NCT01366534|11061892|FG001|Overall Study|Lost to Follow-up|0
6998475|NCT01366534|11061893|FG002|Overall Study|Lost to Follow-up|0
6998476|NCT01366534|11061891|FG000|Overall Study|Migrated|1
6998477|NCT01366534|11061892|FG001|Overall Study|Migrated|1
6998478|NCT01366534|11061893|FG002|Overall Study|Migrated|0
6998479|NCT01366534|11061891|FG000|Overall Study|Declined challenged|0
6998480|NCT01366534|11061892|FG001|Overall Study|Declined challenged|1
6998481|NCT01366534|11061893|FG002|Overall Study|Declined challenged|0
6998482|NCT01366638|11061904|FG000|Overall Study|Withdrawal by Subject|0
6998483|NCT01366638|11061905|FG001|Overall Study|Withdrawal by Subject|0
6998484|NCT01366638|11061906|FG002|Overall Study|Withdrawal by Subject|6
6998485|NCT01366638|11061904|FG000|Overall Study|Other|1
6998486|NCT01366638|11061905|FG001|Overall Study|Other|0
6998487|NCT01366638|11061906|FG002|Overall Study|Other|0
6998488|NCT01366846|11061918|FG000|Overall Study|Withdrawal by Subject|2
6998489|NCT01366846|11061919|FG001|Overall Study|Withdrawal by Subject|0
6998490|NCT01366846|11061920|FG002|Overall Study|Withdrawal by Subject|0
6998491|NCT01366846|11061921|FG003|Overall Study|Withdrawal by Subject|0
6998492|NCT01366846|11061918|FG000|Overall Study|Communication Difficulties|1
6998493|NCT01366846|11061919|FG001|Overall Study|Communication Difficulties|4
6998494|NCT01366846|11061920|FG002|Overall Study|Communication Difficulties|0
6998495|NCT01366846|11061921|FG003|Overall Study|Communication Difficulties|1
6998496|NCT01366846|11061918|FG000|Overall Study|Scheduling Conflicts|0
6998497|NCT01366846|11061919|FG001|Overall Study|Scheduling Conflicts|0
6998498|NCT01366846|11061920|FG002|Overall Study|Scheduling Conflicts|1
6998499|NCT01366846|11061921|FG003|Overall Study|Scheduling Conflicts|0
6998500|NCT01367119|11061964|FG000|Overall Study|Adverse Event|1
6998501|NCT01367119|11061965|FG001|Overall Study|Adverse Event|0
6998502|NCT01367119|11061964|FG000|Overall Study|Withdrawal by Subject|1
6998503|NCT01367119|11061965|FG001|Overall Study|Withdrawal by Subject|1
6998504|NCT01367158|11061982|FG000|Overall Study|Withdrew consent|0
6998505|NCT01367158|11061983|FG001|Overall Study|Withdrew consent|2
6998506|NCT01367158|11061984|FG002|Overall Study|Withdrew consent|1
6827062|NCT00122109|10829562|FG000|Overall Study|Did not meet criteria|6
6827063|NCT00122109|10829563|FG001|Overall Study|Did not meet criteria|7
6827064|NCT00122135|10829574|FG000|Overall Study|Withdrawal by Subject|3
6827065|NCT00122135|10829575|FG001|Overall Study|Withdrawal by Subject|0
6827066|NCT00122187|10829583|FG000|Overall Study|Withdrew because of resource limitations|2
6827067|NCT00122187|10829584|FG001|Overall Study|Withdrew because of resource limitations|2
6827068|NCT00122278|10829594|FG000|Overall Study|Lost to Follow-up|2
6827069|NCT00122278|10829595|FG001|Overall Study|Lost to Follow-up|0
6827070|NCT00122317|10829601|FG000|Overall Study|Death|3
6827071|NCT00122317|10829601|FG000|Overall Study|Adverse Event|4
6827072|NCT00122317|10829601|FG000|Overall Study|Physician Decision|2
6827073|NCT00122317|10829601|FG000|Overall Study|patient non-compliance|1
6827074|NCT00122317|10829601|FG000|Overall Study|Withdrawal by Subject|1
6827075|NCT00122382|10829623|FG000|Double-Blind Study|Adverse Event|9
6827076|NCT00122382|10829624|FG001|Double-Blind Study|Adverse Event|11
6827077|NCT00122382|10829625|FG002|Double-Blind Study|Adverse Event|0
6827078|NCT00122382|10829623|FG000|Double-Blind Study|Death|2
6827079|NCT00122382|10829624|FG001|Double-Blind Study|Death|2
6827080|NCT00122382|10829625|FG002|Double-Blind Study|Death|0
6827081|NCT00122382|10829623|FG000|Double-Blind Study|Lack of Efficacy|0
6827082|NCT00122382|10829624|FG001|Double-Blind Study|Lack of Efficacy|8
6827083|NCT00122382|10829625|FG002|Double-Blind Study|Lack of Efficacy|0
6827084|NCT00122382|10829623|FG000|Double-Blind Study|Lost to Follow-up|2
6827085|NCT00122382|10829624|FG001|Double-Blind Study|Lost to Follow-up|1
6827086|NCT00122382|10829625|FG002|Double-Blind Study|Lost to Follow-up|0
6827087|NCT00122382|10829623|FG000|Double-Blind Study|Pregnancy|2
6827088|NCT00122382|10829624|FG001|Double-Blind Study|Pregnancy|0
6827089|NCT00122382|10829625|FG002|Double-Blind Study|Pregnancy|0
6827090|NCT00122382|10829623|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1
6827091|NCT00122382|10829624|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0
6827092|NCT00122382|10829625|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0
6827093|NCT00122382|10829623|FG000|Double-Blind Study|Withdrawal of Consent|7
6827094|NCT00122382|10829624|FG001|Double-Blind Study|Withdrawal of Consent|3
6827095|NCT00122382|10829625|FG002|Double-Blind Study|Withdrawal of Consent|0
6827096|NCT00122382|10829623|FG000|Double-Blind Study|Protocol Violation|1
6998507|NCT01367158|11061985|FG003|Overall Study|Withdrew consent|0
6998508|NCT01367158|11061986|FG004|Overall Study|Withdrew consent|2
6998509|NCT01367158|11061987|FG005|Overall Study|Withdrew consent|0
6998510|NCT01367158|11061988|FG006|Overall Study|Withdrew consent|0
6998511|NCT01367158|11061989|FG007|Overall Study|Withdrew consent|1
6998512|NCT01367158|11061990|FG008|Overall Study|Withdrew consent|0
6998513|NCT01367158|11061991|FG009|Overall Study|Withdrew consent|0
6998514|NCT01367158|11061992|FG010|Overall Study|Withdrew consent|0
6998515|NCT01367158|11061982|FG000|Overall Study|Lost to Follow-up|0
6998516|NCT01367158|11061983|FG001|Overall Study|Lost to Follow-up|0
6998517|NCT01367158|11061984|FG002|Overall Study|Lost to Follow-up|0
6998518|NCT01367158|11061985|FG003|Overall Study|Lost to Follow-up|1
6998519|NCT01367158|11061986|FG004|Overall Study|Lost to Follow-up|0
6998520|NCT01367158|11061987|FG005|Overall Study|Lost to Follow-up|2
6998521|NCT01367158|11061988|FG006|Overall Study|Lost to Follow-up|0
6998522|NCT01367158|11061989|FG007|Overall Study|Lost to Follow-up|1
6998523|NCT01367158|11061990|FG008|Overall Study|Lost to Follow-up|0
6998524|NCT01367158|11061991|FG009|Overall Study|Lost to Follow-up|0
6998525|NCT01367158|11061992|FG010|Overall Study|Lost to Follow-up|1
6998526|NCT01367158|11061982|FG000|Overall Study|Protocol Violation|0
6998527|NCT01367158|11061983|FG001|Overall Study|Protocol Violation|1
6998528|NCT01367158|11061984|FG002|Overall Study|Protocol Violation|0
6998529|NCT01367158|11061985|FG003|Overall Study|Protocol Violation|0
6998530|NCT01367158|11061986|FG004|Overall Study|Protocol Violation|0
6998531|NCT01367158|11061987|FG005|Overall Study|Protocol Violation|0
6998532|NCT01367158|11061988|FG006|Overall Study|Protocol Violation|0
6998533|NCT01367158|11061989|FG007|Overall Study|Protocol Violation|0
6998534|NCT01367158|11061990|FG008|Overall Study|Protocol Violation|0
6998535|NCT01367158|11061991|FG009|Overall Study|Protocol Violation|0
6998536|NCT01367158|11061992|FG010|Overall Study|Protocol Violation|0
6998537|NCT01367236|11062029|FG000|Overall Study|Withdrawal by Subject|3
6998538|NCT01367236|11062030|FG001|Overall Study|Withdrawal by Subject|1
6998539|NCT01367249|11062038|FG000|Overall Study|Withdrawal by Subject|6
6998540|NCT01367249|11062039|FG001|Overall Study|Withdrawal by Subject|6
6998541|NCT01367249|11062038|FG000|Overall Study|Other|3
6998542|NCT01367249|11062039|FG001|Overall Study|Other|10
6998543|NCT01367275|11062049|FG000|Overall Study|Ineligible|1
6998544|NCT01367275|11062049|FG000|Overall Study|Disease Progression|2
6998545|NCT01367457|11062085|FG000|Overall Study|Death|2
6998546|NCT01367457|11062086|FG001|Overall Study|Death|0
6998547|NCT01367457|11062087|FG002|Overall Study|Death|0
6998548|NCT01367457|11062085|FG000|Overall Study|Investigator's decision|2
6998549|NCT01367457|11062086|FG001|Overall Study|Investigator's decision|0
6998550|NCT01367457|11062087|FG002|Overall Study|Investigator's decision|0
6998551|NCT01367457|11062085|FG000|Overall Study|Clinical decline (CD)|2
6998552|NCT01367457|11062086|FG001|Overall Study|Clinical decline (CD)|0
6998553|NCT01367457|11062087|FG002|Overall Study|Clinical decline (CD)|0
6998554|NCT01367457|11062085|FG000|Overall Study|Progression and death|8
6998555|NCT01367457|11062086|FG001|Overall Study|Progression and death|0
6998556|NCT01367457|11062087|FG002|Overall Study|Progression and death|0
6998557|NCT01367457|11062085|FG000|Overall Study|Toxicity|16
6998558|NCT01367457|11062086|FG001|Overall Study|Toxicity|0
6998559|NCT01367457|11062087|FG002|Overall Study|Toxicity|0
6998560|NCT01367457|11062085|FG000|Overall Study|Progression|137
6998561|NCT01367457|11062086|FG001|Overall Study|Progression|0
6998562|NCT01367457|11062087|FG002|Overall Study|Progression|0
6998563|NCT01367457|11062085|FG000|Overall Study|Patient asks for rest + slow progression|1
6998564|NCT01367457|11062086|FG001|Overall Study|Patient asks for rest + slow progression|0
6998565|NCT01367457|11062087|FG002|Overall Study|Patient asks for rest + slow progression|0
6998566|NCT01367457|11062085|FG000|Overall Study|Investigator's opinion, stable disease|1
6998567|NCT01367457|11062086|FG001|Overall Study|Investigator's opinion, stable disease|0
6998568|NCT01367457|11062087|FG002|Overall Study|Investigator's opinion, stable disease|0
6998569|NCT01367457|11062085|FG000|Overall Study|Bleeding from cavernous haemangioma|1
6998570|NCT01367457|11062086|FG001|Overall Study|Bleeding from cavernous haemangioma|0
6998571|NCT01367457|11062087|FG002|Overall Study|Bleeding from cavernous haemangioma|0
6998572|NCT01367457|11062085|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1
6998573|NCT01367457|11062086|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0
6998574|NCT01367457|11062087|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0
6998575|NCT01367457|11062085|FG000|Overall Study|low grade toxicities + stable disease|1
6998576|NCT01367457|11062086|FG001|Overall Study|low grade toxicities + stable disease|0
6998577|NCT01367457|11062087|FG002|Overall Study|low grade toxicities + stable disease|0
6998578|NCT01367457|11062085|FG000|Overall Study|Choledocolithiasis and pancreatitis|1
6998579|NCT01367457|11062086|FG001|Overall Study|Choledocolithiasis and pancreatitis|0
6998580|NCT01367457|11062087|FG002|Overall Study|Choledocolithiasis and pancreatitis|0
6998581|NCT01367457|11062085|FG000|Overall Study|Withdrawal by Subject|1
6998582|NCT01367457|11062086|FG001|Overall Study|Withdrawal by Subject|0
6998583|NCT01367457|11062087|FG002|Overall Study|Withdrawal by Subject|0
6998584|NCT01367457|11062085|FG000|Overall Study|CD, associated leukaemia|1
6998585|NCT01367457|11062086|FG001|Overall Study|CD, associated leukaemia|0
6998586|NCT01367457|11062087|FG002|Overall Study|CD, associated leukaemia|0
6998587|NCT01367457|11062085|FG000|Overall Study|Uncontrolled pain|1
6998588|NCT01367457|11062086|FG001|Overall Study|Uncontrolled pain|0
6998589|NCT01367457|11062087|FG002|Overall Study|Uncontrolled pain|0
6998590|NCT01367457|11062085|FG000|Overall Study|Overall status worsens to grade 4|1
6998591|NCT01367457|11062086|FG001|Overall Study|Overall status worsens to grade 4|0
6998592|NCT01367457|11062087|FG002|Overall Study|Overall status worsens to grade 4|0
6998593|NCT01367457|11062085|FG000|Overall Study|Stabilisation + frequent infections|1
6998594|NCT01367457|11062086|FG001|Overall Study|Stabilisation + frequent infections|0
6998595|NCT01367457|11062087|FG002|Overall Study|Stabilisation + frequent infections|0
6998596|NCT01367457|11062085|FG000|Overall Study|No clinical benefit|1
6998597|NCT01367457|11062086|FG001|Overall Study|No clinical benefit|0
6998598|NCT01367457|11062087|FG002|Overall Study|No clinical benefit|0
6998599|NCT01367457|11062085|FG000|Overall Study|Intestinal obstruction with necrosis|1
6998600|NCT01367457|11062086|FG001|Overall Study|Intestinal obstruction with necrosis|0
6998601|NCT01367457|11062087|FG002|Overall Study|Intestinal obstruction with necrosis|0
6998602|NCT01367457|11062085|FG000|Overall Study|Overall decline|1
6998603|NCT01367457|11062086|FG001|Overall Study|Overall decline|0
6998604|NCT01367457|11062087|FG002|Overall Study|Overall decline|0
6998605|NCT01367457|11062085|FG000|Overall Study|Rejection of treatment|1
6998606|NCT01367457|11062086|FG001|Overall Study|Rejection of treatment|0
6998607|NCT01367457|11062087|FG002|Overall Study|Rejection of treatment|0
6998608|NCT01367457|11062085|FG000|Overall Study|Lost to Follow-up|1
6998609|NCT01367457|11062086|FG001|Overall Study|Lost to Follow-up|0
6998610|NCT01367457|11062087|FG002|Overall Study|Lost to Follow-up|0
6998611|NCT01367457|11062085|FG000|Overall Study|Death from septic shock|1
6998612|NCT01367457|11062086|FG001|Overall Study|Death from septic shock|0
6998613|NCT01367457|11062087|FG002|Overall Study|Death from septic shock|0
6998614|NCT01367457|11062085|FG000|Overall Study|CD, Suspected disease progression (DP)|1
6998615|NCT01367457|11062086|FG001|Overall Study|CD, Suspected disease progression (DP)|0
6998616|NCT01367457|11062087|FG002|Overall Study|CD, Suspected disease progression (DP)|0
6998617|NCT01367457|11062085|FG000|Overall Study|Patient's Wish|1
6998618|NCT01367457|11062086|FG001|Overall Study|Patient's Wish|0
6998619|NCT01367457|11062087|FG002|Overall Study|Patient's Wish|0
6998620|NCT01367457|11062085|FG000|Overall Study|Palliative. Overall decline|1
6998621|NCT01367457|11062086|FG001|Overall Study|Palliative. Overall decline|0
6998622|NCT01367457|11062087|FG002|Overall Study|Palliative. Overall decline|0
6998623|NCT01367457|11062085|FG000|Overall Study|Suspected DP/suspected active infection|1
6998624|NCT01367457|11062086|FG001|Overall Study|Suspected DP/suspected active infection|0
6998625|NCT01367457|11062087|FG002|Overall Study|Suspected DP/suspected active infection|0
6998626|NCT01367665|11062097|FG000|Overall Study|Death|102
6998627|NCT01367665|11062098|FG001|Overall Study|Death|19
6998628|NCT01367665|11062097|FG000|Overall Study|Lost to Follow-up|222
6998629|NCT01367665|11062098|FG001|Overall Study|Lost to Follow-up|22
6998630|NCT01367665|11062097|FG000|Overall Study|Not Done|118
6998631|NCT01367665|11062098|FG001|Overall Study|Not Done|14
6998632|NCT01367704|11062107|FG000|Overall Study|Lost to Follow-up|47
6998633|NCT01367704|11062108|FG001|Overall Study|Lost to Follow-up|161
6998634|NCT01367834|11062116|FG000|Overall Study|Withdrawal by Subject|2
6998635|NCT01367834|11062117|FG001|Overall Study|Withdrawal by Subject|2
6998636|NCT01367834|11062116|FG000|Overall Study|Study was ended.|0
6998637|NCT01367834|11062117|FG001|Overall Study|Study was ended.|1
6998638|NCT01367847|11062125|FG000|Overall Study|Withdrawal by Subject|2
6998639|NCT01367847|11062126|FG001|Overall Study|Withdrawal by Subject|2
6998640|NCT01367886|11062142|FG000|Overall Study|Lost to Follow-up|4
6998641|NCT01367886|11062142|FG000|Overall Study|Lack of Efficacy|2
6998642|NCT01367886|11062142|FG000|Overall Study|Death|1
6998643|NCT01368042|11062147|FG000|Overall Study|Death|14
6998644|NCT01368042|11062147|FG000|Overall Study|Protocol Violation|11
6998645|NCT01368042|11062147|FG000|Overall Study|Lost to Follow-up|4
6998646|NCT01368042|11062147|FG000|Overall Study|Transplanted|1
6998647|NCT01368081|11062164|FG000|Overall Study|Adverse Event|4
6998648|NCT01368081|11062165|FG001|Overall Study|Adverse Event|4
6998649|NCT01368081|11062166|FG002|Overall Study|Adverse Event|3
6998650|NCT01368081|11062167|FG003|Overall Study|Adverse Event|2
6998651|NCT01368081|11062168|FG004|Overall Study|Adverse Event|2
6998652|NCT01368081|11062169|FG005|Overall Study|Adverse Event|5
6998653|NCT01368081|11062170|FG006|Overall Study|Adverse Event|6
6998654|NCT01368081|11062171|FG007|Overall Study|Adverse Event|2
6998655|NCT01368081|11062172|FG008|Overall Study|Adverse Event|3
6998656|NCT01368081|11062173|FG009|Overall Study|Adverse Event|5
6998657|NCT01368081|11062174|FG010|Overall Study|Adverse Event|6
6998658|NCT01368081|11062175|FG011|Overall Study|Adverse Event|1
6998659|NCT01368081|11062176|FG012|Overall Study|Adverse Event|3
6998660|NCT01368081|11062164|FG000|Overall Study|Lack of Efficacy|0
6998661|NCT01368081|11062165|FG001|Overall Study|Lack of Efficacy|1
6998662|NCT01368081|11062166|FG002|Overall Study|Lack of Efficacy|0
6998663|NCT01368081|11062167|FG003|Overall Study|Lack of Efficacy|1
6998664|NCT01368081|11062168|FG004|Overall Study|Lack of Efficacy|0
6998665|NCT01368081|11062169|FG005|Overall Study|Lack of Efficacy|0
6998666|NCT01368081|11062170|FG006|Overall Study|Lack of Efficacy|0
6998667|NCT01368081|11062171|FG007|Overall Study|Lack of Efficacy|2
6998668|NCT01368081|11062172|FG008|Overall Study|Lack of Efficacy|0
6998669|NCT01368081|11062173|FG009|Overall Study|Lack of Efficacy|0
6998670|NCT01368081|11062174|FG010|Overall Study|Lack of Efficacy|0
6998671|NCT01368081|11062175|FG011|Overall Study|Lack of Efficacy|0
6998672|NCT01368081|11062176|FG012|Overall Study|Lack of Efficacy|0
6998673|NCT01368081|11062164|FG000|Overall Study|Protocol Violation|0
6998674|NCT01368081|11062165|FG001|Overall Study|Protocol Violation|0
6998675|NCT01368081|11062166|FG002|Overall Study|Protocol Violation|0
6998676|NCT01368081|11062167|FG003|Overall Study|Protocol Violation|0
6998677|NCT01368081|11062168|FG004|Overall Study|Protocol Violation|0
6998678|NCT01368081|11062169|FG005|Overall Study|Protocol Violation|1
6998679|NCT01368081|11062170|FG006|Overall Study|Protocol Violation|0
6998680|NCT01368081|11062171|FG007|Overall Study|Protocol Violation|1
6998681|NCT01368081|11062172|FG008|Overall Study|Protocol Violation|0
6998682|NCT01368081|11062173|FG009|Overall Study|Protocol Violation|0
6998683|NCT01368081|11062174|FG010|Overall Study|Protocol Violation|0
6998684|NCT01368081|11062175|FG011|Overall Study|Protocol Violation|0
6998685|NCT01368081|11062176|FG012|Overall Study|Protocol Violation|0
6998686|NCT01368081|11062164|FG000|Overall Study|Lost to Follow-up|0
6998687|NCT01368081|11062165|FG001|Overall Study|Lost to Follow-up|0
6998688|NCT01368081|11062166|FG002|Overall Study|Lost to Follow-up|0
6998689|NCT01368081|11062167|FG003|Overall Study|Lost to Follow-up|0
6998690|NCT01368081|11062168|FG004|Overall Study|Lost to Follow-up|0
6998691|NCT01368081|11062169|FG005|Overall Study|Lost to Follow-up|0
6998692|NCT01368081|11062170|FG006|Overall Study|Lost to Follow-up|0
6998693|NCT01368081|11062171|FG007|Overall Study|Lost to Follow-up|0
6998694|NCT01368081|11062172|FG008|Overall Study|Lost to Follow-up|0
6998695|NCT01368081|11062173|FG009|Overall Study|Lost to Follow-up|0
6998696|NCT01368081|11062174|FG010|Overall Study|Lost to Follow-up|0
6998697|NCT01368081|11062175|FG011|Overall Study|Lost to Follow-up|0
6998698|NCT01368081|11062176|FG012|Overall Study|Lost to Follow-up|1
6998699|NCT01368081|11062164|FG000|Overall Study|Withdrawal by Subject|4
6998700|NCT01368081|11062165|FG001|Overall Study|Withdrawal by Subject|4
6998701|NCT01368081|11062166|FG002|Overall Study|Withdrawal by Subject|1
6998702|NCT01368081|11062167|FG003|Overall Study|Withdrawal by Subject|1
6998703|NCT01368081|11062168|FG004|Overall Study|Withdrawal by Subject|0
6998704|NCT01368081|11062169|FG005|Overall Study|Withdrawal by Subject|3
6998705|NCT01368081|11062170|FG006|Overall Study|Withdrawal by Subject|4
6998706|NCT01368081|11062171|FG007|Overall Study|Withdrawal by Subject|2
6998707|NCT01368081|11062172|FG008|Overall Study|Withdrawal by Subject|5
6998708|NCT01368081|11062173|FG009|Overall Study|Withdrawal by Subject|4
6998709|NCT01368081|11062174|FG010|Overall Study|Withdrawal by Subject|3
6998710|NCT01368081|11062175|FG011|Overall Study|Withdrawal by Subject|2
6998711|NCT01368081|11062176|FG012|Overall Study|Withdrawal by Subject|0
6998712|NCT01368081|11062164|FG000|Overall Study|Other reason not defined above|2
6998713|NCT01368081|11062165|FG001|Overall Study|Other reason not defined above|0
6998714|NCT01368081|11062166|FG002|Overall Study|Other reason not defined above|0
6998715|NCT01368081|11062167|FG003|Overall Study|Other reason not defined above|1
6998716|NCT01368081|11062168|FG004|Overall Study|Other reason not defined above|0
6998717|NCT01368081|11062169|FG005|Overall Study|Other reason not defined above|1
6998718|NCT01368081|11062170|FG006|Overall Study|Other reason not defined above|2
6998719|NCT01368081|11062171|FG007|Overall Study|Other reason not defined above|0
6998720|NCT01368081|11062172|FG008|Overall Study|Other reason not defined above|0
6998721|NCT01368081|11062173|FG009|Overall Study|Other reason not defined above|1
6998722|NCT01368081|11062174|FG010|Overall Study|Other reason not defined above|0
6998723|NCT01368081|11062175|FG011|Overall Study|Other reason not defined above|0
6998724|NCT01368081|11062176|FG012|Overall Study|Other reason not defined above|3
6998725|NCT01368211|11062206|FG000|Second Platelets Transfusion|No need for additional transfusion|1
6998726|NCT01368211|11062207|FG001|Second Platelets Transfusion|No need for additional transfusion|2
6998727|NCT01368276|11062228|FG000|Overall Study|Death|1
6998728|NCT01368276|11062229|FG001|Overall Study|Death|10
6998729|NCT01368406|11062237|FG000|Overall Study|Lost to Follow-up|8
6998730|NCT01368406|11062238|FG001|Overall Study|Lost to Follow-up|4
6998731|NCT01368406|11062237|FG000|Overall Study|Withdrawal by Subject|8
6998732|NCT01368406|11062238|FG001|Overall Study|Withdrawal by Subject|4
6998733|NCT01368406|11062237|FG000|Overall Study|relapse of the disease|3
6998734|NCT01368406|11062238|FG001|Overall Study|relapse of the disease|2
6998735|NCT01368406|11062237|FG000|Overall Study|started working|2
6998736|NCT01368406|11062238|FG001|Overall Study|started working|3
6998737|NCT01368432|11062246|FG000|Overall Study|Lost to Follow-up|0
6998738|NCT01368432|11062247|FG001|Overall Study|Lost to Follow-up|1
6998739|NCT01368536|11062270|FG000|Overall Study|Adverse Event|5
6998740|NCT01368536|11062271|FG001|Overall Study|Adverse Event|6
6998741|NCT01368536|11062272|FG002|Overall Study|Adverse Event|8
6998742|NCT01368536|11062270|FG000|Overall Study|Abnormal laboratory value(s)|0
6998743|NCT01368536|11062271|FG001|Overall Study|Abnormal laboratory value(s)|1
6998744|NCT01368536|11062272|FG002|Overall Study|Abnormal laboratory value(s)|2
6998745|NCT01368536|11062270|FG000|Overall Study|Abnormal test procedure result(s)|0
6998746|NCT01368536|11062271|FG001|Overall Study|Abnormal test procedure result(s)|0
6998747|NCT01368536|11062272|FG002|Overall Study|Abnormal test procedure result(s)|1
6998748|NCT01368536|11062270|FG000|Overall Study|Unsatisfactory therapeutic effect|7
6998749|NCT01368536|11062271|FG001|Overall Study|Unsatisfactory therapeutic effect|2
6998750|NCT01368536|11062272|FG002|Overall Study|Unsatisfactory therapeutic effect|2
6998751|NCT01368536|11062270|FG000|Overall Study|No longer required study medication|0
6998752|NCT01368536|11062271|FG001|Overall Study|No longer required study medication|0
6998753|NCT01368536|11062272|FG002|Overall Study|No longer required study medication|1
6998754|NCT01368536|11062270|FG000|Overall Study|Withdrawal by Subject|2
6998755|NCT01368536|11062271|FG001|Overall Study|Withdrawal by Subject|5
6998756|NCT01368536|11062272|FG002|Overall Study|Withdrawal by Subject|4
6998757|NCT01368536|11062270|FG000|Overall Study|Lost to Follow-up|3
6998758|NCT01368536|11062271|FG001|Overall Study|Lost to Follow-up|3
6998759|NCT01368536|11062272|FG002|Overall Study|Lost to Follow-up|5
6998760|NCT01368536|11062270|FG000|Overall Study|Administrative problems|34
6998761|NCT01368536|11062271|FG001|Overall Study|Administrative problems|39
6998762|NCT01368536|11062272|FG002|Overall Study|Administrative problems|35
6998763|NCT01368536|11062270|FG000|Overall Study|Protocol deviation|0
6998764|NCT01368536|11062271|FG001|Overall Study|Protocol deviation|3
6998765|NCT01368536|11062272|FG002|Overall Study|Protocol deviation|1
6998766|NCT01368562|11062281|FG000|Overall Study|Adverse Event|1
6998767|NCT01368562|11062281|FG000|Overall Study|Disease progression|1
6998768|NCT01368562|11062281|FG000|Overall Study|Lost to Follow-up|1
6998769|NCT01368562|11062281|FG000|Overall Study|Death|6
6998770|NCT01368562|11062281|FG000|Overall Study|Unresponsive to treatment|5
6998771|NCT01368562|11062281|FG000|Overall Study|Other|3
6998772|NCT01368562|11062281|FG000|Overall Study|Other than specified|2
6998773|NCT01368614|11062285|FG000|Screening Period|Screen Failure|58
6998774|NCT01368614|11062286|FG001|Screening Period|Screen Failure|0
6998775|NCT01368614|11062287|FG002|Screening Period|Screen Failure|0
6998776|NCT01368614|11062288|FG003|Screening Period|Screen Failure|0
6998777|NCT01368614|11062285|FG000|Study Period|Withdrawal by Subject|0
6998778|NCT01368614|11062286|FG001|Study Period|Withdrawal by Subject|1
6998779|NCT01368614|11062287|FG002|Study Period|Withdrawal by Subject|1
6998780|NCT01368614|11062288|FG003|Study Period|Withdrawal by Subject|3
6998781|NCT01368614|11062285|FG000|Study Period|Lost to Follow-up|0
6998782|NCT01368614|11062286|FG001|Study Period|Lost to Follow-up|0
6998783|NCT01368614|11062287|FG002|Study Period|Lost to Follow-up|1
6998784|NCT01368614|11062288|FG003|Study Period|Lost to Follow-up|0
7042747|NCT01737710|11127261|FG001|Overall Study|Withdrawal by Subject|1
7042748|NCT01737710|11127262|FG002|Overall Study|Withdrawal by Subject|1
7042749|NCT01737710|11127263|FG003|Overall Study|Withdrawal by Subject|0
7042750|NCT01737710|11127264|FG004|Overall Study|Withdrawal by Subject|0
7042751|NCT01737710|11127260|FG000|Overall Study|Vaccinated in Error/Ineligible|1
7042752|NCT01737710|11127261|FG001|Overall Study|Vaccinated in Error/Ineligible|1
7042753|NCT01737710|11127262|FG002|Overall Study|Vaccinated in Error/Ineligible|0
7042754|NCT01737710|11127263|FG003|Overall Study|Vaccinated in Error/Ineligible|0
7042755|NCT01737710|11127264|FG004|Overall Study|Vaccinated in Error/Ineligible|0
7042756|NCT01737762|11127277|FG000|Overall Study|Adverse Event|2
7042757|NCT01737762|11127278|FG001|Overall Study|Adverse Event|2
6998785|NCT01368835|11062323|FG000|Overall Study|Inclusion criteria/photography quality|22
6998786|NCT01368835|11062323|FG000|Overall Study|Lost to Follow-up|11
6998787|NCT01368900|11062375|FG000|Overall Study|Lost to Follow-up|7
6998788|NCT01368965|11062381|FG000|Overall Study|Lost to Follow-up|12
6998789|NCT01369069|11062393|FG000|Overall Study|Lost to Follow-up|8
6998790|NCT01369069|11062394|FG001|Overall Study|Lost to Follow-up|9
6998791|NCT01369069|11062393|FG000|Overall Study|Withdrawal by Subject|9
6998792|NCT01369069|11062394|FG001|Overall Study|Withdrawal by Subject|7
6998793|NCT01369225|11062411|FG000|Overall Study|Withdrawal by Subject|1
6998794|NCT01369225|11062412|FG001|Overall Study|Withdrawal by Subject|0
6998795|NCT01369225|11062413|FG002|Overall Study|Withdrawal by Subject|2
6998796|NCT01369225|11062414|FG003|Overall Study|Withdrawal by Subject|1
6998797|NCT01369225|11062415|FG004|Overall Study|Withdrawal by Subject|0
6998798|NCT01369225|11062416|FG005|Overall Study|Withdrawal by Subject|0
6998799|NCT01369225|11062411|FG000|Overall Study|Does Not Meet Entrance Criteria|0
6998800|NCT01369225|11062412|FG001|Overall Study|Does Not Meet Entrance Criteria|0
6998801|NCT01369225|11062413|FG002|Overall Study|Does Not Meet Entrance Criteria|1
6998802|NCT01369225|11062414|FG003|Overall Study|Does Not Meet Entrance Criteria|0
6998803|NCT01369225|11062415|FG004|Overall Study|Does Not Meet Entrance Criteria|0
6998804|NCT01369225|11062416|FG005|Overall Study|Does Not Meet Entrance Criteria|0
6998805|NCT01369225|11062411|FG000|Overall Study|Other|1
6998806|NCT01369225|11062412|FG001|Overall Study|Other|0
6998807|NCT01369225|11062413|FG002|Overall Study|Other|0
6998808|NCT01369225|11062414|FG003|Overall Study|Other|0
6998809|NCT01369225|11062415|FG004|Overall Study|Other|1
6998810|NCT01369225|11062416|FG005|Overall Study|Other|0
6998811|NCT01369225|11062411|FG000|Overall Study|Adverse Event|0
6998812|NCT01369225|11062412|FG001|Overall Study|Adverse Event|0
6998813|NCT01369225|11062413|FG002|Overall Study|Adverse Event|0
6998814|NCT01369225|11062414|FG003|Overall Study|Adverse Event|1
6998815|NCT01369225|11062415|FG004|Overall Study|Adverse Event|1
6998816|NCT01369225|11062416|FG005|Overall Study|Adverse Event|0
6998817|NCT01369329|11062433|FG000|Overall Study|Withdrawal by Subject|8
6998818|NCT01369329|11062434|FG001|Overall Study|Withdrawal by Subject|6
6998819|NCT01369329|11062435|FG002|Overall Study|Withdrawal by Subject|10
6998820|NCT01369329|11062433|FG000|Overall Study|Lost to Follow-up|2
6998821|NCT01369329|11062434|FG001|Overall Study|Lost to Follow-up|2
6998822|NCT01369329|11062435|FG002|Overall Study|Lost to Follow-up|2
6998823|NCT01369329|11062433|FG000|Overall Study|Other|2
6998824|NCT01369329|11062434|FG001|Overall Study|Other|3
6998825|NCT01369329|11062435|FG002|Overall Study|Other|2
6998826|NCT01369342|11062446|FG000|Overall Study|Withdrawal by Subject|7
6998827|NCT01369342|11062447|FG001|Overall Study|Withdrawal by Subject|7
6998828|NCT01369342|11062448|FG002|Overall Study|Withdrawal by Subject|2
6998829|NCT01369342|11062446|FG000|Overall Study|Lost to Follow-up|5
6998830|NCT01369342|11062447|FG001|Overall Study|Lost to Follow-up|2
6998831|NCT01369342|11062448|FG002|Overall Study|Lost to Follow-up|1
6998832|NCT01369342|11062446|FG000|Overall Study|Not Treated|1
6998833|NCT01369342|11062447|FG001|Overall Study|Not Treated|0
6998834|NCT01369342|11062448|FG002|Overall Study|Not Treated|0
6998835|NCT01369355|11062462|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9
6998836|NCT01369355|11062463|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12
6998837|NCT01369355|11062464|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6
6998838|NCT01369355|11062465|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7
6998839|NCT01369355|11062466|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14
6998840|NCT01369355|11062467|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25
6998841|NCT01369355|11062468|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0
6998842|NCT01369355|11062469|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0
6998843|NCT01369355|11062470|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0
6998844|NCT01369355|11062462|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15
6998845|NCT01369355|11062463|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14
6998846|NCT01369355|11062464|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15
6998847|NCT01369355|11062465|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15
6998848|NCT01369355|11062466|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126
6998849|NCT01369355|11062467|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217
6998850|NCT01369355|11062468|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0
6998851|NCT01369355|11062469|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0
6998852|NCT01369355|11062470|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0
6998853|NCT01369355|11062462|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
6998854|NCT01369355|11062463|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1
6998855|NCT01369355|11062464|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1
6998856|NCT01369355|11062465|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
6998857|NCT01369355|11062466|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
6998858|NCT01369355|11062467|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2
6998859|NCT01369355|11062468|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
6998860|NCT01369355|11062469|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
6998861|NCT01369355|11062470|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
6998862|NCT01369355|11062462|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1
6998863|NCT01369355|11062463|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
6998864|NCT01369355|11062464|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1
6998865|NCT01369355|11062465|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2
6998866|NCT01369355|11062466|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5
6998867|NCT01369355|11062467|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6
6998868|NCT01369355|11062468|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
6998869|NCT01369355|11062469|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
6998870|NCT01369355|11062470|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
6998871|NCT01369355|11062462|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6
6998872|NCT01369355|11062463|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2
6998873|NCT01369355|11062464|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7
6998874|NCT01369355|11062465|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6
6998875|NCT01369355|11062466|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8
6998876|NCT01369355|11062467|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22
6998877|NCT01369355|11062468|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0
6998878|NCT01369355|11062469|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0
6998879|NCT01369355|11062470|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0
6998880|NCT01369355|11062462|FG000|Week 0 - Week 44 (Maintenance)|Other|0
6998881|NCT01369355|11062463|FG001|Week 0 - Week 44 (Maintenance)|Other|0
6998882|NCT01369355|11062464|FG002|Week 0 - Week 44 (Maintenance)|Other|1
6998883|NCT01369355|11062465|FG003|Week 0 - Week 44 (Maintenance)|Other|0
6998884|NCT01369355|11062466|FG004|Week 0 - Week 44 (Maintenance)|Other|1
6998885|NCT01369355|11062467|FG005|Week 0 - Week 44 (Maintenance)|Other|0
6998886|NCT01369355|11062468|FG006|Week 0 - Week 44 (Maintenance)|Other|0
6998887|NCT01369355|11062469|FG007|Week 0 - Week 44 (Maintenance)|Other|0
6998888|NCT01369355|11062470|FG008|Week 0 - Week 44 (Maintenance)|Other|0
6998889|NCT01369355|11062462|FG000|Long-term Extension (Week 44-272)|Adverse Event|0
6998890|NCT01369355|11062463|FG001|Long-term Extension (Week 44-272)|Adverse Event|0
6998891|NCT01369355|11062464|FG002|Long-term Extension (Week 44-272)|Adverse Event|0
6998892|NCT01369355|11062465|FG003|Long-term Extension (Week 44-272)|Adverse Event|0
6998893|NCT01369355|11062466|FG004|Long-term Extension (Week 44-272)|Adverse Event|0
6998894|NCT01369355|11062467|FG005|Long-term Extension (Week 44-272)|Adverse Event|0
6998895|NCT01369355|11062468|FG006|Long-term Extension (Week 44-272)|Adverse Event|15
6998896|NCT01369355|11062469|FG007|Long-term Extension (Week 44-272)|Adverse Event|29
6998897|NCT01369355|11062470|FG008|Long-term Extension (Week 44-272)|Adverse Event|53
6998898|NCT01369355|11062462|FG000|Long-term Extension (Week 44-272)|Death|0
6998899|NCT01369355|11062463|FG001|Long-term Extension (Week 44-272)|Death|0
6998900|NCT01369355|11062464|FG002|Long-term Extension (Week 44-272)|Death|0
6998901|NCT01369355|11062465|FG003|Long-term Extension (Week 44-272)|Death|0
6998902|NCT01369355|11062466|FG004|Long-term Extension (Week 44-272)|Death|0
6998903|NCT01369355|11062467|FG005|Long-term Extension (Week 44-272)|Death|0
6998904|NCT01369355|11062468|FG006|Long-term Extension (Week 44-272)|Death|0
6998905|NCT01369355|11062469|FG007|Long-term Extension (Week 44-272)|Death|1
6998906|NCT01369355|11062470|FG008|Long-term Extension (Week 44-272)|Death|3
6998907|NCT01369355|11062462|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0
6998908|NCT01369355|11062463|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0
6998909|NCT01369355|11062464|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0
6998910|NCT01369355|11062465|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0
6998911|NCT01369355|11062466|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0
6998912|NCT01369355|11062467|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0
6998913|NCT01369355|11062468|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12
6998914|NCT01369355|11062469|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26
6998915|NCT01369355|11062470|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29
6998916|NCT01369355|11062462|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0
6998917|NCT01369355|11062463|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0
6998918|NCT01369355|11062464|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0
6998919|NCT01369355|11062465|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0
6998920|NCT01369355|11062466|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0
6998921|NCT01369355|11062467|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0
6998922|NCT01369355|11062468|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0
6998923|NCT01369355|11062469|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1
6998924|NCT01369355|11062470|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2
6998925|NCT01369355|11062462|FG000|Long-term Extension (Week 44-272)|Physician Decision|0
6998926|NCT01369355|11062463|FG001|Long-term Extension (Week 44-272)|Physician Decision|0
6998927|NCT01369355|11062464|FG002|Long-term Extension (Week 44-272)|Physician Decision|0
6998928|NCT01369355|11062465|FG003|Long-term Extension (Week 44-272)|Physician Decision|0
6998929|NCT01369355|11062466|FG004|Long-term Extension (Week 44-272)|Physician Decision|0
6998930|NCT01369355|11062467|FG005|Long-term Extension (Week 44-272)|Physician Decision|0
6998931|NCT01369355|11062468|FG006|Long-term Extension (Week 44-272)|Physician Decision|1
6998932|NCT01369355|11062469|FG007|Long-term Extension (Week 44-272)|Physician Decision|5
6998933|NCT01369355|11062470|FG008|Long-term Extension (Week 44-272)|Physician Decision|11
6998934|NCT01369355|11062462|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0
6998935|NCT01369355|11062463|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0
6998936|NCT01369355|11062464|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0
6998937|NCT01369355|11062465|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0
6998938|NCT01369355|11062466|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0
6998939|NCT01369355|11062467|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0
6998940|NCT01369355|11062468|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1
6998941|NCT01369355|11062469|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5
6998942|NCT01369355|11062470|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9
6998943|NCT01369355|11062462|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
6998944|NCT01369355|11062463|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
6998945|NCT01369355|11062464|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
6998946|NCT01369355|11062465|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
6998947|NCT01369355|11062466|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
6998948|NCT01369355|11062467|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
6998949|NCT01369355|11062468|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12
6998950|NCT01369355|11062469|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30
6998951|NCT01369355|11062470|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47
6998952|NCT01369355|11062462|FG000|Long-term Extension (Week 44-272)|Other|0
6998953|NCT01369355|11062463|FG001|Long-term Extension (Week 44-272)|Other|0
6998954|NCT01369355|11062464|FG002|Long-term Extension (Week 44-272)|Other|0
6998955|NCT01369355|11062465|FG003|Long-term Extension (Week 44-272)|Other|0
6998956|NCT01369355|11062466|FG004|Long-term Extension (Week 44-272)|Other|0
6998957|NCT01369355|11062467|FG005|Long-term Extension (Week 44-272)|Other|0
6998958|NCT01369355|11062468|FG006|Long-term Extension (Week 44-272)|Other|110
6998959|NCT01369355|11062469|FG007|Long-term Extension (Week 44-272)|Other|9
6998960|NCT01369355|11062470|FG008|Long-term Extension (Week 44-272)|Other|17
6998961|NCT01369433|11062489|FG000|Overall Study|Adverse Event|31
6998962|NCT01369433|11062490|FG001|Overall Study|Adverse Event|1
6998963|NCT01369433|11062489|FG000|Overall Study|Required significant surgical procedure|1
6998964|NCT01369433|11062490|FG001|Overall Study|Required significant surgical procedure|0
6998965|NCT01369433|11062489|FG000|Overall Study|Non-compliance|1
6998966|NCT01369433|11062490|FG001|Overall Study|Non-compliance|0
6998967|NCT01369433|11062489|FG000|Overall Study|Withdrawal by Subject|5
6998968|NCT01369433|11062490|FG001|Overall Study|Withdrawal by Subject|2
6998969|NCT01369433|11062489|FG000|Overall Study|Study terminated by Sponsor|67
6998970|NCT01369433|11062490|FG001|Overall Study|Study terminated by Sponsor|0
6998971|NCT01369433|11062489|FG000|Overall Study|Lost to Follow-up|1
6998972|NCT01369433|11062490|FG001|Overall Study|Lost to Follow-up|0
6998973|NCT01369433|11062489|FG000|Overall Study|Death|5
6998974|NCT01369433|11062490|FG001|Overall Study|Death|0
6998975|NCT01369433|11062489|FG000|Overall Study|Investigator discretion|6
6998976|NCT01369433|11062490|FG001|Overall Study|Investigator discretion|1
6998977|NCT01369433|11062489|FG000|Overall Study|Progressive Disease|92
6998978|NCT01369433|11062490|FG001|Overall Study|Progressive Disease|12
6998979|NCT01369485|11062498|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7
6998980|NCT01369485|11062499|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5
6998981|NCT01369485|11062498|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12
6998982|NCT01369485|11062499|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8
6998983|NCT01369485|11062498|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2
6998984|NCT01369485|11062499|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4
6998985|NCT01369485|11062498|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2
6998986|NCT01369485|11062499|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0
6998987|NCT01369485|11062498|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11
6998988|NCT01369485|11062499|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9
6998989|NCT01369485|11062498|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2
6998990|NCT01369485|11062499|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3
6998991|NCT01369485|11062498|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3
6998992|NCT01369485|11062499|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4
6998993|NCT01369485|11062498|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17
6998994|NCT01369485|11062499|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20
6998995|NCT01369485|11062498|FG000|Open Label Phase (Week 12 to Month 12)|Death|0
6998996|NCT01369485|11062499|FG001|Open Label Phase (Week 12 to Month 12)|Death|1
6998997|NCT01369485|11062498|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0
6998998|NCT01369485|11062499|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3
6998999|NCT01369498|11062517|FG000|Overall Study|Lack of Efficacy|9
6999000|NCT01369498|11062518|FG001|Overall Study|Lack of Efficacy|9
6999001|NCT01369498|11062519|FG002|Overall Study|Lack of Efficacy|1
6999002|NCT01369498|11062520|FG003|Overall Study|Lack of Efficacy|3
6999003|NCT01369498|11062517|FG000|Overall Study|Adverse Event|1
6999004|NCT01369498|11062518|FG001|Overall Study|Adverse Event|2
6999005|NCT01369498|11062519|FG002|Overall Study|Adverse Event|0
6999006|NCT01369498|11062520|FG003|Overall Study|Adverse Event|1
6999007|NCT01369498|11062517|FG000|Overall Study|Withdrawal of Consent|0
6999008|NCT01369498|11062518|FG001|Overall Study|Withdrawal of Consent|1
6999009|NCT01369498|11062519|FG002|Overall Study|Withdrawal of Consent|1
6999010|NCT01369498|11062520|FG003|Overall Study|Withdrawal of Consent|1
6999011|NCT01369498|11062517|FG000|Overall Study|Death|0
6999012|NCT01369498|11062518|FG001|Overall Study|Death|0
6999013|NCT01369498|11062519|FG002|Overall Study|Death|1
6999014|NCT01369498|11062520|FG003|Overall Study|Death|0
6999015|NCT01369498|11062517|FG000|Overall Study|Investigator's Discretion|1
6999016|NCT01369498|11062518|FG001|Overall Study|Investigator's Discretion|0
6999017|NCT01369498|11062519|FG002|Overall Study|Investigator's Discretion|1
6999018|NCT01369498|11062520|FG003|Overall Study|Investigator's Discretion|3
6999019|NCT01369498|11062517|FG000|Overall Study|Unknown Reason|1
6999020|NCT01369498|11062518|FG001|Overall Study|Unknown Reason|0
6999021|NCT01369498|11062519|FG002|Overall Study|Unknown Reason|11
6999022|NCT01369498|11062520|FG003|Overall Study|Unknown Reason|6
6999023|NCT01369498|11062517|FG000|Overall Study|Disease Progression|0
6999024|NCT01369498|11062518|FG001|Overall Study|Disease Progression|0
6999025|NCT01369498|11062519|FG002|Overall Study|Disease Progression|0
6999026|NCT01369498|11062520|FG003|Overall Study|Disease Progression|1
6999027|NCT01369511|11062535|FG000|Overall Study|Adverse Event|1
6999028|NCT01369511|11062536|FG001|Overall Study|Adverse Event|1
6999029|NCT01369511|11062537|FG002|Overall Study|Adverse Event|5
6999030|NCT01369511|11062538|FG003|Overall Study|Adverse Event|0
6999031|NCT01369511|11062535|FG000|Overall Study|Entry criteria not met|2
6999032|NCT01369511|11062536|FG001|Overall Study|Entry criteria not met|0
6999033|NCT01369511|11062537|FG002|Overall Study|Entry criteria not met|0
6999034|NCT01369511|11062538|FG003|Overall Study|Entry criteria not met|1
6999035|NCT01369511|11062535|FG000|Overall Study|Lost to Follow-up|0
6999036|NCT01369511|11062536|FG001|Overall Study|Lost to Follow-up|1
6999037|NCT01369511|11062537|FG002|Overall Study|Lost to Follow-up|1
6999038|NCT01369511|11062538|FG003|Overall Study|Lost to Follow-up|2
6999039|NCT01369511|11062535|FG000|Overall Study|Protocol Violation|0
6999040|NCT01369511|11062536|FG001|Overall Study|Protocol Violation|1
6999041|NCT01369511|11062537|FG002|Overall Study|Protocol Violation|0
6999042|NCT01369511|11062538|FG003|Overall Study|Protocol Violation|2
6999043|NCT01369511|11062535|FG000|Overall Study|Physician Decision|3
6999044|NCT01369511|11062536|FG001|Overall Study|Physician Decision|4
6999045|NCT01369511|11062537|FG002|Overall Study|Physician Decision|0
6999046|NCT01369511|11062538|FG003|Overall Study|Physician Decision|0
6999047|NCT01369511|11062535|FG000|Overall Study|Sponsor decision|2
6999048|NCT01369511|11062536|FG001|Overall Study|Sponsor decision|0
6999049|NCT01369511|11062537|FG002|Overall Study|Sponsor decision|1
6999050|NCT01369511|11062538|FG003|Overall Study|Sponsor decision|0
6999051|NCT01369511|11062535|FG000|Overall Study|Withdrawal by Subject|5
6999052|NCT01369511|11062536|FG001|Overall Study|Withdrawal by Subject|6
6999053|NCT01369511|11062537|FG002|Overall Study|Withdrawal by Subject|4
6999054|NCT01369511|11062538|FG003|Overall Study|Withdrawal by Subject|6
6999055|NCT01369615|11062550|FG000|Overall Study|Withdrawal by Subject|0
6999056|NCT01369615|11062551|FG001|Overall Study|Withdrawal by Subject|1
6999057|NCT01369615|11062550|FG000|Overall Study|Lost to Follow-up|0
6999058|NCT01369615|11062551|FG001|Overall Study|Lost to Follow-up|1
6999059|NCT01369680|11062561|FG000|Overall Study|Lost to Follow-up|0
6999060|NCT01369680|11062562|FG001|Overall Study|Lost to Follow-up|0
6999061|NCT01369680|11062563|FG002|Overall Study|Lost to Follow-up|1
6999062|NCT01369680|11062564|FG003|Overall Study|Lost to Follow-up|2
6999063|NCT01369784|11062623|FG000|Overall Study|Protocol Violation|12
6999064|NCT01369849|11062630|FG000|Overall Study|Ineligible prior to treatment|0
6999065|NCT01369849|11062631|FG001|Overall Study|Ineligible prior to treatment|0
6999066|NCT01369849|11062632|FG002|Overall Study|Ineligible prior to treatment|1
6999067|NCT01369849|11062630|FG000|Overall Study|Ineligible after receiving treatment|0
6999068|NCT01369849|11062631|FG001|Overall Study|Ineligible after receiving treatment|1
6999069|NCT01369849|11062632|FG002|Overall Study|Ineligible after receiving treatment|0
6999070|NCT01370005|11062667|FG000|Overall Study|Not treated|1
6999071|NCT01370005|11062668|FG001|Overall Study|Not treated|0
6999072|NCT01370005|11062669|FG002|Overall Study|Not treated|0
6999073|NCT01370005|11062667|FG000|Overall Study|Adverse Event|5
6999074|NCT01370005|11062668|FG001|Overall Study|Adverse Event|5
6999075|NCT01370005|11062669|FG002|Overall Study|Adverse Event|6
6999076|NCT01370005|11062667|FG000|Overall Study|Lack of Efficacy|1
6999077|NCT01370005|11062668|FG001|Overall Study|Lack of Efficacy|0
6999078|NCT01370005|11062669|FG002|Overall Study|Lack of Efficacy|0
6999079|NCT01370005|11062667|FG000|Overall Study|Non compliant with protocol|0
6999080|NCT01370005|11062668|FG001|Overall Study|Non compliant with protocol|1
6999081|NCT01370005|11062669|FG002|Overall Study|Non compliant with protocol|2
6999082|NCT01370005|11062667|FG000|Overall Study|Lost to Follow-up|1
6999083|NCT01370005|11062668|FG001|Overall Study|Lost to Follow-up|1
6999084|NCT01370005|11062669|FG002|Overall Study|Lost to Follow-up|1
6999085|NCT01370005|11062667|FG000|Overall Study|Patient refusal to continue,not due toAE|5
6999086|NCT01370005|11062668|FG001|Overall Study|Patient refusal to continue,not due toAE|4
6999087|NCT01370005|11062669|FG002|Overall Study|Patient refusal to continue,not due toAE|0
6999088|NCT01370005|11062667|FG000|Overall Study|Other reason not defined above|3
6999089|NCT01370005|11062668|FG001|Overall Study|Other reason not defined above|0
6999090|NCT01370005|11062669|FG002|Overall Study|Other reason not defined above|2
6999091|NCT01370018|11062677|FG000|Overall Study|Did not meet criteria for analysis|1
6999092|NCT01370083|11062683|FG000|Overall Study|Lost to Follow-up|2
6999093|NCT01370083|11062684|FG001|Overall Study|Lost to Follow-up|0
6999094|NCT01370083|11062683|FG000|Overall Study|Adverse Event|0
6999095|NCT01370083|11062684|FG001|Overall Study|Adverse Event|1
6999096|NCT01370213|11062710|FG000|Overall Study|Early Death|1
6999097|NCT01370213|11062711|FG001|Overall Study|Early Death|0
6999098|NCT01370213|11062712|FG002|Overall Study|Early Death|0
6999099|NCT01370213|11062710|FG000|Overall Study|Not evaluable|0
6999100|NCT01370213|11062711|FG001|Overall Study|Not evaluable|2
6999101|NCT01370213|11062712|FG002|Overall Study|Not evaluable|0
6999102|NCT01370265|11062719|FG000|First Intervention|Adverse Event|1
6999103|NCT01370265|11062720|FG001|First Intervention|Adverse Event|1
6999104|NCT01370317|11062729|FG000|Overall Study|Participant withdrew consent|1
6999105|NCT01370317|11062730|FG001|Overall Study|Participant withdrew consent|0
6999106|NCT01370317|11062729|FG000|Overall Study|Protocol deviation|0
6999107|NCT01370317|11062730|FG001|Overall Study|Protocol deviation|1
6999108|NCT01370356|11062738|FG000|Overall Study|Death|1
6999109|NCT01370356|11062739|FG001|Overall Study|Death|0
6999110|NCT01370356|11062738|FG000|Overall Study|Lack of Efficacy|6
6999111|NCT01370356|11062739|FG001|Overall Study|Lack of Efficacy|28
6999112|NCT01370356|11062738|FG000|Overall Study|Lost to Follow-up|76
6999113|NCT01370356|11062739|FG001|Overall Study|Lost to Follow-up|81
6999114|NCT01370356|11062738|FG000|Overall Study|Withdrawal by Subject|54
6999115|NCT01370356|11062739|FG001|Overall Study|Withdrawal by Subject|59
6999116|NCT01370356|11062738|FG000|Overall Study|Reason not specified|39
6999117|NCT01370356|11062739|FG001|Overall Study|Reason not specified|43
6999118|NCT01370356|11062738|FG000|Overall Study|Protocol Violation|3
6999119|NCT01370356|11062739|FG001|Overall Study|Protocol Violation|3
6999120|NCT01370356|11062738|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12
6999121|NCT01370356|11062739|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9
6999122|NCT01370356|11062738|FG000|Overall Study|AE Not Related to Study Drug|1
6999123|NCT01370356|11062739|FG001|Overall Study|AE Not Related to Study Drug|4
6999124|NCT01370408|11062758|FG000|Overall Study|treatment failure|9
6999125|NCT01370499|11062774|FG000|Overall Study|Adverse Event|38
6999126|NCT01370499|11062775|FG001|Overall Study|Adverse Event|12
6999127|NCT01370499|11062774|FG000|Overall Study|Lack of Efficacy|4
6999128|NCT01370499|11062775|FG001|Overall Study|Lack of Efficacy|2
6999129|NCT01370499|11062774|FG000|Overall Study|Lost to Follow-up|2
6999130|NCT01370499|11062775|FG001|Overall Study|Lost to Follow-up|1
6999131|NCT01370499|11062774|FG000|Overall Study|Physician Decision|3
6999132|NCT01370499|11062775|FG001|Overall Study|Physician Decision|3
6999133|NCT01370499|11062774|FG000|Overall Study|Protocol Violation|5
6999134|NCT01370499|11062775|FG001|Overall Study|Protocol Violation|4
6999135|NCT01370499|11062774|FG000|Overall Study|Withdrawal by Subject|18
6999136|NCT01370499|11062775|FG001|Overall Study|Withdrawal by Subject|7
6999137|NCT01370499|11062774|FG000|Overall Study|Sponsor Decision|41
6999138|NCT01370499|11062775|FG001|Overall Study|Sponsor Decision|15
6999139|NCT01370525|11062785|FG000|Overall Study|Voluntary Discontinuation by Subject|2
6999140|NCT01370525|11062786|FG001|Overall Study|Voluntary Discontinuation by Subject|3
6999141|NCT01370525|11062785|FG000|Overall Study|Eligibility criteria not fulfilled|2
6999142|NCT01370525|11062786|FG001|Overall Study|Eligibility criteria not fulfilled|0
6999143|NCT01370525|11062785|FG000|Overall Study|Adverse Event|0
6999144|NCT01370525|11062786|FG001|Overall Study|Adverse Event|1
6999145|NCT01370525|11062785|FG000|Overall Study|Protocol Violation|2
6999146|NCT01370525|11062786|FG001|Overall Study|Protocol Violation|1
6999147|NCT01370525|11062785|FG000|Overall Study|Lost to follow up|2
6999148|NCT01370525|11062786|FG001|Overall Study|Lost to follow up|6
6999149|NCT01370538|11062794|FG000|Overall Study|Voluntary Discontinuation by Subject|3
6999150|NCT01370538|11062795|FG001|Overall Study|Voluntary Discontinuation by Subject|2
6999151|NCT01370538|11062794|FG000|Overall Study|Eligibility criteria not fulfilled|0
6999152|NCT01370538|11062795|FG001|Overall Study|Eligibility criteria not fulfilled|1
6999153|NCT01370538|11062794|FG000|Overall Study|Adverse Event|1
6999154|NCT01370538|11062795|FG001|Overall Study|Adverse Event|0
6999155|NCT01370538|11062794|FG000|Overall Study|Protocol Violation|8
6999156|NCT01370538|11062795|FG001|Overall Study|Protocol Violation|5
6999157|NCT01370538|11062794|FG000|Overall Study|Development of study specific withdrawal|1
6999158|NCT01370538|11062795|FG001|Overall Study|Development of study specific withdrawal|1
6999159|NCT01370538|11062794|FG000|Overall Study|Lost to follow up|6
6999160|NCT01370538|11062795|FG001|Overall Study|Lost to follow up|10
6999161|NCT01370616|11062807|FG000|Overall Study|Adverse Event|11
6999162|NCT01370616|11062808|FG001|Overall Study|Adverse Event|16
6999163|NCT01370616|11062807|FG000|Overall Study|Death|1
6999164|NCT01370616|11062808|FG001|Overall Study|Death|0
6999165|NCT01370616|11062807|FG000|Overall Study|Lack of Efficacy|6
6999166|NCT01370616|11062808|FG001|Overall Study|Lack of Efficacy|2
6999167|NCT01370616|11062807|FG000|Overall Study|Lost to Follow-up|0
6999168|NCT01370616|11062808|FG001|Overall Study|Lost to Follow-up|3
6999169|NCT01370616|11062807|FG000|Overall Study|Physician Decision|6
6999170|NCT01370616|11062808|FG001|Overall Study|Physician Decision|6
6999171|NCT01370616|11062807|FG000|Overall Study|Progressive Disease|0
6999172|NCT01370616|11062808|FG001|Overall Study|Progressive Disease|1
6999173|NCT01370616|11062807|FG000|Overall Study|Recovery|1
6999174|NCT01370616|11062808|FG001|Overall Study|Recovery|0
6999175|NCT01370616|11062807|FG000|Overall Study|Technical Problems|3
6999176|NCT01370616|11062808|FG001|Overall Study|Technical Problems|5
6999177|NCT01370616|11062807|FG000|Overall Study|Withdrawal by Subject|34
6999178|NCT01370616|11062808|FG001|Overall Study|Withdrawal by Subject|34
6999179|NCT01370642|11062821|FG000|Overall Study|Adverse Event|2
6999180|NCT01370642|11062822|FG001|Overall Study|Adverse Event|1
6999181|NCT01370642|11062823|FG002|Overall Study|Adverse Event|1
6999182|NCT01370642|11062821|FG000|Overall Study|Detectable HCV RNA|0
6999183|NCT01370642|11062822|FG001|Overall Study|Detectable HCV RNA|0
6999184|NCT01370642|11062823|FG002|Overall Study|Detectable HCV RNA|22
6999185|NCT01370642|11062821|FG000|Overall Study|Lost to Follow-up|0
6999186|NCT01370642|11062822|FG001|Overall Study|Lost to Follow-up|0
6999187|NCT01370642|11062823|FG002|Overall Study|Lost to Follow-up|1
6999188|NCT01370642|11062821|FG000|Overall Study|Physician Decision|4
6999189|NCT01370642|11062822|FG001|Overall Study|Physician Decision|1
6999190|NCT01370642|11062823|FG002|Overall Study|Physician Decision|2
6999191|NCT01370642|11062821|FG000|Overall Study|Withdrawal by Subject|2
6999192|NCT01370642|11062822|FG001|Overall Study|Withdrawal by Subject|4
6999193|NCT01370642|11062823|FG002|Overall Study|Withdrawal by Subject|3
6999194|NCT01370655|11062843|FG000|Period 1|Adverse Event|2
6999195|NCT01370655|11062844|FG001|Period 1|Adverse Event|0
6999196|NCT01370655|11062845|FG002|Period 1|Adverse Event|0
6999197|NCT01370655|11062846|FG003|Period 1|Adverse Event|0
6999198|NCT01370655|11062847|FG004|Period 1|Adverse Event|0
6999199|NCT01370655|11062848|FG005|Period 1|Adverse Event|0
6999200|NCT01370655|11062849|FG006|Period 1|Adverse Event|1
6999201|NCT01370655|11062850|FG007|Period 1|Adverse Event|0
6999202|NCT01370655|11062851|FG008|Period 1|Adverse Event|0
6999203|NCT01370655|11062852|FG009|Period 1|Adverse Event|0
6999204|NCT01370655|11062853|FG010|Period 1|Adverse Event|0
6999205|NCT01370655|11062854|FG011|Period 1|Adverse Event|0
6999206|NCT01370655|11062843|FG000|Period 2|Adverse Event|0
6999207|NCT01370655|11062844|FG001|Period 2|Adverse Event|0
6999208|NCT01370655|11062845|FG002|Period 2|Adverse Event|1
6999209|NCT01370655|11062846|FG003|Period 2|Adverse Event|0
6999210|NCT01370655|11062847|FG004|Period 2|Adverse Event|1
6999211|NCT01370655|11062848|FG005|Period 2|Adverse Event|0
6999212|NCT01370655|11062849|FG006|Period 2|Adverse Event|0
6999213|NCT01370655|11062850|FG007|Period 2|Adverse Event|1
6999214|NCT01370655|11062851|FG008|Period 2|Adverse Event|0
6999215|NCT01370655|11062852|FG009|Period 2|Adverse Event|0
6999216|NCT01370655|11062853|FG010|Period 2|Adverse Event|0
6999217|NCT01370655|11062854|FG011|Period 2|Adverse Event|0
6999218|NCT01370655|11062843|FG000|Period 2|met protocol specified stopping criteria|0
6999219|NCT01370655|11062844|FG001|Period 2|met protocol specified stopping criteria|0
6999220|NCT01370655|11062845|FG002|Period 2|met protocol specified stopping criteria|1
6999221|NCT01370655|11062846|FG003|Period 2|met protocol specified stopping criteria|0
6999222|NCT01370655|11062847|FG004|Period 2|met protocol specified stopping criteria|0
6999223|NCT01370655|11062848|FG005|Period 2|met protocol specified stopping criteria|0
6999224|NCT01370655|11062849|FG006|Period 2|met protocol specified stopping criteria|1
6999225|NCT01370655|11062850|FG007|Period 2|met protocol specified stopping criteria|0
6999226|NCT01370655|11062851|FG008|Period 2|met protocol specified stopping criteria|1
6999227|NCT01370655|11062852|FG009|Period 2|met protocol specified stopping criteria|0
6999228|NCT01370655|11062853|FG010|Period 2|met protocol specified stopping criteria|1
6999229|NCT01370655|11062854|FG011|Period 2|met protocol specified stopping criteria|0
6999230|NCT01370655|11062843|FG000|Period 2|Withdrawal by Subject|0
6999231|NCT01370655|11062844|FG001|Period 2|Withdrawal by Subject|0
6999232|NCT01370655|11062845|FG002|Period 2|Withdrawal by Subject|0
6999233|NCT01370655|11062846|FG003|Period 2|Withdrawal by Subject|0
6999234|NCT01370655|11062847|FG004|Period 2|Withdrawal by Subject|0
6999235|NCT01370655|11062848|FG005|Period 2|Withdrawal by Subject|0
6999236|NCT01370655|11062849|FG006|Period 2|Withdrawal by Subject|0
6999237|NCT01370655|11062850|FG007|Period 2|Withdrawal by Subject|0
6999238|NCT01370655|11062851|FG008|Period 2|Withdrawal by Subject|1
6999239|NCT01370655|11062852|FG009|Period 2|Withdrawal by Subject|0
6999240|NCT01370655|11062853|FG010|Period 2|Withdrawal by Subject|0
6999241|NCT01370655|11062854|FG011|Period 2|Withdrawal by Subject|0
6999242|NCT01370694|11062864|FG000|Overall Study|Switched to rituximab|4
6999243|NCT01370694|11062864|FG000|Overall Study|Progressive disease|2
6999244|NCT01370733|11062870|FG000|Overall Study|Withdrawal by Subject|8
6999245|NCT01370733|11062871|FG001|Overall Study|Withdrawal by Subject|8
6999246|NCT01370733|11062870|FG000|Overall Study|Lost to Follow-up|3
6999247|NCT01370733|11062871|FG001|Overall Study|Lost to Follow-up|0
6999248|NCT01370733|11062870|FG000|Overall Study|Adverse Event|2
6999249|NCT01370733|11062871|FG001|Overall Study|Adverse Event|4
6999250|NCT01370733|11062870|FG000|Overall Study|Lack of Efficacy|3
6999251|NCT01370733|11062871|FG001|Overall Study|Lack of Efficacy|5
6999252|NCT01370733|11062870|FG000|Overall Study|Physician Decision|0
6999253|NCT01370733|11062871|FG001|Overall Study|Physician Decision|2
6999254|NCT01370733|11062870|FG000|Overall Study|Protocol Violation|1
6999255|NCT01370733|11062871|FG001|Overall Study|Protocol Violation|3
6999256|NCT01370863|11062892|FG000|Overall Study|Adverse Event|1
6999257|NCT01370863|11062893|FG001|Overall Study|Adverse Event|1
6999258|NCT01370863|11062892|FG000|Overall Study|Did not want second pH/MII monitoring|1
6999259|NCT01370863|11062893|FG001|Overall Study|Did not want second pH/MII monitoring|1
6999260|NCT01370863|11062892|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0
6999261|NCT01370863|11062893|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1
6999262|NCT01371006|11062901|FG000|Overall Study|Adverse Event|1
6999263|NCT01371006|11062902|FG001|Overall Study|Adverse Event|0
6999264|NCT01371539|11062948|FG000|Period One: One Week|Lost to Follow-up|0
6999265|NCT01371539|11062949|FG001|Period One: One Week|Lost to Follow-up|1
6999266|NCT01371539|11062948|FG000|Period Two: One Week|Lost to Follow-up|0
6999267|NCT01371539|11062949|FG001|Period Two: One Week|Lost to Follow-up|1
6999268|NCT01371539|11062948|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0
6999269|NCT01371539|11062949|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1
6999270|NCT01371539|11062948|FG000|Period Two: One Week|Time/job conflict|0
6999271|NCT01371539|11062949|FG001|Period Two: One Week|Time/job conflict|1
6999272|NCT01371552|11062955|FG000|Part 1, First 3 Days|Inconvenience|0
6999273|NCT01371552|11062956|FG001|Part 1, First 3 Days|Inconvenience|0
6999274|NCT01371552|11062957|FG002|Part 1, First 3 Days|Inconvenience|1
6999275|NCT01371552|11062958|FG003|Part 1, First 3 Days|Inconvenience|0
6999276|NCT01371552|11062959|FG004|Part 1, First 3 Days|Inconvenience|0
6999277|NCT01371552|11062960|FG005|Part 1, First 3 Days|Inconvenience|0
6999278|NCT01371565|11062969|FG000|Overall Study|Withdrawal by Subject|1
6999279|NCT01371565|11062969|FG000|Overall Study|Death|1
6999280|NCT01371565|11062969|FG000|Overall Study|Resection of neuroendocrine tumor|1
6999281|NCT01371643|11062975|FG000|Overall Study|Withdrawal by Subject|3
6999282|NCT01371643|11062976|FG001|Overall Study|Withdrawal by Subject|0
6999283|NCT01371656|11062984|FG000|Overall Study|Death|7
6999284|NCT01371656|11062985|FG001|Overall Study|Death|4
6999285|NCT01371656|11062984|FG000|Overall Study|Physician Decision|46
6999286|NCT01371656|11062985|FG001|Overall Study|Physician Decision|7
6999287|NCT01371656|11062984|FG000|Overall Study|Withdrawal by Subject|7
6999288|NCT01371656|11062985|FG001|Overall Study|Withdrawal by Subject|0
6999289|NCT01371656|11062984|FG000|Overall Study|Ineligible|4
6999290|NCT01371656|11062985|FG001|Overall Study|Ineligible|3
6999291|NCT01371708|11062994|FG000|Overall Study|Insufficient clinical response|3
6999292|NCT01371708|11062995|FG001|Overall Study|Insufficient clinical response|2
6999293|NCT01371708|11062996|FG002|Overall Study|Insufficient clinical response|0
6999294|NCT01371708|11062994|FG000|Overall Study|Lost to Follow-up|5
6999295|NCT01371708|11062995|FG001|Overall Study|Lost to Follow-up|9
6999296|NCT01371708|11062996|FG002|Overall Study|Lost to Follow-up|7
6999297|NCT01371708|11062994|FG000|Overall Study|Protocol Violation|2
6999298|NCT01371708|11062995|FG001|Overall Study|Protocol Violation|1
6999299|NCT01371708|11062996|FG002|Overall Study|Protocol Violation|2
6999300|NCT01371708|11062994|FG000|Overall Study|No longer willing to participate|7
6999301|NCT01371708|11062995|FG001|Overall Study|No longer willing to participate|7
6999302|NCT01371708|11062996|FG002|Overall Study|No longer willing to participate|13
6999303|NCT01371708|11062994|FG000|Overall Study|Medication error/not related to AE|0
6999304|NCT01371708|11062995|FG001|Overall Study|Medication error/not related to AE|1
6999305|NCT01371708|11062996|FG002|Overall Study|Medication error/not related to AE|0
6999306|NCT01371708|11062994|FG000|Overall Study|Other|3
6999307|NCT01371708|11062995|FG001|Overall Study|Other|2
6999308|NCT01371708|11062996|FG002|Overall Study|Other|4
6999309|NCT01371708|11062994|FG000|Overall Study|Adverse Event|5
6999310|NCT01371708|11062995|FG001|Overall Study|Adverse Event|8
6999311|NCT01371708|11062996|FG002|Overall Study|Adverse Event|12
6999312|NCT01371708|11062994|FG000|Overall Study|Started but did not receive treatment|1
6999313|NCT01371708|11062995|FG001|Overall Study|Started but did not receive treatment|0
6999314|NCT01371708|11062996|FG002|Overall Study|Started but did not receive treatment|1
6999315|NCT01371721|11063009|FG000|Overall Study|Adverse Event|5
6999316|NCT01371721|11063010|FG001|Overall Study|Adverse Event|4
6999317|NCT01371721|11063011|FG002|Overall Study|Adverse Event|5
6999318|NCT01371721|11063009|FG000|Overall Study|Protocol Violation|6
6999319|NCT01371721|11063010|FG001|Overall Study|Protocol Violation|4
6999320|NCT01371721|11063011|FG002|Overall Study|Protocol Violation|5
6999321|NCT01371721|11063009|FG000|Overall Study|Lost to Follow-up|8
6999322|NCT01371721|11063010|FG001|Overall Study|Lost to Follow-up|2
6999323|NCT01371721|11063011|FG002|Overall Study|Lost to Follow-up|6
6999324|NCT01371721|11063009|FG000|Overall Study|Withdrawal by Subject|5
6999325|NCT01371721|11063010|FG001|Overall Study|Withdrawal by Subject|7
6999326|NCT01371721|11063011|FG002|Overall Study|Withdrawal by Subject|11
6999327|NCT01371721|11063009|FG000|Overall Study|Other|2
6999328|NCT01371721|11063010|FG001|Overall Study|Other|3
6999329|NCT01371721|11063011|FG002|Overall Study|Other|0
6999330|NCT01371721|11063009|FG000|Overall Study|Lack of Efficacy|2
6999331|NCT01371721|11063010|FG001|Overall Study|Lack of Efficacy|4
6999332|NCT01371721|11063011|FG002|Overall Study|Lack of Efficacy|3
6999333|NCT01371721|11063009|FG000|Overall Study|Randomized but not treated|1
6999334|NCT01371721|11063010|FG001|Overall Study|Randomized but not treated|0
6999335|NCT01371721|11063011|FG002|Overall Study|Randomized but not treated|0
6999336|NCT01371734|11063024|FG000|Overall Study|Other|2
6999337|NCT01371734|11063025|FG001|Overall Study|Other|1
6999338|NCT01371734|11063026|FG002|Overall Study|Other|2
6999339|NCT01371734|11063024|FG000|Overall Study|Withdrawal by Subject|3
6999340|NCT01371734|11063025|FG001|Overall Study|Withdrawal by Subject|4
6999341|NCT01371734|11063026|FG002|Overall Study|Withdrawal by Subject|9
6999342|NCT01371734|11063024|FG000|Overall Study|Lost to Follow-up|5
6999343|NCT01371734|11063025|FG001|Overall Study|Lost to Follow-up|3
6999344|NCT01371734|11063026|FG002|Overall Study|Lost to Follow-up|1
6999345|NCT01371734|11063024|FG000|Overall Study|Protocol Violation|3
6999346|NCT01371734|11063025|FG001|Overall Study|Protocol Violation|1
6999347|NCT01371734|11063026|FG002|Overall Study|Protocol Violation|2
6999348|NCT01371734|11063024|FG000|Overall Study|Adverse Event|8
6999349|NCT01371734|11063025|FG001|Overall Study|Adverse Event|8
6999350|NCT01371734|11063026|FG002|Overall Study|Adverse Event|3
6999351|NCT01371734|11063024|FG000|Overall Study|Lack of Efficacy|2
6999352|NCT01371734|11063025|FG001|Overall Study|Lack of Efficacy|2
6999353|NCT01371734|11063026|FG002|Overall Study|Lack of Efficacy|0
6999354|NCT01371747|11063040|FG000|Overall Study|Adverse Event|4
6999355|NCT01371747|11063041|FG001|Overall Study|Adverse Event|2
6999356|NCT01371747|11063042|FG002|Overall Study|Adverse Event|7
6999357|NCT01371747|11063043|FG003|Overall Study|Adverse Event|2
6999358|NCT01371747|11063044|FG004|Overall Study|Adverse Event|2
6999359|NCT01371747|11063045|FG005|Overall Study|Adverse Event|2
6999360|NCT01371747|11063040|FG000|Overall Study|Death|1
6999361|NCT01371747|11063041|FG001|Overall Study|Death|0
6999362|NCT01371747|11063042|FG002|Overall Study|Death|4
6999363|NCT01371747|11063043|FG003|Overall Study|Death|1
6999364|NCT01371747|11063044|FG004|Overall Study|Death|2
6999365|NCT01371747|11063045|FG005|Overall Study|Death|0
6999366|NCT01371747|11063040|FG000|Overall Study|Abnormal Renal Function|0
6999367|NCT01371747|11063041|FG001|Overall Study|Abnormal Renal Function|2
6999368|NCT01371747|11063042|FG002|Overall Study|Abnormal Renal Function|0
6999369|NCT01371747|11063043|FG003|Overall Study|Abnormal Renal Function|1
6999370|NCT01371747|11063044|FG004|Overall Study|Abnormal Renal Function|0
6999371|NCT01371747|11063045|FG005|Overall Study|Abnormal Renal Function|1
6999372|NCT01371747|11063040|FG000|Overall Study|High Serum Potassium Results|1
6999373|NCT01371747|11063041|FG001|Overall Study|High Serum Potassium Results|1
6999374|NCT01371747|11063042|FG002|Overall Study|High Serum Potassium Results|1
6999375|NCT01371747|11063043|FG003|Overall Study|High Serum Potassium Results|2
6999376|NCT01371747|11063044|FG004|Overall Study|High Serum Potassium Results|0
6999377|NCT01371747|11063045|FG005|Overall Study|High Serum Potassium Results|2
6999378|NCT01371747|11063040|FG000|Overall Study|Low Serum Potassium Results|1
6999379|NCT01371747|11063041|FG001|Overall Study|Low Serum Potassium Results|1
6999380|NCT01371747|11063042|FG002|Overall Study|Low Serum Potassium Results|1
6999381|NCT01371747|11063043|FG003|Overall Study|Low Serum Potassium Results|1
6999382|NCT01371747|11063044|FG004|Overall Study|Low Serum Potassium Results|0
6999383|NCT01371747|11063045|FG005|Overall Study|Low Serum Potassium Results|3
6999384|NCT01371747|11063040|FG000|Overall Study|Protocol Violation|0
6999385|NCT01371747|11063041|FG001|Overall Study|Protocol Violation|0
6999386|NCT01371747|11063042|FG002|Overall Study|Protocol Violation|1
6999387|NCT01371747|11063043|FG003|Overall Study|Protocol Violation|0
6999388|NCT01371747|11063044|FG004|Overall Study|Protocol Violation|0
6999389|NCT01371747|11063045|FG005|Overall Study|Protocol Violation|0
6999390|NCT01371747|11063040|FG000|Overall Study|Non-Compliance|3
6999391|NCT01371747|11063041|FG001|Overall Study|Non-Compliance|4
6999392|NCT01371747|11063042|FG002|Overall Study|Non-Compliance|3
6999393|NCT01371747|11063043|FG003|Overall Study|Non-Compliance|0
6999394|NCT01371747|11063044|FG004|Overall Study|Non-Compliance|0
6999395|NCT01371747|11063045|FG005|Overall Study|Non-Compliance|1
6999396|NCT01371747|11063040|FG000|Overall Study|Physician Decision|0
6999397|NCT01371747|11063041|FG001|Overall Study|Physician Decision|0
6999398|NCT01371747|11063042|FG002|Overall Study|Physician Decision|0
6999399|NCT01371747|11063043|FG003|Overall Study|Physician Decision|0
6999400|NCT01371747|11063044|FG004|Overall Study|Physician Decision|1
6999401|NCT01371747|11063045|FG005|Overall Study|Physician Decision|0
6999402|NCT01371747|11063040|FG000|Overall Study|Withdrawal by Subject|6
6999403|NCT01371747|11063041|FG001|Overall Study|Withdrawal by Subject|12
6999404|NCT01371747|11063042|FG002|Overall Study|Withdrawal by Subject|5
6999405|NCT01371747|11063043|FG003|Overall Study|Withdrawal by Subject|2
6999406|NCT01371747|11063044|FG004|Overall Study|Withdrawal by Subject|2
6999407|NCT01371747|11063045|FG005|Overall Study|Withdrawal by Subject|4
6999408|NCT01371747|11063040|FG000|Overall Study|Other Reasons|2
6999409|NCT01371747|11063041|FG001|Overall Study|Other Reasons|1
6999410|NCT01371747|11063042|FG002|Overall Study|Other Reasons|2
6999411|NCT01371747|11063043|FG003|Overall Study|Other Reasons|0
6999412|NCT01371747|11063044|FG004|Overall Study|Other Reasons|0
6999413|NCT01371747|11063045|FG005|Overall Study|Other Reasons|1
6999414|NCT01371825|11063069|FG000|Overall Study|Death|4
6999415|NCT01371838|11063075|FG000|Overall Study|Withdrawal by Subject|27
6999416|NCT01371838|11063076|FG001|Overall Study|Withdrawal by Subject|33
6999417|NCT01371838|11063075|FG000|Overall Study|Lost to Follow-up|10
6999418|NCT01371838|11063076|FG001|Overall Study|Lost to Follow-up|20
6999419|NCT01371838|11063075|FG000|Overall Study|Death|3
6999420|NCT01371838|11063076|FG001|Overall Study|Death|4
6999421|NCT01371838|11063075|FG000|Overall Study|Protocol Violation|3
6999422|NCT01371838|11063076|FG001|Overall Study|Protocol Violation|0
6999423|NCT01371838|11063075|FG000|Overall Study|Investigator Decision|3
6999424|NCT01371838|11063076|FG001|Overall Study|Investigator Decision|8
6999425|NCT01371838|11063075|FG000|Overall Study|Last follow-up visit not conducted|2
6999426|NCT01371838|11063076|FG001|Overall Study|Last follow-up visit not conducted|0
6999427|NCT01371838|11063075|FG000|Overall Study|Lack of therapeutic response|0
6999428|NCT01371838|11063076|FG001|Overall Study|Lack of therapeutic response|1
6999429|NCT01371838|11063075|FG000|Overall Study|Surgery|1
6999430|NCT01371838|11063076|FG001|Overall Study|Surgery|0
6999431|NCT01371851|11063084|FG000|Overall Study|Lost to Follow-up|5
6999432|NCT01371851|11063085|FG001|Overall Study|Lost to Follow-up|8
6999433|NCT01371851|11063084|FG000|Overall Study|was arrested and put in jail|0
6999434|NCT01371851|11063085|FG001|Overall Study|was arrested and put in jail|1
6999435|NCT01371851|11063084|FG000|Overall Study|non study related adverse event|1
6999436|NCT01371851|11063085|FG001|Overall Study|non study related adverse event|0
6999437|NCT01371851|11063084|FG000|Overall Study|Blood Pressure outside study parameters|2
6999438|NCT01371851|11063085|FG001|Overall Study|Blood Pressure outside study parameters|0
6999439|NCT01371877|11063093|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0
7042758|NCT01737762|11127277|FG000|Overall Study|Lost to Follow-up|1
6999440|NCT01371877|11063094|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4
6999441|NCT01371994|11063102|FG000|Overall Study|Adverse Event|3
6999442|NCT01371994|11063103|FG001|Overall Study|Adverse Event|6
6999443|NCT01371994|11063102|FG000|Overall Study|Lack of Efficacy|3
6999444|NCT01371994|11063103|FG001|Overall Study|Lack of Efficacy|0
6999445|NCT01371994|11063102|FG000|Overall Study|Withdrawal by Subject|13
6999446|NCT01371994|11063103|FG001|Overall Study|Withdrawal by Subject|7
6999447|NCT01371994|11063102|FG000|Overall Study|Lost to Follow-up|1
6999448|NCT01371994|11063103|FG001|Overall Study|Lost to Follow-up|1
6999449|NCT01371994|11063102|FG000|Overall Study|Protocol Violation|24
6999450|NCT01371994|11063103|FG001|Overall Study|Protocol Violation|17
6999451|NCT01371994|11063102|FG000|Overall Study|Randomized but Never Received Study Drug|6
6999452|NCT01371994|11063103|FG001|Overall Study|Randomized but Never Received Study Drug|6
6999453|NCT01371994|11063102|FG000|Overall Study|Physician Decision|1
6999454|NCT01371994|11063103|FG001|Overall Study|Physician Decision|1
6999455|NCT01371994|11063102|FG000|Overall Study|Miscellaneous Reasons|6
6999456|NCT01371994|11063103|FG001|Overall Study|Miscellaneous Reasons|4
6999457|NCT01372085|11063119|FG000|Washout Period 2|Physician Decision|0
6999458|NCT01372085|11063120|FG001|Washout Period 2|Physician Decision|0
6999459|NCT01372085|11063121|FG002|Washout Period 2|Physician Decision|0
6999460|NCT01372085|11063122|FG003|Washout Period 2|Physician Decision|0
6999461|NCT01372085|11063123|FG004|Washout Period 2|Physician Decision|1
6999462|NCT01372085|11063124|FG005|Washout Period 2|Physician Decision|0
6999463|NCT01372085|11063125|FG006|Washout Period 2|Physician Decision|0
6999464|NCT01372085|11063126|FG007|Washout Period 2|Physician Decision|0
6999465|NCT01372085|11063127|FG008|Washout Period 2|Physician Decision|0
6999466|NCT01372085|11063128|FG009|Washout Period 2|Physician Decision|0
6999467|NCT01372085|11063119|FG000|Washout Period 3|Withdrawal by Subject|0
6999468|NCT01372085|11063120|FG001|Washout Period 3|Withdrawal by Subject|0
6999469|NCT01372085|11063121|FG002|Washout Period 3|Withdrawal by Subject|0
6999470|NCT01372085|11063122|FG003|Washout Period 3|Withdrawal by Subject|0
6999471|NCT01372085|11063123|FG004|Washout Period 3|Withdrawal by Subject|0
6999472|NCT01372085|11063124|FG005|Washout Period 3|Withdrawal by Subject|2
6999473|NCT01372085|11063125|FG006|Washout Period 3|Withdrawal by Subject|0
6999474|NCT01372085|11063126|FG007|Washout Period 3|Withdrawal by Subject|0
6999475|NCT01372085|11063127|FG008|Washout Period 3|Withdrawal by Subject|0
6999476|NCT01372085|11063128|FG009|Washout Period 3|Withdrawal by Subject|0
6999477|NCT01372150|11063155|FG000|Overall Study|Lack of Efficacy|3
6999478|NCT01372150|11063156|FG001|Overall Study|Lack of Efficacy|0
6999479|NCT01372150|11063157|FG002|Overall Study|Lack of Efficacy|1
6999480|NCT01372150|11063155|FG000|Overall Study|Lost to Follow-up|4
6999481|NCT01372150|11063156|FG001|Overall Study|Lost to Follow-up|5
6999482|NCT01372150|11063157|FG002|Overall Study|Lost to Follow-up|6
6999483|NCT01372150|11063155|FG000|Overall Study|Protocol Violation|1
6999484|NCT01372150|11063156|FG001|Overall Study|Protocol Violation|0
6999485|NCT01372150|11063157|FG002|Overall Study|Protocol Violation|3
6999486|NCT01372150|11063155|FG000|Overall Study|Withdrawal by Subject|2
6999487|NCT01372150|11063156|FG001|Overall Study|Withdrawal by Subject|7
6999488|NCT01372150|11063157|FG002|Overall Study|Withdrawal by Subject|2
6999489|NCT01372150|11063155|FG000|Overall Study|Other|1
6999490|NCT01372150|11063156|FG001|Overall Study|Other|0
6999491|NCT01372150|11063157|FG002|Overall Study|Other|2
6999492|NCT01372150|11063155|FG000|Overall Study|Adverse Event|2
6999493|NCT01372150|11063156|FG001|Overall Study|Adverse Event|1
6999494|NCT01372150|11063157|FG002|Overall Study|Adverse Event|2
6999495|NCT01372150|11063155|FG000|Overall Study|Randomized but not treated|0
6999496|NCT01372150|11063156|FG001|Overall Study|Randomized but not treated|1
6999497|NCT01372150|11063157|FG002|Overall Study|Randomized but not treated|0
6999498|NCT01372384|11063183|FG000|Overall Study|Progression of disease|3
6999499|NCT01372410|11063187|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1
6999500|NCT01372410|11063188|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1
6999501|NCT01372410|11063189|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0
6999502|NCT01372410|11063190|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0
6999503|NCT01372410|11063191|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1
6999504|NCT01372410|11063192|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0
6999505|NCT01372410|11063193|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0
6999506|NCT01372410|11063194|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0
6999507|NCT01372410|11063187|FG000|Treatment Period 1 (7 Days)|Adverse Event|0
6999508|NCT01372410|11063188|FG001|Treatment Period 1 (7 Days)|Adverse Event|1
6999509|NCT01372410|11063189|FG002|Treatment Period 1 (7 Days)|Adverse Event|0
6999510|NCT01372410|11063190|FG003|Treatment Period 1 (7 Days)|Adverse Event|0
6999511|NCT01372410|11063191|FG004|Treatment Period 1 (7 Days)|Adverse Event|0
6999512|NCT01372410|11063192|FG005|Treatment Period 1 (7 Days)|Adverse Event|0
6999513|NCT01372410|11063193|FG006|Treatment Period 1 (7 Days)|Adverse Event|1
6999514|NCT01372410|11063194|FG007|Treatment Period 1 (7 Days)|Adverse Event|0
6999515|NCT01372410|11063187|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0
6999516|NCT01372410|11063188|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0
6999517|NCT01372410|11063189|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0
6999518|NCT01372410|11063190|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0
6999519|NCT01372410|11063191|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1
6999520|NCT01372410|11063192|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0
6999521|NCT01372410|11063193|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0
6999522|NCT01372410|11063194|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0
6999523|NCT01372410|11063187|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
6999524|NCT01372410|11063188|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
6999525|NCT01372410|11063189|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
6999526|NCT01372410|11063190|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
6999527|NCT01372410|11063191|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
6999528|NCT01372410|11063192|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
6999529|NCT01372410|11063193|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1
6999530|NCT01372410|11063194|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
6999531|NCT01372410|11063187|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
6999532|NCT01372410|11063188|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
6999533|NCT01372410|11063189|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
6999534|NCT01372410|11063190|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
6999535|NCT01372410|11063191|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
6999536|NCT01372410|11063192|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
6999537|NCT01372410|11063193|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
6999538|NCT01372410|11063194|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
6999539|NCT01372410|11063187|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0
6999540|NCT01372410|11063188|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0
6999541|NCT01372410|11063189|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0
6999542|NCT01372410|11063190|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0
6999543|NCT01372410|11063191|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1
6999544|NCT01372410|11063192|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0
6999545|NCT01372410|11063193|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0
6999546|NCT01372410|11063194|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0
6999547|NCT01372410|11063187|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
6999548|NCT01372410|11063188|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
6999549|NCT01372410|11063189|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
6999550|NCT01372410|11063190|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
6999551|NCT01372410|11063191|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
6999552|NCT01372410|11063192|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
6999553|NCT01372410|11063193|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
6999554|NCT01372410|11063194|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
6999555|NCT01372410|11063187|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
6999556|NCT01372410|11063188|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
6999557|NCT01372410|11063189|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
6999558|NCT01372410|11063190|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
6999559|NCT01372410|11063191|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
6999560|NCT01372410|11063192|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
6999561|NCT01372410|11063193|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
6999562|NCT01372410|11063194|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1
6999563|NCT01372410|11063187|FG000|Treatment Period 3 (7 Days)|Adverse Event|0
6999564|NCT01372410|11063188|FG001|Treatment Period 3 (7 Days)|Adverse Event|0
6999565|NCT01372410|11063189|FG002|Treatment Period 3 (7 Days)|Adverse Event|1
6999566|NCT01372410|11063190|FG003|Treatment Period 3 (7 Days)|Adverse Event|0
6999567|NCT01372410|11063191|FG004|Treatment Period 3 (7 Days)|Adverse Event|0
6999568|NCT01372410|11063192|FG005|Treatment Period 3 (7 Days)|Adverse Event|0
6999569|NCT01372410|11063193|FG006|Treatment Period 3 (7 Days)|Adverse Event|0
6999570|NCT01372410|11063194|FG007|Treatment Period 3 (7 Days)|Adverse Event|0
6999571|NCT01372410|11063187|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0
6999572|NCT01372410|11063188|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0
6999573|NCT01372410|11063189|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0
6999574|NCT01372410|11063190|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0
6999575|NCT01372410|11063191|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0
6999576|NCT01372410|11063192|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1
6999577|NCT01372410|11063193|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0
6999578|NCT01372410|11063194|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0
6999579|NCT01372501|11063223|FG000|Overall Study|Adverse Event|4
6999580|NCT01372501|11063223|FG000|Overall Study|Device migration|1
6999581|NCT01372605|11063230|FG000|Overall Study|Death|1
6999582|NCT01372605|11063231|FG001|Overall Study|Death|2
6999583|NCT01372605|11063230|FG000|Overall Study|Lost to Follow-up|2
6999584|NCT01372605|11063231|FG001|Overall Study|Lost to Follow-up|1
6999585|NCT01372605|11063230|FG000|Overall Study|Withdrawal by Subject|4
6999586|NCT01372605|11063231|FG001|Overall Study|Withdrawal by Subject|7
6999587|NCT01372605|11063230|FG000|Overall Study|Moved|3
6999588|NCT01372605|11063231|FG001|Overall Study|Moved|0
6999589|NCT01372605|11063230|FG000|Overall Study|Changed medical home|2
6999590|NCT01372605|11063231|FG001|Overall Study|Changed medical home|0
6999591|NCT01372748|11063239|FG000|Overall Study|Lost to Follow-up|16
6999592|NCT01372748|11063240|FG001|Overall Study|Lost to Follow-up|34
6999593|NCT01372748|11063239|FG000|Overall Study|Withdrawal by Subject|7
6999594|NCT01372748|11063240|FG001|Overall Study|Withdrawal by Subject|5
7042759|NCT01737762|11127278|FG001|Overall Study|Lost to Follow-up|0
6999595|NCT01372774|11063248|FG000|Overall Study|Withdrawal prior to treatment|4
6999596|NCT01372774|11063249|FG001|Overall Study|Withdrawal prior to treatment|5
6999597|NCT01372878|11063261|FG000|Overall Study|Withdrawal by Subject|63
6999598|NCT01372878|11063261|FG000|Overall Study|Protocol Violation|17
6999599|NCT01372878|11063261|FG000|Overall Study|incomplete study procedure|104
6999600|NCT01372995|11063268|FG000|Overall Study|Spouse withdrew participant from study|0
6999601|NCT01372995|11063269|FG001|Overall Study|Spouse withdrew participant from study|1
6999602|NCT01372995|11063270|FG002|Overall Study|Spouse withdrew participant from study|0
6999603|NCT01372995|11063268|FG000|Overall Study|Physician Decision|0
6999604|NCT01372995|11063269|FG001|Overall Study|Physician Decision|0
6999605|NCT01372995|11063270|FG002|Overall Study|Physician Decision|1
6999606|NCT01373164|11063283|FG000|Overall Study|Lost to Follow-up|0
6999607|NCT01373164|11063284|FG001|Overall Study|Lost to Follow-up|0
6999608|NCT01373164|11063285|FG002|Overall Study|Lost to Follow-up|1
6999609|NCT01373164|11063286|FG003|Overall Study|Lost to Follow-up|2
6999610|NCT01373164|11063287|FG004|Overall Study|Lost to Follow-up|0
6999611|NCT01373164|11063283|FG000|Overall Study|Withdrawal by Subject|0
6999612|NCT01373164|11063284|FG001|Overall Study|Withdrawal by Subject|1
6999613|NCT01373164|11063285|FG002|Overall Study|Withdrawal by Subject|0
6999614|NCT01373164|11063286|FG003|Overall Study|Withdrawal by Subject|10
6999615|NCT01373164|11063287|FG004|Overall Study|Withdrawal by Subject|2
6999616|NCT01373229|11063302|FG000|Overall Study|Death|3
6999617|NCT01373229|11063302|FG000|Overall Study|Physician Decision|3
6999618|NCT01373294|11063314|FG000|Overall Study|Adverse Event|1
6999619|NCT01373294|11063315|FG001|Overall Study|Adverse Event|0
6999620|NCT01373346|11063321|FG000|Overall Study|Death|1
6999621|NCT01373918|11063369|FG000|Overall Study|Physician Decision|0
6999622|NCT01373918|11063370|FG001|Overall Study|Physician Decision|1
6999623|NCT01373931|11063378|FG000|Lead-in Period|Adverse Event|2
6999624|NCT01373931|11063379|FG001|Lead-in Period|Adverse Event|0
6999625|NCT01373931|11063378|FG000|Period 1|Adverse Event|2
6999626|NCT01373931|11063379|FG001|Period 1|Adverse Event|0
6999627|NCT01373931|11063378|FG000|Period 1|Withdrawal by Subject|0
6999628|NCT01373931|11063379|FG001|Period 1|Withdrawal by Subject|2
6999629|NCT01374087|11063388|FG000|Overall Study|Adverse Event|1
6999630|NCT01374087|11063389|FG001|Overall Study|Adverse Event|0
6999631|NCT01374087|11063388|FG000|Overall Study|Disease progression|2
6999632|NCT01374087|11063389|FG001|Overall Study|Disease progression|2
6999633|NCT01374087|11063388|FG000|Overall Study|Study discontinued|13
6999634|NCT01374087|11063389|FG001|Overall Study|Study discontinued|13
6999635|NCT01374178|11063395|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1
6999636|NCT01374178|11063396|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0
6999637|NCT01374178|11063395|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2
6999638|NCT01374178|11063396|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0
6999639|NCT01374217|11063402|FG000|Overall Study|Lack of Efficacy|13
6999640|NCT01374269|11063408|FG000|Overall Study|Withdrawal by Subject|4
6999641|NCT01374269|11063409|FG001|Overall Study|Withdrawal by Subject|0
6999642|NCT01374269|11063408|FG000|Overall Study|Lost to Follow-up|1
6999643|NCT01374269|11063409|FG001|Overall Study|Lost to Follow-up|3
6999644|NCT01374269|11063408|FG000|Overall Study|closed research|1
6999645|NCT01374269|11063409|FG001|Overall Study|closed research|2
6999646|NCT01374425|11063417|FG000|Overall Study|Radiographic Disease Progression|86
6999647|NCT01374425|11063418|FG001|Overall Study|Radiographic Disease Progression|81
6999648|NCT01374425|11063417|FG000|Overall Study|Clinical Disease Progression|9
6999649|NCT01374425|11063418|FG001|Overall Study|Clinical Disease Progression|6
6999650|NCT01374425|11063417|FG000|Overall Study|Adverse Event|29
6999651|NCT01374425|11063418|FG001|Overall Study|Adverse Event|18
6999652|NCT01374425|11063417|FG000|Overall Study|Death (Progression of Disease)|1
6999653|NCT01374425|11063418|FG001|Overall Study|Death (Progression of Disease)|0
6999654|NCT01374425|11063417|FG000|Overall Study|Death (Adverse Event)|2
6999655|NCT01374425|11063418|FG001|Overall Study|Death (Adverse Event)|4
6999656|NCT01374425|11063417|FG000|Overall Study|Withdrawal by Subject|6
6999657|NCT01374425|11063418|FG001|Overall Study|Withdrawal by Subject|7
6999658|NCT01374425|11063417|FG000|Overall Study|Refused Treatment|10
6999659|NCT01374425|11063418|FG001|Overall Study|Refused Treatment|24
6999660|NCT01374425|11063417|FG000|Overall Study|Protocol Violation|2
6999661|NCT01374425|11063418|FG001|Overall Study|Protocol Violation|3
6999662|NCT01374425|11063417|FG000|Overall Study|Sponsor Decision|0
6999663|NCT01374425|11063418|FG001|Overall Study|Sponsor Decision|1
6999664|NCT01374425|11063417|FG000|Overall Study|Lost to Follow-up|2
6999665|NCT01374425|11063418|FG001|Overall Study|Lost to Follow-up|1
6999666|NCT01374425|11063417|FG000|Overall Study|Other|41
6999667|NCT01374425|11063418|FG001|Overall Study|Other|43
6999668|NCT01374451|11063456|FG000|Overall Study|Administrative problems|1
6999669|NCT01374451|11063457|FG001|Overall Study|Administrative problems|0
6999670|NCT01374568|11063469|FG000|Overall Study|Lab unable to analyze BTM|0
6999671|NCT01374568|11063470|FG001|Overall Study|Lab unable to analyze BTM|2
7042760|NCT01737762|11127277|FG000|Overall Study|Withdrawal by Subject|2
7042761|NCT01737762|11127278|FG001|Overall Study|Withdrawal by Subject|2
7042762|NCT01737762|11127277|FG000|Overall Study|Progressive disease|1
7042763|NCT01737762|11127278|FG001|Overall Study|Progressive disease|2
7042764|NCT01737762|11127277|FG000|Overall Study|Physician Decision|1
7042765|NCT01737762|11127278|FG001|Overall Study|Physician Decision|1
7042766|NCT01737762|11127277|FG000|Overall Study|Moved from area|2
6999672|NCT01374906|11063484|FG000|Overall Study|Abnormal laboratory value(s)|0
6999673|NCT01374906|11063485|FG001|Overall Study|Abnormal laboratory value(s)|3
6999674|NCT01374906|11063484|FG000|Overall Study|Administrative problems|2
6999675|NCT01374906|11063485|FG001|Overall Study|Administrative problems|2
6999676|NCT01374906|11063484|FG000|Overall Study|Adverse Event|10
6999677|NCT01374906|11063485|FG001|Overall Study|Adverse Event|11
6999678|NCT01374906|11063484|FG000|Overall Study|Death|0
6999679|NCT01374906|11063485|FG001|Overall Study|Death|2
6999680|NCT01374906|11063484|FG000|Overall Study|Protocol Violation|2
6999681|NCT01374906|11063485|FG001|Overall Study|Protocol Violation|2
6999682|NCT01374906|11063484|FG000|Overall Study|Withdrawal by Subject|15
6999683|NCT01374906|11063485|FG001|Overall Study|Withdrawal by Subject|9
6999684|NCT01374906|11063484|FG000|Overall Study|Unsatisfactory therapeutic effect|11
6999685|NCT01374906|11063485|FG001|Overall Study|Unsatisfactory therapeutic effect|19
6999686|NCT01374919|11063495|FG000|Overall Study|Withdrawal by Subject|2
6999687|NCT01374971|11063499|FG000|Overall Study|Withdrawal by Subject|1
6999688|NCT01375010|11063505|FG000|Overall Study|Lost to Follow-up|8
6999689|NCT01375010|11063506|FG001|Overall Study|Lost to Follow-up|2
6999690|NCT01375010|11063505|FG000|Overall Study|Withdrawal by Subject|4
6999691|NCT01375010|11063506|FG001|Overall Study|Withdrawal by Subject|2
6999692|NCT01375049|11063512|FG000|Overall Study|Adverse Event|2
6999693|NCT01375049|11063512|FG000|Overall Study|Lost to Follow-up|1
6999694|NCT01375049|11063512|FG000|Overall Study|Withdrawal by Subject|2
6999695|NCT01375049|11063512|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45
6999696|NCT01375075|11063526|FG000|Overall Study|Adverse Event|0
6999697|NCT01375075|11063527|FG001|Overall Study|Adverse Event|0
6999698|NCT01375075|11063528|FG002|Overall Study|Adverse Event|3
6999699|NCT01375075|11063529|FG003|Overall Study|Adverse Event|1
6999700|NCT01375075|11063530|FG004|Overall Study|Adverse Event|0
6999701|NCT01375075|11063531|FG005|Overall Study|Adverse Event|1
6999702|NCT01375075|11063526|FG000|Overall Study|Entry Criterion Not Met|1
6999703|NCT01375075|11063527|FG001|Overall Study|Entry Criterion Not Met|0
6999704|NCT01375075|11063528|FG002|Overall Study|Entry Criterion Not Met|0
6999705|NCT01375075|11063529|FG003|Overall Study|Entry Criterion Not Met|0
6999706|NCT01375075|11063530|FG004|Overall Study|Entry Criterion Not Met|0
6999707|NCT01375075|11063531|FG005|Overall Study|Entry Criterion Not Met|1
6999708|NCT01375075|11063526|FG000|Overall Study|Withdrawal by Subject|0
6999709|NCT01375075|11063527|FG001|Overall Study|Withdrawal by Subject|1
6999710|NCT01375075|11063528|FG002|Overall Study|Withdrawal by Subject|0
6999711|NCT01375075|11063529|FG003|Overall Study|Withdrawal by Subject|0
6999712|NCT01375075|11063530|FG004|Overall Study|Withdrawal by Subject|0
6999713|NCT01375075|11063531|FG005|Overall Study|Withdrawal by Subject|1
6999714|NCT01375205|11063580|FG000|Overall Study|Lost to Follow-up|15
6999715|NCT01375205|11063581|FG001|Overall Study|Lost to Follow-up|12
6999716|NCT01375205|11063580|FG000|Overall Study|Withdrawal by Subject|6
6999717|NCT01375205|11063581|FG001|Overall Study|Withdrawal by Subject|1
6999718|NCT01375374|11063587|FG000|Overall Study|Adverse Event|1
6999719|NCT01375608|11063607|FG000|Overall Study|Withdrawal by Subject|2
6999720|NCT01375673|11063623|FG000|Overall Study|Withdrawal by Subject|0
6999721|NCT01375673|11063624|FG001|Overall Study|Withdrawal by Subject|1
6999722|NCT01375751|11063633|FG000|Overall Study|Other|0
6999723|NCT01375751|11063634|FG001|Overall Study|Other|1
6999724|NCT01375751|11063635|FG002|Overall Study|Other|0
6999725|NCT01375764|11063648|FG000|Overall Study|Lost to Follow-up|0
6999726|NCT01375764|11063649|FG001|Overall Study|Lost to Follow-up|1
6999727|NCT01375764|11063650|FG002|Overall Study|Lost to Follow-up|0
6999728|NCT01375764|11063651|FG003|Overall Study|Lost to Follow-up|0
6999729|NCT01375764|11063652|FG004|Overall Study|Lost to Follow-up|0
6999730|NCT01375764|11063648|FG000|Overall Study|Withdrawal by Subject|2
6999731|NCT01375764|11063649|FG001|Overall Study|Withdrawal by Subject|0
6999732|NCT01375764|11063650|FG002|Overall Study|Withdrawal by Subject|0
6999733|NCT01375764|11063651|FG003|Overall Study|Withdrawal by Subject|0
6999734|NCT01375764|11063652|FG004|Overall Study|Withdrawal by Subject|1
6999735|NCT01375764|11063648|FG000|Overall Study|Other|0
6999736|NCT01375764|11063649|FG001|Overall Study|Other|0
6999737|NCT01375764|11063650|FG002|Overall Study|Other|0
6999738|NCT01375764|11063651|FG003|Overall Study|Other|1
6999739|NCT01375764|11063652|FG004|Overall Study|Other|0
6999740|NCT01375777|11063673|FG000|Overall Study|Withdrawal by Subject|0
6999741|NCT01375777|11063674|FG001|Overall Study|Withdrawal by Subject|2
6999742|NCT01375777|11063675|FG002|Overall Study|Withdrawal by Subject|1
6999743|NCT01375777|11063676|FG003|Overall Study|Withdrawal by Subject|0
6999744|NCT01375777|11063677|FG004|Overall Study|Withdrawal by Subject|1
6999745|NCT01375777|11063678|FG005|Overall Study|Withdrawal by Subject|1
6999746|NCT01375777|11063679|FG006|Overall Study|Withdrawal by Subject|1
6999747|NCT01375777|11063680|FG007|Overall Study|Withdrawal by Subject|2
6999748|NCT01375777|11063681|FG008|Overall Study|Withdrawal by Subject|1
6999749|NCT01375777|11063673|FG000|Overall Study|Lost to Follow-up|1
6999750|NCT01375777|11063674|FG001|Overall Study|Lost to Follow-up|0
6999751|NCT01375777|11063675|FG002|Overall Study|Lost to Follow-up|0
6999752|NCT01375777|11063676|FG003|Overall Study|Lost to Follow-up|0
6999753|NCT01375777|11063677|FG004|Overall Study|Lost to Follow-up|0
6999754|NCT01375777|11063678|FG005|Overall Study|Lost to Follow-up|0
6999755|NCT01375777|11063679|FG006|Overall Study|Lost to Follow-up|1
6999756|NCT01375777|11063680|FG007|Overall Study|Lost to Follow-up|0
6999757|NCT01375777|11063681|FG008|Overall Study|Lost to Follow-up|0
6999758|NCT01375777|11063673|FG000|Overall Study|Other|1
6999759|NCT01375777|11063674|FG001|Overall Study|Other|1
6999760|NCT01375777|11063675|FG002|Overall Study|Other|0
6999761|NCT01375777|11063676|FG003|Overall Study|Other|0
6999762|NCT01375777|11063677|FG004|Overall Study|Other|0
6999763|NCT01375777|11063678|FG005|Overall Study|Other|0
6999764|NCT01375777|11063679|FG006|Overall Study|Other|0
6999765|NCT01375777|11063680|FG007|Overall Study|Other|0
6999766|NCT01375777|11063681|FG008|Overall Study|Other|1
6999767|NCT01376037|11063712|FG000|Overall Study|Lost to Follow-up|0
6999768|NCT01376037|11063713|FG001|Overall Study|Lost to Follow-up|2
6999769|NCT01376089|11063730|FG000|Overall Study|Patient received no contrast media|3
6999770|NCT01376089|11063731|FG001|Overall Study|Patient received no contrast media|4
6999771|NCT01376167|11063744|FG000|Overall Study|Lost to Follow-up|2
6999772|NCT01376167|11063745|FG001|Overall Study|Lost to Follow-up|4
6999773|NCT01376167|11063746|FG002|Overall Study|Lost to Follow-up|2
6999774|NCT01376167|11063744|FG000|Overall Study|Physician Decision|1
6999775|NCT01376167|11063745|FG001|Overall Study|Physician Decision|1
6999776|NCT01376167|11063746|FG002|Overall Study|Physician Decision|0
6999777|NCT01376167|11063744|FG000|Overall Study|Withdrawal by Subject|1
6999778|NCT01376167|11063745|FG001|Overall Study|Withdrawal by Subject|5
6999779|NCT01376167|11063746|FG002|Overall Study|Withdrawal by Subject|4
6999780|NCT01376245|11063761|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66
6999781|NCT01376245|11063762|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
6999782|NCT01376245|11063763|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
6999783|NCT01376245|11063764|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
6999784|NCT01376245|11063765|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
6999785|NCT01376245|11063761|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4
6999786|NCT01376245|11063762|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
6999787|NCT01376245|11063763|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
6999788|NCT01376245|11063764|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
6999789|NCT01376245|11063765|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
6999790|NCT01376245|11063761|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1
6999791|NCT01376245|11063762|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
6999792|NCT01376245|11063763|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
6999793|NCT01376245|11063764|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
6999794|NCT01376245|11063765|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
6999795|NCT01376245|11063761|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2
6999796|NCT01376245|11063762|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
6999797|NCT01376245|11063763|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
6999798|NCT01376245|11063764|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
6999799|NCT01376245|11063765|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
6999800|NCT01376245|11063761|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28
6999801|NCT01376245|11063762|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
6999802|NCT01376245|11063763|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
6999803|NCT01376245|11063764|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
6999804|NCT01376245|11063765|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
6999805|NCT01376245|11063761|FG000|24-week, Double-blind Treatment Period|Adverse Event|0
6999806|NCT01376245|11063762|FG001|24-week, Double-blind Treatment Period|Adverse Event|16
6999807|NCT01376245|11063763|FG002|24-week, Double-blind Treatment Period|Adverse Event|7
6999808|NCT01376245|11063764|FG003|24-week, Double-blind Treatment Period|Adverse Event|8
6999809|NCT01376245|11063765|FG004|24-week, Double-blind Treatment Period|Adverse Event|18
6999810|NCT01376245|11063761|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0
6999811|NCT01376245|11063762|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4
6999812|NCT01376245|11063763|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5
6999813|NCT01376245|11063764|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4
6999814|NCT01376245|11063765|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3
6999815|NCT01376245|11063761|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0
6999816|NCT01376245|11063762|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2
6999817|NCT01376245|11063763|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0
6999818|NCT01376245|11063764|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2
6999819|NCT01376245|11063765|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1
6999820|NCT01376245|11063761|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
6999821|NCT01376245|11063762|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2
6999822|NCT01376245|11063763|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3
6999823|NCT01376245|11063764|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1
6999824|NCT01376245|11063765|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
6999825|NCT01376245|11063761|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0
6999826|NCT01376245|11063762|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2
6999827|NCT01376245|11063763|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0
7042767|NCT01737762|11127278|FG001|Overall Study|Moved from area|1
6999828|NCT01376245|11063764|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1
6999829|NCT01376245|11063765|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1
6999830|NCT01376245|11063761|FG000|24-week, Double-blind Treatment Period|Physician Decision|0
6999831|NCT01376245|11063762|FG001|24-week, Double-blind Treatment Period|Physician Decision|0
6999832|NCT01376245|11063763|FG002|24-week, Double-blind Treatment Period|Physician Decision|1
6999833|NCT01376245|11063764|FG003|24-week, Double-blind Treatment Period|Physician Decision|1
6999834|NCT01376245|11063765|FG004|24-week, Double-blind Treatment Period|Physician Decision|0
6999835|NCT01376245|11063761|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
6999836|NCT01376245|11063762|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
6999837|NCT01376245|11063763|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
6999838|NCT01376245|11063764|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
6999839|NCT01376245|11063765|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
6999840|NCT01376310|11063786|FG000|Overall Study|Study closed/terminated|1
6999841|NCT01376310|11063787|FG001|Overall Study|Study closed/terminated|2
6999842|NCT01376310|11063786|FG000|Overall Study|Withdrawal by Subject|8
6999843|NCT01376310|11063787|FG001|Overall Study|Withdrawal by Subject|2
6999844|NCT01376310|11063786|FG000|Overall Study|Physician Decision|26
6999845|NCT01376310|11063787|FG001|Overall Study|Physician Decision|7
6999846|NCT01376310|11063786|FG000|Overall Study|Lost to Follow-up|1
6999847|NCT01376310|11063787|FG001|Overall Study|Lost to Follow-up|0
6999848|NCT01376349|11063796|FG000|Raondomized Treatment|Withdrawal by Subject|10
6999849|NCT01376349|11063797|FG001|Raondomized Treatment|Withdrawal by Subject|16
6999850|NCT01376349|11063798|FG002|Raondomized Treatment|Withdrawal by Subject|13
6999851|NCT01376349|11063796|FG000|Raondomized Treatment|Adverse Event|13
6999852|NCT01376349|11063797|FG001|Raondomized Treatment|Adverse Event|17
6999853|NCT01376349|11063798|FG002|Raondomized Treatment|Adverse Event|14
6999854|NCT01376349|11063796|FG000|Raondomized Treatment|Unkown|1
6999855|NCT01376349|11063797|FG001|Raondomized Treatment|Unkown|2
6999856|NCT01376349|11063798|FG002|Raondomized Treatment|Unkown|1
6999857|NCT01376349|11063796|FG000|Raondomized Treatment|Alternative Treatment|0
6999858|NCT01376349|11063797|FG001|Raondomized Treatment|Alternative Treatment|0
6999859|NCT01376349|11063798|FG002|Raondomized Treatment|Alternative Treatment|1
6999860|NCT01376388|11063811|FG000|Overall Study|Adverse Event|13
6999861|NCT01376388|11063811|FG000|Overall Study|Lack of Efficacy|2
6999862|NCT01376388|11063811|FG000|Overall Study|Withdrawal by Subject|3
7042768|NCT01737762|11127277|FG000|Overall Study|Trial termination|11
7042769|NCT01737762|11127278|FG001|Overall Study|Trial termination|9
7042770|NCT01737840|11127286|FG000|Overall Study|Diagnosed with an other pathology|2
7042771|NCT01737840|11127287|FG001|Overall Study|Diagnosed with an other pathology|2
7042772|NCT01737879|11127295|FG000|Overall Study|Death|1
7042773|NCT01737879|11127295|FG000|Overall Study|Sponsor decision|40
7042774|NCT01737931|11127302|FG000|Overall Study|Withdrawal by Subject|0
7042775|NCT01737931|11127303|FG001|Overall Study|Withdrawal by Subject|1
7042776|NCT01737931|11127304|FG002|Overall Study|Withdrawal by Subject|1
7042777|NCT01737931|11127302|FG000|Overall Study|Physician Decision|0
7042778|NCT01737931|11127303|FG001|Overall Study|Physician Decision|1
7042779|NCT01737931|11127304|FG002|Overall Study|Physician Decision|0
7042780|NCT01737996|11127329|FG000|Overall Study|Adverse Event|0
7042781|NCT01737996|11127330|FG001|Overall Study|Adverse Event|1
7042782|NCT01737996|11127331|FG002|Overall Study|Adverse Event|1
7042783|NCT01737996|11127329|FG000|Overall Study|Withdrawal by Subject|0
7042784|NCT01737996|11127330|FG001|Overall Study|Withdrawal by Subject|0
7042785|NCT01737996|11127331|FG002|Overall Study|Withdrawal by Subject|1
7042786|NCT01738191|11127341|FG000|Overall Study|Withdrawal by Subject|4
7042787|NCT01738191|11127342|FG001|Overall Study|Withdrawal by Subject|1
7042788|NCT01738438|11127357|FG000|Overall Study|Disease Progression|32
7042789|NCT01738438|11127357|FG000|Overall Study|Adverse Event|3
7042790|NCT01738477|11127363|FG000|Overall Study|Lost to Follow-up|1
7042791|NCT01738477|11127364|FG001|Overall Study|Lost to Follow-up|4
7042792|NCT01738503|11127378|FG000|Induction/Stabilization (Days -14 to -1)|Other|35
7042793|NCT01738503|11127379|FG001|Induction/Stabilization (Days -14 to -1)|Other|0
7042794|NCT01738503|11127380|FG002|Induction/Stabilization (Days -14 to -1)|Other|0
7042795|NCT01738503|11127381|FG003|Induction/Stabilization (Days -14 to -1)|Other|0
7042796|NCT01738503|11127382|FG004|Induction/Stabilization (Days -14 to -1)|Other|0
7042797|NCT01738503|11127383|FG005|Induction/Stabilization (Days -14 to -1)|Other|0
7042798|NCT01738503|11127384|FG006|Induction/Stabilization (Days -14 to -1)|Other|0
7042799|NCT01738503|11127378|FG000|Treatment Period|Adverse Event|0
7042800|NCT01738503|11127379|FG001|Treatment Period|Adverse Event|1
7042801|NCT01738503|11127380|FG002|Treatment Period|Adverse Event|0
7042802|NCT01738503|11127381|FG003|Treatment Period|Adverse Event|1
7042803|NCT01738503|11127382|FG004|Treatment Period|Adverse Event|2
7042804|NCT01738503|11127383|FG005|Treatment Period|Adverse Event|2
7042805|NCT01738503|11127384|FG006|Treatment Period|Adverse Event|2
7042806|NCT01738503|11127378|FG000|Treatment Period|Lost to Follow-up|0
7042807|NCT01738503|11127379|FG001|Treatment Period|Lost to Follow-up|0
7042808|NCT01738503|11127380|FG002|Treatment Period|Lost to Follow-up|3
7042809|NCT01738503|11127381|FG003|Treatment Period|Lost to Follow-up|4
7042810|NCT01738503|11127382|FG004|Treatment Period|Lost to Follow-up|1
7042811|NCT01738503|11127383|FG005|Treatment Period|Lost to Follow-up|1
7042812|NCT01738503|11127384|FG006|Treatment Period|Lost to Follow-up|5
6999863|NCT01376700|11063836|FG000|Overall Study|Sponsor terminated study early|8
6999864|NCT01376700|11063836|FG000|Overall Study|Low or high titer inhibitor|8
6999865|NCT01376804|11063843|FG000|Treatment Period|Withdrawal by Subject|1
6999866|NCT01376804|11063843|FG000|Treatment Period|Adverse Event|6
6999867|NCT01376804|11063843|FG000|Treatment Period|Patient did not receive study drug|1
6999868|NCT01376908|11063849|FG000|Overall Study|Protocol Violation|1
6999869|NCT01376908|11063850|FG001|Overall Study|Protocol Violation|1
6999870|NCT01376908|11063849|FG000|Overall Study|Withdrawal by Subject|1
6999871|NCT01376908|11063850|FG001|Overall Study|Withdrawal by Subject|2
6999872|NCT01377012|11063866|FG000|Core Study|Study terminated by Sponsor|47
6999873|NCT01377012|11063867|FG001|Core Study|Study terminated by Sponsor|54
6999874|NCT01377012|11063868|FG002|Core Study|Study terminated by Sponsor|46
6999875|NCT01377012|11063866|FG000|Core Study|Technical problems|1
6999876|NCT01377012|11063867|FG001|Core Study|Technical problems|0
6999877|NCT01377012|11063868|FG002|Core Study|Technical problems|0
6999878|NCT01377012|11063866|FG000|Core Study|Withdrawal by Subject|15
6999879|NCT01377012|11063867|FG001|Core Study|Withdrawal by Subject|23
6999880|NCT01377012|11063868|FG002|Core Study|Withdrawal by Subject|18
6999881|NCT01377012|11063866|FG000|Core Study|Protocol Violation|7
6999882|NCT01377012|11063867|FG001|Core Study|Protocol Violation|3
6999883|NCT01377012|11063868|FG002|Core Study|Protocol Violation|2
6999884|NCT01377012|11063866|FG000|Core Study|Pregnancy|0
6999885|NCT01377012|11063867|FG001|Core Study|Pregnancy|0
6999886|NCT01377012|11063868|FG002|Core Study|Pregnancy|1
6999887|NCT01377012|11063866|FG000|Core Study|Physician Decision|5
6999888|NCT01377012|11063867|FG001|Core Study|Physician Decision|4
6999889|NCT01377012|11063868|FG002|Core Study|Physician Decision|10
6999890|NCT01377012|11063866|FG000|Core Study|Non-Compliant with study treatment|0
6999891|NCT01377012|11063867|FG001|Core Study|Non-Compliant with study treatment|0
6999892|NCT01377012|11063868|FG002|Core Study|Non-Compliant with study treatment|1
6999893|NCT01377012|11063866|FG000|Core Study|No Longer require treatment|0
6999894|NCT01377012|11063867|FG001|Core Study|No Longer require treatment|0
6999895|NCT01377012|11063868|FG002|Core Study|No Longer require treatment|1
6999896|NCT01377012|11063866|FG000|Core Study|Lost to Follow-up|7
6999897|NCT01377012|11063867|FG001|Core Study|Lost to Follow-up|5
6999898|NCT01377012|11063868|FG002|Core Study|Lost to Follow-up|4
6999899|NCT01377012|11063866|FG000|Core Study|Lack of Efficacy|41
6999900|NCT01377012|11063867|FG001|Core Study|Lack of Efficacy|28
6999901|NCT01377012|11063868|FG002|Core Study|Lack of Efficacy|37
6999902|NCT01377012|11063866|FG000|Core Study|Death|1
6999903|NCT01377012|11063867|FG001|Core Study|Death|1
6999904|NCT01377012|11063868|FG002|Core Study|Death|1
6999905|NCT01377012|11063866|FG000|Core Study|Adverse Event|10
6999906|NCT01377012|11063867|FG001|Core Study|Adverse Event|14
6999907|NCT01377012|11063868|FG002|Core Study|Adverse Event|13
6999908|NCT01377012|11063866|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3
6999909|NCT01377012|11063867|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0
6999910|NCT01377012|11063868|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0
6999911|NCT01377012|11063866|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52
6999912|NCT01377012|11063867|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69
6999913|NCT01377012|11063868|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63
6999914|NCT01377012|11063866|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1
6999915|NCT01377012|11063867|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0
6999916|NCT01377012|11063868|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3
6999917|NCT01377012|11063866|FG000|Extension Study, Weeks 104-260|Physician Decision|1
6999918|NCT01377012|11063867|FG001|Extension Study, Weeks 104-260|Physician Decision|0
6999919|NCT01377012|11063868|FG002|Extension Study, Weeks 104-260|Physician Decision|0
6999920|NCT01377012|11063866|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0
6999921|NCT01377012|11063867|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0
6999922|NCT01377012|11063868|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1
6999923|NCT01377012|11063866|FG000|Extension Study, Weeks 104-260|Adverse Event|0
6999924|NCT01377012|11063867|FG001|Extension Study, Weeks 104-260|Adverse Event|2
6999925|NCT01377012|11063868|FG002|Extension Study, Weeks 104-260|Adverse Event|1
6999926|NCT01377194|11063879|FG000|Overall Study|Adverse Event|3
6999927|NCT01377194|11063880|FG001|Overall Study|Adverse Event|12
6999928|NCT01377194|11063881|FG002|Overall Study|Adverse Event|19
6999929|NCT01377194|11063879|FG000|Overall Study|Lack of Efficacy|3
6999930|NCT01377194|11063880|FG001|Overall Study|Lack of Efficacy|3
6999931|NCT01377194|11063881|FG002|Overall Study|Lack of Efficacy|3
6999932|NCT01377194|11063879|FG000|Overall Study|Protocol Violation|4
6999933|NCT01377194|11063880|FG001|Overall Study|Protocol Violation|10
6999934|NCT01377194|11063881|FG002|Overall Study|Protocol Violation|6
6999935|NCT01377194|11063879|FG000|Overall Study|Withdrawal by Subject|8
6999936|NCT01377194|11063880|FG001|Overall Study|Withdrawal by Subject|10
6999937|NCT01377194|11063881|FG002|Overall Study|Withdrawal by Subject|7
6999938|NCT01377194|11063879|FG000|Overall Study|Lost to Follow-up|14
6999939|NCT01377194|11063880|FG001|Overall Study|Lost to Follow-up|8
6999940|NCT01377194|11063881|FG002|Overall Study|Lost to Follow-up|11
6999941|NCT01377233|11063897|FG000|Open-label|Adverse Event|1
6999942|NCT01377233|11063898|FG001|Open-label|Adverse Event|0
6999943|NCT01377233|11063899|FG002|Open-label|Adverse Event|0
6999944|NCT01377233|11063900|FG003|Open-label|Adverse Event|0
6999945|NCT01377233|11063901|FG004|Open-label|Adverse Event|0
6999946|NCT01377233|11063897|FG000|Open-label|Withdrawal by Subject|3
6999947|NCT01377233|11063898|FG001|Open-label|Withdrawal by Subject|0
6999948|NCT01377233|11063899|FG002|Open-label|Withdrawal by Subject|0
6999949|NCT01377233|11063900|FG003|Open-label|Withdrawal by Subject|0
6999950|NCT01377233|11063901|FG004|Open-label|Withdrawal by Subject|0
6999951|NCT01377233|11063897|FG000|Double-blind|Adverse Event|0
6999952|NCT01377233|11063898|FG001|Double-blind|Adverse Event|1
6999953|NCT01377233|11063899|FG002|Double-blind|Adverse Event|2
6999954|NCT01377233|11063900|FG003|Double-blind|Adverse Event|2
6999955|NCT01377233|11063901|FG004|Double-blind|Adverse Event|0
6827097|NCT00122382|10829624|FG001|Double-Blind Study|Protocol Violation|0
6999956|NCT01377233|11063897|FG000|Double-blind|Protocol Violation|0
6999957|NCT01377233|11063898|FG001|Double-blind|Protocol Violation|0
6999958|NCT01377233|11063899|FG002|Double-blind|Protocol Violation|0
6999959|NCT01377233|11063900|FG003|Double-blind|Protocol Violation|0
6999960|NCT01377233|11063901|FG004|Double-blind|Protocol Violation|1
6999961|NCT01377233|11063897|FG000|Double-blind|Withdrawal by Subject|0
6999962|NCT01377233|11063898|FG001|Double-blind|Withdrawal by Subject|0
6999963|NCT01377233|11063899|FG002|Double-blind|Withdrawal by Subject|0
6999964|NCT01377233|11063900|FG003|Double-blind|Withdrawal by Subject|1
6999965|NCT01377233|11063901|FG004|Double-blind|Withdrawal by Subject|0
6999966|NCT01377233|11063897|FG000|Double-blind|Administrative or other|0
6999967|NCT01377233|11063898|FG001|Double-blind|Administrative or other|0
6999968|NCT01377233|11063899|FG002|Double-blind|Administrative or other|0
6999969|NCT01377233|11063900|FG003|Double-blind|Administrative or other|1
6999970|NCT01377233|11063901|FG004|Double-blind|Administrative or other|1
6999971|NCT01377389|11063917|FG000|Overall Study|Withdrawal by Subject|1
6999972|NCT01377389|11063917|FG000|Overall Study|Screen failure|2
6999973|NCT01377480|11063940|FG000|Overall Study|Protocol Violation|0
6999974|NCT01377480|11063941|FG001|Overall Study|Protocol Violation|0
6999975|NCT01377480|11063942|FG002|Overall Study|Protocol Violation|0
6999976|NCT01377480|11063943|FG003|Overall Study|Protocol Violation|4
6999977|NCT01377480|11063940|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0
6999978|NCT01377480|11063941|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1
6999979|NCT01377480|11063942|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1
6999980|NCT01377480|11063943|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0
6999981|NCT01377480|11063940|FG000|Overall Study|Withdrawal by Subject|0
6999982|NCT01377480|11063941|FG001|Overall Study|Withdrawal by Subject|0
6999983|NCT01377480|11063942|FG002|Overall Study|Withdrawal by Subject|1
6999984|NCT01377480|11063943|FG003|Overall Study|Withdrawal by Subject|0
6999985|NCT01377480|11063940|FG000|Overall Study|Serious adverse event|0
6999986|NCT01377480|11063941|FG001|Overall Study|Serious adverse event|0
6999987|NCT01377480|11063942|FG002|Overall Study|Serious adverse event|1
6999988|NCT01377480|11063943|FG003|Overall Study|Serious adverse event|1
6999989|NCT01377480|11063940|FG000|Overall Study|Other|0
6999990|NCT01377480|11063941|FG001|Overall Study|Other|0
6999991|NCT01377480|11063942|FG002|Overall Study|Other|7
6999992|NCT01377480|11063943|FG003|Overall Study|Other|6
6999993|NCT01377844|11063998|FG000|Overall Study|Withdrawal by Subject|25
6999994|NCT01377844|11063999|FG001|Overall Study|Withdrawal by Subject|28
6999995|NCT01377844|11063998|FG000|Overall Study|Protocol Violation|2
6999996|NCT01377844|11063999|FG001|Overall Study|Protocol Violation|3
6999997|NCT01377844|11063998|FG000|Overall Study|Adverse Event|3
6999998|NCT01377844|11063999|FG001|Overall Study|Adverse Event|0
6999999|NCT01377844|11063998|FG000|Overall Study|Physician Decision|6
7000000|NCT01377844|11063999|FG001|Overall Study|Physician Decision|3
7000001|NCT01377844|11063998|FG000|Overall Study|Study terminated by Sponsor|0
7000002|NCT01377844|11063999|FG001|Overall Study|Study terminated by Sponsor|1
7000003|NCT01377922|11064008|FG000|Overall Study|rescue tx after part 2, entered part 4|1
7000004|NCT01377922|11064009|FG001|Overall Study|rescue tx after part 2, entered part 4|0
7000005|NCT01377987|11064015|FG000|Washout (7 Days)|Withdrawal by Subject|1
7000006|NCT01377987|11064016|FG001|Washout (7 Days)|Withdrawal by Subject|1
7000007|NCT01378104|11064028|FG000|Overall Study|Adverse Event|8
7000008|NCT01378104|11064029|FG001|Overall Study|Adverse Event|8
7000009|NCT01378104|11064028|FG000|Overall Study|Lack of Efficacy|7
7000010|NCT01378104|11064029|FG001|Overall Study|Lack of Efficacy|5
7000011|NCT01378104|11064028|FG000|Overall Study|Withdrawal by Subject|12
7000012|NCT01378104|11064029|FG001|Overall Study|Withdrawal by Subject|13
7000013|NCT01378117|11064040|FG000|Overall Study|withdrawal|2
7000014|NCT01378117|11064041|FG001|Overall Study|withdrawal|1
7000015|NCT01378117|11064042|FG002|Overall Study|withdrawal|2
7000016|NCT01378117|11064040|FG000|Overall Study|discharged before med given|2
7000017|NCT01378117|11064041|FG001|Overall Study|discharged before med given|0
7000018|NCT01378117|11064042|FG002|Overall Study|discharged before med given|1
7000019|NCT01378195|11064057|FG000|Overall Study|Lost to Follow-up|29
7000020|NCT01378195|11064058|FG001|Overall Study|Lost to Follow-up|18
7000021|NCT01378325|11064118|FG000|Overall Study|Protocol Violation|0
7000022|NCT01378325|11064119|FG001|Overall Study|Protocol Violation|1
7000023|NCT01378429|11064149|FG000|Overall Study|Noncompliance with study drug|1
7000024|NCT01378429|11064150|FG001|Overall Study|Noncompliance with study drug|0
7000025|NCT01378858|11064168|FG000|Overall Study|Withdrawal by Subject|4
7000026|NCT01378858|11064169|FG001|Overall Study|Withdrawal by Subject|4
7000027|NCT01378962|11064175|FG000|Overall Study|Death|14
7000028|NCT01378962|11064175|FG000|Overall Study|Lost to Follow-up|1
7000029|NCT01378962|11064175|FG000|Overall Study|Other|2
7000030|NCT01378975|11064181|FG000|Overall Study|Death|77
7000031|NCT01378975|11064182|FG001|Overall Study|Death|46
7000032|NCT01378975|11064181|FG000|Overall Study|Investigator Request|1
7000033|NCT01378975|11064182|FG001|Overall Study|Investigator Request|0
7000034|NCT01378975|11064181|FG000|Overall Study|Lost to Follow-up|4
7000035|NCT01378975|11064182|FG001|Overall Study|Lost to Follow-up|1
7000036|NCT01378975|11064181|FG000|Overall Study|Withdrew Consent|4
7000037|NCT01378975|11064182|FG001|Overall Study|Withdrew Consent|3
7000038|NCT01379508|11064217|FG000|Treatment to Week 104|Adverse Event|2
7000039|NCT01379508|11064218|FG001|Treatment to Week 104|Adverse Event|0
7000040|NCT01379508|11064219|FG002|Treatment to Week 104|Adverse Event|5
7000041|NCT01379508|11064220|FG003|Treatment to Week 104|Adverse Event|0
7000042|NCT01379508|11064217|FG000|Treatment to Week 104|Abnormal lab value|1
7000043|NCT01379508|11064218|FG001|Treatment to Week 104|Abnormal lab value|0
7000044|NCT01379508|11064219|FG002|Treatment to Week 104|Abnormal lab value|0
7000045|NCT01379508|11064220|FG003|Treatment to Week 104|Abnormal lab value|0
7000046|NCT01379508|11064217|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1
7000047|NCT01379508|11064218|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0
7000048|NCT01379508|11064219|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0
7000049|NCT01379508|11064220|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0
7000050|NCT01379508|11064217|FG000|Treatment to Week 104|Withdrawal by Subject|6
7000051|NCT01379508|11064218|FG001|Treatment to Week 104|Withdrawal by Subject|1
7000052|NCT01379508|11064219|FG002|Treatment to Week 104|Withdrawal by Subject|4
7000053|NCT01379508|11064220|FG003|Treatment to Week 104|Withdrawal by Subject|0
7000054|NCT01379508|11064217|FG000|Treatment to Week 104|Lost to Follow-up|5
7000055|NCT01379508|11064218|FG001|Treatment to Week 104|Lost to Follow-up|0
7000056|NCT01379508|11064219|FG002|Treatment to Week 104|Lost to Follow-up|3
7000057|NCT01379508|11064220|FG003|Treatment to Week 104|Lost to Follow-up|0
7000058|NCT01379508|11064217|FG000|Treatment to Week 104|Administrative problems|3
7000059|NCT01379508|11064218|FG001|Treatment to Week 104|Administrative problems|1
7000060|NCT01379508|11064219|FG002|Treatment to Week 104|Administrative problems|0
7000061|NCT01379508|11064220|FG003|Treatment to Week 104|Administrative problems|0
7000062|NCT01379508|11064217|FG000|Treatment to Week 104|Protocol Violation|1
7000063|NCT01379508|11064218|FG001|Treatment to Week 104|Protocol Violation|1
7000064|NCT01379508|11064219|FG002|Treatment to Week 104|Protocol Violation|1
7000065|NCT01379508|11064220|FG003|Treatment to Week 104|Protocol Violation|0
7000066|NCT01379508|11064217|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8
7000067|NCT01379508|11064218|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1
7000068|NCT01379508|11064219|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8
7000069|NCT01379508|11064220|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0
7000070|NCT01379508|11064217|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6
7000071|NCT01379508|11064218|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1
7000072|NCT01379508|11064219|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5
7000073|NCT01379508|11064220|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0
7000074|NCT01379508|11064217|FG000|Extension Period Weeks 109-156|Administrative problems|3
7000075|NCT01379508|11064218|FG001|Extension Period Weeks 109-156|Administrative problems|0
7000076|NCT01379508|11064219|FG002|Extension Period Weeks 109-156|Administrative problems|1
7000077|NCT01379508|11064220|FG003|Extension Period Weeks 109-156|Administrative problems|0
7000078|NCT01379508|11064217|FG000|Extension Period Weeks 109-156|Protocol Violation|2
7000079|NCT01379508|11064218|FG001|Extension Period Weeks 109-156|Protocol Violation|1
7000080|NCT01379508|11064219|FG002|Extension Period Weeks 109-156|Protocol Violation|0
7000081|NCT01379508|11064220|FG003|Extension Period Weeks 109-156|Protocol Violation|0
7000082|NCT01379521|11064236|FG000|Overall Study -Treatment Period|Adverse Event|3
7000083|NCT01379521|11064237|FG001|Overall Study -Treatment Period|Adverse Event|0
7000084|NCT01379521|11064236|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0
7000085|NCT01379521|11064237|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1
7000086|NCT01379521|11064236|FG000|Overall Study -Treatment Period|Disease Progression|23
7000087|NCT01379521|11064237|FG001|Overall Study -Treatment Period|Disease Progression|22
7000088|NCT01379521|11064236|FG000|Overall Study -Treatment Period|New Cancer Therapy|1
7000089|NCT01379521|11064237|FG001|Overall Study -Treatment Period|New Cancer Therapy|0
7000090|NCT01379521|11064236|FG000|Overall Study -Treatment Period|Protocol Deviation|0
7000091|NCT01379521|11064237|FG001|Overall Study -Treatment Period|Protocol Deviation|2
7000092|NCT01379521|11064236|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3
7000093|NCT01379521|11064237|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0
7000094|NCT01379521|11064236|FG000|Overall Study -Treatment Period|Administrative Problems|1
7000095|NCT01379521|11064237|FG001|Overall Study -Treatment Period|Administrative Problems|0
7000096|NCT01379521|11064236|FG000|Overall Study -Treatment Period|Death|2
7000097|NCT01379521|11064237|FG001|Overall Study -Treatment Period|Death|1
7000098|NCT01379521|11064236|FG000|Post-Treatment Evaluations|Disease Progression|22
7000099|NCT01379521|11064237|FG001|Post-Treatment Evaluations|Disease Progression|20
7000100|NCT01379521|11064236|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2
7000101|NCT01379521|11064237|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1
7000102|NCT01379521|11064236|FG000|Post-Treatment Evaluations|Death|1
7000103|NCT01379521|11064237|FG001|Post-Treatment Evaluations|Death|0
7000104|NCT01379534|11064245|FG000|Treatment Phase|Withdrawal by Subject|2
7000105|NCT01379534|11064246|FG001|Treatment Phase|Withdrawal by Subject|2
7000106|NCT01379534|11064245|FG000|Treatment Phase|Progressive disease|13
7000107|NCT01379534|11064246|FG001|Treatment Phase|Progressive disease|22
7000108|NCT01379534|11064245|FG000|Treatment Phase|Adverse Event|7
7000109|NCT01379534|11064246|FG001|Treatment Phase|Adverse Event|7
7000110|NCT01379534|11064245|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0
7000111|NCT01379534|11064246|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1
7000112|NCT01379534|11064245|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3
7000113|NCT01379534|11064246|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0
7000114|NCT01379534|11064245|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0
7000115|NCT01379534|11064246|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1
7000116|NCT01379534|11064245|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1
7000117|NCT01379534|11064246|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0
7000118|NCT01379573|11064252|FG000|Overall Study|Lost to Follow-up|1
7000119|NCT01379573|11064252|FG000|Overall Study|Screen Failure|10
7000120|NCT01379703|11064283|FG000|Study Start Through 9 Months|Lost to Follow-up|2
7000121|NCT01379703|11064284|FG001|Study Start Through 9 Months|Lost to Follow-up|61
7000122|NCT01379703|11064285|FG002|Study Start Through 9 Months|Lost to Follow-up|104
7000123|NCT01379703|11064283|FG000|Study Start Through 9 Months|Adverse Event|0
7000124|NCT01379703|11064284|FG001|Study Start Through 9 Months|Adverse Event|14
7000125|NCT01379703|11064285|FG002|Study Start Through 9 Months|Adverse Event|10
7000126|NCT01379703|11064283|FG000|Study Start Through 9 Months|Withdrawal by Subject|0
7000127|NCT01379703|11064284|FG001|Study Start Through 9 Months|Withdrawal by Subject|6
7000128|NCT01379703|11064285|FG002|Study Start Through 9 Months|Withdrawal by Subject|1
7000129|NCT01379703|11064283|FG000|Study Start Through 9 Months|Treatment Failure|0
7000130|NCT01379703|11064284|FG001|Study Start Through 9 Months|Treatment Failure|2
7000131|NCT01379703|11064285|FG002|Study Start Through 9 Months|Treatment Failure|2
7000132|NCT01379703|11064283|FG000|Study Start Through 9 Months|Patient Noncompliance|0
7000133|NCT01379703|11064284|FG001|Study Start Through 9 Months|Patient Noncompliance|0
7000134|NCT01379703|11064285|FG002|Study Start Through 9 Months|Patient Noncompliance|1
7000135|NCT01379703|11064283|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0
7000136|NCT01379703|11064284|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4
7000137|NCT01379703|11064285|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0
7000138|NCT01379703|11064283|FG000|Study Start Through 9 Months|Medication not available|0
7000139|NCT01379703|11064284|FG001|Study Start Through 9 Months|Medication not available|2
7000140|NCT01379703|11064285|FG002|Study Start Through 9 Months|Medication not available|1
7000141|NCT01379703|11064283|FG000|Study Start Through 9 Months|Poor general condition|0
7000142|NCT01379703|11064284|FG001|Study Start Through 9 Months|Poor general condition|1
7000143|NCT01379703|11064285|FG002|Study Start Through 9 Months|Poor general condition|0
7000144|NCT01379703|11064283|FG000|Study Start Through 9 Months|Increased triglycerides|0
7000145|NCT01379703|11064284|FG001|Study Start Through 9 Months|Increased triglycerides|1
7000146|NCT01379703|11064285|FG002|Study Start Through 9 Months|Increased triglycerides|0
7000147|NCT01379703|11064283|FG000|Study Start Through 9 Months|Reason unknown|2
7000148|NCT01379703|11064284|FG001|Study Start Through 9 Months|Reason unknown|31
7000149|NCT01379703|11064285|FG002|Study Start Through 9 Months|Reason unknown|24
7000150|NCT01379703|11064283|FG000|9 Months Through 18 Months|Lost to Follow-up|0
7000151|NCT01379703|11064284|FG001|9 Months Through 18 Months|Lost to Follow-up|178
7000152|NCT01379703|11064285|FG002|9 Months Through 18 Months|Lost to Follow-up|0
7000153|NCT01379703|11064283|FG000|9 Months Through 18 Months|Withdrawal by Subject|0
7000154|NCT01379703|11064284|FG001|9 Months Through 18 Months|Withdrawal by Subject|11
7000155|NCT01379703|11064285|FG002|9 Months Through 18 Months|Withdrawal by Subject|0
7000156|NCT01379703|11064283|FG000|9 Months Through 18 Months|Adverse Event|0
7000157|NCT01379703|11064284|FG001|9 Months Through 18 Months|Adverse Event|6
7000158|NCT01379703|11064285|FG002|9 Months Through 18 Months|Adverse Event|0
7000159|NCT01379703|11064283|FG000|9 Months Through 18 Months|Treatment failure|0
7000160|NCT01379703|11064284|FG001|9 Months Through 18 Months|Treatment failure|5
7000161|NCT01379703|11064285|FG002|9 Months Through 18 Months|Treatment failure|0
7000162|NCT01379703|11064283|FG000|9 Months Through 18 Months|Patient Noncompliance|0
7000163|NCT01379703|11064284|FG001|9 Months Through 18 Months|Patient Noncompliance|4
7000164|NCT01379703|11064285|FG002|9 Months Through 18 Months|Patient Noncompliance|0
7000165|NCT01379703|11064283|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0
7000166|NCT01379703|11064284|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2
7000167|NCT01379703|11064285|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0
7000168|NCT01379703|11064283|FG000|9 Months Through 18 Months|Fatigue|0
7000169|NCT01379703|11064284|FG001|9 Months Through 18 Months|Fatigue|1
7000170|NCT01379703|11064285|FG002|9 Months Through 18 Months|Fatigue|0
7000171|NCT01379703|11064283|FG000|9 Months Through 18 Months|Reason Unknown|0
7000172|NCT01379703|11064284|FG001|9 Months Through 18 Months|Reason Unknown|23
7000173|NCT01379703|11064285|FG002|9 Months Through 18 Months|Reason Unknown|0
7000174|NCT01379768|11064297|FG000|Overall Study|Adverse Event|1
7000175|NCT01379768|11064298|FG001|Overall Study|Adverse Event|1
7000176|NCT01379768|11064299|FG002|Overall Study|Adverse Event|0
7000177|NCT01379768|11064297|FG000|Overall Study|Lost to Follow-up|2
7000178|NCT01379768|11064298|FG001|Overall Study|Lost to Follow-up|0
7000179|NCT01379768|11064299|FG002|Overall Study|Lost to Follow-up|0
7000180|NCT01379937|11064323|FG000|Overall Study|Protocol Violation|0
7000181|NCT01379937|11064324|FG001|Overall Study|Protocol Violation|0
7000182|NCT01379937|11064325|FG002|Overall Study|Protocol Violation|0
7000183|NCT01379937|11064326|FG003|Overall Study|Protocol Violation|1
7000184|NCT01379937|11064323|FG000|Overall Study|Consent withdrawal|0
7000185|NCT01379937|11064324|FG001|Overall Study|Consent withdrawal|1
7000186|NCT01379937|11064325|FG002|Overall Study|Consent withdrawal|0
7000187|NCT01379937|11064326|FG003|Overall Study|Consent withdrawal|0
7000188|NCT01379937|11064323|FG000|Overall Study|Lost to Follow-up|1
7000189|NCT01379937|11064324|FG001|Overall Study|Lost to Follow-up|2
7000190|NCT01379937|11064325|FG002|Overall Study|Lost to Follow-up|2
7000191|NCT01379937|11064326|FG003|Overall Study|Lost to Follow-up|0
7000192|NCT01380080|11064347|FG000|Overall Study|Death|36
7000193|NCT01380080|11064348|FG001|Overall Study|Death|44
7000194|NCT01380080|11064347|FG000|Overall Study|Site is closing|28
7000195|NCT01380080|11064348|FG001|Overall Study|Site is closing|31
7000196|NCT01380080|11064347|FG000|Overall Study|Not able to get to clinic|7
7000197|NCT01380080|11064348|FG001|Overall Study|Not able to get to clinic|1
7000198|NCT01380080|11064347|FG000|Overall Study|Not willing to adhere to requirements|6
7000199|NCT01380080|11064348|FG001|Overall Study|Not willing to adhere to requirements|2
7000200|NCT01380080|11064347|FG000|Overall Study|Withdrawal by Subject|5
7000201|NCT01380080|11064348|FG001|Overall Study|Withdrawal by Subject|2
7000202|NCT01380080|11064347|FG000|Overall Study|Lost to Follow-up|3
7000203|NCT01380080|11064348|FG001|Overall Study|Lost to Follow-up|3
7000204|NCT01380093|11064354|FG000|Naloxone Challenge Phase|Screen failures|21
7000205|NCT01380093|11064355|FG001|Naloxone Challenge Phase|Screen failures|0
7000206|NCT01380093|11064356|FG002|Naloxone Challenge Phase|Screen failures|0
7000207|NCT01380093|11064357|FG003|Naloxone Challenge Phase|Screen failures|0
7000208|NCT01380093|11064358|FG004|Naloxone Challenge Phase|Screen failures|0
7000209|NCT01380093|11064359|FG005|Naloxone Challenge Phase|Screen failures|0
7000210|NCT01380093|11064360|FG006|Naloxone Challenge Phase|Screen failures|0
7000211|NCT01380093|11064361|FG007|Naloxone Challenge Phase|Screen failures|0
7000212|NCT01380093|11064362|FG008|Naloxone Challenge Phase|Screen failures|0
7000213|NCT01380093|11064354|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0
7000214|NCT01380093|11064355|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1
7000215|NCT01380093|11064356|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0
7000216|NCT01380093|11064357|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0
7000217|NCT01380093|11064358|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0
7000218|NCT01380093|11064359|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0
7000219|NCT01380093|11064360|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0
7000220|NCT01380093|11064361|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0
7000221|NCT01380093|11064362|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0
7000222|NCT01380093|11064354|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0
7000223|NCT01380093|11064355|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3
7000224|NCT01380093|11064356|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1
7000225|NCT01380093|11064357|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0
7000226|NCT01380093|11064358|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0
7000227|NCT01380093|11064359|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0
7000228|NCT01380093|11064360|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0
7000229|NCT01380093|11064361|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0
7000230|NCT01380093|11064362|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0
7000231|NCT01380093|11064354|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
7000232|NCT01380093|11064355|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1
7000233|NCT01380093|11064356|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
7000234|NCT01380093|11064357|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
7000235|NCT01380093|11064358|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
7000236|NCT01380093|11064359|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
7060384|NCT01917968|11156529|FG001|Overall Study|36M Missed Visit|2
7060385|NCT01917968|11156528|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1
7060386|NCT01917968|11156529|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0
7060387|NCT01917968|11156528|FG000|Overall Study|Change in Family Circumstances|0
7060388|NCT01917968|11156529|FG001|Overall Study|Change in Family Circumstances|1
7060389|NCT01917968|11156528|FG000|Overall Study|No Data Available|0
7060390|NCT01917968|11156529|FG001|Overall Study|No Data Available|2
7060391|NCT01918085|11156556|FG000|Test Period 1: Strata Strip|Adverse Event|0
7060392|NCT01918085|11156557|FG001|Test Period 1: Strata Strip|Adverse Event|1
7060393|NCT01918306|11156572|FG000|Overall Study|progresive disease|4
7060394|NCT01918306|11156573|FG001|Overall Study|progresive disease|0
7060395|NCT01918306|11156574|FG002|Overall Study|progresive disease|1
7060396|NCT01918306|11156575|FG003|Overall Study|progresive disease|1
7060397|NCT01918306|11156572|FG000|Overall Study|Withdrawal by Subject|0
7060398|NCT01918306|11156573|FG001|Overall Study|Withdrawal by Subject|0
7000237|NCT01380093|11064360|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
7000238|NCT01380093|11064361|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
7000239|NCT01380093|11064362|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
7042813|NCT01738503|11127378|FG000|Treatment Period|Withdrawal by Subject|0
7060399|NCT01918306|11156574|FG002|Overall Study|Withdrawal by Subject|0
7000240|NCT01380093|11064354|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0
7000241|NCT01380093|11064355|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4
7000242|NCT01380093|11064356|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9
7000243|NCT01380093|11064357|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0
7000244|NCT01380093|11064358|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0
7000245|NCT01380093|11064359|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0
7000246|NCT01380093|11064360|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0
7000247|NCT01380093|11064361|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0
7000248|NCT01380093|11064362|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0
7000249|NCT01380093|11064354|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
7000250|NCT01380093|11064355|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
7000251|NCT01380093|11064356|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
7000252|NCT01380093|11064357|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
7000253|NCT01380093|11064358|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
7000254|NCT01380093|11064359|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
7000255|NCT01380093|11064360|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
7000256|NCT01380093|11064361|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
7000257|NCT01380093|11064362|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
7000258|NCT01380093|11064354|FG000|Drug Discrimination Phase: Day 2|Backup participant|0
7000259|NCT01380093|11064355|FG001|Drug Discrimination Phase: Day 2|Backup participant|0
7000260|NCT01380093|11064356|FG002|Drug Discrimination Phase: Day 2|Backup participant|1
7000261|NCT01380093|11064357|FG003|Drug Discrimination Phase: Day 2|Backup participant|0
7000262|NCT01380093|11064358|FG004|Drug Discrimination Phase: Day 2|Backup participant|0
7000263|NCT01380093|11064359|FG005|Drug Discrimination Phase: Day 2|Backup participant|0
7000264|NCT01380093|11064360|FG006|Drug Discrimination Phase: Day 2|Backup participant|0
7000265|NCT01380093|11064361|FG007|Drug Discrimination Phase: Day 2|Backup participant|0
7000266|NCT01380093|11064362|FG008|Drug Discrimination Phase: Day 2|Backup participant|0
7000267|NCT01380093|11064354|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0
7000268|NCT01380093|11064355|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0
7000269|NCT01380093|11064356|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1
7000270|NCT01380093|11064357|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0
7000271|NCT01380093|11064358|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0
7000272|NCT01380093|11064359|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0
7000273|NCT01380093|11064360|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0
7000274|NCT01380093|11064361|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0
7000275|NCT01380093|11064362|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0
7000276|NCT01380093|11064354|FG000|Treatment Phase: Second Intervention|Other|0
7000277|NCT01380093|11064355|FG001|Treatment Phase: Second Intervention|Other|0
7000278|NCT01380093|11064356|FG002|Treatment Phase: Second Intervention|Other|0
7000279|NCT01380093|11064357|FG003|Treatment Phase: Second Intervention|Other|1
7000280|NCT01380093|11064358|FG004|Treatment Phase: Second Intervention|Other|0
7000281|NCT01380093|11064359|FG005|Treatment Phase: Second Intervention|Other|0
7000282|NCT01380093|11064360|FG006|Treatment Phase: Second Intervention|Other|0
7000283|NCT01380093|11064361|FG007|Treatment Phase: Second Intervention|Other|0
7000284|NCT01380093|11064362|FG008|Treatment Phase: Second Intervention|Other|0
7000285|NCT01380093|11064354|FG000|Treatment Phase: Third Intervention|Non-compliance|0
7000286|NCT01380093|11064355|FG001|Treatment Phase: Third Intervention|Non-compliance|0
7000287|NCT01380093|11064356|FG002|Treatment Phase: Third Intervention|Non-compliance|0
7000288|NCT01380093|11064357|FG003|Treatment Phase: Third Intervention|Non-compliance|0
7000289|NCT01380093|11064358|FG004|Treatment Phase: Third Intervention|Non-compliance|0
7000290|NCT01380093|11064359|FG005|Treatment Phase: Third Intervention|Non-compliance|0
7000291|NCT01380093|11064360|FG006|Treatment Phase: Third Intervention|Non-compliance|0
7000292|NCT01380093|11064361|FG007|Treatment Phase: Third Intervention|Non-compliance|0
7000293|NCT01380093|11064362|FG008|Treatment Phase: Third Intervention|Non-compliance|1
7000294|NCT01380093|11064354|FG000|Treatment Phase: Third Intervention|Other|0
7000295|NCT01380093|11064355|FG001|Treatment Phase: Third Intervention|Other|0
7000296|NCT01380093|11064356|FG002|Treatment Phase: Third Intervention|Other|0
7000297|NCT01380093|11064357|FG003|Treatment Phase: Third Intervention|Other|0
7000298|NCT01380093|11064358|FG004|Treatment Phase: Third Intervention|Other|0
7000299|NCT01380093|11064359|FG005|Treatment Phase: Third Intervention|Other|0
7000300|NCT01380093|11064360|FG006|Treatment Phase: Third Intervention|Other|0
7000301|NCT01380093|11064361|FG007|Treatment Phase: Third Intervention|Other|0
7000302|NCT01380093|11064362|FG008|Treatment Phase: Third Intervention|Other|1
7000303|NCT01380145|11064385|FG000|Overall Study|Progressive disease|4
7000304|NCT01380184|11064391|FG000|Part 1 (19 Days)|Adverse Event|1
7000305|NCT01380184|11064391|FG000|Part 2|Adverse Event|5
7000306|NCT01380184|11064391|FG000|Part 2|Disease Progression|8
7000307|NCT01380184|11064391|FG000|Part 2|Lost to Follow-up|1
7000308|NCT01380327|11064407|FG000|Overall Study|Lost to Follow-up|0
7000309|NCT01380327|11064408|FG001|Overall Study|Lost to Follow-up|1
7000310|NCT01380327|11064409|FG002|Overall Study|Lost to Follow-up|1
7000311|NCT01380327|11064407|FG000|Overall Study|Protocol Violation|3
7000312|NCT01380327|11064408|FG001|Overall Study|Protocol Violation|2
7000313|NCT01380327|11064409|FG002|Overall Study|Protocol Violation|3
7000314|NCT01380327|11064407|FG000|Overall Study|Withdrawal by Subject|0
7000315|NCT01380327|11064408|FG001|Overall Study|Withdrawal by Subject|0
7000316|NCT01380327|11064409|FG002|Overall Study|Withdrawal by Subject|1
7000317|NCT01380327|11064407|FG000|Overall Study|Housing situation precluded ability to k|0
7000318|NCT01380327|11064408|FG001|Overall Study|Housing situation precluded ability to k|0
7000319|NCT01380327|11064409|FG002|Overall Study|Housing situation precluded ability to k|1
7000320|NCT01380327|11064407|FG000|Overall Study|Questionable onset of epilepsy|0
7000321|NCT01380327|11064408|FG001|Overall Study|Questionable onset of epilepsy|0
7000322|NCT01380327|11064409|FG002|Overall Study|Questionable onset of epilepsy|1
7000323|NCT01380379|11064422|FG000|Overall Study|Pregnancy|1
7000324|NCT01380535|11064428|FG000|Overall Study|Adverse Event|3
7000325|NCT01380535|11064429|FG001|Overall Study|Adverse Event|3
7000326|NCT01380535|11064428|FG000|Overall Study|Death|3
7000327|NCT01380535|11064429|FG001|Overall Study|Death|0
7000328|NCT01380535|11064428|FG000|Overall Study|Study site closed|0
7000329|NCT01380535|11064429|FG001|Overall Study|Study site closed|5
7000330|NCT01380535|11064428|FG000|Overall Study|Withdrawal by Subject|1
7000331|NCT01380535|11064429|FG001|Overall Study|Withdrawal by Subject|2
7000332|NCT01380535|11064428|FG000|Overall Study|Protocol Violation|0
7000333|NCT01380535|11064429|FG001|Overall Study|Protocol Violation|2
7000334|NCT01380535|11064428|FG000|Overall Study|Lack of Efficacy|0
7000335|NCT01380535|11064429|FG001|Overall Study|Lack of Efficacy|3
7000336|NCT01380691|11064444|FG000|Washout (7 Days)|Protocol Violation|0
7000337|NCT01380691|11064445|FG001|Washout (7 Days)|Protocol Violation|0
7000338|NCT01380691|11064446|FG002|Washout (7 Days)|Protocol Violation|0
7000339|NCT01380691|11064447|FG003|Washout (7 Days)|Protocol Violation|1
7000340|NCT01380691|11064444|FG000|Washout (7 Days)|Withdrawal by Subject|0
7000341|NCT01380691|11064445|FG001|Washout (7 Days)|Withdrawal by Subject|0
7000342|NCT01380691|11064446|FG002|Washout (7 Days)|Withdrawal by Subject|1
7000343|NCT01380691|11064447|FG003|Washout (7 Days)|Withdrawal by Subject|0
7000344|NCT01380730|11064466|FG000|Overall Study|Death|0
7000345|NCT01380730|11064467|FG001|Overall Study|Death|0
7000346|NCT01380730|11064468|FG002|Overall Study|Death|0
7000347|NCT01380730|11064469|FG003|Overall Study|Death|0
7000348|NCT01380730|11064470|FG004|Overall Study|Death|1
7000349|NCT01380730|11064471|FG005|Overall Study|Death|0
7000350|NCT01380730|11064472|FG006|Overall Study|Death|0
7000351|NCT01380730|11064473|FG007|Overall Study|Death|0
7000352|NCT01380769|11064510|FG000|Overall Study|Withdrawal by Subject|7
7000353|NCT01380769|11064511|FG001|Overall Study|Withdrawal by Subject|11
7000354|NCT01380769|11064510|FG000|Overall Study|Physician Decision|1
7000355|NCT01380769|11064511|FG001|Overall Study|Physician Decision|1
7000356|NCT01380769|11064510|FG000|Overall Study|Adverse Event|1
7000357|NCT01380769|11064511|FG001|Overall Study|Adverse Event|1
7000358|NCT01380769|11064510|FG000|Overall Study|Protocol Violation|0
7000359|NCT01380769|11064511|FG001|Overall Study|Protocol Violation|1
7000360|NCT01380782|11064519|FG000|Overall Study|Adverse Event|0
7000361|NCT01380782|11064520|FG001|Overall Study|Adverse Event|1
7000362|NCT01380782|11064521|FG002|Overall Study|Adverse Event|0
7000363|NCT01380782|11064522|FG003|Overall Study|Adverse Event|0
7000364|NCT01380782|11064519|FG000|Overall Study|Death|1
7000365|NCT01380782|11064520|FG001|Overall Study|Death|0
7000366|NCT01380782|11064521|FG002|Overall Study|Death|0
7000367|NCT01380782|11064522|FG003|Overall Study|Death|0
7000368|NCT01380782|11064519|FG000|Overall Study|Lack of Efficacy|10
7000369|NCT01380782|11064520|FG001|Overall Study|Lack of Efficacy|9
7000370|NCT01380782|11064521|FG002|Overall Study|Lack of Efficacy|10
7000371|NCT01380782|11064522|FG003|Overall Study|Lack of Efficacy|3
7000372|NCT01380782|11064519|FG000|Overall Study|Physician Decision|1
7000373|NCT01380782|11064520|FG001|Overall Study|Physician Decision|0
7000374|NCT01380782|11064521|FG002|Overall Study|Physician Decision|0
7000375|NCT01380782|11064522|FG003|Overall Study|Physician Decision|0
7000376|NCT01380782|11064519|FG000|Overall Study|Withdrawal by Subject|0
7000377|NCT01380782|11064520|FG001|Overall Study|Withdrawal by Subject|0
7000378|NCT01380782|11064521|FG002|Overall Study|Withdrawal by Subject|1
7000379|NCT01380782|11064522|FG003|Overall Study|Withdrawal by Subject|1
7000380|NCT01380834|11064536|FG000|Overall Study|Physician Decision|1
7000381|NCT01380834|11064537|FG001|Overall Study|Physician Decision|0
7000382|NCT01380990|11064558|FG000|Overall Study|Treatment Failure|1
7000383|NCT01380990|11064559|FG001|Overall Study|Treatment Failure|0
7000384|NCT01380990|11064558|FG000|Overall Study|Death|0
7000385|NCT01380990|11064559|FG001|Overall Study|Death|1
7000386|NCT01381016|11064571|FG000|Overall Study|Lost to Follow-up|1
7000387|NCT01381016|11064572|FG001|Overall Study|Lost to Follow-up|1
7000388|NCT01381016|11064571|FG000|Overall Study|Screen Failure|2
7000389|NCT01381016|11064572|FG001|Overall Study|Screen Failure|2
7000390|NCT01381016|11064571|FG000|Overall Study|Withdrawal by Subject|0
7000391|NCT01381016|11064572|FG001|Overall Study|Withdrawal by Subject|1
7000392|NCT01381016|11064571|FG000|Overall Study|Physician Decision|0
7000393|NCT01381016|11064572|FG001|Overall Study|Physician Decision|2
7000394|NCT01381068|11064582|FG000|Overall Study|Death|1
7000395|NCT01381068|11064583|FG001|Overall Study|Death|0
7042814|NCT01738503|11127379|FG001|Treatment Period|Withdrawal by Subject|1
7042815|NCT01738503|11127380|FG002|Treatment Period|Withdrawal by Subject|0
7042816|NCT01738503|11127381|FG003|Treatment Period|Withdrawal by Subject|1
7042817|NCT01738503|11127382|FG004|Treatment Period|Withdrawal by Subject|1
7000396|NCT01381549|11064623|FG000|Overall Study|Ineligible: No organisms isolated|0
7000397|NCT01381549|11064624|FG001|Overall Study|Ineligible: No organisms isolated|0
7000398|NCT01381549|11064625|FG002|Overall Study|Ineligible: No organisms isolated|1
7000399|NCT01381562|11064637|FG000|Overall Study|Adverse Event|0
7000400|NCT01381562|11064638|FG001|Overall Study|Adverse Event|1
7000401|NCT01381562|11064639|FG002|Overall Study|Adverse Event|0
7000402|NCT01381575|11064650|FG000|Overall Study|Serious Adverse Event|1
7000403|NCT01381575|11064651|FG001|Overall Study|Serious Adverse Event|0
7000404|NCT01381575|11064652|FG002|Overall Study|Serious Adverse Event|0
7000405|NCT01381575|11064650|FG000|Overall Study|Non-Serious Adverse Event|0
7000406|NCT01381575|11064651|FG001|Overall Study|Non-Serious Adverse Event|0
7000407|NCT01381575|11064652|FG002|Overall Study|Non-Serious Adverse Event|1
7000408|NCT01381575|11064650|FG000|Overall Study|Protocol Violation|0
7000409|NCT01381575|11064651|FG001|Overall Study|Protocol Violation|1
7000410|NCT01381575|11064652|FG002|Overall Study|Protocol Violation|1
7000411|NCT01381575|11064650|FG000|Overall Study|Withdrawal by Subject|15
7000412|NCT01381575|11064651|FG001|Overall Study|Withdrawal by Subject|9
7000413|NCT01381575|11064652|FG002|Overall Study|Withdrawal by Subject|7
7000414|NCT01381575|11064650|FG000|Overall Study|Migrated/moved from study area|2
7000415|NCT01381575|11064651|FG001|Overall Study|Migrated/moved from study area|12
7000416|NCT01381575|11064652|FG002|Overall Study|Migrated/moved from study area|2
7000417|NCT01381575|11064650|FG000|Overall Study|Lost to Follow-up|8
7000418|NCT01381575|11064651|FG001|Overall Study|Lost to Follow-up|17
7000419|NCT01381575|11064652|FG002|Overall Study|Lost to Follow-up|9
7000420|NCT01381692|11064663|FG000|Overall Study|Adverse Event|1
7000421|NCT01381692|11064664|FG001|Overall Study|Adverse Event|0
7000422|NCT01381692|11064665|FG002|Overall Study|Adverse Event|0
7000423|NCT01381692|11064666|FG003|Overall Study|Adverse Event|0
7000424|NCT01381692|11064667|FG004|Overall Study|Adverse Event|0
7000425|NCT01381692|11064668|FG005|Overall Study|Adverse Event|0
7000426|NCT01381718|11064678|FG000|Overall Study|Withdrawal by Subject|2
7000427|NCT01381718|11064679|FG001|Overall Study|Withdrawal by Subject|5
7000428|NCT01381718|11064678|FG000|Overall Study|Lost to Follow-up|3
7000429|NCT01381718|11064679|FG001|Overall Study|Lost to Follow-up|5
7000430|NCT01381718|11064678|FG000|Overall Study|Toxicity, side effects or complications related to study|0
7000431|NCT01381718|11064679|FG001|Overall Study|Toxicity, side effects or complications related to study|3
7000432|NCT01381874|11064692|FG000|Overall Study|Lost to Follow-up|1
7000433|NCT01381874|11064693|FG001|Overall Study|Lost to Follow-up|1
7000434|NCT01381874|11064694|FG002|Overall Study|Lost to Follow-up|0
7000435|NCT01381874|11064692|FG000|Overall Study|Withdrawal by Subject|9
7000436|NCT01381874|11064693|FG001|Overall Study|Withdrawal by Subject|10
7000437|NCT01381874|11064694|FG002|Overall Study|Withdrawal by Subject|9
7000438|NCT01381874|11064692|FG000|Overall Study|Other|67
7000439|NCT01381874|11064693|FG001|Overall Study|Other|52
7000440|NCT01381874|11064694|FG002|Overall Study|Other|67
7000441|NCT01381900|11064705|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2
7000442|NCT01381900|11064706|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0
7000443|NCT01381900|11064707|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0
7000444|NCT01381900|11064705|FG000|Overall Study|Adverse Event|4
7000445|NCT01381900|11064706|FG001|Overall Study|Adverse Event|6
7000446|NCT01381900|11064707|FG002|Overall Study|Adverse Event|7
7000447|NCT01381900|11064705|FG000|Overall Study|Noncompliance with study drug|0
7000448|NCT01381900|11064706|FG001|Overall Study|Noncompliance with study drug|0
7000449|NCT01381900|11064707|FG002|Overall Study|Noncompliance with study drug|1
7000450|NCT01381900|11064705|FG000|Overall Study|Physician Decision|0
7000451|NCT01381900|11064706|FG001|Overall Study|Physician Decision|1
7000452|NCT01381900|11064707|FG002|Overall Study|Physician Decision|1
7000453|NCT01381900|11064705|FG000|Overall Study|Protocol Violation|0
7000454|NCT01381900|11064706|FG001|Overall Study|Protocol Violation|1
7000455|NCT01381900|11064707|FG002|Overall Study|Protocol Violation|1
7000456|NCT01381900|11064705|FG000|Overall Study|Withdrawal by Subject|0
7000457|NCT01381900|11064706|FG001|Overall Study|Withdrawal by Subject|0
7000458|NCT01381900|11064707|FG002|Overall Study|Withdrawal by Subject|1
7000459|NCT01381900|11064705|FG000|Overall Study|Early withdraw|3
7000460|NCT01381900|11064706|FG001|Overall Study|Early withdraw|1
7000461|NCT01381900|11064707|FG002|Overall Study|Early withdraw|1
7000462|NCT01381926|11064717|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2
7000463|NCT01381926|11064718|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0
7000464|NCT01381926|11064717|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0
7000465|NCT01381926|11064718|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1
7000466|NCT01382212|11064754|FG000|Overall Study|Kidney transplant|1
7000467|NCT01382212|11064754|FG000|Overall Study|Withdrew consent|1
7000468|NCT01382225|11064760|FG000|Overall Study|Adverse Event|3
7000469|NCT01382225|11064761|FG001|Overall Study|Adverse Event|2
7000470|NCT01382225|11064760|FG000|Overall Study|Protocol Violation|2
7000471|NCT01382225|11064761|FG001|Overall Study|Protocol Violation|1
7000472|NCT01382225|11064760|FG000|Overall Study|Subject Withdrew Consent|5
7000473|NCT01382225|11064761|FG001|Overall Study|Subject Withdrew Consent|2
7000474|NCT01382225|11064760|FG000|Overall Study|Other|4
7000475|NCT01382225|11064761|FG001|Overall Study|Other|2
7000476|NCT01382251|11064769|FG000|Overall Study|Surgeries cancelled or delayed|16
7000477|NCT01382251|11064770|FG001|Overall Study|Surgeries cancelled or delayed|16
7000478|NCT01382251|11064769|FG000|Overall Study|Lost to Follow-up|4
7000479|NCT01382251|11064770|FG001|Overall Study|Lost to Follow-up|4
7000480|NCT01382251|11064769|FG000|Overall Study|Contacted after study closed|1
7000481|NCT01382251|11064770|FG001|Overall Study|Contacted after study closed|1
7000482|NCT01382446|11064786|FG000|Overall Study|Withdrawal by Subject|0
7000483|NCT01382446|11064787|FG001|Overall Study|Withdrawal by Subject|1
7000484|NCT01382446|11064786|FG000|Overall Study|Removal from Mechanical Ventilation|3
7000485|NCT01382446|11064787|FG001|Overall Study|Removal from Mechanical Ventilation|3
7000486|NCT01382602|11064795|FG000|Overall Study|Protocol Violation|0
7000487|NCT01382602|11064796|FG001|Overall Study|Protocol Violation|3
7000488|NCT01382602|11064795|FG000|Overall Study|Withdrawal by Subject|0
7000489|NCT01382602|11064796|FG001|Overall Study|Withdrawal by Subject|1
7000490|NCT01382940|11064828|FG000|Overall Study|Adverse Event|19
7000491|NCT01382940|11064828|FG000|Overall Study|Lost to Follow-up|4
7000492|NCT01382940|11064828|FG000|Overall Study|Physician Decision|7
7000493|NCT01382940|11064828|FG000|Overall Study|Withdrawal by Subject|23
7000494|NCT01382940|11064828|FG000|Overall Study|Protocol Violation|20
7000495|NCT01383018|11064841|FG000|Overall Study|Adverse Event|14
7000496|NCT01383018|11064841|FG000|Overall Study|Death|10
7000497|NCT01383018|11064841|FG000|Overall Study|Lost to Follow-up|5
7000498|NCT01383018|11064841|FG000|Overall Study|Physician Decision|5
7000499|NCT01383018|11064841|FG000|Overall Study|Withdrawal by Subject|9
7000500|NCT01383018|11064841|FG000|Overall Study|Subject not implanted|76
7000501|NCT01383018|11064841|FG000|Overall Study|Missed Visit|247
7000502|NCT01383018|11064841|FG000|Overall Study|Site closed early-not compliance related|7
7000503|NCT01383018|11064841|FG000|Overall Study|Patient moved away from site|1
7000504|NCT01383018|11064841|FG000|Overall Study|Subject Incarcerated|1
7000505|NCT01383096|11064858|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
7000506|NCT01383096|11064859|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
7000507|NCT01383096|11064860|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
7000508|NCT01383096|11064858|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
7000509|NCT01383096|11064859|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
7000510|NCT01383096|11064860|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
7000511|NCT01383096|11064858|FG000|Third Intervention (8 Days)|Elevated AST|0
7000512|NCT01383096|11064859|FG001|Third Intervention (8 Days)|Elevated AST|1
7000513|NCT01383096|11064860|FG002|Third Intervention (8 Days)|Elevated AST|0
7000514|NCT01383096|11064858|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
7000515|NCT01383096|11064859|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3
7000516|NCT01383096|11064860|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
7000517|NCT01383096|11064858|FG000|Third Intervention (8 Days)|Adverse Event|1
7000518|NCT01383096|11064859|FG001|Third Intervention (8 Days)|Adverse Event|0
7000519|NCT01383096|11064860|FG002|Third Intervention (8 Days)|Adverse Event|0
7000520|NCT01383096|11064858|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1
7000521|NCT01383096|11064859|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0
7000522|NCT01383096|11064860|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0
7000523|NCT01383096|11064858|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1
7000524|NCT01383096|11064859|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
7000525|NCT01383096|11064860|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
7000526|NCT01383096|11064858|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
7000527|NCT01383096|11064859|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
7000528|NCT01383096|11064860|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
7000529|NCT01383096|11064858|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1
7000530|NCT01383096|11064859|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
7000531|NCT01383096|11064860|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
7000532|NCT01383096|11064858|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1
7000533|NCT01383096|11064859|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0
7000534|NCT01383096|11064860|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0
7000535|NCT01383096|11064858|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1
7000536|NCT01383096|11064859|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
7000537|NCT01383096|11064860|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
7000538|NCT01383161|11064899|FG000|Overall Study|Adverse Event|5
7000539|NCT01383161|11064900|FG001|Overall Study|Adverse Event|1
7000540|NCT01383161|11064899|FG000|Overall Study|Withdrawal by Subject|0
7000541|NCT01383161|11064900|FG001|Overall Study|Withdrawal by Subject|2
7000542|NCT01383161|11064899|FG000|Overall Study|Lack of Efficacy|0
7000543|NCT01383161|11064900|FG001|Overall Study|Lack of Efficacy|1
7000544|NCT01383174|11064908|FG000|3 Month Assessment|Death|0
7000545|NCT01383174|11064909|FG001|3 Month Assessment|Death|1
7000546|NCT01383174|11064908|FG000|3 Month Assessment|Lost to Follow-up|2
7000547|NCT01383174|11064909|FG001|3 Month Assessment|Lost to Follow-up|0
7000548|NCT01383174|11064908|FG000|3 Month Assessment|Refused to complete|4
7000549|NCT01383174|11064909|FG001|3 Month Assessment|Refused to complete|0
7000550|NCT01383174|11064908|FG000|6 Month Assessment|Lost to Follow-up|1
7000551|NCT01383174|11064909|FG001|6 Month Assessment|Lost to Follow-up|1
7000552|NCT01383174|11064908|FG000|6 Month Assessment|Refused to complete|4
7000553|NCT01383174|11064909|FG001|6 Month Assessment|Refused to complete|0
7000554|NCT01383317|11064935|FG000|Overall Study|Lost to Follow-up|2
7000555|NCT01383317|11064936|FG001|Overall Study|Lost to Follow-up|1
7000556|NCT01383317|11064935|FG000|Overall Study|Death|1
7000557|NCT01383317|11064936|FG001|Overall Study|Death|0
7000558|NCT01383317|11064935|FG000|Overall Study|Adverse Event|0
7000559|NCT01383317|11064936|FG001|Overall Study|Adverse Event|1
7000560|NCT01383356|11064942|FG000|Period 1|Adverse Event|5
7000561|NCT01383356|11064943|FG001|Period 1|Adverse Event|3
7000562|NCT01383356|11064942|FG000|Period 1|Non-compliance|3
7000563|NCT01383356|11064943|FG001|Period 1|Non-compliance|0
7000564|NCT01383356|11064942|FG000|Period 1|Out of Range Mid-study-Test|0
7000565|NCT01383356|11064943|FG001|Period 1|Out of Range Mid-study-Test|1
7000566|NCT01383356|11064942|FG000|Period 1|Personal|0
7000567|NCT01383356|11064943|FG001|Period 1|Personal|2
7000568|NCT01383486|11064957|FG000|Overall Study|Lost to Follow-up|10
7000569|NCT01383486|11064957|FG000|Overall Study|Incomplete information for analysis|2
7000570|NCT01383486|11064957|FG000|Overall Study|Did not take any product|6
7000571|NCT01383499|11064962|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1
7000572|NCT01383499|11064963|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0
7000573|NCT01383499|11064964|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0
7000574|NCT01383499|11064965|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0
7000575|NCT01383707|11064991|FG000|Overall Study|Consent withdrawal|6
7000576|NCT01383707|11064991|FG000|Overall Study|Death|19
7000577|NCT01383707|11064991|FG000|Overall Study|Other|8
7000578|NCT01383707|11064991|FG000|Overall Study|Sponsor's decision|2
7000579|NCT01383707|11064991|FG000|Overall Study|Adverse Event|14
7000580|NCT01383707|11064991|FG000|Overall Study|Progressive disease|23
7000581|NCT01383928|11065011|FG000|Overall Study|Initiation of ASCT|2
7000582|NCT01383928|11065012|FG001|Overall Study|Initiation of ASCT|1
7000583|NCT01383928|11065013|FG002|Overall Study|Initiation of ASCT|18
7000584|NCT01383928|11065011|FG000|Overall Study|Adverse Event|1
7000585|NCT01383928|11065012|FG001|Overall Study|Adverse Event|2
7000586|NCT01383928|11065013|FG002|Overall Study|Adverse Event|8
7000587|NCT01383928|11065011|FG000|Overall Study|Other|1
7000588|NCT01383928|11065012|FG001|Overall Study|Other|3
7000589|NCT01383928|11065013|FG002|Overall Study|Other|4
7000590|NCT01383928|11065011|FG000|Overall Study|Progressive Disease|1
7000591|NCT01383928|11065012|FG001|Overall Study|Progressive Disease|1
7000592|NCT01383928|11065013|FG002|Overall Study|Progressive Disease|5
7000593|NCT01383928|11065011|FG000|Overall Study|Withdrawal by Subject|0
7000594|NCT01383928|11065012|FG001|Overall Study|Withdrawal by Subject|0
7000595|NCT01383928|11065013|FG002|Overall Study|Withdrawal by Subject|4
7000596|NCT01383928|11065011|FG000|Overall Study|Unsatisfactory Therapeutic Response|0
7000597|NCT01383928|11065012|FG001|Overall Study|Unsatisfactory Therapeutic Response|0
7000598|NCT01383928|11065013|FG002|Overall Study|Unsatisfactory Therapeutic Response|1
7000599|NCT01383954|11065023|FG000|Overall Study|Lack of Efficacy|2
7000600|NCT01383954|11065023|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2
7000601|NCT01383954|11065023|FG000|Overall Study|Adverse Event|1
7000602|NCT01383954|11065023|FG000|Overall Study|Reason Not Specified|9
7000603|NCT01383993|11065030|FG000|Overall Study|Adverse Event|1
7000604|NCT01383993|11065031|FG001|Overall Study|Adverse Event|1
7000605|NCT01383993|11065032|FG002|Overall Study|Adverse Event|0
7000606|NCT01383993|11065030|FG000|Overall Study|Withdrawal by Subject|0
7000607|NCT01383993|11065031|FG001|Overall Study|Withdrawal by Subject|0
7000608|NCT01383993|11065032|FG002|Overall Study|Withdrawal by Subject|1
7000609|NCT01383993|11065030|FG000|Overall Study|Marketed voriconazole in post-therapy|2
7000610|NCT01383993|11065031|FG001|Overall Study|Marketed voriconazole in post-therapy|0
7000611|NCT01383993|11065032|FG002|Overall Study|Marketed voriconazole in post-therapy|0
7000612|NCT01384019|11065043|FG000|Overall Study|Withdrawal by Subject|3
7000613|NCT01384019|11065044|FG001|Overall Study|Withdrawal by Subject|0
7000614|NCT01384019|11065043|FG000|Overall Study|Death|1
7000615|NCT01384019|11065044|FG001|Overall Study|Death|0
7000616|NCT01384019|11065043|FG000|Overall Study|MRI refusal|6
7000617|NCT01384019|11065044|FG001|Overall Study|MRI refusal|6
7000618|NCT01384292|11065053|FG000|Part B|Severe non-compliance to protocol|1
7000619|NCT01384292|11065054|FG001|Part B|Severe non-compliance to protocol|0
7000620|NCT01384292|11065055|FG002|Part B|Severe non-compliance to protocol|0
7000621|NCT01384734|11065092|FG000|Overall Study|Adverse Event|0
7000622|NCT01384734|11065093|FG001|Overall Study|Adverse Event|3
7000623|NCT01384734|11065094|FG002|Overall Study|Adverse Event|0
7000624|NCT01384734|11065095|FG003|Overall Study|Adverse Event|2
7000625|NCT01384734|11065096|FG004|Overall Study|Adverse Event|7
7000626|NCT01384734|11065092|FG000|Overall Study|Death|1
7000627|NCT01384734|11065093|FG001|Overall Study|Death|0
7000628|NCT01384734|11065094|FG002|Overall Study|Death|1
7000629|NCT01384734|11065095|FG003|Overall Study|Death|0
7000630|NCT01384734|11065096|FG004|Overall Study|Death|0
7000631|NCT01384734|11065092|FG000|Overall Study|Continuation criteria not met|0
7000632|NCT01384734|11065093|FG001|Overall Study|Continuation criteria not met|0
7000633|NCT01384734|11065094|FG002|Overall Study|Continuation criteria not met|1
7000634|NCT01384734|11065095|FG003|Overall Study|Continuation criteria not met|1
7000635|NCT01384734|11065096|FG004|Overall Study|Continuation criteria not met|0
7000636|NCT01384734|11065092|FG000|Overall Study|Lack of Efficacy|3
7000637|NCT01384734|11065093|FG001|Overall Study|Lack of Efficacy|7
7000638|NCT01384734|11065094|FG002|Overall Study|Lack of Efficacy|4
7000639|NCT01384734|11065095|FG003|Overall Study|Lack of Efficacy|4
7000640|NCT01384734|11065096|FG004|Overall Study|Lack of Efficacy|2
7000641|NCT01384734|11065092|FG000|Overall Study|Lost to Follow-up|5
7000642|NCT01384734|11065093|FG001|Overall Study|Lost to Follow-up|3
7000643|NCT01384734|11065094|FG002|Overall Study|Lost to Follow-up|3
7000644|NCT01384734|11065095|FG003|Overall Study|Lost to Follow-up|8
7000645|NCT01384734|11065096|FG004|Overall Study|Lost to Follow-up|5
7000646|NCT01384734|11065092|FG000|Overall Study|Non-compliance with study drug|1
7000647|NCT01384734|11065093|FG001|Overall Study|Non-compliance with study drug|2
7000648|NCT01384734|11065094|FG002|Overall Study|Non-compliance with study drug|6
7000649|NCT01384734|11065095|FG003|Overall Study|Non-compliance with study drug|0
7000650|NCT01384734|11065096|FG004|Overall Study|Non-compliance with study drug|2
7000651|NCT01384734|11065092|FG000|Overall Study|Pregnancy|0
7000652|NCT01384734|11065093|FG001|Overall Study|Pregnancy|1
7000653|NCT01384734|11065094|FG002|Overall Study|Pregnancy|0
7000654|NCT01384734|11065095|FG003|Overall Study|Pregnancy|0
7000655|NCT01384734|11065096|FG004|Overall Study|Pregnancy|1
7000656|NCT01384734|11065092|FG000|Overall Study|Sponsor terminated|0
7000657|NCT01384734|11065093|FG001|Overall Study|Sponsor terminated|0
7000658|NCT01384734|11065094|FG002|Overall Study|Sponsor terminated|0
7000659|NCT01384734|11065095|FG003|Overall Study|Sponsor terminated|0
7000660|NCT01384734|11065096|FG004|Overall Study|Sponsor terminated|1
7000661|NCT01384734|11065092|FG000|Overall Study|Withdrawal by Subject|5
7000662|NCT01384734|11065093|FG001|Overall Study|Withdrawal by Subject|5
7000663|NCT01384734|11065094|FG002|Overall Study|Withdrawal by Subject|6
7000664|NCT01384734|11065095|FG003|Overall Study|Withdrawal by Subject|7
7000665|NCT01384734|11065096|FG004|Overall Study|Withdrawal by Subject|9
7000666|NCT01384734|11065092|FG000|Overall Study|Investigator relocating|0
7000667|NCT01384734|11065093|FG001|Overall Study|Investigator relocating|2
7000668|NCT01384734|11065094|FG002|Overall Study|Investigator relocating|0
7000669|NCT01384734|11065095|FG003|Overall Study|Investigator relocating|3
7000670|NCT01384734|11065096|FG004|Overall Study|Investigator relocating|1
7000671|NCT01384734|11065092|FG000|Overall Study|Unable to come back for visit|1
7000672|NCT01384734|11065093|FG001|Overall Study|Unable to come back for visit|0
7000673|NCT01384734|11065094|FG002|Overall Study|Unable to come back for visit|1
7000674|NCT01384734|11065095|FG003|Overall Study|Unable to come back for visit|1
7000675|NCT01384734|11065096|FG004|Overall Study|Unable to come back for visit|0
7000676|NCT01384734|11065092|FG000|Overall Study|Prison|0
7000677|NCT01384734|11065093|FG001|Overall Study|Prison|0
7000678|NCT01384734|11065094|FG002|Overall Study|Prison|1
7000679|NCT01384734|11065095|FG003|Overall Study|Prison|0
7000680|NCT01384734|11065096|FG004|Overall Study|Prison|0
7000681|NCT01384734|11065092|FG000|Overall Study|As per Exclusion criteria|0
7000682|NCT01384734|11065093|FG001|Overall Study|As per Exclusion criteria|1
7000683|NCT01384734|11065094|FG002|Overall Study|As per Exclusion criteria|0
7000684|NCT01384734|11065095|FG003|Overall Study|As per Exclusion criteria|0
7000685|NCT01384734|11065096|FG004|Overall Study|As per Exclusion criteria|0
7000686|NCT01384734|11065092|FG000|Overall Study|Missed End of treatment visit|0
7000687|NCT01384734|11065093|FG001|Overall Study|Missed End of treatment visit|0
7000688|NCT01384734|11065094|FG002|Overall Study|Missed End of treatment visit|0
7000689|NCT01384734|11065095|FG003|Overall Study|Missed End of treatment visit|1
7000690|NCT01384734|11065096|FG004|Overall Study|Missed End of treatment visit|0
7000691|NCT01384734|11065092|FG000|Overall Study|Adhesion problem|0
7000692|NCT01384734|11065093|FG001|Overall Study|Adhesion problem|0
7000693|NCT01384734|11065094|FG002|Overall Study|Adhesion problem|0
7000694|NCT01384734|11065095|FG003|Overall Study|Adhesion problem|1
7000695|NCT01384734|11065096|FG004|Overall Study|Adhesion problem|0
7000696|NCT01384734|11065092|FG000|Overall Study|Early termination|0
7000697|NCT01384734|11065093|FG001|Overall Study|Early termination|0
7000698|NCT01384734|11065094|FG002|Overall Study|Early termination|0
7000699|NCT01384734|11065095|FG003|Overall Study|Early termination|0
7000700|NCT01384734|11065096|FG004|Overall Study|Early termination|1
7000701|NCT01384734|11065092|FG000|Overall Study|Physician Decision|1
7000702|NCT01384734|11065093|FG001|Overall Study|Physician Decision|0
7000703|NCT01384734|11065094|FG002|Overall Study|Physician Decision|0
7000704|NCT01384734|11065095|FG003|Overall Study|Physician Decision|0
7000705|NCT01384734|11065096|FG004|Overall Study|Physician Decision|0
7000706|NCT01384760|11065107|FG000|Overall Study|Lost to Follow-up|0
7000707|NCT01384760|11065108|FG001|Overall Study|Lost to Follow-up|6
7000708|NCT01384760|11065107|FG000|Overall Study|Protocol Violation|16
7000709|NCT01384760|11065108|FG001|Overall Study|Protocol Violation|0
7000710|NCT01384877|11065116|FG000|Treatment 2|Lost to Follow-up|2
7000711|NCT01384877|11065117|FG001|Treatment 2|Lost to Follow-up|2
7000712|NCT01385098|11065123|FG000|Overall Study|Adverse Event|10
7000713|NCT01385098|11065123|FG000|Overall Study|Lost to Follow-up|4
7000714|NCT01385202|11065166|FG000|Overall Study|Lost to Follow-up|6
7000715|NCT01385202|11065166|FG000|Overall Study|Not Eligible|11
7000716|NCT01385202|11065166|FG000|Overall Study|Withdrawn|1
7000717|NCT01385371|11065182|FG000|Overall Study|Adverse Event|54
7000718|NCT01385371|11065183|FG001|Overall Study|Adverse Event|19
7000719|NCT01385371|11065182|FG000|Overall Study|Lost to Follow-up|16
7000720|NCT01385371|11065183|FG001|Overall Study|Lost to Follow-up|16
7000721|NCT01385371|11065182|FG000|Overall Study|Withdrawal by Subject|52
7000722|NCT01385371|11065183|FG001|Overall Study|Withdrawal by Subject|39
7000723|NCT01385371|11065182|FG000|Overall Study|Protocol Violation|25
7000724|NCT01385371|11065183|FG001|Overall Study|Protocol Violation|21
7000725|NCT01385371|11065182|FG000|Overall Study|Administrative|2
7000726|NCT01385371|11065183|FG001|Overall Study|Administrative|2
7000727|NCT01385566|11065195|FG000|Overall Study|Lost to Follow-up|1
7000728|NCT01385566|11065196|FG001|Overall Study|Lost to Follow-up|0
7000729|NCT01385566|11065197|FG002|Overall Study|Lost to Follow-up|0
7000730|NCT01385566|11065198|FG003|Overall Study|Lost to Follow-up|0
7000731|NCT01385566|11065199|FG004|Overall Study|Lost to Follow-up|0
7000732|NCT01385566|11065200|FG005|Overall Study|Lost to Follow-up|0
7000733|NCT01385566|11065195|FG000|Overall Study|Withdrawal by Subject|0
7000734|NCT01385566|11065196|FG001|Overall Study|Withdrawal by Subject|0
7000735|NCT01385566|11065197|FG002|Overall Study|Withdrawal by Subject|0
7000736|NCT01385566|11065198|FG003|Overall Study|Withdrawal by Subject|1
7000737|NCT01385566|11065199|FG004|Overall Study|Withdrawal by Subject|0
7000738|NCT01385566|11065200|FG005|Overall Study|Withdrawal by Subject|0
7000739|NCT01385748|11065245|FG000|Overall Study|Withdrawal by Subject|7
7000740|NCT01385748|11065246|FG001|Overall Study|Withdrawal by Subject|4
7000741|NCT01385748|11065247|FG002|Overall Study|Withdrawal by Subject|5
7000742|NCT01385748|11065245|FG000|Overall Study|Noncompliance|3
7000743|NCT01385748|11065246|FG001|Overall Study|Noncompliance|1
7000744|NCT01385748|11065247|FG002|Overall Study|Noncompliance|6
7000745|NCT01385748|11065245|FG000|Overall Study|Other|1
7000746|NCT01385748|11065246|FG001|Overall Study|Other|7
7000747|NCT01385748|11065247|FG002|Overall Study|Other|1
7000748|NCT01385748|11065245|FG000|Overall Study|Adverse Event|4
7000749|NCT01385748|11065246|FG001|Overall Study|Adverse Event|2
7000750|NCT01385748|11065247|FG002|Overall Study|Adverse Event|1
7000751|NCT01385995|11065261|FG000|Period 1, 2 Months|Physician Decision|1
7000752|NCT01385995|11065262|FG001|Period 1, 2 Months|Physician Decision|0
7000753|NCT01386008|11065270|FG000|Overall Study|exited w/o incident /study discontinued|17
7000754|NCT01386008|11065270|FG000|Overall Study|Adverse Event|3
7000755|NCT01386554|11065281|FG000|Overall Study|Lost to Follow-up|0
7000756|NCT01386554|11065282|FG001|Overall Study|Lost to Follow-up|0
7000757|NCT01386554|11065283|FG002|Overall Study|Lost to Follow-up|1
7000758|NCT01386554|11065281|FG000|Overall Study|Adverse Event|2
7000759|NCT01386554|11065282|FG001|Overall Study|Adverse Event|5
7000760|NCT01386554|11065283|FG002|Overall Study|Adverse Event|2
7000761|NCT01386554|11065281|FG000|Overall Study|Progressive disease|1
7000762|NCT01386554|11065282|FG001|Overall Study|Progressive disease|2
7000763|NCT01386554|11065283|FG002|Overall Study|Progressive disease|2
7000764|NCT01386554|11065281|FG000|Overall Study|Administration of live vaccines|0
7000765|NCT01386554|11065282|FG001|Overall Study|Administration of live vaccines|1
7000766|NCT01386554|11065283|FG002|Overall Study|Administration of live vaccines|0
7000767|NCT01386554|11065281|FG000|Overall Study|Investigator discretion|0
7000768|NCT01386554|11065282|FG001|Overall Study|Investigator discretion|0
7000769|NCT01386554|11065283|FG002|Overall Study|Investigator discretion|1
7000770|NCT01386554|11065281|FG000|Overall Study|Reason not collected|0
7000771|NCT01386554|11065282|FG001|Overall Study|Reason not collected|1
7000772|NCT01386554|11065283|FG002|Overall Study|Reason not collected|0
7000773|NCT01386606|11065297|FG000|Overall Study|Adverse Event|0
7000774|NCT01386606|11065298|FG001|Overall Study|Adverse Event|1
7000775|NCT01386606|11065299|FG002|Overall Study|Adverse Event|0
7000776|NCT01386606|11065300|FG003|Overall Study|Adverse Event|0
7000777|NCT01386606|11065297|FG000|Overall Study|Withdrawal by Subject|0
7000778|NCT01386606|11065298|FG001|Overall Study|Withdrawal by Subject|1
7000779|NCT01386606|11065299|FG002|Overall Study|Withdrawal by Subject|1
7000780|NCT01386606|11065300|FG003|Overall Study|Withdrawal by Subject|0
7000781|NCT01386606|11065297|FG000|Overall Study|Protocol Violation|1
7000782|NCT01386606|11065298|FG001|Overall Study|Protocol Violation|0
7000783|NCT01386606|11065299|FG002|Overall Study|Protocol Violation|1
7000784|NCT01386606|11065300|FG003|Overall Study|Protocol Violation|1
7000785|NCT01386606|11065297|FG000|Overall Study|Lost to Follow-up|2
7000786|NCT01386606|11065298|FG001|Overall Study|Lost to Follow-up|0
7000787|NCT01386606|11065299|FG002|Overall Study|Lost to Follow-up|0
7000788|NCT01386606|11065300|FG003|Overall Study|Lost to Follow-up|0
7000789|NCT01386606|11065297|FG000|Overall Study|Subject incarcerated|0
7000790|NCT01386606|11065298|FG001|Overall Study|Subject incarcerated|1
7000791|NCT01386606|11065299|FG002|Overall Study|Subject incarcerated|0
7000792|NCT01386606|11065300|FG003|Overall Study|Subject incarcerated|0
7000793|NCT01386606|11065297|FG000|Overall Study|Unable to draw PK|1
7000794|NCT01386606|11065298|FG001|Overall Study|Unable to draw PK|0
7000795|NCT01386606|11065299|FG002|Overall Study|Unable to draw PK|0
7000796|NCT01386606|11065300|FG003|Overall Study|Unable to draw PK|0
7000797|NCT01386606|11065297|FG000|Overall Study|T levels too high|0
7000798|NCT01386606|11065298|FG001|Overall Study|T levels too high|1
7000799|NCT01386606|11065299|FG002|Overall Study|T levels too high|1
7000800|NCT01386606|11065300|FG003|Overall Study|T levels too high|0
7000801|NCT01386645|11065326|FG000|Overall Study|Physician Decision|0
7000802|NCT01386645|11065327|FG001|Overall Study|Physician Decision|0
7000803|NCT01386645|11065328|FG002|Overall Study|Physician Decision|1
7000804|NCT01386645|11065326|FG000|Overall Study|Withdrawal by Subject|0
7000805|NCT01386645|11065327|FG001|Overall Study|Withdrawal by Subject|1
7000806|NCT01386645|11065328|FG002|Overall Study|Withdrawal by Subject|1
7000807|NCT01386788|11065336|FG000|Overall Study|Lost to Follow-up|2
7000808|NCT01386944|11065340|FG000|Overall Study|Adverse Event|26
7000809|NCT01386944|11065340|FG000|Overall Study|Lack of Efficacy|14
7000810|NCT01386944|11065340|FG000|Overall Study|Lost to Follow-up|8
7000811|NCT01386944|11065340|FG000|Overall Study|Unspecified reason|8
7000812|NCT01386970|11065346|FG000|Overall Study|Withdrawal by Subject|0
7000813|NCT01386970|11065347|FG001|Overall Study|Withdrawal by Subject|1
7000814|NCT01386970|11065346|FG000|Overall Study|Adverse Event|4
7000815|NCT01386970|11065347|FG001|Overall Study|Adverse Event|1
7000816|NCT01387022|11065366|FG000|Overall Study|Death|1
7000817|NCT01387022|11065367|FG001|Overall Study|Death|1
7000818|NCT01387022|11065366|FG000|Overall Study|Lost to Follow-up|0
7000819|NCT01387022|11065367|FG001|Overall Study|Lost to Follow-up|3
7000820|NCT01387074|11065373|FG000|Overall Study|Lost to Follow-up|7
7000821|NCT01387074|11065373|FG000|Overall Study|Lack of Efficacy|1
7000822|NCT01387230|11065399|FG000|Overall Study|Adverse Event|0
7000823|NCT01387230|11065400|FG001|Overall Study|Adverse Event|1
7000824|NCT01387230|11065401|FG002|Overall Study|Adverse Event|3
7000825|NCT01387230|11065399|FG000|Overall Study|Lack of Efficacy|8
7000826|NCT01387230|11065400|FG001|Overall Study|Lack of Efficacy|5
7000827|NCT01387230|11065401|FG002|Overall Study|Lack of Efficacy|4
7000828|NCT01387230|11065399|FG000|Overall Study|Protocol-defined Stopping Criteria|6
7000829|NCT01387230|11065400|FG001|Overall Study|Protocol-defined Stopping Criteria|0
7000830|NCT01387230|11065401|FG002|Overall Study|Protocol-defined Stopping Criteria|5
7000831|NCT01387230|11065399|FG000|Overall Study|Lost to Follow-up|0
7000832|NCT01387230|11065400|FG001|Overall Study|Lost to Follow-up|0
7000833|NCT01387230|11065401|FG002|Overall Study|Lost to Follow-up|1
7000834|NCT01387230|11065399|FG000|Overall Study|Withdrawal by Subject|4
7000835|NCT01387230|11065400|FG001|Overall Study|Withdrawal by Subject|1
7000836|NCT01387230|11065401|FG002|Overall Study|Withdrawal by Subject|0
7000837|NCT01387269|11065411|FG000|Overall Study|Death|38
7000838|NCT01387269|11065412|FG001|Overall Study|Death|20
7000839|NCT01387269|11065411|FG000|Overall Study|Other|8
7000840|NCT01387269|11065412|FG001|Overall Study|Other|7
7000841|NCT01387269|11065411|FG000|Overall Study|Unrelated AE|12
7000842|NCT01387269|11065412|FG001|Overall Study|Unrelated AE|3
7000843|NCT01387269|11065411|FG000|Overall Study|Withdrawal by patient|32
7000844|NCT01387269|11065412|FG001|Overall Study|Withdrawal by patient|10
7000845|NCT01387269|11065411|FG000|Overall Study|Study drug-related AE|1
7000846|NCT01387269|11065412|FG001|Overall Study|Study drug-related AE|0
7000847|NCT01387269|11065411|FG000|Overall Study|Lost to Follow-up|1
7000848|NCT01387269|11065412|FG001|Overall Study|Lost to Follow-up|0
7000849|NCT01387282|11065420|FG000|Overall Study|Death|47
7000850|NCT01387282|11065421|FG001|Overall Study|Death|16
7000851|NCT01387282|11065420|FG000|Overall Study|Other|5
7000852|NCT01387282|11065421|FG001|Overall Study|Other|1
7000853|NCT01387282|11065420|FG000|Overall Study|Unrelated AE|6
7000854|NCT01387282|11065421|FG001|Overall Study|Unrelated AE|4
7000855|NCT01387282|11065420|FG000|Overall Study|Withdrawal by patient|33
7000856|NCT01387282|11065421|FG001|Overall Study|Withdrawal by patient|23
7000857|NCT01387282|11065420|FG000|Overall Study|Study drug-related AE|2
7000858|NCT01387282|11065421|FG001|Overall Study|Study drug-related AE|2
7000859|NCT01387282|11065420|FG000|Overall Study|Lost to Follow-up|4
7000860|NCT01387282|11065421|FG001|Overall Study|Lost to Follow-up|1
7000861|NCT01387347|11065429|FG000|Overall Study|Lost to Follow-up|2
7000862|NCT01387347|11065430|FG001|Overall Study|Lost to Follow-up|1
7000863|NCT01387516|11065453|FG000|Overall Study|Lost to Follow-up|4
7000864|NCT01387516|11065454|FG001|Overall Study|Lost to Follow-up|4
7000865|NCT01387516|11065455|FG002|Overall Study|Lost to Follow-up|2
7000866|NCT01387516|11065456|FG003|Overall Study|Lost to Follow-up|3
7000867|NCT01387516|11065453|FG000|Overall Study|Withdrawal by Subject|1
7000868|NCT01387516|11065454|FG001|Overall Study|Withdrawal by Subject|1
7000869|NCT01387516|11065455|FG002|Overall Study|Withdrawal by Subject|2
7000870|NCT01387516|11065456|FG003|Overall Study|Withdrawal by Subject|0
7000871|NCT01387516|11065453|FG000|Overall Study|Death|0
7000872|NCT01387516|11065454|FG001|Overall Study|Death|0
7000873|NCT01387516|11065455|FG002|Overall Study|Death|0
7000874|NCT01387516|11065456|FG003|Overall Study|Death|1
7000875|NCT01387542|11065466|FG000|Overall Study|Adverse Event|3
7000876|NCT01387542|11065466|FG000|Overall Study|Withdrawal by Subject|1
7000877|NCT01387542|11065466|FG000|Overall Study|Changed diagnosis|1
7000878|NCT01387542|11065466|FG000|Overall Study|Insufficient response|1
7000879|NCT01387542|11065466|FG000|Overall Study|Non-compliant|1
7000880|NCT01387542|11065466|FG000|Overall Study|Lost to Follow-up|1
7000881|NCT01387594|11065485|FG000|Overall Study|Withdrawal by Subject|0
7000882|NCT01387594|11065486|FG001|Overall Study|Withdrawal by Subject|2
7000883|NCT01387594|11065485|FG000|Overall Study|Lost to Follow-up|0
7000884|NCT01387594|11065486|FG001|Overall Study|Lost to Follow-up|1
7000885|NCT01387607|11065497|FG000|Overall Study|Adverse Event|23
7000886|NCT01387607|11065498|FG001|Overall Study|Adverse Event|11
7000887|NCT01387607|11065497|FG000|Overall Study|Lack of Efficacy|8
7000888|NCT01387607|11065498|FG001|Overall Study|Lack of Efficacy|6
7000889|NCT01387607|11065497|FG000|Overall Study|Lost to Follow-up|2
7000890|NCT01387607|11065498|FG001|Overall Study|Lost to Follow-up|1
7000891|NCT01387607|11065497|FG000|Overall Study|No longer meets eligibility criteria|0
7000892|NCT01387607|11065498|FG001|Overall Study|No longer meets eligibility criteria|1
7000893|NCT01387607|11065497|FG000|Overall Study|Protocol Violation|1
7000894|NCT01387607|11065498|FG001|Overall Study|Protocol Violation|5
7000895|NCT01387607|11065497|FG000|Overall Study|Withdrawal by Subject|13
7000896|NCT01387607|11065498|FG001|Overall Study|Withdrawal by Subject|14
7000897|NCT01387607|11065497|FG000|Overall Study|Other|1
7000898|NCT01387607|11065498|FG001|Overall Study|Other|1
7000899|NCT01387607|11065497|FG000|Overall Study|Randomized, not treated|3
7000900|NCT01387607|11065498|FG001|Overall Study|Randomized, not treated|6
7000901|NCT01387737|11065532|FG000|Overall Study|Adverse Event|20
7000902|NCT01387737|11065533|FG001|Overall Study|Adverse Event|30
7000903|NCT01387737|11065532|FG000|Overall Study|Lack of Efficacy|1
7000904|NCT01387737|11065533|FG001|Overall Study|Lack of Efficacy|0
7000905|NCT01387737|11065532|FG000|Overall Study|Physician Decision|3
7000906|NCT01387737|11065533|FG001|Overall Study|Physician Decision|10
7000907|NCT01387737|11065532|FG000|Overall Study|Withdrawal by Subject|27
7000908|NCT01387737|11065533|FG001|Overall Study|Withdrawal by Subject|31
7000909|NCT01387737|11065532|FG000|Overall Study|Clearly not eligible for the study|1
7000910|NCT01387737|11065533|FG001|Overall Study|Clearly not eligible for the study|3
7000911|NCT01387789|11065539|FG000|Overall Study|Adverse Event|5
7000912|NCT01387789|11065539|FG000|Overall Study|Lack of Efficacy|2
7000913|NCT01387789|11065539|FG000|Overall Study|Lost to Follow-up|1
7000914|NCT01387932|11065554|FG000|Randomized and Treated|Physician Decision|3
7000915|NCT01387932|11065555|FG001|Randomized and Treated|Physician Decision|2
7000916|NCT01387932|11065554|FG000|Randomized and Treated|Withdrawal by Subject|4
7000917|NCT01387932|11065555|FG001|Randomized and Treated|Withdrawal by Subject|2
7000918|NCT01387932|11065554|FG000|Survival Follow-up|Liver Transplant|24
7000919|NCT01387932|11065555|FG001|Survival Follow-up|Liver Transplant|28
7000920|NCT01387932|11065554|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52
7000921|NCT01387932|11065555|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53
7000922|NCT01387932|11065554|FG000|Survival Follow-up|Withdrawal by Subject|2
7000923|NCT01387932|11065555|FG001|Survival Follow-up|Withdrawal by Subject|4
7000924|NCT01387932|11065554|FG000|Survival Follow-up|Lost to Follow-up|6
7000925|NCT01387932|11065555|FG001|Survival Follow-up|Lost to Follow-up|5
7000926|NCT01388166|11065563|FG000|Overall Study|Adverse Event|16
7000927|NCT01388166|11065563|FG000|Overall Study|Lost to Follow-up|30
7000928|NCT01388166|11065563|FG000|Overall Study|Others than specified above|13
7000929|NCT01388335|11065567|FG000|Period 1|Progressive Disease|1
7000930|NCT01388335|11065567|FG000|Period 2|Progressive Disease|2
7000931|NCT01388335|11065567|FG000|Period 2|Sponsor Decision|1
7000932|NCT01388335|11065567|FG000|Safety Extension|Progressive Disease|7
7000933|NCT01388361|11065582|FG000|Overall Study|Adverse Event|0
7000934|NCT01388361|11065583|FG001|Overall Study|Adverse Event|5
7000935|NCT01388361|11065584|FG002|Overall Study|Adverse Event|1
7000936|NCT01388361|11065582|FG000|Overall Study|Protocol Violation|0
7000937|NCT01388361|11065583|FG001|Overall Study|Protocol Violation|0
7000938|NCT01388361|11065584|FG002|Overall Study|Protocol Violation|2
7000939|NCT01388361|11065582|FG000|Overall Study|Withdrawal criteria|12
7000940|NCT01388361|11065583|FG001|Overall Study|Withdrawal criteria|7
7000941|NCT01388361|11065584|FG002|Overall Study|Withdrawal criteria|10
7000942|NCT01388361|11065582|FG000|Overall Study|Unclassified|0
7000943|NCT01388361|11065583|FG001|Overall Study|Unclassified|0
7000944|NCT01388361|11065584|FG002|Overall Study|Unclassified|1
7000945|NCT01388478|11065592|FG000|Overall Study|Adverse Event|4
7000946|NCT01388478|11065592|FG000|Overall Study|Withdrawal by Subject|1
7000947|NCT01388530|11065596|FG000|Overall Study|Lost to Follow-up|5
7000948|NCT01388543|11065602|FG000|Day 14|Adverse Event|1
7000949|NCT01388543|11065603|FG001|Day 14|Adverse Event|4
7000950|NCT01388647|11065611|FG000|Overall Study|Adverse Event|1
7000951|NCT01388647|11065612|FG001|Overall Study|Adverse Event|2
7000952|NCT01388790|11065623|FG000|Overall Study|Ongoing at data cut-off date|8
7000953|NCT01388816|11065631|FG000|Overall Study|Adverse Event|0
7000954|NCT01388816|11065632|FG001|Overall Study|Adverse Event|2
7000955|NCT01388816|11065633|FG002|Overall Study|Adverse Event|0
7000956|NCT01388816|11065634|FG003|Overall Study|Adverse Event|0
7000957|NCT01388816|11065631|FG000|Overall Study|Lost to Follow-up|0
7000958|NCT01388816|11065632|FG001|Overall Study|Lost to Follow-up|1
7000959|NCT01388816|11065633|FG002|Overall Study|Lost to Follow-up|0
7000960|NCT01388816|11065634|FG003|Overall Study|Lost to Follow-up|0
7000961|NCT01388816|11065631|FG000|Overall Study|Withdrawal by Subject|2
7000962|NCT01388816|11065632|FG001|Overall Study|Withdrawal by Subject|1
7000963|NCT01388816|11065633|FG002|Overall Study|Withdrawal by Subject|1
7000964|NCT01388816|11065634|FG003|Overall Study|Withdrawal by Subject|0
7000965|NCT01388816|11065631|FG000|Overall Study|Protocol Violation|0
7000966|NCT01388816|11065632|FG001|Overall Study|Protocol Violation|0
7000967|NCT01388816|11065633|FG002|Overall Study|Protocol Violation|2
7000968|NCT01388816|11065634|FG003|Overall Study|Protocol Violation|0
7042818|NCT01738503|11127383|FG005|Treatment Period|Withdrawal by Subject|1
7042819|NCT01738503|11127384|FG006|Treatment Period|Withdrawal by Subject|1
7042820|NCT01738503|11127378|FG000|Treatment Period|Protocol Violation|0
7042821|NCT01738503|11127379|FG001|Treatment Period|Protocol Violation|3
7042822|NCT01738503|11127380|FG002|Treatment Period|Protocol Violation|1
7042823|NCT01738503|11127381|FG003|Treatment Period|Protocol Violation|0
7042824|NCT01738503|11127382|FG004|Treatment Period|Protocol Violation|4
7042825|NCT01738503|11127383|FG005|Treatment Period|Protocol Violation|2
7042826|NCT01738503|11127384|FG006|Treatment Period|Protocol Violation|0
7042827|NCT01738503|11127378|FG000|Treatment Period|Other|0
7042828|NCT01738503|11127379|FG001|Treatment Period|Other|0
7042829|NCT01738503|11127380|FG002|Treatment Period|Other|1
7000969|NCT01388907|11065649|FG000|Overall Study|Adverse Event|2
7000970|NCT01388907|11065650|FG001|Overall Study|Adverse Event|0
7000971|NCT01388985|11065669|FG000|Overall Study|Death|0
7000972|NCT01388985|11065670|FG001|Overall Study|Death|1
7000973|NCT01388985|11065669|FG000|Overall Study|Lost to Follow-up|30
7000974|NCT01388985|11065670|FG001|Overall Study|Lost to Follow-up|30
7000975|NCT01388985|11065669|FG000|Overall Study|Withdrawal by Subject|13
7000976|NCT01388985|11065670|FG001|Overall Study|Withdrawal by Subject|4
7000977|NCT01388985|11065669|FG000|Overall Study|Subject unavailable|1
7000978|NCT01388985|11065670|FG001|Overall Study|Subject unavailable|1
7000979|NCT01388985|11065669|FG000|Overall Study|Other (no reason)|0
7000980|NCT01388985|11065670|FG001|Overall Study|Other (no reason)|1
7000981|NCT01388985|11065669|FG000|Overall Study|Error of nurse|5
7000982|NCT01388985|11065670|FG001|Overall Study|Error of nurse|1
7000983|NCT01389102|11065686|FG000|Overall Study|Adverse Event|1
7000984|NCT01389102|11065687|FG001|Overall Study|Adverse Event|3
7000985|NCT01389102|11065688|FG002|Overall Study|Adverse Event|2
7000986|NCT01389102|11065689|FG003|Overall Study|Adverse Event|2
7000987|NCT01389102|11065690|FG004|Overall Study|Adverse Event|2
7000988|NCT01389102|11065691|FG005|Overall Study|Adverse Event|2
7000989|NCT01389102|11065686|FG000|Overall Study|Hurricane Katrina|4
7000990|NCT01389102|11065687|FG001|Overall Study|Hurricane Katrina|2
7000991|NCT01389102|11065688|FG002|Overall Study|Hurricane Katrina|3
7000992|NCT01389102|11065689|FG003|Overall Study|Hurricane Katrina|0
7000993|NCT01389102|11065690|FG004|Overall Study|Hurricane Katrina|3
7000994|NCT01389102|11065691|FG005|Overall Study|Hurricane Katrina|1
7000995|NCT01389102|11065686|FG000|Overall Study|Lost to Follow-up|4
7000996|NCT01389102|11065687|FG001|Overall Study|Lost to Follow-up|1
7000997|NCT01389102|11065688|FG002|Overall Study|Lost to Follow-up|1
7000998|NCT01389102|11065689|FG003|Overall Study|Lost to Follow-up|2
7000999|NCT01389102|11065690|FG004|Overall Study|Lost to Follow-up|4
7001000|NCT01389102|11065691|FG005|Overall Study|Lost to Follow-up|1
7001001|NCT01389102|11065686|FG000|Overall Study|Protocol Violation|0
7001002|NCT01389102|11065687|FG001|Overall Study|Protocol Violation|0
7001003|NCT01389102|11065688|FG002|Overall Study|Protocol Violation|3
7001004|NCT01389102|11065689|FG003|Overall Study|Protocol Violation|0
7001005|NCT01389102|11065690|FG004|Overall Study|Protocol Violation|1
7001006|NCT01389102|11065691|FG005|Overall Study|Protocol Violation|1
7001007|NCT01389102|11065686|FG000|Overall Study|Withdrawal by Subject|7
7001008|NCT01389102|11065687|FG001|Overall Study|Withdrawal by Subject|4
7001009|NCT01389102|11065688|FG002|Overall Study|Withdrawal by Subject|9
7001010|NCT01389102|11065689|FG003|Overall Study|Withdrawal by Subject|2
7001011|NCT01389102|11065690|FG004|Overall Study|Withdrawal by Subject|3
7001012|NCT01389102|11065691|FG005|Overall Study|Withdrawal by Subject|3
7001013|NCT01389102|11065686|FG000|Overall Study|Subject Traveling Out of Country|0
7001014|NCT01389102|11065687|FG001|Overall Study|Subject Traveling Out of Country|0
7001015|NCT01389102|11065688|FG002|Overall Study|Subject Traveling Out of Country|0
7001016|NCT01389102|11065689|FG003|Overall Study|Subject Traveling Out of Country|1
7001017|NCT01389102|11065690|FG004|Overall Study|Subject Traveling Out of Country|0
7001018|NCT01389102|11065691|FG005|Overall Study|Subject Traveling Out of Country|0
7001019|NCT01389102|11065686|FG000|Overall Study|Subject Moved|2
7001020|NCT01389102|11065687|FG001|Overall Study|Subject Moved|0
7001021|NCT01389102|11065688|FG002|Overall Study|Subject Moved|1
7001022|NCT01389102|11065689|FG003|Overall Study|Subject Moved|0
7001023|NCT01389102|11065690|FG004|Overall Study|Subject Moved|0
7001024|NCT01389102|11065691|FG005|Overall Study|Subject Moved|0
7001025|NCT01389102|11065686|FG000|Overall Study|Unavailable due to husband's illness|0
7001026|NCT01389102|11065687|FG001|Overall Study|Unavailable due to husband's illness|1
7001027|NCT01389102|11065688|FG002|Overall Study|Unavailable due to husband's illness|0
7001028|NCT01389102|11065689|FG003|Overall Study|Unavailable due to husband's illness|0
7001029|NCT01389102|11065690|FG004|Overall Study|Unavailable due to husband's illness|0
7001030|NCT01389102|11065691|FG005|Overall Study|Unavailable due to husband's illness|0
7001031|NCT01389102|11065686|FG000|Overall Study|Investigator Judgement|0
7001032|NCT01389102|11065687|FG001|Overall Study|Investigator Judgement|1
7001033|NCT01389102|11065688|FG002|Overall Study|Investigator Judgement|0
7001034|NCT01389102|11065689|FG003|Overall Study|Investigator Judgement|0
7001035|NCT01389102|11065690|FG004|Overall Study|Investigator Judgement|0
7001036|NCT01389102|11065691|FG005|Overall Study|Investigator Judgement|0
7001037|NCT01389128|11065713|FG000|Overall Study|Fetal distress|1
7001038|NCT01389128|11065714|FG001|Overall Study|Fetal distress|0
7001039|NCT01389128|11065713|FG000|Overall Study|Cervix dilation stop|1
7001040|NCT01389128|11065714|FG001|Overall Study|Cervix dilation stop|2
7001041|NCT01389128|11065713|FG000|Overall Study|Rapid labor evolution|3
7001042|NCT01389128|11065714|FG001|Overall Study|Rapid labor evolution|2
7001043|NCT01389128|11065713|FG000|Overall Study|Intolerance to procedure|0
7001044|NCT01389128|11065714|FG001|Overall Study|Intolerance to procedure|2
7001045|NCT01389232|11065724|FG000|Overall Study|Had scaffold removed|15
7001046|NCT01389232|11065724|FG000|Overall Study|Personal reasons|2
7001047|NCT01389232|11065724|FG000|Overall Study|Adverse Event|1
7001048|NCT01389232|11065724|FG000|Overall Study|Death|1
7001049|NCT01389245|11065738|FG000|Overall Study|Protocol Violation|10
7001050|NCT01389245|11065738|FG000|Overall Study|Lost to Follow-up|3
7001051|NCT01389245|11065738|FG000|Overall Study|Withdrawal by Subject|2
7001052|NCT01389258|11065742|FG000|Overall Study|Lost to Follow-up|5
7001053|NCT01389323|11065759|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41
7001054|NCT01389323|11065759|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24
7001055|NCT01389323|11065759|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6
7001056|NCT01389323|11065759|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7
7001057|NCT01389323|11065759|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10
7001058|NCT01389323|11065759|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5
7001059|NCT01389323|11065759|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2
7001060|NCT01389323|11065759|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10
7001061|NCT01389323|11065759|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22
7001062|NCT01389323|11065759|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2
7001063|NCT01389323|11065759|FG000|Follow-up Period (up to 48 Weeks)|Other|3
7001064|NCT01389596|11065773|FG000|Overall Study|Protocol Violation|3
7001065|NCT01389596|11065774|FG001|Overall Study|Protocol Violation|4
7001066|NCT01389596|11065775|FG002|Overall Study|Protocol Violation|3
7001067|NCT01389596|11065773|FG000|Overall Study|Withdrawal by Subject|1
7001068|NCT01389596|11065774|FG001|Overall Study|Withdrawal by Subject|2
7001069|NCT01389596|11065775|FG002|Overall Study|Withdrawal by Subject|2
7001070|NCT01389596|11065773|FG000|Overall Study|Insufficient Clinical Response|3
7001071|NCT01389596|11065774|FG001|Overall Study|Insufficient Clinical Response|4
7001072|NCT01389596|11065775|FG002|Overall Study|Insufficient Clinical Response|5
7001073|NCT01389596|11065773|FG000|Overall Study|Adverse Event|1
7001074|NCT01389596|11065774|FG001|Overall Study|Adverse Event|4
7001075|NCT01389596|11065775|FG002|Overall Study|Adverse Event|0
7001076|NCT01389596|11065773|FG000|Overall Study|Death|0
7001077|NCT01389596|11065774|FG001|Overall Study|Death|1
7001078|NCT01389596|11065775|FG002|Overall Study|Death|0
7001079|NCT01389596|11065773|FG000|Overall Study|Other Unspecified|2
7001080|NCT01389596|11065774|FG001|Overall Study|Other Unspecified|1
7001081|NCT01389596|11065775|FG002|Overall Study|Other Unspecified|0
7001082|NCT01389752|11065783|FG000|Study Period 1|Sponsor decision|0
7001083|NCT01389752|11065784|FG001|Study Period 1|Sponsor decision|2
7001084|NCT01389752|11065783|FG000|Study Period 2|Sponsor decision|1
7001085|NCT01389752|11065784|FG001|Study Period 2|Sponsor decision|0
7001086|NCT01389882|11065809|FG000|Overall Study|Respiratory rate > 80/min during study|1
7001087|NCT01389882|11065810|FG001|Overall Study|Respiratory rate > 80/min during study|3
7001088|NCT01389882|11065809|FG000|Overall Study|Withdrawal by Subject|0
7001089|NCT01389882|11065810|FG001|Overall Study|Withdrawal by Subject|1
7001090|NCT01389973|11065816|FG000|Overall Study|Lost to Follow-up|1
7001091|NCT01389973|11065816|FG000|Overall Study|Trial Stopped by Sponsor|9
7001092|NCT01389973|11065816|FG000|Overall Study|Other|10
7001093|NCT01390038|11065820|FG000|Overall Study|Death|1
7001094|NCT01390038|11065820|FG000|Overall Study|Lost to Follow-up|1
7001095|NCT01390038|11065820|FG000|Overall Study|Withdrawal by Subject|4
7001096|NCT01390038|11065820|FG000|Overall Study|Simpliciti System Removal|2
7001097|NCT01390220|11065842|FG000|Test Dose Phase|Adverse Event|17
7001098|NCT01390220|11065843|FG001|Test Dose Phase|Adverse Event|0
7001099|NCT01390220|11065844|FG002|Test Dose Phase|Adverse Event|0
7001100|NCT01390220|11065842|FG000|Test Dose Phase|Withdrawal by Subject|8
7001101|NCT01390220|11065843|FG001|Test Dose Phase|Withdrawal by Subject|0
7001102|NCT01390220|11065844|FG002|Test Dose Phase|Withdrawal by Subject|0
7001103|NCT01390220|11065842|FG000|Test Dose Phase|Lost to Follow-up|2
7001104|NCT01390220|11065843|FG001|Test Dose Phase|Lost to Follow-up|0
7001105|NCT01390220|11065844|FG002|Test Dose Phase|Lost to Follow-up|0
7001106|NCT01390220|11065842|FG000|Test Dose Phase|Protocol Violation|8
7001107|NCT01390220|11065843|FG001|Test Dose Phase|Protocol Violation|0
7001108|NCT01390220|11065844|FG002|Test Dose Phase|Protocol Violation|0
7001109|NCT01390220|11065842|FG000|Test Dose Phase|No treated seizure cluster episode|37
7001110|NCT01390220|11065843|FG001|Test Dose Phase|No treated seizure cluster episode|0
7001111|NCT01390220|11065844|FG002|Test Dose Phase|No treated seizure cluster episode|0
7001112|NCT01390220|11065842|FG000|Test Dose Phase|Study/Site closure|6
7001113|NCT01390220|11065843|FG001|Test Dose Phase|Study/Site closure|0
7001114|NCT01390220|11065844|FG002|Test Dose Phase|Study/Site closure|0
7001115|NCT01390220|11065842|FG000|Test Dose Phase|Caregiver no longer available|5
7001116|NCT01390220|11065843|FG001|Test Dose Phase|Caregiver no longer available|0
7001117|NCT01390220|11065844|FG002|Test Dose Phase|Caregiver no longer available|0
7001118|NCT01390220|11065842|FG000|Test Dose Phase|Noncompliance|2
7001119|NCT01390220|11065843|FG001|Test Dose Phase|Noncompliance|0
7001120|NCT01390220|11065844|FG002|Test Dose Phase|Noncompliance|0
7001121|NCT01390220|11065842|FG000|Test Dose Phase|Logistical|6
7001122|NCT01390220|11065843|FG001|Test Dose Phase|Logistical|0
7001123|NCT01390220|11065844|FG002|Test Dose Phase|Logistical|0
7001124|NCT01390220|11065842|FG000|Comparative Phase|Withdrawal by Subject|0
7001125|NCT01390220|11065843|FG001|Comparative Phase|Withdrawal by Subject|1
7001126|NCT01390220|11065844|FG002|Comparative Phase|Withdrawal by Subject|0
7001127|NCT01390272|11065883|FG000|Overall Study|Death|3
7001128|NCT01390272|11065884|FG001|Overall Study|Death|2
7001129|NCT01390272|11065883|FG000|Overall Study|Withdrawal by Subject|9
7001130|NCT01390272|11065884|FG001|Overall Study|Withdrawal by Subject|5
7001131|NCT01390272|11065883|FG000|Overall Study|Patient moved, no longer eligible|5
7001132|NCT01390272|11065884|FG001|Overall Study|Patient moved, no longer eligible|8
7001133|NCT01390298|11065890|FG000|Overall Study|Death|1
7001134|NCT01390298|11065890|FG000|Overall Study|long term ICU admission|1
7001135|NCT01390298|11065890|FG000|Overall Study|Withdrawal by Subject|14
7001136|NCT01390298|11065890|FG000|Overall Study|Lost to Follow-up|7
7001137|NCT01390298|11065890|FG000|Overall Study|Surgery cancelled|1
7001138|NCT01390389|11065896|FG000|Overall Study|Withdrawal by Subject|2
7001139|NCT01390389|11065897|FG001|Overall Study|Withdrawal by Subject|0
7001140|NCT01390389|11065896|FG000|Overall Study|Screen Fail|2
7001141|NCT01390389|11065897|FG001|Overall Study|Screen Fail|1
7001142|NCT01390402|11065907|FG000|Overall Study|Death|1
7001143|NCT01390402|11065907|FG000|Overall Study|Disease Progression|4
7001144|NCT01390428|11065917|FG000|Overall Study|Elective Surgery|0
7001145|NCT01390428|11065918|FG001|Overall Study|Elective Surgery|0
7001146|NCT01390428|11065919|FG002|Overall Study|Elective Surgery|0
7001147|NCT01390428|11065920|FG003|Overall Study|Elective Surgery|0
7001148|NCT01390428|11065921|FG004|Overall Study|Elective Surgery|1
7001149|NCT01390428|11065922|FG005|Overall Study|Elective Surgery|0
7001150|NCT01390428|11065917|FG000|Overall Study|Withdrawal by Subject|0
7001151|NCT01390428|11065918|FG001|Overall Study|Withdrawal by Subject|0
7001152|NCT01390428|11065919|FG002|Overall Study|Withdrawal by Subject|1
7001153|NCT01390428|11065920|FG003|Overall Study|Withdrawal by Subject|0
7001154|NCT01390428|11065921|FG004|Overall Study|Withdrawal by Subject|0
7001155|NCT01390428|11065922|FG005|Overall Study|Withdrawal by Subject|0
7001156|NCT01390441|11065941|FG000|Treatment Period|Protocol Violation|0
7001157|NCT01390441|11065942|FG001|Treatment Period|Protocol Violation|1
7001158|NCT01390441|11065943|FG002|Treatment Period|Protocol Violation|0
7001159|NCT01390441|11065944|FG003|Treatment Period|Protocol Violation|0
7001160|NCT01390441|11065945|FG004|Treatment Period|Protocol Violation|0
7001161|NCT01390441|11065941|FG000|Treatment Period|Physician Decision|0
7001162|NCT01390441|11065942|FG001|Treatment Period|Physician Decision|0
7001163|NCT01390441|11065943|FG002|Treatment Period|Physician Decision|0
7001164|NCT01390441|11065944|FG003|Treatment Period|Physician Decision|1
7001165|NCT01390441|11065945|FG004|Treatment Period|Physician Decision|0
7001166|NCT01390441|11065941|FG000|Treatment Period|Lack of Efficacy|0
7001167|NCT01390441|11065942|FG001|Treatment Period|Lack of Efficacy|0
7001168|NCT01390441|11065943|FG002|Treatment Period|Lack of Efficacy|0
7001169|NCT01390441|11065944|FG003|Treatment Period|Lack of Efficacy|0
7001170|NCT01390441|11065945|FG004|Treatment Period|Lack of Efficacy|1
7001171|NCT01390441|11065941|FG000|Treatment Period|Unknown due to early stopping of study|0
7001172|NCT01390441|11065942|FG001|Treatment Period|Unknown due to early stopping of study|0
7001173|NCT01390441|11065943|FG002|Treatment Period|Unknown due to early stopping of study|8
7001174|NCT01390441|11065944|FG003|Treatment Period|Unknown due to early stopping of study|11
7001175|NCT01390441|11065945|FG004|Treatment Period|Unknown due to early stopping of study|7
7001176|NCT01390441|11065941|FG000|Treatment Period|Adverse Event|0
7001177|NCT01390441|11065942|FG001|Treatment Period|Adverse Event|0
7001178|NCT01390441|11065943|FG002|Treatment Period|Adverse Event|1
7001179|NCT01390441|11065944|FG003|Treatment Period|Adverse Event|1
7001180|NCT01390441|11065945|FG004|Treatment Period|Adverse Event|2
7001181|NCT01390441|11065941|FG000|Treatment Period|Withdrawal by Subject|0
7001182|NCT01390441|11065942|FG001|Treatment Period|Withdrawal by Subject|0
7001183|NCT01390441|11065943|FG002|Treatment Period|Withdrawal by Subject|1
7001184|NCT01390441|11065944|FG003|Treatment Period|Withdrawal by Subject|0
7001185|NCT01390441|11065945|FG004|Treatment Period|Withdrawal by Subject|1
7001186|NCT01390441|11065941|FG000|Treatment Period|Lost to Follow-up|1
7001187|NCT01390441|11065942|FG001|Treatment Period|Lost to Follow-up|0
7001188|NCT01390441|11065943|FG002|Treatment Period|Lost to Follow-up|0
7001189|NCT01390441|11065944|FG003|Treatment Period|Lost to Follow-up|0
7001190|NCT01390441|11065945|FG004|Treatment Period|Lost to Follow-up|0
7001191|NCT01390441|11065941|FG000|Extension Period|Protocol Violation|3
7001192|NCT01390441|11065942|FG001|Extension Period|Protocol Violation|1
7001193|NCT01390441|11065943|FG002|Extension Period|Protocol Violation|0
7001194|NCT01390441|11065944|FG003|Extension Period|Protocol Violation|1
7001195|NCT01390441|11065945|FG004|Extension Period|Protocol Violation|0
7001196|NCT01390584|11065985|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0
7001197|NCT01390584|11065986|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0
7001198|NCT01390584|11065987|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1
7001199|NCT01390649|11065996|FG000|Overall Study|Physician Decision|1
7001200|NCT01390779|11066000|FG000|Overall Study|Physician Decision|1
7001201|NCT01390844|11066137|FG000|Treatment Phase|Adverse Event|12
7001202|NCT01390844|11066138|FG001|Treatment Phase|Adverse Event|2
7001203|NCT01390844|11066139|FG002|Treatment Phase|Adverse Event|3
7001204|NCT01390844|11066140|FG003|Treatment Phase|Adverse Event|2
7001205|NCT01390844|11066137|FG000|Treatment Phase|Treatment Failure|23
7001206|NCT01390844|11066138|FG001|Treatment Phase|Treatment Failure|25
7001207|NCT01390844|11066139|FG002|Treatment Phase|Treatment Failure|10
7001208|NCT01390844|11066140|FG003|Treatment Phase|Treatment Failure|13
7001209|NCT01390844|11066137|FG000|Treatment Phase|Non-Medical Reasons|5
7001210|NCT01390844|11066138|FG001|Treatment Phase|Non-Medical Reasons|1
7001211|NCT01390844|11066139|FG002|Treatment Phase|Non-Medical Reasons|8
7001212|NCT01390844|11066140|FG003|Treatment Phase|Non-Medical Reasons|1
7001213|NCT01390844|11066137|FG000|Treatment Phase|Non-GCP Compliant|0
7001214|NCT01390844|11066138|FG001|Treatment Phase|Non-GCP Compliant|0
7001215|NCT01390844|11066139|FG002|Treatment Phase|Non-GCP Compliant|10
7001216|NCT01390844|11066140|FG003|Treatment Phase|Non-GCP Compliant|3
7001217|NCT01390844|11066137|FG000|Follow-Up Phase|Non-Medical Reasons|1
7001218|NCT01390844|11066138|FG001|Follow-Up Phase|Non-Medical Reasons|1
7001219|NCT01390844|11066139|FG002|Follow-Up Phase|Non-Medical Reasons|1
7001220|NCT01390844|11066140|FG003|Follow-Up Phase|Non-Medical Reasons|0
7001221|NCT01390857|11066150|FG000|Overall Study|Protocol Violation|2
7001222|NCT01390857|11066150|FG000|Overall Study|Lost to Follow-up|1
7001223|NCT01390857|11066150|FG000|Overall Study|No Visit after the First Visit|7
7001224|NCT01390948|11066190|FG000|Overall Study|End of Study|1
7001225|NCT01390948|11066191|FG001|Overall Study|End of Study|0
7001226|NCT01390948|11066192|FG002|Overall Study|End of Study|0
7001227|NCT01390948|11066190|FG000|Overall Study|Withdrew consent|2
7001228|NCT01390948|11066191|FG001|Overall Study|Withdrew consent|2
7001229|NCT01390948|11066192|FG002|Overall Study|Withdrew consent|0
7001230|NCT01390948|11066190|FG000|Overall Study|Progressive Disease|2
7001231|NCT01390948|11066191|FG001|Overall Study|Progressive Disease|5
7001232|NCT01390948|11066192|FG002|Overall Study|Progressive Disease|0
7001233|NCT01390948|11066190|FG000|Overall Study|Death during follow-up|10
7001234|NCT01390948|11066191|FG001|Overall Study|Death during follow-up|11
7001235|NCT01390948|11066192|FG002|Overall Study|Death during follow-up|1
7001236|NCT01391000|11066201|FG000|Overall Study|Lost to Follow-up|2
7001237|NCT01391000|11066202|FG001|Overall Study|Lost to Follow-up|0
7001238|NCT01391130|11066219|FG000|Overall Study|Withdrawal by Subject|3
7001239|NCT01391130|11066220|FG001|Overall Study|Withdrawal by Subject|2
7001240|NCT01391130|11066219|FG000|Overall Study|Physician Decision|2
7001241|NCT01391130|11066220|FG001|Overall Study|Physician Decision|3
7001242|NCT01391130|11066219|FG000|Overall Study|Did not Receive Drug|1
7001243|NCT01391130|11066220|FG001|Overall Study|Did not Receive Drug|1
7001244|NCT01391507|11066297|FG000|Overall Study|Death|0
7001245|NCT01391507|11066298|FG001|Overall Study|Death|0
7001246|NCT01391507|11066299|FG002|Overall Study|Death|0
7001247|NCT01391507|11066300|FG003|Overall Study|Death|1
7001248|NCT01391507|11066297|FG000|Overall Study|Adverse Event|1
7001249|NCT01391507|11066298|FG001|Overall Study|Adverse Event|1
7001250|NCT01391507|11066299|FG002|Overall Study|Adverse Event|2
7001251|NCT01391507|11066300|FG003|Overall Study|Adverse Event|2
7001252|NCT01391507|11066297|FG000|Overall Study|Withdrawal by Subject|1
7001253|NCT01391507|11066298|FG001|Overall Study|Withdrawal by Subject|2
7001254|NCT01391507|11066299|FG002|Overall Study|Withdrawal by Subject|1
7001255|NCT01391507|11066300|FG003|Overall Study|Withdrawal by Subject|1
7001256|NCT01391507|11066297|FG000|Overall Study|Lack of Efficacy|0
7001257|NCT01391507|11066298|FG001|Overall Study|Lack of Efficacy|0
7001258|NCT01391507|11066299|FG002|Overall Study|Lack of Efficacy|0
7001259|NCT01391507|11066300|FG003|Overall Study|Lack of Efficacy|1
7001260|NCT01391507|11066297|FG000|Overall Study|Protocol Violation|2
7001261|NCT01391507|11066298|FG001|Overall Study|Protocol Violation|1
7001262|NCT01391507|11066299|FG002|Overall Study|Protocol Violation|1
7001263|NCT01391507|11066300|FG003|Overall Study|Protocol Violation|2
7001264|NCT01391546|11066312|FG000|Overall Study|History of Herpes Zoster (HZ)|1
7001265|NCT01391546|11066313|FG001|Overall Study|History of Herpes Zoster (HZ)|0
7001266|NCT01391663|11066335|FG000|Overall Study|Withdrawal by Subject|0
7001267|NCT01391663|11066336|FG001|Overall Study|Withdrawal by Subject|0
7001268|NCT01391663|11066337|FG002|Overall Study|Withdrawal by Subject|1
7001269|NCT01391663|11066338|FG003|Overall Study|Withdrawal by Subject|0
7001270|NCT01391793|11066350|FG000|Overall Study|Ineligible|3
7001271|NCT01391793|11066351|FG001|Overall Study|Ineligible|0
7001272|NCT01391793|11066350|FG000|Overall Study|Urine Culture Negative or Indeterminate|71
7001273|NCT01391793|11066351|FG001|Overall Study|Urine Culture Negative or Indeterminate|87
7001274|NCT01391793|11066350|FG000|Overall Study|No DMSA|73
7001275|NCT01391793|11066351|FG001|Overall Study|No DMSA|57
7001276|NCT01391819|11066357|FG000|Overall Study|Withdrawal by Subject|56
7001277|NCT01391819|11066357|FG000|Overall Study|Migrated/moved from study area|82
7001278|NCT01391819|11066357|FG000|Overall Study|Lost to Follow-up|252
7001279|NCT01391819|11066357|FG000|Overall Study|Death|3
7001280|NCT01391819|11066357|FG000|Overall Study|Other|9
7001281|NCT01391832|11066366|FG000|Overall Study|Withdrawal by Subject|21
7001282|NCT01391832|11066367|FG001|Overall Study|Withdrawal by Subject|22
7001283|NCT01391832|11066366|FG000|Overall Study|Lost to Follow-up|0
7001284|NCT01391832|11066367|FG001|Overall Study|Lost to Follow-up|1
7001285|NCT01392183|11066393|FG000|First Drug Administration|Adverse Event|3
7001286|NCT01392183|11066394|FG001|First Drug Administration|Adverse Event|2
7001287|NCT01392183|11066393|FG000|First Drug Administration|Death|1
7001288|NCT01392183|11066394|FG001|First Drug Administration|Death|0
7001289|NCT01392183|11066393|FG000|First Drug Administration|Withdrawal by Subject|10
7001290|NCT01392183|11066394|FG001|First Drug Administration|Withdrawal by Subject|17
7001291|NCT01392300|11066404|FG000|Main Period (MP)|Predefined discontinuation criteria|2
7001292|NCT01392300|11066405|FG001|Main Period (MP)|Predefined discontinuation criteria|3
7001293|NCT01392300|11066406|FG002|Main Period (MP)|Predefined discontinuation criteria|0
7001294|NCT01392300|11066404|FG000|Main Period (MP)|Withdrawal by Subject|5
7001295|NCT01392300|11066405|FG001|Main Period (MP)|Withdrawal by Subject|1
7001296|NCT01392300|11066406|FG002|Main Period (MP)|Withdrawal by Subject|0
7001297|NCT01392300|11066404|FG000|Main Period (MP)|Lost to Follow-up|3
7001298|NCT01392300|11066405|FG001|Main Period (MP)|Lost to Follow-up|3
7001299|NCT01392300|11066406|FG002|Main Period (MP)|Lost to Follow-up|0
7001300|NCT01392300|11066404|FG000|Main Period (MP)|Non-compliance|1
7001301|NCT01392300|11066405|FG001|Main Period (MP)|Non-compliance|0
7001302|NCT01392300|11066406|FG002|Main Period (MP)|Non-compliance|0
7001303|NCT01392300|11066404|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0
7001304|NCT01392300|11066405|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0
7001305|NCT01392300|11066406|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13
7001306|NCT01392300|11066404|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0
7001307|NCT01392300|11066405|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0
7001308|NCT01392300|11066406|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3
7001309|NCT01392300|11066404|FG000|Open Label Extension (OLEX) Period|Non-compliance|0
7001310|NCT01392300|11066405|FG001|Open Label Extension (OLEX) Period|Non-compliance|0
7001311|NCT01392300|11066406|FG002|Open Label Extension (OLEX) Period|Non-compliance|1
7001312|NCT01392300|11066404|FG000|Open Label Extension (OLEX) Period|Death|0
7001313|NCT01392300|11066405|FG001|Open Label Extension (OLEX) Period|Death|0
7001314|NCT01392300|11066406|FG002|Open Label Extension (OLEX) Period|Death|4
7001315|NCT01392300|11066404|FG000|Open Label Extension (OLEX) Period|Adverse Event|0
7001316|NCT01392300|11066405|FG001|Open Label Extension (OLEX) Period|Adverse Event|0
7001317|NCT01392300|11066406|FG002|Open Label Extension (OLEX) Period|Adverse Event|7
7001318|NCT01392300|11066404|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
7001319|NCT01392300|11066405|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
7001320|NCT01392300|11066406|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17
7001321|NCT01392300|11066404|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0
7001322|NCT01392300|11066405|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0
7001323|NCT01392300|11066406|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6
7001324|NCT01392326|11066416|FG000|Overall Study|Death|2
7001325|NCT01392326|11066417|FG001|Overall Study|Death|0
7001326|NCT01392326|11066418|FG002|Overall Study|Death|0
7001327|NCT01392326|11066416|FG000|Overall Study|Withdrawal by Subject|12
7001328|NCT01392326|11066417|FG001|Overall Study|Withdrawal by Subject|11
7001329|NCT01392326|11066418|FG002|Overall Study|Withdrawal by Subject|15
7001330|NCT01392326|11066416|FG000|Overall Study|Protocol Violation|2
7001331|NCT01392326|11066417|FG001|Overall Study|Protocol Violation|0
7001332|NCT01392326|11066418|FG002|Overall Study|Protocol Violation|0
7001333|NCT01392326|11066416|FG000|Overall Study|Pregnancy|0
7001334|NCT01392326|11066417|FG001|Overall Study|Pregnancy|0
7001335|NCT01392326|11066418|FG002|Overall Study|Pregnancy|1
7001336|NCT01392326|11066416|FG000|Overall Study|Physician Decision|7
7001337|NCT01392326|11066417|FG001|Overall Study|Physician Decision|5
7001338|NCT01392326|11066418|FG002|Overall Study|Physician Decision|2
7001339|NCT01392326|11066416|FG000|Overall Study|Lost to Follow-up|1
7001340|NCT01392326|11066417|FG001|Overall Study|Lost to Follow-up|3
7001341|NCT01392326|11066418|FG002|Overall Study|Lost to Follow-up|4
7001342|NCT01392326|11066416|FG000|Overall Study|Lack of Efficacy|14
7001343|NCT01392326|11066417|FG001|Overall Study|Lack of Efficacy|10
7001344|NCT01392326|11066418|FG002|Overall Study|Lack of Efficacy|15
7001345|NCT01392326|11066416|FG000|Overall Study|Adverse Event|9
7001346|NCT01392326|11066417|FG001|Overall Study|Adverse Event|6
7001347|NCT01392326|11066418|FG002|Overall Study|Adverse Event|11
7001348|NCT01392378|11066431|FG000|Infant Series|Adverse Event|0
7001349|NCT01392378|11066432|FG001|Infant Series|Adverse Event|0
7001350|NCT01392378|11066433|FG002|Infant Series|Adverse Event|0
7001351|NCT01392378|11066434|FG003|Infant Series|Adverse Event|1
7001352|NCT01392378|11066435|FG004|Infant Series|Adverse Event|0
7001353|NCT01392378|11066431|FG000|Infant Series|Lost to Follow-up|0
7001354|NCT01392378|11066432|FG001|Infant Series|Lost to Follow-up|0
7001355|NCT01392378|11066433|FG002|Infant Series|Lost to Follow-up|0
7001356|NCT01392378|11066434|FG003|Infant Series|Lost to Follow-up|1
7001357|NCT01392378|11066435|FG004|Infant Series|Lost to Follow-up|0
7001358|NCT01392378|11066431|FG000|Infant Series|Protocol Violation|0
7001359|NCT01392378|11066432|FG001|Infant Series|Protocol Violation|1
7001360|NCT01392378|11066433|FG002|Infant Series|Protocol Violation|0
7001361|NCT01392378|11066434|FG003|Infant Series|Protocol Violation|0
7001362|NCT01392378|11066435|FG004|Infant Series|Protocol Violation|0
7001363|NCT01392378|11066431|FG000|Infant Series|Withdrawal by Parent|4
7001364|NCT01392378|11066432|FG001|Infant Series|Withdrawal by Parent|1
7001365|NCT01392378|11066433|FG002|Infant Series|Withdrawal by Parent|0
7001366|NCT01392378|11066434|FG003|Infant Series|Withdrawal by Parent|0
7001367|NCT01392378|11066435|FG004|Infant Series|Withdrawal by Parent|0
7001368|NCT01392378|11066431|FG000|After Infant Series|Lost to Follow-up|0
7001369|NCT01392378|11066432|FG001|After Infant Series|Lost to Follow-up|0
7001370|NCT01392378|11066433|FG002|After Infant Series|Lost to Follow-up|1
7001371|NCT01392378|11066434|FG003|After Infant Series|Lost to Follow-up|0
7001372|NCT01392378|11066435|FG004|After Infant Series|Lost to Follow-up|0
7001373|NCT01392378|11066431|FG000|After Infant Series|Withdrawal by Parent|0
7001374|NCT01392378|11066432|FG001|After Infant Series|Withdrawal by Parent|1
7001375|NCT01392378|11066433|FG002|After Infant Series|Withdrawal by Parent|1
7001376|NCT01392378|11066434|FG003|After Infant Series|Withdrawal by Parent|0
7001377|NCT01392378|11066435|FG004|After Infant Series|Withdrawal by Parent|1
7001378|NCT01392378|11066431|FG000|Toddler Dose|Lost to Follow-up|0
7001379|NCT01392378|11066432|FG001|Toddler Dose|Lost to Follow-up|0
7001380|NCT01392378|11066433|FG002|Toddler Dose|Lost to Follow-up|0
7001381|NCT01392378|11066434|FG003|Toddler Dose|Lost to Follow-up|1
7001382|NCT01392378|11066435|FG004|Toddler Dose|Lost to Follow-up|0
7001383|NCT01392378|11066431|FG000|Toddler Dose|Withdrawal by Parent|0
7001384|NCT01392378|11066432|FG001|Toddler Dose|Withdrawal by Parent|1
7001385|NCT01392378|11066433|FG002|Toddler Dose|Withdrawal by Parent|0
7001386|NCT01392378|11066434|FG003|Toddler Dose|Withdrawal by Parent|1
7001387|NCT01392378|11066435|FG004|Toddler Dose|Withdrawal by Parent|1
7001388|NCT01392443|11066457|FG000|Overall Study|Disease progression|30
7001389|NCT01392443|11066457|FG000|Overall Study|Adverse Event|24
7001390|NCT01392443|11066457|FG000|Overall Study|Death|7
7001391|NCT01392443|11066457|FG000|Overall Study|Withdrawal by Subject|5
7001392|NCT01392443|11066457|FG000|Overall Study|Lost to Follow-up|1
7001393|NCT01392443|11066457|FG000|Overall Study|Protocol Violation|1
7001394|NCT01392469|11066461|FG000|Overall Study|Adverse Event|2
7001395|NCT01392469|11066461|FG000|Overall Study|Withdrawal by Subject|1
7001396|NCT01392469|11066461|FG000|Overall Study|Protocol Violation|1
7001397|NCT01392495|11066476|FG000|Overall Study|Death|3
7001398|NCT01392495|11066476|FG000|Overall Study|Administrative problems|8
7001399|NCT01392495|11066476|FG000|Overall Study|Withdrawal by Subject|2
7001400|NCT01392495|11066476|FG000|Overall Study|Adverse Event|3
7001401|NCT01392547|11066482|FG000|Overall Study|Adverse Event|2
7001402|NCT01392547|11066482|FG000|Overall Study|Non-compliance|2
7001403|NCT01392547|11066482|FG000|Overall Study|Withdrawal criteria|3
7001404|NCT01392547|11066482|FG000|Overall Study|Unclassified|1
7001405|NCT01392560|11066488|FG000|Overall Study|Adverse Event|2
7001406|NCT01392560|11066488|FG000|Overall Study|not entered|8
7001407|NCT01392560|11066488|FG000|Overall Study|discontinued during placebo run-in|2
7001408|NCT01392573|11066496|FG000|Overall Study|Adverse Event|1
7001409|NCT01392573|11066497|FG001|Overall Study|Adverse Event|3
7001410|NCT01392573|11066496|FG000|Overall Study|Lack of Efficacy|1
7001411|NCT01392573|11066497|FG001|Overall Study|Lack of Efficacy|2
7001412|NCT01392573|11066496|FG000|Overall Study|Protocol Violation|0
7001413|NCT01392573|11066497|FG001|Overall Study|Protocol Violation|2
7001414|NCT01392573|11066496|FG000|Overall Study|Withdrawal Criteria|13
7001415|NCT01392573|11066497|FG001|Overall Study|Withdrawal Criteria|15
7001416|NCT01392573|11066496|FG000|Overall Study|Site closure|8
7001417|NCT01392573|11066497|FG001|Overall Study|Site closure|7
7001418|NCT01392573|11066496|FG000|Overall Study|Unclassified|9
7001419|NCT01392573|11066497|FG001|Overall Study|Unclassified|6
7001420|NCT01392677|11066514|FG000|Overall Study|Adverse Event|3
7001421|NCT01392677|11066515|FG001|Overall Study|Adverse Event|1
7001422|NCT01392677|11066514|FG000|Overall Study|Withdrawal by Subject|0
7001423|NCT01392677|11066515|FG001|Overall Study|Withdrawal by Subject|2
7001424|NCT01392677|11066514|FG000|Overall Study|Incorrect enrollment|2
7001425|NCT01392677|11066515|FG001|Overall Study|Incorrect enrollment|3
7001426|NCT01392677|11066514|FG000|Overall Study|Other reason|3
7001427|NCT01392677|11066515|FG001|Overall Study|Other reason|2
7001428|NCT01392742|11066533|FG000|Overall Study|Premature study termination|42
7001429|NCT01392742|11066533|FG000|Overall Study|Failure to return|35
7001430|NCT01392742|11066533|FG000|Overall Study|No treatment/no cooperation/withdrew|12
7001431|NCT01392742|11066533|FG000|Overall Study|Lost to Follow-up|34
7001432|NCT01392742|11066533|FG000|Overall Study|Insufficient therapeutic response (ITR)|30
7001433|NCT01392742|11066533|FG000|Overall Study|ITR and Protocol deviation|1
7001434|NCT01392742|11066533|FG000|Overall Study|Adverse event/intercurrent illness|17
7001435|NCT01392742|11066533|FG000|Overall Study|Protocol Violation|14
7001436|NCT01392742|11066533|FG000|Overall Study|Other|3
7001437|NCT01392742|11066533|FG000|Overall Study|Missing information|13
7001438|NCT01392963|11066547|FG000|Week 0 (First Intervention)|Lost to Follow-up|0
7001439|NCT01392963|11066548|FG001|Week 0 (First Intervention)|Lost to Follow-up|1
7001440|NCT01392963|11066547|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0
7001441|NCT01392963|11066548|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1
7001442|NCT01392963|11066547|FG000|Week 24 Follow-up|Lost to Follow-up|2
7001443|NCT01392963|11066548|FG001|Week 24 Follow-up|Lost to Follow-up|0
7001444|NCT01393106|11066561|FG000|Overall Study|Adverse Event|3
7001445|NCT01393106|11066561|FG000|Overall Study|Withdrawal by Subject|1
7001446|NCT01393106|11066561|FG000|Overall Study|Lack of Efficacy|1
7001447|NCT01393158|11066578|FG000|Overall Study|Adverse Event|1
7001448|NCT01393158|11066579|FG001|Overall Study|Adverse Event|0
7001449|NCT01393301|11066593|FG000|Overall Study|Lost to Follow-up|5
7001450|NCT01393301|11066594|FG001|Overall Study|Lost to Follow-up|3
7001451|NCT01393301|11066593|FG000|Overall Study|Withdrawal by Subject|2
7001452|NCT01393301|11066594|FG001|Overall Study|Withdrawal by Subject|0
7001453|NCT01393301|11066593|FG000|Overall Study|Completed <7 sessions (intervention)|2
7001454|NCT01393301|11066594|FG001|Overall Study|Completed <7 sessions (intervention)|0
7001455|NCT01393405|11066609|FG000|Induction Period (week1-16)|Lack of Efficacy|70
7001456|NCT01393405|11066610|FG001|Induction Period (week1-16)|Lack of Efficacy|0
7001457|NCT01393405|11066611|FG002|Induction Period (week1-16)|Lack of Efficacy|0
7001458|NCT01393405|11066609|FG000|Induction Period (week1-16)|Adverse Event|16
7001459|NCT01393405|11066610|FG001|Induction Period (week1-16)|Adverse Event|0
7001460|NCT01393405|11066611|FG002|Induction Period (week1-16)|Adverse Event|0
7001461|NCT01393405|11066609|FG000|Induction Period (week1-16)|Withdrawal by Subject|9
7001462|NCT01393405|11066610|FG001|Induction Period (week1-16)|Withdrawal by Subject|0
7001463|NCT01393405|11066611|FG002|Induction Period (week1-16)|Withdrawal by Subject|0
7001464|NCT01393405|11066609|FG000|Maintenance Period Week|Lack of Efficacy|0
7001465|NCT01393405|11066610|FG001|Maintenance Period Week|Lack of Efficacy|22
7001466|NCT01393405|11066611|FG002|Maintenance Period Week|Lack of Efficacy|22
7001467|NCT01393405|11066609|FG000|Maintenance Period Week|Adverse Event|0
7001468|NCT01393405|11066610|FG001|Maintenance Period Week|Adverse Event|5
7001469|NCT01393405|11066611|FG002|Maintenance Period Week|Adverse Event|2
7001470|NCT01393405|11066609|FG000|Maintenance Period Week|Withdrawal by Subject|0
7001471|NCT01393405|11066610|FG001|Maintenance Period Week|Withdrawal by Subject|1
7001472|NCT01393405|11066611|FG002|Maintenance Period Week|Withdrawal by Subject|0
7001473|NCT01393405|11066609|FG000|Maintenance Period Week|Lost to Follow-up|0
7001474|NCT01393405|11066610|FG001|Maintenance Period Week|Lost to Follow-up|1
7001475|NCT01393405|11066611|FG002|Maintenance Period Week|Lost to Follow-up|0
7001476|NCT01393444|11066621|FG000|Overall Study|Withdrawal by Subject|1
7001477|NCT01393444|11066621|FG000|Overall Study|Determined ineligible during screening.|2
7001478|NCT01393600|11066642|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
7001479|NCT01393600|11066643|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1
7001480|NCT01393600|11066644|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
7001481|NCT01393600|11066645|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
7001482|NCT01393600|11066642|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
7001483|NCT01393600|11066643|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
7001484|NCT01393600|11066644|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1
7001485|NCT01393600|11066645|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
7001486|NCT01393600|11066642|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
7001487|NCT01393600|11066643|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
7001488|NCT01393600|11066644|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
7001489|NCT01393600|11066645|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1
7001490|NCT01393600|11066642|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
7001491|NCT01393600|11066643|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
7001492|NCT01393600|11066644|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
7001493|NCT01393600|11066645|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1
7001494|NCT01393600|11066642|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
7001495|NCT01393600|11066643|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
7001496|NCT01393600|11066644|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1
7001497|NCT01393600|11066645|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
7001498|NCT01393600|11066642|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
7001499|NCT01393600|11066643|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
7001500|NCT01393600|11066644|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1
7001501|NCT01393600|11066645|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
7001502|NCT01393600|11066642|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
7001503|NCT01393600|11066643|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
7001504|NCT01393600|11066644|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1
7001505|NCT01393600|11066645|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
7001506|NCT01393613|11066661|FG000|Overall Study|Adverse Event|11
7001507|NCT01393613|11066662|FG001|Overall Study|Adverse Event|11
7001508|NCT01393613|11066663|FG002|Overall Study|Adverse Event|13
7001509|NCT01393613|11066664|FG003|Overall Study|Adverse Event|22
7001510|NCT01393613|11066661|FG000|Overall Study|Participant Met Withdrawal Criteria|0
7001511|NCT01393613|11066662|FG001|Overall Study|Participant Met Withdrawal Criteria|0
7001512|NCT01393613|11066663|FG002|Overall Study|Participant Met Withdrawal Criteria|2
7001513|NCT01393613|11066664|FG003|Overall Study|Participant Met Withdrawal Criteria|1
7001514|NCT01393613|11066661|FG000|Overall Study|Physician Decision|2
7001515|NCT01393613|11066662|FG001|Overall Study|Physician Decision|0
7001516|NCT01393613|11066663|FG002|Overall Study|Physician Decision|0
7001517|NCT01393613|11066664|FG003|Overall Study|Physician Decision|1
7001518|NCT01393613|11066661|FG000|Overall Study|Withdrawal by Subject|15
7001519|NCT01393613|11066662|FG001|Overall Study|Withdrawal by Subject|25
7001520|NCT01393613|11066663|FG002|Overall Study|Withdrawal by Subject|23
7001521|NCT01393613|11066664|FG003|Overall Study|Withdrawal by Subject|21
7001522|NCT01393613|11066661|FG000|Overall Study|Protocol Deviation|2
7001523|NCT01393613|11066662|FG001|Overall Study|Protocol Deviation|1
7001524|NCT01393613|11066663|FG002|Overall Study|Protocol Deviation|0
7001525|NCT01393613|11066664|FG003|Overall Study|Protocol Deviation|0
7001526|NCT01393613|11066661|FG000|Overall Study|Lack of Efficacy|9
7001527|NCT01393613|11066662|FG001|Overall Study|Lack of Efficacy|20
7001528|NCT01393613|11066663|FG002|Overall Study|Lack of Efficacy|16
7001529|NCT01393613|11066664|FG003|Overall Study|Lack of Efficacy|21
7001530|NCT01393626|11066680|FG000|Overall Study|Adverse Event|2
7001531|NCT01393626|11066681|FG001|Overall Study|Adverse Event|1
7001532|NCT01393626|11066682|FG002|Overall Study|Adverse Event|5
7001533|NCT01393626|11066683|FG003|Overall Study|Adverse Event|0
7001534|NCT01393626|11066680|FG000|Overall Study|Did not meet entrance criteria|1
7001535|NCT01393626|11066681|FG001|Overall Study|Did not meet entrance criteria|0
7001536|NCT01393626|11066682|FG002|Overall Study|Did not meet entrance criteria|0
7001537|NCT01393626|11066683|FG003|Overall Study|Did not meet entrance criteria|0
7001538|NCT01393626|11066680|FG000|Overall Study|Lack of Efficacy|6
7001539|NCT01393626|11066681|FG001|Overall Study|Lack of Efficacy|6
7001540|NCT01393626|11066682|FG002|Overall Study|Lack of Efficacy|4
7001541|NCT01393626|11066683|FG003|Overall Study|Lack of Efficacy|1
7001542|NCT01393626|11066680|FG000|Overall Study|Lost to Follow-up|1
7001543|NCT01393626|11066681|FG001|Overall Study|Lost to Follow-up|1
7001544|NCT01393626|11066682|FG002|Overall Study|Lost to Follow-up|1
7001545|NCT01393626|11066683|FG003|Overall Study|Lost to Follow-up|0
7001546|NCT01393626|11066680|FG000|Overall Study|Withdrawal by Subject|6
7001547|NCT01393626|11066681|FG001|Overall Study|Withdrawal by Subject|4
7001548|NCT01393626|11066682|FG002|Overall Study|Withdrawal by Subject|0
7001549|NCT01393626|11066683|FG003|Overall Study|Withdrawal by Subject|0
7001550|NCT01393626|11066680|FG000|Overall Study|Other|1
7001551|NCT01393626|11066681|FG001|Overall Study|Other|0
7001552|NCT01393626|11066682|FG002|Overall Study|Other|0
7001553|NCT01393626|11066683|FG003|Overall Study|Other|0
7001554|NCT01393626|11066680|FG000|Overall Study|Protocol Violation|1
7001555|NCT01393626|11066681|FG001|Overall Study|Protocol Violation|0
7001556|NCT01393626|11066682|FG002|Overall Study|Protocol Violation|2
7001557|NCT01393626|11066683|FG003|Overall Study|Protocol Violation|0
7001558|NCT01393730|11066720|FG000|Overall Study|Withdrawal by Subject|3
7001559|NCT01393730|11066720|FG000|Overall Study|Other|2
7001560|NCT01393730|11066720|FG000|Overall Study|Adverse Event|1
7001561|NCT01393743|11066726|FG000|Core Study|Adverse Event|5
7001562|NCT01393743|11066727|FG001|Core Study|Adverse Event|9
7001563|NCT01393743|11066728|FG002|Core Study|Adverse Event|0
7001564|NCT01393743|11066726|FG000|Core Study|Lost to Follow-up|1
7001565|NCT01393743|11066727|FG001|Core Study|Lost to Follow-up|1
7001566|NCT01393743|11066728|FG002|Core Study|Lost to Follow-up|0
7001567|NCT01393743|11066726|FG000|Core Study|Participant's Choice|2
7001568|NCT01393743|11066727|FG001|Core Study|Participant's Choice|3
7001569|NCT01393743|11066728|FG002|Core Study|Participant's Choice|0
7001570|NCT01393743|11066726|FG000|Core Study|Inadequate therapeutic effect|2
7001571|NCT01393743|11066727|FG001|Core Study|Inadequate therapeutic effect|0
7001572|NCT01393743|11066728|FG002|Core Study|Inadequate therapeutic effect|0
7001573|NCT01393743|11066726|FG000|Extension Phase|Adverse Event|0
7001574|NCT01393743|11066727|FG001|Extension Phase|Adverse Event|0
7001575|NCT01393743|11066728|FG002|Extension Phase|Adverse Event|12
7001576|NCT01393743|11066726|FG000|Extension Phase|Lost to Follow-up|0
7001577|NCT01393743|11066727|FG001|Extension Phase|Lost to Follow-up|0
7001578|NCT01393743|11066728|FG002|Extension Phase|Lost to Follow-up|2
7001579|NCT01393743|11066726|FG000|Extension Phase|Participant choice|0
7001580|NCT01393743|11066727|FG001|Extension Phase|Participant choice|0
7001581|NCT01393743|11066728|FG002|Extension Phase|Participant choice|16
7001582|NCT01393743|11066726|FG000|Extension Phase|Inadequate therapeutic effect|0
7001583|NCT01393743|11066727|FG001|Extension Phase|Inadequate therapeutic effect|0
7001584|NCT01393743|11066728|FG002|Extension Phase|Inadequate therapeutic effect|7
7001585|NCT01393743|11066726|FG000|Extension Phase|Withdrawal by Subject|0
7001586|NCT01393743|11066727|FG001|Extension Phase|Withdrawal by Subject|0
7001587|NCT01393743|11066728|FG002|Extension Phase|Withdrawal by Subject|8
7001588|NCT01393743|11066726|FG000|Extension Phase|Pregnancy|0
7001589|NCT01393743|11066727|FG001|Extension Phase|Pregnancy|0
7001590|NCT01393743|11066728|FG002|Extension Phase|Pregnancy|1
7001591|NCT01393743|11066726|FG000|Extension Phase|Other|0
7001592|NCT01393743|11066727|FG001|Extension Phase|Other|0
7001593|NCT01393743|11066728|FG002|Extension Phase|Other|14
7001594|NCT01393821|11066741|FG000|Overall Study|Cancel|1
7001595|NCT01393821|11066742|FG001|Overall Study|Cancel|1
7001596|NCT01393821|11066741|FG000|Overall Study|not evaluable for primary endpoint|4
7001597|NCT01393821|11066742|FG001|Overall Study|not evaluable for primary endpoint|2
7001598|NCT01393899|11066751|FG000|Overall Study|Study terminated by sponsor|1
7001599|NCT01393899|11066752|FG001|Overall Study|Study terminated by sponsor|0
7001600|NCT01393899|11066753|FG002|Overall Study|Study terminated by sponsor|1
7001601|NCT01393899|11066751|FG000|Overall Study|Other|1
7001602|NCT01393899|11066752|FG001|Overall Study|Other|0
7001603|NCT01393899|11066753|FG002|Overall Study|Other|0
7001604|NCT01393899|11066751|FG000|Overall Study|Withdrawal by Subject|2
7001605|NCT01393899|11066752|FG001|Overall Study|Withdrawal by Subject|2
7001606|NCT01393899|11066753|FG002|Overall Study|Withdrawal by Subject|1
7001607|NCT01393899|11066751|FG000|Overall Study|Lost to Follow-up|0
7001608|NCT01393899|11066752|FG001|Overall Study|Lost to Follow-up|0
7001609|NCT01393899|11066753|FG002|Overall Study|Lost to Follow-up|1
7001610|NCT01393899|11066751|FG000|Overall Study|Does not meet entrance criteria|1
7001611|NCT01393899|11066752|FG001|Overall Study|Does not meet entrance criteria|0
7001612|NCT01393899|11066753|FG002|Overall Study|Does not meet entrance criteria|1
7001613|NCT01393899|11066751|FG000|Overall Study|Lack of Efficacy|26
7001614|NCT01393899|11066752|FG001|Overall Study|Lack of Efficacy|21
7001615|NCT01393899|11066753|FG002|Overall Study|Lack of Efficacy|16
7001616|NCT01393899|11066751|FG000|Overall Study|Adverse Event|1
7001617|NCT01393899|11066752|FG001|Overall Study|Adverse Event|5
7001618|NCT01393899|11066753|FG002|Overall Study|Adverse Event|3
7001619|NCT01393964|11066766|FG000|Overall Study|Disease Progression|4
7001620|NCT01393964|11066767|FG001|Overall Study|Disease Progression|3
7001621|NCT01393964|11066768|FG002|Overall Study|Disease Progression|5
7001622|NCT01393964|11066766|FG000|Overall Study|Study drug toxicity|1
7001623|NCT01393964|11066767|FG001|Overall Study|Study drug toxicity|0
7001624|NCT01393964|11066768|FG002|Overall Study|Study drug toxicity|0
7001625|NCT01393964|11066766|FG000|Overall Study|Withdrawal by Subject|0
7001626|NCT01393964|11066767|FG001|Overall Study|Withdrawal by Subject|0
7001627|NCT01393964|11066768|FG002|Overall Study|Withdrawal by Subject|1
7001628|NCT01393964|11066766|FG000|Overall Study|Adverse event unrelated to study drug|0
7001629|NCT01393964|11066767|FG001|Overall Study|Adverse event unrelated to study drug|3
7001630|NCT01393964|11066768|FG002|Overall Study|Adverse event unrelated to study drug|0
7001631|NCT01393964|11066766|FG000|Overall Study|Subject request stop study treatment|0
7001632|NCT01393964|11066767|FG001|Overall Study|Subject request stop study treatment|1
7001633|NCT01393964|11066768|FG002|Overall Study|Subject request stop study treatment|0
7001634|NCT01393964|11066766|FG000|Overall Study|Subject decided to move to transplant|1
7001635|NCT01393964|11066767|FG001|Overall Study|Subject decided to move to transplant|0
7001636|NCT01393964|11066768|FG002|Overall Study|Subject decided to move to transplant|0
7001637|NCT01393964|11066766|FG000|Overall Study|Subject switched to commercial supply|1
7001638|NCT01393964|11066767|FG001|Overall Study|Subject switched to commercial supply|0
7001639|NCT01393964|11066768|FG002|Overall Study|Subject switched to commercial supply|2
7001640|NCT01393964|11066766|FG000|Overall Study|Subject plateaued in terms of effect|1
7001641|NCT01393964|11066767|FG001|Overall Study|Subject plateaued in terms of effect|0
7001642|NCT01393964|11066768|FG002|Overall Study|Subject plateaued in terms of effect|0
7001643|NCT01393964|11066766|FG000|Overall Study|Investigator removed subject from study|0
7001644|NCT01393964|11066767|FG001|Overall Study|Investigator removed subject from study|1
7001645|NCT01393964|11066768|FG002|Overall Study|Investigator removed subject from study|0
7001646|NCT01393964|11066766|FG000|Overall Study|Subject converted to roll-over study|0
7001647|NCT01393964|11066767|FG001|Overall Study|Subject converted to roll-over study|1
7001648|NCT01393964|11066768|FG002|Overall Study|Subject converted to roll-over study|0
7001649|NCT01393964|11066766|FG000|Overall Study|Subject to receive non-protocol therapy|0
7001650|NCT01393964|11066767|FG001|Overall Study|Subject to receive non-protocol therapy|0
7001651|NCT01393964|11066768|FG002|Overall Study|Subject to receive non-protocol therapy|1
7001652|NCT01393990|11066800|FG000|Overall Study|Adverse Event|0
7001653|NCT01393990|11066801|FG001|Overall Study|Adverse Event|0
7001654|NCT01393990|11066802|FG002|Overall Study|Adverse Event|0
7001655|NCT01393990|11066803|FG003|Overall Study|Adverse Event|0
7001656|NCT01393990|11066804|FG004|Overall Study|Adverse Event|0
7001657|NCT01393990|11066805|FG005|Overall Study|Adverse Event|0
7001658|NCT01393990|11066806|FG006|Overall Study|Adverse Event|0
7001659|NCT01393990|11066807|FG007|Overall Study|Adverse Event|0
7001660|NCT01393990|11066808|FG008|Overall Study|Adverse Event|0
7001661|NCT01393990|11066809|FG009|Overall Study|Adverse Event|0
7001662|NCT01393990|11066810|FG010|Overall Study|Adverse Event|0
7001663|NCT01393990|11066811|FG011|Overall Study|Adverse Event|0
7001664|NCT01393990|11066812|FG012|Overall Study|Adverse Event|0
7001665|NCT01393990|11066813|FG013|Overall Study|Adverse Event|0
7001666|NCT01393990|11066814|FG014|Overall Study|Adverse Event|1
7001667|NCT01393990|11066815|FG015|Overall Study|Adverse Event|1
7001668|NCT01393990|11066816|FG016|Overall Study|Adverse Event|0
7001669|NCT01393990|11066817|FG017|Overall Study|Adverse Event|0
7001670|NCT01393990|11066800|FG000|Overall Study|Progressive Disease|1
7001671|NCT01393990|11066801|FG001|Overall Study|Progressive Disease|0
7001672|NCT01393990|11066802|FG002|Overall Study|Progressive Disease|0
7001673|NCT01393990|11066803|FG003|Overall Study|Progressive Disease|1
7001674|NCT01393990|11066804|FG004|Overall Study|Progressive Disease|1
7001675|NCT01393990|11066805|FG005|Overall Study|Progressive Disease|1
7001676|NCT01393990|11066806|FG006|Overall Study|Progressive Disease|1
7001677|NCT01393990|11066807|FG007|Overall Study|Progressive Disease|1
7001678|NCT01393990|11066808|FG008|Overall Study|Progressive Disease|3
7001679|NCT01393990|11066809|FG009|Overall Study|Progressive Disease|1
7001680|NCT01393990|11066810|FG010|Overall Study|Progressive Disease|0
7001681|NCT01393990|11066811|FG011|Overall Study|Progressive Disease|0
7001682|NCT01393990|11066812|FG012|Overall Study|Progressive Disease|0
7001683|NCT01393990|11066813|FG013|Overall Study|Progressive Disease|1
7001684|NCT01393990|11066814|FG014|Overall Study|Progressive Disease|6
7001685|NCT01393990|11066815|FG015|Overall Study|Progressive Disease|1
7001686|NCT01393990|11066816|FG016|Overall Study|Progressive Disease|0
7001687|NCT01393990|11066817|FG017|Overall Study|Progressive Disease|0
7001688|NCT01393990|11066800|FG000|Overall Study|Death|0
7001689|NCT01393990|11066801|FG001|Overall Study|Death|0
7001690|NCT01393990|11066802|FG002|Overall Study|Death|0
7001691|NCT01393990|11066803|FG003|Overall Study|Death|0
7001692|NCT01393990|11066804|FG004|Overall Study|Death|1
7001693|NCT01393990|11066805|FG005|Overall Study|Death|0
7001694|NCT01393990|11066806|FG006|Overall Study|Death|0
7001695|NCT01393990|11066807|FG007|Overall Study|Death|0
7001696|NCT01393990|11066808|FG008|Overall Study|Death|0
7001697|NCT01393990|11066809|FG009|Overall Study|Death|0
7001698|NCT01393990|11066810|FG010|Overall Study|Death|0
7001699|NCT01393990|11066811|FG011|Overall Study|Death|0
7001700|NCT01393990|11066812|FG012|Overall Study|Death|0
7001701|NCT01393990|11066813|FG013|Overall Study|Death|1
7001702|NCT01393990|11066814|FG014|Overall Study|Death|1
7001703|NCT01393990|11066815|FG015|Overall Study|Death|0
7001704|NCT01393990|11066816|FG016|Overall Study|Death|0
7001705|NCT01393990|11066817|FG017|Overall Study|Death|0
7001706|NCT01393990|11066800|FG000|Overall Study|Withdrawal by Subject|0
7001707|NCT01393990|11066801|FG001|Overall Study|Withdrawal by Subject|0
7001708|NCT01393990|11066802|FG002|Overall Study|Withdrawal by Subject|0
7001709|NCT01393990|11066803|FG003|Overall Study|Withdrawal by Subject|0
7001710|NCT01393990|11066804|FG004|Overall Study|Withdrawal by Subject|0
7001711|NCT01393990|11066805|FG005|Overall Study|Withdrawal by Subject|0
7001712|NCT01393990|11066806|FG006|Overall Study|Withdrawal by Subject|0
7001713|NCT01393990|11066807|FG007|Overall Study|Withdrawal by Subject|0
7001714|NCT01393990|11066808|FG008|Overall Study|Withdrawal by Subject|0
7001715|NCT01393990|11066809|FG009|Overall Study|Withdrawal by Subject|0
7001716|NCT01393990|11066810|FG010|Overall Study|Withdrawal by Subject|0
7001717|NCT01393990|11066811|FG011|Overall Study|Withdrawal by Subject|0
7001718|NCT01393990|11066812|FG012|Overall Study|Withdrawal by Subject|0
7001719|NCT01393990|11066813|FG013|Overall Study|Withdrawal by Subject|0
7001720|NCT01393990|11066814|FG014|Overall Study|Withdrawal by Subject|1
7001721|NCT01393990|11066815|FG015|Overall Study|Withdrawal by Subject|1
7001722|NCT01393990|11066816|FG016|Overall Study|Withdrawal by Subject|0
7001723|NCT01393990|11066817|FG017|Overall Study|Withdrawal by Subject|0
7001724|NCT01394185|11066925|FG000|Overall Study|Withdrawal by Subject|2
7001725|NCT01394185|11066926|FG001|Overall Study|Withdrawal by Subject|0
7001726|NCT01394185|11066927|FG002|Overall Study|Withdrawal by Subject|0
7001727|NCT01394185|11066928|FG003|Overall Study|Withdrawal by Subject|0
7001728|NCT01394185|11066929|FG004|Overall Study|Withdrawal by Subject|1
7001729|NCT01394185|11066930|FG005|Overall Study|Withdrawal by Subject|0
7001730|NCT01394185|11066925|FG000|Overall Study|Change in protocol|3
7001731|NCT01394185|11066926|FG001|Overall Study|Change in protocol|0
7001732|NCT01394185|11066927|FG002|Overall Study|Change in protocol|0
7001733|NCT01394185|11066928|FG003|Overall Study|Change in protocol|0
7001734|NCT01394185|11066929|FG004|Overall Study|Change in protocol|3
7001735|NCT01394185|11066930|FG005|Overall Study|Change in protocol|0
7001736|NCT01394185|11066925|FG000|Overall Study|Protocol Violation|1
7001737|NCT01394185|11066926|FG001|Overall Study|Protocol Violation|0
7001738|NCT01394185|11066927|FG002|Overall Study|Protocol Violation|0
7001739|NCT01394185|11066928|FG003|Overall Study|Protocol Violation|1
7001740|NCT01394185|11066929|FG004|Overall Study|Protocol Violation|0
7001741|NCT01394185|11066930|FG005|Overall Study|Protocol Violation|1
7001742|NCT01394250|11066940|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14
7001743|NCT01394250|11066941|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13
7001744|NCT01394250|11066940|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6
7001745|NCT01394250|11066941|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11
7042830|NCT01738503|11127381|FG003|Treatment Period|Other|0
7042831|NCT01738503|11127382|FG004|Treatment Period|Other|0
7042832|NCT01738503|11127383|FG005|Treatment Period|Other|0
7042833|NCT01738503|11127384|FG006|Treatment Period|Other|0
7042834|NCT01738503|11127378|FG000|PET Imaging Sub-study|Adverse Event|0
7042835|NCT01738503|11127379|FG001|PET Imaging Sub-study|Adverse Event|0
7042836|NCT01738503|11127380|FG002|PET Imaging Sub-study|Adverse Event|0
7042837|NCT01738503|11127381|FG003|PET Imaging Sub-study|Adverse Event|0
7042838|NCT01738503|11127382|FG004|PET Imaging Sub-study|Adverse Event|0
7042839|NCT01738503|11127383|FG005|PET Imaging Sub-study|Adverse Event|1
7042840|NCT01738503|11127384|FG006|PET Imaging Sub-study|Adverse Event|0
7042841|NCT01738503|11127378|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0
7042842|NCT01738503|11127379|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0
7042843|NCT01738503|11127380|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0
7042844|NCT01738503|11127381|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0
7042845|NCT01738503|11127382|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0
7042846|NCT01738503|11127383|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1
7042847|NCT01738503|11127384|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1
7042848|NCT01738581|11127408|FG000|Overall Study|Lost to Follow-up|1
7042849|NCT01738581|11127409|FG001|Overall Study|Lost to Follow-up|0
7042850|NCT01738594|11127418|FG000|Registration and Treatment Start|Adverse Event|0
7042851|NCT01738594|11127419|FG001|Registration and Treatment Start|Adverse Event|1
7042852|NCT01738594|11127420|FG002|Registration and Treatment Start|Adverse Event|0
7042853|NCT01738594|11127421|FG003|Registration and Treatment Start|Adverse Event|0
7042854|NCT01738594|11127422|FG004|Registration and Treatment Start|Adverse Event|0
7042855|NCT01738594|11127423|FG005|Registration and Treatment Start|Adverse Event|0
7042856|NCT01738594|11127424|FG006|Registration and Treatment Start|Adverse Event|0
7042857|NCT01738594|11127425|FG007|Registration and Treatment Start|Adverse Event|0
7042858|NCT01738594|11127418|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
7042859|NCT01738594|11127419|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
7042860|NCT01738594|11127420|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
7042861|NCT01738594|11127421|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
7042862|NCT01738594|11127422|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
7042863|NCT01738594|11127423|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1
7042864|NCT01738594|11127424|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
7042865|NCT01738594|11127425|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
7042866|NCT01738594|11127418|FG000|Completed 4 Cycles of Treatment|Progressive disease|0
7042867|NCT01738594|11127419|FG001|Completed 4 Cycles of Treatment|Progressive disease|2
7042868|NCT01738594|11127420|FG002|Completed 4 Cycles of Treatment|Progressive disease|0
7042869|NCT01738594|11127421|FG003|Completed 4 Cycles of Treatment|Progressive disease|0
7042870|NCT01738594|11127422|FG004|Completed 4 Cycles of Treatment|Progressive disease|0
7042871|NCT01738594|11127423|FG005|Completed 4 Cycles of Treatment|Progressive disease|0
7042872|NCT01738594|11127424|FG006|Completed 4 Cycles of Treatment|Progressive disease|0
7042873|NCT01738594|11127425|FG007|Completed 4 Cycles of Treatment|Progressive disease|0
7001746|NCT01394276|11066947|FG000|Overall Study|Related Adverse event (AEs)|15
7001747|NCT01394276|11066947|FG000|Overall Study|Not related AEs|9
7001748|NCT01394276|11066947|FG000|Overall Study|Remission of disease|2
7001749|NCT01394276|11066947|FG000|Overall Study|Insufficient therapeutic effect|17
7001750|NCT01394276|11066947|FG000|Overall Study|Insufficient compliance|9
7001751|NCT01394276|11066947|FG000|Overall Study|Lost to Follow-up|5
7001752|NCT01394276|11066947|FG000|Overall Study|Participant moved to another site|1
7001753|NCT01394276|11066947|FG000|Overall Study|Pregnancy|1
7001754|NCT01394276|11066947|FG000|Overall Study|unavailability of drug at the Hospital|2
7001755|NCT01394276|11066947|FG000|Overall Study|Symptoms of concurrent diseases|1
7001756|NCT01394523|11066963|FG000|Overall Study|Unable to place block|1
7001757|NCT01394523|11066964|FG001|Overall Study|Unable to place block|0
7001758|NCT01394523|11066965|FG002|Overall Study|Unable to place block|0
7001759|NCT01394627|11066982|FG000|First Intervention (1 Day)|poor intravenous access|0
7001760|NCT01394627|11066983|FG001|First Intervention (1 Day)|poor intravenous access|1
7001761|NCT01394627|11066982|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1
7001762|NCT01394627|11066983|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0
7001763|NCT01394718|11067010|FG000|Overall Study|Met protocol-specific stopping criteria|2
7001764|NCT01394718|11067011|FG001|Overall Study|Met protocol-specific stopping criteria|1
7001765|NCT01394939|11067021|FG000|Overall Study|Adverse Event|1
7001766|NCT01394939|11067022|FG001|Overall Study|Adverse Event|3
7001767|NCT01394939|11067023|FG002|Overall Study|Adverse Event|0
7001768|NCT01394939|11067024|FG003|Overall Study|Adverse Event|2
7001769|NCT01394939|11067021|FG000|Overall Study|Death|0
7001770|NCT01394939|11067022|FG001|Overall Study|Death|2
7001771|NCT01394939|11067023|FG002|Overall Study|Death|0
7001772|NCT01394939|11067024|FG003|Overall Study|Death|0
7001773|NCT01394939|11067021|FG000|Overall Study|Physician Decision|0
7001774|NCT01394939|11067022|FG001|Overall Study|Physician Decision|1
7001775|NCT01394939|11067023|FG002|Overall Study|Physician Decision|0
7001776|NCT01394939|11067024|FG003|Overall Study|Physician Decision|0
7001777|NCT01394939|11067021|FG000|Overall Study|Withdrawal by Subject|0
7001778|NCT01394939|11067022|FG001|Overall Study|Withdrawal by Subject|2
7001779|NCT01394939|11067023|FG002|Overall Study|Withdrawal by Subject|0
7001780|NCT01394939|11067024|FG003|Overall Study|Withdrawal by Subject|2
7001781|NCT01394939|11067021|FG000|Overall Study|Others|0
7001782|NCT01394939|11067022|FG001|Overall Study|Others|2
7001783|NCT01394939|11067023|FG002|Overall Study|Others|0
7001784|NCT01394939|11067024|FG003|Overall Study|Others|3
7001785|NCT01394952|11067036|FG000|Overall Study|Lost to Follow-up|0
7001786|NCT01394952|11067037|FG001|Overall Study|Lost to Follow-up|5
7001787|NCT01394952|11067036|FG000|Overall Study|Withdrawal by Subject|10
7001788|NCT01394952|11067037|FG001|Overall Study|Withdrawal by Subject|5
7001789|NCT01394952|11067036|FG000|Overall Study|Physician Decision|2
7001790|NCT01394952|11067037|FG001|Overall Study|Physician Decision|0
7001791|NCT01394952|11067036|FG000|Overall Study|Sponsor Decision|5
7001792|NCT01394952|11067037|FG001|Overall Study|Sponsor Decision|7
7001793|NCT01394978|11067046|FG000|Overall Study|Withdrawal by Subject|2
7001794|NCT01394978|11067047|FG001|Overall Study|Withdrawal by Subject|4
7001795|NCT01394978|11067046|FG000|Overall Study|Lost to Follow-up|13
7001796|NCT01394978|11067047|FG001|Overall Study|Lost to Follow-up|20
7001797|NCT01394978|11067046|FG000|Overall Study|Death|6
7001798|NCT01394978|11067047|FG001|Overall Study|Death|7
7001799|NCT01394991|11067056|FG000|Overall Study|Adverse Event|0
7001800|NCT01394991|11067057|FG001|Overall Study|Adverse Event|4
7001801|NCT01394991|11067056|FG000|Overall Study|Lack of Efficacy|5
7001802|NCT01394991|11067057|FG001|Overall Study|Lack of Efficacy|7
7001803|NCT01394991|11067056|FG000|Overall Study|Lost to Follow-up|6
7001804|NCT01394991|11067057|FG001|Overall Study|Lost to Follow-up|8
7001805|NCT01394991|11067056|FG000|Overall Study|Physician Decision|1
7001806|NCT01394991|11067057|FG001|Overall Study|Physician Decision|3
7001807|NCT01394991|11067056|FG000|Overall Study|Protocol Violation|1
7001808|NCT01394991|11067057|FG001|Overall Study|Protocol Violation|1
7001809|NCT01394991|11067056|FG000|Overall Study|Withdrawal by Subject|20
7001810|NCT01394991|11067057|FG001|Overall Study|Withdrawal by Subject|17
7001811|NCT01394991|11067056|FG000|Overall Study|Chemotherapy Termination|10
7001812|NCT01394991|11067057|FG001|Overall Study|Chemotherapy Termination|15
7001813|NCT01394991|11067056|FG000|Overall Study|Disease Progression|7
7001814|NCT01394991|11067057|FG001|Overall Study|Disease Progression|7
7001815|NCT01394991|11067056|FG000|Overall Study|Prematurely Termination of Trial|9
7001816|NCT01394991|11067057|FG001|Overall Study|Prematurely Termination of Trial|10
7001817|NCT01395017|11067065|FG000|Overall Study|Lost to Follow-up|1
7001818|NCT01395017|11067066|FG001|Overall Study|Lost to Follow-up|0
7001819|NCT01395017|11067065|FG000|Overall Study|Adverse Event|26
7001820|NCT01395017|11067066|FG001|Overall Study|Adverse Event|12
7001821|NCT01395017|11067065|FG000|Overall Study|Physician Decision|11
7001822|NCT01395017|11067066|FG001|Overall Study|Physician Decision|15
7001823|NCT01395017|11067065|FG000|Overall Study|Withdrawal by Subject|14
7001824|NCT01395017|11067066|FG001|Overall Study|Withdrawal by Subject|8
7001825|NCT01395017|11067065|FG000|Overall Study|Protocol deviation|1
7001826|NCT01395017|11067066|FG001|Overall Study|Protocol deviation|2
7001827|NCT01395017|11067065|FG000|Overall Study|Death|4
7001828|NCT01395017|11067066|FG001|Overall Study|Death|3
7001829|NCT01395017|11067065|FG000|Overall Study|Disease progression|42
7001830|NCT01395017|11067066|FG001|Overall Study|Disease progression|58
7001831|NCT01395017|11067065|FG000|Overall Study|Sponsor discontinued study|1
7001832|NCT01395017|11067066|FG001|Overall Study|Sponsor discontinued study|4
7001833|NCT01395030|11067073|FG000|Overall Study|Did not complete FCH PET/CT|7
7001834|NCT01395316|11067095|FG000|Overall Study|Lost to Follow-up|2
7001835|NCT01395316|11067095|FG000|Overall Study|poor MRI quality|1
7001836|NCT01395368|11067115|FG000|Overall Study|Physician Decision|14
7001837|NCT01395368|11067115|FG000|Overall Study|Withdrawal by Subject|2
7001838|NCT01395394|11067122|FG000|Baseline Study Visit|Protocol Violation|1
7001839|NCT01395394|11067123|FG001|Baseline Study Visit|Protocol Violation|0
7001840|NCT01395394|11067124|FG002|Baseline Study Visit|Protocol Violation|0
7001841|NCT01395524|11067135|FG000|Overall Study|Non-compliance with study schedule|1
7001842|NCT01395524|11067136|FG001|Overall Study|Non-compliance with study schedule|0
7001843|NCT01395524|11067137|FG002|Overall Study|Non-compliance with study schedule|1
7001844|NCT01395524|11067135|FG000|Overall Study|Lost to Follow-up|3
7001845|NCT01395524|11067136|FG001|Overall Study|Lost to Follow-up|1
7001846|NCT01395524|11067137|FG002|Overall Study|Lost to Follow-up|1
7001847|NCT01395524|11067135|FG000|Overall Study|Study-Specific Withdrawal Criteria|1
7001848|NCT01395524|11067136|FG001|Overall Study|Study-Specific Withdrawal Criteria|2
7001849|NCT01395524|11067137|FG002|Overall Study|Study-Specific Withdrawal Criteria|0
7001850|NCT01395524|11067135|FG000|Overall Study|Severe noncompliance with protocol|1
7001851|NCT01395524|11067136|FG001|Overall Study|Severe noncompliance with protocol|0
7001852|NCT01395524|11067137|FG002|Overall Study|Severe noncompliance with protocol|0
7001853|NCT01395524|11067135|FG000|Overall Study|Adverse Event|4
7001854|NCT01395524|11067136|FG001|Overall Study|Adverse Event|4
7001855|NCT01395524|11067137|FG002|Overall Study|Adverse Event|3
7001856|NCT01395524|11067135|FG000|Overall Study|Death|1
7001857|NCT01395524|11067136|FG001|Overall Study|Death|0
7001858|NCT01395524|11067137|FG002|Overall Study|Death|0
7001859|NCT01395524|11067135|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2
7001860|NCT01395524|11067136|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0
7001861|NCT01395524|11067137|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0
7001862|NCT01395524|11067135|FG000|Overall Study|Withdrawal by Subject|4
7001863|NCT01395524|11067136|FG001|Overall Study|Withdrawal by Subject|8
7001864|NCT01395524|11067137|FG002|Overall Study|Withdrawal by Subject|8
7001865|NCT01395524|11067135|FG000|Overall Study|Did not receive treatment|1
7001866|NCT01395524|11067136|FG001|Overall Study|Did not receive treatment|1
7001867|NCT01395524|11067137|FG002|Overall Study|Did not receive treatment|3
7001868|NCT01395524|11067135|FG000|Overall Study|Subject had spinal surgery|0
7001869|NCT01395524|11067136|FG001|Overall Study|Subject had spinal surgery|0
7001870|NCT01395524|11067137|FG002|Overall Study|Subject had spinal surgery|1
7001871|NCT01395758|11067151|FG000|Open-label Treatment Period|Withdrawal by Subject|4
7001872|NCT01395758|11067152|FG001|Open-label Treatment Period|Withdrawal by Subject|0
7001873|NCT01395758|11067153|FG002|Open-label Treatment Period|Withdrawal by Subject|0
7001874|NCT01395784|11067160|FG000|Overall Study|Lost to Follow-up|7
7001875|NCT01395784|11067160|FG000|Overall Study|Withdrawal by Subject|3
7001876|NCT01395784|11067160|FG000|Overall Study|Physician Decision|5
7001877|NCT01395810|11067199|FG000|Overall Study|Adverse Event|0
7001878|NCT01395810|11067200|FG001|Overall Study|Adverse Event|1
7001879|NCT01395810|11067201|FG002|Overall Study|Adverse Event|0
7001880|NCT01395810|11067202|FG003|Overall Study|Adverse Event|0
7001881|NCT01395810|11067199|FG000|Overall Study|Lack of Efficacy|0
7001882|NCT01395810|11067200|FG001|Overall Study|Lack of Efficacy|1
7001883|NCT01395810|11067201|FG002|Overall Study|Lack of Efficacy|0
7001884|NCT01395810|11067202|FG003|Overall Study|Lack of Efficacy|0
7001885|NCT01395810|11067199|FG000|Overall Study|Withdrawal criteria|0
7001886|NCT01395810|11067200|FG001|Overall Study|Withdrawal criteria|2
7001887|NCT01395810|11067201|FG002|Overall Study|Withdrawal criteria|0
7001888|NCT01395810|11067202|FG003|Overall Study|Withdrawal criteria|0
7001889|NCT01395810|11067199|FG000|Overall Study|Unclassified|2
7001890|NCT01395810|11067200|FG001|Overall Study|Unclassified|0
7001891|NCT01395810|11067201|FG002|Overall Study|Unclassified|0
7001892|NCT01395810|11067202|FG003|Overall Study|Unclassified|0
7001893|NCT01395823|11067215|FG000|Overall Study|Death|4
7001894|NCT01395823|11067216|FG001|Overall Study|Death|4
7001895|NCT01395823|11067215|FG000|Overall Study|Physician Decision|3
7001896|NCT01395823|11067216|FG001|Overall Study|Physician Decision|1
7001897|NCT01395823|11067215|FG000|Overall Study|Lost to Follow-up|1
7001898|NCT01395823|11067216|FG001|Overall Study|Lost to Follow-up|0
7001899|NCT01395823|11067215|FG000|Overall Study|Transplant|1
7001900|NCT01395823|11067216|FG001|Overall Study|Transplant|0
7001901|NCT01395823|11067215|FG000|Overall Study|GI symptoms|1
7001902|NCT01395823|11067216|FG001|Overall Study|GI symptoms|0
7001903|NCT01395823|11067215|FG000|Overall Study|Withdrawal by Subject|5
7001904|NCT01395823|11067216|FG001|Overall Study|Withdrawal by Subject|4
7001905|NCT01395888|11067224|FG000|2-week Run-in Period|Adverse Event|2
7001906|NCT01395888|11067225|FG001|2-week Run-in Period|Adverse Event|0
7001907|NCT01395888|11067226|FG002|2-week Run-in Period|Adverse Event|0
7001908|NCT01395888|11067224|FG000|2-week Run-in Period|Continuation Criteria Not Met|13
7001909|NCT01395888|11067225|FG001|2-week Run-in Period|Continuation Criteria Not Met|0
7001910|NCT01395888|11067226|FG002|2-week Run-in Period|Continuation Criteria Not Met|0
7001911|NCT01395888|11067224|FG000|2-week Run-in Period|Lost to Follow-up|1
7001912|NCT01395888|11067225|FG001|2-week Run-in Period|Lost to Follow-up|0
7001913|NCT01395888|11067226|FG002|2-week Run-in Period|Lost to Follow-up|0
7001914|NCT01395888|11067224|FG000|2-week Run-in Period|Protocol Violation|2
7001915|NCT01395888|11067225|FG001|2-week Run-in Period|Protocol Violation|0
7001916|NCT01395888|11067226|FG002|2-week Run-in Period|Protocol Violation|0
7001917|NCT01395888|11067224|FG000|2-week Run-in Period|Withdrawal by Subject|4
7001918|NCT01395888|11067225|FG001|2-week Run-in Period|Withdrawal by Subject|0
7001919|NCT01395888|11067226|FG002|2-week Run-in Period|Withdrawal by Subject|0
7001920|NCT01395888|11067224|FG000|Treatment Period (TP)|Adverse Event|0
7001921|NCT01395888|11067225|FG001|Treatment Period (TP)|Adverse Event|7
7001922|NCT01395888|11067226|FG002|Treatment Period (TP)|Adverse Event|6
7001923|NCT01395888|11067224|FG000|Treatment Period (TP)|Lack of Efficacy|0
7001924|NCT01395888|11067225|FG001|Treatment Period (TP)|Lack of Efficacy|4
7001925|NCT01395888|11067226|FG002|Treatment Period (TP)|Lack of Efficacy|3
7001926|NCT01395888|11067224|FG000|Treatment Period (TP)|Protocol Violation|0
7001927|NCT01395888|11067225|FG001|Treatment Period (TP)|Protocol Violation|1
7001928|NCT01395888|11067226|FG002|Treatment Period (TP)|Protocol Violation|5
7001929|NCT01395888|11067224|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
7001930|NCT01395888|11067225|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1
7001931|NCT01395888|11067226|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
7001932|NCT01395888|11067224|FG000|Treatment Period (TP)|Withdrawal by Subject|0
7001933|NCT01395888|11067225|FG001|Treatment Period (TP)|Withdrawal by Subject|2
7001934|NCT01395888|11067226|FG002|Treatment Period (TP)|Withdrawal by Subject|3
7001935|NCT01395901|11067234|FG000|Overall Study|Lost to Follow-up|4
7001936|NCT01395901|11067235|FG001|Overall Study|Lost to Follow-up|0
7001937|NCT01395901|11067234|FG000|Overall Study|Randomized but not received study drug|5
7001938|NCT01395901|11067235|FG001|Overall Study|Randomized but not received study drug|4
7001939|NCT01395901|11067234|FG000|Overall Study|Adverse Event|0
7001940|NCT01395901|11067235|FG001|Overall Study|Adverse Event|1
7001941|NCT01395901|11067234|FG000|Overall Study|Withdrawal of consent|1
7001942|NCT01395901|11067235|FG001|Overall Study|Withdrawal of consent|0
7001943|NCT01395914|11067243|FG000|Overall Study|Unrelated to study drug AE|6
7001944|NCT01395914|11067244|FG001|Overall Study|Unrelated to study drug AE|1
7001945|NCT01395914|11067243|FG000|Overall Study|Death|23
7001946|NCT01395914|11067244|FG001|Overall Study|Death|17
7001947|NCT01395914|11067243|FG000|Overall Study|Other|9
7001948|NCT01395914|11067244|FG001|Overall Study|Other|3
7001949|NCT01395914|11067243|FG000|Overall Study|Withdrawal by patient|27
7001950|NCT01395914|11067244|FG001|Overall Study|Withdrawal by patient|14
7001951|NCT01395914|11067243|FG000|Overall Study|Study drug-related AE|1
7001952|NCT01395914|11067244|FG001|Overall Study|Study drug-related AE|0
7001953|NCT01395914|11067243|FG000|Overall Study|Lost to Follow-up|6
7001954|NCT01395914|11067244|FG001|Overall Study|Lost to Follow-up|2
7001955|NCT01396005|11067265|FG000|Overall Study|Withdrawal by Subject|0
7001956|NCT01396005|11067266|FG001|Overall Study|Withdrawal by Subject|1
7001957|NCT01396005|11067265|FG000|Overall Study|Non-compliance with protocol|0
7001958|NCT01396005|11067266|FG001|Overall Study|Non-compliance with protocol|1
7001959|NCT01396057|11067285|FG000|Overall Study|Adverse Event|2
7001960|NCT01396057|11067286|FG001|Overall Study|Adverse Event|6
7001961|NCT01396057|11067285|FG000|Overall Study|Unsatisfactory therapeutic effect|2
7001962|NCT01396057|11067286|FG001|Overall Study|Unsatisfactory therapeutic effect|6
7001963|NCT01396057|11067285|FG000|Overall Study|Protocol deviation|4
7001964|NCT01396057|11067286|FG001|Overall Study|Protocol deviation|4
7001965|NCT01396057|11067285|FG000|Overall Study|Consent withdrawn|3
7001966|NCT01396057|11067286|FG001|Overall Study|Consent withdrawn|2
7001967|NCT01396070|11067292|FG000|Overall Study|Withdrawal by Subject|2
7001968|NCT01396070|11067292|FG000|Overall Study|Death|2
7001969|NCT01396070|11067292|FG000|Overall Study|Adverse Event|8
7001970|NCT01396070|11067292|FG000|Overall Study|Physician Decision|3
7001971|NCT01396070|11067292|FG000|Overall Study|Lack of Efficacy|4
7001972|NCT01396083|11067299|FG000|Overall Study|Adverse Event|2
7001973|NCT01396083|11067300|FG001|Overall Study|Adverse Event|28
7001974|NCT01396083|11067299|FG000|Overall Study|Unsatisfactory therapeutic effect|2
7001975|NCT01396083|11067300|FG001|Overall Study|Unsatisfactory therapeutic effect|13
7001976|NCT01396083|11067299|FG000|Overall Study|Consent withdrawn|4
7001977|NCT01396083|11067300|FG001|Overall Study|Consent withdrawn|5
7001978|NCT01396083|11067299|FG000|Overall Study|Protocol deviation(s)|0
7001979|NCT01396083|11067300|FG001|Overall Study|Protocol deviation(s)|1
7001980|NCT01396083|11067299|FG000|Overall Study|Abnormal laboratory value(s)|1
7001981|NCT01396083|11067300|FG001|Overall Study|Abnormal laboratory value(s)|0
7001982|NCT01396083|11067299|FG000|Overall Study|Administrative problems|1
7001983|NCT01396083|11067300|FG001|Overall Study|Administrative problems|0
7001984|NCT01396083|11067299|FG000|Overall Study|Lost to Follow-up|1
7001985|NCT01396083|11067300|FG001|Overall Study|Lost to Follow-up|0
7001986|NCT01396148|11067306|FG000|Overall Study|Patient Decision|1
7001987|NCT01396161|11067319|FG000|Overall Study|Withdrawal by Subject|0
7001988|NCT01396161|11067320|FG001|Overall Study|Withdrawal by Subject|0
7001989|NCT01396161|11067321|FG002|Overall Study|Withdrawal by Subject|0
7001990|NCT01396161|11067322|FG003|Overall Study|Withdrawal by Subject|0
7001991|NCT01396161|11067323|FG004|Overall Study|Withdrawal by Subject|1
7001992|NCT01396161|11067324|FG005|Overall Study|Withdrawal by Subject|0
7001993|NCT01396161|11067325|FG006|Overall Study|Withdrawal by Subject|0
7001994|NCT01396161|11067319|FG000|Overall Study|Other|0
7001995|NCT01396161|11067320|FG001|Overall Study|Other|0
7001996|NCT01396161|11067321|FG002|Overall Study|Other|0
7001997|NCT01396161|11067322|FG003|Overall Study|Other|0
7001998|NCT01396161|11067323|FG004|Overall Study|Other|0
7001999|NCT01396161|11067324|FG005|Overall Study|Other|0
7002000|NCT01396161|11067325|FG006|Overall Study|Other|1
7002001|NCT01396187|11067351|FG000|Overall Study|Adverse Event|0
7002002|NCT01396187|11067352|FG001|Overall Study|Adverse Event|1
7002003|NCT01396187|11067353|FG002|Overall Study|Adverse Event|0
7002004|NCT01396187|11067354|FG003|Overall Study|Adverse Event|0
7002005|NCT01396187|11067355|FG004|Overall Study|Adverse Event|0
7002006|NCT01396187|11067351|FG000|Overall Study|Withdrawal by Subject|0
7002007|NCT01396187|11067352|FG001|Overall Study|Withdrawal by Subject|1
7002008|NCT01396187|11067353|FG002|Overall Study|Withdrawal by Subject|1
7002009|NCT01396187|11067354|FG003|Overall Study|Withdrawal by Subject|0
7002010|NCT01396187|11067355|FG004|Overall Study|Withdrawal by Subject|0
7002011|NCT01396187|11067351|FG000|Overall Study|Other|1
7002012|NCT01396187|11067352|FG001|Overall Study|Other|1
7002013|NCT01396187|11067353|FG002|Overall Study|Other|0
7002014|NCT01396187|11067354|FG003|Overall Study|Other|0
7002015|NCT01396187|11067355|FG004|Overall Study|Other|1
7002016|NCT01396265|11067403|FG000|Rifa+Afatinib|Withdrawal by Subject|1
7002017|NCT01396317|11067411|FG000|Overall Study|Adverse Event|1
7002018|NCT01396317|11067412|FG001|Overall Study|Adverse Event|0
7002019|NCT01396395|11067427|FG000|Overall Study|Withdrawal by Subject|10
7002020|NCT01396395|11067428|FG001|Overall Study|Withdrawal by Subject|12
7002021|NCT01396395|11067427|FG000|Overall Study|Protocol Violation|3
7002022|NCT01396395|11067428|FG001|Overall Study|Protocol Violation|1
7002023|NCT01396395|11067427|FG000|Overall Study|Adverse Event|10
7002024|NCT01396395|11067428|FG001|Overall Study|Adverse Event|2
7002025|NCT01396395|11067427|FG000|Overall Study|Lost to Follow-up|17
7002026|NCT01396395|11067428|FG001|Overall Study|Lost to Follow-up|11
7002027|NCT01396395|11067427|FG000|Overall Study|Other|0
7002028|NCT01396395|11067428|FG001|Overall Study|Other|1
7002029|NCT01396421|11067440|FG000|Overall Study|Lost to Follow-up|0
7002030|NCT01396421|11067441|FG001|Overall Study|Lost to Follow-up|0
7002031|NCT01396421|11067442|FG002|Overall Study|Lost to Follow-up|0
7002032|NCT01396421|11067443|FG003|Overall Study|Lost to Follow-up|1
7002033|NCT01396421|11067440|FG000|Overall Study|Adverse Event|17
7002034|NCT01396421|11067441|FG001|Overall Study|Adverse Event|15
7002035|NCT01396421|11067442|FG002|Overall Study|Adverse Event|12
7002036|NCT01396421|11067443|FG003|Overall Study|Adverse Event|32
7002037|NCT01396421|11067440|FG000|Overall Study|Participant Met Withdrawal Criteria|1
7002038|NCT01396421|11067441|FG001|Overall Study|Participant Met Withdrawal Criteria|0
7002039|NCT01396421|11067442|FG002|Overall Study|Participant Met Withdrawal Criteria|1
7002040|NCT01396421|11067443|FG003|Overall Study|Participant Met Withdrawal Criteria|0
7002041|NCT01396421|11067440|FG000|Overall Study|Physician Decision|1
7002042|NCT01396421|11067441|FG001|Overall Study|Physician Decision|1
7002043|NCT01396421|11067442|FG002|Overall Study|Physician Decision|0
7002044|NCT01396421|11067443|FG003|Overall Study|Physician Decision|3
7002045|NCT01396421|11067440|FG000|Overall Study|Withdrawal by Subject|31
7002046|NCT01396421|11067441|FG001|Overall Study|Withdrawal by Subject|24
7002047|NCT01396421|11067442|FG002|Overall Study|Withdrawal by Subject|13
7002048|NCT01396421|11067443|FG003|Overall Study|Withdrawal by Subject|21
7002049|NCT01396421|11067440|FG000|Overall Study|Protocol Deviation|2
7002050|NCT01396421|11067441|FG001|Overall Study|Protocol Deviation|1
7002051|NCT01396421|11067442|FG002|Overall Study|Protocol Deviation|1
7002052|NCT01396421|11067443|FG003|Overall Study|Protocol Deviation|0
7002053|NCT01396421|11067440|FG000|Overall Study|Lack of Efficacy|7
7002054|NCT01396421|11067441|FG001|Overall Study|Lack of Efficacy|17
7002055|NCT01396421|11067442|FG002|Overall Study|Lack of Efficacy|7
7002056|NCT01396421|11067443|FG003|Overall Study|Lack of Efficacy|18
7002057|NCT01396434|11067470|FG000|Overall Study|Lost to Follow-up|1
7002058|NCT01396434|11067471|FG001|Overall Study|Lost to Follow-up|0
7002059|NCT01396434|11067472|FG002|Overall Study|Lost to Follow-up|0
7002060|NCT01396434|11067470|FG000|Overall Study|Other|10
7002061|NCT01396434|11067471|FG001|Overall Study|Other|0
7002062|NCT01396434|11067472|FG002|Overall Study|Other|0
7002063|NCT01396447|11067484|FG000|Overall Study|Did Not Receive Treatment|3
7002064|NCT01396447|11067485|FG001|Overall Study|Did Not Receive Treatment|2
7002065|NCT01396447|11067486|FG002|Overall Study|Did Not Receive Treatment|1
7002066|NCT01396447|11067487|FG003|Overall Study|Did Not Receive Treatment|0
7002067|NCT01396447|11067484|FG000|Overall Study|Adverse Event|15
7002068|NCT01396447|11067485|FG001|Overall Study|Adverse Event|12
7002069|NCT01396447|11067486|FG002|Overall Study|Adverse Event|12
7002070|NCT01396447|11067487|FG003|Overall Study|Adverse Event|17
7002071|NCT01396447|11067484|FG000|Overall Study|Insufficient Therapeutic Response|5
7002072|NCT01396447|11067485|FG001|Overall Study|Insufficient Therapeutic Response|5
7002073|NCT01396447|11067486|FG002|Overall Study|Insufficient Therapeutic Response|2
7002074|NCT01396447|11067487|FG003|Overall Study|Insufficient Therapeutic Response|4
7002075|NCT01396447|11067484|FG000|Overall Study|Protocol Violation|5
7002076|NCT01396447|11067485|FG001|Overall Study|Protocol Violation|2
7002077|NCT01396447|11067486|FG002|Overall Study|Protocol Violation|3
7002078|NCT01396447|11067487|FG003|Overall Study|Protocol Violation|7
7002079|NCT01396447|11067484|FG000|Overall Study|Withdrawal of Consent|11
7002080|NCT01396447|11067485|FG001|Overall Study|Withdrawal of Consent|9
7002081|NCT01396447|11067486|FG002|Overall Study|Withdrawal of Consent|4
7002082|NCT01396447|11067487|FG003|Overall Study|Withdrawal of Consent|15
7002083|NCT01396447|11067484|FG000|Overall Study|Lost to Follow-up|4
7002084|NCT01396447|11067485|FG001|Overall Study|Lost to Follow-up|8
7002085|NCT01396447|11067486|FG002|Overall Study|Lost to Follow-up|7
7002086|NCT01396447|11067487|FG003|Overall Study|Lost to Follow-up|9
7002087|NCT01396447|11067484|FG000|Overall Study|Other Miscellaneous Reasons|0
7002088|NCT01396447|11067485|FG001|Overall Study|Other Miscellaneous Reasons|2
7002089|NCT01396447|11067486|FG002|Overall Study|Other Miscellaneous Reasons|1
7002090|NCT01396447|11067487|FG003|Overall Study|Other Miscellaneous Reasons|0
7002091|NCT01396512|11067512|FG000|Overall Study|Withdrawal by Subject|0
7002092|NCT01396512|11067513|FG001|Overall Study|Withdrawal by Subject|1
7002093|NCT01396525|11067519|FG000|Overall Study|Withdrawal by Subject|8
7002094|NCT01396525|11067519|FG000|Overall Study|Death|14
7002095|NCT01396525|11067519|FG000|Overall Study|Lost to Follow-up|4
7002096|NCT01397084|11067543|FG000|Overall Study|Severe Non-Compliance to Protocol|1
7002097|NCT01397084|11067543|FG000|Overall Study|Protocol Violation|2
7002098|NCT01397084|11067543|FG000|Overall Study|Adverse Event|2
7002099|NCT01397084|11067543|FG000|Overall Study|Withdrawal by Subject|1
7002100|NCT01397084|11067543|FG000|Overall Study|Lost to Follow-up|1
7002101|NCT01397084|11067543|FG000|Overall Study|Used other proton pump inhibitor|1
7002102|NCT01397253|11067549|FG000|Overall Study|Reviewed by only 1 pharmacist|126
7002103|NCT01397253|11067550|FG001|Overall Study|Reviewed by only 1 pharmacist|149
7002104|NCT01397409|11067566|FG000|Stage 2|Adverse Event|0
7002105|NCT01397409|11067567|FG001|Stage 2|Adverse Event|0
7002106|NCT01397409|11067568|FG002|Stage 2|Adverse Event|0
7002107|NCT01397409|11067569|FG003|Stage 2|Adverse Event|0
7002108|NCT01397409|11067570|FG004|Stage 2|Adverse Event|6
7002109|NCT01397409|11067571|FG005|Stage 2|Adverse Event|3
7002110|NCT01397409|11067572|FG006|Stage 2|Adverse Event|0
7002111|NCT01397409|11067573|FG007|Stage 2|Adverse Event|0
7002112|NCT01397409|11067574|FG008|Stage 2|Adverse Event|0
7002113|NCT01397409|11067575|FG009|Stage 2|Adverse Event|0
7002114|NCT01397409|11067566|FG000|Stage 2|Personal Reasons|0
7002115|NCT01397409|11067567|FG001|Stage 2|Personal Reasons|0
7002116|NCT01397409|11067568|FG002|Stage 2|Personal Reasons|0
7002117|NCT01397409|11067569|FG003|Stage 2|Personal Reasons|0
7002118|NCT01397409|11067570|FG004|Stage 2|Personal Reasons|1
7002119|NCT01397409|11067571|FG005|Stage 2|Personal Reasons|0
7002120|NCT01397409|11067572|FG006|Stage 2|Personal Reasons|0
7002121|NCT01397409|11067573|FG007|Stage 2|Personal Reasons|0
7002122|NCT01397409|11067574|FG008|Stage 2|Personal Reasons|0
7002123|NCT01397409|11067575|FG009|Stage 2|Personal Reasons|0
7002124|NCT01397409|11067566|FG000|Stage 2|Other Miscellaneous Reasons|0
7002125|NCT01397409|11067567|FG001|Stage 2|Other Miscellaneous Reasons|0
7002126|NCT01397409|11067568|FG002|Stage 2|Other Miscellaneous Reasons|0
7002127|NCT01397409|11067569|FG003|Stage 2|Other Miscellaneous Reasons|0
7002128|NCT01397409|11067570|FG004|Stage 2|Other Miscellaneous Reasons|1
7002129|NCT01397409|11067571|FG005|Stage 2|Other Miscellaneous Reasons|1
7002130|NCT01397409|11067572|FG006|Stage 2|Other Miscellaneous Reasons|0
7002131|NCT01397409|11067573|FG007|Stage 2|Other Miscellaneous Reasons|0
7002132|NCT01397409|11067574|FG008|Stage 2|Other Miscellaneous Reasons|0
7002133|NCT01397409|11067575|FG009|Stage 2|Other Miscellaneous Reasons|0
7002134|NCT01397409|11067566|FG000|Stage 3|Adverse Event|0
7002135|NCT01397409|11067567|FG001|Stage 3|Adverse Event|0
7002136|NCT01397409|11067568|FG002|Stage 3|Adverse Event|0
7002137|NCT01397409|11067569|FG003|Stage 3|Adverse Event|0
7002138|NCT01397409|11067570|FG004|Stage 3|Adverse Event|0
7002139|NCT01397409|11067571|FG005|Stage 3|Adverse Event|0
7002140|NCT01397409|11067572|FG006|Stage 3|Adverse Event|0
7002141|NCT01397409|11067573|FG007|Stage 3|Adverse Event|1
7002142|NCT01397409|11067574|FG008|Stage 3|Adverse Event|0
7002143|NCT01397409|11067575|FG009|Stage 3|Adverse Event|0
7002144|NCT01397409|11067566|FG000|Stage 3|Other Miscellaneous Reasons|0
7002145|NCT01397409|11067567|FG001|Stage 3|Other Miscellaneous Reasons|0
7002146|NCT01397409|11067568|FG002|Stage 3|Other Miscellaneous Reasons|0
7002147|NCT01397409|11067569|FG003|Stage 3|Other Miscellaneous Reasons|0
7002148|NCT01397409|11067570|FG004|Stage 3|Other Miscellaneous Reasons|0
7002149|NCT01397409|11067571|FG005|Stage 3|Other Miscellaneous Reasons|0
7002150|NCT01397409|11067572|FG006|Stage 3|Other Miscellaneous Reasons|0
7002151|NCT01397409|11067573|FG007|Stage 3|Other Miscellaneous Reasons|1
7002152|NCT01397409|11067574|FG008|Stage 3|Other Miscellaneous Reasons|0
7002153|NCT01397409|11067575|FG009|Stage 3|Other Miscellaneous Reasons|0
7002154|NCT01397422|11067602|FG000|Overall Study|Adverse Event|0
7002155|NCT01397422|11067603|FG001|Overall Study|Adverse Event|3
7002156|NCT01397422|11067604|FG002|Overall Study|Adverse Event|3
7002157|NCT01397422|11067605|FG003|Overall Study|Adverse Event|8
7002158|NCT01397422|11067602|FG000|Overall Study|Withdrawal by Subject|1
7002159|NCT01397422|11067603|FG001|Overall Study|Withdrawal by Subject|0
7002160|NCT01397422|11067604|FG002|Overall Study|Withdrawal by Subject|0
7002161|NCT01397422|11067605|FG003|Overall Study|Withdrawal by Subject|0
7002162|NCT01397422|11067602|FG000|Overall Study|Increased bradykinesia related to PD|1
7002163|NCT01397422|11067603|FG001|Overall Study|Increased bradykinesia related to PD|0
7002164|NCT01397422|11067604|FG002|Overall Study|Increased bradykinesia related to PD|0
7002165|NCT01397422|11067605|FG003|Overall Study|Increased bradykinesia related to PD|0
7002166|NCT01397448|11067620|FG000|Overall Study|Adverse Event|4
7002167|NCT01397448|11067621|FG001|Overall Study|Adverse Event|4
7002168|NCT01397448|11067622|FG002|Overall Study|Adverse Event|6
7002169|NCT01397448|11067620|FG000|Overall Study|Withdrawal by Subject|4
7002170|NCT01397448|11067621|FG001|Overall Study|Withdrawal by Subject|4
7002171|NCT01397448|11067622|FG002|Overall Study|Withdrawal by Subject|3
7002172|NCT01397448|11067620|FG000|Overall Study|Lack of Efficacy|2
7002173|NCT01397448|11067621|FG001|Overall Study|Lack of Efficacy|0
7002174|NCT01397448|11067622|FG002|Overall Study|Lack of Efficacy|5
7002175|NCT01397448|11067620|FG000|Overall Study|Other|8
7002176|NCT01397448|11067621|FG001|Overall Study|Other|7
7002177|NCT01397448|11067622|FG002|Overall Study|Other|4
7002178|NCT01397461|11067633|FG000|Overall Study|Withdrawal by Subject|2
7002179|NCT01397461|11067634|FG001|Overall Study|Withdrawal by Subject|1
7002180|NCT01397461|11067635|FG002|Overall Study|Withdrawal by Subject|0
7002181|NCT01397461|11067633|FG000|Overall Study|Lost to Follow-up|0
7002182|NCT01397461|11067634|FG001|Overall Study|Lost to Follow-up|2
7002183|NCT01397461|11067635|FG002|Overall Study|Lost to Follow-up|1
7002184|NCT01397461|11067633|FG000|Overall Study|Lack of Efficacy|0
7002185|NCT01397461|11067634|FG001|Overall Study|Lack of Efficacy|3
7002186|NCT01397461|11067635|FG002|Overall Study|Lack of Efficacy|0
7002187|NCT01397461|11067633|FG000|Overall Study|Not treated|0
7002188|NCT01397461|11067634|FG001|Overall Study|Not treated|0
7002189|NCT01397461|11067635|FG002|Overall Study|Not treated|1
7002190|NCT01397747|11067675|FG000|Overall Study|Multitarget DNA test excluded|689
7002191|NCT01397747|11067675|FG000|Overall Study|Colonoscopy excluded|304
7002192|NCT01397747|11067675|FG000|Overall Study|FIT excluded|34
7002193|NCT01397786|11067683|FG000|Phase A|Lost to Follow-up|0
7002194|NCT01397786|11067684|FG001|Phase A|Lost to Follow-up|0
7002195|NCT01397786|11067685|FG002|Phase A|Lost to Follow-up|6
7002196|NCT01397786|11067683|FG000|Phase A|Adverse Event|0
7002197|NCT01397786|11067684|FG001|Phase A|Adverse Event|0
7002198|NCT01397786|11067685|FG002|Phase A|Adverse Event|8
7002199|NCT01397786|11067683|FG000|Phase A|Subject Met Withdrawal Criteria|0
7002200|NCT01397786|11067684|FG001|Phase A|Subject Met Withdrawal Criteria|0
7002201|NCT01397786|11067685|FG002|Phase A|Subject Met Withdrawal Criteria|7
7002202|NCT01397786|11067683|FG000|Phase A|Physician Decision|0
7002203|NCT01397786|11067684|FG001|Phase A|Physician Decision|0
7002204|NCT01397786|11067685|FG002|Phase A|Physician Decision|1
7002205|NCT01397786|11067683|FG000|Phase A|Withdrawal by Subject|0
7002206|NCT01397786|11067684|FG001|Phase A|Withdrawal by Subject|0
7002207|NCT01397786|11067685|FG002|Phase A|Withdrawal by Subject|5
7002208|NCT01397786|11067683|FG000|Phase A|Lack of Efficacy|0
7002209|NCT01397786|11067684|FG001|Phase A|Lack of Efficacy|0
7002210|NCT01397786|11067685|FG002|Phase A|Lack of Efficacy|1
7002211|NCT01397786|11067683|FG000|Phase B|Lost to Follow-up|22
7002212|NCT01397786|11067684|FG001|Phase B|Lost to Follow-up|12
7002213|NCT01397786|11067685|FG002|Phase B|Lost to Follow-up|22
7002214|NCT01397786|11067683|FG000|Phase B|Adverse Event|109
7002215|NCT01397786|11067684|FG001|Phase B|Adverse Event|23
7002216|NCT01397786|11067685|FG002|Phase B|Adverse Event|27
7002217|NCT01397786|11067683|FG000|Phase B|Subject Met Withdrawal Criteria|38
7002218|NCT01397786|11067684|FG001|Phase B|Subject Met Withdrawal Criteria|5
7002219|NCT01397786|11067685|FG002|Phase B|Subject Met Withdrawal Criteria|38
7002220|NCT01397786|11067683|FG000|Phase B|Physician Decision|9
7002221|NCT01397786|11067684|FG001|Phase B|Physician Decision|1
7002222|NCT01397786|11067685|FG002|Phase B|Physician Decision|3
7002223|NCT01397786|11067683|FG000|Phase B|Withdrawal by Subject|102
7002224|NCT01397786|11067684|FG001|Phase B|Withdrawal by Subject|45
7002225|NCT01397786|11067685|FG002|Phase B|Withdrawal by Subject|30
7002226|NCT01397786|11067683|FG000|Phase B|Protocol Deviation|1
7002227|NCT01397786|11067684|FG001|Phase B|Protocol Deviation|2
7002228|NCT01397786|11067685|FG002|Phase B|Protocol Deviation|4
7002229|NCT01397786|11067683|FG000|Phase B|Lack of Efficacy|22
7002230|NCT01397786|11067684|FG001|Phase B|Lack of Efficacy|7
7002231|NCT01397786|11067685|FG002|Phase B|Lack of Efficacy|14
7002232|NCT01397825|11067701|FG000|Overall Study|Progressive Disease|10
7002233|NCT01397825|11067702|FG001|Overall Study|Progressive Disease|3
7002234|NCT01397825|11067703|FG002|Overall Study|Progressive Disease|11
7002235|NCT01397825|11067704|FG003|Overall Study|Progressive Disease|1
7002236|NCT01397825|11067705|FG004|Overall Study|Progressive Disease|0
7002237|NCT01397825|11067701|FG000|Overall Study|Symptomatic Deterioration|2
7002238|NCT01397825|11067702|FG001|Overall Study|Symptomatic Deterioration|0
7002239|NCT01397825|11067703|FG002|Overall Study|Symptomatic Deterioration|4
7002240|NCT01397825|11067704|FG003|Overall Study|Symptomatic Deterioration|0
7002241|NCT01397825|11067705|FG004|Overall Study|Symptomatic Deterioration|0
7002242|NCT01397825|11067701|FG000|Overall Study|Adverse Event|0
7002243|NCT01397825|11067702|FG001|Overall Study|Adverse Event|1
7002244|NCT01397825|11067703|FG002|Overall Study|Adverse Event|5
7002245|NCT01397825|11067704|FG003|Overall Study|Adverse Event|1
7002246|NCT01397825|11067705|FG004|Overall Study|Adverse Event|0
7002247|NCT01397825|11067701|FG000|Overall Study|Withdrawal by Subject|1
7002248|NCT01397825|11067702|FG001|Overall Study|Withdrawal by Subject|0
7002249|NCT01397825|11067703|FG002|Overall Study|Withdrawal by Subject|5
7002250|NCT01397825|11067704|FG003|Overall Study|Withdrawal by Subject|1
7002251|NCT01397825|11067705|FG004|Overall Study|Withdrawal by Subject|0
7002252|NCT01397890|11067730|FG000|Overall Study|Withdrawal by Subject|7
7002253|NCT01397890|11067731|FG001|Overall Study|Withdrawal by Subject|11
7002254|NCT01397890|11067730|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7
7002255|NCT01397890|11067731|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6
7002256|NCT01397890|11067730|FG000|Overall Study|Death|2
7002257|NCT01397890|11067731|FG001|Overall Study|Death|3
7002258|NCT01397890|11067730|FG000|Overall Study|Lost to Follow-up|1
7002259|NCT01397890|11067731|FG001|Overall Study|Lost to Follow-up|4
7002260|NCT01397890|11067730|FG000|Overall Study|Condition under Investigation Worsened|1
7002261|NCT01397890|11067731|FG001|Overall Study|Condition under Investigation Worsened|3
7002262|NCT01397890|11067730|FG000|Overall Study|Adverse Event|1
7002263|NCT01397890|11067731|FG001|Overall Study|Adverse Event|2
7002264|NCT01397890|11067730|FG000|Overall Study|Severe Non-Compliance to Protocol|2
7002265|NCT01397890|11067731|FG001|Overall Study|Severe Non-Compliance to Protocol|1
7002266|NCT01397890|11067730|FG000|Overall Study|Others|2
7002267|NCT01397890|11067731|FG001|Overall Study|Others|1
7002268|NCT01398176|11067752|FG000|Overall Study|Lost to Follow-up|1
7002269|NCT01398176|11067753|FG001|Overall Study|Lost to Follow-up|3
7002270|NCT01398176|11067752|FG000|Overall Study|Physician Decision|2
7002271|NCT01398176|11067753|FG001|Overall Study|Physician Decision|3
7002272|NCT01398358|11067771|FG000|Overall Study|Lost to Follow-up|11
7002273|NCT01398358|11067772|FG001|Overall Study|Lost to Follow-up|21
7002274|NCT01398358|11067773|FG002|Overall Study|Lost to Follow-up|18
7002275|NCT01398358|11067771|FG000|Overall Study|Withdrawal by Subject|3
7002276|NCT01398358|11067772|FG001|Overall Study|Withdrawal by Subject|2
7002277|NCT01398358|11067773|FG002|Overall Study|Withdrawal by Subject|2
7002278|NCT01398358|11067771|FG000|Overall Study|no longer eligible|1
7002279|NCT01398358|11067772|FG001|Overall Study|no longer eligible|0
7002280|NCT01398358|11067773|FG002|Overall Study|no longer eligible|1
7002281|NCT01398410|11067783|FG000|Overall Study|Adverse Event|12
7002282|NCT01398410|11067784|FG001|Overall Study|Adverse Event|16
7002283|NCT01398410|11067783|FG000|Overall Study|Participants Choice|8
7002284|NCT01398410|11067784|FG001|Overall Study|Participants Choice|11
7002285|NCT01398410|11067783|FG000|Overall Study|Inadequate Therapeutic Effect|2
7002286|NCT01398410|11067784|FG001|Overall Study|Inadequate Therapeutic Effect|0
7002287|NCT01398410|11067783|FG000|Overall Study|Other|36
7002288|NCT01398410|11067784|FG001|Overall Study|Other|29
7002289|NCT01398514|11067805|FG000|Overall Study|Adverse Event|1
7002290|NCT01398514|11067806|FG001|Overall Study|Adverse Event|0
7002291|NCT01398514|11067805|FG000|Overall Study|Non-compliance with study procedures|2
7002292|NCT01398514|11067806|FG001|Overall Study|Non-compliance with study procedures|0
7002293|NCT01398514|11067805|FG000|Overall Study|Physiologic non-responsiveness|1
7002294|NCT01398514|11067806|FG001|Overall Study|Physiologic non-responsiveness|3
7002295|NCT01398514|11067805|FG000|Overall Study|Failure to show a conditioned response|4
7002296|NCT01398514|11067806|FG001|Overall Study|Failure to show a conditioned response|3
7002297|NCT01398787|11067818|FG000|Overall Study|Adverse Event|1
7002298|NCT01398956|11067837|FG000|Overall Study|Withdrawal by Subject|4
7002299|NCT01398956|11067837|FG000|Overall Study|AE, non-serious non-fatal|4
7002300|NCT01398956|11067837|FG000|Overall Study|Withdrawal Criteria No.3|1
7002301|NCT01398956|11067837|FG000|Overall Study|Subject moved a long distance|1
7002302|NCT01399047|11067866|FG000|Overall Study|Withdrawal by Subject|0
7002303|NCT01399047|11067867|FG001|Overall Study|Withdrawal by Subject|1
7002304|NCT01399099|11067875|FG000|Overall Study|Lost to Follow-up|11
7002305|NCT01399099|11067875|FG000|Overall Study|Physician Decision|1
7002306|NCT01399099|11067875|FG000|Overall Study|Protocol Violation|1
7002307|NCT01399099|11067875|FG000|Overall Study|Skin Irritation|13
7002308|NCT01399099|11067875|FG000|Overall Study|Infection|1
7002309|NCT01399099|11067875|FG000|Overall Study|Miscellaneous|4
7002310|NCT01399125|11067882|FG000|Overall Study|Adverse Event|32
7002311|NCT01399125|11067883|FG001|Overall Study|Adverse Event|30
7002312|NCT01399125|11067882|FG000|Overall Study|Abnormal Lab values|0
7002313|NCT01399125|11067883|FG001|Overall Study|Abnormal Lab values|1
7002314|NCT01399125|11067882|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0
7002315|NCT01399125|11067883|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4
7002316|NCT01399125|11067882|FG000|Overall Study|Withdrawal by Subject|5
7002317|NCT01399125|11067883|FG001|Overall Study|Withdrawal by Subject|8
7002318|NCT01399125|11067882|FG000|Overall Study|Lost to Follow-up|2
7002319|NCT01399125|11067883|FG001|Overall Study|Lost to Follow-up|3
7002320|NCT01399125|11067882|FG000|Overall Study|Administrative Problems|7
7002321|NCT01399125|11067883|FG001|Overall Study|Administrative Problems|11
7002322|NCT01399125|11067882|FG000|Overall Study|Death|0
7002323|NCT01399125|11067883|FG001|Overall Study|Death|1
7002324|NCT01399125|11067882|FG000|Overall Study|Protocol Deviation|5
7002325|NCT01399125|11067883|FG001|Overall Study|Protocol Deviation|2
7002326|NCT01399190|11067889|FG000|Overall Study|Not Eligible for Final Analysis|5
7002327|NCT01399190|11067889|FG000|Overall Study|Adverse Event|8
7002328|NCT01399190|11067889|FG000|Overall Study|Participant's Request|5
7002329|NCT01399190|11067889|FG000|Overall Study|Physician Decision|2
7002330|NCT01399593|11067910|FG000|Overall Study|Physician Decision|1
7002331|NCT01399593|11067911|FG001|Overall Study|Physician Decision|0
7002332|NCT01399593|11067910|FG000|Overall Study|Adverse Event|1
7002333|NCT01399593|11067911|FG001|Overall Study|Adverse Event|0
7002334|NCT01399593|11067910|FG000|Overall Study|Death|1
7002335|NCT01399593|11067911|FG001|Overall Study|Death|1
7002336|NCT01399593|11067910|FG000|Overall Study|Transplantectomy|0
7002337|NCT01399593|11067911|FG001|Overall Study|Transplantectomy|1
7002338|NCT01399619|11067919|FG000|Overall Study|Adverse Event|10
7002339|NCT01399619|11067920|FG001|Overall Study|Adverse Event|0
7002340|NCT01399619|11067921|FG002|Overall Study|Adverse Event|4
7002341|NCT01399619|11067922|FG003|Overall Study|Adverse Event|10
7002342|NCT01399619|11067919|FG000|Overall Study|Lack of Efficacy|9
7002343|NCT01399619|11067920|FG001|Overall Study|Lack of Efficacy|0
7002344|NCT01399619|11067921|FG002|Overall Study|Lack of Efficacy|5
7002345|NCT01399619|11067922|FG003|Overall Study|Lack of Efficacy|0
7002346|NCT01399619|11067919|FG000|Overall Study|Withdrawal by Subject|6
7002347|NCT01399619|11067920|FG001|Overall Study|Withdrawal by Subject|0
7002348|NCT01399619|11067921|FG002|Overall Study|Withdrawal by Subject|3
7002349|NCT01399619|11067922|FG003|Overall Study|Withdrawal by Subject|4
7002350|NCT01399619|11067919|FG000|Overall Study|Protocol Violation|0
7002351|NCT01399619|11067920|FG001|Overall Study|Protocol Violation|0
7002352|NCT01399619|11067921|FG002|Overall Study|Protocol Violation|0
7002353|NCT01399619|11067922|FG003|Overall Study|Protocol Violation|1
7002354|NCT01399619|11067919|FG000|Overall Study|Not treated|0
7002355|NCT01399619|11067920|FG001|Overall Study|Not treated|0
7002356|NCT01399619|11067921|FG002|Overall Study|Not treated|0
7002357|NCT01399619|11067922|FG003|Overall Study|Not treated|2
7002358|NCT01399697|11067940|FG000|Overall Study|Adverse Event|13
7002359|NCT01399697|11067941|FG001|Overall Study|Adverse Event|3
7002360|NCT01399697|11067942|FG002|Overall Study|Adverse Event|1
7002361|NCT01399697|11067940|FG000|Overall Study|Lost to Follow-up|2
7002362|NCT01399697|11067941|FG001|Overall Study|Lost to Follow-up|0
7002363|NCT01399697|11067942|FG002|Overall Study|Lost to Follow-up|0
7002364|NCT01399697|11067940|FG000|Overall Study|Withdrawal by Subject|8
7002365|NCT01399697|11067941|FG001|Overall Study|Withdrawal by Subject|0
7002366|NCT01399697|11067942|FG002|Overall Study|Withdrawal by Subject|0
7002367|NCT01399697|11067940|FG000|Overall Study|Investigator Decisión|1
7002368|NCT01399697|11067941|FG001|Overall Study|Investigator Decisión|0
7002369|NCT01399697|11067942|FG002|Overall Study|Investigator Decisión|2
7002370|NCT01399697|11067940|FG000|Overall Study|Lack of Efficacy|9
7002371|NCT01399697|11067941|FG001|Overall Study|Lack of Efficacy|0
7002372|NCT01399697|11067942|FG002|Overall Study|Lack of Efficacy|1
7002373|NCT01399697|11067940|FG000|Overall Study|Protocol Violation|2
7002374|NCT01399697|11067941|FG001|Overall Study|Protocol Violation|0
7002375|NCT01399697|11067942|FG002|Overall Study|Protocol Violation|0
7002376|NCT01399697|11067940|FG000|Overall Study|Non-Compliant|1
7002377|NCT01399697|11067941|FG001|Overall Study|Non-Compliant|0
7002378|NCT01399697|11067942|FG002|Overall Study|Non-Compliant|0
7002379|NCT01399697|11067940|FG000|Overall Study|Inclusion Error|2
7002380|NCT01399697|11067941|FG001|Overall Study|Inclusion Error|0
7002381|NCT01399697|11067942|FG002|Overall Study|Inclusion Error|0
7002382|NCT01399697|11067940|FG000|Overall Study|Positive result for hepatitis B|1
7002383|NCT01399697|11067941|FG001|Overall Study|Positive result for hepatitis B|0
7002384|NCT01399697|11067942|FG002|Overall Study|Positive result for hepatitis B|0
7002385|NCT01399697|11067940|FG000|Overall Study|Clinical RA remission|1
7002386|NCT01399697|11067941|FG001|Overall Study|Clinical RA remission|0
7002387|NCT01399697|11067942|FG002|Overall Study|Clinical RA remission|0
7002388|NCT01399697|11067940|FG000|Overall Study|Sponsor Decision|1
7002389|NCT01399697|11067941|FG001|Overall Study|Sponsor Decision|0
7002390|NCT01399697|11067942|FG002|Overall Study|Sponsor Decision|0
7002391|NCT01399723|11067955|FG000|Overall Study|Lost to Follow-up|0
7002392|NCT01399723|11067956|FG001|Overall Study|Lost to Follow-up|1
7002393|NCT01399736|11067965|FG000|Overall Study|Withdrawal by Subject|4
7002394|NCT01399736|11067966|FG001|Overall Study|Withdrawal by Subject|2
7002395|NCT01399736|11067965|FG000|Overall Study|Lost to Follow-up|0
7002396|NCT01399736|11067966|FG001|Overall Study|Lost to Follow-up|2
7002397|NCT01399788|11067980|FG000|First Intervention Period|Adverse Event|1
7002398|NCT01399788|11067981|FG001|First Intervention Period|Adverse Event|0
7002399|NCT01399905|11068007|FG000|Overall Study|Withdrawal by Subject|1
7002400|NCT01399905|11068008|FG001|Overall Study|Withdrawal by Subject|1
7002401|NCT01400113|11068021|FG000|Overall Study|Withdrawal by Subject|1
7002402|NCT01400113|11068022|FG001|Overall Study|Withdrawal by Subject|1
7002403|NCT01400139|11068028|FG000|HYD Core Study|Adverse Event|210
7002404|NCT01400139|11068028|FG000|HYD Core Study|Lack of Efficacy|59
7002405|NCT01400139|11068028|FG000|HYD Core Study|Withdrawal by Subject|114
7002406|NCT01400139|11068028|FG000|HYD Core Study|Lost to Follow-up|39
7002407|NCT01400139|11068028|FG000|HYD Core Study|Confirmed or suspected diversion|20
7002408|NCT01400139|11068028|FG000|HYD Core Study|Administrative|56
7002409|NCT01400139|11068028|FG000|HYD Core Study|Did not qualify for Maintenance Period|14
7002410|NCT01400139|11068028|FG000|HYD Extension Period|Adverse Event|8
7002411|NCT01400139|11068028|FG000|HYD Extension Period|Withdrawal by Subject|5
7002412|NCT01400139|11068028|FG000|HYD Extension Period|Administrative|10
7002413|NCT01400243|11068036|FG000|Overall Study|Protocol Violation|8
7002414|NCT01400243|11068037|FG001|Overall Study|Protocol Violation|11
7002415|NCT01400412|11068047|FG000|Overall Study|Lost to Follow-up|4
7002416|NCT01400412|11068048|FG001|Overall Study|Lost to Follow-up|7
7002417|NCT01400412|11068047|FG000|Overall Study|Withdrawal by Subject|3
7002418|NCT01400412|11068048|FG001|Overall Study|Withdrawal by Subject|4
7002419|NCT01400412|11068047|FG000|Overall Study|Unable to complete|3
7002420|NCT01400412|11068048|FG001|Overall Study|Unable to complete|3
7002421|NCT01400412|11068047|FG000|Overall Study|Never started study treatment|0
7002422|NCT01400412|11068048|FG001|Overall Study|Never started study treatment|3
7042874|NCT01738594|11127418|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0
7042875|NCT01738594|11127419|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0
7002423|NCT01400425|11068056|FG000|Overall Study|Withdrawal by Subject|10
7002424|NCT01400451|11068065|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2
7002425|NCT01400451|11068066|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1
7002426|NCT01400451|11068067|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1
7002427|NCT01400451|11068065|FG000|Combination Treatment (or Intended)|Drug Toxicity|0
7002428|NCT01400451|11068066|FG001|Combination Treatment (or Intended)|Drug Toxicity|1
7002429|NCT01400451|11068067|FG002|Combination Treatment (or Intended)|Drug Toxicity|0
7002430|NCT01400451|11068065|FG000|Combination Treatment (or Intended)|Adverse Event|1
7002431|NCT01400451|11068066|FG001|Combination Treatment (or Intended)|Adverse Event|0
7002432|NCT01400451|11068067|FG002|Combination Treatment (or Intended)|Adverse Event|0
7002433|NCT01400451|11068065|FG000|Combination Treatment (or Intended)|Disease Progression|3
7002434|NCT01400451|11068066|FG001|Combination Treatment (or Intended)|Disease Progression|1
7002435|NCT01400451|11068067|FG002|Combination Treatment (or Intended)|Disease Progression|1
7002436|NCT01400451|11068065|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0
7002437|NCT01400451|11068066|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1
7002438|NCT01400451|11068067|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0
7002439|NCT01400503|11068089|FG000|Overall Study|Withdrawal by Subject|1
7002440|NCT01400503|11068089|FG000|Overall Study|Study Terminated by Sponsor|58
7002441|NCT01400503|11068089|FG000|Overall Study|Other|1
7002442|NCT01400516|11068095|FG000|Primary Trial|Withdrawal by Subject|0
7002443|NCT01400516|11068096|FG001|Primary Trial|Withdrawal by Subject|2
7002444|NCT01400698|11068106|FG000|Overall Study|Lost to Follow-up|2
7002445|NCT01400698|11068107|FG001|Overall Study|Lost to Follow-up|5
7002446|NCT01400698|11068108|FG002|Overall Study|Lost to Follow-up|2
7002447|NCT01400698|11068109|FG003|Overall Study|Lost to Follow-up|1
7002448|NCT01400698|11068110|FG004|Overall Study|Lost to Follow-up|4
7002449|NCT01400698|11068111|FG005|Overall Study|Lost to Follow-up|3
7002450|NCT01400698|11068106|FG000|Overall Study|Withdrawal by Subject|8
7002451|NCT01400698|11068107|FG001|Overall Study|Withdrawal by Subject|2
7002452|NCT01400698|11068108|FG002|Overall Study|Withdrawal by Subject|0
7002453|NCT01400698|11068109|FG003|Overall Study|Withdrawal by Subject|4
7002454|NCT01400698|11068110|FG004|Overall Study|Withdrawal by Subject|1
7002455|NCT01400698|11068111|FG005|Overall Study|Withdrawal by Subject|3
7002456|NCT01400698|11068106|FG000|Overall Study|Protocol Violation|0
7002457|NCT01400698|11068107|FG001|Overall Study|Protocol Violation|1
7002458|NCT01400698|11068108|FG002|Overall Study|Protocol Violation|0
7002459|NCT01400698|11068109|FG003|Overall Study|Protocol Violation|0
7002460|NCT01400698|11068110|FG004|Overall Study|Protocol Violation|1
7002461|NCT01400698|11068111|FG005|Overall Study|Protocol Violation|0
7002462|NCT01400698|11068106|FG000|Overall Study|Non-compliance|0
7002463|NCT01400698|11068107|FG001|Overall Study|Non-compliance|1
7002464|NCT01400698|11068108|FG002|Overall Study|Non-compliance|0
7002465|NCT01400698|11068109|FG003|Overall Study|Non-compliance|1
7002466|NCT01400698|11068110|FG004|Overall Study|Non-compliance|0
7002467|NCT01400698|11068111|FG005|Overall Study|Non-compliance|0
7002468|NCT01400698|11068106|FG000|Overall Study|Adverse Event|1
7002469|NCT01400698|11068107|FG001|Overall Study|Adverse Event|0
7002470|NCT01400698|11068108|FG002|Overall Study|Adverse Event|0
7002471|NCT01400698|11068109|FG003|Overall Study|Adverse Event|0
7002472|NCT01400698|11068110|FG004|Overall Study|Adverse Event|0
7002473|NCT01400698|11068111|FG005|Overall Study|Adverse Event|0
7002474|NCT01400698|11068106|FG000|Overall Study|Other|4
7002475|NCT01400698|11068107|FG001|Overall Study|Other|2
7002476|NCT01400698|11068108|FG002|Overall Study|Other|0
7002477|NCT01400698|11068109|FG003|Overall Study|Other|2
7002478|NCT01400698|11068110|FG004|Overall Study|Other|1
7002479|NCT01400698|11068111|FG005|Overall Study|Other|0
7002480|NCT01400815|11068123|FG000|Overall Study|Adverse Event|3
7002481|NCT01400815|11068124|FG001|Overall Study|Adverse Event|0
7002482|NCT01400815|11068123|FG000|Overall Study|Death|0
7002483|NCT01400815|11068124|FG001|Overall Study|Death|1
7002484|NCT01400815|11068123|FG000|Overall Study|Lost to Follow-up|18
7002485|NCT01400815|11068124|FG001|Overall Study|Lost to Follow-up|11
7002486|NCT01400815|11068123|FG000|Overall Study|Protocol Violation|0
7002487|NCT01400815|11068124|FG001|Overall Study|Protocol Violation|1
7002488|NCT01400815|11068123|FG000|Overall Study|Physician Decision|1
7002489|NCT01400815|11068124|FG001|Overall Study|Physician Decision|0
7002490|NCT01400815|11068123|FG000|Overall Study|Withdrawal by Subject|15
7002491|NCT01400815|11068124|FG001|Overall Study|Withdrawal by Subject|8
7002492|NCT01400815|11068123|FG000|Overall Study|Subject in jail|1
7002493|NCT01400815|11068124|FG001|Overall Study|Subject in jail|0
7002494|NCT01400841|11068130|FG000|Initial Study Phase (6 Months)|Death|1
7002495|NCT01400841|11068130|FG000|Extended Study Phase (2 Years)|Adverse Event|2
7002496|NCT01400893|11068140|FG000|Overall Study|Death|27
7002497|NCT01400893|11068141|FG001|Overall Study|Death|21
7002498|NCT01400893|11068140|FG000|Overall Study|Lost to Follow-up|0
7002499|NCT01400893|11068141|FG001|Overall Study|Lost to Follow-up|6
7002500|NCT01400919|11068162|FG000|Overall Study|Withdrawal by Subject|4
7002501|NCT01400919|11068162|FG000|Overall Study|Lost to Follow-up|2
7002502|NCT01400919|11068162|FG000|Overall Study|Missed visit|2
7002503|NCT01400932|11068168|FG000|Overall Study|Adverse Event|10
7002504|NCT01400932|11068169|FG001|Overall Study|Adverse Event|5
7002505|NCT01400932|11068168|FG000|Overall Study|Lack of Efficacy|0
7002506|NCT01400932|11068169|FG001|Overall Study|Lack of Efficacy|3
7002507|NCT01400932|11068168|FG000|Overall Study|Withdrawal by Subject|2
7002508|NCT01400932|11068169|FG001|Overall Study|Withdrawal by Subject|6
7002509|NCT01400932|11068168|FG000|Overall Study|Lost to Follow-up|1
7002510|NCT01400932|11068169|FG001|Overall Study|Lost to Follow-up|0
7002511|NCT01400932|11068168|FG000|Overall Study|Protocol Deviation|0
7002512|NCT01400932|11068169|FG001|Overall Study|Protocol Deviation|1
7002513|NCT01400932|11068168|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1
7002514|NCT01400932|11068169|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0
7002515|NCT01400958|11068177|FG000|Overall Study|Physician Decision|0
7002516|NCT01400958|11068178|FG001|Overall Study|Physician Decision|1
7002517|NCT01400958|11068177|FG000|Overall Study|Withdrawal by Subject|0
7002518|NCT01400958|11068178|FG001|Overall Study|Withdrawal by Subject|1
7002519|NCT01400958|11068177|FG000|Overall Study|Adverse Event|1
7002520|NCT01400958|11068178|FG001|Overall Study|Adverse Event|0
7002521|NCT01400971|11068184|FG000|Overall Study|Death|82
7002522|NCT01400971|11068184|FG000|Overall Study|Lost to Follow-up|196
7002523|NCT01400971|11068184|FG000|Overall Study|Lost to follow up + Subject Decision|2
7002524|NCT01400971|11068184|FG000|Overall Study|Physician Decision|57
7002525|NCT01400971|11068184|FG000|Overall Study|Withdrawal by Subject|158
7002526|NCT01400971|11068184|FG000|Overall Study|Other|422
7002527|NCT01401010|11068190|FG000|Overall Study|Could not interpret assay results|1
7002528|NCT01401010|11068191|FG001|Overall Study|Could not interpret assay results|0
7002529|NCT01401062|11068210|FG000|Overall Study|Death|9
7002530|NCT01401062|11068211|FG001|Overall Study|Death|7
7002531|NCT01401062|11068210|FG000|Overall Study|Physician Decision|1
7002532|NCT01401062|11068211|FG001|Overall Study|Physician Decision|0
7002533|NCT01401062|11068210|FG000|Overall Study|Withdrawal by Subject|1
7002534|NCT01401062|11068211|FG001|Overall Study|Withdrawal by Subject|1
7002535|NCT01401153|11068228|FG000|First Test Day|Learning disabilities; illness|1
7002536|NCT01401153|11068229|FG001|First Test Day|Learning disabilities; illness|10
7002537|NCT01401153|11068228|FG000|Second Test Day|illness|0
7002538|NCT01401153|11068229|FG001|Second Test Day|illness|5
7002539|NCT01401283|11068277|FG000|Overall Study|surgery cancelled|5
7002540|NCT01401283|11068278|FG001|Overall Study|surgery cancelled|8
7002541|NCT01401283|11068277|FG000|Overall Study|preoperative arrhythmia|5
7002542|NCT01401283|11068278|FG001|Overall Study|preoperative arrhythmia|0
7002543|NCT01401283|11068277|FG000|Overall Study|no central venous access|0
7002544|NCT01401283|11068278|FG001|Overall Study|no central venous access|1
7002545|NCT01401283|11068277|FG000|Overall Study|suspicion of malignant hyperthermia|0
7002546|NCT01401283|11068278|FG001|Overall Study|suspicion of malignant hyperthermia|1
7002547|NCT01401322|11068284|FG000|Overall Study|Withdrawal by Subject|1
7002548|NCT01401322|11068284|FG000|Overall Study|Physician Decision|1
7002549|NCT01401361|11068288|FG000|Overall Study|Withdrawal by Subject|16
7002550|NCT01401361|11068288|FG000|Overall Study|Lack of Efficacy|6
7002551|NCT01401361|11068288|FG000|Overall Study|Physician Decision|1
7002552|NCT01401361|11068288|FG000|Overall Study|Lost to Follow-up|3
7002553|NCT01401361|11068288|FG000|Overall Study|Subject/family decision post procedure|2
7002554|NCT01401452|11068292|FG000|Overall Study|Adverse reaction|9
7002555|NCT01401452|11068292|FG000|Overall Study|Lost to Follow-up|12
7002556|NCT01401452|11068292|FG000|Overall Study|Lack of Efficacy|30
7002557|NCT01401452|11068292|FG000|Overall Study|Participant developed breast cancer|1
7002558|NCT01401452|11068292|FG000|Overall Study|Tx stopped due to financial reasons|1
7002559|NCT01401452|11068292|FG000|Overall Study|Tx stopped by psychiatrist|1
7002560|NCT01401452|11068292|FG000|Overall Study|No more visits within the 36 wk followup|4
7002561|NCT01401452|11068292|FG000|Overall Study|Subject did not come to follow up visits|2
7002562|NCT01401452|11068292|FG000|Overall Study|Subject didn't return for routine visits|1
7002563|NCT01401452|11068292|FG000|Overall Study|Subject moved to another city|1
7002564|NCT01401452|11068292|FG000|Overall Study|Subject's wife wants to get pregnant|1
7002565|NCT01401452|11068292|FG000|Overall Study|Psoriatic arthritis|1
7002566|NCT01401452|11068292|FG000|Overall Study|Participant stopped Tx|2
7002567|NCT01401452|11068292|FG000|Overall Study|Discontinuation for personal reasons|1
7002568|NCT01401452|11068292|FG000|Overall Study|Treatment failure|1
7002569|NCT01401452|11068292|FG000|Overall Study|Unsatisfactory output|1
7002570|NCT01401452|11068292|FG000|Overall Study|Subject withdrew because of Tx success|1
7002571|NCT01401452|11068292|FG000|Overall Study|Subject chose to discontinue treatment|1
7002572|NCT01401452|11068292|FG000|Overall Study|Participant withdrew consent|1
7002573|NCT01401465|11068298|FG000|Treatment Period 1|Adverse Event|4
7002574|NCT01401465|11068299|FG001|Treatment Period 1|Adverse Event|1
7002575|NCT01401465|11068298|FG000|Treatment Period 1|Pregnancy|0
7002576|NCT01401465|11068299|FG001|Treatment Period 1|Pregnancy|1
7002577|NCT01401465|11068298|FG000|Treatment Period 1|Protocol Violation|5
7002578|NCT01401465|11068299|FG001|Treatment Period 1|Protocol Violation|0
7002579|NCT01401465|11068298|FG000|Treatment Period 1|Withdrawal by Subject|1
7002580|NCT01401465|11068299|FG001|Treatment Period 1|Withdrawal by Subject|4
7002581|NCT01401465|11068298|FG000|Treatment Period 1|Non-Compliance to Study Drug|1
7002582|NCT01401465|11068299|FG001|Treatment Period 1|Non-Compliance to Study Drug|0
7002583|NCT01401465|11068298|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3
7002584|NCT01401465|11068299|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9
7002585|NCT01401465|11068298|FG000|Treatment Period 1|Scheduling Difficulties|1
7002586|NCT01401465|11068299|FG001|Treatment Period 1|Scheduling Difficulties|1
7002587|NCT01401465|11068298|FG000|Treatment Period 2|Lost to Follow-up|0
7002588|NCT01401465|11068299|FG001|Treatment Period 2|Lost to Follow-up|1
7002589|NCT01401465|11068298|FG000|Treatment Period 2|Withdrawal by Subject|0
7002590|NCT01401465|11068299|FG001|Treatment Period 2|Withdrawal by Subject|1
7002591|NCT01401478|11068308|FG000|Overall Study|Study drug not available|6
7002592|NCT01401478|11068308|FG000|Overall Study|Adverse Event|5
7002593|NCT01401478|11068308|FG000|Overall Study|Hyperphosphatemia|5
7002594|NCT01401478|11068308|FG000|Overall Study|Lost to Follow-up|5
7002595|NCT01401478|11068308|FG000|Overall Study|Kidney transplantation|3
7002596|NCT01401478|11068308|FG000|Overall Study|Withdrawal by Subject|3
7002597|NCT01401478|11068308|FG000|Overall Study|Blood samples not available|1
7002598|NCT01401478|11068308|FG000|Overall Study|Hyperphosphatemia and adverse event|1
7002599|NCT01401478|11068308|FG000|Overall Study|Low intact parathyroid hormone|1
7002600|NCT01401478|11068308|FG000|Overall Study|Serious adverse event|1
7002601|NCT01401530|11068328|FG000|Overall Study|Disease Progression|1
7002602|NCT01401530|11068329|FG001|Overall Study|Disease Progression|2
7002603|NCT01401530|11068330|FG002|Overall Study|Disease Progression|1
7002604|NCT01401530|11068328|FG000|Overall Study|Adverse Event|1
7002605|NCT01401530|11068329|FG001|Overall Study|Adverse Event|1
7002606|NCT01401530|11068330|FG002|Overall Study|Adverse Event|1
7002607|NCT01401530|11068328|FG000|Overall Study|Participant Choice|1
7002608|NCT01401530|11068329|FG001|Overall Study|Participant Choice|2
7002609|NCT01401530|11068330|FG002|Overall Study|Participant Choice|1
7002610|NCT01401530|11068328|FG000|Overall Study|Physician Decision|0
7002611|NCT01401530|11068329|FG001|Overall Study|Physician Decision|1
7002612|NCT01401530|11068330|FG002|Overall Study|Physician Decision|0
7002613|NCT01401647|11068382|FG000|Overall Study|Withdrawal by Subject|1
7002614|NCT01401647|11068383|FG001|Overall Study|Withdrawal by Subject|5
7002615|NCT01401647|11068384|FG002|Overall Study|Withdrawal by Subject|2
7002616|NCT01401647|11068382|FG000|Overall Study|Lost to Follow-up|3
7002617|NCT01401647|11068383|FG001|Overall Study|Lost to Follow-up|3
7002618|NCT01401647|11068384|FG002|Overall Study|Lost to Follow-up|1
7002619|NCT01401842|11068398|FG000|Overall Study|Withdrawal by Subject|3
7002620|NCT01401842|11068399|FG001|Overall Study|Withdrawal by Subject|2
7002621|NCT01401842|11068398|FG000|Overall Study|academic reason|4
7002622|NCT01401842|11068399|FG001|Overall Study|academic reason|1
7002623|NCT01401842|11068398|FG000|Overall Study|changed companies|20
7002624|NCT01401842|11068399|FG001|Overall Study|changed companies|34
7002625|NCT01401842|11068398|FG000|Overall Study|discharged from US Army|3
7002626|NCT01401842|11068399|FG001|Overall Study|discharged from US Army|4
7002627|NCT01401842|11068398|FG000|Overall Study|invalid follow-up strength data|1
7002628|NCT01401842|11068399|FG001|Overall Study|invalid follow-up strength data|4
7002629|NCT01401842|11068398|FG000|Overall Study|on profile|9
7002630|NCT01401842|11068399|FG001|Overall Study|on profile|5
7002631|NCT01401842|11068398|FG000|Overall Study|other/unknown|28
7002632|NCT01401842|11068399|FG001|Overall Study|other/unknown|17
7002633|NCT01401959|11068419|FG000|Enrolled|Withdrawal by Subject|1
7002634|NCT01401959|11068420|FG001|Enrolled|Withdrawal by Subject|0
7002635|NCT01401959|11068421|FG002|Enrolled|Withdrawal by Subject|0
7002636|NCT01401959|11068419|FG000|Treated|Disease Progression|2
7002637|NCT01401959|11068420|FG001|Treated|Disease Progression|2
7002638|NCT01401959|11068421|FG002|Treated|Disease Progression|1
7002639|NCT01401959|11068419|FG000|Treated|Adverse Event|4
7002640|NCT01401959|11068420|FG001|Treated|Adverse Event|3
7002641|NCT01401959|11068421|FG002|Treated|Adverse Event|2
7002642|NCT01401959|11068419|FG000|Treated|Withdrawal by Subject|1
7002643|NCT01401959|11068420|FG001|Treated|Withdrawal by Subject|2
7002644|NCT01401959|11068421|FG002|Treated|Withdrawal by Subject|2
7002645|NCT01401959|11068419|FG000|Treated|Protocol Violation|0
7002646|NCT01401959|11068420|FG001|Treated|Protocol Violation|1
7002647|NCT01401959|11068421|FG002|Treated|Protocol Violation|0
7002648|NCT01402011|11068434|FG000|Delayed Treatment Period|Withdrawal by Subject|1
7002649|NCT01402011|11068435|FG001|Delayed Treatment Period|Withdrawal by Subject|0
7002650|NCT01402011|11068436|FG002|Delayed Treatment Period|Withdrawal by Subject|0
7002651|NCT01402011|11068434|FG000|Active Treatment Period|Withdrawal by Subject|1
7002652|NCT01402011|11068435|FG001|Active Treatment Period|Withdrawal by Subject|3
7002653|NCT01402011|11068436|FG002|Active Treatment Period|Withdrawal by Subject|0
7002654|NCT01402011|11068434|FG000|Nine Month Follow-up|Withdrawal by Subject|0
7002655|NCT01402011|11068435|FG001|Nine Month Follow-up|Withdrawal by Subject|1
7002656|NCT01402011|11068436|FG002|Nine Month Follow-up|Withdrawal by Subject|0
7002657|NCT01402063|11068458|FG000|Overall Study|Withdrawal by Subject|3
7002658|NCT01402063|11068459|FG001|Overall Study|Withdrawal by Subject|3
7002659|NCT01402102|11068467|FG000|Overall Study|Protocol Violation|1
7002660|NCT01402102|11068468|FG001|Overall Study|Protocol Violation|0
7002661|NCT01402102|11068467|FG000|Overall Study|Insufficiency of compliance|1
7002662|NCT01402102|11068468|FG001|Overall Study|Insufficiency of compliance|1
7002663|NCT01402102|11068467|FG000|Overall Study|Withdrawal by Subject|0
7002664|NCT01402102|11068468|FG001|Overall Study|Withdrawal by Subject|2
7002665|NCT01402284|11068504|FG000|Overall Study|Withdrawal consent|2
7002666|NCT01402284|11068504|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1
7002667|NCT01402284|11068504|FG000|Overall Study|Physician Decision|1
7002668|NCT01402284|11068504|FG000|Overall Study|Disease progression on study|10
7002669|NCT01402492|11068545|FG000|Overall Study|Withdrawal by Subject|17
7002670|NCT01402492|11068546|FG001|Overall Study|Withdrawal by Subject|11
7002671|NCT01402492|11068547|FG002|Overall Study|Withdrawal by Subject|11
7002672|NCT01402492|11068545|FG000|Overall Study|Adverse Event|2
7002673|NCT01402492|11068546|FG001|Overall Study|Adverse Event|3
7002674|NCT01402492|11068547|FG002|Overall Study|Adverse Event|4
7002675|NCT01402492|11068545|FG000|Overall Study|Physician Decision|0
7002676|NCT01402492|11068546|FG001|Overall Study|Physician Decision|3
7002677|NCT01402492|11068547|FG002|Overall Study|Physician Decision|0
7002678|NCT01402492|11068545|FG000|Overall Study|Incarcerated (N=3)|2
7002679|NCT01402492|11068546|FG001|Overall Study|Incarcerated (N=3)|0
7002680|NCT01402492|11068547|FG002|Overall Study|Incarcerated (N=3)|1
7002681|NCT01402544|11068555|FG000|Overall Study|Withdrawal by Subject|6
7002682|NCT01402570|11068559|FG000|Overall Study|Adverse Event|1
7002683|NCT01402700|11068564|FG000|Overall Study|Death|3
7002684|NCT01402700|11068564|FG000|Overall Study|Withdrawal by Subject|3
7002685|NCT01402700|11068564|FG000|Overall Study|Missed Visit|1
7002686|NCT01402817|11068568|FG000|Overall Study|Withdrawal by Subject|3
7002687|NCT01402817|11068568|FG000|Overall Study|Study Suspended by FDA|8
7002688|NCT01402869|11068576|FG000|Overall Study|Required Tooth Extraction|0
7002689|NCT01402869|11068577|FG001|Overall Study|Required Tooth Extraction|0
7002690|NCT01402869|11068578|FG002|Overall Study|Required Tooth Extraction|1
7002691|NCT01402947|11068588|FG000|First Intervention|Adverse Event|0
7002692|NCT01402947|11068589|FG001|First Intervention|Adverse Event|1
7002693|NCT01402986|11068599|FG000|Overall Study|Withdrawal by Subject|7
7002694|NCT01402986|11068600|FG001|Overall Study|Withdrawal by Subject|10
7002695|NCT01402986|11068601|FG002|Overall Study|Withdrawal by Subject|7
7002696|NCT01402986|11068602|FG003|Overall Study|Withdrawal by Subject|13
7002697|NCT01402986|11068599|FG000|Overall Study|Death|0
7002698|NCT01402986|11068600|FG001|Overall Study|Death|0
7002699|NCT01402986|11068601|FG002|Overall Study|Death|0
7002700|NCT01402986|11068602|FG003|Overall Study|Death|2
7002701|NCT01402986|11068599|FG000|Overall Study|Lost to Follow-up|0
7002702|NCT01402986|11068600|FG001|Overall Study|Lost to Follow-up|0
7002703|NCT01402986|11068601|FG002|Overall Study|Lost to Follow-up|0
7002704|NCT01402986|11068602|FG003|Overall Study|Lost to Follow-up|1
7002705|NCT01402986|11068599|FG000|Overall Study|Other|2
7002706|NCT01402986|11068600|FG001|Overall Study|Other|5
7002707|NCT01402986|11068601|FG002|Overall Study|Other|1
7002708|NCT01402986|11068602|FG003|Overall Study|Other|6
7002709|NCT01403051|11068614|FG000|Overall Study|Protocol Violation|2
7002710|NCT01403051|11068615|FG001|Overall Study|Protocol Violation|0
7002711|NCT01403051|11068614|FG000|Overall Study|Death|1
7002712|NCT01403051|11068615|FG001|Overall Study|Death|0
7002713|NCT01403051|11068614|FG000|Overall Study|Withdrawal by Subject|2
7002714|NCT01403051|11068615|FG001|Overall Study|Withdrawal by Subject|1
7002715|NCT01403051|11068614|FG000|Overall Study|Lost to Follow-up|5
7002716|NCT01403051|11068615|FG001|Overall Study|Lost to Follow-up|5
7002717|NCT01403064|11068626|FG000|Overall Study|Death|0
7002718|NCT01403064|11068627|FG001|Overall Study|Death|0
7002719|NCT01403064|11068628|FG002|Overall Study|Death|1
7002720|NCT01403064|11068629|FG003|Overall Study|Death|1
7002721|NCT01403064|11068626|FG000|Overall Study|Withdrawal by Subject|0
7002722|NCT01403064|11068627|FG001|Overall Study|Withdrawal by Subject|0
7002723|NCT01403064|11068628|FG002|Overall Study|Withdrawal by Subject|1
7002724|NCT01403064|11068629|FG003|Overall Study|Withdrawal by Subject|1
7002725|NCT01403064|11068626|FG000|Overall Study|Other|1
7002726|NCT01403064|11068627|FG001|Overall Study|Other|0
7002727|NCT01403064|11068628|FG002|Overall Study|Other|2
7002728|NCT01403064|11068629|FG003|Overall Study|Other|1
7002729|NCT01403116|11068650|FG000|Overall Study|Adverse Event|7
7002730|NCT01403116|11068651|FG001|Overall Study|Adverse Event|4
7002731|NCT01403116|11068650|FG000|Overall Study|Lost to Follow-up|7
7002732|NCT01403116|11068651|FG001|Overall Study|Lost to Follow-up|5
7002733|NCT01403116|11068650|FG000|Overall Study|Withdrawal by Subject|12
7002734|NCT01403116|11068651|FG001|Overall Study|Withdrawal by Subject|15
7002735|NCT01403116|11068650|FG000|Overall Study|Non-compliance of study drug|3
7002736|NCT01403116|11068651|FG001|Overall Study|Non-compliance of study drug|0
7002737|NCT01403116|11068650|FG000|Overall Study|Protocol Violation|0
7002738|NCT01403116|11068651|FG001|Overall Study|Protocol Violation|1
7002739|NCT01403116|11068650|FG000|Overall Study|undisclosed Hx of Prostate Ca|1
7002740|NCT01403116|11068651|FG001|Overall Study|undisclosed Hx of Prostate Ca|0
7002741|NCT01403116|11068650|FG000|Overall Study|Hct >54%|2
7002742|NCT01403116|11068651|FG001|Overall Study|Hct >54%|0
7002743|NCT01403116|11068650|FG000|Overall Study|unable to keep appointments|0
7002744|NCT01403116|11068651|FG001|Overall Study|unable to keep appointments|2
7002745|NCT01403610|11068691|FG000|Overall Study|Withdrawal by Subject|2
7002746|NCT01403610|11068692|FG001|Overall Study|Withdrawal by Subject|0
7002747|NCT01403610|11068693|FG002|Overall Study|Withdrawal by Subject|0
7002748|NCT01403610|11068694|FG003|Overall Study|Withdrawal by Subject|0
7002749|NCT01403610|11068691|FG000|Overall Study|Didn't recover from surgery sufficiently|0
7002750|NCT01403610|11068692|FG001|Overall Study|Didn't recover from surgery sufficiently|3
7002751|NCT01403610|11068693|FG002|Overall Study|Didn't recover from surgery sufficiently|0
7002752|NCT01403610|11068694|FG003|Overall Study|Didn't recover from surgery sufficiently|0
7002753|NCT01403805|11068706|FG000|Overall Study|Withdrawal by Subject|0
7002754|NCT01403805|11068707|FG001|Overall Study|Withdrawal by Subject|4
7002755|NCT01403805|11068706|FG000|Overall Study|Lost to Follow-up|0
7002756|NCT01403805|11068707|FG001|Overall Study|Lost to Follow-up|2
7002757|NCT01403805|11068706|FG000|Overall Study|Death|0
7002758|NCT01403805|11068707|FG001|Overall Study|Death|1
7002759|NCT01403987|11068720|FG000|Overall Study|Residents forgot their secret PIN|18
7002760|NCT01403987|11068721|FG001|Overall Study|Residents forgot their secret PIN|17
7002761|NCT01403987|11068722|FG002|Overall Study|Residents forgot their secret PIN|18
7002762|NCT01404208|11068786|FG000|Overall Study|Discontinued|3
7002763|NCT01404208|11068787|FG001|Overall Study|Discontinued|0
7002764|NCT01404234|11068793|FG000|Overall Study|Withdrawal by Subject|2
7002765|NCT01404325|11068808|FG000|Overall Study|Lost to Follow-up|1
7002766|NCT01404325|11068809|FG001|Overall Study|Lost to Follow-up|0
7002767|NCT01404325|11068808|FG000|Overall Study|Death|2
7002768|NCT01404325|11068809|FG001|Overall Study|Death|0
7002769|NCT01404325|11068808|FG000|Overall Study|Graft loss/Retransplantation|1
7002770|NCT01404325|11068809|FG001|Overall Study|Graft loss/Retransplantation|0
7002771|NCT01404325|11068808|FG000|Overall Study|non-specified reason|0
7002772|NCT01404325|11068809|FG001|Overall Study|non-specified reason|2
7002773|NCT01404949|11068885|FG000|Overall Study|Not Treated|1
7002774|NCT01404988|11068892|FG000|Overall Study|Death|2
7002775|NCT01404988|11068893|FG001|Overall Study|Death|0
7002776|NCT01404988|11068894|FG002|Overall Study|Death|2
7002777|NCT01404988|11068892|FG000|Overall Study|Adverse Event|1
7002778|NCT01404988|11068893|FG001|Overall Study|Adverse Event|0
7002779|NCT01404988|11068894|FG002|Overall Study|Adverse Event|0
7002780|NCT01404988|11068892|FG000|Overall Study|Withdrawal by Subject|2
7002781|NCT01404988|11068893|FG001|Overall Study|Withdrawal by Subject|2
7002782|NCT01404988|11068894|FG002|Overall Study|Withdrawal by Subject|0
7002783|NCT01404988|11068892|FG000|Overall Study|Lost to Follow-up|1
7002784|NCT01404988|11068893|FG001|Overall Study|Lost to Follow-up|2
7002785|NCT01404988|11068894|FG002|Overall Study|Lost to Follow-up|1
7002786|NCT01405027|11068907|FG000|Overall Study|Withdrawn consent|3
7002787|NCT01405027|11068908|FG001|Overall Study|Withdrawn consent|0
7002788|NCT01405027|11068907|FG000|Overall Study|Lost to Follow-up|16
7002789|NCT01405027|11068908|FG001|Overall Study|Lost to Follow-up|24
7002790|NCT01405027|11068907|FG000|Overall Study|Investigator judgement|0
7002791|NCT01405027|11068908|FG001|Overall Study|Investigator judgement|2
7002792|NCT01405027|11068907|FG000|Overall Study|Death|1
7002793|NCT01405027|11068908|FG001|Overall Study|Death|0
7002794|NCT01405027|11068907|FG000|Overall Study|Other or Unknown|12
7002795|NCT01405027|11068908|FG001|Overall Study|Other or Unknown|25
7002796|NCT01405053|11068918|FG000|Overall Study|Adverse Event|3
7002797|NCT01405053|11068919|FG001|Overall Study|Adverse Event|0
7002798|NCT01405053|11068918|FG000|Overall Study|Lost to Follow-up|0
7002799|NCT01405053|11068919|FG001|Overall Study|Lost to Follow-up|1
7002800|NCT01405053|11068918|FG000|Overall Study|Participant choice|2
7002801|NCT01405053|11068919|FG001|Overall Study|Participant choice|1
7002802|NCT01405053|11068918|FG000|Overall Study|Inadequate therapeutic effect|2
7002803|NCT01405053|11068919|FG001|Overall Study|Inadequate therapeutic effect|1
7002804|NCT01405053|11068918|FG000|Overall Study|Withdrawal by Subject|3
7002805|NCT01405053|11068919|FG001|Overall Study|Withdrawal by Subject|4
7002806|NCT01405053|11068918|FG000|Overall Study|Other|0
7002807|NCT01405053|11068919|FG001|Overall Study|Other|1
7002808|NCT01405196|11068929|FG000|Overall Study|Study Terminated by Sponsor|0
7002809|NCT01405196|11068930|FG001|Overall Study|Study Terminated by Sponsor|0
7002810|NCT01405196|11068931|FG002|Overall Study|Study Terminated by Sponsor|9
7002811|NCT01405196|11068932|FG003|Overall Study|Study Terminated by Sponsor|0
7002812|NCT01405196|11068929|FG000|Overall Study|Other|2
7002813|NCT01405196|11068930|FG001|Overall Study|Other|2
7002814|NCT01405196|11068931|FG002|Overall Study|Other|5
7002815|NCT01405196|11068932|FG003|Overall Study|Other|0
7002816|NCT01405196|11068929|FG000|Overall Study|Withdrawal by Subject|4
7002817|NCT01405196|11068930|FG001|Overall Study|Withdrawal by Subject|6
7002818|NCT01405196|11068931|FG002|Overall Study|Withdrawal by Subject|3
7002819|NCT01405196|11068932|FG003|Overall Study|Withdrawal by Subject|6
7002820|NCT01405196|11068929|FG000|Overall Study|Adverse Event|2
7002821|NCT01405196|11068930|FG001|Overall Study|Adverse Event|2
7002822|NCT01405196|11068931|FG002|Overall Study|Adverse Event|0
7002823|NCT01405196|11068932|FG003|Overall Study|Adverse Event|2
7002824|NCT01405196|11068929|FG000|Overall Study|Death|1
7002825|NCT01405196|11068930|FG001|Overall Study|Death|0
7002826|NCT01405196|11068931|FG002|Overall Study|Death|3
7002827|NCT01405196|11068932|FG003|Overall Study|Death|0
7002828|NCT01405196|11068929|FG000|Overall Study|Lost to Follow-up|2
7002829|NCT01405196|11068930|FG001|Overall Study|Lost to Follow-up|2
7002830|NCT01405196|11068931|FG002|Overall Study|Lost to Follow-up|3
7002831|NCT01405196|11068932|FG003|Overall Study|Lost to Follow-up|1
7002832|NCT01405456|11068953|FG000|Overall Study|Lost to Follow-up|2
7002833|NCT01405456|11068954|FG001|Overall Study|Lost to Follow-up|1
7002834|NCT01405456|11068953|FG000|Overall Study|Physician Decision|1
7002835|NCT01405456|11068954|FG001|Overall Study|Physician Decision|0
7002836|NCT01405508|11068969|FG000|Overall Study|AE, non-serious non-fatal|1
7002837|NCT01405508|11068970|FG001|Overall Study|AE, non-serious non-fatal|1
7002838|NCT01405508|11068971|FG002|Overall Study|AE, non-serious non-fatal|0
7002839|NCT01405508|11068972|FG003|Overall Study|AE, non-serious non-fatal|0
7002840|NCT01405560|11068982|FG000|Overall Study|Physician Decision|1
7002841|NCT01405742|11068986|FG000|Overall Study|Lost to Follow-up|1
7002842|NCT01405742|11068987|FG001|Overall Study|Lost to Follow-up|0
7002843|NCT01405768|11068995|FG000|Overall Study|Didn't complete questionnaire correctly|4
7002844|NCT01405768|11068996|FG001|Overall Study|Didn't complete questionnaire correctly|0
7002845|NCT01405820|11069014|FG000|Randomized Treatment Period|Adverse Event|3
7002846|NCT01405820|11069015|FG001|Randomized Treatment Period|Adverse Event|3
7002847|NCT01405820|11069016|FG002|Randomized Treatment Period|Adverse Event|3
7002848|NCT01405820|11069017|FG003|Randomized Treatment Period|Adverse Event|0
7002849|NCT01405820|11069018|FG004|Randomized Treatment Period|Adverse Event|2
7002850|NCT01405820|11069019|FG005|Randomized Treatment Period|Adverse Event|1
7002851|NCT01405820|11069014|FG000|Randomized Treatment Period|Withdrawal by Subject|6
7002852|NCT01405820|11069015|FG001|Randomized Treatment Period|Withdrawal by Subject|2
7002853|NCT01405820|11069016|FG002|Randomized Treatment Period|Withdrawal by Subject|2
7002854|NCT01405820|11069017|FG003|Randomized Treatment Period|Withdrawal by Subject|2
7002855|NCT01405820|11069018|FG004|Randomized Treatment Period|Withdrawal by Subject|0
7002856|NCT01405820|11069019|FG005|Randomized Treatment Period|Withdrawal by Subject|0
7002857|NCT01405820|11069014|FG000|Randomized Treatment Period|Other|2
7002858|NCT01405820|11069015|FG001|Randomized Treatment Period|Other|2
7002859|NCT01405820|11069016|FG002|Randomized Treatment Period|Other|1
7002860|NCT01405820|11069017|FG003|Randomized Treatment Period|Other|1
7002861|NCT01405820|11069018|FG004|Randomized Treatment Period|Other|0
7002862|NCT01405820|11069019|FG005|Randomized Treatment Period|Other|0
7002863|NCT01405820|11069014|FG000|Randomized Treatment Period|Physician Decision|0
7002864|NCT01405820|11069015|FG001|Randomized Treatment Period|Physician Decision|2
7002865|NCT01405820|11069016|FG002|Randomized Treatment Period|Physician Decision|1
7002866|NCT01405820|11069017|FG003|Randomized Treatment Period|Physician Decision|0
7002867|NCT01405820|11069018|FG004|Randomized Treatment Period|Physician Decision|0
7002868|NCT01405820|11069019|FG005|Randomized Treatment Period|Physician Decision|0
7002869|NCT01405820|11069014|FG000|Randomized Treatment Period|Rescue|0
7002870|NCT01405820|11069015|FG001|Randomized Treatment Period|Rescue|1
7002871|NCT01405820|11069016|FG002|Randomized Treatment Period|Rescue|13
7002872|NCT01405820|11069017|FG003|Randomized Treatment Period|Rescue|10
7002873|NCT01405820|11069018|FG004|Randomized Treatment Period|Rescue|8
7002874|NCT01405820|11069019|FG005|Randomized Treatment Period|Rescue|8
7002875|NCT01405820|11069014|FG000|Randomized Treatment Period|Incorrect Study Treatment|0
7002876|NCT01405820|11069015|FG001|Randomized Treatment Period|Incorrect Study Treatment|0
7002877|NCT01405820|11069016|FG002|Randomized Treatment Period|Incorrect Study Treatment|3
7002878|NCT01405820|11069017|FG003|Randomized Treatment Period|Incorrect Study Treatment|0
7002879|NCT01405820|11069018|FG004|Randomized Treatment Period|Incorrect Study Treatment|2
7002880|NCT01405820|11069019|FG005|Randomized Treatment Period|Incorrect Study Treatment|0
7002881|NCT01405820|11069014|FG000|Randomized Treatment Period|Treatment Arm Closed|0
7002882|NCT01405820|11069015|FG001|Randomized Treatment Period|Treatment Arm Closed|0
7002883|NCT01405820|11069016|FG002|Randomized Treatment Period|Treatment Arm Closed|20
7002884|NCT01405820|11069017|FG003|Randomized Treatment Period|Treatment Arm Closed|36
7002885|NCT01405820|11069018|FG004|Randomized Treatment Period|Treatment Arm Closed|33
7002886|NCT01405820|11069019|FG005|Randomized Treatment Period|Treatment Arm Closed|28
7002887|NCT01405820|11069014|FG000|Randomized Treatment Period|Death|0
7002888|NCT01405820|11069015|FG001|Randomized Treatment Period|Death|0
7002889|NCT01405820|11069016|FG002|Randomized Treatment Period|Death|0
7002890|NCT01405820|11069017|FG003|Randomized Treatment Period|Death|1
7002891|NCT01405820|11069018|FG004|Randomized Treatment Period|Death|0
7002892|NCT01405820|11069019|FG005|Randomized Treatment Period|Death|0
7002893|NCT01405820|11069014|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0
7002894|NCT01405820|11069015|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0
7002895|NCT01405820|11069016|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0
7002896|NCT01405820|11069017|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1
7002897|NCT01405820|11069018|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0
7002898|NCT01405820|11069019|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0
7002899|NCT01405820|11069014|FG000|Open-Label Treatment Period|Withdrawal by Subject|3
7002900|NCT01405820|11069015|FG001|Open-Label Treatment Period|Withdrawal by Subject|1
7002901|NCT01405820|11069016|FG002|Open-Label Treatment Period|Withdrawal by Subject|1
7002902|NCT01405820|11069017|FG003|Open-Label Treatment Period|Withdrawal by Subject|1
7002903|NCT01405820|11069018|FG004|Open-Label Treatment Period|Withdrawal by Subject|0
7002904|NCT01405820|11069019|FG005|Open-Label Treatment Period|Withdrawal by Subject|1
7002905|NCT01405820|11069014|FG000|Open-Label Treatment Period|Other|1
7002906|NCT01405820|11069015|FG001|Open-Label Treatment Period|Other|1
7002907|NCT01405820|11069016|FG002|Open-Label Treatment Period|Other|1
7002908|NCT01405820|11069017|FG003|Open-Label Treatment Period|Other|1
7002909|NCT01405820|11069018|FG004|Open-Label Treatment Period|Other|1
7002910|NCT01405820|11069019|FG005|Open-Label Treatment Period|Other|1
7002911|NCT01405820|11069014|FG000|Open-Label Treatment Period|Physician Decision|0
7002912|NCT01405820|11069015|FG001|Open-Label Treatment Period|Physician Decision|0
7002913|NCT01405820|11069016|FG002|Open-Label Treatment Period|Physician Decision|1
7002914|NCT01405820|11069017|FG003|Open-Label Treatment Period|Physician Decision|2
7002915|NCT01405820|11069018|FG004|Open-Label Treatment Period|Physician Decision|1
7002916|NCT01405820|11069019|FG005|Open-Label Treatment Period|Physician Decision|0
7002917|NCT01405820|11069014|FG000|Open-Label Treatment Period|Adverse Event|0
7002918|NCT01405820|11069015|FG001|Open-Label Treatment Period|Adverse Event|0
7002919|NCT01405820|11069016|FG002|Open-Label Treatment Period|Adverse Event|0
7002920|NCT01405820|11069017|FG003|Open-Label Treatment Period|Adverse Event|1
7002921|NCT01405820|11069018|FG004|Open-Label Treatment Period|Adverse Event|0
7002922|NCT01405820|11069019|FG005|Open-Label Treatment Period|Adverse Event|0
7002923|NCT01405898|11069041|FG000|Overall Study|Withdrawal by Subject|2
7002924|NCT01405898|11069042|FG001|Overall Study|Withdrawal by Subject|2
7002925|NCT01405911|11069051|FG000|Overall Study|Pre-treatment lab AE|0
7002926|NCT01405911|11069052|FG001|Overall Study|Pre-treatment lab AE|1
7002927|NCT01405911|11069053|FG002|Overall Study|Pre-treatment lab AE|0
7002928|NCT01405911|11069051|FG000|Overall Study|Lost to Follow-up|0
7002929|NCT01405911|11069052|FG001|Overall Study|Lost to Follow-up|1
7002930|NCT01405911|11069053|FG002|Overall Study|Lost to Follow-up|0
7002931|NCT01405911|11069051|FG000|Overall Study|Protocol Violation|1
7002932|NCT01405911|11069052|FG001|Overall Study|Protocol Violation|0
7002933|NCT01405911|11069053|FG002|Overall Study|Protocol Violation|0
7002934|NCT01405911|11069051|FG000|Overall Study|Withdrawal by Subject|3
7002935|NCT01405911|11069052|FG001|Overall Study|Withdrawal by Subject|1
7002936|NCT01405911|11069053|FG002|Overall Study|Withdrawal by Subject|1
7002937|NCT01405924|11069061|FG000|Overall Study|Protocol Violation|8
7002938|NCT01405924|11069061|FG000|Overall Study|Missing/Incomplete Data|2
7002939|NCT01405950|11069078|FG000|Overall Study|Withdrawal by Subject|1
7002940|NCT01405950|11069079|FG001|Overall Study|Withdrawal by Subject|0
7002941|NCT01405950|11069080|FG002|Overall Study|Withdrawal by Subject|0
7002942|NCT01405950|11069081|FG003|Overall Study|Withdrawal by Subject|0
7042876|NCT01738594|11127420|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0
7042877|NCT01738594|11127421|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0
7042878|NCT01738594|11127422|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0
7042879|NCT01738594|11127423|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1
7042880|NCT01738594|11127424|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0
7042881|NCT01738594|11127425|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0
7042882|NCT01738594|11127418|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0
7042883|NCT01738594|11127419|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0
7042884|NCT01738594|11127420|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0
7042885|NCT01738594|11127421|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0
7042886|NCT01738594|11127422|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0
7042887|NCT01738594|11127423|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1
7042888|NCT01738594|11127424|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0
7042889|NCT01738594|11127425|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0
7042890|NCT01738594|11127418|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
7042891|NCT01738594|11127419|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
7042892|NCT01738594|11127420|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
7042893|NCT01738594|11127421|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
7042894|NCT01738594|11127422|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1
7042895|NCT01738594|11127423|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
7042896|NCT01738594|11127424|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
7042897|NCT01738594|11127425|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
7042898|NCT01738594|11127418|FG000|Follow up for 1 Year|Death|0
7042899|NCT01738594|11127419|FG001|Follow up for 1 Year|Death|0
7042900|NCT01738594|11127420|FG002|Follow up for 1 Year|Death|0
7042901|NCT01738594|11127421|FG003|Follow up for 1 Year|Death|0
7042902|NCT01738594|11127422|FG004|Follow up for 1 Year|Death|0
7042903|NCT01738594|11127423|FG005|Follow up for 1 Year|Death|1
7042904|NCT01738594|11127424|FG006|Follow up for 1 Year|Death|0
7042905|NCT01738594|11127425|FG007|Follow up for 1 Year|Death|0
7042906|NCT01738594|11127418|FG000|Follow up for 1 Year|Other|0
7042907|NCT01738594|11127419|FG001|Follow up for 1 Year|Other|0
7042908|NCT01738594|11127420|FG002|Follow up for 1 Year|Other|0
7042909|NCT01738594|11127421|FG003|Follow up for 1 Year|Other|0
7042910|NCT01738594|11127422|FG004|Follow up for 1 Year|Other|0
7042911|NCT01738594|11127423|FG005|Follow up for 1 Year|Other|2
7042912|NCT01738594|11127424|FG006|Follow up for 1 Year|Other|0
7042913|NCT01738594|11127425|FG007|Follow up for 1 Year|Other|0
7042914|NCT01738646|11127435|FG000|Overall Study|Still Receiving Treatment|2
7042915|NCT01738919|11127478|FG000|Overall Study|Lost to Follow-up|1
7042916|NCT01738919|11127479|FG001|Overall Study|Lost to Follow-up|0
7042917|NCT01738919|11127478|FG000|Overall Study|Immigrated|0
7042918|NCT01738919|11127479|FG001|Overall Study|Immigrated|1
7042919|NCT01738919|11127478|FG000|Overall Study|Withdrawal by Subject|0
7042920|NCT01738919|11127479|FG001|Overall Study|Withdrawal by Subject|1
7042921|NCT01738919|11127478|FG000|Overall Study|Not treated in accordance to guidelines|0
7042922|NCT01738919|11127479|FG001|Overall Study|Not treated in accordance to guidelines|1
7042923|NCT01738971|11127490|FG000|Overall Study|Lost to Follow-up|19
7042924|NCT01738971|11127491|FG001|Overall Study|Lost to Follow-up|30
7042925|NCT01738971|11127492|FG002|Overall Study|Lost to Follow-up|17
7042926|NCT01738984|11127502|FG000|Overall Study|Pregnancy|4
7042927|NCT01738984|11127503|FG001|Overall Study|Pregnancy|0
7042928|NCT01738984|11127502|FG000|Overall Study|Withdrawal by Subject|1
7042929|NCT01738984|11127503|FG001|Overall Study|Withdrawal by Subject|0
7042930|NCT01738984|11127502|FG000|Overall Study|Lost to Follow-up|59
7042931|NCT01738984|11127503|FG001|Overall Study|Lost to Follow-up|39
7042932|NCT01739309|11127536|FG000|Overall Study|On study treatment|3
7042933|NCT01739335|11127544|FG000|Overall Study|Lost to Follow-up|7
7002943|NCT01406015|11069091|FG000|Overall Study|Withdrawal by Subject|3
7002944|NCT01406015|11069092|FG001|Overall Study|Withdrawal by Subject|3
7002945|NCT01406574|11069128|FG000|Overall Study|Adverse Event|0
7002946|NCT01406574|11069129|FG001|Overall Study|Adverse Event|0
7002947|NCT01406574|11069130|FG002|Overall Study|Adverse Event|1
7002948|NCT01406574|11069131|FG003|Overall Study|Adverse Event|3
7002949|NCT01406574|11069128|FG000|Overall Study|Physician Decision|0
7002950|NCT01406574|11069129|FG001|Overall Study|Physician Decision|0
7002951|NCT01406574|11069130|FG002|Overall Study|Physician Decision|0
7002952|NCT01406574|11069131|FG003|Overall Study|Physician Decision|1
7002953|NCT01406574|11069128|FG000|Overall Study|Withdrawal by Subject|0
7002954|NCT01406574|11069129|FG001|Overall Study|Withdrawal by Subject|1
7002955|NCT01406574|11069130|FG002|Overall Study|Withdrawal by Subject|0
7002956|NCT01406574|11069131|FG003|Overall Study|Withdrawal by Subject|0
7002957|NCT01406574|11069128|FG000|Overall Study|Definite progression of primary disease|1
7002958|NCT01406574|11069129|FG001|Overall Study|Definite progression of primary disease|0
7002959|NCT01406574|11069130|FG002|Overall Study|Definite progression of primary disease|0
7002960|NCT01406574|11069131|FG003|Overall Study|Definite progression of primary disease|0
7002961|NCT01406652|11069144|FG000|Overall Study|Lost-to-follow-up|3
7002962|NCT01406652|11069145|FG001|Overall Study|Lost-to-follow-up|4
7002963|NCT01406652|11069144|FG000|Overall Study|Withdrawal by Subject|2
7002964|NCT01406652|11069145|FG001|Overall Study|Withdrawal by Subject|2
7002965|NCT01406652|11069144|FG000|Overall Study|Insufficient follow-up|5
7002966|NCT01406652|11069145|FG001|Overall Study|Insufficient follow-up|4
7002967|NCT01406652|11069144|FG000|Overall Study|Infection not sure|10
7002968|NCT01406652|11069145|FG001|Overall Study|Infection not sure|10
7002969|NCT01406717|11069155|FG000|Overall Study|Subject non-compliance|4
7002970|NCT01406717|11069156|FG001|Overall Study|Subject non-compliance|3
7002971|NCT01406717|11069155|FG000|Overall Study|Protocol Violation|5
7002972|NCT01406717|11069156|FG001|Overall Study|Protocol Violation|1
7002973|NCT01406717|11069155|FG000|Overall Study|Lost to Follow-up|14
7002974|NCT01406717|11069156|FG001|Overall Study|Lost to Follow-up|8
7002975|NCT01406717|11069155|FG000|Overall Study|Withdrawal by Subject|19
7002976|NCT01406717|11069156|FG001|Overall Study|Withdrawal by Subject|15
7002977|NCT01406717|11069155|FG000|Overall Study|Adverse Event|1
7002978|NCT01406717|11069156|FG001|Overall Study|Adverse Event|2
7002979|NCT01406717|11069155|FG000|Overall Study|Lack of Efficacy|0
7002980|NCT01406717|11069156|FG001|Overall Study|Lack of Efficacy|1
7002981|NCT01406717|11069155|FG000|Overall Study|Non-completion of visit activity|0
7002982|NCT01406717|11069156|FG001|Overall Study|Non-completion of visit activity|1
7002983|NCT01406795|11069172|FG000|Overall Study|Withdrawal by Subject|1
7002984|NCT01406873|11069178|FG000|Overall Study|Withdrawal by Subject|1
7002985|NCT01406873|11069179|FG001|Overall Study|Withdrawal by Subject|1
7002986|NCT01406938|11069197|FG000|Induction Period|Subject/guardian decision|6
7002987|NCT01406938|11069198|FG001|Induction Period|Subject/guardian decision|8
7002988|NCT01406938|11069199|FG002|Induction Period|Subject/guardian decision|0
7002989|NCT01406938|11069200|FG003|Induction Period|Subject/guardian decision|0
7002990|NCT01406938|11069201|FG004|Induction Period|Subject/guardian decision|0
7002991|NCT01406938|11069202|FG005|Induction Period|Subject/guardian decision|0
7002992|NCT01406938|11069197|FG000|Induction Period|Protocol deviation|1
7002993|NCT01406938|11069198|FG001|Induction Period|Protocol deviation|0
7002994|NCT01406938|11069199|FG002|Induction Period|Protocol deviation|0
7002995|NCT01406938|11069200|FG003|Induction Period|Protocol deviation|0
7002996|NCT01406938|11069201|FG004|Induction Period|Protocol deviation|0
7002997|NCT01406938|11069202|FG005|Induction Period|Protocol deviation|0
7002998|NCT01406938|11069197|FG000|Induction Period|Adverse Event|8
7002999|NCT01406938|11069198|FG001|Induction Period|Adverse Event|9
7003000|NCT01406938|11069199|FG002|Induction Period|Adverse Event|0
7003001|NCT01406938|11069200|FG003|Induction Period|Adverse Event|0
7003002|NCT01406938|11069201|FG004|Induction Period|Adverse Event|0
7003003|NCT01406938|11069202|FG005|Induction Period|Adverse Event|0
7003004|NCT01406938|11069197|FG000|Induction Period|Lack of Efficacy|1
7003005|NCT01406938|11069198|FG001|Induction Period|Lack of Efficacy|0
7003006|NCT01406938|11069199|FG002|Induction Period|Lack of Efficacy|0
7003007|NCT01406938|11069200|FG003|Induction Period|Lack of Efficacy|0
7003008|NCT01406938|11069201|FG004|Induction Period|Lack of Efficacy|0
7003009|NCT01406938|11069202|FG005|Induction Period|Lack of Efficacy|0
7003010|NCT01406938|11069197|FG000|Induction Period|Lost to Follow-up|2
7003011|NCT01406938|11069198|FG001|Induction Period|Lost to Follow-up|3
7003012|NCT01406938|11069199|FG002|Induction Period|Lost to Follow-up|0
7003013|NCT01406938|11069200|FG003|Induction Period|Lost to Follow-up|0
7003014|NCT01406938|11069201|FG004|Induction Period|Lost to Follow-up|0
7003015|NCT01406938|11069202|FG005|Induction Period|Lost to Follow-up|0
7003016|NCT01406938|11069197|FG000|Maintenance Period|Adverse Event|0
7003017|NCT01406938|11069198|FG001|Maintenance Period|Adverse Event|0
7003018|NCT01406938|11069199|FG002|Maintenance Period|Adverse Event|2
7003019|NCT01406938|11069200|FG003|Maintenance Period|Adverse Event|8
7003020|NCT01406938|11069201|FG004|Maintenance Period|Adverse Event|4
7003021|NCT01406938|11069202|FG005|Maintenance Period|Adverse Event|2
7003022|NCT01406938|11069197|FG000|Maintenance Period|Death|0
7003023|NCT01406938|11069198|FG001|Maintenance Period|Death|0
7003024|NCT01406938|11069199|FG002|Maintenance Period|Death|0
7003025|NCT01406938|11069200|FG003|Maintenance Period|Death|0
7003026|NCT01406938|11069201|FG004|Maintenance Period|Death|1
7003027|NCT01406938|11069202|FG005|Maintenance Period|Death|0
7003028|NCT01406938|11069197|FG000|Maintenance Period|Subject/guardian decision|0
7003029|NCT01406938|11069198|FG001|Maintenance Period|Subject/guardian decision|0
7003030|NCT01406938|11069199|FG002|Maintenance Period|Subject/guardian decision|11
7003031|NCT01406938|11069200|FG003|Maintenance Period|Subject/guardian decision|7
7003032|NCT01406938|11069201|FG004|Maintenance Period|Subject/guardian decision|10
7003033|NCT01406938|11069202|FG005|Maintenance Period|Subject/guardian decision|7
7003034|NCT01406938|11069197|FG000|Maintenance Period|Protocol Violation|0
7003035|NCT01406938|11069198|FG001|Maintenance Period|Protocol Violation|0
7003036|NCT01406938|11069199|FG002|Maintenance Period|Protocol Violation|2
7003037|NCT01406938|11069200|FG003|Maintenance Period|Protocol Violation|2
7003038|NCT01406938|11069201|FG004|Maintenance Period|Protocol Violation|2
7003039|NCT01406938|11069202|FG005|Maintenance Period|Protocol Violation|2
7003040|NCT01406938|11069197|FG000|Maintenance Period|Pregnancy|0
7003041|NCT01406938|11069198|FG001|Maintenance Period|Pregnancy|0
7003042|NCT01406938|11069199|FG002|Maintenance Period|Pregnancy|0
7003043|NCT01406938|11069200|FG003|Maintenance Period|Pregnancy|0
7003044|NCT01406938|11069201|FG004|Maintenance Period|Pregnancy|1
7003045|NCT01406938|11069202|FG005|Maintenance Period|Pregnancy|0
7003046|NCT01406938|11069197|FG000|Maintenance Period|Lost to Follow-up|0
7003047|NCT01406938|11069198|FG001|Maintenance Period|Lost to Follow-up|0
7003048|NCT01406938|11069199|FG002|Maintenance Period|Lost to Follow-up|0
7003049|NCT01406938|11069200|FG003|Maintenance Period|Lost to Follow-up|0
7003050|NCT01406938|11069201|FG004|Maintenance Period|Lost to Follow-up|4
7003051|NCT01406938|11069202|FG005|Maintenance Period|Lost to Follow-up|0
7003052|NCT01406938|11069197|FG000|Maintenance Period|Lack of Efficacy|0
7003053|NCT01406938|11069198|FG001|Maintenance Period|Lack of Efficacy|0
7003054|NCT01406938|11069199|FG002|Maintenance Period|Lack of Efficacy|2
7003055|NCT01406938|11069200|FG003|Maintenance Period|Lack of Efficacy|1
7003056|NCT01406938|11069201|FG004|Maintenance Period|Lack of Efficacy|3
7003057|NCT01406938|11069202|FG005|Maintenance Period|Lack of Efficacy|5
7003058|NCT01406938|11069197|FG000|Follow up|Lack of Efficacy|3
7003059|NCT01406938|11069198|FG001|Follow up|Lack of Efficacy|2
7003060|NCT01406938|11069199|FG002|Follow up|Lack of Efficacy|1
7003061|NCT01406938|11069200|FG003|Follow up|Lack of Efficacy|0
7003062|NCT01406938|11069201|FG004|Follow up|Lack of Efficacy|0
7003063|NCT01406938|11069202|FG005|Follow up|Lack of Efficacy|0
7003064|NCT01406938|11069197|FG000|Follow up|Patient/guardian decision|4
7003065|NCT01406938|11069198|FG001|Follow up|Patient/guardian decision|2
7003066|NCT01406938|11069199|FG002|Follow up|Patient/guardian decision|4
7003067|NCT01406938|11069200|FG003|Follow up|Patient/guardian decision|2
7003068|NCT01406938|11069201|FG004|Follow up|Patient/guardian decision|4
7003069|NCT01406938|11069202|FG005|Follow up|Patient/guardian decision|1
7003070|NCT01406938|11069197|FG000|Follow up|Protocol Violation|0
7003071|NCT01406938|11069198|FG001|Follow up|Protocol Violation|0
7003072|NCT01406938|11069199|FG002|Follow up|Protocol Violation|1
7003073|NCT01406938|11069200|FG003|Follow up|Protocol Violation|0
7003074|NCT01406938|11069201|FG004|Follow up|Protocol Violation|0
7003075|NCT01406938|11069202|FG005|Follow up|Protocol Violation|0
7003076|NCT01406938|11069197|FG000|Follow up|Physician Decision|0
7003077|NCT01406938|11069198|FG001|Follow up|Physician Decision|0
7003078|NCT01406938|11069199|FG002|Follow up|Physician Decision|2
7003079|NCT01406938|11069200|FG003|Follow up|Physician Decision|0
7003080|NCT01406938|11069201|FG004|Follow up|Physician Decision|3
7003081|NCT01406938|11069202|FG005|Follow up|Physician Decision|1
7003082|NCT01406938|11069197|FG000|Follow up|Lost to Follow-up|1
7003083|NCT01406938|11069198|FG001|Follow up|Lost to Follow-up|1
7003084|NCT01406938|11069199|FG002|Follow up|Lost to Follow-up|0
7003085|NCT01406938|11069200|FG003|Follow up|Lost to Follow-up|1
7003086|NCT01406938|11069201|FG004|Follow up|Lost to Follow-up|2
7003087|NCT01406938|11069202|FG005|Follow up|Lost to Follow-up|1
7003088|NCT01407276|11069266|FG000|Overall Study|Withdrawal by Subject|0
7003089|NCT01407276|11069267|FG001|Overall Study|Withdrawal by Subject|0
7003090|NCT01407276|11069268|FG002|Overall Study|Withdrawal by Subject|0
7003091|NCT01407276|11069269|FG003|Overall Study|Withdrawal by Subject|0
7003092|NCT01407276|11069270|FG004|Overall Study|Withdrawal by Subject|0
7003093|NCT01407276|11069271|FG005|Overall Study|Withdrawal by Subject|0
7003094|NCT01407276|11069272|FG006|Overall Study|Withdrawal by Subject|0
7003095|NCT01407276|11069273|FG007|Overall Study|Withdrawal by Subject|1
7003096|NCT01407354|11069298|FG000|First Intervention|Withdrawal by Subject|0
7003097|NCT01407354|11069299|FG001|First Intervention|Withdrawal by Subject|2
7003098|NCT01407354|11069298|FG000|First Intervention|Adverse Event|1
7003099|NCT01407354|11069299|FG001|First Intervention|Adverse Event|0
7003100|NCT01407354|11069298|FG000|First Intervention|Physician Decision|1
7003101|NCT01407354|11069299|FG001|First Intervention|Physician Decision|0
7003102|NCT01407367|11069308|FG000|Overall Study|Death|24
7003103|NCT01407367|11069309|FG001|Overall Study|Death|32
7003104|NCT01407367|11069308|FG000|Overall Study|Renal Replacement Therapy (RRT)|12
7003105|NCT01407367|11069309|FG001|Overall Study|Renal Replacement Therapy (RRT)|29
7003106|NCT01407367|11069308|FG000|Overall Study|Withdrawal by Subject|4
7003107|NCT01407367|11069309|FG001|Overall Study|Withdrawal by Subject|15
7003108|NCT01407367|11069308|FG000|Overall Study|Lost to Follow-up|0
7003109|NCT01407367|11069309|FG001|Overall Study|Lost to Follow-up|2
7003110|NCT01407926|11069333|FG000|Overall Study|Lost to Follow-up|55
7003111|NCT01408030|11069351|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1
7003112|NCT01408030|11069352|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0
7003113|NCT01408030|11069353|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1
7003114|NCT01408030|11069354|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0
7003115|NCT01408030|11069351|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2
7003116|NCT01408030|11069352|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6
7003117|NCT01408030|11069353|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0
7003118|NCT01408030|11069354|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3
7003119|NCT01408030|11069351|FG000|Treatment Phase (on Drug)|Protocol Violation|0
7003120|NCT01408030|11069352|FG001|Treatment Phase (on Drug)|Protocol Violation|1
7003121|NCT01408030|11069353|FG002|Treatment Phase (on Drug)|Protocol Violation|0
7003122|NCT01408030|11069354|FG003|Treatment Phase (on Drug)|Protocol Violation|0
7003123|NCT01408030|11069351|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0
7003124|NCT01408030|11069352|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2
7003125|NCT01408030|11069353|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2
7003126|NCT01408030|11069354|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0
7003127|NCT01408030|11069351|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3
7003128|NCT01408030|11069352|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2
7003129|NCT01408030|11069353|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1
7003130|NCT01408030|11069354|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3
7003131|NCT01408030|11069351|FG000|Observation Phase (Off Drug)|Physician Decision|0
7003132|NCT01408030|11069352|FG001|Observation Phase (Off Drug)|Physician Decision|1
7003133|NCT01408030|11069353|FG002|Observation Phase (Off Drug)|Physician Decision|2
7003134|NCT01408030|11069354|FG003|Observation Phase (Off Drug)|Physician Decision|0
7003135|NCT01408030|11069351|FG000|Observation Phase (Off Drug)|Other|1
7003136|NCT01408030|11069352|FG001|Observation Phase (Off Drug)|Other|1
7003137|NCT01408030|11069353|FG002|Observation Phase (Off Drug)|Other|1
7003138|NCT01408030|11069354|FG003|Observation Phase (Off Drug)|Other|1
7003139|NCT01408043|11069364|FG000|Overall Study|unable to collect cells|1
7003140|NCT01408147|11069370|FG000|Overall Study|Withdrawal by Subject|0
7003141|NCT01408147|11069371|FG001|Overall Study|Withdrawal by Subject|1
7003142|NCT01408277|11069379|FG000|Overall Study|Adverse Event|3
7003143|NCT01408277|11069380|FG001|Overall Study|Adverse Event|4
7003144|NCT01408277|11069379|FG000|Overall Study|Lost to Follow-up|1
7003145|NCT01408277|11069380|FG001|Overall Study|Lost to Follow-up|0
7003146|NCT01408277|11069379|FG000|Overall Study|Withdrawal by Subject|2
7003147|NCT01408277|11069380|FG001|Overall Study|Withdrawal by Subject|0
7003148|NCT01408277|11069379|FG000|Overall Study|Protocol Violation|2
7003149|NCT01408277|11069380|FG001|Overall Study|Protocol Violation|0
7003150|NCT01408303|11069389|FG000|Overall Study|Adverse Event|3
7003151|NCT01408303|11069390|FG001|Overall Study|Adverse Event|7
7003152|NCT01408303|11069391|FG002|Overall Study|Adverse Event|2
7003153|NCT01408303|11069389|FG000|Overall Study|Lost to Follow-up|0
7003154|NCT01408303|11069390|FG001|Overall Study|Lost to Follow-up|1
7003155|NCT01408303|11069391|FG002|Overall Study|Lost to Follow-up|2
7003156|NCT01408303|11069389|FG000|Overall Study|Withdrawal by Subject|2
7003157|NCT01408303|11069390|FG001|Overall Study|Withdrawal by Subject|3
7003158|NCT01408303|11069391|FG002|Overall Study|Withdrawal by Subject|1
7003159|NCT01408303|11069389|FG000|Overall Study|Protocol Violation|0
7003160|NCT01408303|11069390|FG001|Overall Study|Protocol Violation|1
7003161|NCT01408303|11069391|FG002|Overall Study|Protocol Violation|0
7003162|NCT01408303|11069389|FG000|Overall Study|Noncompliance|1
7003163|NCT01408303|11069390|FG001|Overall Study|Noncompliance|0
7003164|NCT01408303|11069391|FG002|Overall Study|Noncompliance|1
7003165|NCT01408459|11069410|FG000|Overall Study|Withdrawal by Subject|1
7003166|NCT01408459|11069411|FG001|Overall Study|Withdrawal by Subject|1
7003167|NCT01408485|11069418|FG000|Overall Study|Withdrawal by Subject|21
7003168|NCT01408537|11069422|FG000|Overall Study|Withdrawal by Subject|2
7003169|NCT01408537|11069422|FG000|Overall Study|Protocol Violation|3
7003170|NCT01408537|11069422|FG000|Overall Study|Lost to Follow-up|3
7003171|NCT01408563|11069437|FG000|Overall Study|Ineligible after consent/ registration|2
7003172|NCT01408576|11069444|FG000|Overall Study|Lack of Efficacy|17
7003173|NCT01408576|11069445|FG001|Overall Study|Lack of Efficacy|30
7003174|NCT01408576|11069446|FG002|Overall Study|Lack of Efficacy|48
7003175|NCT01408576|11069444|FG000|Overall Study|Protocol Violation|1
7003176|NCT01408576|11069445|FG001|Overall Study|Protocol Violation|2
7003177|NCT01408576|11069446|FG002|Overall Study|Protocol Violation|2
7003178|NCT01408576|11069444|FG000|Overall Study|Lost to Follow-up|10
7003179|NCT01408576|11069445|FG001|Overall Study|Lost to Follow-up|9
7003180|NCT01408576|11069446|FG002|Overall Study|Lost to Follow-up|17
7003181|NCT01408576|11069444|FG000|Overall Study|Withdrawal by Subject|34
7003182|NCT01408576|11069445|FG001|Overall Study|Withdrawal by Subject|60
7003183|NCT01408576|11069446|FG002|Overall Study|Withdrawal by Subject|66
7003184|NCT01408576|11069444|FG000|Overall Study|Sponsor terminated study|89
7003185|NCT01408576|11069445|FG001|Overall Study|Sponsor terminated study|333
7003186|NCT01408576|11069446|FG002|Overall Study|Sponsor terminated study|330
7003187|NCT01408576|11069444|FG000|Overall Study|AE, serious fatal|4
7003188|NCT01408576|11069445|FG001|Overall Study|AE, serious fatal|4
7003189|NCT01408576|11069446|FG002|Overall Study|AE, serious fatal|1
7003190|NCT01408576|11069444|FG000|Overall Study|SAE, non-fatal|11
7003191|NCT01408576|11069445|FG001|Overall Study|SAE, non-fatal|23
7003192|NCT01408576|11069446|FG002|Overall Study|SAE, non-fatal|14
7003193|NCT01408576|11069444|FG000|Overall Study|AE, non-serious non-fatal|12
7003194|NCT01408576|11069445|FG001|Overall Study|AE, non-serious non-fatal|19
7003195|NCT01408576|11069446|FG002|Overall Study|AE, non-serious non-fatal|11
7003196|NCT01408576|11069444|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
7003197|NCT01408576|11069445|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
7003198|NCT01408576|11069446|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
7003199|NCT01408576|11069444|FG000|Overall Study|AE, unknown type|0
7003200|NCT01408576|11069445|FG001|Overall Study|AE, unknown type|1
7003201|NCT01408576|11069446|FG002|Overall Study|AE, unknown type|0
7003202|NCT01408576|11069444|FG000|Overall Study|Other|10
7003203|NCT01408576|11069445|FG001|Overall Study|Other|16
7003204|NCT01408576|11069446|FG002|Overall Study|Other|18
7003205|NCT01408628|11069466|FG000|Consented|Withdrawal by Subject|12
7003206|NCT01408628|11069466|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3
7003207|NCT01408628|11069466|FG000|Completed 6 Month Follow-Up|Protocol Violation|6
7003208|NCT01408628|11069466|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5
7003209|NCT01408706|11069473|FG000|Overall Study|Physician Decision|1
7003210|NCT01408706|11069474|FG001|Overall Study|Physician Decision|0
7003211|NCT01408732|11069531|FG000|Overall Study|Withdrawal by Subject|2
7003212|NCT01408732|11069532|FG001|Overall Study|Withdrawal by Subject|2
7003213|NCT01408888|11069543|FG000|First Intervention|Adverse Event|0
7003214|NCT01408888|11069544|FG001|First Intervention|Adverse Event|1
7003215|NCT01408888|11069543|FG000|First Intervention|Withdrawal by Subject|0
7003216|NCT01408888|11069544|FG001|First Intervention|Withdrawal by Subject|2
7003217|NCT01408888|11069543|FG000|Second Intervention|Withdrawal by Subject|1
7003218|NCT01408888|11069544|FG001|Second Intervention|Withdrawal by Subject|0
7003219|NCT01408888|11069543|FG000|Second Intervention|Adverse Event|1
7003220|NCT01408888|11069544|FG001|Second Intervention|Adverse Event|0
7003221|NCT01408901|11069564|FG000|6-Week Follow-Up|Lost to Follow-up|2
7003222|NCT01408901|11069565|FG001|6-Week Follow-Up|Lost to Follow-up|1
7003223|NCT01408901|11069566|FG002|6-Week Follow-Up|Lost to Follow-up|3
7003224|NCT01408901|11069567|FG003|6-Week Follow-Up|Lost to Follow-up|2
7003225|NCT01408901|11069564|FG000|6-Week Follow-Up|Death|1
7003226|NCT01408901|11069565|FG001|6-Week Follow-Up|Death|0
7003227|NCT01408901|11069566|FG002|6-Week Follow-Up|Death|0
7003228|NCT01408901|11069567|FG003|6-Week Follow-Up|Death|0
7003229|NCT01408901|11069564|FG000|6-Week Follow-Up|Cancelled visit|0
7003230|NCT01408901|11069565|FG001|6-Week Follow-Up|Cancelled visit|1
7003231|NCT01408901|11069566|FG002|6-Week Follow-Up|Cancelled visit|0
7003232|NCT01408901|11069567|FG003|6-Week Follow-Up|Cancelled visit|2
7003233|NCT01408901|11069564|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
7003234|NCT01408901|11069565|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
7003235|NCT01408901|11069566|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
7003236|NCT01408901|11069567|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2
7003237|NCT01408901|11069564|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1
7003238|NCT01408901|11069565|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0
7003239|NCT01408901|11069566|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0
7003240|NCT01408901|11069567|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0
7003241|NCT01408901|11069564|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0
7003242|NCT01408901|11069565|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2
7003243|NCT01408901|11069566|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0
7003244|NCT01408901|11069567|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1
7003245|NCT01408901|11069564|FG000|26-Week Follow-Up|Lost to Follow-up|1
7003246|NCT01408901|11069565|FG001|26-Week Follow-Up|Lost to Follow-up|1
7003247|NCT01408901|11069566|FG002|26-Week Follow-Up|Lost to Follow-up|0
7003248|NCT01408901|11069567|FG003|26-Week Follow-Up|Lost to Follow-up|1
7003249|NCT01408901|11069564|FG000|26-Week Follow-Up|Death|0
7003250|NCT01408901|11069565|FG001|26-Week Follow-Up|Death|1
7003251|NCT01408901|11069566|FG002|26-Week Follow-Up|Death|0
7003252|NCT01408901|11069567|FG003|26-Week Follow-Up|Death|0
7003253|NCT01408914|11069582|FG000|Overall Study|Could not complete tx in protocol period|5
7003254|NCT01408914|11069583|FG001|Overall Study|Could not complete tx in protocol period|5
7003255|NCT01408914|11069584|FG002|Overall Study|Could not complete tx in protocol period|6
7003256|NCT01408914|11069582|FG000|Overall Study|Lost to Follow-up|4
7003257|NCT01408914|11069583|FG001|Overall Study|Lost to Follow-up|1
7003258|NCT01408914|11069584|FG002|Overall Study|Lost to Follow-up|2
7003259|NCT01408914|11069582|FG000|Overall Study|Physician Decision|1
7003260|NCT01408914|11069583|FG001|Overall Study|Physician Decision|1
7003261|NCT01408914|11069584|FG002|Overall Study|Physician Decision|0
7003262|NCT01408914|11069582|FG000|Overall Study|Withdrawal by Subject|1
7003263|NCT01408914|11069583|FG001|Overall Study|Withdrawal by Subject|0
7003264|NCT01408914|11069584|FG002|Overall Study|Withdrawal by Subject|1
7003265|NCT01408914|11069582|FG000|Overall Study|Moved out of study jurisdiction|1
7003266|NCT01408914|11069583|FG001|Overall Study|Moved out of study jurisdiction|1
7003267|NCT01408914|11069584|FG002|Overall Study|Moved out of study jurisdiction|0
7003268|NCT01408914|11069582|FG000|Overall Study|Late exclusion|0
7003269|NCT01408914|11069583|FG001|Overall Study|Late exclusion|3
7003270|NCT01408914|11069584|FG002|Overall Study|Late exclusion|3
7003271|NCT01408914|11069582|FG000|Overall Study|Change in local TB/HIV norms|0
7003272|NCT01408914|11069583|FG001|Overall Study|Change in local TB/HIV norms|1
7003273|NCT01408914|11069584|FG002|Overall Study|Change in local TB/HIV norms|1
7003274|NCT01409382|11069637|FG000|Overall Study|Lost to Follow-up|1
7003275|NCT01409382|11069638|FG001|Overall Study|Lost to Follow-up|1
7003276|NCT01409382|11069637|FG000|Overall Study|Protocol Violation|0
7003277|NCT01409382|11069638|FG001|Overall Study|Protocol Violation|3
7003278|NCT01409382|11069637|FG000|Overall Study|Multiple pregnancy|2
7003279|NCT01409382|11069638|FG001|Overall Study|Multiple pregnancy|4
7003280|NCT01409382|11069637|FG000|Overall Study|Still pregnant when study ended|13
7003281|NCT01409382|11069638|FG001|Overall Study|Still pregnant when study ended|2
7003282|NCT01409382|11069637|FG000|Overall Study|Did not manage to get pregnant|64
7003283|NCT01409382|11069638|FG001|Overall Study|Did not manage to get pregnant|70
7003284|NCT01409382|11069637|FG000|Overall Study|Had a 2nd trimester loss after accident|1
7003285|NCT01409382|11069638|FG001|Overall Study|Had a 2nd trimester loss after accident|0
7003286|NCT01409434|11069648|FG000|Overall Study|Protocol Violation|4
7003287|NCT01409564|11069654|FG000|Overall Study|low medication compliance|4
7003288|NCT01409564|11069655|FG001|Overall Study|low medication compliance|3
7003289|NCT01409564|11069654|FG000|Overall Study|brain abnormalities found in T1 MR|1
7003290|NCT01409564|11069655|FG001|Overall Study|brain abnormalities found in T1 MR|2
7003291|NCT01409707|11069668|FG000|Overall Study|Withdrawal by Subject|5
7003292|NCT01409707|11069669|FG001|Overall Study|Withdrawal by Subject|17
7003293|NCT01409707|11069670|FG002|Overall Study|Withdrawal by Subject|16
7003294|NCT01409811|11069677|FG000|Overall Study|Insurance denial|1
7003295|NCT01409837|11069683|FG000|Overall Study|Withdrawal by Subject|2
7003296|NCT01409837|11069684|FG001|Overall Study|Withdrawal by Subject|1
7003297|NCT01409837|11069683|FG000|Overall Study|Lost to Follow-up|1
7003298|NCT01409837|11069684|FG001|Overall Study|Lost to Follow-up|0
7003299|NCT01409837|11069683|FG000|Overall Study|Physician Decision|0
7003300|NCT01409837|11069684|FG001|Overall Study|Physician Decision|1
7003301|NCT01409915|11069694|FG000|Overall Study|Adverse Event|0
7003302|NCT01409915|11069695|FG001|Overall Study|Adverse Event|2
7003303|NCT01409915|11069694|FG000|Overall Study|Withdrawal by Subject|0
7003304|NCT01409915|11069695|FG001|Overall Study|Withdrawal by Subject|1
7003305|NCT01409915|11069694|FG000|Overall Study|Protocol Violation|1
7003306|NCT01409915|11069695|FG001|Overall Study|Protocol Violation|0
7003307|NCT01409928|11069701|FG000|Overall Study|Physician Decision|12
7003308|NCT01409993|11069707|FG000|Overall Study|Adverse Event|4
7003309|NCT01409993|11069708|FG001|Overall Study|Adverse Event|4
7003310|NCT01409993|11069709|FG002|Overall Study|Adverse Event|3
7003311|NCT01409993|11069710|FG003|Overall Study|Adverse Event|1
7003312|NCT01409993|11069707|FG000|Overall Study|Withdrawal by Subject|0
7003313|NCT01409993|11069708|FG001|Overall Study|Withdrawal by Subject|0
7003314|NCT01409993|11069709|FG002|Overall Study|Withdrawal by Subject|0
7003315|NCT01409993|11069710|FG003|Overall Study|Withdrawal by Subject|4
7003316|NCT01409993|11069707|FG000|Overall Study|Lost to Follow-up|0
7003317|NCT01409993|11069708|FG001|Overall Study|Lost to Follow-up|1
7003318|NCT01409993|11069709|FG002|Overall Study|Lost to Follow-up|0
7003319|NCT01409993|11069710|FG003|Overall Study|Lost to Follow-up|0
7003320|NCT01410110|11069755|FG000|Overall Study|Withdrawal by Subject|4
7003321|NCT01410110|11069756|FG001|Overall Study|Withdrawal by Subject|2
7003322|NCT01410227|11069762|FG000|Overall Study|Adverse Event|1
7003323|NCT01410227|11069763|FG001|Overall Study|Adverse Event|0
7003324|NCT01410227|11069764|FG002|Overall Study|Adverse Event|0
7003325|NCT01410227|11069765|FG003|Overall Study|Adverse Event|0
7003326|NCT01410227|11069762|FG000|Overall Study|Withdrawal by Subject|3
7003327|NCT01410227|11069763|FG001|Overall Study|Withdrawal by Subject|0
7003328|NCT01410227|11069764|FG002|Overall Study|Withdrawal by Subject|1
7003329|NCT01410227|11069765|FG003|Overall Study|Withdrawal by Subject|0
7003330|NCT01410227|11069762|FG000|Overall Study|Pregnancy|0
7003331|NCT01410227|11069763|FG001|Overall Study|Pregnancy|0
7003332|NCT01410227|11069764|FG002|Overall Study|Pregnancy|0
7003333|NCT01410227|11069765|FG003|Overall Study|Pregnancy|1
7003334|NCT01410227|11069762|FG000|Overall Study|Met Excl. Criteria After Starting Study|0
7003335|NCT01410227|11069763|FG001|Overall Study|Met Excl. Criteria After Starting Study|0
7003336|NCT01410227|11069764|FG002|Overall Study|Met Excl. Criteria After Starting Study|1
7003337|NCT01410227|11069765|FG003|Overall Study|Met Excl. Criteria After Starting Study|0
7003338|NCT01410240|11069778|FG000|Overall Study|Physician Decision|0
7003339|NCT01410240|11069779|FG001|Overall Study|Physician Decision|0
7003340|NCT01410240|11069780|FG002|Overall Study|Physician Decision|1
7003341|NCT01410240|11069778|FG000|Overall Study|Missed week 6 assessments|1
7003342|NCT01410240|11069779|FG001|Overall Study|Missed week 6 assessments|1
7003343|NCT01410240|11069780|FG002|Overall Study|Missed week 6 assessments|1
7003344|NCT01410357|11069797|FG000|Overall Study|Death|2
7003345|NCT01410357|11069798|FG001|Overall Study|Death|1
7003346|NCT01410357|11069797|FG000|Overall Study|Withdrawal by Subject|1
7003347|NCT01410357|11069798|FG001|Overall Study|Withdrawal by Subject|2
7003348|NCT01410357|11069797|FG000|Overall Study|Lost to Follow-up|23
7003349|NCT01410357|11069798|FG001|Overall Study|Lost to Follow-up|21
7003350|NCT01410448|11069817|FG000|Overall Study|No conversion to everolimus|0
7003351|NCT01410448|11069818|FG001|Overall Study|No conversion to everolimus|24
7003352|NCT01410448|11069817|FG000|Overall Study|Graft loss|4
7003353|NCT01410448|11069818|FG001|Overall Study|Graft loss|1
7003354|NCT01410448|11069817|FG000|Overall Study|Administrative issues|2
7003355|NCT01410448|11069818|FG001|Overall Study|Administrative issues|1
7003356|NCT01410448|11069817|FG000|Overall Study|Lost to Follow-up|1
7003357|NCT01410448|11069818|FG001|Overall Study|Lost to Follow-up|0
7003358|NCT01410448|11069817|FG000|Overall Study|Withdrawal by Subject|3
7003359|NCT01410448|11069818|FG001|Overall Study|Withdrawal by Subject|2
7003360|NCT01410448|11069817|FG000|Overall Study|Protocol Violation|0
7003361|NCT01410448|11069818|FG001|Overall Study|Protocol Violation|4
7003362|NCT01410448|11069817|FG000|Overall Study|Death|2
7003363|NCT01410448|11069818|FG001|Overall Study|Death|3
7003364|NCT01410474|11069826|FG000|Overall Study|Withdrawal by Subject|0
7003365|NCT01410474|11069827|FG001|Overall Study|Withdrawal by Subject|1
7003366|NCT01410604|11069856|FG000|Overall Study|Adverse Event|2
7003367|NCT01410604|11069857|FG001|Overall Study|Adverse Event|1
7003368|NCT01410604|11069856|FG000|Overall Study|Lost to Follow-up|1
7003369|NCT01410604|11069857|FG001|Overall Study|Lost to Follow-up|0
7003370|NCT01410604|11069856|FG000|Overall Study|Physician Decision|0
7003371|NCT01410604|11069857|FG001|Overall Study|Physician Decision|1
7003372|NCT01411085|11069880|FG000|Overall Study|Physician Decision|1
7003373|NCT01411085|11069880|FG000|Overall Study|Protocol Violation|1
7003374|NCT01411085|11069880|FG000|Overall Study|Adverse Event|1
7003375|NCT01411215|11069901|FG000|Overall Study|Adverse Event|1
7003376|NCT01411215|11069902|FG001|Overall Study|Adverse Event|2
7003377|NCT01411215|11069901|FG000|Overall Study|Lack of Efficacy|2
7003378|NCT01411215|11069902|FG001|Overall Study|Lack of Efficacy|4
7003379|NCT01411215|11069901|FG000|Overall Study|Lost to Follow-up|12
7003380|NCT01411215|11069902|FG001|Overall Study|Lost to Follow-up|18
7003381|NCT01411215|11069901|FG000|Overall Study|Did not meet entrance criteria|0
7003382|NCT01411215|11069902|FG001|Overall Study|Did not meet entrance criteria|1
7003383|NCT01411215|11069901|FG000|Overall Study|Study terminated by sponsor|2
7003384|NCT01411215|11069902|FG001|Overall Study|Study terminated by sponsor|15
7003385|NCT01411215|11069901|FG000|Overall Study|Protocol Violation|3
7003386|NCT01411215|11069902|FG001|Overall Study|Protocol Violation|5
7003387|NCT01411215|11069901|FG000|Overall Study|Withdrawal by Subject|34
7003388|NCT01411215|11069902|FG001|Overall Study|Withdrawal by Subject|21
7003389|NCT01411215|11069901|FG000|Overall Study|Other|12
7003390|NCT01411215|11069902|FG001|Overall Study|Other|17
7003391|NCT01411215|11069901|FG000|Overall Study|Screen failure|0
7003392|NCT01411215|11069902|FG001|Overall Study|Screen failure|1
7003393|NCT01411228|11069911|FG000|Overall Study|Lost to Follow-up|0
7003394|NCT01411228|11069912|FG001|Overall Study|Lost to Follow-up|0
7003395|NCT01411228|11069913|FG002|Overall Study|Lost to Follow-up|1
7003396|NCT01411228|11069911|FG000|Overall Study|Withdrawal by Subject|1
7003397|NCT01411228|11069912|FG001|Overall Study|Withdrawal by Subject|0
7003398|NCT01411228|11069913|FG002|Overall Study|Withdrawal by Subject|0
7003399|NCT01411319|11069921|FG000|Overall Study|Lost to Follow-up|1
7003400|NCT01411774|11069974|FG000|Overall Study|Withdrawal by Subject|0
7003401|NCT01411774|11069975|FG001|Overall Study|Withdrawal by Subject|3
7003402|NCT01411839|11069983|FG000|Overall Study|Lost to Follow-up|4
7003403|NCT01411839|11069984|FG001|Overall Study|Lost to Follow-up|3
7003404|NCT01411852|11069992|FG000|Prehospital Intervention Phase|No qualifying SBP|5
7003405|NCT01411852|11069993|FG001|Prehospital Intervention Phase|No qualifying SBP|4
7003406|NCT01411852|11069992|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
7003407|NCT01411852|11069993|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
7003408|NCT01411852|11069992|FG000|Prehospital Intervention Phase|Found to be under age|0
7003409|NCT01411852|11069993|FG001|Prehospital Intervention Phase|Found to be under age|1
7003410|NCT01411852|11069992|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5
7003411|NCT01411852|11069993|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0
7003412|NCT01411852|11069992|FG000|Hospital Intervention Phase|Severe head injury|5
7003413|NCT01411852|11069993|FG001|Hospital Intervention Phase|Severe head injury|4
7003414|NCT01411852|11069992|FG000|Hospital Intervention Phase|No qualifying SBP|5
7003415|NCT01411852|11069993|FG001|Hospital Intervention Phase|No qualifying SBP|1
7003416|NCT01411852|11069992|FG000|Hospital Intervention Phase|Miscommunication error|1
7003417|NCT01411852|11069993|FG001|Hospital Intervention Phase|Miscommunication error|2
7003418|NCT01411852|11069992|FG000|Hospital Intervention Phase|CPR administered|3
7003419|NCT01411852|11069993|FG001|Hospital Intervention Phase|CPR administered|1
7003420|NCT01411852|11069992|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4
7003421|NCT01411852|11069993|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1
7003422|NCT01411852|11069992|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0
7003423|NCT01411852|11069993|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2
7003424|NCT01411852|11069992|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0
7003425|NCT01411852|11069993|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1
7003426|NCT01411852|11069992|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0
7003427|NCT01411852|11069993|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4
7003428|NCT01411852|11069992|FG000|Hospital Intervention Phase|Other ineligible|2
7003429|NCT01411852|11069993|FG001|Hospital Intervention Phase|Other ineligible|2
7003430|NCT01411852|11069992|FG000|Hospital Intervention Phase|Spinal cord injury|2
7003431|NCT01411852|11069993|FG001|Hospital Intervention Phase|Spinal cord injury|0
7003432|NCT01411852|11069992|FG000|Hospital Intervention Phase|Withdrawal by Subject|1
7003433|NCT01411852|11069993|FG001|Hospital Intervention Phase|Withdrawal by Subject|0
7003434|NCT01411852|11069992|FG000|Hospital Intervention Phase|Vascular access failed|1
7003435|NCT01411852|11069993|FG001|Hospital Intervention Phase|Vascular access failed|0
7003436|NCT01411891|11070003|FG000|Overall Study|Catheter dislodgement or loss to follow-|3
7003437|NCT01411891|11070004|FG001|Overall Study|Catheter dislodgement or loss to follow-|2
7003438|NCT01411917|11070012|FG000|Overall Study|Patient did not undergo scheduled surger|0
7003439|NCT01411917|11070013|FG001|Overall Study|Patient did not undergo scheduled surger|1
7003440|NCT01411995|11070021|FG000|Overall Study|Failed IUD insertion|0
7003441|NCT01411995|11070022|FG001|Overall Study|Failed IUD insertion|1
7003442|NCT01412021|11070028|FG000|Overall Study|Case Report Forms Not Retrieved|7
7003443|NCT01412021|11070028|FG000|Overall Study|Treatment Prior to Approval|3
7003444|NCT01412021|11070028|FG000|Overall Study|Transferred to Other Hospital|9
7003445|NCT01412060|11070032|FG000|Open-label Run-in Period (RIP)|Adverse Event|86
7003446|NCT01412060|11070033|FG001|Open-label Run-in Period (RIP)|Adverse Event|0
7003447|NCT01412060|11070034|FG002|Open-label Run-in Period (RIP)|Adverse Event|0
7003448|NCT01412060|11070032|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66
7003449|NCT01412060|11070033|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0
7003450|NCT01412060|11070034|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0
7003451|NCT01412060|11070032|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27
7003452|NCT01412060|11070033|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0
7003453|NCT01412060|11070034|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0
7003454|NCT01412060|11070032|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117
7003455|NCT01412060|11070033|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0
7003456|NCT01412060|11070034|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0
7003457|NCT01412060|11070032|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32
7003458|NCT01412060|11070033|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0
7003459|NCT01412060|11070034|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0
7003460|NCT01412060|11070032|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19
7003461|NCT01412060|11070033|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0
7003462|NCT01412060|11070034|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0
7003463|NCT01412060|11070032|FG000|Period Between RIP and SP|Adverse Event|4
7003464|NCT01412060|11070033|FG001|Period Between RIP and SP|Adverse Event|0
7003465|NCT01412060|11070034|FG002|Period Between RIP and SP|Adverse Event|0
7003466|NCT01412060|11070032|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19
7003467|NCT01412060|11070033|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0
7003468|NCT01412060|11070034|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0
7003469|NCT01412060|11070032|FG000|Period Between RIP and SP|Protocol Violation|2
7003470|NCT01412060|11070033|FG001|Period Between RIP and SP|Protocol Violation|0
6827098|NCT00122382|10829625|FG002|Double-Blind Study|Protocol Violation|0
6827099|NCT00122382|10829623|FG000|Double-Blind Study|Methotrexate Discontinued|0
6827100|NCT00122382|10829624|FG001|Double-Blind Study|Methotrexate Discontinued|1
6827101|NCT00122382|10829625|FG002|Double-Blind Study|Methotrexate Discontinued|0
7003471|NCT01412060|11070034|FG002|Period Between RIP and SP|Protocol Violation|0
7003472|NCT01412060|11070032|FG000|Period Between RIP and SP|Withdrawal of Consent|1
7003473|NCT01412060|11070033|FG001|Period Between RIP and SP|Withdrawal of Consent|0
7003474|NCT01412060|11070034|FG002|Period Between RIP and SP|Withdrawal of Consent|0
7003475|NCT01412060|11070032|FG000|Period Between RIP and SP|Lost to Follow-up|5
7003476|NCT01412060|11070033|FG001|Period Between RIP and SP|Lost to Follow-up|0
7003477|NCT01412060|11070034|FG002|Period Between RIP and SP|Lost to Follow-up|0
7003478|NCT01412060|11070032|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23
7003479|NCT01412060|11070033|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0
7003480|NCT01412060|11070034|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0
7003481|NCT01412060|11070032|FG000|Open-label Stabilization Period (SP)|Adverse Event|9
7003482|NCT01412060|11070033|FG001|Open-label Stabilization Period (SP)|Adverse Event|0
7003483|NCT01412060|11070034|FG002|Open-label Stabilization Period (SP)|Adverse Event|0
7003484|NCT01412060|11070032|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9
7003485|NCT01412060|11070033|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0
7003486|NCT01412060|11070034|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0
7003487|NCT01412060|11070032|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14
7003488|NCT01412060|11070033|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0
7003489|NCT01412060|11070034|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0
7003490|NCT01412060|11070032|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40
7003491|NCT01412060|11070033|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0
7003492|NCT01412060|11070034|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0
7003493|NCT01412060|11070032|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9
7003494|NCT01412060|11070033|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0
7003495|NCT01412060|11070034|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0
7003496|NCT01412060|11070032|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19
7003497|NCT01412060|11070033|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0
7003498|NCT01412060|11070034|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0
7003499|NCT01412060|11070032|FG000|Period Between SP and DBP|Protocol Violation|2
7003500|NCT01412060|11070033|FG001|Period Between SP and DBP|Protocol Violation|0
7003501|NCT01412060|11070034|FG002|Period Between SP and DBP|Protocol Violation|0
7003502|NCT01412060|11070032|FG000|Period Between SP and DBP|Withdrawal of Consent|2
7003503|NCT01412060|11070033|FG001|Period Between SP and DBP|Withdrawal of Consent|0
7003504|NCT01412060|11070034|FG002|Period Between SP and DBP|Withdrawal of Consent|0
7003505|NCT01412060|11070032|FG000|Period Between SP and DBP|Lost to Follow-up|1
7003506|NCT01412060|11070033|FG001|Period Between SP and DBP|Lost to Follow-up|0
7003507|NCT01412060|11070034|FG002|Period Between SP and DBP|Lost to Follow-up|0
7003508|NCT01412060|11070032|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4
7003509|NCT01412060|11070033|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0
7003510|NCT01412060|11070034|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0
7003511|NCT01412060|11070032|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55
7003512|NCT01412060|11070033|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0
7003513|NCT01412060|11070034|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0
7003514|NCT01412060|11070032|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0
7003515|NCT01412060|11070033|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5
7003516|NCT01412060|11070034|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6
7003517|NCT01412060|11070032|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0
7003518|NCT01412060|11070033|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4
7003519|NCT01412060|11070034|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5
7003520|NCT01412060|11070032|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0
7003521|NCT01412060|11070033|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10
7003522|NCT01412060|11070034|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15
7003523|NCT01412060|11070032|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0
7003524|NCT01412060|11070033|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6
7003525|NCT01412060|11070034|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5
7003526|NCT01412060|11070032|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0
7003527|NCT01412060|11070033|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11
7003528|NCT01412060|11070034|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27
7003529|NCT01412060|11070032|FG000|Double-blind Treatment Phase (DBP)|Relapse|0
7003530|NCT01412060|11070033|FG001|Double-blind Treatment Phase (DBP)|Relapse|47
7003531|NCT01412060|11070034|FG002|Double-blind Treatment Phase (DBP)|Relapse|25
7003532|NCT01412151|11070048|FG000|Week 0 - 306 - Treatment Period|Death|1
7003533|NCT01412151|11070048|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1
7003534|NCT01412151|11070048|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3
7003535|NCT01412151|11070048|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2
7003536|NCT01412229|11070058|FG000|Overall Study|Physician Decision|1
7003537|NCT01412424|11070089|FG000|Core Treatment Period|Treatment Failure|24
7003538|NCT01412424|11070089|FG000|Core Treatment Period|Adverse Event|21
7003539|NCT01412424|11070089|FG000|Core Treatment Period|Patient Request|5
7003540|NCT01412424|11070089|FG000|Core Treatment Period|Lost to Follow-up|2
7003541|NCT01412424|11070089|FG000|Core Treatment Period|Sponsor Request|1
7003542|NCT01412424|11070089|FG000|Extension Treatment Period|Adverse Event|2
7003543|NCT01412424|11070089|FG000|Extension Treatment Period|Treatment Failure|2
7003544|NCT01412424|11070089|FG000|Extension Treatment Period|Patient Request|2
7003545|NCT01412801|11070130|FG000|Overall Study|Death|0
7003546|NCT01412801|11070131|FG001|Overall Study|Death|1
7003547|NCT01412801|11070132|FG002|Overall Study|Death|0
7003548|NCT01412801|11070133|FG003|Overall Study|Death|4
7003549|NCT01412801|11070134|FG004|Overall Study|Death|2
7003550|NCT01412801|11070135|FG005|Overall Study|Death|2
7003551|NCT01412801|11070130|FG000|Overall Study|Lost to Follow-up|1
7003552|NCT01412801|11070131|FG001|Overall Study|Lost to Follow-up|2
7003553|NCT01412801|11070132|FG002|Overall Study|Lost to Follow-up|4
7003554|NCT01412801|11070133|FG003|Overall Study|Lost to Follow-up|0
7003555|NCT01412801|11070134|FG004|Overall Study|Lost to Follow-up|1
7003556|NCT01412801|11070135|FG005|Overall Study|Lost to Follow-up|1
7003557|NCT01412801|11070130|FG000|Overall Study|Withdrawal by Subject|3
7003558|NCT01412801|11070131|FG001|Overall Study|Withdrawal by Subject|2
7003559|NCT01412801|11070132|FG002|Overall Study|Withdrawal by Subject|1
7003560|NCT01412801|11070133|FG003|Overall Study|Withdrawal by Subject|0
7003561|NCT01412801|11070134|FG004|Overall Study|Withdrawal by Subject|0
7003562|NCT01412801|11070135|FG005|Overall Study|Withdrawal by Subject|0
7003563|NCT01412801|11070130|FG000|Overall Study|Relocated to another area|0
7003564|NCT01412801|11070131|FG001|Overall Study|Relocated to another area|0
7003565|NCT01412801|11070132|FG002|Overall Study|Relocated to another area|2
7003566|NCT01412801|11070133|FG003|Overall Study|Relocated to another area|0
7003567|NCT01412801|11070134|FG004|Overall Study|Relocated to another area|0
7003568|NCT01412801|11070135|FG005|Overall Study|Relocated to another area|0
7003569|NCT01412879|11070169|FG000|Initial Registration (Induction Therapy)|Adverse Event|5
7003570|NCT01412879|11070170|FG001|Initial Registration (Induction Therapy)|Adverse Event|3
7003571|NCT01412879|11070171|FG002|Initial Registration (Induction Therapy)|Adverse Event|0
7003572|NCT01412879|11070169|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1
7003573|NCT01412879|11070170|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3
7003574|NCT01412879|11070171|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0
7003575|NCT01412879|11070169|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0
7003576|NCT01412879|11070170|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1
7003577|NCT01412879|11070171|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0
7003578|NCT01412879|11070169|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6
7003579|NCT01412879|11070170|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1
7003580|NCT01412879|11070171|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0
7003581|NCT01412879|11070169|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1
7003582|NCT01412879|11070170|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0
7003583|NCT01412879|11070171|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0
7042934|NCT01739335|11127545|FG001|Overall Study|Lost to Follow-up|4
7042935|NCT01739335|11127544|FG000|Overall Study|Ineligible patient randomized|0
7042936|NCT01739335|11127545|FG001|Overall Study|Ineligible patient randomized|1
7042937|NCT01739348|11127559|FG000|Part I (Base Study)|Adverse Event|41
7042938|NCT01739348|11127560|FG001|Part I (Base Study)|Adverse Event|52
7042939|NCT01739348|11127561|FG002|Part I (Base Study)|Adverse Event|8
7042940|NCT01739348|11127562|FG003|Part I (Base Study)|Adverse Event|33
7042941|NCT01739348|11127559|FG000|Part I (Base Study)|Death|10
7042942|NCT01739348|11127560|FG001|Part I (Base Study)|Death|7
7042943|NCT01739348|11127561|FG002|Part I (Base Study)|Death|2
7042944|NCT01739348|11127562|FG003|Part I (Base Study)|Death|8
7042945|NCT01739348|11127559|FG000|Part I (Base Study)|Lack of Efficacy|3
7042946|NCT01739348|11127560|FG001|Part I (Base Study)|Lack of Efficacy|8
7042947|NCT01739348|11127561|FG002|Part I (Base Study)|Lack of Efficacy|0
7042948|NCT01739348|11127562|FG003|Part I (Base Study)|Lack of Efficacy|7
7042949|NCT01739348|11127559|FG000|Part I (Base Study)|Lost to Follow-up|4
7042950|NCT01739348|11127560|FG001|Part I (Base Study)|Lost to Follow-up|2
7042951|NCT01739348|11127561|FG002|Part I (Base Study)|Lost to Follow-up|4
7042952|NCT01739348|11127562|FG003|Part I (Base Study)|Lost to Follow-up|4
7042953|NCT01739348|11127559|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3
7042954|NCT01739348|11127560|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2
7042955|NCT01739348|11127561|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0
7042956|NCT01739348|11127562|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0
7042957|NCT01739348|11127559|FG000|Part I (Base Study)|Physician Decision|10
7042958|NCT01739348|11127560|FG001|Part I (Base Study)|Physician Decision|7
7042959|NCT01739348|11127561|FG002|Part I (Base Study)|Physician Decision|1
7042960|NCT01739348|11127562|FG003|Part I (Base Study)|Physician Decision|4
7042961|NCT01739348|11127559|FG000|Part I (Base Study)|Protocol Violation|2
7042962|NCT01739348|11127560|FG001|Part I (Base Study)|Protocol Violation|0
7042963|NCT01739348|11127561|FG002|Part I (Base Study)|Protocol Violation|1
7042964|NCT01739348|11127562|FG003|Part I (Base Study)|Protocol Violation|2
7042965|NCT01739348|11127559|FG000|Part I (Base Study)|Screen Failure|2
7042966|NCT01739348|11127560|FG001|Part I (Base Study)|Screen Failure|0
7042967|NCT01739348|11127561|FG002|Part I (Base Study)|Screen Failure|0
7042968|NCT01739348|11127562|FG003|Part I (Base Study)|Screen Failure|0
7042969|NCT01739348|11127559|FG000|Part I (Base Study)|Site Discontinued Study Participation|1
7042970|NCT01739348|11127560|FG001|Part I (Base Study)|Site Discontinued Study Participation|3
7042971|NCT01739348|11127561|FG002|Part I (Base Study)|Site Discontinued Study Participation|0
7042972|NCT01739348|11127562|FG003|Part I (Base Study)|Site Discontinued Study Participation|0
7042973|NCT01739348|11127559|FG000|Part I (Base Study)|Study Terminated by Sponsor|72
7042974|NCT01739348|11127560|FG001|Part I (Base Study)|Study Terminated by Sponsor|73
7042975|NCT01739348|11127561|FG002|Part I (Base Study)|Study Terminated by Sponsor|0
7042976|NCT01739348|11127562|FG003|Part I (Base Study)|Study Terminated by Sponsor|86
7042977|NCT01739348|11127559|FG000|Part I (Base Study)|Participant Moved|4
7042978|NCT01739348|11127560|FG001|Part I (Base Study)|Participant Moved|3
7042979|NCT01739348|11127561|FG002|Part I (Base Study)|Participant Moved|1
7042980|NCT01739348|11127562|FG003|Part I (Base Study)|Participant Moved|7
7042981|NCT01739348|11127559|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27
7042982|NCT01739348|11127560|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25
7042983|NCT01739348|11127561|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2
7042984|NCT01739348|11127562|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18
7042985|NCT01739348|11127559|FG000|Part I (Base Study)|Withdrawal by Subject|23
7042986|NCT01739348|11127560|FG001|Part I (Base Study)|Withdrawal by Subject|21
7042987|NCT01739348|11127561|FG002|Part I (Base Study)|Withdrawal by Subject|7
7042988|NCT01739348|11127562|FG003|Part I (Base Study)|Withdrawal by Subject|20
7042989|NCT01739348|11127559|FG000|Part II (Extension Study)|Adverse Event|10
7042990|NCT01739348|11127560|FG001|Part II (Extension Study)|Adverse Event|11
7042991|NCT01739348|11127561|FG002|Part II (Extension Study)|Adverse Event|7
7042992|NCT01739348|11127562|FG003|Part II (Extension Study)|Adverse Event|26
7042993|NCT01739348|11127559|FG000|Part II (Extension Study)|Death|3
7042994|NCT01739348|11127560|FG001|Part II (Extension Study)|Death|3
7042995|NCT01739348|11127561|FG002|Part II (Extension Study)|Death|2
7042996|NCT01739348|11127562|FG003|Part II (Extension Study)|Death|6
7042997|NCT01739348|11127559|FG000|Part II (Extension Study)|Lack of Efficacy|1
7042998|NCT01739348|11127560|FG001|Part II (Extension Study)|Lack of Efficacy|5
7042999|NCT01739348|11127561|FG002|Part II (Extension Study)|Lack of Efficacy|0
7043000|NCT01739348|11127562|FG003|Part II (Extension Study)|Lack of Efficacy|1
7043001|NCT01739348|11127559|FG000|Part II (Extension Study)|Lost to Follow-up|3
7043002|NCT01739348|11127560|FG001|Part II (Extension Study)|Lost to Follow-up|4
7043003|NCT01739348|11127561|FG002|Part II (Extension Study)|Lost to Follow-up|0
7043004|NCT01739348|11127562|FG003|Part II (Extension Study)|Lost to Follow-up|1
7003584|NCT01412944|11070193|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
7003585|NCT01412944|11070194|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
7003586|NCT01412944|11070195|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1
7003587|NCT01412944|11070196|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
7003588|NCT01412944|11070197|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
7003589|NCT01412944|11070198|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
7003590|NCT01412944|11070193|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
7003591|NCT01412944|11070194|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
7003592|NCT01412944|11070195|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
7003593|NCT01412944|11070196|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
7003594|NCT01412944|11070197|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
7003595|NCT01412944|11070198|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1
7003596|NCT01412944|11070193|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
7003597|NCT01412944|11070194|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
7003598|NCT01412944|11070195|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
7003599|NCT01412944|11070196|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
7003600|NCT01412944|11070197|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
7003601|NCT01412944|11070198|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1
7003602|NCT01412944|11070193|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1
7003603|NCT01412944|11070194|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0
7003604|NCT01412944|11070195|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0
7003605|NCT01412944|11070196|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0
7003606|NCT01412944|11070197|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0
7003607|NCT01412944|11070198|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0
7003608|NCT01412944|11070193|FG000|IV: Per CAIN457A2307|Protocol deviation|0
7003609|NCT01412944|11070194|FG001|IV: Per CAIN457A2307|Protocol deviation|1
7003610|NCT01412944|11070195|FG002|IV: Per CAIN457A2307|Protocol deviation|0
7003611|NCT01412944|11070196|FG003|IV: Per CAIN457A2307|Protocol deviation|0
7003612|NCT01412944|11070197|FG004|IV: Per CAIN457A2307|Protocol deviation|0
7003613|NCT01412944|11070198|FG005|IV: Per CAIN457A2307|Protocol deviation|0
7003614|NCT01412944|11070193|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0
7003615|NCT01412944|11070194|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1
7003616|NCT01412944|11070195|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0
7003617|NCT01412944|11070196|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0
7003618|NCT01412944|11070197|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0
7003619|NCT01412944|11070198|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0
7003620|NCT01412944|11070193|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0
7003621|NCT01412944|11070194|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0
7003622|NCT01412944|11070195|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1
7003623|NCT01412944|11070196|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1
7003624|NCT01412944|11070197|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1
7003625|NCT01412944|11070198|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0
7003626|NCT01412944|11070193|FG000|Entire: IV + Maintenance|Adverse Event|0
7003627|NCT01412944|11070194|FG001|Entire: IV + Maintenance|Adverse Event|0
7003628|NCT01412944|11070195|FG002|Entire: IV + Maintenance|Adverse Event|0
7003629|NCT01412944|11070196|FG003|Entire: IV + Maintenance|Adverse Event|0
7003630|NCT01412944|11070197|FG004|Entire: IV + Maintenance|Adverse Event|1
7003631|NCT01412944|11070198|FG005|Entire: IV + Maintenance|Adverse Event|0
7003632|NCT01412944|11070193|FG000|Entire: IV + Maintenance|Protocol deviation|0
7003633|NCT01412944|11070194|FG001|Entire: IV + Maintenance|Protocol deviation|0
7003634|NCT01412944|11070195|FG002|Entire: IV + Maintenance|Protocol deviation|0
7003635|NCT01412944|11070196|FG003|Entire: IV + Maintenance|Protocol deviation|0
7003636|NCT01412944|11070197|FG004|Entire: IV + Maintenance|Protocol deviation|0
7003637|NCT01412944|11070198|FG005|Entire: IV + Maintenance|Protocol deviation|1
7003638|NCT01412944|11070193|FG000|Entire: IV + Maintenance|Lost to Follow-up|0
7003639|NCT01412944|11070194|FG001|Entire: IV + Maintenance|Lost to Follow-up|0
7003640|NCT01412944|11070195|FG002|Entire: IV + Maintenance|Lost to Follow-up|0
7003641|NCT01412944|11070196|FG003|Entire: IV + Maintenance|Lost to Follow-up|0
7003642|NCT01412944|11070197|FG004|Entire: IV + Maintenance|Lost to Follow-up|0
7003643|NCT01412944|11070198|FG005|Entire: IV + Maintenance|Lost to Follow-up|1
7003644|NCT01412944|11070193|FG000|Entire: IV + Maintenance|Lack of Efficacy|0
7003645|NCT01412944|11070194|FG001|Entire: IV + Maintenance|Lack of Efficacy|0
7003646|NCT01412944|11070195|FG002|Entire: IV + Maintenance|Lack of Efficacy|0
7003647|NCT01412944|11070196|FG003|Entire: IV + Maintenance|Lack of Efficacy|0
7003648|NCT01412944|11070197|FG004|Entire: IV + Maintenance|Lack of Efficacy|1
7003649|NCT01412944|11070198|FG005|Entire: IV + Maintenance|Lack of Efficacy|0
7003650|NCT01412944|11070193|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2
7003651|NCT01412944|11070194|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1
7003652|NCT01412944|11070195|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0
7003653|NCT01412944|11070196|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0
7003654|NCT01412944|11070197|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0
7003655|NCT01412944|11070198|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0
7003656|NCT01412944|11070193|FG000|Entire: IV + Maintenance|Protocol deviation|0
7003657|NCT01412944|11070194|FG001|Entire: IV + Maintenance|Protocol deviation|1
7003658|NCT01412944|11070195|FG002|Entire: IV + Maintenance|Protocol deviation|0
7003659|NCT01412944|11070196|FG003|Entire: IV + Maintenance|Protocol deviation|0
7003660|NCT01412944|11070197|FG004|Entire: IV + Maintenance|Protocol deviation|0
7003661|NCT01412944|11070198|FG005|Entire: IV + Maintenance|Protocol deviation|0
7003662|NCT01412944|11070193|FG000|Entire: IV + Maintenance|Lost to Follow-up|0
7003663|NCT01412944|11070194|FG001|Entire: IV + Maintenance|Lost to Follow-up|1
7003664|NCT01412944|11070195|FG002|Entire: IV + Maintenance|Lost to Follow-up|0
7003665|NCT01412944|11070196|FG003|Entire: IV + Maintenance|Lost to Follow-up|0
7003666|NCT01412944|11070197|FG004|Entire: IV + Maintenance|Lost to Follow-up|0
7003667|NCT01412944|11070198|FG005|Entire: IV + Maintenance|Lost to Follow-up|0
7003668|NCT01412944|11070193|FG000|Entire: IV + Maintenance|Lack of Efficacy|0
7003669|NCT01412944|11070194|FG001|Entire: IV + Maintenance|Lack of Efficacy|1
7003670|NCT01412944|11070195|FG002|Entire: IV + Maintenance|Lack of Efficacy|0
7003671|NCT01412944|11070196|FG003|Entire: IV + Maintenance|Lack of Efficacy|0
7003672|NCT01412944|11070197|FG004|Entire: IV + Maintenance|Lack of Efficacy|0
7003673|NCT01412944|11070198|FG005|Entire: IV + Maintenance|Lack of Efficacy|0
7003674|NCT01412944|11070193|FG000|Entire: IV + Maintenance|Adverse Event|0
7003675|NCT01412944|11070194|FG001|Entire: IV + Maintenance|Adverse Event|1
7003676|NCT01412944|11070195|FG002|Entire: IV + Maintenance|Adverse Event|0
7003677|NCT01412944|11070196|FG003|Entire: IV + Maintenance|Adverse Event|0
7003678|NCT01412944|11070197|FG004|Entire: IV + Maintenance|Adverse Event|0
7003679|NCT01412944|11070198|FG005|Entire: IV + Maintenance|Adverse Event|0
7003680|NCT01412957|11070216|FG000|Overall Study|Withdrawal by Subject|6
7003681|NCT01412957|11070217|FG001|Overall Study|Withdrawal by Subject|22
7003682|NCT01412957|11070216|FG000|Overall Study|Lost to Follow-up|7
7003683|NCT01412957|11070217|FG001|Overall Study|Lost to Follow-up|2
7003684|NCT01412957|11070216|FG000|Overall Study|Death|136
7003685|NCT01412957|11070217|FG001|Overall Study|Death|133
7003686|NCT01412983|11070223|FG000|1st Period|Ineligible|0
7003687|NCT01412983|11070224|FG001|1st Period|Ineligible|1
7003688|NCT01412983|11070223|FG000|1st Period|Positive slit lamp finding|0
7003689|NCT01412983|11070224|FG001|1st Period|Positive slit lamp finding|1
7003690|NCT01412983|11070223|FG000|1st Period|Unacceptable lens movement|0
7003691|NCT01412983|11070224|FG001|1st Period|Unacceptable lens movement|1
7003692|NCT01412983|11070223|FG000|1st Period|Inability to maintain wear|0
7003693|NCT01412983|11070224|FG001|1st Period|Inability to maintain wear|1
7003694|NCT01413178|11070242|FG000|Overall Study|Toxicity|1
7003695|NCT01413178|11070243|FG001|Overall Study|Toxicity|0
7003696|NCT01413178|11070242|FG000|Overall Study|Ineligible|0
7003697|NCT01413178|11070243|FG001|Overall Study|Ineligible|2
7003698|NCT01413191|11070249|FG000|Overall Study|Lost to Follow-up|5
7003699|NCT01413191|11070249|FG000|Overall Study|Disease Progression|5
7003700|NCT01413191|11070249|FG000|Overall Study|Death|1
7003701|NCT01413204|11070256|FG000|Overall Study|Adverse Event|1
7003702|NCT01413204|11070257|FG001|Overall Study|Adverse Event|2
7003703|NCT01413204|11070258|FG002|Overall Study|Adverse Event|2
7003704|NCT01413204|11070256|FG000|Overall Study|Physician Decision|3
7003705|NCT01413204|11070257|FG001|Overall Study|Physician Decision|0
7003706|NCT01413204|11070258|FG002|Overall Study|Physician Decision|2
7003707|NCT01413204|11070256|FG000|Overall Study|Withdrawal by Subject|1
7003708|NCT01413204|11070257|FG001|Overall Study|Withdrawal by Subject|4
7003709|NCT01413204|11070258|FG002|Overall Study|Withdrawal by Subject|4
7003710|NCT01413204|11070256|FG000|Overall Study|Clearly not eligible for the study|0
7003711|NCT01413204|11070257|FG001|Overall Study|Clearly not eligible for the study|0
7003712|NCT01413204|11070258|FG002|Overall Study|Clearly not eligible for the study|1
7003713|NCT01413204|11070256|FG000|Overall Study|Fasting plasma glucose level increased|1
7003714|NCT01413204|11070257|FG001|Overall Study|Fasting plasma glucose level increased|0
7003715|NCT01413204|11070258|FG002|Overall Study|Fasting plasma glucose level increased|10
7003716|NCT01413360|11070266|FG000|Overall Study|Lost to Follow-up|2
7003717|NCT01413360|11070266|FG000|Overall Study|Adverse Event|1
7003718|NCT01413503|11070270|FG000|Overall Study|Lost to Follow-up|1
7003719|NCT01413542|11070285|FG000|Overall Study|Physician Decision|1
7003720|NCT01413542|11070286|FG001|Overall Study|Physician Decision|0
7003721|NCT01413542|11070287|FG002|Overall Study|Physician Decision|3
7003722|NCT01413542|11070288|FG003|Overall Study|Physician Decision|0
7003723|NCT01413542|11070285|FG000|Overall Study|Adverse Event|0
7003724|NCT01413542|11070286|FG001|Overall Study|Adverse Event|0
7003725|NCT01413542|11070287|FG002|Overall Study|Adverse Event|0
7003726|NCT01413542|11070288|FG003|Overall Study|Adverse Event|1
7003727|NCT01413958|11070320|FG000|Overall Study|Lost to Follow-up|0
7003728|NCT01413958|11070321|FG001|Overall Study|Lost to Follow-up|1
7003729|NCT01414075|11070364|FG000|Overall Study|Adverse Event|1
7003730|NCT01414075|11070365|FG001|Overall Study|Adverse Event|0
7003731|NCT01414075|11070366|FG002|Overall Study|Adverse Event|1
7003732|NCT01414075|11070367|FG003|Overall Study|Adverse Event|0
7003733|NCT01414075|11070364|FG000|Overall Study|Death|1
7003734|NCT01414075|11070365|FG001|Overall Study|Death|0
7003735|NCT01414075|11070366|FG002|Overall Study|Death|0
7003736|NCT01414075|11070367|FG003|Overall Study|Death|1
7003737|NCT01414075|11070364|FG000|Overall Study|Withdrawal by Subject|0
7003738|NCT01414075|11070365|FG001|Overall Study|Withdrawal by Subject|0
7003739|NCT01414075|11070366|FG002|Overall Study|Withdrawal by Subject|0
7003740|NCT01414075|11070367|FG003|Overall Study|Withdrawal by Subject|1
7003741|NCT01414075|11070364|FG000|Overall Study|Other than specified|1
7003742|NCT01414075|11070365|FG001|Overall Study|Other than specified|0
7003743|NCT01414075|11070366|FG002|Overall Study|Other than specified|1
7003744|NCT01414075|11070367|FG003|Overall Study|Other than specified|0
7003745|NCT01414114|11070377|FG000|Overall Study|Adverse Event|2
7003746|NCT01414114|11070377|FG000|Overall Study|Withdrawal by Subject|1
7003747|NCT01414114|11070377|FG000|Overall Study|Other|2
7003748|NCT01414205|11070402|FG000|Overall Study|Death|5
7003749|NCT01414205|11070403|FG001|Overall Study|Death|1
7003750|NCT01414205|11070402|FG000|Overall Study|Lost to Follow-up|1
7003751|NCT01414205|11070403|FG001|Overall Study|Lost to Follow-up|4
7003752|NCT01414205|11070402|FG000|Overall Study|Physician Decision|0
7003753|NCT01414205|11070403|FG001|Overall Study|Physician Decision|1
7003754|NCT01414205|11070402|FG000|Overall Study|Randomized but not Treated|1
7003755|NCT01414205|11070403|FG001|Overall Study|Randomized but not Treated|1
7003756|NCT01414257|11070418|FG000|Overall Study|No Visit After First Day of Treatment|12
7003757|NCT01414257|11070418|FG000|Overall Study|Protocol Violation|10
7003758|NCT01414738|11070458|FG000|Overall Study|Death|26
7003759|NCT01414738|11070458|FG000|Overall Study|Refused testing|5
7003760|NCT01414738|11070458|FG000|Overall Study|Lost to Follow-up|2
7003761|NCT01414738|11070458|FG000|Overall Study|Refused, disease progression|8
7003762|NCT01414738|11070458|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3
7003763|NCT01414855|11070462|FG000|Overall Study|Death|17
7003764|NCT01414855|11070462|FG000|Overall Study|Lost to Follow-up|5
7003765|NCT01414855|11070462|FG000|Overall Study|Withdrawal by Subject|7
7003766|NCT01415349|11070470|FG000|Treatment Period 1|Adverse Event|0
7003767|NCT01415349|11070471|FG001|Treatment Period 1|Adverse Event|1
7003768|NCT01415349|11070470|FG000|Treatment Period 1|Withdrawal by Subject|0
7003769|NCT01415349|11070471|FG001|Treatment Period 1|Withdrawal by Subject|1
7003770|NCT01415401|11070477|FG000|Overall Study|Adverse Event|5
7003771|NCT01415401|11070477|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1
7003772|NCT01415401|11070477|FG000|Overall Study|Terminated by Sponsor|1
7003773|NCT01415440|11070503|FG000|Overall Study|Lost to Follow-up|0
7003774|NCT01415440|11070504|FG001|Overall Study|Lost to Follow-up|1
7003775|NCT01415440|11070505|FG002|Overall Study|Lost to Follow-up|2
7003776|NCT01415440|11070503|FG000|Overall Study|Physician Decision|3
7003777|NCT01415440|11070504|FG001|Overall Study|Physician Decision|0
7003778|NCT01415440|11070505|FG002|Overall Study|Physician Decision|0
7003779|NCT01415440|11070503|FG000|Overall Study|Withdrawal by Subject|1
7003780|NCT01415440|11070504|FG001|Overall Study|Withdrawal by Subject|0
7003781|NCT01415440|11070505|FG002|Overall Study|Withdrawal by Subject|0
7003782|NCT01415518|11070518|FG000|Overall Study|Withdrawal by Subject|2
7003783|NCT01415518|11070519|FG001|Overall Study|Withdrawal by Subject|12
7003784|NCT01415518|11070518|FG000|Overall Study|Protocol Violation|6
7003785|NCT01415518|11070519|FG001|Overall Study|Protocol Violation|8
7003786|NCT01415518|11070518|FG000|Overall Study|Lost to Follow-up|3
7003787|NCT01415518|11070519|FG001|Overall Study|Lost to Follow-up|5
7003788|NCT01415518|11070518|FG000|Overall Study|Adverse Event|3
7003789|NCT01415518|11070519|FG001|Overall Study|Adverse Event|4
7003790|NCT01415518|11070518|FG000|Overall Study|Death|1
7003791|NCT01415518|11070519|FG001|Overall Study|Death|1
7003792|NCT01415518|11070518|FG000|Overall Study|Condition under Investigation Worsened|1
7003793|NCT01415518|11070519|FG001|Overall Study|Condition under Investigation Worsened|1
7003794|NCT01415531|11070527|FG000|Overall Study|Adverse Event|7
7003795|NCT01415531|11070528|FG001|Overall Study|Adverse Event|10
7003796|NCT01415531|11070527|FG000|Overall Study|Lack of Efficacy|3
7003797|NCT01415531|11070528|FG001|Overall Study|Lack of Efficacy|2
7003798|NCT01415531|11070527|FG000|Overall Study|Protocol Violation|0
7003799|NCT01415531|11070528|FG001|Overall Study|Protocol Violation|1
7003800|NCT01415531|11070527|FG000|Overall Study|Withdrawal by Subject|5
7003801|NCT01415531|11070528|FG001|Overall Study|Withdrawal by Subject|4
7003802|NCT01415531|11070527|FG000|Overall Study|Lost to Follow-up|6
7003803|NCT01415531|11070528|FG001|Overall Study|Lost to Follow-up|14
7003804|NCT01415531|11070527|FG000|Overall Study|Lack of Compliance|1
7003805|NCT01415531|11070528|FG001|Overall Study|Lack of Compliance|4
7003806|NCT01415531|11070527|FG000|Overall Study|Other Reasons|3
7003807|NCT01415531|11070528|FG001|Overall Study|Other Reasons|2
7003808|NCT01415908|11070545|FG000|Overall Study|Withdrawal by Subject|1
7003809|NCT01415908|11070546|FG001|Overall Study|Withdrawal by Subject|0
7003810|NCT01415921|11070554|FG000|Overall Study|Adverse Event|0
7003811|NCT01415921|11070555|FG001|Overall Study|Adverse Event|1
7003812|NCT01415921|11070554|FG000|Overall Study|Physician Decision|1
7003813|NCT01415921|11070555|FG001|Overall Study|Physician Decision|1
7003814|NCT01415921|11070554|FG000|Overall Study|Withdrawal by Subject|0
7003815|NCT01415921|11070555|FG001|Overall Study|Withdrawal by Subject|1
7003816|NCT01415921|11070554|FG000|Overall Study|Other|2
7003817|NCT01415921|11070555|FG001|Overall Study|Other|0
7003818|NCT01416142|11070592|FG000|PureVision2 HD|Inability to maintain lens wear|0
7003819|NCT01416142|11070593|FG001|PureVision2 HD|Inability to maintain lens wear|0
7003820|NCT01416142|11070594|FG002|PureVision2 HD|Inability to maintain lens wear|1
7003821|NCT01416155|11070602|FG000|Overall Study|Adverse Event|8
7003822|NCT01416155|11070602|FG000|Overall Study|Positive for anti-BG00002 antibodies|2
7003823|NCT01416155|11070602|FG000|Overall Study|Withdrawal by Subject|33
7003824|NCT01416155|11070602|FG000|Overall Study|Investigator decision|8
7003825|NCT01416155|11070602|FG000|Overall Study|Other|7
7003826|NCT01416181|11070608|FG000|Part 1|Other|10
7003827|NCT01416181|11070609|FG001|Part 1|Other|24
7003828|NCT01416181|11070608|FG000|Part 1|Death|0
7003829|NCT01416181|11070609|FG001|Part 1|Death|1
7003830|NCT01416181|11070608|FG000|Part 1|Investigator Decision|7
7003831|NCT01416181|11070609|FG001|Part 1|Investigator Decision|6
7003832|NCT01416181|11070608|FG000|Part 1|Withdrawal by Subject|74
7003833|NCT01416181|11070609|FG001|Part 1|Withdrawal by Subject|48
7003834|NCT01416181|11070608|FG000|Part 1|Lack of Efficacy|16
7003835|NCT01416181|11070609|FG001|Part 1|Lack of Efficacy|8
7003836|NCT01416181|11070608|FG000|Part 1|Lost to Follow-up|1
7003837|NCT01416181|11070609|FG001|Part 1|Lost to Follow-up|1
7003838|NCT01416181|11070608|FG000|Part 1|Adverse Event|15
7003839|NCT01416181|11070609|FG001|Part 1|Adverse Event|18
7003840|NCT01416181|11070608|FG000|Part 1|Ongoing in Follow-Up|14
7003841|NCT01416181|11070609|FG001|Part 1|Ongoing in Follow-Up|8
7003842|NCT01416181|11070608|FG000|Part 2|Adverse Event|11
7003843|NCT01416181|11070609|FG001|Part 2|Adverse Event|4
7003844|NCT01416181|11070608|FG000|Part 2|Other|234
7003845|NCT01416181|11070609|FG001|Part 2|Other|267
7003846|NCT01416181|11070608|FG000|Part 2|Investigator Decision|6
7003847|NCT01416181|11070609|FG001|Part 2|Investigator Decision|7
7003848|NCT01416181|11070608|FG000|Part 2|Withdrawal by Subject|14
7003849|NCT01416181|11070609|FG001|Part 2|Withdrawal by Subject|5
7003850|NCT01416181|11070608|FG000|Part 2|Lack of Efficacy|4
7003851|NCT01416181|11070609|FG001|Part 2|Lack of Efficacy|1
7003852|NCT01416181|11070608|FG000|Part 2|Lost to Follow-up|2
7003853|NCT01416181|11070609|FG001|Part 2|Lost to Follow-up|2
7003854|NCT01416389|11070632|FG000|Overall Study|Lost to Follow-up|1
7003855|NCT01416389|11070633|FG001|Overall Study|Lost to Follow-up|0
7003856|NCT01416389|11070632|FG000|Overall Study|Started New Therapy|2
7003857|NCT01416389|11070633|FG001|Overall Study|Started New Therapy|0
7003858|NCT01416441|11070641|FG000|Overall Study|Lost to Follow-up|5
7003859|NCT01416441|11070641|FG000|Overall Study|Adverse Event|6
7003860|NCT01416441|11070641|FG000|Overall Study|Sponsor Discontinued Trial Site|43
7003861|NCT01416441|11070641|FG000|Overall Study|Subject Met Withdrawal Criteria|10
7003862|NCT01416441|11070641|FG000|Overall Study|Investigator Withdrew Subject|2
7003863|NCT01416441|11070641|FG000|Overall Study|Subject Withdrew Consent|12
7003864|NCT01416441|11070641|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3
7003865|NCT01416571|11070645|FG000|Overall Study|Lost to Follow-up|2
7003866|NCT01416610|11070668|FG000|Overall Study|Adverse Event|4
7003867|NCT01416610|11070668|FG000|Overall Study|Adverse Event -Patient decision|3
7003868|NCT01416610|11070668|FG000|Overall Study|Lack of Efficacy|4
7003869|NCT01416610|11070668|FG000|Overall Study|No reason given|5
7003870|NCT01416610|11070668|FG000|Overall Study|Withdrawal by Subject|13
7003871|NCT01416610|11070668|FG000|Overall Study|Lost to Follow-up|7
7003872|NCT01416610|11070668|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7
7003873|NCT01416805|11070678|FG000|Overall Study|Lost to Follow-up|4
7003874|NCT01416805|11070679|FG001|Overall Study|Lost to Follow-up|4
7003875|NCT01417000|11070691|FG000|Overall Study|Death|59
7003876|NCT01417000|11070692|FG001|Overall Study|Death|28
7003877|NCT01417000|11070691|FG000|Overall Study|Lost to Follow-up|1
7003878|NCT01417000|11070692|FG001|Overall Study|Lost to Follow-up|0
7003879|NCT01417000|11070691|FG000|Overall Study|Study Terminated by Sponsor|1
7003880|NCT01417000|11070692|FG001|Overall Study|Study Terminated by Sponsor|1
7003881|NCT01417078|11070707|FG000|Overall Study|Withdrawal by Subject|1
7003882|NCT01417104|11070715|FG000|Overall Study|Withdrawal by Subject|5
7003883|NCT01417104|11070716|FG001|Overall Study|Withdrawal by Subject|1
7003884|NCT01417104|11070715|FG000|Overall Study|Failure to make contact|0
7003885|NCT01417104|11070716|FG001|Overall Study|Failure to make contact|1
7003886|NCT01417104|11070715|FG000|Overall Study|Adverse Event|1
7003887|NCT01417104|11070716|FG001|Overall Study|Adverse Event|0
7003888|NCT01417156|11070722|FG000|Overall Study|Adverse Event|12
7003889|NCT01417156|11070722|FG000|Overall Study|Protocol Violation|2
7003890|NCT01417195|11070728|FG000|Overall Study|Stimulation failure|1
7003891|NCT01417195|11070729|FG001|Overall Study|Stimulation failure|0
7003892|NCT01417195|11070728|FG000|Overall Study|No embryos for transfer|0
7003893|NCT01417195|11070729|FG001|Overall Study|No embryos for transfer|1
7003894|NCT01417195|11070728|FG000|Overall Study|No transfer due to risk of OHSS|1
7003895|NCT01417195|11070729|FG001|Overall Study|No transfer due to risk of OHSS|0
7003896|NCT01417195|11070728|FG000|Overall Study|No transfer due to elevated progesterone|1
7003897|NCT01417195|11070729|FG001|Overall Study|No transfer due to elevated progesterone|0
7003898|NCT01417234|11070736|FG000|Overall Study|Subject non-compliant|3
7003899|NCT01417481|11070775|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0
7003900|NCT01417481|11070776|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2
7003901|NCT01418209|11070816|FG000|Overall Study|Withdrawal by Subject|1
7003902|NCT01418209|11070817|FG001|Overall Study|Withdrawal by Subject|0
7003903|NCT01418209|11070818|FG002|Overall Study|Withdrawal by Subject|1
7003904|NCT01418209|11070816|FG000|Overall Study|Did not provide hot flash diary data|1
7003905|NCT01418209|11070817|FG001|Overall Study|Did not provide hot flash diary data|3
7003906|NCT01418209|11070818|FG002|Overall Study|Did not provide hot flash diary data|3
7003907|NCT01418339|11070828|FG000|Overall Study|Adverse Event|5
7003908|NCT01418339|11070829|FG001|Overall Study|Adverse Event|2
7003909|NCT01418339|11070828|FG000|Overall Study|Subject Withdrew Consent|1
7003910|NCT01418339|11070829|FG001|Overall Study|Subject Withdrew Consent|2
7003911|NCT01418339|11070828|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6
7003912|NCT01418339|11070829|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6
7003913|NCT01418352|11070839|FG000|Overall Study|Lost to Follow-up|2
7003914|NCT01418352|11070840|FG001|Overall Study|Lost to Follow-up|0
7003915|NCT01418352|11070841|FG002|Overall Study|Lost to Follow-up|0
7003916|NCT01418352|11070842|FG003|Overall Study|Lost to Follow-up|0
7003917|NCT01418352|11070839|FG000|Overall Study|Adverse Event|0
7003918|NCT01418352|11070840|FG001|Overall Study|Adverse Event|1
7003919|NCT01418352|11070841|FG002|Overall Study|Adverse Event|0
7003920|NCT01418352|11070842|FG003|Overall Study|Adverse Event|0
7003921|NCT01418352|11070839|FG000|Overall Study|Sponsor Discontinued Trial Site|0
7003922|NCT01418352|11070840|FG001|Overall Study|Sponsor Discontinued Trial Site|2
7003923|NCT01418352|11070841|FG002|Overall Study|Sponsor Discontinued Trial Site|2
7003924|NCT01418352|11070842|FG003|Overall Study|Sponsor Discontinued Trial Site|2
7003925|NCT01418352|11070839|FG000|Overall Study|Subject Withdrew Consent|0
7003926|NCT01418352|11070840|FG001|Overall Study|Subject Withdrew Consent|1
7003927|NCT01418352|11070841|FG002|Overall Study|Subject Withdrew Consent|2
7003928|NCT01418352|11070842|FG003|Overall Study|Subject Withdrew Consent|1
7003929|NCT01418352|11070839|FG000|Overall Study|Protocol Deviation|0
7003930|NCT01418352|11070840|FG001|Overall Study|Protocol Deviation|0
7003931|NCT01418352|11070841|FG002|Overall Study|Protocol Deviation|1
7003932|NCT01418352|11070842|FG003|Overall Study|Protocol Deviation|0
7003933|NCT01418352|11070839|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1
7003934|NCT01418352|11070840|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0
7003935|NCT01418352|11070841|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0
7003936|NCT01418352|11070842|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0
7003937|NCT01418365|11070854|FG000|First Intervention|Withdrawal by Subject|0
7003938|NCT01418365|11070855|FG001|First Intervention|Withdrawal by Subject|1
7003939|NCT01418365|11070854|FG000|First Intervention|Non-compliance|1
7003940|NCT01418365|11070855|FG001|First Intervention|Non-compliance|0
7003941|NCT01418365|11070854|FG000|Second Intervention|Withdrawal by Subject|0
7003942|NCT01418365|11070855|FG001|Second Intervention|Withdrawal by Subject|1
7003943|NCT01418378|11070863|FG000|Overall Study|Death|1
7003944|NCT01418378|11070864|FG001|Overall Study|Death|2
7003945|NCT01418378|11070863|FG000|Overall Study|Physician Decision|0
7003946|NCT01418378|11070864|FG001|Overall Study|Physician Decision|1
7003947|NCT01418378|11070863|FG000|Overall Study|ligament imbalance|0
7003948|NCT01418378|11070864|FG001|Overall Study|ligament imbalance|1
7003949|NCT01418378|11070863|FG000|Overall Study|developed chronic myopathy|0
7003950|NCT01418378|11070864|FG001|Overall Study|developed chronic myopathy|1
7003951|NCT01418937|11070886|FG000|Overall Study|Lost to Follow-up|5
7003952|NCT01418937|11070886|FG000|Overall Study|Protocol Violation|1
7003953|NCT01418937|11070886|FG000|Overall Study|Pregnancy|1
7003954|NCT01418937|11070886|FG000|Overall Study|Withdrawal by Subject|1
7003955|NCT01419015|11070890|FG000|Overall Study|Death|2
7003956|NCT01419184|11070904|FG000|Overall Study|Site data not available|3
7003957|NCT01419184|11070905|FG001|Overall Study|Site data not available|2
7003958|NCT01419184|11070904|FG000|Overall Study|No IRLOS-No in-patient end date reported|3
7003959|NCT01419184|11070905|FG001|Overall Study|No IRLOS-No in-patient end date reported|6
7003960|NCT01419184|11070904|FG000|Overall Study|No IRLOS-randomized, not treated|2
7003961|NCT01419184|11070905|FG001|Overall Study|No IRLOS-randomized, not treated|4
7003962|NCT01419184|11070904|FG000|Overall Study|No IRLOS-non trial antibiotic used|1
7003963|NCT01419184|11070905|FG001|Overall Study|No IRLOS-non trial antibiotic used|2
7003964|NCT01419184|11070904|FG000|Overall Study|No IRLOS-No adverse event treatment date|0
7003965|NCT01419184|11070905|FG001|Overall Study|No IRLOS-No adverse event treatment date|1
7003966|NCT01419184|11070904|FG000|Overall Study|Participant randomized, not treated|1
7003967|NCT01419184|11070905|FG001|Overall Study|Participant randomized, not treated|0
7003968|NCT01419197|11070913|FG000|Overall Study|Death|247
7003969|NCT01419197|11070914|FG001|Overall Study|Death|122
7003970|NCT01419197|11070913|FG000|Overall Study|Physician Decision|4
7003971|NCT01419197|11070914|FG001|Overall Study|Physician Decision|4
7003972|NCT01419197|11070913|FG000|Overall Study|Non-compliance|3
7003973|NCT01419197|11070914|FG001|Overall Study|Non-compliance|1
7003974|NCT01419197|11070913|FG000|Overall Study|Withdrawal by Subject|33
7003975|NCT01419197|11070914|FG001|Overall Study|Withdrawal by Subject|32
7003976|NCT01419197|11070913|FG000|Overall Study|Study Completed by Sponsor|103
7003977|NCT01419197|11070914|FG001|Overall Study|Study Completed by Sponsor|34
7003978|NCT01419197|11070913|FG000|Overall Study|Reason Not Specified|0
7003979|NCT01419197|11070914|FG001|Overall Study|Reason Not Specified|1
7003980|NCT01419197|11070913|FG000|Overall Study|Lost to Follow-up|14
7003981|NCT01419197|11070914|FG001|Overall Study|Lost to Follow-up|4
7003982|NCT01419236|11070923|FG000|Overall Study|Adverse Event|1
7003983|NCT01419236|11070924|FG001|Overall Study|Adverse Event|0
7003984|NCT01419236|11070923|FG000|Overall Study|Lack of Efficacy|0
7003985|NCT01419236|11070924|FG001|Overall Study|Lack of Efficacy|1
7003986|NCT01419236|11070923|FG000|Overall Study|Lost to Follow-up|1
7003987|NCT01419236|11070924|FG001|Overall Study|Lost to Follow-up|0
7003988|NCT01419236|11070923|FG000|Overall Study|Physician Decision|1
7003989|NCT01419236|11070924|FG001|Overall Study|Physician Decision|0
7003990|NCT01419236|11070923|FG000|Overall Study|Withdrawal by Subject|1
7003991|NCT01419236|11070924|FG001|Overall Study|Withdrawal by Subject|4
7003992|NCT01419236|11070923|FG000|Overall Study|Entry Criteria Not Met|1
7003993|NCT01419236|11070924|FG001|Overall Study|Entry Criteria Not Met|0
7003994|NCT01419314|11070946|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3
7003995|NCT01419314|11070947|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1
7003996|NCT01419314|11070946|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3
7003997|NCT01419314|11070947|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0
7003998|NCT01419314|11070946|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1
7003999|NCT01419314|11070947|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2
7004000|NCT01419535|11070959|FG000|Overall Study|could not maintain iv line|1
7004001|NCT01419535|11070960|FG001|Overall Study|could not maintain iv line|1
7004002|NCT01419535|11070959|FG000|Overall Study|Withdrawal by Subject|0
7004003|NCT01419535|11070960|FG001|Overall Study|Withdrawal by Subject|1
7004004|NCT01419626|11070969|FG000|Overall Study|Protocol Violation|3
7004005|NCT01419626|11070970|FG001|Overall Study|Protocol Violation|2
7004006|NCT01419626|11070971|FG002|Overall Study|Protocol Violation|2
7004007|NCT01419626|11070969|FG000|Overall Study|Withdrawal by Subject|1
7004008|NCT01419626|11070970|FG001|Overall Study|Withdrawal by Subject|0
7004009|NCT01419626|11070971|FG002|Overall Study|Withdrawal by Subject|0
7004010|NCT01419626|11070969|FG000|Overall Study|Lost to Follow-up|0
7004011|NCT01419626|11070970|FG001|Overall Study|Lost to Follow-up|1
7004012|NCT01419626|11070971|FG002|Overall Study|Lost to Follow-up|1
7004013|NCT01419665|11070985|FG000|Combination Treatment|Adverse Event|7
7004014|NCT01419665|11070986|FG001|Combination Treatment|Adverse Event|10
7004015|NCT01419665|11070985|FG000|Combination Treatment|Physician Decision|5
7004016|NCT01419665|11070986|FG001|Combination Treatment|Physician Decision|8
7004017|NCT01419665|11070985|FG000|Combination Treatment|Protocol Violation|6
7004018|NCT01419665|11070986|FG001|Combination Treatment|Protocol Violation|2
7004019|NCT01419665|11070985|FG000|Combination Treatment|disease progression|10
7004020|NCT01419665|11070986|FG001|Combination Treatment|disease progression|9
7004021|NCT01419665|11070985|FG000|Combination Treatment|Death|5
7004022|NCT01419665|11070986|FG001|Combination Treatment|Death|7
7004023|NCT01419665|11070985|FG000|Combination Treatment|administrative problems|0
7004024|NCT01419665|11070986|FG001|Combination Treatment|administrative problems|1
7004025|NCT01419665|11070985|FG000|Combination Treatment|Withdrawal by Subject|5
7004026|NCT01419665|11070986|FG001|Combination Treatment|Withdrawal by Subject|4
7004027|NCT01419665|11070985|FG000|Maintenance Treatment and/or Follow up|switch to open label|44
7004028|NCT01419665|11070986|FG001|Maintenance Treatment and/or Follow up|switch to open label|39
7004029|NCT01419665|11070985|FG000|Maintenance Treatment and/or Follow up|administrative problems|0
7004030|NCT01419665|11070986|FG001|Maintenance Treatment and/or Follow up|administrative problems|6
7004031|NCT01419665|11070985|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6
7004032|NCT01419665|11070986|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6
7004033|NCT01419665|11070985|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1
7004034|NCT01419665|11070986|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1
7004035|NCT01419665|11070985|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5
7004036|NCT01419665|11070986|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2
7004037|NCT01419665|11070985|FG000|Maintenance Treatment and/or Follow up|disease progression|53
7004038|NCT01419665|11070986|FG001|Maintenance Treatment and/or Follow up|disease progression|37
7004039|NCT01419665|11070985|FG000|Maintenance Treatment and/or Follow up|Death|1
7004040|NCT01419665|11070986|FG001|Maintenance Treatment and/or Follow up|Death|2
7004041|NCT01419665|11070985|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11
7004042|NCT01419665|11070986|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7
7004043|NCT01419665|11070985|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1
7004044|NCT01419665|11070986|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2
7004045|NCT01419665|11070985|FG000|Open Label Phase|Death|1
7004046|NCT01419665|11070986|FG001|Open Label Phase|Death|0
7004047|NCT01419665|11070985|FG000|Open Label Phase|disease progression|0
7004048|NCT01419665|11070986|FG001|Open Label Phase|disease progression|1
7004049|NCT01419717|11070994|FG000|Overall Study|Protocol-specified Criteria|62
7004050|NCT01419717|11070994|FG000|Overall Study|Adverse Event|19
7004051|NCT01419717|11070994|FG000|Overall Study|Death|17
7004052|NCT01419717|11070994|FG000|Overall Study|Withdrawal by Subject|10
7004053|NCT01419717|11070994|FG000|Overall Study|Disease Progression|9
7004054|NCT01419717|11070994|FG000|Overall Study|Other|4
7060400|NCT01918306|11156575|FG003|Overall Study|Withdrawal by Subject|2
7004055|NCT01419717|11070994|FG000|Overall Study|Lost to Follow-up|2
7004056|NCT01419717|11070994|FG000|Overall Study|Administrative Decision|1
7004057|NCT01419717|11070994|FG000|Overall Study|Noncompliance|1
7004058|NCT01419769|11070998|FG000|Overall Study|Did not receive the AXIOS stent|3
7004059|NCT01419769|11070998|FG000|Overall Study|Not evaluable due to pigtail stents|1
7004060|NCT01420068|11071033|FG000|Overall Study|Administrative problems|1
7004061|NCT01420068|11071034|FG001|Overall Study|Administrative problems|3
7004062|NCT01420068|11071033|FG000|Overall Study|Withdrawal by Subject|1
7004063|NCT01420068|11071034|FG001|Overall Study|Withdrawal by Subject|2
7004064|NCT01420081|11071049|FG000|Overall Study|Death|1
7004065|NCT01420081|11071050|FG001|Overall Study|Death|0
7004066|NCT01420081|11071051|FG002|Overall Study|Death|8
7004067|NCT01420081|11071052|FG003|Overall Study|Death|0
7004068|NCT01420081|11071053|FG004|Overall Study|Death|7
7004069|NCT01420081|11071054|FG005|Overall Study|Death|12
7004070|NCT01420081|11071055|FG006|Overall Study|Death|0
7004071|NCT01420081|11071056|FG007|Overall Study|Death|1
7004072|NCT01420081|11071057|FG008|Overall Study|Death|1
7004073|NCT01420081|11071049|FG000|Overall Study|Lost to Follow-up|0
7004074|NCT01420081|11071050|FG001|Overall Study|Lost to Follow-up|0
7004075|NCT01420081|11071051|FG002|Overall Study|Lost to Follow-up|0
7004076|NCT01420081|11071052|FG003|Overall Study|Lost to Follow-up|0
7004077|NCT01420081|11071053|FG004|Overall Study|Lost to Follow-up|1
7004078|NCT01420081|11071054|FG005|Overall Study|Lost to Follow-up|1
7004079|NCT01420081|11071055|FG006|Overall Study|Lost to Follow-up|0
7004080|NCT01420081|11071056|FG007|Overall Study|Lost to Follow-up|0
7004081|NCT01420081|11071057|FG008|Overall Study|Lost to Follow-up|0
7004082|NCT01420081|11071049|FG000|Overall Study|Study Terminated by Sponsor|2
7004083|NCT01420081|11071050|FG001|Overall Study|Study Terminated by Sponsor|1
7004084|NCT01420081|11071051|FG002|Overall Study|Study Terminated by Sponsor|1
7004085|NCT01420081|11071052|FG003|Overall Study|Study Terminated by Sponsor|3
7004086|NCT01420081|11071053|FG004|Overall Study|Study Terminated by Sponsor|11
7004087|NCT01420081|11071054|FG005|Overall Study|Study Terminated by Sponsor|7
7004088|NCT01420081|11071055|FG006|Overall Study|Study Terminated by Sponsor|3
7004089|NCT01420081|11071056|FG007|Overall Study|Study Terminated by Sponsor|2
7004090|NCT01420081|11071057|FG008|Overall Study|Study Terminated by Sponsor|2
7004091|NCT01420081|11071049|FG000|Overall Study|Subject Refused Futher Follow-up|0
7004092|NCT01420081|11071050|FG001|Overall Study|Subject Refused Futher Follow-up|0
7004093|NCT01420081|11071051|FG002|Overall Study|Subject Refused Futher Follow-up|1
7004094|NCT01420081|11071052|FG003|Overall Study|Subject Refused Futher Follow-up|0
7004095|NCT01420081|11071053|FG004|Overall Study|Subject Refused Futher Follow-up|1
7004096|NCT01420081|11071054|FG005|Overall Study|Subject Refused Futher Follow-up|0
7004097|NCT01420081|11071055|FG006|Overall Study|Subject Refused Futher Follow-up|0
7004098|NCT01420081|11071056|FG007|Overall Study|Subject Refused Futher Follow-up|0
7004099|NCT01420081|11071057|FG008|Overall Study|Subject Refused Futher Follow-up|0
7004100|NCT01420081|11071049|FG000|Overall Study|Other Reasons|0
7004101|NCT01420081|11071050|FG001|Overall Study|Other Reasons|0
7004102|NCT01420081|11071051|FG002|Overall Study|Other Reasons|1
7004103|NCT01420081|11071052|FG003|Overall Study|Other Reasons|0
7004104|NCT01420081|11071053|FG004|Overall Study|Other Reasons|0
7004105|NCT01420081|11071054|FG005|Overall Study|Other Reasons|0
7004106|NCT01420081|11071055|FG006|Overall Study|Other Reasons|0
7004107|NCT01420081|11071056|FG007|Overall Study|Other Reasons|0
7004108|NCT01420081|11071057|FG008|Overall Study|Other Reasons|0
7004109|NCT01420536|11071088|FG000|Period 1 (30 Days)|Withdrawal by Subject|3
7004110|NCT01420536|11071089|FG001|Period 1 (30 Days)|Withdrawal by Subject|0
7004111|NCT01420549|11071099|FG000|Overall Study|Adverse Event|1
7004112|NCT01420549|11071100|FG001|Overall Study|Adverse Event|1
7004113|NCT01420549|11071099|FG000|Overall Study|Lost to Follow-up|2
7004114|NCT01420549|11071100|FG001|Overall Study|Lost to Follow-up|2
7004115|NCT01420549|11071099|FG000|Overall Study|Protocol Violation|0
7004116|NCT01420549|11071100|FG001|Overall Study|Protocol Violation|1
7004117|NCT01420549|11071099|FG000|Overall Study|Non-adherence to medication|4
7004118|NCT01420549|11071100|FG001|Overall Study|Non-adherence to medication|1
7004119|NCT01420627|11071106|FG000|EZN-2279 Treatment Period|Adverse Event|1
7043005|NCT01739348|11127559|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0
7043006|NCT01739348|11127560|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0
7043007|NCT01739348|11127561|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0
7043008|NCT01739348|11127562|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1
7043009|NCT01739348|11127559|FG000|Part II (Extension Study)|Physician Decision|7
7043010|NCT01739348|11127560|FG001|Part II (Extension Study)|Physician Decision|11
7043011|NCT01739348|11127561|FG002|Part II (Extension Study)|Physician Decision|6
7043012|NCT01739348|11127562|FG003|Part II (Extension Study)|Physician Decision|12
7043013|NCT01739348|11127559|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329
7043014|NCT01739348|11127560|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315
7043015|NCT01739348|11127561|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34
7043016|NCT01739348|11127562|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323
7043017|NCT01739348|11127559|FG000|Part II (Extension Study)|Participant Moved|3
7043018|NCT01739348|11127560|FG001|Part II (Extension Study)|Participant Moved|3
7043019|NCT01739348|11127561|FG002|Part II (Extension Study)|Participant Moved|0
7043020|NCT01739348|11127562|FG003|Part II (Extension Study)|Participant Moved|3
7043021|NCT01739348|11127559|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18
7043022|NCT01739348|11127560|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12
7043023|NCT01739348|11127561|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8
7043024|NCT01739348|11127562|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16
7043025|NCT01739348|11127559|FG000|Part II (Extension Study)|Withdrawal by Subject|5
7043026|NCT01739348|11127560|FG001|Part II (Extension Study)|Withdrawal by Subject|2
7043027|NCT01739348|11127561|FG002|Part II (Extension Study)|Withdrawal by Subject|4
7043028|NCT01739348|11127562|FG003|Part II (Extension Study)|Withdrawal by Subject|7
7043029|NCT01739400|11127587|FG000|Overall Study|Physician Decision|3
7043030|NCT01739400|11127588|FG001|Overall Study|Physician Decision|0
7043031|NCT01739400|11127587|FG000|Overall Study|Lost to Follow-up|2
7043032|NCT01739400|11127588|FG001|Overall Study|Lost to Follow-up|0
7043033|NCT01739400|11127587|FG000|Overall Study|Death|5
7043034|NCT01739400|11127588|FG001|Overall Study|Death|2
7043035|NCT01739400|11127587|FG000|Overall Study|Withdrawal by Subject|7
7004120|NCT01420679|11071133|FG000|Overall Study|Disease Progression|3
7004121|NCT01420679|11071134|FG001|Overall Study|Disease Progression|2
7004122|NCT01420679|11071133|FG000|Overall Study|Adverse Event|4
7004123|NCT01420679|11071134|FG001|Overall Study|Adverse Event|0
7004124|NCT01420679|11071133|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1
7004125|NCT01420679|11071134|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0
7004126|NCT01420679|11071133|FG000|Overall Study|Patient Decision|1
7004127|NCT01420679|11071134|FG001|Overall Study|Patient Decision|0
7004128|NCT01420679|11071133|FG000|Overall Study|Investigator Decision|1
7004129|NCT01420679|11071134|FG001|Overall Study|Investigator Decision|2
7004130|NCT01420679|11071133|FG000|Overall Study|Sponsor Decision|3
7004131|NCT01420679|11071134|FG001|Overall Study|Sponsor Decision|3
7004132|NCT01420679|11071133|FG000|Overall Study|Other|1
7004133|NCT01420679|11071134|FG001|Overall Study|Other|0
7004134|NCT01421017|11071156|FG000|Overall Study|Withdrawal by Subject|2
7004135|NCT01421017|11071157|FG001|Overall Study|Withdrawal by Subject|0
7004136|NCT01421017|11071158|FG002|Overall Study|Withdrawal by Subject|0
7004137|NCT01421017|11071156|FG000|Overall Study|POD|0
7004138|NCT01421017|11071157|FG001|Overall Study|POD|6
7004139|NCT01421017|11071158|FG002|Overall Study|POD|3
7004140|NCT01421134|11071168|FG000|Overall Study|Adverse Event|3
7004141|NCT01421134|11071169|FG001|Overall Study|Adverse Event|5
7004142|NCT01421134|11071168|FG000|Overall Study|Lack of Efficacy|2
7004143|NCT01421134|11071169|FG001|Overall Study|Lack of Efficacy|4
7004144|NCT01421134|11071168|FG000|Overall Study|Protocol Violation|0
7004145|NCT01421134|11071169|FG001|Overall Study|Protocol Violation|3
7004146|NCT01421134|11071168|FG000|Overall Study|Withdrawal by Subject|1
7004147|NCT01421134|11071169|FG001|Overall Study|Withdrawal by Subject|1
7004148|NCT01421134|11071168|FG000|Overall Study|Administrative|0
7004149|NCT01421134|11071169|FG001|Overall Study|Administrative|1
7004150|NCT01421134|11071168|FG000|Overall Study|Lost to Follow-up|1
7004151|NCT01421134|11071169|FG001|Overall Study|Lost to Follow-up|1
7004152|NCT01421147|11071177|FG000|Treatment Period|Adverse Event|2
7004153|NCT01421147|11071178|FG001|Treatment Period|Adverse Event|3
7004154|NCT01421147|11071177|FG000|Treatment Period|Lost to Follow-up|2
7004155|NCT01421147|11071178|FG001|Treatment Period|Lost to Follow-up|1
7004156|NCT01421147|11071177|FG000|Treatment Period|Physician Decision|2
7004157|NCT01421147|11071178|FG001|Treatment Period|Physician Decision|2
7004158|NCT01421147|11071177|FG000|Treatment Period|Withdrawal by Subject|10
7004159|NCT01421147|11071178|FG001|Treatment Period|Withdrawal by Subject|5
7004160|NCT01421147|11071177|FG000|Extension Period|Adverse Event|0
7004161|NCT01421147|11071178|FG001|Extension Period|Adverse Event|2
7004162|NCT01421147|11071177|FG000|Extension Period|Death|0
7004163|NCT01421147|11071178|FG001|Extension Period|Death|1
7004164|NCT01421147|11071177|FG000|Extension Period|Lost to Follow-up|2
7004165|NCT01421147|11071178|FG001|Extension Period|Lost to Follow-up|5
7004166|NCT01421147|11071177|FG000|Extension Period|Physician Decision|1
7004167|NCT01421147|11071178|FG001|Extension Period|Physician Decision|0
7004168|NCT01421147|11071177|FG000|Extension Period|Withdrawal by Subject|5
7004169|NCT01421147|11071178|FG001|Extension Period|Withdrawal by Subject|3
7004170|NCT01421225|11071213|FG000|Overall Study|Withdrawal by Subject|0
7004171|NCT01421225|11071214|FG001|Overall Study|Withdrawal by Subject|1
7004172|NCT01421277|11071223|FG000|Overall Study|Lack of qualifying event|0
7004173|NCT01421277|11071224|FG001|Overall Study|Lack of qualifying event|61
7004174|NCT01421277|11071223|FG000|Overall Study|Incomplete baseline data|0
7004175|NCT01421277|11071224|FG001|Overall Study|Incomplete baseline data|31
7004176|NCT01421303|11071230|FG000|Overall Study|Lost to Follow-up|13
7004177|NCT01421303|11071230|FG000|Overall Study|Non compliance with study procedure|1
7004178|NCT01421303|11071230|FG000|Overall Study|Other|7
7004179|NCT01421303|11071230|FG000|Overall Study|Withdrawal by Subject|1
7004180|NCT01421342|11071237|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49
7004181|NCT01421342|11071238|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28
7004182|NCT01421342|11071239|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13
7004183|NCT01421342|11071237|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53
7004184|NCT01421342|11071238|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38
7004185|NCT01421342|11071239|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27
7004186|NCT01421342|11071237|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23
7004187|NCT01421342|11071238|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20
7004188|NCT01421342|11071239|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13
7004189|NCT01421342|11071237|FG000|Acute Treatment Phase (12 Weeks)|Death|0
7004190|NCT01421342|11071238|FG001|Acute Treatment Phase (12 Weeks)|Death|0
7004191|NCT01421342|11071239|FG002|Acute Treatment Phase (12 Weeks)|Death|3
7004192|NCT01421342|11071237|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6
7004193|NCT01421342|11071238|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18
7004194|NCT01421342|11071239|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21
7004195|NCT01421342|11071237|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15
7004196|NCT01421342|11071238|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7
7004197|NCT01421342|11071239|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13
7004198|NCT01421342|11071237|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3
7004199|NCT01421342|11071238|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2
7004200|NCT01421342|11071239|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4
7004201|NCT01421342|11071237|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1
7004202|NCT01421342|11071238|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6
7004203|NCT01421342|11071239|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1
7004204|NCT01421342|11071237|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8
7004205|NCT01421342|11071238|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9
7004206|NCT01421342|11071239|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4
7004207|NCT01421342|11071237|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111
7004208|NCT01421342|11071238|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93
7004209|NCT01421342|11071239|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88
7004210|NCT01421342|11071237|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7
7004211|NCT01421342|11071238|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10
7004212|NCT01421342|11071239|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12
7004213|NCT01421342|11071237|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4
7004214|NCT01421342|11071238|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3
7004215|NCT01421342|11071239|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6
7004216|NCT01421342|11071237|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13
7004217|NCT01421342|11071238|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4
7004218|NCT01421342|11071239|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11
7004219|NCT01421342|11071237|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4
7004220|NCT01421342|11071238|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
7004221|NCT01421342|11071239|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
7004222|NCT01421342|11071237|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5
7004223|NCT01421342|11071238|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4
7004224|NCT01421342|11071239|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5
7004225|NCT01421342|11071237|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1
7004226|NCT01421342|11071238|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0
7004227|NCT01421342|11071239|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2
7004228|NCT01421342|11071237|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1
7004229|NCT01421342|11071238|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
7004230|NCT01421342|11071239|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
7004231|NCT01421342|11071237|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
7004232|NCT01421342|11071238|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
7004233|NCT01421342|11071239|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4
7004234|NCT01421342|11071237|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0
7004235|NCT01421342|11071238|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0
7004236|NCT01421342|11071239|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2
7004237|NCT01421342|11071237|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
7004238|NCT01421342|11071238|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5
7004239|NCT01421342|11071239|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
7004240|NCT01421342|11071237|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0
7004241|NCT01421342|11071238|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6
7004242|NCT01421342|11071239|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11
7004243|NCT01421342|11071237|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7
7004244|NCT01421342|11071238|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6
7004245|NCT01421342|11071239|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4
7004246|NCT01421342|11071237|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4
7004247|NCT01421342|11071238|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11
7004248|NCT01421342|11071239|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9
7004249|NCT01421342|11071237|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3
7004250|NCT01421342|11071238|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8
7004251|NCT01421342|11071239|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4
7004252|NCT01421342|11071237|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15
7004253|NCT01421342|11071238|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20
7004254|NCT01421342|11071239|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14
7004255|NCT01421342|11071237|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4
7004256|NCT01421342|11071238|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1
7004257|NCT01421342|11071239|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3
7004258|NCT01421342|11071237|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
7004259|NCT01421342|11071238|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
7004260|NCT01421342|11071239|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
7004261|NCT01421342|11071237|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6
7004262|NCT01421342|11071238|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0
7004263|NCT01421342|11071239|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7
7004264|NCT01421459|11071253|FG000|Overall Study|Adverse Event|6
7004265|NCT01421459|11071254|FG001|Overall Study|Adverse Event|10
7004266|NCT01421459|11071253|FG000|Overall Study|Death|1
7004267|NCT01421459|11071254|FG001|Overall Study|Death|1
7004268|NCT01421459|11071253|FG000|Overall Study|Lack of Efficacy|1
7143153|NCT03026283|11299469|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
7004269|NCT01421459|11071254|FG001|Overall Study|Lack of Efficacy|2
7004270|NCT01421459|11071253|FG000|Overall Study|Lost to Follow-up|8
7004271|NCT01421459|11071254|FG001|Overall Study|Lost to Follow-up|9
7004272|NCT01421459|11071253|FG000|Overall Study|Physician Decision|9
7004273|NCT01421459|11071254|FG001|Overall Study|Physician Decision|9
7004274|NCT01421459|11071253|FG000|Overall Study|Protocol Violation|8
7004275|NCT01421459|11071254|FG001|Overall Study|Protocol Violation|5
7004276|NCT01421459|11071253|FG000|Overall Study|Withdrawal by Subject|12
7004277|NCT01421459|11071254|FG001|Overall Study|Withdrawal by Subject|16
7004278|NCT01421511|11071288|FG000|Overall Study|Lost to Follow-up|11
7004279|NCT01421511|11071289|FG001|Overall Study|Lost to Follow-up|14
7004280|NCT01421511|11071288|FG000|Overall Study|Randomized but didn't receive study drug|1
7004281|NCT01421511|11071289|FG001|Overall Study|Randomized but didn't receive study drug|7
7004282|NCT01421511|11071288|FG000|Overall Study|Physician Decision|0
7004283|NCT01421511|11071289|FG001|Overall Study|Physician Decision|1
7004284|NCT01421511|11071288|FG000|Overall Study|Withdrawal by Subject|6
7004285|NCT01421511|11071289|FG001|Overall Study|Withdrawal by Subject|5
7004286|NCT01421511|11071288|FG000|Overall Study|Death|1
7004287|NCT01421511|11071289|FG001|Overall Study|Death|1
7004288|NCT01421641|11071303|FG000|Overall Study|Protocol Violation|2
7004289|NCT01421641|11071304|FG001|Overall Study|Protocol Violation|2
7004290|NCT01421667|11071323|FG000|Overall Study|Withdrawal by Subject|0
7004291|NCT01421667|11071324|FG001|Overall Study|Withdrawal by Subject|1
7004292|NCT01421667|11071325|FG002|Overall Study|Withdrawal by Subject|2
7004293|NCT01421667|11071326|FG003|Overall Study|Withdrawal by Subject|1
7004294|NCT01421667|11071323|FG000|Overall Study|Lost to Follow-up|0
7004295|NCT01421667|11071324|FG001|Overall Study|Lost to Follow-up|1
7004296|NCT01421667|11071325|FG002|Overall Study|Lost to Follow-up|0
7004297|NCT01421667|11071326|FG003|Overall Study|Lost to Follow-up|0
7004298|NCT01421719|11071344|FG000|Overall Study|Withdrawal by Subject|4
7004299|NCT01422187|11071388|FG000|Overall Study|Personal reason|1
7004300|NCT01422187|11071389|FG001|Overall Study|Personal reason|0
7004301|NCT01422187|11071390|FG002|Overall Study|Personal reason|0
7004302|NCT01422187|11071388|FG000|Overall Study|Lost to Follow-up|0
7004303|NCT01422187|11071389|FG001|Overall Study|Lost to Follow-up|1
7004304|NCT01422187|11071390|FG002|Overall Study|Lost to Follow-up|0
7004305|NCT01422213|11071412|FG000|Overall Study|Adverse Event|8
7004306|NCT01422213|11071413|FG001|Overall Study|Adverse Event|7
7004307|NCT01422213|11071414|FG002|Overall Study|Adverse Event|11
7004308|NCT01422213|11071412|FG000|Overall Study|Lack of Efficacy|10
7004309|NCT01422213|11071413|FG001|Overall Study|Lack of Efficacy|2
7004310|NCT01422213|11071414|FG002|Overall Study|Lack of Efficacy|2
7004311|NCT01422213|11071412|FG000|Overall Study|Non-compliance with study drug|0
7004312|NCT01422213|11071413|FG001|Overall Study|Non-compliance with study drug|1
7004313|NCT01422213|11071414|FG002|Overall Study|Non-compliance with study drug|0
7004314|NCT01422213|11071412|FG000|Overall Study|Protocol Violation|0
7004315|NCT01422213|11071413|FG001|Overall Study|Protocol Violation|2
7004316|NCT01422213|11071414|FG002|Overall Study|Protocol Violation|4
7004317|NCT01422213|11071412|FG000|Overall Study|Withdrawal of Consent|7
7004318|NCT01422213|11071413|FG001|Overall Study|Withdrawal of Consent|3
7004319|NCT01422213|11071414|FG002|Overall Study|Withdrawal of Consent|5
7004320|NCT01422213|11071412|FG000|Overall Study|Lost to Follow-up|3
7004321|NCT01422213|11071413|FG001|Overall Study|Lost to Follow-up|3
7004322|NCT01422213|11071414|FG002|Overall Study|Lost to Follow-up|5
7004323|NCT01422213|11071412|FG000|Overall Study|Administrative or Other Reason(s)|5
7004324|NCT01422213|11071413|FG001|Overall Study|Administrative or Other Reason(s)|4
7004325|NCT01422213|11071414|FG002|Overall Study|Administrative or Other Reason(s)|2
7004326|NCT01422239|11071433|FG000|Overall Study|Lost to Follow-up|4
7004327|NCT01422239|11071434|FG001|Overall Study|Lost to Follow-up|3
7004328|NCT01422304|11071442|FG000|Overall Study|Adverse Event|0
7004329|NCT01422304|11071443|FG001|Overall Study|Adverse Event|1
7004330|NCT01422304|11071442|FG000|Overall Study|Lost to Follow-up|14
7004331|NCT01422304|11071443|FG001|Overall Study|Lost to Follow-up|20
7004332|NCT01422304|11071442|FG000|Overall Study|Never Entered Follow-up|2
7004333|NCT01422304|11071443|FG001|Overall Study|Never Entered Follow-up|1
7004334|NCT01422304|11071442|FG000|Overall Study|Protocol Violation|1
7004335|NCT01422304|11071443|FG001|Overall Study|Protocol Violation|0
7004336|NCT01422304|11071442|FG000|Overall Study|Withdrawal by Subject|4
7004337|NCT01422304|11071443|FG001|Overall Study|Withdrawal by Subject|2
7004338|NCT01422304|11071442|FG000|Overall Study|Did Not Meet Protocol Eligibility|0
7004339|NCT01422304|11071443|FG001|Overall Study|Did Not Meet Protocol Eligibility|2
7004340|NCT01422304|11071442|FG000|Overall Study|Not Treated|3
7004341|NCT01422304|11071443|FG001|Overall Study|Not Treated|11
7004342|NCT01422382|11071458|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1
7004343|NCT01422408|11071462|FG000|Overall Study|Adverse Event|1
7004344|NCT01422408|11071462|FG000|Overall Study|Withdrawal by Subject|3
7004345|NCT01422538|11071482|FG000|Overall Study|Lost to Follow-up|0
7004346|NCT01422538|11071483|FG001|Overall Study|Lost to Follow-up|1
7004347|NCT01422538|11071484|FG002|Overall Study|Lost to Follow-up|1
7004348|NCT01422538|11071482|FG000|Overall Study|Missed visit|0
7004349|NCT01422538|11071483|FG001|Overall Study|Missed visit|1
7004350|NCT01422538|11071484|FG002|Overall Study|Missed visit|1
7004351|NCT01422720|11071493|FG000|Overall Study|Adverse Event|16
7004352|NCT01422720|11071493|FG000|Overall Study|Lack of Efficacy|1
7004353|NCT01422720|11071493|FG000|Overall Study|Withdrawal by Subject|4
7004354|NCT01422720|11071493|FG000|Overall Study|Ineligibility|1
7004355|NCT01422824|11071501|FG000|Overall Study|Case record form not evaluated|1
7004356|NCT01422824|11071501|FG000|Overall Study|Lost to Follow-up|37
7004357|NCT01422850|11071505|FG000|Overall Study|Physician Decision|3
7004358|NCT01422876|11071521|FG000|Week 24|Lost to Follow-up|1
7004359|NCT01422876|11071522|FG001|Week 24|Lost to Follow-up|1
7004360|NCT01422876|11071523|FG002|Week 24|Lost to Follow-up|2
7004361|NCT01422876|11071524|FG003|Week 24|Lost to Follow-up|4
7004362|NCT01422876|11071525|FG004|Week 24|Lost to Follow-up|2
7004363|NCT01422876|11071526|FG005|Week 24|Lost to Follow-up|0
7004364|NCT01422876|11071527|FG006|Week 24|Lost to Follow-up|1
7004365|NCT01422876|11071528|FG007|Week 24|Lost to Follow-up|3
7004366|NCT01422876|11071529|FG008|Week 24|Lost to Follow-up|3
7004367|NCT01422876|11071530|FG009|Week 24|Lost to Follow-up|4
7004368|NCT01422876|11071521|FG000|Week 24|Consent withdrawn|5
7004369|NCT01422876|11071522|FG001|Week 24|Consent withdrawn|1
7004370|NCT01422876|11071523|FG002|Week 24|Consent withdrawn|3
7004371|NCT01422876|11071524|FG003|Week 24|Consent withdrawn|4
7004372|NCT01422876|11071525|FG004|Week 24|Consent withdrawn|5
7004373|NCT01422876|11071526|FG005|Week 24|Consent withdrawn|6
7004374|NCT01422876|11071527|FG006|Week 24|Consent withdrawn|5
7004375|NCT01422876|11071528|FG007|Week 24|Consent withdrawn|4
7004376|NCT01422876|11071529|FG008|Week 24|Consent withdrawn|3
7004377|NCT01422876|11071530|FG009|Week 24|Consent withdrawn|6
7004378|NCT01422876|11071521|FG000|Week 24|Death|0
7004379|NCT01422876|11071522|FG001|Week 24|Death|1
7004380|NCT01422876|11071523|FG002|Week 24|Death|0
7004381|NCT01422876|11071524|FG003|Week 24|Death|0
7004382|NCT01422876|11071525|FG004|Week 24|Death|0
7004383|NCT01422876|11071526|FG005|Week 24|Death|0
7004384|NCT01422876|11071527|FG006|Week 24|Death|0
7004385|NCT01422876|11071528|FG007|Week 24|Death|0
7004386|NCT01422876|11071529|FG008|Week 24|Death|0
7004387|NCT01422876|11071530|FG009|Week 24|Death|0
7004388|NCT01422876|11071521|FG000|Week 52|Lost to Follow-up|3
7004389|NCT01422876|11071522|FG001|Week 52|Lost to Follow-up|5
7004390|NCT01422876|11071523|FG002|Week 52|Lost to Follow-up|7
7004391|NCT01422876|11071524|FG003|Week 52|Lost to Follow-up|5
7004392|NCT01422876|11071525|FG004|Week 52|Lost to Follow-up|8
7004393|NCT01422876|11071526|FG005|Week 52|Lost to Follow-up|5
7004394|NCT01422876|11071527|FG006|Week 52|Lost to Follow-up|5
7004395|NCT01422876|11071528|FG007|Week 52|Lost to Follow-up|8
7004396|NCT01422876|11071529|FG008|Week 52|Lost to Follow-up|7
7004397|NCT01422876|11071530|FG009|Week 52|Lost to Follow-up|8
7004398|NCT01422876|11071521|FG000|Week 52|Consent withdrawn|9
7004399|NCT01422876|11071522|FG001|Week 52|Consent withdrawn|4
7004400|NCT01422876|11071523|FG002|Week 52|Consent withdrawn|6
7004401|NCT01422876|11071524|FG003|Week 52|Consent withdrawn|12
7004402|NCT01422876|11071525|FG004|Week 52|Consent withdrawn|7
7004403|NCT01422876|11071526|FG005|Week 52|Consent withdrawn|12
7004404|NCT01422876|11071527|FG006|Week 52|Consent withdrawn|10
7004405|NCT01422876|11071528|FG007|Week 52|Consent withdrawn|12
7004406|NCT01422876|11071529|FG008|Week 52|Consent withdrawn|13
7004407|NCT01422876|11071530|FG009|Week 52|Consent withdrawn|9
7004408|NCT01422876|11071521|FG000|Week 52|Death|0
7004409|NCT01422876|11071522|FG001|Week 52|Death|1
7004410|NCT01422876|11071523|FG002|Week 52|Death|0
7004411|NCT01422876|11071524|FG003|Week 52|Death|1
7004412|NCT01422876|11071525|FG004|Week 52|Death|0
7004413|NCT01422876|11071526|FG005|Week 52|Death|0
7004414|NCT01422876|11071527|FG006|Week 52|Death|1
7004415|NCT01422876|11071528|FG007|Week 52|Death|3
7004416|NCT01422876|11071529|FG008|Week 52|Death|1
7004417|NCT01422876|11071530|FG009|Week 52|Death|0
7004418|NCT01422889|11071548|FG000|Overall Study|No Data Entered for Study Stent|9
7004419|NCT01422915|11071552|FG000|Overall Study|Adverse Event|1
7004420|NCT01423084|11071559|FG000|Overall Study|Adverse Event|0
7004421|NCT01423084|11071560|FG001|Overall Study|Adverse Event|1
7004422|NCT01423084|11071559|FG000|Overall Study|Withdrawal by Subject|2
7004423|NCT01423084|11071560|FG001|Overall Study|Withdrawal by Subject|3
7004424|NCT01423253|11071576|FG000|Overall Study|Adverse Event|2
7004425|NCT01423253|11071576|FG000|Overall Study|Lack of Efficacy|2
7004426|NCT01423253|11071576|FG000|Overall Study|Lost to Follow-up|1
7004427|NCT01423253|11071576|FG000|Overall Study|Protocol Violation|2
7004428|NCT01423253|11071576|FG000|Overall Study|Withdrawal by Subject|2
7004429|NCT01423604|11071583|FG000|Safety Run-In|Adverse Event|3
7004430|NCT01423604|11071584|FG001|Safety Run-In|Adverse Event|0
7004431|NCT01423604|11071583|FG000|Safety Run-In|Death|1
7004432|NCT01423604|11071584|FG001|Safety Run-In|Death|0
7004433|NCT01423604|11071583|FG000|Safety Run-In|Physician Decision|1
7004434|NCT01423604|11071584|FG001|Safety Run-In|Physician Decision|0
7004435|NCT01423604|11071583|FG000|Safety Run-In|Disease progression|3
7004436|NCT01423604|11071584|FG001|Safety Run-In|Disease progression|0
7004437|NCT01423604|11071583|FG000|Safety Run-In|Patient decision|1
7004438|NCT01423604|11071584|FG001|Safety Run-In|Patient decision|0
7004439|NCT01423604|11071583|FG000|Randomized|Adverse Event|4
7004440|NCT01423604|11071584|FG001|Randomized|Adverse Event|10
7004441|NCT01423604|11071583|FG000|Randomized|Death|1
7004442|NCT01423604|11071584|FG001|Randomized|Death|0
7004443|NCT01423604|11071583|FG000|Randomized|Physician Decision|16
7004444|NCT01423604|11071584|FG001|Randomized|Physician Decision|13
7004445|NCT01423604|11071583|FG000|Randomized|Other - unspecified|37
7004446|NCT01423604|11071584|FG001|Randomized|Other - unspecified|31
7004447|NCT01423604|11071583|FG000|Randomized|Patient decision|5
7004448|NCT01423604|11071584|FG001|Randomized|Patient decision|9
7004449|NCT01423617|11071593|FG000|Overall Study|Lost to Follow-up|0
7004450|NCT01423617|11071594|FG001|Overall Study|Lost to Follow-up|1
7004451|NCT01423812|11071618|FG000|Overall Study|Lost to Follow-up|2
7004452|NCT01423812|11071619|FG001|Overall Study|Lost to Follow-up|2
7004453|NCT01423812|11071618|FG000|Overall Study|Withdrawal by Subject|1
7004454|NCT01423812|11071619|FG001|Overall Study|Withdrawal by Subject|2
7004455|NCT01423916|11071630|FG000|Overall Study|Adverse Event|5
7004456|NCT01423916|11071631|FG001|Overall Study|Adverse Event|9
7004457|NCT01423916|11071632|FG002|Overall Study|Adverse Event|2
7004458|NCT01423916|11071630|FG000|Overall Study|Met Withdrawal Criteria|1
7004459|NCT01423916|11071631|FG001|Overall Study|Met Withdrawal Criteria|1
7004460|NCT01423916|11071632|FG002|Overall Study|Met Withdrawal Criteria|1
7004461|NCT01423916|11071630|FG000|Overall Study|Physician Decision|1
7004462|NCT01423916|11071631|FG001|Overall Study|Physician Decision|0
7004463|NCT01423916|11071632|FG002|Overall Study|Physician Decision|1
7004464|NCT01423916|11071630|FG000|Overall Study|Withdrawal by Subject|3
7004465|NCT01423916|11071631|FG001|Overall Study|Withdrawal by Subject|10
7004466|NCT01423916|11071632|FG002|Overall Study|Withdrawal by Subject|3
7004467|NCT01423916|11071630|FG000|Overall Study|Protocol Deviation|1
7004468|NCT01423916|11071631|FG001|Overall Study|Protocol Deviation|0
7004469|NCT01423916|11071632|FG002|Overall Study|Protocol Deviation|0
7004470|NCT01424189|11071670|FG000|Overall Study|Adverse Event|1
7004471|NCT01424189|11071671|FG001|Overall Study|Adverse Event|0
7004472|NCT01424189|11071670|FG000|Overall Study|Lost to Follow-up|4
7004473|NCT01424189|11071671|FG001|Overall Study|Lost to Follow-up|1
7004474|NCT01424189|11071670|FG000|Overall Study|Withdrawal by Subject|4
7004475|NCT01424189|11071671|FG001|Overall Study|Withdrawal by Subject|4
7004476|NCT01424189|11071670|FG000|Overall Study|Subject moved|1
7004477|NCT01424189|11071671|FG001|Overall Study|Subject moved|0
7004478|NCT01424189|11071670|FG000|Overall Study|Death|3
7004479|NCT01424189|11071671|FG001|Overall Study|Death|1
7004480|NCT01424228|11071688|FG000|Overall Study|Withdrawal by Subject|27
7004481|NCT01424228|11071689|FG001|Overall Study|Withdrawal by Subject|11
7004482|NCT01424228|11071688|FG000|Overall Study|Adverse Event|10
7004483|NCT01424228|11071689|FG001|Overall Study|Adverse Event|14
7004484|NCT01424228|11071688|FG000|Overall Study|Sponsor's decision|9
7004485|NCT01424228|11071689|FG001|Overall Study|Sponsor's decision|12
7004486|NCT01424228|11071688|FG000|Overall Study|Lack of Efficacy|5
7004487|NCT01424228|11071689|FG001|Overall Study|Lack of Efficacy|7
7004488|NCT01424228|11071688|FG000|Overall Study|inclusion/exclusion criteria not met|2
7004489|NCT01424228|11071689|FG001|Overall Study|inclusion/exclusion criteria not met|2
7004490|NCT01424228|11071688|FG000|Overall Study|Non-compliance|2
7004491|NCT01424228|11071689|FG001|Overall Study|Non-compliance|0
7004492|NCT01424228|11071688|FG000|Overall Study|Worsening of symptoms|1
7004493|NCT01424228|11071689|FG001|Overall Study|Worsening of symptoms|0
7004494|NCT01424228|11071688|FG000|Overall Study|Unplanned journey|0
7004495|NCT01424228|11071689|FG001|Overall Study|Unplanned journey|1
7004496|NCT01424306|11071699|FG000|Overall Study|Protocol Violation|0
7004497|NCT01424306|11071700|FG001|Overall Study|Protocol Violation|0
7004498|NCT01424306|11071701|FG002|Overall Study|Protocol Violation|0
7004499|NCT01424306|11071702|FG003|Overall Study|Protocol Violation|0
7004500|NCT01424306|11071703|FG004|Overall Study|Protocol Violation|1
7004501|NCT01424306|11071704|FG005|Overall Study|Protocol Violation|0
7004502|NCT01424397|11071748|FG000|Period-2 (8 Days)|Withdrawal by Subject|0
7004503|NCT01424397|11071749|FG001|Period-2 (8 Days)|Withdrawal by Subject|0
7004504|NCT01424397|11071750|FG002|Period-2 (8 Days)|Withdrawal by Subject|1
7004505|NCT01424397|11071751|FG003|Period-2 (8 Days)|Withdrawal by Subject|0
7004506|NCT01424397|11071752|FG004|Period-2 (8 Days)|Withdrawal by Subject|0
7004507|NCT01424397|11071753|FG005|Period-2 (8 Days)|Withdrawal by Subject|0
7004508|NCT01424397|11071754|FG006|Period-2 (8 Days)|Withdrawal by Subject|0
7004509|NCT01424397|11071755|FG007|Period-2 (8 Days)|Withdrawal by Subject|0
7004510|NCT01424397|11071756|FG008|Period-2 (8 Days)|Withdrawal by Subject|0
7004511|NCT01424397|11071757|FG009|Period-2 (8 Days)|Withdrawal by Subject|0
7004512|NCT01424397|11071758|FG010|Period-2 (8 Days)|Withdrawal by Subject|0
7004513|NCT01424397|11071759|FG011|Period-2 (8 Days)|Withdrawal by Subject|0
7004514|NCT01424501|11071779|FG000|Overall Study|Withdrawal by Subject|1
7004515|NCT01424501|11071780|FG001|Overall Study|Withdrawal by Subject|0
7004516|NCT01424501|11071781|FG002|Overall Study|Withdrawal by Subject|1
7004517|NCT01424501|11071782|FG003|Overall Study|Withdrawal by Subject|0
7004518|NCT01424501|11071783|FG004|Overall Study|Withdrawal by Subject|0
7004519|NCT01424501|11071784|FG005|Overall Study|Withdrawal by Subject|0
7004520|NCT01424501|11071779|FG000|Overall Study|Lost to Follow-up|0
7004521|NCT01424501|11071780|FG001|Overall Study|Lost to Follow-up|1
7004522|NCT01424501|11071781|FG002|Overall Study|Lost to Follow-up|1
7004523|NCT01424501|11071782|FG003|Overall Study|Lost to Follow-up|0
7004524|NCT01424501|11071783|FG004|Overall Study|Lost to Follow-up|0
7004525|NCT01424501|11071784|FG005|Overall Study|Lost to Follow-up|0
7004526|NCT01424514|11071799|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
7004527|NCT01424514|11071800|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
7004528|NCT01424514|11071799|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1
7004529|NCT01424514|11071800|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0
7004530|NCT01424566|11071811|FG000|Single-blind Treatment|Adverse Event|71
7060401|NCT01918306|11156572|FG000|Overall Study|neutropenia|1
7060402|NCT01918306|11156573|FG001|Overall Study|neutropenia|0
7004531|NCT01424566|11071812|FG001|Single-blind Treatment|Adverse Event|0
7004532|NCT01424566|11071813|FG002|Single-blind Treatment|Adverse Event|0
7004533|NCT01424566|11071811|FG000|Single-blind Treatment|Withdrawal by Subject|16
7004534|NCT01424566|11071812|FG001|Single-blind Treatment|Withdrawal by Subject|0
7004535|NCT01424566|11071813|FG002|Single-blind Treatment|Withdrawal by Subject|0
7004536|NCT01424566|11071811|FG000|Single-blind Treatment|Withdrawal by Investigator|2
7004537|NCT01424566|11071812|FG001|Single-blind Treatment|Withdrawal by Investigator|0
7004538|NCT01424566|11071813|FG002|Single-blind Treatment|Withdrawal by Investigator|0
7004539|NCT01424566|11071811|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108
7004540|NCT01424566|11071812|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
7004541|NCT01424566|11071813|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
7004542|NCT01424566|11071811|FG000|Single-blind Treatment|Met Exclusion Criteria|1
7004543|NCT01424566|11071812|FG001|Single-blind Treatment|Met Exclusion Criteria|0
7004544|NCT01424566|11071813|FG002|Single-blind Treatment|Met Exclusion Criteria|0
7004545|NCT01424566|11071811|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2
7004546|NCT01424566|11071812|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0
7004547|NCT01424566|11071813|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0
7004548|NCT01424566|11071811|FG000|Double-blind Treatment|Adverse Event|0
7004549|NCT01424566|11071812|FG001|Double-blind Treatment|Adverse Event|21
7004550|NCT01424566|11071813|FG002|Double-blind Treatment|Adverse Event|13
7004551|NCT01424566|11071811|FG000|Double-blind Treatment|Withdrawal by Subject|0
7004552|NCT01424566|11071812|FG001|Double-blind Treatment|Withdrawal by Subject|2
7004553|NCT01424566|11071813|FG002|Double-blind Treatment|Withdrawal by Subject|0
7004554|NCT01424566|11071811|FG000|Double-blind Treatment|Withdrawal by Investigator|0
7004555|NCT01424566|11071812|FG001|Double-blind Treatment|Withdrawal by Investigator|1
7004556|NCT01424566|11071813|FG002|Double-blind Treatment|Withdrawal by Investigator|1
7004557|NCT01424566|11071811|FG000|Double-blind Treatment|Lack of Efficacy|0
7004558|NCT01424566|11071812|FG001|Double-blind Treatment|Lack of Efficacy|1
7004559|NCT01424566|11071813|FG002|Double-blind Treatment|Lack of Efficacy|1
7004560|NCT01424644|11071822|FG000|Overall Study|Adverse Event|2
7004561|NCT01424644|11071823|FG001|Overall Study|Adverse Event|0
7004562|NCT01424644|11071822|FG000|Overall Study|Withdrawal by Subject|9
7004563|NCT01424644|11071823|FG001|Overall Study|Withdrawal by Subject|12
7004564|NCT01424644|11071822|FG000|Overall Study|Lost to Follow-up|16
7004565|NCT01424644|11071823|FG001|Overall Study|Lost to Follow-up|12
7004566|NCT01424644|11071822|FG000|Overall Study|Protocol Violation|4
7004567|NCT01424644|11071823|FG001|Overall Study|Protocol Violation|3
7004568|NCT01424644|11071822|FG000|Overall Study|Administrative Reason|1
7004569|NCT01424644|11071823|FG001|Overall Study|Administrative Reason|0
7004570|NCT01424644|11071822|FG000|Overall Study|Unable to Classify|1
7004571|NCT01424644|11071823|FG001|Overall Study|Unable to Classify|0
7004572|NCT01424670|11071831|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2
7004573|NCT01424670|11071832|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2
7004574|NCT01424670|11071831|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0
7004575|NCT01424670|11071832|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1
7004576|NCT01424670|11071831|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2
7004577|NCT01424670|11071832|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1
7004578|NCT01424670|11071831|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2
7004579|NCT01424670|11071832|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3
7004580|NCT01424670|11071831|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13
7004581|NCT01424670|11071832|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7
7004582|NCT01424670|11071831|FG000|Continuation Period|Adverse Event|13
7004583|NCT01424670|11071832|FG001|Continuation Period|Adverse Event|5
7004584|NCT01424670|11071831|FG000|Continuation Period|Lost to Follow-up|2
7004585|NCT01424670|11071832|FG001|Continuation Period|Lost to Follow-up|0
7004586|NCT01424670|11071831|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1
7004587|NCT01424670|11071832|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1
7004588|NCT01424670|11071831|FG000|Continuation Period|Physician Decision|5
7004589|NCT01424670|11071832|FG001|Continuation Period|Physician Decision|4
7004590|NCT01424670|11071831|FG000|Continuation Period|Withdrawal by Subject|13
7004591|NCT01424670|11071832|FG001|Continuation Period|Withdrawal by Subject|4
7004592|NCT01424722|11071840|FG000|Overall Study|Sponsor terminated investigation|2258
7004593|NCT01424813|11071846|FG000|Overall Study|Withdrawal by Subject|3
7004594|NCT01424813|11071847|FG001|Overall Study|Withdrawal by Subject|0
7004595|NCT01424813|11071846|FG000|Overall Study|Protocol Violation|1
7004596|NCT01424813|11071847|FG001|Overall Study|Protocol Violation|0
7004597|NCT01424813|11071846|FG000|Overall Study|Other|1
7004598|NCT01424813|11071847|FG001|Overall Study|Other|2
7004599|NCT01424930|11071855|FG000|Overall Study|Adverse Event|0
7004600|NCT01424930|11071856|FG001|Overall Study|Adverse Event|1
7004601|NCT01424930|11071855|FG000|Overall Study|Death|1
7004602|NCT01424930|11071856|FG001|Overall Study|Death|0
7004603|NCT01424930|11071855|FG000|Overall Study|Progressive Disease|3
7004604|NCT01424930|11071856|FG001|Overall Study|Progressive Disease|6
7004605|NCT01424930|11071855|FG000|Overall Study|Screen Failure|0
7004606|NCT01424930|11071856|FG001|Overall Study|Screen Failure|1
7004607|NCT01424930|11071855|FG000|Overall Study|Reason not specified|0
7004608|NCT01424930|11071856|FG001|Overall Study|Reason not specified|6
7004609|NCT01425190|11071874|FG000|Overall Study|Full dose not consumed.|1
7004610|NCT01425190|11071875|FG001|Overall Study|Full dose not consumed.|0
7004611|NCT01425190|11071876|FG002|Overall Study|Full dose not consumed.|0
7004612|NCT01425203|11071886|FG000|Treatment Phase|DC during PR Lead-in Phase|3
7004613|NCT01425203|11071887|FG001|Treatment Phase|DC during PR Lead-in Phase|1
7004614|NCT01425203|11071888|FG002|Treatment Phase|DC during PR Lead-in Phase|0
7004615|NCT01425203|11071886|FG000|Treatment Phase|Failure at futility timepoint|8
7004616|NCT01425203|11071887|FG001|Treatment Phase|Failure at futility timepoint|27
7004617|NCT01425203|11071888|FG002|Treatment Phase|Failure at futility timepoint|0
7004618|NCT01425203|11071886|FG000|Treatment Phase|Other virologic failure criteria|5
7004619|NCT01425203|11071887|FG001|Treatment Phase|Other virologic failure criteria|3
7004620|NCT01425203|11071888|FG002|Treatment Phase|Other virologic failure criteria|0
7004621|NCT01425203|11071886|FG000|Treatment Phase|Unidentified reasons|11
7004622|NCT01425203|11071887|FG001|Treatment Phase|Unidentified reasons|5
7004623|NCT01425203|11071888|FG002|Treatment Phase|Unidentified reasons|0
7004624|NCT01425203|11071886|FG000|Treatment Phase|Did not receive treatment|0
7004625|NCT01425203|11071887|FG001|Treatment Phase|Did not receive treatment|1
7004626|NCT01425203|11071888|FG002|Treatment Phase|Did not receive treatment|0
7004627|NCT01425203|11071886|FG000|Crossover Phase|Failure at futility timepoint|0
7004628|NCT01425203|11071887|FG001|Crossover Phase|Failure at futility timepoint|0
7004629|NCT01425203|11071888|FG002|Crossover Phase|Failure at futility timepoint|3
7004630|NCT01425203|11071886|FG000|Crossover Phase|Other virologic failure criteria|0
7004631|NCT01425203|11071887|FG001|Crossover Phase|Other virologic failure criteria|0
7004632|NCT01425203|11071888|FG002|Crossover Phase|Other virologic failure criteria|3
7004633|NCT01425268|11071906|FG000|Overall Study|Withdrawal by Subject|2
7004634|NCT01425268|11071907|FG001|Overall Study|Withdrawal by Subject|0
7004635|NCT01425268|11071906|FG000|Overall Study|Sponsor Decision|5
7004636|NCT01425268|11071907|FG001|Overall Study|Sponsor Decision|0
7004637|NCT01425268|11071906|FG000|Overall Study|Physician Decision|1
7004638|NCT01425268|11071907|FG001|Overall Study|Physician Decision|0
7004639|NCT01425359|11071926|FG000|Overall Study|Randomized but Not Treated|2
7004640|NCT01425359|11071927|FG001|Overall Study|Randomized but Not Treated|3
7004641|NCT01425359|11071926|FG000|Overall Study|Adverse Event|9
7004642|NCT01425359|11071927|FG001|Overall Study|Adverse Event|8
7004643|NCT01425359|11071926|FG000|Overall Study|Revascularization|0
7004644|NCT01425359|11071927|FG001|Overall Study|Revascularization|1
7004645|NCT01425359|11071926|FG000|Overall Study|Death|0
7004646|NCT01425359|11071927|FG001|Overall Study|Death|1
7004647|NCT01425359|11071926|FG000|Overall Study|Unsatisfactory Response|1
7004648|NCT01425359|11071927|FG001|Overall Study|Unsatisfactory Response|0
7004649|NCT01425359|11071926|FG000|Overall Study|Protocol Violation|1
7004650|NCT01425359|11071927|FG001|Overall Study|Protocol Violation|2
7004651|NCT01425359|11071926|FG000|Overall Study|Subject Withdrew Consent|1
7004652|NCT01425359|11071927|FG001|Overall Study|Subject Withdrew Consent|2
7004653|NCT01425359|11071926|FG000|Overall Study|Investigator's Discretion|2
7004654|NCT01425359|11071927|FG001|Overall Study|Investigator's Discretion|0
7004655|NCT01425359|11071926|FG000|Overall Study|Did Not Meet Qualifying Criteria|3
7004656|NCT01425359|11071927|FG001|Overall Study|Did Not Meet Qualifying Criteria|5
7004657|NCT01425463|11071936|FG000|Overall Study|Adverse Event|5
7004658|NCT01425463|11071937|FG001|Overall Study|Adverse Event|7
7004659|NCT01425463|11071936|FG000|Overall Study|Lack of Efficacy|1
7004660|NCT01425463|11071937|FG001|Overall Study|Lack of Efficacy|1
7004661|NCT01425463|11071936|FG000|Overall Study|Protocol Violation|2
7004662|NCT01425463|11071937|FG001|Overall Study|Protocol Violation|2
7004663|NCT01425463|11071936|FG000|Overall Study|Lost to Follow-up|5
7004664|NCT01425463|11071937|FG001|Overall Study|Lost to Follow-up|2
7004665|NCT01425463|11071936|FG000|Overall Study|Withdrawal by Subject|7
7004666|NCT01425463|11071937|FG001|Overall Study|Withdrawal by Subject|5
7004667|NCT01425463|11071936|FG000|Overall Study|Unknown Reason|4
7004668|NCT01425463|11071937|FG001|Overall Study|Unknown Reason|7
7004669|NCT01425528|11071945|FG000|Overall Study|Withdrawal by Subject|1
7004670|NCT01425528|11071946|FG001|Overall Study|Withdrawal by Subject|1
7004671|NCT01425281|11071954|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1
7004672|NCT01425281|11071955|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0
7004673|NCT01425281|11071954|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3
7004674|NCT01425281|11071955|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0
7004675|NCT01425281|11071954|FG000|At 180-day Clinical Follow-up|Death|0
7004676|NCT01425281|11071955|FG001|At 180-day Clinical Follow-up|Death|1
7004677|NCT01425281|11071954|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1
7004678|NCT01425281|11071955|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1
7004679|NCT01425281|11071954|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1
7004680|NCT01425281|11071955|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0
7004681|NCT01425281|11071954|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2
7004682|NCT01425281|11071955|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1
7004683|NCT01425281|11071954|FG000|At 2-year Clinical Follow-up|Death|2
7004684|NCT01425281|11071955|FG001|At 2-year Clinical Follow-up|Death|0
7004685|NCT01425281|11071954|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1
7004686|NCT01425281|11071955|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0
7004687|NCT01425281|11071954|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1
7004688|NCT01425281|11071955|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0
7004689|NCT01425281|11071954|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3
7004690|NCT01425281|11071955|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3
7004691|NCT01425281|11071954|FG000|At 3-year Clinical Follow-up|Death|2
7004692|NCT01425281|11071955|FG001|At 3-year Clinical Follow-up|Death|3
7004693|NCT01425281|11071954|FG000|At 4-year Clinical Follow-up|Death|7
7004694|NCT01425281|11071955|FG001|At 4-year Clinical Follow-up|Death|3
7004695|NCT01425281|11071954|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3
7004696|NCT01425281|11071955|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2
7004697|NCT01425281|11071954|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10
7004698|NCT01425281|11071955|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10
7004699|NCT01425281|11071954|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6
7004700|NCT01425281|11071955|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5
7004701|NCT01425281|11071954|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4
7004702|NCT01425281|11071955|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1
7004703|NCT01425281|11071954|FG000|At 5-year Clinical Follow-up|Death|2
7004704|NCT01425281|11071955|FG001|At 5-year Clinical Follow-up|Death|0
7004705|NCT01425281|11071954|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2
7004706|NCT01425281|11071955|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1
7004707|NCT01425281|11071954|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19
7004708|NCT01425281|11071955|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7
7004709|NCT01425281|11071954|FG000|At 5-year Clinical Follow-up|Refused/terminated|9
7004710|NCT01425281|11071955|FG001|At 5-year Clinical Follow-up|Refused/terminated|3
7004711|NCT01425632|11071965|FG000|Overall Study|Adverse Event|0
7004712|NCT01425632|11071966|FG001|Overall Study|Adverse Event|1
7004713|NCT01425632|11071967|FG002|Overall Study|Adverse Event|1
7004714|NCT01425632|11071965|FG000|Overall Study|Physician Decision|1
7004715|NCT01425632|11071966|FG001|Overall Study|Physician Decision|0
7004716|NCT01425632|11071967|FG002|Overall Study|Physician Decision|0
7004717|NCT01425632|11071965|FG000|Overall Study|Protocol Violation|0
7004718|NCT01425632|11071966|FG001|Overall Study|Protocol Violation|0
7004719|NCT01425632|11071967|FG002|Overall Study|Protocol Violation|2
7004720|NCT01425632|11071965|FG000|Overall Study|Withdrawal by Subject|0
7004721|NCT01425632|11071966|FG001|Overall Study|Withdrawal by Subject|0
7004722|NCT01425632|11071967|FG002|Overall Study|Withdrawal by Subject|1
7004723|NCT01425723|11071977|FG000|Overall Study|Lack of Efficacy|0
7004724|NCT01425723|11071978|FG001|Overall Study|Lack of Efficacy|1
7004725|NCT01425723|11071977|FG000|Overall Study|Withdrawal by Subject|1
7004726|NCT01425723|11071978|FG001|Overall Study|Withdrawal by Subject|4
7004727|NCT01425723|11071977|FG000|Overall Study|Lost to Follow-up|0
7004728|NCT01425723|11071978|FG001|Overall Study|Lost to Follow-up|3
7004729|NCT01425723|11071977|FG000|Overall Study|Physician Decision|2
7004730|NCT01425723|11071978|FG001|Overall Study|Physician Decision|0
7004731|NCT01425723|11071977|FG000|Overall Study|Other|1
7004732|NCT01425723|11071978|FG001|Overall Study|Other|10
7004733|NCT01425749|11071995|FG000|Overall Study|progression of melanoma|0
7004734|NCT01425749|11071996|FG001|Overall Study|progression of melanoma|1
7004735|NCT01425801|11072005|FG000|Period 1|Withdrawal by Subject|0
7004736|NCT01425801|11072006|FG001|Period 1|Withdrawal by Subject|0
7004737|NCT01425801|11072007|FG002|Period 1|Withdrawal by Subject|0
7004738|NCT01425801|11072008|FG003|Period 1|Withdrawal by Subject|0
7004739|NCT01425801|11072009|FG004|Period 1|Withdrawal by Subject|1
7004740|NCT01425801|11072010|FG005|Period 1|Withdrawal by Subject|0
7004741|NCT01425801|11072005|FG000|Period 2|Withdrawal by Subject|0
7004742|NCT01425801|11072006|FG001|Period 2|Withdrawal by Subject|0
7004743|NCT01425801|11072007|FG002|Period 2|Withdrawal by Subject|0
7004744|NCT01425801|11072008|FG003|Period 2|Withdrawal by Subject|0
7004745|NCT01425801|11072009|FG004|Period 2|Withdrawal by Subject|1
7004746|NCT01425801|11072010|FG005|Period 2|Withdrawal by Subject|0
7004747|NCT01425801|11072005|FG000|Period 3|Stability criteria not fullfilled|0
7004748|NCT01425801|11072006|FG001|Period 3|Stability criteria not fullfilled|0
7004749|NCT01425801|11072007|FG002|Period 3|Stability criteria not fullfilled|1
7004750|NCT01425801|11072008|FG003|Period 3|Stability criteria not fullfilled|0
7004751|NCT01425801|11072009|FG004|Period 3|Stability criteria not fullfilled|0
7004752|NCT01425801|11072010|FG005|Period 3|Stability criteria not fullfilled|0
7004753|NCT01425801|11072005|FG000|Period 4|Not able to maintain visit schedule|0
7004754|NCT01425801|11072006|FG001|Period 4|Not able to maintain visit schedule|0
7004755|NCT01425801|11072007|FG002|Period 4|Not able to maintain visit schedule|1
7004756|NCT01425801|11072008|FG003|Period 4|Not able to maintain visit schedule|0
7004757|NCT01425801|11072009|FG004|Period 4|Not able to maintain visit schedule|0
7004758|NCT01425801|11072010|FG005|Period 4|Not able to maintain visit schedule|0
7004759|NCT01425814|11072024|FG000|Period 1|Stability criteria not fulfilled|0
7004760|NCT01425814|11072025|FG001|Period 1|Stability criteria not fulfilled|1
7004761|NCT01425814|11072026|FG002|Period 1|Stability criteria not fulfilled|0
7004762|NCT01425814|11072027|FG003|Period 1|Stability criteria not fulfilled|0
7004763|NCT01425814|11072028|FG004|Period 1|Stability criteria not fulfilled|0
7004764|NCT01425814|11072029|FG005|Period 1|Stability criteria not fulfilled|0
7004765|NCT01425814|11072024|FG000|Period 2|Stability criteria not fulfilled|0
7004766|NCT01425814|11072025|FG001|Period 2|Stability criteria not fulfilled|1
7004767|NCT01425814|11072026|FG002|Period 2|Stability criteria not fulfilled|0
7004768|NCT01425814|11072027|FG003|Period 2|Stability criteria not fulfilled|0
7004769|NCT01425814|11072028|FG004|Period 2|Stability criteria not fulfilled|0
7004770|NCT01425814|11072029|FG005|Period 2|Stability criteria not fulfilled|0
7004771|NCT01425814|11072024|FG000|Period 3|Adverse Event|0
7004772|NCT01425814|11072025|FG001|Period 3|Adverse Event|0
7004773|NCT01425814|11072026|FG002|Period 3|Adverse Event|0
7004774|NCT01425814|11072027|FG003|Period 3|Adverse Event|0
7004775|NCT01425814|11072028|FG004|Period 3|Adverse Event|0
7004776|NCT01425814|11072029|FG005|Period 3|Adverse Event|1
7004777|NCT01425814|11072024|FG000|Period 4|Adverse Event|1
7004778|NCT01425814|11072025|FG001|Period 4|Adverse Event|0
7004779|NCT01425814|11072026|FG002|Period 4|Adverse Event|1
7004780|NCT01425814|11072027|FG003|Period 4|Adverse Event|0
7004781|NCT01425814|11072028|FG004|Period 4|Adverse Event|0
7004782|NCT01425814|11072029|FG005|Period 4|Adverse Event|0
7004783|NCT01425814|11072024|FG000|Period 5|Stability criteria not fulfilled|0
7004784|NCT01425814|11072025|FG001|Period 5|Stability criteria not fulfilled|0
7004785|NCT01425814|11072026|FG002|Period 5|Stability criteria not fulfilled|1
7004786|NCT01425814|11072027|FG003|Period 5|Stability criteria not fulfilled|0
7004787|NCT01425814|11072028|FG004|Period 5|Stability criteria not fulfilled|0
7004788|NCT01425814|11072029|FG005|Period 5|Stability criteria not fulfilled|1
7004789|NCT01426009|11072057|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1
7004790|NCT01426009|11072057|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1
7004791|NCT01426009|11072057|FG000|Washout 1|Withdrawal by Subject|1
7004792|NCT01426009|11072057|FG000|Washout 1|Personal Reasons|1
7004793|NCT01426009|11072057|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4
7004794|NCT01426009|11072057|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1
7004795|NCT01426009|11072057|FG000|Washout 2|electrive surgery|1
7004796|NCT01426009|11072057|FG000|Washout 3|personal reasons|1
7004797|NCT01426009|11072057|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1
7004798|NCT01426009|11072057|FG000|Washout 4|Lost to Follow-up|1
7004799|NCT01426217|11072079|FG000|Overall Study|lost sample|8
7004800|NCT01426217|11072080|FG001|Overall Study|lost sample|14
7004801|NCT01426269|11072094|FG000|Period 1: 12 Weeks|Adverse Event|5
7004802|NCT01426269|11072095|FG001|Period 1: 12 Weeks|Adverse Event|0
7004803|NCT01426269|11072096|FG002|Period 1: 12 Weeks|Adverse Event|0
7004804|NCT01426269|11072094|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22
7004805|NCT01426269|11072095|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0
7004806|NCT01426269|11072096|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0
7004807|NCT01426269|11072094|FG000|Period 1: 12 Weeks|Protocol Violation|5
7004808|NCT01426269|11072095|FG001|Period 1: 12 Weeks|Protocol Violation|0
7004809|NCT01426269|11072096|FG002|Period 1: 12 Weeks|Protocol Violation|0
7004810|NCT01426269|11072094|FG000|Period 1: 12 Weeks|Lost to Follow-up|22
7004811|NCT01426269|11072095|FG001|Period 1: 12 Weeks|Lost to Follow-up|0
7004812|NCT01426269|11072096|FG002|Period 1: 12 Weeks|Lost to Follow-up|0
7004813|NCT01426269|11072094|FG000|Period 1: 12 Weeks|Pregnancy|1
7004814|NCT01426269|11072095|FG001|Period 1: 12 Weeks|Pregnancy|0
7004815|NCT01426269|11072096|FG002|Period 1: 12 Weeks|Pregnancy|0
7004816|NCT01426269|11072094|FG000|Eligibility for Period 2, Randomization|Did not qualify|42
7004817|NCT01426269|11072095|FG001|Eligibility for Period 2, Randomization|Did not qualify|0
7004818|NCT01426269|11072096|FG002|Eligibility for Period 2, Randomization|Did not qualify|0
7004819|NCT01426269|11072094|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8
7004820|NCT01426269|11072095|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0
7004821|NCT01426269|11072096|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0
7004822|NCT01426269|11072094|FG000|Period 2: 40 Weeks|Adverse Event|0
7004823|NCT01426269|11072095|FG001|Period 2: 40 Weeks|Adverse Event|1
7004824|NCT01426269|11072096|FG002|Period 2: 40 Weeks|Adverse Event|2
7004825|NCT01426269|11072094|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0
7004826|NCT01426269|11072095|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9
7004827|NCT01426269|11072096|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11
7004828|NCT01426269|11072094|FG000|Period 2: 40 Weeks|Protocol Violation|0
7004829|NCT01426269|11072095|FG001|Period 2: 40 Weeks|Protocol Violation|5
7004830|NCT01426269|11072096|FG002|Period 2: 40 Weeks|Protocol Violation|5
7004831|NCT01426269|11072094|FG000|Period 2: 40 Weeks|Lost to Follow-up|0
7004832|NCT01426269|11072095|FG001|Period 2: 40 Weeks|Lost to Follow-up|8
7004833|NCT01426269|11072096|FG002|Period 2: 40 Weeks|Lost to Follow-up|6
7004834|NCT01426269|11072094|FG000|Period 2: 40 Weeks|Site closed|0
7004835|NCT01426269|11072095|FG001|Period 2: 40 Weeks|Site closed|6
7004836|NCT01426269|11072096|FG002|Period 2: 40 Weeks|Site closed|5
7004837|NCT01426269|11072094|FG000|Period 2: 40 Weeks|Relapsed|0
7004838|NCT01426269|11072095|FG001|Period 2: 40 Weeks|Relapsed|9
7004839|NCT01426269|11072096|FG002|Period 2: 40 Weeks|Relapsed|18
7004840|NCT01426347|11072109|FG000|Overall Study|Lost to Follow-up|0
7004841|NCT01426347|11072110|FG001|Overall Study|Lost to Follow-up|3
7004842|NCT01426347|11072109|FG000|Overall Study|Protocol Violation|2
7004843|NCT01426347|11072110|FG001|Overall Study|Protocol Violation|0
7004844|NCT01426347|11072109|FG000|Overall Study|Withdrawal by Subject|5
7004845|NCT01426347|11072110|FG001|Overall Study|Withdrawal by Subject|0
7004846|NCT01426373|11072125|FG000|Overall Study|Adverse Event|6
7004847|NCT01426373|11072125|FG000|Overall Study|Lost to Follow-up|14
7004848|NCT01426373|11072125|FG000|Overall Study|Participant Convenience|10
7004849|NCT01426373|11072125|FG000|Overall Study|Miscellaneous Reasons|4
7004850|NCT01426386|11072137|FG000|Overall Study|Adverse Event|0
7004851|NCT01426386|11072138|FG001|Overall Study|Adverse Event|1
7004852|NCT01426386|11072139|FG002|Overall Study|Adverse Event|0
7004853|NCT01426386|11072140|FG003|Overall Study|Adverse Event|0
7004854|NCT01426386|11072141|FG004|Overall Study|Adverse Event|0
7004855|NCT01426386|11072142|FG005|Overall Study|Adverse Event|0
7004856|NCT01426386|11072137|FG000|Overall Study|Did not attend scheduled visit|1
7004857|NCT01426386|11072138|FG001|Overall Study|Did not attend scheduled visit|4
7004858|NCT01426386|11072139|FG002|Overall Study|Did not attend scheduled visit|0
7004859|NCT01426386|11072140|FG003|Overall Study|Did not attend scheduled visit|0
7004860|NCT01426386|11072141|FG004|Overall Study|Did not attend scheduled visit|2
7004861|NCT01426386|11072142|FG005|Overall Study|Did not attend scheduled visit|1
7004862|NCT01426386|11072137|FG000|Overall Study|Poor response|2
7004863|NCT01426386|11072138|FG001|Overall Study|Poor response|1
7004864|NCT01426386|11072139|FG002|Overall Study|Poor response|2
7004865|NCT01426386|11072140|FG003|Overall Study|Poor response|0
7004866|NCT01426386|11072141|FG004|Overall Study|Poor response|1
7004867|NCT01426386|11072142|FG005|Overall Study|Poor response|0
7004868|NCT01426386|11072137|FG000|Overall Study|Personal reasons|0
7004869|NCT01426386|11072138|FG001|Overall Study|Personal reasons|0
7004870|NCT01426386|11072139|FG002|Overall Study|Personal reasons|0
7004871|NCT01426386|11072140|FG003|Overall Study|Personal reasons|0
7004872|NCT01426386|11072141|FG004|Overall Study|Personal reasons|1
7004873|NCT01426386|11072142|FG005|Overall Study|Personal reasons|0
7004874|NCT01426412|11072165|FG000|Overall Study|Withdrawal by Subject|1
7004875|NCT01426412|11072166|FG001|Overall Study|Withdrawal by Subject|0
7004876|NCT01426412|11072167|FG002|Overall Study|Withdrawal by Subject|0
7004877|NCT01426412|11072168|FG003|Overall Study|Withdrawal by Subject|0
7004878|NCT01426412|11072169|FG004|Overall Study|Withdrawal by Subject|1
7004879|NCT01426412|11072170|FG005|Overall Study|Withdrawal by Subject|0
7004880|NCT01426412|11072171|FG006|Overall Study|Withdrawal by Subject|0
7004881|NCT01426412|11072172|FG007|Overall Study|Withdrawal by Subject|3
7004882|NCT01426412|11072173|FG008|Overall Study|Withdrawal by Subject|1
7004883|NCT01426425|11072204|FG000|Overall Study|Exited prior to EP study|22
7004884|NCT01426425|11072204|FG000|Overall Study|Inclusion/exclusion criteria not met|151
7004885|NCT01426425|11072204|FG000|Overall Study|Met inclusion/exclusion, not treated|2
7004886|NCT01426438|11072211|FG000|Overall Study|Lost to Follow-up|1
7004887|NCT01426438|11072212|FG001|Overall Study|Lost to Follow-up|3
7004888|NCT01426438|11072211|FG000|Overall Study|Off study Treatment|9
7004889|NCT01426438|11072212|FG001|Overall Study|Off study Treatment|3
7004890|NCT01426438|11072211|FG000|Overall Study|Poor scan quality|3
7004891|NCT01426438|11072212|FG001|Overall Study|Poor scan quality|2
7004892|NCT01426438|11072211|FG000|Overall Study|Missed Scan|2
7004893|NCT01426438|11072212|FG001|Overall Study|Missed Scan|2
7004894|NCT01426789|11072242|FG000|Part 1|Protocol deviation|0
7004895|NCT01426789|11072243|FG001|Part 1|Protocol deviation|1
7004896|NCT01426789|11072244|FG002|Part 1|Protocol deviation|0
7004897|NCT01426789|11072245|FG003|Part 1|Protocol deviation|0
7004898|NCT01426789|11072246|FG004|Part 1|Protocol deviation|0
7004899|NCT01426789|11072247|FG005|Part 1|Protocol deviation|0
7004900|NCT01426789|11072242|FG000|Part 1|Lost to Follow-up|1
7004901|NCT01426789|11072243|FG001|Part 1|Lost to Follow-up|2
7004902|NCT01426789|11072244|FG002|Part 1|Lost to Follow-up|0
7004903|NCT01426789|11072245|FG003|Part 1|Lost to Follow-up|0
7004904|NCT01426789|11072246|FG004|Part 1|Lost to Follow-up|0
7004905|NCT01426789|11072247|FG005|Part 1|Lost to Follow-up|0
7004906|NCT01426789|11072242|FG000|Part 1|Lack of Efficacy|2
7004907|NCT01426789|11072243|FG001|Part 1|Lack of Efficacy|1
7004908|NCT01426789|11072244|FG002|Part 1|Lack of Efficacy|0
7004909|NCT01426789|11072245|FG003|Part 1|Lack of Efficacy|0
7004910|NCT01426789|11072246|FG004|Part 1|Lack of Efficacy|0
7004911|NCT01426789|11072247|FG005|Part 1|Lack of Efficacy|0
7004912|NCT01426789|11072242|FG000|Part 1|Adverse Event|3
7004913|NCT01426789|11072243|FG001|Part 1|Adverse Event|0
7004914|NCT01426789|11072244|FG002|Part 1|Adverse Event|0
7004915|NCT01426789|11072245|FG003|Part 1|Adverse Event|0
7004916|NCT01426789|11072246|FG004|Part 1|Adverse Event|0
7004917|NCT01426789|11072247|FG005|Part 1|Adverse Event|0
7004918|NCT01426789|11072242|FG000|Part 2|Protocol deviation|0
7004919|NCT01426789|11072243|FG001|Part 2|Protocol deviation|0
7004920|NCT01426789|11072244|FG002|Part 2|Protocol deviation|1
7004921|NCT01426789|11072245|FG003|Part 2|Protocol deviation|0
7004922|NCT01426789|11072246|FG004|Part 2|Protocol deviation|0
7004923|NCT01426789|11072247|FG005|Part 2|Protocol deviation|0
7004924|NCT01426789|11072242|FG000|Part 2|Death|0
7004925|NCT01426789|11072243|FG001|Part 2|Death|0
7004926|NCT01426789|11072244|FG002|Part 2|Death|1
7004927|NCT01426789|11072245|FG003|Part 2|Death|0
7004928|NCT01426789|11072246|FG004|Part 2|Death|1
7004929|NCT01426789|11072247|FG005|Part 2|Death|0
7004930|NCT01426789|11072242|FG000|Part 2|Administrative problems|0
7004931|NCT01426789|11072243|FG001|Part 2|Administrative problems|0
7004932|NCT01426789|11072244|FG002|Part 2|Administrative problems|2
7004933|NCT01426789|11072245|FG003|Part 2|Administrative problems|0
7004934|NCT01426789|11072246|FG004|Part 2|Administrative problems|1
7004935|NCT01426789|11072247|FG005|Part 2|Administrative problems|0
7004936|NCT01426789|11072242|FG000|Part 2|Lost to Follow-up|0
7004937|NCT01426789|11072243|FG001|Part 2|Lost to Follow-up|0
7004938|NCT01426789|11072244|FG002|Part 2|Lost to Follow-up|4
7004939|NCT01426789|11072245|FG003|Part 2|Lost to Follow-up|0
7004940|NCT01426789|11072246|FG004|Part 2|Lost to Follow-up|1
7004941|NCT01426789|11072247|FG005|Part 2|Lost to Follow-up|0
7004942|NCT01426789|11072242|FG000|Part 2|Withdrawal by Subject|0
7004943|NCT01426789|11072243|FG001|Part 2|Withdrawal by Subject|0
7004944|NCT01426789|11072244|FG002|Part 2|Withdrawal by Subject|0
7004945|NCT01426789|11072245|FG003|Part 2|Withdrawal by Subject|1
7004946|NCT01426789|11072246|FG004|Part 2|Withdrawal by Subject|2
7004947|NCT01426789|11072247|FG005|Part 2|Withdrawal by Subject|0
7004948|NCT01426789|11072242|FG000|Part 2|Lack of Efficacy|0
7004949|NCT01426789|11072243|FG001|Part 2|Lack of Efficacy|0
7004950|NCT01426789|11072244|FG002|Part 2|Lack of Efficacy|5
7004951|NCT01426789|11072245|FG003|Part 2|Lack of Efficacy|0
7004952|NCT01426789|11072246|FG004|Part 2|Lack of Efficacy|2
7004953|NCT01426789|11072247|FG005|Part 2|Lack of Efficacy|0
7004954|NCT01426789|11072242|FG000|Part 2|Adverse Event|0
7004955|NCT01426789|11072243|FG001|Part 2|Adverse Event|0
7004956|NCT01426789|11072244|FG002|Part 2|Adverse Event|2
7004957|NCT01426789|11072245|FG003|Part 2|Adverse Event|0
7004958|NCT01426789|11072246|FG004|Part 2|Adverse Event|1
7004959|NCT01426789|11072247|FG005|Part 2|Adverse Event|0
7004960|NCT01426854|11072266|FG000|Overall Study|Adverse Event|1
7004961|NCT01426854|11072267|FG001|Overall Study|Adverse Event|5
7004962|NCT01426854|11072266|FG000|Overall Study|Subject Decision Unrelated to AE|5
7004963|NCT01426854|11072267|FG001|Overall Study|Subject Decision Unrelated to AE|6
7004964|NCT01426854|11072266|FG000|Overall Study|Lost to Follow-up|3
7004965|NCT01426854|11072267|FG001|Overall Study|Lost to Follow-up|0
7004966|NCT01426854|11072266|FG000|Overall Study|Noncompliance|0
7004967|NCT01426854|11072267|FG001|Overall Study|Noncompliance|1
7004968|NCT01426854|11072266|FG000|Overall Study|Treatment Failure|0
7004969|NCT01426854|11072267|FG001|Overall Study|Treatment Failure|16
7004970|NCT01426854|11072266|FG000|Overall Study|Protocol Deviation|0
7004971|NCT01426854|11072267|FG001|Overall Study|Protocol Deviation|1
7004972|NCT01426854|11072266|FG000|Overall Study|Other|3
7004973|NCT01426854|11072267|FG001|Overall Study|Other|2
7043036|NCT01739400|11127588|FG001|Overall Study|Withdrawal by Subject|7
7043037|NCT01739595|11127596|FG000|Overall Study|Adverse Event|3
7043038|NCT01739595|11127597|FG001|Overall Study|Adverse Event|0
7043039|NCT01739595|11127598|FG002|Overall Study|Adverse Event|0
7043040|NCT01739595|11127596|FG000|Overall Study|Lost to Follow-up|2
7043041|NCT01739595|11127597|FG001|Overall Study|Lost to Follow-up|0
7043042|NCT01739595|11127598|FG002|Overall Study|Lost to Follow-up|0
7043043|NCT01739595|11127596|FG000|Overall Study|Withdrawal by Subject|2
7043044|NCT01739595|11127597|FG001|Overall Study|Withdrawal by Subject|1
7043045|NCT01739595|11127598|FG002|Overall Study|Withdrawal by Subject|2
7043046|NCT01739595|11127596|FG000|Overall Study|Eligibility issue|3
7043047|NCT01739595|11127597|FG001|Overall Study|Eligibility issue|0
7043048|NCT01739595|11127598|FG002|Overall Study|Eligibility issue|0
7043049|NCT01739595|11127596|FG000|Overall Study|Protocol Violation|1
7043050|NCT01739595|11127597|FG001|Overall Study|Protocol Violation|0
7043051|NCT01739595|11127598|FG002|Overall Study|Protocol Violation|0
7043052|NCT01739595|11127596|FG000|Overall Study|Lab assessment|1
7043053|NCT01739595|11127597|FG001|Overall Study|Lab assessment|0
7043054|NCT01739595|11127598|FG002|Overall Study|Lab assessment|0
7043055|NCT01739595|11127596|FG000|Overall Study|Drug discrepancy|1
7043056|NCT01739595|11127597|FG001|Overall Study|Drug discrepancy|0
7043057|NCT01739595|11127598|FG002|Overall Study|Drug discrepancy|0
7043058|NCT01739764|11127617|FG000|Overall Study|Adverse Event|0
7043059|NCT01739764|11127618|FG001|Overall Study|Adverse Event|3
7043060|NCT01739764|11127619|FG002|Overall Study|Adverse Event|4
7043061|NCT01739764|11127617|FG000|Overall Study|Death|4
7043062|NCT01739764|11127618|FG001|Overall Study|Death|6
7043063|NCT01739764|11127619|FG002|Overall Study|Death|38
7043064|NCT01739764|11127617|FG000|Overall Study|Lost to Follow-up|0
7043065|NCT01739764|11127618|FG001|Overall Study|Lost to Follow-up|0
7043066|NCT01739764|11127619|FG002|Overall Study|Lost to Follow-up|5
7043067|NCT01739764|11127617|FG000|Overall Study|Non-Compliance|0
7043068|NCT01739764|11127618|FG001|Overall Study|Non-Compliance|0
7043069|NCT01739764|11127619|FG002|Overall Study|Non-Compliance|1
7043070|NCT01739764|11127617|FG000|Overall Study|Multiple Reasons|3
7043071|NCT01739764|11127618|FG001|Overall Study|Multiple Reasons|2
7043072|NCT01739764|11127619|FG002|Overall Study|Multiple Reasons|3
7043073|NCT01739764|11127617|FG000|Overall Study|Physician Decision|2
7043074|NCT01739764|11127618|FG001|Overall Study|Physician Decision|2
7043075|NCT01739764|11127619|FG002|Overall Study|Physician Decision|4
7043076|NCT01739764|11127617|FG000|Overall Study|Progressive Disease|3
7043077|NCT01739764|11127618|FG001|Overall Study|Progressive Disease|5
7043078|NCT01739764|11127619|FG002|Overall Study|Progressive Disease|16
7043079|NCT01739764|11127617|FG000|Overall Study|Protocol Violation|0
7043080|NCT01739764|11127618|FG001|Overall Study|Protocol Violation|0
7043081|NCT01739764|11127619|FG002|Overall Study|Protocol Violation|2
7043082|NCT01739764|11127617|FG000|Overall Study|Study Terminated by Sponsor|8
7043083|NCT01739764|11127618|FG001|Overall Study|Study Terminated by Sponsor|13
7043084|NCT01739764|11127619|FG002|Overall Study|Study Terminated by Sponsor|26
7043085|NCT01739764|11127617|FG000|Overall Study|Withdrawal by Subject|6
7043086|NCT01739764|11127618|FG001|Overall Study|Withdrawal by Subject|5
7043087|NCT01739764|11127619|FG002|Overall Study|Withdrawal by Subject|27
7043088|NCT01739790|11127629|FG000|Overall Study|Early Trial Termination|2
7043089|NCT01739790|11127630|FG001|Overall Study|Early Trial Termination|4
7043090|NCT01739803|11127638|FG000|Overall Study|Lost to Follow-up|9
7004974|NCT01426958|11072286|FG000|Overall Study|Adverse Event|2
7004975|NCT01427309|11072307|FG000|Overall Study|Lost to Follow-up|130
7004976|NCT01427309|11072308|FG001|Overall Study|Lost to Follow-up|145
7004977|NCT01427309|11072309|FG002|Overall Study|Lost to Follow-up|122
7004978|NCT01427309|11072310|FG003|Overall Study|Lost to Follow-up|135
7004979|NCT01427309|11072307|FG000|Overall Study|Protocol Violation|42
7004980|NCT01427309|11072308|FG001|Overall Study|Protocol Violation|69
7004981|NCT01427309|11072309|FG002|Overall Study|Protocol Violation|125
7004982|NCT01427309|11072310|FG003|Overall Study|Protocol Violation|124
7004983|NCT01427309|11072307|FG000|Overall Study|Adverse Event|0
7004984|NCT01427309|11072308|FG001|Overall Study|Adverse Event|0
7004985|NCT01427309|11072309|FG002|Overall Study|Adverse Event|3
7004986|NCT01427309|11072310|FG003|Overall Study|Adverse Event|1
7004987|NCT01427309|11072307|FG000|Overall Study|Serious adverse event|52
7004988|NCT01427309|11072308|FG001|Overall Study|Serious adverse event|45
7004989|NCT01427309|11072309|FG002|Overall Study|Serious adverse event|50
7004990|NCT01427309|11072310|FG003|Overall Study|Serious adverse event|61
7004991|NCT01427309|11072307|FG000|Overall Study|Withdrawal by Subject|148
7004992|NCT01427309|11072308|FG001|Overall Study|Withdrawal by Subject|148
7004993|NCT01427309|11072309|FG002|Overall Study|Withdrawal by Subject|61
7004994|NCT01427309|11072310|FG003|Overall Study|Withdrawal by Subject|55
7004995|NCT01427608|11072367|FG000|Overall Study|Death|1
7004996|NCT01427608|11072368|FG001|Overall Study|Death|0
7004997|NCT01427608|11072367|FG000|Overall Study|Withdrawal by Subject|7
7004998|NCT01427608|11072368|FG001|Overall Study|Withdrawal by Subject|3
7004999|NCT01427608|11072367|FG000|Overall Study|Relapsed-all cause|13
7005000|NCT01427608|11072368|FG001|Overall Study|Relapsed-all cause|34
7005001|NCT01427608|11072367|FG000|Overall Study|Events not attributed to study meds|0
7005002|NCT01427608|11072368|FG001|Overall Study|Events not attributed to study meds|1
7005003|NCT01427738|11072378|FG000|Overall Study|Death|12
7005004|NCT01427738|11072379|FG001|Overall Study|Death|9
7005005|NCT01427738|11072378|FG000|Overall Study|Severe debilitation, unable to continue|0
7005006|NCT01427738|11072379|FG001|Overall Study|Severe debilitation, unable to continue|1
7005007|NCT01427738|11072378|FG000|Overall Study|Subject unable to get to clinic|5
7005008|NCT01427738|11072379|FG001|Overall Study|Subject unable to get to clinic|2
7005009|NCT01427738|11072378|FG000|Overall Study|Withdrawal by Subject|0
7005010|NCT01427738|11072379|FG001|Overall Study|Withdrawal by Subject|2
7005011|NCT01427738|11072378|FG000|Overall Study|Subject not willing to adhere to reqs|1
7005012|NCT01427738|11072379|FG001|Overall Study|Subject not willing to adhere to reqs|2
7005013|NCT01427738|11072378|FG000|Overall Study|Lost to Follow-up|1
7005014|NCT01427738|11072379|FG001|Overall Study|Lost to Follow-up|5
7005015|NCT01427751|11072387|FG000|Overall Study|Adverse Event|18
7005016|NCT01427751|11072388|FG001|Overall Study|Adverse Event|2
7005017|NCT01427751|11072387|FG000|Overall Study|No further treatment benefit expected|5
7005018|NCT01427751|11072388|FG001|Overall Study|No further treatment benefit expected|1
7005019|NCT01427751|11072387|FG000|Overall Study|Lost to Follow-up|3
7005020|NCT01427751|11072388|FG001|Overall Study|Lost to Follow-up|1
7005021|NCT01427751|11072387|FG000|Overall Study|Withdrawal of consent|2
7005022|NCT01427751|11072388|FG001|Overall Study|Withdrawal of consent|2
7005023|NCT01427751|11072387|FG000|Overall Study|Protocol Violation|6
7005024|NCT01427751|11072388|FG001|Overall Study|Protocol Violation|4
7005025|NCT01427751|11072387|FG000|Overall Study|Death|2
7005026|NCT01427751|11072388|FG001|Overall Study|Death|0
7005027|NCT01427751|11072387|FG000|Overall Study|Other miscellaneous reasons|6
7005028|NCT01427751|11072388|FG001|Overall Study|Other miscellaneous reasons|4
7005029|NCT01427803|11072396|FG000|Overall Study|Lost to Follow-up|32
7005030|NCT01427803|11072397|FG001|Overall Study|Lost to Follow-up|26
7005031|NCT01427803|11072396|FG000|Overall Study|Withdrawal by Subject|20
7005032|NCT01427803|11072397|FG001|Overall Study|Withdrawal by Subject|0
7005033|NCT01427803|11072396|FG000|Overall Study|Unable to complete full treatment period|6
7005034|NCT01427803|11072397|FG001|Overall Study|Unable to complete full treatment period|0
7005035|NCT01427803|11072396|FG000|Overall Study|Protocol Violation|1
7005036|NCT01427803|11072397|FG001|Overall Study|Protocol Violation|0
7005037|NCT01427803|11072396|FG000|Overall Study|Physician Decision|3
7005038|NCT01427803|11072397|FG001|Overall Study|Physician Decision|0
7005039|NCT01427803|11072396|FG000|Overall Study|did not take product|1
7005040|NCT01427803|11072397|FG001|Overall Study|did not take product|0
7005041|NCT01427907|11072407|FG000|Overall Study|Withdrawal by Subject|3
7005042|NCT01427907|11072408|FG001|Overall Study|Withdrawal by Subject|4
7005043|NCT01427920|11072416|FG000|Overall Study|Adverse Event|1
7005044|NCT01427920|11072417|FG001|Overall Study|Adverse Event|2
7005045|NCT01427920|11072416|FG000|Overall Study|Lack of Efficacy|1
7005046|NCT01427920|11072417|FG001|Overall Study|Lack of Efficacy|0
7005047|NCT01427920|11072416|FG000|Overall Study|Protocol Violation|1
7005048|NCT01427920|11072417|FG001|Overall Study|Protocol Violation|3
7005049|NCT01427920|11072416|FG000|Overall Study|Withdrawal Criteria|4
7005050|NCT01427920|11072417|FG001|Overall Study|Withdrawal Criteria|4
7005051|NCT01427920|11072416|FG000|Overall Study|Unclassified|2
7005052|NCT01427920|11072417|FG001|Overall Study|Unclassified|8
7005053|NCT01427933|11072425|FG000|Overall Study|Withdrawal by Subject|5
7005054|NCT01427933|11072426|FG001|Overall Study|Withdrawal by Subject|8
7005055|NCT01427933|11072425|FG000|Overall Study|Lost to Follow-up|1
7005056|NCT01427933|11072426|FG001|Overall Study|Lost to Follow-up|5
7005057|NCT01427933|11072425|FG000|Overall Study|Other|1
7005058|NCT01427933|11072426|FG001|Overall Study|Other|0
7005059|NCT01427933|11072425|FG000|Overall Study|Investigator's Decision|1
7005060|NCT01427933|11072426|FG001|Overall Study|Investigator's Decision|0
7005061|NCT01427972|11072445|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0
7005062|NCT01427972|11072446|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0
7005063|NCT01427972|11072447|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0
7005064|NCT01427972|11072448|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0
7005065|NCT01427972|11072449|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0
7005066|NCT01427972|11072450|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0
7005067|NCT01427972|11072451|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0
7005068|NCT01427972|11072452|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1
7005069|NCT01427972|11072453|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0
7005070|NCT01427972|11072454|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0
7005071|NCT01427972|11072455|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0
7005072|NCT01427972|11072456|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0
7005073|NCT01427972|11072445|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0
7005074|NCT01427972|11072446|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0
7005075|NCT01427972|11072447|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0
7005076|NCT01427972|11072448|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0
7005077|NCT01427972|11072449|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0
7005078|NCT01427972|11072450|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2
7005079|NCT01427972|11072451|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0
7005080|NCT01427972|11072452|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0
7005081|NCT01427972|11072453|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0
7005082|NCT01427972|11072454|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0
7005083|NCT01427972|11072455|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0
7005084|NCT01427972|11072456|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0
7005085|NCT01427972|11072445|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7005086|NCT01427972|11072446|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1
7005087|NCT01427972|11072447|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7005088|NCT01427972|11072448|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7005089|NCT01427972|11072449|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7005090|NCT01427972|11072450|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7005091|NCT01427972|11072451|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7005092|NCT01427972|11072452|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7005093|NCT01427972|11072453|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7005094|NCT01427972|11072454|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7005095|NCT01427972|11072455|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7005096|NCT01427972|11072456|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7005097|NCT01428063|11072489|FG000|Overall Study|Lack of Efficacy|8
7005098|NCT01428063|11072490|FG001|Overall Study|Lack of Efficacy|4
7005099|NCT01428063|11072491|FG002|Overall Study|Lack of Efficacy|1
7005100|NCT01428063|11072489|FG000|Overall Study|Adverse Event|2
7005101|NCT01428063|11072490|FG001|Overall Study|Adverse Event|3
7005102|NCT01428063|11072491|FG002|Overall Study|Adverse Event|0
7005103|NCT01428063|11072489|FG000|Overall Study|Lost to Follow-up|0
7005104|NCT01428063|11072490|FG001|Overall Study|Lost to Follow-up|2
7005105|NCT01428063|11072491|FG002|Overall Study|Lost to Follow-up|0
7005106|NCT01428063|11072489|FG000|Overall Study|No longer meets study criteria|0
7005107|NCT01428063|11072490|FG001|Overall Study|No longer meets study criteria|1
7005108|NCT01428063|11072491|FG002|Overall Study|No longer meets study criteria|0
7005109|NCT01428076|11072512|FG000|Overall Study|Adverse Event|0
7005110|NCT01428076|11072513|FG001|Overall Study|Adverse Event|1
7005111|NCT01428115|11072521|FG000|Overall Study|Lack of Efficacy|3
7005112|NCT01428115|11072521|FG000|Overall Study|Lost to Follow-up|10
7005113|NCT01428115|11072521|FG000|Overall Study|Pregnancy|1
7005114|NCT01428115|11072521|FG000|Overall Study|Protocol Violation|3
7005115|NCT01428115|11072521|FG000|Overall Study|Withdrawal by Subject|4
7005116|NCT01428128|11072526|FG000|Overall Study|Withdrawal by Subject|4
7005117|NCT01428128|11072526|FG000|Overall Study|Screen failure by p53|10
7005118|NCT01428128|11072526|FG000|Overall Study|Received Neulasta in one cycle|2
7005119|NCT01428128|11072526|FG000|Overall Study|Adverse Event|1
7005120|NCT01428193|11072531|FG000|Overall Study|Physician Decision|1
7005121|NCT01428193|11072531|FG000|Overall Study|Elevated screening liver enzymes|1
7005122|NCT01428219|11072535|FG000|Overall Study|25 patients enrolled, 3 were not treated|3
7005123|NCT01428258|11072545|FG000|Intervention 1|Withdrawal by Subject|2
7005124|NCT01428258|11072546|FG001|Intervention 1|Withdrawal by Subject|0
7005125|NCT01428453|11072574|FG000|Overall Study|Adverse Event|2
7005126|NCT01428453|11072575|FG001|Overall Study|Adverse Event|7
7005127|NCT01428453|11072574|FG000|Overall Study|Protocol Violation|1
7005128|NCT01428453|11072575|FG001|Overall Study|Protocol Violation|0
7005129|NCT01428453|11072574|FG000|Overall Study|Lost to Follow-up|0
7005130|NCT01428453|11072575|FG001|Overall Study|Lost to Follow-up|1
7005131|NCT01428453|11072574|FG000|Overall Study|Withdrawal by Subject|3
7005132|NCT01428453|11072575|FG001|Overall Study|Withdrawal by Subject|1
7005133|NCT01428583|11072583|FG000|Overall Study|Adverse Event|75
7005134|NCT01428583|11072583|FG000|Overall Study|Withdrawal by Subject|51
7005135|NCT01428583|11072583|FG000|Overall Study|Lack of Efficacy|37
7005136|NCT01428583|11072583|FG000|Overall Study|Lost to Follow-up|17
7005137|NCT01428583|11072583|FG000|Overall Study|Death|1
7005138|NCT01428583|11072583|FG000|Overall Study|Pregnancy|1
7005139|NCT01428583|11072583|FG000|Overall Study|Protocol Violation|1
7005140|NCT01428583|11072583|FG000|Overall Study|Physician Decision|12
7005141|NCT01428583|11072583|FG000|Overall Study|Non-compliant|25
7005142|NCT01428583|11072583|FG000|Overall Study|Confirmed positive urine drug test|8
7005143|NCT01428583|11072583|FG000|Overall Study|Sponsor's request|3
7005144|NCT01428583|11072583|FG000|Overall Study|Other|6
7005145|NCT01428661|11072590|FG000|Double-Masked Phase|Protocol Violation|9
7005146|NCT01428661|11072591|FG001|Double-Masked Phase|Protocol Violation|4
7005147|NCT01428661|11072592|FG002|Double-Masked Phase|Protocol Violation|0
7005148|NCT01428661|11072590|FG000|Double-Masked Phase|Adverse Event|13
7005149|NCT01428661|11072591|FG001|Double-Masked Phase|Adverse Event|4
7005150|NCT01428661|11072592|FG002|Double-Masked Phase|Adverse Event|0
7005151|NCT01428661|11072590|FG000|Double-Masked Phase|Lost to Follow-up|14
7005152|NCT01428661|11072591|FG001|Double-Masked Phase|Lost to Follow-up|14
7005153|NCT01428661|11072592|FG002|Double-Masked Phase|Lost to Follow-up|0
7005154|NCT01428661|11072590|FG000|Double-Masked Phase|Withdrawal by Subject|18
7005155|NCT01428661|11072591|FG001|Double-Masked Phase|Withdrawal by Subject|20
7005156|NCT01428661|11072592|FG002|Double-Masked Phase|Withdrawal by Subject|0
7005157|NCT01428661|11072590|FG000|Double-Masked Phase|Lack of Efficacy|2
7005158|NCT01428661|11072591|FG001|Double-Masked Phase|Lack of Efficacy|1
7005159|NCT01428661|11072592|FG002|Double-Masked Phase|Lack of Efficacy|0
7005160|NCT01428661|11072590|FG000|Double-Masked Phase|*Various|1
7005161|NCT01428661|11072591|FG001|Double-Masked Phase|*Various|6
7005162|NCT01428661|11072592|FG002|Double-Masked Phase|*Various|0
7005163|NCT01428661|11072590|FG000|Open Label Extension|Protocol Violation|0
7005164|NCT01428661|11072591|FG001|Open Label Extension|Protocol Violation|0
7005165|NCT01428661|11072592|FG002|Open Label Extension|Protocol Violation|9
7005166|NCT01428661|11072590|FG000|Open Label Extension|Adverse Event|0
7005167|NCT01428661|11072591|FG001|Open Label Extension|Adverse Event|0
7005168|NCT01428661|11072592|FG002|Open Label Extension|Adverse Event|15
7005169|NCT01428661|11072590|FG000|Open Label Extension|Lost to Follow-up|0
7005170|NCT01428661|11072591|FG001|Open Label Extension|Lost to Follow-up|0
7005171|NCT01428661|11072592|FG002|Open Label Extension|Lost to Follow-up|38
7005172|NCT01428661|11072590|FG000|Open Label Extension|Withdrawal by Subject|0
7005173|NCT01428661|11072591|FG001|Open Label Extension|Withdrawal by Subject|0
7005174|NCT01428661|11072592|FG002|Open Label Extension|Withdrawal by Subject|49
7005175|NCT01428661|11072590|FG000|Open Label Extension|Lack of Efficacy|0
7005176|NCT01428661|11072591|FG001|Open Label Extension|Lack of Efficacy|0
7005177|NCT01428661|11072592|FG002|Open Label Extension|Lack of Efficacy|24
7005178|NCT01428661|11072590|FG000|Open Label Extension|**Various|0
7005179|NCT01428661|11072591|FG001|Open Label Extension|**Various|0
7005180|NCT01428661|11072592|FG002|Open Label Extension|**Various|185
7005181|NCT01428713|11072600|FG000|Overall Study|Non-compliance|2
7005182|NCT01428713|11072601|FG001|Overall Study|Non-compliance|2
7005183|NCT01428713|11072600|FG000|Overall Study|Withdrawal by Subject|1
7005184|NCT01428713|11072601|FG001|Overall Study|Withdrawal by Subject|1
7005185|NCT01428713|11072600|FG000|Overall Study|Adverse Event|0
7005186|NCT01428713|11072601|FG001|Overall Study|Adverse Event|2
7005187|NCT01428882|11072613|FG000|Overall Study|Lack of Efficacy|2
7005188|NCT01428882|11072614|FG001|Overall Study|Lack of Efficacy|7
7005189|NCT01428882|11072613|FG000|Overall Study|Protocol Violation|4
7005190|NCT01428882|11072614|FG001|Overall Study|Protocol Violation|3
7005191|NCT01429051|11072620|FG000|Titration Phase|Death|1
7005192|NCT01429051|11072620|FG000|Titration Phase|Withdrawal by Subject|7
7005193|NCT01429051|11072620|FG000|Titration Phase|Physician Decision|1
7005194|NCT01429051|11072620|FG000|Titration Phase|Unsuccessful titration at any dose|1
7005195|NCT01429051|11072620|FG000|Titration Phase|Less than 3 BTP episodes per week|2
7005196|NCT01429051|11072620|FG000|Efficacy Phase|Adverse Event|1
7005197|NCT01429051|11072620|FG000|Efficacy Phase|Death|1
7005198|NCT01429051|11072620|FG000|Tolerability Phase|Death|5
7005199|NCT01429051|11072620|FG000|Tolerability Phase|Adverse Event|2
7005200|NCT01429051|11072620|FG000|Tolerability Phase|Withdrawal by Subject|5
7005201|NCT01429051|11072620|FG000|Tolerability Phase|Physician Decision|1
7005202|NCT01429051|11072620|FG000|Tolerability Phase|Other|2
7005203|NCT01429077|11072650|FG000|Overall Study|Lost to Follow-up|0
7005204|NCT01429077|11072651|FG001|Overall Study|Lost to Follow-up|3
7005205|NCT01429285|11072680|FG000|Overall Study|Protocol Violation|9
7005206|NCT01429285|11072681|FG001|Overall Study|Protocol Violation|4
7005207|NCT01429285|11072680|FG000|Overall Study|Missing Data|5
7005208|NCT01429285|11072681|FG001|Overall Study|Missing Data|3
7005209|NCT01429285|11072680|FG000|Overall Study|Erroneously Enrolled Twice|8
7005210|NCT01429285|11072681|FG001|Overall Study|Erroneously Enrolled Twice|2
7005211|NCT01429298|11072689|FG000|Overall Study|Protocol Violation|4
7005212|NCT01429298|11072690|FG001|Overall Study|Protocol Violation|6
7005213|NCT01429441|11072707|FG000|Overall Study|Adverse Event|5
7005214|NCT01429441|11072708|FG001|Overall Study|Adverse Event|1
7005215|NCT01429441|11072707|FG000|Overall Study|Death|0
7005216|NCT01429441|11072708|FG001|Overall Study|Death|2
7005217|NCT01429441|11072707|FG000|Overall Study|Lost to Follow-up|5
7005218|NCT01429441|11072708|FG001|Overall Study|Lost to Follow-up|2
7005219|NCT01429441|11072707|FG000|Overall Study|Physician Decision|1
7005220|NCT01429441|11072708|FG001|Overall Study|Physician Decision|0
7005221|NCT01429441|11072707|FG000|Overall Study|Withdrawal by Subject|27
7005222|NCT01429441|11072708|FG001|Overall Study|Withdrawal by Subject|18
7005223|NCT01429584|11072739|FG000|Overall Study|Withdrawal by Subject|1
7005224|NCT01429584|11072740|FG001|Overall Study|Withdrawal by Subject|0
7005225|NCT01429584|11072739|FG000|Overall Study|Protocol Violation|0
7005226|NCT01429584|11072740|FG001|Overall Study|Protocol Violation|1
7005227|NCT01429623|11072748|FG000|Overall Study|Death|1
7005228|NCT01429623|11072749|FG001|Overall Study|Death|0
7005229|NCT01429623|11072748|FG000|Overall Study|Adverse Event|7
7005230|NCT01429623|11072749|FG001|Overall Study|Adverse Event|14
7005231|NCT01429623|11072748|FG000|Overall Study|Withdrawal by Subject|19
7005232|NCT01429623|11072749|FG001|Overall Study|Withdrawal by Subject|13
7005233|NCT01429623|11072748|FG000|Overall Study|Physician Decision|2
7005234|NCT01429623|11072749|FG001|Overall Study|Physician Decision|3
7005235|NCT01429623|11072748|FG000|Overall Study|Protocol Violation|3
7005236|NCT01429623|11072749|FG001|Overall Study|Protocol Violation|2
7005237|NCT01429623|11072748|FG000|Overall Study|Assorted|1
7005238|NCT01429623|11072749|FG001|Overall Study|Assorted|2
7005239|NCT01429623|11072748|FG000|Overall Study|Conversion to Alzheimer's disease|14
7005240|NCT01429623|11072749|FG001|Overall Study|Conversion to Alzheimer's disease|21
7005241|NCT01429623|11072748|FG000|Overall Study|No post baseline data|4
7005242|NCT01429623|11072749|FG001|Overall Study|No post baseline data|4
7005243|NCT01429792|11072755|FG000|Overall Study|Other Reasons|67
7005244|NCT01429792|11072755|FG000|Overall Study|Unknown Disposition|94
7005245|NCT01429792|11072755|FG000|Overall Study|Negative HCV-RNA at Week 4|1
7005246|NCT01429792|11072755|FG000|Overall Study|Negative HCV-RNA at Week 12|4
7005247|NCT01429792|11072755|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32
7005248|NCT01429792|11072755|FG000|Overall Study|Positive HCV-RNA at Week 24|50
7005249|NCT01429792|11072755|FG000|Overall Study|Withdrawal by Subject|70
7005250|NCT01429792|11072755|FG000|Overall Study|Lost to Follow-up|88
7005251|NCT01430104|11072790|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1
7005252|NCT01430130|11072797|FG000|Overall Study|Lost to Follow-up|1
7005253|NCT01430130|11072797|FG000|Overall Study|Infection on Control Side of Incision|1
7005254|NCT01430403|11072845|FG000|Overall Study|Lost to Follow-up|5
7005255|NCT01430403|11072846|FG001|Overall Study|Lost to Follow-up|5
7005256|NCT01430403|11072847|FG002|Overall Study|Lost to Follow-up|3
7005257|NCT01430403|11072845|FG000|Overall Study|Physician Decision|1
7005258|NCT01430403|11072846|FG001|Overall Study|Physician Decision|0
7005259|NCT01430403|11072847|FG002|Overall Study|Physician Decision|0
7005260|NCT01430403|11072845|FG000|Overall Study|Protocol Violation|2
7005261|NCT01430403|11072846|FG001|Overall Study|Protocol Violation|3
7005262|NCT01430403|11072847|FG002|Overall Study|Protocol Violation|2
7005263|NCT01430403|11072845|FG000|Overall Study|Withdrawal by Subject|9
7005264|NCT01430403|11072846|FG001|Overall Study|Withdrawal by Subject|1
7005265|NCT01430403|11072847|FG002|Overall Study|Withdrawal by Subject|3
7005266|NCT01430442|11072868|FG000|Overall Study|Subject Withdrew Consent|3
7005267|NCT01430442|11072869|FG001|Overall Study|Subject Withdrew Consent|0
7005268|NCT01430442|11072870|FG002|Overall Study|Subject Withdrew Consent|1
7005269|NCT01430442|11072871|FG003|Overall Study|Subject Withdrew Consent|0
7005270|NCT01430442|11072872|FG004|Overall Study|Subject Withdrew Consent|2
7005271|NCT01430442|11072873|FG005|Overall Study|Subject Withdrew Consent|1
7005272|NCT01430442|11072874|FG006|Overall Study|Subject Withdrew Consent|5
7005273|NCT01430442|11072875|FG007|Overall Study|Subject Withdrew Consent|2
7005274|NCT01430442|11072868|FG000|Overall Study|Lost to Follow-up|2
7005275|NCT01430442|11072869|FG001|Overall Study|Lost to Follow-up|0
7005276|NCT01430442|11072870|FG002|Overall Study|Lost to Follow-up|1
7005277|NCT01430442|11072871|FG003|Overall Study|Lost to Follow-up|2
7005278|NCT01430442|11072872|FG004|Overall Study|Lost to Follow-up|2
7005279|NCT01430442|11072873|FG005|Overall Study|Lost to Follow-up|1
7005280|NCT01430442|11072874|FG006|Overall Study|Lost to Follow-up|5
7005281|NCT01430442|11072875|FG007|Overall Study|Lost to Follow-up|1
7005282|NCT01430442|11072868|FG000|Overall Study|Pregnancy|1
7005283|NCT01430442|11072869|FG001|Overall Study|Pregnancy|0
7005284|NCT01430442|11072870|FG002|Overall Study|Pregnancy|0
7005285|NCT01430442|11072871|FG003|Overall Study|Pregnancy|0
7005286|NCT01430442|11072872|FG004|Overall Study|Pregnancy|0
7005287|NCT01430442|11072873|FG005|Overall Study|Pregnancy|1
7005288|NCT01430442|11072874|FG006|Overall Study|Pregnancy|0
7005289|NCT01430442|11072875|FG007|Overall Study|Pregnancy|0
7005290|NCT01430442|11072868|FG000|Overall Study|Patient No Longer Meets Study Criteria|7
7005291|NCT01430442|11072869|FG001|Overall Study|Patient No Longer Meets Study Criteria|6
7005292|NCT01430442|11072870|FG002|Overall Study|Patient No Longer Meets Study Criteria|3
7005293|NCT01430442|11072871|FG003|Overall Study|Patient No Longer Meets Study Criteria|2
7005294|NCT01430442|11072872|FG004|Overall Study|Patient No Longer Meets Study Criteria|5
7005295|NCT01430442|11072873|FG005|Overall Study|Patient No Longer Meets Study Criteria|5
7005296|NCT01430442|11072874|FG006|Overall Study|Patient No Longer Meets Study Criteria|9
7005297|NCT01430442|11072875|FG007|Overall Study|Patient No Longer Meets Study Criteria|6
7005298|NCT01430455|11072893|FG000|Overall Study|Withdrawal by Subject|1
7005299|NCT01430455|11072893|FG000|Overall Study|Switched to follow-up phase|1
7005300|NCT01430468|11072899|FG000|Overall Study|Physician Decision|2
7005301|NCT01430468|11072900|FG001|Overall Study|Physician Decision|1
7005302|NCT01430468|11072899|FG000|Overall Study|Withdrawal by Subject|5
7005303|NCT01430468|11072900|FG001|Overall Study|Withdrawal by Subject|5
7005304|NCT01430559|11072908|FG000|Overall Study|Adverse Event|7
7005305|NCT01430559|11072909|FG001|Overall Study|Adverse Event|3
7005306|NCT01430559|11072908|FG000|Overall Study|Entry criteria not met|1
7005307|NCT01430559|11072909|FG001|Overall Study|Entry criteria not met|1
7005308|NCT01430559|11072908|FG000|Overall Study|Lost to Follow-up|1
7005309|NCT01430559|11072909|FG001|Overall Study|Lost to Follow-up|0
7005310|NCT01430559|11072908|FG000|Overall Study|Medication error|1
7005311|NCT01430559|11072909|FG001|Overall Study|Medication error|0
7005312|NCT01430559|11072908|FG000|Overall Study|Withdrawal by Subject|3
7005313|NCT01430559|11072909|FG001|Overall Study|Withdrawal by Subject|2
7005314|NCT01430559|11072908|FG000|Overall Study|Protocol Violation|1
7005315|NCT01430559|11072909|FG001|Overall Study|Protocol Violation|0
7005316|NCT01430559|11072908|FG000|Overall Study|Other|3
7005317|NCT01430559|11072909|FG001|Overall Study|Other|3
7005318|NCT01430559|11072908|FG000|Overall Study|Randomized, Not Treated|3
7005319|NCT01430559|11072909|FG001|Overall Study|Randomized, Not Treated|3
7005320|NCT01430585|11072920|FG000|Overall Study|Death|1
7005321|NCT01430585|11072920|FG000|Overall Study|Objective Progression or Relapse|3
7005322|NCT01430585|11072920|FG000|Overall Study|Study Terminated by Sponsor|3
7005323|NCT01430585|11072920|FG000|Overall Study|Other|7
7005324|NCT01430611|11072932|FG000|Overall Study|Adverse Event|0
7005325|NCT01430611|11072933|FG001|Overall Study|Adverse Event|1
7005326|NCT01430611|11072932|FG000|Overall Study|Protocol Violation|1
7005327|NCT01430611|11072933|FG001|Overall Study|Protocol Violation|0
7005328|NCT01430611|11072932|FG000|Overall Study|Lost to Follow-up|1
7005329|NCT01430611|11072933|FG001|Overall Study|Lost to Follow-up|0
7005330|NCT01430611|11072932|FG000|Overall Study|Withdrawal by Subject|15
7005331|NCT01430611|11072933|FG001|Overall Study|Withdrawal by Subject|14
7005332|NCT01430624|11072942|FG000|Overall Study|Lost to Follow-up|23
7005333|NCT01430624|11072943|FG001|Overall Study|Lost to Follow-up|29
7005334|NCT01430624|11072944|FG002|Overall Study|Lost to Follow-up|27
7005335|NCT01430624|11072942|FG000|Overall Study|technical or eligibility|5
7005336|NCT01430624|11072943|FG001|Overall Study|technical or eligibility|5
7005337|NCT01430624|11072944|FG002|Overall Study|technical or eligibility|2
7005338|NCT01430754|11072976|FG000|Run-In Phase|Circadian Period Ineligible|24
7005339|NCT01430754|11072977|FG001|Run-In Phase|Circadian Period Ineligible|0
7005340|NCT01430754|11072976|FG000|Run-In Phase|Protocol Violation|6
7005341|NCT01430754|11072977|FG001|Run-In Phase|Protocol Violation|0
7005342|NCT01430754|11072976|FG000|Run-In Phase|Adverse Event|2
7005343|NCT01430754|11072977|FG001|Run-In Phase|Adverse Event|0
7005344|NCT01430754|11072976|FG000|Run-In Phase|Other|2
7005345|NCT01430754|11072977|FG001|Run-In Phase|Other|0
7005346|NCT01430754|11072976|FG000|Run-In Phase|Withdrawal by Subject|2
7005347|NCT01430754|11072977|FG001|Run-In Phase|Withdrawal by Subject|0
7005348|NCT01430754|11072976|FG000|Run-In Phase|Lost to Follow-up|1
7005349|NCT01430754|11072977|FG001|Run-In Phase|Lost to Follow-up|0
7005350|NCT01431079|11073005|FG000|Overall Study|Lost to Follow-up|35
7005351|NCT01431079|11073006|FG001|Overall Study|Lost to Follow-up|39
7005352|NCT01431144|11073051|FG000|Overall Study|Implant mobility and removal|2
7005353|NCT01431144|11073052|FG001|Overall Study|Implant mobility and removal|0
7005354|NCT01431274|11073091|FG000|Overall Study|Adverse Event|51
7005355|NCT01431274|11073092|FG001|Overall Study|Adverse Event|37
7005356|NCT01431274|11073093|FG002|Overall Study|Adverse Event|43
7005357|NCT01431274|11073094|FG003|Overall Study|Adverse Event|30
7005358|NCT01431274|11073095|FG004|Overall Study|Adverse Event|37
7005359|NCT01431274|11073091|FG000|Overall Study|Consent withdrawn not due to AE|29
7005360|NCT01431274|11073092|FG001|Overall Study|Consent withdrawn not due to AE|20
7005361|NCT01431274|11073093|FG002|Overall Study|Consent withdrawn not due to AE|17
7005362|NCT01431274|11073094|FG003|Overall Study|Consent withdrawn not due to AE|20
7005363|NCT01431274|11073095|FG004|Overall Study|Consent withdrawn not due to AE|11
7005364|NCT01431274|11073091|FG000|Overall Study|Non compliant with protocol|5
7005365|NCT01431274|11073092|FG001|Overall Study|Non compliant with protocol|8
7005366|NCT01431274|11073093|FG002|Overall Study|Non compliant with protocol|4
7005367|NCT01431274|11073094|FG003|Overall Study|Non compliant with protocol|4
7005368|NCT01431274|11073095|FG004|Overall Study|Non compliant with protocol|4
7005369|NCT01431274|11073091|FG000|Overall Study|Lost to Follow-up|6
7005370|NCT01431274|11073092|FG001|Overall Study|Lost to Follow-up|7
7005371|NCT01431274|11073093|FG002|Overall Study|Lost to Follow-up|1
7005372|NCT01431274|11073094|FG003|Overall Study|Lost to Follow-up|4
7005373|NCT01431274|11073095|FG004|Overall Study|Lost to Follow-up|0
7005374|NCT01431274|11073091|FG000|Overall Study|Other reason not stated above|6
7005375|NCT01431274|11073092|FG001|Overall Study|Other reason not stated above|5
7005376|NCT01431274|11073093|FG002|Overall Study|Other reason not stated above|7
7005377|NCT01431274|11073094|FG003|Overall Study|Other reason not stated above|2
7005378|NCT01431274|11073095|FG004|Overall Study|Other reason not stated above|4
7005379|NCT01431287|11073112|FG000|Overall Study|not treated|0
7005380|NCT01431287|11073113|FG001|Overall Study|not treated|0
7005381|NCT01431287|11073114|FG002|Overall Study|not treated|1
7005382|NCT01431287|11073115|FG003|Overall Study|not treated|0
7005383|NCT01431287|11073116|FG004|Overall Study|not treated|0
7005384|NCT01431287|11073112|FG000|Overall Study|Adverse Event|59
7005385|NCT01431287|11073113|FG001|Overall Study|Adverse Event|57
7005386|NCT01431287|11073114|FG002|Overall Study|Adverse Event|53
7005387|NCT01431287|11073115|FG003|Overall Study|Adverse Event|33
7005388|NCT01431287|11073116|FG004|Overall Study|Adverse Event|41
7005389|NCT01431287|11073112|FG000|Overall Study|Non compliant with protocol|6
7005390|NCT01431287|11073113|FG001|Overall Study|Non compliant with protocol|6
7005391|NCT01431287|11073114|FG002|Overall Study|Non compliant with protocol|5
7005392|NCT01431287|11073115|FG003|Overall Study|Non compliant with protocol|6
7005393|NCT01431287|11073116|FG004|Overall Study|Non compliant with protocol|5
7005394|NCT01431287|11073112|FG000|Overall Study|Lost to Follow-up|0
7005395|NCT01431287|11073113|FG001|Overall Study|Lost to Follow-up|3
7005396|NCT01431287|11073114|FG002|Overall Study|Lost to Follow-up|2
7005397|NCT01431287|11073115|FG003|Overall Study|Lost to Follow-up|3
7005398|NCT01431287|11073116|FG004|Overall Study|Lost to Follow-up|1
7005399|NCT01431287|11073112|FG000|Overall Study|Consent withdrawn not due to AE|29
7005400|NCT01431287|11073113|FG001|Overall Study|Consent withdrawn not due to AE|30
7005401|NCT01431287|11073114|FG002|Overall Study|Consent withdrawn not due to AE|34
7005402|NCT01431287|11073115|FG003|Overall Study|Consent withdrawn not due to AE|19
7005403|NCT01431287|11073116|FG004|Overall Study|Consent withdrawn not due to AE|29
7005404|NCT01431287|11073112|FG000|Overall Study|not stated above|4
7005405|NCT01431287|11073113|FG001|Overall Study|not stated above|2
7005406|NCT01431287|11073114|FG002|Overall Study|not stated above|2
7005407|NCT01431287|11073115|FG003|Overall Study|not stated above|2
7005408|NCT01431287|11073116|FG004|Overall Study|not stated above|1
7005409|NCT01431521|11073178|FG000|Overall Study|Withdrawal by Subject|0
7005410|NCT01431521|11073179|FG001|Overall Study|Withdrawal by Subject|0
7005411|NCT01431521|11073180|FG002|Overall Study|Withdrawal by Subject|1
7005412|NCT01431521|11073181|FG003|Overall Study|Withdrawal by Subject|0
7005413|NCT01431534|11073193|FG000|Treatment Phase|Adverse Event|0
7005414|NCT01431534|11073194|FG001|Treatment Phase|Adverse Event|0
7005415|NCT01431534|11073195|FG002|Treatment Phase|Adverse Event|1
7005416|NCT01431534|11073193|FG000|Treatment Phase|Progressive Disease|4
7005417|NCT01431534|11073194|FG001|Treatment Phase|Progressive Disease|3
7005418|NCT01431534|11073195|FG002|Treatment Phase|Progressive Disease|10
7005419|NCT01431638|11073210|FG000|Overall Study|Adverse Event|1
7005420|NCT01431638|11073211|FG001|Overall Study|Adverse Event|3
7005421|NCT01431638|11073212|FG002|Overall Study|Adverse Event|1
7005422|NCT01431638|11073210|FG000|Overall Study|Unsatisfactory therapeutic effect|2
7005423|NCT01431638|11073211|FG001|Overall Study|Unsatisfactory therapeutic effect|2
7005424|NCT01431638|11073212|FG002|Overall Study|Unsatisfactory therapeutic effect|4
7005425|NCT01431638|11073210|FG000|Overall Study|Participants condition no longer requires study drug|0
7005426|NCT01431638|11073211|FG001|Overall Study|Participants condition no longer requires study drug|1
7005427|NCT01431638|11073212|FG002|Overall Study|Participants condition no longer requires study drug|0
7005428|NCT01431638|11073210|FG000|Overall Study|Participant withdrew consent|14
7005429|NCT01431638|11073211|FG001|Overall Study|Participant withdrew consent|5
7005430|NCT01431638|11073212|FG002|Overall Study|Participant withdrew consent|8
7005431|NCT01431638|11073210|FG000|Overall Study|Lost to Follow-up|7
7005432|NCT01431638|11073211|FG001|Overall Study|Lost to Follow-up|9
7005433|NCT01431638|11073212|FG002|Overall Study|Lost to Follow-up|7
7005434|NCT01431638|11073210|FG000|Overall Study|Administrative problems|1
7005435|NCT01431638|11073211|FG001|Overall Study|Administrative problems|4
7005436|NCT01431638|11073212|FG002|Overall Study|Administrative problems|6
7005437|NCT01431638|11073210|FG000|Overall Study|Death|1
7005438|NCT01431638|11073211|FG001|Overall Study|Death|0
7005439|NCT01431638|11073212|FG002|Overall Study|Death|0
7005440|NCT01431638|11073210|FG000|Overall Study|Protocol deviation|1
7005441|NCT01431638|11073211|FG001|Overall Study|Protocol deviation|1
7005442|NCT01431638|11073212|FG002|Overall Study|Protocol deviation|4
7005443|NCT01431638|11073210|FG000|Overall Study|Participants Did not enter extension study from core study|39
7005444|NCT01431638|11073211|FG001|Overall Study|Participants Did not enter extension study from core study|46
7005445|NCT01431638|11073212|FG002|Overall Study|Participants Did not enter extension study from core study|32
7005446|NCT01431716|11073224|FG000|Overall Study|Withdrawal of consent|1
7005447|NCT01431950|11073270|FG000|Overall Study|Study Site Closed/Terminated|7
7005448|NCT01431950|11073271|FG001|Overall Study|Study Site Closed/Terminated|3
7005449|NCT01431950|11073270|FG000|Overall Study|Withdrawal by Subject|4
7005450|NCT01431950|11073271|FG001|Overall Study|Withdrawal by Subject|3
7005451|NCT01431950|11073270|FG000|Overall Study|Protocol Violation|2
7005452|NCT01431950|11073271|FG001|Overall Study|Protocol Violation|3
7005453|NCT01431950|11073270|FG000|Overall Study|Adverse Event|2
7005454|NCT01431950|11073271|FG001|Overall Study|Adverse Event|2
7005455|NCT01431950|11073270|FG000|Overall Study|Physician Decision|2
7005456|NCT01431950|11073271|FG001|Overall Study|Physician Decision|1
7005457|NCT01431950|11073270|FG000|Overall Study|Lack of Efficacy|2
7005458|NCT01431950|11073271|FG001|Overall Study|Lack of Efficacy|1
7005459|NCT01431950|11073270|FG000|Overall Study|Lost to Follow-up|0
7005460|NCT01431950|11073271|FG001|Overall Study|Lost to Follow-up|1
7005461|NCT01431950|11073270|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0
7005462|NCT01431950|11073271|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1
7005463|NCT01431963|11073277|FG000|Overall Study|Adverse Event|18
7005464|NCT01431963|11073277|FG000|Overall Study|Lack of Efficacy|7
7005465|NCT01431963|11073277|FG000|Overall Study|Protocol Violation|1
7005466|NCT01431963|11073277|FG000|Overall Study|Protocol-defined Stopping Criteria|2
7005467|NCT01431963|11073277|FG000|Overall Study|Physician Decision|4
7005468|NCT01431963|11073277|FG000|Overall Study|Withdrawal by Subject|3
7005469|NCT01431976|11073281|FG000|Overall Study|Adverse Event|6
7005470|NCT01431976|11073281|FG000|Overall Study|Lack of Efficacy|2
7005471|NCT01431976|11073281|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4
7005472|NCT01431976|11073281|FG000|Overall Study|Physician Decision|1
7005473|NCT01431976|11073281|FG000|Overall Study|Withdrawal by Subject|1
7005474|NCT01432171|11073307|FG000|Overall Study|Death|1
7005475|NCT01432171|11073308|FG001|Overall Study|Death|2
7005476|NCT01432171|11073307|FG000|Overall Study|Lost to Follow-up|6
7005477|NCT01432171|11073308|FG001|Overall Study|Lost to Follow-up|5
7005478|NCT01432171|11073307|FG000|Overall Study|Withdrawal by Subject|3
7005479|NCT01432171|11073308|FG001|Overall Study|Withdrawal by Subject|1
7005480|NCT01432171|11073307|FG000|Overall Study|Noncompliance|2
7005481|NCT01432171|11073308|FG001|Overall Study|Noncompliance|3
7005482|NCT01432171|11073307|FG000|Overall Study|Insurance denial trial coverage|1
7005483|NCT01432171|11073308|FG001|Overall Study|Insurance denial trial coverage|0
7005484|NCT01432171|11073307|FG000|Overall Study|Patient moved to palliative care|1
7005485|NCT01432171|11073308|FG001|Overall Study|Patient moved to palliative care|0
7005486|NCT01432262|11073332|FG000|Overall Study|Withdrawal by Subject|2
7005487|NCT01432262|11073333|FG001|Overall Study|Withdrawal by Subject|1
7005488|NCT01432275|11073339|FG000|First BG Meter System (7 Days)|Adverse Event|0
7005489|NCT01432275|11073340|FG001|First BG Meter System (7 Days)|Adverse Event|2
7005490|NCT01432275|11073339|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0
7005491|NCT01432275|11073340|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1
7005492|NCT01432275|11073339|FG000|Second BG Meter System (7 Days)|Adverse Event|1
7005493|NCT01432275|11073340|FG001|Second BG Meter System (7 Days)|Adverse Event|1
7005494|NCT01432275|11073339|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1
7005495|NCT01432275|11073340|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0
7005496|NCT01432275|11073339|FG000|Second BG Meter System (7 Days)|Physician Decision|0
7005497|NCT01432275|11073340|FG001|Second BG Meter System (7 Days)|Physician Decision|1
7005498|NCT01432275|11073339|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0
7005499|NCT01432275|11073340|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1
7005500|NCT01432275|11073339|FG000|ADC With Calculator (10 Days)|Physician Decision|1
7005501|NCT01432275|11073340|FG001|ADC With Calculator (10 Days)|Physician Decision|1
7005502|NCT01432275|11073339|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2
7005503|NCT01432275|11073340|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0
7005504|NCT01432275|11073339|FG000|ADC With Calculator (10 Days)|Protocol Violation|0
7005505|NCT01432275|11073340|FG001|ADC With Calculator (10 Days)|Protocol Violation|1
7005506|NCT01432327|11073350|FG000|Posttest 3 Months|depression|3
7005507|NCT01432327|11073351|FG001|Posttest 3 Months|depression|0
7005508|NCT01432327|11073352|FG002|Posttest 3 Months|depression|0
7005509|NCT01432327|11073353|FG003|Posttest 3 Months|depression|0
7005510|NCT01432327|11073350|FG000|Posttest 3 Months|Lost to Follow-up|1
7005511|NCT01432327|11073351|FG001|Posttest 3 Months|Lost to Follow-up|0
7005512|NCT01432327|11073352|FG002|Posttest 3 Months|Lost to Follow-up|2
7005513|NCT01432327|11073353|FG003|Posttest 3 Months|Lost to Follow-up|1
7005514|NCT01432327|11073350|FG000|Posttest 3 Months|Allergic reaction|0
7005515|NCT01432327|11073351|FG001|Posttest 3 Months|Allergic reaction|2
7005516|NCT01432327|11073352|FG002|Posttest 3 Months|Allergic reaction|0
7005517|NCT01432327|11073353|FG003|Posttest 3 Months|Allergic reaction|0
7005518|NCT01432327|11073350|FG000|Posttest 6 Months|Lost to Follow-up|0
7005519|NCT01432327|11073351|FG001|Posttest 6 Months|Lost to Follow-up|0
7005520|NCT01432327|11073352|FG002|Posttest 6 Months|Lost to Follow-up|3
7005521|NCT01432327|11073353|FG003|Posttest 6 Months|Lost to Follow-up|2
7005522|NCT01432327|11073350|FG000|Posttest 6 Months|Allergic reaction|0
7005523|NCT01432327|11073351|FG001|Posttest 6 Months|Allergic reaction|0
7005524|NCT01432327|11073352|FG002|Posttest 6 Months|Allergic reaction|1
7005525|NCT01432327|11073353|FG003|Posttest 6 Months|Allergic reaction|0
7005526|NCT01432327|11073350|FG000|Posttest 6 Months|Withdrawal by Subject|0
7005527|NCT01432327|11073351|FG001|Posttest 6 Months|Withdrawal by Subject|0
7005528|NCT01432327|11073352|FG002|Posttest 6 Months|Withdrawal by Subject|1
7005529|NCT01432327|11073353|FG003|Posttest 6 Months|Withdrawal by Subject|0
7005530|NCT01432327|11073350|FG000|Posttest 1 Year|Measurement have to take place in future|24
7005531|NCT01432327|11073351|FG001|Posttest 1 Year|Measurement have to take place in future|28
7005532|NCT01432327|11073352|FG002|Posttest 1 Year|Measurement have to take place in future|15
7005533|NCT01432327|11073353|FG003|Posttest 1 Year|Measurement have to take place in future|20
7005534|NCT01432327|11073350|FG000|Posttest 1 Year|Lost to Follow-up|0
7005535|NCT01432327|11073351|FG001|Posttest 1 Year|Lost to Follow-up|0
7005536|NCT01432327|11073352|FG002|Posttest 1 Year|Lost to Follow-up|4
7005537|NCT01432327|11073353|FG003|Posttest 1 Year|Lost to Follow-up|2
7005538|NCT01432327|11073350|FG000|Posttest 1 Year|Allergic reaction|0
7005539|NCT01432327|11073351|FG001|Posttest 1 Year|Allergic reaction|0
7005540|NCT01432327|11073352|FG002|Posttest 1 Year|Allergic reaction|1
7005541|NCT01432327|11073353|FG003|Posttest 1 Year|Allergic reaction|1
7005542|NCT01432366|11073363|FG000|Overall Study|Non-Responder|7
7005543|NCT01432366|11073363|FG000|Overall Study|Adverse Event|8
7005544|NCT01432366|11073363|FG000|Overall Study|Withdrawal Due to Non-Compliance|3
7005545|NCT01432366|11073363|FG000|Overall Study|Pregnancy|1
7005546|NCT01432366|11073363|FG000|Overall Study|Lost to Follow-up|13
7005547|NCT01432366|11073363|FG000|Overall Study|Lack of Efficacy|1
7005548|NCT01432366|11073363|FG000|Overall Study|Site Closed|20
7005549|NCT01432366|11073363|FG000|Overall Study|Investigator Forget to Complete Visits|1
7005550|NCT01432366|11073363|FG000|Overall Study|Other|14
7005551|NCT01432444|11073380|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10
7005552|NCT01432444|11073381|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0
7005553|NCT01432444|11073382|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0
7005554|NCT01432444|11073380|FG000|Tolerability/Cross-titration Phase|Adverse Event|16
7005555|NCT01432444|11073381|FG001|Tolerability/Cross-titration Phase|Adverse Event|0
7005556|NCT01432444|11073382|FG002|Tolerability/Cross-titration Phase|Adverse Event|0
7005557|NCT01432444|11073380|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5
7005558|NCT01432444|11073381|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
7005559|NCT01432444|11073382|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
7005560|NCT01432444|11073380|FG000|Tolerability/Cross-titration Phase|Physician Decision|8
7005561|NCT01432444|11073381|FG001|Tolerability/Cross-titration Phase|Physician Decision|0
7005562|NCT01432444|11073382|FG002|Tolerability/Cross-titration Phase|Physician Decision|0
7005563|NCT01432444|11073380|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15
7005564|NCT01432444|11073381|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
7005565|NCT01432444|11073382|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
7005566|NCT01432444|11073380|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1
7005567|NCT01432444|11073381|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0
7005568|NCT01432444|11073382|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0
7005569|NCT01432444|11073380|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5
7005570|NCT01432444|11073381|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0
7005571|NCT01432444|11073382|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0
7005572|NCT01432444|11073380|FG000|Treatment Phase|Lost to Follow-up|0
7005573|NCT01432444|11073381|FG001|Treatment Phase|Lost to Follow-up|33
7005574|NCT01432444|11073382|FG002|Treatment Phase|Lost to Follow-up|0
7005575|NCT01432444|11073380|FG000|Treatment Phase|Adverse Event|0
7005576|NCT01432444|11073381|FG001|Treatment Phase|Adverse Event|37
7005577|NCT01432444|11073382|FG002|Treatment Phase|Adverse Event|0
7005578|NCT01432444|11073380|FG000|Treatment Phase|Met Withdrawal Criteria|0
7005579|NCT01432444|11073381|FG001|Treatment Phase|Met Withdrawal Criteria|11
7005580|NCT01432444|11073382|FG002|Treatment Phase|Met Withdrawal Criteria|0
7005581|NCT01432444|11073380|FG000|Treatment Phase|Physician Decision|0
7005582|NCT01432444|11073381|FG001|Treatment Phase|Physician Decision|5
7005583|NCT01432444|11073382|FG002|Treatment Phase|Physician Decision|0
7005584|NCT01432444|11073380|FG000|Treatment Phase|Withdrawal by Subject|0
7005585|NCT01432444|11073381|FG001|Treatment Phase|Withdrawal by Subject|41
7005586|NCT01432444|11073382|FG002|Treatment Phase|Withdrawal by Subject|0
7005587|NCT01432444|11073380|FG000|Treatment Phase|Protocol Deviation|0
7005588|NCT01432444|11073381|FG001|Treatment Phase|Protocol Deviation|3
7005589|NCT01432444|11073382|FG002|Treatment Phase|Protocol Deviation|0
7005590|NCT01432444|11073380|FG000|Treatment Phase|Lack of Efficacy|0
7005591|NCT01432444|11073381|FG001|Treatment Phase|Lack of Efficacy|10
7005592|NCT01432444|11073382|FG002|Treatment Phase|Lack of Efficacy|0
7005593|NCT01432444|11073380|FG000|Extension Phase|Lost to Follow-up|0
7005594|NCT01432444|11073381|FG001|Extension Phase|Lost to Follow-up|0
7005595|NCT01432444|11073382|FG002|Extension Phase|Lost to Follow-up|17
7005596|NCT01432444|11073380|FG000|Extension Phase|Adverse Event|0
7005597|NCT01432444|11073381|FG001|Extension Phase|Adverse Event|0
7005598|NCT01432444|11073382|FG002|Extension Phase|Adverse Event|10
7005599|NCT01432444|11073380|FG000|Extension Phase|Sponsor Discontinued Trial|0
7005600|NCT01432444|11073381|FG001|Extension Phase|Sponsor Discontinued Trial|0
7005601|NCT01432444|11073382|FG002|Extension Phase|Sponsor Discontinued Trial|7
7005602|NCT01432444|11073380|FG000|Extension Phase|Met Withdrawal Criteria|0
7005603|NCT01432444|11073381|FG001|Extension Phase|Met Withdrawal Criteria|0
7005604|NCT01432444|11073382|FG002|Extension Phase|Met Withdrawal Criteria|144
7005605|NCT01432444|11073380|FG000|Extension Phase|Physician Decision|0
7005606|NCT01432444|11073381|FG001|Extension Phase|Physician Decision|0
7005607|NCT01432444|11073382|FG002|Extension Phase|Physician Decision|1
7005608|NCT01432444|11073380|FG000|Extension Phase|Withdrawal by Subject|0
7005609|NCT01432444|11073381|FG001|Extension Phase|Withdrawal by Subject|0
7005610|NCT01432444|11073382|FG002|Extension Phase|Withdrawal by Subject|13
7005611|NCT01432457|11073390|FG000|Overall Study|Adverse Event|7
7005612|NCT01432457|11073391|FG001|Overall Study|Adverse Event|10
7005613|NCT01432457|11073392|FG002|Overall Study|Adverse Event|16
7005614|NCT01432457|11073390|FG000|Overall Study|Lack of Efficacy|2
7005615|NCT01432457|11073391|FG001|Overall Study|Lack of Efficacy|1
7005616|NCT01432457|11073392|FG002|Overall Study|Lack of Efficacy|1
7005617|NCT01432457|11073390|FG000|Overall Study|Lost to Follow-up|11
7005618|NCT01432457|11073391|FG001|Overall Study|Lost to Follow-up|15
7005619|NCT01432457|11073392|FG002|Overall Study|Lost to Follow-up|20
7005620|NCT01432457|11073390|FG000|Overall Study|Protocol Violation|3
7005621|NCT01432457|11073391|FG001|Overall Study|Protocol Violation|2
7005622|NCT01432457|11073392|FG002|Overall Study|Protocol Violation|6
7005623|NCT01432457|11073390|FG000|Overall Study|Withdrawal by Subject|6
7005624|NCT01432457|11073391|FG001|Overall Study|Withdrawal by Subject|11
7005625|NCT01432457|11073392|FG002|Overall Study|Withdrawal by Subject|9
7005626|NCT01432457|11073390|FG000|Overall Study|Reasons not defined|2
7005627|NCT01432457|11073391|FG001|Overall Study|Reasons not defined|3
7005628|NCT01432457|11073392|FG002|Overall Study|Reasons not defined|4
7005629|NCT01432457|11073390|FG000|Overall Study|Did not take study drug|6
7005630|NCT01432457|11073391|FG001|Overall Study|Did not take study drug|6
7005631|NCT01432457|11073392|FG002|Overall Study|Did not take study drug|3
7005632|NCT01432574|11073417|FG000|Overall Study|Moved|2
7005633|NCT01432574|11073417|FG000|Overall Study|Not interested|1
7005634|NCT01432600|11073426|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0
7005635|NCT01432600|11073427|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1
7005636|NCT01432600|11073428|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1
7005637|NCT01432626|11073438|FG000|Overall Study|LV function recovered|2
7005638|NCT01432626|11073438|FG000|Overall Study|Withdrawal by Subject|2
7005639|NCT01432626|11073438|FG000|Overall Study|Only 1 image competed|2
7005640|NCT01432626|11073438|FG000|Overall Study|Imaging agent not available|1
7005641|NCT01432730|11073442|FG000|Period 1|Adverse Event|2
7005642|NCT01432730|11073443|FG001|Period 1|Adverse Event|0
7005643|NCT01432730|11073442|FG000|Period 2|Adverse Event|0
7005644|NCT01432730|11073443|FG001|Period 2|Adverse Event|4
7005645|NCT01432756|11073453|FG000|Overall Study|Lost to Follow-up|1
7005646|NCT01432756|11073454|FG001|Overall Study|Lost to Follow-up|0
7005647|NCT01432756|11073455|FG002|Overall Study|Lost to Follow-up|2
7005648|NCT01432756|11073456|FG003|Overall Study|Lost to Follow-up|1
7005649|NCT01432938|11073474|FG000|First Intervention|Protocol Violation|1
7005650|NCT01432938|11073475|FG001|First Intervention|Protocol Violation|0
7005651|NCT01432938|11073474|FG000|First Intervention|Physician Decision|1
7005652|NCT01432938|11073475|FG001|First Intervention|Physician Decision|0
7005653|NCT01432938|11073474|FG000|Second Intervention|Adverse Event|1
7005654|NCT01432938|11073475|FG001|Second Intervention|Adverse Event|0
7005655|NCT01432951|11073482|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1
7005656|NCT01433055|11073497|FG000|Overall Study|Diagnosed with cancer unrelated to study|1
7005657|NCT01433055|11073498|FG001|Overall Study|Diagnosed with cancer unrelated to study|0
7005658|NCT01433055|11073497|FG000|Overall Study|Severely elevated triglycerides at entry|1
7005659|NCT01433055|11073498|FG001|Overall Study|Severely elevated triglycerides at entry|0
7005660|NCT01433159|11073525|FG000|Overall Study|Adverse Event|1
7005661|NCT01433159|11073526|FG001|Overall Study|Adverse Event|0
7005662|NCT01433159|11073525|FG000|Overall Study|Physician Decision|1
7005663|NCT01433159|11073526|FG001|Overall Study|Physician Decision|0
7005664|NCT01433159|11073525|FG000|Overall Study|Protocol Violation|0
7005665|NCT01433159|11073526|FG001|Overall Study|Protocol Violation|1
7005666|NCT01433172|11073535|FG000|Overall Study|Withdrawal by Subject|0
7005667|NCT01433172|11073536|FG001|Overall Study|Withdrawal by Subject|1
7005668|NCT01433172|11073537|FG002|Overall Study|Withdrawal by Subject|0
7005669|NCT01433172|11073535|FG000|Overall Study|Disease Progression|0
7005670|NCT01433172|11073536|FG001|Overall Study|Disease Progression|0
7005671|NCT01433172|11073537|FG002|Overall Study|Disease Progression|1
7005672|NCT01433172|11073535|FG000|Overall Study|Death|0
7005673|NCT01433172|11073536|FG001|Overall Study|Death|2
7005674|NCT01433172|11073537|FG002|Overall Study|Death|0
7005675|NCT01433250|11073547|FG000|Overall Study|Protocol Violation|0
7005676|NCT01433250|11073548|FG001|Overall Study|Protocol Violation|1
7005677|NCT01433250|11073547|FG000|Overall Study|Withdrawal by Subject|3
7005678|NCT01433250|11073548|FG001|Overall Study|Withdrawal by Subject|2
7005679|NCT01433263|11073556|FG000|Overall Study|Adverse Event|3
7005680|NCT01433263|11073557|FG001|Overall Study|Adverse Event|1
7005681|NCT01433263|11073556|FG000|Overall Study|Death|5
7005682|NCT01433263|11073557|FG001|Overall Study|Death|3
7005683|NCT01433263|11073556|FG000|Overall Study|Lost to Follow-up|0
7005684|NCT01433263|11073557|FG001|Overall Study|Lost to Follow-up|1
7005685|NCT01433263|11073556|FG000|Overall Study|Protocol Deviation|1
7005686|NCT01433263|11073557|FG001|Overall Study|Protocol Deviation|0
7005687|NCT01433263|11073556|FG000|Overall Study|Withdrawal by Subject|10
7005688|NCT01433263|11073557|FG001|Overall Study|Withdrawal by Subject|7
7005689|NCT01433354|11073566|FG000|Overall Study|Adverse Event|6
7005690|NCT01433354|11073566|FG000|Overall Study|Lost to Follow-up|1
7005691|NCT01433354|11073566|FG000|Overall Study|Administrative problems|90
7005692|NCT01433354|11073566|FG000|Overall Study|Protocol Violation|2
7005693|NCT01433354|11073566|FG000|Overall Study|Lack of Efficacy|17
7005694|NCT01433354|11073566|FG000|Overall Study|Subject Withdrew Consent|3
7005695|NCT01433549|11073580|FG000|Phase 2: Second Study Product|Adverse Event|0
7005696|NCT01433549|11073581|FG001|Phase 2: Second Study Product|Adverse Event|1
7005697|NCT01433978|11073614|FG000|Core Study|Adverse Event, Non-Fatal|0
7005698|NCT01433978|11073615|FG001|Core Study|Adverse Event, Non-Fatal|1
7005699|NCT01433978|11073616|FG002|Core Study|Adverse Event, Non-Fatal|0
7005700|NCT01433978|11073614|FG000|Core Study|Lack of Efficacy|5
7005701|NCT01433978|11073615|FG001|Core Study|Lack of Efficacy|1
7005702|NCT01433978|11073616|FG002|Core Study|Lack of Efficacy|0
7005703|NCT01433978|11073614|FG000|Core Study|Study Terminated by Sponsor|6
7005704|NCT01433978|11073615|FG001|Core Study|Study Terminated by Sponsor|9
7005705|NCT01433978|11073616|FG002|Core Study|Study Terminated by Sponsor|0
7005706|NCT01433978|11073614|FG000|Extension Phase|Adverse Event, Non-Fatal|0
7005707|NCT01433978|11073615|FG001|Extension Phase|Adverse Event, Non-Fatal|0
7005708|NCT01433978|11073616|FG002|Extension Phase|Adverse Event, Non-Fatal|1
7005709|NCT01433978|11073614|FG000|Extension Phase|Lack of Efficacy|0
7005710|NCT01433978|11073615|FG001|Extension Phase|Lack of Efficacy|0
7005711|NCT01433978|11073616|FG002|Extension Phase|Lack of Efficacy|1
7005712|NCT01433978|11073614|FG000|Extension Phase|Study Terminated by Sponsor|0
7005713|NCT01433978|11073615|FG001|Extension Phase|Study Terminated by Sponsor|0
7005714|NCT01433978|11073616|FG002|Extension Phase|Study Terminated by Sponsor|4
7005715|NCT01433991|11073627|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2
7005716|NCT01433991|11073628|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0
7005717|NCT01433991|11073629|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0
7005718|NCT01433991|11073630|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0
7005719|NCT01433991|11073627|FG000|Treatment Phase (Combination Agent)|Adverse Event|1
7005720|NCT01433991|11073628|FG001|Treatment Phase (Combination Agent)|Adverse Event|0
7005721|NCT01433991|11073629|FG002|Treatment Phase (Combination Agent)|Adverse Event|3
7005722|NCT01433991|11073630|FG003|Treatment Phase (Combination Agent)|Adverse Event|1
7005723|NCT01433991|11073627|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0
7005724|NCT01433991|11073628|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0
7005725|NCT01433991|11073629|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0
7005726|NCT01433991|11073630|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1
7005727|NCT01433991|11073627|FG000|Treatment Phase (Combination Agent)|Participant Choice|0
7005728|NCT01433991|11073628|FG001|Treatment Phase (Combination Agent)|Participant Choice|0
7005729|NCT01433991|11073629|FG002|Treatment Phase (Combination Agent)|Participant Choice|0
7005730|NCT01433991|11073630|FG003|Treatment Phase (Combination Agent)|Participant Choice|1
7005731|NCT01433991|11073627|FG000|Treatment Phase (Combination Agent)|Clinical progression|0
7005732|NCT01433991|11073628|FG001|Treatment Phase (Combination Agent)|Clinical progression|1
7005733|NCT01433991|11073629|FG002|Treatment Phase (Combination Agent)|Clinical progression|2
7005734|NCT01433991|11073630|FG003|Treatment Phase (Combination Agent)|Clinical progression|3
7005735|NCT01433991|11073627|FG000|Treatment Phase (Combination Agent)|Progressive disease|1
7005736|NCT01433991|11073628|FG001|Treatment Phase (Combination Agent)|Progressive disease|0
7005737|NCT01433991|11073629|FG002|Treatment Phase (Combination Agent)|Progressive disease|0
7005738|NCT01433991|11073630|FG003|Treatment Phase (Combination Agent)|Progressive disease|0
7005739|NCT01433991|11073627|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0
7005740|NCT01433991|11073628|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0
7005741|NCT01433991|11073629|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1
7005742|NCT01433991|11073630|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0
7005743|NCT01434654|11073695|FG000|Overall Study|Withdrawal by Subject|1
7005744|NCT01434654|11073696|FG001|Overall Study|Withdrawal by Subject|0
7005745|NCT01434654|11073695|FG000|Overall Study|Lost to Follow-up|1
7005746|NCT01434654|11073696|FG001|Overall Study|Lost to Follow-up|0
7005747|NCT01434667|11073706|FG000|Overall Study|Lost to Follow-up|5
7005748|NCT01434667|11073707|FG001|Overall Study|Lost to Follow-up|10
7005749|NCT01434680|11073717|FG000|Overall Study|Withdrawal by Subject|1
7005750|NCT01434680|11073718|FG001|Overall Study|Withdrawal by Subject|0
7005751|NCT01434680|11073719|FG002|Overall Study|Withdrawal by Subject|2
7005752|NCT01434680|11073720|FG003|Overall Study|Withdrawal by Subject|0
7005753|NCT01434680|11073717|FG000|Overall Study|Lost to Follow-up|1
7005754|NCT01434680|11073718|FG001|Overall Study|Lost to Follow-up|1
7005755|NCT01434680|11073719|FG002|Overall Study|Lost to Follow-up|0
7005756|NCT01434680|11073720|FG003|Overall Study|Lost to Follow-up|0
7005757|NCT01434680|11073717|FG000|Overall Study|Protocol Violation|1
7005758|NCT01434680|11073718|FG001|Overall Study|Protocol Violation|1
7005759|NCT01434680|11073719|FG002|Overall Study|Protocol Violation|0
7005760|NCT01434680|11073720|FG003|Overall Study|Protocol Violation|0
7005761|NCT01434693|11073734|FG000|Overall Study|Adverse Event|1
7005762|NCT01434693|11073735|FG001|Overall Study|Adverse Event|0
7005763|NCT01434693|11073736|FG002|Overall Study|Adverse Event|0
7005764|NCT01434693|11073737|FG003|Overall Study|Adverse Event|0
7005765|NCT01434693|11073734|FG000|Overall Study|Withdrawal by Subject|1
7005766|NCT01434693|11073735|FG001|Overall Study|Withdrawal by Subject|0
7005767|NCT01434693|11073736|FG002|Overall Study|Withdrawal by Subject|1
7005768|NCT01434693|11073737|FG003|Overall Study|Withdrawal by Subject|1
7005769|NCT01434693|11073734|FG000|Overall Study|Lost to Follow-up|1
7005770|NCT01434693|11073735|FG001|Overall Study|Lost to Follow-up|0
7005771|NCT01434693|11073736|FG002|Overall Study|Lost to Follow-up|0
7005772|NCT01434693|11073737|FG003|Overall Study|Lost to Follow-up|0
7005773|NCT01434810|11073749|FG000|Overall Study|Did not receive treatment|11
7005774|NCT01434810|11073750|FG001|Overall Study|Did not receive treatment|3
7005775|NCT01434810|11073749|FG000|Overall Study|Missing data/received <5hr phototherapy|12
7005776|NCT01434810|11073750|FG001|Overall Study|Missing data/received <5hr phototherapy|7
7005777|NCT01434823|11073758|FG000|Overall Study|Incomplete data in medical record|4
7005778|NCT01434823|11073759|FG001|Overall Study|Incomplete data in medical record|7
7005779|NCT01435018|11073769|FG000|Overall Study|Death|37
7005780|NCT01435018|11073770|FG001|Overall Study|Death|18
7005781|NCT01435018|11073771|FG002|Overall Study|Death|25
7005782|NCT01435018|11073769|FG000|Overall Study|Site is closing|4
7005783|NCT01435018|11073770|FG001|Overall Study|Site is closing|9
7005784|NCT01435018|11073771|FG002|Overall Study|Site is closing|7
7005785|NCT01435018|11073769|FG000|Overall Study|Withdrew consent|0
7005786|NCT01435018|11073770|FG001|Overall Study|Withdrew consent|3
7005787|NCT01435018|11073771|FG002|Overall Study|Withdrew consent|1
7005788|NCT01435018|11073769|FG000|Overall Study|Not willing to adhere to requirements|0
7005789|NCT01435018|11073770|FG001|Overall Study|Not willing to adhere to requirements|2
7005790|NCT01435018|11073771|FG002|Overall Study|Not willing to adhere to requirements|3
7005791|NCT01435018|11073769|FG000|Overall Study|Not able to get to clinic|2
7005792|NCT01435018|11073770|FG001|Overall Study|Not able to get to clinic|0
7005793|NCT01435018|11073771|FG002|Overall Study|Not able to get to clinic|2
7005794|NCT01435018|11073769|FG000|Overall Study|Severe debilitation, unable to continue|0
7005795|NCT01435018|11073770|FG001|Overall Study|Severe debilitation, unable to continue|0
7005796|NCT01435018|11073771|FG002|Overall Study|Severe debilitation, unable to continue|1
7005797|NCT01435018|11073769|FG000|Overall Study|Unable to contact participant/parent|1
7005798|NCT01435018|11073770|FG001|Overall Study|Unable to contact participant/parent|1
7005799|NCT01435018|11073771|FG002|Overall Study|Unable to contact participant/parent|1
7005800|NCT01435018|11073769|FG000|Overall Study|Enrollment Violation|0
7005801|NCT01435018|11073770|FG001|Overall Study|Enrollment Violation|1
7005802|NCT01435018|11073771|FG002|Overall Study|Enrollment Violation|0
7005803|NCT01435018|11073769|FG000|Overall Study|Never started chemotherapy|3
7005804|NCT01435018|11073770|FG001|Overall Study|Never started chemotherapy|0
7005805|NCT01435018|11073771|FG002|Overall Study|Never started chemotherapy|1
7005806|NCT01435031|11073781|FG000|ITT at 1 Month|Withdrawal by Subject|1
7005807|NCT01435031|11073781|FG000|ITT at 1 Month|Death|1
7005808|NCT01435031|11073781|FG000|ITT at 1 Month|Lost to Follow-up|4
7005809|NCT01435031|11073781|FG000|ITT at 6 Months|Death|2
7005810|NCT01435031|11073781|FG000|ITT at 6 Months|Lost to Follow-up|3
7005811|NCT01435031|11073781|FG000|ITT at 1 Year|Death|1
7005812|NCT01435031|11073781|FG000|ITT at 1 Year|Withdrawal by Subject|2
7005813|NCT01435031|11073781|FG000|ITT at 1 Year|Lost to Follow-up|6
7005814|NCT01435031|11073781|FG000|ITT at 2 Years|Death|7
7005815|NCT01435031|11073781|FG000|ITT at 2 Years|Withdrawal by Subject|2
7005816|NCT01435031|11073781|FG000|ITT at 2 Years|Lost to Follow-up|4
7005817|NCT01435031|11073781|FG000|ITT at 3 Years|Death|5
7005818|NCT01435031|11073781|FG000|ITT at 3 Years|Withdrawal by Subject|2
7005819|NCT01435031|11073781|FG000|ITT at 3 Years|Lost to Follow-up|4
7005820|NCT01435031|11073781|FG000|ITT at 4 Years|Death|4
7005821|NCT01435031|11073781|FG000|ITT at 4 Years|Withdrawal by Subject|2
7005822|NCT01435031|11073781|FG000|ITT at 4 Years|Lost to Follow-up|1
7005823|NCT01435122|11073785|FG000|Overall Study|Early withdrawal due to toxicity|8
7005824|NCT01435265|11073795|FG000|Overall Study|Lost to Follow-up|0
7005825|NCT01435265|11073796|FG001|Overall Study|Lost to Follow-up|1
7005826|NCT01435356|11073813|FG000|Overall Study|Adverse Event|2
7005827|NCT01435356|11073814|FG001|Overall Study|Adverse Event|0
7005828|NCT01435356|11073813|FG000|Overall Study|Disease progression/recurrence|17
7005829|NCT01435356|11073814|FG001|Overall Study|Disease progression/recurrence|10
7005830|NCT01435356|11073813|FG000|Overall Study|Protocol Violation|0
7005831|NCT01435356|11073814|FG001|Overall Study|Protocol Violation|1
7005832|NCT01435356|11073813|FG000|Overall Study|Study Discontinuation, amendment 4|5
7005833|NCT01435356|11073814|FG001|Overall Study|Study Discontinuation, amendment 4|11
7005834|NCT01435356|11073813|FG000|Overall Study|Withdrawal by Subject|1
7005835|NCT01435356|11073814|FG001|Overall Study|Withdrawal by Subject|1
7005836|NCT01435356|11073813|FG000|Overall Study|Facial palsy|1
7005837|NCT01435356|11073814|FG001|Overall Study|Facial palsy|0
7005838|NCT01435356|11073813|FG000|Overall Study|IC withdrawal due to study cancellation|1
7005839|NCT01435356|11073814|FG001|Overall Study|IC withdrawal due to study cancellation|0
7005840|NCT01435356|11073813|FG000|Overall Study|Physician Decision|1
7005841|NCT01435356|11073814|FG001|Overall Study|Physician Decision|0
7005842|NCT01435356|11073813|FG000|Overall Study|Patient decision|3
7005843|NCT01435356|11073814|FG001|Overall Study|Patient decision|0
7005844|NCT01435356|11073813|FG000|Overall Study|Patient moved to another city|1
7005845|NCT01435356|11073814|FG001|Overall Study|Patient moved to another city|1
7005846|NCT01435382|11073824|FG000|Overall Study|Lost to Follow-up|1
7005847|NCT01435382|11073825|FG001|Overall Study|Lost to Follow-up|0
7005848|NCT01435382|11073826|FG002|Overall Study|Lost to Follow-up|1
7005849|NCT01435382|11073827|FG003|Overall Study|Lost to Follow-up|0
7005850|NCT01435382|11073824|FG000|Overall Study|Withdrawal by Subject|0
7005851|NCT01435382|11073825|FG001|Overall Study|Withdrawal by Subject|2
7005852|NCT01435382|11073826|FG002|Overall Study|Withdrawal by Subject|0
7005853|NCT01435382|11073827|FG003|Overall Study|Withdrawal by Subject|1
7005854|NCT01435460|11073845|FG000|Overall Study|Adverse Event|2
7005855|NCT01435460|11073846|FG001|Overall Study|Adverse Event|1
7005856|NCT01435460|11073845|FG000|Overall Study|Lost to Follow-up|6
7005857|NCT01435460|11073846|FG001|Overall Study|Lost to Follow-up|1
7005858|NCT01435460|11073845|FG000|Overall Study|Withdrawal by Subject|1
7005859|NCT01435460|11073846|FG001|Overall Study|Withdrawal by Subject|3
7005860|NCT01435460|11073845|FG000|Overall Study|Protocol Violation|0
7005861|NCT01435460|11073846|FG001|Overall Study|Protocol Violation|1
7005862|NCT01435460|11073845|FG000|Overall Study|Did not meet eligibility criteria|2
7005863|NCT01435460|11073846|FG001|Overall Study|Did not meet eligibility criteria|0
7005864|NCT01435577|11073863|FG000|Overall Study|Adverse Event|10
7005865|NCT01435577|11073864|FG001|Overall Study|Adverse Event|0
7005866|NCT01435577|11073863|FG000|Overall Study|Lack of Efficacy|7
7005867|NCT01435577|11073864|FG001|Overall Study|Lack of Efficacy|51
7005868|NCT01435577|11073863|FG000|Overall Study|Alternative treatment started|0
7005869|NCT01435577|11073864|FG001|Overall Study|Alternative treatment started|1
7005870|NCT01435616|11073885|FG000|Overall Study|Adverse Event|39
7005871|NCT01435616|11073886|FG001|Overall Study|Adverse Event|21
7005872|NCT01435616|11073885|FG000|Overall Study|Death|7
7005873|NCT01435616|11073886|FG001|Overall Study|Death|2
7005874|NCT01435616|11073885|FG000|Overall Study|Lost to Follow-up|22
7005875|NCT01435616|11073886|FG001|Overall Study|Lost to Follow-up|13
7005876|NCT01435616|11073885|FG000|Overall Study|Protocol Violation|16
7005877|NCT01435616|11073886|FG001|Overall Study|Protocol Violation|13
7005878|NCT01435616|11073885|FG000|Overall Study|Withdrawal by Subject|66
7005879|NCT01435616|11073886|FG001|Overall Study|Withdrawal by Subject|24
7005880|NCT01435616|11073885|FG000|Overall Study|Physician Decision|20
7005881|NCT01435616|11073886|FG001|Overall Study|Physician Decision|7
7005882|NCT01435616|11073885|FG000|Overall Study|Sponsor Decision|1
7005883|NCT01435616|11073886|FG001|Overall Study|Sponsor Decision|0
7005884|NCT01435655|11073894|FG000|Overall Study|Death|2
7005885|NCT01435655|11073894|FG000|Overall Study|Other|1
7005886|NCT01435759|11073903|FG000|Antidepressant Lead-in Phase|Adverse Event|40
7005887|NCT01435759|11073904|FG001|Antidepressant Lead-in Phase|Adverse Event|0
7005888|NCT01435759|11073905|FG002|Antidepressant Lead-in Phase|Adverse Event|0
7005889|NCT01435759|11073906|FG003|Antidepressant Lead-in Phase|Adverse Event|0
7005890|NCT01435759|11073907|FG004|Antidepressant Lead-in Phase|Adverse Event|0
7005891|NCT01435759|11073908|FG005|Antidepressant Lead-in Phase|Adverse Event|0
7005892|NCT01435759|11073903|FG000|Antidepressant Lead-in Phase|Protocol Violation|16
7005893|NCT01435759|11073904|FG001|Antidepressant Lead-in Phase|Protocol Violation|0
7005894|NCT01435759|11073905|FG002|Antidepressant Lead-in Phase|Protocol Violation|0
7005895|NCT01435759|11073906|FG003|Antidepressant Lead-in Phase|Protocol Violation|0
7005896|NCT01435759|11073907|FG004|Antidepressant Lead-in Phase|Protocol Violation|0
7005897|NCT01435759|11073908|FG005|Antidepressant Lead-in Phase|Protocol Violation|0
7005898|NCT01435759|11073903|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74
7005899|NCT01435759|11073904|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0
7005900|NCT01435759|11073905|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0
7005901|NCT01435759|11073906|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0
7005902|NCT01435759|11073907|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0
7005903|NCT01435759|11073908|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0
7005904|NCT01435759|11073903|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83
7005905|NCT01435759|11073904|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0
7005906|NCT01435759|11073905|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0
7005907|NCT01435759|11073906|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0
7005908|NCT01435759|11073907|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0
7005909|NCT01435759|11073908|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0
7005910|NCT01435759|11073903|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10
7005911|NCT01435759|11073904|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
7005912|NCT01435759|11073905|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
7005913|NCT01435759|11073906|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
7005914|NCT01435759|11073907|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
7005915|NCT01435759|11073908|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
7005916|NCT01435759|11073903|FG000|Antidepressant Lead-in Phase|Other|119
7005917|NCT01435759|11073904|FG001|Antidepressant Lead-in Phase|Other|0
7005918|NCT01435759|11073905|FG002|Antidepressant Lead-in Phase|Other|0
7005919|NCT01435759|11073906|FG003|Antidepressant Lead-in Phase|Other|0
7005920|NCT01435759|11073907|FG004|Antidepressant Lead-in Phase|Other|0
7005921|NCT01435759|11073908|FG005|Antidepressant Lead-in Phase|Other|0
7005922|NCT01435759|11073903|FG000|Double-blind Phase|Adverse Event|7
7143154|NCT03026530|11299484|FG000|Overall Study|Lost to Follow-up|19
7143155|NCT03026530|11299485|FG001|Overall Study|Lost to Follow-up|24
7143156|NCT03026530|11299484|FG000|Overall Study|Protocol Violation|2
7005923|NCT01435759|11073904|FG001|Double-blind Phase|Adverse Event|0
7005924|NCT01435759|11073905|FG002|Double-blind Phase|Adverse Event|1
7005925|NCT01435759|11073906|FG003|Double-blind Phase|Adverse Event|1
7005926|NCT01435759|11073907|FG004|Double-blind Phase|Adverse Event|1
7005927|NCT01435759|11073908|FG005|Double-blind Phase|Adverse Event|3
7005928|NCT01435759|11073903|FG000|Double-blind Phase|Protocol Violation|2
7005929|NCT01435759|11073904|FG001|Double-blind Phase|Protocol Violation|0
7005930|NCT01435759|11073905|FG002|Double-blind Phase|Protocol Violation|1
7005931|NCT01435759|11073906|FG003|Double-blind Phase|Protocol Violation|2
7005932|NCT01435759|11073907|FG004|Double-blind Phase|Protocol Violation|0
7005933|NCT01435759|11073908|FG005|Double-blind Phase|Protocol Violation|1
7005934|NCT01435759|11073903|FG000|Double-blind Phase|Withdrawal by Subject|17
7005935|NCT01435759|11073904|FG001|Double-blind Phase|Withdrawal by Subject|4
7005936|NCT01435759|11073905|FG002|Double-blind Phase|Withdrawal by Subject|3
7005937|NCT01435759|11073906|FG003|Double-blind Phase|Withdrawal by Subject|4
7005938|NCT01435759|11073907|FG004|Double-blind Phase|Withdrawal by Subject|2
7005939|NCT01435759|11073908|FG005|Double-blind Phase|Withdrawal by Subject|2
7005940|NCT01435759|11073903|FG000|Double-blind Phase|Lost to Follow-up|31
7005941|NCT01435759|11073904|FG001|Double-blind Phase|Lost to Follow-up|1
7005942|NCT01435759|11073905|FG002|Double-blind Phase|Lost to Follow-up|2
7005943|NCT01435759|11073906|FG003|Double-blind Phase|Lost to Follow-up|0
7005944|NCT01435759|11073907|FG004|Double-blind Phase|Lost to Follow-up|3
7005945|NCT01435759|11073908|FG005|Double-blind Phase|Lost to Follow-up|3
7005946|NCT01435759|11073903|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1
7005947|NCT01435759|11073904|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
7143157|NCT03026530|11299485|FG001|Overall Study|Protocol Violation|5
7005948|NCT01435759|11073905|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
7005949|NCT01435759|11073906|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
7005950|NCT01435759|11073907|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3
7005951|NCT01435759|11073908|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
7005952|NCT01435759|11073903|FG000|Double-blind Phase|Other|8
7005953|NCT01435759|11073904|FG001|Double-blind Phase|Other|2
7005954|NCT01435759|11073905|FG002|Double-blind Phase|Other|0
7005955|NCT01435759|11073906|FG003|Double-blind Phase|Other|2
7005956|NCT01435759|11073907|FG004|Double-blind Phase|Other|0
7005957|NCT01435759|11073908|FG005|Double-blind Phase|Other|0
7005958|NCT01435772|11073923|FG000|Overall Study|Adverse Event|1
7005959|NCT01435772|11073924|FG001|Overall Study|Adverse Event|0
7005960|NCT01435772|11073925|FG002|Overall Study|Adverse Event|2
7005961|NCT01435772|11073923|FG000|Overall Study|Withdrawal by Subject|0
7005962|NCT01435772|11073924|FG001|Overall Study|Withdrawal by Subject|1
7005963|NCT01435772|11073925|FG002|Overall Study|Withdrawal by Subject|3
7005964|NCT01435772|11073923|FG000|Overall Study|Other - study termination|2
7005965|NCT01435772|11073924|FG001|Overall Study|Other - study termination|2
7005966|NCT01435772|11073925|FG002|Overall Study|Other - study termination|10
7005967|NCT01435798|11073934|FG000|Overall Study|Withdrawal by Subject|1
7005968|NCT01435928|11073953|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83
7005969|NCT01435928|11073954|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0
7005970|NCT01435928|11073955|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0
7005971|NCT01435928|11073953|FG000|Open Label Phase - up to 24 Weeks|Death|1
7005972|NCT01435928|11073954|FG001|Open Label Phase - up to 24 Weeks|Death|0
7005973|NCT01435928|11073955|FG002|Open Label Phase - up to 24 Weeks|Death|0
7005974|NCT01435928|11073953|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46
7005975|NCT01435928|11073954|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
7005976|NCT01435928|11073955|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
7005977|NCT01435928|11073953|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60
7005978|NCT01435928|11073954|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
7005979|NCT01435928|11073955|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
7005980|NCT01435928|11073953|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39
7005981|NCT01435928|11073954|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0
7005982|NCT01435928|11073955|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0
7005983|NCT01435928|11073953|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96
7005984|NCT01435928|11073954|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
7005985|NCT01435928|11073955|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
7005986|NCT01435928|11073953|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44
7005987|NCT01435928|11073954|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
7005988|NCT01435928|11073955|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
7005989|NCT01435928|11073953|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6
7005990|NCT01435928|11073954|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
7005991|NCT01435928|11073955|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
7005992|NCT01435928|11073953|FG000|Open Label Phase - up to 24 Weeks|Administrative|14
7005993|NCT01435928|11073954|FG001|Open Label Phase - up to 24 Weeks|Administrative|0
7005994|NCT01435928|11073955|FG002|Open Label Phase - up to 24 Weeks|Administrative|0
7005995|NCT01435928|11073953|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0
7005996|NCT01435928|11073954|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3
7005997|NCT01435928|11073955|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1
7005998|NCT01435928|11073953|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0
7005999|NCT01435928|11073954|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2
7006000|NCT01435928|11073955|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5
7006001|NCT01435928|11073953|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0
7006002|NCT01435928|11073954|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11
7006003|NCT01435928|11073955|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4
7006004|NCT01435928|11073953|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0
7006005|NCT01435928|11073954|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5
7006006|NCT01435928|11073955|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12
7006007|NCT01435928|11073953|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0
7006008|NCT01435928|11073954|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47
7006009|NCT01435928|11073955|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39
7006010|NCT01435928|11073953|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0
7006011|NCT01435928|11073954|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43
7006012|NCT01435928|11073955|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58
7006013|NCT01435928|11073953|FG000|Double Blind Phase - 28 Weeks|Administrative|0
7006014|NCT01435928|11073954|FG001|Double Blind Phase - 28 Weeks|Administrative|5
7006015|NCT01435928|11073955|FG002|Double Blind Phase - 28 Weeks|Administrative|2
7006016|NCT01436071|11073983|FG000|Overall Study|Adverse Event|1
7006017|NCT01436071|11073984|FG001|Overall Study|Adverse Event|0
7006018|NCT01436071|11073983|FG000|Overall Study|Lack of Efficacy|16
7006019|NCT01436071|11073984|FG001|Overall Study|Lack of Efficacy|7
7006020|NCT01436071|11073983|FG000|Overall Study|Protocol Violation|0
7006021|NCT01436071|11073984|FG001|Overall Study|Protocol Violation|1
7006022|NCT01436071|11073983|FG000|Overall Study|Lost to Follow-up|3
7006023|NCT01436071|11073984|FG001|Overall Study|Lost to Follow-up|1
7006024|NCT01436071|11073983|FG000|Overall Study|Physician Decision|1
7006025|NCT01436071|11073984|FG001|Overall Study|Physician Decision|0
7006026|NCT01436071|11073983|FG000|Overall Study|Withdrawal by Subject|2
7006027|NCT01436071|11073984|FG001|Overall Study|Withdrawal by Subject|2
7006028|NCT01436071|11073983|FG000|Overall Study|Did Not Receive Trial Medication|3
7006029|NCT01436071|11073984|FG001|Overall Study|Did Not Receive Trial Medication|3
7006030|NCT01436110|11073993|FG000|Overall Study|Lack of Efficacy|23
7006031|NCT01436110|11073994|FG001|Overall Study|Lack of Efficacy|14
7006032|NCT01436110|11073995|FG002|Overall Study|Lack of Efficacy|9
7006033|NCT01436110|11073993|FG000|Overall Study|Withdrawal by Subject|6
7006034|NCT01436110|11073994|FG001|Overall Study|Withdrawal by Subject|8
7006035|NCT01436110|11073995|FG002|Overall Study|Withdrawal by Subject|4
7006036|NCT01436110|11073993|FG000|Overall Study|Adverse Event|2
7006037|NCT01436110|11073994|FG001|Overall Study|Adverse Event|1
7006038|NCT01436110|11073995|FG002|Overall Study|Adverse Event|2
7006039|NCT01436110|11073993|FG000|Overall Study|Physician Decision|3
7006040|NCT01436110|11073994|FG001|Overall Study|Physician Decision|1
7006041|NCT01436110|11073995|FG002|Overall Study|Physician Decision|1
7006042|NCT01436110|11073993|FG000|Overall Study|Lost to Follow-up|1
7006043|NCT01436110|11073994|FG001|Overall Study|Lost to Follow-up|1
7006044|NCT01436110|11073995|FG002|Overall Study|Lost to Follow-up|3
7006045|NCT01436110|11073993|FG000|Overall Study|Protocol Violation|3
7006046|NCT01436110|11073994|FG001|Overall Study|Protocol Violation|1
7006047|NCT01436110|11073995|FG002|Overall Study|Protocol Violation|1
7006048|NCT01436110|11073993|FG000|Overall Study|Did Not Receive Trial Medication|1
7006049|NCT01436110|11073994|FG001|Overall Study|Did Not Receive Trial Medication|0
7006050|NCT01436110|11073995|FG002|Overall Study|Did Not Receive Trial Medication|3
7006051|NCT01436149|11074005|FG000|Antidepressant Lead-in Phase|Adverse Event|39
7006052|NCT01436149|11074006|FG001|Antidepressant Lead-in Phase|Adverse Event|0
7006053|NCT01436149|11074007|FG002|Antidepressant Lead-in Phase|Adverse Event|0
7006054|NCT01436149|11074005|FG000|Antidepressant Lead-in Phase|Protocol Violation|29
7006055|NCT01436149|11074006|FG001|Antidepressant Lead-in Phase|Protocol Violation|0
7006056|NCT01436149|11074007|FG002|Antidepressant Lead-in Phase|Protocol Violation|0
7006057|NCT01436149|11074005|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61
7006058|NCT01436149|11074006|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0
7006059|NCT01436149|11074007|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0
7006060|NCT01436149|11074005|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96
7006061|NCT01436149|11074006|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0
7006062|NCT01436149|11074007|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0
7006063|NCT01436149|11074005|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22
7006064|NCT01436149|11074006|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
7006065|NCT01436149|11074007|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
7006066|NCT01436149|11074005|FG000|Antidepressant Lead-in Phase|Other|119
7006067|NCT01436149|11074006|FG001|Antidepressant Lead-in Phase|Other|0
7006068|NCT01436149|11074007|FG002|Antidepressant Lead-in Phase|Other|0
7006069|NCT01436149|11074005|FG000|Randomized Phase|Adverse Event|9
7006070|NCT01436149|11074006|FG001|Randomized Phase|Adverse Event|10
7006071|NCT01436149|11074007|FG002|Randomized Phase|Adverse Event|11
7006072|NCT01436149|11074005|FG000|Randomized Phase|Protocol Violation|4
7006073|NCT01436149|11074006|FG001|Randomized Phase|Protocol Violation|5
7006074|NCT01436149|11074007|FG002|Randomized Phase|Protocol Violation|0
7006075|NCT01436149|11074005|FG000|Randomized Phase|Withdrawal by Subject|16
7006076|NCT01436149|11074006|FG001|Randomized Phase|Withdrawal by Subject|10
7006077|NCT01436149|11074007|FG002|Randomized Phase|Withdrawal by Subject|10
7006078|NCT01436149|11074005|FG000|Randomized Phase|Lost to Follow-up|34
7006079|NCT01436149|11074006|FG001|Randomized Phase|Lost to Follow-up|5
7006080|NCT01436149|11074007|FG002|Randomized Phase|Lost to Follow-up|6
7006081|NCT01436149|11074005|FG000|Randomized Phase|Lack of Efficacy|0
7006082|NCT01436149|11074006|FG001|Randomized Phase|Lack of Efficacy|0
7006083|NCT01436149|11074007|FG002|Randomized Phase|Lack of Efficacy|1
7006084|NCT01436149|11074005|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
7006085|NCT01436149|11074006|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
7006086|NCT01436149|11074007|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
7006087|NCT01436149|11074005|FG000|Randomized Phase|Other|12
7006088|NCT01436149|11074006|FG001|Randomized Phase|Other|5
7006089|NCT01436149|11074007|FG002|Randomized Phase|Other|11
7006090|NCT01436162|11074015|FG000|Single-blind Lead-in Phase|Adverse Event|26
7006091|NCT01436162|11074016|FG001|Single-blind Lead-in Phase|Adverse Event|0
7006092|NCT01436162|11074017|FG002|Single-blind Lead-in Phase|Adverse Event|0
7006093|NCT01436162|11074015|FG000|Single-blind Lead-in Phase|Protocol Violation|24
7006094|NCT01436162|11074016|FG001|Single-blind Lead-in Phase|Protocol Violation|0
7006095|NCT01436162|11074017|FG002|Single-blind Lead-in Phase|Protocol Violation|0
7006096|NCT01436162|11074015|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69
7006097|NCT01436162|11074016|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0
7006098|NCT01436162|11074017|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0
7006099|NCT01436162|11074015|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43
7006100|NCT01436162|11074016|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0
7006101|NCT01436162|11074017|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0
7043091|NCT01739803|11127639|FG001|Overall Study|Lost to Follow-up|6
7006102|NCT01436162|11074015|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13
7006103|NCT01436162|11074016|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
7006104|NCT01436162|11074017|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
7006105|NCT01436162|11074015|FG000|Single-blind Lead-in Phase|Other|107
7006106|NCT01436162|11074016|FG001|Single-blind Lead-in Phase|Other|0
7006107|NCT01436162|11074017|FG002|Single-blind Lead-in Phase|Other|0
7006108|NCT01436162|11074015|FG000|Randomized Phase|Adverse Event|1
7006109|NCT01436162|11074016|FG001|Randomized Phase|Adverse Event|5
7006110|NCT01436162|11074017|FG002|Randomized Phase|Adverse Event|6
7006111|NCT01436162|11074015|FG000|Randomized Phase|Protocol Violation|4
7006112|NCT01436162|11074016|FG001|Randomized Phase|Protocol Violation|4
7006113|NCT01436162|11074017|FG002|Randomized Phase|Protocol Violation|2
7006114|NCT01436162|11074015|FG000|Randomized Phase|Withdrawal by Subject|16
7006115|NCT01436162|11074016|FG001|Randomized Phase|Withdrawal by Subject|9
7006116|NCT01436162|11074017|FG002|Randomized Phase|Withdrawal by Subject|8
7006117|NCT01436162|11074015|FG000|Randomized Phase|Lost to Follow-up|17
7006118|NCT01436162|11074016|FG001|Randomized Phase|Lost to Follow-up|5
7006119|NCT01436162|11074017|FG002|Randomized Phase|Lost to Follow-up|4
7006120|NCT01436162|11074015|FG000|Randomized Phase|Lack of Efficacy|0
7006121|NCT01436162|11074016|FG001|Randomized Phase|Lack of Efficacy|1
7006122|NCT01436162|11074017|FG002|Randomized Phase|Lack of Efficacy|1
7006123|NCT01436162|11074015|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4
7006124|NCT01436162|11074016|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
7006125|NCT01436162|11074017|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0
7006126|NCT01436162|11074015|FG000|Randomized Phase|Other|2
7006127|NCT01436162|11074016|FG001|Randomized Phase|Other|5
7006128|NCT01436162|11074017|FG002|Randomized Phase|Other|4
7006129|NCT01436175|11074025|FG000|Overall Study|Adverse Event|111
7006130|NCT01436175|11074025|FG000|Overall Study|Protocol Violation|49
7006131|NCT01436175|11074025|FG000|Overall Study|Withdrawal by Subject|108
7006132|NCT01436175|11074025|FG000|Overall Study|Lost to Follow-up|89
7006133|NCT01436175|11074025|FG000|Overall Study|Lack of Efficacy|24
7006134|NCT01436175|11074025|FG000|Overall Study|Met blood pressure or pulse withdrawal|63
7006135|NCT01436175|11074025|FG000|Overall Study|Other|826
7006136|NCT01436201|11074030|FG000|Overall Study|Adverse Event|2
7006137|NCT01436201|11074030|FG000|Overall Study|Withdrawal by Subject|1
7006138|NCT01436201|11074030|FG000|Overall Study|Protocol Violation|1
7006139|NCT01436305|11074059|FG000|Overall Study|Death|1
7006140|NCT01436305|11074060|FG001|Overall Study|Death|0
7006141|NCT01436305|11074061|FG002|Overall Study|Death|0
7006142|NCT01436305|11074059|FG000|Overall Study|Lost to Follow-up|0
7006143|NCT01436305|11074060|FG001|Overall Study|Lost to Follow-up|1
7006144|NCT01436305|11074061|FG002|Overall Study|Lost to Follow-up|0
7006145|NCT01436305|11074059|FG000|Overall Study|Withdrawal by Subject|1
7006146|NCT01436305|11074060|FG001|Overall Study|Withdrawal by Subject|3
7006147|NCT01436305|11074061|FG002|Overall Study|Withdrawal by Subject|0
7006148|NCT01436357|11074071|FG000|Overall Study|Death|5
7006149|NCT01436357|11074072|FG001|Overall Study|Death|1
7006150|NCT01436357|11074071|FG000|Overall Study|Enrolled but not vaccinated|1
7006151|NCT01436357|11074072|FG001|Overall Study|Enrolled but not vaccinated|1
7006152|NCT01436357|11074071|FG000|Overall Study|Incarceration|18
7006153|NCT01436357|11074072|FG001|Overall Study|Incarceration|20
7006154|NCT01436357|11074071|FG000|Overall Study|Lost to Follow-up|67
7006155|NCT01436357|11074072|FG001|Overall Study|Lost to Follow-up|61
7006156|NCT01436357|11074071|FG000|Overall Study|Protocol Violation|1
7006157|NCT01436357|11074072|FG001|Overall Study|Protocol Violation|0
7006158|NCT01436357|11074071|FG000|Overall Study|Withdrawal by Subject|26
7006159|NCT01436357|11074072|FG001|Overall Study|Withdrawal by Subject|38
7006160|NCT01436357|11074071|FG000|Overall Study|Physician Decision|3
7006161|NCT01436357|11074072|FG001|Overall Study|Physician Decision|4
7006162|NCT01436357|11074071|FG000|Overall Study|Moved out of area|1
7006163|NCT01436357|11074072|FG001|Overall Study|Moved out of area|2
7006164|NCT01436357|11074071|FG000|Overall Study|Subject in rehab|0
7006165|NCT01436357|11074072|FG001|Overall Study|Subject in rehab|1
7006166|NCT01436370|11074086|FG000|Overall Study|Lost to Follow-up|0
7006167|NCT01436370|11074087|FG001|Overall Study|Lost to Follow-up|0
7006168|NCT01436370|11074088|FG002|Overall Study|Lost to Follow-up|0
7006169|NCT01436370|11074089|FG003|Overall Study|Lost to Follow-up|0
7006170|NCT01436370|11074090|FG004|Overall Study|Lost to Follow-up|1
7006171|NCT01436370|11074091|FG005|Overall Study|Lost to Follow-up|0
7006172|NCT01436370|11074092|FG006|Overall Study|Lost to Follow-up|0
7006173|NCT01436370|11074093|FG007|Overall Study|Lost to Follow-up|0
7006174|NCT01436500|11074125|FG000|Overall Study|Death|1
7006175|NCT01436500|11074126|FG001|Overall Study|Death|0
7006176|NCT01436500|11074127|FG002|Overall Study|Death|0
7006177|NCT01436500|11074128|FG003|Overall Study|Death|0
7006178|NCT01436500|11074129|FG004|Overall Study|Death|0
7006179|NCT01436500|11074125|FG000|Overall Study|Adverse Event|0
7006180|NCT01436500|11074126|FG001|Overall Study|Adverse Event|2
7006181|NCT01436500|11074127|FG002|Overall Study|Adverse Event|2
7006182|NCT01436500|11074128|FG003|Overall Study|Adverse Event|0
7006183|NCT01436500|11074129|FG004|Overall Study|Adverse Event|1
7006184|NCT01436500|11074125|FG000|Overall Study|Withdrawal by Subject|0
7006185|NCT01436500|11074126|FG001|Overall Study|Withdrawal by Subject|0
7006186|NCT01436500|11074127|FG002|Overall Study|Withdrawal by Subject|2
7006187|NCT01436500|11074128|FG003|Overall Study|Withdrawal by Subject|0
7006188|NCT01436500|11074129|FG004|Overall Study|Withdrawal by Subject|2
7006189|NCT01436500|11074125|FG000|Overall Study|Physician Decision|0
7006190|NCT01436500|11074126|FG001|Overall Study|Physician Decision|0
7006191|NCT01436500|11074127|FG002|Overall Study|Physician Decision|1
7006192|NCT01436500|11074128|FG003|Overall Study|Physician Decision|0
7006193|NCT01436500|11074129|FG004|Overall Study|Physician Decision|0
7006194|NCT01436500|11074125|FG000|Overall Study|liver transplant|1
7006195|NCT01436500|11074126|FG001|Overall Study|liver transplant|0
7006196|NCT01436500|11074127|FG002|Overall Study|liver transplant|0
7006197|NCT01436500|11074128|FG003|Overall Study|liver transplant|0
7006198|NCT01436500|11074129|FG004|Overall Study|liver transplant|0
7006199|NCT01436500|11074125|FG000|Overall Study|initiation of dialysis|0
7006200|NCT01436500|11074126|FG001|Overall Study|initiation of dialysis|0
7006201|NCT01436500|11074127|FG002|Overall Study|initiation of dialysis|0
7006202|NCT01436500|11074128|FG003|Overall Study|initiation of dialysis|0
7006203|NCT01436500|11074129|FG004|Overall Study|initiation of dialysis|1
7006204|NCT01436500|11074125|FG000|Overall Study|discontinued study drug|1
7006205|NCT01436500|11074126|FG001|Overall Study|discontinued study drug|0
7006206|NCT01436500|11074127|FG002|Overall Study|discontinued study drug|0
7006207|NCT01436500|11074128|FG003|Overall Study|discontinued study drug|0
7006208|NCT01436500|11074129|FG004|Overall Study|discontinued study drug|0
7006209|NCT01436500|11074125|FG000|Overall Study|Other|0
7006210|NCT01436500|11074126|FG001|Overall Study|Other|1
7006211|NCT01436500|11074127|FG002|Overall Study|Other|0
7006212|NCT01436500|11074128|FG003|Overall Study|Other|1
7006213|NCT01436500|11074129|FG004|Overall Study|Other|0
7006214|NCT01436643|11074154|FG000|2-week Pre-treatment|Abnormal test result|0
7006215|NCT01436643|11074155|FG001|2-week Pre-treatment|Abnormal test result|0
7006216|NCT01436643|11074156|FG002|2-week Pre-treatment|Abnormal test result|0
7006217|NCT01436643|11074157|FG003|2-week Pre-treatment|Abnormal test result|1
7006218|NCT01436643|11074154|FG000|2-week Pre-treatment|Adverse Event|0
7006219|NCT01436643|11074155|FG001|2-week Pre-treatment|Adverse Event|0
7006220|NCT01436643|11074156|FG002|2-week Pre-treatment|Adverse Event|0
7006221|NCT01436643|11074157|FG003|2-week Pre-treatment|Adverse Event|5
7006222|NCT01436643|11074154|FG000|2-week Pre-treatment|Protocol Violation|0
7006223|NCT01436643|11074155|FG001|2-week Pre-treatment|Protocol Violation|0
7006224|NCT01436643|11074156|FG002|2-week Pre-treatment|Protocol Violation|0
7006225|NCT01436643|11074157|FG003|2-week Pre-treatment|Protocol Violation|4
7006226|NCT01436643|11074154|FG000|Core Phase (16 Weeks)|Adverse Event|0
7006227|NCT01436643|11074155|FG001|Core Phase (16 Weeks)|Adverse Event|3
7006228|NCT01436643|11074156|FG002|Core Phase (16 Weeks)|Adverse Event|1
7006229|NCT01436643|11074157|FG003|Core Phase (16 Weeks)|Adverse Event|0
7006230|NCT01436643|11074154|FG000|Core Phase (16 Weeks)|Abnormal Test result|0
7006231|NCT01436643|11074155|FG001|Core Phase (16 Weeks)|Abnormal Test result|0
7006232|NCT01436643|11074156|FG002|Core Phase (16 Weeks)|Abnormal Test result|1
7006233|NCT01436643|11074157|FG003|Core Phase (16 Weeks)|Abnormal Test result|0
7006234|NCT01436643|11074154|FG000|Core Phase (16 Weeks)|Protocol Violation|1
7006235|NCT01436643|11074155|FG001|Core Phase (16 Weeks)|Protocol Violation|1
7006236|NCT01436643|11074156|FG002|Core Phase (16 Weeks)|Protocol Violation|1
7006237|NCT01436643|11074157|FG003|Core Phase (16 Weeks)|Protocol Violation|0
7006238|NCT01437267|11074198|FG000|Overall Study|Withdrawal by Subject|0
7006239|NCT01437267|11074199|FG001|Overall Study|Withdrawal by Subject|0
7006240|NCT01437267|11074200|FG002|Overall Study|Withdrawal by Subject|0
7006241|NCT01437267|11074201|FG003|Overall Study|Withdrawal by Subject|1
7006242|NCT01437267|11074202|FG004|Overall Study|Withdrawal by Subject|0
7006243|NCT01437267|11074203|FG005|Overall Study|Withdrawal by Subject|0
7006244|NCT01437267|11074198|FG000|Overall Study|Protocol Violation|0
7006245|NCT01437267|11074199|FG001|Overall Study|Protocol Violation|1
7006246|NCT01437267|11074200|FG002|Overall Study|Protocol Violation|0
7006247|NCT01437267|11074201|FG003|Overall Study|Protocol Violation|0
7006248|NCT01437267|11074202|FG004|Overall Study|Protocol Violation|0
7006249|NCT01437267|11074203|FG005|Overall Study|Protocol Violation|0
7006250|NCT01437319|11074217|FG000|Phase I|Lost to Follow-up|2
7006251|NCT01437319|11074218|FG001|Phase I|Lost to Follow-up|0
7006252|NCT01437319|11074219|FG002|Phase I|Lost to Follow-up|0
7006253|NCT01437319|11074217|FG000|Phase I|Protocol Violation|1
7006254|NCT01437319|11074218|FG001|Phase I|Protocol Violation|0
7006255|NCT01437319|11074219|FG002|Phase I|Protocol Violation|0
7006256|NCT01437319|11074217|FG000|Phase I|Study related symptoms/complaints|27
7006257|NCT01437319|11074218|FG001|Phase I|Study related symptoms/complaints|0
7006258|NCT01437319|11074219|FG002|Phase I|Study related symptoms/complaints|0
7006259|NCT01437319|11074217|FG000|Phase I|Withdrawal by Subject|25
7006260|NCT01437319|11074218|FG001|Phase I|Withdrawal by Subject|0
7006261|NCT01437319|11074219|FG002|Phase I|Withdrawal by Subject|0
7006262|NCT01437319|11074217|FG000|Phase II|Withdrawal by Subject|0
7006263|NCT01437319|11074218|FG001|Phase II|Withdrawal by Subject|8
7006264|NCT01437319|11074219|FG002|Phase II|Withdrawal by Subject|16
7006265|NCT01437319|11074217|FG000|Phase II|Lost to Follow-up|0
7006266|NCT01437319|11074218|FG001|Phase II|Lost to Follow-up|7
7006267|NCT01437319|11074219|FG002|Phase II|Lost to Follow-up|2
7006268|NCT01437319|11074217|FG000|Phase II|Study related symptoms/complaints|0
7006269|NCT01437319|11074218|FG001|Phase II|Study related symptoms/complaints|28
7006270|NCT01437319|11074219|FG002|Phase II|Study related symptoms/complaints|19
7006271|NCT01437319|11074217|FG000|Phase II|Protocol Violation|0
7006272|NCT01437319|11074218|FG001|Phase II|Protocol Violation|1
7006273|NCT01437319|11074219|FG002|Phase II|Protocol Violation|0
7006274|NCT01437397|11074233|FG000|Overall Study|Lost to Follow-up|9
7006275|NCT01437397|11074234|FG001|Overall Study|Lost to Follow-up|4
7006276|NCT01437397|11074235|FG002|Overall Study|Lost to Follow-up|2
7006277|NCT01437397|11074236|FG003|Overall Study|Lost to Follow-up|4
7006278|NCT01437397|11074237|FG004|Overall Study|Lost to Follow-up|5
7006279|NCT01437397|11074233|FG000|Overall Study|Withdrawal by Subject|11
7006280|NCT01437397|11074234|FG001|Overall Study|Withdrawal by Subject|12
7006281|NCT01437397|11074235|FG002|Overall Study|Withdrawal by Subject|24
7006282|NCT01437397|11074236|FG003|Overall Study|Withdrawal by Subject|11
7006283|NCT01437397|11074237|FG004|Overall Study|Withdrawal by Subject|22
7006284|NCT01437397|11074233|FG000|Overall Study|Protocol Violation|10
7006285|NCT01437397|11074234|FG001|Overall Study|Protocol Violation|12
7006286|NCT01437397|11074235|FG002|Overall Study|Protocol Violation|13
7006287|NCT01437397|11074236|FG003|Overall Study|Protocol Violation|21
7006288|NCT01437397|11074237|FG004|Overall Study|Protocol Violation|19
7006289|NCT01437397|11074233|FG000|Overall Study|Lack of Efficacy|5
7006290|NCT01437397|11074234|FG001|Overall Study|Lack of Efficacy|4
7006291|NCT01437397|11074235|FG002|Overall Study|Lack of Efficacy|8
7006292|NCT01437397|11074236|FG003|Overall Study|Lack of Efficacy|10
7006293|NCT01437397|11074237|FG004|Overall Study|Lack of Efficacy|20
7006294|NCT01437397|11074233|FG000|Overall Study|Adverse Event|21
7006295|NCT01437397|11074234|FG001|Overall Study|Adverse Event|22
7006296|NCT01437397|11074235|FG002|Overall Study|Adverse Event|16
7006297|NCT01437397|11074236|FG003|Overall Study|Adverse Event|14
7006298|NCT01437397|11074237|FG004|Overall Study|Adverse Event|21
7006299|NCT01437397|11074233|FG000|Overall Study|Site termination/COPD exacerbation/other|10
7006300|NCT01437397|11074234|FG001|Overall Study|Site termination/COPD exacerbation/other|8
7006301|NCT01437397|11074235|FG002|Overall Study|Site termination/COPD exacerbation/other|9
7006302|NCT01437397|11074236|FG003|Overall Study|Site termination/COPD exacerbation/other|9
7006303|NCT01437397|11074237|FG004|Overall Study|Site termination/COPD exacerbation/other|14
7006304|NCT01437540|11074273|FG000|Overall Study|Not listed below|7
7006305|NCT01437540|11074274|FG001|Overall Study|Not listed below|6
7006306|NCT01437540|11074273|FG000|Overall Study|COPD exacerbation|13
7006307|NCT01437540|11074274|FG001|Overall Study|COPD exacerbation|3
7006308|NCT01437540|11074273|FG000|Overall Study|Lost to Follow-up|3
7006309|NCT01437540|11074274|FG001|Overall Study|Lost to Follow-up|5
7006310|NCT01437540|11074273|FG000|Overall Study|Lack of Efficacy|23
7006311|NCT01437540|11074274|FG001|Overall Study|Lack of Efficacy|11
7006312|NCT01437540|11074273|FG000|Overall Study|Protocol Violation|24
7006313|NCT01437540|11074274|FG001|Overall Study|Protocol Violation|12
7006314|NCT01437540|11074273|FG000|Overall Study|Adverse Event|26
7006315|NCT01437540|11074274|FG001|Overall Study|Adverse Event|13
7006316|NCT01437540|11074273|FG000|Overall Study|Withdrawal by Subject|31
7006317|NCT01437540|11074274|FG001|Overall Study|Withdrawal by Subject|15
7006318|NCT01437878|11074296|FG000|Overall Study|Withdrawal by Subject|1
7006319|NCT01437878|11074297|FG001|Overall Study|Withdrawal by Subject|0
7006320|NCT01437943|11074305|FG000|Overall Study|Aliskiren trials terminated by Novartis|4
7006321|NCT01437943|11074306|FG001|Overall Study|Aliskiren trials terminated by Novartis|2
7006322|NCT01437943|11074305|FG000|Overall Study|Subject expressed pregnancy plans|1
7006323|NCT01437943|11074306|FG001|Overall Study|Subject expressed pregnancy plans|0
7006324|NCT01437943|11074305|FG000|Overall Study|Adverse Event|2
7006325|NCT01437943|11074306|FG001|Overall Study|Adverse Event|0
7006326|NCT01437995|11074315|FG000|Overall Study|Lost to Follow-up|11
7006327|NCT01437995|11074316|FG001|Overall Study|Lost to Follow-up|18
7006328|NCT01437995|11074317|FG002|Overall Study|Lost to Follow-up|20
7006329|NCT01438060|11074336|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7
7006330|NCT01438060|11074337|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9
7006331|NCT01438060|11074336|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6
7006332|NCT01438060|11074337|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3
7006333|NCT01438060|11074336|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3
7006334|NCT01438060|11074337|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4
7006335|NCT01438060|11074336|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1
7006336|NCT01438060|11074337|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0
7006337|NCT01438060|11074336|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0
7006338|NCT01438060|11074337|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2
7006339|NCT01438060|11074336|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1
7006340|NCT01438060|11074337|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0
7006341|NCT01438060|11074336|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15
7006342|NCT01438060|11074337|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16
7006343|NCT01438060|11074336|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
7006344|NCT01438060|11074337|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
7006345|NCT01438060|11074336|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3
7006346|NCT01438060|11074337|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5
7006347|NCT01438060|11074336|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1
7006348|NCT01438060|11074337|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0
7006349|NCT01438060|11074336|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2
7043092|NCT01739933|11127647|FG000|Overall Study|Death|89
7006350|NCT01438060|11074337|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0
7006351|NCT01438060|11074336|FG000|Extension Phase: Week 10 to Week 130|Death|22
7006352|NCT01438060|11074337|FG001|Extension Phase: Week 10 to Week 130|Death|12
7006353|NCT01438060|11074336|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7
7006354|NCT01438060|11074337|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15
7006355|NCT01438060|11074336|FG000|On Study Beyond Week 140|Adverse Event|0
7006356|NCT01438060|11074337|FG001|On Study Beyond Week 140|Adverse Event|2
7006357|NCT01438060|11074336|FG000|On Study Beyond Week 140|Lack of Efficacy|0
7006358|NCT01438060|11074337|FG001|On Study Beyond Week 140|Lack of Efficacy|1
7006359|NCT01438060|11074336|FG000|On Study Beyond Week 140|Withdrawal by Subject|0
7006360|NCT01438060|11074337|FG001|On Study Beyond Week 140|Withdrawal by Subject|1
7006361|NCT01438060|11074336|FG000|On Study Beyond Week 140|Death|0
7006362|NCT01438060|11074337|FG001|On Study Beyond Week 140|Death|1
7006363|NCT01438060|11074336|FG000|On Study Beyond Week 140|Other Reason|0
7006364|NCT01438060|11074337|FG001|On Study Beyond Week 140|Other Reason|3
7006365|NCT01438151|11074348|FG000|Overall Study|study terminated|8
7006366|NCT01438177|11074352|FG000|Overall Study|Withdrawal by Subject|1
7006367|NCT01438177|11074352|FG000|Overall Study|Initiation of new therapy|1
7006368|NCT01438294|11074362|FG000|Overall Study|Lost to Follow-up|3
7006369|NCT01438294|11074363|FG001|Overall Study|Lost to Follow-up|7
7006370|NCT01438307|11074371|FG000|Overall Study|Death|1
7006371|NCT01438307|11074372|FG001|Overall Study|Death|1
7006372|NCT01438411|11074378|FG000|Overall Study|Adverse Event|8
7006373|NCT01438411|11074378|FG000|Overall Study|Lost to Follow-up|1
7006374|NCT01438411|11074378|FG000|Overall Study|Lack of Efficacy|1
7006375|NCT01438411|11074378|FG000|Overall Study|Withdrawal by Subject|3
7006376|NCT01438424|11074382|FG000|Overall Study|Continuing treatment|29
7006377|NCT01438424|11074382|FG000|Overall Study|Minimal virologic response|95
7006378|NCT01438424|11074382|FG000|Overall Study|Not identified|55
7006379|NCT01438424|11074382|FG000|Overall Study|Withdrawal by Subject|104
7006380|NCT01438424|11074382|FG000|Overall Study|Progression of chronic hepatitis B|22
7006381|NCT01438424|11074382|FG000|Overall Study|Death|22
7006382|NCT01438424|11074382|FG000|Overall Study|Adverse Event|17
7006383|NCT01438424|11074382|FG000|Overall Study|Lost to Follow-up|17
7006384|NCT01438424|11074382|FG000|Overall Study|Abnormal laboratory test result|14
7006385|NCT01438424|11074382|FG000|Overall Study|Need for drug prohibited by protocol|14
7006386|NCT01438424|11074382|FG000|Overall Study|Pregnancy|7
7006387|NCT01438424|11074382|FG000|Overall Study|No longer met inclusion criteria|1
7006388|NCT01438424|11074382|FG000|Overall Study|Participant noncompliance|20
7043093|NCT01739933|11127648|FG001|Overall Study|Death|86
7043094|NCT01739933|11127647|FG000|Overall Study|Withdrawal by Subject|10
7043095|NCT01739933|11127648|FG001|Overall Study|Withdrawal by Subject|8
7043096|NCT01739933|11127647|FG000|Overall Study|Lost to Follow-up|3
7043097|NCT01739933|11127648|FG001|Overall Study|Lost to Follow-up|10
7043098|NCT01739933|11127647|FG000|Overall Study|Did not speak English required for neurospychological testing|4
7043099|NCT01739933|11127648|FG001|Overall Study|Did not speak English required for neurospychological testing|3
7043100|NCT01740089|11127657|FG000|First 12 Weeks of Treatment|Adverse Event|0
7043101|NCT01740089|11127658|FG001|First 12 Weeks of Treatment|Adverse Event|1
7043102|NCT01740089|11127659|FG002|First 12 Weeks of Treatment|Adverse Event|2
7043103|NCT01740089|11127657|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0
7043104|NCT01740089|11127658|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1
7043105|NCT01740089|11127659|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0
7043106|NCT01740089|11127657|FG000|After 12 Weeks|Lack of Efficacy|3
7043107|NCT01740089|11127658|FG001|After 12 Weeks|Lack of Efficacy|1
7043108|NCT01740089|11127659|FG002|After 12 Weeks|Lack of Efficacy|4
7043109|NCT01740089|11127657|FG000|After 12 Weeks|Adverse Event|2
7043110|NCT01740089|11127658|FG001|After 12 Weeks|Adverse Event|0
7043111|NCT01740089|11127659|FG002|After 12 Weeks|Adverse Event|5
7043112|NCT01740089|11127657|FG000|After 12 Weeks|Protocol Violation|1
7043113|NCT01740089|11127658|FG001|After 12 Weeks|Protocol Violation|1
7043114|NCT01740089|11127659|FG002|After 12 Weeks|Protocol Violation|1
7043115|NCT01740089|11127657|FG000|After 12 Weeks|Withdrawal by Subject|1
7043116|NCT01740089|11127658|FG001|After 12 Weeks|Withdrawal by Subject|1
7043117|NCT01740089|11127659|FG002|After 12 Weeks|Withdrawal by Subject|1
7043118|NCT01740128|11127670|FG000|Overall Study|Pregnancy|0
7043119|NCT01740128|11127671|FG001|Overall Study|Pregnancy|1
7043120|NCT01740128|11127670|FG000|Overall Study|Protocol Violation|1
7043121|NCT01740128|11127671|FG001|Overall Study|Protocol Violation|2
7043122|NCT01740128|11127670|FG000|Overall Study|Lost to Follow-up|2
7043123|NCT01740128|11127671|FG001|Overall Study|Lost to Follow-up|2
7043124|NCT01740128|11127670|FG000|Overall Study|Withdrawal by Subject|1
7043125|NCT01740128|11127671|FG001|Overall Study|Withdrawal by Subject|0
7043126|NCT01740128|11127670|FG000|Overall Study|Insufficient protocol compliance|2
7043127|NCT01740128|11127671|FG001|Overall Study|Insufficient protocol compliance|2
7043128|NCT01740323|11127692|FG000|Overall Study|Adverse Event|1
7043129|NCT01740323|11127693|FG001|Overall Study|Adverse Event|0
7043130|NCT01740323|11127692|FG000|Overall Study|Randomized but did not take study drug|1
7043131|NCT01740323|11127693|FG001|Overall Study|Randomized but did not take study drug|0
7043132|NCT01740388|11127718|FG000|Overall Study|Withdrawal by Subject|1
7043133|NCT01740388|11127719|FG001|Overall Study|Withdrawal by Subject|2
7043134|NCT01740388|11127718|FG000|Overall Study|Lost to Follow-up|2
7043135|NCT01740388|11127719|FG001|Overall Study|Lost to Follow-up|0
7006389|NCT01438476|11074398|FG000|Overall Study|Protocol Violation|1
7006390|NCT01438476|11074399|FG001|Overall Study|Protocol Violation|0
7006391|NCT01438476|11074398|FG000|Overall Study|Withdrawal by Subject|1
7006392|NCT01438476|11074399|FG001|Overall Study|Withdrawal by Subject|0
7006393|NCT01438476|11074398|FG000|Overall Study|No Surgery- Disease|8
7006394|NCT01438476|11074399|FG001|Overall Study|No Surgery- Disease|10
7006395|NCT01438476|11074398|FG000|Overall Study|Communication barrier|0
7006396|NCT01438476|11074399|FG001|Overall Study|Communication barrier|1
7006397|NCT01438489|11074408|FG000|Overall Study|Lost to Follow-up|4
7006398|NCT01438489|11074409|FG001|Overall Study|Lost to Follow-up|2
7006399|NCT01438489|11074410|FG002|Overall Study|Lost to Follow-up|2
7006400|NCT01438489|11074408|FG000|Overall Study|Withdrawal by Subject|11
7006401|NCT01438489|11074409|FG001|Overall Study|Withdrawal by Subject|3
7006402|NCT01438489|11074410|FG002|Overall Study|Withdrawal by Subject|8
7006403|NCT01438489|11074408|FG000|Overall Study|Death|0
7006404|NCT01438489|11074409|FG001|Overall Study|Death|0
7006405|NCT01438489|11074410|FG002|Overall Study|Death|1
7006406|NCT01438489|11074408|FG000|Overall Study|Sponsor decision|4
7006407|NCT01438489|11074409|FG001|Overall Study|Sponsor decision|1
7006408|NCT01438489|11074410|FG002|Overall Study|Sponsor decision|4
7006409|NCT01438489|11074408|FG000|Overall Study|Subject choice/Subject moved|2
7006410|NCT01438489|11074409|FG001|Overall Study|Subject choice/Subject moved|1
7006411|NCT01438489|11074410|FG002|Overall Study|Subject choice/Subject moved|1
7006412|NCT01438489|11074408|FG000|Overall Study|Investigator decision|0
7006413|NCT01438489|11074409|FG001|Overall Study|Investigator decision|1
7006414|NCT01438489|11074410|FG002|Overall Study|Investigator decision|0
7006415|NCT01438489|11074408|FG000|Overall Study|AE/SAEs|2
7006416|NCT01438489|11074409|FG001|Overall Study|AE/SAEs|1
7006417|NCT01438489|11074410|FG002|Overall Study|AE/SAEs|1
7006418|NCT01438489|11074408|FG000|Overall Study|Received prohibited medication|1
7006419|NCT01438489|11074409|FG001|Overall Study|Received prohibited medication|0
7006420|NCT01438489|11074410|FG002|Overall Study|Received prohibited medication|0
7006421|NCT01438489|11074408|FG000|Overall Study|Did not complete all 3 follow-up visits|2
7006422|NCT01438489|11074409|FG001|Overall Study|Did not complete all 3 follow-up visits|5
7006423|NCT01438489|11074410|FG002|Overall Study|Did not complete all 3 follow-up visits|2
7006424|NCT01438489|11074408|FG000|Overall Study|Inadequate venous access|0
7006425|NCT01438489|11074409|FG001|Overall Study|Inadequate venous access|2
7006426|NCT01438489|11074410|FG002|Overall Study|Inadequate venous access|0
7006427|NCT01438541|11074420|FG000|Overall Study|Physician Decision|1
7006428|NCT01438541|11074420|FG000|Overall Study|Withdrawal by Subject|1
7006429|NCT01438541|11074420|FG000|Overall Study|discharge from the hospital|5
7006430|NCT01438814|11074432|FG000|Overall Study|Adverse Event|3
7006431|NCT01438814|11074433|FG001|Overall Study|Adverse Event|3
7006432|NCT01438814|11074432|FG000|Overall Study|Protocol Violation|1
7006433|NCT01438814|11074433|FG001|Overall Study|Protocol Violation|2
7006434|NCT01438814|11074432|FG000|Overall Study|Lost to Follow-up|4
7006435|NCT01438814|11074433|FG001|Overall Study|Lost to Follow-up|3
7006436|NCT01438814|11074432|FG000|Overall Study|Withdrawal by Subject|4
7006437|NCT01438814|11074433|FG001|Overall Study|Withdrawal by Subject|2
7006438|NCT01438814|11074432|FG000|Overall Study|Other|2
7006439|NCT01438814|11074433|FG001|Overall Study|Other|4
7006440|NCT01438840|11074441|FG000|Core Study|Adverse Event|0
7006441|NCT01438840|11074442|FG001|Core Study|Adverse Event|3
7006442|NCT01438840|11074443|FG002|Core Study|Adverse Event|0
7006443|NCT01438840|11074441|FG000|Core Study|Lack of Efficacy|15
7006444|NCT01438840|11074442|FG001|Core Study|Lack of Efficacy|7
7006445|NCT01438840|11074443|FG002|Core Study|Lack of Efficacy|0
7006446|NCT01438840|11074441|FG000|Core Study|Withdrawal of consent|1
7006447|NCT01438840|11074442|FG001|Core Study|Withdrawal of consent|0
7006448|NCT01438840|11074443|FG002|Core Study|Withdrawal of consent|0
7006449|NCT01438840|11074441|FG000|Extension Phase|Adverse Event|0
7006450|NCT01438840|11074442|FG001|Extension Phase|Adverse Event|0
7006451|NCT01438840|11074443|FG002|Extension Phase|Adverse Event|3
7006452|NCT01438840|11074441|FG000|Extension Phase|Lost to Follow-up|0
7006453|NCT01438840|11074442|FG001|Extension Phase|Lost to Follow-up|0
7006454|NCT01438840|11074443|FG002|Extension Phase|Lost to Follow-up|1
7006455|NCT01438840|11074441|FG000|Extension Phase|Withdrawal by Subject|0
7006456|NCT01438840|11074442|FG001|Extension Phase|Withdrawal by Subject|0
7006457|NCT01438840|11074443|FG002|Extension Phase|Withdrawal by Subject|3
7006458|NCT01438840|11074441|FG000|Extension Phase|Lack of Efficacy|0
7006459|NCT01438840|11074442|FG001|Extension Phase|Lack of Efficacy|0
7006460|NCT01438840|11074443|FG002|Extension Phase|Lack of Efficacy|2
7006461|NCT01438840|11074441|FG000|Extension Phase|Other|0
7006462|NCT01438840|11074442|FG001|Extension Phase|Other|0
7006463|NCT01438840|11074443|FG002|Extension Phase|Other|1
7006464|NCT01438957|11074455|FG000|Overall Study|Physician Decision|1
7006465|NCT01438957|11074456|FG001|Overall Study|Physician Decision|1
7006466|NCT01438957|11074457|FG002|Overall Study|Physician Decision|0
7006467|NCT01438957|11074458|FG003|Overall Study|Physician Decision|1
7006468|NCT01438957|11074459|FG004|Overall Study|Physician Decision|0
7006469|NCT01438996|11074474|FG000|Overall Study|Not meeting Inclusion Criteria|4
7060403|NCT01918306|11156574|FG002|Overall Study|neutropenia|0
7006470|NCT01438996|11074475|FG001|Overall Study|Not meeting Inclusion Criteria|1
7006471|NCT01438996|11074476|FG002|Overall Study|Not meeting Inclusion Criteria|0
7006472|NCT01439009|11074486|FG000|Overall Study|Physician Decision|5
7060404|NCT01918306|11156575|FG003|Overall Study|neutropenia|0
7006473|NCT01439009|11074487|FG001|Overall Study|Physician Decision|3
7006474|NCT01439009|11074486|FG000|Overall Study|Protocol Violation|2
7006475|NCT01439009|11074487|FG001|Overall Study|Protocol Violation|0
7006476|NCT01439009|11074486|FG000|Overall Study|Deviation of exclusion criteria|1
7006477|NCT01439009|11074487|FG001|Overall Study|Deviation of exclusion criteria|0
7006478|NCT01439074|11074499|FG000|Overall Study|Lost to Follow-up|3
7006479|NCT01439074|11074500|FG001|Overall Study|Lost to Follow-up|4
7006480|NCT01439074|11074499|FG000|Overall Study|Subject shedding|1
7006481|NCT01439074|11074500|FG001|Overall Study|Subject shedding|0
7006482|NCT01439074|11074499|FG000|Overall Study|Withdrawal by Subject|1
7006483|NCT01439074|11074500|FG001|Overall Study|Withdrawal by Subject|5
7006484|NCT01439074|11074499|FG000|Overall Study|Other|4
7006485|NCT01439074|11074500|FG001|Overall Study|Other|4
7006486|NCT01439126|11074512|FG000|Overall Study|Adverse Event|2
7006487|NCT01439126|11074513|FG001|Overall Study|Adverse Event|0
7006488|NCT01439126|11074512|FG000|Overall Study|Withdrawal by Subject|5
7006489|NCT01439126|11074513|FG001|Overall Study|Withdrawal by Subject|21
7006490|NCT01439126|11074512|FG000|Overall Study|Protocol Violation|6
7006491|NCT01439126|11074513|FG001|Overall Study|Protocol Violation|4
7006492|NCT01439126|11074512|FG000|Overall Study|Lost to Follow-up|6
7006493|NCT01439126|11074513|FG001|Overall Study|Lost to Follow-up|3
7006494|NCT01439126|11074512|FG000|Overall Study|Other-Use of prohibited treatment|0
7006495|NCT01439126|11074513|FG001|Overall Study|Other-Use of prohibited treatment|2
7006496|NCT01439126|11074512|FG000|Overall Study|Other-Miscellaneous|12
7006497|NCT01439126|11074513|FG001|Overall Study|Other-Miscellaneous|12
7006498|NCT01439204|11074521|FG000|Overall Study|Withdrawal by Subject|0
7006499|NCT01439204|11074522|FG001|Overall Study|Withdrawal by Subject|1
7006500|NCT01439204|11074521|FG000|Overall Study|Lost to Follow-up|0
7006501|NCT01439204|11074522|FG001|Overall Study|Lost to Follow-up|2
7006502|NCT01439204|11074521|FG000|Overall Study|No longer meets study criteria|1
7006503|NCT01439204|11074522|FG001|Overall Study|No longer meets study criteria|0
7006504|NCT01439204|11074521|FG000|Overall Study|poor/non-compliance|3
7006505|NCT01439204|11074522|FG001|Overall Study|poor/non-compliance|0
7006506|NCT01439282|11074530|FG000|Overall Study|Adverse Event|5
7006507|NCT01439282|11074531|FG001|Overall Study|Adverse Event|0
7006508|NCT01439282|11074530|FG000|Overall Study|Withdrawal by Subject|2
7006509|NCT01439282|11074531|FG001|Overall Study|Withdrawal by Subject|0
7006510|NCT01439282|11074530|FG000|Overall Study|Other|1
7006511|NCT01439282|11074531|FG001|Overall Study|Other|1
7006512|NCT01439360|11074540|FG000|Overall Study|Adverse Event|4
7006513|NCT01439360|11074541|FG001|Overall Study|Adverse Event|16
7006514|NCT01439360|11074540|FG000|Overall Study|Lost to Follow-up|43
7006515|NCT01439360|11074541|FG001|Overall Study|Lost to Follow-up|58
7006516|NCT01439360|11074540|FG000|Overall Study|Others|10
7006517|NCT01439360|11074541|FG001|Overall Study|Others|5
7006518|NCT01439360|11074540|FG000|Overall Study|Protocol Violation|1
7006519|NCT01439360|11074541|FG001|Overall Study|Protocol Violation|0
7006520|NCT01439360|11074540|FG000|Overall Study|Withdrawal by Subject|140
7006521|NCT01439360|11074541|FG001|Overall Study|Withdrawal by Subject|129
7006522|NCT01439373|11074549|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0
7006523|NCT01439373|11074550|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1
7006524|NCT01439373|11074549|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2
7006525|NCT01439373|11074550|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0
7006526|NCT01439555|11074560|FG000|Overall Study|Protocol Violation|1
7006527|NCT01439568|11074566|FG000|Overall Study|Lost to Follow-up|1
7006528|NCT01439568|11074567|FG001|Overall Study|Lost to Follow-up|0
7006529|NCT01439568|11074566|FG000|Overall Study|Withdrawal by Subject|2
7006530|NCT01439568|11074567|FG001|Overall Study|Withdrawal by Subject|2
7006531|NCT01439711|11074598|FG000|Overall Study|Ineligible|13
7006532|NCT01439711|11074598|FG000|Overall Study|Cancel|3
7006533|NCT01439711|11074598|FG000|Overall Study|Progression Prior to Beginning Tx|1
7006534|NCT01439711|11074598|FG000|Overall Study|Adverse Event|5
7006535|NCT01439711|11074598|FG000|Overall Study|Withdrawal by Subject|3
7006536|NCT01439711|11074598|FG000|Overall Study|Progression During Active Tx|3
7006537|NCT01439711|11074598|FG000|Overall Study|Noncompliance|3
7006538|NCT01439711|11074598|FG000|Overall Study|No MRI|9
7006539|NCT01439724|11074604|FG000|Overall Study|missing consultation|9
7006540|NCT01439724|11074605|FG001|Overall Study|missing consultation|8
7006541|NCT01439867|11074631|FG000|Overall Study|Non-compliance|0
7006542|NCT01439867|11074632|FG001|Overall Study|Non-compliance|1
7006543|NCT01439867|11074631|FG000|Overall Study|Withdrawal by Subject|1
7006544|NCT01439867|11074632|FG001|Overall Study|Withdrawal by Subject|2
7006545|NCT01439867|11074631|FG000|Overall Study|Administrative Decision|4
7006546|NCT01439867|11074632|FG001|Overall Study|Administrative Decision|5
7006547|NCT01439867|11074631|FG000|Overall Study|Protocol-specified Criteria|1
7006548|NCT01439867|11074632|FG001|Overall Study|Protocol-specified Criteria|0
7006549|NCT01439880|11074642|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24
7006550|NCT01439880|11074643|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38
7006551|NCT01439880|11074642|FG000|SOC-controlled Period (Year 1)|Death|2
7006552|NCT01439880|11074643|FG001|SOC-controlled Period (Year 1)|Death|1
7006553|NCT01439880|11074642|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0
7006554|NCT01439880|11074643|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1
7006555|NCT01439880|11074642|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10
7006556|NCT01439880|11074643|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5
7006557|NCT01439880|11074642|FG000|SOC-controlled Period (Year 1)|Other|8
7006558|NCT01439880|11074643|FG001|SOC-controlled Period (Year 1)|Other|13
7006559|NCT01439880|11074642|FG000|SOC-controlled Period (Year 1)|Reason Missing|0
7006560|NCT01439880|11074643|FG001|SOC-controlled Period (Year 1)|Reason Missing|2
7006561|NCT01439880|11074642|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21
7006562|NCT01439880|11074643|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30
7006563|NCT01439880|11074642|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30
7006564|NCT01439880|11074643|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66
7006565|NCT01439880|11074642|FG000|All-IP Period (Years 2 to 5)|Death|3
7006566|NCT01439880|11074643|FG001|All-IP Period (Years 2 to 5)|Death|13
7006567|NCT01439880|11074642|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1
7006568|NCT01439880|11074643|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0
7006569|NCT01439880|11074642|FG000|All-IP Period (Years 2 to 5)|Other|14
7006570|NCT01439880|11074643|FG001|All-IP Period (Years 2 to 5)|Other|31
7006571|NCT01439880|11074642|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1
7006572|NCT01439880|11074643|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0
7006573|NCT01439945|11074663|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3
7006574|NCT01439945|11074664|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3
7006575|NCT01439945|11074665|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3
7006576|NCT01439945|11074666|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1
7006577|NCT01439945|11074663|FG000|Double-Blind Treatment Phase|Ineligible|1
7006578|NCT01439945|11074664|FG001|Double-Blind Treatment Phase|Ineligible|2
7006579|NCT01439945|11074665|FG002|Double-Blind Treatment Phase|Ineligible|0
7006580|NCT01439945|11074666|FG003|Double-Blind Treatment Phase|Ineligible|1
7006581|NCT01439971|11074682|FG000|Overall Study|Required number in cohort dosed|0
7006582|NCT01439971|11074683|FG001|Overall Study|Required number in cohort dosed|1
7006583|NCT01439971|11074684|FG002|Overall Study|Required number in cohort dosed|2
7006584|NCT01439971|11074685|FG003|Overall Study|Required number in cohort dosed|0
7006585|NCT01439971|11074686|FG004|Overall Study|Required number in cohort dosed|1
7006586|NCT01440049|11074698|FG000|Overall Study|Adverse Event|5
7006587|NCT01440101|11074705|FG000|Overall Study|Adverse Event|2
7006588|NCT01440101|11074706|FG001|Overall Study|Adverse Event|0
7006589|NCT01440101|11074707|FG002|Overall Study|Adverse Event|0
7006590|NCT01440101|11074705|FG000|Overall Study|Withdrawal by Subject|0
7006591|NCT01440101|11074706|FG001|Overall Study|Withdrawal by Subject|3
7006592|NCT01440101|11074707|FG002|Overall Study|Withdrawal by Subject|1
7006593|NCT01440101|11074705|FG000|Overall Study|Other|0
7006594|NCT01440101|11074706|FG001|Overall Study|Other|1
7006595|NCT01440101|11074707|FG002|Overall Study|Other|0
7006596|NCT01440283|11074716|FG000|Overall Study|Death|3
7006597|NCT01440283|11074716|FG000|Overall Study|Withdrawal by Subject|4
7006598|NCT01440283|11074716|FG000|Overall Study|Physician Decision|3
7006599|NCT01440322|11074728|FG000|Overall Study|Discomfort|2
7006600|NCT01440322|11074729|FG001|Overall Study|Discomfort|0
7006601|NCT01440322|11074728|FG000|Overall Study|Biomicroscopy|1
7006602|NCT01440322|11074729|FG001|Overall Study|Biomicroscopy|0
7006603|NCT01440322|11074728|FG000|Overall Study|Symptoms and Problems|1
7006604|NCT01440322|11074729|FG001|Overall Study|Symptoms and Problems|0
7006605|NCT01440322|11074728|FG000|Overall Study|Unacceptable Subjective Vision|1
7006606|NCT01440322|11074729|FG001|Overall Study|Unacceptable Subjective Vision|0
7006607|NCT01440322|11074728|FG000|Overall Study|Other Product Related|1
7006608|NCT01440322|11074729|FG001|Overall Study|Other Product Related|0
7006609|NCT01440322|11074728|FG000|Overall Study|Unrelated Medical Problem|0
7006610|NCT01440322|11074729|FG001|Overall Study|Unrelated Medical Problem|1
7006611|NCT01440322|11074728|FG000|Overall Study|Other Non-Product Related|1
7006612|NCT01440322|11074729|FG001|Overall Study|Other Non-Product Related|0
7006613|NCT01440374|11074738|FG000|Part 1: Open-label Phase|Adverse Event|5
7006614|NCT01440374|11074739|FG001|Part 1: Open-label Phase|Adverse Event|0
7006615|NCT01440374|11074740|FG002|Part 1: Open-label Phase|Adverse Event|0
7006616|NCT01440374|11074741|FG003|Part 1: Open-label Phase|Adverse Event|0
7006617|NCT01440374|11074738|FG000|Part 1: Open-label Phase|Physician Decision|1
7006618|NCT01440374|11074739|FG001|Part 1: Open-label Phase|Physician Decision|0
7006619|NCT01440374|11074740|FG002|Part 1: Open-label Phase|Physician Decision|0
7006620|NCT01440374|11074741|FG003|Part 1: Open-label Phase|Physician Decision|0
7006621|NCT01440374|11074738|FG000|Part 2; Double-blind Phase|Physician Decision|0
7006622|NCT01440374|11074739|FG001|Part 2; Double-blind Phase|Physician Decision|8
7006623|NCT01440374|11074740|FG002|Part 2; Double-blind Phase|Physician Decision|17
7006624|NCT01440374|11074741|FG003|Part 2; Double-blind Phase|Physician Decision|0
7006625|NCT01440374|11074738|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0
7006626|NCT01440374|11074739|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4
7006627|NCT01440374|11074740|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5
7006628|NCT01440374|11074741|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0
7006629|NCT01440374|11074738|FG000|Part 2; Double-blind Phase|Protocol Violation|0
7006630|NCT01440374|11074739|FG001|Part 2; Double-blind Phase|Protocol Violation|0
7006631|NCT01440374|11074740|FG002|Part 2; Double-blind Phase|Protocol Violation|1
7006632|NCT01440374|11074741|FG003|Part 2; Double-blind Phase|Protocol Violation|0
7006633|NCT01440374|11074738|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0
7043136|NCT01740388|11127718|FG000|Overall Study|Physician Decision|2
7006634|NCT01440374|11074739|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1
7006635|NCT01440374|11074740|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0
7006636|NCT01440374|11074741|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0
7006637|NCT01440374|11074738|FG000|Part 2; Double-blind Phase|Adverse Event|0
7006638|NCT01440374|11074739|FG001|Part 2; Double-blind Phase|Adverse Event|7
7006639|NCT01440374|11074740|FG002|Part 2; Double-blind Phase|Adverse Event|31
7006640|NCT01440374|11074741|FG003|Part 2; Double-blind Phase|Adverse Event|0
7006641|NCT01440374|11074738|FG000|Part 2; Double-blind Phase|Not treated|0
7006642|NCT01440374|11074739|FG001|Part 2; Double-blind Phase|Not treated|0
7006643|NCT01440374|11074740|FG002|Part 2; Double-blind Phase|Not treated|1
7006644|NCT01440374|11074741|FG003|Part 2; Double-blind Phase|Not treated|0
7006645|NCT01440374|11074738|FG000|Part 3: Extension|Withdrawal by Subject|0
7006646|NCT01440374|11074739|FG001|Part 3: Extension|Withdrawal by Subject|0
7006647|NCT01440374|11074740|FG002|Part 3: Extension|Withdrawal by Subject|0
7006648|NCT01440374|11074741|FG003|Part 3: Extension|Withdrawal by Subject|5
7006649|NCT01440374|11074738|FG000|Part 3: Extension|Adverse Event|0
7006650|NCT01440374|11074739|FG001|Part 3: Extension|Adverse Event|0
7006651|NCT01440374|11074740|FG002|Part 3: Extension|Adverse Event|0
7006652|NCT01440374|11074741|FG003|Part 3: Extension|Adverse Event|13
7006653|NCT01440374|11074738|FG000|Part 3: Extension|Physician Decision|0
7006654|NCT01440374|11074739|FG001|Part 3: Extension|Physician Decision|0
7006655|NCT01440374|11074740|FG002|Part 3: Extension|Physician Decision|0
7006656|NCT01440374|11074741|FG003|Part 3: Extension|Physician Decision|14
7006657|NCT01440569|11074781|FG000|Main Study|Enrolled but not treated|1
7006658|NCT01440569|11074782|FG001|Main Study|Enrolled but not treated|0
7006659|NCT01440569|11074781|FG000|Main Study|Adverse Event|9
7006660|NCT01440569|11074782|FG001|Main Study|Adverse Event|0
7006661|NCT01440569|11074781|FG000|Main Study|Pregnancy|1
7006662|NCT01440569|11074782|FG001|Main Study|Pregnancy|0
7006663|NCT01440569|11074781|FG000|Main Study|Investigator's Discretion|1
7006664|NCT01440569|11074782|FG001|Main Study|Investigator's Discretion|1
7006665|NCT01440569|11074781|FG000|Main Study|Withdrew Consent|7
7006666|NCT01440569|11074782|FG001|Main Study|Withdrew Consent|1
7006667|NCT01440569|11074781|FG000|Main Study|Lost to Follow-up|13
7006668|NCT01440569|11074782|FG001|Main Study|Lost to Follow-up|2
7006669|NCT01440569|11074781|FG000|Main Study|Subject Non-Compliance|3
7006670|NCT01440569|11074782|FG001|Main Study|Subject Non-Compliance|0
7006671|NCT01440569|11074781|FG000|Main Study|Protocol Violation|1
7006672|NCT01440569|11074782|FG001|Main Study|Protocol Violation|0
7006673|NCT01440569|11074781|FG000|Open-Label Rollover Phase|Adverse Event|3
7006674|NCT01440569|11074782|FG001|Open-Label Rollover Phase|Adverse Event|0
7006675|NCT01440569|11074781|FG000|Open-Label Rollover Phase|Pregnancy|1
7006676|NCT01440569|11074782|FG001|Open-Label Rollover Phase|Pregnancy|0
7006677|NCT01440569|11074781|FG000|Open-Label Rollover Phase|Lack of Efficacy|2
7006678|NCT01440569|11074782|FG001|Open-Label Rollover Phase|Lack of Efficacy|0
7006679|NCT01440569|11074781|FG000|Open-Label Rollover Phase|Investigator's Discretion|3
7006680|NCT01440569|11074782|FG001|Open-Label Rollover Phase|Investigator's Discretion|1
7006681|NCT01440569|11074781|FG000|Open-Label Rollover Phase|Withdrew Consent|11
7006682|NCT01440569|11074782|FG001|Open-Label Rollover Phase|Withdrew Consent|1
7006683|NCT01440569|11074781|FG000|Open-Label Rollover Phase|Lost to Follow-up|26
7006684|NCT01440569|11074782|FG001|Open-Label Rollover Phase|Lost to Follow-up|3
7006685|NCT01440569|11074781|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1
7006686|NCT01440569|11074782|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1
7006687|NCT01440647|11074799|FG000|Overall Study|Death|2
7006688|NCT01440647|11074800|FG001|Overall Study|Death|3
7006689|NCT01440803|11074834|FG000|Overall Study|Met study stopping rule|2
7006690|NCT01440803|11074835|FG001|Overall Study|Met study stopping rule|1
7006691|NCT01440803|11074834|FG000|Overall Study|Lost to Follow-up|0
7006692|NCT01440803|11074835|FG001|Overall Study|Lost to Follow-up|2
7006693|NCT01440803|11074834|FG000|Overall Study|Withdrawal by Subject|0
7006694|NCT01440803|11074835|FG001|Overall Study|Withdrawal by Subject|1
7006695|NCT01440816|11074844|FG000|Overall Study|Disease Progression|0
7006696|NCT01440816|11074845|FG001|Overall Study|Disease Progression|9
7006697|NCT01440816|11074844|FG000|Overall Study|To Be Seen By Local Oncologist|1
7006698|NCT01440816|11074845|FG001|Overall Study|To Be Seen By Local Oncologist|2
7006699|NCT01440881|11074855|FG000|Overall Study|Death|0
7006700|NCT01440881|11074856|FG001|Overall Study|Death|1
7006701|NCT01440946|11074878|FG000|Overall Study|Lost to Follow-up|1
7006702|NCT01440946|11074879|FG001|Overall Study|Lost to Follow-up|1
7006703|NCT01440946|11074878|FG000|Overall Study|Physician Decision|1
7006704|NCT01440946|11074879|FG001|Overall Study|Physician Decision|0
7006705|NCT01440972|11074892|FG000|Overall Study|Withdrawal by Subject|3
7006706|NCT01440972|11074893|FG001|Overall Study|Withdrawal by Subject|2
7006707|NCT01441063|11074903|FG000|Tocilizumab Alone|Required AZT/VGC addition|3
7006708|NCT01441063|11074903|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1
7006709|NCT01441102|11074914|FG000|Overall Study|Adverse Event|1
7006710|NCT01441102|11074914|FG000|Overall Study|Withdrawal by Subject|2
7006711|NCT01441180|11074921|FG000|Overall Study|Lost to Follow-up|1
7006712|NCT01441180|11074922|FG001|Overall Study|Lost to Follow-up|1
7006713|NCT01441180|11074923|FG002|Overall Study|Lost to Follow-up|1
7006714|NCT01441180|11074921|FG000|Overall Study|Discontinued|0
7006715|NCT01441180|11074922|FG001|Overall Study|Discontinued|0
7006716|NCT01441180|11074923|FG002|Overall Study|Discontinued|2
7006717|NCT01441414|11074977|FG000|Overall Study|Participant died|9
7006718|NCT01441414|11074977|FG000|Overall Study|Other reasons|3
7006719|NCT01441414|11074977|FG000|Overall Study|Study terminated by sponsor|2
7006720|NCT01441414|11074977|FG000|Overall Study|Subject refused further follow-up|1
7006721|NCT01441440|11074996|FG000|Overall Study|Death|1
7006722|NCT01441440|11074997|FG001|Overall Study|Death|0
7006723|NCT01441440|11074998|FG002|Overall Study|Death|1
7006724|NCT01441440|11074996|FG000|Overall Study|Adverse Event|2
7006725|NCT01441440|11074997|FG001|Overall Study|Adverse Event|9
7006726|NCT01441440|11074998|FG002|Overall Study|Adverse Event|9
7006727|NCT01441440|11074996|FG000|Overall Study|Lost to Follow-up|0
7006728|NCT01441440|11074997|FG001|Overall Study|Lost to Follow-up|2
7006729|NCT01441440|11074998|FG002|Overall Study|Lost to Follow-up|1
7006730|NCT01441440|11074996|FG000|Overall Study|Withdrawal by Subject|11
7006731|NCT01441440|11074997|FG001|Overall Study|Withdrawal by Subject|9
7006732|NCT01441440|11074998|FG002|Overall Study|Withdrawal by Subject|9
7006733|NCT01441440|11074996|FG000|Overall Study|Pregnancy|1
7006734|NCT01441440|11074997|FG001|Overall Study|Pregnancy|0
7006735|NCT01441440|11074998|FG002|Overall Study|Pregnancy|0
7006736|NCT01441440|11074996|FG000|Overall Study|Lack of Efficacy|1
7006737|NCT01441440|11074997|FG001|Overall Study|Lack of Efficacy|0
7006738|NCT01441440|11074998|FG002|Overall Study|Lack of Efficacy|1
7006739|NCT01441440|11074996|FG000|Overall Study|Moving|0
7006740|NCT01441440|11074997|FG001|Overall Study|Moving|1
7006741|NCT01441440|11074998|FG002|Overall Study|Moving|1
7006742|NCT01441440|11074996|FG000|Overall Study|Work-related matter|0
7006743|NCT01441440|11074997|FG001|Overall Study|Work-related matter|1
7006744|NCT01441440|11074998|FG002|Overall Study|Work-related matter|0
7006745|NCT01441440|11074996|FG000|Overall Study|Difficllty in keeping the schedule|1
7006746|NCT01441440|11074997|FG001|Overall Study|Difficllty in keeping the schedule|1
7006747|NCT01441440|11074998|FG002|Overall Study|Difficllty in keeping the schedule|0
7006748|NCT01441596|11075039|FG000|Overall Study|Other reason not defined below|0
7006749|NCT01441596|11075040|FG001|Overall Study|Other reason not defined below|2
7006750|NCT01441596|11075041|FG002|Overall Study|Other reason not defined below|1
7006751|NCT01441596|11075039|FG000|Overall Study|Withdrawal by Subject|4
7006752|NCT01441596|11075040|FG001|Overall Study|Withdrawal by Subject|0
7006753|NCT01441596|11075041|FG002|Overall Study|Withdrawal by Subject|2
7006754|NCT01441596|11075039|FG000|Overall Study|Not treated|0
7006755|NCT01441596|11075040|FG001|Overall Study|Not treated|1
7006756|NCT01441596|11075041|FG002|Overall Study|Not treated|1
7006757|NCT01441635|11075059|FG000|Overall Study|Adverse Event|4
7006758|NCT01441635|11075060|FG001|Overall Study|Adverse Event|3
7006759|NCT01441635|11075061|FG002|Overall Study|Adverse Event|1
7006760|NCT01441635|11075062|FG003|Overall Study|Adverse Event|5
7006761|NCT01441635|11075063|FG004|Overall Study|Adverse Event|1
7006762|NCT01441635|11075064|FG005|Overall Study|Adverse Event|2
7006763|NCT01441635|11075065|FG006|Overall Study|Adverse Event|2
7006764|NCT01441635|11075066|FG007|Overall Study|Adverse Event|2
7006765|NCT01441635|11075067|FG008|Overall Study|Adverse Event|1
7006766|NCT01441635|11075068|FG009|Overall Study|Adverse Event|0
7006767|NCT01441635|11075059|FG000|Overall Study|Withdrawal by Subject|1
7006768|NCT01441635|11075060|FG001|Overall Study|Withdrawal by Subject|1
7006769|NCT01441635|11075061|FG002|Overall Study|Withdrawal by Subject|0
7006770|NCT01441635|11075062|FG003|Overall Study|Withdrawal by Subject|1
7006771|NCT01441635|11075063|FG004|Overall Study|Withdrawal by Subject|0
7006772|NCT01441635|11075064|FG005|Overall Study|Withdrawal by Subject|0
7006773|NCT01441635|11075065|FG006|Overall Study|Withdrawal by Subject|2
7006774|NCT01441635|11075066|FG007|Overall Study|Withdrawal by Subject|0
7006775|NCT01441635|11075067|FG008|Overall Study|Withdrawal by Subject|1
7006776|NCT01441635|11075068|FG009|Overall Study|Withdrawal by Subject|1
7006777|NCT01441635|11075059|FG000|Overall Study|Lost to Follow-up|0
7006778|NCT01441635|11075060|FG001|Overall Study|Lost to Follow-up|1
7006779|NCT01441635|11075061|FG002|Overall Study|Lost to Follow-up|1
7006780|NCT01441635|11075062|FG003|Overall Study|Lost to Follow-up|1
7006781|NCT01441635|11075063|FG004|Overall Study|Lost to Follow-up|1
7006782|NCT01441635|11075064|FG005|Overall Study|Lost to Follow-up|3
7006783|NCT01441635|11075065|FG006|Overall Study|Lost to Follow-up|1
7006784|NCT01441635|11075066|FG007|Overall Study|Lost to Follow-up|1
7006785|NCT01441635|11075067|FG008|Overall Study|Lost to Follow-up|0
7006786|NCT01441635|11075068|FG009|Overall Study|Lost to Follow-up|1
7006787|NCT01441635|11075059|FG000|Overall Study|Noncompliance|0
7006788|NCT01441635|11075060|FG001|Overall Study|Noncompliance|1
7006789|NCT01441635|11075061|FG002|Overall Study|Noncompliance|0
7006790|NCT01441635|11075062|FG003|Overall Study|Noncompliance|0
7006791|NCT01441635|11075063|FG004|Overall Study|Noncompliance|0
7006792|NCT01441635|11075064|FG005|Overall Study|Noncompliance|0
7006793|NCT01441635|11075065|FG006|Overall Study|Noncompliance|1
7006794|NCT01441635|11075066|FG007|Overall Study|Noncompliance|0
7006795|NCT01441635|11075067|FG008|Overall Study|Noncompliance|0
7006796|NCT01441635|11075068|FG009|Overall Study|Noncompliance|0
7006797|NCT01441635|11075059|FG000|Overall Study|Surgery or Invasive Intervention|0
7006798|NCT01441635|11075060|FG001|Overall Study|Surgery or Invasive Intervention|0
7006799|NCT01441635|11075061|FG002|Overall Study|Surgery or Invasive Intervention|1
7006800|NCT01441635|11075062|FG003|Overall Study|Surgery or Invasive Intervention|0
7006801|NCT01441635|11075063|FG004|Overall Study|Surgery or Invasive Intervention|0
7006802|NCT01441635|11075064|FG005|Overall Study|Surgery or Invasive Intervention|0
7006803|NCT01441635|11075065|FG006|Overall Study|Surgery or Invasive Intervention|0
7006804|NCT01441635|11075066|FG007|Overall Study|Surgery or Invasive Intervention|0
7006805|NCT01441635|11075067|FG008|Overall Study|Surgery or Invasive Intervention|0
7006806|NCT01441635|11075068|FG009|Overall Study|Surgery or Invasive Intervention|0
7006807|NCT01441635|11075059|FG000|Overall Study|Received Exclusionary Medication|1
7006808|NCT01441635|11075060|FG001|Overall Study|Received Exclusionary Medication|0
7006809|NCT01441635|11075061|FG002|Overall Study|Received Exclusionary Medication|0
7006810|NCT01441635|11075062|FG003|Overall Study|Received Exclusionary Medication|0
7006811|NCT01441635|11075063|FG004|Overall Study|Received Exclusionary Medication|0
7006812|NCT01441635|11075064|FG005|Overall Study|Received Exclusionary Medication|0
7006813|NCT01441635|11075065|FG006|Overall Study|Received Exclusionary Medication|0
7006814|NCT01441635|11075066|FG007|Overall Study|Received Exclusionary Medication|0
7006815|NCT01441635|11075067|FG008|Overall Study|Received Exclusionary Medication|0
7006816|NCT01441635|11075068|FG009|Overall Study|Received Exclusionary Medication|0
7006817|NCT01441635|11075059|FG000|Overall Study|Other|0
7006818|NCT01441635|11075060|FG001|Overall Study|Other|0
7006819|NCT01441635|11075061|FG002|Overall Study|Other|0
7006820|NCT01441635|11075062|FG003|Overall Study|Other|0
7006821|NCT01441635|11075063|FG004|Overall Study|Other|0
7006822|NCT01441635|11075064|FG005|Overall Study|Other|0
7006823|NCT01441635|11075065|FG006|Overall Study|Other|0
7006824|NCT01441635|11075066|FG007|Overall Study|Other|1
7006825|NCT01441635|11075067|FG008|Overall Study|Other|0
7006826|NCT01441635|11075068|FG009|Overall Study|Other|0
7006827|NCT01441765|11075092|FG000|Overall Study|Death|1
7006828|NCT01441765|11075093|FG001|Overall Study|Death|0
7006829|NCT01441960|11075112|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6
7006830|NCT01441960|11075113|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5
7006831|NCT01441960|11075112|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1
7006832|NCT01441960|11075113|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1
7006833|NCT01441960|11075112|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1
7006834|NCT01441960|11075113|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0
7006835|NCT01441973|11075125|FG000|Overall Study|Disease progression|8
7006836|NCT01441973|11075126|FG001|Overall Study|Disease progression|6
7006837|NCT01441973|11075125|FG000|Overall Study|Adverse event unrelated to study drug|3
7006838|NCT01441973|11075126|FG001|Overall Study|Adverse event unrelated to study drug|2
7006839|NCT01441973|11075125|FG000|Overall Study|Participant request to discontinue|1
7006840|NCT01441973|11075126|FG001|Overall Study|Participant request to discontinue|1
7006841|NCT01441973|11075125|FG000|Overall Study|Poor compliance/noncompliance|0
7006842|NCT01441973|11075126|FG001|Overall Study|Poor compliance/noncompliance|1
7006843|NCT01441973|11075125|FG000|Overall Study|Administrative reason by sponsor|3
7006844|NCT01441973|11075126|FG001|Overall Study|Administrative reason by sponsor|5
7006845|NCT01441973|11075125|FG000|Overall Study|Participant withdrew consent|0
7006846|NCT01441973|11075126|FG001|Overall Study|Participant withdrew consent|1
7006847|NCT01442038|11075135|FG000|Overall Study|Death|35
7006848|NCT01442038|11075136|FG001|Overall Study|Death|29
7006849|NCT01442038|11075135|FG000|Overall Study|Investigator-Initiated Early Closure|44
7006850|NCT01442038|11075136|FG001|Overall Study|Investigator-Initiated Early Closure|43
7006851|NCT01442038|11075135|FG000|Overall Study|Participant Withdrew Consent|137
7006852|NCT01442038|11075136|FG001|Overall Study|Participant Withdrew Consent|102
7006853|NCT01442038|11075135|FG000|Overall Study|Lost to Follow-up|37
7006854|NCT01442038|11075136|FG001|Overall Study|Lost to Follow-up|51
7006855|NCT01442038|11075135|FG000|Overall Study|Adverse Event|26
7006856|NCT01442038|11075136|FG001|Overall Study|Adverse Event|15
7006857|NCT01442038|11075135|FG000|Overall Study|Protocol Deviation|9
7006858|NCT01442038|11075136|FG001|Overall Study|Protocol Deviation|20
7006859|NCT01442038|11075135|FG000|Overall Study|Investigator's Discretion|13
7006860|NCT01442038|11075136|FG001|Overall Study|Investigator's Discretion|16
7006861|NCT01442038|11075135|FG000|Overall Study|Study Terminated By Sponsor|2
7006862|NCT01442038|11075136|FG001|Overall Study|Study Terminated By Sponsor|3
7006863|NCT01442064|11075148|FG000|Overall Study|Adverse Event|2
7006864|NCT01442064|11075149|FG001|Overall Study|Adverse Event|2
7006865|NCT01442064|11075150|FG002|Overall Study|Adverse Event|2
7006866|NCT01442064|11075151|FG003|Overall Study|Adverse Event|1
7006867|NCT01442064|11075152|FG004|Overall Study|Adverse Event|2
7006868|NCT01442064|11075153|FG005|Overall Study|Adverse Event|0
7006869|NCT01442064|11075148|FG000|Overall Study|Death|0
7006870|NCT01442064|11075149|FG001|Overall Study|Death|1
7006871|NCT01442064|11075150|FG002|Overall Study|Death|3
7006872|NCT01442064|11075151|FG003|Overall Study|Death|3
7006873|NCT01442064|11075152|FG004|Overall Study|Death|1
7006874|NCT01442064|11075153|FG005|Overall Study|Death|3
7006875|NCT01442064|11075148|FG000|Overall Study|Lost to Follow-up|5
7006876|NCT01442064|11075149|FG001|Overall Study|Lost to Follow-up|5
7006877|NCT01442064|11075150|FG002|Overall Study|Lost to Follow-up|1
7006878|NCT01442064|11075151|FG003|Overall Study|Lost to Follow-up|1
7006879|NCT01442064|11075152|FG004|Overall Study|Lost to Follow-up|3
7006880|NCT01442064|11075153|FG005|Overall Study|Lost to Follow-up|3
7006881|NCT01442064|11075148|FG000|Overall Study|Physician Decision|1
7006882|NCT01442064|11075149|FG001|Overall Study|Physician Decision|1
7006883|NCT01442064|11075150|FG002|Overall Study|Physician Decision|2
7006884|NCT01442064|11075151|FG003|Overall Study|Physician Decision|3
7006885|NCT01442064|11075152|FG004|Overall Study|Physician Decision|3
7006886|NCT01442064|11075153|FG005|Overall Study|Physician Decision|1
7006887|NCT01442064|11075148|FG000|Overall Study|Withdrawal by Subject|6
7006888|NCT01442064|11075149|FG001|Overall Study|Withdrawal by Subject|3
7006889|NCT01442064|11075150|FG002|Overall Study|Withdrawal by Subject|2
7006890|NCT01442064|11075151|FG003|Overall Study|Withdrawal by Subject|2
7006891|NCT01442064|11075152|FG004|Overall Study|Withdrawal by Subject|2
7006892|NCT01442064|11075153|FG005|Overall Study|Withdrawal by Subject|1
7006893|NCT01442064|11075148|FG000|Overall Study|Sponsor decision|82
7006894|NCT01442064|11075149|FG001|Overall Study|Sponsor decision|88
7006895|NCT01442064|11075150|FG002|Overall Study|Sponsor decision|92
7006896|NCT01442064|11075151|FG003|Overall Study|Sponsor decision|88
7006897|NCT01442064|11075152|FG004|Overall Study|Sponsor decision|95
7006898|NCT01442064|11075153|FG005|Overall Study|Sponsor decision|87
7006899|NCT01442064|11075148|FG000|Overall Study|Subject non-compliance|0
7006900|NCT01442064|11075149|FG001|Overall Study|Subject non-compliance|0
7006901|NCT01442064|11075150|FG002|Overall Study|Subject non-compliance|0
7006902|NCT01442064|11075151|FG003|Overall Study|Subject non-compliance|0
7006903|NCT01442064|11075152|FG004|Overall Study|Subject non-compliance|0
7006904|NCT01442064|11075153|FG005|Overall Study|Subject non-compliance|2
7006905|NCT01442064|11075148|FG000|Overall Study|Condition mandated other intervention|1
7006906|NCT01442064|11075149|FG001|Overall Study|Condition mandated other intervention|1
7006907|NCT01442064|11075150|FG002|Overall Study|Condition mandated other intervention|2
7006908|NCT01442064|11075151|FG003|Overall Study|Condition mandated other intervention|0
7006909|NCT01442064|11075152|FG004|Overall Study|Condition mandated other intervention|0
7006910|NCT01442064|11075153|FG005|Overall Study|Condition mandated other intervention|2
7006911|NCT01442103|11075170|FG000|Overall Study|Lost to Follow-up|2
7006912|NCT01442155|11075183|FG000|Overall Study|Complete remission|35
7006913|NCT01442155|11075183|FG000|Overall Study|Recurrence|26
7006914|NCT01442155|11075183|FG000|Overall Study|Adverse Event|2
7006915|NCT01442155|11075183|FG000|Overall Study|Lost to Follow-up|2
7006916|NCT01442181|11075189|FG000|Overall Study|patient refused surgery|1
7006917|NCT01442181|11075190|FG001|Overall Study|patient refused surgery|0
7006918|NCT01442181|11075189|FG000|Overall Study|no insurance for surgery|1
7006919|NCT01442181|11075190|FG001|Overall Study|no insurance for surgery|0
7006920|NCT01442181|11075189|FG000|Overall Study|low ejection factor|0
7006921|NCT01442181|11075190|FG001|Overall Study|low ejection factor|1
7006922|NCT01442181|11075189|FG000|Overall Study|Lost to Follow-up|1
7006923|NCT01442181|11075190|FG001|Overall Study|Lost to Follow-up|1
7006924|NCT01442181|11075189|FG000|Overall Study|patient in an additional study|1
7006925|NCT01442181|11075190|FG001|Overall Study|patient in an additional study|0
7006926|NCT01442181|11075189|FG000|Overall Study|atrial fibrillation not noted|0
7006927|NCT01442181|11075190|FG001|Overall Study|atrial fibrillation not noted|1
7006928|NCT01442376|11075200|FG000|Overall Study|Adverse Event|0
7006929|NCT01442376|11075201|FG001|Overall Study|Adverse Event|3
7006930|NCT01442376|11075202|FG002|Overall Study|Adverse Event|2
7006931|NCT01442376|11075200|FG000|Overall Study|Death|0
7006932|NCT01442376|11075201|FG001|Overall Study|Death|1
7006933|NCT01442376|11075202|FG002|Overall Study|Death|1
7006934|NCT01442376|11075200|FG000|Overall Study|Withdrawal of consent|0
7006935|NCT01442376|11075201|FG001|Overall Study|Withdrawal of consent|0
7006936|NCT01442376|11075202|FG002|Overall Study|Withdrawal of consent|1
7006937|NCT01442376|11075200|FG000|Overall Study|Patients not treated|2
7006938|NCT01442376|11075201|FG001|Overall Study|Patients not treated|3
7006939|NCT01442376|11075202|FG002|Overall Study|Patients not treated|1
7006940|NCT01442376|11075200|FG000|Overall Study|Not eligible for subsequent cycles|1
7006941|NCT01442376|11075201|FG001|Overall Study|Not eligible for subsequent cycles|2
7006942|NCT01442376|11075202|FG002|Overall Study|Not eligible for subsequent cycles|0
7006943|NCT01442493|11075212|FG000|Overall Study|withdrawn from study|3
7006944|NCT01442493|11075213|FG001|Overall Study|withdrawn from study|2
7006945|NCT01442675|11075219|FG000|Overall Study|Protocol Violation|6
7006946|NCT01442675|11075219|FG000|Overall Study|Lost to Follow-up|2
7006947|NCT01442675|11075219|FG000|Overall Study|Withdrawal by Subject|4
7006948|NCT01442688|11075226|FG000|First Intervention|Withdrawal by Subject|1
7006949|NCT01442688|11075227|FG001|First Intervention|Withdrawal by Subject|0
7006950|NCT01442688|11075226|FG000|First Intervention|subject incarcerated|1
7006951|NCT01442688|11075227|FG001|First Intervention|subject incarcerated|0
7006952|NCT01442688|11075226|FG000|Second Intervention|Adverse Event|1
7006953|NCT01442688|11075227|FG001|Second Intervention|Adverse Event|0
7006954|NCT01442714|11075233|FG000|Overall Study|Death|11
7006955|NCT01442714|11075233|FG000|Overall Study|Withdrawal by Subject|1
7006956|NCT01442779|11075239|FG000|Overall Study|Withdrawal by Subject|3
7006957|NCT01442779|11075239|FG000|Overall Study|Death|3
7006958|NCT01442779|11075239|FG000|Overall Study|Non-compliance|1
7006959|NCT01443026|11075254|FG000|Overall Study|Physician Decision|1
7006960|NCT01443026|11075255|FG001|Overall Study|Physician Decision|0
7006961|NCT01443026|11075254|FG000|Overall Study|Death|0
7006962|NCT01443026|11075255|FG001|Overall Study|Death|1
7006963|NCT01443026|11075254|FG000|Overall Study|Withdrawal by Subject|0
7006964|NCT01443026|11075255|FG001|Overall Study|Withdrawal by Subject|3
7006965|NCT01443026|11075254|FG000|Overall Study|Lost to Follow-up|2
7006966|NCT01443026|11075255|FG001|Overall Study|Lost to Follow-up|1
7006967|NCT01443078|11075261|FG000|Overall Study|Responded to neoadjuvant platinum txt|27
7006968|NCT01443078|11075261|FG000|Overall Study|Withdrawal by Subject|1
7006969|NCT01443078|11075261|FG000|Overall Study|Patient had brain mets|1
7006970|NCT01443130|11075271|FG000|Overall Study|Lost to Follow-up|44
7006971|NCT01443130|11075272|FG001|Overall Study|Lost to Follow-up|42
7006972|NCT01443130|11075273|FG002|Overall Study|Lost to Follow-up|50
7006973|NCT01443130|11075274|FG003|Overall Study|Lost to Follow-up|23
7006974|NCT01443130|11075275|FG004|Overall Study|Lost to Follow-up|25
7006975|NCT01443130|11075276|FG005|Overall Study|Lost to Follow-up|21
7006976|NCT01443130|11075271|FG000|Overall Study|Death|0
7006977|NCT01443130|11075272|FG001|Overall Study|Death|1
7006978|NCT01443130|11075273|FG002|Overall Study|Death|0
7006979|NCT01443130|11075274|FG003|Overall Study|Death|7
7006980|NCT01443130|11075275|FG004|Overall Study|Death|10
7006981|NCT01443130|11075276|FG005|Overall Study|Death|8
7006982|NCT01443130|11075271|FG000|Overall Study|Adverse Event|2
7006983|NCT01443130|11075272|FG001|Overall Study|Adverse Event|1
7006984|NCT01443130|11075273|FG002|Overall Study|Adverse Event|1
7006985|NCT01443130|11075274|FG003|Overall Study|Adverse Event|0
7006986|NCT01443130|11075275|FG004|Overall Study|Adverse Event|0
7006987|NCT01443130|11075276|FG005|Overall Study|Adverse Event|0
7006988|NCT01443130|11075271|FG000|Overall Study|Protocol Violation|2
7006989|NCT01443130|11075272|FG001|Overall Study|Protocol Violation|1
7006990|NCT01443130|11075273|FG002|Overall Study|Protocol Violation|3
7006991|NCT01443130|11075274|FG003|Overall Study|Protocol Violation|2
7006992|NCT01443130|11075275|FG004|Overall Study|Protocol Violation|2
7006993|NCT01443130|11075276|FG005|Overall Study|Protocol Violation|3
7006994|NCT01443130|11075271|FG000|Overall Study|Withdrawal by Subject|15
7006995|NCT01443130|11075272|FG001|Overall Study|Withdrawal by Subject|14
7006996|NCT01443130|11075273|FG002|Overall Study|Withdrawal by Subject|12
7006997|NCT01443130|11075274|FG003|Overall Study|Withdrawal by Subject|7
7006998|NCT01443130|11075275|FG004|Overall Study|Withdrawal by Subject|7
7006999|NCT01443130|11075276|FG005|Overall Study|Withdrawal by Subject|2
7007000|NCT01443130|11075271|FG000|Overall Study|Death of Subject's Infant|5
7007001|NCT01443130|11075272|FG001|Overall Study|Death of Subject's Infant|10
7007002|NCT01443130|11075273|FG002|Overall Study|Death of Subject's Infant|11
7007003|NCT01443130|11075274|FG003|Overall Study|Death of Subject's Infant|0
7007004|NCT01443130|11075275|FG004|Overall Study|Death of Subject's Infant|0
7007005|NCT01443130|11075276|FG005|Overall Study|Death of Subject's Infant|0
7007006|NCT01443364|11075290|FG000|Overall Study|Lack of Efficacy|14
7007007|NCT01443364|11075290|FG000|Overall Study|Lost to Follow-up|3
7007008|NCT01443364|11075290|FG000|Overall Study|Withdrawal by Subject|5
7007009|NCT01443364|11075290|FG000|Overall Study|Other Reason|4
7007010|NCT01443364|11075290|FG000|Overall Study|SAE, non-fatal|6
7007011|NCT01443364|11075290|FG000|Overall Study|AE, non-serious non-fatal|8
7007012|NCT01443364|11075290|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
7007013|NCT01443403|11075298|FG000|Overall Study|Adverse Event|1
7007014|NCT01443403|11075299|FG001|Overall Study|Adverse Event|1
7007015|NCT01443403|11075300|FG002|Overall Study|Adverse Event|4
7007016|NCT01443403|11075301|FG003|Overall Study|Adverse Event|5
7007017|NCT01443403|11075298|FG000|Overall Study|Withdrawal by Subject|0
7007018|NCT01443403|11075299|FG001|Overall Study|Withdrawal by Subject|1
7007019|NCT01443403|11075300|FG002|Overall Study|Withdrawal by Subject|2
7007020|NCT01443403|11075301|FG003|Overall Study|Withdrawal by Subject|1
7007021|NCT01443403|11075298|FG000|Overall Study|Lost to Follow-up|0
7007022|NCT01443403|11075299|FG001|Overall Study|Lost to Follow-up|0
7007023|NCT01443403|11075300|FG002|Overall Study|Lost to Follow-up|0
7007024|NCT01443403|11075301|FG003|Overall Study|Lost to Follow-up|1
7007025|NCT01443403|11075298|FG000|Overall Study|Protocol Violation|2
7007026|NCT01443403|11075299|FG001|Overall Study|Protocol Violation|1
7007027|NCT01443403|11075300|FG002|Overall Study|Protocol Violation|1
7007028|NCT01443403|11075301|FG003|Overall Study|Protocol Violation|1
7007029|NCT01443403|11075298|FG000|Overall Study|Use of Prohibited Treatment|2
7007030|NCT01443403|11075299|FG001|Overall Study|Use of Prohibited Treatment|3
7007031|NCT01443403|11075300|FG002|Overall Study|Use of Prohibited Treatment|0
7007032|NCT01443403|11075301|FG003|Overall Study|Use of Prohibited Treatment|0
7007033|NCT01443403|11075298|FG000|Overall Study|Other - Miscellaneous|1
7007034|NCT01443403|11075299|FG001|Overall Study|Other - Miscellaneous|0
7007035|NCT01443403|11075300|FG002|Overall Study|Other - Miscellaneous|0
7007036|NCT01443403|11075301|FG003|Overall Study|Other - Miscellaneous|1
7007037|NCT01443845|11075344|FG000|Overall Study|Protocol Violation|43
7007038|NCT01443845|11075345|FG001|Overall Study|Protocol Violation|45
7007039|NCT01443845|11075344|FG000|Overall Study|Other reasons, such as COPD exacerbation|44
7007040|NCT01443845|11075345|FG001|Overall Study|Other reasons, such as COPD exacerbation|44
7007041|NCT01443845|11075344|FG000|Overall Study|Deterioration in pulmonary function|1
7007042|NCT01443845|11075345|FG001|Overall Study|Deterioration in pulmonary function|4
7007043|NCT01443845|11075344|FG000|Overall Study|Lack of Efficacy|10
7007044|NCT01443845|11075345|FG001|Overall Study|Lack of Efficacy|5
7007045|NCT01443845|11075344|FG000|Overall Study|Adverse Event|64
7007046|NCT01443845|11075345|FG001|Overall Study|Adverse Event|138
7007047|NCT01443845|11075344|FG000|Overall Study|Withdrawal by Subject|63
7007048|NCT01443845|11075345|FG001|Overall Study|Withdrawal by Subject|67
7007049|NCT01443845|11075344|FG000|Overall Study|Military Conflict - Site Terminated|20
7007050|NCT01443845|11075345|FG001|Overall Study|Military Conflict - Site Terminated|21
7007051|NCT01443845|11075344|FG000|Overall Study|Lost to Follow-up|9
7007052|NCT01443845|11075345|FG001|Overall Study|Lost to Follow-up|13
7007053|NCT01443858|11075354|FG000|Overall Study|Withdrawal by Subject|9
7007054|NCT01443858|11075355|FG001|Overall Study|Withdrawal by Subject|8
7007055|NCT01443858|11075356|FG002|Overall Study|Withdrawal by Subject|5
7007056|NCT01443858|11075354|FG000|Overall Study|Lack of Efficacy|1
7007057|NCT01443858|11075355|FG001|Overall Study|Lack of Efficacy|0
7007058|NCT01443858|11075356|FG002|Overall Study|Lack of Efficacy|0
7007059|NCT01443858|11075354|FG000|Overall Study|Lost to Follow-up|5
7007060|NCT01443858|11075355|FG001|Overall Study|Lost to Follow-up|5
7007061|NCT01443858|11075356|FG002|Overall Study|Lost to Follow-up|2
7007062|NCT01444027|11075367|FG000|Overall Study|Withdrawal by Subject|4
7007063|NCT01444027|11075368|FG001|Overall Study|Withdrawal by Subject|10
7007064|NCT01444027|11075369|FG002|Overall Study|Withdrawal by Subject|24
7007065|NCT01444027|11075367|FG000|Overall Study|Lost to Follow-up|26
7007066|NCT01444027|11075368|FG001|Overall Study|Lost to Follow-up|20
7007067|NCT01444027|11075369|FG002|Overall Study|Lost to Follow-up|14
7007068|NCT01444300|11075393|FG000|Overall Study|Adverse Event|4
7007069|NCT01444300|11075394|FG001|Overall Study|Adverse Event|0
7007070|NCT01444378|11075401|FG000|Overall Study|Lost to Follow-up|1
7007071|NCT01444378|11075401|FG000|Overall Study|Withdrawal by Subject|1
7007072|NCT01444378|11075401|FG000|Overall Study|Death|3
7007073|NCT01444378|11075401|FG000|Overall Study|Administrative Closure Of The Study|2
7007074|NCT01444378|11075401|FG000|Overall Study|Missed Visits|10
7007075|NCT01444391|11075408|FG000|Overall Study|Death|1
7007076|NCT01444417|11075414|FG000|Overall Study|Ineligibility Determined|0
7007077|NCT01444417|11075415|FG001|Overall Study|Ineligibility Determined|1
7007078|NCT01444417|11075414|FG000|Overall Study|Withdrawal by Subject|2
7007079|NCT01444417|11075415|FG001|Overall Study|Withdrawal by Subject|0
7007080|NCT01444430|11075423|FG000|Overall Study|Withdrawal by Subject|53
7007081|NCT01444430|11075424|FG001|Overall Study|Withdrawal by Subject|72
7007082|NCT01444430|11075423|FG000|Overall Study|Death|6
7007083|NCT01444430|11075424|FG001|Overall Study|Death|8
7007084|NCT01444430|11075423|FG000|Overall Study|Lost to Follow-up|2
7007085|NCT01444430|11075424|FG001|Overall Study|Lost to Follow-up|0
7007086|NCT01444430|11075423|FG000|Overall Study|CRF termination module not completed.|0
7007087|NCT01444430|11075424|FG001|Overall Study|CRF termination module not completed.|1
7007088|NCT01444456|11075430|FG000|Overall Study|Withdrawal by Subject|21
7007089|NCT01444456|11075430|FG000|Overall Study|Physician Decision|9
7007090|NCT01444456|11075430|FG000|Overall Study|Lost to Follow-up|37
7007091|NCT01444456|11075430|FG000|Overall Study|Death|73
7007092|NCT01444456|11075430|FG000|Overall Study|Ineligibility determined|23
7007093|NCT01444456|11075430|FG000|Overall Study|Other|18
7007094|NCT01444456|11075430|FG000|Overall Study|Not treated|104
7043137|NCT01740388|11127719|FG001|Overall Study|Physician Decision|6
7043138|NCT01740388|11127718|FG000|Overall Study|Subjects missing data, completed|41
7043139|NCT01740388|11127719|FG001|Overall Study|Subjects missing data, completed|36
7043140|NCT01740401|11127725|FG000|Overall Study|Progression of disease|6
7043141|NCT01740401|11127725|FG000|Overall Study|Adverse Event|2
7043142|NCT01740401|11127725|FG000|Overall Study|Did not reach primary endpoint|2
7043143|NCT01740440|11127743|FG000|Overall Study|Lost to Follow-up|3
7043144|NCT01740791|11127778|FG000|Overall Study|Randomized but never treated|5
7043145|NCT01740791|11127779|FG001|Overall Study|Randomized but never treated|3
7043146|NCT01740791|11127780|FG002|Overall Study|Randomized but never treated|2
7043147|NCT01740791|11127781|FG003|Overall Study|Randomized but never treated|2
7043148|NCT01740791|11127782|FG004|Overall Study|Randomized but never treated|1
7043149|NCT01740791|11127783|FG005|Overall Study|Randomized but never treated|3
7043150|NCT01740791|11127778|FG000|Overall Study|Lost to Follow-up|2
7043151|NCT01740791|11127779|FG001|Overall Study|Lost to Follow-up|0
7043152|NCT01740791|11127780|FG002|Overall Study|Lost to Follow-up|2
7043153|NCT01740791|11127781|FG003|Overall Study|Lost to Follow-up|3
7043154|NCT01740791|11127782|FG004|Overall Study|Lost to Follow-up|2
7043155|NCT01740791|11127783|FG005|Overall Study|Lost to Follow-up|3
7043156|NCT01740791|11127778|FG000|Overall Study|Withdrew Consent|4
7043157|NCT01740791|11127779|FG001|Overall Study|Withdrew Consent|0
7043158|NCT01740791|11127780|FG002|Overall Study|Withdrew Consent|1
7043159|NCT01740791|11127781|FG003|Overall Study|Withdrew Consent|2
7043160|NCT01740791|11127782|FG004|Overall Study|Withdrew Consent|0
7043161|NCT01740791|11127783|FG005|Overall Study|Withdrew Consent|3
7043162|NCT01740791|11127778|FG000|Overall Study|Investigator's discretion|1
7043163|NCT01740791|11127779|FG001|Overall Study|Investigator's discretion|0
7043164|NCT01740791|11127780|FG002|Overall Study|Investigator's discretion|1
7043165|NCT01740791|11127781|FG003|Overall Study|Investigator's discretion|0
7043166|NCT01740791|11127782|FG004|Overall Study|Investigator's discretion|0
7043167|NCT01740791|11127783|FG005|Overall Study|Investigator's discretion|1
7043168|NCT01740791|11127778|FG000|Overall Study|Adverse Event|0
7043169|NCT01740791|11127779|FG001|Overall Study|Adverse Event|0
7043170|NCT01740791|11127780|FG002|Overall Study|Adverse Event|0
7043171|NCT01740791|11127781|FG003|Overall Study|Adverse Event|0
7043172|NCT01740791|11127782|FG004|Overall Study|Adverse Event|0
7043173|NCT01740791|11127783|FG005|Overall Study|Adverse Event|1
7043174|NCT01741012|11127845|FG000|Overall Study|Lost to Follow-up|1
7007095|NCT01444651|11075436|FG000|Overall Study|Adverse Event|3
7007096|NCT01444651|11075437|FG001|Overall Study|Adverse Event|2
7007097|NCT01444651|11075436|FG000|Overall Study|Lost to Follow-up|5
7007098|NCT01444651|11075437|FG001|Overall Study|Lost to Follow-up|5
7007099|NCT01444651|11075436|FG000|Overall Study|Non-fasting|2
7007100|NCT01444651|11075437|FG001|Overall Study|Non-fasting|1
7007101|NCT01444651|11075436|FG000|Overall Study|Missing data|1
7007102|NCT01444651|11075437|FG001|Overall Study|Missing data|1
7007103|NCT01444742|11075447|FG000|Overall Study|Death|1
7007104|NCT01444781|11075454|FG000|Overall Study|Lost to Follow-up|0
7007105|NCT01444781|11075455|FG001|Overall Study|Lost to Follow-up|3
7007106|NCT01444781|11075456|FG002|Overall Study|Lost to Follow-up|1
7007107|NCT01444781|11075454|FG000|Overall Study|Withdrawal by Subject|3
7007108|NCT01444781|11075455|FG001|Overall Study|Withdrawal by Subject|1
7007109|NCT01444781|11075456|FG002|Overall Study|Withdrawal by Subject|2
7007110|NCT01444898|11075471|FG000|Overall Study|Withdrawal by Subject|1
7007111|NCT01445080|11075511|FG000|Overall Study|Adverse Event|5
7007112|NCT01445080|11075512|FG001|Overall Study|Adverse Event|3
7007113|NCT01445080|11075513|FG002|Overall Study|Adverse Event|11
7007114|NCT01445080|11075514|FG003|Overall Study|Adverse Event|6
7007115|NCT01445080|11075515|FG004|Overall Study|Adverse Event|2
7007116|NCT01445080|11075516|FG005|Overall Study|Adverse Event|3
7007117|NCT01445080|11075517|FG006|Overall Study|Adverse Event|0
7007118|NCT01445080|11075518|FG007|Overall Study|Adverse Event|3
7007119|NCT01445080|11075519|FG008|Overall Study|Adverse Event|10
7007120|NCT01445080|11075511|FG000|Overall Study|Physician Decision|0
7007121|NCT01445080|11075512|FG001|Overall Study|Physician Decision|0
7007122|NCT01445080|11075513|FG002|Overall Study|Physician Decision|1
7007123|NCT01445080|11075514|FG003|Overall Study|Physician Decision|0
7007124|NCT01445080|11075515|FG004|Overall Study|Physician Decision|0
7007125|NCT01445080|11075516|FG005|Overall Study|Physician Decision|3
7007126|NCT01445080|11075517|FG006|Overall Study|Physician Decision|2
7007127|NCT01445080|11075518|FG007|Overall Study|Physician Decision|2
7007128|NCT01445080|11075519|FG008|Overall Study|Physician Decision|0
7007129|NCT01445080|11075511|FG000|Overall Study|Withdrawal by Subject|1
7007130|NCT01445080|11075512|FG001|Overall Study|Withdrawal by Subject|0
7007131|NCT01445080|11075513|FG002|Overall Study|Withdrawal by Subject|0
7007132|NCT01445080|11075514|FG003|Overall Study|Withdrawal by Subject|1
7007133|NCT01445080|11075515|FG004|Overall Study|Withdrawal by Subject|0
7007134|NCT01445080|11075516|FG005|Overall Study|Withdrawal by Subject|0
7007135|NCT01445080|11075517|FG006|Overall Study|Withdrawal by Subject|0
7007136|NCT01445080|11075518|FG007|Overall Study|Withdrawal by Subject|0
7007137|NCT01445080|11075519|FG008|Overall Study|Withdrawal by Subject|2
7007138|NCT01445080|11075511|FG000|Overall Study|Ineligible/Inevaluable|1
7007139|NCT01445080|11075512|FG001|Overall Study|Ineligible/Inevaluable|2
7007140|NCT01445080|11075513|FG002|Overall Study|Ineligible/Inevaluable|0
7007141|NCT01445080|11075514|FG003|Overall Study|Ineligible/Inevaluable|1
7007142|NCT01445080|11075515|FG004|Overall Study|Ineligible/Inevaluable|2
7007143|NCT01445080|11075516|FG005|Overall Study|Ineligible/Inevaluable|3
7007144|NCT01445080|11075517|FG006|Overall Study|Ineligible/Inevaluable|0
7007145|NCT01445080|11075518|FG007|Overall Study|Ineligible/Inevaluable|0
7007146|NCT01445080|11075519|FG008|Overall Study|Ineligible/Inevaluable|6
7007147|NCT01445171|11075554|FG000|Overall Study|Lost to Follow-up|11
7007148|NCT01445171|11075554|FG000|Overall Study|Withdrawal by Subject|16
7007149|NCT01445171|11075554|FG000|Overall Study|Death|51
7007150|NCT01445171|11075554|FG000|Overall Study|Subjects declined to return for followup|9
7007151|NCT01445171|11075554|FG000|Overall Study|Consented but did not receive device|8
7007152|NCT01445301|11075563|FG000|Overall Study|Adverse Event|15
7007153|NCT01445301|11075564|FG001|Overall Study|Adverse Event|25
7007154|NCT01445301|11075565|FG002|Overall Study|Adverse Event|4
7007155|NCT01445301|11075563|FG000|Overall Study|Lack of Efficacy|0
7007156|NCT01445301|11075564|FG001|Overall Study|Lack of Efficacy|1
7007157|NCT01445301|11075565|FG002|Overall Study|Lack of Efficacy|0
7007158|NCT01445301|11075563|FG000|Overall Study|Protocol Violation|1
7007159|NCT01445301|11075564|FG001|Overall Study|Protocol Violation|0
7007160|NCT01445301|11075565|FG002|Overall Study|Protocol Violation|0
7007161|NCT01445301|11075563|FG000|Overall Study|Protocol-Defined Stopping Criteria|0
7007162|NCT01445301|11075564|FG001|Overall Study|Protocol-Defined Stopping Criteria|1
7007163|NCT01445301|11075565|FG002|Overall Study|Protocol-Defined Stopping Criteria|1
7007164|NCT01445301|11075563|FG000|Overall Study|Physician Decision|0
7007165|NCT01445301|11075564|FG001|Overall Study|Physician Decision|2
7007166|NCT01445301|11075565|FG002|Overall Study|Physician Decision|0
7007167|NCT01445301|11075563|FG000|Overall Study|Withdrawal by Subject|5
7007168|NCT01445301|11075564|FG001|Overall Study|Withdrawal by Subject|6
7007169|NCT01445301|11075565|FG002|Overall Study|Withdrawal by Subject|4
7007170|NCT01445535|11075577|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0
7007171|NCT01445535|11075578|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0
7007172|NCT01445535|11075579|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0
7007173|NCT01445535|11075580|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1
7007174|NCT01445535|11075577|FG000|Overall Study|Disease progression|1
7007175|NCT01445535|11075578|FG001|Overall Study|Disease progression|0
7007176|NCT01445535|11075579|FG002|Overall Study|Disease progression|1
7007177|NCT01445535|11075580|FG003|Overall Study|Disease progression|0
7007178|NCT01445535|11075577|FG000|Overall Study|PI discretion|0
7007179|NCT01445535|11075578|FG001|Overall Study|PI discretion|0
7007180|NCT01445535|11075579|FG002|Overall Study|PI discretion|0
7007181|NCT01445535|11075580|FG003|Overall Study|PI discretion|1
7007182|NCT01445548|11075591|FG000|Overall Study|Adverse Event|1
7007183|NCT01445613|11075595|FG000|30-day Follow-up|Withdrawal by Subject|6
7007184|NCT01445613|11075595|FG000|30-day Follow-up|Physician Decision|3
7007185|NCT01445613|11075595|FG000|30-day Follow-up|Missed visit|23
7007186|NCT01445613|11075595|FG000|30-day Follow-up|Death|3
7007187|NCT01445613|11075595|FG000|1-year Follow-up|Withdrawal by Subject|12
7007188|NCT01445613|11075595|FG000|1-year Follow-up|Missed visit|29
7007189|NCT01445613|11075595|FG000|1-year Follow-up|Lost to Follow-up|2
7007190|NCT01445613|11075595|FG000|1-year Follow-up|Death|30
7007191|NCT01445613|11075595|FG000|1-year Follow-up|Physician Decision|2
7007192|NCT01445613|11075595|FG000|1-year Follow-up|Received a non-study stent|2
7007193|NCT01445652|11075611|FG000|Overall Study|Not comfortable in lenses|5
7007194|NCT01445652|11075612|FG001|Overall Study|Not comfortable in lenses|0
7007195|NCT01445652|11075611|FG000|Overall Study|Failed to attend scheduled visit|2
7007196|NCT01445652|11075612|FG001|Overall Study|Failed to attend scheduled visit|3
7007197|NCT01445652|11075611|FG000|Overall Study|Failed teach session|2
7007198|NCT01445652|11075612|FG001|Overall Study|Failed teach session|0
7007199|NCT01445652|11075611|FG000|Overall Study|Adverse Event|1
7007200|NCT01445652|11075612|FG001|Overall Study|Adverse Event|0
7007201|NCT01445678|11075620|FG000|Overall Study|Adverse Event|12
7007202|NCT01445678|11075621|FG001|Overall Study|Adverse Event|8
7007203|NCT01445678|11075620|FG000|Overall Study|Lack of Efficacy|0
7007204|NCT01445678|11075621|FG001|Overall Study|Lack of Efficacy|2
7007205|NCT01445678|11075620|FG000|Overall Study|Lost to Follow-up|8
7007206|NCT01445678|11075621|FG001|Overall Study|Lost to Follow-up|5
7007207|NCT01445678|11075620|FG000|Overall Study|Protocol Violation|1
7007208|NCT01445678|11075621|FG001|Overall Study|Protocol Violation|1
7007209|NCT01445678|11075620|FG000|Overall Study|Withdrawal by Subject|9
7007210|NCT01445678|11075621|FG001|Overall Study|Withdrawal by Subject|5
7007211|NCT01445730|11075627|FG000|Overall Study|Adverse Event|1
7007212|NCT01445730|11075627|FG000|Overall Study|For the advice of a dentist|1
7007213|NCT01445730|11075627|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9
7007214|NCT01445769|11075631|FG000|Overall Study|Consent Withdrawn|2
7007215|NCT01445769|11075631|FG000|Overall Study|Disease Progression|1
7007216|NCT01445769|11075631|FG000|Overall Study|Lost to Follow-up|5
7007217|NCT01445847|11075648|FG000|Overall Study|Protocol Violation|13
7007218|NCT01445847|11075649|FG001|Overall Study|Protocol Violation|14
7007219|NCT01445847|11075648|FG000|Overall Study|Missed Data|1
7007220|NCT01445847|11075649|FG001|Overall Study|Missed Data|0
7007221|NCT01445886|11075659|FG000|Overall Study|Lost to Follow-up|2
7007222|NCT01445886|11075659|FG000|Overall Study|Protocol Violation|3
7007223|NCT01445951|11075668|FG000|Overall Study|Adverse Event|16
7007224|NCT01445951|11075669|FG001|Overall Study|Adverse Event|9
7007225|NCT01445951|11075670|FG002|Overall Study|Adverse Event|0
7060405|NCT01918306|11156572|FG000|Overall Study|Lack of Efficacy|1
7007226|NCT01445951|11075668|FG000|Overall Study|Protocol Violation|2
7007227|NCT01445951|11075669|FG001|Overall Study|Protocol Violation|2
7007228|NCT01445951|11075670|FG002|Overall Study|Protocol Violation|2
7007229|NCT01445951|11075668|FG000|Overall Study|Withdrawal by Subject|21
7007230|NCT01445951|11075669|FG001|Overall Study|Withdrawal by Subject|16
7007231|NCT01445951|11075670|FG002|Overall Study|Withdrawal by Subject|8
7007232|NCT01445951|11075668|FG000|Overall Study|Physician Decision|3
7007233|NCT01445951|11075669|FG001|Overall Study|Physician Decision|1
7007234|NCT01445951|11075670|FG002|Overall Study|Physician Decision|0
7007235|NCT01445951|11075668|FG000|Overall Study|Lost to Follow-up|1
7007236|NCT01445951|11075669|FG001|Overall Study|Lost to Follow-up|2
7007237|NCT01445951|11075670|FG002|Overall Study|Lost to Follow-up|4
7007238|NCT01445951|11075668|FG000|Overall Study|Pregnancy|0
7007239|NCT01445951|11075669|FG001|Overall Study|Pregnancy|1
7007240|NCT01445951|11075670|FG002|Overall Study|Pregnancy|4
7007241|NCT01445951|11075668|FG000|Overall Study|Death|0
7007242|NCT01445951|11075669|FG001|Overall Study|Death|0
7007243|NCT01445951|11075670|FG002|Overall Study|Death|1
7007244|NCT01445951|11075668|FG000|Overall Study|Non-compliance with study drug|1
7007245|NCT01445951|11075669|FG001|Overall Study|Non-compliance with study drug|2
7007246|NCT01445951|11075670|FG002|Overall Study|Non-compliance with study drug|0
7007247|NCT01445951|11075668|FG000|Overall Study|Non-compliance with protocol|0
7007248|NCT01445951|11075669|FG001|Overall Study|Non-compliance with protocol|1
7007249|NCT01445951|11075670|FG002|Overall Study|Non-compliance with protocol|0
7007250|NCT01445951|11075668|FG000|Overall Study|Sponsor decision - subject travel|0
7007251|NCT01445951|11075669|FG001|Overall Study|Sponsor decision - subject travel|1
7007252|NCT01445951|11075670|FG002|Overall Study|Sponsor decision - subject travel|0
7007253|NCT01445951|11075668|FG000|Overall Study|Cough|0
7007254|NCT01445951|11075669|FG001|Overall Study|Cough|1
7007255|NCT01445951|11075670|FG002|Overall Study|Cough|0
7007256|NCT01446003|11075678|FG000|Period 1|Protocol Violation|2
7007257|NCT01446003|11075679|FG001|Period 1|Protocol Violation|0
7007258|NCT01446003|11075678|FG000|Period 2|Adverse Event|1
7007259|NCT01446003|11075679|FG001|Period 2|Adverse Event|0
7007260|NCT01446042|11075688|FG000|Overall Study|Withdrawal by Subject|12
7007261|NCT01446042|11075689|FG001|Overall Study|Withdrawal by Subject|2
7007262|NCT01446042|11075690|FG002|Overall Study|Withdrawal by Subject|4
7007263|NCT01446042|11075688|FG000|Overall Study|Adverse Event|1
7007264|NCT01446042|11075689|FG001|Overall Study|Adverse Event|0
7007265|NCT01446042|11075690|FG002|Overall Study|Adverse Event|4
7007266|NCT01446042|11075688|FG000|Overall Study|Lost to Follow-up|5
7007267|NCT01446042|11075689|FG001|Overall Study|Lost to Follow-up|0
7007268|NCT01446042|11075690|FG002|Overall Study|Lost to Follow-up|0
7007269|NCT01446042|11075688|FG000|Overall Study|Other reasons|2
7007270|NCT01446042|11075689|FG001|Overall Study|Other reasons|1
7007271|NCT01446042|11075690|FG002|Overall Study|Other reasons|1
7007272|NCT01446159|11075702|FG000|Overall Study|Withdrawal by Subject|1
7007273|NCT01446159|11075703|FG001|Overall Study|Withdrawal by Subject|0
7007274|NCT01446159|11075704|FG002|Overall Study|Withdrawal by Subject|14
7007275|NCT01446159|11075705|FG003|Overall Study|Withdrawal by Subject|11
7007276|NCT01446159|11075702|FG000|Overall Study|Lost to Follow-up|0
7007277|NCT01446159|11075703|FG001|Overall Study|Lost to Follow-up|0
7007278|NCT01446159|11075704|FG002|Overall Study|Lost to Follow-up|1
7007279|NCT01446159|11075705|FG003|Overall Study|Lost to Follow-up|2
7007280|NCT01446159|11075702|FG000|Overall Study|Death|2
7007281|NCT01446159|11075703|FG001|Overall Study|Death|3
7007282|NCT01446159|11075704|FG002|Overall Study|Death|43
7007283|NCT01446159|11075705|FG003|Overall Study|Death|36
7007284|NCT01446159|11075702|FG000|Overall Study|Other|0
7007285|NCT01446159|11075703|FG001|Overall Study|Other|0
7007286|NCT01446159|11075704|FG002|Overall Study|Other|13
7007287|NCT01446159|11075705|FG003|Overall Study|Other|13
7007288|NCT01446237|11075717|FG000|Overall Study|Adverse Event|1
7007289|NCT01446237|11075717|FG000|Overall Study|Lost to Follow-up|2
7007290|NCT01446237|11075717|FG000|Overall Study|Withdrawal by Subject|7
7007291|NCT01446289|11075725|FG000|Overall Study|Withdrawal by Subject|1
7007292|NCT01446289|11075726|FG001|Overall Study|Withdrawal by Subject|0
7007293|NCT01446289|11075727|FG002|Overall Study|Withdrawal by Subject|1
7007294|NCT01446289|11075728|FG003|Overall Study|Withdrawal by Subject|0
7007295|NCT01446419|11075742|FG000|Overall Study|Death|1
7007296|NCT01446419|11075743|FG001|Overall Study|Death|0
7007297|NCT01446419|11075742|FG000|Overall Study|Withdrawal by Subject|1
7007298|NCT01446419|11075743|FG001|Overall Study|Withdrawal by Subject|1
7007299|NCT01446419|11075742|FG000|Overall Study|Terminated per protocol|3
7007300|NCT01446419|11075743|FG001|Overall Study|Terminated per protocol|0
7007301|NCT01446809|11075775|FG000|Overall Study|Adverse Event|0
7007302|NCT01446809|11075776|FG001|Overall Study|Adverse Event|0
7007303|NCT01446809|11075777|FG002|Overall Study|Adverse Event|1
7007304|NCT01446809|11075775|FG000|Overall Study|Failure to complete study procedures|0
7007305|NCT01446809|11075776|FG001|Overall Study|Failure to complete study procedures|0
7007306|NCT01446809|11075777|FG002|Overall Study|Failure to complete study procedures|1
7007307|NCT01446874|11075789|FG000|Overall Study|Not eligible|1
7007308|NCT01446874|11075790|FG001|Overall Study|Not eligible|0
7007309|NCT01446874|11075791|FG002|Overall Study|Not eligible|0
7007310|NCT01446874|11075789|FG000|Overall Study|No surgery/No qualifying surgery|1
7007311|NCT01446874|11075790|FG001|Overall Study|No surgery/No qualifying surgery|0
7007312|NCT01446874|11075791|FG002|Overall Study|No surgery/No qualifying surgery|12
7007313|NCT01446874|11075789|FG000|Overall Study|Non-compliance|0
7007314|NCT01446874|11075790|FG001|Overall Study|Non-compliance|4
7007315|NCT01446874|11075791|FG002|Overall Study|Non-compliance|0
7007316|NCT01446874|11075789|FG000|Overall Study|Antibiotics for pre-op infection|0
7007317|NCT01446874|11075790|FG001|Overall Study|Antibiotics for pre-op infection|0
7007318|NCT01446874|11075791|FG002|Overall Study|Antibiotics for pre-op infection|2
7007319|NCT01446874|11075789|FG000|Overall Study|Withdrawal by Subject|0
7007320|NCT01446874|11075790|FG001|Overall Study|Withdrawal by Subject|0
7007321|NCT01446874|11075791|FG002|Overall Study|Withdrawal by Subject|4
7007322|NCT01446913|11075802|FG000|Overall Study|Significant illness|1
7007323|NCT01446913|11075803|FG001|Overall Study|Significant illness|1
7007324|NCT01446913|11075804|FG002|Overall Study|Significant illness|1
7007325|NCT01446913|11075802|FG000|Overall Study|Withdrawal by Subject|5
7007326|NCT01446913|11075803|FG001|Overall Study|Withdrawal by Subject|3
7007327|NCT01446913|11075804|FG002|Overall Study|Withdrawal by Subject|5
7007328|NCT01446913|11075802|FG000|Overall Study|Physician Decision|0
7007329|NCT01446913|11075803|FG001|Overall Study|Physician Decision|0
7007330|NCT01446913|11075804|FG002|Overall Study|Physician Decision|2
7007331|NCT01446913|11075802|FG000|Overall Study|Lost to Follow-up|3
7007332|NCT01446913|11075803|FG001|Overall Study|Lost to Follow-up|5
7007333|NCT01446913|11075804|FG002|Overall Study|Lost to Follow-up|3
7007334|NCT01446965|11075820|FG000|Randominization|One site was dismissed due to IRB irregularity|30
7007335|NCT01446965|11075821|FG001|Randominization|One site was dismissed due to IRB irregularity|16
7007336|NCT01446965|11075820|FG000|Participants Followed and Analyzed|Lost to Follow-up|10
7007337|NCT01446965|11075821|FG001|Participants Followed and Analyzed|Lost to Follow-up|12
7007338|NCT01447407|11075890|FG000|Overall Study|Withdrawal by Subject|2
7007339|NCT01447407|11075891|FG001|Overall Study|Withdrawal by Subject|0
7007340|NCT01447407|11075892|FG002|Overall Study|Withdrawal by Subject|0
7007341|NCT01447407|11075893|FG003|Overall Study|Withdrawal by Subject|1
7007342|NCT01447407|11075890|FG000|Overall Study|Physician Decision|0
7007343|NCT01447407|11075891|FG001|Overall Study|Physician Decision|0
7007344|NCT01447407|11075892|FG002|Overall Study|Physician Decision|1
7007345|NCT01447407|11075893|FG003|Overall Study|Physician Decision|1
7007346|NCT01447420|11075906|FG000|Overall Study|Adverse Event|2
7007347|NCT01447420|11075907|FG001|Overall Study|Adverse Event|4
7007348|NCT01447420|11075908|FG002|Overall Study|Adverse Event|2
7007349|NCT01447420|11075906|FG000|Overall Study|Protocol Violation|3
7007350|NCT01447420|11075907|FG001|Overall Study|Protocol Violation|3
7007351|NCT01447420|11075908|FG002|Overall Study|Protocol Violation|0
7007352|NCT01447420|11075906|FG000|Overall Study|Withdrawal by Subject|4
7007353|NCT01447420|11075907|FG001|Overall Study|Withdrawal by Subject|1
7007354|NCT01447420|11075908|FG002|Overall Study|Withdrawal by Subject|0
7007355|NCT01447420|11075906|FG000|Overall Study|Lack of Efficacy|1
7007356|NCT01447420|11075907|FG001|Overall Study|Lack of Efficacy|19
7007357|NCT01447420|11075908|FG002|Overall Study|Lack of Efficacy|8
7007358|NCT01447433|11075917|FG000|Overall Study|Lost to Follow-up|0
7007359|NCT01447433|11075918|FG001|Overall Study|Lost to Follow-up|2
7007360|NCT01447433|11075917|FG000|Overall Study|Withdrawal by Subject|3
7007361|NCT01447433|11075918|FG001|Overall Study|Withdrawal by Subject|3
7007362|NCT01447433|11075917|FG000|Overall Study|Protocol Violation|1
7007363|NCT01447433|11075918|FG001|Overall Study|Protocol Violation|1
7007364|NCT01447446|11075930|FG000|Overall Study|Death|6
7007365|NCT01447446|11075931|FG001|Overall Study|Death|3
7007366|NCT01447446|11075932|FG002|Overall Study|Death|2
7007367|NCT01447446|11075933|FG003|Overall Study|Death|1
7007368|NCT01447446|11075934|FG004|Overall Study|Death|7
7007369|NCT01447446|11075935|FG005|Overall Study|Death|0
7007370|NCT01447446|11075930|FG000|Overall Study|Adverse Event|3
7007371|NCT01447446|11075931|FG001|Overall Study|Adverse Event|0
7007372|NCT01447446|11075932|FG002|Overall Study|Adverse Event|1
7007373|NCT01447446|11075933|FG003|Overall Study|Adverse Event|0
7007374|NCT01447446|11075934|FG004|Overall Study|Adverse Event|2
7007375|NCT01447446|11075935|FG005|Overall Study|Adverse Event|0
7007376|NCT01447446|11075930|FG000|Overall Study|Failure to Return/Consent Withdrawn|357
7007377|NCT01447446|11075931|FG001|Overall Study|Failure to Return/Consent Withdrawn|78
7007378|NCT01447446|11075932|FG002|Overall Study|Failure to Return/Consent Withdrawn|31
7007379|NCT01447446|11075933|FG003|Overall Study|Failure to Return/Consent Withdrawn|7
7007380|NCT01447446|11075934|FG004|Overall Study|Failure to Return/Consent Withdrawn|69
7007381|NCT01447446|11075935|FG005|Overall Study|Failure to Return/Consent Withdrawn|9
7007382|NCT01447446|11075930|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300
7007383|NCT01447446|11075931|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71
7007384|NCT01447446|11075932|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52
7007385|NCT01447446|11075933|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21
7007386|NCT01447446|11075934|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92
7007387|NCT01447446|11075935|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14
7007388|NCT01447446|11075930|FG000|Overall Study|Administrative/Other|34
7007389|NCT01447446|11075931|FG001|Overall Study|Administrative/Other|9
7007390|NCT01447446|11075932|FG002|Overall Study|Administrative/Other|10
7007391|NCT01447446|11075933|FG003|Overall Study|Administrative/Other|2
7007392|NCT01447446|11075934|FG004|Overall Study|Administrative/Other|33
7007393|NCT01447446|11075935|FG005|Overall Study|Administrative/Other|4
7007394|NCT01447446|11075930|FG000|Overall Study|SVR12 Assessment|13
7007395|NCT01447446|11075931|FG001|Overall Study|SVR12 Assessment|1
7007396|NCT01447446|11075932|FG002|Overall Study|SVR12 Assessment|2
7007397|NCT01447446|11075933|FG003|Overall Study|SVR12 Assessment|1
7007398|NCT01447446|11075934|FG004|Overall Study|SVR12 Assessment|5
7007399|NCT01447446|11075935|FG005|Overall Study|SVR12 Assessment|5
7007400|NCT01447446|11075930|FG000|Overall Study|New Treatment Started|8
7007401|NCT01447446|11075931|FG001|Overall Study|New Treatment Started|2
7007402|NCT01447446|11075932|FG002|Overall Study|New Treatment Started|1
7007403|NCT01447446|11075933|FG003|Overall Study|New Treatment Started|0
7007404|NCT01447446|11075934|FG004|Overall Study|New Treatment Started|2
7007405|NCT01447446|11075935|FG005|Overall Study|New Treatment Started|0
7007406|NCT01447446|11075930|FG000|Overall Study|Reason not Specified|1
7007407|NCT01447446|11075931|FG001|Overall Study|Reason not Specified|1
7007408|NCT01447446|11075932|FG002|Overall Study|Reason not Specified|1
7007409|NCT01447446|11075933|FG003|Overall Study|Reason not Specified|1
7007410|NCT01447446|11075934|FG004|Overall Study|Reason not Specified|1
7007411|NCT01447446|11075935|FG005|Overall Study|Reason not Specified|0
7007412|NCT01447576|11075976|FG000|Overall Study|Lost to Follow-up|52
7007413|NCT01447576|11075976|FG000|Overall Study|Adverse Event|127
7007414|NCT01447576|11075976|FG000|Overall Study|Participant met withdrawal criteria|40
7007415|NCT01447576|11075976|FG000|Overall Study|Withdrawal by Subject|100
7007416|NCT01447576|11075976|FG000|Overall Study|Protocol deviation|83
7007417|NCT01447576|11075976|FG000|Overall Study|Lack of Efficacy|68
7007418|NCT01447576|11075976|FG000|Overall Study|Physician Decision|6
7007419|NCT01447719|11075993|FG000|Overall Study|Image acquisition failure|2
7007420|NCT01447719|11075993|FG000|Overall Study|Invalid image or not imaged|3
7007421|NCT01447719|11075993|FG000|Overall Study|Subject still living at end of study|79
7007422|NCT01447719|11075993|FG000|Overall Study|Withdrawal by Subject|2
7007423|NCT01447719|11075993|FG000|Overall Study|Family withdrew autopsy consent|7
7007424|NCT01447927|11076034|FG000|Overall Study|Adverse Event|4
7007425|NCT01447927|11076035|FG001|Overall Study|Adverse Event|3
7007426|NCT01447927|11076034|FG000|Overall Study|Withdrawal by Subject|1
7007427|NCT01447927|11076035|FG001|Overall Study|Withdrawal by Subject|0
7007428|NCT01448044|11076043|FG000|Treatment Period|Adverse Event|4
7007429|NCT01448044|11076044|FG001|Treatment Period|Adverse Event|3
7007430|NCT01448044|11076043|FG000|Treatment Period|Lack of Efficacy|5
7007431|NCT01448044|11076044|FG001|Treatment Period|Lack of Efficacy|12
7007432|NCT01448044|11076043|FG000|Treatment Period|Subject requested discontinue study drug|1
7007433|NCT01448044|11076044|FG001|Treatment Period|Subject requested discontinue study drug|0
7007434|NCT01448044|11076043|FG000|Treatment Period|Completed 24 weeks treatment period only|8
7007435|NCT01448044|11076044|FG001|Treatment Period|Completed 24 weeks treatment period only|0
7007436|NCT01448044|11076043|FG000|Treatment Period|Participant does not meet study criteria|1
7007437|NCT01448044|11076044|FG001|Treatment Period|Participant does not meet study criteria|0
7007438|NCT01448044|11076043|FG000|Treatment Period|Lost to Follow-up|2
7007439|NCT01448044|11076044|FG001|Treatment Period|Lost to Follow-up|1
7007440|NCT01448044|11076043|FG000|Treatment Period|Other reason|2
7007441|NCT01448044|11076044|FG001|Treatment Period|Other reason|0
7007442|NCT01448044|11076043|FG000|Follow Up Period|Withdrawal by Subject|1
7007443|NCT01448044|11076044|FG001|Follow Up Period|Withdrawal by Subject|1
7007444|NCT01448044|11076043|FG000|Follow Up Period|Lost to Follow-up|6
7007445|NCT01448044|11076044|FG001|Follow Up Period|Lost to Follow-up|2
7007446|NCT01448044|11076043|FG000|Follow Up Period|Other|5
7007447|NCT01448044|11076044|FG001|Follow Up Period|Other|11
7007448|NCT01448057|11076052|FG000|Overall Study|Protocol Violation|3
7007449|NCT01448057|11076053|FG001|Overall Study|Protocol Violation|2
7007450|NCT01448057|11076052|FG000|Overall Study|Lost to Follow-up|3
7007451|NCT01448057|11076053|FG001|Overall Study|Lost to Follow-up|0
7007452|NCT01448057|11076052|FG000|Overall Study|Adverse Event|0
7007453|NCT01448057|11076053|FG001|Overall Study|Adverse Event|2
7007454|NCT01448057|11076052|FG000|Overall Study|Withdrawal by Subject|2
7007455|NCT01448057|11076053|FG001|Overall Study|Withdrawal by Subject|0
7007456|NCT01448213|11076061|FG000|Overall Study|Lost to Follow-up|12
7007457|NCT01448213|11076062|FG001|Overall Study|Lost to Follow-up|10
7007458|NCT01448213|11076061|FG000|Overall Study|Adverse Event|4
7007459|NCT01448213|11076062|FG001|Overall Study|Adverse Event|10
7007460|NCT01448213|11076061|FG000|Overall Study|Protocol Violation|1
7007461|NCT01448213|11076062|FG001|Overall Study|Protocol Violation|2
7007462|NCT01448616|11076107|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3
7007463|NCT01448616|11076108|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0
7007464|NCT01448616|11076109|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0
7007465|NCT01448616|11076110|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0
7007466|NCT01448616|11076107|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6
7007467|NCT01448616|11076108|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0
7007468|NCT01448616|11076109|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0
7007469|NCT01448616|11076110|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0
7007470|NCT01448616|11076107|FG000|Study Drug (Treatment Phase)|Adverse Event|0
7007471|NCT01448616|11076108|FG001|Study Drug (Treatment Phase)|Adverse Event|1
7007472|NCT01448616|11076109|FG002|Study Drug (Treatment Phase)|Adverse Event|1
7007473|NCT01448616|11076110|FG003|Study Drug (Treatment Phase)|Adverse Event|0
7007474|NCT01448616|11076107|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0
7007475|NCT01448616|11076108|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0
7007476|NCT01448616|11076109|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1
7007477|NCT01448616|11076110|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2
7007478|NCT01448616|11076107|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0
7007479|NCT01448616|11076108|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1
7007480|NCT01448616|11076109|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2
7007481|NCT01448616|11076110|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2
7007482|NCT01448707|11076125|FG000|Overall Study|Adverse Event|3
7007483|NCT01448707|11076126|FG001|Overall Study|Adverse Event|1
7007484|NCT01448707|11076125|FG000|Overall Study|Lost to Follow-up|2
7007485|NCT01448707|11076126|FG001|Overall Study|Lost to Follow-up|6
7007486|NCT01448707|11076125|FG000|Overall Study|Withdrawal by Subject|6
7007487|NCT01448707|11076126|FG001|Overall Study|Withdrawal by Subject|7
7007488|NCT01448707|11076125|FG000|Overall Study|Other|7
7007489|NCT01448707|11076126|FG001|Overall Study|Other|4
7007490|NCT01448824|11076140|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
7007491|NCT01448824|11076141|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
7007492|NCT01448824|11076142|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
7007493|NCT01448824|11076143|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
7007494|NCT01448824|11076144|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
7007495|NCT01448824|11076145|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
7007496|NCT01448824|11076146|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1
7007497|NCT01448824|11076147|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
7007498|NCT01448824|11076140|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
7007499|NCT01448824|11076141|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
7007500|NCT01448824|11076142|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
7007501|NCT01448824|11076143|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1
7007502|NCT01448824|11076144|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2
7007503|NCT01448824|11076145|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1
7007504|NCT01448824|11076146|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
7007505|NCT01448824|11076147|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
7007506|NCT01448824|11076140|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
7007507|NCT01448824|11076141|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
7007508|NCT01448824|11076142|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
7007509|NCT01448824|11076143|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
7007510|NCT01448824|11076144|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
7007511|NCT01448824|11076145|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1
7007512|NCT01448824|11076146|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
7007513|NCT01448824|11076147|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
7007514|NCT01448824|11076140|FG000|Part 1: Washout Period|Lost to Follow-up|1
7007515|NCT01448824|11076141|FG001|Part 1: Washout Period|Lost to Follow-up|0
7007516|NCT01448824|11076142|FG002|Part 1: Washout Period|Lost to Follow-up|0
7007517|NCT01448824|11076143|FG003|Part 1: Washout Period|Lost to Follow-up|0
7007518|NCT01448824|11076144|FG004|Part 1: Washout Period|Lost to Follow-up|0
7007519|NCT01448824|11076145|FG005|Part 1: Washout Period|Lost to Follow-up|0
7007520|NCT01448824|11076146|FG006|Part 1: Washout Period|Lost to Follow-up|0
7007521|NCT01448824|11076147|FG007|Part 1: Washout Period|Lost to Follow-up|0
7007522|NCT01448824|11076140|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
7007523|NCT01448824|11076141|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
7007524|NCT01448824|11076142|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
7007525|NCT01448824|11076143|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
7007526|NCT01448824|11076144|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
7007527|NCT01448824|11076145|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
7007528|NCT01448824|11076146|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
7007529|NCT01448824|11076147|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1
7007530|NCT01448824|11076140|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
7007531|NCT01448824|11076141|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
7007532|NCT01448824|11076142|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
7007533|NCT01448824|11076143|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
7007534|NCT01448824|11076144|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
7007535|NCT01448824|11076145|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
7007536|NCT01448824|11076146|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
7007537|NCT01448824|11076147|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1
7007538|NCT01448824|11076140|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
7007539|NCT01448824|11076141|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
7007540|NCT01448824|11076142|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
7007541|NCT01448824|11076143|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
7007542|NCT01448824|11076144|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
7007543|NCT01448824|11076145|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
7007544|NCT01448824|11076146|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
7007545|NCT01448824|11076147|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1
7007546|NCT01448824|11076140|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
7007547|NCT01448824|11076141|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
7007548|NCT01448824|11076142|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
7007549|NCT01448824|11076143|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
7007550|NCT01448824|11076144|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
7007551|NCT01448824|11076145|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
7007552|NCT01448824|11076146|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
7007553|NCT01448824|11076147|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1
7007554|NCT01448850|11076177|FG000|Overall Study|Death|3
7007555|NCT01448850|11076178|FG001|Overall Study|Death|6
7007556|NCT01448850|11076177|FG000|Overall Study|Withdrawal by Subject|13
7007557|NCT01448850|11076178|FG001|Overall Study|Withdrawal by Subject|21
7007558|NCT01448850|11076177|FG000|Overall Study|Lost to Follow-up|3
7007559|NCT01448850|11076178|FG001|Overall Study|Lost to Follow-up|1
7007560|NCT01448850|11076177|FG000|Overall Study|Other|15
7007561|NCT01448850|11076178|FG001|Overall Study|Other|12
7007562|NCT01449006|11076187|FG000|Overall Study|Lost to Follow-up|1
7007563|NCT01449006|11076188|FG001|Overall Study|Lost to Follow-up|0
7007564|NCT01449006|11076187|FG000|Overall Study|Withdrawal by Subject|1
7007565|NCT01449006|11076188|FG001|Overall Study|Withdrawal by Subject|0
7007566|NCT01449006|11076187|FG000|Overall Study|Protocol Violation|1
7007567|NCT01449006|11076188|FG001|Overall Study|Protocol Violation|0
7007568|NCT01449279|11076202|FG000|Overall Study|Lack of Efficacy|5
7007569|NCT01449279|11076202|FG000|Overall Study|Toxicity|2
7007570|NCT01449370|11076235|FG000|Overall Study|Disease Progression|5
7007571|NCT01449370|11076236|FG001|Overall Study|Disease Progression|4
7007572|NCT01449370|11076237|FG002|Overall Study|Disease Progression|8
7007573|NCT01449370|11076238|FG003|Overall Study|Disease Progression|3
7007574|NCT01449370|11076239|FG004|Overall Study|Disease Progression|3
7007575|NCT01449370|11076240|FG005|Overall Study|Disease Progression|3
7007576|NCT01449370|11076241|FG006|Overall Study|Disease Progression|3
7007577|NCT01449370|11076242|FG007|Overall Study|Disease Progression|2
7007578|NCT01449370|11076243|FG008|Overall Study|Disease Progression|9
7007579|NCT01449370|11076244|FG009|Overall Study|Disease Progression|1
7007580|NCT01449370|11076245|FG010|Overall Study|Disease Progression|3
7007581|NCT01449370|11076246|FG011|Overall Study|Disease Progression|3
7007582|NCT01449370|11076247|FG012|Overall Study|Disease Progression|2
7007583|NCT01449370|11076248|FG013|Overall Study|Disease Progression|8
7007584|NCT01449370|11076249|FG014|Overall Study|Disease Progression|3
7007585|NCT01449370|11076250|FG015|Overall Study|Disease Progression|1
7007586|NCT01449370|11076251|FG016|Overall Study|Disease Progression|4
7007587|NCT01449370|11076252|FG017|Overall Study|Disease Progression|3
7007588|NCT01449370|11076253|FG018|Overall Study|Disease Progression|1
7007589|NCT01449370|11076254|FG019|Overall Study|Disease Progression|2
7007590|NCT01449370|11076255|FG020|Overall Study|Disease Progression|5
7007591|NCT01449370|11076256|FG021|Overall Study|Disease Progression|2
7007592|NCT01449370|11076257|FG022|Overall Study|Disease Progression|3
7007593|NCT01449370|11076258|FG023|Overall Study|Disease Progression|7
7007594|NCT01449370|11076259|FG024|Overall Study|Disease Progression|3
7007595|NCT01449370|11076235|FG000|Overall Study|Adverse Event|1
7007596|NCT01449370|11076236|FG001|Overall Study|Adverse Event|2
7007597|NCT01449370|11076237|FG002|Overall Study|Adverse Event|0
7007598|NCT01449370|11076238|FG003|Overall Study|Adverse Event|1
7007599|NCT01449370|11076239|FG004|Overall Study|Adverse Event|0
7007600|NCT01449370|11076240|FG005|Overall Study|Adverse Event|0
7007601|NCT01449370|11076241|FG006|Overall Study|Adverse Event|0
7007602|NCT01449370|11076242|FG007|Overall Study|Adverse Event|0
7007603|NCT01449370|11076243|FG008|Overall Study|Adverse Event|1
7007604|NCT01449370|11076244|FG009|Overall Study|Adverse Event|1
7007605|NCT01449370|11076245|FG010|Overall Study|Adverse Event|0
7007606|NCT01449370|11076246|FG011|Overall Study|Adverse Event|0
7007607|NCT01449370|11076247|FG012|Overall Study|Adverse Event|0
7007608|NCT01449370|11076248|FG013|Overall Study|Adverse Event|2
7007609|NCT01449370|11076249|FG014|Overall Study|Adverse Event|0
7007610|NCT01449370|11076250|FG015|Overall Study|Adverse Event|1
7007611|NCT01449370|11076251|FG016|Overall Study|Adverse Event|0
7007612|NCT01449370|11076252|FG017|Overall Study|Adverse Event|0
7007613|NCT01449370|11076253|FG018|Overall Study|Adverse Event|1
7007614|NCT01449370|11076254|FG019|Overall Study|Adverse Event|1
7007615|NCT01449370|11076255|FG020|Overall Study|Adverse Event|0
7007616|NCT01449370|11076256|FG021|Overall Study|Adverse Event|1
7007617|NCT01449370|11076257|FG022|Overall Study|Adverse Event|0
7007618|NCT01449370|11076258|FG023|Overall Study|Adverse Event|1
7007619|NCT01449370|11076259|FG024|Overall Study|Adverse Event|3
7007620|NCT01449370|11076235|FG000|Overall Study|Participant Decision|0
7007621|NCT01449370|11076236|FG001|Overall Study|Participant Decision|0
7007622|NCT01449370|11076237|FG002|Overall Study|Participant Decision|0
7007623|NCT01449370|11076238|FG003|Overall Study|Participant Decision|0
7007624|NCT01449370|11076239|FG004|Overall Study|Participant Decision|0
7007625|NCT01449370|11076240|FG005|Overall Study|Participant Decision|0
7007626|NCT01449370|11076241|FG006|Overall Study|Participant Decision|0
7007627|NCT01449370|11076242|FG007|Overall Study|Participant Decision|1
7007628|NCT01449370|11076243|FG008|Overall Study|Participant Decision|1
7007629|NCT01449370|11076244|FG009|Overall Study|Participant Decision|0
7007630|NCT01449370|11076245|FG010|Overall Study|Participant Decision|0
7007631|NCT01449370|11076246|FG011|Overall Study|Participant Decision|0
7007632|NCT01449370|11076247|FG012|Overall Study|Participant Decision|1
7007633|NCT01449370|11076248|FG013|Overall Study|Participant Decision|1
7007634|NCT01449370|11076249|FG014|Overall Study|Participant Decision|0
7007635|NCT01449370|11076250|FG015|Overall Study|Participant Decision|1
7007636|NCT01449370|11076251|FG016|Overall Study|Participant Decision|3
7007637|NCT01449370|11076252|FG017|Overall Study|Participant Decision|0
7007638|NCT01449370|11076253|FG018|Overall Study|Participant Decision|1
7007639|NCT01449370|11076254|FG019|Overall Study|Participant Decision|0
7007640|NCT01449370|11076255|FG020|Overall Study|Participant Decision|0
7007641|NCT01449370|11076256|FG021|Overall Study|Participant Decision|1
7007642|NCT01449370|11076257|FG022|Overall Study|Participant Decision|0
7007643|NCT01449370|11076258|FG023|Overall Study|Participant Decision|0
7007644|NCT01449370|11076259|FG024|Overall Study|Participant Decision|1
7007645|NCT01449370|11076235|FG000|Overall Study|Lost to Follow-up|0
7007646|NCT01449370|11076236|FG001|Overall Study|Lost to Follow-up|0
7007647|NCT01449370|11076237|FG002|Overall Study|Lost to Follow-up|0
7007648|NCT01449370|11076238|FG003|Overall Study|Lost to Follow-up|0
7007649|NCT01449370|11076239|FG004|Overall Study|Lost to Follow-up|0
7007650|NCT01449370|11076240|FG005|Overall Study|Lost to Follow-up|0
7007651|NCT01449370|11076241|FG006|Overall Study|Lost to Follow-up|0
7007652|NCT01449370|11076242|FG007|Overall Study|Lost to Follow-up|0
7007653|NCT01449370|11076243|FG008|Overall Study|Lost to Follow-up|0
7007654|NCT01449370|11076244|FG009|Overall Study|Lost to Follow-up|0
7007655|NCT01449370|11076245|FG010|Overall Study|Lost to Follow-up|0
7007656|NCT01449370|11076246|FG011|Overall Study|Lost to Follow-up|0
7007657|NCT01449370|11076247|FG012|Overall Study|Lost to Follow-up|0
7007658|NCT01449370|11076248|FG013|Overall Study|Lost to Follow-up|0
7007659|NCT01449370|11076249|FG014|Overall Study|Lost to Follow-up|0
7007660|NCT01449370|11076250|FG015|Overall Study|Lost to Follow-up|0
7007661|NCT01449370|11076251|FG016|Overall Study|Lost to Follow-up|0
7007662|NCT01449370|11076252|FG017|Overall Study|Lost to Follow-up|0
7007663|NCT01449370|11076253|FG018|Overall Study|Lost to Follow-up|0
7007664|NCT01449370|11076254|FG019|Overall Study|Lost to Follow-up|0
7007665|NCT01449370|11076255|FG020|Overall Study|Lost to Follow-up|1
7007666|NCT01449370|11076256|FG021|Overall Study|Lost to Follow-up|0
7007667|NCT01449370|11076257|FG022|Overall Study|Lost to Follow-up|0
7007668|NCT01449370|11076258|FG023|Overall Study|Lost to Follow-up|0
7007669|NCT01449370|11076259|FG024|Overall Study|Lost to Follow-up|0
7007670|NCT01449370|11076235|FG000|Overall Study|Other|0
7007671|NCT01449370|11076236|FG001|Overall Study|Other|0
7007672|NCT01449370|11076237|FG002|Overall Study|Other|0
7007673|NCT01449370|11076238|FG003|Overall Study|Other|0
7007674|NCT01449370|11076239|FG004|Overall Study|Other|0
7007675|NCT01449370|11076240|FG005|Overall Study|Other|0
7007676|NCT01449370|11076241|FG006|Overall Study|Other|0
7007677|NCT01449370|11076242|FG007|Overall Study|Other|0
7007678|NCT01449370|11076243|FG008|Overall Study|Other|1
7007679|NCT01449370|11076244|FG009|Overall Study|Other|1
7007680|NCT01449370|11076245|FG010|Overall Study|Other|0
7007681|NCT01449370|11076246|FG011|Overall Study|Other|0
7007682|NCT01449370|11076247|FG012|Overall Study|Other|0
7007683|NCT01449370|11076248|FG013|Overall Study|Other|0
7007684|NCT01449370|11076249|FG014|Overall Study|Other|0
7007685|NCT01449370|11076250|FG015|Overall Study|Other|0
7007686|NCT01449370|11076251|FG016|Overall Study|Other|0
7007687|NCT01449370|11076252|FG017|Overall Study|Other|0
7007688|NCT01449370|11076253|FG018|Overall Study|Other|0
7007689|NCT01449370|11076254|FG019|Overall Study|Other|0
7007690|NCT01449370|11076255|FG020|Overall Study|Other|0
7007691|NCT01449370|11076256|FG021|Overall Study|Other|0
7007692|NCT01449370|11076257|FG022|Overall Study|Other|1
7007693|NCT01449370|11076258|FG023|Overall Study|Other|1
7007694|NCT01449370|11076259|FG024|Overall Study|Other|0
7007695|NCT01449370|11076235|FG000|Overall Study|Medication Prohibited by Protocol|0
7007696|NCT01449370|11076236|FG001|Overall Study|Medication Prohibited by Protocol|0
7007697|NCT01449370|11076237|FG002|Overall Study|Medication Prohibited by Protocol|0
7007698|NCT01449370|11076238|FG003|Overall Study|Medication Prohibited by Protocol|0
7007699|NCT01449370|11076239|FG004|Overall Study|Medication Prohibited by Protocol|0
7007700|NCT01449370|11076240|FG005|Overall Study|Medication Prohibited by Protocol|0
7007701|NCT01449370|11076241|FG006|Overall Study|Medication Prohibited by Protocol|0
7007702|NCT01449370|11076242|FG007|Overall Study|Medication Prohibited by Protocol|0
7007703|NCT01449370|11076243|FG008|Overall Study|Medication Prohibited by Protocol|0
7007704|NCT01449370|11076244|FG009|Overall Study|Medication Prohibited by Protocol|0
7007705|NCT01449370|11076245|FG010|Overall Study|Medication Prohibited by Protocol|0
7007706|NCT01449370|11076246|FG011|Overall Study|Medication Prohibited by Protocol|0
7007707|NCT01449370|11076247|FG012|Overall Study|Medication Prohibited by Protocol|0
7007708|NCT01449370|11076248|FG013|Overall Study|Medication Prohibited by Protocol|0
7007709|NCT01449370|11076249|FG014|Overall Study|Medication Prohibited by Protocol|0
7007710|NCT01449370|11076250|FG015|Overall Study|Medication Prohibited by Protocol|0
7007711|NCT01449370|11076251|FG016|Overall Study|Medication Prohibited by Protocol|0
7007712|NCT01449370|11076252|FG017|Overall Study|Medication Prohibited by Protocol|0
7007713|NCT01449370|11076253|FG018|Overall Study|Medication Prohibited by Protocol|0
7007714|NCT01449370|11076254|FG019|Overall Study|Medication Prohibited by Protocol|0
7007715|NCT01449370|11076255|FG020|Overall Study|Medication Prohibited by Protocol|0
7007716|NCT01449370|11076256|FG021|Overall Study|Medication Prohibited by Protocol|0
7007717|NCT01449370|11076257|FG022|Overall Study|Medication Prohibited by Protocol|0
7007718|NCT01449370|11076258|FG023|Overall Study|Medication Prohibited by Protocol|1
7007719|NCT01449370|11076259|FG024|Overall Study|Medication Prohibited by Protocol|0
7007720|NCT01449370|11076235|FG000|Overall Study|Death|0
7007721|NCT01449370|11076236|FG001|Overall Study|Death|0
7007722|NCT01449370|11076237|FG002|Overall Study|Death|0
7007723|NCT01449370|11076238|FG003|Overall Study|Death|0
7007724|NCT01449370|11076239|FG004|Overall Study|Death|0
7007725|NCT01449370|11076240|FG005|Overall Study|Death|0
7007726|NCT01449370|11076241|FG006|Overall Study|Death|0
7007727|NCT01449370|11076242|FG007|Overall Study|Death|0
7007728|NCT01449370|11076243|FG008|Overall Study|Death|0
7007729|NCT01449370|11076244|FG009|Overall Study|Death|0
7007730|NCT01449370|11076245|FG010|Overall Study|Death|0
7007731|NCT01449370|11076246|FG011|Overall Study|Death|0
7007732|NCT01449370|11076247|FG012|Overall Study|Death|0
7007733|NCT01449370|11076248|FG013|Overall Study|Death|0
7007734|NCT01449370|11076249|FG014|Overall Study|Death|0
7007735|NCT01449370|11076250|FG015|Overall Study|Death|0
7007736|NCT01449370|11076251|FG016|Overall Study|Death|0
7007737|NCT01449370|11076252|FG017|Overall Study|Death|0
7007738|NCT01449370|11076253|FG018|Overall Study|Death|0
7007739|NCT01449370|11076254|FG019|Overall Study|Death|0
7007740|NCT01449370|11076255|FG020|Overall Study|Death|0
7007741|NCT01449370|11076256|FG021|Overall Study|Death|0
7007742|NCT01449370|11076257|FG022|Overall Study|Death|0
7007743|NCT01449370|11076258|FG023|Overall Study|Death|0
7007744|NCT01449370|11076259|FG024|Overall Study|Death|1
7007745|NCT01449461|11076338|FG000|Overall Study|Adverse Event|0
7007746|NCT01449461|11076339|FG001|Overall Study|Adverse Event|3
7007747|NCT01449461|11076340|FG002|Overall Study|Adverse Event|2
7007748|NCT01449461|11076341|FG003|Overall Study|Adverse Event|3
7007749|NCT01449461|11076342|FG004|Overall Study|Adverse Event|4
7007750|NCT01449461|11076343|FG005|Overall Study|Adverse Event|4
7007751|NCT01449461|11076338|FG000|Overall Study|Death|0
7007752|NCT01449461|11076339|FG001|Overall Study|Death|2
7007753|NCT01449461|11076340|FG002|Overall Study|Death|0
7007754|NCT01449461|11076341|FG003|Overall Study|Death|0
7007755|NCT01449461|11076342|FG004|Overall Study|Death|7
7007756|NCT01449461|11076343|FG005|Overall Study|Death|1
7007757|NCT01449461|11076338|FG000|Overall Study|Physician Decision|0
7007758|NCT01449461|11076339|FG001|Overall Study|Physician Decision|1
7007759|NCT01449461|11076340|FG002|Overall Study|Physician Decision|0
7007760|NCT01449461|11076341|FG003|Overall Study|Physician Decision|4
7007761|NCT01449461|11076342|FG004|Overall Study|Physician Decision|1
7007762|NCT01449461|11076343|FG005|Overall Study|Physician Decision|0
7007763|NCT01449461|11076338|FG000|Overall Study|Documented Progressive Disease|4
7007764|NCT01449461|11076339|FG001|Overall Study|Documented Progressive Disease|7
7007765|NCT01449461|11076340|FG002|Overall Study|Documented Progressive Disease|14
7007766|NCT01449461|11076341|FG003|Overall Study|Documented Progressive Disease|15
7007767|NCT01449461|11076342|FG004|Overall Study|Documented Progressive Disease|24
7007768|NCT01449461|11076343|FG005|Overall Study|Documented Progressive Disease|5
7007769|NCT01449461|11076338|FG000|Overall Study|Clinical Progressive Disease|2
7007770|NCT01449461|11076339|FG001|Overall Study|Clinical Progressive Disease|2
7007771|NCT01449461|11076340|FG002|Overall Study|Clinical Progressive Disease|0
7007772|NCT01449461|11076341|FG003|Overall Study|Clinical Progressive Disease|3
7007773|NCT01449461|11076342|FG004|Overall Study|Clinical Progressive Disease|4
7007774|NCT01449461|11076343|FG005|Overall Study|Clinical Progressive Disease|2
7007775|NCT01449461|11076338|FG000|Overall Study|Protocol Violation|0
7007776|NCT01449461|11076339|FG001|Overall Study|Protocol Violation|0
7007777|NCT01449461|11076340|FG002|Overall Study|Protocol Violation|0
7007778|NCT01449461|11076341|FG003|Overall Study|Protocol Violation|1
7007779|NCT01449461|11076342|FG004|Overall Study|Protocol Violation|0
7007780|NCT01449461|11076343|FG005|Overall Study|Protocol Violation|0
7007781|NCT01449461|11076338|FG000|Overall Study|Site Terminated by Sponsor|0
7007782|NCT01449461|11076339|FG001|Overall Study|Site Terminated by Sponsor|1
7007783|NCT01449461|11076340|FG002|Overall Study|Site Terminated by Sponsor|2
7007784|NCT01449461|11076341|FG003|Overall Study|Site Terminated by Sponsor|3
7007785|NCT01449461|11076342|FG004|Overall Study|Site Terminated by Sponsor|4
7007786|NCT01449461|11076343|FG005|Overall Study|Site Terminated by Sponsor|1
7007787|NCT01449461|11076338|FG000|Overall Study|Withdrawal by Subject|0
7007788|NCT01449461|11076339|FG001|Overall Study|Withdrawal by Subject|1
7007789|NCT01449461|11076340|FG002|Overall Study|Withdrawal by Subject|0
7007790|NCT01449461|11076341|FG003|Overall Study|Withdrawal by Subject|0
7007791|NCT01449461|11076342|FG004|Overall Study|Withdrawal by Subject|2
7007792|NCT01449461|11076343|FG005|Overall Study|Withdrawal by Subject|1
7007793|NCT01449461|11076338|FG000|Overall Study|Reason not Specified|0
7007794|NCT01449461|11076339|FG001|Overall Study|Reason not Specified|1
7007795|NCT01449461|11076340|FG002|Overall Study|Reason not Specified|0
7007796|NCT01449461|11076341|FG003|Overall Study|Reason not Specified|3
7007797|NCT01449461|11076342|FG004|Overall Study|Reason not Specified|2
7007798|NCT01449461|11076343|FG005|Overall Study|Reason not Specified|1
7007799|NCT01449526|11076377|FG000|Overall Study|Lost to Follow-up|1
7007800|NCT01449526|11076378|FG001|Overall Study|Lost to Follow-up|2
7007801|NCT01449526|11076377|FG000|Overall Study|Withdrawal by Subject|1
7007802|NCT01449526|11076378|FG001|Overall Study|Withdrawal by Subject|1
7007803|NCT01449526|11076377|FG000|Overall Study|Symptoms/complaints|0
7007804|NCT01449526|11076378|FG001|Overall Study|Symptoms/complaints|1
7007805|NCT01449526|11076377|FG000|Overall Study|Lack of Motivation|0
7007806|NCT01449526|11076378|FG001|Overall Study|Lack of Motivation|1
7007807|NCT01449526|11076377|FG000|Overall Study|Cannot maintain visits|0
7007808|NCT01449526|11076378|FG001|Overall Study|Cannot maintain visits|1
7007809|NCT01449539|11076384|FG000|Overall Study|Withdrawal by Subject|3
7007810|NCT01449539|11076384|FG000|Overall Study|Toxicity not study related|1
7007811|NCT01449630|11076397|FG000|Period 1|Physician Decision|1
7007812|NCT01449630|11076398|FG001|Period 1|Physician Decision|0
7007813|NCT01449630|11076399|FG002|Period 1|Physician Decision|0
7007814|NCT01449630|11076400|FG003|Period 1|Physician Decision|1
7007815|NCT01449630|11076401|FG004|Period 1|Physician Decision|0
7007816|NCT01449630|11076402|FG005|Period 1|Physician Decision|0
7007817|NCT01449630|11076403|FG006|Period 1|Physician Decision|0
7007818|NCT01449630|11076404|FG007|Period 1|Physician Decision|0
7007819|NCT01449630|11076405|FG008|Period 1|Physician Decision|0
7007820|NCT01449630|11076397|FG000|Period 1|Sponsor Decision|0
7007821|NCT01449630|11076398|FG001|Period 1|Sponsor Decision|0
7007822|NCT01449630|11076399|FG002|Period 1|Sponsor Decision|0
7007823|NCT01449630|11076400|FG003|Period 1|Sponsor Decision|0
7007824|NCT01449630|11076401|FG004|Period 1|Sponsor Decision|0
7007825|NCT01449630|11076402|FG005|Period 1|Sponsor Decision|1
7007826|NCT01449630|11076403|FG006|Period 1|Sponsor Decision|0
7007827|NCT01449630|11076404|FG007|Period 1|Sponsor Decision|0
7007828|NCT01449630|11076405|FG008|Period 1|Sponsor Decision|0
7007829|NCT01449630|11076397|FG000|Period 2|Sponsor Decision|0
7007830|NCT01449630|11076398|FG001|Period 2|Sponsor Decision|0
7007831|NCT01449630|11076399|FG002|Period 2|Sponsor Decision|0
7007832|NCT01449630|11076400|FG003|Period 2|Sponsor Decision|0
7007833|NCT01449630|11076401|FG004|Period 2|Sponsor Decision|0
7007834|NCT01449630|11076402|FG005|Period 2|Sponsor Decision|0
7007835|NCT01449630|11076403|FG006|Period 2|Sponsor Decision|1
7007836|NCT01449630|11076404|FG007|Period 2|Sponsor Decision|0
7007837|NCT01449630|11076405|FG008|Period 2|Sponsor Decision|0
7007838|NCT01449682|11076429|FG000|Overall Study|Death|0
7007839|NCT01449682|11076430|FG001|Overall Study|Death|1
7007840|NCT01449682|11076429|FG000|Overall Study|Adverse Event|1
7007841|NCT01449682|11076430|FG001|Overall Study|Adverse Event|0
7007842|NCT01449708|11076438|FG000|Overall Study|Protocol Violation|0
7007843|NCT01449708|11076439|FG001|Overall Study|Protocol Violation|1
7007844|NCT01449708|11076438|FG000|Overall Study|surgical complication|1
7007845|NCT01449708|11076439|FG001|Overall Study|surgical complication|2
7007846|NCT01449708|11076438|FG000|Overall Study|respiratory failure|1
7007847|NCT01449708|11076439|FG001|Overall Study|respiratory failure|0
7007848|NCT01449721|11076450|FG000|Overall Study|Physician Decision|0
7007849|NCT01449721|11076451|FG001|Overall Study|Physician Decision|1
7007850|NCT01449721|11076450|FG000|Overall Study|Physician Decision|0
7007851|NCT01449721|11076451|FG001|Overall Study|Physician Decision|1
7007852|NCT01449812|11076473|FG000|Overall Study|Migrated/moved from study area|1
7007853|NCT01449812|11076474|FG001|Overall Study|Migrated/moved from study area|0
7007854|NCT01449812|11076475|FG002|Overall Study|Migrated/moved from study area|0
7007855|NCT01449812|11076473|FG000|Overall Study|Withdrawal by Subject|0
7007856|NCT01449812|11076474|FG001|Overall Study|Withdrawal by Subject|0
7007857|NCT01449812|11076475|FG002|Overall Study|Withdrawal by Subject|1
7007858|NCT01449812|11076473|FG000|Overall Study|Lost to Follow-up|1
7007859|NCT01449812|11076474|FG001|Overall Study|Lost to Follow-up|0
7007860|NCT01449812|11076475|FG002|Overall Study|Lost to Follow-up|0
7007861|NCT01449929|11076489|FG000|Randomization Phase 96 Week|Adverse Event|5
7007862|NCT01449929|11076490|FG001|Randomization Phase 96 Week|Adverse Event|13
7007863|NCT01449929|11076491|FG002|Randomization Phase 96 Week|Adverse Event|0
7007864|NCT01449929|11076489|FG000|Randomization Phase 96 Week|Lack of Efficacy|3
7007865|NCT01449929|11076490|FG001|Randomization Phase 96 Week|Lack of Efficacy|4
7007866|NCT01449929|11076491|FG002|Randomization Phase 96 Week|Lack of Efficacy|0
7007867|NCT01449929|11076489|FG000|Randomization Phase 96 Week|Protocol Violation|5
7007868|NCT01449929|11076490|FG001|Randomization Phase 96 Week|Protocol Violation|6
7007869|NCT01449929|11076491|FG002|Randomization Phase 96 Week|Protocol Violation|0
7007870|NCT01449929|11076489|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1
7007871|NCT01449929|11076490|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
7007872|NCT01449929|11076491|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
7007873|NCT01449929|11076489|FG000|Randomization Phase 96 Week|Lost to Follow-up|15
7007874|NCT01449929|11076490|FG001|Randomization Phase 96 Week|Lost to Follow-up|18
7007875|NCT01449929|11076491|FG002|Randomization Phase 96 Week|Lost to Follow-up|0
7007876|NCT01449929|11076489|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2
7007877|NCT01449929|11076490|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8
7007878|NCT01449929|11076491|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0
7007879|NCT01449929|11076489|FG000|Randomization Phase 96 Week|Physician Decision|2
7007880|NCT01449929|11076490|FG001|Randomization Phase 96 Week|Physician Decision|3
7007881|NCT01449929|11076491|FG002|Randomization Phase 96 Week|Physician Decision|0
7007882|NCT01449929|11076489|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0
7007883|NCT01449929|11076490|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1
7007884|NCT01449929|11076491|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0
7007885|NCT01449929|11076489|FG000|Extension Phase Approximately 3 Years|Adverse Event|0
7007886|NCT01449929|11076490|FG001|Extension Phase Approximately 3 Years|Adverse Event|0
7007887|NCT01449929|11076491|FG002|Extension Phase Approximately 3 Years|Adverse Event|2
7007888|NCT01449929|11076489|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0
7007889|NCT01449929|11076490|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0
7007890|NCT01449929|11076491|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2
7007891|NCT01449929|11076489|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0
7007892|NCT01449929|11076490|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0
7007893|NCT01449929|11076491|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4
7007894|NCT01449955|11076503|FG000|Overall Study|Withdrawal by Subject|1
7007895|NCT01449955|11076504|FG001|Overall Study|Withdrawal by Subject|2
7007896|NCT01450007|11076520|FG000|Overall Study|Late exclusion before treatment|2
7007897|NCT01450007|11076521|FG001|Overall Study|Late exclusion before treatment|3
7007898|NCT01450007|11076522|FG002|Overall Study|Late exclusion before treatment|2
7007899|NCT01450007|11076520|FG000|Overall Study|Protocol Violation|0
7007900|NCT01450007|11076521|FG001|Overall Study|Protocol Violation|1
7007901|NCT01450007|11076522|FG002|Overall Study|Protocol Violation|1
7007902|NCT01450007|11076520|FG000|Overall Study|Adverse Event|0
7007903|NCT01450007|11076521|FG001|Overall Study|Adverse Event|1
7007904|NCT01450007|11076522|FG002|Overall Study|Adverse Event|0
7007905|NCT01450098|11076532|FG000|Period 3|Protocol Violation|0
7007906|NCT01450098|11076533|FG001|Period 3|Protocol Violation|1
7007907|NCT01450098|11076532|FG000|Period 3|Withdrawal by Subject|0
7007908|NCT01450098|11076533|FG001|Period 3|Withdrawal by Subject|2
7007909|NCT01450137|11076548|FG000|Up to Week 12|Adverse Event|2
7007910|NCT01450137|11076549|FG001|Up to Week 12|Adverse Event|1
7007911|NCT01450137|11076548|FG000|Up to Week 12|Withdrawal by Subject|0
7007912|NCT01450137|11076549|FG001|Up to Week 12|Withdrawal by Subject|2
7007913|NCT01450137|11076548|FG000|Week 12 to Study End|Death|0
7007914|NCT01450137|11076549|FG001|Week 12 to Study End|Death|1
7007915|NCT01450137|11076548|FG000|Week 12 to Study End|Withdrawal by Subject|0
7007916|NCT01450137|11076549|FG001|Week 12 to Study End|Withdrawal by Subject|1
7007917|NCT01450540|11076594|FG000|Overall Study|Withdrawal by Subject|19
7007918|NCT01450540|11076595|FG001|Overall Study|Withdrawal by Subject|13
7007919|NCT01450540|11076594|FG000|Overall Study|protocol deviation|3
7007920|NCT01450540|11076595|FG001|Overall Study|protocol deviation|23
7007921|NCT01450631|11076605|FG000|Overall Study|Lost to Follow-up|2
7007922|NCT01450631|11076606|FG001|Overall Study|Lost to Follow-up|4
7007923|NCT01450631|11076605|FG000|Overall Study|Withdrawal by Subject|1
7007924|NCT01450631|11076606|FG001|Overall Study|Withdrawal by Subject|0
7007925|NCT01450683|11076612|FG000|Overall Study|Adverse Event|2
7007926|NCT01450696|11076618|FG000|Overall Study|Never Treated|1
7007927|NCT01450696|11076619|FG001|Overall Study|Never Treated|1
7007928|NCT01450696|11076618|FG000|Overall Study|Death|77
7007929|NCT01450696|11076619|FG001|Overall Study|Death|84
7007930|NCT01450696|11076618|FG000|Overall Study|Lost to Follow-up|3
7007931|NCT01450696|11076619|FG001|Overall Study|Lost to Follow-up|3
7007932|NCT01450696|11076618|FG000|Overall Study|Non-Compliance|1
7007933|NCT01450696|11076619|FG001|Overall Study|Non-Compliance|0
7007934|NCT01450696|11076618|FG000|Overall Study|Withdrawal by Subject|13
7007935|NCT01450696|11076619|FG001|Overall Study|Withdrawal by Subject|2
7007936|NCT01450696|11076618|FG000|Overall Study|Study Terminated by Sponsor|53
7007937|NCT01450696|11076619|FG001|Overall Study|Study Terminated by Sponsor|58
7007938|NCT01450761|11076627|FG000|Randomization|Subject no longer meets study criteria|1
7007939|NCT01450761|11076628|FG001|Randomization|Subject no longer meets study criteria|2
7007940|NCT01450761|11076627|FG000|Randomization|Withdrawal by Subject|2
7007941|NCT01450761|11076628|FG001|Randomization|Withdrawal by Subject|0
7007942|NCT01450761|11076627|FG000|Randomization|Disease progression|0
7007943|NCT01450761|11076628|FG001|Randomization|Disease progression|2
7007944|NCT01450761|11076627|FG000|Randomization|Adverse Event unrelated to study drug|1
7007945|NCT01450761|11076628|FG001|Randomization|Adverse Event unrelated to study drug|0
7007946|NCT01450761|11076627|FG000|Randomization|Other|0
7007947|NCT01450761|11076628|FG001|Randomization|Other|1
7007948|NCT01450761|11076627|FG000|Lead-in Chemotherapy|Disease progression|33
7007949|NCT01450761|11076628|FG001|Lead-in Chemotherapy|Disease progression|32
7007950|NCT01450761|11076627|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21
7007951|NCT01450761|11076628|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19
7007952|NCT01450761|11076627|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14
7007953|NCT01450761|11076628|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12
7007954|NCT01450761|11076627|FG000|Lead-in Chemotherapy|Study drug toxicity|6
7007955|NCT01450761|11076628|FG001|Lead-in Chemotherapy|Study drug toxicity|10
7007956|NCT01450761|11076627|FG000|Lead-in Chemotherapy|No longer meets study criteria|3
7007957|NCT01450761|11076628|FG001|Lead-in Chemotherapy|No longer meets study criteria|7
7007958|NCT01450761|11076627|FG000|Lead-in Chemotherapy|Death|3
7007959|NCT01450761|11076628|FG001|Lead-in Chemotherapy|Death|3
7007960|NCT01450761|11076627|FG000|Lead-in Chemotherapy|Other|2
7007961|NCT01450761|11076628|FG001|Lead-in Chemotherapy|Other|2
7007962|NCT01450761|11076627|FG000|Lead-in Chemotherapy|Lost to Follow-up|2
7007963|NCT01450761|11076628|FG001|Lead-in Chemotherapy|Lost to Follow-up|0
7007964|NCT01450761|11076627|FG000|Treatment With Blinded Study Therapy|Disease progression|318
7007965|NCT01450761|11076628|FG001|Treatment With Blinded Study Therapy|Disease progression|415
7007966|NCT01450761|11076627|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87
7007967|NCT01450761|11076628|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9
7007968|NCT01450761|11076627|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27
7007969|NCT01450761|11076628|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19
7007970|NCT01450761|11076627|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15
7007971|NCT01450761|11076628|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8
7007972|NCT01450761|11076627|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12
7007973|NCT01450761|11076628|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5
7007974|NCT01450761|11076627|FG000|Treatment With Blinded Study Therapy|Death|5
7007975|NCT01450761|11076628|FG001|Treatment With Blinded Study Therapy|Death|6
7007976|NCT01450761|11076627|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5
7007977|NCT01450761|11076628|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4
7007978|NCT01450761|11076627|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2
7007979|NCT01450761|11076628|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1
7007980|NCT01450761|11076627|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1
7007981|NCT01450761|11076628|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2
7007982|NCT01450761|11076627|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1
7007983|NCT01450761|11076628|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2
7007984|NCT01450761|11076627|FG000|Treatment With Blinded Study Therapy|Not reported|2
7007985|NCT01450761|11076628|FG001|Treatment With Blinded Study Therapy|Not reported|2
7007986|NCT01450761|11076627|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1
7007987|NCT01450761|11076628|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0
7007988|NCT01450761|11076627|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2
7007989|NCT01450761|11076628|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3
7007990|NCT01450800|11076645|FG000|Overall Study|Protocol Violation|1
7007991|NCT01450800|11076646|FG001|Overall Study|Protocol Violation|3
7007992|NCT01450813|11076658|FG000|Overall Study|Physician Decision|1
7007993|NCT01450813|11076659|FG001|Overall Study|Physician Decision|1
7007994|NCT01450813|11076660|FG002|Overall Study|Physician Decision|0
7007995|NCT01450813|11076661|FG003|Overall Study|Physician Decision|3
7007996|NCT01450943|11076685|FG000|Overall Study|Screen failure, loss to follow-up|2
7007997|NCT01450943|11076686|FG001|Overall Study|Screen failure, loss to follow-up|7
7007998|NCT01450943|11076687|FG002|Overall Study|Screen failure, loss to follow-up|6
7043175|NCT01741012|11127845|FG000|Overall Study|Withdrawal by Subject|2
7043176|NCT01741259|11127852|FG000|Overall Study|Protocol Violation|6
7043177|NCT01741259|11127853|FG001|Overall Study|Protocol Violation|4
7043178|NCT01741259|11127852|FG000|Overall Study|Withdrawal by Subject|0
7043179|NCT01741259|11127853|FG001|Overall Study|Withdrawal by Subject|2
7043180|NCT01741532|11127900|FG000|Overall Study|Adverse Event|4
7043181|NCT01741532|11127901|FG001|Overall Study|Adverse Event|0
7043182|NCT01741532|11127900|FG000|Overall Study|Withdrawal by Subject|1
7043183|NCT01741532|11127901|FG001|Overall Study|Withdrawal by Subject|1
7043184|NCT01741532|11127900|FG000|Overall Study|Protocol Violation|0
7043185|NCT01741532|11127901|FG001|Overall Study|Protocol Violation|1
7043186|NCT01741532|11127900|FG000|Overall Study|Worsening of the disease|3
7043187|NCT01741532|11127901|FG001|Overall Study|Worsening of the disease|1
7043188|NCT01741532|11127900|FG000|Overall Study|Sponsor decision|1
7043189|NCT01741532|11127901|FG001|Overall Study|Sponsor decision|0
7043190|NCT01741532|11127900|FG000|Overall Study|Medical event|1
7043191|NCT01741532|11127901|FG001|Overall Study|Medical event|0
7043192|NCT01741545|11127913|FG000|Treatment Period|Lack of Efficacy|0
7043193|NCT01741545|11127914|FG001|Treatment Period|Lack of Efficacy|1
7043194|NCT01741545|11127913|FG000|Treatment Period|Adverse event, non-fatal|1
7043195|NCT01741545|11127914|FG001|Treatment Period|Adverse event, non-fatal|3
7043196|NCT01741545|11127913|FG000|Follow-up Period (24 Weeks)|Other than specified|0
7043197|NCT01741545|11127914|FG001|Follow-up Period (24 Weeks)|Other than specified|1
7043198|NCT01741545|11127913|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
7043199|NCT01741545|11127914|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
7043200|NCT01741688|11127920|FG000|Overall Study|Lack of insurance coverage|2
7043201|NCT01741688|11127920|FG000|Overall Study|Withdrawal by Subject|1
7043202|NCT01741701|11127927|FG000|Overall Study|Adverse Event|5
7043203|NCT01741701|11127928|FG001|Overall Study|Adverse Event|1
7043204|NCT01741701|11127927|FG000|Overall Study|Withdrawal by Subject|0
7043205|NCT01741701|11127928|FG001|Overall Study|Withdrawal by Subject|1
7043206|NCT01741792|11127937|FG000|Overall Study|Death|6
7043207|NCT01741792|11127938|FG001|Overall Study|Death|1
7043208|NCT01741792|11127939|FG002|Overall Study|Death|12
7043209|NCT01742078|11127971|FG000|Overall Study|Withdrawal by Subject|0
7043210|NCT01742078|11127972|FG001|Overall Study|Withdrawal by Subject|0
7043211|NCT01742078|11127973|FG002|Overall Study|Withdrawal by Subject|0
7043212|NCT01742078|11127974|FG003|Overall Study|Withdrawal by Subject|1
7043213|NCT01742078|11127975|FG004|Overall Study|Withdrawal by Subject|0
7043214|NCT01742078|11127976|FG005|Overall Study|Withdrawal by Subject|0
7043215|NCT01742078|11127977|FG006|Overall Study|Withdrawal by Subject|0
7043216|NCT01742078|11127978|FG007|Overall Study|Withdrawal by Subject|0
7043217|NCT01742078|11127979|FG008|Overall Study|Withdrawal by Subject|0
7043218|NCT01742091|11128007|FG000|Overall Study|Adverse Event|0
7043219|NCT01742091|11128008|FG001|Overall Study|Adverse Event|0
7043220|NCT01742091|11128009|FG002|Overall Study|Adverse Event|0
7043221|NCT01742091|11128010|FG003|Overall Study|Adverse Event|0
7043222|NCT01742091|11128011|FG004|Overall Study|Adverse Event|1
7043223|NCT01742091|11128012|FG005|Overall Study|Adverse Event|0
7043224|NCT01742091|11128007|FG000|Overall Study|Physician Decision|0
7043225|NCT01742091|11128008|FG001|Overall Study|Physician Decision|0
7043226|NCT01742091|11128009|FG002|Overall Study|Physician Decision|0
7043227|NCT01742091|11128010|FG003|Overall Study|Physician Decision|0
7043228|NCT01742091|11128011|FG004|Overall Study|Physician Decision|0
7043229|NCT01742091|11128012|FG005|Overall Study|Physician Decision|1
7043230|NCT01742091|11128007|FG000|Overall Study|Withdrawal by Subject|0
7043231|NCT01742091|11128008|FG001|Overall Study|Withdrawal by Subject|0
7043232|NCT01742091|11128009|FG002|Overall Study|Withdrawal by Subject|0
7043233|NCT01742091|11128010|FG003|Overall Study|Withdrawal by Subject|1
7043234|NCT01742091|11128011|FG004|Overall Study|Withdrawal by Subject|0
7043235|NCT01742091|11128012|FG005|Overall Study|Withdrawal by Subject|0
7043236|NCT01742091|11128007|FG000|Overall Study|Lost to Follow-up|0
7043237|NCT01742091|11128008|FG001|Overall Study|Lost to Follow-up|0
7043238|NCT01742091|11128009|FG002|Overall Study|Lost to Follow-up|0
7043239|NCT01742091|11128010|FG003|Overall Study|Lost to Follow-up|0
7043240|NCT01742091|11128011|FG004|Overall Study|Lost to Follow-up|0
7043241|NCT01742091|11128012|FG005|Overall Study|Lost to Follow-up|1
7043242|NCT01742286|11128057|FG000|Escalation Phase|Administrative problems|1
7043243|NCT01742286|11128058|FG001|Escalation Phase|Administrative problems|1
7043244|NCT01742286|11128059|FG002|Escalation Phase|Administrative problems|0
7043245|NCT01742286|11128060|FG003|Escalation Phase|Administrative problems|0
7043246|NCT01742286|11128061|FG004|Escalation Phase|Administrative problems|0
7043247|NCT01742286|11128062|FG005|Escalation Phase|Administrative problems|0
7043248|NCT01742286|11128063|FG006|Escalation Phase|Administrative problems|2
7043249|NCT01742286|11128057|FG000|Escalation Phase|Adverse Event|0
7043250|NCT01742286|11128058|FG001|Escalation Phase|Adverse Event|1
7043251|NCT01742286|11128059|FG002|Escalation Phase|Adverse Event|2
7043252|NCT01742286|11128060|FG003|Escalation Phase|Adverse Event|0
7043253|NCT01742286|11128061|FG004|Escalation Phase|Adverse Event|0
7043254|NCT01742286|11128062|FG005|Escalation Phase|Adverse Event|1
7007999|NCT01451164|11076703|FG000|Overall Study|Adverse Event|19
7008000|NCT01451164|11076704|FG001|Overall Study|Adverse Event|12
7008001|NCT01451164|11076705|FG002|Overall Study|Adverse Event|18
7008002|NCT01451164|11076706|FG003|Overall Study|Adverse Event|21
7008003|NCT01451164|11076703|FG000|Overall Study|Withdrawal Criteria|1
7008004|NCT01451164|11076704|FG001|Overall Study|Withdrawal Criteria|1
7008005|NCT01451164|11076705|FG002|Overall Study|Withdrawal Criteria|1
7008006|NCT01451164|11076706|FG003|Overall Study|Withdrawal Criteria|1
7008007|NCT01451164|11076703|FG000|Overall Study|Physician Decision|2
7008008|NCT01451164|11076704|FG001|Overall Study|Physician Decision|0
7008009|NCT01451164|11076705|FG002|Overall Study|Physician Decision|1
7008010|NCT01451164|11076706|FG003|Overall Study|Physician Decision|0
7008011|NCT01451164|11076703|FG000|Overall Study|Withdrawal by Subject|14
7008012|NCT01451164|11076704|FG001|Overall Study|Withdrawal by Subject|11
7008013|NCT01451164|11076705|FG002|Overall Study|Withdrawal by Subject|16
7008014|NCT01451164|11076706|FG003|Overall Study|Withdrawal by Subject|17
7008015|NCT01451164|11076703|FG000|Overall Study|Protocol Violation|0
7008016|NCT01451164|11076704|FG001|Overall Study|Protocol Violation|1
7008017|NCT01451164|11076705|FG002|Overall Study|Protocol Violation|0
7008018|NCT01451164|11076706|FG003|Overall Study|Protocol Violation|0
7008019|NCT01451164|11076703|FG000|Overall Study|Lack of Efficacy|7
7008020|NCT01451164|11076704|FG001|Overall Study|Lack of Efficacy|9
7008021|NCT01451164|11076705|FG002|Overall Study|Lack of Efficacy|9
7008022|NCT01451164|11076706|FG003|Overall Study|Lack of Efficacy|7
7008023|NCT01451203|11076718|FG000|Double-blind Treatment Period|Did not receive treatment|1
7008024|NCT01451203|11076719|FG001|Double-blind Treatment Period|Did not receive treatment|2
7008025|NCT01451203|11076718|FG000|Double-blind Treatment Period|Consent Withdrawn|3
7008026|NCT01451203|11076719|FG001|Double-blind Treatment Period|Consent Withdrawn|2
7008027|NCT01451203|11076718|FG000|Double-blind Treatment Period|Lack of Efficacy|71
7008028|NCT01451203|11076719|FG001|Double-blind Treatment Period|Lack of Efficacy|36
7008029|NCT01451203|11076718|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0
7008030|NCT01451203|11076719|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1
7008031|NCT01451203|11076718|FG000|Double-blind Treatment Period|Adverse Event|6
7008032|NCT01451203|11076719|FG001|Double-blind Treatment Period|Adverse Event|9
7008033|NCT01451203|11076718|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1
7008034|NCT01451203|11076719|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0
7008035|NCT01451203|11076718|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1
7008036|NCT01451203|11076719|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0
7008037|NCT01451203|11076718|FG000|Double-blind Treatment Period|Investigator decision|2
7008038|NCT01451203|11076719|FG001|Double-blind Treatment Period|Investigator decision|0
7008039|NCT01451203|11076718|FG000|Post-treatment Period|Consent withdrawn|2
7008040|NCT01451203|11076719|FG001|Post-treatment Period|Consent withdrawn|4
7008041|NCT01451203|11076718|FG000|Post-treatment Period|Lack of Efficacy|12
7008042|NCT01451203|11076719|FG001|Post-treatment Period|Lack of Efficacy|28
7008043|NCT01451203|11076718|FG000|Post-treatment Period|Adverse Event|0
7008044|NCT01451203|11076719|FG001|Post-treatment Period|Adverse Event|1
7008045|NCT01451203|11076718|FG000|Post-treatment Period|Investigator decision|0
7008046|NCT01451203|11076719|FG001|Post-treatment Period|Investigator decision|1
7008047|NCT01451398|11076735|FG000|Overall Study|Adverse Event|7
7008048|NCT01451398|11076736|FG001|Overall Study|Adverse Event|9
7008049|NCT01451398|11076735|FG000|Overall Study|Protocol Violation|1
7008050|NCT01451398|11076736|FG001|Overall Study|Protocol Violation|2
7008051|NCT01451398|11076735|FG000|Overall Study|Physician Decision|1
7008052|NCT01451398|11076736|FG001|Overall Study|Physician Decision|1
7008053|NCT01451398|11076735|FG000|Overall Study|Withdrawal by Subject|10
7008054|NCT01451398|11076736|FG001|Overall Study|Withdrawal by Subject|14
7008055|NCT01451398|11076735|FG000|Overall Study|Lost to Follow-up|6
7008056|NCT01451398|11076736|FG001|Overall Study|Lost to Follow-up|4
7008057|NCT01451398|11076735|FG000|Overall Study|Non-compliance with study drug|1
7008058|NCT01451398|11076736|FG001|Overall Study|Non-compliance with study drug|3
7008059|NCT01451398|11076735|FG000|Overall Study|Non-compliance with protocol|1
7008060|NCT01451398|11076736|FG001|Overall Study|Non-compliance with protocol|1
7008061|NCT01451398|11076735|FG000|Overall Study|Moved out of country|0
7008062|NCT01451398|11076736|FG001|Overall Study|Moved out of country|1
7008063|NCT01451398|11076735|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0
7008064|NCT01451398|11076736|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1
7008065|NCT01451398|11076735|FG000|Overall Study|Lack of Efficacy|0
7008066|NCT01451398|11076736|FG001|Overall Study|Lack of Efficacy|1
7008067|NCT01451424|11076755|FG000|Overall Study|Withdrawal by Subject|1
7008068|NCT01451424|11076756|FG001|Overall Study|Withdrawal by Subject|1
7008069|NCT01451424|11076757|FG002|Overall Study|Withdrawal by Subject|0
7008070|NCT01451424|11076758|FG003|Overall Study|Withdrawal by Subject|2
7008071|NCT01451424|11076755|FG000|Overall Study|Lost to Follow-up|0
7008072|NCT01451424|11076756|FG001|Overall Study|Lost to Follow-up|1
7008073|NCT01451424|11076757|FG002|Overall Study|Lost to Follow-up|0
7008074|NCT01451424|11076758|FG003|Overall Study|Lost to Follow-up|1
7008075|NCT01451424|11076755|FG000|Overall Study|Physician Decision|0
7008076|NCT01451424|11076756|FG001|Overall Study|Physician Decision|0
7008077|NCT01451424|11076757|FG002|Overall Study|Physician Decision|1
7008078|NCT01451424|11076758|FG003|Overall Study|Physician Decision|1
7008079|NCT01451424|11076755|FG000|Overall Study|Adverse Event|0
7008080|NCT01451424|11076756|FG001|Overall Study|Adverse Event|0
7008081|NCT01451424|11076757|FG002|Overall Study|Adverse Event|0
7008082|NCT01451424|11076758|FG003|Overall Study|Adverse Event|1
7008083|NCT01451437|11076782|FG000|Overall Study|Adverse Event|0
7008084|NCT01451437|11076783|FG001|Overall Study|Adverse Event|0
7008085|NCT01451437|11076784|FG002|Overall Study|Adverse Event|0
7008086|NCT01451437|11076785|FG003|Overall Study|Adverse Event|0
7008087|NCT01451437|11076786|FG004|Overall Study|Adverse Event|0
7008088|NCT01451437|11076787|FG005|Overall Study|Adverse Event|1
7008089|NCT01451437|11076788|FG006|Overall Study|Adverse Event|1
7008090|NCT01451437|11076789|FG007|Overall Study|Adverse Event|2
7008091|NCT01451437|11076790|FG008|Overall Study|Adverse Event|1
7008092|NCT01451437|11076782|FG000|Overall Study|Physician Decision|1
7008093|NCT01451437|11076783|FG001|Overall Study|Physician Decision|1
7008094|NCT01451437|11076784|FG002|Overall Study|Physician Decision|2
7008095|NCT01451437|11076785|FG003|Overall Study|Physician Decision|0
7008096|NCT01451437|11076786|FG004|Overall Study|Physician Decision|0
7008097|NCT01451437|11076787|FG005|Overall Study|Physician Decision|0
7008098|NCT01451437|11076788|FG006|Overall Study|Physician Decision|0
7008099|NCT01451437|11076789|FG007|Overall Study|Physician Decision|0
7008100|NCT01451437|11076790|FG008|Overall Study|Physician Decision|0
7008101|NCT01451437|11076782|FG000|Overall Study|Disease Progression|0
7008102|NCT01451437|11076783|FG001|Overall Study|Disease Progression|0
7008103|NCT01451437|11076784|FG002|Overall Study|Disease Progression|1
7008104|NCT01451437|11076785|FG003|Overall Study|Disease Progression|1
7008105|NCT01451437|11076786|FG004|Overall Study|Disease Progression|3
7008106|NCT01451437|11076787|FG005|Overall Study|Disease Progression|2
7008107|NCT01451437|11076788|FG006|Overall Study|Disease Progression|3
7008108|NCT01451437|11076789|FG007|Overall Study|Disease Progression|1
7008109|NCT01451437|11076790|FG008|Overall Study|Disease Progression|3
7008110|NCT01451437|11076782|FG000|Overall Study|Protocol Violation|0
7008111|NCT01451437|11076783|FG001|Overall Study|Protocol Violation|0
7008112|NCT01451437|11076784|FG002|Overall Study|Protocol Violation|0
7008113|NCT01451437|11076785|FG003|Overall Study|Protocol Violation|0
7008114|NCT01451437|11076786|FG004|Overall Study|Protocol Violation|0
7008115|NCT01451437|11076787|FG005|Overall Study|Protocol Violation|0
7008116|NCT01451437|11076788|FG006|Overall Study|Protocol Violation|1
7008117|NCT01451437|11076789|FG007|Overall Study|Protocol Violation|0
7008118|NCT01451437|11076790|FG008|Overall Study|Protocol Violation|0
7008119|NCT01451437|11076782|FG000|Overall Study|Withdrawal by Subject|0
7008120|NCT01451437|11076783|FG001|Overall Study|Withdrawal by Subject|0
7008121|NCT01451437|11076784|FG002|Overall Study|Withdrawal by Subject|0
7008122|NCT01451437|11076785|FG003|Overall Study|Withdrawal by Subject|0
7008123|NCT01451437|11076786|FG004|Overall Study|Withdrawal by Subject|1
7008124|NCT01451437|11076787|FG005|Overall Study|Withdrawal by Subject|0
7008125|NCT01451437|11076788|FG006|Overall Study|Withdrawal by Subject|1
7008126|NCT01451437|11076789|FG007|Overall Study|Withdrawal by Subject|0
7008127|NCT01451437|11076790|FG008|Overall Study|Withdrawal by Subject|0
7008128|NCT01451541|11076831|FG000|Overall Study|Adverse Event|4
7008129|NCT01451541|11076832|FG001|Overall Study|Adverse Event|3
7008130|NCT01451541|11076833|FG002|Overall Study|Adverse Event|6
7008131|NCT01451541|11076831|FG000|Overall Study|Lack of Efficacy|2
7008132|NCT01451541|11076832|FG001|Overall Study|Lack of Efficacy|0
7008133|NCT01451541|11076833|FG002|Overall Study|Lack of Efficacy|0
7008134|NCT01451541|11076831|FG000|Overall Study|Lost to Follow-up|4
7008135|NCT01451541|11076832|FG001|Overall Study|Lost to Follow-up|4
7008136|NCT01451541|11076833|FG002|Overall Study|Lost to Follow-up|7
7008137|NCT01451541|11076831|FG000|Overall Study|Withdrawal by Subject|15
7008138|NCT01451541|11076832|FG001|Overall Study|Withdrawal by Subject|8
7008139|NCT01451541|11076833|FG002|Overall Study|Withdrawal by Subject|6
7008140|NCT01451541|11076831|FG000|Overall Study|randomization error, noncompliance|11
7008141|NCT01451541|11076832|FG001|Overall Study|randomization error, noncompliance|10
7008142|NCT01451541|11076833|FG002|Overall Study|randomization error, noncompliance|8
7008143|NCT01451554|11076845|FG000|Overall Study|Withdrawal by Subject|14
7008144|NCT01451554|11076846|FG001|Overall Study|Withdrawal by Subject|9
7008145|NCT01451606|11076854|FG000|Overall Study|Withdrawal by Subject|4
7008146|NCT01451606|11076855|FG001|Overall Study|Withdrawal by Subject|3
7008147|NCT01451645|11076899|FG000|Overall Study|Protocol Violation|1
7008148|NCT01451645|11076900|FG001|Overall Study|Protocol Violation|0
7008149|NCT01451645|11076899|FG000|Overall Study|Adverse Event|0
7008150|NCT01451645|11076900|FG001|Overall Study|Adverse Event|3
7008151|NCT01451645|11076899|FG000|Overall Study|Withdrawal by Subject|4
7008152|NCT01451645|11076900|FG001|Overall Study|Withdrawal by Subject|2
7008153|NCT01451645|11076899|FG000|Overall Study|Lost to Follow-up|4
7008154|NCT01451645|11076900|FG001|Overall Study|Lost to Follow-up|3
7008155|NCT01451749|11076908|FG000|Overall Study|Protocol Violation|14
7008156|NCT01451749|11076909|FG001|Overall Study|Protocol Violation|7
7008157|NCT01451749|11076908|FG000|Overall Study|Lost to Follow-up|15
7008158|NCT01451749|11076909|FG001|Overall Study|Lost to Follow-up|5
7008159|NCT01451749|11076908|FG000|Overall Study|Meet the exclusion criteria,and|1
7008160|NCT01451749|11076909|FG001|Overall Study|Meet the exclusion criteria,and|1
7008161|NCT01451749|11076908|FG000|Overall Study|Adverse Event|2
7008162|NCT01451749|11076909|FG001|Overall Study|Adverse Event|0
7008163|NCT01451749|11076908|FG000|Overall Study|Withdrawal by Subject|0
7008164|NCT01451749|11076909|FG001|Overall Study|Withdrawal by Subject|1
7008165|NCT01451762|11076920|FG000|Overall Study|Lost to Follow-up|3
7008166|NCT01451762|11076921|FG001|Overall Study|Lost to Follow-up|6
7008167|NCT01451762|11076922|FG002|Overall Study|Lost to Follow-up|6
7008168|NCT01451814|11076945|FG000|Overall Study|Withdrawal by Subject|1
7008169|NCT01451814|11076946|FG001|Overall Study|Withdrawal by Subject|1
7008170|NCT01451814|11076945|FG000|Overall Study|Lost to Follow-up|5
7008171|NCT01451814|11076946|FG001|Overall Study|Lost to Follow-up|4
7008172|NCT01451827|11076956|FG000|Overall Study|Adverse Event|2
7008173|NCT01451827|11076957|FG001|Overall Study|Adverse Event|0
7008174|NCT01451827|11076958|FG002|Overall Study|Adverse Event|1
7008175|NCT01451827|11076959|FG003|Overall Study|Adverse Event|1
7008176|NCT01451827|11076956|FG000|Overall Study|Protocol deviation|1
7008177|NCT01451827|11076957|FG001|Overall Study|Protocol deviation|0
7008178|NCT01451827|11076958|FG002|Overall Study|Protocol deviation|0
7008179|NCT01451827|11076959|FG003|Overall Study|Protocol deviation|0
7008180|NCT01451827|11076956|FG000|Overall Study|Lost to Follow-up|0
7008181|NCT01451827|11076957|FG001|Overall Study|Lost to Follow-up|3
7008182|NCT01451827|11076958|FG002|Overall Study|Lost to Follow-up|0
7008183|NCT01451827|11076959|FG003|Overall Study|Lost to Follow-up|2
7008184|NCT01451827|11076956|FG000|Overall Study|Participant met withdrawal criteria|0
7008185|NCT01451827|11076957|FG001|Overall Study|Participant met withdrawal criteria|2
7008186|NCT01451827|11076958|FG002|Overall Study|Participant met withdrawal criteria|0
7008187|NCT01451827|11076959|FG003|Overall Study|Participant met withdrawal criteria|0
7008188|NCT01451827|11076956|FG000|Overall Study|Withdrawal by Subject|0
7008189|NCT01451827|11076957|FG001|Overall Study|Withdrawal by Subject|0
7008190|NCT01451827|11076958|FG002|Overall Study|Withdrawal by Subject|1
7008191|NCT01451827|11076959|FG003|Overall Study|Withdrawal by Subject|1
7008192|NCT01451931|11076972|FG000|Overall Study|Lost to Follow-up|17
7008193|NCT01451931|11076973|FG001|Overall Study|Lost to Follow-up|36
7008194|NCT01451931|11076974|FG002|Overall Study|Lost to Follow-up|21
7008195|NCT01451931|11076972|FG000|Overall Study|Withdrawal by Subject|16
7008196|NCT01451931|11076973|FG001|Overall Study|Withdrawal by Subject|22
7008197|NCT01451931|11076974|FG002|Overall Study|Withdrawal by Subject|22
7008198|NCT01452347|11077049|FG000|Overall Study|Adverse Event|2
7008199|NCT01452347|11077050|FG001|Overall Study|Adverse Event|1
7008200|NCT01452347|11077049|FG000|Overall Study|Non compliance protocol|2
7008201|NCT01452347|11077050|FG001|Overall Study|Non compliance protocol|0
7008202|NCT01452347|11077049|FG000|Overall Study|Lost to Follow-up|2
7008203|NCT01452347|11077050|FG001|Overall Study|Lost to Follow-up|0
7008204|NCT01452347|11077049|FG000|Overall Study|Withdrawal by Subject|3
7008205|NCT01452347|11077050|FG001|Overall Study|Withdrawal by Subject|3
7008206|NCT01452347|11077049|FG000|Overall Study|Not treated|6
7008207|NCT01452347|11077050|FG001|Overall Study|Not treated|3
7008208|NCT01452347|11077049|FG000|Overall Study|Other reason not defined above|2
7008209|NCT01452347|11077050|FG001|Overall Study|Other reason not defined above|0
7008210|NCT01452412|11077060|FG000|Overall Study|Withdrawal by Subject|15
7008211|NCT01452412|11077061|FG001|Overall Study|Withdrawal by Subject|11
7008212|NCT01452412|11077060|FG000|Overall Study|Adverse Event|4
7008213|NCT01452412|11077061|FG001|Overall Study|Adverse Event|3
7008214|NCT01452412|11077060|FG000|Overall Study|Lost to Follow-up|5
7008215|NCT01452412|11077061|FG001|Overall Study|Lost to Follow-up|3
7008216|NCT01452412|11077060|FG000|Overall Study|Death|1
7008217|NCT01452412|11077061|FG001|Overall Study|Death|0
7008218|NCT01452412|11077060|FG000|Overall Study|Initiated dialysis|1
7008219|NCT01452412|11077061|FG001|Overall Study|Initiated dialysis|0
7008220|NCT01452412|11077060|FG000|Overall Study|Other|2
7008221|NCT01452412|11077061|FG001|Overall Study|Other|0
7008222|NCT01452529|11077074|FG000|Run-in Period|Adverse Event|96
7008223|NCT01452529|11077075|FG001|Run-in Period|Adverse Event|0
7008224|NCT01452529|11077076|FG002|Run-in Period|Adverse Event|0
7008225|NCT01452529|11077074|FG000|Run-in Period|Withdrawal by Subject|49
7008226|NCT01452529|11077075|FG001|Run-in Period|Withdrawal by Subject|0
7008227|NCT01452529|11077076|FG002|Run-in Period|Withdrawal by Subject|0
7008228|NCT01452529|11077074|FG000|Run-in Period|Lost to Follow-up|19
7008229|NCT01452529|11077075|FG001|Run-in Period|Lost to Follow-up|0
7008230|NCT01452529|11077076|FG002|Run-in Period|Lost to Follow-up|0
7008231|NCT01452529|11077074|FG000|Run-in Period|Lack of Efficacy|46
7008232|NCT01452529|11077075|FG001|Run-in Period|Lack of Efficacy|0
7008233|NCT01452529|11077076|FG002|Run-in Period|Lack of Efficacy|0
7008234|NCT01452529|11077074|FG000|Run-in Period|Confirmed or suspected diversion|23
7008235|NCT01452529|11077075|FG001|Run-in Period|Confirmed or suspected diversion|0
7008236|NCT01452529|11077076|FG002|Run-in Period|Confirmed or suspected diversion|0
7008237|NCT01452529|11077074|FG000|Run-in Period|Administrative|21
7008238|NCT01452529|11077075|FG001|Run-in Period|Administrative|0
7008239|NCT01452529|11077076|FG002|Run-in Period|Administrative|0
7008240|NCT01452529|11077074|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59
7008241|NCT01452529|11077075|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0
7008242|NCT01452529|11077076|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0
7008243|NCT01452529|11077074|FG000|Double-blind (DB) Period|Adverse Event|0
7008244|NCT01452529|11077075|FG001|Double-blind (DB) Period|Adverse Event|18
7008245|NCT01452529|11077076|FG002|Double-blind (DB) Period|Adverse Event|11
7008246|NCT01452529|11077074|FG000|Double-blind (DB) Period|Withdrawal by Subject|0
7008247|NCT01452529|11077075|FG001|Double-blind (DB) Period|Withdrawal by Subject|15
7008248|NCT01452529|11077076|FG002|Double-blind (DB) Period|Withdrawal by Subject|14
7008249|NCT01452529|11077074|FG000|Double-blind (DB) Period|Lost to Follow-up|0
7008250|NCT01452529|11077075|FG001|Double-blind (DB) Period|Lost to Follow-up|5
7008251|NCT01452529|11077076|FG002|Double-blind (DB) Period|Lost to Follow-up|3
7008252|NCT01452529|11077074|FG000|Double-blind (DB) Period|Lack of Efficacy|0
7008253|NCT01452529|11077075|FG001|Double-blind (DB) Period|Lack of Efficacy|16
7008254|NCT01452529|11077076|FG002|Double-blind (DB) Period|Lack of Efficacy|44
7008255|NCT01452529|11077074|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0
7008256|NCT01452529|11077075|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2
7008257|NCT01452529|11077076|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3
7008258|NCT01452529|11077074|FG000|Double-blind (DB) Period|Administrative|0
7008259|NCT01452529|11077075|FG001|Double-blind (DB) Period|Administrative|11
7008260|NCT01452529|11077076|FG002|Double-blind (DB) Period|Administrative|7
7008261|NCT01452789|11077085|FG000|Overall Study|Withdrawal by Subject|3
7008262|NCT01452789|11077086|FG001|Overall Study|Withdrawal by Subject|2
7008263|NCT01452919|11077092|FG000|Open-Label Treatment|Adverse Event|5
7008264|NCT01452919|11077093|FG001|Open-Label Treatment|Adverse Event|0
7008265|NCT01452919|11077094|FG002|Open-Label Treatment|Adverse Event|0
7008266|NCT01452919|11077092|FG000|Open-Label Treatment|Lost to Follow-up|4
7008267|NCT01452919|11077093|FG001|Open-Label Treatment|Lost to Follow-up|0
7008268|NCT01452919|11077094|FG002|Open-Label Treatment|Lost to Follow-up|0
7008269|NCT01452919|11077092|FG000|Open-Label Treatment|Perceived lack of efficacy|3
7008270|NCT01452919|11077093|FG001|Open-Label Treatment|Perceived lack of efficacy|0
7008271|NCT01452919|11077094|FG002|Open-Label Treatment|Perceived lack of efficacy|0
7008272|NCT01452919|11077092|FG000|Open-Label Treatment|Protocol Violation|4
7008273|NCT01452919|11077093|FG001|Open-Label Treatment|Protocol Violation|0
7008274|NCT01452919|11077094|FG002|Open-Label Treatment|Protocol Violation|0
7008275|NCT01452919|11077092|FG000|Open-Label Treatment|Sponsor Decision|1
7008276|NCT01452919|11077093|FG001|Open-Label Treatment|Sponsor Decision|0
7008277|NCT01452919|11077094|FG002|Open-Label Treatment|Sponsor Decision|0
7008278|NCT01452919|11077092|FG000|Open-Label Treatment|Withdrawal by Subject|2
7008279|NCT01452919|11077093|FG001|Open-Label Treatment|Withdrawal by Subject|0
7008280|NCT01452919|11077094|FG002|Open-Label Treatment|Withdrawal by Subject|0
7008281|NCT01452919|11077092|FG000|Open-Label Treatment|Subject is moving or has moved|1
7008282|NCT01452919|11077093|FG001|Open-Label Treatment|Subject is moving or has moved|0
7008283|NCT01452919|11077094|FG002|Open-Label Treatment|Subject is moving or has moved|0
7008284|NCT01452919|11077092|FG000|Randomization Treatment|Adverse Event|0
7008285|NCT01452919|11077093|FG001|Randomization Treatment|Adverse Event|0
7008286|NCT01452919|11077094|FG002|Randomization Treatment|Adverse Event|2
7008287|NCT01452919|11077092|FG000|Randomization Treatment|Sponsor Decision|0
7008288|NCT01452919|11077093|FG001|Randomization Treatment|Sponsor Decision|1
7008289|NCT01452919|11077094|FG002|Randomization Treatment|Sponsor Decision|0
7008290|NCT01452919|11077092|FG000|Randomization Treatment|Withdrawal by Subject|0
7008291|NCT01452919|11077093|FG001|Randomization Treatment|Withdrawal by Subject|1
7008292|NCT01452919|11077094|FG002|Randomization Treatment|Withdrawal by Subject|0
7008293|NCT01452919|11077092|FG000|Randomization Treatment|Subject is moving or has moved|0
7008294|NCT01452919|11077093|FG001|Randomization Treatment|Subject is moving or has moved|1
7008295|NCT01452919|11077094|FG002|Randomization Treatment|Subject is moving or has moved|0
7008296|NCT01453023|11077104|FG000|Treatment Period (TP) 1|Protocol Violation|1
7008297|NCT01453023|11077105|FG001|Treatment Period (TP) 1|Protocol Violation|0
7008298|NCT01453023|11077104|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0
7008299|NCT01453023|11077105|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1
7008300|NCT01453023|11077104|FG000|Treatment Period 2|Protocol Violation|0
7008301|NCT01453023|11077105|FG001|Treatment Period 2|Protocol Violation|1
7008302|NCT01453036|11077114|FG000|Overall Study|Lost to Follow-up|26
7008303|NCT01453036|11077115|FG001|Overall Study|Lost to Follow-up|115
7008304|NCT01453036|11077116|FG002|Overall Study|Lost to Follow-up|31
7008305|NCT01453049|11077126|FG000|Overall Study|Protocol Violation|2
7008306|NCT01453049|11077127|FG001|Overall Study|Protocol Violation|5
7008307|NCT01453049|11077126|FG000|Overall Study|Lost to Follow-up|2
7008308|NCT01453049|11077127|FG001|Overall Study|Lost to Follow-up|1
7008309|NCT01453049|11077126|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35
7008310|NCT01453049|11077127|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36
7008311|NCT01453049|11077126|FG000|Overall Study|Withdrawal by Subject|1
7008312|NCT01453049|11077127|FG001|Overall Study|Withdrawal by Subject|0
7008313|NCT01453049|11077126|FG000|Overall Study|Randomized in Error|1
7008314|NCT01453049|11077127|FG001|Overall Study|Randomized in Error|0
7008315|NCT01453153|11077145|FG000|Overall Study|Physician Decision|0
7008316|NCT01453153|11077146|FG001|Overall Study|Physician Decision|0
7008317|NCT01453153|11077147|FG002|Overall Study|Physician Decision|1
7008318|NCT01453153|11077145|FG000|Overall Study|Progressive Disease|3
7008319|NCT01453153|11077146|FG001|Overall Study|Progressive Disease|2
7008320|NCT01453153|11077147|FG002|Overall Study|Progressive Disease|16
7008321|NCT01453153|11077145|FG000|Overall Study|Withdrawal by Subject|0
7008322|NCT01453153|11077146|FG001|Overall Study|Withdrawal by Subject|1
7008323|NCT01453153|11077147|FG002|Overall Study|Withdrawal by Subject|2
7008324|NCT01453153|11077145|FG000|Overall Study|Adverse Event|1
7008325|NCT01453153|11077146|FG001|Overall Study|Adverse Event|1
7008326|NCT01453153|11077147|FG002|Overall Study|Adverse Event|1
7008327|NCT01453205|11077175|FG000|Overall Study|Lost to Follow-up|3
7008328|NCT01453205|11077176|FG001|Overall Study|Lost to Follow-up|0
7008329|NCT01453205|11077177|FG002|Overall Study|Lost to Follow-up|1
7008330|NCT01453205|11077175|FG000|Overall Study|Withdrawal by Subject|8
7008331|NCT01453205|11077176|FG001|Overall Study|Withdrawal by Subject|3
7008332|NCT01453205|11077177|FG002|Overall Study|Withdrawal by Subject|0
7008333|NCT01453205|11077175|FG000|Overall Study|Death|24
7008334|NCT01453205|11077176|FG001|Overall Study|Death|22
7008335|NCT01453205|11077177|FG002|Overall Study|Death|18
7008336|NCT01453205|11077175|FG000|Overall Study|Other|45
7008337|NCT01453205|11077176|FG001|Overall Study|Other|27
7008338|NCT01453205|11077177|FG002|Overall Study|Other|35
7008339|NCT01453296|11077188|FG000|Treatment Period 1|Adverse Event|0
7008340|NCT01453296|11077189|FG001|Treatment Period 1|Adverse Event|1
7008341|NCT01453296|11077188|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1
7008342|NCT01453296|11077189|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0
7008343|NCT01453296|11077188|FG000|Treatment Period 2|Adverse Event|1
7008344|NCT01453296|11077189|FG001|Treatment Period 2|Adverse Event|0
7008345|NCT01453296|11077188|FG000|Treatment Period 2|Withdrawal by Subject|1
7008346|NCT01453296|11077189|FG001|Treatment Period 2|Withdrawal by Subject|0
7008347|NCT01453348|11077198|FG000|Overall Study|Death|0
7008348|NCT01453348|11077199|FG001|Overall Study|Death|0
7008349|NCT01453348|11077200|FG002|Overall Study|Death|1
7008350|NCT01453348|11077198|FG000|Overall Study|Withdrawal by Subject|0
7008351|NCT01453348|11077199|FG001|Overall Study|Withdrawal by Subject|1
7008352|NCT01453348|11077200|FG002|Overall Study|Withdrawal by Subject|0
7008353|NCT01453348|11077198|FG000|Overall Study|Protocol Violation|1
7008354|NCT01453348|11077199|FG001|Overall Study|Protocol Violation|0
7008355|NCT01453348|11077200|FG002|Overall Study|Protocol Violation|0
7008356|NCT01453361|11077211|FG000|Overall Study|Disease Progression|6
7008357|NCT01453361|11077211|FG000|Overall Study|Screen-Failures|10
7008358|NCT01453374|11077215|FG000|Overall Study|Adverse Event|7
7008359|NCT01453374|11077215|FG000|Overall Study|Lack of Efficacy|1
7008360|NCT01453374|11077215|FG000|Overall Study|Lost to Follow-up|3
7008361|NCT01453374|11077215|FG000|Overall Study|Withdrawal by Subject|5
7008362|NCT01453374|11077215|FG000|Overall Study|Incarcerated|2
7008363|NCT01453439|11077253|FG000|Treatment Phase|Withdrawal by Subject|13
7008364|NCT01453439|11077254|FG001|Treatment Phase|Withdrawal by Subject|10
7008365|NCT01453439|11077253|FG000|Treatment Phase|Suicidal Ideation|2
7008366|NCT01453439|11077254|FG001|Treatment Phase|Suicidal Ideation|0
7008367|NCT01453439|11077253|FG000|Treatment Phase|Need for higher level of care|1
7008368|NCT01453439|11077254|FG001|Treatment Phase|Need for higher level of care|1
7008369|NCT01453439|11077253|FG000|Treatment Phase|Therapist conflict of interest|1
7008370|NCT01453439|11077254|FG001|Treatment Phase|Therapist conflict of interest|0
7008371|NCT01453439|11077253|FG000|Follow-up|Withdrawal by Subject|0
7008372|NCT01453439|11077254|FG001|Follow-up|Withdrawal by Subject|1
7008373|NCT01453439|11077253|FG000|Follow-up|Lost to Follow-up|5
7008374|NCT01453439|11077254|FG001|Follow-up|Lost to Follow-up|10
7008375|NCT01453595|11077276|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2
7008376|NCT01453595|11077277|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1
7008377|NCT01453595|11077278|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2
7008378|NCT01453725|11077286|FG000|Overall Study|Adverse Event|3
7008379|NCT01453725|11077287|FG001|Overall Study|Adverse Event|3
7008380|NCT01453725|11077286|FG000|Overall Study|Lost to Follow-up|4
7008381|NCT01453725|11077287|FG001|Overall Study|Lost to Follow-up|0
7008382|NCT01453725|11077286|FG000|Overall Study|Non-compliance With Protocol|1
7008383|NCT01453725|11077287|FG001|Overall Study|Non-compliance With Protocol|2
7008384|NCT01453725|11077286|FG000|Overall Study|Protocol Violation|1
7008385|NCT01453725|11077287|FG001|Overall Study|Protocol Violation|0
7008386|NCT01453725|11077286|FG000|Overall Study|Withdrawal by Subject|2
7008387|NCT01453725|11077287|FG001|Overall Study|Withdrawal by Subject|3
7008388|NCT01453725|11077286|FG000|Overall Study|Pregnancy Wish|0
7008389|NCT01453725|11077287|FG001|Overall Study|Pregnancy Wish|2
7008390|NCT01453725|11077286|FG000|Overall Study|Pregnancy|1
7008391|NCT01453725|11077287|FG001|Overall Study|Pregnancy|0
7008392|NCT01453725|11077286|FG000|Overall Study|Physician Decision|1
7008393|NCT01453725|11077287|FG001|Overall Study|Physician Decision|1
7008394|NCT01453855|11077297|FG000|Overall Study|Adverse Event|3
7008395|NCT01453855|11077298|FG001|Overall Study|Adverse Event|4
7008396|NCT01453855|11077297|FG000|Overall Study|Lost to Follow-up|2
7008397|NCT01453855|11077298|FG001|Overall Study|Lost to Follow-up|1
7008398|NCT01453855|11077297|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3
7008399|NCT01453855|11077298|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3
7008400|NCT01453855|11077297|FG000|Overall Study|Noncompliance|1
7008401|NCT01453855|11077298|FG001|Overall Study|Noncompliance|0
7008402|NCT01453855|11077297|FG000|Overall Study|Inadequate Control of IOP|1
7008403|NCT01453855|11077298|FG001|Overall Study|Inadequate Control of IOP|5
7008404|NCT01453855|11077297|FG000|Overall Study|Other|0
7008405|NCT01453855|11077298|FG001|Overall Study|Other|1
7008406|NCT01453998|11077316|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1
7008407|NCT01453998|11077317|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0
7008408|NCT01453998|11077318|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0
7008409|NCT01454063|11077331|FG000|Randomized|Adverse Event|1
7008410|NCT01454063|11077332|FG001|Randomized|Adverse Event|1
7008411|NCT01454063|11077331|FG000|Randomized|Protocol Violation|0
7008412|NCT01454063|11077332|FG001|Randomized|Protocol Violation|1
7008413|NCT01454076|11077343|FG000|Overall Study|Other|2
7008414|NCT01454076|11077344|FG001|Overall Study|Other|0
7008415|NCT01454076|11077345|FG002|Overall Study|Other|0
7008416|NCT01454076|11077346|FG003|Overall Study|Other|1
7008417|NCT01454076|11077347|FG004|Overall Study|Other|2
7008418|NCT01454076|11077343|FG000|Overall Study|Withdrawal by Subject|3
7008419|NCT01454076|11077344|FG001|Overall Study|Withdrawal by Subject|4
7008420|NCT01454076|11077345|FG002|Overall Study|Withdrawal by Subject|2
7008421|NCT01454076|11077346|FG003|Overall Study|Withdrawal by Subject|1
7008422|NCT01454076|11077347|FG004|Overall Study|Withdrawal by Subject|2
7008423|NCT01454076|11077343|FG000|Overall Study|Adverse Event|8
7008424|NCT01454076|11077344|FG001|Overall Study|Adverse Event|2
7008425|NCT01454076|11077345|FG002|Overall Study|Adverse Event|7
7008426|NCT01454076|11077346|FG003|Overall Study|Adverse Event|0
7008427|NCT01454076|11077347|FG004|Overall Study|Adverse Event|2
7008428|NCT01454102|11077384|FG000|Overall Study|Continuing in the treatment period|0
7008429|NCT01454102|11077385|FG001|Overall Study|Continuing in the treatment period|0
7008430|NCT01454102|11077386|FG002|Overall Study|Continuing in the treatment period|0
7008431|NCT01454102|11077387|FG003|Overall Study|Continuing in the treatment period|0
7008432|NCT01454102|11077388|FG004|Overall Study|Continuing in the treatment period|3
7008433|NCT01454102|11077389|FG005|Overall Study|Continuing in the treatment period|3
7008434|NCT01454102|11077390|FG006|Overall Study|Continuing in the treatment period|2
7008435|NCT01454102|11077391|FG007|Overall Study|Continuing in the treatment period|0
7008436|NCT01454102|11077392|FG008|Overall Study|Continuing in the treatment period|1
7008437|NCT01454102|11077393|FG009|Overall Study|Continuing in the treatment period|0
7008438|NCT01454102|11077394|FG010|Overall Study|Continuing in the treatment period|0
7008439|NCT01454102|11077395|FG011|Overall Study|Continuing in the treatment period|4
7008440|NCT01454102|11077396|FG012|Overall Study|Continuing in the treatment period|7
7008441|NCT01454102|11077397|FG013|Overall Study|Continuing in the treatment period|4
7008442|NCT01454102|11077398|FG014|Overall Study|Continuing in the treatment period|3
7008443|NCT01454102|11077399|FG015|Overall Study|Continuing in the treatment period|1
7008444|NCT01454284|11077442|FG000|Overall Study|Adverse Event|20
7008445|NCT01454284|11077443|FG001|Overall Study|Adverse Event|7
7008446|NCT01454284|11077442|FG000|Overall Study|Death|0
7008447|NCT01454284|11077443|FG001|Overall Study|Death|3
7008448|NCT01454284|11077442|FG000|Overall Study|Lost to Follow-up|13
7008449|NCT01454284|11077443|FG001|Overall Study|Lost to Follow-up|8
7008450|NCT01454284|11077442|FG000|Overall Study|Protocol Violation|9
7008451|NCT01454284|11077443|FG001|Overall Study|Protocol Violation|6
7008452|NCT01454284|11077442|FG000|Overall Study|Withdrawal by Subject|58
7008453|NCT01454284|11077443|FG001|Overall Study|Withdrawal by Subject|36
7008454|NCT01454284|11077442|FG000|Overall Study|Physician Decision|16
7008455|NCT01454284|11077443|FG001|Overall Study|Physician Decision|11
7008456|NCT01454284|11077442|FG000|Overall Study|Sponsor Decision|0
7008457|NCT01454284|11077443|FG001|Overall Study|Sponsor Decision|2
7008458|NCT01454401|11077460|FG000|Overall Study|Death|1
7008459|NCT01454401|11077460|FG000|Overall Study|hospitalised|1
7008460|NCT01454401|11077460|FG000|Overall Study|osteomyelitis|2
7008461|NCT01454401|11077460|FG000|Overall Study|non-adherence|1
7008462|NCT01454531|11077489|FG000|Overall Study|Adverse Event|14
7008463|NCT01454531|11077489|FG000|Overall Study|Withdrawal by Subject|5
7008464|NCT01454531|11077489|FG000|Overall Study|Lost to Follow-up|1
7008465|NCT01454531|11077489|FG000|Overall Study|Physician Decision|1
7008466|NCT01454531|11077489|FG000|Overall Study|Delay in IMP administration|1
7008467|NCT01454531|11077489|FG000|Overall Study|Other|1
7008468|NCT01454570|11077493|FG000|Overall Study|Withdrawal by Subject|2
7008469|NCT01454570|11077493|FG000|Overall Study|Screen Failure|7
7008470|NCT01454583|11077500|FG000|1st Year|Lost to Follow-up|1057
7008471|NCT01454583|11077501|FG001|1st Year|Lost to Follow-up|318
7008472|NCT01454583|11077502|FG002|1st Year|Lost to Follow-up|180
7008473|NCT01454583|11077500|FG000|2nd Year|Lost to Follow-up|3965
7008474|NCT01454583|11077501|FG001|2nd Year|Lost to Follow-up|1049
7008475|NCT01454583|11077502|FG002|2nd Year|Lost to Follow-up|737
7008476|NCT01454583|11077500|FG000|3rd Year|Lost to Follow-up|1959
7008477|NCT01454583|11077501|FG001|3rd Year|Lost to Follow-up|512
7008478|NCT01454583|11077502|FG002|3rd Year|Lost to Follow-up|297
7008479|NCT01454596|11077522|FG000|Overall Study|Death|0
7008480|NCT01454596|11077523|FG001|Overall Study|Death|0
7008481|NCT01454596|11077524|FG002|Overall Study|Death|0
7008482|NCT01454596|11077525|FG003|Overall Study|Death|0
7008483|NCT01454596|11077526|FG004|Overall Study|Death|0
7008484|NCT01454596|11077527|FG005|Overall Study|Death|0
7008485|NCT01454596|11077528|FG006|Overall Study|Death|0
7008486|NCT01454596|11077529|FG007|Overall Study|Death|0
7008487|NCT01454596|11077530|FG008|Overall Study|Death|0
7008488|NCT01454596|11077531|FG009|Overall Study|Death|1
7008489|NCT01454596|11077532|FG010|Overall Study|Death|1
7008490|NCT01454596|11077533|FG011|Overall Study|Death|0
7008491|NCT01454726|11077561|FG000|Overall Study|Withdrawal by Subject|0
7008492|NCT01454726|11077562|FG001|Overall Study|Withdrawal by Subject|1
7008493|NCT01454739|11077570|FG000|Overall Study|Protocol Violation|2
7008494|NCT01454739|11077571|FG001|Overall Study|Protocol Violation|3
7008495|NCT01454739|11077570|FG000|Overall Study|Withdrawal by Subject|2
7008496|NCT01454739|11077571|FG001|Overall Study|Withdrawal by Subject|6
7008497|NCT01454739|11077570|FG000|Overall Study|Other|3
7008498|NCT01454739|11077571|FG001|Overall Study|Other|5
7008499|NCT01454739|11077570|FG000|Overall Study|Physician Decision|0
7008500|NCT01454739|11077571|FG001|Overall Study|Physician Decision|5
7008501|NCT01454739|11077570|FG000|Overall Study|Lost to Follow-up|0
7008502|NCT01454739|11077571|FG001|Overall Study|Lost to Follow-up|1
7008503|NCT01454739|11077570|FG000|Overall Study|Adverse Event|0
7008504|NCT01454739|11077571|FG001|Overall Study|Adverse Event|1
7008505|NCT01454778|11077584|FG000|Overall Study|Lost to Follow-up|2
7008506|NCT01454778|11077584|FG000|Overall Study|Death|1
7008507|NCT01454830|11077601|FG000|Overall Study|Withdrawal by Subject|4
7008508|NCT01454830|11077602|FG001|Overall Study|Withdrawal by Subject|4
7008509|NCT01454830|11077601|FG000|Overall Study|Post-allocation Exclude- AHI<10|18
7008510|NCT01454830|11077602|FG001|Overall Study|Post-allocation Exclude- AHI<10|12
7008511|NCT01454830|11077601|FG000|Overall Study|Post-allocation Exclude-refused PAP|0
7008512|NCT01454830|11077602|FG001|Overall Study|Post-allocation Exclude-refused PAP|2
7008513|NCT01454830|11077601|FG000|Overall Study|Post-allocation Exclude-other treatment|6
7008514|NCT01454830|11077602|FG001|Overall Study|Post-allocation Exclude-other treatment|7
7008515|NCT01454830|11077601|FG000|Overall Study|Withdrawal - no polysomnography|3
7008516|NCT01454830|11077602|FG001|Overall Study|Withdrawal - no polysomnography|2
7008517|NCT01454934|11077610|FG000|Overall Study|Clinical progression|28
7008518|NCT01454934|11077611|FG001|Overall Study|Clinical progression|25
7008519|NCT01454934|11077610|FG000|Overall Study|Other|6
7008520|NCT01454934|11077611|FG001|Overall Study|Other|17
7008521|NCT01454934|11077610|FG000|Overall Study|Adverse Event|28
7008522|NCT01454934|11077611|FG001|Overall Study|Adverse Event|24
7008523|NCT01454934|11077610|FG000|Overall Study|Withdrawn consent|2
7008524|NCT01454934|11077611|FG001|Overall Study|Withdrawn consent|5
7008525|NCT01454934|11077610|FG000|Overall Study|Withdrawal by Subject|11
7008526|NCT01454934|11077611|FG001|Overall Study|Withdrawal by Subject|15
7008527|NCT01454934|11077610|FG000|Overall Study|Disease progression|194
7008528|NCT01454934|11077611|FG001|Overall Study|Disease progression|181
7008529|NCT01454934|11077610|FG000|Overall Study|Lost to Follow-up|0
7008530|NCT01454934|11077611|FG001|Overall Study|Lost to Follow-up|1
7008531|NCT01454934|11077610|FG000|Overall Study|Not treated|1
7008532|NCT01454934|11077611|FG001|Overall Study|Not treated|2
7008533|NCT01455012|11077652|FG000|Overall Study|Adverse Event|0
7008534|NCT01455012|11077653|FG001|Overall Study|Adverse Event|2
7008535|NCT01455012|11077652|FG000|Overall Study|Lack of Efficacy|6
7008536|NCT01455012|11077653|FG001|Overall Study|Lack of Efficacy|1
7008537|NCT01455012|11077652|FG000|Overall Study|Withdrawal by Subject|3
7008538|NCT01455012|11077653|FG001|Overall Study|Withdrawal by Subject|1
7008539|NCT01455012|11077652|FG000|Overall Study|Unknown reason|2
7008540|NCT01455012|11077653|FG001|Overall Study|Unknown reason|0
7008541|NCT01455194|11077670|FG000|Overall Study|Screen Failure|20
7008542|NCT01455194|11077671|FG001|Overall Study|Screen Failure|0
7008543|NCT01455194|11077672|FG002|Overall Study|Screen Failure|0
7008544|NCT01455194|11077673|FG003|Overall Study|Screen Failure|0
7008545|NCT01455194|11077670|FG000|Overall Study|Randomisation Failure|90
7008546|NCT01455194|11077671|FG001|Overall Study|Randomisation Failure|0
7008547|NCT01455194|11077672|FG002|Overall Study|Randomisation Failure|0
7008548|NCT01455194|11077673|FG003|Overall Study|Randomisation Failure|0
7008549|NCT01455194|11077670|FG000|Overall Study|Deterioration in asthma|12
7008550|NCT01455194|11077671|FG001|Overall Study|Deterioration in asthma|6
7008551|NCT01455194|11077672|FG002|Overall Study|Deterioration in asthma|14
7008552|NCT01455194|11077673|FG003|Overall Study|Deterioration in asthma|9
7008553|NCT01455194|11077670|FG000|Overall Study|Adverse Event|1
7008554|NCT01455194|11077671|FG001|Overall Study|Adverse Event|1
7008555|NCT01455194|11077672|FG002|Overall Study|Adverse Event|1
7008556|NCT01455194|11077673|FG003|Overall Study|Adverse Event|3
7008557|NCT01455194|11077670|FG000|Overall Study|Withdrawal by Subject|21
7008558|NCT01455194|11077671|FG001|Overall Study|Withdrawal by Subject|16
7008559|NCT01455194|11077672|FG002|Overall Study|Withdrawal by Subject|12
7008560|NCT01455194|11077673|FG003|Overall Study|Withdrawal by Subject|9
7008561|NCT01455194|11077670|FG000|Overall Study|Lost to Follow-up|2
7008562|NCT01455194|11077671|FG001|Overall Study|Lost to Follow-up|0
7008563|NCT01455194|11077672|FG002|Overall Study|Lost to Follow-up|1
7008564|NCT01455194|11077673|FG003|Overall Study|Lost to Follow-up|1
7008565|NCT01455194|11077670|FG000|Overall Study|Pregnancy|0
7008566|NCT01455194|11077671|FG001|Overall Study|Pregnancy|1
7008567|NCT01455194|11077672|FG002|Overall Study|Pregnancy|1
7008568|NCT01455194|11077673|FG003|Overall Study|Pregnancy|0
7008569|NCT01455194|11077670|FG000|Overall Study|Discontinuation criterion fulfilled|3
7008570|NCT01455194|11077671|FG001|Overall Study|Discontinuation criterion fulfilled|2
7008571|NCT01455194|11077672|FG002|Overall Study|Discontinuation criterion fulfilled|0
7008572|NCT01455194|11077673|FG003|Overall Study|Discontinuation criterion fulfilled|2
7008573|NCT01455194|11077670|FG000|Overall Study|Miscellaneous|4
7008574|NCT01455194|11077671|FG001|Overall Study|Miscellaneous|5
7008575|NCT01455194|11077672|FG002|Overall Study|Miscellaneous|1
7008576|NCT01455194|11077673|FG003|Overall Study|Miscellaneous|4
7008577|NCT01455220|11077686|FG000|Overall Study|screen fail|30
7008578|NCT01455415|11077695|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9
7008579|NCT01455415|11077696|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6
7008580|NCT01455415|11077695|FG000|Period 1|Lost To Follow-up Related to Study Drug|3
7008581|NCT01455415|11077696|FG001|Period 1|Lost To Follow-up Related to Study Drug|3
7008582|NCT01455415|11077695|FG000|Period 1|Drug Error not Associated to AE|0
7008583|NCT01455415|11077696|FG001|Period 1|Drug Error not Associated to AE|1
7008584|NCT01455415|11077695|FG000|Period 1|AE Not Related to Study Drug|2
7008585|NCT01455415|11077696|FG001|Period 1|AE Not Related to Study Drug|6
7008586|NCT01455415|11077695|FG000|Period 1|Withdrawal by Subject|4
7008587|NCT01455415|11077696|FG001|Period 1|Withdrawal by Subject|5
7008588|NCT01455415|11077695|FG000|Period 1|Unspecified Reason|1
7008589|NCT01455415|11077696|FG001|Period 1|Unspecified Reason|1
7008590|NCT01455415|11077695|FG000|Period 1|Protocol Violation|0
7008591|NCT01455415|11077696|FG001|Period 1|Protocol Violation|2
7008592|NCT01455415|11077695|FG000|Washout|AE Related to Study Drug|2
7008593|NCT01455415|11077696|FG001|Washout|AE Related to Study Drug|0
7008594|NCT01455415|11077695|FG000|Washout|Lost to Follow-up|1
7008595|NCT01455415|11077696|FG001|Washout|Lost to Follow-up|0
7008596|NCT01455415|11077695|FG000|Washout|Drug Error not Associated to AE|2
7008597|NCT01455415|11077696|FG001|Washout|Drug Error not Associated to AE|1
7008598|NCT01455415|11077695|FG000|Washout|AE Not Related to Study Drug|2
7008599|NCT01455415|11077696|FG001|Washout|AE Not Related to Study Drug|3
7008600|NCT01455415|11077695|FG000|Washout|Unspecified Reason|1
7008601|NCT01455415|11077696|FG001|Washout|Unspecified Reason|2
7008602|NCT01455415|11077695|FG000|Washout|Protocol Violation|0
7008603|NCT01455415|11077696|FG001|Washout|Protocol Violation|1
7008604|NCT01455415|11077695|FG000|Period 2|AE Related to Study Drug|1
7008605|NCT01455415|11077696|FG001|Period 2|AE Related to Study Drug|2
7008606|NCT01455415|11077695|FG000|Period 2|Lost to Follow-up|2
7008607|NCT01455415|11077696|FG001|Period 2|Lost to Follow-up|1
7008608|NCT01455415|11077695|FG000|Period 2|AE Not Related to Study Drug|2
7008609|NCT01455415|11077696|FG001|Period 2|AE Not Related to Study Drug|1
7008610|NCT01455415|11077695|FG000|Period 2|Lack of Efficacy|2
7008611|NCT01455415|11077696|FG001|Period 2|Lack of Efficacy|0
7008612|NCT01455415|11077695|FG000|Period 2|Withdrawal by Subject|2
7008613|NCT01455415|11077696|FG001|Period 2|Withdrawal by Subject|3
7008614|NCT01455415|11077695|FG000|Period 2|Unspecified Reason|2
7008615|NCT01455415|11077696|FG001|Period 2|Unspecified Reason|3
7008616|NCT01455415|11077695|FG000|Period 2|Protocol Violation|2
7008617|NCT01455415|11077696|FG001|Period 2|Protocol Violation|0
7008618|NCT01455415|11077695|FG000|Follow-up|AE Related to Study Drug|0
7008619|NCT01455415|11077696|FG001|Follow-up|AE Related to Study Drug|1
7008620|NCT01455415|11077695|FG000|Follow-up|Lack of Efficacy|0
7008621|NCT01455415|11077696|FG001|Follow-up|Lack of Efficacy|1
7008622|NCT01455415|11077695|FG000|Follow-up|Withdrawal by Subject|2
7008623|NCT01455415|11077696|FG001|Follow-up|Withdrawal by Subject|0
7008624|NCT01455415|11077695|FG000|Follow-up|Unspecified Reason|1
7008625|NCT01455415|11077696|FG001|Follow-up|Unspecified Reason|0
7008626|NCT01455428|11077704|FG000|Overall Study|Protocol Violation|2
7008627|NCT01455428|11077705|FG001|Overall Study|Protocol Violation|1
7008628|NCT01455428|11077704|FG000|Overall Study|Adverse Event|6
7008629|NCT01455428|11077705|FG001|Overall Study|Adverse Event|2
7008630|NCT01455428|11077704|FG000|Overall Study|Lost to Follow-up|1
7008631|NCT01455428|11077705|FG001|Overall Study|Lost to Follow-up|1
7008632|NCT01455428|11077704|FG000|Overall Study|Withdrawal by Subject|2
7008633|NCT01455428|11077705|FG001|Overall Study|Withdrawal by Subject|5
7008634|NCT01455428|11077704|FG000|Overall Study|Did not meet entrance criteria|0
7008635|NCT01455428|11077705|FG001|Overall Study|Did not meet entrance criteria|2
7008636|NCT01455428|11077704|FG000|Overall Study|Insufficient clinical response|0
7008637|NCT01455428|11077705|FG001|Overall Study|Insufficient clinical response|2
7008638|NCT01455428|11077704|FG000|Overall Study|Did not receive treatment|1
7008639|NCT01455428|11077705|FG001|Overall Study|Did not receive treatment|1
7008640|NCT01455428|11077704|FG000|Overall Study|Other|2
7008641|NCT01455428|11077705|FG001|Overall Study|Other|4
7008642|NCT01456039|11077748|FG000|Phase 1 (First Step)|Disease Progression|1
7008643|NCT01456039|11077749|FG001|Phase 1 (First Step)|Disease Progression|1
7008644|NCT01456039|11077750|FG002|Phase 1 (First Step)|Disease Progression|0
7008645|NCT01456039|11077748|FG000|Phase 1 (First Step)|Withdrawal by Subject|1
7008646|NCT01456039|11077749|FG001|Phase 1 (First Step)|Withdrawal by Subject|2
7008647|NCT01456039|11077750|FG002|Phase 1 (First Step)|Withdrawal by Subject|0
7008648|NCT01456039|11077748|FG000|Phase 1 (First Step)|Adverse Event|0
7008649|NCT01456039|11077749|FG001|Phase 1 (First Step)|Adverse Event|3
7008650|NCT01456039|11077750|FG002|Phase 1 (First Step)|Adverse Event|0
7008651|NCT01456039|11077748|FG000|Phase 1 (First Step)|Other|0
7008652|NCT01456039|11077749|FG001|Phase 1 (First Step)|Other|1
7008653|NCT01456039|11077750|FG002|Phase 1 (First Step)|Other|0
7008654|NCT01456039|11077748|FG000|Phase 2 (Second Step)|Disease Progression|0
7008655|NCT01456039|11077749|FG001|Phase 2 (Second Step)|Disease Progression|0
7008656|NCT01456039|11077750|FG002|Phase 2 (Second Step)|Disease Progression|17
7008657|NCT01456039|11077748|FG000|Phase 2 (Second Step)|Adverse Event|0
7008658|NCT01456039|11077749|FG001|Phase 2 (Second Step)|Adverse Event|0
7008659|NCT01456039|11077750|FG002|Phase 2 (Second Step)|Adverse Event|10
7008660|NCT01456039|11077748|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0
7008661|NCT01456039|11077749|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0
7008662|NCT01456039|11077750|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4
7008663|NCT01456039|11077748|FG000|Phase 2 (Second Step)|Protocol Violation|0
7008664|NCT01456039|11077749|FG001|Phase 2 (Second Step)|Protocol Violation|0
7008665|NCT01456039|11077750|FG002|Phase 2 (Second Step)|Protocol Violation|1
7008666|NCT01456039|11077748|FG000|Phase 2 (Second Step)|Other|0
7008667|NCT01456039|11077749|FG001|Phase 2 (Second Step)|Other|0
7008668|NCT01456039|11077750|FG002|Phase 2 (Second Step)|Other|1
7008669|NCT01456052|11077769|FG000|Overall Study|Adverse Event|1
7008670|NCT01456052|11077770|FG001|Overall Study|Adverse Event|1
7008671|NCT01456052|11077771|FG002|Overall Study|Adverse Event|2
7008672|NCT01456052|11077769|FG000|Overall Study|Consent withdrawn|0
7008673|NCT01456052|11077770|FG001|Overall Study|Consent withdrawn|2
7008674|NCT01456052|11077771|FG002|Overall Study|Consent withdrawn|1
7008675|NCT01456052|11077769|FG000|Overall Study|Protocol Violation|0
7008676|NCT01456052|11077770|FG001|Overall Study|Protocol Violation|1
7008677|NCT01456052|11077771|FG002|Overall Study|Protocol Violation|0
7008678|NCT01456052|11077769|FG000|Overall Study|Physician Decision|1
7008679|NCT01456052|11077770|FG001|Overall Study|Physician Decision|0
7008680|NCT01456052|11077771|FG002|Overall Study|Physician Decision|1
7008681|NCT01456052|11077769|FG000|Overall Study|Treatment Failure|0
7008682|NCT01456052|11077770|FG001|Overall Study|Treatment Failure|1
7008683|NCT01456052|11077771|FG002|Overall Study|Treatment Failure|1
7008684|NCT01456130|11077780|FG000|Overall Study|Adverse Event|4
7008685|NCT01456130|11077780|FG000|Overall Study|Voluntary Withdrawal|1
7008686|NCT01456130|11077780|FG000|Overall Study|Lack of Efficacy|4
7008687|NCT01456130|11077780|FG000|Overall Study|Other|1
7008688|NCT01456169|11077791|FG000|Overall Study|Adverse Event|1
7008689|NCT01456169|11077792|FG001|Overall Study|Adverse Event|2
7008690|NCT01456169|11077793|FG002|Overall Study|Adverse Event|7
7008691|NCT01456169|11077791|FG000|Overall Study|Major Protocol Deviation|3
7008692|NCT01456169|11077792|FG001|Overall Study|Major Protocol Deviation|2
7008693|NCT01456169|11077793|FG002|Overall Study|Major Protocol Deviation|3
7008694|NCT01456169|11077791|FG000|Overall Study|Voluntary Withdrawal|3
7008695|NCT01456169|11077792|FG001|Overall Study|Voluntary Withdrawal|0
7008696|NCT01456169|11077793|FG002|Overall Study|Voluntary Withdrawal|2
7008697|NCT01456169|11077791|FG000|Overall Study|Lack of Efficacy|2
7008698|NCT01456169|11077792|FG001|Overall Study|Lack of Efficacy|0
7008699|NCT01456169|11077793|FG002|Overall Study|Lack of Efficacy|0
7008700|NCT01456169|11077791|FG000|Overall Study|Other|1
7008701|NCT01456169|11077792|FG001|Overall Study|Other|1
7008702|NCT01456169|11077793|FG002|Overall Study|Other|0
7008703|NCT01456195|11077805|FG000|Overall Study|Pretreatment Event/Adverse Event|1
7008704|NCT01456195|11077806|FG001|Overall Study|Pretreatment Event/Adverse Event|4
7008705|NCT01456195|11077807|FG002|Overall Study|Pretreatment Event/Adverse Event|1
7008706|NCT01456195|11077805|FG000|Overall Study|Lost to Follow-up|3
7008707|NCT01456195|11077806|FG001|Overall Study|Lost to Follow-up|1
7008708|NCT01456195|11077807|FG002|Overall Study|Lost to Follow-up|3
7008709|NCT01456195|11077805|FG000|Overall Study|Voluntary Withdrawal|5
7008710|NCT01456195|11077806|FG001|Overall Study|Voluntary Withdrawal|3
7008711|NCT01456195|11077807|FG002|Overall Study|Voluntary Withdrawal|7
7008712|NCT01456195|11077805|FG000|Overall Study|Lack of Efficacy|0
7008713|NCT01456195|11077806|FG001|Overall Study|Lack of Efficacy|1
7008714|NCT01456195|11077807|FG002|Overall Study|Lack of Efficacy|0
7008715|NCT01456195|11077805|FG000|Overall Study|Other Reasons|2
7008716|NCT01456195|11077806|FG001|Overall Study|Other Reasons|1
7008717|NCT01456195|11077807|FG002|Overall Study|Other Reasons|3
7008718|NCT01456221|11077817|FG000|Overall Study|Withdrawal by Subject|56
7008719|NCT01456221|11077818|FG001|Overall Study|Withdrawal by Subject|49
7008720|NCT01456221|11077817|FG000|Overall Study|Lost to Follow-up|1
7008721|NCT01456221|11077818|FG001|Overall Study|Lost to Follow-up|4
7008722|NCT01456221|11077817|FG000|Overall Study|Received medication|3
7008723|NCT01456221|11077818|FG001|Overall Study|Received medication|2
7008724|NCT01456221|11077817|FG000|Overall Study|Incomplete data|4
7008725|NCT01456221|11077818|FG001|Overall Study|Incomplete data|2
7008726|NCT01456780|11077849|FG000|Overall Study|Lost to Follow-up|3
7008727|NCT01456780|11077850|FG001|Overall Study|Lost to Follow-up|3
7008728|NCT01456780|11077851|FG002|Overall Study|Lost to Follow-up|0
7008729|NCT01456897|11077861|FG000|Overall Study|Adverse Event|19
7008730|NCT01456897|11077862|FG001|Overall Study|Adverse Event|22
7008731|NCT01456897|11077861|FG000|Overall Study|Protocol Violation|3
7008732|NCT01456897|11077862|FG001|Overall Study|Protocol Violation|4
7008733|NCT01456897|11077861|FG000|Overall Study|Physician Decision|5
7008734|NCT01456897|11077862|FG001|Overall Study|Physician Decision|3
7008735|NCT01456897|11077861|FG000|Overall Study|Withdrawal by Subject|44
7008736|NCT01456897|11077862|FG001|Overall Study|Withdrawal by Subject|17
7008737|NCT01456897|11077861|FG000|Overall Study|Lack of Efficacy|4
7008738|NCT01456897|11077862|FG001|Overall Study|Lack of Efficacy|11
7008739|NCT01456936|11077872|FG000|Overall Study|Other reason|41
7008740|NCT01456936|11077873|FG001|Overall Study|Other reason|30
7008741|NCT01456936|11077874|FG002|Overall Study|Other reason|36
7008742|NCT01456936|11077875|FG003|Overall Study|Other reason|33
7008743|NCT01456936|11077872|FG000|Overall Study|No longer meets eligibility criteria|4
7008744|NCT01456936|11077873|FG001|Overall Study|No longer meets eligibility criteria|8
7008745|NCT01456936|11077874|FG002|Overall Study|No longer meets eligibility criteria|6
7008746|NCT01456936|11077875|FG003|Overall Study|No longer meets eligibility criteria|5
7008747|NCT01456936|11077872|FG000|Overall Study|Protocol Violation|4
7008748|NCT01456936|11077873|FG001|Overall Study|Protocol Violation|2
7008749|NCT01456936|11077874|FG002|Overall Study|Protocol Violation|5
7008750|NCT01456936|11077875|FG003|Overall Study|Protocol Violation|5
7008751|NCT01456936|11077872|FG000|Overall Study|Pregnancy|1
7008752|NCT01456936|11077873|FG001|Overall Study|Pregnancy|0
7008753|NCT01456936|11077874|FG002|Overall Study|Pregnancy|0
7008754|NCT01456936|11077875|FG003|Overall Study|Pregnancy|1
7008755|NCT01456936|11077872|FG000|Overall Study|Insufficient clinical response|4
7008756|NCT01456936|11077873|FG001|Overall Study|Insufficient clinical response|4
7008757|NCT01456936|11077874|FG002|Overall Study|Insufficient clinical response|14
7008758|NCT01456936|11077875|FG003|Overall Study|Insufficient clinical response|13
7008759|NCT01456936|11077872|FG000|Overall Study|No longer willing to participate|195
7008760|NCT01456936|11077873|FG001|Overall Study|No longer willing to participate|218
7008761|NCT01456936|11077874|FG002|Overall Study|No longer willing to participate|224
7008762|NCT01456936|11077875|FG003|Overall Study|No longer willing to participate|248
7008763|NCT01456936|11077872|FG000|Overall Study|Lost to Follow-up|135
7008764|NCT01456936|11077873|FG001|Overall Study|Lost to Follow-up|126
7008765|NCT01456936|11077874|FG002|Overall Study|Lost to Follow-up|144
7008766|NCT01456936|11077875|FG003|Overall Study|Lost to Follow-up|127
7008767|NCT01456936|11077872|FG000|Overall Study|Medication error|0
7008768|NCT01456936|11077873|FG001|Overall Study|Medication error|1
7008769|NCT01456936|11077874|FG002|Overall Study|Medication error|0
7008770|NCT01456936|11077875|FG003|Overall Study|Medication error|1
7008771|NCT01456936|11077872|FG000|Overall Study|Adverse event (study drug)|25
7008772|NCT01456936|11077873|FG001|Overall Study|Adverse event (study drug)|21
7008773|NCT01456936|11077874|FG002|Overall Study|Adverse event (study drug)|26
7008774|NCT01456936|11077875|FG003|Overall Study|Adverse event (study drug)|17
7008775|NCT01456936|11077872|FG000|Overall Study|Adverse event (study drug unrelated)|9
7008776|NCT01456936|11077873|FG001|Overall Study|Adverse event (study drug unrelated)|7
7008777|NCT01456936|11077874|FG002|Overall Study|Adverse event (study drug unrelated)|9
7008778|NCT01456936|11077875|FG003|Overall Study|Adverse event (study drug unrelated)|9
7008779|NCT01456936|11077872|FG000|Overall Study|Death|0
7008780|NCT01456936|11077873|FG001|Overall Study|Death|3
7008781|NCT01456936|11077874|FG002|Overall Study|Death|1
7008782|NCT01456936|11077875|FG003|Overall Study|Death|3
7008783|NCT01456936|11077872|FG000|Overall Study|Randomized but not treated|21
7008784|NCT01456936|11077873|FG001|Overall Study|Randomized but not treated|28
7008785|NCT01456936|11077874|FG002|Overall Study|Randomized but not treated|16
7008786|NCT01456936|11077875|FG003|Overall Study|Randomized but not treated|21
7008787|NCT01456949|11077885|FG000|Enrollment|PI death- incomplete data|6
7008788|NCT01456949|11077885|FG000|Enrollment|Death|1
7008789|NCT01456949|11077885|FG000|Enrollment|I/E criteria not met prior to procedure|13
7008790|NCT01456949|11077885|FG000|Enrollment|Physician Decision|10
7008791|NCT01456949|11077885|FG000|Enrollment|Withdrawal by Subject|7
7008792|NCT01456949|11077885|FG000|Study Cryoablation Procedure & Follow-up|Death|5
7008793|NCT01456949|11077885|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23
7008794|NCT01456949|11077885|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11
7008795|NCT01456949|11077885|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1
7008796|NCT01456949|11077885|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10
7008797|NCT01456949|11077885|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2
7008798|NCT01456949|11077885|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6
7008799|NCT01456949|11077885|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4
7008800|NCT01456962|11077891|FG000|Overall Study|Lost to Follow-up|2
7008801|NCT01456962|11077892|FG001|Overall Study|Lost to Follow-up|1
7008802|NCT01457014|11077898|FG000|First Night|Didn't meet inclusion/exclusion criteria|37
7008803|NCT01457014|11077899|FG001|First Night|Didn't meet inclusion/exclusion criteria|0
7008804|NCT01457014|11077900|FG002|First Night|Didn't meet inclusion/exclusion criteria|0
7008805|NCT01457014|11077901|FG003|First Night|Didn't meet inclusion/exclusion criteria|0
7008806|NCT01457014|11077898|FG000|First Night|Withdrawal by Subject|3
7008807|NCT01457014|11077899|FG001|First Night|Withdrawal by Subject|0
7008808|NCT01457014|11077900|FG002|First Night|Withdrawal by Subject|0
7008809|NCT01457014|11077901|FG003|First Night|Withdrawal by Subject|0
7008810|NCT01457118|11077913|FG000|Overall Study|Adverse Event|1
7008811|NCT01457118|11077914|FG001|Overall Study|Adverse Event|0
7008812|NCT01457118|11077915|FG002|Overall Study|Adverse Event|0
7008813|NCT01457118|11077916|FG003|Overall Study|Adverse Event|1
7008814|NCT01457118|11077913|FG000|Overall Study|Clinical Progression|0
7008815|NCT01457118|11077914|FG001|Overall Study|Clinical Progression|1
7008816|NCT01457118|11077915|FG002|Overall Study|Clinical Progression|0
7008817|NCT01457118|11077916|FG003|Overall Study|Clinical Progression|1
7008818|NCT01457118|11077913|FG000|Overall Study|Physician Decision|2
7008819|NCT01457118|11077914|FG001|Overall Study|Physician Decision|0
7008820|NCT01457118|11077915|FG002|Overall Study|Physician Decision|0
7008821|NCT01457118|11077916|FG003|Overall Study|Physician Decision|0
7008822|NCT01457118|11077913|FG000|Overall Study|Progressive Disease by RECIST|12
7008823|NCT01457118|11077914|FG001|Overall Study|Progressive Disease by RECIST|3
7008824|NCT01457118|11077915|FG002|Overall Study|Progressive Disease by RECIST|1
7008825|NCT01457118|11077916|FG003|Overall Study|Progressive Disease by RECIST|0
7008826|NCT01457118|11077913|FG000|Overall Study|Withdrawal by Subject|5
7008827|NCT01457118|11077914|FG001|Overall Study|Withdrawal by Subject|0
7008828|NCT01457118|11077915|FG002|Overall Study|Withdrawal by Subject|0
7008829|NCT01457118|11077916|FG003|Overall Study|Withdrawal by Subject|0
7008830|NCT01457339|11077934|FG000|Period 3 (100 mg)|Adverse Event|0
7008831|NCT01457339|11077935|FG001|Period 3 (100 mg)|Adverse Event|1
7008832|NCT01457339|11077934|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0
7008833|NCT01457339|11077935|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1
7008834|NCT01457339|11077934|FG000|Period 6 (250 mg)|Family Emergency|1
7008835|NCT01457339|11077935|FG001|Period 6 (250 mg)|Family Emergency|0
7008836|NCT01457339|11077934|FG000|Period 6 (250 mg)|Personal appointment|0
7008837|NCT01457339|11077935|FG001|Period 6 (250 mg)|Personal appointment|1
7008838|NCT01457352|11077960|FG000|Period 1|Adverse Event|2
7008839|NCT01457352|11077961|FG001|Period 1|Adverse Event|0
7008840|NCT01457352|11077960|FG000|Period 1|Withdrawal by Subject|2
7008841|NCT01457352|11077961|FG001|Period 1|Withdrawal by Subject|0
7008842|NCT01457352|11077960|FG000|Period 1|Physician Decision|2
7008843|NCT01457352|11077961|FG001|Period 1|Physician Decision|0
7008844|NCT01457352|11077960|FG000|Period 1|MS related disease progression|1
7008845|NCT01457352|11077961|FG001|Period 1|MS related disease progression|0
7008846|NCT01457352|11077960|FG000|Period 1|Withdrawn|1
7008847|NCT01457352|11077961|FG001|Period 1|Withdrawn|0
7008848|NCT01457352|11077960|FG000|Period 1|withdrew per sponsor|1
7008849|NCT01457352|11077961|FG001|Period 1|withdrew per sponsor|0
7008850|NCT01457352|11077960|FG000|Period 1|Protocol Violation|4
7008851|NCT01457352|11077961|FG001|Period 1|Protocol Violation|0
7008852|NCT01457352|11077960|FG000|Period 1|Did not meet eligibility criteria|3
7008853|NCT01457352|11077961|FG001|Period 1|Did not meet eligibility criteria|0
7008854|NCT01457352|11077960|FG000|Period 2|Withdrawal by Subject|23
7008855|NCT01457352|11077961|FG001|Period 2|Withdrawal by Subject|0
7008856|NCT01457352|11077960|FG000|Period 2|Adverse Event|22
7008857|NCT01457352|11077961|FG001|Period 2|Adverse Event|0
7008858|NCT01457352|11077960|FG000|Period 2|no analysis|10
7008859|NCT01457352|11077961|FG001|Period 2|no analysis|0
7008860|NCT01457352|11077960|FG000|Period 2|Lack of Efficacy|8
7008861|NCT01457352|11077961|FG001|Period 2|Lack of Efficacy|0
7008862|NCT01457352|11077960|FG000|Period 2|Protocol Violation|4
7008863|NCT01457352|11077961|FG001|Period 2|Protocol Violation|0
7008864|NCT01457352|11077960|FG000|Period 2|Sponsor's withdrawal|7
7008865|NCT01457352|11077961|FG001|Period 2|Sponsor's withdrawal|0
7008866|NCT01457352|11077960|FG000|Period 2|Lost to Follow-up|1
7008867|NCT01457352|11077961|FG001|Period 2|Lost to Follow-up|0
7008868|NCT01457352|11077960|FG000|Period 2|dose change|1
7008869|NCT01457352|11077961|FG001|Period 2|dose change|0
7008870|NCT01457352|11077960|FG000|Period 2|Physician Decision|1
7008871|NCT01457352|11077961|FG001|Period 2|Physician Decision|0
7008872|NCT01457352|11077960|FG000|Period 2|Did not meet eligibility criteria|3
7008873|NCT01457352|11077961|FG001|Period 2|Did not meet eligibility criteria|0
7008874|NCT01457352|11077960|FG000|Period 3|Adverse Event|1
7008875|NCT01457352|11077961|FG001|Period 3|Adverse Event|1
7008876|NCT01457352|11077960|FG000|Period 3|Withdrawal by Subject|0
7008877|NCT01457352|11077961|FG001|Period 3|Withdrawal by Subject|2
7008878|NCT01457352|11077960|FG000|Period 3|incorrect treatment|0
7008879|NCT01457352|11077961|FG001|Period 3|incorrect treatment|1
7008880|NCT01457352|11077960|FG000|Period 3|Sponsor's withdrawal|0
7008881|NCT01457352|11077961|FG001|Period 3|Sponsor's withdrawal|1
7043255|NCT01742286|11128063|FG006|Escalation Phase|Adverse Event|0
7043256|NCT01742286|11128057|FG000|Escalation Phase|Disease progression|3
7043257|NCT01742286|11128058|FG001|Escalation Phase|Disease progression|7
7043258|NCT01742286|11128059|FG002|Escalation Phase|Disease progression|4
7043259|NCT01742286|11128060|FG003|Escalation Phase|Disease progression|1
7043260|NCT01742286|11128061|FG004|Escalation Phase|Disease progression|4
7043261|NCT01742286|11128062|FG005|Escalation Phase|Disease progression|3
7043262|NCT01742286|11128063|FG006|Escalation Phase|Disease progression|2
7043263|NCT01742286|11128057|FG000|Escalation Phase|Death|0
7043264|NCT01742286|11128058|FG001|Escalation Phase|Death|0
7043265|NCT01742286|11128059|FG002|Escalation Phase|Death|0
7043266|NCT01742286|11128060|FG003|Escalation Phase|Death|0
7043267|NCT01742286|11128061|FG004|Escalation Phase|Death|0
7043268|NCT01742286|11128062|FG005|Escalation Phase|Death|1
7043269|NCT01742286|11128063|FG006|Escalation Phase|Death|0
7043270|NCT01742286|11128057|FG000|Escalation Phase|Physician Decision|0
7043271|NCT01742286|11128058|FG001|Escalation Phase|Physician Decision|3
7043272|NCT01742286|11128059|FG002|Escalation Phase|Physician Decision|0
7043273|NCT01742286|11128060|FG003|Escalation Phase|Physician Decision|1
7043274|NCT01742286|11128061|FG004|Escalation Phase|Physician Decision|0
7043275|NCT01742286|11128062|FG005|Escalation Phase|Physician Decision|0
7043276|NCT01742286|11128063|FG006|Escalation Phase|Physician Decision|2
7043277|NCT01742286|11128057|FG000|Escalation Phase|Subject/guardian decision|1
7043278|NCT01742286|11128058|FG001|Escalation Phase|Subject/guardian decision|0
7043279|NCT01742286|11128059|FG002|Escalation Phase|Subject/guardian decision|0
7043280|NCT01742286|11128060|FG003|Escalation Phase|Subject/guardian decision|0
7043281|NCT01742286|11128061|FG004|Escalation Phase|Subject/guardian decision|0
7043282|NCT01742286|11128062|FG005|Escalation Phase|Subject/guardian decision|0
7043283|NCT01742286|11128063|FG006|Escalation Phase|Subject/guardian decision|0
7043284|NCT01742286|11128057|FG000|Expansion Phase|Administrative problems|0
7043285|NCT01742286|11128058|FG001|Expansion Phase|Administrative problems|0
7043286|NCT01742286|11128059|FG002|Expansion Phase|Administrative problems|0
7043287|NCT01742286|11128060|FG003|Expansion Phase|Administrative problems|0
7043288|NCT01742286|11128061|FG004|Expansion Phase|Administrative problems|0
7043289|NCT01742286|11128062|FG005|Expansion Phase|Administrative problems|0
7008882|NCT01457703|11078015|FG000|Overall Study|Screen Failure|5
7008883|NCT01457703|11078016|FG001|Overall Study|Screen Failure|7
7008884|NCT01457703|11078015|FG000|Overall Study|Withdrawal by Subject|1
7008885|NCT01457703|11078016|FG001|Overall Study|Withdrawal by Subject|4
7008886|NCT01457846|11078026|FG000|Overall Study|Death before treatment|1
7008887|NCT01457846|11078027|FG001|Overall Study|Death before treatment|2
7008888|NCT01457846|11078026|FG000|Overall Study|Did not receive treatment|0
7008889|NCT01457846|11078027|FG001|Overall Study|Did not receive treatment|1
7008890|NCT01457846|11078026|FG000|Overall Study|Death|27
7008891|NCT01457846|11078027|FG001|Overall Study|Death|16
7008892|NCT01457846|11078026|FG000|Overall Study|Unclassified reason for not completed|11
7008893|NCT01457846|11078027|FG001|Overall Study|Unclassified reason for not completed|10
7008894|NCT01457846|11078026|FG000|Overall Study|Withdrawal by Subject|1
7008895|NCT01457846|11078027|FG001|Overall Study|Withdrawal by Subject|1
7008896|NCT01457846|11078026|FG000|Overall Study|Lost to Follow-up|1
7008897|NCT01457846|11078027|FG001|Overall Study|Lost to Follow-up|0
7008898|NCT01457924|11078042|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0
7008899|NCT01457924|11078043|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4
7008900|NCT01457924|11078044|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1
7008901|NCT01457924|11078045|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0
7008902|NCT01457924|11078046|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2
7008903|NCT01457924|11078042|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0
7008904|NCT01457924|11078043|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0
7008905|NCT01457924|11078044|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0
7008906|NCT01457924|11078045|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0
7008907|NCT01457924|11078046|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1
7008908|NCT01457924|11078042|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1
7008909|NCT01457924|11078043|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
7008910|NCT01457924|11078044|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
7008911|NCT01457924|11078045|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
7008912|NCT01457924|11078046|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
7008913|NCT01457924|11078042|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1
7008914|NCT01457924|11078043|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0
7008915|NCT01457924|11078044|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1
7008916|NCT01457924|11078045|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0
7008917|NCT01457924|11078046|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0
7008918|NCT01457924|11078042|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
7008919|NCT01457924|11078043|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
7008920|NCT01457924|11078044|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
7008921|NCT01457924|11078045|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
7008922|NCT01457924|11078046|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
7008923|NCT01457924|11078042|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
7008924|NCT01457924|11078043|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
7008925|NCT01457924|11078044|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
7008926|NCT01457924|11078045|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
7008927|NCT01457924|11078046|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2
7008928|NCT01457924|11078042|FG000|FUP (Weeks 24-48)|Adverse Event|0
7008929|NCT01457924|11078043|FG001|FUP (Weeks 24-48)|Adverse Event|0
7008930|NCT01457924|11078044|FG002|FUP (Weeks 24-48)|Adverse Event|1
7008931|NCT01457924|11078045|FG003|FUP (Weeks 24-48)|Adverse Event|0
7008932|NCT01457924|11078046|FG004|FUP (Weeks 24-48)|Adverse Event|0
7008933|NCT01457924|11078042|FG000|FUP (Weeks 24-48)|Physician Decision|1
7008934|NCT01457924|11078043|FG001|FUP (Weeks 24-48)|Physician Decision|0
7008935|NCT01457924|11078044|FG002|FUP (Weeks 24-48)|Physician Decision|1
7008936|NCT01457924|11078045|FG003|FUP (Weeks 24-48)|Physician Decision|0
7008937|NCT01457924|11078046|FG004|FUP (Weeks 24-48)|Physician Decision|0
7008938|NCT01457924|11078042|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0
7008939|NCT01457924|11078043|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0
7008940|NCT01457924|11078044|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0
7008941|NCT01457924|11078045|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1
7008942|NCT01457924|11078046|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0
7008943|NCT01457924|11078042|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2
7008944|NCT01457924|11078043|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1
7008945|NCT01457924|11078044|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0
7008946|NCT01457924|11078045|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0
7008947|NCT01457924|11078046|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2
7008948|NCT01457924|11078042|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
7008949|NCT01457924|11078043|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
7008950|NCT01457924|11078044|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
7008951|NCT01457924|11078045|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
7008952|NCT01457924|11078046|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
7008953|NCT01457924|11078042|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
7008954|NCT01457924|11078043|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4
7008955|NCT01457924|11078044|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2
7008956|NCT01457924|11078045|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
7008957|NCT01457924|11078046|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5
7008958|NCT01457924|11078042|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
7008959|NCT01457924|11078043|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0
7008960|NCT01457924|11078044|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
7008961|NCT01457924|11078045|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2
7008962|NCT01457924|11078046|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
7008963|NCT01457950|11078060|FG000|Double-Blind Phase|Continuation Criteria Not Met|1
7008964|NCT01457950|11078061|FG001|Double-Blind Phase|Continuation Criteria Not Met|0
7008965|NCT01457950|11078062|FG002|Double-Blind Phase|Continuation Criteria Not Met|0
7008966|NCT01457950|11078063|FG003|Double-Blind Phase|Continuation Criteria Not Met|0
7008967|NCT01457950|11078060|FG000|Double-Blind Phase|Protocol Violation|2
7008968|NCT01457950|11078061|FG001|Double-Blind Phase|Protocol Violation|1
7008969|NCT01457950|11078062|FG002|Double-Blind Phase|Protocol Violation|0
7008970|NCT01457950|11078063|FG003|Double-Blind Phase|Protocol Violation|0
7008971|NCT01457950|11078060|FG000|Double-Blind Phase|Withdrawal by Subject|6
7008972|NCT01457950|11078061|FG001|Double-Blind Phase|Withdrawal by Subject|2
7008973|NCT01457950|11078062|FG002|Double-Blind Phase|Withdrawal by Subject|0
7008974|NCT01457950|11078063|FG003|Double-Blind Phase|Withdrawal by Subject|0
7008975|NCT01457950|11078060|FG000|Open-Label Phase|Adverse Event|0
7008976|NCT01457950|11078061|FG001|Open-Label Phase|Adverse Event|0
7008977|NCT01457950|11078062|FG002|Open-Label Phase|Adverse Event|0
7008978|NCT01457950|11078063|FG003|Open-Label Phase|Adverse Event|1
7008979|NCT01457950|11078060|FG000|Open-Label Phase|Protocol Violation|0
7008980|NCT01457950|11078061|FG001|Open-Label Phase|Protocol Violation|0
7008981|NCT01457950|11078062|FG002|Open-Label Phase|Protocol Violation|0
7008982|NCT01457950|11078063|FG003|Open-Label Phase|Protocol Violation|1
7008983|NCT01457950|11078060|FG000|Open-Label Phase|Withdrawal by Subject|0
7008984|NCT01457950|11078061|FG001|Open-Label Phase|Withdrawal by Subject|0
7008985|NCT01457950|11078062|FG002|Open-Label Phase|Withdrawal by Subject|2
7008986|NCT01457950|11078063|FG003|Open-Label Phase|Withdrawal by Subject|0
7008987|NCT01458106|11078076|FG000|Overall Study|Withdrawal by Subject|2
7008988|NCT01458106|11078077|FG001|Overall Study|Withdrawal by Subject|0
7008989|NCT01458106|11078076|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1
7008990|NCT01458106|11078077|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0
7008991|NCT01458106|11078076|FG000|Overall Study|Withdrawn Per Protocol|0
7008992|NCT01458106|11078077|FG001|Overall Study|Withdrawn Per Protocol|1
7008993|NCT01458119|11078086|FG000|Overall Study|Physician Decision|4
7008994|NCT01458119|11078086|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1
7008995|NCT01458119|11078086|FG000|Overall Study|Pregnancy|1
7008996|NCT01458119|11078086|FG000|Overall Study|Death|2
7008997|NCT01458119|11078086|FG000|Overall Study|Adverse Event|1
7008998|NCT01458119|11078086|FG000|Overall Study|Consent Withdrawn by Participant|8
7008999|NCT01458119|11078086|FG000|Overall Study|Non-compliance With Study Drug|3
7009000|NCT01458132|11078093|FG000|Overall Study|Other|15
7009001|NCT01458132|11078094|FG001|Overall Study|Other|3
7009002|NCT01458171|11078100|FG000|Overall Study|Adverse Event|1
7009003|NCT01458210|11078106|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2
7009004|NCT01458210|11078106|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2
7009005|NCT01458210|11078106|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2
7009006|NCT01458210|11078106|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1
7009007|NCT01458249|11078115|FG000|Overall Study|Not treated|1
7009008|NCT01458249|11078115|FG000|Overall Study|Adverse Event|4
7009009|NCT01458249|11078115|FG000|Overall Study|Other|2
7009010|NCT01458249|11078115|FG000|Overall Study|Ongoing|1
7009011|NCT01458275|11078123|FG000|Overall Study|Adverse Event|3
7009012|NCT01458275|11078124|FG001|Overall Study|Adverse Event|4
7009013|NCT01458275|11078125|FG002|Overall Study|Adverse Event|1
7009014|NCT01458275|11078123|FG000|Overall Study|Lost to Follow-up|3
7009015|NCT01458275|11078124|FG001|Overall Study|Lost to Follow-up|2
7009016|NCT01458275|11078125|FG002|Overall Study|Lost to Follow-up|5
7009017|NCT01458275|11078123|FG000|Overall Study|Protocol Violation|5
7009018|NCT01458275|11078124|FG001|Overall Study|Protocol Violation|5
7009019|NCT01458275|11078125|FG002|Overall Study|Protocol Violation|2
7009020|NCT01458275|11078123|FG000|Overall Study|Withdrawal by Subject|3
7009021|NCT01458275|11078124|FG001|Overall Study|Withdrawal by Subject|2
7009022|NCT01458275|11078125|FG002|Overall Study|Withdrawal by Subject|1
7009023|NCT01458366|11078150|FG000|Period 1: 70mg/m^2|Physician Decision|2
7009024|NCT01458366|11078151|FG001|Period 1: 70mg/m^2|Physician Decision|0
7009025|NCT01458366|11078152|FG002|Period 1: 70mg/m^2|Physician Decision|0
7009026|NCT01458366|11078153|FG003|Period 1: 70mg/m^2|Physician Decision|0
7009027|NCT01458366|11078154|FG004|Period 1: 70mg/m^2|Physician Decision|0
7009028|NCT01458366|11078150|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
7009029|NCT01458366|11078151|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
7009030|NCT01458366|11078152|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
7009031|NCT01458366|11078153|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
7009032|NCT01458366|11078154|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1
7009033|NCT01458392|11078165|FG000|Overall Study|Death|2
7009034|NCT01458392|11078166|FG001|Overall Study|Death|11
7009035|NCT01458392|11078167|FG002|Overall Study|Death|22
7009036|NCT01458392|11078165|FG000|Overall Study|At the discretion of the sponsor|0
7009037|NCT01458392|11078166|FG001|Overall Study|At the discretion of the sponsor|2
7009038|NCT01458392|11078167|FG002|Overall Study|At the discretion of the sponsor|7
7009039|NCT01458392|11078165|FG000|Overall Study|Patient unwilling to comply with protoco|0
7009040|NCT01458392|11078166|FG001|Overall Study|Patient unwilling to comply with protoco|0
7009041|NCT01458392|11078167|FG002|Overall Study|Patient unwilling to comply with protoco|2
7009042|NCT01458522|11078198|FG000|Overall Study|Withdrawal by Subject|2
7009043|NCT01458522|11078199|FG001|Overall Study|Withdrawal by Subject|2
7009044|NCT01458522|11078198|FG000|Overall Study|Physician Decision|1
7009045|NCT01458522|11078199|FG001|Overall Study|Physician Decision|9
7009046|NCT01458535|11078217|FG000|Overall Study|Other|0
7009047|NCT01458535|11078218|FG001|Overall Study|Other|0
7009048|NCT01458535|11078219|FG002|Overall Study|Other|0
7009049|NCT01458535|11078220|FG003|Overall Study|Other|0
7009050|NCT01458535|11078221|FG004|Overall Study|Other|1
7009051|NCT01458535|11078222|FG005|Overall Study|Other|1
7009052|NCT01458535|11078217|FG000|Overall Study|Withdrawal by Subject|0
7009053|NCT01458535|11078218|FG001|Overall Study|Withdrawal by Subject|0
7009054|NCT01458535|11078219|FG002|Overall Study|Withdrawal by Subject|2
7009055|NCT01458535|11078220|FG003|Overall Study|Withdrawal by Subject|0
7009056|NCT01458535|11078221|FG004|Overall Study|Withdrawal by Subject|1
7009057|NCT01458535|11078222|FG005|Overall Study|Withdrawal by Subject|1
7009058|NCT01458535|11078217|FG000|Overall Study|Lost to Follow-up|0
7009059|NCT01458535|11078218|FG001|Overall Study|Lost to Follow-up|2
7009060|NCT01458535|11078219|FG002|Overall Study|Lost to Follow-up|0
7009061|NCT01458535|11078220|FG003|Overall Study|Lost to Follow-up|3
7009062|NCT01458535|11078221|FG004|Overall Study|Lost to Follow-up|2
7009063|NCT01458535|11078222|FG005|Overall Study|Lost to Follow-up|2
7009064|NCT01458535|11078217|FG000|Overall Study|Adverse Event|0
7009065|NCT01458535|11078218|FG001|Overall Study|Adverse Event|0
7009066|NCT01458535|11078219|FG002|Overall Study|Adverse Event|0
7009067|NCT01458535|11078220|FG003|Overall Study|Adverse Event|1
7009068|NCT01458535|11078221|FG004|Overall Study|Adverse Event|0
7009069|NCT01458535|11078222|FG005|Overall Study|Adverse Event|0
7009070|NCT01458574|11078278|FG000|Overall Study|Adverse Event|5
7009071|NCT01458574|11078279|FG001|Overall Study|Adverse Event|9
7009072|NCT01458574|11078280|FG002|Overall Study|Adverse Event|7
7009073|NCT01458574|11078278|FG000|Overall Study|Lack of Efficacy|70
7009074|NCT01458574|11078279|FG001|Overall Study|Lack of Efficacy|53
7009075|NCT01458574|11078280|FG002|Overall Study|Lack of Efficacy|132
7009076|NCT01458574|11078278|FG000|Overall Study|Lost to Follow-up|3
7009077|NCT01458574|11078279|FG001|Overall Study|Lost to Follow-up|2
7009078|NCT01458574|11078280|FG002|Overall Study|Lost to Follow-up|1
7009079|NCT01458574|11078278|FG000|Overall Study|Pregnancy|1
7009080|NCT01458574|11078279|FG001|Overall Study|Pregnancy|1
7009081|NCT01458574|11078280|FG002|Overall Study|Pregnancy|0
7009082|NCT01458574|11078278|FG000|Overall Study|Protocol Violation|0
7009083|NCT01458574|11078279|FG001|Overall Study|Protocol Violation|1
7009084|NCT01458574|11078280|FG002|Overall Study|Protocol Violation|0
7009085|NCT01458574|11078278|FG000|Overall Study|Withdrawal by Subject|6
7009086|NCT01458574|11078279|FG001|Overall Study|Withdrawal by Subject|3
7009087|NCT01458574|11078280|FG002|Overall Study|Withdrawal by Subject|5
7009088|NCT01458574|11078278|FG000|Overall Study|Other|2
7009089|NCT01458574|11078279|FG001|Overall Study|Other|1
7009090|NCT01458574|11078280|FG002|Overall Study|Other|0
7009091|NCT01458574|11078278|FG000|Overall Study|Randomized but not treated|0
7009092|NCT01458574|11078279|FG001|Overall Study|Randomized but not treated|1
7009093|NCT01458574|11078280|FG002|Overall Study|Randomized but not treated|0
7009094|NCT01458587|11078290|FG000|Overall Study|Withdrawal by Subject|1
7009095|NCT01458587|11078291|FG001|Overall Study|Withdrawal by Subject|0
7009096|NCT01458639|11078299|FG000|Overall Study|Physician Decision|4
7009097|NCT01458639|11078299|FG000|Overall Study|Equipment issue|1
7009098|NCT01458639|11078299|FG000|Overall Study|Inability to obtain subject blood sample|1
7009099|NCT01458951|11078306|FG000|Overall Study|Other|1
7009100|NCT01458951|11078307|FG001|Overall Study|Other|0
7009101|NCT01458951|11078308|FG002|Overall Study|Other|0
7009102|NCT01458951|11078306|FG000|Overall Study|Protocol Violation|5
7009103|NCT01458951|11078307|FG001|Overall Study|Protocol Violation|1
7009104|NCT01458951|11078308|FG002|Overall Study|Protocol Violation|0
7009105|NCT01458951|11078306|FG000|Overall Study|Withdrawal by Subject|2
7009106|NCT01458951|11078307|FG001|Overall Study|Withdrawal by Subject|0
7009107|NCT01458951|11078308|FG002|Overall Study|Withdrawal by Subject|2
7009108|NCT01458951|11078306|FG000|Overall Study|Adverse Event|7
7009109|NCT01458951|11078307|FG001|Overall Study|Adverse Event|0
7009110|NCT01458951|11078308|FG002|Overall Study|Adverse Event|2
7009111|NCT01458951|11078306|FG000|Overall Study|Insufficient Clinical Response|17
7009112|NCT01458951|11078307|FG001|Overall Study|Insufficient Clinical Response|0
7009113|NCT01458951|11078308|FG002|Overall Study|Insufficient Clinical Response|11
7009114|NCT01459016|11078326|FG000|Overall Study|Withdrawal by Subject|11
7009115|NCT01459016|11078326|FG000|Overall Study|Amendment Discontinuation Criteria|4
7009116|NCT01459068|11078332|FG000|Overall Study|Withdrawal by Subject|8
7009117|NCT01459068|11078333|FG001|Overall Study|Withdrawal by Subject|18
7009118|NCT01459068|11078332|FG000|Overall Study|Lost to Follow-up|31
7009119|NCT01459068|11078333|FG001|Overall Study|Lost to Follow-up|15
7009120|NCT01459068|11078332|FG000|Overall Study|Death|0
7009121|NCT01459068|11078333|FG001|Overall Study|Death|1
7009122|NCT01459614|11078358|FG000|Overall Study|Adverse Event|1
7009123|NCT01459614|11078359|FG001|Overall Study|Adverse Event|0
7009124|NCT01459718|11078449|FG000|Overall Study|Physician Decision|1
7009125|NCT01459718|11078449|FG000|Overall Study|Lost to Follow-up|1
7009126|NCT01459718|11078449|FG000|Overall Study|Adverse Event|1
7009127|NCT01459783|11078455|FG000|Baseline to 6 Months|Death|1
7009128|NCT01459783|11078456|FG001|Baseline to 6 Months|Death|0
7009129|NCT01459783|11078455|FG000|Baseline to 6 Months|Withdrawal by Subject|12
7009130|NCT01459783|11078456|FG001|Baseline to 6 Months|Withdrawal by Subject|6
7009131|NCT01459783|11078455|FG000|Baseline to 6 Months|Lost to Follow-up|19
7009132|NCT01459783|11078456|FG001|Baseline to 6 Months|Lost to Follow-up|14
7009133|NCT01459783|11078455|FG000|6 Months to 12 Months|Death|0
7009134|NCT01459783|11078456|FG001|6 Months to 12 Months|Death|1
7009135|NCT01459783|11078455|FG000|6 Months to 12 Months|Withdrawal by Subject|6
7009136|NCT01459783|11078456|FG001|6 Months to 12 Months|Withdrawal by Subject|5
7009137|NCT01459783|11078455|FG000|6 Months to 12 Months|Lost to Follow-up|2
7009138|NCT01459783|11078456|FG001|6 Months to 12 Months|Lost to Follow-up|7
7009139|NCT01459783|11078455|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11
7009140|NCT01459783|11078456|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17
7009141|NCT01459796|11078464|FG000|Overall Study|Non compliance with protocol|2
7009142|NCT01459796|11078465|FG001|Overall Study|Non compliance with protocol|4
7009143|NCT01459796|11078464|FG000|Overall Study|Adverse Event|5
7009144|NCT01459796|11078465|FG001|Overall Study|Adverse Event|5
7009145|NCT01459796|11078464|FG000|Overall Study|Withdrawal by Subject|6
7009146|NCT01459796|11078465|FG001|Overall Study|Withdrawal by Subject|3
7009147|NCT01459796|11078464|FG000|Overall Study|Lost to Follow-up|5
7009148|NCT01459796|11078465|FG001|Overall Study|Lost to Follow-up|4
7009149|NCT01459796|11078464|FG000|Overall Study|Reason unspecified|1
7009150|NCT01459796|11078465|FG001|Overall Study|Reason unspecified|2
7009151|NCT01459796|11078464|FG000|Overall Study|Decision by the sponsor|75
7009152|NCT01459796|11078465|FG001|Overall Study|Decision by the sponsor|108
7009153|NCT01459913|11078475|FG000|Overall Study|Adverse Event|0
7009154|NCT01459913|11078476|FG001|Overall Study|Adverse Event|0
7009155|NCT01459913|11078477|FG002|Overall Study|Adverse Event|0
7009156|NCT01459913|11078478|FG003|Overall Study|Adverse Event|3
7009157|NCT01459913|11078475|FG000|Overall Study|Withdrawal by Subject|4
7009158|NCT01459913|11078476|FG001|Overall Study|Withdrawal by Subject|0
7009159|NCT01459913|11078477|FG002|Overall Study|Withdrawal by Subject|0
7009160|NCT01459913|11078478|FG003|Overall Study|Withdrawal by Subject|5
7009161|NCT01459913|11078475|FG000|Overall Study|Lost to Follow-up|7
7009162|NCT01459913|11078476|FG001|Overall Study|Lost to Follow-up|4
7009163|NCT01459913|11078477|FG002|Overall Study|Lost to Follow-up|1
7009164|NCT01459913|11078478|FG003|Overall Study|Lost to Follow-up|8
7009165|NCT01459913|11078475|FG000|Overall Study|Death|0
7009166|NCT01459913|11078476|FG001|Overall Study|Death|0
7009167|NCT01459913|11078477|FG002|Overall Study|Death|0
7009168|NCT01459913|11078478|FG003|Overall Study|Death|1
7009169|NCT01459913|11078475|FG000|Overall Study|Non- Compliance|0
7009170|NCT01459913|11078476|FG001|Overall Study|Non- Compliance|0
7009171|NCT01459913|11078477|FG002|Overall Study|Non- Compliance|0
7009172|NCT01459913|11078478|FG003|Overall Study|Non- Compliance|3
7009173|NCT01459913|11078475|FG000|Overall Study|Physician Decision|0
7009174|NCT01459913|11078476|FG001|Overall Study|Physician Decision|1
7009175|NCT01459913|11078477|FG002|Overall Study|Physician Decision|0
7009176|NCT01459913|11078478|FG003|Overall Study|Physician Decision|0
7009177|NCT01459913|11078475|FG000|Overall Study|Study Terminated by Sponsor|30
7009178|NCT01459913|11078476|FG001|Overall Study|Study Terminated by Sponsor|15
7009179|NCT01459913|11078477|FG002|Overall Study|Study Terminated by Sponsor|9
7009180|NCT01459913|11078478|FG003|Overall Study|Study Terminated by Sponsor|11
7009181|NCT01459913|11078475|FG000|Overall Study|Other|0
7009182|NCT01459913|11078476|FG001|Overall Study|Other|0
7009183|NCT01459913|11078477|FG002|Overall Study|Other|3
7009184|NCT01459913|11078478|FG003|Overall Study|Other|1
7009185|NCT01459913|11078475|FG000|Overall Study|Did Not Meet Inclusion Criteria|0
7009186|NCT01459913|11078476|FG001|Overall Study|Did Not Meet Inclusion Criteria|0
7009187|NCT01459913|11078477|FG002|Overall Study|Did Not Meet Inclusion Criteria|0
7009188|NCT01459913|11078478|FG003|Overall Study|Did Not Meet Inclusion Criteria|1
7009189|NCT01460290|11078495|FG000|Overall Study|Adverse Event|3
7009190|NCT01460290|11078495|FG000|Overall Study|Elevated liver function|1
7009191|NCT01460342|11078511|FG000|Overall Study|Adverse Event|5
7009192|NCT01460342|11078512|FG001|Overall Study|Adverse Event|4
7009193|NCT01460342|11078511|FG000|Overall Study|Lost to Follow-up|1
7009194|NCT01460342|11078512|FG001|Overall Study|Lost to Follow-up|2
7009195|NCT01460342|11078511|FG000|Overall Study|Protocol Violation|0
7009196|NCT01460342|11078512|FG001|Overall Study|Protocol Violation|1
7009197|NCT01460342|11078511|FG000|Overall Study|Withdrawal by Subject|3
7009198|NCT01460342|11078512|FG001|Overall Study|Withdrawal by Subject|4
7009199|NCT01460342|11078511|FG000|Overall Study|Physician Decision|1
7009200|NCT01460342|11078512|FG001|Overall Study|Physician Decision|3
7009201|NCT01460342|11078511|FG000|Overall Study|Lack of Efficacy|1
7009202|NCT01460342|11078512|FG001|Overall Study|Lack of Efficacy|0
7009203|NCT01460368|11078520|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0
7009204|NCT01460368|11078521|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0
7009205|NCT01460368|11078522|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0
7009206|NCT01460368|11078523|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0
7009207|NCT01460368|11078524|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1
7009208|NCT01460368|11078525|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0
7009209|NCT01460368|11078526|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0
7009210|NCT01460368|11078520|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
7009211|NCT01460368|11078521|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1
7009212|NCT01460368|11078522|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
7009213|NCT01460368|11078523|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
7009214|NCT01460368|11078524|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
7009215|NCT01460368|11078525|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
7009216|NCT01460368|11078526|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1
7143158|NCT03027466|11299522|FG000|Overall Study|Opting out of the app|1869
7143159|NCT03027466|11299523|FG001|Overall Study|Opting out of the app|1819
7143160|NCT03027466|11299524|FG002|Overall Study|Opting out of the app|1743
7143161|NCT03027466|11299525|FG003|Overall Study|Opting out of the app|1821
7143162|NCT03027557|11299538|FG000|Overall Study|Adverse Event|1
7009217|NCT01460368|11078520|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
7009218|NCT01460368|11078521|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1
7009219|NCT01460368|11078522|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
7009220|NCT01460368|11078523|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
7009221|NCT01460368|11078524|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
7009222|NCT01460368|11078525|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
7009223|NCT01460368|11078526|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
7009224|NCT01460368|11078520|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0
7009225|NCT01460368|11078521|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0
7009226|NCT01460368|11078522|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1
7009227|NCT01460368|11078523|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0
7009228|NCT01460368|11078524|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0
7009229|NCT01460368|11078525|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0
7009230|NCT01460368|11078526|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0
7009231|NCT01460368|11078520|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
7009232|NCT01460368|11078521|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
7009233|NCT01460368|11078522|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
7009234|NCT01460368|11078523|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
7009235|NCT01460368|11078524|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
7009236|NCT01460368|11078525|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
7009237|NCT01460368|11078526|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
7009238|NCT01460381|11078537|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1
7009239|NCT01460381|11078538|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0
7009240|NCT01460407|11078546|FG000|Period 2: Day 6 to Day 14|Adverse Event|0
7009241|NCT01460407|11078547|FG001|Period 2: Day 6 to Day 14|Adverse Event|1
7009242|NCT01460446|11078556|FG000|Overall Study|Non-compliance|2
7009243|NCT01460446|11078557|FG001|Overall Study|Non-compliance|9
7009244|NCT01460446|11078556|FG000|Overall Study|Consent Withdrawn|0
7009245|NCT01460446|11078557|FG001|Overall Study|Consent Withdrawn|4
7009246|NCT01460446|11078556|FG000|Overall Study|Non-compliance & Consent Withdrawn|1
7009247|NCT01460446|11078557|FG001|Overall Study|Non-compliance & Consent Withdrawn|3
7009248|NCT01460446|11078556|FG000|Overall Study|Surgery/Illness|1
7009249|NCT01460446|11078557|FG001|Overall Study|Surgery/Illness|1
7009250|NCT01460446|11078556|FG000|Overall Study|Pregnancy|1
7009251|NCT01460446|11078557|FG001|Overall Study|Pregnancy|0
7009252|NCT01460446|11078556|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0
7009253|NCT01460446|11078557|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3
7009254|NCT01460628|11078564|FG000|Overall Study|Adverse Event|3
7009255|NCT01460628|11078564|FG000|Overall Study|Withdrawal by Subject|2
7009256|NCT01460719|11078568|FG000|Overall Study|Adverse Event|1
7009257|NCT01460719|11078568|FG000|Overall Study|Withdrawal by Subject|1
7009258|NCT01460901|11078582|FG000|Overall Study|Withdrawal by Subject|2
7009259|NCT01461005|11078601|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1
7009260|NCT01461044|11078608|FG000|Overall Study|Death|58
7009261|NCT01461044|11078609|FG001|Overall Study|Death|35
7009262|NCT01461044|11078608|FG000|Overall Study|Lost to Follow-up|12
7009263|NCT01461044|11078609|FG001|Overall Study|Lost to Follow-up|5
7009264|NCT01461057|11078620|FG000|Overall Study|Death|10
7009265|NCT01461057|11078621|FG001|Overall Study|Death|9
7009266|NCT01461057|11078620|FG000|Overall Study|Withdrawal by Subject|2
7009267|NCT01461057|11078621|FG001|Overall Study|Withdrawal by Subject|3
7009268|NCT01461057|11078620|FG000|Overall Study|Physician Decision|0
7009269|NCT01461057|11078621|FG001|Overall Study|Physician Decision|2
7009270|NCT01461057|11078620|FG000|Overall Study|Adverse Event|0
7009271|NCT01461057|11078621|FG001|Overall Study|Adverse Event|1
7009272|NCT01461057|11078620|FG000|Overall Study|Progression of Disease|1
7009273|NCT01461057|11078621|FG001|Overall Study|Progression of Disease|0
7009274|NCT01461057|11078620|FG000|Overall Study|Study Terminated by Sponsor|2
7009275|NCT01461057|11078621|FG001|Overall Study|Study Terminated by Sponsor|0
7009276|NCT01461096|11078629|FG000|Overall Study|Death|3
7143163|NCT03027557|11299539|FG001|Overall Study|Adverse Event|0
7009277|NCT01461096|11078630|FG001|Overall Study|Death|6
7009278|NCT01461096|11078629|FG000|Overall Study|Severe debilitation, unable to continue|1
7009279|NCT01461096|11078630|FG001|Overall Study|Severe debilitation, unable to continue|1
7009280|NCT01461096|11078629|FG000|Overall Study|Subj not able to get to clinic|15
7009281|NCT01461096|11078630|FG001|Overall Study|Subj not able to get to clinic|13
7009282|NCT01461096|11078629|FG000|Overall Study|Site is closing|27
7009283|NCT01461096|11078630|FG001|Overall Study|Site is closing|30
7009284|NCT01461096|11078629|FG000|Overall Study|Withdrawal by Subject|5
7009285|NCT01461096|11078630|FG001|Overall Study|Withdrawal by Subject|3
7009286|NCT01461096|11078629|FG000|Overall Study|Subj not willing to adhere to reqs|3
7009287|NCT01461096|11078630|FG001|Overall Study|Subj not willing to adhere to reqs|4
7009288|NCT01461096|11078629|FG000|Overall Study|Lost to Follow-up|8
7009289|NCT01461096|11078630|FG001|Overall Study|Lost to Follow-up|4
7009290|NCT01461369|11078640|FG000|Overall Study|Lack of Efficacy|2
7009291|NCT01461369|11078641|FG001|Overall Study|Lack of Efficacy|0
7009292|NCT01461369|11078642|FG002|Overall Study|Lack of Efficacy|6
7009293|NCT01461369|11078640|FG000|Overall Study|Lost to Follow-up|0
7009294|NCT01461369|11078641|FG001|Overall Study|Lost to Follow-up|0
7009295|NCT01461369|11078642|FG002|Overall Study|Lost to Follow-up|3
7009296|NCT01461369|11078640|FG000|Overall Study|Adverse Event|9
7009297|NCT01461369|11078641|FG001|Overall Study|Adverse Event|12
7009298|NCT01461369|11078642|FG002|Overall Study|Adverse Event|4
7009299|NCT01461369|11078640|FG000|Overall Study|Protocol Violation|1
7009300|NCT01461369|11078641|FG001|Overall Study|Protocol Violation|2
7009301|NCT01461369|11078642|FG002|Overall Study|Protocol Violation|2
7009302|NCT01461369|11078640|FG000|Overall Study|Withdrawal by Subject|1
7009303|NCT01461369|11078641|FG001|Overall Study|Withdrawal by Subject|3
7009304|NCT01461369|11078642|FG002|Overall Study|Withdrawal by Subject|2
7009305|NCT01461538|11078673|FG000|Overall Study|Death|15
7009306|NCT01461538|11078674|FG001|Overall Study|Death|6
7009307|NCT01461538|11078675|FG002|Overall Study|Death|2
7009308|NCT01461538|11078673|FG000|Overall Study|Study Stopped by Sponsor|2
7009309|NCT01461538|11078674|FG001|Overall Study|Study Stopped by Sponsor|1
7009310|NCT01461538|11078675|FG002|Overall Study|Study Stopped by Sponsor|0
7009311|NCT01461538|11078673|FG000|Overall Study|Withdrawal by Subject|1
7009312|NCT01461538|11078674|FG001|Overall Study|Withdrawal by Subject|1
7009313|NCT01461538|11078675|FG002|Overall Study|Withdrawal by Subject|0
7009314|NCT01461551|11078688|FG000|Overall Study|Physician Decision|2
7009315|NCT01461551|11078689|FG001|Overall Study|Physician Decision|1
7009316|NCT01461551|11078690|FG002|Overall Study|Physician Decision|2
7009317|NCT01461707|11078714|FG000|Overall Study|Withdrawal by Subject|1
7009318|NCT01461707|11078715|FG001|Overall Study|Withdrawal by Subject|0
7009319|NCT01461811|11078732|FG000|Overall Study|Adverse Event|2
7009320|NCT01461811|11078733|FG001|Overall Study|Adverse Event|1
7009321|NCT01461811|11078732|FG000|Overall Study|Subject decision unrelated to an AE|1
7009322|NCT01461811|11078733|FG001|Overall Study|Subject decision unrelated to an AE|1
7009323|NCT01461811|11078732|FG000|Overall Study|Noncompliance|1
7009324|NCT01461811|11078733|FG001|Overall Study|Noncompliance|1
7009325|NCT01461928|11078763|FG000|Induction (up to 8 Months)|Adverse Event|76
7009326|NCT01461928|11078764|FG001|Induction (up to 8 Months)|Adverse Event|0
7009327|NCT01461928|11078765|FG002|Induction (up to 8 Months)|Adverse Event|0
7009328|NCT01461928|11078763|FG000|Induction (up to 8 Months)|Death|3
7009329|NCT01461928|11078764|FG001|Induction (up to 8 Months)|Death|0
7009330|NCT01461928|11078765|FG002|Induction (up to 8 Months)|Death|0
7009331|NCT01461928|11078763|FG000|Induction (up to 8 Months)|Lost to Follow-up|5
7009332|NCT01461928|11078764|FG001|Induction (up to 8 Months)|Lost to Follow-up|0
7009333|NCT01461928|11078765|FG002|Induction (up to 8 Months)|Lost to Follow-up|0
7009334|NCT01461928|11078763|FG000|Induction (up to 8 Months)|Physician Decision|9
7009335|NCT01461928|11078764|FG001|Induction (up to 8 Months)|Physician Decision|0
7009336|NCT01461928|11078765|FG002|Induction (up to 8 Months)|Physician Decision|0
7009337|NCT01461928|11078763|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18
7009338|NCT01461928|11078764|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0
7009339|NCT01461928|11078765|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0
7009340|NCT01461928|11078763|FG000|Induction (up to 8 Months)|Disease progression|45
7009341|NCT01461928|11078764|FG001|Induction (up to 8 Months)|Disease progression|0
7009342|NCT01461928|11078765|FG002|Induction (up to 8 Months)|Disease progression|0
7009343|NCT01461928|11078763|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10
7009344|NCT01461928|11078764|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0
7009345|NCT01461928|11078765|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0
7009346|NCT01461928|11078763|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11
7009347|NCT01461928|11078764|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0
7009348|NCT01461928|11078765|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0
7009349|NCT01461928|11078763|FG000|Induction (up to 8 Months)|Not responding to treatment|11
7009350|NCT01461928|11078764|FG001|Induction (up to 8 Months)|Not responding to treatment|0
7009351|NCT01461928|11078765|FG002|Induction (up to 8 Months)|Not responding to treatment|0
7009352|NCT01461928|11078763|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1
7009353|NCT01461928|11078764|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0
7009354|NCT01461928|11078765|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0
7009355|NCT01461928|11078763|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1
7009356|NCT01461928|11078764|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0
7009357|NCT01461928|11078765|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0
7009358|NCT01461928|11078763|FG000|Induction (up to 8 Months)|Sponsor decision|1
7009359|NCT01461928|11078764|FG001|Induction (up to 8 Months)|Sponsor decision|0
7009360|NCT01461928|11078765|FG002|Induction (up to 8 Months)|Sponsor decision|0
7009361|NCT01461928|11078763|FG000|Induction (up to 8 Months)|Protocol deviation|2
7009362|NCT01461928|11078764|FG001|Induction (up to 8 Months)|Protocol deviation|0
7009363|NCT01461928|11078765|FG002|Induction (up to 8 Months)|Protocol deviation|0
7009364|NCT01461928|11078763|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1
7009365|NCT01461928|11078764|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0
7009366|NCT01461928|11078765|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0
7009367|NCT01461928|11078763|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1
7009368|NCT01461928|11078764|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0
7009369|NCT01461928|11078765|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0
7009370|NCT01461928|11078763|FG000|Induction (up to 8 Months)|Promotor request|1
7009371|NCT01461928|11078764|FG001|Induction (up to 8 Months)|Promotor request|0
7009372|NCT01461928|11078765|FG002|Induction (up to 8 Months)|Promotor request|0
7009373|NCT01461928|11078763|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1
7009374|NCT01461928|11078764|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0
7009375|NCT01461928|11078765|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0
7009376|NCT01461928|11078763|FG000|Induction (up to 8 Months)|Medical advisor request|1
7009377|NCT01461928|11078764|FG001|Induction (up to 8 Months)|Medical advisor request|0
7009378|NCT01461928|11078765|FG002|Induction (up to 8 Months)|Medical advisor request|0
7009379|NCT01461928|11078763|FG000|Maintenance I (24 Months)|Death|3
7009380|NCT01461928|11078764|FG001|Maintenance I (24 Months)|Death|0
7009381|NCT01461928|11078765|FG002|Maintenance I (24 Months)|Death|0
7009382|NCT01461928|11078763|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32
7009383|NCT01461928|11078764|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0
7009384|NCT01461928|11078765|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0
7009385|NCT01461928|11078763|FG000|Maintenance I (24 Months)|Lost to Follow-up|2
7009386|NCT01461928|11078764|FG001|Maintenance I (24 Months)|Lost to Follow-up|0
7009387|NCT01461928|11078765|FG002|Maintenance I (24 Months)|Lost to Follow-up|0
7009388|NCT01461928|11078763|FG000|Maintenance I (24 Months)|Diseases progression|91
7009389|NCT01461928|11078764|FG001|Maintenance I (24 Months)|Diseases progression|0
7009390|NCT01461928|11078765|FG002|Maintenance I (24 Months)|Diseases progression|0
7009391|NCT01461928|11078763|FG000|Maintenance I (24 Months)|Adverse Event|70
7009392|NCT01461928|11078764|FG001|Maintenance I (24 Months)|Adverse Event|0
7009393|NCT01461928|11078765|FG002|Maintenance I (24 Months)|Adverse Event|0
7009394|NCT01461928|11078763|FG000|Maintenance I (24 Months)|Physician Decision|9
7009395|NCT01461928|11078764|FG001|Maintenance I (24 Months)|Physician Decision|0
7009396|NCT01461928|11078765|FG002|Maintenance I (24 Months)|Physician Decision|0
7009397|NCT01461928|11078763|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2
7009398|NCT01461928|11078764|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0
7009399|NCT01461928|11078765|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0
7009400|NCT01461928|11078763|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2
7009401|NCT01461928|11078764|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0
7009402|NCT01461928|11078765|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0
7009403|NCT01461928|11078763|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1
7009404|NCT01461928|11078764|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0
7009405|NCT01461928|11078765|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0
7009406|NCT01461928|11078763|FG000|Maintenance I (24 Months)|Not compliant|1
7009407|NCT01461928|11078764|FG001|Maintenance I (24 Months)|Not compliant|0
7009408|NCT01461928|11078765|FG002|Maintenance I (24 Months)|Not compliant|0
7009409|NCT01461928|11078763|FG000|Maintenance I (24 Months)|Did not meet criteria|5
7009410|NCT01461928|11078764|FG001|Maintenance I (24 Months)|Did not meet criteria|0
7009411|NCT01461928|11078765|FG002|Maintenance I (24 Months)|Did not meet criteria|0
7009412|NCT01461928|11078763|FG000|Maintenance II (15 Months)|Adverse Event|0
7009413|NCT01461928|11078764|FG001|Maintenance II (15 Months)|Adverse Event|2
7009414|NCT01461928|11078765|FG002|Maintenance II (15 Months)|Adverse Event|0
7009415|NCT01461928|11078763|FG000|Maintenance II (15 Months)|Death|0
7009416|NCT01461928|11078764|FG001|Maintenance II (15 Months)|Death|10
7009417|NCT01461928|11078765|FG002|Maintenance II (15 Months)|Death|8
7009418|NCT01461928|11078763|FG000|Maintenance II (15 Months)|Physician Decision|0
7009419|NCT01461928|11078764|FG001|Maintenance II (15 Months)|Physician Decision|0
7009420|NCT01461928|11078765|FG002|Maintenance II (15 Months)|Physician Decision|4
7009421|NCT01461928|11078763|FG000|Maintenance II (15 Months)|Lost to Follow-up|0
7009422|NCT01461928|11078764|FG001|Maintenance II (15 Months)|Lost to Follow-up|1
7009423|NCT01461928|11078765|FG002|Maintenance II (15 Months)|Lost to Follow-up|0
7009424|NCT01461928|11078763|FG000|Maintenance II (15 Months)|Moved to another town|0
7009425|NCT01461928|11078764|FG001|Maintenance II (15 Months)|Moved to another town|1
7009426|NCT01461928|11078765|FG002|Maintenance II (15 Months)|Moved to another town|0
7009427|NCT01461928|11078763|FG000|Maintenance II (15 Months)|Disease progression|0
7009428|NCT01461928|11078764|FG001|Maintenance II (15 Months)|Disease progression|0
7009429|NCT01461928|11078765|FG002|Maintenance II (15 Months)|Disease progression|3
7009430|NCT01461928|11078763|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0
7009431|NCT01461928|11078764|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9
7009432|NCT01461928|11078765|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8
7009433|NCT01461928|11078763|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0
7009434|NCT01461928|11078764|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0
7009435|NCT01461928|11078765|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1
7009436|NCT01461928|11078763|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0
7009437|NCT01461928|11078764|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0
7009438|NCT01461928|11078765|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1
7009439|NCT01461928|11078763|FG000|Maintenance II (15 Months)|Withdrew informed consent|0
7009440|NCT01461928|11078764|FG001|Maintenance II (15 Months)|Withdrew informed consent|0
7009441|NCT01461928|11078765|FG002|Maintenance II (15 Months)|Withdrew informed consent|1
7009442|NCT01461928|11078763|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0
7009443|NCT01461928|11078764|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0
7009444|NCT01461928|11078765|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1
7009445|NCT01461980|11078779|FG000|Overall Study|Other|9
7009446|NCT01461980|11078780|FG001|Overall Study|Other|8
7009447|NCT01461980|11078781|FG002|Overall Study|Other|6
7009448|NCT01461980|11078779|FG000|Overall Study|Medication error|7
7009449|NCT01461980|11078780|FG001|Overall Study|Medication error|5
7009450|NCT01461980|11078781|FG002|Overall Study|Medication error|6
7009451|NCT01461980|11078779|FG000|Overall Study|Adverse Event|12
7009452|NCT01461980|11078780|FG001|Overall Study|Adverse Event|5
7009453|NCT01461980|11078781|FG002|Overall Study|Adverse Event|6
7009454|NCT01461980|11078779|FG000|Overall Study|Protocol Violation|12
7009455|NCT01461980|11078780|FG001|Overall Study|Protocol Violation|19
7009456|NCT01461980|11078781|FG002|Overall Study|Protocol Violation|16
7009457|NCT01461980|11078779|FG000|Overall Study|No longer meets eligibility criteria|18
7009458|NCT01461980|11078780|FG001|Overall Study|No longer meets eligibility criteria|9
7009459|NCT01461980|11078781|FG002|Overall Study|No longer meets eligibility criteria|19
7009460|NCT01461980|11078779|FG000|Overall Study|Lost to Follow-up|52
7009461|NCT01461980|11078780|FG001|Overall Study|Lost to Follow-up|53
7009462|NCT01461980|11078781|FG002|Overall Study|Lost to Follow-up|51
7009463|NCT01461980|11078779|FG000|Overall Study|No longer willing to participate|52
7009464|NCT01461980|11078780|FG001|Overall Study|No longer willing to participate|38
7009465|NCT01461980|11078781|FG002|Overall Study|No longer willing to participate|54
7009466|NCT01461980|11078779|FG000|Overall Study|Randomized but not vaccinated|4
7009467|NCT01461980|11078780|FG001|Overall Study|Randomized but not vaccinated|8
7009468|NCT01461980|11078781|FG002|Overall Study|Randomized but not vaccinated|7
7009469|NCT01461993|11078793|FG000|Overall Study|Withdrawal by Subject|60
7009470|NCT01461993|11078794|FG001|Overall Study|Withdrawal by Subject|53
7009471|NCT01461993|11078795|FG002|Overall Study|Withdrawal by Subject|16
7009472|NCT01461993|11078793|FG000|Overall Study|Lost to Follow-up|44
7009473|NCT01461993|11078794|FG001|Overall Study|Lost to Follow-up|48
7009474|NCT01461993|11078795|FG002|Overall Study|Lost to Follow-up|22
7009475|NCT01461993|11078793|FG000|Overall Study|Protocol Violation|10
7009476|NCT01461993|11078794|FG001|Overall Study|Protocol Violation|9
7009477|NCT01461993|11078795|FG002|Overall Study|Protocol Violation|7
7009478|NCT01461993|11078793|FG000|Overall Study|Adverse Event|9
7009479|NCT01461993|11078794|FG001|Overall Study|Adverse Event|11
7009480|NCT01461993|11078795|FG002|Overall Study|Adverse Event|3
7009481|NCT01461993|11078793|FG000|Overall Study|No longer met eligibility criteria|13
7009482|NCT01461993|11078794|FG001|Overall Study|No longer met eligibility criteria|18
7009483|NCT01461993|11078795|FG002|Overall Study|No longer met eligibility criteria|10
7009484|NCT01461993|11078793|FG000|Overall Study|Did not meet entrance criteria|2
7009485|NCT01461993|11078794|FG001|Overall Study|Did not meet entrance criteria|3
7009486|NCT01461993|11078795|FG002|Overall Study|Did not meet entrance criteria|0
7009487|NCT01461993|11078793|FG000|Overall Study|Other|13
7009488|NCT01461993|11078794|FG001|Overall Study|Other|15
7009489|NCT01461993|11078795|FG002|Overall Study|Other|6
7009490|NCT01462045|11078807|FG000|Overall Study|Family matter|0
7009491|NCT01462045|11078808|FG001|Overall Study|Family matter|1
7009492|NCT01462045|11078809|FG002|Overall Study|Family matter|0
7009493|NCT01462084|11078817|FG000|Overall Study|Withdrawal by Subject|1
7009494|NCT01462084|11078818|FG001|Overall Study|Withdrawal by Subject|0
7009495|NCT01462084|11078817|FG000|Overall Study|Protocol Violation|1
7009496|NCT01462084|11078818|FG001|Overall Study|Protocol Violation|1
7009497|NCT01462110|11078827|FG000|Overall Study|Adverse Event|1
7009498|NCT01462110|11078828|FG001|Overall Study|Adverse Event|0
7009499|NCT01462162|11078834|FG000|Overall Study|Adverse Event|5
7009500|NCT01462162|11078834|FG000|Overall Study|Lack of Efficacy|4
7009501|NCT01462162|11078834|FG000|Overall Study|Abnormal laboratory parameters|1
7009502|NCT01462162|11078834|FG000|Overall Study|Other|2
7009503|NCT01462227|11078841|FG000|Second Assignment|Lost to Follow-up|1
7009504|NCT01462227|11078842|FG001|Second Assignment|Lost to Follow-up|0
7009505|NCT01462227|11078843|FG002|Second Assignment|Lost to Follow-up|0
7009506|NCT01462227|11078844|FG003|Second Assignment|Lost to Follow-up|0
7009507|NCT01462227|11078841|FG000|Second Assignment|Protocol Violation|0
7009508|NCT01462227|11078842|FG001|Second Assignment|Protocol Violation|1
7009509|NCT01462227|11078843|FG002|Second Assignment|Protocol Violation|1
7009510|NCT01462227|11078844|FG003|Second Assignment|Protocol Violation|0
7009511|NCT01462266|11078858|FG000|Overall Study|Adverse Event|7
7009512|NCT01462266|11078859|FG001|Overall Study|Adverse Event|6
7009513|NCT01462266|11078858|FG000|Overall Study|Death|2
7009514|NCT01462266|11078859|FG001|Overall Study|Death|1
7009515|NCT01462266|11078858|FG000|Overall Study|Lack of Efficacy|0
7009516|NCT01462266|11078859|FG001|Overall Study|Lack of Efficacy|2
7009517|NCT01462266|11078858|FG000|Overall Study|Lost to Follow-up|4
7009518|NCT01462266|11078859|FG001|Overall Study|Lost to Follow-up|3
7009519|NCT01462266|11078858|FG000|Overall Study|Non-compliance with study drug|3
7009520|NCT01462266|11078859|FG001|Overall Study|Non-compliance with study drug|0
7009521|NCT01462266|11078858|FG000|Overall Study|Creatinine and eGFR, excluded medication|8
7009522|NCT01462266|11078859|FG001|Overall Study|Creatinine and eGFR, excluded medication|4
7009523|NCT01462266|11078858|FG000|Overall Study|Physician Decision|2
7009524|NCT01462266|11078859|FG001|Overall Study|Physician Decision|5
7009525|NCT01462266|11078858|FG000|Overall Study|Protocol Violation|1
7009526|NCT01462266|11078859|FG001|Overall Study|Protocol Violation|3
7009527|NCT01462266|11078858|FG000|Overall Study|Withdrawal by Subject|7
7009528|NCT01462266|11078859|FG001|Overall Study|Withdrawal by Subject|2
7009529|NCT01462266|11078858|FG000|Overall Study|Screen failure|1
7009530|NCT01462266|11078859|FG001|Overall Study|Screen failure|1
7009531|NCT01462318|11078896|FG000|Main Study / TP-DI Study|Other|2
7009532|NCT01462318|11078897|FG001|Main Study / TP-DI Study|Other|0
7009533|NCT01462318|11078898|FG002|Main Study / TP-DI Study|Other|0
7009534|NCT01462318|11078896|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2
7009535|NCT01462318|11078897|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0
7009536|NCT01462318|11078898|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0
7009537|NCT01462318|11078896|FG000|Main Study / TP-DI Study|Adverse Event|4
7009538|NCT01462318|11078897|FG001|Main Study / TP-DI Study|Adverse Event|0
7009539|NCT01462318|11078898|FG002|Main Study / TP-DI Study|Adverse Event|0
7009540|NCT01462318|11078896|FG000|Extension Phase|Lost to Follow-up|0
7009541|NCT01462318|11078897|FG001|Extension Phase|Lost to Follow-up|0
7009542|NCT01462318|11078898|FG002|Extension Phase|Lost to Follow-up|1
7009543|NCT01462318|11078896|FG000|Extension Phase|Other|0
7009544|NCT01462318|11078897|FG001|Extension Phase|Other|0
7009545|NCT01462318|11078898|FG002|Extension Phase|Other|1
7009546|NCT01462318|11078896|FG000|Extension Phase|Disease Progression|0
7009547|NCT01462318|11078897|FG001|Extension Phase|Disease Progression|0
7009548|NCT01462318|11078898|FG002|Extension Phase|Disease Progression|1
7009549|NCT01462318|11078896|FG000|Extension Phase|Withdrawal by Subject|0
7009550|NCT01462318|11078897|FG001|Extension Phase|Withdrawal by Subject|0
7009551|NCT01462318|11078898|FG002|Extension Phase|Withdrawal by Subject|15
7009552|NCT01462318|11078896|FG000|Extension Phase|Investigator Decision|0
7009553|NCT01462318|11078897|FG001|Extension Phase|Investigator Decision|0
7009554|NCT01462318|11078898|FG002|Extension Phase|Investigator Decision|5
7009555|NCT01462318|11078896|FG000|Extension Phase|Adverse Event|0
7009556|NCT01462318|11078897|FG001|Extension Phase|Adverse Event|0
7009557|NCT01462318|11078898|FG002|Extension Phase|Adverse Event|22
7009558|NCT01462344|11078905|FG000|Overall Study|Withdrawal by Subject|245
7009559|NCT01462344|11078906|FG001|Overall Study|Withdrawal by Subject|226
7009560|NCT01462344|11078905|FG000|Overall Study|Adverse Event|24
7009561|NCT01462344|11078906|FG001|Overall Study|Adverse Event|23
7009562|NCT01462344|11078905|FG000|Overall Study|Asthma Exacerbation|34
7009563|NCT01462344|11078906|FG001|Overall Study|Asthma Exacerbation|35
7009564|NCT01462344|11078905|FG000|Overall Study|Lack of Efficacy|5
7009565|NCT01462344|11078906|FG001|Overall Study|Lack of Efficacy|6
7009566|NCT01462344|11078905|FG000|Overall Study|Protocol Violation|68
7009567|NCT01462344|11078906|FG001|Overall Study|Protocol Violation|53
7009568|NCT01462344|11078905|FG000|Overall Study|Lost to Follow-up|7
7009569|NCT01462344|11078906|FG001|Overall Study|Lost to Follow-up|7
7009570|NCT01462357|11078915|FG000|Overall Study|Death|0
7009571|NCT01462357|11078916|FG001|Overall Study|Death|0
7009572|NCT01462357|11078917|FG002|Overall Study|Death|1
7009573|NCT01462357|11078915|FG000|Overall Study|Withdrawal by Subject|3
7009574|NCT01462357|11078916|FG001|Overall Study|Withdrawal by Subject|11
7009575|NCT01462357|11078917|FG002|Overall Study|Withdrawal by Subject|3
7009576|NCT01462357|11078915|FG000|Overall Study|Migrated/moved from study area|2
7009577|NCT01462357|11078916|FG001|Overall Study|Migrated/moved from study area|3
7009578|NCT01462357|11078917|FG002|Overall Study|Migrated/moved from study area|1
7009579|NCT01462357|11078915|FG000|Overall Study|Lost to Follow-up|3
7009580|NCT01462357|11078916|FG001|Overall Study|Lost to Follow-up|5
7009581|NCT01462357|11078917|FG002|Overall Study|Lost to Follow-up|7
7009582|NCT01462435|11078929|FG000|Overall Study|Lack of Efficacy|1
7009583|NCT01462435|11078930|FG001|Overall Study|Lack of Efficacy|0
7009584|NCT01462435|11078931|FG002|Overall Study|Lack of Efficacy|0
7009585|NCT01462435|11078932|FG003|Overall Study|Lack of Efficacy|3
7009586|NCT01462435|11078929|FG000|Overall Study|Physician Decision|0
7009587|NCT01462435|11078930|FG001|Overall Study|Physician Decision|0
7009588|NCT01462435|11078931|FG002|Overall Study|Physician Decision|1
7009589|NCT01462435|11078932|FG003|Overall Study|Physician Decision|0
7009590|NCT01462435|11078929|FG000|Overall Study|Withdrawal by Subject|0
7009591|NCT01462435|11078930|FG001|Overall Study|Withdrawal by Subject|0
7009592|NCT01462435|11078931|FG002|Overall Study|Withdrawal by Subject|0
7009593|NCT01462435|11078932|FG003|Overall Study|Withdrawal by Subject|1
7009594|NCT01462435|11078929|FG000|Overall Study|Lost to Follow-up|0
7009595|NCT01462435|11078930|FG001|Overall Study|Lost to Follow-up|0
7009596|NCT01462435|11078931|FG002|Overall Study|Lost to Follow-up|0
7009597|NCT01462435|11078932|FG003|Overall Study|Lost to Follow-up|1
7009598|NCT01462695|11078948|FG000|Overall Study|Adverse Event|1
7009599|NCT01462695|11078949|FG001|Overall Study|Adverse Event|1
7009600|NCT01462695|11078948|FG000|Overall Study|Death|2
7009601|NCT01462695|11078949|FG001|Overall Study|Death|0
7009602|NCT01462695|11078948|FG000|Overall Study|Lack of Efficacy|6
7009603|NCT01462695|11078949|FG001|Overall Study|Lack of Efficacy|12
7009604|NCT01462695|11078948|FG000|Overall Study|Physician Decision|5
7009605|NCT01462695|11078949|FG001|Overall Study|Physician Decision|0
7009606|NCT01462695|11078948|FG000|Overall Study|Withdrawal by Subject|2
7009607|NCT01462695|11078949|FG001|Overall Study|Withdrawal by Subject|0
7009608|NCT01462695|11078948|FG000|Overall Study|Inevaluable (did not receive study drug)|1
7009609|NCT01462695|11078949|FG001|Overall Study|Inevaluable (did not receive study drug)|0
7009610|NCT01462929|11078976|FG000|Overall Study|Adverse Event|3
7009611|NCT01462929|11078977|FG001|Overall Study|Adverse Event|3
7009612|NCT01462929|11078978|FG002|Overall Study|Adverse Event|4
7009613|NCT01462929|11078976|FG000|Overall Study|Withdrawal by Subject|2
7009614|NCT01462929|11078977|FG001|Overall Study|Withdrawal by Subject|1
7009615|NCT01462929|11078978|FG002|Overall Study|Withdrawal by Subject|0
7009616|NCT01462929|11078976|FG000|Overall Study|Lack of Efficacy|0
7009617|NCT01462929|11078977|FG001|Overall Study|Lack of Efficacy|0
7009618|NCT01462929|11078978|FG002|Overall Study|Lack of Efficacy|1
7009619|NCT01462942|11078991|FG000|Overall Study|Adverse Event|7
7009620|NCT01462942|11078992|FG001|Overall Study|Adverse Event|12
7009621|NCT01462942|11078993|FG002|Overall Study|Adverse Event|10
7009622|NCT01462942|11078994|FG003|Overall Study|Adverse Event|11
7009623|NCT01462942|11078995|FG004|Overall Study|Adverse Event|11
7009624|NCT01462942|11078991|FG000|Overall Study|Other, including COPD exacerbation|3
7009625|NCT01462942|11078992|FG001|Overall Study|Other, including COPD exacerbation|5
7009626|NCT01462942|11078993|FG002|Overall Study|Other, including COPD exacerbation|2
7009627|NCT01462942|11078994|FG003|Overall Study|Other, including COPD exacerbation|8
7009628|NCT01462942|11078995|FG004|Overall Study|Other, including COPD exacerbation|5
7009629|NCT01462942|11078991|FG000|Overall Study|Withdrawal by Subject|14
7009630|NCT01462942|11078992|FG001|Overall Study|Withdrawal by Subject|10
7009631|NCT01462942|11078993|FG002|Overall Study|Withdrawal by Subject|14
7009632|NCT01462942|11078994|FG003|Overall Study|Withdrawal by Subject|16
7009633|NCT01462942|11078995|FG004|Overall Study|Withdrawal by Subject|19
7009634|NCT01462942|11078991|FG000|Overall Study|Lack of Efficacy|6
7009635|NCT01462942|11078992|FG001|Overall Study|Lack of Efficacy|0
7009636|NCT01462942|11078993|FG002|Overall Study|Lack of Efficacy|4
7009637|NCT01462942|11078994|FG003|Overall Study|Lack of Efficacy|5
7009638|NCT01462942|11078995|FG004|Overall Study|Lack of Efficacy|3
7009639|NCT01462942|11078991|FG000|Overall Study|Lost to Follow-up|0
7009640|NCT01462942|11078992|FG001|Overall Study|Lost to Follow-up|1
7009641|NCT01462942|11078993|FG002|Overall Study|Lost to Follow-up|1
7009642|NCT01462942|11078994|FG003|Overall Study|Lost to Follow-up|1
7009643|NCT01462942|11078995|FG004|Overall Study|Lost to Follow-up|1
7009644|NCT01462942|11078991|FG000|Overall Study|Protocol Violation|4
7009645|NCT01462942|11078992|FG001|Overall Study|Protocol Violation|6
7009646|NCT01462942|11078993|FG002|Overall Study|Protocol Violation|9
7009647|NCT01462942|11078994|FG003|Overall Study|Protocol Violation|9
7009648|NCT01462942|11078995|FG004|Overall Study|Protocol Violation|6
7009649|NCT01463007|11079007|FG000|Overall Study|Physician Decision|1
7009650|NCT01463033|11079014|FG000|Overall Study|Lost to Follow-up|4
7009651|NCT01463033|11079015|FG001|Overall Study|Lost to Follow-up|4
7009652|NCT01463033|11079014|FG000|Overall Study|Death|3
7009653|NCT01463033|11079015|FG001|Overall Study|Death|2
7009654|NCT01463098|11079036|FG000|Part A (11 Days)|Participant Choice|2
7009655|NCT01463098|11079037|FG001|Part A (11 Days)|Participant Choice|0
7009656|NCT01463098|11079038|FG002|Part A (11 Days)|Participant Choice|0
7009657|NCT01463098|11079039|FG003|Part A (11 Days)|Participant Choice|0
7009658|NCT01463098|11079040|FG004|Part A (11 Days)|Participant Choice|0
7009659|NCT01463098|11079041|FG005|Part A (11 Days)|Participant Choice|0
7009660|NCT01463098|11079042|FG006|Part A (11 Days)|Participant Choice|0
7009661|NCT01463098|11079043|FG007|Part A (11 Days)|Participant Choice|0
7009662|NCT01463098|11079044|FG008|Part A (11 Days)|Participant Choice|1
7009663|NCT01463098|11079045|FG009|Part A (11 Days)|Participant Choice|0
7009664|NCT01463098|11079046|FG010|Part A (11 Days)|Participant Choice|0
7009665|NCT01463098|11079047|FG011|Part A (11 Days)|Participant Choice|0
7009666|NCT01463098|11079048|FG012|Part A (11 Days)|Participant Choice|0
7009667|NCT01463098|11079049|FG013|Part A (11 Days)|Participant Choice|0
7009668|NCT01463098|11079036|FG000|Part A (11 Days)|Lost to Follow-up|0
7009669|NCT01463098|11079037|FG001|Part A (11 Days)|Lost to Follow-up|0
7009670|NCT01463098|11079038|FG002|Part A (11 Days)|Lost to Follow-up|0
7009671|NCT01463098|11079039|FG003|Part A (11 Days)|Lost to Follow-up|0
7009672|NCT01463098|11079040|FG004|Part A (11 Days)|Lost to Follow-up|1
7009673|NCT01463098|11079041|FG005|Part A (11 Days)|Lost to Follow-up|0
7009674|NCT01463098|11079042|FG006|Part A (11 Days)|Lost to Follow-up|0
7009675|NCT01463098|11079043|FG007|Part A (11 Days)|Lost to Follow-up|0
7009676|NCT01463098|11079044|FG008|Part A (11 Days)|Lost to Follow-up|0
7009677|NCT01463098|11079045|FG009|Part A (11 Days)|Lost to Follow-up|0
7009678|NCT01463098|11079046|FG010|Part A (11 Days)|Lost to Follow-up|0
7009679|NCT01463098|11079047|FG011|Part A (11 Days)|Lost to Follow-up|0
7009680|NCT01463098|11079048|FG012|Part A (11 Days)|Lost to Follow-up|0
7009681|NCT01463098|11079049|FG013|Part A (11 Days)|Lost to Follow-up|0
7009682|NCT01463098|11079036|FG000|Part B (11 Days)|Participant Choice|0
7009683|NCT01463098|11079037|FG001|Part B (11 Days)|Participant Choice|0
7009684|NCT01463098|11079038|FG002|Part B (11 Days)|Participant Choice|0
7009685|NCT01463098|11079039|FG003|Part B (11 Days)|Participant Choice|0
7009686|NCT01463098|11079040|FG004|Part B (11 Days)|Participant Choice|0
7009687|NCT01463098|11079041|FG005|Part B (11 Days)|Participant Choice|0
7009688|NCT01463098|11079042|FG006|Part B (11 Days)|Participant Choice|0
7009689|NCT01463098|11079043|FG007|Part B (11 Days)|Participant Choice|0
7009690|NCT01463098|11079044|FG008|Part B (11 Days)|Participant Choice|0
7009691|NCT01463098|11079045|FG009|Part B (11 Days)|Participant Choice|0
7009692|NCT01463098|11079046|FG010|Part B (11 Days)|Participant Choice|0
7009693|NCT01463098|11079047|FG011|Part B (11 Days)|Participant Choice|1
7009694|NCT01463098|11079048|FG012|Part B (11 Days)|Participant Choice|0
7009695|NCT01463098|11079049|FG013|Part B (11 Days)|Participant Choice|0
7009696|NCT01463111|11079098|FG000|Overall Study|Withdrawal by Subject|2
7009697|NCT01463111|11079098|FG000|Overall Study|Lost to Follow-up|5
7009698|NCT01463111|11079098|FG000|Overall Study|Physician Decision|2
7043290|NCT01742286|11128063|FG006|Expansion Phase|Administrative problems|5
7043291|NCT01742286|11128057|FG000|Expansion Phase|Physician Decision|0
7043292|NCT01742286|11128058|FG001|Expansion Phase|Physician Decision|0
7043293|NCT01742286|11128059|FG002|Expansion Phase|Physician Decision|4
7043294|NCT01742286|11128060|FG003|Expansion Phase|Physician Decision|0
7043295|NCT01742286|11128061|FG004|Expansion Phase|Physician Decision|0
7043296|NCT01742286|11128062|FG005|Expansion Phase|Physician Decision|0
7043297|NCT01742286|11128063|FG006|Expansion Phase|Physician Decision|9
7043298|NCT01742286|11128057|FG000|Expansion Phase|Adverse Event|0
7043299|NCT01742286|11128058|FG001|Expansion Phase|Adverse Event|0
7043300|NCT01742286|11128059|FG002|Expansion Phase|Adverse Event|0
7043301|NCT01742286|11128060|FG003|Expansion Phase|Adverse Event|0
7043302|NCT01742286|11128061|FG004|Expansion Phase|Adverse Event|0
7043303|NCT01742286|11128062|FG005|Expansion Phase|Adverse Event|0
7043304|NCT01742286|11128063|FG006|Expansion Phase|Adverse Event|6
7043305|NCT01742286|11128057|FG000|Expansion Phase|Disease progression|0
7043306|NCT01742286|11128058|FG001|Expansion Phase|Disease progression|0
7043307|NCT01742286|11128059|FG002|Expansion Phase|Disease progression|3
7043308|NCT01742286|11128060|FG003|Expansion Phase|Disease progression|0
7043309|NCT01742286|11128061|FG004|Expansion Phase|Disease progression|0
7043310|NCT01742286|11128062|FG005|Expansion Phase|Disease progression|0
7043311|NCT01742286|11128063|FG006|Expansion Phase|Disease progression|15
7043312|NCT01742286|11128057|FG000|Expansion Phase|Withdrawal by Subject|0
7043313|NCT01742286|11128058|FG001|Expansion Phase|Withdrawal by Subject|0
7043314|NCT01742286|11128059|FG002|Expansion Phase|Withdrawal by Subject|0
7043315|NCT01742286|11128060|FG003|Expansion Phase|Withdrawal by Subject|0
7043316|NCT01742286|11128061|FG004|Expansion Phase|Withdrawal by Subject|0
7043317|NCT01742286|11128062|FG005|Expansion Phase|Withdrawal by Subject|0
7043318|NCT01742286|11128063|FG006|Expansion Phase|Withdrawal by Subject|1
7043319|NCT01742897|11128113|FG000|Overall Study|Adverse Event|3
7043320|NCT01742897|11128113|FG000|Overall Study|Withdrawal by Subject|1
7043321|NCT01742897|11128113|FG000|Overall Study|Other|1
7043322|NCT01743001|11128138|FG000|Overall Study|Physician Decision|1
7043323|NCT01743001|11128139|FG001|Overall Study|Physician Decision|0
7043324|NCT01743001|11128138|FG000|Overall Study|Pregnancy|1
7043325|NCT01743001|11128139|FG001|Overall Study|Pregnancy|0
7043326|NCT01743001|11128138|FG000|Overall Study|Death|1
7043327|NCT01743001|11128139|FG001|Overall Study|Death|0
7043328|NCT01743027|11128149|FG000|Overall Study|Adverse Event|2
7043329|NCT01743027|11128150|FG001|Overall Study|Adverse Event|0
7043330|NCT01743027|11128151|FG002|Overall Study|Adverse Event|0
7043331|NCT01743027|11128152|FG003|Overall Study|Adverse Event|0
7043332|NCT01743027|11128149|FG000|Overall Study|Lost to Follow-up|0
7043333|NCT01743027|11128150|FG001|Overall Study|Lost to Follow-up|0
7043334|NCT01743027|11128151|FG002|Overall Study|Lost to Follow-up|2
7043335|NCT01743027|11128152|FG003|Overall Study|Lost to Follow-up|0
7043336|NCT01743027|11128149|FG000|Overall Study|Progressive Disease|1
7043337|NCT01743027|11128150|FG001|Overall Study|Progressive Disease|4
7043338|NCT01743027|11128151|FG002|Overall Study|Progressive Disease|3
7043339|NCT01743027|11128152|FG003|Overall Study|Progressive Disease|0
7043340|NCT01743027|11128149|FG000|Overall Study|Protocol Violation|1
7043341|NCT01743027|11128150|FG001|Overall Study|Protocol Violation|1
7043342|NCT01743027|11128151|FG002|Overall Study|Protocol Violation|1
7043343|NCT01743027|11128152|FG003|Overall Study|Protocol Violation|0
7043344|NCT01743027|11128149|FG000|Overall Study|Withdrawal by Subject|1
7043345|NCT01743027|11128150|FG001|Overall Study|Withdrawal by Subject|0
7043346|NCT01743027|11128151|FG002|Overall Study|Withdrawal by Subject|3
7043347|NCT01743027|11128152|FG003|Overall Study|Withdrawal by Subject|1
7043348|NCT01743040|11128162|FG000|Overall Study|Death|1
7043349|NCT01743040|11128162|FG000|Overall Study|Lost to Follow-up|66
7043350|NCT01743040|11128162|FG000|Overall Study|Physician Decision|40
7043351|NCT01743040|11128162|FG000|Overall Study|Protocol Violation|1
7043352|NCT01743040|11128162|FG000|Overall Study|Withdrawal by Subject|121
7043353|NCT01743092|11128168|FG000|Overall Study|Lost to Follow-up|14
7009699|NCT01463306|11079131|FG000|Overall Study|Adverse Event|6
7009700|NCT01463306|11079132|FG001|Overall Study|Adverse Event|9
7009701|NCT01463306|11079133|FG002|Overall Study|Adverse Event|3
7009702|NCT01463306|11079131|FG000|Overall Study|Death|3
7009703|NCT01463306|11079132|FG001|Overall Study|Death|3
7009704|NCT01463306|11079133|FG002|Overall Study|Death|0
7009705|NCT01463306|11079131|FG000|Overall Study|Lack of Efficacy|22
7009706|NCT01463306|11079132|FG001|Overall Study|Lack of Efficacy|16
7009707|NCT01463306|11079133|FG002|Overall Study|Lack of Efficacy|1
7009708|NCT01463306|11079131|FG000|Overall Study|Lost to Follow-up|5
7009709|NCT01463306|11079132|FG001|Overall Study|Lost to Follow-up|2
7009710|NCT01463306|11079133|FG002|Overall Study|Lost to Follow-up|0
7009711|NCT01463306|11079131|FG000|Overall Study|Protocol Violation|4
7009712|NCT01463306|11079132|FG001|Overall Study|Protocol Violation|0
7009713|NCT01463306|11079133|FG002|Overall Study|Protocol Violation|0
7009714|NCT01463306|11079131|FG000|Overall Study|Withdrawal by Subject|19
7009715|NCT01463306|11079132|FG001|Overall Study|Withdrawal by Subject|9
7009716|NCT01463306|11079133|FG002|Overall Study|Withdrawal by Subject|1
7009717|NCT01463306|11079131|FG000|Overall Study|Other|26
7009718|NCT01463306|11079132|FG001|Overall Study|Other|13
7009719|NCT01463306|11079133|FG002|Overall Study|Other|0
7009720|NCT01463306|11079131|FG000|Overall Study|Approval expiry at site|1
7009721|NCT01463306|11079132|FG001|Overall Study|Approval expiry at site|0
7009722|NCT01463306|11079133|FG002|Overall Study|Approval expiry at site|0
7009723|NCT01463527|11079158|FG000|Overall Study|Protocol Violation|1
7009724|NCT01463527|11079159|FG001|Overall Study|Protocol Violation|1
7009725|NCT01463527|11079158|FG000|Overall Study|Crying >20% of sedation|5
7009726|NCT01463527|11079159|FG001|Overall Study|Crying >20% of sedation|6
7009727|NCT01463631|11079169|FG000|Overall Study|Withdrawal by Subject|0
7009728|NCT01463631|11079170|FG001|Overall Study|Withdrawal by Subject|0
7009729|NCT01463631|11079171|FG002|Overall Study|Withdrawal by Subject|0
7009730|NCT01463631|11079172|FG003|Overall Study|Withdrawal by Subject|1
7009731|NCT01463631|11079169|FG000|Overall Study|Death|0
7009732|NCT01463631|11079170|FG001|Overall Study|Death|0
7009733|NCT01463631|11079171|FG002|Overall Study|Death|1
7009734|NCT01463631|11079172|FG003|Overall Study|Death|0
7009735|NCT01463631|11079169|FG000|Overall Study|Progressive Disease|0
7009736|NCT01463631|11079170|FG001|Overall Study|Progressive Disease|0
7009737|NCT01463631|11079171|FG002|Overall Study|Progressive Disease|0
7009738|NCT01463631|11079172|FG003|Overall Study|Progressive Disease|5
7009739|NCT01463683|11079187|FG000|Overall Study|Adverse Event|2
7009740|NCT01463683|11079188|FG001|Overall Study|Adverse Event|0
7009741|NCT01463683|11079189|FG002|Overall Study|Adverse Event|0
7009742|NCT01463683|11079187|FG000|Overall Study|Lost to Follow-up|10
7009743|NCT01463683|11079188|FG001|Overall Study|Lost to Follow-up|9
7009744|NCT01463683|11079189|FG002|Overall Study|Lost to Follow-up|7
7009745|NCT01463683|11079187|FG000|Overall Study|Physician Decision|0
7009746|NCT01463683|11079188|FG001|Overall Study|Physician Decision|3
7009747|NCT01463683|11079189|FG002|Overall Study|Physician Decision|1
7009748|NCT01463683|11079187|FG000|Overall Study|Pregnancy|2
7009749|NCT01463683|11079188|FG001|Overall Study|Pregnancy|2
7009750|NCT01463683|11079189|FG002|Overall Study|Pregnancy|1
7009751|NCT01463683|11079187|FG000|Overall Study|Withdrawal by Subject|5
7009752|NCT01463683|11079188|FG001|Overall Study|Withdrawal by Subject|17
7009753|NCT01463683|11079189|FG002|Overall Study|Withdrawal by Subject|2
7009754|NCT01463696|11079205|FG000|Overall Study|Adverse Event|0
7009755|NCT01463696|11079206|FG001|Overall Study|Adverse Event|1
7009756|NCT01463696|11079207|FG002|Overall Study|Adverse Event|0
7009757|NCT01463696|11079208|FG003|Overall Study|Adverse Event|2
7009758|NCT01463696|11079209|FG004|Overall Study|Adverse Event|0
7009759|NCT01463696|11079210|FG005|Overall Study|Adverse Event|1
7009760|NCT01463696|11079211|FG006|Overall Study|Adverse Event|3
7009761|NCT01463696|11079212|FG007|Overall Study|Adverse Event|2
7009762|NCT01463696|11079205|FG000|Overall Study|Lost to Follow-up|0
7009763|NCT01463696|11079206|FG001|Overall Study|Lost to Follow-up|0
7009764|NCT01463696|11079207|FG002|Overall Study|Lost to Follow-up|1
7009765|NCT01463696|11079208|FG003|Overall Study|Lost to Follow-up|0
7009766|NCT01463696|11079209|FG004|Overall Study|Lost to Follow-up|0
7009767|NCT01463696|11079210|FG005|Overall Study|Lost to Follow-up|0
7009768|NCT01463696|11079211|FG006|Overall Study|Lost to Follow-up|0
7009769|NCT01463696|11079212|FG007|Overall Study|Lost to Follow-up|0
7009770|NCT01463696|11079205|FG000|Overall Study|Progressive Disease|0
7009771|NCT01463696|11079206|FG001|Overall Study|Progressive Disease|1
7009772|NCT01463696|11079207|FG002|Overall Study|Progressive Disease|0
7009773|NCT01463696|11079208|FG003|Overall Study|Progressive Disease|1
7009774|NCT01463696|11079209|FG004|Overall Study|Progressive Disease|0
7009775|NCT01463696|11079210|FG005|Overall Study|Progressive Disease|1
7009776|NCT01463696|11079211|FG006|Overall Study|Progressive Disease|4
7009777|NCT01463696|11079212|FG007|Overall Study|Progressive Disease|2
7009778|NCT01463696|11079205|FG000|Overall Study|Withdrawal by Subject|0
7009779|NCT01463696|11079206|FG001|Overall Study|Withdrawal by Subject|0
7009780|NCT01463696|11079207|FG002|Overall Study|Withdrawal by Subject|0
7009781|NCT01463696|11079208|FG003|Overall Study|Withdrawal by Subject|1
7009782|NCT01463696|11079209|FG004|Overall Study|Withdrawal by Subject|1
7009783|NCT01463696|11079210|FG005|Overall Study|Withdrawal by Subject|1
7009784|NCT01463696|11079211|FG006|Overall Study|Withdrawal by Subject|2
7009785|NCT01463696|11079212|FG007|Overall Study|Withdrawal by Subject|0
7009786|NCT01463696|11079205|FG000|Overall Study|Not Treated|0
7009787|NCT01463696|11079206|FG001|Overall Study|Not Treated|0
7009788|NCT01463696|11079207|FG002|Overall Study|Not Treated|0
7009789|NCT01463696|11079208|FG003|Overall Study|Not Treated|0
7009790|NCT01463696|11079209|FG004|Overall Study|Not Treated|0
7009791|NCT01463696|11079210|FG005|Overall Study|Not Treated|0
7009792|NCT01463696|11079211|FG006|Overall Study|Not Treated|1
7009793|NCT01463696|11079212|FG007|Overall Study|Not Treated|0
7009794|NCT01463878|11079232|FG000|Overall Study|no longer met criteria for tube feed|2
7009795|NCT01463878|11079233|FG001|Overall Study|no longer met criteria for tube feed|2
7009796|NCT01463982|11079243|FG000|Overall Study|Withdrawal by Subject|0
7009797|NCT01463982|11079244|FG001|Overall Study|Withdrawal by Subject|1
7009798|NCT01463982|11079245|FG002|Overall Study|Withdrawal by Subject|1
7009799|NCT01463982|11079246|FG003|Overall Study|Withdrawal by Subject|0
7009800|NCT01463982|11079243|FG000|Overall Study|Treatment delay over 5 week|0
7009801|NCT01463982|11079244|FG001|Overall Study|Treatment delay over 5 week|0
7009802|NCT01463982|11079245|FG002|Overall Study|Treatment delay over 5 week|1
7009803|NCT01463982|11079246|FG003|Overall Study|Treatment delay over 5 week|0
7009804|NCT01464021|11079256|FG000|Overall Study|Withdrawal by Subject|13
7009805|NCT01464021|11079256|FG000|Overall Study|Lost to Follow-up|1
7009806|NCT01464021|11079256|FG000|Overall Study|Lack of Efficacy|1
7009807|NCT01464021|11079256|FG000|Overall Study|various|11
7009808|NCT01464255|11079280|FG000|Overall Study|unresolve corneal staining|0
7009809|NCT01464255|11079281|FG001|Overall Study|unresolve corneal staining|1
7009810|NCT01464307|11079290|FG000|Main Period|Death|0
7009811|NCT01464307|11079291|FG001|Main Period|Death|1
7009812|NCT01464307|11079290|FG000|Main Period|Adverse Event|6
7009813|NCT01464307|11079291|FG001|Main Period|Adverse Event|1
7009814|NCT01464307|11079290|FG000|Main Period|Lack of Efficacy|2
7009815|NCT01464307|11079291|FG001|Main Period|Lack of Efficacy|0
7009816|NCT01464307|11079290|FG000|Main Period|Withdrawal by Subject|5
7009817|NCT01464307|11079291|FG001|Main Period|Withdrawal by Subject|2
7009818|NCT01464307|11079290|FG000|Main Period|Predefined discontinuation criteria|2
7009819|NCT01464307|11079291|FG001|Main Period|Predefined discontinuation criteria|1
7009820|NCT01464307|11079290|FG000|Open-Label Extension Period|Adverse Event|15
7009821|NCT01464307|11079291|FG001|Open-Label Extension Period|Adverse Event|0
7009822|NCT01464307|11079290|FG000|Open-Label Extension Period|Withdrawal by Subject|14
7009823|NCT01464307|11079291|FG001|Open-Label Extension Period|Withdrawal by Subject|0
7009824|NCT01464307|11079290|FG000|Open-Label Extension Period|Lack of Efficacy|5
7009825|NCT01464307|11079291|FG001|Open-Label Extension Period|Lack of Efficacy|0
7009826|NCT01464307|11079290|FG000|Open-Label Extension Period|Death|1
7009827|NCT01464307|11079291|FG001|Open-Label Extension Period|Death|0
7009828|NCT01464307|11079290|FG000|Open-Label Extension Period|Lost to Follow-up|1
7009829|NCT01464307|11079291|FG001|Open-Label Extension Period|Lost to Follow-up|0
7009830|NCT01464307|11079290|FG000|Open-Label Extension Period|Non-compliance|9
7009831|NCT01464307|11079291|FG001|Open-Label Extension Period|Non-compliance|0
7009832|NCT01464307|11079290|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6
7009833|NCT01464307|11079291|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0
7009834|NCT01464333|11079298|FG000|Overall Study|Adverse Event|34
7009835|NCT01464333|11079298|FG000|Overall Study|Lack of Efficacy|72
7009836|NCT01464333|11079298|FG000|Overall Study|Withdrawal by Subject|11
7009837|NCT01464333|11079298|FG000|Overall Study|Other|4
7009838|NCT01464333|11079298|FG000|Overall Study|No Hospital Visit|42
7009839|NCT01464346|11079302|FG000|Overall Study|Withdrawal by Subject|0
7009840|NCT01464346|11079303|FG001|Overall Study|Withdrawal by Subject|0
7009841|NCT01464346|11079304|FG002|Overall Study|Withdrawal by Subject|1
7009842|NCT01464424|11079316|FG000|Period 1, First 6 Weeks|Adverse Event|0
7009843|NCT01464424|11079317|FG001|Period 1, First 6 Weeks|Adverse Event|1
7009844|NCT01464619|11079325|FG000|Overall Study|Lost to Follow-up|3
7009845|NCT01464619|11079326|FG001|Overall Study|Lost to Follow-up|4
7009846|NCT01464788|11079357|FG000|Overall Study|Lost to Follow-up|0
7009847|NCT01464788|11079358|FG001|Overall Study|Lost to Follow-up|1
7009848|NCT01464788|11079359|FG002|Overall Study|Lost to Follow-up|0
7009849|NCT01464788|11079357|FG000|Overall Study|Patient had hemorrhage after tPA started|0
7009850|NCT01464788|11079358|FG001|Overall Study|Patient had hemorrhage after tPA started|1
7009851|NCT01464788|11079359|FG002|Overall Study|Patient had hemorrhage after tPA started|0
7009852|NCT01464827|11079383|FG000|Overall Study|Adverse Event|0
7009853|NCT01464827|11079384|FG001|Overall Study|Adverse Event|0
7009854|NCT01464827|11079385|FG002|Overall Study|Adverse Event|0
7009855|NCT01464827|11079386|FG003|Overall Study|Adverse Event|0
7009856|NCT01464827|11079387|FG004|Overall Study|Adverse Event|0
7009857|NCT01464827|11079388|FG005|Overall Study|Adverse Event|0
7009858|NCT01464827|11079389|FG006|Overall Study|Adverse Event|0
7009859|NCT01464827|11079390|FG007|Overall Study|Adverse Event|0
7009860|NCT01464827|11079391|FG008|Overall Study|Adverse Event|0
7009861|NCT01464827|11079392|FG009|Overall Study|Adverse Event|0
7009862|NCT01464827|11079393|FG010|Overall Study|Adverse Event|0
7009863|NCT01464827|11079394|FG011|Overall Study|Adverse Event|0
7009864|NCT01464827|11079395|FG012|Overall Study|Adverse Event|1
7009865|NCT01464827|11079396|FG013|Overall Study|Adverse Event|0
7009866|NCT01464827|11079383|FG000|Overall Study|Withdrawal by Subject|1
7009867|NCT01464827|11079384|FG001|Overall Study|Withdrawal by Subject|0
7009868|NCT01464827|11079385|FG002|Overall Study|Withdrawal by Subject|0
7009869|NCT01464827|11079386|FG003|Overall Study|Withdrawal by Subject|0
7009870|NCT01464827|11079387|FG004|Overall Study|Withdrawal by Subject|1
7009871|NCT01464827|11079388|FG005|Overall Study|Withdrawal by Subject|0
7009872|NCT01464827|11079389|FG006|Overall Study|Withdrawal by Subject|0
7009873|NCT01464827|11079390|FG007|Overall Study|Withdrawal by Subject|1
7009874|NCT01464827|11079391|FG008|Overall Study|Withdrawal by Subject|0
7009875|NCT01464827|11079392|FG009|Overall Study|Withdrawal by Subject|0
7009876|NCT01464827|11079393|FG010|Overall Study|Withdrawal by Subject|0
7009877|NCT01464827|11079394|FG011|Overall Study|Withdrawal by Subject|0
7009878|NCT01464827|11079395|FG012|Overall Study|Withdrawal by Subject|0
7009879|NCT01464827|11079396|FG013|Overall Study|Withdrawal by Subject|0
7009880|NCT01464827|11079383|FG000|Overall Study|Lost to Follow-up|0
7009881|NCT01464827|11079384|FG001|Overall Study|Lost to Follow-up|2
7009882|NCT01464827|11079385|FG002|Overall Study|Lost to Follow-up|0
7009883|NCT01464827|11079386|FG003|Overall Study|Lost to Follow-up|2
7009884|NCT01464827|11079387|FG004|Overall Study|Lost to Follow-up|3
7009885|NCT01464827|11079388|FG005|Overall Study|Lost to Follow-up|1
7009886|NCT01464827|11079389|FG006|Overall Study|Lost to Follow-up|2
7009887|NCT01464827|11079390|FG007|Overall Study|Lost to Follow-up|2
7009888|NCT01464827|11079391|FG008|Overall Study|Lost to Follow-up|0
7009889|NCT01464827|11079392|FG009|Overall Study|Lost to Follow-up|0
7009890|NCT01464827|11079393|FG010|Overall Study|Lost to Follow-up|0
7009891|NCT01464827|11079394|FG011|Overall Study|Lost to Follow-up|1
7009892|NCT01464827|11079395|FG012|Overall Study|Lost to Follow-up|0
7009893|NCT01464827|11079396|FG013|Overall Study|Lost to Follow-up|1
7009894|NCT01464827|11079383|FG000|Overall Study|Other|2
7009895|NCT01464827|11079384|FG001|Overall Study|Other|3
7009896|NCT01464827|11079385|FG002|Overall Study|Other|0
7009897|NCT01464827|11079386|FG003|Overall Study|Other|2
7009898|NCT01464827|11079387|FG004|Overall Study|Other|3
7009899|NCT01464827|11079388|FG005|Overall Study|Other|0
7009900|NCT01464827|11079389|FG006|Overall Study|Other|1
7009901|NCT01464827|11079390|FG007|Overall Study|Other|0
7009902|NCT01464827|11079391|FG008|Overall Study|Other|3
7009903|NCT01464827|11079392|FG009|Overall Study|Other|1
7009904|NCT01464827|11079393|FG010|Overall Study|Other|2
7009905|NCT01464827|11079394|FG011|Overall Study|Other|0
7009906|NCT01464827|11079395|FG012|Overall Study|Other|1
7009907|NCT01464827|11079396|FG013|Overall Study|Other|0
7009908|NCT01464827|11079383|FG000|Overall Study|Not Treated|0
7009909|NCT01464827|11079384|FG001|Overall Study|Not Treated|2
7009910|NCT01464827|11079385|FG002|Overall Study|Not Treated|0
7009911|NCT01464827|11079386|FG003|Overall Study|Not Treated|0
7009912|NCT01464827|11079387|FG004|Overall Study|Not Treated|1
7009913|NCT01464827|11079388|FG005|Overall Study|Not Treated|0
7009914|NCT01464827|11079389|FG006|Overall Study|Not Treated|1
7060406|NCT01918306|11156573|FG001|Overall Study|Lack of Efficacy|0
7060407|NCT01918306|11156574|FG002|Overall Study|Lack of Efficacy|0
7060408|NCT01918306|11156575|FG003|Overall Study|Lack of Efficacy|0
7060409|NCT01918306|11156572|FG000|Overall Study|progress disease, crossover|0
7060410|NCT01918306|11156573|FG001|Overall Study|progress disease, crossover|0
7060411|NCT01918306|11156574|FG002|Overall Study|progress disease, crossover|1
7060412|NCT01918306|11156575|FG003|Overall Study|progress disease, crossover|0
7060413|NCT01918332|11156599|FG000|Overall Study|Adverse Event|0
7060414|NCT01918332|11156600|FG001|Overall Study|Adverse Event|0
7060415|NCT01918332|11156601|FG002|Overall Study|Adverse Event|0
7060416|NCT01918332|11156602|FG003|Overall Study|Adverse Event|1
7060417|NCT01918332|11156599|FG000|Overall Study|Withdrawal by Subject|2
7060418|NCT01918332|11156600|FG001|Overall Study|Withdrawal by Subject|3
7060419|NCT01918332|11156601|FG002|Overall Study|Withdrawal by Subject|2
7060420|NCT01918332|11156602|FG003|Overall Study|Withdrawal by Subject|3
7060421|NCT01918332|11156599|FG000|Overall Study|Protocol Violation|6
7060422|NCT01918332|11156600|FG001|Overall Study|Protocol Violation|2
7060423|NCT01918332|11156601|FG002|Overall Study|Protocol Violation|6
7060424|NCT01918332|11156602|FG003|Overall Study|Protocol Violation|3
7060425|NCT01918332|11156599|FG000|Overall Study|lipid result by central lab did not meet|0
7060426|NCT01918332|11156600|FG001|Overall Study|lipid result by central lab did not meet|0
7060427|NCT01918332|11156601|FG002|Overall Study|lipid result by central lab did not meet|1
7060428|NCT01918332|11156602|FG003|Overall Study|lipid result by central lab did not meet|0
7060429|NCT01918371|11156614|FG000|Overall Study|Missing Data|1
7060430|NCT01918371|11156615|FG001|Overall Study|Missing Data|1
7060431|NCT01918774|11156625|FG000|Overall Study|Lost prior to first CBTw session|4
7060432|NCT01918774|11156625|FG000|Overall Study|Lost to Follow-up|1
7060433|NCT01919112|11156641|FG000|Secondary Analysis-day 30|Death|1
7060434|NCT01919112|11156642|FG001|Secondary Analysis-day 30|Death|1
7060435|NCT01919112|11156643|FG002|Secondary Analysis-day 30|Death|1
7060436|NCT01919112|11156641|FG000|Secondary Analysis-day 30|Lost to Follow-up|1
7060437|NCT01919112|11156642|FG001|Secondary Analysis-day 30|Lost to Follow-up|0
7060438|NCT01919112|11156643|FG002|Secondary Analysis-day 30|Lost to Follow-up|0
7060439|NCT01919164|11156656|FG000|Overall Study|Adverse Event|6
7060440|NCT01919164|11156657|FG001|Overall Study|Adverse Event|4
7060441|NCT01919164|11156658|FG002|Overall Study|Adverse Event|9
7009915|NCT01464827|11079390|FG007|Overall Study|Not Treated|0
7060442|NCT01919164|11156659|FG003|Overall Study|Adverse Event|3
7009916|NCT01464827|11079391|FG008|Overall Study|Not Treated|0
7009917|NCT01464827|11079392|FG009|Overall Study|Not Treated|2
7009918|NCT01464827|11079393|FG010|Overall Study|Not Treated|0
7009919|NCT01464827|11079394|FG011|Overall Study|Not Treated|1
7060443|NCT01919164|11156660|FG004|Overall Study|Adverse Event|2
7009920|NCT01464827|11079395|FG012|Overall Study|Not Treated|0
7009921|NCT01464827|11079396|FG013|Overall Study|Not Treated|2
7009922|NCT01464879|11079450|FG000|Overall Study|Physician Decision|1
7009923|NCT01464879|11079450|FG000|Overall Study|Non-compliance|1
7009924|NCT01464931|11079462|FG000|Overall Study|Withdrawal by Subject|1
7009925|NCT01464931|11079463|FG001|Overall Study|Withdrawal by Subject|0
7009926|NCT01465022|11079485|FG000|Overall Study|Lost to Follow-up|15
7009927|NCT01465022|11079486|FG001|Overall Study|Lost to Follow-up|14
7009928|NCT01465022|11079487|FG002|Overall Study|Lost to Follow-up|0
7009929|NCT01465022|11079485|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8
7009930|NCT01465022|11079486|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9
7009931|NCT01465022|11079487|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0
7009932|NCT01465022|11079485|FG000|Overall Study|Not Randomized|0
7009933|NCT01465022|11079486|FG001|Overall Study|Not Randomized|0
7009934|NCT01465022|11079487|FG002|Overall Study|Not Randomized|70
7009935|NCT01465178|11079508|FG000|Overall Study|Withdrawal by Subject|1
7009936|NCT01465178|11079509|FG001|Overall Study|Withdrawal by Subject|0
7009937|NCT01465191|11079518|FG000|Overall Study|Protocol Violation|6
7009938|NCT01465191|11079519|FG001|Overall Study|Protocol Violation|3
7009939|NCT01465191|11079520|FG002|Overall Study|Protocol Violation|3
7009940|NCT01465191|11079518|FG000|Overall Study|Lost to Follow-up|3
7009941|NCT01465191|11079519|FG001|Overall Study|Lost to Follow-up|6
7009942|NCT01465191|11079520|FG002|Overall Study|Lost to Follow-up|4
7009943|NCT01465347|11079531|FG000|Overall Study|Withdrawal by Subject|1
7009944|NCT01465347|11079532|FG001|Overall Study|Withdrawal by Subject|1
7009945|NCT01465347|11079531|FG000|Overall Study|Physician Decision|0
7009946|NCT01465347|11079532|FG001|Overall Study|Physician Decision|1
7009947|NCT01465347|11079531|FG000|Overall Study|Admitted to hospice|0
7009948|NCT01465347|11079532|FG001|Overall Study|Admitted to hospice|1
7009949|NCT01465386|11079541|FG000|Overall Study|Lack of Efficacy|3
7009950|NCT01465386|11079541|FG000|Overall Study|Adverse Event|1
7009951|NCT01465464|11079564|FG000|Overall Study|Adverse Event|96
7009952|NCT01465464|11079565|FG001|Overall Study|Adverse Event|49
7009953|NCT01465464|11079564|FG000|Overall Study|Lack of Efficacy|139
7009954|NCT01465464|11079565|FG001|Overall Study|Lack of Efficacy|190
7009955|NCT01465464|11079564|FG000|Overall Study|Physician Decision|13
7009956|NCT01465464|11079565|FG001|Overall Study|Physician Decision|5
7009957|NCT01465464|11079564|FG000|Overall Study|Protocol Violation|1
7009958|NCT01465464|11079565|FG001|Overall Study|Protocol Violation|1
7009959|NCT01465464|11079564|FG000|Overall Study|Withdrawal by Subject|46
7009960|NCT01465464|11079565|FG001|Overall Study|Withdrawal by Subject|30
7009961|NCT01465464|11079564|FG000|Overall Study|Other|9
7009962|NCT01465464|11079565|FG001|Overall Study|Other|3
7009963|NCT01465464|11079564|FG000|Overall Study|Ongoing treatment at cutoff date|140
7009964|NCT01465464|11079565|FG001|Overall Study|Ongoing treatment at cutoff date|166
7009965|NCT01465659|11079575|FG000|Completed 1 Cycle of Treatment|Death|0
7009966|NCT01465659|11079576|FG001|Completed 1 Cycle of Treatment|Death|1
7009967|NCT01465659|11079577|FG002|Completed 1 Cycle of Treatment|Death|0
7009968|NCT01465659|11079578|FG003|Completed 1 Cycle of Treatment|Death|0
7009969|NCT01465659|11079575|FG000|Completed 1 Cycle of Treatment|Adverse Event|0
7009970|NCT01465659|11079576|FG001|Completed 1 Cycle of Treatment|Adverse Event|0
7009971|NCT01465659|11079577|FG002|Completed 1 Cycle of Treatment|Adverse Event|0
7009972|NCT01465659|11079578|FG003|Completed 1 Cycle of Treatment|Adverse Event|1
7009973|NCT01465659|11079575|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1
7009974|NCT01465659|11079576|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0
7009975|NCT01465659|11079577|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1
7009976|NCT01465659|11079578|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1
7009977|NCT01465659|11079575|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1
7009978|NCT01465659|11079576|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0
7009979|NCT01465659|11079577|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1
7009980|NCT01465659|11079578|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0
7009981|NCT01465659|11079575|FG000|Completed Follow for 1 Year|Death|6
7009982|NCT01465659|11079576|FG001|Completed Follow for 1 Year|Death|3
7009983|NCT01465659|11079577|FG002|Completed Follow for 1 Year|Death|2
7009984|NCT01465659|11079578|FG003|Completed Follow for 1 Year|Death|4
7009985|NCT01465763|11079594|FG000|Overall Study|Withdrawal by Subject|4
7009986|NCT01465763|11079595|FG001|Overall Study|Withdrawal by Subject|0
7009987|NCT01465763|11079596|FG002|Overall Study|Withdrawal by Subject|1
7009988|NCT01465763|11079594|FG000|Overall Study|Insufficient Clinical Response|11
7009989|NCT01465763|11079595|FG001|Overall Study|Insufficient Clinical Response|0
7009990|NCT01465763|11079596|FG002|Overall Study|Insufficient Clinical Response|1
7009991|NCT01465763|11079594|FG000|Overall Study|Adverse Event|9
7009992|NCT01465763|11079595|FG001|Overall Study|Adverse Event|0
7009993|NCT01465763|11079596|FG002|Overall Study|Adverse Event|1
7009994|NCT01465763|11079594|FG000|Overall Study|Other|2
7009995|NCT01465763|11079595|FG001|Overall Study|Other|0
7009996|NCT01465763|11079596|FG002|Overall Study|Other|0
7009997|NCT01465763|11079594|FG000|Overall Study|Protocol Violation|4
7009998|NCT01465763|11079595|FG001|Overall Study|Protocol Violation|1
7009999|NCT01465763|11079596|FG002|Overall Study|Protocol Violation|1
7010000|NCT01465763|11079594|FG000|Overall Study|Death|1
7010001|NCT01465763|11079595|FG001|Overall Study|Death|0
7010002|NCT01465763|11079596|FG002|Overall Study|Death|0
7010003|NCT01465802|11079608|FG000|Overall Study|Study terminated by sponsor|1
7010004|NCT01465802|11079609|FG001|Overall Study|Study terminated by sponsor|0
7010005|NCT01465802|11079610|FG002|Overall Study|Study terminated by sponsor|0
7010006|NCT01465802|11079611|FG003|Overall Study|Study terminated by sponsor|1
7010007|NCT01465802|11079612|FG004|Overall Study|Study terminated by sponsor|7
7010008|NCT01465802|11079608|FG000|Overall Study|Withdrawal by Subject|7
7010009|NCT01465802|11079609|FG001|Overall Study|Withdrawal by Subject|7
7010010|NCT01465802|11079610|FG002|Overall Study|Withdrawal by Subject|0
7010011|NCT01465802|11079611|FG003|Overall Study|Withdrawal by Subject|8
7010012|NCT01465802|11079612|FG004|Overall Study|Withdrawal by Subject|1
7010013|NCT01465802|11079608|FG000|Overall Study|Lost to Follow-up|1
7010014|NCT01465802|11079609|FG001|Overall Study|Lost to Follow-up|1
7010015|NCT01465802|11079610|FG002|Overall Study|Lost to Follow-up|0
7010016|NCT01465802|11079611|FG003|Overall Study|Lost to Follow-up|0
7010017|NCT01465802|11079612|FG004|Overall Study|Lost to Follow-up|0
7010018|NCT01465802|11079608|FG000|Overall Study|Reason not specified|9
7010019|NCT01465802|11079609|FG001|Overall Study|Reason not specified|4
7010020|NCT01465802|11079610|FG002|Overall Study|Reason not specified|0
7010021|NCT01465802|11079611|FG003|Overall Study|Reason not specified|10
7010022|NCT01465802|11079612|FG004|Overall Study|Reason not specified|2
7010023|NCT01465802|11079608|FG000|Overall Study|Death|15
7010024|NCT01465802|11079609|FG001|Overall Study|Death|12
7010025|NCT01465802|11079610|FG002|Overall Study|Death|0
7010026|NCT01465802|11079611|FG003|Overall Study|Death|10
7010027|NCT01465802|11079612|FG004|Overall Study|Death|2
7010028|NCT01465958|11079630|FG000|Run-in Phase|Protocol Violation|1
7010029|NCT01465958|11079631|FG001|Run-in Phase|Protocol Violation|0
7010030|NCT01465958|11079630|FG000|Subcutaneous (SC) Phase|Adverse Event|0
7010031|NCT01465958|11079631|FG001|Subcutaneous (SC) Phase|Adverse Event|1
7010032|NCT01465997|11079640|FG000|Overall Study|Adverse Event|12
7010033|NCT01465997|11079641|FG001|Overall Study|Adverse Event|22
7010034|NCT01465997|11079640|FG000|Overall Study|Lack of Efficacy|13
7010035|NCT01465997|11079641|FG001|Overall Study|Lack of Efficacy|1
7010036|NCT01465997|11079640|FG000|Overall Study|Protocol Violation|1
7010037|NCT01465997|11079641|FG001|Overall Study|Protocol Violation|4
7010038|NCT01465997|11079640|FG000|Overall Study|Lost to Follow-up|6
7010039|NCT01465997|11079641|FG001|Overall Study|Lost to Follow-up|9
7010040|NCT01465997|11079640|FG000|Overall Study|Withdrawal by Subject|32
7010041|NCT01465997|11079641|FG001|Overall Study|Withdrawal by Subject|35
7010042|NCT01465997|11079640|FG000|Overall Study|investigator's decision|1
7010043|NCT01465997|11079641|FG001|Overall Study|investigator's decision|1
7010044|NCT01465997|11079640|FG000|Overall Study|Death|0
7010045|NCT01465997|11079641|FG001|Overall Study|Death|1
7010046|NCT01465997|11079640|FG000|Overall Study|sponsor's decision|1
7010047|NCT01465997|11079641|FG001|Overall Study|sponsor's decision|1
7010048|NCT01465997|11079640|FG000|Overall Study|subject withdrew consent|1
7010049|NCT01465997|11079641|FG001|Overall Study|subject withdrew consent|0
7010050|NCT01465997|11079640|FG000|Overall Study|local lab unblinded site|1
7010051|NCT01465997|11079641|FG001|Overall Study|local lab unblinded site|0
7010052|NCT01465997|11079640|FG000|Overall Study|withdrew before follow-up|0
7010053|NCT01465997|11079641|FG001|Overall Study|withdrew before follow-up|13
7010054|NCT01465997|11079640|FG000|Overall Study|decision by site staff|0
7010055|NCT01465997|11079641|FG001|Overall Study|decision by site staff|1
7010056|NCT01465997|11079640|FG000|Overall Study|subject left participation SP0993|0
7010057|NCT01465997|11079641|FG001|Overall Study|subject left participation SP0993|1
7010058|NCT01466062|11079649|FG000|Overall Study|Adverse Event|1
7010059|NCT01466062|11079649|FG000|Overall Study|Withdrawal by Subject|1
7010060|NCT01466153|11079669|FG000|Overall Study|Disease Progression|2
7010061|NCT01466153|11079670|FG001|Overall Study|Disease Progression|2
7010062|NCT01466153|11079671|FG002|Overall Study|Disease Progression|0
7010063|NCT01466153|11079669|FG000|Overall Study|Adverse Event|14
7010064|NCT01466153|11079670|FG001|Overall Study|Adverse Event|13
7010065|NCT01466153|11079671|FG002|Overall Study|Adverse Event|17
7010066|NCT01466153|11079669|FG000|Overall Study|Withdrawal of Consent|2
7010067|NCT01466153|11079670|FG001|Overall Study|Withdrawal of Consent|0
7010068|NCT01466153|11079671|FG002|Overall Study|Withdrawal of Consent|0
7010069|NCT01466153|11079669|FG000|Overall Study|Investigator Discretion|3
7010070|NCT01466153|11079670|FG001|Overall Study|Investigator Discretion|2
7010071|NCT01466153|11079671|FG002|Overall Study|Investigator Discretion|2
7010072|NCT01466153|11079669|FG000|Overall Study|Randomized-Not Treated|2
7010073|NCT01466153|11079670|FG001|Overall Study|Randomized-Not Treated|3
7010074|NCT01466153|11079671|FG002|Overall Study|Randomized-Not Treated|4
7010075|NCT01466153|11079669|FG000|Overall Study|Other-Unspecified|6
7010076|NCT01466153|11079670|FG001|Overall Study|Other-Unspecified|4
7010077|NCT01466153|11079671|FG002|Overall Study|Other-Unspecified|2
7010078|NCT01466166|11079681|FG000|Overall Study|Death|1
7010079|NCT01466166|11079681|FG000|Overall Study|Lost to Follow-up|7
7010080|NCT01466166|11079681|FG000|Overall Study|Infusion Reaction (IR)|27
7010081|NCT01466166|11079681|FG000|Overall Study|Adverse Event (Other than IR)|11
7010082|NCT01466166|11079681|FG000|Overall Study|Elevated Serum Uric Acid|78
7010083|NCT01466166|11079681|FG000|Overall Study|Withdrawal by Subject|13
7010084|NCT01466166|11079681|FG000|Overall Study|Sponsor Decision|4
7010085|NCT01466166|11079681|FG000|Overall Study|Protocol Violation/Noncompliance|2
7010086|NCT01466166|11079681|FG000|Overall Study|Other|20
7010087|NCT01466179|11079685|FG000|Overall Study|Ongoing in core study|2
7010088|NCT01466179|11079685|FG000|Overall Study|Physician Decision|46
7010089|NCT01466179|11079685|FG000|Overall Study|Progressive disease|43
7010090|NCT01466179|11079685|FG000|Overall Study|Adverse Event|32
7010091|NCT01466179|11079685|FG000|Overall Study|Disease relapse|23
7010092|NCT01466179|11079685|FG000|Overall Study|Lack of Efficacy|14
7010093|NCT01466179|11079685|FG000|Overall Study|Death|7
7010094|NCT01466179|11079685|FG000|Overall Study|Withdrawal by Subject|7
7010095|NCT01466179|11079685|FG000|Overall Study|Protocol Violation|2
7010096|NCT01466179|11079685|FG000|Overall Study|Other|3
7010097|NCT01466192|11079692|FG000|Overall Study|Physician Decision|1
7010098|NCT01466192|11079692|FG000|Overall Study|Withdrawal by Subject|3
7010099|NCT01466270|11079698|FG000|Overall Study|Withdrawal by Subject|4
7010100|NCT01466270|11079699|FG001|Overall Study|Withdrawal by Subject|1
7010101|NCT01466270|11079698|FG000|Overall Study|Physician Decision|1
7010102|NCT01466270|11079699|FG001|Overall Study|Physician Decision|0
7010103|NCT01466270|11079698|FG000|Overall Study|Lost to Follow-up|1
7010104|NCT01466270|11079699|FG001|Overall Study|Lost to Follow-up|3
7010105|NCT01466270|11079698|FG000|Overall Study|Progression|1
7010106|NCT01466270|11079699|FG001|Overall Study|Progression|0
7010107|NCT01466270|11079698|FG000|Overall Study|Toxicity|4
7010108|NCT01466270|11079699|FG001|Overall Study|Toxicity|1
7010109|NCT01466270|11079698|FG000|Overall Study|Multiple|1
7010110|NCT01466270|11079699|FG001|Overall Study|Multiple|1
7010111|NCT01466348|11079707|FG000|Period I - First Intervention|Withdrawal by Subject|0
7010112|NCT01466348|11079708|FG001|Period I - First Intervention|Withdrawal by Subject|1
7010113|NCT01466387|11079744|FG000|Overall Study|Adverse Event|0
7010114|NCT01466387|11079745|FG001|Overall Study|Adverse Event|0
7010115|NCT01466387|11079746|FG002|Overall Study|Adverse Event|1
7010116|NCT01466387|11079747|FG003|Overall Study|Adverse Event|1
7010117|NCT01466387|11079748|FG004|Overall Study|Adverse Event|0
7010118|NCT01466387|11079749|FG005|Overall Study|Adverse Event|0
7010119|NCT01466387|11079744|FG000|Overall Study|Lost to Follow-up|0
7010120|NCT01466387|11079745|FG001|Overall Study|Lost to Follow-up|0
7010121|NCT01466387|11079746|FG002|Overall Study|Lost to Follow-up|0
7010122|NCT01466387|11079747|FG003|Overall Study|Lost to Follow-up|0
7010123|NCT01466387|11079748|FG004|Overall Study|Lost to Follow-up|0
7010124|NCT01466387|11079749|FG005|Overall Study|Lost to Follow-up|1
7010125|NCT01466387|11079744|FG000|Overall Study|Protocol Violation|1
7010126|NCT01466387|11079745|FG001|Overall Study|Protocol Violation|0
7010127|NCT01466387|11079746|FG002|Overall Study|Protocol Violation|0
7010128|NCT01466387|11079747|FG003|Overall Study|Protocol Violation|1
7010129|NCT01466387|11079748|FG004|Overall Study|Protocol Violation|0
7010130|NCT01466387|11079749|FG005|Overall Study|Protocol Violation|0
7010131|NCT01466491|11079776|FG000|Overall Study|Protocol Violation|0
7010132|NCT01466491|11079777|FG001|Overall Study|Protocol Violation|3
7010133|NCT01466491|11079778|FG002|Overall Study|Protocol Violation|2
7010134|NCT01466491|11079779|FG003|Overall Study|Protocol Violation|0
7010135|NCT01466491|11079776|FG000|Overall Study|Missing Data|0
7010136|NCT01466491|11079777|FG001|Overall Study|Missing Data|0
7010137|NCT01466491|11079778|FG002|Overall Study|Missing Data|1
7010138|NCT01466491|11079779|FG003|Overall Study|Missing Data|0
7010139|NCT01466595|11079791|FG000|Overall Study|Withdrawal by Subject|0
7010140|NCT01466595|11079792|FG001|Overall Study|Withdrawal by Subject|1
7010141|NCT01466660|11079800|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120
7010142|NCT01466660|11079801|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127
7010143|NCT01466660|11079800|FG000|Overall Study|Worsening of underlying cancer disease|5
7010144|NCT01466660|11079801|FG001|Overall Study|Worsening of underlying cancer disease|2
7010145|NCT01466660|11079800|FG000|Overall Study|Other adverse event|19
7010146|NCT01466660|11079801|FG001|Overall Study|Other adverse event|18
7010147|NCT01466660|11079800|FG000|Overall Study|Protocol Violation|2
7010148|NCT01466660|11079801|FG001|Overall Study|Protocol Violation|1
7010149|NCT01466660|11079800|FG000|Overall Study|Refused continuation of trial medication|4
7010150|NCT01466660|11079801|FG001|Overall Study|Refused continuation of trial medication|3
7010151|NCT01466660|11079800|FG000|Overall Study|Other reason not defined above|10
7010152|NCT01466660|11079801|FG001|Overall Study|Other reason not defined above|8
7010153|NCT01466673|11079809|FG000|Overall Study|Non-compliance with study treatment|2
7010154|NCT01466673|11079810|FG001|Overall Study|Non-compliance with study treatment|0
7010155|NCT01466673|11079809|FG000|Overall Study|Lost to Follow-up|3
7010156|NCT01466673|11079810|FG001|Overall Study|Lost to Follow-up|5
7010157|NCT01466673|11079809|FG000|Overall Study|Adverse Event|2
7010158|NCT01466673|11079810|FG001|Overall Study|Adverse Event|1
7010159|NCT01466790|11079844|FG000|Overall Study|Adverse Event|1
7010160|NCT01466790|11079845|FG001|Overall Study|Adverse Event|0
7010161|NCT01466790|11079846|FG002|Overall Study|Adverse Event|0
7010162|NCT01466790|11079847|FG003|Overall Study|Adverse Event|0
7010163|NCT01466790|11079848|FG004|Overall Study|Adverse Event|2
7010164|NCT01466790|11079849|FG005|Overall Study|Adverse Event|0
7010165|NCT01466790|11079850|FG006|Overall Study|Adverse Event|0
7010166|NCT01466790|11079851|FG007|Overall Study|Adverse Event|0
7010167|NCT01466790|11079844|FG000|Overall Study|Lost to Follow-up|2
7010168|NCT01466790|11079845|FG001|Overall Study|Lost to Follow-up|0
7010169|NCT01466790|11079846|FG002|Overall Study|Lost to Follow-up|0
7010170|NCT01466790|11079847|FG003|Overall Study|Lost to Follow-up|0
7010171|NCT01466790|11079848|FG004|Overall Study|Lost to Follow-up|0
7010172|NCT01466790|11079849|FG005|Overall Study|Lost to Follow-up|0
7010173|NCT01466790|11079850|FG006|Overall Study|Lost to Follow-up|0
7010174|NCT01466790|11079851|FG007|Overall Study|Lost to Follow-up|0
7010175|NCT01466790|11079844|FG000|Overall Study|Withdrawal by Subject|1
7010176|NCT01466790|11079845|FG001|Overall Study|Withdrawal by Subject|1
7010177|NCT01466790|11079846|FG002|Overall Study|Withdrawal by Subject|0
7010178|NCT01466790|11079847|FG003|Overall Study|Withdrawal by Subject|0
7010179|NCT01466790|11079848|FG004|Overall Study|Withdrawal by Subject|1
7010180|NCT01466790|11079849|FG005|Overall Study|Withdrawal by Subject|0
7010181|NCT01466790|11079850|FG006|Overall Study|Withdrawal by Subject|1
7010182|NCT01466790|11079851|FG007|Overall Study|Withdrawal by Subject|1
7010183|NCT01466881|11079865|FG000|Overall Study|Ineligible|5
7010184|NCT01466881|11079865|FG000|Overall Study|Adverse Event|6
7010185|NCT01466881|11079865|FG000|Overall Study|Progression/relapse|20
7010186|NCT01466881|11079865|FG000|Overall Study|Death|4
7010187|NCT01466881|11079865|FG000|Overall Study|Other reason not protocol specified|5
7010188|NCT01467076|11079908|FG000|Overall Study|Lost to Follow-up|1
7010189|NCT01467076|11079909|FG001|Overall Study|Lost to Follow-up|0
7010190|NCT01467076|11079910|FG002|Overall Study|Lost to Follow-up|0
7010191|NCT01467271|11079918|FG000|Overall Study|Death|84
7010192|NCT01467271|11079918|FG000|Overall Study|Lost to Follow-up|83
7010193|NCT01467271|11079918|FG000|Overall Study|Retraction of patient's consent|21
7010194|NCT01467271|11079918|FG000|Overall Study|Other reason|14
7010195|NCT01467427|11079924|FG000|Overall Study|Withdrawal by Subject|1
7010196|NCT01467427|11079925|FG001|Overall Study|Withdrawal by Subject|0
7010197|NCT01467427|11079924|FG000|Overall Study|Entered extension phase|11
7010198|NCT01467427|11079925|FG001|Overall Study|Entered extension phase|11
7010199|NCT01467427|11079924|FG000|Overall Study|Not continuing in extension phase|0
7010200|NCT01467427|11079925|FG001|Overall Study|Not continuing in extension phase|2
7010201|NCT01467466|11079935|FG000|Overall Study|Withdrawal by Subject|15
7010202|NCT01467466|11079936|FG001|Overall Study|Withdrawal by Subject|18
7010203|NCT01467466|11079937|FG002|Overall Study|Withdrawal by Subject|13
7010204|NCT01467466|11079938|FG003|Overall Study|Withdrawal by Subject|11
7010205|NCT01467466|11079935|FG000|Overall Study|Revoked Consent Prior To Procedure|10
7010206|NCT01467466|11079936|FG001|Overall Study|Revoked Consent Prior To Procedure|9
7010207|NCT01467466|11079937|FG002|Overall Study|Revoked Consent Prior To Procedure|15
7010208|NCT01467466|11079938|FG003|Overall Study|Revoked Consent Prior To Procedure|5
7010209|NCT01467466|11079935|FG000|Overall Study|Procedure Cancelled|46
7010210|NCT01467466|11079936|FG001|Overall Study|Procedure Cancelled|45
7010211|NCT01467466|11079937|FG002|Overall Study|Procedure Cancelled|25
7010212|NCT01467466|11079938|FG003|Overall Study|Procedure Cancelled|29
7010213|NCT01467466|11079935|FG000|Overall Study|No Endpoint Blood Draw|38
7010214|NCT01467466|11079936|FG001|Overall Study|No Endpoint Blood Draw|32
7010215|NCT01467466|11079937|FG002|Overall Study|No Endpoint Blood Draw|51
7010216|NCT01467466|11079938|FG003|Overall Study|No Endpoint Blood Draw|43
7010217|NCT01467479|11079951|FG000|Overall Study|No Study Medication|1
7010218|NCT01467479|11079952|FG001|Overall Study|No Study Medication|0
7010219|NCT01467479|11079953|FG002|Overall Study|No Study Medication|2
7010220|NCT01467479|11079951|FG000|Overall Study|Adverse Event|1
7010221|NCT01467479|11079952|FG001|Overall Study|Adverse Event|2
7010222|NCT01467479|11079953|FG002|Overall Study|Adverse Event|0
7010223|NCT01467479|11079951|FG000|Overall Study|Death|0
7010224|NCT01467479|11079952|FG001|Overall Study|Death|0
7010225|NCT01467479|11079953|FG002|Overall Study|Death|1
7010226|NCT01467479|11079951|FG000|Overall Study|Lost to Follow-up|2
7010227|NCT01467479|11079952|FG001|Overall Study|Lost to Follow-up|5
7010228|NCT01467479|11079953|FG002|Overall Study|Lost to Follow-up|3
7010229|NCT01467479|11079951|FG000|Overall Study|Withdrawal of Consent|3
7010230|NCT01467479|11079952|FG001|Overall Study|Withdrawal of Consent|7
7010231|NCT01467479|11079953|FG002|Overall Study|Withdrawal of Consent|7
7010232|NCT01467479|11079951|FG000|Overall Study|Study Terminated by Sponsor|1
7010233|NCT01467479|11079952|FG001|Overall Study|Study Terminated by Sponsor|3
7010234|NCT01467479|11079953|FG002|Overall Study|Study Terminated by Sponsor|3
7010235|NCT01467479|11079951|FG000|Overall Study|Other|1
7010236|NCT01467479|11079952|FG001|Overall Study|Other|0
7010237|NCT01467479|11079953|FG002|Overall Study|Other|0
7010238|NCT01467492|11079964|FG000|Overall Study|Withdrawal by Subject|6
7010239|NCT01467492|11079965|FG001|Overall Study|Withdrawal by Subject|4
7010240|NCT01467492|11079964|FG000|Overall Study|Study Terminated by Sponsor|6
7010241|NCT01467492|11079965|FG001|Overall Study|Study Terminated by Sponsor|4
7010242|NCT01467492|11079964|FG000|Overall Study|Adverse Event|4
7010243|NCT01467492|11079965|FG001|Overall Study|Adverse Event|3
7010244|NCT01467492|11079964|FG000|Overall Study|Lost to Follow-up|3
7010245|NCT01467492|11079965|FG001|Overall Study|Lost to Follow-up|2
7010246|NCT01467492|11079964|FG000|Overall Study|Undefined|2
7010247|NCT01467492|11079965|FG001|Overall Study|Undefined|0
7010248|NCT01467492|11079964|FG000|Overall Study|Enrolled But Not Treated|1
7010249|NCT01467492|11079965|FG001|Overall Study|Enrolled But Not Treated|0
7010250|NCT01467505|11079974|FG000|Overall Study|Adverse Event|1
7010251|NCT01467505|11079975|FG001|Overall Study|Adverse Event|0
7010252|NCT01467505|11079974|FG000|Overall Study|Withdrawal by Subject|4
7010253|NCT01467505|11079975|FG001|Overall Study|Withdrawal by Subject|0
7010254|NCT01467505|11079974|FG000|Overall Study|Study Terminated by Sponsor|28
7010255|NCT01467505|11079975|FG001|Overall Study|Study Terminated by Sponsor|3
7010256|NCT01467570|11079992|FG000|Overall Study|Lost to Follow-up|8
7010257|NCT01467570|11079993|FG001|Overall Study|Lost to Follow-up|9
7010258|NCT01467583|11080004|FG000|Overall Study|Death|1
7010259|NCT01467583|11080005|FG001|Overall Study|Death|1
7010260|NCT01467583|11080006|FG002|Overall Study|Death|0
7010261|NCT01467583|11080004|FG000|Overall Study|Withdrawal by Subject|1
7010262|NCT01467583|11080005|FG001|Overall Study|Withdrawal by Subject|0
7010263|NCT01467583|11080006|FG002|Overall Study|Withdrawal by Subject|0
7010264|NCT01467583|11080004|FG000|Overall Study|Protocol Violation|0
7010265|NCT01467583|11080005|FG001|Overall Study|Protocol Violation|0
7010266|NCT01467583|11080006|FG002|Overall Study|Protocol Violation|2
7010267|NCT01467661|11080017|FG000|Overall Study|Adverse Event|16
7010268|NCT01467661|11080017|FG000|Overall Study|Withdrawal by Subject|1
7010269|NCT01467661|11080017|FG000|Overall Study|Lack of Efficacy|3
7010270|NCT01467661|11080017|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1
7010271|NCT01467700|11080027|FG000|Overall Study|Pretreatment Event or Adverse Event|6
7010272|NCT01467700|11080028|FG001|Overall Study|Pretreatment Event or Adverse Event|4
7010273|NCT01467700|11080029|FG002|Overall Study|Pretreatment Event or Adverse Event|2
7010274|NCT01467700|11080030|FG003|Overall Study|Pretreatment Event or Adverse Event|3
7010275|NCT01467700|11080027|FG000|Overall Study|Major Protocol Deviation|3
7010276|NCT01467700|11080028|FG001|Overall Study|Major Protocol Deviation|3
7010277|NCT01467700|11080029|FG002|Overall Study|Major Protocol Deviation|2
7010278|NCT01467700|11080030|FG003|Overall Study|Major Protocol Deviation|3
7010279|NCT01467700|11080027|FG000|Overall Study|Lost to Follow-up|6
7010280|NCT01467700|11080028|FG001|Overall Study|Lost to Follow-up|5
7010281|NCT01467700|11080029|FG002|Overall Study|Lost to Follow-up|2
7010282|NCT01467700|11080030|FG003|Overall Study|Lost to Follow-up|3
7010283|NCT01467700|11080027|FG000|Overall Study|Voluntary Withdrawal|5
7010284|NCT01467700|11080028|FG001|Overall Study|Voluntary Withdrawal|7
7010285|NCT01467700|11080029|FG002|Overall Study|Voluntary Withdrawal|6
7010286|NCT01467700|11080030|FG003|Overall Study|Voluntary Withdrawal|2
7010287|NCT01467700|11080027|FG000|Overall Study|Study Termination|6
7010288|NCT01467700|11080028|FG001|Overall Study|Study Termination|5
7010289|NCT01467700|11080029|FG002|Overall Study|Study Termination|10
7010290|NCT01467700|11080030|FG003|Overall Study|Study Termination|7
7010291|NCT01467700|11080027|FG000|Overall Study|Pregnancy|0
7010292|NCT01467700|11080028|FG001|Overall Study|Pregnancy|1
7010293|NCT01467700|11080029|FG002|Overall Study|Pregnancy|1
7010294|NCT01467700|11080030|FG003|Overall Study|Pregnancy|0
7010295|NCT01467700|11080027|FG000|Overall Study|Lack of Efficacy|2
7010296|NCT01467700|11080028|FG001|Overall Study|Lack of Efficacy|0
7010297|NCT01467700|11080029|FG002|Overall Study|Lack of Efficacy|2
7010298|NCT01467700|11080030|FG003|Overall Study|Lack of Efficacy|1
7010299|NCT01467700|11080027|FG000|Overall Study|Reason not Specified|1
7010300|NCT01467700|11080028|FG001|Overall Study|Reason not Specified|3
7010301|NCT01467700|11080029|FG002|Overall Study|Reason not Specified|2
7010302|NCT01467700|11080030|FG003|Overall Study|Reason not Specified|8
7010303|NCT01467713|11080044|FG000|Overall Study|Pretreatment Event or Adverse Event|9
7010304|NCT01467713|11080045|FG001|Overall Study|Pretreatment Event or Adverse Event|4
7010305|NCT01467713|11080046|FG002|Overall Study|Pretreatment Event or Adverse Event|6
7010306|NCT01467713|11080047|FG003|Overall Study|Pretreatment Event or Adverse Event|5
7010307|NCT01467713|11080044|FG000|Overall Study|Major Protocol Deviation|2
7010308|NCT01467713|11080045|FG001|Overall Study|Major Protocol Deviation|4
7010309|NCT01467713|11080046|FG002|Overall Study|Major Protocol Deviation|4
7010310|NCT01467713|11080047|FG003|Overall Study|Major Protocol Deviation|1
7010311|NCT01467713|11080044|FG000|Overall Study|Lost to Follow-up|9
7010312|NCT01467713|11080045|FG001|Overall Study|Lost to Follow-up|12
7010313|NCT01467713|11080046|FG002|Overall Study|Lost to Follow-up|6
7010314|NCT01467713|11080047|FG003|Overall Study|Lost to Follow-up|9
7010315|NCT01467713|11080044|FG000|Overall Study|Voluntary Withdrawal|18
7010316|NCT01467713|11080045|FG001|Overall Study|Voluntary Withdrawal|14
7010317|NCT01467713|11080046|FG002|Overall Study|Voluntary Withdrawal|21
7010318|NCT01467713|11080047|FG003|Overall Study|Voluntary Withdrawal|20
7010319|NCT01467713|11080044|FG000|Overall Study|Study Termination|23
7010320|NCT01467713|11080045|FG001|Overall Study|Study Termination|33
7010321|NCT01467713|11080046|FG002|Overall Study|Study Termination|28
7010322|NCT01467713|11080047|FG003|Overall Study|Study Termination|29
7010323|NCT01467713|11080044|FG000|Overall Study|Pregnancy|0
7010324|NCT01467713|11080045|FG001|Overall Study|Pregnancy|1
7010325|NCT01467713|11080046|FG002|Overall Study|Pregnancy|1
7010326|NCT01467713|11080047|FG003|Overall Study|Pregnancy|3
7010327|NCT01467713|11080044|FG000|Overall Study|Relapse|35
7010328|NCT01467713|11080045|FG001|Overall Study|Relapse|25
7010329|NCT01467713|11080046|FG002|Overall Study|Relapse|28
7010330|NCT01467713|11080047|FG003|Overall Study|Relapse|35
7010331|NCT01467713|11080044|FG000|Overall Study|Reason not Specified|6
7010332|NCT01467713|11080045|FG001|Overall Study|Reason not Specified|11
7010333|NCT01467713|11080046|FG002|Overall Study|Reason not Specified|8
7010334|NCT01467713|11080047|FG003|Overall Study|Reason not Specified|7
7010335|NCT01467960|11080091|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0
7010336|NCT01467960|11080092|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0
7010337|NCT01467960|11080093|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0
7010338|NCT01467960|11080094|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30
7010339|NCT01467960|11080095|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30
7010340|NCT01467960|11080096|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30
7010341|NCT01468077|11080130|FG000|Overall Study|Adverse Event|2
7010342|NCT01468077|11080131|FG001|Overall Study|Adverse Event|2
7010343|NCT01468077|11080130|FG000|Overall Study|Lack of Efficacy|1
7010344|NCT01468077|11080131|FG001|Overall Study|Lack of Efficacy|1
7010345|NCT01468077|11080130|FG000|Overall Study|Physician Decision|1
7010346|NCT01468077|11080131|FG001|Overall Study|Physician Decision|0
7010347|NCT01468181|11080142|FG000|Overall Study|Adverse Event|8
7010348|NCT01468181|11080143|FG001|Overall Study|Adverse Event|1
7010349|NCT01468181|11080144|FG002|Overall Study|Adverse Event|6
7010350|NCT01468181|11080145|FG003|Overall Study|Adverse Event|2
7010351|NCT01468181|11080146|FG004|Overall Study|Adverse Event|2
7010352|NCT01468181|11080142|FG000|Overall Study|Protocol Violation|2
7010353|NCT01468181|11080143|FG001|Overall Study|Protocol Violation|0
7010354|NCT01468181|11080144|FG002|Overall Study|Protocol Violation|1
7010355|NCT01468181|11080145|FG003|Overall Study|Protocol Violation|0
7010356|NCT01468181|11080146|FG004|Overall Study|Protocol Violation|1
7010357|NCT01468181|11080142|FG000|Overall Study|Physician Decision|0
7010358|NCT01468181|11080143|FG001|Overall Study|Physician Decision|0
7010359|NCT01468181|11080144|FG002|Overall Study|Physician Decision|0
7010360|NCT01468181|11080145|FG003|Overall Study|Physician Decision|1
7010361|NCT01468181|11080146|FG004|Overall Study|Physician Decision|1
7010362|NCT01468181|11080142|FG000|Overall Study|Lost to Follow-up|0
7010363|NCT01468181|11080143|FG001|Overall Study|Lost to Follow-up|0
7010364|NCT01468181|11080144|FG002|Overall Study|Lost to Follow-up|1
7010365|NCT01468181|11080145|FG003|Overall Study|Lost to Follow-up|0
7010366|NCT01468181|11080146|FG004|Overall Study|Lost to Follow-up|1
7010367|NCT01468181|11080142|FG000|Overall Study|Withdrawal by Subject|0
7010368|NCT01468181|11080143|FG001|Overall Study|Withdrawal by Subject|1
7010369|NCT01468181|11080144|FG002|Overall Study|Withdrawal by Subject|0
7010370|NCT01468181|11080145|FG003|Overall Study|Withdrawal by Subject|0
7010371|NCT01468181|11080146|FG004|Overall Study|Withdrawal by Subject|0
7010372|NCT01468207|11080160|FG000|Treatment Period 1|Adverse Event|1
7010373|NCT01468207|11080161|FG001|Treatment Period 1|Adverse Event|0
7010374|NCT01468207|11080162|FG002|Treatment Period 1|Adverse Event|0
7010375|NCT01468207|11080163|FG003|Treatment Period 1|Adverse Event|0
7010376|NCT01468207|11080164|FG004|Treatment Period 1|Adverse Event|0
7010377|NCT01468207|11080165|FG005|Treatment Period 1|Adverse Event|0
7010378|NCT01468207|11080160|FG000|Treatment Period 1|Protocol Violation|1
7010379|NCT01468207|11080161|FG001|Treatment Period 1|Protocol Violation|1
7010380|NCT01468207|11080162|FG002|Treatment Period 1|Protocol Violation|0
7010381|NCT01468207|11080163|FG003|Treatment Period 1|Protocol Violation|0
7010382|NCT01468207|11080164|FG004|Treatment Period 1|Protocol Violation|0
7010383|NCT01468207|11080165|FG005|Treatment Period 1|Protocol Violation|0
7010384|NCT01468207|11080160|FG000|Treatment Period 1|Withdrawal by Subject|5
7010385|NCT01468207|11080161|FG001|Treatment Period 1|Withdrawal by Subject|4
7010386|NCT01468207|11080162|FG002|Treatment Period 1|Withdrawal by Subject|0
7010387|NCT01468207|11080163|FG003|Treatment Period 1|Withdrawal by Subject|0
7010388|NCT01468207|11080164|FG004|Treatment Period 1|Withdrawal by Subject|0
7010389|NCT01468207|11080165|FG005|Treatment Period 1|Withdrawal by Subject|0
7010390|NCT01468207|11080160|FG000|Treatment Period 1|Lost to Follow-up|2
7010391|NCT01468207|11080161|FG001|Treatment Period 1|Lost to Follow-up|1
7010392|NCT01468207|11080162|FG002|Treatment Period 1|Lost to Follow-up|0
7010393|NCT01468207|11080163|FG003|Treatment Period 1|Lost to Follow-up|0
7010394|NCT01468207|11080164|FG004|Treatment Period 1|Lost to Follow-up|0
7010395|NCT01468207|11080165|FG005|Treatment Period 1|Lost to Follow-up|0
7010396|NCT01468207|11080160|FG000|Treatment Period 1|Other|0
7010397|NCT01468207|11080161|FG001|Treatment Period 1|Other|2
7010398|NCT01468207|11080162|FG002|Treatment Period 1|Other|0
7010399|NCT01468207|11080163|FG003|Treatment Period 1|Other|0
7010400|NCT01468207|11080164|FG004|Treatment Period 1|Other|0
7010401|NCT01468207|11080165|FG005|Treatment Period 1|Other|0
7010402|NCT01468207|11080160|FG000|Treatment Period 2|Adverse Event|0
7010403|NCT01468207|11080161|FG001|Treatment Period 2|Adverse Event|0
7010404|NCT01468207|11080162|FG002|Treatment Period 2|Adverse Event|6
7010405|NCT01468207|11080163|FG003|Treatment Period 2|Adverse Event|1
7010406|NCT01468207|11080164|FG004|Treatment Period 2|Adverse Event|2
7010407|NCT01468207|11080165|FG005|Treatment Period 2|Adverse Event|1
7010408|NCT01468207|11080160|FG000|Treatment Period 2|Lack of Efficacy|0
7010409|NCT01468207|11080161|FG001|Treatment Period 2|Lack of Efficacy|0
7010410|NCT01468207|11080162|FG002|Treatment Period 2|Lack of Efficacy|1
7010411|NCT01468207|11080163|FG003|Treatment Period 2|Lack of Efficacy|1
7010412|NCT01468207|11080164|FG004|Treatment Period 2|Lack of Efficacy|0
7010413|NCT01468207|11080165|FG005|Treatment Period 2|Lack of Efficacy|2
7010414|NCT01468207|11080160|FG000|Treatment Period 2|Withdrawal by Subject|0
7010415|NCT01468207|11080161|FG001|Treatment Period 2|Withdrawal by Subject|0
7010416|NCT01468207|11080162|FG002|Treatment Period 2|Withdrawal by Subject|5
7010417|NCT01468207|11080163|FG003|Treatment Period 2|Withdrawal by Subject|0
7010418|NCT01468207|11080164|FG004|Treatment Period 2|Withdrawal by Subject|0
7010419|NCT01468207|11080165|FG005|Treatment Period 2|Withdrawal by Subject|2
7010420|NCT01468207|11080160|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0
7010421|NCT01468207|11080161|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0
7010422|NCT01468207|11080162|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30
7010423|NCT01468207|11080163|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23
7010424|NCT01468207|11080164|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18
7010425|NCT01468207|11080165|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13
7010426|NCT01468207|11080160|FG000|Treatment Period 2|Lost to Follow-up|0
7010427|NCT01468207|11080161|FG001|Treatment Period 2|Lost to Follow-up|0
7010428|NCT01468207|11080162|FG002|Treatment Period 2|Lost to Follow-up|5
7010429|NCT01468207|11080163|FG003|Treatment Period 2|Lost to Follow-up|1
7010430|NCT01468207|11080164|FG004|Treatment Period 2|Lost to Follow-up|0
7010431|NCT01468207|11080165|FG005|Treatment Period 2|Lost to Follow-up|0
7010432|NCT01468207|11080160|FG000|Treatment Period 2|Other|0
7010433|NCT01468207|11080161|FG001|Treatment Period 2|Other|0
7010434|NCT01468207|11080162|FG002|Treatment Period 2|Other|5
7010435|NCT01468207|11080163|FG003|Treatment Period 2|Other|1
7010436|NCT01468207|11080164|FG004|Treatment Period 2|Other|1
7010437|NCT01468207|11080165|FG005|Treatment Period 2|Other|2
7010438|NCT01468233|11080185|FG000|Treatment Period 1|Adverse Event|5
7010439|NCT01468233|11080186|FG001|Treatment Period 1|Adverse Event|3
7010440|NCT01468233|11080187|FG002|Treatment Period 1|Adverse Event|0
7010441|NCT01468233|11080188|FG003|Treatment Period 1|Adverse Event|0
7010442|NCT01468233|11080189|FG004|Treatment Period 1|Adverse Event|0
7010443|NCT01468233|11080190|FG005|Treatment Period 1|Adverse Event|0
7010444|NCT01468233|11080185|FG000|Treatment Period 1|Withdrawal by Subject|3
7010445|NCT01468233|11080186|FG001|Treatment Period 1|Withdrawal by Subject|4
7010446|NCT01468233|11080187|FG002|Treatment Period 1|Withdrawal by Subject|0
7010447|NCT01468233|11080188|FG003|Treatment Period 1|Withdrawal by Subject|0
7010448|NCT01468233|11080189|FG004|Treatment Period 1|Withdrawal by Subject|0
7010449|NCT01468233|11080190|FG005|Treatment Period 1|Withdrawal by Subject|0
7010450|NCT01468233|11080185|FG000|Treatment Period 1|Lost to Follow-up|3
7010451|NCT01468233|11080186|FG001|Treatment Period 1|Lost to Follow-up|0
7010452|NCT01468233|11080187|FG002|Treatment Period 1|Lost to Follow-up|0
7010453|NCT01468233|11080188|FG003|Treatment Period 1|Lost to Follow-up|0
7010454|NCT01468233|11080189|FG004|Treatment Period 1|Lost to Follow-up|0
7010455|NCT01468233|11080190|FG005|Treatment Period 1|Lost to Follow-up|0
7010456|NCT01468233|11080185|FG000|Treatment Period 1|Other|1
7010457|NCT01468233|11080186|FG001|Treatment Period 1|Other|1
7010458|NCT01468233|11080187|FG002|Treatment Period 1|Other|0
7010459|NCT01468233|11080188|FG003|Treatment Period 1|Other|0
7010460|NCT01468233|11080189|FG004|Treatment Period 1|Other|0
7010461|NCT01468233|11080190|FG005|Treatment Period 1|Other|0
7010462|NCT01468233|11080185|FG000|Treatment Period 2|Adverse Event|0
7143164|NCT03027557|11299540|FG002|Overall Study|Adverse Event|0
7183599|NCT01499082|11383689|FG001|Overall Study|Site Closure for Noncompliance|2
7183600|NCT01499082|11383688|FG000|Overall Study|Hypoglycemia|2
7183601|NCT01499082|11383689|FG001|Overall Study|Hypoglycemia|3
7010463|NCT01468233|11080186|FG001|Treatment Period 2|Adverse Event|0
7010464|NCT01468233|11080187|FG002|Treatment Period 2|Adverse Event|3
7010465|NCT01468233|11080188|FG003|Treatment Period 2|Adverse Event|0
7010466|NCT01468233|11080189|FG004|Treatment Period 2|Adverse Event|2
7010467|NCT01468233|11080190|FG005|Treatment Period 2|Adverse Event|1
7010468|NCT01468233|11080185|FG000|Treatment Period 2|Lack of Efficacy|0
7010469|NCT01468233|11080186|FG001|Treatment Period 2|Lack of Efficacy|0
7010470|NCT01468233|11080187|FG002|Treatment Period 2|Lack of Efficacy|9
7010471|NCT01468233|11080188|FG003|Treatment Period 2|Lack of Efficacy|2
7010472|NCT01468233|11080189|FG004|Treatment Period 2|Lack of Efficacy|0
7010473|NCT01468233|11080190|FG005|Treatment Period 2|Lack of Efficacy|1
7010474|NCT01468233|11080185|FG000|Treatment Period 2|Withdrawal by Subject|0
7010475|NCT01468233|11080186|FG001|Treatment Period 2|Withdrawal by Subject|0
7010476|NCT01468233|11080187|FG002|Treatment Period 2|Withdrawal by Subject|9
7010477|NCT01468233|11080188|FG003|Treatment Period 2|Withdrawal by Subject|1
7010478|NCT01468233|11080189|FG004|Treatment Period 2|Withdrawal by Subject|1
7010479|NCT01468233|11080190|FG005|Treatment Period 2|Withdrawal by Subject|1
7010480|NCT01468233|11080185|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0
7010481|NCT01468233|11080186|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0
7010482|NCT01468233|11080187|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84
7010483|NCT01468233|11080188|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25
7010484|NCT01468233|11080189|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22
7010485|NCT01468233|11080190|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20
7010486|NCT01468233|11080185|FG000|Treatment Period 2|Lost to Follow-up|0
7010487|NCT01468233|11080186|FG001|Treatment Period 2|Lost to Follow-up|0
7010488|NCT01468233|11080187|FG002|Treatment Period 2|Lost to Follow-up|3
7010489|NCT01468233|11080188|FG003|Treatment Period 2|Lost to Follow-up|0
7010490|NCT01468233|11080189|FG004|Treatment Period 2|Lost to Follow-up|2
7010491|NCT01468233|11080190|FG005|Treatment Period 2|Lost to Follow-up|0
7010492|NCT01468233|11080185|FG000|Treatment Period 2|Other|0
7010493|NCT01468233|11080186|FG001|Treatment Period 2|Other|0
7010494|NCT01468233|11080187|FG002|Treatment Period 2|Other|3
7010495|NCT01468233|11080188|FG003|Treatment Period 2|Other|0
7010496|NCT01468233|11080189|FG004|Treatment Period 2|Other|1
7010497|NCT01468233|11080190|FG005|Treatment Period 2|Other|0
7010498|NCT01468311|11080208|FG000|Overall Study|mobilization failure|1
7010499|NCT01468311|11080208|FG000|Overall Study|Withdrawal by Subject|1
7010500|NCT01468454|11080233|FG000|Overall Study|Did not have surgery after PET|9
7010501|NCT01468597|11080254|FG000|Overall Study|Found ineligible|17
7010502|NCT01468597|11080254|FG000|Overall Study|concomitant valves|12
7183602|NCT01499082|11383688|FG000|Overall Study|Lost to Follow-up|1
7183603|NCT01499082|11383689|FG001|Overall Study|Lost to Follow-up|3
7010503|NCT01468597|11080254|FG000|Overall Study|off-pump CABG|1
7010504|NCT01468597|11080254|FG000|Overall Study|no platelet function data|5
7010505|NCT01468701|11080284|FG000|Overall Study|Not eligible|91
7010506|NCT01468701|11080285|FG001|Overall Study|Not eligible|140
7010507|NCT01468701|11080286|FG002|Overall Study|Not eligible|29
7010508|NCT01468701|11080287|FG003|Overall Study|Not eligible|12
7010509|NCT01468701|11080288|FG004|Overall Study|Not eligible|22
7010510|NCT01468701|11080289|FG005|Overall Study|Not eligible|2
7010511|NCT01468701|11080290|FG006|Overall Study|Not eligible|39
7010512|NCT01468701|11080291|FG007|Overall Study|Not eligible|1
7010513|NCT01468701|11080292|FG008|Overall Study|Not eligible|40
7010514|NCT01468701|11080293|FG009|Overall Study|Not eligible|126
7010515|NCT01468701|11080294|FG010|Overall Study|Not eligible|39
7010516|NCT01468701|11080295|FG011|Overall Study|Not eligible|33
7010517|NCT01468701|11080296|FG012|Overall Study|Not eligible|1
7010518|NCT01468701|11080297|FG013|Overall Study|Not eligible|19
7010519|NCT01468701|11080298|FG014|Overall Study|Not eligible|1
7010520|NCT01468701|11080299|FG015|Overall Study|Not eligible|32
7010521|NCT01468701|11080300|FG016|Overall Study|Not eligible|0
7010522|NCT01468701|11080284|FG000|Overall Study|Lost to Follow-up|306
7010523|NCT01468701|11080285|FG001|Overall Study|Lost to Follow-up|0
7010524|NCT01468701|11080286|FG002|Overall Study|Lost to Follow-up|0
7010525|NCT01468701|11080287|FG003|Overall Study|Lost to Follow-up|0
7010526|NCT01468701|11080288|FG004|Overall Study|Lost to Follow-up|0
7010527|NCT01468701|11080289|FG005|Overall Study|Lost to Follow-up|0
7010528|NCT01468701|11080290|FG006|Overall Study|Lost to Follow-up|0
7010529|NCT01468701|11080291|FG007|Overall Study|Lost to Follow-up|0
7010530|NCT01468701|11080292|FG008|Overall Study|Lost to Follow-up|215
7010531|NCT01468701|11080293|FG009|Overall Study|Lost to Follow-up|309
7010532|NCT01468701|11080294|FG010|Overall Study|Lost to Follow-up|224
7010533|NCT01468701|11080295|FG011|Overall Study|Lost to Follow-up|212
7010534|NCT01468701|11080296|FG012|Overall Study|Lost to Follow-up|11
7010535|NCT01468701|11080297|FG013|Overall Study|Lost to Follow-up|164
7010536|NCT01468701|11080298|FG014|Overall Study|Lost to Follow-up|17
7010537|NCT01468701|11080299|FG015|Overall Study|Lost to Follow-up|127
7010538|NCT01468701|11080300|FG016|Overall Study|Lost to Follow-up|1
7010539|NCT01468701|11080284|FG000|Overall Study|Withdrawal by Subject|165
7010540|NCT01468701|11080285|FG001|Overall Study|Withdrawal by Subject|0
7010541|NCT01468701|11080286|FG002|Overall Study|Withdrawal by Subject|0
7010542|NCT01468701|11080287|FG003|Overall Study|Withdrawal by Subject|0
7010543|NCT01468701|11080288|FG004|Overall Study|Withdrawal by Subject|0
7010544|NCT01468701|11080289|FG005|Overall Study|Withdrawal by Subject|0
7010545|NCT01468701|11080290|FG006|Overall Study|Withdrawal by Subject|0
7010546|NCT01468701|11080291|FG007|Overall Study|Withdrawal by Subject|0
7010547|NCT01468701|11080292|FG008|Overall Study|Withdrawal by Subject|83
7010548|NCT01468701|11080293|FG009|Overall Study|Withdrawal by Subject|88
7010549|NCT01468701|11080294|FG010|Overall Study|Withdrawal by Subject|100
7010550|NCT01468701|11080295|FG011|Overall Study|Withdrawal by Subject|114
7010551|NCT01468701|11080296|FG012|Overall Study|Withdrawal by Subject|9
7010552|NCT01468701|11080297|FG013|Overall Study|Withdrawal by Subject|47
7010553|NCT01468701|11080298|FG014|Overall Study|Withdrawal by Subject|6
7010554|NCT01468701|11080299|FG015|Overall Study|Withdrawal by Subject|31
7010555|NCT01468701|11080300|FG016|Overall Study|Withdrawal by Subject|0
7010556|NCT01468701|11080284|FG000|Overall Study|Other reasons than listed|437
7010557|NCT01468701|11080285|FG001|Overall Study|Other reasons than listed|0
7010558|NCT01468701|11080286|FG002|Overall Study|Other reasons than listed|0
7010559|NCT01468701|11080287|FG003|Overall Study|Other reasons than listed|0
7010560|NCT01468701|11080288|FG004|Overall Study|Other reasons than listed|0
7010561|NCT01468701|11080289|FG005|Overall Study|Other reasons than listed|0
7010562|NCT01468701|11080290|FG006|Overall Study|Other reasons than listed|0
7010563|NCT01468701|11080291|FG007|Overall Study|Other reasons than listed|0
7010564|NCT01468701|11080292|FG008|Overall Study|Other reasons than listed|318
7010565|NCT01468701|11080293|FG009|Overall Study|Other reasons than listed|658
7010566|NCT01468701|11080294|FG010|Overall Study|Other reasons than listed|433
7010567|NCT01468701|11080295|FG011|Overall Study|Other reasons than listed|504
7010568|NCT01468701|11080296|FG012|Overall Study|Other reasons than listed|28
7010569|NCT01468701|11080297|FG013|Overall Study|Other reasons than listed|239
7010570|NCT01468701|11080298|FG014|Overall Study|Other reasons than listed|39
7010571|NCT01468701|11080299|FG015|Overall Study|Other reasons than listed|172
7010572|NCT01468701|11080300|FG016|Overall Study|Other reasons than listed|0
7010573|NCT01468701|11080284|FG000|Overall Study|No end of study case report form|0
7010574|NCT01468701|11080285|FG001|Overall Study|No end of study case report form|0
7010575|NCT01468701|11080286|FG002|Overall Study|No end of study case report form|0
7010576|NCT01468701|11080287|FG003|Overall Study|No end of study case report form|0
7010577|NCT01468701|11080288|FG004|Overall Study|No end of study case report form|0
7010578|NCT01468701|11080289|FG005|Overall Study|No end of study case report form|0
7010579|NCT01468701|11080290|FG006|Overall Study|No end of study case report form|0
7010580|NCT01468701|11080291|FG007|Overall Study|No end of study case report form|0
7010581|NCT01468701|11080292|FG008|Overall Study|No end of study case report form|4
7010582|NCT01468701|11080293|FG009|Overall Study|No end of study case report form|1
7010583|NCT01468701|11080294|FG010|Overall Study|No end of study case report form|2
7010584|NCT01468701|11080295|FG011|Overall Study|No end of study case report form|3
7010585|NCT01468701|11080296|FG012|Overall Study|No end of study case report form|0
7010586|NCT01468701|11080297|FG013|Overall Study|No end of study case report form|1
7010587|NCT01468701|11080298|FG014|Overall Study|No end of study case report form|0
7010588|NCT01468701|11080299|FG015|Overall Study|No end of study case report form|0
7010589|NCT01468701|11080300|FG016|Overall Study|No end of study case report form|0
7010590|NCT01468701|11080284|FG000|Overall Study|Not being followed up|0
7010591|NCT01468701|11080285|FG001|Overall Study|Not being followed up|4963
7010592|NCT01468701|11080286|FG002|Overall Study|Not being followed up|1755
7010593|NCT01468701|11080287|FG003|Overall Study|Not being followed up|703
7010594|NCT01468701|11080288|FG004|Overall Study|Not being followed up|1714
7010595|NCT01468701|11080289|FG005|Overall Study|Not being followed up|126
7010596|NCT01468701|11080290|FG006|Overall Study|Not being followed up|1170
7010597|NCT01468701|11080291|FG007|Overall Study|Not being followed up|4
7010598|NCT01468701|11080292|FG008|Overall Study|Not being followed up|0
7010599|NCT01468701|11080293|FG009|Overall Study|Not being followed up|0
7010600|NCT01468701|11080294|FG010|Overall Study|Not being followed up|0
7010601|NCT01468701|11080295|FG011|Overall Study|Not being followed up|0
7010602|NCT01468701|11080296|FG012|Overall Study|Not being followed up|0
7010603|NCT01468701|11080297|FG013|Overall Study|Not being followed up|0
7010604|NCT01468701|11080298|FG014|Overall Study|Not being followed up|0
7010605|NCT01468701|11080299|FG015|Overall Study|Not being followed up|0
7010606|NCT01468701|11080300|FG016|Overall Study|Not being followed up|0
7010607|NCT01468818|11080313|FG000|Overall Study|Death during treatment|2
7010608|NCT01468844|11080319|FG000|Overall Study|Adverse Event|1
7010609|NCT01468844|11080320|FG001|Overall Study|Adverse Event|0
7010610|NCT01468844|11080319|FG000|Overall Study|Withdrawal by Subject|1
7010611|NCT01468844|11080320|FG001|Overall Study|Withdrawal by Subject|0
7010612|NCT01468909|11080331|FG000|Overall Study|Never Treated|2
7010613|NCT01468909|11080332|FG001|Overall Study|Never Treated|2
7043354|NCT01743092|11128169|FG001|Overall Study|Lost to Follow-up|15
7043355|NCT01743469|11128196|FG000|Active Treatment Phase|Adverse Event|10
7043356|NCT01743469|11128197|FG001|Active Treatment Phase|Adverse Event|5
7043357|NCT01743469|11128198|FG002|Active Treatment Phase|Adverse Event|8
7043358|NCT01743469|11128199|FG003|Active Treatment Phase|Adverse Event|1
7043359|NCT01743469|11128196|FG000|Active Treatment Phase|Disease Progression|40
7043360|NCT01743469|11128197|FG001|Active Treatment Phase|Disease Progression|47
7043361|NCT01743469|11128198|FG002|Active Treatment Phase|Disease Progression|30
7043362|NCT01743469|11128199|FG003|Active Treatment Phase|Disease Progression|20
7043363|NCT01743469|11128196|FG000|Active Treatment Phase|Withdrawal by Subject|2
7043364|NCT01743469|11128197|FG001|Active Treatment Phase|Withdrawal by Subject|3
7043365|NCT01743469|11128198|FG002|Active Treatment Phase|Withdrawal by Subject|0
7043366|NCT01743469|11128199|FG003|Active Treatment Phase|Withdrawal by Subject|0
7043367|NCT01743469|11128196|FG000|Active Treatment Phase|Missing|1
7043368|NCT01743469|11128197|FG001|Active Treatment Phase|Missing|0
7043369|NCT01743469|11128198|FG002|Active Treatment Phase|Missing|0
7043370|NCT01743469|11128199|FG003|Active Treatment Phase|Missing|0
7043371|NCT01743469|11128196|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
7043372|NCT01743469|11128197|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
7043373|NCT01743469|11128198|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
7043374|NCT01743469|11128199|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
7043375|NCT01743469|11128196|FG000|Follow-up Period - Post-Treatment|Death|43
7043376|NCT01743469|11128197|FG001|Follow-up Period - Post-Treatment|Death|47
7043377|NCT01743469|11128198|FG002|Follow-up Period - Post-Treatment|Death|22
7043378|NCT01743469|11128199|FG003|Follow-up Period - Post-Treatment|Death|16
7043379|NCT01743469|11128196|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1
7043380|NCT01743469|11128197|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1
7043381|NCT01743469|11128198|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0
7043382|NCT01743469|11128199|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0
7043383|NCT01743560|11128224|FG000|Overall Study|Disease progression|26
7043384|NCT01743560|11128224|FG000|Overall Study|Adverse Event|8
7043385|NCT01743560|11128224|FG000|Overall Study|Death|3
7043386|NCT01743560|11128224|FG000|Overall Study|Withdrawal by Subject|2
7043387|NCT01743560|11128224|FG000|Overall Study|Protocol Violation|1
7043388|NCT01743560|11128224|FG000|Overall Study|>1 dose of study drug|3
7043389|NCT01743989|11128286|FG000|Treatment Phase|Unstable MR4.0|0
7043390|NCT01743989|11128287|FG001|Treatment Phase|Unstable MR4.0|6
7043391|NCT01743989|11128288|FG002|Treatment Phase|Unstable MR4.0|263
7043392|NCT01743989|11128286|FG000|Treatment Phase|Adverse Event|0
7043393|NCT01743989|11128287|FG001|Treatment Phase|Adverse Event|4
7043394|NCT01743989|11128288|FG002|Treatment Phase|Adverse Event|67
7043395|NCT01743989|11128286|FG000|Treatment Phase|Withdrawal by Subject|1
7043396|NCT01743989|11128287|FG001|Treatment Phase|Withdrawal by Subject|3
7043397|NCT01743989|11128288|FG002|Treatment Phase|Withdrawal by Subject|28
7043398|NCT01743989|11128286|FG000|Treatment Phase|Death|0
7043399|NCT01743989|11128287|FG001|Treatment Phase|Death|1
7043400|NCT01743989|11128288|FG002|Treatment Phase|Death|3
7043401|NCT01743989|11128286|FG000|Treatment Phase|Abnormal laboratory value(s)|0
7043402|NCT01743989|11128287|FG001|Treatment Phase|Abnormal laboratory value(s)|0
7043403|NCT01743989|11128288|FG002|Treatment Phase|Abnormal laboratory value(s)|3
7043404|NCT01743989|11128286|FG000|Treatment Phase|Protocol deviation|0
7043405|NCT01743989|11128287|FG001|Treatment Phase|Protocol deviation|0
7043406|NCT01743989|11128288|FG002|Treatment Phase|Protocol deviation|3
7010614|NCT01468987|11080344|FG000|Overall Study|Adverse Event|12
7010615|NCT01468987|11080345|FG001|Overall Study|Adverse Event|9
7010616|NCT01468987|11080344|FG000|Overall Study|Death|4
7010617|NCT01468987|11080345|FG001|Overall Study|Death|1
7010618|NCT01468987|11080344|FG000|Overall Study|Lost to Follow-up|10
7010619|NCT01468987|11080345|FG001|Overall Study|Lost to Follow-up|5
7010620|NCT01468987|11080344|FG000|Overall Study|Protocol Violation|8
7010621|NCT01468987|11080345|FG001|Overall Study|Protocol Violation|2
7010622|NCT01468987|11080344|FG000|Overall Study|Withdrawal by Subject|28
7010623|NCT01468987|11080345|FG001|Overall Study|Withdrawal by Subject|28
7010624|NCT01468987|11080344|FG000|Overall Study|Physician Decision|8
7010625|NCT01468987|11080345|FG001|Overall Study|Physician Decision|15
7010626|NCT01468987|11080344|FG000|Overall Study|Sponsor Decision|1
7010627|NCT01468987|11080345|FG001|Overall Study|Sponsor Decision|0
7010628|NCT01469000|11080355|FG000|Overall Study|Withdrawal by Subject|16
7010629|NCT01469000|11080356|FG001|Overall Study|Withdrawal by Subject|3
7010630|NCT01469000|11080355|FG000|Overall Study|Sponsor Decision|4
7010631|NCT01469000|11080356|FG001|Overall Study|Sponsor Decision|1
7010632|NCT01469013|11080367|FG000|Part A (Treatment Period)|Adverse Event|1
7010633|NCT01469013|11080368|FG001|Part A (Treatment Period)|Adverse Event|0
7010634|NCT01469013|11080369|FG002|Part A (Treatment Period)|Adverse Event|0
7010635|NCT01469013|11080370|FG003|Part A (Treatment Period)|Adverse Event|0
7010636|NCT01469013|11080371|FG004|Part A (Treatment Period)|Adverse Event|1
7010637|NCT01469013|11080372|FG005|Part A (Treatment Period)|Adverse Event|0
7010638|NCT01469013|11080373|FG006|Part A (Treatment Period)|Adverse Event|0
7010639|NCT01469013|11080374|FG007|Part A (Treatment Period)|Adverse Event|0
7010640|NCT01469013|11080375|FG008|Part A (Treatment Period)|Adverse Event|0
7010641|NCT01469013|11080376|FG009|Part A (Treatment Period)|Adverse Event|0
7010642|NCT01469013|11080377|FG010|Part A (Treatment Period)|Adverse Event|0
7010643|NCT01469013|11080378|FG011|Part A (Treatment Period)|Adverse Event|0
7010644|NCT01469013|11080379|FG012|Part A (Treatment Period)|Adverse Event|0
7010645|NCT01469013|11080367|FG000|Part A (Treatment Period)|Withdrawal by Subject|0
7010646|NCT01469013|11080368|FG001|Part A (Treatment Period)|Withdrawal by Subject|0
7010647|NCT01469013|11080369|FG002|Part A (Treatment Period)|Withdrawal by Subject|1
7010648|NCT01469013|11080370|FG003|Part A (Treatment Period)|Withdrawal by Subject|0
7010649|NCT01469013|11080371|FG004|Part A (Treatment Period)|Withdrawal by Subject|0
7010650|NCT01469013|11080372|FG005|Part A (Treatment Period)|Withdrawal by Subject|0
7010651|NCT01469013|11080373|FG006|Part A (Treatment Period)|Withdrawal by Subject|0
7010652|NCT01469013|11080374|FG007|Part A (Treatment Period)|Withdrawal by Subject|0
7010653|NCT01469013|11080375|FG008|Part A (Treatment Period)|Withdrawal by Subject|0
7010654|NCT01469013|11080376|FG009|Part A (Treatment Period)|Withdrawal by Subject|0
7010655|NCT01469013|11080377|FG010|Part A (Treatment Period)|Withdrawal by Subject|0
7010656|NCT01469013|11080378|FG011|Part A (Treatment Period)|Withdrawal by Subject|0
7010657|NCT01469013|11080379|FG012|Part A (Treatment Period)|Withdrawal by Subject|0
7010658|NCT01469013|11080367|FG000|Part B (Extension Period)|Adverse Event|0
7010659|NCT01469013|11080368|FG001|Part B (Extension Period)|Adverse Event|0
7010660|NCT01469013|11080369|FG002|Part B (Extension Period)|Adverse Event|0
7010661|NCT01469013|11080370|FG003|Part B (Extension Period)|Adverse Event|0
7010662|NCT01469013|11080371|FG004|Part B (Extension Period)|Adverse Event|0
7010663|NCT01469013|11080372|FG005|Part B (Extension Period)|Adverse Event|2
7010664|NCT01469013|11080373|FG006|Part B (Extension Period)|Adverse Event|5
7010665|NCT01469013|11080374|FG007|Part B (Extension Period)|Adverse Event|5
7010666|NCT01469013|11080375|FG008|Part B (Extension Period)|Adverse Event|3
7010667|NCT01469013|11080376|FG009|Part B (Extension Period)|Adverse Event|3
7010668|NCT01469013|11080377|FG010|Part B (Extension Period)|Adverse Event|1
7010669|NCT01469013|11080378|FG011|Part B (Extension Period)|Adverse Event|6
7010670|NCT01469013|11080379|FG012|Part B (Extension Period)|Adverse Event|3
7010671|NCT01469013|11080367|FG000|Part B (Extension Period)|Withdrawal by Subject|0
7010672|NCT01469013|11080368|FG001|Part B (Extension Period)|Withdrawal by Subject|0
7010673|NCT01469013|11080369|FG002|Part B (Extension Period)|Withdrawal by Subject|0
7010674|NCT01469013|11080370|FG003|Part B (Extension Period)|Withdrawal by Subject|0
7010675|NCT01469013|11080371|FG004|Part B (Extension Period)|Withdrawal by Subject|0
7010676|NCT01469013|11080372|FG005|Part B (Extension Period)|Withdrawal by Subject|0
7010677|NCT01469013|11080373|FG006|Part B (Extension Period)|Withdrawal by Subject|0
7010678|NCT01469013|11080374|FG007|Part B (Extension Period)|Withdrawal by Subject|0
7010679|NCT01469013|11080375|FG008|Part B (Extension Period)|Withdrawal by Subject|1
7010680|NCT01469013|11080376|FG009|Part B (Extension Period)|Withdrawal by Subject|0
7010681|NCT01469013|11080377|FG010|Part B (Extension Period)|Withdrawal by Subject|1
7010682|NCT01469013|11080378|FG011|Part B (Extension Period)|Withdrawal by Subject|0
7010683|NCT01469013|11080379|FG012|Part B (Extension Period)|Withdrawal by Subject|3
7010684|NCT01469052|11080425|FG000|Overall Study|Adverse Event|2
7010685|NCT01469052|11080426|FG001|Overall Study|Adverse Event|3
7010686|NCT01469052|11080427|FG002|Overall Study|Adverse Event|0
7010687|NCT01469052|11080428|FG003|Overall Study|Adverse Event|2
7010688|NCT01469052|11080429|FG004|Overall Study|Adverse Event|0
7010689|NCT01469052|11080430|FG005|Overall Study|Adverse Event|1
7010690|NCT01469052|11080425|FG000|Overall Study|Progressive disease|3
7010691|NCT01469052|11080426|FG001|Overall Study|Progressive disease|0
7010692|NCT01469052|11080427|FG002|Overall Study|Progressive disease|5
7010693|NCT01469052|11080428|FG003|Overall Study|Progressive disease|3
7010694|NCT01469052|11080429|FG004|Overall Study|Progressive disease|7
7010695|NCT01469052|11080430|FG005|Overall Study|Progressive disease|2
7010696|NCT01469052|11080425|FG000|Overall Study|Lack of Efficacy|0
7010697|NCT01469052|11080426|FG001|Overall Study|Lack of Efficacy|0
7010698|NCT01469052|11080427|FG002|Overall Study|Lack of Efficacy|0
7010699|NCT01469052|11080428|FG003|Overall Study|Lack of Efficacy|0
7010700|NCT01469052|11080429|FG004|Overall Study|Lack of Efficacy|0
7010701|NCT01469052|11080430|FG005|Overall Study|Lack of Efficacy|2
7010702|NCT01469052|11080425|FG000|Overall Study|Moved to rollover protocol|1
7010703|NCT01469052|11080426|FG001|Overall Study|Moved to rollover protocol|0
7010704|NCT01469052|11080427|FG002|Overall Study|Moved to rollover protocol|1
7010705|NCT01469052|11080428|FG003|Overall Study|Moved to rollover protocol|0
7010706|NCT01469052|11080429|FG004|Overall Study|Moved to rollover protocol|0
7010707|NCT01469052|11080430|FG005|Overall Study|Moved to rollover protocol|1
7010708|NCT01469052|11080425|FG000|Overall Study|Other|0
7010709|NCT01469052|11080426|FG001|Overall Study|Other|1
7010710|NCT01469052|11080427|FG002|Overall Study|Other|0
7010711|NCT01469052|11080428|FG003|Overall Study|Other|0
7010712|NCT01469052|11080429|FG004|Overall Study|Other|1
7010713|NCT01469052|11080430|FG005|Overall Study|Other|0
7010714|NCT01469065|11080447|FG000|Overall Study|Lack of Efficacy|0
7010715|NCT01469065|11080448|FG001|Overall Study|Lack of Efficacy|0
7010716|NCT01469065|11080449|FG002|Overall Study|Lack of Efficacy|0
7010717|NCT01469065|11080450|FG003|Overall Study|Lack of Efficacy|0
7010718|NCT01469065|11080451|FG004|Overall Study|Lack of Efficacy|1
7010719|NCT01469065|11080447|FG000|Overall Study|Other|0
7010720|NCT01469065|11080448|FG001|Overall Study|Other|1
7010721|NCT01469065|11080449|FG002|Overall Study|Other|0
7010722|NCT01469065|11080450|FG003|Overall Study|Other|0
7010723|NCT01469065|11080451|FG004|Overall Study|Other|0
7010724|NCT01469182|11080469|FG000|Overall Study|Adverse Event|21
7010725|NCT01469182|11080470|FG001|Overall Study|Adverse Event|3
7010726|NCT01469182|11080469|FG000|Overall Study|Lost to Follow-up|3
7010727|NCT01469182|11080470|FG001|Overall Study|Lost to Follow-up|0
7010728|NCT01469182|11080469|FG000|Overall Study|Withdrawal by Subject|4
7010729|NCT01469182|11080470|FG001|Overall Study|Withdrawal by Subject|1
7010730|NCT01469182|11080469|FG000|Overall Study|Protocol Violation|4
7010731|NCT01469182|11080470|FG001|Overall Study|Protocol Violation|2
7010732|NCT01469182|11080469|FG000|Overall Study|Did not meet Protocol Eligibility|3
7010733|NCT01469182|11080470|FG001|Overall Study|Did not meet Protocol Eligibility|0
7010734|NCT01469221|11080478|FG000|Double Blind Phase|Protocol Violation|1
7010735|NCT01469221|11080479|FG001|Double Blind Phase|Protocol Violation|0
7010736|NCT01469221|11080480|FG002|Double Blind Phase|Protocol Violation|0
7010737|NCT01469221|11080478|FG000|Double Blind Phase|Physician Decision|1
7010738|NCT01469221|11080479|FG001|Double Blind Phase|Physician Decision|1
7010739|NCT01469221|11080480|FG002|Double Blind Phase|Physician Decision|0
7010740|NCT01469221|11080478|FG000|Double Blind Phase|Sponsor Terminate Study|12
7010741|NCT01469221|11080479|FG001|Double Blind Phase|Sponsor Terminate Study|16
7010742|NCT01469221|11080480|FG002|Double Blind Phase|Sponsor Terminate Study|0
7010743|NCT01469364|11080500|FG000|Overall Study|Adverse Event|1
7010744|NCT01469364|11080500|FG000|Overall Study|Withdrawal by Subject|1
7010745|NCT01469377|11080507|FG000|Overall Study|Protocol Deviation|7
7010746|NCT01469377|11080508|FG001|Overall Study|Protocol Deviation|10
7010747|NCT01469377|11080509|FG002|Overall Study|Protocol Deviation|10
7010748|NCT01469377|11080507|FG000|Overall Study|Lost to Follow-up|3
7010749|NCT01469377|11080508|FG001|Overall Study|Lost to Follow-up|2
7010750|NCT01469377|11080509|FG002|Overall Study|Lost to Follow-up|5
7010751|NCT01469377|11080507|FG000|Overall Study|Withdrawal of Consent|12
7010752|NCT01469377|11080508|FG001|Overall Study|Withdrawal of Consent|14
7010753|NCT01469377|11080509|FG002|Overall Study|Withdrawal of Consent|15
7010754|NCT01469377|11080507|FG000|Overall Study|Adverse Event|8
7010755|NCT01469377|11080508|FG001|Overall Study|Adverse Event|18
7010756|NCT01469377|11080509|FG002|Overall Study|Adverse Event|36
7010757|NCT01469377|11080507|FG000|Overall Study|Insufficient Therapeutic Response|3
7010758|NCT01469377|11080508|FG001|Overall Study|Insufficient Therapeutic Response|4
7010759|NCT01469377|11080509|FG002|Overall Study|Insufficient Therapeutic Response|0
7010760|NCT01469377|11080507|FG000|Overall Study|Other Miscellaneous Reasons|2
7010761|NCT01469377|11080508|FG001|Overall Study|Other Miscellaneous Reasons|0
7010762|NCT01469377|11080509|FG002|Overall Study|Other Miscellaneous Reasons|0
7010763|NCT01469546|11080517|FG000|Received 5 mg Dose|Adverse Event|13
7010764|NCT01469546|11080517|FG000|Received 5 mg Dose|Death|2
7010765|NCT01469546|11080517|FG000|Received 5 mg Dose|Protocol Violation|2
7010766|NCT01469546|11080517|FG000|Received 5 mg Dose|Progressive Disease|3
7010767|NCT01469546|11080517|FG000|Received 5 mg Dose|Physician Decision|3
7010768|NCT01469637|11080534|FG000|First Intervention|Unacceptable behavior|0
7010769|NCT01469637|11080535|FG001|First Intervention|Unacceptable behavior|1
7010770|NCT01469637|11080534|FG000|Second Intervention|Incarcerated|1
7010771|NCT01469637|11080535|FG001|Second Intervention|Incarcerated|0
7010772|NCT01469819|11080549|FG000|Overall Study|Withdrawal by Subject|1
7010773|NCT01469819|11080549|FG000|Overall Study|Did not meet inclusionary criteria|2
7010774|NCT01469819|11080549|FG000|Overall Study|Could not swallow SmartPill|2
7010775|NCT01469819|11080549|FG000|Overall Study|Technical malfunction of SmartPill data|3
7010776|NCT01470001|11080561|FG000|Overall Study|Lost to Follow-up|1
7010777|NCT01470001|11080562|FG001|Overall Study|Lost to Follow-up|1
7010778|NCT01470001|11080561|FG000|Overall Study|Physician Decision|2
7010779|NCT01470001|11080562|FG001|Overall Study|Physician Decision|0
7010780|NCT01470001|11080561|FG000|Overall Study|Withdrawal by Subject|2
7010781|NCT01470001|11080562|FG001|Overall Study|Withdrawal by Subject|1
7010782|NCT01470144|11080603|FG000|Overall Study|Adverse Event|2
7010783|NCT01470144|11080603|FG000|Overall Study|Death|1
7010784|NCT01470144|11080603|FG000|Overall Study|Lung transplant|6
7010785|NCT01470144|11080603|FG000|Overall Study|Patient's and investigator's decision|1
7010786|NCT01470248|11080632|FG000|Overall Study|Withdrawal by Subject|1
7010787|NCT01470417|11080638|FG000|Overall Study|Disease progression|0
7010788|NCT01470417|11080639|FG001|Overall Study|Disease progression|2
7010789|NCT01470469|11080647|FG000|Overall Study|Withdrawal by Subject|4
7010790|NCT01470469|11080648|FG001|Overall Study|Withdrawal by Subject|6
7010791|NCT01470469|11080647|FG000|Overall Study|Lack of Efficacy|1
7010792|NCT01470469|11080648|FG001|Overall Study|Lack of Efficacy|7
7010793|NCT01470469|11080647|FG000|Overall Study|Adverse Event|0
7010794|NCT01470469|11080648|FG001|Overall Study|Adverse Event|7
7010795|NCT01470469|11080647|FG000|Overall Study|Lost to Follow-up|2
7010796|NCT01470469|11080648|FG001|Overall Study|Lost to Follow-up|2
7010797|NCT01470469|11080647|FG000|Overall Study|Protocol Violation|1
7010798|NCT01470469|11080648|FG001|Overall Study|Protocol Violation|1
7010799|NCT01470469|11080647|FG000|Overall Study|Other|2
7010800|NCT01470469|11080648|FG001|Overall Study|Other|1
7010801|NCT01470599|11080656|FG000|Overall Study|Did not meet entrance criteria|1
7010802|NCT01470599|11080657|FG001|Overall Study|Did not meet entrance criteria|0
7010803|NCT01470599|11080656|FG000|Overall Study|Lost to Follow-up|2
7010804|NCT01470599|11080657|FG001|Overall Study|Lost to Follow-up|1
7010805|NCT01470599|11080656|FG000|Overall Study|Withdrawal by Subject|3
7010806|NCT01470599|11080657|FG001|Overall Study|Withdrawal by Subject|4
7010807|NCT01470599|11080656|FG000|Overall Study|Other|1
7010808|NCT01470599|11080657|FG001|Overall Study|Other|0
7010809|NCT01470599|11080656|FG000|Overall Study|Protocol Violation|3
7010810|NCT01470599|11080657|FG001|Overall Study|Protocol Violation|1
7010811|NCT01470599|11080656|FG000|Overall Study|Adverse event related to study drug|2
7010812|NCT01470599|11080657|FG001|Overall Study|Adverse event related to study drug|5
7010813|NCT01470599|11080656|FG000|Overall Study|Insufficient clinical response|6
7010814|NCT01470599|11080657|FG001|Overall Study|Insufficient clinical response|27
7010815|NCT01470599|11080656|FG000|Overall Study|Adverse event not related to study drug|1
7010816|NCT01470599|11080657|FG001|Overall Study|Adverse event not related to study drug|5
7010817|NCT01470612|11080665|FG000|Overall Study|Adverse Event|20
7010818|NCT01470612|11080666|FG001|Overall Study|Adverse Event|80
7010819|NCT01470612|11080665|FG000|Overall Study|Death|0
7010820|NCT01470612|11080666|FG001|Overall Study|Death|1
7010821|NCT01470612|11080665|FG000|Overall Study|Lack of Efficacy|20
7010822|NCT01470612|11080666|FG001|Overall Study|Lack of Efficacy|326
7010823|NCT01470612|11080665|FG000|Overall Study|Lost to Follow-up|2
7010824|NCT01470612|11080666|FG001|Overall Study|Lost to Follow-up|5
7010825|NCT01470612|11080665|FG000|Overall Study|Did not meet entrance criteria|0
7010826|NCT01470612|11080666|FG001|Overall Study|Did not meet entrance criteria|1
7010827|NCT01470612|11080665|FG000|Overall Study|Pregnancy|2
7010828|NCT01470612|11080666|FG001|Overall Study|Pregnancy|10
7010829|NCT01470612|11080665|FG000|Overall Study|Protocol Violation|2
7010830|NCT01470612|11080666|FG001|Overall Study|Protocol Violation|7
7010831|NCT01470612|11080665|FG000|Overall Study|Withdrawal by Subject|24
7010832|NCT01470612|11080666|FG001|Overall Study|Withdrawal by Subject|79
7010833|NCT01470612|11080665|FG000|Overall Study|Other|14
7010834|NCT01470612|11080666|FG001|Overall Study|Other|156
7010835|NCT01470989|11080702|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103
7010836|NCT01470989|11080703|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136
7010837|NCT01470989|11080702|FG000|Overall Study|Adverse Event|2
7010838|NCT01470989|11080703|FG001|Overall Study|Adverse Event|5
7010839|NCT01470989|11080702|FG000|Overall Study|Abnormal laboratory value|1
7010840|NCT01470989|11080703|FG001|Overall Study|Abnormal laboratory value|1
7010841|NCT01470989|11080702|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7010842|NCT01470989|11080703|FG001|Overall Study|Unsatisfactory therapeutic effect|6
7010843|NCT01470989|11080702|FG000|Overall Study|Withdrawal by Subject|19
7010844|NCT01470989|11080703|FG001|Overall Study|Withdrawal by Subject|17
7010845|NCT01470989|11080702|FG000|Overall Study|Lost to Follow-up|18
7010846|NCT01470989|11080703|FG001|Overall Study|Lost to Follow-up|13
7010847|NCT01470989|11080702|FG000|Overall Study|Administrative problems|2
7010848|NCT01470989|11080703|FG001|Overall Study|Administrative problems|4
7010849|NCT01470989|11080702|FG000|Overall Study|Death|2
7010850|NCT01470989|11080703|FG001|Overall Study|Death|2
7010851|NCT01470989|11080702|FG000|Overall Study|Protocol deviation|1
7010852|NCT01470989|11080703|FG001|Overall Study|Protocol deviation|2
7010853|NCT01471015|11080714|FG000|Overall Study|Death|0
7010854|NCT01471015|11080715|FG001|Overall Study|Death|1
7010855|NCT01471015|11080716|FG002|Overall Study|Death|1
7010856|NCT01471028|11080726|FG000|VTI-208|Adverse Event|39
7010857|NCT01471028|11080727|FG001|VTI-208|Adverse Event|41
7010858|NCT01471028|11080726|FG000|VTI-208|Withdrawal by Subject|0
7010859|NCT01471028|11080727|FG001|VTI-208|Withdrawal by Subject|2
7010860|NCT01471028|11080726|FG000|VTI-208|Lost to Follow-up|1
7010861|NCT01471028|11080727|FG001|VTI-208|Lost to Follow-up|1
7010862|NCT01471028|11080726|FG000|VTI-208E|Death|7
7010863|NCT01471028|11080727|FG001|VTI-208E|Death|10
7010864|NCT01471028|11080726|FG000|VTI-208E|Withdrawal by Subject|1
7010865|NCT01471028|11080727|FG001|VTI-208E|Withdrawal by Subject|0
7010866|NCT01471028|11080726|FG000|VTI-208E|Lost to Follow-up|0
7010867|NCT01471028|11080727|FG001|VTI-208E|Lost to Follow-up|2
7010868|NCT01471054|11080742|FG000|Overall Study|Study terminated prematurely|4
7010869|NCT01471054|11080743|FG001|Overall Study|Study terminated prematurely|0
7010870|NCT01471093|11080761|FG000|Overall Study|Adverse Event|1
7010871|NCT01471093|11080762|FG001|Overall Study|Adverse Event|0
7010872|NCT01471093|11080763|FG002|Overall Study|Adverse Event|0
7010873|NCT01471093|11080764|FG003|Overall Study|Adverse Event|0
7010874|NCT01471171|11080770|FG000|Treatment Period 1|Adverse Event|4
7010875|NCT01471171|11080771|FG001|Treatment Period 1|Adverse Event|1
7010876|NCT01471171|11080770|FG000|Treatment Period 2|Adverse Event|1
7010877|NCT01471171|11080771|FG001|Treatment Period 2|Adverse Event|0
7010878|NCT01471197|11080779|FG000|Overall Study|Disease Progression|4
7010879|NCT01471197|11080780|FG001|Overall Study|Disease Progression|2
7010880|NCT01471197|11080779|FG000|Overall Study|Death|1
7010881|NCT01471197|11080780|FG001|Overall Study|Death|0
7010882|NCT01471197|11080779|FG000|Overall Study|Study Drug Toxicity|1
7010883|NCT01471197|11080780|FG001|Overall Study|Study Drug Toxicity|0
7010884|NCT01471353|11080786|FG000|Overall Study|remain on study|3
7010885|NCT01471379|11080793|FG000|Overall Study|Adverse Event|1
7010886|NCT01471379|11080794|FG001|Overall Study|Adverse Event|0
7010887|NCT01471379|11080795|FG002|Overall Study|Adverse Event|0
7010888|NCT01471379|11080793|FG000|Overall Study|Study terminated|0
7010889|NCT01471379|11080794|FG001|Overall Study|Study terminated|1
7010890|NCT01471379|11080795|FG002|Overall Study|Study terminated|0
7010891|NCT01471522|11080815|FG000|Overall Study|Withdrawal by Subject|28
7010892|NCT01471522|11080816|FG001|Overall Study|Withdrawal by Subject|22
7010893|NCT01471522|11080815|FG000|Overall Study|Lost to Follow-up|36
7010894|NCT01471522|11080816|FG001|Overall Study|Lost to Follow-up|26
7010895|NCT01471574|11080827|FG000|Treatment Period|Lack of Efficacy|12
7010896|NCT01471574|11080828|FG001|Treatment Period|Lack of Efficacy|4
7010897|NCT01471574|11080829|FG002|Treatment Period|Lack of Efficacy|14
7010898|NCT01471574|11080830|FG003|Treatment Period|Lack of Efficacy|1
7010899|NCT01471574|11080827|FG000|Treatment Period|Adverse Event|7
7010900|NCT01471574|11080828|FG001|Treatment Period|Adverse Event|3
7010901|NCT01471574|11080829|FG002|Treatment Period|Adverse Event|6
7010902|NCT01471574|11080830|FG003|Treatment Period|Adverse Event|1
7010903|NCT01471574|11080827|FG000|Treatment Period|Withdrawal by Subject|5
7010904|NCT01471574|11080828|FG001|Treatment Period|Withdrawal by Subject|1
7010905|NCT01471574|11080829|FG002|Treatment Period|Withdrawal by Subject|1
7010906|NCT01471574|11080830|FG003|Treatment Period|Withdrawal by Subject|0
7010907|NCT01471574|11080827|FG000|Treatment Period|Patient Requested Discontinue Study drug|4
7010908|NCT01471574|11080828|FG001|Treatment Period|Patient Requested Discontinue Study drug|0
7010909|NCT01471574|11080829|FG002|Treatment Period|Patient Requested Discontinue Study drug|1
7010910|NCT01471574|11080830|FG003|Treatment Period|Patient Requested Discontinue Study drug|1
7010911|NCT01471574|11080827|FG000|Treatment Period|Lost to Follow-up|1
7010912|NCT01471574|11080828|FG001|Treatment Period|Lost to Follow-up|2
7010913|NCT01471574|11080829|FG002|Treatment Period|Lost to Follow-up|2
7010914|NCT01471574|11080830|FG003|Treatment Period|Lost to Follow-up|0
7010915|NCT01471574|11080827|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1
7010916|NCT01471574|11080828|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0
7010917|NCT01471574|11080829|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0
7010918|NCT01471574|11080830|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0
7010919|NCT01471574|11080827|FG000|Treatment Period|Other|1
7010920|NCT01471574|11080828|FG001|Treatment Period|Other|0
7010921|NCT01471574|11080829|FG002|Treatment Period|Other|0
7010922|NCT01471574|11080830|FG003|Treatment Period|Other|0
7010923|NCT01471574|11080827|FG000|Follow-up Period|Withdrawal by Subject|3
7010924|NCT01471574|11080828|FG001|Follow-up Period|Withdrawal by Subject|0
7010925|NCT01471574|11080829|FG002|Follow-up Period|Withdrawal by Subject|3
7010926|NCT01471574|11080830|FG003|Follow-up Period|Withdrawal by Subject|1
7010927|NCT01471574|11080827|FG000|Follow-up Period|Lost to Follow-up|4
7010928|NCT01471574|11080828|FG001|Follow-up Period|Lost to Follow-up|1
7010929|NCT01471574|11080829|FG002|Follow-up Period|Lost to Follow-up|3
7010930|NCT01471574|11080830|FG003|Follow-up Period|Lost to Follow-up|2
7010931|NCT01471574|11080827|FG000|Follow-up Period|Death|0
7010932|NCT01471574|11080828|FG001|Follow-up Period|Death|0
7010933|NCT01471574|11080829|FG002|Follow-up Period|Death|1
7010934|NCT01471574|11080830|FG003|Follow-up Period|Death|0
7010935|NCT01471574|11080827|FG000|Follow-up Period|Follow-up no longer required|0
7010936|NCT01471574|11080828|FG001|Follow-up Period|Follow-up no longer required|1
7010937|NCT01471574|11080829|FG002|Follow-up Period|Follow-up no longer required|0
7010938|NCT01471574|11080830|FG003|Follow-up Period|Follow-up no longer required|0
7010939|NCT01471691|11080856|FG000|Overall Study|Lack of Efficacy|0
7010940|NCT01471691|11080857|FG001|Overall Study|Lack of Efficacy|1
7010941|NCT01471782|11080869|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2
7010942|NCT01471782|11080870|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2
7010943|NCT01471782|11080871|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1
7010944|NCT01471782|11080872|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0
7010945|NCT01471782|11080873|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5
7010946|NCT01471782|11080874|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3
7010947|NCT01471782|11080869|FG000|Overall Study|Lack of Efficacy|1
7010948|NCT01471782|11080870|FG001|Overall Study|Lack of Efficacy|2
7010949|NCT01471782|11080871|FG002|Overall Study|Lack of Efficacy|1
7010950|NCT01471782|11080872|FG003|Overall Study|Lack of Efficacy|1
7010951|NCT01471782|11080873|FG004|Overall Study|Lack of Efficacy|5
7010952|NCT01471782|11080874|FG005|Overall Study|Lack of Efficacy|18
7010953|NCT01471782|11080869|FG000|Overall Study|Adverse Event|1
7010954|NCT01471782|11080870|FG001|Overall Study|Adverse Event|1
7010955|NCT01471782|11080871|FG002|Overall Study|Adverse Event|2
7010956|NCT01471782|11080872|FG003|Overall Study|Adverse Event|2
7010957|NCT01471782|11080873|FG004|Overall Study|Adverse Event|3
7010958|NCT01471782|11080874|FG005|Overall Study|Adverse Event|1
7010959|NCT01471782|11080869|FG000|Overall Study|Other|0
7010960|NCT01471782|11080870|FG001|Overall Study|Other|0
7010961|NCT01471782|11080871|FG002|Overall Study|Other|1
7010962|NCT01471782|11080872|FG003|Overall Study|Other|1
7010963|NCT01471782|11080873|FG004|Overall Study|Other|6
7010964|NCT01471782|11080874|FG005|Overall Study|Other|5
7010965|NCT01471782|11080869|FG000|Overall Study|Change of Chemotherapy|1
7010966|NCT01471782|11080870|FG001|Overall Study|Change of Chemotherapy|1
7010967|NCT01471782|11080871|FG002|Overall Study|Change of Chemotherapy|0
7010968|NCT01471782|11080872|FG003|Overall Study|Change of Chemotherapy|0
7010969|NCT01471782|11080873|FG004|Overall Study|Change of Chemotherapy|1
7010970|NCT01471782|11080874|FG005|Overall Study|Change of Chemotherapy|4
7010971|NCT01471782|11080869|FG000|Overall Study|Disease Relapse|0
7010972|NCT01471782|11080870|FG001|Overall Study|Disease Relapse|0
7010973|NCT01471782|11080871|FG002|Overall Study|Disease Relapse|0
7010974|NCT01471782|11080872|FG003|Overall Study|Disease Relapse|1
7010975|NCT01471782|11080873|FG004|Overall Study|Disease Relapse|2
7010976|NCT01471782|11080874|FG005|Overall Study|Disease Relapse|1
7010977|NCT01471782|11080869|FG000|Overall Study|Physician Decision|0
7010978|NCT01471782|11080870|FG001|Overall Study|Physician Decision|0
7010979|NCT01471782|11080871|FG002|Overall Study|Physician Decision|0
7010980|NCT01471782|11080872|FG003|Overall Study|Physician Decision|0
7010981|NCT01471782|11080873|FG004|Overall Study|Physician Decision|3
7010982|NCT01471782|11080874|FG005|Overall Study|Physician Decision|8
7010983|NCT01471782|11080869|FG000|Overall Study|Withdrawal by Parent/Guardian|0
7010984|NCT01471782|11080870|FG001|Overall Study|Withdrawal by Parent/Guardian|0
7010985|NCT01471782|11080871|FG002|Overall Study|Withdrawal by Parent/Guardian|0
7010986|NCT01471782|11080872|FG003|Overall Study|Withdrawal by Parent/Guardian|0
7010987|NCT01471782|11080873|FG004|Overall Study|Withdrawal by Parent/Guardian|1
7010988|NCT01471782|11080874|FG005|Overall Study|Withdrawal by Parent/Guardian|0
7010989|NCT01471782|11080869|FG000|Overall Study|Death|0
7010990|NCT01471782|11080870|FG001|Overall Study|Death|0
7010991|NCT01471782|11080871|FG002|Overall Study|Death|0
7010992|NCT01471782|11080872|FG003|Overall Study|Death|0
7010993|NCT01471782|11080873|FG004|Overall Study|Death|0
7010994|NCT01471782|11080874|FG005|Overall Study|Death|1
7010995|NCT01472185|11080901|FG000|Overall Study|Randomized but Not Treated|0
7010996|NCT01472185|11080902|FG001|Overall Study|Randomized but Not Treated|1
7010997|NCT01472185|11080901|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3
7010998|NCT01472185|11080902|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10
7010999|NCT01472185|11080901|FG000|Overall Study|Hyperglycemia|5
7011000|NCT01472185|11080902|FG001|Overall Study|Hyperglycemia|2
7011001|NCT01472185|11080901|FG000|Overall Study|Investigator's Discretion|3
7011002|NCT01472185|11080902|FG001|Overall Study|Investigator's Discretion|1
7011003|NCT01472185|11080901|FG000|Overall Study|Lost to Follow-up|4
7011004|NCT01472185|11080902|FG001|Overall Study|Lost to Follow-up|1
7011005|NCT01472185|11080901|FG000|Overall Study|Protocol Violation|5
7011006|NCT01472185|11080902|FG001|Overall Study|Protocol Violation|1
7011007|NCT01472185|11080901|FG000|Overall Study|Subject Noncompliance|8
7011008|NCT01472185|11080902|FG001|Overall Study|Subject Noncompliance|15
7011009|NCT01472185|11080901|FG000|Overall Study|Subject Withdrew Consent|6
7011010|NCT01472185|11080902|FG001|Overall Study|Subject Withdrew Consent|3
7011011|NCT01472289|11080908|FG000|Overall Study|Death|2
7011012|NCT01472341|11080912|FG000|Overall Study|Started insulin therapy|55
7011013|NCT01472341|11080912|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92
7011014|NCT01472341|11080912|FG000|Overall Study|Withdrawal by Subject|39
7011015|NCT01472341|11080912|FG000|Overall Study|Lost to Follow-up|52
7011016|NCT01472341|11080912|FG000|Overall Study|Laboratory parameters unavailable|25
7011017|NCT01472341|11080912|FG000|Overall Study|Death|9
7011018|NCT01472380|11080916|FG000|Efavirenz Alone|Withdrawal by Subject|1
7011019|NCT01472380|11080916|FG000|1 Day Period Between Dosing|Protocol Violation|1
7011020|NCT01472757|11080967|FG000|Overall Study|Withdrawal by Subject|1
7011021|NCT01472757|11080968|FG001|Overall Study|Withdrawal by Subject|2
7011022|NCT01472757|11080969|FG002|Overall Study|Withdrawal by Subject|2
7011023|NCT01472757|11080970|FG003|Overall Study|Withdrawal by Subject|0
7011024|NCT01472757|11080967|FG000|Overall Study|Asthma exacerbation|4
7011025|NCT01472757|11080968|FG001|Overall Study|Asthma exacerbation|1
7011026|NCT01472757|11080969|FG002|Overall Study|Asthma exacerbation|2
7011027|NCT01472757|11080970|FG003|Overall Study|Asthma exacerbation|1
7011028|NCT01472757|11080967|FG000|Overall Study|Treatment period withdrawal criteria met|21
7011029|NCT01472757|11080968|FG001|Overall Study|Treatment period withdrawal criteria met|8
7011030|NCT01472757|11080969|FG002|Overall Study|Treatment period withdrawal criteria met|9
7011031|NCT01472757|11080970|FG003|Overall Study|Treatment period withdrawal criteria met|12
7011032|NCT01472757|11080967|FG000|Overall Study|Protocol Violation|3
7011033|NCT01472757|11080968|FG001|Overall Study|Protocol Violation|2
7011034|NCT01472757|11080969|FG002|Overall Study|Protocol Violation|4
7011035|NCT01472757|11080970|FG003|Overall Study|Protocol Violation|4
7011036|NCT01472757|11080967|FG000|Overall Study|Other reasons|1
7011037|NCT01472757|11080968|FG001|Overall Study|Other reasons|0
7011038|NCT01472757|11080969|FG002|Overall Study|Other reasons|2
7011039|NCT01472757|11080970|FG003|Overall Study|Other reasons|2
7011040|NCT01472835|11080991|FG000|Overall Study|Lost to Follow-up|2
7011041|NCT01472835|11080992|FG001|Overall Study|Lost to Follow-up|0
7011042|NCT01472939|11081009|FG000|Overall Study|Adverse Event|3
7011043|NCT01472939|11081010|FG001|Overall Study|Adverse Event|7
7011044|NCT01472939|11081011|FG002|Overall Study|Adverse Event|7
7011045|NCT01472939|11081012|FG003|Overall Study|Adverse Event|14
7011046|NCT01472939|11081009|FG000|Overall Study|Lack of Efficacy|1
7011047|NCT01472939|11081010|FG001|Overall Study|Lack of Efficacy|0
7011048|NCT01472939|11081011|FG002|Overall Study|Lack of Efficacy|0
7011049|NCT01472939|11081012|FG003|Overall Study|Lack of Efficacy|1
7011050|NCT01472939|11081009|FG000|Overall Study|Lost to Follow-up|3
7011051|NCT01472939|11081010|FG001|Overall Study|Lost to Follow-up|0
7011052|NCT01472939|11081011|FG002|Overall Study|Lost to Follow-up|2
7011053|NCT01472939|11081012|FG003|Overall Study|Lost to Follow-up|0
7011054|NCT01472939|11081009|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0
7011055|NCT01472939|11081010|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0
7011056|NCT01472939|11081011|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1
7011057|NCT01472939|11081012|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0
7011058|NCT01472939|11081009|FG000|Overall Study|Prohibited Medication|0
7011059|NCT01472939|11081010|FG001|Overall Study|Prohibited Medication|1
7011060|NCT01472939|11081011|FG002|Overall Study|Prohibited Medication|0
7011061|NCT01472939|11081012|FG003|Overall Study|Prohibited Medication|0
7011062|NCT01472939|11081009|FG000|Overall Study|Withdrawal By PI|1
7011063|NCT01472939|11081010|FG001|Overall Study|Withdrawal By PI|0
7011064|NCT01472939|11081011|FG002|Overall Study|Withdrawal By PI|0
7011065|NCT01472939|11081012|FG003|Overall Study|Withdrawal By PI|0
7011066|NCT01472939|11081009|FG000|Overall Study|Protocol Violation|3
7011067|NCT01472939|11081010|FG001|Overall Study|Protocol Violation|3
7011068|NCT01472939|11081011|FG002|Overall Study|Protocol Violation|0
7011069|NCT01472939|11081012|FG003|Overall Study|Protocol Violation|1
7011070|NCT01472939|11081009|FG000|Overall Study|Withdrawal by Subject|9
7011071|NCT01472939|11081010|FG001|Overall Study|Withdrawal by Subject|3
7011072|NCT01472939|11081011|FG002|Overall Study|Withdrawal by Subject|1
7011073|NCT01472939|11081012|FG003|Overall Study|Withdrawal by Subject|4
7011074|NCT01472965|11081027|FG000|Overall Study|Withdrawal by Subject|1
7011075|NCT01472965|11081028|FG001|Overall Study|Withdrawal by Subject|0
7011076|NCT01473355|11081040|FG000|Overall Study|Protocol Violation|2
7011077|NCT01473355|11081040|FG000|Overall Study|Adverse Event|2
7011078|NCT01473355|11081040|FG000|Overall Study|Lost to Follow-up|2
7011079|NCT01473381|11081081|FG000|Overall Study|Adverse Event|8
7011080|NCT01473381|11081082|FG001|Overall Study|Adverse Event|20
7011081|NCT01473381|11081083|FG002|Overall Study|Adverse Event|25
7011082|NCT01473381|11081084|FG003|Overall Study|Adverse Event|17
7011083|NCT01473381|11081081|FG000|Overall Study|Insufficient Therapeutic Response|10
7011084|NCT01473381|11081082|FG001|Overall Study|Insufficient Therapeutic Response|1
7011085|NCT01473381|11081083|FG002|Overall Study|Insufficient Therapeutic Response|2
7011086|NCT01473381|11081084|FG003|Overall Study|Insufficient Therapeutic Response|3
7011087|NCT01473381|11081081|FG000|Overall Study|Protocol Violation|17
7011088|NCT01473381|11081082|FG001|Overall Study|Protocol Violation|23
7011089|NCT01473381|11081083|FG002|Overall Study|Protocol Violation|19
7011090|NCT01473381|11081084|FG003|Overall Study|Protocol Violation|17
7011091|NCT01473381|11081081|FG000|Overall Study|Withdrawal of Consent|20
7011092|NCT01473381|11081082|FG001|Overall Study|Withdrawal of Consent|21
7011093|NCT01473381|11081083|FG002|Overall Study|Withdrawal of Consent|20
7011094|NCT01473381|11081084|FG003|Overall Study|Withdrawal of Consent|26
7011095|NCT01473381|11081081|FG000|Overall Study|Lost to Follow-up|25
7011096|NCT01473381|11081082|FG001|Overall Study|Lost to Follow-up|28
7011097|NCT01473381|11081083|FG002|Overall Study|Lost to Follow-up|35
7011098|NCT01473381|11081084|FG003|Overall Study|Lost to Follow-up|23
7011099|NCT01473381|11081081|FG000|Overall Study|Other Reasons|0
7011100|NCT01473381|11081082|FG001|Overall Study|Other Reasons|0
7011101|NCT01473381|11081083|FG002|Overall Study|Other Reasons|1
7011102|NCT01473381|11081084|FG003|Overall Study|Other Reasons|3
7011103|NCT01473394|11081097|FG000|Overall Study|Adverse Event|13
7011104|NCT01473394|11081098|FG001|Overall Study|Adverse Event|16
7011105|NCT01473394|11081097|FG000|Overall Study|Insufficient Therapeutic Response|4
7011106|NCT01473394|11081098|FG001|Overall Study|Insufficient Therapeutic Response|1
7011107|NCT01473394|11081097|FG000|Overall Study|Protocol Violation|7
7011108|NCT01473394|11081098|FG001|Overall Study|Protocol Violation|5
7011109|NCT01473394|11081097|FG000|Overall Study|Withdrew Consent|12
7011110|NCT01473394|11081098|FG001|Overall Study|Withdrew Consent|10
7011111|NCT01473394|11081097|FG000|Overall Study|Lost to Follow-up|9
7011112|NCT01473394|11081098|FG001|Overall Study|Lost to Follow-up|11
7011113|NCT01473407|11081106|FG000|Overall Study|Physician Decision|1
7011114|NCT01473407|11081107|FG001|Overall Study|Physician Decision|4
7011115|NCT01473407|11081106|FG000|Overall Study|Lost to Follow-up|10
7011116|NCT01473407|11081107|FG001|Overall Study|Lost to Follow-up|4
7011117|NCT01473407|11081106|FG000|Overall Study|Adverse Event|8
7011118|NCT01473407|11081107|FG001|Overall Study|Adverse Event|8
7011119|NCT01473407|11081106|FG000|Overall Study|Randomization Error|3
7011120|NCT01473407|11081107|FG001|Overall Study|Randomization Error|1
7011121|NCT01473407|11081106|FG000|Overall Study|Withdrawal by Subject|4
7011122|NCT01473407|11081107|FG001|Overall Study|Withdrawal by Subject|7
7011123|NCT01473407|11081106|FG000|Overall Study|Kidney Transplant|7
7011124|NCT01473407|11081107|FG001|Overall Study|Kidney Transplant|6
7011125|NCT01473407|11081106|FG000|Overall Study|Vacation/Travel|1
7011126|NCT01473407|11081107|FG001|Overall Study|Vacation/Travel|1
7011127|NCT01473407|11081106|FG000|Overall Study|Elevated Hemoglobin|1
7011128|NCT01473407|11081107|FG001|Overall Study|Elevated Hemoglobin|0
7011129|NCT01473407|11081106|FG000|Overall Study|Patient Received Aranesp|1
7011130|NCT01473407|11081107|FG001|Overall Study|Patient Received Aranesp|0
7011131|NCT01473407|11081106|FG000|Overall Study|Patient Lost Green Card Status|1
7011132|NCT01473407|11081107|FG001|Overall Study|Patient Lost Green Card Status|0
7011133|NCT01473407|11081106|FG000|Overall Study|Temperature Excursion|2
7011134|NCT01473407|11081107|FG001|Overall Study|Temperature Excursion|3
7011135|NCT01473407|11081106|FG000|Overall Study|Transfer to Another Facility/Unit|4
7011136|NCT01473407|11081107|FG001|Overall Study|Transfer to Another Facility/Unit|3
7011137|NCT01473407|11081106|FG000|Overall Study|Sponsor's Decision|10
7011138|NCT01473407|11081107|FG001|Overall Study|Sponsor's Decision|10
7011139|NCT01473407|11081106|FG000|Overall Study|Site Closure|1
7011140|NCT01473407|11081107|FG001|Overall Study|Site Closure|0
7011141|NCT01473420|11081115|FG000|Titration Period (18 Weeks)|Adverse Event|4
7011142|NCT01473420|11081116|FG001|Titration Period (18 Weeks)|Adverse Event|6
7011143|NCT01473420|11081115|FG000|Titration Period (18 Weeks)|Did not meet criteria|32
7011144|NCT01473420|11081116|FG001|Titration Period (18 Weeks)|Did not meet criteria|32
7011145|NCT01473420|11081115|FG000|Maintenance Period (16 Weeks)|Adverse Event|3
7011146|NCT01473420|11081116|FG001|Maintenance Period (16 Weeks)|Adverse Event|2
7011147|NCT01473420|11081115|FG000|Maintenance Period (16 Weeks)|Physician Decision|1
7011148|NCT01473420|11081116|FG001|Maintenance Period (16 Weeks)|Physician Decision|2
7011149|NCT01473420|11081115|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0
7011150|NCT01473420|11081116|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2
7011151|NCT01473420|11081115|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3
7011152|NCT01473420|11081116|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1
7011153|NCT01473420|11081115|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1
7011154|NCT01473420|11081116|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2
7011155|NCT01473420|11081115|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4
7011156|NCT01473420|11081116|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6
7011157|NCT01473420|11081115|FG000|Maintenance Period (16 Weeks)|Site closure|3
7011158|NCT01473420|11081116|FG001|Maintenance Period (16 Weeks)|Site closure|1
7011159|NCT01473420|11081115|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1
7011160|NCT01473420|11081116|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0
7011161|NCT01473420|11081115|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0
7011162|NCT01473420|11081116|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1
7011163|NCT01473420|11081115|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1
7011164|NCT01473420|11081116|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0
7011165|NCT01473420|11081115|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1
7011166|NCT01473420|11081116|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0
7011167|NCT01473524|11081131|FG000|DB Phase|Adverse Event|4
7011168|NCT01473524|11081132|FG001|DB Phase|Adverse Event|8
7011169|NCT01473524|11081133|FG002|DB Phase|Adverse Event|2
7011170|NCT01473524|11081134|FG003|DB Phase|Adverse Event|0
7011171|NCT01473524|11081135|FG004|DB Phase|Adverse Event|0
7011172|NCT01473524|11081136|FG005|DB Phase|Adverse Event|0
7011173|NCT01473524|11081131|FG000|DB Phase|Death|1
7011174|NCT01473524|11081132|FG001|DB Phase|Death|0
7011175|NCT01473524|11081133|FG002|DB Phase|Death|0
7011176|NCT01473524|11081134|FG003|DB Phase|Death|0
7011177|NCT01473524|11081135|FG004|DB Phase|Death|0
7011178|NCT01473524|11081136|FG005|DB Phase|Death|0
7011179|NCT01473524|11081131|FG000|DB Phase|Withdrawal by Subject|2
7011180|NCT01473524|11081132|FG001|DB Phase|Withdrawal by Subject|1
7011181|NCT01473524|11081133|FG002|DB Phase|Withdrawal by Subject|1
7011182|NCT01473524|11081134|FG003|DB Phase|Withdrawal by Subject|0
7011183|NCT01473524|11081135|FG004|DB Phase|Withdrawal by Subject|0
7011184|NCT01473524|11081136|FG005|DB Phase|Withdrawal by Subject|0
7011185|NCT01473524|11081131|FG000|LTSE Phase|Withdrawal by Subject|0
7011186|NCT01473524|11081132|FG001|LTSE Phase|Withdrawal by Subject|0
7011187|NCT01473524|11081133|FG002|LTSE Phase|Withdrawal by Subject|0
7011188|NCT01473524|11081134|FG003|LTSE Phase|Withdrawal by Subject|3
7011189|NCT01473524|11081135|FG004|LTSE Phase|Withdrawal by Subject|3
7011190|NCT01473524|11081136|FG005|LTSE Phase|Withdrawal by Subject|6
7011191|NCT01473524|11081131|FG000|LTSE Phase|Death|0
7011192|NCT01473524|11081132|FG001|LTSE Phase|Death|0
7011193|NCT01473524|11081133|FG002|LTSE Phase|Death|0
7011194|NCT01473524|11081134|FG003|LTSE Phase|Death|0
7011195|NCT01473524|11081135|FG004|LTSE Phase|Death|1
7011196|NCT01473524|11081136|FG005|LTSE Phase|Death|0
7011197|NCT01473524|11081131|FG000|LTSE Phase|Adverse Event of Pruritus|0
7011198|NCT01473524|11081132|FG001|LTSE Phase|Adverse Event of Pruritus|0
7011199|NCT01473524|11081133|FG002|LTSE Phase|Adverse Event of Pruritus|0
7011200|NCT01473524|11081134|FG003|LTSE Phase|Adverse Event of Pruritus|1
7011201|NCT01473524|11081135|FG004|LTSE Phase|Adverse Event of Pruritus|5
7011202|NCT01473524|11081136|FG005|LTSE Phase|Adverse Event of Pruritus|2
7011203|NCT01473524|11081131|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0
7011204|NCT01473524|11081132|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0
7011205|NCT01473524|11081133|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0
7011206|NCT01473524|11081134|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2
7011207|NCT01473524|11081135|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4
7011208|NCT01473524|11081136|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6
7011209|NCT01473524|11081131|FG000|LTSE Phase|Lost to Follow-up|0
7011210|NCT01473524|11081132|FG001|LTSE Phase|Lost to Follow-up|0
7011211|NCT01473524|11081133|FG002|LTSE Phase|Lost to Follow-up|0
7011212|NCT01473524|11081134|FG003|LTSE Phase|Lost to Follow-up|1
7011213|NCT01473524|11081135|FG004|LTSE Phase|Lost to Follow-up|3
7011214|NCT01473524|11081136|FG005|LTSE Phase|Lost to Follow-up|2
7011215|NCT01473524|11081131|FG000|LTSE Phase|Principal Investigator Decision|0
7011216|NCT01473524|11081132|FG001|LTSE Phase|Principal Investigator Decision|0
7011217|NCT01473524|11081133|FG002|LTSE Phase|Principal Investigator Decision|0
7011218|NCT01473524|11081134|FG003|LTSE Phase|Principal Investigator Decision|1
7011219|NCT01473524|11081135|FG004|LTSE Phase|Principal Investigator Decision|1
7011220|NCT01473524|11081136|FG005|LTSE Phase|Principal Investigator Decision|3
7011221|NCT01473524|11081131|FG000|LTSE Phase|Liver Transplantation|0
7011222|NCT01473524|11081132|FG001|LTSE Phase|Liver Transplantation|0
7011223|NCT01473524|11081133|FG002|LTSE Phase|Liver Transplantation|0
7011224|NCT01473524|11081134|FG003|LTSE Phase|Liver Transplantation|0
7011225|NCT01473524|11081135|FG004|LTSE Phase|Liver Transplantation|0
7011226|NCT01473524|11081136|FG005|LTSE Phase|Liver Transplantation|1
7011227|NCT01473524|11081131|FG000|LTSE Phase|Pregnancy|0
7011228|NCT01473524|11081132|FG001|LTSE Phase|Pregnancy|0
7011229|NCT01473524|11081133|FG002|LTSE Phase|Pregnancy|0
7011230|NCT01473524|11081134|FG003|LTSE Phase|Pregnancy|1
7011231|NCT01473524|11081135|FG004|LTSE Phase|Pregnancy|0
7011232|NCT01473524|11081136|FG005|LTSE Phase|Pregnancy|0
7011233|NCT01473524|11081131|FG000|LTSE Phase|Protocol Violation|0
7011234|NCT01473524|11081132|FG001|LTSE Phase|Protocol Violation|0
7011235|NCT01473524|11081133|FG002|LTSE Phase|Protocol Violation|0
7011236|NCT01473524|11081134|FG003|LTSE Phase|Protocol Violation|0
7011237|NCT01473524|11081135|FG004|LTSE Phase|Protocol Violation|0
7011238|NCT01473524|11081136|FG005|LTSE Phase|Protocol Violation|1
7011239|NCT01473563|11081158|FG000|Overall Study|Lost to FU post tx discontinuation|1
7011240|NCT01473589|11081164|FG000|Overall Study|Adverse Event|1
7011241|NCT01473589|11081165|FG001|Overall Study|Adverse Event|1
7011242|NCT01473589|11081164|FG000|Overall Study|Death|2
7011243|NCT01473589|11081165|FG001|Overall Study|Death|0
7011244|NCT01473589|11081164|FG000|Overall Study|Lost to Follow-up|2
7011245|NCT01473589|11081165|FG001|Overall Study|Lost to Follow-up|2
7011246|NCT01473589|11081164|FG000|Overall Study|Protocol Violation|1
7011247|NCT01473589|11081165|FG001|Overall Study|Protocol Violation|0
7011248|NCT01473589|11081164|FG000|Overall Study|Withdrawal by Subject|5
7011249|NCT01473589|11081165|FG001|Overall Study|Withdrawal by Subject|11
7011250|NCT01473589|11081164|FG000|Overall Study|Physician Decision|0
7011251|NCT01473589|11081165|FG001|Overall Study|Physician Decision|1
7011252|NCT01473589|11081164|FG000|Overall Study|Entry criteria not met|0
7011253|NCT01473589|11081165|FG001|Overall Study|Entry criteria not met|1
7011254|NCT01473602|11081175|FG000|Overall Study|Adverse Event|1
7011255|NCT01473602|11081176|FG001|Overall Study|Adverse Event|2
7011256|NCT01473602|11081175|FG000|Overall Study|Death|0
7011257|NCT01473602|11081176|FG001|Overall Study|Death|1
7011258|NCT01473602|11081175|FG000|Overall Study|Lost to Follow-up|1
7011259|NCT01473602|11081176|FG001|Overall Study|Lost to Follow-up|1
7011260|NCT01473602|11081175|FG000|Overall Study|Withdrawal by Subject|5
7011261|NCT01473602|11081176|FG001|Overall Study|Withdrawal by Subject|4
7011262|NCT01473602|11081175|FG000|Overall Study|Physician Decision|1
7011263|NCT01473602|11081176|FG001|Overall Study|Physician Decision|0
7011264|NCT01473758|11081195|FG000|Cycle 1|Adverse Event|10
7011265|NCT01473758|11081196|FG001|Cycle 1|Adverse Event|2
7011266|NCT01473758|11081197|FG002|Cycle 1|Adverse Event|0
7011267|NCT01473758|11081198|FG003|Cycle 1|Adverse Event|0
7011268|NCT01473758|11081195|FG000|Cycle 1|Withdrawal by Subject|1
7011269|NCT01473758|11081196|FG001|Cycle 1|Withdrawal by Subject|1
7011270|NCT01473758|11081197|FG002|Cycle 1|Withdrawal by Subject|0
7011271|NCT01473758|11081198|FG003|Cycle 1|Withdrawal by Subject|0
7011272|NCT01473758|11081195|FG000|Cycle 2|Adverse Event|0
7011273|NCT01473758|11081196|FG001|Cycle 2|Adverse Event|0
7011274|NCT01473758|11081197|FG002|Cycle 2|Adverse Event|5
7011275|NCT01473758|11081198|FG003|Cycle 2|Adverse Event|0
7011276|NCT01473836|11081206|FG000|Overall Study|Adverse Event|4
7011277|NCT01473836|11081206|FG000|Overall Study|Lack of Efficacy|1
7011278|NCT01473836|11081206|FG000|Overall Study|Does not meet entrance criteria|1
7011279|NCT01473940|11081214|FG000|Induction Therapy|Death|0
7011280|NCT01473940|11081215|FG001|Induction Therapy|Death|0
7011281|NCT01473940|11081216|FG002|Induction Therapy|Death|1
7011282|NCT01473940|11081217|FG003|Induction Therapy|Death|1
7011283|NCT01473940|11081214|FG000|Induction Therapy|Progressive Disease|0
7011284|NCT01473940|11081215|FG001|Induction Therapy|Progressive Disease|1
7011285|NCT01473940|11081216|FG002|Induction Therapy|Progressive Disease|1
7011286|NCT01473940|11081217|FG003|Induction Therapy|Progressive Disease|0
7011287|NCT01473940|11081214|FG000|Maintenance Therapy|Progressive Disease|1
7011288|NCT01473940|11081215|FG001|Maintenance Therapy|Progressive Disease|2
7011289|NCT01473940|11081216|FG002|Maintenance Therapy|Progressive Disease|1
7011290|NCT01473940|11081217|FG003|Maintenance Therapy|Progressive Disease|4
7011291|NCT01473953|11081235|FG000|Overall Study|Other|1
7011292|NCT01473953|11081236|FG001|Overall Study|Other|0
7011293|NCT01473953|11081237|FG002|Overall Study|Other|0
7011294|NCT01473953|11081238|FG003|Overall Study|Other|0
7011295|NCT01473953|11081239|FG004|Overall Study|Other|0
7011296|NCT01474018|11081265|FG000|Overall Study|Lost to Follow-up|0
7011297|NCT01474018|11081266|FG001|Overall Study|Lost to Follow-up|1
7011298|NCT01474018|11081265|FG000|Overall Study|Withdrawal by Subject|0
7011299|NCT01474018|11081266|FG001|Overall Study|Withdrawal by Subject|2
7011300|NCT01474239|11081324|FG000|Overall Study|Disease Progression|37
7011301|NCT01474239|11081325|FG001|Overall Study|Disease Progression|25
7011302|NCT01474239|11081324|FG000|Overall Study|Adverse Event|12
7011303|NCT01474239|11081325|FG001|Overall Study|Adverse Event|3
7011304|NCT01474239|11081324|FG000|Overall Study|Withdrawal by Subject|1
7011305|NCT01474239|11081325|FG001|Overall Study|Withdrawal by Subject|2
7011306|NCT01474239|11081324|FG000|Overall Study|Death|1
7011307|NCT01474239|11081325|FG001|Overall Study|Death|1
7011308|NCT01474239|11081324|FG000|Overall Study|Clinical Disease Progression|7
7011309|NCT01474239|11081325|FG001|Overall Study|Clinical Disease Progression|1
7011310|NCT01474239|11081324|FG000|Overall Study|Withdrawal for Economic Reason|1
7011311|NCT01474239|11081325|FG001|Overall Study|Withdrawal for Economic Reason|0
7011312|NCT01474291|11081333|FG000|Overall Study|Not Evaluable for Efficacy|26
7011313|NCT01474291|11081333|FG000|Overall Study|Lack of Treatment Efficacy|88
7011314|NCT01474291|11081333|FG000|Overall Study|Adverse Event|53
7011315|NCT01474291|11081333|FG000|Overall Study|Lost to Follow-up|29
7011316|NCT01474291|11081333|FG000|Overall Study|Patient No Longer Wanted to Participate|12
7011317|NCT01474291|11081333|FG000|Overall Study|No Reason Reported|10
7011318|NCT01474291|11081333|FG000|Overall Study|Death|2
7011319|NCT01474317|11081340|FG000|Overall Study|Adverse Event|1
7011320|NCT01474317|11081340|FG000|Overall Study|Subject ineligible for study|1
7011321|NCT01474434|11081348|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
7011322|NCT01474434|11081349|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
7011323|NCT01474434|11081350|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
7011324|NCT01474434|11081351|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
7011325|NCT01474434|11081348|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
7011326|NCT01474434|11081349|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
7011327|NCT01474434|11081350|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
7011328|NCT01474434|11081351|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1
7011329|NCT01474434|11081348|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1
7011330|NCT01474434|11081349|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
7011331|NCT01474434|11081350|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
7011332|NCT01474434|11081351|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
7011333|NCT01474486|11081365|FG000|Overall Study|Death|2
7011334|NCT01474486|11081365|FG000|Overall Study|Withdrawal by Subject|4
7011335|NCT01474486|11081365|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2
7011336|NCT01474512|11081376|FG000|Induction Period|Adverse Event|6
7011337|NCT01474512|11081377|FG001|Induction Period|Adverse Event|10
7011338|NCT01474512|11081378|FG002|Induction Period|Adverse Event|10
7011339|NCT01474512|11081379|FG003|Induction Period|Adverse Event|0
7011340|NCT01474512|11081380|FG004|Induction Period|Adverse Event|0
7011341|NCT01474512|11081381|FG005|Induction Period|Adverse Event|0
7011342|NCT01474512|11081382|FG006|Induction Period|Adverse Event|0
7011343|NCT01474512|11081383|FG007|Induction Period|Adverse Event|0
7011344|NCT01474512|11081384|FG008|Induction Period|Adverse Event|0
7011345|NCT01474512|11081385|FG009|Induction Period|Adverse Event|0
7011346|NCT01474512|11081386|FG010|Induction Period|Adverse Event|0
7011347|NCT01474512|11081387|FG011|Induction Period|Adverse Event|0
7011348|NCT01474512|11081388|FG012|Induction Period|Adverse Event|0
7011349|NCT01474512|11081389|FG013|Induction Period|Adverse Event|0
7011350|NCT01474512|11081390|FG014|Induction Period|Adverse Event|0
7011351|NCT01474512|11081391|FG015|Induction Period|Adverse Event|0
7011352|NCT01474512|11081392|FG016|Induction Period|Adverse Event|0
7011353|NCT01474512|11081393|FG017|Induction Period|Adverse Event|0
7011354|NCT01474512|11081376|FG000|Induction Period|Lack of Efficacy|7
7011355|NCT01474512|11081377|FG001|Induction Period|Lack of Efficacy|1
7011356|NCT01474512|11081378|FG002|Induction Period|Lack of Efficacy|0
7011357|NCT01474512|11081379|FG003|Induction Period|Lack of Efficacy|0
7011358|NCT01474512|11081380|FG004|Induction Period|Lack of Efficacy|0
7011359|NCT01474512|11081381|FG005|Induction Period|Lack of Efficacy|0
7011360|NCT01474512|11081382|FG006|Induction Period|Lack of Efficacy|0
7011361|NCT01474512|11081383|FG007|Induction Period|Lack of Efficacy|0
7011362|NCT01474512|11081384|FG008|Induction Period|Lack of Efficacy|0
7011363|NCT01474512|11081385|FG009|Induction Period|Lack of Efficacy|0
7011364|NCT01474512|11081386|FG010|Induction Period|Lack of Efficacy|0
7011365|NCT01474512|11081387|FG011|Induction Period|Lack of Efficacy|0
7011366|NCT01474512|11081388|FG012|Induction Period|Lack of Efficacy|0
7011367|NCT01474512|11081389|FG013|Induction Period|Lack of Efficacy|0
7011368|NCT01474512|11081390|FG014|Induction Period|Lack of Efficacy|0
7011369|NCT01474512|11081391|FG015|Induction Period|Lack of Efficacy|0
7011370|NCT01474512|11081392|FG016|Induction Period|Lack of Efficacy|0
7011371|NCT01474512|11081393|FG017|Induction Period|Lack of Efficacy|0
7011372|NCT01474512|11081376|FG000|Induction Period|Withdrawal by Subject|6
7011373|NCT01474512|11081377|FG001|Induction Period|Withdrawal by Subject|6
7011374|NCT01474512|11081378|FG002|Induction Period|Withdrawal by Subject|5
7011375|NCT01474512|11081379|FG003|Induction Period|Withdrawal by Subject|0
7011376|NCT01474512|11081380|FG004|Induction Period|Withdrawal by Subject|0
7011377|NCT01474512|11081381|FG005|Induction Period|Withdrawal by Subject|0
7011378|NCT01474512|11081382|FG006|Induction Period|Withdrawal by Subject|0
7011379|NCT01474512|11081383|FG007|Induction Period|Withdrawal by Subject|0
7011380|NCT01474512|11081384|FG008|Induction Period|Withdrawal by Subject|0
7011381|NCT01474512|11081385|FG009|Induction Period|Withdrawal by Subject|0
7011382|NCT01474512|11081386|FG010|Induction Period|Withdrawal by Subject|0
7011383|NCT01474512|11081387|FG011|Induction Period|Withdrawal by Subject|0
7011384|NCT01474512|11081388|FG012|Induction Period|Withdrawal by Subject|0
7011385|NCT01474512|11081389|FG013|Induction Period|Withdrawal by Subject|0
7011386|NCT01474512|11081390|FG014|Induction Period|Withdrawal by Subject|0
7011387|NCT01474512|11081391|FG015|Induction Period|Withdrawal by Subject|0
7011388|NCT01474512|11081392|FG016|Induction Period|Withdrawal by Subject|0
7011389|NCT01474512|11081393|FG017|Induction Period|Withdrawal by Subject|0
7011390|NCT01474512|11081376|FG000|Induction Period|Protocol Violation|3
7011391|NCT01474512|11081377|FG001|Induction Period|Protocol Violation|6
7011392|NCT01474512|11081378|FG002|Induction Period|Protocol Violation|0
7011393|NCT01474512|11081379|FG003|Induction Period|Protocol Violation|0
7011394|NCT01474512|11081380|FG004|Induction Period|Protocol Violation|0
7011395|NCT01474512|11081381|FG005|Induction Period|Protocol Violation|0
7011396|NCT01474512|11081382|FG006|Induction Period|Protocol Violation|0
7011397|NCT01474512|11081383|FG007|Induction Period|Protocol Violation|0
7011398|NCT01474512|11081384|FG008|Induction Period|Protocol Violation|0
7011399|NCT01474512|11081385|FG009|Induction Period|Protocol Violation|0
7011400|NCT01474512|11081386|FG010|Induction Period|Protocol Violation|0
7011401|NCT01474512|11081387|FG011|Induction Period|Protocol Violation|0
7011402|NCT01474512|11081388|FG012|Induction Period|Protocol Violation|0
7011403|NCT01474512|11081389|FG013|Induction Period|Protocol Violation|0
7011404|NCT01474512|11081390|FG014|Induction Period|Protocol Violation|0
7011405|NCT01474512|11081391|FG015|Induction Period|Protocol Violation|0
7011406|NCT01474512|11081392|FG016|Induction Period|Protocol Violation|0
7011407|NCT01474512|11081393|FG017|Induction Period|Protocol Violation|0
7011408|NCT01474512|11081376|FG000|Induction Period|Sponsor Decision|1
7011409|NCT01474512|11081377|FG001|Induction Period|Sponsor Decision|1
7011410|NCT01474512|11081378|FG002|Induction Period|Sponsor Decision|1
7011411|NCT01474512|11081379|FG003|Induction Period|Sponsor Decision|0
7011412|NCT01474512|11081380|FG004|Induction Period|Sponsor Decision|0
7011413|NCT01474512|11081381|FG005|Induction Period|Sponsor Decision|0
7011414|NCT01474512|11081382|FG006|Induction Period|Sponsor Decision|0
7011415|NCT01474512|11081383|FG007|Induction Period|Sponsor Decision|0
7011416|NCT01474512|11081384|FG008|Induction Period|Sponsor Decision|0
7011417|NCT01474512|11081385|FG009|Induction Period|Sponsor Decision|0
7011418|NCT01474512|11081386|FG010|Induction Period|Sponsor Decision|0
7011419|NCT01474512|11081387|FG011|Induction Period|Sponsor Decision|0
7011420|NCT01474512|11081388|FG012|Induction Period|Sponsor Decision|0
7011421|NCT01474512|11081389|FG013|Induction Period|Sponsor Decision|0
7011422|NCT01474512|11081390|FG014|Induction Period|Sponsor Decision|0
7011423|NCT01474512|11081391|FG015|Induction Period|Sponsor Decision|0
7011424|NCT01474512|11081392|FG016|Induction Period|Sponsor Decision|0
7011425|NCT01474512|11081393|FG017|Induction Period|Sponsor Decision|0
7011426|NCT01474512|11081376|FG000|Induction Period|Lost to Follow-up|1
7011427|NCT01474512|11081377|FG001|Induction Period|Lost to Follow-up|0
7011428|NCT01474512|11081378|FG002|Induction Period|Lost to Follow-up|2
7011429|NCT01474512|11081379|FG003|Induction Period|Lost to Follow-up|0
7011430|NCT01474512|11081380|FG004|Induction Period|Lost to Follow-up|0
7011431|NCT01474512|11081381|FG005|Induction Period|Lost to Follow-up|0
7011432|NCT01474512|11081382|FG006|Induction Period|Lost to Follow-up|0
7011433|NCT01474512|11081383|FG007|Induction Period|Lost to Follow-up|0
7011434|NCT01474512|11081384|FG008|Induction Period|Lost to Follow-up|0
7011435|NCT01474512|11081385|FG009|Induction Period|Lost to Follow-up|0
7011436|NCT01474512|11081386|FG010|Induction Period|Lost to Follow-up|0
7011437|NCT01474512|11081387|FG011|Induction Period|Lost to Follow-up|0
7011438|NCT01474512|11081388|FG012|Induction Period|Lost to Follow-up|0
7011439|NCT01474512|11081389|FG013|Induction Period|Lost to Follow-up|0
7011440|NCT01474512|11081390|FG014|Induction Period|Lost to Follow-up|0
7011441|NCT01474512|11081391|FG015|Induction Period|Lost to Follow-up|0
7011442|NCT01474512|11081392|FG016|Induction Period|Lost to Follow-up|0
7011443|NCT01474512|11081393|FG017|Induction Period|Lost to Follow-up|0
7011444|NCT01474512|11081376|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0
7011445|NCT01474512|11081377|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0
7011446|NCT01474512|11081378|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0
7011447|NCT01474512|11081379|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186
7011448|NCT01474512|11081380|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111
7011449|NCT01474512|11081381|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39
7011450|NCT01474512|11081382|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9
7011451|NCT01474512|11081383|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0
7011452|NCT01474512|11081384|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0
7011453|NCT01474512|11081385|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0
7011454|NCT01474512|11081386|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0
7011455|NCT01474512|11081387|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0
7011456|NCT01474512|11081388|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0
7011457|NCT01474512|11081389|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0
7011458|NCT01474512|11081390|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0
7011459|NCT01474512|11081391|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0
7011460|NCT01474512|11081392|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0
7011461|NCT01474512|11081393|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0
7011462|NCT01474512|11081376|FG000|Maintenance Period|Adverse Event|0
7011463|NCT01474512|11081377|FG001|Maintenance Period|Adverse Event|0
7011464|NCT01474512|11081378|FG002|Maintenance Period|Adverse Event|0
7011465|NCT01474512|11081379|FG003|Maintenance Period|Adverse Event|4
7011466|NCT01474512|11081380|FG004|Maintenance Period|Adverse Event|2
7011467|NCT01474512|11081381|FG005|Maintenance Period|Adverse Event|7
7011468|NCT01474512|11081382|FG006|Maintenance Period|Adverse Event|0
7011469|NCT01474512|11081383|FG007|Maintenance Period|Adverse Event|19
7011470|NCT01474512|11081384|FG008|Maintenance Period|Adverse Event|1
7011471|NCT01474512|11081385|FG009|Maintenance Period|Adverse Event|3
7011472|NCT01474512|11081386|FG010|Maintenance Period|Adverse Event|0
7011473|NCT01474512|11081387|FG011|Maintenance Period|Adverse Event|0
7011474|NCT01474512|11081388|FG012|Maintenance Period|Adverse Event|0
7011475|NCT01474512|11081389|FG013|Maintenance Period|Adverse Event|0
7011476|NCT01474512|11081390|FG014|Maintenance Period|Adverse Event|0
7011477|NCT01474512|11081391|FG015|Maintenance Period|Adverse Event|0
7011478|NCT01474512|11081392|FG016|Maintenance Period|Adverse Event|0
7011479|NCT01474512|11081393|FG017|Maintenance Period|Adverse Event|0
7011480|NCT01474512|11081376|FG000|Maintenance Period|Withdrawal by Subject|0
7011481|NCT01474512|11081377|FG001|Maintenance Period|Withdrawal by Subject|0
7011482|NCT01474512|11081378|FG002|Maintenance Period|Withdrawal by Subject|0
7011483|NCT01474512|11081379|FG003|Maintenance Period|Withdrawal by Subject|6
7011484|NCT01474512|11081380|FG004|Maintenance Period|Withdrawal by Subject|2
7011485|NCT01474512|11081381|FG005|Maintenance Period|Withdrawal by Subject|3
7011486|NCT01474512|11081382|FG006|Maintenance Period|Withdrawal by Subject|1
7011487|NCT01474512|11081383|FG007|Maintenance Period|Withdrawal by Subject|6
7011488|NCT01474512|11081384|FG008|Maintenance Period|Withdrawal by Subject|3
7011489|NCT01474512|11081385|FG009|Maintenance Period|Withdrawal by Subject|1
7011490|NCT01474512|11081386|FG010|Maintenance Period|Withdrawal by Subject|0
7011491|NCT01474512|11081387|FG011|Maintenance Period|Withdrawal by Subject|0
7011492|NCT01474512|11081388|FG012|Maintenance Period|Withdrawal by Subject|0
7011493|NCT01474512|11081389|FG013|Maintenance Period|Withdrawal by Subject|0
7011494|NCT01474512|11081390|FG014|Maintenance Period|Withdrawal by Subject|0
7011495|NCT01474512|11081391|FG015|Maintenance Period|Withdrawal by Subject|0
7011496|NCT01474512|11081392|FG016|Maintenance Period|Withdrawal by Subject|0
7011497|NCT01474512|11081393|FG017|Maintenance Period|Withdrawal by Subject|0
7011498|NCT01474512|11081376|FG000|Maintenance Period|Lost to Follow-up|0
7011499|NCT01474512|11081377|FG001|Maintenance Period|Lost to Follow-up|0
7011500|NCT01474512|11081378|FG002|Maintenance Period|Lost to Follow-up|0
7011501|NCT01474512|11081379|FG003|Maintenance Period|Lost to Follow-up|3
7011502|NCT01474512|11081380|FG004|Maintenance Period|Lost to Follow-up|3
7011503|NCT01474512|11081381|FG005|Maintenance Period|Lost to Follow-up|0
7011504|NCT01474512|11081382|FG006|Maintenance Period|Lost to Follow-up|0
7011505|NCT01474512|11081383|FG007|Maintenance Period|Lost to Follow-up|2
7011506|NCT01474512|11081384|FG008|Maintenance Period|Lost to Follow-up|1
7011507|NCT01474512|11081385|FG009|Maintenance Period|Lost to Follow-up|1
7011508|NCT01474512|11081386|FG010|Maintenance Period|Lost to Follow-up|0
7011509|NCT01474512|11081387|FG011|Maintenance Period|Lost to Follow-up|0
7011510|NCT01474512|11081388|FG012|Maintenance Period|Lost to Follow-up|0
7011511|NCT01474512|11081389|FG013|Maintenance Period|Lost to Follow-up|0
7011512|NCT01474512|11081390|FG014|Maintenance Period|Lost to Follow-up|0
7011513|NCT01474512|11081391|FG015|Maintenance Period|Lost to Follow-up|0
7011514|NCT01474512|11081392|FG016|Maintenance Period|Lost to Follow-up|0
7011515|NCT01474512|11081393|FG017|Maintenance Period|Lost to Follow-up|0
7011516|NCT01474512|11081376|FG000|Maintenance Period|Death|0
7011517|NCT01474512|11081377|FG001|Maintenance Period|Death|0
7011518|NCT01474512|11081378|FG002|Maintenance Period|Death|0
7011519|NCT01474512|11081379|FG003|Maintenance Period|Death|0
7011520|NCT01474512|11081380|FG004|Maintenance Period|Death|0
7011521|NCT01474512|11081381|FG005|Maintenance Period|Death|2
7011522|NCT01474512|11081382|FG006|Maintenance Period|Death|0
7011523|NCT01474512|11081383|FG007|Maintenance Period|Death|0
7011524|NCT01474512|11081384|FG008|Maintenance Period|Death|0
7011525|NCT01474512|11081385|FG009|Maintenance Period|Death|0
7011526|NCT01474512|11081386|FG010|Maintenance Period|Death|0
7011527|NCT01474512|11081387|FG011|Maintenance Period|Death|0
7011528|NCT01474512|11081388|FG012|Maintenance Period|Death|0
7011529|NCT01474512|11081389|FG013|Maintenance Period|Death|0
7011530|NCT01474512|11081390|FG014|Maintenance Period|Death|0
7011531|NCT01474512|11081391|FG015|Maintenance Period|Death|0
7011532|NCT01474512|11081392|FG016|Maintenance Period|Death|0
7011533|NCT01474512|11081393|FG017|Maintenance Period|Death|0
7011534|NCT01474512|11081376|FG000|Maintenance Period|Physician Decision|0
7011535|NCT01474512|11081377|FG001|Maintenance Period|Physician Decision|0
7011536|NCT01474512|11081378|FG002|Maintenance Period|Physician Decision|0
7011537|NCT01474512|11081379|FG003|Maintenance Period|Physician Decision|0
7011538|NCT01474512|11081380|FG004|Maintenance Period|Physician Decision|0
7011539|NCT01474512|11081381|FG005|Maintenance Period|Physician Decision|1
7011540|NCT01474512|11081382|FG006|Maintenance Period|Physician Decision|0
7011541|NCT01474512|11081383|FG007|Maintenance Period|Physician Decision|2
7011542|NCT01474512|11081384|FG008|Maintenance Period|Physician Decision|0
7011543|NCT01474512|11081385|FG009|Maintenance Period|Physician Decision|0
7011544|NCT01474512|11081386|FG010|Maintenance Period|Physician Decision|0
7011545|NCT01474512|11081387|FG011|Maintenance Period|Physician Decision|0
7011546|NCT01474512|11081388|FG012|Maintenance Period|Physician Decision|0
7011547|NCT01474512|11081389|FG013|Maintenance Period|Physician Decision|0
7011548|NCT01474512|11081390|FG014|Maintenance Period|Physician Decision|0
7011549|NCT01474512|11081391|FG015|Maintenance Period|Physician Decision|0
7011550|NCT01474512|11081392|FG016|Maintenance Period|Physician Decision|0
7011551|NCT01474512|11081393|FG017|Maintenance Period|Physician Decision|0
7011552|NCT01474512|11081376|FG000|Maintenance Period|Clinical Relapse|0
7011553|NCT01474512|11081377|FG001|Maintenance Period|Clinical Relapse|0
7011554|NCT01474512|11081378|FG002|Maintenance Period|Clinical Relapse|0
7011555|NCT01474512|11081379|FG003|Maintenance Period|Clinical Relapse|1
7011556|NCT01474512|11081380|FG004|Maintenance Period|Clinical Relapse|0
7011557|NCT01474512|11081381|FG005|Maintenance Period|Clinical Relapse|0
7011558|NCT01474512|11081382|FG006|Maintenance Period|Clinical Relapse|0
7011559|NCT01474512|11081383|FG007|Maintenance Period|Clinical Relapse|0
7011560|NCT01474512|11081384|FG008|Maintenance Period|Clinical Relapse|0
7011561|NCT01474512|11081385|FG009|Maintenance Period|Clinical Relapse|0
7011562|NCT01474512|11081386|FG010|Maintenance Period|Clinical Relapse|0
7011563|NCT01474512|11081387|FG011|Maintenance Period|Clinical Relapse|0
7011564|NCT01474512|11081388|FG012|Maintenance Period|Clinical Relapse|0
7011565|NCT01474512|11081389|FG013|Maintenance Period|Clinical Relapse|0
7011566|NCT01474512|11081390|FG014|Maintenance Period|Clinical Relapse|0
7011567|NCT01474512|11081391|FG015|Maintenance Period|Clinical Relapse|0
7011568|NCT01474512|11081392|FG016|Maintenance Period|Clinical Relapse|0
7011569|NCT01474512|11081393|FG017|Maintenance Period|Clinical Relapse|0
7011570|NCT01474512|11081376|FG000|Maintenance Period|Lack of Efficacy|0
7011571|NCT01474512|11081377|FG001|Maintenance Period|Lack of Efficacy|0
7011572|NCT01474512|11081378|FG002|Maintenance Period|Lack of Efficacy|0
7011573|NCT01474512|11081379|FG003|Maintenance Period|Lack of Efficacy|1
7011574|NCT01474512|11081380|FG004|Maintenance Period|Lack of Efficacy|0
7011575|NCT01474512|11081381|FG005|Maintenance Period|Lack of Efficacy|0
7011576|NCT01474512|11081382|FG006|Maintenance Period|Lack of Efficacy|0
7011577|NCT01474512|11081383|FG007|Maintenance Period|Lack of Efficacy|11
7011578|NCT01474512|11081384|FG008|Maintenance Period|Lack of Efficacy|11
7011579|NCT01474512|11081385|FG009|Maintenance Period|Lack of Efficacy|12
7011580|NCT01474512|11081386|FG010|Maintenance Period|Lack of Efficacy|0
7011581|NCT01474512|11081387|FG011|Maintenance Period|Lack of Efficacy|0
7011582|NCT01474512|11081388|FG012|Maintenance Period|Lack of Efficacy|0
7011583|NCT01474512|11081389|FG013|Maintenance Period|Lack of Efficacy|0
7011584|NCT01474512|11081390|FG014|Maintenance Period|Lack of Efficacy|0
7011585|NCT01474512|11081391|FG015|Maintenance Period|Lack of Efficacy|0
7011586|NCT01474512|11081392|FG016|Maintenance Period|Lack of Efficacy|0
7011587|NCT01474512|11081393|FG017|Maintenance Period|Lack of Efficacy|0
7011588|NCT01474512|11081376|FG000|Maintenance Period|Protocol Violation|0
7011589|NCT01474512|11081377|FG001|Maintenance Period|Protocol Violation|0
7011590|NCT01474512|11081378|FG002|Maintenance Period|Protocol Violation|0
7011591|NCT01474512|11081379|FG003|Maintenance Period|Protocol Violation|1
7011592|NCT01474512|11081380|FG004|Maintenance Period|Protocol Violation|0
7011593|NCT01474512|11081381|FG005|Maintenance Period|Protocol Violation|0
7011594|NCT01474512|11081382|FG006|Maintenance Period|Protocol Violation|0
7011595|NCT01474512|11081383|FG007|Maintenance Period|Protocol Violation|1
7011596|NCT01474512|11081384|FG008|Maintenance Period|Protocol Violation|0
7011597|NCT01474512|11081385|FG009|Maintenance Period|Protocol Violation|1
7011598|NCT01474512|11081386|FG010|Maintenance Period|Protocol Violation|0
7011599|NCT01474512|11081387|FG011|Maintenance Period|Protocol Violation|0
7011600|NCT01474512|11081388|FG012|Maintenance Period|Protocol Violation|0
7011601|NCT01474512|11081389|FG013|Maintenance Period|Protocol Violation|0
7011602|NCT01474512|11081390|FG014|Maintenance Period|Protocol Violation|0
7011603|NCT01474512|11081391|FG015|Maintenance Period|Protocol Violation|0
7011604|NCT01474512|11081392|FG016|Maintenance Period|Protocol Violation|0
7011605|NCT01474512|11081393|FG017|Maintenance Period|Protocol Violation|0
7011606|NCT01474512|11081376|FG000|Maintenance Period|Treated but Discontinued in Induction|0
7011607|NCT01474512|11081377|FG001|Maintenance Period|Treated but Discontinued in Induction|0
7011608|NCT01474512|11081378|FG002|Maintenance Period|Treated but Discontinued in Induction|0
7011609|NCT01474512|11081379|FG003|Maintenance Period|Treated but Discontinued in Induction|0
7011610|NCT01474512|11081380|FG004|Maintenance Period|Treated but Discontinued in Induction|1
7011611|NCT01474512|11081381|FG005|Maintenance Period|Treated but Discontinued in Induction|0
7011612|NCT01474512|11081382|FG006|Maintenance Period|Treated but Discontinued in Induction|0
7011613|NCT01474512|11081383|FG007|Maintenance Period|Treated but Discontinued in Induction|0
7011614|NCT01474512|11081384|FG008|Maintenance Period|Treated but Discontinued in Induction|0
7011615|NCT01474512|11081385|FG009|Maintenance Period|Treated but Discontinued in Induction|0
7011616|NCT01474512|11081386|FG010|Maintenance Period|Treated but Discontinued in Induction|0
7011617|NCT01474512|11081387|FG011|Maintenance Period|Treated but Discontinued in Induction|0
7011618|NCT01474512|11081388|FG012|Maintenance Period|Treated but Discontinued in Induction|0
7011619|NCT01474512|11081389|FG013|Maintenance Period|Treated but Discontinued in Induction|0
7011620|NCT01474512|11081390|FG014|Maintenance Period|Treated but Discontinued in Induction|0
7011621|NCT01474512|11081391|FG015|Maintenance Period|Treated but Discontinued in Induction|0
7011622|NCT01474512|11081392|FG016|Maintenance Period|Treated but Discontinued in Induction|0
7011623|NCT01474512|11081393|FG017|Maintenance Period|Treated but Discontinued in Induction|0
7011624|NCT01474512|11081376|FG000|Long-Term Extension Period|Withdrawal by Subject|0
7011625|NCT01474512|11081377|FG001|Long-Term Extension Period|Withdrawal by Subject|0
7011626|NCT01474512|11081378|FG002|Long-Term Extension Period|Withdrawal by Subject|0
7011627|NCT01474512|11081379|FG003|Long-Term Extension Period|Withdrawal by Subject|0
7011628|NCT01474512|11081380|FG004|Long-Term Extension Period|Withdrawal by Subject|0
7011629|NCT01474512|11081381|FG005|Long-Term Extension Period|Withdrawal by Subject|0
7011630|NCT01474512|11081382|FG006|Long-Term Extension Period|Withdrawal by Subject|0
7011631|NCT01474512|11081383|FG007|Long-Term Extension Period|Withdrawal by Subject|0
7011632|NCT01474512|11081384|FG008|Long-Term Extension Period|Withdrawal by Subject|0
7011633|NCT01474512|11081385|FG009|Long-Term Extension Period|Withdrawal by Subject|0
7011634|NCT01474512|11081386|FG010|Long-Term Extension Period|Withdrawal by Subject|0
7011635|NCT01474512|11081387|FG011|Long-Term Extension Period|Withdrawal by Subject|3
7011636|NCT01474512|11081388|FG012|Long-Term Extension Period|Withdrawal by Subject|61
7011637|NCT01474512|11081389|FG013|Long-Term Extension Period|Withdrawal by Subject|61
7011638|NCT01474512|11081390|FG014|Long-Term Extension Period|Withdrawal by Subject|0
7011639|NCT01474512|11081391|FG015|Long-Term Extension Period|Withdrawal by Subject|0
7011640|NCT01474512|11081392|FG016|Long-Term Extension Period|Withdrawal by Subject|0
7011641|NCT01474512|11081393|FG017|Long-Term Extension Period|Withdrawal by Subject|0
7011642|NCT01474512|11081376|FG000|Long-Term Extension Period|Adverse Event|0
7011643|NCT01474512|11081377|FG001|Long-Term Extension Period|Adverse Event|0
7011644|NCT01474512|11081378|FG002|Long-Term Extension Period|Adverse Event|0
7011645|NCT01474512|11081379|FG003|Long-Term Extension Period|Adverse Event|0
7011646|NCT01474512|11081380|FG004|Long-Term Extension Period|Adverse Event|0
7011647|NCT01474512|11081381|FG005|Long-Term Extension Period|Adverse Event|0
7011648|NCT01474512|11081382|FG006|Long-Term Extension Period|Adverse Event|0
7011649|NCT01474512|11081383|FG007|Long-Term Extension Period|Adverse Event|0
7011650|NCT01474512|11081384|FG008|Long-Term Extension Period|Adverse Event|0
7011651|NCT01474512|11081385|FG009|Long-Term Extension Period|Adverse Event|0
7011652|NCT01474512|11081386|FG010|Long-Term Extension Period|Adverse Event|0
7011653|NCT01474512|11081387|FG011|Long-Term Extension Period|Adverse Event|1
7011654|NCT01474512|11081388|FG012|Long-Term Extension Period|Adverse Event|57
7011655|NCT01474512|11081389|FG013|Long-Term Extension Period|Adverse Event|58
7011656|NCT01474512|11081390|FG014|Long-Term Extension Period|Adverse Event|0
7011657|NCT01474512|11081391|FG015|Long-Term Extension Period|Adverse Event|0
7011658|NCT01474512|11081392|FG016|Long-Term Extension Period|Adverse Event|0
7011659|NCT01474512|11081393|FG017|Long-Term Extension Period|Adverse Event|0
7011660|NCT01474512|11081376|FG000|Long-Term Extension Period|Lost to Follow-up|0
7011661|NCT01474512|11081377|FG001|Long-Term Extension Period|Lost to Follow-up|0
7011662|NCT01474512|11081378|FG002|Long-Term Extension Period|Lost to Follow-up|0
7011663|NCT01474512|11081379|FG003|Long-Term Extension Period|Lost to Follow-up|0
7011664|NCT01474512|11081380|FG004|Long-Term Extension Period|Lost to Follow-up|0
7011665|NCT01474512|11081381|FG005|Long-Term Extension Period|Lost to Follow-up|0
7011666|NCT01474512|11081382|FG006|Long-Term Extension Period|Lost to Follow-up|0
7011667|NCT01474512|11081383|FG007|Long-Term Extension Period|Lost to Follow-up|0
7011668|NCT01474512|11081384|FG008|Long-Term Extension Period|Lost to Follow-up|0
7011669|NCT01474512|11081385|FG009|Long-Term Extension Period|Lost to Follow-up|0
7011670|NCT01474512|11081386|FG010|Long-Term Extension Period|Lost to Follow-up|0
7011671|NCT01474512|11081387|FG011|Long-Term Extension Period|Lost to Follow-up|0
7011672|NCT01474512|11081388|FG012|Long-Term Extension Period|Lost to Follow-up|25
7011673|NCT01474512|11081389|FG013|Long-Term Extension Period|Lost to Follow-up|25
7011674|NCT01474512|11081390|FG014|Long-Term Extension Period|Lost to Follow-up|0
7011675|NCT01474512|11081391|FG015|Long-Term Extension Period|Lost to Follow-up|0
7011676|NCT01474512|11081392|FG016|Long-Term Extension Period|Lost to Follow-up|0
7011677|NCT01474512|11081393|FG017|Long-Term Extension Period|Lost to Follow-up|0
7011678|NCT01474512|11081376|FG000|Long-Term Extension Period|Lack of Efficacy|0
7011679|NCT01474512|11081377|FG001|Long-Term Extension Period|Lack of Efficacy|0
7011680|NCT01474512|11081378|FG002|Long-Term Extension Period|Lack of Efficacy|0
7011681|NCT01474512|11081379|FG003|Long-Term Extension Period|Lack of Efficacy|0
7011682|NCT01474512|11081380|FG004|Long-Term Extension Period|Lack of Efficacy|0
7011683|NCT01474512|11081381|FG005|Long-Term Extension Period|Lack of Efficacy|0
7011684|NCT01474512|11081382|FG006|Long-Term Extension Period|Lack of Efficacy|0
7011685|NCT01474512|11081383|FG007|Long-Term Extension Period|Lack of Efficacy|0
7011686|NCT01474512|11081384|FG008|Long-Term Extension Period|Lack of Efficacy|0
7011687|NCT01474512|11081385|FG009|Long-Term Extension Period|Lack of Efficacy|0
7011688|NCT01474512|11081386|FG010|Long-Term Extension Period|Lack of Efficacy|0
7011689|NCT01474512|11081387|FG011|Long-Term Extension Period|Lack of Efficacy|1
7011690|NCT01474512|11081388|FG012|Long-Term Extension Period|Lack of Efficacy|24
7043407|NCT01743989|11128286|FG000|Treatment Phase|Pregnancy|0
7011691|NCT01474512|11081389|FG013|Long-Term Extension Period|Lack of Efficacy|25
7011692|NCT01474512|11081390|FG014|Long-Term Extension Period|Lack of Efficacy|0
7011693|NCT01474512|11081391|FG015|Long-Term Extension Period|Lack of Efficacy|0
7011694|NCT01474512|11081392|FG016|Long-Term Extension Period|Lack of Efficacy|0
7011695|NCT01474512|11081393|FG017|Long-Term Extension Period|Lack of Efficacy|0
7011696|NCT01474512|11081376|FG000|Long-Term Extension Period|Physician Decision|0
7011697|NCT01474512|11081377|FG001|Long-Term Extension Period|Physician Decision|0
7011698|NCT01474512|11081378|FG002|Long-Term Extension Period|Physician Decision|0
7011699|NCT01474512|11081379|FG003|Long-Term Extension Period|Physician Decision|0
7011700|NCT01474512|11081380|FG004|Long-Term Extension Period|Physician Decision|0
7011701|NCT01474512|11081381|FG005|Long-Term Extension Period|Physician Decision|0
7011702|NCT01474512|11081382|FG006|Long-Term Extension Period|Physician Decision|0
7011703|NCT01474512|11081383|FG007|Long-Term Extension Period|Physician Decision|0
7011704|NCT01474512|11081384|FG008|Long-Term Extension Period|Physician Decision|0
7011705|NCT01474512|11081385|FG009|Long-Term Extension Period|Physician Decision|0
7011706|NCT01474512|11081386|FG010|Long-Term Extension Period|Physician Decision|0
7011707|NCT01474512|11081387|FG011|Long-Term Extension Period|Physician Decision|0
7011708|NCT01474512|11081388|FG012|Long-Term Extension Period|Physician Decision|21
7011709|NCT01474512|11081389|FG013|Long-Term Extension Period|Physician Decision|21
7011710|NCT01474512|11081390|FG014|Long-Term Extension Period|Physician Decision|0
7011711|NCT01474512|11081391|FG015|Long-Term Extension Period|Physician Decision|0
7011712|NCT01474512|11081392|FG016|Long-Term Extension Period|Physician Decision|0
7011713|NCT01474512|11081393|FG017|Long-Term Extension Period|Physician Decision|0
7011714|NCT01474512|11081376|FG000|Long-Term Extension Period|Clinical Relapse|0
7011715|NCT01474512|11081377|FG001|Long-Term Extension Period|Clinical Relapse|0
7011716|NCT01474512|11081378|FG002|Long-Term Extension Period|Clinical Relapse|0
7011717|NCT01474512|11081379|FG003|Long-Term Extension Period|Clinical Relapse|0
7011718|NCT01474512|11081380|FG004|Long-Term Extension Period|Clinical Relapse|0
7011719|NCT01474512|11081381|FG005|Long-Term Extension Period|Clinical Relapse|0
7011720|NCT01474512|11081382|FG006|Long-Term Extension Period|Clinical Relapse|0
7011721|NCT01474512|11081383|FG007|Long-Term Extension Period|Clinical Relapse|0
7011722|NCT01474512|11081384|FG008|Long-Term Extension Period|Clinical Relapse|0
7011723|NCT01474512|11081385|FG009|Long-Term Extension Period|Clinical Relapse|0
7011724|NCT01474512|11081386|FG010|Long-Term Extension Period|Clinical Relapse|0
7011725|NCT01474512|11081387|FG011|Long-Term Extension Period|Clinical Relapse|0
7011726|NCT01474512|11081388|FG012|Long-Term Extension Period|Clinical Relapse|9
7011727|NCT01474512|11081389|FG013|Long-Term Extension Period|Clinical Relapse|9
7011728|NCT01474512|11081390|FG014|Long-Term Extension Period|Clinical Relapse|0
7011729|NCT01474512|11081391|FG015|Long-Term Extension Period|Clinical Relapse|0
7011730|NCT01474512|11081392|FG016|Long-Term Extension Period|Clinical Relapse|0
7011731|NCT01474512|11081393|FG017|Long-Term Extension Period|Clinical Relapse|0
7011732|NCT01474512|11081376|FG000|Long-Term Extension Period|Death|0
7011733|NCT01474512|11081377|FG001|Long-Term Extension Period|Death|0
7011734|NCT01474512|11081378|FG002|Long-Term Extension Period|Death|0
7011735|NCT01474512|11081379|FG003|Long-Term Extension Period|Death|0
7011736|NCT01474512|11081380|FG004|Long-Term Extension Period|Death|0
7011737|NCT01474512|11081381|FG005|Long-Term Extension Period|Death|0
7011738|NCT01474512|11081382|FG006|Long-Term Extension Period|Death|0
7011739|NCT01474512|11081383|FG007|Long-Term Extension Period|Death|0
7011740|NCT01474512|11081384|FG008|Long-Term Extension Period|Death|0
7011741|NCT01474512|11081385|FG009|Long-Term Extension Period|Death|0
7011742|NCT01474512|11081386|FG010|Long-Term Extension Period|Death|0
7011743|NCT01474512|11081387|FG011|Long-Term Extension Period|Death|0
7011744|NCT01474512|11081388|FG012|Long-Term Extension Period|Death|9
7011745|NCT01474512|11081389|FG013|Long-Term Extension Period|Death|9
7011746|NCT01474512|11081390|FG014|Long-Term Extension Period|Death|0
7011747|NCT01474512|11081391|FG015|Long-Term Extension Period|Death|0
7011748|NCT01474512|11081392|FG016|Long-Term Extension Period|Death|0
7011749|NCT01474512|11081393|FG017|Long-Term Extension Period|Death|0
7011750|NCT01474512|11081376|FG000|Long-Term Extension Period|Sponsor Decision|0
7011751|NCT01474512|11081377|FG001|Long-Term Extension Period|Sponsor Decision|0
7011752|NCT01474512|11081378|FG002|Long-Term Extension Period|Sponsor Decision|0
7011753|NCT01474512|11081379|FG003|Long-Term Extension Period|Sponsor Decision|0
7011754|NCT01474512|11081380|FG004|Long-Term Extension Period|Sponsor Decision|0
7011755|NCT01474512|11081381|FG005|Long-Term Extension Period|Sponsor Decision|0
7011756|NCT01474512|11081382|FG006|Long-Term Extension Period|Sponsor Decision|0
7011757|NCT01474512|11081383|FG007|Long-Term Extension Period|Sponsor Decision|0
7011758|NCT01474512|11081384|FG008|Long-Term Extension Period|Sponsor Decision|0
7011759|NCT01474512|11081385|FG009|Long-Term Extension Period|Sponsor Decision|0
7011760|NCT01474512|11081386|FG010|Long-Term Extension Period|Sponsor Decision|0
7011761|NCT01474512|11081387|FG011|Long-Term Extension Period|Sponsor Decision|0
7011762|NCT01474512|11081388|FG012|Long-Term Extension Period|Sponsor Decision|6
7011763|NCT01474512|11081389|FG013|Long-Term Extension Period|Sponsor Decision|6
7011764|NCT01474512|11081390|FG014|Long-Term Extension Period|Sponsor Decision|0
7011765|NCT01474512|11081391|FG015|Long-Term Extension Period|Sponsor Decision|0
7011766|NCT01474512|11081392|FG016|Long-Term Extension Period|Sponsor Decision|0
7011767|NCT01474512|11081393|FG017|Long-Term Extension Period|Sponsor Decision|0
7043408|NCT01743989|11128287|FG001|Treatment Phase|Pregnancy|0
7011768|NCT01474512|11081376|FG000|Long-Term Extension Period|Protocol Violation|0
7011769|NCT01474512|11081377|FG001|Long-Term Extension Period|Protocol Violation|0
7011770|NCT01474512|11081378|FG002|Long-Term Extension Period|Protocol Violation|0
7011771|NCT01474512|11081379|FG003|Long-Term Extension Period|Protocol Violation|0
7011772|NCT01474512|11081380|FG004|Long-Term Extension Period|Protocol Violation|0
7011773|NCT01474512|11081381|FG005|Long-Term Extension Period|Protocol Violation|0
7011774|NCT01474512|11081382|FG006|Long-Term Extension Period|Protocol Violation|0
7011775|NCT01474512|11081383|FG007|Long-Term Extension Period|Protocol Violation|0
7011776|NCT01474512|11081384|FG008|Long-Term Extension Period|Protocol Violation|0
7011777|NCT01474512|11081385|FG009|Long-Term Extension Period|Protocol Violation|0
7011778|NCT01474512|11081386|FG010|Long-Term Extension Period|Protocol Violation|0
7011779|NCT01474512|11081387|FG011|Long-Term Extension Period|Protocol Violation|0
7011780|NCT01474512|11081388|FG012|Long-Term Extension Period|Protocol Violation|5
7011781|NCT01474512|11081389|FG013|Long-Term Extension Period|Protocol Violation|5
7011782|NCT01474512|11081390|FG014|Long-Term Extension Period|Protocol Violation|0
7011783|NCT01474512|11081391|FG015|Long-Term Extension Period|Protocol Violation|0
7011784|NCT01474512|11081392|FG016|Long-Term Extension Period|Protocol Violation|0
7011785|NCT01474512|11081393|FG017|Long-Term Extension Period|Protocol Violation|0
7011786|NCT01474512|11081376|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0
7011787|NCT01474512|11081377|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0
7011788|NCT01474512|11081378|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0
7011789|NCT01474512|11081379|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0
7011790|NCT01474512|11081380|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0
7011791|NCT01474512|11081381|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0
7011792|NCT01474512|11081382|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0
7011793|NCT01474512|11081383|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0
7011794|NCT01474512|11081384|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0
7011795|NCT01474512|11081385|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0
7011796|NCT01474512|11081386|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0
7011797|NCT01474512|11081387|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0
7011798|NCT01474512|11081388|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1
7011799|NCT01474512|11081389|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1
7011800|NCT01474512|11081390|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0
7011801|NCT01474512|11081391|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0
7011802|NCT01474512|11081392|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0
7011803|NCT01474512|11081393|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0
7011804|NCT01474512|11081376|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0
7011805|NCT01474512|11081377|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0
7011806|NCT01474512|11081378|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0
7011807|NCT01474512|11081379|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0
7011808|NCT01474512|11081380|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0
7011809|NCT01474512|11081381|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0
7011810|NCT01474512|11081382|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0
7011811|NCT01474512|11081383|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0
7011812|NCT01474512|11081384|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0
7011813|NCT01474512|11081385|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0
7011814|NCT01474512|11081386|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0
7011815|NCT01474512|11081387|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21
7011816|NCT01474512|11081388|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0
7011817|NCT01474512|11081389|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0
7011818|NCT01474512|11081390|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0
7011819|NCT01474512|11081391|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0
7011820|NCT01474512|11081392|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0
7011821|NCT01474512|11081393|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0
7011822|NCT01474512|11081376|FG000|Post-Treatment Follow-Up|Adverse Event|0
7011823|NCT01474512|11081377|FG001|Post-Treatment Follow-Up|Adverse Event|0
7011824|NCT01474512|11081378|FG002|Post-Treatment Follow-Up|Adverse Event|0
7011825|NCT01474512|11081379|FG003|Post-Treatment Follow-Up|Adverse Event|0
7011826|NCT01474512|11081380|FG004|Post-Treatment Follow-Up|Adverse Event|0
7011827|NCT01474512|11081381|FG005|Post-Treatment Follow-Up|Adverse Event|0
7011828|NCT01474512|11081382|FG006|Post-Treatment Follow-Up|Adverse Event|0
7011829|NCT01474512|11081383|FG007|Post-Treatment Follow-Up|Adverse Event|0
7011830|NCT01474512|11081384|FG008|Post-Treatment Follow-Up|Adverse Event|0
7011831|NCT01474512|11081385|FG009|Post-Treatment Follow-Up|Adverse Event|0
7011832|NCT01474512|11081386|FG010|Post-Treatment Follow-Up|Adverse Event|0
7011833|NCT01474512|11081387|FG011|Post-Treatment Follow-Up|Adverse Event|0
7011834|NCT01474512|11081388|FG012|Post-Treatment Follow-Up|Adverse Event|0
7011835|NCT01474512|11081389|FG013|Post-Treatment Follow-Up|Adverse Event|0
7011836|NCT01474512|11081390|FG014|Post-Treatment Follow-Up|Adverse Event|8
7011837|NCT01474512|11081391|FG015|Post-Treatment Follow-Up|Adverse Event|2
7011838|NCT01474512|11081392|FG016|Post-Treatment Follow-Up|Adverse Event|58
7011839|NCT01474512|11081393|FG017|Post-Treatment Follow-Up|Adverse Event|11
7011840|NCT01474512|11081376|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0
7011841|NCT01474512|11081377|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0
7011842|NCT01474512|11081378|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0
7011843|NCT01474512|11081379|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0
7011844|NCT01474512|11081380|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0
7011845|NCT01474512|11081381|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0
7011846|NCT01474512|11081382|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0
7011847|NCT01474512|11081383|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0
7011848|NCT01474512|11081384|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0
7011849|NCT01474512|11081385|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0
7011850|NCT01474512|11081386|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0
7011851|NCT01474512|11081387|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0
7011852|NCT01474512|11081388|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0
7011853|NCT01474512|11081389|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0
7011854|NCT01474512|11081390|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3
7011855|NCT01474512|11081391|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2
7011856|NCT01474512|11081392|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36
7011857|NCT01474512|11081393|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17
7011858|NCT01474512|11081376|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0
7011859|NCT01474512|11081377|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0
7011860|NCT01474512|11081378|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0
7011861|NCT01474512|11081379|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0
7011862|NCT01474512|11081380|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0
7011863|NCT01474512|11081381|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0
7011864|NCT01474512|11081382|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0
7011865|NCT01474512|11081383|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0
7011866|NCT01474512|11081384|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0
7011867|NCT01474512|11081385|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0
7011868|NCT01474512|11081386|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0
7011869|NCT01474512|11081387|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0
7011870|NCT01474512|11081388|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0
7011871|NCT01474512|11081389|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0
7011872|NCT01474512|11081390|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3
7011873|NCT01474512|11081391|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2
7011874|NCT01474512|11081392|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31
7011875|NCT01474512|11081393|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3
7011876|NCT01474512|11081376|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0
7011877|NCT01474512|11081377|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0
7011878|NCT01474512|11081378|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0
7011879|NCT01474512|11081379|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0
7011880|NCT01474512|11081380|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0
7011881|NCT01474512|11081381|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0
7011882|NCT01474512|11081382|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0
7011883|NCT01474512|11081383|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0
7011884|NCT01474512|11081384|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0
7011885|NCT01474512|11081385|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0
7011886|NCT01474512|11081386|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0
7011887|NCT01474512|11081387|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0
7011888|NCT01474512|11081388|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0
7011889|NCT01474512|11081389|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0
7011890|NCT01474512|11081390|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0
7011891|NCT01474512|11081391|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0
7011892|NCT01474512|11081392|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12
7011893|NCT01474512|11081393|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7
7011894|NCT01474512|11081376|FG000|Post-Treatment Follow-Up|Physician Decision|0
7011895|NCT01474512|11081377|FG001|Post-Treatment Follow-Up|Physician Decision|0
7011896|NCT01474512|11081378|FG002|Post-Treatment Follow-Up|Physician Decision|0
7011897|NCT01474512|11081379|FG003|Post-Treatment Follow-Up|Physician Decision|0
7011898|NCT01474512|11081380|FG004|Post-Treatment Follow-Up|Physician Decision|0
7011899|NCT01474512|11081381|FG005|Post-Treatment Follow-Up|Physician Decision|0
7011900|NCT01474512|11081382|FG006|Post-Treatment Follow-Up|Physician Decision|0
7011901|NCT01474512|11081383|FG007|Post-Treatment Follow-Up|Physician Decision|0
7011902|NCT01474512|11081384|FG008|Post-Treatment Follow-Up|Physician Decision|0
7011903|NCT01474512|11081385|FG009|Post-Treatment Follow-Up|Physician Decision|0
7011904|NCT01474512|11081386|FG010|Post-Treatment Follow-Up|Physician Decision|0
7011905|NCT01474512|11081387|FG011|Post-Treatment Follow-Up|Physician Decision|0
7011906|NCT01474512|11081388|FG012|Post-Treatment Follow-Up|Physician Decision|0
7011907|NCT01474512|11081389|FG013|Post-Treatment Follow-Up|Physician Decision|0
7011908|NCT01474512|11081390|FG014|Post-Treatment Follow-Up|Physician Decision|0
7011909|NCT01474512|11081391|FG015|Post-Treatment Follow-Up|Physician Decision|0
7011910|NCT01474512|11081392|FG016|Post-Treatment Follow-Up|Physician Decision|4
7011911|NCT01474512|11081393|FG017|Post-Treatment Follow-Up|Physician Decision|5
7011912|NCT01474512|11081376|FG000|Post-Treatment Follow-Up|Clinical Relapse|0
7011913|NCT01474512|11081377|FG001|Post-Treatment Follow-Up|Clinical Relapse|0
7011914|NCT01474512|11081378|FG002|Post-Treatment Follow-Up|Clinical Relapse|0
7011915|NCT01474512|11081379|FG003|Post-Treatment Follow-Up|Clinical Relapse|0
7011916|NCT01474512|11081380|FG004|Post-Treatment Follow-Up|Clinical Relapse|0
7011917|NCT01474512|11081381|FG005|Post-Treatment Follow-Up|Clinical Relapse|0
7011918|NCT01474512|11081382|FG006|Post-Treatment Follow-Up|Clinical Relapse|0
7011919|NCT01474512|11081383|FG007|Post-Treatment Follow-Up|Clinical Relapse|0
7011920|NCT01474512|11081384|FG008|Post-Treatment Follow-Up|Clinical Relapse|0
7011921|NCT01474512|11081385|FG009|Post-Treatment Follow-Up|Clinical Relapse|0
7011922|NCT01474512|11081386|FG010|Post-Treatment Follow-Up|Clinical Relapse|0
7011923|NCT01474512|11081387|FG011|Post-Treatment Follow-Up|Clinical Relapse|0
7011924|NCT01474512|11081388|FG012|Post-Treatment Follow-Up|Clinical Relapse|0
7011925|NCT01474512|11081389|FG013|Post-Treatment Follow-Up|Clinical Relapse|0
7011926|NCT01474512|11081390|FG014|Post-Treatment Follow-Up|Clinical Relapse|0
7011927|NCT01474512|11081391|FG015|Post-Treatment Follow-Up|Clinical Relapse|0
7011928|NCT01474512|11081392|FG016|Post-Treatment Follow-Up|Clinical Relapse|6
7011929|NCT01474512|11081393|FG017|Post-Treatment Follow-Up|Clinical Relapse|2
7011930|NCT01474512|11081376|FG000|Post-Treatment Follow-Up|Protocol Violation|0
7011931|NCT01474512|11081377|FG001|Post-Treatment Follow-Up|Protocol Violation|0
7011932|NCT01474512|11081378|FG002|Post-Treatment Follow-Up|Protocol Violation|0
7011933|NCT01474512|11081379|FG003|Post-Treatment Follow-Up|Protocol Violation|0
7011934|NCT01474512|11081380|FG004|Post-Treatment Follow-Up|Protocol Violation|0
7011935|NCT01474512|11081381|FG005|Post-Treatment Follow-Up|Protocol Violation|0
7011936|NCT01474512|11081382|FG006|Post-Treatment Follow-Up|Protocol Violation|0
7011937|NCT01474512|11081383|FG007|Post-Treatment Follow-Up|Protocol Violation|0
7011938|NCT01474512|11081384|FG008|Post-Treatment Follow-Up|Protocol Violation|0
7011939|NCT01474512|11081385|FG009|Post-Treatment Follow-Up|Protocol Violation|0
7011940|NCT01474512|11081386|FG010|Post-Treatment Follow-Up|Protocol Violation|0
7011941|NCT01474512|11081387|FG011|Post-Treatment Follow-Up|Protocol Violation|0
7011942|NCT01474512|11081388|FG012|Post-Treatment Follow-Up|Protocol Violation|0
7011943|NCT01474512|11081389|FG013|Post-Treatment Follow-Up|Protocol Violation|0
7011944|NCT01474512|11081390|FG014|Post-Treatment Follow-Up|Protocol Violation|2
7011945|NCT01474512|11081391|FG015|Post-Treatment Follow-Up|Protocol Violation|2
7011946|NCT01474512|11081392|FG016|Post-Treatment Follow-Up|Protocol Violation|4
7011947|NCT01474512|11081393|FG017|Post-Treatment Follow-Up|Protocol Violation|0
7011948|NCT01474512|11081376|FG000|Post-Treatment Follow-Up|Sponsor Decision|0
7011949|NCT01474512|11081377|FG001|Post-Treatment Follow-Up|Sponsor Decision|0
7011950|NCT01474512|11081378|FG002|Post-Treatment Follow-Up|Sponsor Decision|0
7011951|NCT01474512|11081379|FG003|Post-Treatment Follow-Up|Sponsor Decision|0
7011952|NCT01474512|11081380|FG004|Post-Treatment Follow-Up|Sponsor Decision|0
7011953|NCT01474512|11081381|FG005|Post-Treatment Follow-Up|Sponsor Decision|0
7011954|NCT01474512|11081382|FG006|Post-Treatment Follow-Up|Sponsor Decision|0
7011955|NCT01474512|11081383|FG007|Post-Treatment Follow-Up|Sponsor Decision|0
7011956|NCT01474512|11081384|FG008|Post-Treatment Follow-Up|Sponsor Decision|0
7011957|NCT01474512|11081385|FG009|Post-Treatment Follow-Up|Sponsor Decision|0
7011958|NCT01474512|11081386|FG010|Post-Treatment Follow-Up|Sponsor Decision|0
7011959|NCT01474512|11081387|FG011|Post-Treatment Follow-Up|Sponsor Decision|0
7011960|NCT01474512|11081388|FG012|Post-Treatment Follow-Up|Sponsor Decision|0
7011961|NCT01474512|11081389|FG013|Post-Treatment Follow-Up|Sponsor Decision|0
7011962|NCT01474512|11081390|FG014|Post-Treatment Follow-Up|Sponsor Decision|1
7011963|NCT01474512|11081391|FG015|Post-Treatment Follow-Up|Sponsor Decision|0
7011964|NCT01474512|11081392|FG016|Post-Treatment Follow-Up|Sponsor Decision|4
7011965|NCT01474512|11081393|FG017|Post-Treatment Follow-Up|Sponsor Decision|0
7011966|NCT01474512|11081376|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7011967|NCT01474512|11081377|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7011968|NCT01474512|11081378|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7011969|NCT01474512|11081379|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7011970|NCT01474512|11081380|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7011971|NCT01474512|11081381|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7011972|NCT01474512|11081382|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7011973|NCT01474512|11081383|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7011974|NCT01474512|11081384|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7011975|NCT01474512|11081385|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7011976|NCT01474512|11081386|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7011977|NCT01474512|11081387|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7011978|NCT01474512|11081388|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7011979|NCT01474512|11081389|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7011980|NCT01474512|11081390|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1
7011981|NCT01474512|11081391|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7011982|NCT01474512|11081392|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7011983|NCT01474512|11081393|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1
7011984|NCT01474512|11081376|FG000|Post-Treatment Follow-Up|Death|0
7011985|NCT01474512|11081377|FG001|Post-Treatment Follow-Up|Death|0
7011986|NCT01474512|11081378|FG002|Post-Treatment Follow-Up|Death|0
7011987|NCT01474512|11081379|FG003|Post-Treatment Follow-Up|Death|0
7011988|NCT01474512|11081380|FG004|Post-Treatment Follow-Up|Death|0
7011989|NCT01474512|11081381|FG005|Post-Treatment Follow-Up|Death|0
7011990|NCT01474512|11081382|FG006|Post-Treatment Follow-Up|Death|0
7011991|NCT01474512|11081383|FG007|Post-Treatment Follow-Up|Death|0
7011992|NCT01474512|11081384|FG008|Post-Treatment Follow-Up|Death|0
7011993|NCT01474512|11081385|FG009|Post-Treatment Follow-Up|Death|0
7011994|NCT01474512|11081386|FG010|Post-Treatment Follow-Up|Death|0
7011995|NCT01474512|11081387|FG011|Post-Treatment Follow-Up|Death|0
7011996|NCT01474512|11081388|FG012|Post-Treatment Follow-Up|Death|0
7011997|NCT01474512|11081389|FG013|Post-Treatment Follow-Up|Death|0
7011998|NCT01474512|11081390|FG014|Post-Treatment Follow-Up|Death|0
7011999|NCT01474512|11081391|FG015|Post-Treatment Follow-Up|Death|0
7012000|NCT01474512|11081392|FG016|Post-Treatment Follow-Up|Death|1
7012001|NCT01474512|11081393|FG017|Post-Treatment Follow-Up|Death|0
7012002|NCT01474538|11081425|FG000|Treatment Period 1|Death|1
7012003|NCT01474538|11081426|FG001|Treatment Period 1|Death|0
7012004|NCT01474538|11081425|FG000|Treatment Period 1|Physician Decision|1
7012005|NCT01474538|11081426|FG001|Treatment Period 1|Physician Decision|0
7012006|NCT01474538|11081425|FG000|Treatment Period 1|Withdrawal by Subject|1
7012007|NCT01474538|11081426|FG001|Treatment Period 1|Withdrawal by Subject|3
7012008|NCT01474538|11081425|FG000|Treatment Period 1|Protocol Violation|0
7012009|NCT01474538|11081426|FG001|Treatment Period 1|Protocol Violation|1
7012010|NCT01474538|11081425|FG000|Treatment Period 2|Death|1
7012011|NCT01474538|11081426|FG001|Treatment Period 2|Death|0
7012012|NCT01474538|11081425|FG000|Treatment Period 2|Adverse Event|1
7012013|NCT01474538|11081426|FG001|Treatment Period 2|Adverse Event|1
7012014|NCT01474538|11081425|FG000|Treatment Period 2|Withdrawal by Subject|2
7012015|NCT01474538|11081426|FG001|Treatment Period 2|Withdrawal by Subject|0
7012016|NCT01474538|11081425|FG000|Treatment Period 2|Sponsor decision|1
7012017|NCT01474538|11081426|FG001|Treatment Period 2|Sponsor decision|0
7012018|NCT01474538|11081425|FG000|Treatment Period 2|Physician Decision|0
7012019|NCT01474538|11081426|FG001|Treatment Period 2|Physician Decision|1
7012020|NCT01474538|11081425|FG000|Treatment Period 2|Protocol Violation|1
7012021|NCT01474538|11081426|FG001|Treatment Period 2|Protocol Violation|0
7012022|NCT01474551|11081432|FG000|Overall Study|Death|1
7012023|NCT01474681|11081447|FG000|Overall Study|Death|0
7012024|NCT01474681|11081448|FG001|Overall Study|Death|3
7012025|NCT01474681|11081449|FG002|Overall Study|Death|2
7012026|NCT01474681|11081450|FG003|Overall Study|Death|6
7012027|NCT01474746|11081466|FG000|Overall Study|Lost to Follow-up|1
7012028|NCT01474746|11081467|FG001|Overall Study|Lost to Follow-up|1
7012029|NCT01474746|11081466|FG000|Overall Study|Withdrawal by Subject|2
7012030|NCT01474746|11081467|FG001|Overall Study|Withdrawal by Subject|1
7012031|NCT01474772|11081475|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6
7012032|NCT01474772|11081476|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1
7012033|NCT01474772|11081475|FG000|Period 1|AE not Related to Study Drug|1
7012034|NCT01474772|11081476|FG001|Period 1|AE not Related to Study Drug|0
7012035|NCT01474772|11081475|FG000|Period 1|Withdrawal by Subject|3
7012036|NCT01474772|11081476|FG001|Period 1|Withdrawal by Subject|1
7012037|NCT01474772|11081475|FG000|Period 1|Lost to Follow-up|1
7012038|NCT01474772|11081476|FG001|Period 1|Lost to Follow-up|0
7012039|NCT01474772|11081475|FG000|Period 1|Reason not Specified|1
7012040|NCT01474772|11081476|FG001|Period 1|Reason not Specified|1
7012041|NCT01474772|11081475|FG000|Washout|AE not Related to Study Drug|2
7012042|NCT01474772|11081476|FG001|Washout|AE not Related to Study Drug|0
7012043|NCT01474772|11081475|FG000|Washout|Withdrawal by Subject|1
7012044|NCT01474772|11081476|FG001|Washout|Withdrawal by Subject|0
7012045|NCT01474772|11081475|FG000|Washout|Lost to Follow-up|0
7012046|NCT01474772|11081476|FG001|Washout|Lost to Follow-up|1
7012047|NCT01474772|11081475|FG000|Washout|Reason not Specified|0
7012048|NCT01474772|11081476|FG001|Washout|Reason not Specified|1
7012049|NCT01474772|11081475|FG000|Period 2|Death|0
7012050|NCT01474772|11081476|FG001|Period 2|Death|1
7012051|NCT01474772|11081475|FG000|Period 2|AE Related to Study Drug|0
7012052|NCT01474772|11081476|FG001|Period 2|AE Related to Study Drug|1
7012053|NCT01474772|11081475|FG000|Period 2|AE not Related to Study Drug|4
7012054|NCT01474772|11081476|FG001|Period 2|AE not Related to Study Drug|1
7012055|NCT01474772|11081475|FG000|Period 2|Lack of Efficacy|1
7012056|NCT01474772|11081476|FG001|Period 2|Lack of Efficacy|0
7012057|NCT01474772|11081475|FG000|Period 2|Withdrawal by Subject|3
7012058|NCT01474772|11081476|FG001|Period 2|Withdrawal by Subject|4
7012059|NCT01474772|11081475|FG000|Period 2|Lost to Follow-up|1
7012060|NCT01474772|11081476|FG001|Period 2|Lost to Follow-up|1
7012061|NCT01474772|11081475|FG000|Period 2|Reason not Specified|0
7012062|NCT01474772|11081476|FG001|Period 2|Reason not Specified|2
7012063|NCT01474772|11081475|FG000|Follow-up|AE not Related to Study Drug|0
7012064|NCT01474772|11081476|FG001|Follow-up|AE not Related to Study Drug|1
7012065|NCT01474876|11081498|FG000|Overall Study|Adverse Event|11
7012066|NCT01474876|11081499|FG001|Overall Study|Adverse Event|5
7012067|NCT01474876|11081500|FG002|Overall Study|Adverse Event|0
7012068|NCT01474876|11081498|FG000|Overall Study|Serious Adverse Event|2
7012069|NCT01474876|11081499|FG001|Overall Study|Serious Adverse Event|3
7012070|NCT01474876|11081500|FG002|Overall Study|Serious Adverse Event|0
7012071|NCT01474876|11081498|FG000|Overall Study|Lost to Follow-up|5
7012072|NCT01474876|11081499|FG001|Overall Study|Lost to Follow-up|4
7012073|NCT01474876|11081500|FG002|Overall Study|Lost to Follow-up|0
7012074|NCT01474876|11081498|FG000|Overall Study|Investigator's decision|28
7012075|NCT01474876|11081499|FG001|Overall Study|Investigator's decision|6
7012076|NCT01474876|11081500|FG002|Overall Study|Investigator's decision|0
7012077|NCT01474876|11081498|FG000|Overall Study|Patient's request|19
7012078|NCT01474876|11081499|FG001|Overall Study|Patient's request|5
7012079|NCT01474876|11081500|FG002|Overall Study|Patient's request|0
7012080|NCT01474876|11081498|FG000|Overall Study|Investigator's decision and pt request|1
7012081|NCT01474876|11081499|FG001|Overall Study|Investigator's decision and pt request|0
7012082|NCT01474876|11081500|FG002|Overall Study|Investigator's decision and pt request|0
7043409|NCT01743989|11128288|FG002|Treatment Phase|Pregnancy|2
7043410|NCT01743989|11128286|FG000|Treatment Phase|Lost to Follow-up|0
7043411|NCT01743989|11128287|FG001|Treatment Phase|Lost to Follow-up|0
7043412|NCT01743989|11128288|FG002|Treatment Phase|Lost to Follow-up|2
7043413|NCT01743989|11128286|FG000|Treatment Phase|Abnormal test procedure result(s)|0
7043414|NCT01743989|11128287|FG001|Treatment Phase|Abnormal test procedure result(s)|0
7043415|NCT01743989|11128288|FG002|Treatment Phase|Abnormal test procedure result(s)|1
7043416|NCT01743989|11128286|FG000|Treatment Phase|Administrative problems|0
7043417|NCT01743989|11128287|FG001|Treatment Phase|Administrative problems|0
7043418|NCT01743989|11128288|FG002|Treatment Phase|Administrative problems|1
7043419|NCT01743989|11128286|FG000|Treatment Phase|New cancer (CML) therapy|0
7043420|NCT01743989|11128287|FG001|Treatment Phase|New cancer (CML) therapy|1
7043421|NCT01743989|11128288|FG002|Treatment Phase|New cancer (CML) therapy|0
7043422|NCT01743989|11128286|FG000|Treatment Phase|Physician Decision|0
7043423|NCT01743989|11128287|FG001|Treatment Phase|Physician Decision|0
7043424|NCT01743989|11128288|FG002|Treatment Phase|Physician Decision|3
7043425|NCT01743989|11128286|FG000|Treatment Phase|Patient non-compliance to treatment|0
7043426|NCT01743989|11128287|FG001|Treatment Phase|Patient non-compliance to treatment|0
7043427|NCT01743989|11128288|FG002|Treatment Phase|Patient non-compliance to treatment|3
7043428|NCT01743989|11128286|FG000|Treatment Phase|Not randomized by mistake|0
7043429|NCT01743989|11128287|FG001|Treatment Phase|Not randomized by mistake|0
7043430|NCT01743989|11128288|FG002|Treatment Phase|Not randomized by mistake|1
7043431|NCT01743989|11128286|FG000|Treatment Phase|Included by mistake|0
7043432|NCT01743989|11128287|FG001|Treatment Phase|Included by mistake|0
7043433|NCT01743989|11128288|FG002|Treatment Phase|Included by mistake|1
7043434|NCT01743989|11128286|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82
7043435|NCT01743989|11128287|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59
7043436|NCT01743989|11128288|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0
7043437|NCT01743989|11128286|FG000|TFR Phase|Adverse Event|0
7043438|NCT01743989|11128287|FG001|TFR Phase|Adverse Event|1
7043439|NCT01743989|11128288|FG002|TFR Phase|Adverse Event|0
7043440|NCT01743989|11128286|FG000|TFR Phase|Lost to Follow-up|0
7043441|NCT01743989|11128287|FG001|TFR Phase|Lost to Follow-up|2
7043442|NCT01743989|11128288|FG002|TFR Phase|Lost to Follow-up|0
7043443|NCT01743989|11128286|FG000|TFR Phase|Physician Decision|0
7043444|NCT01743989|11128287|FG001|TFR Phase|Physician Decision|1
7043445|NCT01743989|11128288|FG002|TFR Phase|Physician Decision|0
7043446|NCT01743989|11128286|FG000|TFR Phase|Logistical problems|0
7043447|NCT01743989|11128287|FG001|TFR Phase|Logistical problems|2
7043448|NCT01743989|11128288|FG002|TFR Phase|Logistical problems|0
7043449|NCT01743989|11128286|FG000|TFR Phase|Protocol deviation|0
7043450|NCT01743989|11128287|FG001|TFR Phase|Protocol deviation|1
7043451|NCT01743989|11128288|FG002|TFR Phase|Protocol deviation|0
7043452|NCT01743989|11128286|FG000|TFR Phase|Withdrawal by Subject|0
7043453|NCT01743989|11128287|FG001|TFR Phase|Withdrawal by Subject|2
7043454|NCT01743989|11128288|FG002|TFR Phase|Withdrawal by Subject|0
7043455|NCT01743989|11128286|FG000|Re-treatment Phase|Adverse Event|8
7043456|NCT01743989|11128287|FG001|Re-treatment Phase|Adverse Event|4
7043457|NCT01743989|11128288|FG002|Re-treatment Phase|Adverse Event|0
7043458|NCT01743989|11128286|FG000|Re-treatment Phase|Death|1
7043459|NCT01743989|11128287|FG001|Re-treatment Phase|Death|1
7043460|NCT01743989|11128288|FG002|Re-treatment Phase|Death|0
7043461|NCT01743989|11128286|FG000|Re-treatment Phase|Administrative problems|1
7043462|NCT01743989|11128287|FG001|Re-treatment Phase|Administrative problems|1
7043463|NCT01743989|11128288|FG002|Re-treatment Phase|Administrative problems|0
7043464|NCT01743989|11128286|FG000|Re-treatment Phase|Withdrawal by Subject|5
7043465|NCT01743989|11128287|FG001|Re-treatment Phase|Withdrawal by Subject|1
7043466|NCT01743989|11128288|FG002|Re-treatment Phase|Withdrawal by Subject|0
7043467|NCT01743989|11128286|FG000|Re-treatment Phase|Unstable MR|1
7043468|NCT01743989|11128287|FG001|Re-treatment Phase|Unstable MR|0
7043469|NCT01743989|11128288|FG002|Re-treatment Phase|Unstable MR|0
7043470|NCT01743989|11128286|FG000|Re-treatment Phase|Physician Decision|0
7043471|NCT01743989|11128287|FG001|Re-treatment Phase|Physician Decision|1
7043472|NCT01743989|11128288|FG002|Re-treatment Phase|Physician Decision|0
7043473|NCT01743989|11128286|FG000|Re-treatment Phase|Lost to Follow-up|0
7043474|NCT01743989|11128287|FG001|Re-treatment Phase|Lost to Follow-up|1
7043475|NCT01743989|11128288|FG002|Re-treatment Phase|Lost to Follow-up|0
7043476|NCT01744197|11128301|FG000|Overall Study|Received 1 patch|2
7043477|NCT01744197|11128302|FG001|Overall Study|Received 1 patch|1
7043478|NCT01744197|11128301|FG000|Overall Study|No patch received|2
7043479|NCT01744197|11128302|FG001|Overall Study|No patch received|2
7043480|NCT01744392|11128328|FG000|Overall Study|Physician Decision|1
7043481|NCT01744483|11128336|FG000|Overall Study|Death|9
7043482|NCT01744483|11128337|FG001|Overall Study|Death|4
7043483|NCT01744483|11128338|FG002|Overall Study|Death|11
7043484|NCT01744483|11128336|FG000|Overall Study|Lost to Follow-up|8
7043485|NCT01744483|11128337|FG001|Overall Study|Lost to Follow-up|9
7043486|NCT01744483|11128338|FG002|Overall Study|Lost to Follow-up|11
7043487|NCT01744483|11128336|FG000|Overall Study|Protocol Violation|1
7043488|NCT01744483|11128337|FG001|Overall Study|Protocol Violation|2
7043489|NCT01744483|11128338|FG002|Overall Study|Protocol Violation|1
7012083|NCT01474993|11081518|FG000|Overall Study|Lost to Follow-up|1
7012084|NCT01474993|11081519|FG001|Overall Study|Lost to Follow-up|2
7012085|NCT01474993|11081518|FG000|Overall Study|Adverse Event|0
7012086|NCT01474993|11081519|FG001|Overall Study|Adverse Event|1
7012087|NCT01475071|11081527|FG000|Overall Study|Physician Decision|1
7012088|NCT01475071|11081527|FG000|Overall Study|Withdrawal by Subject|6
7012089|NCT01475071|11081527|FG000|Overall Study|Lost to Follow-up|1
7012090|NCT01475097|11081535|FG000|Overall Study|Protocol Violation|1
7012091|NCT01475097|11081536|FG001|Overall Study|Protocol Violation|1
7012092|NCT01475136|11081546|FG000|Overall Study|Sponsor Decision|0
7012093|NCT01475136|11081547|FG001|Overall Study|Sponsor Decision|1
7012094|NCT01475136|11081548|FG002|Overall Study|Sponsor Decision|0
7012095|NCT01475136|11081549|FG003|Overall Study|Sponsor Decision|0
7012096|NCT01475136|11081546|FG000|Overall Study|Entry Criteria Not Met|0
7012097|NCT01475136|11081547|FG001|Overall Study|Entry Criteria Not Met|2
7012098|NCT01475136|11081548|FG002|Overall Study|Entry Criteria Not Met|3
7012099|NCT01475136|11081549|FG003|Overall Study|Entry Criteria Not Met|1
7012100|NCT01475136|11081546|FG000|Overall Study|Withdrawal by Subject|0
7012101|NCT01475136|11081547|FG001|Overall Study|Withdrawal by Subject|0
7012102|NCT01475136|11081548|FG002|Overall Study|Withdrawal by Subject|0
7012103|NCT01475136|11081549|FG003|Overall Study|Withdrawal by Subject|2
7012104|NCT01475136|11081546|FG000|Overall Study|Adverse Event|1
7012105|NCT01475136|11081547|FG001|Overall Study|Adverse Event|0
7012106|NCT01475136|11081548|FG002|Overall Study|Adverse Event|0
7012107|NCT01475136|11081549|FG003|Overall Study|Adverse Event|1
7012108|NCT01475136|11081546|FG000|Overall Study|Death|0
7012109|NCT01475136|11081547|FG001|Overall Study|Death|0
7012110|NCT01475136|11081548|FG002|Overall Study|Death|0
7012111|NCT01475136|11081549|FG003|Overall Study|Death|1
7012112|NCT01475162|11081559|FG000|Overall Study|Physician Decision|1
7012113|NCT01475162|11081559|FG000|Overall Study|Death|10
7012114|NCT01475162|11081559|FG000|Overall Study|Study closed for safety|3
7012115|NCT01475214|11081571|FG000|Overall Study|Lost to Follow-up|1
7012116|NCT01475214|11081572|FG001|Overall Study|Lost to Follow-up|0
7012117|NCT01475214|11081573|FG002|Overall Study|Lost to Follow-up|1
7012118|NCT01475214|11081571|FG000|Overall Study|Physician Decision|2
7012119|NCT01475214|11081572|FG001|Overall Study|Physician Decision|0
7012120|NCT01475214|11081573|FG002|Overall Study|Physician Decision|0
7012121|NCT01475214|11081571|FG000|Overall Study|Withdrawal by Subject|2
7012122|NCT01475214|11081572|FG001|Overall Study|Withdrawal by Subject|4
7012123|NCT01475214|11081573|FG002|Overall Study|Withdrawal by Subject|1
7012124|NCT01475253|11081585|FG000|Randomized, Blinded Study|Withdrawal by Subject|1
7012125|NCT01475253|11081586|FG001|Randomized, Blinded Study|Withdrawal by Subject|1
7012126|NCT01475253|11081587|FG002|Randomized, Blinded Study|Withdrawal by Subject|0
7012127|NCT01475253|11081588|FG003|Randomized, Blinded Study|Withdrawal by Subject|0
7012128|NCT01475253|11081585|FG000|Randomized, Blinded Study|Lost to Follow-up|1
7012129|NCT01475253|11081586|FG001|Randomized, Blinded Study|Lost to Follow-up|0
7012130|NCT01475253|11081587|FG002|Randomized, Blinded Study|Lost to Follow-up|0
7012131|NCT01475253|11081588|FG003|Randomized, Blinded Study|Lost to Follow-up|0
7012132|NCT01475331|11081608|FG000|Overall Study|Osteophyte obstruction of the proximal|1
7012133|NCT01475331|11081609|FG001|Overall Study|Osteophyte obstruction of the proximal|0
7012134|NCT01475331|11081608|FG000|Overall Study|excessive main duct communication|1
7012135|NCT01475331|11081609|FG001|Overall Study|excessive main duct communication|1
7012136|NCT01475331|11081608|FG000|Overall Study|Loss of needle positioning due pt. cough|1
7012137|NCT01475331|11081609|FG001|Overall Study|Loss of needle positioning due pt. cough|0
7012138|NCT01475331|11081608|FG000|Overall Study|Sign of malignancy during the procedure|2
7012139|NCT01475331|11081609|FG001|Overall Study|Sign of malignancy during the procedure|0
7012140|NCT01475331|11081608|FG000|Overall Study|cyst found to be prohibitively small|0
7012141|NCT01475331|11081609|FG001|Overall Study|cyst found to be prohibitively small|1
7012142|NCT01475370|11081618|FG000|Overall Study|Exacerbation of primary disease|2
7012143|NCT01475370|11081619|FG001|Overall Study|Exacerbation of primary disease|2
7012144|NCT01475370|11081620|FG002|Overall Study|Exacerbation of primary disease|2
7012145|NCT01475370|11081618|FG000|Overall Study|Study drug administration difficult|0
7012146|NCT01475370|11081619|FG001|Overall Study|Study drug administration difficult|1
7012147|NCT01475370|11081620|FG002|Overall Study|Study drug administration difficult|1
7012148|NCT01475370|11081618|FG000|Overall Study|Other than specified|1
7012149|NCT01475370|11081619|FG001|Overall Study|Other than specified|0
7012150|NCT01475370|11081620|FG002|Overall Study|Other than specified|0
7012151|NCT01475461|11081634|FG000|Run-in Period|Not meet eligibility criteria|16
7012152|NCT01475461|11081635|FG001|Run-in Period|Not meet eligibility criteria|0
7012153|NCT01475461|11081636|FG002|Run-in Period|Not meet eligibility criteria|0
7012154|NCT01475461|11081637|FG003|Run-in Period|Not meet eligibility criteria|0
7012155|NCT01475461|11081638|FG004|Run-in Period|Not meet eligibility criteria|0
7012156|NCT01475461|11081639|FG005|Run-in Period|Not meet eligibility criteria|0
7012157|NCT01475461|11081640|FG006|Run-in Period|Not meet eligibility criteria|0
7012158|NCT01475461|11081634|FG000|Run-in Period|Lost to Follow-up|7
7012159|NCT01475461|11081635|FG001|Run-in Period|Lost to Follow-up|0
7012160|NCT01475461|11081636|FG002|Run-in Period|Lost to Follow-up|0
7012161|NCT01475461|11081637|FG003|Run-in Period|Lost to Follow-up|0
7012162|NCT01475461|11081638|FG004|Run-in Period|Lost to Follow-up|0
7012163|NCT01475461|11081639|FG005|Run-in Period|Lost to Follow-up|0
7012164|NCT01475461|11081640|FG006|Run-in Period|Lost to Follow-up|0
7012165|NCT01475461|11081634|FG000|Run-in Period|Withdrawal by Subject|11
7012166|NCT01475461|11081635|FG001|Run-in Period|Withdrawal by Subject|0
7012167|NCT01475461|11081636|FG002|Run-in Period|Withdrawal by Subject|0
7012168|NCT01475461|11081637|FG003|Run-in Period|Withdrawal by Subject|0
7012169|NCT01475461|11081638|FG004|Run-in Period|Withdrawal by Subject|0
7012170|NCT01475461|11081639|FG005|Run-in Period|Withdrawal by Subject|0
7012171|NCT01475461|11081640|FG006|Run-in Period|Withdrawal by Subject|0
7012172|NCT01475461|11081634|FG000|Run-in Period|Other|3
7012173|NCT01475461|11081635|FG001|Run-in Period|Other|0
7012174|NCT01475461|11081636|FG002|Run-in Period|Other|0
7012175|NCT01475461|11081637|FG003|Run-in Period|Other|0
7012176|NCT01475461|11081638|FG004|Run-in Period|Other|0
7012177|NCT01475461|11081639|FG005|Run-in Period|Other|0
7012178|NCT01475461|11081640|FG006|Run-in Period|Other|0
7012179|NCT01475461|11081634|FG000|Run-in Period|Protocol Violation|4
7012180|NCT01475461|11081635|FG001|Run-in Period|Protocol Violation|0
7012181|NCT01475461|11081636|FG002|Run-in Period|Protocol Violation|0
7012182|NCT01475461|11081637|FG003|Run-in Period|Protocol Violation|0
7012183|NCT01475461|11081638|FG004|Run-in Period|Protocol Violation|0
7012184|NCT01475461|11081639|FG005|Run-in Period|Protocol Violation|0
7012185|NCT01475461|11081640|FG006|Run-in Period|Protocol Violation|0
7012186|NCT01475461|11081634|FG000|Treatment Period|Death|0
7012187|NCT01475461|11081635|FG001|Treatment Period|Death|0
7012188|NCT01475461|11081636|FG002|Treatment Period|Death|0
7012189|NCT01475461|11081637|FG003|Treatment Period|Death|1
7012190|NCT01475461|11081638|FG004|Treatment Period|Death|0
7012191|NCT01475461|11081639|FG005|Treatment Period|Death|0
7012192|NCT01475461|11081640|FG006|Treatment Period|Death|0
7012193|NCT01475461|11081634|FG000|Treatment Period|Lost to Follow-up|0
7012194|NCT01475461|11081635|FG001|Treatment Period|Lost to Follow-up|3
7012195|NCT01475461|11081636|FG002|Treatment Period|Lost to Follow-up|2
7012196|NCT01475461|11081637|FG003|Treatment Period|Lost to Follow-up|3
7012197|NCT01475461|11081638|FG004|Treatment Period|Lost to Follow-up|1
7012198|NCT01475461|11081639|FG005|Treatment Period|Lost to Follow-up|2
7012199|NCT01475461|11081640|FG006|Treatment Period|Lost to Follow-up|1
7012200|NCT01475461|11081634|FG000|Treatment Period|Withdrawal by Subject|0
7012201|NCT01475461|11081635|FG001|Treatment Period|Withdrawal by Subject|2
7012202|NCT01475461|11081636|FG002|Treatment Period|Withdrawal by Subject|2
7012203|NCT01475461|11081637|FG003|Treatment Period|Withdrawal by Subject|0
7012204|NCT01475461|11081638|FG004|Treatment Period|Withdrawal by Subject|2
7012205|NCT01475461|11081639|FG005|Treatment Period|Withdrawal by Subject|2
7012206|NCT01475461|11081640|FG006|Treatment Period|Withdrawal by Subject|0
7012207|NCT01475461|11081634|FG000|Treatment Period|Other|0
7012208|NCT01475461|11081635|FG001|Treatment Period|Other|1
7012209|NCT01475461|11081636|FG002|Treatment Period|Other|0
7012210|NCT01475461|11081637|FG003|Treatment Period|Other|0
7012211|NCT01475461|11081638|FG004|Treatment Period|Other|0
7012212|NCT01475461|11081639|FG005|Treatment Period|Other|0
7012213|NCT01475461|11081640|FG006|Treatment Period|Other|0
7012214|NCT01475461|11081634|FG000|Treatment Period|Protocol Violation|0
7012215|NCT01475461|11081635|FG001|Treatment Period|Protocol Violation|1
7012216|NCT01475461|11081636|FG002|Treatment Period|Protocol Violation|0
7012217|NCT01475461|11081637|FG003|Treatment Period|Protocol Violation|0
7012218|NCT01475461|11081638|FG004|Treatment Period|Protocol Violation|0
7012219|NCT01475461|11081639|FG005|Treatment Period|Protocol Violation|0
7012220|NCT01475461|11081640|FG006|Treatment Period|Protocol Violation|1
7012221|NCT01475461|11081634|FG000|Treatment Period|Lack of Efficacy|0
7012222|NCT01475461|11081635|FG001|Treatment Period|Lack of Efficacy|2
7012223|NCT01475461|11081636|FG002|Treatment Period|Lack of Efficacy|0
7012224|NCT01475461|11081637|FG003|Treatment Period|Lack of Efficacy|2
7012225|NCT01475461|11081638|FG004|Treatment Period|Lack of Efficacy|1
7012226|NCT01475461|11081639|FG005|Treatment Period|Lack of Efficacy|1
7012227|NCT01475461|11081640|FG006|Treatment Period|Lack of Efficacy|0
7012228|NCT01475461|11081634|FG000|Treatment Period|Medication Error|0
7012229|NCT01475461|11081635|FG001|Treatment Period|Medication Error|0
7012230|NCT01475461|11081636|FG002|Treatment Period|Medication Error|0
7012231|NCT01475461|11081637|FG003|Treatment Period|Medication Error|1
7012232|NCT01475461|11081638|FG004|Treatment Period|Medication Error|0
7012233|NCT01475461|11081639|FG005|Treatment Period|Medication Error|0
7012234|NCT01475461|11081640|FG006|Treatment Period|Medication Error|0
7012235|NCT01475461|11081634|FG000|Treatment Period|Adverse Event|0
7012236|NCT01475461|11081635|FG001|Treatment Period|Adverse Event|0
7012237|NCT01475461|11081636|FG002|Treatment Period|Adverse Event|0
7012238|NCT01475461|11081637|FG003|Treatment Period|Adverse Event|1
7012239|NCT01475461|11081638|FG004|Treatment Period|Adverse Event|0
7012240|NCT01475461|11081639|FG005|Treatment Period|Adverse Event|0
7012241|NCT01475461|11081640|FG006|Treatment Period|Adverse Event|0
7012242|NCT01475474|11081673|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4
7012243|NCT01475474|11081673|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2
7012244|NCT01475487|11081680|FG000|Overall Study|had to leave early for personal reasons|2
7012245|NCT01475487|11081681|FG001|Overall Study|had to leave early for personal reasons|1
7012246|NCT01475721|11081709|FG000|Overall Study|Death|3
7012247|NCT01475721|11081710|FG001|Overall Study|Death|6
7012248|NCT01475721|11081709|FG000|Overall Study|Withdrawal by Subject|8
7012249|NCT01475721|11081710|FG001|Overall Study|Withdrawal by Subject|8
7012250|NCT01475734|11081718|FG000|Overall Study|Withdrawal by Subject|1
7012251|NCT01475734|11081719|FG001|Overall Study|Withdrawal by Subject|0
7012252|NCT01475734|11081718|FG000|Overall Study|Protocol Violation|1
7012253|NCT01475734|11081719|FG001|Overall Study|Protocol Violation|0
7012254|NCT01475734|11081718|FG000|Overall Study|Physician Decision|0
7012255|NCT01475734|11081719|FG001|Overall Study|Physician Decision|1
7012256|NCT01475825|11081729|FG000|Overall Study|Adverse Event|41
7012257|NCT01475825|11081730|FG001|Overall Study|Adverse Event|15
7012258|NCT01475825|11081731|FG002|Overall Study|Adverse Event|27
7012259|NCT01475825|11081732|FG003|Overall Study|Adverse Event|11
7012260|NCT01475825|11081729|FG000|Overall Study|Death|1
7012261|NCT01475825|11081730|FG001|Overall Study|Death|0
7012262|NCT01475825|11081731|FG002|Overall Study|Death|1
7012263|NCT01475825|11081732|FG003|Overall Study|Death|0
7012264|NCT01475825|11081729|FG000|Overall Study|Lack of Efficacy|0
7012265|NCT01475825|11081730|FG001|Overall Study|Lack of Efficacy|0
7012266|NCT01475825|11081731|FG002|Overall Study|Lack of Efficacy|1
7012267|NCT01475825|11081732|FG003|Overall Study|Lack of Efficacy|0
7012268|NCT01475825|11081729|FG000|Overall Study|Lost to Follow-up|0
7012269|NCT01475825|11081730|FG001|Overall Study|Lost to Follow-up|0
7012270|NCT01475825|11081731|FG002|Overall Study|Lost to Follow-up|3
7012271|NCT01475825|11081732|FG003|Overall Study|Lost to Follow-up|1
7012272|NCT01475825|11081729|FG000|Overall Study|Non-compliance with Study Drug|1
7012273|NCT01475825|11081730|FG001|Overall Study|Non-compliance with Study Drug|2
7012274|NCT01475825|11081731|FG002|Overall Study|Non-compliance with Study Drug|4
7012275|NCT01475825|11081732|FG003|Overall Study|Non-compliance with Study Drug|0
7012276|NCT01475825|11081729|FG000|Overall Study|Other: Not available|0
7012277|NCT01475825|11081730|FG001|Overall Study|Other: Not available|0
7012278|NCT01475825|11081731|FG002|Overall Study|Other: Not available|2
7012279|NCT01475825|11081732|FG003|Overall Study|Other: Not available|0
7012280|NCT01475825|11081729|FG000|Overall Study|Protocol Violation|1
7012281|NCT01475825|11081730|FG001|Overall Study|Protocol Violation|0
7012282|NCT01475825|11081731|FG002|Overall Study|Protocol Violation|0
7012283|NCT01475825|11081732|FG003|Overall Study|Protocol Violation|0
7012284|NCT01475825|11081729|FG000|Overall Study|Physician Decision|0
7012285|NCT01475825|11081730|FG001|Overall Study|Physician Decision|1
7012286|NCT01475825|11081731|FG002|Overall Study|Physician Decision|0
7012287|NCT01475825|11081732|FG003|Overall Study|Physician Decision|0
7012288|NCT01475825|11081729|FG000|Overall Study|Withdrawal by Subject|8
7012289|NCT01475825|11081730|FG001|Overall Study|Withdrawal by Subject|3
7012290|NCT01475825|11081731|FG002|Overall Study|Withdrawal by Subject|11
7012291|NCT01475825|11081732|FG003|Overall Study|Withdrawal by Subject|7
7012292|NCT01475825|11081729|FG000|Overall Study|Did not enter OLC|15
7012293|NCT01475825|11081730|FG001|Overall Study|Did not enter OLC|11
7012294|NCT01475825|11081731|FG002|Overall Study|Did not enter OLC|15
7012295|NCT01475825|11081732|FG003|Overall Study|Did not enter OLC|11
7012296|NCT01475838|11081744|FG000|Randomized Phase|Randomized but Not Treated|0
7012297|NCT01475838|11081745|FG001|Randomized Phase|Randomized but Not Treated|5
7012298|NCT01475838|11081744|FG000|Randomized Phase|Adverse Event|6
7012299|NCT01475838|11081745|FG001|Randomized Phase|Adverse Event|1
7012300|NCT01475838|11081744|FG000|Randomized Phase|Pregnancy|0
7012301|NCT01475838|11081745|FG001|Randomized Phase|Pregnancy|1
7012302|NCT01475838|11081744|FG000|Randomized Phase|Investigators Discretion|1
7012303|NCT01475838|11081745|FG001|Randomized Phase|Investigators Discretion|2
7012304|NCT01475838|11081744|FG000|Randomized Phase|Withdrew Consent|10
7012305|NCT01475838|11081745|FG001|Randomized Phase|Withdrew Consent|14
7012306|NCT01475838|11081744|FG000|Randomized Phase|Lost to Follow-up|3
7012307|NCT01475838|11081745|FG001|Randomized Phase|Lost to Follow-up|4
7012308|NCT01475838|11081744|FG000|Randomized Phase|Participant Noncompliance|1
7012309|NCT01475838|11081745|FG001|Randomized Phase|Participant Noncompliance|5
7012310|NCT01475838|11081744|FG000|Randomized Phase|Protocol Violation|9
7012311|NCT01475838|11081745|FG001|Randomized Phase|Protocol Violation|4
7012312|NCT01475838|11081744|FG000|Extension Phase|Participant Noncompliance|1
7012313|NCT01475838|11081745|FG001|Extension Phase|Participant Noncompliance|0
7012314|NCT01475851|11081754|FG000|Overall Study|Protocol defined stopping criteria|1
7012315|NCT01475851|11081755|FG001|Overall Study|Protocol defined stopping criteria|0
7012316|NCT01476475|11081839|FG000|Overall Study|Adverse Event|6
7012317|NCT01476475|11081840|FG001|Overall Study|Adverse Event|0
7012318|NCT01476475|11081839|FG000|Overall Study|Poor compliance to protocol|1
7012319|NCT01476475|11081840|FG001|Overall Study|Poor compliance to protocol|1
7012320|NCT01476475|11081839|FG000|Overall Study|Other reasons|4
7012321|NCT01476475|11081840|FG001|Overall Study|Other reasons|2
7012322|NCT01476644|11081847|FG000|Overall Study|Death|5
7012323|NCT01476644|11081847|FG000|Overall Study|moved to another state|2
7012324|NCT01476644|11081847|FG000|Overall Study|Lost to Follow-up|19
7012325|NCT01476644|11081847|FG000|Overall Study|Withdrawal by Subject|13
7012326|NCT01476696|11081852|FG000|Overall Study|Sponsor decision|2
7012327|NCT01476696|11081853|FG001|Overall Study|Sponsor decision|1
7012328|NCT01476696|11081854|FG002|Overall Study|Sponsor decision|0
7012329|NCT01476696|11081852|FG000|Overall Study|Withdrawal by Subject|1
7012330|NCT01476696|11081853|FG001|Overall Study|Withdrawal by Subject|0
7012331|NCT01476696|11081854|FG002|Overall Study|Withdrawal by Subject|0
7012332|NCT01476722|11081867|FG000|Overall Study|Adverse Event|1
7012333|NCT01477333|11081893|FG000|Overall Study|Adverse Event|1
7012334|NCT01477333|11081893|FG000|Overall Study|Withdrawal by Subject|1
7012335|NCT01477333|11081893|FG000|Overall Study|Clinical Deterioration|1
7012336|NCT01477749|11081967|FG000|Overall Study|Physician Decision|4
7012337|NCT01477853|11081991|FG000|Phase A|Adverse Event|1
7012338|NCT01477853|11081992|FG001|Phase A|Adverse Event|2
7012339|NCT01477853|11081993|FG002|Phase A|Adverse Event|2
7012340|NCT01477853|11081991|FG000|Phase A|Lost to Follow-up|4
7012341|NCT01477853|11081992|FG001|Phase A|Lost to Follow-up|3
7012342|NCT01477853|11081993|FG002|Phase A|Lost to Follow-up|2
7012343|NCT01477853|11081991|FG000|Phase A|Physician Decision|1
7012344|NCT01477853|11081992|FG001|Phase A|Physician Decision|0
7012345|NCT01477853|11081993|FG002|Phase A|Physician Decision|1
7012346|NCT01477853|11081991|FG000|Phase A|Study terminated by sponsor|37
7012347|NCT01477853|11081992|FG001|Phase A|Study terminated by sponsor|40
7012348|NCT01477853|11081993|FG002|Phase A|Study terminated by sponsor|39
7012349|NCT01477853|11081991|FG000|Phase B|Lost to Follow-up|0
7012350|NCT01477853|11081992|FG001|Phase B|Lost to Follow-up|1
7012351|NCT01477853|11081993|FG002|Phase B|Lost to Follow-up|0
7012352|NCT01477853|11081991|FG000|Phase B|Study terminated by sponsor|12
7012353|NCT01477853|11081992|FG001|Phase B|Study terminated by sponsor|10
7012354|NCT01477853|11081993|FG002|Phase B|Study terminated by sponsor|11
7012355|NCT01477892|11082003|FG000|Overall Study|Withdrawal by Subject|0
7012356|NCT01477892|11082004|FG001|Overall Study|Withdrawal by Subject|2
7012357|NCT01478048|11082021|FG000|Overall Study|Disease Progression|52
7012358|NCT01478048|11082022|FG001|Overall Study|Disease Progression|35
7012359|NCT01478048|11082021|FG000|Overall Study|study drug toxicity|11
7012360|NCT01478048|11082022|FG001|Overall Study|study drug toxicity|14
7012361|NCT01478048|11082021|FG000|Overall Study|Adverse Event|2
7012362|NCT01478048|11082022|FG001|Overall Study|Adverse Event|11
7012363|NCT01478048|11082021|FG000|Overall Study|subject request to discontinue treatment|3
7012364|NCT01478048|11082022|FG001|Overall Study|subject request to discontinue treatment|5
7012365|NCT01478048|11082021|FG000|Overall Study|Withdrawal by Subject|2
7012366|NCT01478048|11082022|FG001|Overall Study|Withdrawal by Subject|5
7012367|NCT01478048|11082021|FG000|Overall Study|non-specified|6
7012368|NCT01478048|11082022|FG001|Overall Study|non-specified|4
7012369|NCT01478048|11082021|FG000|Overall Study|poor/non-compliance|0
7012370|NCT01478048|11082022|FG001|Overall Study|poor/non-compliance|1
7012371|NCT01478048|11082021|FG000|Overall Study|no longer meets study criteria|1
7012372|NCT01478048|11082022|FG001|Overall Study|no longer meets study criteria|0
7012373|NCT01478087|11082028|FG000|Overall Study|due to sponsor closing study|1
7012374|NCT01478321|11082043|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4
7012375|NCT01478321|11082043|FG000|Concurrent Therapy (5 Weeks)|Death|2
7012376|NCT01478321|11082043|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5
7012377|NCT01478321|11082043|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5
7012378|NCT01478321|11082043|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1
7012379|NCT01478321|11082043|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1
7012380|NCT01478321|11082043|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1
7012381|NCT01478321|11082043|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8
7012382|NCT01478347|11082047|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1
7012383|NCT01478347|11082047|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4
7012384|NCT01478347|11082047|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4
7012385|NCT01478360|11082053|FG000|Overall Study|Lost to Follow-up|1
7012386|NCT01478360|11082054|FG001|Overall Study|Lost to Follow-up|0
7012387|NCT01478360|11082053|FG000|Overall Study|Adverse Event|0
7012388|NCT01478360|11082054|FG001|Overall Study|Adverse Event|1
7012389|NCT01478360|11082053|FG000|Overall Study|Administrative problems|1
7012390|NCT01478360|11082054|FG001|Overall Study|Administrative problems|2
7012391|NCT01478373|11082060|FG000|Treatment Phase|Protocol Violation|1
7012392|NCT01478373|11082060|FG000|Survival Phase|Adverse Event|8
7012393|NCT01478373|11082060|FG000|Survival Phase|Protocol Violation|1
7012394|NCT01478373|11082060|FG000|Survival Phase|crossover to another study|2
7012395|NCT01478373|11082060|FG000|Survival Phase|Progressive Disease|27
7012396|NCT01478594|11082087|FG000|Overall Study|Randomized but Never Received Study Drug|0
7012397|NCT01478594|11082088|FG001|Overall Study|Randomized but Never Received Study Drug|1
7012398|NCT01478594|11082087|FG000|Overall Study|Death|45
7012399|NCT01478594|11082088|FG001|Overall Study|Death|18
7012400|NCT01478594|11082087|FG000|Overall Study|Lost to Follow-up|3
7012401|NCT01478594|11082088|FG001|Overall Study|Lost to Follow-up|1
7012402|NCT01478594|11082087|FG000|Overall Study|Withdrawal by Subject|9
7012403|NCT01478594|11082088|FG001|Overall Study|Withdrawal by Subject|3
7012404|NCT01478594|11082087|FG000|Overall Study|Study Closed by Sponsor|8
7012405|NCT01478594|11082088|FG001|Overall Study|Study Closed by Sponsor|5
7012406|NCT01478620|11082147|FG000|Overall Study|Lost to Follow-up|6
7012407|NCT01478828|11082151|FG000|Overall Study|Adverse Event|1
7012408|NCT01478958|11082163|FG000|Overall Study|Withdrawal by Subject|1
7012409|NCT01478958|11082164|FG001|Overall Study|Withdrawal by Subject|1
7012410|NCT01478958|11082165|FG002|Overall Study|Withdrawal by Subject|1
7012411|NCT01478958|11082163|FG000|Overall Study|Weight loss|1
7012412|NCT01478958|11082164|FG001|Overall Study|Weight loss|0
7012413|NCT01478958|11082165|FG002|Overall Study|Weight loss|0
7012414|NCT01478958|11082163|FG000|Overall Study|Re-located|0
7012415|NCT01478958|11082164|FG001|Overall Study|Re-located|1
7012416|NCT01478958|11082165|FG002|Overall Study|Re-located|0
7012417|NCT01478958|11082163|FG000|Overall Study|Unable to comply|0
7012418|NCT01478958|11082164|FG001|Overall Study|Unable to comply|0
7012419|NCT01478958|11082165|FG002|Overall Study|Unable to comply|2
7012420|NCT01478971|11082173|FG000|Standard of Care Period|Adverse Event|1
7012421|NCT01478971|11082173|FG000|Standard of Care Period|Withdrawal by Subject|3
7012422|NCT01478971|11082173|FG000|Standard of Care Period|Death|8
7012423|NCT01478971|11082173|FG000|Standard of Care Period|Lost to Follow-up|9
7012424|NCT01478971|11082173|FG000|Standard of Care Period|Other|4
7012425|NCT01478971|11082173|FG000|Peginesatide Treatment Period|Adverse Event|1
7012426|NCT01478971|11082173|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1
7012427|NCT01478971|11082173|FG000|Peginesatide Treatment Period|Death|4
7012428|NCT01478971|11082173|FG000|Peginesatide Treatment Period|Lost to Follow-up|4
7012429|NCT01478971|11082173|FG000|Peginesatide Treatment Period|Other|4
7012430|NCT01479374|11082209|FG000|Overall Study|Adverse Event|2
7012431|NCT01479374|11082210|FG001|Overall Study|Adverse Event|1
7012432|NCT01479374|11082211|FG002|Overall Study|Adverse Event|0
7012433|NCT01479374|11082209|FG000|Overall Study|Lost to Follow-up|1
7012434|NCT01479374|11082210|FG001|Overall Study|Lost to Follow-up|2
7012435|NCT01479374|11082211|FG002|Overall Study|Lost to Follow-up|0
7012436|NCT01479374|11082209|FG000|Overall Study|Decision Unrelated to Adverse Event|0
7012437|NCT01479374|11082210|FG001|Overall Study|Decision Unrelated to Adverse Event|1
7012438|NCT01479374|11082211|FG002|Overall Study|Decision Unrelated to Adverse Event|0
7012439|NCT01479374|11082209|FG000|Overall Study|Other|0
7012440|NCT01479374|11082210|FG001|Overall Study|Other|4
7012441|NCT01479374|11082211|FG002|Overall Study|Other|5
7012442|NCT01479439|11082231|FG000|Overall Study|Adverse Event|1
7012443|NCT01479439|11082232|FG001|Overall Study|Adverse Event|0
7012444|NCT01479439|11082233|FG002|Overall Study|Adverse Event|0
7012445|NCT01479439|11082231|FG000|Overall Study|Lost to Follow-up|0
7012446|NCT01479439|11082232|FG001|Overall Study|Lost to Follow-up|1
7012447|NCT01479439|11082233|FG002|Overall Study|Lost to Follow-up|0
7012448|NCT01479439|11082231|FG000|Overall Study|Protocol Violation|0
7012449|NCT01479439|11082232|FG001|Overall Study|Protocol Violation|0
7012450|NCT01479439|11082233|FG002|Overall Study|Protocol Violation|2
7012451|NCT01479465|11082248|FG000|Overall Study|Disease Progression|9
7012452|NCT01479465|11082249|FG001|Overall Study|Disease Progression|61
7012453|NCT01479465|11082250|FG002|Overall Study|Disease Progression|65
7012454|NCT01479465|11082251|FG003|Overall Study|Disease Progression|70
7012455|NCT01479465|11082248|FG000|Overall Study|Study Discontinued by Sponsor|0
7012456|NCT01479465|11082249|FG001|Overall Study|Study Discontinued by Sponsor|7
7012457|NCT01479465|11082250|FG002|Overall Study|Study Discontinued by Sponsor|5
7012458|NCT01479465|11082251|FG003|Overall Study|Study Discontinued by Sponsor|3
7012459|NCT01479465|11082248|FG000|Overall Study|Adverse Event|0
7012460|NCT01479465|11082249|FG001|Overall Study|Adverse Event|3
7012461|NCT01479465|11082250|FG002|Overall Study|Adverse Event|6
7012462|NCT01479465|11082251|FG003|Overall Study|Adverse Event|4
7012463|NCT01479465|11082248|FG000|Overall Study|Investigator Discretion|1
7012464|NCT01479465|11082249|FG001|Overall Study|Investigator Discretion|4
7012465|NCT01479465|11082250|FG002|Overall Study|Investigator Discretion|2
7012466|NCT01479465|11082251|FG003|Overall Study|Investigator Discretion|4
7012467|NCT01479465|11082248|FG000|Overall Study|Subject Request|1
7012468|NCT01479465|11082249|FG001|Overall Study|Subject Request|3
7012469|NCT01479465|11082250|FG002|Overall Study|Subject Request|4
7012470|NCT01479465|11082251|FG003|Overall Study|Subject Request|2
7012471|NCT01479465|11082248|FG000|Overall Study|Subject Withdrew Consent|0
7012472|NCT01479465|11082249|FG001|Overall Study|Subject Withdrew Consent|5
7012473|NCT01479465|11082250|FG002|Overall Study|Subject Withdrew Consent|2
7012474|NCT01479465|11082251|FG003|Overall Study|Subject Withdrew Consent|1
7012475|NCT01479465|11082248|FG000|Overall Study|Protocol Violation|0
7012476|NCT01479465|11082249|FG001|Overall Study|Protocol Violation|1
7012477|NCT01479465|11082250|FG002|Overall Study|Protocol Violation|1
7012478|NCT01479465|11082251|FG003|Overall Study|Protocol Violation|0
7012479|NCT01479465|11082248|FG000|Overall Study|Death|0
7012480|NCT01479465|11082249|FG001|Overall Study|Death|0
7012481|NCT01479465|11082250|FG002|Overall Study|Death|0
7012482|NCT01479465|11082251|FG003|Overall Study|Death|1
7012483|NCT01479465|11082248|FG000|Overall Study|Lost to Follow-up|0
7012484|NCT01479465|11082249|FG001|Overall Study|Lost to Follow-up|0
7012485|NCT01479465|11082250|FG002|Overall Study|Lost to Follow-up|1
7012486|NCT01479465|11082251|FG003|Overall Study|Lost to Follow-up|0
7012487|NCT01479530|11082285|FG000|Overall Study|Adverse Event|5
7012488|NCT01479530|11082286|FG001|Overall Study|Adverse Event|6
7012489|NCT01479530|11082285|FG000|Overall Study|Lack of Efficacy|0
7012490|NCT01479530|11082286|FG001|Overall Study|Lack of Efficacy|1
7012491|NCT01479530|11082285|FG000|Overall Study|Protocol Violation|2
7012492|NCT01479530|11082286|FG001|Overall Study|Protocol Violation|3
7012493|NCT01479530|11082285|FG000|Overall Study|Withdrawal of Consent|3
7012494|NCT01479530|11082286|FG001|Overall Study|Withdrawal of Consent|2
7012495|NCT01479595|11082315|FG000|Overall Study|Protocol deviation|0
7012496|NCT01479595|11082316|FG001|Overall Study|Protocol deviation|1
7012497|NCT01479595|11082315|FG000|Overall Study|Adverse Event|2
7012498|NCT01479595|11082316|FG001|Overall Study|Adverse Event|1
7012499|NCT01479621|11082328|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93
7012500|NCT01479621|11082329|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7012501|NCT01479621|11082330|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7012502|NCT01479621|11082331|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7012503|NCT01479621|11082332|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7012504|NCT01479621|11082333|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7012505|NCT01479621|11082334|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7012506|NCT01479621|11082328|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19
7012507|NCT01479621|11082329|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7012508|NCT01479621|11082330|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7012509|NCT01479621|11082331|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7012510|NCT01479621|11082332|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7012511|NCT01479621|11082333|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7012512|NCT01479621|11082334|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7012513|NCT01479621|11082328|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153
7012514|NCT01479621|11082329|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7012515|NCT01479621|11082330|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7012516|NCT01479621|11082331|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7012517|NCT01479621|11082332|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7012518|NCT01479621|11082333|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7012519|NCT01479621|11082334|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7012520|NCT01479621|11082328|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7
7012521|NCT01479621|11082329|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7012522|NCT01479621|11082330|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7012523|NCT01479621|11082331|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7012524|NCT01479621|11082332|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7012525|NCT01479621|11082333|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7012526|NCT01479621|11082334|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7012527|NCT01479621|11082328|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15
7012528|NCT01479621|11082329|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0
7012529|NCT01479621|11082330|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0
7012530|NCT01479621|11082331|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0
7012531|NCT01479621|11082332|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0
7012532|NCT01479621|11082333|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0
7012533|NCT01479621|11082334|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0
7012534|NCT01479621|11082328|FG000|Treatment Period|Adverse Event|0
7012535|NCT01479621|11082329|FG001|Treatment Period|Adverse Event|0
7012536|NCT01479621|11082330|FG002|Treatment Period|Adverse Event|0
7012537|NCT01479621|11082331|FG003|Treatment Period|Adverse Event|0
7012538|NCT01479621|11082332|FG004|Treatment Period|Adverse Event|1
7012539|NCT01479621|11082333|FG005|Treatment Period|Adverse Event|2
7012540|NCT01479621|11082334|FG006|Treatment Period|Adverse Event|2
7012541|NCT01479621|11082328|FG000|Treatment Period|Withdrawal by Subject|0
7012542|NCT01479621|11082329|FG001|Treatment Period|Withdrawal by Subject|4
7012543|NCT01479621|11082330|FG002|Treatment Period|Withdrawal by Subject|2
7012544|NCT01479621|11082331|FG003|Treatment Period|Withdrawal by Subject|2
7012545|NCT01479621|11082332|FG004|Treatment Period|Withdrawal by Subject|5
7012546|NCT01479621|11082333|FG005|Treatment Period|Withdrawal by Subject|5
7012547|NCT01479621|11082334|FG006|Treatment Period|Withdrawal by Subject|1
7012548|NCT01479621|11082328|FG000|Treatment Period|Physician Decision|0
7012549|NCT01479621|11082329|FG001|Treatment Period|Physician Decision|0
7012550|NCT01479621|11082330|FG002|Treatment Period|Physician Decision|0
7012551|NCT01479621|11082331|FG003|Treatment Period|Physician Decision|0
7012552|NCT01479621|11082332|FG004|Treatment Period|Physician Decision|1
7012553|NCT01479621|11082333|FG005|Treatment Period|Physician Decision|1
7012554|NCT01479621|11082334|FG006|Treatment Period|Physician Decision|0
7012555|NCT01479621|11082328|FG000|Treatment Period|Non-compliance to study drug|0
7012556|NCT01479621|11082329|FG001|Treatment Period|Non-compliance to study drug|1
7012557|NCT01479621|11082330|FG002|Treatment Period|Non-compliance to study drug|0
7012558|NCT01479621|11082331|FG003|Treatment Period|Non-compliance to study drug|0
7012559|NCT01479621|11082332|FG004|Treatment Period|Non-compliance to study drug|0
7012560|NCT01479621|11082333|FG005|Treatment Period|Non-compliance to study drug|0
7012561|NCT01479621|11082334|FG006|Treatment Period|Non-compliance to study drug|1
7012562|NCT01479621|11082328|FG000|Treatment Period|Protocol Violation|0
7012563|NCT01479621|11082329|FG001|Treatment Period|Protocol Violation|9
7012564|NCT01479621|11082330|FG002|Treatment Period|Protocol Violation|6
7012565|NCT01479621|11082331|FG003|Treatment Period|Protocol Violation|5
7012566|NCT01479621|11082332|FG004|Treatment Period|Protocol Violation|2
7012567|NCT01479621|11082333|FG005|Treatment Period|Protocol Violation|10
7012568|NCT01479621|11082334|FG006|Treatment Period|Protocol Violation|6
7012569|NCT01479621|11082328|FG000|Treatment Period|Pregnancy|0
7012570|NCT01479621|11082329|FG001|Treatment Period|Pregnancy|0
7012571|NCT01479621|11082330|FG002|Treatment Period|Pregnancy|2
7012572|NCT01479621|11082331|FG003|Treatment Period|Pregnancy|0
7012573|NCT01479621|11082332|FG004|Treatment Period|Pregnancy|0
7012574|NCT01479621|11082333|FG005|Treatment Period|Pregnancy|0
7012575|NCT01479621|11082334|FG006|Treatment Period|Pregnancy|0
7012576|NCT01479621|11082328|FG000|Treatment Period|Sponsor request subject to be withdrawn|0
7012577|NCT01479621|11082329|FG001|Treatment Period|Sponsor request subject to be withdrawn|2
7012578|NCT01479621|11082330|FG002|Treatment Period|Sponsor request subject to be withdrawn|3
7012579|NCT01479621|11082331|FG003|Treatment Period|Sponsor request subject to be withdrawn|1
7012580|NCT01479621|11082332|FG004|Treatment Period|Sponsor request subject to be withdrawn|1
7012581|NCT01479621|11082333|FG005|Treatment Period|Sponsor request subject to be withdrawn|1
7012582|NCT01479621|11082334|FG006|Treatment Period|Sponsor request subject to be withdrawn|3
7012583|NCT01479621|11082328|FG000|Treatment Period|Lost to Follow-up|0
7012584|NCT01479621|11082329|FG001|Treatment Period|Lost to Follow-up|0
7012585|NCT01479621|11082330|FG002|Treatment Period|Lost to Follow-up|1
7012586|NCT01479621|11082331|FG003|Treatment Period|Lost to Follow-up|0
7012587|NCT01479621|11082332|FG004|Treatment Period|Lost to Follow-up|2
7012588|NCT01479621|11082333|FG005|Treatment Period|Lost to Follow-up|2
7012589|NCT01479621|11082334|FG006|Treatment Period|Lost to Follow-up|1
7012590|NCT01479621|11082328|FG000|Treatment Period|Met stopping criteria|0
7012591|NCT01479621|11082329|FG001|Treatment Period|Met stopping criteria|8
7012592|NCT01479621|11082330|FG002|Treatment Period|Met stopping criteria|7
7012593|NCT01479621|11082331|FG003|Treatment Period|Met stopping criteria|4
7012594|NCT01479621|11082332|FG004|Treatment Period|Met stopping criteria|9
7012595|NCT01479621|11082333|FG005|Treatment Period|Met stopping criteria|20
7012596|NCT01479621|11082334|FG006|Treatment Period|Met stopping criteria|6
7012597|NCT01479764|11082359|FG000|Randomized|Adverse Event|1
7012598|NCT01479764|11082360|FG001|Randomized|Adverse Event|1
7012599|NCT01479764|11082359|FG000|Randomized|Withdrawal by Subject|1
7012600|NCT01479764|11082360|FG001|Randomized|Withdrawal by Subject|0
7012601|NCT01479764|11082359|FG000|Treated|Lost to Follow-up|0
7012602|NCT01479764|11082360|FG001|Treated|Lost to Follow-up|2
7012603|NCT01479777|11082366|FG000|Overall Study|Physician Decision|2
7012604|NCT01479868|11082370|FG000|Overall Study|Adverse Event|1
7012605|NCT01479868|11082370|FG000|Overall Study|Lost to Follow-up|4
7012606|NCT01479868|11082370|FG000|Overall Study|Protocol Violation|1
7012607|NCT01479868|11082370|FG000|Overall Study|Withdrawal by Subject|1
7012608|NCT01479868|11082370|FG000|Overall Study|Sponsor's Decision|1
7012609|NCT01479868|11082370|FG000|Overall Study|Initiation of new HCV Therapy|1
7012610|NCT01479985|11082376|FG000|Overall Study|Tablet malfunction, no data saved|1
7012611|NCT01479985|11082377|FG001|Overall Study|Tablet malfunction, no data saved|1
7012612|NCT01479985|11082376|FG000|Overall Study|No decisional conflict scale responses|0
7012613|NCT01479985|11082377|FG001|Overall Study|No decisional conflict scale responses|2
7012614|NCT01479985|11082376|FG000|Overall Study|No post-visit survey|5
7012615|NCT01479985|11082377|FG001|Overall Study|No post-visit survey|3
7012616|NCT01480076|11082385|FG000|Overall Study|Run-in Failure|52
7012617|NCT01480076|11082385|FG000|Overall Study|Adverse Event|39
7012618|NCT01480076|11082385|FG000|Overall Study|Death|2
7012619|NCT01480076|11082385|FG000|Overall Study|Disease Progression|5
7012620|NCT01480076|11082385|FG000|Overall Study|Non-compliance With Study Protocol|15
7012621|NCT01480076|11082385|FG000|Overall Study|Withdrawal by Subject|105
7012622|NCT01480076|11082385|FG000|Overall Study|Lost to Follow-up|7
7012623|NCT01480076|11082385|FG000|Overall Study|Investigator Decision|13
7012624|NCT01480076|11082385|FG000|Overall Study|Other|52
7012625|NCT01480258|11082438|FG000|Infant Series|Protocol Violation|2
7012626|NCT01480258|11082439|FG001|Infant Series|Protocol Violation|0
7012627|NCT01480258|11082438|FG000|Infant Series|Physician Decision|0
7012628|NCT01480258|11082439|FG001|Infant Series|Physician Decision|1
7012629|NCT01480258|11082438|FG000|Infant Series|Not Vaccinated|3
7012630|NCT01480258|11082439|FG001|Infant Series|Not Vaccinated|0
7012631|NCT01480258|11082438|FG000|Infant Series|Adverse Event|1
7012632|NCT01480258|11082439|FG001|Infant Series|Adverse Event|1
7012633|NCT01480258|11082438|FG000|Infant Series|Withdrawal by Subject|1
7012634|NCT01480258|11082439|FG001|Infant Series|Withdrawal by Subject|6
7012635|NCT01480258|11082438|FG000|Interim Period|Lost to Follow-up|0
7012636|NCT01480258|11082439|FG001|Interim Period|Lost to Follow-up|2
7012637|NCT01480258|11082438|FG000|Interim Period|Physician Decision|1
7012638|NCT01480258|11082439|FG001|Interim Period|Physician Decision|0
7012639|NCT01480258|11082438|FG000|Interim Period|Protocol Violation|0
7012640|NCT01480258|11082439|FG001|Interim Period|Protocol Violation|1
7012641|NCT01480258|11082438|FG000|Interim Period|Withdrawal by Subject|9
7012642|NCT01480258|11082439|FG001|Interim Period|Withdrawal by Subject|6
7012643|NCT01480284|11082447|FG000|Overall Study|Withdrawal by Subject|2
7012644|NCT01480284|11082448|FG001|Overall Study|Withdrawal by Subject|0
7012645|NCT01480284|11082447|FG000|Overall Study|Adverse Event|1
7012646|NCT01480284|11082448|FG001|Overall Study|Adverse Event|0
7012647|NCT01480284|11082447|FG000|Overall Study|Study closed/terminated|3
7012648|NCT01480284|11082448|FG001|Overall Study|Study closed/terminated|0
7012649|NCT01480284|11082447|FG000|Overall Study|Lost to Follow-up|1
7012650|NCT01480284|11082448|FG001|Overall Study|Lost to Follow-up|0
7012651|NCT01480284|11082447|FG000|Overall Study|Physician Decision|1
7012652|NCT01480284|11082448|FG001|Overall Study|Physician Decision|0
7012653|NCT01480596|11082460|FG000|Overall Study|Adverse Event|3
7012654|NCT01480596|11082461|FG001|Overall Study|Adverse Event|0
7012655|NCT01480596|11082460|FG000|Overall Study|MG exacerbation or change in medication|2
7012656|NCT01480596|11082461|FG001|Overall Study|MG exacerbation or change in medication|2
7012657|NCT01480674|11082467|FG000|Overall Study|Death|23
7012658|NCT01480674|11082467|FG000|Overall Study|Lost to Follow-up|2
7012659|NCT01480674|11082467|FG000|Overall Study|visit not done|10
7012660|NCT01481116|11082478|FG000|Overall Study|Adverse Event|26
7012661|NCT01481116|11082479|FG001|Overall Study|Adverse Event|26
7012662|NCT01481116|11082480|FG002|Overall Study|Adverse Event|42
7012663|NCT01481116|11082478|FG000|Overall Study|Major Protocol Deviation|3
7012664|NCT01481116|11082479|FG001|Overall Study|Major Protocol Deviation|7
7012665|NCT01481116|11082480|FG002|Overall Study|Major Protocol Deviation|1
7012666|NCT01481116|11082478|FG000|Overall Study|Lost to Follow-up|8
7012667|NCT01481116|11082479|FG001|Overall Study|Lost to Follow-up|12
7012668|NCT01481116|11082480|FG002|Overall Study|Lost to Follow-up|11
7012669|NCT01481116|11082478|FG000|Overall Study|Withdrawal by Subject|37
7012670|NCT01481116|11082479|FG001|Overall Study|Withdrawal by Subject|33
7012671|NCT01481116|11082480|FG002|Overall Study|Withdrawal by Subject|37
7012672|NCT01481116|11082478|FG000|Overall Study|Study Termination|730
7012673|NCT01481116|11082479|FG001|Overall Study|Study Termination|729
7012674|NCT01481116|11082480|FG002|Overall Study|Study Termination|713
7012675|NCT01481116|11082478|FG000|Overall Study|Pregnancy|0
7012676|NCT01481116|11082479|FG001|Overall Study|Pregnancy|0
7012677|NCT01481116|11082480|FG002|Overall Study|Pregnancy|1
7012678|NCT01481116|11082478|FG000|Overall Study|Lack of Efficacy|3
7012679|NCT01481116|11082479|FG001|Overall Study|Lack of Efficacy|3
7012680|NCT01481116|11082480|FG002|Overall Study|Lack of Efficacy|1
7012681|NCT01481116|11082478|FG000|Overall Study|Contraindications|1
7012682|NCT01481116|11082479|FG001|Overall Study|Contraindications|1
7012683|NCT01481116|11082480|FG002|Overall Study|Contraindications|0
7012684|NCT01481116|11082478|FG000|Overall Study|Other|1
7012685|NCT01481116|11082479|FG001|Overall Study|Other|1
7012686|NCT01481116|11082480|FG002|Overall Study|Other|0
7012687|NCT01481116|11082478|FG000|Overall Study|Participant Started Taking Glipizide|1
7012688|NCT01481116|11082479|FG001|Overall Study|Participant Started Taking Glipizide|0
7012689|NCT01481116|11082480|FG002|Overall Study|Participant Started Taking Glipizide|0
7012690|NCT01481116|11082478|FG000|Overall Study|Participant Moved Out of Area|2
7012691|NCT01481116|11082479|FG001|Overall Study|Participant Moved Out of Area|0
7012692|NCT01481116|11082480|FG002|Overall Study|Participant Moved Out of Area|1
7012693|NCT01481116|11082478|FG000|Overall Study|Participant Moved Out of Country|1
7012694|NCT01481116|11082479|FG001|Overall Study|Participant Moved Out of Country|0
7012695|NCT01481116|11082480|FG002|Overall Study|Participant Moved Out of Country|1
7012696|NCT01481116|11082478|FG000|Overall Study|Investigator Decision|3
7012697|NCT01481116|11082479|FG001|Overall Study|Investigator Decision|2
7012698|NCT01481116|11082480|FG002|Overall Study|Investigator Decision|1
7012699|NCT01481116|11082478|FG000|Overall Study|Sponsor Decision|0
7012700|NCT01481116|11082479|FG001|Overall Study|Sponsor Decision|1
7012701|NCT01481116|11082480|FG002|Overall Study|Sponsor Decision|3
7012702|NCT01481116|11082478|FG000|Overall Study|Non-Compliant With Study Drug|0
7012703|NCT01481116|11082479|FG001|Overall Study|Non-Compliant With Study Drug|1
7012704|NCT01481116|11082480|FG002|Overall Study|Non-Compliant With Study Drug|1
7012705|NCT01481116|11082478|FG000|Overall Study|Investigator's Discretion|2
7012706|NCT01481116|11082479|FG001|Overall Study|Investigator's Discretion|0
7012707|NCT01481116|11082480|FG002|Overall Study|Investigator's Discretion|0
7012708|NCT01481116|11082478|FG000|Overall Study|Death|2
7012709|NCT01481116|11082479|FG001|Overall Study|Death|1
7012710|NCT01481116|11082480|FG002|Overall Study|Death|0
7012711|NCT01481116|11082478|FG000|Overall Study|Hypoglycemic Event|4
7012712|NCT01481116|11082479|FG001|Overall Study|Hypoglycemic Event|0
7012713|NCT01481116|11082480|FG002|Overall Study|Hypoglycemic Event|0
7012714|NCT01481324|11082495|FG000|Overall Study|Missing Data|0
7012715|NCT01481324|11082496|FG001|Overall Study|Missing Data|2
7012716|NCT01481324|11082497|FG002|Overall Study|Missing Data|2
7012717|NCT01481779|11082540|FG000|Overall Study|Adverse Event|23
7012718|NCT01481779|11082541|FG001|Overall Study|Adverse Event|5
7012719|NCT01481779|11082540|FG000|Overall Study|Lost to Follow-up|3
7012720|NCT01481779|11082541|FG001|Overall Study|Lost to Follow-up|2
7012721|NCT01481779|11082540|FG000|Overall Study|Protocol Violation|2
7012722|NCT01481779|11082541|FG001|Overall Study|Protocol Violation|3
7012723|NCT01481779|11082540|FG000|Overall Study|Withdrawal by Subject|26
7012724|NCT01481779|11082541|FG001|Overall Study|Withdrawal by Subject|13
7012725|NCT01481779|11082540|FG000|Overall Study|Physician Decision|13
7012726|NCT01481779|11082541|FG001|Overall Study|Physician Decision|4
7012727|NCT01481779|11082540|FG000|Overall Study|Sponsor Decision|3
7012728|NCT01481779|11082541|FG001|Overall Study|Sponsor Decision|1
7012729|NCT01481896|11082547|FG000|Overall Study|Lost to Follow-up|12
7012730|NCT01482065|11082563|FG000|Overall Study|Withdrawal by Subject|0
7012731|NCT01482065|11082564|FG001|Overall Study|Withdrawal by Subject|1
7012732|NCT01482169|11082579|FG000|Overall Study|Physician Decision|2
7012733|NCT01482221|11082589|FG000|Overall Study|Lack of Efficacy|1
7012734|NCT01482221|11082590|FG001|Overall Study|Lack of Efficacy|0
7012735|NCT01482221|11082591|FG002|Overall Study|Lack of Efficacy|1
7012736|NCT01482221|11082589|FG000|Overall Study|Lost to Follow-up|3
7012737|NCT01482221|11082590|FG001|Overall Study|Lost to Follow-up|2
7012738|NCT01482221|11082591|FG002|Overall Study|Lost to Follow-up|1
7012739|NCT01482221|11082589|FG000|Overall Study|Study-Specific Withdrawal Criteria|2
7012740|NCT01482221|11082590|FG001|Overall Study|Study-Specific Withdrawal Criteria|0
7012741|NCT01482221|11082591|FG002|Overall Study|Study-Specific Withdrawal Criteria|1
7043490|NCT01744483|11128336|FG000|Overall Study|Withdrawal by Subject|4
7012742|NCT01482221|11082589|FG000|Overall Study|Condition under Investigation Worsened|3
7012743|NCT01482221|11082590|FG001|Overall Study|Condition under Investigation Worsened|2
7012744|NCT01482221|11082591|FG002|Overall Study|Condition under Investigation Worsened|4
7012745|NCT01482221|11082589|FG000|Overall Study|Severe Non-Compliance to Protocol|1
7012746|NCT01482221|11082590|FG001|Overall Study|Severe Non-Compliance to Protocol|0
7012747|NCT01482221|11082591|FG002|Overall Study|Severe Non-Compliance to Protocol|1
7012748|NCT01482221|11082589|FG000|Overall Study|Adverse Event|1
7012749|NCT01482221|11082590|FG001|Overall Study|Adverse Event|7
7012750|NCT01482221|11082591|FG002|Overall Study|Adverse Event|3
7012751|NCT01482221|11082589|FG000|Overall Study|Withdrawal by Subject|10
7012752|NCT01482221|11082590|FG001|Overall Study|Withdrawal by Subject|7
7012753|NCT01482221|11082591|FG002|Overall Study|Withdrawal by Subject|12
7012754|NCT01482221|11082589|FG000|Overall Study|Incorrect randomization|0
7012755|NCT01482221|11082590|FG001|Overall Study|Incorrect randomization|1
7012756|NCT01482221|11082591|FG002|Overall Study|Incorrect randomization|0
7012757|NCT01482221|11082589|FG000|Overall Study|Physician Decision|0
7012758|NCT01482221|11082590|FG001|Overall Study|Physician Decision|1
7012759|NCT01482221|11082591|FG002|Overall Study|Physician Decision|0
7012760|NCT01482312|11082599|FG000|Period 1, 90 Minutes of Wear|Other|1
7012761|NCT01482312|11082600|FG001|Period 1, 90 Minutes of Wear|Other|0
7012762|NCT01482312|11082601|FG002|Period 1, 90 Minutes of Wear|Other|0
7012763|NCT01482312|11082599|FG000|Period 2, 90 Minutes of Wear|Other|1
7012764|NCT01482312|11082600|FG001|Period 2, 90 Minutes of Wear|Other|0
7012765|NCT01482312|11082601|FG002|Period 2, 90 Minutes of Wear|Other|0
7012766|NCT01482429|11082621|FG000|Care Usual|Protocol Violation|0
7012767|NCT01482429|11082622|FG001|Care Usual|Protocol Violation|172
7012768|NCT01482429|11082621|FG000|Care Usual|Lost to Follow-up|0
7012769|NCT01482429|11082622|FG001|Care Usual|Lost to Follow-up|1
7012770|NCT01482429|11082621|FG000|Protocol|Protocol Violation|275
7012771|NCT01482429|11082622|FG001|Protocol|Protocol Violation|0
7043491|NCT01744483|11128337|FG001|Overall Study|Withdrawal by Subject|6
7043492|NCT01744483|11128338|FG002|Overall Study|Withdrawal by Subject|2
7043493|NCT01744483|11128336|FG000|Overall Study|No ICU Admit|5
7043494|NCT01744483|11128337|FG001|Overall Study|No ICU Admit|1
7043495|NCT01744483|11128338|FG002|Overall Study|No ICU Admit|2
7043496|NCT01744483|11128336|FG000|Overall Study|Routed to OSH|2
7043497|NCT01744483|11128337|FG001|Overall Study|Routed to OSH|0
7043498|NCT01744483|11128338|FG002|Overall Study|Routed to OSH|1
7043499|NCT01744496|11128348|FG000|Titration Period|Adverse Event|2
7043500|NCT01744496|11128349|FG001|Titration Period|Adverse Event|1
7043501|NCT01744496|11128348|FG000|Titration Period|Personal reasons|0
7043502|NCT01744496|11128349|FG001|Titration Period|Personal reasons|1
7043503|NCT01744496|11128348|FG000|Maintenance Period|Adverse Event|1
7043504|NCT01744496|11128349|FG001|Maintenance Period|Adverse Event|3
7043505|NCT01744496|11128348|FG000|Maintenance Period|Protocol Violation|1
7043506|NCT01744496|11128349|FG001|Maintenance Period|Protocol Violation|0
7043507|NCT01744496|11128348|FG000|Maintenance Period|Withdrawal by Subject|1
7043508|NCT01744496|11128349|FG001|Maintenance Period|Withdrawal by Subject|1
7043509|NCT01744496|11128348|FG000|Maintenance Period|Subject left town|1
7043510|NCT01744496|11128349|FG001|Maintenance Period|Subject left town|0
7043511|NCT01744665|11128372|FG000|Monitoring Phase|Adverse Event|4
7043512|NCT01744665|11128372|FG000|Monitoring Phase|Abnormal laboratory value(s)|1
7043513|NCT01744665|11128372|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7
7043514|NCT01744665|11128372|FG000|Monitoring Phase|Withdrawal by Subject|5
7043515|NCT01744665|11128372|FG000|Monitoring Phase|Did not achieve MR4.5|1
7043516|NCT01744665|11128372|FG000|Consolidation Phase|Adverse Event|2
7043517|NCT01744665|11128372|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4
7043518|NCT01744665|11128372|FG000|Consolidation Phase|Withdrawal by Subject|4
7043519|NCT01744665|11128372|FG000|Consolidation Phase|Administrative problems|9
7043520|NCT01744665|11128372|FG000|Re-initiation Phase|Administrative problems|10
7043521|NCT01744665|11128372|FG000|Re-initiation Phase|Adverse Event|1
7043522|NCT01744665|11128372|FG000|Re-initiation Phase|No longer required treatment|1
7043523|NCT01744665|11128372|FG000|Re-initiation Phase|Withdrawal by Subject|1
7043524|NCT01744691|11128379|FG000|Overall Study|Progressive Disease|18
7043525|NCT01744691|11128379|FG000|Overall Study|Unacceptable toxicity, AE or death|18
7043526|NCT01744691|11128379|FG000|Overall Study|Withdrawal of consent for treatment|3
7043527|NCT01744691|11128379|FG000|Overall Study|Physician Decision|4
7043528|NCT01744782|11128455|FG000|Overall Study|Death|1
7044897|NCT01760447|11131135|FG001|Weeks 0-20|Withdrawal by Subject|0
7044898|NCT01760447|11131136|FG002|Weeks 0-20|Withdrawal by Subject|1
7044899|NCT01760447|11131137|FG003|Weeks 0-20|Withdrawal by Subject|0
7044900|NCT01760447|11131134|FG000|Weeks 0-20|Lost to Follow-up|1
7044901|NCT01760447|11131135|FG001|Weeks 0-20|Lost to Follow-up|0
7044902|NCT01760447|11131136|FG002|Weeks 0-20|Lost to Follow-up|1
7044903|NCT01760447|11131137|FG003|Weeks 0-20|Lost to Follow-up|1
7044904|NCT01760447|11131134|FG000|Weeks 0-20|Randomized but not treated|0
7044905|NCT01760447|11131135|FG001|Weeks 0-20|Randomized but not treated|0
7044906|NCT01760447|11131136|FG002|Weeks 0-20|Randomized but not treated|2
7044907|NCT01760447|11131137|FG003|Weeks 0-20|Randomized but not treated|0
7044908|NCT01760447|11131134|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1
7044909|NCT01760447|11131135|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1
7044910|NCT01760447|11131136|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1
7012772|NCT01482767|11082696|FG000|Overall Study|Death|1
7012773|NCT01482767|11082697|FG001|Overall Study|Death|1
7012774|NCT01482767|11082696|FG000|Overall Study|Withdrawal by Subject|7
7012775|NCT01482767|11082697|FG001|Overall Study|Withdrawal by Subject|5
7012776|NCT01482767|11082696|FG000|Overall Study|Lost to Follow-up|12
7012777|NCT01482767|11082697|FG001|Overall Study|Lost to Follow-up|6
7012778|NCT01482767|11082696|FG000|Overall Study|Adverse Event|0
7012779|NCT01482767|11082697|FG001|Overall Study|Adverse Event|3
7012780|NCT01482767|11082696|FG000|Overall Study|Site closure|22
7012781|NCT01482767|11082697|FG001|Overall Study|Site closure|14
7012782|NCT01482767|11082696|FG000|Overall Study|Non-adherence to study requirements|4
7012783|NCT01482767|11082697|FG001|Overall Study|Non-adherence to study requirements|7
7012784|NCT01482767|11082696|FG000|Overall Study|Alternate HCV treatment|7
7012785|NCT01482767|11082697|FG001|Overall Study|Alternate HCV treatment|8
7012786|NCT01482767|11082696|FG000|Overall Study|Ineligible|0
7012787|NCT01482767|11082697|FG001|Overall Study|Ineligible|5
7012788|NCT01482767|11082696|FG000|Overall Study|Nurse error|1
7012789|NCT01482767|11082697|FG001|Overall Study|Nurse error|0
7012790|NCT01482819|11082703|FG000|Overall Study|Lost to Follow-up|2
7012791|NCT01482884|11082713|FG000|Overall Study|Medical decision due to lack of efficacy|0
7012792|NCT01482884|11082714|FG001|Overall Study|Medical decision due to lack of efficacy|1
7012793|NCT01482884|11082713|FG000|Overall Study|Protocol Violation|1
7012794|NCT01482884|11082714|FG001|Overall Study|Protocol Violation|0
7012795|NCT01482884|11082713|FG000|Overall Study|Lost to Follow-up|2
7012796|NCT01482884|11082714|FG001|Overall Study|Lost to Follow-up|2
7012797|NCT01482884|11082713|FG000|Overall Study|Lack of Efficacy|0
7012798|NCT01482884|11082714|FG001|Overall Study|Lack of Efficacy|1
7012799|NCT01482884|11082713|FG000|Overall Study|Adverse Event|2
7012800|NCT01482884|11082714|FG001|Overall Study|Adverse Event|1
7012801|NCT01482884|11082713|FG000|Overall Study|Withdrawal by Subject|8
7012802|NCT01482884|11082714|FG001|Overall Study|Withdrawal by Subject|13
7012803|NCT01482910|11082722|FG000|Overall Study|Adverse Event|6
7012804|NCT01482910|11082723|FG001|Overall Study|Adverse Event|5
7012805|NCT01482910|11082722|FG000|Overall Study|Lost to Follow-up|0
7012806|NCT01482910|11082723|FG001|Overall Study|Lost to Follow-up|1
7012807|NCT01482910|11082722|FG000|Overall Study|Protocol Violation|1
7012808|NCT01482910|11082723|FG001|Overall Study|Protocol Violation|1
7012809|NCT01482910|11082722|FG000|Overall Study|Withdrawal by Subject|7
7012810|NCT01482910|11082723|FG001|Overall Study|Withdrawal by Subject|2
7012811|NCT01482910|11082722|FG000|Overall Study|Death|1
7012812|NCT01482910|11082723|FG001|Overall Study|Death|0
7012813|NCT01482962|11082733|FG000|Overall Study|Progressive Disease|65
7012814|NCT01482962|11082734|FG001|Overall Study|Progressive Disease|53
7012815|NCT01482962|11082733|FG000|Overall Study|Unsatisfactory Therapeutic Response|37
7012816|NCT01482962|11082734|FG001|Overall Study|Unsatisfactory Therapeutic Response|23
7012817|NCT01482962|11082733|FG000|Overall Study|Adverse Event|18
7012818|NCT01482962|11082734|FG001|Overall Study|Adverse Event|22
7012819|NCT01482962|11082733|FG000|Overall Study|Withdrawal by Participant|8
7012820|NCT01482962|11082734|FG001|Overall Study|Withdrawal by Participant|13
7012821|NCT01482962|11082733|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3
7012822|NCT01482962|11082734|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9
7012823|NCT01482962|11082733|FG000|Overall Study|Other Reason|1
7012824|NCT01482962|11082734|FG001|Overall Study|Other Reason|5
7012825|NCT01482962|11082733|FG000|Overall Study|Study Terminated by Sponsor|5
7012826|NCT01482962|11082734|FG001|Overall Study|Study Terminated by Sponsor|2
7012827|NCT01482962|11082733|FG000|Overall Study|Did not Receive Study Drug|1
7012828|NCT01482962|11082734|FG001|Overall Study|Did not Receive Study Drug|6
7012829|NCT01483118|11082744|FG000|Overall Study|Lost to Follow-up|12
7012830|NCT01483118|11082745|FG001|Overall Study|Lost to Follow-up|16
7012831|NCT01483144|11082756|FG000|Overall Study|Adverse Event|9
7012832|NCT01483144|11082757|FG001|Overall Study|Adverse Event|4
7012833|NCT01483144|11082758|FG002|Overall Study|Adverse Event|6
7012834|NCT01483144|11082756|FG000|Overall Study|Withdrawal by Subject|0
7012835|NCT01483144|11082757|FG001|Overall Study|Withdrawal by Subject|2
7012836|NCT01483144|11082758|FG002|Overall Study|Withdrawal by Subject|5
7012837|NCT01483144|11082756|FG000|Overall Study|Physician Decision|1
7012838|NCT01483144|11082757|FG001|Overall Study|Physician Decision|0
7012839|NCT01483144|11082758|FG002|Overall Study|Physician Decision|0
7012840|NCT01483144|11082756|FG000|Overall Study|Lost to Follow-up|2
7012841|NCT01483144|11082757|FG001|Overall Study|Lost to Follow-up|4
7012842|NCT01483144|11082758|FG002|Overall Study|Lost to Follow-up|1
7012843|NCT01483144|11082756|FG000|Overall Study|Protocol Violation|3
7012844|NCT01483144|11082757|FG001|Overall Study|Protocol Violation|3
7012845|NCT01483144|11082758|FG002|Overall Study|Protocol Violation|3
7012846|NCT01483183|11082776|FG000|Overall Study|Physician Decision|0
7012847|NCT01483183|11082777|FG001|Overall Study|Physician Decision|0
7012848|NCT01483183|11082778|FG002|Overall Study|Physician Decision|0
7012849|NCT01483183|11082779|FG003|Overall Study|Physician Decision|0
7012850|NCT01483183|11082780|FG004|Overall Study|Physician Decision|0
7012851|NCT01483183|11082781|FG005|Overall Study|Physician Decision|0
7012852|NCT01483183|11082782|FG006|Overall Study|Physician Decision|2
7012853|NCT01483183|11082783|FG007|Overall Study|Physician Decision|0
7012854|NCT01483183|11082784|FG008|Overall Study|Physician Decision|0
7012855|NCT01483183|11082785|FG009|Overall Study|Physician Decision|0
7012856|NCT01483183|11082776|FG000|Overall Study|Withdrawal by Subject|0
7012857|NCT01483183|11082777|FG001|Overall Study|Withdrawal by Subject|0
7012858|NCT01483183|11082778|FG002|Overall Study|Withdrawal by Subject|0
7012859|NCT01483183|11082779|FG003|Overall Study|Withdrawal by Subject|0
7012860|NCT01483183|11082780|FG004|Overall Study|Withdrawal by Subject|0
7012861|NCT01483183|11082781|FG005|Overall Study|Withdrawal by Subject|0
7012862|NCT01483183|11082782|FG006|Overall Study|Withdrawal by Subject|0
7012863|NCT01483183|11082783|FG007|Overall Study|Withdrawal by Subject|0
7012864|NCT01483183|11082784|FG008|Overall Study|Withdrawal by Subject|0
7012865|NCT01483183|11082785|FG009|Overall Study|Withdrawal by Subject|1
7012866|NCT01483599|11082840|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2
7012867|NCT01483599|11082841|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0
7012868|NCT01483599|11082842|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0
7012869|NCT01483599|11082843|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1
7012870|NCT01483599|11082844|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1
7012871|NCT01483599|11082845|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4
7012872|NCT01483599|11082846|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3
7012873|NCT01483599|11082847|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0
7012874|NCT01483599|11082848|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0
7012875|NCT01483599|11082849|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0
7012876|NCT01483599|11082850|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0
7012877|NCT01483599|11082851|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0
7012878|NCT01483599|11082852|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0
7012879|NCT01483599|11082853|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0
7012880|NCT01483599|11082840|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7012881|NCT01483599|11082841|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
7012882|NCT01483599|11082842|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7012883|NCT01483599|11082843|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
7012884|NCT01483599|11082844|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7012885|NCT01483599|11082845|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7012886|NCT01483599|11082846|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
7012887|NCT01483599|11082847|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7012888|NCT01483599|11082848|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7012889|NCT01483599|11082849|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7012890|NCT01483599|11082850|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7012891|NCT01483599|11082851|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7012892|NCT01483599|11082852|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7012893|NCT01483599|11082853|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7012894|NCT01483599|11082840|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1
7012895|NCT01483599|11082841|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7012896|NCT01483599|11082842|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7012897|NCT01483599|11082843|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7012898|NCT01483599|11082844|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7012899|NCT01483599|11082845|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7012900|NCT01483599|11082846|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7012901|NCT01483599|11082847|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7012902|NCT01483599|11082848|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7012903|NCT01483599|11082849|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7012904|NCT01483599|11082850|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7012905|NCT01483599|11082851|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7012906|NCT01483599|11082852|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7012907|NCT01483599|11082853|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7012908|NCT01483599|11082840|FG000|Controlled Period (CP) (up to Week 16)|Other|0
7012909|NCT01483599|11082841|FG001|Controlled Period (CP) (up to Week 16)|Other|2
7012910|NCT01483599|11082842|FG002|Controlled Period (CP) (up to Week 16)|Other|0
7012911|NCT01483599|11082843|FG003|Controlled Period (CP) (up to Week 16)|Other|1
7012912|NCT01483599|11082844|FG004|Controlled Period (CP) (up to Week 16)|Other|1
7012913|NCT01483599|11082845|FG005|Controlled Period (CP) (up to Week 16)|Other|0
7012914|NCT01483599|11082846|FG006|Controlled Period (CP) (up to Week 16)|Other|0
7012915|NCT01483599|11082847|FG007|Controlled Period (CP) (up to Week 16)|Other|0
7012916|NCT01483599|11082848|FG008|Controlled Period (CP) (up to Week 16)|Other|0
7012917|NCT01483599|11082849|FG009|Controlled Period (CP) (up to Week 16)|Other|0
7012918|NCT01483599|11082850|FG010|Controlled Period (CP) (up to Week 16)|Other|0
7012919|NCT01483599|11082851|FG011|Controlled Period (CP) (up to Week 16)|Other|0
7012920|NCT01483599|11082852|FG012|Controlled Period (CP) (up to Week 16)|Other|0
7012921|NCT01483599|11082853|FG013|Controlled Period (CP) (up to Week 16)|Other|0
7012922|NCT01483599|11082840|FG000|After Controlled Period(Week 16-Week 40)|Death|0
7012923|NCT01483599|11082841|FG001|After Controlled Period(Week 16-Week 40)|Death|0
7012924|NCT01483599|11082842|FG002|After Controlled Period(Week 16-Week 40)|Death|0
7012925|NCT01483599|11082843|FG003|After Controlled Period(Week 16-Week 40)|Death|0
7012926|NCT01483599|11082844|FG004|After Controlled Period(Week 16-Week 40)|Death|0
7012927|NCT01483599|11082845|FG005|After Controlled Period(Week 16-Week 40)|Death|0
7012928|NCT01483599|11082846|FG006|After Controlled Period(Week 16-Week 40)|Death|0
7012929|NCT01483599|11082847|FG007|After Controlled Period(Week 16-Week 40)|Death|0
7012930|NCT01483599|11082848|FG008|After Controlled Period(Week 16-Week 40)|Death|1
7012931|NCT01483599|11082849|FG009|After Controlled Period(Week 16-Week 40)|Death|0
7012932|NCT01483599|11082850|FG010|After Controlled Period(Week 16-Week 40)|Death|0
7012933|NCT01483599|11082851|FG011|After Controlled Period(Week 16-Week 40)|Death|0
7012934|NCT01483599|11082852|FG012|After Controlled Period(Week 16-Week 40)|Death|0
7012935|NCT01483599|11082853|FG013|After Controlled Period(Week 16-Week 40)|Death|0
7012936|NCT01483599|11082840|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7012937|NCT01483599|11082841|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7012938|NCT01483599|11082842|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7012939|NCT01483599|11082843|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7012940|NCT01483599|11082844|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7012941|NCT01483599|11082845|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7012942|NCT01483599|11082846|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7012943|NCT01483599|11082847|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1
7012944|NCT01483599|11082848|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1
7012945|NCT01483599|11082849|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7012946|NCT01483599|11082850|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7012947|NCT01483599|11082851|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7012948|NCT01483599|11082852|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1
7012949|NCT01483599|11082853|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1
7012950|NCT01483599|11082840|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7012951|NCT01483599|11082841|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7012952|NCT01483599|11082842|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7012953|NCT01483599|11082843|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7012954|NCT01483599|11082844|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7012955|NCT01483599|11082845|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7012956|NCT01483599|11082846|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7012957|NCT01483599|11082847|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7012958|NCT01483599|11082848|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
7012959|NCT01483599|11082849|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7012960|NCT01483599|11082850|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7012961|NCT01483599|11082851|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
7012962|NCT01483599|11082852|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7012963|NCT01483599|11082853|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
7012964|NCT01483599|11082840|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7012965|NCT01483599|11082841|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7012966|NCT01483599|11082842|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7012967|NCT01483599|11082843|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7012968|NCT01483599|11082844|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7012969|NCT01483599|11082845|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7012970|NCT01483599|11082846|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7012971|NCT01483599|11082847|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7012972|NCT01483599|11082848|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
7012973|NCT01483599|11082849|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7012974|NCT01483599|11082850|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2
7012975|NCT01483599|11082851|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7012976|NCT01483599|11082852|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7012977|NCT01483599|11082853|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
7012978|NCT01483599|11082840|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7012979|NCT01483599|11082841|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7012980|NCT01483599|11082842|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7012981|NCT01483599|11082843|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7012982|NCT01483599|11082844|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7012983|NCT01483599|11082845|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7012984|NCT01483599|11082846|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7012985|NCT01483599|11082847|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7012986|NCT01483599|11082848|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5
7012987|NCT01483599|11082849|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7012988|NCT01483599|11082850|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7012989|NCT01483599|11082851|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7012990|NCT01483599|11082852|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1
7012991|NCT01483599|11082853|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4
7012992|NCT01483599|11082840|FG000|After Controlled Period(Week 16-Week 40)|Other|0
7012993|NCT01483599|11082841|FG001|After Controlled Period(Week 16-Week 40)|Other|0
7012994|NCT01483599|11082842|FG002|After Controlled Period(Week 16-Week 40)|Other|0
7012995|NCT01483599|11082843|FG003|After Controlled Period(Week 16-Week 40)|Other|0
7012996|NCT01483599|11082844|FG004|After Controlled Period(Week 16-Week 40)|Other|0
7012997|NCT01483599|11082845|FG005|After Controlled Period(Week 16-Week 40)|Other|0
7012998|NCT01483599|11082846|FG006|After Controlled Period(Week 16-Week 40)|Other|0
7012999|NCT01483599|11082847|FG007|After Controlled Period(Week 16-Week 40)|Other|1
7013000|NCT01483599|11082848|FG008|After Controlled Period(Week 16-Week 40)|Other|0
7013001|NCT01483599|11082849|FG009|After Controlled Period(Week 16-Week 40)|Other|4
7013002|NCT01483599|11082850|FG010|After Controlled Period(Week 16-Week 40)|Other|0
7013003|NCT01483599|11082851|FG011|After Controlled Period(Week 16-Week 40)|Other|0
7013004|NCT01483599|11082852|FG012|After Controlled Period(Week 16-Week 40)|Other|1
7013005|NCT01483599|11082853|FG013|After Controlled Period(Week 16-Week 40)|Other|0
7013006|NCT01483625|11082884|FG000|Overall Study|Adverse Event|1
7013007|NCT01483625|11082885|FG001|Overall Study|Adverse Event|1
7013008|NCT01483625|11082884|FG000|Overall Study|Refused to continue medication|2
7013009|NCT01483625|11082885|FG001|Overall Study|Refused to continue medication|1
7013010|NCT01483625|11082884|FG000|Overall Study|Due to other reason|1
7013011|NCT01483625|11082885|FG001|Overall Study|Due to other reason|0
7013012|NCT01483651|11082891|FG000|Overall Study|Withdrawal by Subject|0
7013013|NCT01483651|11082892|FG001|Overall Study|Withdrawal by Subject|1
7013014|NCT01483651|11082893|FG002|Overall Study|Withdrawal by Subject|1
7013015|NCT01483651|11082894|FG003|Overall Study|Withdrawal by Subject|0
7013016|NCT01483651|11082895|FG004|Overall Study|Withdrawal by Subject|0
7013017|NCT01483651|11082896|FG005|Overall Study|Withdrawal by Subject|1
7013018|NCT01483690|11082906|FG000|Overall Study|Adverse Event|1
7013019|NCT01483690|11082907|FG001|Overall Study|Adverse Event|2
7013020|NCT01483690|11082906|FG000|Overall Study|clinical deterioration|1
7013021|NCT01483690|11082907|FG001|Overall Study|clinical deterioration|0
7013022|NCT01483690|11082906|FG000|Overall Study|Physician Decision|0
7013023|NCT01483690|11082907|FG001|Overall Study|Physician Decision|2
7013024|NCT01483690|11082906|FG000|Overall Study|exclusionary procedure|0
7013025|NCT01483690|11082907|FG001|Overall Study|exclusionary procedure|1
7013026|NCT01483924|11082927|FG000|Overall Study|Withdrawal by Subject|2
7013027|NCT01483924|11082928|FG001|Overall Study|Withdrawal by Subject|0
7013028|NCT01483924|11082929|FG002|Overall Study|Withdrawal by Subject|0
7013029|NCT01483924|11082930|FG003|Overall Study|Withdrawal by Subject|1
7013030|NCT01483924|11082931|FG004|Overall Study|Withdrawal by Subject|1
7013031|NCT01483924|11082927|FG000|Overall Study|Adverse Event|0
7013032|NCT01483924|11082928|FG001|Overall Study|Adverse Event|0
7013033|NCT01483924|11082929|FG002|Overall Study|Adverse Event|1
7013034|NCT01483924|11082930|FG003|Overall Study|Adverse Event|1
7013035|NCT01483924|11082931|FG004|Overall Study|Adverse Event|0
7013036|NCT01483924|11082927|FG000|Overall Study|Non-compliance|0
7013037|NCT01483924|11082928|FG001|Overall Study|Non-compliance|0
7013038|NCT01483924|11082929|FG002|Overall Study|Non-compliance|0
7013039|NCT01483924|11082930|FG003|Overall Study|Non-compliance|1
7013040|NCT01483924|11082931|FG004|Overall Study|Non-compliance|1
7013041|NCT01483924|11082927|FG000|Overall Study|Sponsor concern over ECG result|0
7013042|NCT01483924|11082928|FG001|Overall Study|Sponsor concern over ECG result|0
7013043|NCT01483924|11082929|FG002|Overall Study|Sponsor concern over ECG result|0
7013044|NCT01483924|11082930|FG003|Overall Study|Sponsor concern over ECG result|1
7013045|NCT01483924|11082931|FG004|Overall Study|Sponsor concern over ECG result|0
7013046|NCT01483937|11082954|FG000|Overall Study|Withdrawal by Subject|4
7013047|NCT01483937|11082955|FG001|Overall Study|Withdrawal by Subject|3
7013048|NCT01484028|11082986|FG000|Period 1|Lost to Follow-up|0
7013049|NCT01484028|11082987|FG001|Period 1|Lost to Follow-up|1
7013050|NCT01484028|11082988|FG002|Period 1|Lost to Follow-up|0
7013051|NCT01484028|11082989|FG003|Period 1|Lost to Follow-up|0
7013052|NCT01484028|11082986|FG000|Period 1|Non-Compliance to Protocol|0
7013053|NCT01484028|11082987|FG001|Period 1|Non-Compliance to Protocol|1
7013054|NCT01484028|11082988|FG002|Period 1|Non-Compliance to Protocol|0
7013055|NCT01484028|11082989|FG003|Period 1|Non-Compliance to Protocol|1
7013056|NCT01484028|11082986|FG000|Period 1|Lens Discomfort|0
7013057|NCT01484028|11082987|FG001|Period 1|Lens Discomfort|1
7013058|NCT01484028|11082988|FG002|Period 1|Lens Discomfort|0
7013059|NCT01484028|11082989|FG003|Period 1|Lens Discomfort|0
7013060|NCT01484054|11083001|FG000|Period 1|Withdrawal by Subject|0
7013061|NCT01484054|11083002|FG001|Period 1|Withdrawal by Subject|1
7013062|NCT01484132|11083009|FG000|Overall Study|Lost to Follow-up|8
7013063|NCT01484132|11083009|FG000|Overall Study|Difficulty with time commitment|2
7013064|NCT01484132|11083009|FG000|Overall Study|Ineligible|1
7013065|NCT01484132|11083009|FG000|Overall Study|No pre-treatment urine sample collected|1
7013066|NCT01484132|11083009|FG000|Overall Study|No post-treatment urine sample collected|10
7013067|NCT01484197|11083013|FG000|Treatment Period 1|Adverse Event|1
7013068|NCT01484197|11083014|FG001|Treatment Period 1|Adverse Event|0
7013069|NCT01484197|11083015|FG002|Treatment Period 1|Adverse Event|0
7013070|NCT01484197|11083016|FG003|Treatment Period 1|Adverse Event|0
7013071|NCT01484197|11083013|FG000|Treatment Period 2|Subject withdrew consent|0
7013072|NCT01484197|11083014|FG001|Treatment Period 2|Subject withdrew consent|0
7013073|NCT01484197|11083015|FG002|Treatment Period 2|Subject withdrew consent|0
7013074|NCT01484197|11083016|FG003|Treatment Period 2|Subject withdrew consent|1
7013075|NCT01484275|11083028|FG000|Overall Study|Study terminated by sponsor|28
7013076|NCT01484275|11083029|FG001|Overall Study|Study terminated by sponsor|32
7013077|NCT01484275|11083028|FG000|Overall Study|Other|10
7013078|NCT01484275|11083029|FG001|Overall Study|Other|0
7013079|NCT01484275|11083028|FG000|Overall Study|Death|3
7013080|NCT01484275|11083029|FG001|Overall Study|Death|4
7013081|NCT01484275|11083028|FG000|Overall Study|Withdrawal by Subject|1
7013082|NCT01484275|11083029|FG001|Overall Study|Withdrawal by Subject|5
7013083|NCT01484275|11083028|FG000|Overall Study|Lost to Follow-up|1
7013084|NCT01484275|11083029|FG001|Overall Study|Lost to Follow-up|1
7013085|NCT01484431|11083051|FG000|Period 1: High Dose|Physician Decision|0
7013086|NCT01484431|11083052|FG001|Period 1: High Dose|Physician Decision|1
7013087|NCT01484431|11083053|FG002|Period 1: High Dose|Physician Decision|0
7013088|NCT01484431|11083051|FG000|Period 2|Death|0
7013089|NCT01484431|11083052|FG001|Period 2|Death|1
7013090|NCT01484431|11083053|FG002|Period 2|Death|1
7013091|NCT01484431|11083051|FG000|Period 2|Physician Decision|0
7060444|NCT01919164|11156656|FG000|Overall Study|Lost to Follow-up|2
7060445|NCT01919164|11156657|FG001|Overall Study|Lost to Follow-up|2
7060446|NCT01919164|11156658|FG002|Overall Study|Lost to Follow-up|2
7060447|NCT01919164|11156659|FG003|Overall Study|Lost to Follow-up|0
7060448|NCT01919164|11156660|FG004|Overall Study|Lost to Follow-up|4
7060449|NCT01919164|11156656|FG000|Overall Study|Death|1
7060450|NCT01919164|11156657|FG001|Overall Study|Death|0
7060451|NCT01919164|11156658|FG002|Overall Study|Death|0
7060452|NCT01919164|11156659|FG003|Overall Study|Death|0
7060453|NCT01919164|11156660|FG004|Overall Study|Death|0
7060454|NCT01919164|11156656|FG000|Overall Study|Protocol Violation|6
7060455|NCT01919164|11156657|FG001|Overall Study|Protocol Violation|0
7060456|NCT01919164|11156658|FG002|Overall Study|Protocol Violation|3
7060457|NCT01919164|11156659|FG003|Overall Study|Protocol Violation|2
7060458|NCT01919164|11156660|FG004|Overall Study|Protocol Violation|2
7060459|NCT01919164|11156656|FG000|Overall Study|Disease progression|2
7060460|NCT01919164|11156657|FG001|Overall Study|Disease progression|2
7060461|NCT01919164|11156658|FG002|Overall Study|Disease progression|1
7060462|NCT01919164|11156659|FG003|Overall Study|Disease progression|2
7060463|NCT01919164|11156660|FG004|Overall Study|Disease progression|1
7060464|NCT01919164|11156656|FG000|Overall Study|Withdrew consent|13
7060465|NCT01919164|11156657|FG001|Overall Study|Withdrew consent|13
7060466|NCT01919164|11156658|FG002|Overall Study|Withdrew consent|14
7060467|NCT01919164|11156659|FG003|Overall Study|Withdrew consent|14
7060468|NCT01919164|11156660|FG004|Overall Study|Withdrew consent|9
7060469|NCT01919164|11156656|FG000|Overall Study|Other Un-specified|13
7060470|NCT01919164|11156657|FG001|Overall Study|Other Un-specified|9
7060471|NCT01919164|11156658|FG002|Overall Study|Other Un-specified|8
7060472|NCT01919164|11156659|FG003|Overall Study|Other Un-specified|7
7060473|NCT01919164|11156660|FG004|Overall Study|Other Un-specified|15
7060474|NCT01919190|11156674|FG000|Overall Study|Intra-op findings, etc.|3
7060475|NCT01919190|11156675|FG001|Overall Study|Intra-op findings, etc.|0
7060476|NCT01919229|11156698|FG000|Overall Study|Subject/guardian decision|0
7060477|NCT01919229|11156699|FG001|Overall Study|Subject/guardian decision|0
7060478|NCT01919229|11156700|FG002|Overall Study|Subject/guardian decision|1
7060479|NCT01919307|11156708|FG000|Overall Study|Withdrawal by Subject|9
7060480|NCT01919398|11156715|FG000|Overall Study|Progressive Disease|0
7060481|NCT01919398|11156716|FG001|Overall Study|Progressive Disease|0
7060482|NCT01919398|11156717|FG002|Overall Study|Progressive Disease|4
7060483|NCT01919411|11156727|FG000|Overall Study|Lost to Follow-up|2
7060484|NCT01919411|11156728|FG001|Overall Study|Lost to Follow-up|4
7060485|NCT01919411|11156727|FG000|Overall Study|Physician Decision|1
7060486|NCT01919411|11156728|FG001|Overall Study|Physician Decision|0
7060487|NCT01919411|11156727|FG000|Overall Study|Protocol Violation|2
7060488|NCT01919411|11156728|FG001|Overall Study|Protocol Violation|1
7060489|NCT01919489|11156753|FG000|Overall Study|Rejected the need of injections|4
7060490|NCT01919489|11156754|FG001|Overall Study|Rejected the need of injections|7
7060491|NCT01919489|11156753|FG000|Overall Study|Adverse Event|10
7060492|NCT01919489|11156754|FG001|Overall Study|Adverse Event|0
7060493|NCT01919489|11156753|FG000|Overall Study|Hospital readmission|2
7060494|NCT01919489|11156754|FG001|Overall Study|Hospital readmission|9
7060495|NCT01919489|11156753|FG000|Overall Study|Death|2
7013092|NCT01484431|11083052|FG001|Period 2|Physician Decision|0
7013093|NCT01484431|11083053|FG002|Period 2|Physician Decision|1
7013094|NCT01484431|11083051|FG000|Period 2|Non-Compliance with Study Drug|1
7013095|NCT01484431|11083052|FG001|Period 2|Non-Compliance with Study Drug|0
7013096|NCT01484431|11083053|FG002|Period 2|Non-Compliance with Study Drug|0
7013097|NCT01484496|11083068|FG000|Period 1|Protocol Violation|3
7013098|NCT01484496|11083069|FG001|Period 1|Protocol Violation|4
7013099|NCT01484496|11083070|FG002|Period 1|Protocol Violation|0
7013100|NCT01484496|11083071|FG003|Period 1|Protocol Violation|0
7060496|NCT01919489|11156754|FG001|Overall Study|Death|1
7060497|NCT01919489|11156753|FG000|Overall Study|Lost to Follow-up|38
7060498|NCT01919489|11156754|FG001|Overall Study|Lost to Follow-up|27
7060499|NCT01919723|11156781|FG000|Overall Study|Blood Samples Hemolyzed|2
7060500|NCT01919723|11156782|FG001|Overall Study|Blood Samples Hemolyzed|2
7060501|NCT01919801|11156790|FG000|Overall Study|Withdrawal by Subject|1
7060502|NCT01919801|11156791|FG001|Overall Study|Withdrawal by Subject|0
7013101|NCT01484496|11083068|FG000|Period 1|Physician Decision|5
7060503|NCT01919801|11156790|FG000|Overall Study|Physician Decision|0
7060504|NCT01919801|11156791|FG001|Overall Study|Physician Decision|1
7060505|NCT01919801|11156790|FG000|Overall Study|Lost to Follow-up|0
7060506|NCT01919801|11156791|FG001|Overall Study|Lost to Follow-up|1
7060507|NCT01919801|11156790|FG000|Overall Study|Other|0
7060508|NCT01919801|11156791|FG001|Overall Study|Other|1
7013102|NCT01484496|11083069|FG001|Period 1|Physician Decision|1
7013103|NCT01484496|11083070|FG002|Period 1|Physician Decision|0
7013104|NCT01484496|11083071|FG003|Period 1|Physician Decision|0
7013105|NCT01484496|11083068|FG000|Period 1|Lack of Efficacy|10
7013106|NCT01484496|11083069|FG001|Period 1|Lack of Efficacy|15
7013107|NCT01484496|11083070|FG002|Period 1|Lack of Efficacy|0
7013108|NCT01484496|11083071|FG003|Period 1|Lack of Efficacy|0
7013109|NCT01484496|11083068|FG000|Period 1|Adverse Event|25
7013110|NCT01484496|11083069|FG001|Period 1|Adverse Event|40
7013111|NCT01484496|11083070|FG002|Period 1|Adverse Event|0
7013112|NCT01484496|11083071|FG003|Period 1|Adverse Event|0
7013113|NCT01484496|11083068|FG000|Period 1|Withdrawal by Subject|15
7013114|NCT01484496|11083069|FG001|Period 1|Withdrawal by Subject|12
7013115|NCT01484496|11083070|FG002|Period 1|Withdrawal by Subject|0
7013116|NCT01484496|11083071|FG003|Period 1|Withdrawal by Subject|0
7013117|NCT01484496|11083068|FG000|Period 1|Lost to Follow-up|2
7013118|NCT01484496|11083069|FG001|Period 1|Lost to Follow-up|6
7013119|NCT01484496|11083070|FG002|Period 1|Lost to Follow-up|0
7013120|NCT01484496|11083071|FG003|Period 1|Lost to Follow-up|0
7013121|NCT01484496|11083068|FG000|Period 1|Positive Pregnancy|1
7013122|NCT01484496|11083069|FG001|Period 1|Positive Pregnancy|6
7013123|NCT01484496|11083070|FG002|Period 1|Positive Pregnancy|0
7013124|NCT01484496|11083071|FG003|Period 1|Positive Pregnancy|0
7013125|NCT01484496|11083068|FG000|Period 1|Treatment Failure|3
7013126|NCT01484496|11083069|FG001|Period 1|Treatment Failure|6
7013127|NCT01484496|11083070|FG002|Period 1|Treatment Failure|0
7013128|NCT01484496|11083071|FG003|Period 1|Treatment Failure|0
7013129|NCT01484496|11083068|FG000|Period 1|Lack of Compliance|2
7013130|NCT01484496|11083069|FG001|Period 1|Lack of Compliance|1
7013131|NCT01484496|11083070|FG002|Period 1|Lack of Compliance|0
7013132|NCT01484496|11083071|FG003|Period 1|Lack of Compliance|0
7013133|NCT01484496|11083068|FG000|Period 1|Unable to Visit Site|0
7013134|NCT01484496|11083069|FG001|Period 1|Unable to Visit Site|2
7013135|NCT01484496|11083070|FG002|Period 1|Unable to Visit Site|0
7013136|NCT01484496|11083071|FG003|Period 1|Unable to Visit Site|0
7013137|NCT01484496|11083068|FG000|Period 2|Lack of Efficacy|0
7013138|NCT01484496|11083069|FG001|Period 2|Lack of Efficacy|0
7013139|NCT01484496|11083070|FG002|Period 2|Lack of Efficacy|1
7013140|NCT01484496|11083071|FG003|Period 2|Lack of Efficacy|3
7013141|NCT01484496|11083068|FG000|Period 2|Adverse Event|0
7013142|NCT01484496|11083069|FG001|Period 2|Adverse Event|0
7013143|NCT01484496|11083070|FG002|Period 2|Adverse Event|5
7013144|NCT01484496|11083071|FG003|Period 2|Adverse Event|13
7013145|NCT01484496|11083068|FG000|Period 2|Other|0
7013146|NCT01484496|11083069|FG001|Period 2|Other|0
7013147|NCT01484496|11083070|FG002|Period 2|Other|9
7013148|NCT01484496|11083071|FG003|Period 2|Other|6
7013149|NCT01484561|11083081|FG000|Overall Study|Lack of Efficacy|3
7013150|NCT01484561|11083082|FG001|Overall Study|Lack of Efficacy|1
7013151|NCT01484561|11083081|FG000|Overall Study|Lost to Follow-up|1
7013152|NCT01484561|11083082|FG001|Overall Study|Lost to Follow-up|0
7013153|NCT01484561|11083081|FG000|Overall Study|Withdrawal by Subject|3
7013154|NCT01484561|11083082|FG001|Overall Study|Withdrawal by Subject|0
7013155|NCT01484561|11083081|FG000|Overall Study|Other|1
7013156|NCT01484561|11083082|FG001|Overall Study|Other|1
7013157|NCT01484561|11083081|FG000|Overall Study|Adverse Event|1
7013158|NCT01484561|11083082|FG001|Overall Study|Adverse Event|4
7013159|NCT01484834|11083105|FG000|Overall Study|Lost to Follow-up|5
7013160|NCT01484834|11083106|FG001|Overall Study|Lost to Follow-up|8
7013161|NCT01484834|11083107|FG002|Overall Study|Lost to Follow-up|1
7013162|NCT01484834|11083108|FG003|Overall Study|Lost to Follow-up|4
7013163|NCT01484873|11083118|FG000|Overall Study|Withdrawal by Subject|2
7013164|NCT01484912|11083125|FG000|Overall Study|Withdrawal by Subject|1
7013165|NCT01484912|11083126|FG001|Overall Study|Withdrawal by Subject|0
7013166|NCT01484912|11083125|FG000|Overall Study|Physician Decision|0
7013167|NCT01484912|11083126|FG001|Overall Study|Physician Decision|1
7013168|NCT01484938|11083132|FG000|Overall Study|Adverse Event|2
7013169|NCT01484938|11083132|FG000|Overall Study|Lost to Follow-up|1
7013170|NCT01484938|11083132|FG000|Overall Study|Noncompliance|1
7013171|NCT01484951|11083136|FG000|Overall Study|Adverse Event|3
7013172|NCT01484951|11083136|FG000|Overall Study|Personal Reasons|1
7013173|NCT01484951|11083136|FG000|Overall Study|Non-Compliance|1
7013174|NCT01484977|11083140|FG000|Overall Study|Adverse Event|8
7013175|NCT01484977|11083140|FG000|Overall Study|Lack of Efficacy|4
7013176|NCT01484977|11083140|FG000|Overall Study|Protocol Violation|6
7013177|NCT01484977|11083140|FG000|Overall Study|Lost to Follow-up|1
7013178|NCT01484977|11083140|FG000|Overall Study|Withdrawal by Subject|4
7013179|NCT01484977|11083140|FG000|Overall Study|Subject Protocol Non-compliant|1
7013180|NCT01484977|11083140|FG000|Overall Study|Moving Overseas|1
7013181|NCT01484977|11083140|FG000|Overall Study|Low White Blood Cell Count|1
7013182|NCT01484977|11083140|FG000|Overall Study|Lack of Compliance|1
7013183|NCT01485094|11083151|FG000|Overall Study|Adverse Event|1
7013184|NCT01485094|11083152|FG001|Overall Study|Adverse Event|1
7013185|NCT01485094|11083153|FG002|Overall Study|Adverse Event|1
7013186|NCT01485094|11083151|FG000|Overall Study|Lost to Follow-up|1
7013187|NCT01485094|11083152|FG001|Overall Study|Lost to Follow-up|0
7013188|NCT01485094|11083153|FG002|Overall Study|Lost to Follow-up|0
7013189|NCT01485094|11083151|FG000|Overall Study|Withdrawal by Subject|1
7013190|NCT01485094|11083152|FG001|Overall Study|Withdrawal by Subject|1
7013191|NCT01485094|11083153|FG002|Overall Study|Withdrawal by Subject|0
7013192|NCT01485120|11083161|FG000|Overall Study|Withdrawal by Subject|2
7013193|NCT01485172|11083172|FG000|Overall Study|Adverse Event|2
7013194|NCT01485172|11083173|FG001|Overall Study|Adverse Event|1
7013195|NCT01485172|11083174|FG002|Overall Study|Adverse Event|2
7013196|NCT01485172|11083175|FG003|Overall Study|Adverse Event|2
7013197|NCT01485172|11083176|FG004|Overall Study|Adverse Event|1
7013198|NCT01485172|11083177|FG005|Overall Study|Adverse Event|2
7013199|NCT01485172|11083172|FG000|Overall Study|Lack of Efficacy|2
7013200|NCT01485172|11083173|FG001|Overall Study|Lack of Efficacy|0
7013201|NCT01485172|11083174|FG002|Overall Study|Lack of Efficacy|0
7013202|NCT01485172|11083175|FG003|Overall Study|Lack of Efficacy|0
7013203|NCT01485172|11083176|FG004|Overall Study|Lack of Efficacy|0
7013204|NCT01485172|11083177|FG005|Overall Study|Lack of Efficacy|0
7013205|NCT01485172|11083172|FG000|Overall Study|Protocol Violation|0
7013206|NCT01485172|11083173|FG001|Overall Study|Protocol Violation|0
7013207|NCT01485172|11083174|FG002|Overall Study|Protocol Violation|4
7013208|NCT01485172|11083175|FG003|Overall Study|Protocol Violation|5
7013209|NCT01485172|11083176|FG004|Overall Study|Protocol Violation|1
7013210|NCT01485172|11083177|FG005|Overall Study|Protocol Violation|0
7013211|NCT01485172|11083172|FG000|Overall Study|Protocol defined stopping criteria|1
7013212|NCT01485172|11083173|FG001|Overall Study|Protocol defined stopping criteria|0
7013213|NCT01485172|11083174|FG002|Overall Study|Protocol defined stopping criteria|0
7013214|NCT01485172|11083175|FG003|Overall Study|Protocol defined stopping criteria|0
7013215|NCT01485172|11083176|FG004|Overall Study|Protocol defined stopping criteria|1
7013216|NCT01485172|11083177|FG005|Overall Study|Protocol defined stopping criteria|0
7013217|NCT01485172|11083172|FG000|Overall Study|Lost to Follow-up|0
7013218|NCT01485172|11083173|FG001|Overall Study|Lost to Follow-up|0
7013219|NCT01485172|11083174|FG002|Overall Study|Lost to Follow-up|1
7013220|NCT01485172|11083175|FG003|Overall Study|Lost to Follow-up|0
7013221|NCT01485172|11083176|FG004|Overall Study|Lost to Follow-up|0
7013222|NCT01485172|11083177|FG005|Overall Study|Lost to Follow-up|1
7013223|NCT01485172|11083172|FG000|Overall Study|Physician Decision|0
7013224|NCT01485172|11083173|FG001|Overall Study|Physician Decision|0
7013225|NCT01485172|11083174|FG002|Overall Study|Physician Decision|0
7013226|NCT01485172|11083175|FG003|Overall Study|Physician Decision|0
7013227|NCT01485172|11083176|FG004|Overall Study|Physician Decision|1
7013228|NCT01485172|11083177|FG005|Overall Study|Physician Decision|0
7013229|NCT01485172|11083172|FG000|Overall Study|Withdrawal by Subject|2
7013230|NCT01485172|11083173|FG001|Overall Study|Withdrawal by Subject|0
7013231|NCT01485172|11083174|FG002|Overall Study|Withdrawal by Subject|0
7013232|NCT01485172|11083175|FG003|Overall Study|Withdrawal by Subject|1
7013233|NCT01485172|11083176|FG004|Overall Study|Withdrawal by Subject|1
7013234|NCT01485172|11083177|FG005|Overall Study|Withdrawal by Subject|1
7013235|NCT01485354|11083191|FG000|Overall Study|Withdrawal by Subject|5
7013236|NCT01485536|11083207|FG000|Overall Study|Withdrawal by Subject|3
7013237|NCT01485536|11083207|FG000|Overall Study|Adverse Event|1
7013238|NCT01485614|11083230|FG000|Randomization|Not Treated|1
7013239|NCT01485614|11083231|FG001|Randomization|Not Treated|0
7013240|NCT01485614|11083232|FG002|Randomization|Not Treated|0
7013241|NCT01485614|11083233|FG003|Randomization|Not Treated|0
7013242|NCT01485614|11083230|FG000|Weeks 0-20|Lost to Follow-up|2
7013243|NCT01485614|11083231|FG001|Weeks 0-20|Lost to Follow-up|0
7013244|NCT01485614|11083232|FG002|Weeks 0-20|Lost to Follow-up|0
7013245|NCT01485614|11083233|FG003|Weeks 0-20|Lost to Follow-up|0
7013246|NCT01485614|11083230|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5
7013247|NCT01485614|11083231|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2
7013248|NCT01485614|11083232|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0
7013249|NCT01485614|11083233|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0
7013250|NCT01485614|11083230|FG000|Weeks 0-20|Withdrawal by Subject|3
7013251|NCT01485614|11083231|FG001|Weeks 0-20|Withdrawal by Subject|2
7013252|NCT01485614|11083232|FG002|Weeks 0-20|Withdrawal by Subject|1
7013253|NCT01485614|11083233|FG003|Weeks 0-20|Withdrawal by Subject|0
7013254|NCT01485614|11083230|FG000|Weeks 20-54|Lost to Follow-up|4
7013255|NCT01485614|11083231|FG001|Weeks 20-54|Lost to Follow-up|3
7013256|NCT01485614|11083232|FG002|Weeks 20-54|Lost to Follow-up|1
7013257|NCT01485614|11083233|FG003|Weeks 20-54|Lost to Follow-up|0
7013258|NCT01485614|11083230|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2
7013259|NCT01485614|11083231|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2
7013260|NCT01485614|11083232|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1
7013261|NCT01485614|11083233|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0
7013262|NCT01485614|11083230|FG000|Weeks 20-54|Withdrawal by Subject|5
7013263|NCT01485614|11083231|FG001|Weeks 20-54|Withdrawal by Subject|3
7013264|NCT01485614|11083232|FG002|Weeks 20-54|Withdrawal by Subject|0
7013265|NCT01485614|11083233|FG003|Weeks 20-54|Withdrawal by Subject|0
7013266|NCT01485627|11083251|FG000|Overall Study|Patient withdrew|6
7013267|NCT01485627|11083252|FG001|Overall Study|Patient withdrew|5
7013268|NCT01485627|11083251|FG000|Overall Study|Patient died|3
7013269|NCT01485627|11083252|FG001|Overall Study|Patient died|1
7013270|NCT01485627|11083251|FG000|Overall Study|Patient lost to followup|0
7013271|NCT01485627|11083252|FG001|Overall Study|Patient lost to followup|1
7013272|NCT01485627|11083251|FG000|Overall Study|Caregiver withdrew|3
7013273|NCT01485627|11083252|FG001|Overall Study|Caregiver withdrew|3
7013274|NCT01485627|11083251|FG000|Overall Study|Caregiver lost to follow up|11
7013275|NCT01485627|11083252|FG001|Overall Study|Caregiver lost to follow up|12
7013276|NCT01485627|11083251|FG000|Overall Study|Caregiver died|1
7013277|NCT01485627|11083252|FG001|Overall Study|Caregiver died|0
7013278|NCT01485627|11083251|FG000|Overall Study|caregiver was not bereaved|42
7013279|NCT01485627|11083252|FG001|Overall Study|caregiver was not bereaved|35
7013280|NCT01485640|11083262|FG000|Overall Study|Adverse Event|10
7013281|NCT01485640|11083262|FG000|Overall Study|Lack of Efficacy|2
7013282|NCT01485640|11083262|FG000|Overall Study|Protocol Violation|1
7013283|NCT01485640|11083262|FG000|Overall Study|Withdrawal by Subject|14
7013284|NCT01485640|11083262|FG000|Overall Study|Terminated by Sponsor|95
7013285|NCT01485796|11083277|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1
7013286|NCT01485796|11083277|FG000|Period 2: Epoch 2|Withdrawal by Subject|6
7013287|NCT01485796|11083277|FG000|Period 2: Epoch 2|Adverse Event|3
7013288|NCT01485796|11083277|FG000|Period 2: Epoch 2|Switch to safety follow-up|26
7013289|NCT01485796|11083277|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1
7013290|NCT01485796|11083277|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6
7013291|NCT01485796|11083277|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3
7013292|NCT01485796|11083277|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2
7013293|NCT01485887|11083285|FG000|Overall Study|Withdrawal by Subject|2
7013294|NCT01485887|11083285|FG000|Overall Study|Adverse Event|8
7013295|NCT01485887|11083285|FG000|Overall Study|Deterioration of primary disease|1
7013296|NCT01485887|11083285|FG000|Overall Study|Primary disease markedly improved|1
7013297|NCT01485991|11083291|FG000|Overall Study|Adverse Event|0
7013298|NCT01485991|11083292|FG001|Overall Study|Adverse Event|4
7013299|NCT01485991|11083291|FG000|Overall Study|Lost to Follow-up|13
7013300|NCT01485991|11083292|FG001|Overall Study|Lost to Follow-up|10
7013301|NCT01485991|11083291|FG000|Overall Study|Withdrawal by Subject|13
7013302|NCT01485991|11083292|FG001|Overall Study|Withdrawal by Subject|20
7013303|NCT01485991|11083291|FG000|Overall Study|randomized but not treated|6
7013304|NCT01485991|11083292|FG001|Overall Study|randomized but not treated|2
7013305|NCT01486199|11083304|FG000|Two Year Period Between Study Days|Physician Decision|1
7013306|NCT01486199|11083305|FG001|Two Year Period Between Study Days|Physician Decision|0
7013307|NCT01486238|11083313|FG000|Overall Study|Death|0
7013308|NCT01486238|11083314|FG001|Overall Study|Death|2
7013309|NCT01486238|11083313|FG000|Overall Study|Withdrawal by Subject|2
7013310|NCT01486238|11083314|FG001|Overall Study|Withdrawal by Subject|1
7013311|NCT01486238|11083313|FG000|Overall Study|Lost to Follow-up|0
7013312|NCT01486238|11083314|FG001|Overall Study|Lost to Follow-up|3
7013313|NCT01486316|11083323|FG000|Overall Study|Device explanted with/without re-implant|3
7013314|NCT01486316|11083324|FG001|Overall Study|Device explanted with/without re-implant|2
7013315|NCT01486316|11083325|FG002|Overall Study|Device explanted with/without re-implant|0
7013316|NCT01486316|11083326|FG003|Overall Study|Device explanted with/without re-implant|2
7013317|NCT01486316|11083323|FG000|Overall Study|Not meeting eligibility criteria|0
7013318|NCT01486316|11083324|FG001|Overall Study|Not meeting eligibility criteria|0
7013319|NCT01486316|11083325|FG002|Overall Study|Not meeting eligibility criteria|1
7013320|NCT01486316|11083326|FG003|Overall Study|Not meeting eligibility criteria|0
7013321|NCT01486316|11083323|FG000|Overall Study|Withdrawal by Subject|1
7013322|NCT01486316|11083324|FG001|Overall Study|Withdrawal by Subject|0
7013323|NCT01486316|11083325|FG002|Overall Study|Withdrawal by Subject|3
7013324|NCT01486316|11083326|FG003|Overall Study|Withdrawal by Subject|0
7013325|NCT01486316|11083323|FG000|Overall Study|Physician Decision|0
7013326|NCT01486316|11083324|FG001|Overall Study|Physician Decision|0
7013327|NCT01486316|11083325|FG002|Overall Study|Physician Decision|1
7013328|NCT01486316|11083326|FG003|Overall Study|Physician Decision|0
7013329|NCT01486316|11083323|FG000|Overall Study|Death|0
7013330|NCT01486316|11083324|FG001|Overall Study|Death|1
7013331|NCT01486316|11083325|FG002|Overall Study|Death|0
7013332|NCT01486316|11083326|FG003|Overall Study|Death|0
7013333|NCT01486446|11083337|FG000|Overall Study|Adverse Event|1
7013334|NCT01486446|11083338|FG001|Overall Study|Adverse Event|0
7013335|NCT01486758|11083363|FG000|Overall Study|Lost to Follow-up|0
7013336|NCT01486758|11083364|FG001|Overall Study|Lost to Follow-up|1
7013337|NCT01486784|11083377|FG000|Overall Study|Withdrawal by Subject|0
7013338|NCT01486784|11083378|FG001|Overall Study|Withdrawal by Subject|0
7013339|NCT01486784|11083379|FG002|Overall Study|Withdrawal by Subject|1
7013340|NCT01486784|11083380|FG003|Overall Study|Withdrawal by Subject|0
7013341|NCT01486784|11083381|FG004|Overall Study|Withdrawal by Subject|1
7013342|NCT01486784|11083382|FG005|Overall Study|Withdrawal by Subject|2
7013343|NCT01486784|11083377|FG000|Overall Study|Subject did not meet entry criteria|0
7013344|NCT01486784|11083378|FG001|Overall Study|Subject did not meet entry criteria|0
7013345|NCT01486784|11083379|FG002|Overall Study|Subject did not meet entry criteria|0
7013346|NCT01486784|11083380|FG003|Overall Study|Subject did not meet entry criteria|0
7013347|NCT01486784|11083381|FG004|Overall Study|Subject did not meet entry criteria|1
7013348|NCT01486784|11083382|FG005|Overall Study|Subject did not meet entry criteria|0
7013349|NCT01486784|11083377|FG000|Overall Study|Death|0
7013350|NCT01486784|11083378|FG001|Overall Study|Death|0
7013351|NCT01486784|11083379|FG002|Overall Study|Death|0
7013352|NCT01486784|11083380|FG003|Overall Study|Death|0
7013353|NCT01486784|11083381|FG004|Overall Study|Death|0
7013354|NCT01486784|11083382|FG005|Overall Study|Death|1
7013355|NCT01486927|11083400|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1
7013356|NCT01486927|11083400|FG000|Overall Study|Physician Decision|1
7013357|NCT01486927|11083400|FG000|Overall Study|50 Exposure days not reached|2
7013358|NCT01486927|11083400|FG000|Overall Study|Withdrawal by Subject|8
7013359|NCT01486927|11083400|FG000|Overall Study|Subject did not reach 6 mo of treatment|1
7013360|NCT01486966|11083413|FG000|Overall Study|Adverse Event|0
7013361|NCT01486966|11083414|FG001|Overall Study|Adverse Event|1
7013362|NCT01486966|11083413|FG000|Overall Study|Withdrawal by Subject|0
7013363|NCT01486966|11083414|FG001|Overall Study|Withdrawal by Subject|1
7013364|NCT01487161|11083424|FG000|Overall Study|Adverse Event|1
7013365|NCT01487161|11083425|FG001|Overall Study|Adverse Event|0
7013366|NCT01487161|11083426|FG002|Overall Study|Adverse Event|0
7013367|NCT01487161|11083427|FG003|Overall Study|Adverse Event|0
7013368|NCT01487161|11083424|FG000|Overall Study|Withdrawal by Subject|1
7013369|NCT01487161|11083425|FG001|Overall Study|Withdrawal by Subject|1
7013370|NCT01487161|11083426|FG002|Overall Study|Withdrawal by Subject|1
7013371|NCT01487161|11083427|FG003|Overall Study|Withdrawal by Subject|2
7013372|NCT01487161|11083424|FG000|Overall Study|missing data|0
7013373|NCT01487161|11083425|FG001|Overall Study|missing data|1
7013374|NCT01487161|11083426|FG002|Overall Study|missing data|0
7013375|NCT01487161|11083427|FG003|Overall Study|missing data|0
7013376|NCT01487200|11083446|FG000|Overall Study|Withdrawal by Subject|0
7013377|NCT01487200|11083447|FG001|Overall Study|Withdrawal by Subject|1
7013378|NCT01487200|11083448|FG002|Overall Study|Withdrawal by Subject|0
7013379|NCT01487200|11083449|FG003|Overall Study|Withdrawal by Subject|0
7013380|NCT01487265|11083460|FG000|Overall Study|Adverse Event|8
7013381|NCT01487265|11083460|FG000|Overall Study|Withdrawal by Subject|5
7013382|NCT01487265|11083460|FG000|Overall Study|Disease Progression|21
7013383|NCT01487265|11083460|FG000|Overall Study|Death|2
7013384|NCT01487265|11083460|FG000|Overall Study|Still on Treatment|1
7013385|NCT01487525|11083466|FG000|Overall Study|Withdrawal by Subject|0
7013386|NCT01487525|11083467|FG001|Overall Study|Withdrawal by Subject|1
7013387|NCT01487577|11083473|FG000|Overall Study|Became ineligible after signing consent|1
7013388|NCT01487863|11083490|FG000|Overall Study|Death|19
7013389|NCT01487863|11083491|FG001|Overall Study|Death|19
7013390|NCT01488071|11083519|FG000|Overall Study|Adverse Event|15
7013391|NCT01488071|11083520|FG001|Overall Study|Adverse Event|23
7013392|NCT01488071|11083519|FG000|Overall Study|Lack of Efficacy|11
7013393|NCT01488071|11083520|FG001|Overall Study|Lack of Efficacy|17
7013394|NCT01488071|11083519|FG000|Overall Study|Non-compliance with study drug|2
7013395|NCT01488071|11083520|FG001|Overall Study|Non-compliance with study drug|0
7013396|NCT01488071|11083519|FG000|Overall Study|Protocol Violation|5
7013397|NCT01488071|11083520|FG001|Overall Study|Protocol Violation|7
7013398|NCT01488071|11083519|FG000|Overall Study|Withdrawal of Consent|14
7013399|NCT01488071|11083520|FG001|Overall Study|Withdrawal of Consent|12
7013400|NCT01488071|11083519|FG000|Overall Study|Lost to Follow-up|1
7013401|NCT01488071|11083520|FG001|Overall Study|Lost to Follow-up|0
7013402|NCT01488071|11083519|FG000|Overall Study|Administrative or Other Reason(s)|5
7013403|NCT01488071|11083520|FG001|Overall Study|Administrative or Other Reason(s)|4
7013404|NCT01488097|11083526|FG000|Overall Study|Lost to Follow-up|1
7013405|NCT01488370|11083558|FG000|Overall Study|Protocol Violation|0
7013406|NCT01488370|11083559|FG001|Overall Study|Protocol Violation|1
7013407|NCT01488370|11083560|FG002|Overall Study|Protocol Violation|1
7013408|NCT01488448|11083579|FG000|Overall Study|Withdrawal by Subject|3
7013409|NCT01488448|11083580|FG001|Overall Study|Withdrawal by Subject|1
7013410|NCT01488448|11083579|FG000|Overall Study|Adverse Event|9
7013411|NCT01488448|11083580|FG001|Overall Study|Adverse Event|4
7013412|NCT01488448|11083579|FG000|Overall Study|Physician Decision|4
7013413|NCT01488448|11083580|FG001|Overall Study|Physician Decision|9
7013414|NCT01488448|11083579|FG000|Overall Study|Protocol Violation|4
7013415|NCT01488448|11083580|FG001|Overall Study|Protocol Violation|3
7013416|NCT01488487|11083588|FG000|Overall Study|Adverse Event|6
7013417|NCT01488487|11083588|FG000|Overall Study|Death|1
7013418|NCT01488487|11083588|FG000|Overall Study|Withdrawal by Subject|2
7013419|NCT01488578|11083592|FG000|Overall Study|Protocol Violation|1836
7013420|NCT01488994|11083644|FG000|Overall Study|Withdrawal by Subject|0
7013421|NCT01488994|11083645|FG001|Overall Study|Withdrawal by Subject|1
7013422|NCT01489020|11083662|FG000|Overall Study|Withdrawal by Subject|1
7013423|NCT01489020|11083663|FG001|Overall Study|Withdrawal by Subject|0
7013424|NCT01489020|11083664|FG002|Overall Study|Withdrawal by Subject|0
7013425|NCT01489020|11083665|FG003|Overall Study|Withdrawal by Subject|0
7013426|NCT01489020|11083666|FG004|Overall Study|Withdrawal by Subject|0
7013427|NCT01489020|11083667|FG005|Overall Study|Withdrawal by Subject|0
7013428|NCT01489020|11083662|FG000|Overall Study|Adverse Event|0
7013429|NCT01489020|11083663|FG001|Overall Study|Adverse Event|0
7013430|NCT01489020|11083664|FG002|Overall Study|Adverse Event|3
7013431|NCT01489020|11083665|FG003|Overall Study|Adverse Event|0
7013432|NCT01489020|11083666|FG004|Overall Study|Adverse Event|3
7013433|NCT01489020|11083667|FG005|Overall Study|Adverse Event|0
7013434|NCT01489020|11083662|FG000|Overall Study|Concomitant disease|0
7013435|NCT01489020|11083663|FG001|Overall Study|Concomitant disease|0
7013436|NCT01489020|11083664|FG002|Overall Study|Concomitant disease|0
7013437|NCT01489020|11083665|FG003|Overall Study|Concomitant disease|0
7013438|NCT01489020|11083666|FG004|Overall Study|Concomitant disease|3
7013439|NCT01489020|11083667|FG005|Overall Study|Concomitant disease|0
7013440|NCT01489111|11083687|FG000|Overall Study|Withdrawal criterion|1
7013441|NCT01489189|11083693|FG000|Overall Study|Withdrawal by Subject|20
7013442|NCT01489189|11083694|FG001|Overall Study|Withdrawal by Subject|23
7013443|NCT01489189|11083693|FG000|Overall Study|Death|10
7013444|NCT01489189|11083694|FG001|Overall Study|Death|8
7013445|NCT01489189|11083693|FG000|Overall Study|Missed Visit|1
7013446|NCT01489189|11083694|FG001|Overall Study|Missed Visit|4
7013447|NCT01489254|11083704|FG000|Double-blind Part|Adverse Event|7
7013448|NCT01489254|11083705|FG001|Double-blind Part|Adverse Event|2
7013449|NCT01489254|11083706|FG002|Double-blind Part|Adverse Event|2
7013450|NCT01489254|11083707|FG003|Double-blind Part|Adverse Event|0
7013451|NCT01489254|11083704|FG000|Double-blind Part|Pregnancy|1
7013452|NCT01489254|11083705|FG001|Double-blind Part|Pregnancy|3
7013453|NCT01489254|11083706|FG002|Double-blind Part|Pregnancy|0
7013454|NCT01489254|11083707|FG003|Double-blind Part|Pregnancy|0
7013455|NCT01489254|11083704|FG000|Double-blind Part|Withdrawal by Subject|12
7013456|NCT01489254|11083705|FG001|Double-blind Part|Withdrawal by Subject|20
7013457|NCT01489254|11083706|FG002|Double-blind Part|Withdrawal by Subject|1
7013458|NCT01489254|11083707|FG003|Double-blind Part|Withdrawal by Subject|0
7013459|NCT01489254|11083704|FG000|Double-blind Part|Lost to Follow-up|1
7013460|NCT01489254|11083705|FG001|Double-blind Part|Lost to Follow-up|2
7013461|NCT01489254|11083706|FG002|Double-blind Part|Lost to Follow-up|0
7013462|NCT01489254|11083707|FG003|Double-blind Part|Lost to Follow-up|0
7013463|NCT01489254|11083704|FG000|Double-blind Part|Other reasons for not completing study|4
7013464|NCT01489254|11083705|FG001|Double-blind Part|Other reasons for not completing study|6
7013465|NCT01489254|11083706|FG002|Double-blind Part|Other reasons for not completing study|0
7013466|NCT01489254|11083707|FG003|Double-blind Part|Other reasons for not completing study|0
7013467|NCT01489254|11083704|FG000|Open-label Extension Part|Adverse Event|0
7013468|NCT01489254|11083705|FG001|Open-label Extension Part|Adverse Event|0
7013469|NCT01489254|11083706|FG002|Open-label Extension Part|Adverse Event|0
7013470|NCT01489254|11083707|FG003|Open-label Extension Part|Adverse Event|10
7013471|NCT01489254|11083704|FG000|Open-label Extension Part|Pregnancy|0
7013472|NCT01489254|11083705|FG001|Open-label Extension Part|Pregnancy|0
7013473|NCT01489254|11083706|FG002|Open-label Extension Part|Pregnancy|0
7013474|NCT01489254|11083707|FG003|Open-label Extension Part|Pregnancy|3
7013475|NCT01489254|11083704|FG000|Open-label Extension Part|Withdrawal by Subject|0
7013476|NCT01489254|11083705|FG001|Open-label Extension Part|Withdrawal by Subject|0
7013477|NCT01489254|11083706|FG002|Open-label Extension Part|Withdrawal by Subject|0
7013478|NCT01489254|11083707|FG003|Open-label Extension Part|Withdrawal by Subject|30
7013479|NCT01489254|11083704|FG000|Open-label Extension Part|Protocol Violation|0
7013480|NCT01489254|11083705|FG001|Open-label Extension Part|Protocol Violation|0
7013481|NCT01489254|11083706|FG002|Open-label Extension Part|Protocol Violation|0
7013482|NCT01489254|11083707|FG003|Open-label Extension Part|Protocol Violation|1
7013483|NCT01489254|11083704|FG000|Open-label Extension Part|Lost to Follow-up|0
7013484|NCT01489254|11083705|FG001|Open-label Extension Part|Lost to Follow-up|0
7013485|NCT01489254|11083706|FG002|Open-label Extension Part|Lost to Follow-up|0
7013486|NCT01489254|11083707|FG003|Open-label Extension Part|Lost to Follow-up|9
7013487|NCT01489254|11083704|FG000|Open-label Extension Part|Other reasons for not completing study|0
7013488|NCT01489254|11083705|FG001|Open-label Extension Part|Other reasons for not completing study|0
7013489|NCT01489254|11083706|FG002|Open-label Extension Part|Other reasons for not completing study|0
7013490|NCT01489254|11083707|FG003|Open-label Extension Part|Other reasons for not completing study|5
7013491|NCT01489358|11083719|FG000|Overall Study|Lost to Follow-up|0
7013492|NCT01489358|11083720|FG001|Overall Study|Lost to Follow-up|0
7013493|NCT01489358|11083721|FG002|Overall Study|Lost to Follow-up|2
7013494|NCT01489527|11083731|FG000|Overall Study|Pregnancy|9
7013495|NCT01489527|11083732|FG001|Overall Study|Pregnancy|14
7013496|NCT01489527|11083731|FG000|Overall Study|Participant moved|6
7013497|NCT01489527|11083732|FG001|Overall Study|Participant moved|7
7013498|NCT01489527|11083731|FG000|Overall Study|Withdrawal by Subject|0
7013499|NCT01489527|11083732|FG001|Overall Study|Withdrawal by Subject|4
7013500|NCT01489527|11083731|FG000|Overall Study|Lost to Follow-up|5
7013501|NCT01489527|11083732|FG001|Overall Study|Lost to Follow-up|1
7013502|NCT01489527|11083731|FG000|Overall Study|Procedures|1
7013503|NCT01489527|11083732|FG001|Overall Study|Procedures|0
7013504|NCT01489527|11083731|FG000|Overall Study|Not compliant|1
7013505|NCT01489527|11083732|FG001|Overall Study|Not compliant|0
7013506|NCT01489891|11083800|FG000|Overall Study|Endoscopy failure|1
7013507|NCT01489891|11083801|FG001|Overall Study|Endoscopy failure|0
7013508|NCT01489956|11083809|FG000|Overall Study|Lost to Follow-up|1
7013509|NCT01489956|11083810|FG001|Overall Study|Lost to Follow-up|0
7013510|NCT01489956|11083811|FG002|Overall Study|Lost to Follow-up|0
7013511|NCT01489956|11083809|FG000|Overall Study|Withdrawal by Subject|0
7013512|NCT01489956|11083810|FG001|Overall Study|Withdrawal by Subject|0
7013513|NCT01489956|11083811|FG002|Overall Study|Withdrawal by Subject|1
7043529|NCT01744977|11128490|FG000|Overall Study|Withdrawal by Subject|1
7043530|NCT01744977|11128491|FG001|Overall Study|Withdrawal by Subject|2
7043531|NCT01744977|11128490|FG000|Overall Study|Death|2
7043532|NCT01744977|11128491|FG001|Overall Study|Death|3
7043533|NCT01744977|11128490|FG000|Overall Study|Lost to Follow-up|2
7043534|NCT01744977|11128491|FG001|Overall Study|Lost to Follow-up|0
7043535|NCT01744977|11128490|FG000|Overall Study|No longer meets inclusion|6
7043536|NCT01744977|11128491|FG001|Overall Study|No longer meets inclusion|0
7043537|NCT01745094|11128510|FG000|Overall Study|Not Meeting the Eligibility Criteria|1
7043538|NCT01745094|11128511|FG001|Overall Study|Not Meeting the Eligibility Criteria|0
7013514|NCT01490060|11083834|FG000|Cycle 1|Change of Treatment|0
7013515|NCT01490060|11083835|FG001|Cycle 1|Change of Treatment|1
7013516|NCT01490060|11083836|FG002|Cycle 1|Change of Treatment|1
7013517|NCT01490060|11083837|FG003|Cycle 1|Change of Treatment|1
7013518|NCT01490060|11083834|FG000|Cycle 1|Insurance Denied|0
7013519|NCT01490060|11083835|FG001|Cycle 1|Insurance Denied|0
7013520|NCT01490060|11083836|FG002|Cycle 1|Insurance Denied|2
7013521|NCT01490060|11083837|FG003|Cycle 1|Insurance Denied|0
7013522|NCT01490060|11083834|FG000|Cycle 1|Withdrawal by Subject|0
7013523|NCT01490060|11083835|FG001|Cycle 1|Withdrawal by Subject|0
7013524|NCT01490060|11083836|FG002|Cycle 1|Withdrawal by Subject|0
7013525|NCT01490060|11083837|FG003|Cycle 1|Withdrawal by Subject|1
7013526|NCT01490060|11083834|FG000|Cycle 1|Treatment at Another Facility|0
7013527|NCT01490060|11083835|FG001|Cycle 1|Treatment at Another Facility|0
7013528|NCT01490060|11083836|FG002|Cycle 1|Treatment at Another Facility|0
7013529|NCT01490060|11083837|FG003|Cycle 1|Treatment at Another Facility|1
7013530|NCT01490060|11083834|FG000|Cycle 2|Change of Treatment|1
7013531|NCT01490060|11083835|FG001|Cycle 2|Change of Treatment|1
7013532|NCT01490060|11083836|FG002|Cycle 2|Change of Treatment|0
7013533|NCT01490060|11083837|FG003|Cycle 2|Change of Treatment|0
7013534|NCT01490060|11083834|FG000|Cycle 2|Non-Compliance|0
7013535|NCT01490060|11083835|FG001|Cycle 2|Non-Compliance|0
7013536|NCT01490060|11083836|FG002|Cycle 2|Non-Compliance|1
7013537|NCT01490060|11083837|FG003|Cycle 2|Non-Compliance|0
7013538|NCT01490060|11083834|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1
7013539|NCT01490060|11083835|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0
7013540|NCT01490060|11083836|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0
7013541|NCT01490060|11083837|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0
7013542|NCT01490086|11083859|FG000|Overall Study|Consent withdrawn|4
7013543|NCT01490086|11083860|FG001|Overall Study|Consent withdrawn|4
7013544|NCT01490086|11083861|FG002|Overall Study|Consent withdrawn|3
7013545|NCT01490086|11083862|FG003|Overall Study|Consent withdrawn|0
7013546|NCT01490086|11083863|FG004|Overall Study|Consent withdrawn|1
7013547|NCT01490086|11083859|FG000|Overall Study|Non-compliance|0
7013548|NCT01490086|11083860|FG001|Overall Study|Non-compliance|1
7013549|NCT01490086|11083861|FG002|Overall Study|Non-compliance|0
7013550|NCT01490086|11083862|FG003|Overall Study|Non-compliance|0
7013551|NCT01490086|11083863|FG004|Overall Study|Non-compliance|0
7013552|NCT01490086|11083859|FG000|Overall Study|Abnormal laboratory findings|1
7013553|NCT01490086|11083860|FG001|Overall Study|Abnormal laboratory findings|0
7013554|NCT01490086|11083861|FG002|Overall Study|Abnormal laboratory findings|0
7013555|NCT01490086|11083862|FG003|Overall Study|Abnormal laboratory findings|0
7013556|NCT01490086|11083863|FG004|Overall Study|Abnormal laboratory findings|0
7013557|NCT01490086|11083859|FG000|Overall Study|Lost to Follow-up|0
7013558|NCT01490086|11083860|FG001|Overall Study|Lost to Follow-up|0
7013559|NCT01490086|11083861|FG002|Overall Study|Lost to Follow-up|0
7013560|NCT01490086|11083862|FG003|Overall Study|Lost to Follow-up|0
7013561|NCT01490086|11083863|FG004|Overall Study|Lost to Follow-up|1
7013562|NCT01490086|11083859|FG000|Overall Study|Physician Decision|3
7013563|NCT01490086|11083860|FG001|Overall Study|Physician Decision|4
7013564|NCT01490086|11083861|FG002|Overall Study|Physician Decision|2
7013565|NCT01490086|11083862|FG003|Overall Study|Physician Decision|3
7013566|NCT01490086|11083863|FG004|Overall Study|Physician Decision|1
7013567|NCT01490086|11083859|FG000|Overall Study|Adverse Event|0
7013568|NCT01490086|11083860|FG001|Overall Study|Adverse Event|0
7013569|NCT01490086|11083861|FG002|Overall Study|Adverse Event|1
7013570|NCT01490086|11083862|FG003|Overall Study|Adverse Event|2
7013571|NCT01490086|11083863|FG004|Overall Study|Adverse Event|0
7013572|NCT01490086|11083859|FG000|Overall Study|Lack of Efficacy|0
7013573|NCT01490086|11083860|FG001|Overall Study|Lack of Efficacy|3
7013574|NCT01490086|11083861|FG002|Overall Study|Lack of Efficacy|1
7013575|NCT01490086|11083862|FG003|Overall Study|Lack of Efficacy|0
7013576|NCT01490086|11083863|FG004|Overall Study|Lack of Efficacy|8
7013577|NCT01490086|11083859|FG000|Overall Study|Worsening of symptoms|0
7013578|NCT01490086|11083860|FG001|Overall Study|Worsening of symptoms|1
7013579|NCT01490086|11083861|FG002|Overall Study|Worsening of symptoms|0
7013580|NCT01490086|11083862|FG003|Overall Study|Worsening of symptoms|1
7013581|NCT01490086|11083863|FG004|Overall Study|Worsening of symptoms|0
7013582|NCT01490086|11083859|FG000|Overall Study|Subject uncontrollable and abusive|0
7013583|NCT01490086|11083860|FG001|Overall Study|Subject uncontrollable and abusive|1
7013584|NCT01490086|11083861|FG002|Overall Study|Subject uncontrollable and abusive|0
7013585|NCT01490086|11083862|FG003|Overall Study|Subject uncontrollable and abusive|0
7013586|NCT01490086|11083863|FG004|Overall Study|Subject uncontrollable and abusive|0
7013587|NCT01490086|11083859|FG000|Overall Study|Subject left hospital|0
7013588|NCT01490086|11083860|FG001|Overall Study|Subject left hospital|1
7013589|NCT01490086|11083861|FG002|Overall Study|Subject left hospital|0
7013590|NCT01490086|11083862|FG003|Overall Study|Subject left hospital|1
7013591|NCT01490086|11083863|FG004|Overall Study|Subject left hospital|0
7013592|NCT01490125|11083875|FG000|Period I|Adverse Event|4
7013593|NCT01490125|11083876|FG001|Period I|Adverse Event|1
7013594|NCT01490125|11083877|FG002|Period I|Adverse Event|1
7013595|NCT01490125|11083878|FG003|Period I|Adverse Event|3
7013596|NCT01490125|11083879|FG004|Period I|Adverse Event|2
7013597|NCT01490125|11083880|FG005|Period I|Adverse Event|4
7013598|NCT01490125|11083875|FG000|Period I|Protocol Violation|1
7013599|NCT01490125|11083876|FG001|Period I|Protocol Violation|1
7013600|NCT01490125|11083877|FG002|Period I|Protocol Violation|1
7013601|NCT01490125|11083878|FG003|Period I|Protocol Violation|1
7013602|NCT01490125|11083879|FG004|Period I|Protocol Violation|0
7013603|NCT01490125|11083880|FG005|Period I|Protocol Violation|0
7013604|NCT01490125|11083875|FG000|Period I|Withdrawal by Subject|1
7013605|NCT01490125|11083876|FG001|Period I|Withdrawal by Subject|3
7013606|NCT01490125|11083877|FG002|Period I|Withdrawal by Subject|2
7013607|NCT01490125|11083878|FG003|Period I|Withdrawal by Subject|1
7013608|NCT01490125|11083879|FG004|Period I|Withdrawal by Subject|2
7013609|NCT01490125|11083880|FG005|Period I|Withdrawal by Subject|1
7013610|NCT01490125|11083875|FG000|Period II|Adverse Event|2
7013611|NCT01490125|11083876|FG001|Period II|Adverse Event|3
7013612|NCT01490125|11083877|FG002|Period II|Adverse Event|2
7013613|NCT01490125|11083878|FG003|Period II|Adverse Event|2
7013614|NCT01490125|11083879|FG004|Period II|Adverse Event|4
7013615|NCT01490125|11083880|FG005|Period II|Adverse Event|2
7013616|NCT01490125|11083875|FG000|Period II|Protocol Violation|0
7013617|NCT01490125|11083876|FG001|Period II|Protocol Violation|0
7013618|NCT01490125|11083877|FG002|Period II|Protocol Violation|1
7013619|NCT01490125|11083878|FG003|Period II|Protocol Violation|1
7013620|NCT01490125|11083879|FG004|Period II|Protocol Violation|0
7013621|NCT01490125|11083880|FG005|Period II|Protocol Violation|0
7013622|NCT01490125|11083875|FG000|Period II|Lost to Follow-up|0
7013623|NCT01490125|11083876|FG001|Period II|Lost to Follow-up|1
7013624|NCT01490125|11083877|FG002|Period II|Lost to Follow-up|0
7013625|NCT01490125|11083878|FG003|Period II|Lost to Follow-up|0
7013626|NCT01490125|11083879|FG004|Period II|Lost to Follow-up|0
7013627|NCT01490125|11083880|FG005|Period II|Lost to Follow-up|0
7013628|NCT01490125|11083875|FG000|Period II|Withdrawal by Subject|1
7013629|NCT01490125|11083876|FG001|Period II|Withdrawal by Subject|0
7013630|NCT01490125|11083877|FG002|Period II|Withdrawal by Subject|0
7013631|NCT01490125|11083878|FG003|Period II|Withdrawal by Subject|0
7013632|NCT01490125|11083879|FG004|Period II|Withdrawal by Subject|0
7013633|NCT01490125|11083880|FG005|Period II|Withdrawal by Subject|0
7013634|NCT01490125|11083875|FG000|Period III|Adverse Event|3
7013635|NCT01490125|11083876|FG001|Period III|Adverse Event|1
7013636|NCT01490125|11083877|FG002|Period III|Adverse Event|0
7013637|NCT01490125|11083878|FG003|Period III|Adverse Event|1
7013638|NCT01490125|11083879|FG004|Period III|Adverse Event|0
7013639|NCT01490125|11083880|FG005|Period III|Adverse Event|0
7013640|NCT01490125|11083875|FG000|Period III|Death|0
7013641|NCT01490125|11083876|FG001|Period III|Death|0
7013642|NCT01490125|11083877|FG002|Period III|Death|0
7013643|NCT01490125|11083878|FG003|Period III|Death|1
7013644|NCT01490125|11083879|FG004|Period III|Death|0
7013645|NCT01490125|11083880|FG005|Period III|Death|0
7013646|NCT01490125|11083875|FG000|Period III|Lack of Efficacy|0
7013647|NCT01490125|11083876|FG001|Period III|Lack of Efficacy|0
7013648|NCT01490125|11083877|FG002|Period III|Lack of Efficacy|0
7013649|NCT01490125|11083878|FG003|Period III|Lack of Efficacy|0
7013650|NCT01490125|11083879|FG004|Period III|Lack of Efficacy|1
7013651|NCT01490125|11083880|FG005|Period III|Lack of Efficacy|0
7013652|NCT01490294|11083898|FG000|Overall Study|Prematurely discontinuation|4
7013653|NCT01490294|11083899|FG001|Overall Study|Prematurely discontinuation|0
7013654|NCT01490294|11083900|FG002|Overall Study|Prematurely discontinuation|1
7013655|NCT01490294|11083901|FG003|Overall Study|Prematurely discontinuation|1
7013656|NCT01490294|11083898|FG000|Overall Study|Adverse Event|1
7013657|NCT01490294|11083899|FG001|Overall Study|Adverse Event|0
7013658|NCT01490294|11083900|FG002|Overall Study|Adverse Event|0
7013659|NCT01490294|11083901|FG003|Overall Study|Adverse Event|0
7013660|NCT01490450|11083925|FG000|Period 1|Lack of Efficacy|2
7013661|NCT01490450|11083926|FG001|Period 1|Lack of Efficacy|0
7013662|NCT01490450|11083927|FG002|Period 1|Lack of Efficacy|3
7013663|NCT01490450|11083928|FG003|Period 1|Lack of Efficacy|0
7013664|NCT01490450|11083925|FG000|Period 1|Adverse Event|0
7013665|NCT01490450|11083926|FG001|Period 1|Adverse Event|0
7013666|NCT01490450|11083927|FG002|Period 1|Adverse Event|0
7013667|NCT01490450|11083928|FG003|Period 1|Adverse Event|5
7013668|NCT01490450|11083925|FG000|Period 1|Request to discontinue treatment|1
7013669|NCT01490450|11083926|FG001|Period 1|Request to discontinue treatment|0
7013670|NCT01490450|11083927|FG002|Period 1|Request to discontinue treatment|0
7013671|NCT01490450|11083928|FG003|Period 1|Request to discontinue treatment|0
7013672|NCT01490450|11083925|FG000|Period 1|Withdrawal by Subject|0
7013673|NCT01490450|11083926|FG001|Period 1|Withdrawal by Subject|0
7013674|NCT01490450|11083927|FG002|Period 1|Withdrawal by Subject|0
7013675|NCT01490450|11083928|FG003|Period 1|Withdrawal by Subject|3
7013676|NCT01490450|11083925|FG000|Period 1|No longer met study criteria|0
7013677|NCT01490450|11083926|FG001|Period 1|No longer met study criteria|1
7013678|NCT01490450|11083927|FG002|Period 1|No longer met study criteria|1
7013679|NCT01490450|11083928|FG003|Period 1|No longer met study criteria|0
7013680|NCT01490450|11083925|FG000|Period 2|Lack of Efficacy|0
7013681|NCT01490450|11083926|FG001|Period 2|Lack of Efficacy|0
7013682|NCT01490450|11083927|FG002|Period 2|Lack of Efficacy|0
7013683|NCT01490450|11083928|FG003|Period 2|Lack of Efficacy|1
7013684|NCT01490450|11083925|FG000|Period 2|Adverse Event|1
7013685|NCT01490450|11083926|FG001|Period 2|Adverse Event|1
7013686|NCT01490450|11083927|FG002|Period 2|Adverse Event|0
7013687|NCT01490450|11083928|FG003|Period 2|Adverse Event|1
7013688|NCT01490450|11083925|FG000|Period 2|Withdrawal by Subject|1
7013689|NCT01490450|11083926|FG001|Period 2|Withdrawal by Subject|0
7013690|NCT01490450|11083927|FG002|Period 2|Withdrawal by Subject|0
7013691|NCT01490450|11083928|FG003|Period 2|Withdrawal by Subject|0
7013692|NCT01490450|11083925|FG000|Period 2|Lost to Follow-up|0
7013693|NCT01490450|11083926|FG001|Period 2|Lost to Follow-up|0
7013694|NCT01490450|11083927|FG002|Period 2|Lost to Follow-up|0
7013695|NCT01490450|11083928|FG003|Period 2|Lost to Follow-up|2
7013696|NCT01490580|11083943|FG000|Overall Study|Parents withdrew consent|0
7013697|NCT01490580|11083944|FG001|Overall Study|Parents withdrew consent|2
7013698|NCT01490632|11083959|FG000|Part A: Initial Treatment Period|Adverse Event|0
7013699|NCT01490632|11083960|FG001|Part A: Initial Treatment Period|Adverse Event|0
7013700|NCT01490632|11083961|FG002|Part A: Initial Treatment Period|Adverse Event|2
7013701|NCT01490632|11083962|FG003|Part A: Initial Treatment Period|Adverse Event|4
7013702|NCT01490632|11083963|FG004|Part A: Initial Treatment Period|Adverse Event|4
7013703|NCT01490632|11083964|FG005|Part A: Initial Treatment Period|Adverse Event|0
7013704|NCT01490632|11083965|FG006|Part A: Initial Treatment Period|Adverse Event|0
7013705|NCT01490632|11083966|FG007|Part A: Initial Treatment Period|Adverse Event|0
7013706|NCT01490632|11083967|FG008|Part A: Initial Treatment Period|Adverse Event|0
7013707|NCT01490632|11083968|FG009|Part A: Initial Treatment Period|Adverse Event|0
7013708|NCT01490632|11083969|FG010|Part A: Initial Treatment Period|Adverse Event|0
7013709|NCT01490632|11083970|FG011|Part A: Initial Treatment Period|Adverse Event|0
7013710|NCT01490632|11083971|FG012|Part A: Initial Treatment Period|Adverse Event|0
7013711|NCT01490632|11083972|FG013|Part A: Initial Treatment Period|Adverse Event|0
7013712|NCT01490632|11083973|FG014|Part A: Initial Treatment Period|Adverse Event|0
7013713|NCT01490632|11083974|FG015|Part A: Initial Treatment Period|Adverse Event|0
7013714|NCT01490632|11083975|FG016|Part A: Initial Treatment Period|Adverse Event|0
7013715|NCT01490632|11083976|FG017|Part A: Initial Treatment Period|Adverse Event|0
7013716|NCT01490632|11083977|FG018|Part A: Initial Treatment Period|Adverse Event|0
7013717|NCT01490632|11083978|FG019|Part A: Initial Treatment Period|Adverse Event|0
7013718|NCT01490632|11083959|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3
7013719|NCT01490632|11083960|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1
7013720|NCT01490632|11083961|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2
7013721|NCT01490632|11083962|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2
7013722|NCT01490632|11083963|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0
7013723|NCT01490632|11083964|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0
7013724|NCT01490632|11083965|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0
7013725|NCT01490632|11083966|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0
7013726|NCT01490632|11083967|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0
7013727|NCT01490632|11083968|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0
7013728|NCT01490632|11083969|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0
7013729|NCT01490632|11083970|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0
7013730|NCT01490632|11083971|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0
7013731|NCT01490632|11083972|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0
7013732|NCT01490632|11083973|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0
7013733|NCT01490632|11083974|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0
7013734|NCT01490632|11083975|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0
7013735|NCT01490632|11083976|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0
7013736|NCT01490632|11083977|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0
7013737|NCT01490632|11083978|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0
7013738|NCT01490632|11083959|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0
7013739|NCT01490632|11083960|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0
7013740|NCT01490632|11083961|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1
7013741|NCT01490632|11083962|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1
7013742|NCT01490632|11083963|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2
7013743|NCT01490632|11083964|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0
7013744|NCT01490632|11083965|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0
7013745|NCT01490632|11083966|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0
7013746|NCT01490632|11083967|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0
7013747|NCT01490632|11083968|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0
7013748|NCT01490632|11083969|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0
7013749|NCT01490632|11083970|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0
7013750|NCT01490632|11083971|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0
7013751|NCT01490632|11083972|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0
7013752|NCT01490632|11083973|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0
7013753|NCT01490632|11083974|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0
7013754|NCT01490632|11083975|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0
7013755|NCT01490632|11083976|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0
7013756|NCT01490632|11083977|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0
7013757|NCT01490632|11083978|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0
7013758|NCT01490632|11083959|FG000|Part A: Initial Treatment Period|Physician Decision|0
7013759|NCT01490632|11083960|FG001|Part A: Initial Treatment Period|Physician Decision|1
7013760|NCT01490632|11083961|FG002|Part A: Initial Treatment Period|Physician Decision|0
7013761|NCT01490632|11083962|FG003|Part A: Initial Treatment Period|Physician Decision|1
7013762|NCT01490632|11083963|FG004|Part A: Initial Treatment Period|Physician Decision|0
7013763|NCT01490632|11083964|FG005|Part A: Initial Treatment Period|Physician Decision|0
7013764|NCT01490632|11083965|FG006|Part A: Initial Treatment Period|Physician Decision|0
7013765|NCT01490632|11083966|FG007|Part A: Initial Treatment Period|Physician Decision|0
7013766|NCT01490632|11083967|FG008|Part A: Initial Treatment Period|Physician Decision|0
7013767|NCT01490632|11083968|FG009|Part A: Initial Treatment Period|Physician Decision|0
7013768|NCT01490632|11083969|FG010|Part A: Initial Treatment Period|Physician Decision|0
7013769|NCT01490632|11083970|FG011|Part A: Initial Treatment Period|Physician Decision|0
7013770|NCT01490632|11083971|FG012|Part A: Initial Treatment Period|Physician Decision|0
7013771|NCT01490632|11083972|FG013|Part A: Initial Treatment Period|Physician Decision|0
7013772|NCT01490632|11083973|FG014|Part A: Initial Treatment Period|Physician Decision|0
7013773|NCT01490632|11083974|FG015|Part A: Initial Treatment Period|Physician Decision|0
7013774|NCT01490632|11083975|FG016|Part A: Initial Treatment Period|Physician Decision|0
7013775|NCT01490632|11083976|FG017|Part A: Initial Treatment Period|Physician Decision|0
7013776|NCT01490632|11083977|FG018|Part A: Initial Treatment Period|Physician Decision|0
7013777|NCT01490632|11083978|FG019|Part A: Initial Treatment Period|Physician Decision|0
7013778|NCT01490632|11083959|FG000|Part A: Initial Treatment Period|Sponsor Decision|2
7013779|NCT01490632|11083960|FG001|Part A: Initial Treatment Period|Sponsor Decision|0
7013780|NCT01490632|11083961|FG002|Part A: Initial Treatment Period|Sponsor Decision|0
7013781|NCT01490632|11083962|FG003|Part A: Initial Treatment Period|Sponsor Decision|0
7013782|NCT01490632|11083963|FG004|Part A: Initial Treatment Period|Sponsor Decision|0
7013783|NCT01490632|11083964|FG005|Part A: Initial Treatment Period|Sponsor Decision|0
7013784|NCT01490632|11083965|FG006|Part A: Initial Treatment Period|Sponsor Decision|0
7013785|NCT01490632|11083966|FG007|Part A: Initial Treatment Period|Sponsor Decision|0
7013786|NCT01490632|11083967|FG008|Part A: Initial Treatment Period|Sponsor Decision|0
7013787|NCT01490632|11083968|FG009|Part A: Initial Treatment Period|Sponsor Decision|0
7013788|NCT01490632|11083969|FG010|Part A: Initial Treatment Period|Sponsor Decision|0
7013789|NCT01490632|11083970|FG011|Part A: Initial Treatment Period|Sponsor Decision|0
7013790|NCT01490632|11083971|FG012|Part A: Initial Treatment Period|Sponsor Decision|0
7013791|NCT01490632|11083972|FG013|Part A: Initial Treatment Period|Sponsor Decision|0
7013792|NCT01490632|11083973|FG014|Part A: Initial Treatment Period|Sponsor Decision|0
7013793|NCT01490632|11083974|FG015|Part A: Initial Treatment Period|Sponsor Decision|0
7013794|NCT01490632|11083975|FG016|Part A: Initial Treatment Period|Sponsor Decision|0
7013795|NCT01490632|11083976|FG017|Part A: Initial Treatment Period|Sponsor Decision|0
7013796|NCT01490632|11083977|FG018|Part A: Initial Treatment Period|Sponsor Decision|0
7013797|NCT01490632|11083978|FG019|Part A: Initial Treatment Period|Sponsor Decision|0
7013798|NCT01490632|11083959|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2
7013799|NCT01490632|11083960|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2
7013800|NCT01490632|11083961|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0
7013801|NCT01490632|11083962|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1
7013802|NCT01490632|11083963|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2
7013803|NCT01490632|11083964|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0
7013804|NCT01490632|11083965|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0
7013805|NCT01490632|11083966|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0
7013806|NCT01490632|11083967|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0
7013807|NCT01490632|11083968|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0
7013808|NCT01490632|11083969|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0
7013809|NCT01490632|11083970|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0
7013810|NCT01490632|11083971|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0
7013811|NCT01490632|11083972|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0
7013812|NCT01490632|11083973|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0
7013813|NCT01490632|11083974|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0
7013814|NCT01490632|11083975|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0
7013815|NCT01490632|11083976|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0
7013816|NCT01490632|11083977|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0
7013817|NCT01490632|11083978|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0
7013818|NCT01490632|11083959|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7013819|NCT01490632|11083960|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7013820|NCT01490632|11083961|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7013821|NCT01490632|11083962|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7013822|NCT01490632|11083963|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9
7013823|NCT01490632|11083964|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7013824|NCT01490632|11083965|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7013825|NCT01490632|11083966|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7013826|NCT01490632|11083967|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7013827|NCT01490632|11083968|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7013828|NCT01490632|11083969|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7013829|NCT01490632|11083970|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7013830|NCT01490632|11083971|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7013831|NCT01490632|11083972|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7013832|NCT01490632|11083973|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7013833|NCT01490632|11083974|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7013834|NCT01490632|11083975|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7013835|NCT01490632|11083976|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7013836|NCT01490632|11083977|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7013837|NCT01490632|11083978|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7013838|NCT01490632|11083959|FG000|Part B: Extension or Step-Up Period|Adverse Event|0
7013839|NCT01490632|11083960|FG001|Part B: Extension or Step-Up Period|Adverse Event|0
7013840|NCT01490632|11083961|FG002|Part B: Extension or Step-Up Period|Adverse Event|0
7013841|NCT01490632|11083962|FG003|Part B: Extension or Step-Up Period|Adverse Event|0
7013842|NCT01490632|11083963|FG004|Part B: Extension or Step-Up Period|Adverse Event|0
7013843|NCT01490632|11083964|FG005|Part B: Extension or Step-Up Period|Adverse Event|2
7013844|NCT01490632|11083965|FG006|Part B: Extension or Step-Up Period|Adverse Event|2
7013845|NCT01490632|11083966|FG007|Part B: Extension or Step-Up Period|Adverse Event|0
7013846|NCT01490632|11083967|FG008|Part B: Extension or Step-Up Period|Adverse Event|0
7013847|NCT01490632|11083968|FG009|Part B: Extension or Step-Up Period|Adverse Event|2
7013848|NCT01490632|11083969|FG010|Part B: Extension or Step-Up Period|Adverse Event|3
7013849|NCT01490632|11083970|FG011|Part B: Extension or Step-Up Period|Adverse Event|1
7013850|NCT01490632|11083971|FG012|Part B: Extension or Step-Up Period|Adverse Event|0
7013851|NCT01490632|11083972|FG013|Part B: Extension or Step-Up Period|Adverse Event|0
7013852|NCT01490632|11083973|FG014|Part B: Extension or Step-Up Period|Adverse Event|0
7013853|NCT01490632|11083974|FG015|Part B: Extension or Step-Up Period|Adverse Event|0
7013854|NCT01490632|11083975|FG016|Part B: Extension or Step-Up Period|Adverse Event|0
7013855|NCT01490632|11083976|FG017|Part B: Extension or Step-Up Period|Adverse Event|0
7013856|NCT01490632|11083977|FG018|Part B: Extension or Step-Up Period|Adverse Event|0
7013857|NCT01490632|11083978|FG019|Part B: Extension or Step-Up Period|Adverse Event|0
7013858|NCT01490632|11083959|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7013859|NCT01490632|11083960|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7013860|NCT01490632|11083961|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7013861|NCT01490632|11083962|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7013862|NCT01490632|11083963|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7013863|NCT01490632|11083964|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7013864|NCT01490632|11083965|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1
7013865|NCT01490632|11083966|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7013866|NCT01490632|11083967|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1
7013867|NCT01490632|11083968|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3
7013868|NCT01490632|11083969|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1
7013869|NCT01490632|11083970|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7013870|NCT01490632|11083971|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7013871|NCT01490632|11083972|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7013872|NCT01490632|11083973|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7013873|NCT01490632|11083974|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7013874|NCT01490632|11083975|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7013875|NCT01490632|11083976|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7013876|NCT01490632|11083977|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7013877|NCT01490632|11083978|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7013878|NCT01490632|11083959|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7013879|NCT01490632|11083960|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7013880|NCT01490632|11083961|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7013881|NCT01490632|11083962|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7013882|NCT01490632|11083963|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7013883|NCT01490632|11083964|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7013884|NCT01490632|11083965|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2
7013885|NCT01490632|11083966|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7013886|NCT01490632|11083967|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7013887|NCT01490632|11083968|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1
7013888|NCT01490632|11083969|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7013889|NCT01490632|11083970|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7013890|NCT01490632|11083971|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7013891|NCT01490632|11083972|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7013892|NCT01490632|11083973|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7013893|NCT01490632|11083974|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7013894|NCT01490632|11083975|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7013895|NCT01490632|11083976|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7013896|NCT01490632|11083977|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7013897|NCT01490632|11083978|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7013898|NCT01490632|11083959|FG000|Part B: Extension or Step-Up Period|Physician Decision|0
7013899|NCT01490632|11083960|FG001|Part B: Extension or Step-Up Period|Physician Decision|0
7013900|NCT01490632|11083961|FG002|Part B: Extension or Step-Up Period|Physician Decision|0
7013901|NCT01490632|11083962|FG003|Part B: Extension or Step-Up Period|Physician Decision|0
7013902|NCT01490632|11083963|FG004|Part B: Extension or Step-Up Period|Physician Decision|0
7013903|NCT01490632|11083964|FG005|Part B: Extension or Step-Up Period|Physician Decision|0
7013904|NCT01490632|11083965|FG006|Part B: Extension or Step-Up Period|Physician Decision|1
7013905|NCT01490632|11083966|FG007|Part B: Extension or Step-Up Period|Physician Decision|0
7013906|NCT01490632|11083967|FG008|Part B: Extension or Step-Up Period|Physician Decision|0
7013907|NCT01490632|11083968|FG009|Part B: Extension or Step-Up Period|Physician Decision|0
7013908|NCT01490632|11083969|FG010|Part B: Extension or Step-Up Period|Physician Decision|0
7013909|NCT01490632|11083970|FG011|Part B: Extension or Step-Up Period|Physician Decision|0
7013910|NCT01490632|11083971|FG012|Part B: Extension or Step-Up Period|Physician Decision|0
7013911|NCT01490632|11083972|FG013|Part B: Extension or Step-Up Period|Physician Decision|0
7013912|NCT01490632|11083973|FG014|Part B: Extension or Step-Up Period|Physician Decision|0
7013913|NCT01490632|11083974|FG015|Part B: Extension or Step-Up Period|Physician Decision|0
7013914|NCT01490632|11083975|FG016|Part B: Extension or Step-Up Period|Physician Decision|0
7013915|NCT01490632|11083976|FG017|Part B: Extension or Step-Up Period|Physician Decision|0
7013916|NCT01490632|11083977|FG018|Part B: Extension or Step-Up Period|Physician Decision|0
7013917|NCT01490632|11083978|FG019|Part B: Extension or Step-Up Period|Physician Decision|0
7013918|NCT01490632|11083959|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0
7013919|NCT01490632|11083960|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0
7013920|NCT01490632|11083961|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0
7013921|NCT01490632|11083962|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0
7013922|NCT01490632|11083963|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0
7013923|NCT01490632|11083964|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1
7013924|NCT01490632|11083965|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0
7013925|NCT01490632|11083966|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0
7013926|NCT01490632|11083967|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0
7013927|NCT01490632|11083968|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0
7013928|NCT01490632|11083969|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0
7013929|NCT01490632|11083970|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0
7013930|NCT01490632|11083971|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0
7013931|NCT01490632|11083972|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0
7013932|NCT01490632|11083973|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0
7013933|NCT01490632|11083974|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0
7013934|NCT01490632|11083975|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0
7013935|NCT01490632|11083976|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0
7013936|NCT01490632|11083977|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0
7013937|NCT01490632|11083978|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0
7013938|NCT01490632|11083959|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7013939|NCT01490632|11083960|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7013940|NCT01490632|11083961|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7013941|NCT01490632|11083962|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7013942|NCT01490632|11083963|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7013943|NCT01490632|11083964|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7013944|NCT01490632|11083965|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
7013945|NCT01490632|11083966|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7013946|NCT01490632|11083967|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
7013947|NCT01490632|11083968|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7013948|NCT01490632|11083969|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
7013949|NCT01490632|11083970|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2
7013950|NCT01490632|11083971|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7013951|NCT01490632|11083972|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7013952|NCT01490632|11083973|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7013953|NCT01490632|11083974|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7013954|NCT01490632|11083975|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7013955|NCT01490632|11083976|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7013956|NCT01490632|11083977|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7013957|NCT01490632|11083978|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7013958|NCT01490632|11083959|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7013959|NCT01490632|11083960|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7013960|NCT01490632|11083961|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7013961|NCT01490632|11083962|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7013962|NCT01490632|11083963|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7013963|NCT01490632|11083964|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1
7013964|NCT01490632|11083965|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
7013965|NCT01490632|11083966|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
7013966|NCT01490632|11083967|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8
7013967|NCT01490632|11083968|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19
7013968|NCT01490632|11083969|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16
7013969|NCT01490632|11083970|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5
7013970|NCT01490632|11083971|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7013971|NCT01490632|11083972|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7013972|NCT01490632|11083973|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7013973|NCT01490632|11083974|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7013974|NCT01490632|11083975|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7013975|NCT01490632|11083976|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7013976|NCT01490632|11083977|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7013977|NCT01490632|11083978|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7013978|NCT01490632|11083959|FG000|Part C: Washout or Step-Down Period|Adverse Event|0
7013979|NCT01490632|11083960|FG001|Part C: Washout or Step-Down Period|Adverse Event|0
7013980|NCT01490632|11083961|FG002|Part C: Washout or Step-Down Period|Adverse Event|0
7013981|NCT01490632|11083962|FG003|Part C: Washout or Step-Down Period|Adverse Event|0
7013982|NCT01490632|11083963|FG004|Part C: Washout or Step-Down Period|Adverse Event|0
7013983|NCT01490632|11083964|FG005|Part C: Washout or Step-Down Period|Adverse Event|0
7013984|NCT01490632|11083965|FG006|Part C: Washout or Step-Down Period|Adverse Event|0
7013985|NCT01490632|11083966|FG007|Part C: Washout or Step-Down Period|Adverse Event|0
7013986|NCT01490632|11083967|FG008|Part C: Washout or Step-Down Period|Adverse Event|0
7013987|NCT01490632|11083968|FG009|Part C: Washout or Step-Down Period|Adverse Event|0
7013988|NCT01490632|11083969|FG010|Part C: Washout or Step-Down Period|Adverse Event|0
7013989|NCT01490632|11083970|FG011|Part C: Washout or Step-Down Period|Adverse Event|0
7013990|NCT01490632|11083971|FG012|Part C: Washout or Step-Down Period|Adverse Event|0
7013991|NCT01490632|11083972|FG013|Part C: Washout or Step-Down Period|Adverse Event|0
7013992|NCT01490632|11083973|FG014|Part C: Washout or Step-Down Period|Adverse Event|2
7013993|NCT01490632|11083974|FG015|Part C: Washout or Step-Down Period|Adverse Event|2
7013994|NCT01490632|11083975|FG016|Part C: Washout or Step-Down Period|Adverse Event|0
7013995|NCT01490632|11083976|FG017|Part C: Washout or Step-Down Period|Adverse Event|0
7013996|NCT01490632|11083977|FG018|Part C: Washout or Step-Down Period|Adverse Event|0
7013997|NCT01490632|11083978|FG019|Part C: Washout or Step-Down Period|Adverse Event|0
7013998|NCT01490632|11083959|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7013999|NCT01490632|11083960|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7014000|NCT01490632|11083961|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7014001|NCT01490632|11083962|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7014002|NCT01490632|11083963|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7014003|NCT01490632|11083964|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7014004|NCT01490632|11083965|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7014005|NCT01490632|11083966|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7014006|NCT01490632|11083967|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7014007|NCT01490632|11083968|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7014008|NCT01490632|11083969|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7014009|NCT01490632|11083970|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7014010|NCT01490632|11083971|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7014011|NCT01490632|11083972|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1
7014012|NCT01490632|11083973|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7014013|NCT01490632|11083974|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7014014|NCT01490632|11083975|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7014015|NCT01490632|11083976|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7014016|NCT01490632|11083977|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7014017|NCT01490632|11083978|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7014018|NCT01490632|11083959|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7014019|NCT01490632|11083960|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7014020|NCT01490632|11083961|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7014021|NCT01490632|11083962|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7014022|NCT01490632|11083963|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7014023|NCT01490632|11083964|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7014024|NCT01490632|11083965|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7014025|NCT01490632|11083966|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7014026|NCT01490632|11083967|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7014027|NCT01490632|11083968|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7014028|NCT01490632|11083969|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7014029|NCT01490632|11083970|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7014030|NCT01490632|11083971|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7014031|NCT01490632|11083972|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7014032|NCT01490632|11083973|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2
7014033|NCT01490632|11083974|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1
7014034|NCT01490632|11083975|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7014035|NCT01490632|11083976|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7014036|NCT01490632|11083977|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7014037|NCT01490632|11083978|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7014038|NCT01490632|11083959|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7014039|NCT01490632|11083960|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7014040|NCT01490632|11083961|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7014041|NCT01490632|11083962|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7014042|NCT01490632|11083963|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7014043|NCT01490632|11083964|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7014044|NCT01490632|11083965|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7014045|NCT01490632|11083966|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7014046|NCT01490632|11083967|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7014047|NCT01490632|11083968|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7014048|NCT01490632|11083969|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7014049|NCT01490632|11083970|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7014050|NCT01490632|11083971|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5
7014051|NCT01490632|11083972|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9
7014052|NCT01490632|11083973|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14
7014053|NCT01490632|11083974|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34
7014054|NCT01490632|11083975|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7014055|NCT01490632|11083976|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7014056|NCT01490632|11083977|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7014057|NCT01490632|11083978|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7014058|NCT01490632|11083959|FG000|Part D: Re-Treatment Period|Adverse Event|0
7014059|NCT01490632|11083960|FG001|Part D: Re-Treatment Period|Adverse Event|0
7014060|NCT01490632|11083961|FG002|Part D: Re-Treatment Period|Adverse Event|0
7014061|NCT01490632|11083962|FG003|Part D: Re-Treatment Period|Adverse Event|0
7014062|NCT01490632|11083963|FG004|Part D: Re-Treatment Period|Adverse Event|0
7014063|NCT01490632|11083964|FG005|Part D: Re-Treatment Period|Adverse Event|0
7014064|NCT01490632|11083965|FG006|Part D: Re-Treatment Period|Adverse Event|0
7014065|NCT01490632|11083966|FG007|Part D: Re-Treatment Period|Adverse Event|0
7014066|NCT01490632|11083967|FG008|Part D: Re-Treatment Period|Adverse Event|0
7014067|NCT01490632|11083968|FG009|Part D: Re-Treatment Period|Adverse Event|0
7014068|NCT01490632|11083969|FG010|Part D: Re-Treatment Period|Adverse Event|0
7014069|NCT01490632|11083970|FG011|Part D: Re-Treatment Period|Adverse Event|0
7014070|NCT01490632|11083971|FG012|Part D: Re-Treatment Period|Adverse Event|0
7014071|NCT01490632|11083972|FG013|Part D: Re-Treatment Period|Adverse Event|0
7014072|NCT01490632|11083973|FG014|Part D: Re-Treatment Period|Adverse Event|0
7014073|NCT01490632|11083974|FG015|Part D: Re-Treatment Period|Adverse Event|0
7014074|NCT01490632|11083975|FG016|Part D: Re-Treatment Period|Adverse Event|0
7014075|NCT01490632|11083976|FG017|Part D: Re-Treatment Period|Adverse Event|1
7014076|NCT01490632|11083977|FG018|Part D: Re-Treatment Period|Adverse Event|1
7014077|NCT01490632|11083978|FG019|Part D: Re-Treatment Period|Adverse Event|3
7014078|NCT01490632|11083959|FG000|Part D: Re-Treatment Period|Death|0
7014079|NCT01490632|11083960|FG001|Part D: Re-Treatment Period|Death|0
7014080|NCT01490632|11083961|FG002|Part D: Re-Treatment Period|Death|0
7014081|NCT01490632|11083962|FG003|Part D: Re-Treatment Period|Death|0
7014082|NCT01490632|11083963|FG004|Part D: Re-Treatment Period|Death|0
7014083|NCT01490632|11083964|FG005|Part D: Re-Treatment Period|Death|0
7014084|NCT01490632|11083965|FG006|Part D: Re-Treatment Period|Death|0
7014085|NCT01490632|11083966|FG007|Part D: Re-Treatment Period|Death|0
7014086|NCT01490632|11083967|FG008|Part D: Re-Treatment Period|Death|0
7014087|NCT01490632|11083968|FG009|Part D: Re-Treatment Period|Death|0
7014088|NCT01490632|11083969|FG010|Part D: Re-Treatment Period|Death|0
7014089|NCT01490632|11083970|FG011|Part D: Re-Treatment Period|Death|0
7014090|NCT01490632|11083971|FG012|Part D: Re-Treatment Period|Death|0
7014091|NCT01490632|11083972|FG013|Part D: Re-Treatment Period|Death|0
7014092|NCT01490632|11083973|FG014|Part D: Re-Treatment Period|Death|0
7014093|NCT01490632|11083974|FG015|Part D: Re-Treatment Period|Death|0
7014094|NCT01490632|11083975|FG016|Part D: Re-Treatment Period|Death|0
7014095|NCT01490632|11083976|FG017|Part D: Re-Treatment Period|Death|0
7014096|NCT01490632|11083977|FG018|Part D: Re-Treatment Period|Death|1
7014097|NCT01490632|11083978|FG019|Part D: Re-Treatment Period|Death|0
7014098|NCT01490632|11083959|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0
7014099|NCT01490632|11083960|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0
7014100|NCT01490632|11083961|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0
7014101|NCT01490632|11083962|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0
7014102|NCT01490632|11083963|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0
7014103|NCT01490632|11083964|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0
7014104|NCT01490632|11083965|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0
7014105|NCT01490632|11083966|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0
7014106|NCT01490632|11083967|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0
7014107|NCT01490632|11083968|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0
7014108|NCT01490632|11083969|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0
7014109|NCT01490632|11083970|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0
7014110|NCT01490632|11083971|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0
7014111|NCT01490632|11083972|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0
7060509|NCT01919814|11156797|FG000|Overall Study|Adverse Event|1
7014112|NCT01490632|11083973|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0
7014113|NCT01490632|11083974|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0
7014114|NCT01490632|11083975|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0
7014115|NCT01490632|11083976|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3
7014116|NCT01490632|11083977|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1
7014117|NCT01490632|11083978|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2
7014118|NCT01490632|11083959|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0
7014119|NCT01490632|11083960|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0
7014120|NCT01490632|11083961|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0
7014121|NCT01490632|11083962|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0
7014122|NCT01490632|11083963|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0
7014123|NCT01490632|11083964|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0
7014124|NCT01490632|11083965|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0
7014125|NCT01490632|11083966|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0
7014126|NCT01490632|11083967|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0
7014127|NCT01490632|11083968|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0
7014128|NCT01490632|11083969|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0
7014129|NCT01490632|11083970|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0
7014130|NCT01490632|11083971|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0
7014131|NCT01490632|11083972|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0
7014132|NCT01490632|11083973|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0
7014133|NCT01490632|11083974|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0
7014134|NCT01490632|11083975|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0
7014135|NCT01490632|11083976|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0
7014136|NCT01490632|11083977|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1
7014137|NCT01490632|11083978|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0
7014138|NCT01490632|11083959|FG000|Part D: Re-Treatment Period|Physician Decision|0
7014139|NCT01490632|11083960|FG001|Part D: Re-Treatment Period|Physician Decision|0
7014140|NCT01490632|11083961|FG002|Part D: Re-Treatment Period|Physician Decision|0
7014141|NCT01490632|11083962|FG003|Part D: Re-Treatment Period|Physician Decision|0
7014142|NCT01490632|11083963|FG004|Part D: Re-Treatment Period|Physician Decision|0
7014143|NCT01490632|11083964|FG005|Part D: Re-Treatment Period|Physician Decision|0
7014144|NCT01490632|11083965|FG006|Part D: Re-Treatment Period|Physician Decision|0
7014145|NCT01490632|11083966|FG007|Part D: Re-Treatment Period|Physician Decision|0
7014146|NCT01490632|11083967|FG008|Part D: Re-Treatment Period|Physician Decision|0
7014147|NCT01490632|11083968|FG009|Part D: Re-Treatment Period|Physician Decision|0
7014148|NCT01490632|11083969|FG010|Part D: Re-Treatment Period|Physician Decision|0
7014149|NCT01490632|11083970|FG011|Part D: Re-Treatment Period|Physician Decision|0
7014150|NCT01490632|11083971|FG012|Part D: Re-Treatment Period|Physician Decision|0
7014151|NCT01490632|11083972|FG013|Part D: Re-Treatment Period|Physician Decision|0
7014152|NCT01490632|11083973|FG014|Part D: Re-Treatment Period|Physician Decision|0
7014153|NCT01490632|11083974|FG015|Part D: Re-Treatment Period|Physician Decision|0
7014154|NCT01490632|11083975|FG016|Part D: Re-Treatment Period|Physician Decision|0
7014155|NCT01490632|11083976|FG017|Part D: Re-Treatment Period|Physician Decision|0
7014156|NCT01490632|11083977|FG018|Part D: Re-Treatment Period|Physician Decision|1
7014157|NCT01490632|11083978|FG019|Part D: Re-Treatment Period|Physician Decision|1
7014158|NCT01490632|11083959|FG000|Part D: Re-Treatment Period|Protocol Violation|0
7014159|NCT01490632|11083960|FG001|Part D: Re-Treatment Period|Protocol Violation|0
7014160|NCT01490632|11083961|FG002|Part D: Re-Treatment Period|Protocol Violation|0
7014161|NCT01490632|11083962|FG003|Part D: Re-Treatment Period|Protocol Violation|0
7014162|NCT01490632|11083963|FG004|Part D: Re-Treatment Period|Protocol Violation|0
7014163|NCT01490632|11083964|FG005|Part D: Re-Treatment Period|Protocol Violation|0
7014164|NCT01490632|11083965|FG006|Part D: Re-Treatment Period|Protocol Violation|0
7014165|NCT01490632|11083966|FG007|Part D: Re-Treatment Period|Protocol Violation|0
7014166|NCT01490632|11083967|FG008|Part D: Re-Treatment Period|Protocol Violation|0
7014167|NCT01490632|11083968|FG009|Part D: Re-Treatment Period|Protocol Violation|0
7014168|NCT01490632|11083969|FG010|Part D: Re-Treatment Period|Protocol Violation|0
7014169|NCT01490632|11083970|FG011|Part D: Re-Treatment Period|Protocol Violation|0
7014170|NCT01490632|11083971|FG012|Part D: Re-Treatment Period|Protocol Violation|0
7014171|NCT01490632|11083972|FG013|Part D: Re-Treatment Period|Protocol Violation|0
7014172|NCT01490632|11083973|FG014|Part D: Re-Treatment Period|Protocol Violation|0
7014173|NCT01490632|11083974|FG015|Part D: Re-Treatment Period|Protocol Violation|0
7014174|NCT01490632|11083975|FG016|Part D: Re-Treatment Period|Protocol Violation|0
7014175|NCT01490632|11083976|FG017|Part D: Re-Treatment Period|Protocol Violation|0
7014176|NCT01490632|11083977|FG018|Part D: Re-Treatment Period|Protocol Violation|1
7014177|NCT01490632|11083978|FG019|Part D: Re-Treatment Period|Protocol Violation|0
7014178|NCT01490632|11083959|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0
7014179|NCT01490632|11083960|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0
7014180|NCT01490632|11083961|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0
7014181|NCT01490632|11083962|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0
7014182|NCT01490632|11083963|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0
7014183|NCT01490632|11083964|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0
7014184|NCT01490632|11083965|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0
7014185|NCT01490632|11083966|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0
7014186|NCT01490632|11083967|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0
7014187|NCT01490632|11083968|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0
7014188|NCT01490632|11083969|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0
7014189|NCT01490632|11083970|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0
7014190|NCT01490632|11083971|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0
7014191|NCT01490632|11083972|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0
7014192|NCT01490632|11083973|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0
7014193|NCT01490632|11083974|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0
7014194|NCT01490632|11083975|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0
7014195|NCT01490632|11083976|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1
7014196|NCT01490632|11083977|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1
7014197|NCT01490632|11083978|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1
7014198|NCT01490697|11084027|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1
7014199|NCT01490697|11084028|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2
7014200|NCT01490814|11084053|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3
7014201|NCT01490814|11084054|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3
7014202|NCT01490814|11084053|FG000|Overall Study|Physician Decision|1
7014203|NCT01490814|11084054|FG001|Overall Study|Physician Decision|0
7014204|NCT01490814|11084053|FG000|Overall Study|Withdrawal by Subject|0
7014205|NCT01490814|11084054|FG001|Overall Study|Withdrawal by Subject|5
7014206|NCT01490840|11084062|FG000|Phase 1|Lost to Follow-up|1
7014207|NCT01490840|11084063|FG001|Phase 1|Lost to Follow-up|0
7014208|NCT01490840|11084062|FG000|Phase 1|Adverse Event|2
7014209|NCT01490840|11084063|FG001|Phase 1|Adverse Event|1
7014210|NCT01490840|11084062|FG000|Phase 1|Withdrawal by Subject|6
7014211|NCT01490840|11084063|FG001|Phase 1|Withdrawal by Subject|5
7014212|NCT01490840|11084062|FG000|Phase 1|Visit 6a omitted|1
7014213|NCT01490840|11084063|FG001|Phase 1|Visit 6a omitted|0
7014214|NCT01490840|11084062|FG000|Phase 2|Withdrawal by Subject|4
7014215|NCT01490840|11084063|FG001|Phase 2|Withdrawal by Subject|3
7014216|NCT01490840|11084062|FG000|Phase 2|Permanent interruption of fingolimod|0
7014217|NCT01490840|11084063|FG001|Phase 2|Permanent interruption of fingolimod|1
7014218|NCT01490840|11084062|FG000|Phase 2|Lost to Follow-up|1
7014219|NCT01490840|11084063|FG001|Phase 2|Lost to Follow-up|1
7014220|NCT01490840|11084062|FG000|Phase 2|Adverse Event|1
7014221|NCT01490840|11084063|FG001|Phase 2|Adverse Event|1
7014222|NCT01490866|11084069|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6
7014223|NCT01490866|11084069|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6
7014224|NCT01490866|11084069|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5
7014225|NCT01490866|11084069|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1
7014226|NCT01490866|11084069|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1
7014227|NCT01490866|11084069|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2
7014228|NCT01490866|11084069|FG000|Axitinib Maintenance Therapy|Disease Progression|30
7014229|NCT01490866|11084069|FG000|Axitinib Maintenance Therapy|Adverse Event|12
7014230|NCT01490866|11084069|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3
7014231|NCT01490866|11084069|FG000|Axitinib Maintenance Therapy|Protocol Violation|2
7014232|NCT01490866|11084069|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2
7014233|NCT01490918|11084083|FG000|Overall Study|Lost to Follow-up|2
7014234|NCT01490918|11084084|FG001|Overall Study|Lost to Follow-up|1
7014235|NCT01490918|11084085|FG002|Overall Study|Lost to Follow-up|0
7014236|NCT01490918|11084083|FG000|Overall Study|Withdrawal by Subject|7
7014237|NCT01490918|11084084|FG001|Overall Study|Withdrawal by Subject|8
7014238|NCT01490918|11084085|FG002|Overall Study|Withdrawal by Subject|3
7014239|NCT01490918|11084083|FG000|Overall Study|Adverse Event|0
7014240|NCT01490918|11084084|FG001|Overall Study|Adverse Event|0
7014241|NCT01490918|11084085|FG002|Overall Study|Adverse Event|1
7014242|NCT01490918|11084083|FG000|Overall Study|other cause|4
7014243|NCT01490918|11084084|FG001|Overall Study|other cause|5
7014244|NCT01490918|11084085|FG002|Overall Study|other cause|8
7014245|NCT01491035|11084122|FG000|Overall Study|Lost to Follow-up|0
7014246|NCT01491035|11084123|FG001|Overall Study|Lost to Follow-up|0
7014247|NCT01491035|11084124|FG002|Overall Study|Lost to Follow-up|0
7014248|NCT01491035|11084125|FG003|Overall Study|Lost to Follow-up|0
7014249|NCT01491035|11084126|FG004|Overall Study|Lost to Follow-up|1
7014250|NCT01491035|11084127|FG005|Overall Study|Lost to Follow-up|0
7014251|NCT01491035|11084128|FG006|Overall Study|Lost to Follow-up|0
7014252|NCT01491035|11084129|FG007|Overall Study|Lost to Follow-up|0
7014253|NCT01491178|11084170|FG000|Overall Study|Adverse Event|1016
7014254|NCT01491178|11084170|FG000|Overall Study|Improvement of NVAF|210
7014255|NCT01491178|11084170|FG000|Overall Study|To conduct invasive treatment|59
7014256|NCT01491178|11084170|FG000|Overall Study|Lost to follow-up (unknown reason)|287
7014257|NCT01491178|11084170|FG000|Overall Study|Lost to follow-up (changing hospital)|545
7014258|NCT01491178|11084170|FG000|Overall Study|To take a contraindication|20
7014259|NCT01491178|11084170|FG000|Overall Study|Other than specified above|657
7014260|NCT01491607|11084187|FG000|Overall Study|Lost to Follow-up|7
7014261|NCT01491607|11084187|FG000|Overall Study|Withdrawal by Subject|3
7014262|NCT01491672|11084260|FG000|Overall Study|Lost to Follow-up|0
7014263|NCT01491672|11084261|FG001|Overall Study|Lost to Follow-up|4
7014264|NCT01491672|11084262|FG002|Overall Study|Lost to Follow-up|1
7014265|NCT01491672|11084260|FG000|Overall Study|Withdrawal by Subject|6
7014266|NCT01491672|11084261|FG001|Overall Study|Withdrawal by Subject|7
7014267|NCT01491672|11084262|FG002|Overall Study|Withdrawal by Subject|0
7014268|NCT01491672|11084260|FG000|Overall Study|Adverse Event|8
7014269|NCT01491672|11084261|FG001|Overall Study|Adverse Event|10
7014270|NCT01491672|11084262|FG002|Overall Study|Adverse Event|4
7014271|NCT01491672|11084260|FG000|Overall Study|Disease progression|42
7014272|NCT01491672|11084261|FG001|Overall Study|Disease progression|34
7014273|NCT01491672|11084262|FG002|Overall Study|Disease progression|6
7014274|NCT01491672|11084260|FG000|Overall Study|Protocol deviation|0
7014275|NCT01491672|11084261|FG001|Overall Study|Protocol deviation|1
7014276|NCT01491672|11084262|FG002|Overall Study|Protocol deviation|0
7014277|NCT01491672|11084260|FG000|Overall Study|Death|0
7014278|NCT01491672|11084261|FG001|Overall Study|Death|4
7014279|NCT01491672|11084262|FG002|Overall Study|Death|0
7014280|NCT01491737|11084274|FG000|Overall Study|Withdrawal by Subject|20
7014281|NCT01491737|11084275|FG001|Overall Study|Withdrawal by Subject|17
7014282|NCT01491737|11084274|FG000|Overall Study|Lost to Follow-up|2
7014283|NCT01491737|11084275|FG001|Overall Study|Lost to Follow-up|10
7014284|NCT01491737|11084274|FG000|Overall Study|Death|63
7014285|NCT01491737|11084275|FG001|Overall Study|Death|57
7014286|NCT01491737|11084274|FG000|Overall Study|Study Termination by Sponsor|36
7014287|NCT01491737|11084275|FG001|Overall Study|Study Termination by Sponsor|36
7014288|NCT01491737|11084274|FG000|Overall Study|Reason Not Specified|8
7014289|NCT01491737|11084275|FG001|Overall Study|Reason Not Specified|9
7014290|NCT01491802|11084281|FG000|Overall Study|Adverse Event|1
7014291|NCT01491802|11084282|FG001|Overall Study|Adverse Event|1
7014292|NCT01491802|11084281|FG000|Overall Study|Withdrawal by Subject|0
7014293|NCT01491802|11084282|FG001|Overall Study|Withdrawal by Subject|1
7014294|NCT01491841|11084289|FG000|Overall Study|Screen Failure|10
7014295|NCT01491841|11084289|FG000|Overall Study|Withdrawal by Subject|1
7014296|NCT01491854|11084301|FG000|Overall Study|mainly due to premature termination|93
7014297|NCT01491854|11084301|FG000|Overall Study|Death|1
7014298|NCT01491854|11084301|FG000|Overall Study|Withdrawal by Subject|3
7014299|NCT01491854|11084301|FG000|Overall Study|Lost to Follow-up|33
7014300|NCT01491919|11084308|FG000|Overall Study|Insufficient PK sampling|1
7014301|NCT01491919|11084309|FG001|Overall Study|Insufficient PK sampling|2
7014302|NCT01491919|11084310|FG002|Overall Study|Insufficient PK sampling|1
7014303|NCT01491945|11084320|FG000|Overall Study|Death|30
7014304|NCT01491945|11084320|FG000|Overall Study|Withdrwan/LTF|16
7014305|NCT01491945|11084320|FG000|Overall Study|Conversion|4
7014306|NCT01491945|11084320|FG000|Overall Study|Missed Visit|1
7014307|NCT01492088|11084345|FG000|Overall Study|Withdrawal by Patient|0
7014308|NCT01492088|11084346|FG001|Overall Study|Withdrawal by Patient|2
7014309|NCT01492088|11084347|FG002|Overall Study|Withdrawal by Patient|0
7014310|NCT01492088|11084345|FG000|Overall Study|Death|1
7014311|NCT01492088|11084346|FG001|Overall Study|Death|6
7014312|NCT01492088|11084347|FG002|Overall Study|Death|2
7014313|NCT01492088|11084345|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2
7014314|NCT01492088|11084346|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0
7014315|NCT01492088|11084347|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1
7014316|NCT01492088|11084345|FG000|Overall Study|Alive at Last Follow-up|0
7014317|NCT01492088|11084346|FG001|Overall Study|Alive at Last Follow-up|6
7014318|NCT01492088|11084347|FG002|Overall Study|Alive at Last Follow-up|11
7014319|NCT01492101|11084360|FG000|Overall Study|Death|323
7014320|NCT01492101|11084361|FG001|Overall Study|Death|322
7014321|NCT01492101|11084360|FG000|Overall Study|Withdrawal by Subject|14
7014322|NCT01492101|11084361|FG001|Overall Study|Withdrawal by Subject|18
7014323|NCT01492101|11084360|FG000|Overall Study|Lost to Follow-up|0
7014324|NCT01492101|11084361|FG001|Overall Study|Lost to Follow-up|2
7014325|NCT01492400|11084378|FG000|Overall Study|Miscellaneous Reasons|2
7014326|NCT01492400|11084379|FG001|Overall Study|Miscellaneous Reasons|3
7014327|NCT01492400|11084378|FG000|Overall Study|Personal Reasons|0
7014328|NCT01492400|11084379|FG001|Overall Study|Personal Reasons|5
7014329|NCT01492400|11084378|FG000|Overall Study|Lost to Follow-up|3
7014330|NCT01492400|11084379|FG001|Overall Study|Lost to Follow-up|1
7014331|NCT01492400|11084378|FG000|Overall Study|Pregnancy|0
7014332|NCT01492400|11084379|FG001|Overall Study|Pregnancy|1
7014333|NCT01492400|11084378|FG000|Overall Study|Lack of Efficacy|1
7014334|NCT01492400|11084379|FG001|Overall Study|Lack of Efficacy|1
7014335|NCT01492400|11084378|FG000|Overall Study|Adverse Event|10
7014336|NCT01492400|11084379|FG001|Overall Study|Adverse Event|5
7014337|NCT01492426|11084387|FG000|Treatment|Death|0
7014338|NCT01492426|11084388|FG001|Treatment|Death|1
7014339|NCT01492426|11084387|FG000|Treatment|Other|1
7014340|NCT01492426|11084388|FG001|Treatment|Other|0
7014341|NCT01492426|11084387|FG000|Treatment|Adverse Event|25
7014342|NCT01492426|11084388|FG001|Treatment|Adverse Event|25
7014343|NCT01492426|11084387|FG000|Treatment|Lack of Efficacy|38
7014344|NCT01492426|11084388|FG001|Treatment|Lack of Efficacy|5
7014345|NCT01492426|11084387|FG000|Treatment|Participant withdrew consent|1
7014346|NCT01492426|11084388|FG001|Treatment|Participant withdrew consent|2
7014347|NCT01492426|11084387|FG000|Treatment|Poor compliance/noncompliance|1
7014348|NCT01492426|11084388|FG001|Treatment|Poor compliance/noncompliance|0
7014349|NCT01492426|11084387|FG000|Treatment|Subject requested discontinue study drug|7
7014350|NCT01492426|11084388|FG001|Treatment|Subject requested discontinue study drug|3
7014351|NCT01492426|11084387|FG000|Treatment|Lost to Follow-up|9
7014352|NCT01492426|11084388|FG001|Treatment|Lost to Follow-up|4
7014353|NCT01492426|11084387|FG000|Treatment|Participant does not meet study criteria|1
7014354|NCT01492426|11084388|FG001|Treatment|Participant does not meet study criteria|0
7014355|NCT01492426|11084387|FG000|Follow-Up|Protocol Requires no Follow-Up|2
7014356|NCT01492426|11084388|FG001|Follow-Up|Protocol Requires no Follow-Up|1
7014357|NCT01492426|11084387|FG000|Follow-Up|Death|1
7014358|NCT01492426|11084388|FG001|Follow-Up|Death|0
7014359|NCT01492426|11084387|FG000|Follow-Up|Other|4
7014360|NCT01492426|11084388|FG001|Follow-Up|Other|2
7014361|NCT01492426|11084387|FG000|Follow-Up|Participant Withdrew Consent|6
7014362|NCT01492426|11084388|FG001|Follow-Up|Participant Withdrew Consent|1
7014363|NCT01492426|11084387|FG000|Follow-Up|Lost to Follow-up|12
7014364|NCT01492426|11084388|FG001|Follow-Up|Lost to Follow-up|6
7014365|NCT01492439|11084400|FG000|Overall Study|Withdrew from RTE|4
7014366|NCT01492439|11084401|FG001|Overall Study|Withdrew from RTE|9
7014367|NCT01492686|11084439|FG000|Double-blind Phase|Adverse Event|0
7014368|NCT01492686|11084440|FG001|Double-blind Phase|Adverse Event|2
7014369|NCT01492686|11084439|FG000|Double-blind Phase|Physician Decision|0
7014370|NCT01492686|11084440|FG001|Double-blind Phase|Physician Decision|1
7014371|NCT01492686|11084439|FG000|Double-blind Phase|Withdrawal by Subject|0
7014372|NCT01492686|11084440|FG001|Double-blind Phase|Withdrawal by Subject|2
7014373|NCT01492686|11084439|FG000|Double-blind Phase|Due to a discontinuation criterion|2
7014374|NCT01492686|11084440|FG001|Double-blind Phase|Due to a discontinuation criterion|3
7014375|NCT01492686|11084439|FG000|Open-label Phase|Adverse Event|1
7014376|NCT01492686|11084440|FG001|Open-label Phase|Adverse Event|2
7014377|NCT01492686|11084439|FG000|Open-label Phase|Physician Decision|1
7014378|NCT01492686|11084440|FG001|Open-label Phase|Physician Decision|0
7014379|NCT01492686|11084439|FG000|Open-label Phase|Withdrawal by Subject|6
7014380|NCT01492686|11084440|FG001|Open-label Phase|Withdrawal by Subject|7
7014381|NCT01492686|11084439|FG000|Open-label Phase|Due to a discontinuation criterion|4
7014382|NCT01492686|11084440|FG001|Open-label Phase|Due to a discontinuation criterion|9
7014383|NCT01493089|11084468|FG000|Overall Study|Protocol Violation|2
7014384|NCT01493089|11084469|FG001|Overall Study|Protocol Violation|2
7014385|NCT01493089|11084468|FG000|Overall Study|Withdrawal by Subject|1
7014386|NCT01493089|11084469|FG001|Overall Study|Withdrawal by Subject|0
7014387|NCT01493089|11084468|FG000|Overall Study|Physician Decision|0
7014388|NCT01493089|11084469|FG001|Overall Study|Physician Decision|1
7014389|NCT01493284|11084490|FG000|Overall Study|Death|29
7014390|NCT01493284|11084490|FG000|Overall Study|Withdrawal by Subject|32
7014391|NCT01493414|11084494|FG000|Overall Study|Adverse Event|405
7014392|NCT01493414|11084494|FG000|Overall Study|Disease progression|204
7014393|NCT01493414|11084494|FG000|Overall Study|Death|101
7014394|NCT01493414|11084494|FG000|Overall Study|Physician Decision|93
7014395|NCT01493414|11084494|FG000|Overall Study|Withdrawal by Subject|79
7014396|NCT01493414|11084494|FG000|Overall Study|Protocol deviation|27
7014397|NCT01493414|11084494|FG000|Overall Study|Administrative problems|25
7014398|NCT01493414|11084494|FG000|Overall Study|Lost to Follow-up|16
7014399|NCT01493427|11084502|FG000|Overall Study|Adverse Event|10
7014400|NCT01493427|11084502|FG000|Overall Study|Personal Reasons|4
7014401|NCT01493427|11084502|FG000|Overall Study|Lost to Follow-up|2
7014402|NCT01493427|11084502|FG000|Overall Study|Inability to Follow Instructions|2
7014403|NCT01493427|11084502|FG000|Overall Study|Other|2
7014404|NCT01493531|11084509|FG000|Overall Study|Adverse Event|4
7014405|NCT01493531|11084510|FG001|Overall Study|Adverse Event|12
7014406|NCT01493531|11084511|FG002|Overall Study|Adverse Event|9
7014407|NCT01493531|11084509|FG000|Overall Study|Gout flare|3
7014408|NCT01493531|11084510|FG001|Overall Study|Gout flare|0
7014409|NCT01493531|11084511|FG002|Overall Study|Gout flare|2
7014410|NCT01493531|11084509|FG000|Overall Study|Protocol Violation|8
7014411|NCT01493531|11084510|FG001|Overall Study|Protocol Violation|15
7014412|NCT01493531|11084511|FG002|Overall Study|Protocol Violation|12
7014413|NCT01493531|11084509|FG000|Overall Study|Sponsor terminated study|5
7014414|NCT01493531|11084510|FG001|Overall Study|Sponsor terminated study|2
7014415|NCT01493531|11084511|FG002|Overall Study|Sponsor terminated study|3
7014416|NCT01493531|11084509|FG000|Overall Study|Lost to Follow-up|5
7014417|NCT01493531|11084510|FG001|Overall Study|Lost to Follow-up|7
7014418|NCT01493531|11084511|FG002|Overall Study|Lost to Follow-up|11
7014419|NCT01493531|11084509|FG000|Overall Study|Withdrawal by Subject|16
7014420|NCT01493531|11084510|FG001|Overall Study|Withdrawal by Subject|13
7014421|NCT01493531|11084511|FG002|Overall Study|Withdrawal by Subject|11
7014422|NCT01493531|11084509|FG000|Overall Study|Death|0
7014423|NCT01493531|11084510|FG001|Overall Study|Death|1
7014424|NCT01493531|11084511|FG002|Overall Study|Death|0
7014425|NCT01493557|11084522|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
7014426|NCT01493557|11084523|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
7014427|NCT01493557|11084524|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1
7014428|NCT01493557|11084522|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0
7014429|NCT01493557|11084523|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0
7014430|NCT01493557|11084524|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9
7014431|NCT01493557|11084522|FG000|Not Randomized to Management Strategies|Other adverse event|0
7014432|NCT01493557|11084523|FG001|Not Randomized to Management Strategies|Other adverse event|0
7014433|NCT01493557|11084524|FG002|Not Randomized to Management Strategies|Other adverse event|54
7014434|NCT01493557|11084522|FG000|Not Randomized to Management Strategies|Protocol Violation|0
7014435|NCT01493557|11084523|FG001|Not Randomized to Management Strategies|Protocol Violation|0
7014436|NCT01493557|11084524|FG002|Not Randomized to Management Strategies|Protocol Violation|1
7014437|NCT01493557|11084522|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0
7014438|NCT01493557|11084523|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0
7014439|NCT01493557|11084524|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4
7014440|NCT01493557|11084522|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0
7014441|NCT01493557|11084523|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0
7014442|NCT01493557|11084524|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10
7014443|NCT01493557|11084522|FG000|Not Randomized to Management Strategies|Early termination|0
7014444|NCT01493557|11084523|FG001|Not Randomized to Management Strategies|Early termination|0
7014445|NCT01493557|11084524|FG002|Not Randomized to Management Strategies|Early termination|34
7014446|NCT01493557|11084522|FG000|Not Randomized to Management Strategies|Other than stated above|0
7014447|NCT01493557|11084523|FG001|Not Randomized to Management Strategies|Other than stated above|0
7014448|NCT01493557|11084524|FG002|Not Randomized to Management Strategies|Other than stated above|21
7014449|NCT01493557|11084522|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3
7014450|NCT01493557|11084523|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2
7014451|NCT01493557|11084524|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0
7014452|NCT01493557|11084522|FG000|Randomized to Management Strategies|Other adverse event|8
7014453|NCT01493557|11084523|FG001|Randomized to Management Strategies|Other adverse event|5
7014454|NCT01493557|11084524|FG002|Randomized to Management Strategies|Other adverse event|0
7014455|NCT01493557|11084522|FG000|Randomized to Management Strategies|Protocol Violation|3
7014456|NCT01493557|11084523|FG001|Randomized to Management Strategies|Protocol Violation|0
7014457|NCT01493557|11084524|FG002|Randomized to Management Strategies|Protocol Violation|0
7014458|NCT01493557|11084522|FG000|Randomized to Management Strategies|Withdrawal by Subject|0
7014459|NCT01493557|11084523|FG001|Randomized to Management Strategies|Withdrawal by Subject|1
7014460|NCT01493557|11084524|FG002|Randomized to Management Strategies|Withdrawal by Subject|0
7014461|NCT01493557|11084522|FG000|Randomized to Management Strategies|Other than stated above|1
7014462|NCT01493557|11084523|FG001|Randomized to Management Strategies|Other than stated above|3
7014463|NCT01493557|11084524|FG002|Randomized to Management Strategies|Other than stated above|0
7014464|NCT01493557|11084522|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1
7014465|NCT01493557|11084523|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1
7014466|NCT01493557|11084524|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0
7014467|NCT01493557|11084522|FG000|Adding the Second Strategy|Other adverse event|1
7014468|NCT01493557|11084523|FG001|Adding the Second Strategy|Other adverse event|2
7014469|NCT01493557|11084524|FG002|Adding the Second Strategy|Other adverse event|0
7014470|NCT01493557|11084522|FG000|Adding the Second Strategy|Withdrawal by Subject|0
7014471|NCT01493557|11084523|FG001|Adding the Second Strategy|Withdrawal by Subject|1
7014472|NCT01493557|11084524|FG002|Adding the Second Strategy|Withdrawal by Subject|0
7014473|NCT01493687|11084560|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2
7014474|NCT01493687|11084561|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0
7014475|NCT01493687|11084560|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
7014476|NCT01493687|11084561|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
7014477|NCT01493687|11084560|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7
7014478|NCT01493687|11084561|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4
7014479|NCT01493687|11084560|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18
7014480|NCT01493687|11084561|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7
7014481|NCT01493687|11084560|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2
7014482|NCT01493687|11084561|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1
7014483|NCT01493687|11084560|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7
7014484|NCT01493687|11084561|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
7014485|NCT01493687|11084560|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
7014486|NCT01493687|11084561|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
7014487|NCT01493687|11084560|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5
7014488|NCT01493687|11084561|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1
7014489|NCT01493687|11084560|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2
7014490|NCT01493687|11084561|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
7014491|NCT01493687|11084560|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5
7014492|NCT01493687|11084561|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4
7014493|NCT01493687|11084560|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27
7014494|NCT01493687|11084561|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16
7014495|NCT01493687|11084560|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1
7014496|NCT01493687|11084561|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0
7014497|NCT01493687|11084560|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16
7014498|NCT01493687|11084561|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
7014499|NCT01493687|11084560|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5
7014500|NCT01493687|11084561|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1
7143165|NCT03028012|11299560|FG000|Overall Study|Lost to Follow-up|2
7143166|NCT03028012|11299561|FG001|Overall Study|Lost to Follow-up|3
7143167|NCT03028012|11299562|FG002|Overall Study|Lost to Follow-up|3
7014501|NCT01493687|11084560|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0
7014502|NCT01493687|11084561|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1
7014503|NCT01493778|11084573|FG000|Overall Study|Withdrawal by Subject|8
7014504|NCT01493960|11084600|FG000|Overall Study|Adverse Event|0
7014505|NCT01493960|11084601|FG001|Overall Study|Adverse Event|1
7014506|NCT01493960|11084600|FG000|Overall Study|Lack of Efficacy|15
7014507|NCT01493960|11084601|FG001|Overall Study|Lack of Efficacy|9
7014508|NCT01493960|11084600|FG000|Overall Study|Protocol Violation|3
7014509|NCT01493960|11084601|FG001|Overall Study|Protocol Violation|0
7014510|NCT01493960|11084600|FG000|Overall Study|Withdrawal by Subject|10
7014511|NCT01493960|11084601|FG001|Overall Study|Withdrawal by Subject|4
7014512|NCT01493960|11084600|FG000|Overall Study|Non-specified|4
7014513|NCT01493960|11084601|FG001|Overall Study|Non-specified|4
7014514|NCT01494038|11084609|FG000|Overall Study|Protocol Violation|1
7014515|NCT01494038|11084610|FG001|Overall Study|Protocol Violation|1
7014516|NCT01494038|11084609|FG000|Overall Study|Lost to Follow-up|18
7014517|NCT01494038|11084610|FG001|Overall Study|Lost to Follow-up|20
7014518|NCT01494038|11084609|FG000|Overall Study|Withdrawal by Subject|44
7014519|NCT01494038|11084610|FG001|Overall Study|Withdrawal by Subject|34
7014520|NCT01494038|11084609|FG000|Overall Study|Not able to get to clinic|21
7014521|NCT01494038|11084610|FG001|Overall Study|Not able to get to clinic|15
7014522|NCT01494038|11084609|FG000|Overall Study|Not willing to adhere to reqs|2
7014523|NCT01494038|11084610|FG001|Overall Study|Not willing to adhere to reqs|9
7014524|NCT01494038|11084609|FG000|Overall Study|Death|2
7014525|NCT01494038|11084610|FG001|Overall Study|Death|4
7014526|NCT01494298|11084642|FG000|Overall Study|Protocol Violation|2
7014527|NCT01494298|11084643|FG001|Overall Study|Protocol Violation|8
7014528|NCT01494350|11084651|FG000|Overall Study|Worsening of lesion|1
7014529|NCT01494467|11084657|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1
7014530|NCT01494467|11084658|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0
7014531|NCT01494467|11084657|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6
7014532|NCT01494467|11084658|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4
7014533|NCT01494467|11084657|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9
7014534|NCT01494467|11084658|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8
7014535|NCT01494467|11084657|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4
7014536|NCT01494467|11084658|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0
7014537|NCT01494467|11084657|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
7014538|NCT01494467|11084658|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
7014539|NCT01494467|11084657|FG000|Part A Vehicle Control (12 Weeks)|Other|1
7014540|NCT01494467|11084658|FG001|Part A Vehicle Control (12 Weeks)|Other|1
7014541|NCT01494467|11084657|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
7014542|NCT01494467|11084658|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
7014543|NCT01494467|11084657|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2
7014544|NCT01494467|11084658|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0
7014545|NCT01494467|11084657|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1
7014546|NCT01494467|11084658|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
7014547|NCT01494467|11084657|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3
7014548|NCT01494467|11084658|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5
7014549|NCT01494467|11084657|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32
7014550|NCT01494467|11084658|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24
7014551|NCT01494467|11084657|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3
7014552|NCT01494467|11084658|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5
7014553|NCT01494467|11084657|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26
7014554|NCT01494467|11084658|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
7014555|NCT01494467|11084657|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8
7014556|NCT01494467|11084658|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2
7014557|NCT01494506|11084673|FG000|Overall Study|Lack of Efficacy|77
7014558|NCT01494506|11084674|FG001|Overall Study|Lack of Efficacy|83
7014559|NCT01494506|11084675|FG002|Overall Study|Lack of Efficacy|57
7014560|NCT01494506|11084673|FG000|Overall Study|Adverse Event|17
7014561|NCT01494506|11084674|FG001|Overall Study|Adverse Event|10
7014562|NCT01494506|11084675|FG002|Overall Study|Adverse Event|11
7014563|NCT01494506|11084673|FG000|Overall Study|Death|9
7014564|NCT01494506|11084674|FG001|Overall Study|Death|5
7014565|NCT01494506|11084675|FG002|Overall Study|Death|2
7014566|NCT01494506|11084673|FG000|Overall Study|Physician Decision|7
7014567|NCT01494506|11084674|FG001|Overall Study|Physician Decision|5
7014568|NCT01494506|11084675|FG002|Overall Study|Physician Decision|4
7014569|NCT01494506|11084673|FG000|Overall Study|Withdrawal by Subject|17
7014570|NCT01494506|11084674|FG001|Overall Study|Withdrawal by Subject|20
7014571|NCT01494506|11084675|FG002|Overall Study|Withdrawal by Subject|14
7014572|NCT01494506|11084673|FG000|Overall Study|Clinical Deterioration|21
7014573|NCT01494506|11084674|FG001|Overall Study|Clinical Deterioration|17
7014574|NCT01494506|11084675|FG002|Overall Study|Clinical Deterioration|13
7014575|NCT01494506|11084673|FG000|Overall Study|Sponsor Decision|0
7014576|NCT01494506|11084674|FG001|Overall Study|Sponsor Decision|0
7014577|NCT01494506|11084675|FG002|Overall Study|Sponsor Decision|1
7014578|NCT01494506|11084673|FG000|Overall Study|Other|0
7014579|NCT01494506|11084674|FG001|Overall Study|Other|3
7014580|NCT01494506|11084675|FG002|Overall Study|Other|1
7014581|NCT01494532|11084691|FG000|Overall Study|Adverse Event|4
7014582|NCT01494532|11084692|FG001|Overall Study|Adverse Event|1
7014583|NCT01494532|11084693|FG002|Overall Study|Adverse Event|8
7014584|NCT01494532|11084694|FG003|Overall Study|Adverse Event|6
7014585|NCT01494532|11084695|FG004|Overall Study|Adverse Event|5
7014586|NCT01494532|11084696|FG005|Overall Study|Adverse Event|0
7014587|NCT01494532|11084691|FG000|Overall Study|Lack of Efficacy|0
7014588|NCT01494532|11084692|FG001|Overall Study|Lack of Efficacy|0
7014589|NCT01494532|11084693|FG002|Overall Study|Lack of Efficacy|0
7014590|NCT01494532|11084694|FG003|Overall Study|Lack of Efficacy|0
7014591|NCT01494532|11084695|FG004|Overall Study|Lack of Efficacy|2
7014592|NCT01494532|11084696|FG005|Overall Study|Lack of Efficacy|0
7014593|NCT01494532|11084691|FG000|Overall Study|Protocol deviation|2
7014594|NCT01494532|11084692|FG001|Overall Study|Protocol deviation|1
7014595|NCT01494532|11084693|FG002|Overall Study|Protocol deviation|3
7014596|NCT01494532|11084694|FG003|Overall Study|Protocol deviation|2
7014597|NCT01494532|11084695|FG004|Overall Study|Protocol deviation|3
7014598|NCT01494532|11084696|FG005|Overall Study|Protocol deviation|0
7014599|NCT01494532|11084691|FG000|Overall Study|Protocol-defined stopping criteria|0
7014600|NCT01494532|11084692|FG001|Overall Study|Protocol-defined stopping criteria|0
7014601|NCT01494532|11084693|FG002|Overall Study|Protocol-defined stopping criteria|1
7014602|NCT01494532|11084694|FG003|Overall Study|Protocol-defined stopping criteria|0
7014603|NCT01494532|11084695|FG004|Overall Study|Protocol-defined stopping criteria|0
7014604|NCT01494532|11084696|FG005|Overall Study|Protocol-defined stopping criteria|0
7014605|NCT01494532|11084691|FG000|Overall Study|Lost to Follow-up|1
7014606|NCT01494532|11084692|FG001|Overall Study|Lost to Follow-up|0
7014607|NCT01494532|11084693|FG002|Overall Study|Lost to Follow-up|0
7014608|NCT01494532|11084694|FG003|Overall Study|Lost to Follow-up|2
7014609|NCT01494532|11084695|FG004|Overall Study|Lost to Follow-up|0
7014610|NCT01494532|11084696|FG005|Overall Study|Lost to Follow-up|0
7014611|NCT01494532|11084691|FG000|Overall Study|Physician Decision|0
7014612|NCT01494532|11084692|FG001|Overall Study|Physician Decision|1
7014613|NCT01494532|11084693|FG002|Overall Study|Physician Decision|1
7014614|NCT01494532|11084694|FG003|Overall Study|Physician Decision|2
7014615|NCT01494532|11084695|FG004|Overall Study|Physician Decision|0
7014616|NCT01494532|11084696|FG005|Overall Study|Physician Decision|0
7014617|NCT01494532|11084691|FG000|Overall Study|Withdrawal by Subject|3
7014618|NCT01494532|11084692|FG001|Overall Study|Withdrawal by Subject|1
7014619|NCT01494532|11084693|FG002|Overall Study|Withdrawal by Subject|4
7014620|NCT01494532|11084694|FG003|Overall Study|Withdrawal by Subject|3
7014621|NCT01494532|11084695|FG004|Overall Study|Withdrawal by Subject|2
7014622|NCT01494532|11084696|FG005|Overall Study|Withdrawal by Subject|0
7014623|NCT01494584|11084718|FG000|Overall Study|Study Closed/Terminated|1
7014624|NCT01494610|11084741|FG000|Period 1|Withdrawal by Subject|1
7014625|NCT01494610|11084742|FG001|Period 1|Withdrawal by Subject|1
7014626|NCT01494610|11084741|FG000|Period 3|Adverse Event|1
7014627|NCT01494610|11084742|FG001|Period 3|Adverse Event|0
7014628|NCT01494610|11084741|FG000|Period 3|Withdrawal by Subject|1
7014629|NCT01494610|11084742|FG001|Period 3|Withdrawal by Subject|0
7014630|NCT01494610|11084741|FG000|Period 4|Protocol Violation|1
7014631|NCT01494610|11084742|FG001|Period 4|Protocol Violation|0
7014632|NCT01494649|11084756|FG000|Overall Study|Lost to Follow-up|0
7014633|NCT01494649|11084757|FG001|Overall Study|Lost to Follow-up|1
7014634|NCT01494818|11084776|FG000|Overall Study|Relocation|1
7014635|NCT01494818|11084777|FG001|Overall Study|Relocation|2
7014636|NCT01494818|11084776|FG000|Overall Study|Lost to Follow-up|1
7014637|NCT01494818|11084777|FG001|Overall Study|Lost to Follow-up|0
7014638|NCT01494922|11084783|FG000|Overall Study|Adverse Event|1
7014639|NCT01494987|11084789|FG000|Overall Study|Adverse Event|6
7014640|NCT01494987|11084790|FG001|Overall Study|Adverse Event|5
7014641|NCT01494987|11084789|FG000|Overall Study|Hyperglycemia|6
7014642|NCT01494987|11084790|FG001|Overall Study|Hyperglycemia|4
7014643|NCT01494987|11084789|FG000|Overall Study|Investigator's Discretion|1
7014644|NCT01494987|11084790|FG001|Overall Study|Investigator's Discretion|2
7014645|NCT01494987|11084789|FG000|Overall Study|Lost to Follow-up|1
7014646|NCT01494987|11084790|FG001|Overall Study|Lost to Follow-up|1
7014647|NCT01494987|11084789|FG000|Overall Study|Protocol Violation|3
7014648|NCT01494987|11084790|FG001|Overall Study|Protocol Violation|3
7014649|NCT01494987|11084789|FG000|Overall Study|Subject Non-Compliance|9
7014650|NCT01494987|11084790|FG001|Overall Study|Subject Non-Compliance|10
7014651|NCT01494987|11084789|FG000|Overall Study|Subject Withdrew Consent|2
7014652|NCT01494987|11084790|FG001|Overall Study|Subject Withdrew Consent|3
7014653|NCT01495000|11084798|FG000|Overall Study|Lost to Follow-up|2
7014654|NCT01495000|11084799|FG001|Overall Study|Lost to Follow-up|2
7014655|NCT01495000|11084798|FG000|Overall Study|Protocol Violation|1
7014656|NCT01495000|11084799|FG001|Overall Study|Protocol Violation|0
7014657|NCT01495000|11084798|FG000|Overall Study|Withdrawal by Subject|10
7014658|NCT01495000|11084799|FG001|Overall Study|Withdrawal by Subject|10
7014659|NCT01495702|11084855|FG000|Randomized Phase|Randomized But Not Treated|1
7014660|NCT01495702|11084856|FG001|Randomized Phase|Randomized But Not Treated|4
7014661|NCT01495702|11084855|FG000|Randomized Phase|Adverse Event|2
7014662|NCT01495702|11084856|FG001|Randomized Phase|Adverse Event|2
7014663|NCT01495702|11084855|FG000|Randomized Phase|Death|1
7014664|NCT01495702|11084856|FG001|Randomized Phase|Death|0
7014665|NCT01495702|11084855|FG000|Randomized Phase|Lack of Efficacy|2
7014666|NCT01495702|11084856|FG001|Randomized Phase|Lack of Efficacy|0
7014667|NCT01495702|11084855|FG000|Randomized Phase|Investigators Discretion|2
7014668|NCT01495702|11084856|FG001|Randomized Phase|Investigators Discretion|0
7014669|NCT01495702|11084855|FG000|Randomized Phase|Withdrew Consent|10
7014670|NCT01495702|11084856|FG001|Randomized Phase|Withdrew Consent|18
7014671|NCT01495702|11084855|FG000|Randomized Phase|Lost to Follow-up|4
7014672|NCT01495702|11084856|FG001|Randomized Phase|Lost to Follow-up|3
7014673|NCT01495702|11084855|FG000|Randomized Phase|Participant Noncompliance|1
7014674|NCT01495702|11084856|FG001|Randomized Phase|Participant Noncompliance|0
7014675|NCT01495702|11084855|FG000|Randomized Phase|Protocol Violation|3
7014676|NCT01495702|11084856|FG001|Randomized Phase|Protocol Violation|1
7014677|NCT01495793|11084863|FG000|Overall Study|Lost to Follow-up|1
7014678|NCT01495793|11084863|FG000|Overall Study|Violation of inclusion criteria|1
7014679|NCT01495975|11084902|FG000|Overall Study|Lost to Follow-up|1
7014680|NCT01495975|11084903|FG001|Overall Study|Lost to Follow-up|0
7014681|NCT01496066|11084911|FG000|Overall Study|Lost to Follow-up|8
7014682|NCT01496066|11084912|FG001|Overall Study|Lost to Follow-up|5
7014683|NCT01496066|11084911|FG000|Overall Study|Explant|3
7014684|NCT01496066|11084912|FG001|Overall Study|Explant|0
7014685|NCT01496066|11084911|FG000|Overall Study|Death|1
7014686|NCT01496066|11084912|FG001|Overall Study|Death|4
7014687|NCT01496183|11084940|FG000|Overall Study|Physician Decision|3
7014688|NCT01496183|11084941|FG001|Overall Study|Physician Decision|1
7014689|NCT01496183|11084940|FG000|Overall Study|Withdrawal by Subject|0
7014690|NCT01496183|11084941|FG001|Overall Study|Withdrawal by Subject|1
7014691|NCT01496274|11084954|FG000|Overall Study|Protocol Violation|0
7014692|NCT01496274|11084955|FG001|Overall Study|Protocol Violation|1
7014693|NCT01496274|11084954|FG000|Overall Study|Adverse Event|1
7014694|NCT01496274|11084955|FG001|Overall Study|Adverse Event|1
7014695|NCT01496274|11084954|FG000|Overall Study|Withdrawal by Subject|2
7014696|NCT01496274|11084955|FG001|Overall Study|Withdrawal by Subject|0
7014697|NCT01496274|11084954|FG000|Overall Study|Lost to Follow-up|0
7014698|NCT01496274|11084955|FG001|Overall Study|Lost to Follow-up|3
7014699|NCT01496287|11084976|FG000|Overall Study|Lost to Follow-up|1
7014700|NCT01496287|11084976|FG000|Overall Study|Incomplete anesthesia|5
7014701|NCT01496365|11085015|FG000|Overall Study|Adverse Event|2
7014702|NCT01496365|11085016|FG001|Overall Study|Adverse Event|3
7014703|NCT01496365|11085017|FG002|Overall Study|Adverse Event|3
7014704|NCT01496365|11085018|FG003|Overall Study|Adverse Event|2
7014705|NCT01496365|11085019|FG004|Overall Study|Adverse Event|5
7014706|NCT01496365|11085020|FG005|Overall Study|Adverse Event|6
7014707|NCT01496365|11085021|FG006|Overall Study|Adverse Event|4
7014708|NCT01496365|11085015|FG000|Overall Study|Withdrawal by Subject|6
7014709|NCT01496365|11085016|FG001|Overall Study|Withdrawal by Subject|6
7014710|NCT01496365|11085017|FG002|Overall Study|Withdrawal by Subject|0
7014711|NCT01496365|11085018|FG003|Overall Study|Withdrawal by Subject|1
7014712|NCT01496365|11085019|FG004|Overall Study|Withdrawal by Subject|3
7014713|NCT01496365|11085020|FG005|Overall Study|Withdrawal by Subject|2
7014714|NCT01496365|11085021|FG006|Overall Study|Withdrawal by Subject|1
7014715|NCT01496365|11085015|FG000|Overall Study|Protocol Violation|2
7014716|NCT01496365|11085016|FG001|Overall Study|Protocol Violation|1
7014717|NCT01496365|11085017|FG002|Overall Study|Protocol Violation|1
7014718|NCT01496365|11085018|FG003|Overall Study|Protocol Violation|0
7014719|NCT01496365|11085019|FG004|Overall Study|Protocol Violation|0
7014720|NCT01496365|11085020|FG005|Overall Study|Protocol Violation|1
7014721|NCT01496365|11085021|FG006|Overall Study|Protocol Violation|0
7014722|NCT01496365|11085015|FG000|Overall Study|Lack of Efficacy|1
7014723|NCT01496365|11085016|FG001|Overall Study|Lack of Efficacy|0
7014724|NCT01496365|11085017|FG002|Overall Study|Lack of Efficacy|0
7014725|NCT01496365|11085018|FG003|Overall Study|Lack of Efficacy|0
7014726|NCT01496365|11085019|FG004|Overall Study|Lack of Efficacy|0
7014727|NCT01496365|11085020|FG005|Overall Study|Lack of Efficacy|1
7014728|NCT01496365|11085021|FG006|Overall Study|Lack of Efficacy|0
7014729|NCT01496365|11085015|FG000|Overall Study|Lost to Follow-up|0
7014730|NCT01496365|11085016|FG001|Overall Study|Lost to Follow-up|1
7014731|NCT01496365|11085017|FG002|Overall Study|Lost to Follow-up|0
7014732|NCT01496365|11085018|FG003|Overall Study|Lost to Follow-up|0
7014733|NCT01496365|11085019|FG004|Overall Study|Lost to Follow-up|2
7014734|NCT01496365|11085020|FG005|Overall Study|Lost to Follow-up|0
7014735|NCT01496365|11085021|FG006|Overall Study|Lost to Follow-up|0
7014736|NCT01496365|11085015|FG000|Overall Study|Other|4
7014737|NCT01496365|11085016|FG001|Overall Study|Other|4
7014738|NCT01496365|11085017|FG002|Overall Study|Other|2
7014739|NCT01496365|11085018|FG003|Overall Study|Other|1
7014740|NCT01496365|11085019|FG004|Overall Study|Other|3
7014741|NCT01496365|11085020|FG005|Overall Study|Other|0
7014742|NCT01496365|11085021|FG006|Overall Study|Other|1
7014743|NCT01496430|11085040|FG000|Overall Study|Adverse Event|0
7014744|NCT01496430|11085041|FG001|Overall Study|Adverse Event|0
7014745|NCT01496430|11085042|FG002|Overall Study|Adverse Event|1
7014746|NCT01496430|11085040|FG000|Overall Study|Major Protocol Deviation|0
7014747|NCT01496430|11085041|FG001|Overall Study|Major Protocol Deviation|0
7014748|NCT01496430|11085042|FG002|Overall Study|Major Protocol Deviation|1
7014749|NCT01496430|11085040|FG000|Overall Study|Lost to Follow-up|2
7014750|NCT01496430|11085041|FG001|Overall Study|Lost to Follow-up|3
7014751|NCT01496430|11085042|FG002|Overall Study|Lost to Follow-up|1
7014752|NCT01496430|11085040|FG000|Overall Study|Voluntary Withdrawal|2
7014753|NCT01496430|11085041|FG001|Overall Study|Voluntary Withdrawal|1
7014754|NCT01496430|11085042|FG002|Overall Study|Voluntary Withdrawal|6
7014755|NCT01496430|11085040|FG000|Overall Study|Principal Investigator Discretion|0
7014756|NCT01496430|11085041|FG001|Overall Study|Principal Investigator Discretion|1
7014757|NCT01496430|11085042|FG002|Overall Study|Principal Investigator Discretion|1
7014758|NCT01496430|11085040|FG000|Overall Study|Other|2
7014759|NCT01496430|11085041|FG001|Overall Study|Other|0
7014760|NCT01496430|11085042|FG002|Overall Study|Other|0
7014761|NCT01496456|11085050|FG000|Overall Study|Protocol Violation|1
7014762|NCT01496456|11085050|FG000|Overall Study|Lost to Follow-up|7
7014763|NCT01496469|11085059|FG000|Overall Study|Adverse Event|1
7014764|NCT01496469|11085060|FG001|Overall Study|Adverse Event|0
7014765|NCT01496469|11085059|FG000|Overall Study|Protocol Violation|2
7014766|NCT01496469|11085060|FG001|Overall Study|Protocol Violation|0
7014767|NCT01496469|11085059|FG000|Overall Study|Lost to Follow-up|1
7014768|NCT01496469|11085060|FG001|Overall Study|Lost to Follow-up|1
7014769|NCT01496469|11085059|FG000|Overall Study|Withdrawal by Subject|4
7014770|NCT01496469|11085060|FG001|Overall Study|Withdrawal by Subject|4
7014771|NCT01496469|11085059|FG000|Overall Study|BP exceeds protocol limits|1
7014772|NCT01496469|11085060|FG001|Overall Study|BP exceeds protocol limits|2
7014773|NCT01496469|11085059|FG000|Overall Study|Other|1
7014774|NCT01496469|11085060|FG001|Overall Study|Other|1
7043539|NCT01745094|11128512|FG002|Overall Study|Not Meeting the Eligibility Criteria|3
7043540|NCT01745094|11128513|FG003|Overall Study|Not Meeting the Eligibility Criteria|0
7043541|NCT01745094|11128510|FG000|Overall Study|Adverse Event|0
7043542|NCT01745094|11128511|FG001|Overall Study|Adverse Event|0
7043543|NCT01745094|11128512|FG002|Overall Study|Adverse Event|3
7043544|NCT01745094|11128513|FG003|Overall Study|Adverse Event|0
7043545|NCT01745094|11128510|FG000|Overall Study|Withdrawal by Subject|2
7043546|NCT01745094|11128511|FG001|Overall Study|Withdrawal by Subject|0
7043547|NCT01745094|11128512|FG002|Overall Study|Withdrawal by Subject|1
7043548|NCT01745094|11128513|FG003|Overall Study|Withdrawal by Subject|2
7043549|NCT01745094|11128510|FG000|Overall Study|Protocol Violation|1
7043550|NCT01745094|11128511|FG001|Overall Study|Protocol Violation|0
7043551|NCT01745094|11128512|FG002|Overall Study|Protocol Violation|3
7043552|NCT01745094|11128513|FG003|Overall Study|Protocol Violation|1
7043553|NCT01745094|11128510|FG000|Overall Study|Need Further Examinations Due to Biopsy|0
7043554|NCT01745094|11128511|FG001|Overall Study|Need Further Examinations Due to Biopsy|0
7043555|NCT01745094|11128512|FG002|Overall Study|Need Further Examinations Due to Biopsy|1
7043556|NCT01745094|11128513|FG003|Overall Study|Need Further Examinations Due to Biopsy|0
7043557|NCT01745094|11128510|FG000|Overall Study|Show no Stable Solifenacin Intake|0
7043558|NCT01745094|11128511|FG001|Overall Study|Show no Stable Solifenacin Intake|0
7043559|NCT01745094|11128512|FG002|Overall Study|Show no Stable Solifenacin Intake|1
7043560|NCT01745094|11128513|FG003|Overall Study|Show no Stable Solifenacin Intake|0
7043561|NCT01745094|11128510|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1
7043562|NCT01745094|11128511|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0
7043563|NCT01745094|11128512|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0
7043564|NCT01745094|11128513|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0
7043565|NCT01745120|11128528|FG000|Overall Study|Investigator decision|1
7043566|NCT01745120|11128529|FG001|Overall Study|Investigator decision|0
7043567|NCT01745146|11128553|FG000|Overall Study|Withdrawal by Subject|1
7043568|NCT01745146|11128554|FG001|Overall Study|Withdrawal by Subject|3
7043569|NCT01745146|11128553|FG000|Overall Study|Lost to Follow-up|2
7043570|NCT01745146|11128554|FG001|Overall Study|Lost to Follow-up|0
7043571|NCT01745367|11128567|FG000|Overall Study|Death|1
7043572|NCT01745367|11128568|FG001|Overall Study|Death|0
7043573|NCT01745367|11128567|FG000|Overall Study|Withdrawal by Subject|1
7043574|NCT01745367|11128568|FG001|Overall Study|Withdrawal by Subject|2
7043575|NCT01745367|11128567|FG000|Overall Study|Termination of The Study by The Sponsor|6
7043576|NCT01745367|11128568|FG001|Overall Study|Termination of The Study by The Sponsor|18
7043577|NCT01745367|11128567|FG000|Overall Study|Other Reasons Unspecified|0
7043578|NCT01745367|11128568|FG001|Overall Study|Other Reasons Unspecified|2
7043579|NCT01745380|11128576|FG000|Overall Study|Lost to Follow-up|1
7043580|NCT01745380|11128577|FG001|Overall Study|Lost to Follow-up|0
7043581|NCT01745380|11128576|FG000|Overall Study|Lack of Efficacy|0
7043582|NCT01745380|11128577|FG001|Overall Study|Lack of Efficacy|1
7043583|NCT01745393|11128585|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20
7043584|NCT01745393|11128586|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8
7043585|NCT01745393|11128585|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1
7043586|NCT01745393|11128586|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0
7043587|NCT01745393|11128585|FG000|12-month Follow-up|Lost to Follow-up|6
7043588|NCT01745393|11128586|FG001|12-month Follow-up|Lost to Follow-up|5
7043589|NCT01745848|11128605|FG000|Overall Study|Adverse Event|6
7043590|NCT01746017|11128636|FG000|Period 1|Withdrawal by Subject|0
7043591|NCT01746017|11128637|FG001|Period 1|Withdrawal by Subject|0
7043592|NCT01746017|11128638|FG002|Period 1|Withdrawal by Subject|0
7043593|NCT01746017|11128639|FG003|Period 1|Withdrawal by Subject|0
7043594|NCT01746017|11128640|FG004|Period 1|Withdrawal by Subject|0
7043595|NCT01746017|11128641|FG005|Period 1|Withdrawal by Subject|0
7043596|NCT01746017|11128642|FG006|Period 1|Withdrawal by Subject|1
7043597|NCT01746017|11128643|FG007|Period 1|Withdrawal by Subject|0
7043598|NCT01746017|11128644|FG008|Period 1|Withdrawal by Subject|0
7014775|NCT01496612|11085066|FG000|1st Intervention|Adverse Event|1
7014776|NCT01496612|11085067|FG001|1st Intervention|Adverse Event|0
7014777|NCT01496612|11085066|FG000|1st Intervention|Withdrawal by Subject|1
7014778|NCT01496612|11085067|FG001|1st Intervention|Withdrawal by Subject|0
7014779|NCT01496807|11085075|FG000|Overall Study|Progressive Disease|21
7014780|NCT01496807|11085075|FG000|Overall Study|Participant preference/toxicity|8
7014781|NCT01496807|11085075|FG000|Overall Study|Change in diagnosis|1
7014782|NCT01496846|11085085|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
7014783|NCT01496846|11085086|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
7014784|NCT01496846|11085087|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
7014785|NCT01496846|11085088|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
7014786|NCT01496846|11085089|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
7014787|NCT01496846|11085090|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
7014788|NCT01496885|11085101|FG000|Overall Study|Lost to Follow-up|13
7014789|NCT01496885|11085101|FG000|Overall Study|Withdrawal by Subject|7
7014790|NCT01496885|11085101|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2
7014791|NCT01496885|11085101|FG000|Overall Study|Death|1
7014792|NCT01497067|11085105|FG000|Overall Study|Lost to Follow-up|56
7014793|NCT01497067|11085105|FG000|Overall Study|Adverse Event|3
7014794|NCT01497067|11085105|FG000|Overall Study|Patient decision unrel to Adverse Event|10
7014795|NCT01497067|11085105|FG000|Overall Study|Other|13
7014796|NCT01497197|11085112|FG000|Overall Study|Lost to Follow-up|1
7014797|NCT01497197|11085113|FG001|Overall Study|Lost to Follow-up|0
7014798|NCT01497197|11085112|FG000|Overall Study|Protocol Violation|0
7014799|NCT01497197|11085113|FG001|Overall Study|Protocol Violation|2
7014800|NCT01497197|11085112|FG000|Overall Study|Withdrawal by Subject|2
7014801|NCT01497197|11085113|FG001|Overall Study|Withdrawal by Subject|1
7014802|NCT01497197|11085112|FG000|Overall Study|Excessive/lack of response to treatment|1
7014803|NCT01497197|11085113|FG001|Overall Study|Excessive/lack of response to treatment|0
7014804|NCT01497197|11085112|FG000|Overall Study|Risk of OHSS|1
7014805|NCT01497197|11085113|FG001|Overall Study|Risk of OHSS|0
7014806|NCT01497197|11085112|FG000|Overall Study|No oocytes retrieved|3
7014807|NCT01497197|11085113|FG001|Overall Study|No oocytes retrieved|2
7014808|NCT01497197|11085112|FG000|Overall Study|No fertilisation|6
7014809|NCT01497197|11085113|FG001|Overall Study|No fertilisation|5
7014810|NCT01497197|11085112|FG000|Overall Study|Intention to freeze all embryos|0
7014811|NCT01497197|11085113|FG001|Overall Study|Intention to freeze all embryos|1
7014812|NCT01497197|11085112|FG000|Overall Study|All embryos discarded|0
7014813|NCT01497197|11085113|FG001|Overall Study|All embryos discarded|3
7014814|NCT01497197|11085112|FG000|Overall Study|Other|3
7014815|NCT01497197|11085113|FG001|Overall Study|Other|1
7014816|NCT01497262|11085119|FG000|Overall Study|Abnormal Lab Values|4
7014817|NCT01497262|11085119|FG000|Overall Study|Abnormal Test Procedure Result|1
7014818|NCT01497262|11085119|FG000|Overall Study|Physician Decision|1
7014819|NCT01497262|11085119|FG000|Overall Study|Withdrawal by Subject|2
7014820|NCT01497262|11085119|FG000|Overall Study|Adverse Event|2
7014821|NCT01497262|11085119|FG000|Overall Study|Protocol Violation|1
7014822|NCT01497275|11085123|FG000|Overall Study|Death|1
7014823|NCT01497275|11085123|FG000|Overall Study|Adverse Event|1
7014824|NCT01497366|11085129|FG000|Overall Study|Virologic failure|2
7014825|NCT01497366|11085130|FG001|Overall Study|Virologic failure|50
7014826|NCT01497366|11085129|FG000|Overall Study|Lost to Follow-up|11
7014827|NCT01497366|11085130|FG001|Overall Study|Lost to Follow-up|10
7014828|NCT01497366|11085129|FG000|Overall Study|Withdrawal by Subject|6
7014829|NCT01497366|11085130|FG001|Overall Study|Withdrawal by Subject|6
7014830|NCT01497366|11085129|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7
7014831|NCT01497366|11085130|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0
7014832|NCT01497366|11085129|FG000|Overall Study|Other|5
7014833|NCT01497366|11085130|FG001|Overall Study|Other|0
7014834|NCT01497366|11085129|FG000|Overall Study|Death|1
7014835|NCT01497366|11085130|FG001|Overall Study|Death|1
7014836|NCT01497366|11085129|FG000|Overall Study|Randomized but not treated|7
7014837|NCT01497366|11085130|FG001|Overall Study|Randomized but not treated|21
7014838|NCT01497899|11085183|FG000|Double-Blind Phase|Randomized but not Treated|1
7014839|NCT01497899|11085184|FG001|Double-Blind Phase|Randomized but not Treated|0
7014840|NCT01497899|11085185|FG002|Double-Blind Phase|Randomized but not Treated|0
7014841|NCT01497899|11085186|FG003|Double-Blind Phase|Randomized but not Treated|0
7014842|NCT01497899|11085183|FG000|Double-Blind Phase|Adverse Event|1
7014843|NCT01497899|11085184|FG001|Double-Blind Phase|Adverse Event|0
7014844|NCT01497899|11085185|FG002|Double-Blind Phase|Adverse Event|0
7014845|NCT01497899|11085186|FG003|Double-Blind Phase|Adverse Event|0
7014846|NCT01497899|11085183|FG000|Double-Blind Phase|Lack of Efficacy|0
7014847|NCT01497899|11085184|FG001|Double-Blind Phase|Lack of Efficacy|1
7014848|NCT01497899|11085185|FG002|Double-Blind Phase|Lack of Efficacy|0
7014849|NCT01497899|11085186|FG003|Double-Blind Phase|Lack of Efficacy|0
7014850|NCT01497899|11085183|FG000|Double-Blind Phase|Investigator's Discretion|1
7014851|NCT01497899|11085184|FG001|Double-Blind Phase|Investigator's Discretion|0
7014852|NCT01497899|11085185|FG002|Double-Blind Phase|Investigator's Discretion|0
7014853|NCT01497899|11085186|FG003|Double-Blind Phase|Investigator's Discretion|0
7014854|NCT01497899|11085183|FG000|Double-Blind Phase|Withdrew Consent|0
7014855|NCT01497899|11085184|FG001|Double-Blind Phase|Withdrew Consent|1
7014856|NCT01497899|11085185|FG002|Double-Blind Phase|Withdrew Consent|0
7014857|NCT01497899|11085186|FG003|Double-Blind Phase|Withdrew Consent|0
7014858|NCT01497899|11085183|FG000|Double-Blind Phase|Lost to Follow-up|3
7014859|NCT01497899|11085184|FG001|Double-Blind Phase|Lost to Follow-up|2
7014860|NCT01497899|11085185|FG002|Double-Blind Phase|Lost to Follow-up|0
7014861|NCT01497899|11085186|FG003|Double-Blind Phase|Lost to Follow-up|0
7014862|NCT01497899|11085183|FG000|Double-Blind Phase|Subject Non-Compliance|0
7014863|NCT01497899|11085184|FG001|Double-Blind Phase|Subject Non-Compliance|1
7014864|NCT01497899|11085185|FG002|Double-Blind Phase|Subject Non-Compliance|0
7014865|NCT01497899|11085186|FG003|Double-Blind Phase|Subject Non-Compliance|0
7014866|NCT01497899|11085183|FG000|Open-Label Extension Phase|Adverse Event|1
7014867|NCT01497899|11085184|FG001|Open-Label Extension Phase|Adverse Event|0
7014868|NCT01497899|11085185|FG002|Open-Label Extension Phase|Adverse Event|0
7014869|NCT01497899|11085186|FG003|Open-Label Extension Phase|Adverse Event|0
7014870|NCT01497899|11085183|FG000|Open-Label Extension Phase|Death|1
7014871|NCT01497899|11085184|FG001|Open-Label Extension Phase|Death|0
7014872|NCT01497899|11085185|FG002|Open-Label Extension Phase|Death|0
7014873|NCT01497899|11085186|FG003|Open-Label Extension Phase|Death|0
7014874|NCT01497899|11085183|FG000|Open-Label Extension Phase|Withdrew Consent|8
7014875|NCT01497899|11085184|FG001|Open-Label Extension Phase|Withdrew Consent|3
7014876|NCT01497899|11085185|FG002|Open-Label Extension Phase|Withdrew Consent|2
7014877|NCT01497899|11085186|FG003|Open-Label Extension Phase|Withdrew Consent|0
7014878|NCT01497899|11085183|FG000|Open-Label Extension Phase|Pregnancy|0
7014879|NCT01497899|11085184|FG001|Open-Label Extension Phase|Pregnancy|1
7014880|NCT01497899|11085185|FG002|Open-Label Extension Phase|Pregnancy|1
7014881|NCT01497899|11085186|FG003|Open-Label Extension Phase|Pregnancy|0
7014882|NCT01497899|11085183|FG000|Open-Label Extension Phase|Protocol Violation|0
7014883|NCT01497899|11085184|FG001|Open-Label Extension Phase|Protocol Violation|0
7014884|NCT01497899|11085185|FG002|Open-Label Extension Phase|Protocol Violation|1
7014885|NCT01497899|11085186|FG003|Open-Label Extension Phase|Protocol Violation|0
7014886|NCT01497899|11085183|FG000|Open-Label Extension Phase|Lost to Follow-up|9
7014887|NCT01497899|11085184|FG001|Open-Label Extension Phase|Lost to Follow-up|3
7014888|NCT01497899|11085185|FG002|Open-Label Extension Phase|Lost to Follow-up|5
7014889|NCT01497899|11085186|FG003|Open-Label Extension Phase|Lost to Follow-up|5
7014890|NCT01497938|11085195|FG000|Overall Study|Adverse Event|0
7014891|NCT01497938|11085196|FG001|Overall Study|Adverse Event|1
7014892|NCT01497938|11085195|FG000|Overall Study|Physician Decision|0
7014893|NCT01497938|11085196|FG001|Overall Study|Physician Decision|1
7014894|NCT01497938|11085195|FG000|Overall Study|Withdrawal by Subject|4
7014895|NCT01497938|11085196|FG001|Overall Study|Withdrawal by Subject|0
7014896|NCT01497938|11085195|FG000|Overall Study|Device Violation|1
7014897|NCT01497938|11085196|FG001|Overall Study|Device Violation|0
7014898|NCT01498068|11085204|FG000|Overall Study|Withdrawal by Subject|1
7014899|NCT01498068|11085205|FG001|Overall Study|Withdrawal by Subject|1
7014900|NCT01498120|11085211|FG000|Overall Study|Lost to Follow-up|1
7014901|NCT01498120|11085211|FG000|Overall Study|Withdrawal by Subject|5
7014902|NCT01498120|11085211|FG000|Overall Study|AE, non-serious non-fatal|3
7014903|NCT01498120|11085211|FG000|Overall Study|Other|4
7014904|NCT01498185|11085220|FG000|Overall Study|Adverse Event|0
7014905|NCT01498185|11085221|FG001|Overall Study|Adverse Event|0
7014906|NCT01498185|11085222|FG002|Overall Study|Adverse Event|0
7014907|NCT01498185|11085223|FG003|Overall Study|Adverse Event|1
7014908|NCT01498185|11085224|FG004|Overall Study|Adverse Event|0
7014909|NCT01498185|11085220|FG000|Overall Study|Withdrawal by Subject|1
7014910|NCT01498185|11085221|FG001|Overall Study|Withdrawal by Subject|1
7014911|NCT01498185|11085222|FG002|Overall Study|Withdrawal by Subject|0
7014912|NCT01498185|11085223|FG003|Overall Study|Withdrawal by Subject|2
7014913|NCT01498185|11085224|FG004|Overall Study|Withdrawal by Subject|1
7014914|NCT01498185|11085220|FG000|Overall Study|No longer met criteria, etc|0
7014915|NCT01498185|11085221|FG001|Overall Study|No longer met criteria, etc|0
7014916|NCT01498185|11085222|FG002|Overall Study|No longer met criteria, etc|0
7014917|NCT01498185|11085223|FG003|Overall Study|No longer met criteria, etc|0
7014918|NCT01498185|11085224|FG004|Overall Study|No longer met criteria, etc|2
7014919|NCT01498289|11085242|FG000|Overall Study|Adverse Event|16
7014920|NCT01498289|11085243|FG001|Overall Study|Adverse Event|18
7014921|NCT01498289|11085242|FG000|Overall Study|Death|6
7014922|NCT01498289|11085243|FG001|Overall Study|Death|8
7014923|NCT01498289|11085242|FG000|Overall Study|Withdrawal unrelated to AE|16
7014924|NCT01498289|11085243|FG001|Overall Study|Withdrawal unrelated to AE|16
7014925|NCT01498289|11085242|FG000|Overall Study|Progression/relapse|53
7014926|NCT01498289|11085243|FG001|Overall Study|Progression/relapse|59
7014927|NCT01498289|11085242|FG000|Overall Study|Not protocol specified|7
7014928|NCT01498289|11085243|FG001|Overall Study|Not protocol specified|2
7014929|NCT01498289|11085242|FG000|Overall Study|Reason under review|0
7014930|NCT01498289|11085243|FG001|Overall Study|Reason under review|1
7014931|NCT01498445|11085276|FG000|Overall Study|Lack of Efficacy|0
7014932|NCT01498445|11085277|FG001|Overall Study|Lack of Efficacy|0
7014933|NCT01498445|11085278|FG002|Overall Study|Lack of Efficacy|1
7014934|NCT01498445|11085279|FG003|Overall Study|Lack of Efficacy|2
7014935|NCT01498445|11085280|FG004|Overall Study|Lack of Efficacy|0
7014936|NCT01498445|11085281|FG005|Overall Study|Lack of Efficacy|0
7014937|NCT01498445|11085276|FG000|Overall Study|Screen Failure|0
7014938|NCT01498445|11085277|FG001|Overall Study|Screen Failure|0
7014939|NCT01498445|11085278|FG002|Overall Study|Screen Failure|0
7014940|NCT01498445|11085279|FG003|Overall Study|Screen Failure|0
7014941|NCT01498445|11085280|FG004|Overall Study|Screen Failure|1
7014942|NCT01498445|11085281|FG005|Overall Study|Screen Failure|1
7014943|NCT01498575|11085306|FG000|Overall Sample|Withdrawal by Subject|60
7014944|NCT01498575|11085307|FG001|Overall Sample|Withdrawal by Subject|14
7014945|NCT01498575|11085306|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19
7014946|NCT01498575|11085307|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6
7014947|NCT01498575|11085306|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23
7014948|NCT01498575|11085307|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18
7014949|NCT01498640|11085326|FG000|Overall Study|Lost to Follow-up|1
7014950|NCT01498640|11085326|FG000|Overall Study|Death|1
7014951|NCT01498640|11085326|FG000|Overall Study|Other|3
7014952|NCT01498653|11085336|FG000|Overall Study|Adverse Event|2
7014953|NCT01498653|11085337|FG001|Overall Study|Adverse Event|2
7014954|NCT01498653|11085336|FG000|Overall Study|Lack of Efficacy|12
7014955|NCT01498653|11085337|FG001|Overall Study|Lack of Efficacy|26
7014956|NCT01498653|11085336|FG000|Overall Study|Protocol Violation|0
7014957|NCT01498653|11085337|FG001|Overall Study|Protocol Violation|4
7014958|NCT01498653|11085336|FG000|Overall Study|Lost to Follow-up|1
7014959|NCT01498653|11085337|FG001|Overall Study|Lost to Follow-up|0
7014960|NCT01498653|11085336|FG000|Overall Study|Physician Decision|2
7014961|NCT01498653|11085337|FG001|Overall Study|Physician Decision|0
7014962|NCT01498653|11085336|FG000|Overall Study|Withdrawal by Subject|2
7014963|NCT01498653|11085337|FG001|Overall Study|Withdrawal by Subject|3
7014964|NCT01498679|11085345|FG000|Overall Study|Adverse Event|1
7014965|NCT01498679|11085346|FG001|Overall Study|Adverse Event|4
7014966|NCT01498679|11085345|FG000|Overall Study|Lack of Efficacy|72
7014967|NCT01498679|11085346|FG001|Overall Study|Lack of Efficacy|12
7014968|NCT01498679|11085345|FG000|Overall Study|Protocol Violation|4
7014969|NCT01498679|11085346|FG001|Overall Study|Protocol Violation|0
7014970|NCT01498679|11085345|FG000|Overall Study|Physician Decision|0
7014971|NCT01498679|11085346|FG001|Overall Study|Physician Decision|2
7014972|NCT01498679|11085345|FG000|Overall Study|Withdrawal by Subject|12
7014973|NCT01498679|11085346|FG001|Overall Study|Withdrawal by Subject|4
7014974|NCT01498692|11085352|FG000|Overall Study|Death|4
7014975|NCT01498692|11085352|FG000|Overall Study|Withdrawal by Subject|1
7014976|NCT01498692|11085352|FG000|Overall Study|Missed 12-month visit|3
7014977|NCT01498822|11085367|FG000|Overall Study|Protocol Violation|8
7014978|NCT01498822|11085368|FG001|Overall Study|Protocol Violation|4
7014979|NCT01498822|11085367|FG000|Overall Study|Other Reason|5
7014980|NCT01498822|11085368|FG001|Overall Study|Other Reason|2
7014981|NCT01498822|11085367|FG000|Overall Study|Lack of Efficacy|7
7014982|NCT01498822|11085368|FG001|Overall Study|Lack of Efficacy|2
7014983|NCT01498822|11085367|FG000|Overall Study|AE, non-serious non-fatal|8
7014984|NCT01498822|11085368|FG001|Overall Study|AE, non-serious non-fatal|17
7014985|NCT01498822|11085367|FG000|Overall Study|SAE, non-fatal|2
7014986|NCT01498822|11085368|FG001|Overall Study|SAE, non-fatal|2
7014987|NCT01498822|11085367|FG000|Overall Study|Adverse Event, serious fatal|1
7014988|NCT01498822|11085368|FG001|Overall Study|Adverse Event, serious fatal|1
7014989|NCT01498822|11085367|FG000|Overall Study|Withdrawal by Subject|15
7014990|NCT01498822|11085368|FG001|Overall Study|Withdrawal by Subject|25
7014991|NCT01498822|11085367|FG000|Overall Study|Lost to Follow-up|8
7014992|NCT01498822|11085368|FG001|Overall Study|Lost to Follow-up|3
7014993|NCT01498887|11085378|FG000|Overall Study|Administrative problems|1
7014994|NCT01498887|11085379|FG001|Overall Study|Administrative problems|0
7014995|NCT01498887|11085378|FG000|Overall Study|Lost to Follow-up|1
7014996|NCT01498887|11085379|FG001|Overall Study|Lost to Follow-up|1
7014997|NCT01498887|11085378|FG000|Overall Study|Withdrawal by Subject|1
7014998|NCT01498887|11085379|FG001|Overall Study|Withdrawal by Subject|0
7014999|NCT01498887|11085378|FG000|Overall Study|Protocol Violation|1
7015000|NCT01498887|11085379|FG001|Overall Study|Protocol Violation|3
7015001|NCT01498887|11085378|FG000|Overall Study|Lack of Efficacy|5
7015002|NCT01498887|11085379|FG001|Overall Study|Lack of Efficacy|3
7015003|NCT01498887|11085378|FG000|Overall Study|Abnormal result from test procedure|1
7015004|NCT01498887|11085379|FG001|Overall Study|Abnormal result from test procedure|1
7015005|NCT01498887|11085378|FG000|Overall Study|Abnormal laboratory value|2
7015006|NCT01498887|11085379|FG001|Overall Study|Abnormal laboratory value|2
7015007|NCT01498887|11085378|FG000|Overall Study|Adverse Event|4
7015008|NCT01498887|11085379|FG001|Overall Study|Adverse Event|1
7015009|NCT01498952|11085388|FG000|Overall Study|Death|2
7015010|NCT01498952|11085389|FG001|Overall Study|Death|2
7015011|NCT01498952|11085390|FG002|Overall Study|Death|0
7015012|NCT01498952|11085391|FG003|Overall Study|Death|0
7015013|NCT01498952|11085392|FG004|Overall Study|Death|0
7015014|NCT01499043|11085411|FG000|Overall Study|Progressive disease (radiographic)|2
7015015|NCT01499043|11085411|FG000|Overall Study|Progressive disease (clinical)|1
7015016|NCT01499043|11085411|FG000|Overall Study|Withdrawal by Subject|2
7015017|NCT01499043|11085411|FG000|Overall Study|Adverse Event|1
7015018|NCT01499134|11085422|FG000|Overall Study|Withdrawal by Subject|0
7015019|NCT01499134|11085423|FG001|Overall Study|Withdrawal by Subject|1
7015020|NCT01499199|11085447|FG000|Overall Study|Adverse Event|1
7015021|NCT01499199|11085447|FG000|Overall Study|Lack of Efficacy|1
7015022|NCT01499277|11085453|FG000|Overall Study|Adverse Event|3
7015023|NCT01499277|11085454|FG001|Overall Study|Adverse Event|6
7015024|NCT01499277|11085453|FG000|Overall Study|Death|3
7015025|NCT01499277|11085454|FG001|Overall Study|Death|2
7015026|NCT01499277|11085453|FG000|Overall Study|Lost to Follow-up|15
7015027|NCT01499277|11085454|FG001|Overall Study|Lost to Follow-up|8
7015028|NCT01499277|11085453|FG000|Overall Study|Protocol Violation|2
7015029|NCT01499277|11085454|FG001|Overall Study|Protocol Violation|3
7015030|NCT01499277|11085453|FG000|Overall Study|Withdrawal by Subject|16
7015031|NCT01499277|11085454|FG001|Overall Study|Withdrawal by Subject|6
7015032|NCT01499277|11085453|FG000|Overall Study|Lack of therapeutic response and other|8
7015033|NCT01499277|11085454|FG001|Overall Study|Lack of therapeutic response and other|7
7015034|NCT01499290|11085462|FG000|Overall Study|Withdrawal by Subject|22
7015035|NCT01499290|11085463|FG001|Overall Study|Withdrawal by Subject|15
7015036|NCT01499290|11085462|FG000|Overall Study|Not specified in study report|11
7015037|NCT01499290|11085463|FG001|Overall Study|Not specified in study report|5
7015038|NCT01499290|11085462|FG000|Overall Study|Condition improved/subject recovered|1
7015039|NCT01499290|11085463|FG001|Overall Study|Condition improved/subject recovered|0
7015040|NCT01499290|11085462|FG000|Overall Study|Lack of Efficacy|7
7015041|NCT01499290|11085463|FG001|Overall Study|Lack of Efficacy|8
7015042|NCT01499290|11085462|FG000|Overall Study|Adverse Event|14
7015043|NCT01499290|11085463|FG001|Overall Study|Adverse Event|7
7015044|NCT01499303|11085490|FG000|Overall Study|Ongoing|2
7015045|NCT01499303|11085491|FG001|Overall Study|Ongoing|1
7015046|NCT01499303|11085490|FG000|Overall Study|Withdrawal by Subject|0
7015047|NCT01499303|11085491|FG001|Overall Study|Withdrawal by Subject|1
7015048|NCT01499303|11085490|FG000|Overall Study|Adverse Event|1
7015049|NCT01499303|11085491|FG001|Overall Study|Adverse Event|4
7015050|NCT01499303|11085490|FG000|Overall Study|Other|0
7015051|NCT01499303|11085491|FG001|Overall Study|Other|1
7015052|NCT01499355|11085497|FG000|Run-In Period|Study Termination|15
7015053|NCT01499355|11085498|FG001|Run-In Period|Study Termination|0
7015054|NCT01499355|11085499|FG002|Run-In Period|Study Termination|0
7015055|NCT01499355|11085500|FG003|Run-In Period|Study Termination|0
7015056|NCT01499355|11085497|FG000|Run-In Period|Other|3
7015057|NCT01499355|11085498|FG001|Run-In Period|Other|0
7015058|NCT01499355|11085499|FG002|Run-In Period|Other|0
7015059|NCT01499355|11085500|FG003|Run-In Period|Other|0
7015060|NCT01499355|11085497|FG000|Run-In Period|Death|2
7015061|NCT01499355|11085498|FG001|Run-In Period|Death|0
7015062|NCT01499355|11085499|FG002|Run-In Period|Death|0
7015063|NCT01499355|11085500|FG003|Run-In Period|Death|0
7015064|NCT01499355|11085497|FG000|Run-In Period|Investigator Decision|2
7015065|NCT01499355|11085498|FG001|Run-In Period|Investigator Decision|0
7015066|NCT01499355|11085499|FG002|Run-In Period|Investigator Decision|0
7015067|NCT01499355|11085500|FG003|Run-In Period|Investigator Decision|0
7015068|NCT01499355|11085497|FG000|Run-In Period|Consent Withdrawn|1
7015069|NCT01499355|11085498|FG001|Run-In Period|Consent Withdrawn|0
7015070|NCT01499355|11085499|FG002|Run-In Period|Consent Withdrawn|0
7015071|NCT01499355|11085500|FG003|Run-In Period|Consent Withdrawn|0
7015072|NCT01499355|11085497|FG000|Run-In Period|Adverse Event|8
7015073|NCT01499355|11085498|FG001|Run-In Period|Adverse Event|0
7015074|NCT01499355|11085499|FG002|Run-In Period|Adverse Event|0
7015075|NCT01499355|11085500|FG003|Run-In Period|Adverse Event|0
7015076|NCT01499355|11085497|FG000|Double-Blind Period|Adverse Event|0
7015077|NCT01499355|11085498|FG001|Double-Blind Period|Adverse Event|2
7015078|NCT01499355|11085499|FG002|Double-Blind Period|Adverse Event|3
7015079|NCT01499355|11085500|FG003|Double-Blind Period|Adverse Event|2
7015080|NCT01499355|11085497|FG000|Double-Blind Period|Study Termination|0
7015081|NCT01499355|11085498|FG001|Double-Blind Period|Study Termination|18
7015082|NCT01499355|11085499|FG002|Double-Blind Period|Study Termination|16
7015083|NCT01499355|11085500|FG003|Double-Blind Period|Study Termination|14
7015084|NCT01499355|11085497|FG000|Double-Blind Period|Other|0
7015085|NCT01499355|11085498|FG001|Double-Blind Period|Other|1
7015086|NCT01499355|11085499|FG002|Double-Blind Period|Other|2
7015087|NCT01499355|11085500|FG003|Double-Blind Period|Other|2
7015088|NCT01499355|11085497|FG000|Double-Blind Period|Death|0
7015089|NCT01499355|11085498|FG001|Double-Blind Period|Death|1
7015090|NCT01499355|11085499|FG002|Double-Blind Period|Death|0
7015091|NCT01499355|11085500|FG003|Double-Blind Period|Death|0
7015092|NCT01499355|11085497|FG000|Double-Blind Period|Investigator Decision|0
7015093|NCT01499355|11085498|FG001|Double-Blind Period|Investigator Decision|0
7015094|NCT01499355|11085499|FG002|Double-Blind Period|Investigator Decision|3
7015095|NCT01499355|11085500|FG003|Double-Blind Period|Investigator Decision|3
7015096|NCT01499355|11085497|FG000|Double-Blind Period|Consent Withdrawn|0
7015097|NCT01499355|11085498|FG001|Double-Blind Period|Consent Withdrawn|0
7015098|NCT01499355|11085499|FG002|Double-Blind Period|Consent Withdrawn|1
7015099|NCT01499355|11085500|FG003|Double-Blind Period|Consent Withdrawn|2
7015100|NCT01499355|11085497|FG000|Double-Blind Period|Lost to Follow-up|0
7015101|NCT01499355|11085498|FG001|Double-Blind Period|Lost to Follow-up|1
7015102|NCT01499355|11085499|FG002|Double-Blind Period|Lost to Follow-up|0
7015103|NCT01499355|11085500|FG003|Double-Blind Period|Lost to Follow-up|0
7015104|NCT01499368|11085513|FG000|Overall Study|Did not meet I/E criteria|8
7015105|NCT01499368|11085514|FG001|Overall Study|Did not meet I/E criteria|4
7015106|NCT01499368|11085515|FG002|Overall Study|Did not meet I/E criteria|4
7015107|NCT01499368|11085513|FG000|Overall Study|Prohibited Concomitant medication|1
7015108|NCT01499368|11085514|FG001|Overall Study|Prohibited Concomitant medication|1
7015109|NCT01499368|11085515|FG002|Overall Study|Prohibited Concomitant medication|0
7015110|NCT01499368|11085513|FG000|Overall Study|Withdrawal by Subject|11
7015111|NCT01499368|11085514|FG001|Overall Study|Withdrawal by Subject|10
7015112|NCT01499368|11085515|FG002|Overall Study|Withdrawal by Subject|8
7015113|NCT01499368|11085513|FG000|Overall Study|Lost to Follow-up|3
7015114|NCT01499368|11085514|FG001|Overall Study|Lost to Follow-up|2
7015115|NCT01499368|11085515|FG002|Overall Study|Lost to Follow-up|5
7015116|NCT01499368|11085513|FG000|Overall Study|Adverse Event|4
7015117|NCT01499368|11085514|FG001|Overall Study|Adverse Event|0
7015118|NCT01499368|11085515|FG002|Overall Study|Adverse Event|2
7015119|NCT01499368|11085513|FG000|Overall Study|Physician Decision|0
7015120|NCT01499368|11085514|FG001|Overall Study|Physician Decision|1
7015121|NCT01499368|11085515|FG002|Overall Study|Physician Decision|0
7015122|NCT01499368|11085513|FG000|Overall Study|Deviation from visit window|0
7015123|NCT01499368|11085514|FG001|Overall Study|Deviation from visit window|0
7015124|NCT01499368|11085515|FG002|Overall Study|Deviation from visit window|1
7015125|NCT01499368|11085513|FG000|Overall Study|Error of Prescriptions|0
7015126|NCT01499368|11085514|FG001|Overall Study|Error of Prescriptions|0
7015127|NCT01499368|11085515|FG002|Overall Study|Error of Prescriptions|1
7015128|NCT01499511|11085532|FG000|Overall Study|Death|1
7015129|NCT01499511|11085533|FG001|Overall Study|Death|0
7015130|NCT01499576|11085540|FG000|Overall Study|Physician Decision|12
7015131|NCT01499576|11085540|FG000|Overall Study|Withdrawal by Subject|9
7015132|NCT01499667|11085558|FG000|Overall Study|administrative problems|4
7015133|NCT01499667|11085559|FG001|Overall Study|administrative problems|5
7015134|NCT01499667|11085560|FG002|Overall Study|administrative problems|5
7015135|NCT01499667|11085558|FG000|Overall Study|Protocol Violation|1
7015136|NCT01499667|11085559|FG001|Overall Study|Protocol Violation|3
7015137|NCT01499667|11085560|FG002|Overall Study|Protocol Violation|2
7015138|NCT01499667|11085558|FG000|Overall Study|Adverse Event|0
7015139|NCT01499667|11085559|FG001|Overall Study|Adverse Event|2
7015140|NCT01499667|11085560|FG002|Overall Study|Adverse Event|2
7015141|NCT01499667|11085558|FG000|Overall Study|Withdrawal by Subject|2
7015142|NCT01499667|11085559|FG001|Overall Study|Withdrawal by Subject|1
7015143|NCT01499667|11085560|FG002|Overall Study|Withdrawal by Subject|1
7015144|NCT01499667|11085558|FG000|Overall Study|Lack of Efficacy|2
7015145|NCT01499667|11085559|FG001|Overall Study|Lack of Efficacy|0
7015146|NCT01499667|11085560|FG002|Overall Study|Lack of Efficacy|0
7015147|NCT01499810|11085568|FG000|Overall Study|Lost to Follow-up|10
7015148|NCT01499810|11085568|FG000|Overall Study|Protocol Violation|1
7015149|NCT01499810|11085568|FG000|Overall Study|Withdrawal by Subject|1
7015150|NCT01499849|11085575|FG000|Overall Study|Adverse Event|28
7015151|NCT01499849|11085576|FG001|Overall Study|Adverse Event|32
7015152|NCT01499849|11085575|FG000|Overall Study|Chemo completed or Change in Therapy|70
7015153|NCT01499849|11085576|FG001|Overall Study|Chemo completed or Change in Therapy|67
7015154|NCT01499849|11085575|FG000|Overall Study|Withdrawal by Subject|43
7015155|NCT01499849|11085576|FG001|Overall Study|Withdrawal by Subject|43
7015156|NCT01499849|11085575|FG000|Overall Study|Death|5
7015157|NCT01499849|11085576|FG001|Overall Study|Death|7
7015158|NCT01499849|11085575|FG000|Overall Study|Disease Progression|11
7015159|NCT01499849|11085576|FG001|Overall Study|Disease Progression|10
7015160|NCT01499849|11085575|FG000|Overall Study|Protocol Violation|11
7015161|NCT01499849|11085576|FG001|Overall Study|Protocol Violation|11
7015162|NCT01499849|11085575|FG000|Overall Study|Physician Decision|20
7015163|NCT01499849|11085576|FG001|Overall Study|Physician Decision|19
7015164|NCT01499849|11085575|FG000|Overall Study|Lack of Efficacy|3
7015165|NCT01499849|11085576|FG001|Overall Study|Lack of Efficacy|4
7015166|NCT01499849|11085575|FG000|Overall Study|Lost to Follow-up|6
7015167|NCT01499849|11085576|FG001|Overall Study|Lost to Follow-up|3
7015168|NCT01499849|11085575|FG000|Overall Study|Other Reasons|27
7015169|NCT01499849|11085576|FG001|Overall Study|Other Reasons|30
7015170|NCT01499940|11085600|FG000|Overall Study|Study was withdrawn before completion.|9
7015171|NCT01500031|11085604|FG000|Overall Study|Death|1
7015172|NCT01500031|11085604|FG000|Overall Study|Withdrawal by Subject|4
7015173|NCT01500057|11085610|FG000|Overall Study|Lost to Follow-up|6
7015174|NCT01500057|11085611|FG001|Overall Study|Lost to Follow-up|4
7015175|NCT01500083|11085619|FG000|Overall Study|Adverse Event|4
7015176|NCT01500083|11085620|FG001|Overall Study|Adverse Event|17
7015177|NCT01500083|11085619|FG000|Overall Study|Death|0
7015178|NCT01500083|11085620|FG001|Overall Study|Death|2
7015179|NCT01500083|11085619|FG000|Overall Study|Lost to Follow-up|1
7015180|NCT01500083|11085620|FG001|Overall Study|Lost to Follow-up|0
7015181|NCT01500083|11085619|FG000|Overall Study|Withdrawal of Consent|0
7015182|NCT01500083|11085620|FG001|Overall Study|Withdrawal of Consent|1
7015183|NCT01500083|11085619|FG000|Overall Study|Disease Progression|2
7015184|NCT01500083|11085620|FG001|Overall Study|Disease Progression|10
7015185|NCT01500083|11085619|FG000|Overall Study|Investigator Discretion|3
7015186|NCT01500083|11085620|FG001|Overall Study|Investigator Discretion|8
7015187|NCT01500083|11085619|FG000|Overall Study|Other Reasons|2
7015188|NCT01500083|11085620|FG001|Overall Study|Other Reasons|5
7015189|NCT01500096|11085630|FG000|Overall Study|Lost to Follow-up|1
7015190|NCT01500096|11085631|FG001|Overall Study|Lost to Follow-up|0
7015191|NCT01500096|11085632|FG002|Overall Study|Lost to Follow-up|0
7015192|NCT01500096|11085633|FG003|Overall Study|Lost to Follow-up|2
7015193|NCT01500135|11085645|FG000|Overall Study|Withdrawal of Consent|4
7015194|NCT01500135|11085646|FG001|Overall Study|Withdrawal of Consent|0
7015195|NCT01500135|11085645|FG000|Overall Study|Lost to Follow-up|6
7015196|NCT01500135|11085646|FG001|Overall Study|Lost to Follow-up|4
7015197|NCT01500135|11085645|FG000|Overall Study|Fatal Adverse Event (AE)|5
7015198|NCT01500135|11085646|FG001|Overall Study|Fatal Adverse Event (AE)|5
7015199|NCT01500135|11085645|FG000|Overall Study|Principal Investigator (PI) Discretion|1
7015200|NCT01500135|11085646|FG001|Overall Study|Principal Investigator (PI) Discretion|0
7015201|NCT01500135|11085645|FG000|Overall Study|Patient Missed Scheduled Appointments|0
7015202|NCT01500135|11085646|FG001|Overall Study|Patient Missed Scheduled Appointments|1
7015203|NCT01500135|11085645|FG000|Overall Study|Participant was a Safety Concern|1
7015204|NCT01500135|11085646|FG001|Overall Study|Participant was a Safety Concern|0
7015205|NCT01500135|11085645|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0
7015206|NCT01500135|11085646|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1
7015207|NCT01500187|11085654|FG000|Overall Study|Lost to Follow-up|6
7015208|NCT01500187|11085655|FG001|Overall Study|Lost to Follow-up|0
7015209|NCT01500200|11085664|FG000|Stage 1|Adverse Event|1
7015210|NCT01500200|11085665|FG001|Stage 1|Adverse Event|4
7015211|NCT01500200|11085666|FG002|Stage 1|Adverse Event|5
7015212|NCT01500200|11085667|FG003|Stage 1|Adverse Event|0
7015213|NCT01500200|11085668|FG004|Stage 1|Adverse Event|0
7015214|NCT01500200|11085669|FG005|Stage 1|Adverse Event|0
7015215|NCT01500200|11085664|FG000|Stage 1|Lost to Follow-up|2
7015216|NCT01500200|11085665|FG001|Stage 1|Lost to Follow-up|2
7015217|NCT01500200|11085666|FG002|Stage 1|Lost to Follow-up|1
7015218|NCT01500200|11085667|FG003|Stage 1|Lost to Follow-up|0
7015219|NCT01500200|11085668|FG004|Stage 1|Lost to Follow-up|0
7015220|NCT01500200|11085669|FG005|Stage 1|Lost to Follow-up|0
7015221|NCT01500200|11085664|FG000|Stage 1|Withdrawal by Subject|3
7015222|NCT01500200|11085665|FG001|Stage 1|Withdrawal by Subject|0
7015223|NCT01500200|11085666|FG002|Stage 1|Withdrawal by Subject|0
7015224|NCT01500200|11085667|FG003|Stage 1|Withdrawal by Subject|0
7015225|NCT01500200|11085668|FG004|Stage 1|Withdrawal by Subject|0
7015226|NCT01500200|11085669|FG005|Stage 1|Withdrawal by Subject|0
7015227|NCT01500200|11085664|FG000|Stage 1|Noncompliance with Study Drug|1
7015228|NCT01500200|11085665|FG001|Stage 1|Noncompliance with Study Drug|0
7015229|NCT01500200|11085666|FG002|Stage 1|Noncompliance with Study Drug|0
7015230|NCT01500200|11085667|FG003|Stage 1|Noncompliance with Study Drug|0
7015231|NCT01500200|11085668|FG004|Stage 1|Noncompliance with Study Drug|0
7015232|NCT01500200|11085669|FG005|Stage 1|Noncompliance with Study Drug|0
7015233|NCT01500200|11085664|FG000|Stage 1|Physician Decision|1
7015234|NCT01500200|11085665|FG001|Stage 1|Physician Decision|0
7015235|NCT01500200|11085666|FG002|Stage 1|Physician Decision|0
7015236|NCT01500200|11085667|FG003|Stage 1|Physician Decision|0
7015237|NCT01500200|11085668|FG004|Stage 1|Physician Decision|0
7015238|NCT01500200|11085669|FG005|Stage 1|Physician Decision|0
7015239|NCT01500200|11085664|FG000|Stage 2|Adverse Event|0
7015240|NCT01500200|11085665|FG001|Stage 2|Adverse Event|0
7015241|NCT01500200|11085666|FG002|Stage 2|Adverse Event|0
7015242|NCT01500200|11085667|FG003|Stage 2|Adverse Event|0
7015243|NCT01500200|11085668|FG004|Stage 2|Adverse Event|5
7015244|NCT01500200|11085669|FG005|Stage 2|Adverse Event|4
7015245|NCT01500213|11085685|FG000|Overall Study|Adverse Event|35
7015246|NCT01500213|11085686|FG001|Overall Study|Adverse Event|35
7015247|NCT01500213|11085685|FG000|Overall Study|Chemo Completed or Change in Therapy|84
7015248|NCT01500213|11085686|FG001|Overall Study|Chemo Completed or Change in Therapy|81
7015249|NCT01500213|11085685|FG000|Overall Study|Withdrawal by Subject|28
7015250|NCT01500213|11085686|FG001|Overall Study|Withdrawal by Subject|37
7015251|NCT01500213|11085685|FG000|Overall Study|Death|7
7015252|NCT01500213|11085686|FG001|Overall Study|Death|3
7015253|NCT01500213|11085685|FG000|Overall Study|Disease Progression|13
7015254|NCT01500213|11085686|FG001|Overall Study|Disease Progression|21
7015255|NCT01500213|11085685|FG000|Overall Study|Protocol Violation|19
7015256|NCT01500213|11085686|FG001|Overall Study|Protocol Violation|19
7015257|NCT01500213|11085685|FG000|Overall Study|Physician Decision|12
7015258|NCT01500213|11085686|FG001|Overall Study|Physician Decision|10
7015259|NCT01500213|11085685|FG000|Overall Study|Lack of Efficacy|9
7015260|NCT01500213|11085686|FG001|Overall Study|Lack of Efficacy|7
7015261|NCT01500213|11085685|FG000|Overall Study|Lost to Follow-up|3
7015262|NCT01500213|11085686|FG001|Overall Study|Lost to Follow-up|6
7015263|NCT01500213|11085685|FG000|Overall Study|Other Reasons|7
7015264|NCT01500213|11085686|FG001|Overall Study|Other Reasons|5
7015265|NCT01500226|11085694|FG000|Overall Study|Adverse Event|31
7015266|NCT01500226|11085695|FG001|Overall Study|Adverse Event|38
7015267|NCT01500226|11085694|FG000|Overall Study|Chemo Completed or Change in Therapy|235
7015268|NCT01500226|11085695|FG001|Overall Study|Chemo Completed or Change in Therapy|237
7015269|NCT01500226|11085694|FG000|Overall Study|Withdrawal by Subject|93
7015270|NCT01500226|11085695|FG001|Overall Study|Withdrawal by Subject|96
7015271|NCT01500226|11085694|FG000|Overall Study|Death|12
7015272|NCT01500226|11085695|FG001|Overall Study|Death|4
7015273|NCT01500226|11085694|FG000|Overall Study|Disease Progression|16
7015274|NCT01500226|11085695|FG001|Overall Study|Disease Progression|14
7015275|NCT01500226|11085694|FG000|Overall Study|Protocol Violation|53
7015276|NCT01500226|11085695|FG001|Overall Study|Protocol Violation|39
7015277|NCT01500226|11085694|FG000|Overall Study|Physician Decision|17
7015278|NCT01500226|11085695|FG001|Overall Study|Physician Decision|15
7015279|NCT01500226|11085694|FG000|Overall Study|Lack of Efficacy|14
7015280|NCT01500226|11085695|FG001|Overall Study|Lack of Efficacy|30
7015281|NCT01500226|11085694|FG000|Overall Study|Lost to Follow-up|9
7015282|NCT01500226|11085695|FG001|Overall Study|Lost to Follow-up|5
7015283|NCT01500226|11085694|FG000|Overall Study|Other Reasons|19
7015284|NCT01500226|11085695|FG001|Overall Study|Other Reasons|16
7015285|NCT01500252|11085703|FG000|Overall Study|Death|4
7015286|NCT01500252|11085704|FG001|Overall Study|Death|2
7015287|NCT01500252|11085703|FG000|Overall Study|Lost to Follow-up|5
7015288|NCT01500252|11085704|FG001|Overall Study|Lost to Follow-up|4
7015289|NCT01500278|11085713|FG000|Week 0 - Week 12|Lack of Efficacy|0
7015290|NCT01500278|11085714|FG001|Week 0 - Week 12|Lack of Efficacy|1
7015291|NCT01500278|11085713|FG000|Week 0 - Week 12|Protocol Violation|10
7015292|NCT01500278|11085714|FG001|Week 0 - Week 12|Protocol Violation|16
7015293|NCT01500278|11085713|FG000|Week 0 - Week 12|Lost to Follow-up|1
7015294|NCT01500278|11085714|FG001|Week 0 - Week 12|Lost to Follow-up|1
7015295|NCT01500278|11085713|FG000|Week 0 - Week 12|Withdrawal by Subject|7
7015296|NCT01500278|11085714|FG001|Week 0 - Week 12|Withdrawal by Subject|2
7015297|NCT01500278|11085713|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1
7015298|NCT01500278|11085714|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0
7015299|NCT01500278|11085713|FG000|Week 0 - Week 12|Patient decision|1
7015300|NCT01500278|11085714|FG001|Week 0 - Week 12|Patient decision|0
7015301|NCT01500278|11085713|FG000|Week 0 - Week 12|Exclusion criteria not met|1
7015302|NCT01500278|11085714|FG001|Week 0 - Week 12|Exclusion criteria not met|0
7015303|NCT01500278|11085713|FG000|Week 0 - Week 12|Investigator decision|1
7015304|NCT01500278|11085714|FG001|Week 0 - Week 12|Investigator decision|0
7015305|NCT01500278|11085713|FG000|Week 0 - Week 12|Prior history of serious disease|1
7015306|NCT01500278|11085714|FG001|Week 0 - Week 12|Prior history of serious disease|0
7015307|NCT01500278|11085713|FG000|Week 0 - Week 12|Sponsor decision|1
7015308|NCT01500278|11085714|FG001|Week 0 - Week 12|Sponsor decision|0
7015309|NCT01500278|11085713|FG000|Week 0 - Week 12|Personal reason|0
7015310|NCT01500278|11085714|FG001|Week 0 - Week 12|Personal reason|1
7015311|NCT01500278|11085713|FG000|Week 0 - Week 12|Other serious disease|0
7015312|NCT01500278|11085714|FG001|Week 0 - Week 12|Other serious disease|1
7015313|NCT01500278|11085713|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7
7015314|NCT01500278|11085714|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8
7015315|NCT01500278|11085713|FG000|Week 13 - Week 104|Lack of Efficacy|11
7015316|NCT01500278|11085714|FG001|Week 13 - Week 104|Lack of Efficacy|12
7015317|NCT01500278|11085713|FG000|Week 13 - Week 104|Protocol Violation|6
7015318|NCT01500278|11085714|FG001|Week 13 - Week 104|Protocol Violation|6
7015319|NCT01500278|11085713|FG000|Week 13 - Week 104|Lost to Follow-up|6
7015320|NCT01500278|11085714|FG001|Week 13 - Week 104|Lost to Follow-up|5
7015321|NCT01500278|11085713|FG000|Week 13 - Week 104|Withdrawal by Subject|22
7015322|NCT01500278|11085714|FG001|Week 13 - Week 104|Withdrawal by Subject|13
7015323|NCT01500278|11085713|FG000|Week 13 - Week 104|Week 24 Non-Responder|20
7015324|NCT01500278|11085714|FG001|Week 13 - Week 104|Week 24 Non-Responder|16
7015325|NCT01500278|11085713|FG000|Week 13 - Week 104|Non/bad compliance|7
7015326|NCT01500278|11085714|FG001|Week 13 - Week 104|Non/bad compliance|5
7015327|NCT01500278|11085713|FG000|Week 13 - Week 104|Recurrent infections|1
7015328|NCT01500278|11085714|FG001|Week 13 - Week 104|Recurrent infections|0
7015329|NCT01500278|11085713|FG000|Week 13 - Week 104|False positive test|1
7015330|NCT01500278|11085714|FG001|Week 13 - Week 104|False positive test|2
7015331|NCT01500278|11085713|FG000|Week 13 - Week 104|Sponsor request|4
7015332|NCT01500278|11085714|FG001|Week 13 - Week 104|Sponsor request|0
7015333|NCT01500278|11085713|FG000|Week 13 - Week 104|Withdrawn in error|1
7015334|NCT01500278|11085714|FG001|Week 13 - Week 104|Withdrawn in error|0
7015335|NCT01500278|11085713|FG000|Week 13 - Week 104|Exclusion criteria not met|1
7015336|NCT01500278|11085714|FG001|Week 13 - Week 104|Exclusion criteria not met|0
7015337|NCT01500278|11085713|FG000|Week 13 - Week 104|Protocol deviation|1
7015338|NCT01500278|11085714|FG001|Week 13 - Week 104|Protocol deviation|0
7015339|NCT01500278|11085713|FG000|Week 13 - Week 104|Principal investigator retiring|1
7015340|NCT01500278|11085714|FG001|Week 13 - Week 104|Principal investigator retiring|0
7015341|NCT01500278|11085713|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1
7015342|NCT01500278|11085714|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0
7015343|NCT01500278|11085713|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0
7015344|NCT01500278|11085714|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2
7015345|NCT01500278|11085713|FG000|Week 13 - Week 104|Relocation|0
7015346|NCT01500278|11085714|FG001|Week 13 - Week 104|Relocation|1
7015347|NCT01500278|11085713|FG000|Week 13 - Week 104|Sponsor decision|0
7015348|NCT01500278|11085714|FG001|Week 13 - Week 104|Sponsor decision|2
7015349|NCT01500278|11085713|FG000|Week 13 - Week 104|Medical monitor decision|0
7015350|NCT01500278|11085714|FG001|Week 13 - Week 104|Medical monitor decision|2
7015351|NCT01500278|11085713|FG000|Week 13 - Week 104|Personal reason|0
7015352|NCT01500278|11085714|FG001|Week 13 - Week 104|Personal reason|1
7015353|NCT01500278|11085713|FG000|Week 13 - Week 104|Not completed|0
7015354|NCT01500278|11085714|FG001|Week 13 - Week 104|Not completed|1
7015355|NCT01500278|11085713|FG000|Week 13 - Week 104|Death|2
7015356|NCT01500278|11085714|FG001|Week 13 - Week 104|Death|4
7015357|NCT01500278|11085713|FG000|Week 13 - Week 104|Adverse Event|54
7015358|NCT01500278|11085714|FG001|Week 13 - Week 104|Adverse Event|54
7015359|NCT01500317|11085725|FG000|Overall Study|Withdrawal by Subject|3
7015360|NCT01500317|11085726|FG001|Overall Study|Withdrawal by Subject|2
7015361|NCT01500317|11085727|FG002|Overall Study|Withdrawal by Subject|0
7015362|NCT01500382|11085739|FG000|Washout Period|Study site went out of business|0
7015363|NCT01500382|11085740|FG001|Washout Period|Study site went out of business|0
7015364|NCT01500382|11085741|FG002|Washout Period|Study site went out of business|1
7015365|NCT01500382|11085742|FG003|Washout Period|Study site went out of business|0
7015366|NCT01500434|11085752|FG000|Overall Study|Death|1
7015367|NCT01500434|11085752|FG000|Overall Study|Withdrawal by Subject|1
7015368|NCT01500434|11085752|FG000|Overall Study|Missed 12-month follow-up|5
7015369|NCT01500629|11085767|FG000|Washout Period of 14 to 30 Days|Pregnancy|1
7015370|NCT01500629|11085768|FG001|Washout Period of 14 to 30 Days|Pregnancy|0
7015371|NCT01500694|11085783|FG000|Overall Study|Adverse Event|4
7015372|NCT01500694|11085784|FG001|Overall Study|Adverse Event|3
7015373|NCT01500694|11085783|FG000|Overall Study|Protocol Violation|0
7015374|NCT01500694|11085784|FG001|Overall Study|Protocol Violation|1
7015375|NCT01500694|11085783|FG000|Overall Study|Withdrawal by Subject|23
7015376|NCT01500694|11085784|FG001|Overall Study|Withdrawal by Subject|14
7015377|NCT01500694|11085783|FG000|Overall Study|Lost to Follow-up|2
7015378|NCT01500694|11085784|FG001|Overall Study|Lost to Follow-up|3
7015379|NCT01500694|11085783|FG000|Overall Study|Lack of Efficacy|14
7015380|NCT01500694|11085784|FG001|Overall Study|Lack of Efficacy|5
7015381|NCT01500694|11085783|FG000|Overall Study|Other|9
7015382|NCT01500694|11085784|FG001|Overall Study|Other|3
7015383|NCT01500720|11085792|FG000|Overall Study|Randomized But Not Treated|1
7015384|NCT01500720|11085793|FG001|Overall Study|Randomized But Not Treated|1
7015385|NCT01500720|11085792|FG000|Overall Study|Other|4
7015386|NCT01500720|11085793|FG001|Overall Study|Other|8
7015387|NCT01501110|11085828|FG000|Overall Study|Death|0
7015388|NCT01501110|11085829|FG001|Overall Study|Death|1
7015389|NCT01502033|11085851|FG000|Overall Study|1 participant had scalp discomfort|1
7015390|NCT01502033|11085851|FG000|Overall Study|1 participant had worsening depression|1
7015391|NCT01502033|11085851|FG000|Overall Study|1 participant went back to school|1
7015392|NCT01502072|11085860|FG000|Overall Study|Withdrawal by Subject|1
7015393|NCT01502072|11085861|FG001|Overall Study|Withdrawal by Subject|0
7015394|NCT01502072|11085862|FG002|Overall Study|Withdrawal by Subject|0
7015395|NCT01502072|11085860|FG000|Overall Study|Death|0
7015396|NCT01502072|11085861|FG001|Overall Study|Death|1
7015397|NCT01502072|11085862|FG002|Overall Study|Death|0
7015398|NCT01502228|11085870|FG000|Overall Study|Death|1
7015399|NCT01502293|11085877|FG000|Overall Study|Progressive Disease|20
7015400|NCT01502293|11085878|FG001|Overall Study|Progressive Disease|12
7015401|NCT01502293|11085879|FG002|Overall Study|Progressive Disease|2
7015402|NCT01502293|11085877|FG000|Overall Study|Withdrawal by Subject|3
7015403|NCT01502293|11085878|FG001|Overall Study|Withdrawal by Subject|3
7015404|NCT01502293|11085879|FG002|Overall Study|Withdrawal by Subject|1
7015405|NCT01502293|11085877|FG000|Overall Study|Adverse Event|0
7015406|NCT01502293|11085878|FG001|Overall Study|Adverse Event|2
7015407|NCT01502293|11085879|FG002|Overall Study|Adverse Event|0
7015408|NCT01502293|11085877|FG000|Overall Study|Reason Not Specified|2
7015409|NCT01502293|11085878|FG001|Overall Study|Reason Not Specified|0
7015410|NCT01502293|11085879|FG002|Overall Study|Reason Not Specified|0
7015411|NCT01502293|11085877|FG000|Overall Study|Physician Decision|0
7015412|NCT01502293|11085878|FG001|Overall Study|Physician Decision|0
7015413|NCT01502293|11085879|FG002|Overall Study|Physician Decision|1
7015414|NCT01502410|11085916|FG000|Overall Study|Adverse Event|1
7015415|NCT01502410|11085917|FG001|Overall Study|Adverse Event|2
7015416|NCT01502410|11085918|FG002|Overall Study|Adverse Event|0
7015417|NCT01502410|11085919|FG003|Overall Study|Adverse Event|0
7015418|NCT01502410|11085916|FG000|Overall Study|Lack of Efficacy|7
7015419|NCT01502410|11085917|FG001|Overall Study|Lack of Efficacy|7
7015420|NCT01502410|11085918|FG002|Overall Study|Lack of Efficacy|0
7015421|NCT01502410|11085919|FG003|Overall Study|Lack of Efficacy|0
7015422|NCT01502410|11085916|FG000|Overall Study|Physician Decision|0
7015423|NCT01502410|11085917|FG001|Overall Study|Physician Decision|1
7015424|NCT01502410|11085918|FG002|Overall Study|Physician Decision|0
7015425|NCT01502410|11085919|FG003|Overall Study|Physician Decision|0
7015426|NCT01502410|11085916|FG000|Overall Study|Withdrawal by Subject|2
7015427|NCT01502410|11085917|FG001|Overall Study|Withdrawal by Subject|0
7015428|NCT01502410|11085918|FG002|Overall Study|Withdrawal by Subject|0
7015429|NCT01502410|11085919|FG003|Overall Study|Withdrawal by Subject|0
7015430|NCT01502423|11085930|FG000|Overall Study|Withdrawal by Subject|0
7015431|NCT01502423|11085931|FG001|Overall Study|Withdrawal by Subject|1
7015432|NCT01502631|11085939|FG000|Overall Study|Adverse Event|5
7015433|NCT01502631|11085940|FG001|Overall Study|Adverse Event|8
7015434|NCT01502631|11085939|FG000|Overall Study|Lost to Follow-up|2
7015435|NCT01502631|11085940|FG001|Overall Study|Lost to Follow-up|2
7015436|NCT01502631|11085939|FG000|Overall Study|Participant withdrew consent|2
7015437|NCT01502631|11085940|FG001|Overall Study|Participant withdrew consent|4
7015438|NCT01502631|11085939|FG000|Overall Study|Participant non-compliant|1
7015439|NCT01502631|11085940|FG001|Overall Study|Participant non-compliant|0
7015440|NCT01502631|11085939|FG000|Overall Study|Investigator's decision|0
7015441|NCT01502631|11085940|FG001|Overall Study|Investigator's decision|1
7015442|NCT01502631|11085939|FG000|Overall Study|Other|10
7015443|NCT01502631|11085940|FG001|Overall Study|Other|5
7015444|NCT01502644|11085949|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1
7015445|NCT01502644|11085950|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
7015446|NCT01502644|11085951|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
7015447|NCT01502644|11085952|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
7015448|NCT01502644|11085949|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2
7015449|NCT01502644|11085950|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
7015450|NCT01502644|11085951|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
7015451|NCT01502644|11085952|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
7015452|NCT01502644|11085949|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6
7015453|NCT01502644|11085950|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
7015454|NCT01502644|11085951|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
7015455|NCT01502644|11085952|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
7015456|NCT01502644|11085949|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0
7015457|NCT01502644|11085950|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6
7015458|NCT01502644|11085951|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2
7015459|NCT01502644|11085952|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7
7015460|NCT01502644|11085949|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
7015461|NCT01502644|11085950|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
7015462|NCT01502644|11085951|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
7015463|NCT01502644|11085952|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
7015464|NCT01502709|11085962|FG000|Overall Study|Lost to Follow-up|4
7015465|NCT01502709|11085963|FG001|Overall Study|Lost to Follow-up|0
7015466|NCT01502956|11086004|FG000|Overall Study|Death|0
7015467|NCT01502956|11086005|FG001|Overall Study|Death|2
7015468|NCT01502956|11086004|FG000|Overall Study|Lost to Follow-up|14
7015469|NCT01502956|11086005|FG001|Overall Study|Lost to Follow-up|11
7015470|NCT01502956|11086004|FG000|Overall Study|Physician Decision|2
7015471|NCT01502956|11086005|FG001|Overall Study|Physician Decision|3
7015472|NCT01502956|11086004|FG000|Overall Study|Withdrawal by Subject|8
7015473|NCT01502956|11086005|FG001|Overall Study|Withdrawal by Subject|10
7015474|NCT01503021|11086013|FG000|Overall Study|Adverse Event|7
7015475|NCT01503021|11086014|FG001|Overall Study|Adverse Event|6
7015476|NCT01503021|11086013|FG000|Overall Study|Death|0
7015477|NCT01503021|11086014|FG001|Overall Study|Death|2
7015478|NCT01503021|11086013|FG000|Overall Study|Lost to Follow-up|2
7015479|NCT01503021|11086014|FG001|Overall Study|Lost to Follow-up|0
7015480|NCT01503021|11086013|FG000|Overall Study|Physician Decision|3
7015481|NCT01503021|11086014|FG001|Overall Study|Physician Decision|0
7015482|NCT01503021|11086013|FG000|Overall Study|Protocol Violation|1
7015483|NCT01503021|11086014|FG001|Overall Study|Protocol Violation|3
7015484|NCT01503021|11086013|FG000|Overall Study|Withdrawal by Subject|9
7015485|NCT01503021|11086014|FG001|Overall Study|Withdrawal by Subject|8
7015486|NCT01503021|11086013|FG000|Overall Study|Moved, received transplant, etc.|5
7015487|NCT01503021|11086014|FG001|Overall Study|Moved, received transplant, etc.|7
7015488|NCT01503164|11086027|FG000|Overall Study|Withdrawal by Subject|2
7015489|NCT01503164|11086028|FG001|Overall Study|Withdrawal by Subject|1
7015490|NCT01503229|11086034|FG000|Overall Study|Withdrew consent|1
7015491|NCT01504204|11086070|FG000|Overall Study|Lost to Follow-up|1
7015492|NCT01504204|11086071|FG001|Overall Study|Lost to Follow-up|1
7015493|NCT01504412|11086082|FG000|Overall Study|Adverse Event|1
7015494|NCT01504412|11086083|FG001|Overall Study|Adverse Event|8
7015495|NCT01504412|11086084|FG002|Overall Study|Adverse Event|1
7015496|NCT01504412|11086085|FG003|Overall Study|Adverse Event|7
7015497|NCT01504412|11086086|FG004|Overall Study|Adverse Event|10
7015498|NCT01504412|11086082|FG000|Overall Study|Withdrawal by Subject|2
7015499|NCT01504412|11086083|FG001|Overall Study|Withdrawal by Subject|1
7015500|NCT01504412|11086084|FG002|Overall Study|Withdrawal by Subject|1
7015501|NCT01504412|11086085|FG003|Overall Study|Withdrawal by Subject|5
7015502|NCT01504412|11086086|FG004|Overall Study|Withdrawal by Subject|1
7015503|NCT01504412|11086082|FG000|Overall Study|Other|2
7015504|NCT01504412|11086083|FG001|Overall Study|Other|1
7015505|NCT01504412|11086084|FG002|Overall Study|Other|1
7015506|NCT01504412|11086085|FG003|Overall Study|Other|6
7015507|NCT01504412|11086086|FG004|Overall Study|Other|1
7015508|NCT01504412|11086082|FG000|Overall Study|Lost to Follow-up|0
7015509|NCT01504412|11086083|FG001|Overall Study|Lost to Follow-up|2
7015510|NCT01504412|11086084|FG002|Overall Study|Lost to Follow-up|0
7015511|NCT01504412|11086085|FG003|Overall Study|Lost to Follow-up|0
7015512|NCT01504412|11086086|FG004|Overall Study|Lost to Follow-up|0
7015513|NCT01504412|11086082|FG000|Overall Study|Lack of Efficacy|0
7015514|NCT01504412|11086083|FG001|Overall Study|Lack of Efficacy|0
7015515|NCT01504412|11086084|FG002|Overall Study|Lack of Efficacy|1
7015516|NCT01504412|11086085|FG003|Overall Study|Lack of Efficacy|0
7015517|NCT01504412|11086086|FG004|Overall Study|Lack of Efficacy|1
7015518|NCT01504412|11086082|FG000|Overall Study|Death|0
7015519|NCT01504412|11086083|FG001|Overall Study|Death|0
7015520|NCT01504412|11086084|FG002|Overall Study|Death|0
7015521|NCT01504412|11086085|FG003|Overall Study|Death|1
7015522|NCT01504412|11086086|FG004|Overall Study|Death|0
7043599|NCT01746017|11128645|FG009|Period 1|Withdrawal by Subject|0
7015523|NCT01504841|11086120|FG000|Overall Study|Withdrawal by Subject|1
7015524|NCT01504841|11086121|FG001|Overall Study|Withdrawal by Subject|1
7015525|NCT01504841|11086122|FG002|Overall Study|Withdrawal by Subject|0
7015526|NCT01504867|11086140|FG000|Overall Study|Inclusion criteria not met|2
7015527|NCT01504867|11086141|FG001|Overall Study|Inclusion criteria not met|2
7015528|NCT01504867|11086140|FG000|Overall Study|Consent revoked|5
7015529|NCT01504867|11086141|FG001|Overall Study|Consent revoked|1
7015530|NCT01504971|11086160|FG000|Overall Study|Physician Decision|13
7015531|NCT01505010|11086174|FG000|Overall Study|Protocol Violation|0
7015532|NCT01505010|11086175|FG001|Overall Study|Protocol Violation|1
7015533|NCT01505010|11086174|FG000|Overall Study|Lost to Follow-up|0
7015534|NCT01505010|11086175|FG001|Overall Study|Lost to Follow-up|1
7015535|NCT01505114|11086185|FG000|Overall Study|Withdrawal by Subject|5
7015536|NCT01505114|11086186|FG001|Overall Study|Withdrawal by Subject|4
7015537|NCT01505114|11086187|FG002|Overall Study|Withdrawal by Subject|4
7015538|NCT01505114|11086188|FG003|Overall Study|Withdrawal by Subject|7
7015539|NCT01505114|11086185|FG000|Overall Study|Death|1
7015540|NCT01505114|11086186|FG001|Overall Study|Death|0
7015541|NCT01505114|11086187|FG002|Overall Study|Death|0
7015542|NCT01505114|11086188|FG003|Overall Study|Death|1
7015543|NCT01505114|11086185|FG000|Overall Study|unable to adhere to visit schedule|3
7015544|NCT01505114|11086186|FG001|Overall Study|unable to adhere to visit schedule|2
7015545|NCT01505114|11086187|FG002|Overall Study|unable to adhere to visit schedule|3
7015546|NCT01505114|11086188|FG003|Overall Study|unable to adhere to visit schedule|3
7015547|NCT01505114|11086185|FG000|Overall Study|Lost to Follow-up|11
7015548|NCT01505114|11086186|FG001|Overall Study|Lost to Follow-up|5
7015549|NCT01505114|11086187|FG002|Overall Study|Lost to Follow-up|8
7015550|NCT01505114|11086188|FG003|Overall Study|Lost to Follow-up|7
7015551|NCT01505114|11086185|FG000|Overall Study|relocated|4
7015552|NCT01505114|11086186|FG001|Overall Study|relocated|2
7015553|NCT01505114|11086187|FG002|Overall Study|relocated|2
7015554|NCT01505114|11086188|FG003|Overall Study|relocated|3
7015555|NCT01505114|11086185|FG000|Overall Study|inadvertent enrollment due to peanut all|0
7015556|NCT01505114|11086186|FG001|Overall Study|inadvertent enrollment due to peanut all|0
7015557|NCT01505114|11086187|FG002|Overall Study|inadvertent enrollment due to peanut all|0
7015558|NCT01505114|11086188|FG003|Overall Study|inadvertent enrollment due to peanut all|1
7015559|NCT01505114|11086185|FG000|Overall Study|staff safety concerns|0
7015560|NCT01505114|11086186|FG001|Overall Study|staff safety concerns|0
7015561|NCT01505114|11086187|FG002|Overall Study|staff safety concerns|0
7015562|NCT01505114|11086188|FG003|Overall Study|staff safety concerns|1
7015563|NCT01505114|11086185|FG000|Overall Study|investigator decision|1
7015564|NCT01505114|11086186|FG001|Overall Study|investigator decision|0
7015565|NCT01505114|11086187|FG002|Overall Study|investigator decision|1
7015566|NCT01505114|11086188|FG003|Overall Study|investigator decision|0
7015567|NCT01505374|11086222|FG000|Overall Study|Lost to Follow-up|1
7015568|NCT01505374|11086223|FG001|Overall Study|Lost to Follow-up|0
7015569|NCT01505387|11086232|FG000|Overall Study|Protocol Violation|1
7015570|NCT01505387|11086233|FG001|Overall Study|Protocol Violation|0
7015571|NCT01505387|11086232|FG000|Overall Study|Withdrawal by Subject|1
7015572|NCT01505387|11086233|FG001|Overall Study|Withdrawal by Subject|1
7015573|NCT01505491|11086242|FG000|Overall Study|Other reason not listed|1
7015574|NCT01505491|11086243|FG001|Overall Study|Other reason not listed|0
7015575|NCT01505491|11086244|FG002|Overall Study|Other reason not listed|0
7015576|NCT01505491|11086242|FG000|Overall Study|Withdrawal by Subject|1
7015577|NCT01505491|11086243|FG001|Overall Study|Withdrawal by Subject|1
7015578|NCT01505491|11086244|FG002|Overall Study|Withdrawal by Subject|4
7015579|NCT01505491|11086242|FG000|Overall Study|Lost to Follow-up|0
7015580|NCT01505491|11086243|FG001|Overall Study|Lost to Follow-up|0
7015581|NCT01505491|11086244|FG002|Overall Study|Lost to Follow-up|1
7015582|NCT01505530|11086255|FG000|Overall Study|Progressive Disease|19
7015583|NCT01505530|11086256|FG001|Overall Study|Progressive Disease|17
7015584|NCT01505530|11086257|FG002|Overall Study|Progressive Disease|18
7015585|NCT01505530|11086255|FG000|Overall Study|Adverse Event|1
7015586|NCT01505530|11086256|FG001|Overall Study|Adverse Event|1
7015587|NCT01505530|11086257|FG002|Overall Study|Adverse Event|0
7015588|NCT01505530|11086255|FG000|Overall Study|Withdrawal by Subject|7
7015589|NCT01505530|11086256|FG001|Overall Study|Withdrawal by Subject|8
7015590|NCT01505530|11086257|FG002|Overall Study|Withdrawal by Subject|6
7015591|NCT01505530|11086255|FG000|Overall Study|Physician Decision|6
7015592|NCT01505530|11086256|FG001|Overall Study|Physician Decision|2
7015593|NCT01505530|11086257|FG002|Overall Study|Physician Decision|5
7015594|NCT01505530|11086255|FG000|Overall Study|Sponsor Decision|1
7015595|NCT01505530|11086256|FG001|Overall Study|Sponsor Decision|8
7015596|NCT01505530|11086257|FG002|Overall Study|Sponsor Decision|7
7015597|NCT01505530|11086255|FG000|Overall Study|Death|7
7015598|NCT01505530|11086256|FG001|Overall Study|Death|6
7015599|NCT01505530|11086257|FG002|Overall Study|Death|5
7015600|NCT01505530|11086255|FG000|Overall Study|entry criteria not met|0
7015601|NCT01505530|11086256|FG001|Overall Study|entry criteria not met|1
7015602|NCT01505530|11086257|FG002|Overall Study|entry criteria not met|0
7015603|NCT01505634|11086268|FG000|Overall Study|Withdrawal by Subject|2
7015604|NCT01505634|11086269|FG001|Overall Study|Withdrawal by Subject|5
7015605|NCT01505634|11086270|FG002|Overall Study|Withdrawal by Subject|1
7015606|NCT01505634|11086268|FG000|Overall Study|Physician Decision|1
7015607|NCT01505634|11086269|FG001|Overall Study|Physician Decision|1
7015608|NCT01505634|11086270|FG002|Overall Study|Physician Decision|0
7015609|NCT01505634|11086268|FG000|Overall Study|Adverse Event|1
7015610|NCT01505634|11086269|FG001|Overall Study|Adverse Event|0
7015611|NCT01505634|11086270|FG002|Overall Study|Adverse Event|0
7015612|NCT01505634|11086268|FG000|Overall Study|Insufficient supply of drug at site|1
7015613|NCT01505634|11086269|FG001|Overall Study|Insufficient supply of drug at site|0
7015614|NCT01505634|11086270|FG002|Overall Study|Insufficient supply of drug at site|0
7015615|NCT01505634|11086268|FG000|Overall Study|Protocol Violation|2
7015616|NCT01505634|11086269|FG001|Overall Study|Protocol Violation|0
7015617|NCT01505634|11086270|FG002|Overall Study|Protocol Violation|0
7015618|NCT01505634|11086268|FG000|Overall Study|Lost to Follow-up|1
7015619|NCT01505634|11086269|FG001|Overall Study|Lost to Follow-up|4
7015620|NCT01505634|11086270|FG002|Overall Study|Lost to Follow-up|4
7015621|NCT01505634|11086268|FG000|Overall Study|Death|1
7015622|NCT01505634|11086269|FG001|Overall Study|Death|0
7015623|NCT01505634|11086270|FG002|Overall Study|Death|0
7015624|NCT01505634|11086268|FG000|Overall Study|In a conflict zone|0
7015625|NCT01505634|11086269|FG001|Overall Study|In a conflict zone|0
7015626|NCT01505634|11086270|FG002|Overall Study|In a conflict zone|1
7015627|NCT01505647|11086280|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1
7015628|NCT01505647|11086281|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0
7015629|NCT01505647|11086280|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1
7015630|NCT01505647|11086281|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0
7015631|NCT01505647|11086280|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1
7015632|NCT01505647|11086281|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0
7015633|NCT01505647|11086280|FG000|Day 43 Through Day 182 Follow-up|Death|0
7015634|NCT01505647|11086281|FG001|Day 43 Through Day 182 Follow-up|Death|1
7015635|NCT01505647|11086280|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1
7015636|NCT01505647|11086281|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2
7015637|NCT01505868|11086311|FG000|Overall Study|Withdrawal by Subject|1
7015638|NCT01505868|11086312|FG001|Overall Study|Withdrawal by Subject|0
7015639|NCT01505868|11086313|FG002|Overall Study|Withdrawal by Subject|0
7015640|NCT01505868|11086314|FG003|Overall Study|Withdrawal by Subject|0
7015641|NCT01505868|11086315|FG004|Overall Study|Withdrawal by Subject|0
7015642|NCT01505881|11086329|FG000|Overall Study|Adverse Event|0
7015643|NCT01505881|11086330|FG001|Overall Study|Adverse Event|1
7015644|NCT01505881|11086329|FG000|Overall Study|Lost to Follow-up|2
7015645|NCT01505881|11086330|FG001|Overall Study|Lost to Follow-up|0
7015646|NCT01505881|11086329|FG000|Overall Study|Withdrawal by Subject|2
7015647|NCT01505881|11086330|FG001|Overall Study|Withdrawal by Subject|0
7015648|NCT01506193|11086349|FG000|Overall Study|Protocol Violation|1
7015649|NCT01506193|11086350|FG001|Overall Study|Protocol Violation|0
7015650|NCT01506193|11086351|FG002|Overall Study|Protocol Violation|1
7015651|NCT01506193|11086349|FG000|Overall Study|Migrated/moved from study area|0
7015652|NCT01506193|11086350|FG001|Overall Study|Migrated/moved from study area|0
7015653|NCT01506193|11086351|FG002|Overall Study|Migrated/moved from study area|1
7015654|NCT01506193|11086349|FG000|Overall Study|Adverse event, non-fatal|0
7015655|NCT01506193|11086350|FG001|Overall Study|Adverse event, non-fatal|0
7015656|NCT01506193|11086351|FG002|Overall Study|Adverse event, non-fatal|1
7015657|NCT01506193|11086349|FG000|Overall Study|Withdrawal by Subject|5
7015658|NCT01506193|11086350|FG001|Overall Study|Withdrawal by Subject|1
7015659|NCT01506193|11086351|FG002|Overall Study|Withdrawal by Subject|8
7015660|NCT01506193|11086349|FG000|Overall Study|Lost to Follow-up|8
7015661|NCT01506193|11086350|FG001|Overall Study|Lost to Follow-up|3
7015662|NCT01506193|11086351|FG002|Overall Study|Lost to Follow-up|3
7015663|NCT01506271|11086363|FG000|Overall Study|Progressive disease|0
7015664|NCT01506271|11086364|FG001|Overall Study|Progressive disease|1
7015665|NCT01506271|11086365|FG002|Overall Study|Progressive disease|0
7015666|NCT01506271|11086363|FG000|Overall Study|Protocol Violation|3
7015667|NCT01506271|11086364|FG001|Overall Study|Protocol Violation|1
7015668|NCT01506271|11086365|FG002|Overall Study|Protocol Violation|0
7015669|NCT01506271|11086363|FG000|Overall Study|Death|0
7015670|NCT01506271|11086364|FG001|Overall Study|Death|1
7015671|NCT01506271|11086365|FG002|Overall Study|Death|0
7015672|NCT01506271|11086363|FG000|Overall Study|Adverse Event|0
7015673|NCT01506271|11086364|FG001|Overall Study|Adverse Event|2
7015674|NCT01506271|11086365|FG002|Overall Study|Adverse Event|0
7015675|NCT01506271|11086363|FG000|Overall Study|Insufficient supply of study drug|1
7015676|NCT01506271|11086364|FG001|Overall Study|Insufficient supply of study drug|0
7015677|NCT01506271|11086365|FG002|Overall Study|Insufficient supply of study drug|0
7015678|NCT01506271|11086363|FG000|Overall Study|Withdrawal by Subject|0
7015679|NCT01506271|11086364|FG001|Overall Study|Withdrawal by Subject|1
7015680|NCT01506271|11086365|FG002|Overall Study|Withdrawal by Subject|1
7015681|NCT01506271|11086363|FG000|Overall Study|Lost to Follow-up|0
7015682|NCT01506271|11086364|FG001|Overall Study|Lost to Follow-up|1
7015683|NCT01506271|11086365|FG002|Overall Study|Lost to Follow-up|2
7015684|NCT01506323|11086375|FG000|Overall Study|Lost to Follow-up|5
7015685|NCT01506323|11086376|FG001|Overall Study|Lost to Follow-up|4
7015686|NCT01506323|11086375|FG000|Overall Study|Withdrawal by Subject|4
7015687|NCT01506323|11086376|FG001|Overall Study|Withdrawal by Subject|4
7015688|NCT01506323|11086375|FG000|Overall Study|Lack of Efficacy|1
7015689|NCT01506323|11086376|FG001|Overall Study|Lack of Efficacy|3
7015690|NCT01506323|11086375|FG000|Overall Study|Moved out of area|5
7015691|NCT01506323|11086376|FG001|Overall Study|Moved out of area|2
7015692|NCT01506323|11086375|FG000|Overall Study|Schedule or Transportation conflict|8
7015693|NCT01506323|11086376|FG001|Overall Study|Schedule or Transportation conflict|0
7015694|NCT01506323|11086375|FG000|Overall Study|Started another treatment|1
7015695|NCT01506323|11086376|FG001|Overall Study|Started another treatment|0
7015696|NCT01506453|11086393|FG000|Overall Study|Withdrawal prior to treatment|0
7015697|NCT01506453|11086394|FG001|Overall Study|Withdrawal prior to treatment|2
7015698|NCT01506479|11086403|FG000|Overall Study|Lost to Follow-up|1
7015699|NCT01506479|11086404|FG001|Overall Study|Lost to Follow-up|2
7015700|NCT01506479|11086405|FG002|Overall Study|Lost to Follow-up|2
7015701|NCT01506479|11086403|FG000|Overall Study|Withdrawal by Subject|1
7015702|NCT01506479|11086404|FG001|Overall Study|Withdrawal by Subject|2
7015703|NCT01506479|11086405|FG002|Overall Study|Withdrawal by Subject|1
7015704|NCT01506479|11086403|FG000|Overall Study|Missing assessment|1
7015705|NCT01506479|11086404|FG001|Overall Study|Missing assessment|0
7015706|NCT01506479|11086405|FG002|Overall Study|Missing assessment|0
7015707|NCT01506479|11086403|FG000|Overall Study|Adverse Event|0
7015708|NCT01506479|11086404|FG001|Overall Study|Adverse Event|1
7015709|NCT01506479|11086405|FG002|Overall Study|Adverse Event|0
7015710|NCT01506596|11086415|FG000|Overall Study|ineligible pathology|1
7015711|NCT01506609|11086425|FG000|Overall Study|Adverse Event Related to Progression|0
7015712|NCT01506609|11086426|FG001|Overall Study|Adverse Event Related to Progression|0
7015713|NCT01506609|11086427|FG002|Overall Study|Adverse Event Related to Progression|0
7015714|NCT01506609|11086428|FG003|Overall Study|Adverse Event Related to Progression|3
7015715|NCT01506609|11086429|FG004|Overall Study|Adverse Event Related to Progression|7
7015716|NCT01506609|11086430|FG005|Overall Study|Adverse Event Related to Progression|3
7015717|NCT01506609|11086425|FG000|Overall Study|Adverse Event Not Related to Progression|0
7015718|NCT01506609|11086426|FG001|Overall Study|Adverse Event Not Related to Progression|1
7015719|NCT01506609|11086427|FG002|Overall Study|Adverse Event Not Related to Progression|0
7015720|NCT01506609|11086428|FG003|Overall Study|Adverse Event Not Related to Progression|6
7015721|NCT01506609|11086429|FG004|Overall Study|Adverse Event Not Related to Progression|10
7015722|NCT01506609|11086430|FG005|Overall Study|Adverse Event Not Related to Progression|5
7015723|NCT01506609|11086425|FG000|Overall Study|Withdrawal by Subject|0
7015724|NCT01506609|11086426|FG001|Overall Study|Withdrawal by Subject|0
7015725|NCT01506609|11086427|FG002|Overall Study|Withdrawal by Subject|0
7015726|NCT01506609|11086428|FG003|Overall Study|Withdrawal by Subject|9
7015727|NCT01506609|11086429|FG004|Overall Study|Withdrawal by Subject|7
7015728|NCT01506609|11086430|FG005|Overall Study|Withdrawal by Subject|7
7015729|NCT01506609|11086425|FG000|Overall Study|Lost to Follow-up|0
7015730|NCT01506609|11086426|FG001|Overall Study|Lost to Follow-up|0
7015731|NCT01506609|11086427|FG002|Overall Study|Lost to Follow-up|0
7015732|NCT01506609|11086428|FG003|Overall Study|Lost to Follow-up|1
7015733|NCT01506609|11086429|FG004|Overall Study|Lost to Follow-up|2
7015734|NCT01506609|11086430|FG005|Overall Study|Lost to Follow-up|0
7015735|NCT01506609|11086425|FG000|Overall Study|Sponsor Discontinued Study|0
7015736|NCT01506609|11086426|FG001|Overall Study|Sponsor Discontinued Study|0
7015737|NCT01506609|11086427|FG002|Overall Study|Sponsor Discontinued Study|0
7015738|NCT01506609|11086428|FG003|Overall Study|Sponsor Discontinued Study|2
7015739|NCT01506609|11086429|FG004|Overall Study|Sponsor Discontinued Study|2
7015740|NCT01506609|11086430|FG005|Overall Study|Sponsor Discontinued Study|0
7015741|NCT01506609|11086425|FG000|Overall Study|Progressive Disease per Protocol|1
7015742|NCT01506609|11086426|FG001|Overall Study|Progressive Disease per Protocol|0
7015743|NCT01506609|11086427|FG002|Overall Study|Progressive Disease per Protocol|0
7015744|NCT01506609|11086428|FG003|Overall Study|Progressive Disease per Protocol|64
7015745|NCT01506609|11086429|FG004|Overall Study|Progressive Disease per Protocol|57
7015746|NCT01506609|11086430|FG005|Overall Study|Progressive Disease per Protocol|74
7015747|NCT01506609|11086425|FG000|Overall Study|Other, Not Specified|0
7015748|NCT01506609|11086426|FG001|Overall Study|Other, Not Specified|0
7015749|NCT01506609|11086427|FG002|Overall Study|Other, Not Specified|0
7015750|NCT01506609|11086428|FG003|Overall Study|Other, Not Specified|10
7015751|NCT01506609|11086429|FG004|Overall Study|Other, Not Specified|7
7015752|NCT01506609|11086430|FG005|Overall Study|Other, Not Specified|3
7015753|NCT01506609|11086425|FG000|Overall Study|Missing / Unknown Reason|1
7015754|NCT01506609|11086426|FG001|Overall Study|Missing / Unknown Reason|0
7015755|NCT01506609|11086427|FG002|Overall Study|Missing / Unknown Reason|1
7015756|NCT01506609|11086428|FG003|Overall Study|Missing / Unknown Reason|4
7015757|NCT01506609|11086429|FG004|Overall Study|Missing / Unknown Reason|4
7015758|NCT01506609|11086430|FG005|Overall Study|Missing / Unknown Reason|2
7015759|NCT01506726|11086443|FG000|Overall Study|Adverse Event|1
7015760|NCT01506726|11086444|FG001|Overall Study|Adverse Event|2
7015761|NCT01506882|11086452|FG000|Overall Study|Lack of Efficacy|4
7015762|NCT01506882|11086453|FG001|Overall Study|Lack of Efficacy|3
7015763|NCT01506882|11086452|FG000|Overall Study|Lost to Follow-up|1
7015764|NCT01506882|11086453|FG001|Overall Study|Lost to Follow-up|0
7015765|NCT01506882|11086452|FG000|Overall Study|Withdrawal by Subject|9
7015766|NCT01506882|11086453|FG001|Overall Study|Withdrawal by Subject|3
7015767|NCT01506882|11086452|FG000|Overall Study|SAE, non-fatal|2
7015768|NCT01506882|11086453|FG001|Overall Study|SAE, non-fatal|0
7015769|NCT01506882|11086452|FG000|Overall Study|AE, non-serious non-fatal|3
7015770|NCT01506882|11086453|FG001|Overall Study|AE, non-serious non-fatal|1
7015771|NCT01506882|11086452|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
7015772|NCT01506882|11086453|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
7015773|NCT01506882|11086452|FG000|Overall Study|Other Reason|2
7015774|NCT01506882|11086453|FG001|Overall Study|Other Reason|0
7015775|NCT01506908|11086463|FG000|Overall Study|Adverse Event|1
7015776|NCT01506908|11086464|FG001|Overall Study|Adverse Event|0
7015777|NCT01506947|11086472|FG000|Overall Study|Lost to Follow-up|7
7015778|NCT01506947|11086472|FG000|Overall Study|Adverse Event|5
7015779|NCT01506947|11086472|FG000|Overall Study|Death|1
7015780|NCT01506947|11086472|FG000|Overall Study|Did Not Meet Eligibility Criteria|3
7015781|NCT01506960|11086478|FG000|Overall Study|Did not meet angiographic criteria|47
7015782|NCT01507051|11086488|FG000|Overall Study|Withdrawal by Subject|1
7015783|NCT01507051|11086489|FG001|Overall Study|Withdrawal by Subject|3
7015784|NCT01507051|11086490|FG002|Overall Study|Withdrawal by Subject|1
7015785|NCT01507051|11086491|FG003|Overall Study|Withdrawal by Subject|6
7015786|NCT01507051|11086488|FG000|Overall Study|Physician Decision|0
7015787|NCT01507051|11086489|FG001|Overall Study|Physician Decision|0
7015788|NCT01507051|11086490|FG002|Overall Study|Physician Decision|0
7015789|NCT01507051|11086491|FG003|Overall Study|Physician Decision|1
7015790|NCT01507051|11086488|FG000|Overall Study|Adverse Event|1
7015791|NCT01507051|11086489|FG001|Overall Study|Adverse Event|0
7015792|NCT01507051|11086490|FG002|Overall Study|Adverse Event|0
7015793|NCT01507051|11086491|FG003|Overall Study|Adverse Event|0
7015794|NCT01507090|11086501|FG000|Overall Study|incomplete dataset|18
7015795|NCT01507246|11086549|FG000|Overall Study|Required different surgical procedures|2
7015796|NCT01507246|11086550|FG001|Overall Study|Required different surgical procedures|1
7015797|NCT01507298|11086561|FG000|Overall Study|Protocol Violation|0
7015798|NCT01507298|11086562|FG001|Overall Study|Protocol Violation|6
7015799|NCT01507662|11086584|FG000|Overall Study|Death|26
7015800|NCT01507662|11086585|FG001|Overall Study|Death|18
7015801|NCT01507662|11086584|FG000|Overall Study|Withdrawal by Subject|290
7015802|NCT01507662|11086585|FG001|Overall Study|Withdrawal by Subject|287
7015803|NCT01507662|11086584|FG000|Overall Study|Lost to Follow-up|498
7015804|NCT01507662|11086585|FG001|Overall Study|Lost to Follow-up|523
7015805|NCT01507662|11086584|FG000|Overall Study|Proxy interview done|2
7015806|NCT01507662|11086585|FG001|Overall Study|Proxy interview done|3
7015807|NCT01507831|11086613|FG000|Overall Study|Randomized but not treated|0
7015808|NCT01507831|11086614|FG001|Overall Study|Randomized but not treated|3
7015809|NCT01507831|11086613|FG000|Overall Study|Adverse Event|48
7015810|NCT01507831|11086614|FG001|Overall Study|Adverse Event|113
7015811|NCT01507831|11086613|FG000|Overall Study|Death|6
7015812|NCT01507831|11086614|FG001|Overall Study|Death|2
7015813|NCT01507831|11086613|FG000|Overall Study|Poor compliance to protocol|38
7015814|NCT01507831|11086614|FG001|Overall Study|Poor compliance to protocol|60
7015815|NCT01507831|11086613|FG000|Overall Study|Physician Decision|0
7015816|NCT01507831|11086614|FG001|Overall Study|Physician Decision|4
7015817|NCT01507831|11086613|FG000|Overall Study|Participant moved|5
7015818|NCT01507831|11086614|FG001|Overall Study|Participant moved|19
7015819|NCT01507831|11086613|FG000|Overall Study|Consent withdrawn by participant|34
7015820|NCT01507831|11086614|FG001|Overall Study|Consent withdrawn by participant|72
7015821|NCT01507831|11086613|FG000|Overall Study|Related to study drug administration|5
7015822|NCT01507831|11086614|FG001|Overall Study|Related to study drug administration|14
7015823|NCT01507831|11086613|FG000|Overall Study|Last visit outside protocol visit window|51
7015824|NCT01507831|11086614|FG001|Overall Study|Last visit outside protocol visit window|143
7015825|NCT01507831|11086613|FG000|Overall Study|Selection criteria finally not met|0
7015826|NCT01507831|11086614|FG001|Overall Study|Selection criteria finally not met|1
7015827|NCT01507831|11086613|FG000|Overall Study|Site closure|0
7015828|NCT01507831|11086614|FG001|Overall Study|Site closure|3
7015829|NCT01507831|11086613|FG000|Overall Study|Potential lost to follow-up|3
7015830|NCT01507831|11086614|FG001|Overall Study|Potential lost to follow-up|0
7015831|NCT01507831|11086613|FG000|Overall Study|Other|3
7015832|NCT01507831|11086614|FG001|Overall Study|Other|6
7015833|NCT01507896|11086620|FG000|Overall Study|Withdrawal by Subject|1
7015834|NCT01507896|11086620|FG000|Overall Study|The surgery was denied by the sponsor.|1
7015835|NCT01508130|11086687|FG000|Overall Study|Adverse Event|81
7015836|NCT01508130|11086688|FG001|Overall Study|Adverse Event|28
7015837|NCT01508130|11086687|FG000|Overall Study|Death|3
7015838|NCT01508130|11086688|FG001|Overall Study|Death|1
7015839|NCT01508130|11086687|FG000|Overall Study|Protocol Violation|2
7015840|NCT01508130|11086688|FG001|Overall Study|Protocol Violation|0
7015841|NCT01508130|11086687|FG000|Overall Study|Lost to Follow-up|25
7015842|NCT01508130|11086688|FG001|Overall Study|Lost to Follow-up|2
7015843|NCT01508130|11086687|FG000|Overall Study|Withdrawal by Subject|3
7015844|NCT01508130|11086688|FG001|Overall Study|Withdrawal by Subject|3
7015845|NCT01508130|11086687|FG000|Overall Study|Subject's substantial non-compliance|25
7015846|NCT01508130|11086688|FG001|Overall Study|Subject's substantial non-compliance|9
7015847|NCT01508130|11086687|FG000|Overall Study|Insufficient therapeutic response|74
7015848|NCT01508130|11086688|FG001|Overall Study|Insufficient therapeutic response|23
7015849|NCT01508130|11086687|FG000|Overall Study|Administrative|14
7015850|NCT01508130|11086688|FG001|Overall Study|Administrative|3
7015851|NCT01508169|11086698|FG000|Overall Study|Adverse Event|1
7015852|NCT01508169|11086699|FG001|Overall Study|Adverse Event|0
7015853|NCT01508169|11086698|FG000|Overall Study|Withdrawal by Subject|1
7015854|NCT01508169|11086699|FG001|Overall Study|Withdrawal by Subject|0
7015855|NCT01508169|11086698|FG000|Overall Study|Lost to Follow-up|1
7015856|NCT01508169|11086699|FG001|Overall Study|Lost to Follow-up|2
7015857|NCT01508325|11086713|FG000|Overall Study|Withdrawal by Subject|8
7015858|NCT01508325|11086714|FG001|Overall Study|Withdrawal by Subject|9
7015859|NCT01508325|11086713|FG000|Overall Study|Protocol Violation|0
7015860|NCT01508325|11086714|FG001|Overall Study|Protocol Violation|3
7015861|NCT01508325|11086713|FG000|Overall Study|Physician Decision|2
7015862|NCT01508325|11086714|FG001|Overall Study|Physician Decision|1
7015863|NCT01508325|11086713|FG000|Overall Study|Adverse Event|1
7015864|NCT01508325|11086714|FG001|Overall Study|Adverse Event|0
7015865|NCT01508325|11086713|FG000|Overall Study|Lost to Follow-up|5
7015866|NCT01508325|11086714|FG001|Overall Study|Lost to Follow-up|6
7015867|NCT01508325|11086713|FG000|Overall Study|Other|2
7015868|NCT01508325|11086714|FG001|Overall Study|Other|2
7015869|NCT01508650|11086726|FG000|Overall Study|Lost to Follow-up|0
7015870|NCT01508650|11086727|FG001|Overall Study|Lost to Follow-up|3
7015871|NCT01508676|11086735|FG000|Phase I (2 Weeks)|Medication Exclusion|1
7015872|NCT01508676|11086736|FG001|Phase I (2 Weeks)|Medication Exclusion|1
7015873|NCT01508676|11086735|FG000|Phase I (2 Weeks)|Wrong Pain Type|1
7015874|NCT01508676|11086736|FG001|Phase I (2 Weeks)|Wrong Pain Type|0
7015875|NCT01508676|11086735|FG000|Phase I (2 Weeks)|Positive Drug Screen|0
7015876|NCT01508676|11086736|FG001|Phase I (2 Weeks)|Positive Drug Screen|2
7015877|NCT01508676|11086735|FG000|Phase II (2 Weeks)|Skin Sensitivity|0
7015878|NCT01508676|11086736|FG001|Phase II (2 Weeks)|Skin Sensitivity|1
7015879|NCT01508676|11086735|FG000|Phase II (2 Weeks)|Medication Exclusion|1
7015880|NCT01508676|11086736|FG001|Phase II (2 Weeks)|Medication Exclusion|0
7015881|NCT01508702|11086745|FG000|Overall Study|Adverse Event|7
7015882|NCT01508702|11086746|FG001|Overall Study|Adverse Event|3
7015883|NCT01508702|11086745|FG000|Overall Study|Gout flare|2
7015884|NCT01508702|11086746|FG001|Overall Study|Gout flare|0
7015885|NCT01508702|11086745|FG000|Overall Study|Protocol Violation|2
7015886|NCT01508702|11086746|FG001|Overall Study|Protocol Violation|1
7015887|NCT01508702|11086745|FG000|Overall Study|Lost to Follow-up|1
7015888|NCT01508702|11086746|FG001|Overall Study|Lost to Follow-up|2
7015889|NCT01508702|11086745|FG000|Overall Study|Withdrawal by Subject|11
7015890|NCT01508702|11086746|FG001|Overall Study|Withdrawal by Subject|7
7015891|NCT01508910|11086764|FG000|Treatment|Death|2
7015892|NCT01508910|11086765|FG001|Treatment|Death|3
7015893|NCT01508910|11086766|FG002|Treatment|Death|2
7015894|NCT01508910|11086767|FG003|Treatment|Death|0
7015895|NCT01508910|11086764|FG000|Treatment|Lost to Follow-up|0
7015896|NCT01508910|11086765|FG001|Treatment|Lost to Follow-up|0
7015897|NCT01508910|11086766|FG002|Treatment|Lost to Follow-up|2
7015898|NCT01508910|11086767|FG003|Treatment|Lost to Follow-up|1
7015899|NCT01508910|11086764|FG000|Treatment|Withdrawal by Subject|0
7015900|NCT01508910|11086765|FG001|Treatment|Withdrawal by Subject|1
7015901|NCT01508910|11086766|FG002|Treatment|Withdrawal by Subject|6
7015902|NCT01508910|11086767|FG003|Treatment|Withdrawal by Subject|1
7015903|NCT01508910|11086764|FG000|Treatment|Sponsor Decision|0
7015904|NCT01508910|11086765|FG001|Treatment|Sponsor Decision|0
7015905|NCT01508910|11086766|FG002|Treatment|Sponsor Decision|0
7015906|NCT01508910|11086767|FG003|Treatment|Sponsor Decision|1
7015907|NCT01508936|11086781|FG000|Overall Study|Adverse Event|11
7015908|NCT01508936|11086782|FG001|Overall Study|Adverse Event|32
7015909|NCT01508936|11086781|FG000|Overall Study|Lack of Efficacy|0
7015910|NCT01508936|11086782|FG001|Overall Study|Lack of Efficacy|1
7015911|NCT01508936|11086781|FG000|Overall Study|Withdrawal by Subject|4
7015912|NCT01508936|11086782|FG001|Overall Study|Withdrawal by Subject|18
7015913|NCT01508936|11086781|FG000|Overall Study|Protocol Violation|2
7015914|NCT01508936|11086782|FG001|Overall Study|Protocol Violation|3
7015915|NCT01508936|11086781|FG000|Overall Study|Lost to Follow-up|2
7015916|NCT01508936|11086782|FG001|Overall Study|Lost to Follow-up|9
7015917|NCT01508936|11086781|FG000|Overall Study|Other|0
7015918|NCT01508936|11086782|FG001|Overall Study|Other|5
7015919|NCT01508936|11086781|FG000|Overall Study|Data from 2 sites deemed invalid|4
7015920|NCT01508936|11086782|FG001|Overall Study|Data from 2 sites deemed invalid|11
7015921|NCT01509079|11086810|FG000|Overall Study|Lack of Efficacy|0
7015922|NCT01509079|11086811|FG001|Overall Study|Lack of Efficacy|2
7015923|NCT01509079|11086810|FG000|Overall Study|started an excluded medication|0
7015924|NCT01509079|11086811|FG001|Overall Study|started an excluded medication|1
7015925|NCT01509547|11086843|FG000|Overall Study|Lost to Follow-up|24
7015926|NCT01509547|11086844|FG001|Overall Study|Lost to Follow-up|14
7015927|NCT01509547|11086843|FG000|Overall Study|Withdrawal by Subject|11
7015928|NCT01509547|11086844|FG001|Overall Study|Withdrawal by Subject|24
7015929|NCT01509547|11086843|FG000|Overall Study|Physician Decision|0
7015930|NCT01509547|11086844|FG001|Overall Study|Physician Decision|1
7015931|NCT01509664|11086899|FG000|Overall Study|Lost to Follow-up|15
7015932|NCT01509664|11086900|FG001|Overall Study|Lost to Follow-up|21
7015933|NCT01509846|11086929|FG000|Received Vaccination 2|Withdrawal by Subject|0
7015934|NCT01509846|11086930|FG001|Received Vaccination 2|Withdrawal by Subject|0
7015935|NCT01509846|11086931|FG002|Received Vaccination 2|Withdrawal by Subject|1
7015936|NCT01509846|11086932|FG003|Received Vaccination 2|Withdrawal by Subject|0
7015937|NCT01509846|11086933|FG004|Received Vaccination 2|Withdrawal by Subject|0
7015938|NCT01509846|11086929|FG000|Received Vaccination 2|Illness|0
7015939|NCT01509846|11086930|FG001|Received Vaccination 2|Illness|0
7015940|NCT01509846|11086931|FG002|Received Vaccination 2|Illness|0
7015941|NCT01509846|11086932|FG003|Received Vaccination 2|Illness|0
7015942|NCT01509846|11086933|FG004|Received Vaccination 2|Illness|1
7015943|NCT01509846|11086929|FG000|Received Vaccination 2|Not vaccinated per protocol|5
7015944|NCT01509846|11086930|FG001|Received Vaccination 2|Not vaccinated per protocol|0
7015945|NCT01509846|11086931|FG002|Received Vaccination 2|Not vaccinated per protocol|0
7015946|NCT01509846|11086932|FG003|Received Vaccination 2|Not vaccinated per protocol|0
7015947|NCT01509846|11086933|FG004|Received Vaccination 2|Not vaccinated per protocol|2
7015948|NCT01509846|11086929|FG000|Received Vaccination 3|Withdrawal by Subject|0
7015949|NCT01509846|11086930|FG001|Received Vaccination 3|Withdrawal by Subject|1
7015950|NCT01509846|11086931|FG002|Received Vaccination 3|Withdrawal by Subject|0
7015951|NCT01509846|11086932|FG003|Received Vaccination 3|Withdrawal by Subject|0
7015952|NCT01509846|11086933|FG004|Received Vaccination 3|Withdrawal by Subject|0
7015953|NCT01509846|11086929|FG000|Received Vaccination 3|Pregnancy|0
7015954|NCT01509846|11086930|FG001|Received Vaccination 3|Pregnancy|0
7015955|NCT01509846|11086931|FG002|Received Vaccination 3|Pregnancy|0
7015956|NCT01509846|11086932|FG003|Received Vaccination 3|Pregnancy|1
7015957|NCT01509846|11086933|FG004|Received Vaccination 3|Pregnancy|0
7015958|NCT01509846|11086929|FG000|Received Vaccination 3|Lost to Follow-up|0
7015959|NCT01509846|11086930|FG001|Received Vaccination 3|Lost to Follow-up|0
7015960|NCT01509846|11086931|FG002|Received Vaccination 3|Lost to Follow-up|1
7015961|NCT01509846|11086932|FG003|Received Vaccination 3|Lost to Follow-up|0
7015962|NCT01509846|11086933|FG004|Received Vaccination 3|Lost to Follow-up|0
7015963|NCT01510028|11086977|FG000|Overall Study|Lack of Efficacy|1
7015964|NCT01510028|11086978|FG001|Overall Study|Lack of Efficacy|0
7015965|NCT01510028|11086979|FG002|Overall Study|Lack of Efficacy|0
7015966|NCT01510028|11086980|FG003|Overall Study|Lack of Efficacy|0
7015967|NCT01510145|11086992|FG000|Overall Study|Adverse Event|6
7015968|NCT01510145|11086992|FG000|Overall Study|Lost to Follow-up|5
7015969|NCT01510145|11086992|FG000|Overall Study|Withdrawal by Subject|6
7015970|NCT01510145|11086992|FG000|Overall Study|Relative reported subject withdrew|1
7015971|NCT01510158|11086999|FG000|Overall Study|Adverse Event|7
7015972|NCT01510158|11087000|FG001|Overall Study|Adverse Event|8
7015973|NCT01510158|11087001|FG002|Overall Study|Adverse Event|5
7015974|NCT01510158|11086999|FG000|Overall Study|Gout flare|1
7015975|NCT01510158|11087000|FG001|Overall Study|Gout flare|0
7015976|NCT01510158|11087001|FG002|Overall Study|Gout flare|0
7015977|NCT01510158|11086999|FG000|Overall Study|Protocol Violation|17
7015978|NCT01510158|11087000|FG001|Overall Study|Protocol Violation|16
7015979|NCT01510158|11087001|FG002|Overall Study|Protocol Violation|24
7015980|NCT01510158|11086999|FG000|Overall Study|Sponsor terminated study.|2
7015981|NCT01510158|11087000|FG001|Overall Study|Sponsor terminated study.|0
7015982|NCT01510158|11087001|FG002|Overall Study|Sponsor terminated study.|2
7015983|NCT01510158|11086999|FG000|Overall Study|Lost to Follow-up|13
7015984|NCT01510158|11087000|FG001|Overall Study|Lost to Follow-up|16
7015985|NCT01510158|11087001|FG002|Overall Study|Lost to Follow-up|9
7015986|NCT01510158|11086999|FG000|Overall Study|Withdrawal by Subject|10
7015987|NCT01510158|11087000|FG001|Overall Study|Withdrawal by Subject|13
7015988|NCT01510158|11087001|FG002|Overall Study|Withdrawal by Subject|10
7015989|NCT01510158|11086999|FG000|Overall Study|Death|1
7015990|NCT01510158|11087000|FG001|Overall Study|Death|0
7015991|NCT01510158|11087001|FG002|Overall Study|Death|0
7015992|NCT01510717|11087067|FG000|Overall Study|Adverse Event|1
7015993|NCT01510717|11087068|FG001|Overall Study|Adverse Event|2
7015994|NCT01510717|11087067|FG000|Overall Study|Death|1
7015995|NCT01510717|11087068|FG001|Overall Study|Death|0
7015996|NCT01510717|11087067|FG000|Overall Study|Lost to Follow-up|0
7015997|NCT01510717|11087068|FG001|Overall Study|Lost to Follow-up|1
7015998|NCT01510717|11087067|FG000|Overall Study|Withdrawal by Subject|0
7015999|NCT01510717|11087068|FG001|Overall Study|Withdrawal by Subject|2
7016000|NCT01510769|11087078|FG000|Overall Study|Adverse Event|7
7016001|NCT01510769|11087079|FG001|Overall Study|Adverse Event|6
7016002|NCT01510769|11087080|FG002|Overall Study|Adverse Event|4
7016003|NCT01510769|11087078|FG000|Overall Study|Gout Flare|0
7016004|NCT01510769|11087079|FG001|Overall Study|Gout Flare|3
7016005|NCT01510769|11087080|FG002|Overall Study|Gout Flare|1
7016006|NCT01510769|11087078|FG000|Overall Study|Protocol Violation|11
7016007|NCT01510769|11087079|FG001|Overall Study|Protocol Violation|10
7016008|NCT01510769|11087080|FG002|Overall Study|Protocol Violation|9
7016009|NCT01510769|11087078|FG000|Overall Study|Lost to Follow-up|5
7016010|NCT01510769|11087079|FG001|Overall Study|Lost to Follow-up|1
7016011|NCT01510769|11087080|FG002|Overall Study|Lost to Follow-up|5
7016012|NCT01510769|11087078|FG000|Overall Study|Withdrawal by Subject|3
7016013|NCT01510769|11087079|FG001|Overall Study|Withdrawal by Subject|4
7016014|NCT01510769|11087080|FG002|Overall Study|Withdrawal by Subject|3
7016015|NCT01510769|11087078|FG000|Overall Study|Death|1
7016016|NCT01510769|11087079|FG001|Overall Study|Death|1
7016017|NCT01510769|11087080|FG002|Overall Study|Death|0
7016018|NCT01510912|11087095|FG000|Overall Study|Adverse Event|99
7016019|NCT01510912|11087095|FG000|Overall Study|Lack of Efficacy|12
7016020|NCT01510912|11087095|FG000|Overall Study|Non-compliance with trial drug|23
7016021|NCT01510912|11087095|FG000|Overall Study|Withdrawal by Subject|49
7016022|NCT01510912|11087095|FG000|Overall Study|Physician Decision|1
7016023|NCT01510912|11087095|FG000|Overall Study|Protocol Violation|27
7016024|NCT01510912|11087095|FG000|Overall Study|Lost to Follow-up|26
7016025|NCT01510912|11087095|FG000|Overall Study|Other, including joint replacement|5
7016026|NCT01511055|11087109|FG000|Overall Study|Withdrawal by Subject|6
7016027|NCT01511107|11087119|FG000|Overall Study|Ineligible|3
7016028|NCT01511107|11087120|FG001|Overall Study|Ineligible|2
7016029|NCT01511107|11087119|FG000|Overall Study|Lost to Follow-up|10
7016030|NCT01511107|11087120|FG001|Overall Study|Lost to Follow-up|19
7016031|NCT01511107|11087119|FG000|Overall Study|Withdrawal by Subject|9
7016032|NCT01511107|11087120|FG001|Overall Study|Withdrawal by Subject|20
7016033|NCT01511250|11087136|FG000|Overall Study|Withdrawal of Consent|1
7016034|NCT01511250|11087137|FG001|Overall Study|Withdrawal of Consent|0
7016035|NCT01511250|11087138|FG002|Overall Study|Withdrawal of Consent|0
7016036|NCT01511250|11087139|FG003|Overall Study|Withdrawal of Consent|0
7016037|NCT01511250|11087140|FG004|Overall Study|Withdrawal of Consent|0
7016038|NCT01511250|11087141|FG005|Overall Study|Withdrawal of Consent|0
7016039|NCT01511250|11087142|FG006|Overall Study|Withdrawal of Consent|0
7016040|NCT01511250|11087143|FG007|Overall Study|Withdrawal of Consent|1
7016041|NCT01511250|11087144|FG008|Overall Study|Withdrawal of Consent|1
7016042|NCT01511250|11087145|FG009|Overall Study|Withdrawal of Consent|0
7016043|NCT01511250|11087136|FG000|Overall Study|Sponsor/Investigator Decision|1
7016044|NCT01511250|11087137|FG001|Overall Study|Sponsor/Investigator Decision|0
7016045|NCT01511250|11087138|FG002|Overall Study|Sponsor/Investigator Decision|0
7016046|NCT01511250|11087139|FG003|Overall Study|Sponsor/Investigator Decision|0
7016047|NCT01511250|11087140|FG004|Overall Study|Sponsor/Investigator Decision|0
7016048|NCT01511250|11087141|FG005|Overall Study|Sponsor/Investigator Decision|0
7016049|NCT01511250|11087142|FG006|Overall Study|Sponsor/Investigator Decision|0
7016050|NCT01511250|11087143|FG007|Overall Study|Sponsor/Investigator Decision|0
7016051|NCT01511250|11087144|FG008|Overall Study|Sponsor/Investigator Decision|0
7016052|NCT01511250|11087145|FG009|Overall Study|Sponsor/Investigator Decision|0
7016053|NCT01511250|11087136|FG000|Overall Study|Lost to Follow-up|7
7016054|NCT01511250|11087137|FG001|Overall Study|Lost to Follow-up|3
7016055|NCT01511250|11087138|FG002|Overall Study|Lost to Follow-up|3
7016056|NCT01511250|11087139|FG003|Overall Study|Lost to Follow-up|3
7016057|NCT01511250|11087140|FG004|Overall Study|Lost to Follow-up|0
7016058|NCT01511250|11087141|FG005|Overall Study|Lost to Follow-up|0
7016059|NCT01511250|11087142|FG006|Overall Study|Lost to Follow-up|2
7016060|NCT01511250|11087143|FG007|Overall Study|Lost to Follow-up|3
7016061|NCT01511250|11087144|FG008|Overall Study|Lost to Follow-up|13
7016062|NCT01511250|11087145|FG009|Overall Study|Lost to Follow-up|5
7016063|NCT01511250|11087136|FG000|Overall Study|Protocol Violation|0
7016064|NCT01511250|11087137|FG001|Overall Study|Protocol Violation|2
7016065|NCT01511250|11087138|FG002|Overall Study|Protocol Violation|1
7016066|NCT01511250|11087139|FG003|Overall Study|Protocol Violation|0
7016067|NCT01511250|11087140|FG004|Overall Study|Protocol Violation|0
7016068|NCT01511250|11087141|FG005|Overall Study|Protocol Violation|0
7016069|NCT01511250|11087142|FG006|Overall Study|Protocol Violation|0
7016070|NCT01511250|11087143|FG007|Overall Study|Protocol Violation|0
7016071|NCT01511250|11087144|FG008|Overall Study|Protocol Violation|0
7016072|NCT01511250|11087145|FG009|Overall Study|Protocol Violation|0
7043600|NCT01746017|11128646|FG010|Period 1|Withdrawal by Subject|0
7043601|NCT01746017|11128636|FG000|Period 3|Withdrawal by Subject|0
7043602|NCT01746017|11128637|FG001|Period 3|Withdrawal by Subject|0
7043603|NCT01746017|11128638|FG002|Period 3|Withdrawal by Subject|0
7043604|NCT01746017|11128639|FG003|Period 3|Withdrawal by Subject|0
7043605|NCT01746017|11128640|FG004|Period 3|Withdrawal by Subject|0
7043606|NCT01746017|11128641|FG005|Period 3|Withdrawal by Subject|1
7043607|NCT01746017|11128642|FG006|Period 3|Withdrawal by Subject|0
7043608|NCT01746017|11128643|FG007|Period 3|Withdrawal by Subject|0
7043609|NCT01746017|11128644|FG008|Period 3|Withdrawal by Subject|0
7043610|NCT01746017|11128645|FG009|Period 3|Withdrawal by Subject|0
7043611|NCT01746017|11128646|FG010|Period 3|Withdrawal by Subject|0
7043612|NCT01746108|11128722|FG000|Overall Study|Migrated /moved from study area|0
7043613|NCT01746108|11128723|FG001|Overall Study|Migrated /moved from study area|1
7043614|NCT01746108|11128724|FG002|Overall Study|Migrated /moved from study area|0
7043615|NCT01746108|11128722|FG000|Overall Study|Adverse event, non-fatal|0
7043616|NCT01746108|11128723|FG001|Overall Study|Adverse event, non-fatal|1
7043617|NCT01746108|11128724|FG002|Overall Study|Adverse event, non-fatal|0
7043618|NCT01746108|11128722|FG000|Overall Study|Withdrawal by Subject|0
7043619|NCT01746108|11128723|FG001|Overall Study|Withdrawal by Subject|1
7043620|NCT01746108|11128724|FG002|Overall Study|Withdrawal by Subject|0
7043621|NCT01746108|11128722|FG000|Overall Study|Lost to Follow-up|0
7043622|NCT01746108|11128723|FG001|Overall Study|Lost to Follow-up|1
7043623|NCT01746108|11128724|FG002|Overall Study|Lost to Follow-up|0
7043625|NCT01746225|11128747|FG000|Overall Study|Death|1
7043626|NCT01746225|11128748|FG001|Overall Study|Death|0
7043627|NCT01746225|11128749|FG002|Overall Study|Death|1
7043628|NCT01746225|11128747|FG000|Overall Study|Withdrawal by Subject|5
7043629|NCT01746225|11128748|FG001|Overall Study|Withdrawal by Subject|15
7043630|NCT01746225|11128749|FG002|Overall Study|Withdrawal by Subject|19
7043631|NCT01746225|11128747|FG000|Overall Study|Physician Decision|14
7043632|NCT01746225|11128748|FG001|Overall Study|Physician Decision|11
7043633|NCT01746225|11128749|FG002|Overall Study|Physician Decision|3
7043634|NCT01746225|11128747|FG000|Overall Study|Adverse Event|15
7043635|NCT01746225|11128748|FG001|Overall Study|Adverse Event|12
7016073|NCT01511419|11087173|FG000|Dose 2|Physician Decision|1
7016074|NCT01511419|11087174|FG001|Dose 2|Physician Decision|0
7016075|NCT01511445|11087206|FG000|Overall Study|Lost to Follow-up|3
7016076|NCT01511445|11087207|FG001|Overall Study|Lost to Follow-up|1
7016077|NCT01511445|11087206|FG000|Overall Study|Protocol Violation|1
7016078|NCT01511445|11087207|FG001|Overall Study|Protocol Violation|3
7016079|NCT01511445|11087206|FG000|Overall Study|Protocol Violation|1
7016080|NCT01511445|11087207|FG001|Overall Study|Protocol Violation|0
7016081|NCT01511536|11087216|FG000|Phase 1|Other|0
7016082|NCT01511536|11087217|FG001|Phase 1|Other|1
7016083|NCT01511536|11087218|FG002|Phase 1|Other|0
7016084|NCT01511536|11087216|FG000|Phase 2|Other|0
7016085|NCT01511536|11087217|FG001|Phase 2|Other|0
7016086|NCT01511536|11087218|FG002|Phase 2|Other|9
7016087|NCT01511939|11087255|FG000|Overall Study|Withdrawal by Subject|2
7016088|NCT01511939|11087256|FG001|Overall Study|Withdrawal by Subject|1
7016089|NCT01511939|11087257|FG002|Overall Study|Withdrawal by Subject|0
7016090|NCT01512108|11087278|FG000|Overall Study|Adverse Event|9
7016091|NCT01512108|11087279|FG001|Overall Study|Adverse Event|4
7016092|NCT01512108|11087278|FG000|Overall Study|Protocol Violation|1
7016093|NCT01512108|11087279|FG001|Overall Study|Protocol Violation|2
7016094|NCT01512108|11087278|FG000|Overall Study|Withdrawal Criteria|1
7016095|NCT01512108|11087279|FG001|Overall Study|Withdrawal Criteria|0
7016096|NCT01512108|11087278|FG000|Overall Study|Unclassified|11
7016097|NCT01512108|11087279|FG001|Overall Study|Unclassified|3
7016098|NCT01512160|11087289|FG000|Overall Study|Lost to Follow-up|1
7016099|NCT01512160|11087290|FG001|Overall Study|Lost to Follow-up|0
7016100|NCT01512160|11087291|FG002|Overall Study|Lost to Follow-up|0
7016101|NCT01512160|11087292|FG003|Overall Study|Lost to Follow-up|0
7016102|NCT01512160|11087289|FG000|Overall Study|Withdrawal by Subject|1
7016103|NCT01512160|11087290|FG001|Overall Study|Withdrawal by Subject|0
7016104|NCT01512160|11087291|FG002|Overall Study|Withdrawal by Subject|0
7016105|NCT01512160|11087292|FG003|Overall Study|Withdrawal by Subject|1
7016106|NCT01512264|11087328|FG000|Overall Study|Lost to Follow-up|0
7016107|NCT01512264|11087329|FG001|Overall Study|Lost to Follow-up|0
7016108|NCT01512264|11087330|FG002|Overall Study|Lost to Follow-up|0
7016109|NCT01512264|11087331|FG003|Overall Study|Lost to Follow-up|1
7016110|NCT01512368|11087341|FG000|Overall Study|Protocol Violation|3
7016111|NCT01512693|11087365|FG000|Overall Study|Withdrawal by Subject|0
7016112|NCT01512693|11087366|FG001|Overall Study|Withdrawal by Subject|1
7016113|NCT01512745|11087374|FG000|Overall Study|Adverse Event|22
7016114|NCT01512745|11087375|FG001|Overall Study|Adverse Event|3
7016115|NCT01512745|11087374|FG000|Overall Study|Death|9
7016116|NCT01512745|11087375|FG001|Overall Study|Death|13
7016117|NCT01512745|11087374|FG000|Overall Study|Withdrawal by Subject|2
7016118|NCT01512745|11087375|FG001|Overall Study|Withdrawal by Subject|2
7016119|NCT01512745|11087374|FG000|Overall Study|Lost to Follow-up|4
7016120|NCT01512745|11087375|FG001|Overall Study|Lost to Follow-up|0
7016121|NCT01512745|11087374|FG000|Overall Study|Lack of Efficacy|2
7016122|NCT01512745|11087375|FG001|Overall Study|Lack of Efficacy|2
7016123|NCT01512745|11087374|FG000|Overall Study|Protocol Violation|1
7016124|NCT01512745|11087375|FG001|Overall Study|Protocol Violation|0
7016125|NCT01512979|11087417|FG000|Overall Study|Adverse Event|2
7016126|NCT01512979|11087418|FG001|Overall Study|Adverse Event|2
7016127|NCT01512979|11087417|FG000|Overall Study|Protocol Violation|1
7016128|NCT01512979|11087418|FG001|Overall Study|Protocol Violation|4
7016129|NCT01512979|11087417|FG000|Overall Study|Lost to Follow-up|2
7016130|NCT01512979|11087418|FG001|Overall Study|Lost to Follow-up|5
7016131|NCT01512979|11087417|FG000|Overall Study|Withdrawal by Subject|1
7016132|NCT01512979|11087418|FG001|Overall Study|Withdrawal by Subject|2
7016133|NCT01512979|11087417|FG000|Overall Study|Reason other than stated above|13
7016134|NCT01512979|11087418|FG001|Overall Study|Reason other than stated above|9
7016135|NCT01513148|11087435|FG000|Overall Study|Protocol Violation|2
7016136|NCT01513148|11087436|FG001|Overall Study|Protocol Violation|2
7016137|NCT01513239|11087485|FG000|Period 1: Main Phase|Adverse Event|1
7016138|NCT01513239|11087486|FG001|Period 1: Main Phase|Adverse Event|1
7016139|NCT01513239|11087487|FG002|Period 1: Main Phase|Adverse Event|2
7016140|NCT01513239|11087488|FG003|Period 1: Main Phase|Adverse Event|0
7016141|NCT01513239|11087489|FG004|Period 1: Main Phase|Adverse Event|0
7016142|NCT01513239|11087490|FG005|Period 1: Main Phase|Adverse Event|0
7016143|NCT01513239|11087485|FG000|Period 1: Main Phase|Death|29
7016144|NCT01513239|11087486|FG001|Period 1: Main Phase|Death|22
7016145|NCT01513239|11087487|FG002|Period 1: Main Phase|Death|32
7016146|NCT01513239|11087488|FG003|Period 1: Main Phase|Death|0
7016147|NCT01513239|11087489|FG004|Period 1: Main Phase|Death|0
7016148|NCT01513239|11087490|FG005|Period 1: Main Phase|Death|0
7016149|NCT01513239|11087485|FG000|Period 1: Main Phase|Lost to Follow-up|11
7016150|NCT01513239|11087486|FG001|Period 1: Main Phase|Lost to Follow-up|10
7016151|NCT01513239|11087487|FG002|Period 1: Main Phase|Lost to Follow-up|6
7016152|NCT01513239|11087488|FG003|Period 1: Main Phase|Lost to Follow-up|0
7016153|NCT01513239|11087489|FG004|Period 1: Main Phase|Lost to Follow-up|0
7016154|NCT01513239|11087490|FG005|Period 1: Main Phase|Lost to Follow-up|0
7016155|NCT01513239|11087485|FG000|Period 1: Main Phase|Physician Decision|4
7016156|NCT01513239|11087486|FG001|Period 1: Main Phase|Physician Decision|4
7016157|NCT01513239|11087487|FG002|Period 1: Main Phase|Physician Decision|4
7016158|NCT01513239|11087488|FG003|Period 1: Main Phase|Physician Decision|0
7016159|NCT01513239|11087489|FG004|Period 1: Main Phase|Physician Decision|0
7016160|NCT01513239|11087490|FG005|Period 1: Main Phase|Physician Decision|0
7016161|NCT01513239|11087485|FG000|Period 1: Main Phase|Protocol Violation|2
7016162|NCT01513239|11087486|FG001|Period 1: Main Phase|Protocol Violation|2
7016163|NCT01513239|11087487|FG002|Period 1: Main Phase|Protocol Violation|2
7016164|NCT01513239|11087488|FG003|Period 1: Main Phase|Protocol Violation|0
7016165|NCT01513239|11087489|FG004|Period 1: Main Phase|Protocol Violation|0
7016166|NCT01513239|11087490|FG005|Period 1: Main Phase|Protocol Violation|0
7016167|NCT01513239|11087485|FG000|Period 1: Main Phase|Technical Problems|1
7016168|NCT01513239|11087486|FG001|Period 1: Main Phase|Technical Problems|2
7016169|NCT01513239|11087487|FG002|Period 1: Main Phase|Technical Problems|0
7016170|NCT01513239|11087488|FG003|Period 1: Main Phase|Technical Problems|0
7016171|NCT01513239|11087489|FG004|Period 1: Main Phase|Technical Problems|0
7016172|NCT01513239|11087490|FG005|Period 1: Main Phase|Technical Problems|0
7016173|NCT01513239|11087485|FG000|Period 1: Main Phase|Withdrawal by Subject|27
7016174|NCT01513239|11087486|FG001|Period 1: Main Phase|Withdrawal by Subject|29
7016175|NCT01513239|11087487|FG002|Period 1: Main Phase|Withdrawal by Subject|42
7016176|NCT01513239|11087488|FG003|Period 1: Main Phase|Withdrawal by Subject|0
7016177|NCT01513239|11087489|FG004|Period 1: Main Phase|Withdrawal by Subject|0
7016178|NCT01513239|11087490|FG005|Period 1: Main Phase|Withdrawal by Subject|0
7016179|NCT01513239|11087485|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
7016180|NCT01513239|11087486|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
7016181|NCT01513239|11087487|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
7016182|NCT01513239|11087488|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5
7016183|NCT01513239|11087489|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3
7016184|NCT01513239|11087490|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2
7016185|NCT01513239|11087485|FG000|Period 2: 9 Month Extension Phase|Death|0
7016186|NCT01513239|11087486|FG001|Period 2: 9 Month Extension Phase|Death|0
7016187|NCT01513239|11087487|FG002|Period 2: 9 Month Extension Phase|Death|0
7016188|NCT01513239|11087488|FG003|Period 2: 9 Month Extension Phase|Death|2
7016189|NCT01513239|11087489|FG004|Period 2: 9 Month Extension Phase|Death|5
7016190|NCT01513239|11087490|FG005|Period 2: 9 Month Extension Phase|Death|2
7016191|NCT01513239|11087485|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
7016192|NCT01513239|11087486|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
7016193|NCT01513239|11087487|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
7016194|NCT01513239|11087488|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2
7016195|NCT01513239|11087489|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1
7016196|NCT01513239|11087490|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
7016197|NCT01513239|11087485|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0
7016198|NCT01513239|11087486|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0
7016199|NCT01513239|11087487|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0
7016200|NCT01513239|11087488|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1
7016201|NCT01513239|11087489|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0
7016202|NCT01513239|11087490|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0
7016203|NCT01513239|11087485|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0
7016204|NCT01513239|11087486|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0
7016205|NCT01513239|11087487|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0
7016206|NCT01513239|11087488|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0
7016207|NCT01513239|11087489|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1
7016208|NCT01513239|11087490|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1
7016209|NCT01513291|11087504|FG000|Treatment Period|Adverse Event|8
7016210|NCT01513291|11087505|FG001|Treatment Period|Adverse Event|4
7016211|NCT01513291|11087506|FG002|Treatment Period|Adverse Event|0
7016212|NCT01513291|11087507|FG003|Treatment Period|Adverse Event|0
7016213|NCT01513291|11087508|FG004|Treatment Period|Adverse Event|0
7016214|NCT01513291|11087504|FG000|Treatment Period|Lack of Efficacy|3
7016215|NCT01513291|11087505|FG001|Treatment Period|Lack of Efficacy|0
7016216|NCT01513291|11087506|FG002|Treatment Period|Lack of Efficacy|0
7016217|NCT01513291|11087507|FG003|Treatment Period|Lack of Efficacy|0
7016218|NCT01513291|11087508|FG004|Treatment Period|Lack of Efficacy|0
7016219|NCT01513291|11087504|FG000|Treatment Period|Lost to Follow-up|2
7016220|NCT01513291|11087505|FG001|Treatment Period|Lost to Follow-up|3
7016221|NCT01513291|11087506|FG002|Treatment Period|Lost to Follow-up|0
7016222|NCT01513291|11087507|FG003|Treatment Period|Lost to Follow-up|0
7016223|NCT01513291|11087508|FG004|Treatment Period|Lost to Follow-up|0
7016224|NCT01513291|11087504|FG000|Treatment Period|Physician Decision|1
7016225|NCT01513291|11087505|FG001|Treatment Period|Physician Decision|0
7016226|NCT01513291|11087506|FG002|Treatment Period|Physician Decision|0
7016227|NCT01513291|11087507|FG003|Treatment Period|Physician Decision|0
7016228|NCT01513291|11087508|FG004|Treatment Period|Physician Decision|0
7016229|NCT01513291|11087504|FG000|Treatment Period|Protocol Violation|1
7016230|NCT01513291|11087505|FG001|Treatment Period|Protocol Violation|2
7016231|NCT01513291|11087506|FG002|Treatment Period|Protocol Violation|0
7016232|NCT01513291|11087507|FG003|Treatment Period|Protocol Violation|0
7016233|NCT01513291|11087508|FG004|Treatment Period|Protocol Violation|0
7016234|NCT01513291|11087504|FG000|Treatment Period|Withdrawal by Subject|8
7016235|NCT01513291|11087505|FG001|Treatment Period|Withdrawal by Subject|5
7016236|NCT01513291|11087506|FG002|Treatment Period|Withdrawal by Subject|0
7016237|NCT01513291|11087507|FG003|Treatment Period|Withdrawal by Subject|0
7016238|NCT01513291|11087508|FG004|Treatment Period|Withdrawal by Subject|0
7016239|NCT01513291|11087504|FG000|Treatment Period|Randomized not treated|0
7016240|NCT01513291|11087505|FG001|Treatment Period|Randomized not treated|2
7016241|NCT01513291|11087506|FG002|Treatment Period|Randomized not treated|0
7016242|NCT01513291|11087507|FG003|Treatment Period|Randomized not treated|0
7016243|NCT01513291|11087508|FG004|Treatment Period|Randomized not treated|0
7016244|NCT01513291|11087504|FG000|Run-out Period|Lost to Follow-up|0
7016245|NCT01513291|11087505|FG001|Run-out Period|Lost to Follow-up|0
7016246|NCT01513291|11087506|FG002|Run-out Period|Lost to Follow-up|0
7016247|NCT01513291|11087507|FG003|Run-out Period|Lost to Follow-up|1
7016248|NCT01513291|11087508|FG004|Run-out Period|Lost to Follow-up|0
7016249|NCT01513291|11087504|FG000|Run-out Period|Withdrawal by Subject|0
7016250|NCT01513291|11087505|FG001|Run-out Period|Withdrawal by Subject|0
7016251|NCT01513291|11087506|FG002|Run-out Period|Withdrawal by Subject|0
7016252|NCT01513291|11087507|FG003|Run-out Period|Withdrawal by Subject|1
7016253|NCT01513291|11087508|FG004|Run-out Period|Withdrawal by Subject|0
7016254|NCT01513317|11087522|FG000|Overall Study|Withdrawal by Subject|15
7016255|NCT01513317|11087523|FG001|Overall Study|Withdrawal by Subject|4
7016256|NCT01513317|11087522|FG000|Overall Study|Death|1
7016257|NCT01513317|11087523|FG001|Overall Study|Death|1
7016258|NCT01513317|11087522|FG000|Overall Study|Study terminated by sponsor|18
7016259|NCT01513317|11087523|FG001|Overall Study|Study terminated by sponsor|18
7016260|NCT01513317|11087522|FG000|Overall Study|Other|0
7016261|NCT01513317|11087523|FG001|Overall Study|Other|1
7016262|NCT01513330|11087529|FG000|SenSura Mio First,|Adverse Event|2
7016263|NCT01513330|11087530|FG001|SenSura Mio First,|Adverse Event|0
7016264|NCT01513330|11087529|FG000|SenSura Mio First,|Lack of Efficacy|0
7016265|NCT01513330|11087530|FG001|SenSura Mio First,|Lack of Efficacy|1
7016266|NCT01513330|11087529|FG000|SenSura Mio First,|Withdrawal by Subject|1
7016267|NCT01513330|11087530|FG001|SenSura Mio First,|Withdrawal by Subject|1
7016268|NCT01513330|11087529|FG000|SenSura Mio First,|Other|1
7016269|NCT01513330|11087530|FG001|SenSura Mio First,|Other|0
7016270|NCT01513330|11087529|FG000|Standard Care First,|Lack of Efficacy|2
7016271|NCT01513330|11087530|FG001|Standard Care First,|Lack of Efficacy|2
7016272|NCT01513330|11087529|FG000|Standard Care First,|Withdrawal by Subject|1
7016273|NCT01513330|11087530|FG001|Standard Care First,|Withdrawal by Subject|2
7016274|NCT01513330|11087529|FG000|Standard Care First,|Other|1
7016275|NCT01513330|11087530|FG001|Standard Care First,|Other|0
7016276|NCT01513460|11087548|FG000|Overall Study|Death|0
7016277|NCT01513460|11087549|FG001|Overall Study|Death|0
7016278|NCT01513460|11087550|FG002|Overall Study|Death|1
7016279|NCT01513460|11087548|FG000|Overall Study|Lost to Follow-up|0
7016280|NCT01513460|11087549|FG001|Overall Study|Lost to Follow-up|0
7016281|NCT01513460|11087550|FG002|Overall Study|Lost to Follow-up|2
7016282|NCT01513460|11087548|FG000|Overall Study|Abnormal laboratory value|1
7016283|NCT01513460|11087549|FG001|Overall Study|Abnormal laboratory value|0
7016284|NCT01513460|11087550|FG002|Overall Study|Abnormal laboratory value|1
7016285|NCT01513460|11087548|FG000|Overall Study|Lack of Efficacy|1
7016286|NCT01513460|11087549|FG001|Overall Study|Lack of Efficacy|2
7016287|NCT01513460|11087550|FG002|Overall Study|Lack of Efficacy|5
7016288|NCT01513460|11087548|FG000|Overall Study|Protocol deviations|3
7016289|NCT01513460|11087549|FG001|Overall Study|Protocol deviations|4
7016290|NCT01513460|11087550|FG002|Overall Study|Protocol deviations|3
7016291|NCT01513460|11087548|FG000|Overall Study|Withdrawal by Subject|7
7016292|NCT01513460|11087549|FG001|Overall Study|Withdrawal by Subject|8
7016293|NCT01513460|11087550|FG002|Overall Study|Withdrawal by Subject|21
7016294|NCT01513460|11087548|FG000|Overall Study|Adverse Event|16
7016295|NCT01513460|11087549|FG001|Overall Study|Adverse Event|18
7016296|NCT01513460|11087550|FG002|Overall Study|Adverse Event|23
7016297|NCT01513460|11087548|FG000|Overall Study|Abnormal test procedure|1
7016298|NCT01513460|11087549|FG001|Overall Study|Abnormal test procedure|0
7016299|NCT01513460|11087550|FG002|Overall Study|Abnormal test procedure|0
7016300|NCT01513473|11087562|FG000|Main Trial (26 Weeks)|Adverse Event|0
7016301|NCT01513473|11087563|FG001|Main Trial (26 Weeks)|Adverse Event|2
7016302|NCT01513473|11087562|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4
7016303|NCT01513473|11087563|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7
7016304|NCT01513473|11087562|FG000|Main Trial (26 Weeks)|Unclassified|0
7016305|NCT01513473|11087563|FG001|Main Trial (26 Weeks)|Unclassified|2
7016306|NCT01513473|11087562|FG000|Extension Trial (26 Weeks)|Adverse Event|0
7016307|NCT01513473|11087563|FG001|Extension Trial (26 Weeks)|Adverse Event|1
7016308|NCT01513473|11087562|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1
7016309|NCT01513473|11087563|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5
7016310|NCT01513551|11087576|FG000|Overall Study|Death|0
7016311|NCT01513551|11087577|FG001|Overall Study|Death|1
7016312|NCT01513551|11087578|FG002|Overall Study|Death|0
7016313|NCT01513551|11087576|FG000|Overall Study|Lost to Follow-up|3
7016314|NCT01513551|11087577|FG001|Overall Study|Lost to Follow-up|5
7016315|NCT01513551|11087578|FG002|Overall Study|Lost to Follow-up|2
7016316|NCT01513551|11087576|FG000|Overall Study|Withdrawal by Subject|1
7016317|NCT01513551|11087577|FG001|Overall Study|Withdrawal by Subject|0
7016318|NCT01513551|11087578|FG002|Overall Study|Withdrawal by Subject|2
7016319|NCT01513551|11087576|FG000|Overall Study|Randomized but not vaccinated|0
7016320|NCT01513551|11087577|FG001|Overall Study|Randomized but not vaccinated|0
7016321|NCT01513551|11087578|FG002|Overall Study|Randomized but not vaccinated|1
7016322|NCT01513590|11087588|FG000|Overall Study|Adverse Event|2
7016323|NCT01513590|11087589|FG001|Overall Study|Adverse Event|3
7016324|NCT01513590|11087588|FG000|Overall Study|Withdrawal Criteria|3
7016325|NCT01513590|11087589|FG001|Overall Study|Withdrawal Criteria|0
7016326|NCT01513590|11087588|FG000|Overall Study|Unclassified|5
7016327|NCT01513590|11087589|FG001|Overall Study|Unclassified|10
7016328|NCT01513759|11087595|FG000|Overall Study|Protocol Violation|4
7016329|NCT01513759|11087595|FG000|Overall Study|Death during catheter placement|1
7016330|NCT01513967|11087620|FG000|Overall Study|Pregnancy|0
7016331|NCT01513967|11087621|FG001|Overall Study|Pregnancy|0
7016332|NCT01513967|11087622|FG002|Overall Study|Pregnancy|0
7016333|NCT01513967|11087623|FG003|Overall Study|Pregnancy|0
7016334|NCT01513967|11087624|FG004|Overall Study|Pregnancy|0
7016335|NCT01513967|11087625|FG005|Overall Study|Pregnancy|0
7016336|NCT01513967|11087626|FG006|Overall Study|Pregnancy|1
7016337|NCT01513967|11087627|FG007|Overall Study|Pregnancy|0
7016338|NCT01513967|11087620|FG000|Overall Study|missed a study visit|0
7016339|NCT01513967|11087621|FG001|Overall Study|missed a study visit|0
7016340|NCT01513967|11087622|FG002|Overall Study|missed a study visit|0
7016341|NCT01513967|11087623|FG003|Overall Study|missed a study visit|0
7016342|NCT01513967|11087624|FG004|Overall Study|missed a study visit|0
7016343|NCT01513967|11087625|FG005|Overall Study|missed a study visit|0
7016344|NCT01513967|11087626|FG006|Overall Study|missed a study visit|1
7016345|NCT01513967|11087627|FG007|Overall Study|missed a study visit|0
7016346|NCT01513967|11087620|FG000|Overall Study|excluded due to positive drug screen|0
7016347|NCT01513967|11087621|FG001|Overall Study|excluded due to positive drug screen|0
7016348|NCT01513967|11087622|FG002|Overall Study|excluded due to positive drug screen|0
7016349|NCT01513967|11087623|FG003|Overall Study|excluded due to positive drug screen|0
7016350|NCT01513967|11087624|FG004|Overall Study|excluded due to positive drug screen|0
7016351|NCT01513967|11087625|FG005|Overall Study|excluded due to positive drug screen|0
7016352|NCT01513967|11087626|FG006|Overall Study|excluded due to positive drug screen|0
7016353|NCT01513967|11087627|FG007|Overall Study|excluded due to positive drug screen|2
7016354|NCT01513967|11087620|FG000|Overall Study|Physician Decision|0
7016355|NCT01513967|11087621|FG001|Overall Study|Physician Decision|0
7016356|NCT01513967|11087622|FG002|Overall Study|Physician Decision|0
7016357|NCT01513967|11087623|FG003|Overall Study|Physician Decision|0
7016358|NCT01513967|11087624|FG004|Overall Study|Physician Decision|0
7016359|NCT01513967|11087625|FG005|Overall Study|Physician Decision|1
7016360|NCT01513967|11087626|FG006|Overall Study|Physician Decision|0
7016361|NCT01513967|11087627|FG007|Overall Study|Physician Decision|0
7016362|NCT01514136|11087647|FG000|Test Period 1; Test A|Protocol Violation|1
7016363|NCT01514136|11087648|FG001|Test Period 1; Test A|Protocol Violation|0
7016364|NCT01514136|11087649|FG002|Test Period 1; Test A|Protocol Violation|0
7016365|NCT01514136|11087650|FG003|Test Period 1; Test A|Protocol Violation|0
7016366|NCT01514136|11087651|FG004|Test Period 1; Test A|Protocol Violation|0
7016367|NCT01514136|11087652|FG005|Test Period 1; Test A|Protocol Violation|0
7016368|NCT01514136|11087653|FG006|Test Period 1; Test A|Protocol Violation|0
7016369|NCT01514136|11087654|FG007|Test Period 1; Test A|Protocol Violation|0
7016370|NCT01514136|11087647|FG000|Test Period 1; Test A|Break from study holiday|2
7016371|NCT01514136|11087648|FG001|Test Period 1; Test A|Break from study holiday|0
7016372|NCT01514136|11087649|FG002|Test Period 1; Test A|Break from study holiday|0
7016373|NCT01514136|11087650|FG003|Test Period 1; Test A|Break from study holiday|0
7016374|NCT01514136|11087651|FG004|Test Period 1; Test A|Break from study holiday|0
7016375|NCT01514136|11087652|FG005|Test Period 1; Test A|Break from study holiday|0
7016376|NCT01514136|11087653|FG006|Test Period 1; Test A|Break from study holiday|0
7016377|NCT01514136|11087654|FG007|Test Period 1; Test A|Break from study holiday|0
7016378|NCT01514136|11087647|FG000|Test Period 1; Test B|Withdrawal by Subject|0
7016379|NCT01514136|11087648|FG001|Test Period 1; Test B|Withdrawal by Subject|1
7016380|NCT01514136|11087649|FG002|Test Period 1; Test B|Withdrawal by Subject|0
7016381|NCT01514136|11087650|FG003|Test Period 1; Test B|Withdrawal by Subject|0
7016382|NCT01514136|11087651|FG004|Test Period 1; Test B|Withdrawal by Subject|0
7016383|NCT01514136|11087652|FG005|Test Period 1; Test B|Withdrawal by Subject|0
7016384|NCT01514136|11087653|FG006|Test Period 1; Test B|Withdrawal by Subject|0
7016385|NCT01514136|11087654|FG007|Test Period 1; Test B|Withdrawal by Subject|0
7016386|NCT01514136|11087647|FG000|Test Period 1; Test D|Subject took a break due to holiday|0
7016387|NCT01514136|11087648|FG001|Test Period 1; Test D|Subject took a break due to holiday|0
7016388|NCT01514136|11087649|FG002|Test Period 1; Test D|Subject took a break due to holiday|0
7016389|NCT01514136|11087650|FG003|Test Period 1; Test D|Subject took a break due to holiday|2
7016390|NCT01514136|11087651|FG004|Test Period 1; Test D|Subject took a break due to holiday|0
7016391|NCT01514136|11087652|FG005|Test Period 1; Test D|Subject took a break due to holiday|0
7016392|NCT01514136|11087653|FG006|Test Period 1; Test D|Subject took a break due to holiday|0
7016393|NCT01514136|11087654|FG007|Test Period 1; Test D|Subject took a break due to holiday|0
7016394|NCT01514136|11087647|FG000|Test Period 2; Test A*|Adverse Event|0
7016395|NCT01514136|11087648|FG001|Test Period 2; Test A*|Adverse Event|0
7016396|NCT01514136|11087649|FG002|Test Period 2; Test A*|Adverse Event|0
7016397|NCT01514136|11087650|FG003|Test Period 2; Test A*|Adverse Event|0
7016398|NCT01514136|11087651|FG004|Test Period 2; Test A*|Adverse Event|1
7016399|NCT01514136|11087652|FG005|Test Period 2; Test A*|Adverse Event|0
7016400|NCT01514136|11087653|FG006|Test Period 2; Test A*|Adverse Event|0
7016401|NCT01514136|11087654|FG007|Test Period 2; Test A*|Adverse Event|0
7016402|NCT01514136|11087647|FG000|Test Period 2; Test A*|Holiday|0
7016403|NCT01514136|11087648|FG001|Test Period 2; Test A*|Holiday|0
7016404|NCT01514136|11087649|FG002|Test Period 2; Test A*|Holiday|0
7016405|NCT01514136|11087650|FG003|Test Period 2; Test A*|Holiday|0
7016406|NCT01514136|11087651|FG004|Test Period 2; Test A*|Holiday|1
7016407|NCT01514136|11087652|FG005|Test Period 2; Test A*|Holiday|0
7016408|NCT01514136|11087653|FG006|Test Period 2; Test A*|Holiday|0
7016409|NCT01514136|11087654|FG007|Test Period 2; Test A*|Holiday|0
7016410|NCT01514136|11087647|FG000|Test Period 2; Test B*|Withdrawal by Subject|0
7016411|NCT01514136|11087648|FG001|Test Period 2; Test B*|Withdrawal by Subject|0
7016412|NCT01514136|11087649|FG002|Test Period 2; Test B*|Withdrawal by Subject|0
7016413|NCT01514136|11087650|FG003|Test Period 2; Test B*|Withdrawal by Subject|0
7016414|NCT01514136|11087651|FG004|Test Period 2; Test B*|Withdrawal by Subject|0
7016415|NCT01514136|11087652|FG005|Test Period 2; Test B*|Withdrawal by Subject|2
7016416|NCT01514136|11087653|FG006|Test Period 2; Test B*|Withdrawal by Subject|0
7016417|NCT01514136|11087654|FG007|Test Period 2; Test B*|Withdrawal by Subject|0
7016418|NCT01514136|11087647|FG000|Test Period 2; Test C*|Withdrawal by Subject|0
7016419|NCT01514136|11087648|FG001|Test Period 2; Test C*|Withdrawal by Subject|0
7016420|NCT01514136|11087649|FG002|Test Period 2; Test C*|Withdrawal by Subject|0
7016421|NCT01514136|11087650|FG003|Test Period 2; Test C*|Withdrawal by Subject|0
7016422|NCT01514136|11087651|FG004|Test Period 2; Test C*|Withdrawal by Subject|0
7016423|NCT01514136|11087652|FG005|Test Period 2; Test C*|Withdrawal by Subject|0
7016424|NCT01514136|11087653|FG006|Test Period 2; Test C*|Withdrawal by Subject|1
7016425|NCT01514136|11087654|FG007|Test Period 2; Test C*|Withdrawal by Subject|0
6827102|NCT00122382|10829623|FG000|Double-Blind Study|Randomized but not treated|0
7016426|NCT01514136|11087647|FG000|Test Period 2; Test C*|holiday|0
7016427|NCT01514136|11087648|FG001|Test Period 2; Test C*|holiday|0
7016428|NCT01514136|11087649|FG002|Test Period 2; Test C*|holiday|0
7016429|NCT01514136|11087650|FG003|Test Period 2; Test C*|holiday|0
7016430|NCT01514136|11087651|FG004|Test Period 2; Test C*|holiday|0
7016431|NCT01514136|11087652|FG005|Test Period 2; Test C*|holiday|0
7016432|NCT01514136|11087653|FG006|Test Period 2; Test C*|holiday|1
7016433|NCT01514136|11087654|FG007|Test Period 2; Test C*|holiday|0
7016434|NCT01514136|11087647|FG000|Test Period 2; Test C*|Protocol Violation|0
7016435|NCT01514136|11087648|FG001|Test Period 2; Test C*|Protocol Violation|0
7016436|NCT01514136|11087649|FG002|Test Period 2; Test C*|Protocol Violation|0
7016437|NCT01514136|11087650|FG003|Test Period 2; Test C*|Protocol Violation|0
7016438|NCT01514136|11087651|FG004|Test Period 2; Test C*|Protocol Violation|0
7016439|NCT01514136|11087652|FG005|Test Period 2; Test C*|Protocol Violation|0
7016440|NCT01514136|11087653|FG006|Test Period 2; Test C*|Protocol Violation|1
7016441|NCT01514136|11087654|FG007|Test Period 2; Test C*|Protocol Violation|0
7016442|NCT01514201|11087709|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1
7016443|NCT01514201|11087710|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
7016444|NCT01514201|11087711|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
7016445|NCT01514201|11087712|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
7016446|NCT01514201|11087709|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0
7016447|NCT01514201|11087710|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1
7016448|NCT01514201|11087711|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1
7016449|NCT01514201|11087712|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0
7016450|NCT01514201|11087709|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4
7016451|NCT01514201|11087710|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4
7016452|NCT01514201|11087711|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5
7016453|NCT01514201|11087712|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
7016454|NCT01514201|11087709|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1
7016455|NCT01514201|11087710|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1
7016456|NCT01514201|11087711|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
7016457|NCT01514201|11087712|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
7016458|NCT01514201|11087709|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
7016459|NCT01514201|11087710|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
7016460|NCT01514201|11087711|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
7016461|NCT01514201|11087712|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1
7016462|NCT01514201|11087709|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
7016463|NCT01514201|11087710|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
7016464|NCT01514201|11087711|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
7016465|NCT01514201|11087712|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2
7016466|NCT01514201|11087709|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0
7016467|NCT01514201|11087710|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0
7016468|NCT01514201|11087711|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0
7016469|NCT01514201|11087712|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1
7016470|NCT01514201|11087709|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
7016471|NCT01514201|11087710|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
7016472|NCT01514201|11087711|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
7016473|NCT01514201|11087712|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2
7016474|NCT01514201|11087709|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
7016475|NCT01514201|11087710|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
7016476|NCT01514201|11087711|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
7016477|NCT01514201|11087712|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6
7016478|NCT01514201|11087709|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
7016479|NCT01514201|11087710|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
7016480|NCT01514201|11087711|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
7016481|NCT01514201|11087712|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4
7016482|NCT01514201|11087709|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
7016483|NCT01514201|11087710|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
7016484|NCT01514201|11087711|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
7016485|NCT01514201|11087712|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7
7016486|NCT01514201|11087709|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
7016487|NCT01514201|11087710|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
7016488|NCT01514201|11087711|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
7016489|NCT01514201|11087712|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22
7016490|NCT01514240|11087734|FG000|Overall Study|Adverse Event|4
7016491|NCT01514240|11087735|FG001|Overall Study|Adverse Event|4
7016492|NCT01514240|11087734|FG000|Overall Study|Subject Decision|2
7016493|NCT01514240|11087735|FG001|Overall Study|Subject Decision|7
7016494|NCT01514357|11087764|FG000|Overall Study|Screen failure|2
7016495|NCT01514357|11087765|FG001|Overall Study|Screen failure|0
7016496|NCT01514357|11087764|FG000|Overall Study|Withdrawal by Subject|2
7016497|NCT01514357|11087765|FG001|Overall Study|Withdrawal by Subject|0
7016498|NCT01514370|11087773|FG000|Overall Study|Protocol Violation|2
7016499|NCT01514370|11087774|FG001|Overall Study|Protocol Violation|3
7016500|NCT01514370|11087773|FG000|Overall Study|Lost to Follow-up|0
7016501|NCT01514370|11087774|FG001|Overall Study|Lost to Follow-up|2
7016502|NCT01514370|11087773|FG000|Overall Study|Withdrawal by Subject|2
7016503|NCT01514370|11087774|FG001|Overall Study|Withdrawal by Subject|1
7016504|NCT01514370|11087773|FG000|Overall Study|Adverse Event|1
7016505|NCT01514370|11087774|FG001|Overall Study|Adverse Event|3
7016506|NCT01514370|11087773|FG000|Overall Study|Other|6
7016507|NCT01514370|11087774|FG001|Overall Study|Other|7
7016508|NCT01514422|11087791|FG000|Overall Study|Lost to Follow-up|1
7016509|NCT01514448|11087797|FG000|Overall Study|Death|7
7016510|NCT01514448|11087798|FG001|Overall Study|Death|8
7016511|NCT01514448|11087797|FG000|Overall Study|Withdrawal by Subject|2
7016512|NCT01514448|11087798|FG001|Overall Study|Withdrawal by Subject|0
7016513|NCT01514448|11087797|FG000|Overall Study|Lost to Follow-up|2
7016514|NCT01514448|11087798|FG001|Overall Study|Lost to Follow-up|0
7016515|NCT01514448|11087797|FG000|Overall Study|New Cancer Therapy|1
7016516|NCT01514448|11087798|FG001|Overall Study|New Cancer Therapy|0
7016517|NCT01514461|11087808|FG000|Overall Study|Adverse Event|2
7016518|NCT01514461|11087809|FG001|Overall Study|Adverse Event|1
7016519|NCT01514461|11087810|FG002|Overall Study|Adverse Event|3
7016520|NCT01514461|11087808|FG000|Overall Study|Physician Decision|1
7016521|NCT01514461|11087809|FG001|Overall Study|Physician Decision|1
7016522|NCT01514461|11087810|FG002|Overall Study|Physician Decision|0
7016523|NCT01514461|11087808|FG000|Overall Study|Patient/guardian decision|1
7016524|NCT01514461|11087809|FG001|Overall Study|Patient/guardian decision|1
7016525|NCT01514461|11087810|FG002|Overall Study|Patient/guardian decision|1
7016526|NCT01514461|11087808|FG000|Overall Study|Death|1
7016527|NCT01514461|11087809|FG001|Overall Study|Death|0
7016528|NCT01514461|11087810|FG002|Overall Study|Death|0
7016529|NCT01514760|11087838|FG000|Overall Study|Lost to Follow-up|2
7016530|NCT01514864|11087853|FG000|Overall Study|Disease progression|7
7016531|NCT01514864|11087854|FG001|Overall Study|Disease progression|5
7016532|NCT01514864|11087853|FG000|Overall Study|Study drug toxicity|2
7016533|NCT01514864|11087854|FG001|Overall Study|Study drug toxicity|0
7016534|NCT01515189|11087901|FG000|Induction|Disease Progression|109
7016535|NCT01515189|11087902|FG001|Induction|Disease Progression|155
7016536|NCT01515189|11087901|FG000|Induction|Study drug toxicity|86
7016537|NCT01515189|11087902|FG001|Induction|Study drug toxicity|36
7016538|NCT01515189|11087901|FG000|Induction|Death|24
7016539|NCT01515189|11087902|FG001|Induction|Death|17
7016540|NCT01515189|11087901|FG000|Induction|Adverse Event|14
7016541|NCT01515189|11087902|FG001|Induction|Adverse Event|9
7016542|NCT01515189|11087901|FG000|Induction|Withdrawal by Subject|3
7016543|NCT01515189|11087902|FG001|Induction|Withdrawal by Subject|9
7016544|NCT01515189|11087901|FG000|Induction|No longer meets study criteria|0
7016545|NCT01515189|11087902|FG001|Induction|No longer meets study criteria|2
7016546|NCT01515189|11087901|FG000|Induction|Lost to Follow-up|1
7016547|NCT01515189|11087902|FG001|Induction|Lost to Follow-up|0
7016548|NCT01515189|11087901|FG000|Induction|Other|0
7016549|NCT01515189|11087902|FG001|Induction|Other|4
7016550|NCT01515189|11087901|FG000|First Re-Induction Phase|Disease progression|6
7016551|NCT01515189|11087902|FG001|First Re-Induction Phase|Disease progression|14
7016552|NCT01515189|11087901|FG000|First Re-Induction Phase|Study drug toxicity|5
7016553|NCT01515189|11087902|FG001|First Re-Induction Phase|Study drug toxicity|0
7016554|NCT01515189|11087901|FG000|First Re-Induction Phase|Withdrawal by Subject|1
7016555|NCT01515189|11087902|FG001|First Re-Induction Phase|Withdrawal by Subject|1
7016556|NCT01515189|11087901|FG000|First Re-Induction Phase|No longer meets study criteria|1
7016557|NCT01515189|11087902|FG001|First Re-Induction Phase|No longer meets study criteria|0
7016558|NCT01515189|11087901|FG000|First Re-Induction Phase|Other|1
7016559|NCT01515189|11087902|FG001|First Re-Induction Phase|Other|0
7016560|NCT01515319|11087918|FG000|Overall Study|Withdrawal by Subject|0
7016561|NCT01515319|11087919|FG001|Overall Study|Withdrawal by Subject|0
7016562|NCT01515319|11087920|FG002|Overall Study|Withdrawal by Subject|0
7016563|NCT01515319|11087921|FG003|Overall Study|Withdrawal by Subject|0
7016564|NCT01515319|11087922|FG004|Overall Study|Withdrawal by Subject|0
7016565|NCT01515319|11087923|FG005|Overall Study|Withdrawal by Subject|0
7016566|NCT01515319|11087924|FG006|Overall Study|Withdrawal by Subject|1
7016567|NCT01515319|11087925|FG007|Overall Study|Withdrawal by Subject|0
7016568|NCT01515319|11087926|FG008|Overall Study|Withdrawal by Subject|0
7016569|NCT01515319|11087927|FG009|Overall Study|Withdrawal by Subject|0
7016570|NCT01515319|11087918|FG000|Overall Study|Adverse Event|0
7016571|NCT01515319|11087919|FG001|Overall Study|Adverse Event|0
7016572|NCT01515319|11087920|FG002|Overall Study|Adverse Event|0
7016573|NCT01515319|11087921|FG003|Overall Study|Adverse Event|0
7016574|NCT01515319|11087922|FG004|Overall Study|Adverse Event|0
7016575|NCT01515319|11087923|FG005|Overall Study|Adverse Event|0
7016576|NCT01515319|11087924|FG006|Overall Study|Adverse Event|0
7016577|NCT01515319|11087925|FG007|Overall Study|Adverse Event|0
7016578|NCT01515319|11087926|FG008|Overall Study|Adverse Event|3
7016579|NCT01515319|11087927|FG009|Overall Study|Adverse Event|0
7016580|NCT01515319|11087918|FG000|Overall Study|Protocol Violation|0
7016581|NCT01515319|11087919|FG001|Overall Study|Protocol Violation|0
7016582|NCT01515319|11087920|FG002|Overall Study|Protocol Violation|0
7016583|NCT01515319|11087921|FG003|Overall Study|Protocol Violation|0
7016584|NCT01515319|11087922|FG004|Overall Study|Protocol Violation|0
7016585|NCT01515319|11087923|FG005|Overall Study|Protocol Violation|0
7016586|NCT01515319|11087924|FG006|Overall Study|Protocol Violation|0
7016587|NCT01515319|11087925|FG007|Overall Study|Protocol Violation|0
7016588|NCT01515319|11087926|FG008|Overall Study|Protocol Violation|2
7016589|NCT01515319|11087927|FG009|Overall Study|Protocol Violation|0
7016590|NCT01515423|11087967|FG000|Open Label Phase|Adverse Event|57
7016591|NCT01515423|11087968|FG001|Open Label Phase|Adverse Event|0
7016592|NCT01515423|11087969|FG002|Open Label Phase|Adverse Event|0
7016593|NCT01515423|11087967|FG000|Open Label Phase|Death|2
7016594|NCT01515423|11087968|FG001|Open Label Phase|Death|0
7016595|NCT01515423|11087969|FG002|Open Label Phase|Death|0
7016596|NCT01515423|11087967|FG000|Open Label Phase|Lack of Efficacy|117
7016597|NCT01515423|11087968|FG001|Open Label Phase|Lack of Efficacy|0
7016598|NCT01515423|11087969|FG002|Open Label Phase|Lack of Efficacy|0
7016599|NCT01515423|11087967|FG000|Open Label Phase|Lost to Follow-up|21
7016600|NCT01515423|11087968|FG001|Open Label Phase|Lost to Follow-up|0
7016601|NCT01515423|11087969|FG002|Open Label Phase|Lost to Follow-up|0
7016602|NCT01515423|11087967|FG000|Open Label Phase|Withdrawal by Subject|118
7016603|NCT01515423|11087968|FG001|Open Label Phase|Withdrawal by Subject|0
7016604|NCT01515423|11087969|FG002|Open Label Phase|Withdrawal by Subject|0
7016605|NCT01515423|11087967|FG000|Open Label Phase|excluded from DB Phase|70
7016606|NCT01515423|11087968|FG001|Open Label Phase|excluded from DB Phase|0
7016607|NCT01515423|11087969|FG002|Open Label Phase|excluded from DB Phase|0
7016608|NCT01515423|11087967|FG000|Open Label Phase|Other|28
7016609|NCT01515423|11087968|FG001|Open Label Phase|Other|0
7016610|NCT01515423|11087969|FG002|Open Label Phase|Other|0
7016611|NCT01515423|11087967|FG000|DOUBLE BLIND|Adverse Event|0
7016612|NCT01515423|11087968|FG001|DOUBLE BLIND|Adverse Event|15
7016613|NCT01515423|11087969|FG002|DOUBLE BLIND|Adverse Event|13
7016614|NCT01515423|11087967|FG000|DOUBLE BLIND|Death|0
7016615|NCT01515423|11087968|FG001|DOUBLE BLIND|Death|1
7016616|NCT01515423|11087969|FG002|DOUBLE BLIND|Death|2
7016617|NCT01515423|11087967|FG000|DOUBLE BLIND|Lost to Follow-up|0
7016618|NCT01515423|11087968|FG001|DOUBLE BLIND|Lost to Follow-up|7
7016619|NCT01515423|11087969|FG002|DOUBLE BLIND|Lost to Follow-up|12
7016620|NCT01515423|11087967|FG000|DOUBLE BLIND|Pregnancy|0
7016621|NCT01515423|11087968|FG001|DOUBLE BLIND|Pregnancy|2
7016622|NCT01515423|11087969|FG002|DOUBLE BLIND|Pregnancy|0
7016623|NCT01515423|11087967|FG000|DOUBLE BLIND|Withdrawal by Subject|0
7016624|NCT01515423|11087968|FG001|DOUBLE BLIND|Withdrawal by Subject|50
7016625|NCT01515423|11087969|FG002|DOUBLE BLIND|Withdrawal by Subject|53
7016626|NCT01515423|11087967|FG000|DOUBLE BLIND|Other|0
7016627|NCT01515423|11087968|FG001|DOUBLE BLIND|Other|6
7016628|NCT01515423|11087969|FG002|DOUBLE BLIND|Other|12
7016629|NCT01515423|11087967|FG000|DOUBLE BLIND|Blind broken by investigator|0
7016630|NCT01515423|11087968|FG001|DOUBLE BLIND|Blind broken by investigator|1
7016631|NCT01515423|11087969|FG002|DOUBLE BLIND|Blind broken by investigator|0
7016632|NCT01515475|11087980|FG000|Overall Study|Lost to Follow-up|20
7016633|NCT01515475|11087981|FG001|Overall Study|Lost to Follow-up|15
7016634|NCT01515475|11087982|FG002|Overall Study|Lost to Follow-up|12
7016635|NCT01515475|11087983|FG003|Overall Study|Lost to Follow-up|12
7016636|NCT01515865|11088039|FG000|Part A (Open-label)|Other|3
7016637|NCT01515865|11088040|FG001|Part A (Open-label)|Other|0
7016638|NCT01515865|11088041|FG002|Part A (Open-label)|Other|0
7016639|NCT01515865|11088039|FG000|Part B (Open-label)|Withdrawal by Subject|1
7016640|NCT01515865|11088040|FG001|Part B (Open-label)|Withdrawal by Subject|0
7016641|NCT01515865|11088041|FG002|Part B (Open-label)|Withdrawal by Subject|0
7016642|NCT01515865|11088039|FG000|Part B (Open-label)|Other|1
7016643|NCT01515865|11088040|FG001|Part B (Open-label)|Other|0
7016644|NCT01515865|11088041|FG002|Part B (Open-label)|Other|0
7016645|NCT01516008|11088085|FG000|Overall Study|Adverse Event|0
7016646|NCT01516008|11088086|FG001|Overall Study|Adverse Event|2
7016647|NCT01516008|11088087|FG002|Overall Study|Adverse Event|7
7016648|NCT01516008|11088085|FG000|Overall Study|Lack of Efficacy|44
7016649|NCT01516008|11088086|FG001|Overall Study|Lack of Efficacy|14
7016650|NCT01516008|11088087|FG002|Overall Study|Lack of Efficacy|10
7016651|NCT01516008|11088085|FG000|Overall Study|Protocol Violation|1
7016652|NCT01516008|11088086|FG001|Overall Study|Protocol Violation|0
7016653|NCT01516008|11088087|FG002|Overall Study|Protocol Violation|0
7016654|NCT01516008|11088085|FG000|Overall Study|Reason not specified|0
7016655|NCT01516008|11088086|FG001|Overall Study|Reason not specified|0
7016656|NCT01516008|11088087|FG002|Overall Study|Reason not specified|1
7016657|NCT01516437|11088117|FG000|Overall Study|Reason not specified|0
7016658|NCT01516437|11088118|FG001|Overall Study|Reason not specified|0
7016659|NCT01516437|11088119|FG002|Overall Study|Reason not specified|1
7016660|NCT01516437|11088120|FG003|Overall Study|Reason not specified|1
7016661|NCT01516736|11088156|FG000|Overall Study|Withdrawal by Subject|10
7016662|NCT01516736|11088157|FG001|Overall Study|Withdrawal by Subject|4
7016663|NCT01516736|11088156|FG000|Overall Study|Adverse Event|4
7016664|NCT01516736|11088157|FG001|Overall Study|Adverse Event|5
7016665|NCT01516736|11088156|FG000|Overall Study|Death|3
7016666|NCT01516736|11088157|FG001|Overall Study|Death|1
7016667|NCT01516736|11088156|FG000|Overall Study|Physician Decision|2
7016668|NCT01516736|11088157|FG001|Overall Study|Physician Decision|1
7016669|NCT01516736|11088156|FG000|Overall Study|Lack of Efficacy|1
7016670|NCT01516736|11088157|FG001|Overall Study|Lack of Efficacy|0
7016671|NCT01516736|11088156|FG000|Overall Study|Protocol Violation|0
7016672|NCT01516736|11088157|FG001|Overall Study|Protocol Violation|1
7016673|NCT01516736|11088156|FG000|Overall Study|Other (not specified)|0
7016674|NCT01516736|11088157|FG001|Overall Study|Other (not specified)|1
7016675|NCT01516749|11088163|FG000|Active Therapy|Lost to Follow-up|1
7016676|NCT01516749|11088163|FG000|Follow-up Off Therapy|Lost to Follow-up|1
7016677|NCT01516879|11088169|FG000|Overall Study|Withdrawal by Subject|9
7016678|NCT01516879|11088170|FG001|Overall Study|Withdrawal by Subject|11
7016679|NCT01516879|11088169|FG000|Overall Study|Death|0
7016680|NCT01516879|11088170|FG001|Overall Study|Death|2
7016681|NCT01516879|11088169|FG000|Overall Study|Lost to Follow-up|2
7016682|NCT01516879|11088170|FG001|Overall Study|Lost to Follow-up|11
7016683|NCT01516879|11088169|FG000|Overall Study|Other|5
7016684|NCT01516879|11088170|FG001|Overall Study|Other|10
7016685|NCT01516892|11088176|FG000|Overall Study|Adverse Event|25
7016686|NCT01516892|11088176|FG000|Overall Study|Lack of Efficacy|35
7016687|NCT01516892|11088176|FG000|Overall Study|Pregnancy|5
7016688|NCT01516892|11088176|FG000|Overall Study|Lost to Follow-up|82
7016689|NCT01516892|11088176|FG000|Overall Study|Subject Withdrew Consent|92
7016690|NCT01516892|11088176|FG000|Overall Study|Protocol Violation|60
7016691|NCT01516892|11088176|FG000|Overall Study|Other Miscellaneous Reasons|43
7016692|NCT01516892|11088176|FG000|Overall Study|Missing|1
7016693|NCT01516970|11088197|FG000|Overall Study|Lost to Follow-up|7
7016694|NCT01516970|11088198|FG001|Overall Study|Lost to Follow-up|8
7016695|NCT01516970|11088197|FG000|Overall Study|Adverse Event|1
7016696|NCT01516970|11088198|FG001|Overall Study|Adverse Event|5
7016697|NCT01516970|11088197|FG000|Overall Study|Withdrawal by Subject|1
7016698|NCT01516970|11088198|FG001|Overall Study|Withdrawal by Subject|1
7016699|NCT01516970|11088197|FG000|Overall Study|Other|9
7016700|NCT01516970|11088198|FG001|Overall Study|Other|7
7016701|NCT01517178|11088213|FG000|Period 1|Adverse Event|1
7016702|NCT01517178|11088214|FG001|Period 1|Adverse Event|2
7016703|NCT01517178|11088213|FG000|Period 1|Lack of Efficacy|0
7016704|NCT01517178|11088214|FG001|Period 1|Lack of Efficacy|1
7016705|NCT01517178|11088213|FG000|Period 1|E.g. study termination|3
7016706|NCT01517178|11088214|FG001|Period 1|E.g. study termination|1
7016707|NCT01517178|11088213|FG000|Period 1|Withdrawal by Subject|0
7016708|NCT01517178|11088214|FG001|Period 1|Withdrawal by Subject|1
7016709|NCT01517178|11088213|FG000|Period 2|Adverse Event|1
7016710|NCT01517178|11088214|FG001|Period 2|Adverse Event|0
7016711|NCT01517178|11088213|FG000|Period 2|Withdrawal by Subject|3
7016712|NCT01517178|11088214|FG001|Period 2|Withdrawal by Subject|0
7016713|NCT01517178|11088213|FG000|Period 2|E.g. study termination|2
7016714|NCT01517178|11088214|FG001|Period 2|E.g. study termination|2
7016715|NCT01517282|11088224|FG000|Overall Study|Consent withdrawn|0
7016716|NCT01517282|11088225|FG001|Overall Study|Consent withdrawn|1
7016717|NCT01517282|11088226|FG002|Overall Study|Consent withdrawn|1
7016718|NCT01517282|11088227|FG003|Overall Study|Consent withdrawn|1
7016719|NCT01517282|11088224|FG000|Overall Study|Physician Decision|1
7016720|NCT01517282|11088225|FG001|Overall Study|Physician Decision|0
7016721|NCT01517282|11088226|FG002|Overall Study|Physician Decision|0
7016722|NCT01517282|11088227|FG003|Overall Study|Physician Decision|0
7016723|NCT01517295|11088239|FG000|Overall Study|Physician Decision|1
7016724|NCT01517295|11088240|FG001|Overall Study|Physician Decision|0
7016725|NCT01517373|11088251|FG000|Run-in Period|Death|1
7016726|NCT01517373|11088252|FG001|Run-in Period|Death|0
7016727|NCT01517373|11088253|FG002|Run-in Period|Death|0
7016728|NCT01517373|11088254|FG003|Run-in Period|Death|0
7016729|NCT01517373|11088255|FG004|Run-in Period|Death|0
7016730|NCT01517373|11088256|FG005|Run-in Period|Death|0
7016731|NCT01517373|11088251|FG000|Run-in Period|Adverse Event|5
7016732|NCT01517373|11088252|FG001|Run-in Period|Adverse Event|0
7016733|NCT01517373|11088253|FG002|Run-in Period|Adverse Event|0
7016734|NCT01517373|11088254|FG003|Run-in Period|Adverse Event|0
7016735|NCT01517373|11088255|FG004|Run-in Period|Adverse Event|0
7016736|NCT01517373|11088256|FG005|Run-in Period|Adverse Event|0
7016737|NCT01517373|11088251|FG000|Run-in Period|Did not meet eligibility criteria|34
7016738|NCT01517373|11088252|FG001|Run-in Period|Did not meet eligibility criteria|0
7016739|NCT01517373|11088253|FG002|Run-in Period|Did not meet eligibility criteria|0
7016740|NCT01517373|11088254|FG003|Run-in Period|Did not meet eligibility criteria|0
7016741|NCT01517373|11088255|FG004|Run-in Period|Did not meet eligibility criteria|0
7016742|NCT01517373|11088256|FG005|Run-in Period|Did not meet eligibility criteria|0
7016743|NCT01517373|11088251|FG000|Run-in Period|Lost to Follow-up|1
7016744|NCT01517373|11088252|FG001|Run-in Period|Lost to Follow-up|0
7016745|NCT01517373|11088253|FG002|Run-in Period|Lost to Follow-up|0
7016746|NCT01517373|11088254|FG003|Run-in Period|Lost to Follow-up|0
7016747|NCT01517373|11088255|FG004|Run-in Period|Lost to Follow-up|0
7016748|NCT01517373|11088256|FG005|Run-in Period|Lost to Follow-up|0
7016749|NCT01517373|11088251|FG000|Run-in Period|Withdrawal by Subject|12
7016750|NCT01517373|11088252|FG001|Run-in Period|Withdrawal by Subject|0
7016751|NCT01517373|11088253|FG002|Run-in Period|Withdrawal by Subject|0
7016752|NCT01517373|11088254|FG003|Run-in Period|Withdrawal by Subject|0
7016753|NCT01517373|11088255|FG004|Run-in Period|Withdrawal by Subject|0
7016754|NCT01517373|11088256|FG005|Run-in Period|Withdrawal by Subject|0
7016755|NCT01517373|11088251|FG000|Run-in Period|Sponsor Decision|3
7016756|NCT01517373|11088252|FG001|Run-in Period|Sponsor Decision|0
7016757|NCT01517373|11088253|FG002|Run-in Period|Sponsor Decision|0
7016758|NCT01517373|11088254|FG003|Run-in Period|Sponsor Decision|0
7016759|NCT01517373|11088255|FG004|Run-in Period|Sponsor Decision|0
7016760|NCT01517373|11088256|FG005|Run-in Period|Sponsor Decision|0
7016761|NCT01517373|11088251|FG000|Run-in Period|Other|1
7016762|NCT01517373|11088252|FG001|Run-in Period|Other|0
7016763|NCT01517373|11088253|FG002|Run-in Period|Other|0
7016764|NCT01517373|11088254|FG003|Run-in Period|Other|0
7016765|NCT01517373|11088255|FG004|Run-in Period|Other|0
7016766|NCT01517373|11088256|FG005|Run-in Period|Other|0
7016767|NCT01517373|11088251|FG000|Treatment Period|Adverse Event|0
7016768|NCT01517373|11088252|FG001|Treatment Period|Adverse Event|0
7016769|NCT01517373|11088253|FG002|Treatment Period|Adverse Event|0
7016770|NCT01517373|11088254|FG003|Treatment Period|Adverse Event|0
7016771|NCT01517373|11088255|FG004|Treatment Period|Adverse Event|0
7016772|NCT01517373|11088256|FG005|Treatment Period|Adverse Event|2
7016773|NCT01517373|11088251|FG000|Treatment Period|Lost to Follow-up|0
7016774|NCT01517373|11088252|FG001|Treatment Period|Lost to Follow-up|0
7016775|NCT01517373|11088253|FG002|Treatment Period|Lost to Follow-up|1
7016776|NCT01517373|11088254|FG003|Treatment Period|Lost to Follow-up|1
7016777|NCT01517373|11088255|FG004|Treatment Period|Lost to Follow-up|0
7016778|NCT01517373|11088256|FG005|Treatment Period|Lost to Follow-up|0
7016779|NCT01517373|11088251|FG000|Treatment Period|Withdrawal by Subject|0
7016780|NCT01517373|11088252|FG001|Treatment Period|Withdrawal by Subject|3
7016781|NCT01517373|11088253|FG002|Treatment Period|Withdrawal by Subject|2
7016782|NCT01517373|11088254|FG003|Treatment Period|Withdrawal by Subject|2
7016783|NCT01517373|11088255|FG004|Treatment Period|Withdrawal by Subject|2
7016784|NCT01517373|11088256|FG005|Treatment Period|Withdrawal by Subject|3
7016785|NCT01517373|11088251|FG000|Treatment Period|Other|0
7016786|NCT01517373|11088252|FG001|Treatment Period|Other|0
7016787|NCT01517373|11088253|FG002|Treatment Period|Other|0
7016788|NCT01517373|11088254|FG003|Treatment Period|Other|0
7016789|NCT01517373|11088255|FG004|Treatment Period|Other|1
7016790|NCT01517373|11088256|FG005|Treatment Period|Other|0
7016791|NCT01517373|11088251|FG000|Treatment Period|Protocol Violation|0
7016792|NCT01517373|11088252|FG001|Treatment Period|Protocol Violation|0
7016793|NCT01517373|11088253|FG002|Treatment Period|Protocol Violation|0
7016794|NCT01517373|11088254|FG003|Treatment Period|Protocol Violation|0
7016795|NCT01517373|11088255|FG004|Treatment Period|Protocol Violation|1
7016796|NCT01517373|11088256|FG005|Treatment Period|Protocol Violation|0
7016797|NCT01517373|11088251|FG000|Treatment Period|Lack of Efficacy|0
7016798|NCT01517373|11088252|FG001|Treatment Period|Lack of Efficacy|1
7016799|NCT01517373|11088253|FG002|Treatment Period|Lack of Efficacy|1
7016800|NCT01517373|11088254|FG003|Treatment Period|Lack of Efficacy|3
7016801|NCT01517373|11088255|FG004|Treatment Period|Lack of Efficacy|2
7016802|NCT01517373|11088256|FG005|Treatment Period|Lack of Efficacy|0
7016803|NCT01517373|11088251|FG000|Treatment Period|Medication error without AEs|0
7016804|NCT01517373|11088252|FG001|Treatment Period|Medication error without AEs|0
7016805|NCT01517373|11088253|FG002|Treatment Period|Medication error without AEs|2
7016806|NCT01517373|11088254|FG003|Treatment Period|Medication error without AEs|1
7016807|NCT01517373|11088255|FG004|Treatment Period|Medication error without AEs|0
7016808|NCT01517373|11088256|FG005|Treatment Period|Medication error without AEs|2
7016809|NCT01517412|11088271|FG000|Overall Study|Adverse Event|10
7016810|NCT01517412|11088272|FG001|Overall Study|Adverse Event|11
7016811|NCT01517412|11088271|FG000|Overall Study|Lack of Efficacy|10
7016812|NCT01517412|11088272|FG001|Overall Study|Lack of Efficacy|5
7016813|NCT01517412|11088271|FG000|Overall Study|Poor compliance to protocol|8
7016814|NCT01517412|11088272|FG001|Overall Study|Poor compliance to protocol|3
7016815|NCT01517412|11088271|FG000|Overall Study|Other than specified above|8
7016816|NCT01517412|11088272|FG001|Overall Study|Other than specified above|5
7016817|NCT01517750|11088286|FG000|Overall Study|Lost to Follow-up|1
7016818|NCT01517750|11088287|FG001|Overall Study|Lost to Follow-up|2
7016819|NCT01517750|11088288|FG002|Overall Study|Lost to Follow-up|4
7016820|NCT01517750|11088289|FG003|Overall Study|Lost to Follow-up|1
7016821|NCT01517867|11088305|FG000|Overall Study|never started treatment|29
7016822|NCT01517867|11088306|FG001|Overall Study|never started treatment|32
7016823|NCT01517867|11088305|FG000|Overall Study|Withdrawal by Subject|34
7016824|NCT01517867|11088306|FG001|Overall Study|Withdrawal by Subject|30
7016825|NCT01517867|11088305|FG000|Overall Study|Still in treatment at study end|0
7016826|NCT01517867|11088306|FG001|Overall Study|Still in treatment at study end|3
7016827|NCT01517893|11088314|FG000|Overall Study|Withdrawal by Subject|3
7016828|NCT01517893|11088315|FG001|Overall Study|Withdrawal by Subject|0
7016829|NCT01517984|11088324|FG000|Overall Study|Lost to Follow-up|0
7016830|NCT01517984|11088325|FG001|Overall Study|Lost to Follow-up|1
7016831|NCT01517984|11088326|FG002|Overall Study|Lost to Follow-up|0
7016832|NCT01517984|11088327|FG003|Overall Study|Lost to Follow-up|0
7016833|NCT01517984|11088324|FG000|Overall Study|Withdrawal by Subject|1
7016834|NCT01517984|11088325|FG001|Overall Study|Withdrawal by Subject|8
7016835|NCT01517984|11088326|FG002|Overall Study|Withdrawal by Subject|4
7016836|NCT01517984|11088327|FG003|Overall Study|Withdrawal by Subject|1
7016837|NCT01517984|11088324|FG000|Overall Study|Screen Failure|4
7016838|NCT01517984|11088325|FG001|Overall Study|Screen Failure|0
7016839|NCT01517984|11088326|FG002|Overall Study|Screen Failure|0
7016840|NCT01517984|11088327|FG003|Overall Study|Screen Failure|0
7016841|NCT01517984|11088324|FG000|Overall Study|Ineligible for randomization|0
7016842|NCT01517984|11088325|FG001|Overall Study|Ineligible for randomization|14
7016843|NCT01517984|11088326|FG002|Overall Study|Ineligible for randomization|0
7016844|NCT01517984|11088327|FG003|Overall Study|Ineligible for randomization|0
7016845|NCT01518153|11088334|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5
7016846|NCT01518153|11088335|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
7016847|NCT01518153|11088336|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
7016848|NCT01518153|11088334|FG000|Stem Cell Transplant|Death|2
7016849|NCT01518153|11088335|FG001|Stem Cell Transplant|Death|0
7016850|NCT01518153|11088336|FG002|Stem Cell Transplant|Death|0
7016851|NCT01518153|11088334|FG000|Stem Cell Transplant|Secondary graft failure|1
7016852|NCT01518153|11088335|FG001|Stem Cell Transplant|Secondary graft failure|0
7016853|NCT01518153|11088336|FG002|Stem Cell Transplant|Secondary graft failure|0
7016854|NCT01518153|11088334|FG000|Stem Cell Transplant|Adverse Event|1
7016855|NCT01518153|11088335|FG001|Stem Cell Transplant|Adverse Event|0
7016856|NCT01518153|11088336|FG002|Stem Cell Transplant|Adverse Event|0
7016857|NCT01518153|11088334|FG000|Donor Lymphocyte Infusion|Death|0
7016858|NCT01518153|11088335|FG001|Donor Lymphocyte Infusion|Death|2
7016859|NCT01518153|11088336|FG002|Donor Lymphocyte Infusion|Death|1
7043636|NCT01746225|11128749|FG002|Overall Study|Adverse Event|17
7043637|NCT01746225|11128747|FG000|Overall Study|Continuing Treatment|5
7043638|NCT01746225|11128748|FG001|Overall Study|Continuing Treatment|8
7043639|NCT01746225|11128749|FG002|Overall Study|Continuing Treatment|3
7043640|NCT01746368|11128763|FG000|Overall Study|Lost to Follow-up|2
7043641|NCT01746368|11128764|FG001|Overall Study|Lost to Follow-up|0
7043642|NCT01746368|11128763|FG000|Overall Study|Withdrawal by Subject|0
7043643|NCT01746368|11128764|FG001|Overall Study|Withdrawal by Subject|1
7043644|NCT01746732|11128801|FG000|Lead-In Period|Withdrawal by Subject|1
7043645|NCT01746732|11128802|FG001|Lead-In Period|Withdrawal by Subject|0
7043646|NCT01746732|11128803|FG002|Lead-In Period|Withdrawal by Subject|0
7043647|NCT01746732|11128801|FG000|Period 1|Physician Decision|0
7043648|NCT01746732|11128802|FG001|Period 1|Physician Decision|1
7043649|NCT01746732|11128803|FG002|Period 1|Physician Decision|0
7043650|NCT01746732|11128801|FG000|Period 2|Withdrawal by Subject|0
7043651|NCT01746732|11128802|FG001|Period 2|Withdrawal by Subject|0
7043652|NCT01746732|11128803|FG002|Period 2|Withdrawal by Subject|2
7043653|NCT01746732|11128801|FG000|Period 2|Adverse Event|0
7043654|NCT01746732|11128802|FG001|Period 2|Adverse Event|0
7043655|NCT01746732|11128803|FG002|Period 2|Adverse Event|1
7043656|NCT01746732|11128801|FG000|Period 2|Lost to Follow-up|0
7043657|NCT01746732|11128802|FG001|Period 2|Lost to Follow-up|0
7043658|NCT01746732|11128803|FG002|Period 2|Lost to Follow-up|1
7043659|NCT01746862|11128847|FG000|Overall Study|Withdrawal by Subject|1
7043660|NCT01746862|11128848|FG001|Overall Study|Withdrawal by Subject|1
7043661|NCT01746862|11128847|FG000|Overall Study|Protocol Violation|1
7043662|NCT01746862|11128848|FG001|Overall Study|Protocol Violation|0
7043663|NCT01746862|11128847|FG000|Overall Study|Consent withdrawal by parent's guardian|5
7043664|NCT01746862|11128848|FG001|Overall Study|Consent withdrawal by parent's guardian|2
7043665|NCT01746862|11128847|FG000|Overall Study|Entered puberty during the study|1
7043666|NCT01746862|11128848|FG001|Overall Study|Entered puberty during the study|0
7043667|NCT01746901|11128855|FG000|Naloxone Challenge Phase|Adverse Event|2
7043668|NCT01746901|11128856|FG001|Naloxone Challenge Phase|Adverse Event|0
7043669|NCT01746901|11128857|FG002|Naloxone Challenge Phase|Adverse Event|0
7043670|NCT01746901|11128858|FG003|Naloxone Challenge Phase|Adverse Event|0
7043671|NCT01746901|11128859|FG004|Naloxone Challenge Phase|Adverse Event|0
7043672|NCT01746901|11128860|FG005|Naloxone Challenge Phase|Adverse Event|0
7043673|NCT01746901|11128861|FG006|Naloxone Challenge Phase|Adverse Event|0
7016860|NCT01518192|11088347|FG000|Overall Study|Lost to Follow-up|29
7016861|NCT01518192|11088348|FG001|Overall Study|Lost to Follow-up|26
7016862|NCT01518192|11088349|FG002|Overall Study|Lost to Follow-up|35
7016863|NCT01518244|11088363|FG000|Overall Study|Adverse Event|3
7016864|NCT01518257|11088369|FG000|Overall Study|Lost to Follow-up|1
7016865|NCT01518257|11088370|FG001|Overall Study|Lost to Follow-up|0
7016866|NCT01518257|11088369|FG000|Overall Study|Other Miscellaneous Reason|1
7016867|NCT01518257|11088370|FG001|Overall Study|Other Miscellaneous Reason|0
7016868|NCT01518309|11088380|FG000|Overall Study|Adverse Event|6
7016869|NCT01518309|11088380|FG000|Overall Study|Death|6
7016870|NCT01518309|11088380|FG000|Overall Study|Lack of Efficacy|7
7016871|NCT01518309|11088380|FG000|Overall Study|Withdrawal by Subject|6
7016872|NCT01518309|11088380|FG000|Overall Study|Physician Decision|3
7016873|NCT01518309|11088380|FG000|Overall Study|Sponsor Decision|2
7016874|NCT01518309|11088380|FG000|Overall Study|Not in Predefined Categories|9
7016875|NCT01518322|11088384|FG000|Overall Study|FeNO measurement was missing|13
7016876|NCT01518374|11088393|FG000|Overall Study|Withdrawal by Subject|2
7016877|NCT01518374|11088393|FG000|Overall Study|Protocol Violation|3
7016878|NCT01518374|11088393|FG000|Overall Study|Lost to Follow-up|2
7016879|NCT01518699|11088407|FG000|Period 2|Protocol Violation|1
7016880|NCT01518699|11088408|FG001|Period 2|Protocol Violation|1
7016881|NCT01518699|11088409|FG002|Period 2|Protocol Violation|0
7016882|NCT01518699|11088410|FG003|Period 2|Protocol Violation|0
7016883|NCT01518699|11088411|FG004|Period 2|Protocol Violation|0
7016884|NCT01518699|11088412|FG005|Period 2|Protocol Violation|0
7016885|NCT01518699|11088407|FG000|Period 2|Lost to Follow-up|0
7016886|NCT01518699|11088408|FG001|Period 2|Lost to Follow-up|1
7016887|NCT01518699|11088409|FG002|Period 2|Lost to Follow-up|0
7016888|NCT01518699|11088410|FG003|Period 2|Lost to Follow-up|0
7016889|NCT01518699|11088411|FG004|Period 2|Lost to Follow-up|0
7016890|NCT01518699|11088412|FG005|Period 2|Lost to Follow-up|0
7016891|NCT01518699|11088407|FG000|Period 2|Adverse Event|1
7016892|NCT01518699|11088408|FG001|Period 2|Adverse Event|0
7016893|NCT01518699|11088409|FG002|Period 2|Adverse Event|0
7016894|NCT01518699|11088410|FG003|Period 2|Adverse Event|0
7016895|NCT01518699|11088411|FG004|Period 2|Adverse Event|0
7016896|NCT01518699|11088412|FG005|Period 2|Adverse Event|0
7016897|NCT01518946|11088429|FG000|Open-label Phase|Other|4
7016898|NCT01518946|11088430|FG001|Open-label Phase|Other|0
7016899|NCT01518946|11088431|FG002|Open-label Phase|Other|0
7016900|NCT01518946|11088429|FG000|Randomized Phase (First Intervention)|Other|0
7016901|NCT01518946|11088430|FG001|Randomized Phase (First Intervention)|Other|1
7016902|NCT01518946|11088431|FG002|Randomized Phase (First Intervention)|Other|0
7016903|NCT01518972|11088440|FG000|Overall Study|Lost to Follow-up|2
7016904|NCT01518972|11088441|FG001|Overall Study|Lost to Follow-up|1
7016905|NCT01518972|11088440|FG000|Overall Study|Withdrawal by Subject|1
7016906|NCT01518972|11088441|FG001|Overall Study|Withdrawal by Subject|0
7016907|NCT01518972|11088440|FG000|Overall Study|Moved from area|1
7016908|NCT01518972|11088441|FG001|Overall Study|Moved from area|0
7016909|NCT01518972|11088440|FG000|Overall Study|Transportation problems|1
7016910|NCT01518972|11088441|FG001|Overall Study|Transportation problems|0
7016911|NCT01518972|11088440|FG000|Overall Study|Exclusionary medical condition|1
7016912|NCT01518972|11088441|FG001|Overall Study|Exclusionary medical condition|0
7016913|NCT01518972|11088440|FG000|Overall Study|Missed safety visits|0
7016914|NCT01518972|11088441|FG001|Overall Study|Missed safety visits|1
7016915|NCT01518972|11088440|FG000|Overall Study|Exclusionary medication|0
7016916|NCT01518972|11088441|FG001|Overall Study|Exclusionary medication|1
7016917|NCT01518972|11088440|FG000|Overall Study|Declined medication starting on day 12|0
7016918|NCT01518972|11088441|FG001|Overall Study|Declined medication starting on day 12|1
7016919|NCT01519089|11088458|FG000|Overall Study|Adverse Event|4
7016920|NCT01519089|11088459|FG001|Overall Study|Adverse Event|4
7016921|NCT01519089|11088458|FG000|Overall Study|Lack of Efficacy|0
7016922|NCT01519089|11088459|FG001|Overall Study|Lack of Efficacy|2
7016923|NCT01519089|11088458|FG000|Overall Study|Lost to Follow-up|1
7016924|NCT01519089|11088459|FG001|Overall Study|Lost to Follow-up|0
7016925|NCT01519089|11088458|FG000|Overall Study|Withdrawal by Subject|0
7016926|NCT01519089|11088459|FG001|Overall Study|Withdrawal by Subject|2
7016927|NCT01519089|11088458|FG000|Overall Study|Other|2
7016928|NCT01519089|11088459|FG001|Overall Study|Other|6
7016929|NCT01519089|11088458|FG000|Overall Study|Not received study drug|0
7016930|NCT01519089|11088459|FG001|Overall Study|Not received study drug|1
7016931|NCT01519167|11088469|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0
7016932|NCT01519167|11088470|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3
7016933|NCT01519167|11088469|FG000|Overall Study|Adverse Event|0
7016934|NCT01519167|11088470|FG001|Overall Study|Adverse Event|1
7016935|NCT01519167|11088469|FG000|Overall Study|Lack of Efficacy|0
7016936|NCT01519167|11088470|FG001|Overall Study|Lack of Efficacy|1
7016937|NCT01519167|11088469|FG000|Overall Study|Medical condition changes&deep sedation|0
7016938|NCT01519167|11088470|FG001|Overall Study|Medical condition changes&deep sedation|2
7016939|NCT01519167|11088469|FG000|Overall Study|Physician Decision|0
7016940|NCT01519167|11088470|FG001|Overall Study|Physician Decision|1
7016941|NCT01519206|11088476|FG000|Overall Study|Lost to Follow-up|3
7016942|NCT01519206|11088476|FG000|Overall Study|Missed Visit|2
7016943|NCT01519245|11088489|FG000|Overall Study|Met exclusion criteria, not analysed|1
7016944|NCT01519245|11088490|FG001|Overall Study|Met exclusion criteria, not analysed|2
7016945|NCT01519323|11088530|FG000|Overall Study|Death|3
7016946|NCT01519323|11088531|FG001|Overall Study|Death|2
7016947|NCT01519323|11088530|FG000|Overall Study|Study terminated by sponsor|0
7016948|NCT01519323|11088531|FG001|Overall Study|Study terminated by sponsor|1
7016949|NCT01519427|11088552|FG000|Overall Study|disease progression|2
7016950|NCT01519518|11088576|FG000|Overall Study|Consent not available|7
7016951|NCT01519518|11088577|FG001|Overall Study|Consent not available|10
7016952|NCT01519635|11088594|FG000|Overall Study|Withdrawal by Subject|0
7016953|NCT01519635|11088595|FG001|Overall Study|Withdrawal by Subject|1
7016954|NCT01519635|11088594|FG000|Overall Study|No possibility to put a catheter|1
7016955|NCT01519635|11088595|FG001|Overall Study|No possibility to put a catheter|2
7016956|NCT01519661|11088610|FG000|Overall Study|Protocol deviation|6
7016957|NCT01519661|11088610|FG000|Overall Study|Lost to Follow-up|3
7016958|NCT01519661|11088610|FG000|Overall Study|Withdrawal by Subject|17
7016959|NCT01519661|11088610|FG000|Overall Study|Lack of Efficacy|6
7016960|NCT01519661|11088610|FG000|Overall Study|Adverse Event|29
7016961|NCT01519674|11088618|FG000|Overall Study|Adverse Event|3
7016962|NCT01519674|11088619|FG001|Overall Study|Adverse Event|3
7016963|NCT01519674|11088620|FG002|Overall Study|Adverse Event|0
7016964|NCT01519674|11088618|FG000|Overall Study|Lack of Efficacy|1
7016965|NCT01519674|11088619|FG001|Overall Study|Lack of Efficacy|1
7016966|NCT01519674|11088620|FG002|Overall Study|Lack of Efficacy|1
7016967|NCT01519674|11088618|FG000|Overall Study|Protocol Violation|0
7016968|NCT01519674|11088619|FG001|Overall Study|Protocol Violation|3
7016969|NCT01519674|11088620|FG002|Overall Study|Protocol Violation|1
7016970|NCT01519674|11088618|FG000|Overall Study|Withdrawal Criteria|7
7016971|NCT01519674|11088619|FG001|Overall Study|Withdrawal Criteria|2
7016972|NCT01519674|11088620|FG002|Overall Study|Withdrawal Criteria|7
7016973|NCT01519674|11088618|FG000|Overall Study|Unsclassified|10
7016974|NCT01519674|11088619|FG001|Overall Study|Unsclassified|4
7016975|NCT01519674|11088620|FG002|Overall Study|Unsclassified|3
7016976|NCT01519700|11088632|FG000|Overall Study|Death|1
7016977|NCT01519700|11088633|FG001|Overall Study|Death|0
7016978|NCT01519700|11088634|FG002|Overall Study|Death|0
7016979|NCT01519700|11088635|FG003|Overall Study|Death|0
7016980|NCT01519700|11088632|FG000|Overall Study|Lost to Follow-up|0
7016981|NCT01519700|11088633|FG001|Overall Study|Lost to Follow-up|0
7016982|NCT01519700|11088634|FG002|Overall Study|Lost to Follow-up|1
7016983|NCT01519700|11088635|FG003|Overall Study|Lost to Follow-up|1
7016984|NCT01519700|11088632|FG000|Overall Study|Physician Decision|1
7016985|NCT01519700|11088633|FG001|Overall Study|Physician Decision|1
7016986|NCT01519700|11088634|FG002|Overall Study|Physician Decision|3
7016987|NCT01519700|11088635|FG003|Overall Study|Physician Decision|0
7016988|NCT01519700|11088632|FG000|Overall Study|Withdrawal by Subject|5
7016989|NCT01519700|11088633|FG001|Overall Study|Withdrawal by Subject|3
7016990|NCT01519700|11088634|FG002|Overall Study|Withdrawal by Subject|3
7016991|NCT01519700|11088635|FG003|Overall Study|Withdrawal by Subject|2
7016992|NCT01519700|11088632|FG000|Overall Study|Other Reason|2
7016993|NCT01519700|11088633|FG001|Overall Study|Other Reason|2
7016994|NCT01519700|11088634|FG002|Overall Study|Other Reason|0
7016995|NCT01519700|11088635|FG003|Overall Study|Other Reason|4
7016996|NCT01519765|11088666|FG000|Overall Study|Adverse Event|0
7016997|NCT01519765|11088667|FG001|Overall Study|Adverse Event|1
7016998|NCT01519765|11088666|FG000|Overall Study|Lack of Efficacy|2
7016999|NCT01519765|11088667|FG001|Overall Study|Lack of Efficacy|0
7017000|NCT01519765|11088666|FG000|Overall Study|Protocol Violation|1
7017001|NCT01519765|11088667|FG001|Overall Study|Protocol Violation|0
7017002|NCT01519765|11088666|FG000|Overall Study|Withdrawal by Subject|0
7017003|NCT01519765|11088667|FG001|Overall Study|Withdrawal by Subject|1
7017004|NCT01519778|11088674|FG000|Overall Study|Withdrawal by Subject|3
7017005|NCT01519778|11088674|FG000|Overall Study|Lost to Follow-up|10
7017006|NCT01519778|11088674|FG000|Overall Study|Physician Decision|1
7017007|NCT01519791|11088680|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2
7017008|NCT01519791|11088681|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1
7017009|NCT01519791|11088680|FG000|Overall Study|Protocol Violation|6
7017010|NCT01519791|11088681|FG001|Overall Study|Protocol Violation|19
7017011|NCT01519791|11088680|FG000|Overall Study|Other Reason|87
7017012|NCT01519791|11088681|FG001|Overall Study|Other Reason|222
7017013|NCT01519791|11088680|FG000|Overall Study|subjects randomized in error|2
7017014|NCT01519791|11088681|FG001|Overall Study|subjects randomized in error|0
7017015|NCT01519791|11088680|FG000|Overall Study|Lack of Efficacy|16
7017016|NCT01519791|11088681|FG001|Overall Study|Lack of Efficacy|20
7017017|NCT01519791|11088680|FG000|Overall Study|SAE, non-fatal|6
7017018|NCT01519791|11088681|FG001|Overall Study|SAE, non-fatal|22
7017019|NCT01519791|11088680|FG000|Overall Study|AE, serious fatal|0
7017020|NCT01519791|11088681|FG001|Overall Study|AE, serious fatal|1
7017021|NCT01519791|11088680|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0
7017022|NCT01519791|11088681|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1
7017023|NCT01519791|11088680|FG000|Overall Study|AE, non-serious non-fatal|12
7017024|NCT01519791|11088681|FG001|Overall Study|AE, non-serious non-fatal|31
7017025|NCT01519791|11088680|FG000|Overall Study|Withdrawal by Subject|15
7017026|NCT01519791|11088681|FG001|Overall Study|Withdrawal by Subject|37
7017027|NCT01519791|11088680|FG000|Overall Study|Lost to Follow-up|6
7017028|NCT01519791|11088681|FG001|Overall Study|Lost to Follow-up|14
7017029|NCT01519817|11088689|FG000|Overall Study|Withdrawal by Subject|1
7017030|NCT01519817|11088690|FG001|Overall Study|Withdrawal by Subject|0
7017031|NCT01519817|11088691|FG002|Overall Study|Withdrawal by Subject|0
7017032|NCT01519817|11088692|FG003|Overall Study|Withdrawal by Subject|0
7017033|NCT01519817|11088689|FG000|Overall Study|Off study due to infection|0
7017034|NCT01519817|11088690|FG001|Overall Study|Off study due to infection|0
7017035|NCT01519817|11088691|FG002|Overall Study|Off study due to infection|0
7017036|NCT01519817|11088692|FG003|Overall Study|Off study due to infection|1
7017037|NCT01519869|11088702|FG000|Overall Study|Lost to Follow-up|1
7017038|NCT01519921|11088717|FG000|Overall Study|Adverse Event|10
7017039|NCT01519921|11088718|FG001|Overall Study|Adverse Event|9
7017040|NCT01519921|11088717|FG000|Overall Study|Lack of Efficacy|4
7017041|NCT01519921|11088718|FG001|Overall Study|Lack of Efficacy|3
7017042|NCT01519921|11088717|FG000|Overall Study|Withdrawal by Subject|3
7017043|NCT01519921|11088718|FG001|Overall Study|Withdrawal by Subject|0
7017044|NCT01519921|11088717|FG000|Overall Study|Lost to Follow-up|2
7017045|NCT01519921|11088718|FG001|Overall Study|Lost to Follow-up|1
7017046|NCT01519921|11088717|FG000|Overall Study|Treatment refusal|2
7017047|NCT01519921|11088718|FG001|Overall Study|Treatment refusal|1
7017048|NCT01519921|11088717|FG000|Overall Study|High alanine aminotransferase (ALT)|0
7017049|NCT01519921|11088718|FG001|Overall Study|High alanine aminotransferase (ALT)|1
7017050|NCT01519934|11088724|FG000|Overall Study|Lost to Follow-up|3
7017051|NCT01519947|11088732|FG000|Overall Study|Death|0
7017052|NCT01519947|11088733|FG001|Overall Study|Death|0
7017053|NCT01519947|11088734|FG002|Overall Study|Death|0
7017054|NCT01519947|11088735|FG003|Overall Study|Death|1
7017055|NCT01519947|11088732|FG000|Overall Study|Protocol Violation|0
7017056|NCT01519947|11088733|FG001|Overall Study|Protocol Violation|0
7017057|NCT01519947|11088734|FG002|Overall Study|Protocol Violation|2
7017058|NCT01519947|11088735|FG003|Overall Study|Protocol Violation|1
7017059|NCT01519947|11088732|FG000|Overall Study|Peritoneal Dialysis Needed|0
7017060|NCT01519947|11088733|FG001|Overall Study|Peritoneal Dialysis Needed|1
7017061|NCT01519947|11088734|FG002|Overall Study|Peritoneal Dialysis Needed|0
7017062|NCT01519947|11088735|FG003|Overall Study|Peritoneal Dialysis Needed|0
7017063|NCT01519947|11088732|FG000|Overall Study|Development of Anemia|0
7017064|NCT01519947|11088733|FG001|Overall Study|Development of Anemia|1
7017065|NCT01519947|11088734|FG002|Overall Study|Development of Anemia|0
7017066|NCT01519947|11088735|FG003|Overall Study|Development of Anemia|1
7017067|NCT01519947|11088732|FG000|Overall Study|Blood Transfusion|0
7017068|NCT01519947|11088733|FG001|Overall Study|Blood Transfusion|1
7017069|NCT01519947|11088734|FG002|Overall Study|Blood Transfusion|1
7017070|NCT01519947|11088735|FG003|Overall Study|Blood Transfusion|0
7017071|NCT01519947|11088732|FG000|Overall Study|Withdrawal by Subject|0
7017072|NCT01519947|11088733|FG001|Overall Study|Withdrawal by Subject|1
7017073|NCT01519947|11088734|FG002|Overall Study|Withdrawal by Subject|0
7017074|NCT01519947|11088735|FG003|Overall Study|Withdrawal by Subject|1
7017075|NCT01519947|11088732|FG000|Overall Study|Lost to Follow-up|0
7017076|NCT01519947|11088733|FG001|Overall Study|Lost to Follow-up|0
7017077|NCT01519947|11088734|FG002|Overall Study|Lost to Follow-up|3
7017078|NCT01519947|11088735|FG003|Overall Study|Lost to Follow-up|2
7017079|NCT01519947|11088732|FG000|Overall Study|Poor Response|1
7017080|NCT01519947|11088733|FG001|Overall Study|Poor Response|0
7017081|NCT01519947|11088734|FG002|Overall Study|Poor Response|0
7017082|NCT01519947|11088735|FG003|Overall Study|Poor Response|1
7017083|NCT01519947|11088732|FG000|Overall Study|Adverse Event|1
7017084|NCT01519947|11088733|FG001|Overall Study|Adverse Event|0
7017085|NCT01519947|11088734|FG002|Overall Study|Adverse Event|1
7017086|NCT01519947|11088735|FG003|Overall Study|Adverse Event|1
7017087|NCT01520324|11088758|FG000|Overall Study|Subject discontinued (moderate illness)|1
7017088|NCT01520363|11088764|FG000|Overall Study|Withdrawal by Subject|2
7017089|NCT01520363|11088765|FG001|Overall Study|Withdrawal by Subject|0
7017090|NCT01520402|11088795|FG000|Overall Study|Withdrawal by Subject|2
7017091|NCT01520402|11088795|FG000|Overall Study|Physician Decision|3
7017092|NCT01520506|11088826|FG000|Overall Study|Missed Visit|4
7017093|NCT01520506|11088826|FG000|Overall Study|Lost to Follow-up|1
7017094|NCT01520506|11088826|FG000|Overall Study|Withdrawal by Subject|1
7017095|NCT01520870|11088902|FG000|Overall Study|Withdrawal by Subject|2
7017096|NCT01520909|11088908|FG000|Part 1 (Randomized Period)|Adverse Event|1
7017097|NCT01520909|11088909|FG001|Part 1 (Randomized Period)|Adverse Event|2
7017098|NCT01520909|11088910|FG002|Part 1 (Randomized Period)|Adverse Event|0
7017099|NCT01520909|11088908|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
7017100|NCT01520909|11088909|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
7017101|NCT01520909|11088910|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4
7017102|NCT01520909|11088908|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
7017103|NCT01520909|11088909|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
7017104|NCT01520909|11088910|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2
7017105|NCT01520909|11088908|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
7017106|NCT01520909|11088909|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
7017107|NCT01520909|11088910|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1
7017108|NCT01520922|11088932|FG000|Treatment Phase|Physician Decision|2
7017109|NCT01520922|11088933|FG001|Treatment Phase|Physician Decision|1
7017110|NCT01520922|11088932|FG000|Treatment Phase|Progression|0
7017111|NCT01520922|11088933|FG001|Treatment Phase|Progression|2
7017112|NCT01520922|11088932|FG000|Treatment Phase|Adverse Event|3
7017113|NCT01520922|11088933|FG001|Treatment Phase|Adverse Event|5
7017114|NCT01520922|11088932|FG000|Follow up|Lost to Follow-up|0
7017115|NCT01520922|11088933|FG001|Follow up|Lost to Follow-up|1
7017116|NCT01520922|11088932|FG000|Survival Follow-up|Withdrawal by Subject|1
7017117|NCT01520922|11088933|FG001|Survival Follow-up|Withdrawal by Subject|0
7017118|NCT01520987|11088947|FG000|Overall Study|Withdrawal by Subject|1
7017119|NCT01520987|11088948|FG001|Overall Study|Withdrawal by Subject|0
7017120|NCT01520987|11088949|FG002|Overall Study|Withdrawal by Subject|0
7017121|NCT01520987|11088950|FG003|Overall Study|Withdrawal by Subject|0
7017122|NCT01520987|11088951|FG004|Overall Study|Withdrawal by Subject|0
7017123|NCT01520987|11088952|FG005|Overall Study|Withdrawal by Subject|1
7017124|NCT01520987|11088953|FG006|Overall Study|Withdrawal by Subject|0
7017125|NCT01520987|11088954|FG007|Overall Study|Withdrawal by Subject|0
7017126|NCT01521117|11088979|FG000|First Intervention (6 Weeks)|Adverse Event|5
7017127|NCT01521117|11088980|FG001|First Intervention (6 Weeks)|Adverse Event|1
7017128|NCT01521117|11088979|FG000|First Intervention (6 Weeks)|Scheduling Issues|0
7017129|NCT01521117|11088980|FG001|First Intervention (6 Weeks)|Scheduling Issues|2
7017130|NCT01521117|11088979|FG000|Second Intervention (6 Weeks)|Adverse Event|0
7017131|NCT01521117|11088980|FG001|Second Intervention (6 Weeks)|Adverse Event|3
7017132|NCT01521364|11088995|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1
7017133|NCT01521364|11088995|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1
7017134|NCT01521494|11089011|FG000|Overall Study|Adverse Event|1
7017135|NCT01521494|11089012|FG001|Overall Study|Adverse Event|2
7017136|NCT01521494|11089013|FG002|Overall Study|Adverse Event|9
7017137|NCT01521494|11089014|FG003|Overall Study|Adverse Event|6
7017138|NCT01521494|11089015|FG004|Overall Study|Adverse Event|2
7017139|NCT01521494|11089011|FG000|Overall Study|Lack of Efficacy|0
7017140|NCT01521494|11089012|FG001|Overall Study|Lack of Efficacy|0
7017141|NCT01521494|11089013|FG002|Overall Study|Lack of Efficacy|0
7017142|NCT01521494|11089014|FG003|Overall Study|Lack of Efficacy|0
7017143|NCT01521494|11089015|FG004|Overall Study|Lack of Efficacy|2
7017144|NCT01521494|11089011|FG000|Overall Study|Withdrawal by Subject|1
7017145|NCT01521494|11089012|FG001|Overall Study|Withdrawal by Subject|1
7017146|NCT01521494|11089013|FG002|Overall Study|Withdrawal by Subject|0
7017147|NCT01521494|11089014|FG003|Overall Study|Withdrawal by Subject|2
7017148|NCT01521494|11089015|FG004|Overall Study|Withdrawal by Subject|0
7017149|NCT01521494|11089011|FG000|Overall Study|Decrease in serum phosphate|0
7017150|NCT01521494|11089012|FG001|Overall Study|Decrease in serum phosphate|2
7017151|NCT01521494|11089013|FG002|Overall Study|Decrease in serum phosphate|3
7017152|NCT01521494|11089014|FG003|Overall Study|Decrease in serum phosphate|12
7017153|NCT01521494|11089015|FG004|Overall Study|Decrease in serum phosphate|0
7017154|NCT01521494|11089011|FG000|Overall Study|Decrease in serum calcium|0
7017155|NCT01521494|11089012|FG001|Overall Study|Decrease in serum calcium|0
7017156|NCT01521494|11089013|FG002|Overall Study|Decrease in serum calcium|0
7017157|NCT01521494|11089014|FG003|Overall Study|Decrease in serum calcium|1
7017158|NCT01521494|11089015|FG004|Overall Study|Decrease in serum calcium|1
7017159|NCT01521494|11089011|FG000|Overall Study|Physician Decision|0
7017160|NCT01521494|11089012|FG001|Overall Study|Physician Decision|0
7017161|NCT01521494|11089013|FG002|Overall Study|Physician Decision|0
7017162|NCT01521494|11089014|FG003|Overall Study|Physician Decision|0
7017163|NCT01521494|11089015|FG004|Overall Study|Physician Decision|2
7017164|NCT01521507|11089029|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2
7017165|NCT01521507|11089030|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0
7017166|NCT01521507|11089029|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1
7017167|NCT01521507|11089030|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3
7017168|NCT01521507|11089029|FG000|Stage 1: Randomized Design|Lost to Follow-up|0
7017169|NCT01521507|11089030|FG001|Stage 1: Randomized Design|Lost to Follow-up|2
7017170|NCT01521507|11089029|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0
7017171|NCT01521507|11089030|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1
7017172|NCT01521507|11089029|FG000|Stage 2: Observational Design|Withdrawal by Subject|3
7017173|NCT01521507|11089030|FG001|Stage 2: Observational Design|Withdrawal by Subject|1
7017174|NCT01521507|11089029|FG000|Stage 2: Observational Design|Physician Decision|1
7017175|NCT01521507|11089030|FG001|Stage 2: Observational Design|Physician Decision|0
7017176|NCT01521559|11089054|FG000|Overall Study|Adverse Event|0
7017177|NCT01521559|11089055|FG001|Overall Study|Adverse Event|4
7017178|NCT01521559|11089054|FG000|Overall Study|Death|1
7017179|NCT01521559|11089055|FG001|Overall Study|Death|0
7017180|NCT01521559|11089054|FG000|Overall Study|Withdrawal by Subject|9
7017181|NCT01521559|11089055|FG001|Overall Study|Withdrawal by Subject|11
7017182|NCT01521559|11089054|FG000|Overall Study|Lost to Follow-up|3
7017183|NCT01521559|11089055|FG001|Overall Study|Lost to Follow-up|1
7017184|NCT01521559|11089054|FG000|Overall Study|Protocol Violation|1
7017185|NCT01521559|11089055|FG001|Overall Study|Protocol Violation|0
7017186|NCT01521559|11089054|FG000|Overall Study|Other|1
7017187|NCT01521559|11089055|FG001|Overall Study|Other|2
7017188|NCT01521884|11089091|FG000|Overall Study|Non Responders|10
7017189|NCT01521884|11089091|FG000|Overall Study|Adverse Event|5
7017190|NCT01521884|11089091|FG000|Overall Study|Pregnancy|1
7017191|NCT01521884|11089091|FG000|Overall Study|Withdrawal by Subject|1
7017192|NCT01521884|11089091|FG000|Overall Study|Physician Decision|2
7017193|NCT01521884|11089091|FG000|Overall Study|Protocol Violation|3
7017194|NCT01521884|11089091|FG000|Overall Study|Participant non-eligible|1
7017195|NCT01521884|11089091|FG000|Overall Study|Lost to Follow-up|4
7017196|NCT01521897|11089095|FG000|Overall Study|Protocol Violation|18
7017197|NCT01521897|11089095|FG000|Overall Study|Lost to Follow-up|5
7017198|NCT01521923|11089103|FG000|Overall Study|AE, serious fatal|1
7017199|NCT01521923|11089104|FG001|Overall Study|AE, serious fatal|0
7017200|NCT01521923|11089105|FG002|Overall Study|AE, serious fatal|0
7017201|NCT01521923|11089106|FG003|Overall Study|AE, serious fatal|0
7017202|NCT01521923|11089103|FG000|Overall Study|SAE, non-fatal|0
7017203|NCT01521923|11089104|FG001|Overall Study|SAE, non-fatal|2
7017204|NCT01521923|11089105|FG002|Overall Study|SAE, non-fatal|2
7017205|NCT01521923|11089106|FG003|Overall Study|SAE, non-fatal|0
7017206|NCT01521923|11089103|FG000|Overall Study|AE, non-serious, non-fatal|1
7017207|NCT01521923|11089104|FG001|Overall Study|AE, non-serious, non-fatal|3
7017208|NCT01521923|11089105|FG002|Overall Study|AE, non-serious, non-fatal|6
7017209|NCT01521923|11089106|FG003|Overall Study|AE, non-serious, non-fatal|2
7017210|NCT01521923|11089103|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
7017211|NCT01521923|11089104|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
7017212|NCT01521923|11089105|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
7017213|NCT01521923|11089106|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1
7017214|NCT01521923|11089103|FG000|Overall Study|Lack of Efficacy|1
7017215|NCT01521923|11089104|FG001|Overall Study|Lack of Efficacy|1
7017216|NCT01521923|11089105|FG002|Overall Study|Lack of Efficacy|0
7017217|NCT01521923|11089106|FG003|Overall Study|Lack of Efficacy|0
7017218|NCT01521923|11089103|FG000|Overall Study|Protocol Violation|0
7017219|NCT01521923|11089104|FG001|Overall Study|Protocol Violation|0
7017220|NCT01521923|11089105|FG002|Overall Study|Protocol Violation|1
7017221|NCT01521923|11089106|FG003|Overall Study|Protocol Violation|0
7017222|NCT01521923|11089103|FG000|Overall Study|Lost to Follow-up|1
7017223|NCT01521923|11089104|FG001|Overall Study|Lost to Follow-up|0
7017224|NCT01521923|11089105|FG002|Overall Study|Lost to Follow-up|2
7017225|NCT01521923|11089106|FG003|Overall Study|Lost to Follow-up|1
7017226|NCT01521923|11089103|FG000|Overall Study|Withdrawal by Subject|1
7017227|NCT01521923|11089104|FG001|Overall Study|Withdrawal by Subject|1
7017228|NCT01521923|11089105|FG002|Overall Study|Withdrawal by Subject|1
7017229|NCT01521923|11089106|FG003|Overall Study|Withdrawal by Subject|2
7017230|NCT01521923|11089103|FG000|Overall Study|Other|2
7017231|NCT01521923|11089104|FG001|Overall Study|Other|1
7017232|NCT01521923|11089105|FG002|Overall Study|Other|3
7017233|NCT01521923|11089106|FG003|Overall Study|Other|6
7017234|NCT01521923|11089103|FG000|Overall Study|AE, captured in Period 1|0
7017235|NCT01521923|11089104|FG001|Overall Study|AE, captured in Period 1|1
7017236|NCT01521923|11089105|FG002|Overall Study|AE, captured in Period 1|0
7017237|NCT01521923|11089106|FG003|Overall Study|AE, captured in Period 1|1
7017238|NCT01522235|11089134|FG000|Overall Study|Physician Decision|1
7017239|NCT01522235|11089135|FG001|Overall Study|Physician Decision|1
7017240|NCT01522248|11089147|FG000|Overall Study|Lost to Follow-up|1
7017241|NCT01522248|11089148|FG001|Overall Study|Lost to Follow-up|0
7017242|NCT01522404|11089175|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1
7017243|NCT01522404|11089176|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0
7017244|NCT01522404|11089175|FG000|First Intervention (up to Week 29)|Adverse Event|1
7017245|NCT01522404|11089176|FG001|First Intervention (up to Week 29)|Adverse Event|0
7017246|NCT01522404|11089175|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1
7017247|NCT01522404|11089176|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0
7017248|NCT01522443|11089205|FG000|Overall Study|No longer receiving clinical benefit|36
7017249|NCT01522443|11089206|FG001|Overall Study|No longer receiving clinical benefit|28
7017250|NCT01522443|11089205|FG000|Overall Study|Adverse Event|10
7017251|NCT01522443|11089206|FG001|Overall Study|Adverse Event|15
7017252|NCT01522443|11089205|FG000|Overall Study|Withdrawal by Subject|5
7017253|NCT01522443|11089206|FG001|Overall Study|Withdrawal by Subject|8
7017254|NCT01522443|11089205|FG000|Overall Study|No study treatment given|1
7017255|NCT01522443|11089206|FG001|Overall Study|No study treatment given|1
7017256|NCT01522443|11089205|FG000|Overall Study|Other|1
7017257|NCT01522443|11089206|FG001|Overall Study|Other|3
7017258|NCT01522456|11089212|FG000|Overall Study|Adverse Event|2
7017259|NCT01522456|11089212|FG000|Overall Study|Lost to Follow-up|2
7017260|NCT01522456|11089212|FG000|Overall Study|Withdrawal by Subject|2
7017261|NCT01522456|11089212|FG000|Overall Study|Pregnancy|1
7017262|NCT01522456|11089212|FG000|Overall Study|Tolerability Assessment|1
7017263|NCT01522651|11089228|FG000|Overall Study|Adverse Event|3
7017264|NCT01522651|11089229|FG001|Overall Study|Adverse Event|4
7017265|NCT01522651|11089230|FG002|Overall Study|Adverse Event|4
7017266|NCT01522651|11089231|FG003|Overall Study|Adverse Event|5
7017267|NCT01522651|11089232|FG004|Overall Study|Adverse Event|4
7017268|NCT01522651|11089228|FG000|Overall Study|Cardioversion|1
7017269|NCT01522651|11089229|FG001|Overall Study|Cardioversion|0
7017270|NCT01522651|11089230|FG002|Overall Study|Cardioversion|0
7017271|NCT01522651|11089231|FG003|Overall Study|Cardioversion|0
7017272|NCT01522651|11089232|FG004|Overall Study|Cardioversion|0
7017273|NCT01522651|11089228|FG000|Overall Study|Device Malfunction|0
7017274|NCT01522651|11089229|FG001|Overall Study|Device Malfunction|1
7017275|NCT01522651|11089230|FG002|Overall Study|Device Malfunction|0
7017276|NCT01522651|11089231|FG003|Overall Study|Device Malfunction|0
7017277|NCT01522651|11089232|FG004|Overall Study|Device Malfunction|0
7017278|NCT01522651|11089228|FG000|Overall Study|Investigator's Discretion|0
7017279|NCT01522651|11089229|FG001|Overall Study|Investigator's Discretion|1
7017280|NCT01522651|11089230|FG002|Overall Study|Investigator's Discretion|0
7017281|NCT01522651|11089231|FG003|Overall Study|Investigator's Discretion|0
7017282|NCT01522651|11089232|FG004|Overall Study|Investigator's Discretion|0
7017283|NCT01522651|11089228|FG000|Overall Study|Protocol Violation|3
7017284|NCT01522651|11089229|FG001|Overall Study|Protocol Violation|0
7017285|NCT01522651|11089230|FG002|Overall Study|Protocol Violation|0
7017286|NCT01522651|11089231|FG003|Overall Study|Protocol Violation|0
7017287|NCT01522651|11089232|FG004|Overall Study|Protocol Violation|0
7017288|NCT01522651|11089228|FG000|Overall Study|Reason Not Specified|0
7017289|NCT01522651|11089229|FG001|Overall Study|Reason Not Specified|0
7017290|NCT01522651|11089230|FG002|Overall Study|Reason Not Specified|0
7017291|NCT01522651|11089231|FG003|Overall Study|Reason Not Specified|1
7017292|NCT01522651|11089232|FG004|Overall Study|Reason Not Specified|0
7017293|NCT01522651|11089228|FG000|Overall Study|Participant Non-Compliance|1
7017294|NCT01522651|11089229|FG001|Overall Study|Participant Non-Compliance|0
7017295|NCT01522651|11089230|FG002|Overall Study|Participant Non-Compliance|0
7017296|NCT01522651|11089231|FG003|Overall Study|Participant Non-Compliance|0
7017297|NCT01522651|11089232|FG004|Overall Study|Participant Non-Compliance|0
7017298|NCT01522651|11089228|FG000|Overall Study|Withdrew Consent|1
7017299|NCT01522651|11089229|FG001|Overall Study|Withdrew Consent|1
7017300|NCT01522651|11089230|FG002|Overall Study|Withdrew Consent|0
7017301|NCT01522651|11089231|FG003|Overall Study|Withdrew Consent|1
7017302|NCT01522651|11089232|FG004|Overall Study|Withdrew Consent|1
7017303|NCT01522651|11089228|FG000|Overall Study|Randomized but Never Treated|0
7017304|NCT01522651|11089229|FG001|Overall Study|Randomized but Never Treated|1
7017305|NCT01522651|11089230|FG002|Overall Study|Randomized but Never Treated|0
7017306|NCT01522651|11089231|FG003|Overall Study|Randomized but Never Treated|1
7017307|NCT01522651|11089232|FG004|Overall Study|Randomized but Never Treated|1
7017308|NCT01522950|11089274|FG000|Overall Study|Withdrawal by Subject|3
7017309|NCT01522950|11089275|FG001|Overall Study|Withdrawal by Subject|2
7017310|NCT01522950|11089276|FG002|Overall Study|Withdrawal by Subject|1
7017311|NCT01522950|11089274|FG000|Overall Study|Adverse Event|3
7017312|NCT01522950|11089275|FG001|Overall Study|Adverse Event|1
7017313|NCT01522950|11089276|FG002|Overall Study|Adverse Event|1
7017314|NCT01522950|11089274|FG000|Overall Study|Protocol Violation|0
7017315|NCT01522950|11089275|FG001|Overall Study|Protocol Violation|0
7017316|NCT01522950|11089276|FG002|Overall Study|Protocol Violation|2
7017317|NCT01522950|11089274|FG000|Overall Study|Death|0
7017318|NCT01522950|11089275|FG001|Overall Study|Death|1
7017319|NCT01522950|11089276|FG002|Overall Study|Death|1
7017320|NCT01522950|11089274|FG000|Overall Study|Study Medication Sensitivity|0
7017321|NCT01522950|11089275|FG001|Overall Study|Study Medication Sensitivity|1
7017322|NCT01522950|11089276|FG002|Overall Study|Study Medication Sensitivity|0
7017323|NCT01523275|11089301|FG000|Overall Study|Lost to Follow-up|1
7017324|NCT01523275|11089302|FG001|Overall Study|Lost to Follow-up|2
7017325|NCT01523275|11089301|FG000|Overall Study|Withdrawal by Subject|1
7017326|NCT01523275|11089302|FG001|Overall Study|Withdrawal by Subject|0
7017327|NCT01523301|11089310|FG000|Overall Study|Adverse Event|25
7017328|NCT01523301|11089311|FG001|Overall Study|Adverse Event|16
7017329|NCT01523301|11089310|FG000|Overall Study|Lack of Efficacy|0
7017330|NCT01523301|11089311|FG001|Overall Study|Lack of Efficacy|2
7017331|NCT01523301|11089310|FG000|Overall Study|Protocol Violation|3
7017332|NCT01523301|11089311|FG001|Overall Study|Protocol Violation|4
7017333|NCT01523301|11089310|FG000|Overall Study|Lost to Follow-up|1
7017334|NCT01523301|11089311|FG001|Overall Study|Lost to Follow-up|0
7017335|NCT01523301|11089310|FG000|Overall Study|Withdrawal by Subject|6
7017336|NCT01523301|11089311|FG001|Overall Study|Withdrawal by Subject|8
7017337|NCT01523301|11089310|FG000|Overall Study|Other Reason|0
7017338|NCT01523301|11089311|FG001|Overall Study|Other Reason|2
7017339|NCT01523366|11089319|FG000|Treatment Period 1|Withdrawal by Subject|1
7017340|NCT01523366|11089320|FG001|Treatment Period 1|Withdrawal by Subject|0
7017341|NCT01523366|11089319|FG000|Treatment Period 2|Not completed at least 7 days treatment|1
7017342|NCT01523366|11089320|FG001|Treatment Period 2|Not completed at least 7 days treatment|0
7017343|NCT01523392|11089330|FG000|Treatment Period 1|Withdrawal by Subject|2
7017344|NCT01523392|11089331|FG001|Treatment Period 1|Withdrawal by Subject|0
7017345|NCT01523392|11089330|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1
7017346|NCT01523392|11089331|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0
7017347|NCT01523392|11089330|FG000|Washout Period - 10 to 14 Days|Adverse Event|1
7017348|NCT01523392|11089331|FG001|Washout Period - 10 to 14 Days|Adverse Event|0
7017349|NCT01523457|11089341|FG000|Overall Study|Withdrawal by Subject|7
7017350|NCT01523457|11089342|FG001|Overall Study|Withdrawal by Subject|2
7017351|NCT01523587|11089371|FG000|Overall Study|Other than listed|5
7017352|NCT01523587|11089372|FG001|Overall Study|Other than listed|5
7017353|NCT01523587|11089371|FG000|Overall Study|Worsening of underlying cancer disease|19
7017354|NCT01523587|11089372|FG001|Overall Study|Worsening of underlying cancer disease|34
7017355|NCT01523587|11089371|FG000|Overall Study|Adverse Event|68
7017356|NCT01523587|11089372|FG001|Overall Study|Adverse Event|52
7017357|NCT01523587|11089371|FG000|Overall Study|Protocol Violation|5
7017358|NCT01523587|11089372|FG001|Overall Study|Protocol Violation|3
7017359|NCT01523587|11089371|FG000|Overall Study|Lost to Follow-up|2
7017360|NCT01523587|11089372|FG001|Overall Study|Lost to Follow-up|2
7017361|NCT01523587|11089371|FG000|Overall Study|Withdrawal by Subject|28
7017362|NCT01523587|11089372|FG001|Overall Study|Withdrawal by Subject|20
7017363|NCT01523587|11089371|FG000|Overall Study|Withdrew due to Progressive disease|265
7017364|NCT01523587|11089372|FG001|Overall Study|Withdrew due to Progressive disease|279
7017365|NCT01523587|11089371|FG000|Overall Study|Randomised but bot treated|6
7017366|NCT01523587|11089372|FG001|Overall Study|Randomised but bot treated|2
7017367|NCT01523743|11089401|FG000|Period 1|Adverse Event|1
7017368|NCT01523743|11089402|FG001|Period 1|Adverse Event|0
7017369|NCT01523743|11089401|FG000|Period 1|Withdrawal by Subject|6
7017370|NCT01523743|11089402|FG001|Period 1|Withdrawal by Subject|2
7017371|NCT01523743|11089401|FG000|Period 1|Lost to Follow-up|1
7017372|NCT01523743|11089402|FG001|Period 1|Lost to Follow-up|0
7017373|NCT01523743|11089401|FG000|Period 1|Lack of Efficacy|1
7017374|NCT01523743|11089402|FG001|Period 1|Lack of Efficacy|0
7017375|NCT01523743|11089401|FG000|Period 1|Felt unable to empty bladder|1
7017376|NCT01523743|11089402|FG001|Period 1|Felt unable to empty bladder|0
7017377|NCT01523743|11089401|FG000|Period 2|Withdrawal by Subject|0
7017378|NCT01523743|11089402|FG001|Period 2|Withdrawal by Subject|2
7017379|NCT01523743|11089401|FG000|Period 2|Adverse Event|1
7017380|NCT01523743|11089402|FG001|Period 2|Adverse Event|0
7017381|NCT01523756|11089408|FG000|Baseline Period|Adverse Event|0
7017382|NCT01523756|11089409|FG001|Baseline Period|Adverse Event|1
7017383|NCT01523756|11089408|FG000|Test Period 1|Adverse Event|1
7017384|NCT01523756|11089409|FG001|Test Period 1|Adverse Event|0
7017385|NCT01523756|11089408|FG000|Test Period 2|Withdrawal by Subject|0
7017386|NCT01523756|11089409|FG001|Test Period 2|Withdrawal by Subject|1
7043674|NCT01746901|11128862|FG007|Naloxone Challenge Phase|Adverse Event|0
7043675|NCT01746901|11128863|FG008|Naloxone Challenge Phase|Adverse Event|0
7043676|NCT01746901|11128855|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1
7043677|NCT01746901|11128856|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0
7043678|NCT01746901|11128857|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0
7043679|NCT01746901|11128858|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0
7043680|NCT01746901|11128859|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0
7043681|NCT01746901|11128860|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0
7043682|NCT01746901|11128861|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0
7043683|NCT01746901|11128862|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0
7043684|NCT01746901|11128863|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0
7043685|NCT01746901|11128855|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0
7043686|NCT01746901|11128856|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3
7043687|NCT01746901|11128857|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0
7043688|NCT01746901|11128858|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0
7043689|NCT01746901|11128859|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0
7043690|NCT01746901|11128860|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0
7043691|NCT01746901|11128861|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0
7043692|NCT01746901|11128862|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0
7043693|NCT01746901|11128863|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0
7043694|NCT01746901|11128855|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0
7043695|NCT01746901|11128856|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2
7043696|NCT01746901|11128857|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1
7043697|NCT01746901|11128858|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0
7043698|NCT01746901|11128859|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0
7043699|NCT01746901|11128860|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0
7043700|NCT01746901|11128861|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0
7043701|NCT01746901|11128862|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0
7043702|NCT01746901|11128863|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0
7043703|NCT01746901|11128855|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
7043704|NCT01746901|11128856|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9
7043705|NCT01746901|11128857|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10
7043706|NCT01746901|11128858|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
7043707|NCT01746901|11128859|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
7043708|NCT01746901|11128860|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
7043709|NCT01746901|11128861|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
7043710|NCT01746901|11128862|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
7043711|NCT01746901|11128863|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
7043712|NCT01746901|11128855|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0
7043713|NCT01746901|11128856|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3
7043714|NCT01746901|11128857|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3
7043715|NCT01746901|11128858|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0
7043716|NCT01746901|11128859|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0
7043717|NCT01746901|11128860|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0
7043718|NCT01746901|11128861|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0
7043719|NCT01746901|11128862|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0
7043720|NCT01746901|11128863|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0
7043721|NCT01746901|11128855|FG000|Treatment Phase: First Intervention|Protocol Violation|0
7043722|NCT01746901|11128856|FG001|Treatment Phase: First Intervention|Protocol Violation|0
7017387|NCT01523873|11089474|FG000|Overall Study|Protocol Violation|422
7017388|NCT01523886|11089482|FG000|Overall Study|surgery cancelled|0
7017389|NCT01523886|11089483|FG001|Overall Study|surgery cancelled|1
7017390|NCT01524133|11089519|FG000|Treatment Phase|Withdrawal by Subject|13
7017391|NCT01524133|11089520|FG001|Treatment Phase|Withdrawal by Subject|28
7017392|NCT01524133|11089521|FG002|Treatment Phase|Withdrawal by Subject|31
7017393|NCT01524133|11089519|FG000|Treatment Phase|Physician Decision|6
7017394|NCT01524133|11089520|FG001|Treatment Phase|Physician Decision|3
7017395|NCT01524133|11089521|FG002|Treatment Phase|Physician Decision|3
7017396|NCT01524133|11089519|FG000|Treatment Phase|Lost to Follow-up|0
7017397|NCT01524133|11089520|FG001|Treatment Phase|Lost to Follow-up|1
7017398|NCT01524133|11089521|FG002|Treatment Phase|Lost to Follow-up|2
7017399|NCT01524133|11089519|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4
7017400|NCT01524133|11089520|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5
7017401|NCT01524133|11089521|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10
7017402|NCT01524133|11089519|FG000|Overall Study 52 Weeks|Physician Decision|1
7017403|NCT01524133|11089520|FG001|Overall Study 52 Weeks|Physician Decision|0
7017404|NCT01524133|11089521|FG002|Overall Study 52 Weeks|Physician Decision|2
7017405|NCT01524133|11089519|FG000|Overall Study 52 Weeks|Lost to Follow-up|16
7017406|NCT01524133|11089520|FG001|Overall Study 52 Weeks|Lost to Follow-up|15
7017407|NCT01524133|11089521|FG002|Overall Study 52 Weeks|Lost to Follow-up|15
7017408|NCT01524198|11089531|FG000|Overall Study|Protocol Violation|8
7017409|NCT01524198|11089532|FG001|Overall Study|Protocol Violation|6
7017410|NCT01524198|11089531|FG000|Overall Study|Withdrawal by Subject|15
7017411|NCT01524198|11089532|FG001|Overall Study|Withdrawal by Subject|10
7017412|NCT01524224|11089546|FG000|Overall Study|Progressive Disease|1
7017413|NCT01524224|11089547|FG001|Overall Study|Progressive Disease|0
7017414|NCT01524224|11089548|FG002|Overall Study|Progressive Disease|2
7017415|NCT01524224|11089549|FG003|Overall Study|Progressive Disease|1
7017416|NCT01524224|11089550|FG004|Overall Study|Progressive Disease|2
7017417|NCT01524224|11089551|FG005|Overall Study|Progressive Disease|1
7017418|NCT01524224|11089552|FG006|Overall Study|Progressive Disease|1
7017419|NCT01524224|11089553|FG007|Overall Study|Progressive Disease|5
7017420|NCT01524224|11089546|FG000|Overall Study|Withdrawal by Subject|2
7017421|NCT01524224|11089547|FG001|Overall Study|Withdrawal by Subject|0
7017422|NCT01524224|11089548|FG002|Overall Study|Withdrawal by Subject|0
7017423|NCT01524224|11089549|FG003|Overall Study|Withdrawal by Subject|0
7017424|NCT01524224|11089550|FG004|Overall Study|Withdrawal by Subject|0
7017425|NCT01524224|11089551|FG005|Overall Study|Withdrawal by Subject|0
7017426|NCT01524224|11089552|FG006|Overall Study|Withdrawal by Subject|2
7017427|NCT01524224|11089553|FG007|Overall Study|Withdrawal by Subject|0
7017428|NCT01524224|11089546|FG000|Overall Study|Adverse Event|0
7017429|NCT01524224|11089547|FG001|Overall Study|Adverse Event|1
7017430|NCT01524224|11089548|FG002|Overall Study|Adverse Event|0
7017431|NCT01524224|11089549|FG003|Overall Study|Adverse Event|0
7017432|NCT01524224|11089550|FG004|Overall Study|Adverse Event|0
7017433|NCT01524224|11089551|FG005|Overall Study|Adverse Event|1
7017434|NCT01524224|11089552|FG006|Overall Study|Adverse Event|0
7017435|NCT01524224|11089553|FG007|Overall Study|Adverse Event|0
7017436|NCT01524224|11089546|FG000|Overall Study|Physician Decision|0
7017437|NCT01524224|11089547|FG001|Overall Study|Physician Decision|0
7017438|NCT01524224|11089548|FG002|Overall Study|Physician Decision|0
7017439|NCT01524224|11089549|FG003|Overall Study|Physician Decision|1
7017440|NCT01524224|11089550|FG004|Overall Study|Physician Decision|1
7017441|NCT01524224|11089551|FG005|Overall Study|Physician Decision|0
7017442|NCT01524224|11089552|FG006|Overall Study|Physician Decision|0
7017443|NCT01524224|11089553|FG007|Overall Study|Physician Decision|1
7017444|NCT01524224|11089546|FG000|Overall Study|Sponsor Decision|0
7017445|NCT01524224|11089547|FG001|Overall Study|Sponsor Decision|0
7017446|NCT01524224|11089548|FG002|Overall Study|Sponsor Decision|0
7017447|NCT01524224|11089549|FG003|Overall Study|Sponsor Decision|0
7017448|NCT01524224|11089550|FG004|Overall Study|Sponsor Decision|1
7017449|NCT01524224|11089551|FG005|Overall Study|Sponsor Decision|0
7017450|NCT01524224|11089552|FG006|Overall Study|Sponsor Decision|0
7017451|NCT01524224|11089553|FG007|Overall Study|Sponsor Decision|0
7017452|NCT01524289|11089573|FG000|Overall Study|Lost to Follow-up|0
7017453|NCT01524289|11089574|FG001|Overall Study|Lost to Follow-up|1
7017454|NCT01524289|11089573|FG000|Overall Study|Physician Decision|1
7017455|NCT01524289|11089574|FG001|Overall Study|Physician Decision|0
7017456|NCT01524289|11089573|FG000|Overall Study|Protocol Violation|5
7017457|NCT01524289|11089574|FG001|Overall Study|Protocol Violation|1
7017458|NCT01524289|11089573|FG000|Overall Study|Withdrawal by Subject|11
7017459|NCT01524289|11089574|FG001|Overall Study|Withdrawal by Subject|7
7017460|NCT01524289|11089573|FG000|Overall Study|Adverse Event|12
7017461|NCT01524289|11089574|FG001|Overall Study|Adverse Event|5
7017462|NCT01524289|11089573|FG000|Overall Study|Did not take study medication|1
7017463|NCT01524289|11089574|FG001|Overall Study|Did not take study medication|0
7017464|NCT01524627|11089597|FG000|Overall Study|Physician Decision|0
7017465|NCT01524627|11089598|FG001|Overall Study|Physician Decision|1
7017466|NCT01524627|11089597|FG000|Overall Study|Lost to Follow-up|1
7017467|NCT01524627|11089598|FG001|Overall Study|Lost to Follow-up|1
7017468|NCT01524679|11089606|FG000|Overall Study|Lost to Follow-up|1
7017469|NCT01524679|11089607|FG001|Overall Study|Lost to Follow-up|4
7017470|NCT01524679|11089606|FG000|Overall Study|Withdrawal by Subject|4
7017471|NCT01524679|11089607|FG001|Overall Study|Withdrawal by Subject|4
7017472|NCT01524679|11089606|FG000|Overall Study|Adverse Event|9
7017473|NCT01524679|11089607|FG001|Overall Study|Adverse Event|0
7017474|NCT01524679|11089606|FG000|Overall Study|Protocol Violation|1
7017475|NCT01524679|11089607|FG001|Overall Study|Protocol Violation|0
7017476|NCT01524679|11089606|FG000|Overall Study|Lack of Efficacy|2
7017477|NCT01524679|11089607|FG001|Overall Study|Lack of Efficacy|0
7017478|NCT01524679|11089606|FG000|Overall Study|e.g.wish for children, relocation|6
7017479|NCT01524679|11089607|FG001|Overall Study|e.g.wish for children, relocation|1
7017480|NCT01524692|11089613|FG000|Overall Study|Withdrawal by Subject|3
7017481|NCT01524770|11089618|FG000|First Intervention|Withdrawal by Subject|1
7017482|NCT01524770|11089619|FG001|First Intervention|Withdrawal by Subject|0
7017483|NCT01524770|11089618|FG000|First Intervention|Adverse Event|1
7017484|NCT01524770|11089619|FG001|First Intervention|Adverse Event|1
7017485|NCT01524770|11089618|FG000|First Intervention|Protocol Violation|1
7017486|NCT01524770|11089619|FG001|First Intervention|Protocol Violation|0
7017487|NCT01524783|11089627|FG000|Blinded Period|Adverse Event|64
7017488|NCT01524783|11089628|FG001|Blinded Period|Adverse Event|7
7017489|NCT01524783|11089629|FG002|Blinded Period|Adverse Event|0
7017490|NCT01524783|11089627|FG000|Blinded Period|Disease Progression|89
7017491|NCT01524783|11089628|FG001|Blinded Period|Disease Progression|75
7017492|NCT01524783|11089629|FG002|Blinded Period|Disease Progression|0
7017493|NCT01524783|11089627|FG000|Blinded Period|Withdrawal by Subject|19
7017494|NCT01524783|11089628|FG001|Blinded Period|Withdrawal by Subject|6
7017495|NCT01524783|11089629|FG002|Blinded Period|Withdrawal by Subject|0
7017496|NCT01524783|11089627|FG000|Blinded Period|Protocol deviation|2
7017497|NCT01524783|11089628|FG001|Blinded Period|Protocol deviation|1
7017498|NCT01524783|11089629|FG002|Blinded Period|Protocol deviation|0
7017499|NCT01524783|11089627|FG000|Blinded Period|Death|5
7017500|NCT01524783|11089628|FG001|Blinded Period|Death|2
7017501|NCT01524783|11089629|FG002|Blinded Period|Death|0
7017502|NCT01524783|11089627|FG000|Open-label Period|Disease progression|13
7017503|NCT01524783|11089628|FG001|Open-label Period|Disease progression|0
7017504|NCT01524783|11089629|FG002|Open-label Period|Disease progression|2
7017505|NCT01524783|11089627|FG000|Open-label Period|Administrative problems|5
7017506|NCT01524783|11089628|FG001|Open-label Period|Administrative problems|0
7017507|NCT01524783|11089629|FG002|Open-label Period|Administrative problems|2
7017508|NCT01524783|11089627|FG000|Open-label Period|Adverse Event|5
7017509|NCT01524783|11089628|FG001|Open-label Period|Adverse Event|0
7017510|NCT01524783|11089629|FG002|Open-label Period|Adverse Event|1
7017511|NCT01524783|11089627|FG000|Open-label Period|Withdrawal by Subject|2
7017512|NCT01524783|11089628|FG001|Open-label Period|Withdrawal by Subject|0
7017513|NCT01524783|11089629|FG002|Open-label Period|Withdrawal by Subject|1
7017514|NCT01524783|11089627|FG000|Open-label Period|Protocol deviation|1
7017515|NCT01524783|11089628|FG001|Open-label Period|Protocol deviation|0
7017516|NCT01524783|11089629|FG002|Open-label Period|Protocol deviation|0
7017517|NCT01524796|11089641|FG000|Overall Study|Adverse Event|13
7017518|NCT01524796|11089641|FG000|Overall Study|Lack of Efficacy|3
7017519|NCT01524796|11089641|FG000|Overall Study|Lost to Follow-up|1
7017520|NCT01524796|11089641|FG000|Overall Study|The price|1
7017521|NCT01524796|11089641|FG000|Overall Study|Withdrawal by Subject|4
7017522|NCT01524796|11089641|FG000|Overall Study|Move|1
7017523|NCT01524796|11089641|FG000|Overall Study|Deterioration of pains|1
7017524|NCT01524796|11089641|FG000|Overall Study|Gall stone surgery|1
7017525|NCT01524796|11089641|FG000|Overall Study|Nervous about confidentiality|1
7017526|NCT01524796|11089641|FG000|Overall Study|Switch to carbamazapine|1
7017527|NCT01524796|11089641|FG000|Overall Study|Adverse Event and Lack of Efficacy|1
7017528|NCT01524887|11089648|FG000|Overall Study|Withdrawal by Subject|6
7017529|NCT01524887|11089649|FG001|Overall Study|Withdrawal by Subject|2
7017530|NCT01524887|11089650|FG002|Overall Study|Withdrawal by Subject|3
7017531|NCT01524887|11089648|FG000|Overall Study|Adverse Event|5
7017532|NCT01524887|11089649|FG001|Overall Study|Adverse Event|1
7017533|NCT01524887|11089650|FG002|Overall Study|Adverse Event|1
7017534|NCT01524887|11089648|FG000|Overall Study|Protocol Violation|0
7017535|NCT01524887|11089649|FG001|Overall Study|Protocol Violation|0
7017536|NCT01524887|11089650|FG002|Overall Study|Protocol Violation|1
7017537|NCT01524887|11089648|FG000|Overall Study|Study termination|73
7017538|NCT01524887|11089649|FG001|Overall Study|Study termination|87
7017539|NCT01524887|11089650|FG002|Overall Study|Study termination|79
7017540|NCT01524887|11089648|FG000|Overall Study|Withdrawal by Caregiver|0
7017541|NCT01524887|11089649|FG001|Overall Study|Withdrawal by Caregiver|0
7017542|NCT01524887|11089650|FG002|Overall Study|Withdrawal by Caregiver|2
7017543|NCT01524887|11089648|FG000|Overall Study|Use of prohibited medication|1
7017544|NCT01524887|11089649|FG001|Overall Study|Use of prohibited medication|0
7017545|NCT01524887|11089650|FG002|Overall Study|Use of prohibited medication|0
7017546|NCT01524900|11089663|FG000|Overall Study|Lost to Follow-up|3
7017547|NCT01524900|11089664|FG001|Overall Study|Lost to Follow-up|12
7017548|NCT01524900|11089665|FG002|Overall Study|Lost to Follow-up|1
7017549|NCT01524900|11089666|FG003|Overall Study|Lost to Follow-up|0
7017550|NCT01524900|11089667|FG004|Overall Study|Lost to Follow-up|0
7017551|NCT01524900|11089663|FG000|Overall Study|Other reason than stated above|1
7017552|NCT01524900|11089664|FG001|Overall Study|Other reason than stated above|1
7017553|NCT01524900|11089665|FG002|Overall Study|Other reason than stated above|0
7017554|NCT01524900|11089666|FG003|Overall Study|Other reason than stated above|0
7017555|NCT01524900|11089667|FG004|Overall Study|Other reason than stated above|0
7017556|NCT01524900|11089663|FG000|Overall Study|No reason documented|2
7017557|NCT01524900|11089664|FG001|Overall Study|No reason documented|1
7017558|NCT01524900|11089665|FG002|Overall Study|No reason documented|0
7017559|NCT01524900|11089666|FG003|Overall Study|No reason documented|1
7017560|NCT01524900|11089667|FG004|Overall Study|No reason documented|0
7017561|NCT01524913|11089683|FG000|Overall Study|Lost to Follow-up|4
7017562|NCT01524913|11089684|FG001|Overall Study|Lost to Follow-up|0
7017563|NCT01524913|11089685|FG002|Overall Study|Lost to Follow-up|0
7017564|NCT01524978|11089704|FG000|Overall Study|Other|16
7017565|NCT01524978|11089705|FG001|Overall Study|Other|2
7017566|NCT01524978|11089706|FG002|Overall Study|Other|1
7017567|NCT01524978|11089707|FG003|Overall Study|Other|2
7017568|NCT01524978|11089708|FG004|Overall Study|Other|1
7017569|NCT01524978|11089709|FG005|Overall Study|Other|3
7017570|NCT01524978|11089710|FG006|Overall Study|Other|17
7017571|NCT01524978|11089711|FG007|Overall Study|Other|1
7017572|NCT01524978|11089712|FG008|Overall Study|Other|2
7017573|NCT01524978|11089713|FG009|Overall Study|Other|2
7017574|NCT01524978|11089714|FG010|Overall Study|Other|5
7017575|NCT01524978|11089704|FG000|Overall Study|Withdrawal by Subject|12
7017576|NCT01524978|11089705|FG001|Overall Study|Withdrawal by Subject|0
7017577|NCT01524978|11089706|FG002|Overall Study|Withdrawal by Subject|1
7017578|NCT01524978|11089707|FG003|Overall Study|Withdrawal by Subject|1
7017579|NCT01524978|11089708|FG004|Overall Study|Withdrawal by Subject|3
7017580|NCT01524978|11089709|FG005|Overall Study|Withdrawal by Subject|1
7017581|NCT01524978|11089710|FG006|Overall Study|Withdrawal by Subject|6
7017582|NCT01524978|11089711|FG007|Overall Study|Withdrawal by Subject|2
7017583|NCT01524978|11089712|FG008|Overall Study|Withdrawal by Subject|4
7017584|NCT01524978|11089713|FG009|Overall Study|Withdrawal by Subject|0
7017585|NCT01524978|11089714|FG010|Overall Study|Withdrawal by Subject|5
7017586|NCT01524978|11089704|FG000|Overall Study|Lost to Follow-up|0
7017587|NCT01524978|11089705|FG001|Overall Study|Lost to Follow-up|0
7017588|NCT01524978|11089706|FG002|Overall Study|Lost to Follow-up|3
7017589|NCT01524978|11089707|FG003|Overall Study|Lost to Follow-up|0
7017590|NCT01524978|11089708|FG004|Overall Study|Lost to Follow-up|1
7017591|NCT01524978|11089709|FG005|Overall Study|Lost to Follow-up|1
7017592|NCT01524978|11089710|FG006|Overall Study|Lost to Follow-up|2
7017593|NCT01524978|11089711|FG007|Overall Study|Lost to Follow-up|0
7017594|NCT01524978|11089712|FG008|Overall Study|Lost to Follow-up|1
7017595|NCT01524978|11089713|FG009|Overall Study|Lost to Follow-up|1
7017596|NCT01524978|11089714|FG010|Overall Study|Lost to Follow-up|1
7017597|NCT01524978|11089704|FG000|Overall Study|Death|34
7017598|NCT01524978|11089705|FG001|Overall Study|Death|2
7017599|NCT01524978|11089706|FG002|Overall Study|Death|5
7017600|NCT01524978|11089707|FG003|Overall Study|Death|24
7017601|NCT01524978|11089708|FG004|Overall Study|Death|4
7017602|NCT01524978|11089709|FG005|Overall Study|Death|4
7017603|NCT01524978|11089710|FG006|Overall Study|Death|1
7017604|NCT01524978|11089711|FG007|Overall Study|Death|9
7017605|NCT01524978|11089712|FG008|Overall Study|Death|5
7017606|NCT01524978|11089713|FG009|Overall Study|Death|6
7017607|NCT01524978|11089714|FG010|Overall Study|Death|17
7017608|NCT01524991|11089729|FG000|Overall Study|Adverse Event|12
7017609|NCT01524991|11089729|FG000|Overall Study|Death|1
7017610|NCT01524991|11089729|FG000|Overall Study|Disease ProgressionDu|17
7017611|NCT01524991|11089729|FG000|Overall Study|Other complicating disease|1
7017612|NCT01524991|11089729|FG000|Overall Study|Withdrawal by Subject|2
7017613|NCT01524991|11089729|FG000|Overall Study|Symptomatic Deterioration|1
7017614|NCT01525082|11089733|FG000|Overall Study|Death|1
7017615|NCT01525225|11089749|FG000|Enrollment|No longer met study criteria|1
7017616|NCT01525225|11089749|FG000|Enrollment|Other|1
7017617|NCT01525238|11089756|FG000|Overall Study|Withdrawal by Subject|1
7017618|NCT01525238|11089757|FG001|Overall Study|Withdrawal by Subject|0
7017619|NCT01525238|11089758|FG002|Overall Study|Withdrawal by Subject|0
7017620|NCT01525407|11089768|FG000|Overall Study|Change in recipient treatment plan|2
7017621|NCT01525407|11089769|FG001|Overall Study|Change in recipient treatment plan|2
7017622|NCT01525407|11089768|FG000|Overall Study|Withdrawal by Subject|0
7017623|NCT01525407|11089769|FG001|Overall Study|Withdrawal by Subject|1
7017624|NCT01525407|11089768|FG000|Overall Study|Transplant was delayed|0
7017625|NCT01525407|11089769|FG001|Overall Study|Transplant was delayed|1
7017626|NCT01525407|11089768|FG000|Overall Study|Delay in Transplant|1
7017627|NCT01525407|11089769|FG001|Overall Study|Delay in Transplant|0
7017628|NCT01525550|11089786|FG000|Overall Study|Lost to Follow-up|8
7017629|NCT01525550|11089787|FG001|Overall Study|Lost to Follow-up|2
7017630|NCT01525550|11089786|FG000|Overall Study|Death|19
7017631|NCT01525550|11089787|FG001|Overall Study|Death|28
7017632|NCT01525550|11089786|FG000|Overall Study|Other|0
7017633|NCT01525550|11089787|FG001|Overall Study|Other|4
7017634|NCT01525550|11089786|FG000|Overall Study|Sponsor's Decision|30
7017635|NCT01525550|11089787|FG001|Overall Study|Sponsor's Decision|11
7017636|NCT01525550|11089786|FG000|Overall Study|Withdrawal by Subject|4
7017637|NCT01525550|11089787|FG001|Overall Study|Withdrawal by Subject|0
7017638|NCT01525589|11089800|FG000|Overall Study|Non-treatment-related AE|1
7017639|NCT01525589|11089801|FG001|Overall Study|Non-treatment-related AE|0
7017640|NCT01525589|11089802|FG002|Overall Study|Non-treatment-related AE|0
7017641|NCT01525589|11089800|FG000|Overall Study|Progressive disease|48
7017642|NCT01525589|11089801|FG001|Overall Study|Progressive disease|15
7017643|NCT01525589|11089802|FG002|Overall Study|Progressive disease|29
7017644|NCT01525589|11089800|FG000|Overall Study|Never treated|2
7017645|NCT01525589|11089801|FG001|Overall Study|Never treated|0
7017646|NCT01525589|11089802|FG002|Overall Study|Never treated|0
7017647|NCT01525589|11089800|FG000|Overall Study|Physician Decision|4
7017648|NCT01525589|11089801|FG001|Overall Study|Physician Decision|2
7017649|NCT01525589|11089802|FG002|Overall Study|Physician Decision|2
7017650|NCT01525589|11089800|FG000|Overall Study|Death|0
7017651|NCT01525589|11089801|FG001|Overall Study|Death|0
7017652|NCT01525589|11089802|FG002|Overall Study|Death|2
7017653|NCT01525589|11089800|FG000|Overall Study|Treatment-related AE|1
7017654|NCT01525589|11089801|FG001|Overall Study|Treatment-related AE|1
7017655|NCT01525589|11089802|FG002|Overall Study|Treatment-related AE|2
7017656|NCT01525589|11089800|FG000|Overall Study|Other reasons|0
7017657|NCT01525589|11089801|FG001|Overall Study|Other reasons|1
7017658|NCT01525589|11089802|FG002|Overall Study|Other reasons|0
7017659|NCT01525589|11089800|FG000|Overall Study|Withdrawal by Subject|0
7017660|NCT01525589|11089801|FG001|Overall Study|Withdrawal by Subject|1
7017661|NCT01525589|11089802|FG002|Overall Study|Withdrawal by Subject|0
7017662|NCT01525602|11089818|FG000|Overall Study|Adverse Event|1
7017663|NCT01525602|11089819|FG001|Overall Study|Adverse Event|0
7017664|NCT01525602|11089820|FG002|Overall Study|Adverse Event|1
7017665|NCT01525602|11089821|FG003|Overall Study|Adverse Event|1
7017666|NCT01525602|11089822|FG004|Overall Study|Adverse Event|3
7017667|NCT01525602|11089823|FG005|Overall Study|Adverse Event|3
7017668|NCT01525602|11089824|FG006|Overall Study|Adverse Event|0
7017669|NCT01525602|11089825|FG007|Overall Study|Adverse Event|1
7017670|NCT01525602|11089818|FG000|Overall Study|Disease progression|6
7017671|NCT01525602|11089819|FG001|Overall Study|Disease progression|3
7017672|NCT01525602|11089820|FG002|Overall Study|Disease progression|2
7017673|NCT01525602|11089821|FG003|Overall Study|Disease progression|5
7017674|NCT01525602|11089822|FG004|Overall Study|Disease progression|22
7017675|NCT01525602|11089823|FG005|Overall Study|Disease progression|2
7017676|NCT01525602|11089824|FG006|Overall Study|Disease progression|3
7017677|NCT01525602|11089825|FG007|Overall Study|Disease progression|3
7017678|NCT01525602|11089818|FG000|Overall Study|Clinical progression|2
7017679|NCT01525602|11089819|FG001|Overall Study|Clinical progression|0
7017680|NCT01525602|11089820|FG002|Overall Study|Clinical progression|0
7017681|NCT01525602|11089821|FG003|Overall Study|Clinical progression|0
7017682|NCT01525602|11089822|FG004|Overall Study|Clinical progression|0
7017683|NCT01525602|11089823|FG005|Overall Study|Clinical progression|0
7017684|NCT01525602|11089824|FG006|Overall Study|Clinical progression|1
7017685|NCT01525602|11089825|FG007|Overall Study|Clinical progression|1
7017686|NCT01525602|11089818|FG000|Overall Study|Non-compliance|0
7017687|NCT01525602|11089819|FG001|Overall Study|Non-compliance|0
7017688|NCT01525602|11089820|FG002|Overall Study|Non-compliance|0
7017689|NCT01525602|11089821|FG003|Overall Study|Non-compliance|0
7017690|NCT01525602|11089822|FG004|Overall Study|Non-compliance|1
7017691|NCT01525602|11089823|FG005|Overall Study|Non-compliance|0
7017692|NCT01525602|11089824|FG006|Overall Study|Non-compliance|0
7017693|NCT01525602|11089825|FG007|Overall Study|Non-compliance|0
7017694|NCT01525602|11089818|FG000|Overall Study|Withdrawal by Subject|0
7017695|NCT01525602|11089819|FG001|Overall Study|Withdrawal by Subject|0
7017696|NCT01525602|11089820|FG002|Overall Study|Withdrawal by Subject|0
7017697|NCT01525602|11089821|FG003|Overall Study|Withdrawal by Subject|0
7017698|NCT01525602|11089822|FG004|Overall Study|Withdrawal by Subject|3
7017699|NCT01525602|11089823|FG005|Overall Study|Withdrawal by Subject|1
7017700|NCT01525602|11089824|FG006|Overall Study|Withdrawal by Subject|0
7017701|NCT01525602|11089825|FG007|Overall Study|Withdrawal by Subject|1
7017702|NCT01525602|11089818|FG000|Overall Study|Physician Decision|0
7017703|NCT01525602|11089819|FG001|Overall Study|Physician Decision|0
7017704|NCT01525602|11089820|FG002|Overall Study|Physician Decision|0
7017705|NCT01525602|11089821|FG003|Overall Study|Physician Decision|0
7017706|NCT01525602|11089822|FG004|Overall Study|Physician Decision|3
7017707|NCT01525602|11089823|FG005|Overall Study|Physician Decision|0
7017708|NCT01525602|11089824|FG006|Overall Study|Physician Decision|1
7017709|NCT01525602|11089825|FG007|Overall Study|Physician Decision|0
7017710|NCT01525602|11089818|FG000|Overall Study|Death|0
7017711|NCT01525602|11089819|FG001|Overall Study|Death|0
7017712|NCT01525602|11089820|FG002|Overall Study|Death|0
7017713|NCT01525602|11089821|FG003|Overall Study|Death|0
7017714|NCT01525602|11089822|FG004|Overall Study|Death|1
7017715|NCT01525602|11089823|FG005|Overall Study|Death|1
7017716|NCT01525602|11089824|FG006|Overall Study|Death|0
7017717|NCT01525602|11089825|FG007|Overall Study|Death|0
7017718|NCT01525602|11089818|FG000|Overall Study|Unqualified based on biopsy; not dosed|0
7017719|NCT01525602|11089819|FG001|Overall Study|Unqualified based on biopsy; not dosed|0
7017720|NCT01525602|11089820|FG002|Overall Study|Unqualified based on biopsy; not dosed|0
7017721|NCT01525602|11089821|FG003|Overall Study|Unqualified based on biopsy; not dosed|0
7017722|NCT01525602|11089822|FG004|Overall Study|Unqualified based on biopsy; not dosed|0
7017723|NCT01525602|11089823|FG005|Overall Study|Unqualified based on biopsy; not dosed|0
7017724|NCT01525602|11089824|FG006|Overall Study|Unqualified based on biopsy; not dosed|1
7017725|NCT01525602|11089825|FG007|Overall Study|Unqualified based on biopsy; not dosed|1
7017726|NCT01525615|11089853|FG000|Overall Study|Adverse Event|11
7017727|NCT01525615|11089854|FG001|Overall Study|Adverse Event|7
7017728|NCT01525615|11089855|FG002|Overall Study|Adverse Event|5
7017729|NCT01525615|11089853|FG000|Overall Study|Lost to Follow-up|1
7017730|NCT01525615|11089854|FG001|Overall Study|Lost to Follow-up|0
7017731|NCT01525615|11089855|FG002|Overall Study|Lost to Follow-up|0
7017732|NCT01525615|11089853|FG000|Overall Study|Withdrawal by Subject|1
7017733|NCT01525615|11089854|FG001|Overall Study|Withdrawal by Subject|0
7017734|NCT01525615|11089855|FG002|Overall Study|Withdrawal by Subject|0
7017735|NCT01525615|11089853|FG000|Overall Study|Other reason not described above|1
7017736|NCT01525615|11089854|FG001|Overall Study|Other reason not described above|0
7017737|NCT01525615|11089855|FG002|Overall Study|Other reason not described above|1
7017738|NCT01525628|11089868|FG000|Overall Study|Adverse Event|1
7017739|NCT01525628|11089869|FG001|Overall Study|Adverse Event|1
7017740|NCT01525628|11089870|FG002|Overall Study|Adverse Event|2
7017741|NCT01525628|11089871|FG003|Overall Study|Adverse Event|0
7017742|NCT01525628|11089872|FG004|Overall Study|Adverse Event|1
7017743|NCT01525628|11089868|FG000|Overall Study|Lack of Efficacy|0
7017744|NCT01525628|11089869|FG001|Overall Study|Lack of Efficacy|2
7017745|NCT01525628|11089870|FG002|Overall Study|Lack of Efficacy|2
7017746|NCT01525628|11089871|FG003|Overall Study|Lack of Efficacy|1
7017747|NCT01525628|11089872|FG004|Overall Study|Lack of Efficacy|2
7017748|NCT01525628|11089868|FG000|Overall Study|Protocol Violation|0
7017749|NCT01525628|11089869|FG001|Overall Study|Protocol Violation|0
7017750|NCT01525628|11089870|FG002|Overall Study|Protocol Violation|1
7017751|NCT01525628|11089871|FG003|Overall Study|Protocol Violation|0
7017752|NCT01525628|11089872|FG004|Overall Study|Protocol Violation|0
7017753|NCT01525628|11089868|FG000|Overall Study|Lost to Follow-up|1
7017754|NCT01525628|11089869|FG001|Overall Study|Lost to Follow-up|1
7017755|NCT01525628|11089870|FG002|Overall Study|Lost to Follow-up|0
7017756|NCT01525628|11089871|FG003|Overall Study|Lost to Follow-up|0
7017757|NCT01525628|11089872|FG004|Overall Study|Lost to Follow-up|0
7017758|NCT01525628|11089868|FG000|Overall Study|Withdrawal by Subject|0
7017759|NCT01525628|11089869|FG001|Overall Study|Withdrawal by Subject|1
7017760|NCT01525628|11089870|FG002|Overall Study|Withdrawal by Subject|0
7017761|NCT01525628|11089871|FG003|Overall Study|Withdrawal by Subject|0
7017762|NCT01525628|11089872|FG004|Overall Study|Withdrawal by Subject|0
7017763|NCT01525628|11089868|FG000|Overall Study|Other reason not defined above|0
7017764|NCT01525628|11089869|FG001|Overall Study|Other reason not defined above|0
7017765|NCT01525628|11089870|FG002|Overall Study|Other reason not defined above|0
7017766|NCT01525628|11089871|FG003|Overall Study|Other reason not defined above|3
7017767|NCT01525628|11089872|FG004|Overall Study|Other reason not defined above|0
7017768|NCT01525641|11089886|FG000|Overall Study|Case report form not collected|25
7017769|NCT01525641|11089886|FG000|Overall Study|No visit since the first visit|16
7017770|NCT01525641|11089886|FG000|Overall Study|Adverse Event|73
7017771|NCT01525641|11089886|FG000|Overall Study|Lack of Efficacy|24
7017772|NCT01525641|11089886|FG000|Overall Study|Improvement|5
7017773|NCT01525641|11089886|FG000|Overall Study|Lost to follow-up (relocation)|1
7017774|NCT01525641|11089886|FG000|Overall Study|Lost to follow-up (Unknown reason)|10
7017775|NCT01525641|11089886|FG000|Overall Study|Lost to follow-up (Changing hospital)|19
7017776|NCT01525641|11089886|FG000|Overall Study|Other than stated above|7
7017777|NCT01525849|11089907|FG000|Overall Study|Lost to Follow-up|3
7017778|NCT01525849|11089908|FG001|Overall Study|Lost to Follow-up|2
7017779|NCT01525849|11089907|FG000|Overall Study|Withdrawal by Subject|1
7017780|NCT01525849|11089908|FG001|Overall Study|Withdrawal by Subject|9
7017781|NCT01525849|11089907|FG000|Overall Study|Unrelated medical issue (not treated)|1
7017782|NCT01525849|11089908|FG001|Overall Study|Unrelated medical issue (not treated)|2
7017783|NCT01525849|11089907|FG000|Overall Study|Anatomic exclusion criteria identified|0
7017784|NCT01525849|11089908|FG001|Overall Study|Anatomic exclusion criteria identified|3
7017785|NCT01525875|11089920|FG000|Placebo-controlled Period|Withdrawal by Subject|1
7017786|NCT01525875|11089921|FG001|Placebo-controlled Period|Withdrawal by Subject|2
7017787|NCT01525875|11089920|FG000|Open-label Period|Lost to Follow-up|0
7017788|NCT01525875|11089921|FG001|Open-label Period|Lost to Follow-up|2
7017789|NCT01526057|11089930|FG000|Overall Study|Withdrawal by Subject|3
7017790|NCT01526057|11089931|FG001|Overall Study|Withdrawal by Subject|2
7017791|NCT01526057|11089932|FG002|Overall Study|Withdrawal by Subject|2
7017792|NCT01526057|11089930|FG000|Overall Study|Adverse Event|3
7017793|NCT01526057|11089931|FG001|Overall Study|Adverse Event|1
7017794|NCT01526057|11089932|FG002|Overall Study|Adverse Event|1
7017795|NCT01526057|11089930|FG000|Overall Study|Death|1
7017796|NCT01526057|11089931|FG001|Overall Study|Death|0
7017797|NCT01526057|11089932|FG002|Overall Study|Death|0
7017798|NCT01526057|11089930|FG000|Overall Study|Lost to Follow-up|1
7017799|NCT01526057|11089931|FG001|Overall Study|Lost to Follow-up|0
7017800|NCT01526057|11089932|FG002|Overall Study|Lost to Follow-up|1
7017801|NCT01526057|11089930|FG000|Overall Study|Other|1
7017802|NCT01526057|11089931|FG001|Overall Study|Other|0
7017803|NCT01526057|11089932|FG002|Overall Study|Other|1
7017804|NCT01526057|11089930|FG000|Overall Study|Protocol Violation|0
7017805|NCT01526057|11089931|FG001|Overall Study|Protocol Violation|0
7017806|NCT01526057|11089932|FG002|Overall Study|Protocol Violation|1
7017807|NCT01526148|11089942|FG000|Overall Study|Adverse Event|6
7017808|NCT01526148|11089943|FG001|Overall Study|Adverse Event|5
7017809|NCT01526148|11089942|FG000|Overall Study|Lost to Follow-up|3
7017810|NCT01526148|11089943|FG001|Overall Study|Lost to Follow-up|6
7017811|NCT01526148|11089942|FG000|Overall Study|Withdrawal by Subject|2
7017812|NCT01526148|11089943|FG001|Overall Study|Withdrawal by Subject|0
7017813|NCT01526148|11089942|FG000|Overall Study|Unstable Medical Condition|1
7017814|NCT01526148|11089943|FG001|Overall Study|Unstable Medical Condition|0
7017815|NCT01526148|11089942|FG000|Overall Study|Unable to discontinue concomitant med|1
7017816|NCT01526148|11089943|FG001|Overall Study|Unable to discontinue concomitant med|0
7017817|NCT01526148|11089942|FG000|Overall Study|Moved out of state|1
7017818|NCT01526148|11089943|FG001|Overall Study|Moved out of state|0
7017819|NCT01526148|11089942|FG000|Overall Study|Incarcerated|0
7017820|NCT01526148|11089943|FG001|Overall Study|Incarcerated|2
7017821|NCT01526551|11090001|FG000|Overall Study|Lack of returned parental consent form|424
7017822|NCT01526733|11090026|FG000|Phase 1|Protocol Violation|1
7017823|NCT01526733|11090027|FG001|Phase 1|Protocol Violation|0
7017824|NCT01526733|11090026|FG000|Phase 1|Withdrawal by Subject|1
7017825|NCT01526733|11090027|FG001|Phase 1|Withdrawal by Subject|1
7017826|NCT01526785|11090034|FG000|Overall Study|Study Terminated by Sponsor|8
7017827|NCT01526785|11090034|FG000|Overall Study|Death|2
7017828|NCT01526785|11090034|FG000|Overall Study|Physician Decision|1
7017829|NCT01526785|11090034|FG000|Overall Study|Withdrawal by Subject|2
7017830|NCT01526889|11090040|FG000|Treatment Period|Adverse Event|2
7017831|NCT01526889|11090041|FG001|Treatment Period|Adverse Event|0
7017832|NCT01526889|11090040|FG000|Treatment Extension Period|Administrative problems|1
7017833|NCT01526889|11090041|FG001|Treatment Extension Period|Administrative problems|0
7017834|NCT01526928|11090060|FG000|Overall Study|Progressive Disease|35
7017835|NCT01526928|11090061|FG001|Overall Study|Progressive Disease|17
7017836|NCT01526928|11090062|FG002|Overall Study|Progressive Disease|150
7017837|NCT01526928|11090063|FG003|Overall Study|Progressive Disease|182
7017838|NCT01526928|11090064|FG004|Overall Study|Progressive Disease|76
7017839|NCT01526928|11090065|FG005|Overall Study|Progressive Disease|4
7017840|NCT01526928|11090060|FG000|Overall Study|Adverse Event|2
7017841|NCT01526928|11090061|FG001|Overall Study|Adverse Event|1
7017842|NCT01526928|11090062|FG002|Overall Study|Adverse Event|29
7017843|NCT01526928|11090063|FG003|Overall Study|Adverse Event|40
7017844|NCT01526928|11090064|FG004|Overall Study|Adverse Event|13
7017845|NCT01526928|11090065|FG005|Overall Study|Adverse Event|2
7017846|NCT01526928|11090060|FG000|Overall Study|Death|0
7017847|NCT01526928|11090061|FG001|Overall Study|Death|0
7017848|NCT01526928|11090062|FG002|Overall Study|Death|3
7017849|NCT01526928|11090063|FG003|Overall Study|Death|0
7017850|NCT01526928|11090064|FG004|Overall Study|Death|0
7017851|NCT01526928|11090065|FG005|Overall Study|Death|0
7017852|NCT01526928|11090060|FG000|Overall Study|Withdrawal by Subject|1
7017853|NCT01526928|11090061|FG001|Overall Study|Withdrawal by Subject|0
7017854|NCT01526928|11090062|FG002|Overall Study|Withdrawal by Subject|13
7017855|NCT01526928|11090063|FG003|Overall Study|Withdrawal by Subject|11
7017856|NCT01526928|11090064|FG004|Overall Study|Withdrawal by Subject|3
7017857|NCT01526928|11090065|FG005|Overall Study|Withdrawal by Subject|0
7017858|NCT01526928|11090060|FG000|Overall Study|Physician Decision|0
7017859|NCT01526928|11090061|FG001|Overall Study|Physician Decision|0
7017860|NCT01526928|11090062|FG002|Overall Study|Physician Decision|2
7017861|NCT01526928|11090063|FG003|Overall Study|Physician Decision|5
7017862|NCT01526928|11090064|FG004|Overall Study|Physician Decision|0
7017863|NCT01526928|11090065|FG005|Overall Study|Physician Decision|0
7017864|NCT01526928|11090060|FG000|Overall Study|Other Reason|0
7017865|NCT01526928|11090061|FG001|Overall Study|Other Reason|1
7017866|NCT01526928|11090062|FG002|Overall Study|Other Reason|11
7017867|NCT01526928|11090063|FG003|Overall Study|Other Reason|4
7017868|NCT01526928|11090064|FG004|Overall Study|Other Reason|1
7017869|NCT01526928|11090065|FG005|Overall Study|Other Reason|0
7017870|NCT01526928|11090060|FG000|Overall Study|Lost to Follow-up|0
7017871|NCT01526928|11090061|FG001|Overall Study|Lost to Follow-up|0
7017872|NCT01526928|11090062|FG002|Overall Study|Lost to Follow-up|0
7017873|NCT01526928|11090063|FG003|Overall Study|Lost to Follow-up|1
7017874|NCT01526928|11090064|FG004|Overall Study|Lost to Follow-up|0
7017875|NCT01526928|11090065|FG005|Overall Study|Lost to Follow-up|0
7017876|NCT01526928|11090060|FG000|Overall Study|Protocol Deviation|0
7017877|NCT01526928|11090061|FG001|Overall Study|Protocol Deviation|0
7017878|NCT01526928|11090062|FG002|Overall Study|Protocol Deviation|0
7017879|NCT01526928|11090063|FG003|Overall Study|Protocol Deviation|2
7017880|NCT01526928|11090064|FG004|Overall Study|Protocol Deviation|0
7017881|NCT01526928|11090065|FG005|Overall Study|Protocol Deviation|0
7017882|NCT01526928|11090060|FG000|Overall Study|Missing|0
7017883|NCT01526928|11090061|FG001|Overall Study|Missing|0
7017884|NCT01526928|11090062|FG002|Overall Study|Missing|1
7017885|NCT01526928|11090063|FG003|Overall Study|Missing|0
7017886|NCT01526928|11090064|FG004|Overall Study|Missing|2
7017887|NCT01526928|11090065|FG005|Overall Study|Missing|0
7017888|NCT01527006|11090123|FG000|Core Study|Adverse Event|0
7017889|NCT01527006|11090124|FG001|Core Study|Adverse Event|2
7017890|NCT01527006|11090123|FG000|Core Study|Lost to Follow-up|0
7017891|NCT01527006|11090124|FG001|Core Study|Lost to Follow-up|1
7017892|NCT01527006|11090123|FG000|Core Study|Subject Choice|1
7017893|NCT01527006|11090124|FG001|Core Study|Subject Choice|0
7017894|NCT01527006|11090123|FG000|Core Study|Inadequate Therapeutic Effect|1
7017895|NCT01527006|11090124|FG001|Core Study|Inadequate Therapeutic Effect|0
7017896|NCT01527006|11090123|FG000|Core Study|Withdrawal by Subject|0
7017897|NCT01527006|11090124|FG001|Core Study|Withdrawal by Subject|1
7017898|NCT01527006|11090123|FG000|Core Study|Other|0
7017899|NCT01527006|11090124|FG001|Core Study|Other|2
7017900|NCT01527006|11090123|FG000|Extension Phase|Adverse Event|4
7017901|NCT01527006|11090124|FG001|Extension Phase|Adverse Event|2
7017902|NCT01527006|11090123|FG000|Extension Phase|Lost to Follow-up|0
7017903|NCT01527006|11090124|FG001|Extension Phase|Lost to Follow-up|1
7017904|NCT01527006|11090123|FG000|Extension Phase|Subject Choice|1
7017905|NCT01527006|11090124|FG001|Extension Phase|Subject Choice|1
7017906|NCT01527006|11090123|FG000|Extension Phase|Inadequate therapeutic effect|1
7017907|NCT01527006|11090124|FG001|Extension Phase|Inadequate therapeutic effect|1
7017908|NCT01527006|11090123|FG000|Extension Phase|Other|0
7017909|NCT01527006|11090124|FG001|Extension Phase|Other|3
7017910|NCT01527110|11090149|FG000|Overall Study|Adverse Event|1
7017911|NCT01527357|11090164|FG000|Overall Study|Death|8
7017912|NCT01527357|11090165|FG001|Overall Study|Death|2
7017913|NCT01527357|11090164|FG000|Overall Study|Lost to Follow-up|6
7017914|NCT01527357|11090165|FG001|Overall Study|Lost to Follow-up|4
7017915|NCT01527357|11090164|FG000|Overall Study|Withdrew Consent|1
7017916|NCT01527357|11090165|FG001|Overall Study|Withdrew Consent|1
7017917|NCT01527357|11090164|FG000|Overall Study|Non-compliance|0
7017918|NCT01527357|11090165|FG001|Overall Study|Non-compliance|1
7017919|NCT01527357|11090164|FG000|Overall Study|No Day 29 Visit|0
7017920|NCT01527357|11090165|FG001|Overall Study|No Day 29 Visit|1
7017921|NCT01527357|11090164|FG000|Overall Study|Did Not Receive Treatment|2
7017922|NCT01527357|11090165|FG001|Overall Study|Did Not Receive Treatment|0
7017923|NCT01527370|11090171|FG000|Overall Study|Withdrawal by Subject|4
7017924|NCT01527370|11090171|FG000|Overall Study|Physician Decision|1
7017925|NCT01527370|11090171|FG000|Overall Study|Death|1
7017926|NCT01527383|11090177|FG000|Overall Study|Adverse Event|5
7017927|NCT01527383|11090178|FG001|Overall Study|Adverse Event|0
7017928|NCT01527383|11090177|FG000|Overall Study|Lost to Follow-up|3
7017929|NCT01527383|11090178|FG001|Overall Study|Lost to Follow-up|0
7017930|NCT01527383|11090177|FG000|Overall Study|Physician Decision|2
7017931|NCT01527383|11090178|FG001|Overall Study|Physician Decision|0
7017932|NCT01527383|11090177|FG000|Overall Study|Pregnancy|1
7017933|NCT01527383|11090178|FG001|Overall Study|Pregnancy|0
7017934|NCT01527383|11090177|FG000|Overall Study|Protocol Violation|1
7017935|NCT01527383|11090178|FG001|Overall Study|Protocol Violation|0
7017936|NCT01527383|11090177|FG000|Overall Study|Screen failure|1
7017937|NCT01527383|11090178|FG001|Overall Study|Screen failure|0
7017938|NCT01527383|11090177|FG000|Overall Study|Participant moved|0
7017939|NCT01527383|11090178|FG001|Overall Study|Participant moved|1
7017940|NCT01527383|11090177|FG000|Overall Study|Withdrawal by Subject|2
7017941|NCT01527383|11090178|FG001|Overall Study|Withdrawal by Subject|3
7017942|NCT01527487|11090186|FG000|Overall Study|MD Discretion/Lack of Efficacy|3
7017943|NCT01527487|11090187|FG001|Overall Study|MD Discretion/Lack of Efficacy|4
7017944|NCT01527487|11090186|FG000|Overall Study|Disease Progression|4
7017945|NCT01527487|11090187|FG001|Overall Study|Disease Progression|1
7017946|NCT01527487|11090186|FG000|Overall Study|Adverse Event|1
7017947|NCT01527487|11090187|FG001|Overall Study|Adverse Event|1
7017948|NCT01527487|11090186|FG000|Overall Study|Death|0
7017949|NCT01527487|11090187|FG001|Overall Study|Death|1
7017950|NCT01527500|11090202|FG000|Part A|Administrative|11
7017951|NCT01527500|11090203|FG001|Part A|Administrative|7
7017952|NCT01527500|11090202|FG000|Part A|Adverse Event|4
7017953|NCT01527500|11090203|FG001|Part A|Adverse Event|2
7017954|NCT01527500|11090202|FG000|Part A|Death|4
7017955|NCT01527500|11090203|FG001|Part A|Death|1
7017956|NCT01527500|11090202|FG000|Part A|Lost to Follow-up|0
7017957|NCT01527500|11090203|FG001|Part A|Lost to Follow-up|1
7017958|NCT01527500|11090202|FG000|Part A|Protocol Deviation|9
7017959|NCT01527500|11090203|FG001|Part A|Protocol Deviation|2
7017960|NCT01527500|11090202|FG000|Part A|Withdrawal by Subject|2
7017961|NCT01527500|11090203|FG001|Part A|Withdrawal by Subject|0
7017962|NCT01527500|11090202|FG000|Part B|Adverse Event|1
7017963|NCT01527500|11090203|FG001|Part B|Adverse Event|0
7017964|NCT01527682|11090230|FG000|Overall Study|Protocol Violation|8
7017965|NCT01528033|11090236|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8
7017966|NCT01528033|11090237|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7
7017967|NCT01528033|11090236|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3
7017968|NCT01528033|11090237|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3
7017969|NCT01528033|11090236|FG000|Primary Endpoint Assessment ITT|Death|2
7017970|NCT01528033|11090237|FG001|Primary Endpoint Assessment ITT|Death|2
7017971|NCT01528033|11090236|FG000|Primary Endpoint Assessment ITT|Physician Decision|2
7017972|NCT01528033|11090237|FG001|Primary Endpoint Assessment ITT|Physician Decision|1
7017973|NCT01528033|11090236|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2
7017974|NCT01528033|11090237|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2
7017975|NCT01528033|11090236|FG000|Follow Up|No data available|46
7017976|NCT01528033|11090237|FG001|Follow Up|No data available|44
7017977|NCT01528072|11090243|FG000|Overall Study|Withdrawal by Subject|5
7017978|NCT01528072|11090243|FG000|Overall Study|Physician Decision|1
7017979|NCT01528072|11090243|FG000|Overall Study|Determined not eligible by AEAC|1
7017980|NCT01528072|11090243|FG000|Overall Study|Missed Visit|2
7017981|NCT01528072|11090243|FG000|Overall Study|Lost to Follow-up|5
7017982|NCT01528072|11090243|FG000|Overall Study|Explanted|2
7017983|NCT01528072|11090243|FG000|Overall Study|Site Closure|4
7017984|NCT01528072|11090243|FG000|Overall Study|Death|2
7017985|NCT01528072|11090243|FG000|Overall Study|Early Termination of Study|52
7017986|NCT01528215|11090288|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4
7017987|NCT01528215|11090289|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1
7017988|NCT01528215|11090288|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2
7017989|NCT01528215|11090289|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2
7017990|NCT01528215|11090288|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10
7017991|NCT01528215|11090289|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13
7017992|NCT01528215|11090288|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3
7017993|NCT01528215|11090289|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0
7017994|NCT01528254|11090306|FG000|Overall Study|Administrative problems|96
7017995|NCT01528254|11090307|FG001|Overall Study|Administrative problems|94
7017996|NCT01528254|11090306|FG000|Overall Study|Adverse Event|28
7017997|NCT01528254|11090307|FG001|Overall Study|Adverse Event|44
7017998|NCT01528254|11090306|FG000|Overall Study|Lost to Follow-up|17
7017999|NCT01528254|11090307|FG001|Overall Study|Lost to Follow-up|24
7018000|NCT01528254|11090306|FG000|Overall Study|Death|13
7018001|NCT01528254|11090307|FG001|Overall Study|Death|9
7018002|NCT01528254|11090306|FG000|Overall Study|Protocol deviation|9
7018003|NCT01528254|11090307|FG001|Overall Study|Protocol deviation|19
7018004|NCT01528254|11090306|FG000|Overall Study|New therapy for study indication|8
7018005|NCT01528254|11090307|FG001|Overall Study|New therapy for study indication|6
7018006|NCT01528254|11090306|FG000|Overall Study|Unsatisfactory therapeutic effect|6
7018007|NCT01528254|11090307|FG001|Overall Study|Unsatisfactory therapeutic effect|8
7018008|NCT01528254|11090306|FG000|Overall Study|Withdrawal by Subject|5
7018009|NCT01528254|11090307|FG001|Overall Study|Withdrawal by Subject|4
7018010|NCT01528254|11090306|FG000|Overall Study|Abnormal laboratory value(s)|3
7018011|NCT01528254|11090307|FG001|Overall Study|Abnormal laboratory value(s)|7
7018012|NCT01528254|11090306|FG000|Overall Study|Abnormal test procedure result(s)|1
7018013|NCT01528254|11090307|FG001|Overall Study|Abnormal test procedure result(s)|0
7018014|NCT01528254|11090306|FG000|Overall Study|No longer requires study drug|1
7018015|NCT01528254|11090307|FG001|Overall Study|No longer requires study drug|1
7018016|NCT01528345|11090329|FG000|Overall Study|Adverse Event|10
7018017|NCT01528345|11090330|FG001|Overall Study|Adverse Event|1
7018018|NCT01528345|11090329|FG000|Overall Study|Death|1
7018019|NCT01528345|11090330|FG001|Overall Study|Death|1
7018020|NCT01528345|11090329|FG000|Overall Study|Non-compliance with study treatment|1
7018021|NCT01528345|11090330|FG001|Overall Study|Non-compliance with study treatment|0
7018022|NCT01528345|11090329|FG000|Overall Study|Progressive Disease|26
7018023|NCT01528345|11090330|FG001|Overall Study|Progressive Disease|40
7018024|NCT01528345|11090329|FG000|Overall Study|Study Terminated by Sponsor|4
7018025|NCT01528345|11090330|FG001|Overall Study|Study Terminated by Sponsor|8
7018026|NCT01528345|11090329|FG000|Overall Study|Subject/Guardian Decision|5
7018027|NCT01528345|11090330|FG001|Overall Study|Subject/Guardian Decision|0
7018028|NCT01528605|11090346|FG000|Overall Study|Lost to Follow-up|1
7018029|NCT01528605|11090347|FG001|Overall Study|Lost to Follow-up|0
7018030|NCT01528605|11090348|FG002|Overall Study|Lost to Follow-up|1
7018031|NCT01528605|11090349|FG003|Overall Study|Lost to Follow-up|1
7018032|NCT01528605|11090350|FG004|Overall Study|Lost to Follow-up|0
7018033|NCT01528605|11090351|FG005|Overall Study|Lost to Follow-up|0
7018034|NCT01528605|11090346|FG000|Overall Study|Death|1
7018035|NCT01528605|11090347|FG001|Overall Study|Death|0
7018036|NCT01528605|11090348|FG002|Overall Study|Death|0
7018037|NCT01528605|11090349|FG003|Overall Study|Death|0
7018038|NCT01528605|11090350|FG004|Overall Study|Death|0
7018039|NCT01528605|11090351|FG005|Overall Study|Death|0
7018040|NCT01528709|11090367|FG000|Overall Study|Death|2
7018041|NCT01528709|11090368|FG001|Overall Study|Death|0
7018042|NCT01528709|11090367|FG000|Overall Study|Withdrawal by Subject|10
7018043|NCT01528709|11090368|FG001|Overall Study|Withdrawal by Subject|15
7018044|NCT01528709|11090367|FG000|Overall Study|allergy|1
7018045|NCT01528709|11090368|FG001|Overall Study|allergy|0
7018046|NCT01528735|11090376|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
7018047|NCT01528735|11090377|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
7018048|NCT01528735|11090376|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1
7018049|NCT01528735|11090377|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0
7018050|NCT01528787|11090389|FG000|Overall Study|Withdrawal by Subject|0
7018051|NCT01528787|11090390|FG001|Overall Study|Withdrawal by Subject|0
7018052|NCT01528787|11090391|FG002|Overall Study|Withdrawal by Subject|0
7018053|NCT01528787|11090392|FG003|Overall Study|Withdrawal by Subject|1
7018054|NCT01528787|11090389|FG000|Overall Study|Family Emergency|0
7018055|NCT01528787|11090390|FG001|Overall Study|Family Emergency|0
7018056|NCT01528787|11090391|FG002|Overall Study|Family Emergency|1
7018057|NCT01528787|11090392|FG003|Overall Study|Family Emergency|0
7018058|NCT01528969|11090421|FG000|Overall Study|absent from the school at baseline|2
7018059|NCT01528969|11090422|FG001|Overall Study|absent from the school at baseline|0
7018060|NCT01529034|11090428|FG000|Overall Study|Discontinued prior to study treatment|14
7018061|NCT01529034|11090428|FG000|Overall Study|Site closure|62
7018062|NCT01529034|11090428|FG000|Overall Study|Study termination|29
7018063|NCT01529034|11090428|FG000|Overall Study|Withdrawal by Subject|25
7018064|NCT01529034|11090428|FG000|Overall Study|No treated SCs within protocol window|13
7018065|NCT01529034|11090428|FG000|Overall Study|Noncompliance|8
7018066|NCT01529034|11090428|FG000|Overall Study|Caregiver no longer available|7
7018067|NCT01529034|11090428|FG000|Overall Study|Adverse Event|4
7018068|NCT01529034|11090428|FG000|Overall Study|Protocol Violation|4
7018069|NCT01529034|11090428|FG000|Overall Study|Lack of Efficacy|4
7018070|NCT01529034|11090428|FG000|Overall Study|Investigator no longer available|2
7018071|NCT01529034|11090428|FG000|Overall Study|Study drug not available|2
7018072|NCT01529112|11090445|FG000|Overall Study|Adverse Event|2
7018073|NCT01529112|11090446|FG001|Overall Study|Adverse Event|0
7018074|NCT01529112|11090445|FG000|Overall Study|Death|59
7018075|NCT01529112|11090446|FG001|Overall Study|Death|38
7018076|NCT01529112|11090445|FG000|Overall Study|Protocol Violation|1
7018077|NCT01529112|11090446|FG001|Overall Study|Protocol Violation|0
7018078|NCT01529112|11090445|FG000|Overall Study|Withdrawal by Subject|7
7018079|NCT01529112|11090446|FG001|Overall Study|Withdrawal by Subject|3
7018080|NCT01529268|11090458|FG000|Overall Study|Lost to Follow-up|9
7018081|NCT01529268|11090459|FG001|Overall Study|Lost to Follow-up|3
7018082|NCT01529268|11090458|FG000|Overall Study|Moved|3
7018083|NCT01529268|11090459|FG001|Overall Study|Moved|0
7018084|NCT01529346|11090470|FG000|Overall Study|Lost to Follow-up|2
7018085|NCT01529346|11090471|FG001|Overall Study|Lost to Follow-up|0
7018086|NCT01529346|11090472|FG002|Overall Study|Lost to Follow-up|1
7018087|NCT01529346|11090473|FG003|Overall Study|Lost to Follow-up|0
7018088|NCT01529346|11090474|FG004|Overall Study|Lost to Follow-up|0
7018089|NCT01529346|11090470|FG000|Overall Study|Other|0
7018090|NCT01529346|11090471|FG001|Overall Study|Other|1
7018091|NCT01529346|11090472|FG002|Overall Study|Other|1
7018092|NCT01529346|11090473|FG003|Overall Study|Other|0
7018093|NCT01529346|11090474|FG004|Overall Study|Other|0
7018094|NCT01529385|11090489|FG000|Overall Study|Lost to Follow-up|2
7018095|NCT01529385|11090490|FG001|Overall Study|Lost to Follow-up|1
7018096|NCT01529515|11090527|FG000|TRANSITION PHASE|Adverse Event|16
7018097|NCT01529515|11090528|FG001|TRANSITION PHASE|Adverse Event|0
7018098|NCT01529515|11090529|FG002|TRANSITION PHASE|Adverse Event|0
7018099|NCT01529515|11090530|FG003|TRANSITION PHASE|Adverse Event|0
7018100|NCT01529515|11090527|FG000|TRANSITION PHASE|Death|1
7018101|NCT01529515|11090528|FG001|TRANSITION PHASE|Death|0
7018102|NCT01529515|11090529|FG002|TRANSITION PHASE|Death|0
7018103|NCT01529515|11090530|FG003|TRANSITION PHASE|Death|0
7018104|NCT01529515|11090527|FG000|TRANSITION PHASE|Lack of Efficacy|19
7018105|NCT01529515|11090528|FG001|TRANSITION PHASE|Lack of Efficacy|0
7018106|NCT01529515|11090529|FG002|TRANSITION PHASE|Lack of Efficacy|0
7018107|NCT01529515|11090530|FG003|TRANSITION PHASE|Lack of Efficacy|0
7018108|NCT01529515|11090527|FG000|TRANSITION PHASE|Lost to Follow-up|19
7018109|NCT01529515|11090528|FG001|TRANSITION PHASE|Lost to Follow-up|0
7018110|NCT01529515|11090529|FG002|TRANSITION PHASE|Lost to Follow-up|0
7018111|NCT01529515|11090530|FG003|TRANSITION PHASE|Lost to Follow-up|0
7018112|NCT01529515|11090527|FG000|TRANSITION PHASE|Protocol Violation|4
7018113|NCT01529515|11090528|FG001|TRANSITION PHASE|Protocol Violation|0
7018114|NCT01529515|11090529|FG002|TRANSITION PHASE|Protocol Violation|0
7018115|NCT01529515|11090530|FG003|TRANSITION PHASE|Protocol Violation|0
7018116|NCT01529515|11090527|FG000|TRANSITION PHASE|Withdrawal by Subject|51
7018117|NCT01529515|11090528|FG001|TRANSITION PHASE|Withdrawal by Subject|0
7018118|NCT01529515|11090529|FG002|TRANSITION PHASE|Withdrawal by Subject|0
7018119|NCT01529515|11090530|FG003|TRANSITION PHASE|Withdrawal by Subject|0
7018120|NCT01529515|11090527|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8
7018121|NCT01529515|11090528|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
7018122|NCT01529515|11090529|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
7018123|NCT01529515|11090530|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
7018124|NCT01529515|11090527|FG000|TRANSITION PHASE|Other|9
7018125|NCT01529515|11090528|FG001|TRANSITION PHASE|Other|0
7018126|NCT01529515|11090529|FG002|TRANSITION PHASE|Other|0
7018127|NCT01529515|11090530|FG003|TRANSITION PHASE|Other|0
7018128|NCT01529515|11090527|FG000|MAINTENANCE PHASE|Adverse Event|0
7018129|NCT01529515|11090528|FG001|MAINTENANCE PHASE|Adverse Event|10
7018130|NCT01529515|11090529|FG002|MAINTENANCE PHASE|Adverse Event|0
7018131|NCT01529515|11090530|FG003|MAINTENANCE PHASE|Adverse Event|0
7018132|NCT01529515|11090527|FG000|MAINTENANCE PHASE|Lack of Efficacy|0
7018133|NCT01529515|11090528|FG001|MAINTENANCE PHASE|Lack of Efficacy|9
7018134|NCT01529515|11090529|FG002|MAINTENANCE PHASE|Lack of Efficacy|0
7018135|NCT01529515|11090530|FG003|MAINTENANCE PHASE|Lack of Efficacy|0
7018136|NCT01529515|11090527|FG000|MAINTENANCE PHASE|Lost to Follow-up|0
7018137|NCT01529515|11090528|FG001|MAINTENANCE PHASE|Lost to Follow-up|5
7018138|NCT01529515|11090529|FG002|MAINTENANCE PHASE|Lost to Follow-up|0
7018139|NCT01529515|11090530|FG003|MAINTENANCE PHASE|Lost to Follow-up|0
7018140|NCT01529515|11090527|FG000|MAINTENANCE PHASE|Protocol Violation|0
7018141|NCT01529515|11090528|FG001|MAINTENANCE PHASE|Protocol Violation|12
7018142|NCT01529515|11090529|FG002|MAINTENANCE PHASE|Protocol Violation|0
7018143|NCT01529515|11090530|FG003|MAINTENANCE PHASE|Protocol Violation|0
7018144|NCT01529515|11090527|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0
7018145|NCT01529515|11090528|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15
7018146|NCT01529515|11090529|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0
7018147|NCT01529515|11090530|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0
7018148|NCT01529515|11090527|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0
7018149|NCT01529515|11090528|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13
7018150|NCT01529515|11090529|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0
7018151|NCT01529515|11090530|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0
7018152|NCT01529515|11090527|FG000|MAINTENANCE PHASE|Other|0
7018153|NCT01529515|11090528|FG001|MAINTENANCE PHASE|Other|10
7018154|NCT01529515|11090529|FG002|MAINTENANCE PHASE|Other|0
7018155|NCT01529515|11090530|FG003|MAINTENANCE PHASE|Other|0
7018156|NCT01529515|11090527|FG000|DOUBLE BLIND PHASE|Adverse Event|0
7018157|NCT01529515|11090528|FG001|DOUBLE BLIND PHASE|Adverse Event|0
7018158|NCT01529515|11090529|FG002|DOUBLE BLIND PHASE|Adverse Event|1
7018159|NCT01529515|11090530|FG003|DOUBLE BLIND PHASE|Adverse Event|0
7018160|NCT01529515|11090527|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0
7018161|NCT01529515|11090528|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0
7018162|NCT01529515|11090529|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1
7018163|NCT01529515|11090530|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3
7018164|NCT01529515|11090527|FG000|DOUBLE BLIND PHASE|Pregnancy|0
7018165|NCT01529515|11090528|FG001|DOUBLE BLIND PHASE|Pregnancy|0
7018166|NCT01529515|11090529|FG002|DOUBLE BLIND PHASE|Pregnancy|1
7018167|NCT01529515|11090530|FG003|DOUBLE BLIND PHASE|Pregnancy|0
7018168|NCT01529515|11090527|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0
7018169|NCT01529515|11090528|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0
7018170|NCT01529515|11090529|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10
7018171|NCT01529515|11090530|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7
7018172|NCT01529515|11090527|FG000|DOUBLE BLIND PHASE|Protocol Violation|0
7018173|NCT01529515|11090528|FG001|DOUBLE BLIND PHASE|Protocol Violation|0
7018174|NCT01529515|11090529|FG002|DOUBLE BLIND PHASE|Protocol Violation|1
7018175|NCT01529515|11090530|FG003|DOUBLE BLIND PHASE|Protocol Violation|0
7018176|NCT01529515|11090527|FG000|DOUBLE BLIND PHASE|Other|0
7018177|NCT01529515|11090528|FG001|DOUBLE BLIND PHASE|Other|0
7018178|NCT01529515|11090529|FG002|DOUBLE BLIND PHASE|Other|9
7018179|NCT01529515|11090530|FG003|DOUBLE BLIND PHASE|Other|2
7018180|NCT01529606|11090539|FG000|Overall Study|Lost to Follow-up|21
7018181|NCT01529606|11090540|FG001|Overall Study|Lost to Follow-up|18
7018182|NCT01529632|11090548|FG000|Overall Study|Administrative problem|2
7018183|NCT01529632|11090549|FG001|Overall Study|Administrative problem|1
7018184|NCT01529632|11090548|FG000|Overall Study|Protocol Violation|0
7018185|NCT01529632|11090549|FG001|Overall Study|Protocol Violation|1
7018186|NCT01529632|11090548|FG000|Overall Study|Adverse Event|1
7018187|NCT01529632|11090549|FG001|Overall Study|Adverse Event|1
7018188|NCT01529645|11090565|FG000|Overall Study|Lost to Follow-up|0
7018189|NCT01529645|11090566|FG001|Overall Study|Lost to Follow-up|1
7018190|NCT01529645|11090567|FG002|Overall Study|Lost to Follow-up|1
7018191|NCT01529645|11090568|FG003|Overall Study|Lost to Follow-up|1
7018192|NCT01529645|11090569|FG004|Overall Study|Lost to Follow-up|1
7018193|NCT01529645|11090570|FG005|Overall Study|Lost to Follow-up|0
7018194|NCT01529645|11090571|FG006|Overall Study|Lost to Follow-up|2
7018195|NCT01529645|11090572|FG007|Overall Study|Lost to Follow-up|0
7018196|NCT01529645|11090573|FG008|Overall Study|Lost to Follow-up|1
7018197|NCT01529645|11090574|FG009|Overall Study|Lost to Follow-up|0
7018198|NCT01529645|11090565|FG000|Overall Study|SAE - Premature contractions|0
7018199|NCT01529645|11090566|FG001|Overall Study|SAE - Premature contractions|0
7018200|NCT01529645|11090567|FG002|Overall Study|SAE - Premature contractions|1
7018201|NCT01529645|11090568|FG003|Overall Study|SAE - Premature contractions|0
7018202|NCT01529645|11090569|FG004|Overall Study|SAE - Premature contractions|0
7018203|NCT01529645|11090570|FG005|Overall Study|SAE - Premature contractions|0
7018204|NCT01529645|11090571|FG006|Overall Study|SAE - Premature contractions|0
7018205|NCT01529645|11090572|FG007|Overall Study|SAE - Premature contractions|0
7018206|NCT01529645|11090573|FG008|Overall Study|SAE - Premature contractions|0
7018207|NCT01529645|11090574|FG009|Overall Study|SAE - Premature contractions|0
7018208|NCT01529645|11090565|FG000|Overall Study|Withdrawal by Subject|2
7018209|NCT01529645|11090566|FG001|Overall Study|Withdrawal by Subject|0
7018210|NCT01529645|11090567|FG002|Overall Study|Withdrawal by Subject|0
7018211|NCT01529645|11090568|FG003|Overall Study|Withdrawal by Subject|1
7018212|NCT01529645|11090569|FG004|Overall Study|Withdrawal by Subject|1
7018213|NCT01529645|11090570|FG005|Overall Study|Withdrawal by Subject|1
7018214|NCT01529645|11090571|FG006|Overall Study|Withdrawal by Subject|0
7018215|NCT01529645|11090572|FG007|Overall Study|Withdrawal by Subject|0
7018216|NCT01529645|11090573|FG008|Overall Study|Withdrawal by Subject|0
7018217|NCT01529645|11090574|FG009|Overall Study|Withdrawal by Subject|0
7018218|NCT01529749|11090608|FG000|Overall Study|Lost to Follow-up|0
7018219|NCT01529749|11090609|FG001|Overall Study|Lost to Follow-up|1
7018220|NCT01529749|11090610|FG002|Overall Study|Lost to Follow-up|1
7018221|NCT01529749|11090611|FG003|Overall Study|Lost to Follow-up|0
7018222|NCT01529749|11090608|FG000|Overall Study|Physician Decision|0
7018223|NCT01529749|11090609|FG001|Overall Study|Physician Decision|0
7018224|NCT01529749|11090610|FG002|Overall Study|Physician Decision|0
7018225|NCT01529749|11090611|FG003|Overall Study|Physician Decision|1
7018226|NCT01529749|11090608|FG000|Overall Study|Withdrawal by Subject|0
7018227|NCT01529749|11090609|FG001|Overall Study|Withdrawal by Subject|1
7018228|NCT01529749|11090610|FG002|Overall Study|Withdrawal by Subject|1
7018229|NCT01529749|11090611|FG003|Overall Study|Withdrawal by Subject|0
7018230|NCT01529749|11090608|FG000|Overall Study|Protocol Violation|0
7018231|NCT01529749|11090609|FG001|Overall Study|Protocol Violation|0
7018232|NCT01529749|11090610|FG002|Overall Study|Protocol Violation|0
7018233|NCT01529749|11090611|FG003|Overall Study|Protocol Violation|1
7043723|NCT01746901|11128857|FG002|Treatment Phase: First Intervention|Protocol Violation|0
7043724|NCT01746901|11128858|FG003|Treatment Phase: First Intervention|Protocol Violation|0
7018234|NCT01530256|11090656|FG000|Overall Study|Death|2
7018235|NCT01530334|11090660|FG000|Overall Study|Adverse Event|3
7018236|NCT01530334|11090660|FG000|Overall Study|unknown reason|1
7018237|NCT01530334|11090660|FG000|Overall Study|Progressive disease|47
7018238|NCT01530464|11090691|FG000|Washout (24h)|Withdrawal by Subject|1
7018239|NCT01530464|11090692|FG001|Washout (24h)|Withdrawal by Subject|0
7018240|NCT01530464|11090691|FG000|Washout (24h)|Withdrawal by Subject|0
7018241|NCT01530464|11090692|FG001|Washout (24h)|Withdrawal by Subject|1
7018242|NCT01531153|11090717|FG000|Overall Study|Withdrawal by Subject|10
7018243|NCT01531153|11090718|FG001|Overall Study|Withdrawal by Subject|9
7018244|NCT01531153|11090719|FG002|Overall Study|Withdrawal by Subject|15
7018245|NCT01531205|11090730|FG000|Overall Study|Did not proceed to surgery|1
7018246|NCT01531673|11090767|FG000|Overall Study|Non-Compliance|0
7018247|NCT01531673|11090768|FG001|Overall Study|Non-Compliance|0
7018248|NCT01531673|11090769|FG002|Overall Study|Non-Compliance|0
7018249|NCT01531673|11090770|FG003|Overall Study|Non-Compliance|0
7018250|NCT01531673|11090771|FG004|Overall Study|Non-Compliance|0
7018251|NCT01531673|11090772|FG005|Overall Study|Non-Compliance|1
7018252|NCT01531673|11090773|FG006|Overall Study|Non-Compliance|0
7018253|NCT01531673|11090774|FG007|Overall Study|Non-Compliance|0
7018254|NCT01531673|11090775|FG008|Overall Study|Non-Compliance|0
7018255|NCT01531673|11090776|FG009|Overall Study|Non-Compliance|0
7018256|NCT01531673|11090777|FG010|Overall Study|Non-Compliance|0
7018257|NCT01531673|11090778|FG011|Overall Study|Non-Compliance|0
7018258|NCT01531673|11090779|FG012|Overall Study|Non-Compliance|0
7018259|NCT01531673|11090767|FG000|Overall Study|Adverse Event|0
7018260|NCT01531673|11090768|FG001|Overall Study|Adverse Event|1
7018261|NCT01531673|11090769|FG002|Overall Study|Adverse Event|0
7018262|NCT01531673|11090770|FG003|Overall Study|Adverse Event|0
7018263|NCT01531673|11090771|FG004|Overall Study|Adverse Event|0
7018264|NCT01531673|11090772|FG005|Overall Study|Adverse Event|0
7018265|NCT01531673|11090773|FG006|Overall Study|Adverse Event|0
7018266|NCT01531673|11090774|FG007|Overall Study|Adverse Event|0
7018267|NCT01531673|11090775|FG008|Overall Study|Adverse Event|0
7018268|NCT01531673|11090776|FG009|Overall Study|Adverse Event|0
7018269|NCT01531673|11090777|FG010|Overall Study|Adverse Event|0
7018270|NCT01531673|11090778|FG011|Overall Study|Adverse Event|0
7018271|NCT01531673|11090779|FG012|Overall Study|Adverse Event|0
7018272|NCT01531673|11090767|FG000|Overall Study|Lost to Follow-up|0
7018273|NCT01531673|11090768|FG001|Overall Study|Lost to Follow-up|0
7018274|NCT01531673|11090769|FG002|Overall Study|Lost to Follow-up|0
7018275|NCT01531673|11090770|FG003|Overall Study|Lost to Follow-up|0
7018276|NCT01531673|11090771|FG004|Overall Study|Lost to Follow-up|1
7018277|NCT01531673|11090772|FG005|Overall Study|Lost to Follow-up|0
7018278|NCT01531673|11090773|FG006|Overall Study|Lost to Follow-up|0
7018279|NCT01531673|11090774|FG007|Overall Study|Lost to Follow-up|0
7018280|NCT01531673|11090775|FG008|Overall Study|Lost to Follow-up|0
7018281|NCT01531673|11090776|FG009|Overall Study|Lost to Follow-up|0
7018282|NCT01531673|11090777|FG010|Overall Study|Lost to Follow-up|0
7018283|NCT01531673|11090778|FG011|Overall Study|Lost to Follow-up|0
7018284|NCT01531673|11090779|FG012|Overall Study|Lost to Follow-up|0
7018285|NCT01531673|11090767|FG000|Overall Study|Other|0
7018286|NCT01531673|11090768|FG001|Overall Study|Other|0
7018287|NCT01531673|11090769|FG002|Overall Study|Other|0
7018288|NCT01531673|11090770|FG003|Overall Study|Other|1
7018289|NCT01531673|11090771|FG004|Overall Study|Other|0
7018290|NCT01531673|11090772|FG005|Overall Study|Other|0
7018291|NCT01531673|11090773|FG006|Overall Study|Other|0
7018292|NCT01531673|11090774|FG007|Overall Study|Other|0
7018293|NCT01531673|11090775|FG008|Overall Study|Other|0
7018294|NCT01531673|11090776|FG009|Overall Study|Other|1
7018295|NCT01531673|11090777|FG010|Overall Study|Other|0
7018296|NCT01531673|11090778|FG011|Overall Study|Other|0
7018297|NCT01531673|11090779|FG012|Overall Study|Other|0
7018298|NCT01531725|11090831|FG000|Overall Study|Protocol Violation|5
7018299|NCT01531894|11090853|FG000|Overall Study|Physician Decision|8
7018300|NCT01531894|11090853|FG000|Overall Study|Death|1
7018301|NCT01531998|11090866|FG000|Overall Study|Withdrawal by Subject|3
7018302|NCT01532388|11090920|FG000|3-month Follow-up|Lost to Follow-up|68
7018303|NCT01532388|11090921|FG001|3-month Follow-up|Lost to Follow-up|68
7018304|NCT01532388|11090920|FG000|6-month Follow-up|Lost to Follow-up|74
7018305|NCT01532388|11090921|FG001|6-month Follow-up|Lost to Follow-up|66
7018306|NCT01532388|11090920|FG000|12-month Follow-up|Lost to Follow-up|69
7018307|NCT01532388|11090921|FG001|12-month Follow-up|Lost to Follow-up|67
7018308|NCT01532414|11090930|FG000|Overall Study|Lost to Follow-up|3
7018309|NCT01532414|11090931|FG001|Overall Study|Lost to Follow-up|0
7018310|NCT01532414|11090932|FG002|Overall Study|Lost to Follow-up|1
7018311|NCT01532414|11090930|FG000|Overall Study|Withdrawal by Subject|3
7018312|NCT01532414|11090931|FG001|Overall Study|Withdrawal by Subject|0
7018313|NCT01532414|11090932|FG002|Overall Study|Withdrawal by Subject|0
7018314|NCT01532414|11090930|FG000|Overall Study|No V6 semen sample|0
7018315|NCT01532414|11090931|FG001|Overall Study|No V6 semen sample|1
7018316|NCT01532414|11090932|FG002|Overall Study|No V6 semen sample|0
7018317|NCT01532414|11090930|FG000|Overall Study|Adverse Event|0
7018318|NCT01532414|11090931|FG001|Overall Study|Adverse Event|1
7018319|NCT01532414|11090932|FG002|Overall Study|Adverse Event|1
7018320|NCT01532414|11090930|FG000|Overall Study|Unable to complete 24 hour PK|0
7018321|NCT01532414|11090931|FG001|Overall Study|Unable to complete 24 hour PK|0
7018322|NCT01532414|11090932|FG002|Overall Study|Unable to complete 24 hour PK|1
7018323|NCT01532414|11090930|FG000|Overall Study|Withdrawn by sponsor|1
7018324|NCT01532414|11090931|FG001|Overall Study|Withdrawn by sponsor|0
7018325|NCT01532414|11090932|FG002|Overall Study|Withdrawn by sponsor|0
7018326|NCT01532570|11090953|FG000|Overall Study|Lack of Efficacy|1
7018327|NCT01532570|11090954|FG001|Overall Study|Lack of Efficacy|0
7018328|NCT01532570|11090955|FG002|Overall Study|Lack of Efficacy|0
7018329|NCT01532570|11090956|FG003|Overall Study|Lack of Efficacy|0
7018330|NCT01532570|11090953|FG000|Overall Study|Withdrawal by Subject|0
7018331|NCT01532570|11090954|FG001|Overall Study|Withdrawal by Subject|1
7018332|NCT01532570|11090955|FG002|Overall Study|Withdrawal by Subject|0
7018333|NCT01532570|11090956|FG003|Overall Study|Withdrawal by Subject|0
7018334|NCT01532648|11090975|FG000|Overall Study|Lost to Follow-up|3
7018335|NCT01532648|11090976|FG001|Overall Study|Lost to Follow-up|4
7018336|NCT01532648|11090975|FG000|Overall Study|Lack of Efficacy|4
7018337|NCT01532648|11090976|FG001|Overall Study|Lack of Efficacy|1
7018338|NCT01532648|11090975|FG000|Overall Study|Protocol Violation|1
7018339|NCT01532648|11090976|FG001|Overall Study|Protocol Violation|1
7018340|NCT01532648|11090975|FG000|Overall Study|Adverse Event|12
7018341|NCT01532648|11090976|FG001|Overall Study|Adverse Event|9
7018342|NCT01532648|11090975|FG000|Overall Study|Withdrawal by Subject|16
7018343|NCT01532648|11090976|FG001|Overall Study|Withdrawal by Subject|2
7018344|NCT01532687|11090984|FG000|Overall Study|Death|2
7018345|NCT01532687|11090985|FG001|Overall Study|Death|0
7018346|NCT01532687|11090984|FG000|Overall Study|Adverse Event|6
7018347|NCT01532687|11090985|FG001|Overall Study|Adverse Event|1
7018348|NCT01532687|11090984|FG000|Overall Study|Withdrawal by Subject|1
7018349|NCT01532687|11090985|FG001|Overall Study|Withdrawal by Subject|0
7018350|NCT01532687|11090984|FG000|Overall Study|Physician Decision|2
7018351|NCT01532687|11090985|FG001|Overall Study|Physician Decision|1
7018352|NCT01532687|11090984|FG000|Overall Study|Protocol-defined delay > 3 weeks|3
7018353|NCT01532687|11090985|FG001|Overall Study|Protocol-defined delay > 3 weeks|0
7018354|NCT01532869|11091007|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0
7018355|NCT01532869|11091008|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1
7018356|NCT01532869|11091007|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2
7018357|NCT01532869|11091008|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3
7018358|NCT01532869|11091007|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0
7018359|NCT01532869|11091008|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1
7018360|NCT01532869|11091007|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1
7018361|NCT01532869|11091008|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0
7018362|NCT01532869|11091007|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
7018363|NCT01532869|11091008|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
7018364|NCT01532869|11091007|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4
7018365|NCT01532869|11091008|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2
7018366|NCT01532869|11091007|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0
7018367|NCT01532869|11091008|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3
7018368|NCT01532869|11091007|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4
7018369|NCT01532869|11091008|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5
7018370|NCT01532869|11091007|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0
7018371|NCT01532869|11091008|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1
7018372|NCT01532869|11091007|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1
7018373|NCT01532869|11091008|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0
7018374|NCT01532869|11091007|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0
7018375|NCT01532869|11091008|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1
7018376|NCT01532869|11091007|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5
7018377|NCT01532869|11091008|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3
7018378|NCT01532869|11091007|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1
7018379|NCT01532869|11091008|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0
7018380|NCT01532869|11091007|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4
7018381|NCT01532869|11091008|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1
7018382|NCT01532869|11091007|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1
7018383|NCT01532869|11091008|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0
7018384|NCT01532869|11091007|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
7018385|NCT01532869|11091008|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
7018386|NCT01532869|11091007|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
7018387|NCT01532869|11091008|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
7018388|NCT01532908|11091021|FG000|Overall Study|Not Transplanted|1
7018389|NCT01532908|11091022|FG001|Overall Study|Not Transplanted|0
7018390|NCT01532921|11091028|FG000|Overall Study|Death|3
7018391|NCT01532921|11091028|FG000|Overall Study|Withdrawal by Subject|2
7018392|NCT01532921|11091028|FG000|Overall Study|Lost to Follow-up|3
7018393|NCT01532921|11091028|FG000|Overall Study|Physician Decision|7
7018394|NCT01532921|11091028|FG000|Overall Study|Device was explanted during procedure|1
7018395|NCT01532934|11091038|FG000|Overall Study|Lost to Follow-up|11
7018396|NCT01532934|11091039|FG001|Overall Study|Lost to Follow-up|11
7018397|NCT01532934|11091038|FG000|Overall Study|In controlled environment|3
7018398|NCT01532934|11091039|FG001|Overall Study|In controlled environment|2
7018399|NCT01532986|11091091|FG000|Overall Study|Death|9
7018400|NCT01532986|11091092|FG001|Overall Study|Death|9
7018401|NCT01532986|11091091|FG000|Overall Study|Withdrawal by Subject|7
7018402|NCT01532986|11091092|FG001|Overall Study|Withdrawal by Subject|10
7018403|NCT01532986|11091091|FG000|Overall Study|Physician Decision|7
7018404|NCT01532986|11091092|FG001|Overall Study|Physician Decision|5
7018405|NCT01532999|11091101|FG000|Overall Study|Lost to Follow-up|14
7018406|NCT01532999|11091102|FG001|Overall Study|Lost to Follow-up|8
7018407|NCT01532999|11091101|FG000|Overall Study|Physician Decision|1
7018408|NCT01532999|11091102|FG001|Overall Study|Physician Decision|2
7018409|NCT01532999|11091101|FG000|Overall Study|Withdrawal by Subject|5
7018410|NCT01532999|11091102|FG001|Overall Study|Withdrawal by Subject|0
7018411|NCT01532999|11091101|FG000|Overall Study|Relocated|2
7018412|NCT01532999|11091102|FG001|Overall Study|Relocated|0
7018413|NCT01532999|11091101|FG000|Overall Study|should not have been randomized|1
7018414|NCT01532999|11091102|FG001|Overall Study|should not have been randomized|0
7018415|NCT01532999|11091101|FG000|Overall Study|substantial noncompliance|2
7018416|NCT01532999|11091102|FG001|Overall Study|substantial noncompliance|0
7018417|NCT01532999|11091101|FG000|Overall Study|no show for week 9 assessments|6
7018418|NCT01532999|11091102|FG001|Overall Study|no show for week 9 assessments|4
7018419|NCT01532999|11091101|FG000|Overall Study|Adverse Event|0
7018420|NCT01532999|11091102|FG001|Overall Study|Adverse Event|1
7018421|NCT01532999|11091101|FG000|Overall Study|incarcerated|0
7018422|NCT01532999|11091102|FG001|Overall Study|incarcerated|1
7018423|NCT01532999|11091101|FG000|Overall Study|New job|0
7018424|NCT01532999|11091102|FG001|Overall Study|New job|2
7018425|NCT01533181|11091153|FG000|Overall Study|Disease progression pre-active treatment|0
7018426|NCT01533181|11091154|FG001|Overall Study|Disease progression pre-active treatment|1
7018427|NCT01533181|11091153|FG000|Overall Study|Patient withdrawal pre-active treatment|1
7018428|NCT01533181|11091154|FG001|Overall Study|Patient withdrawal pre-active treatment|0
7018429|NCT01533246|11091169|FG000|Overall Study|Adverse Event|1
7018430|NCT01533246|11091169|FG000|Overall Study|Withdrawal by Subject|1
7018431|NCT01533428|11091179|FG000|Overall Study|Adverse Event|0
7018432|NCT01533428|11091180|FG001|Overall Study|Adverse Event|1
7018433|NCT01533428|11091179|FG000|Overall Study|Lost to Follow-up|2
7018434|NCT01533428|11091180|FG001|Overall Study|Lost to Follow-up|1
7018435|NCT01533428|11091179|FG000|Overall Study|Withdrawal by Subject|7
7018436|NCT01533428|11091180|FG001|Overall Study|Withdrawal by Subject|6
7018437|NCT01533493|11091188|FG000|Overall Study|Adverse Event|2
7018438|NCT01533493|11091189|FG001|Overall Study|Adverse Event|1
7018439|NCT01533493|11091188|FG000|Overall Study|Withdrawal by Subject|1
7018440|NCT01533493|11091189|FG001|Overall Study|Withdrawal by Subject|2
7018441|NCT01533493|11091188|FG000|Overall Study|Lost to Follow-up|2
7018442|NCT01533493|11091189|FG001|Overall Study|Lost to Follow-up|0
7018443|NCT01533688|11091207|FG000|Overall Study|Withdrawal by Subject|5
7018444|NCT01533688|11091208|FG001|Overall Study|Withdrawal by Subject|4
7018445|NCT01533688|11091209|FG002|Overall Study|Withdrawal by Subject|3
7018446|NCT01533688|11091207|FG000|Overall Study|Medically unstable|1
7018447|NCT01533688|11091208|FG001|Overall Study|Medically unstable|3
7018448|NCT01533688|11091209|FG002|Overall Study|Medically unstable|3
7018449|NCT01533688|11091207|FG000|Overall Study|Had colonoscopy at outside hospital|2
7018450|NCT01533688|11091208|FG001|Overall Study|Had colonoscopy at outside hospital|3
7018451|NCT01533688|11091209|FG002|Overall Study|Had colonoscopy at outside hospital|2
7018452|NCT01533922|11091219|FG000|Overall Study|Adverse Event|5
7018453|NCT01533922|11091220|FG001|Overall Study|Adverse Event|8
7018454|NCT01533922|11091221|FG002|Overall Study|Adverse Event|6
7018455|NCT01533922|11091222|FG003|Overall Study|Adverse Event|3
7018456|NCT01533922|11091223|FG004|Overall Study|Adverse Event|4
7018457|NCT01533922|11091219|FG000|Overall Study|Lack of Efficacy|0
7018458|NCT01533922|11091220|FG001|Overall Study|Lack of Efficacy|0
7018459|NCT01533922|11091221|FG002|Overall Study|Lack of Efficacy|1
7018460|NCT01533922|11091222|FG003|Overall Study|Lack of Efficacy|0
7018461|NCT01533922|11091223|FG004|Overall Study|Lack of Efficacy|0
7018462|NCT01533922|11091219|FG000|Overall Study|Protocol Violation|0
7018463|NCT01533922|11091220|FG001|Overall Study|Protocol Violation|3
7018464|NCT01533922|11091221|FG002|Overall Study|Protocol Violation|0
7018465|NCT01533922|11091222|FG003|Overall Study|Protocol Violation|0
7018466|NCT01533922|11091223|FG004|Overall Study|Protocol Violation|1
7018467|NCT01533922|11091219|FG000|Overall Study|Withdrawal by Subject|3
7018468|NCT01533922|11091220|FG001|Overall Study|Withdrawal by Subject|1
7018469|NCT01533922|11091221|FG002|Overall Study|Withdrawal by Subject|2
7018470|NCT01533922|11091222|FG003|Overall Study|Withdrawal by Subject|2
7018471|NCT01533922|11091223|FG004|Overall Study|Withdrawal by Subject|1
7018472|NCT01533922|11091219|FG000|Overall Study|Other reason not defined above|2
7018473|NCT01533922|11091220|FG001|Overall Study|Other reason not defined above|0
7018474|NCT01533922|11091221|FG002|Overall Study|Other reason not defined above|1
7018475|NCT01533922|11091222|FG003|Overall Study|Other reason not defined above|0
7018476|NCT01533922|11091223|FG004|Overall Study|Other reason not defined above|0
7018477|NCT01533935|11091235|FG000|Overall Study|Adverse Event|5
7018478|NCT01533935|11091236|FG001|Overall Study|Adverse Event|7
7018479|NCT01533935|11091237|FG002|Overall Study|Adverse Event|1
7018480|NCT01533935|11091238|FG003|Overall Study|Adverse Event|5
7018481|NCT01533935|11091239|FG004|Overall Study|Adverse Event|3
7018482|NCT01533935|11091235|FG000|Overall Study|Protocol Violation|0
7018483|NCT01533935|11091236|FG001|Overall Study|Protocol Violation|2
7018484|NCT01533935|11091237|FG002|Overall Study|Protocol Violation|0
7018485|NCT01533935|11091238|FG003|Overall Study|Protocol Violation|0
7018486|NCT01533935|11091239|FG004|Overall Study|Protocol Violation|0
7018487|NCT01533935|11091235|FG000|Overall Study|Lost to Follow-up|0
7018488|NCT01533935|11091236|FG001|Overall Study|Lost to Follow-up|0
7018489|NCT01533935|11091237|FG002|Overall Study|Lost to Follow-up|1
7018490|NCT01533935|11091238|FG003|Overall Study|Lost to Follow-up|0
7018491|NCT01533935|11091239|FG004|Overall Study|Lost to Follow-up|0
7018492|NCT01533935|11091235|FG000|Overall Study|Withdrawal by Subject|0
7018493|NCT01533935|11091236|FG001|Overall Study|Withdrawal by Subject|4
7018494|NCT01533935|11091237|FG002|Overall Study|Withdrawal by Subject|5
7018495|NCT01533935|11091238|FG003|Overall Study|Withdrawal by Subject|2
7018496|NCT01533935|11091239|FG004|Overall Study|Withdrawal by Subject|4
7018497|NCT01533935|11091235|FG000|Overall Study|Other reason not defined above|1
7018498|NCT01533935|11091236|FG001|Overall Study|Other reason not defined above|0
7018499|NCT01533935|11091237|FG002|Overall Study|Other reason not defined above|1
7018500|NCT01533935|11091238|FG003|Overall Study|Other reason not defined above|0
7018501|NCT01533935|11091239|FG004|Overall Study|Other reason not defined above|1
7018502|NCT01534078|11091277|FG000|Overall Study|Death|1
7018503|NCT01534078|11091277|FG000|Overall Study|Withdrawal by Subject|1
7018504|NCT01534182|11091283|FG000|Overall Study|Administrative problems|1
7018505|NCT01534182|11091284|FG001|Overall Study|Administrative problems|0
7018506|NCT01534182|11091283|FG000|Overall Study|Withdrawal by Subject|4
7018507|NCT01534182|11091284|FG001|Overall Study|Withdrawal by Subject|7
7018508|NCT01534182|11091283|FG000|Overall Study|Adverse Event|7
7018509|NCT01534182|11091284|FG001|Overall Study|Adverse Event|3
7018510|NCT01534195|11091293|FG000|Overall Study|Withdrawal by Subject|1
7018511|NCT01534195|11091294|FG001|Overall Study|Withdrawal by Subject|1
7018512|NCT01534208|11091302|FG000|Overall Study|Lost to Follow-up|19
7018513|NCT01534208|11091303|FG001|Overall Study|Lost to Follow-up|14
7018514|NCT01534208|11091302|FG000|Overall Study|Withdrawal by Subject|6
7018515|NCT01534208|11091303|FG001|Overall Study|Withdrawal by Subject|20
7018516|NCT01534208|11091302|FG000|Overall Study|Adverse Event|15
7018517|NCT01534208|11091303|FG001|Overall Study|Adverse Event|8
7018518|NCT01534208|11091302|FG000|Overall Study|Physician Decision|2
7018519|NCT01534208|11091303|FG001|Overall Study|Physician Decision|0
7018520|NCT01534208|11091302|FG000|Overall Study|Lack of Efficacy|0
7018521|NCT01534208|11091303|FG001|Overall Study|Lack of Efficacy|3
7018522|NCT01534208|11091302|FG000|Overall Study|Protocol Violation|2
7018523|NCT01534208|11091303|FG001|Overall Study|Protocol Violation|2
7018524|NCT01534208|11091302|FG000|Overall Study|Sponsor decision|4
7018525|NCT01534208|11091303|FG001|Overall Study|Sponsor decision|1
7018526|NCT01534208|11091302|FG000|Overall Study|Subject relocation|2
7018527|NCT01534208|11091303|FG001|Overall Study|Subject relocation|0
7018528|NCT01534208|11091302|FG000|Overall Study|Lab assessment|2
7018529|NCT01534208|11091303|FG001|Overall Study|Lab assessment|1
7018530|NCT01534208|11091302|FG000|Overall Study|Eligibility error|3
7018531|NCT01534208|11091303|FG001|Overall Study|Eligibility error|0
7018532|NCT01534208|11091302|FG000|Overall Study|PCP decision|1
7018533|NCT01534208|11091303|FG001|Overall Study|PCP decision|0
7018534|NCT01534208|11091302|FG000|Overall Study|Needed prohibited meds|1
7018535|NCT01534208|11091303|FG001|Overall Study|Needed prohibited meds|0
7018536|NCT01534260|11091311|FG000|Overall Study|Adverse Event|1
7018537|NCT01534260|11091312|FG001|Overall Study|Adverse Event|8
7018538|NCT01534260|11091311|FG000|Overall Study|Death|2
7018539|NCT01534260|11091312|FG001|Overall Study|Death|0
7018540|NCT01534260|11091311|FG000|Overall Study|Lack of Efficacy|1
7018541|NCT01534260|11091312|FG001|Overall Study|Lack of Efficacy|1
7018542|NCT01534260|11091311|FG000|Overall Study|Withdrawal by Subject|1
7018543|NCT01534260|11091312|FG001|Overall Study|Withdrawal by Subject|3
7018544|NCT01534260|11091311|FG000|Overall Study|Disease Progression|8
7018545|NCT01534260|11091312|FG001|Overall Study|Disease Progression|6
7018546|NCT01534260|11091311|FG000|Overall Study|Physician Decision|3
7018547|NCT01534260|11091312|FG001|Overall Study|Physician Decision|1
7018548|NCT01534260|11091311|FG000|Overall Study|No treatment, per protocol|0
7018549|NCT01534260|11091312|FG001|Overall Study|No treatment, per protocol|1
7018550|NCT01534273|11091322|FG000|Period 1|Physician Decision|0
7018551|NCT01534273|11091323|FG001|Period 1|Physician Decision|0
7018552|NCT01534273|11091324|FG002|Period 1|Physician Decision|0
7018553|NCT01534273|11091325|FG003|Period 1|Physician Decision|1
7018554|NCT01534273|11091326|FG004|Period 1|Physician Decision|0
7018555|NCT01534273|11091327|FG005|Period 1|Physician Decision|0
7018556|NCT01534273|11091328|FG006|Period 1|Physician Decision|0
7018557|NCT01534351|11091352|FG000|Overall Study|Study Terminated Early|1
7018558|NCT01534351|11091353|FG001|Overall Study|Study Terminated Early|0
7018559|NCT01534351|11091354|FG002|Overall Study|Study Terminated Early|0
7018560|NCT01534520|11091383|FG000|Overall Study|Adverse Event|0
7018561|NCT01534520|11091384|FG001|Overall Study|Adverse Event|1
7018562|NCT01534533|11091398|FG000|Overall Study|Lost to Follow-up|3
7018563|NCT01534533|11091399|FG001|Overall Study|Lost to Follow-up|0
7018564|NCT01534533|11091400|FG002|Overall Study|Lost to Follow-up|4
7018565|NCT01534533|11091401|FG003|Overall Study|Lost to Follow-up|3
7018566|NCT01534533|11091398|FG000|Overall Study|Withdrawal by Subject|5
7018567|NCT01534533|11091399|FG001|Overall Study|Withdrawal by Subject|3
7018568|NCT01534533|11091400|FG002|Overall Study|Withdrawal by Subject|4
7018569|NCT01534533|11091401|FG003|Overall Study|Withdrawal by Subject|1
7018570|NCT01534637|11091413|FG000|Overall Study|Physician Decision|3
7018571|NCT01534637|11091413|FG000|Overall Study|Lack of Efficacy|3
7018572|NCT01534637|11091413|FG000|Overall Study|Withdrawal by Subject|1
7018573|NCT01534637|11091413|FG000|Overall Study|Adverse Event|1
7018574|NCT01534637|11091413|FG000|Overall Study|Liver Mets before treatment|1
7018575|NCT01534663|11091419|FG000|Overall Study|Lost to Follow-up|0
7018576|NCT01534663|11091420|FG001|Overall Study|Lost to Follow-up|2
7018577|NCT01534663|11091419|FG000|Overall Study|Adverse Event|2
7018578|NCT01534663|11091420|FG001|Overall Study|Adverse Event|1
7018579|NCT01534962|11091450|FG000|Overall Study|Randomized but did not start treatment|2
7018580|NCT01534962|11091451|FG001|Overall Study|Randomized but did not start treatment|0
7018581|NCT01534962|11091452|FG002|Overall Study|Randomized but did not start treatment|0
7018582|NCT01534962|11091453|FG003|Overall Study|Randomized but did not start treatment|1
7018583|NCT01534962|11091450|FG000|Overall Study|Discontinued at AF recurrence|35
7018584|NCT01534962|11091451|FG001|Overall Study|Discontinued at AF recurrence|26
7018585|NCT01534962|11091452|FG002|Overall Study|Discontinued at AF recurrence|24
7018586|NCT01534962|11091453|FG003|Overall Study|Discontinued at AF recurrence|31
7018587|NCT01535040|11091506|FG000|Overall Study|Physician Decision|0
7018588|NCT01535040|11091507|FG001|Overall Study|Physician Decision|1
7018589|NCT01535040|11091506|FG000|Overall Study|Withdrawal by Subject|13
7018590|NCT01535040|11091507|FG001|Overall Study|Withdrawal by Subject|10
7018591|NCT01535040|11091506|FG000|Overall Study|Never Started|9
7018592|NCT01535040|11091507|FG001|Overall Study|Never Started|4
7018593|NCT01535040|11091506|FG000|Overall Study|Toxicity|7
7018594|NCT01535040|11091507|FG001|Overall Study|Toxicity|5
7018595|NCT01535040|11091506|FG000|Overall Study|Multiple Reasons|1
7018596|NCT01535040|11091507|FG001|Overall Study|Multiple Reasons|1
7018597|NCT01535053|11091515|FG000|Overall Study|Ineligible|1
7018598|NCT01535053|11091516|FG001|Overall Study|Ineligible|2
7018599|NCT01535222|11091532|FG000|Overall Study|Inclusion/exclusion|0
7018600|NCT01535222|11091533|FG001|Overall Study|Inclusion/exclusion|0
7018601|NCT01535222|11091534|FG002|Overall Study|Inclusion/exclusion|1
7018602|NCT01535222|11091535|FG003|Overall Study|Inclusion/exclusion|0
7018603|NCT01535222|11091536|FG004|Overall Study|Inclusion/exclusion|0
7018604|NCT01535222|11091537|FG005|Overall Study|Inclusion/exclusion|0
7018605|NCT01535235|11091553|FG000|Overall Study|Adverse Event|1
7018606|NCT01535235|11091554|FG001|Overall Study|Adverse Event|0
7018607|NCT01535261|11091560|FG000|Overall Study|Physician Decision|8
7018608|NCT01535261|11091560|FG000|Overall Study|Protocol Violation|3
7018609|NCT01535261|11091560|FG000|Overall Study|Death|5
7018610|NCT01535261|11091560|FG000|Overall Study|Lost to Follow-up|8
7018611|NCT01535261|11091560|FG000|Overall Study|Withdrawal by Subject|14
7018612|NCT01535261|11091560|FG000|Overall Study|Adverse Event|12
7018613|NCT01535287|11091566|FG000|Overall Study|drug not prepared in time|5
7018614|NCT01535287|11091567|FG001|Overall Study|drug not prepared in time|6
7018615|NCT01535443|11091600|FG000|Overall Study|Physician Decision|3
7018616|NCT01535560|11091607|FG000|Overall Study|Adverse Event|12
7018617|NCT01535560|11091608|FG001|Overall Study|Adverse Event|7
7018618|NCT01535560|11091607|FG000|Overall Study|Lost to Follow-up|1
7018619|NCT01535560|11091608|FG001|Overall Study|Lost to Follow-up|3
7018620|NCT01535560|11091607|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3
7018621|NCT01535560|11091608|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1
7018622|NCT01535560|11091607|FG000|Overall Study|Treatment Failure|21
7018623|NCT01535560|11091608|FG001|Overall Study|Treatment Failure|83
7018624|NCT01535560|11091607|FG000|Overall Study|Other|0
7018625|NCT01535560|11091608|FG001|Overall Study|Other|1
7018626|NCT01535560|11091607|FG000|Overall Study|Randomized in Error|0
7018627|NCT01535560|11091608|FG001|Overall Study|Randomized in Error|1
7018628|NCT01535599|11091629|FG000|Overall Study|Adverse Event|6
7018629|NCT01535599|11091630|FG001|Overall Study|Adverse Event|15
7018630|NCT01535599|11091629|FG000|Overall Study|Lost to Follow-up|3
7018631|NCT01535599|11091630|FG001|Overall Study|Lost to Follow-up|4
7018632|NCT01535599|11091629|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4
7018633|NCT01535599|11091630|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3
7018634|NCT01535599|11091629|FG000|Overall Study|Treatment Failure|33
7018635|NCT01535599|11091630|FG001|Overall Study|Treatment Failure|66
7018636|NCT01535599|11091629|FG000|Overall Study|BL Culture + for Group A Strep|0
7018637|NCT01535599|11091630|FG001|Overall Study|BL Culture + for Group A Strep|1
7018638|NCT01535599|11091629|FG000|Overall Study|BL Culture + for Yeast//Fungi|0
7018639|NCT01535599|11091630|FG001|Overall Study|BL Culture + for Yeast//Fungi|1
7018640|NCT01535599|11091629|FG000|Overall Study|Randomized in Error|2
7018641|NCT01535599|11091630|FG001|Overall Study|Randomized in Error|4
7018642|NCT01535599|11091629|FG000|Overall Study|Did not use product|1
7018643|NCT01535599|11091630|FG001|Overall Study|Did not use product|0
7018644|NCT01535599|11091629|FG000|Overall Study|Other|1
7018645|NCT01535599|11091630|FG001|Overall Study|Other|0
7018646|NCT01535599|11091629|FG000|Overall Study|Stopped medication|0
7018647|NCT01535599|11091630|FG001|Overall Study|Stopped medication|1
7018648|NCT01535599|11091629|FG000|Overall Study|Noncompliance|0
7018649|NCT01535599|11091630|FG001|Overall Study|Noncompliance|1
7018650|NCT01535638|11091636|FG000|Treatment 1 (Single Dose)|Protocol Violation|0
7018651|NCT01535638|11091637|FG001|Treatment 1 (Single Dose)|Protocol Violation|0
7018652|NCT01535638|11091638|FG002|Treatment 1 (Single Dose)|Protocol Violation|0
7018653|NCT01535638|11091639|FG003|Treatment 1 (Single Dose)|Protocol Violation|0
7018654|NCT01535638|11091640|FG004|Treatment 1 (Single Dose)|Protocol Violation|0
7018655|NCT01535638|11091641|FG005|Treatment 1 (Single Dose)|Protocol Violation|1
7018656|NCT01535638|11091636|FG000|Treatment 3 (Single Dose)|Protocol Violation|0
7018657|NCT01535638|11091637|FG001|Treatment 3 (Single Dose)|Protocol Violation|0
7018658|NCT01535638|11091638|FG002|Treatment 3 (Single Dose)|Protocol Violation|0
7018659|NCT01535638|11091639|FG003|Treatment 3 (Single Dose)|Protocol Violation|1
7018660|NCT01535638|11091640|FG004|Treatment 3 (Single Dose)|Protocol Violation|0
7018661|NCT01535638|11091641|FG005|Treatment 3 (Single Dose)|Protocol Violation|0
7018662|NCT01535729|11091658|FG000|Overall Study|Withdrawal by Subject|2
7018663|NCT01535729|11091658|FG000|Overall Study|Disease progression|230
7018664|NCT01535729|11091658|FG000|Overall Study|Discontinued treatment|25
7018665|NCT01535729|11091658|FG000|Overall Study|Lost to Follow-up|8
7018666|NCT01535729|11091658|FG000|Overall Study|Death|52
7018667|NCT01535729|11091658|FG000|Overall Study|Other|19
7018668|NCT01535729|11091658|FG000|Overall Study|Did not sign informed consent|1
7018669|NCT01535729|11091658|FG000|Overall Study|No previous chemotherapy|33
7018670|NCT01535729|11091658|FG000|Overall Study|NSCLC grade IV histology not confirmed|20
7018671|NCT01535729|11091658|FG000|Overall Study|Protocol Violation|11
7018672|NCT01535729|11091658|FG000|Overall Study|Screening failure|1
7018673|NCT01535729|11091658|FG000|Overall Study|Not treated|9
7018674|NCT01535729|11091658|FG000|Overall Study|No participant record available|5
7018675|NCT01536067|11091706|FG000|Overall Study|Disease Progression|1
7018676|NCT01536093|11091712|FG000|Overall Study|Death|1
7018677|NCT01536093|11091713|FG001|Overall Study|Death|2
7018678|NCT01536093|11091712|FG000|Overall Study|absence of maternal colostrum|2
7018679|NCT01536093|11091713|FG001|Overall Study|absence of maternal colostrum|0
7018680|NCT01536093|11091712|FG000|Overall Study|Withdrawal by Subject|0
7018681|NCT01536093|11091713|FG001|Overall Study|Withdrawal by Subject|1
7018682|NCT01536119|11091721|FG000|Overall Study|Lost to Follow-up|17
7018683|NCT01536119|11091722|FG001|Overall Study|Lost to Follow-up|14
7018684|NCT01536145|11091728|FG000|Overall Study|Progressive disease|3
7018685|NCT01536145|11091729|FG001|Overall Study|Progressive disease|4
7018686|NCT01536145|11091730|FG002|Overall Study|Progressive disease|1
7018687|NCT01536145|11091731|FG003|Overall Study|Progressive disease|2
7018688|NCT01536145|11091732|FG004|Overall Study|Progressive disease|1
7018689|NCT01536145|11091733|FG005|Overall Study|Progressive disease|2
7018690|NCT01536145|11091734|FG006|Overall Study|Progressive disease|1
7018691|NCT01536145|11091735|FG007|Overall Study|Progressive disease|2
7018692|NCT01536145|11091736|FG008|Overall Study|Progressive disease|1
7018693|NCT01536145|11091737|FG009|Overall Study|Progressive disease|3
7018694|NCT01536145|11091738|FG010|Overall Study|Progressive disease|3
7018695|NCT01536145|11091728|FG000|Overall Study|Withdrawal by Subject|0
7018696|NCT01536145|11091729|FG001|Overall Study|Withdrawal by Subject|0
7018697|NCT01536145|11091730|FG002|Overall Study|Withdrawal by Subject|1
7018698|NCT01536145|11091731|FG003|Overall Study|Withdrawal by Subject|0
7018699|NCT01536145|11091732|FG004|Overall Study|Withdrawal by Subject|0
7018700|NCT01536145|11091733|FG005|Overall Study|Withdrawal by Subject|1
7018701|NCT01536145|11091734|FG006|Overall Study|Withdrawal by Subject|0
7018702|NCT01536145|11091735|FG007|Overall Study|Withdrawal by Subject|0
7018703|NCT01536145|11091736|FG008|Overall Study|Withdrawal by Subject|2
7018704|NCT01536145|11091737|FG009|Overall Study|Withdrawal by Subject|0
7018705|NCT01536145|11091738|FG010|Overall Study|Withdrawal by Subject|2
7018706|NCT01536145|11091728|FG000|Overall Study|Other|0
7018707|NCT01536145|11091729|FG001|Overall Study|Other|0
7018708|NCT01536145|11091730|FG002|Overall Study|Other|0
7018709|NCT01536145|11091731|FG003|Overall Study|Other|0
7018710|NCT01536145|11091732|FG004|Overall Study|Other|1
7018711|NCT01536145|11091733|FG005|Overall Study|Other|0
7018712|NCT01536145|11091734|FG006|Overall Study|Other|0
7018713|NCT01536145|11091735|FG007|Overall Study|Other|0
7018714|NCT01536145|11091736|FG008|Overall Study|Other|0
7018715|NCT01536145|11091737|FG009|Overall Study|Other|3
7018716|NCT01536145|11091738|FG010|Overall Study|Other|2
7018717|NCT01536145|11091728|FG000|Overall Study|Death|0
7018718|NCT01536145|11091729|FG001|Overall Study|Death|0
7018719|NCT01536145|11091730|FG002|Overall Study|Death|0
7018720|NCT01536145|11091731|FG003|Overall Study|Death|0
7018721|NCT01536145|11091732|FG004|Overall Study|Death|0
7018722|NCT01536145|11091733|FG005|Overall Study|Death|0
7018723|NCT01536145|11091734|FG006|Overall Study|Death|1
7018724|NCT01536145|11091735|FG007|Overall Study|Death|0
7018725|NCT01536145|11091736|FG008|Overall Study|Death|0
7018726|NCT01536145|11091737|FG009|Overall Study|Death|0
7018727|NCT01536145|11091738|FG010|Overall Study|Death|0
7018728|NCT01536145|11091728|FG000|Overall Study|Adverse Event|0
7018729|NCT01536145|11091729|FG001|Overall Study|Adverse Event|0
7018730|NCT01536145|11091730|FG002|Overall Study|Adverse Event|0
7018731|NCT01536145|11091731|FG003|Overall Study|Adverse Event|0
7018732|NCT01536145|11091732|FG004|Overall Study|Adverse Event|0
7018733|NCT01536145|11091733|FG005|Overall Study|Adverse Event|0
7018734|NCT01536145|11091734|FG006|Overall Study|Adverse Event|0
7018735|NCT01536145|11091735|FG007|Overall Study|Adverse Event|2
7018736|NCT01536145|11091736|FG008|Overall Study|Adverse Event|0
7018737|NCT01536145|11091737|FG009|Overall Study|Adverse Event|0
7018738|NCT01536145|11091738|FG010|Overall Study|Adverse Event|3
7018739|NCT01536171|11091769|FG000|Overall Study|Withdrawal by Subject|1
7018740|NCT01536262|11091795|FG000|Overall Study|Adverse Event|6
7018741|NCT01536262|11091796|FG001|Overall Study|Adverse Event|1
7018742|NCT01536262|11091797|FG002|Overall Study|Adverse Event|2
7018743|NCT01536262|11091795|FG000|Overall Study|Withdrawal by Subject|1
7018744|NCT01536262|11091796|FG001|Overall Study|Withdrawal by Subject|1
7018745|NCT01536262|11091797|FG002|Overall Study|Withdrawal by Subject|0
7018746|NCT01536262|11091795|FG000|Overall Study|Other than stated above|1
7018747|NCT01536262|11091796|FG001|Overall Study|Other than stated above|0
7018748|NCT01536262|11091797|FG002|Overall Study|Other than stated above|0
7043725|NCT01746901|11128859|FG004|Treatment Phase: First Intervention|Protocol Violation|0
7043726|NCT01746901|11128860|FG005|Treatment Phase: First Intervention|Protocol Violation|0
7043727|NCT01746901|11128861|FG006|Treatment Phase: First Intervention|Protocol Violation|1
7043728|NCT01746901|11128862|FG007|Treatment Phase: First Intervention|Protocol Violation|0
7043729|NCT01746901|11128863|FG008|Treatment Phase: First Intervention|Protocol Violation|0
7043730|NCT01746901|11128855|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0
7043731|NCT01746901|11128856|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0
7043732|NCT01746901|11128857|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0
7043733|NCT01746901|11128858|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0
7043734|NCT01746901|11128859|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0
7043735|NCT01746901|11128860|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0
7043736|NCT01746901|11128861|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0
7043737|NCT01746901|11128862|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1
7043738|NCT01746901|11128863|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0
7043739|NCT01746901|11128855|FG000|Treatment Phase: Third Intervention|Protocol Violation|0
7043740|NCT01746901|11128856|FG001|Treatment Phase: Third Intervention|Protocol Violation|0
7043741|NCT01746901|11128857|FG002|Treatment Phase: Third Intervention|Protocol Violation|0
7043742|NCT01746901|11128858|FG003|Treatment Phase: Third Intervention|Protocol Violation|0
7043743|NCT01746901|11128859|FG004|Treatment Phase: Third Intervention|Protocol Violation|0
7043744|NCT01746901|11128860|FG005|Treatment Phase: Third Intervention|Protocol Violation|1
7043745|NCT01746901|11128861|FG006|Treatment Phase: Third Intervention|Protocol Violation|1
7043746|NCT01746901|11128862|FG007|Treatment Phase: Third Intervention|Protocol Violation|0
7043747|NCT01746901|11128863|FG008|Treatment Phase: Third Intervention|Protocol Violation|0
7043748|NCT01746901|11128855|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
7043749|NCT01746901|11128856|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
7043750|NCT01746901|11128857|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
7043751|NCT01746901|11128858|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1
7043752|NCT01746901|11128859|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
7043753|NCT01746901|11128860|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
7043754|NCT01746901|11128861|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
7043755|NCT01746901|11128862|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
7043756|NCT01746901|11128863|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
7043757|NCT01746901|11128855|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0
7043758|NCT01746901|11128856|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0
7043759|NCT01746901|11128857|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0
7043760|NCT01746901|11128858|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0
7043761|NCT01746901|11128859|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0
7043762|NCT01746901|11128860|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1
7043763|NCT01746901|11128861|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0
7043764|NCT01746901|11128862|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0
7043765|NCT01746901|11128863|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1
7043766|NCT01746901|11128855|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0
7043767|NCT01746901|11128856|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0
7043768|NCT01746901|11128857|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0
7043769|NCT01746901|11128858|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0
7043770|NCT01746901|11128859|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0
7043771|NCT01746901|11128860|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0
7043772|NCT01746901|11128861|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1
7043773|NCT01746901|11128862|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0
7043774|NCT01746901|11128863|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1
7043775|NCT01747486|11128933|FG000|Stage 1|Physician Decision|3
7043776|NCT01747486|11128934|FG001|Stage 1|Physician Decision|0
7043777|NCT01747486|11128933|FG000|Stage 1|Withdrawal by Subject|4
7043778|NCT01747486|11128934|FG001|Stage 1|Withdrawal by Subject|3
7043779|NCT01747486|11128933|FG000|Stage 1|Disease progression|4
7043780|NCT01747486|11128934|FG001|Stage 1|Disease progression|9
7043781|NCT01747486|11128933|FG000|Stage 1|Death|1
7043782|NCT01747486|11128934|FG001|Stage 1|Death|1
7043783|NCT01747486|11128933|FG000|Stage 2|Physician Decision|2
7043784|NCT01747486|11128934|FG001|Stage 2|Physician Decision|0
7043785|NCT01747486|11128933|FG000|Stage 2|Withdrawal by Subject|1
7043786|NCT01747486|11128934|FG001|Stage 2|Withdrawal by Subject|0
7018749|NCT01536379|11091817|FG000|Overall Study|Adverse Event|1
7018750|NCT01536379|11091818|FG001|Overall Study|Adverse Event|2
7018751|NCT01536379|11091817|FG000|Overall Study|Withdrawal by Subject|1
7018752|NCT01536379|11091818|FG001|Overall Study|Withdrawal by Subject|1
7018753|NCT01536392|11091826|FG000|Overall Study|Adverse Event|2
7018754|NCT01536392|11091827|FG001|Overall Study|Adverse Event|2
7018755|NCT01536392|11091826|FG000|Overall Study|Physician Decision|2
7018756|NCT01536392|11091827|FG001|Overall Study|Physician Decision|3
7018757|NCT01536392|11091826|FG000|Overall Study|Withdrawal by Subject|3
7018758|NCT01536392|11091827|FG001|Overall Study|Withdrawal by Subject|6
7018759|NCT01536392|11091826|FG000|Overall Study|Non Compliance|3
7018760|NCT01536392|11091827|FG001|Overall Study|Non Compliance|4
7018761|NCT01536392|11091826|FG000|Overall Study|Completed therapy early|3
7018762|NCT01536392|11091827|FG001|Overall Study|Completed therapy early|0
7018763|NCT01536405|11091835|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8
7018764|NCT01536405|11091836|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4
7018765|NCT01536405|11091835|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12
7018766|NCT01536405|11091836|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18
7018767|NCT01536405|11091835|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20
7018768|NCT01536405|11091836|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22
7018769|NCT01536405|11091835|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17
7018770|NCT01536405|11091836|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13
7018771|NCT01536405|11091835|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
7018772|NCT01536405|11091836|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
7018773|NCT01536405|11091835|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9
7018774|NCT01536405|11091836|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10
7018775|NCT01536405|11091835|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
7018776|NCT01536405|11091836|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
7018777|NCT01536405|11091835|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3
7018778|NCT01536405|11091836|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2
7018779|NCT01536405|11091835|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1
7018780|NCT01536405|11091836|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0
7018781|NCT01536405|11091835|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16
7018782|NCT01536405|11091836|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14
7018783|NCT01536405|11091835|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0
7018784|NCT01536405|11091836|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2
7018785|NCT01536405|11091835|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0
7018786|NCT01536405|11091836|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1
7018787|NCT01536405|11091835|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
7018788|NCT01536405|11091836|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
7018789|NCT01536418|11091844|FG000|Overall Study|Protocol Violation|2
7018790|NCT01536418|11091845|FG001|Overall Study|Protocol Violation|3
7018791|NCT01536418|11091844|FG000|Overall Study|Physician Decision|1
7018792|NCT01536418|11091845|FG001|Overall Study|Physician Decision|3
7018793|NCT01536418|11091844|FG000|Overall Study|Study closed/terminated|41
7018794|NCT01536418|11091845|FG001|Overall Study|Study closed/terminated|37
7018795|NCT01536418|11091844|FG000|Overall Study|Lack of Efficacy|10
7018796|NCT01536418|11091845|FG001|Overall Study|Lack of Efficacy|16
7018797|NCT01536418|11091844|FG000|Overall Study|Adverse Event|9
7018798|NCT01536418|11091845|FG001|Overall Study|Adverse Event|4
7018799|NCT01536418|11091844|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1
7018800|NCT01536418|11091845|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0
7018801|NCT01536418|11091844|FG000|Overall Study|Withdrawal by Subject|5
7018802|NCT01536418|11091845|FG001|Overall Study|Withdrawal by Subject|3
7018803|NCT01536535|11091865|FG000|Overall Study|Withdrawal by Subject|10
7018804|NCT01536535|11091866|FG001|Overall Study|Withdrawal by Subject|5
7018805|NCT01536535|11091865|FG000|Overall Study|Lost to Follow-up|4
7018806|NCT01536535|11091866|FG001|Overall Study|Lost to Follow-up|6
7018807|NCT01536535|11091865|FG000|Overall Study|Physician Decision|1
7018808|NCT01536535|11091866|FG001|Overall Study|Physician Decision|1
7018809|NCT01536535|11091865|FG000|Overall Study|Participant moved|0
7018810|NCT01536535|11091866|FG001|Overall Study|Participant moved|1
7018811|NCT01536561|11091873|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40
7018812|NCT01536561|11091873|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2
7018813|NCT01536561|11091873|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1
7018814|NCT01536561|11091873|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1
7018815|NCT01536561|11091873|FG000|Dosimetric and Therapeutic Treatment|Death|2
7018816|NCT01536561|11091873|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13
7018817|NCT01536574|11091882|FG000|Overall Study|Adverse Event|4
7018818|NCT01536574|11091883|FG001|Overall Study|Adverse Event|5
7018819|NCT01536574|11091882|FG000|Overall Study|Withdrawal by Subject|1
7018820|NCT01536574|11091883|FG001|Overall Study|Withdrawal by Subject|2
7018821|NCT01536574|11091882|FG000|Overall Study|Lack of Efficacy|1
7018822|NCT01536574|11091883|FG001|Overall Study|Lack of Efficacy|0
7018823|NCT01536587|11091889|FG000|Overall Study|Adverse Event|2
7018824|NCT01536704|11091893|FG000|Washout Period 1|Withdrawal by Subject|1
7018825|NCT01536704|11091894|FG001|Washout Period 1|Withdrawal by Subject|2
7018826|NCT01536704|11091895|FG002|Washout Period 1|Withdrawal by Subject|0
7018827|NCT01536704|11091896|FG003|Washout Period 1|Withdrawal by Subject|0
7018828|NCT01536704|11091893|FG000|Washout Period 2|Adverse Event|1
7018829|NCT01536704|11091894|FG001|Washout Period 2|Adverse Event|0
7018830|NCT01536704|11091895|FG002|Washout Period 2|Adverse Event|0
7018831|NCT01536704|11091896|FG003|Washout Period 2|Adverse Event|0
7018832|NCT01536704|11091893|FG000|Washout Period 2|Withdrawal by Subject|0
7018833|NCT01536704|11091894|FG001|Washout Period 2|Withdrawal by Subject|0
7018834|NCT01536704|11091895|FG002|Washout Period 2|Withdrawal by Subject|0
7018835|NCT01536704|11091896|FG003|Washout Period 2|Withdrawal by Subject|1
7018836|NCT01536704|11091893|FG000|Period 3|Adverse Event|0
7018837|NCT01536704|11091894|FG001|Period 3|Adverse Event|0
7018838|NCT01536704|11091895|FG002|Period 3|Adverse Event|0
7018839|NCT01536704|11091896|FG003|Period 3|Adverse Event|1
7018840|NCT01536704|11091893|FG000|Washout Period 3|Adverse Event|0
7018841|NCT01536704|11091894|FG001|Washout Period 3|Adverse Event|0
7018842|NCT01536704|11091895|FG002|Washout Period 3|Adverse Event|1
7018843|NCT01536704|11091896|FG003|Washout Period 3|Adverse Event|0
7018844|NCT01536795|11091912|FG000|Overall Study|Lost to Follow-up|0
7018845|NCT01536795|11091913|FG001|Overall Study|Lost to Follow-up|2
7018846|NCT01536795|11091912|FG000|Overall Study|Lack of Efficacy|1
7018847|NCT01536795|11091913|FG001|Overall Study|Lack of Efficacy|0
7018848|NCT01536860|11091919|FG000|Washout Period (3 Days)|Lost to Follow-up|1
7018849|NCT01536860|11091920|FG001|Washout Period (3 Days)|Lost to Follow-up|0
7018850|NCT01536860|11091921|FG002|Washout Period (3 Days)|Lost to Follow-up|0
7018851|NCT01536951|11091961|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0
7018852|NCT01536951|11091962|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0
7018853|NCT01536951|11091963|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1
7018854|NCT01536951|11091964|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0
7018855|NCT01536951|11091965|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0
7018856|NCT01536951|11091966|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0
7018857|NCT01536951|11091967|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0
7018858|NCT01536951|11091968|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0
7018859|NCT01536951|11091969|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0
7018860|NCT01536951|11091961|FG000|Second Intervention and Washout Period 2|Adverse Event|0
7018861|NCT01536951|11091962|FG001|Second Intervention and Washout Period 2|Adverse Event|0
7018862|NCT01536951|11091963|FG002|Second Intervention and Washout Period 2|Adverse Event|0
7018863|NCT01536951|11091964|FG003|Second Intervention and Washout Period 2|Adverse Event|0
7018864|NCT01536951|11091965|FG004|Second Intervention and Washout Period 2|Adverse Event|0
7018865|NCT01536951|11091966|FG005|Second Intervention and Washout Period 2|Adverse Event|0
7018866|NCT01536951|11091967|FG006|Second Intervention and Washout Period 2|Adverse Event|0
7018867|NCT01536951|11091968|FG007|Second Intervention and Washout Period 2|Adverse Event|1
7018868|NCT01536951|11091969|FG008|Second Intervention and Washout Period 2|Adverse Event|0
7018869|NCT01537042|11091998|FG000|Overall Study|Adverse Event|0
7018870|NCT01537042|11091999|FG001|Overall Study|Adverse Event|2
7018871|NCT01537042|11091998|FG000|Overall Study|Lack of Efficacy|0
7018872|NCT01537042|11091999|FG001|Overall Study|Lack of Efficacy|1
7018873|NCT01537042|11091998|FG000|Overall Study|Protocol Violation|0
7018874|NCT01537042|11091999|FG001|Overall Study|Protocol Violation|1
7018875|NCT01537042|11091998|FG000|Overall Study|Other|0
7018876|NCT01537042|11091999|FG001|Overall Study|Other|1
7018877|NCT01537068|11092011|FG000|Overall Study|Lost to Follow-up|2
7018878|NCT01537068|11092012|FG001|Overall Study|Lost to Follow-up|1
7018879|NCT01537068|11092011|FG000|Overall Study|Adverse Event|0
7018880|NCT01537068|11092012|FG001|Overall Study|Adverse Event|1
7018881|NCT01537068|11092011|FG000|Overall Study|Withdrawal by Subject|1
7018882|NCT01537068|11092012|FG001|Overall Study|Withdrawal by Subject|1
7018883|NCT01537068|11092011|FG000|Overall Study|Lack of Efficacy|1
7018884|NCT01537068|11092012|FG001|Overall Study|Lack of Efficacy|0
7018885|NCT01537081|11092021|FG000|Overall Study|Adverse Event|5
7018886|NCT01537081|11092022|FG001|Overall Study|Adverse Event|2
7018887|NCT01537081|11092023|FG002|Overall Study|Adverse Event|2
7018888|NCT01537081|11092021|FG000|Overall Study|Lack of Efficacy|2
7018889|NCT01537081|11092022|FG001|Overall Study|Lack of Efficacy|1
7018890|NCT01537081|11092023|FG002|Overall Study|Lack of Efficacy|0
7018891|NCT01537081|11092021|FG000|Overall Study|Lost to Follow-up|17
7018892|NCT01537081|11092022|FG001|Overall Study|Lost to Follow-up|15
7018893|NCT01537081|11092023|FG002|Overall Study|Lost to Follow-up|9
7018894|NCT01537081|11092021|FG000|Overall Study|Protocol Violation|3
7018895|NCT01537081|11092022|FG001|Overall Study|Protocol Violation|2
7018896|NCT01537081|11092023|FG002|Overall Study|Protocol Violation|2
7018897|NCT01537081|11092021|FG000|Overall Study|Withdrawal by Subject|6
7018898|NCT01537081|11092022|FG001|Overall Study|Withdrawal by Subject|11
7018899|NCT01537081|11092023|FG002|Overall Study|Withdrawal by Subject|3
7018900|NCT01537081|11092021|FG000|Overall Study|Physician Decision|5
7018901|NCT01537081|11092022|FG001|Overall Study|Physician Decision|6
7018902|NCT01537081|11092023|FG002|Overall Study|Physician Decision|0
7018903|NCT01537081|11092021|FG000|Overall Study|Sponsor decision|0
7018904|NCT01537081|11092022|FG001|Overall Study|Sponsor decision|1
7018905|NCT01537081|11092023|FG002|Overall Study|Sponsor decision|0
7018906|NCT01537081|11092021|FG000|Overall Study|Assigned but never dosed|1
7018907|NCT01537081|11092022|FG001|Overall Study|Assigned but never dosed|0
7018908|NCT01537081|11092023|FG002|Overall Study|Assigned but never dosed|0
7018909|NCT01537120|11092032|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1
7018910|NCT01537120|11092032|FG000|3 Weeks Placebo|Withdrawal by Subject|1
7018911|NCT01537133|11092042|FG000|Overall Study|Withdrawal by Subject|2
7018912|NCT01537133|11092043|FG001|Overall Study|Withdrawal by Subject|0
7018913|NCT01537133|11092044|FG002|Overall Study|Withdrawal by Subject|0
7018914|NCT01537133|11092045|FG003|Overall Study|Withdrawal by Subject|0
7018915|NCT01537133|11092042|FG000|Overall Study|Lost to Follow-up|1
7018916|NCT01537133|11092043|FG001|Overall Study|Lost to Follow-up|0
7018917|NCT01537133|11092044|FG002|Overall Study|Lost to Follow-up|0
7018918|NCT01537133|11092045|FG003|Overall Study|Lost to Follow-up|0
7018919|NCT01537198|11092072|FG000|Overall Study|RSV infection|2
7018920|NCT01537198|11092072|FG000|Overall Study|Adverse Event|4
7018921|NCT01537198|11092072|FG000|Overall Study|No Further Visits to the Clinic|37
7018922|NCT01537198|11092072|FG000|Overall Study|Other|111
7018923|NCT01537211|11092078|FG000|Overall Study|Lost to Follow-up|0
7018924|NCT01537211|11092079|FG001|Overall Study|Lost to Follow-up|1
7018925|NCT01537393|11092117|FG000|Overall Study|Exclude prior to study|32
7018926|NCT01537393|11092118|FG001|Overall Study|Exclude prior to study|44
7018927|NCT01537393|11092117|FG000|Overall Study|Death|20
7018928|NCT01537393|11092118|FG001|Overall Study|Death|32
7018929|NCT01537393|11092117|FG000|Overall Study|Withdrawal by Subject|18
7018930|NCT01537393|11092118|FG001|Overall Study|Withdrawal by Subject|17
7018931|NCT01537393|11092117|FG000|Overall Study|Lost to Follow-up|53
7018932|NCT01537393|11092118|FG001|Overall Study|Lost to Follow-up|48
7018933|NCT01537393|11092117|FG000|Overall Study|Failure - Regrafted|28
7018934|NCT01537393|11092118|FG001|Overall Study|Failure - Regrafted|43
7018935|NCT01537393|11092117|FG000|Overall Study|Failure - Not regrafted|2
7018936|NCT01537393|11092118|FG001|Overall Study|Failure - Not regrafted|6
7018937|NCT01537393|11092117|FG000|Overall Study|Censored (severe event unrelated to PT)|1
7018938|NCT01537393|11092118|FG001|Overall Study|Censored (severe event unrelated to PT)|1
7018939|NCT01537432|11092135|FG000|Overall Study|Lost to Follow-up|3
7018940|NCT01537432|11092136|FG001|Overall Study|Lost to Follow-up|1
7018941|NCT01537432|11092135|FG000|Overall Study|Withdrawal by Subject|0
7018942|NCT01537432|11092136|FG001|Overall Study|Withdrawal by Subject|1
7018943|NCT01537432|11092135|FG000|Overall Study|Administrative problems|1
7018944|NCT01537432|11092136|FG001|Overall Study|Administrative problems|0
7018945|NCT01537432|11092135|FG000|Overall Study|Adverse Event|1
7018946|NCT01537432|11092136|FG001|Overall Study|Adverse Event|0
7018947|NCT01537432|11092135|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7018948|NCT01537432|11092136|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7018949|NCT01537549|11092142|FG000|Overall Study|Lost to Follow-up|1
7018950|NCT01537549|11092142|FG000|Overall Study|Withdrawal by Subject|2
7018951|NCT01537783|11092177|FG000|Overall Study|Lost to Follow-up|11
7018952|NCT01537783|11092178|FG001|Overall Study|Lost to Follow-up|2
7018953|NCT01537887|11092197|FG000|Period 1|Physician Decision|0
7018954|NCT01537887|11092198|FG001|Period 1|Physician Decision|0
7018955|NCT01537887|11092199|FG002|Period 1|Physician Decision|0
7018956|NCT01537887|11092200|FG003|Period 1|Physician Decision|0
7018957|NCT01537887|11092201|FG004|Period 1|Physician Decision|1
7018958|NCT01537887|11092202|FG005|Period 1|Physician Decision|1
7018959|NCT01537887|11092197|FG000|Period 1|Did not receive treatment|0
7018960|NCT01537887|11092198|FG001|Period 1|Did not receive treatment|0
7018961|NCT01537887|11092199|FG002|Period 1|Did not receive treatment|1
7018962|NCT01537887|11092200|FG003|Period 1|Did not receive treatment|0
7018963|NCT01537887|11092201|FG004|Period 1|Did not receive treatment|0
7018964|NCT01537887|11092202|FG005|Period 1|Did not receive treatment|0
7018965|NCT01537887|11092197|FG000|Period 2|Withdrawal by Subject|0
7018966|NCT01537887|11092198|FG001|Period 2|Withdrawal by Subject|1
7018967|NCT01537887|11092199|FG002|Period 2|Withdrawal by Subject|0
7018968|NCT01537887|11092200|FG003|Period 2|Withdrawal by Subject|0
7018969|NCT01537887|11092201|FG004|Period 2|Withdrawal by Subject|0
7018970|NCT01537887|11092202|FG005|Period 2|Withdrawal by Subject|0
7018971|NCT01537887|11092197|FG000|Period 3|Adverse Event|0
7018972|NCT01537887|11092198|FG001|Period 3|Adverse Event|0
7018973|NCT01537887|11092199|FG002|Period 3|Adverse Event|1
7018974|NCT01537887|11092200|FG003|Period 3|Adverse Event|0
7018975|NCT01537887|11092201|FG004|Period 3|Adverse Event|0
7018976|NCT01537887|11092202|FG005|Period 3|Adverse Event|0
7018977|NCT01537887|11092197|FG000|Period 3|Withdrawal by Subject|0
7018978|NCT01537887|11092198|FG001|Period 3|Withdrawal by Subject|1
7018979|NCT01537887|11092199|FG002|Period 3|Withdrawal by Subject|0
7018980|NCT01537887|11092200|FG003|Period 3|Withdrawal by Subject|0
7018981|NCT01537887|11092201|FG004|Period 3|Withdrawal by Subject|0
7018982|NCT01537887|11092202|FG005|Period 3|Withdrawal by Subject|0
7018983|NCT01538199|11092230|FG000|Overall Study|Lost to Follow-up|1
7018984|NCT01538199|11092231|FG001|Overall Study|Lost to Follow-up|2
7018985|NCT01538199|11092232|FG002|Overall Study|Lost to Follow-up|1
7018986|NCT01538199|11092233|FG003|Overall Study|Lost to Follow-up|0
7018987|NCT01538199|11092230|FG000|Overall Study|participant did not have time|1
7018988|NCT01538199|11092231|FG001|Overall Study|participant did not have time|0
7018989|NCT01538199|11092232|FG002|Overall Study|participant did not have time|0
7018990|NCT01538199|11092233|FG003|Overall Study|participant did not have time|2
7018991|NCT01538199|11092230|FG000|Overall Study|Lack of Efficacy|0
7018992|NCT01538199|11092231|FG001|Overall Study|Lack of Efficacy|1
7018993|NCT01538199|11092232|FG002|Overall Study|Lack of Efficacy|0
7018994|NCT01538199|11092233|FG003|Overall Study|Lack of Efficacy|0
7018995|NCT01538472|11092250|FG000|Overall Study|Disease Progression|3
7018996|NCT01538472|11092250|FG000|Overall Study|Death|1
7018997|NCT01538628|11092265|FG000|Overall Study|Withdrawal by Subject|1
7018998|NCT01538628|11092266|FG001|Overall Study|Withdrawal by Subject|1
7018999|NCT01538628|11092265|FG000|Overall Study|Lost to Follow-up|0
7019000|NCT01538628|11092266|FG001|Overall Study|Lost to Follow-up|1
7019001|NCT01538719|11092275|FG000|Overall Study|Lost to Follow-up|2
7019002|NCT01538719|11092276|FG001|Overall Study|Lost to Follow-up|0
7019003|NCT01539083|11092305|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4
7019004|NCT01539083|11092306|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0
7019005|NCT01539083|11092307|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0
7019006|NCT01539083|11092305|FG000|Before Randomization (VCD Induction)|Adverse Event|14
7019007|NCT01539083|11092306|FG001|Before Randomization (VCD Induction)|Adverse Event|0
7019008|NCT01539083|11092307|FG002|Before Randomization (VCD Induction)|Adverse Event|0
7019009|NCT01539083|11092305|FG000|Before Randomization (VCD Induction)|Death|6
7019010|NCT01539083|11092306|FG001|Before Randomization (VCD Induction)|Death|0
7019011|NCT01539083|11092307|FG002|Before Randomization (VCD Induction)|Death|0
7019012|NCT01539083|11092305|FG000|Before Randomization (VCD Induction)|Protocol Violation|2
7019013|NCT01539083|11092306|FG001|Before Randomization (VCD Induction)|Protocol Violation|0
7019014|NCT01539083|11092307|FG002|Before Randomization (VCD Induction)|Protocol Violation|0
7019015|NCT01539083|11092305|FG000|Before Randomization (VCD Induction)|Physician Decision|14
7019016|NCT01539083|11092306|FG001|Before Randomization (VCD Induction)|Physician Decision|0
7019017|NCT01539083|11092307|FG002|Before Randomization (VCD Induction)|Physician Decision|0
7019018|NCT01539083|11092305|FG000|Before Randomization (VCD Induction)|Progressive Disease|8
7019019|NCT01539083|11092306|FG001|Before Randomization (VCD Induction)|Progressive Disease|0
7019020|NCT01539083|11092307|FG002|Before Randomization (VCD Induction)|Progressive Disease|0
7019021|NCT01539083|11092305|FG000|Before Randomization (VCD Induction)|Other|5
7019022|NCT01539083|11092306|FG001|Before Randomization (VCD Induction)|Other|0
7019023|NCT01539083|11092307|FG002|Before Randomization (VCD Induction)|Other|0
7019024|NCT01539083|11092305|FG000|After Randomization (TP and VTP)|Physician Decision|0
7019025|NCT01539083|11092306|FG001|After Randomization (TP and VTP)|Physician Decision|0
7019026|NCT01539083|11092307|FG002|After Randomization (TP and VTP)|Physician Decision|1
7019027|NCT01539083|11092305|FG000|After Randomization (TP and VTP)|Other|0
7019028|NCT01539083|11092306|FG001|After Randomization (TP and VTP)|Other|1
7019029|NCT01539083|11092307|FG002|After Randomization (TP and VTP)|Other|1
7019030|NCT01539083|11092305|FG000|After Randomization (TP and VTP)|Adverse Event|0
7019031|NCT01539083|11092306|FG001|After Randomization (TP and VTP)|Adverse Event|1
7019032|NCT01539083|11092307|FG002|After Randomization (TP and VTP)|Adverse Event|1
7019033|NCT01539083|11092305|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0
7019034|NCT01539083|11092306|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2
7019035|NCT01539083|11092307|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2
7019036|NCT01539083|11092305|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0
7019037|NCT01539083|11092306|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5
7019038|NCT01539083|11092307|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4
7019039|NCT01539083|11092305|FG000|After Randomization (TP and VTP)|Progressive Disease|0
7019040|NCT01539083|11092306|FG001|After Randomization (TP and VTP)|Progressive Disease|6
7019041|NCT01539083|11092307|FG002|After Randomization (TP and VTP)|Progressive Disease|3
7019042|NCT01539083|11092305|FG000|After Randomization (TP and VTP)|Death|0
7019043|NCT01539083|11092306|FG001|After Randomization (TP and VTP)|Death|6
7019044|NCT01539083|11092307|FG002|After Randomization (TP and VTP)|Death|11
7019045|NCT01539239|11092325|FG000|Overall Study|Death|5
7019046|NCT01539239|11092326|FG001|Overall Study|Death|5
7019047|NCT01539239|11092325|FG000|Overall Study|Lost to Follow-up|7
7019048|NCT01539239|11092326|FG001|Overall Study|Lost to Follow-up|12
7019049|NCT01539291|11092335|FG000|Study GS-US-312-0116|Adverse Event|9
7019050|NCT01539291|11092336|FG001|Study GS-US-312-0116|Adverse Event|0
7019051|NCT01539291|11092337|FG002|Study GS-US-312-0116|Adverse Event|0
7019052|NCT01539291|11092338|FG003|Study GS-US-312-0116|Adverse Event|0
7019053|NCT01539291|11092335|FG000|Study GS-US-312-0116|Physician Decision|1
7019054|NCT01539291|11092336|FG001|Study GS-US-312-0116|Physician Decision|0
7019055|NCT01539291|11092337|FG002|Study GS-US-312-0116|Physician Decision|0
7019056|NCT01539291|11092338|FG003|Study GS-US-312-0116|Physician Decision|0
7019057|NCT01539291|11092335|FG000|Study GS-US-312-0116|Withdrawal by Subject|12
7019058|NCT01539291|11092336|FG001|Study GS-US-312-0116|Withdrawal by Subject|0
7019059|NCT01539291|11092337|FG002|Study GS-US-312-0116|Withdrawal by Subject|0
7019060|NCT01539291|11092338|FG003|Study GS-US-312-0116|Withdrawal by Subject|0
7019061|NCT01539291|11092335|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2
7019062|NCT01539291|11092336|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0
7019063|NCT01539291|11092337|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0
7019064|NCT01539291|11092338|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0
7019065|NCT01539291|11092335|FG000|Study GS-US-312-0116|Other|1
7019066|NCT01539291|11092336|FG001|Study GS-US-312-0116|Other|0
7019067|NCT01539291|11092337|FG002|Study GS-US-312-0116|Other|0
7019068|NCT01539291|11092338|FG003|Study GS-US-312-0116|Other|0
7019069|NCT01539291|11092335|FG000|Study GS-US-312-0117|Adverse Event|22
7019070|NCT01539291|11092336|FG001|Study GS-US-312-0117|Adverse Event|1
7019071|NCT01539291|11092337|FG002|Study GS-US-312-0117|Adverse Event|9
7019072|NCT01539291|11092338|FG003|Study GS-US-312-0117|Adverse Event|12
7019073|NCT01539291|11092335|FG000|Study GS-US-312-0117|Physician Decision|9
7019074|NCT01539291|11092336|FG001|Study GS-US-312-0117|Physician Decision|0
7019075|NCT01539291|11092337|FG002|Study GS-US-312-0117|Physician Decision|6
7019076|NCT01539291|11092338|FG003|Study GS-US-312-0117|Physician Decision|4
7019077|NCT01539291|11092335|FG000|Study GS-US-312-0117|Withdrawal by Subject|5
7019078|NCT01539291|11092336|FG001|Study GS-US-312-0117|Withdrawal by Subject|0
7019079|NCT01539291|11092337|FG002|Study GS-US-312-0117|Withdrawal by Subject|6
7019080|NCT01539291|11092338|FG003|Study GS-US-312-0117|Withdrawal by Subject|4
7019081|NCT01539291|11092335|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3
7019082|NCT01539291|11092336|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0
7019083|NCT01539291|11092337|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0
7019084|NCT01539291|11092338|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5
7019085|NCT01539291|11092335|FG000|Study GS-US-312-0117|Other|2
7019086|NCT01539291|11092336|FG001|Study GS-US-312-0117|Other|1
7019087|NCT01539291|11092337|FG002|Study GS-US-312-0117|Other|1
7019088|NCT01539291|11092338|FG003|Study GS-US-312-0117|Other|1
7019089|NCT01539317|11092357|FG000|Overall Study|Screening Error. Deleted from analysis.|1
7019090|NCT01539317|11092358|FG001|Overall Study|Screening Error. Deleted from analysis.|0
7019091|NCT01539512|11092369|FG000|Overall Study|Adverse Event|9
7019092|NCT01539512|11092370|FG001|Overall Study|Adverse Event|7
7019093|NCT01539512|11092369|FG000|Overall Study|Physician Decision|1
7019094|NCT01539512|11092370|FG001|Overall Study|Physician Decision|1
7019095|NCT01539512|11092369|FG000|Overall Study|Withdrawal by Subject|12
7019096|NCT01539512|11092370|FG001|Overall Study|Withdrawal by Subject|5
7019097|NCT01539512|11092369|FG000|Overall Study|Richter's Transformation|1
7019098|NCT01539512|11092370|FG001|Overall Study|Richter's Transformation|0
7019099|NCT01539525|11092379|FG000|Overall Study|Lost to Follow-up|19
7019100|NCT01539525|11092380|FG001|Overall Study|Lost to Follow-up|12
7019101|NCT01539525|11092381|FG002|Overall Study|Lost to Follow-up|11
7019102|NCT01539525|11092379|FG000|Overall Study|Withdrawal by Subject|0
7019103|NCT01539525|11092380|FG001|Overall Study|Withdrawal by Subject|3
7019104|NCT01539525|11092381|FG002|Overall Study|Withdrawal by Subject|2
7019105|NCT01539525|11092379|FG000|Overall Study|Protocol Violation|1
7019106|NCT01539525|11092380|FG001|Overall Study|Protocol Violation|1
7019107|NCT01539525|11092381|FG002|Overall Study|Protocol Violation|4
7019108|NCT01539538|11092394|FG000|Overall Study|Adverse Event|13
7019109|NCT01539538|11092395|FG001|Overall Study|Adverse Event|18
7019110|NCT01539538|11092394|FG000|Overall Study|Lack of Efficacy|13
7019111|NCT01539538|11092395|FG001|Overall Study|Lack of Efficacy|16
7019112|NCT01539538|11092394|FG000|Overall Study|Withdrawal by Subject|2
7019113|NCT01539538|11092395|FG001|Overall Study|Withdrawal by Subject|3
7019114|NCT01539538|11092394|FG000|Overall Study|PCA no longer required or PCA problem|3
7019115|NCT01539538|11092395|FG001|Overall Study|PCA no longer required or PCA problem|7
7019116|NCT01539642|11092403|FG000|Overall Study|Lack of Efficacy|20
7019117|NCT01539642|11092404|FG001|Overall Study|Lack of Efficacy|18
7019118|NCT01539642|11092403|FG000|Overall Study|Patient ready for early discharge|8
7019119|NCT01539642|11092404|FG001|Overall Study|Patient ready for early discharge|7
7019120|NCT01539642|11092403|FG000|Overall Study|Adverse Event|6
7019121|NCT01539642|11092404|FG001|Overall Study|Adverse Event|4
7019122|NCT01539642|11092403|FG000|Overall Study|Withdrawal by Subject|2
7019123|NCT01539642|11092404|FG001|Overall Study|Withdrawal by Subject|2
7019124|NCT01539759|11092419|FG000|Overall Study|Lost to Follow-up|6
7019125|NCT01539759|11092420|FG001|Overall Study|Lost to Follow-up|8
7019126|NCT01539837|11092429|FG000|Overall Study|reduce neutrophil level|0
7019127|NCT01539837|11092430|FG001|Overall Study|reduce neutrophil level|1
7019128|NCT01539837|11092431|FG002|Overall Study|reduce neutrophil level|1
7019129|NCT01539837|11092429|FG000|Overall Study|bad compliance|0
7019130|NCT01539837|11092430|FG001|Overall Study|bad compliance|0
7019131|NCT01539837|11092431|FG002|Overall Study|bad compliance|1
7019132|NCT01540474|11092527|FG000|Vaccination Period|Lost to Follow-up|0
7019133|NCT01540474|11092528|FG001|Vaccination Period|Lost to Follow-up|1
7019134|NCT01540474|11092529|FG002|Vaccination Period|Lost to Follow-up|0
7019135|NCT01540474|11092530|FG003|Vaccination Period|Lost to Follow-up|0
7019136|NCT01540487|11092543|FG000|Overall Study|Protocol Violation|1
7019137|NCT01540487|11092544|FG001|Overall Study|Protocol Violation|0
7019138|NCT01540565|11092558|FG000|Overall Study|Ineligible|2
7019139|NCT01540838|11092628|FG000|Overall Study|Open nasogastric tube|9
7019140|NCT01540838|11092629|FG001|Overall Study|Open nasogastric tube|7
7019141|NCT01540838|11092628|FG000|Overall Study|Treatment doses missing|8
7060510|NCT01919814|11156798|FG001|Overall Study|Adverse Event|0
7060511|NCT01919814|11156797|FG000|Overall Study|Protocol Violation|1
7060512|NCT01919814|11156798|FG001|Overall Study|Protocol Violation|0
7060513|NCT01919814|11156797|FG000|Overall Study|Withdrawal by Subject|1
7060514|NCT01919814|11156798|FG001|Overall Study|Withdrawal by Subject|0
7019142|NCT01540838|11092629|FG001|Overall Study|Treatment doses missing|12
7019143|NCT01540838|11092628|FG000|Overall Study|Additional antibiotic treatment|1
7019144|NCT01540838|11092629|FG001|Overall Study|Additional antibiotic treatment|2
7019145|NCT01540838|11092628|FG000|Overall Study|Died before treatment initiation|1
7019146|NCT01540838|11092629|FG001|Overall Study|Died before treatment initiation|1
7019147|NCT01540838|11092628|FG000|Overall Study|Not BM. Other treatment|3
7019148|NCT01540838|11092629|FG001|Overall Study|Not BM. Other treatment|1
7019149|NCT01540851|11092637|FG000|Overall Study|Lost to Follow-up|14
7019150|NCT01540851|11092638|FG001|Overall Study|Lost to Follow-up|15
7019151|NCT01540851|11092637|FG000|Overall Study|Withdrawal by Subject|7
7019152|NCT01540851|11092638|FG001|Overall Study|Withdrawal by Subject|3
7019153|NCT01540981|11092648|FG000|Overall Study|Withdrawal by Subject|1
7019154|NCT01540981|11092649|FG001|Overall Study|Withdrawal by Subject|0
7019155|NCT01541215|11092657|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6
7019156|NCT01541215|11092658|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8
7019157|NCT01541215|11092657|FG000|Treatment Period (52 Weeks)|Non-compliance|4
7019158|NCT01541215|11092658|FG001|Treatment Period (52 Weeks)|Non-compliance|4
7019159|NCT01541215|11092657|FG000|Treatment Period (52 Weeks)|Adverse Event|0
7019160|NCT01541215|11092658|FG001|Treatment Period (52 Weeks)|Adverse Event|1
7019161|NCT01541215|11092657|FG000|Treatment Period (52 Weeks)|Unclassified|0
7019162|NCT01541215|11092658|FG001|Treatment Period (52 Weeks)|Unclassified|3
7019163|NCT01541215|11092657|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1
7019164|NCT01541215|11092658|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0
7019165|NCT01541215|11092657|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1
7019166|NCT01541215|11092658|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0
7019167|NCT01541254|11092668|FG000|Overall Study|Withdrawal by Subject|1
7019168|NCT01541254|11092668|FG000|Overall Study|excluded - metal allergy|1
7019169|NCT01541254|11092668|FG000|Overall Study|enrolled after study closed|1
7019170|NCT01541254|11092668|FG000|Overall Study|GI bleed prior to procedure|1
7019171|NCT01541254|11092668|FG000|Overall Study|stent not required|1
7019172|NCT01541254|11092668|FG000|Overall Study|alternate stent used|1
7019173|NCT01541371|11092677|FG000|Overall Study|Withdrawal by Subject|14
7019174|NCT01541371|11092677|FG000|Overall Study|Lost to Follow-up|21
7019175|NCT01541371|11092677|FG000|Overall Study|Adverse Event|15
7019176|NCT01541371|11092677|FG000|Overall Study|Lack of Efficacy|12
7019177|NCT01541371|11092677|FG000|Overall Study|Protocol Violation|6
7019178|NCT01541371|11092677|FG000|Overall Study|Study medication non-compliance|3
7019179|NCT01541371|11092677|FG000|Overall Study|Other|6
7019180|NCT01541644|11092707|FG000|Overall Study|Withdrawal by Subject|3
7019181|NCT01541748|11092720|FG000|Overall Study|Lost to Follow-up|17
7019182|NCT01541748|11092720|FG000|Overall Study|Moved out of state|1
7019183|NCT01541748|11092720|FG000|Overall Study|Withdrawal by Subject|7
7019184|NCT01541748|11092720|FG000|Overall Study|Screen failure|5
7019185|NCT01541748|11092720|FG000|Overall Study|Did not receive study device|1
7019186|NCT01541826|11092736|FG000|Overall Study|Lost to Follow-up|2
7019187|NCT01541826|11092737|FG001|Overall Study|Lost to Follow-up|3
7019188|NCT01541826|11092738|FG002|Overall Study|Lost to Follow-up|0
7019189|NCT01541826|11092736|FG000|Overall Study|Withdrawal by Subject|2
7019190|NCT01541826|11092737|FG001|Overall Study|Withdrawal by Subject|0
7019191|NCT01541826|11092738|FG002|Overall Study|Withdrawal by Subject|0
7019192|NCT01541865|11092746|FG000|Overall Study|Lost to Follow-up|11
7019193|NCT01541865|11092746|FG000|Overall Study|Withdrawal by Subject|9
7019194|NCT01541865|11092746|FG000|Overall Study|Adverse Event|1
7019195|NCT01541865|11092746|FG000|Overall Study|Protocol Violation|1
7019196|NCT01541917|11092764|FG000|Overall Study|Lost to Follow-up|2
7019197|NCT01541917|11092765|FG001|Overall Study|Lost to Follow-up|2
7019198|NCT01541917|11092764|FG000|Overall Study|Withdrawal by Subject|13
7019199|NCT01541917|11092765|FG001|Overall Study|Withdrawal by Subject|7
7019200|NCT01541930|11092774|FG000|Overall Study|Withdrawal by Subject|1
7019201|NCT01541969|11092791|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0
7019202|NCT01541969|11092792|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1
7019203|NCT01541969|11092791|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
7019204|NCT01541969|11092792|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
7019205|NCT01541969|11092791|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2
7019206|NCT01541969|11092792|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0
7019207|NCT01541969|11092791|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1
7019208|NCT01541969|11092792|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0
7019209|NCT01541969|11092791|FG000|Double-blind (0-12 Weeks)|Adverse Event|2
7019210|NCT01541969|11092792|FG001|Double-blind (0-12 Weeks)|Adverse Event|0
7019211|NCT01541969|11092791|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
7019212|NCT01541969|11092792|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
7019213|NCT01541969|11092791|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1
7019214|NCT01541969|11092792|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0
7019215|NCT01541969|11092791|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
7019216|NCT01541969|11092792|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
7019217|NCT01541969|11092791|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6
7019218|NCT01541969|11092792|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8
7019219|NCT01541969|11092791|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2
7019220|NCT01541969|11092792|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3
7019221|NCT01542034|11092803|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20
7019222|NCT01542034|11092804|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12
7019223|NCT01542034|11092803|FG000|Overall Study|Administrative decision|0
7019224|NCT01542034|11092804|FG001|Overall Study|Administrative decision|3
7019225|NCT01542034|11092803|FG000|Overall Study|Subject Noncompliance|1
7019226|NCT01542034|11092804|FG001|Overall Study|Subject Noncompliance|0
7019227|NCT01542034|11092803|FG000|Overall Study|Adverse Event|2
7019228|NCT01542034|11092804|FG001|Overall Study|Adverse Event|2
7019229|NCT01542034|11092803|FG000|Overall Study|Lost to Follow-up|7
7019230|NCT01542034|11092804|FG001|Overall Study|Lost to Follow-up|6
7019231|NCT01542528|11092868|FG000|Overall Study|Lost to Follow-up|2
7019232|NCT01542528|11092869|FG001|Overall Study|Lost to Follow-up|1
7019233|NCT01542528|11092868|FG000|Overall Study|Physician Decision|1
7019234|NCT01542528|11092869|FG001|Overall Study|Physician Decision|0
7019235|NCT01542528|11092868|FG000|Overall Study|Withdrawal by Subject|9
7019236|NCT01542528|11092869|FG001|Overall Study|Withdrawal by Subject|6
7019237|NCT01542632|11092890|FG000|Overall Study|Withdrawal of Consent|0
7019238|NCT01542632|11092891|FG001|Overall Study|Withdrawal of Consent|0
7019239|NCT01542632|11092892|FG002|Overall Study|Withdrawal of Consent|0
7019240|NCT01542632|11092893|FG003|Overall Study|Withdrawal of Consent|2
7019241|NCT01542632|11092894|FG004|Overall Study|Withdrawal of Consent|3
7019242|NCT01542632|11092895|FG005|Overall Study|Withdrawal of Consent|0
7019243|NCT01542632|11092890|FG000|Overall Study|Adverse Event|0
7019244|NCT01542632|11092891|FG001|Overall Study|Adverse Event|0
7019245|NCT01542632|11092892|FG002|Overall Study|Adverse Event|1
7019246|NCT01542632|11092893|FG003|Overall Study|Adverse Event|0
7019247|NCT01542632|11092894|FG004|Overall Study|Adverse Event|0
7019248|NCT01542632|11092895|FG005|Overall Study|Adverse Event|0
7019249|NCT01542632|11092890|FG000|Overall Study|Lost to Follow-up|0
7019250|NCT01542632|11092891|FG001|Overall Study|Lost to Follow-up|1
7019251|NCT01542632|11092892|FG002|Overall Study|Lost to Follow-up|0
7019252|NCT01542632|11092893|FG003|Overall Study|Lost to Follow-up|0
7019253|NCT01542632|11092894|FG004|Overall Study|Lost to Follow-up|0
7019254|NCT01542632|11092895|FG005|Overall Study|Lost to Follow-up|0
7019255|NCT01542632|11092890|FG000|Overall Study|Sponsor/Investigator Decision|0
7019256|NCT01542632|11092891|FG001|Overall Study|Sponsor/Investigator Decision|0
7019257|NCT01542632|11092892|FG002|Overall Study|Sponsor/Investigator Decision|0
7019258|NCT01542632|11092893|FG003|Overall Study|Sponsor/Investigator Decision|0
7019259|NCT01542632|11092894|FG004|Overall Study|Sponsor/Investigator Decision|1
7019260|NCT01542632|11092895|FG005|Overall Study|Sponsor/Investigator Decision|0
7043787|NCT01747486|11128933|FG000|Stage 2|New Cancer Therapy|3
7043788|NCT01747486|11128934|FG001|Stage 2|New Cancer Therapy|0
7043789|NCT01747486|11128933|FG000|Stage 2|Disease Progression|3
7043790|NCT01747486|11128934|FG001|Stage 2|Disease Progression|0
7043791|NCT01747499|11128945|FG000|Overall Study|Steroid refractory aGvHD|1
7043792|NCT01747499|11128946|FG001|Overall Study|Steroid refractory aGvHD|0
7043793|NCT01747499|11128947|FG002|Overall Study|Steroid refractory aGvHD|0
7043794|NCT01747499|11128948|FG003|Overall Study|Steroid refractory aGvHD|1
7043795|NCT01747499|11128949|FG004|Overall Study|Steroid refractory aGvHD|4
7043796|NCT01747499|11128945|FG000|Overall Study|Physician Decision|0
7043797|NCT01747499|11128946|FG001|Overall Study|Physician Decision|1
7043798|NCT01747499|11128947|FG002|Overall Study|Physician Decision|0
7043799|NCT01747499|11128948|FG003|Overall Study|Physician Decision|0
7043800|NCT01747499|11128949|FG004|Overall Study|Physician Decision|2
7043801|NCT01747499|11128945|FG000|Overall Study|Death|0
7043802|NCT01747499|11128946|FG001|Overall Study|Death|0
7043803|NCT01747499|11128947|FG002|Overall Study|Death|0
7043804|NCT01747499|11128948|FG003|Overall Study|Death|1
7043805|NCT01747499|11128949|FG004|Overall Study|Death|1
7043806|NCT01747499|11128945|FG000|Overall Study|Withdrawal by Subject|0
7043807|NCT01747499|11128946|FG001|Overall Study|Withdrawal by Subject|0
7043808|NCT01747499|11128947|FG002|Overall Study|Withdrawal by Subject|0
7043809|NCT01747499|11128948|FG003|Overall Study|Withdrawal by Subject|0
7043810|NCT01747499|11128949|FG004|Overall Study|Withdrawal by Subject|6
7043811|NCT01747499|11128945|FG000|Overall Study|Developed AML and death|0
7043812|NCT01747499|11128946|FG001|Overall Study|Developed AML and death|0
7043813|NCT01747499|11128947|FG002|Overall Study|Developed AML and death|0
7043814|NCT01747499|11128948|FG003|Overall Study|Developed AML and death|0
7043815|NCT01747499|11128949|FG004|Overall Study|Developed AML and death|1
7043816|NCT01747499|11128945|FG000|Overall Study|Determined not to be eligible|0
7043817|NCT01747499|11128946|FG001|Overall Study|Determined not to be eligible|0
7043818|NCT01747499|11128947|FG002|Overall Study|Determined not to be eligible|0
7043819|NCT01747499|11128948|FG003|Overall Study|Determined not to be eligible|0
7043820|NCT01747499|11128949|FG004|Overall Study|Determined not to be eligible|1
7043821|NCT01747551|11128965|FG000|Overall Study|Progressive Disease|24
7043822|NCT01747551|11128966|FG001|Overall Study|Progressive Disease|17
7043823|NCT01747551|11128965|FG000|Overall Study|Death|3
7043824|NCT01747551|11128966|FG001|Overall Study|Death|1
7043825|NCT01747551|11128965|FG000|Overall Study|Adverse Event|7
7043826|NCT01747551|11128966|FG001|Overall Study|Adverse Event|1
7043827|NCT01747551|11128965|FG000|Overall Study|Prolonged Treatment Delay|2
7043828|NCT01747551|11128966|FG001|Overall Study|Prolonged Treatment Delay|0
7043829|NCT01747551|11128965|FG000|Overall Study|Withdrawal by Subject|3
7043830|NCT01747551|11128966|FG001|Overall Study|Withdrawal by Subject|1
7043831|NCT01747551|11128965|FG000|Overall Study|Physician Decision|2
7043832|NCT01747551|11128966|FG001|Overall Study|Physician Decision|1
7043833|NCT01747551|11128965|FG000|Overall Study|Other|2
7043834|NCT01747551|11128966|FG001|Overall Study|Other|0
7043835|NCT01747629|11128974|FG000|Overall Study|Adverse Event|1
7019261|NCT01542788|11092933|FG000|Overall Study|Randomized but Not Treated|2
7019262|NCT01542788|11092934|FG001|Overall Study|Randomized but Not Treated|0
7019263|NCT01542788|11092933|FG000|Overall Study|Lack of Efficacy|41
7019264|NCT01542788|11092934|FG001|Overall Study|Lack of Efficacy|71
7019265|NCT01542788|11092933|FG000|Overall Study|Lost to Follow-up|5
7019266|NCT01542788|11092934|FG001|Overall Study|Lost to Follow-up|0
7019267|NCT01542788|11092933|FG000|Overall Study|Death|3
7019268|NCT01542788|11092934|FG001|Overall Study|Death|0
7019269|NCT01542788|11092933|FG000|Overall Study|Protocol Violation|2
7019270|NCT01542788|11092934|FG001|Overall Study|Protocol Violation|0
7019271|NCT01542788|11092933|FG000|Overall Study|Physician Decision|1
7019272|NCT01542788|11092934|FG001|Overall Study|Physician Decision|0
7019273|NCT01542788|11092933|FG000|Overall Study|Withdrawal by Subject|1
7019274|NCT01542788|11092934|FG001|Overall Study|Withdrawal by Subject|0
7019275|NCT01543087|11092976|FG000|Stage 1 (48 Months)|Lost to Follow-up|3
7019276|NCT01543087|11092977|FG001|Stage 1 (48 Months)|Lost to Follow-up|4
7019277|NCT01543087|11092978|FG002|Stage 1 (48 Months)|Lost to Follow-up|12
7019278|NCT01543087|11092979|FG003|Stage 1 (48 Months)|Lost to Follow-up|0
7019279|NCT01543087|11092980|FG004|Stage 1 (48 Months)|Lost to Follow-up|0
7019280|NCT01543087|11092981|FG005|Stage 1 (48 Months)|Lost to Follow-up|0
7019281|NCT01543087|11092976|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1
7019282|NCT01543087|11092977|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0
7019283|NCT01543087|11092978|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1
7019284|NCT01543087|11092979|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2
7019285|NCT01543087|11092980|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0
7019286|NCT01543087|11092981|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0
7019287|NCT01543087|11092976|FG000|Stage 1 (48 Months)|No longer willing to participate|5
7019288|NCT01543087|11092977|FG001|Stage 1 (48 Months)|No longer willing to participate|3
7019289|NCT01543087|11092978|FG002|Stage 1 (48 Months)|No longer willing to participate|18
7019290|NCT01543087|11092979|FG003|Stage 1 (48 Months)|No longer willing to participate|6
7019291|NCT01543087|11092980|FG004|Stage 1 (48 Months)|No longer willing to participate|3
7019292|NCT01543087|11092981|FG005|Stage 1 (48 Months)|No longer willing to participate|0
7019293|NCT01543087|11092976|FG000|Stage 1 (48 Months)|Other than specified|5
7019294|NCT01543087|11092977|FG001|Stage 1 (48 Months)|Other than specified|0
7019295|NCT01543087|11092978|FG002|Stage 1 (48 Months)|Other than specified|9
7019296|NCT01543087|11092979|FG003|Stage 1 (48 Months)|Other than specified|0
7019297|NCT01543087|11092980|FG004|Stage 1 (48 Months)|Other than specified|0
7019298|NCT01543087|11092981|FG005|Stage 1 (48 Months)|Other than specified|0
7019299|NCT01543087|11092976|FG000|Stage 1 (48 Months)|Protocol Violation|0
7019300|NCT01543087|11092977|FG001|Stage 1 (48 Months)|Protocol Violation|3
7019301|NCT01543087|11092978|FG002|Stage 1 (48 Months)|Protocol Violation|0
7019302|NCT01543087|11092979|FG003|Stage 1 (48 Months)|Protocol Violation|0
7019303|NCT01543087|11092980|FG004|Stage 1 (48 Months)|Protocol Violation|0
7019304|NCT01543087|11092981|FG005|Stage 1 (48 Months)|Protocol Violation|0
7019305|NCT01543087|11092976|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
7019306|NCT01543087|11092977|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1
7019307|NCT01543087|11092978|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
7019308|NCT01543087|11092979|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
7019309|NCT01543087|11092980|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2
7019310|NCT01543087|11092981|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
7019311|NCT01543087|11092976|FG000|Booster Stage (26 Months)|Lost to Follow-up|0
7019312|NCT01543087|11092977|FG001|Booster Stage (26 Months)|Lost to Follow-up|0
7019313|NCT01543087|11092978|FG002|Booster Stage (26 Months)|Lost to Follow-up|1
7019314|NCT01543087|11092979|FG003|Booster Stage (26 Months)|Lost to Follow-up|0
7019315|NCT01543087|11092980|FG004|Booster Stage (26 Months)|Lost to Follow-up|0
7019316|NCT01543087|11092981|FG005|Booster Stage (26 Months)|Lost to Follow-up|0
7019317|NCT01543152|11093022|FG000|Overall Study|Withdrawal by Subject|0
7019318|NCT01543152|11093023|FG001|Overall Study|Withdrawal by Subject|2
7019319|NCT01543152|11093024|FG002|Overall Study|Withdrawal by Subject|0
7019320|NCT01543152|11093025|FG003|Overall Study|Withdrawal by Subject|0
7019321|NCT01543152|11093026|FG004|Overall Study|Withdrawal by Subject|0
7019322|NCT01543204|11093050|FG000|Overall Study|Non-compliance|1
7019323|NCT01543204|11093050|FG000|Overall Study|Adverse Event|1
7019324|NCT01543204|11093050|FG000|Overall Study|Withdrawal by Subject|4
7019325|NCT01543204|11093050|FG000|Overall Study|Requirement for Alternative Therapy|1
7019326|NCT01543204|11093050|FG000|Overall Study|Lost to Follow-up|1
7019327|NCT01543490|11093060|FG000|Overall Study|Adverse Event|4
7019328|NCT01543490|11093061|FG001|Overall Study|Adverse Event|0
7019329|NCT01543490|11093060|FG000|Overall Study|Physician Decision|1
7019330|NCT01543490|11093061|FG001|Overall Study|Physician Decision|0
7019331|NCT01543490|11093060|FG000|Overall Study|Lack of Efficacy|3
7019332|NCT01543490|11093061|FG001|Overall Study|Lack of Efficacy|3
7019333|NCT01543490|11093060|FG000|Overall Study|Lost to Follow-up|5
7019334|NCT01543490|11093061|FG001|Overall Study|Lost to Follow-up|0
7019335|NCT01543490|11093060|FG000|Overall Study|Withdrawal by Subject|2
7019336|NCT01543490|11093061|FG001|Overall Study|Withdrawal by Subject|0
7019337|NCT01543490|11093060|FG000|Overall Study|Other-Various Administrative Reasons|1
7043836|NCT01747629|11128975|FG001|Overall Study|Adverse Event|2
7019338|NCT01543490|11093061|FG001|Overall Study|Other-Various Administrative Reasons|2
7019339|NCT01543503|11093069|FG000|Overall Study|Lost to Follow-up|32
7019340|NCT01543503|11093070|FG001|Overall Study|Lost to Follow-up|36
7019341|NCT01543503|11093069|FG000|Overall Study|Adverse Event|9
7019342|NCT01543503|11093070|FG001|Overall Study|Adverse Event|13
7019343|NCT01543503|11093069|FG000|Overall Study|Lack of Efficacy|4
7019344|NCT01543503|11093070|FG001|Overall Study|Lack of Efficacy|16
7019345|NCT01543503|11093069|FG000|Overall Study|Participant withdrew informed consent|8
7019346|NCT01543503|11093070|FG001|Overall Study|Participant withdrew informed consent|10
7019347|NCT01543503|11093069|FG000|Overall Study|Change of jobs|0
7019348|NCT01543503|11093070|FG001|Overall Study|Change of jobs|1
7019349|NCT01543503|11093069|FG000|Overall Study|Intolerance to the biologic treatment|0
7019350|NCT01543503|11093070|FG001|Overall Study|Intolerance to the biologic treatment|1
7019351|NCT01543503|11093069|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1
7019352|NCT01543503|11093070|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0
7019353|NCT01543503|11093069|FG000|Overall Study|Participant did not complete last visit|0
7019354|NCT01543503|11093070|FG001|Overall Study|Participant did not complete last visit|2
7019355|NCT01543503|11093069|FG000|Overall Study|Refused to continue treatment|7
7019356|NCT01543503|11093070|FG001|Overall Study|Refused to continue treatment|0
7019357|NCT01543503|11093069|FG000|Overall Study|Incorrect medication received|1
7019358|NCT01543503|11093070|FG001|Overall Study|Incorrect medication received|0
7019359|NCT01543503|11093069|FG000|Overall Study|Participant moved to another city|2
7019360|NCT01543503|11093070|FG001|Overall Study|Participant moved to another city|0
7019361|NCT01543503|11093069|FG000|Overall Study|Participant will not return for visits|0
7019362|NCT01543503|11093070|FG001|Overall Study|Participant will not return for visits|2
7019363|NCT01543503|11093069|FG000|Overall Study|Participant transferred to another city|1
7019364|NCT01543503|11093070|FG001|Overall Study|Participant transferred to another city|0
7019365|NCT01543503|11093069|FG000|Overall Study|Participant moved to Scotland|1
7019366|NCT01543503|11093070|FG001|Overall Study|Participant moved to Scotland|0
7019367|NCT01543503|11093069|FG000|Overall Study|Participant decision to stop treatment|1
7019368|NCT01543503|11093070|FG001|Overall Study|Participant decision to stop treatment|0
7019369|NCT01543503|11093069|FG000|Overall Study|Investigator did not wish to participate|1
7019370|NCT01543503|11093070|FG001|Overall Study|Investigator did not wish to participate|1
7019371|NCT01543503|11093069|FG000|Overall Study|Participant recruited after closing date|0
7019372|NCT01543503|11093070|FG001|Overall Study|Participant recruited after closing date|1
7019373|NCT01543503|11093069|FG000|Overall Study|Site stopped participation|5
7019374|NCT01543503|11093070|FG001|Overall Study|Site stopped participation|1
7019375|NCT01543503|11093069|FG000|Overall Study|Participant did not attend a visit|1
7019376|NCT01543503|11093070|FG001|Overall Study|Participant did not attend a visit|0
7019377|NCT01543503|11093069|FG000|Overall Study|Moved to other rheumatologic site|0
7019378|NCT01543503|11093070|FG001|Overall Study|Moved to other rheumatologic site|1
7019379|NCT01543503|11093069|FG000|Overall Study|Participant consented to another study|0
7019380|NCT01543503|11093070|FG001|Overall Study|Participant consented to another study|2
7019381|NCT01543503|11093069|FG000|Overall Study|Participant went to United States|1
7019382|NCT01543503|11093070|FG001|Overall Study|Participant went to United States|0
7019383|NCT01543503|11093069|FG000|Overall Study|Screen failure|1
7019384|NCT01543503|11093070|FG001|Overall Study|Screen failure|0
7019385|NCT01543685|11093096|FG000|Overall Study|Lack of Efficacy|1
7019386|NCT01543685|11093097|FG001|Overall Study|Lack of Efficacy|2
7019387|NCT01543685|11093098|FG002|Overall Study|Lack of Efficacy|2
7019388|NCT01543685|11093099|FG003|Overall Study|Lack of Efficacy|0
7019389|NCT01543685|11093100|FG004|Overall Study|Lack of Efficacy|2
7019390|NCT01543685|11093096|FG000|Overall Study|Adverse Event|2
7019391|NCT01543685|11093097|FG001|Overall Study|Adverse Event|1
7019392|NCT01543685|11093098|FG002|Overall Study|Adverse Event|0
7019393|NCT01543685|11093099|FG003|Overall Study|Adverse Event|0
7019394|NCT01543685|11093100|FG004|Overall Study|Adverse Event|2
7019395|NCT01543776|11093114|FG000|Overall Study|Withdrawal by Subject|2
7019396|NCT01543776|11093115|FG001|Overall Study|Withdrawal by Subject|2
7019397|NCT01543828|11093123|FG000|Treatment 2|Lost to Follow-up|1
7019398|NCT01543828|11093124|FG001|Treatment 2|Lost to Follow-up|0
7019399|NCT01543958|11093132|FG000|Overall Study|Loss to follow-up|3
7019400|NCT01543958|11093132|FG000|Overall Study|ART initiation|1
7019401|NCT01544114|11093162|FG000|Overall Study|Withdrawal by Subject|0
7019402|NCT01544114|11093163|FG001|Overall Study|Withdrawal by Subject|0
7019403|NCT01544114|11093164|FG002|Overall Study|Withdrawal by Subject|3
7019404|NCT01544114|11093162|FG000|Overall Study|Lost to Follow-up|0
7019405|NCT01544114|11093163|FG001|Overall Study|Lost to Follow-up|2
7019406|NCT01544114|11093164|FG002|Overall Study|Lost to Follow-up|0
7019407|NCT01544114|11093162|FG000|Overall Study|Adverse Event|1
7019408|NCT01544114|11093163|FG001|Overall Study|Adverse Event|1
7019409|NCT01544114|11093164|FG002|Overall Study|Adverse Event|2
7019410|NCT01544114|11093162|FG000|Overall Study|Protocol Violation|0
7019411|NCT01544114|11093163|FG001|Overall Study|Protocol Violation|1
7019412|NCT01544114|11093164|FG002|Overall Study|Protocol Violation|0
7019413|NCT01544153|11093178|FG000|Overall Study|Under 18|0
7019414|NCT01544153|11093179|FG001|Overall Study|Under 18|1
7019415|NCT01544153|11093180|FG002|Overall Study|Under 18|0
7019416|NCT01544153|11093181|FG003|Overall Study|Under 18|0
7019417|NCT01544153|11093178|FG000|Overall Study|Non-smoker|0
7019418|NCT01544153|11093179|FG001|Overall Study|Non-smoker|0
7019419|NCT01544153|11093180|FG002|Overall Study|Non-smoker|1
7019420|NCT01544153|11093181|FG003|Overall Study|Non-smoker|0
7019421|NCT01544179|11093200|FG000|Overall Study|Death|50
7019422|NCT01544179|11093201|FG001|Overall Study|Death|37
7019423|NCT01544179|11093200|FG000|Overall Study|Lost to Follow-up|0
7019424|NCT01544179|11093201|FG001|Overall Study|Lost to Follow-up|1
7019425|NCT01544179|11093200|FG000|Overall Study|Adverse Event|0
7019426|NCT01544179|11093201|FG001|Overall Study|Adverse Event|1
7019427|NCT01544179|11093200|FG000|Overall Study|Withdrawal by Subject|12
7019428|NCT01544179|11093201|FG001|Overall Study|Withdrawal by Subject|7
7019429|NCT01544179|11093200|FG000|Overall Study|Eligibility criteria not fulfilled|1
7019430|NCT01544179|11093201|FG001|Overall Study|Eligibility criteria not fulfilled|0
7019431|NCT01544309|11093209|FG000|Overall Study|Withdrawal by Subject|12
7019432|NCT01544309|11093210|FG001|Overall Study|Withdrawal by Subject|7
7019433|NCT01544309|11093209|FG000|Overall Study|Protocol Violation|2
7019434|NCT01544309|11093210|FG001|Overall Study|Protocol Violation|1
7019435|NCT01544309|11093209|FG000|Overall Study|Physician Decision|4
7019436|NCT01544309|11093210|FG001|Overall Study|Physician Decision|1
7019437|NCT01544309|11093209|FG000|Overall Study|Not performed pre-dose examination|1
7019438|NCT01544309|11093210|FG001|Overall Study|Not performed pre-dose examination|2
7019439|NCT01544309|11093209|FG000|Overall Study|Administered prohibit prior medication|1
7019440|NCT01544309|11093210|FG001|Overall Study|Administered prohibit prior medication|0
7019441|NCT01544348|11093226|FG000|Overall Study|Lost to Follow-up|1
7019442|NCT01544348|11093227|FG001|Overall Study|Lost to Follow-up|0
7019443|NCT01544348|11093228|FG002|Overall Study|Lost to Follow-up|0
7019444|NCT01544348|11093229|FG003|Overall Study|Lost to Follow-up|0
7019445|NCT01544348|11093230|FG004|Overall Study|Lost to Follow-up|0
7019446|NCT01544348|11093231|FG005|Overall Study|Lost to Follow-up|0
7019447|NCT01544348|11093232|FG006|Overall Study|Lost to Follow-up|1
7019448|NCT01544348|11093233|FG007|Overall Study|Lost to Follow-up|0
7019449|NCT01544348|11093226|FG000|Overall Study|Withdrawal by Subject|1
7019450|NCT01544348|11093227|FG001|Overall Study|Withdrawal by Subject|0
7019451|NCT01544348|11093228|FG002|Overall Study|Withdrawal by Subject|0
7019452|NCT01544348|11093229|FG003|Overall Study|Withdrawal by Subject|0
7019453|NCT01544348|11093230|FG004|Overall Study|Withdrawal by Subject|1
7019454|NCT01544348|11093231|FG005|Overall Study|Withdrawal by Subject|2
7019455|NCT01544348|11093232|FG006|Overall Study|Withdrawal by Subject|1
7019456|NCT01544348|11093233|FG007|Overall Study|Withdrawal by Subject|0
7019457|NCT01544348|11093226|FG000|Overall Study|Physician Decision|0
7019458|NCT01544348|11093227|FG001|Overall Study|Physician Decision|0
7019459|NCT01544348|11093228|FG002|Overall Study|Physician Decision|0
7019460|NCT01544348|11093229|FG003|Overall Study|Physician Decision|0
7019461|NCT01544348|11093230|FG004|Overall Study|Physician Decision|0
7019462|NCT01544348|11093231|FG005|Overall Study|Physician Decision|1
7019463|NCT01544348|11093232|FG006|Overall Study|Physician Decision|0
7019464|NCT01544348|11093233|FG007|Overall Study|Physician Decision|0
7019465|NCT01544478|11093279|FG000|Overall Study|Adverse Event|1
7019466|NCT01544478|11093279|FG000|Overall Study|Death|1
7019467|NCT01544478|11093279|FG000|Overall Study|Lost to Follow-up|48
7019468|NCT01544478|11093279|FG000|Overall Study|Physician Decision|15
7019469|NCT01544478|11093279|FG000|Overall Study|Pregnancy|1
7019470|NCT01544478|11093279|FG000|Overall Study|Withdrawal by Subject|52
7019471|NCT01544491|11093285|FG000|Overall Study|Withdrawal by Subject|3
7019472|NCT01544491|11093286|FG001|Overall Study|Withdrawal by Subject|2
7019473|NCT01544491|11093285|FG000|Overall Study|Lost to Follow-up|0
7019474|NCT01544491|11093286|FG001|Overall Study|Lost to Follow-up|1
7019475|NCT01544491|11093285|FG000|Overall Study|administrative problems|2
7019476|NCT01544491|11093286|FG001|Overall Study|administrative problems|0
7019477|NCT01544582|11093295|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1
7019478|NCT01544582|11093296|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0
7019479|NCT01544582|11093297|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0
7019480|NCT01544582|11093298|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0
7019481|NCT01544582|11093295|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33
7019482|NCT01544582|11093296|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0
7019483|NCT01544582|11093297|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0
7019484|NCT01544582|11093298|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0
7019485|NCT01544582|11093295|FG000|Analysis Population|Participant Refuses to Continue Study|0
7019486|NCT01544582|11093296|FG001|Analysis Population|Participant Refuses to Continue Study|15
7019487|NCT01544582|11093297|FG002|Analysis Population|Participant Refuses to Continue Study|17
7019488|NCT01544582|11093298|FG003|Analysis Population|Participant Refuses to Continue Study|4
7019489|NCT01544582|11093295|FG000|Analysis Population|Physician Decision|0
7019490|NCT01544582|11093296|FG001|Analysis Population|Physician Decision|13
7019491|NCT01544582|11093297|FG002|Analysis Population|Physician Decision|10
7019492|NCT01544582|11093298|FG003|Analysis Population|Physician Decision|9
7019493|NCT01544582|11093295|FG000|Analysis Population|Safety Reason|0
7019494|NCT01544582|11093296|FG001|Analysis Population|Safety Reason|33
7019495|NCT01544582|11093297|FG002|Analysis Population|Safety Reason|31
7019496|NCT01544582|11093298|FG003|Analysis Population|Safety Reason|8
7019497|NCT01544582|11093295|FG000|Analysis Population|Effectiveness Reason|0
7019498|NCT01544582|11093296|FG001|Analysis Population|Effectiveness Reason|48
7019499|NCT01544582|11093297|FG002|Analysis Population|Effectiveness Reason|29
7019500|NCT01544582|11093298|FG003|Analysis Population|Effectiveness Reason|12
7019501|NCT01544582|11093295|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0
7019502|NCT01544582|11093296|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0
7019503|NCT01544582|11093297|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0
7019504|NCT01544582|11093298|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1
7019505|NCT01544582|11093295|FG000|Analysis Population|Lost to Follow-up|0
7019506|NCT01544582|11093296|FG001|Analysis Population|Lost to Follow-up|6
7019507|NCT01544582|11093297|FG002|Analysis Population|Lost to Follow-up|6
7019508|NCT01544582|11093298|FG003|Analysis Population|Lost to Follow-up|5
7019509|NCT01544582|11093295|FG000|Analysis Population|Bad Tolerance to Treatment|0
7019510|NCT01544582|11093296|FG001|Analysis Population|Bad Tolerance to Treatment|0
7019511|NCT01544582|11093297|FG002|Analysis Population|Bad Tolerance to Treatment|2
7019512|NCT01544582|11093298|FG003|Analysis Population|Bad Tolerance to Treatment|0
7019513|NCT01544582|11093295|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0
7019514|NCT01544582|11093296|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0
7019515|NCT01544582|11093297|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3
7019516|NCT01544582|11093298|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0
7019517|NCT01544582|11093295|FG000|Analysis Population|Intolerance|0
7019518|NCT01544582|11093296|FG001|Analysis Population|Intolerance|1
7019519|NCT01544582|11093297|FG002|Analysis Population|Intolerance|0
7019520|NCT01544582|11093298|FG003|Analysis Population|Intolerance|0
7019521|NCT01544582|11093295|FG000|Analysis Population|Liver Transplantation|0
7019522|NCT01544582|11093296|FG001|Analysis Population|Liver Transplantation|0
7019523|NCT01544582|11093297|FG002|Analysis Population|Liver Transplantation|1
7019524|NCT01544582|11093298|FG003|Analysis Population|Liver Transplantation|0
7019525|NCT01544582|11093295|FG000|Analysis Population|No Social Insurance|0
7019526|NCT01544582|11093296|FG001|Analysis Population|No Social Insurance|0
7019527|NCT01544582|11093297|FG002|Analysis Population|No Social Insurance|1
7019528|NCT01544582|11093298|FG003|Analysis Population|No Social Insurance|0
7019529|NCT01544582|11093295|FG000|Analysis Population|Poor Adherence|0
7019530|NCT01544582|11093296|FG001|Analysis Population|Poor Adherence|0
7019531|NCT01544582|11093297|FG002|Analysis Population|Poor Adherence|1
7019532|NCT01544582|11093298|FG003|Analysis Population|Poor Adherence|0
7019533|NCT01544582|11093295|FG000|Analysis Population|Poor Participant Compliance|0
7019534|NCT01544582|11093296|FG001|Analysis Population|Poor Participant Compliance|1
7019535|NCT01544582|11093297|FG002|Analysis Population|Poor Participant Compliance|0
7019536|NCT01544582|11093298|FG003|Analysis Population|Poor Participant Compliance|0
7019537|NCT01544582|11093295|FG000|Analysis Population|Programmed Surgery|0
7019538|NCT01544582|11093296|FG001|Analysis Population|Programmed Surgery|1
7019539|NCT01544582|11093297|FG002|Analysis Population|Programmed Surgery|0
7019540|NCT01544582|11093298|FG003|Analysis Population|Programmed Surgery|0
7019541|NCT01544582|11093295|FG000|Analysis Population|Participant in Jail|0
7019542|NCT01544582|11093296|FG001|Analysis Population|Participant in Jail|0
7019543|NCT01544582|11093297|FG002|Analysis Population|Participant in Jail|1
7019544|NCT01544582|11093298|FG003|Analysis Population|Participant in Jail|0
7019545|NCT01544595|11093317|FG000|Status at Week 68|Adverse Event|3
7019546|NCT01544595|11093318|FG001|Status at Week 68|Adverse Event|2
7019547|NCT01544595|11093319|FG002|Status at Week 68|Adverse Event|1
7019548|NCT01544595|11093320|FG003|Status at Week 68|Adverse Event|0
7019549|NCT01544595|11093321|FG004|Status at Week 68|Adverse Event|0
7019550|NCT01544595|11093322|FG005|Status at Week 68|Adverse Event|0
7019551|NCT01544595|11093317|FG000|Status at Week 68|Lack of Efficacy|1
7019552|NCT01544595|11093318|FG001|Status at Week 68|Lack of Efficacy|0
7019553|NCT01544595|11093319|FG002|Status at Week 68|Lack of Efficacy|0
7019554|NCT01544595|11093320|FG003|Status at Week 68|Lack of Efficacy|0
7019555|NCT01544595|11093321|FG004|Status at Week 68|Lack of Efficacy|0
7019556|NCT01544595|11093322|FG005|Status at Week 68|Lack of Efficacy|0
7019557|NCT01544595|11093317|FG000|Status at Week 68|Lost to Follow-up|1
7019558|NCT01544595|11093318|FG001|Status at Week 68|Lost to Follow-up|1
7019559|NCT01544595|11093319|FG002|Status at Week 68|Lost to Follow-up|0
7019560|NCT01544595|11093320|FG003|Status at Week 68|Lost to Follow-up|0
7019561|NCT01544595|11093321|FG004|Status at Week 68|Lost to Follow-up|0
7019562|NCT01544595|11093322|FG005|Status at Week 68|Lost to Follow-up|0
7019563|NCT01544595|11093317|FG000|Status at Week 68|Non-compliance with study treatment|1
7019564|NCT01544595|11093318|FG001|Status at Week 68|Non-compliance with study treatment|0
7019565|NCT01544595|11093319|FG002|Status at Week 68|Non-compliance with study treatment|0
7019566|NCT01544595|11093320|FG003|Status at Week 68|Non-compliance with study treatment|1
7019567|NCT01544595|11093321|FG004|Status at Week 68|Non-compliance with study treatment|0
7019568|NCT01544595|11093322|FG005|Status at Week 68|Non-compliance with study treatment|0
7019569|NCT01544595|11093317|FG000|Status at Week 68|Protocol Violation|2
7019570|NCT01544595|11093318|FG001|Status at Week 68|Protocol Violation|0
7019571|NCT01544595|11093319|FG002|Status at Week 68|Protocol Violation|1
7019572|NCT01544595|11093320|FG003|Status at Week 68|Protocol Violation|1
7019573|NCT01544595|11093321|FG004|Status at Week 68|Protocol Violation|0
7019574|NCT01544595|11093322|FG005|Status at Week 68|Protocol Violation|0
7019575|NCT01544595|11093317|FG000|Status at Week 68|Technical problems|1
7019576|NCT01544595|11093318|FG001|Status at Week 68|Technical problems|0
7019577|NCT01544595|11093319|FG002|Status at Week 68|Technical problems|0
7019578|NCT01544595|11093320|FG003|Status at Week 68|Technical problems|1
7019579|NCT01544595|11093321|FG004|Status at Week 68|Technical problems|0
7019580|NCT01544595|11093322|FG005|Status at Week 68|Technical problems|0
7019581|NCT01544595|11093317|FG000|Status at Week 68|Withdrawal by Subject|0
7019582|NCT01544595|11093318|FG001|Status at Week 68|Withdrawal by Subject|1
7019583|NCT01544595|11093319|FG002|Status at Week 68|Withdrawal by Subject|1
7019584|NCT01544595|11093320|FG003|Status at Week 68|Withdrawal by Subject|2
7019585|NCT01544595|11093321|FG004|Status at Week 68|Withdrawal by Subject|0
7019586|NCT01544595|11093322|FG005|Status at Week 68|Withdrawal by Subject|0
7019587|NCT01544595|11093317|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30
7019588|NCT01544595|11093318|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13
7019589|NCT01544595|11093319|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60
7019590|NCT01544595|11093320|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46
7019591|NCT01544595|11093321|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0
7019592|NCT01544595|11093322|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0
7019593|NCT01544595|11093317|FG000|Status at Week 156|Withdrawal by Subject|9
7019594|NCT01544595|11093318|FG001|Status at Week 156|Withdrawal by Subject|10
7019595|NCT01544595|11093319|FG002|Status at Week 156|Withdrawal by Subject|4
7019596|NCT01544595|11093320|FG003|Status at Week 156|Withdrawal by Subject|9
7019597|NCT01544595|11093321|FG004|Status at Week 156|Withdrawal by Subject|20
7019598|NCT01544595|11093322|FG005|Status at Week 156|Withdrawal by Subject|6
7019599|NCT01544595|11093317|FG000|Status at Week 156|Adverse Event|9
7019600|NCT01544595|11093318|FG001|Status at Week 156|Adverse Event|11
7019601|NCT01544595|11093319|FG002|Status at Week 156|Adverse Event|1
7019602|NCT01544595|11093320|FG003|Status at Week 156|Adverse Event|3
7019603|NCT01544595|11093321|FG004|Status at Week 156|Adverse Event|4
7019604|NCT01544595|11093322|FG005|Status at Week 156|Adverse Event|2
7019605|NCT01544595|11093317|FG000|Status at Week 156|Lost to Follow-up|4
7019606|NCT01544595|11093318|FG001|Status at Week 156|Lost to Follow-up|4
7019607|NCT01544595|11093319|FG002|Status at Week 156|Lost to Follow-up|0
7019608|NCT01544595|11093320|FG003|Status at Week 156|Lost to Follow-up|1
7019609|NCT01544595|11093321|FG004|Status at Week 156|Lost to Follow-up|4
7019610|NCT01544595|11093322|FG005|Status at Week 156|Lost to Follow-up|1
7019611|NCT01544595|11093317|FG000|Status at Week 156|Non-compliance with study treatement|0
7019612|NCT01544595|11093318|FG001|Status at Week 156|Non-compliance with study treatement|1
7019613|NCT01544595|11093319|FG002|Status at Week 156|Non-compliance with study treatement|0
7019614|NCT01544595|11093320|FG003|Status at Week 156|Non-compliance with study treatement|1
7019615|NCT01544595|11093321|FG004|Status at Week 156|Non-compliance with study treatement|0
7019616|NCT01544595|11093322|FG005|Status at Week 156|Non-compliance with study treatement|1
7019617|NCT01544595|11093317|FG000|Status at Week 156|Physician Decision|0
7019618|NCT01544595|11093318|FG001|Status at Week 156|Physician Decision|3
7019619|NCT01544595|11093319|FG002|Status at Week 156|Physician Decision|1
7019620|NCT01544595|11093320|FG003|Status at Week 156|Physician Decision|0
7019621|NCT01544595|11093321|FG004|Status at Week 156|Physician Decision|0
7019622|NCT01544595|11093322|FG005|Status at Week 156|Physician Decision|0
7019623|NCT01544595|11093317|FG000|Status at Week 156|Pregnancy|2
7019624|NCT01544595|11093318|FG001|Status at Week 156|Pregnancy|3
7019625|NCT01544595|11093319|FG002|Status at Week 156|Pregnancy|0
7019626|NCT01544595|11093320|FG003|Status at Week 156|Pregnancy|0
7019627|NCT01544595|11093321|FG004|Status at Week 156|Pregnancy|0
7019628|NCT01544595|11093322|FG005|Status at Week 156|Pregnancy|0
7019629|NCT01544595|11093317|FG000|Status at Week 156|Protocol Violation|3
7019630|NCT01544595|11093318|FG001|Status at Week 156|Protocol Violation|1
7019631|NCT01544595|11093319|FG002|Status at Week 156|Protocol Violation|2
7019632|NCT01544595|11093320|FG003|Status at Week 156|Protocol Violation|2
7019633|NCT01544595|11093321|FG004|Status at Week 156|Protocol Violation|0
7019634|NCT01544595|11093322|FG005|Status at Week 156|Protocol Violation|0
7019635|NCT01544595|11093317|FG000|Status at Week 156|Technical problems|3
7019636|NCT01544595|11093318|FG001|Status at Week 156|Technical problems|1
7019637|NCT01544595|11093319|FG002|Status at Week 156|Technical problems|0
7019638|NCT01544595|11093320|FG003|Status at Week 156|Technical problems|1
7019639|NCT01544595|11093321|FG004|Status at Week 156|Technical problems|0
7019640|NCT01544595|11093322|FG005|Status at Week 156|Technical problems|0
7019641|NCT01544595|11093317|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86
7019642|NCT01544595|11093318|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44
7019643|NCT01544595|11093319|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131
7019644|NCT01544595|11093320|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145
7019645|NCT01544595|11093321|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0
7019646|NCT01544595|11093322|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0
7019647|NCT01544595|11093317|FG000|Status at Week 156|Lack of Efficacy|1
7019648|NCT01544595|11093318|FG001|Status at Week 156|Lack of Efficacy|0
7019649|NCT01544595|11093319|FG002|Status at Week 156|Lack of Efficacy|1
7019650|NCT01544595|11093320|FG003|Status at Week 156|Lack of Efficacy|4
7019651|NCT01544595|11093321|FG004|Status at Week 156|Lack of Efficacy|10
7019652|NCT01544595|11093322|FG005|Status at Week 156|Lack of Efficacy|5
7019653|NCT01544920|11093342|FG000|Overall Study|Adverse Event|0
7019654|NCT01544920|11093343|FG001|Overall Study|Adverse Event|3
7019655|NCT01544920|11093342|FG000|Overall Study|Death|0
7019656|NCT01544920|11093343|FG001|Overall Study|Death|1
7019657|NCT01544920|11093342|FG000|Overall Study|Lost to Follow-up|11
7019658|NCT01544920|11093343|FG001|Overall Study|Lost to Follow-up|12
7019659|NCT01544920|11093342|FG000|Overall Study|Protocol Violation|0
7019660|NCT01544920|11093343|FG001|Overall Study|Protocol Violation|2
7019661|NCT01544920|11093342|FG000|Overall Study|Physician Decision|4
7019662|NCT01544920|11093343|FG001|Overall Study|Physician Decision|1
7019663|NCT01544920|11093342|FG000|Overall Study|Withdrawal by Subject|4
7019664|NCT01544920|11093343|FG001|Overall Study|Withdrawal by Subject|4
7019665|NCT01545076|11093360|FG000|IgPro10 Restabilization Period|Adverse Event|4
7019666|NCT01545076|11093361|FG001|IgPro10 Restabilization Period|Adverse Event|0
7019667|NCT01545076|11093362|FG002|IgPro10 Restabilization Period|Adverse Event|0
7019668|NCT01545076|11093363|FG003|IgPro10 Restabilization Period|Adverse Event|0
7019669|NCT01545076|11093364|FG004|IgPro10 Restabilization Period|Adverse Event|0
7019670|NCT01545076|11093360|FG000|IgPro10 Restabilization Period|Physician Decision|2
7019671|NCT01545076|11093361|FG001|IgPro10 Restabilization Period|Physician Decision|0
7019672|NCT01545076|11093362|FG002|IgPro10 Restabilization Period|Physician Decision|0
7019673|NCT01545076|11093363|FG003|IgPro10 Restabilization Period|Physician Decision|0
7019674|NCT01545076|11093364|FG004|IgPro10 Restabilization Period|Physician Decision|0
7019675|NCT01545076|11093360|FG000|IgPro10 Restabilization Period|Protocol Violation|1
7019676|NCT01545076|11093361|FG001|IgPro10 Restabilization Period|Protocol Violation|0
7019677|NCT01545076|11093362|FG002|IgPro10 Restabilization Period|Protocol Violation|0
7019678|NCT01545076|11093363|FG003|IgPro10 Restabilization Period|Protocol Violation|0
7019679|NCT01545076|11093364|FG004|IgPro10 Restabilization Period|Protocol Violation|0
7019680|NCT01545076|11093360|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22
7019681|NCT01545076|11093361|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
7019682|NCT01545076|11093362|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
7019683|NCT01545076|11093363|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
7019684|NCT01545076|11093364|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
7019685|NCT01545076|11093360|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7
7019686|NCT01545076|11093361|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0
7019687|NCT01545076|11093362|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0
7019688|NCT01545076|11093363|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0
7019689|NCT01545076|11093364|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0
7019690|NCT01545076|11093360|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
7019691|NCT01545076|11093361|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
7019692|NCT01545076|11093362|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
7019693|NCT01545076|11093363|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1
7019694|NCT01545076|11093364|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
7019695|NCT01545076|11093360|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0
7019696|NCT01545076|11093361|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10
7019697|NCT01545076|11093362|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18
7019698|NCT01545076|11093363|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32
7019699|NCT01545076|11093364|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0
7019700|NCT01545076|11093360|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
7019701|NCT01545076|11093361|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1
7019702|NCT01545076|11093362|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1
7019703|NCT01545076|11093363|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
7019704|NCT01545076|11093364|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
7019705|NCT01545076|11093360|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0
7019706|NCT01545076|11093361|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8
7019707|NCT01545076|11093362|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2
7019708|NCT01545076|11093363|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3
7019709|NCT01545076|11093364|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0
7019710|NCT01545375|11093426|FG000|Overall Study|Adverse Event|2
7019711|NCT01545375|11093427|FG001|Overall Study|Adverse Event|1
7019712|NCT01545375|11093426|FG000|Overall Study|Lost to Follow-up|34
7019713|NCT01545375|11093427|FG001|Overall Study|Lost to Follow-up|31
7019714|NCT01545375|11093426|FG000|Overall Study|Protocol Violation|3
7019715|NCT01545375|11093427|FG001|Overall Study|Protocol Violation|3
7019716|NCT01545375|11093426|FG000|Overall Study|Withdrawal by Subject|58
7019717|NCT01545375|11093427|FG001|Overall Study|Withdrawal by Subject|55
7019718|NCT01545388|11093436|FG000|Overall Study|Adverse Event|2
7019719|NCT01545388|11093437|FG001|Overall Study|Adverse Event|4
7019720|NCT01545388|11093438|FG002|Overall Study|Adverse Event|1
7019721|NCT01545388|11093436|FG000|Overall Study|Lack of Efficacy|3
7019722|NCT01545388|11093437|FG001|Overall Study|Lack of Efficacy|2
7019723|NCT01545388|11093438|FG002|Overall Study|Lack of Efficacy|5
7019724|NCT01545388|11093436|FG000|Overall Study|Participant moved or relocated|1
7019725|NCT01545388|11093437|FG001|Overall Study|Participant moved or relocated|0
7019726|NCT01545388|11093438|FG002|Overall Study|Participant moved or relocated|0
7019727|NCT01545388|11093436|FG000|Overall Study|Withdrawal by Subject|1
7019728|NCT01545388|11093437|FG001|Overall Study|Withdrawal by Subject|4
7019729|NCT01545388|11093438|FG002|Overall Study|Withdrawal by Subject|2
7019730|NCT01545388|11093436|FG000|Overall Study|Other|1
7019731|NCT01545388|11093437|FG001|Overall Study|Other|1
7019732|NCT01545388|11093438|FG002|Overall Study|Other|0
7019733|NCT01545817|11093542|FG000|Pazopanib|Disease progression|51
7019734|NCT01545817|11093543|FG001|Pazopanib|Disease progression|0
7019735|NCT01545817|11093542|FG000|Pazopanib|Adverse Event|19
7019736|NCT01545817|11093543|FG001|Pazopanib|Adverse Event|0
7019737|NCT01545817|11093542|FG000|Pazopanib|Other reason|4
7019738|NCT01545817|11093543|FG001|Pazopanib|Other reason|0
7019739|NCT01545817|11093542|FG000|Everolimus|Other reason|0
7019740|NCT01545817|11093543|FG001|Everolimus|Other reason|7
7019741|NCT01545817|11093542|FG000|Everolimus|Disease progression|0
7019742|NCT01545817|11093543|FG001|Everolimus|Disease progression|25
7019743|NCT01545817|11093542|FG000|Everolimus|Adverse Event|0
7019744|NCT01545817|11093543|FG001|Everolimus|Adverse Event|6
7019745|NCT01545934|11093569|FG000|Overall Study|Withdrawal by Subject|4
7019746|NCT01545934|11093570|FG001|Overall Study|Withdrawal by Subject|3
7019747|NCT01545934|11093569|FG000|Overall Study|Lost to Follow-up|1
7019748|NCT01545934|11093570|FG001|Overall Study|Lost to Follow-up|0
7019749|NCT01546038|11093583|FG000|Overall Study|Death|15
7019750|NCT01546038|11093584|FG001|Overall Study|Death|6
7019751|NCT01546038|11093585|FG002|Overall Study|Death|4
7019752|NCT01546038|11093586|FG003|Overall Study|Death|2
7019753|NCT01546038|11093587|FG004|Overall Study|Death|9
7019754|NCT01546038|11093588|FG005|Overall Study|Death|3
7019755|NCT01546038|11093589|FG006|Overall Study|Death|46
7019756|NCT01546038|11093590|FG007|Overall Study|Death|76
7019757|NCT01546038|11093591|FG008|Overall Study|Death|39
7019758|NCT01546038|11093583|FG000|Overall Study|Lost to Follow-up|0
7019759|NCT01546038|11093584|FG001|Overall Study|Lost to Follow-up|0
7019760|NCT01546038|11093585|FG002|Overall Study|Lost to Follow-up|0
7019761|NCT01546038|11093586|FG003|Overall Study|Lost to Follow-up|0
7019762|NCT01546038|11093587|FG004|Overall Study|Lost to Follow-up|1
7019763|NCT01546038|11093588|FG005|Overall Study|Lost to Follow-up|0
7019764|NCT01546038|11093589|FG006|Overall Study|Lost to Follow-up|2
7019765|NCT01546038|11093590|FG007|Overall Study|Lost to Follow-up|1
7019766|NCT01546038|11093591|FG008|Overall Study|Lost to Follow-up|0
7019767|NCT01546038|11093583|FG000|Overall Study|Withdrawal by Subject|1
7019768|NCT01546038|11093584|FG001|Overall Study|Withdrawal by Subject|0
7019769|NCT01546038|11093585|FG002|Overall Study|Withdrawal by Subject|0
7019770|NCT01546038|11093586|FG003|Overall Study|Withdrawal by Subject|1
7019771|NCT01546038|11093587|FG004|Overall Study|Withdrawal by Subject|0
7019772|NCT01546038|11093588|FG005|Overall Study|Withdrawal by Subject|1
7019773|NCT01546038|11093589|FG006|Overall Study|Withdrawal by Subject|3
7019774|NCT01546038|11093590|FG007|Overall Study|Withdrawal by Subject|3
7019775|NCT01546038|11093591|FG008|Overall Study|Withdrawal by Subject|1
7019776|NCT01546038|11093583|FG000|Overall Study|: Randomized, not treated|0
7019777|NCT01546038|11093584|FG001|Overall Study|: Randomized, not treated|0
7019778|NCT01546038|11093585|FG002|Overall Study|: Randomized, not treated|0
7019779|NCT01546038|11093586|FG003|Overall Study|: Randomized, not treated|0
7019780|NCT01546038|11093587|FG004|Overall Study|: Randomized, not treated|0
7019781|NCT01546038|11093588|FG005|Overall Study|: Randomized, not treated|0
7019782|NCT01546038|11093589|FG006|Overall Study|: Randomized, not treated|2
7019783|NCT01546038|11093590|FG007|Overall Study|: Randomized, not treated|4
7019784|NCT01546038|11093591|FG008|Overall Study|: Randomized, not treated|3
7019785|NCT01546142|11093643|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15
7019786|NCT01546142|11093644|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15
7019787|NCT01546142|11093643|FG000|Overall Study|Subject Noncompliance|1
7019788|NCT01546142|11093644|FG001|Overall Study|Subject Noncompliance|1
7019789|NCT01546142|11093643|FG000|Overall Study|Adverse Event|6
7019790|NCT01546142|11093644|FG001|Overall Study|Adverse Event|3
7019791|NCT01546142|11093643|FG000|Overall Study|Lost to Follow-up|20
7019792|NCT01546142|11093644|FG001|Overall Study|Lost to Follow-up|15
7019793|NCT01546142|11093643|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1
7019794|NCT01546142|11093644|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0
7019795|NCT01546142|11093643|FG000|Overall Study|Subject Randomized but Not Treated|1
7019796|NCT01546142|11093644|FG001|Overall Study|Subject Randomized but Not Treated|0
7019797|NCT01546155|11093650|FG000|Overall Study|could not tolerate long scan duration|3
7019798|NCT01546168|11093656|FG000|Overall Study|Lost to Follow-up|1
7019799|NCT01546168|11093657|FG001|Overall Study|Lost to Follow-up|0
7019800|NCT01546168|11093656|FG000|Overall Study|Withdrawal by Subject|1
7019801|NCT01546168|11093657|FG001|Overall Study|Withdrawal by Subject|0
7019802|NCT01546168|11093656|FG000|Overall Study|ineligible after signing consent|2
7019803|NCT01546168|11093657|FG001|Overall Study|ineligible after signing consent|0
7019804|NCT01546519|11093697|FG000|Overall Study|Adverse Event|0
7019805|NCT01546519|11093698|FG001|Overall Study|Adverse Event|0
7019806|NCT01546519|11093699|FG002|Overall Study|Adverse Event|1
7019807|NCT01546519|11093700|FG003|Overall Study|Adverse Event|1
7019808|NCT01546519|11093697|FG000|Overall Study|Death|0
7019809|NCT01546519|11093698|FG001|Overall Study|Death|1
7019810|NCT01546519|11093699|FG002|Overall Study|Death|3
7019811|NCT01546519|11093700|FG003|Overall Study|Death|1
7019812|NCT01546519|11093697|FG000|Overall Study|related to disease progression|2
7019813|NCT01546519|11093698|FG001|Overall Study|related to disease progression|2
7019814|NCT01546519|11093699|FG002|Overall Study|related to disease progression|2
7019815|NCT01546519|11093700|FG003|Overall Study|related to disease progression|1
7019816|NCT01546519|11093697|FG000|Overall Study|Physician Decision|6
7019817|NCT01546519|11093698|FG001|Overall Study|Physician Decision|5
7019818|NCT01546519|11093699|FG002|Overall Study|Physician Decision|2
7019819|NCT01546519|11093700|FG003|Overall Study|Physician Decision|3
7019820|NCT01546519|11093697|FG000|Overall Study|Withdrawal by Subject|1
7019821|NCT01546519|11093698|FG001|Overall Study|Withdrawal by Subject|0
7019822|NCT01546519|11093699|FG002|Overall Study|Withdrawal by Subject|0
7019823|NCT01546519|11093700|FG003|Overall Study|Withdrawal by Subject|0
7019824|NCT01546623|11093716|FG000|Overall Study|Adverse Event|2
7019825|NCT01546623|11093717|FG001|Overall Study|Adverse Event|3
7019826|NCT01546623|11093716|FG000|Overall Study|Major Protocol Deviation|1
7019827|NCT01546623|11093717|FG001|Overall Study|Major Protocol Deviation|1
7019828|NCT01546623|11093716|FG000|Overall Study|High Prostate specific antigen|2
7019829|NCT01546623|11093717|FG001|Overall Study|High Prostate specific antigen|1
7019830|NCT01546623|11093716|FG000|Overall Study|Did Not Receive Study Drug|1
7019831|NCT01546623|11093717|FG001|Overall Study|Did Not Receive Study Drug|1
7019832|NCT01546649|11093734|FG000|Overall Study|Adverse Event|4
7019833|NCT01546649|11093735|FG001|Overall Study|Adverse Event|5
7019834|NCT01546649|11093734|FG000|Overall Study|Protocol Violation|1
7019835|NCT01546649|11093735|FG001|Overall Study|Protocol Violation|0
7019836|NCT01546649|11093734|FG000|Overall Study|Lack of Efficacy|1
7019837|NCT01546649|11093735|FG001|Overall Study|Lack of Efficacy|0
7019838|NCT01546649|11093734|FG000|Overall Study|Recurrence|1
7019839|NCT01546649|11093735|FG001|Overall Study|Recurrence|1
7019840|NCT01546649|11093734|FG000|Overall Study|Discovery of secondary cancer|0
7019841|NCT01546649|11093735|FG001|Overall Study|Discovery of secondary cancer|1
7019842|NCT01546649|11093734|FG000|Overall Study|Withdrawal by Subject|1
7019843|NCT01546649|11093735|FG001|Overall Study|Withdrawal by Subject|2
7019844|NCT01546688|11093752|FG000|Overall Study|Adverse Event|0
7019845|NCT01546688|11093753|FG001|Overall Study|Adverse Event|4
7019846|NCT01546688|11093752|FG000|Overall Study|Withdrawal by Subject|2
7019847|NCT01546688|11093753|FG001|Overall Study|Withdrawal by Subject|1
7019848|NCT01546688|11093752|FG000|Overall Study|Lack of Efficacy|1
7019849|NCT01546688|11093753|FG001|Overall Study|Lack of Efficacy|0
7019850|NCT01546857|11093761|FG000|Overall Study|Withdrawal by Subject|2
7019851|NCT01546857|11093762|FG001|Overall Study|Withdrawal by Subject|3
7019852|NCT01546922|11093769|FG000|First Period of 10 Weeks|Protocol Violation|3
7019853|NCT01546922|11093770|FG001|First Period of 10 Weeks|Protocol Violation|1
7019854|NCT01546922|11093769|FG000|First Period of 10 Weeks|Withdrawal by Subject|1
7019855|NCT01546922|11093770|FG001|First Period of 10 Weeks|Withdrawal by Subject|1
7019856|NCT01546922|11093769|FG000|First Period of 10 Weeks|Investigator's judgment|1
7019857|NCT01546922|11093770|FG001|First Period of 10 Weeks|Investigator's judgment|0
7019858|NCT01546922|11093769|FG000|Second Period of 10 Weeks|Protocol Violation|3
7019859|NCT01546922|11093770|FG001|Second Period of 10 Weeks|Protocol Violation|1
7019860|NCT01546922|11093769|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0
7019861|NCT01546922|11093770|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2
7019862|NCT01547130|11093787|FG000|Overall Study|Lost to Follow-up|9
7019863|NCT01547130|11093788|FG001|Overall Study|Lost to Follow-up|5
7019864|NCT01547286|11093811|FG000|Overall Study|Did not meet all eligibility criteria|1
7019865|NCT01547286|11093811|FG000|Overall Study|Physician Decision|1
7019866|NCT01547299|11093818|FG000|Overall Study|Withdrawal by Subject|2
7019867|NCT01547299|11093819|FG001|Overall Study|Withdrawal by Subject|2
7019868|NCT01547390|11093827|FG000|Overall Study|Withdrawal by Subject|10
7019869|NCT01547390|11093828|FG001|Overall Study|Withdrawal by Subject|7
7019870|NCT01547390|11093827|FG000|Overall Study|termination of pregnancy|0
7019871|NCT01547390|11093828|FG001|Overall Study|termination of pregnancy|1
7019872|NCT01547390|11093827|FG000|Overall Study|Lost to Follow-up|0
7019873|NCT01547390|11093828|FG001|Overall Study|Lost to Follow-up|2
7019874|NCT01547390|11093827|FG000|Overall Study|Adverse Event|3
7019875|NCT01547390|11093828|FG001|Overall Study|Adverse Event|0
7019876|NCT01547598|11093836|FG000|Overall Study|Withdrew consent|1
7019877|NCT01547598|11093837|FG001|Overall Study|Withdrew consent|1
7019878|NCT01547598|11093836|FG000|Overall Study|Lost to Follow-up|1
7019879|NCT01547598|11093837|FG001|Overall Study|Lost to Follow-up|1
7019880|NCT01547598|11093836|FG000|Overall Study|Adverse Event|1
7019881|NCT01547598|11093837|FG001|Overall Study|Adverse Event|1
7019882|NCT01547598|11093836|FG000|Overall Study|Protocol Violation|1
7019883|NCT01547598|11093837|FG001|Overall Study|Protocol Violation|1
7019884|NCT01547598|11093836|FG000|Overall Study|Other Miscellaneous Reasons|2
7019885|NCT01547598|11093837|FG001|Overall Study|Other Miscellaneous Reasons|1
7019886|NCT01547780|11093862|FG000|Baseline PET Scan|Physician Decision|1
7019887|NCT01547780|11093863|FG001|Baseline PET Scan|Physician Decision|0
7019888|NCT01547780|11093864|FG002|Baseline PET Scan|Physician Decision|1
7019889|NCT01547780|11093865|FG003|Baseline PET Scan|Physician Decision|0
7019890|NCT01547780|11093862|FG000|Baseline PET Scan|Withdrawal by Subject|2
7019891|NCT01547780|11093863|FG001|Baseline PET Scan|Withdrawal by Subject|0
7019892|NCT01547780|11093864|FG002|Baseline PET Scan|Withdrawal by Subject|1
7019893|NCT01547780|11093865|FG003|Baseline PET Scan|Withdrawal by Subject|0
7019894|NCT01548287|11093893|FG000|Screening|No reason provided|0
7019895|NCT01548287|11093894|FG001|Screening|No reason provided|0
7019896|NCT01548287|11093895|FG002|Screening|No reason provided|0
7019897|NCT01548287|11093896|FG003|Screening|No reason provided|0
7019898|NCT01548287|11093897|FG004|Screening|No reason provided|9
7019899|NCT01548287|11093893|FG000|Screening|Did not meet eligibility criteria|0
7019900|NCT01548287|11093894|FG001|Screening|Did not meet eligibility criteria|0
7019901|NCT01548287|11093895|FG002|Screening|Did not meet eligibility criteria|0
7019902|NCT01548287|11093896|FG003|Screening|Did not meet eligibility criteria|0
7019903|NCT01548287|11093897|FG004|Screening|Did not meet eligibility criteria|74
7019904|NCT01548287|11093893|FG000|Randomized Period|Did not meet inclusion criteria|0
7019905|NCT01548287|11093894|FG001|Randomized Period|Did not meet inclusion criteria|0
7019906|NCT01548287|11093895|FG002|Randomized Period|Did not meet inclusion criteria|2
7019907|NCT01548287|11093896|FG003|Randomized Period|Did not meet inclusion criteria|0
7019908|NCT01548287|11093897|FG004|Randomized Period|Did not meet inclusion criteria|0
7019909|NCT01548287|11093893|FG000|Randomized Period|Adverse Event|0
7019910|NCT01548287|11093894|FG001|Randomized Period|Adverse Event|2
7019911|NCT01548287|11093895|FG002|Randomized Period|Adverse Event|5
7019912|NCT01548287|11093896|FG003|Randomized Period|Adverse Event|0
7019913|NCT01548287|11093897|FG004|Randomized Period|Adverse Event|0
7019914|NCT01548404|11093918|FG000|Overall Study|Adverse Event|3
7019915|NCT01548404|11093919|FG001|Overall Study|Adverse Event|1
7019916|NCT01548404|11093918|FG000|Overall Study|Physician Decision|2
7019917|NCT01548404|11093919|FG001|Overall Study|Physician Decision|1
7019918|NCT01548404|11093918|FG000|Overall Study|Inadequate response to study treatment|23
7019919|NCT01548404|11093919|FG001|Overall Study|Inadequate response to study treatment|7
7019920|NCT01548404|11093918|FG000|Overall Study|Lost to Follow-up|2
7019921|NCT01548404|11093919|FG001|Overall Study|Lost to Follow-up|0
7019922|NCT01548404|11093918|FG000|Overall Study|Withdrawal by Subject|0
7019923|NCT01548404|11093919|FG001|Overall Study|Withdrawal by Subject|3
7019924|NCT01548404|11093918|FG000|Overall Study|Other than specified above|0
7019925|NCT01548404|11093919|FG001|Overall Study|Other than specified above|2
7019926|NCT01548417|11093928|FG000|Overall Study|Withdrawal by Subject|0
7019927|NCT01548417|11093929|FG001|Overall Study|Withdrawal by Subject|2
7019928|NCT01548573|11093935|FG000|Overall Study|Death|3
7019929|NCT01548573|11093935|FG000|Overall Study|Withdrawal by Subject|2
7019930|NCT01548599|11093942|FG000|Overall Study|Lost to Follow-up|0
7019931|NCT01548599|11093943|FG001|Overall Study|Lost to Follow-up|1
7019932|NCT01548599|11093942|FG000|Overall Study|Withdrawal by Subject|4
7019933|NCT01548599|11093943|FG001|Overall Study|Withdrawal by Subject|0
7019934|NCT01548599|11093942|FG000|Overall Study|Death|2
7019935|NCT01548599|11093943|FG001|Overall Study|Death|1
7019936|NCT01548638|11093952|FG000|Overall Study|Protocol Violation|3
7019937|NCT01548638|11093952|FG000|Overall Study|Withdrawal by Subject|1
7019938|NCT01548768|11093992|FG000|Overall Study|Withdrawal by Subject|0
7019939|NCT01548768|11093993|FG001|Overall Study|Withdrawal by Subject|2
7019940|NCT01548768|11093994|FG002|Overall Study|Withdrawal by Subject|1
7019941|NCT01548768|11093995|FG003|Overall Study|Withdrawal by Subject|0
7019942|NCT01548768|11093992|FG000|Overall Study|Physician Decision|1
7019943|NCT01548768|11093993|FG001|Overall Study|Physician Decision|0
7019944|NCT01548768|11093994|FG002|Overall Study|Physician Decision|0
7019945|NCT01548768|11093995|FG003|Overall Study|Physician Decision|0
7019946|NCT01548768|11093992|FG000|Overall Study|Adverse Event|0
7019947|NCT01548768|11093993|FG001|Overall Study|Adverse Event|0
7019948|NCT01548768|11093994|FG002|Overall Study|Adverse Event|0
7019949|NCT01548768|11093995|FG003|Overall Study|Adverse Event|1
7019950|NCT01548768|11093992|FG000|Overall Study|Non-Compliance|0
7019951|NCT01548768|11093993|FG001|Overall Study|Non-Compliance|0
7019952|NCT01548768|11093994|FG002|Overall Study|Non-Compliance|0
7019953|NCT01548768|11093995|FG003|Overall Study|Non-Compliance|3
7019954|NCT01549002|11094021|FG000|Overall Study|Excessive pain|0
7019955|NCT01549002|11094022|FG001|Overall Study|Excessive pain|2
7019956|NCT01549002|11094021|FG000|Overall Study|Moderate sedation required|0
7019957|NCT01549002|11094022|FG001|Overall Study|Moderate sedation required|2
7019958|NCT01549041|11094030|FG000|Overall Study|Lack of Efficacy|2
7019959|NCT01549041|11094031|FG001|Overall Study|Lack of Efficacy|4
7019960|NCT01549041|11094030|FG000|Overall Study|Adverse Event|0
7019961|NCT01549041|11094031|FG001|Overall Study|Adverse Event|4
7019962|NCT01549275|11094048|FG000|Overall Study|Lost to Follow-up|1
7019963|NCT01549275|11094049|FG001|Overall Study|Lost to Follow-up|0
7019964|NCT01549392|11094083|FG000|Overall Study|Withdrawal by Subject|1
7019965|NCT01549392|11094084|FG001|Overall Study|Withdrawal by Subject|0
7019966|NCT01549613|11094112|FG000|Overall Study|Lost to Follow-up|11
7019967|NCT01549613|11094113|FG001|Overall Study|Lost to Follow-up|11
7019968|NCT01549652|11094122|FG000|Overall Study|Did Not Receive Allocated Intervention|0
7019969|NCT01549652|11094123|FG001|Overall Study|Did Not Receive Allocated Intervention|0
7019970|NCT01549652|11094124|FG002|Overall Study|Did Not Receive Allocated Intervention|2
7019971|NCT01549652|11094125|FG003|Overall Study|Did Not Receive Allocated Intervention|0
7019972|NCT01549652|11094122|FG000|Overall Study|Study Drug Titration Failure|5
7019973|NCT01549652|11094123|FG001|Overall Study|Study Drug Titration Failure|6
7019974|NCT01549652|11094124|FG002|Overall Study|Study Drug Titration Failure|0
7019975|NCT01549652|11094125|FG003|Overall Study|Study Drug Titration Failure|0
7019976|NCT01549652|11094122|FG000|Overall Study|Withdrawal Effect|0
7019977|NCT01549652|11094123|FG001|Overall Study|Withdrawal Effect|2
7019978|NCT01549652|11094124|FG002|Overall Study|Withdrawal Effect|0
7019979|NCT01549652|11094125|FG003|Overall Study|Withdrawal Effect|0
7019980|NCT01549652|11094122|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5
7019981|NCT01549652|11094123|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1
7019982|NCT01549652|11094124|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0
7019983|NCT01549652|11094125|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0
7019984|NCT01549652|11094122|FG000|Overall Study|Problem with Infusion|1
7019985|NCT01549652|11094123|FG001|Overall Study|Problem with Infusion|0
7019986|NCT01549652|11094124|FG002|Overall Study|Problem with Infusion|0
7019987|NCT01549652|11094125|FG003|Overall Study|Problem with Infusion|0
7019988|NCT01549652|11094122|FG000|Overall Study|Titration Non-Compliance|1
7019989|NCT01549652|11094123|FG001|Overall Study|Titration Non-Compliance|3
7019990|NCT01549652|11094124|FG002|Overall Study|Titration Non-Compliance|4
7019991|NCT01549652|11094125|FG003|Overall Study|Titration Non-Compliance|5
7019992|NCT01549652|11094122|FG000|Overall Study|Titration Side Effects|0
7019993|NCT01549652|11094123|FG001|Overall Study|Titration Side Effects|0
7019994|NCT01549652|11094124|FG002|Overall Study|Titration Side Effects|6
7019995|NCT01549652|11094125|FG003|Overall Study|Titration Side Effects|3
7019996|NCT01549652|11094122|FG000|Overall Study|Withdrawal by Subject|0
7019997|NCT01549652|11094123|FG001|Overall Study|Withdrawal by Subject|0
7019998|NCT01549652|11094124|FG002|Overall Study|Withdrawal by Subject|5
7019999|NCT01549652|11094125|FG003|Overall Study|Withdrawal by Subject|3
7020000|NCT01549860|11094133|FG000|Overall Study|Withdrawal by Subject|1
7020001|NCT01549860|11094134|FG001|Overall Study|Withdrawal by Subject|0
7020002|NCT01549860|11094133|FG000|Overall Study|Physician Decision|1
7020003|NCT01549860|11094134|FG001|Overall Study|Physician Decision|1
7020004|NCT01549873|11094142|FG000|Overall Study|Physician Decision|0
7020005|NCT01549873|11094143|FG001|Overall Study|Physician Decision|1
7020006|NCT01549886|11094151|FG000|Overall Study|Sponsor's decision|2
7020007|NCT01549886|11094152|FG001|Overall Study|Sponsor's decision|3
7043837|NCT01747629|11128974|FG000|Overall Study|Withdrawal by Subject|2
7043838|NCT01747629|11128975|FG001|Overall Study|Withdrawal by Subject|2
7043839|NCT01747629|11128974|FG000|Overall Study|Noncompliance|1
7043840|NCT01747629|11128975|FG001|Overall Study|Noncompliance|1
7043841|NCT01747629|11128974|FG000|Overall Study|Inclusion criteria not met|1
7043842|NCT01747629|11128975|FG001|Overall Study|Inclusion criteria not met|0
7043843|NCT01747629|11128974|FG000|Overall Study|Not treated|1
7043844|NCT01747629|11128975|FG001|Overall Study|Not treated|0
7043845|NCT01747629|11128974|FG000|Overall Study|Other|2
7043846|NCT01747629|11128975|FG001|Overall Study|Other|1
7043847|NCT01747655|11128981|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5
7043848|NCT01747655|11128982|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0
7043849|NCT01747655|11128981|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8
7043850|NCT01747655|11128982|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0
7043851|NCT01747655|11128981|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1
7043852|NCT01747655|11128982|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0
7043853|NCT01747772|11128988|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9
7043854|NCT01747811|11128998|FG000|Overall Study|Lack of Efficacy|2
7043855|NCT01747811|11128999|FG001|Overall Study|Lack of Efficacy|4
7043856|NCT01747837|11129009|FG000|Overall Study|Lost to Follow-up|5
7043857|NCT01747837|11129010|FG001|Overall Study|Lost to Follow-up|2
7043858|NCT01747837|11129009|FG000|Overall Study|Death|4
7043859|NCT01747837|11129010|FG001|Overall Study|Death|4
7043860|NCT01747876|11129044|FG000|Overall Study|Adverse Event|1
7043861|NCT01747876|11129045|FG001|Overall Study|Adverse Event|0
7043862|NCT01747876|11129046|FG002|Overall Study|Adverse Event|2
7043863|NCT01747876|11129044|FG000|Overall Study|Withdrawal by Subject|0
7043864|NCT01747876|11129045|FG001|Overall Study|Withdrawal by Subject|1
7043865|NCT01747876|11129046|FG002|Overall Study|Withdrawal by Subject|1
7043866|NCT01747876|11129044|FG000|Overall Study|Disease progression|4
7043867|NCT01747876|11129045|FG001|Overall Study|Disease progression|13
7043868|NCT01747876|11129046|FG002|Overall Study|Disease progression|8
7043869|NCT01747876|11129044|FG000|Overall Study|Trtment duration compl. as per protocol|0
7043870|NCT01747876|11129045|FG001|Overall Study|Trtment duration compl. as per protocol|1
7043871|NCT01747876|11129046|FG002|Overall Study|Trtment duration compl. as per protocol|1
7043872|NCT01747915|11129060|FG000|Overall Study|Other|1
7043873|NCT01747915|11129061|FG001|Overall Study|Other|1
7043874|NCT01747915|11129062|FG002|Overall Study|Other|1
7043875|NCT01747915|11129060|FG000|Overall Study|Adverse Event|8
7043876|NCT01747915|11129061|FG001|Overall Study|Adverse Event|5
7043877|NCT01747915|11129062|FG002|Overall Study|Adverse Event|2
7043878|NCT01747915|11129060|FG000|Overall Study|Death|0
7043879|NCT01747915|11129061|FG001|Overall Study|Death|0
7043880|NCT01747915|11129062|FG002|Overall Study|Death|1
7043881|NCT01747915|11129060|FG000|Overall Study|Lack of Efficacy|0
7043882|NCT01747915|11129061|FG001|Overall Study|Lack of Efficacy|1
7043883|NCT01747915|11129062|FG002|Overall Study|Lack of Efficacy|0
7043884|NCT01747915|11129060|FG000|Overall Study|Lost to Follow-up|1
7043885|NCT01747915|11129061|FG001|Overall Study|Lost to Follow-up|0
7043886|NCT01747915|11129062|FG002|Overall Study|Lost to Follow-up|0
7043887|NCT01747915|11129060|FG000|Overall Study|Withdrawal by Subject|4
7043888|NCT01747915|11129061|FG001|Overall Study|Withdrawal by Subject|4
7043889|NCT01747915|11129062|FG002|Overall Study|Withdrawal by Subject|1
7043890|NCT01747915|11129060|FG000|Overall Study|Protocol Violation|1
7043891|NCT01747915|11129061|FG001|Overall Study|Protocol Violation|0
7043892|NCT01747915|11129062|FG002|Overall Study|Protocol Violation|0
7043893|NCT01747915|11129060|FG000|Overall Study|Pregnancy|0
7043894|NCT01747915|11129061|FG001|Overall Study|Pregnancy|0
7043895|NCT01747915|11129062|FG002|Overall Study|Pregnancy|1
7020008|NCT01549951|11094169|FG000|Overall Study|Adverse Event|15
7020009|NCT01549951|11094169|FG000|Overall Study|Withdrawal by Subject|2
7020010|NCT01549951|11094169|FG000|Overall Study|Unsatisfactory therapeutic response|1
7020011|NCT01549951|11094169|FG000|Overall Study|Progressive disease|29
7020012|NCT01549951|11094169|FG000|Overall Study|Symptomatic deterioration|1
7020013|NCT01549951|11094169|FG000|Overall Study|Other|2
7020014|NCT01549964|11094177|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50
7020015|NCT01549964|11094178|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104
7020016|NCT01549964|11094179|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104
7020017|NCT01549964|11094180|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105
7020018|NCT01549964|11094177|FG000|24-Week Treatment Period|Voluntary Withdrawal|6
7020019|NCT01549964|11094178|FG001|24-Week Treatment Period|Voluntary Withdrawal|3
7020020|NCT01549964|11094179|FG002|24-Week Treatment Period|Voluntary Withdrawal|3
7020021|NCT01549964|11094180|FG003|24-Week Treatment Period|Voluntary Withdrawal|8
7020022|NCT01549964|11094177|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1
7020023|NCT01549964|11094178|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
7020024|NCT01549964|11094179|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
7020025|NCT01549964|11094180|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
7020026|NCT01549964|11094177|FG000|24-Week Treatment Period|Lost to Follow-up|1
7020027|NCT01549964|11094178|FG001|24-Week Treatment Period|Lost to Follow-up|0
7020028|NCT01549964|11094179|FG002|24-Week Treatment Period|Lost to Follow-up|1
7020029|NCT01549964|11094180|FG003|24-Week Treatment Period|Lost to Follow-up|2
7020030|NCT01549964|11094177|FG000|24-Week Treatment Period|Lack of Efficacy|1
7020031|NCT01549964|11094178|FG001|24-Week Treatment Period|Lack of Efficacy|0
7020032|NCT01549964|11094179|FG002|24-Week Treatment Period|Lack of Efficacy|1
7020033|NCT01549964|11094180|FG003|24-Week Treatment Period|Lack of Efficacy|1
7020034|NCT01549964|11094177|FG000|24-Week Treatment Period|Other|1
7020035|NCT01549964|11094178|FG001|24-Week Treatment Period|Other|0
7020036|NCT01549964|11094179|FG002|24-Week Treatment Period|Other|1
7020037|NCT01549964|11094180|FG003|24-Week Treatment Period|Other|0
7020038|NCT01549964|11094177|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
7020039|NCT01549964|11094178|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
7020040|NCT01549964|11094179|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1
7020041|NCT01549964|11094180|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
7020042|NCT01549964|11094177|FG000|24-Week Treatment Period|Randomized but Not Treated|0
7020043|NCT01549964|11094178|FG001|24-Week Treatment Period|Randomized but Not Treated|0
7020044|NCT01549964|11094179|FG002|24-Week Treatment Period|Randomized but Not Treated|0
7020045|NCT01549964|11094180|FG003|24-Week Treatment Period|Randomized but Not Treated|1
7020046|NCT01549964|11094177|FG000|24-Week Treatment Period|Completion Status Unknown|1
7020047|NCT01549964|11094178|FG001|24-Week Treatment Period|Completion Status Unknown|0
7020048|NCT01549964|11094179|FG002|24-Week Treatment Period|Completion Status Unknown|1
7020049|NCT01549964|11094180|FG003|24-Week Treatment Period|Completion Status Unknown|0
7020050|NCT01549964|11094177|FG000|80-Week Extension Period|Pregnancy|0
7020051|NCT01549964|11094178|FG001|80-Week Extension Period|Pregnancy|0
7020052|NCT01549964|11094179|FG002|80-Week Extension Period|Pregnancy|1
7020053|NCT01549964|11094180|FG003|80-Week Extension Period|Pregnancy|0
7020054|NCT01549964|11094177|FG000|80-Week Extension Period|Study Terminated by Sponsor|65
7020055|NCT01549964|11094178|FG001|80-Week Extension Period|Study Terminated by Sponsor|137
7020056|NCT01549964|11094179|FG002|80-Week Extension Period|Study Terminated by Sponsor|132
7020057|NCT01549964|11094180|FG003|80-Week Extension Period|Study Terminated by Sponsor|132
7020058|NCT01549964|11094177|FG000|80-Week Extension Period|Voluntary Withdrawal|0
7020059|NCT01549964|11094178|FG001|80-Week Extension Period|Voluntary Withdrawal|1
7020060|NCT01549964|11094179|FG002|80-Week Extension Period|Voluntary Withdrawal|4
7020061|NCT01549964|11094180|FG003|80-Week Extension Period|Voluntary Withdrawal|2
7020062|NCT01549964|11094177|FG000|80-Week Extension Period|Lost to Follow-up|1
7020063|NCT01549964|11094178|FG001|80-Week Extension Period|Lost to Follow-up|0
7020064|NCT01549964|11094179|FG002|80-Week Extension Period|Lost to Follow-up|2
7020065|NCT01549964|11094180|FG003|80-Week Extension Period|Lost to Follow-up|1
7020066|NCT01549964|11094177|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0
7020067|NCT01549964|11094178|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0
7020068|NCT01549964|11094179|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1
7020069|NCT01549964|11094180|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2
7020070|NCT01550744|11094254|FG000|Open-Label|Lost to Follow-up|7
7020071|NCT01550744|11094255|FG001|Open-Label|Lost to Follow-up|0
7020072|NCT01550744|11094256|FG002|Open-Label|Lost to Follow-up|0
7020073|NCT01550744|11094254|FG000|Open-Label|Withdrawal by Subject|13
7020074|NCT01550744|11094255|FG001|Open-Label|Withdrawal by Subject|0
7020075|NCT01550744|11094256|FG002|Open-Label|Withdrawal by Subject|0
7020076|NCT01550744|11094254|FG000|Open-Label|Adverse Event|11
7020077|NCT01550744|11094255|FG001|Open-Label|Adverse Event|0
7020078|NCT01550744|11094256|FG002|Open-Label|Adverse Event|0
7020079|NCT01550744|11094254|FG000|Open-Label|Lack of Efficacy|4
7020080|NCT01550744|11094255|FG001|Open-Label|Lack of Efficacy|0
7020081|NCT01550744|11094256|FG002|Open-Label|Lack of Efficacy|0
7020082|NCT01550744|11094254|FG000|Open-Label|Protocol Violation|4
7020083|NCT01550744|11094255|FG001|Open-Label|Protocol Violation|0
7020084|NCT01550744|11094256|FG002|Open-Label|Protocol Violation|0
7020085|NCT01550744|11094254|FG000|Open-Label|Not all 3 study drug injections received|2
7020086|NCT01550744|11094255|FG001|Open-Label|Not all 3 study drug injections received|0
7020087|NCT01550744|11094256|FG002|Open-Label|Not all 3 study drug injections received|0
7020088|NCT01550744|11094254|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58
7020089|NCT01550744|11094255|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0
7020090|NCT01550744|11094256|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0
7020091|NCT01550744|11094254|FG000|Open-Label|Other|1
7020092|NCT01550744|11094255|FG001|Open-Label|Other|0
7020093|NCT01550744|11094256|FG002|Open-Label|Other|0
7020094|NCT01550744|11094254|FG000|Double-Blind|Lost to Follow-up|0
7020095|NCT01550744|11094255|FG001|Double-Blind|Lost to Follow-up|6
7020096|NCT01550744|11094256|FG002|Double-Blind|Lost to Follow-up|12
7020097|NCT01550744|11094254|FG000|Double-Blind|Withdrawal by Subject|0
7020098|NCT01550744|11094255|FG001|Double-Blind|Withdrawal by Subject|2
7020099|NCT01550744|11094256|FG002|Double-Blind|Withdrawal by Subject|15
7020100|NCT01550744|11094254|FG000|Double-Blind|Adverse Event|0
7020101|NCT01550744|11094255|FG001|Double-Blind|Adverse Event|4
7020102|NCT01550744|11094256|FG002|Double-Blind|Adverse Event|15
7020103|NCT01550744|11094254|FG000|Double-Blind|Death|0
7020104|NCT01550744|11094255|FG001|Double-Blind|Death|1
7020105|NCT01550744|11094256|FG002|Double-Blind|Death|0
7020106|NCT01550744|11094254|FG000|Double-Blind|Lack of Efficacy|0
7020107|NCT01550744|11094255|FG001|Double-Blind|Lack of Efficacy|2
7020108|NCT01550744|11094256|FG002|Double-Blind|Lack of Efficacy|8
7020109|NCT01550744|11094254|FG000|Double-Blind|Protocol Violation|0
7020110|NCT01550744|11094255|FG001|Double-Blind|Protocol Violation|0
7020111|NCT01550744|11094256|FG002|Double-Blind|Protocol Violation|4
7020112|NCT01550744|11094254|FG000|Double-Blind|Pregnancy|0
7020113|NCT01550744|11094255|FG001|Double-Blind|Pregnancy|0
7020114|NCT01550744|11094256|FG002|Double-Blind|Pregnancy|3
7020115|NCT01550744|11094254|FG000|Double-Blind|Other|0
7020116|NCT01550744|11094255|FG001|Double-Blind|Other|2
7020117|NCT01550744|11094256|FG002|Double-Blind|Other|10
7020118|NCT01550757|11094267|FG000|Overall Study|Lost to Follow-up|21
7020119|NCT01550757|11094268|FG001|Overall Study|Lost to Follow-up|14
7020120|NCT01550757|11094269|FG002|Overall Study|Lost to Follow-up|42
7020121|NCT01550757|11094270|FG003|Overall Study|Lost to Follow-up|53
7020122|NCT01550757|11094267|FG000|Overall Study|Withdrawal by Subject|2
7020123|NCT01550757|11094268|FG001|Overall Study|Withdrawal by Subject|0
7020124|NCT01550757|11094269|FG002|Overall Study|Withdrawal by Subject|3
7020125|NCT01550757|11094270|FG003|Overall Study|Withdrawal by Subject|1
7020126|NCT01550965|11094293|FG000|Overall Study|Adverse Event|26
7020127|NCT01550965|11094293|FG000|Overall Study|Withdrawal by Subject|10
7020128|NCT01550965|11094293|FG000|Overall Study|Lost to Follow-up|2
7020129|NCT01550965|11094293|FG000|Overall Study|Lack of Efficacy|59
7020130|NCT01550965|11094293|FG000|Overall Study|Other|13
7020131|NCT01551173|11094317|FG000|Overall Study|Withdrawal by Subject|11
7020132|NCT01551173|11094318|FG001|Overall Study|Withdrawal by Subject|16
7020133|NCT01551173|11094317|FG000|Overall Study|Adverse Event|7
7020134|NCT01551173|11094318|FG001|Overall Study|Adverse Event|6
7020135|NCT01551173|11094317|FG000|Overall Study|Lost to Follow-up|5
7020136|NCT01551173|11094318|FG001|Overall Study|Lost to Follow-up|7
7020137|NCT01551173|11094317|FG000|Overall Study|Other|5
7020138|NCT01551173|11094318|FG001|Overall Study|Other|3
7020139|NCT01551212|11094340|FG000|Overall Study|Graft loss/Retransplantation|0
7020140|NCT01551212|11094341|FG001|Overall Study|Graft loss/Retransplantation|1
7020141|NCT01551212|11094340|FG000|Overall Study|Administrative problems|1
7020142|NCT01551212|11094341|FG001|Overall Study|Administrative problems|2
7020143|NCT01551212|11094340|FG000|Overall Study|Lost to Follow-up|0
7020144|NCT01551212|11094341|FG001|Overall Study|Lost to Follow-up|1
7020145|NCT01551212|11094340|FG000|Overall Study|Protocol Violation|0
7020146|NCT01551212|11094341|FG001|Overall Study|Protocol Violation|1
7020147|NCT01551212|11094340|FG000|Overall Study|Withdrawal by Subject|0
7020148|NCT01551212|11094341|FG001|Overall Study|Withdrawal by Subject|7
7020149|NCT01551212|11094340|FG000|Overall Study|Death|2
7020150|NCT01551212|11094341|FG001|Overall Study|Death|4
7020151|NCT01551212|11094340|FG000|Overall Study|Never Received Study Treatment|2
7020152|NCT01551212|11094341|FG001|Overall Study|Never Received Study Treatment|4
7020153|NCT01551303|11094358|FG000|Overall Study|failed awareness check on vision test|4
7020154|NCT01551303|11094359|FG001|Overall Study|failed awareness check on vision test|7
7020155|NCT01551355|11094371|FG000|Overall Study|Lost to Follow-up|51
7020156|NCT01551355|11094372|FG001|Overall Study|Lost to Follow-up|49
7020157|NCT01551355|11094373|FG002|Overall Study|Lost to Follow-up|34
7020158|NCT01551355|11094374|FG003|Overall Study|Lost to Follow-up|24
7020159|NCT01551355|11094375|FG004|Overall Study|Lost to Follow-up|9
7020160|NCT01551355|11094376|FG005|Overall Study|Lost to Follow-up|6
7020161|NCT01551420|11094386|FG000|In-laboratory (Part A)|Lost to Follow-up|2
7020162|NCT01551420|11094387|FG001|In-laboratory (Part A)|Lost to Follow-up|1
7020163|NCT01551420|11094386|FG000|In-laboratory (Part A)|Withdrawal by Subject|2
7020164|NCT01551420|11094387|FG001|In-laboratory (Part A)|Withdrawal by Subject|0
7020165|NCT01551420|11094386|FG000|In-laboratory (Part A)|Scheduling conflict|2
7020166|NCT01551420|11094387|FG001|In-laboratory (Part A)|Scheduling conflict|1
7020167|NCT01551420|11094386|FG000|Screened for Part B Eligibility|Declined participation|8
7020168|NCT01551420|11094387|FG001|Screened for Part B Eligibility|Declined participation|1
7020169|NCT01551420|11094386|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1
7020170|NCT01551420|11094387|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2
7020171|NCT01551420|11094386|FG000|Home Use (Part B)|Withdrawal by Subject|6
7020172|NCT01551420|11094387|FG001|Home Use (Part B)|Withdrawal by Subject|0
7020173|NCT01551420|11094386|FG000|Home Use (Part B)|Withdrawal by staff|0
7020174|NCT01551420|11094387|FG001|Home Use (Part B)|Withdrawal by staff|1
7020175|NCT01551693|11094395|FG000|Overall Study|Disease Progression|1
7020176|NCT01551693|11094396|FG001|Overall Study|Disease Progression|0
7020177|NCT01551693|11094395|FG000|Overall Study|Adverse Event|0
7020178|NCT01551693|11094396|FG001|Overall Study|Adverse Event|1
7020179|NCT01551693|11094395|FG000|Overall Study|Withdrawal by Subject|0
7020180|NCT01551693|11094396|FG001|Overall Study|Withdrawal by Subject|1
7020181|NCT01551745|11094402|FG000|Overall Study|Withdrawal by Subject|1
7020182|NCT01551745|11094402|FG000|Overall Study|Disease Progression|2
7020183|NCT01551758|11094408|FG000|Overall Study|Adverse Event|29
7020184|NCT01551758|11094409|FG001|Overall Study|Adverse Event|43
7020185|NCT01551758|11094408|FG000|Overall Study|Lack of Efficacy|0
7020186|NCT01551758|11094409|FG001|Overall Study|Lack of Efficacy|1
7020187|NCT01551758|11094408|FG000|Overall Study|Protocol Violation|5
7020188|NCT01551758|11094409|FG001|Overall Study|Protocol Violation|6
7020189|NCT01551758|11094408|FG000|Overall Study|Met Protocol-defined stopping criteria|8
7020190|NCT01551758|11094409|FG001|Overall Study|Met Protocol-defined stopping criteria|10
7020191|NCT01551758|11094408|FG000|Overall Study|Lost to Follow-up|29
7020192|NCT01551758|11094409|FG001|Overall Study|Lost to Follow-up|25
7020193|NCT01551758|11094408|FG000|Overall Study|Physician Decision|9
7020194|NCT01551758|11094409|FG001|Overall Study|Physician Decision|3
7020195|NCT01551758|11094408|FG000|Overall Study|Withdrawal by Subject|14
7020196|NCT01551758|11094409|FG001|Overall Study|Withdrawal by Subject|17
7020197|NCT01552057|11094437|FG000|Overall Study|Adverse Event|14
7020198|NCT01552057|11094438|FG001|Overall Study|Adverse Event|15
7020199|NCT01552057|11094437|FG000|Overall Study|Lack of Efficacy|8
7020200|NCT01552057|11094438|FG001|Overall Study|Lack of Efficacy|23
7020201|NCT01552057|11094437|FG000|Overall Study|Withdrawal by Subject|5
7020202|NCT01552057|11094438|FG001|Overall Study|Withdrawal by Subject|8
7020203|NCT01552057|11094437|FG000|Overall Study|Entry Criteria Not Met|2
7020204|NCT01552057|11094438|FG001|Overall Study|Entry Criteria Not Met|2
7020205|NCT01552057|11094437|FG000|Overall Study|Physician Decision|1
7020206|NCT01552057|11094438|FG001|Overall Study|Physician Decision|0
7020207|NCT01552369|11094473|FG000|Overall Study|Did not consent to extended follow up|8
7020208|NCT01552369|11094474|FG001|Overall Study|Did not consent to extended follow up|9
7020209|NCT01552408|11094484|FG000|Overall Study|Lost to Follow-up|2
7020210|NCT01552408|11094485|FG001|Overall Study|Lost to Follow-up|0
7020211|NCT01552408|11094484|FG000|Overall Study|Relocation|0
7020212|NCT01552408|11094485|FG001|Overall Study|Relocation|1
7020213|NCT01552408|11094484|FG000|Overall Study|Withdrawal by Subject|2
7020214|NCT01552408|11094485|FG001|Overall Study|Withdrawal by Subject|1
7020215|NCT01552603|11094492|FG000|Overall Study|Physician Decision|1
7020216|NCT01552681|11094498|FG000|Overall Study|Withdrawal by Subject|4
7020217|NCT01552681|11094499|FG001|Overall Study|Withdrawal by Subject|0
7020218|NCT01552681|11094498|FG000|Overall Study|Physician Decision|1
7020219|NCT01552681|11094499|FG001|Overall Study|Physician Decision|0
7020220|NCT01552681|11094498|FG000|Overall Study|Subject moved away|0
7020221|NCT01552681|11094499|FG001|Overall Study|Subject moved away|1
7020222|NCT01552694|11094507|FG000|Overall Study|Lost to Follow-up|0
7020223|NCT01552694|11094508|FG001|Overall Study|Lost to Follow-up|1
7020224|NCT01552694|11094507|FG000|Overall Study|Protocol Violation|0
7020225|NCT01552694|11094508|FG001|Overall Study|Protocol Violation|1
7060515|NCT01919970|11156806|FG000|Overall Study|Withdrawal by Subject|3
7060516|NCT01919970|11156807|FG001|Overall Study|Withdrawal by Subject|0
7060517|NCT01920061|11156837|FG000|Overall Study|Death|1
7060518|NCT01920061|11156838|FG001|Overall Study|Death|1
7060519|NCT01920061|11156839|FG002|Overall Study|Death|0
7060520|NCT01920061|11156840|FG003|Overall Study|Death|1
7060521|NCT01920061|11156841|FG004|Overall Study|Death|1
7060522|NCT01920061|11156842|FG005|Overall Study|Death|0
7060523|NCT01920061|11156843|FG006|Overall Study|Death|0
7060524|NCT01920061|11156844|FG007|Overall Study|Death|1
7060525|NCT01920061|11156845|FG008|Overall Study|Death|0
7060526|NCT01920061|11156846|FG009|Overall Study|Death|1
7060527|NCT01920061|11156847|FG010|Overall Study|Death|0
7060528|NCT01920061|11156848|FG011|Overall Study|Death|1
7020226|NCT01552772|11094514|FG000|Overall Study|Lost to Follow-up|2
7020227|NCT01552772|11094514|FG000|Overall Study|Adverse Event|1
7060529|NCT01920061|11156849|FG012|Overall Study|Death|0
7060530|NCT01920061|11156850|FG013|Overall Study|Death|2
7060531|NCT01920061|11156851|FG014|Overall Study|Death|0
7060532|NCT01920061|11156852|FG015|Overall Study|Death|0
7060533|NCT01920061|11156853|FG016|Overall Study|Death|0
7060534|NCT01920061|11156854|FG017|Overall Study|Death|0
7060535|NCT01920061|11156855|FG018|Overall Study|Death|1
7020228|NCT01552772|11094514|FG000|Overall Study|Protocol Deviation|1
7020229|NCT01552902|11094546|FG000|Overall Study|Adverse Event|1
7020230|NCT01552902|11094547|FG001|Overall Study|Adverse Event|15
7020231|NCT01552902|11094548|FG002|Overall Study|Adverse Event|14
7060536|NCT01920061|11156856|FG019|Overall Study|Death|0
7060537|NCT01920061|11156837|FG000|Overall Study|Lost to Follow-up|0
7060538|NCT01920061|11156838|FG001|Overall Study|Lost to Follow-up|2
7020232|NCT01552902|11094546|FG000|Overall Study|Protocol Violation|3
7020233|NCT01552902|11094547|FG001|Overall Study|Protocol Violation|3
7020234|NCT01552902|11094548|FG002|Overall Study|Protocol Violation|3
7020235|NCT01552902|11094546|FG000|Overall Study|Lack of Efficacy|4
7020236|NCT01552902|11094547|FG001|Overall Study|Lack of Efficacy|3
7020237|NCT01552902|11094548|FG002|Overall Study|Lack of Efficacy|1
7020238|NCT01552902|11094546|FG000|Overall Study|Withdrawal by Subject|1
7020239|NCT01552902|11094547|FG001|Overall Study|Withdrawal by Subject|9
7020240|NCT01552902|11094548|FG002|Overall Study|Withdrawal by Subject|6
7020241|NCT01552902|11094546|FG000|Overall Study|Lost to Follow-up|1
7020242|NCT01552902|11094547|FG001|Overall Study|Lost to Follow-up|3
7020243|NCT01552902|11094548|FG002|Overall Study|Lost to Follow-up|6
7020244|NCT01552902|11094546|FG000|Overall Study|Other|3
7020245|NCT01552902|11094547|FG001|Overall Study|Other|4
7020246|NCT01552902|11094548|FG002|Overall Study|Other|3
7020247|NCT01552915|11094559|FG000|Overall Study|Adverse Event|3
7020248|NCT01552915|11094560|FG001|Overall Study|Adverse Event|14
7020249|NCT01552915|11094561|FG002|Overall Study|Adverse Event|3
7020250|NCT01552915|11094559|FG000|Overall Study|Lost to Follow-up|4
7020251|NCT01552915|11094560|FG001|Overall Study|Lost to Follow-up|6
7020252|NCT01552915|11094561|FG002|Overall Study|Lost to Follow-up|5
7020253|NCT01552915|11094559|FG000|Overall Study|Withdrawal by Subject|6
7020254|NCT01552915|11094560|FG001|Overall Study|Withdrawal by Subject|4
7020255|NCT01552915|11094561|FG002|Overall Study|Withdrawal by Subject|5
7020256|NCT01552915|11094559|FG000|Overall Study|Protocol Violation|0
7020257|NCT01552915|11094560|FG001|Overall Study|Protocol Violation|4
7020258|NCT01552915|11094561|FG002|Overall Study|Protocol Violation|4
7020259|NCT01552915|11094559|FG000|Overall Study|Lack of Efficacy|8
7020260|NCT01552915|11094560|FG001|Overall Study|Lack of Efficacy|1
7020261|NCT01552915|11094561|FG002|Overall Study|Lack of Efficacy|4
7020262|NCT01552915|11094559|FG000|Overall Study|Other|2
7020263|NCT01552915|11094560|FG001|Overall Study|Other|0
7020264|NCT01552915|11094561|FG002|Overall Study|Other|6
7020265|NCT01552928|11094573|FG000|Period 3|Adverse Event|0
7020266|NCT01552928|11094574|FG001|Period 3|Adverse Event|0
7020267|NCT01552928|11094575|FG002|Period 3|Adverse Event|1
7020268|NCT01552928|11094576|FG003|Period 3|Adverse Event|0
7020269|NCT01552954|11094595|FG000|Overall Study|Adverse Event|1
7020270|NCT01552954|11094596|FG001|Overall Study|Adverse Event|2
7020271|NCT01552954|11094595|FG000|Overall Study|Lost to Follow-up|1
7020272|NCT01552954|11094596|FG001|Overall Study|Lost to Follow-up|1
7020273|NCT01552954|11094595|FG000|Overall Study|Withdrawal by Subject|1
7020274|NCT01552954|11094596|FG001|Overall Study|Withdrawal by Subject|1
7020275|NCT01552954|11094595|FG000|Overall Study|Protocol Violation|1
7020276|NCT01552954|11094596|FG001|Overall Study|Protocol Violation|2
7020277|NCT01552954|11094595|FG000|Overall Study|diagnosed DM|1
7020278|NCT01552954|11094596|FG001|Overall Study|diagnosed DM|0
7020279|NCT01553084|11094622|FG000|Overall Study|Withdrawal by Subject|15
7020280|NCT01553084|11094623|FG001|Overall Study|Withdrawal by Subject|13
7020281|NCT01553084|11094624|FG002|Overall Study|Withdrawal by Subject|35
7020282|NCT01553136|11094636|FG000|Overall Study|Adverse Event|3
7020283|NCT01553136|11094637|FG001|Overall Study|Adverse Event|2
7020284|NCT01553136|11094636|FG000|Overall Study|Withdrawal by Subject|2
7020285|NCT01553136|11094637|FG001|Overall Study|Withdrawal by Subject|3
7020286|NCT01553136|11094636|FG000|Overall Study|Lost to Follow-up|4
7020287|NCT01553136|11094637|FG001|Overall Study|Lost to Follow-up|10
7020288|NCT01553136|11094636|FG000|Overall Study|Physician Decision|2
7020289|NCT01553136|11094637|FG001|Overall Study|Physician Decision|3
7020290|NCT01553136|11094636|FG000|Overall Study|Scheduling Difficulties|5
7020291|NCT01553136|11094637|FG001|Overall Study|Scheduling Difficulties|4
7020292|NCT01553188|11094647|FG000|Overall Study|Patient choice|1
7020293|NCT01553188|11094648|FG001|Overall Study|Patient choice|0
7020294|NCT01553188|11094649|FG002|Overall Study|Patient choice|0
7020295|NCT01553188|11094650|FG003|Overall Study|Patient choice|0
7020296|NCT01553188|11094647|FG000|Overall Study|Intercurrent illness and adverse event|0
7020297|NCT01553188|11094648|FG001|Overall Study|Intercurrent illness and adverse event|1
7020298|NCT01553188|11094649|FG002|Overall Study|Intercurrent illness and adverse event|2
7020299|NCT01553188|11094650|FG003|Overall Study|Intercurrent illness and adverse event|0
7020300|NCT01553279|11094674|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1
7020301|NCT01553279|11094675|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0
7020302|NCT01553279|11094674|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1
7020303|NCT01553279|11094675|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1
7020304|NCT01553279|11094674|FG000|Interim Period|Withdrawal by Subject|2
7020305|NCT01553279|11094675|FG001|Interim Period|Withdrawal by Subject|2
7020306|NCT01553279|11094674|FG000|Interim Period|Lost to Follow-up|1
7020307|NCT01553279|11094675|FG001|Interim Period|Lost to Follow-up|0
7020308|NCT01553279|11094674|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0
7020309|NCT01553279|11094675|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5
7143168|NCT03028129|11299595|FG000|Overall Study|Adverse Event|13
7020310|NCT01553279|11094674|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3
7020311|NCT01553279|11094675|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2
7020312|NCT01553318|11094690|FG000|Overall Study|Protocol Violation|3
7020313|NCT01553318|11094691|FG001|Overall Study|Protocol Violation|2
7020314|NCT01553591|11094706|FG000|Overall Study|Voluntarily withdrew|94
7143169|NCT03028129|11299596|FG001|Overall Study|Adverse Event|2
7020315|NCT01553591|11094707|FG001|Overall Study|Voluntarily withdrew|79
7020316|NCT01553591|11094708|FG002|Overall Study|Voluntarily withdrew|96
7020317|NCT01553591|11094706|FG000|Overall Study|Adverse Event|36
7020318|NCT01553591|11094707|FG001|Overall Study|Adverse Event|45
7020319|NCT01553591|11094708|FG002|Overall Study|Adverse Event|16
7020320|NCT01553591|11094706|FG000|Overall Study|Lost to Follow-up|25
7020321|NCT01553591|11094707|FG001|Overall Study|Lost to Follow-up|23
7020322|NCT01553591|11094708|FG002|Overall Study|Lost to Follow-up|16
7020323|NCT01553591|11094706|FG000|Overall Study|Physician decision: other|11
7020324|NCT01553591|11094707|FG001|Overall Study|Physician decision: other|14
7020325|NCT01553591|11094708|FG002|Overall Study|Physician decision: other|16
7020326|NCT01553591|11094706|FG000|Overall Study|Physician decision: lack of efficacy|2
7020327|NCT01553591|11094707|FG001|Overall Study|Physician decision: lack of efficacy|3
7020328|NCT01553591|11094708|FG002|Overall Study|Physician decision: lack of efficacy|7
7020329|NCT01553591|11094706|FG000|Overall Study|Protocol Violation|3
7020330|NCT01553591|11094707|FG001|Overall Study|Protocol Violation|4
7020331|NCT01553591|11094708|FG002|Overall Study|Protocol Violation|4
7020332|NCT01553591|11094706|FG000|Overall Study|Sponsor decision|1
7020333|NCT01553591|11094707|FG001|Overall Study|Sponsor decision|0
7020334|NCT01553591|11094708|FG002|Overall Study|Sponsor decision|3
7020335|NCT01553591|11094706|FG000|Overall Study|Randomized and never dispensed drug|0
7020336|NCT01553591|11094707|FG001|Overall Study|Randomized and never dispensed drug|1
7020337|NCT01553591|11094708|FG002|Overall Study|Randomized and never dispensed drug|0
7043896|NCT01748071|11129122|FG000|Overall Study|Adverse Event|2
7043897|NCT01748071|11129123|FG001|Overall Study|Adverse Event|2
7043898|NCT01748071|11129124|FG002|Overall Study|Adverse Event|0
7043899|NCT01748292|11129143|FG000|Overall Study|Adverse Event|2
7043900|NCT01748292|11129144|FG001|Overall Study|Adverse Event|4
7043901|NCT01748292|11129143|FG000|Overall Study|Lost to Follow-up|0
7043902|NCT01748292|11129144|FG001|Overall Study|Lost to Follow-up|3
7043903|NCT01748292|11129143|FG000|Overall Study|Death|0
7043904|NCT01748292|11129144|FG001|Overall Study|Death|3
7043905|NCT01748292|11129143|FG000|Overall Study|Withdrawal by Subject|0
7043906|NCT01748292|11129144|FG001|Overall Study|Withdrawal by Subject|2
7043907|NCT01748552|11129162|FG000|Intervention Period 2 and Washout|Physician Decision|0
7043908|NCT01748552|11129163|FG001|Intervention Period 2 and Washout|Physician Decision|0
7043909|NCT01748552|11129164|FG002|Intervention Period 2 and Washout|Physician Decision|1
7043910|NCT01748552|11129165|FG003|Intervention Period 2 and Washout|Physician Decision|0
7043911|NCT01748552|11129166|FG004|Intervention Period 2 and Washout|Physician Decision|0
7043912|NCT01748552|11129167|FG005|Intervention Period 2 and Washout|Physician Decision|0
7043913|NCT01748552|11129168|FG006|Intervention Period 2 and Washout|Physician Decision|0
7043914|NCT01748552|11129169|FG007|Intervention Period 2 and Washout|Physician Decision|0
7043915|NCT01748552|11129170|FG008|Intervention Period 2 and Washout|Physician Decision|0
7043916|NCT01748552|11129171|FG009|Intervention Period 2 and Washout|Physician Decision|0
7043917|NCT01748552|11129172|FG010|Intervention Period 2 and Washout|Physician Decision|0
7043918|NCT01748552|11129173|FG011|Intervention Period 2 and Washout|Physician Decision|0
7043919|NCT01748552|11129162|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0
7043920|NCT01748552|11129163|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0
7043921|NCT01748552|11129164|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0
7043922|NCT01748552|11129165|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0
7043923|NCT01748552|11129166|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0
7043924|NCT01748552|11129167|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0
7043925|NCT01748552|11129168|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3
7043926|NCT01748552|11129169|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3
7043927|NCT01748552|11129170|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3
7043928|NCT01748552|11129171|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0
7043929|NCT01748552|11129172|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0
7043930|NCT01748552|11129173|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0
7043931|NCT01748760|11129231|FG000|Overall Study|Withdrawal by Subject|1
7043932|NCT01748760|11129232|FG001|Overall Study|Withdrawal by Subject|1
7043933|NCT01748760|11129231|FG000|Overall Study|Lost to Follow-up|5
7043934|NCT01748760|11129232|FG001|Overall Study|Lost to Follow-up|1
7043935|NCT01748825|11129289|FG000|Dose Escalation|Refused further treatment|2
7043936|NCT01748825|11129290|FG001|Dose Escalation|Refused further treatment|2
7043937|NCT01748825|11129291|FG002|Dose Escalation|Refused further treatment|0
7043938|NCT01748825|11129292|FG003|Dose Escalation|Refused further treatment|0
7043939|NCT01748825|11129293|FG004|Dose Escalation|Refused further treatment|1
7043940|NCT01748825|11129294|FG005|Dose Escalation|Refused further treatment|2
7043941|NCT01748825|11129295|FG006|Dose Escalation|Refused further treatment|0
7043942|NCT01748825|11129296|FG007|Dose Escalation|Refused further treatment|0
7043943|NCT01748825|11129297|FG008|Dose Escalation|Refused further treatment|0
7043944|NCT01748825|11129298|FG009|Dose Escalation|Refused further treatment|0
7043945|NCT01748825|11129289|FG000|Dose Escalation|Switched to alternative treatment|0
7043946|NCT01748825|11129290|FG001|Dose Escalation|Switched to alternative treatment|0
7043947|NCT01748825|11129291|FG002|Dose Escalation|Switched to alternative treatment|0
7043948|NCT01748825|11129292|FG003|Dose Escalation|Switched to alternative treatment|1
7043949|NCT01748825|11129293|FG004|Dose Escalation|Switched to alternative treatment|0
7020338|NCT01553747|11094728|FG000|Overall Study|Protocol Violation|0
7020339|NCT01553747|11094729|FG001|Overall Study|Protocol Violation|2
7020340|NCT01553747|11094730|FG002|Overall Study|Protocol Violation|0
7020341|NCT01553747|11094728|FG000|Overall Study|Voluntarily withdrew|70
7020342|NCT01553747|11094729|FG001|Overall Study|Voluntarily withdrew|66
7020343|NCT01553747|11094730|FG002|Overall Study|Voluntarily withdrew|74
7020344|NCT01553747|11094728|FG000|Overall Study|Adverse event or SAE|32
7020345|NCT01553747|11094729|FG001|Overall Study|Adverse event or SAE|28
7020346|NCT01553747|11094730|FG002|Overall Study|Adverse event or SAE|19
7020347|NCT01553747|11094728|FG000|Overall Study|Physician decision: other|10
7020348|NCT01553747|11094729|FG001|Overall Study|Physician decision: other|8
7020349|NCT01553747|11094730|FG002|Overall Study|Physician decision: other|7
7020350|NCT01553747|11094728|FG000|Overall Study|Lost to Follow-up|11
7020351|NCT01553747|11094729|FG001|Overall Study|Lost to Follow-up|5
7020352|NCT01553747|11094730|FG002|Overall Study|Lost to Follow-up|6
7020353|NCT01553747|11094728|FG000|Overall Study|Sponsor decision, specify|7
7020354|NCT01553747|11094729|FG001|Overall Study|Sponsor decision, specify|5
7020355|NCT01553747|11094730|FG002|Overall Study|Sponsor decision, specify|0
7020356|NCT01553747|11094728|FG000|Overall Study|Physician decision: lack of efficacy|1
7020357|NCT01553747|11094729|FG001|Overall Study|Physician decision: lack of efficacy|5
7020358|NCT01553747|11094730|FG002|Overall Study|Physician decision: lack of efficacy|3
7020359|NCT01553851|11094741|FG000|Overall Study|Adverse Event|2
7020360|NCT01553851|11094741|FG000|Overall Study|constipation|1
7020361|NCT01553916|11094745|FG000|Overall Study|Withdrawal by Subject|2
7020362|NCT01553916|11094745|FG000|Overall Study|Pre-treatment MRI metastatic disease|1
7020363|NCT01554176|11094751|FG000|Treatment Phase|Protocol Violation|1
7020364|NCT01554176|11094752|FG001|Treatment Phase|Protocol Violation|2
7020365|NCT01554176|11094753|FG002|Treatment Phase|Protocol Violation|0
7020366|NCT01554176|11094754|FG003|Treatment Phase|Protocol Violation|0
7020367|NCT01554176|11094755|FG004|Treatment Phase|Protocol Violation|0
7020368|NCT01554176|11094751|FG000|Treatment Phase|Physician Decision|1
7020369|NCT01554176|11094752|FG001|Treatment Phase|Physician Decision|1
7020370|NCT01554176|11094753|FG002|Treatment Phase|Physician Decision|0
7020371|NCT01554176|11094754|FG003|Treatment Phase|Physician Decision|0
7020372|NCT01554176|11094755|FG004|Treatment Phase|Physician Decision|0
7020373|NCT01554176|11094751|FG000|Treatment Phase|Lack of Efficacy|0
7020374|NCT01554176|11094752|FG001|Treatment Phase|Lack of Efficacy|1
7020375|NCT01554176|11094753|FG002|Treatment Phase|Lack of Efficacy|0
7020376|NCT01554176|11094754|FG003|Treatment Phase|Lack of Efficacy|0
7020377|NCT01554176|11094755|FG004|Treatment Phase|Lack of Efficacy|0
7020378|NCT01554176|11094751|FG000|Treatment Phase|Adverse event, non-fatal|1
7020379|NCT01554176|11094752|FG001|Treatment Phase|Adverse event, non-fatal|1
7020380|NCT01554176|11094753|FG002|Treatment Phase|Adverse event, non-fatal|0
7020381|NCT01554176|11094754|FG003|Treatment Phase|Adverse event, non-fatal|0
7020382|NCT01554176|11094755|FG004|Treatment Phase|Adverse event, non-fatal|0
7020383|NCT01554176|11094751|FG000|Treatment Phase|Non-compliance with study drug|1
7020384|NCT01554176|11094752|FG001|Treatment Phase|Non-compliance with study drug|0
7020385|NCT01554176|11094753|FG002|Treatment Phase|Non-compliance with study drug|0
7020386|NCT01554176|11094754|FG003|Treatment Phase|Non-compliance with study drug|0
7020387|NCT01554176|11094755|FG004|Treatment Phase|Non-compliance with study drug|0
7020388|NCT01554176|11094751|FG000|Treatment Phase|Withdrawal by Subject|1
7020389|NCT01554176|11094752|FG001|Treatment Phase|Withdrawal by Subject|0
7020390|NCT01554176|11094753|FG002|Treatment Phase|Withdrawal by Subject|0
7020391|NCT01554176|11094754|FG003|Treatment Phase|Withdrawal by Subject|0
7020392|NCT01554176|11094755|FG004|Treatment Phase|Withdrawal by Subject|0
7020393|NCT01554176|11094751|FG000|Treatment Phase|Lost to Follow-up|3
7020394|NCT01554176|11094752|FG001|Treatment Phase|Lost to Follow-up|0
7020395|NCT01554176|11094753|FG002|Treatment Phase|Lost to Follow-up|0
7020396|NCT01554176|11094754|FG003|Treatment Phase|Lost to Follow-up|0
7020397|NCT01554176|11094755|FG004|Treatment Phase|Lost to Follow-up|0
7020398|NCT01554176|11094751|FG000|Run-out Phase|Protocol Violation|0
7020399|NCT01554176|11094752|FG001|Run-out Phase|Protocol Violation|0
7020400|NCT01554176|11094753|FG002|Run-out Phase|Protocol Violation|0
7020401|NCT01554176|11094754|FG003|Run-out Phase|Protocol Violation|1
7020402|NCT01554176|11094755|FG004|Run-out Phase|Protocol Violation|0
7020403|NCT01554241|11094771|FG000|Overall Study|Death|3
7020404|NCT01554241|11094772|FG001|Overall Study|Death|1
7020405|NCT01554241|11094773|FG002|Overall Study|Death|1
7020406|NCT01554241|11094774|FG003|Overall Study|Death|0
7020407|NCT01554241|11094771|FG000|Overall Study|protocol specified renal stone|0
7020408|NCT01554241|11094772|FG001|Overall Study|protocol specified renal stone|0
7020409|NCT01554241|11094773|FG002|Overall Study|protocol specified renal stone|0
7020410|NCT01554241|11094774|FG003|Overall Study|protocol specified renal stone|1
7020411|NCT01554241|11094771|FG000|Overall Study|protocol specified change in eGFR|0
7020412|NCT01554241|11094772|FG001|Overall Study|protocol specified change in eGFR|0
7020413|NCT01554241|11094773|FG002|Overall Study|protocol specified change in eGFR|1
7020414|NCT01554241|11094774|FG003|Overall Study|protocol specified change in eGFR|0
7020415|NCT01554241|11094771|FG000|Overall Study|Withdrawal by Subject|0
7020416|NCT01554241|11094772|FG001|Overall Study|Withdrawal by Subject|0
7020417|NCT01554241|11094773|FG002|Overall Study|Withdrawal by Subject|2
7020418|NCT01554241|11094774|FG003|Overall Study|Withdrawal by Subject|0
7020419|NCT01554514|11094809|FG000|Overall Study|1 patient ineligible with congenital TTP|1
7020420|NCT01554514|11094809|FG000|Overall Study|Physician Decision|1
7020421|NCT01554527|11094816|FG000|Overall Study|Withdrawal by Subject|1
7020422|NCT01554527|11094817|FG001|Overall Study|Withdrawal by Subject|0
7020423|NCT01554527|11094818|FG002|Overall Study|Withdrawal by Subject|3
7020424|NCT01554527|11094816|FG000|Overall Study|Lost to Follow-up|0
7020425|NCT01554527|11094817|FG001|Overall Study|Lost to Follow-up|0
7020426|NCT01554527|11094818|FG002|Overall Study|Lost to Follow-up|4
7020427|NCT01554527|11094816|FG000|Overall Study|Physician Decision|0
7020428|NCT01554527|11094817|FG001|Overall Study|Physician Decision|0
7020429|NCT01554527|11094818|FG002|Overall Study|Physician Decision|1
7020430|NCT01554579|11094829|FG000|Overall Study|Adverse Event|6
7020431|NCT01554579|11094830|FG001|Overall Study|Adverse Event|25
7020432|NCT01554579|11094829|FG000|Overall Study|Lack of Efficacy|2
7020433|NCT01554579|11094830|FG001|Overall Study|Lack of Efficacy|1
7020434|NCT01554579|11094829|FG000|Overall Study|Withdrawal by Subject|2
7020435|NCT01554579|11094830|FG001|Overall Study|Withdrawal by Subject|1
7020436|NCT01554618|11094839|FG000|Randomized Through Start of Treatment|Adverse Event|1
7020437|NCT01554618|11094840|FG001|Randomized Through Start of Treatment|Adverse Event|0
7020438|NCT01554618|11094839|FG000|Controlled Assessment Period|Lost to Follow-up|2
7020439|NCT01554618|11094840|FG001|Controlled Assessment Period|Lost to Follow-up|1
7020440|NCT01554618|11094839|FG000|Controlled Assessment Period|Withdrawal by Subject|6
7020441|NCT01554618|11094840|FG001|Controlled Assessment Period|Withdrawal by Subject|0
7020442|NCT01554618|11094839|FG000|Open-Label Extension Period|Withdrawal by Subject|2
7020443|NCT01554618|11094840|FG001|Open-Label Extension Period|Withdrawal by Subject|3
7020444|NCT01554618|11094839|FG000|Open-Label Extension Period|Physician Decision|0
7020445|NCT01554618|11094840|FG001|Open-Label Extension Period|Physician Decision|1
7020446|NCT01554618|11094839|FG000|Open-Label Extension Period|Lost to Follow-up|1
7020447|NCT01554618|11094840|FG001|Open-Label Extension Period|Lost to Follow-up|1
7020448|NCT01554904|11094876|FG000|Overall Study|Withdrawal by Subject|3
7020449|NCT01554904|11094876|FG000|Overall Study|Had sleep apnea on Home Study 1|1
7020450|NCT01555125|11094887|FG000|Induction Period|Lost to Follow-up|0
7020451|NCT01555125|11094888|FG001|Induction Period|Lost to Follow-up|2
7020452|NCT01555125|11094889|FG002|Induction Period|Lost to Follow-up|0
7020453|NCT01555125|11094890|FG003|Induction Period|Lost to Follow-up|0
7020454|NCT01555125|11094891|FG004|Induction Period|Lost to Follow-up|0
7020455|NCT01555125|11094887|FG000|Induction Period|Adverse Event|0
7020456|NCT01555125|11094888|FG001|Induction Period|Adverse Event|1
7020457|NCT01555125|11094889|FG002|Induction Period|Adverse Event|0
7020458|NCT01555125|11094890|FG003|Induction Period|Adverse Event|0
7020459|NCT01555125|11094891|FG004|Induction Period|Adverse Event|1
7020460|NCT01555125|11094887|FG000|Induction Period|Subject / guardian decision|0
7020461|NCT01555125|11094888|FG001|Induction Period|Subject / guardian decision|0
7020462|NCT01555125|11094889|FG002|Induction Period|Subject / guardian decision|0
7020463|NCT01555125|11094890|FG003|Induction Period|Subject / guardian decision|0
7020464|NCT01555125|11094891|FG004|Induction Period|Subject / guardian decision|2
7020465|NCT01555125|11094887|FG000|Induction Period|Death|1
7020466|NCT01555125|11094888|FG001|Induction Period|Death|0
7020467|NCT01555125|11094889|FG002|Induction Period|Death|0
7020468|NCT01555125|11094890|FG003|Induction Period|Death|0
7020469|NCT01555125|11094891|FG004|Induction Period|Death|0
7020470|NCT01555125|11094887|FG000|Maintenance Period|Adverse Event|1
7020471|NCT01555125|11094888|FG001|Maintenance Period|Adverse Event|1
7020472|NCT01555125|11094889|FG002|Maintenance Period|Adverse Event|0
7020473|NCT01555125|11094890|FG003|Maintenance Period|Adverse Event|0
7020474|NCT01555125|11094891|FG004|Maintenance Period|Adverse Event|0
7020475|NCT01555125|11094887|FG000|Maintenance Period|Subject / guardian decision|1
7020476|NCT01555125|11094888|FG001|Maintenance Period|Subject / guardian decision|2
7020477|NCT01555125|11094889|FG002|Maintenance Period|Subject / guardian decision|0
7020478|NCT01555125|11094890|FG003|Maintenance Period|Subject / guardian decision|0
7020479|NCT01555125|11094891|FG004|Maintenance Period|Subject / guardian decision|0
7020480|NCT01555125|11094887|FG000|Maintenance Period|Lost to Follow-up|2
7020481|NCT01555125|11094888|FG001|Maintenance Period|Lost to Follow-up|0
7020482|NCT01555125|11094889|FG002|Maintenance Period|Lost to Follow-up|0
7020483|NCT01555125|11094890|FG003|Maintenance Period|Lost to Follow-up|1
7060539|NCT01920061|11156839|FG002|Overall Study|Lost to Follow-up|0
7020484|NCT01555125|11094891|FG004|Maintenance Period|Lost to Follow-up|0
7020485|NCT01555125|11094887|FG000|Maintenance Period|Lack of Efficacy|6
7020486|NCT01555125|11094888|FG001|Maintenance Period|Lack of Efficacy|1
7020487|NCT01555125|11094889|FG002|Maintenance Period|Lack of Efficacy|3
7020488|NCT01555125|11094890|FG003|Maintenance Period|Lack of Efficacy|0
7020489|NCT01555125|11094891|FG004|Maintenance Period|Lack of Efficacy|0
7020490|NCT01555125|11094887|FG000|Maintenance Period|Physician Decision|0
7020491|NCT01555125|11094888|FG001|Maintenance Period|Physician Decision|0
7020492|NCT01555125|11094889|FG002|Maintenance Period|Physician Decision|1
7020493|NCT01555125|11094890|FG003|Maintenance Period|Physician Decision|0
7020494|NCT01555125|11094891|FG004|Maintenance Period|Physician Decision|0
7020495|NCT01555125|11094887|FG000|Maintenance Period|Death|0
7020496|NCT01555125|11094888|FG001|Maintenance Period|Death|0
7020497|NCT01555125|11094889|FG002|Maintenance Period|Death|0
7020498|NCT01555125|11094890|FG003|Maintenance Period|Death|1
7020499|NCT01555125|11094891|FG004|Maintenance Period|Death|0
7020500|NCT01555125|11094887|FG000|Extension|Adverse Event|1
7020501|NCT01555125|11094888|FG001|Extension|Adverse Event|2
7020502|NCT01555125|11094889|FG002|Extension|Adverse Event|1
7020503|NCT01555125|11094890|FG003|Extension|Adverse Event|1
7020504|NCT01555125|11094891|FG004|Extension|Adverse Event|0
7020505|NCT01555125|11094887|FG000|Extension|Protocol deviation|1
7020506|NCT01555125|11094888|FG001|Extension|Protocol deviation|0
7020507|NCT01555125|11094889|FG002|Extension|Protocol deviation|0
7020508|NCT01555125|11094890|FG003|Extension|Protocol deviation|0
7020509|NCT01555125|11094891|FG004|Extension|Protocol deviation|0
7020510|NCT01555125|11094887|FG000|Extension|Lack of Efficacy|7
7020511|NCT01555125|11094888|FG001|Extension|Lack of Efficacy|6
7020512|NCT01555125|11094889|FG002|Extension|Lack of Efficacy|3
7020513|NCT01555125|11094890|FG003|Extension|Lack of Efficacy|0
7020514|NCT01555125|11094891|FG004|Extension|Lack of Efficacy|0
7020515|NCT01555125|11094887|FG000|Extension|Lost to Follow-up|2
7020516|NCT01555125|11094888|FG001|Extension|Lost to Follow-up|1
7020517|NCT01555125|11094889|FG002|Extension|Lost to Follow-up|2
7020518|NCT01555125|11094890|FG003|Extension|Lost to Follow-up|0
7020519|NCT01555125|11094891|FG004|Extension|Lost to Follow-up|0
7020520|NCT01555125|11094887|FG000|Extension|Study terminated by sponsor|32
7020521|NCT01555125|11094888|FG001|Extension|Study terminated by sponsor|33
7020522|NCT01555125|11094889|FG002|Extension|Study terminated by sponsor|16
7020523|NCT01555125|11094890|FG003|Extension|Study terminated by sponsor|20
7020524|NCT01555125|11094891|FG004|Extension|Study terminated by sponsor|0
7020525|NCT01555125|11094887|FG000|Extension|Subject/guardian decision|1
7020526|NCT01555125|11094888|FG001|Extension|Subject/guardian decision|9
7020527|NCT01555125|11094889|FG002|Extension|Subject/guardian decision|1
7020528|NCT01555125|11094890|FG003|Extension|Subject/guardian decision|0
7020529|NCT01555125|11094891|FG004|Extension|Subject/guardian decision|0
7020530|NCT01555125|11094887|FG000|Extension|Technical Problems|1
7020531|NCT01555125|11094888|FG001|Extension|Technical Problems|0
7020532|NCT01555125|11094889|FG002|Extension|Technical Problems|0
7020533|NCT01555125|11094890|FG003|Extension|Technical Problems|1
7020534|NCT01555125|11094891|FG004|Extension|Technical Problems|0
7020535|NCT01555125|11094887|FG000|Follow-Up Period|Lost to Follow-up|1
7020536|NCT01555125|11094888|FG001|Follow-Up Period|Lost to Follow-up|0
7020537|NCT01555125|11094889|FG002|Follow-Up Period|Lost to Follow-up|0
7020538|NCT01555125|11094890|FG003|Follow-Up Period|Lost to Follow-up|0
7020539|NCT01555125|11094891|FG004|Follow-Up Period|Lost to Follow-up|0
7020540|NCT01555125|11094887|FG000|Follow-Up Period|Subject / guardian decision|3
7020541|NCT01555125|11094888|FG001|Follow-Up Period|Subject / guardian decision|1
7020542|NCT01555125|11094889|FG002|Follow-Up Period|Subject / guardian decision|1
7020543|NCT01555125|11094890|FG003|Follow-Up Period|Subject / guardian decision|1
7020544|NCT01555125|11094891|FG004|Follow-Up Period|Subject / guardian decision|0
7020545|NCT01555138|11094908|FG000|Overall Study|Death|0
7020546|NCT01555138|11094909|FG001|Overall Study|Death|1
7020547|NCT01555138|11094908|FG000|Overall Study|Lost to Follow-up|1
7020548|NCT01555138|11094909|FG001|Overall Study|Lost to Follow-up|0
7020549|NCT01555138|11094908|FG000|Overall Study|Abnormal Lab reults|1
7020550|NCT01555138|11094909|FG001|Overall Study|Abnormal Lab reults|3
7020551|NCT01555138|11094908|FG000|Overall Study|Lack of Efficacy|2
7020552|NCT01555138|11094909|FG001|Overall Study|Lack of Efficacy|2
7020553|NCT01555138|11094908|FG000|Overall Study|Protocol Violation|5
7020554|NCT01555138|11094909|FG001|Overall Study|Protocol Violation|3
7020555|NCT01555138|11094908|FG000|Overall Study|Administrative problems|8
7020556|NCT01555138|11094909|FG001|Overall Study|Administrative problems|0
7020557|NCT01555138|11094908|FG000|Overall Study|Withdrawal by Subject|16
7020558|NCT01555138|11094909|FG001|Overall Study|Withdrawal by Subject|15
7020559|NCT01555138|11094908|FG000|Overall Study|Adverse Event|14
7020560|NCT01555138|11094909|FG001|Overall Study|Adverse Event|14
7020561|NCT01555151|11094919|FG000|Overall Study|Withdrawal by Subject|6
7020562|NCT01555151|11094920|FG001|Overall Study|Withdrawal by Subject|2
7020563|NCT01555151|11094921|FG002|Overall Study|Withdrawal by Subject|0
7020564|NCT01555151|11094922|FG003|Overall Study|Withdrawal by Subject|2
7020565|NCT01555151|11094919|FG000|Overall Study|Administrative|3
7020566|NCT01555151|11094920|FG001|Overall Study|Administrative|1
7020567|NCT01555151|11094921|FG002|Overall Study|Administrative|2
7020568|NCT01555151|11094922|FG003|Overall Study|Administrative|0
7020569|NCT01555151|11094919|FG000|Overall Study|Protocol Violation|3
7020570|NCT01555151|11094920|FG001|Overall Study|Protocol Violation|3
7020571|NCT01555151|11094921|FG002|Overall Study|Protocol Violation|3
7020572|NCT01555151|11094922|FG003|Overall Study|Protocol Violation|5
7020573|NCT01555151|11094919|FG000|Overall Study|Adverse Event|1
7020574|NCT01555151|11094920|FG001|Overall Study|Adverse Event|2
7020575|NCT01555151|11094921|FG002|Overall Study|Adverse Event|1
7020576|NCT01555151|11094922|FG003|Overall Study|Adverse Event|2
7020577|NCT01555151|11094919|FG000|Overall Study|Lost to Follow-up|0
7020578|NCT01555151|11094920|FG001|Overall Study|Lost to Follow-up|0
7020579|NCT01555151|11094921|FG002|Overall Study|Lost to Follow-up|0
7020580|NCT01555151|11094922|FG003|Overall Study|Lost to Follow-up|1
7020581|NCT01555164|11094935|FG000|Overall Study|Adverse Event|5
7020582|NCT01555164|11094936|FG001|Overall Study|Adverse Event|7
7020583|NCT01555164|11094935|FG000|Overall Study|Hyperglycemia|0
7020584|NCT01555164|11094936|FG001|Overall Study|Hyperglycemia|1
7020585|NCT01555164|11094935|FG000|Overall Study|Investigator's Discretion|2
7020586|NCT01555164|11094936|FG001|Overall Study|Investigator's Discretion|2
7020587|NCT01555164|11094935|FG000|Overall Study|Lost to Follow-up|4
7020588|NCT01555164|11094936|FG001|Overall Study|Lost to Follow-up|3
7020589|NCT01555164|11094935|FG000|Overall Study|Protocol Violation|9
7020590|NCT01555164|11094936|FG001|Overall Study|Protocol Violation|5
7020591|NCT01555164|11094935|FG000|Overall Study|Subject Non-compliance|14
7020592|NCT01555164|11094936|FG001|Overall Study|Subject Non-compliance|6
7020593|NCT01555164|11094935|FG000|Overall Study|Subject Withdrew Consent|6
7020594|NCT01555164|11094936|FG001|Overall Study|Subject Withdrew Consent|11
7020595|NCT01555463|11094944|FG000|Treatment|Adverse Event|6
7020596|NCT01555463|11094945|FG001|Treatment|Adverse Event|12
7020597|NCT01555463|11094944|FG000|Treatment|Withdrawal by Subject|24
7020598|NCT01555463|11094945|FG001|Treatment|Withdrawal by Subject|36
7020599|NCT01555463|11094944|FG000|Treatment|Lost to Follow-up|28
7020600|NCT01555463|11094945|FG001|Treatment|Lost to Follow-up|23
7020601|NCT01555463|11094944|FG000|Treatment|Protocol Violation|4
7020602|NCT01555463|11094945|FG001|Treatment|Protocol Violation|5
7020603|NCT01555463|11094944|FG000|Treatment|Other reason|2
7020604|NCT01555463|11094945|FG001|Treatment|Other reason|3
7020605|NCT01555463|11094944|FG000|Follow up|Adverse Event|2
7020606|NCT01555463|11094945|FG001|Follow up|Adverse Event|5
7020607|NCT01555463|11094944|FG000|Follow up|Death|0
7020608|NCT01555463|11094945|FG001|Follow up|Death|1
7020609|NCT01555463|11094944|FG000|Follow up|Withdrawal by Subject|22
7020610|NCT01555463|11094945|FG001|Follow up|Withdrawal by Subject|22
7020611|NCT01555463|11094944|FG000|Follow up|Lost to Follow-up|9
7020612|NCT01555463|11094945|FG001|Follow up|Lost to Follow-up|10
7020613|NCT01555463|11094944|FG000|Follow up|Protocol Violation|2
7020614|NCT01555463|11094945|FG001|Follow up|Protocol Violation|4
7020615|NCT01555463|11094944|FG000|Follow up|Other reason|3
7020616|NCT01555463|11094945|FG001|Follow up|Other reason|3
7020617|NCT01555671|11094975|FG000|Overall Study|Physician Decision|20
7020618|NCT01555671|11094976|FG001|Overall Study|Physician Decision|25
7020619|NCT01555762|11095011|FG000|Overall Study|No information on Bevacizumab intake|11
7020620|NCT01555762|11095011|FG000|Overall Study|Missing start date of infusion|8
7020621|NCT01555762|11095011|FG000|Overall Study|75 years old or more ticked No|1
7020622|NCT01555762|11095011|FG000|Overall Study|Treatment with Bevacizumab ticked No|24
7020623|NCT01555762|11095011|FG000|Overall Study|Death linked to progression of disease|165
7020624|NCT01555762|11095011|FG000|Overall Study|Lost follow-up/moved house/changed team|35
7020625|NCT01555762|11095011|FG000|Overall Study|Investigator's decision|10
7020626|NCT01555762|11095011|FG000|Overall Study|Participant not wishing to continue|5
7020627|NCT01555762|11095011|FG000|Overall Study|Missing data|1
7020628|NCT01555762|11095011|FG000|Overall Study|Death linked to an adverse event|14
7020629|NCT01555931|11095017|FG000|Overall Study|Lost to Follow-up|2
7020630|NCT01555931|11095018|FG001|Overall Study|Lost to Follow-up|5
7020631|NCT01555983|11095033|FG000|Overall Study|Withdrawal by Subject|1
7020632|NCT01555983|11095034|FG001|Overall Study|Withdrawal by Subject|0
7020633|NCT01555983|11095035|FG002|Overall Study|Withdrawal by Subject|0
7020634|NCT01555983|11095036|FG003|Overall Study|Withdrawal by Subject|0
7020635|NCT01555983|11095037|FG004|Overall Study|Withdrawal by Subject|1
7020636|NCT01555983|11095038|FG005|Overall Study|Withdrawal by Subject|1
7020637|NCT01556165|11095063|FG000|Overall Study|Adverse Event|5
7020638|NCT01556165|11095064|FG001|Overall Study|Adverse Event|3
7020639|NCT01556165|11095063|FG000|Overall Study|Protocol Violation|0
7020640|NCT01556165|11095064|FG001|Overall Study|Protocol Violation|3
7020641|NCT01556165|11095063|FG000|Overall Study|Withdrawal of Consent|7
7020642|NCT01556165|11095064|FG001|Overall Study|Withdrawal of Consent|1
7020643|NCT01556438|11095126|FG000|Overall Study|Adverse Event|4
7020644|NCT01556438|11095127|FG001|Overall Study|Adverse Event|2
7020645|NCT01556438|11095126|FG000|Overall Study|Sponsor Decision|0
7020646|NCT01556438|11095127|FG001|Overall Study|Sponsor Decision|2
7020647|NCT01556438|11095126|FG000|Overall Study|Progressive Disease|0
7020648|NCT01556438|11095127|FG001|Overall Study|Progressive Disease|6
7020649|NCT01556438|11095126|FG000|Overall Study|Death|0
7020650|NCT01556438|11095127|FG001|Overall Study|Death|1
7020651|NCT01556763|11095196|FG000|Overall Study|Withdrawal by Subject|0
7020652|NCT01556763|11095197|FG001|Overall Study|Withdrawal by Subject|1
7020653|NCT01556763|11095198|FG002|Overall Study|Withdrawal by Subject|0
7020654|NCT01556932|11095212|FG000|Time Point 60 Minutes|Withdrawal by Subject|1
7020655|NCT01556932|11095213|FG001|Time Point 60 Minutes|Withdrawal by Subject|1
7020656|NCT01556997|11095221|FG000|Overall Study|Adverse Event|10
7020657|NCT01556997|11095222|FG001|Overall Study|Adverse Event|12
7020658|NCT01556997|11095223|FG002|Overall Study|Adverse Event|12
7020659|NCT01556997|11095221|FG000|Overall Study|Lost to Follow-up|6
7020660|NCT01556997|11095222|FG001|Overall Study|Lost to Follow-up|6
7020661|NCT01556997|11095223|FG002|Overall Study|Lost to Follow-up|4
7020662|NCT01556997|11095221|FG000|Overall Study|Physician Decision|1
7020663|NCT01556997|11095222|FG001|Overall Study|Physician Decision|1
7020664|NCT01556997|11095223|FG002|Overall Study|Physician Decision|1
7020665|NCT01556997|11095221|FG000|Overall Study|Withdrawal by Subject|7
7020666|NCT01556997|11095222|FG001|Overall Study|Withdrawal by Subject|6
7020667|NCT01556997|11095223|FG002|Overall Study|Withdrawal by Subject|8
7020668|NCT01556997|11095221|FG000|Overall Study|Other|2
7020669|NCT01556997|11095222|FG001|Overall Study|Other|3
7020670|NCT01556997|11095223|FG002|Overall Study|Other|7
7043950|NCT01748825|11129294|FG005|Dose Escalation|Switched to alternative treatment|0
7060540|NCT01920061|11156840|FG003|Overall Study|Lost to Follow-up|0
7020671|NCT01557166|11095233|FG000|Overall Study|Adverse Event|20
7020672|NCT01557166|11095234|FG001|Overall Study|Adverse Event|6
7020673|NCT01557166|11095233|FG000|Overall Study|Lack of Efficacy|2
7020674|NCT01557166|11095234|FG001|Overall Study|Lack of Efficacy|1
7020675|NCT01557166|11095233|FG000|Overall Study|Protocol Violation|8
7020676|NCT01557166|11095234|FG001|Overall Study|Protocol Violation|5
7020677|NCT01557166|11095233|FG000|Overall Study|Withdrawn consent|12
7020678|NCT01557166|11095234|FG001|Overall Study|Withdrawn consent|20
7020679|NCT01557166|11095233|FG000|Overall Study|Target dose not tolerated|1
7020680|NCT01557166|11095234|FG001|Overall Study|Target dose not tolerated|0
7020681|NCT01557166|11095233|FG000|Overall Study|Psychiatric disorder|1
7020682|NCT01557166|11095234|FG001|Overall Study|Psychiatric disorder|0
7020683|NCT01557166|11095233|FG000|Overall Study|Unclassified|2
7020684|NCT01557166|11095234|FG001|Overall Study|Unclassified|5
7020685|NCT01557244|11095245|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2
7020686|NCT01557244|11095246|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
7020687|NCT01557244|11095247|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
7020688|NCT01557244|11095248|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
7020689|NCT01557244|11095249|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
7020690|NCT01557244|11095250|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2
7020691|NCT01557244|11095251|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
7020692|NCT01557244|11095245|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2
7020693|NCT01557244|11095246|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
7020694|NCT01557244|11095247|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1
7020695|NCT01557244|11095248|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
7020696|NCT01557244|11095249|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
7020697|NCT01557244|11095250|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
7020698|NCT01557244|11095251|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
7020699|NCT01557244|11095245|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1
7020700|NCT01557244|11095246|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
7020701|NCT01557244|11095247|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
7020702|NCT01557244|11095248|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
7020703|NCT01557244|11095249|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
7020704|NCT01557244|11095250|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
7020705|NCT01557244|11095251|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
7020706|NCT01557244|11095245|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2
7020707|NCT01557244|11095246|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
7020708|NCT01557244|11095247|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
7020709|NCT01557244|11095248|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
7020710|NCT01557244|11095249|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
7020711|NCT01557244|11095250|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3
7020712|NCT01557244|11095251|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
7020713|NCT01557244|11095245|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
7020714|NCT01557244|11095246|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1
7020715|NCT01557244|11095247|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
7020716|NCT01557244|11095248|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
7020717|NCT01557244|11095249|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
7020718|NCT01557244|11095250|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
7020719|NCT01557244|11095251|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
7020720|NCT01557244|11095245|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
7020721|NCT01557244|11095246|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
7020722|NCT01557244|11095247|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
7020723|NCT01557244|11095248|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
7020724|NCT01557244|11095249|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
7020725|NCT01557244|11095250|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1
7020726|NCT01557244|11095251|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1
7020727|NCT01557244|11095245|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0
7020728|NCT01557244|11095246|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1
7020729|NCT01557244|11095247|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1
7020730|NCT01557244|11095248|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0
7020731|NCT01557244|11095249|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0
7020732|NCT01557244|11095250|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1
7020733|NCT01557244|11095251|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0
7020734|NCT01557244|11095245|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2
7020735|NCT01557244|11095246|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0
7020736|NCT01557244|11095247|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2
7020737|NCT01557244|11095248|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0
7020738|NCT01557244|11095249|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0
7020739|NCT01557244|11095250|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0
7020740|NCT01557244|11095251|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0
7020741|NCT01557244|11095245|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1
7020742|NCT01557244|11095246|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1
7020743|NCT01557244|11095247|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0
7020744|NCT01557244|11095248|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0
7020745|NCT01557244|11095249|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0
7020746|NCT01557244|11095250|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1
7020747|NCT01557244|11095251|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0
7020748|NCT01557244|11095245|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1
7020749|NCT01557244|11095246|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1
7020750|NCT01557244|11095247|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
7020751|NCT01557244|11095248|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
7020752|NCT01557244|11095249|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
7020753|NCT01557244|11095250|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
7020754|NCT01557244|11095251|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
7020755|NCT01557244|11095245|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
7020756|NCT01557244|11095246|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
7020757|NCT01557244|11095247|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
7020758|NCT01557244|11095248|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1
7020759|NCT01557244|11095249|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
7020760|NCT01557244|11095250|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
7020761|NCT01557244|11095251|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
7020762|NCT01557244|11095245|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1
7020763|NCT01557244|11095246|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2
7020764|NCT01557244|11095247|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
7020765|NCT01557244|11095248|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
7020766|NCT01557244|11095249|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
7020767|NCT01557244|11095250|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
7020768|NCT01557244|11095251|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
7020769|NCT01557283|11095279|FG000|Overall Study|Lost to Follow-up|7
7020770|NCT01557283|11095279|FG000|Overall Study|Non-responder|19
7020771|NCT01557283|11095279|FG000|Overall Study|Adverse Event|7
7020772|NCT01557283|11095279|FG000|Overall Study|Lack of Efficacy|1
7020773|NCT01557283|11095279|FG000|Overall Study|Non-compliance|1
7020774|NCT01557283|11095279|FG000|Overall Study|Withdrawal by Subject|1
7020775|NCT01557283|11095279|FG000|Overall Study|Participant's weight too high for dose|1
7020776|NCT01557283|11095279|FG000|Overall Study|Worsening of psoriasis|1
7020777|NCT01557283|11095279|FG000|Overall Study|Other|6
7020778|NCT01557348|11095294|FG000|Overall Study|Adverse Event|6
7020779|NCT01557348|11095295|FG001|Overall Study|Adverse Event|16
7020780|NCT01557348|11095294|FG000|Overall Study|Infusion reaction event|5
7020781|NCT01557348|11095295|FG001|Overall Study|Infusion reaction event|5
7020782|NCT01557348|11095294|FG000|Overall Study|Death|7
7020783|NCT01557348|11095295|FG001|Overall Study|Death|4
7020784|NCT01557348|11095294|FG000|Overall Study|Insufficient Therapeutic Response|13
7020785|NCT01557348|11095295|FG001|Overall Study|Insufficient Therapeutic Response|28
7020786|NCT01557348|11095294|FG000|Overall Study|Withdrawal by Subject|5
7020787|NCT01557348|11095295|FG001|Overall Study|Withdrawal by Subject|4
7020788|NCT01557348|11095294|FG000|Overall Study|Lost to Follow-up|26
7020789|NCT01557348|11095295|FG001|Overall Study|Lost to Follow-up|22
7020790|NCT01557348|11095294|FG000|Overall Study|Administrative|18
7020791|NCT01557348|11095295|FG001|Overall Study|Administrative|11
7020792|NCT01557400|11095302|FG000|Overall Study|Transitioned to Commercial Drug Product|40
7020793|NCT01557400|11095302|FG000|Overall Study|Adverse Event|3
7020794|NCT01557400|11095302|FG000|Overall Study|Lost to Follow-up|5
7020795|NCT01557400|11095302|FG000|Overall Study|Withdrawal by Subject|9
7020796|NCT01557504|11095313|FG000|Overall Study|Physician Decision|1
7020797|NCT01557504|11095314|FG001|Overall Study|Physician Decision|0
7020798|NCT01557517|11095328|FG000|Overall Study|Death|1
7020799|NCT01557517|11095329|FG001|Overall Study|Death|0
7020800|NCT01557517|11095328|FG000|Overall Study|Refused further treatment|0
7020801|NCT01557517|11095329|FG001|Overall Study|Refused further treatment|2
7020802|NCT01557517|11095328|FG000|Overall Study|Adverse Event|0
7020803|NCT01557517|11095329|FG001|Overall Study|Adverse Event|2
7020804|NCT01557517|11095328|FG000|Overall Study|Pt declined before treatment started|1
7020805|NCT01557517|11095329|FG001|Overall Study|Pt declined before treatment started|0
7020806|NCT01557569|11095344|FG000|Overall Study|Adverse Event|2
7020807|NCT01557569|11095345|FG001|Overall Study|Adverse Event|0
7020808|NCT01557569|11095344|FG000|Overall Study|high blood pressure|0
7020809|NCT01557569|11095345|FG001|Overall Study|high blood pressure|1
7020810|NCT01557569|11095344|FG000|Overall Study|Withdrawal by Subject|3
7020811|NCT01557569|11095345|FG001|Overall Study|Withdrawal by Subject|5
7020812|NCT01557569|11095344|FG000|Overall Study|noncompliance with rules of residential|0
7020813|NCT01557569|11095345|FG001|Overall Study|noncompliance with rules of residential|1
7020814|NCT01557582|11095351|FG000|Overall Study|Protocol Violation|4
7020815|NCT01557582|11095351|FG000|Overall Study|Operator error|2
7020816|NCT01557842|11095381|FG000|Overall Study|Lost to Follow-up|0
7020817|NCT01557842|11095382|FG001|Overall Study|Lost to Follow-up|1
7020818|NCT01557842|11095381|FG000|Overall Study|Death|1
7020819|NCT01557842|11095382|FG001|Overall Study|Death|0
7020820|NCT01557842|11095381|FG000|Overall Study|Lack of Efficacy|0
7020821|NCT01557842|11095382|FG001|Overall Study|Lack of Efficacy|1
7020822|NCT01557842|11095381|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3
7020823|NCT01557842|11095382|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0
7020824|NCT01557842|11095381|FG000|Overall Study|Study Terminated by Sponsor|3
7020825|NCT01557842|11095382|FG001|Overall Study|Study Terminated by Sponsor|4
7020826|NCT01557842|11095381|FG000|Overall Study|Not Ablated|2
7020827|NCT01557842|11095382|FG001|Overall Study|Not Ablated|0
7020828|NCT01557920|11095407|FG000|Overall Study|Withdrawal by Subject|2
7020829|NCT01557920|11095408|FG001|Overall Study|Withdrawal by Subject|3
7020830|NCT01557920|11095407|FG000|Overall Study|Lack of Efficacy|1
7020831|NCT01557920|11095408|FG001|Overall Study|Lack of Efficacy|0
7020832|NCT01557946|11095443|FG000|Overall Study|Adverse Event|3
7020833|NCT01557946|11095444|FG001|Overall Study|Adverse Event|0
7020834|NCT01558089|11095475|FG000|Overall Study|Adverse Event|1
7020835|NCT01558089|11095475|FG000|Overall Study|Lack of Efficacy|1
7020836|NCT01558089|11095475|FG000|Overall Study|Lost to Follow-up|5
7020837|NCT01558089|11095475|FG000|Overall Study|Withdrawal by Subject|6
7020838|NCT01558271|11095486|FG000|Overall Study|Adverse Event|6
7020839|NCT01558271|11095487|FG001|Overall Study|Adverse Event|3
7020840|NCT01558271|11095488|FG002|Overall Study|Adverse Event|4
7020841|NCT01558271|11095486|FG000|Overall Study|Lost to Follow-up|1
7020842|NCT01558271|11095487|FG001|Overall Study|Lost to Follow-up|0
7020843|NCT01558271|11095488|FG002|Overall Study|Lost to Follow-up|0
7020844|NCT01558271|11095486|FG000|Overall Study|Protocol Violation|1
7020845|NCT01558271|11095487|FG001|Overall Study|Protocol Violation|0
7020846|NCT01558271|11095488|FG002|Overall Study|Protocol Violation|0
7020847|NCT01558271|11095486|FG000|Overall Study|Withdrawal by Subject|10
7020848|NCT01558271|11095487|FG001|Overall Study|Withdrawal by Subject|6
7020849|NCT01558271|11095488|FG002|Overall Study|Withdrawal by Subject|12
7020850|NCT01558271|11095486|FG000|Overall Study|Physician Decision|0
7020851|NCT01558271|11095487|FG001|Overall Study|Physician Decision|2
7020852|NCT01558271|11095488|FG002|Overall Study|Physician Decision|1
7020853|NCT01558297|11095503|FG000|Overall Study|Withdrawal by Subject|2
7020854|NCT01558297|11095504|FG001|Overall Study|Withdrawal by Subject|2
7020855|NCT01558297|11095505|FG002|Overall Study|Withdrawal by Subject|1
7020856|NCT01558596|11095515|FG000|Overall Study|Withdrawal by Subject|1
7020857|NCT01558596|11095516|FG001|Overall Study|Withdrawal by Subject|0
7020858|NCT01558596|11095515|FG000|Overall Study|surgery elsewhere or cancelled|1
7020859|NCT01558596|11095516|FG001|Overall Study|surgery elsewhere or cancelled|1
7020860|NCT01558596|11095515|FG000|Overall Study|Protocol Violation|1
7020861|NCT01558596|11095516|FG001|Overall Study|Protocol Violation|0
7020862|NCT01558635|11095522|FG000|Overall Study|Death|1
7020863|NCT01558635|11095522|FG000|Overall Study|Withdrawal by Subject|2
7020864|NCT01558635|11095522|FG000|Overall Study|Physician Decision|1
7020865|NCT01558635|11095522|FG000|Overall Study|Subject received other treatment|1
7020866|NCT01558635|11095522|FG000|Overall Study|Reveal XT was explanted|1
7020867|NCT01558674|11095539|FG000|Part 1|Study Terminated by Sponsor|10
7020868|NCT01558674|11095540|FG001|Part 1|Study Terminated by Sponsor|0
7020869|NCT01558674|11095539|FG000|Part 1|Withdrawal by Subject|1
7020870|NCT01558674|11095540|FG001|Part 1|Withdrawal by Subject|0
7020871|NCT01558739|11095568|FG000|Overall Study|Adverse Event|7
7020872|NCT01558739|11095568|FG000|Overall Study|Withdrawal by Subject|2
7020873|NCT01558739|11095568|FG000|Overall Study|Death|3
7020874|NCT01558739|11095568|FG000|Overall Study|Disease Progression|4
7020875|NCT01558739|11095568|FG000|Overall Study|Protocol Violation|1
7020876|NCT01558752|11095574|FG000|Overall Study|Physician Decision|2
7020877|NCT01558752|11095575|FG001|Overall Study|Physician Decision|0
7020878|NCT01559012|11095594|FG000|Overall Study|Withdrawal by Subject|0
7020879|NCT01559012|11095595|FG001|Overall Study|Withdrawal by Subject|1
7020880|NCT01559090|11095632|FG000|Stage I|Withdrawal by Subject|2
7020881|NCT01559090|11095633|FG001|Stage I|Withdrawal by Subject|2
7020882|NCT01559090|11095634|FG002|Stage I|Withdrawal by Subject|3
7020883|NCT01559090|11095632|FG000|Stage II|Withdrawal by Subject|1
7020884|NCT01559090|11095633|FG001|Stage II|Withdrawal by Subject|0
7020885|NCT01559090|11095634|FG002|Stage II|Withdrawal by Subject|0
7020886|NCT01559116|11095642|FG000|Overall Study|Adverse Event|10
7020887|NCT01559116|11095642|FG000|Overall Study|Lack of Efficacy|1
7020888|NCT01559116|11095642|FG000|Overall Study|Lost to Follow-up|1
7020889|NCT01559116|11095642|FG000|Overall Study|Protocol Violation|1
7020890|NCT01559116|11095642|FG000|Overall Study|Withdrawal by Subject|4
7020891|NCT01559116|11095642|FG000|Overall Study|other than stated above|9
7020892|NCT01559129|11095661|FG000|Treatment Phase|Adverse Event|0
7020893|NCT01559129|11095662|FG001|Treatment Phase|Adverse Event|2
7020894|NCT01559129|11095661|FG000|Treatment Phase|Progressive Disease|1
7020895|NCT01559129|11095662|FG001|Treatment Phase|Progressive Disease|1
7020896|NCT01559129|11095661|FG000|Treatment Phase|Lack of Efficacy|0
7020897|NCT01559129|11095662|FG001|Treatment Phase|Lack of Efficacy|1
7020898|NCT01559129|11095661|FG000|Treatment Phase|Study Terminated by Sponsor|3
7020899|NCT01559129|11095662|FG001|Treatment Phase|Study Terminated by Sponsor|2
7020900|NCT01559129|11095661|FG000|Treatment Phase|Protocol Exclusion Criteria|1
7020901|NCT01559129|11095662|FG001|Treatment Phase|Protocol Exclusion Criteria|0
7020902|NCT01559129|11095661|FG000|Treatment Phase|Did Not Receive Study Drug|0
7020903|NCT01559129|11095662|FG001|Treatment Phase|Did Not Receive Study Drug|1
7020904|NCT01559129|11095661|FG000|Open-label Extension Period|Adverse Event|1
7020905|NCT01559129|11095662|FG001|Open-label Extension Period|Adverse Event|0
7020906|NCT01559129|11095661|FG000|Open-label Extension Period|Study Terminated by Sponsor|5
7020907|NCT01559129|11095662|FG001|Open-label Extension Period|Study Terminated by Sponsor|2
7020908|NCT01559259|11095679|FG000|Overall Study|Withdrawal by Subject|0
7020909|NCT01559259|11095680|FG001|Overall Study|Withdrawal by Subject|0
7020910|NCT01559259|11095681|FG002|Overall Study|Withdrawal by Subject|0
7020911|NCT01559259|11095682|FG003|Overall Study|Withdrawal by Subject|1
7020912|NCT01559259|11095683|FG004|Overall Study|Withdrawal by Subject|0
7020913|NCT01559259|11095679|FG000|Overall Study|Adverse Event|0
7020914|NCT01559259|11095680|FG001|Overall Study|Adverse Event|1
7020915|NCT01559259|11095681|FG002|Overall Study|Adverse Event|1
7020916|NCT01559259|11095682|FG003|Overall Study|Adverse Event|0
7020917|NCT01559259|11095683|FG004|Overall Study|Adverse Event|0
7020918|NCT01559311|11095698|FG000|Overall Study|Protocol Violation|0
7020919|NCT01559311|11095699|FG001|Overall Study|Protocol Violation|0
7020920|NCT01559311|11095700|FG002|Overall Study|Protocol Violation|2
7020921|NCT01559311|11095698|FG000|Overall Study|Difficulty in cannulating the lateral ve|1
7020922|NCT01559311|11095699|FG001|Overall Study|Difficulty in cannulating the lateral ve|0
7020923|NCT01559311|11095700|FG002|Overall Study|Difficulty in cannulating the lateral ve|0
7020924|NCT01559311|11095698|FG000|Overall Study|Withdrawal by Subject|2
7020925|NCT01559311|11095699|FG001|Overall Study|Withdrawal by Subject|1
7020926|NCT01559311|11095700|FG002|Overall Study|Withdrawal by Subject|0
7020927|NCT01559311|11095698|FG000|Overall Study|Death|0
7020928|NCT01559311|11095699|FG001|Overall Study|Death|2
7020929|NCT01559311|11095700|FG002|Overall Study|Death|3
7020930|NCT01559311|11095698|FG000|Overall Study|Lost to Follow-up|0
7020931|NCT01559311|11095699|FG001|Overall Study|Lost to Follow-up|3
7020932|NCT01559311|11095700|FG002|Overall Study|Lost to Follow-up|2
7020933|NCT01559311|11095698|FG000|Overall Study|Adverse Event|0
7020934|NCT01559311|11095699|FG001|Overall Study|Adverse Event|0
7020935|NCT01559311|11095700|FG002|Overall Study|Adverse Event|1
7020936|NCT01559389|11095710|FG000|Overall Study|Withdrawal by Subject|20
7020937|NCT01559389|11095711|FG001|Overall Study|Withdrawal by Subject|20
7020938|NCT01559454|11095723|FG000|Overall Study|Lost to Follow-up|3
7020939|NCT01559454|11095724|FG001|Overall Study|Lost to Follow-up|2
7020940|NCT01559454|11095723|FG000|Overall Study|Withdrawal by Subject|0
7020941|NCT01559454|11095724|FG001|Overall Study|Withdrawal by Subject|1
7020942|NCT01559454|11095723|FG000|Overall Study|Physician Decision|0
7020943|NCT01559454|11095724|FG001|Overall Study|Physician Decision|1
7020944|NCT01559454|11095723|FG000|Overall Study|Protocol Violation|0
7020945|NCT01559454|11095724|FG001|Overall Study|Protocol Violation|1
7020946|NCT01559454|11095723|FG000|Overall Study|Lack of Efficacy|0
7020947|NCT01559454|11095724|FG001|Overall Study|Lack of Efficacy|1
7020948|NCT01559675|11095751|FG000|Overall Study|Protocol Violation|1
7020949|NCT01559675|11095752|FG001|Overall Study|Protocol Violation|2
7020950|NCT01559675|11095751|FG000|Overall Study|2nd operation on same patient excluded|14
7020951|NCT01559675|11095752|FG001|Overall Study|2nd operation on same patient excluded|12
7020952|NCT01559844|11095758|FG000|Overall Study|Consent Withdrawn|7
7020953|NCT01559844|11095758|FG000|Overall Study|Death|5
7020954|NCT01559844|11095758|FG000|Overall Study|Efficacy Failure|10
7020955|NCT01559844|11095758|FG000|Overall Study|No Longer A Transplant Candidate|3
7020956|NCT01560234|11095807|FG000|Overall Study|Lost to Follow-up|3
7020957|NCT01560234|11095808|FG001|Overall Study|Lost to Follow-up|0
7020958|NCT01560234|11095809|FG002|Overall Study|Lost to Follow-up|1
7020959|NCT01560234|11095810|FG003|Overall Study|Lost to Follow-up|0
7020960|NCT01560234|11095811|FG004|Overall Study|Lost to Follow-up|0
7020961|NCT01560234|11095812|FG005|Overall Study|Lost to Follow-up|2
7020962|NCT01560234|11095813|FG006|Overall Study|Lost to Follow-up|0
7020963|NCT01560234|11095814|FG007|Overall Study|Lost to Follow-up|2
7020964|NCT01560403|11095848|FG000|Overall Study|Lost to Follow-up|0
7020965|NCT01560403|11095849|FG001|Overall Study|Lost to Follow-up|1
7020966|NCT01560416|11095857|FG000|Randomized Phase|Crossover Participants|7
7020967|NCT01560416|11095858|FG001|Randomized Phase|Crossover Participants|0
7020968|NCT01560429|11095868|FG000|Overall Study|Protocol Violation|3
7020969|NCT01560429|11095869|FG001|Overall Study|Protocol Violation|6
7020970|NCT01560780|11095888|FG000|Overall Study|Death|2
7020971|NCT01560780|11095889|FG001|Overall Study|Death|1
7020972|NCT01560780|11095888|FG000|Overall Study|Patient Preference|11
7020973|NCT01560780|11095889|FG001|Overall Study|Patient Preference|11
7020974|NCT01560819|11095897|FG000|Overall Study|Physician Decision|1
7020975|NCT01560819|11095898|FG001|Overall Study|Physician Decision|0
7020976|NCT01560871|11095904|FG000|Overall Study|transportation issues|2
7020977|NCT01560871|11095905|FG001|Overall Study|transportation issues|1
7020978|NCT01560871|11095904|FG000|Overall Study|relocation|1
7020979|NCT01560871|11095905|FG001|Overall Study|relocation|0
7020980|NCT01560871|11095904|FG000|Overall Study|readmission to a hospital|2
7020981|NCT01560871|11095905|FG001|Overall Study|readmission to a hospital|1
7020982|NCT01560871|11095904|FG000|Overall Study|Lost to Follow-up|1
7020983|NCT01560871|11095905|FG001|Overall Study|Lost to Follow-up|0
7020984|NCT01560949|11095921|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6
7020985|NCT01560949|11095921|FG000|Surgery Phase|Physician Decision|3
7020986|NCT01560988|11095937|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7
7020987|NCT01560988|11095938|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4
7020988|NCT01560988|11095937|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3
7020989|NCT01560988|11095938|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0
7020990|NCT01560988|11095937|FG000|Washout (Six Weeks)|Lost to Follow-up|2
7020991|NCT01560988|11095938|FG001|Washout (Six Weeks)|Lost to Follow-up|2
7020992|NCT01561079|11095967|FG000|Overall Study|Physician Decision|17
7020993|NCT01561079|11095967|FG000|Overall Study|Withdrawal by Subject|59
7020994|NCT01561079|11095967|FG000|Overall Study|Protocol Violation|2
7020995|NCT01561300|11096010|FG000|Run in on Placebo|Adverse Event|1
7020996|NCT01561300|11096011|FG001|Run in on Placebo|Adverse Event|0
7020997|NCT01561313|11096020|FG000|Overall Study|Withdrawal by Subject|1
7020998|NCT01561313|11096021|FG001|Overall Study|Withdrawal by Subject|0
7020999|NCT01561313|11096020|FG000|Overall Study|Adverse event and withdrawal by subject|1
7021000|NCT01561313|11096021|FG001|Overall Study|Adverse event and withdrawal by subject|0
7021001|NCT01561560|11096036|FG000|First Two Weeks of Wear|Time/job conflict|0
7021002|NCT01561560|11096037|FG001|First Two Weeks of Wear|Time/job conflict|1
7021003|NCT01561560|11096036|FG000|First Two Weeks of Wear|Adverse Event|0
7021004|NCT01561560|11096037|FG001|First Two Weeks of Wear|Adverse Event|1
7021005|NCT01561560|11096036|FG000|Second Two Weeks of Wear|Adverse Event|0
7021006|NCT01561560|11096037|FG001|Second Two Weeks of Wear|Adverse Event|1
7021007|NCT01561755|11096079|FG000|Overall Study|Lost to Follow-up|0
7021008|NCT01561755|11096080|FG001|Overall Study|Lost to Follow-up|1
7021009|NCT01561898|11096094|FG000|Overall Study|Withdrawal by Subject|0
7021010|NCT01561898|11096095|FG001|Overall Study|Withdrawal by Subject|8
7021011|NCT01561898|11096096|FG002|Overall Study|Withdrawal by Subject|12
7021012|NCT01561898|11096097|FG003|Overall Study|Withdrawal by Subject|5
7021013|NCT01561898|11096094|FG000|Overall Study|Lack of Efficacy|0
7021014|NCT01561898|11096095|FG001|Overall Study|Lack of Efficacy|8
7021015|NCT01561898|11096096|FG002|Overall Study|Lack of Efficacy|10
7021016|NCT01561898|11096097|FG003|Overall Study|Lack of Efficacy|5
7021017|NCT01561898|11096094|FG000|Overall Study|Worsening of complications|0
7021018|NCT01561898|11096095|FG001|Overall Study|Worsening of complications|1
7021019|NCT01561898|11096096|FG002|Overall Study|Worsening of complications|0
7021020|NCT01561898|11096097|FG003|Overall Study|Worsening of complications|0
7021021|NCT01561898|11096094|FG000|Overall Study|Lost to Follow-up|0
7021022|NCT01561898|11096095|FG001|Overall Study|Lost to Follow-up|0
7021023|NCT01561898|11096096|FG002|Overall Study|Lost to Follow-up|1
7021024|NCT01561898|11096097|FG003|Overall Study|Lost to Follow-up|0
7021025|NCT01561898|11096094|FG000|Overall Study|Adverse Event|1
7021026|NCT01561898|11096095|FG001|Overall Study|Adverse Event|19
7021027|NCT01561898|11096096|FG002|Overall Study|Adverse Event|14
7021028|NCT01561898|11096097|FG003|Overall Study|Adverse Event|9
7021029|NCT01561898|11096094|FG000|Overall Study|Physician Decision|1
7021030|NCT01561898|11096095|FG001|Overall Study|Physician Decision|5
7021031|NCT01561898|11096096|FG002|Overall Study|Physician Decision|7
7021032|NCT01561898|11096097|FG003|Overall Study|Physician Decision|1
7021033|NCT01561963|11096105|FG000|Overall Study|Adverse Event|1
7021034|NCT01561976|11096120|FG000|Period 1|Adverse Event|0
7021035|NCT01561976|11096121|FG001|Period 1|Adverse Event|0
7021036|NCT01561976|11096122|FG002|Period 1|Adverse Event|1
7021037|NCT01561976|11096123|FG003|Period 1|Adverse Event|0
7021038|NCT01561976|11096124|FG004|Period 1|Adverse Event|0
7021039|NCT01561976|11096125|FG005|Period 1|Adverse Event|0
7021040|NCT01561976|11096120|FG000|Washout Period 1 (7 Days)|Adverse Event|0
7021041|NCT01561976|11096121|FG001|Washout Period 1 (7 Days)|Adverse Event|0
7021042|NCT01561976|11096122|FG002|Washout Period 1 (7 Days)|Adverse Event|0
7021043|NCT01561976|11096123|FG003|Washout Period 1 (7 Days)|Adverse Event|1
7021044|NCT01561976|11096124|FG004|Washout Period 1 (7 Days)|Adverse Event|0
7021045|NCT01561976|11096125|FG005|Washout Period 1 (7 Days)|Adverse Event|0
7021046|NCT01561976|11096120|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7021047|NCT01561976|11096121|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7021048|NCT01561976|11096122|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7021049|NCT01561976|11096123|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7021050|NCT01561976|11096124|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7021051|NCT01561976|11096125|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1
7021052|NCT01561976|11096120|FG000|Washout Period 2 (7 Days)|Non-compliance|1
7021053|NCT01561976|11096121|FG001|Washout Period 2 (7 Days)|Non-compliance|0
7021054|NCT01561976|11096122|FG002|Washout Period 2 (7 Days)|Non-compliance|1
7021055|NCT01561976|11096123|FG003|Washout Period 2 (7 Days)|Non-compliance|0
7021056|NCT01561976|11096124|FG004|Washout Period 2 (7 Days)|Non-compliance|0
7021057|NCT01561976|11096125|FG005|Washout Period 2 (7 Days)|Non-compliance|0
7021058|NCT01562028|11096135|FG000|Overall Study|Withdrawal by Subject|1
7021059|NCT01562028|11096136|FG001|Overall Study|Withdrawal by Subject|1
7021060|NCT01562028|11096135|FG000|Overall Study|Lost to Follow-up|2
7021061|NCT01562028|11096136|FG001|Overall Study|Lost to Follow-up|1
7021062|NCT01562275|11096168|FG000|Stage 1|Adverse Event|0
7021063|NCT01562275|11096169|FG001|Stage 1|Adverse Event|0
7021064|NCT01562275|11096170|FG002|Stage 1|Adverse Event|0
7021065|NCT01562275|11096171|FG003|Stage 1|Adverse Event|1
7021066|NCT01562275|11096172|FG004|Stage 1|Adverse Event|1
7021067|NCT01562275|11096173|FG005|Stage 1|Adverse Event|0
7021068|NCT01562275|11096174|FG006|Stage 1|Adverse Event|0
7021069|NCT01562275|11096175|FG007|Stage 1|Adverse Event|0
7021070|NCT01562275|11096176|FG008|Stage 1|Adverse Event|0
7021071|NCT01562275|11096177|FG009|Stage 1|Adverse Event|1
7021072|NCT01562275|11096178|FG010|Stage 1|Adverse Event|0
7021073|NCT01562275|11096179|FG011|Stage 1|Adverse Event|0
7021074|NCT01562275|11096180|FG012|Stage 1|Adverse Event|0
7021075|NCT01562275|11096168|FG000|Stage 1|Death|1
7021076|NCT01562275|11096169|FG001|Stage 1|Death|0
7021077|NCT01562275|11096170|FG002|Stage 1|Death|0
7021078|NCT01562275|11096171|FG003|Stage 1|Death|0
7021079|NCT01562275|11096172|FG004|Stage 1|Death|0
7021080|NCT01562275|11096173|FG005|Stage 1|Death|0
7021081|NCT01562275|11096174|FG006|Stage 1|Death|0
7021082|NCT01562275|11096175|FG007|Stage 1|Death|0
7021083|NCT01562275|11096176|FG008|Stage 1|Death|0
7021084|NCT01562275|11096177|FG009|Stage 1|Death|0
7021085|NCT01562275|11096178|FG010|Stage 1|Death|0
7021086|NCT01562275|11096179|FG011|Stage 1|Death|0
7021087|NCT01562275|11096180|FG012|Stage 1|Death|0
7021088|NCT01562275|11096168|FG000|Stage 1|Non Compliance|0
7021089|NCT01562275|11096169|FG001|Stage 1|Non Compliance|0
7021090|NCT01562275|11096170|FG002|Stage 1|Non Compliance|1
7021091|NCT01562275|11096171|FG003|Stage 1|Non Compliance|0
7021092|NCT01562275|11096172|FG004|Stage 1|Non Compliance|0
7021093|NCT01562275|11096173|FG005|Stage 1|Non Compliance|0
7021094|NCT01562275|11096174|FG006|Stage 1|Non Compliance|0
7021095|NCT01562275|11096175|FG007|Stage 1|Non Compliance|0
7021096|NCT01562275|11096176|FG008|Stage 1|Non Compliance|0
7021097|NCT01562275|11096177|FG009|Stage 1|Non Compliance|0
7021098|NCT01562275|11096178|FG010|Stage 1|Non Compliance|0
7021099|NCT01562275|11096179|FG011|Stage 1|Non Compliance|0
7021100|NCT01562275|11096180|FG012|Stage 1|Non Compliance|0
7021101|NCT01562275|11096168|FG000|Stage 1|Physician Decision|0
7021102|NCT01562275|11096169|FG001|Stage 1|Physician Decision|0
7021103|NCT01562275|11096170|FG002|Stage 1|Physician Decision|0
7021104|NCT01562275|11096171|FG003|Stage 1|Physician Decision|0
7021105|NCT01562275|11096172|FG004|Stage 1|Physician Decision|1
7021106|NCT01562275|11096173|FG005|Stage 1|Physician Decision|0
7021107|NCT01562275|11096174|FG006|Stage 1|Physician Decision|1
7021108|NCT01562275|11096175|FG007|Stage 1|Physician Decision|0
7021109|NCT01562275|11096176|FG008|Stage 1|Physician Decision|1
7021110|NCT01562275|11096177|FG009|Stage 1|Physician Decision|0
7021111|NCT01562275|11096178|FG010|Stage 1|Physician Decision|0
7021112|NCT01562275|11096179|FG011|Stage 1|Physician Decision|0
7021113|NCT01562275|11096180|FG012|Stage 1|Physician Decision|0
7021114|NCT01562275|11096168|FG000|Stage 1|Progression of Disease|2
7021115|NCT01562275|11096169|FG001|Stage 1|Progression of Disease|6
7021116|NCT01562275|11096170|FG002|Stage 1|Progression of Disease|2
7021117|NCT01562275|11096171|FG003|Stage 1|Progression of Disease|1
7021118|NCT01562275|11096172|FG004|Stage 1|Progression of Disease|2
7021119|NCT01562275|11096173|FG005|Stage 1|Progression of Disease|4
7021120|NCT01562275|11096174|FG006|Stage 1|Progression of Disease|1
7021121|NCT01562275|11096175|FG007|Stage 1|Progression of Disease|7
7021122|NCT01562275|11096176|FG008|Stage 1|Progression of Disease|2
7021123|NCT01562275|11096177|FG009|Stage 1|Progression of Disease|5
7021124|NCT01562275|11096178|FG010|Stage 1|Progression of Disease|3
7021125|NCT01562275|11096179|FG011|Stage 1|Progression of Disease|0
7021126|NCT01562275|11096180|FG012|Stage 1|Progression of Disease|0
7021127|NCT01562275|11096168|FG000|Stage 1|Withdrawal by Subject|0
7021128|NCT01562275|11096169|FG001|Stage 1|Withdrawal by Subject|1
7021129|NCT01562275|11096170|FG002|Stage 1|Withdrawal by Subject|0
7021130|NCT01562275|11096171|FG003|Stage 1|Withdrawal by Subject|2
7021131|NCT01562275|11096172|FG004|Stage 1|Withdrawal by Subject|0
7021132|NCT01562275|11096173|FG005|Stage 1|Withdrawal by Subject|0
7021133|NCT01562275|11096174|FG006|Stage 1|Withdrawal by Subject|1
7021134|NCT01562275|11096175|FG007|Stage 1|Withdrawal by Subject|0
7021135|NCT01562275|11096176|FG008|Stage 1|Withdrawal by Subject|0
7021136|NCT01562275|11096177|FG009|Stage 1|Withdrawal by Subject|1
7021137|NCT01562275|11096178|FG010|Stage 1|Withdrawal by Subject|0
7021138|NCT01562275|11096179|FG011|Stage 1|Withdrawal by Subject|0
7021139|NCT01562275|11096180|FG012|Stage 1|Withdrawal by Subject|0
7021140|NCT01562275|11096168|FG000|Stage 2|Death|0
7021141|NCT01562275|11096169|FG001|Stage 2|Death|0
7021142|NCT01562275|11096170|FG002|Stage 2|Death|0
7021143|NCT01562275|11096171|FG003|Stage 2|Death|0
7021144|NCT01562275|11096172|FG004|Stage 2|Death|0
7021145|NCT01562275|11096173|FG005|Stage 2|Death|0
7021146|NCT01562275|11096174|FG006|Stage 2|Death|0
7021147|NCT01562275|11096175|FG007|Stage 2|Death|0
7021148|NCT01562275|11096176|FG008|Stage 2|Death|0
7021149|NCT01562275|11096177|FG009|Stage 2|Death|0
7021150|NCT01562275|11096178|FG010|Stage 2|Death|0
7021151|NCT01562275|11096179|FG011|Stage 2|Death|2
7021152|NCT01562275|11096180|FG012|Stage 2|Death|1
7021153|NCT01562275|11096168|FG000|Stage 2|Progression of Disease|0
7021154|NCT01562275|11096169|FG001|Stage 2|Progression of Disease|0
7021155|NCT01562275|11096170|FG002|Stage 2|Progression of Disease|0
7021156|NCT01562275|11096171|FG003|Stage 2|Progression of Disease|0
7021157|NCT01562275|11096172|FG004|Stage 2|Progression of Disease|0
7021158|NCT01562275|11096173|FG005|Stage 2|Progression of Disease|0
7021159|NCT01562275|11096174|FG006|Stage 2|Progression of Disease|0
7021160|NCT01562275|11096175|FG007|Stage 2|Progression of Disease|0
7021161|NCT01562275|11096176|FG008|Stage 2|Progression of Disease|0
7021162|NCT01562275|11096177|FG009|Stage 2|Progression of Disease|0
7021163|NCT01562275|11096178|FG010|Stage 2|Progression of Disease|0
7021164|NCT01562275|11096179|FG011|Stage 2|Progression of Disease|12
7021165|NCT01562275|11096180|FG012|Stage 2|Progression of Disease|4
7021166|NCT01562314|11096212|FG000|Overall Study|Adverse Event|10
7021167|NCT01562314|11096213|FG001|Overall Study|Adverse Event|5
7021168|NCT01562314|11096212|FG000|Overall Study|Met Withdrawal Criteria|3
7021169|NCT01562314|11096213|FG001|Overall Study|Met Withdrawal Criteria|2
7021170|NCT01562314|11096212|FG000|Overall Study|Withdrawal by Subject|0
7021171|NCT01562314|11096213|FG001|Overall Study|Withdrawal by Subject|1
7021172|NCT01562327|11096219|FG000|Overall Study|Adverse Event|2
7021173|NCT01562327|11096219|FG000|Overall Study|Lack of Efficacy|1
7021174|NCT01562327|11096219|FG000|Overall Study|Participant drop-out|1
7021175|NCT01562327|11096219|FG000|Overall Study|Infusion not received at 6 month window|4
7021176|NCT01562444|11096248|FG000|Overall Study|Did not meet entry criteria|2
7021177|NCT01562444|11096249|FG001|Overall Study|Did not meet entry criteria|0
7021178|NCT01562444|11096250|FG002|Overall Study|Did not meet entry criteria|3
7021179|NCT01562444|11096248|FG000|Overall Study|Did not comply with blood draw schedule|1
7021180|NCT01562444|11096249|FG001|Overall Study|Did not comply with blood draw schedule|0
7021181|NCT01562444|11096250|FG002|Overall Study|Did not comply with blood draw schedule|1
7021182|NCT01562444|11096248|FG000|Overall Study|Unavailable serological results|0
7021183|NCT01562444|11096249|FG001|Overall Study|Unavailable serological results|2
7021184|NCT01562444|11096250|FG002|Overall Study|Unavailable serological results|2
7021185|NCT01562444|11096248|FG000|Overall Study|Protocol forbidden concomitant vaccine|1
7021186|NCT01562444|11096249|FG001|Overall Study|Protocol forbidden concomitant vaccine|0
7021187|NCT01562444|11096250|FG002|Overall Study|Protocol forbidden concomitant vaccine|1
7021188|NCT01562444|11096248|FG000|Overall Study|Protocol forbidden medication|1
7021189|NCT01562444|11096249|FG001|Overall Study|Protocol forbidden medication|0
7021190|NCT01562444|11096250|FG002|Overall Study|Protocol forbidden medication|0
7021191|NCT01562548|11096262|FG000|Overall Study|Lost to Follow-up|0
7021192|NCT01562548|11096263|FG001|Overall Study|Lost to Follow-up|0
7021193|NCT01562548|11096264|FG002|Overall Study|Lost to Follow-up|1
7021194|NCT01562548|11096265|FG003|Overall Study|Lost to Follow-up|0
7021195|NCT01562613|11096277|FG000|Overall Study|Lost to Follow-up|2
7021196|NCT01562613|11096277|FG000|Overall Study|Withdrawal by Subject|2
7021197|NCT01562743|11096290|FG000|Overall Study|Adverse Event|29
7021198|NCT01562743|11096290|FG000|Overall Study|Lack of Efficacy|3
7021199|NCT01562743|11096290|FG000|Overall Study|Withdrawal by Subject|13
7021200|NCT01562743|11096290|FG000|Overall Study|Protocol Violation|1
7021201|NCT01562743|11096290|FG000|Overall Study|Discontinuation criteria|2
7021202|NCT01562743|11096290|FG000|Overall Study|Lost to Follow-up|2
7021203|NCT01562743|11096290|FG000|Overall Study|Physician Decision|2
7021204|NCT01562782|11096300|FG000|Overall Study|Withdrawal by Subject|3
7021205|NCT01562782|11096301|FG001|Overall Study|Withdrawal by Subject|3
7021206|NCT01562782|11096300|FG000|Overall Study|screen failure|1
7021207|NCT01562782|11096301|FG001|Overall Study|screen failure|2
7021208|NCT01562873|11096307|FG000|Overall Study|Disease Progression per RECIST|10
7021209|NCT01562873|11096308|FG001|Overall Study|Disease Progression per RECIST|0
7021210|NCT01562873|11096307|FG000|Overall Study|Adverse Event|1
7021211|NCT01562873|11096308|FG001|Overall Study|Adverse Event|0
7021212|NCT01562873|11096307|FG000|Overall Study|Clinical Disease Progression|9
7021213|NCT01562873|11096308|FG001|Overall Study|Clinical Disease Progression|0
7021214|NCT01562873|11096307|FG000|Overall Study|Clinical PD and adverse event|1
7021215|NCT01562873|11096308|FG001|Overall Study|Clinical PD and adverse event|0
7021216|NCT01563029|11096330|FG000|Overall Study|Adverse Event|1
7021217|NCT01563029|11096331|FG001|Overall Study|Adverse Event|0
7021218|NCT01563029|11096332|FG002|Overall Study|Adverse Event|1
7021219|NCT01563029|11096333|FG003|Overall Study|Adverse Event|2
7021220|NCT01563029|11096334|FG004|Overall Study|Adverse Event|1
7021221|NCT01563029|11096330|FG000|Overall Study|Lack of Efficacy|42
7021222|NCT01563029|11096331|FG001|Overall Study|Lack of Efficacy|16
7021223|NCT01563029|11096332|FG002|Overall Study|Lack of Efficacy|23
7021224|NCT01563029|11096333|FG003|Overall Study|Lack of Efficacy|21
7021225|NCT01563029|11096334|FG004|Overall Study|Lack of Efficacy|19
7021226|NCT01563029|11096330|FG000|Overall Study|Protocol Violation|1
7021227|NCT01563029|11096331|FG001|Overall Study|Protocol Violation|2
7021228|NCT01563029|11096332|FG002|Overall Study|Protocol Violation|3
7021229|NCT01563029|11096333|FG003|Overall Study|Protocol Violation|1
7021230|NCT01563029|11096334|FG004|Overall Study|Protocol Violation|3
7021231|NCT01563029|11096330|FG000|Overall Study|Protocol defined stopping criteria|1
7021232|NCT01563029|11096331|FG001|Overall Study|Protocol defined stopping criteria|0
7021233|NCT01563029|11096332|FG002|Overall Study|Protocol defined stopping criteria|0
7021234|NCT01563029|11096333|FG003|Overall Study|Protocol defined stopping criteria|0
7021235|NCT01563029|11096334|FG004|Overall Study|Protocol defined stopping criteria|0
7021236|NCT01563029|11096330|FG000|Overall Study|Lost to Follow-up|1
7021237|NCT01563029|11096331|FG001|Overall Study|Lost to Follow-up|0
7021238|NCT01563029|11096332|FG002|Overall Study|Lost to Follow-up|1
7021239|NCT01563029|11096333|FG003|Overall Study|Lost to Follow-up|1
7021240|NCT01563029|11096334|FG004|Overall Study|Lost to Follow-up|1
7021241|NCT01563029|11096330|FG000|Overall Study|Physician Decision|3
7021242|NCT01563029|11096331|FG001|Overall Study|Physician Decision|5
7021243|NCT01563029|11096332|FG002|Overall Study|Physician Decision|2
7021244|NCT01563029|11096333|FG003|Overall Study|Physician Decision|4
7021245|NCT01563029|11096334|FG004|Overall Study|Physician Decision|2
7021246|NCT01563029|11096330|FG000|Overall Study|Withdrawal by Subject|4
7021247|NCT01563029|11096331|FG001|Overall Study|Withdrawal by Subject|1
7021248|NCT01563029|11096332|FG002|Overall Study|Withdrawal by Subject|3
7021249|NCT01563029|11096333|FG003|Overall Study|Withdrawal by Subject|4
7021250|NCT01563029|11096334|FG004|Overall Study|Withdrawal by Subject|3
7021251|NCT01563172|11096367|FG000|Overall Study|Adverse Event|5
7021252|NCT01563172|11096367|FG000|Overall Study|Lost to Follow-up|2
7021253|NCT01563172|11096367|FG000|Overall Study|Other (Protocol deviation)|5
7021254|NCT01563172|11096367|FG000|Overall Study|Other (Not specified)|1
7021255|NCT01563185|11096382|FG000|Overall Study|Withdrawal by Subject|1
7021256|NCT01563185|11096382|FG000|Overall Study|Non-Compliance with study drug|1
7043951|NCT01748825|11129295|FG006|Dose Escalation|Switched to alternative treatment|0
7043952|NCT01748825|11129296|FG007|Dose Escalation|Switched to alternative treatment|0
7043953|NCT01748825|11129297|FG008|Dose Escalation|Switched to alternative treatment|0
7043954|NCT01748825|11129298|FG009|Dose Escalation|Switched to alternative treatment|0
7043955|NCT01748825|11129289|FG000|Dose Escalation|Adverse Event|0
7043956|NCT01748825|11129290|FG001|Dose Escalation|Adverse Event|0
7043957|NCT01748825|11129291|FG002|Dose Escalation|Adverse Event|0
7043958|NCT01748825|11129292|FG003|Dose Escalation|Adverse Event|0
7043959|NCT01748825|11129293|FG004|Dose Escalation|Adverse Event|0
7043960|NCT01748825|11129294|FG005|Dose Escalation|Adverse Event|0
7043961|NCT01748825|11129295|FG006|Dose Escalation|Adverse Event|1
7043962|NCT01748825|11129296|FG007|Dose Escalation|Adverse Event|0
7043963|NCT01748825|11129297|FG008|Dose Escalation|Adverse Event|0
7043964|NCT01748825|11129298|FG009|Dose Escalation|Adverse Event|0
7043965|NCT01748825|11129289|FG000|Dose Expansion|Refused further treatment|0
7043966|NCT01748825|11129290|FG001|Dose Expansion|Refused further treatment|0
7043967|NCT01748825|11129291|FG002|Dose Expansion|Refused further treatment|0
7043968|NCT01748825|11129292|FG003|Dose Expansion|Refused further treatment|0
7043969|NCT01748825|11129293|FG004|Dose Expansion|Refused further treatment|0
7043970|NCT01748825|11129294|FG005|Dose Expansion|Refused further treatment|0
7043971|NCT01748825|11129295|FG006|Dose Expansion|Refused further treatment|0
7043972|NCT01748825|11129296|FG007|Dose Expansion|Refused further treatment|0
7043973|NCT01748825|11129297|FG008|Dose Expansion|Refused further treatment|1
7043974|NCT01748825|11129298|FG009|Dose Expansion|Refused further treatment|1
7043975|NCT01748825|11129289|FG000|Dose Expansion|Switched to alternative treatment|0
7043976|NCT01748825|11129290|FG001|Dose Expansion|Switched to alternative treatment|0
7043977|NCT01748825|11129291|FG002|Dose Expansion|Switched to alternative treatment|0
7043978|NCT01748825|11129292|FG003|Dose Expansion|Switched to alternative treatment|0
7043979|NCT01748825|11129293|FG004|Dose Expansion|Switched to alternative treatment|0
7043980|NCT01748825|11129294|FG005|Dose Expansion|Switched to alternative treatment|0
7043981|NCT01748825|11129295|FG006|Dose Expansion|Switched to alternative treatment|0
7043982|NCT01748825|11129296|FG007|Dose Expansion|Switched to alternative treatment|0
7043983|NCT01748825|11129297|FG008|Dose Expansion|Switched to alternative treatment|0
7043984|NCT01748825|11129298|FG009|Dose Expansion|Switched to alternative treatment|1
7043985|NCT01748825|11129289|FG000|Dose Expansion|Adverse Event|0
7043986|NCT01748825|11129290|FG001|Dose Expansion|Adverse Event|0
7043987|NCT01748825|11129291|FG002|Dose Expansion|Adverse Event|0
7043988|NCT01748825|11129292|FG003|Dose Expansion|Adverse Event|0
7043989|NCT01748825|11129293|FG004|Dose Expansion|Adverse Event|0
7043990|NCT01748825|11129294|FG005|Dose Expansion|Adverse Event|0
7043991|NCT01748825|11129295|FG006|Dose Expansion|Adverse Event|0
7043992|NCT01748825|11129296|FG007|Dose Expansion|Adverse Event|0
7043993|NCT01748825|11129297|FG008|Dose Expansion|Adverse Event|0
7043994|NCT01748825|11129298|FG009|Dose Expansion|Adverse Event|3
7043995|NCT01748825|11129289|FG000|Dose Expansion|Physician Decision|0
7043996|NCT01748825|11129290|FG001|Dose Expansion|Physician Decision|0
7043997|NCT01748825|11129291|FG002|Dose Expansion|Physician Decision|0
7043998|NCT01748825|11129292|FG003|Dose Expansion|Physician Decision|0
7043999|NCT01748825|11129293|FG004|Dose Expansion|Physician Decision|0
7044000|NCT01748825|11129294|FG005|Dose Expansion|Physician Decision|0
7044001|NCT01748825|11129295|FG006|Dose Expansion|Physician Decision|0
7044002|NCT01748825|11129296|FG007|Dose Expansion|Physician Decision|0
7044003|NCT01748825|11129297|FG008|Dose Expansion|Physician Decision|1
7044004|NCT01748825|11129298|FG009|Dose Expansion|Physician Decision|0
7044005|NCT01748994|11129360|FG000|Overall Study|Lost to Follow-up|8
7044006|NCT01748994|11129361|FG001|Overall Study|Lost to Follow-up|6
7044007|NCT01749033|11129370|FG000|Overall Study|Did not receive allocated intervention|3
7044008|NCT01749033|11129371|FG001|Overall Study|Did not receive allocated intervention|3
7044009|NCT01749033|11129372|FG002|Overall Study|Did not receive allocated intervention|0
7044010|NCT01749033|11129370|FG000|Overall Study|Lost to Follow-up|0
7044011|NCT01749033|11129371|FG001|Overall Study|Lost to Follow-up|2
7044012|NCT01749033|11129372|FG002|Overall Study|Lost to Follow-up|1
7044013|NCT01749735|11129423|FG000|Overall Study|Withdrawal by Subject|1
7044014|NCT01749735|11129424|FG001|Overall Study|Withdrawal by Subject|0
7044015|NCT01749800|11129433|FG000|Overall Study|not meeting inclusion criteria|3
7044016|NCT01749800|11129434|FG001|Overall Study|not meeting inclusion criteria|0
7044017|NCT01749800|11129435|FG002|Overall Study|not meeting inclusion criteria|0
7044018|NCT01749800|11129433|FG000|Overall Study|Withdrawal by Subject|0
7021257|NCT01563237|11096390|FG000|Overall Study|Lost to Follow-up|6
7021258|NCT01563237|11096391|FG001|Overall Study|Lost to Follow-up|0
7021259|NCT01563237|11096390|FG000|Overall Study|Withdrawal by Subject|1
7021260|NCT01563237|11096391|FG001|Overall Study|Withdrawal by Subject|0
7021261|NCT01563237|11096390|FG000|Overall Study|Adverse Event|1
7021262|NCT01563237|11096391|FG001|Overall Study|Adverse Event|0
7021263|NCT01563237|11096390|FG000|Overall Study|Medical Reasons|1
7021264|NCT01563237|11096391|FG001|Overall Study|Medical Reasons|0
7021265|NCT01563237|11096390|FG000|Overall Study|Death|1
7021266|NCT01563237|11096391|FG001|Overall Study|Death|0
7021267|NCT01563354|11096399|FG000|Core Phase|Adverse Event|5
7021268|NCT01563354|11096400|FG001|Core Phase|Adverse Event|15
7021269|NCT01563354|11096401|FG002|Core Phase|Adverse Event|13
7021270|NCT01563354|11096399|FG000|Core Phase|Withdrawal by Subject|1
7021271|NCT01563354|11096400|FG001|Core Phase|Withdrawal by Subject|0
7021272|NCT01563354|11096401|FG002|Core Phase|Withdrawal by Subject|3
7021273|NCT01563354|11096399|FG000|Core Phase|Lost to Follow-up|1
7021274|NCT01563354|11096400|FG001|Core Phase|Lost to Follow-up|0
7021275|NCT01563354|11096401|FG002|Core Phase|Lost to Follow-up|0
7021276|NCT01563354|11096399|FG000|Core Phase|Death|1
7021277|NCT01563354|11096400|FG001|Core Phase|Death|5
7021278|NCT01563354|11096401|FG002|Core Phase|Death|2
7021279|NCT01563354|11096399|FG000|Core Phase|Diseasse progression|18
7021280|NCT01563354|11096400|FG001|Core Phase|Diseasse progression|7
7021281|NCT01563354|11096401|FG002|Core Phase|Diseasse progression|8
7021282|NCT01563354|11096399|FG000|Core Phase|Protocol deviation|2
7021283|NCT01563354|11096400|FG001|Core Phase|Protocol deviation|0
7021284|NCT01563354|11096401|FG002|Core Phase|Protocol deviation|0
7021285|NCT01563354|11096399|FG000|Core Phase|PI decision - did not enter extension|0
7021286|NCT01563354|11096400|FG001|Core Phase|PI decision - did not enter extension|1
7021287|NCT01563354|11096401|FG002|Core Phase|PI decision - did not enter extension|0
7021288|NCT01563354|11096399|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1
7021289|NCT01563354|11096400|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0
7021290|NCT01563354|11096401|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0
7021291|NCT01563354|11096399|FG000|Extension Phase|Adverse Event|0
7021292|NCT01563354|11096400|FG001|Extension Phase|Adverse Event|3
7021293|NCT01563354|11096401|FG002|Extension Phase|Adverse Event|2
7021294|NCT01563354|11096399|FG000|Extension Phase|Withdrawal by Subject|0
7021295|NCT01563354|11096400|FG001|Extension Phase|Withdrawal by Subject|1
7021296|NCT01563354|11096401|FG002|Extension Phase|Withdrawal by Subject|0
7021297|NCT01563354|11096399|FG000|Extension Phase|Administration problems|3
7021298|NCT01563354|11096400|FG001|Extension Phase|Administration problems|2
7021299|NCT01563354|11096401|FG002|Extension Phase|Administration problems|3
7021300|NCT01563354|11096399|FG000|Extension Phase|Disease progression|9
7021301|NCT01563354|11096400|FG001|Extension Phase|Disease progression|8
7021302|NCT01563354|11096401|FG002|Extension Phase|Disease progression|10
7021303|NCT01563536|11096432|FG000|Overall Study|Withdrawal by Subject|0
7021304|NCT01563536|11096433|FG001|Overall Study|Withdrawal by Subject|2
7021305|NCT01563536|11096432|FG000|Overall Study|Lost to Follow-up|1
7021306|NCT01563536|11096433|FG001|Overall Study|Lost to Follow-up|0
7021307|NCT01563913|11096441|FG000|Overall Study|Physician Decision|1
7021308|NCT01563913|11096442|FG001|Overall Study|Physician Decision|0
7021309|NCT01563913|11096441|FG000|Overall Study|Spouse Passed Away|1
7021310|NCT01563913|11096442|FG001|Overall Study|Spouse Passed Away|0
7021311|NCT01563978|11096450|FG000|Overall Study|Physician Decision|1
7021312|NCT01563978|11096451|FG001|Overall Study|Physician Decision|0
7021313|NCT01563978|11096450|FG000|Overall Study|Lost to Follow-up|1
7021314|NCT01563978|11096451|FG001|Overall Study|Lost to Follow-up|0
7021315|NCT01563978|11096450|FG000|Overall Study|Dev. of study specific discont. criteria|1
7021316|NCT01563978|11096451|FG001|Overall Study|Dev. of study specific discont. criteria|0
7021317|NCT01563978|11096450|FG000|Overall Study|Adverse Event|1
7021318|NCT01563978|11096451|FG001|Overall Study|Adverse Event|2
7021319|NCT01564277|11096459|FG000|Overall Study|Protocol Violation|0
7021320|NCT01564277|11096460|FG001|Overall Study|Protocol Violation|1
7021321|NCT01564277|11096459|FG000|Overall Study|Physician Decision|1
7021322|NCT01564277|11096460|FG001|Overall Study|Physician Decision|0
7021323|NCT01564394|11096468|FG000|Overall Study|Withdrawal by Subject|6
7021324|NCT01564394|11096469|FG001|Overall Study|Withdrawal by Subject|10
7021325|NCT01564407|11096480|FG000|Overall Study|Lost to Follow-up|0
7021326|NCT01564407|11096481|FG001|Overall Study|Lost to Follow-up|1
7021327|NCT01564407|11096482|FG002|Overall Study|Lost to Follow-up|0
7021328|NCT01564407|11096483|FG003|Overall Study|Lost to Follow-up|0
7021329|NCT01564407|11096484|FG004|Overall Study|Lost to Follow-up|0
7021330|NCT01564407|11096480|FG000|Overall Study|Withdrawal by Subject|0
7021331|NCT01564407|11096481|FG001|Overall Study|Withdrawal by Subject|1
7021332|NCT01564407|11096482|FG002|Overall Study|Withdrawal by Subject|0
7021333|NCT01564407|11096483|FG003|Overall Study|Withdrawal by Subject|0
7021334|NCT01564407|11096484|FG004|Overall Study|Withdrawal by Subject|0
7021335|NCT01564407|11096480|FG000|Overall Study|funding lost, study ended|0
7021336|NCT01564407|11096481|FG001|Overall Study|funding lost, study ended|0
7021337|NCT01564407|11096482|FG002|Overall Study|funding lost, study ended|0
7021338|NCT01564407|11096483|FG003|Overall Study|funding lost, study ended|1
7021339|NCT01564407|11096484|FG004|Overall Study|funding lost, study ended|0
7021340|NCT01564459|11096508|FG000|Run-In|Adverse Event|7
7021341|NCT01564459|11096509|FG001|Run-In|Adverse Event|0
7021342|NCT01564459|11096510|FG002|Run-In|Adverse Event|0
7021343|NCT01564459|11096508|FG000|Run-In|Lost to Follow-up|1
7021344|NCT01564459|11096509|FG001|Run-In|Lost to Follow-up|0
7021345|NCT01564459|11096510|FG002|Run-In|Lost to Follow-up|0
7021346|NCT01564459|11096508|FG000|Run-In|Non-compliance with study drug|2
7021347|NCT01564459|11096509|FG001|Run-In|Non-compliance with study drug|0
7021348|NCT01564459|11096510|FG002|Run-In|Non-compliance with study drug|0
7021349|NCT01564459|11096508|FG000|Run-In|Protocol Violation|1
7021350|NCT01564459|11096509|FG001|Run-In|Protocol Violation|0
7021351|NCT01564459|11096510|FG002|Run-In|Protocol Violation|0
7021352|NCT01564459|11096508|FG000|Run-In|Withdrawal by Subject|1
7021353|NCT01564459|11096509|FG001|Run-In|Withdrawal by Subject|0
7021354|NCT01564459|11096510|FG002|Run-In|Withdrawal by Subject|0
7021355|NCT01564459|11096508|FG000|Double-blind Treatment|Adverse Event|0
7021356|NCT01564459|11096509|FG001|Double-blind Treatment|Adverse Event|0
7021357|NCT01564459|11096510|FG002|Double-blind Treatment|Adverse Event|1
7021358|NCT01564758|11096557|FG000|Overall Study|Death|8
7021359|NCT01564758|11096557|FG000|Overall Study|Adverse Event|3
7021360|NCT01564758|11096557|FG000|Overall Study|Other|3
7021361|NCT01564784|11096563|FG000|Overall Study|Other|1
7021362|NCT01564784|11096564|FG001|Overall Study|Other|0
7021363|NCT01564784|11096563|FG000|Overall Study|Subject refused further follow-up|1
7021364|NCT01564784|11096564|FG001|Overall Study|Subject refused further follow-up|6
7021365|NCT01564784|11096563|FG000|Overall Study|Lost to Follow-up|1
7021366|NCT01564784|11096564|FG001|Overall Study|Lost to Follow-up|1
7021367|NCT01564784|11096563|FG000|Overall Study|Death|131
7021368|NCT01564784|11096564|FG001|Overall Study|Death|126
7021369|NCT01564862|11096573|FG000|Overall Study|Pretreatment Event or Adverse Event|6
7021370|NCT01564862|11096574|FG001|Overall Study|Pretreatment Event or Adverse Event|12
7021371|NCT01564862|11096575|FG002|Overall Study|Pretreatment Event or Adverse Event|6
7021372|NCT01564862|11096573|FG000|Overall Study|Major Protocol Deviation|3
7021373|NCT01564862|11096574|FG001|Overall Study|Major Protocol Deviation|3
7021374|NCT01564862|11096575|FG002|Overall Study|Major Protocol Deviation|4
7021375|NCT01564862|11096573|FG000|Overall Study|Lost to Follow-up|10
7021376|NCT01564862|11096574|FG001|Overall Study|Lost to Follow-up|8
7021377|NCT01564862|11096575|FG002|Overall Study|Lost to Follow-up|6
7021378|NCT01564862|11096573|FG000|Overall Study|Voluntary Withdrawal|9
7021379|NCT01564862|11096574|FG001|Overall Study|Voluntary Withdrawal|6
7021380|NCT01564862|11096575|FG002|Overall Study|Voluntary Withdrawal|8
7021381|NCT01564862|11096573|FG000|Overall Study|Lack of Efficacy|1
7021382|NCT01564862|11096574|FG001|Overall Study|Lack of Efficacy|5
7021383|NCT01564862|11096575|FG002|Overall Study|Lack of Efficacy|6
7021384|NCT01564862|11096573|FG000|Overall Study|Other reason(s)|1
7021385|NCT01564862|11096574|FG001|Overall Study|Other reason(s)|0
7021386|NCT01564862|11096575|FG002|Overall Study|Other reason(s)|0
7021387|NCT01565083|11096605|FG000|Overall Study|Withdrawal by Subject|6
7021388|NCT01565083|11096606|FG001|Overall Study|Withdrawal by Subject|4
7021389|NCT01565083|11096605|FG000|Overall Study|Lost to Follow-up|2
7021390|NCT01565083|11096606|FG001|Overall Study|Lost to Follow-up|7
7021391|NCT01565083|11096605|FG000|Overall Study|Death|22
7021392|NCT01565083|11096606|FG001|Overall Study|Death|23
7021393|NCT01565083|11096605|FG000|Overall Study|Other|3
7021394|NCT01565083|11096606|FG001|Overall Study|Other|5
7021395|NCT01565148|11096616|FG000|Overall Study|Withdrawal by Subject|1
7021396|NCT01565148|11096617|FG001|Overall Study|Withdrawal by Subject|1
7021397|NCT01565148|11096618|FG002|Overall Study|Withdrawal by Subject|1
7021398|NCT01565148|11096619|FG003|Overall Study|Withdrawal by Subject|2
7021399|NCT01565148|11096616|FG000|Overall Study|Lost to Follow-up|4
7021400|NCT01565148|11096617|FG001|Overall Study|Lost to Follow-up|4
7021401|NCT01565148|11096618|FG002|Overall Study|Lost to Follow-up|0
7021402|NCT01565148|11096619|FG003|Overall Study|Lost to Follow-up|3
7021403|NCT01565148|11096616|FG000|Overall Study|Rescue Therapy|8
7021404|NCT01565148|11096617|FG001|Overall Study|Rescue Therapy|5
7021405|NCT01565148|11096618|FG002|Overall Study|Rescue Therapy|5
7021406|NCT01565148|11096619|FG003|Overall Study|Rescue Therapy|8
7021407|NCT01565148|11096616|FG000|Overall Study|Death|0
7021408|NCT01565148|11096617|FG001|Overall Study|Death|0
7021409|NCT01565148|11096618|FG002|Overall Study|Death|1
7021410|NCT01565148|11096619|FG003|Overall Study|Death|0
7021411|NCT01565148|11096616|FG000|Overall Study|Physician Decision|2
7021412|NCT01565148|11096617|FG001|Overall Study|Physician Decision|5
7021413|NCT01565148|11096618|FG002|Overall Study|Physician Decision|0
7021414|NCT01565148|11096619|FG003|Overall Study|Physician Decision|0
7021415|NCT01565291|11096635|FG000|Overall Study|Withdrawal by Subject|1
7021416|NCT01565291|11096636|FG001|Overall Study|Withdrawal by Subject|0
7021417|NCT01565343|11096663|FG000|Overall Study|Administrative decision/technical issues|1
7021418|NCT01565343|11096664|FG001|Overall Study|Administrative decision/technical issues|0
7021419|NCT01565343|11096665|FG002|Overall Study|Administrative decision/technical issues|0
7021420|NCT01565499|11096687|FG000|Overall Study|Physician Decision|1
7021421|NCT01565499|11096687|FG000|Overall Study|Adverse Event|5
7021422|NCT01565499|11096687|FG000|Overall Study|Withdrawal by Subject|2
7021423|NCT01565564|11096711|FG000|Overall Study|Lost to Follow-up|5
7021424|NCT01565564|11096712|FG001|Overall Study|Lost to Follow-up|1
7021425|NCT01565642|11096724|FG000|Overall Study|Withdrawal by Subject|2
7021426|NCT01565642|11096725|FG001|Overall Study|Withdrawal by Subject|1
7021427|NCT01565668|11096733|FG000|Overall Study|Death|2
7021428|NCT01565668|11096734|FG001|Overall Study|Death|1
7021429|NCT01565668|11096733|FG000|Overall Study|Lack of Efficacy|4
7021430|NCT01565668|11096734|FG001|Overall Study|Lack of Efficacy|2
7021431|NCT01565668|11096733|FG000|Overall Study|Participant went on Hospice Care|1
7021432|NCT01565668|11096734|FG001|Overall Study|Participant went on Hospice Care|0
7021433|NCT01565668|11096733|FG000|Overall Study|Adverse Event|6
7021434|NCT01565668|11096734|FG001|Overall Study|Adverse Event|1
7021435|NCT01565668|11096733|FG000|Overall Study|Randomized, but never received drug|0
7021436|NCT01565668|11096734|FG001|Overall Study|Randomized, but never received drug|2
7021437|NCT01565668|11096733|FG000|Overall Study|Progressive disease|13
7021438|NCT01565668|11096734|FG001|Overall Study|Progressive disease|14
7021439|NCT01565668|11096733|FG000|Overall Study|Withdrawal by Subject|1
7021440|NCT01565668|11096734|FG001|Overall Study|Withdrawal by Subject|3
7021441|NCT01565668|11096733|FG000|Overall Study|HSCT Transplant|11
7021442|NCT01565668|11096734|FG001|Overall Study|HSCT Transplant|15
7021443|NCT01565694|11096740|FG000|Dose-Titration Period|Adverse Event|4
7021444|NCT01565694|11096740|FG000|Dose-Titration Period|Protocol Violation|10
7021445|NCT01565694|11096740|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4
7021446|NCT01565707|11096748|FG000|Overall Study|Adverse Event|1
7021447|NCT01565707|11096749|FG001|Overall Study|Adverse Event|6
7021448|NCT01565707|11096750|FG002|Overall Study|Adverse Event|2
7021449|NCT01565707|11096751|FG003|Overall Study|Adverse Event|1
7021450|NCT01565707|11096748|FG000|Overall Study|Lost to Follow-up|1
7021451|NCT01565707|11096749|FG001|Overall Study|Lost to Follow-up|0
7021452|NCT01565707|11096750|FG002|Overall Study|Lost to Follow-up|0
7021453|NCT01565707|11096751|FG003|Overall Study|Lost to Follow-up|0
7021454|NCT01565707|11096748|FG000|Overall Study|Protocol Violation|1
7021455|NCT01565707|11096749|FG001|Overall Study|Protocol Violation|0
7021456|NCT01565707|11096750|FG002|Overall Study|Protocol Violation|0
7021457|NCT01565707|11096751|FG003|Overall Study|Protocol Violation|1
7021458|NCT01565707|11096748|FG000|Overall Study|Withdrawal by Subject|3
7021459|NCT01565707|11096749|FG001|Overall Study|Withdrawal by Subject|1
7021460|NCT01565707|11096750|FG002|Overall Study|Withdrawal by Subject|1
7021461|NCT01565707|11096751|FG003|Overall Study|Withdrawal by Subject|1
7021462|NCT01565707|11096748|FG000|Overall Study|Randomized but not evaluable|2
7021463|NCT01565707|11096749|FG001|Overall Study|Randomized but not evaluable|0
7021464|NCT01565707|11096750|FG002|Overall Study|Randomized but not evaluable|0
7021465|NCT01565707|11096751|FG003|Overall Study|Randomized but not evaluable|0
7021466|NCT01565707|11096748|FG000|Overall Study|Miscellaneous|1
7021467|NCT01565707|11096749|FG001|Overall Study|Miscellaneous|1
7021468|NCT01565707|11096750|FG002|Overall Study|Miscellaneous|0
7021469|NCT01565707|11096751|FG003|Overall Study|Miscellaneous|2
7021470|NCT01565850|11096770|FG000|Overall Study|Adverse Event|0
7021471|NCT01565850|11096771|FG001|Overall Study|Adverse Event|1
7021472|NCT01565850|11096770|FG000|Overall Study|Lost to Follow-up|12
7021473|NCT01565850|11096771|FG001|Overall Study|Lost to Follow-up|4
7021474|NCT01565850|11096770|FG000|Overall Study|Investigator's Discretion|2
7021475|NCT01565850|11096771|FG001|Overall Study|Investigator's Discretion|1
7021476|NCT01565850|11096770|FG000|Overall Study|Participant noncompliance|2
7021477|NCT01565850|11096771|FG001|Overall Study|Participant noncompliance|0
7021478|NCT01565850|11096770|FG000|Overall Study|Withdrew Consent|4
7021479|NCT01565850|11096771|FG001|Overall Study|Withdrew Consent|2
7021480|NCT01565889|11096783|FG000|Part A|Withdrawal by Subject|1
7021481|NCT01565889|11096784|FG001|Part A|Withdrawal by Subject|0
7021482|NCT01565889|11096785|FG002|Part A|Withdrawal by Subject|0
7021483|NCT01565889|11096786|FG003|Part A|Withdrawal by Subject|0
7021484|NCT01565889|11096787|FG004|Part A|Withdrawal by Subject|0
7021485|NCT01565889|11096788|FG005|Part A|Withdrawal by Subject|0
7021486|NCT01565889|11096783|FG000|Part B|Withdrawal by Subject|0
7021487|NCT01565889|11096784|FG001|Part B|Withdrawal by Subject|0
7021488|NCT01565889|11096785|FG002|Part B|Withdrawal by Subject|0
7021489|NCT01565889|11096786|FG003|Part B|Withdrawal by Subject|0
7021490|NCT01565889|11096787|FG004|Part B|Withdrawal by Subject|0
7021491|NCT01565889|11096788|FG005|Part B|Withdrawal by Subject|1
7021492|NCT01565889|11096783|FG000|Part B|Lack of Efficacy|0
7021493|NCT01565889|11096784|FG001|Part B|Lack of Efficacy|0
7021494|NCT01565889|11096785|FG002|Part B|Lack of Efficacy|0
7021495|NCT01565889|11096786|FG003|Part B|Lack of Efficacy|0
7021496|NCT01565889|11096787|FG004|Part B|Lack of Efficacy|0
7021497|NCT01565889|11096788|FG005|Part B|Lack of Efficacy|2
7021498|NCT01565889|11096783|FG000|Part B|Lost to Follow-up|0
7021499|NCT01565889|11096784|FG001|Part B|Lost to Follow-up|0
7021500|NCT01565889|11096785|FG002|Part B|Lost to Follow-up|0
7021501|NCT01565889|11096786|FG003|Part B|Lost to Follow-up|0
7021502|NCT01565889|11096787|FG004|Part B|Lost to Follow-up|0
7021503|NCT01565889|11096788|FG005|Part B|Lost to Follow-up|1
7021504|NCT01565928|11096823|FG000|Overall Study|Adverse Event|3
7021505|NCT01565928|11096823|FG000|Overall Study|Other|3
7021506|NCT01565928|11096823|FG000|Overall Study|Progressive Disease|13
7021507|NCT01565928|11096823|FG000|Overall Study|Withdrawal by Subject|1
7021508|NCT01565928|11096823|FG000|Overall Study|Death|2
7021509|NCT01565941|11096832|FG000|Overall Study|Withdrawn by parent/guardian|3
7021510|NCT01565941|11096833|FG001|Overall Study|Withdrawn by parent/guardian|2
7021511|NCT01565941|11096832|FG000|Overall Study|Randomized; did not receive intevention|8
7021512|NCT01565941|11096833|FG001|Overall Study|Randomized; did not receive intevention|2
7021513|NCT01565980|11096843|FG000|Overall Study|Death|1
7021514|NCT01565980|11096844|FG001|Overall Study|Death|0
7021515|NCT01565980|11096843|FG000|Overall Study|Lost to Follow-up|1
7021516|NCT01565980|11096844|FG001|Overall Study|Lost to Follow-up|0
7021517|NCT01565980|11096843|FG000|Overall Study|health complications|1
7021518|NCT01565980|11096844|FG001|Overall Study|health complications|1
7021519|NCT01565980|11096843|FG000|Overall Study|stopped medical treatment|1
7021520|NCT01565980|11096844|FG001|Overall Study|stopped medical treatment|0
7021521|NCT01565980|11096843|FG000|Overall Study|Withdrawal by Subject|0
7021522|NCT01565980|11096844|FG001|Overall Study|Withdrawal by Subject|3
7021523|NCT01565993|11096856|FG000|Overall Study|Physician Decision|0
7021524|NCT01565993|11096857|FG001|Overall Study|Physician Decision|3
7021525|NCT01566214|11096886|FG000|Overall Study|Lost to Follow-up|3
7021526|NCT01566214|11096887|FG001|Overall Study|Lost to Follow-up|0
7021527|NCT01566435|11096911|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1
7021528|NCT01566604|11096980|FG000|Overall Study|Patient's inability to use the device|1
7021529|NCT01566604|11096981|FG001|Overall Study|Patient's inability to use the device|0
7021530|NCT01566604|11096980|FG000|Overall Study|Administrative problems|1
7021531|NCT01566604|11096981|FG001|Overall Study|Administrative problems|0
7021532|NCT01566604|11096980|FG000|Overall Study|Lack of Efficacy|1
7021533|NCT01566604|11096981|FG001|Overall Study|Lack of Efficacy|2
7021534|NCT01566604|11096980|FG000|Overall Study|Protocol deviation|2
7021535|NCT01566604|11096981|FG001|Overall Study|Protocol deviation|0
7021536|NCT01566604|11096980|FG000|Overall Study|Abnormal laboratory value|2
7021537|NCT01566604|11096981|FG001|Overall Study|Abnormal laboratory value|0
7021538|NCT01566604|11096980|FG000|Overall Study|Death|4
7021539|NCT01566604|11096981|FG001|Overall Study|Death|1
7021540|NCT01566604|11096980|FG000|Overall Study|Adverse Event|4
7021541|NCT01566604|11096981|FG001|Overall Study|Adverse Event|2
7021542|NCT01566604|11096980|FG000|Overall Study|Withdrawal by Subject|9
7021543|NCT01566604|11096981|FG001|Overall Study|Withdrawal by Subject|6
7021544|NCT01566721|11097008|FG000|Treatment Period|Withdrawal by Subject|35
7021545|NCT01566721|11097009|FG001|Treatment Period|Withdrawal by Subject|9
7021546|NCT01566721|11097008|FG000|Treatment Period|Disease Progression/Recurrence|37
7021547|NCT01566721|11097009|FG001|Treatment Period|Disease Progression/Recurrence|13
7021548|NCT01566721|11097008|FG000|Treatment Period|Investigator/Sponsor Decision|6
7021549|NCT01566721|11097009|FG001|Treatment Period|Investigator/Sponsor Decision|3
7021550|NCT01566721|11097008|FG000|Treatment Period|Other|13
7021551|NCT01566721|11097009|FG001|Treatment Period|Other|2
7021552|NCT01566721|11097008|FG000|Treatment Period|Lack of Compliance|5
7021553|NCT01566721|11097009|FG001|Treatment Period|Lack of Compliance|1
7021554|NCT01566721|11097008|FG000|Treatment Period|Adverse Event|100
7021555|NCT01566721|11097009|FG001|Treatment Period|Adverse Event|30
7021556|NCT01566721|11097008|FG000|Treatment Period|Pregnancy|1
7021557|NCT01566721|11097009|FG001|Treatment Period|Pregnancy|0
7021558|NCT01566721|11097008|FG000|Safety Follow-up|Physician Decision|6
7021559|NCT01566721|11097009|FG001|Safety Follow-up|Physician Decision|4
7021560|NCT01566721|11097008|FG000|Safety Follow-up|Lost to Follow-up|101
7021561|NCT01566721|11097009|FG001|Safety Follow-up|Lost to Follow-up|48
7021562|NCT01566721|11097008|FG000|Safety Follow-up|Withdrawal by Subject|155
7021563|NCT01566721|11097009|FG001|Safety Follow-up|Withdrawal by Subject|49
7021564|NCT01566721|11097008|FG000|Safety Follow-up|Death|28
7021565|NCT01566721|11097009|FG001|Safety Follow-up|Death|4
7021566|NCT01566721|11097008|FG000|Safety Follow-up|Non-compliance|7
7021567|NCT01566721|11097009|FG001|Safety Follow-up|Non-compliance|3
7021568|NCT01566721|11097008|FG000|Safety Follow-up|Protocol Violation|7
7021569|NCT01566721|11097009|FG001|Safety Follow-up|Protocol Violation|0
7021570|NCT01566721|11097008|FG000|Safety Follow-up|Site closure|2
7021571|NCT01566721|11097009|FG001|Safety Follow-up|Site closure|3
7021572|NCT01566721|11097008|FG000|Safety Follow-up|Erroneous reporting or late reporting|2
7021573|NCT01566721|11097009|FG001|Safety Follow-up|Erroneous reporting or late reporting|0
7021574|NCT01566721|11097008|FG000|Safety Follow-up|Missing|7
7021575|NCT01566721|11097009|FG001|Safety Follow-up|Missing|2
7021576|NCT01566721|11097008|FG000|Safety Follow-up|Disease progression /disease recurrence|223
7021577|NCT01566721|11097009|FG001|Safety Follow-up|Disease progression /disease recurrence|90
7021578|NCT01566721|11097008|FG000|Safety Follow-up|Sponsor decision|1
7021579|NCT01566721|11097009|FG001|Safety Follow-up|Sponsor decision|0
7021580|NCT01566721|11097008|FG000|Safety Follow-up|Adverse Event|8
7021581|NCT01566721|11097009|FG001|Safety Follow-up|Adverse Event|4
7021582|NCT01566773|11097022|FG000|Overall Study|Protocol specified criteria|4
7021583|NCT01566773|11097022|FG000|Overall Study|Protocol Violation|4
7021584|NCT01566773|11097022|FG000|Overall Study|Withdrawal by Subject|9
7021585|NCT01566773|11097022|FG000|Overall Study|Administrative reason|1
7021586|NCT01566773|11097022|FG000|Overall Study|Adverse Event|10
7021587|NCT01566773|11097022|FG000|Overall Study|Physician Decision|2
7021588|NCT01566981|11097053|FG000|Overall Study|Lost to Follow-up|5
7021589|NCT01566981|11097054|FG001|Overall Study|Lost to Follow-up|8
7021590|NCT01567085|11097079|FG000|Overall Study|Death|6
7021591|NCT01567085|11097079|FG000|Overall Study|Adverse Event|6
7021592|NCT01567085|11097079|FG000|Overall Study|Lost to Follow-up|3
7021593|NCT01567085|11097079|FG000|Overall Study|Graft loss|2
7021594|NCT01567085|11097079|FG000|Overall Study|Renal transplantectomy|1
7021595|NCT01567085|11097079|FG000|Overall Study|Returned to chronic dialysis|1
7021596|NCT01567085|11097079|FG000|Overall Study|Terminal chronic kidney dysfunction|1
7021597|NCT01567163|11097092|FG000|Overall Study|Progressive Disease|2
7021598|NCT01567163|11097092|FG000|Overall Study|Lost to Follow-up|2
7021599|NCT01567306|11097107|FG000|Overall Study|Protocol Violation|2
7021600|NCT01567306|11097108|FG001|Overall Study|Protocol Violation|2
7021601|NCT01567306|11097109|FG002|Overall Study|Protocol Violation|0
7021602|NCT01567306|11097110|FG003|Overall Study|Protocol Violation|3
7021603|NCT01567306|11097111|FG004|Overall Study|Protocol Violation|1
7021604|NCT01567306|11097112|FG005|Overall Study|Protocol Violation|1
7021605|NCT01567306|11097107|FG000|Overall Study|Change site living|1
7021606|NCT01567306|11097108|FG001|Overall Study|Change site living|0
7021607|NCT01567306|11097109|FG002|Overall Study|Change site living|0
7021608|NCT01567306|11097110|FG003|Overall Study|Change site living|0
7021609|NCT01567306|11097111|FG004|Overall Study|Change site living|0
7021610|NCT01567306|11097112|FG005|Overall Study|Change site living|0
7021611|NCT01567306|11097107|FG000|Overall Study|Adverse Event|0
7021612|NCT01567306|11097108|FG001|Overall Study|Adverse Event|0
7021613|NCT01567306|11097109|FG002|Overall Study|Adverse Event|0
7021614|NCT01567306|11097110|FG003|Overall Study|Adverse Event|2
7021615|NCT01567306|11097111|FG004|Overall Study|Adverse Event|4
7021616|NCT01567306|11097112|FG005|Overall Study|Adverse Event|1
7021617|NCT01567306|11097107|FG000|Overall Study|Lost to Follow-up|0
7021618|NCT01567306|11097108|FG001|Overall Study|Lost to Follow-up|0
7021619|NCT01567306|11097109|FG002|Overall Study|Lost to Follow-up|0
7021620|NCT01567306|11097110|FG003|Overall Study|Lost to Follow-up|0
7021621|NCT01567306|11097111|FG004|Overall Study|Lost to Follow-up|2
7021622|NCT01567306|11097112|FG005|Overall Study|Lost to Follow-up|0
7021623|NCT01567306|11097107|FG000|Overall Study|Withdrawal by Subject|0
7021624|NCT01567306|11097108|FG001|Overall Study|Withdrawal by Subject|0
7021625|NCT01567306|11097109|FG002|Overall Study|Withdrawal by Subject|0
7021626|NCT01567306|11097110|FG003|Overall Study|Withdrawal by Subject|0
7021627|NCT01567306|11097111|FG004|Overall Study|Withdrawal by Subject|0
7021628|NCT01567306|11097112|FG005|Overall Study|Withdrawal by Subject|1
7021629|NCT01567462|11097132|FG000|Overall Study|Withdrawal by Subject|4
7021630|NCT01567462|11097133|FG001|Overall Study|Withdrawal by Subject|7
7021631|NCT01567527|11097141|FG000|Conversion Phase.|Protocol deviation|3
7021632|NCT01567527|11097142|FG001|Conversion Phase.|Protocol deviation|0
7021633|NCT01567527|11097143|FG002|Conversion Phase.|Protocol deviation|0
7021634|NCT01567527|11097144|FG003|Conversion Phase.|Protocol deviation|0
7021635|NCT01567527|11097145|FG004|Conversion Phase.|Protocol deviation|0
7021636|NCT01567527|11097141|FG000|Conversion Phase.|Met withdrawal criteria|10
7021637|NCT01567527|11097142|FG001|Conversion Phase.|Met withdrawal criteria|0
7021638|NCT01567527|11097143|FG002|Conversion Phase.|Met withdrawal criteria|0
7021639|NCT01567527|11097144|FG003|Conversion Phase.|Met withdrawal criteria|0
7021640|NCT01567527|11097145|FG004|Conversion Phase.|Met withdrawal criteria|0
7021641|NCT01567527|11097141|FG000|Conversion Phase.|Withdrawal by Subject|32
7021642|NCT01567527|11097142|FG001|Conversion Phase.|Withdrawal by Subject|0
7021643|NCT01567527|11097143|FG002|Conversion Phase.|Withdrawal by Subject|0
7021644|NCT01567527|11097144|FG003|Conversion Phase.|Withdrawal by Subject|0
7021645|NCT01567527|11097145|FG004|Conversion Phase.|Withdrawal by Subject|0
7021646|NCT01567527|11097141|FG000|Conversion Phase.|Lost to Follow-up|16
7021647|NCT01567527|11097142|FG001|Conversion Phase.|Lost to Follow-up|0
7021648|NCT01567527|11097143|FG002|Conversion Phase.|Lost to Follow-up|0
7021649|NCT01567527|11097144|FG003|Conversion Phase.|Lost to Follow-up|0
7021650|NCT01567527|11097145|FG004|Conversion Phase.|Lost to Follow-up|0
7021651|NCT01567527|11097141|FG000|Conversion Phase.|Lack of Efficacy|2
7021652|NCT01567527|11097142|FG001|Conversion Phase.|Lack of Efficacy|0
7021653|NCT01567527|11097143|FG002|Conversion Phase.|Lack of Efficacy|0
7021654|NCT01567527|11097144|FG003|Conversion Phase.|Lack of Efficacy|0
7021655|NCT01567527|11097145|FG004|Conversion Phase.|Lack of Efficacy|0
7021656|NCT01567527|11097141|FG000|Conversion Phase.|Adverse Event|33
7021657|NCT01567527|11097142|FG001|Conversion Phase.|Adverse Event|0
7021658|NCT01567527|11097143|FG002|Conversion Phase.|Adverse Event|0
7021659|NCT01567527|11097144|FG003|Conversion Phase.|Adverse Event|0
7021660|NCT01567527|11097145|FG004|Conversion Phase.|Adverse Event|0
7021661|NCT01567527|11097141|FG000|Conversion Phase.|Withdrawn by the investigator|3
7021662|NCT01567527|11097142|FG001|Conversion Phase.|Withdrawn by the investigator|0
7021663|NCT01567527|11097143|FG002|Conversion Phase.|Withdrawn by the investigator|0
7021664|NCT01567527|11097144|FG003|Conversion Phase.|Withdrawn by the investigator|0
7021665|NCT01567527|11097145|FG004|Conversion Phase.|Withdrawn by the investigator|0
7021666|NCT01567527|11097141|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
7021667|NCT01567527|11097142|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41
7021668|NCT01567527|11097143|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
7021669|NCT01567527|11097144|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
7021670|NCT01567527|11097145|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
7021671|NCT01567527|11097141|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
7021672|NCT01567527|11097142|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45
7021673|NCT01567527|11097143|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
7021674|NCT01567527|11097144|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
7021675|NCT01567527|11097145|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
7021676|NCT01567527|11097141|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
7021677|NCT01567527|11097142|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44
7021678|NCT01567527|11097143|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
7021679|NCT01567527|11097144|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
7021680|NCT01567527|11097145|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
7021681|NCT01567527|11097141|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
7021682|NCT01567527|11097142|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12
7021683|NCT01567527|11097143|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
7021684|NCT01567527|11097144|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
7021685|NCT01567527|11097145|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
7021686|NCT01567527|11097141|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
7021687|NCT01567527|11097142|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63
7021688|NCT01567527|11097143|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
7021689|NCT01567527|11097144|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
7021690|NCT01567527|11097145|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
7021691|NCT01567527|11097141|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
7021692|NCT01567527|11097142|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2
7021693|NCT01567527|11097143|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
7021694|NCT01567527|11097144|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
7021695|NCT01567527|11097145|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
7021696|NCT01567527|11097141|FG000|IM Depot Stabilization.|Protocol deviation|0
7021697|NCT01567527|11097142|FG001|IM Depot Stabilization.|Protocol deviation|0
7021698|NCT01567527|11097143|FG002|IM Depot Stabilization.|Protocol deviation|5
7021699|NCT01567527|11097144|FG003|IM Depot Stabilization.|Protocol deviation|0
7021700|NCT01567527|11097145|FG004|IM Depot Stabilization.|Protocol deviation|0
7021701|NCT01567527|11097141|FG000|IM Depot Stabilization.|Met withdrawal criteria|0
7021702|NCT01567527|11097142|FG001|IM Depot Stabilization.|Met withdrawal criteria|0
7021703|NCT01567527|11097143|FG002|IM Depot Stabilization.|Met withdrawal criteria|26
7021704|NCT01567527|11097144|FG003|IM Depot Stabilization.|Met withdrawal criteria|0
7021705|NCT01567527|11097145|FG004|IM Depot Stabilization.|Met withdrawal criteria|0
7021706|NCT01567527|11097141|FG000|IM Depot Stabilization.|Withdrawal by Subject|0
7021707|NCT01567527|11097142|FG001|IM Depot Stabilization.|Withdrawal by Subject|0
7021708|NCT01567527|11097143|FG002|IM Depot Stabilization.|Withdrawal by Subject|56
7021709|NCT01567527|11097144|FG003|IM Depot Stabilization.|Withdrawal by Subject|0
7021710|NCT01567527|11097145|FG004|IM Depot Stabilization.|Withdrawal by Subject|0
7021711|NCT01567527|11097141|FG000|IM Depot Stabilization.|Sponsor discontinued study|0
7021712|NCT01567527|11097142|FG001|IM Depot Stabilization.|Sponsor discontinued study|0
7021713|NCT01567527|11097143|FG002|IM Depot Stabilization.|Sponsor discontinued study|1
7021714|NCT01567527|11097144|FG003|IM Depot Stabilization.|Sponsor discontinued study|0
7021715|NCT01567527|11097145|FG004|IM Depot Stabilization.|Sponsor discontinued study|0
7021716|NCT01567527|11097141|FG000|IM Depot Stabilization.|Lost to Follow-up|0
7021717|NCT01567527|11097142|FG001|IM Depot Stabilization.|Lost to Follow-up|0
7021718|NCT01567527|11097143|FG002|IM Depot Stabilization.|Lost to Follow-up|21
7021719|NCT01567527|11097144|FG003|IM Depot Stabilization.|Lost to Follow-up|0
7021720|NCT01567527|11097145|FG004|IM Depot Stabilization.|Lost to Follow-up|0
7021721|NCT01567527|11097141|FG000|IM Depot Stabilization.|Lack of Efficacy|0
7021722|NCT01567527|11097142|FG001|IM Depot Stabilization.|Lack of Efficacy|0
7021723|NCT01567527|11097143|FG002|IM Depot Stabilization.|Lack of Efficacy|7
7021724|NCT01567527|11097144|FG003|IM Depot Stabilization.|Lack of Efficacy|0
7021725|NCT01567527|11097145|FG004|IM Depot Stabilization.|Lack of Efficacy|0
7021726|NCT01567527|11097141|FG000|IM Depot Stabilization.|Adverse Event|0
7021727|NCT01567527|11097142|FG001|IM Depot Stabilization.|Adverse Event|0
7021728|NCT01567527|11097143|FG002|IM Depot Stabilization.|Adverse Event|37
7021729|NCT01567527|11097144|FG003|IM Depot Stabilization.|Adverse Event|0
7021730|NCT01567527|11097145|FG004|IM Depot Stabilization.|Adverse Event|0
7021731|NCT01567527|11097141|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0
7021732|NCT01567527|11097142|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0
7021733|NCT01567527|11097143|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6
7021734|NCT01567527|11097144|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0
7021735|NCT01567527|11097145|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0
7021736|NCT01567527|11097141|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0
7021737|NCT01567527|11097142|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0
7021738|NCT01567527|11097143|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0
7021739|NCT01567527|11097144|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1
7021740|NCT01567527|11097145|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1
7021741|NCT01567527|11097141|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
7021742|NCT01567527|11097142|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
7021743|NCT01567527|11097143|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
7021744|NCT01567527|11097144|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16
7021745|NCT01567527|11097145|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33
7021746|NCT01567527|11097141|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
7021747|NCT01567527|11097142|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
7044019|NCT01749800|11129434|FG001|Overall Study|Withdrawal by Subject|1
7021748|NCT01567527|11097143|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
7021749|NCT01567527|11097144|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4
7021750|NCT01567527|11097145|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7
7021751|NCT01567527|11097141|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
7021752|NCT01567527|11097142|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
7021753|NCT01567527|11097143|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
7021754|NCT01567527|11097144|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7
7021755|NCT01567527|11097145|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1
7021756|NCT01567527|11097141|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
7021757|NCT01567527|11097142|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
7021758|NCT01567527|11097143|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
7021759|NCT01567527|11097144|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13
7021760|NCT01567527|11097145|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10
7021761|NCT01567527|11097141|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
7021762|NCT01567527|11097142|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
7021763|NCT01567527|11097143|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
7021764|NCT01567527|11097144|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1
7021765|NCT01567527|11097145|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3
7021766|NCT01567527|11097141|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
7021767|NCT01567527|11097142|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
7021768|NCT01567527|11097143|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
7021769|NCT01567527|11097144|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19
7021770|NCT01567527|11097145|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35
7021771|NCT01567527|11097141|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7021772|NCT01567527|11097142|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7021773|NCT01567527|11097143|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7021774|NCT01567527|11097144|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8
7021775|NCT01567527|11097145|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5
7021776|NCT01567826|11097156|FG000|Overall Study|Lost to Follow-up|3
7021777|NCT01567826|11097157|FG001|Overall Study|Lost to Follow-up|2
7021778|NCT01567852|11097175|FG000|Overall Study|Withdrawal by Subject|3
7021779|NCT01567852|11097176|FG001|Overall Study|Withdrawal by Subject|6
7021780|NCT01567852|11097175|FG000|Overall Study|ECT discontinued|1
7021781|NCT01567852|11097176|FG001|Overall Study|ECT discontinued|1
7021782|NCT01567865|11097186|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0
7021783|NCT01567865|11097187|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1
7021784|NCT01567865|11097188|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3
7021785|NCT01567865|11097189|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2
7021786|NCT01567865|11097186|FG000|Evaluated for Immunogenicity|Missing blood sample|17
7021787|NCT01567865|11097187|FG001|Evaluated for Immunogenicity|Missing blood sample|24
7021788|NCT01567865|11097188|FG002|Evaluated for Immunogenicity|Missing blood sample|16
7021789|NCT01567865|11097189|FG003|Evaluated for Immunogenicity|Missing blood sample|28
7021790|NCT01568034|11097231|FG000|Overall Study|Withdrawal by Subject|1
7021791|NCT01568034|11097232|FG001|Overall Study|Withdrawal by Subject|0
7021792|NCT01568034|11097233|FG002|Overall Study|Withdrawal by Subject|0
7021793|NCT01568034|11097234|FG003|Overall Study|Withdrawal by Subject|0
7021794|NCT01568047|11097248|FG000|Overall Study|Ineligibility|1
7021795|NCT01568047|11097249|FG001|Overall Study|Ineligibility|0
7021796|NCT01568047|11097250|FG002|Overall Study|Ineligibility|0
7021797|NCT01568047|11097251|FG003|Overall Study|Ineligibility|0
7021798|NCT01568047|11097248|FG000|Overall Study|Withdrawal by Subject|0
7021799|NCT01568047|11097249|FG001|Overall Study|Withdrawal by Subject|1
7021800|NCT01568047|11097250|FG002|Overall Study|Withdrawal by Subject|0
7021801|NCT01568047|11097251|FG003|Overall Study|Withdrawal by Subject|0
7021802|NCT01568047|11097248|FG000|Overall Study|Adverse Event|0
7021803|NCT01568047|11097249|FG001|Overall Study|Adverse Event|0
7021804|NCT01568047|11097250|FG002|Overall Study|Adverse Event|1
7021805|NCT01568047|11097251|FG003|Overall Study|Adverse Event|1
7021806|NCT01568112|11097286|FG000|Overall Study|Randomized But Not Treated|0
7021807|NCT01568112|11097287|FG001|Overall Study|Randomized But Not Treated|1
7021808|NCT01568112|11097288|FG002|Overall Study|Randomized But Not Treated|0
7021809|NCT01568112|11097289|FG003|Overall Study|Randomized But Not Treated|0
7021810|NCT01568112|11097286|FG000|Overall Study|Withdrew due to Adverse Event|2
7021811|NCT01568112|11097287|FG001|Overall Study|Withdrew due to Adverse Event|4
7021812|NCT01568112|11097288|FG002|Overall Study|Withdrew due to Adverse Event|6
7021813|NCT01568112|11097289|FG003|Overall Study|Withdrew due to Adverse Event|3
7021814|NCT01568112|11097286|FG000|Overall Study|Lost to Follow-up|0
7021815|NCT01568112|11097287|FG001|Overall Study|Lost to Follow-up|0
7021816|NCT01568112|11097288|FG002|Overall Study|Lost to Follow-up|0
7021817|NCT01568112|11097289|FG003|Overall Study|Lost to Follow-up|1
7021818|NCT01568112|11097286|FG000|Overall Study|Withdrawal by Subject|2
7021819|NCT01568112|11097287|FG001|Overall Study|Withdrawal by Subject|3
7021820|NCT01568112|11097288|FG002|Overall Study|Withdrawal by Subject|0
7021821|NCT01568112|11097289|FG003|Overall Study|Withdrawal by Subject|7
7021822|NCT01568112|11097286|FG000|Overall Study|Withdrawal by Physician|1
7021823|NCT01568112|11097287|FG001|Overall Study|Withdrawal by Physician|0
7021824|NCT01568112|11097288|FG002|Overall Study|Withdrawal by Physician|1
7021825|NCT01568112|11097289|FG003|Overall Study|Withdrawal by Physician|1
7021826|NCT01568320|11097309|FG000|Overall Study|Death|20
7021827|NCT01568320|11097309|FG000|Overall Study|Lost to Follow-up|9
7021828|NCT01568320|11097309|FG000|Overall Study|Withdrawal by Subject|10
7021829|NCT01568320|11097309|FG000|Overall Study|Conversion to open repair|1
7021830|NCT01568320|11097309|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1
7021831|NCT01568593|11097332|FG000|Overall Study|Lack of Efficacy|4
7021832|NCT01568593|11097333|FG001|Overall Study|Lack of Efficacy|1
7021833|NCT01568593|11097332|FG000|Overall Study|Adverse Event|3
7021834|NCT01568593|11097333|FG001|Overall Study|Adverse Event|2
7021835|NCT01568866|11097354|FG000|Overall Study|Disease Progression|208
7021836|NCT01568866|11097355|FG001|Overall Study|Disease Progression|183
7021837|NCT01568866|11097354|FG000|Overall Study|Adverse Event|94
7021838|NCT01568866|11097355|FG001|Overall Study|Adverse Event|96
7021839|NCT01568866|11097354|FG000|Overall Study|Patient Request|55
7021840|NCT01568866|11097355|FG001|Overall Study|Patient Request|71
7021841|NCT01568866|11097354|FG000|Overall Study|Physician Decision|40
7021842|NCT01568866|11097355|FG001|Overall Study|Physician Decision|32
7021843|NCT01568866|11097354|FG000|Overall Study|Withdrawal by Subject|19
7021844|NCT01568866|11097355|FG001|Overall Study|Withdrawal by Subject|11
7021845|NCT01568866|11097354|FG000|Overall Study|Death|10
7021846|NCT01568866|11097355|FG001|Overall Study|Death|18
7021847|NCT01568866|11097354|FG000|Overall Study|Protocol Non-compliance|2
7021848|NCT01568866|11097355|FG001|Overall Study|Protocol Non-compliance|4
7021849|NCT01568866|11097354|FG000|Overall Study|Lost to Follow-up|1
7021850|NCT01568866|11097355|FG001|Overall Study|Lost to Follow-up|0
7021851|NCT01568866|11097354|FG000|Overall Study|Randomized but Not Dosed|9
7021852|NCT01568866|11097355|FG001|Overall Study|Randomized but Not Dosed|1
7021853|NCT01568892|11097363|FG000|Open-label Phase|Adverse Event|2
7021854|NCT01568892|11097364|FG001|Open-label Phase|Adverse Event|0
7021855|NCT01568892|11097363|FG000|Open-label Phase|Lack of Efficacy|4
7021856|NCT01568892|11097364|FG001|Open-label Phase|Lack of Efficacy|2
7021857|NCT01568892|11097363|FG000|Open-label Phase|Lost to Follow-up|0
7021858|NCT01568892|11097364|FG001|Open-label Phase|Lost to Follow-up|1
7021859|NCT01569022|11097393|FG000|First Intervention|Lost to Follow-up|2
7021860|NCT01569022|11097394|FG001|First Intervention|Lost to Follow-up|1
7021861|NCT01569022|11097393|FG000|Second Intervention|Lost to Follow-up|2
7021862|NCT01569022|11097394|FG001|Second Intervention|Lost to Follow-up|2
7021863|NCT01569074|11097407|FG000|Overall Study|Study stopped|6
7021864|NCT01569074|11097408|FG001|Overall Study|Study stopped|6
7021865|NCT01569074|11097409|FG002|Overall Study|Study stopped|8
7021866|NCT01569074|11097410|FG003|Overall Study|Study stopped|7
7021867|NCT01569074|11097411|FG004|Overall Study|Study stopped|7
7021868|NCT01569074|11097407|FG000|Overall Study|Study-specific discontinuation criteria|0
7021869|NCT01569074|11097408|FG001|Overall Study|Study-specific discontinuation criteria|1
7021870|NCT01569074|11097409|FG002|Overall Study|Study-specific discontinuation criteria|0
7021871|NCT01569074|11097410|FG003|Overall Study|Study-specific discontinuation criteria|0
7021872|NCT01569074|11097411|FG004|Overall Study|Study-specific discontinuation criteria|0
7021873|NCT01569074|11097407|FG000|Overall Study|Severe non-compliance to protocol|0
7021874|NCT01569074|11097408|FG001|Overall Study|Severe non-compliance to protocol|0
7021875|NCT01569074|11097409|FG002|Overall Study|Severe non-compliance to protocol|1
7021876|NCT01569074|11097410|FG003|Overall Study|Severe non-compliance to protocol|0
7021877|NCT01569074|11097411|FG004|Overall Study|Severe non-compliance to protocol|0
7021878|NCT01569074|11097407|FG000|Overall Study|eg change in circumstances|0
7021879|NCT01569074|11097408|FG001|Overall Study|eg change in circumstances|2
7021880|NCT01569074|11097409|FG002|Overall Study|eg change in circumstances|0
7021881|NCT01569074|11097410|FG003|Overall Study|eg change in circumstances|1
7021882|NCT01569074|11097411|FG004|Overall Study|eg change in circumstances|1
7021883|NCT01569074|11097407|FG000|Overall Study|Adverse Event|1
7021884|NCT01569074|11097408|FG001|Overall Study|Adverse Event|0
7021885|NCT01569074|11097409|FG002|Overall Study|Adverse Event|3
7021886|NCT01569074|11097410|FG003|Overall Study|Adverse Event|0
7021887|NCT01569074|11097411|FG004|Overall Study|Adverse Event|0
7021888|NCT01569152|11097472|FG000|Phase IIa, Period 1|Early Escape|5
7021889|NCT01569152|11097473|FG001|Phase IIa, Period 1|Early Escape|22
7021890|NCT01569152|11097474|FG002|Phase IIa, Period 1|Early Escape|0
7021891|NCT01569152|11097472|FG000|Phase IIa, Period 1|Adverse Event|4
7021892|NCT01569152|11097473|FG001|Phase IIa, Period 1|Adverse Event|0
7021893|NCT01569152|11097474|FG002|Phase IIa, Period 1|Adverse Event|0
7021894|NCT01569152|11097472|FG000|Phase IIa, Period 1|Lost to Follow-up|1
7021895|NCT01569152|11097473|FG001|Phase IIa, Period 1|Lost to Follow-up|0
7021896|NCT01569152|11097474|FG002|Phase IIa, Period 1|Lost to Follow-up|0
7021897|NCT01569152|11097472|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9
7021898|NCT01569152|11097473|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8
7021899|NCT01569152|11097474|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0
7021900|NCT01569152|11097472|FG000|Phase IIa, Period 1|Protocol Violation|0
7021901|NCT01569152|11097473|FG001|Phase IIa, Period 1|Protocol Violation|1
7021902|NCT01569152|11097474|FG002|Phase IIa, Period 1|Protocol Violation|0
7021903|NCT01569152|11097472|FG000|Phase IIa, Period 1|Withdrawal by Subject|2
7021904|NCT01569152|11097473|FG001|Phase IIa, Period 1|Withdrawal by Subject|1
7021905|NCT01569152|11097474|FG002|Phase IIa, Period 1|Withdrawal by Subject|0
7021906|NCT01569152|11097472|FG000|Safety Extension, Period 3|Adverse Event|0
7021907|NCT01569152|11097473|FG001|Safety Extension, Period 3|Adverse Event|0
7021908|NCT01569152|11097474|FG002|Safety Extension, Period 3|Adverse Event|4
7021909|NCT01569152|11097472|FG000|Safety Extension, Period 3|Withdrawal by Subject|0
7021910|NCT01569152|11097473|FG001|Safety Extension, Period 3|Withdrawal by Subject|0
7021911|NCT01569152|11097474|FG002|Safety Extension, Period 3|Withdrawal by Subject|2
7021912|NCT01569152|11097472|FG000|Safety Extension, Period 3|Physician Decision|0
7021913|NCT01569152|11097473|FG001|Safety Extension, Period 3|Physician Decision|0
7021914|NCT01569152|11097474|FG002|Safety Extension, Period 3|Physician Decision|2
7021915|NCT01569152|11097472|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0
7021916|NCT01569152|11097473|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0
7021917|NCT01569152|11097474|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47
7044020|NCT01749800|11129435|FG002|Overall Study|Withdrawal by Subject|0
7044021|NCT01749982|11129478|FG000|Overall Study|Physician Decision|0
7044022|NCT01749982|11129479|FG001|Overall Study|Physician Decision|0
7044023|NCT01749982|11129480|FG002|Overall Study|Physician Decision|0
7044024|NCT01749982|11129481|FG003|Overall Study|Physician Decision|1
7044025|NCT01749982|11129478|FG000|Overall Study|Lost to Follow-up|0
7044026|NCT01749982|11129479|FG001|Overall Study|Lost to Follow-up|0
7044027|NCT01749982|11129480|FG002|Overall Study|Lost to Follow-up|0
7044028|NCT01749982|11129481|FG003|Overall Study|Lost to Follow-up|1
7044029|NCT01749982|11129478|FG000|Overall Study|Withdrawal by Subject|0
7044030|NCT01749982|11129479|FG001|Overall Study|Withdrawal by Subject|0
7044031|NCT01749982|11129480|FG002|Overall Study|Withdrawal by Subject|0
7044032|NCT01749982|11129481|FG003|Overall Study|Withdrawal by Subject|1
7044033|NCT01750190|11129506|FG000|Overall Study|Adverse Event|47
7044034|NCT01750190|11129507|FG001|Overall Study|Adverse Event|19
7044035|NCT01750190|11129506|FG000|Overall Study|Death|38
7044036|NCT01750190|11129507|FG001|Overall Study|Death|11
7044037|NCT01750190|11129506|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2
7044038|NCT01750190|11129507|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43
7044039|NCT01750190|11129506|FG000|Overall Study|Lost to Follow-up|28
7044040|NCT01750190|11129507|FG001|Overall Study|Lost to Follow-up|7
7044041|NCT01750190|11129506|FG000|Overall Study|Physician Decision|16
7044042|NCT01750190|11129507|FG001|Overall Study|Physician Decision|17
7044043|NCT01750190|11129506|FG000|Overall Study|Protocol Violation|6
7044044|NCT01750190|11129507|FG001|Overall Study|Protocol Violation|5
7044045|NCT01750190|11129506|FG000|Overall Study|Study/Site Terminated by Sponsor|4
7044046|NCT01750190|11129507|FG001|Overall Study|Study/Site Terminated by Sponsor|1
7044047|NCT01750190|11129506|FG000|Overall Study|Withdrawal by Subject|83
7044048|NCT01750190|11129507|FG001|Overall Study|Withdrawal by Subject|89
7044049|NCT01750190|11129506|FG000|Overall Study|Kidney Transplant|8
7044050|NCT01750190|11129507|FG001|Overall Study|Kidney Transplant|4
7044051|NCT01750190|11129506|FG000|Overall Study|Dialysis|22
7044052|NCT01750190|11129507|FG001|Overall Study|Dialysis|8
7044053|NCT01750190|11129506|FG000|Overall Study|Other than Specified|13
7044054|NCT01750190|11129507|FG001|Overall Study|Other than Specified|4
7044055|NCT01750229|11129513|FG000|Randomized Crossover Phase|Adverse Event|1
7044056|NCT01750229|11129513|FG000|Randomized Crossover Phase|Withdrawal by Subject|1
7044057|NCT01750229|11129513|FG000|Long-term Follow-up Phase|Adverse Event|2
7044058|NCT01750229|11129513|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1
7044059|NCT01750242|11129523|FG000|Overall Study|Unreadable Images|3
7044060|NCT01750268|11129540|FG000|Overall Study|Lost to Follow-up|0
7044061|NCT01750268|11129541|FG001|Overall Study|Lost to Follow-up|2
7044062|NCT01750268|11129540|FG000|Overall Study|Physician Decision|0
7044063|NCT01750268|11129541|FG001|Overall Study|Physician Decision|3
7044064|NCT01750268|11129540|FG000|Overall Study|Withdrawal by Subject|2
7044065|NCT01750268|11129541|FG001|Overall Study|Withdrawal by Subject|0
7044066|NCT01750294|11129547|FG000|Overall Study|Withdrawal by Subject|1
7044067|NCT01750294|11129547|FG000|Overall Study|Safety Endpoint|1
7044068|NCT01750346|11129554|FG000|Overall Study|Adverse Event|1
7044069|NCT01750346|11129555|FG001|Overall Study|Adverse Event|0
7044070|NCT01750346|11129556|FG002|Overall Study|Adverse Event|0
7044071|NCT01750684|11129584|FG000|Overall Study|Death|1
7044072|NCT01750684|11129585|FG001|Overall Study|Death|0
7044073|NCT01750684|11129584|FG000|Overall Study|Non-compliance with Study Drug|0
7044074|NCT01750684|11129585|FG001|Overall Study|Non-compliance with Study Drug|1
7044075|NCT01750684|11129584|FG000|Overall Study|Withdrawn by Sponsor|0
7044076|NCT01750684|11129585|FG001|Overall Study|Withdrawn by Sponsor|1
7044077|NCT01750684|11129584|FG000|Overall Study|Protocol Violation|1
7044078|NCT01750684|11129585|FG001|Overall Study|Protocol Violation|0
7044079|NCT01750697|11129592|FG000|Overall Study|Transferred Back to Local Hospital|1
7044080|NCT01750697|11129592|FG000|Overall Study|Physician and Family Decision|1
7044081|NCT01750697|11129592|FG000|Overall Study|Transferred to Adult Services|5
7044082|NCT01750697|11129592|FG000|Overall Study|Physician Decision|1
7044083|NCT01750697|11129592|FG000|Overall Study|Withdrawal by Subject|1
7044084|NCT01750840|11129599|FG000|Overall Study|Lost to Follow-up|4
7044085|NCT01750879|11129606|FG000|Overall Study|Adverse Event|8
7021918|NCT01569295|11097496|FG000|Overall Study|Progressive Disease|75
7021919|NCT01569295|11097497|FG001|Overall Study|Progressive Disease|139
7021920|NCT01569295|11097496|FG000|Overall Study|Adverse Event|39
7021921|NCT01569295|11097497|FG001|Overall Study|Adverse Event|14
7021922|NCT01569295|11097496|FG000|Overall Study|Withdrawal by Subject|25
7021923|NCT01569295|11097497|FG001|Overall Study|Withdrawal by Subject|12
7021924|NCT01569295|11097496|FG000|Overall Study|Death|19
7021925|NCT01569295|11097497|FG001|Overall Study|Death|15
7021926|NCT01569295|11097496|FG000|Overall Study|Physician Decision|13
7021927|NCT01569295|11097497|FG001|Overall Study|Physician Decision|18
7021928|NCT01569295|11097496|FG000|Overall Study|Study Terminated by Sponsor|24
7021929|NCT01569295|11097497|FG001|Overall Study|Study Terminated by Sponsor|2
7021930|NCT01569295|11097496|FG000|Overall Study|Other Reason not Specified|3
7021931|NCT01569295|11097497|FG001|Overall Study|Other Reason not Specified|5
7021932|NCT01569295|11097496|FG000|Overall Study|Non-Compliance with Study Drug|6
7021933|NCT01569295|11097497|FG001|Overall Study|Non-Compliance with Study Drug|1
7021934|NCT01569295|11097496|FG000|Overall Study|Other Anticancer/Experimental Therapy|2
7021935|NCT01569295|11097497|FG001|Overall Study|Other Anticancer/Experimental Therapy|2
7021936|NCT01569295|11097496|FG000|Overall Study|Lost to Follow-up|1
7021937|NCT01569295|11097497|FG001|Overall Study|Lost to Follow-up|1
7021938|NCT01569438|11097506|FG000|Overall Study|Lack of Efficacy|1
7021939|NCT01569438|11097507|FG001|Overall Study|Lack of Efficacy|2
7021940|NCT01569438|11097506|FG000|Overall Study|Withdrawal by Subject|0
7021941|NCT01569438|11097507|FG001|Overall Study|Withdrawal by Subject|3
7021942|NCT01569438|11097506|FG000|Overall Study|Adverse Event|2
7021943|NCT01569438|11097507|FG001|Overall Study|Adverse Event|15
7021944|NCT01569438|11097506|FG000|Overall Study|Protocol Violation|2
7021945|NCT01569438|11097507|FG001|Overall Study|Protocol Violation|0
7021946|NCT01569438|11097506|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1
7021947|NCT01569438|11097507|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0
7021948|NCT01569438|11097506|FG000|Overall Study|Sponsor/Physician decision|1
7021949|NCT01569438|11097507|FG001|Overall Study|Sponsor/Physician decision|1
7021950|NCT01569438|11097506|FG000|Overall Study|Unable to adhere to study schedule|0
7021951|NCT01569438|11097507|FG001|Overall Study|Unable to adhere to study schedule|1
7021952|NCT01569464|11097526|FG000|Overall Study|Adverse Event|4
7021953|NCT01569464|11097527|FG001|Overall Study|Adverse Event|0
7021954|NCT01569464|11097526|FG000|Overall Study|Lack of Efficacy|1
7021955|NCT01569464|11097527|FG001|Overall Study|Lack of Efficacy|0
7021956|NCT01569464|11097526|FG000|Overall Study|Protocol Violation|1
7021957|NCT01569464|11097527|FG001|Overall Study|Protocol Violation|0
7021958|NCT01569464|11097526|FG000|Overall Study|Lost to Follow-up|2
7021959|NCT01569464|11097527|FG001|Overall Study|Lost to Follow-up|3
7021960|NCT01569464|11097526|FG000|Overall Study|Withdrawal by Subject|1
7021961|NCT01569464|11097527|FG001|Overall Study|Withdrawal by Subject|1
7021962|NCT01569464|11097526|FG000|Overall Study|Other|1
7021963|NCT01569464|11097527|FG001|Overall Study|Other|1
7021964|NCT01569568|11097546|FG000|Overall Study|Physician Decision|0
7021965|NCT01569568|11097547|FG001|Overall Study|Physician Decision|2
7021966|NCT01569594|11097553|FG000|Overall Study|Physician Decision|4
7021967|NCT01569594|11097553|FG000|Overall Study|Death|13
7021968|NCT01569594|11097553|FG000|Overall Study|Lost to Follow-up|22
7021969|NCT01569594|11097553|FG000|Overall Study|Adverse Event|2
7021970|NCT01569594|11097553|FG000|Overall Study|Withdrawal by Subject|13
7021971|NCT01569594|11097553|FG000|Overall Study|Other|4
7021972|NCT01569594|11097553|FG000|Overall Study|No ECM used|9
7021973|NCT01569763|11097572|FG000|Overall Study|Lack of Efficacy|2
7021974|NCT01569763|11097573|FG001|Overall Study|Lack of Efficacy|7
7021975|NCT01569763|11097572|FG000|Overall Study|Adverse Event|1
7021976|NCT01569763|11097573|FG001|Overall Study|Adverse Event|0
7021977|NCT01569841|11097607|FG000|Period A (6 Weeks)|Withdrawal by Subject|0
7021978|NCT01569841|11097608|FG001|Period A (6 Weeks)|Withdrawal by Subject|1
7021979|NCT01570192|11097627|FG000|Overall Study|no qualifying organism|6
7021980|NCT01570192|11097628|FG001|Overall Study|no qualifying organism|12
7021981|NCT01570192|11097627|FG000|Overall Study|changed to palliative care|1
7021982|NCT01570192|11097628|FG001|Overall Study|changed to palliative care|0
7021983|NCT01570192|11097627|FG000|Overall Study|Physician Decision|0
7021984|NCT01570192|11097628|FG001|Overall Study|Physician Decision|1
7021985|NCT01570244|11097639|FG000|Microgynon+Faldaprevir|Adverse Event|1
7021986|NCT01570283|11097648|FG000|Cohort 1: Dose Level 1|Death|0
7021987|NCT01570283|11097649|FG001|Cohort 1: Dose Level 1|Death|1
7021988|NCT01570283|11097650|FG002|Cohort 1: Dose Level 1|Death|0
7021989|NCT01570283|11097651|FG003|Cohort 1: Dose Level 1|Death|0
7021990|NCT01570283|11097652|FG004|Cohort 1: Dose Level 1|Death|0
7021991|NCT01570283|11097653|FG005|Cohort 1: Dose Level 1|Death|0
7021992|NCT01570283|11097648|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
7021993|NCT01570283|11097649|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1
7021994|NCT01570283|11097650|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
7021995|NCT01570283|11097651|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
7021996|NCT01570283|11097652|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
7021997|NCT01570283|11097653|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
7021998|NCT01570283|11097648|FG000|Cohort 2: Dose Level 2|Death|0
7021999|NCT01570283|11097649|FG001|Cohort 2: Dose Level 2|Death|0
7022000|NCT01570283|11097650|FG002|Cohort 2: Dose Level 2|Death|1
7022001|NCT01570283|11097651|FG003|Cohort 2: Dose Level 2|Death|0
7022002|NCT01570283|11097652|FG004|Cohort 2: Dose Level 2|Death|0
7022003|NCT01570283|11097653|FG005|Cohort 2: Dose Level 2|Death|0
7022004|NCT01570283|11097648|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
7022005|NCT01570283|11097649|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
7022006|NCT01570283|11097650|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
7022007|NCT01570283|11097651|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1
7022008|NCT01570283|11097652|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
7022009|NCT01570283|11097653|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
7022010|NCT01570283|11097648|FG000|Cohort 3: Dose Level 3|Death|0
7022011|NCT01570283|11097649|FG001|Cohort 3: Dose Level 3|Death|0
7022012|NCT01570283|11097650|FG002|Cohort 3: Dose Level 3|Death|0
7022013|NCT01570283|11097651|FG003|Cohort 3: Dose Level 3|Death|0
7022014|NCT01570283|11097652|FG004|Cohort 3: Dose Level 3|Death|0
7022015|NCT01570283|11097653|FG005|Cohort 3: Dose Level 3|Death|1
7022016|NCT01570283|11097648|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
7022017|NCT01570283|11097649|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
7022018|NCT01570283|11097650|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
7022019|NCT01570283|11097651|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
7022020|NCT01570283|11097652|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
7022021|NCT01570283|11097653|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1
7022022|NCT01570309|11097669|FG000|Overall Study|Withdrawal by Subject|3
7022023|NCT01570309|11097670|FG001|Overall Study|Withdrawal by Subject|3
7022024|NCT01570361|11097686|FG000|Overall Study|Subject discontinued|1
7022025|NCT01570361|11097687|FG001|Overall Study|Subject discontinued|2
7022026|NCT01570361|11097686|FG000|Overall Study|Sponsor closing the study|51
7022027|NCT01570361|11097687|FG001|Overall Study|Sponsor closing the study|50
7022028|NCT01570361|11097686|FG000|Overall Study|Subject excluded|5
7022029|NCT01570361|11097687|FG001|Overall Study|Subject excluded|3
7022030|NCT01570361|11097686|FG000|Overall Study|Subject withdrew consent|14
7022031|NCT01570361|11097687|FG001|Overall Study|Subject withdrew consent|9
7022032|NCT01570361|11097686|FG000|Overall Study|Adverse Event|2
7022033|NCT01570361|11097687|FG001|Overall Study|Adverse Event|1
7022034|NCT01570361|11097686|FG000|Overall Study|Lost to Follow-up|4
7022035|NCT01570361|11097687|FG001|Overall Study|Lost to Follow-up|4
7022036|NCT01570361|11097686|FG000|Overall Study|Death|5
7022037|NCT01570361|11097687|FG001|Overall Study|Death|4
7022038|NCT01570361|11097686|FG000|Overall Study|Other|0
7022039|NCT01570361|11097687|FG001|Overall Study|Other|2
7022040|NCT01570387|11097700|FG000|Overall Study|Adverse Event|1
7022041|NCT01570387|11097701|FG001|Overall Study|Adverse Event|0
7022042|NCT01570387|11097702|FG002|Overall Study|Adverse Event|0
7022043|NCT01570387|11097703|FG003|Overall Study|Adverse Event|0
7022044|NCT01570387|11097700|FG000|Overall Study|Death|0
7022045|NCT01570387|11097701|FG001|Overall Study|Death|0
7022046|NCT01570387|11097702|FG002|Overall Study|Death|0
7022047|NCT01570387|11097703|FG003|Overall Study|Death|1
7022048|NCT01570387|11097700|FG000|Overall Study|Withdrawal by Subject|0
7022049|NCT01570387|11097701|FG001|Overall Study|Withdrawal by Subject|0
7022050|NCT01570387|11097702|FG002|Overall Study|Withdrawal by Subject|0
7022051|NCT01570387|11097703|FG003|Overall Study|Withdrawal by Subject|1
7022052|NCT01570491|11097712|FG000|Overall Study|Lost to Follow-up|3
7022053|NCT01570491|11097713|FG001|Overall Study|Lost to Follow-up|1
7022054|NCT01570491|11097712|FG000|Overall Study|treatment: not given or discontinued|2
7022055|NCT01570491|11097713|FG001|Overall Study|treatment: not given or discontinued|0
7022056|NCT01570686|11097721|FG000|Overall Study|Abnormal test procedure result(s)|1
7022057|NCT01570686|11097722|FG001|Overall Study|Abnormal test procedure result(s)|1
7022058|NCT01570686|11097721|FG000|Overall Study|Administrative problems|0
7022059|NCT01570686|11097722|FG001|Overall Study|Administrative problems|1
7022060|NCT01570686|11097721|FG000|Overall Study|Adverse Event|8
7022061|NCT01570686|11097722|FG001|Overall Study|Adverse Event|6
7022062|NCT01570686|11097721|FG000|Overall Study|Lost to Follow-up|4
7022063|NCT01570686|11097722|FG001|Overall Study|Lost to Follow-up|3
7022064|NCT01570686|11097721|FG000|Overall Study|Protocol Deviation|3
7022065|NCT01570686|11097722|FG001|Overall Study|Protocol Deviation|0
7022066|NCT01570686|11097721|FG000|Overall Study|Withdrawal by Subject|4
7022067|NCT01570686|11097722|FG001|Overall Study|Withdrawal by Subject|4
7022068|NCT01570686|11097721|FG000|Overall Study|Unsatisfactory therapeutic effect|2
7022069|NCT01570686|11097722|FG001|Overall Study|Unsatisfactory therapeutic effect|1
7022070|NCT01570751|11097730|FG000|Period A (16 Weeks)|Protocol Violation|1
7022071|NCT01570751|11097731|FG001|Period A (16 Weeks)|Protocol Violation|1
7022072|NCT01570751|11097730|FG000|Period A (16 Weeks)|Withdrawal criteria|0
7022073|NCT01570751|11097731|FG001|Period A (16 Weeks)|Withdrawal criteria|1
7022074|NCT01570751|11097730|FG000|Period A (16 Weeks)|Unclassified|2
7022075|NCT01570751|11097731|FG001|Period A (16 Weeks)|Unclassified|3
7022076|NCT01570751|11097730|FG000|Period B (16 Weeks)|Adverse Event|1
7022077|NCT01570751|11097731|FG001|Period B (16 Weeks)|Adverse Event|0
7022078|NCT01570751|11097730|FG000|Period B (16 Weeks)|Protocol Violation|0
7022079|NCT01570751|11097731|FG001|Period B (16 Weeks)|Protocol Violation|1
7022080|NCT01570868|11097750|FG000|Overall Study|Adverse Event|8
7022081|NCT01570868|11097751|FG001|Overall Study|Adverse Event|1
7022082|NCT01570868|11097750|FG000|Overall Study|FDA Recommendation|23
7022083|NCT01570868|11097751|FG001|Overall Study|FDA Recommendation|3
7022084|NCT01570868|11097750|FG000|Overall Study|Physician Decision|10
7022085|NCT01570868|11097751|FG001|Overall Study|Physician Decision|4
7022086|NCT01570868|11097750|FG000|Overall Study|Lost to Follow-up|1
7022087|NCT01570868|11097751|FG001|Overall Study|Lost to Follow-up|0
7022088|NCT01570868|11097750|FG000|Overall Study|Withdrawal by Subject|1
7022089|NCT01570868|11097751|FG001|Overall Study|Withdrawal by Subject|0
7022090|NCT01571232|11097763|FG000|Overall Study|Lost to Follow-up|0
7022091|NCT01571232|11097764|FG001|Overall Study|Lost to Follow-up|1
7022092|NCT01571232|11097763|FG000|Overall Study|Withdrawal by Subject|1
7022093|NCT01571232|11097764|FG001|Overall Study|Withdrawal by Subject|0
7022094|NCT01571284|11097771|FG000|Overall Study|Participant's decision|84
7022095|NCT01571284|11097771|FG000|Overall Study|Lost to Follow-up|3
7022096|NCT01571284|11097771|FG000|Overall Study|Enrolled but not treated|2
7022097|NCT01571284|11097771|FG000|Overall Study|Other than specified above|80
7022098|NCT01571362|11097775|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11
7022099|NCT01571362|11097776|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
7022100|NCT01571362|11097777|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
7022101|NCT01571362|11097775|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7
7022102|NCT01571362|11097776|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0
7022103|NCT01571362|11097777|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0
7022104|NCT01571362|11097775|FG000|Open-Label Conversion + Titration Period|Adverse Event|57
7022105|NCT01571362|11097776|FG001|Open-Label Conversion + Titration Period|Adverse Event|0
7022106|NCT01571362|11097777|FG002|Open-Label Conversion + Titration Period|Adverse Event|0
7022107|NCT01571362|11097775|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10
7022108|NCT01571362|11097776|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0
7022109|NCT01571362|11097777|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0
7022110|NCT01571362|11097775|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41
7022111|NCT01571362|11097776|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
7022112|NCT01571362|11097777|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
7022113|NCT01571362|11097775|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3
7022114|NCT01571362|11097776|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0
7022115|NCT01571362|11097777|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0
7022116|NCT01571362|11097775|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
7022117|NCT01571362|11097776|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11
7022118|NCT01571362|11097777|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5
7022119|NCT01571362|11097775|FG000|Double-Blind Treatment Period|Protocol Violation|0
7022120|NCT01571362|11097776|FG001|Double-Blind Treatment Period|Protocol Violation|8
7022121|NCT01571362|11097777|FG002|Double-Blind Treatment Period|Protocol Violation|9
7022122|NCT01571362|11097775|FG000|Double-Blind Treatment Period|Adverse Event|0
7022123|NCT01571362|11097776|FG001|Double-Blind Treatment Period|Adverse Event|9
7022124|NCT01571362|11097777|FG002|Double-Blind Treatment Period|Adverse Event|14
7022125|NCT01571362|11097775|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
7022126|NCT01571362|11097776|FG001|Double-Blind Treatment Period|Lost to Follow-up|3
7022127|NCT01571362|11097777|FG002|Double-Blind Treatment Period|Lost to Follow-up|6
7022128|NCT01571362|11097775|FG000|Double-Blind Treatment Period|Insufficient clinical response|0
7022129|NCT01571362|11097776|FG001|Double-Blind Treatment Period|Insufficient clinical response|16
7022130|NCT01571362|11097777|FG002|Double-Blind Treatment Period|Insufficient clinical response|4
7022131|NCT01571362|11097775|FG000|Double-Blind Treatment Period|Other - unspecified|0
7022132|NCT01571362|11097776|FG001|Double-Blind Treatment Period|Other - unspecified|6
7022133|NCT01571362|11097777|FG002|Double-Blind Treatment Period|Other - unspecified|1
7022134|NCT01571453|11097796|FG000|Overall Study|Adverse Event|14
7022135|NCT01571453|11097797|FG001|Overall Study|Adverse Event|32
7022136|NCT01571453|11097796|FG000|Overall Study|Lack of Efficacy|8
7022137|NCT01571453|11097797|FG001|Overall Study|Lack of Efficacy|3
7022138|NCT01571453|11097796|FG000|Overall Study|Non-compliance|2
7022139|NCT01571453|11097797|FG001|Overall Study|Non-compliance|4
7022140|NCT01571453|11097796|FG000|Overall Study|Protocol Violation|1
7022141|NCT01571453|11097797|FG001|Overall Study|Protocol Violation|5
7022142|NCT01571453|11097796|FG000|Overall Study|Withdrawal of consent|5
7022143|NCT01571453|11097797|FG001|Overall Study|Withdrawal of consent|13
7022144|NCT01571453|11097796|FG000|Overall Study|Lost to Follow-up|4
7022145|NCT01571453|11097797|FG001|Overall Study|Lost to Follow-up|2
7022146|NCT01571453|11097796|FG000|Overall Study|Administrative or other reason(s)|4
7022147|NCT01571453|11097797|FG001|Overall Study|Administrative or other reason(s)|3
7022148|NCT01571596|11097810|FG000|Overall Study|Adverse Event|2
7022149|NCT01571596|11097811|FG001|Overall Study|Adverse Event|0
7022150|NCT01571596|11097812|FG002|Overall Study|Adverse Event|0
7022151|NCT01571596|11097810|FG000|Overall Study|Study Terminated by the Sponsor|0
7022152|NCT01571596|11097811|FG001|Overall Study|Study Terminated by the Sponsor|1
7022153|NCT01571596|11097812|FG002|Overall Study|Study Terminated by the Sponsor|1
7022154|NCT01572038|11097822|FG000|Overall Study|Death|648
7022155|NCT01572038|11097822|FG000|Overall Study|Withdrawal by Subject|204
7022156|NCT01572038|11097822|FG000|Overall Study|Lost to Follow-up|81
7022157|NCT01572038|11097822|FG000|Overall Study|Physician Decision|20
7022158|NCT01572038|11097822|FG000|Overall Study|Patient Decision|14
7022159|NCT01572038|11097822|FG000|Overall Study|Progressive Disease|8
7022160|NCT01572038|11097822|FG000|Overall Study|Site Closed Before Completing Form|6
7022161|NCT01572038|11097822|FG000|Overall Study|Enrolled into Another Trial|3
7022162|NCT01572038|11097822|FG000|Overall Study|Participated in Another Trial|3
7022163|NCT01572038|11097822|FG000|Overall Study|Termination by Sponsor|2
7022164|NCT01572038|11097822|FG000|Overall Study|Patient Deterioration|1
7022165|NCT01572038|11097822|FG000|Overall Study|Sponsor Decision|1
7022166|NCT01572389|11097861|FG000|Overall Study|Death|1
7022167|NCT01572389|11097862|FG001|Overall Study|Death|3
7022168|NCT01572389|11097861|FG000|Overall Study|Withdrawal by Subject|14
7022169|NCT01572389|11097862|FG001|Overall Study|Withdrawal by Subject|2
7022170|NCT01572389|11097861|FG000|Overall Study|Lost to Follow-up|25
7022171|NCT01572389|11097862|FG001|Overall Study|Lost to Follow-up|14
7022172|NCT01572389|11097861|FG000|Overall Study|Only A1C or Assessment was Collected|6
7022173|NCT01572389|11097862|FG001|Overall Study|Only A1C or Assessment was Collected|2
7022174|NCT01572727|11097879|FG000|Overall Study|Adverse Event|43
7022175|NCT01572727|11097880|FG001|Overall Study|Adverse Event|15
7022176|NCT01572727|11097879|FG000|Overall Study|Lost to Follow-up|1
7022177|NCT01572727|11097880|FG001|Overall Study|Lost to Follow-up|1
7022178|NCT01572727|11097879|FG000|Overall Study|Physician Decision|23
7022179|NCT01572727|11097880|FG001|Overall Study|Physician Decision|9
7022180|NCT01572727|11097879|FG000|Overall Study|Progressive disease|59
7022181|NCT01572727|11097880|FG001|Overall Study|Progressive disease|82
7022182|NCT01572727|11097879|FG000|Overall Study|Protocol Violation|0
7022183|NCT01572727|11097880|FG001|Overall Study|Protocol Violation|1
7022184|NCT01572727|11097879|FG000|Overall Study|Study terminated by sponsor|61
7022185|NCT01572727|11097880|FG001|Overall Study|Study terminated by sponsor|83
7022186|NCT01572727|11097879|FG000|Overall Study|Parent/guardian decision|14
7022187|NCT01572727|11097880|FG001|Overall Study|Parent/guardian decision|9
7022188|NCT01572727|11097879|FG000|Overall Study|Death|2
7022189|NCT01572727|11097880|FG001|Overall Study|Death|2
7022190|NCT01572727|11097879|FG000|Overall Study|Untreated|4
7022191|NCT01572727|11097880|FG001|Overall Study|Untreated|7
7022192|NCT01572740|11097888|FG000|Overall Study|Adverse Event|1
7022193|NCT01572740|11097889|FG001|Overall Study|Adverse Event|1
7022194|NCT01572740|11097888|FG000|Overall Study|Withdrawal by Subject|1
7022195|NCT01572740|11097889|FG001|Overall Study|Withdrawal by Subject|1
7022196|NCT01572740|11097888|FG000|Overall Study|unclassified|4
7022197|NCT01572740|11097889|FG001|Overall Study|unclassified|3
7022198|NCT01572792|11097900|FG000|Lead-in Study|Lost to Follow-up|5
7022199|NCT01572792|11097901|FG001|Lead-in Study|Lost to Follow-up|9
7022200|NCT01572792|11097902|FG002|Lead-in Study|Lost to Follow-up|4
7022201|NCT01572792|11097903|FG003|Lead-in Study|Lost to Follow-up|2
7022202|NCT01572792|11097904|FG004|Lead-in Study|Lost to Follow-up|4
7022203|NCT01572792|11097900|FG000|Lead-in Study|Withdrawal by Subject|22
7022204|NCT01572792|11097901|FG001|Lead-in Study|Withdrawal by Subject|11
7022205|NCT01572792|11097902|FG002|Lead-in Study|Withdrawal by Subject|12
7022206|NCT01572792|11097903|FG003|Lead-in Study|Withdrawal by Subject|24
7022207|NCT01572792|11097904|FG004|Lead-in Study|Withdrawal by Subject|11
7022208|NCT01572792|11097900|FG000|Lead-in Study|Protocol Violation|19
7022209|NCT01572792|11097901|FG001|Lead-in Study|Protocol Violation|10
7022210|NCT01572792|11097902|FG002|Lead-in Study|Protocol Violation|12
7022211|NCT01572792|11097903|FG003|Lead-in Study|Protocol Violation|13
7022212|NCT01572792|11097904|FG004|Lead-in Study|Protocol Violation|21
7022213|NCT01572792|11097900|FG000|Lead-in Study|Lack of Efficacy|20
7022214|NCT01572792|11097901|FG001|Lead-in Study|Lack of Efficacy|5
7022215|NCT01572792|11097902|FG002|Lead-in Study|Lack of Efficacy|4
7022216|NCT01572792|11097903|FG003|Lead-in Study|Lack of Efficacy|8
7022217|NCT01572792|11097904|FG004|Lead-in Study|Lack of Efficacy|10
7022218|NCT01572792|11097900|FG000|Lead-in Study|Adverse Event|21
7022219|NCT01572792|11097901|FG001|Lead-in Study|Adverse Event|21
7022220|NCT01572792|11097902|FG002|Lead-in Study|Adverse Event|22
7022221|NCT01572792|11097903|FG003|Lead-in Study|Adverse Event|16
7022222|NCT01572792|11097904|FG004|Lead-in Study|Adverse Event|14
7022223|NCT01572792|11097900|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14
7022224|NCT01572792|11097901|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10
7022225|NCT01572792|11097902|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8
7022226|NCT01572792|11097903|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9
7060541|NCT01920061|11156841|FG004|Overall Study|Lost to Follow-up|0
7022227|NCT01572792|11097904|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9
7022228|NCT01572792|11097900|FG000|Extension Study|Lost to Follow-up|6
7022229|NCT01572792|11097901|FG001|Extension Study|Lost to Follow-up|2
7022230|NCT01572792|11097902|FG002|Extension Study|Lost to Follow-up|0
7022231|NCT01572792|11097903|FG003|Extension Study|Lost to Follow-up|3
7022232|NCT01572792|11097904|FG004|Extension Study|Lost to Follow-up|3
7022233|NCT01572792|11097900|FG000|Extension Study|Withdrawal by Subject|7
7022234|NCT01572792|11097901|FG001|Extension Study|Withdrawal by Subject|6
7022235|NCT01572792|11097902|FG002|Extension Study|Withdrawal by Subject|11
7022236|NCT01572792|11097903|FG003|Extension Study|Withdrawal by Subject|8
7022237|NCT01572792|11097904|FG004|Extension Study|Withdrawal by Subject|14
7022238|NCT01572792|11097900|FG000|Extension Study|Protocol Violation|0
7022239|NCT01572792|11097901|FG001|Extension Study|Protocol Violation|4
7022240|NCT01572792|11097902|FG002|Extension Study|Protocol Violation|3
7022241|NCT01572792|11097903|FG003|Extension Study|Protocol Violation|4
7022242|NCT01572792|11097904|FG004|Extension Study|Protocol Violation|3
7022243|NCT01572792|11097900|FG000|Extension Study|Lack of Efficacy|2
7022244|NCT01572792|11097901|FG001|Extension Study|Lack of Efficacy|3
7022245|NCT01572792|11097902|FG002|Extension Study|Lack of Efficacy|3
7022246|NCT01572792|11097903|FG003|Extension Study|Lack of Efficacy|2
7022247|NCT01572792|11097904|FG004|Extension Study|Lack of Efficacy|2
7022248|NCT01572792|11097900|FG000|Extension Study|Adverse Event|7
7022249|NCT01572792|11097901|FG001|Extension Study|Adverse Event|6
7022250|NCT01572792|11097902|FG002|Extension Study|Adverse Event|5
7022251|NCT01572792|11097903|FG003|Extension Study|Adverse Event|6
7022252|NCT01572792|11097904|FG004|Extension Study|Adverse Event|4
7022253|NCT01572792|11097900|FG000|Extension Study|Site termination/COPD exacerbation/other|3
7022254|NCT01572792|11097901|FG001|Extension Study|Site termination/COPD exacerbation/other|8
7022255|NCT01572792|11097902|FG002|Extension Study|Site termination/COPD exacerbation/other|4
7022256|NCT01572792|11097903|FG003|Extension Study|Site termination/COPD exacerbation/other|6
7022257|NCT01572792|11097904|FG004|Extension Study|Site termination/COPD exacerbation/other|6
7022258|NCT01572844|11097917|FG000|Overall Study|Physician Decision|1
7022259|NCT01572844|11097918|FG001|Overall Study|Physician Decision|1
7022260|NCT01572909|11097929|FG000|Overall Study|Adverse Event|7
7022261|NCT01572909|11097930|FG001|Overall Study|Adverse Event|2
7022262|NCT01572909|11097929|FG000|Overall Study|Death|3
7022263|NCT01572909|11097930|FG001|Overall Study|Death|1
7022264|NCT01572909|11097929|FG000|Overall Study|Lost to Follow-up|8
7022265|NCT01572909|11097930|FG001|Overall Study|Lost to Follow-up|7
7022266|NCT01572909|11097929|FG000|Overall Study|Physician Decision|1
7022267|NCT01572909|11097930|FG001|Overall Study|Physician Decision|1
7022268|NCT01572909|11097929|FG000|Overall Study|Technical Issues|1
7022269|NCT01572909|11097930|FG001|Overall Study|Technical Issues|0
7022270|NCT01572909|11097929|FG000|Overall Study|Withdrawal by Subject|12
7022271|NCT01572909|11097930|FG001|Overall Study|Withdrawal by Subject|11
7022272|NCT01572909|11097929|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0
7022273|NCT01572909|11097930|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3
7022274|NCT01572922|11097938|FG000|Overall Study|Adverse Event|1
7022275|NCT01572922|11097938|FG000|Overall Study|Protocol Violation|1
7022276|NCT01572922|11097938|FG000|Overall Study|Death|1
7022277|NCT01572948|11097949|FG000|Overall Study|Lost to Follow-up|1
7022278|NCT01572948|11097950|FG001|Overall Study|Lost to Follow-up|0
7022279|NCT01572948|11097949|FG000|Overall Study|unable to contact|0
7022280|NCT01572948|11097950|FG001|Overall Study|unable to contact|1
7022281|NCT01573000|11097962|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27
7022282|NCT01573000|11097963|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32
7022283|NCT01573000|11097962|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4
7022284|NCT01573000|11097963|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
7022285|NCT01573000|11097962|FG000|Dosimetric and Therapeutic Treatment|Death|0
7022286|NCT01573000|11097963|FG001|Dosimetric and Therapeutic Treatment|Death|1
7022287|NCT01573000|11097962|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2
7022288|NCT01573000|11097963|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0
7022289|NCT01573000|11097962|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2
7022290|NCT01573000|11097963|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0
7022291|NCT01573000|11097962|FG000|Crossover Phase|Lack of Efficacy|0
7022292|NCT01573000|11097963|FG001|Crossover Phase|Lack of Efficacy|13
7022293|NCT01573000|11097962|FG000|Crossover Phase|Lost to Follow-up|0
7022294|NCT01573000|11097963|FG001|Crossover Phase|Lost to Follow-up|2
7022295|NCT01573000|11097962|FG000|Crossover Phase|Death|0
7022296|NCT01573000|11097963|FG001|Crossover Phase|Death|3
7022297|NCT01573000|11097962|FG000|Long-Term Follow-Up|Death|3
7022298|NCT01573000|11097963|FG001|Long-Term Follow-Up|Death|0
7022299|NCT01573000|11097962|FG000|Long-Term Follow-Up|Lost to Follow-up|0
7022300|NCT01573000|11097963|FG001|Long-Term Follow-Up|Lost to Follow-up|1
7022301|NCT01573442|11098051|FG000|Overall Study|Cancels|9
7022302|NCT01573442|11098052|FG001|Overall Study|Cancels|10
7022303|NCT01573624|11098066|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
7022304|NCT01573624|11098067|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
7022305|NCT01573624|11098068|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
7022306|NCT01573624|11098069|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
7143170|NCT03028129|11299595|FG000|Overall Study|Lost to Follow-up|50
7143171|NCT03028129|11299596|FG001|Overall Study|Lost to Follow-up|38
7143172|NCT03028129|11299595|FG000|Overall Study|Physician Decision|0
7143173|NCT03028129|11299596|FG001|Overall Study|Physician Decision|1
7143174|NCT03028129|11299595|FG000|Overall Study|Protocol Violation|1
7143175|NCT03028129|11299596|FG001|Overall Study|Protocol Violation|1
7022307|NCT01573624|11098070|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
7022308|NCT01573624|11098071|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
7022309|NCT01573624|11098072|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
7022310|NCT01573624|11098066|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4
7022311|NCT01573624|11098067|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3
7022312|NCT01573624|11098068|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6
7022313|NCT01573624|11098069|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
7022314|NCT01573624|11098070|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2
7022315|NCT01573624|11098071|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0
7143176|NCT03028129|11299595|FG000|Overall Study|Withdrawal by Subject|62
7022316|NCT01573624|11098072|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
7022317|NCT01573624|11098066|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1
7022318|NCT01573624|11098067|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
7022319|NCT01573624|11098068|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
7022320|NCT01573624|11098069|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
7022321|NCT01573624|11098070|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
7022322|NCT01573624|11098071|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
7022323|NCT01573624|11098072|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
7022324|NCT01573624|11098066|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
7022325|NCT01573624|11098067|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7022326|NCT01573624|11098068|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
7022327|NCT01573624|11098069|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7022328|NCT01573624|11098070|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7022329|NCT01573624|11098071|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2
7022330|NCT01573624|11098072|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7022331|NCT01573624|11098066|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
7022332|NCT01573624|11098067|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
7022333|NCT01573624|11098068|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
7022334|NCT01573624|11098069|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
7022335|NCT01573624|11098070|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
7022336|NCT01573624|11098071|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
7022337|NCT01573624|11098072|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
7022338|NCT01573624|11098066|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
7022339|NCT01573624|11098067|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
7022340|NCT01573624|11098068|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
7022341|NCT01573624|11098069|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
7022342|NCT01573624|11098070|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
7022343|NCT01573624|11098071|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1
7022344|NCT01573624|11098072|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
7022345|NCT01573624|11098066|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
7022346|NCT01573624|11098067|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
7022347|NCT01573624|11098068|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
7022348|NCT01573624|11098069|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
7022349|NCT01573624|11098070|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
7022350|NCT01573624|11098071|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
7022351|NCT01573624|11098072|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
7022352|NCT01573624|11098066|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
7022353|NCT01573624|11098067|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
7022354|NCT01573624|11098068|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2
7022355|NCT01573624|11098069|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
7022356|NCT01573624|11098070|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
7022357|NCT01573624|11098071|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
7022358|NCT01573624|11098072|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
7022359|NCT01573624|11098066|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
7022360|NCT01573624|11098067|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
7022361|NCT01573624|11098068|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
7022362|NCT01573624|11098069|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
7022363|NCT01573624|11098070|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
7022364|NCT01573624|11098071|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1
7022365|NCT01573624|11098072|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
7022366|NCT01573624|11098066|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
7022367|NCT01573624|11098067|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
7022368|NCT01573624|11098068|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
7022369|NCT01573624|11098069|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2
7022370|NCT01573624|11098070|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
7022371|NCT01573624|11098071|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
7022372|NCT01573624|11098072|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
7022373|NCT01573624|11098066|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
7022374|NCT01573624|11098067|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
7022375|NCT01573624|11098068|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
7022376|NCT01573624|11098069|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
7022377|NCT01573624|11098070|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
7022378|NCT01573624|11098071|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
7022379|NCT01573624|11098072|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
7022380|NCT01573624|11098066|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5
7022381|NCT01573624|11098067|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4
7022382|NCT01573624|11098068|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
7022383|NCT01573624|11098069|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1
7022384|NCT01573624|11098070|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3
7022385|NCT01573624|11098071|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
7022386|NCT01573624|11098072|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0
7022387|NCT01573624|11098066|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
7022388|NCT01573624|11098067|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1
7022389|NCT01573624|11098068|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
7022390|NCT01573624|11098069|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
7022391|NCT01573624|11098070|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
7022392|NCT01573624|11098071|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2
7022393|NCT01573624|11098072|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
7022394|NCT01573624|11098066|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1
7022395|NCT01573624|11098067|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
7022396|NCT01573624|11098068|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
7022397|NCT01573624|11098069|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
7022398|NCT01573624|11098070|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
7022399|NCT01573624|11098071|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
7022400|NCT01573624|11098072|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
7022401|NCT01573624|11098066|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
7022402|NCT01573624|11098067|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
7022403|NCT01573624|11098068|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
7022404|NCT01573624|11098069|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
7022405|NCT01573624|11098070|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
7022406|NCT01573624|11098071|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
7022407|NCT01573624|11098072|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
7022408|NCT01573624|11098066|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1
7022409|NCT01573624|11098067|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
7022410|NCT01573624|11098068|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
7022411|NCT01573624|11098069|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
7022412|NCT01573624|11098070|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
7022413|NCT01573624|11098071|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
7022414|NCT01573624|11098072|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
7022415|NCT01573624|11098066|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
7022416|NCT01573624|11098067|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
7022417|NCT01573624|11098068|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
7022418|NCT01573624|11098069|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
7022419|NCT01573624|11098070|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
7022420|NCT01573624|11098071|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
7022421|NCT01573624|11098072|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
7022422|NCT01573624|11098066|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
7022423|NCT01573624|11098067|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
7022424|NCT01573624|11098068|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
7022425|NCT01573624|11098069|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
7022426|NCT01573624|11098070|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
7022427|NCT01573624|11098071|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
7022428|NCT01573624|11098072|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
7022429|NCT01573624|11098066|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
7022430|NCT01573624|11098067|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1
7022431|NCT01573624|11098068|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
7022432|NCT01573624|11098069|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
7022433|NCT01573624|11098070|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
7022434|NCT01573624|11098071|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
7022435|NCT01573624|11098072|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
7022436|NCT01573624|11098066|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
7022437|NCT01573624|11098067|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1
7022438|NCT01573624|11098068|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
7022439|NCT01573624|11098069|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
7022440|NCT01573624|11098070|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
7022441|NCT01573624|11098071|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
7022442|NCT01573624|11098072|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
7022443|NCT01573624|11098066|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7022444|NCT01573624|11098067|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7022445|NCT01573624|11098068|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7022446|NCT01573624|11098069|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7022447|NCT01573624|11098070|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7022448|NCT01573624|11098071|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
7022449|NCT01573624|11098072|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
7022450|NCT01573624|11098066|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
7022451|NCT01573624|11098067|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
7022452|NCT01573624|11098068|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
7022453|NCT01573624|11098069|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
7022454|NCT01573624|11098070|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
7022455|NCT01573624|11098071|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
7022456|NCT01573624|11098072|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
7022457|NCT01573624|11098066|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2
7022458|NCT01573624|11098067|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
7022459|NCT01573624|11098068|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
7022460|NCT01573624|11098069|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
7022461|NCT01573624|11098070|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
7022462|NCT01573624|11098071|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
7022463|NCT01573624|11098072|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4
7022464|NCT01573624|11098066|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
7022465|NCT01573624|11098067|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
7022466|NCT01573624|11098068|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
7022467|NCT01573624|11098069|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
7022468|NCT01573624|11098070|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
7022469|NCT01573624|11098071|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
7022470|NCT01573624|11098072|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
7022471|NCT01573624|11098066|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1
7022472|NCT01573624|11098067|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
7022473|NCT01573624|11098068|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
7022474|NCT01573624|11098069|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
7022475|NCT01573624|11098070|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
7022476|NCT01573624|11098071|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
7022477|NCT01573624|11098072|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
7022478|NCT01573624|11098066|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
7022479|NCT01573624|11098067|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
7022480|NCT01573624|11098068|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
7022481|NCT01573624|11098069|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
7022482|NCT01573624|11098070|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2
7022483|NCT01573624|11098071|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1
7022484|NCT01573624|11098072|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
7022485|NCT01573624|11098066|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1
7022486|NCT01573624|11098067|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
7022487|NCT01573624|11098068|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
7022488|NCT01573624|11098069|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
7022489|NCT01573624|11098070|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
7022490|NCT01573624|11098071|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
7022491|NCT01573624|11098072|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
7022492|NCT01573767|11098103|FG000|Overall Study|Adverse Event|0
7022493|NCT01573767|11098104|FG001|Overall Study|Adverse Event|1
7022494|NCT01573767|11098105|FG002|Overall Study|Adverse Event|0
7022495|NCT01573767|11098106|FG003|Overall Study|Adverse Event|1
7022496|NCT01573767|11098103|FG000|Overall Study|Lack of Efficacy|18
7022497|NCT01573767|11098104|FG001|Overall Study|Lack of Efficacy|15
7022498|NCT01573767|11098105|FG002|Overall Study|Lack of Efficacy|12
7022499|NCT01573767|11098106|FG003|Overall Study|Lack of Efficacy|17
7022500|NCT01573767|11098103|FG000|Overall Study|Protocol Violation|3
7022501|NCT01573767|11098104|FG001|Overall Study|Protocol Violation|1
7022502|NCT01573767|11098105|FG002|Overall Study|Protocol Violation|1
7022503|NCT01573767|11098106|FG003|Overall Study|Protocol Violation|3
7022504|NCT01573767|11098103|FG000|Overall Study|Lost to Follow-up|0
7022505|NCT01573767|11098104|FG001|Overall Study|Lost to Follow-up|1
7022506|NCT01573767|11098105|FG002|Overall Study|Lost to Follow-up|1
7022507|NCT01573767|11098106|FG003|Overall Study|Lost to Follow-up|1
7022508|NCT01573767|11098103|FG000|Overall Study|Physician Decision|1
7022509|NCT01573767|11098104|FG001|Overall Study|Physician Decision|2
7022510|NCT01573767|11098105|FG002|Overall Study|Physician Decision|0
7022511|NCT01573767|11098106|FG003|Overall Study|Physician Decision|2
7022512|NCT01573767|11098103|FG000|Overall Study|Withdrawal by Subject|0
7022513|NCT01573767|11098104|FG001|Overall Study|Withdrawal by Subject|1
7022514|NCT01573767|11098105|FG002|Overall Study|Withdrawal by Subject|0
7022515|NCT01573767|11098106|FG003|Overall Study|Withdrawal by Subject|0
7022516|NCT01573910|11098118|FG000|Overall Study|Adverse Event|4
7022517|NCT01573910|11098119|FG001|Overall Study|Adverse Event|4
7022518|NCT01573910|11098118|FG000|Overall Study|Lost to Follow-up|2
7022519|NCT01573910|11098119|FG001|Overall Study|Lost to Follow-up|1
7022520|NCT01573910|11098118|FG000|Overall Study|Withdrawal by Subject|0
7022521|NCT01573910|11098119|FG001|Overall Study|Withdrawal by Subject|1
7022522|NCT01573910|11098118|FG000|Overall Study|Protocol Violation|3
7022523|NCT01573910|11098119|FG001|Overall Study|Protocol Violation|0
7022524|NCT01573910|11098118|FG000|Overall Study|Patient decision unrelated to Advs Event|11
7022525|NCT01573910|11098119|FG001|Overall Study|Patient decision unrelated to Advs Event|11
7022526|NCT01574079|11098131|FG000|Overall Study|Physician Decision|0
7022527|NCT01574079|11098132|FG001|Overall Study|Physician Decision|2
7022528|NCT01574079|11098131|FG000|Overall Study|Lost to Follow-up|1
7022529|NCT01574079|11098132|FG001|Overall Study|Lost to Follow-up|0
7022530|NCT01574157|11098154|FG000|Overall Study|Withdrawal by Subject|4
7022531|NCT01574157|11098155|FG001|Overall Study|Withdrawal by Subject|5
7022532|NCT01574157|11098154|FG000|Overall Study|Lost to Follow-up|0
7022533|NCT01574157|11098155|FG001|Overall Study|Lost to Follow-up|3
7022534|NCT01574248|11098178|FG000|Overall Study|Withdrawal by Subject|2
7022535|NCT01574248|11098179|FG001|Overall Study|Withdrawal by Subject|0
7022536|NCT01574248|11098178|FG000|Overall Study|Missing primary endpoint data|1
7022537|NCT01574248|11098179|FG001|Overall Study|Missing primary endpoint data|0
7022538|NCT01574326|11098191|FG000|Overall Study|Randomized but not treated|0
7022539|NCT01574326|11098192|FG001|Overall Study|Randomized but not treated|1
7022540|NCT01574326|11098191|FG000|Overall Study|Withdrawal by Participant|2
7022541|NCT01574326|11098192|FG001|Overall Study|Withdrawal by Participant|4
7022542|NCT01574326|11098191|FG000|Overall Study|Physician Decision|5
7022543|NCT01574326|11098192|FG001|Overall Study|Physician Decision|3
7022544|NCT01574326|11098191|FG000|Overall Study|Adverse Event|1
7022545|NCT01574326|11098192|FG001|Overall Study|Adverse Event|3
7022546|NCT01574326|11098191|FG000|Overall Study|Other: Mainly kidney transplant|8
7022547|NCT01574326|11098192|FG001|Overall Study|Other: Mainly kidney transplant|8
7022548|NCT01574352|11098205|FG000|Overall Study|Withdrawal by Subject|6
7022549|NCT01574352|11098206|FG001|Overall Study|Withdrawal by Subject|13
7022550|NCT01574352|11098205|FG000|Overall Study|Injury in non-camp related sport|1
7022551|NCT01574352|11098206|FG001|Overall Study|Injury in non-camp related sport|0
7022552|NCT01574612|11098212|FG000|Overall Study|Adverse Event|3
7022553|NCT01574612|11098212|FG000|Overall Study|non compliant with drug|2
7022554|NCT01574612|11098212|FG000|Overall Study|Withdrawal by Subject|1
7022555|NCT01574612|11098212|FG000|Overall Study|Lost to Follow-up|2
7022556|NCT01574651|11098218|FG000|Overall Study|Lost to Follow-up|2
7022557|NCT01574651|11098219|FG001|Overall Study|Lost to Follow-up|4
7022558|NCT01574651|11098218|FG000|Overall Study|Administrative problems|0
7022559|NCT01574651|11098219|FG001|Overall Study|Administrative problems|1
7022560|NCT01574651|11098218|FG000|Overall Study|Death|3
7022561|NCT01574651|11098219|FG001|Overall Study|Death|3
7022562|NCT01574651|11098218|FG000|Overall Study|Patient's inability to use the device|0
7022563|NCT01574651|11098219|FG001|Overall Study|Patient's inability to use the device|1
7022564|NCT01574651|11098218|FG000|Overall Study|Adverse Event|36
7022565|NCT01574651|11098219|FG001|Overall Study|Adverse Event|27
7022566|NCT01574651|11098218|FG000|Overall Study|Abnormal laboratory value(s)|1
7022567|NCT01574651|11098219|FG001|Overall Study|Abnormal laboratory value(s)|0
7022568|NCT01574651|11098218|FG000|Overall Study|Abnormal test procedure result(s)|1
7022569|NCT01574651|11098219|FG001|Overall Study|Abnormal test procedure result(s)|1
7022570|NCT01574651|11098218|FG000|Overall Study|Unsatisfactory therapeutic effect|6
7022571|NCT01574651|11098219|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7022572|NCT01574651|11098218|FG000|Overall Study|Protocol Violation|3
7022573|NCT01574651|11098219|FG001|Overall Study|Protocol Violation|5
7022574|NCT01574651|11098218|FG000|Overall Study|Withdrawal by Subject|9
7022575|NCT01574651|11098219|FG001|Overall Study|Withdrawal by Subject|10
7022576|NCT01574703|11098229|FG000|Overall Study|Adverse Event|0
7022577|NCT01574703|11098230|FG001|Overall Study|Adverse Event|2
7022578|NCT01574703|11098231|FG002|Overall Study|Adverse Event|1
7022579|NCT01574703|11098232|FG003|Overall Study|Adverse Event|1
7022580|NCT01574703|11098229|FG000|Overall Study|Protocol Violation|0
7022581|NCT01574703|11098230|FG001|Overall Study|Protocol Violation|0
7022582|NCT01574703|11098231|FG002|Overall Study|Protocol Violation|0
7022583|NCT01574703|11098232|FG003|Overall Study|Protocol Violation|1
7022584|NCT01574703|11098229|FG000|Overall Study|Unspecified Reason|27
7022585|NCT01574703|11098230|FG001|Overall Study|Unspecified Reason|15
7022586|NCT01574703|11098231|FG002|Overall Study|Unspecified Reason|20
7022587|NCT01574703|11098232|FG003|Overall Study|Unspecified Reason|16
7022588|NCT01574703|11098229|FG000|Overall Study|Withdrawal by Subject|53
7022589|NCT01574703|11098230|FG001|Overall Study|Withdrawal by Subject|52
7022590|NCT01574703|11098231|FG002|Overall Study|Withdrawal by Subject|36
7022591|NCT01574703|11098232|FG003|Overall Study|Withdrawal by Subject|61
7022592|NCT01574703|11098229|FG000|Overall Study|Met Withdrawal Criteria|0
7022593|NCT01574703|11098230|FG001|Overall Study|Met Withdrawal Criteria|1
7022594|NCT01574703|11098231|FG002|Overall Study|Met Withdrawal Criteria|1
7022595|NCT01574703|11098232|FG003|Overall Study|Met Withdrawal Criteria|0
7022596|NCT01574703|11098229|FG000|Overall Study|Lost to Follow-up|43
7022597|NCT01574703|11098230|FG001|Overall Study|Lost to Follow-up|41
7022598|NCT01574703|11098231|FG002|Overall Study|Lost to Follow-up|46
7022599|NCT01574703|11098232|FG003|Overall Study|Lost to Follow-up|35
7022600|NCT01574703|11098229|FG000|Overall Study|Death|2
7022601|NCT01574703|11098230|FG001|Overall Study|Death|1
7022602|NCT01574703|11098231|FG002|Overall Study|Death|1
7022603|NCT01574703|11098232|FG003|Overall Study|Death|0
7022604|NCT01574716|11098247|FG000|Part 1|Death|3
7022605|NCT01574716|11098248|FG001|Part 1|Death|1
7022606|NCT01574716|11098249|FG002|Part 1|Death|8
7022607|NCT01574716|11098250|FG003|Part 1|Death|0
7022608|NCT01574716|11098251|FG004|Part 1|Death|0
7022609|NCT01574716|11098247|FG000|Part 1|Discontinuation of study by sponsor|0
7022610|NCT01574716|11098248|FG001|Part 1|Discontinuation of study by sponsor|0
7022611|NCT01574716|11098249|FG002|Part 1|Discontinuation of study by sponsor|1
7022612|NCT01574716|11098250|FG003|Part 1|Discontinuation of study by sponsor|0
7022613|NCT01574716|11098251|FG004|Part 1|Discontinuation of study by sponsor|0
7022614|NCT01574716|11098247|FG000|Part 1|Withdrawal by Subject|0
7022615|NCT01574716|11098248|FG001|Part 1|Withdrawal by Subject|2
7022616|NCT01574716|11098249|FG002|Part 1|Withdrawal by Subject|0
7022617|NCT01574716|11098250|FG003|Part 1|Withdrawal by Subject|0
7022618|NCT01574716|11098251|FG004|Part 1|Withdrawal by Subject|0
7022619|NCT01574716|11098247|FG000|Part 1|Lost to Follow-up|0
7022620|NCT01574716|11098248|FG001|Part 1|Lost to Follow-up|1
7022621|NCT01574716|11098249|FG002|Part 1|Lost to Follow-up|0
7022622|NCT01574716|11098250|FG003|Part 1|Lost to Follow-up|0
7022623|NCT01574716|11098251|FG004|Part 1|Lost to Follow-up|0
7022624|NCT01574716|11098247|FG000|Part 2|Progressive disease|0
7022625|NCT01574716|11098248|FG001|Part 2|Progressive disease|0
7022626|NCT01574716|11098249|FG002|Part 2|Progressive disease|0
7022627|NCT01574716|11098250|FG003|Part 2|Progressive disease|1
7022628|NCT01574716|11098251|FG004|Part 2|Progressive disease|0
7022629|NCT01574716|11098247|FG000|Part 2|Death|0
7022630|NCT01574716|11098248|FG001|Part 2|Death|0
7022631|NCT01574716|11098249|FG002|Part 2|Death|0
7022632|NCT01574716|11098250|FG003|Part 2|Death|76
7022633|NCT01574716|11098251|FG004|Part 2|Death|35
7022634|NCT01574716|11098247|FG000|Part 2|Discontinuation of study by sponsor|0
7022635|NCT01574716|11098248|FG001|Part 2|Discontinuation of study by sponsor|0
7022636|NCT01574716|11098249|FG002|Part 2|Discontinuation of study by sponsor|0
7022637|NCT01574716|11098250|FG003|Part 2|Discontinuation of study by sponsor|51
7022638|NCT01574716|11098251|FG004|Part 2|Discontinuation of study by sponsor|31
7022639|NCT01574716|11098247|FG000|Part 2|Withdrawal by Subject|0
7022640|NCT01574716|11098248|FG001|Part 2|Withdrawal by Subject|0
7022641|NCT01574716|11098249|FG002|Part 2|Withdrawal by Subject|0
7022642|NCT01574716|11098250|FG003|Part 2|Withdrawal by Subject|5
7022643|NCT01574716|11098251|FG004|Part 2|Withdrawal by Subject|4
7022644|NCT01574716|11098247|FG000|Part 2|Brain metastases|0
7022645|NCT01574716|11098248|FG001|Part 2|Brain metastases|0
7022646|NCT01574716|11098249|FG002|Part 2|Brain metastases|0
7022647|NCT01574716|11098250|FG003|Part 2|Brain metastases|1
7022648|NCT01574716|11098251|FG004|Part 2|Brain metastases|0
7022649|NCT01574716|11098247|FG000|Part 2|Lost to Follow-up|0
7022650|NCT01574716|11098248|FG001|Part 2|Lost to Follow-up|0
7022651|NCT01574716|11098249|FG002|Part 2|Lost to Follow-up|0
7022652|NCT01574716|11098250|FG003|Part 2|Lost to Follow-up|3
7022653|NCT01574716|11098251|FG004|Part 2|Lost to Follow-up|0
7022654|NCT01575054|11098268|FG000|Overall Study|Other Reasons|5
7022655|NCT01575054|11098269|FG001|Overall Study|Other Reasons|3
7022656|NCT01575054|11098268|FG000|Overall Study|Protocol Violation|2
7022657|NCT01575054|11098269|FG001|Overall Study|Protocol Violation|1
7022658|NCT01575054|11098268|FG000|Overall Study|Personal Reasons|10
7022659|NCT01575054|11098269|FG001|Overall Study|Personal Reasons|11
7022660|NCT01575054|11098268|FG000|Overall Study|Lost to Follow-up|3
7022661|NCT01575054|11098269|FG001|Overall Study|Lost to Follow-up|3
7022662|NCT01575054|11098268|FG000|Overall Study|Adverse Event|9
7022663|NCT01575054|11098269|FG001|Overall Study|Adverse Event|8
7022664|NCT01575197|11098287|FG000|Overall Study|Migration out of study area|1
7022665|NCT01575197|11098288|FG001|Overall Study|Migration out of study area|5
7022666|NCT01575197|11098289|FG002|Overall Study|Migration out of study area|4
7022667|NCT01575197|11098287|FG000|Overall Study|SAE|0
7022668|NCT01575197|11098288|FG001|Overall Study|SAE|1
7022669|NCT01575197|11098289|FG002|Overall Study|SAE|0
7022670|NCT01575197|11098287|FG000|Overall Study|Lost to Follow-up|0
7022671|NCT01575197|11098288|FG001|Overall Study|Lost to Follow-up|1
7022672|NCT01575197|11098289|FG002|Overall Study|Lost to Follow-up|0
7022673|NCT01575197|11098287|FG000|Overall Study|Withdrawal by Subject|0
7022674|NCT01575197|11098288|FG001|Overall Study|Withdrawal by Subject|1
7022675|NCT01575197|11098289|FG002|Overall Study|Withdrawal by Subject|1
7022676|NCT01575197|11098287|FG000|Overall Study|Protocol Violation|2
7022677|NCT01575197|11098288|FG001|Overall Study|Protocol Violation|1
7022678|NCT01575197|11098289|FG002|Overall Study|Protocol Violation|1
7022679|NCT01575561|11098308|FG000|Overall Study|Adverse Event|9
7022680|NCT01575561|11098308|FG000|Overall Study|Lack of Efficacy|8
7022681|NCT01575561|11098308|FG000|Overall Study|Lost to Follow-up|6
7022682|NCT01575561|11098308|FG000|Overall Study|Protocol Violation|4
7022683|NCT01575561|11098308|FG000|Overall Study|Withdrawal by Subject|11
7022684|NCT01575561|11098308|FG000|Overall Study|administration|1
7022685|NCT01575769|11098320|FG000|Overall Study|Adverse Event|1
7022686|NCT01575769|11098320|FG000|Overall Study|Study terminated by sponsor|40
7022687|NCT01575808|11098328|FG000|Overall Study|Death|2
7022688|NCT01575808|11098329|FG001|Overall Study|Death|0
7022689|NCT01575808|11098328|FG000|Overall Study|Withdrawal by Subject|1
7022690|NCT01575808|11098329|FG001|Overall Study|Withdrawal by Subject|0
7022691|NCT01575834|11098339|FG000|Overall Study|Withdrawal by Subject|352
7022692|NCT01575834|11098340|FG001|Overall Study|Withdrawal by Subject|390
7022693|NCT01575834|11098339|FG000|Overall Study|Death|81
7022694|NCT01575834|11098340|FG001|Overall Study|Death|74
7022695|NCT01575834|11098339|FG000|Overall Study|Other|70
7022696|NCT01575834|11098340|FG001|Overall Study|Other|70
7022697|NCT01575834|11098339|FG000|Overall Study|Adverse Event|63
7022698|NCT01575834|11098340|FG001|Overall Study|Adverse Event|61
7022699|NCT01575834|11098339|FG000|Overall Study|Lost to Follow-up|55
7022700|NCT01575834|11098340|FG001|Overall Study|Lost to Follow-up|68
7022701|NCT01575834|11098339|FG000|Overall Study|Noncompliance|52
7022702|NCT01575834|11098340|FG001|Overall Study|Noncompliance|27
7022703|NCT01575834|11098339|FG000|Overall Study|Administrative decision|15
7022704|NCT01575834|11098340|FG001|Overall Study|Administrative decision|33
7022705|NCT01575834|11098339|FG000|Overall Study|Ineligibility Determined|5
7022706|NCT01575834|11098340|FG001|Overall Study|Ineligibility Determined|8
7022707|NCT01575834|11098339|FG000|Overall Study|Protocol Deviation|4
7022708|NCT01575834|11098340|FG001|Overall Study|Protocol Deviation|3
7022709|NCT01575834|11098339|FG000|Overall Study|Requirement for Alternative Therapy|2
7022710|NCT01575834|11098340|FG001|Overall Study|Requirement for Alternative Therapy|4
7022711|NCT01575873|11098354|FG000|Overall Study|Withdrawal by Subject|15
7022712|NCT01575873|11098355|FG001|Overall Study|Withdrawal by Subject|20
7022713|NCT01575873|11098356|FG002|Overall Study|Withdrawal by Subject|34
7022714|NCT01575873|11098357|FG003|Overall Study|Withdrawal by Subject|34
7022715|NCT01575873|11098354|FG000|Overall Study|Adverse Event|7
7022716|NCT01575873|11098355|FG001|Overall Study|Adverse Event|7
7022717|NCT01575873|11098356|FG002|Overall Study|Adverse Event|9
7022718|NCT01575873|11098357|FG003|Overall Study|Adverse Event|12
7022719|NCT01575873|11098354|FG000|Overall Study|Lost to Follow-up|1
7022720|NCT01575873|11098355|FG001|Overall Study|Lost to Follow-up|3
7022721|NCT01575873|11098356|FG002|Overall Study|Lost to Follow-up|13
7022722|NCT01575873|11098357|FG003|Overall Study|Lost to Follow-up|5
7022723|NCT01575873|11098354|FG000|Overall Study|Death|3
7022724|NCT01575873|11098355|FG001|Overall Study|Death|2
7022725|NCT01575873|11098356|FG002|Overall Study|Death|8
7022726|NCT01575873|11098357|FG003|Overall Study|Death|9
7022727|NCT01575873|11098354|FG000|Overall Study|Noncompliance|1
7022728|NCT01575873|11098355|FG001|Overall Study|Noncompliance|2
7022729|NCT01575873|11098356|FG002|Overall Study|Noncompliance|4
7022730|NCT01575873|11098357|FG003|Overall Study|Noncompliance|3
7022731|NCT01575873|11098354|FG000|Overall Study|Administrative decision|1
7022732|NCT01575873|11098355|FG001|Overall Study|Administrative decision|1
7022733|NCT01575873|11098356|FG002|Overall Study|Administrative decision|1
7022734|NCT01575873|11098357|FG003|Overall Study|Administrative decision|0
7022735|NCT01575873|11098354|FG000|Overall Study|Protocol deviation|0
7022736|NCT01575873|11098355|FG001|Overall Study|Protocol deviation|1
7022737|NCT01575873|11098356|FG002|Overall Study|Protocol deviation|0
7022738|NCT01575873|11098357|FG003|Overall Study|Protocol deviation|1
7022739|NCT01575873|11098354|FG000|Overall Study|Requirement for Alternative Therapy|0
7022740|NCT01575873|11098355|FG001|Overall Study|Requirement for Alternative Therapy|0
7022741|NCT01575873|11098356|FG002|Overall Study|Requirement for Alternative Therapy|1
7022742|NCT01575873|11098357|FG003|Overall Study|Requirement for Alternative Therapy|1
7022743|NCT01575873|11098354|FG000|Overall Study|Other|0
7022744|NCT01575873|11098355|FG001|Overall Study|Other|0
7022745|NCT01575873|11098356|FG002|Overall Study|Other|4
7022746|NCT01575873|11098357|FG003|Overall Study|Other|2
7022747|NCT01575899|11098368|FG000|Overall Study|Lost to Follow-up|3
7022748|NCT01575899|11098369|FG001|Overall Study|Lost to Follow-up|4
7022749|NCT01575899|11098370|FG002|Overall Study|Lost to Follow-up|2
7022750|NCT01575899|11098368|FG000|Overall Study|Protocol Violation|2
7022751|NCT01575899|11098369|FG001|Overall Study|Protocol Violation|1
7022752|NCT01575899|11098370|FG002|Overall Study|Protocol Violation|0
7022753|NCT01576016|11098408|FG000|Lead Safety|Death|132
7022754|NCT01576016|11098409|FG001|Lead Safety|Death|0
7022755|NCT01576016|11098408|FG000|Lead Safety|Withdrawal by Subject|81
7022756|NCT01576016|11098409|FG001|Lead Safety|Withdrawal by Subject|0
7022757|NCT01576016|11098408|FG000|Lead Safety|System Explanted without Replacement|24
7022758|NCT01576016|11098409|FG001|Lead Safety|System Explanted without Replacement|0
7022759|NCT01576016|11098408|FG000|Lead Safety|Physician Decision|14
7022760|NCT01576016|11098409|FG001|Lead Safety|Physician Decision|0
7022761|NCT01576016|11098408|FG000|Lead Safety|Lost to Follow-up|13
7022762|NCT01576016|11098409|FG001|Lead Safety|Lost to Follow-up|0
7022763|NCT01576016|11098408|FG000|Lead Safety|Unsuccessful implant|2
7022764|NCT01576016|11098409|FG001|Lead Safety|Unsuccessful implant|0
7022765|NCT01576016|11098408|FG000|Lead Safety|Sponsor request|1
7022766|NCT01576016|11098409|FG001|Lead Safety|Sponsor request|0
7022767|NCT01576016|11098408|FG000|Lead Safety|Device replaced with CRT-D|1
7022768|NCT01576016|11098409|FG001|Lead Safety|Device replaced with CRT-D|0
7022769|NCT01576016|11098408|FG000|Lead Safety|Patient on Palliative Care|1
7022770|NCT01576016|11098409|FG001|Lead Safety|Patient on Palliative Care|0
7022771|NCT01576016|11098408|FG000|Lead Safety|Patient noncompliance|1
7022772|NCT01576016|11098409|FG001|Lead Safety|Patient noncompliance|0
7022773|NCT01576016|11098408|FG000|Lead Safety|Too far from study site|1
7022774|NCT01576016|11098409|FG001|Lead Safety|Too far from study site|0
7022775|NCT01576016|11098408|FG000|Lead Safety|System deactivated|1
7022776|NCT01576016|11098409|FG001|Lead Safety|System deactivated|0
7022777|NCT01576016|11098408|FG000|Lead Safety|Patient no longer followed by study PI|1
7022778|NCT01576016|11098409|FG001|Lead Safety|Patient no longer followed by study PI|0
7022779|NCT01576016|11098408|FG000|MRI Safety|Withdrawal by Subject|0
7022780|NCT01576016|11098409|FG001|MRI Safety|Withdrawal by Subject|10
7022781|NCT01576016|11098408|FG000|MRI Safety|Non-MRI Compatible Device or Material|0
7022782|NCT01576016|11098409|FG001|MRI Safety|Non-MRI Compatible Device or Material|5
7022783|NCT01576016|11098408|FG000|MRI Safety|Has not yet completed MRI scan|0
7022784|NCT01576016|11098409|FG001|MRI Safety|Has not yet completed MRI scan|56
7022785|NCT01576016|11098408|FG000|MRI Safety|MRI scan not performed at MRI visit|0
7022786|NCT01576016|11098409|FG001|MRI Safety|MRI scan not performed at MRI visit|3
7022787|NCT01576042|11098419|FG000|Overall Study|Physician Decision|2
7022788|NCT01576042|11098420|FG001|Overall Study|Physician Decision|0
7022789|NCT01576146|11098444|FG000|Extension Period 1|Adverse Event|2
7022790|NCT01576146|11098444|FG000|Extension Period 1|Death|2
7022791|NCT01576146|11098444|FG000|Extension Period 1|Physician Decision|2
7022792|NCT01576146|11098444|FG000|Extension Period 1|Withdrawal by Subject|1
7022793|NCT01576146|11098444|FG000|Extension Period 1|Lost to Follow-up|1
7022794|NCT01576146|11098444|FG000|Extension Period 1|Parathyroidectomy|1
7022795|NCT01576146|11098444|FG000|Extension Period 1|Renal Transplant|1
7022796|NCT01576146|11098444|FG000|Extension Period 2|Sponsor Decision|13
7022797|NCT01576146|11098444|FG000|Extension Period 2|Death|1
7022798|NCT01576146|11098444|FG000|Extension Period 2|Adverse Event|1
7022799|NCT01576146|11098444|FG000|Extension Period 2|Renal Transplant|1
7022800|NCT01576146|11098444|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1
7022801|NCT01576159|11098452|FG000|Overall Study|Withdrawal by Subject|0
7022802|NCT01576159|11098453|FG001|Overall Study|Withdrawal by Subject|1
7022803|NCT01576159|11098454|FG002|Overall Study|Withdrawal by Subject|0
7022804|NCT01576159|11098455|FG003|Overall Study|Withdrawal by Subject|0
7022805|NCT01576159|11098452|FG000|Overall Study|Physician Decision|0
7022806|NCT01576159|11098453|FG001|Overall Study|Physician Decision|0
7022807|NCT01576159|11098454|FG002|Overall Study|Physician Decision|1
7022808|NCT01576159|11098455|FG003|Overall Study|Physician Decision|0
7022809|NCT01576159|11098452|FG000|Overall Study|Lost to Follow-up|0
7022810|NCT01576159|11098453|FG001|Overall Study|Lost to Follow-up|0
7022811|NCT01576159|11098454|FG002|Overall Study|Lost to Follow-up|0
7022812|NCT01576159|11098455|FG003|Overall Study|Lost to Follow-up|1
7022813|NCT01576159|11098452|FG000|Overall Study|Protocol Violation|1
7022814|NCT01576159|11098453|FG001|Overall Study|Protocol Violation|0
7022815|NCT01576159|11098454|FG002|Overall Study|Protocol Violation|0
7022816|NCT01576159|11098455|FG003|Overall Study|Protocol Violation|0
7022817|NCT01576172|11098474|FG000|Overall Study|Ineligible|2
7022818|NCT01576172|11098475|FG001|Overall Study|Ineligible|1
7022819|NCT01576172|11098474|FG000|Overall Study|Withdrawal by Subject|2
7022820|NCT01576172|11098475|FG001|Overall Study|Withdrawal by Subject|0
7022821|NCT01576172|11098474|FG000|Overall Study|Insurance issue|1
7022822|NCT01576172|11098475|FG001|Overall Study|Insurance issue|0
7022823|NCT01576341|11098493|FG000|Overall Study|Withdrawal by Subject|24
7022824|NCT01576341|11098493|FG000|Overall Study|Adverse Event|10
7022825|NCT01576341|11098493|FG000|Overall Study|Death|21
7022826|NCT01576341|11098493|FG000|Overall Study|Physician Decision|2
7022827|NCT01576341|11098493|FG000|Overall Study|Lost to Follow-up|2
7022828|NCT01576341|11098493|FG000|Overall Study|Kidney transplantation|10
7022829|NCT01576341|11098493|FG000|Overall Study|Protocol Violation|12
7022830|NCT01576341|11098493|FG000|Overall Study|Other|12
7022831|NCT01576367|11098500|FG000|Overall Study|Unsatisfactory therapeutic effect|2
7022832|NCT01576367|11098500|FG000|Overall Study|Moved to commercial use after 6 months|1
7022833|NCT01576406|11098510|FG000|Overall Study|Lost to Follow-up|1
7022834|NCT01576406|11098511|FG001|Overall Study|Lost to Follow-up|2
7022835|NCT01576406|11098512|FG002|Overall Study|Lost to Follow-up|0
7022836|NCT01576406|11098513|FG003|Overall Study|Lost to Follow-up|0
7022837|NCT01576406|11098514|FG004|Overall Study|Lost to Follow-up|0
7022838|NCT01576406|11098515|FG005|Overall Study|Lost to Follow-up|0
7022839|NCT01576406|11098510|FG000|Overall Study|Death|3
7022840|NCT01576406|11098511|FG001|Overall Study|Death|4
7022841|NCT01576406|11098512|FG002|Overall Study|Death|8
7022842|NCT01576406|11098513|FG003|Overall Study|Death|5
7022843|NCT01576406|11098514|FG004|Overall Study|Death|7
7022844|NCT01576406|11098515|FG005|Overall Study|Death|9
7022845|NCT01576406|11098510|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0
7022846|NCT01576406|11098511|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0
7022847|NCT01576406|11098512|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1
7022848|NCT01576406|11098513|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1
7022849|NCT01576406|11098514|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0
7022850|NCT01576406|11098515|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0
7022851|NCT01576406|11098510|FG000|Overall Study|Withdrawal the consent|2
7022852|NCT01576406|11098511|FG001|Overall Study|Withdrawal the consent|2
7022853|NCT01576406|11098512|FG002|Overall Study|Withdrawal the consent|5
7022854|NCT01576406|11098513|FG003|Overall Study|Withdrawal the consent|1
7022855|NCT01576406|11098514|FG004|Overall Study|Withdrawal the consent|1
7022856|NCT01576406|11098515|FG005|Overall Study|Withdrawal the consent|3
7022857|NCT01576406|11098510|FG000|Overall Study|Other|0
7022858|NCT01576406|11098511|FG001|Overall Study|Other|0
7022859|NCT01576406|11098512|FG002|Overall Study|Other|2
7022860|NCT01576406|11098513|FG003|Overall Study|Other|2
7022861|NCT01576406|11098514|FG004|Overall Study|Other|0
7022862|NCT01576406|11098515|FG005|Overall Study|Other|0
7022863|NCT01576484|11098540|FG000|Overall Study|Adverse Event|1
7022864|NCT01576484|11098541|FG001|Overall Study|Adverse Event|1
7022865|NCT01576484|11098540|FG000|Overall Study|Protocol Violation|0
7022866|NCT01576484|11098541|FG001|Overall Study|Protocol Violation|2
7022867|NCT01576484|11098540|FG000|Overall Study|Sponsor Decision|2
7022868|NCT01576484|11098541|FG001|Overall Study|Sponsor Decision|8
7022869|NCT01576484|11098540|FG000|Overall Study|Withdrawal by Subject|0
7022870|NCT01576484|11098541|FG001|Overall Study|Withdrawal by Subject|3
7022871|NCT01576484|11098540|FG000|Overall Study|Other|2
7022872|NCT01576484|11098541|FG001|Overall Study|Other|5
7044086|NCT01750879|11129607|FG001|Overall Study|Adverse Event|0
7060542|NCT01920061|11156842|FG005|Overall Study|Lost to Follow-up|0
7060543|NCT01920061|11156843|FG006|Overall Study|Lost to Follow-up|1
7060544|NCT01920061|11156844|FG007|Overall Study|Lost to Follow-up|0
7060545|NCT01920061|11156845|FG008|Overall Study|Lost to Follow-up|0
7044087|NCT01750879|11129606|FG000|Overall Study|Lack of Efficacy|1
7044088|NCT01750879|11129607|FG001|Overall Study|Lack of Efficacy|0
7044089|NCT01750879|11129606|FG000|Overall Study|Withdrawal by Subject|1
7044090|NCT01750879|11129607|FG001|Overall Study|Withdrawal by Subject|0
7044091|NCT01750879|11129606|FG000|Overall Study|Did not complete per protocol|0
7044092|NCT01750879|11129607|FG001|Overall Study|Did not complete per protocol|3
7044093|NCT01750918|11129634|FG000|Overall Study|Last patient transitioned to a rollover protocol|0
7044094|NCT01750918|11129635|FG001|Overall Study|Last patient transitioned to a rollover protocol|0
7044095|NCT01750918|11129636|FG002|Overall Study|Last patient transitioned to a rollover protocol|5
7044096|NCT01750918|11129637|FG003|Overall Study|Last patient transitioned to a rollover protocol|2
7044097|NCT01750918|11129638|FG004|Overall Study|Last patient transitioned to a rollover protocol|0
7044098|NCT01750918|11129639|FG005|Overall Study|Last patient transitioned to a rollover protocol|2
7044099|NCT01750918|11129640|FG006|Overall Study|Last patient transitioned to a rollover protocol|1
7044100|NCT01750918|11129641|FG007|Overall Study|Last patient transitioned to a rollover protocol|1
7044101|NCT01750918|11129634|FG000|Overall Study|Lost to Follow-up|0
7044102|NCT01750918|11129635|FG001|Overall Study|Lost to Follow-up|0
7044103|NCT01750918|11129636|FG002|Overall Study|Lost to Follow-up|2
7044104|NCT01750918|11129637|FG003|Overall Study|Lost to Follow-up|2
7044105|NCT01750918|11129638|FG004|Overall Study|Lost to Follow-up|0
7044106|NCT01750918|11129639|FG005|Overall Study|Lost to Follow-up|0
7044107|NCT01750918|11129640|FG006|Overall Study|Lost to Follow-up|0
7044108|NCT01750918|11129641|FG007|Overall Study|Lost to Follow-up|1
7044109|NCT01750918|11129634|FG000|Overall Study|Withdrawal by Subject|0
7044110|NCT01750918|11129635|FG001|Overall Study|Withdrawal by Subject|0
7044111|NCT01750918|11129636|FG002|Overall Study|Withdrawal by Subject|1
7044112|NCT01750918|11129637|FG003|Overall Study|Withdrawal by Subject|2
7044113|NCT01750918|11129638|FG004|Overall Study|Withdrawal by Subject|1
7044114|NCT01750918|11129639|FG005|Overall Study|Withdrawal by Subject|1
7044115|NCT01750918|11129640|FG006|Overall Study|Withdrawal by Subject|2
7044116|NCT01750918|11129641|FG007|Overall Study|Withdrawal by Subject|2
7044117|NCT01751061|11129712|FG000|Overall Study|Death|1
7044118|NCT01751061|11129713|FG001|Overall Study|Death|0
7044119|NCT01751061|11129712|FG000|Overall Study|patient death|5
7044120|NCT01751061|11129713|FG001|Overall Study|patient death|0
7044121|NCT01751061|11129712|FG000|Overall Study|Lost to Follow-up|40
7044122|NCT01751061|11129713|FG001|Overall Study|Lost to Follow-up|25
7044123|NCT01751061|11129712|FG000|Overall Study|patient regained decisional capacity|4
7044124|NCT01751061|11129713|FG001|Overall Study|patient regained decisional capacity|8
7044125|NCT01751061|11129712|FG000|Overall Study|Withdrawal by Subject|4
7044126|NCT01751061|11129713|FG001|Overall Study|Withdrawal by Subject|1
7044127|NCT01751061|11129712|FG000|Overall Study|Physician Decision|2
7044128|NCT01751061|11129713|FG001|Overall Study|Physician Decision|0
7044129|NCT01751087|11129722|FG000|Overall Study|Withdrawal by Subject|1
7044130|NCT01751087|11129723|FG001|Overall Study|Withdrawal by Subject|0
7044131|NCT01751087|11129724|FG002|Overall Study|Withdrawal by Subject|0
7044132|NCT01751087|11129722|FG000|Overall Study|Physician Decision|0
7044133|NCT01751087|11129723|FG001|Overall Study|Physician Decision|0
7044134|NCT01751087|11129724|FG002|Overall Study|Physician Decision|1
7044135|NCT01751113|11129732|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0
7044136|NCT01751113|11129733|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0
7044137|NCT01751113|11129734|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0
7044138|NCT01751113|11129735|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1
7044139|NCT01751113|11129736|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1
7044140|NCT01751113|11129737|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0
7044141|NCT01751113|11129732|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0
7044142|NCT01751113|11129733|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0
7044143|NCT01751113|11129734|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0
7044144|NCT01751113|11129735|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0
7044145|NCT01751113|11129736|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0
7044146|NCT01751113|11129737|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1
7044147|NCT01751139|11129746|FG000|Overall Study|Other|135
7044148|NCT01751139|11129746|FG000|Overall Study|Sponsor study termination|1609
7060546|NCT01920061|11156846|FG009|Overall Study|Lost to Follow-up|0
7022873|NCT01576705|11098582|FG000|Overall Study|TSH > 7 mIU/L at baseline|3
7022874|NCT01576705|11098583|FG001|Overall Study|TSH > 7 mIU/L at baseline|7
7022875|NCT01576705|11098584|FG002|Overall Study|TSH > 7 mIU/L at baseline|5
7022876|NCT01576705|11098585|FG003|Overall Study|TSH > 7 mIU/L at baseline|3
7022877|NCT01576705|11098582|FG000|Overall Study|invalid ICF|0
7022878|NCT01576705|11098583|FG001|Overall Study|invalid ICF|1
7022879|NCT01576705|11098584|FG002|Overall Study|invalid ICF|0
7022880|NCT01576705|11098585|FG003|Overall Study|invalid ICF|0
7022881|NCT01576718|11098601|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49
7022882|NCT01576718|11098602|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7022883|NCT01576718|11098603|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7022884|NCT01576718|11098604|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7022885|NCT01576718|11098605|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7022886|NCT01576718|11098606|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7022887|NCT01576718|11098607|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7022888|NCT01576718|11098601|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17
7022889|NCT01576718|11098602|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7022890|NCT01576718|11098603|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7022891|NCT01576718|11098604|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7022892|NCT01576718|11098605|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7022893|NCT01576718|11098606|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7022894|NCT01576718|11098607|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7022895|NCT01576718|11098601|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166
7022896|NCT01576718|11098602|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7022897|NCT01576718|11098603|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7022898|NCT01576718|11098604|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7022899|NCT01576718|11098605|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7022900|NCT01576718|11098606|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7022901|NCT01576718|11098607|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7022902|NCT01576718|11098601|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2
7022903|NCT01576718|11098602|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7022904|NCT01576718|11098603|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7022905|NCT01576718|11098604|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7022906|NCT01576718|11098605|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7022907|NCT01576718|11098606|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7022908|NCT01576718|11098607|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7022909|NCT01576718|11098601|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15
7022910|NCT01576718|11098602|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0
7022911|NCT01576718|11098603|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0
7022912|NCT01576718|11098604|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0
7022913|NCT01576718|11098605|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0
7022914|NCT01576718|11098606|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0
7022915|NCT01576718|11098607|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0
7022916|NCT01576718|11098601|FG000|Treatment Period|Adverse Event|0
7022917|NCT01576718|11098602|FG001|Treatment Period|Adverse Event|1
7022918|NCT01576718|11098603|FG002|Treatment Period|Adverse Event|1
7022919|NCT01576718|11098604|FG003|Treatment Period|Adverse Event|1
7022920|NCT01576718|11098605|FG004|Treatment Period|Adverse Event|1
7022921|NCT01576718|11098606|FG005|Treatment Period|Adverse Event|1
7022922|NCT01576718|11098607|FG006|Treatment Period|Adverse Event|0
7022923|NCT01576718|11098601|FG000|Treatment Period|Withdrawal by Subject|0
7022924|NCT01576718|11098602|FG001|Treatment Period|Withdrawal by Subject|1
7022925|NCT01576718|11098603|FG002|Treatment Period|Withdrawal by Subject|1
7022926|NCT01576718|11098604|FG003|Treatment Period|Withdrawal by Subject|0
7022927|NCT01576718|11098605|FG004|Treatment Period|Withdrawal by Subject|2
7022928|NCT01576718|11098606|FG005|Treatment Period|Withdrawal by Subject|4
7022929|NCT01576718|11098607|FG006|Treatment Period|Withdrawal by Subject|2
7022930|NCT01576718|11098601|FG000|Treatment Period|Physician Decision|0
7022931|NCT01576718|11098602|FG001|Treatment Period|Physician Decision|1
7022932|NCT01576718|11098603|FG002|Treatment Period|Physician Decision|1
7022933|NCT01576718|11098604|FG003|Treatment Period|Physician Decision|1
7022934|NCT01576718|11098605|FG004|Treatment Period|Physician Decision|1
7022935|NCT01576718|11098606|FG005|Treatment Period|Physician Decision|0
7022936|NCT01576718|11098607|FG006|Treatment Period|Physician Decision|0
7022937|NCT01576718|11098601|FG000|Treatment Period|Protocol Violation|0
7022938|NCT01576718|11098602|FG001|Treatment Period|Protocol Violation|5
7022939|NCT01576718|11098603|FG002|Treatment Period|Protocol Violation|4
7022940|NCT01576718|11098604|FG003|Treatment Period|Protocol Violation|10
7022941|NCT01576718|11098605|FG004|Treatment Period|Protocol Violation|6
7022942|NCT01576718|11098606|FG005|Treatment Period|Protocol Violation|8
7022943|NCT01576718|11098607|FG006|Treatment Period|Protocol Violation|12
7022944|NCT01576718|11098601|FG000|Treatment Period|Sponsor request|0
7022945|NCT01576718|11098602|FG001|Treatment Period|Sponsor request|1
7022946|NCT01576718|11098603|FG002|Treatment Period|Sponsor request|0
7022947|NCT01576718|11098604|FG003|Treatment Period|Sponsor request|0
7022948|NCT01576718|11098605|FG004|Treatment Period|Sponsor request|0
7022949|NCT01576718|11098606|FG005|Treatment Period|Sponsor request|1
7022950|NCT01576718|11098607|FG006|Treatment Period|Sponsor request|0
7022951|NCT01576718|11098601|FG000|Treatment Period|Met stopping criteria|0
7022952|NCT01576718|11098602|FG001|Treatment Period|Met stopping criteria|16
7022953|NCT01576718|11098603|FG002|Treatment Period|Met stopping criteria|13
7022954|NCT01576718|11098604|FG003|Treatment Period|Met stopping criteria|19
7022955|NCT01576718|11098605|FG004|Treatment Period|Met stopping criteria|16
7022956|NCT01576718|11098606|FG005|Treatment Period|Met stopping criteria|33
7022957|NCT01576718|11098607|FG006|Treatment Period|Met stopping criteria|15
7022958|NCT01576718|11098601|FG000|Treatment Period|Lost to Follow-up|0
7022959|NCT01576718|11098602|FG001|Treatment Period|Lost to Follow-up|0
7022960|NCT01576718|11098603|FG002|Treatment Period|Lost to Follow-up|0
7022961|NCT01576718|11098604|FG003|Treatment Period|Lost to Follow-up|0
7022962|NCT01576718|11098605|FG004|Treatment Period|Lost to Follow-up|1
7022963|NCT01576718|11098606|FG005|Treatment Period|Lost to Follow-up|0
7022964|NCT01576718|11098607|FG006|Treatment Period|Lost to Follow-up|0
7022965|NCT01576718|11098601|FG000|Treatment Period|Noncompliance to study medication|0
7022966|NCT01576718|11098602|FG001|Treatment Period|Noncompliance to study medication|0
7022967|NCT01576718|11098603|FG002|Treatment Period|Noncompliance to study medication|0
7022968|NCT01576718|11098604|FG003|Treatment Period|Noncompliance to study medication|0
7022969|NCT01576718|11098605|FG004|Treatment Period|Noncompliance to study medication|0
7022970|NCT01576718|11098606|FG005|Treatment Period|Noncompliance to study medication|1
7022971|NCT01576718|11098607|FG006|Treatment Period|Noncompliance to study medication|1
7022972|NCT01576783|11098623|FG000|Overall Study|Change in Medical Care|1
7022973|NCT01576783|11098624|FG001|Overall Study|Change in Medical Care|0
7022974|NCT01576783|11098623|FG000|Overall Study|Lost to Follow-up|14
7022975|NCT01576783|11098624|FG001|Overall Study|Lost to Follow-up|16
7022976|NCT01576783|11098623|FG000|Overall Study|Withdrawal by Subject|5
7022977|NCT01576783|11098624|FG001|Overall Study|Withdrawal by Subject|1
7022978|NCT01577160|11098665|FG000|Overall Study|Adverse Event|9
7022979|NCT01577160|11098665|FG000|Overall Study|Lack of Efficacy|15
7022980|NCT01577160|11098665|FG000|Overall Study|Lost to Follow-up|40
7022981|NCT01577160|11098665|FG000|Overall Study|Withdrawal by Subject|18
7022982|NCT01577160|11098665|FG000|Overall Study|Subject Uncooperative|7
7022983|NCT01577160|11098665|FG000|Overall Study|Other|9
7022984|NCT01577186|11098669|FG000|Overall Study|Adverse Event|23
7022985|NCT01577186|11098669|FG000|Overall Study|Death|1
7022986|NCT01577186|11098669|FG000|Overall Study|Lost to Follow-up|28
7022987|NCT01577186|11098669|FG000|Overall Study|Withdrawal by Subject|35
7022988|NCT01577186|11098669|FG000|Overall Study|Insufficient Response|18
7022989|NCT01577186|11098669|FG000|Overall Study|Ineligible to Continue|15
7022990|NCT01577186|11098669|FG000|Overall Study|Non-Compliant|8
7022991|NCT01577186|11098669|FG000|Overall Study|Other|2
7022992|NCT01577381|11098695|FG000|Overall Study|Discontinued|2
7022993|NCT01577381|11098696|FG001|Overall Study|Discontinued|1
7022994|NCT01577381|11098697|FG002|Overall Study|Discontinued|2
7022995|NCT01577381|11098698|FG003|Overall Study|Discontinued|2
7022996|NCT01577381|11098695|FG000|Overall Study|Ongoing at Date of Cut-Off|0
7022997|NCT01577381|11098696|FG001|Overall Study|Ongoing at Date of Cut-Off|2
7022998|NCT01577381|11098697|FG002|Overall Study|Ongoing at Date of Cut-Off|1
7022999|NCT01577381|11098698|FG003|Overall Study|Ongoing at Date of Cut-Off|0
7023000|NCT01577745|11098737|FG000|Overall Study|Withdrawal by Subject|0
7023001|NCT01577745|11098738|FG001|Overall Study|Withdrawal by Subject|1
7023002|NCT01577745|11098739|FG002|Overall Study|Withdrawal by Subject|0
7023003|NCT01577745|11098740|FG003|Overall Study|Withdrawal by Subject|3
7023004|NCT01577745|11098741|FG004|Overall Study|Withdrawal by Subject|2
7023005|NCT01577745|11098742|FG005|Overall Study|Withdrawal by Subject|0
7023006|NCT01577745|11098737|FG000|Overall Study|Death|3
7023007|NCT01577745|11098738|FG001|Overall Study|Death|2
7023008|NCT01577745|11098739|FG002|Overall Study|Death|2
7023009|NCT01577745|11098740|FG003|Overall Study|Death|1
7023010|NCT01577745|11098741|FG004|Overall Study|Death|1
7023011|NCT01577745|11098742|FG005|Overall Study|Death|3
7023012|NCT01577745|11098737|FG000|Overall Study|Physician Decision|0
7023013|NCT01577745|11098738|FG001|Overall Study|Physician Decision|0
7023014|NCT01577745|11098739|FG002|Overall Study|Physician Decision|0
7023015|NCT01577745|11098740|FG003|Overall Study|Physician Decision|1
7023016|NCT01577745|11098741|FG004|Overall Study|Physician Decision|1
7023017|NCT01577745|11098742|FG005|Overall Study|Physician Decision|0
7023018|NCT01577745|11098737|FG000|Overall Study|Lost to Follow-up|0
7023019|NCT01577745|11098738|FG001|Overall Study|Lost to Follow-up|0
7023020|NCT01577745|11098739|FG002|Overall Study|Lost to Follow-up|0
7023021|NCT01577745|11098740|FG003|Overall Study|Lost to Follow-up|0
7023022|NCT01577745|11098741|FG004|Overall Study|Lost to Follow-up|0
7023023|NCT01577745|11098742|FG005|Overall Study|Lost to Follow-up|1
7023024|NCT01577745|11098737|FG000|Overall Study|Alternative Therapy|0
7023025|NCT01577745|11098738|FG001|Overall Study|Alternative Therapy|0
7023026|NCT01577745|11098739|FG002|Overall Study|Alternative Therapy|0
7023027|NCT01577745|11098740|FG003|Overall Study|Alternative Therapy|1
7023028|NCT01577745|11098741|FG004|Overall Study|Alternative Therapy|1
7023029|NCT01577745|11098742|FG005|Overall Study|Alternative Therapy|0
7023030|NCT01577758|11098761|FG000|Dose Escalation Phase|Adverse Event|0
7023031|NCT01577758|11098762|FG001|Dose Escalation Phase|Adverse Event|0
7023032|NCT01577758|11098763|FG002|Dose Escalation Phase|Adverse Event|0
7023033|NCT01577758|11098764|FG003|Dose Escalation Phase|Adverse Event|0
7023034|NCT01577758|11098765|FG004|Dose Escalation Phase|Adverse Event|0
7023035|NCT01577758|11098766|FG005|Dose Escalation Phase|Adverse Event|2
7023036|NCT01577758|11098767|FG006|Dose Escalation Phase|Adverse Event|1
7023037|NCT01577758|11098768|FG007|Dose Escalation Phase|Adverse Event|0
7023038|NCT01577758|11098761|FG000|Dose Escalation Phase|Symptomatic Deterioration|0
7023039|NCT01577758|11098762|FG001|Dose Escalation Phase|Symptomatic Deterioration|0
7023040|NCT01577758|11098763|FG002|Dose Escalation Phase|Symptomatic Deterioration|1
7023041|NCT01577758|11098764|FG003|Dose Escalation Phase|Symptomatic Deterioration|0
7023042|NCT01577758|11098765|FG004|Dose Escalation Phase|Symptomatic Deterioration|1
7023043|NCT01577758|11098766|FG005|Dose Escalation Phase|Symptomatic Deterioration|1
7023044|NCT01577758|11098767|FG006|Dose Escalation Phase|Symptomatic Deterioration|0
7023045|NCT01577758|11098768|FG007|Dose Escalation Phase|Symptomatic Deterioration|0
7023046|NCT01577758|11098761|FG000|Dose Escalation Phase|Withdrawal by Subject|0
7023047|NCT01577758|11098762|FG001|Dose Escalation Phase|Withdrawal by Subject|0
7023048|NCT01577758|11098763|FG002|Dose Escalation Phase|Withdrawal by Subject|0
7023049|NCT01577758|11098764|FG003|Dose Escalation Phase|Withdrawal by Subject|0
7023050|NCT01577758|11098765|FG004|Dose Escalation Phase|Withdrawal by Subject|0
7023051|NCT01577758|11098766|FG005|Dose Escalation Phase|Withdrawal by Subject|1
7023052|NCT01577758|11098767|FG006|Dose Escalation Phase|Withdrawal by Subject|0
7023053|NCT01577758|11098768|FG007|Dose Escalation Phase|Withdrawal by Subject|0
7023054|NCT01577758|11098761|FG000|Dose Escalation Phase|Progression Disease|2
7023055|NCT01577758|11098762|FG001|Dose Escalation Phase|Progression Disease|2
7023056|NCT01577758|11098763|FG002|Dose Escalation Phase|Progression Disease|1
7023057|NCT01577758|11098764|FG003|Dose Escalation Phase|Progression Disease|2
7023058|NCT01577758|11098765|FG004|Dose Escalation Phase|Progression Disease|5
7023059|NCT01577758|11098766|FG005|Dose Escalation Phase|Progression Disease|0
7023060|NCT01577758|11098767|FG006|Dose Escalation Phase|Progression Disease|0
7023061|NCT01577758|11098768|FG007|Dose Escalation Phase|Progression Disease|0
7023062|NCT01577758|11098761|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0
7023063|NCT01577758|11098762|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0
7023064|NCT01577758|11098763|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0
7023065|NCT01577758|11098764|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0
7023066|NCT01577758|11098765|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0
7023067|NCT01577758|11098766|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0
7023068|NCT01577758|11098767|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0
7023069|NCT01577758|11098768|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4
7023070|NCT01577758|11098761|FG000|mCRC Expansion Phase|Withdrawal by Subject|0
7023071|NCT01577758|11098762|FG001|mCRC Expansion Phase|Withdrawal by Subject|0
7023072|NCT01577758|11098763|FG002|mCRC Expansion Phase|Withdrawal by Subject|0
7023073|NCT01577758|11098764|FG003|mCRC Expansion Phase|Withdrawal by Subject|0
7143177|NCT03028129|11299596|FG001|Overall Study|Withdrawal by Subject|45
7183604|NCT01496976|11383697|FG000|Overall Study|Withdrew - received stem cell transplant|1
7183605|NCT01488890|11383705|FG000|Overall Study|Serious adverse event|2
7023074|NCT01577758|11098765|FG004|mCRC Expansion Phase|Withdrawal by Subject|0
7023075|NCT01577758|11098766|FG005|mCRC Expansion Phase|Withdrawal by Subject|0
7023076|NCT01577758|11098767|FG006|mCRC Expansion Phase|Withdrawal by Subject|0
7023077|NCT01577758|11098768|FG007|mCRC Expansion Phase|Withdrawal by Subject|2
7023078|NCT01577758|11098761|FG000|mCRC Expansion Phase|Progression Disease|0
7023079|NCT01577758|11098762|FG001|mCRC Expansion Phase|Progression Disease|0
7023080|NCT01577758|11098763|FG002|mCRC Expansion Phase|Progression Disease|0
7060547|NCT01920061|11156847|FG010|Overall Study|Lost to Follow-up|3
7023081|NCT01577758|11098764|FG003|mCRC Expansion Phase|Progression Disease|0
7023082|NCT01577758|11098765|FG004|mCRC Expansion Phase|Progression Disease|0
7023083|NCT01577758|11098766|FG005|mCRC Expansion Phase|Progression Disease|0
7023084|NCT01577758|11098767|FG006|mCRC Expansion Phase|Progression Disease|0
7023085|NCT01577758|11098768|FG007|mCRC Expansion Phase|Progression Disease|19
7023086|NCT01578187|11098816|FG000|Usability Phase|Withdrawal by Subject|1
7183606|NCT01488890|11383706|FG001|Overall Study|Serious adverse event|0
7183607|NCT01488890|11383707|FG002|Overall Study|Serious adverse event|0
7183608|NCT01488890|11383708|FG003|Overall Study|Serious adverse event|0
7023087|NCT01578330|11098848|FG000|Overall Study|Adverse Event|2
7023088|NCT01578330|11098848|FG000|Overall Study|Protocol Violation|5
7023089|NCT01578486|11098852|FG000|Overall Study|Physician Decision|3
7023090|NCT01578486|11098852|FG000|Overall Study|Withdrawal by Subject|2
7023091|NCT01578499|11098858|FG000|Overall Study|Reason not Specified|0
7023092|NCT01578499|11098859|FG001|Overall Study|Reason not Specified|1
7183609|NCT01488890|11383705|FG000|Overall Study|Protocol Violation|3
7023093|NCT01578499|11098858|FG000|Overall Study|Lost to Follow-up|2
7023094|NCT01578499|11098859|FG001|Overall Study|Lost to Follow-up|1
7023095|NCT01578499|11098858|FG000|Overall Study|Withdrawal by Subject|10
7023096|NCT01578499|11098859|FG001|Overall Study|Withdrawal by Subject|16
7023097|NCT01578499|11098858|FG000|Overall Study|Death|20
7023098|NCT01578499|11098859|FG001|Overall Study|Death|25
7023099|NCT01578499|11098858|FG000|Overall Study|Died and End of Study Page not Completed|2
7044149|NCT01751139|11129746|FG000|Overall Study|Lost to Follow-up|240
7183610|NCT01488890|11383706|FG001|Overall Study|Protocol Violation|0
7143178|NCT03028142|11299602|FG000|Overall Study|Adverse Event|1
7143179|NCT03028142|11299603|FG001|Overall Study|Adverse Event|1
7023100|NCT01578499|11098859|FG001|Overall Study|Died and End of Study Page not Completed|0
7023101|NCT01578551|11098871|FG000|Overall Study|Adverse Event|1
7023102|NCT01578551|11098872|FG001|Overall Study|Adverse Event|0
7023103|NCT01578850|11098918|FG000|Period 1|Insufficient Clinical Response|1
7023104|NCT01578850|11098919|FG001|Period 1|Insufficient Clinical Response|0
7023105|NCT01578850|11098920|FG002|Period 1|Insufficient Clinical Response|0
7023106|NCT01578850|11098918|FG000|Period 1|Adverse Event|11
7023107|NCT01578850|11098919|FG001|Period 1|Adverse Event|0
7023108|NCT01578850|11098920|FG002|Period 1|Adverse Event|0
7023109|NCT01578850|11098918|FG000|Period 1|Death|1
7023110|NCT01578850|11098919|FG001|Period 1|Death|0
7023111|NCT01578850|11098920|FG002|Period 1|Death|0
7023112|NCT01578850|11098918|FG000|Period 1|Does Not Meet Entrance Criteria|12
7023113|NCT01578850|11098919|FG001|Period 1|Does Not Meet Entrance Criteria|0
7023114|NCT01578850|11098920|FG002|Period 1|Does Not Meet Entrance Criteria|0
7023115|NCT01578850|11098918|FG000|Period 1|Withdrawal by Subject|9
7023116|NCT01578850|11098919|FG001|Period 1|Withdrawal by Subject|0
7023117|NCT01578850|11098920|FG002|Period 1|Withdrawal by Subject|0
7023118|NCT01578850|11098918|FG000|Period 1|Study Terminated by Sponsor|3
7023119|NCT01578850|11098919|FG001|Period 1|Study Terminated by Sponsor|0
7023120|NCT01578850|11098920|FG002|Period 1|Study Terminated by Sponsor|0
7023121|NCT01578850|11098918|FG000|Period 2|Insufficient Clinical Response|0
7023122|NCT01578850|11098919|FG001|Period 2|Insufficient Clinical Response|1
7023123|NCT01578850|11098920|FG002|Period 2|Insufficient Clinical Response|0
7023124|NCT01578850|11098918|FG000|Period 2|Adverse Event|0
7023125|NCT01578850|11098919|FG001|Period 2|Adverse Event|3
7023126|NCT01578850|11098920|FG002|Period 2|Adverse Event|6
7023127|NCT01578850|11098918|FG000|Period 2|Lost to Follow-up|0
7023128|NCT01578850|11098919|FG001|Period 2|Lost to Follow-up|1
7023129|NCT01578850|11098920|FG002|Period 2|Lost to Follow-up|2
7023130|NCT01578850|11098918|FG000|Period 2|Withdrawal by Subject|0
7023131|NCT01578850|11098919|FG001|Period 2|Withdrawal by Subject|2
7023132|NCT01578850|11098920|FG002|Period 2|Withdrawal by Subject|2
7023133|NCT01578850|11098918|FG000|Period 2|Study Terminated by Sponsor|0
7023134|NCT01578850|11098919|FG001|Period 2|Study Terminated by Sponsor|5
7023135|NCT01578850|11098920|FG002|Period 2|Study Terminated by Sponsor|4
7023136|NCT01578850|11098918|FG000|Period 2|Unspecified Reasons|0
7023137|NCT01578850|11098919|FG001|Period 2|Unspecified Reasons|1
7023138|NCT01578850|11098920|FG002|Period 2|Unspecified Reasons|0
7023139|NCT01579006|11098943|FG000|Overall Study|Lack of Efficacy|10
7023140|NCT01579006|11098943|FG000|Overall Study|Adverse Event|13
7023141|NCT01579006|11098943|FG000|Overall Study|Withdrawal by Subject|5
7023142|NCT01579006|11098943|FG000|Overall Study|Non-compliance|3
7023143|NCT01579006|11098943|FG000|Overall Study|Due to participant's health fund|1
7023144|NCT01579006|11098943|FG000|Overall Study|Scheduled surgery|1
7023145|NCT01579318|11099034|FG000|Overall Study|Disease Progression|1
7023146|NCT01579474|11099044|FG000|Overall Study|Adverse Event|1
7023147|NCT01579474|11099045|FG001|Overall Study|Adverse Event|13
7023148|NCT01579474|11099046|FG002|Overall Study|Adverse Event|2
7023149|NCT01579474|11099047|FG003|Overall Study|Adverse Event|0
7023150|NCT01579474|11099048|FG004|Overall Study|Adverse Event|0
7023151|NCT01579474|11099049|FG005|Overall Study|Adverse Event|1
7023152|NCT01579474|11099044|FG000|Overall Study|Lack of Efficacy|1
7023153|NCT01579474|11099045|FG001|Overall Study|Lack of Efficacy|0
7023154|NCT01579474|11099046|FG002|Overall Study|Lack of Efficacy|0
7023155|NCT01579474|11099047|FG003|Overall Study|Lack of Efficacy|0
7023156|NCT01579474|11099048|FG004|Overall Study|Lack of Efficacy|1
7023157|NCT01579474|11099049|FG005|Overall Study|Lack of Efficacy|0
7023158|NCT01579474|11099044|FG000|Overall Study|Withdrawal by Subject|1
7023159|NCT01579474|11099045|FG001|Overall Study|Withdrawal by Subject|0
7023160|NCT01579474|11099046|FG002|Overall Study|Withdrawal by Subject|0
7023161|NCT01579474|11099047|FG003|Overall Study|Withdrawal by Subject|0
7023162|NCT01579474|11099048|FG004|Overall Study|Withdrawal by Subject|0
7023163|NCT01579474|11099049|FG005|Overall Study|Withdrawal by Subject|0
7023164|NCT01579565|11099073|FG000|Randomized|Adverse Event|1
7023165|NCT01579565|11099074|FG001|Randomized|Adverse Event|3
7023166|NCT01579565|11099073|FG000|Randomized|Withdrawal by Subject|3
7023167|NCT01579565|11099074|FG001|Randomized|Withdrawal by Subject|0
7023168|NCT01579565|11099073|FG000|Randomized|inadequate preoperative pupil dilation|0
7023169|NCT01579565|11099074|FG001|Randomized|inadequate preoperative pupil dilation|1
7023170|NCT01579565|11099073|FG000|Randomized|prohibited preoperative eating|1
7023171|NCT01579565|11099074|FG001|Randomized|prohibited preoperative eating|0
7023172|NCT01579565|11099073|FG000|Randomized|prohibited preoperative medication|0
7023173|NCT01579565|11099074|FG001|Randomized|prohibited preoperative medication|1
7023174|NCT01579565|11099073|FG000|Treated|Physician Decision|0
7023175|NCT01579565|11099074|FG001|Treated|Physician Decision|1
7023176|NCT01579565|11099073|FG000|Treated|Lost to Follow-up|2
7023177|NCT01579565|11099074|FG001|Treated|Lost to Follow-up|1
7023178|NCT01579565|11099073|FG000|Treated|declined to return for final visit|0
7023179|NCT01579565|11099074|FG001|Treated|declined to return for final visit|1
7023180|NCT01579578|11099084|FG000|Overall Study|Death|4
7023181|NCT01579578|11099085|FG001|Overall Study|Death|1
7023182|NCT01579578|11099084|FG000|Overall Study|Lost to Follow-up|1
7023183|NCT01579578|11099085|FG001|Overall Study|Lost to Follow-up|1
7023184|NCT01579578|11099084|FG000|Overall Study|Withdrawal by Subject|2
7023185|NCT01579578|11099085|FG001|Overall Study|Withdrawal by Subject|1
7023186|NCT01579578|11099084|FG000|Overall Study|Eligibility criteria|3
7023187|NCT01579578|11099085|FG001|Overall Study|Eligibility criteria|9
7023188|NCT01579578|11099084|FG000|Overall Study|Ongoing|3
7023189|NCT01579578|11099085|FG001|Overall Study|Ongoing|0
7023190|NCT01579812|11099109|FG000|Overall Study|Ineligible after treatment start|40
7023191|NCT01579812|11099109|FG000|Overall Study|Patient choice|3
7023192|NCT01579812|11099109|FG000|Overall Study|Noncompliance|3
7023193|NCT01579812|11099109|FG000|Overall Study|Withdrawal by Subject|6
7023194|NCT01579916|11099118|FG000|Overall Study|Lost to Follow-up|6
7023195|NCT01579916|11099119|FG001|Overall Study|Lost to Follow-up|1
7023196|NCT01579916|11099118|FG000|Overall Study|Withdrawal by Subject|1
7023197|NCT01579916|11099119|FG001|Overall Study|Withdrawal by Subject|1
7023198|NCT01579916|11099118|FG000|Overall Study|Death|1
7023199|NCT01579916|11099119|FG001|Overall Study|Death|0
7023200|NCT01580020|11099127|FG000|Overall Study|Lack of Efficacy|0
7023201|NCT01580020|11099128|FG001|Overall Study|Lack of Efficacy|5
7023202|NCT01580020|11099129|FG002|Overall Study|Lack of Efficacy|0
7023203|NCT01580020|11099130|FG003|Overall Study|Lack of Efficacy|1
7023204|NCT01580020|11099127|FG000|Overall Study|Withdrawal by Subject|0
7023205|NCT01580020|11099128|FG001|Overall Study|Withdrawal by Subject|1
7023206|NCT01580020|11099129|FG002|Overall Study|Withdrawal by Subject|1
7023207|NCT01580020|11099130|FG003|Overall Study|Withdrawal by Subject|0
7023208|NCT01580020|11099127|FG000|Overall Study|Adverse Event|1
7023209|NCT01580020|11099128|FG001|Overall Study|Adverse Event|1
7023210|NCT01580020|11099129|FG002|Overall Study|Adverse Event|1
7023211|NCT01580020|11099130|FG003|Overall Study|Adverse Event|1
7023212|NCT01580020|11099127|FG000|Overall Study|Administrative Problems|0
7023213|NCT01580020|11099128|FG001|Overall Study|Administrative Problems|0
7023214|NCT01580020|11099129|FG002|Overall Study|Administrative Problems|1
7023215|NCT01580020|11099130|FG003|Overall Study|Administrative Problems|0
7023216|NCT01580020|11099127|FG000|Overall Study|Lost to Follow-up|0
7023217|NCT01580020|11099128|FG001|Overall Study|Lost to Follow-up|0
7023218|NCT01580020|11099129|FG002|Overall Study|Lost to Follow-up|1
7023219|NCT01580020|11099130|FG003|Overall Study|Lost to Follow-up|0
7023220|NCT01580293|11099171|FG000|Part A_Main Trial|Adverse Event|0
7023221|NCT01580293|11099172|FG001|Part A_Main Trial|Adverse Event|2
7023222|NCT01580293|11099173|FG002|Part A_Main Trial|Adverse Event|0
7023223|NCT01580293|11099171|FG000|Part A_Main Trial|Withdrawal by Subject|1
7023224|NCT01580293|11099172|FG001|Part A_Main Trial|Withdrawal by Subject|4
7023225|NCT01580293|11099173|FG002|Part A_Main Trial|Withdrawal by Subject|0
7023226|NCT01580293|11099171|FG000|Part A_Main Trial|Non-adherence to the protocol|1
7023227|NCT01580293|11099172|FG001|Part A_Main Trial|Non-adherence to the protocol|0
7023228|NCT01580293|11099173|FG002|Part A_Main Trial|Non-adherence to the protocol|0
7023229|NCT01580293|11099171|FG000|Part A_Extension|Adverse Event|0
7023230|NCT01580293|11099172|FG001|Part A_Extension|Adverse Event|2
7023231|NCT01580293|11099173|FG002|Part A_Extension|Adverse Event|0
7023232|NCT01580293|11099171|FG000|Part A_Extension|Withdrawal by Subject|0
7023233|NCT01580293|11099172|FG001|Part A_Extension|Withdrawal by Subject|3
7023234|NCT01580293|11099173|FG002|Part A_Extension|Withdrawal by Subject|0
7023235|NCT01580293|11099171|FG000|Part A_Extension|Lost to Follow-up|0
7023236|NCT01580293|11099172|FG001|Part A_Extension|Lost to Follow-up|1
7023237|NCT01580293|11099173|FG002|Part A_Extension|Lost to Follow-up|0
7023238|NCT01580293|11099171|FG000|Part A_Extension|Other Reason|0
7023239|NCT01580293|11099172|FG001|Part A_Extension|Other Reason|1
7023240|NCT01580293|11099173|FG002|Part A_Extension|Other Reason|0
7023241|NCT01580293|11099171|FG000|Part A_Extension|Completed Japan only|0
7023242|NCT01580293|11099172|FG001|Part A_Extension|Completed Japan only|5
7023243|NCT01580293|11099173|FG002|Part A_Extension|Completed Japan only|0
7023244|NCT01580293|11099171|FG000|Part B|Withdrawal by Subject|0
7023245|NCT01580293|11099172|FG001|Part B|Withdrawal by Subject|0
7023246|NCT01580293|11099173|FG002|Part B|Withdrawal by Subject|1
7023247|NCT01580293|11099171|FG000|Part B|Other reason|0
7023248|NCT01580293|11099172|FG001|Part B|Other reason|0
7023249|NCT01580293|11099173|FG002|Part B|Other reason|1
7023250|NCT01580488|11099234|FG000|Overall Study|Withdrawal by Subject|1
7023251|NCT01580670|11099270|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1
7023252|NCT01580670|11099270|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1
7023253|NCT01580969|11099287|FG000|Overall Study|Physician Decision|3
7023254|NCT01580969|11099288|FG001|Overall Study|Physician Decision|0
7023255|NCT01580969|11099289|FG002|Overall Study|Physician Decision|0
7023256|NCT01580995|11099299|FG000|Overall Study|Lost to Follow-up|2
7023257|NCT01580995|11099300|FG001|Overall Study|Lost to Follow-up|2
7023258|NCT01581021|11099318|FG000|Overall Study|Lost to Follow-up|4
7023259|NCT01581021|11099319|FG001|Overall Study|Lost to Follow-up|6
7023260|NCT01581021|11099318|FG000|Overall Study|More than 2 hooks in thoracic|3
7023261|NCT01581021|11099319|FG001|Overall Study|More than 2 hooks in thoracic|0
7023262|NCT01581021|11099318|FG000|Overall Study|Neuromuscular|2
7023263|NCT01581021|11099319|FG001|Overall Study|Neuromuscular|1
7023264|NCT01581021|11099318|FG000|Overall Study|Not Randomized|1
7023265|NCT01581021|11099319|FG001|Overall Study|Not Randomized|2
7023266|NCT01581021|11099318|FG000|Overall Study|Lenke 6 Classification|0
7023267|NCT01581021|11099319|FG001|Overall Study|Lenke 6 Classification|1
7023268|NCT01581021|11099318|FG000|Overall Study|Lack of Efficacy|0
7023269|NCT01581021|11099319|FG001|Overall Study|Lack of Efficacy|1
7023270|NCT01581281|11099328|FG000|Overall Study|Early Study Closure|15
7023271|NCT01581281|11099329|FG001|Overall Study|Early Study Closure|6
7023272|NCT01581281|11099330|FG002|Overall Study|Early Study Closure|12
7023273|NCT01581307|11099339|FG000|Overall Study|Withdrawal by Subject|1
7023274|NCT01581593|11099386|FG000|Overall Study|Withdrawal by Subject|1
7023275|NCT01581619|11099394|FG000|Overall Study|Withdrawal by Subject|1
7023276|NCT01581619|11099394|FG000|Overall Study|Lost to Follow-up|1
7023277|NCT01581684|11099427|FG000|Overall Study|Other reason not defined|0
7023278|NCT01581684|11099428|FG001|Overall Study|Other reason not defined|0
7023279|NCT01581684|11099429|FG002|Overall Study|Other reason not defined|0
7023280|NCT01581684|11099430|FG003|Overall Study|Other reason not defined|0
7023281|NCT01581684|11099431|FG004|Overall Study|Other reason not defined|0
7023282|NCT01581684|11099432|FG005|Overall Study|Other reason not defined|0
7023283|NCT01581684|11099433|FG006|Overall Study|Other reason not defined|0
7023284|NCT01581684|11099434|FG007|Overall Study|Other reason not defined|0
7023285|NCT01581684|11099435|FG008|Overall Study|Other reason not defined|1
7023286|NCT01581684|11099436|FG009|Overall Study|Other reason not defined|0
7023287|NCT01581931|11099480|FG000|Washout|Adverse Event|0
7023288|NCT01581931|11099481|FG001|Washout|Adverse Event|1
7023289|NCT01582009|11099491|FG000|Overall Study|Withdrawal by Subject|1
7023290|NCT01582009|11099491|FG000|Overall Study|Physician Decision|1
7023291|NCT01582061|11099497|FG000|Overall Study|Lack of Efficacy|3
7023292|NCT01582061|11099498|FG001|Overall Study|Lack of Efficacy|23
7023293|NCT01582061|11099497|FG000|Overall Study|Adverse Event|12
7023294|NCT01582061|11099498|FG001|Overall Study|Adverse Event|8
7023295|NCT01582061|11099497|FG000|Overall Study|Withdrawal by Subject|10
7023296|NCT01582061|11099498|FG001|Overall Study|Withdrawal by Subject|4
7023297|NCT01582061|11099497|FG000|Overall Study|Abnormal laboratory value(s)|1
7023298|NCT01582061|11099498|FG001|Overall Study|Abnormal laboratory value(s)|0
7023299|NCT01582061|11099497|FG000|Overall Study|Death|0
7023300|NCT01582061|11099498|FG001|Overall Study|Death|1
7023301|NCT01582061|11099497|FG000|Overall Study|condition no longer requires study drug|1
7023302|NCT01582061|11099498|FG001|Overall Study|condition no longer requires study drug|0
7023303|NCT01582061|11099497|FG000|Overall Study|Lost to Follow-up|1
7023304|NCT01582061|11099498|FG001|Overall Study|Lost to Follow-up|0
7023305|NCT01582152|11099525|FG000|Overall Study|Disease Progression|4
7023306|NCT01582152|11099526|FG001|Overall Study|Disease Progression|5
7023307|NCT01582152|11099525|FG000|Overall Study|Adverse Event|2
7023308|NCT01582152|11099526|FG001|Overall Study|Adverse Event|1
7023309|NCT01582178|11099534|FG000|Overall Study|Physician Decision|6
7023310|NCT01582178|11099535|FG001|Overall Study|Physician Decision|5
7023311|NCT01582243|11099541|FG000|Overall Study|Withdrawal by Subject|1
7023312|NCT01582243|11099541|FG000|Overall Study|Adverse Event|1
7023313|NCT01582243|11099541|FG000|Overall Study|Lost to Follow-up|1
7023314|NCT01582282|11099548|FG000|Overall Study|Adverse Event|1
7023315|NCT01582282|11099549|FG001|Overall Study|Adverse Event|1
7023316|NCT01582282|11099550|FG002|Overall Study|Adverse Event|0
7023317|NCT01582282|11099548|FG000|Overall Study|Lost to Follow-up|1
7023318|NCT01582282|11099549|FG001|Overall Study|Lost to Follow-up|0
7023319|NCT01582282|11099550|FG002|Overall Study|Lost to Follow-up|0
7023320|NCT01582282|11099548|FG000|Overall Study|fasting blood glucose outside Protocol|0
7023321|NCT01582282|11099549|FG001|Overall Study|fasting blood glucose outside Protocol|1
7023322|NCT01582282|11099550|FG002|Overall Study|fasting blood glucose outside Protocol|0
7023323|NCT01582308|11099558|FG000|Period 1|Withdrawal by Subject|0
7023324|NCT01582308|11099559|FG001|Period 1|Withdrawal by Subject|0
7023325|NCT01582308|11099560|FG002|Period 1|Withdrawal by Subject|0
7023326|NCT01582308|11099561|FG003|Period 1|Withdrawal by Subject|0
7023327|NCT01582308|11099562|FG004|Period 1|Withdrawal by Subject|0
7023328|NCT01582308|11099563|FG005|Period 1|Withdrawal by Subject|0
7023329|NCT01582308|11099564|FG006|Period 1|Withdrawal by Subject|1
7023330|NCT01582308|11099565|FG007|Period 1|Withdrawal by Subject|0
7023331|NCT01582308|11099566|FG008|Period 1|Withdrawal by Subject|0
7023332|NCT01582308|11099567|FG009|Period 1|Withdrawal by Subject|0
7023333|NCT01582308|11099558|FG000|10-day Washout Following Period 1|Physician Decision|0
7023334|NCT01582308|11099559|FG001|10-day Washout Following Period 1|Physician Decision|0
7023335|NCT01582308|11099560|FG002|10-day Washout Following Period 1|Physician Decision|0
7023336|NCT01582308|11099561|FG003|10-day Washout Following Period 1|Physician Decision|0
7023337|NCT01582308|11099562|FG004|10-day Washout Following Period 1|Physician Decision|1
7023338|NCT01582308|11099563|FG005|10-day Washout Following Period 1|Physician Decision|0
7023339|NCT01582308|11099564|FG006|10-day Washout Following Period 1|Physician Decision|0
7023340|NCT01582308|11099565|FG007|10-day Washout Following Period 1|Physician Decision|0
7023341|NCT01582308|11099566|FG008|10-day Washout Following Period 1|Physician Decision|0
7023342|NCT01582308|11099567|FG009|10-day Washout Following Period 1|Physician Decision|0
7023343|NCT01582308|11099558|FG000|Period 4|Physician Decision|1
7023344|NCT01582308|11099559|FG001|Period 4|Physician Decision|0
7023345|NCT01582308|11099560|FG002|Period 4|Physician Decision|0
7023346|NCT01582308|11099561|FG003|Period 4|Physician Decision|0
7023347|NCT01582308|11099562|FG004|Period 4|Physician Decision|0
7023348|NCT01582308|11099563|FG005|Period 4|Physician Decision|1
7023349|NCT01582308|11099564|FG006|Period 4|Physician Decision|0
7023350|NCT01582308|11099565|FG007|Period 4|Physician Decision|0
7023351|NCT01582308|11099566|FG008|Period 4|Physician Decision|0
7023352|NCT01582308|11099567|FG009|Period 4|Physician Decision|1
7023353|NCT01582451|11099582|FG000|Overall Study|Adverse Event|1
7023354|NCT01582451|11099583|FG001|Overall Study|Adverse Event|3
7023355|NCT01582451|11099582|FG000|Overall Study|Death|3
7023356|NCT01582451|11099583|FG001|Overall Study|Death|3
7023357|NCT01582451|11099582|FG000|Overall Study|Lost to Follow-up|0
7023358|NCT01582451|11099583|FG001|Overall Study|Lost to Follow-up|2
7023359|NCT01582451|11099582|FG000|Overall Study|Protocol Violation|11
7023360|NCT01582451|11099583|FG001|Overall Study|Protocol Violation|3
7023361|NCT01582451|11099582|FG000|Overall Study|Withdrawal by Subject|13
7023362|NCT01582451|11099583|FG001|Overall Study|Withdrawal by Subject|9
7023363|NCT01582451|11099582|FG000|Overall Study|Physician Decision|3
7023364|NCT01582451|11099583|FG001|Overall Study|Physician Decision|0
7023365|NCT01582451|11099582|FG000|Overall Study|Sponsor Decision|1
7023366|NCT01582451|11099583|FG001|Overall Study|Sponsor Decision|0
7023367|NCT01582789|11099609|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1
7023368|NCT01582789|11099610|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0
7023369|NCT01582854|11099620|FG000|Overall Study|Death|8
7023370|NCT01582854|11099621|FG001|Overall Study|Death|5
7023371|NCT01582854|11099620|FG000|Overall Study|Adverse Event|2
7023372|NCT01582854|11099621|FG001|Overall Study|Adverse Event|3
7023373|NCT01582854|11099620|FG000|Overall Study|Withdrawal by Participant|8
7023374|NCT01582854|11099621|FG001|Overall Study|Withdrawal by Participant|11
7023375|NCT01582854|11099620|FG000|Overall Study|Lost to Follow-up|1
7023376|NCT01582854|11099621|FG001|Overall Study|Lost to Follow-up|2
7023377|NCT01582854|11099620|FG000|Overall Study|Physician Decision|0
7023378|NCT01582854|11099621|FG001|Overall Study|Physician Decision|1
7023379|NCT01582854|11099620|FG000|Overall Study|Recurrent Stroke|13
7023380|NCT01582854|11099621|FG001|Overall Study|Recurrent Stroke|8
7023381|NCT01582854|11099620|FG000|Overall Study|Disallowed Concomitant Medication|3
7023382|NCT01582854|11099621|FG001|Overall Study|Disallowed Concomitant Medication|2
7023383|NCT01582854|11099620|FG000|Overall Study|Carotid or Neurosurgery|0
7023384|NCT01582854|11099621|FG001|Overall Study|Carotid or Neurosurgery|1
7023385|NCT01582854|11099620|FG000|Overall Study|General Anaesthesia|0
7023386|NCT01582854|11099621|FG001|Overall Study|General Anaesthesia|1
7023387|NCT01582854|11099620|FG000|Overall Study|Other Miscellaneous Reason|1
7023388|NCT01582854|11099621|FG001|Overall Study|Other Miscellaneous Reason|0
7023389|NCT01582945|11099631|FG000|Overall Study|Intolerable side-effects|1
7023390|NCT01582945|11099631|FG000|Overall Study|Scheduling conflicts|1
7023391|NCT01582971|11099637|FG000|Overall Study|Death|2
7023392|NCT01582971|11099638|FG001|Overall Study|Death|1
7023393|NCT01582971|11099637|FG000|Overall Study|Lost to Follow-up|18
7023394|NCT01582971|11099638|FG001|Overall Study|Lost to Follow-up|21
7023395|NCT01582971|11099637|FG000|Overall Study|Withdrawal by Subject|4
7023396|NCT01582971|11099638|FG001|Overall Study|Withdrawal by Subject|2
7023397|NCT01582971|11099637|FG000|Overall Study|Other|15
7023398|NCT01582971|11099638|FG001|Overall Study|Other|13
7023399|NCT01583166|11099661|FG000|Overall Study|Withdrawal by Subject|4
7023400|NCT01583166|11099662|FG001|Overall Study|Withdrawal by Subject|6
7023401|NCT01583179|11099670|FG000|Overall Study|Screen failure|1
7023402|NCT01583179|11099671|FG001|Overall Study|Screen failure|2
7023403|NCT01583218|11099679|FG000|Overall Study|Withdrawal by Subject|43
7023404|NCT01583218|11099680|FG001|Overall Study|Withdrawal by Subject|29
7023405|NCT01583218|11099679|FG000|Overall Study|Death|206
7023406|NCT01583218|11099680|FG001|Overall Study|Death|211
7023407|NCT01583218|11099679|FG000|Overall Study|Lost to Follow-up|11
7023408|NCT01583218|11099680|FG001|Overall Study|Lost to Follow-up|17
7023409|NCT01583218|11099679|FG000|Overall Study|Adverse event or serious adverse event|3
7023410|NCT01583218|11099680|FG001|Overall Study|Adverse event or serious adverse event|3
7023411|NCT01583218|11099679|FG000|Overall Study|Patient /Family decision|3
7023412|NCT01583218|11099680|FG001|Overall Study|Patient /Family decision|0
7023413|NCT01583218|11099679|FG000|Overall Study|Cannot contact patient directly|1
7023414|NCT01583218|11099680|FG001|Overall Study|Cannot contact patient directly|2
7023415|NCT01583218|11099679|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0
7023416|NCT01583218|11099680|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2
7023417|NCT01583218|11099679|FG000|Overall Study|Patient did not wish to attend visits|0
7023418|NCT01583218|11099680|FG001|Overall Study|Patient did not wish to attend visits|1
7023419|NCT01583218|11099679|FG000|Overall Study|Patient randomized but not dosed|17
7023420|NCT01583218|11099680|FG001|Overall Study|Patient randomized but not dosed|16
7023421|NCT01583218|11099679|FG000|Overall Study|Patient was assessed via phone in person|1
7023422|NCT01583218|11099680|FG001|Overall Study|Patient was assessed via phone in person|0
7023423|NCT01583218|11099679|FG000|Overall Study|Patient deemed ineligible after random|2
7023424|NCT01583218|11099680|FG001|Overall Study|Patient deemed ineligible after random|0
7023425|NCT01583218|11099679|FG000|Overall Study|Patient was early terminated from study|0
7023426|NCT01583218|11099680|FG001|Overall Study|Patient was early terminated from study|1
7023427|NCT01583218|11099679|FG000|Overall Study|Patient was randomized due to mistake|1
7023428|NCT01583218|11099680|FG001|Overall Study|Patient was randomized due to mistake|0
7023429|NCT01583218|11099679|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0
7023430|NCT01583218|11099680|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1
7023431|NCT01583218|11099679|FG000|Overall Study|Withdraw of consent on day of random|1
7023432|NCT01583218|11099680|FG001|Overall Study|Withdraw of consent on day of random|0
7044150|NCT01751139|11129746|FG000|Overall Study|Withdrawal by Subject|251
7044151|NCT01751139|11129746|FG000|Overall Study|Adverse Event|1
7044152|NCT01751139|11129746|FG000|Overall Study|Death|31
7044153|NCT01751165|11129753|FG000|Overall Study|Adverse event, serious fatal|1
7044154|NCT01751165|11129754|FG001|Overall Study|Adverse event, serious fatal|0
7044155|NCT01751165|11129755|FG002|Overall Study|Adverse event, serious fatal|1
7044156|NCT01751165|11129753|FG000|Overall Study|Withdrawal by Subject|0
7044157|NCT01751165|11129754|FG001|Overall Study|Withdrawal by Subject|0
7044158|NCT01751165|11129755|FG002|Overall Study|Withdrawal by Subject|1
7044159|NCT01751165|11129753|FG000|Overall Study|Serious adverse event|0
7044160|NCT01751165|11129754|FG001|Overall Study|Serious adverse event|2
7044161|NCT01751165|11129755|FG002|Overall Study|Serious adverse event|0
7044162|NCT01751165|11129753|FG000|Overall Study|Lost to Follow-up|1
7044163|NCT01751165|11129754|FG001|Overall Study|Lost to Follow-up|1
7044164|NCT01751165|11129755|FG002|Overall Study|Lost to Follow-up|1
7044165|NCT01751178|11129768|FG000|Overall Study|Adverse Event|2
7044166|NCT01751178|11129769|FG001|Overall Study|Adverse Event|0
7044167|NCT01751178|11129770|FG002|Overall Study|Adverse Event|0
7044168|NCT01751178|11129768|FG000|Overall Study|Other Reason (unknown)|1
7044169|NCT01751178|11129769|FG001|Overall Study|Other Reason (unknown)|0
7044170|NCT01751178|11129770|FG002|Overall Study|Other Reason (unknown)|2
7044911|NCT01760447|11131137|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0
7044912|NCT01760447|11131134|FG000|Weeks 20-54|Withdrawal by Subject|2
7044913|NCT01760447|11131135|FG001|Weeks 20-54|Withdrawal by Subject|1
7044914|NCT01760447|11131136|FG002|Weeks 20-54|Withdrawal by Subject|1
7044915|NCT01760447|11131137|FG003|Weeks 20-54|Withdrawal by Subject|2
7044916|NCT01760447|11131134|FG000|Weeks 20-54|Lost to Follow-up|0
7044917|NCT01760447|11131135|FG001|Weeks 20-54|Lost to Follow-up|0
7044918|NCT01760447|11131136|FG002|Weeks 20-54|Lost to Follow-up|1
7044919|NCT01760447|11131137|FG003|Weeks 20-54|Lost to Follow-up|2
7044920|NCT01760733|11131165|FG000|Waiting List|Death|18
7044921|NCT01760733|11131165|FG000|Waiting List|Removed from waiting list|41
7044922|NCT01760733|11131165|FG000|Waiting List|Not received a transplant yet|13
7044923|NCT01760733|11131165|FG000|Transplanted|Not reached 10 years post transplant|184
7044924|NCT01760733|11131165|FG000|Transplanted|Death|26
7044925|NCT01760733|11131165|FG000|Transplanted|Graft loss|7
7044926|NCT01760876|11131179|FG000|Overall Study|Non-cardiac death (head injury)|1
7044927|NCT01760876|11131179|FG000|Overall Study|Carcinoma of prostate|1
7044928|NCT01760876|11131179|FG000|Overall Study|Impaired renal function|1
7044929|NCT01760876|11131179|FG000|Overall Study|Major depression|1
7044930|NCT01760876|11131179|FG000|Overall Study|Very poor baseline OCT quality|2
7044931|NCT01760954|11131187|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8
7044932|NCT01760954|11131188|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8
7044933|NCT01760954|11131189|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4
7044934|NCT01760954|11131190|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5
7044935|NCT01760954|11131187|FG000|Treatment Period (6 Months)|Adverse Event|5
7044936|NCT01760954|11131188|FG001|Treatment Period (6 Months)|Adverse Event|3
7044937|NCT01760954|11131189|FG002|Treatment Period (6 Months)|Adverse Event|4
7044938|NCT01760954|11131190|FG003|Treatment Period (6 Months)|Adverse Event|10
7044939|NCT01760954|11131187|FG000|Treatment Period (6 Months)|Lost to Follow-up|9
7044940|NCT01760954|11131188|FG001|Treatment Period (6 Months)|Lost to Follow-up|1
7044941|NCT01760954|11131189|FG002|Treatment Period (6 Months)|Lost to Follow-up|4
7044942|NCT01760954|11131190|FG003|Treatment Period (6 Months)|Lost to Follow-up|3
7044943|NCT01760954|11131187|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
7044944|NCT01760954|11131188|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
7044945|NCT01760954|11131189|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
7044946|NCT01760954|11131190|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2
7044947|NCT01760954|11131187|FG000|Treatment Period (6 Months)|Pregnancy|5
7044948|NCT01760954|11131188|FG001|Treatment Period (6 Months)|Pregnancy|0
7044949|NCT01760954|11131189|FG002|Treatment Period (6 Months)|Pregnancy|3
7044950|NCT01760954|11131190|FG003|Treatment Period (6 Months)|Pregnancy|2
7044951|NCT01760954|11131187|FG000|Treatment Period (6 Months)|Non-compliance|1
7044952|NCT01760954|11131188|FG001|Treatment Period (6 Months)|Non-compliance|4
7044953|NCT01760954|11131189|FG002|Treatment Period (6 Months)|Non-compliance|0
7044954|NCT01760954|11131190|FG003|Treatment Period (6 Months)|Non-compliance|3
7044955|NCT01760954|11131187|FG000|Treatment Period (6 Months)|Other|0
7044956|NCT01760954|11131188|FG001|Treatment Period (6 Months)|Other|3
7044957|NCT01760954|11131189|FG002|Treatment Period (6 Months)|Other|3
7044958|NCT01760954|11131190|FG003|Treatment Period (6 Months)|Other|1
7044959|NCT01760954|11131187|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1
7044960|NCT01760954|11131188|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6
7044961|NCT01760954|11131189|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0
7044962|NCT01760954|11131190|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0
7044963|NCT01760954|11131187|FG000|Treatment Period (6 Months)|Exclusionary Medication|1
7044964|NCT01760954|11131188|FG001|Treatment Period (6 Months)|Exclusionary Medication|0
7044965|NCT01760954|11131189|FG002|Treatment Period (6 Months)|Exclusionary Medication|0
7044966|NCT01760954|11131190|FG003|Treatment Period (6 Months)|Exclusionary Medication|0
7023433|NCT01583296|11099688|FG000|Overall Study|Withdrawal by Subject|11
7023434|NCT01583296|11099689|FG001|Overall Study|Withdrawal by Subject|10
7023435|NCT01583374|11099698|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6
7023436|NCT01583374|11099699|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7
7023437|NCT01583374|11099700|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12
7023438|NCT01583374|11099701|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7023439|NCT01583374|11099702|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7023440|NCT01583374|11099703|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7023441|NCT01583374|11099704|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7023442|NCT01583374|11099705|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7023443|NCT01583374|11099706|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7023444|NCT01583374|11099698|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3
7023445|NCT01583374|11099699|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2
7023446|NCT01583374|11099700|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5
7023447|NCT01583374|11099701|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7023448|NCT01583374|11099702|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7023449|NCT01583374|11099703|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7023450|NCT01583374|11099704|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7023451|NCT01583374|11099705|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7023452|NCT01583374|11099706|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7023453|NCT01583374|11099698|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
7023454|NCT01583374|11099699|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
7023455|NCT01583374|11099700|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7023456|NCT01583374|11099701|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7023457|NCT01583374|11099702|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7023458|NCT01583374|11099703|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7023459|NCT01583374|11099704|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7023460|NCT01583374|11099705|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7023461|NCT01583374|11099706|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7023462|NCT01583374|11099698|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8
7023463|NCT01583374|11099699|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3
7023464|NCT01583374|11099700|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5
7023465|NCT01583374|11099701|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7023466|NCT01583374|11099702|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7023467|NCT01583374|11099703|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7023468|NCT01583374|11099704|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7023469|NCT01583374|11099705|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7023470|NCT01583374|11099706|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7023471|NCT01583374|11099698|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1
7023472|NCT01583374|11099699|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2
7023473|NCT01583374|11099700|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
7023474|NCT01583374|11099701|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
7023475|NCT01583374|11099702|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
7023476|NCT01583374|11099703|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
7023477|NCT01583374|11099704|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
7023478|NCT01583374|11099705|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
7023479|NCT01583374|11099706|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
7023480|NCT01583374|11099698|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7023481|NCT01583374|11099699|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7023482|NCT01583374|11099700|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3
7023483|NCT01583374|11099701|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7023484|NCT01583374|11099702|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7023485|NCT01583374|11099703|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7023486|NCT01583374|11099704|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7023487|NCT01583374|11099705|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7023488|NCT01583374|11099706|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7023489|NCT01583374|11099698|FG000|Placebo-controlled Phase (Week 0-24)|Other|0
7023490|NCT01583374|11099699|FG001|Placebo-controlled Phase (Week 0-24)|Other|1
7023491|NCT01583374|11099700|FG002|Placebo-controlled Phase (Week 0-24)|Other|0
7023492|NCT01583374|11099701|FG003|Placebo-controlled Phase (Week 0-24)|Other|0
7023493|NCT01583374|11099702|FG004|Placebo-controlled Phase (Week 0-24)|Other|0
7023494|NCT01583374|11099703|FG005|Placebo-controlled Phase (Week 0-24)|Other|0
7023495|NCT01583374|11099704|FG006|Placebo-controlled Phase (Week 0-24)|Other|0
7023496|NCT01583374|11099705|FG007|Placebo-controlled Phase (Week 0-24)|Other|0
7023497|NCT01583374|11099706|FG008|Placebo-controlled Phase (Week 0-24)|Other|0
7023498|NCT01583374|11099698|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
7023499|NCT01583374|11099699|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
7023500|NCT01583374|11099700|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
7023501|NCT01583374|11099701|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
7023502|NCT01583374|11099702|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
7023503|NCT01583374|11099703|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
7023504|NCT01583374|11099704|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
7023505|NCT01583374|11099705|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1
7023506|NCT01583374|11099706|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
7023507|NCT01583374|11099698|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0
7023508|NCT01583374|11099699|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1
7023509|NCT01583374|11099700|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2
7023510|NCT01583374|11099701|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0
7023511|NCT01583374|11099702|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1
7023512|NCT01583374|11099703|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1
7023513|NCT01583374|11099704|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0
7023514|NCT01583374|11099705|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1
7023515|NCT01583374|11099706|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0
7023516|NCT01583374|11099698|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
7023517|NCT01583374|11099699|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
7023518|NCT01583374|11099700|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
7023519|NCT01583374|11099701|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6
7023520|NCT01583374|11099702|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3
7023521|NCT01583374|11099703|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
7023522|NCT01583374|11099704|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5
7023523|NCT01583374|11099705|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1
7023524|NCT01583374|11099706|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
7023525|NCT01583374|11099698|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
7023526|NCT01583374|11099699|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2
7023527|NCT01583374|11099700|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1
7023528|NCT01583374|11099701|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
7023529|NCT01583374|11099702|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1
7023530|NCT01583374|11099703|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
7023531|NCT01583374|11099704|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
7023532|NCT01583374|11099705|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
7023533|NCT01583374|11099706|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
7023534|NCT01583374|11099698|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
7023535|NCT01583374|11099699|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
7023536|NCT01583374|11099700|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
7023537|NCT01583374|11099701|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
7023538|NCT01583374|11099702|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
7023539|NCT01583374|11099703|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2
7023540|NCT01583374|11099704|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
7023541|NCT01583374|11099705|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
7023542|NCT01583374|11099706|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
7023543|NCT01583374|11099698|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0
7023544|NCT01583374|11099699|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5
7023545|NCT01583374|11099700|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
7023546|NCT01583374|11099701|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
7023547|NCT01583374|11099702|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6
7023548|NCT01583374|11099703|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
7023549|NCT01583374|11099704|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
7023550|NCT01583374|11099705|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3
7023551|NCT01583374|11099706|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1
7023552|NCT01583374|11099698|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0
7023553|NCT01583374|11099699|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
7023554|NCT01583374|11099700|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6
7023555|NCT01583374|11099701|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7
7023556|NCT01583374|11099702|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10
7023557|NCT01583374|11099703|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7
7023558|NCT01583374|11099704|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
7023559|NCT01583374|11099705|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2
7023560|NCT01583374|11099706|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
7023561|NCT01583374|11099698|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
7023562|NCT01583374|11099699|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
7023563|NCT01583374|11099700|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
7023564|NCT01583374|11099701|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
7023565|NCT01583374|11099702|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
7023566|NCT01583374|11099703|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
7023567|NCT01583374|11099704|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
7023568|NCT01583374|11099705|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
7023569|NCT01583374|11099706|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
7023570|NCT01583374|11099698|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0
7023571|NCT01583374|11099699|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11
7023572|NCT01583374|11099700|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11
7023573|NCT01583374|11099701|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1
7023574|NCT01583374|11099702|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12
7023575|NCT01583374|11099703|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7
7023576|NCT01583374|11099704|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5
7023577|NCT01583374|11099705|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3
7023578|NCT01583374|11099706|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3
7023579|NCT01583374|11099698|FG000|Long-Term Extension Phase Weeks 52-260|Death|0
7023580|NCT01583374|11099699|FG001|Long-Term Extension Phase Weeks 52-260|Death|0
7023581|NCT01583374|11099700|FG002|Long-Term Extension Phase Weeks 52-260|Death|0
7023582|NCT01583374|11099701|FG003|Long-Term Extension Phase Weeks 52-260|Death|0
7023583|NCT01583374|11099702|FG004|Long-Term Extension Phase Weeks 52-260|Death|1
7023584|NCT01583374|11099703|FG005|Long-Term Extension Phase Weeks 52-260|Death|0
7023585|NCT01583374|11099704|FG006|Long-Term Extension Phase Weeks 52-260|Death|1
7023586|NCT01583374|11099705|FG007|Long-Term Extension Phase Weeks 52-260|Death|0
7023587|NCT01583374|11099706|FG008|Long-Term Extension Phase Weeks 52-260|Death|0
7023588|NCT01583374|11099698|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
7023589|NCT01583374|11099699|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
7023590|NCT01583374|11099700|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
7023591|NCT01583374|11099701|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
7023592|NCT01583374|11099702|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
7023593|NCT01583374|11099703|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
7023594|NCT01583374|11099704|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
7023595|NCT01583374|11099705|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
7023596|NCT01583374|11099706|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
7023597|NCT01583374|11099698|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
7023598|NCT01583374|11099699|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5
7023599|NCT01583374|11099700|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
7023600|NCT01583374|11099701|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2
7023601|NCT01583374|11099702|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
7023602|NCT01583374|11099703|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
7023603|NCT01583374|11099704|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5
7023604|NCT01583374|11099705|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
7023605|NCT01583374|11099706|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
7023606|NCT01583530|11099743|FG000|Overall Study|Adverse Event|0
7023607|NCT01583530|11099744|FG001|Overall Study|Adverse Event|0
7023608|NCT01583530|11099745|FG002|Overall Study|Adverse Event|0
7023609|NCT01583530|11099746|FG003|Overall Study|Adverse Event|0
7023610|NCT01583530|11099747|FG004|Overall Study|Adverse Event|0
7023611|NCT01583530|11099748|FG005|Overall Study|Adverse Event|1
7023612|NCT01583530|11099743|FG000|Overall Study|Withdrawal by Subject|0
7023613|NCT01583530|11099744|FG001|Overall Study|Withdrawal by Subject|3
7023614|NCT01583530|11099745|FG002|Overall Study|Withdrawal by Subject|0
7023615|NCT01583530|11099746|FG003|Overall Study|Withdrawal by Subject|1
7023616|NCT01583530|11099747|FG004|Overall Study|Withdrawal by Subject|1
7023617|NCT01583530|11099748|FG005|Overall Study|Withdrawal by Subject|2
7023618|NCT01583530|11099743|FG000|Overall Study|Lost to Follow-up|0
7023619|NCT01583530|11099744|FG001|Overall Study|Lost to Follow-up|0
7023620|NCT01583530|11099745|FG002|Overall Study|Lost to Follow-up|0
7023621|NCT01583530|11099746|FG003|Overall Study|Lost to Follow-up|0
7023622|NCT01583530|11099747|FG004|Overall Study|Lost to Follow-up|3
7023623|NCT01583530|11099748|FG005|Overall Study|Lost to Follow-up|0
7023624|NCT01583530|11099743|FG000|Overall Study|Lack of compliance|0
7023625|NCT01583530|11099744|FG001|Overall Study|Lack of compliance|0
7023626|NCT01583530|11099745|FG002|Overall Study|Lack of compliance|0
7023627|NCT01583530|11099746|FG003|Overall Study|Lack of compliance|0
7023628|NCT01583530|11099747|FG004|Overall Study|Lack of compliance|1
7023629|NCT01583530|11099748|FG005|Overall Study|Lack of compliance|0
7023630|NCT01584024|11099822|FG000|Overall Study|Lost to Follow-up|10
7023631|NCT01584024|11099822|FG000|Overall Study|Withdrawal by Subject|3
7023632|NCT01584232|11099829|FG000|Overall Study|Adverse Event|3
7023633|NCT01584232|11099830|FG001|Overall Study|Adverse Event|1
7023634|NCT01584232|11099829|FG000|Overall Study|Withdrawal by Subject|2
7023635|NCT01584232|11099830|FG001|Overall Study|Withdrawal by Subject|1
7023636|NCT01584232|11099829|FG000|Overall Study|Physician Decision|2
7023637|NCT01584232|11099830|FG001|Overall Study|Physician Decision|1
7023638|NCT01584232|11099829|FG000|Overall Study|Lost to Follow-up|1
7023639|NCT01584232|11099830|FG001|Overall Study|Lost to Follow-up|0
7023640|NCT01584440|11099856|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1
7023641|NCT01584440|11099857|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0
7023642|NCT01584440|11099858|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0
7023643|NCT01584440|11099859|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0
7023644|NCT01584440|11099860|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0
7023645|NCT01584440|11099856|FG000|Stage 1 (5 Weeks)|Adverse Event|5
7023646|NCT01584440|11099857|FG001|Stage 1 (5 Weeks)|Adverse Event|3
7023647|NCT01584440|11099858|FG002|Stage 1 (5 Weeks)|Adverse Event|0
7023648|NCT01584440|11099859|FG003|Stage 1 (5 Weeks)|Adverse Event|0
7023649|NCT01584440|11099860|FG004|Stage 1 (5 Weeks)|Adverse Event|0
7023650|NCT01584440|11099856|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1
7023651|NCT01584440|11099857|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0
7023652|NCT01584440|11099858|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0
7023653|NCT01584440|11099859|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0
7023654|NCT01584440|11099860|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0
7023655|NCT01584440|11099856|FG000|Stage 1 (5 Weeks)|Protocol Violation|2
7023656|NCT01584440|11099857|FG001|Stage 1 (5 Weeks)|Protocol Violation|3
7023657|NCT01584440|11099858|FG002|Stage 1 (5 Weeks)|Protocol Violation|0
7023658|NCT01584440|11099859|FG003|Stage 1 (5 Weeks)|Protocol Violation|0
7023659|NCT01584440|11099860|FG004|Stage 1 (5 Weeks)|Protocol Violation|0
7023660|NCT01584440|11099856|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1
7023661|NCT01584440|11099857|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0
7023662|NCT01584440|11099858|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0
7023663|NCT01584440|11099859|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0
7023664|NCT01584440|11099860|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0
7023665|NCT01584440|11099856|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0
7023666|NCT01584440|11099857|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2
7023667|NCT01584440|11099858|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0
7023668|NCT01584440|11099859|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0
7023669|NCT01584440|11099860|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0
7023670|NCT01584440|11099856|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0
7023671|NCT01584440|11099857|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0
7023672|NCT01584440|11099858|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1
7023673|NCT01584440|11099859|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2
7023674|NCT01584440|11099860|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0
7023675|NCT01584440|11099856|FG000|Stage 2 (5 Weeks)|Adverse Event|0
7023676|NCT01584440|11099857|FG001|Stage 2 (5 Weeks)|Adverse Event|0
7023677|NCT01584440|11099858|FG002|Stage 2 (5 Weeks)|Adverse Event|1
7023678|NCT01584440|11099859|FG003|Stage 2 (5 Weeks)|Adverse Event|2
7023679|NCT01584440|11099860|FG004|Stage 2 (5 Weeks)|Adverse Event|1
7023680|NCT01584440|11099856|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0
7023681|NCT01584440|11099857|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0
7023682|NCT01584440|11099858|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1
7023683|NCT01584440|11099859|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0
7023684|NCT01584440|11099860|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0
7023685|NCT01584648|11099931|FG000|Overall Study|Death|136
7023686|NCT01584648|11099932|FG001|Overall Study|Death|146
7023687|NCT01584648|11099931|FG000|Overall Study|Lost to Follow-up|9
7023688|NCT01584648|11099932|FG001|Overall Study|Lost to Follow-up|9
7023689|NCT01584648|11099931|FG000|Overall Study|Investigator discretion|3
7023690|NCT01584648|11099932|FG001|Overall Study|Investigator discretion|2
7023691|NCT01584648|11099931|FG000|Overall Study|Withdrew consent|13
7023692|NCT01584648|11099932|FG001|Overall Study|Withdrew consent|4
7023693|NCT01584648|11099931|FG000|Overall Study|Study closed/terminated|50
7023694|NCT01584648|11099932|FG001|Overall Study|Study closed/terminated|23
7023695|NCT01584648|11099931|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0
7023696|NCT01584648|11099932|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28
7023697|NCT01584843|11099945|FG000|First Treatment Period|Adverse Event|0
7023698|NCT01584843|11099946|FG001|First Treatment Period|Adverse Event|0
7023699|NCT01584843|11099947|FG002|First Treatment Period|Adverse Event|1
7023700|NCT01584843|11099948|FG003|First Treatment Period|Adverse Event|0
7023701|NCT01584843|11099949|FG004|First Treatment Period|Adverse Event|0
7023702|NCT01584843|11099950|FG005|First Treatment Period|Adverse Event|0
7023703|NCT01584843|11099945|FG000|First Treatment Period|Protocol Violation|0
7023704|NCT01584843|11099946|FG001|First Treatment Period|Protocol Violation|0
7023705|NCT01584843|11099947|FG002|First Treatment Period|Protocol Violation|0
7023706|NCT01584843|11099948|FG003|First Treatment Period|Protocol Violation|0
7023707|NCT01584843|11099949|FG004|First Treatment Period|Protocol Violation|0
7023708|NCT01584843|11099950|FG005|First Treatment Period|Protocol Violation|1
7023709|NCT01584843|11099945|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0
7023710|NCT01584843|11099946|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0
7023711|NCT01584843|11099947|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0
7023712|NCT01584843|11099948|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0
7023713|NCT01584843|11099949|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0
7023714|NCT01584843|11099950|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1
7023715|NCT01584843|11099945|FG000|Second Treatment Period|Withdrawal by Subject|0
7023716|NCT01584843|11099946|FG001|Second Treatment Period|Withdrawal by Subject|0
7023717|NCT01584843|11099947|FG002|Second Treatment Period|Withdrawal by Subject|0
7023718|NCT01584843|11099948|FG003|Second Treatment Period|Withdrawal by Subject|0
7023719|NCT01584843|11099949|FG004|Second Treatment Period|Withdrawal by Subject|0
7023720|NCT01584843|11099950|FG005|Second Treatment Period|Withdrawal by Subject|1
7023721|NCT01585025|11099969|FG000|Overall Study|Withdrawal by Subject|0
7023722|NCT01585025|11099970|FG001|Overall Study|Withdrawal by Subject|3
7023723|NCT01585025|11099971|FG002|Overall Study|Withdrawal by Subject|4
7023724|NCT01585038|11099981|FG000|Overall Study|Adverse Event|2
7023725|NCT01585038|11099982|FG001|Overall Study|Adverse Event|2
7023726|NCT01585155|11099997|FG000|Overall Study|Adverse Event|1
7023727|NCT01585155|11099997|FG000|Overall Study|Lack of Efficacy|2
7023728|NCT01585155|11099997|FG000|Overall Study|Worsening ulcerative colitis|2
7023729|NCT01585168|11100003|FG000|Overall Study|Lost to Follow-up|3
7023730|NCT01585168|11100004|FG001|Overall Study|Lost to Follow-up|1
7023731|NCT01585168|11100005|FG002|Overall Study|Lost to Follow-up|1
7023732|NCT01585168|11100006|FG003|Overall Study|Lost to Follow-up|1
7023733|NCT01585194|11100014|FG000|Overall Study|Withdrawal by Subject|1
7023734|NCT01585194|11100014|FG000|Overall Study|Physician Decision|2
7023735|NCT01585194|11100014|FG000|Overall Study|Lack of insurance|1
7023736|NCT01585246|11100027|FG000|Overall Study|Lost to Follow-up|0
7023737|NCT01585246|11100028|FG001|Overall Study|Lost to Follow-up|0
7023738|NCT01585246|11100029|FG002|Overall Study|Lost to Follow-up|2
7023739|NCT01585246|11100030|FG003|Overall Study|Lost to Follow-up|1
7023740|NCT01585246|11100031|FG004|Overall Study|Lost to Follow-up|0
7023741|NCT01585246|11100027|FG000|Overall Study|Protocol Violation|0
7023742|NCT01585246|11100028|FG001|Overall Study|Protocol Violation|0
7023743|NCT01585246|11100029|FG002|Overall Study|Protocol Violation|0
7023744|NCT01585246|11100030|FG003|Overall Study|Protocol Violation|0
7023745|NCT01585246|11100031|FG004|Overall Study|Protocol Violation|1
7023746|NCT01585246|11100027|FG000|Overall Study|Withdrawal by Subject|0
7023747|NCT01585246|11100028|FG001|Overall Study|Withdrawal by Subject|0
7023748|NCT01585246|11100029|FG002|Overall Study|Withdrawal by Subject|1
7023749|NCT01585246|11100030|FG003|Overall Study|Withdrawal by Subject|2
7023750|NCT01585246|11100031|FG004|Overall Study|Withdrawal by Subject|1
7023751|NCT01585246|11100027|FG000|Overall Study|Other|0
7023752|NCT01585246|11100028|FG001|Overall Study|Other|1
7023753|NCT01585246|11100029|FG002|Overall Study|Other|1
7023754|NCT01585246|11100030|FG003|Overall Study|Other|1
7023755|NCT01585246|11100031|FG004|Overall Study|Other|0
7023756|NCT01585272|11100046|FG000|Overall Study|Adverse Event|22
7023757|NCT01585272|11100046|FG000|Overall Study|Protocol Violation|7
7023758|NCT01585272|11100046|FG000|Overall Study|Withdrawal by Subject|10
7023759|NCT01585298|11100050|FG000|Overall Study|Study completion was not documented.|1
7023760|NCT01585298|11100050|FG000|Overall Study|Protocol deviation|1
7023761|NCT01585298|11100050|FG000|Overall Study|Administrative problems|4
7023762|NCT01585298|11100050|FG000|Overall Study|Lost to Follow-up|2
7023763|NCT01585298|11100050|FG000|Overall Study|Withdrawal by Subject|4
7023764|NCT01585298|11100050|FG000|Overall Study|Abnormal test procedure results|1
7023765|NCT01585298|11100050|FG000|Overall Study|Adverse Event|24
7023766|NCT01585428|11100062|FG000|Overall Study|Death during treatment|1
7023767|NCT01585428|11100063|FG001|Overall Study|Death during treatment|0
7023768|NCT01585558|11100082|FG000|Overall Study|Withdrawal by Subject|4
7023769|NCT01585558|11100083|FG001|Overall Study|Withdrawal by Subject|5
7023770|NCT01585558|11100084|FG002|Overall Study|Withdrawal by Subject|8
7023771|NCT01585558|11100082|FG000|Overall Study|Lost to Follow-up|2
7023772|NCT01585558|11100083|FG001|Overall Study|Lost to Follow-up|0
7023773|NCT01585558|11100084|FG002|Overall Study|Lost to Follow-up|3
7023774|NCT01585558|11100082|FG000|Overall Study|Adverse Event|3
7023775|NCT01585558|11100083|FG001|Overall Study|Adverse Event|4
7023776|NCT01585558|11100084|FG002|Overall Study|Adverse Event|1
7023777|NCT01585558|11100082|FG000|Overall Study|Protocol Violation|4
7023778|NCT01585558|11100083|FG001|Overall Study|Protocol Violation|3
7023779|NCT01585558|11100084|FG002|Overall Study|Protocol Violation|2
7023780|NCT01585558|11100082|FG000|Overall Study|Lack of Efficacy|0
7023781|NCT01585558|11100083|FG001|Overall Study|Lack of Efficacy|0
7023782|NCT01585558|11100084|FG002|Overall Study|Lack of Efficacy|1
7023783|NCT01585584|11100092|FG000|Overall Study|Lack of Efficacy|1
7023784|NCT01585584|11100092|FG000|Overall Study|Withdrawal by Subject|1
7023785|NCT01585584|11100092|FG000|Overall Study|Physician Decision|2
7023786|NCT01585766|11100106|FG000|Overall Study|Withdrawal by Subject|0
7023787|NCT01585766|11100107|FG001|Overall Study|Withdrawal by Subject|1
7023788|NCT01585766|11100108|FG002|Overall Study|Withdrawal by Subject|1
7023789|NCT01585766|11100109|FG003|Overall Study|Withdrawal by Subject|0
7023790|NCT01585766|11100110|FG004|Overall Study|Withdrawal by Subject|0
7023791|NCT01585766|11100111|FG005|Overall Study|Withdrawal by Subject|0
7023792|NCT01585766|11100106|FG000|Overall Study|Death|0
7023793|NCT01585766|11100107|FG001|Overall Study|Death|1
7023794|NCT01585766|11100108|FG002|Overall Study|Death|0
7023795|NCT01585766|11100109|FG003|Overall Study|Death|0
7023796|NCT01585766|11100110|FG004|Overall Study|Death|0
7023797|NCT01585766|11100111|FG005|Overall Study|Death|0
7023798|NCT01585766|11100106|FG000|Overall Study|Physician Decision|0
7023799|NCT01585766|11100107|FG001|Overall Study|Physician Decision|0
7023800|NCT01585766|11100108|FG002|Overall Study|Physician Decision|1
7023801|NCT01585766|11100109|FG003|Overall Study|Physician Decision|0
7023802|NCT01585766|11100110|FG004|Overall Study|Physician Decision|0
7023803|NCT01585766|11100111|FG005|Overall Study|Physician Decision|0
7023804|NCT01585831|11100144|FG000|Overall Study|Physician Decision|0
7023805|NCT01585831|11100145|FG001|Overall Study|Physician Decision|1
7023806|NCT01585831|11100144|FG000|Overall Study|Withdrawal by Subject|2
7023807|NCT01585831|11100145|FG001|Overall Study|Withdrawal by Subject|1
7023808|NCT01585961|11100151|FG000|Overall Study|Death|6
7023809|NCT01585961|11100151|FG000|Overall Study|Physician Decision|1
7023810|NCT01585961|11100151|FG000|Overall Study|Decision to use non-study catheter|1
7023811|NCT01585961|11100151|FG000|Overall Study|Withdrawal by Subject|1
7023812|NCT01585961|11100151|FG000|Overall Study|Lost to Follow-up|23
7023813|NCT01585961|11100151|FG000|Overall Study|Ablation cancelled for slow-heal wound|1
7023814|NCT01585987|11100157|FG000|Randomized|Withdrawal by Subject|0
7023815|NCT01585987|11100158|FG001|Randomized|Withdrawal by Subject|4
7023816|NCT01585987|11100157|FG000|Randomized|No longer met criteria|0
7023817|NCT01585987|11100158|FG001|Randomized|No longer met criteria|2
7023818|NCT01585987|11100157|FG000|Treated|Disease Progression|39
7023819|NCT01585987|11100158|FG001|Treated|Disease Progression|36
7023820|NCT01585987|11100157|FG000|Treated|Study Drug Toxicity|9
7023821|NCT01585987|11100158|FG001|Treated|Study Drug Toxicity|5
7023822|NCT01585987|11100157|FG000|Treated|Adverse Event|3
7023823|NCT01585987|11100158|FG001|Treated|Adverse Event|0
7023824|NCT01585987|11100157|FG000|Treated|Withdrawal by Subject|1
7023825|NCT01585987|11100158|FG001|Treated|Withdrawal by Subject|2
7023826|NCT01585987|11100157|FG000|Treated|Death|1
7023827|NCT01585987|11100158|FG001|Treated|Death|0
7023828|NCT01585987|11100157|FG000|Treated|Lost to Follow-up|0
7023829|NCT01585987|11100158|FG001|Treated|Lost to Follow-up|1
7023830|NCT01585987|11100157|FG000|Treated|Maximum Clinical Benefit|0
7023831|NCT01585987|11100158|FG001|Treated|Maximum Clinical Benefit|1
7023832|NCT01585987|11100157|FG000|Treated|Non-Specified|1
7023833|NCT01585987|11100158|FG001|Treated|Non-Specified|2
7023834|NCT01585987|11100157|FG000|Treated|Subject Request|0
7023835|NCT01585987|11100158|FG001|Treated|Subject Request|1
7023836|NCT01585987|11100157|FG000|Treated|Poor/Non-Compliance|0
7023837|NCT01585987|11100158|FG001|Treated|Poor/Non-Compliance|1
7023838|NCT01586156|11100211|FG000|Overall Study|Pregnancy|0
7023839|NCT01586156|11100212|FG001|Overall Study|Pregnancy|1
7023840|NCT01586156|11100213|FG002|Overall Study|Pregnancy|0
7023841|NCT01586195|11100221|FG000|Overall Study|Death|11
7023842|NCT01586195|11100221|FG000|Overall Study|Withdrawal of Consent|5
7023843|NCT01586195|11100221|FG000|Overall Study|Started new anti-melanoma therapy|1
7023844|NCT01586195|11100221|FG000|Overall Study|Reason not specified|9
7023845|NCT01586338|11100234|FG000|Overall Study|Adverse Event|3
7023846|NCT01586338|11100234|FG000|Overall Study|Lost to Follow-up|1
7023847|NCT01586338|11100234|FG000|Overall Study|Withdrawal by participant|3
7023848|NCT01586338|11100234|FG000|Overall Study|Other|1
7023849|NCT01586364|11100238|FG000|Overall Study|Withdrawal by Subject|40
7023850|NCT01586364|11100238|FG000|Overall Study|Adverse Event|37
7023851|NCT01586364|11100238|FG000|Overall Study|Lost to Follow-up|17
7023852|NCT01586364|11100238|FG000|Overall Study|Protocol Violation|16
7023853|NCT01586364|11100238|FG000|Overall Study|Lack of Efficacy|1
7023854|NCT01586364|11100238|FG000|Overall Study|Other-Did not feel better post-treatment|1
7023855|NCT01586364|11100238|FG000|Overall Study|Other-Subject wasn't getting much relief|1
7023856|NCT01586364|11100238|FG000|Overall Study|Other-Site closure due to PI illness|1
7023857|NCT01586364|11100238|FG000|Overall Study|Other-PI discretion, site closing|2
7023858|NCT01586364|11100238|FG000|Overall Study|Other-Not specified|1
7023859|NCT01586624|11100250|FG000|Overall Study|Adverse Event|3
7023860|NCT01586624|11100251|FG001|Overall Study|Adverse Event|0
7023861|NCT01586624|11100252|FG002|Overall Study|Adverse Event|2
7023862|NCT01586624|11100253|FG003|Overall Study|Adverse Event|1
7023863|NCT01586624|11100254|FG004|Overall Study|Adverse Event|3
7023864|NCT01586624|11100255|FG005|Overall Study|Adverse Event|3
7023865|NCT01586624|11100256|FG006|Overall Study|Adverse Event|2
7023866|NCT01586624|11100257|FG007|Overall Study|Adverse Event|3
7023867|NCT01586624|11100250|FG000|Overall Study|Physician Decision|0
7023868|NCT01586624|11100251|FG001|Overall Study|Physician Decision|1
7023869|NCT01586624|11100252|FG002|Overall Study|Physician Decision|1
7023870|NCT01586624|11100253|FG003|Overall Study|Physician Decision|0
7023871|NCT01586624|11100254|FG004|Overall Study|Physician Decision|2
7023872|NCT01586624|11100255|FG005|Overall Study|Physician Decision|0
7023873|NCT01586624|11100256|FG006|Overall Study|Physician Decision|1
7023874|NCT01586624|11100257|FG007|Overall Study|Physician Decision|1
7023875|NCT01586624|11100250|FG000|Overall Study|Withdrawal by Subject|0
7023876|NCT01586624|11100251|FG001|Overall Study|Withdrawal by Subject|0
7023877|NCT01586624|11100252|FG002|Overall Study|Withdrawal by Subject|0
7023878|NCT01586624|11100253|FG003|Overall Study|Withdrawal by Subject|1
7023879|NCT01586624|11100254|FG004|Overall Study|Withdrawal by Subject|0
7023880|NCT01586624|11100255|FG005|Overall Study|Withdrawal by Subject|0
7023881|NCT01586624|11100256|FG006|Overall Study|Withdrawal by Subject|0
7023882|NCT01586624|11100257|FG007|Overall Study|Withdrawal by Subject|0
7023883|NCT01586624|11100250|FG000|Overall Study|Evidence of disease progression|1
7023884|NCT01586624|11100251|FG001|Overall Study|Evidence of disease progression|3
7023885|NCT01586624|11100252|FG002|Overall Study|Evidence of disease progression|2
7023886|NCT01586624|11100253|FG003|Overall Study|Evidence of disease progression|5
7023887|NCT01586624|11100254|FG004|Overall Study|Evidence of disease progression|3
7023888|NCT01586624|11100255|FG005|Overall Study|Evidence of disease progression|5
7023889|NCT01586624|11100256|FG006|Overall Study|Evidence of disease progression|4
7023890|NCT01586624|11100257|FG007|Overall Study|Evidence of disease progression|6
7023891|NCT01586624|11100250|FG000|Overall Study|Screen failure (no treatment received)|0
7023892|NCT01586624|11100251|FG001|Overall Study|Screen failure (no treatment received)|0
7023893|NCT01586624|11100252|FG002|Overall Study|Screen failure (no treatment received)|0
7023894|NCT01586624|11100253|FG003|Overall Study|Screen failure (no treatment received)|0
7023895|NCT01586624|11100254|FG004|Overall Study|Screen failure (no treatment received)|0
7023896|NCT01586624|11100255|FG005|Overall Study|Screen failure (no treatment received)|0
7023897|NCT01586624|11100256|FG006|Overall Study|Screen failure (no treatment received)|1
7023898|NCT01586624|11100257|FG007|Overall Study|Screen failure (no treatment received)|0
7023899|NCT01586806|11100292|FG000|Overall Study|Protocol Violation|0
7023900|NCT01586806|11100293|FG001|Overall Study|Protocol Violation|1
7023901|NCT01586806|11100294|FG002|Overall Study|Protocol Violation|0
7023902|NCT01586806|11100292|FG000|Overall Study|Withdrawal by Subject|1
7023903|NCT01586806|11100293|FG001|Overall Study|Withdrawal by Subject|0
7023904|NCT01586806|11100294|FG002|Overall Study|Withdrawal by Subject|0
7023905|NCT01586806|11100292|FG000|Overall Study|Lost to Follow-up|2
7023906|NCT01586806|11100293|FG001|Overall Study|Lost to Follow-up|3
7023907|NCT01586806|11100294|FG002|Overall Study|Lost to Follow-up|2
7023908|NCT01586819|11100304|FG000|Overall Study|Withdrawal by Subject|1
7023909|NCT01586819|11100305|FG001|Overall Study|Withdrawal by Subject|0
7023910|NCT01587001|11100354|FG000|Overall Study|Lost to Follow-up|2
7023911|NCT01587001|11100355|FG001|Overall Study|Lost to Follow-up|0
7023912|NCT01587001|11100354|FG000|Overall Study|Insufficient samples to complete testing|4
7023913|NCT01587001|11100355|FG001|Overall Study|Insufficient samples to complete testing|1
7023914|NCT01587014|11100362|FG000|Overall Study|Death|2
7023915|NCT01587079|11100375|FG000|Overall Study|Protocol-specified criteria|9
7023916|NCT01587079|11100375|FG000|Overall Study|Protocol Violation|5
7023917|NCT01587079|11100375|FG000|Overall Study|Lost to Follow-up|2
7023918|NCT01587079|11100375|FG000|Overall Study|Physician Decision|2
7023919|NCT01587079|11100375|FG000|Overall Study|Withdrawal by Subject|7
7023920|NCT01587079|11100375|FG000|Overall Study|Adverse Event|14
7023921|NCT01587118|11100418|FG000|Overall Study|Adverse Event|3
7023922|NCT01587118|11100418|FG000|Overall Study|Lost to Follow-up|2
7023923|NCT01587118|11100418|FG000|Overall Study|Relocation|1
7023924|NCT01587118|11100418|FG000|Overall Study|nonresponse|1
7023925|NCT01587274|11100425|FG000|Overall Study|Lost to Follow-up|4
7023926|NCT01587274|11100426|FG001|Overall Study|Lost to Follow-up|5
7023927|NCT01587274|11100427|FG002|Overall Study|Lost to Follow-up|3
7023928|NCT01587651|11100438|FG000|Overall Study|Adverse Event|0
7023929|NCT01587651|11100439|FG001|Overall Study|Adverse Event|1
7023930|NCT01587651|11100440|FG002|Overall Study|Adverse Event|0
7023931|NCT01587651|11100438|FG000|Overall Study|Protocol Violation|0
7023932|NCT01587651|11100439|FG001|Overall Study|Protocol Violation|1
7023933|NCT01587651|11100440|FG002|Overall Study|Protocol Violation|1
7023934|NCT01587651|11100438|FG000|Overall Study|Withdrawal by Subject|0
7023935|NCT01587651|11100439|FG001|Overall Study|Withdrawal by Subject|1
7023936|NCT01587651|11100440|FG002|Overall Study|Withdrawal by Subject|0
7023937|NCT01587703|11100467|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1
7023938|NCT01587703|11100468|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7023939|NCT01587703|11100469|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7023940|NCT01587703|11100470|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7023941|NCT01587703|11100471|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7023942|NCT01587703|11100472|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7023943|NCT01587703|11100473|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7023944|NCT01587703|11100474|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7023945|NCT01587703|11100475|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7023946|NCT01587703|11100476|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7023947|NCT01587703|11100477|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7023948|NCT01587703|11100478|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7023949|NCT01587703|11100479|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7023950|NCT01587703|11100480|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7023951|NCT01587703|11100481|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7023952|NCT01587703|11100482|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7023953|NCT01587703|11100483|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7023954|NCT01587703|11100484|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7023955|NCT01587703|11100485|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7023956|NCT01587703|11100467|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7023957|NCT01587703|11100468|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7023958|NCT01587703|11100469|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7023959|NCT01587703|11100470|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7023960|NCT01587703|11100471|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7023961|NCT01587703|11100472|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1
7023962|NCT01587703|11100473|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7023963|NCT01587703|11100474|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2
7023964|NCT01587703|11100475|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7023965|NCT01587703|11100476|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7023966|NCT01587703|11100477|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7023967|NCT01587703|11100478|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7023968|NCT01587703|11100479|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7023969|NCT01587703|11100480|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7023970|NCT01587703|11100481|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7023971|NCT01587703|11100482|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7023972|NCT01587703|11100483|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7023973|NCT01587703|11100484|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7023974|NCT01587703|11100485|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7023975|NCT01587703|11100467|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7023976|NCT01587703|11100468|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7023977|NCT01587703|11100469|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7023978|NCT01587703|11100470|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7023979|NCT01587703|11100471|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7023980|NCT01587703|11100472|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7023981|NCT01587703|11100473|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2
7023982|NCT01587703|11100474|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7023983|NCT01587703|11100475|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7023984|NCT01587703|11100476|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7023985|NCT01587703|11100477|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7023986|NCT01587703|11100478|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7023987|NCT01587703|11100479|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7023988|NCT01587703|11100480|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7023989|NCT01587703|11100481|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7023990|NCT01587703|11100482|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7023991|NCT01587703|11100483|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7023992|NCT01587703|11100484|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7023993|NCT01587703|11100485|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7023994|NCT01587703|11100467|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2
7023995|NCT01587703|11100468|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4
7023996|NCT01587703|11100469|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1
7023997|NCT01587703|11100470|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3
7023998|NCT01587703|11100471|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4
7023999|NCT01587703|11100472|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7
7024000|NCT01587703|11100473|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30
7024001|NCT01587703|11100474|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7
7024002|NCT01587703|11100475|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0
7024003|NCT01587703|11100476|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0
7024004|NCT01587703|11100477|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0
7024005|NCT01587703|11100478|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0
7024006|NCT01587703|11100479|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0
7024007|NCT01587703|11100480|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0
7024008|NCT01587703|11100481|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0
7024009|NCT01587703|11100482|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0
7024010|NCT01587703|11100483|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0
7024011|NCT01587703|11100484|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0
7024012|NCT01587703|11100485|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0
7024013|NCT01587703|11100467|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0
7024014|NCT01587703|11100468|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0
7024015|NCT01587703|11100469|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0
7024016|NCT01587703|11100470|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0
7024017|NCT01587703|11100471|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0
7024018|NCT01587703|11100472|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0
7024019|NCT01587703|11100473|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0
7024020|NCT01587703|11100474|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0
7024021|NCT01587703|11100475|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1
7024022|NCT01587703|11100476|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9
7024023|NCT01587703|11100477|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3
7024024|NCT01587703|11100478|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0
7024025|NCT01587703|11100479|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0
7024026|NCT01587703|11100480|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0
7024027|NCT01587703|11100481|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0
7024028|NCT01587703|11100482|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0
7024029|NCT01587703|11100483|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0
7024030|NCT01587703|11100484|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0
7024031|NCT01587703|11100485|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0
7024032|NCT01587703|11100467|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7024033|NCT01587703|11100468|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7024034|NCT01587703|11100469|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7024035|NCT01587703|11100470|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7024036|NCT01587703|11100471|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7024037|NCT01587703|11100472|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7024038|NCT01587703|11100473|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7024039|NCT01587703|11100474|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7024040|NCT01587703|11100475|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1
7024041|NCT01587703|11100476|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7024042|NCT01587703|11100477|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1
7024043|NCT01587703|11100478|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7024044|NCT01587703|11100479|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7024045|NCT01587703|11100480|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7024046|NCT01587703|11100481|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7024047|NCT01587703|11100482|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7024048|NCT01587703|11100483|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7024049|NCT01587703|11100484|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7024050|NCT01587703|11100485|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7024051|NCT01587703|11100467|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7024052|NCT01587703|11100468|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7024053|NCT01587703|11100469|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7024054|NCT01587703|11100470|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7024055|NCT01587703|11100471|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7024056|NCT01587703|11100472|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7024057|NCT01587703|11100473|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7024058|NCT01587703|11100474|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7024059|NCT01587703|11100475|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7024060|NCT01587703|11100476|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1
7024061|NCT01587703|11100477|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1
7024062|NCT01587703|11100478|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7024063|NCT01587703|11100479|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7024064|NCT01587703|11100480|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7024065|NCT01587703|11100481|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7024066|NCT01587703|11100482|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7024067|NCT01587703|11100483|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7024068|NCT01587703|11100484|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7024069|NCT01587703|11100485|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7024070|NCT01587703|11100467|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7024071|NCT01587703|11100468|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7024072|NCT01587703|11100469|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7024073|NCT01587703|11100470|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7024074|NCT01587703|11100471|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7024075|NCT01587703|11100472|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7024076|NCT01587703|11100473|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7024077|NCT01587703|11100474|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7024078|NCT01587703|11100475|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1
7024079|NCT01587703|11100476|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7024080|NCT01587703|11100477|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7024081|NCT01587703|11100478|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7024082|NCT01587703|11100479|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7024083|NCT01587703|11100480|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7024084|NCT01587703|11100481|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7024085|NCT01587703|11100482|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7024086|NCT01587703|11100483|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7024087|NCT01587703|11100484|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7024088|NCT01587703|11100485|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7024089|NCT01587703|11100467|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7024090|NCT01587703|11100468|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7024091|NCT01587703|11100469|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7024092|NCT01587703|11100470|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7024093|NCT01587703|11100471|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7024094|NCT01587703|11100472|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7024095|NCT01587703|11100473|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7024096|NCT01587703|11100474|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7024097|NCT01587703|11100475|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7024098|NCT01587703|11100476|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7024099|NCT01587703|11100477|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7024100|NCT01587703|11100478|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7024101|NCT01587703|11100479|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7024102|NCT01587703|11100480|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7024103|NCT01587703|11100481|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7024104|NCT01587703|11100482|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7024105|NCT01587703|11100483|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7024106|NCT01587703|11100484|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7024107|NCT01587703|11100485|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1
7024108|NCT01587703|11100467|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7024109|NCT01587703|11100468|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7024110|NCT01587703|11100469|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7024111|NCT01587703|11100470|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7024112|NCT01587703|11100471|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7024113|NCT01587703|11100472|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7024114|NCT01587703|11100473|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7024115|NCT01587703|11100474|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7024116|NCT01587703|11100475|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7024117|NCT01587703|11100476|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7024118|NCT01587703|11100477|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7024119|NCT01587703|11100478|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7024120|NCT01587703|11100479|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7024121|NCT01587703|11100480|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7024122|NCT01587703|11100481|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7024123|NCT01587703|11100482|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7024124|NCT01587703|11100483|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7024125|NCT01587703|11100484|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5
7024126|NCT01587703|11100485|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4
7024127|NCT01587703|11100467|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7024128|NCT01587703|11100468|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7024129|NCT01587703|11100469|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7024130|NCT01587703|11100470|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7024131|NCT01587703|11100471|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7024132|NCT01587703|11100472|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7024133|NCT01587703|11100473|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7024134|NCT01587703|11100474|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7024135|NCT01587703|11100475|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7024136|NCT01587703|11100476|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7024137|NCT01587703|11100477|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7024138|NCT01587703|11100478|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7024139|NCT01587703|11100479|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7024140|NCT01587703|11100480|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7024141|NCT01587703|11100481|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7024142|NCT01587703|11100482|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1
7024143|NCT01587703|11100483|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7024144|NCT01587703|11100484|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7024145|NCT01587703|11100485|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7024146|NCT01587703|11100467|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7024147|NCT01587703|11100468|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7024148|NCT01587703|11100469|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7024149|NCT01587703|11100470|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7024150|NCT01587703|11100471|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7024151|NCT01587703|11100472|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7024152|NCT01587703|11100473|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7024153|NCT01587703|11100474|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7024154|NCT01587703|11100475|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7024155|NCT01587703|11100476|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7024156|NCT01587703|11100477|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7024157|NCT01587703|11100478|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1
7024158|NCT01587703|11100479|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7024159|NCT01587703|11100480|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7024160|NCT01587703|11100481|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2
7024161|NCT01587703|11100482|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7024162|NCT01587703|11100483|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7024163|NCT01587703|11100484|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7024164|NCT01587703|11100485|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7024165|NCT01587703|11100467|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0
7024166|NCT01587703|11100468|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0
7024167|NCT01587703|11100469|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0
7024168|NCT01587703|11100470|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0
7024169|NCT01587703|11100471|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0
7024170|NCT01587703|11100472|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0
7024171|NCT01587703|11100473|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0
7024172|NCT01587703|11100474|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0
7024173|NCT01587703|11100475|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0
7024174|NCT01587703|11100476|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0
7024175|NCT01587703|11100477|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0
7024176|NCT01587703|11100478|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2
7024177|NCT01587703|11100479|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2
7024178|NCT01587703|11100480|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1
7024179|NCT01587703|11100481|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1
7024180|NCT01587703|11100482|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3
7024181|NCT01587703|11100483|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8
7024182|NCT01587703|11100484|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0
7024183|NCT01587703|11100485|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0
7024184|NCT01587703|11100467|FG000|Part2(Median Exposure of 1.41 Months)|Death|0
7024185|NCT01587703|11100468|FG001|Part2(Median Exposure of 1.41 Months)|Death|0
7024186|NCT01587703|11100469|FG002|Part2(Median Exposure of 1.41 Months)|Death|0
7024187|NCT01587703|11100470|FG003|Part2(Median Exposure of 1.41 Months)|Death|0
7024188|NCT01587703|11100471|FG004|Part2(Median Exposure of 1.41 Months)|Death|0
7024189|NCT01587703|11100472|FG005|Part2(Median Exposure of 1.41 Months)|Death|0
7024190|NCT01587703|11100473|FG006|Part2(Median Exposure of 1.41 Months)|Death|0
7024191|NCT01587703|11100474|FG007|Part2(Median Exposure of 1.41 Months)|Death|0
7024192|NCT01587703|11100475|FG008|Part2(Median Exposure of 1.41 Months)|Death|0
7024193|NCT01587703|11100476|FG009|Part2(Median Exposure of 1.41 Months)|Death|0
7024194|NCT01587703|11100477|FG010|Part2(Median Exposure of 1.41 Months)|Death|0
7024195|NCT01587703|11100478|FG011|Part2(Median Exposure of 1.41 Months)|Death|8
7024196|NCT01587703|11100479|FG012|Part2(Median Exposure of 1.41 Months)|Death|12
7024197|NCT01587703|11100480|FG013|Part2(Median Exposure of 1.41 Months)|Death|21
7024198|NCT01587703|11100481|FG014|Part2(Median Exposure of 1.41 Months)|Death|16
7024199|NCT01587703|11100482|FG015|Part2(Median Exposure of 1.41 Months)|Death|17
7024200|NCT01587703|11100483|FG016|Part2(Median Exposure of 1.41 Months)|Death|5
7024201|NCT01587703|11100484|FG017|Part2(Median Exposure of 1.41 Months)|Death|0
7024202|NCT01587703|11100485|FG018|Part2(Median Exposure of 1.41 Months)|Death|0
7024203|NCT01587703|11100467|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7024204|NCT01587703|11100468|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7024205|NCT01587703|11100469|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7024206|NCT01587703|11100470|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7024207|NCT01587703|11100471|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7024208|NCT01587703|11100472|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7024209|NCT01587703|11100473|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7024210|NCT01587703|11100474|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7024211|NCT01587703|11100475|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7024212|NCT01587703|11100476|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7024213|NCT01587703|11100477|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7024214|NCT01587703|11100478|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1
7024215|NCT01587703|11100479|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7024216|NCT01587703|11100480|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7024217|NCT01587703|11100481|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7024218|NCT01587703|11100482|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7024219|NCT01587703|11100483|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7024220|NCT01587703|11100484|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7024221|NCT01587703|11100485|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7024222|NCT01587885|11100544|FG000|Treatment Period 1|Failure to Return|0
7024223|NCT01587885|11100545|FG001|Treatment Period 1|Failure to Return|1
7024224|NCT01587885|11100544|FG000|Treatment Period 1|Protocol Violation|0
7024225|NCT01587885|11100545|FG001|Treatment Period 1|Protocol Violation|2
7024226|NCT01587898|11100556|FG000|Overall Study|Adverse Event|1
7024227|NCT01587898|11100557|FG001|Overall Study|Adverse Event|1
7024228|NCT01587898|11100558|FG002|Overall Study|Adverse Event|0
7024229|NCT01587898|11100559|FG003|Overall Study|Adverse Event|0
7024230|NCT01587898|11100556|FG000|Overall Study|Protocol Violation|0
7024231|NCT01587898|11100557|FG001|Overall Study|Protocol Violation|2
7024232|NCT01587898|11100558|FG002|Overall Study|Protocol Violation|1
7024233|NCT01587898|11100559|FG003|Overall Study|Protocol Violation|1
7024234|NCT01587898|11100556|FG000|Overall Study|Lost to Follow-up|0
7024235|NCT01587898|11100557|FG001|Overall Study|Lost to Follow-up|0
7024236|NCT01587898|11100558|FG002|Overall Study|Lost to Follow-up|0
7024237|NCT01587898|11100559|FG003|Overall Study|Lost to Follow-up|1
7024238|NCT01587898|11100556|FG000|Overall Study|Withdrawal by Subject|2
7024239|NCT01587898|11100557|FG001|Overall Study|Withdrawal by Subject|1
7024240|NCT01587898|11100558|FG002|Overall Study|Withdrawal by Subject|0
7024241|NCT01587898|11100559|FG003|Overall Study|Withdrawal by Subject|0
7024242|NCT01587898|11100556|FG000|Overall Study|Met haemoglobin stopping criteria|1
7024243|NCT01587898|11100557|FG001|Overall Study|Met haemoglobin stopping criteria|1
7024244|NCT01587898|11100558|FG002|Overall Study|Met haemoglobin stopping criteria|1
7024245|NCT01587898|11100559|FG003|Overall Study|Met haemoglobin stopping criteria|0
7024246|NCT01587924|11100576|FG000|Overall Study|Adverse Event|0
7024247|NCT01587924|11100577|FG001|Overall Study|Adverse Event|2
7024248|NCT01587924|11100578|FG002|Overall Study|Adverse Event|0
7024249|NCT01587924|11100579|FG003|Overall Study|Adverse Event|0
7024250|NCT01587924|11100576|FG000|Overall Study|Protocol Violation|2
7024251|NCT01587924|11100577|FG001|Overall Study|Protocol Violation|1
7024252|NCT01587924|11100578|FG002|Overall Study|Protocol Violation|2
7024253|NCT01587924|11100579|FG003|Overall Study|Protocol Violation|1
7024254|NCT01587924|11100576|FG000|Overall Study|Met Hemoglobin stopping criteria|2
7024255|NCT01587924|11100577|FG001|Overall Study|Met Hemoglobin stopping criteria|0
7024256|NCT01587924|11100578|FG002|Overall Study|Met Hemoglobin stopping criteria|1
7024257|NCT01587924|11100579|FG003|Overall Study|Met Hemoglobin stopping criteria|0
7024258|NCT01587924|11100576|FG000|Overall Study|Withdrawal by Subject|0
7024259|NCT01587924|11100577|FG001|Overall Study|Withdrawal by Subject|1
7024260|NCT01587924|11100578|FG002|Overall Study|Withdrawal by Subject|1
7024261|NCT01587924|11100579|FG003|Overall Study|Withdrawal by Subject|0
7024262|NCT01587989|11100604|FG000|12-Week Open-Label Run-In Period|Physician Decision|7
7024263|NCT01587989|11100605|FG001|12-Week Open-Label Run-In Period|Physician Decision|0
7024264|NCT01587989|11100606|FG002|12-Week Open-Label Run-In Period|Physician Decision|0
7024265|NCT01587989|11100604|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1
7024266|NCT01587989|11100605|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
7024267|NCT01587989|11100606|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
7024268|NCT01587989|11100604|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4
7024269|NCT01587989|11100605|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0
7024270|NCT01587989|11100606|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0
7024271|NCT01587989|11100604|FG000|Randomized Study Treatment|Withdrawal by Subject|0
7024272|NCT01587989|11100605|FG001|Randomized Study Treatment|Withdrawal by Subject|1
7024273|NCT01587989|11100606|FG002|Randomized Study Treatment|Withdrawal by Subject|0
7024274|NCT01587989|11100604|FG000|Randomized Study Treatment|Screening failure|0
7024275|NCT01587989|11100605|FG001|Randomized Study Treatment|Screening failure|1
7024276|NCT01587989|11100606|FG002|Randomized Study Treatment|Screening failure|0
7024277|NCT01587989|11100604|FG000|Randomized Study Treatment|Physician Decision|0
7024278|NCT01587989|11100605|FG001|Randomized Study Treatment|Physician Decision|0
7024279|NCT01587989|11100606|FG002|Randomized Study Treatment|Physician Decision|1
7024280|NCT01588106|11100614|FG000|Overall Study|Withdrawal by Subject|5
7024281|NCT01588106|11100615|FG001|Overall Study|Withdrawal by Subject|4
7024282|NCT01588184|11100636|FG000|Overall Study|Death|1
7024283|NCT01588184|11100637|FG001|Overall Study|Death|0
7024284|NCT01588184|11100638|FG002|Overall Study|Death|0
7024285|NCT01588184|11100639|FG003|Overall Study|Death|1
7024286|NCT01588184|11100640|FG004|Overall Study|Death|1
7024287|NCT01588184|11100641|FG005|Overall Study|Death|1
7024288|NCT01588184|11100636|FG000|Overall Study|Withdrawal by Subject|2
7024289|NCT01588184|11100637|FG001|Overall Study|Withdrawal by Subject|4
7024290|NCT01588184|11100638|FG002|Overall Study|Withdrawal by Subject|0
7024291|NCT01588184|11100639|FG003|Overall Study|Withdrawal by Subject|1
7024292|NCT01588184|11100640|FG004|Overall Study|Withdrawal by Subject|0
7024293|NCT01588184|11100641|FG005|Overall Study|Withdrawal by Subject|0
7024294|NCT01588184|11100636|FG000|Overall Study|Bevacizumab treatment provision changed|0
7024295|NCT01588184|11100637|FG001|Overall Study|Bevacizumab treatment provision changed|6
7024296|NCT01588184|11100638|FG002|Overall Study|Bevacizumab treatment provision changed|2
7024297|NCT01588184|11100639|FG003|Overall Study|Bevacizumab treatment provision changed|0
7024298|NCT01588184|11100640|FG004|Overall Study|Bevacizumab treatment provision changed|1
7024299|NCT01588184|11100641|FG005|Overall Study|Bevacizumab treatment provision changed|3
7024300|NCT01588184|11100636|FG000|Overall Study|multiple reasons|0
7024301|NCT01588184|11100637|FG001|Overall Study|multiple reasons|3
7024302|NCT01588184|11100638|FG002|Overall Study|multiple reasons|0
7024303|NCT01588184|11100639|FG003|Overall Study|multiple reasons|1
7024304|NCT01588184|11100640|FG004|Overall Study|multiple reasons|0
7024305|NCT01588184|11100641|FG005|Overall Study|multiple reasons|0
7024306|NCT01588197|11100657|FG000|Overall Study|Lack of Efficacy|0
7024307|NCT01588197|11100658|FG001|Overall Study|Lack of Efficacy|1
7024308|NCT01588197|11100657|FG000|Overall Study|No MRI|1
7024309|NCT01588197|11100658|FG001|Overall Study|No MRI|0
7024310|NCT01588353|11100680|FG000|Step2|Withdrawal by Subject|0
7024311|NCT01588353|11100681|FG001|Step2|Withdrawal by Subject|1
7024312|NCT01588353|11100682|FG002|Step2|Withdrawal by Subject|0
7024313|NCT01588353|11100680|FG000|Step3|Adverse Event|0
7024314|NCT01588353|11100681|FG001|Step3|Adverse Event|0
7024315|NCT01588353|11100682|FG002|Step3|Adverse Event|2
7024316|NCT01588366|11100694|FG000|Overall Study|Adverse Event|0
7024317|NCT01588366|11100695|FG001|Overall Study|Adverse Event|1
7024318|NCT01588366|11100696|FG002|Overall Study|Adverse Event|0
7024319|NCT01588366|11100697|FG003|Overall Study|Adverse Event|1
7024320|NCT01588366|11100698|FG004|Overall Study|Adverse Event|0
7024321|NCT01588366|11100699|FG005|Overall Study|Adverse Event|2
7024322|NCT01588405|11100715|FG000|Overall Study|Adverse Event|1
7024323|NCT01588405|11100715|FG000|Overall Study|Clinical Worsening|1
7024324|NCT01588496|11100775|FG000|Overall Study|Withdrawal by Subject|0
7024325|NCT01588496|11100776|FG001|Overall Study|Withdrawal by Subject|1
7024326|NCT01588496|11100777|FG002|Overall Study|Withdrawal by Subject|0
7024327|NCT01588509|11100787|FG000|Overall Study|Lost to Follow-up|1
7024328|NCT01588509|11100788|FG001|Overall Study|Lost to Follow-up|0
7024329|NCT01588548|11100800|FG000|Overall Study|Withdrawal by Subject|0
7024330|NCT01588548|11100801|FG001|Overall Study|Withdrawal by Subject|1
7024331|NCT01588548|11100802|FG002|Overall Study|Withdrawal by Subject|1
7024332|NCT01588548|11100803|FG003|Overall Study|Withdrawal by Subject|1
7024333|NCT01588548|11100804|FG004|Overall Study|Withdrawal by Subject|2
7024334|NCT01588548|11100805|FG005|Overall Study|Withdrawal by Subject|3
7024335|NCT01588548|11100800|FG000|Overall Study|Adverse Event|0
7024336|NCT01588548|11100801|FG001|Overall Study|Adverse Event|0
7024337|NCT01588548|11100802|FG002|Overall Study|Adverse Event|1
7024338|NCT01588548|11100803|FG003|Overall Study|Adverse Event|2
7024339|NCT01588548|11100804|FG004|Overall Study|Adverse Event|1
7024340|NCT01588548|11100805|FG005|Overall Study|Adverse Event|0
7024341|NCT01588548|11100800|FG000|Overall Study|Condition Under Investigation Worsened|3
7024342|NCT01588548|11100801|FG001|Overall Study|Condition Under Investigation Worsened|6
7024343|NCT01588548|11100802|FG002|Overall Study|Condition Under Investigation Worsened|4
7024344|NCT01588548|11100803|FG003|Overall Study|Condition Under Investigation Worsened|4
7024345|NCT01588548|11100804|FG004|Overall Study|Condition Under Investigation Worsened|3
7024346|NCT01588548|11100805|FG005|Overall Study|Condition Under Investigation Worsened|3
7024347|NCT01588951|11100834|FG000|Overall Study|Ineligible in retrospect|0
7024348|NCT01588951|11100835|FG001|Overall Study|Ineligible in retrospect|0
7024349|NCT01588951|11100836|FG002|Overall Study|Ineligible in retrospect|1
7024350|NCT01588990|11100844|FG000|Phase A|Withdrawal by Subject|5
7024351|NCT01588990|11100844|FG000|Phase A|Physician Decision|11
7024352|NCT01588990|11100844|FG000|Phase A|Other|14
7024353|NCT01588990|11100844|FG000|Phase A|Lost to Follow-up|1
7024354|NCT01588990|11100844|FG000|Phase A|Death|5
7024355|NCT01588990|11100844|FG000|Phase A|Adverse Event|28
7024356|NCT01588990|11100844|FG000|Phase A|Still on therapy at end of study|6
7024357|NCT01588990|11100844|FG000|Phase B|Adverse Event|2
7024358|NCT01588990|11100844|FG000|Phase B|Still on therapy at end of study|5
7024359|NCT01588990|11100844|FG000|Phase B|Withdrawal by Subject|3
7024360|NCT01588990|11100844|FG000|Phase B|Physician Decision|4
7024361|NCT01588990|11100844|FG000|Phase B|Other|2
7024362|NCT01589094|11100852|FG000|Overall Study|Did not receive treatment|2
7024363|NCT01589185|11100861|FG000|Overall Study|Death|1
7024364|NCT01589185|11100862|FG001|Overall Study|Death|2
7024365|NCT01589185|11100863|FG002|Overall Study|Death|2
7024366|NCT01589185|11100864|FG003|Overall Study|Death|0
7024367|NCT01589185|11100865|FG004|Overall Study|Death|1
7024368|NCT01589185|11100861|FG000|Overall Study|Lost to Follow-up|1
7024369|NCT01589185|11100862|FG001|Overall Study|Lost to Follow-up|0
7024370|NCT01589185|11100863|FG002|Overall Study|Lost to Follow-up|2
7024371|NCT01589185|11100864|FG003|Overall Study|Lost to Follow-up|3
7024372|NCT01589185|11100865|FG004|Overall Study|Lost to Follow-up|0
7024373|NCT01589237|11100882|FG000|Part A (52 Weeks)|Subject/guardian decision|2
7024374|NCT01589237|11100883|FG001|Part A (52 Weeks)|Subject/guardian decision|3
7024375|NCT01589237|11100884|FG002|Part A (52 Weeks)|Subject/guardian decision|2
7024376|NCT01589237|11100885|FG003|Part A (52 Weeks)|Subject/guardian decision|0
7024377|NCT01589237|11100882|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
7024378|NCT01589237|11100883|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1
7024379|NCT01589237|11100884|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
7024380|NCT01589237|11100885|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
7024381|NCT01589237|11100882|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
7024382|NCT01589237|11100883|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
7024383|NCT01589237|11100884|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4
7024384|NCT01589237|11100885|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3
7024385|NCT01589237|11100882|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0
7024386|NCT01589237|11100883|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0
7024387|NCT01589237|11100884|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0
7024388|NCT01589237|11100885|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1
7024389|NCT01589445|11100917|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1
7024390|NCT01589445|11100917|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1
7024391|NCT01589445|11100917|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2
7024392|NCT01589445|11100917|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1
7024393|NCT01589445|11100917|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2
7024394|NCT01589445|11100917|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1
7024395|NCT01589445|11100917|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2
7024396|NCT01589445|11100917|FG000|002 (Metformin)-3 Months|Protocol Violation|2
7024397|NCT01589445|11100917|FG000|002 (Metformin)-3 Months|Adverse Event|2
7024398|NCT01589445|11100917|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2
7024399|NCT01589497|11100934|FG000|Overall Study|Withdrawal by Subject|0
7024400|NCT01589497|11100935|FG001|Overall Study|Withdrawal by Subject|1
7024401|NCT01589497|11100936|FG002|Overall Study|Withdrawal by Subject|0
7024402|NCT01589497|11100937|FG003|Overall Study|Withdrawal by Subject|1
7024403|NCT01589497|11100934|FG000|Overall Study|Death|1
7024404|NCT01589497|11100935|FG001|Overall Study|Death|0
7024405|NCT01589497|11100936|FG002|Overall Study|Death|0
7024406|NCT01589497|11100937|FG003|Overall Study|Death|0
7024407|NCT01589497|11100934|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0
7024408|NCT01589497|11100935|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0
7024409|NCT01589497|11100936|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1
7024410|NCT01589497|11100937|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0
7044171|NCT01751412|11129846|FG000|Overall Study|Disease Progression Before Treatment|1
7024411|NCT01589653|11100967|FG000|Overall Study|Protocol Violation|3
7024412|NCT01589653|11100968|FG001|Overall Study|Protocol Violation|1
7024413|NCT01589653|11100967|FG000|Overall Study|Withdrawal criteria|4
7024414|NCT01589653|11100968|FG001|Overall Study|Withdrawal criteria|7
7024415|NCT01589653|11100967|FG000|Overall Study|Unclassified|0
7024416|NCT01589653|11100968|FG001|Overall Study|Unclassified|3
7024417|NCT01589770|11100976|FG000|Overall Study|EGFR <60ml/min|6
7024418|NCT01589770|11100977|FG001|Overall Study|EGFR <60ml/min|4
7024419|NCT01589770|11100976|FG000|Overall Study|claustrophobic when entering cardiac MRI|2
7024420|NCT01589770|11100977|FG001|Overall Study|claustrophobic when entering cardiac MRI|1
7024421|NCT01589822|11100986|FG000|Overall Study|Withdrawal by Subject|1
7024422|NCT01589822|11100987|FG001|Overall Study|Withdrawal by Subject|2
7024423|NCT01589822|11100988|FG002|Overall Study|Withdrawal by Subject|0
7024424|NCT01589822|11100986|FG000|Overall Study|Death|1
7024425|NCT01589822|11100987|FG001|Overall Study|Death|0
7024426|NCT01589822|11100988|FG002|Overall Study|Death|0
7024427|NCT01589822|11100986|FG000|Overall Study|Missed 90 day visit|2
7024428|NCT01589822|11100987|FG001|Overall Study|Missed 90 day visit|1
7024429|NCT01589822|11100988|FG002|Overall Study|Missed 90 day visit|1
7024430|NCT01590017|11101003|FG000|Overall Study|Adverse Event|1
7024431|NCT01590017|11101003|FG000|Overall Study|Withdrawal by Subject|1
7024432|NCT01590017|11101003|FG000|Overall Study|Lack of Efficacy|1
7024433|NCT01590017|11101003|FG000|Overall Study|Physician Decision|1
7024434|NCT01590082|11101009|FG000|Overall Study|Withdrawal by Subject|1
7024435|NCT01590082|11101010|FG001|Overall Study|Withdrawal by Subject|0
7024436|NCT01590082|11101009|FG000|Overall Study|Ineligible|1
7024437|NCT01590082|11101010|FG001|Overall Study|Ineligible|0
7024438|NCT01590212|11101019|FG000|Overall Study|Withdrawal by Subject|2
7024439|NCT01590212|11101020|FG001|Overall Study|Withdrawal by Subject|2
7024440|NCT01590212|11101021|FG002|Overall Study|Withdrawal by Subject|2
7024441|NCT01590212|11101019|FG000|Overall Study|Lost to Follow-up|1
7024442|NCT01590212|11101020|FG001|Overall Study|Lost to Follow-up|2
7024443|NCT01590212|11101021|FG002|Overall Study|Lost to Follow-up|3
7024444|NCT01590433|11101040|FG000|Overall Study|Lost to Follow-up|20
7024445|NCT01590433|11101041|FG001|Overall Study|Lost to Follow-up|8
7024446|NCT01590433|11101040|FG000|Overall Study|Withdrawal by Subject|21
7024447|NCT01590433|11101041|FG001|Overall Study|Withdrawal by Subject|11
7024448|NCT01590433|11101040|FG000|Overall Study|Adverse Event|11
7024449|NCT01590433|11101041|FG001|Overall Study|Adverse Event|3
7024450|NCT01590563|11101052|FG000|Overall Study|simple uterine hyperplasia - not related|1
7024451|NCT01590758|11101059|FG000|Overall Study|Withdrawal by Subject|0
7024452|NCT01590758|11101060|FG001|Overall Study|Withdrawal by Subject|3
7024453|NCT01590758|11101059|FG000|Overall Study|Physician Decision|1
7024454|NCT01590758|11101060|FG001|Overall Study|Physician Decision|2
7024455|NCT01590758|11101059|FG000|Overall Study|Lost to Follow-up|4
7024456|NCT01590758|11101060|FG001|Overall Study|Lost to Follow-up|2
7024457|NCT01590771|11101068|FG000|Overall Study|Other Protocol Specified Criteria|5
7024458|NCT01590771|11101069|FG001|Overall Study|Other Protocol Specified Criteria|14
7024459|NCT01590771|11101068|FG000|Overall Study|Withdrawal by Subject|8
7024460|NCT01590771|11101069|FG001|Overall Study|Withdrawal by Subject|15
7024461|NCT01590771|11101068|FG000|Overall Study|Protocol Violation|1
7024462|NCT01590771|11101069|FG001|Overall Study|Protocol Violation|2
7024463|NCT01590771|11101068|FG000|Overall Study|Lost to Follow-up|1
7024464|NCT01590771|11101069|FG001|Overall Study|Lost to Follow-up|1
7024465|NCT01590771|11101068|FG000|Overall Study|Lack of Efficacy|1
7024466|NCT01590771|11101069|FG001|Overall Study|Lack of Efficacy|0
7024467|NCT01590771|11101068|FG000|Overall Study|Adverse Event|3
7024468|NCT01590771|11101069|FG001|Overall Study|Adverse Event|7
7024469|NCT01590797|11101077|FG000|Overall Study|Adverse Event|4
7024470|NCT01590797|11101078|FG001|Overall Study|Adverse Event|3
7024471|NCT01590797|11101077|FG000|Overall Study|Lack of Efficacy|0
7024472|NCT01590797|11101078|FG001|Overall Study|Lack of Efficacy|2
7024473|NCT01590797|11101077|FG000|Overall Study|Lost to Follow-up|0
7024474|NCT01590797|11101078|FG001|Overall Study|Lost to Follow-up|1
7024475|NCT01590797|11101077|FG000|Overall Study|Protocol Violation|4
7024476|NCT01590797|11101078|FG001|Overall Study|Protocol Violation|1
7024477|NCT01590797|11101077|FG000|Overall Study|Withdrawal by Subject|7
7024478|NCT01590797|11101078|FG001|Overall Study|Withdrawal by Subject|5
7024479|NCT01590797|11101077|FG000|Overall Study|Other Protocol Specified Criteria|2
7024480|NCT01590797|11101078|FG001|Overall Study|Other Protocol Specified Criteria|4
7024481|NCT01590810|11101089|FG000|Overall Study|Physician Decision|0
7024482|NCT01590810|11101090|FG001|Overall Study|Physician Decision|1
7024483|NCT01590810|11101091|FG002|Overall Study|Physician Decision|1
7024484|NCT01590810|11101092|FG003|Overall Study|Physician Decision|0
7024485|NCT01590810|11101093|FG004|Overall Study|Physician Decision|0
7024486|NCT01590888|11101140|FG000|Overall Study|Adverse Event|3
7024487|NCT01590888|11101141|FG001|Overall Study|Adverse Event|0
7024488|NCT01590888|11101142|FG002|Overall Study|Adverse Event|1
7024489|NCT01590888|11101140|FG000|Overall Study|Lost to Follow-up|1
7024490|NCT01590888|11101141|FG001|Overall Study|Lost to Follow-up|0
7024491|NCT01590888|11101142|FG002|Overall Study|Lost to Follow-up|0
7024492|NCT01591330|11101225|FG000|Period 1|Adverse Event|1
7024493|NCT01591330|11101226|FG001|Period 1|Adverse Event|0
7024494|NCT01591330|11101227|FG002|Period 1|Adverse Event|0
7024495|NCT01591330|11101228|FG003|Period 1|Adverse Event|0
7024496|NCT01591330|11101225|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1
7024497|NCT01591330|11101226|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0
7024498|NCT01591330|11101227|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0
7024499|NCT01591330|11101228|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0
7024500|NCT01591330|11101225|FG000|Period 2|Adverse Event|1
7024501|NCT01591330|11101226|FG001|Period 2|Adverse Event|0
7024502|NCT01591330|11101227|FG002|Period 2|Adverse Event|0
7024503|NCT01591330|11101228|FG003|Period 2|Adverse Event|0
7024504|NCT01591382|11101240|FG000|Overall Study|Discharged Prior to Study Completion|2
7024505|NCT01591382|11101241|FG001|Overall Study|Discharged Prior to Study Completion|1
7024506|NCT01591382|11101240|FG000|Overall Study|Participant Opted for Morphine PCA|1
7024507|NCT01591382|11101241|FG001|Overall Study|Participant Opted for Morphine PCA|1
7024508|NCT01591460|11101256|FG000|Overall Study|Adverse Event or Intercurrent Illness|5
7024509|NCT01591460|11101256|FG000|Overall Study|Futility Rule (Week 12)|7
7024510|NCT01591460|11101256|FG000|Overall Study|Futility Rule (Week 24)|3
7024511|NCT01591460|11101256|FG000|Overall Study|Rebound or Breakthrough|3
7024512|NCT01591460|11101256|FG000|Overall Study|Treatment Discontinued by Error|1
7024513|NCT01591460|11101256|FG000|Overall Study|Lost to Follow-up|1
7024514|NCT01591460|11101256|FG000|Overall Study|Noncompliance|1
7024515|NCT01591460|11101256|FG000|Overall Study|Participant Refusal|3
7024516|NCT01591460|11101256|FG000|Overall Study|Withdrawal by Subject|1
7024517|NCT01591460|11101256|FG000|Overall Study|Protocol Violation|1
7024518|NCT01591499|11101268|FG000|Baseline Visit|Withdrawal by Subject|0
7024519|NCT01591499|11101269|FG001|Baseline Visit|Withdrawal by Subject|2
7024520|NCT01591499|11101270|FG002|Baseline Visit|Withdrawal by Subject|0
7024521|NCT01591499|11101271|FG003|Baseline Visit|Withdrawal by Subject|2
7024522|NCT01591499|11101268|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
7024523|NCT01591499|11101269|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
7024524|NCT01591499|11101270|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
7024525|NCT01591499|11101271|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
7024526|NCT01591499|11101268|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4
7024527|NCT01591499|11101269|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3
7024528|NCT01591499|11101270|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1
7024529|NCT01591499|11101271|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3
7024530|NCT01591616|11101295|FG000|Overall Study|Withdrawal by Subject|1
7024531|NCT01591681|11101443|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3
7024532|NCT01591681|11101443|FG000|Overall Study|Failed to use system during run-in|1
7143180|NCT03028142|11299604|FG002|Overall Study|Adverse Event|0
7143181|NCT03028142|11299605|FG003|Overall Study|Adverse Event|0
7143182|NCT03028142|11299606|FG004|Overall Study|Adverse Event|0
7024533|NCT01591785|11101466|FG000|Overall Study|worsening condition|1
7024534|NCT01591785|11101467|FG001|Overall Study|worsening condition|2
7024535|NCT01591785|11101466|FG000|Overall Study|Protocol Violation|2
7024536|NCT01591785|11101467|FG001|Overall Study|Protocol Violation|0
7024537|NCT01591785|11101466|FG000|Overall Study|Lost to Follow-up|1
7024538|NCT01591785|11101467|FG001|Overall Study|Lost to Follow-up|0
7024539|NCT01591863|11101482|FG000|Overall Study|Adverse Event|3
7024540|NCT01591863|11101482|FG000|Overall Study|Withdrawal by Subject|1
7024541|NCT01591863|11101482|FG000|Overall Study|recurrence|9
7024542|NCT01591863|11101482|FG000|Overall Study|Lack of Efficacy|1
7024543|NCT01592045|11101492|FG000|Overall Study|Disease Progression|1
7024544|NCT01592045|11101493|FG001|Overall Study|Disease Progression|1
7024545|NCT01592045|11101492|FG000|Overall Study|Adverse Event|1
7024546|NCT01592045|11101493|FG001|Overall Study|Adverse Event|1
7024547|NCT01592045|11101492|FG000|Overall Study|Withdrawal by Subject|1
7024548|NCT01592045|11101493|FG001|Overall Study|Withdrawal by Subject|0
7024549|NCT01592045|11101492|FG000|Overall Study|Moved out of country|2
7024550|NCT01592045|11101493|FG001|Overall Study|Moved out of country|0
7024551|NCT01592240|11101510|FG000|Overall Study|Adverse Event|1
7024552|NCT01592240|11101511|FG001|Overall Study|Adverse Event|0
7024553|NCT01592240|11101512|FG002|Overall Study|Adverse Event|0
7024554|NCT01592240|11101513|FG003|Overall Study|Adverse Event|1
7024555|NCT01592240|11101514|FG004|Overall Study|Adverse Event|1
7024556|NCT01592240|11101515|FG005|Overall Study|Adverse Event|0
7024557|NCT01592240|11101516|FG006|Overall Study|Adverse Event|0
7024558|NCT01592240|11101510|FG000|Overall Study|Death|0
7024559|NCT01592240|11101511|FG001|Overall Study|Death|1
7024560|NCT01592240|11101512|FG002|Overall Study|Death|0
7024561|NCT01592240|11101513|FG003|Overall Study|Death|0
7024562|NCT01592240|11101514|FG004|Overall Study|Death|0
7024563|NCT01592240|11101515|FG005|Overall Study|Death|0
7024564|NCT01592240|11101516|FG006|Overall Study|Death|0
7060548|NCT01920061|11156848|FG011|Overall Study|Lost to Follow-up|0
7024565|NCT01592240|11101510|FG000|Overall Study|Lost to Follow-up|1
7024566|NCT01592240|11101511|FG001|Overall Study|Lost to Follow-up|3
7024567|NCT01592240|11101512|FG002|Overall Study|Lost to Follow-up|1
7024568|NCT01592240|11101513|FG003|Overall Study|Lost to Follow-up|0
7024569|NCT01592240|11101514|FG004|Overall Study|Lost to Follow-up|3
7024570|NCT01592240|11101515|FG005|Overall Study|Lost to Follow-up|2
7024571|NCT01592240|11101516|FG006|Overall Study|Lost to Follow-up|0
7024572|NCT01592240|11101510|FG000|Overall Study|Protocol Violation|0
7024573|NCT01592240|11101511|FG001|Overall Study|Protocol Violation|0
7024574|NCT01592240|11101512|FG002|Overall Study|Protocol Violation|0
7024575|NCT01592240|11101513|FG003|Overall Study|Protocol Violation|0
7143183|NCT03028142|11299607|FG005|Overall Study|Adverse Event|1
7024576|NCT01592240|11101514|FG004|Overall Study|Protocol Violation|0
7024577|NCT01592240|11101515|FG005|Overall Study|Protocol Violation|1
7024578|NCT01592240|11101516|FG006|Overall Study|Protocol Violation|0
7024579|NCT01592240|11101510|FG000|Overall Study|Withdrawal by Subject|0
7024580|NCT01592240|11101511|FG001|Overall Study|Withdrawal by Subject|4
7024581|NCT01592240|11101512|FG002|Overall Study|Withdrawal by Subject|4
7024582|NCT01592240|11101513|FG003|Overall Study|Withdrawal by Subject|1
7024583|NCT01592240|11101514|FG004|Overall Study|Withdrawal by Subject|3
7024584|NCT01592240|11101515|FG005|Overall Study|Withdrawal by Subject|0
7024585|NCT01592240|11101516|FG006|Overall Study|Withdrawal by Subject|2
7024586|NCT01592240|11101510|FG000|Overall Study|Other|0
7024587|NCT01592240|11101511|FG001|Overall Study|Other|3
7024588|NCT01592240|11101512|FG002|Overall Study|Other|1
7024589|NCT01592240|11101513|FG003|Overall Study|Other|1
7024590|NCT01592240|11101514|FG004|Overall Study|Other|0
7024591|NCT01592240|11101515|FG005|Overall Study|Other|0
7024592|NCT01592240|11101516|FG006|Overall Study|Other|1
7024593|NCT01592240|11101510|FG000|Overall Study|Did Not Meet Entrance Criteria|1
7024594|NCT01592240|11101511|FG001|Overall Study|Did Not Meet Entrance Criteria|0
7024595|NCT01592240|11101512|FG002|Overall Study|Did Not Meet Entrance Criteria|1
7024596|NCT01592240|11101513|FG003|Overall Study|Did Not Meet Entrance Criteria|0
7024597|NCT01592240|11101514|FG004|Overall Study|Did Not Meet Entrance Criteria|0
7024598|NCT01592240|11101515|FG005|Overall Study|Did Not Meet Entrance Criteria|0
7024599|NCT01592240|11101516|FG006|Overall Study|Did Not Meet Entrance Criteria|0
7024600|NCT01592292|11101539|FG000|Overall Study|Follow-up loss|3
7024601|NCT01592292|11101540|FG001|Overall Study|Follow-up loss|3
7024602|NCT01592292|11101541|FG002|Overall Study|Follow-up loss|1
7024603|NCT01592292|11101542|FG003|Overall Study|Follow-up loss|0
7024604|NCT01592292|11101539|FG000|Overall Study|Withdrew consent|2
7024605|NCT01592292|11101540|FG001|Overall Study|Withdrew consent|1
7024606|NCT01592292|11101541|FG002|Overall Study|Withdrew consent|0
7024607|NCT01592292|11101542|FG003|Overall Study|Withdrew consent|0
7024608|NCT01592292|11101539|FG000|Overall Study|Other|1
7024609|NCT01592292|11101540|FG001|Overall Study|Other|1
7024610|NCT01592292|11101541|FG002|Overall Study|Other|2
7024611|NCT01592292|11101542|FG003|Overall Study|Other|1
7024612|NCT01592344|11101550|FG000|Overall Study|Adverse Event|1
7024613|NCT01592344|11101551|FG001|Overall Study|Adverse Event|1
7024614|NCT01592344|11101550|FG000|Overall Study|Lack of Efficacy|1
7024615|NCT01592344|11101551|FG001|Overall Study|Lack of Efficacy|0
7024616|NCT01592344|11101550|FG000|Overall Study|not available at primary outcome visit|2
7024617|NCT01592344|11101551|FG001|Overall Study|not available at primary outcome visit|4
7024618|NCT01592409|11101569|FG000|Overall Study|Withdrawal by Subject|0
7024619|NCT01592409|11101570|FG001|Overall Study|Withdrawal by Subject|1
7024620|NCT01592695|11101601|FG000|Overall Study|Lost to Follow-up|8
7024621|NCT01592695|11101602|FG001|Overall Study|Lost to Follow-up|4
7024622|NCT01592708|11101610|FG000|Overall Study|Protocol Violation|3
7024623|NCT01592708|11101611|FG001|Overall Study|Protocol Violation|0
7024624|NCT01592747|11101623|FG000|Overall Study|Loss of Therapeutic Response|107
7024625|NCT01592747|11101624|FG001|Overall Study|Loss of Therapeutic Response|108
7024626|NCT01592747|11101625|FG002|Overall Study|Loss of Therapeutic Response|100
7024627|NCT01592747|11101623|FG000|Overall Study|Inclusion/Exclusion criteria not met|0
7024628|NCT01592747|11101624|FG001|Overall Study|Inclusion/Exclusion criteria not met|1
7024629|NCT01592747|11101625|FG002|Overall Study|Inclusion/Exclusion criteria not met|1
7024630|NCT01592747|11101623|FG000|Overall Study|Adverse Event|1
7024631|NCT01592747|11101624|FG001|Overall Study|Adverse Event|0
7024632|NCT01592747|11101625|FG002|Overall Study|Adverse Event|0
7024633|NCT01592747|11101623|FG000|Overall Study|Protocol Violation|4
7024634|NCT01592747|11101624|FG001|Overall Study|Protocol Violation|0
7024635|NCT01592747|11101625|FG002|Overall Study|Protocol Violation|4
7024636|NCT01592747|11101623|FG000|Overall Study|Lack of Efficacy|0
7024637|NCT01592747|11101624|FG001|Overall Study|Lack of Efficacy|1
7024638|NCT01592747|11101625|FG002|Overall Study|Lack of Efficacy|0
7024639|NCT01592747|11101623|FG000|Overall Study|Withdrawal by Subject|2
7024640|NCT01592747|11101624|FG001|Overall Study|Withdrawal by Subject|0
7024641|NCT01592747|11101625|FG002|Overall Study|Withdrawal by Subject|2
7024642|NCT01592747|11101623|FG000|Overall Study|Lost to Follow-up|1
7024643|NCT01592747|11101624|FG001|Overall Study|Lost to Follow-up|0
7024644|NCT01592747|11101625|FG002|Overall Study|Lost to Follow-up|1
7024645|NCT01592747|11101623|FG000|Overall Study|Other Reasons|1
7024646|NCT01592747|11101624|FG001|Overall Study|Other Reasons|1
7024647|NCT01592747|11101625|FG002|Overall Study|Other Reasons|0
7024648|NCT01592760|11101637|FG000|24-hour Follow-Up|Lost to Follow-up|4
7024649|NCT01592760|11101638|FG001|24-hour Follow-Up|Lost to Follow-up|3
7024650|NCT01592760|11101639|FG002|24-hour Follow-Up|Lost to Follow-up|2
7024651|NCT01592773|11101650|FG000|Overall Study|Study Terminated by Sponsor|582
7024652|NCT01592773|11101650|FG000|Overall Study|Withdrawal by Subject|35
7024653|NCT01592773|11101650|FG000|Overall Study|Lost to Follow-up|19
7024654|NCT01592773|11101650|FG000|Overall Study|Adverse Event|17
7024655|NCT01592773|11101650|FG000|Overall Study|Lack of Efficacy|9
7024656|NCT01592773|11101650|FG000|Overall Study|Protocol Violation|2
7024657|NCT01592773|11101650|FG000|Overall Study|Inclusion/exclusion not meet|1
7024658|NCT01592773|11101650|FG000|Overall Study|Other Reason|1
7024659|NCT01592786|11101654|FG000|Overall Study|Adverse Event|60
7024660|NCT01592786|11101654|FG000|Overall Study|Lack of Efficacy|19
7024661|NCT01592786|11101654|FG000|Overall Study|Protocol Violation|14
7024662|NCT01592786|11101654|FG000|Overall Study|Withdrawal by Subject|23
7024663|NCT01592786|11101654|FG000|Overall Study|Lost to Follow-up|19
7024664|NCT01592786|11101654|FG000|Overall Study|Other|3
7024665|NCT01592864|11101675|FG000|Overall Study|Withdrawal by Subject|0
7024666|NCT01592864|11101676|FG001|Overall Study|Withdrawal by Subject|1
7024667|NCT01593020|11101684|FG000|Overall Study|Adverse Event|1
7024668|NCT01593020|11101685|FG001|Overall Study|Adverse Event|1
7024669|NCT01593020|11101684|FG000|Overall Study|Death|0
7024670|NCT01593020|11101685|FG001|Overall Study|Death|1
7024671|NCT01593020|11101684|FG000|Overall Study|Ineligible|1
7024672|NCT01593020|11101685|FG001|Overall Study|Ineligible|0
7024673|NCT01593696|11101717|FG000|Dose Escalation|Progressive Disease|2
7024674|NCT01593696|11101718|FG001|Dose Escalation|Progressive Disease|0
7024675|NCT01593696|11101719|FG002|Dose Escalation|Progressive Disease|0
7024676|NCT01593696|11101720|FG003|Dose Escalation|Progressive Disease|0
7024677|NCT01593696|11101717|FG000|Dose Expansion|Fungal infection|0
7024678|NCT01593696|11101718|FG001|Dose Expansion|Fungal infection|0
7024679|NCT01593696|11101719|FG002|Dose Expansion|Fungal infection|1
7024680|NCT01593696|11101720|FG003|Dose Expansion|Fungal infection|0
7024681|NCT01593787|11101753|FG000|Overall Study|Adverse Event|1
7024682|NCT01593787|11101754|FG001|Overall Study|Adverse Event|0
7024683|NCT01593787|11101755|FG002|Overall Study|Adverse Event|0
7024684|NCT01593917|11101765|FG000|Overall Study|Death|67
7024685|NCT01593917|11101765|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60
7024686|NCT01593917|11101765|FG000|Overall Study|Withdrawal by Subject|23
7024687|NCT01593917|11101765|FG000|Overall Study|Lost to Follow-up|12
7024688|NCT01593917|11101765|FG000|Overall Study|Protocol Violation|5
7024689|NCT01593917|11101765|FG000|Overall Study|Physician Decision|3
7024690|NCT01594125|11101774|FG000|Overall Study|Withdrawal by Subject|1
7024691|NCT01594125|11101775|FG001|Overall Study|Withdrawal by Subject|0
7024692|NCT01594125|11101776|FG002|Overall Study|Withdrawal by Subject|0
7024693|NCT01594125|11101777|FG003|Overall Study|Withdrawal by Subject|1
7024694|NCT01594125|11101778|FG004|Overall Study|Withdrawal by Subject|0
7024695|NCT01594125|11101774|FG000|Overall Study|Progressive Disease|3
7024696|NCT01594125|11101775|FG001|Overall Study|Progressive Disease|12
7024697|NCT01594125|11101776|FG002|Overall Study|Progressive Disease|3
7024698|NCT01594125|11101777|FG003|Overall Study|Progressive Disease|3
7024699|NCT01594125|11101778|FG004|Overall Study|Progressive Disease|7
7024700|NCT01594281|11101793|FG000|Interventional Core Phase|Protocol Deviation|1
7024701|NCT01594281|11101794|FG001|Interventional Core Phase|Protocol Deviation|0
7024702|NCT01594281|11101795|FG002|Interventional Core Phase|Protocol Deviation|0
7024703|NCT01594281|11101793|FG000|Interventional Core Phase|Subject Withdrew Consent|0
7024704|NCT01594281|11101794|FG001|Interventional Core Phase|Subject Withdrew Consent|1
7024705|NCT01594281|11101795|FG002|Interventional Core Phase|Subject Withdrew Consent|1
7024706|NCT01594281|11101793|FG000|Interventional Core Phase|Death|1
7024707|NCT01594281|11101794|FG001|Interventional Core Phase|Death|1
7024708|NCT01594281|11101795|FG002|Interventional Core Phase|Death|2
7024709|NCT01594281|11101793|FG000|Interventional Core Phase|Lost to Follow-up|1
7024710|NCT01594281|11101794|FG001|Interventional Core Phase|Lost to Follow-up|4
7024711|NCT01594281|11101795|FG002|Interventional Core Phase|Lost to Follow-up|1
7024712|NCT01594281|11101793|FG000|Interventional Core Phase|Adverse Event|4
7024713|NCT01594281|11101794|FG001|Interventional Core Phase|Adverse Event|4
7024714|NCT01594281|11101795|FG002|Interventional Core Phase|Adverse Event|4
7024715|NCT01594281|11101793|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2
7024716|NCT01594281|11101794|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2
7024717|NCT01594281|11101795|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0
7024718|NCT01594281|11101793|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0
7024719|NCT01594281|11101794|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0
7024720|NCT01594281|11101795|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1
7024721|NCT01594281|11101793|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1
7024722|NCT01594281|11101794|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0
7024723|NCT01594281|11101795|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1
7024724|NCT01594333|11101817|FG000|Overall Study|Death|96
7024725|NCT01594333|11101818|FG001|Overall Study|Death|83
7024726|NCT01594333|11101817|FG000|Overall Study|Lost to Follow-up|5
7024727|NCT01594333|11101818|FG001|Overall Study|Lost to Follow-up|5
7024728|NCT01594333|11101817|FG000|Overall Study|Withdrawal by Subject|60
7024729|NCT01594333|11101818|FG001|Overall Study|Withdrawal by Subject|63
7024730|NCT01594411|11101837|FG000|Overall Study|Lost to Follow-up|2
7024731|NCT01594476|11101850|FG000|Overall Study|Protocol Violation|1
7024732|NCT01594476|11101851|FG001|Overall Study|Protocol Violation|3
7024733|NCT01594749|11101915|FG000|Overall Study|Adverse Event|2
7024734|NCT01594749|11101916|FG001|Overall Study|Adverse Event|1
7024735|NCT01594749|11101915|FG000|Overall Study|Withdrawal by Subject|2
7024736|NCT01594749|11101916|FG001|Overall Study|Withdrawal by Subject|2
7024737|NCT01594749|11101915|FG000|Overall Study|Protocol Violation|2
7024738|NCT01594749|11101916|FG001|Overall Study|Protocol Violation|0
7024739|NCT01594749|11101915|FG000|Overall Study|Physician Decision|1
7024740|NCT01594749|11101916|FG001|Overall Study|Physician Decision|1
7060549|NCT01920061|11156849|FG012|Overall Study|Lost to Follow-up|0
7024741|NCT01594749|11101915|FG000|Overall Study|Non-compliance with Protocol|0
7024742|NCT01594749|11101916|FG001|Overall Study|Non-compliance with Protocol|1
7024743|NCT01594749|11101915|FG000|Overall Study|Lost to Follow-up|1
7024744|NCT01594749|11101916|FG001|Overall Study|Lost to Follow-up|0
7024745|NCT01594749|11101915|FG000|Overall Study|Death|9
7024746|NCT01594749|11101916|FG001|Overall Study|Death|3
7024747|NCT01594749|11101915|FG000|Overall Study|Not Treated|4
7024748|NCT01594749|11101916|FG001|Overall Study|Not Treated|10
7024749|NCT01594749|11101915|FG000|Overall Study|Lost Source Documentation|1
7024750|NCT01594749|11101916|FG001|Overall Study|Lost Source Documentation|0
7024751|NCT01594762|11101924|FG000|Overall Study|Withdrawal by Subject|1
7024752|NCT01594762|11101925|FG001|Overall Study|Withdrawal by Subject|0
7024753|NCT01594762|11101924|FG000|Overall Study|Lost to Follow-up|10
7024754|NCT01594762|11101925|FG001|Overall Study|Lost to Follow-up|10
7024755|NCT01594827|11101933|FG000|Overall Study|Adverse Event|1
7024756|NCT01594827|11101934|FG001|Overall Study|Adverse Event|0
7024757|NCT01594827|11101933|FG000|Overall Study|Physician Decision|3
7024758|NCT01594827|11101934|FG001|Overall Study|Physician Decision|0
7024759|NCT01594853|11101944|FG000|Overall Study|Withdrawal by Subject|1
7024760|NCT01594853|11101945|FG001|Overall Study|Withdrawal by Subject|1
7024761|NCT01594853|11101944|FG000|Overall Study|Lost to Follow-up|1
7024762|NCT01594853|11101945|FG001|Overall Study|Lost to Follow-up|1
7024763|NCT01594853|11101944|FG000|Overall Study|noncompliance with exercise|0
7024764|NCT01594853|11101945|FG001|Overall Study|noncompliance with exercise|1
7024765|NCT01594931|11101954|FG000|Overall Study|Adverse Event|3
7024766|NCT01594931|11101955|FG001|Overall Study|Adverse Event|1
7024767|NCT01594931|11101956|FG002|Overall Study|Adverse Event|1
7024768|NCT01594931|11101954|FG000|Overall Study|Withdrawal by Subject|2
7024769|NCT01594931|11101955|FG001|Overall Study|Withdrawal by Subject|1
7024770|NCT01594931|11101956|FG002|Overall Study|Withdrawal by Subject|1
7024771|NCT01594931|11101954|FG000|Overall Study|Lack of Efficacy|7
7024772|NCT01594931|11101955|FG001|Overall Study|Lack of Efficacy|2
7024773|NCT01594931|11101956|FG002|Overall Study|Lack of Efficacy|2
7024774|NCT01594931|11101954|FG000|Overall Study|Lost to Follow-up|4
7024775|NCT01594931|11101955|FG001|Overall Study|Lost to Follow-up|3
7024776|NCT01594931|11101956|FG002|Overall Study|Lost to Follow-up|3
7024777|NCT01594931|11101954|FG000|Overall Study|Protocol Violation|2
7024778|NCT01594931|11101955|FG001|Overall Study|Protocol Violation|1
7024779|NCT01594931|11101956|FG002|Overall Study|Protocol Violation|0
7024780|NCT01594931|11101954|FG000|Overall Study|No defiined|11
7024781|NCT01594931|11101955|FG001|Overall Study|No defiined|4
7024782|NCT01594931|11101956|FG002|Overall Study|No defiined|7
7024783|NCT01594970|11101967|FG000|Overall Study|Non-Adverse Event Related|4
7024784|NCT01594970|11101968|FG001|Overall Study|Non-Adverse Event Related|5
7024785|NCT01594970|11101969|FG002|Overall Study|Non-Adverse Event Related|6
7024786|NCT01594970|11101967|FG000|Overall Study|Adverse Event|17
7024787|NCT01594970|11101968|FG001|Overall Study|Adverse Event|23
7024788|NCT01594970|11101969|FG002|Overall Study|Adverse Event|23
7024789|NCT01594970|11101967|FG000|Overall Study|Lost to Follow-up|54
7024790|NCT01594970|11101968|FG001|Overall Study|Lost to Follow-up|54
7024791|NCT01594970|11101969|FG002|Overall Study|Lost to Follow-up|37
7024792|NCT01595438|11101997|FG000|Overall Study|Lost to Follow-up|20
7024793|NCT01595438|11101998|FG001|Overall Study|Lost to Follow-up|20
7024794|NCT01595438|11101997|FG000|Overall Study|Withdrawal by Subject|12
7024795|NCT01595438|11101998|FG001|Overall Study|Withdrawal by Subject|12
7024796|NCT01595438|11101997|FG000|Overall Study|Other Eligibility criteria|11
7024797|NCT01595438|11101998|FG001|Overall Study|Other Eligibility criteria|9
7024798|NCT01595529|11102033|FG000|Overall Study|Adverse Event|2
7024799|NCT01595529|11102034|FG001|Overall Study|Adverse Event|0
7024800|NCT01595529|11102033|FG000|Overall Study|Subject Non-Compliant|2
7024801|NCT01595529|11102034|FG001|Overall Study|Subject Non-Compliant|0
7024802|NCT01595529|11102033|FG000|Overall Study|Lost to Follow-up|8
7024803|NCT01595529|11102034|FG001|Overall Study|Lost to Follow-up|14
7024804|NCT01595529|11102033|FG000|Overall Study|Protocol Violation|1
7024805|NCT01595529|11102034|FG001|Overall Study|Protocol Violation|2
7024806|NCT01595529|11102033|FG000|Overall Study|Physician Decision|1
7024807|NCT01595529|11102034|FG001|Overall Study|Physician Decision|0
7024808|NCT01595529|11102033|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3
7024809|NCT01595529|11102034|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3
7024810|NCT01595529|11102033|FG000|Overall Study|Administrative Decision|1
7024811|NCT01595529|11102034|FG001|Overall Study|Administrative Decision|0
7024812|NCT01595529|11102033|FG000|Overall Study|Entry Failure/Screening Failure|6
7024813|NCT01595529|11102034|FG001|Overall Study|Entry Failure/Screening Failure|1
7024814|NCT01595646|11102043|FG000|Overall Study|Withdrawal by Subject|1
7024815|NCT01595646|11102044|FG001|Overall Study|Withdrawal by Subject|0
7024816|NCT01595646|11102045|FG002|Overall Study|Withdrawal by Subject|0
7024817|NCT01596062|11102086|FG000|Overall Study|Adverse Event|1
7024818|NCT01596062|11102087|FG001|Overall Study|Adverse Event|0
7024819|NCT01596062|11102088|FG002|Overall Study|Adverse Event|2
7024820|NCT01596062|11102086|FG000|Overall Study|Lack of Efficacy|0
7024821|NCT01596062|11102087|FG001|Overall Study|Lack of Efficacy|0
7024822|NCT01596062|11102088|FG002|Overall Study|Lack of Efficacy|1
7024823|NCT01596127|11102100|FG000|Overall Study|Patient Ineligible|1
7024824|NCT01596335|11102126|FG000|Overall Study|exacerbation of primary disease|5
7024825|NCT01596335|11102127|FG001|Overall Study|exacerbation of primary disease|9
7024826|NCT01596504|11102136|FG000|Overall Study|Participant's Private Reason|0
7024827|NCT01596504|11102137|FG001|Overall Study|Participant's Private Reason|1
7024828|NCT01596504|11102138|FG002|Overall Study|Participant's Private Reason|0
7024829|NCT01596504|11102136|FG000|Overall Study|Adverse Event|1
7024830|NCT01596504|11102137|FG001|Overall Study|Adverse Event|2
7024831|NCT01596504|11102138|FG002|Overall Study|Adverse Event|1
7024832|NCT01596504|11102136|FG000|Overall Study|Withdrawal by Subject|1
7024833|NCT01596504|11102137|FG001|Overall Study|Withdrawal by Subject|0
7024834|NCT01596504|11102138|FG002|Overall Study|Withdrawal by Subject|0
7024835|NCT01596582|11102149|FG000|Overall Study|Deemed ineligible after study visit|3
7024836|NCT01596582|11102150|FG001|Overall Study|Deemed ineligible after study visit|6
7024837|NCT01596582|11102149|FG000|Overall Study|Missing all outcome data|1
7024838|NCT01596582|11102150|FG001|Overall Study|Missing all outcome data|1
7044172|NCT01751568|11129866|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1
7044173|NCT01751568|11129867|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0
7044174|NCT01751568|11129868|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0
7044175|NCT01751646|11129878|FG000|Overall Study|Lost to Follow-up|5
7044176|NCT01751646|11129879|FG001|Overall Study|Lost to Follow-up|1
7044177|NCT01751646|11129878|FG000|Overall Study|Withdrawal by Subject|0
7044178|NCT01751646|11129879|FG001|Overall Study|Withdrawal by Subject|4
7044179|NCT01751646|11129878|FG000|Overall Study|Starting hormone therapy|1
7044180|NCT01751646|11129879|FG001|Overall Study|Starting hormone therapy|0
7044181|NCT01751646|11129878|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2
7044182|NCT01751646|11129879|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3
7044183|NCT01751646|11129878|FG000|Overall Study|Inadvertent enrollment|1
7044184|NCT01751646|11129879|FG001|Overall Study|Inadvertent enrollment|1
7044185|NCT01751646|11129878|FG000|Overall Study|Moved out of the area|1
7044186|NCT01751646|11129879|FG001|Overall Study|Moved out of the area|5
7044187|NCT01751646|11129878|FG000|Overall Study|Inability to attend required visits|0
7044188|NCT01751646|11129879|FG001|Overall Study|Inability to attend required visits|1
7044189|NCT01751646|11129878|FG000|Overall Study|Off study due to multiple obligations|0
7044190|NCT01751646|11129879|FG001|Overall Study|Off study due to multiple obligations|1
7044191|NCT01751646|11129878|FG000|Overall Study|Fails to comply with study requirements|0
7044192|NCT01751646|11129879|FG001|Overall Study|Fails to comply with study requirements|1
7044193|NCT01751646|11129878|FG000|Overall Study|Childcare issues|1
7044194|NCT01751646|11129879|FG001|Overall Study|Childcare issues|1
7044195|NCT01751724|11129891|FG000|Overall Study|extubated bef.start assigned treatment|1
7044196|NCT01751724|11129892|FG001|Overall Study|extubated bef.start assigned treatment|0
7044197|NCT01751724|11129891|FG000|Overall Study|withdrawn by parent|0
7044198|NCT01751724|11129892|FG001|Overall Study|withdrawn by parent|2
7044199|NCT01751802|11129900|FG000|Overall Study|Adverse Event|4
7044200|NCT01751802|11129901|FG001|Overall Study|Adverse Event|2
7044201|NCT01751867|11129915|FG000|Overall Study|Completed treatment,dropped in follow-up|4
7044202|NCT01751867|11129916|FG001|Overall Study|Completed treatment,dropped in follow-up|8
7044203|NCT01751867|11129915|FG000|Overall Study|Diease Progression|4
7044204|NCT01751867|11129916|FG001|Overall Study|Diease Progression|18
7044205|NCT01751867|11129915|FG000|Overall Study|Adverse Event|8
7044206|NCT01751867|11129916|FG001|Overall Study|Adverse Event|15
7044207|NCT01751867|11129915|FG000|Overall Study|Poor Compliance|0
7044208|NCT01751867|11129916|FG001|Overall Study|Poor Compliance|5
7044209|NCT01751867|11129915|FG000|Overall Study|Withdrawal by Subject|3
7044210|NCT01751867|11129916|FG001|Overall Study|Withdrawal by Subject|1
7044211|NCT01751867|11129915|FG000|Overall Study|Physician Decision|4
7044212|NCT01751867|11129916|FG001|Overall Study|Physician Decision|7
7044213|NCT01751867|11129915|FG000|Overall Study|Protocol Violation|0
7044214|NCT01751867|11129916|FG001|Overall Study|Protocol Violation|2
7044215|NCT01751867|11129915|FG000|Overall Study|Death|0
7044216|NCT01751867|11129916|FG001|Overall Study|Death|5
7044217|NCT01751867|11129915|FG000|Overall Study|Other|11
7044218|NCT01751867|11129916|FG001|Overall Study|Other|37
7044219|NCT01751867|11129915|FG000|Overall Study|Randomized but not treated.|2
7044220|NCT01751867|11129916|FG001|Overall Study|Randomized but not treated.|1
7044221|NCT01752036|11129937|FG000|Overall Study|Death|2
7044222|NCT01752634|11129965|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1
7044223|NCT01752634|11129966|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1
7044224|NCT01752634|11129967|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1
7044225|NCT01752634|11129968|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0
7044226|NCT01752634|11129969|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0
7044227|NCT01752634|11129970|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3
7044228|NCT01752634|11129965|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0
7044229|NCT01752634|11129966|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1
7044230|NCT01752634|11129967|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0
7044231|NCT01752634|11129968|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0
7044232|NCT01752634|11129969|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0
7044233|NCT01752634|11129970|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0
7044234|NCT01752634|11129965|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2
7044235|NCT01752634|11129966|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3
7024839|NCT01596972|11102221|FG000|Overall Study|Physician Decision|1
7024840|NCT01596972|11102222|FG001|Overall Study|Physician Decision|9
7024841|NCT01596972|11102221|FG000|Overall Study|Lost to Follow-up|0
7024842|NCT01596972|11102222|FG001|Overall Study|Lost to Follow-up|4
7024843|NCT01596972|11102221|FG000|Overall Study|Withdrawal by Subject|0
7024844|NCT01596972|11102222|FG001|Overall Study|Withdrawal by Subject|1
7024845|NCT01597050|11102230|FG000|Overall Study|Withdrawal by Subject|1
7024846|NCT01597050|11102231|FG001|Overall Study|Withdrawal by Subject|0
7024847|NCT01597193|11102264|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7
7024848|NCT01597193|11102265|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8
7024849|NCT01597193|11102266|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0
7024850|NCT01597193|11102267|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0
7024851|NCT01597193|11102268|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0
7024852|NCT01597193|11102269|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0
7024853|NCT01597193|11102270|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0
7024854|NCT01597193|11102264|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
7024855|NCT01597193|11102265|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
7024856|NCT01597193|11102266|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
7024857|NCT01597193|11102267|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1
7024858|NCT01597193|11102268|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2
7024859|NCT01597193|11102269|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3
7024860|NCT01597193|11102270|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
7024861|NCT01597193|11102264|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0
7024862|NCT01597193|11102265|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0
7024863|NCT01597193|11102266|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14
7024864|NCT01597193|11102267|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18
7024865|NCT01597193|11102268|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14
7024866|NCT01597193|11102269|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18
7024867|NCT01597193|11102270|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11
7024868|NCT01597193|11102264|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0
7024869|NCT01597193|11102265|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0
7024870|NCT01597193|11102266|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0
7024871|NCT01597193|11102267|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0
7024872|NCT01597193|11102268|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0
7024873|NCT01597193|11102269|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1
7024874|NCT01597193|11102270|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0
7024875|NCT01597193|11102264|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
7024876|NCT01597193|11102265|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
7024877|NCT01597193|11102266|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
7024878|NCT01597193|11102267|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1
7024879|NCT01597193|11102268|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
7024880|NCT01597193|11102269|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1
7024881|NCT01597193|11102270|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
7024882|NCT01597245|11102295|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1
7024883|NCT01597245|11102296|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5
7024884|NCT01597245|11102297|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5
7024885|NCT01597245|11102298|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4
7024886|NCT01597245|11102299|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0
7024887|NCT01597245|11102300|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0
7024888|NCT01597245|11102301|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0
7024889|NCT01597245|11102302|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0
7024890|NCT01597245|11102303|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0
7024891|NCT01597245|11102304|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0
7024892|NCT01597245|11102305|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0
7024893|NCT01597245|11102306|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0
7024894|NCT01597245|11102307|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0
7024895|NCT01597245|11102308|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0
7024896|NCT01597245|11102309|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0
7024897|NCT01597245|11102310|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0
7024898|NCT01597245|11102311|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0
7024899|NCT01597245|11102312|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0
7024900|NCT01597245|11102313|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0
7024901|NCT01597245|11102314|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0
7024902|NCT01597245|11102315|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0
7024903|NCT01597245|11102295|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
7024904|NCT01597245|11102296|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8
7024905|NCT01597245|11102297|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6
7024906|NCT01597245|11102298|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
7024907|NCT01597245|11102299|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7024908|NCT01597245|11102300|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7024909|NCT01597245|11102301|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7024910|NCT01597245|11102302|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7024911|NCT01597245|11102303|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7024912|NCT01597245|11102304|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7024913|NCT01597245|11102305|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7024914|NCT01597245|11102306|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7024915|NCT01597245|11102307|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7024916|NCT01597245|11102308|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7024917|NCT01597245|11102309|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7024918|NCT01597245|11102310|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7024919|NCT01597245|11102311|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7024920|NCT01597245|11102312|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7024921|NCT01597245|11102313|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7024922|NCT01597245|11102314|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7024923|NCT01597245|11102315|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7024924|NCT01597245|11102295|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2
7024925|NCT01597245|11102296|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4
7024926|NCT01597245|11102297|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5
7024927|NCT01597245|11102298|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2
7024928|NCT01597245|11102299|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7024929|NCT01597245|11102300|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7024930|NCT01597245|11102301|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7024931|NCT01597245|11102302|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7024932|NCT01597245|11102303|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7024933|NCT01597245|11102304|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7024934|NCT01597245|11102305|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7024935|NCT01597245|11102306|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7024936|NCT01597245|11102307|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7024937|NCT01597245|11102308|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7024938|NCT01597245|11102309|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7024939|NCT01597245|11102310|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7024940|NCT01597245|11102311|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7024941|NCT01597245|11102312|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7024942|NCT01597245|11102313|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7024943|NCT01597245|11102314|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7024944|NCT01597245|11102315|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7024945|NCT01597245|11102295|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1
7024946|NCT01597245|11102296|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5
7024947|NCT01597245|11102297|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2
7024948|NCT01597245|11102298|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7024949|NCT01597245|11102299|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7024950|NCT01597245|11102300|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7024951|NCT01597245|11102301|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7024952|NCT01597245|11102302|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7024953|NCT01597245|11102303|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7024954|NCT01597245|11102304|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7024955|NCT01597245|11102305|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7024956|NCT01597245|11102306|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7024957|NCT01597245|11102307|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7024958|NCT01597245|11102308|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7024959|NCT01597245|11102309|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7024960|NCT01597245|11102310|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7024961|NCT01597245|11102311|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7024962|NCT01597245|11102312|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7024963|NCT01597245|11102313|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7024964|NCT01597245|11102314|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7024965|NCT01597245|11102315|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7024966|NCT01597245|11102295|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1
7024967|NCT01597245|11102296|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0
7024968|NCT01597245|11102297|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0
7024969|NCT01597245|11102298|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1
7024970|NCT01597245|11102299|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0
7024971|NCT01597245|11102300|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0
7024972|NCT01597245|11102301|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0
7024973|NCT01597245|11102302|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0
7024974|NCT01597245|11102303|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0
7024975|NCT01597245|11102304|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0
7024976|NCT01597245|11102305|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0
7024977|NCT01597245|11102306|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0
7024978|NCT01597245|11102307|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0
7024979|NCT01597245|11102308|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0
7024980|NCT01597245|11102309|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0
7024981|NCT01597245|11102310|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0
7024982|NCT01597245|11102311|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0
7024983|NCT01597245|11102312|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0
7024984|NCT01597245|11102313|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0
7024985|NCT01597245|11102314|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0
7024986|NCT01597245|11102315|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0
7024987|NCT01597245|11102295|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
7024988|NCT01597245|11102296|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
7024989|NCT01597245|11102297|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1
7024990|NCT01597245|11102298|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7024991|NCT01597245|11102299|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7024992|NCT01597245|11102300|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7024993|NCT01597245|11102301|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7024994|NCT01597245|11102302|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7024995|NCT01597245|11102303|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7024996|NCT01597245|11102304|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7024997|NCT01597245|11102305|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7024998|NCT01597245|11102306|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7024999|NCT01597245|11102307|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7025000|NCT01597245|11102308|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7025001|NCT01597245|11102309|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7025002|NCT01597245|11102310|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7025003|NCT01597245|11102311|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7025004|NCT01597245|11102312|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7025005|NCT01597245|11102313|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7025006|NCT01597245|11102314|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7025007|NCT01597245|11102315|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7025008|NCT01597245|11102295|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7025009|NCT01597245|11102296|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7025010|NCT01597245|11102297|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7025011|NCT01597245|11102298|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7025012|NCT01597245|11102299|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7025013|NCT01597245|11102300|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1
7025014|NCT01597245|11102301|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1
7025015|NCT01597245|11102302|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7025016|NCT01597245|11102303|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7025017|NCT01597245|11102304|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7025018|NCT01597245|11102305|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7025019|NCT01597245|11102306|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7025020|NCT01597245|11102307|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7025021|NCT01597245|11102308|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7025022|NCT01597245|11102309|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7025023|NCT01597245|11102310|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7025024|NCT01597245|11102311|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7025025|NCT01597245|11102312|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7025026|NCT01597245|11102313|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7025027|NCT01597245|11102314|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7025028|NCT01597245|11102315|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7025029|NCT01597245|11102295|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7025030|NCT01597245|11102296|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7025031|NCT01597245|11102297|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7025032|NCT01597245|11102298|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7025033|NCT01597245|11102299|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150
7025034|NCT01597245|11102300|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22
7025035|NCT01597245|11102301|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80
7025036|NCT01597245|11102302|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2
7025037|NCT01597245|11102303|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7025038|NCT01597245|11102304|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114
7025039|NCT01597245|11102305|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7025040|NCT01597245|11102306|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7025041|NCT01597245|11102307|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7025042|NCT01597245|11102308|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7025043|NCT01597245|11102309|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7025044|NCT01597245|11102310|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7025045|NCT01597245|11102311|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7025046|NCT01597245|11102312|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7025047|NCT01597245|11102313|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7025048|NCT01597245|11102314|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7025049|NCT01597245|11102315|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7025050|NCT01597245|11102295|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7025051|NCT01597245|11102296|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7025052|NCT01597245|11102297|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7025053|NCT01597245|11102298|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7025054|NCT01597245|11102299|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7025055|NCT01597245|11102300|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1
7025056|NCT01597245|11102301|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7025057|NCT01597245|11102302|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7025058|NCT01597245|11102303|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3
7025059|NCT01597245|11102304|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7025060|NCT01597245|11102305|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2
7025061|NCT01597245|11102306|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10
7025062|NCT01597245|11102307|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4
7025063|NCT01597245|11102308|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7025064|NCT01597245|11102309|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7025065|NCT01597245|11102310|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7025066|NCT01597245|11102311|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7025067|NCT01597245|11102312|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7025068|NCT01597245|11102313|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7025069|NCT01597245|11102314|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7025070|NCT01597245|11102315|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7025071|NCT01597245|11102295|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7025072|NCT01597245|11102296|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7025073|NCT01597245|11102297|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7025074|NCT01597245|11102298|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7025075|NCT01597245|11102299|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4
7025076|NCT01597245|11102300|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
7025077|NCT01597245|11102301|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
7025078|NCT01597245|11102302|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
7025079|NCT01597245|11102303|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
7025080|NCT01597245|11102304|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
7025081|NCT01597245|11102305|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
7025082|NCT01597245|11102306|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
7025083|NCT01597245|11102307|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
7025084|NCT01597245|11102308|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7025085|NCT01597245|11102309|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7025086|NCT01597245|11102310|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7025087|NCT01597245|11102311|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7025088|NCT01597245|11102312|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7025089|NCT01597245|11102313|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7025090|NCT01597245|11102314|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7025091|NCT01597245|11102315|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7025092|NCT01597245|11102295|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7025093|NCT01597245|11102296|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7025094|NCT01597245|11102297|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7025095|NCT01597245|11102298|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7025096|NCT01597245|11102299|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
7025097|NCT01597245|11102300|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
7025098|NCT01597245|11102301|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
7025099|NCT01597245|11102302|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7025100|NCT01597245|11102303|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
7025101|NCT01597245|11102304|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
7025102|NCT01597245|11102305|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6
7025103|NCT01597245|11102306|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5
7025104|NCT01597245|11102307|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
7025105|NCT01597245|11102308|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7025106|NCT01597245|11102309|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7025107|NCT01597245|11102310|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7025108|NCT01597245|11102311|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7025109|NCT01597245|11102312|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7025110|NCT01597245|11102313|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7025111|NCT01597245|11102314|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7025112|NCT01597245|11102315|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7025113|NCT01597245|11102295|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7025114|NCT01597245|11102296|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7025115|NCT01597245|11102297|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7025116|NCT01597245|11102298|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7025117|NCT01597245|11102299|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
7060550|NCT01920061|11156850|FG013|Overall Study|Lost to Follow-up|0
7025118|NCT01597245|11102300|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7025119|NCT01597245|11102301|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7025120|NCT01597245|11102302|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7025121|NCT01597245|11102303|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3
7025122|NCT01597245|11102304|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
7025123|NCT01597245|11102305|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2
7025124|NCT01597245|11102306|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7025125|NCT01597245|11102307|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
7025126|NCT01597245|11102308|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7025127|NCT01597245|11102309|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7025128|NCT01597245|11102310|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7025129|NCT01597245|11102311|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7025130|NCT01597245|11102312|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7025131|NCT01597245|11102313|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7025132|NCT01597245|11102314|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7025133|NCT01597245|11102315|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7025134|NCT01597245|11102295|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7025135|NCT01597245|11102296|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7025136|NCT01597245|11102297|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7025137|NCT01597245|11102298|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7025138|NCT01597245|11102299|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3
7025139|NCT01597245|11102300|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4
7025140|NCT01597245|11102301|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
7025141|NCT01597245|11102302|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7025142|NCT01597245|11102303|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
7025143|NCT01597245|11102304|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
7025144|NCT01597245|11102305|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
7025145|NCT01597245|11102306|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
7025146|NCT01597245|11102307|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
7025147|NCT01597245|11102308|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7025148|NCT01597245|11102309|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7025149|NCT01597245|11102310|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7025150|NCT01597245|11102311|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7025151|NCT01597245|11102312|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7025152|NCT01597245|11102313|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7025153|NCT01597245|11102314|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7025154|NCT01597245|11102315|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7025155|NCT01597245|11102295|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7025156|NCT01597245|11102296|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7025157|NCT01597245|11102297|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7025158|NCT01597245|11102298|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7025159|NCT01597245|11102299|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7025160|NCT01597245|11102300|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
7025161|NCT01597245|11102301|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7025162|NCT01597245|11102302|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7025163|NCT01597245|11102303|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
7025164|NCT01597245|11102304|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
7025165|NCT01597245|11102305|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
7025166|NCT01597245|11102306|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
7025167|NCT01597245|11102307|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7025168|NCT01597245|11102308|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7025169|NCT01597245|11102309|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7025170|NCT01597245|11102310|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7025171|NCT01597245|11102311|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7025172|NCT01597245|11102312|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7025173|NCT01597245|11102313|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7025174|NCT01597245|11102314|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7025175|NCT01597245|11102315|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7025176|NCT01597245|11102295|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7025177|NCT01597245|11102296|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7025178|NCT01597245|11102297|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7025179|NCT01597245|11102298|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7025180|NCT01597245|11102299|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7025181|NCT01597245|11102300|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7025182|NCT01597245|11102301|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7025183|NCT01597245|11102302|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7025184|NCT01597245|11102303|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7025185|NCT01597245|11102304|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7025186|NCT01597245|11102305|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1
7025187|NCT01597245|11102306|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7025188|NCT01597245|11102307|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7025189|NCT01597245|11102308|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7025190|NCT01597245|11102309|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7025191|NCT01597245|11102310|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7025192|NCT01597245|11102311|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7025193|NCT01597245|11102312|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7025194|NCT01597245|11102313|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7025195|NCT01597245|11102314|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7025196|NCT01597245|11102315|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7025197|NCT01597245|11102295|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7025198|NCT01597245|11102296|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7025199|NCT01597245|11102297|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7025200|NCT01597245|11102298|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7025201|NCT01597245|11102299|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7025202|NCT01597245|11102300|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7025203|NCT01597245|11102301|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7025204|NCT01597245|11102302|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7025205|NCT01597245|11102303|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7025206|NCT01597245|11102304|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7025207|NCT01597245|11102305|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7025208|NCT01597245|11102306|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7025209|NCT01597245|11102307|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7025210|NCT01597245|11102308|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1
7025211|NCT01597245|11102309|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69
7025212|NCT01597245|11102310|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70
7025213|NCT01597245|11102311|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7025214|NCT01597245|11102312|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7025215|NCT01597245|11102313|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7025216|NCT01597245|11102314|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7025217|NCT01597245|11102315|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7025218|NCT01597245|11102295|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7025219|NCT01597245|11102296|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7025220|NCT01597245|11102297|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7025221|NCT01597245|11102298|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7025222|NCT01597245|11102299|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7025223|NCT01597245|11102300|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7025224|NCT01597245|11102301|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7025225|NCT01597245|11102302|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7025226|NCT01597245|11102303|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7025227|NCT01597245|11102304|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7025228|NCT01597245|11102305|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7025229|NCT01597245|11102306|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7025230|NCT01597245|11102307|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7025231|NCT01597245|11102308|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1
7025232|NCT01597245|11102309|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62
7025233|NCT01597245|11102310|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63
7025234|NCT01597245|11102311|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7025235|NCT01597245|11102312|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7025236|NCT01597245|11102313|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7025237|NCT01597245|11102314|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7025238|NCT01597245|11102315|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7025239|NCT01597245|11102295|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7025240|NCT01597245|11102296|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7025241|NCT01597245|11102297|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7025242|NCT01597245|11102298|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7025243|NCT01597245|11102299|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7025244|NCT01597245|11102300|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7025245|NCT01597245|11102301|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7025246|NCT01597245|11102302|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7025247|NCT01597245|11102303|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7025248|NCT01597245|11102304|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7025249|NCT01597245|11102305|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7025250|NCT01597245|11102306|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7025251|NCT01597245|11102307|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7025252|NCT01597245|11102308|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7025253|NCT01597245|11102309|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38
7025254|NCT01597245|11102310|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38
7025255|NCT01597245|11102311|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7025256|NCT01597245|11102312|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7025257|NCT01597245|11102313|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7025258|NCT01597245|11102314|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7025259|NCT01597245|11102315|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7025260|NCT01597245|11102295|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7025261|NCT01597245|11102296|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7025262|NCT01597245|11102297|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7025263|NCT01597245|11102298|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7025264|NCT01597245|11102299|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7025265|NCT01597245|11102300|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7025266|NCT01597245|11102301|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7025267|NCT01597245|11102302|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7025268|NCT01597245|11102303|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7025269|NCT01597245|11102304|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7025270|NCT01597245|11102305|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7025271|NCT01597245|11102306|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7025272|NCT01597245|11102307|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7025273|NCT01597245|11102308|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7025274|NCT01597245|11102309|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26
7025275|NCT01597245|11102310|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26
7025276|NCT01597245|11102311|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7025277|NCT01597245|11102312|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7025278|NCT01597245|11102313|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7025279|NCT01597245|11102314|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7025280|NCT01597245|11102315|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7025281|NCT01597245|11102295|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7025282|NCT01597245|11102296|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7025283|NCT01597245|11102297|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7025284|NCT01597245|11102298|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7025285|NCT01597245|11102299|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7025286|NCT01597245|11102300|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7025287|NCT01597245|11102301|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7025288|NCT01597245|11102302|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7025289|NCT01597245|11102303|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7025290|NCT01597245|11102304|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7025291|NCT01597245|11102305|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7025292|NCT01597245|11102306|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7025293|NCT01597245|11102307|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7025294|NCT01597245|11102308|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1
7025295|NCT01597245|11102309|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11
7025296|NCT01597245|11102310|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12
7025297|NCT01597245|11102311|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7025298|NCT01597245|11102312|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7025299|NCT01597245|11102313|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7025300|NCT01597245|11102314|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7025301|NCT01597245|11102315|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7025302|NCT01597245|11102295|FG000|Long Term Extension (Week 60 - Week 264)|Death|0
7025303|NCT01597245|11102296|FG001|Long Term Extension (Week 60 - Week 264)|Death|0
7025304|NCT01597245|11102297|FG002|Long Term Extension (Week 60 - Week 264)|Death|0
7025305|NCT01597245|11102298|FG003|Long Term Extension (Week 60 - Week 264)|Death|0
7025306|NCT01597245|11102299|FG004|Long Term Extension (Week 60 - Week 264)|Death|0
7025307|NCT01597245|11102300|FG005|Long Term Extension (Week 60 - Week 264)|Death|0
7025308|NCT01597245|11102301|FG006|Long Term Extension (Week 60 - Week 264)|Death|0
7025309|NCT01597245|11102302|FG007|Long Term Extension (Week 60 - Week 264)|Death|0
7025310|NCT01597245|11102303|FG008|Long Term Extension (Week 60 - Week 264)|Death|0
7025311|NCT01597245|11102304|FG009|Long Term Extension (Week 60 - Week 264)|Death|0
7025312|NCT01597245|11102305|FG010|Long Term Extension (Week 60 - Week 264)|Death|0
7025313|NCT01597245|11102306|FG011|Long Term Extension (Week 60 - Week 264)|Death|0
7025314|NCT01597245|11102307|FG012|Long Term Extension (Week 60 - Week 264)|Death|0
7025315|NCT01597245|11102308|FG013|Long Term Extension (Week 60 - Week 264)|Death|0
7025316|NCT01597245|11102309|FG014|Long Term Extension (Week 60 - Week 264)|Death|8
7025317|NCT01597245|11102310|FG015|Long Term Extension (Week 60 - Week 264)|Death|8
7025318|NCT01597245|11102311|FG016|Long Term Extension (Week 60 - Week 264)|Death|0
7025319|NCT01597245|11102312|FG017|Long Term Extension (Week 60 - Week 264)|Death|0
7025320|NCT01597245|11102313|FG018|Long Term Extension (Week 60 - Week 264)|Death|0
7025321|NCT01597245|11102314|FG019|Long Term Extension (Week 60 - Week 264)|Death|0
7025322|NCT01597245|11102315|FG020|Long Term Extension (Week 60 - Week 264)|Death|0
7025323|NCT01597245|11102295|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7025324|NCT01597245|11102296|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7025325|NCT01597245|11102297|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7025326|NCT01597245|11102298|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7025327|NCT01597245|11102299|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7025328|NCT01597245|11102300|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7025329|NCT01597245|11102301|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7025330|NCT01597245|11102302|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7025331|NCT01597245|11102303|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7025332|NCT01597245|11102304|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7025333|NCT01597245|11102305|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7025334|NCT01597245|11102306|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7025335|NCT01597245|11102307|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7025336|NCT01597245|11102308|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7025337|NCT01597245|11102309|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6
7025338|NCT01597245|11102310|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6
7025339|NCT01597245|11102311|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7025340|NCT01597245|11102312|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7025341|NCT01597245|11102313|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7025342|NCT01597245|11102314|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7025343|NCT01597245|11102315|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7025344|NCT01597245|11102295|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7025345|NCT01597245|11102296|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7025346|NCT01597245|11102297|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7025347|NCT01597245|11102298|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7025348|NCT01597245|11102299|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7025349|NCT01597245|11102300|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7025350|NCT01597245|11102301|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7025351|NCT01597245|11102302|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7025352|NCT01597245|11102303|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7025353|NCT01597245|11102304|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7025354|NCT01597245|11102305|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7025355|NCT01597245|11102306|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7025356|NCT01597245|11102307|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7025357|NCT01597245|11102308|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7025358|NCT01597245|11102309|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4
7025359|NCT01597245|11102310|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4
7025360|NCT01597245|11102311|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7025361|NCT01597245|11102312|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7025362|NCT01597245|11102313|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7025363|NCT01597245|11102314|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7025364|NCT01597245|11102315|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7025365|NCT01597245|11102295|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7025366|NCT01597245|11102296|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7025367|NCT01597245|11102297|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7025368|NCT01597245|11102298|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7025369|NCT01597245|11102299|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7025370|NCT01597245|11102300|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7025371|NCT01597245|11102301|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7025372|NCT01597245|11102302|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7025373|NCT01597245|11102303|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7025374|NCT01597245|11102304|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7025375|NCT01597245|11102305|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7025376|NCT01597245|11102306|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7025377|NCT01597245|11102307|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7025378|NCT01597245|11102308|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7025379|NCT01597245|11102309|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1
7025380|NCT01597245|11102310|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1
7025381|NCT01597245|11102311|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7025382|NCT01597245|11102312|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7025383|NCT01597245|11102313|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7025384|NCT01597245|11102314|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7025385|NCT01597245|11102315|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7025386|NCT01597245|11102295|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7025387|NCT01597245|11102296|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7025388|NCT01597245|11102297|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7025389|NCT01597245|11102298|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7025390|NCT01597245|11102299|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7025391|NCT01597245|11102300|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7025392|NCT01597245|11102301|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7025393|NCT01597245|11102302|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7025394|NCT01597245|11102303|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7025395|NCT01597245|11102304|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7025396|NCT01597245|11102305|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7025397|NCT01597245|11102306|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7025398|NCT01597245|11102307|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7025399|NCT01597245|11102308|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23
7025400|NCT01597245|11102309|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7025401|NCT01597245|11102310|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7025402|NCT01597245|11102311|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7025403|NCT01597245|11102312|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7025404|NCT01597245|11102313|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7025405|NCT01597245|11102314|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7025406|NCT01597245|11102315|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7025407|NCT01597245|11102295|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7025408|NCT01597245|11102296|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7025409|NCT01597245|11102297|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7025410|NCT01597245|11102298|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7025411|NCT01597245|11102299|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7025412|NCT01597245|11102300|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7025413|NCT01597245|11102301|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7025414|NCT01597245|11102302|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7025415|NCT01597245|11102303|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7025416|NCT01597245|11102304|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7025417|NCT01597245|11102305|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7025418|NCT01597245|11102306|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7025419|NCT01597245|11102307|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7025420|NCT01597245|11102308|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7025421|NCT01597245|11102309|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7025422|NCT01597245|11102310|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7025423|NCT01597245|11102311|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9
7025424|NCT01597245|11102312|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5
7025425|NCT01597245|11102313|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8
7025426|NCT01597245|11102314|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63
7025427|NCT01597245|11102315|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13
7025428|NCT01597245|11102295|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7025429|NCT01597245|11102296|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7025430|NCT01597245|11102297|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7025431|NCT01597245|11102298|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7025432|NCT01597245|11102299|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7025433|NCT01597245|11102300|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7025434|NCT01597245|11102301|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7025435|NCT01597245|11102302|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7025436|NCT01597245|11102303|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7025437|NCT01597245|11102304|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7025438|NCT01597245|11102305|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7025439|NCT01597245|11102306|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7025440|NCT01597245|11102307|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7025441|NCT01597245|11102308|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7025442|NCT01597245|11102309|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7025443|NCT01597245|11102310|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7025444|NCT01597245|11102311|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7025445|NCT01597245|11102312|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1
7025446|NCT01597245|11102313|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1
7025447|NCT01597245|11102314|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41
7025448|NCT01597245|11102315|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13
7025449|NCT01597245|11102295|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7025450|NCT01597245|11102296|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7025451|NCT01597245|11102297|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7025452|NCT01597245|11102298|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7025453|NCT01597245|11102299|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7025454|NCT01597245|11102300|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7025455|NCT01597245|11102301|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7025456|NCT01597245|11102302|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7025457|NCT01597245|11102303|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7025458|NCT01597245|11102304|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7025459|NCT01597245|11102305|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7025460|NCT01597245|11102306|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7025461|NCT01597245|11102307|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7025462|NCT01597245|11102308|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7025463|NCT01597245|11102309|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7025464|NCT01597245|11102310|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7025465|NCT01597245|11102311|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2
7025466|NCT01597245|11102312|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7025467|NCT01597245|11102313|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7025468|NCT01597245|11102314|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29
7025469|NCT01597245|11102315|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3
7025470|NCT01597245|11102295|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7025471|NCT01597245|11102296|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7025472|NCT01597245|11102297|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7025473|NCT01597245|11102298|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7025474|NCT01597245|11102299|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7025475|NCT01597245|11102300|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7025476|NCT01597245|11102301|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7025477|NCT01597245|11102302|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7025478|NCT01597245|11102303|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7025479|NCT01597245|11102304|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7025480|NCT01597245|11102305|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7025481|NCT01597245|11102306|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7025482|NCT01597245|11102307|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7025483|NCT01597245|11102308|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7025484|NCT01597245|11102309|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7025485|NCT01597245|11102310|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7025486|NCT01597245|11102311|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7025487|NCT01597245|11102312|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7025488|NCT01597245|11102313|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1
7025489|NCT01597245|11102314|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14
7025490|NCT01597245|11102315|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4
7025491|NCT01597245|11102295|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7025492|NCT01597245|11102296|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7025493|NCT01597245|11102297|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7025494|NCT01597245|11102298|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7025495|NCT01597245|11102299|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7025496|NCT01597245|11102300|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7025497|NCT01597245|11102301|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7025498|NCT01597245|11102302|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7025499|NCT01597245|11102303|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7025500|NCT01597245|11102304|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7025501|NCT01597245|11102305|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7025502|NCT01597245|11102306|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7025503|NCT01597245|11102307|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7025504|NCT01597245|11102308|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7025505|NCT01597245|11102309|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7025506|NCT01597245|11102310|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7025507|NCT01597245|11102311|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1
7025508|NCT01597245|11102312|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7025509|NCT01597245|11102313|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7025510|NCT01597245|11102314|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9
7025511|NCT01597245|11102315|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1
7025512|NCT01597245|11102295|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7025513|NCT01597245|11102296|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7025514|NCT01597245|11102297|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7025515|NCT01597245|11102298|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7025516|NCT01597245|11102299|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7025517|NCT01597245|11102300|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7025518|NCT01597245|11102301|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7025519|NCT01597245|11102302|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7025520|NCT01597245|11102303|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7025521|NCT01597245|11102304|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7025522|NCT01597245|11102305|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7025523|NCT01597245|11102306|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7025524|NCT01597245|11102307|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7025525|NCT01597245|11102308|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7025526|NCT01597245|11102309|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7025527|NCT01597245|11102310|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7025528|NCT01597245|11102311|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1
7025529|NCT01597245|11102312|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7025530|NCT01597245|11102313|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7025531|NCT01597245|11102314|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6
7025532|NCT01597245|11102315|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2
7025533|NCT01597245|11102295|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7025534|NCT01597245|11102296|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7025535|NCT01597245|11102297|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7025536|NCT01597245|11102298|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7025537|NCT01597245|11102299|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7025538|NCT01597245|11102300|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7025539|NCT01597245|11102301|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7025540|NCT01597245|11102302|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7025541|NCT01597245|11102303|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7025542|NCT01597245|11102304|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7025543|NCT01597245|11102305|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7025544|NCT01597245|11102306|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7025545|NCT01597245|11102307|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7025546|NCT01597245|11102308|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7025547|NCT01597245|11102309|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7025548|NCT01597245|11102310|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7025549|NCT01597245|11102311|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2
7025550|NCT01597245|11102312|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7025551|NCT01597245|11102313|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7025552|NCT01597245|11102314|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3
7025553|NCT01597245|11102315|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7025554|NCT01597245|11102295|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7025555|NCT01597245|11102296|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7025556|NCT01597245|11102297|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7025557|NCT01597245|11102298|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7025558|NCT01597245|11102299|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7025559|NCT01597245|11102300|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7025560|NCT01597245|11102301|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7025561|NCT01597245|11102302|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7025562|NCT01597245|11102303|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7025563|NCT01597245|11102304|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7025564|NCT01597245|11102305|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7025565|NCT01597245|11102306|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7025566|NCT01597245|11102307|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7025567|NCT01597245|11102308|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7025568|NCT01597245|11102309|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7025569|NCT01597245|11102310|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7025570|NCT01597245|11102311|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1
7025571|NCT01597245|11102312|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7025572|NCT01597245|11102313|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7025573|NCT01597245|11102314|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1
7025574|NCT01597245|11102315|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7025575|NCT01597245|11102295|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7025576|NCT01597245|11102296|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7025577|NCT01597245|11102297|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7025578|NCT01597245|11102298|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7025579|NCT01597245|11102299|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7025580|NCT01597245|11102300|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7025581|NCT01597245|11102301|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7025582|NCT01597245|11102302|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7025583|NCT01597245|11102303|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7025584|NCT01597245|11102304|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7025585|NCT01597245|11102305|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7025586|NCT01597245|11102306|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7025587|NCT01597245|11102307|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7025588|NCT01597245|11102308|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7025589|NCT01597245|11102309|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7025590|NCT01597245|11102310|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7025591|NCT01597245|11102311|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7025592|NCT01597245|11102312|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7025593|NCT01597245|11102313|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7025594|NCT01597245|11102314|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1
7025595|NCT01597245|11102315|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7025596|NCT01597258|11102348|FG000|Overall Study|No Drug Administration|1
7025597|NCT01597375|11102352|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1
7025598|NCT01597375|11102353|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0
7025599|NCT01597375|11102352|FG000|First Intervention (4 Weeks)|Needed surgery|1
7025600|NCT01597375|11102353|FG001|First Intervention (4 Weeks)|Needed surgery|0
7025601|NCT01597375|11102352|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0
7025602|NCT01597375|11102353|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1
7025603|NCT01597375|11102352|FG000|Washout (2 Weeks)|Adverse Event|1
7025604|NCT01597375|11102353|FG001|Washout (2 Weeks)|Adverse Event|0
7025605|NCT01597375|11102352|FG000|Second Intervention|Failed to react at both Aspirin|1
7025606|NCT01597375|11102353|FG001|Second Intervention|Failed to react at both Aspirin|1
7025607|NCT01597479|11102373|FG000|Overall Study|Protocol Violation|1
7025608|NCT01597479|11102374|FG001|Overall Study|Protocol Violation|0
7025609|NCT01597479|11102373|FG000|Overall Study|Lost to Follow-up|1
7025610|NCT01597479|11102374|FG001|Overall Study|Lost to Follow-up|0
7025611|NCT01597492|11102383|FG000|Overall Study|Withdrawal by Subject|1
7025612|NCT01597492|11102384|FG001|Overall Study|Withdrawal by Subject|2
7025613|NCT01597492|11102383|FG000|Overall Study|Adverse Event|3
7025614|NCT01597492|11102384|FG001|Overall Study|Adverse Event|0
7025615|NCT01597492|11102383|FG000|Overall Study|Lost to Follow-up|0
7025616|NCT01597492|11102384|FG001|Overall Study|Lost to Follow-up|2
7025617|NCT01597492|11102383|FG000|Overall Study|Other Reason|2
7025618|NCT01597492|11102384|FG001|Overall Study|Other Reason|0
7025619|NCT01597505|11102392|FG000|Overall Study|Physician Decision|5
7025620|NCT01597505|11102393|FG001|Overall Study|Physician Decision|0
7025621|NCT01597505|11102392|FG000|Overall Study|Adverse Event|19
7025622|NCT01597505|11102393|FG001|Overall Study|Adverse Event|7
7025623|NCT01597505|11102392|FG000|Overall Study|Lost to Follow-up|4
7025624|NCT01597505|11102393|FG001|Overall Study|Lost to Follow-up|2
7025625|NCT01597505|11102392|FG000|Overall Study|Withdrawal by Subject|10
7025626|NCT01597505|11102393|FG001|Overall Study|Withdrawal by Subject|18
7025627|NCT01597505|11102392|FG000|Overall Study|Other|5
7025628|NCT01597505|11102393|FG001|Overall Study|Other|6
7025629|NCT01597505|11102392|FG000|Overall Study|Missing|1
7025630|NCT01597505|11102393|FG001|Overall Study|Missing|0
7025631|NCT01597557|11102402|FG000|Overall Study|Did not undergo cardioversion procedure|4
7025632|NCT01597557|11102403|FG001|Overall Study|Did not undergo cardioversion procedure|3
7025633|NCT01597596|11102411|FG000|Overall Study|Study terminated by sponsor|1
7025634|NCT01597596|11102412|FG001|Overall Study|Study terminated by sponsor|0
7025635|NCT01597596|11102411|FG000|Overall Study|Physician Decision|0
7025636|NCT01597596|11102412|FG001|Overall Study|Physician Decision|1
7025637|NCT01597622|11102418|FG000|Overall Study|Adverse Event|7
7025638|NCT01597622|11102418|FG000|Overall Study|Lack of Efficacy|3
7025639|NCT01597622|11102418|FG000|Overall Study|Protocol Violation|1
7025640|NCT01597622|11102418|FG000|Overall Study|Lost to Follow-up|1
7025641|NCT01597622|11102418|FG000|Overall Study|Investigator Discretion|5
7025642|NCT01597622|11102418|FG000|Overall Study|Withdrawal by Subject|20
7025643|NCT01597622|11102418|FG000|Overall Study|Death|1
7025644|NCT01597635|11102425|FG000|Part A|Adverse Event|3
7025645|NCT01597635|11102426|FG001|Part A|Adverse Event|0
7025646|NCT01597635|11102427|FG002|Part A|Adverse Event|0
7025647|NCT01597635|11102425|FG000|Part B|Adverse Event|0
7025648|NCT01597635|11102426|FG001|Part B|Adverse Event|0
7025649|NCT01597635|11102427|FG002|Part B|Adverse Event|1
7025650|NCT01597635|11102425|FG000|Part B|Protocol Violation|0
7025651|NCT01597635|11102426|FG001|Part B|Protocol Violation|1
7025652|NCT01597635|11102427|FG002|Part B|Protocol Violation|0
7025653|NCT01597635|11102425|FG000|Part B|Protocol-defined stopping criteria|0
7025654|NCT01597635|11102426|FG001|Part B|Protocol-defined stopping criteria|4
7025655|NCT01597635|11102427|FG002|Part B|Protocol-defined stopping criteria|3
7025656|NCT01597635|11102425|FG000|Part B|Withdrawal by Subject|0
7025657|NCT01597635|11102426|FG001|Part B|Withdrawal by Subject|1
7025658|NCT01597635|11102427|FG002|Part B|Withdrawal by Subject|0
7025659|NCT01597791|11102467|FG000|Overall Study|Physician Decision|2
7025660|NCT01597791|11102468|FG001|Overall Study|Physician Decision|1
7025661|NCT01597791|11102467|FG000|Overall Study|Cesarean Section|6
7025662|NCT01597791|11102468|FG001|Overall Study|Cesarean Section|7
7025663|NCT01597791|11102467|FG000|Overall Study|Subject withdrawal|0
7025664|NCT01597791|11102468|FG001|Overall Study|Subject withdrawal|1
7025665|NCT01597791|11102467|FG000|Overall Study|Protocol Violation|0
7025666|NCT01597791|11102468|FG001|Overall Study|Protocol Violation|1
7025667|NCT01597908|11102503|FG000|Randomized Phase|Death|217
7025668|NCT01597908|11102504|FG001|Randomized Phase|Death|238
7025669|NCT01597908|11102505|FG002|Randomized Phase|Death|0
7025670|NCT01597908|11102503|FG000|Randomized Phase|Sponsor Decision|93
7025671|NCT01597908|11102504|FG001|Randomized Phase|Sponsor Decision|39
7025672|NCT01597908|11102505|FG002|Randomized Phase|Sponsor Decision|0
7025673|NCT01597908|11102503|FG000|Randomized Phase|Lost to Follow-up|9
7025674|NCT01597908|11102504|FG001|Randomized Phase|Lost to Follow-up|16
7025675|NCT01597908|11102505|FG002|Randomized Phase|Lost to Follow-up|0
7025676|NCT01597908|11102503|FG000|Randomized Phase|Physician Decision|6
7025677|NCT01597908|11102504|FG001|Randomized Phase|Physician Decision|3
7025678|NCT01597908|11102505|FG002|Randomized Phase|Physician Decision|0
7025679|NCT01597908|11102503|FG000|Randomized Phase|Withdrawal by Subject|26
7025680|NCT01597908|11102504|FG001|Randomized Phase|Withdrawal by Subject|22
7025681|NCT01597908|11102505|FG002|Randomized Phase|Withdrawal by Subject|0
7025682|NCT01597908|11102503|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0
7025683|NCT01597908|11102504|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34
7025684|NCT01597908|11102505|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0
7025685|NCT01597908|11102503|FG000|Crossover Phase|Death|0
7025686|NCT01597908|11102504|FG001|Crossover Phase|Death|0
7025687|NCT01597908|11102505|FG002|Crossover Phase|Death|11
7025688|NCT01597908|11102503|FG000|Crossover Phase|Withdrawal by Subject|0
7025689|NCT01597908|11102504|FG001|Crossover Phase|Withdrawal by Subject|0
7025690|NCT01597908|11102505|FG002|Crossover Phase|Withdrawal by Subject|3
7025691|NCT01597908|11102503|FG000|Crossover Phase|Sponsor Decision|0
7025692|NCT01597908|11102504|FG001|Crossover Phase|Sponsor Decision|0
7025693|NCT01597908|11102505|FG002|Crossover Phase|Sponsor Decision|20
7025694|NCT01597973|11102516|FG000|Overall Study|Found ineligible before study medication started|4
7025695|NCT01597973|11102517|FG001|Overall Study|Found ineligible before study medication started|2
7025696|NCT01597973|11102516|FG000|Overall Study|Eligible pathogen not confirmed|14
7025697|NCT01597973|11102517|FG001|Overall Study|Eligible pathogen not confirmed|15
7025698|NCT01597973|11102516|FG000|Overall Study|LAR not authorized to consent|0
7025699|NCT01597973|11102517|FG001|Overall Study|LAR not authorized to consent|1
7025700|NCT01597973|11102516|FG000|Overall Study|Ineligible due to early seizures|1
7025701|NCT01597973|11102517|FG001|Overall Study|Ineligible due to early seizures|0
7025702|NCT01597973|11102516|FG000|Overall Study|Ineligible due to non-target infection|1
7025703|NCT01597973|11102517|FG001|Overall Study|Ineligible due to non-target infection|1
7025704|NCT01598090|11102539|FG000|Treatment Period|Poor/non-compliance|0
7025705|NCT01598090|11102540|FG001|Treatment Period|Poor/non-compliance|2
7025706|NCT01598090|11102541|FG002|Treatment Period|Poor/non-compliance|0
7025707|NCT01598090|11102539|FG000|Treatment Period|No longer meet study criteria|0
7025708|NCT01598090|11102540|FG001|Treatment Period|No longer meet study criteria|1
7025709|NCT01598090|11102541|FG002|Treatment Period|No longer meet study criteria|0
7025710|NCT01598090|11102539|FG000|Treatment Period|Lack of Efficacy|5
7025711|NCT01598090|11102540|FG001|Treatment Period|Lack of Efficacy|14
7025712|NCT01598090|11102541|FG002|Treatment Period|Lack of Efficacy|6
7025713|NCT01598090|11102539|FG000|Treatment Period|Adverse Event|2
7025714|NCT01598090|11102540|FG001|Treatment Period|Adverse Event|33
7025715|NCT01598090|11102541|FG002|Treatment Period|Adverse Event|17
7025716|NCT01598090|11102539|FG000|Treatment Period|Other reasons|0
7025717|NCT01598090|11102540|FG001|Treatment Period|Other reasons|4
7025718|NCT01598090|11102541|FG002|Treatment Period|Other reasons|1
7025719|NCT01598090|11102539|FG000|Treatment Period|Withdrawal by Subject|3
7025720|NCT01598090|11102540|FG001|Treatment Period|Withdrawal by Subject|13
7025721|NCT01598090|11102541|FG002|Treatment Period|Withdrawal by Subject|10
7025722|NCT01598090|11102539|FG000|Treatment Period|Lost to Follow-up|1
7025723|NCT01598090|11102540|FG001|Treatment Period|Lost to Follow-up|5
7025724|NCT01598090|11102541|FG002|Treatment Period|Lost to Follow-up|1
7025725|NCT01598090|11102539|FG000|Follow-up Period|Death|0
7025726|NCT01598090|11102540|FG001|Follow-up Period|Death|1
7025727|NCT01598090|11102541|FG002|Follow-up Period|Death|0
7025728|NCT01598090|11102539|FG000|Follow-up Period|No longer required per protocol|1
7025729|NCT01598090|11102540|FG001|Follow-up Period|No longer required per protocol|3
7025730|NCT01598090|11102541|FG002|Follow-up Period|No longer required per protocol|2
7025731|NCT01598090|11102539|FG000|Follow-up Period|Not reported|0
7025732|NCT01598090|11102540|FG001|Follow-up Period|Not reported|10
7025733|NCT01598090|11102541|FG002|Follow-up Period|Not reported|4
7025734|NCT01598090|11102539|FG000|Follow-up Period|Withdrawal by Subject|0
7025735|NCT01598090|11102540|FG001|Follow-up Period|Withdrawal by Subject|3
7025736|NCT01598090|11102541|FG002|Follow-up Period|Withdrawal by Subject|2
7025737|NCT01598090|11102539|FG000|Follow-up Period|Other reasons|2
7025738|NCT01598090|11102540|FG001|Follow-up Period|Other reasons|8
7025739|NCT01598090|11102541|FG002|Follow-up Period|Other reasons|8
7025740|NCT01598090|11102539|FG000|Follow-up Period|Lost to Follow-up|2
7025741|NCT01598090|11102540|FG001|Follow-up Period|Lost to Follow-up|10
7025742|NCT01598090|11102541|FG002|Follow-up Period|Lost to Follow-up|12
7025743|NCT01598129|11102552|FG000|Overall Study|Disease progression|6
7025744|NCT01598129|11102552|FG000|Overall Study|Deterioration of WHO status to WHO 4|2
7025745|NCT01598129|11102552|FG000|Overall Study|Withdrawal by Subject|1
7025746|NCT01598298|11102581|FG000|Overall Study|Not eligible|5
7025747|NCT01598298|11102582|FG001|Overall Study|Not eligible|5
7025748|NCT01598298|11102581|FG000|Overall Study|Adverse Event|21
7025749|NCT01598298|11102582|FG001|Overall Study|Adverse Event|19
7025750|NCT01598298|11102581|FG000|Overall Study|Progression/relapse|0
7025751|NCT01598298|11102582|FG001|Overall Study|Progression/relapse|2
7025752|NCT01598298|11102581|FG000|Overall Study|Withdrawal by Subject|10
7025753|NCT01598298|11102582|FG001|Overall Study|Withdrawal by Subject|15
7025754|NCT01598298|11102581|FG000|Overall Study|Other reason (not protocol specified)|4
7025755|NCT01598298|11102582|FG001|Overall Study|Other reason (not protocol specified)|0
7025756|NCT01598311|11102590|FG000|Overall Study|Physician Decision|4
7025757|NCT01598311|11102591|FG001|Overall Study|Physician Decision|5
7025758|NCT01598311|11102590|FG000|Overall Study|Adverse Event|9
7025759|NCT01598311|11102591|FG001|Overall Study|Adverse Event|13
7025760|NCT01598311|11102590|FG000|Overall Study|Lost to Follow-up|7
7025761|NCT01598311|11102591|FG001|Overall Study|Lost to Follow-up|12
7025762|NCT01598311|11102590|FG000|Overall Study|Withdrawal by Subject|9
7025763|NCT01598311|11102591|FG001|Overall Study|Withdrawal by Subject|13
7025764|NCT01598311|11102590|FG000|Overall Study|No reason provided.|0
7025765|NCT01598311|11102591|FG001|Overall Study|No reason provided.|5
7025766|NCT01598311|11102590|FG000|Overall Study|Randomized but never treated|8
7025767|NCT01598311|11102591|FG001|Overall Study|Randomized but never treated|5
7025768|NCT01598311|11102590|FG000|Overall Study|Treated but no confirmed CDAD|9
7025769|NCT01598311|11102591|FG001|Overall Study|Treated but no confirmed CDAD|8
7025770|NCT01598311|11102590|FG000|Overall Study|Assigned to CB but received vancomycin|1
7025771|NCT01598311|11102591|FG001|Overall Study|Assigned to CB but received vancomycin|0
7025772|NCT01598506|11102606|FG000|Overall Study|Withdrawal by Subject|2
7025773|NCT01598532|11102611|FG000|Overall Study|Lost to Follow-up|3
7025774|NCT01598532|11102611|FG000|Overall Study|Did not meet inclusion criteria|8
7025775|NCT01598610|11102622|FG000|Overall Study|Adverse Event|1
7025776|NCT01598662|11102628|FG000|Overall Study|Lost to Follow-up|10
7025777|NCT01598662|11102629|FG001|Overall Study|Lost to Follow-up|17
7025778|NCT01598662|11102628|FG000|Overall Study|Physician Decision|1
7025779|NCT01598662|11102629|FG001|Overall Study|Physician Decision|2
7025780|NCT01598662|11102628|FG000|Overall Study|IUD expelled before month 6|0
7025781|NCT01598662|11102629|FG001|Overall Study|IUD expelled before month 6|2
7025782|NCT01598753|11102658|FG000|Overall Study|Adverse Event|1
7025783|NCT01598753|11102659|FG001|Overall Study|Adverse Event|9
7025784|NCT01598753|11102660|FG002|Overall Study|Adverse Event|1
7025785|NCT01598753|11102661|FG003|Overall Study|Adverse Event|7
7025786|NCT01598753|11102658|FG000|Overall Study|Lost to Follow-up|4
7025787|NCT01598753|11102659|FG001|Overall Study|Lost to Follow-up|3
7025788|NCT01598753|11102660|FG002|Overall Study|Lost to Follow-up|7
7025789|NCT01598753|11102661|FG003|Overall Study|Lost to Follow-up|5
7025790|NCT01598753|11102658|FG000|Overall Study|Physician Decision|0
7025791|NCT01598753|11102659|FG001|Overall Study|Physician Decision|1
7025792|NCT01598753|11102660|FG002|Overall Study|Physician Decision|0
7025793|NCT01598753|11102661|FG003|Overall Study|Physician Decision|2
7025794|NCT01598753|11102658|FG000|Overall Study|Withdrawal by Subject|7
7025795|NCT01598753|11102659|FG001|Overall Study|Withdrawal by Subject|2
7025796|NCT01598753|11102660|FG002|Overall Study|Withdrawal by Subject|0
7025797|NCT01598753|11102661|FG003|Overall Study|Withdrawal by Subject|1
7025798|NCT01598896|11102686|FG000|Overall Study|Withdrawal by Subject|0
7025799|NCT01598896|11102687|FG001|Overall Study|Withdrawal by Subject|1
7025800|NCT01598896|11102686|FG000|Overall Study|Lack of Efficacy|0
7025801|NCT01598896|11102687|FG001|Overall Study|Lack of Efficacy|1
7025802|NCT01598987|11102702|FG000|Baseline to Month 12|Administrative problems|2
7025803|NCT01598987|11102702|FG000|Baseline to Month 12|Withdrawal by Subject|4
7025804|NCT01598987|11102702|FG000|Baseline to 24 Month|Withdrawal by Subject|5
7025805|NCT01598987|11102702|FG000|Baseline to 24 Month|Administrative problems|2
7025806|NCT01598987|11102702|FG000|Baseline to 24 Month|Lost to Follow-up|1
7025807|NCT01599104|11102716|FG000|Overall Study|Withdrawal by Subject|1
7025808|NCT01599104|11102717|FG001|Overall Study|Withdrawal by Subject|1
7025809|NCT01599104|11102718|FG002|Overall Study|Withdrawal by Subject|2
7025810|NCT01599104|11102716|FG000|Overall Study|Technical Problems|1
7025811|NCT01599104|11102717|FG001|Overall Study|Technical Problems|0
7025812|NCT01599104|11102718|FG002|Overall Study|Technical Problems|0
7025813|NCT01599104|11102716|FG000|Overall Study|Physician Decision|3
7025814|NCT01599104|11102717|FG001|Overall Study|Physician Decision|2
7025815|NCT01599104|11102718|FG002|Overall Study|Physician Decision|2
7025816|NCT01599104|11102716|FG000|Overall Study|Non-compliance with study treatment|0
7025817|NCT01599104|11102717|FG001|Overall Study|Non-compliance with study treatment|1
7025818|NCT01599104|11102718|FG002|Overall Study|Non-compliance with study treatment|0
7025819|NCT01599104|11102716|FG000|Overall Study|Lack of Efficacy|4
7025820|NCT01599104|11102717|FG001|Overall Study|Lack of Efficacy|4
7025821|NCT01599104|11102718|FG002|Overall Study|Lack of Efficacy|10
7025822|NCT01599104|11102716|FG000|Overall Study|Adverse Event|7
7025823|NCT01599104|11102717|FG001|Overall Study|Adverse Event|6
7025824|NCT01599104|11102718|FG002|Overall Study|Adverse Event|12
7025825|NCT01599234|11102728|FG000|Overall Study|Adverse Event|9
7025826|NCT01599234|11102729|FG001|Overall Study|Adverse Event|5
7025827|NCT01599234|11102728|FG000|Overall Study|Withdrawal by Subject|2
7025828|NCT01599234|11102729|FG001|Overall Study|Withdrawal by Subject|1
7025829|NCT01599234|11102728|FG000|Overall Study|Lost to Follow-up|1
7025830|NCT01599234|11102729|FG001|Overall Study|Lost to Follow-up|2
7025831|NCT01599234|11102728|FG000|Overall Study|Lack of Efficacy|2
7025832|NCT01599234|11102729|FG001|Overall Study|Lack of Efficacy|4
7025833|NCT01599234|11102728|FG000|Overall Study|Unable to operate spray|1
7025834|NCT01599234|11102729|FG001|Overall Study|Unable to operate spray|0
7025835|NCT01599234|11102728|FG000|Overall Study|Sponsor request as creatinine levels <50|0
7025836|NCT01599234|11102729|FG001|Overall Study|Sponsor request as creatinine levels <50|1
7025837|NCT01599234|11102728|FG000|Overall Study|Death|1
7025838|NCT01599234|11102729|FG001|Overall Study|Death|0
7025839|NCT01599234|11102728|FG000|Overall Study|Patient would not stop driving|1
7025840|NCT01599234|11102729|FG001|Overall Study|Patient would not stop driving|0
7025841|NCT01599234|11102728|FG000|Overall Study|Contra-indication discovered|0
7025842|NCT01599234|11102729|FG001|Overall Study|Contra-indication discovered|1
7025843|NCT01599234|11102728|FG000|Overall Study|Pregnancy|0
7025844|NCT01599234|11102729|FG001|Overall Study|Pregnancy|1
7025845|NCT01599325|11102744|FG000|Primary Parent Phase|Adverse Event|5
7025846|NCT01599325|11102744|FG000|Primary Parent Phase|Disease Progression|7
7025847|NCT01599325|11102744|FG000|Primary Parent Phase|Withdrawal by Subject|20
7025848|NCT01599325|11102744|FG000|Primary Parent Phase|Death|13
7025849|NCT01599325|11102744|FG000|Primary Parent Phase|Protocol Violation|1
7025850|NCT01599325|11102744|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9
7025851|NCT01599325|11102744|FG000|Primary Parent Phase|Other|2
7025852|NCT01599325|11102744|FG000|Extension Phase|Study Closure|1
7025853|NCT01599325|11102744|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1
7025854|NCT01599325|11102744|FG000|Extension Phase|Lack of Therapeutic Effect|4
7025855|NCT01599325|11102744|FG000|Extension Phase|Disease Progression|1
7025856|NCT01599325|11102744|FG000|Extension Phase|Withdrawal by Subject|8
7025857|NCT01599585|11102751|FG000|Overall Study|Withdrawal by Subject|16
7025858|NCT01599585|11102752|FG001|Overall Study|Withdrawal by Subject|9
7025859|NCT01599585|11102751|FG000|Overall Study|Lost to Follow-up|3
7025860|NCT01599585|11102752|FG001|Overall Study|Lost to Follow-up|5
7025861|NCT01599585|11102751|FG000|Overall Study|randomized did not start treatment|3
7025862|NCT01599585|11102752|FG001|Overall Study|randomized did not start treatment|3
7025863|NCT01599637|11102761|FG000|Overall Study|administrative problems|0
7025864|NCT01599637|11102762|FG001|Overall Study|administrative problems|2
7025865|NCT01599637|11102763|FG002|Overall Study|administrative problems|0
7025866|NCT01599637|11102761|FG000|Overall Study|Adverse Event|1
7025867|NCT01599637|11102762|FG001|Overall Study|Adverse Event|0
7025868|NCT01599637|11102763|FG002|Overall Study|Adverse Event|0
7025869|NCT01599650|11102776|FG000|Overall Study|Administrative issue|1
7025870|NCT01599650|11102777|FG001|Overall Study|Administrative issue|0
7025871|NCT01599650|11102778|FG002|Overall Study|Administrative issue|1
7025872|NCT01599650|11102776|FG000|Overall Study|Physician Decision|2
7025873|NCT01599650|11102777|FG001|Overall Study|Physician Decision|0
7025874|NCT01599650|11102778|FG002|Overall Study|Physician Decision|7
7025875|NCT01599650|11102776|FG000|Overall Study|Protocol Violation|0
7025876|NCT01599650|11102777|FG001|Overall Study|Protocol Violation|3
7025877|NCT01599650|11102778|FG002|Overall Study|Protocol Violation|0
7025878|NCT01599650|11102776|FG000|Overall Study|Death|2
7025879|NCT01599650|11102777|FG001|Overall Study|Death|1
7025880|NCT01599650|11102778|FG002|Overall Study|Death|2
7025881|NCT01599650|11102776|FG000|Overall Study|Lost to Follow-up|3
7025882|NCT01599650|11102777|FG001|Overall Study|Lost to Follow-up|3
7025883|NCT01599650|11102778|FG002|Overall Study|Lost to Follow-up|3
7025884|NCT01599650|11102776|FG000|Overall Study|Withdrawal by Subject|11
7025885|NCT01599650|11102777|FG001|Overall Study|Withdrawal by Subject|11
7025886|NCT01599650|11102778|FG002|Overall Study|Withdrawal by Subject|10
7025887|NCT01599650|11102776|FG000|Overall Study|Adverse Event|3
7025888|NCT01599650|11102777|FG001|Overall Study|Adverse Event|8
7025889|NCT01599650|11102778|FG002|Overall Study|Adverse Event|4
7025890|NCT01599754|11102790|FG000|Overall Study|Anticancer therapy need not in protocol|5
7025891|NCT01599754|11102791|FG001|Overall Study|Anticancer therapy need not in protocol|2
7025892|NCT01599754|11102790|FG000|Overall Study|Participant noncompliance|4
7025893|NCT01599754|11102791|FG001|Overall Study|Participant noncompliance|4
7025894|NCT01599754|11102790|FG000|Overall Study|Lost to Follow-up|13
7025895|NCT01599754|11102791|FG001|Overall Study|Lost to Follow-up|6
7025896|NCT01599754|11102790|FG000|Overall Study|Death|31
7025897|NCT01599754|11102791|FG001|Overall Study|Death|33
7025898|NCT01599754|11102790|FG000|Overall Study|Adverse Event|3
7025899|NCT01599754|11102791|FG001|Overall Study|Adverse Event|2
7025900|NCT01599754|11102790|FG000|Overall Study|Investigator decision|1
7025901|NCT01599754|11102791|FG001|Overall Study|Investigator decision|3
7025902|NCT01599754|11102790|FG000|Overall Study|Withdrawal by Subject|24
7025903|NCT01599754|11102791|FG001|Overall Study|Withdrawal by Subject|25
7025904|NCT01599754|11102790|FG000|Overall Study|Study terminated by sponsor|282
7025905|NCT01599754|11102791|FG001|Overall Study|Study terminated by sponsor|285
7025906|NCT01599793|11102797|FG000|Overall Study|Adverse Event|2
7025907|NCT01599806|11102803|FG000|Overall Study|Lost to Follow-up|20
7025908|NCT01599806|11102804|FG001|Overall Study|Lost to Follow-up|20
7025909|NCT01599806|11102803|FG000|Overall Study|Withdrawal by Subject|12
7025910|NCT01599806|11102804|FG001|Overall Study|Withdrawal by Subject|12
7025911|NCT01599806|11102803|FG000|Overall Study|Other Eligibility criteria|11
7025912|NCT01599806|11102804|FG001|Overall Study|Other Eligibility criteria|9
7025913|NCT01600014|11102814|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24
7025914|NCT01600014|11102815|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0
7025915|NCT01600014|11102814|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203
7025916|NCT01600014|11102815|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0
7025917|NCT01600014|11102814|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6
7025918|NCT01600014|11102815|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0
7025919|NCT01600014|11102814|FG000|1. Cycle & Observation Period D1 to W52|Other|27
7025920|NCT01600014|11102815|FG001|1. Cycle & Observation Period D1 to W52|Other|0
7025921|NCT01600014|11102814|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14
7025922|NCT01600014|11102815|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0
7025923|NCT01600014|11102814|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6
7025924|NCT01600014|11102815|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0
7025925|NCT01600014|11102814|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8
7025926|NCT01600014|11102815|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0
7025927|NCT01600014|11102814|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1
7025928|NCT01600014|11102815|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2
7025929|NCT01600014|11102814|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1
7025930|NCT01600014|11102815|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3
7025931|NCT01600014|11102814|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2
7025932|NCT01600014|11102815|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1
7025933|NCT01600014|11102814|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1
7025934|NCT01600014|11102815|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0
7025935|NCT01600014|11102814|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5
7025936|NCT01600014|11102815|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0
7025937|NCT01600014|11102814|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
7025938|NCT01600014|11102815|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
7025939|NCT01600014|11102814|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1
7025940|NCT01600014|11102815|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3
7025941|NCT01600014|11102814|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1
7025942|NCT01600014|11102815|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0
7025943|NCT01600014|11102814|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1
7025944|NCT01600014|11102815|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0
7025945|NCT01600014|11102814|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1
7025946|NCT01600014|11102815|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0
7025947|NCT01600053|11102833|FG000|Overall Study|Adverse Event|2
7025948|NCT01600053|11102833|FG000|Overall Study|trial will not meet the interim endpoint|9
7025949|NCT01600092|11102839|FG000|Overall Study|Adverse Event|2
7025950|NCT01600092|11102840|FG001|Overall Study|Adverse Event|0
7025951|NCT01600092|11102839|FG000|Overall Study|Lost to Follow-up|4
7025952|NCT01600092|11102840|FG001|Overall Study|Lost to Follow-up|6
7025953|NCT01600092|11102839|FG000|Overall Study|Withdrawal by parent/guardian|8
7025954|NCT01600092|11102840|FG001|Overall Study|Withdrawal by parent/guardian|6
7025955|NCT01600092|11102839|FG000|Overall Study|Physician Decision|1
7025956|NCT01600092|11102840|FG001|Overall Study|Physician Decision|1
7025957|NCT01600092|11102839|FG000|Overall Study|Randomized but not vaccinated|3
7025958|NCT01600092|11102840|FG001|Overall Study|Randomized but not vaccinated|3
7025959|NCT01600105|11102848|FG000|Total Participants|Withdrawal by Subject|1
7025960|NCT01600105|11102849|FG001|Total Participants|Withdrawal by Subject|0
7025961|NCT01600105|11102848|FG000|Total Participants|No images in PACS|10
7025962|NCT01600105|11102849|FG001|Total Participants|No images in PACS|0
7025963|NCT01600105|11102848|FG000|Total Participants|Insufficient image quality|30
7025964|NCT01600105|11102849|FG001|Total Participants|Insufficient image quality|10
7025965|NCT01600105|11102848|FG000|Sub Study I|Insufficient image quality|0
7025966|NCT01600105|11102849|FG001|Sub Study I|Insufficient image quality|10
7025967|NCT01600105|11102848|FG000|Sub Study II|Withdrawal by Subject|1
7025968|NCT01600105|11102849|FG001|Sub Study II|Withdrawal by Subject|0
7025969|NCT01600105|11102848|FG000|Sub Study II|No images in PACS|1
7025970|NCT01600105|11102849|FG001|Sub Study II|No images in PACS|0
7025971|NCT01600105|11102848|FG000|Sub Study II|Insufficient image quality|3
7025972|NCT01600105|11102849|FG001|Sub Study II|Insufficient image quality|0
7025973|NCT01600105|11102848|FG000|Sub Study III|Insufficient image quality|5
7025974|NCT01600105|11102849|FG001|Sub Study III|Insufficient image quality|0
7025975|NCT01600105|11102848|FG000|Sub Study V|Poor Image Quality|2
7025976|NCT01600105|11102849|FG001|Sub Study V|Poor Image Quality|0
7025977|NCT01600326|11102886|FG000|Overall Study|Lost to Follow-up|1
7025978|NCT01600326|11102887|FG001|Overall Study|Lost to Follow-up|1
7025979|NCT01600586|11102914|FG000|Overall Study|Physician Decision|3
7025980|NCT01600586|11102915|FG001|Overall Study|Physician Decision|3
7025981|NCT01600716|11102950|FG000|Overall Study|Other Reasons|3
7025982|NCT01600716|11102951|FG001|Overall Study|Other Reasons|1
7025983|NCT01600716|11102950|FG000|Overall Study|Personal Reasons|0
7025984|NCT01600716|11102951|FG001|Overall Study|Personal Reasons|2
7025985|NCT01600716|11102950|FG000|Overall Study|Lost to Follow-up|0
7025986|NCT01600716|11102951|FG001|Overall Study|Lost to Follow-up|2
7025987|NCT01600716|11102950|FG000|Overall Study|Pregnancy|1
7025988|NCT01600716|11102951|FG001|Overall Study|Pregnancy|0
7025989|NCT01600716|11102950|FG000|Overall Study|Lack of Efficacy|2
7025990|NCT01600716|11102951|FG001|Overall Study|Lack of Efficacy|1
7025991|NCT01600716|11102950|FG000|Overall Study|Adverse Event|1
7025992|NCT01600716|11102951|FG001|Overall Study|Adverse Event|1
7025993|NCT01600885|11102963|FG000|First Period|Adverse Event|1
7025994|NCT01600885|11102964|FG001|First Period|Adverse Event|1
7025995|NCT01600885|11102963|FG000|First Period|moved out of area|1
7025996|NCT01600885|11102964|FG001|First Period|moved out of area|0
7025997|NCT01601132|11102986|FG000|Overall Study|Patient withdrew consent|1
7025998|NCT01601132|11102986|FG000|Overall Study|Protocol deviation|1
7025999|NCT01601470|11103022|FG000|Period 2 - LCZ696|Physician Decision|1
7026000|NCT01601496|11103028|FG000|Overall Study|Physician Decision|1
7026001|NCT01601496|11103028|FG000|Overall Study|Withdrawal by Subject|1
7026002|NCT01601496|11103028|FG000|Overall Study|Lost to Follow-up|6
7026003|NCT01601496|11103028|FG000|Overall Study|Death|4
7026004|NCT01601496|11103028|FG000|Overall Study|Other: patient refusal to continue|3
7026005|NCT01601535|11103038|FG000|Phase 1|Adverse Event|1
7026006|NCT01601535|11103039|FG001|Phase 1|Adverse Event|0
7026007|NCT01601535|11103040|FG002|Phase 1|Adverse Event|2
7026008|NCT01601535|11103041|FG003|Phase 1|Adverse Event|1
7026009|NCT01601535|11103042|FG004|Phase 1|Adverse Event|0
7026010|NCT01601535|11103043|FG005|Phase 1|Adverse Event|0
7026011|NCT01601535|11103038|FG000|Phase 1|Withdrawal by Subject|2
7026012|NCT01601535|11103039|FG001|Phase 1|Withdrawal by Subject|1
7026013|NCT01601535|11103040|FG002|Phase 1|Withdrawal by Subject|1
7026014|NCT01601535|11103041|FG003|Phase 1|Withdrawal by Subject|2
7026015|NCT01601535|11103042|FG004|Phase 1|Withdrawal by Subject|0
7026016|NCT01601535|11103043|FG005|Phase 1|Withdrawal by Subject|0
7026017|NCT01601535|11103038|FG000|Phase 1|Progressive Disease|2
7026018|NCT01601535|11103039|FG001|Phase 1|Progressive Disease|3
7026019|NCT01601535|11103040|FG002|Phase 1|Progressive Disease|2
7026020|NCT01601535|11103041|FG003|Phase 1|Progressive Disease|1
7026021|NCT01601535|11103042|FG004|Phase 1|Progressive Disease|0
7026022|NCT01601535|11103043|FG005|Phase 1|Progressive Disease|0
7026023|NCT01601535|11103038|FG000|Phase 1|Started Another Treatment|1
7026024|NCT01601535|11103039|FG001|Phase 1|Started Another Treatment|2
7026025|NCT01601535|11103040|FG002|Phase 1|Started Another Treatment|0
7026026|NCT01601535|11103041|FG003|Phase 1|Started Another Treatment|0
7026027|NCT01601535|11103042|FG004|Phase 1|Started Another Treatment|0
7026028|NCT01601535|11103043|FG005|Phase 1|Started Another Treatment|0
7026029|NCT01601535|11103038|FG000|Phase 2|Adverse Event|0
7026030|NCT01601535|11103039|FG001|Phase 2|Adverse Event|0
7026031|NCT01601535|11103040|FG002|Phase 2|Adverse Event|0
7026032|NCT01601535|11103041|FG003|Phase 2|Adverse Event|0
7026033|NCT01601535|11103042|FG004|Phase 2|Adverse Event|5
7026034|NCT01601535|11103043|FG005|Phase 2|Adverse Event|1
7026035|NCT01601535|11103038|FG000|Phase 2|Withdrawal by Subject|0
7026036|NCT01601535|11103039|FG001|Phase 2|Withdrawal by Subject|0
7026037|NCT01601535|11103040|FG002|Phase 2|Withdrawal by Subject|0
7026038|NCT01601535|11103041|FG003|Phase 2|Withdrawal by Subject|0
7026039|NCT01601535|11103042|FG004|Phase 2|Withdrawal by Subject|8
7026040|NCT01601535|11103043|FG005|Phase 2|Withdrawal by Subject|2
7026041|NCT01601535|11103038|FG000|Phase 2|Progressive Disease|0
7026042|NCT01601535|11103039|FG001|Phase 2|Progressive Disease|0
7026043|NCT01601535|11103040|FG002|Phase 2|Progressive Disease|0
7026044|NCT01601535|11103041|FG003|Phase 2|Progressive Disease|0
7026045|NCT01601535|11103042|FG004|Phase 2|Progressive Disease|5
7026046|NCT01601535|11103043|FG005|Phase 2|Progressive Disease|7
7026047|NCT01601535|11103038|FG000|Phase 2|Started Another Treatment|0
7026048|NCT01601535|11103039|FG001|Phase 2|Started Another Treatment|0
7026049|NCT01601535|11103040|FG002|Phase 2|Started Another Treatment|0
7026050|NCT01601535|11103041|FG003|Phase 2|Started Another Treatment|0
7026051|NCT01601535|11103042|FG004|Phase 2|Started Another Treatment|1
7026052|NCT01601535|11103043|FG005|Phase 2|Started Another Treatment|2
7026053|NCT01601626|11103069|FG000|Overall Study|Death|1
7026054|NCT01601626|11103070|FG001|Overall Study|Death|1
7026055|NCT01601626|11103071|FG002|Overall Study|Death|1
7026056|NCT01601626|11103069|FG000|Overall Study|Lost to Follow-up|1
7026057|NCT01601626|11103070|FG001|Overall Study|Lost to Follow-up|2
7026058|NCT01601626|11103071|FG002|Overall Study|Lost to Follow-up|0
7026059|NCT01601626|11103069|FG000|Overall Study|Unable to Get to Clinic|0
7026060|NCT01601626|11103070|FG001|Overall Study|Unable to Get to Clinic|1
7026061|NCT01601626|11103071|FG002|Overall Study|Unable to Get to Clinic|0
7026062|NCT01601626|11103069|FG000|Overall Study|Withdrawal by Subject|0
7026063|NCT01601626|11103070|FG001|Overall Study|Withdrawal by Subject|1
7026064|NCT01601626|11103071|FG002|Overall Study|Withdrawal by Subject|1
7026065|NCT01601626|11103069|FG000|Overall Study|Not Willing to Adhere to Requirements|1
7026066|NCT01601626|11103070|FG001|Overall Study|Not Willing to Adhere to Requirements|0
7026067|NCT01601626|11103071|FG002|Overall Study|Not Willing to Adhere to Requirements|0
7026068|NCT01601652|11103079|FG000|Overall Study|Death|1
7026069|NCT01601704|11103089|FG000|Overall Study|Randomized but not dispensed study med|1
7026070|NCT01601704|11103090|FG001|Overall Study|Randomized but not dispensed study med|4
7026071|NCT01601821|11103102|FG000|Overall Study|Death|2
7026072|NCT01601821|11103103|FG001|Overall Study|Death|5
7026073|NCT01601821|11103102|FG000|Overall Study|Protocol Violation|2
7026074|NCT01601821|11103103|FG001|Overall Study|Protocol Violation|2
7026075|NCT01601821|11103102|FG000|Overall Study|Lost to Follow-up|6
7026076|NCT01601821|11103103|FG001|Overall Study|Lost to Follow-up|14
7026077|NCT01601821|11103102|FG000|Overall Study|Withdrawal by Subject|1
7026078|NCT01601821|11103103|FG001|Overall Study|Withdrawal by Subject|0
7026079|NCT01601821|11103102|FG000|Overall Study|Graft Loss|6
7026080|NCT01601821|11103103|FG001|Overall Study|Graft Loss|6
7026081|NCT01601821|11103102|FG000|Overall Study|Study Events|7
7026082|NCT01601821|11103103|FG001|Overall Study|Study Events|1
7026083|NCT01601821|11103102|FG000|Overall Study|Other|5
7026084|NCT01601821|11103103|FG001|Overall Study|Other|1
7026085|NCT01601847|11103111|FG000|Overall Study|Death|1
7026086|NCT01601847|11103112|FG001|Overall Study|Death|0
7026087|NCT01601847|11103111|FG000|Overall Study|Withdrawal by Subject|11
7026088|NCT01601847|11103112|FG001|Overall Study|Withdrawal by Subject|7
7026089|NCT01601847|11103111|FG000|Overall Study|Lost to Follow-up|1
7026090|NCT01601847|11103112|FG001|Overall Study|Lost to Follow-up|3
7026091|NCT01601873|11103130|FG000|Overall Study|Lost to Follow-up|2
7026092|NCT01601873|11103131|FG001|Overall Study|Lost to Follow-up|3
7026093|NCT01602120|11103156|FG000|Overall Study|Adverse Event|3
7026094|NCT01602120|11103157|FG001|Overall Study|Adverse Event|6
7026095|NCT01602120|11103158|FG002|Overall Study|Adverse Event|0
7026096|NCT01602120|11103159|FG003|Overall Study|Adverse Event|2
7026097|NCT01602120|11103156|FG000|Overall Study|Death|0
7026098|NCT01602120|11103157|FG001|Overall Study|Death|4
7026099|NCT01602120|11103158|FG002|Overall Study|Death|0
7026100|NCT01602120|11103159|FG003|Overall Study|Death|0
7026101|NCT01602120|11103156|FG000|Overall Study|Lost to Follow-up|0
7026102|NCT01602120|11103157|FG001|Overall Study|Lost to Follow-up|1
7026103|NCT01602120|11103158|FG002|Overall Study|Lost to Follow-up|0
7026104|NCT01602120|11103159|FG003|Overall Study|Lost to Follow-up|1
7026105|NCT01602120|11103156|FG000|Overall Study|Protocol Violation|1
7026106|NCT01602120|11103157|FG001|Overall Study|Protocol Violation|1
7026107|NCT01602120|11103158|FG002|Overall Study|Protocol Violation|0
7026108|NCT01602120|11103159|FG003|Overall Study|Protocol Violation|0
7026109|NCT01602120|11103156|FG000|Overall Study|Non-compliance|0
7026110|NCT01602120|11103157|FG001|Overall Study|Non-compliance|3
7026111|NCT01602120|11103158|FG002|Overall Study|Non-compliance|0
7026112|NCT01602120|11103159|FG003|Overall Study|Non-compliance|1
7026113|NCT01602120|11103156|FG000|Overall Study|Withdrawal by Subject|8
7026114|NCT01602120|11103157|FG001|Overall Study|Withdrawal by Subject|17
7026115|NCT01602120|11103158|FG002|Overall Study|Withdrawal by Subject|0
7026116|NCT01602120|11103159|FG003|Overall Study|Withdrawal by Subject|3
7026117|NCT01602120|11103156|FG000|Overall Study|Study Terminated by Sponsor|12
7026118|NCT01602120|11103157|FG001|Overall Study|Study Terminated by Sponsor|24
7026119|NCT01602120|11103158|FG002|Overall Study|Study Terminated by Sponsor|17
7026120|NCT01602120|11103159|FG003|Overall Study|Study Terminated by Sponsor|44
7026121|NCT01602120|11103156|FG000|Overall Study|Physician Decision|2
7026122|NCT01602120|11103157|FG001|Overall Study|Physician Decision|3
7026123|NCT01602120|11103158|FG002|Overall Study|Physician Decision|0
7026124|NCT01602120|11103159|FG003|Overall Study|Physician Decision|0
7026125|NCT01602120|11103156|FG000|Overall Study|Unspecified Reason|3
7026126|NCT01602120|11103157|FG001|Overall Study|Unspecified Reason|1
7026127|NCT01602120|11103158|FG002|Overall Study|Unspecified Reason|0
7026128|NCT01602120|11103159|FG003|Overall Study|Unspecified Reason|2
7026129|NCT01602224|11103193|FG000|Overall Study|Adverse Event|0
7026130|NCT01602224|11103194|FG001|Overall Study|Adverse Event|1
7026131|NCT01602224|11103195|FG002|Overall Study|Adverse Event|0
7026132|NCT01602224|11103193|FG000|Overall Study|Investigator Decison|1
7026133|NCT01602224|11103194|FG001|Overall Study|Investigator Decison|0
7026134|NCT01602224|11103195|FG002|Overall Study|Investigator Decison|0
7026135|NCT01602224|11103193|FG000|Overall Study|Lost to Follow-up|0
7026136|NCT01602224|11103194|FG001|Overall Study|Lost to Follow-up|0
7026137|NCT01602224|11103195|FG002|Overall Study|Lost to Follow-up|1
7026138|NCT01602224|11103193|FG000|Overall Study|Protocol Violation|0
7026139|NCT01602224|11103194|FG001|Overall Study|Protocol Violation|1
7026140|NCT01602224|11103195|FG002|Overall Study|Protocol Violation|0
7026141|NCT01602224|11103193|FG000|Overall Study|Sponsor Decision|2
7026142|NCT01602224|11103194|FG001|Overall Study|Sponsor Decision|3
7026143|NCT01602224|11103195|FG002|Overall Study|Sponsor Decision|2
7026144|NCT01602224|11103193|FG000|Overall Study|Withdrawal by Subject|5
7026145|NCT01602224|11103194|FG001|Overall Study|Withdrawal by Subject|3
7026146|NCT01602224|11103195|FG002|Overall Study|Withdrawal by Subject|3
7026147|NCT01602315|11103212|FG000|Overall Study|Protocol Violation|0
7026148|NCT01602315|11103213|FG001|Overall Study|Protocol Violation|0
7026149|NCT01602315|11103214|FG002|Overall Study|Protocol Violation|0
7026150|NCT01602315|11103215|FG003|Overall Study|Protocol Violation|0
7026151|NCT01602315|11103216|FG004|Overall Study|Protocol Violation|0
7026152|NCT01602315|11103217|FG005|Overall Study|Protocol Violation|1
7026153|NCT01602315|11103218|FG006|Overall Study|Protocol Violation|0
7026154|NCT01602315|11103212|FG000|Overall Study|Physician Decision|2
7026155|NCT01602315|11103213|FG001|Overall Study|Physician Decision|0
7026156|NCT01602315|11103214|FG002|Overall Study|Physician Decision|0
7026157|NCT01602315|11103215|FG003|Overall Study|Physician Decision|0
7026158|NCT01602315|11103216|FG004|Overall Study|Physician Decision|2
7026159|NCT01602315|11103217|FG005|Overall Study|Physician Decision|1
7026160|NCT01602315|11103218|FG006|Overall Study|Physician Decision|1
7026161|NCT01602315|11103212|FG000|Overall Study|Disease progression|6
7026162|NCT01602315|11103213|FG001|Overall Study|Disease progression|3
7026163|NCT01602315|11103214|FG002|Overall Study|Disease progression|10
7026164|NCT01602315|11103215|FG003|Overall Study|Disease progression|1
7026165|NCT01602315|11103216|FG004|Overall Study|Disease progression|41
7026166|NCT01602315|11103217|FG005|Overall Study|Disease progression|12
7026167|NCT01602315|11103218|FG006|Overall Study|Disease progression|15
7026168|NCT01602315|11103212|FG000|Overall Study|Death|1
7026169|NCT01602315|11103213|FG001|Overall Study|Death|1
7026170|NCT01602315|11103214|FG002|Overall Study|Death|1
7026171|NCT01602315|11103215|FG003|Overall Study|Death|1
7026172|NCT01602315|11103216|FG004|Overall Study|Death|7
7026173|NCT01602315|11103217|FG005|Overall Study|Death|2
7026174|NCT01602315|11103218|FG006|Overall Study|Death|2
7026175|NCT01602315|11103212|FG000|Overall Study|Withdrawal by Subject|2
7026176|NCT01602315|11103213|FG001|Overall Study|Withdrawal by Subject|0
7026177|NCT01602315|11103214|FG002|Overall Study|Withdrawal by Subject|2
7026178|NCT01602315|11103215|FG003|Overall Study|Withdrawal by Subject|0
7026179|NCT01602315|11103216|FG004|Overall Study|Withdrawal by Subject|6
7026180|NCT01602315|11103217|FG005|Overall Study|Withdrawal by Subject|0
7026181|NCT01602315|11103218|FG006|Overall Study|Withdrawal by Subject|1
7026182|NCT01602315|11103212|FG000|Overall Study|Adverse Event|5
7026183|NCT01602315|11103213|FG001|Overall Study|Adverse Event|1
7026184|NCT01602315|11103214|FG002|Overall Study|Adverse Event|5
7026185|NCT01602315|11103215|FG003|Overall Study|Adverse Event|4
7026186|NCT01602315|11103216|FG004|Overall Study|Adverse Event|15
7026187|NCT01602315|11103217|FG005|Overall Study|Adverse Event|3
7026188|NCT01602315|11103218|FG006|Overall Study|Adverse Event|9
7026189|NCT01602315|11103212|FG000|Overall Study|Subject/guardian decision|0
7026190|NCT01602315|11103213|FG001|Overall Study|Subject/guardian decision|0
7026191|NCT01602315|11103214|FG002|Overall Study|Subject/guardian decision|0
7026192|NCT01602315|11103215|FG003|Overall Study|Subject/guardian decision|0
7026193|NCT01602315|11103216|FG004|Overall Study|Subject/guardian decision|0
7026194|NCT01602315|11103217|FG005|Overall Study|Subject/guardian decision|0
7026195|NCT01602315|11103218|FG006|Overall Study|Subject/guardian decision|1
7026196|NCT01602315|11103212|FG000|Overall Study|Cross-over patients to combo treatment|0
7026197|NCT01602315|11103213|FG001|Overall Study|Cross-over patients to combo treatment|0
7026198|NCT01602315|11103214|FG002|Overall Study|Cross-over patients to combo treatment|0
7026199|NCT01602315|11103215|FG003|Overall Study|Cross-over patients to combo treatment|0
7026200|NCT01602315|11103216|FG004|Overall Study|Cross-over patients to combo treatment|0
7026201|NCT01602315|11103217|FG005|Overall Study|Cross-over patients to combo treatment|16
7026202|NCT01602315|11103218|FG006|Overall Study|Cross-over patients to combo treatment|0
7026203|NCT01602341|11103256|FG000|Overall Study|Adverse Event|0
7026204|NCT01602341|11103257|FG001|Overall Study|Adverse Event|1
7026205|NCT01602419|11103267|FG000|Overall Study|Not treated with Wilate|9
7026206|NCT01602419|11103267|FG000|Overall Study|Adverse Drug Reaction|4
7026207|NCT01602419|11103267|FG000|Overall Study|Insurance issues|3
7026208|NCT01602419|11103267|FG000|Overall Study|Changed treatment centre|1
7026209|NCT01602419|11103267|FG000|Overall Study|Treatment centre closed|1
7026210|NCT01602419|11103267|FG000|Overall Study|Withdrawal by Subject|5
7026211|NCT01602419|11103267|FG000|Overall Study|Lost to Follow-up|6
7026212|NCT01602484|11103314|FG000|Overall Study|Airway issues unrelated to study|0
7026213|NCT01602484|11103315|FG001|Overall Study|Airway issues unrelated to study|1
7026214|NCT01602510|11103321|FG000|Open Label Phase|Adverse Event|46
7026215|NCT01602510|11103322|FG001|Open Label Phase|Adverse Event|0
7026216|NCT01602510|11103323|FG002|Open Label Phase|Adverse Event|0
7026217|NCT01602510|11103321|FG000|Open Label Phase|Lack of Efficacy|22
7026218|NCT01602510|11103322|FG001|Open Label Phase|Lack of Efficacy|0
7026219|NCT01602510|11103323|FG002|Open Label Phase|Lack of Efficacy|0
7026220|NCT01602510|11103321|FG000|Open Label Phase|Protocol Violation|15
7026221|NCT01602510|11103322|FG001|Open Label Phase|Protocol Violation|0
7026222|NCT01602510|11103323|FG002|Open Label Phase|Protocol Violation|0
7026223|NCT01602510|11103321|FG000|Open Label Phase|Met protocol-defined stopping criteria|122
7026224|NCT01602510|11103322|FG001|Open Label Phase|Met protocol-defined stopping criteria|0
7026225|NCT01602510|11103323|FG002|Open Label Phase|Met protocol-defined stopping criteria|0
7026226|NCT01602510|11103321|FG000|Open Label Phase|Lost to Follow-up|22
7026227|NCT01602510|11103322|FG001|Open Label Phase|Lost to Follow-up|0
7026228|NCT01602510|11103323|FG002|Open Label Phase|Lost to Follow-up|0
7026229|NCT01602510|11103321|FG000|Open Label Phase|Physician Decision|19
7026230|NCT01602510|11103322|FG001|Open Label Phase|Physician Decision|0
7026231|NCT01602510|11103323|FG002|Open Label Phase|Physician Decision|0
7026232|NCT01602510|11103321|FG000|Open Label Phase|Withdrawal by Subject|57
7026233|NCT01602510|11103322|FG001|Open Label Phase|Withdrawal by Subject|0
7026234|NCT01602510|11103323|FG002|Open Label Phase|Withdrawal by Subject|0
7026235|NCT01602510|11103321|FG000|Randomized Phase|Adverse Event|0
7026236|NCT01602510|11103322|FG001|Randomized Phase|Adverse Event|2
7026237|NCT01602510|11103323|FG002|Randomized Phase|Adverse Event|6
7026238|NCT01602510|11103321|FG000|Randomized Phase|Lack of Efficacy|0
7026239|NCT01602510|11103322|FG001|Randomized Phase|Lack of Efficacy|4
7026240|NCT01602510|11103323|FG002|Randomized Phase|Lack of Efficacy|4
7026241|NCT01602510|11103321|FG000|Randomized Phase|Protocol Violation|0
7026242|NCT01602510|11103322|FG001|Randomized Phase|Protocol Violation|3
7026243|NCT01602510|11103323|FG002|Randomized Phase|Protocol Violation|3
7026244|NCT01602510|11103321|FG000|Randomized Phase|Met protocol-defined stopping criteria|0
7026245|NCT01602510|11103322|FG001|Randomized Phase|Met protocol-defined stopping criteria|58
7026246|NCT01602510|11103323|FG002|Randomized Phase|Met protocol-defined stopping criteria|48
7026247|NCT01602510|11103321|FG000|Randomized Phase|Lost to Follow-up|0
7026248|NCT01602510|11103322|FG001|Randomized Phase|Lost to Follow-up|1
7026249|NCT01602510|11103323|FG002|Randomized Phase|Lost to Follow-up|3
7026250|NCT01602510|11103321|FG000|Randomized Phase|Physician Decision|0
7026251|NCT01602510|11103322|FG001|Randomized Phase|Physician Decision|0
7026252|NCT01602510|11103323|FG002|Randomized Phase|Physician Decision|2
7026253|NCT01602510|11103321|FG000|Randomized Phase|Withdrawal by Subject|0
7026254|NCT01602510|11103322|FG001|Randomized Phase|Withdrawal by Subject|6
7026255|NCT01602510|11103323|FG002|Randomized Phase|Withdrawal by Subject|7
7026256|NCT01602549|11103331|FG000|Overall Study|Protocol Violation|0
7026257|NCT01602549|11103332|FG001|Overall Study|Protocol Violation|1
7026258|NCT01602549|11103331|FG000|Overall Study|Withdrawal by Subject|1
7026259|NCT01602549|11103332|FG001|Overall Study|Withdrawal by Subject|0
7044236|NCT01752634|11129967|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0
7044237|NCT01752634|11129968|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0
7044238|NCT01752634|11129969|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0
7044239|NCT01752634|11129970|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3
7044240|NCT01752634|11129965|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3
7044241|NCT01752634|11129966|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0
7044242|NCT01752634|11129967|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2
7044243|NCT01752634|11129968|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0
7044244|NCT01752634|11129969|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0
7044245|NCT01752634|11129970|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4
7044246|NCT01752634|11129965|FG000|Week 24 to Week 260|Lack of Efficacy|15
7044247|NCT01752634|11129966|FG001|Week 24 to Week 260|Lack of Efficacy|7
7044248|NCT01752634|11129967|FG002|Week 24 to Week 260|Lack of Efficacy|7
7044249|NCT01752634|11129968|FG003|Week 24 to Week 260|Lack of Efficacy|3
7044250|NCT01752634|11129969|FG004|Week 24 to Week 260|Lack of Efficacy|4
7044251|NCT01752634|11129970|FG005|Week 24 to Week 260|Lack of Efficacy|0
7044252|NCT01752634|11129965|FG000|Week 24 to Week 260|Subject/guardian decision|12
7044253|NCT01752634|11129966|FG001|Week 24 to Week 260|Subject/guardian decision|10
7044254|NCT01752634|11129967|FG002|Week 24 to Week 260|Subject/guardian decision|9
7044255|NCT01752634|11129968|FG003|Week 24 to Week 260|Subject/guardian decision|5
7044256|NCT01752634|11129969|FG004|Week 24 to Week 260|Subject/guardian decision|5
7044257|NCT01752634|11129970|FG005|Week 24 to Week 260|Subject/guardian decision|0
7044258|NCT01752634|11129965|FG000|Week 24 to Week 260|Physician Decision|1
7044259|NCT01752634|11129966|FG001|Week 24 to Week 260|Physician Decision|2
7044260|NCT01752634|11129967|FG002|Week 24 to Week 260|Physician Decision|4
7044261|NCT01752634|11129968|FG003|Week 24 to Week 260|Physician Decision|2
7044262|NCT01752634|11129969|FG004|Week 24 to Week 260|Physician Decision|1
7044263|NCT01752634|11129970|FG005|Week 24 to Week 260|Physician Decision|0
7044264|NCT01752634|11129965|FG000|Week 24 to Week 260|Death|0
7044265|NCT01752634|11129966|FG001|Week 24 to Week 260|Death|1
7044266|NCT01752634|11129967|FG002|Week 24 to Week 260|Death|0
7044267|NCT01752634|11129968|FG003|Week 24 to Week 260|Death|0
7044268|NCT01752634|11129969|FG004|Week 24 to Week 260|Death|0
7044269|NCT01752634|11129970|FG005|Week 24 to Week 260|Death|0
7044270|NCT01752634|11129965|FG000|Week 24 to Week 260|Pregnancy|0
7044271|NCT01752634|11129966|FG001|Week 24 to Week 260|Pregnancy|0
7044272|NCT01752634|11129967|FG002|Week 24 to Week 260|Pregnancy|1
7044273|NCT01752634|11129968|FG003|Week 24 to Week 260|Pregnancy|0
7044274|NCT01752634|11129969|FG004|Week 24 to Week 260|Pregnancy|0
7044275|NCT01752634|11129970|FG005|Week 24 to Week 260|Pregnancy|0
7044276|NCT01752634|11129965|FG000|Week 24 to Week 260|Noncompliance with study treatment|0
7044277|NCT01752634|11129966|FG001|Week 24 to Week 260|Noncompliance with study treatment|0
7044278|NCT01752634|11129967|FG002|Week 24 to Week 260|Noncompliance with study treatment|1
7044279|NCT01752634|11129968|FG003|Week 24 to Week 260|Noncompliance with study treatment|0
7044280|NCT01752634|11129969|FG004|Week 24 to Week 260|Noncompliance with study treatment|0
7044281|NCT01752634|11129970|FG005|Week 24 to Week 260|Noncompliance with study treatment|0
7044282|NCT01752634|11129965|FG000|Week 24 to Week 260|Lost to Follow-up|2
7044283|NCT01752634|11129966|FG001|Week 24 to Week 260|Lost to Follow-up|2
7044284|NCT01752634|11129967|FG002|Week 24 to Week 260|Lost to Follow-up|3
7044285|NCT01752634|11129968|FG003|Week 24 to Week 260|Lost to Follow-up|0
7044286|NCT01752634|11129969|FG004|Week 24 to Week 260|Lost to Follow-up|2
7044287|NCT01752634|11129970|FG005|Week 24 to Week 260|Lost to Follow-up|0
7044288|NCT01752634|11129965|FG000|Week 24 to Week 260|Adverse Event|4
7044289|NCT01752634|11129966|FG001|Week 24 to Week 260|Adverse Event|8
7044290|NCT01752634|11129967|FG002|Week 24 to Week 260|Adverse Event|8
7044291|NCT01752634|11129968|FG003|Week 24 to Week 260|Adverse Event|4
7044292|NCT01752634|11129969|FG004|Week 24 to Week 260|Adverse Event|2
7044293|NCT01752634|11129970|FG005|Week 24 to Week 260|Adverse Event|0
7044294|NCT01752842|11129991|FG000|Overall Study|Adverse Event|3
7044295|NCT01752842|11129992|FG001|Overall Study|Adverse Event|0
7044296|NCT01752842|11129991|FG000|Overall Study|Withdrawal by Subject|0
7044297|NCT01752842|11129992|FG001|Overall Study|Withdrawal by Subject|2
7044298|NCT01752855|11130000|FG000|Overall Study|Adverse Event|1
7044299|NCT01752855|11130001|FG001|Overall Study|Adverse Event|0
7044300|NCT01752855|11130000|FG000|Overall Study|Withdrew Consent|0
7044301|NCT01752855|11130001|FG001|Overall Study|Withdrew Consent|2
7044302|NCT01752855|11130000|FG000|Overall Study|Lack of Efficacy|0
7044303|NCT01752855|11130001|FG001|Overall Study|Lack of Efficacy|2
7044304|NCT01752907|11130009|FG000|Overall Study|Withdrawal by Subject|4
7044305|NCT01752907|11130010|FG001|Overall Study|Withdrawal by Subject|10
7044306|NCT01752907|11130009|FG000|Overall Study|Lost to Follow-up|2
7044307|NCT01752907|11130010|FG001|Overall Study|Lost to Follow-up|1
7044308|NCT01752907|11130009|FG000|Overall Study|Decision by Sponsor|6
7044309|NCT01752907|11130010|FG001|Overall Study|Decision by Sponsor|9
7044310|NCT01752933|11130018|FG000|Treatment|Disease Progression|3
7026260|NCT01602562|11103342|FG000|Overall Study|Adverse Event|3
7026261|NCT01602562|11103343|FG001|Overall Study|Adverse Event|1
7026262|NCT01602562|11103342|FG000|Overall Study|Physician Decision|1
7026263|NCT01602562|11103343|FG001|Overall Study|Physician Decision|1
7026264|NCT01602562|11103342|FG000|Overall Study|Withdrawal by Subject|1
7026265|NCT01602562|11103343|FG001|Overall Study|Withdrawal by Subject|1
7026266|NCT01602744|11103401|FG000|Overall Study|Death|17
7026267|NCT01602744|11103402|FG001|Overall Study|Death|15
7026268|NCT01602744|11103401|FG000|Overall Study|Lost to Follow-up|13
7026269|NCT01602744|11103402|FG001|Overall Study|Lost to Follow-up|8
7026270|NCT01602965|11103410|FG000|Overall Study|Lost to Follow-up|4
7026271|NCT01602965|11103411|FG001|Overall Study|Lost to Follow-up|2
7026272|NCT01603082|11103428|FG000|Overall Study|Adverse Event|0
7026273|NCT01603082|11103429|FG001|Overall Study|Adverse Event|1
7026274|NCT01603082|11103428|FG000|Overall Study|Withdrawal by Subject|1
6922201|NCT00810069|10950712|FG000|Lead-in Period I|Physician Decision|1
6922202|NCT00810069|10950713|FG001|Lead-in Period I|Physician Decision|0
6922203|NCT00810069|10950714|FG002|Lead-in Period I|Physician Decision|0
6922204|NCT00810069|10950712|FG000|Lead-in Period I|Protocol Violation|1
7026275|NCT01603082|11103429|FG001|Overall Study|Withdrawal by Subject|0
7026276|NCT01603082|11103428|FG000|Overall Study|Failed inclusion criterion after dosed|1
7026277|NCT01603082|11103429|FG001|Overall Study|Failed inclusion criterion after dosed|0
7026278|NCT01603277|11103437|FG000|Overall Study|Adverse Event|1
6922205|NCT00810069|10950713|FG001|Lead-in Period I|Protocol Violation|0
7026279|NCT01603277|11103438|FG001|Overall Study|Adverse Event|2
7026280|NCT01603277|11103437|FG000|Overall Study|Physician Decision|0
7026281|NCT01603277|11103438|FG001|Overall Study|Physician Decision|1
7026282|NCT01603277|11103437|FG000|Overall Study|Protocol Violation|6
7026283|NCT01603277|11103438|FG001|Overall Study|Protocol Violation|10
7026284|NCT01603277|11103437|FG000|Overall Study|Withdrawal by Subject|5
7026285|NCT01603277|11103438|FG001|Overall Study|Withdrawal by Subject|4
7026286|NCT01603277|11103437|FG000|Overall Study|Non-Compliance|2
7026287|NCT01603277|11103438|FG001|Overall Study|Non-Compliance|1
7026288|NCT01603355|11103444|FG000|Overall Study|Lack of Efficacy|2
7026289|NCT01603459|11103469|FG000|Overall Study|Adverse Event|5
7026290|NCT01603459|11103469|FG000|Overall Study|Withdrawal by Subject|5
7026291|NCT01603459|11103469|FG000|Overall Study|Lost to Follow-up|3
7026292|NCT01603459|11103469|FG000|Overall Study|Predefined discontinuation criteria|3
7026293|NCT01603459|11103469|FG000|Overall Study|Non-compliance|1
7026294|NCT01603459|11103469|FG000|Overall Study|Administrative reason|1
7026295|NCT01603602|11103494|FG000|Overall Study|Adverse Event|1
7026296|NCT01603602|11103495|FG001|Overall Study|Adverse Event|0
7026297|NCT01603602|11103496|FG002|Overall Study|Adverse Event|0
7026298|NCT01603602|11103494|FG000|Overall Study|Personal Reasons|1
7026299|NCT01603602|11103495|FG001|Overall Study|Personal Reasons|0
7026300|NCT01603602|11103496|FG002|Overall Study|Personal Reasons|1
7026301|NCT01603615|11103504|FG000|Overall Study|Did not Receive Treatment|7
7026302|NCT01603615|11103504|FG000|Overall Study|Lost to Follow-up|9
7026303|NCT01603615|11103504|FG000|Overall Study|Personal Reasons|17
7026304|NCT01603615|11103504|FG000|Overall Study|Other Miscellaneous|1
7026305|NCT01603628|11103511|FG000|Overall Study|Personal Reasons|1
7026306|NCT01603628|11103512|FG001|Overall Study|Personal Reasons|1
7026307|NCT01603628|11103513|FG002|Overall Study|Personal Reasons|2
7026308|NCT01603628|11103511|FG000|Overall Study|Protocol Violation|1
7026309|NCT01603628|11103512|FG001|Overall Study|Protocol Violation|1
7026310|NCT01603628|11103513|FG002|Overall Study|Protocol Violation|0
7026311|NCT01603628|11103511|FG000|Overall Study|Lost to Follow-up|0
7026312|NCT01603628|11103512|FG001|Overall Study|Lost to Follow-up|1
7026313|NCT01603628|11103513|FG002|Overall Study|Lost to Follow-up|0
7026314|NCT01603628|11103511|FG000|Overall Study|Other Miscellaneous Reason|1
7026315|NCT01603628|11103512|FG001|Overall Study|Other Miscellaneous Reason|0
7026316|NCT01603628|11103513|FG002|Overall Study|Other Miscellaneous Reason|0
7026317|NCT01603641|11103521|FG000|Overall Study|Did not Receive Treatment|3
7026318|NCT01603641|11103521|FG000|Overall Study|Adverse Event|1
7026319|NCT01603641|11103521|FG000|Overall Study|Lack of Efficacy|1
7026320|NCT01603641|11103521|FG000|Overall Study|Lost to Follow-up|6
7026321|NCT01603641|11103521|FG000|Overall Study|Personal Reasons|18
7026322|NCT01603641|11103521|FG000|Overall Study|Other Miscellaneous Reasons|6
7026323|NCT01603875|11103528|FG000|Overall Study|Preexisting rabies antibody|3
7026324|NCT01603875|11103529|FG001|Overall Study|Preexisting rabies antibody|4
7026325|NCT01603875|11103530|FG002|Overall Study|Preexisting rabies antibody|3
7026326|NCT01603875|11103528|FG000|Overall Study|Lost to Follow-up|4
7026327|NCT01603875|11103529|FG001|Overall Study|Lost to Follow-up|3
7026328|NCT01603875|11103530|FG002|Overall Study|Lost to Follow-up|6
7026329|NCT01603875|11103528|FG000|Overall Study|Protocol Violation|0
6922206|NCT00810069|10950714|FG002|Lead-in Period I|Protocol Violation|0
7026330|NCT01603875|11103529|FG001|Overall Study|Protocol Violation|1
7026331|NCT01603875|11103530|FG002|Overall Study|Protocol Violation|0
7026332|NCT01604265|11103568|FG000|Overall Study|Adverse Event|1
7026333|NCT01604265|11103569|FG001|Overall Study|Adverse Event|0
7026334|NCT01604265|11103568|FG000|Overall Study|Withdrawal by Subject|1
7026335|NCT01604265|11103569|FG001|Overall Study|Withdrawal by Subject|0
7026336|NCT01604278|11103577|FG000|Overall Study|Lack of Efficacy|0
7026337|NCT01604278|11103578|FG001|Overall Study|Lack of Efficacy|1
7026338|NCT01604278|11103577|FG000|Overall Study|Lost to Follow-up|1
7026339|NCT01604278|11103578|FG001|Overall Study|Lost to Follow-up|0
7026340|NCT01604278|11103577|FG000|Overall Study|Administrative problems|2
7026341|NCT01604278|11103578|FG001|Overall Study|Administrative problems|1
7026342|NCT01604278|11103577|FG000|Overall Study|Withdrawal by Subject|3
7026343|NCT01604278|11103578|FG001|Overall Study|Withdrawal by Subject|3
7026344|NCT01604278|11103577|FG000|Overall Study|Adverse Event|3
7026345|NCT01604278|11103578|FG001|Overall Study|Adverse Event|5
7026346|NCT01604278|11103577|FG000|Overall Study|Protocol Deviation|5
7026347|NCT01604278|11103578|FG001|Overall Study|Protocol Deviation|3
7026348|NCT01604343|11103612|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5
7026349|NCT01604343|11103613|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
7026350|NCT01604343|11103614|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4
7026351|NCT01604343|11103615|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
7026352|NCT01604343|11103616|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3
7026353|NCT01604343|11103612|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19
7026354|NCT01604343|11103613|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
7026355|NCT01604343|11103614|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12
7026356|NCT01604343|11103615|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
7026357|NCT01604343|11103616|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16
7026358|NCT01604343|11103612|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25
7026359|NCT01604343|11103613|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0
7026360|NCT01604343|11103614|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41
7026361|NCT01604343|11103615|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0
7026362|NCT01604343|11103616|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42
7026363|NCT01604343|11103612|FG000|Prior to W52 Administration(Through W52)|Death|5
7026364|NCT01604343|11103613|FG001|Prior to W52 Administration(Through W52)|Death|0
7026365|NCT01604343|11103614|FG002|Prior to W52 Administration(Through W52)|Death|2
7026366|NCT01604343|11103615|FG003|Prior to W52 Administration(Through W52)|Death|0
7026367|NCT01604343|11103616|FG004|Prior to W52 Administration(Through W52)|Death|4
7026368|NCT01604343|11103612|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24
7026369|NCT01604343|11103613|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
7026370|NCT01604343|11103614|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5
7026371|NCT01604343|11103615|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
7026372|NCT01604343|11103616|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14
7026373|NCT01604343|11103612|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4
7026374|NCT01604343|11103613|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0
7026375|NCT01604343|11103614|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1
7026376|NCT01604343|11103615|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0
7026377|NCT01604343|11103616|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2
7026378|NCT01604343|11103612|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1
7060551|NCT01920061|11156851|FG014|Overall Study|Lost to Follow-up|0
7060552|NCT01920061|11156852|FG015|Overall Study|Lost to Follow-up|0
7060553|NCT01920061|11156853|FG016|Overall Study|Lost to Follow-up|0
7060554|NCT01920061|11156854|FG017|Overall Study|Lost to Follow-up|1
7060555|NCT01920061|11156855|FG018|Overall Study|Lost to Follow-up|4
7060556|NCT01920061|11156856|FG019|Overall Study|Lost to Follow-up|3
7060557|NCT01920061|11156837|FG000|Overall Study|Other|1
7060558|NCT01920061|11156838|FG001|Overall Study|Other|1
7060559|NCT01920061|11156839|FG002|Overall Study|Other|2
7060560|NCT01920061|11156840|FG003|Overall Study|Other|1
7060561|NCT01920061|11156841|FG004|Overall Study|Other|0
7060562|NCT01920061|11156842|FG005|Overall Study|Other|1
7060563|NCT01920061|11156843|FG006|Overall Study|Other|0
7060564|NCT01920061|11156844|FG007|Overall Study|Other|0
7060565|NCT01920061|11156845|FG008|Overall Study|Other|0
7060566|NCT01920061|11156846|FG009|Overall Study|Other|1
7060567|NCT01920061|11156847|FG010|Overall Study|Other|1
7060568|NCT01920061|11156848|FG011|Overall Study|Other|2
7060569|NCT01920061|11156849|FG012|Overall Study|Other|1
7060570|NCT01920061|11156850|FG013|Overall Study|Other|4
7060571|NCT01920061|11156851|FG014|Overall Study|Other|0
7060572|NCT01920061|11156852|FG015|Overall Study|Other|1
7060573|NCT01920061|11156853|FG016|Overall Study|Other|1
7060574|NCT01920061|11156854|FG017|Overall Study|Other|0
7060575|NCT01920061|11156855|FG018|Overall Study|Other|1
7060576|NCT01920061|11156856|FG019|Overall Study|Other|1
7060577|NCT01920061|11156837|FG000|Overall Study|Participant refused further follow-up|0
7060578|NCT01920061|11156838|FG001|Overall Study|Participant refused further follow-up|0
7060579|NCT01920061|11156839|FG002|Overall Study|Participant refused further follow-up|0
7060580|NCT01920061|11156840|FG003|Overall Study|Participant refused further follow-up|0
7060581|NCT01920061|11156841|FG004|Overall Study|Participant refused further follow-up|1
7060582|NCT01920061|11156842|FG005|Overall Study|Participant refused further follow-up|1
7060583|NCT01920061|11156843|FG006|Overall Study|Participant refused further follow-up|0
7060584|NCT01920061|11156844|FG007|Overall Study|Participant refused further follow-up|0
7060585|NCT01920061|11156845|FG008|Overall Study|Participant refused further follow-up|1
7060586|NCT01920061|11156846|FG009|Overall Study|Participant refused further follow-up|0
7060587|NCT01920061|11156847|FG010|Overall Study|Participant refused further follow-up|1
7026379|NCT01604343|11103613|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0
7026380|NCT01604343|11103614|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1
7026381|NCT01604343|11103615|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0
7026382|NCT01604343|11103616|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0
7026383|NCT01604343|11103612|FG000|Prior to W52 Administration(Through W52)|Other|15
7026384|NCT01604343|11103613|FG001|Prior to W52 Administration(Through W52)|Other|0
7026385|NCT01604343|11103614|FG002|Prior to W52 Administration(Through W52)|Other|10
7026386|NCT01604343|11103615|FG003|Prior to W52 Administration(Through W52)|Other|0
7026387|NCT01604343|11103616|FG004|Prior to W52 Administration(Through W52)|Other|6
7026388|NCT01604343|11103612|FG000|Week 52 to Week 104|Lost to Follow-up|0
7026389|NCT01604343|11103613|FG001|Week 52 to Week 104|Lost to Follow-up|2
7026390|NCT01604343|11103614|FG002|Week 52 to Week 104|Lost to Follow-up|4
7026391|NCT01604343|11103615|FG003|Week 52 to Week 104|Lost to Follow-up|2
7026392|NCT01604343|11103616|FG004|Week 52 to Week 104|Lost to Follow-up|1
7026393|NCT01604343|11103612|FG000|Week 52 to Week 104|Withdrawal by Subject|0
7026394|NCT01604343|11103613|FG001|Week 52 to Week 104|Withdrawal by Subject|7
7026395|NCT01604343|11103614|FG002|Week 52 to Week 104|Withdrawal by Subject|12
7026396|NCT01604343|11103615|FG003|Week 52 to Week 104|Withdrawal by Subject|8
7026397|NCT01604343|11103616|FG004|Week 52 to Week 104|Withdrawal by Subject|4
7026398|NCT01604343|11103612|FG000|Week 52 to Week 104|Adverse Event|0
7026399|NCT01604343|11103613|FG001|Week 52 to Week 104|Adverse Event|12
7026400|NCT01604343|11103614|FG002|Week 52 to Week 104|Adverse Event|26
7026401|NCT01604343|11103615|FG003|Week 52 to Week 104|Adverse Event|21
7026402|NCT01604343|11103616|FG004|Week 52 to Week 104|Adverse Event|27
7026403|NCT01604343|11103612|FG000|Week 52 to Week 104|Death|0
7026404|NCT01604343|11103613|FG001|Week 52 to Week 104|Death|4
7026405|NCT01604343|11103614|FG002|Week 52 to Week 104|Death|2
7026406|NCT01604343|11103615|FG003|Week 52 to Week 104|Death|5
7026407|NCT01604343|11103616|FG004|Week 52 to Week 104|Death|0
7026408|NCT01604343|11103612|FG000|Week 52 to Week 104|Lack of Efficacy|0
7026409|NCT01604343|11103613|FG001|Week 52 to Week 104|Lack of Efficacy|6
7026410|NCT01604343|11103614|FG002|Week 52 to Week 104|Lack of Efficacy|11
7026411|NCT01604343|11103615|FG003|Week 52 to Week 104|Lack of Efficacy|2
7026412|NCT01604343|11103616|FG004|Week 52 to Week 104|Lack of Efficacy|3
7026413|NCT01604343|11103612|FG000|Week 52 to Week 104|Physician Decision|0
7026414|NCT01604343|11103613|FG001|Week 52 to Week 104|Physician Decision|1
7026415|NCT01604343|11103614|FG002|Week 52 to Week 104|Physician Decision|0
7026416|NCT01604343|11103615|FG003|Week 52 to Week 104|Physician Decision|0
7026417|NCT01604343|11103616|FG004|Week 52 to Week 104|Physician Decision|2
7026418|NCT01604343|11103612|FG000|Week 52 to Week 104|Pregnancy|0
7026419|NCT01604343|11103613|FG001|Week 52 to Week 104|Pregnancy|0
7026420|NCT01604343|11103614|FG002|Week 52 to Week 104|Pregnancy|1
7026421|NCT01604343|11103615|FG003|Week 52 to Week 104|Pregnancy|2
7026422|NCT01604343|11103616|FG004|Week 52 to Week 104|Pregnancy|1
7026423|NCT01604343|11103612|FG000|Week 52 to Week 104|Other|0
7026424|NCT01604343|11103613|FG001|Week 52 to Week 104|Other|11
7026425|NCT01604343|11103614|FG002|Week 52 to Week 104|Other|11
7026426|NCT01604343|11103615|FG003|Week 52 to Week 104|Other|6
7026427|NCT01604343|11103616|FG004|Week 52 to Week 104|Other|3
7026428|NCT01604343|11103612|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3
7026429|NCT01604343|11103613|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
7026430|NCT01604343|11103614|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2
7026431|NCT01604343|11103615|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
7026432|NCT01604343|11103616|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
7026433|NCT01604343|11103612|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12
7026434|NCT01604343|11103613|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4
7026435|NCT01604343|11103614|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11
7026436|NCT01604343|11103615|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3
7026437|NCT01604343|11103616|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14
7026438|NCT01604343|11103612|FG000|Safety Follow-up Period (Week 104-120)|Other|15
7026439|NCT01604343|11103613|FG001|Safety Follow-up Period (Week 104-120)|Other|2
7026440|NCT01604343|11103614|FG002|Safety Follow-up Period (Week 104-120)|Other|20
7026441|NCT01604343|11103615|FG003|Safety Follow-up Period (Week 104-120)|Other|6
7026442|NCT01604343|11103616|FG004|Safety Follow-up Period (Week 104-120)|Other|14
7026443|NCT01604408|11103628|FG000|Treatment Period 1|Protocol Violation|0
7026444|NCT01604408|11103629|FG001|Treatment Period 1|Protocol Violation|1
7026445|NCT01604408|11103628|FG000|Treatment Period 2|Withdrawal by Subject|1
7026446|NCT01604408|11103629|FG001|Treatment Period 2|Withdrawal by Subject|1
7026447|NCT01604408|11103628|FG000|Treatment Period 2|Protocol Violation|1
7026448|NCT01604408|11103629|FG001|Treatment Period 2|Protocol Violation|0
7026449|NCT01604408|11103628|FG000|Treatment Period 2|Adverse Event|0
7026450|NCT01604408|11103629|FG001|Treatment Period 2|Adverse Event|1
7026451|NCT01604408|11103628|FG000|Treatment Period 3|Protocol Violation|1
7026452|NCT01604408|11103629|FG001|Treatment Period 3|Protocol Violation|1
7026453|NCT01604408|11103628|FG000|Treatment Period 3|Adverse Event|0
7026454|NCT01604408|11103629|FG001|Treatment Period 3|Adverse Event|3
7026455|NCT01604408|11103628|FG000|Treatment Period 3|Withdrawal by Subject|3
7026456|NCT01604408|11103629|FG001|Treatment Period 3|Withdrawal by Subject|1
7026457|NCT01604408|11103628|FG000|Treatment Period 3|Sponsor Decision|1
7026458|NCT01604408|11103629|FG001|Treatment Period 3|Sponsor Decision|0
7026459|NCT01604408|11103628|FG000|Treatment Period 4|Death|1
7026460|NCT01604408|11103629|FG001|Treatment Period 4|Death|0
7026461|NCT01604408|11103628|FG000|Treatment Period 4|Withdrawal by Subject|2
7026462|NCT01604408|11103629|FG001|Treatment Period 4|Withdrawal by Subject|1
7026463|NCT01604408|11103628|FG000|Treatment Period 4|Adverse Event|0
7026464|NCT01604408|11103629|FG001|Treatment Period 4|Adverse Event|1
7026465|NCT01604408|11103628|FG000|Treatment Period 5|Adverse Event|4
7026466|NCT01604408|11103629|FG001|Treatment Period 5|Adverse Event|0
7026467|NCT01604408|11103628|FG000|Treatment Period 6|Lost to Follow-up|0
7026468|NCT01604408|11103629|FG001|Treatment Period 6|Lost to Follow-up|1
7026469|NCT01604408|11103628|FG000|Treatment Period 6|Adverse Event|2
7026470|NCT01604408|11103629|FG001|Treatment Period 6|Adverse Event|0
7026471|NCT01604408|11103628|FG000|Treatment Period 6|Sponsor decision|0
7026472|NCT01604408|11103629|FG001|Treatment Period 6|Sponsor decision|1
7026473|NCT01604408|11103628|FG000|Observation Period|Adverse Event|1
7026474|NCT01604408|11103629|FG001|Observation Period|Adverse Event|1
7026475|NCT01604408|11103628|FG000|Observation Period|Withdrawal by Subject|0
7026476|NCT01604408|11103629|FG001|Observation Period|Withdrawal by Subject|2
7026477|NCT01604785|11103642|FG000|Overall Study|Repeat Visits Not Included in Analysis|7
7026478|NCT01604785|11103643|FG001|Overall Study|Repeat Visits Not Included in Analysis|1
7026479|NCT01604824|11103653|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
7026480|NCT01604824|11103654|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
7026481|NCT01604824|11103655|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
7026482|NCT01604824|11103656|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
7026483|NCT01604824|11103657|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2
7026484|NCT01604824|11103658|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
7026485|NCT01604824|11103653|FG000|Open-label Extension (OLE) Period|Refused to come into office|0
7026486|NCT01604824|11103654|FG001|Open-label Extension (OLE) Period|Refused to come into office|0
7026487|NCT01604824|11103655|FG002|Open-label Extension (OLE) Period|Refused to come into office|0
7026488|NCT01604824|11103656|FG003|Open-label Extension (OLE) Period|Refused to come into office|0
7026489|NCT01604824|11103657|FG004|Open-label Extension (OLE) Period|Refused to come into office|1
7026490|NCT01604824|11103658|FG005|Open-label Extension (OLE) Period|Refused to come into office|0
7026491|NCT01604850|11103672|FG000|Overall Study|Enrolled but never treated|0
7026492|NCT01604850|11103673|FG001|Overall Study|Enrolled but never treated|1
7026493|NCT01604850|11103672|FG000|Overall Study|Efficacy Failure|50
7026494|NCT01604850|11103673|FG001|Overall Study|Efficacy Failure|29
7026495|NCT01604850|11103672|FG000|Overall Study|Lost to Follow-up|1
7026496|NCT01604850|11103673|FG001|Overall Study|Lost to Follow-up|0
7026497|NCT01604850|11103672|FG000|Overall Study|Subject withdrew consent|1
7026498|NCT01604850|11103673|FG001|Overall Study|Subject withdrew consent|0
7026499|NCT01604941|11103681|FG000|Overall Study|Adverse Event|1
7026500|NCT01604941|11103682|FG001|Overall Study|Adverse Event|2
7026501|NCT01604941|11103683|FG002|Overall Study|Adverse Event|0
7026502|NCT01604941|11103684|FG003|Overall Study|Adverse Event|0
7026503|NCT01604941|11103685|FG004|Overall Study|Adverse Event|1
7026504|NCT01604941|11103686|FG005|Overall Study|Adverse Event|5
7026505|NCT01604941|11103681|FG000|Overall Study|Non-compliance|1
7026506|NCT01604941|11103682|FG001|Overall Study|Non-compliance|0
7026507|NCT01604941|11103683|FG002|Overall Study|Non-compliance|0
7026508|NCT01604941|11103684|FG003|Overall Study|Non-compliance|0
7026509|NCT01604941|11103685|FG004|Overall Study|Non-compliance|0
7026510|NCT01604941|11103686|FG005|Overall Study|Non-compliance|0
7026511|NCT01604941|11103681|FG000|Overall Study|Participant Decision|0
7026512|NCT01604941|11103682|FG001|Overall Study|Participant Decision|0
7026513|NCT01604941|11103683|FG002|Overall Study|Participant Decision|0
7026514|NCT01604941|11103684|FG003|Overall Study|Participant Decision|0
7026515|NCT01604941|11103685|FG004|Overall Study|Participant Decision|0
7026516|NCT01604941|11103686|FG005|Overall Study|Participant Decision|2
7026517|NCT01604941|11103681|FG000|Overall Study|Early Study Termination|9
7026518|NCT01604941|11103682|FG001|Overall Study|Early Study Termination|2
7026519|NCT01604941|11103683|FG002|Overall Study|Early Study Termination|3
7026520|NCT01604941|11103684|FG003|Overall Study|Early Study Termination|3
7026521|NCT01604941|11103685|FG004|Overall Study|Early Study Termination|0
7026522|NCT01604941|11103686|FG005|Overall Study|Early Study Termination|0
7026523|NCT01605071|11103698|FG000|Overall Study|Withdrawal by Subject|3
7026524|NCT01605071|11103699|FG001|Overall Study|Withdrawal by Subject|2
7026525|NCT01605097|11103707|FG000|Overall Study|Protocol Violation|1
7026526|NCT01605136|11103714|FG000|Study Period|Withdrawal by Subject|2
7026527|NCT01605136|11103715|FG001|Study Period|Withdrawal by Subject|0
7026528|NCT01605136|11103714|FG000|Study Period|Physician Decision|1
7026529|NCT01605136|11103715|FG001|Study Period|Physician Decision|1
7026530|NCT01605136|11103714|FG000|Study Period|Lost to Follow-up|0
7026531|NCT01605136|11103715|FG001|Study Period|Lost to Follow-up|2
7026532|NCT01605136|11103714|FG000|Safety Follow-Up Period|Withdrawal by Subject|1
7026533|NCT01605136|11103715|FG001|Safety Follow-Up Period|Withdrawal by Subject|2
7026534|NCT01605227|11103723|FG000|Overall Study|Did not receive study treatment|2
7026535|NCT01605227|11103724|FG001|Overall Study|Did not receive study treatment|3
7026536|NCT01605227|11103723|FG000|Overall Study|Adverse Event|228
7026537|NCT01605227|11103724|FG001|Overall Study|Adverse Event|42
7026538|NCT01605227|11103723|FG000|Overall Study|Progressive Disease|132
7026539|NCT01605227|11103724|FG001|Overall Study|Progressive Disease|128
7026540|NCT01605227|11103723|FG000|Overall Study|Clinical Deterioration|227
7026541|NCT01605227|11103724|FG001|Overall Study|Clinical Deterioration|133
7026542|NCT01605227|11103723|FG000|Overall Study|Lost to Follow-up|1
7026543|NCT01605227|11103724|FG001|Overall Study|Lost to Follow-up|0
7026544|NCT01605227|11103723|FG000|Overall Study|Protocol Violation|1
7026545|NCT01605227|11103724|FG001|Overall Study|Protocol Violation|0
7026546|NCT01605227|11103723|FG000|Overall Study|Physician Decision|9
7026547|NCT01605227|11103724|FG001|Overall Study|Physician Decision|7
7026548|NCT01605227|11103723|FG000|Overall Study|Withdrawal by Subject|18
7026549|NCT01605227|11103724|FG001|Overall Study|Withdrawal by Subject|14
7026550|NCT01605227|11103723|FG000|Overall Study|Sponsor Decision|2
7026551|NCT01605227|11103724|FG001|Overall Study|Sponsor Decision|0
7026552|NCT01605227|11103723|FG000|Overall Study|Started New Therapy|1
7026553|NCT01605227|11103724|FG001|Overall Study|Started New Therapy|0
7026554|NCT01605227|11103723|FG000|Overall Study|Subject Decision|0
7026555|NCT01605227|11103724|FG001|Overall Study|Subject Decision|1
7026556|NCT01605227|11103723|FG000|Overall Study|Dose Held >6 weeks|0
7026557|NCT01605227|11103724|FG001|Overall Study|Dose Held >6 weeks|1
7026558|NCT01605396|11103741|FG000|Overall Study|Adverse Event|5
7026559|NCT01605396|11103742|FG001|Overall Study|Adverse Event|3
7026560|NCT01605396|11103741|FG000|Overall Study|Lost to Follow-up|1
7026561|NCT01605396|11103742|FG001|Overall Study|Lost to Follow-up|0
7026562|NCT01605396|11103741|FG000|Overall Study|Non-Compliance With Study Drug|1
7026563|NCT01605396|11103742|FG001|Overall Study|Non-Compliance With Study Drug|1
7026564|NCT01605396|11103741|FG000|Overall Study|Physician Decision|2
7026565|NCT01605396|11103742|FG001|Overall Study|Physician Decision|2
7026566|NCT01605396|11103741|FG000|Overall Study|Progressive Disease|23
7026567|NCT01605396|11103742|FG001|Overall Study|Progressive Disease|27
7026568|NCT01605396|11103741|FG000|Overall Study|Withdrawal by Subject|4
7026569|NCT01605396|11103742|FG001|Overall Study|Withdrawal by Subject|2
7026570|NCT01605396|11103741|FG000|Overall Study|Transfer Off Study|4
7026571|NCT01605396|11103742|FG001|Overall Study|Transfer Off Study|5
7026572|NCT01605461|11103766|FG000|Overall Study|Lost to Follow-up|3
7026573|NCT01605461|11103766|FG000|Overall Study|Withdrawal by Subject|1
7026574|NCT01605799|11103799|FG000|Overall Study|Withdrawal by Subject|2
7026575|NCT01605799|11103800|FG001|Overall Study|Withdrawal by Subject|1
7026576|NCT01605825|11103808|FG000|Overall Study|Adverse Event|4
7026577|NCT01605825|11103809|FG001|Overall Study|Adverse Event|2
7026578|NCT01605825|11103808|FG000|Overall Study|Withdrawal by Subject|0
7026579|NCT01605825|11103809|FG001|Overall Study|Withdrawal by Subject|1
7026580|NCT01605825|11103808|FG000|Overall Study|Non-Compliance -Investigational Drug|3
7026581|NCT01605825|11103809|FG001|Overall Study|Non-Compliance -Investigational Drug|0
7026582|NCT01605825|11103808|FG000|Overall Study|Non-Compliance with Protocol|3
7026583|NCT01605825|11103809|FG001|Overall Study|Non-Compliance with Protocol|0
7026584|NCT01605877|11103815|FG000|Overall Study|Withdrawal by Subject|1
7026585|NCT01605916|11103855|FG000|Overall Study|Adverse Event|1
7026586|NCT01605916|11103856|FG001|Overall Study|Adverse Event|0
7026587|NCT01605916|11103857|FG002|Overall Study|Adverse Event|0
7026588|NCT01605916|11103858|FG003|Overall Study|Adverse Event|1
7026589|NCT01605916|11103859|FG004|Overall Study|Adverse Event|0
7026590|NCT01605916|11103855|FG000|Overall Study|Lack of Efficacy|2
7026591|NCT01605916|11103856|FG001|Overall Study|Lack of Efficacy|3
7026592|NCT01605916|11103857|FG002|Overall Study|Lack of Efficacy|3
7026593|NCT01605916|11103858|FG003|Overall Study|Lack of Efficacy|5
7026594|NCT01605916|11103859|FG004|Overall Study|Lack of Efficacy|4
7026595|NCT01605916|11103855|FG000|Overall Study|Withdrawal by Subject|1
7026596|NCT01605916|11103856|FG001|Overall Study|Withdrawal by Subject|1
7026597|NCT01605916|11103857|FG002|Overall Study|Withdrawal by Subject|0
7026598|NCT01605916|11103858|FG003|Overall Study|Withdrawal by Subject|0
7026599|NCT01605916|11103859|FG004|Overall Study|Withdrawal by Subject|2
7026600|NCT01606007|11103884|FG000|Overall Study|Reason 'Other' in the protocol|0
7026601|NCT01606007|11103885|FG001|Overall Study|Reason 'Other' in the protocol|1
7026602|NCT01606007|11103886|FG002|Overall Study|Reason 'Other' in the protocol|1
7026603|NCT01606007|11103884|FG000|Overall Study|Pregnancy|0
7026604|NCT01606007|11103885|FG001|Overall Study|Pregnancy|1
7026605|NCT01606007|11103886|FG002|Overall Study|Pregnancy|1
7026606|NCT01606007|11103884|FG000|Overall Study|Withdrawal by Subject|8
7026607|NCT01606007|11103885|FG001|Overall Study|Withdrawal by Subject|6
7026608|NCT01606007|11103886|FG002|Overall Study|Withdrawal by Subject|1
7026609|NCT01606007|11103884|FG000|Overall Study|Adverse Event|0
7026610|NCT01606007|11103885|FG001|Overall Study|Adverse Event|1
7026611|NCT01606007|11103886|FG002|Overall Study|Adverse Event|1
7026612|NCT01606007|11103884|FG000|Overall Study|discontinue study treatment|0
7026613|NCT01606007|11103885|FG001|Overall Study|discontinue study treatment|2
7026614|NCT01606007|11103886|FG002|Overall Study|discontinue study treatment|1
7026615|NCT01606007|11103884|FG000|Overall Study|Lost to Follow-up|6
7026616|NCT01606007|11103885|FG001|Overall Study|Lost to Follow-up|8
7026617|NCT01606007|11103886|FG002|Overall Study|Lost to Follow-up|5
7026618|NCT01606007|11103884|FG000|Overall Study|Poor/Non-compliance|1
7026619|NCT01606007|11103885|FG001|Overall Study|Poor/Non-compliance|0
7026620|NCT01606007|11103886|FG002|Overall Study|Poor/Non-compliance|0
7026621|NCT01606137|11103903|FG000|Overall Study|Adverse Event|85
7026622|NCT01606137|11103903|FG000|Overall Study|Withdrawal by Subject|74
7026623|NCT01606137|11103903|FG000|Overall Study|Lack of Efficacy|56
7026624|NCT01606137|11103903|FG000|Overall Study|Lost to Follow-up|15
7026625|NCT01606137|11103903|FG000|Overall Study|Protocol Violation|1
7026626|NCT01606137|11103903|FG000|Overall Study|Patient non-compliance|9
7026627|NCT01606137|11103903|FG000|Overall Study|Death|1
7026628|NCT01606137|11103903|FG000|Overall Study|Decreased/no pain|4
7026629|NCT01606137|11103903|FG000|Overall Study|Issues with driving|4
7026630|NCT01606137|11103903|FG000|Overall Study|multiple sclerosis less stable|1
7026631|NCT01606137|11103903|FG000|Overall Study|Increased bilirubin|1
7026632|NCT01606137|11103903|FG000|Overall Study|Spray causes nausea|1
7026633|NCT01606137|11103903|FG000|Overall Study|Not enough improvement|4
7026634|NCT01606137|11103903|FG000|Overall Study|Wanted to try another treatment|1
7026635|NCT01606137|11103903|FG000|Overall Study|Patient leaving country|1
7026636|NCT01606137|11103903|FG000|Overall Study|Personal reasons|1
7026637|NCT01606137|11103903|FG000|Overall Study|Unable to tolerate study med. taste|1
7026638|NCT01606137|11103903|FG000|Overall Study|Patient moving|1
7026639|NCT01606137|11103903|FG000|Overall Study|Unable to collect consistent data|1
7026640|NCT01606176|11103909|FG000|Overall Study|Adverse Event|2
7026641|NCT01606176|11103910|FG001|Overall Study|Adverse Event|3
7026642|NCT01606176|11103909|FG000|Overall Study|Disease progression|1
7026643|NCT01606176|11103910|FG001|Overall Study|Disease progression|0
7026644|NCT01606176|11103909|FG000|Overall Study|Withdrawal by Subject|1
7026645|NCT01606176|11103910|FG001|Overall Study|Withdrawal by Subject|0
7026646|NCT01606189|11103916|FG000|Second Intenvention (14-20 Days)|Adverse Event|0
7026647|NCT01606189|11103917|FG001|Second Intenvention (14-20 Days)|Adverse Event|0
7026648|NCT01606189|11103918|FG002|Second Intenvention (14-20 Days)|Adverse Event|0
7026649|NCT01606189|11103919|FG003|Second Intenvention (14-20 Days)|Adverse Event|0
7026650|NCT01606189|11103920|FG004|Second Intenvention (14-20 Days)|Adverse Event|0
7026651|NCT01606189|11103921|FG005|Second Intenvention (14-20 Days)|Adverse Event|1
7026652|NCT01606189|11103916|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
7026653|NCT01606189|11103917|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
7026654|NCT01606189|11103918|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
7026655|NCT01606189|11103919|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
7026656|NCT01606189|11103920|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
7026657|NCT01606189|11103921|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1
7026658|NCT01606202|11103931|FG000|Overall Study|Adverse Event|5
7026659|NCT01606202|11103932|FG001|Overall Study|Adverse Event|0
7026660|NCT01606202|11103931|FG000|Overall Study|Withdrawal by Subject|2
7026661|NCT01606202|11103932|FG001|Overall Study|Withdrawal by Subject|1
7026662|NCT01606202|11103931|FG000|Overall Study|Personal problems|0
7026663|NCT01606202|11103932|FG001|Overall Study|Personal problems|1
7026664|NCT01606202|11103931|FG000|Overall Study|Problems with administration|0
7026665|NCT01606202|11103932|FG001|Overall Study|Problems with administration|1
7026666|NCT01606228|11103938|FG000|Overall Study|Lost to Follow-up|20
7026667|NCT01606228|11103938|FG000|Overall Study|Withdrawal by Subject|3
7026668|NCT01606228|11103938|FG000|Overall Study|Non-compliant|3
7026669|NCT01606228|11103938|FG000|Overall Study|Lack of Efficacy|2
7026670|NCT01606228|11103938|FG000|Overall Study|Adverse Event|1
7026671|NCT01606254|11103946|FG000|Overall Study|Withdrawal by Subject|1
7026672|NCT01606254|11103947|FG001|Overall Study|Withdrawal by Subject|3
7026673|NCT01606254|11103948|FG002|Overall Study|Withdrawal by Subject|0
7026674|NCT01606254|11103949|FG003|Overall Study|Withdrawal by Subject|2
7026675|NCT01606254|11103946|FG000|Overall Study|Adverse Event|1
7026676|NCT01606254|11103947|FG001|Overall Study|Adverse Event|1
7026677|NCT01606254|11103948|FG002|Overall Study|Adverse Event|0
7026678|NCT01606254|11103949|FG003|Overall Study|Adverse Event|1
7026679|NCT01606306|11103965|FG000|Overall Study|Lack of Efficacy|2
7026680|NCT01606306|11103966|FG001|Overall Study|Lack of Efficacy|1
7026681|NCT01606306|11103967|FG002|Overall Study|Lack of Efficacy|4
7026682|NCT01606306|11103968|FG003|Overall Study|Lack of Efficacy|4
7026683|NCT01606306|11103969|FG004|Overall Study|Lack of Efficacy|1
7026684|NCT01606306|11103970|FG005|Overall Study|Lack of Efficacy|2
7026685|NCT01606306|11103965|FG000|Overall Study|Adverse Event|1
7026686|NCT01606306|11103966|FG001|Overall Study|Adverse Event|0
7026687|NCT01606306|11103967|FG002|Overall Study|Adverse Event|1
7026688|NCT01606306|11103968|FG003|Overall Study|Adverse Event|1
7026689|NCT01606306|11103969|FG004|Overall Study|Adverse Event|2
7026690|NCT01606306|11103970|FG005|Overall Study|Adverse Event|0
7026691|NCT01606306|11103965|FG000|Overall Study|Lost to Follow-up|7
7026692|NCT01606306|11103966|FG001|Overall Study|Lost to Follow-up|4
7026693|NCT01606306|11103967|FG002|Overall Study|Lost to Follow-up|5
7026694|NCT01606306|11103968|FG003|Overall Study|Lost to Follow-up|4
7026695|NCT01606306|11103969|FG004|Overall Study|Lost to Follow-up|3
7026696|NCT01606306|11103970|FG005|Overall Study|Lost to Follow-up|5
7026697|NCT01606306|11103965|FG000|Overall Study|Withdrawal by Subject|4
7026698|NCT01606306|11103966|FG001|Overall Study|Withdrawal by Subject|3
7026699|NCT01606306|11103967|FG002|Overall Study|Withdrawal by Subject|4
7026700|NCT01606306|11103968|FG003|Overall Study|Withdrawal by Subject|4
7026701|NCT01606306|11103969|FG004|Overall Study|Withdrawal by Subject|5
7026702|NCT01606306|11103970|FG005|Overall Study|Withdrawal by Subject|4
7026703|NCT01606306|11103965|FG000|Overall Study|Physician Decision|1
7026704|NCT01606306|11103966|FG001|Overall Study|Physician Decision|2
7026705|NCT01606306|11103967|FG002|Overall Study|Physician Decision|0
7026706|NCT01606306|11103968|FG003|Overall Study|Physician Decision|0
7026707|NCT01606306|11103969|FG004|Overall Study|Physician Decision|0
7026708|NCT01606306|11103970|FG005|Overall Study|Physician Decision|0
7026709|NCT01606319|11103978|FG000|Overall Study|Lost to Follow-up|17
7026710|NCT01606319|11103979|FG001|Overall Study|Lost to Follow-up|14
7026711|NCT01606319|11103978|FG000|Overall Study|Withdrawal by Subject|9
7026712|NCT01606319|11103979|FG001|Overall Study|Withdrawal by Subject|12
7026713|NCT01606319|11103978|FG000|Overall Study|Physician Decision|1
7026714|NCT01606319|11103979|FG001|Overall Study|Physician Decision|2
7026715|NCT01606319|11103978|FG000|Overall Study|Lack of Efficacy|6
7026716|NCT01606319|11103979|FG001|Overall Study|Lack of Efficacy|8
7026717|NCT01606319|11103978|FG000|Overall Study|Adverse Event|1
7026718|NCT01606319|11103979|FG001|Overall Study|Adverse Event|4
7026719|NCT01606670|11103985|FG000|Overall Study|Adverse Event|6
7026720|NCT01606670|11103985|FG000|Overall Study|Lack of Efficacy|2
7026721|NCT01606670|11103985|FG000|Overall Study|Lost to Follow-up|3
7026722|NCT01606670|11103985|FG000|Overall Study|Withdrawal by Subject|3
7026723|NCT01606670|11103985|FG000|Overall Study|Other Reason|2
7026724|NCT01606748|11104004|FG000|Overall Study|Adverse Event|1
7026725|NCT01606748|11104005|FG001|Overall Study|Adverse Event|0
7026726|NCT01606748|11104004|FG000|Overall Study|Progressive Disease|1
7026727|NCT01606748|11104005|FG001|Overall Study|Progressive Disease|0
7026728|NCT01606748|11104004|FG000|Overall Study|Withdrawal by Subject|1
7026729|NCT01606748|11104005|FG001|Overall Study|Withdrawal by Subject|0
7026730|NCT01606761|11104026|FG000|Prior to Week 24|Lost to Follow-up|0
7026731|NCT01606761|11104027|FG001|Prior to Week 24|Lost to Follow-up|3
7026732|NCT01606761|11104028|FG002|Prior to Week 24|Lost to Follow-up|2
7026733|NCT01606761|11104029|FG003|Prior to Week 24|Lost to Follow-up|0
7026734|NCT01606761|11104030|FG004|Prior to Week 24|Lost to Follow-up|0
7026735|NCT01606761|11104026|FG000|Prior to Week 24|Withdrawal by Subject|12
7026736|NCT01606761|11104027|FG001|Prior to Week 24|Withdrawal by Subject|10
7026737|NCT01606761|11104028|FG002|Prior to Week 24|Withdrawal by Subject|9
7026738|NCT01606761|11104029|FG003|Prior to Week 24|Withdrawal by Subject|0
7026739|NCT01606761|11104030|FG004|Prior to Week 24|Withdrawal by Subject|0
7026740|NCT01606761|11104026|FG000|Prior to Week 24|Adverse Event|11
7026741|NCT01606761|11104027|FG001|Prior to Week 24|Adverse Event|18
7026742|NCT01606761|11104028|FG002|Prior to Week 24|Adverse Event|22
7026743|NCT01606761|11104029|FG003|Prior to Week 24|Adverse Event|0
7026744|NCT01606761|11104030|FG004|Prior to Week 24|Adverse Event|0
7026745|NCT01606761|11104026|FG000|Prior to Week 24|Lack of Efficacy|15
7026746|NCT01606761|11104027|FG001|Prior to Week 24|Lack of Efficacy|14
7026747|NCT01606761|11104028|FG002|Prior to Week 24|Lack of Efficacy|8
7026748|NCT01606761|11104029|FG003|Prior to Week 24|Lack of Efficacy|0
7026749|NCT01606761|11104030|FG004|Prior to Week 24|Lack of Efficacy|0
7026750|NCT01606761|11104026|FG000|Prior to Week 24|Physician Decision|0
7026751|NCT01606761|11104027|FG001|Prior to Week 24|Physician Decision|3
7026752|NCT01606761|11104028|FG002|Prior to Week 24|Physician Decision|1
7026753|NCT01606761|11104029|FG003|Prior to Week 24|Physician Decision|0
7026754|NCT01606761|11104030|FG004|Prior to Week 24|Physician Decision|0
7026755|NCT01606761|11104026|FG000|Prior to Week 24|Other|4
7026756|NCT01606761|11104027|FG001|Prior to Week 24|Other|7
7026757|NCT01606761|11104028|FG002|Prior to Week 24|Other|5
7026758|NCT01606761|11104029|FG003|Prior to Week 24|Other|0
7026759|NCT01606761|11104030|FG004|Prior to Week 24|Other|0
7026760|NCT01606761|11104026|FG000|Week 24 to Week 52|Lost to Follow-up|0
7026761|NCT01606761|11104027|FG001|Week 24 to Week 52|Lost to Follow-up|1
7026762|NCT01606761|11104028|FG002|Week 24 to Week 52|Lost to Follow-up|1
7026763|NCT01606761|11104029|FG003|Week 24 to Week 52|Lost to Follow-up|1
7026764|NCT01606761|11104030|FG004|Week 24 to Week 52|Lost to Follow-up|0
7026765|NCT01606761|11104026|FG000|Week 24 to Week 52|Withdrawal by Subject|0
7026766|NCT01606761|11104027|FG001|Week 24 to Week 52|Withdrawal by Subject|6
7026767|NCT01606761|11104028|FG002|Week 24 to Week 52|Withdrawal by Subject|3
7026768|NCT01606761|11104029|FG003|Week 24 to Week 52|Withdrawal by Subject|0
7026769|NCT01606761|11104030|FG004|Week 24 to Week 52|Withdrawal by Subject|0
7026770|NCT01606761|11104026|FG000|Week 24 to Week 52|Adverse Event|0
7026771|NCT01606761|11104027|FG001|Week 24 to Week 52|Adverse Event|11
7026772|NCT01606761|11104028|FG002|Week 24 to Week 52|Adverse Event|14
7026773|NCT01606761|11104029|FG003|Week 24 to Week 52|Adverse Event|3
7026774|NCT01606761|11104030|FG004|Week 24 to Week 52|Adverse Event|15
7026775|NCT01606761|11104026|FG000|Week 24 to Week 52|Death|0
7026776|NCT01606761|11104027|FG001|Week 24 to Week 52|Death|0
7026777|NCT01606761|11104028|FG002|Week 24 to Week 52|Death|2
7026778|NCT01606761|11104029|FG003|Week 24 to Week 52|Death|1
7026779|NCT01606761|11104030|FG004|Week 24 to Week 52|Death|0
7026780|NCT01606761|11104026|FG000|Week 24 to Week 52|Lack of Efficacy|0
7026781|NCT01606761|11104027|FG001|Week 24 to Week 52|Lack of Efficacy|13
7026782|NCT01606761|11104028|FG002|Week 24 to Week 52|Lack of Efficacy|7
7026783|NCT01606761|11104029|FG003|Week 24 to Week 52|Lack of Efficacy|10
7026784|NCT01606761|11104030|FG004|Week 24 to Week 52|Lack of Efficacy|3
7026785|NCT01606761|11104026|FG000|Week 24 to Week 52|Physician Decision|0
7026786|NCT01606761|11104027|FG001|Week 24 to Week 52|Physician Decision|1
7026787|NCT01606761|11104028|FG002|Week 24 to Week 52|Physician Decision|1
7026788|NCT01606761|11104029|FG003|Week 24 to Week 52|Physician Decision|0
7026789|NCT01606761|11104030|FG004|Week 24 to Week 52|Physician Decision|0
7026790|NCT01606761|11104026|FG000|Week 24 to Week 52|Other|0
7026791|NCT01606761|11104027|FG001|Week 24 to Week 52|Other|1
7026792|NCT01606761|11104028|FG002|Week 24 to Week 52|Other|5
7026793|NCT01606761|11104029|FG003|Week 24 to Week 52|Other|2
7026794|NCT01606761|11104030|FG004|Week 24 to Week 52|Other|2
7026795|NCT01606761|11104026|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
7026796|NCT01606761|11104027|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
7026797|NCT01606761|11104028|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2
7026798|NCT01606761|11104029|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
7026799|NCT01606761|11104030|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
7026800|NCT01606761|11104026|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4
7026801|NCT01606761|11104027|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
7026802|NCT01606761|11104028|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
7026803|NCT01606761|11104029|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1
7026804|NCT01606761|11104030|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3
7026805|NCT01606761|11104026|FG000|Safety Follow-up Period (Week 52-68)|Death|0
7026806|NCT01606761|11104027|FG001|Safety Follow-up Period (Week 52-68)|Death|0
7026807|NCT01606761|11104028|FG002|Safety Follow-up Period (Week 52-68)|Death|0
7026808|NCT01606761|11104029|FG003|Safety Follow-up Period (Week 52-68)|Death|0
7026809|NCT01606761|11104030|FG004|Safety Follow-up Period (Week 52-68)|Death|1
7026810|NCT01606761|11104026|FG000|Safety Follow-up Period (Week 52-68)|Other|0
7026811|NCT01606761|11104027|FG001|Safety Follow-up Period (Week 52-68)|Other|3
7026812|NCT01606761|11104028|FG002|Safety Follow-up Period (Week 52-68)|Other|9
7026813|NCT01606761|11104029|FG003|Safety Follow-up Period (Week 52-68)|Other|1
7026814|NCT01606761|11104030|FG004|Safety Follow-up Period (Week 52-68)|Other|3
7026815|NCT01606787|11104047|FG000|Overall Study|Withdrawal by Subject|4
7026816|NCT01606787|11104048|FG001|Overall Study|Withdrawal by Subject|5
7026817|NCT01606787|11104047|FG000|Overall Study|Surgery canceled|0
7026818|NCT01606787|11104048|FG001|Overall Study|Surgery canceled|2
6922207|NCT00810069|10950712|FG000|Lead-in Period I|Withdrawal by Subject|46
6922208|NCT00810069|10950713|FG001|Lead-in Period I|Withdrawal by Subject|0
6922209|NCT00810069|10950714|FG002|Lead-in Period I|Withdrawal by Subject|0
6922210|NCT00810069|10950712|FG000|Lead-in Period I|Protocol entry criterion not met|5
6922211|NCT00810069|10950713|FG001|Lead-in Period I|Protocol entry criterion not met|0
6922212|NCT00810069|10950714|FG002|Lead-in Period I|Protocol entry criterion not met|0
7026819|NCT01606800|11104056|FG000|Overall Study|Adverse Event|3
7026820|NCT01606800|11104057|FG001|Overall Study|Adverse Event|1
7026821|NCT01606800|11104056|FG000|Overall Study|Participant withdrew consent|0
7026822|NCT01606800|11104057|FG001|Overall Study|Participant withdrew consent|1
7026823|NCT01606800|11104056|FG000|Overall Study|Missing completion status|2
7026824|NCT01606800|11104057|FG001|Overall Study|Missing completion status|0
7026825|NCT01607073|11104072|FG000|Overall Study|Adverse Event|1
7026826|NCT01607346|11104115|FG000|Overall Study|Adverse Event|3
7026827|NCT01607398|11104121|FG000|Overall Study|Adverse Event|0
7026828|NCT01607398|11104122|FG001|Overall Study|Adverse Event|2
7026829|NCT01607398|11104121|FG000|Overall Study|Severe COPD|2
7026830|NCT01607398|11104122|FG001|Overall Study|Severe COPD|0
7026831|NCT01607476|11104178|FG000|Overall Study|Withdrawal by Subject|1
7026832|NCT01607476|11104179|FG001|Overall Study|Withdrawal by Subject|0
7026833|NCT01607476|11104180|FG002|Overall Study|Withdrawal by Subject|1
7026834|NCT01607476|11104178|FG000|Overall Study|Lost to Follow-up|0
7026835|NCT01607476|11104179|FG001|Overall Study|Lost to Follow-up|0
7026836|NCT01607476|11104180|FG002|Overall Study|Lost to Follow-up|2
7026837|NCT01607554|11104188|FG000|Overall Study|Disease progression|2
7026838|NCT01607593|11104192|FG000|Overall Study|Adverse Event|15
7026839|NCT01607593|11104192|FG000|Overall Study|Lack of Efficacy|16
7026840|NCT01607593|11104192|FG000|Overall Study|Lost to Follow-up|25
7026841|NCT01607593|11104192|FG000|Overall Study|Continuation|33
7026842|NCT01607593|11104192|FG000|Overall Study|Other|4
7026843|NCT01607892|11104234|FG000|Overall Study|Need of treatment not allowed per protocol|0
7026844|NCT01607892|11104235|FG001|Overall Study|Need of treatment not allowed per protocol|0
7026845|NCT01607892|11104236|FG002|Overall Study|Need of treatment not allowed per protocol|0
7026846|NCT01607892|11104237|FG003|Overall Study|Need of treatment not allowed per protocol|1
7026847|NCT01607892|11104238|FG004|Overall Study|Need of treatment not allowed per protocol|0
7026848|NCT01607892|11104234|FG000|Overall Study|Death|4
7026849|NCT01607892|11104235|FG001|Overall Study|Death|2
7026850|NCT01607892|11104236|FG002|Overall Study|Death|8
6922213|NCT00810069|10950712|FG000|Lead-in Period I|Randomization criteria not met|158
7026851|NCT01607892|11104237|FG003|Overall Study|Death|10
7026852|NCT01607892|11104238|FG004|Overall Study|Death|3
7026853|NCT01607892|11104234|FG000|Overall Study|Investigator discretion|2
7026854|NCT01607892|11104235|FG001|Overall Study|Investigator discretion|4
7026855|NCT01607892|11104236|FG002|Overall Study|Investigator discretion|4
7026856|NCT01607892|11104237|FG003|Overall Study|Investigator discretion|8
7026857|NCT01607892|11104238|FG004|Overall Study|Investigator discretion|0
7026858|NCT01607892|11104234|FG000|Overall Study|Other treatments became available|1
7026859|NCT01607892|11104235|FG001|Overall Study|Other treatments became available|1
6827103|NCT00122382|10829624|FG001|Double-Blind Study|Randomized but not treated|2
7026860|NCT01607892|11104236|FG002|Overall Study|Other treatments became available|0
7026861|NCT01607892|11104237|FG003|Overall Study|Other treatments became available|0
7026862|NCT01607892|11104238|FG004|Overall Study|Other treatments became available|2
7026863|NCT01607892|11104234|FG000|Overall Study|Intercurrent illness|1
7026864|NCT01607892|11104235|FG001|Overall Study|Intercurrent illness|0
7026865|NCT01607892|11104236|FG002|Overall Study|Intercurrent illness|0
7026866|NCT01607892|11104237|FG003|Overall Study|Intercurrent illness|3
7026867|NCT01607892|11104238|FG004|Overall Study|Intercurrent illness|0
7026868|NCT01607892|11104234|FG000|Overall Study|Non-Compliance with study procedures|0
7026869|NCT01607892|11104235|FG001|Overall Study|Non-Compliance with study procedures|0
7026870|NCT01607892|11104236|FG002|Overall Study|Non-Compliance with study procedures|1
7026871|NCT01607892|11104237|FG003|Overall Study|Non-Compliance with study procedures|0
7026872|NCT01607892|11104238|FG004|Overall Study|Non-Compliance with study procedures|0
7026873|NCT01607892|11104234|FG000|Overall Study|Consent withdrawn by participant|9
7026874|NCT01607892|11104235|FG001|Overall Study|Consent withdrawn by participant|4
7026875|NCT01607892|11104236|FG002|Overall Study|Consent withdrawn by participant|24
7026876|NCT01607892|11104237|FG003|Overall Study|Consent withdrawn by participant|14
7026877|NCT01607892|11104238|FG004|Overall Study|Consent withdrawn by participant|4
7026878|NCT01607892|11104234|FG000|Overall Study|Disease progression|38
7026879|NCT01607892|11104235|FG001|Overall Study|Disease progression|13
7026880|NCT01607892|11104236|FG002|Overall Study|Disease progression|37
7026881|NCT01607892|11104237|FG003|Overall Study|Disease progression|57
7026882|NCT01607892|11104238|FG004|Overall Study|Disease progression|9
7026883|NCT01607892|11104234|FG000|Overall Study|Incidence or severity of Adverse events|3
7026884|NCT01607892|11104235|FG001|Overall Study|Incidence or severity of Adverse events|3
7026885|NCT01607892|11104236|FG002|Overall Study|Incidence or severity of Adverse events|7
7026886|NCT01607892|11104237|FG003|Overall Study|Incidence or severity of Adverse events|2
7026887|NCT01607892|11104238|FG004|Overall Study|Incidence or severity of Adverse events|6
7026888|NCT01607905|11104271|FG000|Overall Study|Withdrawal by participant|7
7026889|NCT01607905|11104272|FG001|Overall Study|Withdrawal by participant|2
7026890|NCT01607905|11104273|FG002|Overall Study|Withdrawal by participant|4
7026891|NCT01607905|11104274|FG003|Overall Study|Withdrawal by participant|6
7026892|NCT01607905|11104275|FG004|Overall Study|Withdrawal by participant|0
7026893|NCT01607905|11104276|FG005|Overall Study|Withdrawal by participant|4
7026894|NCT01607905|11104277|FG006|Overall Study|Withdrawal by participant|12
7026895|NCT01607905|11104271|FG000|Overall Study|Incidence or severity of AEs|5
7026896|NCT01607905|11104272|FG001|Overall Study|Incidence or severity of AEs|1
7026897|NCT01607905|11104273|FG002|Overall Study|Incidence or severity of AEs|1
7026898|NCT01607905|11104274|FG003|Overall Study|Incidence or severity of AEs|3
7026899|NCT01607905|11104275|FG004|Overall Study|Incidence or severity of AEs|0
7026900|NCT01607905|11104276|FG005|Overall Study|Incidence or severity of AEs|2
7026901|NCT01607905|11104277|FG006|Overall Study|Incidence or severity of AEs|8
7026902|NCT01607905|11104271|FG000|Overall Study|Disease progression|44
7026903|NCT01607905|11104272|FG001|Overall Study|Disease progression|16
7026904|NCT01607905|11104273|FG002|Overall Study|Disease progression|15
7026905|NCT01607905|11104274|FG003|Overall Study|Disease progression|11
7026906|NCT01607905|11104275|FG004|Overall Study|Disease progression|6
7026907|NCT01607905|11104276|FG005|Overall Study|Disease progression|7
7026908|NCT01607905|11104277|FG006|Overall Study|Disease progression|21
7026909|NCT01607905|11104271|FG000|Overall Study|Non-compliance with study procedures|0
7026910|NCT01607905|11104272|FG001|Overall Study|Non-compliance with study procedures|0
7026911|NCT01607905|11104273|FG002|Overall Study|Non-compliance with study procedures|0
7026912|NCT01607905|11104274|FG003|Overall Study|Non-compliance with study procedures|0
7026913|NCT01607905|11104275|FG004|Overall Study|Non-compliance with study procedures|0
7026914|NCT01607905|11104276|FG005|Overall Study|Non-compliance with study procedures|0
7026915|NCT01607905|11104277|FG006|Overall Study|Non-compliance with study procedures|1
7026916|NCT01607905|11104271|FG000|Overall Study|Death|1
7026917|NCT01607905|11104272|FG001|Overall Study|Death|1
7026918|NCT01607905|11104273|FG002|Overall Study|Death|1
7026919|NCT01607905|11104274|FG003|Overall Study|Death|1
7026920|NCT01607905|11104275|FG004|Overall Study|Death|0
7026921|NCT01607905|11104276|FG005|Overall Study|Death|0
7026922|NCT01607905|11104277|FG006|Overall Study|Death|3
7026923|NCT01607905|11104271|FG000|Overall Study|Other treatments become available|1
7026924|NCT01607905|11104272|FG001|Overall Study|Other treatments become available|0
7026925|NCT01607905|11104273|FG002|Overall Study|Other treatments become available|0
7026926|NCT01607905|11104274|FG003|Overall Study|Other treatments become available|0
7026927|NCT01607905|11104275|FG004|Overall Study|Other treatments become available|0
7026928|NCT01607905|11104276|FG005|Overall Study|Other treatments become available|0
7026929|NCT01607905|11104277|FG006|Overall Study|Other treatments become available|1
7026930|NCT01607905|11104271|FG000|Overall Study|Investigator discretion|0
7026931|NCT01607905|11104272|FG001|Overall Study|Investigator discretion|0
7026932|NCT01607905|11104273|FG002|Overall Study|Investigator discretion|0
7026933|NCT01607905|11104274|FG003|Overall Study|Investigator discretion|0
7026934|NCT01607905|11104275|FG004|Overall Study|Investigator discretion|0
7026935|NCT01607905|11104276|FG005|Overall Study|Investigator discretion|1
7026936|NCT01607905|11104277|FG006|Overall Study|Investigator discretion|0
7026937|NCT01607905|11104271|FG000|Overall Study|Other|1
7026938|NCT01607905|11104272|FG001|Overall Study|Other|0
7026939|NCT01607905|11104273|FG002|Overall Study|Other|0
7026940|NCT01607905|11104274|FG003|Overall Study|Other|0
7026941|NCT01607905|11104275|FG004|Overall Study|Other|0
7026942|NCT01607905|11104276|FG005|Overall Study|Other|0
7026943|NCT01607905|11104277|FG006|Overall Study|Other|1
7026944|NCT01607905|11104271|FG000|Overall Study|Randomized but not treated|1
7026945|NCT01607905|11104272|FG001|Overall Study|Randomized but not treated|0
7026946|NCT01607905|11104273|FG002|Overall Study|Randomized but not treated|0
7026947|NCT01607905|11104274|FG003|Overall Study|Randomized but not treated|0
7026948|NCT01607905|11104275|FG004|Overall Study|Randomized but not treated|1
7026949|NCT01607905|11104276|FG005|Overall Study|Randomized but not treated|1
7026950|NCT01607905|11104277|FG006|Overall Study|Randomized but not treated|0
7026951|NCT01607957|11104337|FG000|Overall Study|Not treated|1
7026952|NCT01607957|11104338|FG001|Overall Study|Not treated|1
7026953|NCT01607957|11104337|FG000|Overall Study|Death|367
7026954|NCT01607957|11104338|FG001|Overall Study|Death|211
7026955|NCT01607957|11104337|FG000|Overall Study|Lost to Follow-up|3
7026956|NCT01607957|11104338|FG001|Overall Study|Lost to Follow-up|3
7026957|NCT01607957|11104337|FG000|Overall Study|Participant refusal|1
7026958|NCT01607957|11104338|FG001|Overall Study|Participant refusal|0
7026959|NCT01608087|11104357|FG000|Overall Study|Lost to Follow-up|0
7026960|NCT01608087|11104358|FG001|Overall Study|Lost to Follow-up|1
7026961|NCT01608087|11104359|FG002|Overall Study|Lost to Follow-up|0
7026962|NCT01608087|11104357|FG000|Overall Study|Other Reason|0
7026963|NCT01608087|11104358|FG001|Overall Study|Other Reason|1
7026964|NCT01608087|11104359|FG002|Overall Study|Other Reason|0
7026965|NCT01608308|11104405|FG000|Overall Study|pretreatment medical and billing reasons|0
7026966|NCT01608308|11104406|FG001|Overall Study|pretreatment medical and billing reasons|2
7026967|NCT01608321|11104414|FG000|Overall Study|Withdrawal by Subject|1
7026968|NCT01608321|11104415|FG001|Overall Study|Withdrawal by Subject|0
7026969|NCT01608724|11104438|FG000|Overall Study|Withdrawal by Subject|131
7026970|NCT01608724|11104438|FG000|Overall Study|Lost to Follow-up|41
7026971|NCT01608724|11104438|FG000|Overall Study|Study-specific discontinuation criteria|32
7026972|NCT01608724|11104438|FG000|Overall Study|Adverse Event|29
7026973|NCT01608724|11104438|FG000|Overall Study|Protocol Violation|6
7026974|NCT01608724|11104438|FG000|Overall Study|bood sugar too high, etc.|3
7026975|NCT01608724|11104438|FG000|Overall Study|Safety reasons|1
7026976|NCT01609010|11104469|FG000|Overall Study|Stable disease (SD)|22
7026977|NCT01609010|11104470|FG001|Overall Study|Stable disease (SD)|16
7026978|NCT01609010|11104469|FG000|Overall Study|Progressive disease (PD)|8
7026979|NCT01609010|11104470|FG001|Overall Study|Progressive disease (PD)|10
7026980|NCT01609010|11104469|FG000|Overall Study|Adverse Event|3
7026981|NCT01609010|11104470|FG001|Overall Study|Adverse Event|6
7026982|NCT01609010|11104469|FG000|Overall Study|Withdrawal by Subject|2
7026983|NCT01609010|11104470|FG001|Overall Study|Withdrawal by Subject|2
7026984|NCT01609010|11104469|FG000|Overall Study|Other|2
7026985|NCT01609010|11104470|FG001|Overall Study|Other|0
7026986|NCT01609010|11104469|FG000|Overall Study|Other malignancy|1
7026987|NCT01609010|11104470|FG001|Overall Study|Other malignancy|0
7026988|NCT01609010|11104469|FG000|Overall Study|Pathology review|2
7026989|NCT01609010|11104470|FG001|Overall Study|Pathology review|1
7026990|NCT01609010|11104469|FG000|Overall Study|Protocol Violation|1
7026991|NCT01609010|11104470|FG001|Overall Study|Protocol Violation|1
7026992|NCT01609010|11104469|FG000|Overall Study|New cancer|1
7026993|NCT01609010|11104470|FG001|Overall Study|New cancer|0
7026994|NCT01609010|11104469|FG000|Overall Study|Lost to Follow-up|1
7026995|NCT01609010|11104470|FG001|Overall Study|Lost to Follow-up|1
7026996|NCT01609023|11104476|FG000|Overall Study|Lack of Efficacy|3
7026997|NCT01609023|11104476|FG000|Overall Study|Withdrawal by Subject|4
7026998|NCT01609023|11104476|FG000|Overall Study|Lost to Follow-up|8
7026999|NCT01609023|11104476|FG000|Overall Study|Toxicity|3
7027000|NCT01609023|11104476|FG000|Overall Study|Disease progression|10
7027001|NCT01609023|11104476|FG000|Overall Study|Physician Decision|2
7027002|NCT01609023|11104476|FG000|Overall Study|Death|2
7027003|NCT01609023|11104476|FG000|Overall Study|Personal reasons|1
7027004|NCT01609062|11104482|FG000|Extension Phase|Terminated by Sponsor|14
7027005|NCT01609062|11104483|FG001|Extension Phase|Terminated by Sponsor|9
7027006|NCT01609062|11104482|FG000|Extension Phase|Discontinued drug and then was pregnant|1
7027007|NCT01609062|11104483|FG001|Extension Phase|Discontinued drug and then was pregnant|0
7027008|NCT01609062|11104482|FG000|Extension Phase|Anticipated surgery & transition to EAP|0
7027009|NCT01609062|11104483|FG001|Extension Phase|Anticipated surgery & transition to EAP|1
7044311|NCT01752933|11130019|FG001|Treatment|Disease Progression|29
7044312|NCT01752933|11130018|FG000|Treatment|Withdrawal by Subject|0
7044313|NCT01752933|11130019|FG001|Treatment|Withdrawal by Subject|5
7044314|NCT01752933|11130018|FG000|Treatment|Adverse Event|1
7044315|NCT01752933|11130019|FG001|Treatment|Adverse Event|4
7044316|NCT01752933|11130018|FG000|Treatment|Physician Decision|0
7044317|NCT01752933|11130019|FG001|Treatment|Physician Decision|3
7044318|NCT01752933|11130018|FG000|Treatment|Death|0
7044319|NCT01752933|11130019|FG001|Treatment|Death|2
7044320|NCT01752933|11130018|FG000|Treatment|Hepatocellular carcinoma not confirmed|0
7044321|NCT01752933|11130019|FG001|Treatment|Hepatocellular carcinoma not confirmed|1
7044322|NCT01752933|11130018|FG000|Treatment|Patient noncompliant|0
7044323|NCT01752933|11130019|FG001|Treatment|Patient noncompliant|1
7044324|NCT01752933|11130018|FG000|Treatment|Patient unable to travel to appointments|0
7044325|NCT01752933|11130019|FG001|Treatment|Patient unable to travel to appointments|1
7044326|NCT01752933|11130018|FG000|Overall Study and Follow-up|Death|4
7027010|NCT01609218|11104490|FG000|Period 1|Adverse Event|3
7027011|NCT01609218|11104491|FG001|Period 1|Adverse Event|5
7027012|NCT01609218|11104490|FG000|Period 1|Sponsor Decision|0
7027013|NCT01609218|11104491|FG001|Period 1|Sponsor Decision|1
7027014|NCT01609218|11104490|FG000|Period 2|Adverse Event|1
7027015|NCT01609218|11104491|FG001|Period 2|Adverse Event|0
7027016|NCT01609257|11104499|FG000|Overall Study|Lost to Follow-up|2
7027017|NCT01609257|11104500|FG001|Overall Study|Lost to Follow-up|1
7027018|NCT01609257|11104499|FG000|Overall Study|Voluntary Withdrawal by Subject|0
7027019|NCT01609257|11104500|FG001|Overall Study|Voluntary Withdrawal by Subject|1
7027020|NCT01609257|11104499|FG000|Overall Study|Non-compliance/Protocol deviation|4
7027021|NCT01609257|11104500|FG001|Overall Study|Non-compliance/Protocol deviation|6
7027022|NCT01609296|11104509|FG000|Overall Study|Death|253
7027023|NCT01609296|11104509|FG000|Overall Study|Withdrawal by Subject|151
7027024|NCT01609296|11104509|FG000|Overall Study|Lost to Follow-up|21
7027025|NCT01609296|11104509|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35
7027026|NCT01609296|11104509|FG000|Overall Study|missed visit but known to be alive|28
7027027|NCT01609478|11104529|FG000|Overall Study|Adverse Event|3
7027028|NCT01609478|11104530|FG001|Overall Study|Adverse Event|1
7027029|NCT01609478|11104531|FG002|Overall Study|Adverse Event|5
7027030|NCT01609478|11104529|FG000|Overall Study|Protocol Deviation|0
7027031|NCT01609478|11104530|FG001|Overall Study|Protocol Deviation|1
7027032|NCT01609478|11104531|FG002|Overall Study|Protocol Deviation|1
7027033|NCT01609478|11104529|FG000|Overall Study|Non-Compliance with study treatment|1
7027034|NCT01609478|11104530|FG001|Overall Study|Non-Compliance with study treatment|0
7027035|NCT01609478|11104531|FG002|Overall Study|Non-Compliance with study treatment|0
7027036|NCT01609478|11104529|FG000|Overall Study|Physician Decision|1
7027037|NCT01609478|11104530|FG001|Overall Study|Physician Decision|0
7027038|NCT01609478|11104531|FG002|Overall Study|Physician Decision|1
7027039|NCT01609478|11104529|FG000|Overall Study|Withdrawal by Subject|2
7027040|NCT01609478|11104530|FG001|Overall Study|Withdrawal by Subject|0
7027041|NCT01609478|11104531|FG002|Overall Study|Withdrawal by Subject|2
7027042|NCT01609543|11104539|FG000|Overall Study|Disease Progression|28
7027043|NCT01609543|11104539|FG000|Overall Study|Adverse Event|5
7027044|NCT01609543|11104539|FG000|Overall Study|Withdrawal by Subject|1
7027045|NCT01609543|11104539|FG000|Overall Study|Protocol Violation|1
7027046|NCT01609543|11104539|FG000|Overall Study|Death|7
7027047|NCT01609556|11104560|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7027048|NCT01609556|11104561|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7027049|NCT01609556|11104562|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7027050|NCT01609556|11104563|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7027051|NCT01609556|11104564|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
7027052|NCT01609556|11104565|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7027053|NCT01609556|11104566|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7027054|NCT01609556|11104567|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
7027055|NCT01609556|11104568|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
7027056|NCT01609556|11104569|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7027057|NCT01609556|11104570|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
7027058|NCT01609556|11104571|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
7027059|NCT01609556|11104572|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7027060|NCT01609556|11104573|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7027061|NCT01609556|11104574|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7027062|NCT01609556|11104575|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7027063|NCT01609556|11104560|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
7027064|NCT01609556|11104561|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1
7027065|NCT01609556|11104562|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1
7027066|NCT01609556|11104563|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1
7027067|NCT01609556|11104564|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8
7027068|NCT01609556|11104565|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13
7027069|NCT01609556|11104566|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5
7027070|NCT01609556|11104567|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4
7027071|NCT01609556|11104568|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3
7027072|NCT01609556|11104569|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3
7027073|NCT01609556|11104570|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6
7027074|NCT01609556|11104571|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3
7027075|NCT01609556|11104572|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
7027076|NCT01609556|11104573|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
7027077|NCT01609556|11104574|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
7027078|NCT01609556|11104575|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
7027079|NCT01609556|11104560|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7027080|NCT01609556|11104561|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7027081|NCT01609556|11104562|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7027082|NCT01609556|11104563|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7027083|NCT01609556|11104564|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7027084|NCT01609556|11104565|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2
7027085|NCT01609556|11104566|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2
7027086|NCT01609556|11104567|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7027087|NCT01609556|11104568|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7027088|NCT01609556|11104569|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1
7027089|NCT01609556|11104570|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1
7027090|NCT01609556|11104571|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2
7027091|NCT01609556|11104572|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7027092|NCT01609556|11104573|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7027093|NCT01609556|11104574|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7027094|NCT01609556|11104575|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7027095|NCT01609556|11104560|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7027096|NCT01609556|11104561|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7027097|NCT01609556|11104562|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7027098|NCT01609556|11104563|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7027099|NCT01609556|11104564|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7027100|NCT01609556|11104565|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1
7027101|NCT01609556|11104566|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7027102|NCT01609556|11104567|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7027103|NCT01609556|11104568|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7027104|NCT01609556|11104569|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7027105|NCT01609556|11104570|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7027106|NCT01609556|11104571|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1
7027107|NCT01609556|11104572|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7027108|NCT01609556|11104573|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7027109|NCT01609556|11104574|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7027110|NCT01609556|11104575|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7027111|NCT01609556|11104560|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7027112|NCT01609556|11104561|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7027113|NCT01609556|11104562|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7027114|NCT01609556|11104563|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7027115|NCT01609556|11104564|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7027116|NCT01609556|11104565|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1
7027117|NCT01609556|11104566|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7027118|NCT01609556|11104567|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7027119|NCT01609556|11104568|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7027120|NCT01609556|11104569|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7027121|NCT01609556|11104570|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7027122|NCT01609556|11104571|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7027123|NCT01609556|11104572|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7027124|NCT01609556|11104573|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7027125|NCT01609556|11104574|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7027126|NCT01609556|11104575|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7027127|NCT01609556|11104560|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7027128|NCT01609556|11104561|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7027129|NCT01609556|11104562|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7027130|NCT01609556|11104563|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7027131|NCT01609556|11104564|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7027132|NCT01609556|11104565|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7027133|NCT01609556|11104566|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7027134|NCT01609556|11104567|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7027135|NCT01609556|11104568|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1
7027136|NCT01609556|11104569|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7027137|NCT01609556|11104570|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7027138|NCT01609556|11104571|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7027139|NCT01609556|11104572|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7027140|NCT01609556|11104573|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7027141|NCT01609556|11104574|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7027142|NCT01609556|11104575|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7027143|NCT01609556|11104560|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2
7027144|NCT01609556|11104561|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0
7027145|NCT01609556|11104562|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0
7027146|NCT01609556|11104563|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0
7027147|NCT01609556|11104564|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0
7027148|NCT01609556|11104565|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1
7027149|NCT01609556|11104566|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0
7027150|NCT01609556|11104567|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0
7027151|NCT01609556|11104568|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0
7027152|NCT01609556|11104569|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0
7027153|NCT01609556|11104570|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1
7027154|NCT01609556|11104571|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0
7027155|NCT01609556|11104572|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0
7027156|NCT01609556|11104573|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0
7027157|NCT01609556|11104574|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0
7027158|NCT01609556|11104575|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0
7027159|NCT01609556|11104560|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7027160|NCT01609556|11104561|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7027161|NCT01609556|11104562|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7027162|NCT01609556|11104563|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7027163|NCT01609556|11104564|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7027164|NCT01609556|11104565|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7027165|NCT01609556|11104566|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7027166|NCT01609556|11104567|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7027167|NCT01609556|11104568|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7027168|NCT01609556|11104569|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7027169|NCT01609556|11104570|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7027170|NCT01609556|11104571|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7027171|NCT01609556|11104572|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4
7027172|NCT01609556|11104573|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2
7027173|NCT01609556|11104574|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2
7027174|NCT01609556|11104575|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2
7027175|NCT01609556|11104560|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7027176|NCT01609556|11104561|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7027177|NCT01609556|11104562|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7027178|NCT01609556|11104563|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7027179|NCT01609556|11104564|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7027180|NCT01609556|11104565|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7027181|NCT01609556|11104566|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7027182|NCT01609556|11104567|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7027183|NCT01609556|11104568|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7027184|NCT01609556|11104569|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7027185|NCT01609556|11104570|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7027186|NCT01609556|11104571|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7027187|NCT01609556|11104572|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32
7027188|NCT01609556|11104573|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13
7027189|NCT01609556|11104574|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20
7027190|NCT01609556|11104575|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27
7027191|NCT01609556|11104560|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7027192|NCT01609556|11104561|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7027193|NCT01609556|11104562|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7027194|NCT01609556|11104563|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7027195|NCT01609556|11104564|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7027196|NCT01609556|11104565|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7027197|NCT01609556|11104566|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7027198|NCT01609556|11104567|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7027199|NCT01609556|11104568|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7027200|NCT01609556|11104569|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7027201|NCT01609556|11104570|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7027202|NCT01609556|11104571|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7027203|NCT01609556|11104572|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3
7027204|NCT01609556|11104573|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3
7027205|NCT01609556|11104574|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3
7027206|NCT01609556|11104575|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2
7027207|NCT01609556|11104560|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7027208|NCT01609556|11104561|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7027209|NCT01609556|11104562|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7027210|NCT01609556|11104563|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7027211|NCT01609556|11104564|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7027212|NCT01609556|11104565|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7027213|NCT01609556|11104566|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7027214|NCT01609556|11104567|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7027215|NCT01609556|11104568|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7027216|NCT01609556|11104569|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7027217|NCT01609556|11104570|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7027218|NCT01609556|11104571|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7027219|NCT01609556|11104572|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1
7027220|NCT01609556|11104573|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7027221|NCT01609556|11104574|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7027222|NCT01609556|11104575|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7027223|NCT01609556|11104560|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7027224|NCT01609556|11104561|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7027225|NCT01609556|11104562|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7027226|NCT01609556|11104563|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7027227|NCT01609556|11104564|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7027228|NCT01609556|11104565|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7027229|NCT01609556|11104566|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7027230|NCT01609556|11104567|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7027231|NCT01609556|11104568|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7027232|NCT01609556|11104569|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7027233|NCT01609556|11104570|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7027234|NCT01609556|11104571|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7027235|NCT01609556|11104572|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1
7027236|NCT01609556|11104573|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4
7027237|NCT01609556|11104574|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2
7027238|NCT01609556|11104575|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5
7027239|NCT01609556|11104560|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7027240|NCT01609556|11104561|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7027241|NCT01609556|11104562|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7027242|NCT01609556|11104563|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7027243|NCT01609556|11104564|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7027244|NCT01609556|11104565|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7027245|NCT01609556|11104566|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7027246|NCT01609556|11104567|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7027247|NCT01609556|11104568|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7027248|NCT01609556|11104569|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7027249|NCT01609556|11104570|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7027250|NCT01609556|11104571|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7027251|NCT01609556|11104572|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7027252|NCT01609556|11104573|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7027253|NCT01609556|11104574|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7027254|NCT01609556|11104575|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1
7027255|NCT01609556|11104560|FG000|Dose Expansion: Maximum 124 Weeks|Death|0
7027256|NCT01609556|11104561|FG001|Dose Expansion: Maximum 124 Weeks|Death|0
7027257|NCT01609556|11104562|FG002|Dose Expansion: Maximum 124 Weeks|Death|0
7027258|NCT01609556|11104563|FG003|Dose Expansion: Maximum 124 Weeks|Death|0
7027259|NCT01609556|11104564|FG004|Dose Expansion: Maximum 124 Weeks|Death|0
7027260|NCT01609556|11104565|FG005|Dose Expansion: Maximum 124 Weeks|Death|0
7027261|NCT01609556|11104566|FG006|Dose Expansion: Maximum 124 Weeks|Death|0
7027262|NCT01609556|11104567|FG007|Dose Expansion: Maximum 124 Weeks|Death|0
7027263|NCT01609556|11104568|FG008|Dose Expansion: Maximum 124 Weeks|Death|0
7027264|NCT01609556|11104569|FG009|Dose Expansion: Maximum 124 Weeks|Death|0
7027265|NCT01609556|11104570|FG010|Dose Expansion: Maximum 124 Weeks|Death|0
7027266|NCT01609556|11104571|FG011|Dose Expansion: Maximum 124 Weeks|Death|0
7027267|NCT01609556|11104572|FG012|Dose Expansion: Maximum 124 Weeks|Death|4
7027268|NCT01609556|11104573|FG013|Dose Expansion: Maximum 124 Weeks|Death|2
7027269|NCT01609556|11104574|FG014|Dose Expansion: Maximum 124 Weeks|Death|0
7027270|NCT01609556|11104575|FG015|Dose Expansion: Maximum 124 Weeks|Death|3
7027271|NCT01609556|11104560|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7027272|NCT01609556|11104561|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7027273|NCT01609556|11104562|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7027274|NCT01609556|11104563|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7027275|NCT01609556|11104564|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7027276|NCT01609556|11104565|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7027277|NCT01609556|11104566|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7027278|NCT01609556|11104567|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7027279|NCT01609556|11104568|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7027280|NCT01609556|11104569|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7027281|NCT01609556|11104570|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7027282|NCT01609556|11104571|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7027283|NCT01609556|11104572|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1
7027284|NCT01609556|11104573|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7027285|NCT01609556|11104574|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7027286|NCT01609556|11104575|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7027287|NCT01609582|11104618|FG000|Overall Study|Adverse Event|20
7027288|NCT01609582|11104619|FG001|Overall Study|Adverse Event|18
7027289|NCT01609582|11104618|FG000|Overall Study|Lost to Follow-up|10
7027290|NCT01609582|11104619|FG001|Overall Study|Lost to Follow-up|10
7027291|NCT01609582|11104618|FG000|Overall Study|Withdrawal by Subject|21
7027292|NCT01609582|11104619|FG001|Overall Study|Withdrawal by Subject|15
7027293|NCT01609582|11104618|FG000|Overall Study|Study Terminated by Sponsor|1543
7027294|NCT01609582|11104619|FG001|Overall Study|Study Terminated by Sponsor|1548
7027295|NCT01609582|11104618|FG000|Overall Study|Other|9
7027296|NCT01609582|11104619|FG001|Overall Study|Other|10
7027297|NCT01609582|11104618|FG000|Overall Study|Randomized, but not treated|0
7027298|NCT01609582|11104619|FG001|Overall Study|Randomized, but not treated|3
7027299|NCT01609933|11104625|FG000|Overall Study|Adverse Event|1
7027300|NCT01609933|11104625|FG000|Overall Study|Withdrawal by Subject|3
7027301|NCT01610037|11104643|FG000|All Patients|Adverse Event|27
7027302|NCT01610037|11104644|FG001|All Patients|Adverse Event|22
7027303|NCT01610037|11104645|FG002|All Patients|Adverse Event|26
7027304|NCT01610037|11104643|FG000|All Patients|Withdrawal by Subject|12
7027305|NCT01610037|11104644|FG001|All Patients|Withdrawal by Subject|10
7027306|NCT01610037|11104645|FG002|All Patients|Withdrawal by Subject|20
7027307|NCT01610037|11104643|FG000|All Patients|Unsatisfactory therapeutic effect|9
7027308|NCT01610037|11104644|FG001|All Patients|Unsatisfactory therapeutic effect|8
7027309|NCT01610037|11104645|FG002|All Patients|Unsatisfactory therapeutic effect|27
7027310|NCT01610037|11104643|FG000|All Patients|Death|4
7027311|NCT01610037|11104644|FG001|All Patients|Death|2
7027312|NCT01610037|11104645|FG002|All Patients|Death|1
7027313|NCT01610037|11104643|FG000|All Patients|Protocol deviation|4
7027314|NCT01610037|11104644|FG001|All Patients|Protocol deviation|3
7027315|NCT01610037|11104645|FG002|All Patients|Protocol deviation|3
7027316|NCT01610037|11104643|FG000|All Patients|Abnormal laboratory value|1
7027317|NCT01610037|11104644|FG001|All Patients|Abnormal laboratory value|1
7027318|NCT01610037|11104645|FG002|All Patients|Abnormal laboratory value|0
7027319|NCT01610037|11104643|FG000|All Patients|Administrative problems|1
7027320|NCT01610037|11104644|FG001|All Patients|Administrative problems|4
7027321|NCT01610037|11104645|FG002|All Patients|Administrative problems|4
7027322|NCT01610037|11104643|FG000|All Patients|Lost to Follow-up|1
7027323|NCT01610037|11104644|FG001|All Patients|Lost to Follow-up|0
7027324|NCT01610037|11104645|FG002|All Patients|Lost to Follow-up|0
7027325|NCT01610037|11104643|FG000|All Patients|Abnormal test procedure result(s)|0
7027326|NCT01610037|11104644|FG001|All Patients|Abnormal test procedure result(s)|1
7027327|NCT01610037|11104645|FG002|All Patients|Abnormal test procedure result(s)|3
7027328|NCT01610037|11104643|FG000|Treatment and Follow up Period|Subject withdrew consent|13
7027329|NCT01610037|11104644|FG001|Treatment and Follow up Period|Subject withdrew consent|14
7027330|NCT01610037|11104645|FG002|Treatment and Follow up Period|Subject withdrew consent|16
7027331|NCT01610037|11104643|FG000|Treatment and Follow up Period|Death|10
7027332|NCT01610037|11104644|FG001|Treatment and Follow up Period|Death|5
7027333|NCT01610037|11104645|FG002|Treatment and Follow up Period|Death|4
7027334|NCT01610037|11104643|FG000|Treatment and Follow up Period|Administrative problems|1
7027335|NCT01610037|11104644|FG001|Treatment and Follow up Period|Administrative problems|3
7027336|NCT01610037|11104645|FG002|Treatment and Follow up Period|Administrative problems|2
7027337|NCT01610037|11104643|FG000|Treatment and Follow up Period|Lost to Follow-up|1
7027338|NCT01610037|11104644|FG001|Treatment and Follow up Period|Lost to Follow-up|6
7027339|NCT01610037|11104645|FG002|Treatment and Follow up Period|Lost to Follow-up|4
7027340|NCT01610063|11104655|FG000|Overall Study|Lost to Follow-up|42
7027341|NCT01610063|11104656|FG001|Overall Study|Lost to Follow-up|20
7027342|NCT01610076|11104664|FG000|Overall Study|Technical issue with video|0
7027343|NCT01610076|11104665|FG001|Overall Study|Technical issue with video|1
7027344|NCT01610076|11104664|FG000|Overall Study|Lost to Follow-up|3
7027345|NCT01610076|11104665|FG001|Overall Study|Lost to Follow-up|4
7027346|NCT01610167|11104681|FG000|Overall Study|Scheduling conflict.|0
7027347|NCT01610167|11104682|FG001|Overall Study|Scheduling conflict.|0
7027348|NCT01610167|11104683|FG002|Overall Study|Scheduling conflict.|2
7027349|NCT01610206|11104693|FG000|Overall Study|Adverse Event|10
7027350|NCT01610206|11104694|FG001|Overall Study|Adverse Event|30
7027351|NCT01610271|11104702|FG000|Overall Study|Surgery not complete|0
7027352|NCT01610271|11104703|FG001|Overall Study|Surgery not complete|1
7027353|NCT01610271|11104702|FG000|Overall Study|Prosthesis not implanted|2
7027354|NCT01610271|11104703|FG001|Overall Study|Prosthesis not implanted|3
7027355|NCT01610284|11104713|FG000|Randomization Phase|Adverse Event|1
7027356|NCT01610284|11104714|FG001|Randomization Phase|Adverse Event|0
7027357|NCT01610284|11104713|FG000|Randomization Phase|Physician Decision|1
7027358|NCT01610284|11104714|FG001|Randomization Phase|Physician Decision|1
7027359|NCT01610284|11104713|FG000|Randomization Phase|Death|0
7027360|NCT01610284|11104714|FG001|Randomization Phase|Death|1
7027361|NCT01610284|11104713|FG000|Treatment Phase|Adverse Event|80
7027362|NCT01610284|11104714|FG001|Treatment Phase|Adverse Event|12
7027363|NCT01610284|11104713|FG000|Treatment Phase|Lost to Follow-up|1
7027364|NCT01610284|11104714|FG001|Treatment Phase|Lost to Follow-up|0
7027365|NCT01610284|11104713|FG000|Treatment Phase|Non-compliance with Study Treatment|8
7027366|NCT01610284|11104714|FG001|Treatment Phase|Non-compliance with Study Treatment|1
7027367|NCT01610284|11104713|FG000|Treatment Phase|Physician Decision|27
7027368|NCT01610284|11104714|FG001|Treatment Phase|Physician Decision|24
7027369|NCT01610284|11104713|FG000|Treatment Phase|Progressive Disease|377
7027370|NCT01610284|11104714|FG001|Treatment Phase|Progressive Disease|486
7027371|NCT01610284|11104713|FG000|Treatment Phase|Protocol Deviation|2
7027372|NCT01610284|11104714|FG001|Treatment Phase|Protocol Deviation|3
7027373|NCT01610284|11104713|FG000|Treatment Phase|Study terminated by Sponsor|18
7027374|NCT01610284|11104714|FG001|Treatment Phase|Study terminated by Sponsor|15
7027375|NCT01610284|11104713|FG000|Treatment Phase|Subject/Guardian Decision|55
7027376|NCT01610284|11104714|FG001|Treatment Phase|Subject/Guardian Decision|23
7027377|NCT01610284|11104713|FG000|Treatment Phase|Death|6
7027378|NCT01610284|11104714|FG001|Treatment Phase|Death|5
7027379|NCT01610284|11104713|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2
7027380|NCT01610284|11104714|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
7027381|NCT01610284|11104713|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10
7027382|NCT01610284|11104714|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3
7027383|NCT01610284|11104713|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24
7027384|NCT01610284|11104714|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8
7027385|NCT01610284|11104713|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11
7027386|NCT01610284|11104714|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
7027387|NCT01610284|11104713|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4
7027388|NCT01610284|11104714|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4
7027389|NCT01610284|11104713|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38
7027390|NCT01610284|11104714|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13
7027391|NCT01610297|11104720|FG000|Overall Study|Lost to Follow-up|1
7027392|NCT01610336|11104735|FG000|Overall Study|Progressive Disease|4
7027393|NCT01610336|11104736|FG001|Overall Study|Progressive Disease|6
7027394|NCT01610336|11104737|FG002|Overall Study|Progressive Disease|6
7027395|NCT01610336|11104738|FG003|Overall Study|Progressive Disease|5
7027396|NCT01610336|11104739|FG004|Overall Study|Progressive Disease|3
7027397|NCT01610336|11104740|FG005|Overall Study|Progressive Disease|10
7027398|NCT01610336|11104741|FG006|Overall Study|Progressive Disease|1
7027399|NCT01610336|11104742|FG007|Overall Study|Progressive Disease|6
7027400|NCT01610336|11104743|FG008|Overall Study|Progressive Disease|6
7027401|NCT01610336|11104744|FG009|Overall Study|Progressive Disease|40
7027402|NCT01610336|11104745|FG010|Overall Study|Progressive Disease|36
7027403|NCT01610336|11104735|FG000|Overall Study|Adverse Event|0
7027404|NCT01610336|11104736|FG001|Overall Study|Adverse Event|0
7027405|NCT01610336|11104737|FG002|Overall Study|Adverse Event|0
7027406|NCT01610336|11104738|FG003|Overall Study|Adverse Event|1
7027407|NCT01610336|11104739|FG004|Overall Study|Adverse Event|1
7027408|NCT01610336|11104740|FG005|Overall Study|Adverse Event|1
7027409|NCT01610336|11104741|FG006|Overall Study|Adverse Event|0
7027410|NCT01610336|11104742|FG007|Overall Study|Adverse Event|0
7027411|NCT01610336|11104743|FG008|Overall Study|Adverse Event|2
7027412|NCT01610336|11104744|FG009|Overall Study|Adverse Event|8
7027413|NCT01610336|11104745|FG010|Overall Study|Adverse Event|6
7027414|NCT01610336|11104735|FG000|Overall Study|Subject/Guardian decision|1
7027415|NCT01610336|11104736|FG001|Overall Study|Subject/Guardian decision|1
7027416|NCT01610336|11104737|FG002|Overall Study|Subject/Guardian decision|0
7027417|NCT01610336|11104738|FG003|Overall Study|Subject/Guardian decision|1
7027418|NCT01610336|11104739|FG004|Overall Study|Subject/Guardian decision|0
7027419|NCT01610336|11104740|FG005|Overall Study|Subject/Guardian decision|0
7027420|NCT01610336|11104741|FG006|Overall Study|Subject/Guardian decision|0
7027421|NCT01610336|11104742|FG007|Overall Study|Subject/Guardian decision|1
7027422|NCT01610336|11104743|FG008|Overall Study|Subject/Guardian decision|0
7027423|NCT01610336|11104744|FG009|Overall Study|Subject/Guardian decision|2
7027424|NCT01610336|11104745|FG010|Overall Study|Subject/Guardian decision|2
7027425|NCT01610336|11104735|FG000|Overall Study|Death|0
7027426|NCT01610336|11104736|FG001|Overall Study|Death|0
7027427|NCT01610336|11104737|FG002|Overall Study|Death|0
7027428|NCT01610336|11104738|FG003|Overall Study|Death|0
7027429|NCT01610336|11104739|FG004|Overall Study|Death|0
7027430|NCT01610336|11104740|FG005|Overall Study|Death|1
7027431|NCT01610336|11104741|FG006|Overall Study|Death|3
7027432|NCT01610336|11104742|FG007|Overall Study|Death|0
7027433|NCT01610336|11104743|FG008|Overall Study|Death|0
7027434|NCT01610336|11104744|FG009|Overall Study|Death|1
7027435|NCT01610336|11104745|FG010|Overall Study|Death|2
7027436|NCT01610336|11104735|FG000|Overall Study|Non-Compliance with study treatment|0
7027437|NCT01610336|11104736|FG001|Overall Study|Non-Compliance with study treatment|0
7027438|NCT01610336|11104737|FG002|Overall Study|Non-Compliance with study treatment|0
7027439|NCT01610336|11104738|FG003|Overall Study|Non-Compliance with study treatment|0
7027440|NCT01610336|11104739|FG004|Overall Study|Non-Compliance with study treatment|0
7027441|NCT01610336|11104740|FG005|Overall Study|Non-Compliance with study treatment|0
7027442|NCT01610336|11104741|FG006|Overall Study|Non-Compliance with study treatment|0
7027443|NCT01610336|11104742|FG007|Overall Study|Non-Compliance with study treatment|0
7027444|NCT01610336|11104743|FG008|Overall Study|Non-Compliance with study treatment|0
7027445|NCT01610336|11104744|FG009|Overall Study|Non-Compliance with study treatment|1
7027446|NCT01610336|11104745|FG010|Overall Study|Non-Compliance with study treatment|0
7027447|NCT01610336|11104735|FG000|Overall Study|Physician Decision|0
7027448|NCT01610336|11104736|FG001|Overall Study|Physician Decision|0
7027449|NCT01610336|11104737|FG002|Overall Study|Physician Decision|0
7027450|NCT01610336|11104738|FG003|Overall Study|Physician Decision|0
7027451|NCT01610336|11104739|FG004|Overall Study|Physician Decision|0
7027452|NCT01610336|11104740|FG005|Overall Study|Physician Decision|0
7027453|NCT01610336|11104741|FG006|Overall Study|Physician Decision|1
7027454|NCT01610336|11104742|FG007|Overall Study|Physician Decision|0
7027455|NCT01610336|11104743|FG008|Overall Study|Physician Decision|0
7027456|NCT01610336|11104744|FG009|Overall Study|Physician Decision|0
7027457|NCT01610336|11104745|FG010|Overall Study|Physician Decision|0
7027458|NCT01610336|11104735|FG000|Overall Study|Protocol Deviation|0
7027459|NCT01610336|11104736|FG001|Overall Study|Protocol Deviation|0
7027460|NCT01610336|11104737|FG002|Overall Study|Protocol Deviation|0
7027461|NCT01610336|11104738|FG003|Overall Study|Protocol Deviation|0
7027462|NCT01610336|11104739|FG004|Overall Study|Protocol Deviation|0
7027463|NCT01610336|11104740|FG005|Overall Study|Protocol Deviation|0
7027464|NCT01610336|11104741|FG006|Overall Study|Protocol Deviation|0
7027465|NCT01610336|11104742|FG007|Overall Study|Protocol Deviation|0
7027466|NCT01610336|11104743|FG008|Overall Study|Protocol Deviation|0
7027467|NCT01610336|11104744|FG009|Overall Study|Protocol Deviation|1
7027468|NCT01610336|11104745|FG010|Overall Study|Protocol Deviation|0
7027469|NCT01610336|11104735|FG000|Overall Study|Transfer to another trial|0
7027470|NCT01610336|11104736|FG001|Overall Study|Transfer to another trial|0
7027471|NCT01610336|11104737|FG002|Overall Study|Transfer to another trial|0
7027472|NCT01610336|11104738|FG003|Overall Study|Transfer to another trial|0
7027473|NCT01610336|11104739|FG004|Overall Study|Transfer to another trial|0
7027474|NCT01610336|11104740|FG005|Overall Study|Transfer to another trial|0
7027475|NCT01610336|11104741|FG006|Overall Study|Transfer to another trial|0
7027476|NCT01610336|11104742|FG007|Overall Study|Transfer to another trial|0
7027477|NCT01610336|11104743|FG008|Overall Study|Transfer to another trial|0
7027478|NCT01610336|11104744|FG009|Overall Study|Transfer to another trial|0
7027479|NCT01610336|11104745|FG010|Overall Study|Transfer to another trial|1
7027480|NCT01610414|11104775|FG000|Study Start - Month 13|Serious Adverse Event|65
7027481|NCT01610414|11104776|FG001|Study Start - Month 13|Serious Adverse Event|67
7027482|NCT01610414|11104775|FG000|Study Start - Month 13|Adverse Event|14
7027483|NCT01610414|11104776|FG001|Study Start - Month 13|Adverse Event|14
7027484|NCT01610414|11104775|FG000|Study Start - Month 13|Protocol Violation|3
7027485|NCT01610414|11104776|FG001|Study Start - Month 13|Protocol Violation|1
7027486|NCT01610414|11104775|FG000|Study Start - Month 13|Withdrawal by Subject|23
7027487|NCT01610414|11104776|FG001|Study Start - Month 13|Withdrawal by Subject|30
7027488|NCT01610414|11104775|FG000|Study Start - Month 13|Migrated/moved from study area|2
7027489|NCT01610414|11104776|FG001|Study Start - Month 13|Migrated/moved from study area|4
7027490|NCT01610414|11104775|FG000|Study Start - Month 13|Lost to Follow-up|4
7027491|NCT01610414|11104776|FG001|Study Start - Month 13|Lost to Follow-up|6
7027492|NCT01610414|11104775|FG000|Study Start - Month 13|Suspected HZ episode|1
7027493|NCT01610414|11104776|FG001|Study Start - Month 13|Suspected HZ episode|3
7027494|NCT01610414|11104775|FG000|Study Start - Month 13|Other reasons for withdrawal|3
7027495|NCT01610414|11104776|FG001|Study Start - Month 13|Other reasons for withdrawal|4
7027496|NCT01610414|11104775|FG000|Month 13 - Month 25|Serious Adverse Event|35
7027497|NCT01610414|11104776|FG001|Month 13 - Month 25|Serious Adverse Event|38
7027498|NCT01610414|11104775|FG000|Month 13 - Month 25|Adverse Event|8
7027499|NCT01610414|11104776|FG001|Month 13 - Month 25|Adverse Event|4
7027500|NCT01610414|11104775|FG000|Month 13 - Month 25|Withdrawal by Subject|7
7027501|NCT01610414|11104776|FG001|Month 13 - Month 25|Withdrawal by Subject|8
7027502|NCT01610414|11104775|FG000|Month 13 - Month 25|Migrated/moved from study area|4
7027503|NCT01610414|11104776|FG001|Month 13 - Month 25|Migrated/moved from study area|2
7027504|NCT01610414|11104775|FG000|Month 13 - Month 25|Protocol Violation|0
7027505|NCT01610414|11104776|FG001|Month 13 - Month 25|Protocol Violation|2
7027506|NCT01610414|11104775|FG000|Month 13 - Month 25|Lost to Follow-up|5
7027507|NCT01610414|11104776|FG001|Month 13 - Month 25|Lost to Follow-up|9
7027508|NCT01610414|11104775|FG000|Month 13 - Month 25|Other reasons for withdrawal|6
7027509|NCT01610414|11104776|FG001|Month 13 - Month 25|Other reasons for withdrawal|7
7027510|NCT01610414|11104775|FG000|After Month 25|Study end not reached|48
7027511|NCT01610414|11104776|FG001|After Month 25|Study end not reached|53
7027512|NCT01610492|11104792|FG000|Overall Study|Adverse Event|1
7027513|NCT01610492|11104792|FG000|Overall Study|Lack of Efficacy|3
7027514|NCT01610492|11104792|FG000|Overall Study|Other: Reached stopping criteria|1
7027515|NCT01610492|11104792|FG000|Overall Study|Other:Treatment stopped due to remission|1
7027516|NCT01610557|11104800|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
7027517|NCT01610557|11104801|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1
7027518|NCT01610557|11104802|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
7027519|NCT01610557|11104803|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
7027520|NCT01610557|11104804|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
7027521|NCT01610557|11104800|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0
7027522|NCT01610557|11104801|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0
7027523|NCT01610557|11104802|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0
7027524|NCT01610557|11104803|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0
7027525|NCT01610557|11104804|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3
7027526|NCT01610596|11104840|FG000|Overall Study|Lost to Follow-up|0
7027527|NCT01610596|11104841|FG001|Overall Study|Lost to Follow-up|1
7027528|NCT01610687|11104847|FG000|Overall Study|Lack of Efficacy|26
7027529|NCT01610687|11104847|FG000|Overall Study|Adverse Event|18
7027530|NCT01610687|11104847|FG000|Overall Study|Moved out of area|6
7027531|NCT01610687|11104847|FG000|Overall Study|Withdrawal by Subject|7
7027532|NCT01610687|11104847|FG000|Overall Study|Lost to Follow-up|4
7027533|NCT01610687|11104847|FG000|Overall Study|Symptom control without study medication|2
7027534|NCT01610687|11104847|FG000|Overall Study|Unable to make journey|1
7027535|NCT01610687|11104847|FG000|Overall Study|Death|1
7027536|NCT01610687|11104847|FG000|Overall Study|Cannabis affecting job|1
7027537|NCT01610687|11104847|FG000|Overall Study|Felt more alter without study medication|1
7027538|NCT01610700|11104853|FG000|Overall Study|Adverse Event|3
7027539|NCT01610700|11104854|FG001|Overall Study|Adverse Event|1
7027540|NCT01610700|11104853|FG000|Overall Study|Withdrawal by Subject|0
7027541|NCT01610700|11104854|FG001|Overall Study|Withdrawal by Subject|1
7027542|NCT01610700|11104853|FG000|Overall Study|subject took one dose of street cannabis|0
7027543|NCT01610700|11104854|FG001|Overall Study|subject took one dose of street cannabis|1
7027544|NCT01610713|11104863|FG000|Overall Study|Adverse Event|3
7027545|NCT01610713|11104864|FG001|Overall Study|Adverse Event|0
7027546|NCT01610713|11104863|FG000|Overall Study|Lack of Efficacy|1
7027547|NCT01610713|11104864|FG001|Overall Study|Lack of Efficacy|0
7027548|NCT01610713|11104863|FG000|Overall Study|low mood and poor motivation|1
7027549|NCT01610713|11104864|FG001|Overall Study|low mood and poor motivation|0
7027550|NCT01610713|11104863|FG000|Overall Study|adv. to use original dose/amitriptyline|1
7027551|NCT01610713|11104864|FG001|Overall Study|adv. to use original dose/amitriptyline|0
7027552|NCT01610713|11104863|FG000|Overall Study|Lost to Follow-up|0
7027553|NCT01610713|11104864|FG001|Overall Study|Lost to Follow-up|1
7027554|NCT01610752|11104873|FG000|Overall Study|Miscarriage/Pregnancy loss|0
7027555|NCT01610752|11104874|FG001|Overall Study|Miscarriage/Pregnancy loss|0
7027556|NCT01610752|11104875|FG002|Overall Study|Miscarriage/Pregnancy loss|4
7027557|NCT01610791|11104883|FG000|Overall Study|Lost to Follow-up|7
7027558|NCT01610791|11104883|FG000|Overall Study|Adverse Event|6
7027559|NCT01610791|11104883|FG000|Overall Study|Physician Decision|1
7027560|NCT01610791|11104883|FG000|Overall Study|Adverse event and Investigator decision|1
7027561|NCT01610791|11104883|FG000|Overall Study|Death|1
7027562|NCT01610791|11104883|FG000|Overall Study|Not determined|5
7027563|NCT01611090|11104889|FG000|Randomized Period|Lost to Follow-up|8
7027564|NCT01611090|11104890|FG001|Randomized Period|Lost to Follow-up|3
7027565|NCT01611090|11104891|FG002|Randomized Period|Lost to Follow-up|0
7027566|NCT01611090|11104889|FG000|Randomized Period|Withdrawal by Subject|22
7027567|NCT01611090|11104890|FG001|Randomized Period|Withdrawal by Subject|26
7027568|NCT01611090|11104891|FG002|Randomized Period|Withdrawal by Subject|0
7027569|NCT01611090|11104889|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0
7027570|NCT01611090|11104890|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0
7027571|NCT01611090|11104891|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4
7027572|NCT01611090|11104889|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0
7027573|NCT01611090|11104890|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0
7027574|NCT01611090|11104891|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1
7027575|NCT01611155|11104900|FG000|Overall Study|Adverse Event|1
7027576|NCT01611155|11104901|FG001|Overall Study|Adverse Event|1
7027577|NCT01611155|11104900|FG000|Overall Study|Refused further treatment|6
7027578|NCT01611155|11104901|FG001|Overall Study|Refused further treatment|4
7027579|NCT01611155|11104900|FG000|Overall Study|Disease progression|1
7027580|NCT01611155|11104901|FG001|Overall Study|Disease progression|0
7027581|NCT01611155|11104900|FG000|Overall Study|Withdrawal by Subject|1
7027582|NCT01611155|11104901|FG001|Overall Study|Withdrawal by Subject|0
7027583|NCT01611155|11104900|FG000|Overall Study|Alternative treatment|0
7027584|NCT01611155|11104901|FG001|Overall Study|Alternative treatment|1
7027585|NCT01611155|11104900|FG000|Overall Study|Ineligible patient|0
7027586|NCT01611155|11104901|FG001|Overall Study|Ineligible patient|1
7027587|NCT01611194|11104909|FG000|Overall Study|Lost to Follow-up|0
7027588|NCT01611194|11104910|FG001|Overall Study|Lost to Follow-up|1
7027589|NCT01611194|11104909|FG000|Overall Study|Withdrawal by Subject|0
7027590|NCT01611194|11104910|FG001|Overall Study|Withdrawal by Subject|1
7027591|NCT01611194|11104909|FG000|Overall Study|drug use|0
7027592|NCT01611194|11104910|FG001|Overall Study|drug use|1
7027593|NCT01611259|11104916|FG000|Overall Study|Physician Decision|1
7027594|NCT01611259|11104916|FG000|Overall Study|Lack of Efficacy|2
7027595|NCT01611259|11104916|FG000|Overall Study|Adverse Event|4
7027596|NCT01611259|11104916|FG000|Overall Study|Withdrawal by Subject|7
7027597|NCT01611298|11104920|FG000|Overall Study|Relapsed|2
7027598|NCT01611454|11104926|FG000|Overall Study|Lack of Efficacy|18
7027599|NCT01611454|11104927|FG001|Overall Study|Lack of Efficacy|10
7027600|NCT01611558|11104937|FG000|Induction Phase|Study drug toxicity|15
7027601|NCT01611558|11104937|FG000|Induction Phase|Disease progression|18
7027602|NCT01611558|11104937|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1
7027603|NCT01611558|11104937|FG000|Induction Phase|Adverse event unrelated to study drug|3
7027604|NCT01611558|11104937|FG000|Induction Phase|Death|1
7027605|NCT01611558|11104937|FG000|Maintenance Phase|Withdrawal by Subject|1
7027606|NCT01611558|11104937|FG000|Maintenance Phase|Elevated Uric acid|1
7027607|NCT01611792|11104965|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12
7027608|NCT01611792|11104966|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9
7027609|NCT01611792|11104965|FG000|Followup: at 6 Months|Lost to Follow-up|6
7027610|NCT01611792|11104966|FG001|Followup: at 6 Months|Lost to Follow-up|13
7027611|NCT01611857|11104975|FG000|Overall Study|Withdrawal by Subject|0
7027612|NCT01611857|11104976|FG001|Overall Study|Withdrawal by Subject|2
7027613|NCT01611935|11104986|FG000|Overall Study|Family Declined Participation|1
7027614|NCT01611935|11104987|FG001|Overall Study|Family Declined Participation|0
7027615|NCT01611974|11105005|FG000|Overall Study|Death|10
7027616|NCT01611974|11105006|FG001|Overall Study|Death|12
7027617|NCT01611974|11105007|FG002|Overall Study|Death|10
7027618|NCT01611974|11105005|FG000|Overall Study|Lost to Follow-up|0
7027619|NCT01611974|11105006|FG001|Overall Study|Lost to Follow-up|1
7027620|NCT01611974|11105007|FG002|Overall Study|Lost to Follow-up|0
7027621|NCT01611974|11105005|FG000|Overall Study|Physician Decision|5
7027622|NCT01611974|11105006|FG001|Overall Study|Physician Decision|1
7027623|NCT01611974|11105007|FG002|Overall Study|Physician Decision|2
7027624|NCT01611974|11105005|FG000|Overall Study|Withdrawal by Subject|0
7027625|NCT01611974|11105006|FG001|Overall Study|Withdrawal by Subject|1
7027626|NCT01611974|11105007|FG002|Overall Study|Withdrawal by Subject|4
7027627|NCT01612000|11105019|FG000|Overall Study|Lost to Follow-up|6
7027628|NCT01612000|11105020|FG001|Overall Study|Lost to Follow-up|4
7027629|NCT01612000|11105021|FG002|Overall Study|Lost to Follow-up|4
7027630|NCT01612000|11105022|FG003|Overall Study|Lost to Follow-up|8
7027631|NCT01612000|11105019|FG000|Overall Study|Physician Decision|0
7027632|NCT01612000|11105020|FG001|Overall Study|Physician Decision|0
7027633|NCT01612000|11105021|FG002|Overall Study|Physician Decision|1
7027634|NCT01612000|11105022|FG003|Overall Study|Physician Decision|0
7027635|NCT01612000|11105019|FG000|Overall Study|Withdrawal by Subject|3
7027636|NCT01612000|11105020|FG001|Overall Study|Withdrawal by Subject|1
7027637|NCT01612000|11105021|FG002|Overall Study|Withdrawal by Subject|2
7027638|NCT01612000|11105022|FG003|Overall Study|Withdrawal by Subject|2
7027639|NCT01612156|11105034|FG000|Overall Study|Protocol Violation|2
7027640|NCT01612156|11105035|FG001|Overall Study|Protocol Violation|0
7027641|NCT01612676|11105067|FG000|Overall Study|Adverse Event|2
7027642|NCT01612676|11105068|FG001|Overall Study|Adverse Event|3
7027643|NCT01612676|11105069|FG002|Overall Study|Adverse Event|1
7027644|NCT01612676|11105070|FG003|Overall Study|Adverse Event|3
7027645|NCT01612676|11105067|FG000|Overall Study|Protocol Violation|0
7027646|NCT01612676|11105068|FG001|Overall Study|Protocol Violation|1
7027647|NCT01612676|11105069|FG002|Overall Study|Protocol Violation|0
7027648|NCT01612676|11105070|FG003|Overall Study|Protocol Violation|0
7027649|NCT01612702|11105084|FG000|Overall Study|Protocol Violation|11
7027650|NCT01612702|11105085|FG001|Overall Study|Protocol Violation|11
7027651|NCT01612780|11105116|FG000|Overall Study|Treatment not completed|1
7027652|NCT01612780|11105116|FG000|Overall Study|Withdrawal by Subject|5
7027653|NCT01612858|11105131|FG000|Overall Study|Withdrawal by Subject|5
7027654|NCT01612858|11105132|FG001|Overall Study|Withdrawal by Subject|1
7027655|NCT01613027|11105156|FG000|Overall Study|Lost to Follow-up|5
7027656|NCT01613027|11105156|FG000|Overall Study|Switched Physician|1
7027657|NCT01613027|11105156|FG000|Overall Study|Lack of Efficacy|1
7027658|NCT01613027|11105156|FG000|Overall Study|Patient's Decision Due to Adverse Event|1
7027659|NCT01613131|11105162|FG000|Overall Study|Withdrawal by Subject|3
7027660|NCT01613131|11105163|FG001|Overall Study|Withdrawal by Subject|5
7027661|NCT01613222|11105169|FG000|Overall Study|Physician Decision|1
7027662|NCT01613222|11105169|FG000|Overall Study|Unable to place arterial line|1
7027663|NCT01613222|11105169|FG000|Overall Study|Reused disposable sensors|10
7027664|NCT01613248|11105188|FG000|Overall Study|Adverse Event|0
7027665|NCT01613248|11105189|FG001|Overall Study|Adverse Event|0
7027666|NCT01613248|11105190|FG002|Overall Study|Adverse Event|0
7027667|NCT01613248|11105191|FG003|Overall Study|Adverse Event|1
7027668|NCT01613248|11105192|FG004|Overall Study|Adverse Event|0
7027669|NCT01613248|11105193|FG005|Overall Study|Adverse Event|0
7027670|NCT01613248|11105188|FG000|Overall Study|Withdrawal by Subject|3
7027671|NCT01613248|11105189|FG001|Overall Study|Withdrawal by Subject|2
7027672|NCT01613248|11105190|FG002|Overall Study|Withdrawal by Subject|2
7027673|NCT01613248|11105191|FG003|Overall Study|Withdrawal by Subject|5
7027674|NCT01613248|11105192|FG004|Overall Study|Withdrawal by Subject|0
7027675|NCT01613248|11105193|FG005|Overall Study|Withdrawal by Subject|1
7027676|NCT01613248|11105188|FG000|Overall Study|Lost to Follow-up|5
7027677|NCT01613248|11105189|FG001|Overall Study|Lost to Follow-up|7
7027678|NCT01613248|11105190|FG002|Overall Study|Lost to Follow-up|4
7027679|NCT01613248|11105191|FG003|Overall Study|Lost to Follow-up|8
7027680|NCT01613248|11105192|FG004|Overall Study|Lost to Follow-up|4
7027681|NCT01613248|11105193|FG005|Overall Study|Lost to Follow-up|2
7027682|NCT01613248|11105188|FG000|Overall Study|Study Terminated by Sponsor|4
7027683|NCT01613248|11105189|FG001|Overall Study|Study Terminated by Sponsor|6
7027684|NCT01613248|11105190|FG002|Overall Study|Study Terminated by Sponsor|8
7027685|NCT01613248|11105191|FG003|Overall Study|Study Terminated by Sponsor|8
7027686|NCT01613248|11105192|FG004|Overall Study|Study Terminated by Sponsor|9
7027687|NCT01613248|11105193|FG005|Overall Study|Study Terminated by Sponsor|11
7027688|NCT01613248|11105188|FG000|Overall Study|Physician Decision|8
7027689|NCT01613248|11105189|FG001|Overall Study|Physician Decision|8
7027690|NCT01613248|11105190|FG002|Overall Study|Physician Decision|9
7027691|NCT01613248|11105191|FG003|Overall Study|Physician Decision|4
7027692|NCT01613248|11105192|FG004|Overall Study|Physician Decision|7
7027693|NCT01613248|11105193|FG005|Overall Study|Physician Decision|6
7027694|NCT01613248|11105188|FG000|Overall Study|Lack of Qualifying Event|9
7027695|NCT01613248|11105189|FG001|Overall Study|Lack of Qualifying Event|11
7027696|NCT01613248|11105190|FG002|Overall Study|Lack of Qualifying Event|10
7027697|NCT01613248|11105191|FG003|Overall Study|Lack of Qualifying Event|11
7027698|NCT01613248|11105192|FG004|Overall Study|Lack of Qualifying Event|15
7027699|NCT01613248|11105193|FG005|Overall Study|Lack of Qualifying Event|18
7027700|NCT01613248|11105188|FG000|Overall Study|Pregnancy|0
7027701|NCT01613248|11105189|FG001|Overall Study|Pregnancy|0
7027702|NCT01613248|11105190|FG002|Overall Study|Pregnancy|0
7027703|NCT01613248|11105191|FG003|Overall Study|Pregnancy|1
7027704|NCT01613248|11105192|FG004|Overall Study|Pregnancy|0
7027705|NCT01613248|11105193|FG005|Overall Study|Pregnancy|0
7027706|NCT01613326|11105226|FG000|Overall Study|Adverse Event|7
7027707|NCT01613326|11105227|FG001|Overall Study|Adverse Event|5
7027708|NCT01613326|11105226|FG000|Overall Study|Withdrawal by Subject|3
7027709|NCT01613326|11105227|FG001|Overall Study|Withdrawal by Subject|4
7027710|NCT01613326|11105226|FG000|Overall Study|Abnormal test procedure result(s)|2
7027711|NCT01613326|11105227|FG001|Overall Study|Abnormal test procedure result(s)|0
7027712|NCT01613326|11105226|FG000|Overall Study|inability to use device|1
7027713|NCT01613326|11105227|FG001|Overall Study|inability to use device|0
7027714|NCT01613326|11105226|FG000|Overall Study|Lack of Efficacy|0
7027715|NCT01613326|11105227|FG001|Overall Study|Lack of Efficacy|1
7027716|NCT01613326|11105226|FG000|Overall Study|Lost to Follow-up|0
7027717|NCT01613326|11105227|FG001|Overall Study|Lost to Follow-up|1
7027718|NCT01613326|11105226|FG000|Overall Study|Administrative|0
7027719|NCT01613326|11105227|FG001|Overall Study|Administrative|2
7027720|NCT01613326|11105226|FG000|Overall Study|Protocol Violation|0
7027721|NCT01613326|11105227|FG001|Overall Study|Protocol Violation|1
7027722|NCT01613378|11105241|FG000|Overall Study|Lack of Efficacy|13
7027723|NCT01613378|11105241|FG000|Overall Study|Adverse Event|11
7027724|NCT01613378|11105241|FG000|Overall Study|Withdrawal by Subject|8
7027725|NCT01613378|11105241|FG000|Overall Study|Death|2
7027726|NCT01613378|11105241|FG000|Overall Study|Lost to Follow-up|1
7027727|NCT01613378|11105241|FG000|Overall Study|Other Reason|4
7027728|NCT01613417|11105247|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13
7027729|NCT01613417|11105248|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7
7027730|NCT01613599|11105264|FG000|Overall Study|Death|9
7027731|NCT01613599|11105264|FG000|Overall Study|Lost to Follow-up|5
7027732|NCT01613599|11105264|FG000|Overall Study|Withdrawal by Subject|8
7027733|NCT01613599|11105264|FG000|Overall Study|Reason not specified|3
7027734|NCT01613716|11105268|FG000|Overall Study|screen failures|3
7027735|NCT01613716|11105268|FG000|Overall Study|Lost to Follow-up|4
7027736|NCT01614093|11105277|FG000|Overall Study|Withdrawal by Subject|1
7027737|NCT01614249|11105288|FG000|Overall Study|Lost to Follow-up|11
7027738|NCT01614249|11105289|FG001|Overall Study|Lost to Follow-up|23
7027739|NCT01614457|11105306|FG000|Overall Study|Non-Compliance|1
7027740|NCT01614457|11105307|FG001|Overall Study|Non-Compliance|0
7027741|NCT01614457|11105306|FG000|Overall Study|Pregnancy (Self or Partner)|1
7027742|NCT01614457|11105307|FG001|Overall Study|Pregnancy (Self or Partner)|0
7027743|NCT01614470|11105315|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
7027744|NCT01614470|11105316|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
7027745|NCT01614470|11105317|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
7027746|NCT01614470|11105315|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
7027747|NCT01614470|11105316|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
7027748|NCT01614470|11105317|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0
7027749|NCT01614600|11105339|FG000|Overall Study|Unacceptable fit|1
7027750|NCT01614600|11105339|FG000|Overall Study|Discomfort|1
7027751|NCT01614600|11105339|FG000|Overall Study|Unable to remove lens at the end of day|1
7027752|NCT01614600|11105339|FG000|Overall Study|Protocol deviation|1
7027753|NCT01614769|11105357|FG000|Period 1|Discontinued due to Hypoglycemia|0
7027754|NCT01614769|11105358|FG001|Period 1|Discontinued due to Hypoglycemia|0
7027755|NCT01614769|11105359|FG002|Period 1|Discontinued due to Hypoglycemia|0
7027756|NCT01614769|11105360|FG003|Period 1|Discontinued due to Hypoglycemia|1
7027757|NCT01614769|11105361|FG004|Period 1|Discontinued due to Hypoglycemia|0
7027758|NCT01614769|11105362|FG005|Period 1|Discontinued due to Hypoglycemia|1
7027759|NCT01614769|11105357|FG000|Period 1|Protocol Violation|0
7027760|NCT01614769|11105358|FG001|Period 1|Protocol Violation|0
7027761|NCT01614769|11105359|FG002|Period 1|Protocol Violation|0
7027762|NCT01614769|11105360|FG003|Period 1|Protocol Violation|1
7027763|NCT01614769|11105361|FG004|Period 1|Protocol Violation|0
7027764|NCT01614769|11105362|FG005|Period 1|Protocol Violation|0
7027765|NCT01614769|11105357|FG000|Period 1|Withdrawal by Subject|1
7027766|NCT01614769|11105358|FG001|Period 1|Withdrawal by Subject|0
7027767|NCT01614769|11105359|FG002|Period 1|Withdrawal by Subject|0
7027768|NCT01614769|11105360|FG003|Period 1|Withdrawal by Subject|0
7027769|NCT01614769|11105361|FG004|Period 1|Withdrawal by Subject|0
7027770|NCT01614769|11105362|FG005|Period 1|Withdrawal by Subject|0
7027771|NCT01614769|11105357|FG000|Period 3|Withdrawal by Subject|0
7027772|NCT01614769|11105358|FG001|Period 3|Withdrawal by Subject|0
7027773|NCT01614769|11105359|FG002|Period 3|Withdrawal by Subject|1
7027774|NCT01614769|11105360|FG003|Period 3|Withdrawal by Subject|0
7027775|NCT01614769|11105361|FG004|Period 3|Withdrawal by Subject|0
7027776|NCT01614769|11105362|FG005|Period 3|Withdrawal by Subject|0
7027777|NCT01614795|11105374|FG000|Overall Study|Adverse Event|0
7027778|NCT01614795|11105375|FG001|Overall Study|Adverse Event|0
7027779|NCT01614795|11105376|FG002|Overall Study|Adverse Event|1
7027780|NCT01614795|11105377|FG003|Overall Study|Adverse Event|1
7027781|NCT01614795|11105374|FG000|Overall Study|Lack of Efficacy|10
7027782|NCT01614795|11105375|FG001|Overall Study|Lack of Efficacy|10
7027783|NCT01614795|11105376|FG002|Overall Study|Lack of Efficacy|9
7027784|NCT01614795|11105377|FG003|Overall Study|Lack of Efficacy|8
7027785|NCT01614795|11105374|FG000|Overall Study|Physician Decision|1
7027786|NCT01614795|11105375|FG001|Overall Study|Physician Decision|0
7027787|NCT01614795|11105376|FG002|Overall Study|Physician Decision|1
7027788|NCT01614795|11105377|FG003|Overall Study|Physician Decision|1
7027789|NCT01614795|11105374|FG000|Overall Study|Withdrawal by Subject|0
7027790|NCT01614795|11105375|FG001|Overall Study|Withdrawal by Subject|1
7027791|NCT01614795|11105376|FG002|Overall Study|Withdrawal by Subject|0
7027792|NCT01614795|11105377|FG003|Overall Study|Withdrawal by Subject|2
7027793|NCT01614795|11105374|FG000|Overall Study|Ineligible|0
7027794|NCT01614795|11105375|FG001|Overall Study|Ineligible|1
7027795|NCT01614795|11105376|FG002|Overall Study|Ineligible|0
7027796|NCT01614795|11105377|FG003|Overall Study|Ineligible|0
7027797|NCT01614886|11105408|FG000|Overall Study|Adverse Event|15
7027798|NCT01614886|11105409|FG001|Overall Study|Adverse Event|20
7027799|NCT01614886|11105408|FG000|Overall Study|Withdrawal by Subject|4
7027800|NCT01614886|11105409|FG001|Overall Study|Withdrawal by Subject|4
7027801|NCT01614886|11105408|FG000|Overall Study|Death|1
7027802|NCT01614886|11105409|FG001|Overall Study|Death|0
7027803|NCT01614886|11105408|FG000|Overall Study|Protocol deviation|0
7027804|NCT01614886|11105409|FG001|Overall Study|Protocol deviation|2
7027805|NCT01614925|11105417|FG000|Overall Study|Withdrawal by Subject|1
7027806|NCT01614925|11105418|FG001|Overall Study|Withdrawal by Subject|0
7027807|NCT01614925|11105417|FG000|Overall Study|Protocol Violation|3
7027808|NCT01614925|11105418|FG001|Overall Study|Protocol Violation|2
7027809|NCT01615198|11105435|FG000|Overall Study|Withdrawal by Subject|5
7027810|NCT01615198|11105436|FG001|Overall Study|Withdrawal by Subject|5
7027811|NCT01615198|11105435|FG000|Overall Study|Protocol deviation|1
7027812|NCT01615198|11105436|FG001|Overall Study|Protocol deviation|1
7027813|NCT01615198|11105435|FG000|Overall Study|Physician Decision|5
7027814|NCT01615198|11105436|FG001|Overall Study|Physician Decision|1
7027815|NCT01615198|11105435|FG000|Overall Study|Lost to Follow-up|1
7027816|NCT01615198|11105436|FG001|Overall Study|Lost to Follow-up|1
7027817|NCT01615198|11105435|FG000|Overall Study|Lack of Efficacy|1
7027818|NCT01615198|11105436|FG001|Overall Study|Lack of Efficacy|6
7027819|NCT01615198|11105435|FG000|Overall Study|Adverse Event|11
7027820|NCT01615198|11105436|FG001|Overall Study|Adverse Event|5
7027821|NCT01615263|11105444|FG000|Overall Study|Post-randomization exclusion|0
7027822|NCT01615263|11105445|FG001|Overall Study|Post-randomization exclusion|2
7027823|NCT01615328|11105453|FG000|Overall Study|Lost to Follow-up|3
7027824|NCT01615328|11105454|FG001|Overall Study|Lost to Follow-up|5
7027825|NCT01615822|11105498|FG000|Period 1|Withdrawal by Subject|0
7027826|NCT01615822|11105499|FG001|Period 1|Withdrawal by Subject|1
7027827|NCT01615822|11105500|FG002|Period 1|Withdrawal by Subject|0
7027828|NCT01615822|11105498|FG000|Period 1|Adverse Event|1
7027829|NCT01615822|11105499|FG001|Period 1|Adverse Event|1
7027830|NCT01615822|11105500|FG002|Period 1|Adverse Event|0
7027831|NCT01615822|11105498|FG000|Period 2|Lost to Follow-up|0
7027832|NCT01615822|11105499|FG001|Period 2|Lost to Follow-up|1
7027833|NCT01615822|11105500|FG002|Period 2|Lost to Follow-up|2
7027834|NCT01615939|11105513|FG000|Overall Study|Lost to Follow-up|5
7143184|NCT03028142|11299602|FG000|Overall Study|Withdrawal by Subject|0
7027835|NCT01615939|11105514|FG001|Overall Study|Lost to Follow-up|0
7044327|NCT01752933|11130019|FG001|Overall Study and Follow-up|Death|34
7044328|NCT01752933|11130018|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0
7044329|NCT01752933|11130019|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7
7044330|NCT01752933|11130018|FG000|Overall Study and Follow-up|Withdrawal by Subject|0
7044331|NCT01752933|11130019|FG001|Overall Study and Follow-up|Withdrawal by Subject|3
7044332|NCT01752933|11130018|FG000|Overall Study and Follow-up|Lost to Follow-up|0
7044333|NCT01752933|11130019|FG001|Overall Study and Follow-up|Lost to Follow-up|2
7044334|NCT01752985|11130029|FG000|Treatment Period|Subject request to discontinue treatment|1
7044335|NCT01752985|11130030|FG001|Treatment Period|Subject request to discontinue treatment|0
7044336|NCT01752985|11130031|FG002|Treatment Period|Subject request to discontinue treatment|1
7044337|NCT01752985|11130029|FG000|Treatment Period|Subject no longer meets study criteria|0
7044338|NCT01752985|11130030|FG001|Treatment Period|Subject no longer meets study criteria|1
7044339|NCT01752985|11130031|FG002|Treatment Period|Subject no longer meets study criteria|1
7044340|NCT01752985|11130029|FG000|Treatment Period|Adverse Event|2
7044341|NCT01752985|11130030|FG001|Treatment Period|Adverse Event|1
7044342|NCT01752985|11130031|FG002|Treatment Period|Adverse Event|2
7044343|NCT01752985|11130029|FG000|Treatment Period|Withdrawal by Subject|1
7044344|NCT01752985|11130030|FG001|Treatment Period|Withdrawal by Subject|1
7044345|NCT01752985|11130031|FG002|Treatment Period|Withdrawal by Subject|0
7044346|NCT01752985|11130029|FG000|Treatment Period|Lost to Follow-up|0
7044347|NCT01752985|11130030|FG001|Treatment Period|Lost to Follow-up|0
7044348|NCT01752985|11130031|FG002|Treatment Period|Lost to Follow-up|1
7044349|NCT01753076|11130041|FG000|Overall Study|Adverse Event|17
7044350|NCT01753076|11130042|FG001|Overall Study|Adverse Event|18
7044351|NCT01753076|11130041|FG000|Overall Study|Lack of Efficacy|3
7044352|NCT01753076|11130042|FG001|Overall Study|Lack of Efficacy|1
7044353|NCT01753076|11130041|FG000|Overall Study|Lost to Follow-up|2
7044354|NCT01753076|11130042|FG001|Overall Study|Lost to Follow-up|1
7044355|NCT01753076|11130041|FG000|Overall Study|Physician Decision|4
7044356|NCT01753076|11130042|FG001|Overall Study|Physician Decision|2
7044357|NCT01753076|11130041|FG000|Overall Study|Withdrawal by Subject|14
7044358|NCT01753076|11130042|FG001|Overall Study|Withdrawal by Subject|24
7044359|NCT01753076|11130041|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1
7044360|NCT01753076|11130042|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0
7044361|NCT01753115|11130053|FG000|Overall Study|Lost to Follow-up|3
7027836|NCT01616173|11105541|FG000|Overall Study|Lost to Follow-up|0
7027837|NCT01616173|11105542|FG001|Overall Study|Lost to Follow-up|2
7027838|NCT01616173|11105543|FG002|Overall Study|Lost to Follow-up|0
7027839|NCT01616459|11105555|FG000|Overall Study|Adverse Event|1
7027840|NCT01616459|11105556|FG001|Overall Study|Adverse Event|1
7027841|NCT01616459|11105557|FG002|Overall Study|Adverse Event|2
7027842|NCT01616459|11105558|FG003|Overall Study|Adverse Event|0
7027843|NCT01616459|11105555|FG000|Overall Study|Lost to Follow-up|1
7027844|NCT01616459|11105556|FG001|Overall Study|Lost to Follow-up|11
7027845|NCT01616459|11105557|FG002|Overall Study|Lost to Follow-up|3
7027846|NCT01616459|11105558|FG003|Overall Study|Lost to Follow-up|2
7027847|NCT01616459|11105555|FG000|Overall Study|Protocol Violation|0
7027848|NCT01616459|11105556|FG001|Overall Study|Protocol Violation|0
7027849|NCT01616459|11105557|FG002|Overall Study|Protocol Violation|0
7027850|NCT01616459|11105558|FG003|Overall Study|Protocol Violation|2
7027851|NCT01616459|11105555|FG000|Overall Study|Withdrawal by Subject|2
7027852|NCT01616459|11105556|FG001|Overall Study|Withdrawal by Subject|4
7027853|NCT01616459|11105557|FG002|Overall Study|Withdrawal by Subject|4
7027854|NCT01616459|11105558|FG003|Overall Study|Withdrawal by Subject|4
7027855|NCT01616459|11105555|FG000|Overall Study|Other reason|0
7027856|NCT01616459|11105556|FG001|Overall Study|Other reason|1
7027857|NCT01616459|11105557|FG002|Overall Study|Other reason|1
7027858|NCT01616459|11105558|FG003|Overall Study|Other reason|0
7027859|NCT01616563|11105573|FG000|Overall Study|Lost to Follow-up|40
7027860|NCT01616654|11105595|FG000|Overall Study|Lack of Efficacy|1
7027861|NCT01616654|11105596|FG001|Overall Study|Lack of Efficacy|0
7027862|NCT01616654|11105597|FG002|Overall Study|Lack of Efficacy|0
7027863|NCT01616654|11105598|FG003|Overall Study|Lack of Efficacy|0
7027864|NCT01616654|11105599|FG004|Overall Study|Lack of Efficacy|1
7027865|NCT01616654|11105595|FG000|Overall Study|Adverse Event|0
7027866|NCT01616654|11105596|FG001|Overall Study|Adverse Event|1
7027867|NCT01616654|11105597|FG002|Overall Study|Adverse Event|2
7027868|NCT01616654|11105598|FG003|Overall Study|Adverse Event|1
7027869|NCT01616654|11105599|FG004|Overall Study|Adverse Event|0
7027870|NCT01616654|11105595|FG000|Overall Study|Withdrawal by Subject|2
7027871|NCT01616654|11105596|FG001|Overall Study|Withdrawal by Subject|2
7027872|NCT01616654|11105597|FG002|Overall Study|Withdrawal by Subject|3
7027873|NCT01616654|11105598|FG003|Overall Study|Withdrawal by Subject|1
7027874|NCT01616654|11105599|FG004|Overall Study|Withdrawal by Subject|5
7027875|NCT01616654|11105595|FG000|Overall Study|Protocol Violation|0
7027876|NCT01616654|11105596|FG001|Overall Study|Protocol Violation|5
7027877|NCT01616654|11105597|FG002|Overall Study|Protocol Violation|2
7027878|NCT01616654|11105598|FG003|Overall Study|Protocol Violation|4
7027879|NCT01616654|11105599|FG004|Overall Study|Protocol Violation|4
7027880|NCT01616654|11105595|FG000|Overall Study|Lost to Follow-up|1
7027881|NCT01616654|11105596|FG001|Overall Study|Lost to Follow-up|0
7027882|NCT01616654|11105597|FG002|Overall Study|Lost to Follow-up|3
7027883|NCT01616654|11105598|FG003|Overall Study|Lost to Follow-up|2
7027884|NCT01616654|11105599|FG004|Overall Study|Lost to Follow-up|1
7027885|NCT01616654|11105595|FG000|Overall Study|Pregnancy|1
7027886|NCT01616654|11105596|FG001|Overall Study|Pregnancy|0
7027887|NCT01616654|11105597|FG002|Overall Study|Pregnancy|0
7027888|NCT01616654|11105598|FG003|Overall Study|Pregnancy|0
7027889|NCT01616654|11105599|FG004|Overall Study|Pregnancy|1
7027890|NCT01616693|11105616|FG000|Evaluated for Safety|Physician Decision|1
7027891|NCT01616693|11105617|FG001|Evaluated for Safety|Physician Decision|0
7027892|NCT01616693|11105618|FG002|Evaluated for Safety|Physician Decision|1
7027893|NCT01616693|11105619|FG003|Evaluated for Safety|Physician Decision|0
7027894|NCT01616693|11105616|FG000|Received Both Vaccines|Adverse Event|2
7027895|NCT01616693|11105617|FG001|Received Both Vaccines|Adverse Event|0
7027896|NCT01616693|11105618|FG002|Received Both Vaccines|Adverse Event|0
7027897|NCT01616693|11105619|FG003|Received Both Vaccines|Adverse Event|0
7027898|NCT01616693|11105616|FG000|Received Both Vaccines|Withdrawal by Subject|7
7027899|NCT01616693|11105617|FG001|Received Both Vaccines|Withdrawal by Subject|7
7027900|NCT01616693|11105618|FG002|Received Both Vaccines|Withdrawal by Subject|8
7027901|NCT01616693|11105619|FG003|Received Both Vaccines|Withdrawal by Subject|15
7027902|NCT01616693|11105616|FG000|Received Both Vaccines|Lost to Follow-up|4
7027903|NCT01616693|11105617|FG001|Received Both Vaccines|Lost to Follow-up|3
7027904|NCT01616693|11105618|FG002|Received Both Vaccines|Lost to Follow-up|4
7027905|NCT01616693|11105619|FG003|Received Both Vaccines|Lost to Follow-up|4
7027906|NCT01616693|11105616|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4
7027907|NCT01616693|11105617|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2
7027908|NCT01616693|11105618|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6
7027909|NCT01616693|11105619|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1
7027910|NCT01616771|11105633|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4
7027911|NCT01616953|11105644|FG000|Overall Study|Lost to Follow-up|1
7027912|NCT01616953|11105645|FG001|Overall Study|Lost to Follow-up|0
7027913|NCT01616953|11105644|FG000|Overall Study|lack of bone and soft tissue|1
7027914|NCT01616953|11105645|FG001|Overall Study|lack of bone and soft tissue|0
7027915|NCT01617005|11105651|FG000|Overall Study|Pregnancy|1
7027916|NCT01617005|11105651|FG000|Overall Study|Lack of motivation for treatment|1
7027917|NCT01617070|11105655|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1
7027918|NCT01617434|11105694|FG000|Overall Study|Adverse Event|12
7027919|NCT01617434|11105695|FG001|Overall Study|Adverse Event|3
7027920|NCT01617434|11105694|FG000|Overall Study|Protocol Violation|8
7027921|NCT01617434|11105695|FG001|Overall Study|Protocol Violation|7
7027922|NCT01617434|11105694|FG000|Overall Study|Withdrawal Criteria|12
7027923|NCT01617434|11105695|FG001|Overall Study|Withdrawal Criteria|37
7027924|NCT01617434|11105694|FG000|Overall Study|Unclassified|3
7027925|NCT01617434|11105695|FG001|Overall Study|Unclassified|4
7027926|NCT01617447|11105703|FG000|Overall Study|Adverse Event|0
7027927|NCT01617447|11105704|FG001|Overall Study|Adverse Event|1
7027928|NCT01617447|11105703|FG000|Overall Study|Physician Decision|0
7027929|NCT01617447|11105704|FG001|Overall Study|Physician Decision|2
7027930|NCT01617460|11105710|FG000|Overall Study|Adverse Event|10
7027931|NCT01617460|11105710|FG000|Overall Study|Physician Decision|16
7027932|NCT01617460|11105710|FG000|Overall Study|Protocol Violation|5
7027933|NCT01617460|11105710|FG000|Overall Study|Withdrawal by Subject|9
7027934|NCT01617629|11105737|FG000|Overall Study|Death|2
7027935|NCT01617629|11105737|FG000|Overall Study|Investigator's Clinical Judgement|1
7027936|NCT01617629|11105737|FG000|Overall Study|Reason Not Specified|1
7027937|NCT01617629|11105737|FG000|Overall Study|Participant Withdrew Consent|2
7027938|NCT01617655|11105743|FG000|Overall Study|Adverse Event|2
7027939|NCT01617655|11105744|FG001|Overall Study|Adverse Event|3
7027940|NCT01617655|11105743|FG000|Overall Study|Poor compliance to protocol|1
7027941|NCT01617655|11105744|FG001|Overall Study|Poor compliance to protocol|4
7027942|NCT01617655|11105743|FG000|Overall Study|Participants moved|0
7027943|NCT01617655|11105744|FG001|Overall Study|Participants moved|4
7027944|NCT01617655|11105743|FG000|Overall Study|Consent withdrawn by participant|1
7027945|NCT01617655|11105744|FG001|Overall Study|Consent withdrawn by participant|1
7027946|NCT01617655|11105743|FG000|Overall Study|Last visit outside protocol visit window|1
7027947|NCT01617655|11105744|FG001|Overall Study|Last visit outside protocol visit window|10
7027948|NCT01617655|11105743|FG000|Overall Study|Site closure|3
7027949|NCT01617655|11105744|FG001|Overall Study|Site closure|5
7027950|NCT01617655|11105743|FG000|Overall Study|Other than specified above|1
7027951|NCT01617655|11105744|FG001|Overall Study|Other than specified above|2
7027952|NCT01617668|11105754|FG000|Overall Study|Adverse Event|7
7027953|NCT01617668|11105755|FG001|Overall Study|Adverse Event|0
7027954|NCT01617668|11105756|FG002|Overall Study|Adverse Event|12
7027955|NCT01617668|11105757|FG003|Overall Study|Adverse Event|5
7027956|NCT01617668|11105754|FG000|Overall Study|Physician Decision|1
7027957|NCT01617668|11105755|FG001|Overall Study|Physician Decision|2
7027958|NCT01617668|11105756|FG002|Overall Study|Physician Decision|3
7027959|NCT01617668|11105757|FG003|Overall Study|Physician Decision|0
7027960|NCT01617668|11105754|FG000|Overall Study|Progressive Disease|4
7027961|NCT01617668|11105755|FG001|Overall Study|Progressive Disease|4
7027962|NCT01617668|11105756|FG002|Overall Study|Progressive Disease|6
7027963|NCT01617668|11105757|FG003|Overall Study|Progressive Disease|9
7027964|NCT01617668|11105754|FG000|Overall Study|Subject/guardian decision|1
7027965|NCT01617668|11105755|FG001|Overall Study|Subject/guardian decision|3
7027966|NCT01617668|11105756|FG002|Overall Study|Subject/guardian decision|2
7027967|NCT01617668|11105757|FG003|Overall Study|Subject/guardian decision|1
7027968|NCT01617681|11105775|FG000|Period 1 Double Blind|Adverse Event|2
7027969|NCT01617681|11105776|FG001|Period 1 Double Blind|Adverse Event|0
7027970|NCT01617681|11105777|FG002|Period 1 Double Blind|Adverse Event|0
7027971|NCT01617681|11105778|FG003|Period 1 Double Blind|Adverse Event|2
7027972|NCT01617681|11105779|FG004|Period 1 Double Blind|Adverse Event|0
7027973|NCT01617681|11105775|FG000|Period 1 Double Blind|Withdrawal by Subject|1
7027974|NCT01617681|11105776|FG001|Period 1 Double Blind|Withdrawal by Subject|1
7027975|NCT01617681|11105777|FG002|Period 1 Double Blind|Withdrawal by Subject|1
7027976|NCT01617681|11105778|FG003|Period 1 Double Blind|Withdrawal by Subject|0
7027977|NCT01617681|11105779|FG004|Period 1 Double Blind|Withdrawal by Subject|0
7027978|NCT01617681|11105775|FG000|Period 2 Open Label|Adverse Event|0
7027979|NCT01617681|11105776|FG001|Period 2 Open Label|Adverse Event|0
7027980|NCT01617681|11105777|FG002|Period 2 Open Label|Adverse Event|0
7027981|NCT01617681|11105778|FG003|Period 2 Open Label|Adverse Event|0
7027982|NCT01617681|11105779|FG004|Period 2 Open Label|Adverse Event|3
7027983|NCT01617681|11105775|FG000|Period 2 Open Label|Withdrawal by Subject|0
7027984|NCT01617681|11105776|FG001|Period 2 Open Label|Withdrawal by Subject|0
7027985|NCT01617681|11105777|FG002|Period 2 Open Label|Withdrawal by Subject|0
7027986|NCT01617681|11105778|FG003|Period 2 Open Label|Withdrawal by Subject|0
7027987|NCT01617681|11105779|FG004|Period 2 Open Label|Withdrawal by Subject|3
7027988|NCT01617967|11105794|FG000|Overall Study|Protocol Violation|0
7027989|NCT01617967|11105795|FG001|Overall Study|Protocol Violation|0
7027990|NCT01617967|11105796|FG002|Overall Study|Protocol Violation|0
7027991|NCT01617967|11105797|FG003|Overall Study|Protocol Violation|1
7027992|NCT01617967|11105798|FG004|Overall Study|Protocol Violation|0
7027993|NCT01617967|11105799|FG005|Overall Study|Protocol Violation|0
7027994|NCT01617967|11105794|FG000|Overall Study|Withdrawal by Subject|0
7027995|NCT01617967|11105795|FG001|Overall Study|Withdrawal by Subject|0
7027996|NCT01617967|11105796|FG002|Overall Study|Withdrawal by Subject|0
7027997|NCT01617967|11105797|FG003|Overall Study|Withdrawal by Subject|0
7027998|NCT01617967|11105798|FG004|Overall Study|Withdrawal by Subject|0
7027999|NCT01617967|11105799|FG005|Overall Study|Withdrawal by Subject|1
7028000|NCT01617967|11105794|FG000|Overall Study|Dosing Suspended by Sponsor|1
7028001|NCT01617967|11105795|FG001|Overall Study|Dosing Suspended by Sponsor|0
7028002|NCT01617967|11105796|FG002|Overall Study|Dosing Suspended by Sponsor|0
7028003|NCT01617967|11105797|FG003|Overall Study|Dosing Suspended by Sponsor|0
7028004|NCT01617967|11105798|FG004|Overall Study|Dosing Suspended by Sponsor|0
7028005|NCT01617967|11105799|FG005|Overall Study|Dosing Suspended by Sponsor|0
7028006|NCT01618019|11105816|FG000|Overall Study|Withdrawal by Subject|14
7028007|NCT01618019|11105817|FG001|Overall Study|Withdrawal by Subject|14
7028008|NCT01618162|11105825|FG000|Overall Study|Protocol Violation|13
7028009|NCT01618162|11105826|FG001|Overall Study|Protocol Violation|10
7028010|NCT01618162|11105825|FG000|Overall Study|Adverse Event|9
7028011|NCT01618162|11105826|FG001|Overall Study|Adverse Event|2
7028012|NCT01618162|11105825|FG000|Overall Study|Withdrawal Criteria|2
7028013|NCT01618162|11105826|FG001|Overall Study|Withdrawal Criteria|10
7028014|NCT01618162|11105825|FG000|Overall Study|Unclassified|14
7028015|NCT01618162|11105826|FG001|Overall Study|Unclassified|13
7028016|NCT01618214|11105834|FG000|Overall Study|Adverse Event|3
7028017|NCT01618214|11105835|FG001|Overall Study|Adverse Event|1
7028018|NCT01618214|11105834|FG000|Overall Study|Lack of Efficacy|1
7028019|NCT01618214|11105835|FG001|Overall Study|Lack of Efficacy|1
7028020|NCT01618214|11105834|FG000|Overall Study|Protocol Violation|1
7028021|NCT01618214|11105835|FG001|Overall Study|Protocol Violation|4
7028022|NCT01618214|11105834|FG000|Overall Study|Withdrawal Criteria|1
7028023|NCT01618214|11105835|FG001|Overall Study|Withdrawal Criteria|2
7028024|NCT01618214|11105834|FG000|Overall Study|Unclassified|4
7028025|NCT01618214|11105835|FG001|Overall Study|Unclassified|5
7028026|NCT01618266|11105854|FG000|Overall Study|Lost to Follow-up|9
7028027|NCT01618266|11105854|FG000|Overall Study|Treatment satisfaction|10
7028028|NCT01618266|11105854|FG000|Overall Study|Other reasons|11
7028029|NCT01618266|11105854|FG000|Overall Study|Lack of Efficacy|23
7028030|NCT01618266|11105854|FG000|Overall Study|Protocol Violation|43
7028031|NCT01618305|11105860|FG000|Overall Study|Death|0
7028032|NCT01618305|11105861|FG001|Overall Study|Death|1
7028033|NCT01618305|11105860|FG000|Overall Study|Lost to Follow-up|11
7028034|NCT01618305|11105861|FG001|Overall Study|Lost to Follow-up|7
7028035|NCT01618305|11105860|FG000|Overall Study|Protocol Violation|1
7028036|NCT01618305|11105861|FG001|Overall Study|Protocol Violation|0
7028037|NCT01618305|11105860|FG000|Overall Study|Withdrawal by Subject|3
7028038|NCT01618305|11105861|FG001|Overall Study|Withdrawal by Subject|2
7028039|NCT01618669|11105886|FG000|Overall Study|Lost to Follow-up|1
7028040|NCT01618669|11105887|FG001|Overall Study|Lost to Follow-up|1
7028041|NCT01618669|11105886|FG000|Overall Study|Randomized but Never Received Study Drug|3
7028042|NCT01618669|11105887|FG001|Overall Study|Randomized but Never Received Study Drug|2
7028043|NCT01618669|11105886|FG000|Overall Study|Adverse Event|16
7028044|NCT01618669|11105887|FG001|Overall Study|Adverse Event|7
7028045|NCT01618669|11105886|FG000|Overall Study|Protocol Violation|5
7028046|NCT01618669|11105887|FG001|Overall Study|Protocol Violation|3
7028047|NCT01618669|11105886|FG000|Overall Study|Withdrawal by Subject|9
7028048|NCT01618669|11105887|FG001|Overall Study|Withdrawal by Subject|9
7028049|NCT01618669|11105886|FG000|Overall Study|Miscellaneous Reason|0
7028050|NCT01618669|11105887|FG001|Overall Study|Miscellaneous Reason|1
7028051|NCT01618695|11105909|FG000|Core Phase|Adverse Event|4
7028052|NCT01618695|11105910|FG001|Core Phase|Adverse Event|5
7028053|NCT01618695|11105911|FG002|Core Phase|Adverse Event|15
7028054|NCT01618695|11105912|FG003|Core Phase|Adverse Event|20
7028055|NCT01618695|11105909|FG000|Core Phase|Lost to Follow-up|0
7028056|NCT01618695|11105910|FG001|Core Phase|Lost to Follow-up|0
7028057|NCT01618695|11105911|FG002|Core Phase|Lost to Follow-up|1
7028058|NCT01618695|11105912|FG003|Core Phase|Lost to Follow-up|0
7028059|NCT01618695|11105909|FG000|Core Phase|Withdrawal by Subject|16
7028060|NCT01618695|11105910|FG001|Core Phase|Withdrawal by Subject|11
7028061|NCT01618695|11105911|FG002|Core Phase|Withdrawal by Subject|9
7028062|NCT01618695|11105912|FG003|Core Phase|Withdrawal by Subject|13
7028063|NCT01618695|11105909|FG000|Core Phase|Pregnancy|2
7028064|NCT01618695|11105910|FG001|Core Phase|Pregnancy|0
7028065|NCT01618695|11105911|FG002|Core Phase|Pregnancy|0
7028066|NCT01618695|11105912|FG003|Core Phase|Pregnancy|0
7028067|NCT01618695|11105909|FG000|Core Phase|Lack of Efficacy|1
7028068|NCT01618695|11105910|FG001|Core Phase|Lack of Efficacy|2
7028069|NCT01618695|11105911|FG002|Core Phase|Lack of Efficacy|1
7028070|NCT01618695|11105912|FG003|Core Phase|Lack of Efficacy|1
7028071|NCT01618695|11105909|FG000|Core Phase|Other than specified|1
7028072|NCT01618695|11105910|FG001|Core Phase|Other than specified|2
7028073|NCT01618695|11105911|FG002|Core Phase|Other than specified|2
7028074|NCT01618695|11105912|FG003|Core Phase|Other than specified|2
7028075|NCT01618695|11105909|FG000|Core Phase|Not treated|1
7028076|NCT01618695|11105910|FG001|Core Phase|Not treated|0
7028077|NCT01618695|11105911|FG002|Core Phase|Not treated|2
7028078|NCT01618695|11105912|FG003|Core Phase|Not treated|0
7028079|NCT01618695|11105909|FG000|Extension Phase|Lack of Efficacy|17
7028080|NCT01618695|11105910|FG001|Extension Phase|Lack of Efficacy|33
7028081|NCT01618695|11105911|FG002|Extension Phase|Lack of Efficacy|26
7028082|NCT01618695|11105912|FG003|Extension Phase|Lack of Efficacy|24
7028083|NCT01618695|11105909|FG000|Extension Phase|Pregnancy|2
7028084|NCT01618695|11105910|FG001|Extension Phase|Pregnancy|0
7028085|NCT01618695|11105911|FG002|Extension Phase|Pregnancy|1
7028086|NCT01618695|11105912|FG003|Extension Phase|Pregnancy|1
7028087|NCT01618695|11105909|FG000|Extension Phase|Withdrawal by Subject|43
7028088|NCT01618695|11105910|FG001|Extension Phase|Withdrawal by Subject|48
7028089|NCT01618695|11105911|FG002|Extension Phase|Withdrawal by Subject|42
7028090|NCT01618695|11105912|FG003|Extension Phase|Withdrawal by Subject|33
7028091|NCT01618695|11105909|FG000|Extension Phase|Adverse Event|18
7028092|NCT01618695|11105910|FG001|Extension Phase|Adverse Event|16
7028093|NCT01618695|11105911|FG002|Extension Phase|Adverse Event|9
7028094|NCT01618695|11105912|FG003|Extension Phase|Adverse Event|20
7028095|NCT01618695|11105909|FG000|Extension Phase|Lost to Follow-up|2
7028096|NCT01618695|11105910|FG001|Extension Phase|Lost to Follow-up|1
7028097|NCT01618695|11105911|FG002|Extension Phase|Lost to Follow-up|1
7028098|NCT01618695|11105912|FG003|Extension Phase|Lost to Follow-up|1
7028099|NCT01618695|11105909|FG000|Extension Phase|Other than specified|13
7028100|NCT01618695|11105910|FG001|Extension Phase|Other than specified|18
7028101|NCT01618695|11105911|FG002|Extension Phase|Other than specified|13
7028102|NCT01618695|11105912|FG003|Extension Phase|Other than specified|18
7028103|NCT01618708|11105925|FG000|Overall Study|Adverse Event|10
7028104|NCT01618708|11105926|FG001|Overall Study|Adverse Event|10
7028105|NCT01618708|11105925|FG000|Overall Study|Lost to Follow-up|3
7028106|NCT01618708|11105926|FG001|Overall Study|Lost to Follow-up|3
7028107|NCT01618708|11105925|FG000|Overall Study|Withdrawal by Subject|17
7028108|NCT01618708|11105926|FG001|Overall Study|Withdrawal by Subject|22
7028109|NCT01618708|11105925|FG000|Overall Study|Lack of Efficacy|8
7028110|NCT01618708|11105926|FG001|Overall Study|Lack of Efficacy|8
7028111|NCT01618708|11105925|FG000|Overall Study|Technical problems|2
7028112|NCT01618708|11105926|FG001|Overall Study|Technical problems|0
7028113|NCT01618708|11105925|FG000|Overall Study|Other than specified above|1
7028114|NCT01618708|11105926|FG001|Overall Study|Other than specified above|1
7028115|NCT01618708|11105925|FG000|Overall Study|Randomized but not treated|3
7028116|NCT01618708|11105926|FG001|Overall Study|Randomized but not treated|2
7028117|NCT01618838|11105933|FG000|Overall Study|slow accrual, trial closed prematurely.|4
7028118|NCT01618864|11105938|FG000|Overall Study|Withdrawal by Subject|2
7028119|NCT01618864|11105938|FG000|Overall Study|Lost to Follow-up|2
7028120|NCT01618916|11105953|FG000|Overall Study|Adverse Event|1
7028121|NCT01618916|11105954|FG001|Overall Study|Adverse Event|0
7028122|NCT01618916|11105955|FG002|Overall Study|Adverse Event|0
7028123|NCT01618916|11105956|FG003|Overall Study|Adverse Event|0
7028124|NCT01618916|11105957|FG004|Overall Study|Adverse Event|0
7028125|NCT01618916|11105958|FG005|Overall Study|Adverse Event|0
7028126|NCT01618916|11105953|FG000|Overall Study|Withdrawal by Subject|0
7028127|NCT01618916|11105954|FG001|Overall Study|Withdrawal by Subject|1
7028128|NCT01618916|11105955|FG002|Overall Study|Withdrawal by Subject|1
7028129|NCT01618916|11105956|FG003|Overall Study|Withdrawal by Subject|0
7028130|NCT01618916|11105957|FG004|Overall Study|Withdrawal by Subject|1
7028131|NCT01618916|11105958|FG005|Overall Study|Withdrawal by Subject|0
7028132|NCT01618916|11105953|FG000|Overall Study|Lost to Follow-up|1
7028133|NCT01618916|11105954|FG001|Overall Study|Lost to Follow-up|0
7028134|NCT01618916|11105955|FG002|Overall Study|Lost to Follow-up|0
7028135|NCT01618916|11105956|FG003|Overall Study|Lost to Follow-up|2
7028136|NCT01618916|11105957|FG004|Overall Study|Lost to Follow-up|0
7028137|NCT01618916|11105958|FG005|Overall Study|Lost to Follow-up|0
7028138|NCT01618968|11106001|FG000|Overall Study|Adverse Event|1
7028139|NCT01618968|11106002|FG001|Overall Study|Adverse Event|0
7028140|NCT01618968|11106003|FG002|Overall Study|Adverse Event|0
7028141|NCT01618968|11106004|FG003|Overall Study|Adverse Event|0
7028142|NCT01618968|11106001|FG000|Overall Study|Death|0
7028143|NCT01618968|11106002|FG001|Overall Study|Death|0
7028144|NCT01618968|11106003|FG002|Overall Study|Death|0
7028145|NCT01618968|11106004|FG003|Overall Study|Death|1
7028146|NCT01619059|11106015|FG000|Short-Term (ST) Treatment Period|Adverse Event|1
7028147|NCT01619059|11106016|FG001|Short-Term (ST) Treatment Period|Adverse Event|0
7028148|NCT01619059|11106015|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2
7028149|NCT01619059|11106016|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5
7028150|NCT01619059|11106015|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2
7028151|NCT01619059|11106016|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4
7028152|NCT01619059|11106015|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1
7028153|NCT01619059|11106016|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2
7028154|NCT01619059|11106015|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0
7028155|NCT01619059|11106016|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1
7028156|NCT01619059|11106015|FG000|Long-Term (LT) Treatment Period|Adverse Event|2
7028157|NCT01619059|11106016|FG001|Long-Term (LT) Treatment Period|Adverse Event|3
7028158|NCT01619059|11106015|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3
7028159|NCT01619059|11106016|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2
7028160|NCT01619059|11106015|FG000|Long-Term (LT) Treatment Period|Death|1
7028161|NCT01619059|11106016|FG001|Long-Term (LT) Treatment Period|Death|0
7028162|NCT01619059|11106015|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2
7028163|NCT01619059|11106016|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2
7028164|NCT01619059|11106015|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0
7028165|NCT01619059|11106016|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1
7028166|NCT01619410|11106024|FG000|Overall Study|Lost to Follow-up|7
7028167|NCT01619410|11106025|FG001|Overall Study|Lost to Follow-up|4
7028168|NCT01619423|11106035|FG000|Part 1 (Dose Escalation)|High basal Mn|0
7028169|NCT01619423|11106036|FG001|Part 1 (Dose Escalation)|High basal Mn|2
7028170|NCT01619423|11106037|FG002|Part 1 (Dose Escalation)|High basal Mn|0
7028171|NCT01619423|11106038|FG003|Part 1 (Dose Escalation)|High basal Mn|0
7028172|NCT01619579|11106051|FG000|Overall Study|Withdrawal by Subject|0
7028173|NCT01619579|11106052|FG001|Overall Study|Withdrawal by Subject|3
7028174|NCT01619787|11106064|FG000|Overall Study|Lost to Follow-up|5
7028175|NCT01619852|11106090|FG000|24 Hour Assessment|Withdrawal by Subject|1
7028176|NCT01619852|11106091|FG001|24 Hour Assessment|Withdrawal by Subject|1
7028177|NCT01619852|11106090|FG000|3 Month Follow up|Lost to Follow-up|31
7028178|NCT01619852|11106091|FG001|3 Month Follow up|Lost to Follow-up|34
7028179|NCT01619865|11106098|FG000|Overall Study|Adverse Event|1
7028180|NCT01619865|11106098|FG000|Overall Study|Death|2
7028181|NCT01619865|11106098|FG000|Overall Study|subject not able to comply|1
7028182|NCT01619878|11106103|FG000|6 Week Follow-up Phase|Adverse Event|1
7028183|NCT01619878|11106103|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1
7028184|NCT01619878|11106103|FG000|Follow-up at 12 Months of Age|Death|2
7028185|NCT01620060|11106133|FG000|Overall Study|Adverse Event|9
7028186|NCT01620060|11106133|FG000|Overall Study|Protocol Violation|1
7028187|NCT01620060|11106133|FG000|Overall Study|Withdrawal by Subject|1
7028188|NCT01620060|11106133|FG000|Overall Study|Did not comply with Study Produre|1
7028189|NCT01620060|11106133|FG000|Overall Study|Family emergency|1
7028190|NCT01620060|11106133|FG000|Overall Study|Per Sponsor Decision|2
7028191|NCT01620086|11106139|FG000|Overall Study|Withdrawal by Subject|3
7028192|NCT01620086|11106140|FG001|Overall Study|Withdrawal by Subject|3
7028193|NCT01620086|11106141|FG002|Overall Study|Withdrawal by Subject|0
7028194|NCT01620086|11106139|FG000|Overall Study|failed study criteria|1
7028195|NCT01620086|11106140|FG001|Overall Study|failed study criteria|4
7028196|NCT01620086|11106141|FG002|Overall Study|failed study criteria|0
7028197|NCT01620086|11106139|FG000|Overall Study|Physician Decision|1
7028198|NCT01620086|11106140|FG001|Overall Study|Physician Decision|0
7028199|NCT01620086|11106141|FG002|Overall Study|Physician Decision|0
7028200|NCT01620138|11106152|FG000|Overall Study|Withdrawal by Subject|3
7028201|NCT01620138|11106153|FG001|Overall Study|Withdrawal by Subject|0
7028202|NCT01620138|11106152|FG000|Overall Study|Lack of Efficacy|1
7028203|NCT01620138|11106153|FG001|Overall Study|Lack of Efficacy|0
7028204|NCT01620138|11106152|FG000|Overall Study|Adverse Event|2
7028205|NCT01620138|11106153|FG001|Overall Study|Adverse Event|0
7028206|NCT01620177|11106159|FG000|Overall Study|Failure at Screening Visit|43
7028207|NCT01620177|11106159|FG000|Overall Study|Withdrawal by Subject|26
7028208|NCT01620177|11106159|FG000|Overall Study|Lost to Follow-up|7
7028209|NCT01620177|11106159|FG000|Overall Study|Physician Decision|2
7028210|NCT01620177|11106159|FG000|Overall Study|Randomized, Not Active due to Scheduling|1
7028211|NCT01620255|11106214|FG000|Overall Study|Withdrawal by Subject|4
7028212|NCT01620255|11106215|FG001|Overall Study|Withdrawal by Subject|1
7028213|NCT01620255|11106216|FG002|Overall Study|Withdrawal by Subject|1
7028214|NCT01620255|11106217|FG003|Overall Study|Withdrawal by Subject|2
7028215|NCT01620255|11106218|FG004|Overall Study|Withdrawal by Subject|4
7028216|NCT01620255|11106214|FG000|Overall Study|Participant underwent fecal transplant|0
7028217|NCT01620255|11106215|FG001|Overall Study|Participant underwent fecal transplant|0
7028218|NCT01620255|11106216|FG002|Overall Study|Participant underwent fecal transplant|1
7028219|NCT01620255|11106217|FG003|Overall Study|Participant underwent fecal transplant|0
7028220|NCT01620255|11106218|FG004|Overall Study|Participant underwent fecal transplant|0
7028221|NCT01620255|11106214|FG000|Overall Study|Non-compliance|0
7028222|NCT01620255|11106215|FG001|Overall Study|Non-compliance|1
7028223|NCT01620255|11106216|FG002|Overall Study|Non-compliance|0
7028224|NCT01620255|11106217|FG003|Overall Study|Non-compliance|0
7028225|NCT01620255|11106218|FG004|Overall Study|Non-compliance|0
7028226|NCT01620255|11106214|FG000|Overall Study|Adverse Event|0
7028227|NCT01620255|11106215|FG001|Overall Study|Adverse Event|4
7028228|NCT01620255|11106216|FG002|Overall Study|Adverse Event|0
7028229|NCT01620255|11106217|FG003|Overall Study|Adverse Event|1
7028230|NCT01620255|11106218|FG004|Overall Study|Adverse Event|1
7028231|NCT01620255|11106214|FG000|Overall Study|Withdrawn at discretion of investigator|0
7028232|NCT01620255|11106215|FG001|Overall Study|Withdrawn at discretion of investigator|0
7028233|NCT01620255|11106216|FG002|Overall Study|Withdrawn at discretion of investigator|0
7028234|NCT01620255|11106217|FG003|Overall Study|Withdrawn at discretion of investigator|0
7028235|NCT01620255|11106218|FG004|Overall Study|Withdrawn at discretion of investigator|1
7028236|NCT01620489|11106232|FG000|Overall Study|Adverse Event|17
7028237|NCT01620489|11106233|FG001|Overall Study|Adverse Event|4
7028238|NCT01620489|11106232|FG000|Overall Study|Protocol Violation|0
7028239|NCT01620489|11106233|FG001|Overall Study|Protocol Violation|3
7028240|NCT01620489|11106232|FG000|Overall Study|Withdrawal Criteria|17
7028241|NCT01620489|11106233|FG001|Overall Study|Withdrawal Criteria|25
7028242|NCT01620489|11106232|FG000|Overall Study|Unclassified|1
7028243|NCT01620489|11106233|FG001|Overall Study|Unclassified|2
7028244|NCT01620528|11106242|FG000|Treatment Period|Did Not Receive Study Drug|0
7028245|NCT01620528|11106243|FG001|Treatment Period|Did Not Receive Study Drug|0
7028246|NCT01620528|11106244|FG002|Treatment Period|Did Not Receive Study Drug|1
7028247|NCT01620528|11106242|FG000|Treatment Period|Withdrawal by Subject|35
7028248|NCT01620528|11106243|FG001|Treatment Period|Withdrawal by Subject|21
7028249|NCT01620528|11106244|FG002|Treatment Period|Withdrawal by Subject|16
7028250|NCT01620528|11106242|FG000|Treatment Period|Adverse Event|17
7028251|NCT01620528|11106243|FG001|Treatment Period|Adverse Event|13
7028252|NCT01620528|11106244|FG002|Treatment Period|Adverse Event|21
7028253|NCT01620528|11106242|FG000|Treatment Period|Lost to Follow-up|16
7028254|NCT01620528|11106243|FG001|Treatment Period|Lost to Follow-up|8
7028255|NCT01620528|11106244|FG002|Treatment Period|Lost to Follow-up|14
7028256|NCT01620528|11106242|FG000|Treatment Period|Other|9
7028257|NCT01620528|11106243|FG001|Treatment Period|Other|5
7028258|NCT01620528|11106244|FG002|Treatment Period|Other|7
7028259|NCT01620528|11106242|FG000|Treatment Period|Subject Noncompliant|11
7028260|NCT01620528|11106243|FG001|Treatment Period|Subject Noncompliant|2
7028261|NCT01620528|11106244|FG002|Treatment Period|Subject Noncompliant|2
7028262|NCT01620528|11106242|FG000|Treatment Period|Pregnancy|7
7028263|NCT01620528|11106243|FG001|Treatment Period|Pregnancy|2
7028264|NCT01620528|11106244|FG002|Treatment Period|Pregnancy|2
7028265|NCT01620528|11106242|FG000|Treatment Period|Surgery/Invasive Intervention|5
7028266|NCT01620528|11106243|FG001|Treatment Period|Surgery/Invasive Intervention|1
7028267|NCT01620528|11106244|FG002|Treatment Period|Surgery/Invasive Intervention|3
7028268|NCT01620528|11106242|FG000|Treatment Period|Exclusionary Medication Received|0
7028269|NCT01620528|11106243|FG001|Treatment Period|Exclusionary Medication Received|1
7028270|NCT01620528|11106244|FG002|Treatment Period|Exclusionary Medication Received|0
7028271|NCT01620528|11106242|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
7028272|NCT01620528|11106243|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7
7028273|NCT01620528|11106244|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
7028274|NCT01620528|11106242|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3
7028275|NCT01620528|11106243|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2
7028276|NCT01620528|11106244|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4
7028277|NCT01620528|11106242|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0
7028278|NCT01620528|11106243|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1
7028279|NCT01620528|11106244|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1
7028280|NCT01620528|11106242|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8
7028281|NCT01620528|11106243|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3
7028282|NCT01620528|11106244|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4
7028283|NCT01620528|11106242|FG000|Post-Treatment Follow-Up Period|Other|6
7028284|NCT01620528|11106243|FG001|Post-Treatment Follow-Up Period|Other|4
7028285|NCT01620528|11106244|FG002|Post-Treatment Follow-Up Period|Other|2
7028286|NCT01620762|11106276|FG000|Overall Study|Protocol Violation|1
7028287|NCT01620762|11106277|FG001|Overall Study|Protocol Violation|1
7028288|NCT01620762|11106278|FG002|Overall Study|Protocol Violation|1
7028289|NCT01620762|11106276|FG000|Overall Study|Adverse Event|9
7028290|NCT01620762|11106277|FG001|Overall Study|Adverse Event|5
7028291|NCT01620762|11106278|FG002|Overall Study|Adverse Event|2
7028292|NCT01620762|11106276|FG000|Overall Study|Withdrawal by Subject|23
7028293|NCT01620762|11106277|FG001|Overall Study|Withdrawal by Subject|26
7028294|NCT01620762|11106278|FG002|Overall Study|Withdrawal by Subject|27
7028295|NCT01620762|11106276|FG000|Overall Study|Lost to Follow-up|11
7028296|NCT01620762|11106277|FG001|Overall Study|Lost to Follow-up|17
7028297|NCT01620762|11106278|FG002|Overall Study|Lost to Follow-up|10
7028298|NCT01620762|11106276|FG000|Overall Study|Protocol deviation|1
7028299|NCT01620762|11106277|FG001|Overall Study|Protocol deviation|1
7028300|NCT01620762|11106278|FG002|Overall Study|Protocol deviation|6
7028301|NCT01620762|11106276|FG000|Overall Study|Subject deterioration|0
7028302|NCT01620762|11106277|FG001|Overall Study|Subject deterioration|1
7028303|NCT01620762|11106278|FG002|Overall Study|Subject deterioration|1
7028304|NCT01620762|11106276|FG000|Overall Study|Non-specified|3
7028305|NCT01620762|11106277|FG001|Overall Study|Non-specified|6
7028306|NCT01620762|11106278|FG002|Overall Study|Non-specified|5
7028307|NCT01620762|11106276|FG000|Overall Study|Use of prohibted therapies|0
7028308|NCT01620762|11106277|FG001|Overall Study|Use of prohibted therapies|1
7028309|NCT01620762|11106278|FG002|Overall Study|Use of prohibted therapies|1
7028310|NCT01620983|11106289|FG000|Overall Study|Lost to Follow-up|8
7028311|NCT01620983|11106290|FG001|Overall Study|Lost to Follow-up|4
7028312|NCT01620983|11106291|FG002|Overall Study|Lost to Follow-up|9
7028313|NCT01620983|11106289|FG000|Overall Study|Withdrawal by Subject|6
7028314|NCT01620983|11106290|FG001|Overall Study|Withdrawal by Subject|8
7028315|NCT01620983|11106291|FG002|Overall Study|Withdrawal by Subject|1
7028316|NCT01620983|11106289|FG000|Overall Study|Death|2
7028317|NCT01620983|11106290|FG001|Overall Study|Death|0
7028318|NCT01620983|11106291|FG002|Overall Study|Death|0
7028319|NCT01620983|11106289|FG000|Overall Study|Physician Decision|3
7028320|NCT01620983|11106290|FG001|Overall Study|Physician Decision|10
7028321|NCT01620983|11106291|FG002|Overall Study|Physician Decision|5
7028322|NCT01621126|11106314|FG000|Overall Study|Physician Decision|6
7028323|NCT01621178|11106321|FG000|Overall Study|Adverse Event|5
7028324|NCT01621178|11106322|FG001|Overall Study|Adverse Event|2
7028325|NCT01621178|11106323|FG002|Overall Study|Adverse Event|8
7028326|NCT01621178|11106321|FG000|Overall Study|Death|6
7028327|NCT01621178|11106322|FG001|Overall Study|Death|7
7028328|NCT01621178|11106323|FG002|Overall Study|Death|2
7028329|NCT01621178|11106321|FG000|Overall Study|Lost to Follow-up|1
7028330|NCT01621178|11106322|FG001|Overall Study|Lost to Follow-up|2
7028331|NCT01621178|11106323|FG002|Overall Study|Lost to Follow-up|1
7028332|NCT01621178|11106321|FG000|Overall Study|Withdrawal by Subject|14
7028333|NCT01621178|11106322|FG001|Overall Study|Withdrawal by Subject|17
7028334|NCT01621178|11106323|FG002|Overall Study|Withdrawal by Subject|18
7028335|NCT01621178|11106321|FG000|Overall Study|Physician Decision|5
7028336|NCT01621178|11106322|FG001|Overall Study|Physician Decision|2
7028337|NCT01621178|11106323|FG002|Overall Study|Physician Decision|7
7028338|NCT01621191|11106335|FG000|Overall Study|Adverse Event|9
7028339|NCT01621191|11106335|FG000|Overall Study|Withdrawal by Subject|8
7028340|NCT01621191|11106335|FG000|Overall Study|Lack of Efficacy|6
7028341|NCT01621191|11106335|FG000|Overall Study|Lost to Follow-up|1
7028342|NCT01621191|11106335|FG000|Overall Study|Site Removed From Study|1
7028343|NCT01621490|11106365|FG000|Overall Study|Participant completed treatment|4
7028344|NCT01621490|11106366|FG001|Overall Study|Participant completed treatment|4
7028345|NCT01621490|11106367|FG002|Overall Study|Participant completed treatment|1
7028346|NCT01621490|11106368|FG003|Overall Study|Participant completed treatment|0
7028347|NCT01621490|11106369|FG004|Overall Study|Participant completed treatment|0
7028348|NCT01621490|11106370|FG005|Overall Study|Participant completed treatment|0
7028349|NCT01621490|11106371|FG006|Overall Study|Participant completed treatment|0
7028350|NCT01621490|11106372|FG007|Overall Study|Participant completed treatment|1
7028351|NCT01621490|11106373|FG008|Overall Study|Participant completed treatment|0
7028352|NCT01621490|11106365|FG000|Overall Study|Patient could not travel|1
7028353|NCT01621490|11106366|FG001|Overall Study|Patient could not travel|0
7028354|NCT01621490|11106367|FG002|Overall Study|Patient could not travel|0
7028355|NCT01621490|11106368|FG003|Overall Study|Patient could not travel|0
7028356|NCT01621490|11106369|FG004|Overall Study|Patient could not travel|0
7028357|NCT01621490|11106370|FG005|Overall Study|Patient could not travel|0
7028358|NCT01621490|11106371|FG006|Overall Study|Patient could not travel|0
7028359|NCT01621490|11106372|FG007|Overall Study|Patient could not travel|0
7028360|NCT01621490|11106373|FG008|Overall Study|Patient could not travel|0
7028361|NCT01621490|11106365|FG000|Overall Study|Subject no longer meets study criteria|0
7028362|NCT01621490|11106366|FG001|Overall Study|Subject no longer meets study criteria|0
7028363|NCT01621490|11106367|FG002|Overall Study|Subject no longer meets study criteria|0
7028364|NCT01621490|11106368|FG003|Overall Study|Subject no longer meets study criteria|0
7028365|NCT01621490|11106369|FG004|Overall Study|Subject no longer meets study criteria|1
7028366|NCT01621490|11106370|FG005|Overall Study|Subject no longer meets study criteria|0
7028367|NCT01621490|11106371|FG006|Overall Study|Subject no longer meets study criteria|0
7028368|NCT01621490|11106372|FG007|Overall Study|Subject no longer meets study criteria|0
7028369|NCT01621490|11106373|FG008|Overall Study|Subject no longer meets study criteria|0
7028370|NCT01621490|11106365|FG000|Overall Study|Maximum clinical benefit|3
7028371|NCT01621490|11106366|FG001|Overall Study|Maximum clinical benefit|2
7028372|NCT01621490|11106367|FG002|Overall Study|Maximum clinical benefit|0
7028373|NCT01621490|11106368|FG003|Overall Study|Maximum clinical benefit|0
7028374|NCT01621490|11106369|FG004|Overall Study|Maximum clinical benefit|0
7028375|NCT01621490|11106370|FG005|Overall Study|Maximum clinical benefit|0
7028376|NCT01621490|11106371|FG006|Overall Study|Maximum clinical benefit|1
7028377|NCT01621490|11106372|FG007|Overall Study|Maximum clinical benefit|2
7028378|NCT01621490|11106373|FG008|Overall Study|Maximum clinical benefit|0
7028379|NCT01621490|11106365|FG000|Overall Study|Withdrawal by Subject|1
7028380|NCT01621490|11106366|FG001|Overall Study|Withdrawal by Subject|0
7028381|NCT01621490|11106367|FG002|Overall Study|Withdrawal by Subject|0
7028382|NCT01621490|11106368|FG003|Overall Study|Withdrawal by Subject|0
7028383|NCT01621490|11106369|FG004|Overall Study|Withdrawal by Subject|0
7028384|NCT01621490|11106370|FG005|Overall Study|Withdrawal by Subject|3
7028385|NCT01621490|11106371|FG006|Overall Study|Withdrawal by Subject|0
7028386|NCT01621490|11106372|FG007|Overall Study|Withdrawal by Subject|0
7028387|NCT01621490|11106373|FG008|Overall Study|Withdrawal by Subject|0
7028388|NCT01621490|11106365|FG000|Overall Study|Subject request to discontinue study|1
7028389|NCT01621490|11106366|FG001|Overall Study|Subject request to discontinue study|3
7028390|NCT01621490|11106367|FG002|Overall Study|Subject request to discontinue study|1
7028391|NCT01621490|11106368|FG003|Overall Study|Subject request to discontinue study|1
7028392|NCT01621490|11106369|FG004|Overall Study|Subject request to discontinue study|0
7028393|NCT01621490|11106370|FG005|Overall Study|Subject request to discontinue study|2
7028394|NCT01621490|11106371|FG006|Overall Study|Subject request to discontinue study|1
7028395|NCT01621490|11106372|FG007|Overall Study|Subject request to discontinue study|0
7028396|NCT01621490|11106373|FG008|Overall Study|Subject request to discontinue study|1
7028397|NCT01621490|11106365|FG000|Overall Study|Adverse event unrelated to study drug|2
7028398|NCT01621490|11106366|FG001|Overall Study|Adverse event unrelated to study drug|1
7028399|NCT01621490|11106367|FG002|Overall Study|Adverse event unrelated to study drug|0
7028400|NCT01621490|11106368|FG003|Overall Study|Adverse event unrelated to study drug|0
7028401|NCT01621490|11106369|FG004|Overall Study|Adverse event unrelated to study drug|0
7028402|NCT01621490|11106370|FG005|Overall Study|Adverse event unrelated to study drug|0
7028403|NCT01621490|11106371|FG006|Overall Study|Adverse event unrelated to study drug|0
7028404|NCT01621490|11106372|FG007|Overall Study|Adverse event unrelated to study drug|2
7028405|NCT01621490|11106373|FG008|Overall Study|Adverse event unrelated to study drug|1
7028406|NCT01621490|11106365|FG000|Overall Study|Disease progression|27
7028407|NCT01621490|11106366|FG001|Overall Study|Disease progression|28
7028408|NCT01621490|11106367|FG002|Overall Study|Disease progression|1
7028409|NCT01621490|11106368|FG003|Overall Study|Disease progression|5
7028410|NCT01621490|11106369|FG004|Overall Study|Disease progression|3
7028411|NCT01621490|11106370|FG005|Overall Study|Disease progression|8
7028412|NCT01621490|11106371|FG006|Overall Study|Disease progression|7
7028413|NCT01621490|11106372|FG007|Overall Study|Disease progression|0
7028414|NCT01621490|11106373|FG008|Overall Study|Disease progression|4
7028415|NCT01621490|11106365|FG000|Overall Study|Study drug toxicity|1
7028416|NCT01621490|11106366|FG001|Overall Study|Study drug toxicity|4
7028417|NCT01621490|11106367|FG002|Overall Study|Study drug toxicity|5
7028418|NCT01621490|11106368|FG003|Overall Study|Study drug toxicity|3
7028419|NCT01621490|11106369|FG004|Overall Study|Study drug toxicity|1
7028420|NCT01621490|11106370|FG005|Overall Study|Study drug toxicity|10
7028421|NCT01621490|11106371|FG006|Overall Study|Study drug toxicity|1
7028422|NCT01621490|11106372|FG007|Overall Study|Study drug toxicity|4
7028423|NCT01621490|11106373|FG008|Overall Study|Study drug toxicity|1
7028424|NCT01621490|11106365|FG000|Overall Study|Death|0
7028425|NCT01621490|11106366|FG001|Overall Study|Death|0
7028426|NCT01621490|11106367|FG002|Overall Study|Death|0
7028427|NCT01621490|11106368|FG003|Overall Study|Death|0
7028428|NCT01621490|11106369|FG004|Overall Study|Death|0
7028429|NCT01621490|11106370|FG005|Overall Study|Death|0
7028430|NCT01621490|11106371|FG006|Overall Study|Death|0
7028431|NCT01621490|11106372|FG007|Overall Study|Death|1
7028432|NCT01621490|11106373|FG008|Overall Study|Death|0
7028433|NCT01621490|11106365|FG000|Overall Study|Grade 4 Lipase elevation|1
7028434|NCT01621490|11106366|FG001|Overall Study|Grade 4 Lipase elevation|0
7028435|NCT01621490|11106367|FG002|Overall Study|Grade 4 Lipase elevation|0
7028436|NCT01621490|11106368|FG003|Overall Study|Grade 4 Lipase elevation|0
7028437|NCT01621490|11106369|FG004|Overall Study|Grade 4 Lipase elevation|0
7028438|NCT01621490|11106370|FG005|Overall Study|Grade 4 Lipase elevation|0
7028439|NCT01621490|11106371|FG006|Overall Study|Grade 4 Lipase elevation|0
7028440|NCT01621490|11106372|FG007|Overall Study|Grade 4 Lipase elevation|0
7028441|NCT01621490|11106373|FG008|Overall Study|Grade 4 Lipase elevation|0
7028442|NCT01621490|11106365|FG000|Overall Study|BMS informed of patient status|0
7028443|NCT01621490|11106366|FG001|Overall Study|BMS informed of patient status|0
7028444|NCT01621490|11106367|FG002|Overall Study|BMS informed of patient status|1
7028445|NCT01621490|11106368|FG003|Overall Study|BMS informed of patient status|0
7028446|NCT01621490|11106369|FG004|Overall Study|BMS informed of patient status|0
7028447|NCT01621490|11106370|FG005|Overall Study|BMS informed of patient status|0
7028448|NCT01621490|11106371|FG006|Overall Study|BMS informed of patient status|0
7028449|NCT01621490|11106372|FG007|Overall Study|BMS informed of patient status|0
7028450|NCT01621490|11106373|FG008|Overall Study|BMS informed of patient status|0
7028451|NCT01621490|11106365|FG000|Overall Study|Investigator decision|0
7028452|NCT01621490|11106366|FG001|Overall Study|Investigator decision|0
7028453|NCT01621490|11106367|FG002|Overall Study|Investigator decision|1
7028454|NCT01621490|11106368|FG003|Overall Study|Investigator decision|0
7028455|NCT01621490|11106369|FG004|Overall Study|Investigator decision|1
7028456|NCT01621490|11106370|FG005|Overall Study|Investigator decision|0
7028457|NCT01621490|11106371|FG006|Overall Study|Investigator decision|1
7028458|NCT01621490|11106372|FG007|Overall Study|Investigator decision|0
7028459|NCT01621490|11106373|FG008|Overall Study|Investigator decision|0
7028460|NCT01621490|11106365|FG000|Overall Study|Documented disease progression|0
7028461|NCT01621490|11106366|FG001|Overall Study|Documented disease progression|0
7028462|NCT01621490|11106367|FG002|Overall Study|Documented disease progression|1
7028463|NCT01621490|11106368|FG003|Overall Study|Documented disease progression|0
7028464|NCT01621490|11106369|FG004|Overall Study|Documented disease progression|0
7028465|NCT01621490|11106370|FG005|Overall Study|Documented disease progression|0
7028466|NCT01621490|11106371|FG006|Overall Study|Documented disease progression|0
7028467|NCT01621490|11106372|FG007|Overall Study|Documented disease progression|0
7028468|NCT01621490|11106373|FG008|Overall Study|Documented disease progression|0
7028469|NCT01621490|11106365|FG000|Overall Study|Patient reached treatment 2 yr limit|0
7028470|NCT01621490|11106366|FG001|Overall Study|Patient reached treatment 2 yr limit|1
7028471|NCT01621490|11106367|FG002|Overall Study|Patient reached treatment 2 yr limit|0
7028472|NCT01621490|11106368|FG003|Overall Study|Patient reached treatment 2 yr limit|0
7028473|NCT01621490|11106369|FG004|Overall Study|Patient reached treatment 2 yr limit|0
7028474|NCT01621490|11106370|FG005|Overall Study|Patient reached treatment 2 yr limit|0
7028475|NCT01621490|11106371|FG006|Overall Study|Patient reached treatment 2 yr limit|0
7028476|NCT01621490|11106372|FG007|Overall Study|Patient reached treatment 2 yr limit|0
7028477|NCT01621490|11106373|FG008|Overall Study|Patient reached treatment 2 yr limit|0
7028478|NCT01621490|11106365|FG000|Overall Study|Clinical deterioration|0
7028479|NCT01621490|11106366|FG001|Overall Study|Clinical deterioration|1
7028480|NCT01621490|11106367|FG002|Overall Study|Clinical deterioration|0
7028481|NCT01621490|11106368|FG003|Overall Study|Clinical deterioration|0
7028482|NCT01621490|11106369|FG004|Overall Study|Clinical deterioration|0
7028483|NCT01621490|11106370|FG005|Overall Study|Clinical deterioration|0
7028484|NCT01621490|11106371|FG006|Overall Study|Clinical deterioration|0
7028485|NCT01621490|11106372|FG007|Overall Study|Clinical deterioration|0
7028486|NCT01621490|11106373|FG008|Overall Study|Clinical deterioration|0
7028487|NCT01621490|11106365|FG000|Overall Study|Complete response|0
7028488|NCT01621490|11106366|FG001|Overall Study|Complete response|0
7028489|NCT01621490|11106367|FG002|Overall Study|Complete response|0
7028490|NCT01621490|11106368|FG003|Overall Study|Complete response|0
7028491|NCT01621490|11106369|FG004|Overall Study|Complete response|0
7028492|NCT01621490|11106370|FG005|Overall Study|Complete response|0
7028493|NCT01621490|11106371|FG006|Overall Study|Complete response|0
7028494|NCT01621490|11106372|FG007|Overall Study|Complete response|0
7028495|NCT01621490|11106373|FG008|Overall Study|Complete response|1
7028496|NCT01621490|11106365|FG000|Overall Study|Patient delayed due to toxicity|0
7028497|NCT01621490|11106366|FG001|Overall Study|Patient delayed due to toxicity|0
7028498|NCT01621490|11106367|FG002|Overall Study|Patient delayed due to toxicity|0
7028499|NCT01621490|11106368|FG003|Overall Study|Patient delayed due to toxicity|0
7028500|NCT01621490|11106369|FG004|Overall Study|Patient delayed due to toxicity|0
7028501|NCT01621490|11106370|FG005|Overall Study|Patient delayed due to toxicity|1
7028502|NCT01621490|11106371|FG006|Overall Study|Patient delayed due to toxicity|0
7028503|NCT01621490|11106372|FG007|Overall Study|Patient delayed due to toxicity|0
7028504|NCT01621490|11106373|FG008|Overall Study|Patient delayed due to toxicity|0
7028505|NCT01621542|11106492|FG000|Overall Study|Adverse Event|0
7028506|NCT01621542|11106493|FG001|Overall Study|Adverse Event|0
7028507|NCT01621542|11106494|FG002|Overall Study|Adverse Event|1
7028508|NCT01621542|11106495|FG003|Overall Study|Adverse Event|3
7028509|NCT01621542|11106496|FG004|Overall Study|Adverse Event|0
7028510|NCT01621542|11106497|FG005|Overall Study|Adverse Event|0
7028511|NCT01621542|11106492|FG000|Overall Study|Death|0
7028512|NCT01621542|11106493|FG001|Overall Study|Death|1
7028513|NCT01621542|11106494|FG002|Overall Study|Death|0
7028514|NCT01621542|11106495|FG003|Overall Study|Death|0
7028515|NCT01621542|11106496|FG004|Overall Study|Death|0
7028516|NCT01621542|11106497|FG005|Overall Study|Death|0
7028517|NCT01621542|11106492|FG000|Overall Study|Physician Decision|1
7028518|NCT01621542|11106493|FG001|Overall Study|Physician Decision|0
7028519|NCT01621542|11106494|FG002|Overall Study|Physician Decision|1
7028520|NCT01621542|11106495|FG003|Overall Study|Physician Decision|13
7028521|NCT01621542|11106496|FG004|Overall Study|Physician Decision|3
7028522|NCT01621542|11106497|FG005|Overall Study|Physician Decision|1
7028523|NCT01621542|11106492|FG000|Overall Study|Withdrawal by Subject|2
7028524|NCT01621542|11106493|FG001|Overall Study|Withdrawal by Subject|0
7028525|NCT01621542|11106494|FG002|Overall Study|Withdrawal by Subject|1
7028526|NCT01621542|11106495|FG003|Overall Study|Withdrawal by Subject|3
7028527|NCT01621542|11106496|FG004|Overall Study|Withdrawal by Subject|3
7028528|NCT01621542|11106497|FG005|Overall Study|Withdrawal by Subject|3
7028529|NCT01621542|11106492|FG000|Overall Study|progression/treatment failure|2
7028530|NCT01621542|11106493|FG001|Overall Study|progression/treatment failure|4
7028531|NCT01621542|11106494|FG002|Overall Study|progression/treatment failure|3
7028532|NCT01621542|11106495|FG003|Overall Study|progression/treatment failure|7
7028533|NCT01621542|11106496|FG004|Overall Study|progression/treatment failure|3
7028534|NCT01621542|11106497|FG005|Overall Study|progression/treatment failure|5
7028535|NCT01621542|11106492|FG000|Overall Study|Protocol Violation|0
7028536|NCT01621542|11106493|FG001|Overall Study|Protocol Violation|0
7028537|NCT01621542|11106494|FG002|Overall Study|Protocol Violation|0
7028538|NCT01621542|11106495|FG003|Overall Study|Protocol Violation|1
7028539|NCT01621542|11106496|FG004|Overall Study|Protocol Violation|0
7028540|NCT01621542|11106497|FG005|Overall Study|Protocol Violation|0
7028541|NCT01621542|11106492|FG000|Overall Study|study stopped by sponsor|0
7028542|NCT01621542|11106493|FG001|Overall Study|study stopped by sponsor|0
7028543|NCT01621542|11106494|FG002|Overall Study|study stopped by sponsor|0
7028544|NCT01621542|11106495|FG003|Overall Study|study stopped by sponsor|1
7028545|NCT01621542|11106496|FG004|Overall Study|study stopped by sponsor|0
7028546|NCT01621542|11106497|FG005|Overall Study|study stopped by sponsor|0
7028547|NCT01621802|11106556|FG000|Overall Study|Protocol Violation|0
7028548|NCT01621802|11106557|FG001|Overall Study|Protocol Violation|0
7028549|NCT01621802|11106558|FG002|Overall Study|Protocol Violation|0
7028550|NCT01621802|11106559|FG003|Overall Study|Protocol Violation|0
7028551|NCT01621802|11106560|FG004|Overall Study|Protocol Violation|0
7028552|NCT01621802|11106561|FG005|Overall Study|Protocol Violation|1
7028553|NCT01621802|11106556|FG000|Overall Study|Withdrawal by Subject|8
7028554|NCT01621802|11106557|FG001|Overall Study|Withdrawal by Subject|4
7028555|NCT01621802|11106558|FG002|Overall Study|Withdrawal by Subject|4
7028556|NCT01621802|11106559|FG003|Overall Study|Withdrawal by Subject|2
7028557|NCT01621802|11106560|FG004|Overall Study|Withdrawal by Subject|2
7028558|NCT01621802|11106561|FG005|Overall Study|Withdrawal by Subject|0
7028559|NCT01621802|11106556|FG000|Overall Study|Migrated/moved from study area|0
7028560|NCT01621802|11106557|FG001|Overall Study|Migrated/moved from study area|0
7028561|NCT01621802|11106558|FG002|Overall Study|Migrated/moved from study area|2
7028562|NCT01621802|11106559|FG003|Overall Study|Migrated/moved from study area|0
7028563|NCT01621802|11106560|FG004|Overall Study|Migrated/moved from study area|1
7028564|NCT01621802|11106561|FG005|Overall Study|Migrated/moved from study area|0
7028565|NCT01621802|11106556|FG000|Overall Study|Others|3
7028566|NCT01621802|11106557|FG001|Overall Study|Others|3
7028567|NCT01621802|11106558|FG002|Overall Study|Others|3
7028568|NCT01621802|11106559|FG003|Overall Study|Others|2
7028569|NCT01621802|11106560|FG004|Overall Study|Others|1
7028570|NCT01621802|11106561|FG005|Overall Study|Others|0
7028571|NCT01621802|11106556|FG000|Overall Study|Lost to Follow-up|36
7028572|NCT01621802|11106557|FG001|Overall Study|Lost to Follow-up|16
7028573|NCT01621802|11106558|FG002|Overall Study|Lost to Follow-up|24
7028574|NCT01621802|11106559|FG003|Overall Study|Lost to Follow-up|7
7028575|NCT01621802|11106560|FG004|Overall Study|Lost to Follow-up|31
7028576|NCT01621802|11106561|FG005|Overall Study|Lost to Follow-up|11
7028577|NCT01621880|11106580|FG000|Overall Study|Adverse Event|5
7028578|NCT01621880|11106581|FG001|Overall Study|Adverse Event|1
7028579|NCT01621880|11106580|FG000|Overall Study|Withdrawal by Subject|5
7028580|NCT01621880|11106581|FG001|Overall Study|Withdrawal by Subject|4
7028581|NCT01622231|11106599|FG000|Overall Study|Physician Decision|1
7028582|NCT01622231|11106599|FG000|Overall Study|Withdrawal by Subject|1
7028583|NCT01622348|11106625|FG000|Overall Study|Withdrawal by Subject|1
7028584|NCT01622348|11106626|FG001|Overall Study|Withdrawal by Subject|0
7028585|NCT01622348|11106627|FG002|Overall Study|Withdrawal by Subject|1
7028586|NCT01622569|11106648|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4
7028587|NCT01622569|11106649|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2
7028588|NCT01622569|11106650|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3
7028589|NCT01622569|11106651|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
7028590|NCT01622569|11106648|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
7028591|NCT01622569|11106649|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
7028592|NCT01622569|11106650|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1
7028593|NCT01622569|11106651|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
7028594|NCT01622569|11106648|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6
7028595|NCT01622569|11106649|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
7028596|NCT01622569|11106650|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3
7028597|NCT01622569|11106651|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2
7028598|NCT01622569|11106648|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
7028599|NCT01622569|11106649|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2
7028600|NCT01622569|11106650|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
7028601|NCT01622569|11106651|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1
7028602|NCT01622569|11106648|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
7028603|NCT01622569|11106649|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
7028604|NCT01622569|11106650|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
7028605|NCT01622569|11106651|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
7028606|NCT01622569|11106648|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
7028607|NCT01622569|11106649|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2
7028608|NCT01622569|11106650|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
7028609|NCT01622569|11106651|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
7028610|NCT01622569|11106648|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
7028611|NCT01622569|11106649|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
7028612|NCT01622569|11106650|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2
7028613|NCT01622569|11106651|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
7028614|NCT01622569|11106648|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
7028615|NCT01622569|11106649|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
7028616|NCT01622569|11106650|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
7028617|NCT01622569|11106651|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1
7028618|NCT01622660|11106671|FG000|Overall Study|Adverse Event|1
7028619|NCT01622673|11106681|FG000|Treatment Period 1|Withdrawal by Subject|0
7028620|NCT01622673|11106682|FG001|Treatment Period 1|Withdrawal by Subject|0
7028621|NCT01622673|11106683|FG002|Treatment Period 1|Withdrawal by Subject|0
7028622|NCT01622673|11106684|FG003|Treatment Period 1|Withdrawal by Subject|1
7028623|NCT01622673|11106685|FG004|Treatment Period 1|Withdrawal by Subject|0
7028624|NCT01622673|11106686|FG005|Treatment Period 1|Withdrawal by Subject|0
7028625|NCT01622673|11106681|FG000|Treatment Period 1|Protocol Violation|0
7028626|NCT01622673|11106682|FG001|Treatment Period 1|Protocol Violation|1
7028627|NCT01622673|11106683|FG002|Treatment Period 1|Protocol Violation|0
7028628|NCT01622673|11106684|FG003|Treatment Period 1|Protocol Violation|0
7028629|NCT01622673|11106685|FG004|Treatment Period 1|Protocol Violation|0
7028630|NCT01622673|11106686|FG005|Treatment Period 1|Protocol Violation|0
7028631|NCT01622673|11106681|FG000|Treatment Period 2|Withdrawal by Subject|0
7028632|NCT01622673|11106682|FG001|Treatment Period 2|Withdrawal by Subject|0
7028633|NCT01622673|11106683|FG002|Treatment Period 2|Withdrawal by Subject|0
7028634|NCT01622673|11106684|FG003|Treatment Period 2|Withdrawal by Subject|1
7028635|NCT01622673|11106685|FG004|Treatment Period 2|Withdrawal by Subject|0
7028636|NCT01622673|11106686|FG005|Treatment Period 2|Withdrawal by Subject|0
7028637|NCT01622673|11106681|FG000|Treatment Period 3|Protocol Violation|0
7028638|NCT01622673|11106682|FG001|Treatment Period 3|Protocol Violation|1
7028639|NCT01622673|11106683|FG002|Treatment Period 3|Protocol Violation|0
7028640|NCT01622673|11106684|FG003|Treatment Period 3|Protocol Violation|0
7028641|NCT01622673|11106685|FG004|Treatment Period 3|Protocol Violation|0
7028642|NCT01622673|11106686|FG005|Treatment Period 3|Protocol Violation|0
7028643|NCT01623050|11106720|FG000|Overall Study|Lost to Follow-up|9
7028644|NCT01623115|11106726|FG000|Overall Study|Randomized but not treated|0
7028645|NCT01623115|11106727|FG001|Overall Study|Randomized but not treated|1
7028646|NCT01623115|11106726|FG000|Overall Study|Physician Decision|1
7028647|NCT01623115|11106727|FG001|Overall Study|Physician Decision|0
7028648|NCT01623115|11106726|FG000|Overall Study|Participants moved|1
7028649|NCT01623115|11106727|FG001|Overall Study|Participants moved|5
7028650|NCT01623115|11106726|FG000|Overall Study|Adverse Event|10
7028651|NCT01623115|11106727|FG001|Overall Study|Adverse Event|13
7028652|NCT01623115|11106726|FG000|Overall Study|Poor compliance to protocol|4
7028653|NCT01623115|11106727|FG001|Overall Study|Poor compliance to protocol|10
7028654|NCT01623115|11106726|FG000|Overall Study|Consent withdrawn by participant|2
7028655|NCT01623115|11106727|FG001|Overall Study|Consent withdrawn by participant|6
7028656|NCT01623115|11106726|FG000|Overall Study|Related to study drug administration|0
7028657|NCT01623115|11106727|FG001|Overall Study|Related to study drug administration|2
7028658|NCT01623115|11106726|FG000|Overall Study|Last visit outside protocol visit window|14
7028659|NCT01623115|11106727|FG001|Overall Study|Last visit outside protocol visit window|26
7028660|NCT01623115|11106726|FG000|Overall Study|Site closure|1
7028661|NCT01623115|11106727|FG001|Overall Study|Site closure|7
7028662|NCT01623115|11106726|FG000|Overall Study|Death|0
7028663|NCT01623115|11106727|FG001|Overall Study|Death|4
7028664|NCT01623115|11106726|FG000|Overall Study|Other than specified above|0
7028665|NCT01623115|11106727|FG001|Overall Study|Other than specified above|3
7028666|NCT01623154|11106733|FG000|Overall Study|Did not drink Pranactin Citric|4
7028667|NCT01623271|11106739|FG000|Overall Study|Withdrawal by Subject|2
7028668|NCT01623310|11106743|FG000|Overall Study|Adverse Event|21
7028669|NCT01623310|11106743|FG000|Overall Study|Lost to Follow-up|18
7028670|NCT01623310|11106743|FG000|Overall Study|Lack of Efficacy|6
7028671|NCT01623310|11106743|FG000|Overall Study|Protocol Violation|6
7028672|NCT01623310|11106743|FG000|Overall Study|Withdrawal by Subject|25
7028673|NCT01623310|11106743|FG000|Overall Study|Became potentially child-bearing|1
7028674|NCT01623310|11106743|FG000|Overall Study|Diagnoses of bilateral cateracts|1
7028675|NCT01623310|11106743|FG000|Overall Study|Investigators Discretion-Noncompliant|1
7044362|NCT01753115|11130054|FG001|Overall Study|Lost to Follow-up|6
7044363|NCT01753115|11130055|FG002|Overall Study|Lost to Follow-up|8
7044364|NCT01753115|11130053|FG000|Overall Study|Withdrawal by Subject|6
7044365|NCT01753115|11130054|FG001|Overall Study|Withdrawal by Subject|5
7044366|NCT01753115|11130055|FG002|Overall Study|Withdrawal by Subject|6
7044367|NCT01753115|11130053|FG000|Overall Study|Subject non-compliant|3
7044368|NCT01753115|11130054|FG001|Overall Study|Subject non-compliant|3
7044369|NCT01753115|11130055|FG002|Overall Study|Subject non-compliant|0
7044370|NCT01753115|11130053|FG000|Overall Study|Used excluded drug|0
7044371|NCT01753115|11130054|FG001|Overall Study|Used excluded drug|1
7044372|NCT01753115|11130055|FG002|Overall Study|Used excluded drug|0
7044373|NCT01753193|11130063|FG000|Overall Study|Withdrawal by Subject|23
7044374|NCT01753193|11130063|FG000|Overall Study|Lost to Follow-up|6
7044375|NCT01753193|11130063|FG000|Overall Study|Death|1
7044376|NCT01753193|11130063|FG000|Overall Study|Other|16
7044377|NCT01753297|11130069|FG000|Overall Study|Lost to Follow-up|7
7044378|NCT01753297|11130070|FG001|Overall Study|Lost to Follow-up|2
7044379|NCT01753297|11130069|FG000|Overall Study|Withdrawal by Subject|26
7044380|NCT01753297|11130070|FG001|Overall Study|Withdrawal by Subject|23
7044381|NCT01753297|11130069|FG000|Overall Study|Adverse Event (up to Month 36)|1
7044382|NCT01753297|11130070|FG001|Overall Study|Adverse Event (up to Month 36)|1
7044383|NCT01753297|11130069|FG000|Overall Study|Death|0
7044384|NCT01753297|11130070|FG001|Overall Study|Death|2
7044385|NCT01753297|11130069|FG000|Overall Study|Did not attend end of study visit|7
7044386|NCT01753297|11130070|FG001|Overall Study|Did not attend end of study visit|8
7044387|NCT01753310|11130080|FG000|Overall Study|Entered into open label extension study|25
7044388|NCT01753310|11130081|FG001|Overall Study|Entered into open label extension study|22
7044389|NCT01753310|11130080|FG000|Overall Study|Adverse Event|1
7044390|NCT01753310|11130081|FG001|Overall Study|Adverse Event|0
7044391|NCT01753310|11130080|FG000|Overall Study|Lost to Follow-up|2
7044392|NCT01753310|11130081|FG001|Overall Study|Lost to Follow-up|0
7044393|NCT01753310|11130080|FG000|Overall Study|Subject decision|2
7044394|NCT01753310|11130081|FG001|Overall Study|Subject decision|2
7044395|NCT01753310|11130080|FG000|Overall Study|Sponsor decision|1
7044396|NCT01753310|11130081|FG001|Overall Study|Sponsor decision|0
7044397|NCT01753310|11130080|FG000|Overall Study|Withdrawal by Subject|1
7044398|NCT01753310|11130081|FG001|Overall Study|Withdrawal by Subject|0
7044399|NCT01753323|11130090|FG000|Overall Study|Lack of Efficacy|0
7044400|NCT01753323|11130091|FG001|Overall Study|Lack of Efficacy|0
7044401|NCT01753323|11130092|FG002|Overall Study|Lack of Efficacy|8
7044402|NCT01753323|11130090|FG000|Overall Study|Protocol deviation|1
7044403|NCT01753323|11130091|FG001|Overall Study|Protocol deviation|0
7044404|NCT01753323|11130092|FG002|Overall Study|Protocol deviation|0
7044405|NCT01753323|11130090|FG000|Overall Study|Adverse Event|0
7044406|NCT01753323|11130091|FG001|Overall Study|Adverse Event|0
7044407|NCT01753323|11130092|FG002|Overall Study|Adverse Event|1
7044408|NCT01753336|11130101|FG000|Overall Study|Patient decision|12
7044409|NCT01753336|11130101|FG000|Overall Study|Lost to Follow-up|3
7044410|NCT01753336|11130101|FG000|Overall Study|Physician Decision|2
7044411|NCT01753336|11130101|FG000|Overall Study|Sponsor's decision|2
7044412|NCT01753336|11130101|FG000|Overall Study|Withdrawal by Subject|1
7044413|NCT01753401|11130116|FG000|Double-blind Period (8 Weeks)|Adverse Event|0
7044414|NCT01753401|11130117|FG001|Double-blind Period (8 Weeks)|Adverse Event|2
7044415|NCT01753401|11130118|FG002|Double-blind Period (8 Weeks)|Adverse Event|0
7044416|NCT01753401|11130119|FG003|Double-blind Period (8 Weeks)|Adverse Event|0
7044417|NCT01753401|11130116|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1
7044418|NCT01753401|11130117|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1
7044419|NCT01753401|11130118|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0
7044420|NCT01753401|11130119|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0
7044421|NCT01753401|11130116|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0
7044422|NCT01753401|11130117|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1
7028676|NCT01623531|11106766|FG000|Overall Study|Death|1
7028677|NCT01623531|11106767|FG001|Overall Study|Death|0
7028678|NCT01623531|11106766|FG000|Overall Study|Protocol Violation|2
7028679|NCT01623531|11106767|FG001|Overall Study|Protocol Violation|1
7028680|NCT01623531|11106766|FG000|Overall Study|Missing data at primary outcome time poi|1
7028681|NCT01623531|11106767|FG001|Overall Study|Missing data at primary outcome time poi|1
7028682|NCT01623596|11106778|FG000|Overall Study|Abnormal laboratory values|2
7028683|NCT01623596|11106779|FG001|Overall Study|Abnormal laboratory values|0
7028684|NCT01623596|11106778|FG000|Overall Study|Administrative problems|9
7028685|NCT01623596|11106779|FG001|Overall Study|Administrative problems|13
7028686|NCT01623596|11106778|FG000|Overall Study|Adverse Event|20
7028687|NCT01623596|11106779|FG001|Overall Study|Adverse Event|29
7028688|NCT01623596|11106778|FG000|Overall Study|Death|0
7028689|NCT01623596|11106779|FG001|Overall Study|Death|2
7028690|NCT01623596|11106778|FG000|Overall Study|Lost to Follow-up|12
7028691|NCT01623596|11106779|FG001|Overall Study|Lost to Follow-up|16
7028692|NCT01623596|11106778|FG000|Overall Study|Withdrawal by Subject|13
7028693|NCT01623596|11106779|FG001|Overall Study|Withdrawal by Subject|31
7028694|NCT01623596|11106778|FG000|Overall Study|Patient no longer requires study drug|1
7028695|NCT01623596|11106779|FG001|Overall Study|Patient no longer requires study drug|0
7028696|NCT01623596|11106778|FG000|Overall Study|Protocol Violation|0
7028697|NCT01623596|11106779|FG001|Overall Study|Protocol Violation|6
7028698|NCT01623596|11106778|FG000|Overall Study|Lack of Efficacy|5
7028699|NCT01623596|11106779|FG001|Overall Study|Lack of Efficacy|3
7028700|NCT01623752|11106800|FG000|Phase 1 (78 Weeks)|No Data|249
7028701|NCT01623752|11106801|FG001|Phase 1 (78 Weeks)|No Data|66
7028702|NCT01623752|11106802|FG002|Phase 1 (78 Weeks)|No Data|2
7028703|NCT01623752|11106800|FG000|Phase 1 (78 Weeks)|Other|33
7028704|NCT01623752|11106801|FG001|Phase 1 (78 Weeks)|Other|20
7028705|NCT01623752|11106802|FG002|Phase 1 (78 Weeks)|Other|0
7028706|NCT01623752|11106800|FG000|Phase 1 (78 Weeks)|Adverse Event|122
7028707|NCT01623752|11106801|FG001|Phase 1 (78 Weeks)|Adverse Event|39
7028708|NCT01623752|11106802|FG002|Phase 1 (78 Weeks)|Adverse Event|0
7028709|NCT01623752|11106800|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227
7028710|NCT01623752|11106801|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82
7028711|NCT01623752|11106802|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0
7028712|NCT01623752|11106800|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14
7028713|NCT01623752|11106801|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2
7028714|NCT01623752|11106802|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0
7028715|NCT01623752|11106800|FG000|Phase 2 (78 Weeks)|Other|5
7028716|NCT01623752|11106801|FG001|Phase 2 (78 Weeks)|Other|1
7028717|NCT01623752|11106802|FG002|Phase 2 (78 Weeks)|Other|0
7028718|NCT01623752|11106800|FG000|Phase 2 (78 Weeks)|No Data|43
7028719|NCT01623752|11106801|FG001|Phase 2 (78 Weeks)|No Data|11
7028720|NCT01623752|11106802|FG002|Phase 2 (78 Weeks)|No Data|0
7028721|NCT01623752|11106800|FG000|Phase 2 (78 Weeks)|Adverse Event|4
7028722|NCT01623752|11106801|FG001|Phase 2 (78 Weeks)|Adverse Event|4
7028723|NCT01623752|11106802|FG002|Phase 2 (78 Weeks)|Adverse Event|0
7028724|NCT01623830|11106813|FG000|Overall Study|Withdrawal by Subject|6
7028725|NCT01623830|11106814|FG001|Overall Study|Withdrawal by Subject|7
7028726|NCT01623830|11106813|FG000|Overall Study|Exclusion from Study|1
7028727|NCT01623830|11106814|FG001|Overall Study|Exclusion from Study|2
7028728|NCT01624090|11106828|FG000|Overall Study|DLT, taken off therapy|0
7028729|NCT01624090|11106829|FG001|Overall Study|DLT, taken off therapy|1
7028730|NCT01624090|11106830|FG002|Overall Study|DLT, taken off therapy|0
7028731|NCT01624090|11106831|FG003|Overall Study|DLT, taken off therapy|0
7028732|NCT01624090|11106828|FG000|Overall Study|Withdrew prior to treatment|0
7028733|NCT01624090|11106829|FG001|Overall Study|Withdrew prior to treatment|1
7028734|NCT01624090|11106830|FG002|Overall Study|Withdrew prior to treatment|0
7028735|NCT01624090|11106831|FG003|Overall Study|Withdrew prior to treatment|0
7028736|NCT01624090|11106828|FG000|Overall Study|Died on study|0
7028737|NCT01624090|11106829|FG001|Overall Study|Died on study|0
7028738|NCT01624090|11106830|FG002|Overall Study|Died on study|2
7028739|NCT01624090|11106831|FG003|Overall Study|Died on study|0
7028740|NCT01624090|11106828|FG000|Overall Study|Did not complete 1 crse of therapy|0
7028741|NCT01624090|11106829|FG001|Overall Study|Did not complete 1 crse of therapy|0
7028742|NCT01624090|11106830|FG002|Overall Study|Did not complete 1 crse of therapy|2
7028743|NCT01624090|11106831|FG003|Overall Study|Did not complete 1 crse of therapy|0
7028744|NCT01624090|11106828|FG000|Overall Study|Dose escalated|0
7028745|NCT01624090|11106829|FG001|Overall Study|Dose escalated|0
7028746|NCT01624090|11106830|FG002|Overall Study|Dose escalated|3
7028747|NCT01624090|11106831|FG003|Overall Study|Dose escalated|0
7028748|NCT01624142|11106843|FG000|Overall Study|Withdrawal by Subject|14
7028749|NCT01624142|11106844|FG001|Overall Study|Withdrawal by Subject|4
7028750|NCT01624142|11106843|FG000|Overall Study|Death|3
7028751|NCT01624142|11106844|FG001|Overall Study|Death|6
7028752|NCT01624142|11106843|FG000|Overall Study|Study Closure|12
7028753|NCT01624142|11106844|FG001|Overall Study|Study Closure|6
7028754|NCT01624142|11106843|FG000|Overall Study|Lost to Follow-up|2
7028755|NCT01624142|11106844|FG001|Overall Study|Lost to Follow-up|0
7028756|NCT01624142|11106843|FG000|Overall Study|Other|1
7028757|NCT01624142|11106844|FG001|Overall Study|Other|0
7028758|NCT01624194|11106866|FG000|Overall Study|Lost to Follow-up|1
7028759|NCT01624194|11106867|FG001|Overall Study|Lost to Follow-up|0
7028760|NCT01624194|11106866|FG000|Overall Study|Withdrawal by Subject|1
7028761|NCT01624194|11106867|FG001|Overall Study|Withdrawal by Subject|0
7028762|NCT01624233|11106874|FG000|Period 2 - Induction|Adverse Event|1
7028763|NCT01624233|11106874|FG000|Period 3 - Maintenance|Adverse Event|2
7028764|NCT01624233|11106874|FG000|Period 3 - Maintenance|Lack of Efficacy|1
7028765|NCT01624233|11106874|FG000|Period 3 - Maintenance|Physician Decision|2
7028766|NCT01624233|11106874|FG000|Period 3 - Maintenance|Withdrawal by Subject|2
7028767|NCT01624233|11106874|FG000|Period 4 - Drug Free Period|Relapsed|61
7028768|NCT01624233|11106874|FG000|Period 5 - Retreatment Period|Adverse Event|5
7028769|NCT01624233|11106874|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1
7028770|NCT01624233|11106874|FG000|Period 5 - Retreatment Period|Physician Decision|1
7028771|NCT01624233|11106874|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3
7028772|NCT01624233|11106874|FG000|Period 6: Follow-up|Adverse Event|3
7028773|NCT01624233|11106874|FG000|Period 6: Follow-up|Lack of Efficacy|2
7028774|NCT01624233|11106874|FG000|Period 6: Follow-up|Physician Decision|1
7028775|NCT01624233|11106874|FG000|Period 6: Follow-up|Withdrawal by Subject|3
7028776|NCT01624259|11106884|FG000|Overall Study|Adverse Event|18
7028777|NCT01624259|11106885|FG001|Overall Study|Adverse Event|18
7028778|NCT01624259|11106884|FG000|Overall Study|Protocol Violation|1
7028779|NCT01624259|11106885|FG001|Overall Study|Protocol Violation|2
7028780|NCT01624259|11106884|FG000|Overall Study|Withdrawal by Subject|5
7028781|NCT01624259|11106885|FG001|Overall Study|Withdrawal by Subject|7
7028782|NCT01624259|11106884|FG000|Overall Study|Physician Decision|1
7028783|NCT01624259|11106885|FG001|Overall Study|Physician Decision|1
7028784|NCT01624259|11106884|FG000|Overall Study|Lost to Follow-up|2
7028785|NCT01624259|11106885|FG001|Overall Study|Lost to Follow-up|3
7028786|NCT01624259|11106884|FG000|Overall Study|Abnormal laboratory measure|3
7028787|NCT01624259|11106885|FG001|Overall Study|Abnormal laboratory measure|0
7028788|NCT01624467|11106917|FG000|Overall Study|Withdrawal by Subject|2
7028789|NCT01624467|11106917|FG000|Overall Study|Lost to Follow-up|1
7028790|NCT01624467|11106917|FG000|Overall Study|Adverse Event|7
7028791|NCT01624467|11106917|FG000|Overall Study|Progressive Disease|19
7028792|NCT01624467|11106917|FG000|Overall Study|Per Sponsor Requirement|1
7028793|NCT01624467|11106917|FG000|Overall Study|Subject Withdrew from Treatment|1
7028794|NCT01624506|11106925|FG000|Overall Study|Lost to Follow-up|29
7028795|NCT01624506|11106926|FG001|Overall Study|Lost to Follow-up|15
7028796|NCT01624506|11106925|FG000|Overall Study|Withdrawal by Subject|9
7028797|NCT01624506|11106926|FG001|Overall Study|Withdrawal by Subject|2
7028798|NCT01624506|11106925|FG000|Overall Study|Death|1
7028799|NCT01624506|11106926|FG001|Overall Study|Death|0
7028800|NCT01624506|11106925|FG000|Overall Study|LINX explants|23
7028801|NCT01624506|11106926|FG001|Overall Study|LINX explants|0
7028802|NCT01624506|11106925|FG000|Overall Study|Adverse Event|3
7028803|NCT01624506|11106926|FG001|Overall Study|Adverse Event|0
7028804|NCT01624662|11106936|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2
7028805|NCT01624662|11106937|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
7028806|NCT01624662|11106938|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
7028807|NCT01624662|11106939|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0
7028808|NCT01624662|11106936|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5
7028809|NCT01624662|11106937|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1
7028810|NCT01624662|11106938|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
7028811|NCT01624662|11106939|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
7028812|NCT01624662|11106936|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
7028813|NCT01624662|11106937|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1
7028814|NCT01624662|11106938|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
7028815|NCT01624662|11106939|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
7028816|NCT01624662|11106936|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3
7028817|NCT01624662|11106937|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
7028818|NCT01624662|11106938|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3
7028819|NCT01624662|11106939|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
7028820|NCT01624662|11106936|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
7028821|NCT01624662|11106937|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
7028822|NCT01624662|11106938|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
7028823|NCT01624662|11106939|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
7028824|NCT01624662|11106936|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
7028825|NCT01624662|11106937|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1
7028826|NCT01624662|11106938|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
7028827|NCT01624662|11106939|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
7028828|NCT01624662|11106936|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
7028829|NCT01624662|11106937|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
7028830|NCT01624662|11106938|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
7028831|NCT01624662|11106939|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
7028832|NCT01624870|11106960|FG000|Overall Study|Death|19
7028833|NCT01624870|11106960|FG000|Overall Study|Withdrawal by Subject|1
7028834|NCT01624870|11106960|FG000|Overall Study|CoreValve not implanted|6
7028835|NCT01624870|11106960|FG000|Overall Study|Lost to follow up|1
7028836|NCT01624974|11106991|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0
7082209|NCT02139644|11192564|FG002|Treatment Period|Non-compliance|0
7028837|NCT01624974|11106992|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2
7028838|NCT01624974|11106991|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1
7028839|NCT01624974|11106992|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2
7028840|NCT01624974|11106991|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5
7028841|NCT01624974|11106992|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3
7028842|NCT01624974|11106991|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1
7028843|NCT01624974|11106992|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0
7028844|NCT01624974|11106991|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0
7028845|NCT01624974|11106992|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1
7028846|NCT01624974|11106991|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1
7028847|NCT01624974|11106992|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1
7028848|NCT01624974|11106991|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0
7028849|NCT01624974|11106992|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1
7028850|NCT01624974|11106991|FG000|Period IV Washout (4 Weeks)|Adverse Event|2
7028851|NCT01624974|11106992|FG001|Period IV Washout (4 Weeks)|Adverse Event|0
7028852|NCT01624974|11106991|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0
7028853|NCT01624974|11106992|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1
7028854|NCT01624974|11106991|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1
7028855|NCT01624974|11106992|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0
7028856|NCT01624974|11106991|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3
7028857|NCT01624974|11106992|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0
7028858|NCT01624974|11106991|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1
7028859|NCT01624974|11106992|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0
7028860|NCT01625000|11107004|FG000|Overall Study|Physician Decision|15
7028861|NCT01625000|11107005|FG001|Overall Study|Physician Decision|7
7028862|NCT01625000|11107006|FG002|Overall Study|Physician Decision|7
7028863|NCT01625000|11107007|FG003|Overall Study|Physician Decision|2
7028864|NCT01625000|11107008|FG004|Overall Study|Physician Decision|15
7028865|NCT01625000|11107004|FG000|Overall Study|Protocol Violation|3
7028866|NCT01625000|11107005|FG001|Overall Study|Protocol Violation|10
7028867|NCT01625000|11107006|FG002|Overall Study|Protocol Violation|4
7028868|NCT01625000|11107007|FG003|Overall Study|Protocol Violation|1
7028869|NCT01625000|11107008|FG004|Overall Study|Protocol Violation|2
7028870|NCT01625000|11107004|FG000|Overall Study|Withdrawal by Subject|19
7028871|NCT01625000|11107005|FG001|Overall Study|Withdrawal by Subject|16
7028872|NCT01625000|11107006|FG002|Overall Study|Withdrawal by Subject|11
7028873|NCT01625000|11107007|FG003|Overall Study|Withdrawal by Subject|9
7028874|NCT01625000|11107008|FG004|Overall Study|Withdrawal by Subject|17
7028875|NCT01625000|11107004|FG000|Overall Study|Adverse Event (including Death)|15
7028876|NCT01625000|11107005|FG001|Overall Study|Adverse Event (including Death)|19
7028877|NCT01625000|11107006|FG002|Overall Study|Adverse Event (including Death)|11
7028878|NCT01625000|11107007|FG003|Overall Study|Adverse Event (including Death)|7
7028879|NCT01625000|11107008|FG004|Overall Study|Adverse Event (including Death)|21
7028880|NCT01625091|11107027|FG000|Intervention|Death|1
7028881|NCT01625091|11107028|FG001|Intervention|Death|1
7028882|NCT01625091|11107027|FG000|Intervention|Withdrawal by Subject|4
7028883|NCT01625091|11107028|FG001|Intervention|Withdrawal by Subject|1
7028884|NCT01625091|11107027|FG000|Intervention|Adverse Event|0
7028885|NCT01625091|11107028|FG001|Intervention|Adverse Event|2
7028886|NCT01625091|11107027|FG000|Intervention|Lost to Follow-up|4
7028887|NCT01625091|11107028|FG001|Intervention|Lost to Follow-up|4
7028888|NCT01625091|11107027|FG000|Intervention|Study termination|2
7028889|NCT01625091|11107028|FG001|Intervention|Study termination|3
7028890|NCT01625091|11107027|FG000|Post-intervention|Death|0
7028891|NCT01625091|11107028|FG001|Post-intervention|Death|1
7028892|NCT01625091|11107027|FG000|Post-intervention|Lost to Follow-up|2
7028893|NCT01625091|11107028|FG001|Post-intervention|Lost to Follow-up|0
7028894|NCT01625091|11107027|FG000|Post-intervention|Study termination|2
7028895|NCT01625091|11107028|FG001|Post-intervention|Study termination|1
7028896|NCT01625182|11107049|FG000|Overall Study|Administrative problems|1
7028897|NCT01625182|11107050|FG001|Overall Study|Administrative problems|0
7028898|NCT01625182|11107049|FG000|Overall Study|Protocol deviation|0
7028899|NCT01625182|11107050|FG001|Overall Study|Protocol deviation|2
7028900|NCT01625182|11107049|FG000|Overall Study|Adverse Event|2
7028901|NCT01625182|11107050|FG001|Overall Study|Adverse Event|0
7028902|NCT01625182|11107049|FG000|Overall Study|Withdrawal by Subject|5
7028903|NCT01625182|11107050|FG001|Overall Study|Withdrawal by Subject|1
7028904|NCT01625182|11107049|FG000|Overall Study|Lack of Efficacy|12
7028905|NCT01625182|11107050|FG001|Overall Study|Lack of Efficacy|8
7028906|NCT01625338|11107064|FG000|Overall Study|Enrolled but not Treated|0
7028907|NCT01625338|11107065|FG001|Overall Study|Enrolled but not Treated|0
7028908|NCT01625338|11107066|FG002|Overall Study|Enrolled but not Treated|1
7028909|NCT01625338|11107064|FG000|Overall Study|Efficacy Failure|27
7028910|NCT01625338|11107065|FG001|Overall Study|Efficacy Failure|39
7028911|NCT01625338|11107066|FG002|Overall Study|Efficacy Failure|31
7028912|NCT01625338|11107064|FG000|Overall Study|Lost to Follow-up|3
7028913|NCT01625338|11107065|FG001|Overall Study|Lost to Follow-up|3
7028914|NCT01625338|11107066|FG002|Overall Study|Lost to Follow-up|2
7028915|NCT01625338|11107064|FG000|Overall Study|Investigator Decision|0
7060588|NCT01920061|11156848|FG011|Overall Study|Participant refused further follow-up|0
7028916|NCT01625338|11107065|FG001|Overall Study|Investigator Decision|2
7028917|NCT01625338|11107066|FG002|Overall Study|Investigator Decision|1
7028918|NCT01625338|11107064|FG000|Overall Study|Subject Withdrew Consent|1
7028919|NCT01625338|11107065|FG001|Overall Study|Subject Withdrew Consent|0
7028920|NCT01625338|11107066|FG002|Overall Study|Subject Withdrew Consent|2
7028921|NCT01625338|11107064|FG000|Overall Study|Adverse Event|1
7028922|NCT01625338|11107065|FG001|Overall Study|Adverse Event|0
7028923|NCT01625338|11107066|FG002|Overall Study|Adverse Event|1
7028924|NCT01625338|11107064|FG000|Overall Study|Study Discontinued by Sponsor|0
7028925|NCT01625338|11107065|FG001|Overall Study|Study Discontinued by Sponsor|0
7028926|NCT01625338|11107066|FG002|Overall Study|Study Discontinued by Sponsor|1
7028927|NCT01625377|11107076|FG000|Overall Study|Death|1
7028928|NCT01625377|11107077|FG001|Overall Study|Death|1
7028929|NCT01625377|11107076|FG000|Overall Study|Administrative Problem|1
7028930|NCT01625377|11107077|FG001|Overall Study|Administrative Problem|1
7028931|NCT01625377|11107076|FG000|Overall Study|Protocol Violation|0
7028932|NCT01625377|11107077|FG001|Overall Study|Protocol Violation|3
7028933|NCT01625377|11107076|FG000|Overall Study|Adverse Event|3
7028934|NCT01625377|11107077|FG001|Overall Study|Adverse Event|16
7028935|NCT01625377|11107076|FG000|Overall Study|Graft loss|1
7028936|NCT01625377|11107077|FG001|Overall Study|Graft loss|0
7028937|NCT01625377|11107076|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7028938|NCT01625377|11107077|FG001|Overall Study|Unsatisfactory therapeutic effect|1
7028939|NCT01625377|11107076|FG000|Overall Study|Abnormal laboratory values|1
7028940|NCT01625377|11107077|FG001|Overall Study|Abnormal laboratory values|0
7028941|NCT01625689|11107109|FG000|Overall Study|Migration|2
7028942|NCT01625689|11107110|FG001|Overall Study|Migration|1
7028943|NCT01625845|11107118|FG000|Overall Study|Adverse Event|1
7028944|NCT01625845|11107119|FG001|Overall Study|Adverse Event|2
7028945|NCT01625845|11107118|FG000|Overall Study|Lost to Follow-up|2
7028946|NCT01625845|11107119|FG001|Overall Study|Lost to Follow-up|1
7028947|NCT01625845|11107118|FG000|Overall Study|Withdrawal by Subject|2
7028948|NCT01625845|11107119|FG001|Overall Study|Withdrawal by Subject|0
7028949|NCT01625897|11107127|FG000|Overall Study|Adverse Event|27
7028950|NCT01625897|11107128|FG001|Overall Study|Adverse Event|10
7028951|NCT01625897|11107127|FG000|Overall Study|Physician Decision|0
7028952|NCT01625897|11107128|FG001|Overall Study|Physician Decision|1
7028953|NCT01625897|11107127|FG000|Overall Study|Withdrawal by Subject|25
7028954|NCT01625897|11107128|FG001|Overall Study|Withdrawal by Subject|3
7028955|NCT01625910|11107136|FG000|Overall Study|Lost to Follow-up|3
7028956|NCT01625910|11107137|FG001|Overall Study|Lost to Follow-up|4
7028957|NCT01625988|11107152|FG000|Overall Study|Lost to Follow-up|5
7028958|NCT01625988|11107153|FG001|Overall Study|Lost to Follow-up|6
7028959|NCT01625988|11107152|FG000|Overall Study|Withdrawal by Subject|8
7028960|NCT01625988|11107153|FG001|Overall Study|Withdrawal by Subject|3
7028961|NCT01625988|11107152|FG000|Overall Study|Adverse Event|0
7028962|NCT01625988|11107153|FG001|Overall Study|Adverse Event|1
7028963|NCT01625988|11107152|FG000|Overall Study|Lack of Efficacy|0
7028964|NCT01625988|11107153|FG001|Overall Study|Lack of Efficacy|1
7028965|NCT01625988|11107152|FG000|Overall Study|Randomized Inappropriately|1
7028966|NCT01625988|11107153|FG001|Overall Study|Randomized Inappropriately|0
7028967|NCT01625988|11107152|FG000|Overall Study|Protocol Violation|0
7028968|NCT01625988|11107153|FG001|Overall Study|Protocol Violation|2
7028969|NCT01626118|11107170|FG000|Overall Study|Lack of Efficacy|1
7028970|NCT01626118|11107171|FG001|Overall Study|Lack of Efficacy|0
7028971|NCT01626118|11107172|FG002|Overall Study|Lack of Efficacy|1
7028972|NCT01626118|11107173|FG003|Overall Study|Lack of Efficacy|3
7028973|NCT01626118|11107170|FG000|Overall Study|Lost to Follow-up|1
7028974|NCT01626118|11107171|FG001|Overall Study|Lost to Follow-up|0
7028975|NCT01626118|11107172|FG002|Overall Study|Lost to Follow-up|0
7028976|NCT01626118|11107173|FG003|Overall Study|Lost to Follow-up|0
7028977|NCT01626118|11107170|FG000|Overall Study|Adverse Event|0
7028978|NCT01626118|11107171|FG001|Overall Study|Adverse Event|1
7028979|NCT01626118|11107172|FG002|Overall Study|Adverse Event|1
7028980|NCT01626118|11107173|FG003|Overall Study|Adverse Event|0
7028981|NCT01626118|11107170|FG000|Overall Study|Investigator Decision|0
7028982|NCT01626118|11107171|FG001|Overall Study|Investigator Decision|1
7028983|NCT01626118|11107172|FG002|Overall Study|Investigator Decision|0
7028984|NCT01626118|11107173|FG003|Overall Study|Investigator Decision|0
7028985|NCT01626352|11107183|FG000|Overall Study|Disease Progression|3
7028986|NCT01626352|11107183|FG000|Overall Study|Intercurrent Illness|2
7028987|NCT01626352|11107183|FG000|Overall Study|Death|2
7028988|NCT01626352|11107183|FG000|Overall Study|Withdrawal by Subject|1
7028989|NCT01626352|11107183|FG000|Overall Study|Non-Compliance|1
7028990|NCT01626352|11107183|FG000|Overall Study|Never Treated|1
7028991|NCT01626391|11107192|FG000|Overall Study|Physician Decision|1
7028992|NCT01626391|11107193|FG001|Overall Study|Physician Decision|0
7028993|NCT01626391|11107192|FG000|Overall Study|Withdrawal by Subject|1
7028994|NCT01626391|11107193|FG001|Overall Study|Withdrawal by Subject|0
7028995|NCT01626456|11107201|FG000|Overall Study|Withdrawal by Subject|21
7028996|NCT01626456|11107202|FG001|Overall Study|Withdrawal by Subject|46
7028997|NCT01626456|11107201|FG000|Overall Study|Adverse Event|2
7028998|NCT01626456|11107202|FG001|Overall Study|Adverse Event|27
7028999|NCT01626456|11107201|FG000|Overall Study|Lost to Follow-up|2
7029000|NCT01626456|11107202|FG001|Overall Study|Lost to Follow-up|27
7029001|NCT01626456|11107201|FG000|Overall Study|Lack of Efficacy|6
7029002|NCT01626456|11107202|FG001|Overall Study|Lack of Efficacy|7
7029003|NCT01626456|11107201|FG000|Overall Study|Physician Decision|1
7029004|NCT01626456|11107202|FG001|Overall Study|Physician Decision|4
7029005|NCT01626456|11107201|FG000|Overall Study|Protocol Violation|1
7029006|NCT01626456|11107202|FG001|Overall Study|Protocol Violation|1
7029007|NCT01626456|11107201|FG000|Overall Study|Site Closure|2
7029008|NCT01626456|11107202|FG001|Overall Study|Site Closure|3
7029009|NCT01626456|11107201|FG000|Overall Study|Incarceration|0
7029010|NCT01626456|11107202|FG001|Overall Study|Incarceration|2
7029011|NCT01626495|11107217|FG000|Overall Study|Adverse Event|3
7029012|NCT01626495|11107217|FG000|Overall Study|Disease progression|27
7029013|NCT01626495|11107217|FG000|Overall Study|Withdrawal by Subject|1
7029014|NCT01626495|11107217|FG000|Overall Study|Administrative problem|1
7029015|NCT01626495|11107217|FG000|Overall Study|Death|2
7029016|NCT01626495|11107217|FG000|Overall Study|Physician Decision|1
7029017|NCT01626495|11107217|FG000|Overall Study|New cancer therapy|16
7029018|NCT01626495|11107217|FG000|Overall Study|Manufacturing failure|1
7029019|NCT01626690|11107234|FG000|Overall Study|Protocol Violation|1
7029020|NCT01626690|11107235|FG001|Overall Study|Protocol Violation|0
7029021|NCT01626690|11107234|FG000|Overall Study|Adverse Event|1
7029022|NCT01626690|11107235|FG001|Overall Study|Adverse Event|0
7029023|NCT01626859|11107256|FG000|Overall Study|Adverse Event|1
7029024|NCT01626859|11107257|FG001|Overall Study|Adverse Event|3
7029025|NCT01626859|11107258|FG002|Overall Study|Adverse Event|2
7029026|NCT01626859|11107256|FG000|Overall Study|Physician Decision|0
7029027|NCT01626859|11107257|FG001|Overall Study|Physician Decision|1
7029028|NCT01626859|11107258|FG002|Overall Study|Physician Decision|0
7029029|NCT01626859|11107256|FG000|Overall Study|Withdrawal by Subject|1
7029030|NCT01626859|11107257|FG001|Overall Study|Withdrawal by Subject|4
7029031|NCT01626859|11107258|FG002|Overall Study|Withdrawal by Subject|2
7029032|NCT01626872|11107269|FG000|Overall Study|Physician Decision|13
7029033|NCT01626872|11107270|FG001|Overall Study|Physician Decision|9
7029034|NCT01626872|11107271|FG002|Overall Study|Physician Decision|6
7029035|NCT01626872|11107269|FG000|Overall Study|Withdrawal by Subject|19
7029036|NCT01626872|11107270|FG001|Overall Study|Withdrawal by Subject|27
7029037|NCT01626872|11107271|FG002|Overall Study|Withdrawal by Subject|8
7029038|NCT01626872|11107269|FG000|Overall Study|Adverse Event (including Death)|20
7029039|NCT01626872|11107270|FG001|Overall Study|Adverse Event (including Death)|28
7029040|NCT01626872|11107271|FG002|Overall Study|Adverse Event (including Death)|8
7029041|NCT01626872|11107269|FG000|Overall Study|Protocol Violation (including Pregnancy)|0
7029042|NCT01626872|11107270|FG001|Overall Study|Protocol Violation (including Pregnancy)|2
7029043|NCT01626872|11107271|FG002|Overall Study|Protocol Violation (including Pregnancy)|2
7029044|NCT01626885|11107279|FG000|Overall Study|Adverse Event|8
7029045|NCT01626885|11107279|FG000|Overall Study|Withdrawal by Subject|4
7029046|NCT01626989|11107283|FG000|Screening Period|Screen Failure|15
7029047|NCT01626989|11107284|FG001|Screening Period|Screen Failure|0
7029048|NCT01626989|11107285|FG002|Screening Period|Screen Failure|0
7029049|NCT01626989|11107283|FG000|Screening Period|Withdrawal by Subject|2
7029050|NCT01626989|11107284|FG001|Screening Period|Withdrawal by Subject|0
7029051|NCT01626989|11107285|FG002|Screening Period|Withdrawal by Subject|0
7029052|NCT01627067|11107331|FG000|Overall Study|Screen Failure|1
7029053|NCT01627249|11107340|FG000|Overall Study|Death|3
7029054|NCT01627249|11107341|FG001|Overall Study|Death|5
7029055|NCT01627249|11107342|FG002|Overall Study|Death|3
7029056|NCT01627249|11107340|FG000|Overall Study|Withdrawal by Subject|12
7029057|NCT01627249|11107341|FG001|Overall Study|Withdrawal by Subject|6
7029058|NCT01627249|11107342|FG002|Overall Study|Withdrawal by Subject|9
7029059|NCT01627249|11107340|FG000|Overall Study|Missed Visit|1
7029060|NCT01627249|11107341|FG001|Overall Study|Missed Visit|1
7029061|NCT01627249|11107342|FG002|Overall Study|Missed Visit|0
7029062|NCT01627327|11107371|FG000|Overall Study|Adverse Event|6
7029063|NCT01627327|11107372|FG001|Overall Study|Adverse Event|12
7029064|NCT01627327|11107371|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0
7029065|NCT01627327|11107372|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2
7029066|NCT01627327|11107371|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4
7029067|NCT01627327|11107372|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9
7029068|NCT01627327|11107371|FG000|Overall Study|Protocol Violation|4
7029069|NCT01627327|11107372|FG001|Overall Study|Protocol Violation|10
7029070|NCT01627327|11107371|FG000|Overall Study|Lost to Follow-up|1
7029071|NCT01627327|11107372|FG001|Overall Study|Lost to Follow-up|3
7029072|NCT01627327|11107371|FG000|Overall Study|Physician Decision|1
7029073|NCT01627327|11107372|FG001|Overall Study|Physician Decision|0
7029074|NCT01627327|11107371|FG000|Overall Study|Withdrawal by Subject|3
7029075|NCT01627327|11107372|FG001|Overall Study|Withdrawal by Subject|3
7029076|NCT01627340|11107380|FG000|Overall Study|Adverse Event|1
7029077|NCT01627340|11107381|FG001|Overall Study|Adverse Event|0
7029078|NCT01627340|11107380|FG000|Overall Study|Lost to Follow-up|8
7029079|NCT01627340|11107381|FG001|Overall Study|Lost to Follow-up|4
7029080|NCT01627340|11107380|FG000|Overall Study|Pregnancy|1
7029081|NCT01627340|11107381|FG001|Overall Study|Pregnancy|0
7029082|NCT01627340|11107380|FG000|Overall Study|Withdrawal by Subject|2
7029083|NCT01627340|11107381|FG001|Overall Study|Withdrawal by Subject|0
7029084|NCT01627691|11107389|FG000|Overall Study|Death|11
7029085|NCT01627691|11107389|FG000|Overall Study|Lost to Follow-up|3
7029086|NCT01627691|11107389|FG000|Overall Study|Withdrawal by Subject|1
7029087|NCT01627691|11107389|FG000|Overall Study|Missed the visit|3
7029088|NCT01627782|11107397|FG000|Overall Study|Adverse Event|1
7029089|NCT01627782|11107398|FG001|Overall Study|Adverse Event|2
7029090|NCT01627782|11107399|FG002|Overall Study|Adverse Event|0
7029091|NCT01627782|11107400|FG003|Overall Study|Adverse Event|1
7029092|NCT01627782|11107397|FG000|Overall Study|Lack of Efficacy|11
7029093|NCT01627782|11107398|FG001|Overall Study|Lack of Efficacy|1
7029094|NCT01627782|11107399|FG002|Overall Study|Lack of Efficacy|15
7029095|NCT01627782|11107400|FG003|Overall Study|Lack of Efficacy|2
7029096|NCT01627782|11107397|FG000|Overall Study|Protocol Violation|1
7029097|NCT01627782|11107398|FG001|Overall Study|Protocol Violation|0
7029098|NCT01627782|11107399|FG002|Overall Study|Protocol Violation|0
7029099|NCT01627782|11107400|FG003|Overall Study|Protocol Violation|0
7029100|NCT01627782|11107397|FG000|Overall Study|Withdrawal by Subject|2
7029101|NCT01627782|11107398|FG001|Overall Study|Withdrawal by Subject|1
7029102|NCT01627782|11107399|FG002|Overall Study|Withdrawal by Subject|0
7029103|NCT01627782|11107400|FG003|Overall Study|Withdrawal by Subject|0
7029104|NCT01627782|11107397|FG000|Overall Study|Other|0
7029105|NCT01627782|11107398|FG001|Overall Study|Other|2
7029106|NCT01627782|11107399|FG002|Overall Study|Other|0
7029107|NCT01627782|11107400|FG003|Overall Study|Other|3
7029108|NCT01627782|11107397|FG000|Overall Study|Randomized But Not Treated|1
7029109|NCT01627782|11107398|FG001|Overall Study|Randomized But Not Treated|0
7029110|NCT01627782|11107399|FG002|Overall Study|Randomized But Not Treated|0
7029111|NCT01627782|11107400|FG003|Overall Study|Randomized But Not Treated|0
7029112|NCT01627860|11107414|FG000|Overall Study|Adverse Event|9
7029113|NCT01627860|11107415|FG001|Overall Study|Adverse Event|4
7029114|NCT01627860|11107414|FG000|Overall Study|Withdrawal by Subject|2
7029115|NCT01627860|11107415|FG001|Overall Study|Withdrawal by Subject|1
7029116|NCT01627860|11107414|FG000|Overall Study|Seizure frequency doubled|0
7029117|NCT01627860|11107415|FG001|Overall Study|Seizure frequency doubled|1
7029118|NCT01627860|11107414|FG000|Overall Study|Protocol Violation|1
7029119|NCT01627860|11107415|FG001|Overall Study|Protocol Violation|0
7029120|NCT01628107|11107453|FG000|Overall Study|Withdrawal by Subject|17
7029121|NCT01628107|11107453|FG000|Overall Study|Lost to Follow-up|4
7029122|NCT01628107|11107453|FG000|Overall Study|Adverse Event|33
7029123|NCT01628107|11107453|FG000|Overall Study|Physician Decision|2
7029124|NCT01628107|11107453|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1
7029125|NCT01628107|11107453|FG000|Overall Study|Non-compliant with Study Procedures|10
7029126|NCT01628107|11107453|FG000|Overall Study|Not Treated|8
7029127|NCT01628107|11107453|FG000|Overall Study|Sponsor Decision|11
7029128|NCT01628107|11107453|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7
7029129|NCT01628107|11107453|FG000|Overall Study|Relocated|8
7029130|NCT01628107|11107453|FG000|Overall Study|Kidney Transplant|9
7029131|NCT01628107|11107453|FG000|Overall Study|Use of Standard of Care|9
7029132|NCT01628120|11107457|FG000|Overall Study|Withdrawal by Subject|7
7029133|NCT01628120|11107457|FG000|Overall Study|Adverse Event|12
7029134|NCT01628120|11107457|FG000|Overall Study|Lost to Follow-up|1
7029135|NCT01628120|11107457|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2
7029136|NCT01628120|11107457|FG000|Overall Study|Non-compliant with Study Procedures|1
7029137|NCT01628120|11107457|FG000|Overall Study|Not Treated|3
7029138|NCT01628120|11107457|FG000|Overall Study|Sponsor Decision|5
7029139|NCT01628120|11107457|FG000|Overall Study|Switched Dialysis Method|2
7029140|NCT01628120|11107457|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3
7029141|NCT01628120|11107457|FG000|Overall Study|Moved or Relocated|5
7029142|NCT01628120|11107457|FG000|Overall Study|Kidney Transplant|2
7029143|NCT01628120|11107457|FG000|Overall Study|Use of Standard of Care|1
7029144|NCT01628198|11107465|FG000|Overall Study|Lost to Follow-up|7
7029145|NCT01628198|11107465|FG000|Overall Study|Withdrawal by Subject|10
7029146|NCT01628198|11107465|FG000|Overall Study|Screen failure|1
7029147|NCT01628367|11107480|FG000|Overall Study|Adverse Event|1
7029148|NCT01628367|11107481|FG001|Overall Study|Adverse Event|0
7029149|NCT01628393|11107490|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1
7029150|NCT01628393|11107491|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0
7029151|NCT01628393|11107492|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0
7029152|NCT01628393|11107493|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0
7029153|NCT01628393|11107494|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0
7029154|NCT01628393|11107490|FG000|Placebo-controlled Treatment Period|Protocol Violation|0
7029155|NCT01628393|11107491|FG001|Placebo-controlled Treatment Period|Protocol Violation|1
7029156|NCT01628393|11107492|FG002|Placebo-controlled Treatment Period|Protocol Violation|0
7029157|NCT01628393|11107493|FG003|Placebo-controlled Treatment Period|Protocol Violation|0
7029158|NCT01628393|11107494|FG004|Placebo-controlled Treatment Period|Protocol Violation|0
7029159|NCT01628393|11107490|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2
7029160|NCT01628393|11107491|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1
7029161|NCT01628393|11107492|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1
7029162|NCT01628393|11107493|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0
7029163|NCT01628393|11107494|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0
7029164|NCT01628393|11107490|FG000|Blinded Active Extension Period|Adverse Event|0
7029165|NCT01628393|11107491|FG001|Blinded Active Extension Period|Adverse Event|1
7029166|NCT01628393|11107492|FG002|Blinded Active Extension Period|Adverse Event|0
7029167|NCT01628393|11107493|FG003|Blinded Active Extension Period|Adverse Event|2
7029168|NCT01628393|11107494|FG004|Blinded Active Extension Period|Adverse Event|2
7029169|NCT01628393|11107490|FG000|Blinded Active Extension Period|Lack of Efficacy|0
7029170|NCT01628393|11107491|FG001|Blinded Active Extension Period|Lack of Efficacy|0
7029171|NCT01628393|11107492|FG002|Blinded Active Extension Period|Lack of Efficacy|2
7029172|NCT01628393|11107493|FG003|Blinded Active Extension Period|Lack of Efficacy|0
7029173|NCT01628393|11107494|FG004|Blinded Active Extension Period|Lack of Efficacy|2
7029174|NCT01628393|11107490|FG000|Blinded Active Extension Period|Physician Decision|0
7029175|NCT01628393|11107491|FG001|Blinded Active Extension Period|Physician Decision|3
7029176|NCT01628393|11107492|FG002|Blinded Active Extension Period|Physician Decision|0
7029177|NCT01628393|11107493|FG003|Blinded Active Extension Period|Physician Decision|1
7029178|NCT01628393|11107494|FG004|Blinded Active Extension Period|Physician Decision|0
7029179|NCT01628393|11107490|FG000|Blinded Active Extension Period|Protocol Violation|0
7029180|NCT01628393|11107491|FG001|Blinded Active Extension Period|Protocol Violation|0
7029181|NCT01628393|11107492|FG002|Blinded Active Extension Period|Protocol Violation|2
7029182|NCT01628393|11107493|FG003|Blinded Active Extension Period|Protocol Violation|1
7029183|NCT01628393|11107494|FG004|Blinded Active Extension Period|Protocol Violation|0
7029184|NCT01628393|11107490|FG000|Blinded Active Extension Period|Withdrawal by Subject|0
7029185|NCT01628393|11107491|FG001|Blinded Active Extension Period|Withdrawal by Subject|6
7029186|NCT01628393|11107492|FG002|Blinded Active Extension Period|Withdrawal by Subject|2
7029187|NCT01628393|11107493|FG003|Blinded Active Extension Period|Withdrawal by Subject|0
7029188|NCT01628393|11107494|FG004|Blinded Active Extension Period|Withdrawal by Subject|2
7029189|NCT01628510|11107510|FG000|Overall Study|Withdrawal by Subject|0
7029190|NCT01628510|11107511|FG001|Overall Study|Withdrawal by Subject|4
7029191|NCT01628510|11107510|FG000|Overall Study|Death|3
7029192|NCT01628510|11107511|FG001|Overall Study|Death|1
7029193|NCT01628549|11107528|FG000|Overall Study|Adverse Event|1
7029194|NCT01628549|11107529|FG001|Overall Study|Adverse Event|1
7029195|NCT01628549|11107530|FG002|Overall Study|Adverse Event|0
7029196|NCT01628549|11107531|FG003|Overall Study|Adverse Event|4
7029197|NCT01628549|11107528|FG000|Overall Study|Lost to Follow-up|3
7029198|NCT01628549|11107529|FG001|Overall Study|Lost to Follow-up|4
7029199|NCT01628549|11107530|FG002|Overall Study|Lost to Follow-up|3
7029200|NCT01628549|11107531|FG003|Overall Study|Lost to Follow-up|3
7029201|NCT01628549|11107528|FG000|Overall Study|Withdrawal by Subject|3
7029202|NCT01628549|11107529|FG001|Overall Study|Withdrawal by Subject|4
7029203|NCT01628549|11107530|FG002|Overall Study|Withdrawal by Subject|4
7029204|NCT01628549|11107531|FG003|Overall Study|Withdrawal by Subject|1
7029205|NCT01628549|11107528|FG000|Overall Study|Protocol Violation|2
7029206|NCT01628549|11107529|FG001|Overall Study|Protocol Violation|1
7029207|NCT01628549|11107530|FG002|Overall Study|Protocol Violation|1
7029208|NCT01628549|11107531|FG003|Overall Study|Protocol Violation|0
7029209|NCT01628549|11107528|FG000|Overall Study|withdrawn for noncompliance|0
7029210|NCT01628549|11107529|FG001|Overall Study|withdrawn for noncompliance|2
7029211|NCT01628549|11107530|FG002|Overall Study|withdrawn for noncompliance|1
7029212|NCT01628549|11107531|FG003|Overall Study|withdrawn for noncompliance|0
7029213|NCT01628549|11107528|FG000|Overall Study|abnormal laboratory test results|0
7029214|NCT01628549|11107529|FG001|Overall Study|abnormal laboratory test results|0
7029215|NCT01628549|11107530|FG002|Overall Study|abnormal laboratory test results|1
7029216|NCT01628549|11107531|FG003|Overall Study|abnormal laboratory test results|0
7029217|NCT01628549|11107528|FG000|Overall Study|positive pregnancy test|0
7029218|NCT01628549|11107529|FG001|Overall Study|positive pregnancy test|0
7029219|NCT01628549|11107530|FG002|Overall Study|positive pregnancy test|0
7029220|NCT01628549|11107531|FG003|Overall Study|positive pregnancy test|1
7029221|NCT01628692|11107559|FG000|Overall Study|Lack of Efficacy|4
7029222|NCT01628692|11107560|FG001|Overall Study|Lack of Efficacy|4
7029223|NCT01628692|11107561|FG002|Overall Study|Lack of Efficacy|5
7029224|NCT01628692|11107562|FG003|Overall Study|Lack of Efficacy|1
7029225|NCT01628692|11107563|FG004|Overall Study|Lack of Efficacy|4
7029226|NCT01628692|11107564|FG005|Overall Study|Lack of Efficacy|7
7029227|NCT01628692|11107559|FG000|Overall Study|Adverse Event|2
7029228|NCT01628692|11107560|FG001|Overall Study|Adverse Event|0
7029229|NCT01628692|11107561|FG002|Overall Study|Adverse Event|2
7029230|NCT01628692|11107562|FG003|Overall Study|Adverse Event|0
7029231|NCT01628692|11107563|FG004|Overall Study|Adverse Event|0
7029232|NCT01628692|11107564|FG005|Overall Study|Adverse Event|0
7029233|NCT01628692|11107559|FG000|Overall Study|Withdrawal by Subject|0
7029234|NCT01628692|11107560|FG001|Overall Study|Withdrawal by Subject|1
7029235|NCT01628692|11107561|FG002|Overall Study|Withdrawal by Subject|1
7029236|NCT01628692|11107562|FG003|Overall Study|Withdrawal by Subject|0
7029237|NCT01628692|11107563|FG004|Overall Study|Withdrawal by Subject|0
7029238|NCT01628692|11107564|FG005|Overall Study|Withdrawal by Subject|0
7029239|NCT01628692|11107559|FG000|Overall Study|Death|0
7029240|NCT01628692|11107560|FG001|Overall Study|Death|1
7029241|NCT01628692|11107561|FG002|Overall Study|Death|0
7029242|NCT01628692|11107562|FG003|Overall Study|Death|0
7029243|NCT01628692|11107563|FG004|Overall Study|Death|0
7029244|NCT01628692|11107564|FG005|Overall Study|Death|0
7029245|NCT01628692|11107559|FG000|Overall Study|Poor compliance/noncompliance|1
7029246|NCT01628692|11107560|FG001|Overall Study|Poor compliance/noncompliance|0
7029247|NCT01628692|11107561|FG002|Overall Study|Poor compliance/noncompliance|0
7029248|NCT01628692|11107562|FG003|Overall Study|Poor compliance/noncompliance|0
7029249|NCT01628692|11107563|FG004|Overall Study|Poor compliance/noncompliance|0
7029250|NCT01628692|11107564|FG005|Overall Study|Poor compliance/noncompliance|0
7029251|NCT01628692|11107559|FG000|Overall Study|Administrative reason by sponsor|0
7029252|NCT01628692|11107560|FG001|Overall Study|Administrative reason by sponsor|0
7029253|NCT01628692|11107561|FG002|Overall Study|Administrative reason by sponsor|0
7029254|NCT01628692|11107562|FG003|Overall Study|Administrative reason by sponsor|0
7029255|NCT01628692|11107563|FG004|Overall Study|Administrative reason by sponsor|0
7029256|NCT01628692|11107564|FG005|Overall Study|Administrative reason by sponsor|1
7029257|NCT01628692|11107559|FG000|Overall Study|Completed 12 Week only|0
7029258|NCT01628692|11107560|FG001|Overall Study|Completed 12 Week only|0
7029259|NCT01628692|11107561|FG002|Overall Study|Completed 12 Week only|0
7029260|NCT01628692|11107562|FG003|Overall Study|Completed 12 Week only|0
7029261|NCT01628692|11107563|FG004|Overall Study|Completed 12 Week only|0
7029262|NCT01628692|11107564|FG005|Overall Study|Completed 12 Week only|1
7029263|NCT01628848|11107592|FG000|Overall Study|Adverse Event|9
7029264|NCT01628848|11107593|FG001|Overall Study|Adverse Event|7
7029265|NCT01628848|11107592|FG000|Overall Study|Lack of Efficacy|0
7029266|NCT01628848|11107593|FG001|Overall Study|Lack of Efficacy|4
7029267|NCT01628848|11107592|FG000|Overall Study|Withdrawal by Subject|0
7029268|NCT01628848|11107593|FG001|Overall Study|Withdrawal by Subject|2
7029269|NCT01628848|11107592|FG000|Overall Study|Physician Decision|3
7029270|NCT01628848|11107593|FG001|Overall Study|Physician Decision|1
7029271|NCT01628874|11107601|FG000|Overall Study|Physician Decision|1
7029272|NCT01628874|11107602|FG001|Overall Study|Physician Decision|1
7029273|NCT01628874|11107601|FG000|Overall Study|Age >4 months|4
7029274|NCT01628874|11107602|FG001|Overall Study|Age >4 months|2
7029275|NCT01628913|11107610|FG000|Overall Study|Adverse Event|12
7029276|NCT01628913|11107611|FG001|Overall Study|Adverse Event|5
7029277|NCT01628913|11107610|FG000|Overall Study|Disease Progression|11
7029278|NCT01628913|11107611|FG001|Overall Study|Disease Progression|14
7029279|NCT01628913|11107610|FG000|Overall Study|Protocol Violation|1
7029280|NCT01628913|11107611|FG001|Overall Study|Protocol Violation|0
7029281|NCT01628913|11107610|FG000|Overall Study|Death|1
7029282|NCT01628913|11107611|FG001|Overall Study|Death|0
7029283|NCT01628913|11107610|FG000|Overall Study|study terminated by Sponsor|4
7029284|NCT01628913|11107611|FG001|Overall Study|study terminated by Sponsor|9
7029285|NCT01628913|11107610|FG000|Overall Study|Withdrawal by Subject|1
7029286|NCT01628913|11107611|FG001|Overall Study|Withdrawal by Subject|0
7029287|NCT01628913|11107610|FG000|Overall Study|Physician Decision|1
7029288|NCT01628913|11107611|FG001|Overall Study|Physician Decision|3
7029289|NCT01628926|11107620|FG000|Overall Study|Adverse Event|13
7029290|NCT01628926|11107621|FG001|Overall Study|Adverse Event|11
7029291|NCT01628926|11107622|FG002|Overall Study|Adverse Event|9
7029292|NCT01628926|11107620|FG000|Overall Study|Lack of Efficacy|2
7029293|NCT01628926|11107621|FG001|Overall Study|Lack of Efficacy|1
7029294|NCT01628926|11107622|FG002|Overall Study|Lack of Efficacy|5
7029295|NCT01628926|11107620|FG000|Overall Study|Withdrawal by Subject|6
7029296|NCT01628926|11107621|FG001|Overall Study|Withdrawal by Subject|4
7029297|NCT01628926|11107622|FG002|Overall Study|Withdrawal by Subject|2
7029298|NCT01628926|11107620|FG000|Overall Study|Protocol Violation|0
7029299|NCT01628926|11107621|FG001|Overall Study|Protocol Violation|1
7029300|NCT01628926|11107622|FG002|Overall Study|Protocol Violation|0
7029301|NCT01628926|11107620|FG000|Overall Study|Discontinuation criteria|3
7029302|NCT01628926|11107621|FG001|Overall Study|Discontinuation criteria|4
7029303|NCT01628926|11107622|FG002|Overall Study|Discontinuation criteria|0
7029304|NCT01628926|11107620|FG000|Overall Study|Physician Decision|2
7029305|NCT01628926|11107621|FG001|Overall Study|Physician Decision|2
7029306|NCT01628926|11107622|FG002|Overall Study|Physician Decision|1
7029307|NCT01628965|11107631|FG000|Overall Study|Adverse Event|30
7029308|NCT01628965|11107631|FG000|Overall Study|Lack of Efficacy|7
7029309|NCT01628965|11107631|FG000|Overall Study|Withdrawal by Subject|3
7029310|NCT01628965|11107631|FG000|Overall Study|Lost to Follow-up|1
7029311|NCT01628965|11107631|FG000|Overall Study|Discontinuation criteria|8
7029312|NCT01629381|11107651|FG000|Overall Study|Withdrawal by Subject|2
7029313|NCT01629381|11107652|FG001|Overall Study|Withdrawal by Subject|5
7029314|NCT01629563|11107664|FG000|Overall Study|Adverse Event|16
7029315|NCT01629563|11107665|FG001|Overall Study|Adverse Event|16
7029316|NCT01629563|11107664|FG000|Overall Study|Death|2
7029317|NCT01629563|11107665|FG001|Overall Study|Death|0
7029318|NCT01629563|11107664|FG000|Overall Study|Lack of Efficacy|2
7029319|NCT01629563|11107665|FG001|Overall Study|Lack of Efficacy|3
7029320|NCT01629563|11107664|FG000|Overall Study|Lost to Follow-up|1
7029321|NCT01629563|11107665|FG001|Overall Study|Lost to Follow-up|0
7029322|NCT01629563|11107664|FG000|Overall Study|Pregnancy|1
7029323|NCT01629563|11107665|FG001|Overall Study|Pregnancy|2
7029324|NCT01629563|11107664|FG000|Overall Study|Protocol Violation|0
7029325|NCT01629563|11107665|FG001|Overall Study|Protocol Violation|1
7029326|NCT01629563|11107664|FG000|Overall Study|Withdrawal by Subject|27
7029327|NCT01629563|11107665|FG001|Overall Study|Withdrawal by Subject|20
7029328|NCT01629563|11107664|FG000|Overall Study|surgery|0
7029329|NCT01629563|11107665|FG001|Overall Study|surgery|3
7029330|NCT01629563|11107664|FG000|Overall Study|Lack of return of menses|12
7029331|NCT01629563|11107665|FG001|Overall Study|Lack of return of menses|7
7029332|NCT01629563|11107664|FG000|Overall Study|Protocol Violation|0
7029333|NCT01629563|11107665|FG001|Overall Study|Protocol Violation|1
7029334|NCT01629589|11107673|FG000|Overall Study|Protocol Violation|4
7029335|NCT01629589|11107674|FG001|Overall Study|Protocol Violation|2
7029336|NCT01629589|11107673|FG000|Overall Study|Lost to Follow-up|2
7029337|NCT01629589|11107674|FG001|Overall Study|Lost to Follow-up|1
7029338|NCT01629589|11107673|FG000|Overall Study|Withdrawal by Subject|2
7029339|NCT01629589|11107674|FG001|Overall Study|Withdrawal by Subject|3
7029340|NCT01629589|11107673|FG000|Overall Study|Did not receive study vaccine|0
7029341|NCT01629589|11107674|FG001|Overall Study|Did not receive study vaccine|1
7029342|NCT01629667|11107687|FG000|Overall Study|Lost to Follow-up|0
7029343|NCT01629667|11107688|FG001|Overall Study|Lost to Follow-up|1
7029344|NCT01629667|11107689|FG002|Overall Study|Lost to Follow-up|1
7029345|NCT01629667|11107687|FG000|Overall Study|Withdrawal by Subject|31
7029346|NCT01629667|11107688|FG001|Overall Study|Withdrawal by Subject|20
7029347|NCT01629667|11107689|FG002|Overall Study|Withdrawal by Subject|28
7029348|NCT01629667|11107687|FG000|Overall Study|Death|1
7029349|NCT01629667|11107688|FG001|Overall Study|Death|5
7029350|NCT01629667|11107689|FG002|Overall Study|Death|3
7029351|NCT01629667|11107687|FG000|Overall Study|Randomized, not treated|2
7029352|NCT01629667|11107688|FG001|Overall Study|Randomized, not treated|1
7029353|NCT01629667|11107689|FG002|Overall Study|Randomized, not treated|0
7029354|NCT01629667|11107687|FG000|Overall Study|Ongoing AE worsening right heart failure|0
7029355|NCT01629667|11107688|FG001|Overall Study|Ongoing AE worsening right heart failure|1
7029356|NCT01629667|11107689|FG002|Overall Study|Ongoing AE worsening right heart failure|0
7029357|NCT01629667|11107687|FG000|Overall Study|Requiring lung transplant|2
7029358|NCT01629667|11107688|FG001|Overall Study|Requiring lung transplant|1
7029359|NCT01629667|11107689|FG002|Overall Study|Requiring lung transplant|3
7029360|NCT01629667|11107687|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9
7029361|NCT01629667|11107688|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11
7029362|NCT01629667|11107689|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8
7029363|NCT01629667|11107687|FG000|Overall Study|Started other medicine|1
7029364|NCT01629667|11107688|FG001|Overall Study|Started other medicine|0
7029365|NCT01629667|11107689|FG002|Overall Study|Started other medicine|1
7029366|NCT01629667|11107687|FG000|Overall Study|Site error in safety follow-up|0
7029367|NCT01629667|11107688|FG001|Overall Study|Site error in safety follow-up|0
7029368|NCT01629667|11107689|FG002|Overall Study|Site error in safety follow-up|1
7029369|NCT01629667|11107687|FG000|Overall Study|Enrolled in another clinical study|0
7029370|NCT01629667|11107688|FG001|Overall Study|Enrolled in another clinical study|1
7029371|NCT01629667|11107689|FG002|Overall Study|Enrolled in another clinical study|0
7029372|NCT01629667|11107687|FG000|Overall Study|Code break|1
7029373|NCT01629667|11107688|FG001|Overall Study|Code break|0
7029374|NCT01629667|11107689|FG002|Overall Study|Code break|0
7029375|NCT01629693|11107701|FG000|Overall Study|Lost to Follow-up|2
7029376|NCT01629693|11107702|FG001|Overall Study|Lost to Follow-up|4
7029377|NCT01629693|11107701|FG000|Overall Study|Withdrawal by Subject|2
7029378|NCT01629693|11107702|FG001|Overall Study|Withdrawal by Subject|2
7029379|NCT01629693|11107701|FG000|Overall Study|Adverse Event|1
7029380|NCT01629693|11107702|FG001|Overall Study|Adverse Event|0
7029381|NCT01629693|11107701|FG000|Overall Study|Investigator decision|0
7029382|NCT01629693|11107702|FG001|Overall Study|Investigator decision|1
7029383|NCT01629693|11107701|FG000|Overall Study|Poor comfort of study lenses|0
7029384|NCT01629693|11107702|FG001|Overall Study|Poor comfort of study lenses|2
7029385|NCT01629693|11107701|FG000|Overall Study|Subject decision unrelated to AE|0
7029386|NCT01629693|11107702|FG001|Overall Study|Subject decision unrelated to AE|1
7029387|NCT01629706|11107708|FG000|Phase 1 PureVision|Screen Failure|4
7029388|NCT01629706|11107708|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1
7029389|NCT01629706|11107708|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1
7029390|NCT01629706|11107708|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3
7029391|NCT01629706|11107708|FG000|Phase 2 Habitual|Screen Failure|6
7029392|NCT01629706|11107708|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1
7029393|NCT01629706|11107708|FG000|Phase 2 Habitual|Relocation prior to Dispense|1
7029394|NCT01629706|11107708|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1
7029395|NCT01629706|11107708|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1
7029396|NCT01629823|11107742|FG000|Trial Period|Missed visit|11
7029397|NCT01629823|11107743|FG001|Trial Period|Missed visit|9
7029398|NCT01629823|11107744|FG002|Trial Period|Missed visit|8
7029399|NCT01629823|11107742|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1
7029400|NCT01629823|11107743|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1
7029401|NCT01629823|11107744|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1
7029402|NCT01629823|11107742|FG000|Trial Period|Pregnancy|1
7029403|NCT01629823|11107743|FG001|Trial Period|Pregnancy|0
7029404|NCT01629823|11107744|FG002|Trial Period|Pregnancy|0
7029405|NCT01629823|11107742|FG000|Trial Period|Adverse Event|0
7029406|NCT01629823|11107743|FG001|Trial Period|Adverse Event|1
7029407|NCT01629823|11107744|FG002|Trial Period|Adverse Event|0
7029408|NCT01629823|11107742|FG000|Trial Period|Out-of-window visit|0
7029409|NCT01629823|11107743|FG001|Trial Period|Out-of-window visit|2
7029410|NCT01629823|11107744|FG002|Trial Period|Out-of-window visit|0
7029411|NCT01629823|11107742|FG000|Trial Period|Failed to hold medication|0
7029412|NCT01629823|11107743|FG001|Trial Period|Failed to hold medication|0
7029413|NCT01629823|11107744|FG002|Trial Period|Failed to hold medication|1
7029414|NCT01629823|11107742|FG000|Washout Period|Safety|2
7029415|NCT01629823|11107743|FG001|Washout Period|Safety|5
7029416|NCT01629823|11107744|FG002|Washout Period|Safety|0
7029417|NCT01629823|11107742|FG000|Washout Period|Pregnancy|1
7029418|NCT01629823|11107743|FG001|Washout Period|Pregnancy|0
7029419|NCT01629823|11107744|FG002|Washout Period|Pregnancy|0
7029420|NCT01629823|11107742|FG000|Washout Period|Protocol Violation|0
7029421|NCT01629823|11107743|FG001|Washout Period|Protocol Violation|1
7029422|NCT01629823|11107744|FG002|Washout Period|Protocol Violation|0
7029423|NCT01629953|11107763|FG000|Overall Study|Death|3
7029424|NCT01629953|11107764|FG001|Overall Study|Death|1
7029425|NCT01629953|11107763|FG000|Overall Study|Lost to Follow-up|10
7029426|NCT01629953|11107764|FG001|Overall Study|Lost to Follow-up|14
7029427|NCT01629966|11107773|FG000|Overall Study|Pregnancy|0
7029428|NCT01629966|11107774|FG001|Overall Study|Pregnancy|1
7029429|NCT01629966|11107775|FG002|Overall Study|Pregnancy|0
7029430|NCT01629966|11107773|FG000|Overall Study|Lost to Follow-up|10
7029431|NCT01629966|11107774|FG001|Overall Study|Lost to Follow-up|13
7029432|NCT01629966|11107775|FG002|Overall Study|Lost to Follow-up|9
7029433|NCT01629966|11107773|FG000|Overall Study|Withdrawal by Subject|8
7029434|NCT01629966|11107774|FG001|Overall Study|Withdrawal by Subject|9
7029435|NCT01629966|11107775|FG002|Overall Study|Withdrawal by Subject|16
7029436|NCT01629966|11107773|FG000|Overall Study|Protocol Violation|7
7029437|NCT01629966|11107774|FG001|Overall Study|Protocol Violation|9
7029438|NCT01629966|11107775|FG002|Overall Study|Protocol Violation|7
7029439|NCT01629966|11107773|FG000|Overall Study|Lack of Efficacy|5
7029440|NCT01629966|11107774|FG001|Overall Study|Lack of Efficacy|2
7029441|NCT01629966|11107775|FG002|Overall Study|Lack of Efficacy|4
7029442|NCT01629966|11107773|FG000|Overall Study|Adverse Event|11
7029443|NCT01629966|11107774|FG001|Overall Study|Adverse Event|18
7029444|NCT01629966|11107775|FG002|Overall Study|Adverse Event|30
7044423|NCT01753401|11130118|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0
7044424|NCT01753401|11130119|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0
7044425|NCT01753401|11130116|FG000|Open Label Period (44 Weeks)|Adverse Event|0
7044426|NCT01753401|11130117|FG001|Open Label Period (44 Weeks)|Adverse Event|0
7044427|NCT01753401|11130118|FG002|Open Label Period (44 Weeks)|Adverse Event|3
7044428|NCT01753401|11130119|FG003|Open Label Period (44 Weeks)|Adverse Event|4
7044429|NCT01753401|11130116|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0
7044430|NCT01753401|11130117|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0
7044431|NCT01753401|11130118|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0
7044432|NCT01753401|11130119|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2
7044433|NCT01753401|11130116|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0
7044434|NCT01753401|11130117|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0
7044435|NCT01753401|11130118|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1
7044436|NCT01753401|11130119|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1
7044437|NCT01753401|11130116|FG000|Open Label Period (44 Weeks)|Reason not provided|0
7044438|NCT01753401|11130117|FG001|Open Label Period (44 Weeks)|Reason not provided|0
7044439|NCT01753401|11130118|FG002|Open Label Period (44 Weeks)|Reason not provided|0
7044440|NCT01753401|11130119|FG003|Open Label Period (44 Weeks)|Reason not provided|2
7044441|NCT01753518|11130131|FG000|Intention-to-Treat Analysis|Missing consent form|5
7044442|NCT01753518|11130132|FG001|Intention-to-Treat Analysis|Missing consent form|3
7044443|NCT01753518|11130131|FG000|Intention-to-Treat Analysis|Multifetal gestation|2
7044444|NCT01753518|11130132|FG001|Intention-to-Treat Analysis|Multifetal gestation|3
7044445|NCT01753518|11130131|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0
7044446|NCT01753518|11130132|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1
7044447|NCT01753518|11130131|FG000|Postpartum Follow-up|Lost to Follow-up|22
7044448|NCT01753518|11130132|FG001|Postpartum Follow-up|Lost to Follow-up|15
7044449|NCT01753570|11130151|FG000|Overall Study|Adverse Event|1
7044450|NCT01753570|11130152|FG001|Overall Study|Adverse Event|0
7044451|NCT01753570|11130153|FG002|Overall Study|Adverse Event|1
7044452|NCT01753570|11130151|FG000|Overall Study|Physician Decision|0
7044453|NCT01753570|11130152|FG001|Overall Study|Physician Decision|1
7044454|NCT01753570|11130153|FG002|Overall Study|Physician Decision|0
7044455|NCT01753570|11130151|FG000|Overall Study|Withdrawal by Subject|1
7044456|NCT01753570|11130152|FG001|Overall Study|Withdrawal by Subject|4
7044457|NCT01753570|11130153|FG002|Overall Study|Withdrawal by Subject|0
7044458|NCT01753856|11130203|FG000|Overall Study|Adverse Event|1
7044459|NCT01753856|11130204|FG001|Overall Study|Adverse Event|0
7044460|NCT01753856|11130203|FG000|Overall Study|Withdrawal by Subject|0
7044461|NCT01753856|11130204|FG001|Overall Study|Withdrawal by Subject|2
7044462|NCT01753856|11130203|FG000|Overall Study|Sponsor Decision|2
7044463|NCT01753856|11130204|FG001|Overall Study|Sponsor Decision|0
7044464|NCT01753999|11130213|FG000|Period 1 - Initial Assignment|Physician Decision|2
7044465|NCT01753999|11130214|FG001|Period 1 - Initial Assignment|Physician Decision|3
7044466|NCT01753999|11130213|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19
7044467|NCT01753999|11130214|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20
7044468|NCT01753999|11130213|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18
7044469|NCT01753999|11130214|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27
7044470|NCT01753999|11130213|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13
7044471|NCT01753999|11130214|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17
7044472|NCT01753999|11130213|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3
7029445|NCT01630135|11107804|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0
7029446|NCT01630135|11107805|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2
7029447|NCT01630616|11107826|FG000|Overall Study|Adverse Event|0
7029448|NCT01630616|11107827|FG001|Overall Study|Adverse Event|0
7029449|NCT01630616|11107828|FG002|Overall Study|Adverse Event|0
7029450|NCT01630616|11107829|FG003|Overall Study|Adverse Event|1
7029451|NCT01630616|11107830|FG004|Overall Study|Adverse Event|0
7029452|NCT01630616|11107831|FG005|Overall Study|Adverse Event|0
7029453|NCT01630616|11107826|FG000|Overall Study|Withdrawal by Subject|0
7029454|NCT01630616|11107827|FG001|Overall Study|Withdrawal by Subject|0
7029455|NCT01630616|11107828|FG002|Overall Study|Withdrawal by Subject|0
7029456|NCT01630616|11107829|FG003|Overall Study|Withdrawal by Subject|2
7029457|NCT01630616|11107830|FG004|Overall Study|Withdrawal by Subject|0
7029458|NCT01630616|11107831|FG005|Overall Study|Withdrawal by Subject|0
7029459|NCT01630811|11107857|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1
7029460|NCT01630811|11107858|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0
7029461|NCT01630889|11107866|FG000|Overall Study|Death|2
7029462|NCT01630889|11107866|FG000|Overall Study|Withdrawal by Subject|1
7029463|NCT01630889|11107866|FG000|Overall Study|Other than Specified|2
7029464|NCT01630889|11107866|FG000|Overall Study|Lost to Follow-up|4
7029465|NCT01630889|11107866|FG000|Overall Study|Other|1
7029466|NCT01631188|11107897|FG000|Overall Study|Physician Decision|75
7029467|NCT01631214|11107903|FG000|Overall Study|Withdrawal by Subject|276
7029468|NCT01631214|11107904|FG001|Overall Study|Withdrawal by Subject|290
7029469|NCT01631214|11107903|FG000|Overall Study|Death|113
7029470|NCT01631214|11107904|FG001|Overall Study|Death|106
7029471|NCT01631214|11107903|FG000|Overall Study|Lost to Follow-up|54
7029472|NCT01631214|11107904|FG001|Overall Study|Lost to Follow-up|40
7029473|NCT01631214|11107903|FG000|Overall Study|Adverse Event|45
7029474|NCT01631214|11107904|FG001|Overall Study|Adverse Event|45
7029475|NCT01631214|11107903|FG000|Overall Study|Other|22
7029476|NCT01631214|11107904|FG001|Overall Study|Other|19
7029477|NCT01631214|11107903|FG000|Overall Study|Noncompliance|16
7029478|NCT01631214|11107904|FG001|Overall Study|Noncompliance|15
7029479|NCT01631214|11107903|FG000|Overall Study|Requirement for Alternative Therapy|8
7029480|NCT01631214|11107904|FG001|Overall Study|Requirement for Alternative Therapy|3
7029481|NCT01631214|11107903|FG000|Overall Study|Protocol Deviation|4
7029482|NCT01631214|11107904|FG001|Overall Study|Protocol Deviation|3
7029483|NCT01631214|11107903|FG000|Overall Study|Ineligibility determined|5
7029484|NCT01631214|11107904|FG001|Overall Study|Ineligibility determined|2
7029485|NCT01631214|11107903|FG000|Overall Study|Administrative Decision|1
7029486|NCT01631214|11107904|FG001|Overall Study|Administrative Decision|0
7029487|NCT01631227|11107914|FG000|Overall Study|withdrawn consent|27
7029488|NCT01631227|11107915|FG001|Overall Study|withdrawn consent|21
7029489|NCT01631227|11107914|FG000|Overall Study|Adverse Event|1
7029490|NCT01631227|11107915|FG001|Overall Study|Adverse Event|0
7029491|NCT01631227|11107914|FG000|Overall Study|administrative|2
7029492|NCT01631227|11107915|FG001|Overall Study|administrative|1
7029493|NCT01631435|11107926|FG000|Overall Study|Adverse Event|2
7029494|NCT01631435|11107926|FG000|Overall Study|Withdrawal by Subject|2
7029495|NCT01631435|11107926|FG000|Overall Study|incomplete study procedure|5
7029496|NCT01631474|11107936|FG000|Overall Study|Lost to Follow-up|8
7029497|NCT01631474|11107937|FG001|Overall Study|Lost to Follow-up|5
7029498|NCT01631474|11107938|FG002|Overall Study|Lost to Follow-up|7
7029499|NCT01631474|11107939|FG003|Overall Study|Lost to Follow-up|5
7029500|NCT01631474|11107940|FG004|Overall Study|Lost to Follow-up|5
7029501|NCT01631474|11107936|FG000|Overall Study|Withdrawal by Subject|4
7029502|NCT01631474|11107937|FG001|Overall Study|Withdrawal by Subject|4
7029503|NCT01631474|11107938|FG002|Overall Study|Withdrawal by Subject|2
7029504|NCT01631474|11107939|FG003|Overall Study|Withdrawal by Subject|6
7029505|NCT01631474|11107940|FG004|Overall Study|Withdrawal by Subject|5
7029506|NCT01631474|11107936|FG000|Overall Study|Lack of Efficacy|2
7029507|NCT01631474|11107937|FG001|Overall Study|Lack of Efficacy|2
7029508|NCT01631474|11107938|FG002|Overall Study|Lack of Efficacy|0
7029509|NCT01631474|11107939|FG003|Overall Study|Lack of Efficacy|0
7029510|NCT01631474|11107940|FG004|Overall Study|Lack of Efficacy|2
7029511|NCT01631474|11107936|FG000|Overall Study|Noncompliance with Study Drug|0
7029512|NCT01631474|11107937|FG001|Overall Study|Noncompliance with Study Drug|0
7029513|NCT01631474|11107938|FG002|Overall Study|Noncompliance with Study Drug|0
7029514|NCT01631474|11107939|FG003|Overall Study|Noncompliance with Study Drug|0
7029515|NCT01631474|11107940|FG004|Overall Study|Noncompliance with Study Drug|1
7029516|NCT01631474|11107936|FG000|Overall Study|Adverse Event|0
7029517|NCT01631474|11107937|FG001|Overall Study|Adverse Event|1
7029518|NCT01631474|11107938|FG002|Overall Study|Adverse Event|0
7029519|NCT01631474|11107939|FG003|Overall Study|Adverse Event|0
7029520|NCT01631474|11107940|FG004|Overall Study|Adverse Event|0
7029521|NCT01631747|11108008|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1
7029522|NCT01631747|11108009|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0
7029523|NCT01631747|11108008|FG000|Live Birth|Pregnancy Termination|1
7029524|NCT01631747|11108009|FG001|Live Birth|Pregnancy Termination|0
7029525|NCT01631747|11108008|FG000|Live Birth|MIscarriage|2
7029526|NCT01631747|11108009|FG001|Live Birth|MIscarriage|0
7029527|NCT01631747|11108008|FG000|Live Birth|Stillbirth|1
7029528|NCT01631747|11108009|FG001|Live Birth|Stillbirth|1
7029529|NCT01631747|11108008|FG000|One Year Infant Outcomes|Patient Refused|13
7029530|NCT01631747|11108009|FG001|One Year Infant Outcomes|Patient Refused|9
7029531|NCT01631812|11108016|FG000|Overall Study|Adverse Event|25
7029532|NCT01631812|11108016|FG000|Overall Study|Lack of Efficacy|5
7029533|NCT01631812|11108016|FG000|Overall Study|Withdrawal by Subject|4
7029534|NCT01631812|11108016|FG000|Overall Study|Physician Decision|3
7029535|NCT01631825|11108020|FG000|Overall Study|Adverse Event|42
7029536|NCT01631825|11108020|FG000|Overall Study|Lack of Efficacy|7
7029537|NCT01631825|11108020|FG000|Overall Study|Withdrawal by Subject|9
7029538|NCT01631825|11108020|FG000|Overall Study|Protocol Violation|4
7029539|NCT01631825|11108020|FG000|Overall Study|Discontinuation criteria|1
7029540|NCT01631825|11108020|FG000|Overall Study|Physician Decision|2
7029541|NCT01631864|11108026|FG000|Overall Study|Withdrawal by Subject|0
7029542|NCT01631864|11108027|FG001|Overall Study|Withdrawal by Subject|1
7029543|NCT01631864|11108026|FG000|Overall Study|Adverse Event|2
7029544|NCT01631864|11108027|FG001|Overall Study|Adverse Event|3
7029545|NCT01632150|11108042|FG000|Overall Study|Disease progression|27
7029546|NCT01632150|11108042|FG000|Overall Study|Study drug toxicity|1
7029547|NCT01632150|11108042|FG000|Overall Study|Unrelated adverse event|7
7029548|NCT01632150|11108042|FG000|Overall Study|Withdrawal by Subject|2
7029549|NCT01632150|11108042|FG000|Overall Study|Patient underwent autologous transplant|1
7029550|NCT01632150|11108042|FG000|Overall Study|Moved to compassionate program|2
7029551|NCT01632241|11108069|FG000|Double-blinded (Up to Week 52)|Site Closed|3
7029552|NCT01632241|11108070|FG001|Double-blinded (Up to Week 52)|Site Closed|5
7029553|NCT01632241|11108069|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2
7029554|NCT01632241|11108070|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6
7029555|NCT01632241|11108069|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1
7029556|NCT01632241|11108070|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8
7029557|NCT01632241|11108069|FG000|Double-blinded (Up to Week 52)|Physician Decision|9
7029558|NCT01632241|11108070|FG001|Double-blinded (Up to Week 52)|Physician Decision|12
7029559|NCT01632241|11108069|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9
7029560|NCT01632241|11108070|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15
7029561|NCT01632241|11108069|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10
7029562|NCT01632241|11108070|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14
7029563|NCT01632241|11108069|FG000|Double-blinded (Up to Week 52)|Adverse Event|10
7029564|NCT01632241|11108070|FG001|Double-blinded (Up to Week 52)|Adverse Event|19
7029565|NCT01632241|11108069|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5
7029566|NCT01632241|11108070|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2
7029567|NCT01632241|11108069|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1
7029568|NCT01632241|11108070|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4
7029569|NCT01632241|11108069|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1
7029570|NCT01632241|11108070|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4
7029571|NCT01632241|11108069|FG000|Open-label (Week 52 to Week 76)|Site Closed|2
7029572|NCT01632241|11108070|FG001|Open-label (Week 52 to Week 76)|Site Closed|8
7029573|NCT01632241|11108069|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0
7029574|NCT01632241|11108070|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2
7029575|NCT01632241|11108069|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0
7029576|NCT01632241|11108070|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2
7029577|NCT01632241|11108069|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1
7029578|NCT01632241|11108070|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0
7029579|NCT01632280|11108088|FG000|Overall Study|Withdrawal by Subject|1
7029580|NCT01632280|11108089|FG001|Overall Study|Withdrawal by Subject|0
7029581|NCT01632306|11108097|FG000|Overall Study|Protocol Violation|1
7029582|NCT01632306|11108098|FG001|Overall Study|Protocol Violation|0
7029583|NCT01632306|11108099|FG002|Overall Study|Protocol Violation|0
7029584|NCT01632345|11108110|FG000|Treatment: Part I|Adverse Event|1
7029585|NCT01632345|11108111|FG001|Treatment: Part I|Adverse Event|4
7029586|NCT01632345|11108112|FG002|Treatment: Part I|Adverse Event|2
7029587|NCT01632345|11108113|FG003|Treatment: Part I|Adverse Event|1
7029588|NCT01632345|11108114|FG004|Treatment: Part I|Adverse Event|3
7029589|NCT01632345|11108115|FG005|Treatment: Part I|Adverse Event|0
7029590|NCT01632345|11108116|FG006|Treatment: Part I|Adverse Event|0
7029591|NCT01632345|11108110|FG000|Treatment: Part I|Lack of Efficacy|0
7029592|NCT01632345|11108111|FG001|Treatment: Part I|Lack of Efficacy|1
7029593|NCT01632345|11108112|FG002|Treatment: Part I|Lack of Efficacy|0
7029594|NCT01632345|11108113|FG003|Treatment: Part I|Lack of Efficacy|1
7029595|NCT01632345|11108114|FG004|Treatment: Part I|Lack of Efficacy|1
7029596|NCT01632345|11108115|FG005|Treatment: Part I|Lack of Efficacy|0
7029597|NCT01632345|11108116|FG006|Treatment: Part I|Lack of Efficacy|0
7029598|NCT01632345|11108110|FG000|Treatment: Part I|Lost to Follow-up|3
7029599|NCT01632345|11108111|FG001|Treatment: Part I|Lost to Follow-up|2
7029600|NCT01632345|11108112|FG002|Treatment: Part I|Lost to Follow-up|1
7029601|NCT01632345|11108113|FG003|Treatment: Part I|Lost to Follow-up|3
7029602|NCT01632345|11108114|FG004|Treatment: Part I|Lost to Follow-up|4
7029603|NCT01632345|11108115|FG005|Treatment: Part I|Lost to Follow-up|0
7029604|NCT01632345|11108116|FG006|Treatment: Part I|Lost to Follow-up|0
7029605|NCT01632345|11108110|FG000|Treatment: Part I|Non-Compliance with Study Drug|3
7029606|NCT01632345|11108111|FG001|Treatment: Part I|Non-Compliance with Study Drug|2
7029607|NCT01632345|11108112|FG002|Treatment: Part I|Non-Compliance with Study Drug|2
7029608|NCT01632345|11108113|FG003|Treatment: Part I|Non-Compliance with Study Drug|1
7029609|NCT01632345|11108114|FG004|Treatment: Part I|Non-Compliance with Study Drug|0
7029610|NCT01632345|11108115|FG005|Treatment: Part I|Non-Compliance with Study Drug|0
7029611|NCT01632345|11108116|FG006|Treatment: Part I|Non-Compliance with Study Drug|0
7029612|NCT01632345|11108110|FG000|Treatment: Part I|Physician Decision|2
7029613|NCT01632345|11108111|FG001|Treatment: Part I|Physician Decision|1
7029614|NCT01632345|11108112|FG002|Treatment: Part I|Physician Decision|0
7029615|NCT01632345|11108113|FG003|Treatment: Part I|Physician Decision|0
7029616|NCT01632345|11108114|FG004|Treatment: Part I|Physician Decision|1
7029617|NCT01632345|11108115|FG005|Treatment: Part I|Physician Decision|0
7029618|NCT01632345|11108116|FG006|Treatment: Part I|Physician Decision|0
7029619|NCT01632345|11108110|FG000|Treatment: Part I|Pregnancy|0
7029620|NCT01632345|11108111|FG001|Treatment: Part I|Pregnancy|1
7029621|NCT01632345|11108112|FG002|Treatment: Part I|Pregnancy|0
7029622|NCT01632345|11108113|FG003|Treatment: Part I|Pregnancy|0
7029623|NCT01632345|11108114|FG004|Treatment: Part I|Pregnancy|0
7029624|NCT01632345|11108115|FG005|Treatment: Part I|Pregnancy|0
7029625|NCT01632345|11108116|FG006|Treatment: Part I|Pregnancy|0
7029626|NCT01632345|11108110|FG000|Treatment: Part I|Protocol Deviation|0
7029627|NCT01632345|11108111|FG001|Treatment: Part I|Protocol Deviation|0
7029628|NCT01632345|11108112|FG002|Treatment: Part I|Protocol Deviation|1
7029629|NCT01632345|11108113|FG003|Treatment: Part I|Protocol Deviation|1
7029630|NCT01632345|11108114|FG004|Treatment: Part I|Protocol Deviation|0
7029631|NCT01632345|11108115|FG005|Treatment: Part I|Protocol Deviation|0
7029632|NCT01632345|11108116|FG006|Treatment: Part I|Protocol Deviation|0
7029633|NCT01632345|11108110|FG000|Treatment: Part I|Withdrawal by Subject|3
7029634|NCT01632345|11108111|FG001|Treatment: Part I|Withdrawal by Subject|4
7029635|NCT01632345|11108112|FG002|Treatment: Part I|Withdrawal by Subject|4
7029636|NCT01632345|11108113|FG003|Treatment: Part I|Withdrawal by Subject|1
7029637|NCT01632345|11108114|FG004|Treatment: Part I|Withdrawal by Subject|4
7029638|NCT01632345|11108115|FG005|Treatment: Part I|Withdrawal by Subject|0
7029639|NCT01632345|11108116|FG006|Treatment: Part I|Withdrawal by Subject|0
7029640|NCT01632345|11108110|FG000|Treatment: Part II|Adverse Event|0
7029641|NCT01632345|11108111|FG001|Treatment: Part II|Adverse Event|0
7029642|NCT01632345|11108112|FG002|Treatment: Part II|Adverse Event|0
7029643|NCT01632345|11108113|FG003|Treatment: Part II|Adverse Event|0
7029644|NCT01632345|11108114|FG004|Treatment: Part II|Adverse Event|0
7029645|NCT01632345|11108115|FG005|Treatment: Part II|Adverse Event|3
7029646|NCT01632345|11108116|FG006|Treatment: Part II|Adverse Event|8
7029647|NCT01632345|11108110|FG000|Treatment: Part II|Lost to Follow-up|0
7029648|NCT01632345|11108111|FG001|Treatment: Part II|Lost to Follow-up|0
7029649|NCT01632345|11108112|FG002|Treatment: Part II|Lost to Follow-up|0
7029650|NCT01632345|11108113|FG003|Treatment: Part II|Lost to Follow-up|0
7029651|NCT01632345|11108114|FG004|Treatment: Part II|Lost to Follow-up|0
7029652|NCT01632345|11108115|FG005|Treatment: Part II|Lost to Follow-up|3
7029653|NCT01632345|11108116|FG006|Treatment: Part II|Lost to Follow-up|1
7029654|NCT01632345|11108110|FG000|Treatment: Part II|Non-Compliance with Study Drug|0
7029655|NCT01632345|11108111|FG001|Treatment: Part II|Non-Compliance with Study Drug|0
7029656|NCT01632345|11108112|FG002|Treatment: Part II|Non-Compliance with Study Drug|0
7029657|NCT01632345|11108113|FG003|Treatment: Part II|Non-Compliance with Study Drug|0
7029658|NCT01632345|11108114|FG004|Treatment: Part II|Non-Compliance with Study Drug|0
7029659|NCT01632345|11108115|FG005|Treatment: Part II|Non-Compliance with Study Drug|3
7029660|NCT01632345|11108116|FG006|Treatment: Part II|Non-Compliance with Study Drug|0
7029661|NCT01632345|11108110|FG000|Treatment: Part II|Withdrawal by Subject|0
7029662|NCT01632345|11108111|FG001|Treatment: Part II|Withdrawal by Subject|0
7029663|NCT01632345|11108112|FG002|Treatment: Part II|Withdrawal by Subject|0
7029664|NCT01632345|11108113|FG003|Treatment: Part II|Withdrawal by Subject|0
7029665|NCT01632345|11108114|FG004|Treatment: Part II|Withdrawal by Subject|0
7029666|NCT01632345|11108115|FG005|Treatment: Part II|Withdrawal by Subject|2
7029667|NCT01632345|11108116|FG006|Treatment: Part II|Withdrawal by Subject|2
7029668|NCT01632566|11108140|FG000|Overall Study|Withdrawal by Subject|0
7029669|NCT01632566|11108141|FG001|Overall Study|Withdrawal by Subject|1
7029670|NCT01632566|11108142|FG002|Overall Study|Withdrawal by Subject|0
7029671|NCT01632566|11108143|FG003|Overall Study|Withdrawal by Subject|0
7029672|NCT01632566|11108144|FG004|Overall Study|Withdrawal by Subject|0
7029673|NCT01632566|11108140|FG000|Overall Study|Sponsor Decision|0
7029674|NCT01632566|11108141|FG001|Overall Study|Sponsor Decision|2
7029675|NCT01632566|11108142|FG002|Overall Study|Sponsor Decision|9
7029676|NCT01632566|11108143|FG003|Overall Study|Sponsor Decision|2
7029677|NCT01632566|11108144|FG004|Overall Study|Sponsor Decision|2
7029678|NCT01632579|11108160|FG000|Washout Period|Adverse Event|1
7029679|NCT01632579|11108161|FG001|Washout Period|Adverse Event|0
7029680|NCT01632579|11108162|FG002|Washout Period|Adverse Event|0
7029681|NCT01632579|11108163|FG003|Washout Period|Adverse Event|0
7029682|NCT01632579|11108164|FG004|Washout Period|Adverse Event|0
7029683|NCT01632579|11108165|FG005|Washout Period|Adverse Event|0
7029684|NCT01632579|11108166|FG006|Washout Period|Adverse Event|0
7029685|NCT01632579|11108167|FG007|Washout Period|Adverse Event|0
7029686|NCT01632579|11108168|FG008|Washout Period|Adverse Event|0
7029687|NCT01632579|11108160|FG000|Period 2 (Second Intervention)|Adverse Event|1
7029688|NCT01632579|11108161|FG001|Period 2 (Second Intervention)|Adverse Event|0
7029689|NCT01632579|11108162|FG002|Period 2 (Second Intervention)|Adverse Event|0
7029690|NCT01632579|11108163|FG003|Period 2 (Second Intervention)|Adverse Event|0
7029691|NCT01632579|11108164|FG004|Period 2 (Second Intervention)|Adverse Event|0
7029692|NCT01632579|11108165|FG005|Period 2 (Second Intervention)|Adverse Event|0
7029693|NCT01632579|11108166|FG006|Period 2 (Second Intervention)|Adverse Event|0
7029694|NCT01632579|11108167|FG007|Period 2 (Second Intervention)|Adverse Event|0
7029695|NCT01632579|11108168|FG008|Period 2 (Second Intervention)|Adverse Event|0
7029696|NCT01632800|11108225|FG000|Overall Study|Subject did not fit in apparatus|1
7029697|NCT01632891|11108231|FG000|Overall Study|Lost to Follow-up|0
7029698|NCT01632891|11108232|FG001|Overall Study|Lost to Follow-up|1
7029699|NCT01632891|11108231|FG000|Overall Study|Withdrawal by Subject|1
7029700|NCT01632891|11108232|FG001|Overall Study|Withdrawal by Subject|0
7029701|NCT01632904|11108244|FG000|Overall Study|Adverse Event|4
7029702|NCT01632904|11108245|FG001|Overall Study|Adverse Event|1
7029703|NCT01632904|11108244|FG000|Overall Study|Physician Decision|0
7029704|NCT01632904|11108245|FG001|Overall Study|Physician Decision|1
7029705|NCT01632904|11108244|FG000|Overall Study|Subject decision|3
7029706|NCT01632904|11108245|FG001|Overall Study|Subject decision|2
7029707|NCT01632904|11108244|FG000|Overall Study|Disease Progression|0
7029708|NCT01632904|11108245|FG001|Overall Study|Disease Progression|1
7029709|NCT01632904|11108244|FG000|Overall Study|Reason for discontinuation not available|0
7029710|NCT01632904|11108245|FG001|Overall Study|Reason for discontinuation not available|1
7029711|NCT01633060|11108259|FG000|Randomization Phase|Protocol deviation|1
7029712|NCT01633060|11108260|FG001|Randomization Phase|Protocol deviation|2
7029713|NCT01633060|11108259|FG000|Randomization Phase|Technical problem|0
7029714|NCT01633060|11108260|FG001|Randomization Phase|Technical problem|1
7029715|NCT01633060|11108259|FG000|Treatment Phase|Adverse Event|24
7029716|NCT01633060|11108260|FG001|Treatment Phase|Adverse Event|3
7029717|NCT01633060|11108259|FG000|Treatment Phase|Lost to Follow-up|1
7029718|NCT01633060|11108260|FG001|Treatment Phase|Lost to Follow-up|0
7029719|NCT01633060|11108259|FG000|Treatment Phase|Physician Decision|16
7029720|NCT01633060|11108260|FG001|Treatment Phase|Physician Decision|7
7029721|NCT01633060|11108259|FG000|Treatment Phase|Progressive Disease|210
7029722|NCT01633060|11108260|FG001|Treatment Phase|Progressive Disease|120
7029723|NCT01633060|11108259|FG000|Treatment Phase|Protocol Deviation|1
7029724|NCT01633060|11108260|FG001|Treatment Phase|Protocol Deviation|0
7029725|NCT01633060|11108259|FG000|Treatment Phase|Study Terminated by sponsor|7
7029726|NCT01633060|11108260|FG001|Treatment Phase|Study Terminated by sponsor|3
7029727|NCT01633060|11108259|FG000|Treatment Phase|Subject/guardian decision|25
7029728|NCT01633060|11108260|FG001|Treatment Phase|Subject/guardian decision|4
7029729|NCT01633060|11108259|FG000|Treatment Phase|Death|4
7029730|NCT01633060|11108260|FG001|Treatment Phase|Death|3
7029731|NCT01633060|11108259|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2
7029732|NCT01633060|11108260|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
7029733|NCT01633060|11108259|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1
7029734|NCT01633060|11108260|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0
7029735|NCT01633060|11108259|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10
7029736|NCT01633060|11108260|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1
7029737|NCT01633060|11108259|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1
7029738|NCT01633060|11108260|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0
7029739|NCT01633060|11108259|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
7029740|NCT01633060|11108260|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
7029741|NCT01633060|11108259|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1
7029742|NCT01633060|11108260|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0
7029743|NCT01633112|11108270|FG000|Overall Study|Lack of Efficacy|1
7029744|NCT01633112|11108271|FG001|Overall Study|Lack of Efficacy|6
7029745|NCT01633112|11108272|FG002|Overall Study|Lack of Efficacy|13
7029746|NCT01633112|11108270|FG000|Overall Study|Abnormal laboratory value(s)|3
7029747|NCT01633112|11108271|FG001|Overall Study|Abnormal laboratory value(s)|1
7029748|NCT01633112|11108272|FG002|Overall Study|Abnormal laboratory value(s)|0
7029749|NCT01633112|11108270|FG000|Overall Study|Abnormal test procedure result(s)|0
7029750|NCT01633112|11108271|FG001|Overall Study|Abnormal test procedure result(s)|1
7029751|NCT01633112|11108272|FG002|Overall Study|Abnormal test procedure result(s)|0
7029752|NCT01633112|11108270|FG000|Overall Study|Administrative problems|1
7029753|NCT01633112|11108271|FG001|Overall Study|Administrative problems|2
7029754|NCT01633112|11108272|FG002|Overall Study|Administrative problems|5
7029755|NCT01633112|11108270|FG000|Overall Study|Adverse Event|16
7029756|NCT01633112|11108271|FG001|Overall Study|Adverse Event|18
7029757|NCT01633112|11108272|FG002|Overall Study|Adverse Event|20
7029758|NCT01633112|11108270|FG000|Overall Study|Lost to Follow-up|7
7029759|NCT01633112|11108271|FG001|Overall Study|Lost to Follow-up|19
7029760|NCT01633112|11108272|FG002|Overall Study|Lost to Follow-up|6
7029761|NCT01633112|11108270|FG000|Overall Study|Protocol Violation|4
7029762|NCT01633112|11108271|FG001|Overall Study|Protocol Violation|0
7029763|NCT01633112|11108272|FG002|Overall Study|Protocol Violation|2
7029764|NCT01633112|11108270|FG000|Overall Study|Subject no longer requires study drug|0
7029765|NCT01633112|11108271|FG001|Overall Study|Subject no longer requires study drug|0
7029766|NCT01633112|11108272|FG002|Overall Study|Subject no longer requires study drug|1
7029767|NCT01633112|11108270|FG000|Overall Study|Withdrawal by Subject|20
7029768|NCT01633112|11108271|FG001|Overall Study|Withdrawal by Subject|12
7029769|NCT01633112|11108272|FG002|Overall Study|Withdrawal by Subject|41
7029770|NCT01633112|11108270|FG000|Overall Study|missing Study Completion CRF|1
7029771|NCT01633112|11108271|FG001|Overall Study|missing Study Completion CRF|1
7029772|NCT01633112|11108272|FG002|Overall Study|missing Study Completion CRF|4
7029773|NCT01633788|11108303|FG000|Overall Study|Adverse Event|1
7029774|NCT01633788|11108304|FG001|Overall Study|Adverse Event|3
7029775|NCT01633788|11108305|FG002|Overall Study|Adverse Event|3
7029776|NCT01633788|11108306|FG003|Overall Study|Adverse Event|3
7029777|NCT01633788|11108303|FG000|Overall Study|Lost to Follow-up|2
7029778|NCT01633788|11108304|FG001|Overall Study|Lost to Follow-up|2
7029779|NCT01633788|11108305|FG002|Overall Study|Lost to Follow-up|2
7029780|NCT01633788|11108306|FG003|Overall Study|Lost to Follow-up|0
7029781|NCT01633788|11108303|FG000|Overall Study|Personal Reasons|3
7029782|NCT01633788|11108304|FG001|Overall Study|Personal Reasons|1
7029783|NCT01633788|11108305|FG002|Overall Study|Personal Reasons|1
7029784|NCT01633788|11108306|FG003|Overall Study|Personal Reasons|3
7029785|NCT01633788|11108303|FG000|Overall Study|Protocol Violation|1
7029786|NCT01633788|11108304|FG001|Overall Study|Protocol Violation|0
7029787|NCT01633788|11108305|FG002|Overall Study|Protocol Violation|1
7029788|NCT01633788|11108306|FG003|Overall Study|Protocol Violation|0
7029789|NCT01633788|11108303|FG000|Overall Study|Other Reasons|0
7029790|NCT01633788|11108304|FG001|Overall Study|Other Reasons|2
7029791|NCT01633788|11108305|FG002|Overall Study|Other Reasons|3
7029792|NCT01633788|11108306|FG003|Overall Study|Other Reasons|7
7029793|NCT01633944|11108346|FG000|Open-label Titration Phase|Adverse Event|109
7029794|NCT01633944|11108347|FG001|Open-label Titration Phase|Adverse Event|0
7029795|NCT01633944|11108348|FG002|Open-label Titration Phase|Adverse Event|0
7029796|NCT01633944|11108346|FG000|Open-label Titration Phase|Lack of Efficacy|33
7029797|NCT01633944|11108347|FG001|Open-label Titration Phase|Lack of Efficacy|0
7029798|NCT01633944|11108348|FG002|Open-label Titration Phase|Lack of Efficacy|0
7029799|NCT01633944|11108346|FG000|Open-label Titration Phase|Withdrawal by Subject|34
7029800|NCT01633944|11108347|FG001|Open-label Titration Phase|Withdrawal by Subject|0
7029801|NCT01633944|11108348|FG002|Open-label Titration Phase|Withdrawal by Subject|0
7029802|NCT01633944|11108346|FG000|Open-label Titration Phase|Protocol Violation|24
7029803|NCT01633944|11108347|FG001|Open-label Titration Phase|Protocol Violation|0
7029804|NCT01633944|11108348|FG002|Open-label Titration Phase|Protocol Violation|0
7029805|NCT01633944|11108346|FG000|Open-label Titration Phase|Lost to Follow-up|22
7029806|NCT01633944|11108347|FG001|Open-label Titration Phase|Lost to Follow-up|0
7029807|NCT01633944|11108348|FG002|Open-label Titration Phase|Lost to Follow-up|0
7029808|NCT01633944|11108346|FG000|Open-label Titration Phase|Other|68
7029809|NCT01633944|11108347|FG001|Open-label Titration Phase|Other|0
7029810|NCT01633944|11108348|FG002|Open-label Titration Phase|Other|0
7029811|NCT01633944|11108346|FG000|Double-blind Treatment Phase|Adverse Event|0
7029812|NCT01633944|11108347|FG001|Double-blind Treatment Phase|Adverse Event|13
7029813|NCT01633944|11108348|FG002|Double-blind Treatment Phase|Adverse Event|7
7029814|NCT01633944|11108346|FG000|Double-blind Treatment Phase|Lack of Efficacy|0
7029815|NCT01633944|11108347|FG001|Double-blind Treatment Phase|Lack of Efficacy|8
7029816|NCT01633944|11108348|FG002|Double-blind Treatment Phase|Lack of Efficacy|23
7029817|NCT01633944|11108346|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0
7029818|NCT01633944|11108347|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11
7029819|NCT01633944|11108348|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8
7029820|NCT01633944|11108346|FG000|Double-blind Treatment Phase|Protocol Violation|0
7029821|NCT01633944|11108347|FG001|Double-blind Treatment Phase|Protocol Violation|7
7029822|NCT01633944|11108348|FG002|Double-blind Treatment Phase|Protocol Violation|10
7029823|NCT01633944|11108346|FG000|Double-blind Treatment Phase|Lost to Follow-up|0
7029824|NCT01633944|11108347|FG001|Double-blind Treatment Phase|Lost to Follow-up|4
7029825|NCT01633944|11108348|FG002|Double-blind Treatment Phase|Lost to Follow-up|9
7029826|NCT01633944|11108346|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
7029827|NCT01633944|11108347|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3
7029828|NCT01633944|11108348|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
7029829|NCT01633944|11108346|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0
7029830|NCT01633944|11108347|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1
7029831|NCT01633944|11108348|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0
7029832|NCT01633944|11108346|FG000|Double-blind Treatment Phase|Other|0
7029833|NCT01633944|11108347|FG001|Double-blind Treatment Phase|Other|7
7029834|NCT01633944|11108348|FG002|Double-blind Treatment Phase|Other|0
7029835|NCT01634100|11108356|FG000|Overall Study|Withdrawal by Subject|1
7029836|NCT01634100|11108357|FG001|Overall Study|Withdrawal by Subject|0
7029837|NCT01634100|11108358|FG002|Overall Study|Withdrawal by Subject|1
7029838|NCT01634100|11108359|FG003|Overall Study|Withdrawal by Subject|0
7029839|NCT01634100|11108360|FG004|Overall Study|Withdrawal by Subject|0
7029840|NCT01634100|11108361|FG005|Overall Study|Withdrawal by Subject|0
7029841|NCT01634113|11108372|FG000|Overall Study|Not treated|0
7029842|NCT01634113|11108373|FG001|Overall Study|Not treated|0
7029843|NCT01634113|11108374|FG002|Overall Study|Not treated|1
7029844|NCT01634139|11108385|FG000|Overall Study|Non compliant with protocol|1
7029845|NCT01634139|11108386|FG001|Overall Study|Non compliant with protocol|0
7029846|NCT01634139|11108387|FG002|Overall Study|Non compliant with protocol|0
7029847|NCT01634139|11108385|FG000|Overall Study|Consent withdrawn not due to AE|4
7029848|NCT01634139|11108386|FG001|Overall Study|Consent withdrawn not due to AE|3
7029849|NCT01634139|11108387|FG002|Overall Study|Consent withdrawn not due to AE|2
7029850|NCT01634139|11108385|FG000|Overall Study|Other|4
7029851|NCT01634139|11108386|FG001|Overall Study|Other|0
7029852|NCT01634139|11108387|FG002|Overall Study|Other|3
7029853|NCT01634139|11108385|FG000|Overall Study|Lost to Follow-up|0
7029854|NCT01634139|11108386|FG001|Overall Study|Lost to Follow-up|2
7029855|NCT01634139|11108387|FG002|Overall Study|Lost to Follow-up|0
7029856|NCT01634139|11108385|FG000|Overall Study|Not treated|1
7029857|NCT01634139|11108386|FG001|Overall Study|Not treated|1
7029858|NCT01634139|11108387|FG002|Overall Study|Not treated|0
7029859|NCT01634152|11108398|FG000|Overall Study|Adverse Event|2
7029860|NCT01634152|11108399|FG001|Overall Study|Adverse Event|0
7029861|NCT01634152|11108400|FG002|Overall Study|Adverse Event|2
7029862|NCT01634152|11108398|FG000|Overall Study|Consent withdrawn not due to AE|1
7029863|NCT01634152|11108399|FG001|Overall Study|Consent withdrawn not due to AE|0
7029864|NCT01634152|11108400|FG002|Overall Study|Consent withdrawn not due to AE|1
7029865|NCT01634152|11108398|FG000|Overall Study|Not treated|0
7029866|NCT01634152|11108399|FG001|Overall Study|Not treated|1
7029867|NCT01634152|11108400|FG002|Overall Study|Not treated|0
7029868|NCT01634152|11108398|FG000|Overall Study|Other reason not defined above|1
7029869|NCT01634152|11108399|FG001|Overall Study|Other reason not defined above|0
7029870|NCT01634152|11108400|FG002|Overall Study|Other reason not defined above|1
7029871|NCT01634165|11108408|FG000|Period 2|Adverse Event|0
7029872|NCT01634165|11108409|FG001|Period 2|Adverse Event|1
7029873|NCT01634165|11108410|FG002|Period 2|Adverse Event|0
7029874|NCT01634165|11108411|FG003|Period 2|Adverse Event|0
7029875|NCT01634178|11108421|FG000|Treatment Period 1|Adverse Event|0
7029876|NCT01634178|11108422|FG001|Treatment Period 1|Adverse Event|1
7029877|NCT01634178|11108421|FG000|Treatment Period 2|Adverse Event|1
7029878|NCT01634178|11108422|FG001|Treatment Period 2|Adverse Event|0
7029879|NCT01634243|11108453|FG000|Overall Study|Adverse Event|5
7029880|NCT01634243|11108454|FG001|Overall Study|Adverse Event|5
7029881|NCT01634243|11108453|FG000|Overall Study|Lack of Efficacy|1
7029882|NCT01634243|11108454|FG001|Overall Study|Lack of Efficacy|0
7029883|NCT01634360|11108481|FG000|Overall Study|Adverse Event|10
7029884|NCT01634360|11108482|FG001|Overall Study|Adverse Event|34
7029885|NCT01634360|11108481|FG000|Overall Study|subject withdrew consent|13
7029886|NCT01634360|11108482|FG001|Overall Study|subject withdrew consent|23
7029887|NCT01634360|11108481|FG000|Overall Study|Protocol Violation|1
7029888|NCT01634360|11108482|FG001|Overall Study|Protocol Violation|1
7029889|NCT01634360|11108481|FG000|Overall Study|Lack of Efficacy|4
7029890|NCT01634360|11108482|FG001|Overall Study|Lack of Efficacy|14
7029891|NCT01634360|11108481|FG000|Overall Study|Other|3
7029892|NCT01634360|11108482|FG001|Overall Study|Other|20
7029893|NCT01634360|11108481|FG000|Overall Study|Study termination by sponsor|18
7029894|NCT01634360|11108482|FG001|Overall Study|Study termination by sponsor|44
7029895|NCT01634555|11108488|FG000|Overall Study|Adverse Event|3
7029896|NCT01634555|11108488|FG000|Overall Study|Physician Decision|1
7029897|NCT01634659|11108504|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2
7029898|NCT01634659|11108505|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0
7029899|NCT01634659|11108504|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1
7029900|NCT01634659|11108505|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0
7029901|NCT01634854|11108513|FG000|Overall Study|Cesarean delivery|2
7029902|NCT01634854|11108514|FG001|Overall Study|Cesarean delivery|7
7029903|NCT01635153|11108551|FG000|Overall Study|Lost to Follow-up|40
7029904|NCT01635153|11108552|FG001|Overall Study|Lost to Follow-up|43
7029905|NCT01635218|11108561|FG000|Overall Study|Lost to Follow-up|3
7029906|NCT01635218|11108562|FG001|Overall Study|Lost to Follow-up|7
7029907|NCT01635218|11108563|FG002|Overall Study|Lost to Follow-up|6
7029908|NCT01635283|11108584|FG000|Overall Study|Tumor Progression|3
7029909|NCT01635283|11108584|FG000|Overall Study|Lost to Follow-up|1
7029910|NCT01635764|11108609|FG000|Overall Study|Adverse Event|46
7029911|NCT01635764|11108609|FG000|Overall Study|Lack of Efficacy|76
7029912|NCT01635764|11108609|FG000|Overall Study|Exceed Protocol-specified Interventions|2
7029913|NCT01635764|11108609|FG000|Overall Study|Protocol Deviation|1
7029914|NCT01635764|11108609|FG000|Overall Study|Withdrew Consent|67
7029915|NCT01635764|11108609|FG000|Overall Study|Lost to Follow-up|53
7029916|NCT01635764|11108609|FG000|Overall Study|Other|28
7029917|NCT01635855|11108620|FG000|Overall Study|Withdrawal by Subject|4
7029918|NCT01635920|11108630|FG000|Overall Study|Adverse Event|1
7029919|NCT01635920|11108631|FG001|Overall Study|Adverse Event|0
7029920|NCT01635920|11108630|FG000|Overall Study|Lost to Follow-up|0
7029921|NCT01635920|11108631|FG001|Overall Study|Lost to Follow-up|1
7029922|NCT01635920|11108630|FG000|Overall Study|Subject decision|2
7029923|NCT01635920|11108631|FG001|Overall Study|Subject decision|0
7029924|NCT01635933|11108640|FG000|Overall Study|Adverse Event|1
7029925|NCT01635933|11108641|FG001|Overall Study|Adverse Event|0
7029926|NCT01635933|11108640|FG000|Overall Study|Lost to Follow-up|0
7029927|NCT01635933|11108641|FG001|Overall Study|Lost to Follow-up|5
7029928|NCT01635933|11108640|FG000|Overall Study|Subject decision|1
7029929|NCT01635933|11108641|FG001|Overall Study|Subject decision|1
7029930|NCT01635933|11108640|FG000|Overall Study|Noncompliance|0
7029931|NCT01635933|11108641|FG001|Overall Study|Noncompliance|1
7029932|NCT01635933|11108640|FG000|Overall Study|No longer had transportation|0
7029933|NCT01635933|11108641|FG001|Overall Study|No longer had transportation|1
7029934|NCT01635998|11108649|FG000|Overall Study|Death|1
7029935|NCT01635998|11108650|FG001|Overall Study|Death|1
7029936|NCT01635998|11108649|FG000|Overall Study|Lost to Follow-up|2
7029937|NCT01635998|11108650|FG001|Overall Study|Lost to Follow-up|1
7029938|NCT01635998|11108649|FG000|Overall Study|Withdrawal by Subject|1
7029939|NCT01635998|11108650|FG001|Overall Study|Withdrawal by Subject|5
7029940|NCT01636076|11108667|FG000|Overall Study|Terminated by sponsor|1
7029941|NCT01636076|11108668|FG001|Overall Study|Terminated by sponsor|1
7029942|NCT01636076|11108667|FG000|Overall Study|Lack of Efficacy|0
7029943|NCT01636076|11108668|FG001|Overall Study|Lack of Efficacy|1
7029944|NCT01636076|11108667|FG000|Overall Study|Lost to Follow-up|1
7029945|NCT01636076|11108668|FG001|Overall Study|Lost to Follow-up|0
7029946|NCT01636076|11108667|FG000|Overall Study|Physician Decision|1
7029947|NCT01636076|11108668|FG001|Overall Study|Physician Decision|1
7029948|NCT01636076|11108667|FG000|Overall Study|Non-compliance with study treatment|1
7029949|NCT01636076|11108668|FG001|Overall Study|Non-compliance with study treatment|1
7029950|NCT01636076|11108667|FG000|Overall Study|Adverse Event|6
7029951|NCT01636076|11108668|FG001|Overall Study|Adverse Event|11
7029952|NCT01636076|11108667|FG000|Overall Study|Withdrawal by Subject|7
7029953|NCT01636076|11108668|FG001|Overall Study|Withdrawal by Subject|10
7029954|NCT01636362|11108719|FG000|Overall Study|Physician Decision|6
7029955|NCT01636362|11108719|FG000|Overall Study|Subject healed, not returning|1
7029956|NCT01636362|11108719|FG000|Overall Study|Withdrawal by Subject|1
7029957|NCT01636687|11108752|FG000|Induction Period|Withdrawal by Subject|1
7029958|NCT01636687|11108753|FG001|Induction Period|Withdrawal by Subject|0
7029959|NCT01636687|11108754|FG002|Induction Period|Withdrawal by Subject|0
7029960|NCT01636687|11108755|FG003|Induction Period|Withdrawal by Subject|0
7029961|NCT01636687|11108756|FG004|Induction Period|Withdrawal by Subject|0
7029962|NCT01636687|11108752|FG000|Induction Period|Adverse Event|1
7029963|NCT01636687|11108753|FG001|Induction Period|Adverse Event|0
7029964|NCT01636687|11108754|FG002|Induction Period|Adverse Event|0
7029965|NCT01636687|11108755|FG003|Induction Period|Adverse Event|0
7029966|NCT01636687|11108756|FG004|Induction Period|Adverse Event|1
7029967|NCT01636687|11108752|FG000|Induction Period|Lack of Efficacy|0
7029968|NCT01636687|11108753|FG001|Induction Period|Lack of Efficacy|0
7029969|NCT01636687|11108754|FG002|Induction Period|Lack of Efficacy|0
7029970|NCT01636687|11108755|FG003|Induction Period|Lack of Efficacy|0
7029971|NCT01636687|11108756|FG004|Induction Period|Lack of Efficacy|1
7029972|NCT01636687|11108752|FG000|Induction Period|Physician Decision|1
7029973|NCT01636687|11108753|FG001|Induction Period|Physician Decision|0
7029974|NCT01636687|11108754|FG002|Induction Period|Physician Decision|0
7029975|NCT01636687|11108755|FG003|Induction Period|Physician Decision|0
7029976|NCT01636687|11108756|FG004|Induction Period|Physician Decision|0
7029977|NCT01636687|11108752|FG000|Maintenance Period|Withdrawal by Subject|2
7029978|NCT01636687|11108753|FG001|Maintenance Period|Withdrawal by Subject|0
7029979|NCT01636687|11108754|FG002|Maintenance Period|Withdrawal by Subject|2
7029980|NCT01636687|11108755|FG003|Maintenance Period|Withdrawal by Subject|0
7029981|NCT01636687|11108756|FG004|Maintenance Period|Withdrawal by Subject|0
7029982|NCT01636687|11108752|FG000|Maintenance Period|Adverse Event|1
7029983|NCT01636687|11108753|FG001|Maintenance Period|Adverse Event|0
7029984|NCT01636687|11108754|FG002|Maintenance Period|Adverse Event|0
7029985|NCT01636687|11108755|FG003|Maintenance Period|Adverse Event|0
7029986|NCT01636687|11108756|FG004|Maintenance Period|Adverse Event|0
7029987|NCT01636687|11108752|FG000|Maintenance Period|Lack of Efficacy|4
7029988|NCT01636687|11108753|FG001|Maintenance Period|Lack of Efficacy|1
7029989|NCT01636687|11108754|FG002|Maintenance Period|Lack of Efficacy|0
7029990|NCT01636687|11108755|FG003|Maintenance Period|Lack of Efficacy|0
7029991|NCT01636687|11108756|FG004|Maintenance Period|Lack of Efficacy|0
7029992|NCT01636687|11108752|FG000|Maintenance Period|Lost to Follow-up|1
7029993|NCT01636687|11108753|FG001|Maintenance Period|Lost to Follow-up|1
7029994|NCT01636687|11108754|FG002|Maintenance Period|Lost to Follow-up|0
7029995|NCT01636687|11108755|FG003|Maintenance Period|Lost to Follow-up|0
7029996|NCT01636687|11108756|FG004|Maintenance Period|Lost to Follow-up|1
7029997|NCT01636687|11108752|FG000|Maintenance Period|Physician Decision|0
7029998|NCT01636687|11108753|FG001|Maintenance Period|Physician Decision|0
7029999|NCT01636687|11108754|FG002|Maintenance Period|Physician Decision|0
7030000|NCT01636687|11108755|FG003|Maintenance Period|Physician Decision|0
7030001|NCT01636687|11108756|FG004|Maintenance Period|Physician Decision|1
7030002|NCT01636687|11108752|FG000|Extension Period|technical problems|0
7030003|NCT01636687|11108753|FG001|Extension Period|technical problems|1
7030004|NCT01636687|11108754|FG002|Extension Period|technical problems|2
7030005|NCT01636687|11108755|FG003|Extension Period|technical problems|1
7030006|NCT01636687|11108756|FG004|Extension Period|technical problems|0
7030007|NCT01636687|11108752|FG000|Extension Period|Adverse Event|4
7030008|NCT01636687|11108753|FG001|Extension Period|Adverse Event|3
7030009|NCT01636687|11108754|FG002|Extension Period|Adverse Event|2
7030010|NCT01636687|11108755|FG003|Extension Period|Adverse Event|1
7030011|NCT01636687|11108756|FG004|Extension Period|Adverse Event|0
7030012|NCT01636687|11108752|FG000|Extension Period|Lack of Efficacy|7
7030013|NCT01636687|11108753|FG001|Extension Period|Lack of Efficacy|0
7030014|NCT01636687|11108754|FG002|Extension Period|Lack of Efficacy|2
7030015|NCT01636687|11108755|FG003|Extension Period|Lack of Efficacy|1
7030016|NCT01636687|11108756|FG004|Extension Period|Lack of Efficacy|0
7030017|NCT01636687|11108752|FG000|Extension Period|Lost to Follow-up|1
7030018|NCT01636687|11108753|FG001|Extension Period|Lost to Follow-up|0
7030019|NCT01636687|11108754|FG002|Extension Period|Lost to Follow-up|1
7030020|NCT01636687|11108755|FG003|Extension Period|Lost to Follow-up|0
7030021|NCT01636687|11108756|FG004|Extension Period|Lost to Follow-up|0
7030022|NCT01636687|11108752|FG000|Extension Period|Physician Decision|1
7030023|NCT01636687|11108753|FG001|Extension Period|Physician Decision|0
7030024|NCT01636687|11108754|FG002|Extension Period|Physician Decision|0
7030025|NCT01636687|11108755|FG003|Extension Period|Physician Decision|1
7030026|NCT01636687|11108756|FG004|Extension Period|Physician Decision|0
7030027|NCT01636687|11108752|FG000|Extension Period|study terminated by sponsor|33
7030028|NCT01636687|11108753|FG001|Extension Period|study terminated by sponsor|50
7030029|NCT01636687|11108754|FG002|Extension Period|study terminated by sponsor|17
7030030|NCT01636687|11108755|FG003|Extension Period|study terminated by sponsor|23
7030031|NCT01636687|11108756|FG004|Extension Period|study terminated by sponsor|0
7030032|NCT01636687|11108752|FG000|Extension Period|Withdrawal by Subject|1
7030033|NCT01636687|11108753|FG001|Extension Period|Withdrawal by Subject|0
7030034|NCT01636687|11108754|FG002|Extension Period|Withdrawal by Subject|1
7030035|NCT01636687|11108755|FG003|Extension Period|Withdrawal by Subject|1
7030036|NCT01636687|11108756|FG004|Extension Period|Withdrawal by Subject|0
7030037|NCT01636687|11108752|FG000|Follow-up Period|Withdrawal by Subject|1
7030038|NCT01636687|11108753|FG001|Follow-up Period|Withdrawal by Subject|0
7030039|NCT01636687|11108754|FG002|Follow-up Period|Withdrawal by Subject|0
7030040|NCT01636687|11108755|FG003|Follow-up Period|Withdrawal by Subject|0
7030041|NCT01636687|11108756|FG004|Follow-up Period|Withdrawal by Subject|1
7030042|NCT01636713|11108777|FG000|Overall Study|Adverse Event|16
7030043|NCT01636713|11108778|FG001|Overall Study|Adverse Event|16
7030044|NCT01636713|11108779|FG002|Overall Study|Adverse Event|7
7030045|NCT01636713|11108777|FG000|Overall Study|Lack of Efficacy|6
7030046|NCT01636713|11108778|FG001|Overall Study|Lack of Efficacy|6
7030047|NCT01636713|11108779|FG002|Overall Study|Lack of Efficacy|2
7030048|NCT01636713|11108777|FG000|Overall Study|Protocol Violation|3
7030049|NCT01636713|11108778|FG001|Overall Study|Protocol Violation|0
7030050|NCT01636713|11108779|FG002|Overall Study|Protocol Violation|1
7030051|NCT01636713|11108777|FG000|Overall Study|Lost to Follow-up|0
7030052|NCT01636713|11108778|FG001|Overall Study|Lost to Follow-up|0
7030053|NCT01636713|11108779|FG002|Overall Study|Lost to Follow-up|1
7030054|NCT01636713|11108777|FG000|Overall Study|Withdrawal by Subject|5
7030055|NCT01636713|11108778|FG001|Overall Study|Withdrawal by Subject|4
7030056|NCT01636713|11108779|FG002|Overall Study|Withdrawal by Subject|8
7030057|NCT01636713|11108777|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2
7030058|NCT01636713|11108778|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2
7030059|NCT01636713|11108779|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4
7030060|NCT01636778|11108791|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3
7030061|NCT01636778|11108792|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
7030062|NCT01636778|11108793|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
7030063|NCT01636778|11108791|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1
7030064|NCT01636778|11108792|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
7030065|NCT01636778|11108793|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
7030066|NCT01636778|11108791|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0
7030067|NCT01636778|11108792|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7
7030068|NCT01636778|11108793|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0
7030069|NCT01636778|11108791|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0
7030070|NCT01636778|11108792|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1
7030071|NCT01636778|11108793|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0
7030072|NCT01636778|11108791|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0
7030073|NCT01636778|11108792|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2
7030074|NCT01636778|11108793|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0
7030075|NCT01636778|11108791|FG000|Follow-up Period After Part 2|Other|0
7030076|NCT01636778|11108792|FG001|Follow-up Period After Part 2|Other|0
7030077|NCT01636778|11108793|FG002|Follow-up Period After Part 2|Other|1
7030078|NCT01636778|11108791|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
7030079|NCT01636778|11108792|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
7030080|NCT01636778|11108793|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1
7030081|NCT01636778|11108791|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0
7030082|NCT01636778|11108792|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0
7030083|NCT01636778|11108793|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2
7030084|NCT01636934|11108807|FG000|Overall Study|Withdrawal by Subject|3
7030085|NCT01636934|11108808|FG001|Overall Study|Withdrawal by Subject|2
7030086|NCT01636934|11108807|FG000|Overall Study|Chemo cancel|1
7030087|NCT01636934|11108808|FG001|Overall Study|Chemo cancel|0
7030088|NCT01636934|11108807|FG000|Overall Study|Too ill to continue|1
7030089|NCT01636934|11108808|FG001|Overall Study|Too ill to continue|0
7030090|NCT01636934|11108807|FG000|Overall Study|Never started study medication|1
7143185|NCT03028142|11299603|FG001|Overall Study|Withdrawal by Subject|0
7143186|NCT03028142|11299604|FG002|Overall Study|Withdrawal by Subject|0
7143187|NCT03028142|11299605|FG003|Overall Study|Withdrawal by Subject|0
7030091|NCT01636934|11108808|FG001|Overall Study|Never started study medication|1
7030092|NCT01636947|11108816|FG000|Overall Study|Not Treated|2
7030093|NCT01636947|11108817|FG001|Overall Study|Not Treated|2
7030094|NCT01636947|11108816|FG000|Overall Study|Lost to Follow-up|4
7030095|NCT01636947|11108817|FG001|Overall Study|Lost to Follow-up|0
7030096|NCT01636947|11108816|FG000|Overall Study|Protocol Violation|1
7030097|NCT01636947|11108817|FG001|Overall Study|Protocol Violation|1
7030098|NCT01636947|11108816|FG000|Overall Study|Withdrawal by Subject|3
7030099|NCT01636947|11108817|FG001|Overall Study|Withdrawal by Subject|3
7030100|NCT01636947|11108816|FG000|Overall Study|Adverse Event|1
7030101|NCT01636947|11108817|FG001|Overall Study|Adverse Event|1
7030102|NCT01636947|11108816|FG000|Overall Study|Did Not Meet Eligibility Criteria|1
7030103|NCT01636947|11108817|FG001|Overall Study|Did Not Meet Eligibility Criteria|4
7030104|NCT01636960|11108823|FG000|Induction Phase|Adverse Event|2
7030105|NCT01636960|11108823|FG000|Maintenance Phase|Continued drug after regulatory approval|3
7030106|NCT01636960|11108823|FG000|Maintenance Phase|Adverse Event|3
7030107|NCT01636960|11108823|FG000|Maintenance Phase|Progressive disease|1
7030108|NCT01636986|11108829|FG000|Overall Study|Withdrawal by Subject|0
7030109|NCT01636986|11108830|FG001|Overall Study|Withdrawal by Subject|1
7030110|NCT01636986|11108829|FG000|Overall Study|Corneal Staining|0
7030111|NCT01636986|11108830|FG001|Overall Study|Corneal Staining|1
7044473|NCT01753999|11130214|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5
7044474|NCT01753999|11130213|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1
7044475|NCT01753999|11130214|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1
7044476|NCT01754129|11130225|FG000|Overall Study|Death|13
7044477|NCT01754129|11130225|FG000|Overall Study|Duodopa discontinuation|9
7044478|NCT01754129|11130225|FG000|Overall Study|Lost to Follow-up|7
7044479|NCT01754129|11130225|FG000|Overall Study|Withdrew consent|1
7044480|NCT01754129|11130225|FG000|Overall Study|Inclusion/exclusion criteria violation|3
7044481|NCT01754194|11130238|FG000|Overall Study|Lost to Follow-up|39
7044482|NCT01754194|11130239|FG001|Overall Study|Lost to Follow-up|14
7044483|NCT01754194|11130238|FG000|Overall Study|Withdrawal by Subject|4
7044484|NCT01754194|11130239|FG001|Overall Study|Withdrawal by Subject|5
7044485|NCT01754194|11130238|FG000|Overall Study|Other|9
7044486|NCT01754194|11130239|FG001|Overall Study|Other|8
7044487|NCT01754259|11130253|FG000|Overall Study|Withdrawal by Subject|2
7044488|NCT01754259|11130254|FG001|Overall Study|Withdrawal by Subject|4
7044489|NCT01754259|11130253|FG000|Overall Study|Adverse Event|3
7044490|NCT01754259|11130254|FG001|Overall Study|Adverse Event|1
7044491|NCT01754259|11130253|FG000|Overall Study|Lost to Follow-up|0
7044492|NCT01754259|11130254|FG001|Overall Study|Lost to Follow-up|1
7044493|NCT01754376|11130269|FG000|Overall Study|Adverse Event|1
7044494|NCT01754376|11130269|FG000|Overall Study|Lack of Efficacy|2
7044495|NCT01754402|11130290|FG000|Overall Study|Death|0
7044496|NCT01754402|11130291|FG001|Overall Study|Death|0
7044497|NCT01754402|11130292|FG002|Overall Study|Death|1
7044498|NCT01754402|11130290|FG000|Overall Study|Adverse Event|2
7044499|NCT01754402|11130291|FG001|Overall Study|Adverse Event|2
7044500|NCT01754402|11130292|FG002|Overall Study|Adverse Event|1
7044501|NCT01754402|11130290|FG000|Overall Study|Withdrawal by Subject|0
7044502|NCT01754402|11130291|FG001|Overall Study|Withdrawal by Subject|0
7044503|NCT01754402|11130292|FG002|Overall Study|Withdrawal by Subject|1
7044504|NCT01754402|11130290|FG000|Overall Study|Lack of Efficacy|0
7044505|NCT01754402|11130291|FG001|Overall Study|Lack of Efficacy|0
7044506|NCT01754402|11130292|FG002|Overall Study|Lack of Efficacy|1
7044507|NCT01754467|11130301|FG000|Overall Study|Lost to Follow-up|1
7044508|NCT01754493|11130315|FG000|Overall Study|Adverse Event|1
7044509|NCT01754493|11130315|FG000|Overall Study|Lost to Follow-up|3
7044510|NCT01754493|11130315|FG000|Overall Study|Withdrawal by Subject|1
7044511|NCT01754493|11130315|FG000|Overall Study|Moved out of town|1
7044512|NCT01754493|11130315|FG000|Overall Study|Scheduling conflict|1
7044513|NCT01754727|11130352|FG000|Overall Study|Adalimumab Treatment was not Documented|2
7044514|NCT01754753|11130358|FG000|Overall Study|Study close|43
7143188|NCT03028142|11299606|FG004|Overall Study|Withdrawal by Subject|1
7143189|NCT03028142|11299607|FG005|Overall Study|Withdrawal by Subject|0
7143190|NCT03028415|11299640|FG000|Overall Study|Lost to Follow-up|6
7143191|NCT03028415|11299641|FG001|Overall Study|Lost to Follow-up|3
7143192|NCT03028415|11299640|FG000|Overall Study|Withdrawal by Subject|1
7143193|NCT03028415|11299641|FG001|Overall Study|Withdrawal by Subject|0
7143194|NCT03028415|11299640|FG000|Overall Study|Discontinued due to COVID-19|1
7143195|NCT03028415|11299641|FG001|Overall Study|Discontinued due to COVID-19|0
7143196|NCT03028870|11299681|FG000|Overall Study|Adverse Event|7
7143197|NCT03028870|11299682|FG001|Overall Study|Adverse Event|4
7143198|NCT03028870|11299683|FG002|Overall Study|Adverse Event|3
7044515|NCT01754753|11130359|FG001|Overall Study|Study close|44
7044516|NCT01754753|11130358|FG000|Overall Study|Lost to Follow-up|9
7044517|NCT01754753|11130359|FG001|Overall Study|Lost to Follow-up|5
7044518|NCT01754766|11130368|FG000|Overall Study|Personal reasons|1
7044519|NCT01754766|11130369|FG001|Overall Study|Personal reasons|1
7044520|NCT01754766|11130370|FG002|Overall Study|Personal reasons|0
7044521|NCT01754922|11130389|FG000|Overall Study|Adverse Event|0
7143199|NCT03028870|11299684|FG003|Overall Study|Adverse Event|3
7143200|NCT03028870|11299681|FG000|Overall Study|Withdrawal by Subject|1
7143201|NCT03028870|11299682|FG001|Overall Study|Withdrawal by Subject|1
7143202|NCT03028870|11299683|FG002|Overall Study|Withdrawal by Subject|1
7143203|NCT03028870|11299684|FG003|Overall Study|Withdrawal by Subject|2
7143204|NCT03028870|11299681|FG000|Overall Study|Lost to Follow-up|1
7143205|NCT03028870|11299682|FG001|Overall Study|Lost to Follow-up|0
7143206|NCT03028870|11299683|FG002|Overall Study|Lost to Follow-up|0
7143207|NCT03028870|11299684|FG003|Overall Study|Lost to Follow-up|0
7143208|NCT03028870|11299681|FG000|Overall Study|Lack of Efficacy|3
7143209|NCT03028870|11299682|FG001|Overall Study|Lack of Efficacy|0
7143210|NCT03028870|11299683|FG002|Overall Study|Lack of Efficacy|0
7143211|NCT03028870|11299684|FG003|Overall Study|Lack of Efficacy|0
7143212|NCT03028870|11299681|FG000|Overall Study|Administrative|5
7030112|NCT01637077|11108838|FG000|Overall Study|Cancel|1
7030113|NCT01637077|11108839|FG001|Overall Study|Cancel|1
7030114|NCT01637077|11108838|FG000|Overall Study|Withdrawal by Subject|1
7030115|NCT01637077|11108839|FG001|Overall Study|Withdrawal by Subject|0
7030116|NCT01637077|11108838|FG000|Overall Study|No cycle 1 questionnaire data|2
7030117|NCT01637077|11108839|FG001|Overall Study|No cycle 1 questionnaire data|0
7030118|NCT01637142|11108849|FG000|Washout Period (at Least 3 Days)|Physician Decision|1
7030119|NCT01637272|11108859|FG000|Overall Study|Adverse Event|6
7030120|NCT01637272|11108859|FG000|Overall Study|Unsatisfactory therapeutic effect|2
7030121|NCT01637272|11108859|FG000|Overall Study|Withdrawal by Subject|3
7030122|NCT01637272|11108859|FG000|Overall Study|Lost to Follow-up|2
7030123|NCT01637272|11108859|FG000|Overall Study|completed core, did not enter ext. phase|4
7030124|NCT01637272|11108859|FG000|Overall Study|Administrative problems|1
7030125|NCT01637272|11108859|FG000|Overall Study|Protocol Violation|2
7030126|NCT01637402|11108878|FG000|Standard Dose Regimen|Lack of Efficacy|2
7030127|NCT01637402|11108879|FG001|Standard Dose Regimen|Lack of Efficacy|0
7030128|NCT01637402|11108878|FG000|Standard Dose Regimen|Adverse Event|1
7030129|NCT01637402|11108879|FG001|Standard Dose Regimen|Adverse Event|0
7030130|NCT01637402|11108878|FG000|Week 12 Evaluation|Lack of Efficacy|6
7030131|NCT01637402|11108879|FG001|Week 12 Evaluation|Lack of Efficacy|0
7030132|NCT01637402|11108878|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0
7030133|NCT01637402|11108879|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4
7030134|NCT01637402|11108878|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4
7030135|NCT01637402|11108879|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0
7030136|NCT01637402|11108878|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5
7030137|NCT01637402|11108879|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0
7030138|NCT01637584|11108906|FG000|Overall Study|Withdrawal by Subject|1
7030139|NCT01637584|11108907|FG001|Overall Study|Withdrawal by Subject|3
7030140|NCT01637623|11108917|FG000|Overall Study|Lost to Follow-up|0
7030141|NCT01637623|11108918|FG001|Overall Study|Lost to Follow-up|0
7030142|NCT01637623|11108919|FG002|Overall Study|Lost to Follow-up|2
7030143|NCT01637623|11108917|FG000|Overall Study|Physician Decision|1
7030144|NCT01637623|11108918|FG001|Overall Study|Physician Decision|0
7030145|NCT01637623|11108919|FG002|Overall Study|Physician Decision|1
7030146|NCT01637922|11108933|FG000|Overall Study|Adverse Event|0
7030147|NCT01637922|11108934|FG001|Overall Study|Adverse Event|1
7030148|NCT01637922|11108933|FG000|Overall Study|Protocol Violation|0
7030149|NCT01637922|11108934|FG001|Overall Study|Protocol Violation|1
7030150|NCT01637922|11108933|FG000|Overall Study|Withdrawal by Subject|0
7030151|NCT01637922|11108934|FG001|Overall Study|Withdrawal by Subject|3
7030152|NCT01637922|11108933|FG000|Overall Study|Lost to Follow-up|2
7030153|NCT01637922|11108934|FG001|Overall Study|Lost to Follow-up|0
7030154|NCT01637961|11108950|FG000|Overall Study|Ineligible: wrong primary|1
7030155|NCT01637961|11108950|FG000|Overall Study|Ineligible: inadequate pathology|1
7030156|NCT01638000|11108962|FG000|Overall Study|Randomized but Never Received Drug|7
7030157|NCT01638000|11108963|FG001|Overall Study|Randomized but Never Received Drug|10
7030158|NCT01638000|11108962|FG000|Overall Study|Adverse Event|14
7030159|NCT01638000|11108963|FG001|Overall Study|Adverse Event|16
7030160|NCT01638000|11108962|FG000|Overall Study|Lack of Efficacy|5
7030161|NCT01638000|11108963|FG001|Overall Study|Lack of Efficacy|6
7030162|NCT01638000|11108962|FG000|Overall Study|Protocol Violation|11
7030163|NCT01638000|11108963|FG001|Overall Study|Protocol Violation|13
7030164|NCT01638000|11108962|FG000|Overall Study|Withdrawal by Subject|21
7030165|NCT01638000|11108963|FG001|Overall Study|Withdrawal by Subject|24
7030166|NCT01638000|11108962|FG000|Overall Study|Miscellaneous|2
7030167|NCT01638000|11108963|FG001|Overall Study|Miscellaneous|2
7030168|NCT01638013|11108972|FG000|Overall Study|Adverse Event|36
7030169|NCT01638013|11108973|FG001|Overall Study|Adverse Event|29
7030170|NCT01638013|11108974|FG002|Overall Study|Adverse Event|48
7030171|NCT01638013|11108972|FG000|Overall Study|Lack of Efficacy|39
7030172|NCT01638013|11108973|FG001|Overall Study|Lack of Efficacy|11
7030173|NCT01638013|11108974|FG002|Overall Study|Lack of Efficacy|14
7030174|NCT01638013|11108972|FG000|Overall Study|Protocol Violation|10
7030175|NCT01638013|11108973|FG001|Overall Study|Protocol Violation|7
7030176|NCT01638013|11108974|FG002|Overall Study|Protocol Violation|11
7030177|NCT01638013|11108972|FG000|Overall Study|Met discontinuation criteria|4
7143213|NCT03028870|11299682|FG001|Overall Study|Administrative|5
7143214|NCT03028870|11299683|FG002|Overall Study|Administrative|12
7143215|NCT03028870|11299684|FG003|Overall Study|Administrative|4
7143216|NCT03029143|11299738|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8
7143217|NCT03029143|11299739|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0
7030178|NCT01638013|11108973|FG001|Overall Study|Met discontinuation criteria|0
7030179|NCT01638013|11108974|FG002|Overall Study|Met discontinuation criteria|7
7030180|NCT01638013|11108972|FG000|Overall Study|Subject Lost to Follow up|1
7030181|NCT01638013|11108973|FG001|Overall Study|Subject Lost to Follow up|0
7030182|NCT01638013|11108974|FG002|Overall Study|Subject Lost to Follow up|1
7030183|NCT01638013|11108972|FG000|Overall Study|Miscellaneous|25
7030184|NCT01638013|11108973|FG001|Overall Study|Miscellaneous|19
7030185|NCT01638013|11108974|FG002|Overall Study|Miscellaneous|23
7030186|NCT01638013|11108972|FG000|Overall Study|Withdrawal of Consent|16
7030187|NCT01638013|11108973|FG001|Overall Study|Withdrawal of Consent|12
7030188|NCT01638013|11108974|FG002|Overall Study|Withdrawal of Consent|16
7030189|NCT01638013|11108972|FG000|Overall Study|Not met inclusion or exclusion criteria|0
7030190|NCT01638013|11108973|FG001|Overall Study|Not met inclusion or exclusion criteria|0
7030191|NCT01638013|11108974|FG002|Overall Study|Not met inclusion or exclusion criteria|1
7030192|NCT01638390|11109004|FG000|Overall Study|screening failures|21
7030193|NCT01638429|11109025|FG000|Overall Study|Withdrawal by Subject|1
7030194|NCT01638546|11109045|FG000|Overall Study|Adverse Event|1
7030195|NCT01638546|11109046|FG001|Overall Study|Adverse Event|3
7030196|NCT01638559|11109054|FG000|Overall Study|Lost to Follow-up|1
7030197|NCT01638559|11109054|FG000|Overall Study|Withdrawal by Subject|1
7030198|NCT01638559|11109054|FG000|Overall Study|Subject declined to travel for biopsy|1
7030199|NCT01638819|11109071|FG000|Overall Study|Lost to Follow-up|1
7030200|NCT01638819|11109072|FG001|Overall Study|Lost to Follow-up|0
7030201|NCT01639001|11109079|FG000|Overall Study|Refused further follow-up|9
7030202|NCT01639001|11109080|FG001|Overall Study|Refused further follow-up|12
7030203|NCT01639001|11109079|FG000|Overall Study|Lost to Follow-up|3
7030204|NCT01639001|11109080|FG001|Overall Study|Lost to Follow-up|0
7030205|NCT01639001|11109079|FG000|Overall Study|Death|62
7030206|NCT01639001|11109080|FG001|Overall Study|Death|61
7030207|NCT01639001|11109079|FG000|Overall Study|Randomized but not treated|0
7030208|NCT01639001|11109080|FG001|Overall Study|Randomized but not treated|2
7030209|NCT01639001|11109079|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1
7030210|NCT01639001|11109080|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2
7030211|NCT01639040|11109090|FG000|Overall Study|Adverse Event|1
7030212|NCT01639040|11109091|FG001|Overall Study|Adverse Event|0
7030213|NCT01639144|11109102|FG000|Overall Study|Withdrawal by Subject|4
7030214|NCT01639144|11109103|FG001|Overall Study|Withdrawal by Subject|2
7030215|NCT01639144|11109102|FG000|Overall Study|Physician Decision|2
7030216|NCT01639144|11109103|FG001|Overall Study|Physician Decision|0
7030217|NCT01639144|11109102|FG000|Overall Study|Met postoperative exclusion criteria|4
7030218|NCT01639144|11109103|FG001|Overall Study|Met postoperative exclusion criteria|3
7030219|NCT01639339|11109124|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26
7030220|NCT01639339|11109125|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19
7030221|NCT01639339|11109124|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11
7030222|NCT01639339|11109125|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5
7030223|NCT01639339|11109124|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5
7030224|NCT01639339|11109125|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4
7030225|NCT01639339|11109124|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0
7030226|NCT01639339|11109125|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2
7030227|NCT01639339|11109124|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2
7030228|NCT01639339|11109125|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1
7030229|NCT01639339|11109124|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10
7030230|NCT01639339|11109125|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7
7030231|NCT01639339|11109124|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0
7030232|NCT01639339|11109125|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2
7030233|NCT01639339|11109124|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0
7030234|NCT01639339|11109125|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1
7030235|NCT01639339|11109124|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0
7030236|NCT01639339|11109125|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1
7030237|NCT01639339|11109124|FG000|Open-label Period (Up to Week 28)|Adverse Event|1
7030238|NCT01639339|11109125|FG001|Open-label Period (Up to Week 28)|Adverse Event|4
7030239|NCT01639469|11109150|FG000|Overall Study|Death|4
7030240|NCT01639469|11109151|FG001|Overall Study|Death|2
7030241|NCT01639469|11109150|FG000|Overall Study|Lost to Follow-up|1
7030242|NCT01639469|11109151|FG001|Overall Study|Lost to Follow-up|1
7030243|NCT01639495|11109157|FG000|Overall Study|Lost to Follow-up|6
7030244|NCT01639495|11109157|FG000|Overall Study|Consented but didn't have study catheter|4
7030245|NCT01639495|11109157|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4
7030246|NCT01639495|11109157|FG000|Overall Study|No radiofrequency energy applied|2
7030247|NCT01639560|11109163|FG000|Overall Study|Withdrawal by Subject|9
7030248|NCT01639560|11109164|FG001|Overall Study|Withdrawal by Subject|14
7030249|NCT01639560|11109163|FG000|Overall Study|Lack of Efficacy|1
7030250|NCT01639560|11109164|FG001|Overall Study|Lack of Efficacy|2
7030251|NCT01639560|11109163|FG000|Overall Study|Lost to Follow-up|9
7030252|NCT01639560|11109164|FG001|Overall Study|Lost to Follow-up|11
7030253|NCT01639560|11109163|FG000|Overall Study|Adverse Event|0
7030254|NCT01639560|11109164|FG001|Overall Study|Adverse Event|2
7030255|NCT01639703|11109193|FG000|Overall Study|Withdrawal by Subject|5
7030256|NCT01639703|11109193|FG000|Overall Study|Other reason|7
7030257|NCT01639729|11109209|FG000|Overall Study|Withdrawal by Subject|1
7030258|NCT01639729|11109210|FG001|Overall Study|Withdrawal by Subject|0
7030259|NCT01639729|11109211|FG002|Overall Study|Withdrawal by Subject|1
7030260|NCT01639729|11109212|FG003|Overall Study|Withdrawal by Subject|1
7030261|NCT01639729|11109213|FG004|Overall Study|Withdrawal by Subject|0
7030262|NCT01639729|11109214|FG005|Overall Study|Withdrawal by Subject|0
7030263|NCT01639742|11109224|FG000|Overall Study|Study Ongoing|17
7030264|NCT01639742|11109224|FG000|Overall Study|Lost to Follow-up|1
7030265|NCT01639755|11109228|FG000|Overall Study|Study Ongoing|15
7030266|NCT01639755|11109228|FG000|Overall Study|Patient had device explantation|4
7143218|NCT03029143|11299740|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0
7143219|NCT03029143|11299738|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12
7143220|NCT03029143|11299739|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0
7030267|NCT01639833|11109234|FG000|Overall Study|Death|4
7030268|NCT01639833|11109235|FG001|Overall Study|Death|2
7030269|NCT01639833|11109234|FG000|Overall Study|Withdrawal by Subject|2
7030270|NCT01639833|11109235|FG001|Overall Study|Withdrawal by Subject|2
7030271|NCT01640054|11109250|FG000|Overall Study|Study-specific disc criteria|1
7030272|NCT01640054|11109250|FG000|Overall Study|Lack of Efficacy|3
7030273|NCT01640054|11109250|FG000|Overall Study|Adverse Event|2
7030274|NCT01640184|11109262|FG000|Overall Study|Death|1
7030275|NCT01640184|11109263|FG001|Overall Study|Death|0
7030276|NCT01640184|11109264|FG002|Overall Study|Death|0
7030277|NCT01640184|11109262|FG000|Overall Study|Lost to Follow-up|4
7030278|NCT01640184|11109263|FG001|Overall Study|Lost to Follow-up|1
7030279|NCT01640184|11109264|FG002|Overall Study|Lost to Follow-up|0
7030280|NCT01640184|11109262|FG000|Overall Study|Physician Decision|3
7030281|NCT01640184|11109263|FG001|Overall Study|Physician Decision|0
7030282|NCT01640184|11109264|FG002|Overall Study|Physician Decision|0
7030283|NCT01640184|11109262|FG000|Overall Study|Withdrawal by Subject|0
7030284|NCT01640184|11109263|FG001|Overall Study|Withdrawal by Subject|1
7030285|NCT01640184|11109264|FG002|Overall Study|Withdrawal by Subject|1
7030286|NCT01640184|11109262|FG000|Overall Study|Protocol Violation|0
7030287|NCT01640184|11109263|FG001|Overall Study|Protocol Violation|0
7030288|NCT01640184|11109264|FG002|Overall Study|Protocol Violation|1
7030289|NCT01640249|11109291|FG000|Period 1|Withdrawal by Subject|1
7030290|NCT01640249|11109292|FG001|Period 1|Withdrawal by Subject|0
7030291|NCT01640249|11109293|FG002|Period 1|Withdrawal by Subject|0
7030292|NCT01640249|11109294|FG003|Period 1|Withdrawal by Subject|0
7030293|NCT01640249|11109295|FG004|Period 1|Withdrawal by Subject|0
7030294|NCT01640249|11109296|FG005|Period 1|Withdrawal by Subject|1
7030295|NCT01640249|11109297|FG006|Period 1|Withdrawal by Subject|0
7030296|NCT01640288|11109318|FG000|Overall Study|Equipment Failure or Poor Image Quality|4
7030297|NCT01640288|11109319|FG001|Overall Study|Equipment Failure or Poor Image Quality|5
7030298|NCT01640288|11109318|FG000|Overall Study|Screen Failure|20
7030299|NCT01640288|11109319|FG001|Overall Study|Screen Failure|18
7030300|NCT01640288|11109318|FG000|Overall Study|Withdrawn by PI|5
7030301|NCT01640288|11109319|FG001|Overall Study|Withdrawn by PI|0
7030302|NCT01640288|11109318|FG000|Overall Study|Withdrawal by Subject|1
7030303|NCT01640288|11109319|FG001|Overall Study|Withdrawal by Subject|0
7030304|NCT01640314|11109328|FG000|Overall Study|Protocol Violation|0
7030305|NCT01640314|11109329|FG001|Overall Study|Protocol Violation|1
7030306|NCT01640353|11109353|FG000|Overall Study|Withdrew prior to treatment|10
7030307|NCT01640353|11109353|FG000|Overall Study|Withdrawn from analysis at term site|12
7030308|NCT01640353|11109353|FG000|Overall Study|Withdrawal by Subject|5
7030309|NCT01640353|11109353|FG000|Overall Study|Death|2
7030310|NCT01640353|11109353|FG000|Overall Study|Early site termination|3
7030311|NCT01640353|11109353|FG000|Overall Study|Lost to Follow-up|12
7030312|NCT01640353|11109353|FG000|Overall Study|Physician Decision|1
7030313|NCT01640366|11109357|FG000|Overall Study|Withdrawal by Subject|1
7030314|NCT01640366|11109357|FG000|Overall Study|Protocol Violation|16
7030315|NCT01640366|11109357|FG000|Overall Study|Lost to Follow-up|5
7030316|NCT01640808|11109379|FG000|Overall Study|Unable to continue dynamic CT|14
7030317|NCT01640808|11109380|FG001|Overall Study|Unable to continue dynamic CT|4
7030318|NCT01640808|11109379|FG000|Overall Study|Withdrawal by Subject|12
7030319|NCT01640808|11109380|FG001|Overall Study|Withdrawal by Subject|4
7030320|NCT01640808|11109379|FG000|Overall Study|Lost to Follow-up|4
7030321|NCT01640808|11109380|FG001|Overall Study|Lost to Follow-up|0
7030322|NCT01640808|11109379|FG000|Overall Study|Start an antiviral therapy using IFN|3
7030323|NCT01640808|11109380|FG001|Overall Study|Start an antiviral therapy using IFN|0
7030324|NCT01640808|11109379|FG000|Overall Study|Administration of anticancer drugs|2
7030325|NCT01640808|11109380|FG001|Overall Study|Administration of anticancer drugs|1
7030326|NCT01640808|11109379|FG000|Overall Study|Physician Decision|19
7030327|NCT01640808|11109380|FG001|Overall Study|Physician Decision|5
7030328|NCT01640808|11109379|FG000|Overall Study|Randomized but not treated|4
7030329|NCT01640808|11109380|FG001|Overall Study|Randomized but not treated|2
7030330|NCT01640873|11109403|FG000|Overall Study|Protocol Violation|2
7030331|NCT01640873|11109404|FG001|Overall Study|Protocol Violation|1
7030332|NCT01640925|11109412|FG000|Overall Study|Withdrawal by Subject|1
7030333|NCT01640925|11109413|FG001|Overall Study|Withdrawal by Subject|0
7030334|NCT01640925|11109412|FG000|Overall Study|Previously enrolled in this trial|13
7030335|NCT01640925|11109413|FG001|Overall Study|Previously enrolled in this trial|11
7030336|NCT01640951|11109427|FG000|Overall Study|Adverse Event|8
7030337|NCT01640951|11109428|FG001|Overall Study|Adverse Event|3
7030338|NCT01640951|11109429|FG002|Overall Study|Adverse Event|10
7030339|NCT01640951|11109430|FG003|Overall Study|Adverse Event|6
7030340|NCT01640951|11109431|FG004|Overall Study|Adverse Event|1
7030341|NCT01640951|11109432|FG005|Overall Study|Adverse Event|11
7030342|NCT01640951|11109433|FG006|Overall Study|Adverse Event|1
7030343|NCT01640951|11109434|FG007|Overall Study|Adverse Event|3
7030344|NCT01640951|11109427|FG000|Overall Study|Lack of Efficacy|20
7030345|NCT01640951|11109428|FG001|Overall Study|Lack of Efficacy|1
7030346|NCT01640951|11109429|FG002|Overall Study|Lack of Efficacy|7
7030347|NCT01640951|11109430|FG003|Overall Study|Lack of Efficacy|14
7030348|NCT01640951|11109431|FG004|Overall Study|Lack of Efficacy|0
7030349|NCT01640951|11109432|FG005|Overall Study|Lack of Efficacy|6
7030350|NCT01640951|11109433|FG006|Overall Study|Lack of Efficacy|5
7030351|NCT01640951|11109434|FG007|Overall Study|Lack of Efficacy|6
7030352|NCT01640951|11109427|FG000|Overall Study|Lost to Follow-up|1
7030353|NCT01640951|11109428|FG001|Overall Study|Lost to Follow-up|0
7030354|NCT01640951|11109429|FG002|Overall Study|Lost to Follow-up|6
7030355|NCT01640951|11109430|FG003|Overall Study|Lost to Follow-up|2
7030356|NCT01640951|11109431|FG004|Overall Study|Lost to Follow-up|2
7030357|NCT01640951|11109432|FG005|Overall Study|Lost to Follow-up|3
7030358|NCT01640951|11109433|FG006|Overall Study|Lost to Follow-up|1
7030359|NCT01640951|11109434|FG007|Overall Study|Lost to Follow-up|1
7030360|NCT01640951|11109427|FG000|Overall Study|Non-compliance with study treatment|0
7030361|NCT01640951|11109428|FG001|Overall Study|Non-compliance with study treatment|0
7030362|NCT01640951|11109429|FG002|Overall Study|Non-compliance with study treatment|1
7030363|NCT01640951|11109430|FG003|Overall Study|Non-compliance with study treatment|1
7030364|NCT01640951|11109431|FG004|Overall Study|Non-compliance with study treatment|1
7030365|NCT01640951|11109432|FG005|Overall Study|Non-compliance with study treatment|4
7030366|NCT01640951|11109433|FG006|Overall Study|Non-compliance with study treatment|1
7030367|NCT01640951|11109434|FG007|Overall Study|Non-compliance with study treatment|0
7030368|NCT01640951|11109427|FG000|Overall Study|Physician Decision|2
7030369|NCT01640951|11109428|FG001|Overall Study|Physician Decision|5
7030370|NCT01640951|11109429|FG002|Overall Study|Physician Decision|2
7030371|NCT01640951|11109430|FG003|Overall Study|Physician Decision|2
7030372|NCT01640951|11109431|FG004|Overall Study|Physician Decision|2
7030373|NCT01640951|11109432|FG005|Overall Study|Physician Decision|3
7030374|NCT01640951|11109433|FG006|Overall Study|Physician Decision|3
7030375|NCT01640951|11109434|FG007|Overall Study|Physician Decision|0
7030376|NCT01640951|11109427|FG000|Overall Study|Pregnancy|3
7030377|NCT01640951|11109428|FG001|Overall Study|Pregnancy|0
7030378|NCT01640951|11109429|FG002|Overall Study|Pregnancy|0
7030379|NCT01640951|11109430|FG003|Overall Study|Pregnancy|4
7030380|NCT01640951|11109431|FG004|Overall Study|Pregnancy|0
7030381|NCT01640951|11109432|FG005|Overall Study|Pregnancy|0
7030382|NCT01640951|11109433|FG006|Overall Study|Pregnancy|2
7030383|NCT01640951|11109434|FG007|Overall Study|Pregnancy|0
7030384|NCT01640951|11109427|FG000|Overall Study|Protocol Deviation|0
7030385|NCT01640951|11109428|FG001|Overall Study|Protocol Deviation|1
7030386|NCT01640951|11109429|FG002|Overall Study|Protocol Deviation|2
7030387|NCT01640951|11109430|FG003|Overall Study|Protocol Deviation|1
7030388|NCT01640951|11109431|FG004|Overall Study|Protocol Deviation|0
7030389|NCT01640951|11109432|FG005|Overall Study|Protocol Deviation|1
7030390|NCT01640951|11109433|FG006|Overall Study|Protocol Deviation|0
7030391|NCT01640951|11109434|FG007|Overall Study|Protocol Deviation|0
7030392|NCT01640951|11109427|FG000|Overall Study|Subject/Guardian decision|12
7030393|NCT01640951|11109428|FG001|Overall Study|Subject/Guardian decision|4
7030394|NCT01640951|11109429|FG002|Overall Study|Subject/Guardian decision|13
7030395|NCT01640951|11109430|FG003|Overall Study|Subject/Guardian decision|15
7030396|NCT01640951|11109431|FG004|Overall Study|Subject/Guardian decision|7
7030397|NCT01640951|11109432|FG005|Overall Study|Subject/Guardian decision|19
7030398|NCT01640951|11109433|FG006|Overall Study|Subject/Guardian decision|5
7030399|NCT01640951|11109434|FG007|Overall Study|Subject/Guardian decision|4
7030400|NCT01640951|11109427|FG000|Overall Study|Death|0
7030401|NCT01640951|11109428|FG001|Overall Study|Death|1
7030402|NCT01640951|11109429|FG002|Overall Study|Death|1
7030403|NCT01640951|11109430|FG003|Overall Study|Death|0
7030404|NCT01640951|11109431|FG004|Overall Study|Death|0
7030405|NCT01640951|11109432|FG005|Overall Study|Death|0
7030406|NCT01640951|11109433|FG006|Overall Study|Death|0
7030407|NCT01640951|11109434|FG007|Overall Study|Death|2
7030408|NCT01640964|11109457|FG000|Overall Study|Lost to Follow-up|0
7030409|NCT01640964|11109458|FG001|Overall Study|Lost to Follow-up|0
7030410|NCT01640964|11109459|FG002|Overall Study|Lost to Follow-up|1
7030411|NCT01640964|11109457|FG000|Overall Study|Protocol Deviation|1
7030412|NCT01640964|11109458|FG001|Overall Study|Protocol Deviation|1
7030413|NCT01640964|11109459|FG002|Overall Study|Protocol Deviation|2
7030414|NCT01641081|11109477|FG000|Period 1|Sponsor request (potential unblinding)|0
7030415|NCT01641081|11109478|FG001|Period 1|Sponsor request (potential unblinding)|0
7030416|NCT01641081|11109479|FG002|Period 1|Sponsor request (potential unblinding)|0
7030417|NCT01641081|11109480|FG003|Period 1|Sponsor request (potential unblinding)|0
7030418|NCT01641081|11109481|FG004|Period 1|Sponsor request (potential unblinding)|0
7030419|NCT01641081|11109482|FG005|Period 1|Sponsor request (potential unblinding)|0
7030420|NCT01641081|11109483|FG006|Period 1|Sponsor request (potential unblinding)|1
7030421|NCT01641081|11109484|FG007|Period 1|Sponsor request (potential unblinding)|0
7030422|NCT01641081|11109485|FG008|Period 1|Sponsor request (potential unblinding)|0
7030423|NCT01641081|11109486|FG009|Period 1|Sponsor request (potential unblinding)|0
7030424|NCT01641081|11109477|FG000|Period 1|Protocol Violation|0
7030425|NCT01641081|11109478|FG001|Period 1|Protocol Violation|0
7030426|NCT01641081|11109479|FG002|Period 1|Protocol Violation|0
7030427|NCT01641081|11109480|FG003|Period 1|Protocol Violation|0
7030428|NCT01641081|11109481|FG004|Period 1|Protocol Violation|1
7030429|NCT01641081|11109482|FG005|Period 1|Protocol Violation|0
7030430|NCT01641081|11109483|FG006|Period 1|Protocol Violation|0
7030431|NCT01641081|11109484|FG007|Period 1|Protocol Violation|1
7030432|NCT01641081|11109485|FG008|Period 1|Protocol Violation|0
7030433|NCT01641081|11109486|FG009|Period 1|Protocol Violation|0
7030434|NCT01641081|11109477|FG000|Period 1|Adverse Event|1
7030435|NCT01641081|11109478|FG001|Period 1|Adverse Event|0
7030436|NCT01641081|11109479|FG002|Period 1|Adverse Event|0
7030437|NCT01641081|11109480|FG003|Period 1|Adverse Event|0
7030438|NCT01641081|11109481|FG004|Period 1|Adverse Event|0
7030439|NCT01641081|11109482|FG005|Period 1|Adverse Event|0
7030440|NCT01641081|11109483|FG006|Period 1|Adverse Event|0
7030441|NCT01641081|11109484|FG007|Period 1|Adverse Event|2
7030442|NCT01641081|11109485|FG008|Period 1|Adverse Event|0
7030443|NCT01641081|11109486|FG009|Period 1|Adverse Event|0
7030444|NCT01641081|11109477|FG000|Period 2|Adverse Event|0
7030445|NCT01641081|11109478|FG001|Period 2|Adverse Event|0
7030446|NCT01641081|11109479|FG002|Period 2|Adverse Event|0
7030447|NCT01641081|11109480|FG003|Period 2|Adverse Event|0
7030448|NCT01641081|11109481|FG004|Period 2|Adverse Event|0
7030449|NCT01641081|11109482|FG005|Period 2|Adverse Event|1
7030450|NCT01641081|11109483|FG006|Period 2|Adverse Event|0
7030451|NCT01641081|11109484|FG007|Period 2|Adverse Event|0
7030452|NCT01641081|11109485|FG008|Period 2|Adverse Event|0
7030453|NCT01641081|11109486|FG009|Period 2|Adverse Event|0
7030454|NCT01641081|11109477|FG000|Period 2|Withdrawal by Subject|0
7030455|NCT01641081|11109478|FG001|Period 2|Withdrawal by Subject|0
7030456|NCT01641081|11109479|FG002|Period 2|Withdrawal by Subject|0
7030457|NCT01641081|11109480|FG003|Period 2|Withdrawal by Subject|1
7030458|NCT01641081|11109481|FG004|Period 2|Withdrawal by Subject|0
7030459|NCT01641081|11109482|FG005|Period 2|Withdrawal by Subject|0
7030460|NCT01641081|11109483|FG006|Period 2|Withdrawal by Subject|2
7030461|NCT01641081|11109484|FG007|Period 2|Withdrawal by Subject|0
7030462|NCT01641081|11109485|FG008|Period 2|Withdrawal by Subject|0
7030463|NCT01641081|11109486|FG009|Period 2|Withdrawal by Subject|0
7030464|NCT01641081|11109477|FG000|Period 2|Protocol Violation|1
7030465|NCT01641081|11109478|FG001|Period 2|Protocol Violation|0
7030466|NCT01641081|11109479|FG002|Period 2|Protocol Violation|0
7030467|NCT01641081|11109480|FG003|Period 2|Protocol Violation|0
7030468|NCT01641081|11109481|FG004|Period 2|Protocol Violation|0
7030469|NCT01641081|11109482|FG005|Period 2|Protocol Violation|0
7030470|NCT01641081|11109483|FG006|Period 2|Protocol Violation|0
7030471|NCT01641081|11109484|FG007|Period 2|Protocol Violation|0
7030472|NCT01641081|11109485|FG008|Period 2|Protocol Violation|0
7030473|NCT01641081|11109486|FG009|Period 2|Protocol Violation|0
7030474|NCT01641081|11109477|FG000|Period 3|Adverse Event|0
7030475|NCT01641081|11109478|FG001|Period 3|Adverse Event|0
7030476|NCT01641081|11109479|FG002|Period 3|Adverse Event|1
7030477|NCT01641081|11109480|FG003|Period 3|Adverse Event|0
7030478|NCT01641081|11109481|FG004|Period 3|Adverse Event|0
7030479|NCT01641081|11109482|FG005|Period 3|Adverse Event|0
7030480|NCT01641081|11109483|FG006|Period 3|Adverse Event|0
7030481|NCT01641081|11109484|FG007|Period 3|Adverse Event|0
7030482|NCT01641081|11109485|FG008|Period 3|Adverse Event|0
7030483|NCT01641081|11109486|FG009|Period 3|Adverse Event|0
7030484|NCT01641081|11109477|FG000|Period 3|Withdrawal by Subject|0
7030485|NCT01641081|11109478|FG001|Period 3|Withdrawal by Subject|0
7030486|NCT01641081|11109479|FG002|Period 3|Withdrawal by Subject|0
7030487|NCT01641081|11109480|FG003|Period 3|Withdrawal by Subject|0
7030488|NCT01641081|11109481|FG004|Period 3|Withdrawal by Subject|0
7030489|NCT01641081|11109482|FG005|Period 3|Withdrawal by Subject|0
7030490|NCT01641081|11109483|FG006|Period 3|Withdrawal by Subject|0
7030491|NCT01641081|11109484|FG007|Period 3|Withdrawal by Subject|0
7030492|NCT01641081|11109485|FG008|Period 3|Withdrawal by Subject|1
7030493|NCT01641081|11109486|FG009|Period 3|Withdrawal by Subject|0
7030494|NCT01641081|11109477|FG000|Period 4|Adverse Event|0
7030495|NCT01641081|11109478|FG001|Period 4|Adverse Event|1
7030496|NCT01641081|11109479|FG002|Period 4|Adverse Event|0
7030497|NCT01641081|11109480|FG003|Period 4|Adverse Event|1
7030498|NCT01641081|11109481|FG004|Period 4|Adverse Event|0
7030499|NCT01641081|11109482|FG005|Period 4|Adverse Event|0
7030500|NCT01641081|11109483|FG006|Period 4|Adverse Event|0
7030501|NCT01641081|11109484|FG007|Period 4|Adverse Event|0
7030502|NCT01641081|11109485|FG008|Period 4|Adverse Event|0
7030503|NCT01641081|11109486|FG009|Period 4|Adverse Event|0
7030504|NCT01641081|11109477|FG000|Period 5|Adverse Event|0
7030505|NCT01641081|11109478|FG001|Period 5|Adverse Event|0
7030506|NCT01641081|11109479|FG002|Period 5|Adverse Event|2
7030507|NCT01641081|11109480|FG003|Period 5|Adverse Event|0
7030508|NCT01641081|11109481|FG004|Period 5|Adverse Event|0
7030509|NCT01641081|11109482|FG005|Period 5|Adverse Event|0
7030510|NCT01641081|11109483|FG006|Period 5|Adverse Event|0
7030511|NCT01641081|11109484|FG007|Period 5|Adverse Event|0
7030512|NCT01641081|11109485|FG008|Period 5|Adverse Event|0
7030513|NCT01641081|11109486|FG009|Period 5|Adverse Event|0
7030514|NCT01641133|11109508|FG000|Overall Study|Protocol Violation|0
7030515|NCT01641133|11109509|FG001|Overall Study|Protocol Violation|1
7030516|NCT01641133|11109510|FG002|Overall Study|Protocol Violation|1
7030517|NCT01641133|11109508|FG000|Overall Study|Migrated/moved from study area|5
7030518|NCT01641133|11109509|FG001|Overall Study|Migrated/moved from study area|3
7030519|NCT01641133|11109510|FG002|Overall Study|Migrated/moved from study area|1
7030520|NCT01641133|11109508|FG000|Overall Study|Adverse Event|0
7030521|NCT01641133|11109509|FG001|Overall Study|Adverse Event|0
7030522|NCT01641133|11109510|FG002|Overall Study|Adverse Event|1
7030523|NCT01641133|11109508|FG000|Overall Study|Withdrawal by Subject|5
7030524|NCT01641133|11109509|FG001|Overall Study|Withdrawal by Subject|3
7030525|NCT01641133|11109510|FG002|Overall Study|Withdrawal by Subject|3
7030526|NCT01641133|11109508|FG000|Overall Study|Lost to Follow-up|0
7030527|NCT01641133|11109509|FG001|Overall Study|Lost to Follow-up|2
7030528|NCT01641133|11109510|FG002|Overall Study|Lost to Follow-up|2
7030529|NCT01641159|11109520|FG000|Overall Study|Lost to Follow-up|2
7030530|NCT01641159|11109521|FG001|Overall Study|Lost to Follow-up|1
7030531|NCT01641159|11109520|FG000|Overall Study|Withdrawal by Subject|0
7030532|NCT01641159|11109521|FG001|Overall Study|Withdrawal by Subject|1
7030533|NCT01641198|11109530|FG000|After 12 Months of Function|Lost to Follow-up|3
7030534|NCT01641198|11109531|FG001|After 12 Months of Function|Lost to Follow-up|2
7030535|NCT01641198|11109532|FG002|After 12 Months of Function|Lost to Follow-up|2
7030536|NCT01641198|11109530|FG000|After 12 Months of Function|Protocol Violation|1
7030537|NCT01641198|11109531|FG001|After 12 Months of Function|Protocol Violation|0
7030538|NCT01641198|11109532|FG002|After 12 Months of Function|Protocol Violation|0
7030539|NCT01641198|11109530|FG000|After 12 Months of Function|Adverse Event|0
7030540|NCT01641198|11109531|FG001|After 12 Months of Function|Adverse Event|1
7030541|NCT01641198|11109532|FG002|After 12 Months of Function|Adverse Event|0
7030542|NCT01641198|11109530|FG000|After 24 Months of Function|Lost to Follow-up|4
7030543|NCT01641198|11109531|FG001|After 24 Months of Function|Lost to Follow-up|9
7030544|NCT01641198|11109532|FG002|After 24 Months of Function|Lost to Follow-up|6
7030545|NCT01641198|11109530|FG000|At 15-20 Years of Function|Lost to Follow-up|5
7030546|NCT01641198|11109531|FG001|At 15-20 Years of Function|Lost to Follow-up|1
7030547|NCT01641198|11109532|FG002|At 15-20 Years of Function|Lost to Follow-up|1
7030548|NCT01641198|11109530|FG000|At 15-20 Years of Function|Death|1
7030549|NCT01641198|11109531|FG001|At 15-20 Years of Function|Death|0
7030550|NCT01641198|11109532|FG002|At 15-20 Years of Function|Death|1
7030551|NCT01641237|11109541|FG000|Period II|Withdrawal by Subject|1
7030552|NCT01641237|11109542|FG001|Period II|Withdrawal by Subject|0
7030553|NCT01641237|11109543|FG002|Period II|Withdrawal by Subject|0
7030554|NCT01641237|11109544|FG003|Period II|Withdrawal by Subject|0
7030555|NCT01641237|11109541|FG000|Period III|Lost to Follow-up|1
7030556|NCT01641237|11109542|FG001|Period III|Lost to Follow-up|0
7030557|NCT01641237|11109543|FG002|Period III|Lost to Follow-up|0
7030558|NCT01641237|11109544|FG003|Period III|Lost to Follow-up|0
7030559|NCT01641367|11109560|FG000|Cohorts|Death|18
7030560|NCT01641367|11109561|FG001|Cohorts|Death|1
7030561|NCT01641367|11109562|FG002|Cohorts|Death|2
7030562|NCT01641367|11109563|FG003|Cohorts|Death|0
7030563|NCT01641367|11109564|FG004|Cohorts|Death|1
7030564|NCT01641367|11109565|FG005|Cohorts|Death|1
7030565|NCT01641367|11109566|FG006|Cohorts|Death|0
7030566|NCT01641367|11109567|FG007|Cohorts|Death|0
7030567|NCT01641367|11109560|FG000|Cohorts|Lost to Follow-up|16
7030568|NCT01641367|11109561|FG001|Cohorts|Lost to Follow-up|0
7030569|NCT01641367|11109562|FG002|Cohorts|Lost to Follow-up|2
7030570|NCT01641367|11109563|FG003|Cohorts|Lost to Follow-up|0
7030571|NCT01641367|11109564|FG004|Cohorts|Lost to Follow-up|2
7030572|NCT01641367|11109565|FG005|Cohorts|Lost to Follow-up|0
7030573|NCT01641367|11109566|FG006|Cohorts|Lost to Follow-up|0
7030574|NCT01641367|11109567|FG007|Cohorts|Lost to Follow-up|0
7030575|NCT01641367|11109560|FG000|Randomized Adherence Intervention|Death|0
7030576|NCT01641367|11109561|FG001|Randomized Adherence Intervention|Death|0
7030577|NCT01641367|11109562|FG002|Randomized Adherence Intervention|Death|0
7030578|NCT01641367|11109563|FG003|Randomized Adherence Intervention|Death|0
7030579|NCT01641367|11109564|FG004|Randomized Adherence Intervention|Death|0
7030580|NCT01641367|11109565|FG005|Randomized Adherence Intervention|Death|0
7030581|NCT01641367|11109566|FG006|Randomized Adherence Intervention|Death|11
7030582|NCT01641367|11109567|FG007|Randomized Adherence Intervention|Death|12
7030583|NCT01641367|11109560|FG000|Randomized Adherence Intervention|Lost to Follow-up|0
7030584|NCT01641367|11109561|FG001|Randomized Adherence Intervention|Lost to Follow-up|0
7030585|NCT01641367|11109562|FG002|Randomized Adherence Intervention|Lost to Follow-up|0
7030586|NCT01641367|11109563|FG003|Randomized Adherence Intervention|Lost to Follow-up|0
7030587|NCT01641367|11109564|FG004|Randomized Adherence Intervention|Lost to Follow-up|0
7030588|NCT01641367|11109565|FG005|Randomized Adherence Intervention|Lost to Follow-up|0
7030589|NCT01641367|11109566|FG006|Randomized Adherence Intervention|Lost to Follow-up|8
7030590|NCT01641367|11109567|FG007|Randomized Adherence Intervention|Lost to Follow-up|12
7030591|NCT01641471|11109611|FG000|Overall Study|Withdrawal by Subject|19
7030592|NCT01641471|11109612|FG001|Overall Study|Withdrawal by Subject|19
7030593|NCT01641471|11109611|FG000|Overall Study|Lost to Follow-up|2
7030594|NCT01641471|11109612|FG001|Overall Study|Lost to Follow-up|4
7030595|NCT01641471|11109611|FG000|Overall Study|Protocol Violation|2
7030596|NCT01641471|11109612|FG001|Overall Study|Protocol Violation|4
7030597|NCT01641640|11109618|FG000|Overall Study|Enrolled but not treated|1
7030598|NCT01641640|11109618|FG000|Overall Study|Efficacy failure|29
7030599|NCT01641640|11109618|FG000|Overall Study|Lost to Follow-up|3
7030600|NCT01641640|11109618|FG000|Overall Study|Withdrawal by Subject|2
7030601|NCT01641640|11109618|FG000|Overall Study|Adverse Event|1
7030602|NCT01641692|11109634|FG000|Treatment Period 1|Adverse Event|1
7030603|NCT01641692|11109635|FG001|Treatment Period 1|Adverse Event|0
7030604|NCT01641692|11109636|FG002|Treatment Period 1|Adverse Event|0
7030605|NCT01641692|11109637|FG003|Treatment Period 1|Adverse Event|0
7030606|NCT01641692|11109638|FG004|Treatment Period 1|Adverse Event|0
7030607|NCT01641692|11109639|FG005|Treatment Period 1|Adverse Event|0
7030608|NCT01641692|11109640|FG006|Treatment Period 1|Adverse Event|0
7030609|NCT01641692|11109641|FG007|Treatment Period 1|Adverse Event|0
7030610|NCT01641692|11109634|FG000|Treatment Period 1|Lack of Efficacy|0
7030611|NCT01641692|11109635|FG001|Treatment Period 1|Lack of Efficacy|0
7030612|NCT01641692|11109636|FG002|Treatment Period 1|Lack of Efficacy|0
7030613|NCT01641692|11109637|FG003|Treatment Period 1|Lack of Efficacy|0
7030614|NCT01641692|11109638|FG004|Treatment Period 1|Lack of Efficacy|0
7030615|NCT01641692|11109639|FG005|Treatment Period 1|Lack of Efficacy|0
7030616|NCT01641692|11109640|FG006|Treatment Period 1|Lack of Efficacy|0
7030617|NCT01641692|11109641|FG007|Treatment Period 1|Lack of Efficacy|1
7030618|NCT01641692|11109634|FG000|Treatment Period 1|Protocol Violation|1
7030619|NCT01641692|11109635|FG001|Treatment Period 1|Protocol Violation|0
7030620|NCT01641692|11109636|FG002|Treatment Period 1|Protocol Violation|0
7030621|NCT01641692|11109637|FG003|Treatment Period 1|Protocol Violation|0
7030622|NCT01641692|11109638|FG004|Treatment Period 1|Protocol Violation|2
7030623|NCT01641692|11109639|FG005|Treatment Period 1|Protocol Violation|0
7030624|NCT01641692|11109640|FG006|Treatment Period 1|Protocol Violation|0
7030625|NCT01641692|11109641|FG007|Treatment Period 1|Protocol Violation|0
7030626|NCT01641692|11109634|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0
7030627|NCT01641692|11109635|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0
7030628|NCT01641692|11109636|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0
7030629|NCT01641692|11109637|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0
7030630|NCT01641692|11109638|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1
7030631|NCT01641692|11109639|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0
7030632|NCT01641692|11109640|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0
7030633|NCT01641692|11109641|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1
7030634|NCT01641692|11109634|FG000|Treatment Period 1|Lost to Follow-up|0
7030635|NCT01641692|11109635|FG001|Treatment Period 1|Lost to Follow-up|0
7030636|NCT01641692|11109636|FG002|Treatment Period 1|Lost to Follow-up|1
7030637|NCT01641692|11109637|FG003|Treatment Period 1|Lost to Follow-up|0
7030638|NCT01641692|11109638|FG004|Treatment Period 1|Lost to Follow-up|0
7030639|NCT01641692|11109639|FG005|Treatment Period 1|Lost to Follow-up|0
7030640|NCT01641692|11109640|FG006|Treatment Period 1|Lost to Follow-up|0
7030641|NCT01641692|11109641|FG007|Treatment Period 1|Lost to Follow-up|0
7030642|NCT01641692|11109634|FG000|Treatment Period 1|Physician Decision|0
7030643|NCT01641692|11109635|FG001|Treatment Period 1|Physician Decision|0
7030644|NCT01641692|11109636|FG002|Treatment Period 1|Physician Decision|0
7030645|NCT01641692|11109637|FG003|Treatment Period 1|Physician Decision|0
7030646|NCT01641692|11109638|FG004|Treatment Period 1|Physician Decision|1
7030647|NCT01641692|11109639|FG005|Treatment Period 1|Physician Decision|0
7030648|NCT01641692|11109640|FG006|Treatment Period 1|Physician Decision|0
7030649|NCT01641692|11109641|FG007|Treatment Period 1|Physician Decision|0
7030650|NCT01641692|11109634|FG000|Treatment Period 1|Withdrawal by Subject|0
7030651|NCT01641692|11109635|FG001|Treatment Period 1|Withdrawal by Subject|0
7030652|NCT01641692|11109636|FG002|Treatment Period 1|Withdrawal by Subject|0
7030653|NCT01641692|11109637|FG003|Treatment Period 1|Withdrawal by Subject|0
7030654|NCT01641692|11109638|FG004|Treatment Period 1|Withdrawal by Subject|0
7030655|NCT01641692|11109639|FG005|Treatment Period 1|Withdrawal by Subject|2
7030656|NCT01641692|11109640|FG006|Treatment Period 1|Withdrawal by Subject|0
7030657|NCT01641692|11109641|FG007|Treatment Period 1|Withdrawal by Subject|1
7030658|NCT01641692|11109634|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2
7030659|NCT01641692|11109635|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0
7030660|NCT01641692|11109636|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0
7030661|NCT01641692|11109637|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0
7030662|NCT01641692|11109638|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0
7030663|NCT01641692|11109639|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0
7030664|NCT01641692|11109640|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0
7030665|NCT01641692|11109641|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0
7030666|NCT01641692|11109634|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0
7030667|NCT01641692|11109635|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0
7030668|NCT01641692|11109636|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0
7030669|NCT01641692|11109637|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0
7030670|NCT01641692|11109638|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0
7030671|NCT01641692|11109639|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0
7030672|NCT01641692|11109640|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1
7030673|NCT01641692|11109641|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0
7030674|NCT01641692|11109634|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
7030675|NCT01641692|11109635|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
7030676|NCT01641692|11109636|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
7030677|NCT01641692|11109637|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
7030678|NCT01641692|11109638|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
7030679|NCT01641692|11109639|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
7030680|NCT01641692|11109640|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
7030681|NCT01641692|11109641|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
7030682|NCT01641692|11109634|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
7030683|NCT01641692|11109635|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
7030684|NCT01641692|11109636|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
7030685|NCT01641692|11109637|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
7030686|NCT01641692|11109638|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
7030687|NCT01641692|11109639|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
7030688|NCT01641692|11109640|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
7030689|NCT01641692|11109641|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
7030690|NCT01641692|11109634|FG000|Treatment Period 2|Lack of Efficacy|1
7030691|NCT01641692|11109635|FG001|Treatment Period 2|Lack of Efficacy|0
7030692|NCT01641692|11109636|FG002|Treatment Period 2|Lack of Efficacy|0
7030693|NCT01641692|11109637|FG003|Treatment Period 2|Lack of Efficacy|0
7030694|NCT01641692|11109638|FG004|Treatment Period 2|Lack of Efficacy|0
7030695|NCT01641692|11109639|FG005|Treatment Period 2|Lack of Efficacy|0
7030696|NCT01641692|11109640|FG006|Treatment Period 2|Lack of Efficacy|0
7030697|NCT01641692|11109641|FG007|Treatment Period 2|Lack of Efficacy|0
7030698|NCT01641692|11109634|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1
7030699|NCT01641692|11109635|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0
7030700|NCT01641692|11109636|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0
7030701|NCT01641692|11109637|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0
7030702|NCT01641692|11109638|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0
7030703|NCT01641692|11109639|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0
7030704|NCT01641692|11109640|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0
7030705|NCT01641692|11109641|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0
7030706|NCT01641692|11109634|FG000|Treatment Period 2|Lost to Follow-up|0
7030707|NCT01641692|11109635|FG001|Treatment Period 2|Lost to Follow-up|0
7030708|NCT01641692|11109636|FG002|Treatment Period 2|Lost to Follow-up|0
7030709|NCT01641692|11109637|FG003|Treatment Period 2|Lost to Follow-up|0
7030710|NCT01641692|11109638|FG004|Treatment Period 2|Lost to Follow-up|0
7030711|NCT01641692|11109639|FG005|Treatment Period 2|Lost to Follow-up|1
7030712|NCT01641692|11109640|FG006|Treatment Period 2|Lost to Follow-up|0
7030713|NCT01641692|11109641|FG007|Treatment Period 2|Lost to Follow-up|0
7030714|NCT01641692|11109634|FG000|Treatment Period 2|Withdrawal by Subject|1
7030715|NCT01641692|11109635|FG001|Treatment Period 2|Withdrawal by Subject|0
7030716|NCT01641692|11109636|FG002|Treatment Period 2|Withdrawal by Subject|0
7030717|NCT01641692|11109637|FG003|Treatment Period 2|Withdrawal by Subject|0
7030718|NCT01641692|11109638|FG004|Treatment Period 2|Withdrawal by Subject|0
7030719|NCT01641692|11109639|FG005|Treatment Period 2|Withdrawal by Subject|1
7030720|NCT01641692|11109640|FG006|Treatment Period 2|Withdrawal by Subject|0
7030721|NCT01641692|11109641|FG007|Treatment Period 2|Withdrawal by Subject|1
7030722|NCT01641692|11109634|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
7030723|NCT01641692|11109635|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
7030724|NCT01641692|11109636|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
7030725|NCT01641692|11109637|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
7030726|NCT01641692|11109638|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3
7030727|NCT01641692|11109639|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
7030728|NCT01641692|11109640|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1
7030729|NCT01641692|11109641|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
7030730|NCT01641692|11109634|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7030731|NCT01641692|11109635|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7030732|NCT01641692|11109636|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
7030733|NCT01641692|11109637|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7030734|NCT01641692|11109638|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7030735|NCT01641692|11109639|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
7030736|NCT01641692|11109640|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7030737|NCT01641692|11109641|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
7030738|NCT01641692|11109634|FG000|Treatment Period 3|Adverse Event|0
7030739|NCT01641692|11109635|FG001|Treatment Period 3|Adverse Event|0
7030740|NCT01641692|11109636|FG002|Treatment Period 3|Adverse Event|0
7030741|NCT01641692|11109637|FG003|Treatment Period 3|Adverse Event|0
7030742|NCT01641692|11109638|FG004|Treatment Period 3|Adverse Event|0
7030743|NCT01641692|11109639|FG005|Treatment Period 3|Adverse Event|0
7030744|NCT01641692|11109640|FG006|Treatment Period 3|Adverse Event|1
7030745|NCT01641692|11109641|FG007|Treatment Period 3|Adverse Event|0
7030746|NCT01641692|11109634|FG000|Treatment Period 3|Protocol Violation|0
7030747|NCT01641692|11109635|FG001|Treatment Period 3|Protocol Violation|0
7030748|NCT01641692|11109636|FG002|Treatment Period 3|Protocol Violation|1
7030749|NCT01641692|11109637|FG003|Treatment Period 3|Protocol Violation|0
7030750|NCT01641692|11109638|FG004|Treatment Period 3|Protocol Violation|0
7030751|NCT01641692|11109639|FG005|Treatment Period 3|Protocol Violation|0
7030752|NCT01641692|11109640|FG006|Treatment Period 3|Protocol Violation|0
7030753|NCT01641692|11109641|FG007|Treatment Period 3|Protocol Violation|0
7030754|NCT01641692|11109634|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0
7030755|NCT01641692|11109635|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0
7030756|NCT01641692|11109636|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0
7030757|NCT01641692|11109637|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0
7030758|NCT01641692|11109638|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0
7030759|NCT01641692|11109639|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0
7030760|NCT01641692|11109640|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1
7030761|NCT01641692|11109641|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0
7030762|NCT01641692|11109634|FG000|Treatment Period 3|Lost to Follow-up|0
7030763|NCT01641692|11109635|FG001|Treatment Period 3|Lost to Follow-up|1
7030764|NCT01641692|11109636|FG002|Treatment Period 3|Lost to Follow-up|0
7030765|NCT01641692|11109637|FG003|Treatment Period 3|Lost to Follow-up|0
7030766|NCT01641692|11109638|FG004|Treatment Period 3|Lost to Follow-up|0
7030767|NCT01641692|11109639|FG005|Treatment Period 3|Lost to Follow-up|0
7030768|NCT01641692|11109640|FG006|Treatment Period 3|Lost to Follow-up|0
7030769|NCT01641692|11109641|FG007|Treatment Period 3|Lost to Follow-up|0
7030770|NCT01641692|11109634|FG000|Washout Period 3 or Follow-up|Protocol Violation|0
7030771|NCT01641692|11109635|FG001|Washout Period 3 or Follow-up|Protocol Violation|0
7030772|NCT01641692|11109636|FG002|Washout Period 3 or Follow-up|Protocol Violation|0
7030773|NCT01641692|11109637|FG003|Washout Period 3 or Follow-up|Protocol Violation|0
7030774|NCT01641692|11109638|FG004|Washout Period 3 or Follow-up|Protocol Violation|0
7030775|NCT01641692|11109639|FG005|Washout Period 3 or Follow-up|Protocol Violation|1
7030776|NCT01641692|11109640|FG006|Washout Period 3 or Follow-up|Protocol Violation|0
7030777|NCT01641692|11109641|FG007|Washout Period 3 or Follow-up|Protocol Violation|0
7030778|NCT01641692|11109634|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
7030779|NCT01641692|11109635|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
7030780|NCT01641692|11109636|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
7030781|NCT01641692|11109637|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
7030782|NCT01641692|11109638|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
7030783|NCT01641692|11109639|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
7030784|NCT01641692|11109640|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
7030785|NCT01641692|11109641|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
7030786|NCT01641809|11109664|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
7030787|NCT01641809|11109665|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
7030788|NCT01641809|11109666|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0
7030789|NCT01641809|11109667|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
7030790|NCT01641809|11109664|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0
7030791|NCT01641809|11109665|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1
7030792|NCT01641809|11109666|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0
7030793|NCT01641809|11109667|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1
7030794|NCT01641809|11109664|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1
7030795|NCT01641809|11109665|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2
7030796|NCT01641809|11109666|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0
7030797|NCT01641809|11109667|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3
7030798|NCT01641809|11109664|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2
7030799|NCT01641809|11109665|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1
7030800|NCT01641809|11109666|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1
7030801|NCT01641809|11109667|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0
7030802|NCT01641809|11109664|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4
7030803|NCT01641809|11109665|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1
7030804|NCT01641809|11109666|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2
7030805|NCT01641809|11109667|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3
7030806|NCT01641809|11109664|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0
7030807|NCT01641809|11109665|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1
7030808|NCT01641809|11109666|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3
7030809|NCT01641809|11109667|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7
7030810|NCT01641809|11109664|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2
7030811|NCT01641809|11109665|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3
7030812|NCT01641809|11109666|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1
7030813|NCT01641809|11109667|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0
7030814|NCT01641809|11109664|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
7030815|NCT01641809|11109665|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1
7030816|NCT01641809|11109666|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
7030817|NCT01641809|11109667|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
7030818|NCT01641809|11109664|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2
7030819|NCT01641809|11109665|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0
7030820|NCT01641809|11109666|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1
7030821|NCT01641809|11109667|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2
7030822|NCT01641809|11109664|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1
7030823|NCT01641809|11109665|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1
7030824|NCT01641809|11109666|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0
7030825|NCT01641809|11109667|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2
7030826|NCT01641809|11109664|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1
7030827|NCT01641809|11109665|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0
7030828|NCT01641809|11109666|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1
7030829|NCT01641809|11109667|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2
7030830|NCT01641809|11109664|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2
7030831|NCT01641809|11109665|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3
7030832|NCT01641809|11109666|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1
7030833|NCT01641809|11109667|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0
7030834|NCT01641809|11109664|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0
7030835|NCT01641809|11109665|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1
7030836|NCT01641809|11109666|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1
7030837|NCT01641809|11109667|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0
7030838|NCT01641809|11109664|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5
7030839|NCT01641809|11109665|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4
7030840|NCT01641809|11109666|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5
7030841|NCT01641809|11109667|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0
7030842|NCT01641809|11109664|FG000|Open-label (Week 96 to Week 324)|Site closed|1
7030843|NCT01641809|11109665|FG001|Open-label (Week 96 to Week 324)|Site closed|0
7030844|NCT01641809|11109666|FG002|Open-label (Week 96 to Week 324)|Site closed|0
7030845|NCT01641809|11109667|FG003|Open-label (Week 96 to Week 324)|Site closed|0
7030846|NCT01641809|11109664|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1
7030847|NCT01641809|11109665|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1
7030848|NCT01641809|11109666|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0
7030849|NCT01641809|11109667|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0
7030850|NCT01641809|11109664|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4
7030851|NCT01641809|11109665|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1
7030852|NCT01641809|11109666|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0
7030853|NCT01641809|11109667|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0
7030854|NCT01641809|11109664|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3
7030855|NCT01641809|11109665|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2
7030856|NCT01641809|11109666|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1
7030857|NCT01641809|11109667|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0
7030858|NCT01641822|11109687|FG000|Run-in Phase|Noncompliance with study drug|1
7030859|NCT01641822|11109688|FG001|Run-in Phase|Noncompliance with study drug|0
7030860|NCT01641822|11109689|FG002|Run-in Phase|Noncompliance with study drug|0
7030861|NCT01641822|11109687|FG000|Run-in Phase|Adverse Event|3
7030862|NCT01641822|11109688|FG001|Run-in Phase|Adverse Event|0
7030863|NCT01641822|11109689|FG002|Run-in Phase|Adverse Event|0
7030864|NCT01641822|11109687|FG000|Run-in Phase|Withdrew consent|1
7030865|NCT01641822|11109688|FG001|Run-in Phase|Withdrew consent|0
7030866|NCT01641822|11109689|FG002|Run-in Phase|Withdrew consent|0
7030867|NCT01641822|11109687|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9
7030868|NCT01641822|11109688|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0
7030869|NCT01641822|11109689|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0
7030870|NCT01641822|11109687|FG000|Comparative Phase|Noncompliance with study drug|0
7030871|NCT01641822|11109688|FG001|Comparative Phase|Noncompliance with study drug|1
7030872|NCT01641822|11109689|FG002|Comparative Phase|Noncompliance with study drug|0
7030873|NCT01641822|11109687|FG000|Comparative Phase|Investigator's discretion|0
7030874|NCT01641822|11109688|FG001|Comparative Phase|Investigator's discretion|0
7030875|NCT01641822|11109689|FG002|Comparative Phase|Investigator's discretion|1
7030876|NCT01641822|11109687|FG000|Comparative Phase|Pregnancy|0
7030877|NCT01641822|11109688|FG001|Comparative Phase|Pregnancy|0
7030878|NCT01641822|11109689|FG002|Comparative Phase|Pregnancy|1
7030879|NCT01641822|11109687|FG000|Comparative Phase|Adverse event, serious fatal|0
7030880|NCT01641822|11109688|FG001|Comparative Phase|Adverse event, serious fatal|1
7030881|NCT01641822|11109689|FG002|Comparative Phase|Adverse event, serious fatal|0
7030882|NCT01641822|11109687|FG000|Comparative Phase|Withdrew consent|0
7030883|NCT01641822|11109688|FG001|Comparative Phase|Withdrew consent|3
7030884|NCT01641822|11109689|FG002|Comparative Phase|Withdrew consent|7
7030885|NCT01641822|11109687|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0
7030886|NCT01641822|11109688|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1
7030887|NCT01641822|11109689|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1
7030888|NCT01641861|11109702|FG000|Overall Study|Lost to Follow-up|21
7030889|NCT01641861|11109703|FG001|Overall Study|Lost to Follow-up|16
7030890|NCT01641861|11109702|FG000|Overall Study|Lost the tooth due to normal exfoliation|14
7030891|NCT01641861|11109703|FG001|Overall Study|Lost the tooth due to normal exfoliation|8
7030892|NCT01641861|11109702|FG000|Overall Study|Died due to drowning|0
7030893|NCT01641861|11109703|FG001|Overall Study|Died due to drowning|1
7030894|NCT01641900|11109711|FG000|Overall Study|Withdrawal by Subject|2
7030895|NCT01641900|11109712|FG001|Overall Study|Withdrawal by Subject|2
7030896|NCT01641926|11109724|FG000|Overall Study|Adverse Event|5
7030897|NCT01641926|11109725|FG001|Overall Study|Adverse Event|2
7030898|NCT01641926|11109726|FG002|Overall Study|Adverse Event|3
7030899|NCT01641926|11109727|FG003|Overall Study|Adverse Event|1
7030900|NCT01641926|11109724|FG000|Overall Study|Lost to Follow-up|2
7030901|NCT01641926|11109725|FG001|Overall Study|Lost to Follow-up|2
7030902|NCT01641926|11109726|FG002|Overall Study|Lost to Follow-up|1
7030903|NCT01641926|11109727|FG003|Overall Study|Lost to Follow-up|0
7030904|NCT01641926|11109724|FG000|Overall Study|Physician Decision|6
7030905|NCT01641926|11109725|FG001|Overall Study|Physician Decision|5
7030906|NCT01641926|11109726|FG002|Overall Study|Physician Decision|0
7030907|NCT01641926|11109727|FG003|Overall Study|Physician Decision|1
7030908|NCT01641926|11109724|FG000|Overall Study|Protocol Violation|1
7030909|NCT01641926|11109725|FG001|Overall Study|Protocol Violation|0
7030910|NCT01641926|11109726|FG002|Overall Study|Protocol Violation|0
7030911|NCT01641926|11109727|FG003|Overall Study|Protocol Violation|1
7030912|NCT01641926|11109724|FG000|Overall Study|Withdrawal by Subject|13
7030913|NCT01641926|11109725|FG001|Overall Study|Withdrawal by Subject|5
7030914|NCT01641926|11109726|FG002|Overall Study|Withdrawal by Subject|6
7030915|NCT01641926|11109727|FG003|Overall Study|Withdrawal by Subject|1
7030916|NCT01641926|11109724|FG000|Overall Study|Not Treated|1
7030917|NCT01641926|11109725|FG001|Overall Study|Not Treated|1
7030918|NCT01641926|11109726|FG002|Overall Study|Not Treated|1
7030919|NCT01641926|11109727|FG003|Overall Study|Not Treated|0
7030920|NCT01641939|11109740|FG000|Overall Study|Death|90
7030921|NCT01641939|11109741|FG001|Overall Study|Death|187
7030922|NCT01641939|11109742|FG002|Overall Study|Death|61
7030923|NCT01641939|11109740|FG000|Overall Study|Lost to Follow-up|3
7030924|NCT01641939|11109741|FG001|Overall Study|Lost to Follow-up|2
7030925|NCT01641939|11109742|FG002|Overall Study|Lost to Follow-up|1
7030926|NCT01641939|11109740|FG000|Overall Study|Withdrawal by Subject|14
7030927|NCT01641939|11109741|FG001|Overall Study|Withdrawal by Subject|11
7030928|NCT01641939|11109742|FG002|Overall Study|Withdrawal by Subject|5
7030929|NCT01641939|11109740|FG000|Overall Study|Study Terminated by Sponsor|10
7030930|NCT01641939|11109741|FG001|Overall Study|Study Terminated by Sponsor|28
7030931|NCT01641939|11109742|FG002|Overall Study|Study Terminated by Sponsor|3
7030932|NCT01641952|11109752|FG000|Overall Study|Lost to Follow-up|28
7030933|NCT01641952|11109752|FG000|Overall Study|Adverse Event|6
7030934|NCT01641991|11109768|FG000|Overall Study|Physician Decision|0
7030935|NCT01641991|11109769|FG001|Overall Study|Physician Decision|1
7030936|NCT01641991|11109770|FG002|Overall Study|Physician Decision|7
7030937|NCT01641991|11109771|FG003|Overall Study|Physician Decision|5
7030938|NCT01641991|11109768|FG000|Overall Study|Withdrawal by Subject|4
7030939|NCT01641991|11109769|FG001|Overall Study|Withdrawal by Subject|2
7030940|NCT01641991|11109770|FG002|Overall Study|Withdrawal by Subject|1
7030941|NCT01641991|11109771|FG003|Overall Study|Withdrawal by Subject|5
7030942|NCT01641991|11109768|FG000|Overall Study|Adverse Event|2
7030943|NCT01641991|11109769|FG001|Overall Study|Adverse Event|1
7030944|NCT01641991|11109770|FG002|Overall Study|Adverse Event|2
7030945|NCT01641991|11109771|FG003|Overall Study|Adverse Event|1
7030946|NCT01641991|11109768|FG000|Overall Study|Lost to Follow-up|0
7030947|NCT01641991|11109769|FG001|Overall Study|Lost to Follow-up|2
7030948|NCT01641991|11109770|FG002|Overall Study|Lost to Follow-up|3
7030949|NCT01641991|11109771|FG003|Overall Study|Lost to Follow-up|1
7030950|NCT01641991|11109768|FG000|Overall Study|Protocol Violation|1
7030951|NCT01641991|11109769|FG001|Overall Study|Protocol Violation|1
7030952|NCT01641991|11109770|FG002|Overall Study|Protocol Violation|3
7030953|NCT01641991|11109771|FG003|Overall Study|Protocol Violation|0
7030954|NCT01641991|11109768|FG000|Overall Study|Pregnancy|0
7030955|NCT01641991|11109769|FG001|Overall Study|Pregnancy|0
7030956|NCT01641991|11109770|FG002|Overall Study|Pregnancy|1
7030957|NCT01641991|11109771|FG003|Overall Study|Pregnancy|0
7030958|NCT01641991|11109768|FG000|Overall Study|no longer eligible|2
7030959|NCT01641991|11109769|FG001|Overall Study|no longer eligible|1
7030960|NCT01641991|11109770|FG002|Overall Study|no longer eligible|0
7030961|NCT01641991|11109771|FG003|Overall Study|no longer eligible|4
7030962|NCT01642212|11109815|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26
7030963|NCT01642212|11109816|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
7030964|NCT01642212|11109817|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
7030965|NCT01642212|11109818|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
7030966|NCT01642212|11109819|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
7030967|NCT01642212|11109815|FG000|Double-blind Treatment|Other|0
7030968|NCT01642212|11109816|FG001|Double-blind Treatment|Other|2
7030969|NCT01642212|11109817|FG002|Double-blind Treatment|Other|1
7030970|NCT01642212|11109818|FG003|Double-blind Treatment|Other|0
7030971|NCT01642212|11109819|FG004|Double-blind Treatment|Other|0
7030972|NCT01642212|11109815|FG000|Double-blind Treatment|Non-compliance|0
7030973|NCT01642212|11109816|FG001|Double-blind Treatment|Non-compliance|1
7030974|NCT01642212|11109817|FG002|Double-blind Treatment|Non-compliance|0
7030975|NCT01642212|11109818|FG003|Double-blind Treatment|Non-compliance|0
7030976|NCT01642212|11109819|FG004|Double-blind Treatment|Non-compliance|0
7030977|NCT01642212|11109815|FG000|Double-blind Treatment|Adverse Event|0
7030978|NCT01642212|11109816|FG001|Double-blind Treatment|Adverse Event|0
7030979|NCT01642212|11109817|FG002|Double-blind Treatment|Adverse Event|1
7030980|NCT01642212|11109818|FG003|Double-blind Treatment|Adverse Event|0
7030981|NCT01642212|11109819|FG004|Double-blind Treatment|Adverse Event|0
7030982|NCT01642212|11109815|FG000|Open-label Extension|Adverse Event|0
7030983|NCT01642212|11109816|FG001|Open-label Extension|Adverse Event|0
7030984|NCT01642212|11109817|FG002|Open-label Extension|Adverse Event|0
7030985|NCT01642212|11109818|FG003|Open-label Extension|Adverse Event|3
7030986|NCT01642212|11109819|FG004|Open-label Extension|Adverse Event|0
7030987|NCT01642212|11109815|FG000|Open-label Extension|Sponsor Decision|0
7030988|NCT01642212|11109816|FG001|Open-label Extension|Sponsor Decision|0
7030989|NCT01642212|11109817|FG002|Open-label Extension|Sponsor Decision|0
7030990|NCT01642212|11109818|FG003|Open-label Extension|Sponsor Decision|7
7030991|NCT01642212|11109819|FG004|Open-label Extension|Sponsor Decision|4
7030992|NCT01642212|11109815|FG000|Open-label Extension|Consent Withdrawn|0
7030993|NCT01642212|11109816|FG001|Open-label Extension|Consent Withdrawn|0
7030994|NCT01642212|11109817|FG002|Open-label Extension|Consent Withdrawn|0
7030995|NCT01642212|11109818|FG003|Open-label Extension|Consent Withdrawn|0
7030996|NCT01642212|11109819|FG004|Open-label Extension|Consent Withdrawn|2
7030997|NCT01642212|11109815|FG000|Open-label Extension|Lost to Follow-up|0
7030998|NCT01642212|11109816|FG001|Open-label Extension|Lost to Follow-up|0
7030999|NCT01642212|11109817|FG002|Open-label Extension|Lost to Follow-up|0
7031000|NCT01642212|11109818|FG003|Open-label Extension|Lost to Follow-up|0
7031001|NCT01642212|11109819|FG004|Open-label Extension|Lost to Follow-up|1
7031002|NCT01642212|11109815|FG000|Open-label Extension|Other|0
7031003|NCT01642212|11109816|FG001|Open-label Extension|Other|0
7031004|NCT01642212|11109817|FG002|Open-label Extension|Other|0
7031005|NCT01642212|11109818|FG003|Open-label Extension|Other|0
7031006|NCT01642212|11109819|FG004|Open-label Extension|Other|1
7031007|NCT01642251|11109837|FG000|Overall Study|Progressive disease|0
7031008|NCT01642251|11109838|FG001|Overall Study|Progressive disease|0
7031009|NCT01642251|11109839|FG002|Overall Study|Progressive disease|3
7031010|NCT01642251|11109840|FG003|Overall Study|Progressive disease|3
7031011|NCT01642251|11109837|FG000|Overall Study|Adverse Event|0
7031012|NCT01642251|11109838|FG001|Overall Study|Adverse Event|0
7031013|NCT01642251|11109839|FG002|Overall Study|Adverse Event|5
7031014|NCT01642251|11109840|FG003|Overall Study|Adverse Event|4
7031015|NCT01642251|11109837|FG000|Overall Study|Death|0
7031016|NCT01642251|11109838|FG001|Overall Study|Death|0
7031017|NCT01642251|11109839|FG002|Overall Study|Death|1
7031018|NCT01642251|11109840|FG003|Overall Study|Death|3
7031019|NCT01642251|11109837|FG000|Overall Study|Withdrawal by Subject|0
7031020|NCT01642251|11109838|FG001|Overall Study|Withdrawal by Subject|0
7031021|NCT01642251|11109839|FG002|Overall Study|Withdrawal by Subject|1
7031022|NCT01642251|11109840|FG003|Overall Study|Withdrawal by Subject|3
7031023|NCT01642251|11109837|FG000|Overall Study|Alternative therapy|0
7031024|NCT01642251|11109838|FG001|Overall Study|Alternative therapy|0
7031025|NCT01642251|11109839|FG002|Overall Study|Alternative therapy|0
7031026|NCT01642251|11109840|FG003|Overall Study|Alternative therapy|2
7031027|NCT01642251|11109837|FG000|Overall Study|Other complicating disease|0
7031028|NCT01642251|11109838|FG001|Overall Study|Other complicating disease|0
7031029|NCT01642251|11109839|FG002|Overall Study|Other complicating disease|1
7031030|NCT01642251|11109840|FG003|Overall Study|Other complicating disease|0
7031031|NCT01642251|11109837|FG000|Overall Study|Ineligible/never start protocol therapy|0
7031032|NCT01642251|11109838|FG001|Overall Study|Ineligible/never start protocol therapy|0
7031033|NCT01642251|11109839|FG002|Overall Study|Ineligible/never start protocol therapy|11
7031034|NCT01642251|11109840|FG003|Overall Study|Ineligible/never start protocol therapy|8
7031035|NCT01642277|11109851|FG000|Overall Study|Adverse Event|10
7031036|NCT01642277|11109852|FG001|Overall Study|Adverse Event|0
7031037|NCT01642277|11109851|FG000|Overall Study|Physician Decision|2
7031038|NCT01642277|11109852|FG001|Overall Study|Physician Decision|0
7031039|NCT01642277|11109851|FG000|Overall Study|Protocol Violation|1
7031040|NCT01642277|11109852|FG001|Overall Study|Protocol Violation|0
7031041|NCT01642277|11109851|FG000|Overall Study|Withdrawal by Subject|11
7031042|NCT01642277|11109852|FG001|Overall Study|Withdrawal by Subject|0
7031043|NCT01642407|11109859|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3
7031044|NCT01642407|11109859|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1
7031045|NCT01642407|11109859|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1
7031046|NCT01642589|11109890|FG000|Overall Study|Withdrawal by Subject|1
7031047|NCT01642589|11109891|FG001|Overall Study|Withdrawal by Subject|1
7031048|NCT01642602|11109897|FG000|Overall Study|Adverse Event|2
7031049|NCT01642615|11109901|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1
7031050|NCT01642615|11109902|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
7031051|NCT01642615|11109903|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
7031052|NCT01642615|11109901|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1
7031053|NCT01642615|11109902|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0
7031054|NCT01642615|11109903|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0
7031055|NCT01642615|11109901|FG000|Open Label Maintenance Phase|Lost to Follow-up|1
7031056|NCT01642615|11109902|FG001|Open Label Maintenance Phase|Lost to Follow-up|0
7031057|NCT01642615|11109903|FG002|Open Label Maintenance Phase|Lost to Follow-up|0
7031058|NCT01642615|11109901|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1
7031059|NCT01642615|11109902|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0
7031060|NCT01642615|11109903|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0
7031061|NCT01642615|11109901|FG000|Open Label Maintenance Phase|Did not receive treatment|1
7031062|NCT01642615|11109902|FG001|Open Label Maintenance Phase|Did not receive treatment|0
7031063|NCT01642615|11109903|FG002|Open Label Maintenance Phase|Did not receive treatment|0
7031064|NCT01642615|11109901|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0
7031065|NCT01642615|11109902|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1
7031066|NCT01642615|11109903|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3
7031067|NCT01642615|11109901|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0
7031068|NCT01642615|11109902|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5
7031069|NCT01642615|11109903|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2
7031070|NCT01642615|11109901|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
7031071|NCT01642615|11109902|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1
7031072|NCT01642615|11109903|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
7031073|NCT01642615|11109901|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
7031074|NCT01642615|11109902|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
7031075|NCT01642615|11109903|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1
7031076|NCT01642914|11109914|FG000|Overall Study|Adverse Event|11
7031077|NCT01642914|11109915|FG001|Overall Study|Adverse Event|7
7031078|NCT01642914|11109916|FG002|Overall Study|Adverse Event|15
7031079|NCT01642914|11109914|FG000|Overall Study|Lack of Efficacy|9
7031080|NCT01642914|11109915|FG001|Overall Study|Lack of Efficacy|4
7031081|NCT01642914|11109916|FG002|Overall Study|Lack of Efficacy|2
7031082|NCT01642914|11109914|FG000|Overall Study|Protocol Violation|15
7031083|NCT01642914|11109915|FG001|Overall Study|Protocol Violation|13
7031084|NCT01642914|11109916|FG002|Overall Study|Protocol Violation|6
7031085|NCT01642914|11109914|FG000|Overall Study|Withdrawal by Subject|5
7031086|NCT01642914|11109915|FG001|Overall Study|Withdrawal by Subject|5
7031087|NCT01642914|11109916|FG002|Overall Study|Withdrawal by Subject|10
7031088|NCT01642914|11109914|FG000|Overall Study|Lost to Follow-up|5
7031089|NCT01642914|11109915|FG001|Overall Study|Lost to Follow-up|3
7031090|NCT01642914|11109916|FG002|Overall Study|Lost to Follow-up|7
7031091|NCT01642914|11109914|FG000|Overall Study|Other Reason|1
7031092|NCT01642914|11109915|FG001|Overall Study|Other Reason|0
7031093|NCT01642914|11109916|FG002|Overall Study|Other Reason|0
7031094|NCT01643044|11109928|FG000|Overall Study|Lost to Follow-up|1
7031095|NCT01643044|11109929|FG001|Overall Study|Lost to Follow-up|1
7031096|NCT01643044|11109928|FG000|Overall Study|Miscarried baby|2
7031097|NCT01643044|11109929|FG001|Overall Study|Miscarried baby|2
7031098|NCT01643044|11109928|FG000|Overall Study|Delivered outside of hospital|1
7031099|NCT01643044|11109929|FG001|Overall Study|Delivered outside of hospital|2
7044522|NCT01754922|11130390|FG001|Overall Study|Adverse Event|1
7044523|NCT01755026|11130399|FG000|Overall Study|Adverse Event|1
7044524|NCT01755026|11130400|FG001|Overall Study|Adverse Event|0
7044525|NCT01755026|11130399|FG000|Overall Study|Withdrawal by Subject|1
7044526|NCT01755026|11130400|FG001|Overall Study|Withdrawal by Subject|1
7044527|NCT01755091|11130409|FG000|Overall Study|Withdrawal by Subject|6
7044528|NCT01755091|11130410|FG001|Overall Study|Withdrawal by Subject|1
7044529|NCT01755091|11130411|FG002|Overall Study|Withdrawal by Subject|3
7044530|NCT01755091|11130409|FG000|Overall Study|Adverse Event|1
7044531|NCT01755091|11130410|FG001|Overall Study|Adverse Event|1
7044532|NCT01755091|11130411|FG002|Overall Study|Adverse Event|1
7044533|NCT01755091|11130409|FG000|Overall Study|Lost to Follow-up|1
7044534|NCT01755091|11130410|FG001|Overall Study|Lost to Follow-up|0
7044535|NCT01755091|11130411|FG002|Overall Study|Lost to Follow-up|1
7044536|NCT01755091|11130409|FG000|Overall Study|Physician Decision|1
7044537|NCT01755091|11130410|FG001|Overall Study|Physician Decision|1
7044538|NCT01755091|11130411|FG002|Overall Study|Physician Decision|2
7044539|NCT01755156|11130430|FG000|Phase A (Weeks 0-24)|Adverse Event|2
7044540|NCT01755156|11130431|FG001|Phase A (Weeks 0-24)|Adverse Event|3
7044541|NCT01755156|11130430|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1
7044542|NCT01755156|11130431|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0
7044543|NCT01755156|11130430|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5
7044544|NCT01755156|11130431|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3
7060589|NCT01920061|11156849|FG012|Overall Study|Participant refused further follow-up|1
7060590|NCT01920061|11156850|FG013|Overall Study|Participant refused further follow-up|0
7060591|NCT01920061|11156851|FG014|Overall Study|Participant refused further follow-up|1
7060592|NCT01920061|11156852|FG015|Overall Study|Participant refused further follow-up|2
7060593|NCT01920061|11156853|FG016|Overall Study|Participant refused further follow-up|1
7060594|NCT01920061|11156854|FG017|Overall Study|Participant refused further follow-up|1
7060595|NCT01920061|11156855|FG018|Overall Study|Participant refused further follow-up|0
7060596|NCT01920061|11156856|FG019|Overall Study|Participant refused further follow-up|0
7060597|NCT01920152|11156921|FG000|Overall Study|Withdrawal by Subject|1
7060598|NCT01920152|11156922|FG001|Overall Study|Withdrawal by Subject|2
7044545|NCT01755156|11130430|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1
7060599|NCT01920178|11156930|FG000|Overall Study|Lost to Follow-up|2
7060600|NCT01920178|11156931|FG001|Overall Study|Lost to Follow-up|1
7044546|NCT01755156|11130431|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0
7044547|NCT01755156|11130430|FG000|Phase A (Weeks 0-24)|Physician Decision|0
7044548|NCT01755156|11130431|FG001|Phase A (Weeks 0-24)|Physician Decision|1
7031100|NCT01643408|11109953|FG000|Overall Study|Adverse Event|12
7031101|NCT01643408|11109953|FG000|Overall Study|Other|2
7031102|NCT01643473|11109959|FG000|Overall Study|Lost to Follow-up|1
7031103|NCT01643473|11109960|FG001|Overall Study|Lost to Follow-up|0
7031104|NCT01643668|11109975|FG000|Overall Study|Death|1
7031105|NCT01643772|11109995|FG000|Overall Study|Protocol Violation|0
7031106|NCT01643772|11109996|FG001|Overall Study|Protocol Violation|0
7031107|NCT01643772|11109997|FG002|Overall Study|Protocol Violation|0
7031108|NCT01643772|11109998|FG003|Overall Study|Protocol Violation|1
7031109|NCT01643772|11109995|FG000|Overall Study|Adverse Event|0
7031110|NCT01643772|11109996|FG001|Overall Study|Adverse Event|0
7031111|NCT01643772|11109997|FG002|Overall Study|Adverse Event|0
7031112|NCT01643772|11109998|FG003|Overall Study|Adverse Event|1
7031113|NCT01643798|11110010|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1
7031114|NCT01643798|11110011|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0
7031115|NCT01643850|11110031|FG000|Overall Study|Withdrawal by Subject|0
7031116|NCT01643850|11110032|FG001|Overall Study|Withdrawal by Subject|0
7031117|NCT01643850|11110033|FG002|Overall Study|Withdrawal by Subject|0
7031118|NCT01643850|11110034|FG003|Overall Study|Withdrawal by Subject|0
7031119|NCT01643850|11110035|FG004|Overall Study|Withdrawal by Subject|1
7031120|NCT01643850|11110036|FG005|Overall Study|Withdrawal by Subject|0
7031121|NCT01643850|11110037|FG006|Overall Study|Withdrawal by Subject|0
7031122|NCT01643850|11110038|FG007|Overall Study|Withdrawal by Subject|0
7031123|NCT01643850|11110039|FG008|Overall Study|Withdrawal by Subject|0
7031124|NCT01643850|11110031|FG000|Overall Study|Lost to Follow-up|0
7031125|NCT01643850|11110032|FG001|Overall Study|Lost to Follow-up|0
7031126|NCT01643850|11110033|FG002|Overall Study|Lost to Follow-up|0
7031127|NCT01643850|11110034|FG003|Overall Study|Lost to Follow-up|0
7031128|NCT01643850|11110035|FG004|Overall Study|Lost to Follow-up|0
7031129|NCT01643850|11110036|FG005|Overall Study|Lost to Follow-up|0
7031130|NCT01643850|11110037|FG006|Overall Study|Lost to Follow-up|1
7031131|NCT01643850|11110038|FG007|Overall Study|Lost to Follow-up|0
7031132|NCT01643850|11110039|FG008|Overall Study|Lost to Follow-up|1
7031133|NCT01643850|11110031|FG000|Overall Study|Adverse Event|0
7031134|NCT01643850|11110032|FG001|Overall Study|Adverse Event|0
7031135|NCT01643850|11110033|FG002|Overall Study|Adverse Event|0
7031136|NCT01643850|11110034|FG003|Overall Study|Adverse Event|0
7031137|NCT01643850|11110035|FG004|Overall Study|Adverse Event|1
7031138|NCT01643850|11110036|FG005|Overall Study|Adverse Event|0
7031139|NCT01643850|11110037|FG006|Overall Study|Adverse Event|0
7031140|NCT01643850|11110038|FG007|Overall Study|Adverse Event|0
7031141|NCT01643850|11110039|FG008|Overall Study|Adverse Event|0
7031142|NCT01643850|11110031|FG000|Overall Study|Administrative Problems|0
7031143|NCT01643850|11110032|FG001|Overall Study|Administrative Problems|0
7031144|NCT01643850|11110033|FG002|Overall Study|Administrative Problems|1
7031145|NCT01643850|11110034|FG003|Overall Study|Administrative Problems|0
7031146|NCT01643850|11110035|FG004|Overall Study|Administrative Problems|1
7031147|NCT01643850|11110036|FG005|Overall Study|Administrative Problems|0
7031148|NCT01643850|11110037|FG006|Overall Study|Administrative Problems|0
7031149|NCT01643850|11110038|FG007|Overall Study|Administrative Problems|0
7031150|NCT01643850|11110039|FG008|Overall Study|Administrative Problems|0
7031151|NCT01643928|11110119|FG000|Overall Study|Lost to Follow-up|1
7031152|NCT01643928|11110120|FG001|Overall Study|Lost to Follow-up|0
7031153|NCT01643928|11110121|FG002|Overall Study|Lost to Follow-up|2
7031154|NCT01643928|11110122|FG003|Overall Study|Lost to Follow-up|0
7031155|NCT01643928|11110123|FG004|Overall Study|Lost to Follow-up|0
7031156|NCT01643928|11110119|FG000|Overall Study|Withdrawal by Subject|2
7031157|NCT01643928|11110120|FG001|Overall Study|Withdrawal by Subject|0
7031158|NCT01643928|11110121|FG002|Overall Study|Withdrawal by Subject|0
7031159|NCT01643928|11110122|FG003|Overall Study|Withdrawal by Subject|1
7031160|NCT01643928|11110123|FG004|Overall Study|Withdrawal by Subject|0
7031161|NCT01643928|11110119|FG000|Overall Study|Pregnancy|0
7031162|NCT01643928|11110120|FG001|Overall Study|Pregnancy|0
7031163|NCT01643928|11110121|FG002|Overall Study|Pregnancy|0
7031164|NCT01643928|11110122|FG003|Overall Study|Pregnancy|1
7031165|NCT01643928|11110123|FG004|Overall Study|Pregnancy|0
7031166|NCT01643928|11110119|FG000|Overall Study|Other|5
7031167|NCT01643928|11110120|FG001|Overall Study|Other|1
7031168|NCT01643928|11110121|FG002|Overall Study|Other|1
7031169|NCT01643928|11110122|FG003|Overall Study|Other|0
7031170|NCT01643928|11110123|FG004|Overall Study|Other|0
7031171|NCT01643928|11110119|FG000|Overall Study|Adverse Event|2
7031172|NCT01643928|11110120|FG001|Overall Study|Adverse Event|1
7031173|NCT01643928|11110121|FG002|Overall Study|Adverse Event|0
7031174|NCT01643928|11110122|FG003|Overall Study|Adverse Event|1
7031175|NCT01643928|11110123|FG004|Overall Study|Adverse Event|2
7031176|NCT01644149|11110171|FG000|Overall Study|Withdrawal by Subject|1
7031177|NCT01644149|11110172|FG001|Overall Study|Withdrawal by Subject|0
7031178|NCT01644149|11110171|FG000|Overall Study|Lost to Follow-up|3
7031179|NCT01644149|11110172|FG001|Overall Study|Lost to Follow-up|1
7031180|NCT01644175|11110181|FG000|Overall Study|Randomized But Not Treated|0
7031181|NCT01644175|11110182|FG001|Overall Study|Randomized But Not Treated|2
7031182|NCT01644175|11110181|FG000|Overall Study|Adverse Event|8
7031183|NCT01644175|11110182|FG001|Overall Study|Adverse Event|13
7031184|NCT01644175|11110181|FG000|Overall Study|Death|1
7031185|NCT01644175|11110182|FG001|Overall Study|Death|2
7031186|NCT01644175|11110181|FG000|Overall Study|Poor compliance to protocol|9
7031187|NCT01644175|11110182|FG001|Overall Study|Poor compliance to protocol|10
7031188|NCT01644175|11110181|FG000|Overall Study|Physician Decision|1
7031189|NCT01644175|11110182|FG001|Overall Study|Physician Decision|2
7031190|NCT01644175|11110181|FG000|Overall Study|Participant Moved|1
7031191|NCT01644175|11110182|FG001|Overall Study|Participant Moved|2
7031192|NCT01644175|11110181|FG000|Overall Study|Consent withdrawn by participant|3
7031193|NCT01644175|11110182|FG001|Overall Study|Consent withdrawn by participant|4
7031194|NCT01644175|11110181|FG000|Overall Study|Related to Autoinjector Administration|2
7031195|NCT01644175|11110182|FG001|Overall Study|Related to Autoinjector Administration|1
7031196|NCT01644175|11110181|FG000|Overall Study|Last visit outside protocol visit window|4
7031197|NCT01644175|11110182|FG001|Overall Study|Last visit outside protocol visit window|11
7031198|NCT01644175|11110181|FG000|Overall Study|Selection criteria finally not met|0
7031199|NCT01644175|11110182|FG001|Overall Study|Selection criteria finally not met|1
7031200|NCT01644175|11110181|FG000|Overall Study|Site closure|2
7031201|NCT01644175|11110182|FG001|Overall Study|Site closure|2
7031202|NCT01644175|11110181|FG000|Overall Study|Lost to Follow-up|1
7031203|NCT01644175|11110182|FG001|Overall Study|Lost to Follow-up|0
7031204|NCT01644175|11110181|FG000|Overall Study|Other than specified above|0
7031205|NCT01644175|11110182|FG001|Overall Study|Other than specified above|3
7031206|NCT01644188|11110190|FG000|Overall Study|Adverse Event|44
7031207|NCT01644188|11110191|FG001|Overall Study|Adverse Event|20
7031208|NCT01644188|11110190|FG000|Overall Study|Poor compliance to protocol|26
7031209|NCT01644188|11110191|FG001|Overall Study|Poor compliance to protocol|14
7031210|NCT01644188|11110190|FG000|Overall Study|Physician Decision|1
7031211|NCT01644188|11110191|FG001|Overall Study|Physician Decision|3
7031212|NCT01644188|11110190|FG000|Overall Study|Participant moved|7
7031213|NCT01644188|11110191|FG001|Overall Study|Participant moved|2
7031214|NCT01644188|11110190|FG000|Overall Study|Related to auto-injector administration|2
7031215|NCT01644188|11110191|FG001|Overall Study|Related to auto-injector administration|2
7031216|NCT01644188|11110190|FG000|Overall Study|Consent withdrawn by participant|14
7031217|NCT01644188|11110191|FG001|Overall Study|Consent withdrawn by participant|7
7031218|NCT01644188|11110190|FG000|Overall Study|Selection criteria finally not met|2
7031219|NCT01644188|11110191|FG001|Overall Study|Selection criteria finally not met|0
7031220|NCT01644188|11110190|FG000|Overall Study|Lost to Follow-up|1
7031221|NCT01644188|11110191|FG001|Overall Study|Lost to Follow-up|0
7031222|NCT01644188|11110190|FG000|Overall Study|Death|4
7031223|NCT01644188|11110191|FG001|Overall Study|Death|3
7031224|NCT01644188|11110190|FG000|Overall Study|Last visit outside protocol visit window|14
7031225|NCT01644188|11110191|FG001|Overall Study|Last visit outside protocol visit window|16
7031226|NCT01644188|11110190|FG000|Overall Study|Site closure|1
7031227|NCT01644188|11110191|FG001|Overall Study|Site closure|1
7031228|NCT01644188|11110190|FG000|Overall Study|Other than specified above|6
7031229|NCT01644188|11110191|FG001|Overall Study|Other than specified above|7
7031230|NCT01644474|11110230|FG000|Overall Study|Poor compliance to protocol|1
7031231|NCT01644474|11110231|FG001|Overall Study|Poor compliance to protocol|0
7031232|NCT01644474|11110230|FG000|Overall Study|Consent withdrawn by participant|0
7031233|NCT01644474|11110231|FG001|Overall Study|Consent withdrawn by participant|1
7031234|NCT01644474|11110230|FG000|Overall Study|Participant moved|0
7031235|NCT01644474|11110231|FG001|Overall Study|Participant moved|1
7031236|NCT01644474|11110230|FG000|Overall Study|Adverse Event|4
7031237|NCT01644474|11110231|FG001|Overall Study|Adverse Event|5
7031238|NCT01644474|11110230|FG000|Overall Study|Site scheduling error|1
7031239|NCT01644474|11110231|FG001|Overall Study|Site scheduling error|1
7031240|NCT01644474|11110230|FG000|Overall Study|Protocol Violation|1
7031241|NCT01644474|11110231|FG001|Overall Study|Protocol Violation|0
7031242|NCT01644500|11110240|FG000|Overall Study|Adverse Event|6
7031243|NCT01644500|11110241|FG001|Overall Study|Adverse Event|1
7031244|NCT01644500|11110242|FG002|Overall Study|Adverse Event|2
7031245|NCT01644500|11110240|FG000|Overall Study|Death|0
7031246|NCT01644500|11110241|FG001|Overall Study|Death|1
7031247|NCT01644500|11110242|FG002|Overall Study|Death|0
7031248|NCT01644500|11110240|FG000|Overall Study|Lost to Follow-up|3
7031249|NCT01644500|11110241|FG001|Overall Study|Lost to Follow-up|8
7031250|NCT01644500|11110242|FG002|Overall Study|Lost to Follow-up|0
7031251|NCT01644500|11110240|FG000|Overall Study|Protocol Violation|1
7031252|NCT01644500|11110241|FG001|Overall Study|Protocol Violation|1
7031253|NCT01644500|11110242|FG002|Overall Study|Protocol Violation|0
7031254|NCT01644500|11110240|FG000|Overall Study|Withdrawal by Subject|11
7031255|NCT01644500|11110241|FG001|Overall Study|Withdrawal by Subject|12
7031256|NCT01644500|11110242|FG002|Overall Study|Withdrawal by Subject|12
7031257|NCT01644500|11110240|FG000|Overall Study|Physician Decision|1
7031258|NCT01644500|11110241|FG001|Overall Study|Physician Decision|1
7031259|NCT01644500|11110242|FG002|Overall Study|Physician Decision|1
7031260|NCT01644565|11110250|FG000|Overall Study|Undisclosed Medical History|1
7031261|NCT01644565|11110251|FG001|Overall Study|Undisclosed Medical History|0
7031262|NCT01644565|11110252|FG002|Overall Study|Undisclosed Medical History|0
7031263|NCT01644565|11110253|FG003|Overall Study|Undisclosed Medical History|0
7031264|NCT01644565|11110254|FG004|Overall Study|Undisclosed Medical History|0
7031265|NCT01644565|11110255|FG005|Overall Study|Undisclosed Medical History|0
7031266|NCT01644565|11110256|FG006|Overall Study|Undisclosed Medical History|0
7031267|NCT01644565|11110257|FG007|Overall Study|Undisclosed Medical History|0
7031268|NCT01644565|11110258|FG008|Overall Study|Undisclosed Medical History|0
7031269|NCT01644565|11110250|FG000|Overall Study|Lost to Follow-up|0
7031270|NCT01644565|11110251|FG001|Overall Study|Lost to Follow-up|0
7031271|NCT01644565|11110252|FG002|Overall Study|Lost to Follow-up|0
7031272|NCT01644565|11110253|FG003|Overall Study|Lost to Follow-up|1
7031273|NCT01644565|11110254|FG004|Overall Study|Lost to Follow-up|0
7031274|NCT01644565|11110255|FG005|Overall Study|Lost to Follow-up|0
7031275|NCT01644565|11110256|FG006|Overall Study|Lost to Follow-up|0
7031276|NCT01644565|11110257|FG007|Overall Study|Lost to Follow-up|2
7031277|NCT01644565|11110258|FG008|Overall Study|Lost to Follow-up|0
7031278|NCT01644565|11110250|FG000|Overall Study|Family emergency|0
7031279|NCT01644565|11110251|FG001|Overall Study|Family emergency|0
7031280|NCT01644565|11110252|FG002|Overall Study|Family emergency|0
7031281|NCT01644565|11110253|FG003|Overall Study|Family emergency|0
7031282|NCT01644565|11110254|FG004|Overall Study|Family emergency|1
7031283|NCT01644565|11110255|FG005|Overall Study|Family emergency|0
7031284|NCT01644565|11110256|FG006|Overall Study|Family emergency|0
7031285|NCT01644565|11110257|FG007|Overall Study|Family emergency|0
7031286|NCT01644565|11110258|FG008|Overall Study|Family emergency|0
7031287|NCT01644565|11110250|FG000|Overall Study|Relocation|0
7031288|NCT01644565|11110251|FG001|Overall Study|Relocation|0
7031289|NCT01644565|11110252|FG002|Overall Study|Relocation|0
7031290|NCT01644565|11110253|FG003|Overall Study|Relocation|0
7031291|NCT01644565|11110254|FG004|Overall Study|Relocation|0
7031292|NCT01644565|11110255|FG005|Overall Study|Relocation|0
7031293|NCT01644565|11110256|FG006|Overall Study|Relocation|0
7031294|NCT01644565|11110257|FG007|Overall Study|Relocation|0
7031295|NCT01644565|11110258|FG008|Overall Study|Relocation|1
7031296|NCT01644617|11110281|FG000|Overall Study|Withdrawal by Subject|3
7031297|NCT01644617|11110282|FG001|Overall Study|Withdrawal by Subject|4
7031298|NCT01644617|11110283|FG002|Overall Study|Withdrawal by Subject|1
7031299|NCT01644617|11110281|FG000|Overall Study|Lost to Follow-up|0
7031300|NCT01644617|11110282|FG001|Overall Study|Lost to Follow-up|1
7031301|NCT01644617|11110283|FG002|Overall Study|Lost to Follow-up|0
7031302|NCT01644617|11110281|FG000|Overall Study|Adverse Event|3
7031303|NCT01644617|11110282|FG001|Overall Study|Adverse Event|0
7031304|NCT01644617|11110283|FG002|Overall Study|Adverse Event|6
7031305|NCT01644643|11110295|FG000|Overall Study|Death|1
7031306|NCT01644643|11110296|FG001|Overall Study|Death|0
7031307|NCT01644643|11110297|FG002|Overall Study|Death|3
7031308|NCT01644643|11110298|FG003|Overall Study|Death|3
7031309|NCT01644643|11110295|FG000|Overall Study|Lost to Follow-up|0
7031310|NCT01644643|11110296|FG001|Overall Study|Lost to Follow-up|0
7031311|NCT01644643|11110297|FG002|Overall Study|Lost to Follow-up|0
7031312|NCT01644643|11110298|FG003|Overall Study|Lost to Follow-up|4
7031313|NCT01644643|11110295|FG000|Overall Study|Withdrawal by Subject|1
7031314|NCT01644643|11110296|FG001|Overall Study|Withdrawal by Subject|0
7031315|NCT01644643|11110297|FG002|Overall Study|Withdrawal by Subject|2
7031316|NCT01644643|11110298|FG003|Overall Study|Withdrawal by Subject|1
7031317|NCT01644643|11110295|FG000|Overall Study|Other Eligibility criteria|0
7031318|NCT01644643|11110296|FG001|Overall Study|Other Eligibility criteria|0
7031319|NCT01644643|11110297|FG002|Overall Study|Other Eligibility criteria|0
7031320|NCT01644643|11110298|FG003|Overall Study|Other Eligibility criteria|2
7031321|NCT01644734|11110318|FG000|Overall Study|Adverse Event|4
7031322|NCT01644734|11110318|FG000|Overall Study|Lost to Follow-up|17
7031323|NCT01644734|11110318|FG000|Overall Study|Reasons other than stated above|7
7031324|NCT01644734|11110318|FG000|Overall Study|Missing documentation|238
7031325|NCT01644890|11110324|FG000|Overall Study|Adverse Event|7
7031326|NCT01644890|11110325|FG001|Overall Study|Adverse Event|20
7031327|NCT01644890|11110324|FG000|Overall Study|Death|1
7031328|NCT01644890|11110325|FG001|Overall Study|Death|3
7031329|NCT01644890|11110324|FG000|Overall Study|Physician Decision|3
7031330|NCT01644890|11110325|FG001|Overall Study|Physician Decision|9
7031331|NCT01644890|11110324|FG000|Overall Study|Protocol Violation|6
7031332|NCT01644890|11110325|FG001|Overall Study|Protocol Violation|7
7031333|NCT01644890|11110324|FG000|Overall Study|Withdrawal by Subject|19
7031334|NCT01644890|11110325|FG001|Overall Study|Withdrawal by Subject|27
7031335|NCT01644890|11110324|FG000|Overall Study|Progression Disease|160
7031336|NCT01644890|11110325|FG001|Overall Study|Progression Disease|131
7031337|NCT01644890|11110324|FG000|Overall Study|Clinical Progression|6
7031338|NCT01644890|11110325|FG001|Overall Study|Clinical Progression|6
7031339|NCT01644890|11110324|FG000|Overall Study|> 28 days since last dose of study drug|6
7031340|NCT01644890|11110325|FG001|Overall Study|> 28 days since last dose of study drug|3
7031341|NCT01644890|11110324|FG000|Overall Study|Other|8
7031342|NCT01644890|11110325|FG001|Overall Study|Other|9
7031343|NCT01645111|11110349|FG000|Overall Study|Did not require Clevidipine|15
7031344|NCT01645176|11110353|FG000|Overall Study|Lack of Efficacy|4
7031345|NCT01645176|11110353|FG000|Overall Study|did not complete final MRI|1
7031346|NCT01645280|11110362|FG000|Overall Study|Death|0
7031347|NCT01645280|11110363|FG001|Overall Study|Death|1
7031348|NCT01645280|11110364|FG002|Overall Study|Death|0
7031349|NCT01645280|11110365|FG003|Overall Study|Death|0
7031350|NCT01645280|11110366|FG004|Overall Study|Death|0
7031351|NCT01645280|11110362|FG000|Overall Study|Withdrawal by Subject|4
7031352|NCT01645280|11110363|FG001|Overall Study|Withdrawal by Subject|0
7031353|NCT01645280|11110364|FG002|Overall Study|Withdrawal by Subject|2
7031354|NCT01645280|11110365|FG003|Overall Study|Withdrawal by Subject|4
7031355|NCT01645280|11110366|FG004|Overall Study|Withdrawal by Subject|5
7031356|NCT01645280|11110362|FG000|Overall Study|Lost to Follow-up|0
7031357|NCT01645280|11110363|FG001|Overall Study|Lost to Follow-up|0
7031358|NCT01645280|11110364|FG002|Overall Study|Lost to Follow-up|0
7031359|NCT01645280|11110365|FG003|Overall Study|Lost to Follow-up|2
7031360|NCT01645280|11110366|FG004|Overall Study|Lost to Follow-up|1
7031361|NCT01645280|11110362|FG000|Overall Study|Other|1
7031362|NCT01645280|11110363|FG001|Overall Study|Other|1
7031363|NCT01645280|11110364|FG002|Overall Study|Other|2
7031364|NCT01645280|11110365|FG003|Overall Study|Other|0
7031365|NCT01645280|11110366|FG004|Overall Study|Other|0
7031366|NCT01645280|11110362|FG000|Overall Study|Treatment not completed/Completed f/u|1
7031367|NCT01645280|11110363|FG001|Overall Study|Treatment not completed/Completed f/u|1
7031368|NCT01645280|11110364|FG002|Overall Study|Treatment not completed/Completed f/u|2
7031369|NCT01645280|11110365|FG003|Overall Study|Treatment not completed/Completed f/u|0
7031370|NCT01645280|11110366|FG004|Overall Study|Treatment not completed/Completed f/u|2
7031371|NCT01645735|11110394|FG000|Overall Study|Physician Decision|2
7031372|NCT01645735|11110395|FG001|Overall Study|Physician Decision|0
7031373|NCT01645735|11110394|FG000|Overall Study|Withdrawal by Subject|1
7031374|NCT01645735|11110395|FG001|Overall Study|Withdrawal by Subject|0
7031375|NCT01645735|11110394|FG000|Overall Study|Protocol Violation|1
7031376|NCT01645735|11110395|FG001|Overall Study|Protocol Violation|0
7031377|NCT01645735|11110394|FG000|Overall Study|Adverse Event|0
7031378|NCT01645735|11110395|FG001|Overall Study|Adverse Event|1
7031379|NCT01645930|11110402|FG000|Overall Study|Participants Ongoing on Study Treatment|22
7031380|NCT01645930|11110402|FG000|Overall Study|Progressive Disease|12
7031381|NCT01645930|11110402|FG000|Overall Study|Adverse Event|4
7031382|NCT01645930|11110402|FG000|Overall Study|Unsatisfactory Therapeutic Response|2
7031383|NCT01645930|11110402|FG000|Overall Study|Withdrawal by Participant|2
7031384|NCT01645930|11110402|FG000|Overall Study|Reason not Defined|1
7031385|NCT01646021|11110408|FG000|Overall Study|Death|77
7031386|NCT01646021|11110409|FG001|Overall Study|Death|83
7031387|NCT01646021|11110408|FG000|Overall Study|Study Terminated by Sponsor|50
7031388|NCT01646021|11110409|FG001|Overall Study|Study Terminated by Sponsor|41
7031389|NCT01646021|11110408|FG000|Overall Study|Lost to Follow-up|2
7031390|NCT01646021|11110409|FG001|Overall Study|Lost to Follow-up|2
7031391|NCT01646021|11110408|FG000|Overall Study|Withdrawal by Subject|10
7031392|NCT01646021|11110409|FG001|Overall Study|Withdrawal by Subject|15
7031393|NCT01646073|11110417|FG000|Period A (12 Weeks)|Adverse Event|0
7031394|NCT01646073|11110418|FG001|Period A (12 Weeks)|Adverse Event|2
7031395|NCT01646073|11110417|FG000|Period A (12 Weeks)|Withdrawal by Subject|1
7031396|NCT01646073|11110418|FG001|Period A (12 Weeks)|Withdrawal by Subject|1
7031397|NCT01646073|11110417|FG000|Period A (12 Weeks)|Lack of Efficacy|1
7031398|NCT01646073|11110418|FG001|Period A (12 Weeks)|Lack of Efficacy|0
7031399|NCT01646073|11110417|FG000|Period A (12 Weeks)|Protocol Violation|0
7031400|NCT01646073|11110418|FG001|Period A (12 Weeks)|Protocol Violation|1
7031401|NCT01646073|11110417|FG000|Period A (12 Weeks)|Other|0
7031402|NCT01646073|11110418|FG001|Period A (12 Weeks)|Other|1
7031403|NCT01646073|11110417|FG000|Period B (12 Weeks)|Adverse Event|0
7031404|NCT01646073|11110418|FG001|Period B (12 Weeks)|Adverse Event|7
7031405|NCT01646073|11110417|FG000|Period B (12 Weeks)|Withdrawal by Subject|1
7031406|NCT01646073|11110418|FG001|Period B (12 Weeks)|Withdrawal by Subject|5
7031407|NCT01646073|11110417|FG000|Period B (12 Weeks)|Lost to Follow-up|0
7031408|NCT01646073|11110418|FG001|Period B (12 Weeks)|Lost to Follow-up|1
7031409|NCT01646125|11110429|FG000|Overall Study|Untreated|2
7031410|NCT01646125|11110430|FG001|Overall Study|Untreated|5
7031411|NCT01646125|11110429|FG000|Overall Study|Adverse Event|2
7031412|NCT01646125|11110430|FG001|Overall Study|Adverse Event|1
7031413|NCT01646125|11110429|FG000|Overall Study|Death|1
7031414|NCT01646125|11110430|FG001|Overall Study|Death|1
7031415|NCT01646125|11110429|FG000|Overall Study|Physician Decision|1
7031416|NCT01646125|11110430|FG001|Overall Study|Physician Decision|3
7031417|NCT01646125|11110429|FG000|Overall Study|Progressive disease|22
7031418|NCT01646125|11110430|FG001|Overall Study|Progressive disease|16
7031419|NCT01646125|11110429|FG000|Overall Study|Study terminated by sponsor|2
7031420|NCT01646125|11110430|FG001|Overall Study|Study terminated by sponsor|1
7031421|NCT01646125|11110429|FG000|Overall Study|Subject/Guardian decision|1
7031422|NCT01646125|11110430|FG001|Overall Study|Subject/Guardian decision|1
7031423|NCT01646138|11110442|FG000|Overall Study|Lost to Follow-up|0
7031424|NCT01646138|11110443|FG001|Overall Study|Lost to Follow-up|0
7031425|NCT01646138|11110444|FG002|Overall Study|Lost to Follow-up|0
7031426|NCT01646138|11110445|FG003|Overall Study|Lost to Follow-up|0
7031427|NCT01646138|11110446|FG004|Overall Study|Lost to Follow-up|2
7031428|NCT01646177|11110466|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2
7031429|NCT01646177|11110467|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4
7031430|NCT01646177|11110468|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9
7031431|NCT01646177|11110469|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8
7031432|NCT01646177|11110470|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
7031433|NCT01646177|11110471|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
7031434|NCT01646177|11110472|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
7031435|NCT01646177|11110473|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
7031436|NCT01646177|11110474|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
7031437|NCT01646177|11110475|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
7031438|NCT01646177|11110476|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
7031439|NCT01646177|11110477|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
7031440|NCT01646177|11110466|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1
7031441|NCT01646177|11110467|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3
7031442|NCT01646177|11110468|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8
7031443|NCT01646177|11110469|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7
7031444|NCT01646177|11110470|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
7031445|NCT01646177|11110471|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
7031446|NCT01646177|11110472|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
7031447|NCT01646177|11110473|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
7031448|NCT01646177|11110474|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
7031449|NCT01646177|11110475|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
7031450|NCT01646177|11110476|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
7031451|NCT01646177|11110477|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
7031452|NCT01646177|11110466|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3
7031453|NCT01646177|11110467|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2
7031454|NCT01646177|11110468|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
7031455|NCT01646177|11110469|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
7031456|NCT01646177|11110470|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
7031457|NCT01646177|11110471|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
7031458|NCT01646177|11110472|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
7031459|NCT01646177|11110473|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
7031460|NCT01646177|11110474|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
7031461|NCT01646177|11110475|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
7031462|NCT01646177|11110476|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
7031463|NCT01646177|11110477|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
7031464|NCT01646177|11110466|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
7031465|NCT01646177|11110467|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
7031466|NCT01646177|11110468|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
7031467|NCT01646177|11110469|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
7031468|NCT01646177|11110470|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
7031469|NCT01646177|11110471|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
7031470|NCT01646177|11110472|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
7031471|NCT01646177|11110473|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
7031472|NCT01646177|11110474|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
7031473|NCT01646177|11110475|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
7031474|NCT01646177|11110476|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
7031475|NCT01646177|11110477|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
7031476|NCT01646177|11110466|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7031477|NCT01646177|11110467|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7031478|NCT01646177|11110468|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2
7031479|NCT01646177|11110469|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1
7031480|NCT01646177|11110470|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7031481|NCT01646177|11110471|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7031482|NCT01646177|11110472|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7031483|NCT01646177|11110473|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7031484|NCT01646177|11110474|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7031485|NCT01646177|11110475|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7031486|NCT01646177|11110476|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7031487|NCT01646177|11110477|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7031488|NCT01646177|11110466|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3
7031489|NCT01646177|11110467|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
7031490|NCT01646177|11110468|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
7031491|NCT01646177|11110469|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
7031492|NCT01646177|11110470|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
7031493|NCT01646177|11110471|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
7031494|NCT01646177|11110472|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
7031495|NCT01646177|11110473|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
7031496|NCT01646177|11110474|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
7031497|NCT01646177|11110475|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
7031498|NCT01646177|11110476|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
7031499|NCT01646177|11110477|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
7031500|NCT01646177|11110466|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0
7031501|NCT01646177|11110467|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0
7031502|NCT01646177|11110468|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0
7031503|NCT01646177|11110469|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0
7031504|NCT01646177|11110470|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16
7031505|NCT01646177|11110471|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34
7031506|NCT01646177|11110472|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43
7031507|NCT01646177|11110473|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30
7044549|NCT01755156|11130430|FG000|Phase A (Weeks 0-24)|Protocol Violation|1
7031508|NCT01646177|11110474|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0
7031509|NCT01646177|11110475|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0
7031510|NCT01646177|11110476|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0
7031511|NCT01646177|11110477|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0
7031512|NCT01646177|11110466|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
7031513|NCT01646177|11110467|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
7031514|NCT01646177|11110468|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
7031515|NCT01646177|11110469|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
7031516|NCT01646177|11110470|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11
7031517|NCT01646177|11110471|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30
7031518|NCT01646177|11110472|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29
7031519|NCT01646177|11110473|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27
7031520|NCT01646177|11110474|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
7031521|NCT01646177|11110475|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
7031522|NCT01646177|11110476|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
7031523|NCT01646177|11110477|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
7031524|NCT01646177|11110466|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
7031525|NCT01646177|11110467|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
7031526|NCT01646177|11110468|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
7031527|NCT01646177|11110469|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
7031528|NCT01646177|11110470|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6
7031529|NCT01646177|11110471|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17
7031530|NCT01646177|11110472|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23
7031531|NCT01646177|11110473|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18
7031532|NCT01646177|11110474|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
7031533|NCT01646177|11110475|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
7031534|NCT01646177|11110476|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
7031535|NCT01646177|11110477|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
7031536|NCT01646177|11110466|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
7031537|NCT01646177|11110467|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
7031538|NCT01646177|11110468|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
7031539|NCT01646177|11110469|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
7031540|NCT01646177|11110470|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6
7031541|NCT01646177|11110471|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14
7031542|NCT01646177|11110472|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10
7031543|NCT01646177|11110473|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11
7031544|NCT01646177|11110474|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
7031545|NCT01646177|11110475|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
7031546|NCT01646177|11110476|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
7031547|NCT01646177|11110477|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
7031548|NCT01646177|11110466|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0
7031549|NCT01646177|11110467|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0
7031550|NCT01646177|11110468|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0
7031551|NCT01646177|11110469|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0
7031552|NCT01646177|11110470|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3
7031553|NCT01646177|11110471|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5
7031554|NCT01646177|11110472|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5
7031555|NCT01646177|11110473|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5
7031556|NCT01646177|11110474|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0
7031557|NCT01646177|11110475|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0
7031558|NCT01646177|11110476|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0
7031559|NCT01646177|11110477|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0
7031560|NCT01646177|11110466|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
7031561|NCT01646177|11110467|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
7031562|NCT01646177|11110468|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
7031563|NCT01646177|11110469|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
7031564|NCT01646177|11110470|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1
7031565|NCT01646177|11110471|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4
7031566|NCT01646177|11110472|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
7031567|NCT01646177|11110473|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5
7031568|NCT01646177|11110474|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
7031569|NCT01646177|11110475|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
7031570|NCT01646177|11110476|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
7031571|NCT01646177|11110477|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
7031572|NCT01646177|11110466|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
7031573|NCT01646177|11110467|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
7031574|NCT01646177|11110468|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
7031575|NCT01646177|11110469|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
7031576|NCT01646177|11110470|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3
7031577|NCT01646177|11110471|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2
7031578|NCT01646177|11110472|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2
7031579|NCT01646177|11110473|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2
7031580|NCT01646177|11110474|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
7031581|NCT01646177|11110475|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
7031582|NCT01646177|11110476|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
7031583|NCT01646177|11110477|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
7031584|NCT01646177|11110466|FG000|Long-Term Extension Period (Week 12-264)|Death|0
7031585|NCT01646177|11110467|FG001|Long-Term Extension Period (Week 12-264)|Death|0
7031586|NCT01646177|11110468|FG002|Long-Term Extension Period (Week 12-264)|Death|0
7031587|NCT01646177|11110469|FG003|Long-Term Extension Period (Week 12-264)|Death|0
7031588|NCT01646177|11110470|FG004|Long-Term Extension Period (Week 12-264)|Death|1
7031589|NCT01646177|11110471|FG005|Long-Term Extension Period (Week 12-264)|Death|3
7031590|NCT01646177|11110472|FG006|Long-Term Extension Period (Week 12-264)|Death|1
7031591|NCT01646177|11110473|FG007|Long-Term Extension Period (Week 12-264)|Death|3
7031592|NCT01646177|11110474|FG008|Long-Term Extension Period (Week 12-264)|Death|0
7031593|NCT01646177|11110475|FG009|Long-Term Extension Period (Week 12-264)|Death|0
7031594|NCT01646177|11110476|FG010|Long-Term Extension Period (Week 12-264)|Death|0
7031595|NCT01646177|11110477|FG011|Long-Term Extension Period (Week 12-264)|Death|0
7031596|NCT01646177|11110466|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
7031597|NCT01646177|11110467|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
7031598|NCT01646177|11110468|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
7031599|NCT01646177|11110469|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
7031600|NCT01646177|11110470|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1
7031601|NCT01646177|11110471|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1
7031602|NCT01646177|11110472|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1
7031603|NCT01646177|11110473|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4
7031604|NCT01646177|11110474|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
7031605|NCT01646177|11110475|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
7031606|NCT01646177|11110476|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
7031607|NCT01646177|11110477|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
7031608|NCT01646177|11110466|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7031609|NCT01646177|11110467|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7031610|NCT01646177|11110468|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7031611|NCT01646177|11110469|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7031612|NCT01646177|11110470|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7031613|NCT01646177|11110471|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7031614|NCT01646177|11110472|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7031615|NCT01646177|11110473|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1
7031616|NCT01646177|11110474|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7031617|NCT01646177|11110475|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7031618|NCT01646177|11110476|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7031619|NCT01646177|11110477|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7031620|NCT01646177|11110466|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
7031621|NCT01646177|11110467|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
7031622|NCT01646177|11110468|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
7031623|NCT01646177|11110469|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
7031624|NCT01646177|11110470|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
7031625|NCT01646177|11110471|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3
7031626|NCT01646177|11110472|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2
7031627|NCT01646177|11110473|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1
7031628|NCT01646177|11110474|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
7031629|NCT01646177|11110475|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
7031630|NCT01646177|11110476|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
7031631|NCT01646177|11110477|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
7031632|NCT01646177|11110466|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
7031633|NCT01646177|11110467|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
7031634|NCT01646177|11110468|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
7031635|NCT01646177|11110469|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
7031636|NCT01646177|11110470|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
7031637|NCT01646177|11110471|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
7031638|NCT01646177|11110472|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
7031639|NCT01646177|11110473|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
7031640|NCT01646177|11110474|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13
7031641|NCT01646177|11110475|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28
7031642|NCT01646177|11110476|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34
7031643|NCT01646177|11110477|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30
7031644|NCT01646177|11110466|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
7031645|NCT01646177|11110467|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
7031646|NCT01646177|11110468|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
7031647|NCT01646177|11110469|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
7031648|NCT01646177|11110470|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
7031649|NCT01646177|11110471|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
7031650|NCT01646177|11110472|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
7031651|NCT01646177|11110473|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
7031652|NCT01646177|11110474|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7
7031653|NCT01646177|11110475|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21
7031654|NCT01646177|11110476|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19
7031655|NCT01646177|11110477|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19
7031656|NCT01646177|11110466|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
7031657|NCT01646177|11110467|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
7031658|NCT01646177|11110468|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
7031659|NCT01646177|11110469|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
7031660|NCT01646177|11110470|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
7031661|NCT01646177|11110471|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
7031662|NCT01646177|11110472|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
7031663|NCT01646177|11110473|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
7031664|NCT01646177|11110474|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4
7031665|NCT01646177|11110475|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8
7031666|NCT01646177|11110476|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9
7031667|NCT01646177|11110477|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9
7031668|NCT01646177|11110466|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
7031669|NCT01646177|11110467|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
7031670|NCT01646177|11110468|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
7031671|NCT01646177|11110469|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
7031672|NCT01646177|11110470|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
7031673|NCT01646177|11110471|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
7031674|NCT01646177|11110472|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
7031675|NCT01646177|11110473|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
7031676|NCT01646177|11110474|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4
7031677|NCT01646177|11110475|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9
7031678|NCT01646177|11110476|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8
7031679|NCT01646177|11110477|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9
7031680|NCT01646177|11110466|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
7031681|NCT01646177|11110467|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
7031682|NCT01646177|11110468|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
7031683|NCT01646177|11110469|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
7031684|NCT01646177|11110470|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
7031685|NCT01646177|11110471|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
7031686|NCT01646177|11110472|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
7031687|NCT01646177|11110473|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
7031688|NCT01646177|11110474|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1
7031689|NCT01646177|11110475|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6
7031690|NCT01646177|11110476|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4
7031691|NCT01646177|11110477|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7
7031692|NCT01646177|11110466|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
7031693|NCT01646177|11110467|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
7031694|NCT01646177|11110468|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
7031695|NCT01646177|11110469|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
7031696|NCT01646177|11110470|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
7031697|NCT01646177|11110471|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
7031698|NCT01646177|11110472|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
7031699|NCT01646177|11110473|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
7031700|NCT01646177|11110474|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1
7031701|NCT01646177|11110475|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2
7031702|NCT01646177|11110476|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2
7031703|NCT01646177|11110477|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3
7031704|NCT01646177|11110466|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
7031705|NCT01646177|11110467|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
7031706|NCT01646177|11110468|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
7031707|NCT01646177|11110469|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
7031708|NCT01646177|11110470|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
7044550|NCT01755156|11130431|FG001|Phase A (Weeks 0-24)|Protocol Violation|1
7031709|NCT01646177|11110471|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
7031710|NCT01646177|11110472|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
7031711|NCT01646177|11110473|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
7031712|NCT01646177|11110474|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
7031713|NCT01646177|11110475|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1
7031714|NCT01646177|11110476|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1
7031715|NCT01646177|11110477|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3
7031716|NCT01646177|11110466|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
7031717|NCT01646177|11110467|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
7031718|NCT01646177|11110468|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
7031719|NCT01646177|11110469|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
7031720|NCT01646177|11110470|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
7031721|NCT01646177|11110471|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
7031722|NCT01646177|11110472|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
7031723|NCT01646177|11110473|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
7031724|NCT01646177|11110474|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
7031725|NCT01646177|11110475|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1
7031726|NCT01646177|11110476|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1
7031727|NCT01646177|11110477|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1
7031728|NCT01646177|11110466|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0
7031729|NCT01646177|11110467|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0
7031730|NCT01646177|11110468|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0
7031731|NCT01646177|11110469|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0
7031732|NCT01646177|11110470|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0
7031733|NCT01646177|11110471|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0
7031734|NCT01646177|11110472|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0
7031735|NCT01646177|11110473|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0
7031736|NCT01646177|11110474|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1
7031737|NCT01646177|11110475|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0
7031738|NCT01646177|11110476|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1
7031739|NCT01646177|11110477|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1
7031740|NCT01646177|11110466|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7031741|NCT01646177|11110467|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7031742|NCT01646177|11110468|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7031743|NCT01646177|11110469|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7031744|NCT01646177|11110470|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7031745|NCT01646177|11110471|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7031746|NCT01646177|11110472|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7031747|NCT01646177|11110473|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7031748|NCT01646177|11110474|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7031749|NCT01646177|11110475|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7031750|NCT01646177|11110476|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1
7031751|NCT01646177|11110477|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1
7031752|NCT01646203|11110500|FG000|Overall Study|Adverse Event|2
7031753|NCT01646203|11110501|FG001|Overall Study|Adverse Event|0
7031754|NCT01646203|11110502|FG002|Overall Study|Adverse Event|1
7031755|NCT01646203|11110500|FG000|Overall Study|Withdrawal by Subject|0
7031756|NCT01646203|11110501|FG001|Overall Study|Withdrawal by Subject|1
7031757|NCT01646203|11110502|FG002|Overall Study|Withdrawal by Subject|0
7031758|NCT01646203|11110500|FG000|Overall Study|Physician's Decision|0
7031759|NCT01646203|11110501|FG001|Overall Study|Physician's Decision|1
7031760|NCT01646203|11110502|FG002|Overall Study|Physician's Decision|0
7031761|NCT01646216|11110517|FG000|Overall Study|Baseline step length difference (<5cm)|10
7031762|NCT01646216|11110518|FG001|Overall Study|Baseline step length difference (<5cm)|10
7031763|NCT01646216|11110517|FG000|Overall Study|Did not complete training|0
7031764|NCT01646216|11110518|FG001|Overall Study|Did not complete training|2
7031765|NCT01646216|11110517|FG000|Overall Study|Investigator decision|1
7031766|NCT01646216|11110518|FG001|Overall Study|Investigator decision|1
7031767|NCT01646255|11110530|FG000|Overall Study|Adverse Event|7
7031768|NCT01646255|11110531|FG001|Overall Study|Adverse Event|8
7031769|NCT01646255|11110530|FG000|Overall Study|Lack of Efficacy|2
7031770|NCT01646255|11110531|FG001|Overall Study|Lack of Efficacy|0
7031771|NCT01646255|11110530|FG000|Overall Study|Withdrawal by Subject|10
7031772|NCT01646255|11110531|FG001|Overall Study|Withdrawal by Subject|6
7031773|NCT01646255|11110530|FG000|Overall Study|Compliance is not well|1
7031774|NCT01646255|11110531|FG001|Overall Study|Compliance is not well|0
7031775|NCT01646255|11110530|FG000|Overall Study|Inclusion Criteria Deviation|1
7031776|NCT01646255|11110531|FG001|Overall Study|Inclusion Criteria Deviation|0
7031777|NCT01646268|11110540|FG000|Overall Study|Adverse Event|6
7031778|NCT01646268|11110541|FG001|Overall Study|Adverse Event|7
7031779|NCT01646268|11110540|FG000|Overall Study|Lack of Efficacy|1
7031780|NCT01646268|11110541|FG001|Overall Study|Lack of Efficacy|3
7031781|NCT01646268|11110540|FG000|Overall Study|Protocol Violation|0
7031782|NCT01646268|11110541|FG001|Overall Study|Protocol Violation|1
7031783|NCT01646268|11110540|FG000|Overall Study|Withdrawal by Subject|2
7031784|NCT01646268|11110541|FG001|Overall Study|Withdrawal by Subject|5
7031785|NCT01646268|11110540|FG000|Overall Study|Other|2
7031786|NCT01646268|11110541|FG001|Overall Study|Other|0
7031787|NCT01646320|11110549|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3
7031788|NCT01646320|11110550|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0
7031789|NCT01646320|11110549|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
7031790|NCT01646320|11110550|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1
7031791|NCT01646320|11110549|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2
7031792|NCT01646320|11110550|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2
7031793|NCT01646320|11110549|FG000|Short-term Period (Day 1 to Week 24)|Other|1
7031794|NCT01646320|11110550|FG001|Short-term Period (Day 1 to Week 24)|Other|0
7031795|NCT01646320|11110549|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
7031796|NCT01646320|11110550|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
7031797|NCT01646320|11110549|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2
7031798|NCT01646320|11110550|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0
7031799|NCT01646320|11110549|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2
7031800|NCT01646320|11110550|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0
7031801|NCT01646320|11110549|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0
7031802|NCT01646320|11110550|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2
7031803|NCT01646320|11110549|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4
7031804|NCT01646320|11110550|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2
7031805|NCT01646320|11110549|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0
7031806|NCT01646320|11110550|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1
7031807|NCT01646320|11110549|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0
7031808|NCT01646320|11110550|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2
7031809|NCT01646385|11110562|FG000|Overall Study|Death|202
7031810|NCT01646385|11110563|FG001|Overall Study|Death|222
7031811|NCT01646385|11110562|FG000|Overall Study|Switched to alternate biologic|636
7031812|NCT01646385|11110563|FG001|Overall Study|Switched to alternate biologic|649
7031813|NCT01646398|11110571|FG000|Overall Study|Withdrawal by Subject|1
7031814|NCT01646398|11110572|FG001|Overall Study|Withdrawal by Subject|0
7031815|NCT01646645|11110578|FG000|Overall Study|No Treated|1
7031816|NCT01646645|11110578|FG000|Overall Study|Inevaluable Donor|29
7031817|NCT01646827|11110603|FG000|Overall Study|Lost to Follow-up|0
7031818|NCT01646827|11110604|FG001|Overall Study|Lost to Follow-up|3
7031819|NCT01646827|11110603|FG000|Overall Study|Physician Decision|1
7031820|NCT01646827|11110604|FG001|Overall Study|Physician Decision|2
7031821|NCT01646827|11110603|FG000|Overall Study|Withdrawal by Subject|1
7031822|NCT01646827|11110604|FG001|Overall Study|Withdrawal by Subject|0
7031823|NCT01647282|11110623|FG000|Overall Study|Physician Decision|7
7031824|NCT01647282|11110624|FG001|Overall Study|Physician Decision|5
7031825|NCT01647516|11110646|FG000|Induction Period (IP)|Physician Decision|2
7031826|NCT01647516|11110647|FG001|Induction Period (IP)|Physician Decision|0
7031827|NCT01647516|11110648|FG002|Induction Period (IP)|Physician Decision|0
7031828|NCT01647516|11110649|FG003|Induction Period (IP)|Physician Decision|0
7031829|NCT01647516|11110650|FG004|Induction Period (IP)|Physician Decision|0
7031830|NCT01647516|11110651|FG005|Induction Period (IP)|Physician Decision|0
7031831|NCT01647516|11110646|FG000|Induction Period (IP)|Adverse Event|1
7031832|NCT01647516|11110647|FG001|Induction Period (IP)|Adverse Event|2
7031833|NCT01647516|11110648|FG002|Induction Period (IP)|Adverse Event|0
7031834|NCT01647516|11110649|FG003|Induction Period (IP)|Adverse Event|0
7031835|NCT01647516|11110650|FG004|Induction Period (IP)|Adverse Event|0
7031836|NCT01647516|11110651|FG005|Induction Period (IP)|Adverse Event|0
7031837|NCT01647516|11110646|FG000|Induction Period (IP)|Withdrawal by Subject|1
7031838|NCT01647516|11110647|FG001|Induction Period (IP)|Withdrawal by Subject|0
7031839|NCT01647516|11110648|FG002|Induction Period (IP)|Withdrawal by Subject|3
7031840|NCT01647516|11110649|FG003|Induction Period (IP)|Withdrawal by Subject|0
7031841|NCT01647516|11110650|FG004|Induction Period (IP)|Withdrawal by Subject|0
7031842|NCT01647516|11110651|FG005|Induction Period (IP)|Withdrawal by Subject|0
7031843|NCT01647516|11110646|FG000|Induction Period (IP)|Participant Choice|0
7031844|NCT01647516|11110647|FG001|Induction Period (IP)|Participant Choice|0
7031845|NCT01647516|11110648|FG002|Induction Period (IP)|Participant Choice|1
7031846|NCT01647516|11110649|FG003|Induction Period (IP)|Participant Choice|0
7031847|NCT01647516|11110650|FG004|Induction Period (IP)|Participant Choice|0
7031848|NCT01647516|11110651|FG005|Induction Period (IP)|Participant Choice|0
7031849|NCT01647516|11110646|FG000|Induction Period (IP)|Lack of Efficacy|1
7031850|NCT01647516|11110647|FG001|Induction Period (IP)|Lack of Efficacy|0
7031851|NCT01647516|11110648|FG002|Induction Period (IP)|Lack of Efficacy|0
7031852|NCT01647516|11110649|FG003|Induction Period (IP)|Lack of Efficacy|0
7031853|NCT01647516|11110650|FG004|Induction Period (IP)|Lack of Efficacy|0
7031854|NCT01647516|11110651|FG005|Induction Period (IP)|Lack of Efficacy|0
7031855|NCT01647516|11110646|FG000|Induction Period (IP)|No study drug received|1
7031856|NCT01647516|11110647|FG001|Induction Period (IP)|No study drug received|1
7031857|NCT01647516|11110648|FG002|Induction Period (IP)|No study drug received|0
7031858|NCT01647516|11110649|FG003|Induction Period (IP)|No study drug received|0
7031859|NCT01647516|11110650|FG004|Induction Period (IP)|No study drug received|0
7031860|NCT01647516|11110651|FG005|Induction Period (IP)|No study drug received|0
7031861|NCT01647516|11110646|FG000|Maintenance Period (MP)|Adverse Event|2
7031862|NCT01647516|11110647|FG001|Maintenance Period (MP)|Adverse Event|1
7031863|NCT01647516|11110648|FG002|Maintenance Period (MP)|Adverse Event|0
7031864|NCT01647516|11110649|FG003|Maintenance Period (MP)|Adverse Event|0
7031865|NCT01647516|11110650|FG004|Maintenance Period (MP)|Adverse Event|0
7031866|NCT01647516|11110651|FG005|Maintenance Period (MP)|Adverse Event|0
7031867|NCT01647516|11110646|FG000|Maintenance Period (MP)|Non-compliance|1
7031868|NCT01647516|11110647|FG001|Maintenance Period (MP)|Non-compliance|0
7031869|NCT01647516|11110648|FG002|Maintenance Period (MP)|Non-compliance|0
7031870|NCT01647516|11110649|FG003|Maintenance Period (MP)|Non-compliance|0
7031871|NCT01647516|11110650|FG004|Maintenance Period (MP)|Non-compliance|0
7031872|NCT01647516|11110651|FG005|Maintenance Period (MP)|Non-compliance|0
7031873|NCT01647516|11110646|FG000|Maintenance Period (MP)|Withdrawal by Subject|0
7031874|NCT01647516|11110647|FG001|Maintenance Period (MP)|Withdrawal by Subject|1
7031875|NCT01647516|11110648|FG002|Maintenance Period (MP)|Withdrawal by Subject|1
7031876|NCT01647516|11110649|FG003|Maintenance Period (MP)|Withdrawal by Subject|0
7031877|NCT01647516|11110650|FG004|Maintenance Period (MP)|Withdrawal by Subject|0
7031878|NCT01647516|11110651|FG005|Maintenance Period (MP)|Withdrawal by Subject|0
7031879|NCT01647516|11110646|FG000|Maintenance Period (MP)|Lack of Efficacy|1
7031880|NCT01647516|11110647|FG001|Maintenance Period (MP)|Lack of Efficacy|4
7031881|NCT01647516|11110648|FG002|Maintenance Period (MP)|Lack of Efficacy|1
7031882|NCT01647516|11110649|FG003|Maintenance Period (MP)|Lack of Efficacy|0
7031883|NCT01647516|11110650|FG004|Maintenance Period (MP)|Lack of Efficacy|0
7031884|NCT01647516|11110651|FG005|Maintenance Period (MP)|Lack of Efficacy|0
7031885|NCT01647516|11110646|FG000|Open-Label Period|Adverse Event|0
7031886|NCT01647516|11110647|FG001|Open-Label Period|Adverse Event|0
7031887|NCT01647516|11110648|FG002|Open-Label Period|Adverse Event|0
7031888|NCT01647516|11110649|FG003|Open-Label Period|Adverse Event|5
7031889|NCT01647516|11110650|FG004|Open-Label Period|Adverse Event|6
7031890|NCT01647516|11110651|FG005|Open-Label Period|Adverse Event|3
7031891|NCT01647516|11110646|FG000|Open-Label Period|Pregnancy|0
7031892|NCT01647516|11110647|FG001|Open-Label Period|Pregnancy|0
7031893|NCT01647516|11110648|FG002|Open-Label Period|Pregnancy|0
7031894|NCT01647516|11110649|FG003|Open-Label Period|Pregnancy|0
7031895|NCT01647516|11110650|FG004|Open-Label Period|Pregnancy|0
7031896|NCT01647516|11110651|FG005|Open-Label Period|Pregnancy|1
7031897|NCT01647516|11110646|FG000|Open-Label Period|Non-compliance|0
7031898|NCT01647516|11110647|FG001|Open-Label Period|Non-compliance|0
7031899|NCT01647516|11110648|FG002|Open-Label Period|Non-compliance|0
7031900|NCT01647516|11110649|FG003|Open-Label Period|Non-compliance|1
7031901|NCT01647516|11110650|FG004|Open-Label Period|Non-compliance|0
7031902|NCT01647516|11110651|FG005|Open-Label Period|Non-compliance|1
7031903|NCT01647516|11110646|FG000|Open-Label Period|Physician Decision|0
7031904|NCT01647516|11110647|FG001|Open-Label Period|Physician Decision|0
7031905|NCT01647516|11110648|FG002|Open-Label Period|Physician Decision|0
7031906|NCT01647516|11110649|FG003|Open-Label Period|Physician Decision|1
7031907|NCT01647516|11110650|FG004|Open-Label Period|Physician Decision|1
7031908|NCT01647516|11110651|FG005|Open-Label Period|Physician Decision|0
7031909|NCT01647516|11110646|FG000|Open-Label Period|Withdrawal by Subject|0
7031910|NCT01647516|11110647|FG001|Open-Label Period|Withdrawal by Subject|0
7031911|NCT01647516|11110648|FG002|Open-Label Period|Withdrawal by Subject|0
7031912|NCT01647516|11110649|FG003|Open-Label Period|Withdrawal by Subject|9
7031913|NCT01647516|11110650|FG004|Open-Label Period|Withdrawal by Subject|11
7031914|NCT01647516|11110651|FG005|Open-Label Period|Withdrawal by Subject|6
7031915|NCT01647516|11110646|FG000|Open-Label Period|Lost to Follow-up|0
7031916|NCT01647516|11110647|FG001|Open-Label Period|Lost to Follow-up|0
7031917|NCT01647516|11110648|FG002|Open-Label Period|Lost to Follow-up|0
7031918|NCT01647516|11110649|FG003|Open-Label Period|Lost to Follow-up|1
7031919|NCT01647516|11110650|FG004|Open-Label Period|Lost to Follow-up|0
7031920|NCT01647516|11110651|FG005|Open-Label Period|Lost to Follow-up|1
7031921|NCT01647516|11110646|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0
7031922|NCT01647516|11110647|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0
7031923|NCT01647516|11110648|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0
7031924|NCT01647516|11110649|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18
7031925|NCT01647516|11110650|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13
7031926|NCT01647516|11110651|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23
7031927|NCT01647516|11110646|FG000|Open-Label Period|Lack of Efficacy|0
7031928|NCT01647516|11110647|FG001|Open-Label Period|Lack of Efficacy|0
7031929|NCT01647516|11110648|FG002|Open-Label Period|Lack of Efficacy|0
7031930|NCT01647516|11110649|FG003|Open-Label Period|Lack of Efficacy|7
7031931|NCT01647516|11110650|FG004|Open-Label Period|Lack of Efficacy|9
7031932|NCT01647516|11110651|FG005|Open-Label Period|Lack of Efficacy|10
7031933|NCT01647516|11110646|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0
7031934|NCT01647516|11110647|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0
7031935|NCT01647516|11110648|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0
7031936|NCT01647516|11110649|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7
7031937|NCT01647516|11110650|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9
7031938|NCT01647516|11110651|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10
7031939|NCT01647516|11110646|FG000|Open-Label Period|No completion / discontinuation visit|0
7031940|NCT01647516|11110647|FG001|Open-Label Period|No completion / discontinuation visit|0
7031941|NCT01647516|11110648|FG002|Open-Label Period|No completion / discontinuation visit|0
7031942|NCT01647516|11110649|FG003|Open-Label Period|No completion / discontinuation visit|0
7031943|NCT01647516|11110650|FG004|Open-Label Period|No completion / discontinuation visit|2
7031944|NCT01647516|11110651|FG005|Open-Label Period|No completion / discontinuation visit|1
7031945|NCT01647542|11110669|FG000|Overall Study|Major Protocol Deviation|1
7031946|NCT01647542|11110670|FG001|Overall Study|Major Protocol Deviation|0
7031947|NCT01647542|11110671|FG002|Overall Study|Major Protocol Deviation|0
7031948|NCT01647542|11110669|FG000|Overall Study|Adverse Event|4
7031949|NCT01647542|11110670|FG001|Overall Study|Adverse Event|5
7031950|NCT01647542|11110671|FG002|Overall Study|Adverse Event|4
7031951|NCT01647542|11110669|FG000|Overall Study|Lost to Follow-up|0
7031952|NCT01647542|11110670|FG001|Overall Study|Lost to Follow-up|2
7031953|NCT01647542|11110671|FG002|Overall Study|Lost to Follow-up|2
7031954|NCT01647542|11110669|FG000|Overall Study|Withdrawal by Subject|6
7031955|NCT01647542|11110670|FG001|Overall Study|Withdrawal by Subject|4
7031956|NCT01647542|11110671|FG002|Overall Study|Withdrawal by Subject|0
7031957|NCT01647542|11110669|FG000|Overall Study|Study Termination|64
7031958|NCT01647542|11110670|FG001|Overall Study|Study Termination|61
7031959|NCT01647542|11110671|FG002|Overall Study|Study Termination|65
7031960|NCT01647542|11110669|FG000|Overall Study|Lack of Efficacy|1
7031961|NCT01647542|11110670|FG001|Overall Study|Lack of Efficacy|1
7031962|NCT01647542|11110671|FG002|Overall Study|Lack of Efficacy|0
7031963|NCT01647542|11110669|FG000|Overall Study|Death|0
7031964|NCT01647542|11110670|FG001|Overall Study|Death|0
7031965|NCT01647542|11110671|FG002|Overall Study|Death|1
7031966|NCT01647711|11110693|FG000|Overall Study|Progressive disease|6
7031967|NCT01647711|11110694|FG001|Overall Study|Progressive disease|2
7031968|NCT01647711|11110695|FG002|Overall Study|Progressive disease|6
7031969|NCT01647711|11110696|FG003|Overall Study|Progressive disease|8
7031970|NCT01647711|11110697|FG004|Overall Study|Progressive disease|2
7031971|NCT01647711|11110693|FG000|Overall Study|Other adverse event|0
7031972|NCT01647711|11110694|FG001|Overall Study|Other adverse event|0
7031973|NCT01647711|11110695|FG002|Overall Study|Other adverse event|2
7031974|NCT01647711|11110696|FG003|Overall Study|Other adverse event|0
7031975|NCT01647711|11110697|FG004|Overall Study|Other adverse event|2
7031976|NCT01647711|11110693|FG000|Overall Study|Protocol Violation|0
7031977|NCT01647711|11110694|FG001|Overall Study|Protocol Violation|0
7031978|NCT01647711|11110695|FG002|Overall Study|Protocol Violation|0
7031979|NCT01647711|11110696|FG003|Overall Study|Protocol Violation|0
7031980|NCT01647711|11110697|FG004|Overall Study|Protocol Violation|1
7031981|NCT01647711|11110693|FG000|Overall Study|Refused to continue taking medication|0
7031982|NCT01647711|11110694|FG001|Overall Study|Refused to continue taking medication|0
7031983|NCT01647711|11110695|FG002|Overall Study|Refused to continue taking medication|0
7031984|NCT01647711|11110696|FG003|Overall Study|Refused to continue taking medication|2
7031985|NCT01647711|11110697|FG004|Overall Study|Refused to continue taking medication|1
7031986|NCT01647711|11110693|FG000|Overall Study|Other reason not defined|0
7031987|NCT01647711|11110694|FG001|Overall Study|Other reason not defined|1
7031988|NCT01647711|11110695|FG002|Overall Study|Other reason not defined|1
7031989|NCT01647711|11110696|FG003|Overall Study|Other reason not defined|1
7031990|NCT01647711|11110697|FG004|Overall Study|Other reason not defined|0
7031991|NCT01647958|11110739|FG000|Initial Study|Lost to Follow-up|2
7031992|NCT01647958|11110740|FG001|Initial Study|Lost to Follow-up|3
7031993|NCT01647958|11110739|FG000|Continuation Phase|treatment received during Overall Study|39
7031994|NCT01647958|11110740|FG001|Continuation Phase|treatment received during Overall Study|0
7031995|NCT01647958|11110739|FG000|Extended Follow-up Phase|Lost to Follow-up|8
7031996|NCT01647958|11110740|FG001|Extended Follow-up Phase|Lost to Follow-up|0
7031997|NCT01648101|11110758|FG000|Titration Phase (4 Weeks)|Protocol Violation|2
7031998|NCT01648101|11110759|FG001|Titration Phase (4 Weeks)|Protocol Violation|1
7031999|NCT01648101|11110760|FG002|Titration Phase (4 Weeks)|Protocol Violation|2
7032000|NCT01648101|11110758|FG000|Titration Phase (4 Weeks)|Adverse Event|0
7032001|NCT01648101|11110759|FG001|Titration Phase (4 Weeks)|Adverse Event|2
7032002|NCT01648101|11110760|FG002|Titration Phase (4 Weeks)|Adverse Event|3
7032003|NCT01648101|11110758|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
7032004|NCT01648101|11110759|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
7032005|NCT01648101|11110760|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1
7032006|NCT01648101|11110758|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1
7032007|NCT01648101|11110759|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0
7032008|NCT01648101|11110760|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1
7032009|NCT01648101|11110758|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
7032010|NCT01648101|11110759|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0
7032011|NCT01648101|11110760|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
7032012|NCT01648101|11110758|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1
7032013|NCT01648101|11110759|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3
7032014|NCT01648101|11110760|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4
7032015|NCT01648101|11110758|FG000|Transition Phase (4 Weeks)|Adverse Event|4
7032016|NCT01648101|11110759|FG001|Transition Phase (4 Weeks)|Adverse Event|3
7032017|NCT01648101|11110760|FG002|Transition Phase (4 Weeks)|Adverse Event|2
7060601|NCT01920477|11156952|FG000|Overall Study|Adverse Event|0
7032018|NCT01648101|11110758|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0
7032019|NCT01648101|11110759|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2
7032020|NCT01648101|11110760|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0
7032021|NCT01648101|11110758|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0
7032022|NCT01648101|11110759|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0
7032023|NCT01648101|11110760|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2
7032024|NCT01648101|11110758|FG000|Transition Phase (4 Weeks)|Study Terminated|1
7032025|NCT01648101|11110759|FG001|Transition Phase (4 Weeks)|Study Terminated|0
7032026|NCT01648101|11110760|FG002|Transition Phase (4 Weeks)|Study Terminated|0
7032027|NCT01648101|11110758|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
7032028|NCT01648101|11110759|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1
7032029|NCT01648101|11110760|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
7032030|NCT01648140|11110776|FG000|Overall Study|Physician Decision|1
7032031|NCT01648140|11110777|FG001|Overall Study|Physician Decision|0
7032032|NCT01648140|11110778|FG002|Overall Study|Physician Decision|0
7032033|NCT01648140|11110779|FG003|Overall Study|Physician Decision|0
7032034|NCT01648140|11110776|FG000|Overall Study|Lack of Efficacy|4
7032035|NCT01648140|11110777|FG001|Overall Study|Lack of Efficacy|7
7032036|NCT01648140|11110778|FG002|Overall Study|Lack of Efficacy|1
7032037|NCT01648140|11110779|FG003|Overall Study|Lack of Efficacy|0
7032038|NCT01648140|11110776|FG000|Overall Study|Adverse Event|3
7032039|NCT01648140|11110777|FG001|Overall Study|Adverse Event|1
7032040|NCT01648140|11110778|FG002|Overall Study|Adverse Event|2
7032041|NCT01648140|11110779|FG003|Overall Study|Adverse Event|0
7032042|NCT01648140|11110776|FG000|Overall Study|Withdrawal by Subject|2
7032043|NCT01648140|11110777|FG001|Overall Study|Withdrawal by Subject|3
7032044|NCT01648140|11110778|FG002|Overall Study|Withdrawal by Subject|3
7032045|NCT01648140|11110779|FG003|Overall Study|Withdrawal by Subject|2
7032046|NCT01648140|11110776|FG000|Overall Study|Lost to Follow-up|2
7032047|NCT01648140|11110777|FG001|Overall Study|Lost to Follow-up|1
7032048|NCT01648140|11110778|FG002|Overall Study|Lost to Follow-up|2
7032049|NCT01648140|11110779|FG003|Overall Study|Lost to Follow-up|0
7032050|NCT01648166|11110800|FG000|Overall Study|inadequate toenail samples|53
7032051|NCT01648166|11110801|FG001|Overall Study|inadequate toenail samples|100
7032052|NCT01648283|11110807|FG000|Overall Study|Withdrawal by Subject|14
7032053|NCT01648348|11110849|FG000|Overall Study|Cancel|1
7032054|NCT01648348|11110850|FG001|Overall Study|Cancel|0
7032055|NCT01648348|11110851|FG002|Overall Study|Cancel|0
7032056|NCT01648348|11110852|FG003|Overall Study|Cancel|0
7032057|NCT01648348|11110853|FG004|Overall Study|Cancel|3
7032058|NCT01648348|11110854|FG005|Overall Study|Cancel|6
7032059|NCT01648348|11110849|FG000|Overall Study|Replaced for MTD analysis|1
7032060|NCT01648348|11110850|FG001|Overall Study|Replaced for MTD analysis|0
7032061|NCT01648348|11110851|FG002|Overall Study|Replaced for MTD analysis|1
7032062|NCT01648348|11110852|FG003|Overall Study|Replaced for MTD analysis|0
7032063|NCT01648348|11110853|FG004|Overall Study|Replaced for MTD analysis|0
7032064|NCT01648348|11110854|FG005|Overall Study|Replaced for MTD analysis|0
7032065|NCT01648582|11110887|FG000|Overall Study|Adverse Event|6
7032066|NCT01648582|11110888|FG001|Overall Study|Adverse Event|11
7032067|NCT01648582|11110889|FG002|Overall Study|Adverse Event|2
7032068|NCT01648582|11110887|FG000|Overall Study|Lost to Follow-up|9
7032069|NCT01648582|11110888|FG001|Overall Study|Lost to Follow-up|6
7032070|NCT01648582|11110889|FG002|Overall Study|Lost to Follow-up|8
7032071|NCT01648582|11110887|FG000|Overall Study|Protocol Violation|1
7032072|NCT01648582|11110888|FG001|Overall Study|Protocol Violation|2
7032073|NCT01648582|11110889|FG002|Overall Study|Protocol Violation|1
7032074|NCT01648582|11110887|FG000|Overall Study|Withdrawal by Subject|15
7032075|NCT01648582|11110888|FG001|Overall Study|Withdrawal by Subject|17
7032076|NCT01648582|11110889|FG002|Overall Study|Withdrawal by Subject|17
7032077|NCT01648582|11110887|FG000|Overall Study|Physician Decision|0
7032078|NCT01648582|11110888|FG001|Overall Study|Physician Decision|1
7032079|NCT01648582|11110889|FG002|Overall Study|Physician Decision|3
7032080|NCT01648582|11110887|FG000|Overall Study|Death|1
7032081|NCT01648582|11110888|FG001|Overall Study|Death|0
7032082|NCT01648582|11110889|FG002|Overall Study|Death|0
7032083|NCT01648582|11110887|FG000|Overall Study|Sponsor Decision|0
7032084|NCT01648582|11110888|FG001|Overall Study|Sponsor Decision|1
7032085|NCT01648582|11110889|FG002|Overall Study|Sponsor Decision|1
7032086|NCT01648699|11110900|FG000|Overall Study|Death|1
7032087|NCT01648699|11110900|FG000|Overall Study|Lost to Follow-up|2
7032088|NCT01648699|11110900|FG000|Overall Study|Unspecified/unable to complete 4 visits|2
7032089|NCT01648764|11110927|FG000|Overall Study|Progressive Disease|0
7032090|NCT01648764|11110928|FG001|Overall Study|Progressive Disease|1
7032091|NCT01648764|11110929|FG002|Overall Study|Progressive Disease|0
7032092|NCT01648764|11110930|FG003|Overall Study|Progressive Disease|0
7032093|NCT01648764|11110931|FG004|Overall Study|Progressive Disease|0
7032094|NCT01648764|11110932|FG005|Overall Study|Progressive Disease|1
7032095|NCT01648764|11110933|FG006|Overall Study|Progressive Disease|1
7032096|NCT01648764|11110934|FG007|Overall Study|Progressive Disease|0
7032097|NCT01648764|11110935|FG008|Overall Study|Progressive Disease|0
7032098|NCT01648764|11110936|FG009|Overall Study|Progressive Disease|2
7032099|NCT01648764|11110937|FG010|Overall Study|Progressive Disease|0
7032100|NCT01648764|11110938|FG011|Overall Study|Progressive Disease|1
7032101|NCT01648764|11110939|FG012|Overall Study|Progressive Disease|2
7032102|NCT01648764|11110940|FG013|Overall Study|Progressive Disease|1
7032103|NCT01648764|11110927|FG000|Overall Study|Adverse Event|0
7032104|NCT01648764|11110928|FG001|Overall Study|Adverse Event|0
7032105|NCT01648764|11110929|FG002|Overall Study|Adverse Event|0
7032106|NCT01648764|11110930|FG003|Overall Study|Adverse Event|0
7032107|NCT01648764|11110931|FG004|Overall Study|Adverse Event|0
7032108|NCT01648764|11110932|FG005|Overall Study|Adverse Event|1
7032109|NCT01648764|11110933|FG006|Overall Study|Adverse Event|0
7032110|NCT01648764|11110934|FG007|Overall Study|Adverse Event|0
7032111|NCT01648764|11110935|FG008|Overall Study|Adverse Event|0
7032112|NCT01648764|11110936|FG009|Overall Study|Adverse Event|1
7032113|NCT01648764|11110937|FG010|Overall Study|Adverse Event|0
7032114|NCT01648764|11110938|FG011|Overall Study|Adverse Event|3
7032115|NCT01648764|11110939|FG012|Overall Study|Adverse Event|1
7032116|NCT01648764|11110940|FG013|Overall Study|Adverse Event|1
7032117|NCT01648764|11110927|FG000|Overall Study|Death|0
7032118|NCT01648764|11110928|FG001|Overall Study|Death|0
7032119|NCT01648764|11110929|FG002|Overall Study|Death|0
7032120|NCT01648764|11110930|FG003|Overall Study|Death|0
7032121|NCT01648764|11110931|FG004|Overall Study|Death|0
7032122|NCT01648764|11110932|FG005|Overall Study|Death|0
7032123|NCT01648764|11110933|FG006|Overall Study|Death|1
7032124|NCT01648764|11110934|FG007|Overall Study|Death|0
7032125|NCT01648764|11110935|FG008|Overall Study|Death|0
7032126|NCT01648764|11110936|FG009|Overall Study|Death|0
7032127|NCT01648764|11110937|FG010|Overall Study|Death|0
7032128|NCT01648764|11110938|FG011|Overall Study|Death|0
7032129|NCT01648764|11110939|FG012|Overall Study|Death|0
7032130|NCT01648764|11110940|FG013|Overall Study|Death|1
7032131|NCT01648764|11110927|FG000|Overall Study|Withdrawal by Subject|0
7032132|NCT01648764|11110928|FG001|Overall Study|Withdrawal by Subject|0
7032133|NCT01648764|11110929|FG002|Overall Study|Withdrawal by Subject|0
7032134|NCT01648764|11110930|FG003|Overall Study|Withdrawal by Subject|0
7032135|NCT01648764|11110931|FG004|Overall Study|Withdrawal by Subject|0
7032136|NCT01648764|11110932|FG005|Overall Study|Withdrawal by Subject|0
7032137|NCT01648764|11110933|FG006|Overall Study|Withdrawal by Subject|2
7032138|NCT01648764|11110934|FG007|Overall Study|Withdrawal by Subject|0
7032139|NCT01648764|11110935|FG008|Overall Study|Withdrawal by Subject|0
7032140|NCT01648764|11110936|FG009|Overall Study|Withdrawal by Subject|0
7032141|NCT01648764|11110937|FG010|Overall Study|Withdrawal by Subject|0
7032142|NCT01648764|11110938|FG011|Overall Study|Withdrawal by Subject|0
7032143|NCT01648764|11110939|FG012|Overall Study|Withdrawal by Subject|1
7032144|NCT01648764|11110940|FG013|Overall Study|Withdrawal by Subject|0
7032145|NCT01648764|11110927|FG000|Overall Study|Investigator Decision|0
7032146|NCT01648764|11110928|FG001|Overall Study|Investigator Decision|0
7032147|NCT01648764|11110929|FG002|Overall Study|Investigator Decision|0
7032148|NCT01648764|11110930|FG003|Overall Study|Investigator Decision|0
7032149|NCT01648764|11110931|FG004|Overall Study|Investigator Decision|0
7032150|NCT01648764|11110932|FG005|Overall Study|Investigator Decision|0
7032151|NCT01648764|11110933|FG006|Overall Study|Investigator Decision|1
7032152|NCT01648764|11110934|FG007|Overall Study|Investigator Decision|0
7032153|NCT01648764|11110935|FG008|Overall Study|Investigator Decision|0
7032154|NCT01648764|11110936|FG009|Overall Study|Investigator Decision|0
7032155|NCT01648764|11110937|FG010|Overall Study|Investigator Decision|0
7032156|NCT01648764|11110938|FG011|Overall Study|Investigator Decision|1
7032157|NCT01648764|11110939|FG012|Overall Study|Investigator Decision|0
7032158|NCT01648764|11110940|FG013|Overall Study|Investigator Decision|0
7032159|NCT01648790|11110974|FG000|Treatment 3|Withdrawal by Subject|0
7032160|NCT01648790|11110975|FG001|Treatment 3|Withdrawal by Subject|0
7032161|NCT01648790|11110976|FG002|Treatment 3|Withdrawal by Subject|0
7032162|NCT01648790|11110977|FG003|Treatment 3|Withdrawal by Subject|1
7032163|NCT01648790|11110978|FG004|Treatment 3|Withdrawal by Subject|0
7032164|NCT01649232|11111004|FG000|Overall Study|Physician Decision|2
7032165|NCT01649232|11111005|FG001|Overall Study|Physician Decision|0
7032166|NCT01649271|11111019|FG000|Overall Study|Progressive disease|4
7032167|NCT01649271|11111020|FG001|Overall Study|Progressive disease|5
7032168|NCT01649271|11111019|FG000|Overall Study|Other Adverse Event|0
7032169|NCT01649271|11111020|FG001|Overall Study|Other Adverse Event|2
7032170|NCT01649271|11111019|FG000|Overall Study|Withdrawal by Subject|1
7032171|NCT01649271|11111020|FG001|Overall Study|Withdrawal by Subject|0
7032172|NCT01649271|11111019|FG000|Overall Study|Other than stated above|1
7032173|NCT01649271|11111020|FG001|Overall Study|Other than stated above|0
7032174|NCT01649297|11111032|FG000|Overall Study|Adverse Event|5
7032175|NCT01649297|11111033|FG001|Overall Study|Adverse Event|5
7032176|NCT01649297|11111034|FG002|Overall Study|Adverse Event|4
7032177|NCT01649297|11111035|FG003|Overall Study|Adverse Event|13
7032178|NCT01649297|11111036|FG004|Overall Study|Adverse Event|1
7032179|NCT01649297|11111032|FG000|Overall Study|Lack of Efficacy|0
7032180|NCT01649297|11111033|FG001|Overall Study|Lack of Efficacy|0
7032181|NCT01649297|11111034|FG002|Overall Study|Lack of Efficacy|0
7032182|NCT01649297|11111035|FG003|Overall Study|Lack of Efficacy|0
7032183|NCT01649297|11111036|FG004|Overall Study|Lack of Efficacy|1
7032184|NCT01649297|11111032|FG000|Overall Study|Non compliant with Protocol|1
7032185|NCT01649297|11111033|FG001|Overall Study|Non compliant with Protocol|0
7032186|NCT01649297|11111034|FG002|Overall Study|Non compliant with Protocol|3
7032187|NCT01649297|11111035|FG003|Overall Study|Non compliant with Protocol|2
7032188|NCT01649297|11111036|FG004|Overall Study|Non compliant with Protocol|1
7032189|NCT01649297|11111032|FG000|Overall Study|Lost to Follow-up|1
7032190|NCT01649297|11111033|FG001|Overall Study|Lost to Follow-up|1
7032191|NCT01649297|11111034|FG002|Overall Study|Lost to Follow-up|4
7032192|NCT01649297|11111035|FG003|Overall Study|Lost to Follow-up|3
7032193|NCT01649297|11111036|FG004|Overall Study|Lost to Follow-up|0
7032194|NCT01649297|11111032|FG000|Overall Study|Patient withdrawal (not due to AE)|3
7032195|NCT01649297|11111033|FG001|Overall Study|Patient withdrawal (not due to AE)|6
7032196|NCT01649297|11111034|FG002|Overall Study|Patient withdrawal (not due to AE)|4
7032197|NCT01649297|11111035|FG003|Overall Study|Patient withdrawal (not due to AE)|1
7032198|NCT01649297|11111036|FG004|Overall Study|Patient withdrawal (not due to AE)|1
7032199|NCT01649297|11111032|FG000|Overall Study|For other reason|4
7032200|NCT01649297|11111033|FG001|Overall Study|For other reason|1
7032201|NCT01649297|11111034|FG002|Overall Study|For other reason|2
7032202|NCT01649297|11111035|FG003|Overall Study|For other reason|0
7032203|NCT01649297|11111036|FG004|Overall Study|For other reason|0
7032204|NCT01649375|11111060|FG000|Up to Week 16|Adverse Event|2
7032205|NCT01649375|11111061|FG001|Up to Week 16|Adverse Event|5
7032206|NCT01649375|11111062|FG002|Up to Week 16|Adverse Event|4
7032207|NCT01649375|11111063|FG003|Up to Week 16|Adverse Event|0
7032208|NCT01649375|11111064|FG004|Up to Week 16|Adverse Event|0
7032209|NCT01649375|11111060|FG000|Up to Week 16|Lack of Efficacy|0
7032210|NCT01649375|11111061|FG001|Up to Week 16|Lack of Efficacy|0
7032211|NCT01649375|11111062|FG002|Up to Week 16|Lack of Efficacy|1
7032212|NCT01649375|11111063|FG003|Up to Week 16|Lack of Efficacy|0
7032213|NCT01649375|11111064|FG004|Up to Week 16|Lack of Efficacy|0
7032214|NCT01649375|11111060|FG000|Up to Week 16|Physician Decision|0
7032215|NCT01649375|11111061|FG001|Up to Week 16|Physician Decision|0
7032216|NCT01649375|11111062|FG002|Up to Week 16|Physician Decision|1
7032217|NCT01649375|11111063|FG003|Up to Week 16|Physician Decision|0
7032218|NCT01649375|11111064|FG004|Up to Week 16|Physician Decision|0
7032219|NCT01649375|11111060|FG000|Up to Week 16|Withdrawal by Subject|2
7032220|NCT01649375|11111061|FG001|Up to Week 16|Withdrawal by Subject|1
7032221|NCT01649375|11111062|FG002|Up to Week 16|Withdrawal by Subject|2
7032222|NCT01649375|11111063|FG003|Up to Week 16|Withdrawal by Subject|0
7032223|NCT01649375|11111064|FG004|Up to Week 16|Withdrawal by Subject|0
7032224|NCT01649375|11111060|FG000|Up to Week 16|Death|1
7032225|NCT01649375|11111061|FG001|Up to Week 16|Death|0
7032226|NCT01649375|11111062|FG002|Up to Week 16|Death|0
7032227|NCT01649375|11111063|FG003|Up to Week 16|Death|0
7032228|NCT01649375|11111064|FG004|Up to Week 16|Death|0
7032229|NCT01649375|11111060|FG000|Week 16 up to Week 260|Lack of Efficacy|7
7032230|NCT01649375|11111061|FG001|Week 16 up to Week 260|Lack of Efficacy|4
7032231|NCT01649375|11111062|FG002|Week 16 up to Week 260|Lack of Efficacy|0
7032232|NCT01649375|11111063|FG003|Week 16 up to Week 260|Lack of Efficacy|4
7032233|NCT01649375|11111064|FG004|Week 16 up to Week 260|Lack of Efficacy|2
7032234|NCT01649375|11111060|FG000|Week 16 up to Week 260|Non-compliance|0
7032235|NCT01649375|11111061|FG001|Week 16 up to Week 260|Non-compliance|1
7032236|NCT01649375|11111062|FG002|Week 16 up to Week 260|Non-compliance|0
7032237|NCT01649375|11111063|FG003|Week 16 up to Week 260|Non-compliance|1
7032238|NCT01649375|11111064|FG004|Week 16 up to Week 260|Non-compliance|0
7032239|NCT01649375|11111060|FG000|Week 16 up to Week 260|Physician Decision|0
7032240|NCT01649375|11111061|FG001|Week 16 up to Week 260|Physician Decision|2
7032241|NCT01649375|11111062|FG002|Week 16 up to Week 260|Physician Decision|0
7032242|NCT01649375|11111063|FG003|Week 16 up to Week 260|Physician Decision|0
7032243|NCT01649375|11111064|FG004|Week 16 up to Week 260|Physician Decision|0
7032244|NCT01649375|11111060|FG000|Week 16 up to Week 260|Technical issues|0
7032245|NCT01649375|11111061|FG001|Week 16 up to Week 260|Technical issues|1
7032246|NCT01649375|11111062|FG002|Week 16 up to Week 260|Technical issues|0
7032247|NCT01649375|11111063|FG003|Week 16 up to Week 260|Technical issues|1
7032248|NCT01649375|11111064|FG004|Week 16 up to Week 260|Technical issues|0
7032249|NCT01649375|11111060|FG000|Week 16 up to Week 260|Withdrawal by Subject|7
7032250|NCT01649375|11111061|FG001|Week 16 up to Week 260|Withdrawal by Subject|2
7032251|NCT01649375|11111062|FG002|Week 16 up to Week 260|Withdrawal by Subject|0
7032252|NCT01649375|11111063|FG003|Week 16 up to Week 260|Withdrawal by Subject|3
7032253|NCT01649375|11111064|FG004|Week 16 up to Week 260|Withdrawal by Subject|1
7032254|NCT01649375|11111060|FG000|Week 16 up to Week 260|Death|1
7032255|NCT01649375|11111061|FG001|Week 16 up to Week 260|Death|1
7032256|NCT01649375|11111062|FG002|Week 16 up to Week 260|Death|0
7032257|NCT01649375|11111063|FG003|Week 16 up to Week 260|Death|0
7032258|NCT01649375|11111064|FG004|Week 16 up to Week 260|Death|0
7032259|NCT01649375|11111060|FG000|Week 16 up to Week 260|Adverse Event|5
7032260|NCT01649375|11111061|FG001|Week 16 up to Week 260|Adverse Event|2
7032261|NCT01649375|11111062|FG002|Week 16 up to Week 260|Adverse Event|0
7032262|NCT01649375|11111063|FG003|Week 16 up to Week 260|Adverse Event|3
7032263|NCT01649375|11111064|FG004|Week 16 up to Week 260|Adverse Event|2
7032264|NCT01649427|11111074|FG000|Overall Study|Adverse Event|1
7032265|NCT01649427|11111075|FG001|Overall Study|Adverse Event|1
7032266|NCT01649427|11111074|FG000|Overall Study|Withdrawal by Subject|8
7032267|NCT01649427|11111075|FG001|Overall Study|Withdrawal by Subject|7
7032268|NCT01649427|11111074|FG000|Overall Study|Lost to Follow-up|0
7032269|NCT01649427|11111075|FG001|Overall Study|Lost to Follow-up|1
7032270|NCT01649427|11111074|FG000|Overall Study|Graft loss|0
7032271|NCT01649427|11111075|FG001|Overall Study|Graft loss|1
7032272|NCT01649427|11111074|FG000|Overall Study|Surgical problems during nephrectomy|2
7032273|NCT01649427|11111075|FG001|Overall Study|Surgical problems during nephrectomy|2
7032274|NCT01649557|11111084|FG000|Overall Study|Lost to Follow-up|5
7032275|NCT01649557|11111085|FG001|Overall Study|Lost to Follow-up|0
7032276|NCT01649557|11111086|FG002|Overall Study|Lost to Follow-up|3
7032277|NCT01649557|11111084|FG000|Overall Study|Adverse Event|7
7032278|NCT01649557|11111085|FG001|Overall Study|Adverse Event|5
7032279|NCT01649557|11111086|FG002|Overall Study|Adverse Event|1
7032280|NCT01649557|11111084|FG000|Overall Study|Met withdrawal criteria|4
7032281|NCT01649557|11111085|FG001|Overall Study|Met withdrawal criteria|0
7032282|NCT01649557|11111086|FG002|Overall Study|Met withdrawal criteria|0
7032283|NCT01649557|11111084|FG000|Overall Study|Physician Decision|8
7032284|NCT01649557|11111085|FG001|Overall Study|Physician Decision|2
7032285|NCT01649557|11111086|FG002|Overall Study|Physician Decision|1
7032286|NCT01649557|11111084|FG000|Overall Study|Withdrawal by Subject|15
7032287|NCT01649557|11111085|FG001|Overall Study|Withdrawal by Subject|5
7032288|NCT01649557|11111086|FG002|Overall Study|Withdrawal by Subject|4
7032289|NCT01649557|11111084|FG000|Overall Study|Protocol deviation|0
7032290|NCT01649557|11111085|FG001|Overall Study|Protocol deviation|2
7032291|NCT01649557|11111086|FG002|Overall Study|Protocol deviation|0
7032292|NCT01649557|11111084|FG000|Overall Study|Lack of Efficacy|5
7032293|NCT01649557|11111085|FG001|Overall Study|Lack of Efficacy|0
7032294|NCT01649557|11111086|FG002|Overall Study|Lack of Efficacy|0
7032295|NCT01649765|11111114|FG000|Overall Study|Adverse Event|5
7032296|NCT01649765|11111115|FG001|Overall Study|Adverse Event|3
7032297|NCT01649765|11111114|FG000|Overall Study|Lack of Efficacy|1
7032298|NCT01649765|11111115|FG001|Overall Study|Lack of Efficacy|1
7032299|NCT01649765|11111114|FG000|Overall Study|Physician Decision|0
7032300|NCT01649765|11111115|FG001|Overall Study|Physician Decision|3
7032301|NCT01649765|11111114|FG000|Overall Study|Protocol Violation|1
7032302|NCT01649765|11111115|FG001|Overall Study|Protocol Violation|0
7032303|NCT01649765|11111114|FG000|Overall Study|Withdrawal by Subject|2
7032304|NCT01649765|11111115|FG001|Overall Study|Withdrawal by Subject|1
7032305|NCT01649791|11111122|FG000|Overall Study|Disease Progression|2
7032306|NCT01649791|11111122|FG000|Overall Study|Adverse Event|1
7032307|NCT01649804|11111126|FG000|Overall Study|Administrative/Other|8
7032308|NCT01649856|11111132|FG000|Overall Study|Withdrawal by Subject|14
7032309|NCT01649856|11111133|FG001|Overall Study|Withdrawal by Subject|14
7032310|NCT01649856|11111132|FG000|Overall Study|Protocol Violation|4
7032311|NCT01649856|11111133|FG001|Overall Study|Protocol Violation|4
7032312|NCT01649856|11111132|FG000|Overall Study|Treatment Failure|1
7032313|NCT01649856|11111133|FG001|Overall Study|Treatment Failure|1
7032314|NCT01649856|11111132|FG000|Overall Study|Death|69
7032315|NCT01649856|11111133|FG001|Overall Study|Death|34
7032316|NCT01649856|11111132|FG000|Overall Study|Stable or Progressed Disease|5
7032317|NCT01649856|11111133|FG001|Overall Study|Stable or Progressed Disease|3
7032318|NCT01649856|11111132|FG000|Overall Study|Lost to Follow-up|20
7032319|NCT01649856|11111133|FG001|Overall Study|Lost to Follow-up|16
7032320|NCT01649856|11111132|FG000|Overall Study|Lack of Compliance|6
7032321|NCT01649856|11111133|FG001|Overall Study|Lack of Compliance|1
7032322|NCT01649856|11111132|FG000|Overall Study|Other|20
7032323|NCT01649856|11111133|FG001|Overall Study|Other|5
7032324|NCT01649869|11111141|FG000|Overall Study|Family member illness|1
7032325|NCT01649869|11111142|FG001|Overall Study|Family member illness|0
7032326|NCT01649869|11111141|FG000|Overall Study|Required treatment outside protocol|1
7032327|NCT01649869|11111142|FG001|Overall Study|Required treatment outside protocol|0
7032328|NCT01649869|11111141|FG000|Overall Study|Severe hearing loss borderline eligible|0
7032329|NCT01649869|11111142|FG001|Overall Study|Severe hearing loss borderline eligible|1
7032330|NCT01650194|11111160|FG000|Overall Study|Progressive Disease (PD)|35
7032331|NCT01650194|11111160|FG000|Overall Study|Withdrawal by Subject|2
7032332|NCT01650194|11111160|FG000|Overall Study|Miscellaneous|10
7032333|NCT01650246|11111165|FG000|Overall Study|Adverse Event|23
7032334|NCT01650246|11111165|FG000|Overall Study|Protocol Violation|5
7032335|NCT01650246|11111165|FG000|Overall Study|Sponsor terminated study|53
7032336|NCT01650246|11111165|FG000|Overall Study|Lost to Follow-up|5
7032337|NCT01650246|11111165|FG000|Overall Study|Withdrawal by Subject|26
7032338|NCT01650246|11111165|FG000|Overall Study|Death|1
7032339|NCT01650246|11111165|FG000|Overall Study|Lack of Efficacy|30
7032340|NCT01650259|11111171|FG000|Overall Study|Improvement|105
7032341|NCT01650259|11111172|FG001|Overall Study|Improvement|0
7032342|NCT01650259|11111171|FG000|Overall Study|Adverse Event|127
7032343|NCT01650259|11111172|FG001|Overall Study|Adverse Event|0
7032344|NCT01650259|11111171|FG000|Overall Study|Lack of Efficacy|143
7032345|NCT01650259|11111172|FG001|Overall Study|Lack of Efficacy|0
7032346|NCT01650259|11111171|FG000|Overall Study|Lost to Follow-up|435
7032347|NCT01650259|11111172|FG001|Overall Study|Lost to Follow-up|0
7032348|NCT01650259|11111171|FG000|Overall Study|Patients had no visit after entry|70
7032349|NCT01650259|11111172|FG001|Overall Study|Patients had no visit after entry|0
7032350|NCT01650259|11111171|FG000|Overall Study|CRF not collected|98
7032351|NCT01650259|11111172|FG001|Overall Study|CRF not collected|82
7032352|NCT01650259|11111171|FG000|Overall Study|Not treated|1
7032353|NCT01650259|11111172|FG001|Overall Study|Not treated|7
7032354|NCT01650259|11111171|FG000|Overall Study|Other than listed|64
7032355|NCT01650259|11111172|FG001|Overall Study|Other than listed|146
7044551|NCT01755156|11130430|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6
7044552|NCT01755156|11130431|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13
7032356|NCT01650519|11111222|FG000|Overall Study|Withdrawal by Subject|1
7032357|NCT01650519|11111223|FG001|Overall Study|Withdrawal by Subject|0
7032358|NCT01650558|11111243|FG000|Overall Study|Migration out of study area|61
7032359|NCT01650558|11111244|FG001|Overall Study|Migration out of study area|71
7032360|NCT01650558|11111245|FG002|Overall Study|Migration out of study area|56
7032361|NCT01650558|11111243|FG000|Overall Study|Lost to Follow-up|10
7032362|NCT01650558|11111244|FG001|Overall Study|Lost to Follow-up|13
7032363|NCT01650558|11111245|FG002|Overall Study|Lost to Follow-up|6
7032364|NCT01650558|11111243|FG000|Overall Study|Death|10
7032365|NCT01650558|11111244|FG001|Overall Study|Death|6
7032366|NCT01650558|11111245|FG002|Overall Study|Death|8
7032367|NCT01650558|11111243|FG000|Overall Study|Withdrawal by Subject|1
7032368|NCT01650558|11111244|FG001|Overall Study|Withdrawal by Subject|1
7032369|NCT01650558|11111245|FG002|Overall Study|Withdrawal by Subject|3
7032370|NCT01650558|11111243|FG000|Overall Study|Non-compliant participant|1
7032371|NCT01650558|11111244|FG001|Overall Study|Non-compliant participant|0
7032372|NCT01650558|11111245|FG002|Overall Study|Non-compliant participant|2
7032373|NCT01650558|11111243|FG000|Overall Study|Physician Decision|0
7032374|NCT01650558|11111244|FG001|Overall Study|Physician Decision|1
7032375|NCT01650558|11111245|FG002|Overall Study|Physician Decision|0
7032376|NCT01650636|11111263|FG000|Washout up to 5 Months|Withdrawal by Subject|4
7032377|NCT01650636|11111264|FG001|Washout up to 5 Months|Withdrawal by Subject|8
7032378|NCT01650636|11111263|FG000|Washout up to 5 Months|Physician Decision|2
7032379|NCT01650636|11111264|FG001|Washout up to 5 Months|Physician Decision|2
7032380|NCT01650636|11111263|FG000|Washout up to 5 Months|Death|1
7032381|NCT01650636|11111264|FG001|Washout up to 5 Months|Death|0
7032382|NCT01650636|11111263|FG000|Washout up to 5 Months|Lost to Follow-up|2
7032383|NCT01650636|11111264|FG001|Washout up to 5 Months|Lost to Follow-up|8
7032384|NCT01650636|11111263|FG000|Washout up to 9 Months|Withdrawal by Subject|4
7032385|NCT01650636|11111264|FG001|Washout up to 9 Months|Withdrawal by Subject|2
7032386|NCT01650636|11111263|FG000|Washout up to 9 Months|Lost to Follow-up|2
7032387|NCT01650636|11111264|FG001|Washout up to 9 Months|Lost to Follow-up|1
7032388|NCT01650779|11111270|FG000|Overall Study|Withdrawal by Subject|1
7032389|NCT01650805|11111276|FG000|Overall Study|Withdrawal by Subject|1
7032390|NCT01650805|11111277|FG001|Overall Study|Withdrawal by Subject|0
7032391|NCT01650831|11111283|FG000|Overall Study|Screen failure|1
7032392|NCT01651000|11111302|FG000|Overall Study|Adverse Event|2
7032393|NCT01651000|11111303|FG001|Overall Study|Adverse Event|8
7032394|NCT01651000|11111302|FG000|Overall Study|Lost to Follow-up|3
7032395|NCT01651000|11111303|FG001|Overall Study|Lost to Follow-up|2
7032396|NCT01651000|11111302|FG000|Overall Study|Protocol Violation|0
7032397|NCT01651000|11111303|FG001|Overall Study|Protocol Violation|3
7032398|NCT01651000|11111302|FG000|Overall Study|Withdrawal by Subject|2
7032399|NCT01651000|11111303|FG001|Overall Study|Withdrawal by Subject|10
7032400|NCT01651000|11111302|FG000|Overall Study|Subject noncompliance|0
7032401|NCT01651000|11111303|FG001|Overall Study|Subject noncompliance|3
7032402|NCT01651000|11111302|FG000|Overall Study|Lack of Efficacy|1
7032403|NCT01651000|11111303|FG001|Overall Study|Lack of Efficacy|1
7032404|NCT01651000|11111302|FG000|Overall Study|Physician Decision|1
7032405|NCT01651000|11111303|FG001|Overall Study|Physician Decision|0
7032406|NCT01651000|11111302|FG000|Overall Study|Administrative reason|1
7032407|NCT01651000|11111303|FG001|Overall Study|Administrative reason|0
7032408|NCT01651000|11111302|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0
7032409|NCT01651000|11111303|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1
7032410|NCT01651039|11111309|FG000|Overall Study|Non-evaluables|5
7032411|NCT01651039|11111309|FG000|Overall Study|Physician Decision|2
7032412|NCT01651039|11111309|FG000|Overall Study|Withdrawal by Subject|1
7032413|NCT01651039|11111309|FG000|Overall Study|Progressive Disease|22
7032414|NCT01651052|11111313|FG000|Overall Study|Death|21
7032415|NCT01651052|11111313|FG000|Overall Study|Explant|1
7032416|NCT01651052|11111313|FG000|Overall Study|Withdrawal by Subject|1
7032417|NCT01651052|11111313|FG000|Overall Study|Lost to Follow-up|3
7032418|NCT01651117|11111329|FG000|Overall Study|Death|2
7032419|NCT01651117|11111330|FG001|Overall Study|Death|3
7032420|NCT01651117|11111331|FG002|Overall Study|Death|2
7032421|NCT01651117|11111332|FG003|Overall Study|Death|2
7032422|NCT01651208|11111368|FG000|Overall Study|Lost to Follow-up|14
7032423|NCT01651208|11111369|FG001|Overall Study|Lost to Follow-up|16
7032424|NCT01651260|11111376|FG000|Overall Study|unable to apply product|3
7032425|NCT01651780|11111412|FG000|Overall Study|Physician decision: No 30-day visit|2
7032426|NCT01651780|11111413|FG001|Overall Study|Physician decision: No 30-day visit|1
7032427|NCT01651780|11111412|FG000|Overall Study|Reason Not Specified: No 30-day visit|2
7032428|NCT01651780|11111413|FG001|Overall Study|Reason Not Specified: No 30-day visit|2
7032429|NCT01651780|11111412|FG000|Overall Study|Withdrawal by Subject|2
7032430|NCT01651780|11111413|FG001|Overall Study|Withdrawal by Subject|0
7032431|NCT01651780|11111412|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3
7032432|NCT01651780|11111413|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7032433|NCT01651780|11111412|FG000|Overall Study|Lost to Follow-up|1
7032434|NCT01651780|11111413|FG001|Overall Study|Lost to Follow-up|2
7032435|NCT01651780|11111412|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1
7032436|NCT01651780|11111413|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5
7032437|NCT01651936|11111464|FG000|Base Study|Adverse Event|3
7032438|NCT01651936|11111465|FG001|Base Study|Adverse Event|0
7032439|NCT01651936|11111466|FG002|Base Study|Adverse Event|0
7032440|NCT01651936|11111464|FG000|Base Study|Withdrawal by Subject|1
7032441|NCT01651936|11111465|FG001|Base Study|Withdrawal by Subject|1
7032442|NCT01651936|11111466|FG002|Base Study|Withdrawal by Subject|0
7032443|NCT01651936|11111464|FG000|Base Study|Early Escape|2
7032444|NCT01651936|11111465|FG001|Base Study|Early Escape|8
7032445|NCT01651936|11111466|FG002|Base Study|Early Escape|0
7032446|NCT01651936|11111464|FG000|Base Study|Study terminated by sponsor|21
7032447|NCT01651936|11111465|FG001|Base Study|Study terminated by sponsor|16
7032448|NCT01651936|11111466|FG002|Base Study|Study terminated by sponsor|0
7032449|NCT01651936|11111464|FG000|Extension Study|Lack of Efficacy|0
7032450|NCT01651936|11111465|FG001|Extension Study|Lack of Efficacy|0
7032451|NCT01651936|11111466|FG002|Extension Study|Lack of Efficacy|1
7032452|NCT01651936|11111464|FG000|Extension Study|Study terminated by sponsor|0
7032453|NCT01651936|11111465|FG001|Extension Study|Study terminated by sponsor|0
7032454|NCT01651936|11111466|FG002|Extension Study|Study terminated by sponsor|13
7032455|NCT01651949|11111476|FG000|Overall Study|Unknown status|4
7032456|NCT01651949|11111477|FG001|Overall Study|Unknown status|4
7032457|NCT01651949|11111478|FG002|Overall Study|Unknown status|0
7032458|NCT01651949|11111476|FG000|Overall Study|Lost to Follow-up|30
7032459|NCT01651949|11111477|FG001|Overall Study|Lost to Follow-up|56
7032460|NCT01651949|11111478|FG002|Overall Study|Lost to Follow-up|20
7032461|NCT01651949|11111476|FG000|Overall Study|Protocol Violation|0
7032462|NCT01651949|11111477|FG001|Overall Study|Protocol Violation|2
7032463|NCT01651949|11111478|FG002|Overall Study|Protocol Violation|1
7032464|NCT01651949|11111476|FG000|Overall Study|Physician Decision|0
7032465|NCT01651949|11111477|FG001|Overall Study|Physician Decision|2
7032466|NCT01651949|11111478|FG002|Overall Study|Physician Decision|0
7032467|NCT01651949|11111476|FG000|Overall Study|Adverse Event|0
7032468|NCT01651949|11111477|FG001|Overall Study|Adverse Event|2
7032469|NCT01651949|11111478|FG002|Overall Study|Adverse Event|1
7032470|NCT01651949|11111476|FG000|Overall Study|Screen failure|2
7032471|NCT01651949|11111477|FG001|Overall Study|Screen failure|2
7032472|NCT01651949|11111478|FG002|Overall Study|Screen failure|0
7032473|NCT01651949|11111476|FG000|Overall Study|Withdrawal by Subject|17
7032474|NCT01651949|11111477|FG001|Overall Study|Withdrawal by Subject|18
7032475|NCT01651949|11111478|FG002|Overall Study|Withdrawal by Subject|9
7032476|NCT01652287|11111507|FG000|Overall Study|Withdrawal by Subject|2
7032477|NCT01652287|11111508|FG001|Overall Study|Withdrawal by Subject|0
7032478|NCT01652469|11111516|FG000|Overall Study|Withdrawal by Subject|1
7032479|NCT01652469|11111517|FG001|Overall Study|Withdrawal by Subject|4
7032480|NCT01652469|11111516|FG000|Overall Study|Lost to Follow-up|0
7032481|NCT01652469|11111517|FG001|Overall Study|Lost to Follow-up|2
7032482|NCT01652573|11111536|FG000|Overall Study|Adverse Event|0
7032483|NCT01652573|11111537|FG001|Overall Study|Adverse Event|1
7032484|NCT01652664|11111545|FG000|Overall Study|Treatment Failure|5
7032485|NCT01652664|11111546|FG001|Overall Study|Treatment Failure|1
7032486|NCT01652664|11111545|FG000|Overall Study|Inadequate IOP control|1
7032487|NCT01652664|11111546|FG001|Overall Study|Inadequate IOP control|0
7032488|NCT01652690|11111555|FG000|Overall Study|Withdrawal by Subject|16
7032489|NCT01652690|11111556|FG001|Overall Study|Withdrawal by Subject|4
7032490|NCT01652690|11111555|FG000|Overall Study|Other|8
7032491|NCT01652690|11111556|FG001|Overall Study|Other|9
7032492|NCT01652690|11111555|FG000|Overall Study|Lost to Follow-up|6
7032493|NCT01652690|11111556|FG001|Overall Study|Lost to Follow-up|6
7032494|NCT01652690|11111555|FG000|Overall Study|Death|5
7032495|NCT01652690|11111556|FG001|Overall Study|Death|2
7032496|NCT01652703|11111568|FG000|Overall Study|Withdrawal by Subject|0
7032497|NCT01652703|11111569|FG001|Overall Study|Withdrawal by Subject|1
7032498|NCT01652703|11111570|FG002|Overall Study|Withdrawal by Subject|3
7032499|NCT01652703|11111571|FG003|Overall Study|Withdrawal by Subject|1
7032500|NCT01652703|11111572|FG004|Overall Study|Withdrawal by Subject|0
7032501|NCT01652703|11111573|FG005|Overall Study|Withdrawal by Subject|1
7032502|NCT01652703|11111568|FG000|Overall Study|Other|0
7032503|NCT01652703|11111569|FG001|Overall Study|Other|0
7032504|NCT01652703|11111570|FG002|Overall Study|Other|0
7032505|NCT01652703|11111571|FG003|Overall Study|Other|1
7032506|NCT01652703|11111572|FG004|Overall Study|Other|1
7032507|NCT01652703|11111573|FG005|Overall Study|Other|1
7032508|NCT01652716|11111589|FG000|Overall Study|Loss of glucose control|1
7032509|NCT01652716|11111590|FG001|Overall Study|Loss of glucose control|0
7032510|NCT01652716|11111589|FG000|Overall Study|Administrative|0
7032511|NCT01652716|11111590|FG001|Overall Study|Administrative|2
7032512|NCT01652716|11111589|FG000|Overall Study|Investigator decision|1
7032513|NCT01652716|11111590|FG001|Overall Study|Investigator decision|4
7032514|NCT01652716|11111589|FG000|Overall Study|Lost to Follow-up|12
7032515|NCT01652716|11111590|FG001|Overall Study|Lost to Follow-up|11
7032516|NCT01652716|11111589|FG000|Overall Study|Protocol Violation|2
7032517|NCT01652716|11111590|FG001|Overall Study|Protocol Violation|1
7032518|NCT01652716|11111589|FG000|Overall Study|Adverse Event|7
7032519|NCT01652716|11111590|FG001|Overall Study|Adverse Event|10
7032520|NCT01652716|11111589|FG000|Overall Study|Withdrawal by Subject|33
7032521|NCT01652716|11111590|FG001|Overall Study|Withdrawal by Subject|18
7032522|NCT01652729|11111599|FG000|Overall Study|Withdrawal by Subject|14
7032523|NCT01652729|11111600|FG001|Overall Study|Withdrawal by Subject|7
7032524|NCT01652729|11111601|FG002|Overall Study|Withdrawal by Subject|7
7032525|NCT01652729|11111599|FG000|Overall Study|Adverse Event|4
7032526|NCT01652729|11111600|FG001|Overall Study|Adverse Event|0
7032527|NCT01652729|11111601|FG002|Overall Study|Adverse Event|3
7032528|NCT01652729|11111599|FG000|Overall Study|Physician Decision|1
7032529|NCT01652729|11111600|FG001|Overall Study|Physician Decision|0
7032530|NCT01652729|11111601|FG002|Overall Study|Physician Decision|1
7032531|NCT01652729|11111599|FG000|Overall Study|Protocol Violation|1
7032532|NCT01652729|11111600|FG001|Overall Study|Protocol Violation|0
7032533|NCT01652729|11111601|FG002|Overall Study|Protocol Violation|0
7032534|NCT01652729|11111599|FG000|Overall Study|Lost to Follow-up|6
7032535|NCT01652729|11111600|FG001|Overall Study|Lost to Follow-up|6
7032536|NCT01652729|11111601|FG002|Overall Study|Lost to Follow-up|3
7032537|NCT01652729|11111599|FG000|Overall Study|Administrative|1
7032538|NCT01652729|11111600|FG001|Overall Study|Administrative|0
7032539|NCT01652729|11111601|FG002|Overall Study|Administrative|0
7032540|NCT01652872|11111611|FG000|Overall Study|Death|36
7032541|NCT01652872|11111612|FG001|Overall Study|Death|39
7032542|NCT01652872|11111611|FG000|Overall Study|Lost to Follow-up|28
7032543|NCT01652872|11111612|FG001|Overall Study|Lost to Follow-up|23
7032544|NCT01652872|11111611|FG000|Overall Study|Decision by sponsor|5
7032545|NCT01652872|11111612|FG001|Overall Study|Decision by sponsor|7
7032546|NCT01652872|11111611|FG000|Overall Study|Withdrawal by Subject|76
7032547|NCT01652872|11111612|FG001|Overall Study|Withdrawal by Subject|84
7032548|NCT01652885|11111618|FG000|Overall Study|Adverse Event|1
7032549|NCT01653132|11111647|FG000|First Intervention|Protocol Violation|1
7032550|NCT01653132|11111648|FG001|First Intervention|Protocol Violation|0
7032551|NCT01653158|11111658|FG000|Overall Study|Death|0
7032552|NCT01653158|11111659|FG001|Overall Study|Death|0
7032553|NCT01653158|11111660|FG002|Overall Study|Death|0
7032554|NCT01653158|11111661|FG003|Overall Study|Death|1
7032555|NCT01653158|11111662|FG004|Overall Study|Death|0
7032556|NCT01653158|11111663|FG005|Overall Study|Death|0
7032557|NCT01653158|11111664|FG006|Overall Study|Death|0
7032558|NCT01653158|11111665|FG007|Overall Study|Death|2
7032559|NCT01653158|11111658|FG000|Overall Study|Adverse Event|0
7032560|NCT01653158|11111659|FG001|Overall Study|Adverse Event|0
7032561|NCT01653158|11111660|FG002|Overall Study|Adverse Event|0
7032562|NCT01653158|11111661|FG003|Overall Study|Adverse Event|1
7032563|NCT01653158|11111662|FG004|Overall Study|Adverse Event|0
7032564|NCT01653158|11111663|FG005|Overall Study|Adverse Event|0
7032565|NCT01653158|11111664|FG006|Overall Study|Adverse Event|0
7032566|NCT01653158|11111665|FG007|Overall Study|Adverse Event|3
7032567|NCT01653158|11111658|FG000|Overall Study|Other|0
7032568|NCT01653158|11111659|FG001|Overall Study|Other|0
7032569|NCT01653158|11111660|FG002|Overall Study|Other|0
7032570|NCT01653158|11111661|FG003|Overall Study|Other|0
7032571|NCT01653158|11111662|FG004|Overall Study|Other|0
7032572|NCT01653158|11111663|FG005|Overall Study|Other|0
7032573|NCT01653158|11111664|FG006|Overall Study|Other|0
7032574|NCT01653158|11111665|FG007|Overall Study|Other|1
7032575|NCT01653158|11111658|FG000|Overall Study|Progressive disease|0
7032576|NCT01653158|11111659|FG001|Overall Study|Progressive disease|0
7032577|NCT01653158|11111660|FG002|Overall Study|Progressive disease|0
7032578|NCT01653158|11111661|FG003|Overall Study|Progressive disease|0
7032579|NCT01653158|11111662|FG004|Overall Study|Progressive disease|1
7032580|NCT01653158|11111663|FG005|Overall Study|Progressive disease|1
7032581|NCT01653158|11111664|FG006|Overall Study|Progressive disease|2
7032582|NCT01653158|11111665|FG007|Overall Study|Progressive disease|9
7032583|NCT01653158|11111658|FG000|Overall Study|Withdrawal by Subject|1
7032584|NCT01653158|11111659|FG001|Overall Study|Withdrawal by Subject|0
7032585|NCT01653158|11111660|FG002|Overall Study|Withdrawal by Subject|0
7032586|NCT01653158|11111661|FG003|Overall Study|Withdrawal by Subject|0
7032587|NCT01653158|11111662|FG004|Overall Study|Withdrawal by Subject|0
7032588|NCT01653158|11111663|FG005|Overall Study|Withdrawal by Subject|0
7032589|NCT01653158|11111664|FG006|Overall Study|Withdrawal by Subject|0
7032590|NCT01653158|11111665|FG007|Overall Study|Withdrawal by Subject|0
7032591|NCT01653262|11111692|FG000|Overall Study|Lack of Efficacy|1
7032592|NCT01653262|11111692|FG000|Overall Study|SAE, non-fatal|1
7032593|NCT01653262|11111692|FG000|Overall Study|AE, non-serious non-fatal|1
7032594|NCT01653327|11111707|FG000|Overall Study|Withdrawal by Subject|1
7032595|NCT01653704|11111748|FG000|Overall Study|Technical failure during recording|1
7032596|NCT01653704|11111749|FG001|Overall Study|Technical failure during recording|1
7032597|NCT01653704|11111748|FG000|Overall Study|Performance not reflective of training|1
7032598|NCT01653704|11111749|FG001|Overall Study|Performance not reflective of training|0
7032599|NCT01653743|11111757|FG000|Overall Study|Withdrawal by Subject|1
7032600|NCT01653743|11111758|FG001|Overall Study|Withdrawal by Subject|0
7032601|NCT01653743|11111757|FG000|Overall Study|Investigator discretion|3
7032602|NCT01653743|11111758|FG001|Overall Study|Investigator discretion|0
7032603|NCT01653782|11111767|FG000|Overall Study|Withdrawal by Subject|9
7032604|NCT01653782|11111768|FG001|Overall Study|Withdrawal by Subject|15
7032605|NCT01653782|11111769|FG002|Overall Study|Withdrawal by Subject|4
7032606|NCT01653782|11111767|FG000|Overall Study|Lost to Follow-up|7
7032607|NCT01653782|11111768|FG001|Overall Study|Lost to Follow-up|3
7032608|NCT01653782|11111769|FG002|Overall Study|Lost to Follow-up|2
7032609|NCT01653847|11111779|FG000|Overall Study|Withdrawal by Subject|1
7032610|NCT01653847|11111780|FG001|Overall Study|Withdrawal by Subject|0
7032611|NCT01653912|11111788|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
7032612|NCT01653912|11111789|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1
7032613|NCT01653912|11111790|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
7032614|NCT01653912|11111791|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
7032615|NCT01653912|11111792|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
7032616|NCT01653912|11111793|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
7032617|NCT01653912|11111788|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
7032618|NCT01653912|11111789|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
7032619|NCT01653912|11111790|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2
7032620|NCT01653912|11111791|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
7032621|NCT01653912|11111792|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
7032622|NCT01653912|11111793|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
7032623|NCT01653912|11111788|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
7032624|NCT01653912|11111789|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
7032625|NCT01653912|11111790|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
7032626|NCT01653912|11111791|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1
7032627|NCT01653912|11111792|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
7032628|NCT01653912|11111793|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
7032629|NCT01653912|11111788|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
7032630|NCT01653912|11111789|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
7032631|NCT01653912|11111790|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
7032632|NCT01653912|11111791|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1
7032633|NCT01653912|11111792|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
7032634|NCT01653912|11111793|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
7032635|NCT01653912|11111788|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0
7032636|NCT01653912|11111789|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0
7032637|NCT01653912|11111790|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0
7032638|NCT01653912|11111791|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0
7032639|NCT01653912|11111792|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0
7032640|NCT01653912|11111793|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1
7032641|NCT01653912|11111788|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0
7032642|NCT01653912|11111789|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0
7032643|NCT01653912|11111790|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0
7032644|NCT01653912|11111791|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0
7032645|NCT01653912|11111792|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0
7032646|NCT01653912|11111793|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6
7032647|NCT01653912|11111788|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
7032648|NCT01653912|11111789|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
7032649|NCT01653912|11111790|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
7032650|NCT01653912|11111791|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
7032651|NCT01653912|11111792|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
7032652|NCT01653912|11111793|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1
7032653|NCT01654224|11111818|FG000|Overall Study|Lost to Follow-up|2
7032654|NCT01654224|11111819|FG001|Overall Study|Lost to Follow-up|2
7032655|NCT01654224|11111818|FG000|Overall Study|Did not receive allocation|1
7032656|NCT01654224|11111819|FG001|Overall Study|Did not receive allocation|8
7032657|NCT01654224|11111818|FG000|Overall Study|Insufficient blood sample|3
7032658|NCT01654224|11111819|FG001|Overall Study|Insufficient blood sample|2
7032659|NCT01654250|11111827|FG000|Overall Study|Lost to Follow-up|1
7032660|NCT01654250|11111828|FG001|Overall Study|Lost to Follow-up|0
7032661|NCT01654276|11111857|FG000|Overall Study|Lack of Efficacy|1
7032662|NCT01654276|11111857|FG000|Overall Study|Lost to Follow-up|4
7032663|NCT01654276|11111857|FG000|Overall Study|Withdrawal by Subject|1
7032664|NCT01654289|11111864|FG000|Overall Study|Withdrawal by Subject|10
7032665|NCT01654289|11111865|FG001|Overall Study|Withdrawal by Subject|8
7032666|NCT01654289|11111866|FG002|Overall Study|Withdrawal by Subject|5
7032667|NCT01654289|11111864|FG000|Overall Study|Withdrew from intervention only|17
7032668|NCT01654289|11111865|FG001|Overall Study|Withdrew from intervention only|20
7032669|NCT01654289|11111866|FG002|Overall Study|Withdrew from intervention only|0
7032670|NCT01654302|11111876|FG000|Second Intervention (Day 7)|Lost to Follow-up|1
7032671|NCT01654302|11111877|FG001|Second Intervention (Day 7)|Lost to Follow-up|1
7032672|NCT01654380|11111885|FG000|Part B, Period 1|Physician Decision|0
7032673|NCT01654380|11111886|FG001|Part B, Period 1|Physician Decision|0
7032674|NCT01654380|11111887|FG002|Part B, Period 1|Physician Decision|1
7032675|NCT01654380|11111888|FG003|Part B, Period 1|Physician Decision|0
7032676|NCT01654523|11111914|FG000|Overall Study|Withdrawal by Subject|1
7032677|NCT01654536|11111920|FG000|Overall Study|Lost to Follow-up|5
7032678|NCT01654536|11111921|FG001|Overall Study|Lost to Follow-up|5
7032679|NCT01654536|11111920|FG000|Overall Study|Physician Decision|12
7032680|NCT01654536|11111921|FG001|Overall Study|Physician Decision|8
7032681|NCT01654536|11111920|FG000|Overall Study|Withdrawal by Subject|27
7032682|NCT01654536|11111921|FG001|Overall Study|Withdrawal by Subject|25
7032683|NCT01654549|11111930|FG000|Overall Study|H.pylori eradication not successful|0
7032684|NCT01654549|11111931|FG001|Overall Study|H.pylori eradication not successful|1
7032685|NCT01654601|11111943|FG000|1st Administration|Withdrawal by Subject|2
7032686|NCT01654601|11111944|FG001|1st Administration|Withdrawal by Subject|0
7032687|NCT01654601|11111943|FG000|1st Administration|Protocol Violation|0
7032688|NCT01654601|11111944|FG001|1st Administration|Protocol Violation|2
7032689|NCT01654601|11111943|FG000|2nd Administration|Adverse Event|1
7032690|NCT01654601|11111944|FG001|2nd Administration|Adverse Event|0
7032691|NCT01654601|11111943|FG000|2nd Administration|Protocol Violation|0
7032692|NCT01654601|11111944|FG001|2nd Administration|Protocol Violation|1
7032693|NCT01654666|11111953|FG000|Overall Study|Protocol Violation|7
7032694|NCT01654666|11111954|FG001|Overall Study|Protocol Violation|4
7032695|NCT01654666|11111955|FG002|Overall Study|Protocol Violation|8
7032696|NCT01654666|11111953|FG000|Overall Study|Lost to Follow-up|4
7032697|NCT01654666|11111954|FG001|Overall Study|Lost to Follow-up|5
7032698|NCT01654666|11111955|FG002|Overall Study|Lost to Follow-up|5
7032699|NCT01654666|11111953|FG000|Overall Study|Withdrawal by Subject|4
7032700|NCT01654666|11111954|FG001|Overall Study|Withdrawal by Subject|4
7032701|NCT01654666|11111955|FG002|Overall Study|Withdrawal by Subject|1
7032702|NCT01655069|11111999|FG000|Overall Study|Physician Decision|0
7032703|NCT01655069|11112000|FG001|Overall Study|Physician Decision|0
7032704|NCT01655069|11112001|FG002|Overall Study|Physician Decision|0
7032705|NCT01655069|11112002|FG003|Overall Study|Physician Decision|1
7032706|NCT01655069|11111999|FG000|Overall Study|Adverse Event|6
7032707|NCT01655069|11112000|FG001|Overall Study|Adverse Event|7
7032708|NCT01655069|11112001|FG002|Overall Study|Adverse Event|2
7032709|NCT01655069|11112002|FG003|Overall Study|Adverse Event|3
7032710|NCT01655069|11111999|FG000|Overall Study|Lack of Efficacy|0
7032711|NCT01655069|11112000|FG001|Overall Study|Lack of Efficacy|1
7032712|NCT01655069|11112001|FG002|Overall Study|Lack of Efficacy|0
7032713|NCT01655069|11112002|FG003|Overall Study|Lack of Efficacy|0
7032714|NCT01655069|11111999|FG000|Overall Study|No Treatment Needed|0
7032715|NCT01655069|11112000|FG001|Overall Study|No Treatment Needed|1
7032716|NCT01655069|11112001|FG002|Overall Study|No Treatment Needed|0
7032717|NCT01655069|11112002|FG003|Overall Study|No Treatment Needed|0
7032718|NCT01655069|11111999|FG000|Overall Study|Withdrawal by Subject|2
7032719|NCT01655069|11112000|FG001|Overall Study|Withdrawal by Subject|3
7032720|NCT01655069|11112001|FG002|Overall Study|Withdrawal by Subject|0
7032721|NCT01655069|11112002|FG003|Overall Study|Withdrawal by Subject|0
7032722|NCT01655381|11112024|FG000|Overall Study|Investigator Decision|1
7032723|NCT01655381|11112024|FG000|Overall Study|Moved to Another City|1
7032724|NCT01655381|11112024|FG000|Overall Study|Insufficient Treatment Response|1
7032725|NCT01655498|11112029|FG000|Overall Study|Unrelated health issue|2
7032726|NCT01655498|11112029|FG000|Overall Study|Protocol Violation|2
7032727|NCT01655498|11112029|FG000|Overall Study|Withdrawal by Subject|1
7032728|NCT01655693|11112048|FG000|Overall Study|Progression of Disease|92
7032729|NCT01655693|11112049|FG001|Overall Study|Progression of Disease|76
7032730|NCT01655693|11112050|FG002|Overall Study|Progression of Disease|58
7032731|NCT01655693|11112048|FG000|Overall Study|Death|8
7032732|NCT01655693|11112049|FG001|Overall Study|Death|9
7032733|NCT01655693|11112050|FG002|Overall Study|Death|12
7032734|NCT01655693|11112048|FG000|Overall Study|Serious Adverse Event|3
7032735|NCT01655693|11112049|FG001|Overall Study|Serious Adverse Event|15
7032736|NCT01655693|11112050|FG002|Overall Study|Serious Adverse Event|11
7032737|NCT01655693|11112048|FG000|Overall Study|Withdrawal by Subject|3
7032738|NCT01655693|11112049|FG001|Overall Study|Withdrawal by Subject|2
7032739|NCT01655693|11112050|FG002|Overall Study|Withdrawal by Subject|20
7032740|NCT01655693|11112048|FG000|Overall Study|Adverse Event|3
7032741|NCT01655693|11112049|FG001|Overall Study|Adverse Event|11
7032742|NCT01655693|11112050|FG002|Overall Study|Adverse Event|3
7032743|NCT01655693|11112048|FG000|Overall Study|Aggravation of Liver Dysfunction|5
7032744|NCT01655693|11112049|FG001|Overall Study|Aggravation of Liver Dysfunction|4
7032745|NCT01655693|11112050|FG002|Overall Study|Aggravation of Liver Dysfunction|0
7032746|NCT01655693|11112048|FG000|Overall Study|Non-Compliance|0
7032747|NCT01655693|11112049|FG001|Overall Study|Non-Compliance|0
7032748|NCT01655693|11112050|FG002|Overall Study|Non-Compliance|7
7032749|NCT01655693|11112048|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1
7032750|NCT01655693|11112049|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3
7032751|NCT01655693|11112050|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0
7032752|NCT01655693|11112048|FG000|Overall Study|Protocol Violation|1
7032753|NCT01655693|11112049|FG001|Overall Study|Protocol Violation|0
7032754|NCT01655693|11112050|FG002|Overall Study|Protocol Violation|3
7032755|NCT01655693|11112048|FG000|Overall Study|Lost to Follow-up|1
7032756|NCT01655693|11112049|FG001|Overall Study|Lost to Follow-up|0
7032757|NCT01655693|11112050|FG002|Overall Study|Lost to Follow-up|1
7032758|NCT01655693|11112048|FG000|Overall Study|Screening Failure|1
7032759|NCT01655693|11112049|FG001|Overall Study|Screening Failure|0
7032760|NCT01655693|11112050|FG002|Overall Study|Screening Failure|0
7032761|NCT01655693|11112048|FG000|Overall Study|Other|8
7032762|NCT01655693|11112049|FG001|Overall Study|Other|6
7032763|NCT01655693|11112050|FG002|Overall Study|Other|15
7032764|NCT01655823|11112077|FG000|Overall Study|Lost to Follow-up|0
7032765|NCT01655823|11112078|FG001|Overall Study|Lost to Follow-up|1
7032766|NCT01655823|11112079|FG002|Overall Study|Lost to Follow-up|0
7032767|NCT01655823|11112080|FG003|Overall Study|Lost to Follow-up|0
7032768|NCT01655823|11112081|FG004|Overall Study|Lost to Follow-up|1
7032769|NCT01655823|11112077|FG000|Overall Study|Withdrawal by Subject|0
7032770|NCT01655823|11112078|FG001|Overall Study|Withdrawal by Subject|1
7032771|NCT01655823|11112079|FG002|Overall Study|Withdrawal by Subject|0
7032772|NCT01655823|11112080|FG003|Overall Study|Withdrawal by Subject|1
7032773|NCT01655823|11112081|FG004|Overall Study|Withdrawal by Subject|0
7032774|NCT01655901|11112093|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1
7032775|NCT01655901|11112094|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1
7032776|NCT01655901|11112095|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1
7032777|NCT01655901|11112096|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0
7032778|NCT01655901|11112097|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1
7032779|NCT01655901|11112098|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0
7032780|NCT01656161|11112111|FG000|Overall Study|Death|3
7032781|NCT01656161|11112111|FG000|Overall Study|Adverse Event|2
7032782|NCT01656161|11112111|FG000|Overall Study|Protocol Violation|1
7032783|NCT01656161|11112111|FG000|Overall Study|Withdrawal by Subject|1
7032784|NCT01656200|11112127|FG000|Overall Study|Withdrawal by Subject|1
7032785|NCT01656304|11112137|FG000|Overall Study|Ineligible, uncontrolled hypertension|1
7032786|NCT01656395|11112147|FG000|Overall Study|Adverse Event|1
7032787|NCT01656395|11112148|FG001|Overall Study|Adverse Event|14
7032788|NCT01656395|11112149|FG002|Overall Study|Adverse Event|5
7032789|NCT01656395|11112150|FG003|Overall Study|Adverse Event|4
7032790|NCT01656395|11112151|FG004|Overall Study|Adverse Event|5
7032791|NCT01656395|11112152|FG005|Overall Study|Adverse Event|7
7032792|NCT01656395|11112153|FG006|Overall Study|Adverse Event|0
7032793|NCT01656395|11112154|FG007|Overall Study|Adverse Event|0
7032794|NCT01656395|11112147|FG000|Overall Study|Lack of Efficacy|1
7032795|NCT01656395|11112148|FG001|Overall Study|Lack of Efficacy|8
7032796|NCT01656395|11112149|FG002|Overall Study|Lack of Efficacy|6
7032797|NCT01656395|11112150|FG003|Overall Study|Lack of Efficacy|1
7032798|NCT01656395|11112151|FG004|Overall Study|Lack of Efficacy|1
7032799|NCT01656395|11112152|FG005|Overall Study|Lack of Efficacy|6
7032800|NCT01656395|11112153|FG006|Overall Study|Lack of Efficacy|0
7032801|NCT01656395|11112154|FG007|Overall Study|Lack of Efficacy|0
7032802|NCT01656395|11112147|FG000|Overall Study|Lost to Follow-up|1
7032803|NCT01656395|11112148|FG001|Overall Study|Lost to Follow-up|0
7032804|NCT01656395|11112149|FG002|Overall Study|Lost to Follow-up|0
7032805|NCT01656395|11112150|FG003|Overall Study|Lost to Follow-up|0
7032806|NCT01656395|11112151|FG004|Overall Study|Lost to Follow-up|0
7032807|NCT01656395|11112152|FG005|Overall Study|Lost to Follow-up|0
7032808|NCT01656395|11112153|FG006|Overall Study|Lost to Follow-up|0
7032809|NCT01656395|11112154|FG007|Overall Study|Lost to Follow-up|0
7032810|NCT01656395|11112147|FG000|Overall Study|Non-Compliance with Study Drug|1
7032811|NCT01656395|11112148|FG001|Overall Study|Non-Compliance with Study Drug|1
7032812|NCT01656395|11112149|FG002|Overall Study|Non-Compliance with Study Drug|0
7032813|NCT01656395|11112150|FG003|Overall Study|Non-Compliance with Study Drug|0
7032814|NCT01656395|11112151|FG004|Overall Study|Non-Compliance with Study Drug|1
7032815|NCT01656395|11112152|FG005|Overall Study|Non-Compliance with Study Drug|1
7032816|NCT01656395|11112153|FG006|Overall Study|Non-Compliance with Study Drug|0
7032817|NCT01656395|11112154|FG007|Overall Study|Non-Compliance with Study Drug|0
7032818|NCT01656395|11112147|FG000|Overall Study|Other|0
7032819|NCT01656395|11112148|FG001|Overall Study|Other|0
7032820|NCT01656395|11112149|FG002|Overall Study|Other|1
7032821|NCT01656395|11112150|FG003|Overall Study|Other|0
7032822|NCT01656395|11112151|FG004|Overall Study|Other|0
7032823|NCT01656395|11112152|FG005|Overall Study|Other|1
7032824|NCT01656395|11112153|FG006|Overall Study|Other|0
7032825|NCT01656395|11112154|FG007|Overall Study|Other|0
7032826|NCT01656395|11112147|FG000|Overall Study|Physician Decision|2
7032827|NCT01656395|11112148|FG001|Overall Study|Physician Decision|3
7032828|NCT01656395|11112149|FG002|Overall Study|Physician Decision|3
7032829|NCT01656395|11112150|FG003|Overall Study|Physician Decision|2
7032830|NCT01656395|11112151|FG004|Overall Study|Physician Decision|3
7032831|NCT01656395|11112152|FG005|Overall Study|Physician Decision|3
7032832|NCT01656395|11112153|FG006|Overall Study|Physician Decision|0
7032833|NCT01656395|11112154|FG007|Overall Study|Physician Decision|0
7032834|NCT01656395|11112147|FG000|Overall Study|Pregnancy|0
7032835|NCT01656395|11112148|FG001|Overall Study|Pregnancy|0
7032836|NCT01656395|11112149|FG002|Overall Study|Pregnancy|1
7032837|NCT01656395|11112150|FG003|Overall Study|Pregnancy|0
7032838|NCT01656395|11112151|FG004|Overall Study|Pregnancy|0
7032839|NCT01656395|11112152|FG005|Overall Study|Pregnancy|0
7032840|NCT01656395|11112153|FG006|Overall Study|Pregnancy|0
7032841|NCT01656395|11112154|FG007|Overall Study|Pregnancy|0
7032842|NCT01656395|11112147|FG000|Overall Study|Progressive Disease|0
7032843|NCT01656395|11112148|FG001|Overall Study|Progressive Disease|0
7032844|NCT01656395|11112149|FG002|Overall Study|Progressive Disease|0
7032845|NCT01656395|11112150|FG003|Overall Study|Progressive Disease|0
7032846|NCT01656395|11112151|FG004|Overall Study|Progressive Disease|0
7032847|NCT01656395|11112152|FG005|Overall Study|Progressive Disease|1
7032848|NCT01656395|11112153|FG006|Overall Study|Progressive Disease|0
7032849|NCT01656395|11112154|FG007|Overall Study|Progressive Disease|0
7032850|NCT01656395|11112147|FG000|Overall Study|Protocol Violation|6
7032851|NCT01656395|11112148|FG001|Overall Study|Protocol Violation|6
7032852|NCT01656395|11112149|FG002|Overall Study|Protocol Violation|9
7032853|NCT01656395|11112150|FG003|Overall Study|Protocol Violation|2
7032854|NCT01656395|11112151|FG004|Overall Study|Protocol Violation|4
7032855|NCT01656395|11112152|FG005|Overall Study|Protocol Violation|10
7032856|NCT01656395|11112153|FG006|Overall Study|Protocol Violation|0
7032857|NCT01656395|11112154|FG007|Overall Study|Protocol Violation|0
7032858|NCT01656395|11112147|FG000|Overall Study|Screen Failure|2
7032859|NCT01656395|11112148|FG001|Overall Study|Screen Failure|1
7032860|NCT01656395|11112149|FG002|Overall Study|Screen Failure|7
7032861|NCT01656395|11112150|FG003|Overall Study|Screen Failure|1
7032862|NCT01656395|11112151|FG004|Overall Study|Screen Failure|0
7032863|NCT01656395|11112152|FG005|Overall Study|Screen Failure|8
7032864|NCT01656395|11112153|FG006|Overall Study|Screen Failure|0
7032865|NCT01656395|11112154|FG007|Overall Study|Screen Failure|0
7032866|NCT01656395|11112147|FG000|Overall Study|Withdrawal by Subject|3
7032867|NCT01656395|11112148|FG001|Overall Study|Withdrawal by Subject|1
7032868|NCT01656395|11112149|FG002|Overall Study|Withdrawal by Subject|4
7032869|NCT01656395|11112150|FG003|Overall Study|Withdrawal by Subject|2
7032870|NCT01656395|11112151|FG004|Overall Study|Withdrawal by Subject|0
7032871|NCT01656395|11112152|FG005|Overall Study|Withdrawal by Subject|3
7032872|NCT01656395|11112153|FG006|Overall Study|Withdrawal by Subject|0
7032873|NCT01656395|11112154|FG007|Overall Study|Withdrawal by Subject|0
7032874|NCT01656408|11112178|FG000|Overall Study|Adverse Event|0
7032875|NCT01656408|11112179|FG001|Overall Study|Adverse Event|0
7032876|NCT01656408|11112180|FG002|Overall Study|Adverse Event|1
7032877|NCT01656408|11112181|FG003|Overall Study|Adverse Event|0
7032878|NCT01656408|11112182|FG004|Overall Study|Adverse Event|0
7032879|NCT01656408|11112183|FG005|Overall Study|Adverse Event|1
7032880|NCT01656408|11112184|FG006|Overall Study|Adverse Event|1
7032881|NCT01656408|11112185|FG007|Overall Study|Adverse Event|0
7032882|NCT01656408|11112186|FG008|Overall Study|Adverse Event|1
7032883|NCT01656408|11112187|FG009|Overall Study|Adverse Event|0
7032884|NCT01656408|11112178|FG000|Overall Study|Physician Decision|1
7032885|NCT01656408|11112179|FG001|Overall Study|Physician Decision|0
7032886|NCT01656408|11112180|FG002|Overall Study|Physician Decision|1
7032887|NCT01656408|11112181|FG003|Overall Study|Physician Decision|0
7032888|NCT01656408|11112182|FG004|Overall Study|Physician Decision|1
7032889|NCT01656408|11112183|FG005|Overall Study|Physician Decision|1
7032890|NCT01656408|11112184|FG006|Overall Study|Physician Decision|0
7032891|NCT01656408|11112185|FG007|Overall Study|Physician Decision|1
7032892|NCT01656408|11112186|FG008|Overall Study|Physician Decision|1
7032893|NCT01656408|11112187|FG009|Overall Study|Physician Decision|3
7032894|NCT01656733|11112261|FG000|Overall Study|No permission to collect birth outcomes|0
7032895|NCT01656733|11112262|FG001|Overall Study|No permission to collect birth outcomes|1
7032896|NCT01656733|11112261|FG000|Overall Study|Delivery at another hospital|0
7032897|NCT01656733|11112262|FG001|Overall Study|Delivery at another hospital|2
7032898|NCT01656733|11112261|FG000|Overall Study|Spontaneous abortion|0
7032899|NCT01656733|11112262|FG001|Overall Study|Spontaneous abortion|1
7032900|NCT01656759|11112270|FG000|Overall Study|Protocol Violation|2
7032901|NCT01656759|11112271|FG001|Overall Study|Protocol Violation|3
7044553|NCT01755156|11130430|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0
7044554|NCT01755156|11130431|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2
7044555|NCT01755156|11130430|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
7044556|NCT01755156|11130431|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
7044557|NCT01755156|11130430|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12
7044558|NCT01755156|11130431|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5
7044559|NCT01755156|11130430|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27
7044560|NCT01755156|11130431|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31
7044561|NCT01755195|11130458|FG000|Overall Study|Participant noncompliance|2
7044562|NCT01755195|11130458|FG000|Overall Study|Switched to alternative treatment|4
7044563|NCT01755195|11130458|FG000|Overall Study|Withdrawal by Subject|1
7044564|NCT01755195|11130458|FG000|Overall Study|Participant refused to start treatment|1
7044565|NCT01755195|11130458|FG000|Overall Study|Participant has been consented for another trial|1
7044566|NCT01755195|11130458|FG000|Overall Study|Refused further treatment|3
7044567|NCT01755195|11130458|FG000|Overall Study|Complicating disease/intercurrent illness|1
7044568|NCT01755234|11130464|FG000|Overall Study|Lost to Follow-up|11
7044569|NCT01755234|11130465|FG001|Overall Study|Lost to Follow-up|6
7044570|NCT01755234|11130464|FG000|Overall Study|Change in surgical case|2
7044571|NCT01755234|11130465|FG001|Overall Study|Change in surgical case|1
7044572|NCT01755234|11130464|FG000|Overall Study|case cancelled|1
7044573|NCT01755234|11130465|FG001|Overall Study|case cancelled|0
7044574|NCT01755234|11130464|FG000|Overall Study|Withdrawal by Subject|0
7044575|NCT01755234|11130465|FG001|Overall Study|Withdrawal by Subject|1
7044576|NCT01755234|11130464|FG000|Overall Study|unblinded|1
7044577|NCT01755234|11130465|FG001|Overall Study|unblinded|0
7044578|NCT01755416|11130471|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1
7044579|NCT01755416|11130472|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2
7044580|NCT01755546|11130485|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1
7044581|NCT01755546|11130485|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3
7044582|NCT01755546|11130485|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1
7044583|NCT01755546|11130485|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5
7044584|NCT01755546|11130485|FG000|Titration Phase|Adverse Event|11
7044585|NCT01755546|11130485|FG000|Titration Phase|Lack of Efficacy|18
7044586|NCT01755546|11130485|FG000|Titration Phase|Protocol Violation|9
7044587|NCT01755546|11130485|FG000|Titration Phase|Lost to Follow-up|2
7044588|NCT01755546|11130485|FG000|Titration Phase|Other and Continuing|22
7044589|NCT01755546|11130485|FG000|Titration Phase|Withdrawal by Subject|8
7044590|NCT01755546|11130485|FG000|Long Term Treatment|Adverse Event|12
7044591|NCT01755546|11130485|FG000|Long Term Treatment|Lack of Efficacy|6
7044592|NCT01755546|11130485|FG000|Long Term Treatment|Protocol Violation|10
7032902|NCT01656850|11112288|FG000|First Intervention (3 Months)|Withdrawal by Subject|3
7032903|NCT01656850|11112289|FG001|First Intervention (3 Months)|Withdrawal by Subject|4
7032904|NCT01656889|11112301|FG000|Treatment Period, 12 Weeks|Adverse Event|10
7032905|NCT01656889|11112302|FG001|Treatment Period, 12 Weeks|Adverse Event|4
7032906|NCT01656889|11112301|FG000|Treatment Period, 12 Weeks|Death|0
7032907|NCT01656889|11112302|FG001|Treatment Period, 12 Weeks|Death|1
7032908|NCT01656889|11112301|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1
7032909|NCT01656889|11112302|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1
7032910|NCT01656889|11112301|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1
7032911|NCT01656889|11112302|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2
7032912|NCT01656889|11112301|FG000|Treatment Period, 12 Weeks|Protocol Violation|0
7032913|NCT01656889|11112302|FG001|Treatment Period, 12 Weeks|Protocol Violation|1
7032914|NCT01656889|11112301|FG000|Treatment Period, 12 Weeks|Moved out of the area|0
7032915|NCT01656889|11112302|FG001|Treatment Period, 12 Weeks|Moved out of the area|2
7032916|NCT01656889|11112301|FG000|Post Treatment Follow-Up, 3 Months|Death|1
7032917|NCT01656889|11112302|FG001|Post Treatment Follow-Up, 3 Months|Death|5
7032918|NCT01656889|11112301|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1
7032919|NCT01656889|11112302|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2
7032920|NCT01656889|11112301|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2
7032921|NCT01656889|11112302|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1
7032922|NCT01656889|11112301|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0
7032923|NCT01656889|11112302|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1
7032924|NCT01656967|11112310|FG000|Overall Study|faulty monitor|1
7032925|NCT01656967|11112311|FG001|Overall Study|faulty monitor|0
7032926|NCT01656967|11112310|FG000|Overall Study|unsuccessful ETT insertion|3
7032927|NCT01656967|11112311|FG001|Overall Study|unsuccessful ETT insertion|2
7032928|NCT01657019|11112321|FG000|Overall Study|Withdrawal by Subject|65
7032929|NCT01657019|11112321|FG000|Overall Study|Adverse Event|55
7032930|NCT01657019|11112321|FG000|Overall Study|Lost to Follow-up|48
7032931|NCT01657019|11112321|FG000|Overall Study|Protocol Violation|6
7032932|NCT01657019|11112321|FG000|Overall Study|Lack of Efficacy|3
7032933|NCT01657019|11112321|FG000|Overall Study|Other|58
7032934|NCT01657032|11112327|FG000|Overall Study|Lost to Follow-up|0
7143221|NCT03029143|11299740|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0
7143222|NCT03029143|11299738|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1
7143223|NCT03029143|11299739|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0
7032935|NCT01657032|11112328|FG001|Overall Study|Lost to Follow-up|7
7032936|NCT01657162|11112336|FG000|Overall Study|Adverse Event|26
7032937|NCT01657162|11112337|FG001|Overall Study|Adverse Event|36
7032938|NCT01657162|11112336|FG000|Overall Study|Withdrawal by Subject|13
7032939|NCT01657162|11112337|FG001|Overall Study|Withdrawal by Subject|13
7032940|NCT01657162|11112336|FG000|Overall Study|Continuing Significant Deterioration|9
7032941|NCT01657162|11112337|FG001|Overall Study|Continuing Significant Deterioration|3
7032942|NCT01657162|11112336|FG000|Overall Study|Refusal of Treatment|4
7032943|NCT01657162|11112337|FG001|Overall Study|Refusal of Treatment|6
7032944|NCT01657162|11112336|FG000|Overall Study|Lost to Follow-up|3
7032945|NCT01657162|11112337|FG001|Overall Study|Lost to Follow-up|4
7032946|NCT01657162|11112336|FG000|Overall Study|Death|2
7032947|NCT01657162|11112337|FG001|Overall Study|Death|3
7032948|NCT01657162|11112336|FG000|Overall Study|Inability to Complete Study Procedures|1
7032949|NCT01657162|11112337|FG001|Overall Study|Inability to Complete Study Procedures|7
7032950|NCT01657162|11112336|FG000|Overall Study|Protocol Violation|1
7032951|NCT01657162|11112337|FG001|Overall Study|Protocol Violation|0
7032952|NCT01657162|11112336|FG000|Overall Study|Hypersensitivity to Alendronate|0
7032953|NCT01657162|11112337|FG001|Overall Study|Hypersensitivity to Alendronate|1
7032954|NCT01657162|11112336|FG000|Overall Study|Other than Specified|0
7032955|NCT01657162|11112337|FG001|Overall Study|Other than Specified|2
7032956|NCT01657253|11112345|FG000|Overall Study|Lost to Follow-up|6
7032957|NCT01657253|11112346|FG001|Overall Study|Lost to Follow-up|5
7032958|NCT01657253|11112345|FG000|Overall Study|Withdrawal by Subject|11
7032959|NCT01657253|11112346|FG001|Overall Study|Withdrawal by Subject|12
7032960|NCT01657253|11112345|FG000|Overall Study|Adverse Event|0
7032961|NCT01657253|11112346|FG001|Overall Study|Adverse Event|1
7032962|NCT01657266|11112354|FG000|Overall Study|Lost to Follow-up|2
7032963|NCT01657266|11112355|FG001|Overall Study|Lost to Follow-up|2
7032964|NCT01657266|11112354|FG000|Overall Study|Adverse Event|2
7032965|NCT01657266|11112355|FG001|Overall Study|Adverse Event|3
7032966|NCT01657292|11112361|FG000|Overall Study|Adverse Event|6
7032967|NCT01657292|11112361|FG000|Overall Study|Withdrawal by Subject|2
7032968|NCT01657292|11112361|FG000|Overall Study|Violation of eligibility criteria|1
7032969|NCT01657292|11112361|FG000|Overall Study|Change of therapy|1
7032970|NCT01657305|11112368|FG000|Overall Study|Lack of Wound Closure at Day 28|15
7032971|NCT01657305|11112368|FG000|Overall Study|Withdrawal by Subject|4
7032972|NCT01657305|11112368|FG000|Overall Study|Adverse Event|1
7032973|NCT01657305|11112368|FG000|Overall Study|Lost to Follow-up|1
7032974|NCT01657305|11112368|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4
7032975|NCT01657370|11112430|FG000|Overall Study|Withdrawal by Subject|0
7143224|NCT03029143|11299740|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0
7032976|NCT01657370|11112431|FG001|Overall Study|Withdrawal by Subject|0
7032977|NCT01657370|11112432|FG002|Overall Study|Withdrawal by Subject|1
7032978|NCT01657370|11112433|FG003|Overall Study|Withdrawal by Subject|0
7032979|NCT01657370|11112434|FG004|Overall Study|Withdrawal by Subject|0
7032980|NCT01657370|11112435|FG005|Overall Study|Withdrawal by Subject|1
7032981|NCT01657370|11112430|FG000|Overall Study|Physician Decision|2
7032982|NCT01657370|11112431|FG001|Overall Study|Physician Decision|3
7032983|NCT01657370|11112432|FG002|Overall Study|Physician Decision|1
7032984|NCT01657370|11112433|FG003|Overall Study|Physician Decision|2
7032985|NCT01657370|11112434|FG004|Overall Study|Physician Decision|5
7032986|NCT01657370|11112435|FG005|Overall Study|Physician Decision|0
7032987|NCT01657370|11112430|FG000|Overall Study|Lack of Qualifying Event|1
7032988|NCT01657370|11112431|FG001|Overall Study|Lack of Qualifying Event|0
7032989|NCT01657370|11112432|FG002|Overall Study|Lack of Qualifying Event|3
7032990|NCT01657370|11112433|FG003|Overall Study|Lack of Qualifying Event|2
7032991|NCT01657370|11112434|FG004|Overall Study|Lack of Qualifying Event|1
7032992|NCT01657370|11112435|FG005|Overall Study|Lack of Qualifying Event|2
7032993|NCT01657370|11112430|FG000|Overall Study|Adverse Event|0
7032994|NCT01657370|11112431|FG001|Overall Study|Adverse Event|0
7032995|NCT01657370|11112432|FG002|Overall Study|Adverse Event|0
7032996|NCT01657370|11112433|FG003|Overall Study|Adverse Event|0
7032997|NCT01657370|11112434|FG004|Overall Study|Adverse Event|1
7032998|NCT01657370|11112435|FG005|Overall Study|Adverse Event|0
7032999|NCT01657370|11112430|FG000|Overall Study|Protocol Violation|1
7033000|NCT01657370|11112431|FG001|Overall Study|Protocol Violation|1
7033001|NCT01657370|11112432|FG002|Overall Study|Protocol Violation|1
7033002|NCT01657370|11112433|FG003|Overall Study|Protocol Violation|1
7033003|NCT01657370|11112434|FG004|Overall Study|Protocol Violation|0
7033004|NCT01657370|11112435|FG005|Overall Study|Protocol Violation|0
7033005|NCT01657370|11112430|FG000|Overall Study|Lost to Follow-up|2
7033006|NCT01657370|11112431|FG001|Overall Study|Lost to Follow-up|0
7033007|NCT01657370|11112432|FG002|Overall Study|Lost to Follow-up|1
7033008|NCT01657370|11112433|FG003|Overall Study|Lost to Follow-up|0
7033009|NCT01657370|11112434|FG004|Overall Study|Lost to Follow-up|0
7033010|NCT01657370|11112435|FG005|Overall Study|Lost to Follow-up|1
7033011|NCT01657461|11112456|FG000|Overall Study|Death|9
7033012|NCT01657461|11112457|FG001|Overall Study|Death|12
7033013|NCT01657461|11112456|FG000|Overall Study|Lost to Follow-up|0
7033014|NCT01657461|11112457|FG001|Overall Study|Lost to Follow-up|3
7033015|NCT01657461|11112456|FG000|Overall Study|Physician Decision|0
7033016|NCT01657461|11112457|FG001|Overall Study|Physician Decision|2
7033017|NCT01657461|11112456|FG000|Overall Study|Withdrawal by Subject|1
7033018|NCT01657461|11112457|FG001|Overall Study|Withdrawal by Subject|3
7033019|NCT01657760|11112469|FG000|Overall Study|Withdrawal by Subject|0
7033020|NCT01657760|11112470|FG001|Overall Study|Withdrawal by Subject|0
7033021|NCT01657760|11112471|FG002|Overall Study|Withdrawal by Subject|0
7033022|NCT01657760|11112472|FG003|Overall Study|Withdrawal by Subject|1
7033023|NCT01657760|11112469|FG000|Overall Study|Physician Decision|1
7033024|NCT01657760|11112470|FG001|Overall Study|Physician Decision|1
7033025|NCT01657760|11112471|FG002|Overall Study|Physician Decision|1
7033026|NCT01657760|11112472|FG003|Overall Study|Physician Decision|2
7033027|NCT01657799|11112487|FG000|Overall Study|Adverse Event Related to progression|6
7033028|NCT01657799|11112488|FG001|Overall Study|Adverse Event Related to progression|8
7033029|NCT01657799|11112489|FG002|Overall Study|Adverse Event Related to progression|12
7033030|NCT01657799|11112487|FG000|Overall Study|Adverse Event Not Related to Progression|5
7033031|NCT01657799|11112488|FG001|Overall Study|Adverse Event Not Related to Progression|4
7033032|NCT01657799|11112489|FG002|Overall Study|Adverse Event Not Related to Progression|4
7033033|NCT01657799|11112487|FG000|Overall Study|Withdrawal by Subject|13
7033034|NCT01657799|11112488|FG001|Overall Study|Withdrawal by Subject|10
7033035|NCT01657799|11112489|FG002|Overall Study|Withdrawal by Subject|10
7033036|NCT01657799|11112487|FG000|Overall Study|Lost to Follow-up|1
7033037|NCT01657799|11112488|FG001|Overall Study|Lost to Follow-up|0
7033038|NCT01657799|11112489|FG002|Overall Study|Lost to Follow-up|1
7033039|NCT01657799|11112487|FG000|Overall Study|Disease Progression|2
7033040|NCT01657799|11112488|FG001|Overall Study|Disease Progression|4
7033041|NCT01657799|11112489|FG002|Overall Study|Disease Progression|4
7033042|NCT01657799|11112487|FG000|Overall Study|Progressive Disease Clinical|7
7033043|NCT01657799|11112488|FG001|Overall Study|Progressive Disease Clinical|4
7033044|NCT01657799|11112489|FG002|Overall Study|Progressive Disease Clinical|7
7033045|NCT01657799|11112487|FG000|Overall Study|Radiographic & Clinical Progression|16
7033046|NCT01657799|11112488|FG001|Overall Study|Radiographic & Clinical Progression|11
7033047|NCT01657799|11112489|FG002|Overall Study|Radiographic & Clinical Progression|15
7033048|NCT01657799|11112487|FG000|Overall Study|Other|52
7033049|NCT01657799|11112488|FG001|Overall Study|Other|62
7033050|NCT01657799|11112489|FG002|Overall Study|Other|49
7033051|NCT01657877|11112497|FG000|Overall Study|Withdrawal by Subject|4
7033052|NCT01657877|11112497|FG000|Overall Study|Protocol Violation|6
7033053|NCT01657877|11112497|FG000|Overall Study|Adverse Event|2
7033054|NCT01657877|11112497|FG000|Overall Study|Other Reason|2
7033055|NCT01657903|11112514|FG000|Overall Study|Lost to Follow-up|1
7033056|NCT01657903|11112514|FG000|Overall Study|Withdrawal by Subject|1
7033057|NCT01658020|11112527|FG000|Overall Study|Adverse Event|3
7033058|NCT01658020|11112528|FG001|Overall Study|Adverse Event|3
7033059|NCT01658020|11112527|FG000|Overall Study|Lost to Follow-up|1
7033060|NCT01658020|11112528|FG001|Overall Study|Lost to Follow-up|0
7033061|NCT01658020|11112527|FG000|Overall Study|Withdrawal by Subject|4
7033062|NCT01658020|11112528|FG001|Overall Study|Withdrawal by Subject|5
7033063|NCT01658020|11112527|FG000|Overall Study|Protocol Violation|0
7033064|NCT01658020|11112528|FG001|Overall Study|Protocol Violation|1
7033065|NCT01658072|11112544|FG000|Overall Study|Protocol Violation|4
7033066|NCT01658072|11112545|FG001|Overall Study|Protocol Violation|2
7033067|NCT01658150|11112551|FG000|Overall Study|Withdrawal by Subject|1
7033068|NCT01658436|11112565|FG000|Overall Study|Adverse Event|6
7033069|NCT01658436|11112566|FG001|Overall Study|Adverse Event|5
7033070|NCT01658436|11112565|FG000|Overall Study|Physician Decision|1
7033071|NCT01658436|11112566|FG001|Overall Study|Physician Decision|0
7033072|NCT01658436|11112565|FG000|Overall Study|Progressive disease|12
7033073|NCT01658436|11112566|FG001|Overall Study|Progressive disease|4
7033074|NCT01658436|11112565|FG000|Overall Study|Study terminated by sponsor|0
7033075|NCT01658436|11112566|FG001|Overall Study|Study terminated by sponsor|1
7033076|NCT01658436|11112565|FG000|Overall Study|Subject/guardian decision|0
7033077|NCT01658436|11112566|FG001|Overall Study|Subject/guardian decision|1
7033078|NCT01658436|11112565|FG000|Overall Study|Death|1
7033079|NCT01658436|11112566|FG001|Overall Study|Death|0
7033080|NCT01658514|11112575|FG000|Overall Study|Protocol Violation|1
7033081|NCT01658514|11112576|FG001|Overall Study|Protocol Violation|0
7033082|NCT01658514|11112577|FG002|Overall Study|Protocol Violation|2
7033083|NCT01658579|11112588|FG000|Treatment Period A|Other|0
7033084|NCT01658579|11112589|FG001|Treatment Period A|Other|0
7033085|NCT01658579|11112590|FG002|Treatment Period A|Other|1
7033086|NCT01658579|11112591|FG003|Treatment Period A|Other|1
7033087|NCT01658579|11112588|FG000|Treatment Period A|Adverse Event|1
7033088|NCT01658579|11112589|FG001|Treatment Period A|Adverse Event|0
7033089|NCT01658579|11112590|FG002|Treatment Period A|Adverse Event|0
7033090|NCT01658579|11112591|FG003|Treatment Period A|Adverse Event|0
7033091|NCT01658579|11112588|FG000|Treatment Period B|Other|0
7033092|NCT01658579|11112589|FG001|Treatment Period B|Other|0
7033093|NCT01658579|11112590|FG002|Treatment Period B|Other|0
7033094|NCT01658579|11112591|FG003|Treatment Period B|Other|1
7033095|NCT01658735|11112609|FG000|Overall Study|Lack of Efficacy|1
7033096|NCT01658735|11112610|FG001|Overall Study|Lack of Efficacy|0
7033097|NCT01658735|11112611|FG002|Overall Study|Lack of Efficacy|1
7033098|NCT01658735|11112609|FG000|Overall Study|Lost to Follow-up|1
7033099|NCT01658735|11112610|FG001|Overall Study|Lost to Follow-up|1
7033100|NCT01658735|11112611|FG002|Overall Study|Lost to Follow-up|0
7033101|NCT01658735|11112609|FG000|Overall Study|Protocol Violation|0
7033102|NCT01658735|11112610|FG001|Overall Study|Protocol Violation|1
7033103|NCT01658735|11112611|FG002|Overall Study|Protocol Violation|0
7033104|NCT01658735|11112609|FG000|Overall Study|Withdrawal by Subject|3
7033105|NCT01658735|11112610|FG001|Overall Study|Withdrawal by Subject|5
7033106|NCT01658735|11112611|FG002|Overall Study|Withdrawal by Subject|3
7033107|NCT01658904|11112626|FG000|Overall Study|Principal Investigator discretion|2
7033108|NCT01658904|11112627|FG001|Overall Study|Principal Investigator discretion|0
7033109|NCT01658904|11112628|FG002|Overall Study|Principal Investigator discretion|0
7033110|NCT01658943|11112641|FG000|Overall Study|Adverse Event|6
7033111|NCT01658943|11112642|FG001|Overall Study|Adverse Event|13
7033112|NCT01658943|11112641|FG000|Overall Study|Withdrawal by Subject|9
7033113|NCT01658943|11112642|FG001|Overall Study|Withdrawal by Subject|2
7033114|NCT01658943|11112641|FG000|Overall Study|Progression/Relapse|39
7033115|NCT01658943|11112642|FG001|Overall Study|Progression/Relapse|40
7033116|NCT01658943|11112641|FG000|Overall Study|Death|4
7033117|NCT01658943|11112642|FG001|Overall Study|Death|2
7033118|NCT01658943|11112641|FG000|Overall Study|not protocol specified|4
7033119|NCT01658943|11112642|FG001|Overall Study|not protocol specified|1
7033120|NCT01658943|11112641|FG000|Overall Study|Not eligible|7
7033121|NCT01658943|11112642|FG001|Overall Study|Not eligible|9
7033122|NCT01658943|11112641|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1
7033123|NCT01658943|11112642|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0
7033124|NCT01659021|11112659|FG000|Main Study|Adverse Event|2
7033125|NCT01659021|11112660|FG001|Main Study|Adverse Event|3
7033126|NCT01659021|11112659|FG000|Main Study|Lost to Follow-up|1
7033127|NCT01659021|11112660|FG001|Main Study|Lost to Follow-up|0
7033128|NCT01659021|11112659|FG000|Main Study|Unknown Reasons|2
7033129|NCT01659021|11112660|FG001|Main Study|Unknown Reasons|1
7033130|NCT01659021|11112659|FG000|Main Study|Physician Decision|34
7033131|NCT01659021|11112660|FG001|Main Study|Physician Decision|16
7033132|NCT01659021|11112659|FG000|Main Study|Withdrawal by Subject|19
7033133|NCT01659021|11112660|FG001|Main Study|Withdrawal by Subject|16
7033134|NCT01659021|11112659|FG000|Main Study|Study Terminated by Sponsor|16
7033135|NCT01659021|11112660|FG001|Main Study|Study Terminated by Sponsor|1
7033136|NCT01659021|11112659|FG000|Long-Term Follow Up|Lost to Follow-up|3
7033137|NCT01659021|11112660|FG001|Long-Term Follow Up|Lost to Follow-up|3
7033138|NCT01659021|11112659|FG000|Long-Term Follow Up|Withdrawal by Subject|2
7033139|NCT01659021|11112660|FG001|Long-Term Follow Up|Withdrawal by Subject|1
7033140|NCT01659125|11112670|FG000|Overall Study|Withdrawal by Subject|2
7033141|NCT01659125|11112670|FG000|Overall Study|Lost to Follow-up|7
7033142|NCT01659125|11112670|FG000|Overall Study|Technical Problem|1
7033143|NCT01659125|11112670|FG000|Overall Study|Time Constraints|2
7033144|NCT01659125|11112670|FG000|Overall Study|Failed to Start Treatment|2
7033145|NCT01659255|11112691|FG000|Overall Study|Adverse Event|0
7033146|NCT01659255|11112692|FG001|Overall Study|Adverse Event|0
7033147|NCT01659255|11112693|FG002|Overall Study|Adverse Event|0
7033148|NCT01659255|11112694|FG003|Overall Study|Adverse Event|0
7033149|NCT01659255|11112695|FG004|Overall Study|Adverse Event|0
7033150|NCT01659255|11112696|FG005|Overall Study|Adverse Event|1
7033151|NCT01659255|11112697|FG006|Overall Study|Adverse Event|1
7033152|NCT01659255|11112698|FG007|Overall Study|Adverse Event|0
7033153|NCT01659255|11112699|FG008|Overall Study|Adverse Event|0
7033154|NCT01659255|11112700|FG009|Overall Study|Adverse Event|1
7033155|NCT01659255|11112701|FG010|Overall Study|Adverse Event|0
7033156|NCT01659255|11112702|FG011|Overall Study|Adverse Event|1
7033157|NCT01659255|11112703|FG012|Overall Study|Adverse Event|0
7033158|NCT01659255|11112704|FG013|Overall Study|Adverse Event|2
7033159|NCT01659255|11112705|FG014|Overall Study|Adverse Event|0
7033160|NCT01659255|11112706|FG015|Overall Study|Adverse Event|1
7033161|NCT01659255|11112707|FG016|Overall Study|Adverse Event|0
7033162|NCT01659255|11112691|FG000|Overall Study|Death|0
7033163|NCT01659255|11112692|FG001|Overall Study|Death|1
7033164|NCT01659255|11112693|FG002|Overall Study|Death|0
7033165|NCT01659255|11112694|FG003|Overall Study|Death|0
7033166|NCT01659255|11112695|FG004|Overall Study|Death|0
7033167|NCT01659255|11112696|FG005|Overall Study|Death|0
7033168|NCT01659255|11112697|FG006|Overall Study|Death|0
7033169|NCT01659255|11112698|FG007|Overall Study|Death|1
7033170|NCT01659255|11112699|FG008|Overall Study|Death|1
7033171|NCT01659255|11112700|FG009|Overall Study|Death|0
7033172|NCT01659255|11112701|FG010|Overall Study|Death|0
7033173|NCT01659255|11112702|FG011|Overall Study|Death|0
7033174|NCT01659255|11112703|FG012|Overall Study|Death|1
7033175|NCT01659255|11112704|FG013|Overall Study|Death|1
7033176|NCT01659255|11112705|FG014|Overall Study|Death|2
7033177|NCT01659255|11112706|FG015|Overall Study|Death|1
7033178|NCT01659255|11112707|FG016|Overall Study|Death|0
7033179|NCT01659255|11112691|FG000|Overall Study|Progressive Disease|2
7033180|NCT01659255|11112692|FG001|Overall Study|Progressive Disease|0
7033181|NCT01659255|11112693|FG002|Overall Study|Progressive Disease|0
7033182|NCT01659255|11112694|FG003|Overall Study|Progressive Disease|0
7033183|NCT01659255|11112695|FG004|Overall Study|Progressive Disease|0
7033184|NCT01659255|11112696|FG005|Overall Study|Progressive Disease|0
7033185|NCT01659255|11112697|FG006|Overall Study|Progressive Disease|0
7033186|NCT01659255|11112698|FG007|Overall Study|Progressive Disease|1
7033187|NCT01659255|11112699|FG008|Overall Study|Progressive Disease|0
7033188|NCT01659255|11112700|FG009|Overall Study|Progressive Disease|2
7033189|NCT01659255|11112701|FG010|Overall Study|Progressive Disease|2
7033190|NCT01659255|11112702|FG011|Overall Study|Progressive Disease|3
7033191|NCT01659255|11112703|FG012|Overall Study|Progressive Disease|5
7033192|NCT01659255|11112704|FG013|Overall Study|Progressive Disease|13
7033193|NCT01659255|11112705|FG014|Overall Study|Progressive Disease|6
7033194|NCT01659255|11112706|FG015|Overall Study|Progressive Disease|2
7033195|NCT01659255|11112707|FG016|Overall Study|Progressive Disease|3
7033196|NCT01659255|11112691|FG000|Overall Study|Withdrew Consent|0
7033197|NCT01659255|11112692|FG001|Overall Study|Withdrew Consent|0
7033198|NCT01659255|11112693|FG002|Overall Study|Withdrew Consent|0
7033199|NCT01659255|11112694|FG003|Overall Study|Withdrew Consent|0
7033200|NCT01659255|11112695|FG004|Overall Study|Withdrew Consent|0
7033201|NCT01659255|11112696|FG005|Overall Study|Withdrew Consent|0
7033202|NCT01659255|11112697|FG006|Overall Study|Withdrew Consent|0
7033203|NCT01659255|11112698|FG007|Overall Study|Withdrew Consent|0
7033204|NCT01659255|11112699|FG008|Overall Study|Withdrew Consent|0
7033205|NCT01659255|11112700|FG009|Overall Study|Withdrew Consent|0
7033206|NCT01659255|11112701|FG010|Overall Study|Withdrew Consent|1
7033207|NCT01659255|11112702|FG011|Overall Study|Withdrew Consent|0
7033208|NCT01659255|11112703|FG012|Overall Study|Withdrew Consent|0
7033209|NCT01659255|11112704|FG013|Overall Study|Withdrew Consent|1
7033210|NCT01659255|11112705|FG014|Overall Study|Withdrew Consent|0
7033211|NCT01659255|11112706|FG015|Overall Study|Withdrew Consent|0
7033212|NCT01659255|11112707|FG016|Overall Study|Withdrew Consent|0
7033213|NCT01659255|11112691|FG000|Overall Study|Investigator Decision|0
7033214|NCT01659255|11112692|FG001|Overall Study|Investigator Decision|0
7033215|NCT01659255|11112693|FG002|Overall Study|Investigator Decision|0
7033216|NCT01659255|11112694|FG003|Overall Study|Investigator Decision|0
7033217|NCT01659255|11112695|FG004|Overall Study|Investigator Decision|0
7033218|NCT01659255|11112696|FG005|Overall Study|Investigator Decision|0
7033219|NCT01659255|11112697|FG006|Overall Study|Investigator Decision|0
7033220|NCT01659255|11112698|FG007|Overall Study|Investigator Decision|0
7033221|NCT01659255|11112699|FG008|Overall Study|Investigator Decision|0
7033222|NCT01659255|11112700|FG009|Overall Study|Investigator Decision|0
7033223|NCT01659255|11112701|FG010|Overall Study|Investigator Decision|0
7033224|NCT01659255|11112702|FG011|Overall Study|Investigator Decision|0
7033225|NCT01659255|11112703|FG012|Overall Study|Investigator Decision|1
7033226|NCT01659255|11112704|FG013|Overall Study|Investigator Decision|1
7033227|NCT01659255|11112705|FG014|Overall Study|Investigator Decision|0
7033228|NCT01659255|11112706|FG015|Overall Study|Investigator Decision|0
7033229|NCT01659255|11112707|FG016|Overall Study|Investigator Decision|0
7033230|NCT01659255|11112691|FG000|Overall Study|Sponsor's Decision|0
7033231|NCT01659255|11112692|FG001|Overall Study|Sponsor's Decision|0
7033232|NCT01659255|11112693|FG002|Overall Study|Sponsor's Decision|0
7033233|NCT01659255|11112694|FG003|Overall Study|Sponsor's Decision|0
7033234|NCT01659255|11112695|FG004|Overall Study|Sponsor's Decision|0
7033235|NCT01659255|11112696|FG005|Overall Study|Sponsor's Decision|0
7033236|NCT01659255|11112697|FG006|Overall Study|Sponsor's Decision|1
7033237|NCT01659255|11112698|FG007|Overall Study|Sponsor's Decision|0
7033238|NCT01659255|11112699|FG008|Overall Study|Sponsor's Decision|0
7033239|NCT01659255|11112700|FG009|Overall Study|Sponsor's Decision|0
7033240|NCT01659255|11112701|FG010|Overall Study|Sponsor's Decision|0
7033241|NCT01659255|11112702|FG011|Overall Study|Sponsor's Decision|0
7033242|NCT01659255|11112703|FG012|Overall Study|Sponsor's Decision|0
7033243|NCT01659255|11112704|FG013|Overall Study|Sponsor's Decision|0
7033244|NCT01659255|11112705|FG014|Overall Study|Sponsor's Decision|0
7033245|NCT01659255|11112706|FG015|Overall Study|Sponsor's Decision|0
7033246|NCT01659255|11112707|FG016|Overall Study|Sponsor's Decision|0
7033247|NCT01659255|11112691|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0
7033248|NCT01659255|11112692|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0
7033249|NCT01659255|11112693|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0
7033250|NCT01659255|11112694|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0
7033251|NCT01659255|11112695|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0
7033252|NCT01659255|11112696|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0
7033253|NCT01659255|11112697|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0
7033254|NCT01659255|11112698|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0
7033255|NCT01659255|11112699|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0
7033256|NCT01659255|11112700|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0
7033257|NCT01659255|11112701|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0
7033258|NCT01659255|11112702|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0
7033259|NCT01659255|11112703|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0
7033260|NCT01659255|11112704|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0
7033261|NCT01659255|11112705|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0
7033262|NCT01659255|11112706|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1
7033263|NCT01659255|11112707|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0
7033264|NCT01659255|11112691|FG000|Overall Study|Participant Went on to Have an Allograft|0
7033265|NCT01659255|11112692|FG001|Overall Study|Participant Went on to Have an Allograft|0
7033266|NCT01659255|11112693|FG002|Overall Study|Participant Went on to Have an Allograft|0
7033267|NCT01659255|11112694|FG003|Overall Study|Participant Went on to Have an Allograft|0
7033268|NCT01659255|11112695|FG004|Overall Study|Participant Went on to Have an Allograft|0
7033269|NCT01659255|11112696|FG005|Overall Study|Participant Went on to Have an Allograft|0
7033270|NCT01659255|11112697|FG006|Overall Study|Participant Went on to Have an Allograft|0
7033271|NCT01659255|11112698|FG007|Overall Study|Participant Went on to Have an Allograft|0
7033272|NCT01659255|11112699|FG008|Overall Study|Participant Went on to Have an Allograft|0
7033273|NCT01659255|11112700|FG009|Overall Study|Participant Went on to Have an Allograft|0
7033274|NCT01659255|11112701|FG010|Overall Study|Participant Went on to Have an Allograft|0
7033275|NCT01659255|11112702|FG011|Overall Study|Participant Went on to Have an Allograft|0
7033276|NCT01659255|11112703|FG012|Overall Study|Participant Went on to Have an Allograft|1
7033277|NCT01659255|11112704|FG013|Overall Study|Participant Went on to Have an Allograft|0
7033278|NCT01659255|11112705|FG014|Overall Study|Participant Went on to Have an Allograft|0
7033279|NCT01659255|11112706|FG015|Overall Study|Participant Went on to Have an Allograft|0
7033280|NCT01659255|11112707|FG016|Overall Study|Participant Went on to Have an Allograft|0
7033281|NCT01659320|11112754|FG000|Overall Study|Withdrawal by Subject|2
7033282|NCT01659320|11112754|FG000|Overall Study|Physician Decision|1
7033283|NCT01659567|11112758|FG000|Overall Study|Lack of Efficacy|22
7033284|NCT01659567|11112758|FG000|Overall Study|Switched to Pegferon|6
7033285|NCT01659567|11112758|FG000|Overall Study|Adverse Event|12
7033286|NCT01659567|11112758|FG000|Overall Study|Good result at early stage of treatment|5
7033287|NCT01659567|11112758|FG000|Overall Study|Withdrawal by Subject|64
7033288|NCT01659567|11112758|FG000|Overall Study|Progression of the main disease|1
7033289|NCT01659567|11112758|FG000|Overall Study|Other|13
7033290|NCT01659736|11112764|FG000|Treatment Period|Adverse Event|1
7033291|NCT01659736|11112765|FG001|Treatment Period|Adverse Event|1
7033292|NCT01659736|11112764|FG000|Treatment Period|Protocol Violation|3
7033293|NCT01659736|11112765|FG001|Treatment Period|Protocol Violation|1
7033294|NCT01659736|11112764|FG000|Treatment Period|Withdrawal by Subject|1
7033295|NCT01659736|11112765|FG001|Treatment Period|Withdrawal by Subject|0
7033296|NCT01659736|11112764|FG000|3-month Follow-up|Lost to Follow-up|0
7033297|NCT01659736|11112765|FG001|3-month Follow-up|Lost to Follow-up|1
7033298|NCT01659853|11112773|FG000|Washout , 3 to 7 Days|Adverse Event|1
7033299|NCT01659853|11112774|FG001|Washout , 3 to 7 Days|Adverse Event|0
7033300|NCT01659853|11112773|FG000|Washout , 3 to 7 Days|Protocol Violation|1
7033301|NCT01659853|11112774|FG001|Washout , 3 to 7 Days|Protocol Violation|0
7033302|NCT01659996|11112794|FG000|Overall Study|Protocol Violation|3
7033303|NCT01659996|11112795|FG001|Overall Study|Protocol Violation|3
7033304|NCT01659996|11112796|FG002|Overall Study|Protocol Violation|3
7033305|NCT01659996|11112794|FG000|Overall Study|Lost to Follow-up|1
7033306|NCT01659996|11112795|FG001|Overall Study|Lost to Follow-up|3
7033307|NCT01659996|11112796|FG002|Overall Study|Lost to Follow-up|2
7033308|NCT01659996|11112794|FG000|Overall Study|Adverse Event|0
7033309|NCT01659996|11112795|FG001|Overall Study|Adverse Event|0
7033310|NCT01659996|11112796|FG002|Overall Study|Adverse Event|1
7033311|NCT01659996|11112794|FG000|Overall Study|Withdrawal by Subject|4
7033312|NCT01659996|11112795|FG001|Overall Study|Withdrawal by Subject|1
7033313|NCT01659996|11112796|FG002|Overall Study|Withdrawal by Subject|5
7033314|NCT01660022|11112812|FG000|First Sequence (7 Days)|Withdrawal by Subject|0
7033315|NCT01660022|11112813|FG001|First Sequence (7 Days)|Withdrawal by Subject|1
7033316|NCT01660022|11112814|FG002|First Sequence (7 Days)|Withdrawal by Subject|0
7033317|NCT01660022|11112815|FG003|First Sequence (7 Days)|Withdrawal by Subject|1
7033318|NCT01660022|11112816|FG004|First Sequence (7 Days)|Withdrawal by Subject|0
7033319|NCT01660022|11112817|FG005|First Sequence (7 Days)|Withdrawal by Subject|0
7033320|NCT01660022|11112812|FG000|First Sequence (7 Days)|Adverse Event|0
7033321|NCT01660022|11112813|FG001|First Sequence (7 Days)|Adverse Event|0
7033322|NCT01660022|11112814|FG002|First Sequence (7 Days)|Adverse Event|0
7033323|NCT01660022|11112815|FG003|First Sequence (7 Days)|Adverse Event|0
7033324|NCT01660022|11112816|FG004|First Sequence (7 Days)|Adverse Event|1
7033325|NCT01660022|11112817|FG005|First Sequence (7 Days)|Adverse Event|3
7033326|NCT01660022|11112812|FG000|First Sequence (7 Days)|Protocol Violation|0
7033327|NCT01660022|11112813|FG001|First Sequence (7 Days)|Protocol Violation|0
7033328|NCT01660022|11112814|FG002|First Sequence (7 Days)|Protocol Violation|0
7033329|NCT01660022|11112815|FG003|First Sequence (7 Days)|Protocol Violation|0
7033330|NCT01660022|11112816|FG004|First Sequence (7 Days)|Protocol Violation|0
7033331|NCT01660022|11112817|FG005|First Sequence (7 Days)|Protocol Violation|1
7033332|NCT01660256|11112909|FG000|Overall Study|Adverse Event|4
7033333|NCT01660256|11112910|FG001|Overall Study|Adverse Event|0
7033334|NCT01660256|11112911|FG002|Overall Study|Adverse Event|2
7033335|NCT01660256|11112909|FG000|Overall Study|Withdrawal by Subject|1
7033336|NCT01660256|11112910|FG001|Overall Study|Withdrawal by Subject|0
7033337|NCT01660256|11112911|FG002|Overall Study|Withdrawal by Subject|2
7033338|NCT01660334|11112923|FG000|Overall Study|Lost to Follow-up|1
7033339|NCT01660412|11112927|FG000|Overall Study|Protocol Violation|0
7033340|NCT01660412|11112928|FG001|Overall Study|Protocol Violation|3
7033341|NCT01660711|11112948|FG000|Overall Study|Adverse Event|7
7033342|NCT01660711|11112948|FG000|Overall Study|Withdrawal by Subject|1
7033343|NCT01660763|11112958|FG000|Overall Study|Lack of Efficacy|45
7033344|NCT01660763|11112959|FG001|Overall Study|Lack of Efficacy|50
7033345|NCT01660763|11112958|FG000|Overall Study|Adverse Event|22
7033346|NCT01660763|11112959|FG001|Overall Study|Adverse Event|7
7033347|NCT01660763|11112958|FG000|Overall Study|Protocol Violation|1
7033348|NCT01660763|11112959|FG001|Overall Study|Protocol Violation|0
7033349|NCT01660763|11112958|FG000|Overall Study|Withdrawal by Subject|4
7033350|NCT01660763|11112959|FG001|Overall Study|Withdrawal by Subject|0
7033351|NCT01660763|11112958|FG000|Overall Study|Patient ready for early discharge|28
7033352|NCT01660763|11112959|FG001|Overall Study|Patient ready for early discharge|4
7033353|NCT01660906|11112992|FG000|Overall Study|Discontinued due to study drug toxicity|3
7033354|NCT01661062|11112996|FG000|Overall Study|Completed Treatment Off Study|3
7033355|NCT01661062|11112996|FG000|Overall Study|Withdrawal by Subject|2
7033356|NCT01661140|11113008|FG000|Open-Label Period|Adverse Event|44
7033357|NCT01661140|11113009|FG001|Open-Label Period|Adverse Event|0
7033358|NCT01661140|11113010|FG002|Open-Label Period|Adverse Event|0
7033359|NCT01661140|11113008|FG000|Open-Label Period|Protocol Violation|3
7033360|NCT01661140|11113009|FG001|Open-Label Period|Protocol Violation|0
7033361|NCT01661140|11113010|FG002|Open-Label Period|Protocol Violation|0
7033362|NCT01661140|11113008|FG000|Open-Label Period|Withdrawal by Subject|5
7033363|NCT01661140|11113009|FG001|Open-Label Period|Withdrawal by Subject|0
7033364|NCT01661140|11113010|FG002|Open-Label Period|Withdrawal by Subject|0
7033365|NCT01661140|11113008|FG000|Open-Label Period|Investigator Decision|3
7033366|NCT01661140|11113009|FG001|Open-Label Period|Investigator Decision|0
7033367|NCT01661140|11113010|FG002|Open-Label Period|Investigator Decision|0
7033368|NCT01661140|11113008|FG000|Open-Label Period|Death|1
7033369|NCT01661140|11113009|FG001|Open-Label Period|Death|0
7033370|NCT01661140|11113010|FG002|Open-Label Period|Death|0
7033371|NCT01661140|11113008|FG000|Open-Label Period|Administrative/Other|1
7033372|NCT01661140|11113009|FG001|Open-Label Period|Administrative/Other|0
7033373|NCT01661140|11113010|FG002|Open-Label Period|Administrative/Other|0
7033374|NCT01661140|11113008|FG000|Open-Label Period|Sponsor termination|16
7033375|NCT01661140|11113009|FG001|Open-Label Period|Sponsor termination|0
7033376|NCT01661140|11113010|FG002|Open-Label Period|Sponsor termination|0
7033377|NCT01661140|11113008|FG000|Open-Label Period|Did not meet EULAR criteria|1
7033378|NCT01661140|11113009|FG001|Open-Label Period|Did not meet EULAR criteria|0
7033379|NCT01661140|11113010|FG002|Open-Label Period|Did not meet EULAR criteria|0
7033380|NCT01661140|11113008|FG000|Open-Label Period|Lost to Follow-up|2
7033381|NCT01661140|11113009|FG001|Open-Label Period|Lost to Follow-up|0
7033382|NCT01661140|11113010|FG002|Open-Label Period|Lost to Follow-up|0
7033383|NCT01661140|11113008|FG000|Double-Blind Period|Refused Treatment|0
7033384|NCT01661140|11113009|FG001|Double-Blind Period|Refused Treatment|0
7033385|NCT01661140|11113010|FG002|Double-Blind Period|Refused Treatment|1
7033386|NCT01661140|11113008|FG000|Double-Blind Period|Adverse Event|0
7033387|NCT01661140|11113009|FG001|Double-Blind Period|Adverse Event|16
7033388|NCT01661140|11113010|FG002|Double-Blind Period|Adverse Event|18
7033389|NCT01661140|11113008|FG000|Double-Blind Period|Protocol Violation|0
7033390|NCT01661140|11113009|FG001|Double-Blind Period|Protocol Violation|2
7033391|NCT01661140|11113010|FG002|Double-Blind Period|Protocol Violation|3
7033392|NCT01661140|11113008|FG000|Double-Blind Period|Withdrawal by Subject|0
7033393|NCT01661140|11113009|FG001|Double-Blind Period|Withdrawal by Subject|1
7033394|NCT01661140|11113010|FG002|Double-Blind Period|Withdrawal by Subject|3
7033395|NCT01661140|11113008|FG000|Double-Blind Period|Investigator's Decision|0
7033396|NCT01661140|11113009|FG001|Double-Blind Period|Investigator's Decision|1
7033397|NCT01661140|11113010|FG002|Double-Blind Period|Investigator's Decision|2
7033398|NCT01661140|11113008|FG000|Double-Blind Period|Sponsor Termination|0
7033399|NCT01661140|11113009|FG001|Double-Blind Period|Sponsor Termination|14
7033400|NCT01661140|11113010|FG002|Double-Blind Period|Sponsor Termination|17
7033401|NCT01661140|11113008|FG000|Double-Blind Period|Administrative/Other|0
7033402|NCT01661140|11113009|FG001|Double-Blind Period|Administrative/Other|7
7033403|NCT01661140|11113010|FG002|Double-Blind Period|Administrative/Other|6
7033404|NCT01661179|11113018|FG000|Overall Study|Death|1
7033405|NCT01661179|11113018|FG000|Overall Study|Withdrawal by Subject|1
7033406|NCT01661179|11113018|FG000|Overall Study|Other Eligibility criteria|4
7033407|NCT01661205|11113022|FG000|Overall Study|Physician Decision|2
7033408|NCT01661595|11113044|FG000|Phase 1: Week 0-4|Adverse Event|1
7033409|NCT01661595|11113045|FG001|Phase 1: Week 0-4|Adverse Event|0
7033410|NCT01661595|11113046|FG002|Phase 1: Week 0-4|Adverse Event|0
7033411|NCT01661595|11113047|FG003|Phase 1: Week 0-4|Adverse Event|0
7033412|NCT01661595|11113044|FG000|Phase 2: Week 5-8.|Protocol Violation|0
7033413|NCT01661595|11113045|FG001|Phase 2: Week 5-8.|Protocol Violation|0
7033414|NCT01661595|11113046|FG002|Phase 2: Week 5-8.|Protocol Violation|1
7033415|NCT01661595|11113047|FG003|Phase 2: Week 5-8.|Protocol Violation|0
7033416|NCT01661686|11113075|FG000|Overall Study|Lost to Follow-up|2
7033417|NCT01661686|11113076|FG001|Overall Study|Lost to Follow-up|1
7033418|NCT01661686|11113075|FG000|Overall Study|did not receive allocated intervention|0
7033419|NCT01661686|11113076|FG001|Overall Study|did not receive allocated intervention|1
7033420|NCT01661790|11113124|FG000|Overall Study|Lost to Follow-up|0
7033421|NCT01661790|11113125|FG001|Overall Study|Lost to Follow-up|2
7033422|NCT01661933|11113131|FG000|Low-dose Gluten Challenge|Physician Decision|2
7033423|NCT01661933|11113131|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2
7033424|NCT01661972|11113148|FG000|Overall Study|Adverse Event|1
7033425|NCT01661972|11113149|FG001|Overall Study|Adverse Event|2
7033426|NCT01661972|11113148|FG000|Overall Study|Death during Treatment period|1
7033427|NCT01661972|11113149|FG001|Overall Study|Death during Treatment period|1
7033428|NCT01661972|11113148|FG000|Overall Study|Withdrawal by Subject|0
7033429|NCT01661972|11113149|FG001|Overall Study|Withdrawal by Subject|1
7033430|NCT01662024|11113157|FG000|Overall Study|Pregnancy|2
7033431|NCT01662024|11113157|FG000|Overall Study|Withdrawal by Subject|3
7033432|NCT01662063|11113166|FG000|Overall Study|Adverse Event or Intercurrent Illness|1
7033433|NCT01662063|11113167|FG001|Overall Study|Adverse Event or Intercurrent Illness|12
7033434|NCT01662063|11113168|FG002|Overall Study|Adverse Event or Intercurrent Illness|0
7033435|NCT01662063|11113166|FG000|Overall Study|Lack of Efficacy|1
7033436|NCT01662063|11113167|FG001|Overall Study|Lack of Efficacy|6
7033437|NCT01662063|11113168|FG002|Overall Study|Lack of Efficacy|0
7033438|NCT01662063|11113166|FG000|Overall Study|Lost to Follow-up|0
7033439|NCT01662063|11113167|FG001|Overall Study|Lost to Follow-up|4
7033440|NCT01662063|11113168|FG002|Overall Study|Lost to Follow-up|0
7033441|NCT01662063|11113166|FG000|Overall Study|Protocol Violation|1
7033442|NCT01662063|11113167|FG001|Overall Study|Protocol Violation|0
7033443|NCT01662063|11113168|FG002|Overall Study|Protocol Violation|0
7033444|NCT01662063|11113166|FG000|Overall Study|Withdrawal by Subject|2
7033445|NCT01662063|11113167|FG001|Overall Study|Withdrawal by Subject|4
7033446|NCT01662063|11113168|FG002|Overall Study|Withdrawal by Subject|1
7033447|NCT01662063|11113166|FG000|Overall Study|Physician Decision|0
7033448|NCT01662063|11113167|FG001|Overall Study|Physician Decision|2
7033449|NCT01662063|11113168|FG002|Overall Study|Physician Decision|0
7033450|NCT01662063|11113166|FG000|Overall Study|Other|0
7033451|NCT01662063|11113167|FG001|Overall Study|Other|1
7033452|NCT01662063|11113168|FG002|Overall Study|Other|0
7033453|NCT01662310|11113198|FG000|Run-In or Stabilization Phase|Adverse Event|11
7033454|NCT01662310|11113199|FG001|Run-In or Stabilization Phase|Adverse Event|0
7033455|NCT01662310|11113200|FG002|Run-In or Stabilization Phase|Adverse Event|0
7033456|NCT01662310|11113201|FG003|Run-In or Stabilization Phase|Adverse Event|0
7033457|NCT01662310|11113202|FG004|Run-In or Stabilization Phase|Adverse Event|0
7033458|NCT01662310|11113198|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9
7033459|NCT01662310|11113199|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0
7033460|NCT01662310|11113200|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0
7033461|NCT01662310|11113201|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0
7033462|NCT01662310|11113202|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0
7033463|NCT01662310|11113198|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4
7033464|NCT01662310|11113199|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0
7033465|NCT01662310|11113200|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0
7033466|NCT01662310|11113201|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0
7033467|NCT01662310|11113202|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0
7033468|NCT01662310|11113198|FG000|Run-In or Stabilization Phase|Protocol Violation|15
7033469|NCT01662310|11113199|FG001|Run-In or Stabilization Phase|Protocol Violation|0
7033470|NCT01662310|11113200|FG002|Run-In or Stabilization Phase|Protocol Violation|0
7033471|NCT01662310|11113201|FG003|Run-In or Stabilization Phase|Protocol Violation|0
7033472|NCT01662310|11113202|FG004|Run-In or Stabilization Phase|Protocol Violation|0
7033473|NCT01662310|11113198|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25
7033474|NCT01662310|11113199|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0
7033475|NCT01662310|11113200|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0
7033476|NCT01662310|11113201|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0
7033477|NCT01662310|11113202|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0
7033478|NCT01662310|11113198|FG000|Run-In or Stabilization Phase|Other|1
7033479|NCT01662310|11113199|FG001|Run-In or Stabilization Phase|Other|0
7033480|NCT01662310|11113200|FG002|Run-In or Stabilization Phase|Other|0
7033481|NCT01662310|11113201|FG003|Run-In or Stabilization Phase|Other|0
7033482|NCT01662310|11113202|FG004|Run-In or Stabilization Phase|Other|0
7033483|NCT01662310|11113198|FG000|Double-Blind Phase|Adverse Event|0
7033484|NCT01662310|11113199|FG001|Double-Blind Phase|Adverse Event|0
7033485|NCT01662310|11113200|FG002|Double-Blind Phase|Adverse Event|1
7033486|NCT01662310|11113201|FG003|Double-Blind Phase|Adverse Event|0
7033487|NCT01662310|11113202|FG004|Double-Blind Phase|Adverse Event|0
7033488|NCT01662310|11113198|FG000|Double-Blind Phase|Lost to Follow-up|0
7033489|NCT01662310|11113199|FG001|Double-Blind Phase|Lost to Follow-up|3
7033490|NCT01662310|11113200|FG002|Double-Blind Phase|Lost to Follow-up|0
7033491|NCT01662310|11113201|FG003|Double-Blind Phase|Lost to Follow-up|0
7033492|NCT01662310|11113202|FG004|Double-Blind Phase|Lost to Follow-up|0
7033493|NCT01662310|11113198|FG000|Double-Blind Phase|Pregnancy|0
7033494|NCT01662310|11113199|FG001|Double-Blind Phase|Pregnancy|2
7033495|NCT01662310|11113200|FG002|Double-Blind Phase|Pregnancy|0
7033496|NCT01662310|11113201|FG003|Double-Blind Phase|Pregnancy|0
7033497|NCT01662310|11113202|FG004|Double-Blind Phase|Pregnancy|0
7033498|NCT01662310|11113198|FG000|Double-Blind Phase|Withdrawal by Subject|0
7033499|NCT01662310|11113199|FG001|Double-Blind Phase|Withdrawal by Subject|9
7033500|NCT01662310|11113200|FG002|Double-Blind Phase|Withdrawal by Subject|3
7033501|NCT01662310|11113201|FG003|Double-Blind Phase|Withdrawal by Subject|0
7033502|NCT01662310|11113202|FG004|Double-Blind Phase|Withdrawal by Subject|0
7033503|NCT01662310|11113198|FG000|Double-Blind Phase|Other|0
7033504|NCT01662310|11113199|FG001|Double-Blind Phase|Other|0
7033505|NCT01662310|11113200|FG002|Double-Blind Phase|Other|1
7033506|NCT01662310|11113201|FG003|Double-Blind Phase|Other|0
7033507|NCT01662310|11113202|FG004|Double-Blind Phase|Other|0
7033508|NCT01662310|11113198|FG000|Double-Blind Phase|Randomized but not treated|0
7033509|NCT01662310|11113199|FG001|Double-Blind Phase|Randomized but not treated|1
7033510|NCT01662310|11113200|FG002|Double-Blind Phase|Randomized but not treated|0
7033511|NCT01662310|11113201|FG003|Double-Blind Phase|Randomized but not treated|0
7033512|NCT01662310|11113202|FG004|Double-Blind Phase|Randomized but not treated|0
7033513|NCT01662310|11113198|FG000|Open-Label Extension Phase|Adverse Event|0
7033514|NCT01662310|11113199|FG001|Open-Label Extension Phase|Adverse Event|0
7033515|NCT01662310|11113200|FG002|Open-Label Extension Phase|Adverse Event|0
7033516|NCT01662310|11113201|FG003|Open-Label Extension Phase|Adverse Event|3
7033517|NCT01662310|11113202|FG004|Open-Label Extension Phase|Adverse Event|0
7033518|NCT01662310|11113198|FG000|Open-Label Extension Phase|Death|0
7033519|NCT01662310|11113199|FG001|Open-Label Extension Phase|Death|0
7033520|NCT01662310|11113200|FG002|Open-Label Extension Phase|Death|0
7033521|NCT01662310|11113201|FG003|Open-Label Extension Phase|Death|1
7033522|NCT01662310|11113202|FG004|Open-Label Extension Phase|Death|0
7033523|NCT01662310|11113198|FG000|Open-Label Extension Phase|Lack of Efficacy|0
7033524|NCT01662310|11113199|FG001|Open-Label Extension Phase|Lack of Efficacy|0
7033525|NCT01662310|11113200|FG002|Open-Label Extension Phase|Lack of Efficacy|0
7033526|NCT01662310|11113201|FG003|Open-Label Extension Phase|Lack of Efficacy|2
7033527|NCT01662310|11113202|FG004|Open-Label Extension Phase|Lack of Efficacy|2
7033528|NCT01662310|11113198|FG000|Open-Label Extension Phase|Lost to Follow-up|0
7033529|NCT01662310|11113199|FG001|Open-Label Extension Phase|Lost to Follow-up|0
7033530|NCT01662310|11113200|FG002|Open-Label Extension Phase|Lost to Follow-up|0
7033531|NCT01662310|11113201|FG003|Open-Label Extension Phase|Lost to Follow-up|2
7033532|NCT01662310|11113202|FG004|Open-Label Extension Phase|Lost to Follow-up|1
7033533|NCT01662310|11113198|FG000|Open-Label Extension Phase|Pregnancy|0
7033534|NCT01662310|11113199|FG001|Open-Label Extension Phase|Pregnancy|0
7033535|NCT01662310|11113200|FG002|Open-Label Extension Phase|Pregnancy|0
7033536|NCT01662310|11113201|FG003|Open-Label Extension Phase|Pregnancy|1
7033537|NCT01662310|11113202|FG004|Open-Label Extension Phase|Pregnancy|0
7033538|NCT01662310|11113198|FG000|Open-Label Extension Phase|Withdrawal by Subject|0
7033539|NCT01662310|11113199|FG001|Open-Label Extension Phase|Withdrawal by Subject|0
7033540|NCT01662310|11113200|FG002|Open-Label Extension Phase|Withdrawal by Subject|0
7033541|NCT01662310|11113201|FG003|Open-Label Extension Phase|Withdrawal by Subject|2
7033542|NCT01662310|11113202|FG004|Open-Label Extension Phase|Withdrawal by Subject|7
7033543|NCT01662336|11113214|FG000|Overall Study|Adverse Event|1
7033544|NCT01662336|11113214|FG000|Overall Study|No longer on LPV/r|30
7033545|NCT01662336|11113214|FG000|Overall Study|Other|29
7033546|NCT01662336|11113214|FG000|Overall Study|Withdrawal by Subject|6
7033547|NCT01662362|11113223|FG000|Overall Study|Lost to Follow-up|38
7033548|NCT01662440|11113232|FG000|Overall Study|Adverse Event|1
7033549|NCT01662440|11113233|FG001|Overall Study|Adverse Event|0
7033550|NCT01662440|11113234|FG002|Overall Study|Adverse Event|0
7033551|NCT01662440|11113235|FG003|Overall Study|Adverse Event|1
7033552|NCT01662440|11113232|FG000|Overall Study|Death|0
7033553|NCT01662440|11113233|FG001|Overall Study|Death|1
7033554|NCT01662440|11113234|FG002|Overall Study|Death|0
7033555|NCT01662440|11113235|FG003|Overall Study|Death|0
7033556|NCT01662440|11113232|FG000|Overall Study|Lost to Follow-up|2
7033557|NCT01662440|11113233|FG001|Overall Study|Lost to Follow-up|2
7033558|NCT01662440|11113234|FG002|Overall Study|Lost to Follow-up|4
7033559|NCT01662440|11113235|FG003|Overall Study|Lost to Follow-up|1
7033560|NCT01662440|11113232|FG000|Overall Study|Subject moved to another country.|0
7033561|NCT01662440|11113233|FG001|Overall Study|Subject moved to another country.|1
7033562|NCT01662440|11113234|FG002|Overall Study|Subject moved to another country.|0
7033563|NCT01662440|11113235|FG003|Overall Study|Subject moved to another country.|0
7033564|NCT01662440|11113232|FG000|Overall Study|Protocol Violation|1
7033565|NCT01662440|11113233|FG001|Overall Study|Protocol Violation|0
7033566|NCT01662440|11113234|FG002|Overall Study|Protocol Violation|0
7033567|NCT01662440|11113235|FG003|Overall Study|Protocol Violation|0
7033568|NCT01662440|11113232|FG000|Overall Study|Withdrawal by Subject|5
7033569|NCT01662440|11113233|FG001|Overall Study|Withdrawal by Subject|2
7033570|NCT01662440|11113234|FG002|Overall Study|Withdrawal by Subject|2
7033571|NCT01662440|11113235|FG003|Overall Study|Withdrawal by Subject|2
7033572|NCT01662492|11113258|FG000|Overall Study|Other miscellaneous reasons.|1
7033573|NCT01662492|11113259|FG001|Overall Study|Other miscellaneous reasons.|0
7033574|NCT01662492|11113260|FG002|Overall Study|Other miscellaneous reasons.|1
7033575|NCT01662492|11113258|FG000|Overall Study|Withdrawal by Subject|0
7033576|NCT01662492|11113259|FG001|Overall Study|Withdrawal by Subject|0
7033577|NCT01662492|11113260|FG002|Overall Study|Withdrawal by Subject|1
7033578|NCT01662492|11113258|FG000|Overall Study|Protocol Violation|1
7033579|NCT01662492|11113259|FG001|Overall Study|Protocol Violation|0
7033580|NCT01662492|11113260|FG002|Overall Study|Protocol Violation|0
7033581|NCT01662492|11113258|FG000|Overall Study|Lost to Follow-up|0
7033582|NCT01662492|11113259|FG001|Overall Study|Lost to Follow-up|0
7033583|NCT01662492|11113260|FG002|Overall Study|Lost to Follow-up|2
7033584|NCT01662492|11113258|FG000|Overall Study|Lack of Efficacy|1
7033585|NCT01662492|11113259|FG001|Overall Study|Lack of Efficacy|1
7033586|NCT01662492|11113260|FG002|Overall Study|Lack of Efficacy|2
7033587|NCT01662505|11113271|FG000|Overall Study|Progressive disease|6
7033588|NCT01662505|11113272|FG001|Overall Study|Progressive disease|1
7033589|NCT01662505|11113273|FG002|Overall Study|Progressive disease|5
7033590|NCT01662505|11113271|FG000|Overall Study|Refused cont. medication|0
7033591|NCT01662505|11113272|FG001|Overall Study|Refused cont. medication|0
7033592|NCT01662505|11113273|FG002|Overall Study|Refused cont. medication|1
7033593|NCT01662505|11113271|FG000|Overall Study|Not specified above|1
7033594|NCT01662505|11113272|FG001|Overall Study|Not specified above|3
7033595|NCT01662505|11113273|FG002|Overall Study|Not specified above|2
7033596|NCT01662635|11113303|FG000|Overall Study|scarce samples for evaluation|30
7033597|NCT01662648|11113311|FG000|Overall Study|Death|1
7033598|NCT01662648|11113312|FG001|Overall Study|Death|3
7033599|NCT01662648|11113311|FG000|Overall Study|Adverse Event|40
7033600|NCT01662648|11113312|FG001|Overall Study|Adverse Event|37
7033601|NCT01662648|11113311|FG000|Overall Study|Lack of Efficacy|17
7033602|NCT01662648|11113312|FG001|Overall Study|Lack of Efficacy|16
7033603|NCT01662648|11113311|FG000|Overall Study|Participant ineligible to continue trial|1
7033604|NCT01662648|11113312|FG001|Overall Study|Participant ineligible to continue trial|1
7033605|NCT01662648|11113311|FG000|Overall Study|Lost to Follow-up|24
7033606|NCT01662648|11113312|FG001|Overall Study|Lost to Follow-up|36
7033607|NCT01662648|11113311|FG000|Overall Study|Withdrawal by Subject|36
7033608|NCT01662648|11113312|FG001|Overall Study|Withdrawal by Subject|53
7033609|NCT01662648|11113311|FG000|Overall Study|Participant non-compliant|16
7033610|NCT01662648|11113312|FG001|Overall Study|Participant non-compliant|20
7033611|NCT01662648|11113311|FG000|Overall Study|Other|8
7033612|NCT01662648|11113312|FG001|Overall Study|Other|11
7033613|NCT01662648|11113311|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3
7033614|NCT01662648|11113312|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0
7033615|NCT01662648|11113311|FG000|Overall Study|LOE and other reason unspecified|1
7033616|NCT01662648|11113312|FG001|Overall Study|LOE and other reason unspecified|0
7033617|NCT01662648|11113311|FG000|Overall Study|LOE and Participant non-compliant|0
7033618|NCT01662648|11113312|FG001|Overall Study|LOE and Participant non-compliant|1
7033619|NCT01662895|11113386|FG000|Overall Study|Lost to Follow-up|0
7033620|NCT01662895|11113387|FG001|Overall Study|Lost to Follow-up|1
7033621|NCT01662986|11113421|FG000|Overall Study|Adverse Event|5
7033622|NCT01662986|11113422|FG001|Overall Study|Adverse Event|4
7033623|NCT01662986|11113421|FG000|Overall Study|Protocol Violation|2
7033624|NCT01662986|11113422|FG001|Overall Study|Protocol Violation|3
7060602|NCT01920477|11156953|FG001|Overall Study|Adverse Event|1
7033625|NCT01662986|11113421|FG000|Overall Study|Lost to Follow-up|5
7033626|NCT01662986|11113422|FG001|Overall Study|Lost to Follow-up|4
7033627|NCT01662986|11113421|FG000|Overall Study|Withdrawal by Subject|2
7033628|NCT01662986|11113422|FG001|Overall Study|Withdrawal by Subject|2
7033629|NCT01662986|11113421|FG000|Overall Study|Not Treated|1
7033630|NCT01662986|11113422|FG001|Overall Study|Not Treated|0
7033631|NCT01662986|11113421|FG000|Overall Study|Other than stated above|3
7033632|NCT01662986|11113422|FG001|Overall Study|Other than stated above|0
7033633|NCT01662999|11113434|FG000|Period 3|Withdrawal by Subject|0
7033634|NCT01662999|11113435|FG001|Period 3|Withdrawal by Subject|1
7033635|NCT01662999|11113436|FG002|Period 3|Withdrawal by Subject|0
7033636|NCT01662999|11113437|FG003|Period 3|Withdrawal by Subject|0
7033637|NCT01662999|11113438|FG004|Period 3|Withdrawal by Subject|0
7033638|NCT01662999|11113439|FG005|Period 3|Withdrawal by Subject|0
7033639|NCT01663103|11113475|FG000|Overall Study|Withdrawal by Subject|1
7033640|NCT01663103|11113476|FG001|Overall Study|Withdrawal by Subject|2
7033641|NCT01663103|11113475|FG000|Overall Study|Adverse Event|1
7033642|NCT01663103|11113476|FG001|Overall Study|Adverse Event|0
7033643|NCT01663103|11113475|FG000|Overall Study|dog bite|1
7033644|NCT01663103|11113476|FG001|Overall Study|dog bite|0
7033645|NCT01663233|11113488|FG000|Overall Study|Withdrawal by Subject|3
7033646|NCT01663233|11113489|FG001|Overall Study|Withdrawal by Subject|2
7033647|NCT01663233|11113488|FG000|Overall Study|Protocol Deviation|1
7033648|NCT01663233|11113489|FG001|Overall Study|Protocol Deviation|4
7033649|NCT01663233|11113488|FG000|Overall Study|Lost to Follow-up|0
7033650|NCT01663233|11113489|FG001|Overall Study|Lost to Follow-up|1
7033651|NCT01663402|11113511|FG000|Overall Study|Randomized but not treated|19
7033652|NCT01663402|11113512|FG001|Overall Study|Randomized but not treated|11
7033653|NCT01663402|11113511|FG000|Overall Study|Adverse Event|347
7033654|NCT01663402|11113512|FG001|Overall Study|Adverse Event|362
7033655|NCT01663402|11113511|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0
7033656|NCT01663402|11113512|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730
7033657|NCT01663402|11113511|FG000|Overall Study|Poor compliance to protocol|529
7033658|NCT01663402|11113512|FG001|Overall Study|Poor compliance to protocol|454
7033659|NCT01663402|11113511|FG000|Overall Study|Physician Decision|77
7033660|NCT01663402|11113512|FG001|Overall Study|Physician Decision|62
7033661|NCT01663402|11113511|FG000|Overall Study|Site terminated by sponsor|1
7033662|NCT01663402|11113512|FG001|Overall Study|Site terminated by sponsor|3
7033663|NCT01663402|11113511|FG000|Overall Study|Participant moved|139
7033664|NCT01663402|11113512|FG001|Overall Study|Participant moved|104
7033665|NCT01663402|11113511|FG000|Overall Study|Withdrawal by Subject|118
7033666|NCT01663402|11113512|FG001|Overall Study|Withdrawal by Subject|91
7033667|NCT01663402|11113511|FG000|Overall Study|Related to study drug administration|96
7033668|NCT01663402|11113512|FG001|Overall Study|Related to study drug administration|105
7033669|NCT01663402|11113511|FG000|Overall Study|Lost to Follow-up|17
7033670|NCT01663402|11113512|FG001|Overall Study|Lost to Follow-up|15
7033671|NCT01663402|11113511|FG000|Overall Study|Other than specified above|172
7033672|NCT01663402|11113512|FG001|Overall Study|Other than specified above|147
7033673|NCT01663506|11113518|FG000|Overall Study|Lack of Efficacy|3
7033674|NCT01663506|11113518|FG000|Overall Study|Consent Withdrawal by Subject|1
7033675|NCT01663506|11113518|FG000|Overall Study|Lost to Follow-up|1
7033676|NCT01663506|11113518|FG000|Overall Study|Adverse Event|1
7033677|NCT01663506|11113518|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2
7033678|NCT01663532|11113524|FG000|Overall Study|Lost to Follow-up|9
7033679|NCT01663532|11113525|FG001|Overall Study|Lost to Follow-up|10
7033680|NCT01663532|11113524|FG000|Overall Study|Adverse Event|7
7033681|NCT01663532|11113525|FG001|Overall Study|Adverse Event|13
7033682|NCT01663532|11113524|FG000|Overall Study|Met Withdrawal Criteria|7
7033683|NCT01663532|11113525|FG001|Overall Study|Met Withdrawal Criteria|6
7143225|NCT03029143|11299738|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6
7033684|NCT01663532|11113524|FG000|Overall Study|Physician Decision|1
7033685|NCT01663532|11113525|FG001|Overall Study|Physician Decision|1
7033686|NCT01663532|11113524|FG000|Overall Study|Withdrawal by Subject|35
7033687|NCT01663532|11113525|FG001|Overall Study|Withdrawal by Subject|17
7033688|NCT01663532|11113524|FG000|Overall Study|Lack of Efficacy|15
7033689|NCT01663532|11113525|FG001|Overall Study|Lack of Efficacy|60
7033690|NCT01663623|11113533|FG000|Overall Study|Adverse Event|3
7033691|NCT01663623|11113534|FG001|Overall Study|Adverse Event|7
7033692|NCT01663623|11113533|FG000|Overall Study|Lack of Efficacy|5
7033693|NCT01663623|11113534|FG001|Overall Study|Lack of Efficacy|6
7033694|NCT01663623|11113533|FG000|Overall Study|Protocol Violation|0
7033695|NCT01663623|11113534|FG001|Overall Study|Protocol Violation|1
7033696|NCT01663623|11113533|FG000|Overall Study|Other-Study closed/terminated|1
7033697|NCT01663623|11113534|FG001|Overall Study|Other-Study closed/terminated|1
7033698|NCT01663623|11113533|FG000|Overall Study|Physician Decision|1
7033699|NCT01663623|11113534|FG001|Overall Study|Physician Decision|4
7033700|NCT01663623|11113533|FG000|Overall Study|Withdrawal by Subject|2
7033701|NCT01663623|11113534|FG001|Overall Study|Withdrawal by Subject|1
7033702|NCT01663636|11113542|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25
7033703|NCT01663636|11113543|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31
7033704|NCT01663714|11113549|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
7033705|NCT01663714|11113549|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11
7033706|NCT01663714|11113549|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16
7033707|NCT01663714|11113549|FG000|Long-Term Follow-Up|Lost to Follow-up|1
7033708|NCT01663714|11113549|FG000|Long-Term Follow-Up|Death|4
7033709|NCT01663714|11113549|FG000|Long-Term Follow-Up|Non-compliance|1
7033710|NCT01663727|11113557|FG000|Overall Study|Death|161
7033711|NCT01663727|11113558|FG001|Overall Study|Death|155
7033712|NCT01663727|11113557|FG000|Overall Study|Lost to Follow-up|10
7033713|NCT01663727|11113558|FG001|Overall Study|Lost to Follow-up|8
7033714|NCT01663727|11113557|FG000|Overall Study|Withdrawal by Subject|18
7033715|NCT01663727|11113558|FG001|Overall Study|Withdrawal by Subject|25
7033716|NCT01663727|11113557|FG000|Overall Study|Study Terminated|51
7033717|NCT01663727|11113558|FG001|Overall Study|Study Terminated|50
7033718|NCT01663727|11113557|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1
7033719|NCT01663727|11113558|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0
7183611|NCT01488890|11383707|FG002|Overall Study|Protocol Violation|4
7033720|NCT01663727|11113557|FG000|Overall Study|Withdrawal prior to dosing.|1
7033721|NCT01663727|11113558|FG001|Overall Study|Withdrawal prior to dosing.|0
7033722|NCT01663740|11113566|FG000|Overall Study|Lost to Follow-up|1
7033723|NCT01663740|11113567|FG001|Overall Study|Lost to Follow-up|4
7033724|NCT01663740|11113566|FG000|Overall Study|Other|9
7033725|NCT01663740|11113567|FG001|Overall Study|Other|2
7033726|NCT01663740|11113566|FG000|Overall Study|Inclusion/Exclusion not met|1
7033727|NCT01663740|11113567|FG001|Overall Study|Inclusion/Exclusion not met|0
7033728|NCT01663740|11113566|FG000|Overall Study|Death|0
7033729|NCT01663740|11113567|FG001|Overall Study|Death|1
7033730|NCT01663740|11113566|FG000|Overall Study|Withdrawal by Subject|2
7033731|NCT01663740|11113567|FG001|Overall Study|Withdrawal by Subject|1
7033732|NCT01663740|11113566|FG000|Overall Study|No end of study status|3
7033733|NCT01663740|11113567|FG001|Overall Study|No end of study status|0
7033734|NCT01663857|11113586|FG000|Overall Study|Withdrew Consent to Study Participation|0
7033735|NCT01663857|11113587|FG001|Overall Study|Withdrew Consent to Study Participation|1
7033736|NCT01663857|11113588|FG002|Overall Study|Withdrew Consent to Study Participation|7
7033737|NCT01663857|11113589|FG003|Overall Study|Withdrew Consent to Study Participation|3
7033738|NCT01663857|11113586|FG000|Overall Study|Lost to Follow-up|0
7033739|NCT01663857|11113587|FG001|Overall Study|Lost to Follow-up|0
7033740|NCT01663857|11113588|FG002|Overall Study|Lost to Follow-up|3
7033741|NCT01663857|11113589|FG003|Overall Study|Lost to Follow-up|1
7033742|NCT01663896|11113605|FG000|Overall Study|Various reasons|43
7033743|NCT01663987|11113622|FG000|Overall Study|Adverse Event|7
7033744|NCT01663987|11113623|FG001|Overall Study|Adverse Event|2
7033745|NCT01663987|11113622|FG000|Overall Study|Lost to Follow-up|1
7033746|NCT01663987|11113623|FG001|Overall Study|Lost to Follow-up|1
7033747|NCT01663987|11113622|FG000|Overall Study|Withdrawal by Subject|2
7033748|NCT01663987|11113623|FG001|Overall Study|Withdrawal by Subject|3
7033749|NCT01663987|11113622|FG000|Overall Study|Other reason not defined above|3
7033750|NCT01663987|11113623|FG001|Overall Study|Other reason not defined above|0
7033751|NCT01664039|11113631|FG000|Overall Study|Adverse Event|3
7033752|NCT01664039|11113632|FG001|Overall Study|Adverse Event|4
7033753|NCT01664039|11113631|FG000|Overall Study|Lost to Follow-up|1
7033754|NCT01664039|11113632|FG001|Overall Study|Lost to Follow-up|1
7033755|NCT01664039|11113631|FG000|Overall Study|Withdrawal by Subject|1
7033756|NCT01664039|11113632|FG001|Overall Study|Withdrawal by Subject|3
7033757|NCT01664039|11113631|FG000|Overall Study|Noncompliance|1
7033758|NCT01664039|11113632|FG001|Overall Study|Noncompliance|1
7033759|NCT01664052|11113640|FG000|Phase 1|No device placement|6
7033760|NCT01664052|11113641|FG001|Phase 1|No device placement|0
7033761|NCT01664052|11113640|FG000|Phase 1|No HSG 1 hr post placement|1
7033762|NCT01664052|11113641|FG001|Phase 1|No HSG 1 hr post placement|0
7033763|NCT01664052|11113640|FG000|Phase 2|No device placement|0
7033764|NCT01664052|11113641|FG001|Phase 2|No device placement|4
7033765|NCT01664078|11113648|FG000|Overall Study|Death|9
7033766|NCT01664078|11113648|FG000|Overall Study|Withdrawal by Subject|4
7033767|NCT01664078|11113648|FG000|Overall Study|Lost to Follow-up|2
7033768|NCT01664078|11113648|FG000|Overall Study|missed 5 year visit|1
7033769|NCT01664078|11113648|FG000|Overall Study|Other|53
7033770|NCT01664091|11113698|FG000|Overall Study|Death|1
7033771|NCT01664091|11113698|FG000|Overall Study|Disease Progression|2
7033772|NCT01664091|11113698|FG000|Overall Study|Lost to Follow-up|2
7033773|NCT01664091|11113698|FG000|Overall Study|Withdrawal by Subject|1
7033774|NCT01664104|11113703|FG000|Overall Study|Adverse Event|6
7033775|NCT01664104|11113703|FG000|Overall Study|Lack of Efficacy|2
7033776|NCT01664104|11113703|FG000|Overall Study|Withdrawal by Subject|1
7033777|NCT01664104|11113703|FG000|Overall Study|Lost to Follow-up|4
7033778|NCT01664104|11113703|FG000|Overall Study|Other|1
7033779|NCT01664104|11113703|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2
7033780|NCT01664130|11113716|FG000|Overall Study|competing secondary disease|2
7033781|NCT01664247|11113725|FG000|Overall Study|Adverse Event|5
7033782|NCT01664247|11113726|FG001|Overall Study|Adverse Event|3
7033783|NCT01664247|11113725|FG000|Overall Study|Protocol Violation|3
7033784|NCT01664247|11113726|FG001|Overall Study|Protocol Violation|5
7033785|NCT01664247|11113725|FG000|Overall Study|Withdrawal Criteria|1
7033786|NCT01664247|11113726|FG001|Overall Study|Withdrawal Criteria|4
7033787|NCT01664247|11113725|FG000|Overall Study|Unclassified|5
7033788|NCT01664247|11113726|FG001|Overall Study|Unclassified|29
7033789|NCT01664494|11113732|FG000|Overall Study|Withdrawal by Subject|27
7033790|NCT01664494|11113732|FG000|Overall Study|Death|18
7033791|NCT01664494|11113732|FG000|Overall Study|Other|49
7033792|NCT01664494|11113732|FG000|Overall Study|Lost to Follow-up|99
7033793|NCT01664533|11113736|FG000|Overall Study|Death|42
7033794|NCT01664533|11113736|FG000|Overall Study|Lost to Follow-up|3
7033795|NCT01664533|11113736|FG000|Overall Study|Study termination|9
7033796|NCT01664533|11113736|FG000|Overall Study|Protocol Violation|3
7033797|NCT01664624|11113754|FG000|Overall Study|Adverse Event|0
7033798|NCT01664624|11113755|FG001|Overall Study|Adverse Event|1
7033799|NCT01664624|11113756|FG002|Overall Study|Adverse Event|0
7033800|NCT01664624|11113757|FG003|Overall Study|Adverse Event|0
7033801|NCT01664923|11113821|FG000|Period1:Double Blind Phase-29 Months|Death|8
7060603|NCT01920477|11156952|FG000|Overall Study|Lack of Efficacy|1
7033802|NCT01664923|11113822|FG001|Period1:Double Blind Phase-29 Months|Death|6
7033803|NCT01664923|11113821|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0
7033804|NCT01664923|11113822|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1
7033805|NCT01664923|11113821|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2
7033806|NCT01664923|11113822|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0
7033807|NCT01664923|11113821|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12
7033808|NCT01664923|11113822|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8
7033809|NCT01664923|11113821|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65
7033810|NCT01664923|11113822|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132
7033811|NCT01664923|11113821|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14
7033812|NCT01664923|11113822|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9
7033813|NCT01664923|11113821|FG000|Period1:Double Blind Phase-29 Months|Other|3
7033814|NCT01664923|11113822|FG001|Period1:Double Blind Phase-29 Months|Other|4
7033815|NCT01664923|11113821|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1
7033816|NCT01664923|11113822|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0
7033817|NCT01664923|11113821|FG000|Period 2: Open-label Phase-36 Months|Death|3
7033818|NCT01664923|11113822|FG001|Period 2: Open-label Phase-36 Months|Death|1
7033819|NCT01664923|11113821|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1
7033820|NCT01664923|11113822|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1
7033821|NCT01664923|11113821|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28
7033822|NCT01664923|11113822|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9
7033823|NCT01664923|11113821|FG000|Period 2: Open-label Phase-36 Months|Other|3
7033824|NCT01664923|11113822|FG001|Period 2: Open-label Phase-36 Months|Other|1
7033825|NCT01664923|11113821|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4
7033826|NCT01664923|11113822|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7
7033827|NCT01664923|11113821|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2
7033828|NCT01664923|11113822|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4
7033829|NCT01664949|11113834|FG000|Overall Study|Adverse Event|11
7033830|NCT01664949|11113835|FG001|Overall Study|Adverse Event|12
7033831|NCT01664949|11113834|FG000|Overall Study|Lack of Efficacy|1
7033832|NCT01664949|11113835|FG001|Overall Study|Lack of Efficacy|1
7033833|NCT01664949|11113834|FG000|Overall Study|Lost to Follow-up|1
7033834|NCT01664949|11113835|FG001|Overall Study|Lost to Follow-up|2
7033835|NCT01664949|11113834|FG000|Overall Study|Personal Reasons|3
7033836|NCT01664949|11113835|FG001|Overall Study|Personal Reasons|4
7033837|NCT01664949|11113834|FG000|Overall Study|Protocol Violation|5
7033838|NCT01664949|11113835|FG001|Overall Study|Protocol Violation|5
7033839|NCT01664949|11113834|FG000|Overall Study|Other Miscellaneous Reasons|3
7033840|NCT01664949|11113835|FG001|Overall Study|Other Miscellaneous Reasons|1
7033841|NCT01665430|11113909|FG000|Overall Study|Adverse Event|1
7033842|NCT01665430|11113909|FG000|Overall Study|Withdrawal by Subject|6
7033843|NCT01665430|11113909|FG000|Overall Study|Other Unspecified|2
7033844|NCT01665599|11113922|FG000|Overall Study|Adverse Event|1
7033845|NCT01665599|11113922|FG000|Overall Study|Consent Withdrawn|1
7033846|NCT01665599|11113922|FG000|Overall Study|Investigator/Sponsor decision|1
7033847|NCT01665599|11113922|FG000|Overall Study|Death|1
7033848|NCT01665599|11113922|FG000|Overall Study|Lost to Follow-up|2
7033849|NCT01665599|11113922|FG000|Overall Study|Participant Left for More Than 3 Months|1
7033850|NCT01665599|11113922|FG000|Overall Study|Could Not Continue Due to Time Constrain|1
7033851|NCT01665768|11113926|FG000|Overall Study|Adverse Event|3
7033852|NCT01665768|11113926|FG000|Overall Study|Lack of Efficacy|19
7033853|NCT01665768|11113926|FG000|Overall Study|Withdrawal by Subject|1
7033854|NCT01665807|11113933|FG000|Overall Study|Withdrawal by Subject|2
7033855|NCT01665807|11113934|FG001|Overall Study|Withdrawal by Subject|0
7033856|NCT01665807|11113935|FG002|Overall Study|Withdrawal by Subject|1
7033857|NCT01665911|11113952|FG000|Overall Study|Protocol Violation|4
7033858|NCT01665911|11113952|FG000|Overall Study|Withdrawal by Subject|1
7033859|NCT01665911|11113952|FG000|Overall Study|Adverse Event|1
7033860|NCT01666002|11113972|FG000|Overall Study|Lost to Follow-up|5
7033861|NCT01666002|11113973|FG001|Overall Study|Lost to Follow-up|0
7033862|NCT01666119|11113980|FG000|Overall Study|Adverse Event|6
7033863|NCT01666119|11113980|FG000|Overall Study|Withdrawal by Subject|16
7033864|NCT01666119|11113980|FG000|Overall Study|Lost to Follow-up|7
7033865|NCT01666119|11113980|FG000|Overall Study|non compliance with study medication, pa|18
7033866|NCT01666119|11113980|FG000|Overall Study|Subject experiencing withdrawal symptoms|5
7033867|NCT01666314|11114010|FG000|Overall Study|Adverse Event|3
7033868|NCT01666314|11114011|FG001|Overall Study|Adverse Event|13
7033869|NCT01666314|11114012|FG002|Overall Study|Adverse Event|7
7033870|NCT01666314|11114013|FG003|Overall Study|Adverse Event|7
7033871|NCT01666314|11114010|FG000|Overall Study|Progressive Disease|11
7033872|NCT01666314|11114011|FG001|Overall Study|Progressive Disease|9
7033873|NCT01666314|11114012|FG002|Overall Study|Progressive Disease|19
7033874|NCT01666314|11114013|FG003|Overall Study|Progressive Disease|20
7033875|NCT01666314|11114010|FG000|Overall Study|Symptomatic Deterioration|1
7033876|NCT01666314|11114011|FG001|Overall Study|Symptomatic Deterioration|0
7033877|NCT01666314|11114012|FG002|Overall Study|Symptomatic Deterioration|2
7033878|NCT01666314|11114013|FG003|Overall Study|Symptomatic Deterioration|0
7033879|NCT01666314|11114010|FG000|Overall Study|Unsatisfactory Therapeutic Response|7
7033880|NCT01666314|11114011|FG001|Overall Study|Unsatisfactory Therapeutic Response|2
7033881|NCT01666314|11114012|FG002|Overall Study|Unsatisfactory Therapeutic Response|1
7033882|NCT01666314|11114013|FG003|Overall Study|Unsatisfactory Therapeutic Response|1
7033883|NCT01666314|11114010|FG000|Overall Study|Withdrawal by Subject|1
7033884|NCT01666314|11114011|FG001|Overall Study|Withdrawal by Subject|1
7033885|NCT01666314|11114012|FG002|Overall Study|Withdrawal by Subject|2
7033886|NCT01666314|11114013|FG003|Overall Study|Withdrawal by Subject|3
7033887|NCT01666314|11114010|FG000|Overall Study|Reason not Specified|10
7033888|NCT01666314|11114011|FG001|Overall Study|Reason not Specified|7
7033889|NCT01666314|11114012|FG002|Overall Study|Reason not Specified|5
7033890|NCT01666314|11114013|FG003|Overall Study|Reason not Specified|5
7033891|NCT01666444|11114036|FG000|Overall Study|Did not initiate treatment|2
7033892|NCT01666444|11114037|FG001|Overall Study|Did not initiate treatment|1
7033893|NCT01666652|11114048|FG000|Overall Study|Serious Adverse Event|0
7033894|NCT01666652|11114049|FG001|Overall Study|Serious Adverse Event|0
7033895|NCT01666652|11114050|FG002|Overall Study|Serious Adverse Event|0
7033896|NCT01666652|11114051|FG003|Overall Study|Serious Adverse Event|1
7033897|NCT01666652|11114052|FG004|Overall Study|Serious Adverse Event|0
7033898|NCT01666652|11114048|FG000|Overall Study|Withdrawal by Subject|0
7033899|NCT01666652|11114049|FG001|Overall Study|Withdrawal by Subject|0
7033900|NCT01666652|11114050|FG002|Overall Study|Withdrawal by Subject|0
7033901|NCT01666652|11114051|FG003|Overall Study|Withdrawal by Subject|0
7033902|NCT01666652|11114052|FG004|Overall Study|Withdrawal by Subject|1
7033903|NCT01666652|11114048|FG000|Overall Study|Moved from study area|1
7033904|NCT01666652|11114049|FG001|Overall Study|Moved from study area|0
7033905|NCT01666652|11114050|FG002|Overall Study|Moved from study area|0
7033906|NCT01666652|11114051|FG003|Overall Study|Moved from study area|2
7033907|NCT01666652|11114052|FG004|Overall Study|Moved from study area|0
7033908|NCT01666652|11114048|FG000|Overall Study|Lost to Follow-up|1
7033909|NCT01666652|11114049|FG001|Overall Study|Lost to Follow-up|1
7033910|NCT01666652|11114050|FG002|Overall Study|Lost to Follow-up|1
7033911|NCT01666652|11114051|FG003|Overall Study|Lost to Follow-up|1
7033912|NCT01666652|11114052|FG004|Overall Study|Lost to Follow-up|0
7033913|NCT01666730|11114064|FG000|Overall Study|Adverse Event|16
7033914|NCT01666730|11114064|FG000|Overall Study|Death|2
7033915|NCT01666730|11114064|FG000|Overall Study|Physician Decision|5
7033916|NCT01666730|11114064|FG000|Overall Study|Withdrawal by Subject|9
7033917|NCT01666730|11114064|FG000|Overall Study|Disease progression/relapse|18
7033918|NCT01666782|11114070|FG000|Overall Study|Received 2 doses of vaccine|0
7033919|NCT01666782|11114071|FG001|Overall Study|Received 2 doses of vaccine|1
7033920|NCT01666782|11114070|FG000|Overall Study|Enrolled both years; year 1 data used|4
7033921|NCT01666782|11114071|FG001|Overall Study|Enrolled both years; year 1 data used|0
7033922|NCT01666951|11114088|FG000|Overall Study|Not dosed|1
7033923|NCT01666951|11114089|FG001|Overall Study|Not dosed|1
7033924|NCT01667107|11114104|FG000|Overall Study|Adverse Event|4
7033925|NCT01667107|11114105|FG001|Overall Study|Adverse Event|3
7033926|NCT01667107|11114104|FG000|Overall Study|Tolerability issues|0
7033927|NCT01667107|11114105|FG001|Overall Study|Tolerability issues|2
7033928|NCT01667107|11114104|FG000|Overall Study|Protocol Violation|0
7033929|NCT01667107|11114105|FG001|Overall Study|Protocol Violation|1
7033930|NCT01667107|11114104|FG000|Overall Study|Lack of Efficacy|0
7033931|NCT01667107|11114105|FG001|Overall Study|Lack of Efficacy|1
7033932|NCT01667224|11114113|FG000|Overall Study|Withdrawal by Subject|3
7033933|NCT01667224|11114114|FG001|Overall Study|Withdrawal by Subject|1
7033934|NCT01667224|11114113|FG000|Overall Study|Protocol Violation|1
7033935|NCT01667224|11114114|FG001|Overall Study|Protocol Violation|1
7033936|NCT01667419|11114208|FG000|Overall Study|Reason Not Specified|1
7033937|NCT01667419|11114209|FG001|Overall Study|Reason Not Specified|0
7033938|NCT01667419|11114210|FG002|Overall Study|Reason Not Specified|0
7033939|NCT01667419|11114211|FG003|Overall Study|Reason Not Specified|0
7033940|NCT01667419|11114208|FG000|Overall Study|Withdrawal by Subject|16
7033941|NCT01667419|11114209|FG001|Overall Study|Withdrawal by Subject|8
7033942|NCT01667419|11114210|FG002|Overall Study|Withdrawal by Subject|9
7033943|NCT01667419|11114211|FG003|Overall Study|Withdrawal by Subject|8
7033944|NCT01667419|11114208|FG000|Overall Study|Non-compliance|0
7033945|NCT01667419|11114209|FG001|Overall Study|Non-compliance|0
7033946|NCT01667419|11114210|FG002|Overall Study|Non-compliance|0
7033947|NCT01667419|11114211|FG003|Overall Study|Non-compliance|1
7033948|NCT01667419|11114208|FG000|Overall Study|Protocol Violation|1
7033949|NCT01667419|11114209|FG001|Overall Study|Protocol Violation|0
7033950|NCT01667419|11114210|FG002|Overall Study|Protocol Violation|0
7033951|NCT01667419|11114211|FG003|Overall Study|Protocol Violation|0
7033952|NCT01667419|11114208|FG000|Overall Study|Lost to Follow-up|7
7033953|NCT01667419|11114209|FG001|Overall Study|Lost to Follow-up|6
7033954|NCT01667419|11114210|FG002|Overall Study|Lost to Follow-up|2
7033955|NCT01667419|11114211|FG003|Overall Study|Lost to Follow-up|4
7033956|NCT01667419|11114208|FG000|Overall Study|Death|18
7033957|NCT01667419|11114209|FG001|Overall Study|Death|33
7033958|NCT01667419|11114210|FG002|Overall Study|Death|25
7033959|NCT01667419|11114211|FG003|Overall Study|Death|26
7033960|NCT01667432|11114222|FG000|Overall Study|Premature Study Termination|26
7033961|NCT01667432|11114222|FG000|Overall Study|Failure to Return|10
7033962|NCT01667432|11114222|FG000|Overall Study|Moved to Another Center|3
7033963|NCT01667432|11114222|FG000|Overall Study|Lost to Follow-up|3
7033964|NCT01667432|11114222|FG000|Overall Study|Refused Treatment/Withdrew Consent|1
7033965|NCT01667432|11114222|FG000|Overall Study|Insufficient Therapeutic Response|4
7033966|NCT01667432|11114222|FG000|Overall Study|Adverse Event|1
7033967|NCT01667432|11114222|FG000|Overall Study|Protocol Deviation|2
7033968|NCT01667432|11114222|FG000|Overall Study|Principal Investigator Decision|1
7033969|NCT01667432|11114222|FG000|Overall Study|Reason Not Specified|2
7033970|NCT01667432|11114222|FG000|Overall Study|Missing Information|4
7033971|NCT01667549|11114243|FG000|Overall Study|Withdrawal by Subject|3
7033972|NCT01667549|11114244|FG001|Overall Study|Withdrawal by Subject|5
7033973|NCT01667549|11114245|FG002|Overall Study|Withdrawal by Subject|7
7033974|NCT01667549|11114246|FG003|Overall Study|Withdrawal by Subject|6
7033975|NCT01667549|11114247|FG004|Overall Study|Withdrawal by Subject|1
7033976|NCT01667562|11114264|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30
7033977|NCT01667562|11114265|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0
7033978|NCT01667562|11114264|FG000|Erlotinib Phase|Lost to Follow-up|0
7033979|NCT01667562|11114265|FG001|Erlotinib Phase|Lost to Follow-up|1
7033980|NCT01667562|11114264|FG000|Erlotinib Phase|Adverse Event|0
7033981|NCT01667562|11114265|FG001|Erlotinib Phase|Adverse Event|1
7033982|NCT01667562|11114264|FG000|Erlotinib Phase|Switch to Commercial Drug|0
7033983|NCT01667562|11114265|FG001|Erlotinib Phase|Switch to Commercial Drug|1
7033984|NCT01667679|11114272|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2
7033985|NCT01667679|11114273|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6
7033986|NCT01667679|11114272|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2
7033987|NCT01667679|11114273|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0
7033988|NCT01667679|11114272|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2
7033989|NCT01667679|11114273|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0
7033990|NCT01667679|11114272|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1
7033991|NCT01667679|11114273|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0
7033992|NCT01667679|11114272|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6
7033993|NCT01667679|11114273|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13
7033994|NCT01667679|11114272|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
7033995|NCT01667679|11114273|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
7033996|NCT01667679|11114272|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0
7033997|NCT01667679|11114273|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2
7033998|NCT01667679|11114272|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0
7033999|NCT01667679|11114273|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2
7034000|NCT01667679|11114272|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0
7034001|NCT01667679|11114273|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3
7034002|NCT01667679|11114272|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0
7034003|NCT01667679|11114273|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1
7034004|NCT01667679|11114272|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6
7034005|NCT01667679|11114273|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4
7034006|NCT01667679|11114272|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2
7034007|NCT01667679|11114273|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0
7034008|NCT01667679|11114272|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8
7034009|NCT01667679|11114273|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10
7034010|NCT01667679|11114272|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3
7034011|NCT01667679|11114273|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4
7034012|NCT01667679|11114272|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1
7034013|NCT01667679|11114273|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0
7034014|NCT01667679|11114272|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1
7034015|NCT01667679|11114273|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0
7034016|NCT01667679|11114272|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1
7034017|NCT01667679|11114273|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0
7034018|NCT01667679|11114272|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0
7034019|NCT01667679|11114273|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1
7034020|NCT01667679|11114272|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0
7034021|NCT01667679|11114273|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1
7034022|NCT01667679|11114272|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0
7034023|NCT01667679|11114273|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1
7034024|NCT01667679|11114272|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0
7034025|NCT01667679|11114273|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1
7034026|NCT01667731|11114286|FG000|Overall Study|Enrolled but not treated|0
7034027|NCT01667731|11114287|FG001|Overall Study|Enrolled but not treated|0
7034028|NCT01667731|11114288|FG002|Overall Study|Enrolled but not treated|0
7034029|NCT01667731|11114289|FG003|Overall Study|Enrolled but not treated|0
7034030|NCT01667731|11114290|FG004|Overall Study|Enrolled but not treated|1
7034031|NCT01667731|11114286|FG000|Overall Study|Efficacy Failure|1
7034032|NCT01667731|11114287|FG001|Overall Study|Efficacy Failure|12
7034033|NCT01667731|11114288|FG002|Overall Study|Efficacy Failure|0
7034034|NCT01667731|11114289|FG003|Overall Study|Efficacy Failure|1
7034035|NCT01667731|11114290|FG004|Overall Study|Efficacy Failure|24
7034036|NCT01667731|11114286|FG000|Overall Study|Lost to Follow-up|2
7034037|NCT01667731|11114287|FG001|Overall Study|Lost to Follow-up|3
7034038|NCT01667731|11114288|FG002|Overall Study|Lost to Follow-up|1
7034039|NCT01667731|11114289|FG003|Overall Study|Lost to Follow-up|1
7034040|NCT01667731|11114290|FG004|Overall Study|Lost to Follow-up|2
7034041|NCT01667731|11114286|FG000|Overall Study|Subject Withdrew Consent|2
7034042|NCT01667731|11114287|FG001|Overall Study|Subject Withdrew Consent|0
7034043|NCT01667731|11114288|FG002|Overall Study|Subject Withdrew Consent|1
7034044|NCT01667731|11114289|FG003|Overall Study|Subject Withdrew Consent|0
7034045|NCT01667731|11114290|FG004|Overall Study|Subject Withdrew Consent|1
7034046|NCT01667731|11114286|FG000|Overall Study|Death|0
7034047|NCT01667731|11114287|FG001|Overall Study|Death|1
7034048|NCT01667731|11114288|FG002|Overall Study|Death|0
7034049|NCT01667731|11114289|FG003|Overall Study|Death|0
7034050|NCT01667731|11114290|FG004|Overall Study|Death|0
7034051|NCT01667900|11114330|FG000|Part B|Death|0
7034052|NCT01667900|11114331|FG001|Part B|Death|0
7034053|NCT01667900|11114332|FG002|Part B|Death|0
7034054|NCT01667900|11114333|FG003|Part B|Death|0
7034055|NCT01667900|11114334|FG004|Part B|Death|0
7034056|NCT01667900|11114335|FG005|Part B|Death|0
7034057|NCT01667900|11114336|FG006|Part B|Death|0
7034058|NCT01667900|11114337|FG007|Part B|Death|0
7034059|NCT01667900|11114338|FG008|Part B|Death|0
7034060|NCT01667900|11114339|FG009|Part B|Death|0
7034061|NCT01667900|11114340|FG010|Part B|Death|0
7034062|NCT01667900|11114341|FG011|Part B|Death|0
7034063|NCT01667900|11114342|FG012|Part B|Death|0
7034064|NCT01667900|11114343|FG013|Part B|Death|0
7034065|NCT01667900|11114344|FG014|Part B|Death|0
7034066|NCT01667900|11114345|FG015|Part B|Death|0
7034067|NCT01667900|11114346|FG016|Part B|Death|1
7034068|NCT01667900|11114347|FG017|Part B|Death|0
7034069|NCT01667900|11114348|FG018|Part B|Death|0
7034070|NCT01667900|11114349|FG019|Part B|Death|0
7034071|NCT01667926|11114371|FG000|Overall Study|Withdrawal by Subject|1
7034072|NCT01667926|11114372|FG001|Overall Study|Withdrawal by Subject|2
7034073|NCT01667926|11114373|FG002|Overall Study|Withdrawal by Subject|2
7034074|NCT01667926|11114371|FG000|Overall Study|Physician Decision|0
7034075|NCT01667926|11114372|FG001|Overall Study|Physician Decision|0
7034076|NCT01667926|11114373|FG002|Overall Study|Physician Decision|1
7034077|NCT01667926|11114371|FG000|Overall Study|Time committment|0
7034078|NCT01667926|11114372|FG001|Overall Study|Time committment|0
7034079|NCT01667926|11114373|FG002|Overall Study|Time committment|2
7034080|NCT01667926|11114371|FG000|Overall Study|Inclusion/Exclusion Criteria|0
7034081|NCT01667926|11114372|FG001|Overall Study|Inclusion/Exclusion Criteria|0
7034082|NCT01667926|11114373|FG002|Overall Study|Inclusion/Exclusion Criteria|5
7034083|NCT01667926|11114371|FG000|Overall Study|Lost to Follow-up|1
7034084|NCT01667926|11114372|FG001|Overall Study|Lost to Follow-up|2
7034085|NCT01667926|11114373|FG002|Overall Study|Lost to Follow-up|1
7034086|NCT01667926|11114371|FG000|Overall Study|Side effects|3
7034087|NCT01667926|11114372|FG001|Overall Study|Side effects|0
7034088|NCT01667926|11114373|FG002|Overall Study|Side effects|0
7034089|NCT01668004|11114388|FG000|Overall Study|Adverse Event|7
7034090|NCT01668004|11114388|FG000|Overall Study|Withdrawal by Subject|2
7034091|NCT01668004|11114388|FG000|Overall Study|Lost to Follow-up|5
7034092|NCT01668004|11114388|FG000|Overall Study|Lack of Efficacy|9
7034093|NCT01668004|11114388|FG000|Overall Study|Non-compliance with treatment|2
7034094|NCT01668173|11114436|FG000|Overall Study|Adverse Event|3
7034095|NCT01668173|11114436|FG000|Overall Study|Trial suspension|4
7034096|NCT01668355|11114442|FG000|Overall Study|Death|3
7034097|NCT01668355|11114443|FG001|Overall Study|Death|1
7034098|NCT01668355|11114442|FG000|Overall Study|Withdrawal by Subject|6
7034099|NCT01668355|11114443|FG001|Overall Study|Withdrawal by Subject|1
7034100|NCT01668537|11114452|FG000|Overall Study|Request to Discontinue Prematurely|1
7034101|NCT01668537|11114453|FG001|Overall Study|Request to Discontinue Prematurely|1
7034102|NCT01668537|11114452|FG000|Overall Study|Subject unwilling/unable to comply|5
7034103|NCT01668537|11114453|FG001|Overall Study|Subject unwilling/unable to comply|0
7034104|NCT01668537|11114452|FG000|Overall Study|Reason Precludes Participation|1
7034105|NCT01668537|11114453|FG001|Overall Study|Reason Precludes Participation|0
7034106|NCT01668537|11114452|FG000|Overall Study|Lost to Follow-up|13
7034107|NCT01668537|11114453|FG001|Overall Study|Lost to Follow-up|6
7034108|NCT01668537|11114452|FG000|Overall Study|Other|2
7034109|NCT01668537|11114453|FG001|Overall Study|Other|3
7034110|NCT01668589|11114463|FG000|Overall Study|Lost to Follow-up|29
7034111|NCT01668589|11114464|FG001|Overall Study|Lost to Follow-up|37
7034112|NCT01668589|11114465|FG002|Overall Study|Lost to Follow-up|15
7034113|NCT01668589|11114466|FG003|Overall Study|Lost to Follow-up|5
7034114|NCT01668589|11114463|FG000|Overall Study|Full Consent/Agreement Withdrawn|54
7034115|NCT01668589|11114464|FG001|Overall Study|Full Consent/Agreement Withdrawn|8
7034116|NCT01668589|11114465|FG002|Overall Study|Full Consent/Agreement Withdrawn|11
7034117|NCT01668589|11114466|FG003|Overall Study|Full Consent/Agreement Withdrawn|4
7034118|NCT01668589|11114463|FG000|Overall Study|Death|12
7034119|NCT01668589|11114464|FG001|Overall Study|Death|3
7034120|NCT01668589|11114465|FG002|Overall Study|Death|2
7034121|NCT01668589|11114466|FG003|Overall Study|Death|11
7034122|NCT01668589|11114463|FG000|Overall Study|Other|44
7034123|NCT01668589|11114464|FG001|Overall Study|Other|10
7034124|NCT01668589|11114465|FG002|Overall Study|Other|7
7034125|NCT01668589|11114466|FG003|Overall Study|Other|15
7034126|NCT01668654|11114504|FG000|Overall Study|Study Closed/Terminated|3
7034127|NCT01668654|11114504|FG000|Overall Study|Withdrawal by Subject|1
7034128|NCT01668667|11114512|FG000|Overall Study|Adverse Event|3
7034129|NCT01668667|11114513|FG001|Overall Study|Adverse Event|6
7034130|NCT01668667|11114514|FG002|Overall Study|Adverse Event|4
7034131|NCT01668667|11114515|FG003|Overall Study|Adverse Event|4
7034132|NCT01668667|11114512|FG000|Overall Study|Lack of Efficacy|3
7034133|NCT01668667|11114513|FG001|Overall Study|Lack of Efficacy|2
7034134|NCT01668667|11114514|FG002|Overall Study|Lack of Efficacy|2
7034135|NCT01668667|11114515|FG003|Overall Study|Lack of Efficacy|3
7034136|NCT01668667|11114512|FG000|Overall Study|Protocol Violation|6
7034137|NCT01668667|11114513|FG001|Overall Study|Protocol Violation|10
7034138|NCT01668667|11114514|FG002|Overall Study|Protocol Violation|12
7034139|NCT01668667|11114515|FG003|Overall Study|Protocol Violation|5
7034140|NCT01668667|11114512|FG000|Overall Study|Lost to Follow-up|9
7034141|NCT01668667|11114513|FG001|Overall Study|Lost to Follow-up|4
7034142|NCT01668667|11114514|FG002|Overall Study|Lost to Follow-up|7
7034143|NCT01668667|11114515|FG003|Overall Study|Lost to Follow-up|6
7034144|NCT01668667|11114512|FG000|Overall Study|Physician Decision|3
7034145|NCT01668667|11114513|FG001|Overall Study|Physician Decision|0
7034146|NCT01668667|11114514|FG002|Overall Study|Physician Decision|1
7034147|NCT01668667|11114515|FG003|Overall Study|Physician Decision|0
7034148|NCT01668667|11114512|FG000|Overall Study|Withdrawal by Subject|7
7034149|NCT01668667|11114513|FG001|Overall Study|Withdrawal by Subject|4
7034150|NCT01668667|11114514|FG002|Overall Study|Withdrawal by Subject|5
7034151|NCT01668667|11114515|FG003|Overall Study|Withdrawal by Subject|5
7034152|NCT01668797|11114527|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3
7034153|NCT01668797|11114528|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0
7034154|NCT01668797|11114529|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0
7034155|NCT01668797|11114530|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0
7034156|NCT01668797|11114527|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3
7034157|NCT01668797|11114528|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
7034158|NCT01668797|11114529|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
7034159|NCT01668797|11114530|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
7034160|NCT01668797|11114527|FG000|Phase A (Conversion Phase)|Physician Decision|2
7034161|NCT01668797|11114528|FG001|Phase A (Conversion Phase)|Physician Decision|0
7034162|NCT01668797|11114529|FG002|Phase A (Conversion Phase)|Physician Decision|0
7034163|NCT01668797|11114530|FG003|Phase A (Conversion Phase)|Physician Decision|0
7034164|NCT01668797|11114527|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16
7034165|NCT01668797|11114528|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0
7034166|NCT01668797|11114529|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0
7034167|NCT01668797|11114530|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0
7034168|NCT01668797|11114527|FG000|Phase A (Conversion Phase)|Protocol Violation|2
7034169|NCT01668797|11114528|FG001|Phase A (Conversion Phase)|Protocol Violation|0
7034170|NCT01668797|11114529|FG002|Phase A (Conversion Phase)|Protocol Violation|0
7034171|NCT01668797|11114530|FG003|Phase A (Conversion Phase)|Protocol Violation|0
7034172|NCT01668797|11114527|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7
7034173|NCT01668797|11114528|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0
7034174|NCT01668797|11114529|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0
7034175|NCT01668797|11114530|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0
7034176|NCT01668797|11114527|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8
7034177|NCT01668797|11114528|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
7034178|NCT01668797|11114529|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
7034179|NCT01668797|11114530|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
7034180|NCT01668797|11114527|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19
7034181|NCT01668797|11114528|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
7034182|NCT01668797|11114529|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
7034183|NCT01668797|11114530|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
7034184|NCT01668797|11114527|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0
7034185|NCT01668797|11114528|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16
7034186|NCT01668797|11114529|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0
7034187|NCT01668797|11114530|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0
7034188|NCT01668797|11114527|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
7034189|NCT01668797|11114528|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22
7034190|NCT01668797|11114529|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
7034191|NCT01668797|11114530|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
7034192|NCT01668797|11114527|FG000|Phase B (Stabilization Phase)|Physician Decision|0
7034193|NCT01668797|11114528|FG001|Phase B (Stabilization Phase)|Physician Decision|11
7034194|NCT01668797|11114529|FG002|Phase B (Stabilization Phase)|Physician Decision|0
7034195|NCT01668797|11114530|FG003|Phase B (Stabilization Phase)|Physician Decision|0
7034196|NCT01668797|11114527|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0
7034197|NCT01668797|11114528|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60
7034198|NCT01668797|11114529|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0
7034199|NCT01668797|11114530|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0
7034200|NCT01668797|11114527|FG000|Phase B (Stabilization Phase)|Protocol Violation|0
7034201|NCT01668797|11114528|FG001|Phase B (Stabilization Phase)|Protocol Violation|3
7034202|NCT01668797|11114529|FG002|Phase B (Stabilization Phase)|Protocol Violation|0
7034203|NCT01668797|11114530|FG003|Phase B (Stabilization Phase)|Protocol Violation|0
7034204|NCT01668797|11114527|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0
7034205|NCT01668797|11114528|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21
7034206|NCT01668797|11114529|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0
7034207|NCT01668797|11114530|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0
7034208|NCT01668797|11114527|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
7034209|NCT01668797|11114528|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43
7034210|NCT01668797|11114529|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
7034211|NCT01668797|11114530|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
7034212|NCT01668797|11114527|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
7034213|NCT01668797|11114528|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86
7034214|NCT01668797|11114529|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
7034215|NCT01668797|11114530|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
7034216|NCT01668797|11114527|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
7034217|NCT01668797|11114528|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
7034218|NCT01668797|11114529|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4
7034219|NCT01668797|11114530|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6
7034220|NCT01668797|11114527|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
7034221|NCT01668797|11114528|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
7034222|NCT01668797|11114529|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
7034223|NCT01668797|11114530|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
7034224|NCT01668797|11114527|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
7034225|NCT01668797|11114528|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
7034226|NCT01668797|11114529|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5
7034227|NCT01668797|11114530|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2
7034228|NCT01668797|11114527|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
7034229|NCT01668797|11114528|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
7034230|NCT01668797|11114529|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3
7034231|NCT01668797|11114530|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5
7034232|NCT01668797|11114527|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
7034233|NCT01668797|11114528|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
7034234|NCT01668797|11114529|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2
7034235|NCT01668797|11114530|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
7034236|NCT01668797|11114527|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
7143226|NCT03029143|11299739|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0
7143227|NCT03029143|11299740|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0
7143228|NCT03029143|11299738|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142
7143229|NCT03029143|11299739|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0
7034237|NCT01668797|11114528|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
7034238|NCT01668797|11114529|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2
7034239|NCT01668797|11114530|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10
7034240|NCT01668797|11114527|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
7034241|NCT01668797|11114528|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
7034242|NCT01668797|11114529|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11
7034243|NCT01668797|11114530|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30
7034244|NCT01668797|11114527|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
7034245|NCT01668797|11114528|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
7034246|NCT01668797|11114529|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4
7034247|NCT01668797|11114530|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2
7034248|NCT01668797|11114527|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
7034249|NCT01668797|11114528|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
7034250|NCT01668797|11114529|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49
7034251|NCT01668797|11114530|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38
7034252|NCT01668966|11114560|FG000|Overall Study|Withdrawal by Subject|1
7034253|NCT01668966|11114560|FG000|Overall Study|Death|1
7034254|NCT01668966|11114560|FG000|Overall Study|Not treated|2
7034255|NCT01669122|11114568|FG000|Period I|Lost to Follow-up|1
7034256|NCT01669122|11114568|FG000|Washout Period II|Protocol Violation|2
7034257|NCT01669174|11114581|FG000|Overall Study|Subject withdrew consent|2
7034258|NCT01669174|11114582|FG001|Overall Study|Subject withdrew consent|2
7034259|NCT01669174|11114581|FG000|Overall Study|Lost to Follow-up|1
7034260|NCT01669174|11114582|FG001|Overall Study|Lost to Follow-up|0
7034261|NCT01669174|11114581|FG000|Overall Study|Adverse Event|2
7034262|NCT01669174|11114582|FG001|Overall Study|Adverse Event|2
7034263|NCT01669174|11114581|FG000|Overall Study|Administrative problems|1
7034264|NCT01669174|11114582|FG001|Overall Study|Administrative problems|2
7034265|NCT01669343|11114588|FG000|Part A: All Patients|Withdrawal by Subject|7
7034266|NCT01669343|11114588|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2
7034267|NCT01669343|11114588|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13
7183612|NCT01488890|11383708|FG003|Overall Study|Protocol Violation|0
7183613|NCT01488890|11383705|FG000|Overall Study|Lost to Follow-up|13
7034268|NCT01669343|11114588|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3
7034269|NCT01669343|11114588|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1
7044593|NCT01755546|11130485|FG000|Long Term Treatment|Withdrawal by Subject|35
7044594|NCT01755546|11130485|FG000|Long Term Treatment|Lost to Follow-up|17
7044595|NCT01755546|11130485|FG000|Long Term Treatment|other and ongoing|41
7044596|NCT01755598|11130491|FG000|Overall Study|Other|109
7044597|NCT01755598|11130492|FG001|Overall Study|Other|109
7044598|NCT01755598|11130491|FG000|Overall Study|Lost to Follow-up|32
7044599|NCT01755598|11130492|FG001|Overall Study|Lost to Follow-up|43
7044600|NCT01755598|11130491|FG000|Overall Study|Migrated/moved from study area|76
7044601|NCT01755598|11130492|FG001|Overall Study|Migrated/moved from study area|65
7044602|NCT01755598|11130491|FG000|Overall Study|Withdrawal by Subject|22
7044603|NCT01755598|11130492|FG001|Overall Study|Withdrawal by Subject|31
7044604|NCT01755598|11130491|FG000|Overall Study|Protocol Violation|7
7044605|NCT01755598|11130492|FG001|Overall Study|Protocol Violation|7
7044606|NCT01755598|11130491|FG000|Overall Study|Adverse Event|19
7044607|NCT01755598|11130492|FG001|Overall Study|Adverse Event|28
7044608|NCT01755637|11130498|FG000|Period 1|Adverse Event|0
7044609|NCT01755637|11130499|FG001|Period 1|Adverse Event|1
7044610|NCT01755702|11130511|FG000|Wash Out Period I|Other Reason|3
7044611|NCT01755702|11130511|FG000|Washout Period II|Other Reason|5
7044612|NCT01755767|11130525|FG000|Overall Study|Progressive Disease|8
7044613|NCT01755767|11130526|FG001|Overall Study|Progressive Disease|7
7044614|NCT01755767|11130527|FG002|Overall Study|Progressive Disease|91
7044615|NCT01755767|11130528|FG003|Overall Study|Progressive Disease|43
7044616|NCT01755767|11130525|FG000|Overall Study|Clinical Disease Progression|4
7044617|NCT01755767|11130526|FG001|Overall Study|Clinical Disease Progression|2
7044618|NCT01755767|11130527|FG002|Overall Study|Clinical Disease Progression|29
7044619|NCT01755767|11130528|FG003|Overall Study|Clinical Disease Progression|20
7044620|NCT01755767|11130525|FG000|Overall Study|Radiographic Disease Progression|9
7044621|NCT01755767|11130526|FG001|Overall Study|Radiographic Disease Progression|4
7044622|NCT01755767|11130527|FG002|Overall Study|Radiographic Disease Progression|44
7044623|NCT01755767|11130528|FG003|Overall Study|Radiographic Disease Progression|27
7044624|NCT01755767|11130525|FG000|Overall Study|Adverse Event|6
7044625|NCT01755767|11130526|FG001|Overall Study|Adverse Event|0
7044626|NCT01755767|11130527|FG002|Overall Study|Adverse Event|28
7044627|NCT01755767|11130528|FG003|Overall Study|Adverse Event|11
7044628|NCT01755767|11130525|FG000|Overall Study|Death|1
7044629|NCT01755767|11130526|FG001|Overall Study|Death|2
7044630|NCT01755767|11130527|FG002|Overall Study|Death|15
7044631|NCT01755767|11130528|FG003|Overall Study|Death|4
7044632|NCT01755767|11130525|FG000|Overall Study|Subject Decision|0
7044633|NCT01755767|11130526|FG001|Overall Study|Subject Decision|0
7044634|NCT01755767|11130527|FG002|Overall Study|Subject Decision|10
7044635|NCT01755767|11130528|FG003|Overall Study|Subject Decision|3
7044636|NCT01755767|11130525|FG000|Overall Study|Withdrawal by Subject|0
7044637|NCT01755767|11130526|FG001|Overall Study|Withdrawal by Subject|0
7044638|NCT01755767|11130527|FG002|Overall Study|Withdrawal by Subject|2
7044639|NCT01755767|11130528|FG003|Overall Study|Withdrawal by Subject|1
7044640|NCT01755767|11130525|FG000|Overall Study|Other|0
7044641|NCT01755767|11130526|FG001|Overall Study|Other|0
7044642|NCT01755767|11130527|FG002|Overall Study|Other|2
7044643|NCT01755767|11130528|FG003|Overall Study|Other|3
7044644|NCT01755767|11130525|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0
7044645|NCT01755767|11130526|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0
7044646|NCT01755767|11130527|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5
7044647|NCT01755767|11130528|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2
7044648|NCT01755858|11130540|FG000|Overall Study|Adverse Event|1
7044649|NCT01755858|11130541|FG001|Overall Study|Adverse Event|1
7044650|NCT01756053|11130574|FG000|Period 1 (10 Days)|Protocol Violation|1
7044651|NCT01756053|11130575|FG001|Period 1 (10 Days)|Protocol Violation|1
7044652|NCT01756053|11130574|FG000|Period 2 (10 Days)|Protocol Violation|0
7044653|NCT01756053|11130575|FG001|Period 2 (10 Days)|Protocol Violation|2
7044654|NCT01756079|11130581|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4
7044655|NCT01756079|11130581|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5
7044656|NCT01756079|11130581|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2
7044657|NCT01756079|11130581|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20
7044658|NCT01756079|11130581|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4
7044659|NCT01756157|11130586|FG000|First Intervention Period|Withdrawal by Subject|1
7044660|NCT01756157|11130587|FG001|First Intervention Period|Withdrawal by Subject|0
7044661|NCT01756157|11130586|FG000|First Intervention Period|Lost to Follow-up|0
7044662|NCT01756157|11130587|FG001|First Intervention Period|Lost to Follow-up|2
7044663|NCT01756235|11130610|FG000|Overall Study|Adalimumab Treatment was not Documented|2
7044664|NCT01756274|11130614|FG000|Overall Study|Protocol Violation|2
7044665|NCT01756274|11130614|FG000|Overall Study|Laboratory error|1
7044666|NCT01756300|11130619|FG000|Overall Study|Death|1
7044667|NCT01756300|11130619|FG000|Overall Study|Withdrawal by Subject|1
7044668|NCT01756352|11130640|FG000|Overall Study|moved away and lost to followup|1
7044669|NCT01756456|11130654|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0
7044670|NCT01756456|11130655|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0
7044671|NCT01756456|11130656|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0
7034270|NCT01669421|11114595|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1
7034271|NCT01669421|11114595|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1
7034272|NCT01669577|11114627|FG000|Overall Study|Death|22
7034273|NCT01669577|11114627|FG000|Overall Study|Lost to Follow-up|78
7034274|NCT01669577|11114627|FG000|Overall Study|Physician Decision|34
7034275|NCT01669629|11114640|FG000|Period 1|protocol deviation|1
7034276|NCT01669629|11114641|FG001|Period 1|protocol deviation|2
7034277|NCT01669798|11114697|FG000|Overall Study|Physician Decision|5
7034278|NCT01669811|11114703|FG000|Overall Study|Investigator decision|0
7034279|NCT01669811|11114704|FG001|Overall Study|Investigator decision|1
7034280|NCT01669811|11114703|FG000|Overall Study|Withdrawal by Subject|1
7034281|NCT01669811|11114704|FG001|Overall Study|Withdrawal by Subject|2
7034282|NCT01669811|11114703|FG000|Overall Study|Adverse Event|2
7034283|NCT01669811|11114704|FG001|Overall Study|Adverse Event|6
7034284|NCT01669811|11114703|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0
7034285|NCT01669811|11114704|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2
7034286|NCT01669902|11114715|FG000|Overall Study|Adverse Event|11
7034287|NCT01669902|11114715|FG000|Overall Study|Lack of Efficacy|10
7034288|NCT01669902|11114715|FG000|Overall Study|Other|8
7034289|NCT01669928|11114721|FG000|First Intervention|Withdrawal by Subject|3
7034290|NCT01669928|11114722|FG001|First Intervention|Withdrawal by Subject|5
7034291|NCT01670019|11114732|FG000|Overall Study|Adverse Event|3
7034292|NCT01670019|11114733|FG001|Overall Study|Adverse Event|0
7034293|NCT01670019|11114732|FG000|Overall Study|Withdrawal by Subject|6
7034294|NCT01670019|11114733|FG001|Overall Study|Withdrawal by Subject|0
7034295|NCT01670045|11114739|FG000|Overall Study|Withdrawal by Subject|3
7034296|NCT01670045|11114739|FG000|Overall Study|Adverse Event|1
7034297|NCT01670045|11114739|FG000|Overall Study|Death|1
7034298|NCT01670045|11114739|FG000|Overall Study|Lost to Follow-up|11
7034299|NCT01670097|11114745|FG000|Overall Study|Started Phase 1 cancer treatment|1
7034300|NCT01670097|11114746|FG001|Overall Study|Started Phase 1 cancer treatment|0
7034301|NCT01670097|11114745|FG000|Overall Study|Study burden|1
7034302|NCT01670097|11114746|FG001|Overall Study|Study burden|0
7034303|NCT01670097|11114745|FG000|Overall Study|COPD exacerbation|0
7034304|NCT01670097|11114746|FG001|Overall Study|COPD exacerbation|1
7034305|NCT01670097|11114745|FG000|Overall Study|Neutropenia|0
7034306|NCT01670097|11114746|FG001|Overall Study|Neutropenia|1
7034307|NCT01670097|11114745|FG000|Overall Study|Clinical deterioration|0
7034308|NCT01670097|11114746|FG001|Overall Study|Clinical deterioration|1
7034309|NCT01670097|11114745|FG000|Overall Study|Disease progression|0
7034310|NCT01670097|11114746|FG001|Overall Study|Disease progression|1
7034311|NCT01670188|11114763|FG000|Overall Study|Death|0
7034312|NCT01670188|11114764|FG001|Overall Study|Death|1
7034313|NCT01670279|11114777|FG000|Overall Study|Adverse Event|0
7034314|NCT01670279|11114778|FG001|Overall Study|Adverse Event|1
7034315|NCT01670279|11114779|FG002|Overall Study|Adverse Event|0
7034316|NCT01670279|11114780|FG003|Overall Study|Adverse Event|0
7034317|NCT01670279|11114777|FG000|Overall Study|Physician Decision|0
7034318|NCT01670279|11114778|FG001|Overall Study|Physician Decision|1
7034319|NCT01670279|11114779|FG002|Overall Study|Physician Decision|0
7034320|NCT01670279|11114780|FG003|Overall Study|Physician Decision|0
7034321|NCT01670279|11114777|FG000|Overall Study|Participant met withdrawal criteria|0
7034322|NCT01670279|11114778|FG001|Overall Study|Participant met withdrawal criteria|0
7034323|NCT01670279|11114779|FG002|Overall Study|Participant met withdrawal criteria|0
7034324|NCT01670279|11114780|FG003|Overall Study|Participant met withdrawal criteria|1
7034325|NCT01670292|11114788|FG000|Overall Study|Lost to Follow-up|14
7034326|NCT01670526|11114811|FG000|Overall Study|Withdrawal by Subject|3
7034327|NCT01670526|11114812|FG001|Overall Study|Withdrawal by Subject|1
7034328|NCT01670526|11114811|FG000|Overall Study|Lost to Follow-up|9
7034329|NCT01670526|11114812|FG001|Overall Study|Lost to Follow-up|5
7034330|NCT01670721|11114818|FG000|Overall Study|Participant's decision|15
7034331|NCT01670721|11114818|FG000|Overall Study|Other than specified above|38
7034332|NCT01671007|11114846|FG000|Overall Study|Other reasons than listed|166
7034333|NCT01671007|11114847|FG001|Overall Study|Other reasons than listed|373
7034334|NCT01671007|11114848|FG002|Overall Study|Other reasons than listed|197
7034335|NCT01671007|11114849|FG003|Overall Study|Other reasons than listed|228
7034336|NCT01671007|11114850|FG004|Overall Study|Other reasons than listed|14
7034337|NCT01671007|11114851|FG005|Overall Study|Other reasons than listed|71
7034338|NCT01671007|11114852|FG006|Overall Study|Other reasons than listed|17
7034339|NCT01671007|11114853|FG007|Overall Study|Other reasons than listed|66
7034340|NCT01671007|11114854|FG008|Overall Study|Other reasons than listed|0
7034341|NCT01671007|11114846|FG000|Overall Study|Withdrawal by Subject|36
7034342|NCT01671007|11114847|FG001|Overall Study|Withdrawal by Subject|59
7034343|NCT01671007|11114848|FG002|Overall Study|Withdrawal by Subject|53
7034344|NCT01671007|11114849|FG003|Overall Study|Withdrawal by Subject|58
7034345|NCT01671007|11114850|FG004|Overall Study|Withdrawal by Subject|4
7034346|NCT01671007|11114851|FG005|Overall Study|Withdrawal by Subject|15
7034347|NCT01671007|11114852|FG006|Overall Study|Withdrawal by Subject|1
7034348|NCT01671007|11114853|FG007|Overall Study|Withdrawal by Subject|19
7034349|NCT01671007|11114854|FG008|Overall Study|Withdrawal by Subject|0
7034350|NCT01671007|11114846|FG000|Overall Study|Lost to Follow-up|93
7034351|NCT01671007|11114847|FG001|Overall Study|Lost to Follow-up|142
7034352|NCT01671007|11114848|FG002|Overall Study|Lost to Follow-up|91
7034353|NCT01671007|11114849|FG003|Overall Study|Lost to Follow-up|63
7034354|NCT01671007|11114850|FG004|Overall Study|Lost to Follow-up|7
7034355|NCT01671007|11114851|FG005|Overall Study|Lost to Follow-up|20
7034356|NCT01671007|11114852|FG006|Overall Study|Lost to Follow-up|2
7034357|NCT01671007|11114853|FG007|Overall Study|Lost to Follow-up|28
7034358|NCT01671007|11114854|FG008|Overall Study|Lost to Follow-up|0
7034359|NCT01671007|11114846|FG000|Overall Study|No end of study case report form|3
7034360|NCT01671007|11114847|FG001|Overall Study|No end of study case report form|1
7034361|NCT01671007|11114848|FG002|Overall Study|No end of study case report form|0
7034362|NCT01671007|11114849|FG003|Overall Study|No end of study case report form|2
7034363|NCT01671007|11114850|FG004|Overall Study|No end of study case report form|0
7034364|NCT01671007|11114851|FG005|Overall Study|No end of study case report form|0
7034365|NCT01671007|11114852|FG006|Overall Study|No end of study case report form|0
7034366|NCT01671007|11114853|FG007|Overall Study|No end of study case report form|0
7034367|NCT01671007|11114854|FG008|Overall Study|No end of study case report form|0
7034368|NCT01671007|11114846|FG000|Overall Study|Not eligible|23
7034369|NCT01671007|11114847|FG001|Overall Study|Not eligible|76
7034370|NCT01671007|11114848|FG002|Overall Study|Not eligible|25
7034371|NCT01671007|11114849|FG003|Overall Study|Not eligible|17
7034372|NCT01671007|11114850|FG004|Overall Study|Not eligible|0
7034373|NCT01671007|11114851|FG005|Overall Study|Not eligible|6
7034374|NCT01671007|11114852|FG006|Overall Study|Not eligible|1
7034375|NCT01671007|11114853|FG007|Overall Study|Not eligible|19
7034376|NCT01671007|11114854|FG008|Overall Study|Not eligible|0
7034377|NCT01671059|11114865|FG000|Overall Study|Adverse Event|4
7034378|NCT01671059|11114865|FG000|Overall Study|Lack of Efficacy|1
7034379|NCT01671085|11114872|FG000|Overall Study|Withdrawal by Subject|1
7034380|NCT01671085|11114873|FG001|Overall Study|Withdrawal by Subject|0
7034381|NCT01671111|11114880|FG000|Overall Study|Adverse Event|2
7034382|NCT01671111|11114880|FG000|Overall Study|Lack of Efficacy|1
7034383|NCT01671111|11114880|FG000|Overall Study|Withdrawal by Subject|2
7034384|NCT01671111|11114880|FG000|Overall Study|Physician Decision|1
7034385|NCT01671111|11114880|FG000|Overall Study|Other|24
7034386|NCT01671280|11114888|FG000|Overall Study|Withdrawal by Subject|2
7034387|NCT01671319|11114901|FG000|Overall Study|Withdrawal by Subject|1
7034388|NCT01671332|11114907|FG000|Overall Study|Withdrawal by Subject|1
7034389|NCT01671332|11114908|FG001|Overall Study|Withdrawal by Subject|1
7034390|NCT01671345|11114916|FG000|Overall Study|Lost to Follow-up|10
7034391|NCT01671345|11114917|FG001|Overall Study|Lost to Follow-up|6
7034392|NCT01671345|11114916|FG000|Overall Study|visit with non-participating physician|3
7034393|NCT01671345|11114917|FG001|Overall Study|visit with non-participating physician|3
7034394|NCT01671488|11114935|FG000|Overall Study|Withdrawal by Subject|1
7034395|NCT01671748|11114950|FG000|4 Week run-in Phase|Withdrawal by Subject|1
7034396|NCT01671748|11114951|FG001|4 Week run-in Phase|Withdrawal by Subject|0
7034397|NCT01671748|11114950|FG000|4 Week run-in Phase|Adverse Event|1
7034398|NCT01671748|11114951|FG001|4 Week run-in Phase|Adverse Event|0
7034399|NCT01671748|11114950|FG000|4 Week run-in Phase|Not eligible|9
7034400|NCT01671748|11114951|FG001|4 Week run-in Phase|Not eligible|0
7034401|NCT01672294|11114968|FG000|Overall Study|Withdrawal by Subject|4
7034402|NCT01672294|11114969|FG001|Overall Study|Withdrawal by Subject|4
7034403|NCT01672294|11114970|FG002|Overall Study|Withdrawal by Subject|4
7034404|NCT01672294|11114971|FG003|Overall Study|Withdrawal by Subject|4
7034405|NCT01672294|11114968|FG000|Overall Study|Excluded by study|1
7034406|NCT01672294|11114969|FG001|Overall Study|Excluded by study|1
7034407|NCT01672294|11114970|FG002|Overall Study|Excluded by study|0
7034408|NCT01672294|11114971|FG003|Overall Study|Excluded by study|0
7034409|NCT01672294|11114968|FG000|Overall Study|Lost to Follow-up|1
7034410|NCT01672294|11114969|FG001|Overall Study|Lost to Follow-up|16
7034411|NCT01672294|11114970|FG002|Overall Study|Lost to Follow-up|7
7034412|NCT01672294|11114971|FG003|Overall Study|Lost to Follow-up|9
7034413|NCT01672710|11114992|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0
7034414|NCT01672710|11114993|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1
7034415|NCT01672710|11114992|FG000|3 Month Follow up|Lost to Follow-up|2
7034416|NCT01672710|11114993|FG001|3 Month Follow up|Lost to Follow-up|3
7034417|NCT01672710|11114992|FG000|3 Month Follow up|follow up due after termination date|4
7034418|NCT01672710|11114993|FG001|3 Month Follow up|follow up due after termination date|1
7034419|NCT01672723|11114999|FG000|First Intervention|Adverse Event|3
7034420|NCT01672723|11115000|FG001|First Intervention|Adverse Event|0
7034421|NCT01672736|11115006|FG000|Overall Study|Available drug expired on 31 May 16|3
7034422|NCT01672788|11115010|FG000|Washout Period 2 (7 Days)|Adverse Event|0
7034423|NCT01672788|11115011|FG001|Washout Period 2 (7 Days)|Adverse Event|0
7034424|NCT01672788|11115012|FG002|Washout Period 2 (7 Days)|Adverse Event|0
7034425|NCT01672788|11115013|FG003|Washout Period 2 (7 Days)|Adverse Event|1
7034426|NCT01672801|11115025|FG000|Overall Study|Screen Failure|0
7034427|NCT01672801|11115026|FG001|Overall Study|Screen Failure|1
7034428|NCT01672853|11115041|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0
7034429|NCT01672853|11115042|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4
7034430|NCT01672853|11115043|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0
7034431|NCT01672853|11115041|FG000|Overall Study|Pregnancy|0
7034432|NCT01672853|11115042|FG001|Overall Study|Pregnancy|1
7034433|NCT01672853|11115043|FG002|Overall Study|Pregnancy|0
7034434|NCT01672853|11115041|FG000|Overall Study|Investigator's Discretion|1
7034435|NCT01672853|11115042|FG001|Overall Study|Investigator's Discretion|0
7034436|NCT01672853|11115043|FG002|Overall Study|Investigator's Discretion|0
7034437|NCT01672853|11115041|FG000|Overall Study|Withdrew Consent|5
7034438|NCT01672853|11115042|FG001|Overall Study|Withdrew Consent|5
7034439|NCT01672853|11115043|FG002|Overall Study|Withdrew Consent|5
7034440|NCT01672853|11115041|FG000|Overall Study|Adverse Event|4
7034441|NCT01672853|11115042|FG001|Overall Study|Adverse Event|6
7034442|NCT01672853|11115043|FG002|Overall Study|Adverse Event|8
7034443|NCT01672853|11115041|FG000|Overall Study|Lost to Follow-up|0
7034444|NCT01672853|11115042|FG001|Overall Study|Lost to Follow-up|1
7034445|NCT01672853|11115043|FG002|Overall Study|Lost to Follow-up|0
7034446|NCT01672853|11115041|FG000|Overall Study|Randomized but Never Treated|0
7034447|NCT01672853|11115042|FG001|Overall Study|Randomized but Never Treated|0
7034448|NCT01672853|11115043|FG002|Overall Study|Randomized but Never Treated|1
7034449|NCT01672866|11115054|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40
7034450|NCT01672866|11115055|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42
7034451|NCT01672866|11115056|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35
7034452|NCT01672866|11115054|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9
7034453|NCT01672866|11115055|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8
7034454|NCT01672866|11115056|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12
7034455|NCT01672866|11115054|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3
7034456|NCT01672866|11115055|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3
7034457|NCT01672866|11115056|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5
7034458|NCT01672866|11115054|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3
7034459|NCT01672866|11115055|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3
7034460|NCT01672866|11115056|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3
7034461|NCT01672866|11115054|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3
7034462|NCT01672866|11115055|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3
7034463|NCT01672866|11115056|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2
7034464|NCT01672866|11115054|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2
7034465|NCT01672866|11115055|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0
7034466|NCT01672866|11115056|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0
7034467|NCT01672866|11115054|FG000|Blinded Phase (up to 240 Weeks)|Death|0
7034468|NCT01672866|11115055|FG001|Blinded Phase (up to 240 Weeks)|Death|0
7034469|NCT01672866|11115056|FG002|Blinded Phase (up to 240 Weeks)|Death|1
7034470|NCT01672866|11115054|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3
7034471|NCT01672866|11115055|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0
7034472|NCT01672866|11115056|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0
7034473|NCT01672866|11115054|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11
7034474|NCT01672866|11115055|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15
7034475|NCT01672866|11115056|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16
7034476|NCT01672866|11115054|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8
7034477|NCT01672866|11115055|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15
7034478|NCT01672866|11115056|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15
7034479|NCT01672866|11115054|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1
7034480|NCT01672866|11115055|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0
7034481|NCT01672866|11115056|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1
7034482|NCT01672866|11115054|FG000|Open-Label Phase (up to 240 Weeks)|Death|1
7034483|NCT01672866|11115055|FG001|Open-Label Phase (up to 240 Weeks)|Death|0
7034484|NCT01672866|11115056|FG002|Open-Label Phase (up to 240 Weeks)|Death|0
7034485|NCT01672866|11115054|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1
7034486|NCT01672866|11115055|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0
7034487|NCT01672866|11115056|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0
7034488|NCT01672879|11115069|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43
7034489|NCT01672879|11115070|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55
7034490|NCT01672879|11115071|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61
7034491|NCT01672879|11115069|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14
7034492|NCT01672879|11115070|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7
7034493|NCT01672879|11115071|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6
7034494|NCT01672879|11115069|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5
7034495|NCT01672879|11115070|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2
7034496|NCT01672879|11115071|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7
7034497|NCT01672879|11115069|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4
7034498|NCT01672879|11115070|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3
7034499|NCT01672879|11115071|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1
7034500|NCT01672879|11115069|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5
7034501|NCT01672879|11115070|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0
7034502|NCT01672879|11115071|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2
7034503|NCT01672879|11115069|FG000|Blinded Phase (Up to 240 Weeks)|Death|0
7034504|NCT01672879|11115070|FG001|Blinded Phase (Up to 240 Weeks)|Death|2
7034505|NCT01672879|11115071|FG002|Blinded Phase (Up to 240 Weeks)|Death|0
7034506|NCT01672879|11115069|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1
7034507|NCT01672879|11115070|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0
7034508|NCT01672879|11115071|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0
7060604|NCT01920477|11156953|FG001|Overall Study|Lack of Efficacy|0
7034509|NCT01672879|11115069|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0
7034510|NCT01672879|11115070|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0
7034511|NCT01672879|11115071|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1
7034512|NCT01672879|11115069|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15
7034513|NCT01672879|11115070|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17
7034514|NCT01672879|11115071|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8
7034515|NCT01672879|11115069|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8
7034516|NCT01672879|11115070|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16
7034517|NCT01672879|11115071|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6
7034518|NCT01672879|11115069|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5
7034519|NCT01672879|11115070|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1
7034520|NCT01672879|11115071|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1
7034521|NCT01672879|11115069|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1
7034522|NCT01672879|11115070|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0
7034523|NCT01672879|11115071|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1
7034524|NCT01672879|11115069|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1
7034525|NCT01672879|11115070|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0
7034526|NCT01672879|11115071|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0
7034527|NCT01672957|11115080|FG000|Overall Study|Protocol Violation|48
7034528|NCT01672957|11115080|FG000|Overall Study|Death|2
7034529|NCT01672957|11115080|FG000|Overall Study|ICF Signed After Transplantation|5
7034530|NCT01672970|11115084|FG000|Overall Study|Lack of Efficacy|12
7034531|NCT01672970|11115084|FG000|Overall Study|Adverse Event|18
7034532|NCT01672970|11115084|FG000|Overall Study|Withdrawal by Subject|2
7034533|NCT01672970|11115084|FG000|Overall Study|Lost to Follow-up|5
7034534|NCT01672970|11115084|FG000|Overall Study|Other|9
7034535|NCT01672970|11115084|FG000|Overall Study|Enrolled but not treated|1
7034536|NCT01673009|11115146|FG000|Overall Study|Physician Decision|5
7034537|NCT01673009|11115146|FG000|Overall Study|Withdrawal by Subject|8
7034538|NCT01673126|11115166|FG000|Overall Study|change of diagnosis|4
7034539|NCT01673126|11115167|FG001|Overall Study|change of diagnosis|3
7034540|NCT01673178|11115178|FG000|Overall Study|Lost to Follow-up|0
7034541|NCT01673178|11115179|FG001|Overall Study|Lost to Follow-up|1
7034542|NCT01673178|11115180|FG002|Overall Study|Lost to Follow-up|0
7034543|NCT01673178|11115181|FG003|Overall Study|Lost to Follow-up|0
7034544|NCT01673178|11115182|FG004|Overall Study|Lost to Follow-up|0
7034545|NCT01673178|11115178|FG000|Overall Study|Withdrawal by Subject|0
7034546|NCT01673178|11115179|FG001|Overall Study|Withdrawal by Subject|0
7034547|NCT01673178|11115180|FG002|Overall Study|Withdrawal by Subject|1
7034548|NCT01673178|11115181|FG003|Overall Study|Withdrawal by Subject|4
7034549|NCT01673178|11115182|FG004|Overall Study|Withdrawal by Subject|2
7034550|NCT01673178|11115178|FG000|Overall Study|Protocol Violation|1
7034551|NCT01673178|11115179|FG001|Overall Study|Protocol Violation|1
7034552|NCT01673178|11115180|FG002|Overall Study|Protocol Violation|0
7034553|NCT01673178|11115181|FG003|Overall Study|Protocol Violation|1
7034554|NCT01673178|11115182|FG004|Overall Study|Protocol Violation|0
7034555|NCT01673178|11115178|FG000|Overall Study|Adverse Event|1
7034556|NCT01673178|11115179|FG001|Overall Study|Adverse Event|0
7034557|NCT01673178|11115180|FG002|Overall Study|Adverse Event|0
7034558|NCT01673178|11115181|FG003|Overall Study|Adverse Event|2
7034559|NCT01673178|11115182|FG004|Overall Study|Adverse Event|0
7034560|NCT01673178|11115178|FG000|Overall Study|Other|1
7034561|NCT01673178|11115179|FG001|Overall Study|Other|0
7034562|NCT01673178|11115180|FG002|Overall Study|Other|2
7034563|NCT01673178|11115181|FG003|Overall Study|Other|1
7034564|NCT01673178|11115182|FG004|Overall Study|Other|0
7034565|NCT01673282|11115213|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9
7034566|NCT01673282|11115214|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5
7034567|NCT01673282|11115213|FG000|Overall Study|Lack of Efficacy|9
7034568|NCT01673282|11115214|FG001|Overall Study|Lack of Efficacy|2
7034569|NCT01673282|11115213|FG000|Overall Study|Lost to Follow-up|11
7034570|NCT01673282|11115214|FG001|Overall Study|Lost to Follow-up|10
7034571|NCT01673282|11115213|FG000|Overall Study|Withdrawal by Subject|3
7034572|NCT01673282|11115214|FG001|Overall Study|Withdrawal by Subject|3
7034573|NCT01673282|11115213|FG000|Overall Study|Other|1
7034574|NCT01673282|11115214|FG001|Overall Study|Other|6
7034575|NCT01673347|11115220|FG000|Overall Study|failure of allograft|7
7034576|NCT01673373|11115224|FG000|Overall Study|Death|2
7034577|NCT01673386|11115228|FG000|Overall Study|Study terminated by sponsor|16
7034578|NCT01673386|11115229|FG001|Overall Study|Study terminated by sponsor|22
7034579|NCT01673386|11115228|FG000|Overall Study|Adverse Event|5
7034580|NCT01673386|11115229|FG001|Overall Study|Adverse Event|2
7034581|NCT01673386|11115228|FG000|Overall Study|Progressive disease|4
7034582|NCT01673386|11115229|FG001|Overall Study|Progressive disease|1
7034583|NCT01673386|11115228|FG000|Overall Study|Withdrawal by Subject|0
7034584|NCT01673386|11115229|FG001|Overall Study|Withdrawal by Subject|2
7034585|NCT01673490|11115235|FG000|Overall Study|Lost to Follow-up|1
7034586|NCT01673490|11115235|FG000|Overall Study|Adverse Event|3
7034587|NCT01673490|11115235|FG000|Overall Study|Withdrawal by Subject|3
7034588|NCT01673594|11115250|FG000|Overall Study|Adverse Event|3
7034589|NCT01673594|11115251|FG001|Overall Study|Adverse Event|1
7034590|NCT01673594|11115250|FG000|Overall Study|Lost to Follow-up|1
7034591|NCT01673594|11115251|FG001|Overall Study|Lost to Follow-up|0
7034592|NCT01673594|11115250|FG000|Overall Study|Physician Decision|2
7034593|NCT01673594|11115251|FG001|Overall Study|Physician Decision|4
7034594|NCT01673594|11115250|FG000|Overall Study|Withdrawal by Subject|0
7034595|NCT01673594|11115251|FG001|Overall Study|Withdrawal by Subject|1
7034596|NCT01673646|11115260|FG000|Overall Study|Adverse Event|2
7034597|NCT01673646|11115261|FG001|Overall Study|Adverse Event|1
7034598|NCT01673646|11115262|FG002|Overall Study|Adverse Event|1
7034599|NCT01673646|11115260|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7034600|NCT01673646|11115261|FG001|Overall Study|Unsatisfactory therapeutic effect|2
7034601|NCT01673646|11115262|FG002|Overall Study|Unsatisfactory therapeutic effect|0
7034602|NCT01673646|11115260|FG000|Overall Study|Condition no longer requires study drug|0
7034603|NCT01673646|11115261|FG001|Overall Study|Condition no longer requires study drug|1
7034604|NCT01673646|11115262|FG002|Overall Study|Condition no longer requires study drug|0
7034605|NCT01673646|11115260|FG000|Overall Study|Withdrawal by Subject|0
7034606|NCT01673646|11115261|FG001|Overall Study|Withdrawal by Subject|2
7034607|NCT01673646|11115262|FG002|Overall Study|Withdrawal by Subject|2
7034608|NCT01673646|11115260|FG000|Overall Study|Completed Core/did not enter Ext.|2
7034609|NCT01673646|11115261|FG001|Overall Study|Completed Core/did not enter Ext.|1
7034610|NCT01673646|11115262|FG002|Overall Study|Completed Core/did not enter Ext.|1
7034611|NCT01673698|11115276|FG000|Overall Study|Lost to Follow-up|51
7034612|NCT01673698|11115277|FG001|Overall Study|Lost to Follow-up|13
7034613|NCT01673854|11115297|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7
7034614|NCT01673854|11115297|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6
7034615|NCT01673854|11115297|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2
7034616|NCT01673854|11115297|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1
7034617|NCT01673854|11115297|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1
7034618|NCT01673854|11115297|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1
7034619|NCT01673854|11115297|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2
7034620|NCT01673854|11115297|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7
7034621|NCT01673854|11115297|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12
7034622|NCT01673854|11115297|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5
7034623|NCT01673854|11115297|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1
7034624|NCT01673854|11115297|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1
7034625|NCT01673984|11115315|FG000|Overall Study|Adverse Event|1
7034626|NCT01673984|11115316|FG001|Overall Study|Adverse Event|0
7034627|NCT01673984|11115315|FG000|Overall Study|Study termination|9
7034628|NCT01673984|11115316|FG001|Overall Study|Study termination|6
7034629|NCT01674010|11115322|FG000|Open Treatment Phase 1|Adverse Event|10
7034630|NCT01674010|11115323|FG001|Open Treatment Phase 1|Adverse Event|0
7034631|NCT01674010|11115324|FG002|Open Treatment Phase 1|Adverse Event|0
7034632|NCT01674010|11115322|FG000|Open Treatment Phase 1|Death|1
7034633|NCT01674010|11115323|FG001|Open Treatment Phase 1|Death|0
7034634|NCT01674010|11115324|FG002|Open Treatment Phase 1|Death|0
7034635|NCT01674010|11115322|FG000|Open Treatment Phase 1|Lost to Follow-up|19
7034636|NCT01674010|11115323|FG001|Open Treatment Phase 1|Lost to Follow-up|0
7034637|NCT01674010|11115324|FG002|Open Treatment Phase 1|Lost to Follow-up|0
7034638|NCT01674010|11115322|FG000|Open Treatment Phase 1|Physician Decision|9
7034639|NCT01674010|11115323|FG001|Open Treatment Phase 1|Physician Decision|0
7034640|NCT01674010|11115324|FG002|Open Treatment Phase 1|Physician Decision|0
7034641|NCT01674010|11115322|FG000|Open Treatment Phase 1|Protocol Violation|7
7034642|NCT01674010|11115323|FG001|Open Treatment Phase 1|Protocol Violation|0
7034643|NCT01674010|11115324|FG002|Open Treatment Phase 1|Protocol Violation|0
7034644|NCT01674010|11115322|FG000|Open Treatment Phase 1|Sponsor Decision|79
7034645|NCT01674010|11115323|FG001|Open Treatment Phase 1|Sponsor Decision|0
7034646|NCT01674010|11115324|FG002|Open Treatment Phase 1|Sponsor Decision|0
7034647|NCT01674010|11115322|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30
7034648|NCT01674010|11115323|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0
7034649|NCT01674010|11115324|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0
7034650|NCT01674010|11115322|FG000|Open Treatment Phase 1|Withdrawal by Subject|25
7034651|NCT01674010|11115323|FG001|Open Treatment Phase 1|Withdrawal by Subject|0
7034652|NCT01674010|11115324|FG002|Open Treatment Phase 1|Withdrawal by Subject|0
7034653|NCT01674010|11115322|FG000|Randomization Phase 2|Adverse Event|0
7034654|NCT01674010|11115323|FG001|Randomization Phase 2|Adverse Event|1
7034655|NCT01674010|11115324|FG002|Randomization Phase 2|Adverse Event|1
7034656|NCT01674010|11115322|FG000|Randomization Phase 2|Lost to Follow-up|0
7034657|NCT01674010|11115323|FG001|Randomization Phase 2|Lost to Follow-up|1
7034658|NCT01674010|11115324|FG002|Randomization Phase 2|Lost to Follow-up|2
7034659|NCT01674010|11115322|FG000|Randomization Phase 2|Mood episode recurrence|0
7034660|NCT01674010|11115323|FG001|Randomization Phase 2|Mood episode recurrence|8
7034661|NCT01674010|11115324|FG002|Randomization Phase 2|Mood episode recurrence|2
7034662|NCT01674010|11115322|FG000|Randomization Phase 2|Physician Decision|0
7034663|NCT01674010|11115323|FG001|Randomization Phase 2|Physician Decision|0
7034664|NCT01674010|11115324|FG002|Randomization Phase 2|Physician Decision|2
7034665|NCT01674010|11115322|FG000|Randomization Phase 2|Pregnancy|0
7034666|NCT01674010|11115323|FG001|Randomization Phase 2|Pregnancy|1
7034667|NCT01674010|11115324|FG002|Randomization Phase 2|Pregnancy|1
7034668|NCT01674010|11115322|FG000|Randomization Phase 2|Protocol Violation|0
7034669|NCT01674010|11115323|FG001|Randomization Phase 2|Protocol Violation|1
7034670|NCT01674010|11115324|FG002|Randomization Phase 2|Protocol Violation|1
7034671|NCT01674010|11115322|FG000|Randomization Phase 2|Sponsor Decision|0
7034672|NCT01674010|11115323|FG001|Randomization Phase 2|Sponsor Decision|42
7034673|NCT01674010|11115324|FG002|Randomization Phase 2|Sponsor Decision|45
7034674|NCT01674010|11115322|FG000|Randomization Phase 2|Withdrawal by Subject|0
7034675|NCT01674010|11115323|FG001|Randomization Phase 2|Withdrawal by Subject|8
7034676|NCT01674010|11115324|FG002|Randomization Phase 2|Withdrawal by Subject|7
7034677|NCT01674062|11115334|FG000|Overall Study|Insufficient Therapeutic Response|56
7034678|NCT01674062|11115335|FG001|Overall Study|Insufficient Therapeutic Response|26
7034679|NCT01674062|11115334|FG000|Overall Study|Other|8
7034680|NCT01674062|11115335|FG001|Overall Study|Other|1
7034681|NCT01674062|11115334|FG000|Overall Study|Adverse Event|1
7034682|NCT01674062|11115335|FG001|Overall Study|Adverse Event|1
7034683|NCT01674062|11115334|FG000|Overall Study|Death|0
7034684|NCT01674062|11115335|FG001|Overall Study|Death|1
7034685|NCT01674062|11115334|FG000|Overall Study|Programming Error|1
7034686|NCT01674062|11115335|FG001|Overall Study|Programming Error|0
7034687|NCT01674569|11115350|FG000|Overall Study|Adverse Event|0
7034688|NCT01674569|11115351|FG001|Overall Study|Adverse Event|2
7034689|NCT01674569|11115352|FG002|Overall Study|Adverse Event|0
7034690|NCT01674569|11115353|FG003|Overall Study|Adverse Event|1
7034691|NCT01674569|11115354|FG004|Overall Study|Adverse Event|2
7034692|NCT01674569|11115355|FG005|Overall Study|Adverse Event|2
7034693|NCT01674569|11115350|FG000|Overall Study|Protocol Violation|0
7034694|NCT01674569|11115351|FG001|Overall Study|Protocol Violation|1
7034695|NCT01674569|11115352|FG002|Overall Study|Protocol Violation|1
7034696|NCT01674569|11115353|FG003|Overall Study|Protocol Violation|0
7034697|NCT01674569|11115354|FG004|Overall Study|Protocol Violation|0
7034698|NCT01674569|11115355|FG005|Overall Study|Protocol Violation|0
7034699|NCT01674569|11115350|FG000|Overall Study|Withdrawal by Subject|0
7034700|NCT01674569|11115351|FG001|Overall Study|Withdrawal by Subject|0
7034701|NCT01674569|11115352|FG002|Overall Study|Withdrawal by Subject|1
7034702|NCT01674569|11115353|FG003|Overall Study|Withdrawal by Subject|0
7034703|NCT01674569|11115354|FG004|Overall Study|Withdrawal by Subject|0
7034704|NCT01674569|11115355|FG005|Overall Study|Withdrawal by Subject|0
7034705|NCT01674621|11115364|FG000|Overall Study|Adverse Event|3
7034706|NCT01674621|11115365|FG001|Overall Study|Adverse Event|2
7034707|NCT01674621|11115366|FG002|Overall Study|Adverse Event|5
7034708|NCT01674621|11115367|FG003|Overall Study|Adverse Event|5
7034709|NCT01674621|11115368|FG004|Overall Study|Adverse Event|1
7034710|NCT01674621|11115364|FG000|Overall Study|Inability to Complete Study Procedures|0
7034711|NCT01674621|11115365|FG001|Overall Study|Inability to Complete Study Procedures|0
7034712|NCT01674621|11115366|FG002|Overall Study|Inability to Complete Study Procedures|0
7034713|NCT01674621|11115367|FG003|Overall Study|Inability to Complete Study Procedures|0
7034714|NCT01674621|11115368|FG004|Overall Study|Inability to Complete Study Procedures|2
7034715|NCT01674621|11115364|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
7034716|NCT01674621|11115365|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
7034717|NCT01674621|11115366|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
7034718|NCT01674621|11115367|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1
7034719|NCT01674621|11115368|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
7034720|NCT01674621|11115364|FG000|Overall Study|Withdrawal by Subject|2
7034721|NCT01674621|11115365|FG001|Overall Study|Withdrawal by Subject|5
7034722|NCT01674621|11115366|FG002|Overall Study|Withdrawal by Subject|2
7034723|NCT01674621|11115367|FG003|Overall Study|Withdrawal by Subject|0
7034724|NCT01674621|11115368|FG004|Overall Study|Withdrawal by Subject|1
7034725|NCT01674621|11115364|FG000|Overall Study|Other than specified|0
7034726|NCT01674621|11115365|FG001|Overall Study|Other than specified|1
7034727|NCT01674621|11115366|FG002|Overall Study|Other than specified|0
7034728|NCT01674621|11115367|FG003|Overall Study|Other than specified|0
7034729|NCT01674621|11115368|FG004|Overall Study|Other than specified|2
7034730|NCT01674634|11115381|FG000|Overall Study|Withdrawal by Subject|3
7034731|NCT01674634|11115381|FG000|Overall Study|Lost to Follow-up|3
7034732|NCT01674647|11115391|FG000|Treatment Period|Death|4
7034733|NCT01674647|11115392|FG001|Treatment Period|Death|1
7034734|NCT01674647|11115391|FG000|Treatment Period|Efficacy outcome reached|0
7034735|NCT01674647|11115392|FG001|Treatment Period|Efficacy outcome reached|1
7034736|NCT01674647|11115391|FG000|Treatment Period|Physician Decision|3
7034737|NCT01674647|11115392|FG001|Treatment Period|Physician Decision|1
7034738|NCT01674647|11115391|FG000|Treatment Period|Adverse Event|60
7034739|NCT01674647|11115392|FG001|Treatment Period|Adverse Event|22
7034740|NCT01674647|11115391|FG000|Treatment Period|Non-compliance with study drug|3
7034741|NCT01674647|11115392|FG001|Treatment Period|Non-compliance with study drug|0
7034742|NCT01674647|11115391|FG000|Treatment Period|Lost to Follow-up|1
7034743|NCT01674647|11115392|FG001|Treatment Period|Lost to Follow-up|1
7034744|NCT01674647|11115391|FG000|Treatment Period|Withdrawal by Subject|19
7034745|NCT01674647|11115392|FG001|Treatment Period|Withdrawal by Subject|16
7034746|NCT01674647|11115391|FG000|Treatment Period|Switching to other therapy|5
7034747|NCT01674647|11115392|FG001|Treatment Period|Switching to other therapy|2
7034748|NCT01674647|11115391|FG000|Treatment Period|Logistical difficulties|5
7034749|NCT01674647|11115392|FG001|Treatment Period|Logistical difficulties|8
7034750|NCT01674647|11115391|FG000|Treatment Period|Treatment failure|0
7034751|NCT01674647|11115392|FG001|Treatment Period|Treatment failure|14
7034752|NCT01674647|11115391|FG000|Treatment Period|Protocol Violation|56
7034753|NCT01674647|11115392|FG001|Treatment Period|Protocol Violation|36
7034754|NCT01674647|11115391|FG000|30-day Safety Follow-up Period|Death|3
7034755|NCT01674647|11115392|FG001|30-day Safety Follow-up Period|Death|2
7034756|NCT01674647|11115391|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0
7034757|NCT01674647|11115392|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1
7034758|NCT01674647|11115391|FG000|30-day Safety Follow-up Period|Protocol Violation|39
7034759|NCT01674647|11115392|FG001|30-day Safety Follow-up Period|Protocol Violation|22
7034760|NCT01674647|11115391|FG000|30-day Safety Follow-up Period|Logistical difficulties|1
7034761|NCT01674647|11115392|FG001|30-day Safety Follow-up Period|Logistical difficulties|3
7034762|NCT01674647|11115391|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7
7034763|NCT01674647|11115392|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8
7034764|NCT01674647|11115391|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8
7034765|NCT01674647|11115392|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5
7034766|NCT01674712|11115403|FG000|Overall Study|Adverse Event|5
7034767|NCT01674712|11115404|FG001|Overall Study|Adverse Event|6
7034768|NCT01674712|11115405|FG002|Overall Study|Adverse Event|3
7034769|NCT01674712|11115406|FG003|Overall Study|Adverse Event|4
7034770|NCT01674712|11115407|FG004|Overall Study|Adverse Event|6
7034771|NCT01674712|11115403|FG000|Overall Study|Lost to Follow-up|1
7034772|NCT01674712|11115404|FG001|Overall Study|Lost to Follow-up|0
7034773|NCT01674712|11115405|FG002|Overall Study|Lost to Follow-up|0
7034774|NCT01674712|11115406|FG003|Overall Study|Lost to Follow-up|0
7034775|NCT01674712|11115407|FG004|Overall Study|Lost to Follow-up|0
7034776|NCT01674712|11115403|FG000|Overall Study|Protocol Violation|2
7034777|NCT01674712|11115404|FG001|Overall Study|Protocol Violation|0
7034778|NCT01674712|11115405|FG002|Overall Study|Protocol Violation|0
7034779|NCT01674712|11115406|FG003|Overall Study|Protocol Violation|0
7034780|NCT01674712|11115407|FG004|Overall Study|Protocol Violation|0
7034781|NCT01674712|11115403|FG000|Overall Study|Withdrawal by Subject|2
7034782|NCT01674712|11115404|FG001|Overall Study|Withdrawal by Subject|2
7034783|NCT01674712|11115405|FG002|Overall Study|Withdrawal by Subject|5
7034784|NCT01674712|11115406|FG003|Overall Study|Withdrawal by Subject|4
7034785|NCT01674712|11115407|FG004|Overall Study|Withdrawal by Subject|3
7034786|NCT01674712|11115403|FG000|Overall Study|Administrative|0
7034787|NCT01674712|11115404|FG001|Overall Study|Administrative|1
7034788|NCT01674712|11115405|FG002|Overall Study|Administrative|0
7034789|NCT01674712|11115406|FG003|Overall Study|Administrative|0
7034790|NCT01674712|11115407|FG004|Overall Study|Administrative|1
7034791|NCT01674712|11115403|FG000|Overall Study|Lack of Efficacy|0
7034792|NCT01674712|11115404|FG001|Overall Study|Lack of Efficacy|0
7034793|NCT01674712|11115405|FG002|Overall Study|Lack of Efficacy|1
7034794|NCT01674712|11115406|FG003|Overall Study|Lack of Efficacy|0
7034795|NCT01674712|11115407|FG004|Overall Study|Lack of Efficacy|1
7034796|NCT01674725|11115421|FG000|Overall Study|Adverse Event|1
7034797|NCT01674725|11115422|FG001|Overall Study|Adverse Event|0
7034798|NCT01674725|11115421|FG000|Overall Study|Did not receive study drug|1
7034799|NCT01674725|11115422|FG001|Overall Study|Did not receive study drug|0
7034800|NCT01674725|11115421|FG000|Overall Study|Withdrawal by Subject|1
7034801|NCT01674725|11115422|FG001|Overall Study|Withdrawal by Subject|0
7034802|NCT01674725|11115421|FG000|Overall Study|Lost to Follow-up|0
7034803|NCT01674725|11115422|FG001|Overall Study|Lost to Follow-up|1
7034804|NCT01675050|11115430|FG000|Period One Treatment|Withdrawal by Subject|1
7034805|NCT01675050|11115431|FG001|Period One Treatment|Withdrawal by Subject|0
7034806|NCT01675128|11115444|FG000|Overall Study|Disease progression on study|1
7034807|NCT01675128|11115445|FG001|Overall Study|Disease progression on study|1
7034808|NCT01675128|11115446|FG002|Overall Study|Disease progression on study|1
7034809|NCT01675128|11115444|FG000|Overall Study|Refused further treatment|1
7034810|NCT01675128|11115445|FG001|Overall Study|Refused further treatment|0
7034811|NCT01675128|11115446|FG002|Overall Study|Refused further treatment|0
7034812|NCT01675128|11115444|FG000|Overall Study|Pulmonary complication; off study|0
7034813|NCT01675128|11115445|FG001|Overall Study|Pulmonary complication; off study|1
7034814|NCT01675128|11115446|FG002|Overall Study|Pulmonary complication; off study|0
7034815|NCT01675141|11115461|FG000|Overall Study|Lenalidomide outside NIH|3
7034816|NCT01675141|11115461|FG000|Overall Study|Withdrawal by Subject|3
7034817|NCT01675141|11115461|FG000|Overall Study|Physician Decision|4
7034818|NCT01675141|11115461|FG000|Overall Study|No treatment, per protocol|1
7034819|NCT01675154|11115469|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0
7034820|NCT01675154|11115470|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1
7034821|NCT01675154|11115471|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0
7034822|NCT01675154|11115472|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0
7034823|NCT01675167|11115496|FG000|Open-label Titration Phase|Adverse Event|81
7034824|NCT01675167|11115497|FG001|Open-label Titration Phase|Adverse Event|0
7034825|NCT01675167|11115498|FG002|Open-label Titration Phase|Adverse Event|0
7034826|NCT01675167|11115496|FG000|Open-label Titration Phase|Lack of Efficacy|63
7034827|NCT01675167|11115497|FG001|Open-label Titration Phase|Lack of Efficacy|0
7034828|NCT01675167|11115498|FG002|Open-label Titration Phase|Lack of Efficacy|0
7034829|NCT01675167|11115496|FG000|Open-label Titration Phase|Withdrawal by Subject|46
7034830|NCT01675167|11115497|FG001|Open-label Titration Phase|Withdrawal by Subject|0
7034831|NCT01675167|11115498|FG002|Open-label Titration Phase|Withdrawal by Subject|0
7034832|NCT01675167|11115496|FG000|Open-label Titration Phase|Protocol Violation|43
7034833|NCT01675167|11115497|FG001|Open-label Titration Phase|Protocol Violation|0
7034834|NCT01675167|11115498|FG002|Open-label Titration Phase|Protocol Violation|0
7034835|NCT01675167|11115496|FG000|Open-label Titration Phase|Lost to Follow-up|15
7034836|NCT01675167|11115497|FG001|Open-label Titration Phase|Lost to Follow-up|0
7034837|NCT01675167|11115498|FG002|Open-label Titration Phase|Lost to Follow-up|0
7034838|NCT01675167|11115496|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1
7034839|NCT01675167|11115497|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
7034840|NCT01675167|11115498|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
7034841|NCT01675167|11115496|FG000|Open-label Titration Phase|Other|55
7034842|NCT01675167|11115497|FG001|Open-label Titration Phase|Other|0
7034843|NCT01675167|11115498|FG002|Open-label Titration Phase|Other|0
7034844|NCT01675167|11115496|FG000|Double-blind Treatment Phase|Lack of Efficacy|0
7034845|NCT01675167|11115497|FG001|Double-blind Treatment Phase|Lack of Efficacy|19
7034846|NCT01675167|11115498|FG002|Double-blind Treatment Phase|Lack of Efficacy|61
7034847|NCT01675167|11115496|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0
7034848|NCT01675167|11115497|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11
7034849|NCT01675167|11115498|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6
7034850|NCT01675167|11115496|FG000|Double-blind Treatment Phase|Adverse Event|0
7034851|NCT01675167|11115497|FG001|Double-blind Treatment Phase|Adverse Event|5
7034852|NCT01675167|11115498|FG002|Double-blind Treatment Phase|Adverse Event|13
7034853|NCT01675167|11115496|FG000|Double-blind Treatment Phase|Protocol Violation|0
7034854|NCT01675167|11115497|FG001|Double-blind Treatment Phase|Protocol Violation|4
7034855|NCT01675167|11115498|FG002|Double-blind Treatment Phase|Protocol Violation|11
7034856|NCT01675167|11115496|FG000|Double-blind Treatment Phase|Lost to Follow-up|0
7034857|NCT01675167|11115497|FG001|Double-blind Treatment Phase|Lost to Follow-up|1
7034858|NCT01675167|11115498|FG002|Double-blind Treatment Phase|Lost to Follow-up|5
7034859|NCT01675167|11115496|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
7034860|NCT01675167|11115497|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
7034861|NCT01675167|11115498|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9
7034862|NCT01675167|11115496|FG000|Double-blind Treatment Phase|Other|0
7034863|NCT01675167|11115497|FG001|Double-blind Treatment Phase|Other|7
7034864|NCT01675167|11115498|FG002|Double-blind Treatment Phase|Other|5
7034865|NCT01675427|11115515|FG000|Overall Study|Withdrawal by Subject|7
7034866|NCT01675427|11115515|FG000|Overall Study|Participant Refused Sample Collection|18
7034867|NCT01675427|11115515|FG000|Overall Study|Sample not Collected by Mistake|2
7034868|NCT01675427|11115515|FG000|Overall Study|Lost to Follow-up|5
7034869|NCT01675427|11115515|FG000|Overall Study|Other|2
7034870|NCT01675492|11115558|FG000|Overall Study|study completed early - product approval|42
7034871|NCT01675531|11115563|FG000|Overall Study|Adverse Event|9
7034872|NCT01675531|11115563|FG000|Overall Study|Withdrawal by Subject|7
7034873|NCT01675531|11115563|FG000|Overall Study|Lack of Efficacy|1
7034874|NCT01675531|11115563|FG000|Overall Study|Protocol Violation|8
7034875|NCT01675544|11115568|FG000|Overall Study|Withdrawal by Subject|2
7044672|NCT01756456|11130657|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1
7044673|NCT01756456|11130658|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1
7044674|NCT01756456|11130659|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1
7044675|NCT01756456|11130654|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0
7044676|NCT01756456|11130655|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0
7044677|NCT01756456|11130656|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0
7044678|NCT01756456|11130657|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2
7044679|NCT01756456|11130658|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1
7044680|NCT01756456|11130659|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0
7044681|NCT01756456|11130654|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0
7044682|NCT01756456|11130655|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1
7044683|NCT01756456|11130656|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0
7044684|NCT01756456|11130657|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0
7044685|NCT01756456|11130658|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0
7044686|NCT01756456|11130659|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0
7044687|NCT01756456|11130654|FG000|Treatment Period: Phase I/II|Adverse Event|1
7044688|NCT01756456|11130655|FG001|Treatment Period: Phase I/II|Adverse Event|0
7044689|NCT01756456|11130656|FG002|Treatment Period: Phase I/II|Adverse Event|2
7044690|NCT01756456|11130657|FG003|Treatment Period: Phase I/II|Adverse Event|3
7044691|NCT01756456|11130658|FG004|Treatment Period: Phase I/II|Adverse Event|9
7044692|NCT01756456|11130659|FG005|Treatment Period: Phase I/II|Adverse Event|1
7044693|NCT01756456|11130654|FG000|Treatment Period: Phase I/II|Other causes|0
7044694|NCT01756456|11130655|FG001|Treatment Period: Phase I/II|Other causes|0
7044695|NCT01756456|11130656|FG002|Treatment Period: Phase I/II|Other causes|0
7044696|NCT01756456|11130657|FG003|Treatment Period: Phase I/II|Other causes|1
7044697|NCT01756456|11130658|FG004|Treatment Period: Phase I/II|Other causes|2
7044698|NCT01756456|11130659|FG005|Treatment Period: Phase I/II|Other causes|2
7034876|NCT01675596|11115572|FG000|Overall Study|Death|6
7034877|NCT01675596|11115572|FG000|Overall Study|Exit with other reason|1
7034878|NCT01675596|11115572|FG000|Overall Study|Missed Visit|1
7034879|NCT01675622|11115578|FG000|Overall Study|Withdrawal by Subject|2
7034880|NCT01675622|11115579|FG001|Overall Study|Withdrawal by Subject|2
7034881|NCT01675622|11115578|FG000|Overall Study|Adverse Event|12
7034882|NCT01675622|11115579|FG001|Overall Study|Adverse Event|10
7034883|NCT01675622|11115578|FG000|Overall Study|Protocol Violation|4
7034884|NCT01675622|11115579|FG001|Overall Study|Protocol Violation|1
7034885|NCT01675622|11115578|FG000|Overall Study|Lack of Efficacy|2
7034886|NCT01675622|11115579|FG001|Overall Study|Lack of Efficacy|4
7034887|NCT01675622|11115578|FG000|Overall Study|Lost to Follow-up|1
7034888|NCT01675622|11115579|FG001|Overall Study|Lost to Follow-up|3
7034889|NCT01675622|11115578|FG000|Overall Study|Other|5
7034890|NCT01675622|11115579|FG001|Overall Study|Other|4
7034891|NCT01675661|11115601|FG000|Overall Study|Lost to Follow-up|22
7034892|NCT01675661|11115602|FG001|Overall Study|Lost to Follow-up|23
7034893|NCT01675661|11115601|FG000|Overall Study|Practical problems|9
7034894|NCT01675661|11115602|FG001|Overall Study|Practical problems|5
7034895|NCT01675661|11115601|FG000|Overall Study|Moved away|5
7034896|NCT01675661|11115602|FG001|Overall Study|Moved away|6
7034897|NCT01675661|11115601|FG000|Overall Study|Withdrawal by Subject|3
7034898|NCT01675661|11115602|FG001|Overall Study|Withdrawal by Subject|7
7034899|NCT01675661|11115601|FG000|Overall Study|Physician Decision|0
7034900|NCT01675661|11115602|FG001|Overall Study|Physician Decision|2
7034901|NCT01675661|11115601|FG000|Overall Study|Death|0
7034902|NCT01675661|11115602|FG001|Overall Study|Death|1
7034903|NCT01675661|11115601|FG000|Overall Study|Other reason|1
7034904|NCT01675661|11115602|FG001|Overall Study|Other reason|2
7034905|NCT01675765|11115610|FG000|Overall Study|Progressive disease|4
7034906|NCT01675765|11115611|FG001|Overall Study|Progressive disease|4
7034907|NCT01675765|11115610|FG000|Overall Study|Adverse Event|1
7034908|NCT01675765|11115611|FG001|Overall Study|Adverse Event|2
7034909|NCT01675765|11115610|FG000|Overall Study|Withdrawal by Subject|2
7034910|NCT01675765|11115611|FG001|Overall Study|Withdrawal by Subject|0
7034911|NCT01675765|11115610|FG000|Overall Study|Death|1
7034912|NCT01675765|11115611|FG001|Overall Study|Death|0
7034913|NCT01675765|11115610|FG000|Overall Study|Clinical progression|3
7034914|NCT01675765|11115611|FG001|Overall Study|Clinical progression|2
7034915|NCT01675882|11115630|FG000|Overall Study|Adverse Event|0
7034916|NCT01675882|11115631|FG001|Overall Study|Adverse Event|2
7034917|NCT01675882|11115632|FG002|Overall Study|Adverse Event|1
7034918|NCT01675882|11115633|FG003|Overall Study|Adverse Event|0
7034919|NCT01675882|11115630|FG000|Overall Study|Participant unwilling to continue|2
7034920|NCT01675882|11115631|FG001|Overall Study|Participant unwilling to continue|4
7034921|NCT01675882|11115632|FG002|Overall Study|Participant unwilling to continue|2
7034922|NCT01675882|11115633|FG003|Overall Study|Participant unwilling to continue|1
7034923|NCT01675882|11115630|FG000|Overall Study|Lost to Follow-up|0
7034924|NCT01675882|11115631|FG001|Overall Study|Lost to Follow-up|1
7034925|NCT01675882|11115632|FG002|Overall Study|Lost to Follow-up|0
7034926|NCT01675882|11115633|FG003|Overall Study|Lost to Follow-up|0
7034927|NCT01675882|11115630|FG000|Overall Study|Non-compliance|0
7034928|NCT01675882|11115631|FG001|Overall Study|Non-compliance|0
7034929|NCT01675882|11115632|FG002|Overall Study|Non-compliance|0
7034930|NCT01675882|11115633|FG003|Overall Study|Non-compliance|1
7034931|NCT01676012|11115643|FG000|Overall Study|Adverse Event|2
7034932|NCT01676012|11115643|FG000|Overall Study|incomplete set of videos|1
7034933|NCT01676116|11115649|FG000|Overall Study|Withdrawal criteria|2
7034934|NCT01676116|11115650|FG001|Overall Study|Withdrawal criteria|14
7034935|NCT01676116|11115649|FG000|Overall Study|Adverse Event|1
7034936|NCT01676116|11115650|FG001|Overall Study|Adverse Event|2
7034937|NCT01676116|11115649|FG000|Overall Study|Unclassified|4
7034938|NCT01676116|11115650|FG001|Overall Study|Unclassified|10
7034939|NCT01676116|11115649|FG000|Overall Study|Protocol Violation|9
7034940|NCT01676116|11115650|FG001|Overall Study|Protocol Violation|3
7034941|NCT01676220|11115658|FG000|Overall Study|Randomized But Not Treated|4
7034942|NCT01676220|11115659|FG001|Overall Study|Randomized But Not Treated|1
7034943|NCT01676220|11115658|FG000|Overall Study|Adverse Event|10
7034944|NCT01676220|11115659|FG001|Overall Study|Adverse Event|8
7034945|NCT01676220|11115658|FG000|Overall Study|Lack of Efficacy|2
7034946|NCT01676220|11115659|FG001|Overall Study|Lack of Efficacy|5
7034947|NCT01676220|11115658|FG000|Overall Study|Protocol Violation|11
7034948|NCT01676220|11115659|FG001|Overall Study|Protocol Violation|12
7034949|NCT01676220|11115658|FG000|Overall Study|Received Rescue Therapy|14
7034950|NCT01676220|11115659|FG001|Overall Study|Received Rescue Therapy|22
7034951|NCT01676220|11115658|FG000|Overall Study|Personal Reason|34
7034952|NCT01676220|11115659|FG001|Overall Study|Personal Reason|45
7034953|NCT01676220|11115658|FG000|Overall Study|Lost to Follow-up|11
7034954|NCT01676220|11115659|FG001|Overall Study|Lost to Follow-up|18
7034955|NCT01676220|11115658|FG000|Overall Study|Selection Criterion/Protocol Violation|9
7034956|NCT01676220|11115659|FG001|Overall Study|Selection Criterion/Protocol Violation|9
7034957|NCT01676220|11115658|FG000|Overall Study|Site Closure/Site Withdrawal|1
7034958|NCT01676220|11115659|FG001|Overall Study|Site Closure/Site Withdrawal|4
7034959|NCT01676220|11115658|FG000|Overall Study|Perceived Lack of Efficacy|3
7034960|NCT01676220|11115659|FG001|Overall Study|Perceived Lack of Efficacy|1
7034961|NCT01676220|11115658|FG000|Overall Study|Non Serious Hypoglycemia|2
7034962|NCT01676220|11115659|FG001|Overall Study|Non Serious Hypoglycemia|0
7034963|NCT01676220|11115658|FG000|Overall Study|No More Need of Insulin|1
7034964|NCT01676220|11115659|FG001|Overall Study|No More Need of Insulin|0
7034965|NCT01676727|11115732|FG000|Overall Study|Death|18
7034966|NCT01676727|11115732|FG000|Overall Study|Withdrawal by Subject|6
7034967|NCT01676727|11115732|FG000|Overall Study|Screening failure|5
7034968|NCT01676727|11115732|FG000|Overall Study|Not willing to attend 1-year visit|2
7034969|NCT01676727|11115732|FG000|Overall Study|Valve explanted|1
7034970|NCT01676896|11115749|FG000|Overall Study|Withdrawal by Subject|12
7034971|NCT01676896|11115750|FG001|Overall Study|Withdrawal by Subject|7
7034972|NCT01676896|11115751|FG002|Overall Study|Withdrawal by Subject|19
7034973|NCT01676909|11115761|FG000|Overall Study|Withdrawal by Subject|3
7034974|NCT01676909|11115762|FG001|Overall Study|Withdrawal by Subject|5
7034975|NCT01676909|11115761|FG000|Overall Study|Lost to Follow-up|15
7034976|NCT01676909|11115762|FG001|Overall Study|Lost to Follow-up|9
7034977|NCT01677182|11115773|FG000|Overall Study|Adverse Event|2
7034978|NCT01677182|11115774|FG001|Overall Study|Adverse Event|1
7034979|NCT01677182|11115775|FG002|Overall Study|Adverse Event|8
7034980|NCT01677182|11115773|FG000|Overall Study|Protocol Violation|5
7034981|NCT01677182|11115774|FG001|Overall Study|Protocol Violation|1
7034982|NCT01677182|11115775|FG002|Overall Study|Protocol Violation|4
7034983|NCT01677182|11115773|FG000|Overall Study|Lost to Follow-up|4
7034984|NCT01677182|11115774|FG001|Overall Study|Lost to Follow-up|0
7034985|NCT01677182|11115775|FG002|Overall Study|Lost to Follow-up|3
7034986|NCT01677182|11115773|FG000|Overall Study|Withdrawal by Subject|7
7034987|NCT01677182|11115774|FG001|Overall Study|Withdrawal by Subject|12
7034988|NCT01677182|11115775|FG002|Overall Study|Withdrawal by Subject|10
7034989|NCT01677182|11115773|FG000|Overall Study|Study termination|12
7034990|NCT01677182|11115774|FG001|Overall Study|Study termination|9
7034991|NCT01677182|11115775|FG002|Overall Study|Study termination|11
7034992|NCT01677182|11115773|FG000|Overall Study|Lack of Efficacy|3
7034993|NCT01677182|11115774|FG001|Overall Study|Lack of Efficacy|0
7034994|NCT01677182|11115775|FG002|Overall Study|Lack of Efficacy|1
7034995|NCT01677182|11115773|FG000|Overall Study|Other reasons|1
7034996|NCT01677182|11115774|FG001|Overall Study|Other reasons|5
7034997|NCT01677182|11115775|FG002|Overall Study|Other reasons|2
7034998|NCT01677195|11115786|FG000|Overall Study|Lost to Follow-up|14
7034999|NCT01677195|11115787|FG001|Overall Study|Lost to Follow-up|22
7035000|NCT01677195|11115788|FG002|Overall Study|Lost to Follow-up|22
7035001|NCT01677195|11115786|FG000|Overall Study|Withdrawal by Subject|1
7035002|NCT01677195|11115787|FG001|Overall Study|Withdrawal by Subject|0
7035003|NCT01677195|11115788|FG002|Overall Study|Withdrawal by Subject|1
7035004|NCT01677195|11115786|FG000|Overall Study|Adverse Event|6
7035005|NCT01677195|11115787|FG001|Overall Study|Adverse Event|4
7035006|NCT01677195|11115788|FG002|Overall Study|Adverse Event|1
7035007|NCT01677195|11115786|FG000|Overall Study|Physician Decision|1
7035008|NCT01677195|11115787|FG001|Overall Study|Physician Decision|2
7035009|NCT01677195|11115788|FG002|Overall Study|Physician Decision|2
7035010|NCT01677195|11115786|FG000|Overall Study|Pregnancy|0
7035011|NCT01677195|11115787|FG001|Overall Study|Pregnancy|1
7035012|NCT01677195|11115788|FG002|Overall Study|Pregnancy|0
7035013|NCT01677195|11115786|FG000|Overall Study|Protocol Violation|7
7035014|NCT01677195|11115787|FG001|Overall Study|Protocol Violation|3
7035015|NCT01677195|11115788|FG002|Overall Study|Protocol Violation|4
7035016|NCT01677299|11115806|FG000|Overall Study|Adverse Event|0
7035017|NCT01677299|11115807|FG001|Overall Study|Adverse Event|2
7035018|NCT01677299|11115808|FG002|Overall Study|Adverse Event|1
7035019|NCT01677299|11115809|FG003|Overall Study|Adverse Event|0
7035020|NCT01677299|11115806|FG000|Overall Study|Withdrawal by Subject|0
7035021|NCT01677299|11115807|FG001|Overall Study|Withdrawal by Subject|1
7035022|NCT01677299|11115808|FG002|Overall Study|Withdrawal by Subject|0
7035023|NCT01677299|11115809|FG003|Overall Study|Withdrawal by Subject|1
7035024|NCT01677377|11115835|FG000|Overall Study|Protocol Violation|1
7035025|NCT01677377|11115836|FG001|Overall Study|Protocol Violation|0
7035026|NCT01677377|11115837|FG002|Overall Study|Protocol Violation|0
7035027|NCT01677377|11115835|FG000|Overall Study|Lost to Follow-up|0
7035028|NCT01677377|11115836|FG001|Overall Study|Lost to Follow-up|1
7035029|NCT01677377|11115837|FG002|Overall Study|Lost to Follow-up|1
7035030|NCT01677377|11115835|FG000|Overall Study|Withdrawal by Subject|0
7035031|NCT01677377|11115836|FG001|Overall Study|Withdrawal by Subject|0
7035032|NCT01677377|11115837|FG002|Overall Study|Withdrawal by Subject|3
7035033|NCT01677377|11115835|FG000|Overall Study|Lack of Efficacy|0
7035034|NCT01677377|11115836|FG001|Overall Study|Lack of Efficacy|0
7035035|NCT01677377|11115837|FG002|Overall Study|Lack of Efficacy|1
7035036|NCT01677377|11115835|FG000|Overall Study|Pregnancy|0
7035037|NCT01677377|11115836|FG001|Overall Study|Pregnancy|0
7035038|NCT01677377|11115837|FG002|Overall Study|Pregnancy|1
7035039|NCT01677507|11115845|FG000|Initial Assignment|Adverse Event|0
7035040|NCT01677507|11115846|FG001|Initial Assignment|Adverse Event|1
7035041|NCT01677507|11115845|FG000|Initial Assignment|Protocol Violation|0
7035042|NCT01677507|11115846|FG001|Initial Assignment|Protocol Violation|1
7035043|NCT01677507|11115845|FG000|Second Assigment|Withdrawal by Subject|2
7035044|NCT01677507|11115846|FG001|Second Assigment|Withdrawal by Subject|2
7035045|NCT01677507|11115845|FG000|Second Assigment|Adverse Event|1
7035046|NCT01677507|11115846|FG001|Second Assigment|Adverse Event|3
7035047|NCT01677624|11115854|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1
7035048|NCT01677741|11115866|FG000|Overall Study|Death|0
7035049|NCT01677741|11115867|FG001|Overall Study|Death|0
7035050|NCT01677741|11115868|FG002|Overall Study|Death|0
7035051|NCT01677741|11115869|FG003|Overall Study|Death|1
7035052|NCT01677741|11115870|FG004|Overall Study|Death|0
7035053|NCT01677741|11115871|FG005|Overall Study|Death|1
7035054|NCT01677741|11115872|FG006|Overall Study|Death|0
7035055|NCT01677741|11115873|FG007|Overall Study|Death|0
7035056|NCT01677741|11115866|FG000|Overall Study|Withdrawal by Subject|2
7035057|NCT01677741|11115867|FG001|Overall Study|Withdrawal by Subject|7
7035058|NCT01677741|11115868|FG002|Overall Study|Withdrawal by Subject|5
7035059|NCT01677741|11115869|FG003|Overall Study|Withdrawal by Subject|4
7035060|NCT01677741|11115870|FG004|Overall Study|Withdrawal by Subject|11
7035061|NCT01677741|11115871|FG005|Overall Study|Withdrawal by Subject|20
7035062|NCT01677741|11115872|FG006|Overall Study|Withdrawal by Subject|4
7035063|NCT01677741|11115873|FG007|Overall Study|Withdrawal by Subject|2
7035064|NCT01677741|11115866|FG000|Overall Study|Enrolled in a rollover study|0
7035065|NCT01677741|11115867|FG001|Overall Study|Enrolled in a rollover study|3
7035066|NCT01677741|11115868|FG002|Overall Study|Enrolled in a rollover study|2
7035067|NCT01677741|11115869|FG003|Overall Study|Enrolled in a rollover study|1
7035068|NCT01677741|11115870|FG004|Overall Study|Enrolled in a rollover study|6
7035069|NCT01677741|11115871|FG005|Overall Study|Enrolled in a rollover study|6
7035070|NCT01677741|11115872|FG006|Overall Study|Enrolled in a rollover study|7
7035071|NCT01677741|11115873|FG007|Overall Study|Enrolled in a rollover study|0
7035072|NCT01677741|11115866|FG000|Overall Study|Progressive disease|1
7035073|NCT01677741|11115867|FG001|Overall Study|Progressive disease|0
7035074|NCT01677741|11115868|FG002|Overall Study|Progressive disease|1
7035075|NCT01677741|11115869|FG003|Overall Study|Progressive disease|0
7035076|NCT01677741|11115870|FG004|Overall Study|Progressive disease|0
7035077|NCT01677741|11115871|FG005|Overall Study|Progressive disease|1
7035078|NCT01677741|11115872|FG006|Overall Study|Progressive disease|0
7035079|NCT01677741|11115873|FG007|Overall Study|Progressive disease|0
7035080|NCT01677767|11115907|FG000|Overall Study|Adverse Event|1
7035081|NCT01677767|11115907|FG000|Overall Study|Death|4
7035082|NCT01677767|11115907|FG000|Overall Study|Protocol Violation|4
7035083|NCT01677767|11115907|FG000|Overall Study|Withdrawal by Subject|10
7035084|NCT01677767|11115907|FG000|Overall Study|Non-compliance by the participants|3
7035085|NCT01677858|11115918|FG000|Overall Study|Adverse Event|0
7035086|NCT01677858|11115919|FG001|Overall Study|Adverse Event|0
7035087|NCT01677858|11115920|FG002|Overall Study|Adverse Event|2
7035088|NCT01677858|11115921|FG003|Overall Study|Adverse Event|3
7035089|NCT01677858|11115922|FG004|Overall Study|Adverse Event|13
7035090|NCT01677858|11115918|FG000|Overall Study|Death|0
7035091|NCT01677858|11115919|FG001|Overall Study|Death|0
7035092|NCT01677858|11115920|FG002|Overall Study|Death|0
7035093|NCT01677858|11115921|FG003|Overall Study|Death|0
7035094|NCT01677858|11115922|FG004|Overall Study|Death|1
7035095|NCT01677858|11115918|FG000|Overall Study|Physician Decision|1
7035096|NCT01677858|11115919|FG001|Overall Study|Physician Decision|0
7143230|NCT03029143|11299740|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0
7143231|NCT03029143|11299738|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0
7143232|NCT03029143|11299739|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3
7143233|NCT03029143|11299740|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9
7143234|NCT03029143|11299738|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0
7143235|NCT03029143|11299739|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1
7143236|NCT03029143|11299740|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3
7035097|NCT01677858|11115920|FG002|Overall Study|Physician Decision|2
7035098|NCT01677858|11115921|FG003|Overall Study|Physician Decision|0
7035099|NCT01677858|11115922|FG004|Overall Study|Physician Decision|12
7035100|NCT01677858|11115918|FG000|Overall Study|Progressive Disease|2
7035101|NCT01677858|11115919|FG001|Overall Study|Progressive Disease|1
7035102|NCT01677858|11115920|FG002|Overall Study|Progressive Disease|9
7035103|NCT01677858|11115921|FG003|Overall Study|Progressive Disease|3
7035104|NCT01677858|11115922|FG004|Overall Study|Progressive Disease|43
7035105|NCT01677858|11115918|FG000|Overall Study|Withdrawal by Subject|0
7035106|NCT01677858|11115919|FG001|Overall Study|Withdrawal by Subject|1
7035107|NCT01677858|11115920|FG002|Overall Study|Withdrawal by Subject|1
7035108|NCT01677858|11115921|FG003|Overall Study|Withdrawal by Subject|0
7035109|NCT01677858|11115922|FG004|Overall Study|Withdrawal by Subject|15
7035110|NCT01677858|11115918|FG000|Overall Study|Lost to Follow-up|0
7035111|NCT01677858|11115919|FG001|Overall Study|Lost to Follow-up|0
7035112|NCT01677858|11115920|FG002|Overall Study|Lost to Follow-up|0
7035113|NCT01677858|11115921|FG003|Overall Study|Lost to Follow-up|0
7035114|NCT01677858|11115922|FG004|Overall Study|Lost to Follow-up|1
7035115|NCT01677910|11115942|FG000|Double-Blind Treatment Period|Adverse Event|6
7035116|NCT01677910|11115943|FG001|Double-Blind Treatment Period|Adverse Event|2
7035117|NCT01677910|11115944|FG002|Double-Blind Treatment Period|Adverse Event|3
7035118|NCT01677910|11115945|FG003|Double-Blind Treatment Period|Adverse Event|0
7035119|NCT01677910|11115942|FG000|Double-Blind Treatment Period|Physician Decision|0
7035120|NCT01677910|11115943|FG001|Double-Blind Treatment Period|Physician Decision|0
7035121|NCT01677910|11115944|FG002|Double-Blind Treatment Period|Physician Decision|1
7035122|NCT01677910|11115945|FG003|Double-Blind Treatment Period|Physician Decision|0
7035123|NCT01677910|11115942|FG000|Double-Blind Treatment Period|Withdrawal of consent|1
7035124|NCT01677910|11115943|FG001|Double-Blind Treatment Period|Withdrawal of consent|0
7035125|NCT01677910|11115944|FG002|Double-Blind Treatment Period|Withdrawal of consent|3
7035126|NCT01677910|11115945|FG003|Double-Blind Treatment Period|Withdrawal of consent|0
7035127|NCT01677910|11115942|FG000|Double-Blind Treatment Period|Reason Not Specified|0
7035128|NCT01677910|11115943|FG001|Double-Blind Treatment Period|Reason Not Specified|1
7035129|NCT01677910|11115944|FG002|Double-Blind Treatment Period|Reason Not Specified|0
7035130|NCT01677910|11115945|FG003|Double-Blind Treatment Period|Reason Not Specified|0
7035131|NCT01677910|11115942|FG000|Open-Label Extension Period (OLE)|Physician Decision|0
7035132|NCT01677910|11115943|FG001|Open-Label Extension Period (OLE)|Physician Decision|0
7035133|NCT01677910|11115944|FG002|Open-Label Extension Period (OLE)|Physician Decision|0
7035134|NCT01677910|11115945|FG003|Open-Label Extension Period (OLE)|Physician Decision|4
7035135|NCT01677910|11115942|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0
7035136|NCT01677910|11115943|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0
7035137|NCT01677910|11115944|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0
7035138|NCT01677910|11115945|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2
7035139|NCT01677910|11115942|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
7035140|NCT01677910|11115943|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
7035141|NCT01677910|11115944|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
7035142|NCT01677910|11115945|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
7035143|NCT01677910|11115942|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0
7035144|NCT01677910|11115943|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0
7035145|NCT01677910|11115944|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0
7035146|NCT01677910|11115945|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5
7035147|NCT01677910|11115942|FG000|Open-Label Extension Period (OLE)|Adverse Event|0
7060605|NCT01920477|11156952|FG000|Overall Study|Study closed/terminated|14
7060606|NCT01920477|11156953|FG001|Overall Study|Study closed/terminated|15
7060607|NCT01920477|11156952|FG000|Overall Study|Withdrawal by Subject|0
7060608|NCT01920477|11156953|FG001|Overall Study|Withdrawal by Subject|1
7060609|NCT01920555|11156964|FG000|Overall Study|Physician Decision|1
7060610|NCT01920555|11156965|FG001|Overall Study|Physician Decision|2
7060611|NCT01920555|11156966|FG002|Overall Study|Physician Decision|1
7060612|NCT01920555|11156967|FG003|Overall Study|Physician Decision|2
7060613|NCT01920555|11156968|FG004|Overall Study|Physician Decision|0
7060614|NCT01920555|11156964|FG000|Overall Study|Lack of Efficacy|2
7060615|NCT01920555|11156965|FG001|Overall Study|Lack of Efficacy|0
7060616|NCT01920555|11156966|FG002|Overall Study|Lack of Efficacy|0
7060617|NCT01920555|11156967|FG003|Overall Study|Lack of Efficacy|0
7060618|NCT01920555|11156968|FG004|Overall Study|Lack of Efficacy|0
7060619|NCT01920555|11156964|FG000|Overall Study|Travel Difficulties|1
7060620|NCT01920555|11156965|FG001|Overall Study|Travel Difficulties|1
7060621|NCT01920555|11156966|FG002|Overall Study|Travel Difficulties|0
7060622|NCT01920555|11156967|FG003|Overall Study|Travel Difficulties|0
7060623|NCT01920555|11156968|FG004|Overall Study|Travel Difficulties|1
7060624|NCT01920555|11156964|FG000|Overall Study|Lost to Follow-up|0
7060625|NCT01920555|11156965|FG001|Overall Study|Lost to Follow-up|1
7060626|NCT01920555|11156966|FG002|Overall Study|Lost to Follow-up|0
7060627|NCT01920555|11156967|FG003|Overall Study|Lost to Follow-up|1
7060628|NCT01920555|11156968|FG004|Overall Study|Lost to Follow-up|0
7060629|NCT01920568|11156982|FG000|Overall Study|Adverse Event|27
7060630|NCT01920568|11156983|FG001|Overall Study|Adverse Event|8
7060631|NCT01920568|11156982|FG000|Overall Study|Protocol Violation|5
7060632|NCT01920568|11156983|FG001|Overall Study|Protocol Violation|3
7060633|NCT01920568|11156982|FG000|Overall Study|Lost to Follow-up|2
7060634|NCT01920568|11156983|FG001|Overall Study|Lost to Follow-up|2
7060635|NCT01920568|11156982|FG000|Overall Study|Physician Decision|13
7060636|NCT01920568|11156983|FG001|Overall Study|Physician Decision|4
7060637|NCT01920568|11156982|FG000|Overall Study|Withdrawal by Subject|79
7060638|NCT01920568|11156983|FG001|Overall Study|Withdrawal by Subject|55
7060639|NCT01920568|11156982|FG000|Overall Study|Death due to disease progression|25
7060640|NCT01920568|11156983|FG001|Overall Study|Death due to disease progression|12
7060641|NCT01920594|11156992|FG000|Overall Study|Adverse Event|4
7060642|NCT01920594|11156993|FG001|Overall Study|Adverse Event|2
7060643|NCT01920594|11156992|FG000|Overall Study|Lost to Follow-up|1
7060644|NCT01920594|11156993|FG001|Overall Study|Lost to Follow-up|0
7060645|NCT01920594|11156992|FG000|Overall Study|Recovery|2
7060646|NCT01920594|11156993|FG001|Overall Study|Recovery|0
7060647|NCT01920594|11156992|FG000|Overall Study|Investigator discretion|0
7060648|NCT01920594|11156993|FG001|Overall Study|Investigator discretion|1
7060649|NCT01920711|11157001|FG000|Overall Study|Death|347
7060650|NCT01920711|11157002|FG001|Overall Study|Death|356
7060651|NCT01920711|11157001|FG000|Overall Study|Lost to Follow-up|13
7143237|NCT03029143|11299738|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0
7143238|NCT03029143|11299739|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1
7143239|NCT03029143|11299740|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3
7143240|NCT03029143|11299738|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0
7143241|NCT03029143|11299739|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10
7143242|NCT03029143|11299740|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1
7143243|NCT03029143|11299738|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0
7035148|NCT01677910|11115943|FG001|Open-Label Extension Period (OLE)|Adverse Event|0
7035149|NCT01677910|11115944|FG002|Open-Label Extension Period (OLE)|Adverse Event|0
7035150|NCT01677910|11115945|FG003|Open-Label Extension Period (OLE)|Adverse Event|15
7035151|NCT01677910|11115942|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0
7035152|NCT01677910|11115943|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0
7035153|NCT01677910|11115944|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0
7035154|NCT01677910|11115945|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1
7035155|NCT01677936|11115957|FG000|Overall Study|Lost to Follow-up|4
7035156|NCT01677936|11115958|FG001|Overall Study|Lost to Follow-up|1
7035157|NCT01677936|11115957|FG000|Overall Study|Protocol Violation|3
7035158|NCT01677936|11115958|FG001|Overall Study|Protocol Violation|0
7035159|NCT01677936|11115957|FG000|Overall Study|Adverse Event|1
7035160|NCT01677936|11115958|FG001|Overall Study|Adverse Event|0
7035161|NCT01677936|11115957|FG000|Overall Study|Lost to Follow-up|1
7035162|NCT01677936|11115958|FG001|Overall Study|Lost to Follow-up|0
7035163|NCT01677936|11115957|FG000|Overall Study|Protocol Violation|0
7035164|NCT01677936|11115958|FG001|Overall Study|Protocol Violation|4
7035165|NCT01677988|11115964|FG000|Overall Study|Lack of Efficacy|2
7035166|NCT01678131|11115972|FG000|Overall Study|Adverse Event|0
7035167|NCT01678131|11115973|FG001|Overall Study|Adverse Event|1
7035168|NCT01678131|11115974|FG002|Overall Study|Adverse Event|0
7035169|NCT01678131|11115972|FG000|Overall Study|Withdrawal by Subject|0
7035170|NCT01678131|11115973|FG001|Overall Study|Withdrawal by Subject|0
7035171|NCT01678131|11115974|FG002|Overall Study|Withdrawal by Subject|2
7035172|NCT01678144|11115982|FG000|Stage 1: MAR Classic|Adverse Event|1
7035173|NCT01678209|11115998|FG000|Overall Study|could not scan twice|1
7035174|NCT01678209|11115999|FG001|Overall Study|could not scan twice|1
7035175|NCT01678209|11116000|FG002|Overall Study|could not scan twice|1
7035176|NCT01678209|11115998|FG000|Overall Study|scheduling conflicts|0
7035177|NCT01678209|11115999|FG001|Overall Study|scheduling conflicts|0
7035178|NCT01678209|11116000|FG002|Overall Study|scheduling conflicts|1
7035179|NCT01678209|11115998|FG000|Overall Study|screen fail|16
7035180|NCT01678209|11115999|FG001|Overall Study|screen fail|17
7035181|NCT01678209|11116000|FG002|Overall Study|screen fail|16
7035182|NCT01678313|11116010|FG000|Completed the 3-month Therapy|Lost to Follow-up|3
7035183|NCT01678313|11116011|FG001|Completed the 3-month Therapy|Lost to Follow-up|8
7035184|NCT01678313|11116010|FG000|Completed the 3-month Therapy|Physician Decision|3
7035185|NCT01678313|11116011|FG001|Completed the 3-month Therapy|Physician Decision|4
7035186|NCT01678313|11116010|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8
7035187|NCT01678313|11116011|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9
7035188|NCT01678313|11116010|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11
7035189|NCT01678313|11116011|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12
7035190|NCT01678560|11116023|FG000|Overall Study|Physician Decision|4
7035191|NCT01678560|11116024|FG001|Overall Study|Physician Decision|4
7035192|NCT01678560|11116023|FG000|Overall Study|Death|0
7035193|NCT01678560|11116024|FG001|Overall Study|Death|1
7035194|NCT01678560|11116023|FG000|Overall Study|Withdrawal by Subject|0
7035195|NCT01678560|11116024|FG001|Overall Study|Withdrawal by Subject|1
7035196|NCT01678807|11116046|FG000|Overall Study|Adverse Event|4
7035197|NCT01678807|11116047|FG001|Overall Study|Adverse Event|4
7035198|NCT01678807|11116048|FG002|Overall Study|Adverse Event|0
7035199|NCT01678807|11116046|FG000|Overall Study|Withdrawn by Parent/Guardian|0
7035200|NCT01678807|11116047|FG001|Overall Study|Withdrawn by Parent/Guardian|1
7035201|NCT01678807|11116048|FG002|Overall Study|Withdrawn by Parent/Guardian|0
7035202|NCT01678820|11116059|FG000|Overall Study|Study Terminated by Sponsor|45
7035203|NCT01678820|11116060|FG001|Overall Study|Study Terminated by Sponsor|43
7035204|NCT01678820|11116061|FG002|Overall Study|Study Terminated by Sponsor|43
7035205|NCT01678820|11116059|FG000|Overall Study|Withdrawal by Subject|2
7035206|NCT01678820|11116060|FG001|Overall Study|Withdrawal by Subject|5
7035207|NCT01678820|11116061|FG002|Overall Study|Withdrawal by Subject|2
7035208|NCT01678820|11116059|FG000|Overall Study|Protocol Specified Criteria|2
7035209|NCT01678820|11116060|FG001|Overall Study|Protocol Specified Criteria|3
7035210|NCT01678820|11116061|FG002|Overall Study|Protocol Specified Criteria|1
7035211|NCT01678820|11116059|FG000|Overall Study|Adverse Event|2
7035212|NCT01678820|11116060|FG001|Overall Study|Adverse Event|2
7035213|NCT01678820|11116061|FG002|Overall Study|Adverse Event|2
7035214|NCT01678820|11116059|FG000|Overall Study|Lost to Follow-up|7
7035215|NCT01678820|11116060|FG001|Overall Study|Lost to Follow-up|2
7035216|NCT01678820|11116061|FG002|Overall Study|Lost to Follow-up|2
7035217|NCT01678820|11116059|FG000|Overall Study|Non-compliance with study drug|0
7035218|NCT01678820|11116060|FG001|Overall Study|Non-compliance with study drug|1
7035219|NCT01678820|11116061|FG002|Overall Study|Non-compliance with study drug|0
7035220|NCT01678820|11116059|FG000|Overall Study|Physician Decision|0
7035221|NCT01678820|11116060|FG001|Overall Study|Physician Decision|0
7035222|NCT01678820|11116061|FG002|Overall Study|Physician Decision|1
7035223|NCT01678820|11116059|FG000|Overall Study|Protocol Violation|4
7035224|NCT01678820|11116060|FG001|Overall Study|Protocol Violation|5
7035225|NCT01678820|11116061|FG002|Overall Study|Protocol Violation|4
7035226|NCT01678820|11116059|FG000|Overall Study|Not treated with double-blind study drug|0
7035227|NCT01678820|11116060|FG001|Overall Study|Not treated with double-blind study drug|2
7035228|NCT01678820|11116061|FG002|Overall Study|Not treated with double-blind study drug|2
7035229|NCT01678898|11116096|FG000|PB-102-F01|Adverse Event|0
7035230|NCT01678898|11116097|FG001|PB-102-F01|Adverse Event|1
7035231|NCT01678898|11116098|FG002|PB-102-F01|Adverse Event|0
7035232|NCT01678898|11116096|FG000|PB-102-F01|Physician Decision|0
7035233|NCT01678898|11116097|FG001|PB-102-F01|Physician Decision|1
7035234|NCT01678898|11116098|FG002|PB-102-F01|Physician Decision|0
7035235|NCT01678911|11116115|FG000|Second Intervention|Lost to Follow-up|2
7035236|NCT01678911|11116116|FG001|Second Intervention|Lost to Follow-up|0
7035237|NCT01678924|11116126|FG000|Overall Study|Adverse Event|1
7035238|NCT01678924|11116127|FG001|Overall Study|Adverse Event|1
7035239|NCT01678924|11116128|FG002|Overall Study|Adverse Event|0
7035240|NCT01678924|11116129|FG003|Overall Study|Adverse Event|1
7035241|NCT01678924|11116126|FG000|Overall Study|Lack of Efficacy|7
7035242|NCT01678924|11116127|FG001|Overall Study|Lack of Efficacy|2
7035243|NCT01678924|11116128|FG002|Overall Study|Lack of Efficacy|0
7035244|NCT01678924|11116129|FG003|Overall Study|Lack of Efficacy|5
7035245|NCT01678924|11116126|FG000|Overall Study|Lost to Follow-up|0
7035246|NCT01678924|11116127|FG001|Overall Study|Lost to Follow-up|4
7035247|NCT01678924|11116128|FG002|Overall Study|Lost to Follow-up|0
7035248|NCT01678924|11116129|FG003|Overall Study|Lost to Follow-up|2
7035249|NCT01678924|11116126|FG000|Overall Study|Personal Reasons|2
7035250|NCT01678924|11116127|FG001|Overall Study|Personal Reasons|2
7035251|NCT01678924|11116128|FG002|Overall Study|Personal Reasons|2
7035252|NCT01678924|11116129|FG003|Overall Study|Personal Reasons|7
7035253|NCT01678924|11116126|FG000|Overall Study|Withdrawal by Subject|0
7035254|NCT01678924|11116127|FG001|Overall Study|Withdrawal by Subject|3
7035255|NCT01678924|11116128|FG002|Overall Study|Withdrawal by Subject|0
7035256|NCT01678924|11116129|FG003|Overall Study|Withdrawal by Subject|2
7035257|NCT01678924|11116126|FG000|Overall Study|Unable to attend scheduled visits|0
7035258|NCT01678924|11116127|FG001|Overall Study|Unable to attend scheduled visits|0
7035259|NCT01678924|11116128|FG002|Overall Study|Unable to attend scheduled visits|0
7035260|NCT01678924|11116129|FG003|Overall Study|Unable to attend scheduled visits|1
7035261|NCT01679002|11116155|FG000|Overall Study|Adverse Event|1
7035262|NCT01679002|11116156|FG001|Overall Study|Adverse Event|1
7035263|NCT01679002|11116157|FG002|Overall Study|Adverse Event|0
7035264|NCT01679236|11116202|FG000|Overall Study|Lost to Follow-up|15
7035265|NCT01679236|11116203|FG001|Overall Study|Lost to Follow-up|15
7035266|NCT01679301|11116209|FG000|Screening Period|screen failure|3
7035267|NCT01679301|11116210|FG001|Screening Period|screen failure|0
7035268|NCT01679301|11116211|FG002|Screening Period|screen failure|0
7035269|NCT01679405|11116232|FG000|Overall Study|Death|2
7035270|NCT01679405|11116233|FG001|Overall Study|Death|5
7035271|NCT01679613|11116248|FG000|Overall Study|other than stated above|0
7035272|NCT01679613|11116249|FG001|Overall Study|other than stated above|1
7035273|NCT01679613|11116250|FG002|Overall Study|other than stated above|2
7035274|NCT01679613|11116251|FG003|Overall Study|other than stated above|2
7035275|NCT01680016|11116260|FG000|Overall Study|Adverse Event|0
7035276|NCT01680016|11116261|FG001|Overall Study|Adverse Event|0
7035277|NCT01680016|11116262|FG002|Overall Study|Adverse Event|1
7035278|NCT01680016|11116263|FG003|Overall Study|Adverse Event|4
7035279|NCT01680016|11116260|FG000|Overall Study|The Subject went out of The Trial|1
7035280|NCT01680016|11116261|FG001|Overall Study|The Subject went out of The Trial|0
7035281|NCT01680016|11116262|FG002|Overall Study|The Subject went out of The Trial|3
7035282|NCT01680016|11116263|FG003|Overall Study|The Subject went out of The Trial|0
7035283|NCT01680016|11116260|FG000|Overall Study|Protocol Violation|0
7035284|NCT01680016|11116261|FG001|Overall Study|Protocol Violation|1
7035285|NCT01680016|11116262|FG002|Overall Study|Protocol Violation|0
7035286|NCT01680016|11116263|FG003|Overall Study|Protocol Violation|0
7035287|NCT01680016|11116260|FG000|Overall Study|Withdrawal by Subject|5
7035288|NCT01680016|11116261|FG001|Overall Study|Withdrawal by Subject|7
7035289|NCT01680016|11116262|FG002|Overall Study|Withdrawal by Subject|1
7035290|NCT01680016|11116263|FG003|Overall Study|Withdrawal by Subject|1
7035291|NCT01680159|11116289|FG000|Screening Period|Not meet criteria for dose-up period|7
7035292|NCT01680159|11116289|FG000|Increased Dose Period|Adverse Event|6
7035293|NCT01680159|11116289|FG000|Increased Dose Period|Withdrawal by Subject|2
7035294|NCT01680341|11116355|FG000|Overall Study|Adverse Event|3
7035295|NCT01680341|11116356|FG001|Overall Study|Adverse Event|2
7035296|NCT01680341|11116355|FG000|Overall Study|Unclassified|18
7035297|NCT01680341|11116356|FG001|Overall Study|Unclassified|15
7035298|NCT01680458|11116362|FG000|Overall Study|Protocol Violation|3
7035299|NCT01680497|11116366|FG000|Overall Study|Lost to Follow-up|2
7035300|NCT01680861|11116433|FG000|Early Post-transplant Period|Protocol Violation|1
7035301|NCT01680861|11116434|FG001|Early Post-transplant Period|Protocol Violation|1
7035302|NCT01680991|11116463|FG000|Overall Study|Adverse Event|1
7035303|NCT01680991|11116464|FG001|Overall Study|Adverse Event|0
7035304|NCT01680991|11116465|FG002|Overall Study|Adverse Event|0
7035305|NCT01680991|11116463|FG000|Overall Study|Death|1
7035306|NCT01680991|11116464|FG001|Overall Study|Death|0
7035307|NCT01680991|11116465|FG002|Overall Study|Death|1
7035308|NCT01680991|11116463|FG000|Overall Study|Protocol Violation|0
7035309|NCT01680991|11116464|FG001|Overall Study|Protocol Violation|1
7035310|NCT01680991|11116465|FG002|Overall Study|Protocol Violation|0
7035311|NCT01680991|11116463|FG000|Overall Study|Withdrawal by Subject|5
7035312|NCT01680991|11116464|FG001|Overall Study|Withdrawal by Subject|1
7035313|NCT01680991|11116465|FG002|Overall Study|Withdrawal by Subject|0
7035314|NCT01680991|11116463|FG000|Overall Study|Progressive disease (PD)|0
7035315|NCT01680991|11116464|FG001|Overall Study|Progressive disease (PD)|10
7035316|NCT01680991|11116465|FG002|Overall Study|Progressive disease (PD)|0
7035317|NCT01680991|11116463|FG000|Overall Study|Physician Decision|0
7035318|NCT01680991|11116464|FG001|Overall Study|Physician Decision|7
7035319|NCT01680991|11116465|FG002|Overall Study|Physician Decision|2
7035320|NCT01680991|11116463|FG000|Overall Study|Bad physical condition|0
7035321|NCT01680991|11116464|FG001|Overall Study|Bad physical condition|0
7035322|NCT01680991|11116465|FG002|Overall Study|Bad physical condition|1
7035323|NCT01680991|11116463|FG000|Overall Study|PD confirmed in other hospital|1
7035324|NCT01680991|11116464|FG001|Overall Study|PD confirmed in other hospital|0
7035325|NCT01680991|11116465|FG002|Overall Study|PD confirmed in other hospital|0
7035326|NCT01681004|11116477|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1
7035327|NCT01681004|11116478|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2
7035328|NCT01681004|11116477|FG000|Study Completion|Lost to Follow-up|8
7035329|NCT01681004|11116478|FG001|Study Completion|Lost to Follow-up|3
7035330|NCT01681004|11116477|FG000|Study Completion|Physician Decision|1
7035331|NCT01681004|11116478|FG001|Study Completion|Physician Decision|3
7035332|NCT01681004|11116477|FG000|Study Completion|Site Termination|2
7035333|NCT01681004|11116478|FG001|Study Completion|Site Termination|1
7035334|NCT01681004|11116477|FG000|Study Completion|Death|1
7035335|NCT01681004|11116478|FG001|Study Completion|Death|1
7035336|NCT01681069|11116503|FG000|Overall Study|Withdrawal by Subject|4
7035337|NCT01681069|11116504|FG001|Overall Study|Withdrawal by Subject|5
7035338|NCT01681069|11116503|FG000|Overall Study|Protocol Violation|1
7035339|NCT01681069|11116504|FG001|Overall Study|Protocol Violation|1
7035340|NCT01681069|11116503|FG000|Overall Study|Adverse Event|0
7035341|NCT01681069|11116504|FG001|Overall Study|Adverse Event|1
7035342|NCT01681186|11116538|FG000|Washout Period From Second Intervention|Adverse Event|0
7035343|NCT01681186|11116539|FG001|Washout Period From Second Intervention|Adverse Event|0
7035344|NCT01681186|11116540|FG002|Washout Period From Second Intervention|Adverse Event|0
7035345|NCT01681186|11116541|FG003|Washout Period From Second Intervention|Adverse Event|0
7035346|NCT01681186|11116542|FG004|Washout Period From Second Intervention|Adverse Event|0
7035347|NCT01681186|11116543|FG005|Washout Period From Second Intervention|Adverse Event|0
7035348|NCT01681186|11116544|FG006|Washout Period From Second Intervention|Adverse Event|1
7035349|NCT01681186|11116545|FG007|Washout Period From Second Intervention|Adverse Event|0
7035350|NCT01681186|11116538|FG000|Washout Period From Second Intervention|Protocol Violation|0
7035351|NCT01681186|11116539|FG001|Washout Period From Second Intervention|Protocol Violation|0
7035352|NCT01681186|11116540|FG002|Washout Period From Second Intervention|Protocol Violation|0
7035353|NCT01681186|11116541|FG003|Washout Period From Second Intervention|Protocol Violation|0
7035354|NCT01681186|11116542|FG004|Washout Period From Second Intervention|Protocol Violation|0
7035355|NCT01681186|11116543|FG005|Washout Period From Second Intervention|Protocol Violation|0
7035356|NCT01681186|11116544|FG006|Washout Period From Second Intervention|Protocol Violation|0
7035357|NCT01681186|11116545|FG007|Washout Period From Second Intervention|Protocol Violation|1
7035358|NCT01681186|11116538|FG000|Washout Period From Third Intervention|Lost to Follow-up|0
7035359|NCT01681186|11116539|FG001|Washout Period From Third Intervention|Lost to Follow-up|0
7035360|NCT01681186|11116540|FG002|Washout Period From Third Intervention|Lost to Follow-up|0
7035361|NCT01681186|11116541|FG003|Washout Period From Third Intervention|Lost to Follow-up|0
7035362|NCT01681186|11116542|FG004|Washout Period From Third Intervention|Lost to Follow-up|0
7035363|NCT01681186|11116543|FG005|Washout Period From Third Intervention|Lost to Follow-up|0
7035364|NCT01681186|11116544|FG006|Washout Period From Third Intervention|Lost to Follow-up|1
7035365|NCT01681186|11116545|FG007|Washout Period From Third Intervention|Lost to Follow-up|0
7035366|NCT01681186|11116538|FG000|Fourth Intervention|Protocol Violation|0
7035367|NCT01681186|11116539|FG001|Fourth Intervention|Protocol Violation|0
7035368|NCT01681186|11116540|FG002|Fourth Intervention|Protocol Violation|0
7035369|NCT01681186|11116541|FG003|Fourth Intervention|Protocol Violation|0
7035370|NCT01681186|11116542|FG004|Fourth Intervention|Protocol Violation|0
7035371|NCT01681186|11116543|FG005|Fourth Intervention|Protocol Violation|0
7035372|NCT01681186|11116544|FG006|Fourth Intervention|Protocol Violation|0
7035373|NCT01681186|11116545|FG007|Fourth Intervention|Protocol Violation|1
7035374|NCT01681212|11116575|FG000|Overall Study|No longer met study criteria|5
7035375|NCT01681212|11116575|FG000|Overall Study|Administrative reason by sponsor|1
7035376|NCT01681277|11116584|FG000|Overall Study|Adverse Event|1
7035377|NCT01681277|11116585|FG001|Overall Study|Adverse Event|0
7035378|NCT01681277|11116586|FG002|Overall Study|Adverse Event|0
7035379|NCT01681277|11116587|FG003|Overall Study|Adverse Event|0
7035380|NCT01681277|11116588|FG004|Overall Study|Adverse Event|0
7035381|NCT01681368|11116604|FG000|Overall Study|Refused further treatment|1
7035382|NCT01681368|11116604|FG000|Overall Study|Refused further follow up|1
7035383|NCT01681433|11116610|FG000|Overall Study|Lack of Efficacy|23
7035384|NCT01681433|11116611|FG001|Overall Study|Lack of Efficacy|23
7035385|NCT01681433|11116610|FG000|Overall Study|Withdrawal by Subject|5
7035386|NCT01681433|11116611|FG001|Overall Study|Withdrawal by Subject|5
7035387|NCT01681433|11116610|FG000|Overall Study|Protocol Violation|2
7035388|NCT01681433|11116611|FG001|Overall Study|Protocol Violation|0
7035389|NCT01681433|11116610|FG000|Overall Study|Adverse Event|2
7035390|NCT01681433|11116611|FG001|Overall Study|Adverse Event|4
7035391|NCT01681433|11116610|FG000|Overall Study|Lost to Follow-up|0
7035392|NCT01681433|11116611|FG001|Overall Study|Lost to Follow-up|1
7035393|NCT01681472|11116621|FG000|Overall Study|Adverse Event|0
7035394|NCT01681472|11116622|FG001|Overall Study|Adverse Event|1
7035395|NCT01681472|11116623|FG002|Overall Study|Adverse Event|0
7035396|NCT01681472|11116624|FG003|Overall Study|Adverse Event|0
7035397|NCT01681511|11116645|FG000|Overall Study|No Treatment Received|1
7035398|NCT01681511|11116646|FG001|Overall Study|No Treatment Received|3
7035399|NCT01681511|11116645|FG000|Overall Study|Failed Inclusion/Exclusion|3
7035400|NCT01681511|11116646|FG001|Overall Study|Failed Inclusion/Exclusion|0
7035401|NCT01681511|11116645|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3
7035402|NCT01681511|11116646|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6
7035403|NCT01681511|11116645|FG000|Overall Study|No Daily Urine Sample Collected|0
7035404|NCT01681511|11116646|FG001|Overall Study|No Daily Urine Sample Collected|1
7035405|NCT01681511|11116645|FG000|Overall Study|No post-catheter sample collected|11
7035406|NCT01681511|11116646|FG001|Overall Study|No post-catheter sample collected|4
7035407|NCT01681576|11116654|FG000|Period 1|Adverse Event|1
7035408|NCT01681576|11116655|FG001|Period 1|Adverse Event|0
7035409|NCT01681576|11116654|FG000|Period 1|Protocol Deviation|1
7035410|NCT01681576|11116655|FG001|Period 1|Protocol Deviation|0
7035411|NCT01681576|11116654|FG000|Period 2|subject/guardian decision|3
7035412|NCT01681576|11116655|FG001|Period 2|subject/guardian decision|1
7035413|NCT01681576|11116654|FG000|Period 2|Non-compliance with study treatment|1
7035414|NCT01681576|11116655|FG001|Period 2|Non-compliance with study treatment|0
7035415|NCT01681628|11116665|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14
7035416|NCT01681628|11116666|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6
7035417|NCT01681628|11116665|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0
7035418|NCT01681628|11116666|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15
7035419|NCT01681628|11116665|FG000|19 Months Follow-up|Death|1
7035420|NCT01681628|11116666|FG001|19 Months Follow-up|Death|0
7035421|NCT01681628|11116665|FG000|19 Months Follow-up|Lost to Follow-up|61
7035422|NCT01681628|11116666|FG001|19 Months Follow-up|Lost to Follow-up|43
7035423|NCT01681771|11116677|FG000|Overall Study|Lost to Follow-up|4
7035424|NCT01681771|11116678|FG001|Overall Study|Lost to Follow-up|2
7035425|NCT01681836|11116688|FG000|Second Intervention|Withdrawal by Subject|0
7035426|NCT01681836|11116689|FG001|Second Intervention|Withdrawal by Subject|1
7035427|NCT01681849|11116698|FG000|Overall Study|Protocol Violation|2
7035428|NCT01681849|11116699|FG001|Overall Study|Protocol Violation|0
7035429|NCT01681849|11116700|FG002|Overall Study|Protocol Violation|0
7035430|NCT01681849|11116698|FG000|Overall Study|Withdrawal by Subject|3
7035431|NCT01681849|11116699|FG001|Overall Study|Withdrawal by Subject|5
7035432|NCT01681849|11116700|FG002|Overall Study|Withdrawal by Subject|33
7035433|NCT01681849|11116698|FG000|Overall Study|Lost to Follow-up|3
7035434|NCT01681849|11116699|FG001|Overall Study|Lost to Follow-up|2
7035435|NCT01681849|11116700|FG002|Overall Study|Lost to Follow-up|6
7035436|NCT01681992|11116710|FG000|Overall Study|Adverse Event|3
7035437|NCT01681992|11116711|FG001|Overall Study|Adverse Event|2
7035438|NCT01681992|11116712|FG002|Overall Study|Adverse Event|3
7035439|NCT01681992|11116710|FG000|Overall Study|Lost to Follow-up|36
7035440|NCT01681992|11116711|FG001|Overall Study|Lost to Follow-up|38
7035441|NCT01681992|11116712|FG002|Overall Study|Lost to Follow-up|53
7035442|NCT01681992|11116710|FG000|Overall Study|As Per Sponsor Decision|0
7035443|NCT01681992|11116711|FG001|Overall Study|As Per Sponsor Decision|0
7035444|NCT01681992|11116712|FG002|Overall Study|As Per Sponsor Decision|1
7035445|NCT01681992|11116710|FG000|Overall Study|Protocol Violation|0
7035446|NCT01681992|11116711|FG001|Overall Study|Protocol Violation|0
7035447|NCT01681992|11116712|FG002|Overall Study|Protocol Violation|1
7035448|NCT01681992|11116710|FG000|Overall Study|Withdrawal by Subject|27
7035449|NCT01681992|11116711|FG001|Overall Study|Withdrawal by Subject|30
7035450|NCT01681992|11116712|FG002|Overall Study|Withdrawal by Subject|25
7035451|NCT01682031|11116722|FG000|Overall Study|Withdrawal by Subject|0
7035452|NCT01682031|11116723|FG001|Overall Study|Withdrawal by Subject|1
7035453|NCT01682031|11116722|FG000|Overall Study|Adverse Event|0
7035454|NCT01682031|11116723|FG001|Overall Study|Adverse Event|2
7035455|NCT01682031|11116722|FG000|Overall Study|MRI results indicate increased nodul|0
7035456|NCT01682031|11116723|FG001|Overall Study|MRI results indicate increased nodul|1
7035457|NCT01682031|11116722|FG000|Overall Study|Patient could not swallow tablets|1
7035458|NCT01682031|11116723|FG001|Overall Study|Patient could not swallow tablets|0
7035459|NCT01682031|11116722|FG000|Overall Study|Patient stopped selenium on his own|0
7035460|NCT01682031|11116723|FG001|Overall Study|Patient stopped selenium on his own|1
7035461|NCT01682044|11116729|FG000|Overall Study|Death|1
7035462|NCT01682044|11116729|FG000|Overall Study|Progression|3
7035463|NCT01682083|11116735|FG000|Overall Study|Lost to Follow-up|11
7035464|NCT01682083|11116736|FG001|Overall Study|Lost to Follow-up|18
7035465|NCT01682083|11116735|FG000|Overall Study|Withdrawal by Subject|31
7035466|NCT01682083|11116736|FG001|Overall Study|Withdrawal by Subject|40
7035467|NCT01682083|11116735|FG000|Overall Study|Death|60
7035468|NCT01682083|11116736|FG001|Overall Study|Death|93
7035469|NCT01682083|11116735|FG000|Overall Study|Physician Decision|5
7035470|NCT01682083|11116736|FG001|Overall Study|Physician Decision|4
7044699|NCT01756456|11130654|FG000|Follow Up Period Phase I/II|still in study after week 20|0
7044700|NCT01756456|11130655|FG001|Follow Up Period Phase I/II|still in study after week 20|0
7044701|NCT01756456|11130656|FG002|Follow Up Period Phase I/II|still in study after week 20|0
7060652|NCT01920711|11157002|FG001|Overall Study|Lost to Follow-up|14
7035471|NCT01682148|11116759|FG000|Overall Study|Withdrawal by Subject|2
7035472|NCT01682148|11116760|FG001|Overall Study|Withdrawal by Subject|0
7035473|NCT01682148|11116759|FG000|Overall Study|Lost to Follow-up|1
7035474|NCT01682148|11116760|FG001|Overall Study|Lost to Follow-up|2
7035475|NCT01682148|11116759|FG000|Overall Study|Protocol Violation|1
7035476|NCT01682148|11116760|FG001|Overall Study|Protocol Violation|1
7035477|NCT01682213|11116771|FG000|Overall Study|Withdrawal by Subject|2
7035478|NCT01682460|11116776|FG000|Overall Study|Withdrawal by Subject|2
7035479|NCT01682460|11116776|FG000|Overall Study|Did not meet inclusion criteria|2
7035480|NCT01682512|11116783|FG000|Overall Study|Adverse Event|6
7035481|NCT01682512|11116784|FG001|Overall Study|Adverse Event|5
7035482|NCT01682512|11116785|FG002|Overall Study|Adverse Event|2
7035483|NCT01682512|11116783|FG000|Overall Study|Withdrawal by Subject|2
7035484|NCT01682512|11116784|FG001|Overall Study|Withdrawal by Subject|6
7035485|NCT01682512|11116785|FG002|Overall Study|Withdrawal by Subject|3
7035486|NCT01682512|11116783|FG000|Overall Study|Physician Decision|0
7035487|NCT01682512|11116784|FG001|Overall Study|Physician Decision|2
7035488|NCT01682512|11116785|FG002|Overall Study|Physician Decision|0
7035489|NCT01682512|11116783|FG000|Overall Study|Study terminated by sponsor|46
7035490|NCT01682512|11116784|FG001|Overall Study|Study terminated by sponsor|43
7035491|NCT01682512|11116785|FG002|Overall Study|Study terminated by sponsor|0
7035492|NCT01682512|11116783|FG000|Overall Study|Lost to Follow-up|3
7035493|NCT01682512|11116784|FG001|Overall Study|Lost to Follow-up|0
7035494|NCT01682512|11116785|FG002|Overall Study|Lost to Follow-up|2
7035495|NCT01682512|11116783|FG000|Overall Study|Protocol Violation|2
7035496|NCT01682512|11116784|FG001|Overall Study|Protocol Violation|3
7035497|NCT01682512|11116785|FG002|Overall Study|Protocol Violation|2
7035498|NCT01682512|11116783|FG000|Overall Study|Primary lack of efficacy|10
7035499|NCT01682512|11116784|FG001|Overall Study|Primary lack of efficacy|7
7035500|NCT01682512|11116785|FG002|Overall Study|Primary lack of efficacy|7
7035501|NCT01682512|11116783|FG000|Overall Study|Secondary lack of efficacy|1
7035502|NCT01682512|11116784|FG001|Overall Study|Secondary lack of efficacy|1
7035503|NCT01682512|11116785|FG002|Overall Study|Secondary lack of efficacy|0
7035504|NCT01682512|11116783|FG000|Overall Study|Other than stated above|2
7035505|NCT01682512|11116784|FG001|Overall Study|Other than stated above|4
7035506|NCT01682512|11116785|FG002|Overall Study|Other than stated above|2
7035507|NCT01682603|11116808|FG000|Overall Study|Lost to Follow-up|3
7035508|NCT01682681|11116829|FG000|Overall Study|Lack of Efficacy|62
7035509|NCT01682681|11116829|FG000|Overall Study|Withdrawal by Subject|1
7143244|NCT03029143|11299739|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6
7143245|NCT03029143|11299740|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7
7143246|NCT03029143|11299738|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0
7143247|NCT03029143|11299739|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2
7143248|NCT03029143|11299740|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1
7143249|NCT03029208|11299751|FG000|Overall Study|Withdrawal by Subject|2
7143250|NCT03029208|11299752|FG001|Overall Study|Withdrawal by Subject|3
7143251|NCT03029208|11299751|FG000|Overall Study|Lost to Follow-up|0
7143252|NCT03029208|11299752|FG001|Overall Study|Lost to Follow-up|1
7143253|NCT03029247|11299769|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3
7143254|NCT03029247|11299770|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0
7035510|NCT01682681|11116829|FG000|Overall Study|Moved to other hospital|10
7035511|NCT01682681|11116829|FG000|Overall Study|Lost to Follow-up|174
7035512|NCT01682681|11116829|FG000|Overall Study|Adverse Event|46
7035513|NCT01682681|11116829|FG000|Overall Study|tapering of topiramate|5
7035514|NCT01682681|11116829|FG000|Overall Study|Other|21
7035515|NCT01682681|11116829|FG000|Overall Study|Low compliance|13
7035516|NCT01682720|11116837|FG000|Overall Study|Randomized but Not Treated|0
7035517|NCT01682720|11116838|FG001|Overall Study|Randomized but Not Treated|1
7035518|NCT01682720|11116839|FG002|Overall Study|Randomized but Not Treated|1
7035519|NCT01682720|11116840|FG003|Overall Study|Randomized but Not Treated|0
7035520|NCT01682720|11116837|FG000|Overall Study|Terminated by Sponsor|83
7035521|NCT01682720|11116838|FG001|Overall Study|Terminated by Sponsor|0
7035522|NCT01682720|11116839|FG002|Overall Study|Terminated by Sponsor|0
7035523|NCT01682720|11116840|FG003|Overall Study|Terminated by Sponsor|0
7035524|NCT01682720|11116837|FG000|Overall Study|Efficacy Failure|0
7035525|NCT01682720|11116838|FG001|Overall Study|Efficacy Failure|3
7035526|NCT01682720|11116839|FG002|Overall Study|Efficacy Failure|3
7035527|NCT01682720|11116840|FG003|Overall Study|Efficacy Failure|30
7035528|NCT01682720|11116837|FG000|Overall Study|Lost to Follow-up|1
7035529|NCT01682720|11116838|FG001|Overall Study|Lost to Follow-up|1
7035530|NCT01682720|11116839|FG002|Overall Study|Lost to Follow-up|0
7035531|NCT01682720|11116840|FG003|Overall Study|Lost to Follow-up|6
7035532|NCT01682720|11116837|FG000|Overall Study|Subject Withdrew Consent|0
7035533|NCT01682720|11116838|FG001|Overall Study|Subject Withdrew Consent|0
7035534|NCT01682720|11116839|FG002|Overall Study|Subject Withdrew Consent|2
7035535|NCT01682720|11116840|FG003|Overall Study|Subject Withdrew Consent|2
7035536|NCT01682720|11116837|FG000|Overall Study|Adverse Event|1
7035537|NCT01682720|11116838|FG001|Overall Study|Adverse Event|0
7035538|NCT01682720|11116839|FG002|Overall Study|Adverse Event|1
7035539|NCT01682720|11116840|FG003|Overall Study|Adverse Event|1
7035540|NCT01682759|11116852|FG000|Overall Study|Death|2
7035541|NCT01682759|11116853|FG001|Overall Study|Death|1
7143255|NCT03029247|11299769|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1
7035542|NCT01682759|11116852|FG000|Overall Study|Lost to Follow-up|10
7035543|NCT01682759|11116853|FG001|Overall Study|Lost to Follow-up|13
7035544|NCT01682759|11116852|FG000|Overall Study|Physician Decision|1
7035545|NCT01682759|11116853|FG001|Overall Study|Physician Decision|1
7035546|NCT01682759|11116852|FG000|Overall Study|Withdrawal by Subject|56
7035547|NCT01682759|11116853|FG001|Overall Study|Withdrawal by Subject|55
7035548|NCT01682811|11116866|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0
7035549|NCT01682811|11116867|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0
7035550|NCT01682811|11116868|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0
7035551|NCT01682811|11116869|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0
7035552|NCT01682811|11116870|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1
7035553|NCT01682811|11116871|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0
7035554|NCT01682811|11116872|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0
7035555|NCT01682811|11116866|FG000|Part 2 Dose Level 1|Protocol Violation|0
7035556|NCT01682811|11116867|FG001|Part 2 Dose Level 1|Protocol Violation|0
7035557|NCT01682811|11116868|FG002|Part 2 Dose Level 1|Protocol Violation|0
7035558|NCT01682811|11116869|FG003|Part 2 Dose Level 1|Protocol Violation|0
7035559|NCT01682811|11116870|FG004|Part 2 Dose Level 1|Protocol Violation|4
7035560|NCT01682811|11116871|FG005|Part 2 Dose Level 1|Protocol Violation|0
7035561|NCT01682811|11116872|FG006|Part 2 Dose Level 1|Protocol Violation|0
7035562|NCT01682811|11116866|FG000|Part 2 Dose Level 1|Lost to Follow-up|0
7035563|NCT01682811|11116867|FG001|Part 2 Dose Level 1|Lost to Follow-up|0
7035564|NCT01682811|11116868|FG002|Part 2 Dose Level 1|Lost to Follow-up|0
7035565|NCT01682811|11116869|FG003|Part 2 Dose Level 1|Lost to Follow-up|0
7035566|NCT01682811|11116870|FG004|Part 2 Dose Level 1|Lost to Follow-up|6
7035567|NCT01682811|11116871|FG005|Part 2 Dose Level 1|Lost to Follow-up|0
7035568|NCT01682811|11116872|FG006|Part 2 Dose Level 1|Lost to Follow-up|0
7035569|NCT01682811|11116866|FG000|Part 2 Dose Level 2|Lost to Follow-up|0
7035570|NCT01682811|11116867|FG001|Part 2 Dose Level 2|Lost to Follow-up|0
7035571|NCT01682811|11116868|FG002|Part 2 Dose Level 2|Lost to Follow-up|0
7035572|NCT01682811|11116869|FG003|Part 2 Dose Level 2|Lost to Follow-up|0
7035573|NCT01682811|11116870|FG004|Part 2 Dose Level 2|Lost to Follow-up|0
7035574|NCT01682811|11116871|FG005|Part 2 Dose Level 2|Lost to Follow-up|3
7035575|NCT01682811|11116872|FG006|Part 2 Dose Level 2|Lost to Follow-up|0
7035576|NCT01682837|11116891|FG000|Baseline|Withdrawal by Subject|5
7035577|NCT01682863|11116904|FG000|Overall Study|Subject/guardian decision|19
7035578|NCT01682863|11116905|FG001|Overall Study|Subject/guardian decision|12
7035579|NCT01682863|11116906|FG002|Overall Study|Subject/guardian decision|10
7035580|NCT01682863|11116904|FG000|Overall Study|Lost to Follow-up|5
7035581|NCT01682863|11116905|FG001|Overall Study|Lost to Follow-up|1
7035582|NCT01682863|11116906|FG002|Overall Study|Lost to Follow-up|6
7035583|NCT01682863|11116904|FG000|Overall Study|Death|1
7035584|NCT01682863|11116905|FG001|Overall Study|Death|3
7035585|NCT01682863|11116906|FG002|Overall Study|Death|4
7035586|NCT01682863|11116904|FG000|Overall Study|Protocol deviation|1
7035587|NCT01682863|11116905|FG001|Overall Study|Protocol deviation|0
7035588|NCT01682863|11116906|FG002|Overall Study|Protocol deviation|1
7035589|NCT01682863|11116904|FG000|Overall Study|Technical problems|1
7035590|NCT01682863|11116905|FG001|Overall Study|Technical problems|0
7035591|NCT01682863|11116906|FG002|Overall Study|Technical problems|0
7035592|NCT01682863|11116904|FG000|Overall Study|Adverse Event|0
7035593|NCT01682863|11116905|FG001|Overall Study|Adverse Event|1
7035594|NCT01682863|11116906|FG002|Overall Study|Adverse Event|2
7035595|NCT01682863|11116904|FG000|Overall Study|Physician Decision|0
7035596|NCT01682863|11116905|FG001|Overall Study|Physician Decision|0
7035597|NCT01682863|11116906|FG002|Overall Study|Physician Decision|1
7035598|NCT01682876|11116918|FG000|Overall Study|Administrative reason|4
7035599|NCT01682876|11116919|FG001|Overall Study|Administrative reason|4
7035600|NCT01682876|11116920|FG002|Overall Study|Administrative reason|0
7035601|NCT01682876|11116921|FG003|Overall Study|Administrative reason|3
7035602|NCT01682876|11116918|FG000|Overall Study|Adverse Event|0
7035603|NCT01682876|11116919|FG001|Overall Study|Adverse Event|0
7035604|NCT01682876|11116920|FG002|Overall Study|Adverse Event|0
7035605|NCT01682876|11116921|FG003|Overall Study|Adverse Event|1
7035606|NCT01682876|11116918|FG000|Overall Study|Lost to Follow-up|11
7035607|NCT01682876|11116919|FG001|Overall Study|Lost to Follow-up|15
7035608|NCT01682876|11116920|FG002|Overall Study|Lost to Follow-up|9
7035609|NCT01682876|11116921|FG003|Overall Study|Lost to Follow-up|11
7035610|NCT01682876|11116918|FG000|Overall Study|Protocol Violation|1
7035611|NCT01682876|11116919|FG001|Overall Study|Protocol Violation|1
7035612|NCT01682876|11116920|FG002|Overall Study|Protocol Violation|1
7035613|NCT01682876|11116921|FG003|Overall Study|Protocol Violation|1
7035614|NCT01682876|11116918|FG000|Overall Study|Withdrawal by Subject|4
7035615|NCT01682876|11116919|FG001|Overall Study|Withdrawal by Subject|0
7035616|NCT01682876|11116920|FG002|Overall Study|Withdrawal by Subject|0
7035617|NCT01682876|11116921|FG003|Overall Study|Withdrawal by Subject|2
7035618|NCT01682876|11116918|FG000|Overall Study|Other|1
7035619|NCT01682876|11116919|FG001|Overall Study|Other|0
7035620|NCT01682876|11116920|FG002|Overall Study|Other|1
7035621|NCT01682876|11116921|FG003|Overall Study|Other|1
7035622|NCT01683019|11116946|FG000|Overall Study|Withdrawal by Subject|2
7035623|NCT01683019|11116947|FG001|Overall Study|Withdrawal by Subject|1
7035624|NCT01683019|11116948|FG002|Overall Study|Withdrawal by Subject|4
7035625|NCT01683058|11116956|FG000|Overall Study|Lost to Follow-up|9
7035626|NCT01683058|11116956|FG000|Overall Study|Adverse Event|6
7035627|NCT01683058|11116956|FG000|Overall Study|Subject Met Withdrawal Criteria|5
7035628|NCT01683058|11116956|FG000|Overall Study|Withdrawal by Subject|7
7035629|NCT01683058|11116956|FG000|Overall Study|Lack of Efficacy|2
7035630|NCT01683071|11116967|FG000|Part 1|Lack of Efficacy|1
7035631|NCT01683071|11116968|FG001|Part 1|Lack of Efficacy|0
7035632|NCT01683071|11116969|FG002|Part 1|Lack of Efficacy|0
7035633|NCT01683071|11116970|FG003|Part 1|Lack of Efficacy|3
7035634|NCT01683071|11116971|FG004|Part 1|Lack of Efficacy|0
7060653|NCT01920711|11157001|FG000|Overall Study|Withdrawal by Subject|4
7060654|NCT01920711|11157002|FG001|Overall Study|Withdrawal by Subject|3
7060655|NCT01920854|11157029|FG000|Overall Study|Withdrawal by Subject|1
7060656|NCT01920854|11157030|FG001|Overall Study|Withdrawal by Subject|0
7060657|NCT01920854|11157031|FG002|Overall Study|Withdrawal by Subject|0
7060658|NCT01920854|11157032|FG003|Overall Study|Withdrawal by Subject|0
7060659|NCT01920854|11157033|FG004|Overall Study|Withdrawal by Subject|1
7060660|NCT01920854|11157034|FG005|Overall Study|Withdrawal by Subject|0
7143256|NCT03029247|11299770|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1
7143257|NCT03029247|11299769|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7
7143258|NCT03029247|11299770|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4
7143259|NCT03029247|11299769|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2
7143260|NCT03029247|11299770|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2
7143261|NCT03029585|11299778|FG000|Overall Study|Death|1
7143262|NCT03029585|11299779|FG001|Overall Study|Death|1
7060661|NCT01920854|11157035|FG006|Overall Study|Withdrawal by Subject|1
7060662|NCT01920893|11157072|FG000|Overall Study|Adverse Event|5
7060663|NCT01920893|11157073|FG001|Overall Study|Adverse Event|2
7060664|NCT01920893|11157072|FG000|Overall Study|Lack of Efficacy|2
7060665|NCT01920893|11157073|FG001|Overall Study|Lack of Efficacy|0
7060666|NCT01920958|11157080|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5
7060667|NCT01921101|11157086|FG000|Overall Study|Death|16
7060668|NCT01921101|11157087|FG001|Overall Study|Death|6
7060669|NCT01921179|11157095|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3
7060670|NCT01921179|11157096|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3
7060671|NCT01921179|11157095|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2
7060672|NCT01921179|11157096|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0
7060673|NCT01921205|11157105|FG000|Overall Study|Adverse Event|12
7060674|NCT01921205|11157106|FG001|Overall Study|Adverse Event|7
7060675|NCT01921205|11157105|FG000|Overall Study|Lack of Efficacy|1
7060676|NCT01921205|11157106|FG001|Overall Study|Lack of Efficacy|0
7060677|NCT01921205|11157105|FG000|Overall Study|Protocol Violation|1
7060678|NCT01921205|11157106|FG001|Overall Study|Protocol Violation|3
7060679|NCT01921205|11157105|FG000|Overall Study|Lost to Follow-up|1
7060680|NCT01921205|11157106|FG001|Overall Study|Lost to Follow-up|1
7060681|NCT01921205|11157105|FG000|Overall Study|Withdrawal by Subject|6
7060682|NCT01921205|11157106|FG001|Overall Study|Withdrawal by Subject|5
7060683|NCT01921205|11157105|FG000|Overall Study|Use Of Prohibited Medication|0
7060684|NCT01921205|11157106|FG001|Overall Study|Use Of Prohibited Medication|1
7060685|NCT01921205|11157105|FG000|Overall Study|The Excessive Use Of Rescue Medication|0
7060686|NCT01921205|11157106|FG001|Overall Study|The Excessive Use Of Rescue Medication|1
7060687|NCT01921205|11157105|FG000|Overall Study|Non Compliance Of The Parent|0
7060688|NCT01921205|11157106|FG001|Overall Study|Non Compliance Of The Parent|1
7060689|NCT01921205|11157105|FG000|Overall Study|Non Compliance Of Child|0
7060690|NCT01921205|11157106|FG001|Overall Study|Non Compliance Of Child|1
7060691|NCT01921257|11157112|FG000|Overall Study|Adverse Event|1
7060692|NCT01921257|11157112|FG000|Overall Study|Protocol Violation|1
7060693|NCT01921257|11157112|FG000|Overall Study|Withdrawal by Subject|1
7060694|NCT01921270|11157117|FG000|Overall Study|Withdrawal by Subject|1
7060695|NCT01921348|11157136|FG000|Overall Study|Withdrawal by Subject|1
7060696|NCT01921348|11157137|FG001|Overall Study|Withdrawal by Subject|0
7060697|NCT01921348|11157136|FG000|Overall Study|Lost to Follow-up|0
7060698|NCT01921348|11157137|FG001|Overall Study|Lost to Follow-up|2
7060699|NCT01921387|11157143|FG000|Overall Study|Adverse Event|1
7060700|NCT01921517|11157154|FG000|Overall Study|Lost to Follow-up|5
7060701|NCT01921517|11157155|FG001|Overall Study|Lost to Follow-up|0
7060702|NCT01921517|11157154|FG000|Overall Study|Newly diagnosed health concern|2
7060703|NCT01921517|11157155|FG001|Overall Study|Newly diagnosed health concern|0
7143263|NCT03029585|11299778|FG000|Overall Study|Withdrawal by Subject|1
7035635|NCT01683071|11116972|FG005|Part 1|Lack of Efficacy|0
7060704|NCT01921517|11157154|FG000|Overall Study|Physician Decision|0
7060705|NCT01921517|11157155|FG001|Overall Study|Physician Decision|2
7060706|NCT01921517|11157154|FG000|Overall Study|Withdrawal by Subject|7
7060707|NCT01921517|11157155|FG001|Overall Study|Withdrawal by Subject|3
7060708|NCT01921517|11157154|FG000|Overall Study|Subject missed final imaging|1
7060709|NCT01921517|11157155|FG001|Overall Study|Subject missed final imaging|4
7060710|NCT01921829|11157182|FG000|Overall Study|Withdrawal by Subject|0
7060711|NCT01921829|11157183|FG001|Overall Study|Withdrawal by Subject|1
7060712|NCT01922011|11157216|FG000|Overall Study|Protocol Violation|0
7060713|NCT01922011|11157217|FG001|Overall Study|Protocol Violation|1
7060714|NCT01922011|11157216|FG000|Overall Study|Physician Decision|0
7060715|NCT01922011|11157217|FG001|Overall Study|Physician Decision|1
7143264|NCT03029585|11299779|FG001|Overall Study|Withdrawal by Subject|0
7143265|NCT03029624|11299785|FG000|Overall Study|Adverse Event|1
7035636|NCT01683071|11116967|FG000|Part 1|Withdrawal by Subject|1
7035637|NCT01683071|11116968|FG001|Part 1|Withdrawal by Subject|2
7035638|NCT01683071|11116969|FG002|Part 1|Withdrawal by Subject|2
7035639|NCT01683071|11116970|FG003|Part 1|Withdrawal by Subject|1
7035640|NCT01683071|11116971|FG004|Part 1|Withdrawal by Subject|0
7035641|NCT01683071|11116972|FG005|Part 1|Withdrawal by Subject|0
7035642|NCT01683071|11116967|FG000|Part 1|Surgery Cancelled|1
7035643|NCT01683071|11116968|FG001|Part 1|Surgery Cancelled|0
7035644|NCT01683071|11116969|FG002|Part 1|Surgery Cancelled|0
7035645|NCT01683071|11116970|FG003|Part 1|Surgery Cancelled|0
7035646|NCT01683071|11116971|FG004|Part 1|Surgery Cancelled|0
7035647|NCT01683071|11116972|FG005|Part 1|Surgery Cancelled|0
7035648|NCT01683071|11116967|FG000|Part 1|Did not receive study drug|1
7035649|NCT01683071|11116968|FG001|Part 1|Did not receive study drug|0
7035650|NCT01683071|11116969|FG002|Part 1|Did not receive study drug|0
7035651|NCT01683071|11116970|FG003|Part 1|Did not receive study drug|1
7035652|NCT01683071|11116971|FG004|Part 1|Did not receive study drug|0
7035653|NCT01683071|11116972|FG005|Part 1|Did not receive study drug|0
7035654|NCT01683071|11116967|FG000|Part 1|Early termination; met exclusion criteria|0
7035655|NCT01683071|11116968|FG001|Part 1|Early termination; met exclusion criteria|2
7035656|NCT01683071|11116969|FG002|Part 1|Early termination; met exclusion criteria|1
7035657|NCT01683071|11116970|FG003|Part 1|Early termination; met exclusion criteria|0
7035658|NCT01683071|11116971|FG004|Part 1|Early termination; met exclusion criteria|0
7035659|NCT01683071|11116972|FG005|Part 1|Early termination; met exclusion criteria|0
7035660|NCT01683071|11116967|FG000|Part 2|Lack of Efficacy|0
7035661|NCT01683071|11116968|FG001|Part 2|Lack of Efficacy|0
7035662|NCT01683071|11116969|FG002|Part 2|Lack of Efficacy|0
7035663|NCT01683071|11116970|FG003|Part 2|Lack of Efficacy|0
7035664|NCT01683071|11116971|FG004|Part 2|Lack of Efficacy|3
7035665|NCT01683071|11116972|FG005|Part 2|Lack of Efficacy|4
7035666|NCT01683071|11116967|FG000|Part 2|Lost to Follow-up|0
7035667|NCT01683071|11116968|FG001|Part 2|Lost to Follow-up|0
7035668|NCT01683071|11116969|FG002|Part 2|Lost to Follow-up|0
7035669|NCT01683071|11116970|FG003|Part 2|Lost to Follow-up|0
7035670|NCT01683071|11116971|FG004|Part 2|Lost to Follow-up|2
7035671|NCT01683071|11116972|FG005|Part 2|Lost to Follow-up|0
7035672|NCT01683071|11116967|FG000|Part 2|Withdrawal by Subject|0
7035673|NCT01683071|11116968|FG001|Part 2|Withdrawal by Subject|0
7035674|NCT01683071|11116969|FG002|Part 2|Withdrawal by Subject|0
7035675|NCT01683071|11116970|FG003|Part 2|Withdrawal by Subject|0
7035676|NCT01683071|11116971|FG004|Part 2|Withdrawal by Subject|3
7035677|NCT01683071|11116972|FG005|Part 2|Withdrawal by Subject|3
7035678|NCT01683071|11116967|FG000|Part 2|Surgery cancelled|0
7035679|NCT01683071|11116968|FG001|Part 2|Surgery cancelled|0
7035680|NCT01683071|11116969|FG002|Part 2|Surgery cancelled|0
7035681|NCT01683071|11116970|FG003|Part 2|Surgery cancelled|0
7035682|NCT01683071|11116971|FG004|Part 2|Surgery cancelled|4
7035683|NCT01683071|11116972|FG005|Part 2|Surgery cancelled|2
7035684|NCT01683071|11116967|FG000|Part 2|Did not receive study drug|0
7035685|NCT01683071|11116968|FG001|Part 2|Did not receive study drug|0
7035686|NCT01683071|11116969|FG002|Part 2|Did not receive study drug|0
7035687|NCT01683071|11116970|FG003|Part 2|Did not receive study drug|0
7035688|NCT01683071|11116971|FG004|Part 2|Did not receive study drug|2
7035689|NCT01683071|11116972|FG005|Part 2|Did not receive study drug|1
7035690|NCT01683071|11116967|FG000|Part 2|Met exclusion criterion|0
7035691|NCT01683071|11116968|FG001|Part 2|Met exclusion criterion|0
7035692|NCT01683071|11116969|FG002|Part 2|Met exclusion criterion|0
7035693|NCT01683071|11116970|FG003|Part 2|Met exclusion criterion|0
7035694|NCT01683071|11116971|FG004|Part 2|Met exclusion criterion|1
7035695|NCT01683071|11116972|FG005|Part 2|Met exclusion criterion|1
7035696|NCT01683071|11116967|FG000|Part 2|Protocol deviation|0
7035697|NCT01683071|11116968|FG001|Part 2|Protocol deviation|0
7035698|NCT01683071|11116969|FG002|Part 2|Protocol deviation|0
7035699|NCT01683071|11116970|FG003|Part 2|Protocol deviation|0
7035700|NCT01683071|11116971|FG004|Part 2|Protocol deviation|1
7035701|NCT01683071|11116972|FG005|Part 2|Protocol deviation|2
7035702|NCT01683071|11116967|FG000|Part 2|Withdrawal by investigator decision|0
7035703|NCT01683071|11116968|FG001|Part 2|Withdrawal by investigator decision|0
7035704|NCT01683071|11116969|FG002|Part 2|Withdrawal by investigator decision|0
7035705|NCT01683071|11116970|FG003|Part 2|Withdrawal by investigator decision|0
7035706|NCT01683071|11116971|FG004|Part 2|Withdrawal by investigator decision|1
7035707|NCT01683071|11116972|FG005|Part 2|Withdrawal by investigator decision|2
7035708|NCT01683266|11116994|FG000|Overall Study|Adverse Event|5
7035709|NCT01683266|11116995|FG001|Overall Study|Adverse Event|4
7035710|NCT01683266|11116994|FG000|Overall Study|Lack of Efficacy|5
7035711|NCT01683266|11116995|FG001|Overall Study|Lack of Efficacy|2
7035712|NCT01683266|11116994|FG000|Overall Study|Protocol Violation|13
7035713|NCT01683266|11116995|FG001|Overall Study|Protocol Violation|6
7035714|NCT01683266|11116994|FG000|Overall Study|Personal Reason|17
7035715|NCT01683266|11116995|FG001|Overall Study|Personal Reason|25
7035716|NCT01683266|11116994|FG000|Overall Study|Selection Criterion / Protocol Violation|7
7035717|NCT01683266|11116995|FG001|Overall Study|Selection Criterion / Protocol Violation|5
7035718|NCT01683266|11116994|FG000|Overall Study|Lost to Follow-up|5
7035719|NCT01683266|11116995|FG001|Overall Study|Lost to Follow-up|0
7035720|NCT01683266|11116994|FG000|Overall Study|Site Closure / Site Withdrawal|1
7035721|NCT01683266|11116995|FG001|Overall Study|Site Closure / Site Withdrawal|3
7035722|NCT01683266|11116994|FG000|Overall Study|Nonserious Hypoglycemia|0
7035723|NCT01683266|11116995|FG001|Overall Study|Nonserious Hypoglycemia|3
7035724|NCT01683266|11116994|FG000|Overall Study|Perceived Lack of Efficacy|1
7035725|NCT01683266|11116995|FG001|Overall Study|Perceived Lack of Efficacy|1
7035726|NCT01683266|11116994|FG000|Overall Study|Possibly Hypoglycemia|1
7035727|NCT01683266|11116995|FG001|Overall Study|Possibly Hypoglycemia|0
7035728|NCT01683266|11116994|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0
7035729|NCT01683266|11116995|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1
7035730|NCT01683383|11117012|FG000|Overall Study|Infant was not transported|1
7035731|NCT01683383|11117013|FG001|Overall Study|Infant was not transported|0
7035732|NCT01683409|11117024|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
7035733|NCT01683409|11117025|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
7035734|NCT01683409|11117026|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1
7035735|NCT01683409|11117027|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
7035736|NCT01683409|11117028|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
7035737|NCT01683409|11117024|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0
7035738|NCT01683409|11117025|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3
7035739|NCT01683409|11117026|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0
7035740|NCT01683409|11117027|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1
7035741|NCT01683409|11117028|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1
7035742|NCT01683409|11117024|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
7035743|NCT01683409|11117025|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1
7035744|NCT01683409|11117026|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
7035745|NCT01683409|11117027|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
7035746|NCT01683409|11117028|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
7035747|NCT01683409|11117024|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
7035748|NCT01683409|11117025|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
7035749|NCT01683409|11117026|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
7035750|NCT01683409|11117027|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
7035751|NCT01683409|11117028|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
7035752|NCT01683409|11117024|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
7035753|NCT01683409|11117025|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
7035754|NCT01683409|11117026|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1
7035755|NCT01683409|11117027|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
7035756|NCT01683409|11117028|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
7035757|NCT01683409|11117024|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
7035758|NCT01683409|11117025|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
7035759|NCT01683409|11117026|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
7035760|NCT01683409|11117027|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
7035761|NCT01683409|11117028|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
7035762|NCT01683409|11117024|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
7035763|NCT01683409|11117025|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
7035764|NCT01683409|11117026|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
7035765|NCT01683409|11117027|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
7035766|NCT01683409|11117028|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
7035767|NCT01683409|11117024|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1
7035768|NCT01683409|11117025|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0
7035769|NCT01683409|11117026|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0
7035770|NCT01683409|11117027|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0
7035771|NCT01683409|11117028|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0
7035772|NCT01683409|11117024|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0
7035773|NCT01683409|11117025|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4
7035774|NCT01683409|11117026|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0
7035775|NCT01683409|11117027|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1
7035776|NCT01683409|11117028|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2
7035777|NCT01683409|11117024|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0
7035778|NCT01683409|11117025|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0
7035779|NCT01683409|11117026|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0
7035780|NCT01683409|11117027|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0
7035781|NCT01683409|11117028|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3
7035782|NCT01683409|11117024|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0
7035783|NCT01683409|11117025|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0
7035784|NCT01683409|11117026|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1
7035785|NCT01683409|11117027|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0
7035786|NCT01683409|11117028|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0
7035787|NCT01683565|11117069|FG000|Overall Study|Lost to Follow-up|2
7035788|NCT01683565|11117070|FG001|Overall Study|Lost to Follow-up|0
7035789|NCT01683565|11117069|FG000|Overall Study|Discontinued Intervention|1
7035790|NCT01683565|11117070|FG001|Overall Study|Discontinued Intervention|1
7035791|NCT01683604|11117078|FG000|Overall Study|Adverse Event|2
7035792|NCT01683604|11117078|FG000|Overall Study|Lack of Efficacy|1
7035793|NCT01683604|11117078|FG000|Overall Study|Other|2
7035794|NCT01683838|11117102|FG000|Overall Study|Adverse Event|12
7035795|NCT01683838|11117103|FG001|Overall Study|Adverse Event|2
7035796|NCT01683838|11117102|FG000|Overall Study|Protocol Violation|3
7035797|NCT01683838|11117103|FG001|Overall Study|Protocol Violation|1
7035798|NCT01683838|11117102|FG000|Overall Study|Withdrawal by Subject|6
7035799|NCT01683838|11117103|FG001|Overall Study|Withdrawal by Subject|5
7035800|NCT01683838|11117102|FG000|Overall Study|Lost to Follow-up|1
7035801|NCT01683838|11117103|FG001|Overall Study|Lost to Follow-up|1
7035802|NCT01683838|11117102|FG000|Overall Study|Other|4
7035803|NCT01683838|11117103|FG001|Overall Study|Other|3
7035804|NCT01683994|11117114|FG000|Overall Study|Withdrawal by Subject|1
7035805|NCT01683994|11117115|FG001|Overall Study|Withdrawal by Subject|0
7035806|NCT01683994|11117116|FG002|Overall Study|Withdrawal by Subject|0
7035807|NCT01683994|11117117|FG003|Overall Study|Withdrawal by Subject|1
7035808|NCT01683994|11117118|FG004|Overall Study|Withdrawal by Subject|0
7035809|NCT01683994|11117114|FG000|Overall Study|Intercurrent illness|0
7035810|NCT01683994|11117115|FG001|Overall Study|Intercurrent illness|0
7035811|NCT01683994|11117116|FG002|Overall Study|Intercurrent illness|0
7035812|NCT01683994|11117117|FG003|Overall Study|Intercurrent illness|2
7035813|NCT01683994|11117118|FG004|Overall Study|Intercurrent illness|1
7035814|NCT01684033|11117154|FG000|Period 1, First 30 Days|Adverse Event|1
7035815|NCT01684033|11117155|FG001|Period 1, First 30 Days|Adverse Event|1
7035816|NCT01684033|11117154|FG000|Period 1, First 30 Days|Noncompliance|1
7035817|NCT01684033|11117155|FG001|Period 1, First 30 Days|Noncompliance|0
7035818|NCT01684033|11117154|FG000|Period 1, First 30 Days|Withdrawal by Subject|1
7035819|NCT01684033|11117155|FG001|Period 1, First 30 Days|Withdrawal by Subject|0
7035820|NCT01684033|11117154|FG000|Period 1, First 30 Days|Lost to Follow-up|1
7035821|NCT01684033|11117155|FG001|Period 1, First 30 Days|Lost to Follow-up|0
7035822|NCT01684033|11117154|FG000|Period 2, Second 30 Days|Adverse Event|1
7035823|NCT01684033|11117155|FG001|Period 2, Second 30 Days|Adverse Event|0
7035824|NCT01684046|11117161|FG000|Period 1, First 30 Days|Adverse Event|0
7035825|NCT01684046|11117162|FG001|Period 1, First 30 Days|Adverse Event|2
7035826|NCT01684202|11117172|FG000|Dose-escalation Period|Adverse Event|0
7035827|NCT01684202|11117173|FG001|Dose-escalation Period|Adverse Event|1
7035828|NCT01684202|11117174|FG002|Dose-escalation Period|Adverse Event|0
7035829|NCT01684202|11117175|FG003|Dose-escalation Period|Adverse Event|0
7035830|NCT01684202|11117172|FG000|Dose-escalation Period|Withdrawal by Subject|1
7035831|NCT01684202|11117173|FG001|Dose-escalation Period|Withdrawal by Subject|0
7035832|NCT01684202|11117174|FG002|Dose-escalation Period|Withdrawal by Subject|0
7035833|NCT01684202|11117175|FG003|Dose-escalation Period|Withdrawal by Subject|0
7035834|NCT01684202|11117172|FG000|Maintenance Period|Adverse Event|1
7035835|NCT01684202|11117173|FG001|Maintenance Period|Adverse Event|1
7035836|NCT01684202|11117174|FG002|Maintenance Period|Adverse Event|1
7035837|NCT01684202|11117175|FG003|Maintenance Period|Adverse Event|1
7035838|NCT01684202|11117172|FG000|Maintenance Period|Physician Decision|0
7035839|NCT01684202|11117173|FG001|Maintenance Period|Physician Decision|1
7035840|NCT01684202|11117174|FG002|Maintenance Period|Physician Decision|0
7035841|NCT01684202|11117175|FG003|Maintenance Period|Physician Decision|0
7035842|NCT01684202|11117172|FG000|Maintenance Period|Withdrawal by Subject|0
7035843|NCT01684202|11117173|FG001|Maintenance Period|Withdrawal by Subject|1
7035844|NCT01684202|11117174|FG002|Maintenance Period|Withdrawal by Subject|0
7035845|NCT01684202|11117175|FG003|Maintenance Period|Withdrawal by Subject|0
7035846|NCT01684215|11117189|FG000|Phase 1, Part 1|Adverse Event|1
7035847|NCT01684215|11117190|FG001|Phase 1, Part 1|Adverse Event|0
7035848|NCT01684215|11117191|FG002|Phase 1, Part 1|Adverse Event|0
7035849|NCT01684215|11117192|FG003|Phase 1, Part 1|Adverse Event|0
7035850|NCT01684215|11117189|FG000|Phase 1, Part 1|Objective progression or relapse|5
7035851|NCT01684215|11117190|FG001|Phase 1, Part 1|Objective progression or relapse|6
7035852|NCT01684215|11117191|FG002|Phase 1, Part 1|Objective progression or relapse|0
7035853|NCT01684215|11117192|FG003|Phase 1, Part 1|Objective progression or relapse|0
7035854|NCT01684215|11117189|FG000|Phase 1, Part 2|Adverse Event|0
7035855|NCT01684215|11117190|FG001|Phase 1, Part 2|Adverse Event|0
7035856|NCT01684215|11117191|FG002|Phase 1, Part 2|Adverse Event|1
7035857|NCT01684215|11117192|FG003|Phase 1, Part 2|Adverse Event|0
7035858|NCT01684215|11117189|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
7035859|NCT01684215|11117190|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
7035860|NCT01684215|11117191|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4
7035861|NCT01684215|11117192|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
7035862|NCT01684215|11117189|FG000|Phase 1, Part 2|Withdrawal by Subject|0
7035863|NCT01684215|11117190|FG001|Phase 1, Part 2|Withdrawal by Subject|0
7035864|NCT01684215|11117191|FG002|Phase 1, Part 2|Withdrawal by Subject|1
7035865|NCT01684215|11117192|FG003|Phase 1, Part 2|Withdrawal by Subject|0
7035866|NCT01684215|11117189|FG000|Phase 2|Death|0
7035867|NCT01684215|11117190|FG001|Phase 2|Death|0
7035868|NCT01684215|11117191|FG002|Phase 2|Death|0
7035869|NCT01684215|11117192|FG003|Phase 2|Death|8
7035870|NCT01684215|11117189|FG000|Phase 2|Study terminated by sponsor|0
7035871|NCT01684215|11117190|FG001|Phase 2|Study terminated by sponsor|0
7035872|NCT01684215|11117191|FG002|Phase 2|Study terminated by sponsor|0
7035873|NCT01684215|11117192|FG003|Phase 2|Study terminated by sponsor|30
7035874|NCT01684215|11117189|FG000|Phase 2|Enrolled but not treated|0
7035875|NCT01684215|11117190|FG001|Phase 2|Enrolled but not treated|0
7035876|NCT01684215|11117191|FG002|Phase 2|Enrolled but not treated|0
7035877|NCT01684215|11117192|FG003|Phase 2|Enrolled but not treated|1
7035878|NCT01684215|11117189|FG000|Phase 2|Lost to Follow-up|0
7035879|NCT01684215|11117190|FG001|Phase 2|Lost to Follow-up|0
7035880|NCT01684215|11117191|FG002|Phase 2|Lost to Follow-up|0
7035881|NCT01684215|11117192|FG003|Phase 2|Lost to Follow-up|4
7035882|NCT01684423|11117223|FG000|Overall Study|Withdrawal by Subject|0
7035883|NCT01684423|11117224|FG001|Overall Study|Withdrawal by Subject|0
7035884|NCT01684423|11117225|FG002|Overall Study|Withdrawal by Subject|1
7035885|NCT01684423|11117226|FG003|Overall Study|Withdrawal by Subject|0
7035886|NCT01684423|11117227|FG004|Overall Study|Withdrawal by Subject|0
7035887|NCT01684878|11117280|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1
7035888|NCT01684878|11117281|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1
7035889|NCT01684878|11117282|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0
7035890|NCT01684878|11117283|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0
7035891|NCT01684878|11117280|FG000|Part 1: Safety Run in Phase|Death|15
7035892|NCT01684878|11117281|FG001|Part 1: Safety Run in Phase|Death|20
7035893|NCT01684878|11117282|FG002|Part 1: Safety Run in Phase|Death|0
7035894|NCT01684878|11117283|FG003|Part 1: Safety Run in Phase|Death|0
7035895|NCT01684878|11117280|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0
7035896|NCT01684878|11117281|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2
7035897|NCT01684878|11117282|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0
7035898|NCT01684878|11117283|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0
7035899|NCT01684878|11117280|FG000|Part 2: Randomized Phase|Participant withdrew consent|0
7035900|NCT01684878|11117281|FG001|Part 2: Randomized Phase|Participant withdrew consent|0
7035901|NCT01684878|11117282|FG002|Part 2: Randomized Phase|Participant withdrew consent|1
7035902|NCT01684878|11117283|FG003|Part 2: Randomized Phase|Participant withdrew consent|2
7035903|NCT01684878|11117280|FG000|Part 2: Randomized Phase|Lost to Follow-up|0
7035904|NCT01684878|11117281|FG001|Part 2: Randomized Phase|Lost to Follow-up|0
7035905|NCT01684878|11117282|FG002|Part 2: Randomized Phase|Lost to Follow-up|2
7035906|NCT01684878|11117283|FG003|Part 2: Randomized Phase|Lost to Follow-up|0
7035907|NCT01684878|11117280|FG000|Part 2: Randomized Phase|Death|0
7035908|NCT01684878|11117281|FG001|Part 2: Randomized Phase|Death|0
7035909|NCT01684878|11117282|FG002|Part 2: Randomized Phase|Death|62
7035910|NCT01684878|11117283|FG003|Part 2: Randomized Phase|Death|68
7035911|NCT01684878|11117280|FG000|Part 2: Randomized Phase|Alive at data-cut|0
7035912|NCT01684878|11117281|FG001|Part 2: Randomized Phase|Alive at data-cut|0
7035913|NCT01684878|11117282|FG002|Part 2: Randomized Phase|Alive at data-cut|13
7035914|NCT01684878|11117283|FG003|Part 2: Randomized Phase|Alive at data-cut|7
7035915|NCT01684878|11117280|FG000|Part 2: Randomized Phase|Participant noncompliance|0
7035916|NCT01684878|11117281|FG001|Part 2: Randomized Phase|Participant noncompliance|0
7035917|NCT01684878|11117282|FG002|Part 2: Randomized Phase|Participant noncompliance|0
7035918|NCT01684878|11117283|FG003|Part 2: Randomized Phase|Participant noncompliance|1
7035919|NCT01684930|11117312|FG000|Overall Study|Withdrawal by Subject|3
7035920|NCT01684930|11117313|FG001|Overall Study|Withdrawal by Subject|1
7035921|NCT01684943|11117322|FG000|Overall Study|Inadequate Venous Access|3
7035922|NCT01684943|11117323|FG001|Overall Study|Inadequate Venous Access|0
7035923|NCT01684943|11117324|FG002|Overall Study|Inadequate Venous Access|0
7035924|NCT01684943|11117322|FG000|Overall Study|Principal Investigator Determination|1
7035925|NCT01684943|11117323|FG001|Overall Study|Principal Investigator Determination|0
7035926|NCT01684943|11117324|FG002|Overall Study|Principal Investigator Determination|0
7035927|NCT01684943|11117322|FG000|Overall Study|Excluded from Analysis|1
7035928|NCT01684943|11117323|FG001|Overall Study|Excluded from Analysis|1
7035929|NCT01684943|11117324|FG002|Overall Study|Excluded from Analysis|1
7035930|NCT01684943|11117322|FG000|Overall Study|Lost to Follow-up|3
7035931|NCT01684943|11117323|FG001|Overall Study|Lost to Follow-up|0
7035932|NCT01684943|11117324|FG002|Overall Study|Lost to Follow-up|0
7035933|NCT01684943|11117322|FG000|Overall Study|Planning Pregnancy|1
7035934|NCT01684943|11117323|FG001|Overall Study|Planning Pregnancy|0
7035935|NCT01684943|11117324|FG002|Overall Study|Planning Pregnancy|0
7035936|NCT01685047|11117341|FG000|Overall Study|Withdrawal by Subject|20
7035937|NCT01685047|11117341|FG000|Overall Study|Death|26
7035938|NCT01685047|11117341|FG000|Overall Study|Lost to Follow-up|8
7035939|NCT01685047|11117341|FG000|Overall Study|Physician Decision|25
7035940|NCT01685047|11117341|FG000|Overall Study|Adverse Event|5
7035941|NCT01685047|11117341|FG000|Overall Study|patient withdrawn by sponsor|1
7035942|NCT01685060|11117345|FG000|Overall Study|Rollover patients|16
7035943|NCT01685060|11117345|FG000|Overall Study|Adverse Event|12
7035944|NCT01685060|11117345|FG000|Overall Study|Progressive disease|69
7035945|NCT01685060|11117345|FG000|Overall Study|Physician Decision|14
7035946|NCT01685060|11117345|FG000|Overall Study|Subject/guardian decision|20
7035947|NCT01685060|11117345|FG000|Overall Study|Lost to Follow-up|1
7035948|NCT01685060|11117345|FG000|Overall Study|Death|8
7035949|NCT01685073|11117351|FG000|Overall Study|Lost to Follow-up|6
7035950|NCT01685073|11117352|FG001|Overall Study|Lost to Follow-up|8
7035951|NCT01685073|11117351|FG000|Overall Study|Withdrawal by Subject|24
7035952|NCT01685073|11117352|FG001|Overall Study|Withdrawal by Subject|24
7035953|NCT01685138|11117358|FG000|Overall Study|Lost to Follow-up|1
7035954|NCT01685138|11117358|FG000|Overall Study|Protocol Violation|1
7035955|NCT01685138|11117358|FG000|Overall Study|No longer requires treatment|1
7035956|NCT01685138|11117358|FG000|Overall Study|Subject/guardian decision|2
7035957|NCT01685138|11117358|FG000|Overall Study|Physician Decision|6
7035958|NCT01685138|11117358|FG000|Overall Study|Death|10
7035959|NCT01685138|11117358|FG000|Overall Study|Adverse Event|18
7035960|NCT01685138|11117358|FG000|Overall Study|Progressive disease|53
7035961|NCT01685203|11117369|FG000|Overall Study|Lost to Follow-up|3
7035962|NCT01685203|11117370|FG001|Overall Study|Lost to Follow-up|3
7035963|NCT01685203|11117371|FG002|Overall Study|Lost to Follow-up|0
7035964|NCT01685203|11117372|FG003|Overall Study|Lost to Follow-up|1
7035965|NCT01685203|11117373|FG004|Overall Study|Lost to Follow-up|0
7035966|NCT01685203|11117374|FG005|Overall Study|Lost to Follow-up|0
7035967|NCT01685203|11117375|FG006|Overall Study|Lost to Follow-up|0
7035968|NCT01685203|11117369|FG000|Overall Study|Adverse Event|0
7035969|NCT01685203|11117370|FG001|Overall Study|Adverse Event|0
7035970|NCT01685203|11117371|FG002|Overall Study|Adverse Event|0
7035971|NCT01685203|11117372|FG003|Overall Study|Adverse Event|0
7035972|NCT01685203|11117373|FG004|Overall Study|Adverse Event|0
7035973|NCT01685203|11117374|FG005|Overall Study|Adverse Event|2
7035974|NCT01685203|11117375|FG006|Overall Study|Adverse Event|0
7035975|NCT01685203|11117369|FG000|Overall Study|Adverse event and withdrew consent|1
7035976|NCT01685203|11117370|FG001|Overall Study|Adverse event and withdrew consent|0
7035977|NCT01685203|11117371|FG002|Overall Study|Adverse event and withdrew consent|0
7035978|NCT01685203|11117372|FG003|Overall Study|Adverse event and withdrew consent|0
7035979|NCT01685203|11117373|FG004|Overall Study|Adverse event and withdrew consent|0
7035980|NCT01685203|11117374|FG005|Overall Study|Adverse event and withdrew consent|0
7035981|NCT01685203|11117375|FG006|Overall Study|Adverse event and withdrew consent|0
7035982|NCT01685203|11117369|FG000|Overall Study|Patient's decision|0
7035983|NCT01685203|11117370|FG001|Overall Study|Patient's decision|0
7035984|NCT01685203|11117371|FG002|Overall Study|Patient's decision|0
7035985|NCT01685203|11117372|FG003|Overall Study|Patient's decision|0
7035986|NCT01685203|11117373|FG004|Overall Study|Patient's decision|0
7035987|NCT01685203|11117374|FG005|Overall Study|Patient's decision|1
7035988|NCT01685203|11117375|FG006|Overall Study|Patient's decision|0
7035989|NCT01685216|11117391|FG000|Overall Study|Did not receive study drug|1
7035990|NCT01685229|11117397|FG000|Overall Study|Subjects missing Study Exit form|3
7035991|NCT01685229|11117398|FG001|Overall Study|Subjects missing Study Exit form|1
7035992|NCT01685229|11117397|FG000|Overall Study|Lost to Follow-up|16
7035993|NCT01685229|11117398|FG001|Overall Study|Lost to Follow-up|10
7035994|NCT01685229|11117397|FG000|Overall Study|Withdrawal by Subject|6
7035995|NCT01685229|11117398|FG001|Overall Study|Withdrawal by Subject|5
7035996|NCT01685229|11117397|FG000|Overall Study|Death|1
7035997|NCT01685229|11117398|FG001|Overall Study|Death|0
7035998|NCT01685372|11117427|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3
7035999|NCT01685372|11117428|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4
7036000|NCT01685437|11117438|FG000|Overall Study|Withdrawal by Subject|22
7036001|NCT01685437|11117438|FG000|Overall Study|Lost to Follow-up|3
7036002|NCT01685437|11117438|FG000|Overall Study|Adverse Event|1
7036003|NCT01685437|11117438|FG000|Overall Study|Protocol Violation|4
7036004|NCT01685437|11117438|FG000|Overall Study|Unable to make visits due to work|1
7036005|NCT01685697|11117469|FG000|Overall Study|Protocol Violation|3
7036006|NCT01685697|11117470|FG001|Overall Study|Protocol Violation|3
7036007|NCT01685801|11117480|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
7036008|NCT01685801|11117481|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
7036009|NCT01685801|11117482|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
7036010|NCT01685801|11117483|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1
7036011|NCT01685801|11117480|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
7036012|NCT01685801|11117481|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
7036013|NCT01685801|11117482|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
7036014|NCT01685801|11117483|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
7036015|NCT01685840|11117502|FG000|Overall Study|Death|77
7036016|NCT01685840|11117503|FG001|Overall Study|Death|66
7036017|NCT01685840|11117502|FG000|Overall Study|Lost to Follow-up|27
7036018|NCT01685840|11117503|FG001|Overall Study|Lost to Follow-up|25
7036019|NCT01685840|11117502|FG000|Overall Study|Physician Decision|3
7036020|NCT01685840|11117503|FG001|Overall Study|Physician Decision|7
7036021|NCT01685840|11117502|FG000|Overall Study|Withdrawal by Subject|14
7036022|NCT01685840|11117503|FG001|Overall Study|Withdrawal by Subject|17
7036023|NCT01685840|11117502|FG000|Overall Study|Futility|197
7036024|NCT01685840|11117503|FG001|Overall Study|Futility|200
7036025|NCT01685840|11117502|FG000|Overall Study|Had VAD, Dialysis or Transplant|11
7036026|NCT01685840|11117503|FG001|Overall Study|Had VAD, Dialysis or Transplant|17
7036027|NCT01685983|11117511|FG000|Overall Study|Adverse Event|7
7036028|NCT01685983|11117511|FG000|Overall Study|Death|1
7036029|NCT01685983|11117511|FG000|Overall Study|Withdrawal by Subject|19
7036030|NCT01685983|11117511|FG000|Overall Study|Protocol Violation|2
7036031|NCT01685983|11117511|FG000|Overall Study|Physician Decision|13
7036032|NCT01685983|11117511|FG000|Overall Study|Other|7
7036033|NCT01685983|11117511|FG000|Overall Study|Progressive Disease|32
7036034|NCT01685983|11117511|FG000|Overall Study|Noncompliance with Study Drug|1
7036035|NCT01686152|11117527|FG000|Overall Study|Withdrawal by Subject|11
7036036|NCT01686152|11117528|FG001|Overall Study|Withdrawal by Subject|11
7036037|NCT01686152|11117529|FG002|Overall Study|Withdrawal by Subject|3
7036038|NCT01686152|11117527|FG000|Overall Study|Drug Code Unblinded|0
7036039|NCT01686152|11117528|FG001|Overall Study|Drug Code Unblinded|1
7036040|NCT01686152|11117529|FG002|Overall Study|Drug Code Unblinded|0
7036041|NCT01686152|11117527|FG000|Overall Study|Protocol Violation|6
7036042|NCT01686152|11117528|FG001|Overall Study|Protocol Violation|1
7036043|NCT01686152|11117529|FG002|Overall Study|Protocol Violation|0
7036044|NCT01686152|11117527|FG000|Overall Study|Adverse Event|12
7036045|NCT01686152|11117528|FG001|Overall Study|Adverse Event|11
7036046|NCT01686152|11117529|FG002|Overall Study|Adverse Event|0
7036047|NCT01686152|11117527|FG000|Overall Study|Lack of Efficacy|0
7036048|NCT01686152|11117528|FG001|Overall Study|Lack of Efficacy|0
7036049|NCT01686152|11117529|FG002|Overall Study|Lack of Efficacy|1
7036050|NCT01686152|11117527|FG000|Overall Study|IP Non-compliance|5
7036051|NCT01686152|11117528|FG001|Overall Study|IP Non-compliance|5
7036052|NCT01686152|11117529|FG002|Overall Study|IP Non-compliance|0
7036053|NCT01686152|11117527|FG000|Overall Study|Lost to Follow-up|7
7036054|NCT01686152|11117528|FG001|Overall Study|Lost to Follow-up|6
7036055|NCT01686152|11117529|FG002|Overall Study|Lost to Follow-up|5
7036056|NCT01686373|11117543|FG000|Overall Study|Lost to Follow-up|3
7036057|NCT01686373|11117544|FG001|Overall Study|Lost to Follow-up|0
7036058|NCT01686373|11117543|FG000|Overall Study|Withdrawal by Subject|0
7036059|NCT01686373|11117544|FG001|Overall Study|Withdrawal by Subject|1
7036060|NCT01686373|11117543|FG000|Overall Study|Adverse Event|0
7036061|NCT01686373|11117544|FG001|Overall Study|Adverse Event|1
7036062|NCT01686438|11117553|FG000|Overall Study|Lost to Follow-up|8
7036063|NCT01686438|11117554|FG001|Overall Study|Lost to Follow-up|9
7036064|NCT01686438|11117555|FG002|Overall Study|Lost to Follow-up|10
7036065|NCT01686438|11117553|FG000|Overall Study|Adverse Event|0
7036066|NCT01686438|11117554|FG001|Overall Study|Adverse Event|0
7036067|NCT01686438|11117555|FG002|Overall Study|Adverse Event|1
7036068|NCT01686438|11117553|FG000|Overall Study|Protocol Violation|0
7036069|NCT01686438|11117554|FG001|Overall Study|Protocol Violation|0
7036070|NCT01686438|11117555|FG002|Overall Study|Protocol Violation|1
7036071|NCT01686438|11117553|FG000|Overall Study|Withdrawal by Subject|0
7036072|NCT01686438|11117554|FG001|Overall Study|Withdrawal by Subject|0
7036073|NCT01686438|11117555|FG002|Overall Study|Withdrawal by Subject|1
7036074|NCT01686568|11117595|FG000|Main Study|Withdrawal by Subject|1
7036075|NCT01686568|11117596|FG001|Main Study|Withdrawal by Subject|3
7036076|NCT01686568|11117595|FG000|Main Study|Noncompliance with protocol|0
7036077|NCT01686568|11117596|FG001|Main Study|Noncompliance with protocol|1
7036078|NCT01686568|11117595|FG000|Main Study|Liver enzymes above range of exclusion|1
7036079|NCT01686568|11117596|FG001|Main Study|Liver enzymes above range of exclusion|0
7036080|NCT01686568|11117595|FG000|Sub-Study|Not consented for sub-study|2
7036081|NCT01686568|11117596|FG001|Sub-Study|Not consented for sub-study|2
7036082|NCT01686581|11117602|FG000|Overall Study|Side-effects or Health Problems|15
7036083|NCT01686581|11117602|FG000|Overall Study|Lack of Efficacy|90
7143266|NCT03029624|11299785|FG000|Overall Study|Withdrawal by Subject|1
7143267|NCT03029624|11299785|FG000|Overall Study|Lack of Efficacy|1
7143268|NCT03029624|11299785|FG000|Overall Study|MRI need|2
7143269|NCT03029650|11299791|FG000|Washout (1 Week)|Withdrawal by Subject|1
7143270|NCT03029650|11299792|FG001|Washout (1 Week)|Withdrawal by Subject|1
7143271|NCT03029650|11299791|FG000|Washout (1 Week)|Physician Decision|0
7143272|NCT03029650|11299792|FG001|Washout (1 Week)|Physician Decision|1
7143279|NCT03029819|11299822|FG000|Overall Study|Lost to Follow-up|3
7143280|NCT03029819|11299823|FG001|Overall Study|Lost to Follow-up|5
7036084|NCT01686581|11117602|FG000|Overall Study|Participant Concerned about Risks|6
7036085|NCT01686581|11117602|FG000|Overall Study|Thinks Injections Too Painful|8
7036086|NCT01686581|11117602|FG000|Overall Study|Thinks Injections Take Too Much Time|2
7036087|NCT01686581|11117602|FG000|Overall Study|Trying to get Pregnant or Nursing|2
7036088|NCT01686581|11117602|FG000|Overall Study|Thinks it is Inconvenient|17
7036089|NCT01686581|11117602|FG000|Overall Study|Other Miscellaneous Reasons|36
7036090|NCT01686581|11117602|FG000|Overall Study|Reason Missing|1
7036091|NCT01686633|11117609|FG000|Overall Study|Lack of Efficacy|33
7036092|NCT01686633|11117610|FG001|Overall Study|Lack of Efficacy|13
7036093|NCT01686633|11117611|FG002|Overall Study|Lack of Efficacy|11
7036094|NCT01686633|11117609|FG000|Overall Study|Withdrawal by Subject|8
7036095|NCT01686633|11117610|FG001|Overall Study|Withdrawal by Subject|8
7036096|NCT01686633|11117611|FG002|Overall Study|Withdrawal by Subject|5
7036097|NCT01686633|11117609|FG000|Overall Study|Physician Decision|3
7036098|NCT01686633|11117610|FG001|Overall Study|Physician Decision|4
7036099|NCT01686633|11117611|FG002|Overall Study|Physician Decision|4
7143281|NCT03029819|11299822|FG000|Overall Study|Removed due to disruptive behavior|0
7036100|NCT01686633|11117609|FG000|Overall Study|Adverse Event|4
7036101|NCT01686633|11117610|FG001|Overall Study|Adverse Event|3
7036102|NCT01686633|11117611|FG002|Overall Study|Adverse Event|3
7036103|NCT01686633|11117609|FG000|Overall Study|Protocol Violation|2
7036104|NCT01686633|11117610|FG001|Overall Study|Protocol Violation|3
7036105|NCT01686633|11117611|FG002|Overall Study|Protocol Violation|0
7036106|NCT01686633|11117609|FG000|Overall Study|Protocol-defined Stopping Criteria|1
7036107|NCT01686633|11117610|FG001|Overall Study|Protocol-defined Stopping Criteria|0
7036108|NCT01686633|11117611|FG002|Overall Study|Protocol-defined Stopping Criteria|1
7036109|NCT01686633|11117609|FG000|Overall Study|Lost to Follow-up|0
7036110|NCT01686633|11117610|FG001|Overall Study|Lost to Follow-up|1
7143282|NCT03029819|11299823|FG001|Overall Study|Removed due to disruptive behavior|1
7143283|NCT03030599|11299841|FG000|Open Label Treatment and Titration|Protocol deviation|8
7036111|NCT01686633|11117611|FG002|Overall Study|Lost to Follow-up|1
7036112|NCT01686828|11117651|FG000|Overall Study|Physician Decision|1
7036113|NCT01686828|11117652|FG001|Overall Study|Physician Decision|0
7036114|NCT01686828|11117653|FG002|Overall Study|Physician Decision|0
7036115|NCT01686828|11117654|FG003|Overall Study|Physician Decision|0
7036116|NCT01686828|11117651|FG000|Overall Study|New Job|0
7036117|NCT01686828|11117652|FG001|Overall Study|New Job|1
7036118|NCT01686828|11117653|FG002|Overall Study|New Job|0
7036119|NCT01686828|11117654|FG003|Overall Study|New Job|0
7036120|NCT01686828|11117651|FG000|Overall Study|Weight Loss|0
7036121|NCT01686828|11117652|FG001|Overall Study|Weight Loss|0
7036122|NCT01686828|11117653|FG002|Overall Study|Weight Loss|1
7036123|NCT01686828|11117654|FG003|Overall Study|Weight Loss|0
7036124|NCT01686932|11117670|FG000|Period 1|Adverse Event|1
7036125|NCT01686932|11117671|FG001|Period 1|Adverse Event|1
7036126|NCT01686958|11117677|FG000|Overall Study|Withdrawal by Subject|1
7036127|NCT01687101|11117695|FG000|Overall Study|Lost to Follow-up|7
7036128|NCT01687166|11117707|FG000|Overall Study|Attempt subject|2
7036129|NCT01687166|11117708|FG001|Overall Study|Attempt subject|3
7036130|NCT01687166|11117709|FG002|Overall Study|Attempt subject|2
7036131|NCT01687166|11117710|FG003|Overall Study|Attempt subject|0
7036132|NCT01687166|11117707|FG000|Overall Study|Did not meet eligibility criteria|4
7036133|NCT01687166|11117708|FG001|Overall Study|Did not meet eligibility criteria|6
7036134|NCT01687166|11117709|FG002|Overall Study|Did not meet eligibility criteria|1
7036135|NCT01687166|11117710|FG003|Overall Study|Did not meet eligibility criteria|1
7036136|NCT01687166|11117707|FG000|Overall Study|Adverse Event|2
7036137|NCT01687166|11117708|FG001|Overall Study|Adverse Event|1
7036138|NCT01687166|11117709|FG002|Overall Study|Adverse Event|0
7036139|NCT01687166|11117710|FG003|Overall Study|Adverse Event|0
7036140|NCT01687166|11117707|FG000|Overall Study|Physician Decision|3
7036141|NCT01687166|11117708|FG001|Overall Study|Physician Decision|2
7036142|NCT01687166|11117709|FG002|Overall Study|Physician Decision|1
7036143|NCT01687166|11117710|FG003|Overall Study|Physician Decision|0
7036144|NCT01687166|11117707|FG000|Overall Study|Withdrawal by Subject|11
7036145|NCT01687166|11117708|FG001|Overall Study|Withdrawal by Subject|4
7036146|NCT01687166|11117709|FG002|Overall Study|Withdrawal by Subject|3
7036147|NCT01687166|11117710|FG003|Overall Study|Withdrawal by Subject|0
7036148|NCT01687166|11117707|FG000|Overall Study|Lost to Follow-up|2
7036149|NCT01687166|11117708|FG001|Overall Study|Lost to Follow-up|5
7036150|NCT01687166|11117709|FG002|Overall Study|Lost to Follow-up|1
7036151|NCT01687166|11117710|FG003|Overall Study|Lost to Follow-up|0
7036152|NCT01687166|11117707|FG000|Overall Study|Equipment/Device Availability|0
7036153|NCT01687166|11117708|FG001|Overall Study|Equipment/Device Availability|1
7036154|NCT01687166|11117709|FG002|Overall Study|Equipment/Device Availability|0
7036155|NCT01687166|11117710|FG003|Overall Study|Equipment/Device Availability|0
7036156|NCT01687166|11117707|FG000|Overall Study|Death|1
7036157|NCT01687166|11117708|FG001|Overall Study|Death|1
7036158|NCT01687166|11117709|FG002|Overall Study|Death|0
7036159|NCT01687166|11117710|FG003|Overall Study|Death|0
7036160|NCT01687166|11117707|FG000|Overall Study|Protocol Violation|1
7036161|NCT01687166|11117708|FG001|Overall Study|Protocol Violation|1
7036162|NCT01687166|11117709|FG002|Overall Study|Protocol Violation|1
7036163|NCT01687166|11117710|FG003|Overall Study|Protocol Violation|0
7036164|NCT01687166|11117707|FG000|Overall Study|Subject moved out of state|0
7036165|NCT01687166|11117708|FG001|Overall Study|Subject moved out of state|1
7036166|NCT01687166|11117709|FG002|Overall Study|Subject moved out of state|0
7036167|NCT01687166|11117710|FG003|Overall Study|Subject moved out of state|0
7036168|NCT01687166|11117707|FG000|Overall Study|Patient unable to be compliant|1
7036169|NCT01687166|11117708|FG001|Overall Study|Patient unable to be compliant|0
7036170|NCT01687166|11117709|FG002|Overall Study|Patient unable to be compliant|0
7036171|NCT01687166|11117710|FG003|Overall Study|Patient unable to be compliant|0
7036172|NCT01687166|11117707|FG000|Overall Study|Physician choice to use different device|1
7036173|NCT01687166|11117708|FG001|Overall Study|Physician choice to use different device|2
7036174|NCT01687166|11117709|FG002|Overall Study|Physician choice to use different device|4
7036175|NCT01687166|11117710|FG003|Overall Study|Physician choice to use different device|0
7036176|NCT01687166|11117707|FG000|Overall Study|Insurance|0
7036177|NCT01687166|11117708|FG001|Overall Study|Insurance|0
7036178|NCT01687166|11117709|FG002|Overall Study|Insurance|1
7036179|NCT01687166|11117710|FG003|Overall Study|Insurance|1
7036180|NCT01687218|11117731|FG000|Overall Study|Withdrawal by Subject|2
7036181|NCT01687218|11117732|FG001|Overall Study|Withdrawal by Subject|3
7036182|NCT01687218|11117733|FG002|Overall Study|Withdrawal by Subject|0
7036183|NCT01687218|11117734|FG003|Overall Study|Withdrawal by Subject|1
7036184|NCT01687218|11117735|FG004|Overall Study|Withdrawal by Subject|1
7036185|NCT01687218|11117736|FG005|Overall Study|Withdrawal by Subject|0
7036186|NCT01687218|11117731|FG000|Overall Study|Relocated, no follow-up planned|1
7036187|NCT01687218|11117732|FG001|Overall Study|Relocated, no follow-up planned|0
7036188|NCT01687218|11117733|FG002|Overall Study|Relocated, no follow-up planned|1
7036189|NCT01687218|11117734|FG003|Overall Study|Relocated, no follow-up planned|1
7036190|NCT01687218|11117735|FG004|Overall Study|Relocated, no follow-up planned|0
7036191|NCT01687218|11117736|FG005|Overall Study|Relocated, no follow-up planned|0
7036192|NCT01687257|11117763|FG000|Overall Study|Efficacy Failure|6
7036193|NCT01687257|11117764|FG001|Overall Study|Efficacy Failure|0
7036194|NCT01687257|11117765|FG002|Overall Study|Efficacy Failure|5
7036195|NCT01687257|11117763|FG000|Overall Study|Subject Withdrew Consent|1
7036196|NCT01687257|11117764|FG001|Overall Study|Subject Withdrew Consent|1
7036197|NCT01687257|11117765|FG002|Overall Study|Subject Withdrew Consent|1
7036198|NCT01687257|11117763|FG000|Overall Study|Adverse Event|1
7036199|NCT01687257|11117764|FG001|Overall Study|Adverse Event|0
7036200|NCT01687257|11117765|FG002|Overall Study|Adverse Event|0
7036201|NCT01687257|11117763|FG000|Overall Study|Investigator's Discretion|0
7036202|NCT01687257|11117764|FG001|Overall Study|Investigator's Discretion|3
7036203|NCT01687257|11117765|FG002|Overall Study|Investigator's Discretion|0
7036204|NCT01687270|11117779|FG000|Overall Study|Lack of Efficacy|11
7036205|NCT01687270|11117779|FG000|Overall Study|Lost to Follow-up|1
7036206|NCT01687283|11117785|FG000|Overall Study|Adverse Event|11
7036207|NCT01687283|11117786|FG001|Overall Study|Adverse Event|4
7036208|NCT01687283|11117785|FG000|Overall Study|Lack of Efficacy|3
7036209|NCT01687283|11117786|FG001|Overall Study|Lack of Efficacy|1
7036210|NCT01687283|11117785|FG000|Overall Study|Protocol Violation|1
7143284|NCT03030599|11299842|FG001|Open Label Treatment and Titration|Protocol deviation|0
7143285|NCT03030599|11299843|FG002|Open Label Treatment and Titration|Protocol deviation|0
7143286|NCT03030599|11299841|FG000|Open Label Treatment and Titration|Other|1
7143287|NCT03030599|11299842|FG001|Open Label Treatment and Titration|Other|0
7143288|NCT03030599|11299843|FG002|Open Label Treatment and Titration|Other|0
7143289|NCT03030599|11299841|FG000|Open Label Treatment and Titration|Physician Decision|3
7143290|NCT03030599|11299842|FG001|Open Label Treatment and Titration|Physician Decision|0
7143291|NCT03030599|11299843|FG002|Open Label Treatment and Titration|Physician Decision|0
7143292|NCT03030599|11299841|FG000|Open Label Treatment and Titration|Lack of Efficacy|1
7143293|NCT03030599|11299842|FG001|Open Label Treatment and Titration|Lack of Efficacy|0
7143294|NCT03030599|11299843|FG002|Open Label Treatment and Titration|Lack of Efficacy|0
7143295|NCT03030599|11299841|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4
7143296|NCT03030599|11299842|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0
7036211|NCT01687283|11117786|FG001|Overall Study|Protocol Violation|3
7036212|NCT01687283|11117785|FG000|Overall Study|protocol defined stopping criteria|8
7036213|NCT01687283|11117786|FG001|Overall Study|protocol defined stopping criteria|10
7036214|NCT01687283|11117785|FG000|Overall Study|Lost to Follow-up|1
7036215|NCT01687283|11117786|FG001|Overall Study|Lost to Follow-up|1
7036216|NCT01687283|11117785|FG000|Overall Study|Investigator discretion|2
7036217|NCT01687283|11117786|FG001|Overall Study|Investigator discretion|0
7036218|NCT01687283|11117785|FG000|Overall Study|Withdrawal by Subject|9
7036219|NCT01687283|11117786|FG001|Overall Study|Withdrawal by Subject|8
7036220|NCT01687296|11117794|FG000|Overall Study|Lack of Efficacy|1
7036221|NCT01687296|11117795|FG001|Overall Study|Lack of Efficacy|1
7036222|NCT01687296|11117794|FG000|Overall Study|Protocol Violation|0
7036223|NCT01687296|11117795|FG001|Overall Study|Protocol Violation|1
7036224|NCT01687296|11117794|FG000|Overall Study|Withdrawal by Subject|6
7036225|NCT01687296|11117795|FG001|Overall Study|Withdrawal by Subject|3
7036226|NCT01687413|11117825|FG000|Overall Study|Withdrawal by Subject|0
7036227|NCT01687413|11117826|FG001|Overall Study|Withdrawal by Subject|2
7036228|NCT01687413|11117825|FG000|Overall Study|Not eligible|0
7036229|NCT01687413|11117826|FG001|Overall Study|Not eligible|2
7036230|NCT01687413|11117825|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1
7036231|NCT01687413|11117826|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0
7036232|NCT01687478|11117852|FG000|Overall Study|Adverse Event|3
7036233|NCT01687478|11117853|FG001|Overall Study|Adverse Event|10
7036234|NCT01687478|11117852|FG000|Overall Study|Lost to Follow-up|1
7036235|NCT01687478|11117853|FG001|Overall Study|Lost to Follow-up|3
7036236|NCT01687478|11117852|FG000|Overall Study|Protocol Violation|0
7036237|NCT01687478|11117853|FG001|Overall Study|Protocol Violation|2
7036238|NCT01687478|11117852|FG000|Overall Study|Withdrawal by Subject|21
7036239|NCT01687478|11117853|FG001|Overall Study|Withdrawal by Subject|19
7143297|NCT03030599|11299843|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0
7143298|NCT03030599|11299841|FG000|Open Label Treatment and Titration|Adverse Event|18
7143299|NCT03030599|11299842|FG001|Open Label Treatment and Titration|Adverse Event|0
7183614|NCT01488890|11383706|FG001|Overall Study|Lost to Follow-up|10
7036240|NCT01687478|11117852|FG000|Overall Study|Physician Decision|1
7036241|NCT01687478|11117853|FG001|Overall Study|Physician Decision|3
7036242|NCT01687478|11117852|FG000|Overall Study|Entry Criteria Not Met|6
7036243|NCT01687478|11117853|FG001|Overall Study|Entry Criteria Not Met|2
7036244|NCT01687595|11117861|FG000|Overall Study|Withdrawal by Subject|8
7036245|NCT01687595|11117862|FG001|Overall Study|Withdrawal by Subject|0
7036246|NCT01687595|11117861|FG000|Overall Study|Lost to Follow-up|3
7036247|NCT01687595|11117862|FG001|Overall Study|Lost to Follow-up|1
7036248|NCT01687595|11117861|FG000|Overall Study|Investigator's decision|1
7036249|NCT01687595|11117862|FG001|Overall Study|Investigator's decision|0
7036250|NCT01687595|11117861|FG000|Overall Study|Sponsor's decision|1
7036251|NCT01687595|11117862|FG001|Overall Study|Sponsor's decision|0
7036252|NCT01687595|11117861|FG000|Overall Study|Noncompliance|1
7036253|NCT01687595|11117862|FG001|Overall Study|Noncompliance|2
7036254|NCT01687595|11117861|FG000|Overall Study|Other than specified|56
7036255|NCT01687595|11117862|FG001|Overall Study|Other than specified|7
7036256|NCT01687673|11117868|FG000|Overall Study|Physician Decision|1
7044702|NCT01756456|11130657|FG003|Follow Up Period Phase I/II|still in study after week 20|25
7044703|NCT01756456|11130658|FG004|Follow Up Period Phase I/II|still in study after week 20|23
7036257|NCT01687712|11117874|FG000|Cycle 1|Not Biochemically Pregnant|386
7036258|NCT01687712|11117875|FG001|Cycle 1|Not Biochemically Pregnant|348
7036259|NCT01687712|11117874|FG000|Cycle 1|Early Pregnancy Loss|43
7036260|NCT01687712|11117875|FG001|Cycle 1|Early Pregnancy Loss|60
7036261|NCT01687712|11117874|FG000|Cycle 1|Ectopic Pregnancy|5
7036262|NCT01687712|11117875|FG001|Cycle 1|Ectopic Pregnancy|5
7036263|NCT01687712|11117874|FG000|Cycle 1|Heterotropic Pregnancy|1
7036264|NCT01687712|11117875|FG001|Cycle 1|Heterotropic Pregnancy|0
7036265|NCT01687712|11117874|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9
7036266|NCT01687712|11117875|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14
7036267|NCT01687712|11117874|FG000|Cycle 1|Abortion|3
7036268|NCT01687712|11117875|FG001|Cycle 1|Abortion|0
7036269|NCT01687712|11117874|FG000|Cycle 1|Intrauterine Fetal Death|0
7036270|NCT01687712|11117875|FG001|Cycle 1|Intrauterine Fetal Death|1
7036271|NCT01687712|11117874|FG000|Cycle 1|Lost to Follow-up|1
7036272|NCT01687712|11117875|FG001|Cycle 1|Lost to Follow-up|1
7036273|NCT01687712|11117874|FG000|Cycle 2|Not Biochemically Pregnant|74
7036274|NCT01687712|11117875|FG001|Cycle 2|Not Biochemically Pregnant|77
7036275|NCT01687712|11117874|FG000|Cycle 2|Early Pregnancy Loss|18
7036276|NCT01687712|11117875|FG001|Cycle 2|Early Pregnancy Loss|16
7036277|NCT01687712|11117874|FG000|Cycle 2|Ectopic Pregnancy|0
7036278|NCT01687712|11117875|FG001|Cycle 2|Ectopic Pregnancy|1
7143300|NCT03030599|11299843|FG002|Open Label Treatment and Titration|Adverse Event|0
7143301|NCT03030599|11299841|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6
7036279|NCT01687712|11117874|FG000|Cycle 2|Still Birth|1
7036280|NCT01687712|11117875|FG001|Cycle 2|Still Birth|0
7036281|NCT01687712|11117874|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0
7036282|NCT01687712|11117875|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1
7036283|NCT01687712|11117874|FG000|Cycle 3|Not Biochemically Pregnant|21
7036284|NCT01687712|11117875|FG001|Cycle 3|Not Biochemically Pregnant|22
7036285|NCT01687712|11117874|FG000|Cycle 3|Early Pregnancy Loss|1
7036286|NCT01687712|11117875|FG001|Cycle 3|Early Pregnancy Loss|2
7036287|NCT01687712|11117874|FG000|Cycle 3|Ectopic Pregnancy|1
7036288|NCT01687712|11117875|FG001|Cycle 3|Ectopic Pregnancy|0
7036289|NCT01687712|11117874|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1
7036290|NCT01687712|11117875|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0
7036291|NCT01687998|11117901|FG000|Overall Study|Withdrawal by Subject|49
7036292|NCT01687998|11117902|FG001|Overall Study|Withdrawal by Subject|51
7036293|NCT01687998|11117901|FG000|Overall Study|Known to be Alive at Study End|54
7036294|NCT01687998|11117902|FG001|Overall Study|Known to be Alive at Study End|62
7036295|NCT01687998|11117901|FG000|Overall Study|Lost to Follow-up|9
7036296|NCT01687998|11117902|FG001|Overall Study|Lost to Follow-up|7
7036297|NCT01688037|11117911|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1
7036298|NCT01688037|11117912|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0
7036299|NCT01688037|11117913|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1
7036300|NCT01688037|11117911|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1
7036301|NCT01688037|11117912|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2
7036302|NCT01688037|11117913|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3
7036303|NCT01688037|11117911|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4
7143302|NCT03030599|11299842|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0
7036304|NCT01688037|11117912|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0
7036305|NCT01688037|11117913|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
7036306|NCT01688037|11117911|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
7036307|NCT01688037|11117912|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
7036308|NCT01688037|11117913|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
7036309|NCT01688037|11117911|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0
7036310|NCT01688037|11117912|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1
7036311|NCT01688037|11117913|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0
7036312|NCT01688037|11117911|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4
7036313|NCT01688037|11117912|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1
7036314|NCT01688037|11117913|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1
7036315|NCT01688037|11117911|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0
7036316|NCT01688037|11117912|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0
7036317|NCT01688037|11117913|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2
7036318|NCT01688037|11117911|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1
7036319|NCT01688037|11117912|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2
7036320|NCT01688037|11117913|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0
7036321|NCT01688037|11117911|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
7036322|NCT01688037|11117912|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
7036323|NCT01688037|11117913|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1
7036324|NCT01688037|11117911|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
7036325|NCT01688037|11117912|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1
7036326|NCT01688037|11117913|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
7036327|NCT01688050|11117925|FG000|Overall Study|Death|7
7036328|NCT01688050|11117925|FG000|Overall Study|Conversion to open repair|1
7036329|NCT01688050|11117925|FG000|Overall Study|Lost to Follow-up|13
7036330|NCT01688050|11117925|FG000|Overall Study|Withdrawal by Subject|10
7036331|NCT01688466|11117965|FG000|Overall Study|Withdrawal by Subject|2
7036332|NCT01688466|11117966|FG001|Overall Study|Withdrawal by Subject|1
7036333|NCT01688466|11117965|FG000|Overall Study|Death|0
7036334|NCT01688466|11117966|FG001|Overall Study|Death|1
7036335|NCT01688466|11117965|FG000|Overall Study|Adverse Event|0
7036336|NCT01688466|11117966|FG001|Overall Study|Adverse Event|4
7036337|NCT01688466|11117965|FG000|Overall Study|Not evaluable|0
7036338|NCT01688466|11117966|FG001|Overall Study|Not evaluable|1
7036339|NCT01688635|11117985|FG000|Washout 1|Withdrawal by Subject|1
7036340|NCT01688635|11117986|FG001|Washout 1|Withdrawal by Subject|0
7036341|NCT01688635|11117985|FG000|Washout 1|Adverse Event|0
7036342|NCT01688635|11117986|FG001|Washout 1|Adverse Event|1
7036343|NCT01688635|11117985|FG000|Washout 1|Physician Decision|0
7036344|NCT01688635|11117986|FG001|Washout 1|Physician Decision|1
7036345|NCT01688635|11117985|FG000|Washout 2|Physician Decision|1
7036346|NCT01688635|11117986|FG001|Washout 2|Physician Decision|0
7036347|NCT01688635|11117985|FG000|Washout 2|Withdrawal by Subject|1
7036348|NCT01688635|11117986|FG001|Washout 2|Withdrawal by Subject|0
7036349|NCT01688635|11117985|FG000|Washout 2|Sponsor Decision|1
7036350|NCT01688635|11117986|FG001|Washout 2|Sponsor Decision|2
7036351|NCT01688635|11117985|FG000|Washout 3|Withdrawal by Subject|1
7036352|NCT01688635|11117986|FG001|Washout 3|Withdrawal by Subject|0
7036353|NCT01688726|11117995|FG000|Overall Study|Adverse Event|1
7036354|NCT01688726|11117996|FG001|Overall Study|Adverse Event|0
7036355|NCT01688726|11117995|FG000|Overall Study|Relocated abroad|0
7036356|NCT01688726|11117996|FG001|Overall Study|Relocated abroad|1
7036357|NCT01688739|11118016|FG000|Overall Study|Administrative Decision|1
7036358|NCT01688739|11118017|FG001|Overall Study|Administrative Decision|0
7036359|NCT01688739|11118018|FG002|Overall Study|Administrative Decision|0
7036360|NCT01688739|11118019|FG003|Overall Study|Administrative Decision|0
7036361|NCT01688739|11118020|FG004|Overall Study|Administrative Decision|0
7036362|NCT01688739|11118021|FG005|Overall Study|Administrative Decision|0
7036363|NCT01688739|11118022|FG006|Overall Study|Administrative Decision|0
7036364|NCT01688739|11118023|FG007|Overall Study|Administrative Decision|0
7036365|NCT01688739|11118024|FG008|Overall Study|Administrative Decision|0
7036366|NCT01688739|11118025|FG009|Overall Study|Administrative Decision|0
7036367|NCT01688830|11118076|FG000|Overall Study|Lost to Follow-up|0
7036368|NCT01688830|11118077|FG001|Overall Study|Lost to Follow-up|0
7036369|NCT01688830|11118078|FG002|Overall Study|Lost to Follow-up|0
7036370|NCT01688830|11118079|FG003|Overall Study|Lost to Follow-up|0
7036371|NCT01688830|11118080|FG004|Overall Study|Lost to Follow-up|0
7036372|NCT01688830|11118081|FG005|Overall Study|Lost to Follow-up|0
7036373|NCT01688830|11118082|FG006|Overall Study|Lost to Follow-up|0
7036374|NCT01688830|11118083|FG007|Overall Study|Lost to Follow-up|0
7036375|NCT01688830|11118084|FG008|Overall Study|Lost to Follow-up|0
7036376|NCT01688830|11118085|FG009|Overall Study|Lost to Follow-up|0
7036377|NCT01688830|11118086|FG010|Overall Study|Lost to Follow-up|1
7036378|NCT01688830|11118087|FG011|Overall Study|Lost to Follow-up|0
7036379|NCT01688830|11118088|FG012|Overall Study|Lost to Follow-up|0
7143303|NCT03030599|11299843|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0
7143304|NCT03030599|11299841|FG000|Open Label Treatment and Titration|Sponsor decision|2
7143305|NCT03030599|11299842|FG001|Open Label Treatment and Titration|Sponsor decision|0
7143306|NCT03030599|11299843|FG002|Open Label Treatment and Titration|Sponsor decision|0
7143307|NCT03030599|11299841|FG000|Open Label Treatment and Titration|Lost to Follow-up|3
7143308|NCT03030599|11299842|FG001|Open Label Treatment and Titration|Lost to Follow-up|0
7143309|NCT03030599|11299843|FG002|Open Label Treatment and Titration|Lost to Follow-up|0
7143310|NCT03030599|11299841|FG000|Stable Dose|Protocol deviation|3
7143311|NCT03030599|11299842|FG001|Stable Dose|Protocol deviation|0
7143312|NCT03030599|11299843|FG002|Stable Dose|Protocol deviation|0
7143313|NCT03030599|11299841|FG000|Stable Dose|Adverse Event|1
7143314|NCT03030599|11299842|FG001|Stable Dose|Adverse Event|0
6827104|NCT00122382|10829625|FG002|Double-Blind Study|Randomized but not treated|0
6922214|NCT00810069|10950713|FG001|Lead-in Period I|Randomization criteria not met|0
6922215|NCT00810069|10950714|FG002|Lead-in Period I|Randomization criteria not met|0
6922216|NCT00810069|10950712|FG000|Double-Blind Period II|Adverse Event|0
6922217|NCT00810069|10950713|FG001|Double-Blind Period II|Adverse Event|9
6922218|NCT00810069|10950714|FG002|Double-Blind Period II|Adverse Event|8
6922219|NCT00810069|10950712|FG000|Double-Blind Period II|Lack of Efficacy|0
6922220|NCT00810069|10950713|FG001|Double-Blind Period II|Lack of Efficacy|7
6922221|NCT00810069|10950714|FG002|Double-Blind Period II|Lack of Efficacy|12
6922222|NCT00810069|10950712|FG000|Double-Blind Period II|Lost to Follow-up|0
6922223|NCT00810069|10950713|FG001|Double-Blind Period II|Lost to Follow-up|9
6922224|NCT00810069|10950714|FG002|Double-Blind Period II|Lost to Follow-up|9
6922225|NCT00810069|10950712|FG000|Double-Blind Period II|Physician Decision|0
6922226|NCT00810069|10950713|FG001|Double-Blind Period II|Physician Decision|0
6922227|NCT00810069|10950714|FG002|Double-Blind Period II|Physician Decision|1
7036380|NCT01688830|11118089|FG013|Overall Study|Lost to Follow-up|0
7036381|NCT01688830|11118090|FG014|Overall Study|Lost to Follow-up|0
7143315|NCT03030599|11299843|FG002|Stable Dose|Adverse Event|0
6922228|NCT00810069|10950712|FG000|Double-Blind Period II|Withdrawal by Subject|0
6922229|NCT00810069|10950713|FG001|Double-Blind Period II|Withdrawal by Subject|21
6922230|NCT00810069|10950714|FG002|Double-Blind Period II|Withdrawal by Subject|35
6922231|NCT00810069|10950712|FG000|Double-Blind Period II|Protocol entry criterion not met|0
7036382|NCT01688830|11118091|FG015|Overall Study|Lost to Follow-up|0
7036383|NCT01688830|11118092|FG016|Overall Study|Lost to Follow-up|0
7036384|NCT01688830|11118093|FG017|Overall Study|Lost to Follow-up|0
7036385|NCT01688830|11118094|FG018|Overall Study|Lost to Follow-up|0
7036386|NCT01688830|11118095|FG019|Overall Study|Lost to Follow-up|0
7036387|NCT01688830|11118096|FG020|Overall Study|Lost to Follow-up|0
7036388|NCT01688882|11118201|FG000|Overall Study|Adverse Event|1
7036389|NCT01688882|11118202|FG001|Overall Study|Adverse Event|0
7036390|NCT01688882|11118201|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7036391|NCT01688882|11118202|FG001|Overall Study|Unsatisfactory therapeutic effect|1
7036392|NCT01688882|11118201|FG000|Overall Study|Administrative problems|1
7036393|NCT01688882|11118202|FG001|Overall Study|Administrative problems|0
7036394|NCT01688921|11118218|FG000|Overall Study|Lost to Follow-up|7
7036395|NCT01688921|11118219|FG001|Overall Study|Lost to Follow-up|13
7036396|NCT01688921|11118218|FG000|Overall Study|Physician Decision|6
7036397|NCT01688921|11118219|FG001|Overall Study|Physician Decision|1
7036398|NCT01688921|11118218|FG000|Overall Study|Protocol Violation|0
7036399|NCT01688921|11118219|FG001|Overall Study|Protocol Violation|1
7036400|NCT01688921|11118218|FG000|Overall Study|informed consent|3
7036401|NCT01688921|11118219|FG001|Overall Study|informed consent|0
7036402|NCT01688973|11118228|FG000|Overall Study|Ineligible|2
7036403|NCT01688973|11118229|FG001|Overall Study|Ineligible|3
7036404|NCT01688999|11118239|FG000|Overall Study|Withdrawal by Subject|5
7036405|NCT01688999|11118240|FG001|Overall Study|Withdrawal by Subject|1
7036406|NCT01688999|11118241|FG002|Overall Study|Withdrawal by Subject|1
7036407|NCT01688999|11118239|FG000|Overall Study|Adverse Event|2
7036408|NCT01688999|11118240|FG001|Overall Study|Adverse Event|0
7036409|NCT01688999|11118241|FG002|Overall Study|Adverse Event|2
7036410|NCT01688999|11118239|FG000|Overall Study|Ineligible/Not treated|1
7036411|NCT01688999|11118240|FG001|Overall Study|Ineligible/Not treated|0
7036412|NCT01688999|11118241|FG002|Overall Study|Ineligible/Not treated|0
7036413|NCT01689207|11118264|FG000|Overall Study|Adverse Event|0
7036414|NCT01689207|11118265|FG001|Overall Study|Adverse Event|1
7036415|NCT01689207|11118266|FG002|Overall Study|Adverse Event|0
7036416|NCT01689207|11118267|FG003|Overall Study|Adverse Event|0
7036417|NCT01689207|11118268|FG004|Overall Study|Adverse Event|2
7036418|NCT01689207|11118269|FG005|Overall Study|Adverse Event|1
7036419|NCT01689207|11118270|FG006|Overall Study|Adverse Event|0
7036420|NCT01689207|11118271|FG007|Overall Study|Adverse Event|0
7036421|NCT01689207|11118272|FG008|Overall Study|Adverse Event|1
7036422|NCT01689207|11118273|FG009|Overall Study|Adverse Event|0
7036423|NCT01689207|11118274|FG010|Overall Study|Adverse Event|0
7036424|NCT01689337|11118308|FG000|Overall Study|Study Discontinuation|1
7036425|NCT01689363|11118323|FG000|Overall Study|Protocol Violation|0
7036426|NCT01689363|11118324|FG001|Overall Study|Protocol Violation|1
7036427|NCT01689363|11118325|FG002|Overall Study|Protocol Violation|0
7036428|NCT01689363|11118326|FG003|Overall Study|Protocol Violation|0
7036429|NCT01689363|11118327|FG004|Overall Study|Protocol Violation|0
7036430|NCT01689363|11118328|FG005|Overall Study|Protocol Violation|0
7036431|NCT01689363|11118329|FG006|Overall Study|Protocol Violation|0
7036432|NCT01689363|11118330|FG007|Overall Study|Protocol Violation|0
7036433|NCT01689532|11118352|FG000|Overall Study|Adverse Event|9
7036434|NCT01689532|11118353|FG001|Overall Study|Adverse Event|5
7036435|NCT01689532|11118352|FG000|Overall Study|Lack of Efficacy|2
7036436|NCT01689532|11118353|FG001|Overall Study|Lack of Efficacy|2
7036437|NCT01689532|11118352|FG000|Overall Study|Withdrawal by Subject|1
7036438|NCT01689532|11118353|FG001|Overall Study|Withdrawal by Subject|2
7036439|NCT01689532|11118352|FG000|Overall Study|Physician Decision|2
7036440|NCT01689532|11118353|FG001|Overall Study|Physician Decision|0
7036441|NCT01689649|11118359|FG000|Overall Study|Lack of Efficacy|3
7036442|NCT01689649|11118359|FG000|Overall Study|Non-compliance|11
7036443|NCT01689649|11118359|FG000|Overall Study|Protocol Violation|3
7036444|NCT01689649|11118359|FG000|Overall Study|Lost to Follow-up|5
7036445|NCT01689857|11118383|FG000|Overall Study|Lost to Follow-up|5
7036446|NCT01689857|11118384|FG001|Overall Study|Lost to Follow-up|2
7036447|NCT01690052|11118399|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1
7036448|NCT01690052|11118400|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2
7036449|NCT01690130|11118419|FG000|Overall Study|Subject have cancelled visit.|1
7036450|NCT01690130|11118420|FG001|Overall Study|Subject have cancelled visit.|0
7036451|NCT01690143|11118426|FG000|Overall Study|Withdrawal by Subject|1
7036452|NCT01690520|11118450|FG000|Overall Study|Death|25
7036453|NCT01690520|11118451|FG001|Overall Study|Death|21
7036454|NCT01690520|11118450|FG000|Overall Study|Lost to Follow-up|2
7036455|NCT01690520|11118451|FG001|Overall Study|Lost to Follow-up|3
7036456|NCT01690520|11118450|FG000|Overall Study|Withdrawal by Subject|2
7036457|NCT01690520|11118451|FG001|Overall Study|Withdrawal by Subject|0
7036458|NCT01690520|11118450|FG000|Overall Study|Relapse|0
7036459|NCT01690520|11118451|FG001|Overall Study|Relapse|1
7036460|NCT01690520|11118450|FG000|Overall Study|Other|0
7036461|NCT01690520|11118451|FG001|Overall Study|Other|1
7036462|NCT01690520|11118450|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22
7036463|NCT01690520|11118451|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21
7036464|NCT01690988|11118486|FG000|Overall Study|Withdrawal by Subject|2
7036465|NCT01690988|11118487|FG001|Overall Study|Withdrawal by Subject|2
7036466|NCT01690988|11118488|FG002|Overall Study|Withdrawal by Subject|3
7036467|NCT01690988|11118486|FG000|Overall Study|Physician Decision|0
7036468|NCT01690988|11118487|FG001|Overall Study|Physician Decision|0
7036469|NCT01690988|11118488|FG002|Overall Study|Physician Decision|1
7036470|NCT01690988|11118486|FG000|Overall Study|Operation Cancelled|1
7036471|NCT01690988|11118487|FG001|Overall Study|Operation Cancelled|1
7036472|NCT01690988|11118488|FG002|Overall Study|Operation Cancelled|0
7036473|NCT01690988|11118486|FG000|Overall Study|Determined ineligible|1
7036474|NCT01690988|11118487|FG001|Overall Study|Determined ineligible|0
7036475|NCT01690988|11118488|FG002|Overall Study|Determined ineligible|0
7036476|NCT01690988|11118486|FG000|Overall Study|Death|1
7036477|NCT01690988|11118487|FG001|Overall Study|Death|1
7036478|NCT01690988|11118488|FG002|Overall Study|Death|1
7036479|NCT01690988|11118486|FG000|Overall Study|Sedated|1
7036480|NCT01690988|11118487|FG001|Overall Study|Sedated|1
7036481|NCT01690988|11118488|FG002|Overall Study|Sedated|2
7036482|NCT01691014|11118503|FG000|Overall Study|Premature Termination|1
7036483|NCT01691014|11118504|FG001|Overall Study|Premature Termination|6
7036484|NCT01691014|11118505|FG002|Overall Study|Premature Termination|0
7143316|NCT03030599|11299841|FG000|Stable Dose|Lost to Follow-up|1
7143317|NCT03030599|11299842|FG001|Stable Dose|Lost to Follow-up|0
7143318|NCT03030599|11299843|FG002|Stable Dose|Lost to Follow-up|0
7143319|NCT03030599|11299841|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0
7143320|NCT03030599|11299842|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0
7143321|NCT03030599|11299843|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2
7143322|NCT03030599|11299841|FG000|Double Blind Randomized Withdrawal|Adverse Event|0
7143323|NCT03030599|11299842|FG001|Double Blind Randomized Withdrawal|Adverse Event|0
7143324|NCT03030599|11299843|FG002|Double Blind Randomized Withdrawal|Adverse Event|3
7143325|NCT03030599|11299841|FG000|Double Blind Randomized Withdrawal|Randomized in error|0
7143326|NCT03030599|11299842|FG001|Double Blind Randomized Withdrawal|Randomized in error|0
7143327|NCT03030599|11299843|FG002|Double Blind Randomized Withdrawal|Randomized in error|2
7143328|NCT03030599|11299841|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0
7143329|NCT03030599|11299842|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0
7143330|NCT03030599|11299843|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1
7143331|NCT03030599|11299841|FG000|Open-label Extension|Adverse Event|3
7143332|NCT03030599|11299842|FG001|Open-label Extension|Adverse Event|0
7143333|NCT03030599|11299843|FG002|Open-label Extension|Adverse Event|0
7143334|NCT03030599|11299841|FG000|Open-label Extension|Lost to Follow-up|2
7143335|NCT03030599|11299842|FG001|Open-label Extension|Lost to Follow-up|0
7143336|NCT03030599|11299843|FG002|Open-label Extension|Lost to Follow-up|0
7143337|NCT03030599|11299841|FG000|Open-label Extension|Lack of Efficacy|1
7143338|NCT03030599|11299842|FG001|Open-label Extension|Lack of Efficacy|0
7143339|NCT03030599|11299843|FG002|Open-label Extension|Lack of Efficacy|0
7143340|NCT03030599|11299841|FG000|Open-label Extension|Other Reason|1
7143341|NCT03030599|11299842|FG001|Open-label Extension|Other Reason|0
7143342|NCT03030599|11299843|FG002|Open-label Extension|Other Reason|0
7143343|NCT03030989|11299886|FG000|Overall Study|Fever|2
7143344|NCT03030989|11299887|FG001|Overall Study|Fever|2
7143345|NCT03030989|11299886|FG000|Overall Study|Rash|2
7143346|NCT03030989|11299887|FG001|Overall Study|Rash|1
7143347|NCT03030989|11299886|FG000|Overall Study|Fatigue/Overwhelmed|1
7143348|NCT03030989|11299887|FG001|Overall Study|Fatigue/Overwhelmed|5
7143349|NCT03030989|11299886|FG000|Overall Study|Positive Blood Cultures|2
7143350|NCT03030989|11299887|FG001|Overall Study|Positive Blood Cultures|1
7143351|NCT03030989|11299886|FG000|Overall Study|Line Removed|0
7143352|NCT03030989|11299887|FG001|Overall Study|Line Removed|2
7143353|NCT03030989|11299886|FG000|Overall Study|No longer interested|5
7143354|NCT03030989|11299887|FG001|Overall Study|No longer interested|3
7143355|NCT03031431|11299893|FG000|Overall Study|Infant removed by maternal request|1
7143356|NCT03031496|11299897|FG000|Period 1|Adverse Event|2
7143357|NCT03031496|11299898|FG001|Period 1|Adverse Event|0
7143358|NCT03031496|11299897|FG000|Period 1|Withdrawal by Subject|0
7143359|NCT03031496|11299898|FG001|Period 1|Withdrawal by Subject|2
7143360|NCT03031678|11299904|FG000|Overall Study|Study closed prior to completion|1
7143361|NCT03031899|11299921|FG000|Overall Study|Protocol Violation|1
7143362|NCT03031899|11299921|FG000|Overall Study|lesion disappeared after stopping habit|1
7143363|NCT03031938|11299931|FG000|Overall Study|Death|1
7143364|NCT03031938|11299932|FG001|Overall Study|Death|0
7143365|NCT03032380|11299949|FG000|Overall Study|Adverse Event|0
7143366|NCT03032380|11299950|FG001|Overall Study|Adverse Event|1
7143367|NCT03032380|11299949|FG000|Overall Study|Lack of Efficacy|1
7143368|NCT03032380|11299950|FG001|Overall Study|Lack of Efficacy|0
7143369|NCT03032380|11299949|FG000|Overall Study|Withdrawal by Subject|2
7143370|NCT03032380|11299950|FG001|Overall Study|Withdrawal by Subject|3
7143371|NCT03032380|11299949|FG000|Overall Study|Recovery|0
7143372|NCT03032380|11299950|FG001|Overall Study|Recovery|1
7143373|NCT03032380|11299949|FG000|Overall Study|Death|39
7143374|NCT03032380|11299950|FG001|Overall Study|Death|34
7143375|NCT03032380|11299949|FG000|Overall Study|Other - Miscellaneous|0
7143376|NCT03032380|11299950|FG001|Overall Study|Other - Miscellaneous|1
7143377|NCT03032523|11299967|FG000|Overall Study|Withdrawal by Subject|2
7036485|NCT01691014|11118506|FG003|Overall Study|Premature Termination|3
7143378|NCT03032523|11299968|FG001|Overall Study|Withdrawal by Subject|2
7036486|NCT01691014|11118503|FG000|Overall Study|Other|0
7143379|NCT03032523|11299967|FG000|Overall Study|Physician Decision|1
7143380|NCT03032523|11299968|FG001|Overall Study|Physician Decision|0
7143381|NCT03033394|11300008|FG000|Completed Pharmacokinetic Analysis|Missing data|1
7183615|NCT01488890|11383707|FG002|Overall Study|Lost to Follow-up|20
7036487|NCT01691014|11118504|FG001|Overall Study|Other|0
7036488|NCT01691014|11118505|FG002|Overall Study|Other|2
7036489|NCT01691014|11118506|FG003|Overall Study|Other|0
7036490|NCT01691014|11118503|FG000|Overall Study|Withdrawal by Subject|0
7036491|NCT01691014|11118504|FG001|Overall Study|Withdrawal by Subject|1
7036492|NCT01691014|11118505|FG002|Overall Study|Withdrawal by Subject|1
7036493|NCT01691014|11118506|FG003|Overall Study|Withdrawal by Subject|1
7036494|NCT01691014|11118503|FG000|Overall Study|Adverse Event|0
7036495|NCT01691014|11118504|FG001|Overall Study|Adverse Event|5
7036496|NCT01691014|11118505|FG002|Overall Study|Adverse Event|1
7036497|NCT01691014|11118506|FG003|Overall Study|Adverse Event|1
7036498|NCT01691014|11118503|FG000|Overall Study|Lack of Efficacy|2
7036499|NCT01691014|11118504|FG001|Overall Study|Lack of Efficacy|3
7036500|NCT01691014|11118505|FG002|Overall Study|Lack of Efficacy|7
7036501|NCT01691014|11118506|FG003|Overall Study|Lack of Efficacy|0
7036502|NCT01691092|11118521|FG000|Overall Study|Lost to Follow-up|10
7036503|NCT01691092|11118521|FG000|Overall Study|Physician Decision|4
7036504|NCT01691092|11118521|FG000|Overall Study|Withdrawal by Subject|3
7036505|NCT01691092|11118521|FG000|Overall Study|non-compliance|3
7036506|NCT01691092|11118521|FG000|Overall Study|used for different study|2
7036507|NCT01691092|11118521|FG000|Overall Study|screen fail|19
7036508|NCT01691105|11118527|FG000|1 Month Follow-up|Lost to Follow-up|41
7036509|NCT01691105|11118528|FG001|1 Month Follow-up|Lost to Follow-up|38
7036510|NCT01691105|11118527|FG000|1 Month Follow-up|Death|2
7036511|NCT01691105|11118528|FG001|1 Month Follow-up|Death|3
7143382|NCT03033394|11300008|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3
7143383|NCT03033394|11300008|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1
7143384|NCT03033394|11300008|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1
7143385|NCT03033394|11300008|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1
7143386|NCT03033745|11300029|FG000|Overall Study|Protocol Violation|0
7143387|NCT03033745|11300030|FG001|Overall Study|Protocol Violation|0
7143388|NCT03033745|11300031|FG002|Overall Study|Protocol Violation|1
7143389|NCT03033745|11300029|FG000|Overall Study|Adverse Event|1
7143390|NCT03033745|11300030|FG001|Overall Study|Adverse Event|0
7143391|NCT03033745|11300031|FG002|Overall Study|Adverse Event|1
7143392|NCT03033745|11300029|FG000|Overall Study|Withdrawal by Subject|0
7143393|NCT03033745|11300030|FG001|Overall Study|Withdrawal by Subject|1
7143394|NCT03033745|11300031|FG002|Overall Study|Withdrawal by Subject|0
7143395|NCT03033784|11300048|FG000|Overall Study|Anxiety related to MRI scanner|0
7143396|NCT03033784|11300049|FG001|Overall Study|Anxiety related to MRI scanner|1
7143397|NCT03033784|11300050|FG002|Overall Study|Anxiety related to MRI scanner|0
7143398|NCT03033784|11300051|FG003|Overall Study|Anxiety related to MRI scanner|0
7143399|NCT03033784|11300052|FG004|Overall Study|Anxiety related to MRI scanner|0
7143400|NCT03033784|11300053|FG005|Overall Study|Anxiety related to MRI scanner|0
7143401|NCT03033784|11300054|FG006|Overall Study|Anxiety related to MRI scanner|0
7143402|NCT03033784|11300055|FG007|Overall Study|Anxiety related to MRI scanner|0
7143403|NCT03033784|11300056|FG008|Overall Study|Anxiety related to MRI scanner|0
7143404|NCT03033784|11300057|FG009|Overall Study|Anxiety related to MRI scanner|0
7143405|NCT03033784|11300058|FG010|Overall Study|Anxiety related to MRI scanner|0
7143406|NCT03033784|11300059|FG011|Overall Study|Anxiety related to MRI scanner|0
7143407|NCT03033784|11300060|FG012|Overall Study|Anxiety related to MRI scanner|0
7143408|NCT03033784|11300048|FG000|Overall Study|Withdrawal by Subject|0
7143409|NCT03033784|11300049|FG001|Overall Study|Withdrawal by Subject|0
7143410|NCT03033784|11300050|FG002|Overall Study|Withdrawal by Subject|0
7143411|NCT03033784|11300051|FG003|Overall Study|Withdrawal by Subject|0
7143412|NCT03033784|11300052|FG004|Overall Study|Withdrawal by Subject|0
7143413|NCT03033784|11300053|FG005|Overall Study|Withdrawal by Subject|0
7143414|NCT03033784|11300054|FG006|Overall Study|Withdrawal by Subject|0
7143415|NCT03033784|11300055|FG007|Overall Study|Withdrawal by Subject|0
7143416|NCT03033784|11300056|FG008|Overall Study|Withdrawal by Subject|0
7143417|NCT03033784|11300057|FG009|Overall Study|Withdrawal by Subject|0
7143418|NCT03033784|11300058|FG010|Overall Study|Withdrawal by Subject|0
7143419|NCT03033784|11300059|FG011|Overall Study|Withdrawal by Subject|0
7143420|NCT03033784|11300060|FG012|Overall Study|Withdrawal by Subject|2
7143421|NCT03034044|11300071|FG000|Overall Study|Enrolled, but not received Xyntha|1
7143422|NCT03034057|11300075|FG000|Overall Study|Withdrawal by Subject|10
7143423|NCT03034057|11300075|FG000|Overall Study|Protocol Violation|1
7143424|NCT03034057|11300075|FG000|Overall Study|Not defined|2
7143425|NCT03034057|11300075|FG000|Overall Study|Lost to Follow-up|19
7143426|NCT03034057|11300075|FG000|Overall Study|Adverse Event|22
7143427|NCT03034057|11300075|FG000|Overall Study|Medication error without associated AE|1
7036512|NCT01691105|11118527|FG000|6 Month Follow-up|Lost to Follow-up|39
7036513|NCT01691105|11118528|FG001|6 Month Follow-up|Lost to Follow-up|58
7036514|NCT01691105|11118527|FG000|6 Month Follow-up|Death|13
7036515|NCT01691105|11118528|FG001|6 Month Follow-up|Death|13
7036516|NCT01691105|11118527|FG000|12 Month Follow-up|Lost to Follow-up|50
7036517|NCT01691105|11118528|FG001|12 Month Follow-up|Lost to Follow-up|71
7036518|NCT01691105|11118527|FG000|12 Month Follow-up|Death|22
7036519|NCT01691105|11118528|FG001|12 Month Follow-up|Death|30
7036520|NCT01691105|11118527|FG000|12 Month Biochemical Verification|Death|22
7036521|NCT01691105|11118528|FG001|12 Month Biochemical Verification|Death|30
7036522|NCT01691105|11118527|FG000|12 Month Biochemical Verification|Lost to Follow-up|50
7036523|NCT01691105|11118528|FG001|12 Month Biochemical Verification|Lost to Follow-up|71
7036524|NCT01691105|11118527|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352
7036525|NCT01691105|11118528|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401
7036526|NCT01691248|11118536|FG000|Overall Study|Protocol Violation|43
7036527|NCT01691248|11118537|FG001|Overall Study|Protocol Violation|27
7036528|NCT01691248|11118536|FG000|Overall Study|Adverse Event|24
7036529|NCT01691248|11118537|FG001|Overall Study|Adverse Event|22
7036530|NCT01691248|11118536|FG000|Overall Study|Withdrawal by Subject|20
7036531|NCT01691248|11118537|FG001|Overall Study|Withdrawal by Subject|18
7036532|NCT01691248|11118536|FG000|Overall Study|Confirmed CDAD|14
7036533|NCT01691248|11118537|FG001|Overall Study|Confirmed CDAD|31
7036534|NCT01691248|11118536|FG000|Overall Study|Lost to Follow-up|2
7036535|NCT01691248|11118537|FG001|Overall Study|Lost to Follow-up|5
7036536|NCT01691248|11118536|FG000|Overall Study|Reason not provided|4
7036537|NCT01691248|11118537|FG001|Overall Study|Reason not provided|4
7036538|NCT01691248|11118536|FG000|Overall Study|Not Treated|4
7036539|NCT01691248|11118537|FG001|Overall Study|Not Treated|7
7036540|NCT01691378|11118590|FG000|Overall Study|Withdrawal by Subject|2
7036541|NCT01691378|11118591|FG001|Overall Study|Withdrawal by Subject|0
7036542|NCT01691378|11118590|FG000|Overall Study|Lost to Follow-up|5
7036543|NCT01691378|11118591|FG001|Overall Study|Lost to Follow-up|2
7036544|NCT01691430|11118599|FG000|Overall Study|Death|17
7036545|NCT01691430|11118600|FG001|Overall Study|Death|16
7036546|NCT01691430|11118599|FG000|Overall Study|Withdrawal by Subject|5
7036547|NCT01691430|11118600|FG001|Overall Study|Withdrawal by Subject|1
7036548|NCT01691430|11118599|FG000|Overall Study|Lost to Follow-up|0
7036549|NCT01691430|11118600|FG001|Overall Study|Lost to Follow-up|3
7143428|NCT03034135|11300079|FG000|Overall Study|Withdrawal by Subject|2
7036550|NCT01691482|11118606|FG000|Treatment Period 2|Adverse Event|0
7036551|NCT01691482|11118607|FG001|Treatment Period 2|Adverse Event|1
7036552|NCT01691482|11118606|FG000|Treatment Period 2|Protocol Violation|1
7036553|NCT01691482|11118607|FG001|Treatment Period 2|Protocol Violation|1
7036554|NCT01691508|11118616|FG000|Overall Study|Adverse Event|3
7036555|NCT01691508|11118617|FG001|Overall Study|Adverse Event|3
7036556|NCT01691508|11118616|FG000|Overall Study|Withdrawal by Subject|1
7036557|NCT01691508|11118617|FG001|Overall Study|Withdrawal by Subject|0
7036558|NCT01691521|11118626|FG000|Overall Study|Adverse Event|4
7036559|NCT01691521|11118627|FG001|Overall Study|Adverse Event|0
7036560|NCT01691521|11118628|FG002|Overall Study|Adverse Event|1
7036561|NCT01691521|11118626|FG000|Overall Study|Lack of Efficacy|1
7036562|NCT01691521|11118627|FG001|Overall Study|Lack of Efficacy|1
7036563|NCT01691521|11118628|FG002|Overall Study|Lack of Efficacy|2
7036564|NCT01691521|11118626|FG000|Overall Study|Protocol Violation|0
7036565|NCT01691521|11118627|FG001|Overall Study|Protocol Violation|3
7036566|NCT01691521|11118628|FG002|Overall Study|Protocol Violation|0
7036567|NCT01691521|11118626|FG000|Overall Study|Lost to Follow-up|0
7036568|NCT01691521|11118627|FG001|Overall Study|Lost to Follow-up|2
7036569|NCT01691521|11118628|FG002|Overall Study|Lost to Follow-up|2
7036570|NCT01691521|11118626|FG000|Overall Study|Physician Decision|2
7036571|NCT01691521|11118627|FG001|Overall Study|Physician Decision|1
7036572|NCT01691521|11118628|FG002|Overall Study|Physician Decision|0
7036573|NCT01691521|11118626|FG000|Overall Study|Withdrawal by Subject|5
7036574|NCT01691521|11118627|FG001|Overall Study|Withdrawal by Subject|9
7036575|NCT01691521|11118628|FG002|Overall Study|Withdrawal by Subject|4
7036576|NCT01691612|11118684|FG000|Overall Study|deemed ineligible after 1st visit|6
7036577|NCT01691612|11118684|FG000|Overall Study|Adverse Event|1
7036578|NCT01691768|11118702|FG000|Overall Study|Death|0
7036579|NCT01691768|11118703|FG001|Overall Study|Death|2
7036580|NCT01691768|11118702|FG000|Overall Study|Lost to Follow-up|4
7036581|NCT01691768|11118703|FG001|Overall Study|Lost to Follow-up|3
7036582|NCT01691768|11118702|FG000|Overall Study|Withdrawal by Subject|10
7143429|NCT03034460|11300085|FG000|Overall Study|Adverse Event|0
7036583|NCT01691768|11118703|FG001|Overall Study|Withdrawal by Subject|9
7036584|NCT01691768|11118702|FG000|Overall Study|Relocated|0
7036585|NCT01691768|11118703|FG001|Overall Study|Relocated|1
7036586|NCT01691768|11118702|FG000|Overall Study|Investigator decision|1
7036587|NCT01691768|11118703|FG001|Overall Study|Investigator decision|1
7036588|NCT01691781|11118712|FG000|Overall Study|Withdrawal by Subject|4
7036589|NCT01691781|11118713|FG001|Overall Study|Withdrawal by Subject|3
7036590|NCT01691781|11118712|FG000|Overall Study|Physician Decision|1
7036591|NCT01691781|11118713|FG001|Overall Study|Physician Decision|1
7036592|NCT01691781|11118712|FG000|Overall Study|Protocol Violation|2
7036593|NCT01691781|11118713|FG001|Overall Study|Protocol Violation|2
7036594|NCT01691781|11118712|FG000|Overall Study|Adverse Event|0
7036595|NCT01691781|11118713|FG001|Overall Study|Adverse Event|1
7036596|NCT01691794|11118722|FG000|Overall Study|Poor/Non-Compliance|1
7036597|NCT01691794|11118723|FG001|Overall Study|Poor/Non-Compliance|4
7036598|NCT01691794|11118724|FG002|Overall Study|Poor/Non-Compliance|1
7036599|NCT01691794|11118722|FG000|Overall Study|Death|0
7036600|NCT01691794|11118723|FG001|Overall Study|Death|0
7036601|NCT01691794|11118724|FG002|Overall Study|Death|1
7036602|NCT01691794|11118722|FG000|Overall Study|Lack of Efficacy|0
7036603|NCT01691794|11118723|FG001|Overall Study|Lack of Efficacy|7
7036604|NCT01691794|11118724|FG002|Overall Study|Lack of Efficacy|1
7036605|NCT01691794|11118722|FG000|Overall Study|Participant request to discontinue|0
7060716|NCT01922011|11157216|FG000|Overall Study|Parent/Guardian Decision|3
7036606|NCT01691794|11118723|FG001|Overall Study|Participant request to discontinue|1
7036607|NCT01691794|11118724|FG002|Overall Study|Participant request to discontinue|0
7036608|NCT01691794|11118722|FG000|Overall Study|Adverse Event|0
7036609|NCT01691794|11118723|FG001|Overall Study|Adverse Event|1
7036610|NCT01691794|11118724|FG002|Overall Study|Adverse Event|1
7036611|NCT01691794|11118722|FG000|Overall Study|Completed Only first 24 weeks of study|0
7036612|NCT01691794|11118723|FG001|Overall Study|Completed Only first 24 weeks of study|2
7036613|NCT01691794|11118724|FG002|Overall Study|Completed Only first 24 weeks of study|3
7036614|NCT01691794|11118722|FG000|Overall Study|Did not complete first 24 weeks of study|0
7036615|NCT01691794|11118723|FG001|Overall Study|Did not complete first 24 weeks of study|3
7036616|NCT01691794|11118724|FG002|Overall Study|Did not complete first 24 weeks of study|3
7036617|NCT01691820|11118734|FG000|Overall Study|Consent withdrawal (not due to an AE)|9
7036618|NCT01691820|11118735|FG001|Overall Study|Consent withdrawal (not due to an AE)|15
7036619|NCT01691820|11118734|FG000|Overall Study|Migrated/moved from study area|7
7036620|NCT01691820|11118735|FG001|Overall Study|Migrated/moved from study area|4
7036621|NCT01691820|11118734|FG000|Overall Study|Lost to Follow-up|6
7036622|NCT01691820|11118735|FG001|Overall Study|Lost to Follow-up|17
7036623|NCT01691820|11118734|FG000|Overall Study|Other (unspecified)|4
7036624|NCT01691820|11118735|FG001|Overall Study|Other (unspecified)|1
7036625|NCT01691859|11118758|FG000|Overall Study|Adverse Event|19
7036626|NCT01691859|11118758|FG000|Overall Study|Lack of Efficacy|11
7036627|NCT01691859|11118758|FG000|Overall Study|Protocol Violation|4
7036628|NCT01691859|11118758|FG000|Overall Study|Product commercially available|221
7036629|NCT01691859|11118758|FG000|Overall Study|Study closed/terminated|50
7036630|NCT01691859|11118758|FG000|Overall Study|Lost to Follow-up|5
7036631|NCT01691859|11118758|FG000|Overall Study|Physician Decision|6
7036632|NCT01691859|11118758|FG000|Overall Study|Withdrawal by Subject|31
7036633|NCT01691885|11118762|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1
7036634|NCT01691885|11118763|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1
7036635|NCT01691885|11118762|FG000|Washout Period (7-9 Days)|Adverse Event|0
7036636|NCT01691885|11118763|FG001|Washout Period (7-9 Days)|Adverse Event|1
7036637|NCT01691898|11118775|FG000|Overall Study|Death|34
7036638|NCT01691898|11118776|FG001|Overall Study|Death|32
7036639|NCT01691898|11118777|FG002|Overall Study|Death|6
7036640|NCT01691898|11118778|FG003|Overall Study|Death|3
7036641|NCT01691898|11118779|FG004|Overall Study|Death|8
7036642|NCT01691898|11118780|FG005|Overall Study|Death|31
7036643|NCT01691898|11118775|FG000|Overall Study|Adverse Event|0
7036644|NCT01691898|11118776|FG001|Overall Study|Adverse Event|1
7036645|NCT01691898|11118777|FG002|Overall Study|Adverse Event|0
7036646|NCT01691898|11118778|FG003|Overall Study|Adverse Event|1
7036647|NCT01691898|11118779|FG004|Overall Study|Adverse Event|1
7036648|NCT01691898|11118780|FG005|Overall Study|Adverse Event|0
7036649|NCT01691898|11118775|FG000|Overall Study|Progression of Disease|1
7036650|NCT01691898|11118776|FG001|Overall Study|Progression of Disease|2
7036651|NCT01691898|11118777|FG002|Overall Study|Progression of Disease|1
7036652|NCT01691898|11118778|FG003|Overall Study|Progression of Disease|0
7036653|NCT01691898|11118779|FG004|Overall Study|Progression of Disease|0
7036654|NCT01691898|11118780|FG005|Overall Study|Progression of Disease|1
7036655|NCT01691898|11118775|FG000|Overall Study|Lost to Follow-up|3
7036656|NCT01691898|11118776|FG001|Overall Study|Lost to Follow-up|1
7036657|NCT01691898|11118777|FG002|Overall Study|Lost to Follow-up|0
7036658|NCT01691898|11118778|FG003|Overall Study|Lost to Follow-up|0
7036659|NCT01691898|11118779|FG004|Overall Study|Lost to Follow-up|1
7036660|NCT01691898|11118780|FG005|Overall Study|Lost to Follow-up|0
7036661|NCT01691898|11118775|FG000|Overall Study|Withdrawal by Subject|9
7036662|NCT01691898|11118776|FG001|Overall Study|Withdrawal by Subject|8
7036663|NCT01691898|11118777|FG002|Overall Study|Withdrawal by Subject|2
7036664|NCT01691898|11118778|FG003|Overall Study|Withdrawal by Subject|1
7036665|NCT01691898|11118779|FG004|Overall Study|Withdrawal by Subject|3
7036666|NCT01691898|11118780|FG005|Overall Study|Withdrawal by Subject|3
7036667|NCT01691898|11118775|FG000|Overall Study|Non-Compliance|0
7036668|NCT01691898|11118776|FG001|Overall Study|Non-Compliance|0
7036669|NCT01691898|11118777|FG002|Overall Study|Non-Compliance|0
7036670|NCT01691898|11118778|FG003|Overall Study|Non-Compliance|0
7036671|NCT01691898|11118779|FG004|Overall Study|Non-Compliance|1
7036672|NCT01691898|11118780|FG005|Overall Study|Non-Compliance|0
7036673|NCT01692119|11118823|FG000|Overall Study|Protocol Violation|3
7036674|NCT01692119|11118824|FG001|Overall Study|Protocol Violation|1
7036675|NCT01692119|11118823|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17
7036676|NCT01692119|11118824|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0
7036677|NCT01692197|11118830|FG000|Overall Study|Failed Screening|3
7036678|NCT01692275|11118841|FG000|Overall Study|Lost to Follow-up|57
7036679|NCT01692275|11118842|FG001|Overall Study|Lost to Follow-up|48
7036680|NCT01692275|11118841|FG000|Overall Study|Withdrawal by Subject|9
7036681|NCT01692275|11118842|FG001|Overall Study|Withdrawal by Subject|11
7036682|NCT01692301|11118862|FG000|Overall Study|Adverse Event|15
7036683|NCT01692301|11118863|FG001|Overall Study|Adverse Event|12
7060717|NCT01922011|11157217|FG001|Overall Study|Parent/Guardian Decision|0
7036684|NCT01692301|11118862|FG000|Overall Study|Death|1
7036685|NCT01692301|11118863|FG001|Overall Study|Death|2
7036686|NCT01692301|11118862|FG000|Overall Study|Lack of Efficacy|0
7036687|NCT01692301|11118863|FG001|Overall Study|Lack of Efficacy|5
7036688|NCT01692301|11118862|FG000|Overall Study|Non-compliance with study treatment|1
7036689|NCT01692301|11118863|FG001|Overall Study|Non-compliance with study treatment|2
7036690|NCT01692301|11118862|FG000|Overall Study|Protocol deviation|9
7036691|NCT01692301|11118863|FG001|Overall Study|Protocol deviation|2
7036692|NCT01692301|11118862|FG000|Overall Study|Patient/guardian decision|16
7036693|NCT01692301|11118863|FG001|Overall Study|Patient/guardian decision|15
7036694|NCT01692301|11118862|FG000|Overall Study|Technical problems|0
7036695|NCT01692301|11118863|FG001|Overall Study|Technical problems|1
7036696|NCT01692301|11118862|FG000|Overall Study|Physician Decision|2
7036697|NCT01692301|11118863|FG001|Overall Study|Physician Decision|2
7036698|NCT01692301|11118862|FG000|Overall Study|Lost to Follow-up|1
7036699|NCT01692301|11118863|FG001|Overall Study|Lost to Follow-up|1
7036700|NCT01692626|11118887|FG000|Overall Study|Death|0
7036701|NCT01692626|11118888|FG001|Overall Study|Death|1
7036702|NCT01692626|11118887|FG000|Overall Study|Adverse Event|2
7036703|NCT01692626|11118888|FG001|Overall Study|Adverse Event|3
7036704|NCT01692626|11118887|FG000|Overall Study|Protocol Violation|1
7036705|NCT01692626|11118888|FG001|Overall Study|Protocol Violation|2
7036706|NCT01692626|11118887|FG000|Overall Study|Withdrawal by Subject|1
7036707|NCT01692626|11118888|FG001|Overall Study|Withdrawal by Subject|0
7036708|NCT01692730|11118895|FG000|Overall Study|Lost to Follow-up|225
7036709|NCT01692730|11118896|FG001|Overall Study|Lost to Follow-up|227
7036710|NCT01692782|11118935|FG000|Overall Study|Adverse Event|12
7036711|NCT01692782|11118936|FG001|Overall Study|Adverse Event|32
7143430|NCT03034460|11300086|FG001|Overall Study|Adverse Event|1
7036712|NCT01692782|11118937|FG002|Overall Study|Adverse Event|2
7036713|NCT01692782|11118935|FG000|Overall Study|Lack of Efficacy|1
7143431|NCT03034460|11300085|FG000|Overall Study|Withdrawal by Subject|2
7143432|NCT03034460|11300086|FG001|Overall Study|Withdrawal by Subject|2
7143433|NCT03034460|11300085|FG000|Overall Study|Personal Reasons|1
7143434|NCT03034460|11300086|FG001|Overall Study|Personal Reasons|0
7143435|NCT03034577|11300098|FG000|Overall Study|Withdrawal by Subject|6
7143436|NCT03034577|11300099|FG001|Overall Study|Withdrawal by Subject|9
7143437|NCT03034577|11300098|FG000|Overall Study|Lost to Follow-up|25
7143438|NCT03034577|11300099|FG001|Overall Study|Lost to Follow-up|26
7143439|NCT03034772|11300109|FG000|Overall Study|Adverse Event|0
7143440|NCT03034772|11300110|FG001|Overall Study|Adverse Event|1
7143441|NCT03034772|11300109|FG000|Overall Study|Withdrawal by Subject|0
7143442|NCT03034772|11300110|FG001|Overall Study|Withdrawal by Subject|1
7143443|NCT03034915|11300119|FG000|Overall Study|Adverse Event|29
7143444|NCT03034915|11300120|FG001|Overall Study|Adverse Event|32
7036714|NCT01692782|11118936|FG001|Overall Study|Lack of Efficacy|2
7036715|NCT01692782|11118937|FG002|Overall Study|Lack of Efficacy|0
7036716|NCT01692782|11118935|FG000|Overall Study|Lost to Follow-up|2
7036717|NCT01692782|11118936|FG001|Overall Study|Lost to Follow-up|7
7036718|NCT01692782|11118937|FG002|Overall Study|Lost to Follow-up|1
7036719|NCT01692782|11118935|FG000|Overall Study|Pregnancy|1
7036720|NCT01692782|11118936|FG001|Overall Study|Pregnancy|0
7036721|NCT01692782|11118937|FG002|Overall Study|Pregnancy|0
7036722|NCT01692782|11118935|FG000|Overall Study|Protocol Violation|1
7036723|NCT01692782|11118936|FG001|Overall Study|Protocol Violation|0
7036724|NCT01692782|11118937|FG002|Overall Study|Protocol Violation|2
7036725|NCT01692782|11118935|FG000|Overall Study|Non-complance with study drug|0
7036726|NCT01692782|11118936|FG001|Overall Study|Non-complance with study drug|4
7036727|NCT01692782|11118937|FG002|Overall Study|Non-complance with study drug|1
7036728|NCT01692782|11118935|FG000|Overall Study|Non-compliant with study visits|0
7036729|NCT01692782|11118936|FG001|Overall Study|Non-compliant with study visits|0
7036730|NCT01692782|11118937|FG002|Overall Study|Non-compliant with study visits|1
7036731|NCT01692782|11118935|FG000|Overall Study|SAE not related to study drug|0
7036732|NCT01692782|11118936|FG001|Overall Study|SAE not related to study drug|1
7036733|NCT01692782|11118937|FG002|Overall Study|SAE not related to study drug|0
7036734|NCT01692782|11118935|FG000|Overall Study|Withdrawal by Subject|3
7036735|NCT01692782|11118936|FG001|Overall Study|Withdrawal by Subject|10
7036736|NCT01692782|11118937|FG002|Overall Study|Withdrawal by Subject|3
7143445|NCT03034915|11300121|FG002|Overall Study|Adverse Event|22
7143446|NCT03034915|11300119|FG000|Overall Study|Lost to Follow-up|5
7143447|NCT03034915|11300120|FG001|Overall Study|Lost to Follow-up|13
7143448|NCT03034915|11300121|FG002|Overall Study|Lost to Follow-up|3
7143449|NCT03034915|11300119|FG000|Overall Study|Withdrawal by Subject|29
7143450|NCT03034915|11300120|FG001|Overall Study|Withdrawal by Subject|46
7143451|NCT03034915|11300121|FG002|Overall Study|Withdrawal by Subject|41
7143452|NCT03034915|11300119|FG000|Overall Study|Protocol Deviation|2
7143453|NCT03034915|11300120|FG001|Overall Study|Protocol Deviation|14
7143454|NCT03034915|11300121|FG002|Overall Study|Protocol Deviation|7
7143455|NCT03034915|11300119|FG000|Overall Study|Lack of Efficacy|8
7036737|NCT01692938|11118947|FG000|Overall Study|Protocol Deviation|1
7036738|NCT01692938|11118948|FG001|Overall Study|Protocol Deviation|1
7036739|NCT01692938|11118947|FG000|Overall Study|Study completed prior to site completion|3
7036740|NCT01692938|11118948|FG001|Overall Study|Study completed prior to site completion|3
7036741|NCT01693029|11118978|FG000|Overall Study|Withdrawal by Subject|15
7036742|NCT01693029|11118979|FG001|Overall Study|Withdrawal by Subject|22
7036743|NCT01693029|11118978|FG000|Overall Study|Kidney transplantation|7
7143456|NCT03034915|11300120|FG001|Overall Study|Lack of Efficacy|16
7036744|NCT01693029|11118979|FG001|Overall Study|Kidney transplantation|7
7036745|NCT01693029|11118978|FG000|Overall Study|Bindinging anti-EPO antibodies|6
7036746|NCT01693029|11118979|FG001|Overall Study|Bindinging anti-EPO antibodies|2
7036747|NCT01693029|11118978|FG000|Overall Study|Protocol Violation|6
7036748|NCT01693029|11118979|FG001|Overall Study|Protocol Violation|7
7036749|NCT01693029|11118978|FG000|Overall Study|Change in dialysis modality|2
7036750|NCT01693029|11118979|FG001|Overall Study|Change in dialysis modality|1
7036751|NCT01693029|11118978|FG000|Overall Study|Physician Decision|0
7036752|NCT01693029|11118979|FG001|Overall Study|Physician Decision|2
7036753|NCT01693029|11118978|FG000|Overall Study|Lost to Follow-up|0
7036754|NCT01693029|11118979|FG001|Overall Study|Lost to Follow-up|1
7036755|NCT01693029|11118978|FG000|Overall Study|Adverse Event|1
7036756|NCT01693029|11118979|FG001|Overall Study|Adverse Event|6
7036757|NCT01693029|11118978|FG000|Overall Study|Death|5
7036758|NCT01693029|11118979|FG001|Overall Study|Death|8
7036759|NCT01693029|11118978|FG000|Overall Study|Non-compliance|2
7036760|NCT01693029|11118979|FG001|Overall Study|Non-compliance|1
7036761|NCT01693068|11118987|FG000|Randomization Period|On-study|2
7143457|NCT03034915|11300121|FG002|Overall Study|Lack of Efficacy|18
7143458|NCT03034915|11300119|FG000|Overall Study|Site closed|2
7143459|NCT03034915|11300120|FG001|Overall Study|Site closed|2
7143460|NCT03034915|11300121|FG002|Overall Study|Site closed|4
7143461|NCT03034915|11300119|FG000|Overall Study|Protocol-defined withdrawal criteria met|19
7143462|NCT03034915|11300120|FG001|Overall Study|Protocol-defined withdrawal criteria met|26
7143463|NCT03034915|11300121|FG002|Overall Study|Protocol-defined withdrawal criteria met|29
7143464|NCT03034915|11300119|FG000|Overall Study|Physician Decision|1
7143465|NCT03034915|11300120|FG001|Overall Study|Physician Decision|5
7143466|NCT03034915|11300121|FG002|Overall Study|Physician Decision|2
7143467|NCT03034954|11300143|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1
7143468|NCT03034954|11300144|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0
7143469|NCT03034967|11300156|FG000|Overall Study|Withdrawal by Subject|9
7143470|NCT03034967|11300157|FG001|Overall Study|Withdrawal by Subject|2
7143471|NCT03034967|11300158|FG002|Overall Study|Withdrawal by Subject|6
7143472|NCT03034967|11300159|FG003|Overall Study|Withdrawal by Subject|6
7143473|NCT03034967|11300160|FG004|Overall Study|Withdrawal by Subject|9
7143474|NCT03034967|11300161|FG005|Overall Study|Withdrawal by Subject|2
7143475|NCT03034967|11300156|FG000|Overall Study|Physician Decision|1
7143476|NCT03034967|11300157|FG001|Overall Study|Physician Decision|0
7143477|NCT03034967|11300158|FG002|Overall Study|Physician Decision|1
7143478|NCT03034967|11300159|FG003|Overall Study|Physician Decision|1
7143479|NCT03034967|11300160|FG004|Overall Study|Physician Decision|1
7143480|NCT03034967|11300161|FG005|Overall Study|Physician Decision|0
7143481|NCT03034967|11300156|FG000|Overall Study|Lost to Follow-up|0
7143482|NCT03034967|11300157|FG001|Overall Study|Lost to Follow-up|0
7143483|NCT03034967|11300158|FG002|Overall Study|Lost to Follow-up|0
7143484|NCT03034967|11300159|FG003|Overall Study|Lost to Follow-up|1
7143485|NCT03034967|11300160|FG004|Overall Study|Lost to Follow-up|0
7143486|NCT03034967|11300161|FG005|Overall Study|Lost to Follow-up|2
7143487|NCT03034967|11300156|FG000|Overall Study|Liver function test abnormality|0
7143488|NCT03034967|11300157|FG001|Overall Study|Liver function test abnormality|0
7143489|NCT03034967|11300158|FG002|Overall Study|Liver function test abnormality|1
7143490|NCT03034967|11300159|FG003|Overall Study|Liver function test abnormality|0
7143491|NCT03034967|11300160|FG004|Overall Study|Liver function test abnormality|0
7143492|NCT03034967|11300161|FG005|Overall Study|Liver function test abnormality|0
7143493|NCT03034967|11300156|FG000|Overall Study|Protocol Violation|1
7143494|NCT03034967|11300157|FG001|Overall Study|Protocol Violation|0
7143495|NCT03034967|11300158|FG002|Overall Study|Protocol Violation|0
7143496|NCT03034967|11300159|FG003|Overall Study|Protocol Violation|0
7143497|NCT03034967|11300160|FG004|Overall Study|Protocol Violation|0
7143498|NCT03034967|11300161|FG005|Overall Study|Protocol Violation|2
7143499|NCT03034967|11300156|FG000|Overall Study|Lack of Efficacy|0
7143500|NCT03034967|11300157|FG001|Overall Study|Lack of Efficacy|1
7143501|NCT03034967|11300158|FG002|Overall Study|Lack of Efficacy|2
7143502|NCT03034967|11300159|FG003|Overall Study|Lack of Efficacy|1
7143503|NCT03034967|11300160|FG004|Overall Study|Lack of Efficacy|1
7143504|NCT03034967|11300161|FG005|Overall Study|Lack of Efficacy|0
6922232|NCT00810069|10950713|FG001|Double-Blind Period II|Protocol entry criterion not met|0
6974630|NCT01189266|11026781|FG001|Overall Study|Withdrawal by Subject|0
7036762|NCT01693068|11118988|FG001|Randomization Period|On-study|5
7036763|NCT01693068|11118989|FG002|Randomization Period|On-study|0
7036764|NCT01693068|11118987|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0
7143505|NCT03034967|11300156|FG000|Overall Study|Adverse Event, non-fatal|3
7143506|NCT03034967|11300157|FG001|Overall Study|Adverse Event, non-fatal|1
7143507|NCT03034967|11300158|FG002|Overall Study|Adverse Event, non-fatal|2
7143508|NCT03034967|11300159|FG003|Overall Study|Adverse Event, non-fatal|0
7143509|NCT03034967|11300160|FG004|Overall Study|Adverse Event, non-fatal|2
7143510|NCT03034967|11300161|FG005|Overall Study|Adverse Event, non-fatal|8
7143511|NCT03034967|11300156|FG000|Overall Study|Adverse Event, Serious Fatal|0
7143512|NCT03034967|11300157|FG001|Overall Study|Adverse Event, Serious Fatal|1
7143513|NCT03034967|11300158|FG002|Overall Study|Adverse Event, Serious Fatal|1
7143514|NCT03034967|11300159|FG003|Overall Study|Adverse Event, Serious Fatal|2
7143515|NCT03034967|11300160|FG004|Overall Study|Adverse Event, Serious Fatal|1
7143516|NCT03034967|11300161|FG005|Overall Study|Adverse Event, Serious Fatal|1
7143517|NCT03035032|11300180|FG000|Overall Study|Adverse Event|2
7036765|NCT01693068|11118988|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0
7036766|NCT01693068|11118989|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1
7036767|NCT01693120|11118997|FG000|Enrollment|Lost to Follow-up|1
7036768|NCT01693120|11118997|FG000|Enrollment|Withdrawal by Subject|10
7036769|NCT01693120|11118997|FG000|Enrollment|Protocol Violation|46
7036770|NCT01693120|11118997|FG000|Enrollment|Physician Decision|3
7036771|NCT01693120|11118997|FG000|Enrollment|Adverse Event|1
7036772|NCT01693120|11118997|FG000|Enrollment|Study closed|8
7036773|NCT01693120|11118997|FG000|Enrollment|Other|1
7036774|NCT01693120|11118997|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1
7036775|NCT01693120|11118997|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5
7036776|NCT01693120|11118997|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3
7036777|NCT01693120|11118997|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1
7036778|NCT01693120|11118997|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7
7036779|NCT01693185|11119003|FG000|Overall Study|diagnostic procedure after colonoscopy|0
7036780|NCT01693185|11119004|FG001|Overall Study|diagnostic procedure after colonoscopy|6
7036781|NCT01693250|11119012|FG000|Overall Study|Lost to Follow-up|2
7036782|NCT01693250|11119013|FG001|Overall Study|Lost to Follow-up|2
7036783|NCT01693523|11119024|FG000|Overall Study|Adverse Event|2
7036784|NCT01693523|11119025|FG001|Overall Study|Adverse Event|1
7036785|NCT01693523|11119026|FG002|Overall Study|Adverse Event|0
7036786|NCT01693523|11119024|FG000|Overall Study|Death|0
7036787|NCT01693523|11119025|FG001|Overall Study|Death|1
7036788|NCT01693523|11119026|FG002|Overall Study|Death|1
7036789|NCT01693523|11119024|FG000|Overall Study|Lost to Follow-up|0
7036790|NCT01693523|11119025|FG001|Overall Study|Lost to Follow-up|0
7036791|NCT01693523|11119026|FG002|Overall Study|Lost to Follow-up|4
7036792|NCT01693523|11119024|FG000|Overall Study|Physician Decision|0
7036793|NCT01693523|11119025|FG001|Overall Study|Physician Decision|0
7036794|NCT01693523|11119026|FG002|Overall Study|Physician Decision|1
7036795|NCT01693523|11119024|FG000|Overall Study|Withdrawal by Subject|1
7036796|NCT01693523|11119025|FG001|Overall Study|Withdrawal by Subject|2
7036797|NCT01693523|11119026|FG002|Overall Study|Withdrawal by Subject|2
7036798|NCT01693523|11119024|FG000|Overall Study|Lack of compliance study medication|1
7036799|NCT01693523|11119025|FG001|Overall Study|Lack of compliance study medication|2
7036800|NCT01693523|11119026|FG002|Overall Study|Lack of compliance study medication|0
7036801|NCT01693523|11119024|FG000|Overall Study|Chemotherapy was held|1
7036802|NCT01693523|11119025|FG001|Overall Study|Chemotherapy was held|2
7036803|NCT01693523|11119026|FG002|Overall Study|Chemotherapy was held|0
7036804|NCT01693562|11119056|FG000|Escalation Phase|Withdrawal by Subject|0
7036805|NCT01693562|11119057|FG001|Escalation Phase|Withdrawal by Subject|1
7036806|NCT01693562|11119058|FG002|Escalation Phase|Withdrawal by Subject|0
7036807|NCT01693562|11119059|FG003|Escalation Phase|Withdrawal by Subject|0
7143518|NCT03035032|11300180|FG000|Overall Study|Death|9
7143519|NCT03035032|11300180|FG000|Overall Study|Lost to Follow-up|1
7143520|NCT03035032|11300180|FG000|Overall Study|Progressive Disease|22
7143521|NCT03035032|11300180|FG000|Overall Study|Protocol Violation|2
7143522|NCT03035032|11300180|FG000|Overall Study|Withdrawal by Subject|2
7143523|NCT03035032|11300180|FG000|Overall Study|Physician Decision|5
7143524|NCT03035864|11300244|FG000|Treatment Period|Adverse Event|1
7143525|NCT03035864|11300245|FG001|Treatment Period|Adverse Event|0
7143526|NCT03035864|11300244|FG000|Treatment Period|Other|3
7143527|NCT03035864|11300245|FG001|Treatment Period|Other|1
7143528|NCT03035864|11300244|FG000|Follow-up Period|Adverse Event|1
7143529|NCT03035864|11300245|FG001|Follow-up Period|Adverse Event|0
7143530|NCT03035864|11300244|FG000|Follow-up Period|Lost to Follow-up|6
7143531|NCT03035864|11300245|FG001|Follow-up Period|Lost to Follow-up|2
7143532|NCT03035864|11300244|FG000|Follow-up Period|Physician Decision|1
7143533|NCT03035864|11300245|FG001|Follow-up Period|Physician Decision|0
7143534|NCT03035864|11300244|FG000|Follow-up Period|Other|3
7036808|NCT01693562|11119060|FG004|Escalation Phase|Withdrawal by Subject|0
7036809|NCT01693562|11119061|FG005|Escalation Phase|Withdrawal by Subject|2
7036810|NCT01693562|11119062|FG006|Escalation Phase|Withdrawal by Subject|0
7036811|NCT01693562|11119063|FG007|Escalation Phase|Withdrawal by Subject|0
7036812|NCT01693562|11119064|FG008|Escalation Phase|Withdrawal by Subject|0
7036813|NCT01693562|11119065|FG009|Escalation Phase|Withdrawal by Subject|0
7036814|NCT01693562|11119066|FG010|Escalation Phase|Withdrawal by Subject|0
7036815|NCT01693562|11119067|FG011|Escalation Phase|Withdrawal by Subject|0
7036816|NCT01693562|11119068|FG012|Escalation Phase|Withdrawal by Subject|0
7036817|NCT01693562|11119069|FG013|Escalation Phase|Withdrawal by Subject|0
7036818|NCT01693562|11119070|FG014|Escalation Phase|Withdrawal by Subject|0
7036819|NCT01693562|11119071|FG015|Escalation Phase|Withdrawal by Subject|0
7036820|NCT01693562|11119072|FG016|Escalation Phase|Withdrawal by Subject|0
7036821|NCT01693562|11119073|FG017|Escalation Phase|Withdrawal by Subject|0
7143535|NCT03035864|11300245|FG001|Follow-up Period|Other|2
7143536|NCT03035916|11300254|FG000|Overall Study|Puncture failed|0
7143537|NCT03035916|11300255|FG001|Overall Study|Puncture failed|2
7143538|NCT03035916|11300256|FG002|Overall Study|Puncture failed|0
7143539|NCT03035942|11300272|FG000|Overall Study|Adverse Event|8
7143540|NCT03035942|11300273|FG001|Overall Study|Adverse Event|4
7143541|NCT03035942|11300274|FG002|Overall Study|Adverse Event|5
7143542|NCT03036072|11300295|FG000|Overall Study|Death|0
7143543|NCT03036072|11300296|FG001|Overall Study|Death|1
7036822|NCT01693562|11119074|FG018|Escalation Phase|Withdrawal by Subject|0
7036823|NCT01693562|11119075|FG019|Escalation Phase|Withdrawal by Subject|0
7036824|NCT01693562|11119076|FG020|Escalation Phase|Withdrawal by Subject|0
7036825|NCT01693562|11119077|FG021|Escalation Phase|Withdrawal by Subject|0
7036826|NCT01693562|11119078|FG022|Escalation Phase|Withdrawal by Subject|0
7036827|NCT01693562|11119056|FG000|Escalation Phase|Death|4
7036828|NCT01693562|11119057|FG001|Escalation Phase|Death|2
7036829|NCT01693562|11119058|FG002|Escalation Phase|Death|0
7036830|NCT01693562|11119059|FG003|Escalation Phase|Death|3
7036831|NCT01693562|11119060|FG004|Escalation Phase|Death|6
7036832|NCT01693562|11119061|FG005|Escalation Phase|Death|4
7036833|NCT01693562|11119062|FG006|Escalation Phase|Death|0
7036834|NCT01693562|11119063|FG007|Escalation Phase|Death|0
7036835|NCT01693562|11119064|FG008|Escalation Phase|Death|0
7036836|NCT01693562|11119065|FG009|Escalation Phase|Death|0
7036837|NCT01693562|11119066|FG010|Escalation Phase|Death|0
7036838|NCT01693562|11119067|FG011|Escalation Phase|Death|0
7036839|NCT01693562|11119068|FG012|Escalation Phase|Death|0
7036840|NCT01693562|11119069|FG013|Escalation Phase|Death|0
7036841|NCT01693562|11119070|FG014|Escalation Phase|Death|0
7036842|NCT01693562|11119071|FG015|Escalation Phase|Death|0
7036843|NCT01693562|11119072|FG016|Escalation Phase|Death|0
7036844|NCT01693562|11119073|FG017|Escalation Phase|Death|0
7036845|NCT01693562|11119074|FG018|Escalation Phase|Death|0
7036846|NCT01693562|11119075|FG019|Escalation Phase|Death|0
7036847|NCT01693562|11119076|FG020|Escalation Phase|Death|0
7036848|NCT01693562|11119077|FG021|Escalation Phase|Death|0
7036849|NCT01693562|11119078|FG022|Escalation Phase|Death|0
7036850|NCT01693562|11119056|FG000|Escalation Phase|Lost to Follow-up|0
7036851|NCT01693562|11119057|FG001|Escalation Phase|Lost to Follow-up|1
7036852|NCT01693562|11119058|FG002|Escalation Phase|Lost to Follow-up|1
7036853|NCT01693562|11119059|FG003|Escalation Phase|Lost to Follow-up|0
7036854|NCT01693562|11119060|FG004|Escalation Phase|Lost to Follow-up|0
7036855|NCT01693562|11119061|FG005|Escalation Phase|Lost to Follow-up|0
7036856|NCT01693562|11119062|FG006|Escalation Phase|Lost to Follow-up|0
7036857|NCT01693562|11119063|FG007|Escalation Phase|Lost to Follow-up|0
7036858|NCT01693562|11119064|FG008|Escalation Phase|Lost to Follow-up|0
7036859|NCT01693562|11119065|FG009|Escalation Phase|Lost to Follow-up|0
7036860|NCT01693562|11119066|FG010|Escalation Phase|Lost to Follow-up|0
7036861|NCT01693562|11119067|FG011|Escalation Phase|Lost to Follow-up|0
7036862|NCT01693562|11119068|FG012|Escalation Phase|Lost to Follow-up|0
7036863|NCT01693562|11119069|FG013|Escalation Phase|Lost to Follow-up|0
7036864|NCT01693562|11119070|FG014|Escalation Phase|Lost to Follow-up|0
7036865|NCT01693562|11119071|FG015|Escalation Phase|Lost to Follow-up|0
7036866|NCT01693562|11119072|FG016|Escalation Phase|Lost to Follow-up|0
7036867|NCT01693562|11119073|FG017|Escalation Phase|Lost to Follow-up|0
7036868|NCT01693562|11119074|FG018|Escalation Phase|Lost to Follow-up|0
7036869|NCT01693562|11119075|FG019|Escalation Phase|Lost to Follow-up|0
7036870|NCT01693562|11119076|FG020|Escalation Phase|Lost to Follow-up|0
7036871|NCT01693562|11119077|FG021|Escalation Phase|Lost to Follow-up|0
7036872|NCT01693562|11119078|FG022|Escalation Phase|Lost to Follow-up|0
7036873|NCT01693562|11119056|FG000|Escalation Phase|Other|0
7036874|NCT01693562|11119057|FG001|Escalation Phase|Other|0
7036875|NCT01693562|11119058|FG002|Escalation Phase|Other|2
7036876|NCT01693562|11119059|FG003|Escalation Phase|Other|0
7143544|NCT03036072|11300295|FG000|Overall Study|Withdrawal by Subject|0
7143545|NCT03036072|11300296|FG001|Overall Study|Withdrawal by Subject|1
7143546|NCT03036072|11300295|FG000|Overall Study|Physician Decision|0
7143547|NCT03036072|11300296|FG001|Overall Study|Physician Decision|1
7143548|NCT03036124|11300304|FG000|Overall Study|Lost to Follow-up|0
7143549|NCT03036124|11300305|FG001|Overall Study|Lost to Follow-up|2
7143550|NCT03036124|11300304|FG000|Overall Study|Withdrawal by Subject|5
7143551|NCT03036124|11300305|FG001|Overall Study|Withdrawal by Subject|4
7143552|NCT03036150|11300313|FG000|Overall Study|Withdrawal by Subject|8
7143553|NCT03036150|11300314|FG001|Overall Study|Withdrawal by Subject|3
7143554|NCT03036150|11300313|FG000|Overall Study|Lost to Follow-up|2
7143555|NCT03036150|11300314|FG001|Overall Study|Lost to Follow-up|2
7036877|NCT01693562|11119060|FG004|Escalation Phase|Other|0
7036878|NCT01693562|11119061|FG005|Escalation Phase|Other|1
7036879|NCT01693562|11119062|FG006|Escalation Phase|Other|0
7036880|NCT01693562|11119063|FG007|Escalation Phase|Other|0
7036881|NCT01693562|11119064|FG008|Escalation Phase|Other|0
7036882|NCT01693562|11119065|FG009|Escalation Phase|Other|0
7036883|NCT01693562|11119066|FG010|Escalation Phase|Other|0
7036884|NCT01693562|11119067|FG011|Escalation Phase|Other|0
7036885|NCT01693562|11119068|FG012|Escalation Phase|Other|0
7036886|NCT01693562|11119069|FG013|Escalation Phase|Other|0
7036887|NCT01693562|11119070|FG014|Escalation Phase|Other|0
7036888|NCT01693562|11119071|FG015|Escalation Phase|Other|0
7036889|NCT01693562|11119072|FG016|Escalation Phase|Other|0
7036890|NCT01693562|11119073|FG017|Escalation Phase|Other|0
7036891|NCT01693562|11119074|FG018|Escalation Phase|Other|0
7036892|NCT01693562|11119075|FG019|Escalation Phase|Other|0
7036893|NCT01693562|11119076|FG020|Escalation Phase|Other|0
7036894|NCT01693562|11119077|FG021|Escalation Phase|Other|0
7036895|NCT01693562|11119078|FG022|Escalation Phase|Other|0
7143556|NCT03036813|11300410|FG000|Overall Study|Adverse Event|6
7143557|NCT03036813|11300411|FG001|Overall Study|Adverse Event|11
7143558|NCT03036813|11300412|FG002|Overall Study|Adverse Event|6
7036896|NCT01693562|11119056|FG000|Exploration Phase|Withdrawal by Subject|0
7036897|NCT01693562|11119057|FG001|Exploration Phase|Withdrawal by Subject|0
7036898|NCT01693562|11119058|FG002|Exploration Phase|Withdrawal by Subject|0
7036899|NCT01693562|11119059|FG003|Exploration Phase|Withdrawal by Subject|0
7036900|NCT01693562|11119060|FG004|Exploration Phase|Withdrawal by Subject|0
7036901|NCT01693562|11119061|FG005|Exploration Phase|Withdrawal by Subject|0
7036902|NCT01693562|11119062|FG006|Exploration Phase|Withdrawal by Subject|2
7036903|NCT01693562|11119063|FG007|Exploration Phase|Withdrawal by Subject|0
7036904|NCT01693562|11119064|FG008|Exploration Phase|Withdrawal by Subject|0
7036905|NCT01693562|11119065|FG009|Exploration Phase|Withdrawal by Subject|0
7036906|NCT01693562|11119066|FG010|Exploration Phase|Withdrawal by Subject|0
7036907|NCT01693562|11119067|FG011|Exploration Phase|Withdrawal by Subject|0
7036908|NCT01693562|11119068|FG012|Exploration Phase|Withdrawal by Subject|0
7036909|NCT01693562|11119069|FG013|Exploration Phase|Withdrawal by Subject|0
7036910|NCT01693562|11119070|FG014|Exploration Phase|Withdrawal by Subject|0
7036911|NCT01693562|11119071|FG015|Exploration Phase|Withdrawal by Subject|0
7036912|NCT01693562|11119072|FG016|Exploration Phase|Withdrawal by Subject|0
7036913|NCT01693562|11119073|FG017|Exploration Phase|Withdrawal by Subject|0
7036914|NCT01693562|11119074|FG018|Exploration Phase|Withdrawal by Subject|0
7036915|NCT01693562|11119075|FG019|Exploration Phase|Withdrawal by Subject|0
7036916|NCT01693562|11119076|FG020|Exploration Phase|Withdrawal by Subject|0
7036917|NCT01693562|11119077|FG021|Exploration Phase|Withdrawal by Subject|0
7036918|NCT01693562|11119078|FG022|Exploration Phase|Withdrawal by Subject|0
7036919|NCT01693562|11119056|FG000|Exploration Phase|Death|0
7036920|NCT01693562|11119057|FG001|Exploration Phase|Death|0
7036921|NCT01693562|11119058|FG002|Exploration Phase|Death|0
7036922|NCT01693562|11119059|FG003|Exploration Phase|Death|0
7036923|NCT01693562|11119060|FG004|Exploration Phase|Death|0
7036924|NCT01693562|11119061|FG005|Exploration Phase|Death|0
7036925|NCT01693562|11119062|FG006|Exploration Phase|Death|17
7036926|NCT01693562|11119063|FG007|Exploration Phase|Death|0
7036927|NCT01693562|11119064|FG008|Exploration Phase|Death|0
7036928|NCT01693562|11119065|FG009|Exploration Phase|Death|0
7036929|NCT01693562|11119066|FG010|Exploration Phase|Death|0
7036930|NCT01693562|11119067|FG011|Exploration Phase|Death|0
7036931|NCT01693562|11119068|FG012|Exploration Phase|Death|0
7036932|NCT01693562|11119069|FG013|Exploration Phase|Death|0
7036933|NCT01693562|11119070|FG014|Exploration Phase|Death|0
7036934|NCT01693562|11119071|FG015|Exploration Phase|Death|0
7036935|NCT01693562|11119072|FG016|Exploration Phase|Death|0
7036936|NCT01693562|11119073|FG017|Exploration Phase|Death|0
7036937|NCT01693562|11119074|FG018|Exploration Phase|Death|0
7036938|NCT01693562|11119075|FG019|Exploration Phase|Death|0
7036939|NCT01693562|11119076|FG020|Exploration Phase|Death|0
7036940|NCT01693562|11119077|FG021|Exploration Phase|Death|0
7036941|NCT01693562|11119078|FG022|Exploration Phase|Death|0
7036942|NCT01693562|11119056|FG000|Exploration Phase|Other|0
7036943|NCT01693562|11119057|FG001|Exploration Phase|Other|0
7036944|NCT01693562|11119058|FG002|Exploration Phase|Other|0
7036945|NCT01693562|11119059|FG003|Exploration Phase|Other|0
7036946|NCT01693562|11119060|FG004|Exploration Phase|Other|0
7036947|NCT01693562|11119061|FG005|Exploration Phase|Other|0
7036948|NCT01693562|11119062|FG006|Exploration Phase|Other|2
7036949|NCT01693562|11119063|FG007|Exploration Phase|Other|0
7036950|NCT01693562|11119064|FG008|Exploration Phase|Other|0
7036951|NCT01693562|11119065|FG009|Exploration Phase|Other|0
7036952|NCT01693562|11119066|FG010|Exploration Phase|Other|0
7036953|NCT01693562|11119067|FG011|Exploration Phase|Other|0
7036954|NCT01693562|11119068|FG012|Exploration Phase|Other|0
7036955|NCT01693562|11119069|FG013|Exploration Phase|Other|0
7036956|NCT01693562|11119070|FG014|Exploration Phase|Other|0
7036957|NCT01693562|11119071|FG015|Exploration Phase|Other|0
7036958|NCT01693562|11119072|FG016|Exploration Phase|Other|0
7036959|NCT01693562|11119073|FG017|Exploration Phase|Other|0
7036960|NCT01693562|11119074|FG018|Exploration Phase|Other|0
7036961|NCT01693562|11119075|FG019|Exploration Phase|Other|0
7036962|NCT01693562|11119076|FG020|Exploration Phase|Other|0
7036963|NCT01693562|11119077|FG021|Exploration Phase|Other|0
7036964|NCT01693562|11119078|FG022|Exploration Phase|Other|0
7036965|NCT01693562|11119056|FG000|Expansion Phase|Withdrawal by Subject|0
7036966|NCT01693562|11119057|FG001|Expansion Phase|Withdrawal by Subject|0
7036967|NCT01693562|11119058|FG002|Expansion Phase|Withdrawal by Subject|0
7036968|NCT01693562|11119059|FG003|Expansion Phase|Withdrawal by Subject|0
7036969|NCT01693562|11119060|FG004|Expansion Phase|Withdrawal by Subject|0
7036970|NCT01693562|11119061|FG005|Expansion Phase|Withdrawal by Subject|0
7036971|NCT01693562|11119062|FG006|Expansion Phase|Withdrawal by Subject|0
7036972|NCT01693562|11119063|FG007|Expansion Phase|Withdrawal by Subject|16
7036973|NCT01693562|11119064|FG008|Expansion Phase|Withdrawal by Subject|2
7036974|NCT01693562|11119065|FG009|Expansion Phase|Withdrawal by Subject|54
7036975|NCT01693562|11119066|FG010|Expansion Phase|Withdrawal by Subject|2
7036976|NCT01693562|11119067|FG011|Expansion Phase|Withdrawal by Subject|2
7036977|NCT01693562|11119068|FG012|Expansion Phase|Withdrawal by Subject|3
7036978|NCT01693562|11119069|FG013|Expansion Phase|Withdrawal by Subject|5
7036979|NCT01693562|11119070|FG014|Expansion Phase|Withdrawal by Subject|16
7036980|NCT01693562|11119071|FG015|Expansion Phase|Withdrawal by Subject|7
7036981|NCT01693562|11119072|FG016|Expansion Phase|Withdrawal by Subject|40
7036982|NCT01693562|11119073|FG017|Expansion Phase|Withdrawal by Subject|4
7036983|NCT01693562|11119074|FG018|Expansion Phase|Withdrawal by Subject|8
7036984|NCT01693562|11119075|FG019|Expansion Phase|Withdrawal by Subject|3
7036985|NCT01693562|11119076|FG020|Expansion Phase|Withdrawal by Subject|1
7036986|NCT01693562|11119077|FG021|Expansion Phase|Withdrawal by Subject|8
7036987|NCT01693562|11119078|FG022|Expansion Phase|Withdrawal by Subject|1
7036988|NCT01693562|11119056|FG000|Expansion Phase|Death|0
7036989|NCT01693562|11119057|FG001|Expansion Phase|Death|0
7036990|NCT01693562|11119058|FG002|Expansion Phase|Death|0
7036991|NCT01693562|11119059|FG003|Expansion Phase|Death|0
7036992|NCT01693562|11119060|FG004|Expansion Phase|Death|0
7036993|NCT01693562|11119061|FG005|Expansion Phase|Death|0
7036994|NCT01693562|11119062|FG006|Expansion Phase|Death|0
7036995|NCT01693562|11119063|FG007|Expansion Phase|Death|42
7036996|NCT01693562|11119064|FG008|Expansion Phase|Death|17
7036997|NCT01693562|11119065|FG009|Expansion Phase|Death|208
7036998|NCT01693562|11119066|FG010|Expansion Phase|Death|30
7036999|NCT01693562|11119067|FG011|Expansion Phase|Death|8
7037000|NCT01693562|11119068|FG012|Expansion Phase|Death|19
7037001|NCT01693562|11119069|FG013|Expansion Phase|Death|42
7037002|NCT01693562|11119070|FG014|Expansion Phase|Death|23
7037003|NCT01693562|11119071|FG015|Expansion Phase|Death|23
7037004|NCT01693562|11119072|FG016|Expansion Phase|Death|128
7037005|NCT01693562|11119073|FG017|Expansion Phase|Death|16
7037006|NCT01693562|11119074|FG018|Expansion Phase|Death|36
7037007|NCT01693562|11119075|FG019|Expansion Phase|Death|16
7037008|NCT01693562|11119076|FG020|Expansion Phase|Death|17
7037009|NCT01693562|11119077|FG021|Expansion Phase|Death|35
7037010|NCT01693562|11119078|FG022|Expansion Phase|Death|7
7037011|NCT01693562|11119056|FG000|Expansion Phase|Lost to Follow-up|0
7037012|NCT01693562|11119057|FG001|Expansion Phase|Lost to Follow-up|0
7037013|NCT01693562|11119058|FG002|Expansion Phase|Lost to Follow-up|0
7037014|NCT01693562|11119059|FG003|Expansion Phase|Lost to Follow-up|0
7037015|NCT01693562|11119060|FG004|Expansion Phase|Lost to Follow-up|0
7037016|NCT01693562|11119061|FG005|Expansion Phase|Lost to Follow-up|0
7143559|NCT03036813|11300410|FG000|Overall Study|Withdrawal by Subject|12
7143560|NCT03036813|11300411|FG001|Overall Study|Withdrawal by Subject|6
7143561|NCT03036813|11300412|FG002|Overall Study|Withdrawal by Subject|10
7143562|NCT03036813|11300410|FG000|Overall Study|Lost to Follow-up|1
7143563|NCT03036813|11300411|FG001|Overall Study|Lost to Follow-up|1
7143564|NCT03036813|11300412|FG002|Overall Study|Lost to Follow-up|0
7143565|NCT03036813|11300410|FG000|Overall Study|Physician Decision|2
7143566|NCT03036813|11300411|FG001|Overall Study|Physician Decision|1
7143567|NCT03036813|11300412|FG002|Overall Study|Physician Decision|1
7143568|NCT03036813|11300410|FG000|Overall Study|Non-Compliance|1
7143569|NCT03036813|11300411|FG001|Overall Study|Non-Compliance|5
7143570|NCT03036813|11300412|FG002|Overall Study|Non-Compliance|3
7143571|NCT03036813|11300410|FG000|Overall Study|Pregnancy|0
7143572|NCT03036813|11300411|FG001|Overall Study|Pregnancy|0
7143573|NCT03036813|11300412|FG002|Overall Study|Pregnancy|1
7143574|NCT03036813|11300410|FG000|Overall Study|Other|0
7143575|NCT03036813|11300411|FG001|Overall Study|Other|3
7143576|NCT03036813|11300412|FG002|Overall Study|Other|5
7143577|NCT03036839|11300426|FG000|Overall Study|Adverse Event|0
7143578|NCT03036839|11300427|FG001|Overall Study|Adverse Event|0
7143579|NCT03036839|11300428|FG002|Overall Study|Adverse Event|1
7143580|NCT03036839|11300426|FG000|Overall Study|Death|3
7143581|NCT03036839|11300427|FG001|Overall Study|Death|0
7143582|NCT03036839|11300428|FG002|Overall Study|Death|3
7143583|NCT03036839|11300426|FG000|Overall Study|Withdrew Consent|0
7143584|NCT03036839|11300427|FG001|Overall Study|Withdrew Consent|0
7143585|NCT03036839|11300428|FG002|Overall Study|Withdrew Consent|1
7143586|NCT03036852|11300442|FG000|Overall Study|Death|2
7143587|NCT03036852|11300442|FG000|Overall Study|Lack of Efficacy|2
7143588|NCT03036852|11300442|FG000|Overall Study|Adverse Event|1
7143589|NCT03036852|11300442|FG000|Overall Study|Lost to Follow-up|1
7143590|NCT03037307|11300490|FG000|Period 1|Did Not Meet Study Criteria|0
7143591|NCT03037307|11300491|FG001|Period 1|Did Not Meet Study Criteria|0
7143592|NCT03037307|11300492|FG002|Period 1|Did Not Meet Study Criteria|0
7143593|NCT03037307|11300493|FG003|Period 1|Did Not Meet Study Criteria|1
7037017|NCT01693562|11119062|FG006|Expansion Phase|Lost to Follow-up|0
7037018|NCT01693562|11119063|FG007|Expansion Phase|Lost to Follow-up|1
7037019|NCT01693562|11119064|FG008|Expansion Phase|Lost to Follow-up|2
7037020|NCT01693562|11119065|FG009|Expansion Phase|Lost to Follow-up|10
7037021|NCT01693562|11119066|FG010|Expansion Phase|Lost to Follow-up|4
7037022|NCT01693562|11119067|FG011|Expansion Phase|Lost to Follow-up|4
7037023|NCT01693562|11119068|FG012|Expansion Phase|Lost to Follow-up|1
7037024|NCT01693562|11119069|FG013|Expansion Phase|Lost to Follow-up|3
7037025|NCT01693562|11119070|FG014|Expansion Phase|Lost to Follow-up|0
7037026|NCT01693562|11119071|FG015|Expansion Phase|Lost to Follow-up|1
7037027|NCT01693562|11119072|FG016|Expansion Phase|Lost to Follow-up|1
7037028|NCT01693562|11119073|FG017|Expansion Phase|Lost to Follow-up|0
7037029|NCT01693562|11119074|FG018|Expansion Phase|Lost to Follow-up|2
7143594|NCT03037307|11300494|FG004|Period 1|Did Not Meet Study Criteria|0
7143595|NCT03037307|11300495|FG005|Period 1|Did Not Meet Study Criteria|0
7143596|NCT03037489|11300506|FG000|Overall Study|Adverse Event|4
7143597|NCT03037489|11300507|FG001|Overall Study|Adverse Event|0
7143598|NCT03037489|11300506|FG000|Overall Study|Withdrawal by Subject|3
7143599|NCT03037489|11300507|FG001|Overall Study|Withdrawal by Subject|0
7143600|NCT03037580|11300524|FG000|Overall Study|Withdrawal by Subject|3
7143601|NCT03037580|11300525|FG001|Overall Study|Withdrawal by Subject|0
7143602|NCT03037580|11300524|FG000|Overall Study|Adverse Event|1
7143603|NCT03037580|11300525|FG001|Overall Study|Adverse Event|0
7037030|NCT01693562|11119075|FG019|Expansion Phase|Lost to Follow-up|1
7037031|NCT01693562|11119076|FG020|Expansion Phase|Lost to Follow-up|2
7037032|NCT01693562|11119077|FG021|Expansion Phase|Lost to Follow-up|2
7037033|NCT01693562|11119078|FG022|Expansion Phase|Lost to Follow-up|1
7037034|NCT01693562|11119056|FG000|Expansion Phase|Other|0
7037035|NCT01693562|11119057|FG001|Expansion Phase|Other|0
7037036|NCT01693562|11119058|FG002|Expansion Phase|Other|0
7037037|NCT01693562|11119059|FG003|Expansion Phase|Other|0
7037038|NCT01693562|11119060|FG004|Expansion Phase|Other|0
7037039|NCT01693562|11119061|FG005|Expansion Phase|Other|0
7143604|NCT03037580|11300524|FG000|Overall Study|Study Terminated by Sponsor|12
7143605|NCT03037580|11300525|FG001|Overall Study|Study Terminated by Sponsor|15
7143606|NCT03037580|11300524|FG000|Overall Study|Death|0
7143607|NCT03037580|11300525|FG001|Overall Study|Death|1
7143608|NCT03037619|11300533|FG000|Overall Study|Lost to Follow-up|0
7143609|NCT03037619|11300534|FG001|Overall Study|Lost to Follow-up|1
7143610|NCT03038113|11300574|FG000|Overall Study|Withdrawal by Subject|0
7143611|NCT03038113|11300575|FG001|Overall Study|Withdrawal by Subject|0
7143612|NCT03038113|11300576|FG002|Overall Study|Withdrawal by Subject|1
7143613|NCT03038113|11300577|FG003|Overall Study|Withdrawal by Subject|0
7143614|NCT03038113|11300578|FG004|Overall Study|Withdrawal by Subject|0
7143615|NCT03038113|11300579|FG005|Overall Study|Withdrawal by Subject|0
7143616|NCT03038113|11300580|FG006|Overall Study|Withdrawal by Subject|0
7143617|NCT03038113|11300581|FG007|Overall Study|Withdrawal by Subject|0
7143618|NCT03038113|11300582|FG008|Overall Study|Withdrawal by Subject|0
7143619|NCT03038113|11300583|FG009|Overall Study|Withdrawal by Subject|0
7143620|NCT03038113|11300584|FG010|Overall Study|Withdrawal by Subject|0
7143621|NCT03038113|11300585|FG011|Overall Study|Withdrawal by Subject|0
7143622|NCT03038113|11300586|FG012|Overall Study|Withdrawal by Subject|0
7143623|NCT03038113|11300587|FG013|Overall Study|Withdrawal by Subject|1
7143624|NCT03038113|11300574|FG000|Overall Study|Lost to Follow-up|0
7143625|NCT03038113|11300575|FG001|Overall Study|Lost to Follow-up|0
7143626|NCT03038113|11300576|FG002|Overall Study|Lost to Follow-up|0
7143627|NCT03038113|11300577|FG003|Overall Study|Lost to Follow-up|0
7143628|NCT03038113|11300578|FG004|Overall Study|Lost to Follow-up|0
6922233|NCT00810069|10950714|FG002|Double-Blind Period II|Protocol entry criterion not met|1
6922234|NCT00810069|10950712|FG000|Double-Blind Period II|Clinical relapse|0
6922235|NCT00810069|10950713|FG001|Double-Blind Period II|Clinical relapse|3
6922236|NCT00810069|10950714|FG002|Double-Blind Period II|Clinical relapse|0
6922237|NCT00810069|10950712|FG000|Double-Blind Period II|Protocol Violation|0
6922238|NCT00810069|10950713|FG001|Double-Blind Period II|Protocol Violation|7
6922239|NCT00810069|10950714|FG002|Double-Blind Period II|Protocol Violation|6
6922240|NCT00810082|10950725|FG000|Overall Study|Lost to Follow-up|0
6922241|NCT00810082|10950726|FG001|Overall Study|Lost to Follow-up|4
6922242|NCT00810108|10950738|FG000|Overall Study|Withdrawal by Subject|1
6922243|NCT00810108|10950739|FG001|Overall Study|Withdrawal by Subject|0
6922244|NCT00810199|10950746|FG000|Overall Study|Adverse Event|24
6922245|NCT00810199|10950747|FG001|Overall Study|Adverse Event|26
6922246|NCT00810199|10950746|FG000|Overall Study|Death|4
6922247|NCT00810199|10950747|FG001|Overall Study|Death|6
6922248|NCT00810199|10950746|FG000|Overall Study|Withdrew consent|9
6922249|NCT00810199|10950747|FG001|Overall Study|Withdrew consent|12
6922250|NCT00810199|10950746|FG000|Overall Study|Insufficient therapeutic response|5
6922251|NCT00810199|10950747|FG001|Overall Study|Insufficient therapeutic response|14
6922252|NCT00810199|10950746|FG000|Overall Study|Refused treatment/Did not cooperate|7
6922253|NCT00810199|10950747|FG001|Overall Study|Refused treatment/Did not cooperate|7
6922254|NCT00810199|10950746|FG000|Overall Study|Administrative/Other|5
6922255|NCT00810199|10950747|FG001|Overall Study|Administrative/Other|6
6922256|NCT00810199|10950746|FG000|Overall Study|Protocol Violation|2
6922257|NCT00810199|10950747|FG001|Overall Study|Protocol Violation|6
6922258|NCT00810199|10950746|FG000|Overall Study|Failure to return|1
6922259|NCT00810199|10950747|FG001|Overall Study|Failure to return|4
6922260|NCT00810199|10950746|FG000|Overall Study|Did not receive study drug|2
6922261|NCT00810199|10950747|FG001|Overall Study|Did not receive study drug|1
6922262|NCT00810264|10950759|FG000|Overall Study|Lost to Follow-up|191
6922263|NCT00810264|10950759|FG000|Overall Study|Withdrawal by subject or physician|721
6922264|NCT00810264|10950759|FG000|Overall Study|Death|641
6922265|NCT00810277|10950767|FG000|Overall Study|Adverse Event|1
6922266|NCT00810342|10950781|FG000|Month 1 Follow-up|Lost to Follow-up|4
6922267|NCT00810342|10950782|FG001|Month 1 Follow-up|Lost to Follow-up|2
6922268|NCT00810342|10950781|FG000|Month 1 Follow-up|Pregnancy|1
6922269|NCT00810342|10950782|FG001|Month 1 Follow-up|Pregnancy|0
7037040|NCT01693562|11119062|FG006|Expansion Phase|Other|0
7037041|NCT01693562|11119063|FG007|Expansion Phase|Other|3
7037042|NCT01693562|11119064|FG008|Expansion Phase|Other|1
7143629|NCT03038113|11300579|FG005|Overall Study|Lost to Follow-up|0
7143630|NCT03038113|11300580|FG006|Overall Study|Lost to Follow-up|1
6922270|NCT00810342|10950781|FG000|6-month Follow-up|Lost to Follow-up|18
6922271|NCT00810342|10950782|FG001|6-month Follow-up|Lost to Follow-up|6
6922272|NCT00810342|10950781|FG000|6-month Follow-up|Pregnancy|6
6922273|NCT00810342|10950782|FG001|6-month Follow-up|Pregnancy|2
7037043|NCT01693562|11119065|FG009|Expansion Phase|Other|28
7037044|NCT01693562|11119066|FG010|Expansion Phase|Other|4
7037045|NCT01693562|11119067|FG011|Expansion Phase|Other|7
7037046|NCT01693562|11119068|FG012|Expansion Phase|Other|0
7037047|NCT01693562|11119069|FG013|Expansion Phase|Other|1
7143631|NCT03038113|11300581|FG007|Overall Study|Lost to Follow-up|0
7143632|NCT03038113|11300582|FG008|Overall Study|Lost to Follow-up|0
7143633|NCT03038113|11300583|FG009|Overall Study|Lost to Follow-up|0
7143634|NCT03038113|11300584|FG010|Overall Study|Lost to Follow-up|0
7143635|NCT03038113|11300585|FG011|Overall Study|Lost to Follow-up|0
7143636|NCT03038113|11300586|FG012|Overall Study|Lost to Follow-up|0
7143637|NCT03038113|11300587|FG013|Overall Study|Lost to Follow-up|0
7143638|NCT03038126|11300636|FG000|Overall Study|Death|1
7143639|NCT03038126|11300637|FG001|Overall Study|Death|1
7143640|NCT03038126|11300636|FG000|Overall Study|Withdrawal by Subject|5
7143641|NCT03038126|11300637|FG001|Overall Study|Withdrawal by Subject|0
7143642|NCT03038126|11300636|FG000|Overall Study|Lost to Follow-up|0
7143643|NCT03038126|11300637|FG001|Overall Study|Lost to Follow-up|1
7143644|NCT03038126|11300636|FG000|Overall Study|Long Term Hospitalization|2
7143645|NCT03038126|11300637|FG001|Overall Study|Long Term Hospitalization|0
7143646|NCT03038126|11300636|FG000|Overall Study|Too Ill to Participate|1
7143647|NCT03038126|11300637|FG001|Overall Study|Too Ill to Participate|2
7143648|NCT03038620|11300668|FG000|Overall Study|Lost to Follow-up|18
7143649|NCT03038620|11300669|FG001|Overall Study|Lost to Follow-up|23
7143650|NCT03038620|11300668|FG000|Overall Study|Withdrawal by Subject|0
7143651|NCT03038620|11300669|FG001|Overall Study|Withdrawal by Subject|15
7143652|NCT03038620|11300668|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1
7143653|NCT03038620|11300669|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0
7143654|NCT03038880|11300697|FG000|Overall Study|Death|1
7143655|NCT03038880|11300698|FG001|Overall Study|Death|2
7143656|NCT03038880|11300699|FG002|Overall Study|Death|0
7143657|NCT03038880|11300697|FG000|Overall Study|Physician Decision|2
7143658|NCT03038880|11300698|FG001|Overall Study|Physician Decision|1
7143659|NCT03038880|11300699|FG002|Overall Study|Physician Decision|0
7143660|NCT03039023|11300712|FG000|Overall Study|Withdrawal by Subject|1
7143661|NCT03039023|11300713|FG001|Overall Study|Withdrawal by Subject|0
7143662|NCT03039023|11300714|FG002|Overall Study|Withdrawal by Subject|1
7143663|NCT03039023|11300715|FG003|Overall Study|Withdrawal by Subject|1
7143664|NCT03039023|11300716|FG004|Overall Study|Withdrawal by Subject|0
7143665|NCT03039023|11300712|FG000|Overall Study|Physician Decision|0
7143666|NCT03039023|11300713|FG001|Overall Study|Physician Decision|0
7143667|NCT03039023|11300714|FG002|Overall Study|Physician Decision|0
7143668|NCT03039023|11300715|FG003|Overall Study|Physician Decision|1
7143669|NCT03039023|11300716|FG004|Overall Study|Physician Decision|0
7143670|NCT03039192|11300748|FG000|Overall Study|Lost to Follow-up|4
7143671|NCT03039192|11300749|FG001|Overall Study|Lost to Follow-up|4
7143672|NCT03039192|11300748|FG000|Overall Study|Adverse event, serious fatal|0
7143673|NCT03039192|11300749|FG001|Overall Study|Adverse event, serious fatal|1
7143674|NCT03039192|11300748|FG000|Overall Study|Adverse event, non-fatal|0
7143675|NCT03039192|11300749|FG001|Overall Study|Adverse event, non-fatal|2
7143676|NCT03039192|11300748|FG000|Overall Study|Withdrawal by Subject|6
7143677|NCT03039192|11300749|FG001|Overall Study|Withdrawal by Subject|9
7143678|NCT03039192|11300748|FG000|Overall Study|Discontinued from treatment phase|19
7143679|NCT03039192|11300749|FG001|Overall Study|Discontinued from treatment phase|12
7143680|NCT03039192|11300748|FG000|Overall Study|Other|3
7143681|NCT03039192|11300749|FG001|Overall Study|Other|2
7143682|NCT03039283|11300755|FG000|Overall Study|Protocol Violation|2
7143683|NCT03039569|11300770|FG000|Overall Study|Lost to Follow-up|5
7143684|NCT03039569|11300771|FG001|Overall Study|Lost to Follow-up|4
7143685|NCT03039621|11300780|FG000|Overall Study|Violation of inclusion criteria|3
7143686|NCT03039621|11300781|FG001|Overall Study|Violation of inclusion criteria|2
7143687|NCT03039621|11300780|FG000|Overall Study|Non-compliance with protocol requirement|4
7143688|NCT03039621|11300781|FG001|Overall Study|Non-compliance with protocol requirement|5
7143689|NCT03039621|11300780|FG000|Overall Study|Necessity to use drugs forbidden by pro|4
7143690|NCT03039621|11300781|FG001|Overall Study|Necessity to use drugs forbidden by pro|7
7143691|NCT03039621|11300780|FG000|Overall Study|Violation of non-inclusion criteria|1
7143692|NCT03039621|11300781|FG001|Overall Study|Violation of non-inclusion criteria|2
7143693|NCT03039686|11300790|FG000|Double-blind Period|Administrative Reason by Sponsor|24
7143694|NCT03039686|11300791|FG001|Double-blind Period|Administrative Reason by Sponsor|25
7143695|NCT03039686|11300792|FG002|Double-blind Period|Administrative Reason by Sponsor|21
7143696|NCT03039686|11300790|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1
7143697|NCT03039686|11300791|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2
7143698|NCT03039686|11300792|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0
7143699|NCT03039686|11300790|FG000|Double-blind Period|Withdrawal by Subject|2
7143700|NCT03039686|11300791|FG001|Double-blind Period|Withdrawal by Subject|2
7143701|NCT03039686|11300792|FG002|Double-blind Period|Withdrawal by Subject|1
7143702|NCT03039686|11300790|FG000|Double-blind Period|Death|0
7143703|NCT03039686|11300791|FG001|Double-blind Period|Death|0
7143704|NCT03039686|11300792|FG002|Double-blind Period|Death|1
7037048|NCT01693562|11119070|FG014|Expansion Phase|Other|1
7037049|NCT01693562|11119071|FG015|Expansion Phase|Other|0
7143705|NCT03039686|11300790|FG000|Open Label Period|Administrative Reason by Sponsor|0
7037050|NCT01693562|11119072|FG016|Expansion Phase|Other|28
7037051|NCT01693562|11119073|FG017|Expansion Phase|Other|0
7037052|NCT01693562|11119074|FG018|Expansion Phase|Other|1
7037053|NCT01693562|11119075|FG019|Expansion Phase|Other|0
7037054|NCT01693562|11119076|FG020|Expansion Phase|Other|1
7037055|NCT01693562|11119077|FG021|Expansion Phase|Other|17
7037056|NCT01693562|11119078|FG022|Expansion Phase|Other|1
7037057|NCT01693614|11119164|FG000|Overall Study|Adverse Event|7
7037058|NCT01693614|11119165|FG001|Overall Study|Adverse Event|11
7037059|NCT01693614|11119166|FG002|Overall Study|Adverse Event|5
7037060|NCT01693614|11119164|FG000|Overall Study|Disease progression|11
7037061|NCT01693614|11119165|FG001|Overall Study|Disease progression|8
7037062|NCT01693614|11119166|FG002|Overall Study|Disease progression|7
7037063|NCT01693614|11119164|FG000|Overall Study|Protocol Violation|5
7037064|NCT01693614|11119165|FG001|Overall Study|Protocol Violation|2
7037065|NCT01693614|11119166|FG002|Overall Study|Protocol Violation|1
7037066|NCT01693614|11119164|FG000|Overall Study|Death|1
7037067|NCT01693614|11119165|FG001|Overall Study|Death|0
7037068|NCT01693614|11119166|FG002|Overall Study|Death|0
7037069|NCT01693614|11119164|FG000|Overall Study|Physician Decision|1
7037070|NCT01693614|11119165|FG001|Overall Study|Physician Decision|1
7037071|NCT01693614|11119166|FG002|Overall Study|Physician Decision|4
7037072|NCT01693614|11119164|FG000|Overall Study|Withdrawal by subject/guardian|0
7037073|NCT01693614|11119165|FG001|Overall Study|Withdrawal by subject/guardian|0
7037074|NCT01693614|11119166|FG002|Overall Study|Withdrawal by subject/guardian|2
7037075|NCT01693614|11119164|FG000|Overall Study|Withdrawal by Subject|1
7037076|NCT01693614|11119165|FG001|Overall Study|Withdrawal by Subject|0
7037077|NCT01693614|11119166|FG002|Overall Study|Withdrawal by Subject|5
7037078|NCT01694121|11119202|FG000|Overall Study|Participant used false ID, was withdrawn|1
7037079|NCT01694121|11119203|FG001|Overall Study|Participant used false ID, was withdrawn|0
7044704|NCT01756456|11130659|FG005|Follow Up Period Phase I/II|still in study after week 20|25
7044705|NCT01756456|11130654|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
7044706|NCT01756456|11130655|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1
7044707|NCT01756456|11130656|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
7044708|NCT01756456|11130657|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
7044709|NCT01756456|11130658|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
7044710|NCT01756456|11130659|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
7044711|NCT01756456|11130654|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0
7044712|NCT01756456|11130655|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0
7143706|NCT03039686|11300791|FG001|Open Label Period|Administrative Reason by Sponsor|34
7143707|NCT03039686|11300792|FG002|Open Label Period|Administrative Reason by Sponsor|41
7143708|NCT03039686|11300790|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0
7143709|NCT03039686|11300791|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1
7143710|NCT03039686|11300792|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0
7143711|NCT03039686|11300790|FG000|Open Label Period|Withdrawal by Subject|0
7143712|NCT03039686|11300791|FG001|Open Label Period|Withdrawal by Subject|3
7143713|NCT03039686|11300792|FG002|Open Label Period|Withdrawal by Subject|1
7143714|NCT03039699|11300812|FG000|Overall Study|Incorrect inclusion|5
7143715|NCT03039699|11300813|FG001|Overall Study|Incorrect inclusion|4
7143716|NCT03039699|11300812|FG000|Overall Study|Lack of data to assess study endpoint|5
7143717|NCT03039699|11300813|FG001|Overall Study|Lack of data to assess study endpoint|3
7143718|NCT03039699|11300812|FG000|Overall Study|Bacterial infection|12
7143719|NCT03039699|11300813|FG001|Overall Study|Bacterial infection|28
7044713|NCT01756456|11130656|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0
7044714|NCT01756456|11130657|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0
7044715|NCT01756456|11130658|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0
7044716|NCT01756456|11130659|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1
7044717|NCT01756456|11130654|FG000|Follow Up Period Phase I/II|Adverse Event|1
7044718|NCT01756456|11130655|FG001|Follow Up Period Phase I/II|Adverse Event|0
7044719|NCT01756456|11130656|FG002|Follow Up Period Phase I/II|Adverse Event|0
7044720|NCT01756456|11130657|FG003|Follow Up Period Phase I/II|Adverse Event|5
7044721|NCT01756456|11130658|FG004|Follow Up Period Phase I/II|Adverse Event|0
7044722|NCT01756456|11130659|FG005|Follow Up Period Phase I/II|Adverse Event|1
7044723|NCT01756456|11130654|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0
7044724|NCT01756456|11130655|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0
7044725|NCT01756456|11130656|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1
7143720|NCT03039738|11300821|FG000|Overall Study|Incomplete data sets|54
7143721|NCT03039738|11300822|FG001|Overall Study|Incomplete data sets|0
7183616|NCT01488890|11383708|FG003|Overall Study|Lost to Follow-up|3
7183617|NCT01488890|11383705|FG000|Overall Study|Withdrawal by Subject|14
7183618|NCT01488890|11383706|FG001|Overall Study|Withdrawal by Subject|10
7044726|NCT01756456|11130657|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2
7044727|NCT01756456|11130658|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0
7044728|NCT01756456|11130659|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1
7044729|NCT01756456|11130654|FG000|Follow Up Period Phase I/II|Other causes|0
7044730|NCT01756456|11130655|FG001|Follow Up Period Phase I/II|Other causes|0
7044731|NCT01756456|11130656|FG002|Follow Up Period Phase I/II|Other causes|0
7044732|NCT01756456|11130657|FG003|Follow Up Period Phase I/II|Other causes|1
7044733|NCT01756456|11130658|FG004|Follow Up Period Phase I/II|Other causes|3
7044734|NCT01756456|11130659|FG005|Follow Up Period Phase I/II|Other causes|5
7037080|NCT01694420|11119227|FG000|Overall Study|Lost to Follow-up|3
7037081|NCT01694433|11119233|FG000|Overall Study|Adverse Event|7
7037082|NCT01694433|11119234|FG001|Overall Study|Adverse Event|0
7037083|NCT01694433|11119233|FG000|Overall Study|Physician Decision|1
7037084|NCT01694433|11119234|FG001|Overall Study|Physician Decision|0
7037085|NCT01694433|11119233|FG000|Overall Study|Withdrawal by Subject|3
7037086|NCT01694433|11119234|FG001|Overall Study|Withdrawal by Subject|4
7037087|NCT01694485|11119245|FG000|Overall Study|Withdrawal by Subject|20
7037088|NCT01694485|11119246|FG001|Overall Study|Withdrawal by Subject|6
7037089|NCT01694485|11119247|FG002|Overall Study|Withdrawal by Subject|7
7037090|NCT01694485|11119248|FG003|Overall Study|Withdrawal by Subject|25
7037091|NCT01694485|11119249|FG004|Overall Study|Withdrawal by Subject|18
7143722|NCT03040024|11300844|FG000|Overall Study|Adverse Event|0
7143723|NCT03040024|11300845|FG001|Overall Study|Adverse Event|1
7143724|NCT03040024|11300846|FG002|Overall Study|Adverse Event|0
7143725|NCT03040024|11300844|FG000|Overall Study|Death|0
7143726|NCT03040024|11300845|FG001|Overall Study|Death|1
7143727|NCT03040024|11300846|FG002|Overall Study|Death|0
7143728|NCT03040024|11300844|FG000|Overall Study|Physician Decision|0
7143729|NCT03040024|11300845|FG001|Overall Study|Physician Decision|0
7143730|NCT03040024|11300846|FG002|Overall Study|Physician Decision|1
7143731|NCT03040336|11300865|FG000|Overall Study|Death|1
7143732|NCT03040336|11300866|FG001|Overall Study|Death|0
7143733|NCT03040336|11300865|FG000|Overall Study|Withdrawal by Subject|2
7143734|NCT03040336|11300866|FG001|Overall Study|Withdrawal by Subject|3
7143735|NCT03040674|11300923|FG000|Overall Study|Lost to Follow-up|225
7143736|NCT03040674|11300923|FG000|Overall Study|Death|23
6827105|NCT00122382|10829623|FG000|Open-Label Study|Adverse Event|0
6827106|NCT00122382|10829624|FG001|Open-Label Study|Adverse Event|0
6827107|NCT00122382|10829625|FG002|Open-Label Study|Adverse Event|11
6827108|NCT00122382|10829623|FG000|Open-Label Study|Death|0
6827109|NCT00122382|10829624|FG001|Open-Label Study|Death|0
6827110|NCT00122382|10829625|FG002|Open-Label Study|Death|2
6827111|NCT00122382|10829623|FG000|Open-Label Study|Lack of Efficacy|0
6827112|NCT00122382|10829624|FG001|Open-Label Study|Lack of Efficacy|0
6827113|NCT00122382|10829625|FG002|Open-Label Study|Lack of Efficacy|3
6827114|NCT00122382|10829623|FG000|Open-Label Study|Lost to Follow-up|0
6827115|NCT00122382|10829624|FG001|Open-Label Study|Lost to Follow-up|0
6827116|NCT00122382|10829625|FG002|Open-Label Study|Lost to Follow-up|3
6827117|NCT00122382|10829623|FG000|Open-Label Study|Pregnancy|0
6827118|NCT00122382|10829624|FG001|Open-Label Study|Pregnancy|0
6827119|NCT00122382|10829625|FG002|Open-Label Study|Pregnancy|2
6827120|NCT00122382|10829623|FG000|Open-Label Study|Poor/Non-Compliance|0
6827121|NCT00122382|10829624|FG001|Open-Label Study|Poor/Non-Compliance|0
6827122|NCT00122382|10829625|FG002|Open-Label Study|Poor/Non-Compliance|1
6827123|NCT00122382|10829623|FG000|Open-Label Study|Withdrawal of Consent|0
6827124|NCT00122382|10829624|FG001|Open-Label Study|Withdrawal of Consent|0
6827125|NCT00122382|10829625|FG002|Open-Label Study|Withdrawal of Consent|4
6827126|NCT00122460|10829666|FG000|Overall Study|investigational study phase ongoing|7
6827127|NCT00122460|10829667|FG001|Overall Study|investigational study phase ongoing|1
6827128|NCT00122681|10829675|FG000|Overall Study|Adverse Event|20
6827129|NCT00122681|10829676|FG001|Overall Study|Adverse Event|16
6827130|NCT00122681|10829675|FG000|Overall Study|Lost to Follow-up|1080
6827131|NCT00122681|10829676|FG001|Overall Study|Lost to Follow-up|1097
6827132|NCT00122681|10829675|FG000|Overall Study|Protocol Violation|7
6827133|NCT00122681|10829676|FG001|Overall Study|Protocol Violation|10
6827134|NCT00122681|10829675|FG000|Overall Study|Withdrawal by Subject|257
6827135|NCT00122681|10829676|FG001|Overall Study|Withdrawal by Subject|251
6827136|NCT00122681|10829675|FG000|Overall Study|Personal reasons|150
6827137|NCT00122681|10829676|FG001|Overall Study|Personal reasons|147
6827138|NCT00122954|10829692|FG000|Overall Study|Withdrawal by Subject|2
6827139|NCT00122954|10829693|FG001|Overall Study|Withdrawal by Subject|2
6827140|NCT00122954|10829692|FG000|Overall Study|Protocol Violation|0
6827141|NCT00122954|10829693|FG001|Overall Study|Protocol Violation|1
6827142|NCT00122980|10829701|FG000|Overall Study|Death|0
6827143|NCT00122980|10829702|FG001|Overall Study|Death|1
6827144|NCT00122980|10829701|FG000|Overall Study|Physician Decision|2
6827145|NCT00122980|10829702|FG001|Overall Study|Physician Decision|0
6827146|NCT00122980|10829701|FG000|Overall Study|Protocol Violation|5
6827147|NCT00122980|10829702|FG001|Overall Study|Protocol Violation|1
6827148|NCT00122980|10829701|FG000|Overall Study|Withdrawal by Subject|2
7037092|NCT01694485|11119245|FG000|Overall Study|Sponsor Decision|3
7037093|NCT01694485|11119246|FG001|Overall Study|Sponsor Decision|0
6827149|NCT00122980|10829702|FG001|Overall Study|Withdrawal by Subject|3
6827150|NCT00122980|10829701|FG000|Overall Study|Adjudicated stroke (study endpoint)|7
6827151|NCT00122980|10829702|FG001|Overall Study|Adjudicated stroke (study endpoint)|0
6827152|NCT00122980|10829701|FG000|Overall Study|Study termination|27
6827153|NCT00122980|10829702|FG001|Overall Study|Study termination|35
6827154|NCT00123422|10829757|FG000|Overall Study|Physician Decision|2
6827155|NCT00123422|10829758|FG001|Overall Study|Physician Decision|2
6827156|NCT00123422|10829759|FG002|Overall Study|Physician Decision|6
6827157|NCT00123422|10829757|FG000|Overall Study|Withdrawal by Subject|1
6827158|NCT00123422|10829758|FG001|Overall Study|Withdrawal by Subject|2
6827159|NCT00123422|10829759|FG002|Overall Study|Withdrawal by Subject|2
6827160|NCT00123422|10829757|FG000|Overall Study|Lost to Follow-up|1
7143737|NCT03040687|11300931|FG000|Overall Study|Withdrawal by Subject|1
7037094|NCT01694485|11119247|FG002|Overall Study|Sponsor Decision|0
7037095|NCT01694485|11119248|FG003|Overall Study|Sponsor Decision|2
7037096|NCT01694485|11119249|FG004|Overall Study|Sponsor Decision|0
7037097|NCT01694485|11119245|FG000|Overall Study|Lost to Follow-up|9
7037098|NCT01694485|11119246|FG001|Overall Study|Lost to Follow-up|1
7037099|NCT01694485|11119247|FG002|Overall Study|Lost to Follow-up|6
7037100|NCT01694485|11119248|FG003|Overall Study|Lost to Follow-up|10
7037101|NCT01694485|11119249|FG004|Overall Study|Lost to Follow-up|7
7037102|NCT01694485|11119245|FG000|Overall Study|Death|1
7143738|NCT03040687|11300932|FG001|Overall Study|Withdrawal by Subject|0
7143739|NCT03040687|11300933|FG002|Overall Study|Withdrawal by Subject|0
7143740|NCT03040713|11300941|FG000|Overall Study|Positive amyloid scan|3
7143741|NCT03040986|11300951|FG000|Overall Study|Hospice|1
7143742|NCT03040986|11300952|FG001|Overall Study|Hospice|0
7143743|NCT03040986|11300951|FG000|Overall Study|Adverse Event|2
7143744|NCT03040986|11300952|FG001|Overall Study|Adverse Event|1
7143745|NCT03040986|11300951|FG000|Overall Study|Disease progression on study|3
7143746|NCT03040986|11300952|FG001|Overall Study|Disease progression on study|1
7143747|NCT03041025|11300963|FG000|Overall Study|Adverse Event|0
7143748|NCT03041025|11300964|FG001|Overall Study|Adverse Event|0
7143749|NCT03041025|11300965|FG002|Overall Study|Adverse Event|1
7143750|NCT03041025|11300963|FG000|Overall Study|Lost to Follow-up|1
7143751|NCT03041025|11300964|FG001|Overall Study|Lost to Follow-up|0
7143752|NCT03041025|11300965|FG002|Overall Study|Lost to Follow-up|0
7143753|NCT03041025|11300963|FG000|Overall Study|Withdrawal by Subject|0
7143754|NCT03041025|11300964|FG001|Overall Study|Withdrawal by Subject|0
7143755|NCT03041025|11300965|FG002|Overall Study|Withdrawal by Subject|1
7143756|NCT03041038|11300978|FG000|Overall Study|Withdrawal by Subject|4
7143757|NCT03041038|11300979|FG001|Overall Study|Withdrawal by Subject|0
7143758|NCT03041038|11300978|FG000|Overall Study|Lost to Follow-up|1
7143759|NCT03041038|11300979|FG001|Overall Study|Lost to Follow-up|1
7143760|NCT03041038|11300978|FG000|Overall Study|Protocol Violation|1
7143761|NCT03041038|11300979|FG001|Overall Study|Protocol Violation|1
7143762|NCT03041090|11300989|FG000|Overall Study|technical error|0
7143763|NCT03041090|11300990|FG001|Overall Study|technical error|3
7143764|NCT03041116|11300998|FG000|Double-blind|Death|0
7143765|NCT03041116|11300999|FG001|Double-blind|Death|2
7143766|NCT03041116|11300998|FG000|Double-blind|Withdrawal by Subject|0
7143767|NCT03041116|11300999|FG001|Double-blind|Withdrawal by Subject|4
7143768|NCT03041116|11300998|FG000|Open-label|Death|1
7143769|NCT03041116|11300999|FG001|Open-label|Death|0
7143770|NCT03041116|11300998|FG000|Open-label|Termination of the study by Sponsor|39
7143771|NCT03041116|11300999|FG001|Open-label|Termination of the study by Sponsor|37
7143772|NCT03041116|11300998|FG000|Open-label|Withdrawal by Subject|1
7143773|NCT03041116|11300999|FG001|Open-label|Withdrawal by Subject|0
7143774|NCT03041181|11301011|FG000|Overall Study|Disease Progression|1
7143775|NCT03041181|11301012|FG001|Overall Study|Disease Progression|2
7143776|NCT03041792|11301044|FG000|Overall Study|Adverse Event|4
7143777|NCT03041792|11301045|FG001|Overall Study|Adverse Event|0
7143778|NCT03041792|11301044|FG000|Overall Study|Death in the family|0
7143779|NCT03041792|11301045|FG001|Overall Study|Death in the family|2
7143780|NCT03041792|11301044|FG000|Overall Study|Randomized but not treated|0
7143781|NCT03041792|11301045|FG001|Overall Study|Randomized but not treated|1
7143782|NCT03042312|11301096|FG000|Overall Study|Administrative Reason|1
7143783|NCT03042312|11301097|FG001|Overall Study|Administrative Reason|1
7143784|NCT03042312|11301096|FG000|Overall Study|Adverse Event|0
7143785|NCT03042312|11301097|FG001|Overall Study|Adverse Event|1
7143786|NCT03042312|11301096|FG000|Overall Study|Lost to Follow-up|1
7143787|NCT03042312|11301097|FG001|Overall Study|Lost to Follow-up|3
7143788|NCT03042312|11301096|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4
7143789|NCT03042312|11301097|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2
7143790|NCT03042312|11301096|FG000|Overall Study|Withdrawal by Subject|4
7143791|NCT03042312|11301097|FG001|Overall Study|Withdrawal by Subject|5
7143792|NCT03042559|11301105|FG000|Overall Study|drop out|1
7143793|NCT03042559|11301106|FG001|Overall Study|drop out|1
7143794|NCT03042767|11301123|FG000|Overall Study|Lost to Follow-up|1
7143795|NCT03042767|11301124|FG001|Overall Study|Lost to Follow-up|2
7143796|NCT03042910|11301130|FG000|Overall Study|Adverse Event|1
7143797|NCT03042910|11301130|FG000|Overall Study|Disease Progression|2
7143798|NCT03042910|11301130|FG000|Overall Study|Withdrawal by Subject|3
7037103|NCT01694485|11119246|FG001|Overall Study|Death|0
7143799|NCT03042910|11301130|FG000|Overall Study|Enrolled but not treated|1
7143800|NCT03043365|11301163|FG000|Weeks 0 to Week 8|Adverse Event|1
7143801|NCT03043365|11301164|FG001|Weeks 0 to Week 8|Adverse Event|3
7143802|NCT03043365|11301163|FG000|Weeks 0 to Week 8|Lost to Follow-up|2
7143803|NCT03043365|11301164|FG001|Weeks 0 to Week 8|Lost to Follow-up|0
7143804|NCT03043365|11301163|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1
7037104|NCT01694485|11119247|FG002|Overall Study|Death|0
7143805|NCT03043365|11301164|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0
7037105|NCT01694485|11119248|FG003|Overall Study|Death|1
7037106|NCT01694485|11119249|FG004|Overall Study|Death|0
7037107|NCT01694706|11119292|FG000|Overall Study|Adverse Event|0
7143806|NCT03043560|11301183|FG000|Overall Study|Discontinued Intervention|1
7143807|NCT03043560|11301184|FG001|Overall Study|Discontinued Intervention|2
7037108|NCT01694706|11119293|FG001|Overall Study|Adverse Event|1
7037109|NCT01694706|11119294|FG002|Overall Study|Adverse Event|0
7037110|NCT01694706|11119292|FG000|Overall Study|other reason not defined above|1
7143808|NCT03043560|11301183|FG000|Overall Study|Lost to Follow-up|0
7143809|NCT03043560|11301184|FG001|Overall Study|Lost to Follow-up|1
7143810|NCT03043651|11301190|FG000|Overall Study|Death|1
7143811|NCT03043651|11301190|FG000|Overall Study|Progressive Disease|2
7143812|NCT03043651|11301190|FG000|Overall Study|Adverse Event|2
7143813|NCT03043651|11301190|FG000|Overall Study|Withdrawal by Subject|4
7143814|NCT03043651|11301190|FG000|Overall Study|Study Terminated by Sponsor|39
7143815|NCT03044106|11301225|FG000|Washout (1 Week)|Withdrawal by Subject|0
7143816|NCT03044106|11301226|FG001|Washout (1 Week)|Withdrawal by Subject|2
7143817|NCT03044197|11301241|FG000|Overall Study|Withdrawal by Subject|3
7143818|NCT03044197|11301242|FG001|Overall Study|Withdrawal by Subject|1
7143819|NCT03044249|11301250|FG000|Overall Study|Adverse Event|4
7143820|NCT03044249|11301251|FG001|Overall Study|Adverse Event|9
7143821|NCT03044249|11301250|FG000|Overall Study|Lost to Follow-up|1
7143822|NCT03044249|11301251|FG001|Overall Study|Lost to Follow-up|0
7143823|NCT03044249|11301250|FG000|Overall Study|Non-compliance with Study Drug|1
7143824|NCT03044249|11301251|FG001|Overall Study|Non-compliance with Study Drug|0
7143825|NCT03044249|11301250|FG000|Overall Study|Study Terminated by Sponsor|2
7143826|NCT03044249|11301251|FG001|Overall Study|Study Terminated by Sponsor|0
7143827|NCT03044249|11301250|FG000|Overall Study|Withdrawal by Subject|2
7143828|NCT03044249|11301251|FG001|Overall Study|Withdrawal by Subject|5
7143829|NCT03044353|11301265|FG000|Overall Study|Adverse Event|0
7143830|NCT03044353|11301266|FG001|Overall Study|Adverse Event|1
7143831|NCT03044353|11301267|FG002|Overall Study|Adverse Event|0
7143832|NCT03044431|11301278|FG000|Overall Study|Lost to Follow-up|59
7143833|NCT03044574|11301284|FG000|Overall Study|Lost to Follow-up|37
7143834|NCT03044574|11301285|FG001|Overall Study|Lost to Follow-up|45
7143835|NCT03044730|11301300|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1
7143836|NCT03044730|11301300|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1
7143837|NCT03044730|11301300|FG000|3 Cycles of Pembro + Capecitab|Death|1
7143838|NCT03044730|11301300|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1
7143839|NCT03044730|11301300|FG000|Cycles 4 and Beyond|Progressive Disease|9
7143840|NCT03044730|11301300|FG000|Cycles 4 and Beyond|Adverse Event|1
7143841|NCT03044730|11301300|FG000|On Follow-up for 2 Years|Still in follow-up|7
7143842|NCT03044730|11301300|FG000|On Follow-up for 2 Years|Lost to Follow-up|1
7143843|NCT03044730|11301300|FG000|On Follow-up for 2 Years|Death|17
7143844|NCT03044886|11301308|FG000|Overall Study|Lost to Follow-up|15
7143845|NCT03044886|11301309|FG001|Overall Study|Lost to Follow-up|10
7143846|NCT03044886|11301310|FG002|Overall Study|Lost to Follow-up|12
7143847|NCT03045081|11301320|FG000|Overall Study|Withdrawal by Subject|6
7143848|NCT03045081|11301321|FG001|Overall Study|Withdrawal by Subject|11
7143849|NCT03045302|11301327|FG000|Overall Study|Pre-treatment adverse event|1
7143850|NCT03045328|11301331|FG000|Overall Study|Withdrawal by Subject|2
7143851|NCT03045887|11301369|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3
7143852|NCT03045887|11301370|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
7143853|NCT03045887|11301371|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
7143854|NCT03045887|11301372|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
7143855|NCT03045887|11301373|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
7143856|NCT03045887|11301374|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
7143857|NCT03045887|11301375|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
7143858|NCT03045887|11301376|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
7143859|NCT03045887|11301377|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
7143860|NCT03045887|11301378|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
7143861|NCT03045887|11301369|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
7143862|NCT03045887|11301370|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
7143863|NCT03045887|11301371|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
7143864|NCT03045887|11301372|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1
7143865|NCT03045887|11301373|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
7143866|NCT03045887|11301374|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
7037111|NCT01694706|11119293|FG001|Overall Study|other reason not defined above|0
7143867|NCT03045887|11301375|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
7143868|NCT03045887|11301376|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
7143869|NCT03045887|11301377|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
7143870|NCT03045887|11301378|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
7143871|NCT03045887|11301369|FG000|Part A, Period 2 (1 Day)|Adverse Event|1
7143872|NCT03045887|11301370|FG001|Part A, Period 2 (1 Day)|Adverse Event|0
7143873|NCT03045887|11301371|FG002|Part A, Period 2 (1 Day)|Adverse Event|0
7143874|NCT03045887|11301372|FG003|Part A, Period 2 (1 Day)|Adverse Event|0
7143875|NCT03045887|11301373|FG004|Part A, Period 2 (1 Day)|Adverse Event|0
7143876|NCT03045887|11301374|FG005|Part A, Period 2 (1 Day)|Adverse Event|0
7143877|NCT03045887|11301375|FG006|Part A, Period 2 (1 Day)|Adverse Event|0
7037112|NCT01694706|11119294|FG002|Overall Study|other reason not defined above|0
7037113|NCT01694771|11119305|FG000|Overall Study|Adverse Event|18
7037114|NCT01694771|11119306|FG001|Overall Study|Adverse Event|16
7037115|NCT01694771|11119305|FG000|Overall Study|Lack of Efficacy|1
7037116|NCT01694771|11119306|FG001|Overall Study|Lack of Efficacy|0
7037117|NCT01694771|11119305|FG000|Overall Study|Non compliance protocol|7
7037118|NCT01694771|11119306|FG001|Overall Study|Non compliance protocol|6
7037119|NCT01694771|11119305|FG000|Overall Study|Lost to Follow-up|2
7037120|NCT01694771|11119306|FG001|Overall Study|Lost to Follow-up|3
7143878|NCT03045887|11301376|FG007|Part A, Period 2 (1 Day)|Adverse Event|0
7143879|NCT03045887|11301377|FG008|Part A, Period 2 (1 Day)|Adverse Event|0
7143880|NCT03045887|11301378|FG009|Part A, Period 2 (1 Day)|Adverse Event|0
7143881|NCT03045887|11301369|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
7143882|NCT03045887|11301370|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
7143883|NCT03045887|11301371|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1
7143884|NCT03045887|11301372|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1
7143885|NCT03045887|11301373|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
7143886|NCT03045887|11301374|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
7143887|NCT03045887|11301375|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
7143888|NCT03045887|11301376|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
7143889|NCT03045887|11301377|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
7143890|NCT03045887|11301378|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
7143891|NCT03045887|11301369|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
7143892|NCT03045887|11301370|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
7143893|NCT03045887|11301371|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
7143894|NCT03045887|11301372|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1
7143895|NCT03045887|11301373|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
7143896|NCT03045887|11301374|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
7143897|NCT03045887|11301375|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
7143898|NCT03045887|11301376|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
7143899|NCT03045887|11301377|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
7143900|NCT03045887|11301378|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
7143901|NCT03046056|11301412|FG000|Overall Study|Non-responder at Week 10|6
7143902|NCT03046056|11301413|FG001|Overall Study|Non-responder at Week 10|6
7143903|NCT03046056|11301414|FG002|Overall Study|Non-responder at Week 10|4
7143904|NCT03046056|11301412|FG000|Overall Study|Protocol-specified Disease Worsening|3
7143905|NCT03046056|11301413|FG001|Overall Study|Protocol-specified Disease Worsening|3
7143906|NCT03046056|11301414|FG002|Overall Study|Protocol-specified Disease Worsening|1
7143907|NCT03046056|11301412|FG000|Overall Study|Adverse Event|1
7143908|NCT03046056|11301413|FG001|Overall Study|Adverse Event|5
7143909|NCT03046056|11301414|FG002|Overall Study|Adverse Event|0
7143910|NCT03046056|11301412|FG000|Overall Study|Non-compliance With Study Drug|0
7143911|NCT03046056|11301413|FG001|Overall Study|Non-compliance With Study Drug|0
7143912|NCT03046056|11301414|FG002|Overall Study|Non-compliance With Study Drug|2
7143913|NCT03046056|11301412|FG000|Overall Study|Protocol Violation|1
7143914|NCT03046056|11301413|FG001|Overall Study|Protocol Violation|1
7143915|NCT03046056|11301414|FG002|Overall Study|Protocol Violation|0
7143916|NCT03046056|11301412|FG000|Overall Study|Investigator's Discretion|0
7143917|NCT03046056|11301413|FG001|Overall Study|Investigator's Discretion|1
7143918|NCT03046056|11301414|FG002|Overall Study|Investigator's Discretion|0
7143919|NCT03046056|11301412|FG000|Overall Study|Withdrew Consent|1
7143920|NCT03046056|11301413|FG001|Overall Study|Withdrew Consent|0
7143921|NCT03046056|11301414|FG002|Overall Study|Withdrew Consent|0
7143922|NCT03046446|11301440|FG000|Overall Study|Lack of Efficacy|7
7143923|NCT03046446|11301440|FG000|Overall Study|Adverse Event|6
7143924|NCT03046446|11301440|FG000|Overall Study|Lost to Follow-up|3
7143925|NCT03046446|11301440|FG000|Overall Study|Withdrawal by Subject|14
7143926|NCT03046446|11301440|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3
7143927|NCT03046446|11301440|FG000|Overall Study|Disease Progression (see caveats)|25
7143928|NCT03046446|11301440|FG000|Overall Study|Non OA related knee surgery|1
7143929|NCT03047551|11301503|FG000|Overall Study|Did not receive TAS|1
7143930|NCT03047551|11301504|FG001|Overall Study|Did not receive TAS|0
7143931|NCT03047551|11301503|FG000|Overall Study|Physician Decision|1
7143932|NCT03047551|11301504|FG001|Overall Study|Physician Decision|0
7143933|NCT03047551|11301503|FG000|Overall Study|Withdrawal by Subject|0
7143934|NCT03047551|11301504|FG001|Overall Study|Withdrawal by Subject|1
7143935|NCT03047551|11301503|FG000|Overall Study|Probe malfunction|0
7143936|NCT03047551|11301504|FG001|Overall Study|Probe malfunction|1
7143937|NCT03047551|11301503|FG000|Overall Study|Ineligible|0
7143938|NCT03047551|11301504|FG001|Overall Study|Ineligible|1
7143939|NCT03047720|11301512|FG000|First Intervention (6weeks)|Participant data entry insufficient|7
7037121|NCT01694771|11119305|FG000|Overall Study|Consent withdrawn|7
7037122|NCT01694771|11119306|FG001|Overall Study|Consent withdrawn|9
7143940|NCT03047720|11301513|FG001|First Intervention (6weeks)|Participant data entry insufficient|0
7143941|NCT03047980|11301519|FG000|Overall Study|Adverse Event|1
7143942|NCT03048058|11301529|FG000|Overall Study|Lost to Follow-up|4
7143943|NCT03048058|11301530|FG001|Overall Study|Lost to Follow-up|0
7037123|NCT01694771|11119305|FG000|Overall Study|Other reasons|5
7037124|NCT01694771|11119306|FG001|Overall Study|Other reasons|6
7037125|NCT01695135|11119337|FG000|Double-blind Treatment Phase|Progressive disease|50
7037126|NCT01695135|11119338|FG001|Double-blind Treatment Phase|Progressive disease|110
7037127|NCT01695135|11119339|FG002|Double-blind Treatment Phase|Progressive disease|0
7143944|NCT03048058|11301529|FG000|Overall Study|Withdrawal by Subject|0
7143945|NCT03048058|11301530|FG001|Overall Study|Withdrawal by Subject|4
7143946|NCT03048500|11301549|FG000|2 Cycles of Treatment|Withdrawal by Subject|1
7143947|NCT03048500|11301549|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4
7143948|NCT03048500|11301549|FG000|Reached 1st Response/Continued Treatment|Death|1
7143949|NCT03048500|11301549|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1
7143950|NCT03048500|11301549|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1
7143951|NCT03048500|11301549|FG000|Follow up for 3 Years|Currently in Follow-up|4
7143952|NCT03048500|11301549|FG000|Follow up for 3 Years|Death|12
7143953|NCT03048747|11301553|FG000|Overall Study|Adverse Event|2
7037128|NCT01695135|11119340|FG003|Double-blind Treatment Phase|Progressive disease|0
7037129|NCT01695135|11119337|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6
7037130|NCT01695135|11119338|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14
7037131|NCT01695135|11119339|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0
7037132|NCT01695135|11119340|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0
7037133|NCT01695135|11119337|FG000|Double-blind Treatment Phase|Adverse Event|7
7037134|NCT01695135|11119338|FG001|Double-blind Treatment Phase|Adverse Event|7
7037135|NCT01695135|11119339|FG002|Double-blind Treatment Phase|Adverse Event|0
7037136|NCT01695135|11119340|FG003|Double-blind Treatment Phase|Adverse Event|0
7037137|NCT01695135|11119337|FG000|Double-blind Treatment Phase|Other|1
7037138|NCT01695135|11119338|FG001|Double-blind Treatment Phase|Other|3
7037139|NCT01695135|11119339|FG002|Double-blind Treatment Phase|Other|0
7037140|NCT01695135|11119340|FG003|Double-blind Treatment Phase|Other|0
7037141|NCT01695135|11119337|FG000|Double-blind Treatment Phase|Physician Decision|6
7037142|NCT01695135|11119338|FG001|Double-blind Treatment Phase|Physician Decision|3
7037143|NCT01695135|11119339|FG002|Double-blind Treatment Phase|Physician Decision|0
7037144|NCT01695135|11119340|FG003|Double-blind Treatment Phase|Physician Decision|0
7037145|NCT01695135|11119337|FG000|Double-blind Treatment Phase|Death|1
7037146|NCT01695135|11119338|FG001|Double-blind Treatment Phase|Death|1
7037147|NCT01695135|11119339|FG002|Double-blind Treatment Phase|Death|0
7037148|NCT01695135|11119340|FG003|Double-blind Treatment Phase|Death|0
7037149|NCT01695135|11119337|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0
7037150|NCT01695135|11119338|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1
7037151|NCT01695135|11119339|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0
7037152|NCT01695135|11119340|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0
7037153|NCT01695135|11119337|FG000|Open Label Extension Treatment Phase|Progressive disease|0
7037154|NCT01695135|11119338|FG001|Open Label Extension Treatment Phase|Progressive disease|0
7037155|NCT01695135|11119339|FG002|Open Label Extension Treatment Phase|Progressive disease|13
7037156|NCT01695135|11119340|FG003|Open Label Extension Treatment Phase|Progressive disease|22
7037157|NCT01695135|11119337|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0
7037158|NCT01695135|11119338|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0
7037159|NCT01695135|11119339|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6
7037160|NCT01695135|11119340|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16
7037161|NCT01695135|11119337|FG000|Open Label Extension Treatment Phase|Adverse Event|0
7037162|NCT01695135|11119338|FG001|Open Label Extension Treatment Phase|Adverse Event|0
7143954|NCT03048747|11301553|FG000|Overall Study|Participant Met Withdrawal Criteria|2
7143955|NCT03048747|11301553|FG000|Overall Study|Physician Decision|1
7143956|NCT03049280|11301567|FG000|Overall Study|Physician Decision|1
7143957|NCT03049488|11301579|FG000|Overall Study|Lost to Follow-up|1
7143958|NCT03049488|11301580|FG001|Overall Study|Lost to Follow-up|1
7143959|NCT03049488|11301581|FG002|Overall Study|Lost to Follow-up|0
7143960|NCT03049488|11301582|FG003|Overall Study|Lost to Follow-up|0
7143961|NCT03049488|11301583|FG004|Overall Study|Lost to Follow-up|0
7143962|NCT03049488|11301584|FG005|Overall Study|Lost to Follow-up|0
7143963|NCT03049488|11301579|FG000|Overall Study|Moved from Area|1
7143964|NCT03049488|11301580|FG001|Overall Study|Moved from Area|0
7143965|NCT03049488|11301581|FG002|Overall Study|Moved from Area|0
7143966|NCT03049488|11301582|FG003|Overall Study|Moved from Area|1
7143967|NCT03049488|11301583|FG004|Overall Study|Moved from Area|1
7143968|NCT03049488|11301584|FG005|Overall Study|Moved from Area|0
7143969|NCT03049488|11301579|FG000|Overall Study|Physician Decision|0
7037163|NCT01695135|11119339|FG002|Open Label Extension Treatment Phase|Adverse Event|11
7037164|NCT01695135|11119340|FG003|Open Label Extension Treatment Phase|Adverse Event|16
7143970|NCT03049488|11301580|FG001|Overall Study|Physician Decision|1
7143971|NCT03049488|11301581|FG002|Overall Study|Physician Decision|0
7143972|NCT03049488|11301582|FG003|Overall Study|Physician Decision|0
7143973|NCT03049488|11301583|FG004|Overall Study|Physician Decision|0
7037165|NCT01695135|11119337|FG000|Open Label Extension Treatment Phase|Other|0
7037166|NCT01695135|11119338|FG001|Open Label Extension Treatment Phase|Other|0
7037167|NCT01695135|11119339|FG002|Open Label Extension Treatment Phase|Other|4
7037168|NCT01695135|11119340|FG003|Open Label Extension Treatment Phase|Other|7
7037169|NCT01695135|11119337|FG000|Open Label Extension Treatment Phase|Physician Decision|0
7143974|NCT03049488|11301584|FG005|Overall Study|Physician Decision|0
7037170|NCT01695135|11119338|FG001|Open Label Extension Treatment Phase|Physician Decision|0
7037171|NCT01695135|11119339|FG002|Open Label Extension Treatment Phase|Physician Decision|4
7037172|NCT01695135|11119340|FG003|Open Label Extension Treatment Phase|Physician Decision|1
7037173|NCT01695135|11119337|FG000|Open Label Extension Treatment Phase|Death|0
7037174|NCT01695135|11119338|FG001|Open Label Extension Treatment Phase|Death|0
7037175|NCT01695135|11119339|FG002|Open Label Extension Treatment Phase|Death|2
7037176|NCT01695135|11119340|FG003|Open Label Extension Treatment Phase|Death|7
7037177|NCT01695135|11119337|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0
7037178|NCT01695135|11119338|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0
7037179|NCT01695135|11119339|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0
7037180|NCT01695135|11119340|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1
7037181|NCT01695239|11119352|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1
7037182|NCT01695239|11119353|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1
7037183|NCT01695239|11119354|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3
7037184|NCT01695239|11119355|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4
7037185|NCT01695239|11119356|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7037186|NCT01695239|11119357|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7037187|NCT01695239|11119358|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7037188|NCT01695239|11119359|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7037189|NCT01695239|11119360|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7037190|NCT01695239|11119361|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7037191|NCT01695239|11119362|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7037192|NCT01695239|11119363|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7037193|NCT01695239|11119364|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7143975|NCT03049488|11301579|FG000|Overall Study|Withdrawal by Subject|0
7143976|NCT03049488|11301580|FG001|Overall Study|Withdrawal by Subject|0
7143977|NCT03049488|11301581|FG002|Overall Study|Withdrawal by Subject|0
7143978|NCT03049488|11301582|FG003|Overall Study|Withdrawal by Subject|1
7143979|NCT03049488|11301583|FG004|Overall Study|Withdrawal by Subject|1
7143980|NCT03049488|11301584|FG005|Overall Study|Withdrawal by Subject|0
7143981|NCT03049748|11301610|FG000|Overall Study|Lost to Follow-up|1
7143982|NCT03049748|11301611|FG001|Overall Study|Lost to Follow-up|0
7143983|NCT03049748|11301610|FG000|Overall Study|Death|3
7143984|NCT03049748|11301611|FG001|Overall Study|Death|0
7143985|NCT03049748|11301610|FG000|Overall Study|Withdrawal by Subject|0
7143986|NCT03049748|11301611|FG001|Overall Study|Withdrawal by Subject|3
7143987|NCT03049748|11301610|FG000|Overall Study|Protocol Violation|0
7143988|NCT03049748|11301611|FG001|Overall Study|Protocol Violation|2
7143989|NCT03049748|11301610|FG000|Overall Study|Moved out of state (relocation)|0
7143990|NCT03049748|11301611|FG001|Overall Study|Moved out of state (relocation)|1
7143991|NCT03049852|11301620|FG000|Overall Study|Lost to Follow-up|0
7143992|NCT03049852|11301621|FG001|Overall Study|Lost to Follow-up|1
7143993|NCT03049852|11301622|FG002|Overall Study|Lost to Follow-up|0
7143994|NCT03050307|11301707|FG000|Overall Study|Adverse Event|4
7143995|NCT03050307|11301708|FG001|Overall Study|Adverse Event|2
7143996|NCT03050307|11301707|FG000|Overall Study|Significant Protocol Deviation|0
7143997|NCT03050307|11301708|FG001|Overall Study|Significant Protocol Deviation|1
7143998|NCT03050307|11301707|FG000|Overall Study|Lost to Follow-up|0
7143999|NCT03050307|11301708|FG001|Overall Study|Lost to Follow-up|1
7144000|NCT03050307|11301707|FG000|Overall Study|Voluntary Withdrawal|3
7144001|NCT03050307|11301708|FG001|Overall Study|Voluntary Withdrawal|4
7144002|NCT03050307|11301707|FG000|Overall Study|Reason not Specified|1
7144003|NCT03050307|11301708|FG001|Overall Study|Reason not Specified|1
7144004|NCT03050359|11301727|FG000|Overall Study|Randomized But Not Treated|2
7144005|NCT03050359|11301728|FG001|Overall Study|Randomized But Not Treated|0
7144006|NCT03050359|11301727|FG000|Overall Study|Pretreatment Event/Adverse Event|5
7144007|NCT03050359|11301728|FG001|Overall Study|Pretreatment Event/Adverse Event|10
7144008|NCT03050359|11301727|FG000|Overall Study|Significant Protocol Deviation|2
7144009|NCT03050359|11301728|FG001|Overall Study|Significant Protocol Deviation|3
7144010|NCT03050359|11301727|FG000|Overall Study|Lost to Follow-up|2
7144011|NCT03050359|11301728|FG001|Overall Study|Lost to Follow-up|1
7144012|NCT03050359|11301727|FG000|Overall Study|Voluntary Withdrawal|4
7144013|NCT03050359|11301728|FG001|Overall Study|Voluntary Withdrawal|6
7144014|NCT03050359|11301727|FG000|Overall Study|Pregnancy|1
7144015|NCT03050359|11301728|FG001|Overall Study|Pregnancy|0
7144016|NCT03050359|11301727|FG000|Overall Study|Reason Not Specified|1
7144017|NCT03050359|11301728|FG001|Overall Study|Reason Not Specified|0
7144018|NCT03050372|11301736|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1
7144019|NCT03050372|11301737|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0
7037194|NCT01695239|11119365|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7037195|NCT01695239|11119352|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2
7144020|NCT03050372|11301736|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0
7144021|NCT03050372|11301737|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1
7144022|NCT03050450|11301747|FG000|Overall Study|Physician Decision|1
7144023|NCT03050450|11301748|FG001|Overall Study|Physician Decision|0
7144024|NCT03050450|11301749|FG002|Overall Study|Physician Decision|0
7144025|NCT03050450|11301750|FG003|Overall Study|Physician Decision|0
7144026|NCT03050450|11301751|FG004|Overall Study|Physician Decision|0
7144027|NCT03050801|11301832|FG000|Experiment 1|Lost to Follow-up|0
7144028|NCT03050801|11301833|FG001|Experiment 1|Lost to Follow-up|1
7144029|NCT03050801|11301834|FG002|Experiment 1|Lost to Follow-up|0
7144030|NCT03050801|11301835|FG003|Experiment 1|Lost to Follow-up|0
7144031|NCT03050801|11301836|FG004|Experiment 1|Lost to Follow-up|0
7144032|NCT03050801|11301837|FG005|Experiment 1|Lost to Follow-up|0
7144033|NCT03050801|11301832|FG000|Experiment 1|Physician Decision|0
7144034|NCT03050801|11301833|FG001|Experiment 1|Physician Decision|3
7144035|NCT03050801|11301834|FG002|Experiment 1|Physician Decision|0
7144036|NCT03050801|11301835|FG003|Experiment 1|Physician Decision|0
7144037|NCT03050801|11301836|FG004|Experiment 1|Physician Decision|0
7144038|NCT03050801|11301837|FG005|Experiment 1|Physician Decision|0
7144039|NCT03050801|11301832|FG000|Experiment 1|Change of experimental design|0
7144040|NCT03050801|11301833|FG001|Experiment 1|Change of experimental design|3
7144041|NCT03050801|11301834|FG002|Experiment 1|Change of experimental design|0
7144042|NCT03050801|11301835|FG003|Experiment 1|Change of experimental design|0
7144043|NCT03050801|11301836|FG004|Experiment 1|Change of experimental design|0
7144044|NCT03050801|11301837|FG005|Experiment 1|Change of experimental design|0
7144045|NCT03050801|11301832|FG000|Experiment 1|Unable to obtain critical rTMS measure|0
7144046|NCT03050801|11301833|FG001|Experiment 1|Unable to obtain critical rTMS measure|0
7144047|NCT03050801|11301834|FG002|Experiment 1|Unable to obtain critical rTMS measure|2
7144048|NCT03050801|11301835|FG003|Experiment 1|Unable to obtain critical rTMS measure|0
7144049|NCT03050801|11301836|FG004|Experiment 1|Unable to obtain critical rTMS measure|0
7144050|NCT03050801|11301837|FG005|Experiment 1|Unable to obtain critical rTMS measure|0
7144051|NCT03050801|11301832|FG000|Experiment 2|Lost to Follow-up|0
7144052|NCT03050801|11301833|FG001|Experiment 2|Lost to Follow-up|0
7144053|NCT03050801|11301834|FG002|Experiment 2|Lost to Follow-up|0
7144054|NCT03050801|11301835|FG003|Experiment 2|Lost to Follow-up|1
7144055|NCT03050801|11301836|FG004|Experiment 2|Lost to Follow-up|1
7144056|NCT03050801|11301837|FG005|Experiment 2|Lost to Follow-up|0
7144057|NCT03050801|11301832|FG000|Experiment 2|Physician Decision|0
7144058|NCT03050801|11301833|FG001|Experiment 2|Physician Decision|0
7144059|NCT03050801|11301834|FG002|Experiment 2|Physician Decision|0
7144060|NCT03050801|11301835|FG003|Experiment 2|Physician Decision|0
7144061|NCT03050801|11301836|FG004|Experiment 2|Physician Decision|1
7144062|NCT03050801|11301837|FG005|Experiment 2|Physician Decision|0
7144063|NCT03050801|11301832|FG000|Experiment 2|Pregnancy|0
7144064|NCT03050801|11301833|FG001|Experiment 2|Pregnancy|0
7144065|NCT03050801|11301834|FG002|Experiment 2|Pregnancy|0
7144066|NCT03050801|11301835|FG003|Experiment 2|Pregnancy|0
7144067|NCT03050801|11301836|FG004|Experiment 2|Pregnancy|1
7144068|NCT03050801|11301837|FG005|Experiment 2|Pregnancy|0
7144069|NCT03050801|11301832|FG000|Experiment 2|Withdrawal by Subject|0
7144070|NCT03050801|11301833|FG001|Experiment 2|Withdrawal by Subject|0
7144071|NCT03050801|11301834|FG002|Experiment 2|Withdrawal by Subject|0
7144072|NCT03050801|11301835|FG003|Experiment 2|Withdrawal by Subject|1
7144073|NCT03050801|11301836|FG004|Experiment 2|Withdrawal by Subject|0
7144074|NCT03050801|11301837|FG005|Experiment 2|Withdrawal by Subject|0
7144075|NCT03050801|11301832|FG000|Experiment 2|Poor data quality|0
7144076|NCT03050801|11301833|FG001|Experiment 2|Poor data quality|0
7144077|NCT03050801|11301834|FG002|Experiment 2|Poor data quality|0
7144078|NCT03050801|11301835|FG003|Experiment 2|Poor data quality|4
7144079|NCT03050801|11301836|FG004|Experiment 2|Poor data quality|1
7144080|NCT03050801|11301837|FG005|Experiment 2|Poor data quality|0
7144081|NCT03050801|11301832|FG000|Experiment 2|Discomfort during stimulation|0
7144082|NCT03050801|11301833|FG001|Experiment 2|Discomfort during stimulation|0
7144083|NCT03050801|11301834|FG002|Experiment 2|Discomfort during stimulation|0
7144084|NCT03050801|11301835|FG003|Experiment 2|Discomfort during stimulation|0
7144085|NCT03050801|11301836|FG004|Experiment 2|Discomfort during stimulation|0
7144086|NCT03050801|11301837|FG005|Experiment 2|Discomfort during stimulation|2
7144087|NCT03051100|11301865|FG000|Overall Study|Withdrawal by Subject|1
7144088|NCT03051100|11301866|FG001|Overall Study|Withdrawal by Subject|0
7144089|NCT03051165|11301872|FG000|Overall Study|Withdrawal by Subject|1
7144090|NCT03051165|11301872|FG000|Overall Study|Early termination of study|12
7144091|NCT03051607|11301890|FG000|Overall Study|Adverse Event|66
7183619|NCT01488890|11383707|FG002|Overall Study|Withdrawal by Subject|11
7183620|NCT01488890|11383708|FG003|Overall Study|Withdrawal by Subject|2
7183621|NCT01436396|11383724|FG000|Overall Study|Protocol Violation|7
7183622|NCT01436396|11383725|FG001|Overall Study|Protocol Violation|5
7183623|NCT01436396|11383724|FG000|Overall Study|Adverse Event|1
7183624|NCT01436396|11383725|FG001|Overall Study|Adverse Event|2
7183625|NCT01436396|11383724|FG000|Overall Study|Withdrawal by Subject|19
7183626|NCT01436396|11383725|FG001|Overall Study|Withdrawal by Subject|29
7183627|NCT01436396|11383724|FG000|Overall Study|Serious adverse event|2
7183628|NCT01436396|11383725|FG001|Overall Study|Serious adverse event|3
7183629|NCT01436396|11383724|FG000|Overall Study|Lost to Follow-up|3
7183630|NCT01436396|11383725|FG001|Overall Study|Lost to Follow-up|3
7183631|NCT01411241|11383733|FG000|Overall Study|Protocol Violation|0
7183632|NCT01411241|11383734|FG001|Overall Study|Protocol Violation|5
7183633|NCT01411241|11383733|FG000|Overall Study|Withdrawal by Subject|9
7183634|NCT01411241|11383734|FG001|Overall Study|Withdrawal by Subject|10
7144092|NCT03051620|11301894|FG000|Overall Study|Lost to Follow-up|6
7144093|NCT03051620|11301894|FG000|Overall Study|n=124 enrolled in extension (all completed)|12
7144094|NCT03052322|11301934|FG000|Overall Study|Other un-specified|1
7144095|NCT03052322|11301935|FG001|Overall Study|Other un-specified|2
7144096|NCT03052322|11301934|FG000|Overall Study|Withdrawal by Subject|10
7144097|NCT03052322|11301935|FG001|Overall Study|Withdrawal by Subject|9
7144098|NCT03052322|11301934|FG000|Overall Study|Death|0
7144099|NCT03052322|11301935|FG001|Overall Study|Death|2
7144100|NCT03052322|11301934|FG000|Overall Study|Lack of Efficacy|1
7144101|NCT03052322|11301935|FG001|Overall Study|Lack of Efficacy|2
7144102|NCT03052322|11301934|FG000|Overall Study|Protocol Violation|1
7144103|NCT03052322|11301935|FG001|Overall Study|Protocol Violation|0
7144104|NCT03052322|11301934|FG000|Overall Study|Lost to Follow-up|2
7144105|NCT03052322|11301935|FG001|Overall Study|Lost to Follow-up|4
7144106|NCT03052322|11301934|FG000|Overall Study|Adverse Event|6
7144107|NCT03052322|11301935|FG001|Overall Study|Adverse Event|13
7144108|NCT03052426|11301944|FG000|Overall Study|Withdrawal by Subject|0
7144109|NCT03052426|11301945|FG001|Overall Study|Withdrawal by Subject|1
7144110|NCT03052426|11301946|FG002|Overall Study|Withdrawal by Subject|0
7144111|NCT03052426|11301944|FG000|Overall Study|Lost to Follow-up|2
7144112|NCT03052426|11301945|FG001|Overall Study|Lost to Follow-up|0
7144113|NCT03052426|11301946|FG002|Overall Study|Lost to Follow-up|1
7144114|NCT03052517|11301962|FG000|Overall Study|Study Terminated By Sponsor|928
7144115|NCT03052517|11301963|FG001|Overall Study|Study Terminated By Sponsor|938
7144116|NCT03052517|11301964|FG002|Overall Study|Study Terminated By Sponsor|296
7144117|NCT03052517|11301962|FG000|Overall Study|Subject/Guardian Decision|50
7144118|NCT03052517|11301963|FG001|Overall Study|Subject/Guardian Decision|45
7144119|NCT03052517|11301964|FG002|Overall Study|Subject/Guardian Decision|22
7144120|NCT03052517|11301962|FG000|Overall Study|Lack of Efficacy|23
7037196|NCT01695239|11119353|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2
7037197|NCT01695239|11119354|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2
7037198|NCT01695239|11119355|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3
7037199|NCT01695239|11119356|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0
7037200|NCT01695239|11119357|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0
7037201|NCT01695239|11119358|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0
7037202|NCT01695239|11119359|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0
7037203|NCT01695239|11119360|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0
7037204|NCT01695239|11119361|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0
7037205|NCT01695239|11119362|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0
7037206|NCT01695239|11119363|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0
7037207|NCT01695239|11119364|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0
7037208|NCT01695239|11119365|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0
7037209|NCT01695239|11119352|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4
7037210|NCT01695239|11119353|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7037211|NCT01695239|11119354|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2
7037212|NCT01695239|11119355|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7144121|NCT03052517|11301963|FG001|Overall Study|Lack of Efficacy|14
7144122|NCT03052517|11301964|FG002|Overall Study|Lack of Efficacy|7
7144123|NCT03052517|11301962|FG000|Overall Study|Adverse Event|6
7144124|NCT03052517|11301963|FG001|Overall Study|Adverse Event|5
7144125|NCT03052517|11301964|FG002|Overall Study|Adverse Event|0
7144126|NCT03052517|11301962|FG000|Overall Study|Physician Decision|4
7144127|NCT03052517|11301963|FG001|Overall Study|Physician Decision|5
7144128|NCT03052517|11301964|FG002|Overall Study|Physician Decision|1
7144129|NCT03052517|11301962|FG000|Overall Study|Death|3
7144130|NCT03052517|11301963|FG001|Overall Study|Death|0
7144131|NCT03052517|11301964|FG002|Overall Study|Death|1
7144132|NCT03052517|11301962|FG000|Overall Study|Lost to Follow-up|2
7144133|NCT03052517|11301963|FG001|Overall Study|Lost to Follow-up|4
7144134|NCT03052517|11301964|FG002|Overall Study|Lost to Follow-up|0
7144135|NCT03052517|11301962|FG000|Overall Study|Pregnancy|1
7144136|NCT03052517|11301963|FG001|Overall Study|Pregnancy|0
7144137|NCT03052517|11301964|FG002|Overall Study|Pregnancy|1
7144138|NCT03052517|11301962|FG000|Overall Study|Non-Compliance With Study Treatment|0
7144139|NCT03052517|11301963|FG001|Overall Study|Non-Compliance With Study Treatment|2
7144140|NCT03052517|11301964|FG002|Overall Study|Non-Compliance With Study Treatment|0
7144141|NCT03052517|11301962|FG000|Overall Study|Technical Problems|0
7144142|NCT03052517|11301963|FG001|Overall Study|Technical Problems|1
7144143|NCT03052517|11301964|FG002|Overall Study|Technical Problems|0
7144144|NCT03052725|11301978|FG000|Overall Study|Adverse Event|2
7144145|NCT03052725|11301979|FG001|Overall Study|Adverse Event|0
7144146|NCT03052725|11301978|FG000|Overall Study|Withdrawal by Subject|3
7144147|NCT03052725|11301979|FG001|Overall Study|Withdrawal by Subject|4
7037213|NCT01695239|11119356|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7144148|NCT03052725|11301978|FG000|Overall Study|Pregnancy|0
7144149|NCT03052725|11301979|FG001|Overall Study|Pregnancy|1
7144150|NCT03052725|11301978|FG000|Overall Study|Site closure|0
7144151|NCT03052725|11301979|FG001|Overall Study|Site closure|1
7144152|NCT03052725|11301978|FG000|Overall Study|Study terminated by sponsor|143
7144153|NCT03052725|11301979|FG001|Overall Study|Study terminated by sponsor|144
7144154|NCT03052751|11301986|FG000|Dosing Period 1|Adverse Event|0
7144155|NCT03052751|11301987|FG001|Dosing Period 1|Adverse Event|1
7144156|NCT03052751|11301988|FG002|Dosing Period 1|Adverse Event|0
7144157|NCT03052751|11301989|FG003|Dosing Period 1|Adverse Event|0
7144158|NCT03052751|11301990|FG004|Dosing Period 1|Adverse Event|0
7144159|NCT03052751|11301991|FG005|Dosing Period 1|Adverse Event|0
7144160|NCT03052751|11301986|FG000|Dosing Period 2|Adverse Event|0
7144161|NCT03052751|11301987|FG001|Dosing Period 2|Adverse Event|0
7144162|NCT03052751|11301988|FG002|Dosing Period 2|Adverse Event|3
7144163|NCT03052751|11301989|FG003|Dosing Period 2|Adverse Event|0
7144164|NCT03052751|11301990|FG004|Dosing Period 2|Adverse Event|0
7144165|NCT03052751|11301991|FG005|Dosing Period 2|Adverse Event|0
7144166|NCT03052751|11301986|FG000|Observation Period|Adverse Event|0
7144167|NCT03052751|11301987|FG001|Observation Period|Adverse Event|0
7144168|NCT03052751|11301988|FG002|Observation Period|Adverse Event|0
7144169|NCT03052751|11301989|FG003|Observation Period|Adverse Event|0
7144170|NCT03052751|11301990|FG004|Observation Period|Adverse Event|1
7144171|NCT03052751|11301991|FG005|Observation Period|Adverse Event|0
7144172|NCT03052764|11302003|FG000|Double-Blind Treatment Period|Adverse Event|2
7144173|NCT03052764|11302004|FG001|Double-Blind Treatment Period|Adverse Event|0
7144174|NCT03052764|11302003|FG000|Double-Blind Treatment Period|Lack of Efficacy|1
6827161|NCT00123422|10829758|FG001|Overall Study|Lost to Follow-up|2
6827162|NCT00123422|10829759|FG002|Overall Study|Lost to Follow-up|2
6827163|NCT00123474|10829771|FG000|Randomized to Treatment|Randomized, never treated|1
6827164|NCT00123474|10829772|FG001|Randomized to Treatment|Randomized, never treated|4
6827165|NCT00123474|10829773|FG002|Randomized to Treatment|Randomized, never treated|2
6827166|NCT00123474|10829774|FG003|Randomized to Treatment|Randomized, never treated|1
6827167|NCT00123474|10829771|FG000|As Treated at Study Closure|not reported when site closed|1
6827168|NCT00123474|10829772|FG001|As Treated at Study Closure|not reported when site closed|0
6827169|NCT00123474|10829773|FG002|As Treated at Study Closure|not reported when site closed|1
6827170|NCT00123474|10829774|FG003|As Treated at Study Closure|not reported when site closed|0
6827171|NCT00123474|10829771|FG000|As Treated at Study Closure|Adverse Event|10
6827172|NCT00123474|10829772|FG001|As Treated at Study Closure|Adverse Event|4
6827173|NCT00123474|10829773|FG002|As Treated at Study Closure|Adverse Event|10
6827174|NCT00123474|10829774|FG003|As Treated at Study Closure|Adverse Event|8
6827175|NCT00123474|10829771|FG000|As Treated at Study Closure|Disease Progression|35
6827176|NCT00123474|10829772|FG001|As Treated at Study Closure|Disease Progression|42
6827177|NCT00123474|10829773|FG002|As Treated at Study Closure|Disease Progression|29
6827178|NCT00123474|10829774|FG003|As Treated at Study Closure|Disease Progression|27
6827179|NCT00123474|10829771|FG000|As Treated at Study Closure|Investigator Request|12
6827180|NCT00123474|10829772|FG001|As Treated at Study Closure|Investigator Request|6
6827181|NCT00123474|10829773|FG002|As Treated at Study Closure|Investigator Request|7
6827182|NCT00123474|10829774|FG003|As Treated at Study Closure|Investigator Request|5
6827183|NCT00123474|10829771|FG000|As Treated at Study Closure|non-specified|54
6827184|NCT00123474|10829772|FG001|As Treated at Study Closure|non-specified|47
6827185|NCT00123474|10829773|FG002|As Treated at Study Closure|non-specified|57
6827186|NCT00123474|10829774|FG003|As Treated at Study Closure|non-specified|60
6827187|NCT00123474|10829771|FG000|As Treated at Study Closure|Study Drug Toxicity|39
6827188|NCT00123474|10829772|FG001|As Treated at Study Closure|Study Drug Toxicity|45
6827189|NCT00123474|10829773|FG002|As Treated at Study Closure|Study Drug Toxicity|45
6827190|NCT00123474|10829774|FG003|As Treated at Study Closure|Study Drug Toxicity|51
6827191|NCT00123474|10829771|FG000|As Treated at Study Closure|Withdrawal by Subject|14
6827192|NCT00123474|10829772|FG001|As Treated at Study Closure|Withdrawal by Subject|19
6827193|NCT00123474|10829773|FG002|As Treated at Study Closure|Withdrawal by Subject|18
6827194|NCT00123474|10829774|FG003|As Treated at Study Closure|Withdrawal by Subject|16
6827195|NCT00123487|10829807|FG000|Randomized|Death prior to starting treatment|0
6827196|NCT00123487|10829808|FG001|Randomized|Death prior to starting treatment|1
6827197|NCT00123487|10829807|FG000|Randomized|SAE prior to starting treatment|1
6827198|NCT00123487|10829808|FG001|Randomized|SAE prior to starting treatment|0
6827199|NCT00123487|10829807|FG000|Treated With Study Drug|Adverse Event|23
6827200|NCT00123487|10829808|FG001|Treated With Study Drug|Adverse Event|22
6827201|NCT00123487|10829807|FG000|Treated With Study Drug|Disease Progression|141
6827202|NCT00123487|10829808|FG001|Treated With Study Drug|Disease Progression|122
6827203|NCT00123487|10829807|FG000|Treated With Study Drug|Physician Decision|8
6827204|NCT00123487|10829808|FG001|Treated With Study Drug|Physician Decision|9
6827205|NCT00123487|10829807|FG000|Treated With Study Drug|Other|59
6827206|NCT00123487|10829808|FG001|Treated With Study Drug|Other|58
6827207|NCT00123487|10829807|FG000|Treated With Study Drug|Study Drug Toxicity|62
6827208|NCT00123487|10829808|FG001|Treated With Study Drug|Study Drug Toxicity|80
6827209|NCT00123487|10829807|FG000|Treated With Study Drug|Withdrawal by Subject|11
6827210|NCT00123487|10829808|FG001|Treated With Study Drug|Withdrawal by Subject|13
6827211|NCT00123487|10829807|FG000|Treated With Study Drug|Unknown (case report form lost)|0
6827212|NCT00123487|10829808|FG001|Treated With Study Drug|Unknown (case report form lost)|1
6827213|NCT00123734|10829863|FG000|Overall Study|Death|3
6827214|NCT00123734|10829863|FG000|Overall Study|Lost to Follow-up|3
6827215|NCT00123734|10829863|FG000|Overall Study|Dropout|1
6827216|NCT00123734|10829863|FG000|Overall Study|Withdrawal by Subject|1
6827217|NCT00123955|10829872|FG000|Overall Study|Adverse Event|1
6827218|NCT00123955|10829873|FG001|Overall Study|Adverse Event|0
7144175|NCT03052764|11302004|FG001|Double-Blind Treatment Period|Lack of Efficacy|0
7144176|NCT03052764|11302003|FG000|Double-Blind Treatment Period|Protocol Violation|2
7144177|NCT03052764|11302004|FG001|Double-Blind Treatment Period|Protocol Violation|1
7144178|NCT03052764|11302003|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3
7144179|NCT03052764|11302004|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1
7144180|NCT03052764|11302003|FG000|Double-Blind Treatment Period|Reason not Specified|2
7144181|NCT03052764|11302004|FG001|Double-Blind Treatment Period|Reason not Specified|1
7144182|NCT03052816|11302014|FG000|Overall Study|Withdrawal by Subject|1
7144183|NCT03052816|11302015|FG001|Overall Study|Withdrawal by Subject|0
7144184|NCT03052816|11302014|FG000|Overall Study|Desired opioids|2
7144185|NCT03052816|11302015|FG001|Overall Study|Desired opioids|0
7144186|NCT03052959|11302025|FG000|Overall Study|Lost to Follow-up|4
7144187|NCT03052959|11302026|FG001|Overall Study|Lost to Follow-up|5
7144188|NCT03053050|11302046|FG000|Randomized Phase|Study Terminated by Sponsor|259
7144189|NCT03053050|11302047|FG001|Randomized Phase|Study Terminated by Sponsor|260
7144190|NCT03053050|11302048|FG002|Randomized Phase|Study Terminated by Sponsor|128
7144191|NCT03053050|11302049|FG003|Randomized Phase|Study Terminated by Sponsor|0
7144192|NCT03053050|11302046|FG000|Randomized Phase|Withdrew Consent|16
7144193|NCT03053050|11302047|FG001|Randomized Phase|Withdrew Consent|8
7144194|NCT03053050|11302048|FG002|Randomized Phase|Withdrew Consent|9
7144195|NCT03053050|11302049|FG003|Randomized Phase|Withdrew Consent|0
7144196|NCT03053050|11302046|FG000|Randomized Phase|Investigator's Discretion|6
7144197|NCT03053050|11302047|FG001|Randomized Phase|Investigator's Discretion|6
7144198|NCT03053050|11302048|FG002|Randomized Phase|Investigator's Discretion|3
7144199|NCT03053050|11302049|FG003|Randomized Phase|Investigator's Discretion|0
7144200|NCT03053050|11302046|FG000|Randomized Phase|Lost to Follow-up|5
7144201|NCT03053050|11302047|FG001|Randomized Phase|Lost to Follow-up|1
7144202|NCT03053050|11302048|FG002|Randomized Phase|Lost to Follow-up|1
7144203|NCT03053050|11302049|FG003|Randomized Phase|Lost to Follow-up|0
7144204|NCT03053050|11302046|FG000|Randomized Phase|Adverse Event|0
7144205|NCT03053050|11302047|FG001|Randomized Phase|Adverse Event|1
7144206|NCT03053050|11302048|FG002|Randomized Phase|Adverse Event|0
7144207|NCT03053050|11302049|FG003|Randomized Phase|Adverse Event|0
7144208|NCT03053050|11302046|FG000|Randomized Phase|Randomized but Never Treated|2
7144209|NCT03053050|11302047|FG001|Randomized Phase|Randomized but Never Treated|2
7144210|NCT03053050|11302048|FG002|Randomized Phase|Randomized but Never Treated|2
7144211|NCT03053050|11302049|FG003|Randomized Phase|Randomized but Never Treated|0
7144212|NCT03053050|11302046|FG000|Randomized Phase|Entered the Open-Label Phase|36
7144213|NCT03053050|11302047|FG001|Randomized Phase|Entered the Open-Label Phase|45
7144214|NCT03053050|11302048|FG002|Randomized Phase|Entered the Open-Label Phase|18
7144215|NCT03053050|11302049|FG003|Randomized Phase|Entered the Open-Label Phase|0
7144216|NCT03053050|11302046|FG000|Open-label Phase|Study Terminated by Sponsor|0
7144217|NCT03053050|11302047|FG001|Open-label Phase|Study Terminated by Sponsor|0
7144218|NCT03053050|11302048|FG002|Open-label Phase|Study Terminated by Sponsor|0
7144219|NCT03053050|11302049|FG003|Open-label Phase|Study Terminated by Sponsor|89
7144220|NCT03053050|11302046|FG000|Open-label Phase|Withdrew Consent|0
7144221|NCT03053050|11302047|FG001|Open-label Phase|Withdrew Consent|0
7144222|NCT03053050|11302048|FG002|Open-label Phase|Withdrew Consent|0
7144223|NCT03053050|11302049|FG003|Open-label Phase|Withdrew Consent|6
7144224|NCT03053050|11302046|FG000|Open-label Phase|Investigator's Discretion|0
7144225|NCT03053050|11302047|FG001|Open-label Phase|Investigator's Discretion|0
7144226|NCT03053050|11302048|FG002|Open-label Phase|Investigator's Discretion|0
7144227|NCT03053050|11302049|FG003|Open-label Phase|Investigator's Discretion|4
7144228|NCT03053063|11302061|FG000|Randomized Phase|Study Terminated by Sponsor|326
7144229|NCT03053063|11302062|FG001|Randomized Phase|Study Terminated by Sponsor|317
7144230|NCT03053063|11302063|FG002|Randomized Phase|Study Terminated by Sponsor|161
7144231|NCT03053063|11302064|FG003|Randomized Phase|Study Terminated by Sponsor|0
7144232|NCT03053063|11302061|FG000|Randomized Phase|Withdrew consent|8
7144233|NCT03053063|11302062|FG001|Randomized Phase|Withdrew consent|11
7144234|NCT03053063|11302063|FG002|Randomized Phase|Withdrew consent|5
7144235|NCT03053063|11302064|FG003|Randomized Phase|Withdrew consent|0
6827219|NCT00123955|10829872|FG000|Overall Study|Withdrawal by Subject|4
6827220|NCT00123955|10829873|FG001|Overall Study|Withdrawal by Subject|3
6827221|NCT00123955|10829872|FG000|Overall Study|Death|0
6827222|NCT00123955|10829873|FG001|Overall Study|Death|1
6827223|NCT00124020|10829881|FG000|Overall Study|Death|67
6827224|NCT00124020|10829882|FG001|Overall Study|Death|71
6827225|NCT00124020|10829881|FG000|Overall Study|Withdrawal by Subject|13
6827226|NCT00124020|10829882|FG001|Overall Study|Withdrawal by Subject|11
6827227|NCT00124020|10829881|FG000|Overall Study|Lost to Follow-up|5
6827228|NCT00124020|10829882|FG001|Overall Study|Lost to Follow-up|8
6827229|NCT00124020|10829881|FG000|Overall Study|Other|1
6827230|NCT00124020|10829882|FG001|Overall Study|Other|1
6827231|NCT00124020|10829881|FG000|Overall Study|Transfer to another hospital|2
6827232|NCT00124020|10829882|FG001|Overall Study|Transfer to another hospital|0
6827233|NCT00124072|10829892|FG000|Overall Study|Lost to Follow-up for Mortality|0
6827234|NCT00124072|10829893|FG001|Overall Study|Lost to Follow-up for Mortality|3
6827235|NCT00124072|10829894|FG002|Overall Study|Lost to Follow-up for Mortality|2
6827236|NCT00124072|10829895|FG003|Overall Study|Lost to Follow-up for Mortality|2
6827237|NCT00124072|10829892|FG000|Overall Study|Lost to Follow-up for Morbidity|15
6827238|NCT00124072|10829893|FG001|Overall Study|Lost to Follow-up for Morbidity|25
6827239|NCT00124072|10829894|FG002|Overall Study|Lost to Follow-up for Morbidity|19
6827240|NCT00124072|10829895|FG003|Overall Study|Lost to Follow-up for Morbidity|18
7144236|NCT03053063|11302061|FG000|Randomized Phase|Investigator's Discretion|8
7144237|NCT03053063|11302062|FG001|Randomized Phase|Investigator's Discretion|6
7144238|NCT03053063|11302063|FG002|Randomized Phase|Investigator's Discretion|2
7144239|NCT03053063|11302064|FG003|Randomized Phase|Investigator's Discretion|0
7144240|NCT03053063|11302061|FG000|Randomized Phase|Lost to Follow-up|3
7144241|NCT03053063|11302062|FG001|Randomized Phase|Lost to Follow-up|5
7144242|NCT03053063|11302063|FG002|Randomized Phase|Lost to Follow-up|1
7144243|NCT03053063|11302064|FG003|Randomized Phase|Lost to Follow-up|0
7144244|NCT03053063|11302061|FG000|Randomized Phase|Adverse Event|0
7144245|NCT03053063|11302062|FG001|Randomized Phase|Adverse Event|1
7144246|NCT03053063|11302063|FG002|Randomized Phase|Adverse Event|0
7144247|NCT03053063|11302064|FG003|Randomized Phase|Adverse Event|0
7144248|NCT03053063|11302061|FG000|Randomized Phase|Randomized but Never Treated|1
7144249|NCT03053063|11302062|FG001|Randomized Phase|Randomized but Never Treated|3
7144250|NCT03053063|11302063|FG002|Randomized Phase|Randomized but Never Treated|2
7144251|NCT03053063|11302064|FG003|Randomized Phase|Randomized but Never Treated|0
7144252|NCT03053063|11302061|FG000|Randomized Phase|Entered the Open-Label Phase|9
7144253|NCT03053063|11302062|FG001|Randomized Phase|Entered the Open-Label Phase|11
7144254|NCT03053063|11302063|FG002|Randomized Phase|Entered the Open-Label Phase|3
7144255|NCT03053063|11302064|FG003|Randomized Phase|Entered the Open-Label Phase|0
7144256|NCT03053063|11302061|FG000|Open-Label Phase|Study Terminated by Sponsor|0
7144257|NCT03053063|11302062|FG001|Open-Label Phase|Study Terminated by Sponsor|0
7144258|NCT03053063|11302063|FG002|Open-Label Phase|Study Terminated by Sponsor|0
7144259|NCT03053063|11302064|FG003|Open-Label Phase|Study Terminated by Sponsor|19
7144260|NCT03053063|11302061|FG000|Open-Label Phase|Death|0
7144261|NCT03053063|11302062|FG001|Open-Label Phase|Death|0
7144262|NCT03053063|11302063|FG002|Open-Label Phase|Death|0
7037214|NCT01695239|11119357|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7037215|NCT01695239|11119358|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7037216|NCT01695239|11119359|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7037217|NCT01695239|11119360|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7037218|NCT01695239|11119361|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7037219|NCT01695239|11119362|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7037220|NCT01695239|11119363|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7037221|NCT01695239|11119364|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7037222|NCT01695239|11119365|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7037223|NCT01695239|11119352|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3
7037224|NCT01695239|11119353|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1
7037225|NCT01695239|11119354|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1
7037226|NCT01695239|11119355|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7037227|NCT01695239|11119356|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7037228|NCT01695239|11119357|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7037229|NCT01695239|11119358|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7037230|NCT01695239|11119359|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7037231|NCT01695239|11119360|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7037232|NCT01695239|11119361|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7037233|NCT01695239|11119362|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7037234|NCT01695239|11119363|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7037235|NCT01695239|11119364|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7037236|NCT01695239|11119365|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7037237|NCT01695239|11119352|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3
7037238|NCT01695239|11119353|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7037239|NCT01695239|11119354|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1
7037240|NCT01695239|11119355|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7037241|NCT01695239|11119356|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7037242|NCT01695239|11119357|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7037243|NCT01695239|11119358|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7037244|NCT01695239|11119359|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7037245|NCT01695239|11119360|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7037246|NCT01695239|11119361|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7037247|NCT01695239|11119362|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7037248|NCT01695239|11119363|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7037249|NCT01695239|11119364|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7037250|NCT01695239|11119365|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7037251|NCT01695239|11119352|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
7037252|NCT01695239|11119353|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7037253|NCT01695239|11119354|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
7037254|NCT01695239|11119355|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7037255|NCT01695239|11119356|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7044735|NCT01756833|11130684|FG000|Overall Study|Withdrawal by Subject|4
7144263|NCT03053063|11302064|FG003|Open-Label Phase|Death|2
7144264|NCT03053063|11302061|FG000|Open-Label Phase|Investigator's discretion|0
7144265|NCT03053063|11302062|FG001|Open-Label Phase|Investigator's discretion|0
7037256|NCT01695239|11119357|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7037257|NCT01695239|11119358|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7037258|NCT01695239|11119359|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7037259|NCT01695239|11119360|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7060718|NCT01922011|11157216|FG000|Overall Study|Lost to Follow-up|0
7060719|NCT01922011|11157217|FG001|Overall Study|Lost to Follow-up|1
7144266|NCT03053063|11302063|FG002|Open-Label Phase|Investigator's discretion|0
7144267|NCT03053063|11302064|FG003|Open-Label Phase|Investigator's discretion|2
7144268|NCT03053180|11302073|FG000|Overall Study|Failure to Return|1
7144269|NCT03053271|11302077|FG000|Overall Study|Did not meet randomization criteria|3
7144270|NCT03053271|11302077|FG000|Overall Study|Withdrawal by Subject|1
7144271|NCT03053427|11302093|FG000|Overall Study|Adverse Event|4
7144272|NCT03053427|11302094|FG001|Overall Study|Adverse Event|4
7144273|NCT03053427|11302093|FG000|Overall Study|Lack of Efficacy|1
7144274|NCT03053427|11302094|FG001|Overall Study|Lack of Efficacy|3
7144275|NCT03053427|11302093|FG000|Overall Study|Lost to Follow-up|2
7144276|NCT03053427|11302094|FG001|Overall Study|Lost to Follow-up|2
7144277|NCT03053427|11302093|FG000|Overall Study|Worsening of the target disease|0
7144278|NCT03053427|11302094|FG001|Overall Study|Worsening of the target disease|1
7144279|NCT03053427|11302093|FG000|Overall Study|Protocol Deviation|3
7144280|NCT03053427|11302094|FG001|Overall Study|Protocol Deviation|3
7144281|NCT03053427|11302093|FG000|Overall Study|Withdrawal by Subject|3
7144282|NCT03053427|11302094|FG001|Overall Study|Withdrawal by Subject|2
7144283|NCT03053427|11302093|FG000|Overall Study|Miscellaneous|0
7144284|NCT03053427|11302094|FG001|Overall Study|Miscellaneous|1
7144285|NCT03053492|11302102|FG000|Overall Study|Adverse Event|1
7144286|NCT03053492|11302103|FG001|Overall Study|Adverse Event|1
7144287|NCT03053492|11302102|FG000|Overall Study|Withdrawal by Subject|7
7144288|NCT03053492|11302103|FG001|Overall Study|Withdrawal by Subject|5
7144289|NCT03054064|11302120|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1
7144290|NCT03054064|11302120|FG000|Overall Study|Investigator Decision|2
7144291|NCT03054064|11302120|FG000|Overall Study|Bladder Issue|1
7037260|NCT01695239|11119361|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7037261|NCT01695239|11119362|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7037262|NCT01695239|11119363|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7037263|NCT01695239|11119364|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7037264|NCT01695239|11119365|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7037265|NCT01695239|11119352|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1
7037266|NCT01695239|11119353|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0
7037267|NCT01695239|11119354|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0
7037268|NCT01695239|11119355|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0
7037269|NCT01695239|11119356|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0
7037270|NCT01695239|11119357|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0
7037271|NCT01695239|11119358|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0
7037272|NCT01695239|11119359|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0
7037273|NCT01695239|11119360|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0
7037274|NCT01695239|11119361|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0
7037275|NCT01695239|11119362|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0
7037276|NCT01695239|11119363|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0
7044736|NCT01756833|11130685|FG001|Overall Study|Withdrawal by Subject|3
7060720|NCT01922011|11157216|FG000|Overall Study|Missed Test-of-Cure Visit|0
7060721|NCT01922011|11157217|FG001|Overall Study|Missed Test-of-Cure Visit|2
7060722|NCT01922011|11157216|FG000|Overall Study|Not Treated|1
7060723|NCT01922011|11157217|FG001|Overall Study|Not Treated|0
7060724|NCT01922011|11157216|FG000|Overall Study|Lack of willing home health agency|1
7144292|NCT03054064|11302120|FG000|Overall Study|High Blood Pressure|1
6811737|NCT01208207|10815565|FG003|Part II|Withdrawal by Subject|10
7144293|NCT03054064|11302120|FG000|Overall Study|Change in Status|1
7144294|NCT03054337|11302152|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1
7144295|NCT03054337|11302153|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2
7144296|NCT03054337|11302154|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1
7144297|NCT03054337|11302155|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0
7144298|NCT03054337|11302156|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0
7144299|NCT03054337|11302157|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1
6922274|NCT00810342|10950781|FG000|12-month Followup|Pregnancy|9
6922275|NCT00810342|10950782|FG001|12-month Followup|Pregnancy|10
6922276|NCT00810342|10950781|FG000|12-month Followup|Lost to Follow-up|3
6922277|NCT00810342|10950782|FG001|12-month Followup|Lost to Follow-up|1
7144300|NCT03054350|11302190|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4
7144301|NCT03054350|11302191|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2
7144302|NCT03054350|11302192|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1
7144303|NCT03054350|11302193|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2
7144304|NCT03054350|11302194|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4
7144305|NCT03054350|11302195|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3
7144306|NCT03054350|11302190|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0
7144307|NCT03054350|11302191|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0
7144308|NCT03054350|11302192|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1
7144309|NCT03054350|11302193|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0
7144310|NCT03054350|11302194|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0
7144311|NCT03054350|11302195|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0
7144312|NCT03054350|11302190|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1
7144313|NCT03054350|11302191|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0
7144314|NCT03054350|11302192|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0
7144315|NCT03054350|11302193|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1
7144316|NCT03054350|11302194|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0
7144317|NCT03054350|11302195|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0
7144318|NCT03054350|11302190|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0
7144319|NCT03054350|11302191|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0
7144320|NCT03054350|11302192|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1
7144321|NCT03054350|11302193|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0
7144322|NCT03054350|11302194|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0
7144323|NCT03054350|11302195|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0
7144324|NCT03054428|11302229|FG000|Overall Study|Physician Decision|0
7144325|NCT03054428|11302230|FG001|Overall Study|Physician Decision|1
7144326|NCT03054428|11302231|FG002|Overall Study|Physician Decision|1
7144327|NCT03054428|11302229|FG000|Overall Study|Lack of Efficacy|3
7144328|NCT03054428|11302230|FG001|Overall Study|Lack of Efficacy|1
7144329|NCT03054428|11302231|FG002|Overall Study|Lack of Efficacy|0
7144330|NCT03054428|11302229|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0
7144331|NCT03054428|11302230|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0
7144332|NCT03054428|11302231|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1
7144333|NCT03054428|11302229|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1
7144334|NCT03054428|11302230|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0
7144335|NCT03054428|11302231|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0
7144336|NCT03054428|11302229|FG000|Overall Study|Transitioned to OLE study|76
7144337|NCT03054428|11302230|FG001|Overall Study|Transitioned to OLE study|76
7144338|NCT03054428|11302231|FG002|Overall Study|Transitioned to OLE study|73
7144339|NCT03054428|11302229|FG000|Overall Study|Withdrawal by Subject|3
7144340|NCT03054428|11302230|FG001|Overall Study|Withdrawal by Subject|2
7144341|NCT03054428|11302231|FG002|Overall Study|Withdrawal by Subject|3
7144342|NCT03054428|11302229|FG000|Overall Study|Lost to Follow-up|0
7144343|NCT03054428|11302230|FG001|Overall Study|Lost to Follow-up|0
7144344|NCT03054428|11302231|FG002|Overall Study|Lost to Follow-up|1
7144345|NCT03054870|11302326|FG000|Day of Ventilation Imaging|Protocol Violation|4
7144346|NCT03054870|11302326|FG000|Day of Ventilation Imaging|Lost to Follow-up|1
7144347|NCT03055195|11302378|FG000|Overall Study|Lack of Efficacy|1
7144348|NCT03055195|11302379|FG001|Overall Study|Lack of Efficacy|0
7144349|NCT03055195|11302378|FG000|Overall Study|Withdrawal by Subject|6
7144350|NCT03055195|11302379|FG001|Overall Study|Withdrawal by Subject|7
7144351|NCT03055195|11302378|FG000|Overall Study|Study Terminated by Sponsor|2
7144352|NCT03055195|11302379|FG001|Overall Study|Study Terminated by Sponsor|6
7144353|NCT03055195|11302378|FG000|Overall Study|Protocol Violation|2
7144354|NCT03055195|11302379|FG001|Overall Study|Protocol Violation|1
7144355|NCT03055195|11302378|FG000|Overall Study|Physician Decision|1
7144356|NCT03055195|11302379|FG001|Overall Study|Physician Decision|0
7144357|NCT03055221|11302385|FG000|Overall Study|Adverse Event|2
7144358|NCT03055221|11302385|FG000|Overall Study|Withdrawal by Subject|4
7144359|NCT03055221|11302385|FG000|Overall Study|Death|6
7144360|NCT03055221|11302385|FG000|Overall Study|Physician Decision|1
7144361|NCT03055221|11302385|FG000|Overall Study|Study terminated by Sponsor|3
7144362|NCT03055260|11302391|FG000|Overall Study|Withdrawal by Subject|1
7144363|NCT03055260|11302392|FG001|Overall Study|Withdrawal by Subject|0
7144364|NCT03055338|11302401|FG000|Overall Study|Lost to Follow-up|9
7144365|NCT03055338|11302402|FG001|Overall Study|Lost to Follow-up|2
7144366|NCT03055338|11302403|FG002|Overall Study|Lost to Follow-up|3
7144367|NCT03055338|11302401|FG000|Overall Study|No Post-treatment Protocol Contact|0
7144368|NCT03055338|11302402|FG001|Overall Study|No Post-treatment Protocol Contact|1
7144369|NCT03055338|11302403|FG002|Overall Study|No Post-treatment Protocol Contact|0
7144370|NCT03055338|11302401|FG000|Overall Study|Physician Decision|0
7144371|NCT03055338|11302402|FG001|Overall Study|Physician Decision|0
7144372|NCT03055338|11302403|FG002|Overall Study|Physician Decision|2
7144373|NCT03055338|11302401|FG000|Overall Study|Withdrawal by Subject|9
7144374|NCT03055338|11302402|FG001|Overall Study|Withdrawal by Subject|8
7144375|NCT03055338|11302403|FG002|Overall Study|Withdrawal by Subject|7
7144376|NCT03055494|11302413|FG000|Overall Study|Lost to Follow-up|6
7144377|NCT03055494|11302414|FG001|Overall Study|Lost to Follow-up|0
7144378|NCT03055494|11302413|FG000|Overall Study|Physician Decision|2
7144379|NCT03055494|11302414|FG001|Overall Study|Physician Decision|0
7144380|NCT03055494|11302413|FG000|Overall Study|Withdrawal by Subject|1
7144381|NCT03055494|11302414|FG001|Overall Study|Withdrawal by Subject|0
7144382|NCT03055494|11302413|FG000|Overall Study|Adverse Event|0
7144383|NCT03055494|11302414|FG001|Overall Study|Adverse Event|1
7144384|NCT03055494|11302413|FG000|Overall Study|Non-compliance with study treatment|1
7144385|NCT03055494|11302414|FG001|Overall Study|Non-compliance with study treatment|0
7144386|NCT03055624|11302421|FG000|Overall Study|Study closed|9
7144387|NCT03055806|11302433|FG000|Overall Study|Adverse Event|0
7144388|NCT03055806|11302434|FG001|Overall Study|Adverse Event|0
7144389|NCT03055806|11302435|FG002|Overall Study|Adverse Event|1
7144390|NCT03055806|11302436|FG003|Overall Study|Adverse Event|1
7144391|NCT03055806|11302433|FG000|Overall Study|Lost to Follow-up|0
7144392|NCT03055806|11302434|FG001|Overall Study|Lost to Follow-up|3
7144393|NCT03055806|11302435|FG002|Overall Study|Lost to Follow-up|6
7144394|NCT03055806|11302436|FG003|Overall Study|Lost to Follow-up|7
7144395|NCT03055806|11302433|FG000|Overall Study|Physician Decision|1
7144396|NCT03055806|11302434|FG001|Overall Study|Physician Decision|0
7144397|NCT03055806|11302435|FG002|Overall Study|Physician Decision|0
7144398|NCT03055806|11302436|FG003|Overall Study|Physician Decision|1
7144399|NCT03055806|11302433|FG000|Overall Study|Protocol Violation|1
7144400|NCT03055806|11302434|FG001|Overall Study|Protocol Violation|0
7144401|NCT03055806|11302435|FG002|Overall Study|Protocol Violation|0
7144402|NCT03055806|11302436|FG003|Overall Study|Protocol Violation|0
7144403|NCT03055806|11302433|FG000|Overall Study|Withdrawal of consent to continue drug|1
7144404|NCT03055806|11302434|FG001|Overall Study|Withdrawal of consent to continue drug|1
7144405|NCT03055806|11302435|FG002|Overall Study|Withdrawal of consent to continue drug|2
7144406|NCT03055806|11302436|FG003|Overall Study|Withdrawal of consent to continue drug|0
7144407|NCT03055806|11302433|FG000|Overall Study|Withdrawal of consent to continue study|2
7144408|NCT03055806|11302434|FG001|Overall Study|Withdrawal of consent to continue study|3
7144409|NCT03055806|11302435|FG002|Overall Study|Withdrawal of consent to continue study|4
7144410|NCT03055806|11302436|FG003|Overall Study|Withdrawal of consent to continue study|6
7144411|NCT03055806|11302433|FG000|Overall Study|Partner not willing to try intercourse|1
7144412|NCT03055806|11302434|FG001|Overall Study|Partner not willing to try intercourse|0
7144413|NCT03055806|11302435|FG002|Overall Study|Partner not willing to try intercourse|0
7144414|NCT03055806|11302436|FG003|Overall Study|Partner not willing to try intercourse|0
7144415|NCT03055832|11302448|FG000|Week 2|Withdrawal by Subject|1
7144416|NCT03055832|11302449|FG001|Week 2|Withdrawal by Subject|0
7144417|NCT03055858|11302469|FG000|Overall Study|Death|5
7144418|NCT03055858|11302469|FG000|Overall Study|Adverse Event|1
7144419|NCT03055936|11302481|FG000|Overall Study|Adverse Event|0
7144420|NCT03055936|11302482|FG001|Overall Study|Adverse Event|1
7144421|NCT03055936|11302483|FG002|Overall Study|Adverse Event|1
7144422|NCT03055936|11302484|FG003|Overall Study|Adverse Event|1
7144423|NCT03055936|11302481|FG000|Overall Study|Personal reason|2
7144424|NCT03055936|11302482|FG001|Overall Study|Personal reason|0
7144425|NCT03055936|11302483|FG002|Overall Study|Personal reason|1
7144426|NCT03055936|11302484|FG003|Overall Study|Personal reason|0
7144427|NCT03055988|11302518|FG000|Period 1|Adverse Event|0
7144428|NCT03055988|11302519|FG001|Period 1|Adverse Event|1
7144429|NCT03055988|11302518|FG000|Period 1|Lost to Follow-up|1
7144430|NCT03055988|11302519|FG001|Period 1|Lost to Follow-up|0
7144431|NCT03055988|11302518|FG000|Period 1|Withdrawal by Subject|0
7144432|NCT03055988|11302519|FG001|Period 1|Withdrawal by Subject|4
7144433|NCT03055988|11302518|FG000|Period 2|Adverse Event|0
7144434|NCT03055988|11302519|FG001|Period 2|Adverse Event|1
7144435|NCT03055988|11302518|FG000|Period 2|Other than listed|1
7144436|NCT03055988|11302519|FG001|Period 2|Other than listed|1
7144437|NCT03056040|11302527|FG000|Primary Evaluation Period|Withdrawal by Subject|1
7144438|NCT03056040|11302528|FG001|Primary Evaluation Period|Withdrawal by Subject|1
7144439|NCT03056040|11302527|FG000|Primary Evaluation Period|Lack of Efficacy|0
7144440|NCT03056040|11302528|FG001|Primary Evaluation Period|Lack of Efficacy|1
7144441|NCT03056040|11302527|FG000|Primary Evaluation Period|Pregnancy|0
7144442|NCT03056040|11302528|FG001|Primary Evaluation Period|Pregnancy|1
7144443|NCT03056300|11302538|FG000|Overall Study|Surgical reason per study protocol|3
7144444|NCT03056352|11302542|FG000|Overall Study|Lost to Follow-up|1
7144445|NCT03056573|11302564|FG000|Overall Study|Death|2
7144446|NCT03056573|11302565|FG001|Overall Study|Death|4
7144447|NCT03056573|11302564|FG000|Overall Study|Withdrawal by Subject|2
7144448|NCT03056573|11302565|FG001|Overall Study|Withdrawal by Subject|0
7144449|NCT03056573|11302564|FG000|Overall Study|Lost to Follow-up|1
7144450|NCT03056573|11302565|FG001|Overall Study|Lost to Follow-up|1
7144451|NCT03056690|11302573|FG000|Overall Study|Adverse Event|3
7144452|NCT03056690|11302574|FG001|Overall Study|Adverse Event|2
7144453|NCT03056690|11302573|FG000|Overall Study|Lack of Efficacy|1
7144454|NCT03056690|11302574|FG001|Overall Study|Lack of Efficacy|2
7144455|NCT03056690|11302573|FG000|Overall Study|Lost to Follow-up|3
7144456|NCT03056690|11302574|FG001|Overall Study|Lost to Follow-up|2
7144457|NCT03056690|11302573|FG000|Overall Study|Protocol Violation|2
7144458|NCT03056690|11302574|FG001|Overall Study|Protocol Violation|2
7144459|NCT03056690|11302573|FG000|Overall Study|Withdrawal by Subject|3
7144460|NCT03056690|11302574|FG001|Overall Study|Withdrawal by Subject|6
7144461|NCT03056690|11302573|FG000|Overall Study|Non-compliance with Study Drug|1
7144462|NCT03056690|11302574|FG001|Overall Study|Non-compliance with Study Drug|0
7144463|NCT03056690|11302573|FG000|Overall Study|Miscellaneous|1
7144464|NCT03056690|11302574|FG001|Overall Study|Miscellaneous|2
7144465|NCT03057496|11302597|FG000|Overall Study|Withdrawal by Subject|8
7144466|NCT03057496|11302597|FG000|Overall Study|Lost to Follow-up|5
7144467|NCT03057496|11302597|FG000|Overall Study|Did not use device during home trial|3
7144468|NCT03057496|11302597|FG000|Overall Study|Device failure|2
7144469|NCT03057977|11302618|FG000|Discontinuation From Treatment|Withdrawal by Subject|124
7144470|NCT03057977|11302619|FG001|Discontinuation From Treatment|Withdrawal by Subject|92
7144471|NCT03057977|11302618|FG000|Discontinuation From Treatment|Lost to Follow-up|11
7144472|NCT03057977|11302619|FG001|Discontinuation From Treatment|Lost to Follow-up|17
7144473|NCT03057977|11302618|FG000|Discontinuation From Treatment|Protocol Violation|6
7144474|NCT03057977|11302619|FG001|Discontinuation From Treatment|Protocol Violation|5
7144475|NCT03057977|11302618|FG000|Discontinuation From Treatment|Not treated|4
7144476|NCT03057977|11302619|FG001|Discontinuation From Treatment|Not treated|0
7144477|NCT03057977|11302618|FG000|Discontinuation From Treatment|Adverse Event|343
7144478|NCT03057977|11302619|FG001|Discontinuation From Treatment|Adverse Event|337
7144479|NCT03057977|11302618|FG000|Discontinuation From Treatment|Reason Unknown|0
7144480|NCT03057977|11302619|FG001|Discontinuation From Treatment|Reason Unknown|1
7144481|NCT03057977|11302618|FG000|Discontinuation From Treatment|Personal Reasons|1
7144482|NCT03057977|11302619|FG001|Discontinuation From Treatment|Personal Reasons|1
7144483|NCT03057977|11302618|FG000|Discontinuation From Treatment|Unblinded medication|1
7144484|NCT03057977|11302619|FG001|Discontinuation From Treatment|Unblinded medication|0
7144485|NCT03057977|11302618|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1
7144486|NCT03057977|11302619|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1
7144487|NCT03057977|11302618|FG000|Discontinuation From Treatment|Principle Investigator Decision|2
7144488|NCT03057977|11302619|FG001|Discontinuation From Treatment|Principle Investigator Decision|0
7144489|NCT03057977|11302618|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2
7144490|NCT03057977|11302619|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4
7144491|NCT03057977|11302618|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4
7144492|NCT03057977|11302619|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3
7144493|NCT03057977|11302618|FG000|Discontinuation From Treatment|Unable to continue treatment|4
7144494|NCT03057977|11302619|FG001|Discontinuation From Treatment|Unable to continue treatment|1
7144495|NCT03057977|11302618|FG000|Discontinuation From Treatment|Not attending study visit|3
7144496|NCT03057977|11302619|FG001|Discontinuation From Treatment|Not attending study visit|10
7144497|NCT03057977|11302618|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1
7144498|NCT03057977|11302619|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4
7144499|NCT03057977|11302618|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8
7144500|NCT03057977|11302619|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6
7144501|NCT03057977|11302618|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9
7144502|NCT03057977|11302619|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9
7144503|NCT03057977|11302618|FG000|Discontinuation From Trial|Limited follow-up agreed|2
7144504|NCT03057977|11302619|FG001|Discontinuation From Trial|Limited follow-up agreed|2
7144505|NCT03057977|11302618|FG000|Discontinuation From Trial|Withdrawal by Subject|9
7144506|NCT03057977|11302619|FG001|Discontinuation From Trial|Withdrawal by Subject|11
7144507|NCT03058679|11302627|FG000|Baseline to Week 6|Lost to Follow-up|3
7037277|NCT01695239|11119364|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0
7037278|NCT01695239|11119365|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0
7037279|NCT01695239|11119352|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7037280|NCT01695239|11119353|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7037281|NCT01695239|11119354|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7037282|NCT01695239|11119355|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7037283|NCT01695239|11119356|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7037284|NCT01695239|11119357|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7037285|NCT01695239|11119358|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7037286|NCT01695239|11119359|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9
7037287|NCT01695239|11119360|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7037288|NCT01695239|11119361|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7037289|NCT01695239|11119362|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7037290|NCT01695239|11119363|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7037291|NCT01695239|11119364|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7037292|NCT01695239|11119365|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7037293|NCT01695239|11119352|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7037294|NCT01695239|11119353|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7144508|NCT03058679|11302628|FG001|Baseline to Week 6|Lost to Follow-up|2
7144509|NCT03058679|11302627|FG000|Baseline to Week 6|Change in Crohn's disease medication|4
7144510|NCT03058679|11302628|FG001|Baseline to Week 6|Change in Crohn's disease medication|2
7144511|NCT03058679|11302627|FG000|Baseline to Week 6|Adverse Event|6
7144512|NCT03058679|11302628|FG001|Baseline to Week 6|Adverse Event|6
7144513|NCT03058679|11302627|FG000|Baseline to Week 6|Withdrawal by Subject|4
7144514|NCT03058679|11302628|FG001|Baseline to Week 6|Withdrawal by Subject|3
7144515|NCT03058679|11302627|FG000|Baseline to Week 6|Difficulty following the diet|0
7144516|NCT03058679|11302628|FG001|Baseline to Week 6|Difficulty following the diet|2
7144517|NCT03058679|11302627|FG000|Baseline to Week 6|Physician Decision|1
7144518|NCT03058679|11302628|FG001|Baseline to Week 6|Physician Decision|0
7144519|NCT03058679|11302627|FG000|Week 6 to Week 12|Change in medication|5
7144520|NCT03058679|11302628|FG001|Week 6 to Week 12|Change in medication|7
7144521|NCT03058679|11302627|FG000|Week 6 to Week 12|Adverse Event|4
7144522|NCT03058679|11302628|FG001|Week 6 to Week 12|Adverse Event|3
7144523|NCT03058679|11302627|FG000|Week 6 to Week 12|Withdrawal by Subject|9
7144524|NCT03058679|11302628|FG001|Week 6 to Week 12|Withdrawal by Subject|4
7144525|NCT03058679|11302627|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2
7144526|NCT03058679|11302628|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3
7144527|NCT03058692|11302636|FG000|Overall Study|Lost to Follow-up|2
7144528|NCT03058692|11302637|FG001|Overall Study|Lost to Follow-up|1
7144529|NCT03058692|11302636|FG000|Overall Study|Withdrawal by Subject|1
7144530|NCT03058692|11302637|FG001|Overall Study|Withdrawal by Subject|1
7144531|NCT03058991|11302647|FG000|Overall Study|Lost to Follow-up|17
7144532|NCT03058991|11302648|FG001|Overall Study|Lost to Follow-up|12
7144533|NCT03058991|11302649|FG002|Overall Study|Lost to Follow-up|12
7144534|NCT03058991|11302647|FG000|Overall Study|Withdrawal by Subject|1
7144535|NCT03058991|11302648|FG001|Overall Study|Withdrawal by Subject|0
7144536|NCT03058991|11302649|FG002|Overall Study|Withdrawal by Subject|0
7144537|NCT03060447|11302672|FG000|Overall Study|Withdrawal by Subject|2
7144538|NCT03060447|11302673|FG001|Overall Study|Withdrawal by Subject|0
7144539|NCT03060512|11302691|FG000|Overall Study|Adverse Event|4
7144540|NCT03060512|11302692|FG001|Overall Study|Adverse Event|6
7144541|NCT03060512|11302691|FG000|Overall Study|Lost to Follow-up|1
7144542|NCT03060512|11302692|FG001|Overall Study|Lost to Follow-up|1
7144543|NCT03060512|11302691|FG000|Overall Study|Withdrawal by Subject|1
7144544|NCT03060512|11302692|FG001|Overall Study|Withdrawal by Subject|0
7144545|NCT03060512|11302691|FG000|Overall Study|Non-compliance with study medication|1
7144546|NCT03060512|11302692|FG001|Overall Study|Non-compliance with study medication|2
7144547|NCT03060551|11302703|FG000|Overall Study|Withdrawal by Subject|1
7144548|NCT03060551|11302703|FG000|Overall Study|Adverse Event|1
7144549|NCT03061097|11302718|FG000|Overall Study|Withdrawal by Subject|0
7144550|NCT03061097|11302719|FG001|Overall Study|Withdrawal by Subject|3
7144551|NCT03061175|11302727|FG000|Baseline|Participant was deemed ineligible|1
7144552|NCT03061175|11302728|FG001|Baseline|Participant was deemed ineligible|0
7144553|NCT03061175|11302727|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6
7144554|NCT03061175|11302728|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2
7144555|NCT03061175|11302727|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0
7144556|NCT03061175|11302728|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1
7144557|NCT03061175|11302727|FG000|Followup 2 at 6 Months|Lost to Follow-up|4
7144558|NCT03061175|11302728|FG001|Followup 2 at 6 Months|Lost to Follow-up|7
7144559|NCT03061188|11302738|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0
6827241|NCT00124072|10829892|FG000|Overall Study|Death|499
6827242|NCT00124072|10829893|FG001|Overall Study|Death|484
6827243|NCT00124072|10829894|FG002|Overall Study|Death|471
6827244|NCT00124072|10829895|FG003|Overall Study|Death|480
6827245|NCT00124449|10829916|FG000|6-month Double-Blind Treatment Period|Adverse Event|1
6827246|NCT00124449|10829917|FG001|6-month Double-Blind Treatment Period|Adverse Event|0
6827247|NCT00124449|10829916|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3
6827248|NCT00124449|10829917|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8
6827249|NCT00124449|10829916|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
6827250|NCT00124449|10829917|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
7037295|NCT01695239|11119354|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7037296|NCT01695239|11119355|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7037297|NCT01695239|11119356|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7037298|NCT01695239|11119357|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7037299|NCT01695239|11119358|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7037300|NCT01695239|11119359|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1
7037301|NCT01695239|11119360|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7037302|NCT01695239|11119361|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7037303|NCT01695239|11119362|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7037304|NCT01695239|11119363|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7037305|NCT01695239|11119364|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7037306|NCT01695239|11119365|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7037307|NCT01695239|11119352|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7037308|NCT01695239|11119353|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7037309|NCT01695239|11119354|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7037310|NCT01695239|11119355|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7037311|NCT01695239|11119356|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7037312|NCT01695239|11119357|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7037313|NCT01695239|11119358|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7037314|NCT01695239|11119359|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1
7037315|NCT01695239|11119360|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7037316|NCT01695239|11119361|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7037317|NCT01695239|11119362|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7037318|NCT01695239|11119363|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7037319|NCT01695239|11119364|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7037320|NCT01695239|11119365|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7037321|NCT01695239|11119352|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0
7037322|NCT01695239|11119353|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0
7037323|NCT01695239|11119354|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0
7037324|NCT01695239|11119355|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0
7037325|NCT01695239|11119356|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0
7037326|NCT01695239|11119357|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0
7037327|NCT01695239|11119358|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0
7037328|NCT01695239|11119359|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0
7037329|NCT01695239|11119360|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37
7037330|NCT01695239|11119361|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31
7037331|NCT01695239|11119362|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0
7037332|NCT01695239|11119363|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0
7037333|NCT01695239|11119364|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0
7037334|NCT01695239|11119365|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0
7037335|NCT01695239|11119352|FG000|Extension Long-Term Extension Periods|Adverse Event|0
7037336|NCT01695239|11119353|FG001|Extension Long-Term Extension Periods|Adverse Event|0
7037337|NCT01695239|11119354|FG002|Extension Long-Term Extension Periods|Adverse Event|0
7037338|NCT01695239|11119355|FG003|Extension Long-Term Extension Periods|Adverse Event|0
7037339|NCT01695239|11119356|FG004|Extension Long-Term Extension Periods|Adverse Event|0
7037340|NCT01695239|11119357|FG005|Extension Long-Term Extension Periods|Adverse Event|0
7037341|NCT01695239|11119358|FG006|Extension Long-Term Extension Periods|Adverse Event|0
7037342|NCT01695239|11119359|FG007|Extension Long-Term Extension Periods|Adverse Event|0
7037343|NCT01695239|11119360|FG008|Extension Long-Term Extension Periods|Adverse Event|15
7037344|NCT01695239|11119361|FG009|Extension Long-Term Extension Periods|Adverse Event|21
7037345|NCT01695239|11119362|FG010|Extension Long-Term Extension Periods|Adverse Event|0
7037346|NCT01695239|11119363|FG011|Extension Long-Term Extension Periods|Adverse Event|0
7037347|NCT01695239|11119364|FG012|Extension Long-Term Extension Periods|Adverse Event|0
7037348|NCT01695239|11119365|FG013|Extension Long-Term Extension Periods|Adverse Event|0
7037349|NCT01695239|11119352|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7144560|NCT03061188|11302739|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0
7144561|NCT03061188|11302740|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1
7144562|NCT03061188|11302741|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1
7144563|NCT03061188|11302738|FG000|On Follow-up for 3 Years|Death|0
7144564|NCT03061188|11302739|FG001|On Follow-up for 3 Years|Death|3
7144565|NCT03061188|11302740|FG002|On Follow-up for 3 Years|Death|5
7144566|NCT03061188|11302741|FG003|On Follow-up for 3 Years|Death|2
7144567|NCT03061188|11302738|FG000|On Follow-up for 3 Years|Still in follow-up|0
7144568|NCT03061188|11302739|FG001|On Follow-up for 3 Years|Still in follow-up|0
7144569|NCT03061188|11302740|FG002|On Follow-up for 3 Years|Still in follow-up|0
7144570|NCT03061188|11302741|FG003|On Follow-up for 3 Years|Still in follow-up|3
7144571|NCT03061214|11302759|FG000|Overall Study|Withdrawal by Subject|21
7144572|NCT03061214|11302760|FG001|Overall Study|Withdrawal by Subject|26
7144573|NCT03061214|11302761|FG002|Overall Study|Withdrawal by Subject|9
7144574|NCT03061214|11302759|FG000|Overall Study|Lost to Follow-up|3
7144575|NCT03061214|11302760|FG001|Overall Study|Lost to Follow-up|1
7144576|NCT03061214|11302761|FG002|Overall Study|Lost to Follow-up|1
7144577|NCT03061214|11302759|FG000|Overall Study|Death|1
7144578|NCT03061214|11302760|FG001|Overall Study|Death|1
7144579|NCT03061214|11302761|FG002|Overall Study|Death|0
7144580|NCT03061331|11302771|FG000|Washout Period (8 Weeks)|Adverse Event|2
7144581|NCT03061331|11302772|FG001|Washout Period (8 Weeks)|Adverse Event|1
7144582|NCT03062891|11302833|FG000|Overall Study|Withdrawal by Subject|2
7144583|NCT03062891|11302834|FG001|Overall Study|Withdrawal by Subject|0
7144584|NCT03062891|11302833|FG000|Overall Study|Lost to Follow-up|50
7144585|NCT03062891|11302834|FG001|Overall Study|Lost to Follow-up|38
7144586|NCT03063086|11302861|FG000|Overall Study|technical problems|1
7144587|NCT03063086|11302862|FG001|Overall Study|technical problems|0
7144588|NCT03063086|11302863|FG002|Overall Study|technical problems|0
7144589|NCT03063086|11302864|FG003|Overall Study|technical problems|0
7144590|NCT03063086|11302865|FG004|Overall Study|technical problems|0
7144591|NCT03063086|11302866|FG005|Overall Study|technical problems|0
7144592|NCT03063086|11302861|FG000|Overall Study|Adverse Event|1
7144593|NCT03063086|11302862|FG001|Overall Study|Adverse Event|1
7144594|NCT03063086|11302863|FG002|Overall Study|Adverse Event|1
7144595|NCT03063086|11302864|FG003|Overall Study|Adverse Event|1
7144596|NCT03063086|11302865|FG004|Overall Study|Adverse Event|0
7144597|NCT03063086|11302866|FG005|Overall Study|Adverse Event|0
7144598|NCT03063086|11302861|FG000|Overall Study|subject/guardian decision|1
7144599|NCT03063086|11302862|FG001|Overall Study|subject/guardian decision|0
7144600|NCT03063086|11302863|FG002|Overall Study|subject/guardian decision|0
7144601|NCT03063086|11302864|FG003|Overall Study|subject/guardian decision|0
7144602|NCT03063086|11302865|FG004|Overall Study|subject/guardian decision|0
7144603|NCT03063086|11302866|FG005|Overall Study|subject/guardian decision|0
7144604|NCT03063086|11302861|FG000|Overall Study|Non-compliance with study treatment|0
7144605|NCT03063086|11302862|FG001|Overall Study|Non-compliance with study treatment|0
7144606|NCT03063086|11302863|FG002|Overall Study|Non-compliance with study treatment|0
7144607|NCT03063086|11302864|FG003|Overall Study|Non-compliance with study treatment|1
7144608|NCT03063086|11302865|FG004|Overall Study|Non-compliance with study treatment|0
7144609|NCT03063086|11302866|FG005|Overall Study|Non-compliance with study treatment|1
7144610|NCT03063086|11302861|FG000|Overall Study|Physician Decision|0
7144611|NCT03063086|11302862|FG001|Overall Study|Physician Decision|0
7144612|NCT03063086|11302863|FG002|Overall Study|Physician Decision|0
7144613|NCT03063086|11302864|FG003|Overall Study|Physician Decision|1
7144614|NCT03063086|11302865|FG004|Overall Study|Physician Decision|0
7144615|NCT03063086|11302866|FG005|Overall Study|Physician Decision|0
7144616|NCT03064438|11302930|FG000|Overall Study|Lost to Follow-up|1
7144617|NCT03064438|11302931|FG001|Overall Study|Lost to Follow-up|0
7144618|NCT03064438|11302930|FG000|Overall Study|Withdrawal by Subject|0
7144619|NCT03064438|11302931|FG001|Overall Study|Withdrawal by Subject|1
7144620|NCT03064451|11302937|FG000|Overall Study|Lost to Follow-up|1
7144621|NCT03064451|11302937|FG000|Overall Study|Mapping Failure|4
7144622|NCT03064451|11302937|FG000|Overall Study|Exited prior to procedure|8
7144623|NCT03064451|11302937|FG000|Overall Study|Withdrew consent: 3-month FU visit|1
7144624|NCT03064841|11302941|FG000|Overall Study|Inclusion/exclusion criteria violation|4
7144625|NCT03064841|11302941|FG000|Overall Study|No glycated haemoglobinA1c measurement|11
7144626|NCT03064841|11302941|FG000|Overall Study|Screen failure|2
7144627|NCT03065023|11302949|FG000|Overall Study|Progressive Disease|0
7144628|NCT03065023|11302950|FG001|Overall Study|Progressive Disease|1
7144629|NCT03065023|11302951|FG002|Overall Study|Progressive Disease|0
7144630|NCT03065023|11302952|FG003|Overall Study|Progressive Disease|0
7037350|NCT01695239|11119353|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7144631|NCT03065023|11302953|FG004|Overall Study|Progressive Disease|0
7037351|NCT01695239|11119354|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7144632|NCT03065023|11302949|FG000|Overall Study|Death|2
7144633|NCT03065023|11302950|FG001|Overall Study|Death|0
6897069|NCT00636441|10915728|FG003|Overall Study|Late, ineligible|0
7144634|NCT03065023|11302951|FG002|Overall Study|Death|1
7144635|NCT03065023|11302952|FG003|Overall Study|Death|1
7144636|NCT03065023|11302953|FG004|Overall Study|Death|0
7144637|NCT03065023|11302949|FG000|Overall Study|Lost to Follow-up|0
7144638|NCT03065023|11302950|FG001|Overall Study|Lost to Follow-up|1
7144639|NCT03065023|11302951|FG002|Overall Study|Lost to Follow-up|0
7144640|NCT03065023|11302952|FG003|Overall Study|Lost to Follow-up|0
7144641|NCT03065023|11302953|FG004|Overall Study|Lost to Follow-up|0
7144642|NCT03065023|11302949|FG000|Overall Study|Participant Decision|0
7144643|NCT03065023|11302950|FG001|Overall Study|Participant Decision|0
7144644|NCT03065023|11302951|FG002|Overall Study|Participant Decision|0
7144645|NCT03065023|11302952|FG003|Overall Study|Participant Decision|1
7144646|NCT03065023|11302953|FG004|Overall Study|Participant Decision|0
7144647|NCT03065023|11302949|FG000|Overall Study|Withdrawal by Subject|0
7144648|NCT03065023|11302950|FG001|Overall Study|Withdrawal by Subject|0
7144649|NCT03065023|11302951|FG002|Overall Study|Withdrawal by Subject|0
7144650|NCT03065023|11302952|FG003|Overall Study|Withdrawal by Subject|1
7144651|NCT03065023|11302953|FG004|Overall Study|Withdrawal by Subject|0
7183635|NCT01411241|11383733|FG000|Overall Study|Serious Adverse Event|0
7183636|NCT01411241|11383734|FG001|Overall Study|Serious Adverse Event|3
7183637|NCT01411241|11383733|FG000|Overall Study|Lost to Follow-up|2
7183638|NCT01411241|11383734|FG001|Overall Study|Lost to Follow-up|4
7183639|NCT01374516|11383742|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43
7183640|NCT01374516|11383743|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14
7183641|NCT01374516|11383742|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3
7183642|NCT01374516|11383743|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0
7183643|NCT01374516|11383742|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480
7183644|NCT01374516|11383743|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240
7183645|NCT01374516|11383742|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106
7183646|NCT01374516|11383743|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46
7183647|NCT01374516|11383742|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7
7183648|NCT01374516|11383743|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9
7183649|NCT01374516|11383742|FG000|Surveillance Expansion Period|Protocol Violation|386
7183650|NCT01374516|11383743|FG001|Surveillance Expansion Period|Protocol Violation|217
7183651|NCT01374516|11383742|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870
7183652|NCT01374516|11383743|FG001|Surveillance Expansion Period|Withdrawal by Subject|986
7183653|NCT01374516|11383742|FG000|Surveillance Expansion Period|Lost to Follow-up|73
7183654|NCT01374516|11383743|FG001|Surveillance Expansion Period|Lost to Follow-up|45
7183655|NCT01374516|11383742|FG000|Surveillance Expansion Period|Serious adverse event|20
7183656|NCT01374516|11383743|FG001|Surveillance Expansion Period|Serious adverse event|5
7183657|NCT01373281|11383758|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40
7183658|NCT01373281|11383759|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23
7183659|NCT01373281|11383758|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5
7183660|NCT01373281|11383759|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2
7183661|NCT01373281|11383758|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5
7183662|NCT01373281|11383759|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1
7183663|NCT01373281|11383758|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4
7183664|NCT01373281|11383759|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1
7183665|NCT01373281|11383758|FG000|Surveillance Expansion Period|Withdrawal by Subject|180
7183666|NCT01373281|11383759|FG001|Surveillance Expansion Period|Withdrawal by Subject|105
7183667|NCT01373281|11383758|FG000|Surveillance Expansion Period|Protocol Violation|9
7183668|NCT01373281|11383759|FG001|Surveillance Expansion Period|Protocol Violation|1
7183669|NCT01373281|11383758|FG000|Surveillance Expansion Period|Lost to Follow-up|10
7183670|NCT01373281|11383759|FG001|Surveillance Expansion Period|Lost to Follow-up|8
7183671|NCT01373281|11383758|FG000|Surveillance Expansion Period|Serious adverse event|3
7183672|NCT01373281|11383759|FG001|Surveillance Expansion Period|Serious adverse event|4
7183673|NCT01302847|11383780|FG000|Overall Study|Ongoing|0
7183674|NCT01302847|11383781|FG001|Overall Study|Ongoing|0
7183675|NCT01302847|11383782|FG002|Overall Study|Ongoing|0
7183676|NCT01302847|11383783|FG003|Overall Study|Ongoing|0
7183677|NCT01302847|11383784|FG004|Overall Study|Ongoing|0
7183678|NCT01302847|11383785|FG005|Overall Study|Ongoing|27
7183679|NCT01302847|11383786|FG006|Overall Study|Ongoing|22
7183680|NCT01302847|11383787|FG007|Overall Study|Ongoing|17
7183681|NCT01302847|11383780|FG000|Overall Study|Death|0
7183682|NCT01302847|11383781|FG001|Overall Study|Death|1
7183683|NCT01302847|11383782|FG002|Overall Study|Death|0
7183684|NCT01302847|11383783|FG003|Overall Study|Death|0
7183685|NCT01302847|11383784|FG004|Overall Study|Death|0
7183686|NCT01302847|11383785|FG005|Overall Study|Death|1
7183687|NCT01302847|11383786|FG006|Overall Study|Death|1
7183688|NCT01302847|11383787|FG007|Overall Study|Death|0
7183689|NCT01302847|11383780|FG000|Overall Study|Pregnancy|2
7183690|NCT01302847|11383781|FG001|Overall Study|Pregnancy|0
7183691|NCT01302847|11383782|FG002|Overall Study|Pregnancy|0
7183692|NCT01302847|11383783|FG003|Overall Study|Pregnancy|0
7183693|NCT01302847|11383784|FG004|Overall Study|Pregnancy|0
7183694|NCT01302847|11383785|FG005|Overall Study|Pregnancy|0
7183695|NCT01302847|11383786|FG006|Overall Study|Pregnancy|0
7183696|NCT01302847|11383787|FG007|Overall Study|Pregnancy|0
7183697|NCT01302847|11383780|FG000|Overall Study|Virologic failure|0
7144652|NCT03065400|11302990|FG000|Overall Study|Adverse Event|1
7144653|NCT03065400|11302990|FG000|Overall Study|Physician Decision|3
7144654|NCT03065400|11302990|FG000|Overall Study|Withdrawal by Subject|1
7144655|NCT03065400|11302990|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5
7144656|NCT03065530|11302998|FG000|Overall Study|Lack of Efficacy|1
7144657|NCT03065530|11302999|FG001|Overall Study|Lack of Efficacy|1
7144658|NCT03065530|11303000|FG002|Overall Study|Lack of Efficacy|0
7144659|NCT03065530|11303001|FG003|Overall Study|Lack of Efficacy|1
7144660|NCT03065530|11302998|FG000|Overall Study|Protocol Violation|1
7144661|NCT03065530|11302999|FG001|Overall Study|Protocol Violation|0
7144662|NCT03065530|11303000|FG002|Overall Study|Protocol Violation|1
7144663|NCT03065530|11303001|FG003|Overall Study|Protocol Violation|1
7144664|NCT03066193|11303032|FG000|Overall Study|Withdrawal by Subject|1
7144665|NCT03066609|11303039|FG000|INDUCTION|Pregnancy|0
7144666|NCT03066609|11303040|FG001|INDUCTION|Pregnancy|0
7144667|NCT03066609|11303041|FG002|INDUCTION|Pregnancy|1
7144668|NCT03066609|11303042|FG003|INDUCTION|Pregnancy|0
7144669|NCT03066609|11303039|FG000|INDUCTION|Lack of Efficacy|0
7144670|NCT03066609|11303040|FG001|INDUCTION|Lack of Efficacy|0
7144671|NCT03066609|11303041|FG002|INDUCTION|Lack of Efficacy|1
7144672|NCT03066609|11303042|FG003|INDUCTION|Lack of Efficacy|0
7144673|NCT03066609|11303039|FG000|INDUCTION|Adverse Event|2
7144674|NCT03066609|11303040|FG001|INDUCTION|Adverse Event|2
7144675|NCT03066609|11303041|FG002|INDUCTION|Adverse Event|0
7144676|NCT03066609|11303042|FG003|INDUCTION|Adverse Event|0
7144677|NCT03066609|11303039|FG000|MAINTENANCE|Adverse Event|0
7144678|NCT03066609|11303040|FG001|MAINTENANCE|Adverse Event|0
7144679|NCT03066609|11303041|FG002|MAINTENANCE|Adverse Event|0
7144680|NCT03066609|11303042|FG003|MAINTENANCE|Adverse Event|1
7144681|NCT03066609|11303039|FG000|MAINTENANCE|Withdrawal by Subject|4
7144682|NCT03066609|11303040|FG001|MAINTENANCE|Withdrawal by Subject|2
7144683|NCT03066609|11303041|FG002|MAINTENANCE|Withdrawal by Subject|1
7144684|NCT03066609|11303042|FG003|MAINTENANCE|Withdrawal by Subject|1
7144685|NCT03066609|11303039|FG000|MAINTENANCE|Lost to Follow-up|0
7144686|NCT03066609|11303040|FG001|MAINTENANCE|Lost to Follow-up|1
7144687|NCT03066609|11303041|FG002|MAINTENANCE|Lost to Follow-up|1
7144688|NCT03066609|11303042|FG003|MAINTENANCE|Lost to Follow-up|0
7144689|NCT03066609|11303039|FG000|MAINTENANCE|Pregnancy|1
7144690|NCT03066609|11303040|FG001|MAINTENANCE|Pregnancy|0
7144691|NCT03066609|11303041|FG002|MAINTENANCE|Pregnancy|0
7144692|NCT03066609|11303042|FG003|MAINTENANCE|Pregnancy|0
7144693|NCT03066609|11303039|FG000|MAINTENANCE|Lack of Efficacy|2
7144694|NCT03066609|11303040|FG001|MAINTENANCE|Lack of Efficacy|1
7144695|NCT03066609|11303041|FG002|MAINTENANCE|Lack of Efficacy|0
7144696|NCT03066609|11303042|FG003|MAINTENANCE|Lack of Efficacy|1
7144697|NCT03066609|11303039|FG000|OVERALL STUDY|Adverse Event|2
7144698|NCT03066609|11303040|FG001|OVERALL STUDY|Adverse Event|2
7144699|NCT03066609|11303041|FG002|OVERALL STUDY|Adverse Event|0
7144700|NCT03066609|11303042|FG003|OVERALL STUDY|Adverse Event|1
7144701|NCT03066609|11303039|FG000|OVERALL STUDY|Withdrawal by Subject|4
7144702|NCT03066609|11303040|FG001|OVERALL STUDY|Withdrawal by Subject|2
7144703|NCT03066609|11303041|FG002|OVERALL STUDY|Withdrawal by Subject|1
7144704|NCT03066609|11303042|FG003|OVERALL STUDY|Withdrawal by Subject|2
7144705|NCT03066609|11303039|FG000|OVERALL STUDY|Lost to Follow-up|1
7144706|NCT03066609|11303040|FG001|OVERALL STUDY|Lost to Follow-up|1
7144707|NCT03066609|11303041|FG002|OVERALL STUDY|Lost to Follow-up|1
7144708|NCT03066609|11303042|FG003|OVERALL STUDY|Lost to Follow-up|1
7144709|NCT03066609|11303039|FG000|OVERALL STUDY|Pregnancy|1
7144710|NCT03066609|11303040|FG001|OVERALL STUDY|Pregnancy|0
7144711|NCT03066609|11303041|FG002|OVERALL STUDY|Pregnancy|1
7144712|NCT03066609|11303042|FG003|OVERALL STUDY|Pregnancy|0
7144713|NCT03066609|11303039|FG000|OVERALL STUDY|Lack of Efficacy|2
7144714|NCT03066609|11303040|FG001|OVERALL STUDY|Lack of Efficacy|1
7144715|NCT03066609|11303041|FG002|OVERALL STUDY|Lack of Efficacy|1
7144716|NCT03066609|11303042|FG003|OVERALL STUDY|Lack of Efficacy|1
7144717|NCT03066609|11303039|FG000|OVERALL STUDY|discontinued follow up|0
7144718|NCT03066609|11303040|FG001|OVERALL STUDY|discontinued follow up|2
7144719|NCT03066609|11303041|FG002|OVERALL STUDY|discontinued follow up|0
7144720|NCT03066609|11303042|FG003|OVERALL STUDY|discontinued follow up|0
7144721|NCT03066778|11303055|FG000|Overall Study|Death|167
7144722|NCT03066778|11303056|FG001|Overall Study|Death|183
7144723|NCT03066778|11303055|FG000|Overall Study|Withdrawal by Subject|4
7144724|NCT03066778|11303056|FG001|Overall Study|Withdrawal by Subject|5
7144725|NCT03066778|11303055|FG000|Overall Study|Ongoing in Study|57
7144726|NCT03066778|11303056|FG001|Overall Study|Ongoing in Study|37
7144727|NCT03066804|11303064|FG000|Overall Study|Physician Decision|0
7144728|NCT03066804|11303065|FG001|Overall Study|Physician Decision|4
7144729|NCT03066804|11303064|FG000|Overall Study|Death|23
7144730|NCT03066804|11303065|FG001|Overall Study|Death|17
7144731|NCT03066804|11303064|FG000|Overall Study|Withdrawal by Subject|19
7144732|NCT03066804|11303065|FG001|Overall Study|Withdrawal by Subject|25
7144733|NCT03066804|11303064|FG000|Overall Study|Lost to Follow-up|2
7144734|NCT03066804|11303065|FG001|Overall Study|Lost to Follow-up|0
7144735|NCT03066804|11303064|FG000|Overall Study|Adverse Event|2
7144736|NCT03066804|11303065|FG001|Overall Study|Adverse Event|3
7144737|NCT03066804|11303064|FG000|Overall Study|Technical problems|5
7144738|NCT03066804|11303065|FG001|Overall Study|Technical problems|1
7144739|NCT03066830|11303074|FG000|Overall Study|At the Participant's own Request|16
7144740|NCT03066830|11303075|FG001|Overall Study|At the Participant's own Request|17
7144741|NCT03066830|11303074|FG000|Overall Study|Other|3
7144742|NCT03066830|11303075|FG001|Overall Study|Other|0
7144743|NCT03066830|11303074|FG000|Overall Study|Poor Compliance to Protocol|1
7144744|NCT03066830|11303075|FG001|Overall Study|Poor Compliance to Protocol|0
7144745|NCT03066830|11303074|FG000|Overall Study|Adverse Event|2
7144746|NCT03066830|11303075|FG001|Overall Study|Adverse Event|2
7144747|NCT03066830|11303074|FG000|Overall Study|Lost to Follow-up|11
7144748|NCT03066830|11303075|FG001|Overall Study|Lost to Follow-up|3
7144749|NCT03066999|11303089|FG000|Overall Study|abnormal urethraBladder neck contracture|0
7144750|NCT03066999|11303090|FG001|Overall Study|abnormal urethraBladder neck contracture|2
7144751|NCT03067311|11303099|FG000|Overall Study|Lost to Follow-up|1
7144752|NCT03067311|11303100|FG001|Overall Study|Lost to Follow-up|1
7144753|NCT03067311|11303099|FG000|Overall Study|Moved away|1
7144754|NCT03067311|11303100|FG001|Overall Study|Moved away|1
7144755|NCT03067441|11303108|FG000|Overall Study|Withdrawal by Subject|16
7144756|NCT03067441|11303109|FG001|Overall Study|Withdrawal by Subject|34
7144757|NCT03067441|11303108|FG000|Overall Study|Lost to Follow-up|7
7144758|NCT03067441|11303109|FG001|Overall Study|Lost to Follow-up|5
7144759|NCT03067441|11303108|FG000|Overall Study|Adverse Event|7
7144760|NCT03067441|11303109|FG001|Overall Study|Adverse Event|14
7144761|NCT03067441|11303108|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1
7144762|NCT03067441|11303109|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0
7144763|NCT03067441|11303108|FG000|Overall Study|Physician Decision|1
7144764|NCT03067441|11303109|FG001|Overall Study|Physician Decision|3
7144765|NCT03067441|11303108|FG000|Overall Study|Other|1
7144766|NCT03067441|11303109|FG001|Overall Study|Other|1
7144767|NCT03067987|11303128|FG000|Overall Study|Lost to Follow-up|7
7144768|NCT03067987|11303129|FG001|Overall Study|Lost to Follow-up|10
7144769|NCT03067987|11303128|FG000|Overall Study|Protocol Violation|1
7144770|NCT03067987|11303129|FG001|Overall Study|Protocol Violation|2
7144771|NCT03067987|11303128|FG000|Overall Study|Withdrawal by Subject|2
7144772|NCT03067987|11303129|FG001|Overall Study|Withdrawal by Subject|1
7144773|NCT03068455|11303151|FG000|Pre-treatment Period|Disease progression|0
7144774|NCT03068455|11303152|FG001|Pre-treatment Period|Disease progression|1
7144775|NCT03068455|11303151|FG000|Pre-treatment Period|Participant withdrew consent|1
7144776|NCT03068455|11303152|FG001|Pre-treatment Period|Participant withdrew consent|1
7144777|NCT03068455|11303151|FG000|Pre-treatment Period|Poor/non-compliance|0
7144778|NCT03068455|11303152|FG001|Pre-treatment Period|Poor/non-compliance|1
7144779|NCT03068455|11303151|FG000|Pre-treatment Period|Participant no longer meets study criteria|1
7144780|NCT03068455|11303152|FG001|Pre-treatment Period|Participant no longer meets study criteria|3
7144781|NCT03068455|11303151|FG000|Pre-treatment Period|Not reported|2
7144782|NCT03068455|11303152|FG001|Pre-treatment Period|Not reported|1
7144783|NCT03068455|11303151|FG000|Treatment Period|Disease progression|166
7144784|NCT03068455|11303152|FG001|Treatment Period|Disease progression|208
7144785|NCT03068455|11303151|FG000|Treatment Period|Study drug toxicity|317
7144786|NCT03068455|11303152|FG001|Treatment Period|Study drug toxicity|104
7144787|NCT03068455|11303151|FG000|Treatment Period|Adverse Event unrelated to study drug|15
7144788|NCT03068455|11303152|FG001|Treatment Period|Adverse Event unrelated to study drug|7
7144789|NCT03068455|11303151|FG000|Treatment Period|Participant request to stop therapy|33
7144790|NCT03068455|11303152|FG001|Treatment Period|Participant request to stop therapy|20
7144791|NCT03068455|11303151|FG000|Treatment Period|Participant withdrew consent|5
7144792|NCT03068455|11303152|FG001|Treatment Period|Participant withdrew consent|10
7144793|NCT03068455|11303151|FG000|Treatment Period|Poor/non-compliance|3
7144794|NCT03068455|11303152|FG001|Treatment Period|Poor/non-compliance|0
7144795|NCT03068455|11303151|FG000|Treatment Period|Participant no longer meets study criteria|1
7144796|NCT03068455|11303152|FG001|Treatment Period|Participant no longer meets study criteria|3
7144797|NCT03068455|11303151|FG000|Treatment Period|Other reasons|12
7144798|NCT03068455|11303152|FG001|Treatment Period|Other reasons|4
7144799|NCT03068468|11303160|FG000|Placebo-Controlled Period|Randomized but not Treated|1
7144800|NCT03068468|11303161|FG001|Placebo-Controlled Period|Randomized but not Treated|3
7144801|NCT03068468|11303162|FG002|Placebo-Controlled Period|Randomized but not Treated|0
7144802|NCT03068468|11303163|FG003|Placebo-Controlled Period|Randomized but not Treated|0
7144803|NCT03068468|11303160|FG000|Placebo-Controlled Period|Lack of Efficacy|0
7144804|NCT03068468|11303161|FG001|Placebo-Controlled Period|Lack of Efficacy|1
7144805|NCT03068468|11303162|FG002|Placebo-Controlled Period|Lack of Efficacy|0
7144806|NCT03068468|11303163|FG003|Placebo-Controlled Period|Lack of Efficacy|0
7144807|NCT03068468|11303160|FG000|Placebo-Controlled Period|Adverse Event|16
7144808|NCT03068468|11303161|FG001|Placebo-Controlled Period|Adverse Event|21
7144809|NCT03068468|11303162|FG002|Placebo-Controlled Period|Adverse Event|0
7144810|NCT03068468|11303163|FG003|Placebo-Controlled Period|Adverse Event|0
7144811|NCT03068468|11303160|FG000|Placebo-Controlled Period|Withdrawal by Subject|3
7144812|NCT03068468|11303161|FG001|Placebo-Controlled Period|Withdrawal by Subject|11
7144813|NCT03068468|11303162|FG002|Placebo-Controlled Period|Withdrawal by Subject|0
7144814|NCT03068468|11303163|FG003|Placebo-Controlled Period|Withdrawal by Subject|0
7144815|NCT03068468|11303160|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1
7144816|NCT03068468|11303161|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2
7144817|NCT03068468|11303162|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7144818|NCT03068468|11303163|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7144819|NCT03068468|11303160|FG000|Placebo-Controlled Period|Reason Not Specified|1
7144820|NCT03068468|11303161|FG001|Placebo-Controlled Period|Reason Not Specified|6
7144821|NCT03068468|11303162|FG002|Placebo-Controlled Period|Reason Not Specified|0
7144822|NCT03068468|11303163|FG003|Placebo-Controlled Period|Reason Not Specified|0
7144823|NCT03068468|11303160|FG000|Placebo-Controlled Period|Death|0
7144824|NCT03068468|11303161|FG001|Placebo-Controlled Period|Death|1
7144825|NCT03068468|11303162|FG002|Placebo-Controlled Period|Death|0
7144826|NCT03068468|11303163|FG003|Placebo-Controlled Period|Death|0
7144827|NCT03068468|11303160|FG000|Open-Label Extension Period|Lack of Efficacy|0
7144828|NCT03068468|11303161|FG001|Open-Label Extension Period|Lack of Efficacy|0
7144829|NCT03068468|11303162|FG002|Open-Label Extension Period|Lack of Efficacy|1
7144830|NCT03068468|11303163|FG003|Open-Label Extension Period|Lack of Efficacy|2
7144831|NCT03068468|11303160|FG000|Open-Label Extension Period|Adverse Event|0
7144832|NCT03068468|11303161|FG001|Open-Label Extension Period|Adverse Event|0
7144833|NCT03068468|11303162|FG002|Open-Label Extension Period|Adverse Event|13
7144834|NCT03068468|11303163|FG003|Open-Label Extension Period|Adverse Event|17
7144835|NCT03068468|11303160|FG000|Open-Label Extension Period|Withdrawal by Subject|0
7144836|NCT03068468|11303161|FG001|Open-Label Extension Period|Withdrawal by Subject|0
7144837|NCT03068468|11303162|FG002|Open-Label Extension Period|Withdrawal by Subject|7
7144838|NCT03068468|11303163|FG003|Open-Label Extension Period|Withdrawal by Subject|20
7144839|NCT03068468|11303160|FG000|Open-Label Extension Period|Death|0
7144840|NCT03068468|11303161|FG001|Open-Label Extension Period|Death|0
7144841|NCT03068468|11303162|FG002|Open-Label Extension Period|Death|0
7144842|NCT03068468|11303163|FG003|Open-Label Extension Period|Death|1
7144843|NCT03068468|11303160|FG000|Open-Label Extension Period|Lost to Follow-up|0
7144844|NCT03068468|11303161|FG001|Open-Label Extension Period|Lost to Follow-up|0
7144845|NCT03068468|11303162|FG002|Open-Label Extension Period|Lost to Follow-up|1
7144846|NCT03068468|11303163|FG003|Open-Label Extension Period|Lost to Follow-up|0
7144847|NCT03068468|11303160|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0
7144848|NCT03068468|11303161|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0
7144849|NCT03068468|11303162|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2
7144850|NCT03068468|11303163|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0
7144851|NCT03068468|11303160|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0
7144852|NCT03068468|11303161|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0
7144853|NCT03068468|11303162|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115
7144854|NCT03068468|11303163|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228
7144855|NCT03068468|11303160|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0
7144856|NCT03068468|11303161|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0
7144857|NCT03068468|11303162|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0
7144858|NCT03068468|11303163|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4
7144859|NCT03068468|11303160|FG000|Open-Label Extension Period|Reason not Specified|0
7144860|NCT03068468|11303161|FG001|Open-Label Extension Period|Reason not Specified|0
7144861|NCT03068468|11303162|FG002|Open-Label Extension Period|Reason not Specified|1
7144862|NCT03068468|11303163|FG003|Open-Label Extension Period|Reason not Specified|4
7144863|NCT03068754|11303182|FG000|Randomized Treatment Period (RTP)|Adverse Event|1
7144864|NCT03068754|11303183|FG001|Randomized Treatment Period (RTP)|Adverse Event|3
7144865|NCT03068754|11303184|FG002|Randomized Treatment Period (RTP)|Adverse Event|0
7144866|NCT03068754|11303185|FG003|Randomized Treatment Period (RTP)|Adverse Event|0
7144867|NCT03068754|11303182|FG000|Randomized Treatment Period (RTP)|Death|2
7144868|NCT03068754|11303183|FG001|Randomized Treatment Period (RTP)|Death|2
7144869|NCT03068754|11303184|FG002|Randomized Treatment Period (RTP)|Death|0
7144870|NCT03068754|11303185|FG003|Randomized Treatment Period (RTP)|Death|0
7144871|NCT03068754|11303182|FG000|Randomized Treatment Period (RTP)|Disease progression|1
7144872|NCT03068754|11303183|FG001|Randomized Treatment Period (RTP)|Disease progression|2
7144873|NCT03068754|11303184|FG002|Randomized Treatment Period (RTP)|Disease progression|0
7144874|NCT03068754|11303185|FG003|Randomized Treatment Period (RTP)|Disease progression|0
7144875|NCT03068754|11303182|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1
7144876|NCT03068754|11303183|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0
7144877|NCT03068754|11303184|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0
7144878|NCT03068754|11303185|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0
7144879|NCT03068754|11303182|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6
6922278|NCT00810355|10950793|FG000|Overall Study|Lost to Follow-up|13
6922279|NCT00810355|10950794|FG001|Overall Study|Lost to Follow-up|17
6922280|NCT00810355|10950795|FG002|Overall Study|Lost to Follow-up|11
6922281|NCT00810355|10950793|FG000|Overall Study|Withdrawal by Subject|1
6922282|NCT00810355|10950794|FG001|Overall Study|Withdrawal by Subject|0
6922283|NCT00810355|10950795|FG002|Overall Study|Withdrawal by Subject|0
6922284|NCT00810368|10950805|FG000|Overall Study|Lost to Follow-up|4
6922285|NCT00810368|10950806|FG001|Overall Study|Lost to Follow-up|2
6922286|NCT00810368|10950805|FG000|Overall Study|Lack of Efficacy|2
6922287|NCT00810368|10950806|FG001|Overall Study|Lack of Efficacy|0
6922288|NCT00810394|10950814|FG000|Overall Study|Withdrawal by Subject|3
6922289|NCT00810407|10950818|FG000|Overall Study|Protocol Violation|3
6922290|NCT00810407|10950818|FG000|Overall Study|No Visit After First Day of Treatment|3
6922291|NCT00810511|10950839|FG000|Overall Study|Protocol Violation|0
6922292|NCT00810511|10950840|FG001|Overall Study|Protocol Violation|1
6922293|NCT00810511|10950839|FG000|Overall Study|Lack of Efficacy|9
6922294|NCT00810511|10950840|FG001|Overall Study|Lack of Efficacy|1
6922295|NCT00810511|10950839|FG000|Overall Study|death in the family|0
6922296|NCT00810511|10950840|FG001|Overall Study|death in the family|1
6922297|NCT00810511|10950839|FG000|Overall Study|Lost to Follow-up|1
6922298|NCT00810511|10950840|FG001|Overall Study|Lost to Follow-up|0
6922299|NCT00810511|10950839|FG000|Overall Study|deposits on contact lens|0
6922300|NCT00810511|10950840|FG001|Overall Study|deposits on contact lens|1
6922301|NCT00810602|10950850|FG000|Overall Study|Withdrawal by Subject|8
6922302|NCT00810602|10950851|FG001|Overall Study|Withdrawal by Subject|3
6922303|NCT00810615|10950857|FG000|Overall Study|Withdrawal by Subject|1
6922304|NCT00810615|10950858|FG001|Overall Study|Withdrawal by Subject|1
6922305|NCT00810641|10950879|FG000|Overall Study|Withdrawal by Subject|0
6922306|NCT00810641|10950880|FG001|Overall Study|Withdrawal by Subject|1
6922307|NCT00810641|10950881|FG002|Overall Study|Withdrawal by Subject|2
7144880|NCT03068754|11303183|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2
7183698|NCT01302847|11383781|FG001|Overall Study|Virologic failure|2
6922308|NCT00810693|10950892|FG000|Treatment Period|Adverse Event|8
6922309|NCT00810693|10950893|FG001|Treatment Period|Adverse Event|1
6922310|NCT00810693|10950894|FG002|Treatment Period|Adverse Event|7
6922311|NCT00810693|10950892|FG000|Treatment Period|Death|0
7144881|NCT03068754|11303184|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0
7144882|NCT03068754|11303185|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0
7144883|NCT03068754|11303182|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1
7144884|NCT03068754|11303183|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0
7144885|NCT03068754|11303184|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0
7144886|NCT03068754|11303185|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0
7144887|NCT03068754|11303182|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0
7144888|NCT03068754|11303183|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1
7144889|NCT03068754|11303184|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0
7144890|NCT03068754|11303185|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0
7144891|NCT03068754|11303182|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55
7144892|NCT03068754|11303183|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29
7144893|NCT03068754|11303184|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0
7144894|NCT03068754|11303185|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0
7144895|NCT03068754|11303182|FG000|Open Label Extension Period (OLE)|Adverse Event|0
7144896|NCT03068754|11303183|FG001|Open Label Extension Period (OLE)|Adverse Event|0
7144897|NCT03068754|11303184|FG002|Open Label Extension Period (OLE)|Adverse Event|0
7144898|NCT03068754|11303185|FG003|Open Label Extension Period (OLE)|Adverse Event|1
7144899|NCT03068754|11303182|FG000|Open Label Extension Period (OLE)|Death|0
7144900|NCT03068754|11303183|FG001|Open Label Extension Period (OLE)|Death|0
7144901|NCT03068754|11303184|FG002|Open Label Extension Period (OLE)|Death|0
7144902|NCT03068754|11303185|FG003|Open Label Extension Period (OLE)|Death|1
7144903|NCT03068754|11303182|FG000|Open Label Extension Period (OLE)|Disease progression|0
7144904|NCT03068754|11303183|FG001|Open Label Extension Period (OLE)|Disease progression|0
7144905|NCT03068754|11303184|FG002|Open Label Extension Period (OLE)|Disease progression|3
7144906|NCT03068754|11303185|FG003|Open Label Extension Period (OLE)|Disease progression|1
7144907|NCT03068754|11303182|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0
7144908|NCT03068754|11303183|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0
7144909|NCT03068754|11303184|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5
7144910|NCT03068754|11303185|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0
7144911|NCT03068754|11303182|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0
7144912|NCT03068754|11303183|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0
7144913|NCT03068754|11303184|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1
7144914|NCT03068754|11303185|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0
7183699|NCT01302847|11383782|FG002|Overall Study|Virologic failure|2
6922312|NCT00810693|10950893|FG001|Treatment Period|Death|1
7037352|NCT01695239|11119355|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7037353|NCT01695239|11119356|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7037354|NCT01695239|11119357|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7037355|NCT01695239|11119358|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7037356|NCT01695239|11119359|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7037357|NCT01695239|11119360|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6
7037358|NCT01695239|11119361|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7
7037359|NCT01695239|11119362|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7037360|NCT01695239|11119363|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7037361|NCT01695239|11119364|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7037362|NCT01695239|11119365|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7037363|NCT01695239|11119352|FG000|Extension Long-Term Extension Periods|Physician Decision|0
7037364|NCT01695239|11119353|FG001|Extension Long-Term Extension Periods|Physician Decision|0
7037365|NCT01695239|11119354|FG002|Extension Long-Term Extension Periods|Physician Decision|0
7037366|NCT01695239|11119355|FG003|Extension Long-Term Extension Periods|Physician Decision|0
7037367|NCT01695239|11119356|FG004|Extension Long-Term Extension Periods|Physician Decision|0
7037368|NCT01695239|11119357|FG005|Extension Long-Term Extension Periods|Physician Decision|0
7037369|NCT01695239|11119358|FG006|Extension Long-Term Extension Periods|Physician Decision|0
7037370|NCT01695239|11119359|FG007|Extension Long-Term Extension Periods|Physician Decision|0
7037371|NCT01695239|11119360|FG008|Extension Long-Term Extension Periods|Physician Decision|3
7037372|NCT01695239|11119361|FG009|Extension Long-Term Extension Periods|Physician Decision|0
7037373|NCT01695239|11119362|FG010|Extension Long-Term Extension Periods|Physician Decision|0
7037374|NCT01695239|11119363|FG011|Extension Long-Term Extension Periods|Physician Decision|0
6922313|NCT00810693|10950894|FG002|Treatment Period|Death|2
6922314|NCT00810693|10950892|FG000|Treatment Period|Lack of Efficacy|0
6922315|NCT00810693|10950893|FG001|Treatment Period|Lack of Efficacy|0
6922316|NCT00810693|10950894|FG002|Treatment Period|Lack of Efficacy|1
6922317|NCT00810693|10950892|FG000|Treatment Period|Lost to Follow-up|1
6922318|NCT00810693|10950893|FG001|Treatment Period|Lost to Follow-up|0
6922319|NCT00810693|10950894|FG002|Treatment Period|Lost to Follow-up|0
7037375|NCT01695239|11119364|FG012|Extension Long-Term Extension Periods|Physician Decision|0
7037376|NCT01695239|11119365|FG013|Extension Long-Term Extension Periods|Physician Decision|0
7037377|NCT01695239|11119352|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0
6922320|NCT00810693|10950892|FG000|Treatment Period|Non-compliance|1
7037378|NCT01695239|11119353|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0
7037379|NCT01695239|11119354|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0
7037380|NCT01695239|11119355|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0
7037381|NCT01695239|11119356|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0
7037382|NCT01695239|11119357|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0
7037383|NCT01695239|11119358|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0
7037384|NCT01695239|11119359|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0
7037385|NCT01695239|11119360|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2
7037386|NCT01695239|11119361|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1
7037387|NCT01695239|11119362|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0
7037388|NCT01695239|11119363|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0
7037389|NCT01695239|11119364|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0
7037390|NCT01695239|11119365|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0
7060725|NCT01922011|11157217|FG001|Overall Study|Lack of willing home health agency|0
7060726|NCT01922011|11157216|FG000|Overall Study|Randomized in error|1
7060727|NCT01922011|11157217|FG001|Overall Study|Randomized in error|0
7060728|NCT01922037|11157240|FG000|Overall Study|Withdrawal by Subject|2
7060729|NCT01922037|11157241|FG001|Overall Study|Withdrawal by Subject|44
7060730|NCT01922037|11157240|FG000|Overall Study|Adverse Event|1
7060731|NCT01922037|11157241|FG001|Overall Study|Adverse Event|7
7060732|NCT01922037|11157240|FG000|Overall Study|Death|0
7144915|NCT03068754|11303182|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0
7144916|NCT03068754|11303183|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0
7144917|NCT03068754|11303184|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12
7144918|NCT03068754|11303185|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3
6922321|NCT00810693|10950893|FG001|Treatment Period|Non-compliance|0
6922322|NCT00810693|10950894|FG002|Treatment Period|Non-compliance|0
6922323|NCT00810693|10950892|FG000|Treatment Period|Protocol Violation|1
6922324|NCT00810693|10950893|FG001|Treatment Period|Protocol Violation|2
6922325|NCT00810693|10950894|FG002|Treatment Period|Protocol Violation|2
6922326|NCT00810693|10950892|FG000|Treatment Period|Withdrawal by Subject|6
6922327|NCT00810693|10950893|FG001|Treatment Period|Withdrawal by Subject|2
6922328|NCT00810693|10950894|FG002|Treatment Period|Withdrawal by Subject|3
6922329|NCT00810693|10950892|FG000|Treatment Period|Not treated|0
6922330|NCT00810693|10950893|FG001|Treatment Period|Not treated|1
6922331|NCT00810693|10950894|FG002|Treatment Period|Not treated|1
6922332|NCT00810693|10950892|FG000|Follow-up Period (FUP)|Adverse Event|3
6922333|NCT00810693|10950893|FG001|Follow-up Period (FUP)|Adverse Event|1
6922334|NCT00810693|10950894|FG002|Follow-up Period (FUP)|Adverse Event|1
6922335|NCT00810693|10950892|FG000|Follow-up Period (FUP)|Death|2
6922336|NCT00810693|10950893|FG001|Follow-up Period (FUP)|Death|0
6922337|NCT00810693|10950894|FG002|Follow-up Period (FUP)|Death|1
6922338|NCT00810693|10950892|FG000|Follow-up Period (FUP)|Lost to Follow-up|1
6922339|NCT00810693|10950893|FG001|Follow-up Period (FUP)|Lost to Follow-up|0
6922340|NCT00810693|10950894|FG002|Follow-up Period (FUP)|Lost to Follow-up|2
7144919|NCT03068767|11303197|FG000|Overall Study|Lost to Follow-up|7
6922341|NCT00810693|10950892|FG000|Follow-up Period (FUP)|Protocol Violation|0
6922342|NCT00810693|10950893|FG001|Follow-up Period (FUP)|Protocol Violation|1
6922343|NCT00810693|10950894|FG002|Follow-up Period (FUP)|Protocol Violation|0
6922344|NCT00810693|10950892|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2
6922345|NCT00810693|10950893|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1
6922346|NCT00810693|10950894|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0
6922347|NCT00810810|10950929|FG000|Overall Study|Withdrawal by Subject|0
6922348|NCT00810810|10950930|FG001|Overall Study|Withdrawal by Subject|8
6922349|NCT00810810|10950931|FG002|Overall Study|Withdrawal by Subject|10
6922350|NCT00810810|10950932|FG003|Overall Study|Withdrawal by Subject|8
6922351|NCT00810810|10950929|FG000|Overall Study|Physician Decision|0
6922352|NCT00810810|10950930|FG001|Overall Study|Physician Decision|3
6922353|NCT00810810|10950931|FG002|Overall Study|Physician Decision|1
6922354|NCT00810810|10950932|FG003|Overall Study|Physician Decision|5
6922355|NCT00810901|10950957|FG000|Overall Study|Lost to Follow-up|88
6922356|NCT00810901|10950958|FG001|Overall Study|Lost to Follow-up|58
6922357|NCT00811018|10950964|FG000|Overall Study|Additional Chronic Treatment|31
6922358|NCT00811018|10950964|FG000|Overall Study|Adverse Event|79
6922359|NCT00811018|10950964|FG000|Overall Study|Death|147
6922360|NCT00811018|10950964|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4
6922361|NCT00811018|10950964|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70
7144920|NCT03068767|11303198|FG001|Overall Study|Lost to Follow-up|3
7144921|NCT03068767|11303197|FG000|Overall Study|Protocol Violation|3
7144922|NCT03068767|11303198|FG001|Overall Study|Protocol Violation|0
7144923|NCT03069313|11303238|FG000|Overall Study|Adverse Event|5
7144924|NCT03069352|11303244|FG000|Overall Study|Ongoing|12
7144925|NCT03069352|11303245|FG001|Overall Study|Ongoing|40
7144926|NCT03069365|11303251|FG000|Overall Study|Adverse Event|1
7144927|NCT03069482|11303257|FG000|Overall Study|Lost to Follow-up|0
7144928|NCT03069482|11303258|FG001|Overall Study|Lost to Follow-up|1
6922362|NCT00811018|10950964|FG000|Overall Study|Investigator Decision|57
6922363|NCT00811018|10950964|FG000|Overall Study|Lost to Follow-up|19
6922364|NCT00811018|10950964|FG000|Overall Study|Pregnancy|6
6922365|NCT00811018|10950964|FG000|Overall Study|Sponsor Decision|450
7144929|NCT03069482|11303257|FG000|Overall Study|Physician Decision|1
7144930|NCT03069482|11303258|FG001|Overall Study|Physician Decision|0
7144931|NCT03069716|11303278|FG000|Run-in Period (2 Weeks)|Adverse Event|1
7144932|NCT03069716|11303279|FG001|Run-in Period (2 Weeks)|Adverse Event|0
7144933|NCT03069716|11303280|FG002|Run-in Period (2 Weeks)|Adverse Event|0
7144934|NCT03069716|11303278|FG000|Run-in Period (2 Weeks)|Protocol Violation|1
7144935|NCT03069716|11303279|FG001|Run-in Period (2 Weeks)|Protocol Violation|0
7144936|NCT03069716|11303280|FG002|Run-in Period (2 Weeks)|Protocol Violation|0
7144937|NCT03069716|11303278|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5
7144938|NCT03069716|11303279|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0
7144939|NCT03069716|11303280|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0
7144940|NCT03069716|11303278|FG000|Randomized Treatment|Withdrawal by Subject|0
7144941|NCT03069716|11303279|FG001|Randomized Treatment|Withdrawal by Subject|2
7144942|NCT03069716|11303280|FG002|Randomized Treatment|Withdrawal by Subject|0
7144943|NCT03069989|11303289|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1
7144944|NCT03069989|11303290|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0
7144945|NCT03070171|11303299|FG000|Treatment Period 2 + Washout|Other Adverse Event|0
7144946|NCT03070171|11303300|FG001|Treatment Period 2 + Washout|Other Adverse Event|1
7144947|NCT03070171|11303299|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0
7144948|NCT03070171|11303300|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1
7144949|NCT03070431|11303306|FG000|Overall Study|Withdrawal by Subject|2
7144950|NCT03070431|11303306|FG000|Overall Study|Lost to Follow-up|2
7144951|NCT03070483|11303342|FG000|Overall Study|Lost to Follow-up|2
7144952|NCT03070782|11303370|FG000|Overall Study|Adverse Event|3
7144953|NCT03070782|11303371|FG001|Overall Study|Adverse Event|0
7144954|NCT03070782|11303372|FG002|Overall Study|Adverse Event|3
7144955|NCT03070782|11303373|FG003|Overall Study|Adverse Event|1
7144956|NCT03070782|11303374|FG004|Overall Study|Adverse Event|6
7144957|NCT03070782|11303375|FG005|Overall Study|Adverse Event|2
7144958|NCT03070782|11303370|FG000|Overall Study|Withdrawal by Subject|2
7144959|NCT03070782|11303371|FG001|Overall Study|Withdrawal by Subject|1
7144960|NCT03070782|11303372|FG002|Overall Study|Withdrawal by Subject|1
7144961|NCT03070782|11303373|FG003|Overall Study|Withdrawal by Subject|0
7144962|NCT03070782|11303374|FG004|Overall Study|Withdrawal by Subject|4
7144963|NCT03070782|11303375|FG005|Overall Study|Withdrawal by Subject|3
7144964|NCT03070782|11303370|FG000|Overall Study|Reason Not Specified|2
6827251|NCT00124449|10829916|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1
6827252|NCT00124449|10829917|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0
6827253|NCT00124449|10829916|FG000|6-month Double-Blind Treatment Period|Sponsor request|0
6827254|NCT00124449|10829917|FG001|6-month Double-Blind Treatment Period|Sponsor request|1
6827255|NCT00124449|10829916|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0
6827256|NCT00124449|10829917|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1
6827257|NCT00124449|10829916|FG000|18-Month Untreated Observation Period|Adverse Event|0
6827258|NCT00124449|10829917|FG001|18-Month Untreated Observation Period|Adverse Event|1
6827259|NCT00124449|10829916|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11
6827260|NCT00124449|10829917|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12
6827261|NCT00124449|10829916|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1
6827262|NCT00124449|10829917|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0
6827263|NCT00124449|10829916|FG000|18-Month Untreated Observation Period|Pregnancy|1
6827264|NCT00124449|10829917|FG001|18-Month Untreated Observation Period|Pregnancy|0
6827265|NCT00124449|10829916|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1
6827266|NCT00124449|10829917|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0
6827267|NCT00124449|10829916|FG000|18-Month Untreated Observation Period|Relocated|1
6827268|NCT00124449|10829917|FG001|18-Month Untreated Observation Period|Relocated|0
6827269|NCT00124462|10829926|FG000|Overall Study|Lost to Follow-up|3
6827270|NCT00124462|10829927|FG001|Overall Study|Lost to Follow-up|3
6827271|NCT00124462|10829926|FG000|Overall Study|Physician Decision|3
6827272|NCT00124462|10829927|FG001|Overall Study|Physician Decision|4
6827273|NCT00124462|10829926|FG000|Overall Study|Withdrawal by Subject|4
6827274|NCT00124462|10829927|FG001|Overall Study|Withdrawal by Subject|5
6827275|NCT00124462|10829926|FG000|Overall Study|Device fitting, n=2, other hlth issues|1
6827276|NCT00124462|10829927|FG001|Overall Study|Device fitting, n=2, other hlth issues|1
6827277|NCT00124618|10829954|FG000|Overall Study|Ineligible|1
6827278|NCT00124657|10829961|FG000|Overall Study|Toxicity|0
6827279|NCT00124657|10829962|FG001|Overall Study|Toxicity|0
6827280|NCT00124657|10829963|FG002|Overall Study|Toxicity|1
6827281|NCT00124657|10829961|FG000|Overall Study|Non-compliance|1
6827282|NCT00124657|10829962|FG001|Overall Study|Non-compliance|0
6827283|NCT00124657|10829963|FG002|Overall Study|Non-compliance|4
6827284|NCT00124657|10829961|FG000|Overall Study|Progressive disease|14
6827285|NCT00124657|10829962|FG001|Overall Study|Progressive disease|5
6827286|NCT00124657|10829963|FG002|Overall Study|Progressive disease|27
6827287|NCT00124657|10829961|FG000|Overall Study|Intercurrent illness|1
6827288|NCT00124657|10829962|FG001|Overall Study|Intercurrent illness|0
6827289|NCT00124657|10829963|FG002|Overall Study|Intercurrent illness|0
6827290|NCT00124709|10829986|FG000|Overall Study|Randomized but did not take medication|3
6827291|NCT00124709|10829987|FG001|Overall Study|Randomized but did not take medication|1
6827292|NCT00124709|10829986|FG000|Overall Study|Adverse Event|3
7144965|NCT03070782|11303371|FG001|Overall Study|Reason Not Specified|0
7144966|NCT03070782|11303372|FG002|Overall Study|Reason Not Specified|0
7144967|NCT03070782|11303373|FG003|Overall Study|Reason Not Specified|1
7144968|NCT03070782|11303374|FG004|Overall Study|Reason Not Specified|2
7144969|NCT03070782|11303375|FG005|Overall Study|Reason Not Specified|1
7037391|NCT01695239|11119352|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0
7037392|NCT01695239|11119353|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0
7037393|NCT01695239|11119354|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0
7037394|NCT01695239|11119355|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0
7037395|NCT01695239|11119356|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0
7037396|NCT01695239|11119357|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0
7037397|NCT01695239|11119358|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0
7037398|NCT01695239|11119359|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0
7037399|NCT01695239|11119360|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2
7037400|NCT01695239|11119361|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1
7037401|NCT01695239|11119362|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0
7037402|NCT01695239|11119363|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0
7037403|NCT01695239|11119364|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0
7037404|NCT01695239|11119365|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0
7037405|NCT01695239|11119352|FG000|Extension Long-Term Extension Periods|Death|0
7037406|NCT01695239|11119353|FG001|Extension Long-Term Extension Periods|Death|0
7037407|NCT01695239|11119354|FG002|Extension Long-Term Extension Periods|Death|0
7037408|NCT01695239|11119355|FG003|Extension Long-Term Extension Periods|Death|0
7037409|NCT01695239|11119356|FG004|Extension Long-Term Extension Periods|Death|0
7037410|NCT01695239|11119357|FG005|Extension Long-Term Extension Periods|Death|0
7037411|NCT01695239|11119358|FG006|Extension Long-Term Extension Periods|Death|0
7037412|NCT01695239|11119359|FG007|Extension Long-Term Extension Periods|Death|0
7037413|NCT01695239|11119360|FG008|Extension Long-Term Extension Periods|Death|1
7037414|NCT01695239|11119361|FG009|Extension Long-Term Extension Periods|Death|0
7037415|NCT01695239|11119362|FG010|Extension Long-Term Extension Periods|Death|0
7037416|NCT01695239|11119363|FG011|Extension Long-Term Extension Periods|Death|0
7037417|NCT01695239|11119364|FG012|Extension Long-Term Extension Periods|Death|0
7037418|NCT01695239|11119365|FG013|Extension Long-Term Extension Periods|Death|0
7037419|NCT01695239|11119352|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7037420|NCT01695239|11119353|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7037421|NCT01695239|11119354|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7144970|NCT03070782|11303370|FG000|Overall Study|Ineligibility|0
7144971|NCT03070782|11303371|FG001|Overall Study|Ineligibility|0
7144972|NCT03070782|11303372|FG002|Overall Study|Ineligibility|0
7144973|NCT03070782|11303373|FG003|Overall Study|Ineligibility|1
7144974|NCT03070782|11303374|FG004|Overall Study|Ineligibility|0
7144975|NCT03070782|11303375|FG005|Overall Study|Ineligibility|1
7144976|NCT03070782|11303370|FG000|Overall Study|Pregnancy|0
7144977|NCT03070782|11303371|FG001|Overall Study|Pregnancy|0
7144978|NCT03070782|11303372|FG002|Overall Study|Pregnancy|0
7144979|NCT03070782|11303373|FG003|Overall Study|Pregnancy|1
7144980|NCT03070782|11303374|FG004|Overall Study|Pregnancy|0
7144981|NCT03070782|11303375|FG005|Overall Study|Pregnancy|0
7144982|NCT03070782|11303370|FG000|Overall Study|Investigator Judgement|0
7144983|NCT03070782|11303371|FG001|Overall Study|Investigator Judgement|0
7144984|NCT03070782|11303372|FG002|Overall Study|Investigator Judgement|0
7144985|NCT03070782|11303373|FG003|Overall Study|Investigator Judgement|1
7144986|NCT03070782|11303374|FG004|Overall Study|Investigator Judgement|0
7144987|NCT03070782|11303375|FG005|Overall Study|Investigator Judgement|0
7144988|NCT03070964|11303389|FG000|Overall Study|Progressive disease|8
7144989|NCT03070964|11303389|FG000|Overall Study|Treatment-unrelated adverse event|2
7144990|NCT03070964|11303389|FG000|Overall Study|Never treated|1
7144991|NCT03070964|11303389|FG000|Overall Study|Physician Decision|1
7144992|NCT03070964|11303389|FG000|Overall Study|Withdrawal by Subject|1
7144993|NCT03070964|11303389|FG000|Overall Study|Adverse Event|1
7144994|NCT03071094|11303395|FG000|Overall Study|Death|1
7144995|NCT03071094|11303396|FG001|Overall Study|Death|1
7144996|NCT03071094|11303395|FG000|Overall Study|Adverse Event|1
7144997|NCT03071094|11303396|FG001|Overall Study|Adverse Event|0
7144998|NCT03071263|11303404|FG000|Overall Study|Adverse Event|1
7144999|NCT03071263|11303405|FG001|Overall Study|Adverse Event|3
7145000|NCT03071263|11303404|FG000|Overall Study|Withdrawal by Subject|1
7145001|NCT03071263|11303405|FG001|Overall Study|Withdrawal by Subject|3
7145002|NCT03071263|11303404|FG000|Overall Study|Physician Decision|1
7145003|NCT03071263|11303405|FG001|Overall Study|Physician Decision|0
7145004|NCT03071263|11303404|FG000|Overall Study|Participant moved to another city|0
7145005|NCT03071263|11303405|FG001|Overall Study|Participant moved to another city|1
7145006|NCT03071276|11303411|FG000|Overall Study|Adverse Event|1
7145007|NCT03071276|11303411|FG000|Overall Study|Lack of Efficacy|14
7145008|NCT03072160|11303425|FG000|Overall Study|Adverse Event|3
7145009|NCT03072160|11303426|FG001|Overall Study|Adverse Event|1
7037422|NCT01695239|11119355|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7145010|NCT03072160|11303425|FG000|Overall Study|Refused further treatment|6
7145011|NCT03072160|11303426|FG001|Overall Study|Refused further treatment|1
7145012|NCT03072160|11303425|FG000|Overall Study|Physician Decision|1
7145013|NCT03072160|11303426|FG001|Overall Study|Physician Decision|0
7037423|NCT01695239|11119356|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7037424|NCT01695239|11119357|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7037425|NCT01695239|11119358|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7037426|NCT01695239|11119359|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7145014|NCT03072160|11303425|FG000|Overall Study|Disease progression on study|1
7145015|NCT03072160|11303426|FG001|Overall Study|Disease progression on study|1
7145016|NCT03072160|11303425|FG000|Overall Study|No contact|0
7145017|NCT03072160|11303426|FG001|Overall Study|No contact|1
7145018|NCT03072719|11303483|FG000|Overall Study|Adverse Event|1
7145019|NCT03072719|11303484|FG001|Overall Study|Adverse Event|1
7145020|NCT03072875|11303499|FG000|Overall Study|Lost to Follow-up|1
7145021|NCT03073005|11303512|FG000|Overall Study|Death|6
7145022|NCT03073005|11303513|FG001|Overall Study|Death|0
7145023|NCT03073005|11303514|FG002|Overall Study|Death|7
7145024|NCT03073005|11303515|FG003|Overall Study|Death|0
7145025|NCT03073005|11303512|FG000|Overall Study|caregiver withdrew bc of pt death|0
7145026|NCT03073005|11303513|FG001|Overall Study|caregiver withdrew bc of pt death|6
7145027|NCT03073005|11303514|FG002|Overall Study|caregiver withdrew bc of pt death|0
7145028|NCT03073005|11303515|FG003|Overall Study|caregiver withdrew bc of pt death|7
7145029|NCT03073005|11303512|FG000|Overall Study|Lost to Follow-up|2
7145030|NCT03073005|11303513|FG001|Overall Study|Lost to Follow-up|2
7145031|NCT03073005|11303514|FG002|Overall Study|Lost to Follow-up|1
7145032|NCT03073005|11303515|FG003|Overall Study|Lost to Follow-up|2
7145033|NCT03073005|11303512|FG000|Overall Study|Withdrawal by Subject|0
7145034|NCT03073005|11303513|FG001|Overall Study|Withdrawal by Subject|4
7145035|NCT03073005|11303514|FG002|Overall Study|Withdrawal by Subject|4
7145036|NCT03073005|11303515|FG003|Overall Study|Withdrawal by Subject|4
7145037|NCT03073109|11303530|FG000|Overall Study|Adverse Event|0
7145038|NCT03073109|11303531|FG001|Overall Study|Adverse Event|1
7145039|NCT03073109|11303530|FG000|Overall Study|Other|2
7145040|NCT03073109|11303531|FG001|Overall Study|Other|0
7145041|NCT03073109|11303530|FG000|Overall Study|Lost to Follow-up|8
7145042|NCT03073109|11303531|FG001|Overall Study|Lost to Follow-up|1
7145043|NCT03073200|11303566|FG000|Double Blind Treatment Period|Protocol Violation|1
7145044|NCT03073200|11303567|FG001|Double Blind Treatment Period|Protocol Violation|0
7145045|NCT03073200|11303568|FG002|Double Blind Treatment Period|Protocol Violation|0
7145046|NCT03073200|11303569|FG003|Double Blind Treatment Period|Protocol Violation|0
7145047|NCT03073200|11303570|FG004|Double Blind Treatment Period|Protocol Violation|0
7145048|NCT03073200|11303571|FG005|Double Blind Treatment Period|Protocol Violation|0
7145049|NCT03073200|11303572|FG006|Double Blind Treatment Period|Protocol Violation|0
7145050|NCT03073200|11303573|FG007|Double Blind Treatment Period|Protocol Violation|0
7145051|NCT03073200|11303574|FG008|Double Blind Treatment Period|Protocol Violation|0
7145052|NCT03073200|11303575|FG009|Double Blind Treatment Period|Protocol Violation|0
7145053|NCT03073200|11303576|FG010|Double Blind Treatment Period|Protocol Violation|0
7145054|NCT03073200|11303577|FG011|Double Blind Treatment Period|Protocol Violation|0
7145055|NCT03073200|11303578|FG012|Double Blind Treatment Period|Protocol Violation|0
7145056|NCT03073200|11303579|FG013|Double Blind Treatment Period|Protocol Violation|0
7145057|NCT03073200|11303580|FG014|Double Blind Treatment Period|Protocol Violation|0
7145058|NCT03073200|11303566|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7145059|NCT03073200|11303567|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1
7145060|NCT03073200|11303568|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
6922366|NCT00811018|10950964|FG000|Overall Study|Withdrawal by Subject|70
6922367|NCT00811018|10950964|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9
6922368|NCT00811018|10950964|FG000|Overall Study|Other|26
6922369|NCT00811057|10950971|FG000|Overall Study|Protocol Violation|5
6922370|NCT00811057|10950972|FG001|Overall Study|Protocol Violation|10
6922371|NCT00811057|10950973|FG002|Overall Study|Protocol Violation|10
6922372|NCT00811070|10950987|FG000|Overall Study|Death|0
6922373|NCT00811070|10950988|FG001|Overall Study|Death|0
6922374|NCT00811070|10950989|FG002|Overall Study|Death|0
6922375|NCT00811070|10950990|FG003|Overall Study|Death|2
6922376|NCT00811070|10950991|FG004|Overall Study|Death|5
6922377|NCT00811070|10950992|FG005|Overall Study|Death|0
6922378|NCT00811070|10950987|FG000|Overall Study|Other|1
7044737|NCT01756846|11130693|FG000|Overall Study|Lost to Follow-up|5
6922379|NCT00811070|10950988|FG001|Overall Study|Other|0
6922380|NCT00811070|10950989|FG002|Overall Study|Other|0
6922381|NCT00811070|10950990|FG003|Overall Study|Other|0
6922382|NCT00811070|10950991|FG004|Overall Study|Other|0
6922383|NCT00811070|10950992|FG005|Overall Study|Other|0
6922384|NCT00811070|10950987|FG000|Overall Study|Withdrawal by Subject|0
6922385|NCT00811070|10950988|FG001|Overall Study|Withdrawal by Subject|1
6922386|NCT00811070|10950989|FG002|Overall Study|Withdrawal by Subject|0
6922387|NCT00811070|10950990|FG003|Overall Study|Withdrawal by Subject|0
7145061|NCT03073200|11303569|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
6922388|NCT00811070|10950991|FG004|Overall Study|Withdrawal by Subject|0
6922389|NCT00811070|10950992|FG005|Overall Study|Withdrawal by Subject|0
6922390|NCT00811070|10950987|FG000|Overall Study|Physician Decision|0
6922391|NCT00811070|10950988|FG001|Overall Study|Physician Decision|0
6922392|NCT00811070|10950989|FG002|Overall Study|Physician Decision|0
7145062|NCT03073200|11303570|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7145063|NCT03073200|11303571|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7145064|NCT03073200|11303572|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7145065|NCT03073200|11303573|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7145066|NCT03073200|11303574|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7145067|NCT03073200|11303575|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7145068|NCT03073200|11303576|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7145069|NCT03073200|11303577|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7145070|NCT03073200|11303578|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7145071|NCT03073200|11303579|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7145072|NCT03073200|11303580|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7145073|NCT03073200|11303566|FG000|Double Blind Treatment Period|Withdrawal by Subject|1
7145074|NCT03073200|11303567|FG001|Double Blind Treatment Period|Withdrawal by Subject|0
7145075|NCT03073200|11303568|FG002|Double Blind Treatment Period|Withdrawal by Subject|0
7145076|NCT03073200|11303569|FG003|Double Blind Treatment Period|Withdrawal by Subject|0
7145077|NCT03073200|11303570|FG004|Double Blind Treatment Period|Withdrawal by Subject|0
7145078|NCT03073200|11303571|FG005|Double Blind Treatment Period|Withdrawal by Subject|0
7145079|NCT03073200|11303572|FG006|Double Blind Treatment Period|Withdrawal by Subject|0
7145080|NCT03073200|11303573|FG007|Double Blind Treatment Period|Withdrawal by Subject|0
7145081|NCT03073200|11303574|FG008|Double Blind Treatment Period|Withdrawal by Subject|0
7145082|NCT03073200|11303575|FG009|Double Blind Treatment Period|Withdrawal by Subject|0
7145083|NCT03073200|11303576|FG010|Double Blind Treatment Period|Withdrawal by Subject|0
7145084|NCT03073200|11303577|FG011|Double Blind Treatment Period|Withdrawal by Subject|0
7145085|NCT03073200|11303578|FG012|Double Blind Treatment Period|Withdrawal by Subject|0
7145086|NCT03073200|11303579|FG013|Double Blind Treatment Period|Withdrawal by Subject|0
7145087|NCT03073200|11303580|FG014|Double Blind Treatment Period|Withdrawal by Subject|0
7145088|NCT03073200|11303566|FG000|Open-Label Maintenance Period|Lost to Follow-up|0
7145089|NCT03073200|11303567|FG001|Open-Label Maintenance Period|Lost to Follow-up|0
7145090|NCT03073200|11303568|FG002|Open-Label Maintenance Period|Lost to Follow-up|0
7145091|NCT03073200|11303569|FG003|Open-Label Maintenance Period|Lost to Follow-up|1
7145092|NCT03073200|11303570|FG004|Open-Label Maintenance Period|Lost to Follow-up|2
7145093|NCT03073200|11303571|FG005|Open-Label Maintenance Period|Lost to Follow-up|0
7145094|NCT03073200|11303572|FG006|Open-Label Maintenance Period|Lost to Follow-up|0
7145095|NCT03073200|11303573|FG007|Open-Label Maintenance Period|Lost to Follow-up|0
7145096|NCT03073200|11303574|FG008|Open-Label Maintenance Period|Lost to Follow-up|0
7145097|NCT03073200|11303575|FG009|Open-Label Maintenance Period|Lost to Follow-up|0
7145098|NCT03073200|11303576|FG010|Open-Label Maintenance Period|Lost to Follow-up|0
7145099|NCT03073200|11303577|FG011|Open-Label Maintenance Period|Lost to Follow-up|0
7145100|NCT03073200|11303578|FG012|Open-Label Maintenance Period|Lost to Follow-up|0
7145101|NCT03073200|11303579|FG013|Open-Label Maintenance Period|Lost to Follow-up|0
7145102|NCT03073200|11303580|FG014|Open-Label Maintenance Period|Lost to Follow-up|0
7145103|NCT03073200|11303566|FG000|Open-Label Maintenance Period|Participant moved to another city|0
7145104|NCT03073200|11303567|FG001|Open-Label Maintenance Period|Participant moved to another city|0
7145105|NCT03073200|11303568|FG002|Open-Label Maintenance Period|Participant moved to another city|0
7145106|NCT03073200|11303569|FG003|Open-Label Maintenance Period|Participant moved to another city|1
7145107|NCT03073200|11303570|FG004|Open-Label Maintenance Period|Participant moved to another city|0
7145108|NCT03073200|11303571|FG005|Open-Label Maintenance Period|Participant moved to another city|0
7145109|NCT03073200|11303572|FG006|Open-Label Maintenance Period|Participant moved to another city|0
7145110|NCT03073200|11303573|FG007|Open-Label Maintenance Period|Participant moved to another city|0
7145111|NCT03073200|11303574|FG008|Open-Label Maintenance Period|Participant moved to another city|0
7145112|NCT03073200|11303575|FG009|Open-Label Maintenance Period|Participant moved to another city|0
7145113|NCT03073200|11303576|FG010|Open-Label Maintenance Period|Participant moved to another city|0
7145114|NCT03073200|11303577|FG011|Open-Label Maintenance Period|Participant moved to another city|0
7145115|NCT03073200|11303578|FG012|Open-Label Maintenance Period|Participant moved to another city|0
7145116|NCT03073200|11303579|FG013|Open-Label Maintenance Period|Participant moved to another city|0
7145117|NCT03073200|11303580|FG014|Open-Label Maintenance Period|Participant moved to another city|0
7145118|NCT03073200|11303566|FG000|Open-Label Maintenance Period|Lack of Efficacy|0
7037427|NCT01695239|11119360|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7037428|NCT01695239|11119361|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7037429|NCT01695239|11119362|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7037430|NCT01695239|11119363|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1
7037431|NCT01695239|11119364|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6
7037432|NCT01695239|11119365|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
7037433|NCT01695239|11119352|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7037434|NCT01695239|11119353|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7037435|NCT01695239|11119354|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7037436|NCT01695239|11119355|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7037437|NCT01695239|11119356|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7037438|NCT01695239|11119357|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7145119|NCT03073200|11303567|FG001|Open-Label Maintenance Period|Lack of Efficacy|0
7145120|NCT03073200|11303568|FG002|Open-Label Maintenance Period|Lack of Efficacy|0
7145121|NCT03073200|11303569|FG003|Open-Label Maintenance Period|Lack of Efficacy|0
7145122|NCT03073200|11303570|FG004|Open-Label Maintenance Period|Lack of Efficacy|1
7145123|NCT03073200|11303571|FG005|Open-Label Maintenance Period|Lack of Efficacy|0
7145124|NCT03073200|11303572|FG006|Open-Label Maintenance Period|Lack of Efficacy|0
7145125|NCT03073200|11303573|FG007|Open-Label Maintenance Period|Lack of Efficacy|0
7145126|NCT03073200|11303574|FG008|Open-Label Maintenance Period|Lack of Efficacy|0
7145127|NCT03073200|11303575|FG009|Open-Label Maintenance Period|Lack of Efficacy|0
7145128|NCT03073200|11303576|FG010|Open-Label Maintenance Period|Lack of Efficacy|0
7145129|NCT03073200|11303577|FG011|Open-Label Maintenance Period|Lack of Efficacy|0
7145130|NCT03073200|11303578|FG012|Open-Label Maintenance Period|Lack of Efficacy|0
7145131|NCT03073200|11303579|FG013|Open-Label Maintenance Period|Lack of Efficacy|0
7145132|NCT03073200|11303580|FG014|Open-Label Maintenance Period|Lack of Efficacy|0
7145133|NCT03073200|11303566|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0
7145134|NCT03073200|11303567|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0
7145135|NCT03073200|11303568|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0
7145136|NCT03073200|11303569|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2
7145137|NCT03073200|11303570|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1
6922393|NCT00811070|10950990|FG003|Overall Study|Physician Decision|0
6922394|NCT00811070|10950991|FG004|Overall Study|Physician Decision|0
6922395|NCT00811070|10950992|FG005|Overall Study|Physician Decision|1
6922396|NCT00811135|10951008|FG000|Overall Study|Adverse Event/Intercurrent Illness|8
6922397|NCT00811135|10951008|FG000|Overall Study|Death|3
6922398|NCT00811135|10951008|FG000|Overall Study|Protocol Violation|2
6922399|NCT00811135|10951008|FG000|Overall Study|Violation of Selection Criteria|1
7037439|NCT01695239|11119358|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7037440|NCT01695239|11119359|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7037441|NCT01695239|11119360|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7037442|NCT01695239|11119361|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7037443|NCT01695239|11119362|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7037444|NCT01695239|11119363|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7037445|NCT01695239|11119364|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1
7037446|NCT01695239|11119365|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1
7037447|NCT01695239|11119352|FG000|Post-Treatment Follow-Up Period|Physician Decision|0
7037448|NCT01695239|11119353|FG001|Post-Treatment Follow-Up Period|Physician Decision|0
7037449|NCT01695239|11119354|FG002|Post-Treatment Follow-Up Period|Physician Decision|0
7037450|NCT01695239|11119355|FG003|Post-Treatment Follow-Up Period|Physician Decision|0
7037451|NCT01695239|11119356|FG004|Post-Treatment Follow-Up Period|Physician Decision|0
7037452|NCT01695239|11119357|FG005|Post-Treatment Follow-Up Period|Physician Decision|0
7037453|NCT01695239|11119358|FG006|Post-Treatment Follow-Up Period|Physician Decision|0
6922400|NCT00811135|10951008|FG000|Overall Study|Refused Treatment|1
6922401|NCT00811135|10951008|FG000|Overall Study|Withdrawal by Subject|3
6922402|NCT00811135|10951008|FG000|Overall Study|Administrative/Other Unspecified|11
6922403|NCT00811135|10951008|FG000|Overall Study|Ongoing|59
6922404|NCT00811174|10951012|FG000|Overall Study|Protocol Violation|2
6922405|NCT00811174|10951012|FG000|Overall Study|Sponsors Decision|1
6922406|NCT00811187|10951018|FG000|Overall Study|Unable to place device / procedure abort|3
6922407|NCT00811187|10951019|FG001|Overall Study|Unable to place device / procedure abort|3
6922408|NCT00811252|10951028|FG000|Overall Study|Adverse Event|6
6922409|NCT00811252|10951029|FG001|Overall Study|Adverse Event|10
6922410|NCT00811252|10951030|FG002|Overall Study|Adverse Event|15
6922411|NCT00811252|10951028|FG000|Overall Study|Lack of Efficacy|7
6922412|NCT00811252|10951029|FG001|Overall Study|Lack of Efficacy|2
6922413|NCT00811252|10951030|FG002|Overall Study|Lack of Efficacy|0
6922414|NCT00811252|10951028|FG000|Overall Study|Protocol Violation|3
6922415|NCT00811252|10951029|FG001|Overall Study|Protocol Violation|3
6922416|NCT00811252|10951030|FG002|Overall Study|Protocol Violation|2
6922417|NCT00811252|10951028|FG000|Overall Study|Withdrawal of Consent|1
6922418|NCT00811252|10951029|FG001|Overall Study|Withdrawal of Consent|2
6922419|NCT00811252|10951030|FG002|Overall Study|Withdrawal of Consent|2
6922420|NCT00811252|10951028|FG000|Overall Study|Lost to Follow-up|0
6922421|NCT00811252|10951029|FG001|Overall Study|Lost to Follow-up|0
6922422|NCT00811252|10951030|FG002|Overall Study|Lost to Follow-up|2
6922423|NCT00811252|10951028|FG000|Overall Study|Administrative or Other Reasons|0
6922424|NCT00811252|10951029|FG001|Overall Study|Administrative or Other Reasons|3
6922425|NCT00811252|10951030|FG002|Overall Study|Administrative or Other Reasons|2
6922426|NCT00811395|10951059|FG000|Extension Treatment|Adverse Event|1
6922427|NCT00811395|10951060|FG001|Extension Treatment|Adverse Event|2
6922428|NCT00811395|10951061|FG002|Extension Treatment|Adverse Event|2
6922429|NCT00811395|10951062|FG003|Extension Treatment|Adverse Event|2
6922430|NCT00811395|10951063|FG004|Extension Treatment|Adverse Event|0
6922431|NCT00811395|10951064|FG005|Extension Treatment|Adverse Event|1
6922432|NCT00811395|10951059|FG000|Extension Treatment|Progressive disease|1
6922433|NCT00811395|10951060|FG001|Extension Treatment|Progressive disease|1
6922434|NCT00811395|10951061|FG002|Extension Treatment|Progressive disease|0
6922435|NCT00811395|10951062|FG003|Extension Treatment|Progressive disease|0
6922436|NCT00811395|10951063|FG004|Extension Treatment|Progressive disease|0
6922437|NCT00811395|10951064|FG005|Extension Treatment|Progressive disease|0
7145138|NCT03073200|11303571|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0
7145139|NCT03073200|11303572|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0
7145140|NCT03073200|11303573|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0
7145141|NCT03073200|11303574|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0
7145142|NCT03073200|11303575|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0
7145143|NCT03073200|11303576|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0
7145144|NCT03073200|11303577|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0
7145145|NCT03073200|11303578|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0
7145146|NCT03073200|11303579|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0
7145147|NCT03073200|11303580|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0
6922438|NCT00811395|10951059|FG000|Extension Treatment|Participant did not wish to continue|0
6922439|NCT00811395|10951060|FG001|Extension Treatment|Participant did not wish to continue|3
6922440|NCT00811395|10951061|FG002|Extension Treatment|Participant did not wish to continue|0
6922441|NCT00811395|10951062|FG003|Extension Treatment|Participant did not wish to continue|1
6922442|NCT00811395|10951063|FG004|Extension Treatment|Participant did not wish to continue|0
6922443|NCT00811395|10951064|FG005|Extension Treatment|Participant did not wish to continue|1
6922444|NCT00811395|10951059|FG000|Extension Treatment|Other than above|0
6922445|NCT00811395|10951060|FG001|Extension Treatment|Other than above|0
6922446|NCT00811395|10951061|FG002|Extension Treatment|Other than above|1
6922447|NCT00811395|10951062|FG003|Extension Treatment|Other than above|0
6922448|NCT00811395|10951063|FG004|Extension Treatment|Other than above|0
6922449|NCT00811395|10951064|FG005|Extension Treatment|Other than above|0
6922450|NCT00811473|10951091|FG000|Overall Study|Adverse Event|3
6922451|NCT00811473|10951092|FG001|Overall Study|Adverse Event|12
6922452|NCT00811473|10951091|FG000|Overall Study|Lost to Follow-up|5
6922453|NCT00811473|10951092|FG001|Overall Study|Lost to Follow-up|1
6922454|NCT00811473|10951091|FG000|Overall Study|Withdrawal by Subject|2
6922455|NCT00811473|10951092|FG001|Overall Study|Withdrawal by Subject|4
6922456|NCT00811473|10951091|FG000|Overall Study|Severe non-compliance to protocol|2
6922457|NCT00811473|10951092|FG001|Overall Study|Severe non-compliance to protocol|4
6922458|NCT00811473|10951091|FG000|Overall Study|Lack of therapeutic response|4
6922459|NCT00811473|10951092|FG001|Overall Study|Lack of therapeutic response|1
6922460|NCT00811473|10951091|FG000|Overall Study|Condition under investigation worsened|1
6922461|NCT00811473|10951092|FG001|Overall Study|Condition under investigation worsened|3
6922462|NCT00811473|10951091|FG000|Overall Study|Other 2|4
6922463|NCT00811473|10951092|FG001|Overall Study|Other 2|1
6922464|NCT00811473|10951091|FG000|Overall Study|Incorrect Enrollment|1
6922465|NCT00811473|10951092|FG001|Overall Study|Incorrect Enrollment|0
6922466|NCT00811473|10951091|FG000|Overall Study|Safety Reasons|1
6922467|NCT00811473|10951092|FG001|Overall Study|Safety Reasons|0
6922468|NCT00811577|10951109|FG000|Overall Study|Lost to Follow-up|7
6922469|NCT00811577|10951110|FG001|Overall Study|Lost to Follow-up|1
6922470|NCT00811577|10951109|FG000|Overall Study|Withdrawal by Subject|3
6922471|NCT00811577|10951110|FG001|Overall Study|Withdrawal by Subject|0
6922472|NCT00811642|10951159|FG000|Overall Study|Adverse Event|3
6922473|NCT00811642|10951159|FG000|Overall Study|Protocol Violation|1
6922474|NCT00811642|10951159|FG000|Overall Study|Death|2
6922475|NCT00811642|10951159|FG000|Overall Study|Withdrawal by Subject|7
6922476|NCT00811642|10951159|FG000|Overall Study|Cumulative use of antifungal agent|2
6922477|NCT00811655|10951163|FG000|Overall Study|Physician Decision|1
6922478|NCT00811720|10951169|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2
6922479|NCT00811720|10951170|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4
7037454|NCT01695239|11119359|FG007|Post-Treatment Follow-Up Period|Physician Decision|0
7037455|NCT01695239|11119360|FG008|Post-Treatment Follow-Up Period|Physician Decision|0
7037456|NCT01695239|11119361|FG009|Post-Treatment Follow-Up Period|Physician Decision|0
7037457|NCT01695239|11119362|FG010|Post-Treatment Follow-Up Period|Physician Decision|0
7037458|NCT01695239|11119363|FG011|Post-Treatment Follow-Up Period|Physician Decision|0
7037459|NCT01695239|11119364|FG012|Post-Treatment Follow-Up Period|Physician Decision|2
7037460|NCT01695239|11119365|FG013|Post-Treatment Follow-Up Period|Physician Decision|0
7037461|NCT01695239|11119352|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0
7037462|NCT01695239|11119353|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0
7037463|NCT01695239|11119354|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0
7145148|NCT03073200|11303566|FG000|Extension Period|Lost to Follow-up|0
7145149|NCT03073200|11303567|FG001|Extension Period|Lost to Follow-up|0
7145150|NCT03073200|11303568|FG002|Extension Period|Lost to Follow-up|0
7145151|NCT03073200|11303569|FG003|Extension Period|Lost to Follow-up|0
7145152|NCT03073200|11303570|FG004|Extension Period|Lost to Follow-up|0
7145153|NCT03073200|11303571|FG005|Extension Period|Lost to Follow-up|0
7145154|NCT03073200|11303572|FG006|Extension Period|Lost to Follow-up|1
7145155|NCT03073200|11303573|FG007|Extension Period|Lost to Follow-up|1
7145156|NCT03073200|11303574|FG008|Extension Period|Lost to Follow-up|0
7145157|NCT03073200|11303575|FG009|Extension Period|Lost to Follow-up|0
7145158|NCT03073200|11303576|FG010|Extension Period|Lost to Follow-up|0
7145159|NCT03073200|11303577|FG011|Extension Period|Lost to Follow-up|0
7145160|NCT03073200|11303578|FG012|Extension Period|Lost to Follow-up|0
7145161|NCT03073200|11303579|FG013|Extension Period|Lost to Follow-up|0
7145162|NCT03073200|11303580|FG014|Extension Period|Lost to Follow-up|0
7145163|NCT03073200|11303566|FG000|Extension Period|Sponsor Decision|0
7145164|NCT03073200|11303567|FG001|Extension Period|Sponsor Decision|0
7145165|NCT03073200|11303568|FG002|Extension Period|Sponsor Decision|0
7145166|NCT03073200|11303569|FG003|Extension Period|Sponsor Decision|0
7145167|NCT03073200|11303570|FG004|Extension Period|Sponsor Decision|0
7145168|NCT03073200|11303571|FG005|Extension Period|Sponsor Decision|0
7145169|NCT03073200|11303572|FG006|Extension Period|Sponsor Decision|0
7145170|NCT03073200|11303573|FG007|Extension Period|Sponsor Decision|0
7145171|NCT03073200|11303574|FG008|Extension Period|Sponsor Decision|1
7145172|NCT03073200|11303575|FG009|Extension Period|Sponsor Decision|0
7145173|NCT03073200|11303576|FG010|Extension Period|Sponsor Decision|0
7145174|NCT03073200|11303577|FG011|Extension Period|Sponsor Decision|0
7145175|NCT03073200|11303578|FG012|Extension Period|Sponsor Decision|0
7145176|NCT03073200|11303579|FG013|Extension Period|Sponsor Decision|0
7145177|NCT03073200|11303580|FG014|Extension Period|Sponsor Decision|0
7145178|NCT03073200|11303566|FG000|Extension Period|Withdrawal by Parent/Guardian|0
7145179|NCT03073200|11303567|FG001|Extension Period|Withdrawal by Parent/Guardian|0
7145180|NCT03073200|11303568|FG002|Extension Period|Withdrawal by Parent/Guardian|0
7145181|NCT03073200|11303569|FG003|Extension Period|Withdrawal by Parent/Guardian|0
7145182|NCT03073200|11303570|FG004|Extension Period|Withdrawal by Parent/Guardian|0
7145183|NCT03073200|11303571|FG005|Extension Period|Withdrawal by Parent/Guardian|0
7145184|NCT03073200|11303572|FG006|Extension Period|Withdrawal by Parent/Guardian|1
7145185|NCT03073200|11303573|FG007|Extension Period|Withdrawal by Parent/Guardian|3
7145186|NCT03073200|11303574|FG008|Extension Period|Withdrawal by Parent/Guardian|1
7145187|NCT03073200|11303575|FG009|Extension Period|Withdrawal by Parent/Guardian|0
7145188|NCT03073200|11303576|FG010|Extension Period|Withdrawal by Parent/Guardian|0
7145189|NCT03073200|11303577|FG011|Extension Period|Withdrawal by Parent/Guardian|0
7145190|NCT03073200|11303578|FG012|Extension Period|Withdrawal by Parent/Guardian|0
7145191|NCT03073200|11303579|FG013|Extension Period|Withdrawal by Parent/Guardian|0
7145192|NCT03073200|11303580|FG014|Extension Period|Withdrawal by Parent/Guardian|0
7145193|NCT03073200|11303566|FG000|Extension Period|Withdrawal by Subject|0
7145194|NCT03073200|11303567|FG001|Extension Period|Withdrawal by Subject|0
7145195|NCT03073200|11303568|FG002|Extension Period|Withdrawal by Subject|0
7145196|NCT03073200|11303569|FG003|Extension Period|Withdrawal by Subject|0
7145197|NCT03073200|11303570|FG004|Extension Period|Withdrawal by Subject|0
7145198|NCT03073200|11303571|FG005|Extension Period|Withdrawal by Subject|0
7145199|NCT03073200|11303572|FG006|Extension Period|Withdrawal by Subject|1
7145200|NCT03073200|11303573|FG007|Extension Period|Withdrawal by Subject|2
7145201|NCT03073200|11303574|FG008|Extension Period|Withdrawal by Subject|0
7145202|NCT03073200|11303575|FG009|Extension Period|Withdrawal by Subject|0
7145203|NCT03073200|11303576|FG010|Extension Period|Withdrawal by Subject|0
7145204|NCT03073200|11303577|FG011|Extension Period|Withdrawal by Subject|0
7145205|NCT03073200|11303578|FG012|Extension Period|Withdrawal by Subject|0
7145206|NCT03073200|11303579|FG013|Extension Period|Withdrawal by Subject|0
7145207|NCT03073200|11303580|FG014|Extension Period|Withdrawal by Subject|0
7145208|NCT03073200|11303566|FG000|Randomized Withdrawal Period|Lost to Follow-up|0
7145209|NCT03073200|11303567|FG001|Randomized Withdrawal Period|Lost to Follow-up|0
7145210|NCT03073200|11303568|FG002|Randomized Withdrawal Period|Lost to Follow-up|0
7145211|NCT03073200|11303569|FG003|Randomized Withdrawal Period|Lost to Follow-up|0
7145212|NCT03073200|11303570|FG004|Randomized Withdrawal Period|Lost to Follow-up|0
7145213|NCT03073200|11303571|FG005|Randomized Withdrawal Period|Lost to Follow-up|0
7145214|NCT03073200|11303572|FG006|Randomized Withdrawal Period|Lost to Follow-up|0
7145215|NCT03073200|11303573|FG007|Randomized Withdrawal Period|Lost to Follow-up|0
7145216|NCT03073200|11303574|FG008|Randomized Withdrawal Period|Lost to Follow-up|0
7145217|NCT03073200|11303575|FG009|Randomized Withdrawal Period|Lost to Follow-up|0
7145218|NCT03073200|11303576|FG010|Randomized Withdrawal Period|Lost to Follow-up|0
7145219|NCT03073200|11303577|FG011|Randomized Withdrawal Period|Lost to Follow-up|1
7145220|NCT03073200|11303578|FG012|Randomized Withdrawal Period|Lost to Follow-up|0
7145221|NCT03073200|11303579|FG013|Randomized Withdrawal Period|Lost to Follow-up|0
7145222|NCT03073200|11303580|FG014|Randomized Withdrawal Period|Lost to Follow-up|0
7145223|NCT03073200|11303566|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7145224|NCT03073200|11303567|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7037464|NCT01695239|11119355|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0
7037465|NCT01695239|11119356|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0
7037466|NCT01695239|11119357|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0
7037467|NCT01695239|11119358|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0
7037468|NCT01695239|11119359|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0
7037469|NCT01695239|11119360|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0
7044738|NCT01756846|11130694|FG001|Overall Study|Lost to Follow-up|10
7145225|NCT03073200|11303568|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7145226|NCT03073200|11303569|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7145227|NCT03073200|11303570|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7145228|NCT03073200|11303571|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7145229|NCT03073200|11303572|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7145230|NCT03073200|11303573|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7183700|NCT01302847|11383783|FG003|Overall Study|Virologic failure|0
7037470|NCT01695239|11119361|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0
7037471|NCT01695239|11119362|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0
7037472|NCT01695239|11119363|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0
7037473|NCT01695239|11119364|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0
7037474|NCT01695239|11119365|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1
7037475|NCT01695746|11119432|FG000|Overall Study|Adverse Event|1
7037476|NCT01695746|11119432|FG000|Overall Study|Non-compliance by the participant|3
7037477|NCT01695746|11119432|FG000|Overall Study|Protocol Violation|5
7037478|NCT01695746|11119432|FG000|Overall Study|Participant not willing to participate|3
7037479|NCT01695772|11119437|FG000|Overall Study|Withdrawal by Subject|18
7037480|NCT01695772|11119437|FG000|Overall Study|Progressive Disease|8
7037481|NCT01695772|11119437|FG000|Overall Study|Investigator Decision|5
7037482|NCT01695772|11119437|FG000|Overall Study|Lost to Follow-up|4
7037483|NCT01695772|11119437|FG000|Overall Study|Protocol Violation|2
7037484|NCT01695772|11119437|FG000|Overall Study|Unspecified Reason|1
7037485|NCT01695954|11119443|FG000|Overall Study|Withdrawal by Subject|4
7037486|NCT01695954|11119444|FG001|Overall Study|Withdrawal by Subject|0
7037487|NCT01695954|11119443|FG000|Overall Study|Adverse Event|0
7037488|NCT01695954|11119444|FG001|Overall Study|Adverse Event|2
7037489|NCT01695993|11119455|FG000|Overall Study|Lost to Follow-up|2
7037490|NCT01695993|11119456|FG001|Overall Study|Lost to Follow-up|1
7037491|NCT01695993|11119457|FG002|Overall Study|Lost to Follow-up|3
7037492|NCT01695993|11119455|FG000|Overall Study|Withdrawal by Subject|2
7037493|NCT01695993|11119456|FG001|Overall Study|Withdrawal by Subject|2
7037494|NCT01695993|11119457|FG002|Overall Study|Withdrawal by Subject|2
7037495|NCT01695993|11119455|FG000|Overall Study|To ill to continue|1
7037496|NCT01695993|11119456|FG001|Overall Study|To ill to continue|2
7037497|NCT01695993|11119457|FG002|Overall Study|To ill to continue|0
7037498|NCT01695993|11119455|FG000|Overall Study|Changed Medical Facility|0
7037499|NCT01695993|11119456|FG001|Overall Study|Changed Medical Facility|0
7037500|NCT01695993|11119457|FG002|Overall Study|Changed Medical Facility|1
7037501|NCT01696032|11119469|FG000|Overall Study|Withdrawal by Subject|0
7037502|NCT01696032|11119470|FG001|Overall Study|Withdrawal by Subject|0
7037503|NCT01696032|11119471|FG002|Overall Study|Withdrawal by Subject|1
7037504|NCT01696032|11119472|FG003|Overall Study|Withdrawal by Subject|2
7145231|NCT03073200|11303574|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7145232|NCT03073200|11303575|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7145233|NCT03073200|11303576|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7145234|NCT03073200|11303577|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1
7145235|NCT03073200|11303578|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7145236|NCT03073200|11303579|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7145237|NCT03073200|11303580|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7145238|NCT03073200|11303566|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0
7145239|NCT03073200|11303567|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0
7145240|NCT03073200|11303568|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0
7145241|NCT03073200|11303569|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0
7145242|NCT03073200|11303570|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0
7145243|NCT03073200|11303571|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0
7145244|NCT03073200|11303572|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0
7145245|NCT03073200|11303573|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0
7145246|NCT03073200|11303574|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0
7145247|NCT03073200|11303575|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0
7145248|NCT03073200|11303576|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1
7145249|NCT03073200|11303577|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1
7145250|NCT03073200|11303578|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0
7145251|NCT03073200|11303579|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0
7145252|NCT03073200|11303580|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0
7145253|NCT03073200|11303566|FG000|Randomized Withdrawal Period|Adverse Event|0
7145254|NCT03073200|11303567|FG001|Randomized Withdrawal Period|Adverse Event|0
7145255|NCT03073200|11303568|FG002|Randomized Withdrawal Period|Adverse Event|0
7145256|NCT03073200|11303569|FG003|Randomized Withdrawal Period|Adverse Event|0
7145257|NCT03073200|11303570|FG004|Randomized Withdrawal Period|Adverse Event|0
7145258|NCT03073200|11303571|FG005|Randomized Withdrawal Period|Adverse Event|0
7145259|NCT03073200|11303572|FG006|Randomized Withdrawal Period|Adverse Event|0
6922480|NCT00811720|10951169|FG000|All Treated Patients|Adverse Event|20
6922481|NCT00811720|10951170|FG001|All Treated Patients|Adverse Event|62
6922482|NCT00811720|10951169|FG000|All Treated Patients|Lack of Efficacy|22
6922483|NCT00811720|10951170|FG001|All Treated Patients|Lack of Efficacy|18
6922484|NCT00811720|10951169|FG000|All Treated Patients|Non-compliance|0
6922485|NCT00811720|10951170|FG001|All Treated Patients|Non-compliance|14
6922486|NCT00811720|10951169|FG000|All Treated Patients|Protocol Violation|9
6922487|NCT00811720|10951170|FG001|All Treated Patients|Protocol Violation|16
7037505|NCT01696032|11119469|FG000|Overall Study|Death|14
7037506|NCT01696032|11119470|FG001|Overall Study|Death|4
7037507|NCT01696032|11119471|FG002|Overall Study|Death|43
7037508|NCT01696032|11119472|FG003|Overall Study|Death|18
7145260|NCT03073200|11303573|FG007|Randomized Withdrawal Period|Adverse Event|0
7145261|NCT03073200|11303574|FG008|Randomized Withdrawal Period|Adverse Event|0
7145262|NCT03073200|11303575|FG009|Randomized Withdrawal Period|Adverse Event|0
7145263|NCT03073200|11303576|FG010|Randomized Withdrawal Period|Adverse Event|1
7145264|NCT03073200|11303577|FG011|Randomized Withdrawal Period|Adverse Event|0
7145265|NCT03073200|11303578|FG012|Randomized Withdrawal Period|Adverse Event|0
7145266|NCT03073200|11303579|FG013|Randomized Withdrawal Period|Adverse Event|0
7145267|NCT03073200|11303580|FG014|Randomized Withdrawal Period|Adverse Event|0
7145268|NCT03073200|11303566|FG000|Post-Treatment Follow-Up Period|Adverse Event|0
7145269|NCT03073200|11303567|FG001|Post-Treatment Follow-Up Period|Adverse Event|0
7145270|NCT03073200|11303568|FG002|Post-Treatment Follow-Up Period|Adverse Event|0
6922488|NCT00811720|10951169|FG000|All Treated Patients|Withdrawal by Subject|28
6922489|NCT00811720|10951170|FG001|All Treated Patients|Withdrawal by Subject|34
6922490|NCT00811720|10951169|FG000|All Treated Patients|Lost to Follow-up|10
6922491|NCT00811720|10951170|FG001|All Treated Patients|Lost to Follow-up|16
6922492|NCT00811720|10951169|FG000|All Treated Patients|Other Reason|7
6922493|NCT00811720|10951170|FG001|All Treated Patients|Other Reason|4
6922494|NCT00811733|10951178|FG000|Overall Study|Investigator Discretion|10
6922495|NCT00811733|10951179|FG001|Overall Study|Investigator Discretion|8
6922496|NCT00811733|10951178|FG000|Overall Study|Withdrawal by Subject|1
6922497|NCT00811733|10951179|FG001|Overall Study|Withdrawal by Subject|2
6922498|NCT00811928|10951197|FG000|Overall Study|AEs and SAEs Including Death|7
6922499|NCT00811928|10951198|FG001|Overall Study|AEs and SAEs Including Death|11
6922500|NCT00811928|10951197|FG000|Overall Study|Withdrawal by Subject|18
6922501|NCT00811928|10951198|FG001|Overall Study|Withdrawal by Subject|12
6922502|NCT00811928|10951197|FG000|Overall Study|Did Not Take Study Drug|3
6922503|NCT00811928|10951198|FG001|Overall Study|Did Not Take Study Drug|0
6922504|NCT00811928|10951197|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7
6922505|NCT00811928|10951198|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4
6922506|NCT00811928|10951197|FG000|Overall Study|Investigator Decision|2
6922507|NCT00811928|10951198|FG001|Overall Study|Investigator Decision|1
6922508|NCT00811928|10951197|FG000|Overall Study|Poor Compliance|2
6922509|NCT00811928|10951198|FG001|Overall Study|Poor Compliance|5
6922510|NCT00811941|10951206|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2
6922511|NCT00811941|10951207|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8
6922512|NCT00811941|10951206|FG000|All Treated Patients|Adverse Event|2
6922513|NCT00811941|10951207|FG001|All Treated Patients|Adverse Event|43
6922514|NCT00811941|10951206|FG000|All Treated Patients|Lack of Efficacy|2
6922515|NCT00811941|10951207|FG001|All Treated Patients|Lack of Efficacy|3
6922516|NCT00811941|10951206|FG000|All Treated Patients|Non-compliance|1
6922517|NCT00811941|10951207|FG001|All Treated Patients|Non-compliance|8
6922518|NCT00811941|10951206|FG000|All Treated Patients|Protocol Violation|5
6922519|NCT00811941|10951207|FG001|All Treated Patients|Protocol Violation|17
6922520|NCT00811941|10951206|FG000|All Treated Patients|Withdrawal by Subject|35
6922521|NCT00811941|10951207|FG001|All Treated Patients|Withdrawal by Subject|94
6922522|NCT00811941|10951206|FG000|All Treated Patients|Lost to Follow-up|3
6922523|NCT00811941|10951207|FG001|All Treated Patients|Lost to Follow-up|12
6922524|NCT00811941|10951206|FG000|All Treated Patients|Other Reason|4
6922525|NCT00811941|10951207|FG001|All Treated Patients|Other Reason|14
6922526|NCT00811954|10951216|FG000|Overall Study|Death|10
6922527|NCT00811954|10951217|FG001|Overall Study|Death|6
6922528|NCT00811954|10951218|FG002|Overall Study|Death|13
7060733|NCT01922037|11157241|FG001|Overall Study|Death|5
7060734|NCT01922037|11157240|FG000|Overall Study|Pregnancy|0
7060735|NCT01922037|11157241|FG001|Overall Study|Pregnancy|2
7060736|NCT01922037|11157240|FG000|Overall Study|Participant non-compliance|4
7060737|NCT01922037|11157241|FG001|Overall Study|Participant non-compliance|46
7060738|NCT01922037|11157240|FG000|Overall Study|Investigator/Sponsor decision|1
7060739|NCT01922037|11157241|FG001|Overall Study|Investigator/Sponsor decision|4
7060740|NCT01922037|11157240|FG000|Overall Study|Other unspecified|2
7060741|NCT01922037|11157241|FG001|Overall Study|Other unspecified|66
7060742|NCT01922089|11157308|FG000|Overall Study|Adverse Event|18
7060743|NCT01922089|11157309|FG001|Overall Study|Adverse Event|13
7060744|NCT01922089|11157308|FG000|Overall Study|Protocol Deviation|10
7060745|NCT01922089|11157309|FG001|Overall Study|Protocol Deviation|7
7060746|NCT01922089|11157308|FG000|Overall Study|Withdrawal by Subject|3
7060747|NCT01922089|11157309|FG001|Overall Study|Withdrawal by Subject|4
7060748|NCT01922089|11157308|FG000|Overall Study|administrative problems|4
7060749|NCT01922089|11157309|FG001|Overall Study|administrative problems|1
7060750|NCT01922089|11157308|FG000|Overall Study|Physician Decision|2
7060751|NCT01922089|11157309|FG001|Overall Study|Physician Decision|3
7060752|NCT01922089|11157308|FG000|Overall Study|Death|2
6922529|NCT00811954|10951216|FG000|Overall Study|Lost to Follow-up|29
6922530|NCT00811954|10951217|FG001|Overall Study|Lost to Follow-up|23
6922531|NCT00811954|10951218|FG002|Overall Study|Lost to Follow-up|34
6922532|NCT00811954|10951216|FG000|Overall Study|Not able to get to clinic|28
7060753|NCT01922089|11157309|FG001|Overall Study|Death|1
7060754|NCT01922089|11157308|FG000|Overall Study|Lost to Follow-up|0
7060755|NCT01922089|11157309|FG001|Overall Study|Lost to Follow-up|1
7060756|NCT01922102|11157318|FG000|Overall Study|Withdrawal by Subject|7
7145271|NCT03073200|11303569|FG003|Post-Treatment Follow-Up Period|Adverse Event|0
6922533|NCT00811954|10951217|FG001|Overall Study|Not able to get to clinic|35
6922534|NCT00811954|10951218|FG002|Overall Study|Not able to get to clinic|30
6922535|NCT00811954|10951216|FG000|Overall Study|Not willing to adhere to requirements|12
6922536|NCT00811954|10951217|FG001|Overall Study|Not willing to adhere to requirements|2
6922537|NCT00811954|10951218|FG002|Overall Study|Not willing to adhere to requirements|16
6922538|NCT00811954|10951216|FG000|Overall Study|Withdraw consent prior study completion|4
7037509|NCT01696032|11119469|FG000|Overall Study|Lost to Follow-up|0
7037510|NCT01696032|11119470|FG001|Overall Study|Lost to Follow-up|1
7037511|NCT01696032|11119471|FG002|Overall Study|Lost to Follow-up|0
7037512|NCT01696032|11119472|FG003|Overall Study|Lost to Follow-up|0
7037513|NCT01696032|11119469|FG000|Overall Study|Database lock|0
7037514|NCT01696032|11119470|FG001|Overall Study|Database lock|1
7037515|NCT01696032|11119471|FG002|Overall Study|Database lock|7
7037516|NCT01696032|11119472|FG003|Overall Study|Database lock|2
7037517|NCT01696045|11119488|FG000|Overall Study|Study drug toxicity|1
7037518|NCT01696045|11119489|FG001|Overall Study|Study drug toxicity|5
7037519|NCT01696045|11119488|FG000|Overall Study|Disease progression|2
7037520|NCT01696045|11119489|FG001|Overall Study|Disease progression|2
6922539|NCT00811954|10951217|FG001|Overall Study|Withdraw consent prior study completion|6
6922540|NCT00811954|10951218|FG002|Overall Study|Withdraw consent prior study completion|5
6922541|NCT00811954|10951216|FG000|Overall Study|Site Closure|4
6922542|NCT00811954|10951217|FG001|Overall Study|Site Closure|0
6922543|NCT00811954|10951218|FG002|Overall Study|Site Closure|1
6922544|NCT00811954|10951216|FG000|Overall Study|Severe Debilitation|2
6922545|NCT00811954|10951217|FG001|Overall Study|Severe Debilitation|0
6922546|NCT00811954|10951218|FG002|Overall Study|Severe Debilitation|1
7145272|NCT03073200|11303570|FG004|Post-Treatment Follow-Up Period|Adverse Event|0
7145273|NCT03073200|11303571|FG005|Post-Treatment Follow-Up Period|Adverse Event|0
7145274|NCT03073200|11303572|FG006|Post-Treatment Follow-Up Period|Adverse Event|0
7145275|NCT03073200|11303573|FG007|Post-Treatment Follow-Up Period|Adverse Event|0
7145276|NCT03073200|11303574|FG008|Post-Treatment Follow-Up Period|Adverse Event|0
7145277|NCT03073200|11303575|FG009|Post-Treatment Follow-Up Period|Adverse Event|0
7037521|NCT01696058|11119497|FG000|Overall Study|Adverse Event|21
7037522|NCT01696058|11119498|FG001|Overall Study|Adverse Event|11
7037523|NCT01696058|11119497|FG000|Overall Study|Lack of Efficacy|2
7037524|NCT01696058|11119498|FG001|Overall Study|Lack of Efficacy|3
7037525|NCT01696058|11119497|FG000|Overall Study|Protocol Violation|9
7037526|NCT01696058|11119498|FG001|Overall Study|Protocol Violation|3
7037527|NCT01696058|11119497|FG000|Overall Study|Lost to Follow-up|2
7037528|NCT01696058|11119498|FG001|Overall Study|Lost to Follow-up|5
7037529|NCT01696058|11119497|FG000|Overall Study|Withdrawal by Subject|4
7037530|NCT01696058|11119498|FG001|Overall Study|Withdrawal by Subject|6
7037531|NCT01696058|11119497|FG000|Overall Study|Other reason prematurely discontinued|5
7037532|NCT01696058|11119498|FG001|Overall Study|Other reason prematurely discontinued|3
7037533|NCT01696071|11119504|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1
7037534|NCT01696071|11119505|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0
7037535|NCT01696188|11119523|FG000|Overall Study|Protocol Violation|1
7037536|NCT01696188|11119524|FG001|Overall Study|Protocol Violation|1
7037537|NCT01696214|11119534|FG000|Overall Study|Lost to Follow-up|1
7037538|NCT01696214|11119535|FG001|Overall Study|Lost to Follow-up|0
7037539|NCT01696214|11119536|FG002|Overall Study|Lost to Follow-up|0
7037540|NCT01696214|11119537|FG003|Overall Study|Lost to Follow-up|0
7037541|NCT01696279|11119555|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1
7037542|NCT01696279|11119556|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
7037543|NCT01696279|11119557|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
7037544|NCT01696279|11119558|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
7037545|NCT01696279|11119555|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
7037546|NCT01696279|11119556|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5
7037547|NCT01696279|11119557|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
7037548|NCT01696279|11119558|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
7037549|NCT01696279|11119555|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
7037550|NCT01696279|11119556|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1
7037551|NCT01696279|11119557|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
7037552|NCT01696279|11119558|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
7037553|NCT01696279|11119555|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
7145278|NCT03073200|11303576|FG010|Post-Treatment Follow-Up Period|Adverse Event|0
7145279|NCT03073200|11303577|FG011|Post-Treatment Follow-Up Period|Adverse Event|0
7145280|NCT03073200|11303578|FG012|Post-Treatment Follow-Up Period|Adverse Event|0
7145281|NCT03073200|11303579|FG013|Post-Treatment Follow-Up Period|Adverse Event|2
7145282|NCT03073200|11303580|FG014|Post-Treatment Follow-Up Period|Adverse Event|0
6922547|NCT00811954|10951216|FG000|Overall Study|Complete Protocol: No follow-up|0
6922548|NCT00811954|10951217|FG001|Overall Study|Complete Protocol: No follow-up|0
6922549|NCT00811954|10951218|FG002|Overall Study|Complete Protocol: No follow-up|1
6922550|NCT00812097|10951230|FG000|Overall Study|Death|3
6922551|NCT00812097|10951231|FG001|Overall Study|Death|10
7037554|NCT01696279|11119556|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1
7044739|NCT01756846|11130693|FG000|Overall Study|Withdrawal by Subject|1
7037555|NCT01696279|11119557|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
7037556|NCT01696279|11119558|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
7037557|NCT01696279|11119555|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
7037558|NCT01696279|11119556|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3
7037559|NCT01696279|11119557|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
7037560|NCT01696279|11119558|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
7037561|NCT01696279|11119555|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
7037562|NCT01696279|11119556|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7
7037563|NCT01696279|11119557|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
7037564|NCT01696279|11119558|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
7037565|NCT01696279|11119555|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
7037566|NCT01696279|11119556|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2
7037567|NCT01696279|11119557|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
7037568|NCT01696279|11119558|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
7037569|NCT01696279|11119555|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
7037570|NCT01696279|11119556|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
7037571|NCT01696279|11119557|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1
7037572|NCT01696279|11119558|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
7037573|NCT01696279|11119555|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
7037574|NCT01696279|11119556|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
7037575|NCT01696279|11119557|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
7037576|NCT01696279|11119558|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6
7037577|NCT01696279|11119555|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
7037578|NCT01696279|11119556|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
7037579|NCT01696279|11119557|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
7037580|NCT01696279|11119558|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1
7037581|NCT01696279|11119555|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
7037582|NCT01696279|11119556|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
7037583|NCT01696279|11119557|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
7037584|NCT01696279|11119558|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1
7037585|NCT01696396|11119580|FG000|Overall Study|Withdrawal by Subject|19
7037586|NCT01696396|11119581|FG001|Overall Study|Withdrawal by Subject|5
7037587|NCT01696396|11119582|FG002|Overall Study|Withdrawal by Subject|19
7037588|NCT01696396|11119583|FG003|Overall Study|Withdrawal by Subject|11
7037589|NCT01696396|11119580|FG000|Overall Study|Decision by Sponsor|3
7037590|NCT01696396|11119581|FG001|Overall Study|Decision by Sponsor|1
7037591|NCT01696396|11119582|FG002|Overall Study|Decision by Sponsor|2
7037592|NCT01696396|11119583|FG003|Overall Study|Decision by Sponsor|2
7037593|NCT01696396|11119580|FG000|Overall Study|Lost to Follow-up|9
7037594|NCT01696396|11119581|FG001|Overall Study|Lost to Follow-up|1
7037595|NCT01696396|11119582|FG002|Overall Study|Lost to Follow-up|4
7037596|NCT01696396|11119583|FG003|Overall Study|Lost to Follow-up|1
7037597|NCT01696396|11119580|FG000|Overall Study|Death|0
7145283|NCT03073200|11303566|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7145284|NCT03073200|11303567|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7145285|NCT03073200|11303568|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7145286|NCT03073200|11303569|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7145287|NCT03073200|11303570|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7145288|NCT03073200|11303571|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7145289|NCT03073200|11303572|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0
6922552|NCT00812097|10951232|FG002|Overall Study|Death|3
6922553|NCT00812097|10951233|FG003|Overall Study|Death|3
6922554|NCT00812097|10951230|FG000|Overall Study|Withdrawal by Subject|14
6922555|NCT00812097|10951231|FG001|Overall Study|Withdrawal by Subject|12
7145290|NCT03073200|11303573|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7145291|NCT03073200|11303574|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7145292|NCT03073200|11303575|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7145293|NCT03073200|11303576|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7145294|NCT03073200|11303577|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7145295|NCT03073200|11303578|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7145296|NCT03073200|11303579|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1
7145297|NCT03073200|11303580|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7145298|NCT03073200|11303566|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0
7145299|NCT03073200|11303567|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0
7145300|NCT03073200|11303568|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0
7145301|NCT03073200|11303569|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0
7145302|NCT03073200|11303570|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0
7037598|NCT01696396|11119581|FG001|Overall Study|Death|0
7037599|NCT01696396|11119582|FG002|Overall Study|Death|1
7037600|NCT01696396|11119583|FG003|Overall Study|Death|0
7037601|NCT01696643|11119599|FG000|Overall Study|Adverse Event|15
7037602|NCT01696643|11119600|FG001|Overall Study|Adverse Event|7
6922556|NCT00812097|10951232|FG002|Overall Study|Withdrawal by Subject|8
7145303|NCT03073200|11303571|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0
7145304|NCT03073200|11303572|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0
7145305|NCT03073200|11303573|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0
7145306|NCT03073200|11303574|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0
7145307|NCT03073200|11303575|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0
7145308|NCT03073200|11303576|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0
7145309|NCT03073200|11303577|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0
7145310|NCT03073200|11303578|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0
7145311|NCT03073200|11303579|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1
7145312|NCT03073200|11303580|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0
7145313|NCT03073200|11303566|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0
7145314|NCT03073200|11303567|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0
7145315|NCT03073200|11303568|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0
7145316|NCT03073200|11303569|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0
7145317|NCT03073200|11303570|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0
7145318|NCT03073200|11303571|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0
7145319|NCT03073200|11303572|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0
7145320|NCT03073200|11303573|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0
7145321|NCT03073200|11303574|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0
7145322|NCT03073200|11303575|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0
7145323|NCT03073200|11303576|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0
7145324|NCT03073200|11303577|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0
7145325|NCT03073200|11303578|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0
7145326|NCT03073200|11303579|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1
7145327|NCT03073200|11303580|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0
7145328|NCT03073200|11303566|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7145329|NCT03073200|11303567|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7145330|NCT03073200|11303568|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7145331|NCT03073200|11303569|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7145332|NCT03073200|11303570|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7145333|NCT03073200|11303571|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7145334|NCT03073200|11303572|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7145335|NCT03073200|11303573|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7145336|NCT03073200|11303574|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7145337|NCT03073200|11303575|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7145338|NCT03073200|11303576|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7145339|NCT03073200|11303577|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7145340|NCT03073200|11303578|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7145341|NCT03073200|11303579|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7145342|NCT03073200|11303580|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1
7145343|NCT03073200|11303566|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7145344|NCT03073200|11303567|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7145345|NCT03073200|11303568|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7145346|NCT03073200|11303569|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7145347|NCT03073200|11303570|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7145348|NCT03073200|11303571|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7145349|NCT03073200|11303572|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7145350|NCT03073200|11303573|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7145351|NCT03073200|11303574|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7145352|NCT03073200|11303575|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7145353|NCT03073200|11303576|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
6922557|NCT00812097|10951233|FG003|Overall Study|Withdrawal by Subject|2
6922558|NCT00812097|10951230|FG000|Overall Study|Lost to Follow-up|90
6922559|NCT00812097|10951231|FG001|Overall Study|Lost to Follow-up|14
6922560|NCT00812097|10951232|FG002|Overall Study|Lost to Follow-up|17
6922561|NCT00812097|10951233|FG003|Overall Study|Lost to Follow-up|5
6922562|NCT00812097|10951230|FG000|Overall Study|Explantation of study device(s)|27
6922563|NCT00812097|10951231|FG001|Overall Study|Explantation of study device(s)|29
6922564|NCT00812097|10951232|FG002|Overall Study|Explantation of study device(s)|14
6922565|NCT00812097|10951233|FG003|Overall Study|Explantation of study device(s)|20
6922566|NCT00812097|10951230|FG000|Overall Study|Unknown reasons and patient/doctor moves|111
6922567|NCT00812097|10951231|FG001|Overall Study|Unknown reasons and patient/doctor moves|24
6922568|NCT00812097|10951232|FG002|Overall Study|Unknown reasons and patient/doctor moves|15
6922569|NCT00812097|10951233|FG003|Overall Study|Unknown reasons and patient/doctor moves|5
6974631|NCT01189266|11026782|FG002|Overall Study|Withdrawal by Subject|1
6974632|NCT01189266|11026780|FG000|Overall Study|Patient refuses further therapy|1
6974633|NCT01189266|11026781|FG001|Overall Study|Patient refuses further therapy|0
6974634|NCT01189266|11026782|FG002|Overall Study|Patient refuses further therapy|7
7145354|NCT03073200|11303577|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7145355|NCT03073200|11303578|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7145356|NCT03073200|11303579|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11
7145357|NCT03073200|11303580|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7145358|NCT03073200|11303566|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7145359|NCT03073200|11303567|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7145360|NCT03073200|11303568|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7145361|NCT03073200|11303569|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7145362|NCT03073200|11303570|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7145363|NCT03073200|11303571|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7145364|NCT03073200|11303572|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7145365|NCT03073200|11303573|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7145366|NCT03073200|11303574|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7145367|NCT03073200|11303575|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7145368|NCT03073200|11303576|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7145369|NCT03073200|11303577|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7145370|NCT03073200|11303578|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7145371|NCT03073200|11303579|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9
7145372|NCT03073200|11303580|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7145373|NCT03073200|11303566|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7145374|NCT03073200|11303567|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7145375|NCT03073200|11303568|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7145376|NCT03073200|11303569|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7145377|NCT03073200|11303570|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7145378|NCT03073200|11303571|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7145379|NCT03073200|11303572|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7145380|NCT03073200|11303573|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7145381|NCT03073200|11303574|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7145382|NCT03073200|11303575|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7145383|NCT03073200|11303576|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7145384|NCT03073200|11303577|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7145385|NCT03073200|11303578|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7145386|NCT03073200|11303579|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2
7145387|NCT03073200|11303580|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7145388|NCT03073213|11303605|FG000|Multiple Dose Period|Protocol Violation|0
7145389|NCT03073213|11303606|FG001|Multiple Dose Period|Protocol Violation|0
7145390|NCT03073213|11303607|FG002|Multiple Dose Period|Protocol Violation|1
7145391|NCT03073798|11303635|FG000|Overall Study|Adverse Event|1
7145392|NCT03073798|11303635|FG000|Overall Study|Withdrawal by Subject|1
7145393|NCT03074162|11303660|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0
7145394|NCT03074162|11303661|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0
7145395|NCT03074162|11303662|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1
7145396|NCT03074162|11303663|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0
7145397|NCT03074162|11303664|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0
7145398|NCT03074162|11303665|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0
7145399|NCT03074162|11303660|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0
7145400|NCT03074162|11303661|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0
7145401|NCT03074162|11303662|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1
7145402|NCT03074162|11303663|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0
7145403|NCT03074162|11303664|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0
7145404|NCT03074162|11303665|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1
7145405|NCT03074162|11303660|FG000|Period 3|Withdrawal by Subject|1
7145406|NCT03074162|11303661|FG001|Period 3|Withdrawal by Subject|0
7145407|NCT03074162|11303662|FG002|Period 3|Withdrawal by Subject|0
7145408|NCT03074162|11303663|FG003|Period 3|Withdrawal by Subject|0
7145409|NCT03074162|11303664|FG004|Period 3|Withdrawal by Subject|1
7145410|NCT03074162|11303665|FG005|Period 3|Withdrawal by Subject|0
7145411|NCT03074331|11303673|FG000|Overall Study|Enrolled but Not Treated|1
7145412|NCT03074331|11303673|FG000|Overall Study|Lost to Follow-up|5
7145413|NCT03074331|11303673|FG000|Overall Study|Withdrew Consent|1
7145414|NCT03074500|11303689|FG000|Overall Study|Lost to Follow-up|1
7145415|NCT03074500|11303690|FG001|Overall Study|Lost to Follow-up|0
7145416|NCT03074500|11303691|FG002|Overall Study|Lost to Follow-up|0
7145417|NCT03074500|11303689|FG000|Overall Study|Lack of Efficacy|0
7145418|NCT03074500|11303690|FG001|Overall Study|Lack of Efficacy|1
7145419|NCT03074500|11303691|FG002|Overall Study|Lack of Efficacy|0
7145420|NCT03074500|11303689|FG000|Overall Study|Adverse Event|0
7145421|NCT03074500|11303690|FG001|Overall Study|Adverse Event|0
7145422|NCT03074500|11303691|FG002|Overall Study|Adverse Event|1
7145423|NCT03075163|11303730|FG000|Overall Study|not eligible for treatment limb|138
7145424|NCT03075163|11303731|FG001|Overall Study|not eligible for treatment limb|138
7145425|NCT03075267|11303740|FG000|Overall Study|Protocol Violation|1
7145426|NCT03075267|11303741|FG001|Overall Study|Protocol Violation|0
7145427|NCT03075267|11303742|FG002|Overall Study|Protocol Violation|0
7145428|NCT03075410|11303759|FG000|Part A-Period 2 (14 Days)|Personal reasons|1
7145429|NCT03075410|11303760|FG001|Part A-Period 2 (14 Days)|Personal reasons|0
7145430|NCT03075410|11303761|FG002|Part A-Period 2 (14 Days)|Personal reasons|1
7145431|NCT03075410|11303762|FG003|Part A-Period 2 (14 Days)|Personal reasons|0
7145432|NCT03075410|11303763|FG004|Part A-Period 2 (14 Days)|Personal reasons|0
7145433|NCT03075410|11303764|FG005|Part A-Period 2 (14 Days)|Personal reasons|0
7145434|NCT03075410|11303765|FG006|Part A-Period 2 (14 Days)|Personal reasons|0
7145435|NCT03075410|11303766|FG007|Part A-Period 2 (14 Days)|Personal reasons|0
7145436|NCT03075410|11303767|FG008|Part A-Period 2 (14 Days)|Personal reasons|0
7145437|NCT03075410|11303759|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1
7145438|NCT03075410|11303760|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
7145439|NCT03075410|11303761|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
7145440|NCT03075410|11303762|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
7145441|NCT03075410|11303763|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
7145442|NCT03075410|11303764|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
7145443|NCT03075410|11303765|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
7145444|NCT03075410|11303766|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
7145445|NCT03075410|11303767|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
7145446|NCT03075501|11303797|FG000|Overall Study|Scheduling difficulties|15
7145447|NCT03075501|11303798|FG001|Overall Study|Scheduling difficulties|9
7145448|NCT03075644|11303811|FG000|Overall Study|Withdrawal by Subject|1
7145449|NCT03075644|11303812|FG001|Overall Study|Withdrawal by Subject|1
7145450|NCT03075761|11303821|FG000|Overall Study|Lost to Follow-up|1
7145451|NCT03075761|11303822|FG001|Overall Study|Lost to Follow-up|6
7145452|NCT03075839|11303833|FG000|Overall Study|Lost to Follow-up|4
7145453|NCT03075878|11303837|FG000|Overall Study|Physician Decision|1
7145454|NCT03075891|11303843|FG000|Overall Study|Withdrawal by Subject|3
7145455|NCT03075891|11303844|FG001|Overall Study|Withdrawal by Subject|6
7145456|NCT03075891|11303843|FG000|Overall Study|Lost to Follow-up|1
6922570|NCT00812253|10951249|FG000|Overall Study|Withdrawal by Subject|3
6922571|NCT00812253|10951250|FG001|Overall Study|Withdrawal by Subject|2
6922572|NCT00812253|10951249|FG000|Overall Study|Protocol Violation|1
6922573|NCT00812253|10951250|FG001|Overall Study|Protocol Violation|1
6922574|NCT00812253|10951249|FG000|Overall Study|Lost to Follow-up|2
6922575|NCT00812253|10951250|FG001|Overall Study|Lost to Follow-up|0
6922576|NCT00812331|10951261|FG000|Overall Study|Adverse Event|1
6922577|NCT00812331|10951262|FG001|Overall Study|Adverse Event|0
6922578|NCT00812331|10951263|FG002|Overall Study|Adverse Event|0
6922579|NCT00812331|10951264|FG003|Overall Study|Adverse Event|0
6922580|NCT00812331|10951265|FG004|Overall Study|Adverse Event|0
6922581|NCT00812461|10951275|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23
6922582|NCT00812461|10951276|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17
6922583|NCT00812461|10951275|FG000|All Treated Patients|Adverse Event|8
6922584|NCT00812461|10951276|FG001|All Treated Patients|Adverse Event|15
6922585|NCT00812461|10951275|FG000|All Treated Patients|Lack of Efficacy|13
6922586|NCT00812461|10951276|FG001|All Treated Patients|Lack of Efficacy|7
6922587|NCT00812461|10951275|FG000|All Treated Patients|Non-compliance|6
6922588|NCT00812461|10951276|FG001|All Treated Patients|Non-compliance|9
6922589|NCT00812461|10951275|FG000|All Treated Patients|Protocol Violation|36
6922590|NCT00812461|10951276|FG001|All Treated Patients|Protocol Violation|27
6922591|NCT00812461|10951275|FG000|All Treated Patients|Withdrawal by Subject|45
6922592|NCT00812461|10951276|FG001|All Treated Patients|Withdrawal by Subject|54
6922593|NCT00812461|10951275|FG000|All Treated Patients|Lost to Follow-up|11
6922594|NCT00812461|10951276|FG001|All Treated Patients|Lost to Follow-up|14
6922595|NCT00812461|10951275|FG000|All Treated Patients|Other Reason|13
6922596|NCT00812461|10951276|FG001|All Treated Patients|Other Reason|21
6922597|NCT00812487|10951284|FG000|Overall Study|Lost to Follow-up|2
7037603|NCT01696643|11119599|FG000|Overall Study|Death|1
7037604|NCT01696643|11119600|FG001|Overall Study|Death|2
7037605|NCT01696643|11119599|FG000|Overall Study|Lack of Efficacy|3
7037606|NCT01696643|11119600|FG001|Overall Study|Lack of Efficacy|0
7037607|NCT01696643|11119599|FG000|Overall Study|Lost to Follow-up|67
7037608|NCT01696643|11119600|FG001|Overall Study|Lost to Follow-up|67
6922598|NCT00812487|10951285|FG001|Overall Study|Lost to Follow-up|0
6922599|NCT00812487|10951284|FG000|Overall Study|Withdrawal by Subject|3
6922600|NCT00812487|10951285|FG001|Overall Study|Withdrawal by Subject|2
6922601|NCT00812487|10951284|FG000|Overall Study|Transfer to ICU prior to intervention|1
6922602|NCT00812487|10951285|FG001|Overall Study|Transfer to ICU prior to intervention|0
6922603|NCT00812487|10951284|FG000|Overall Study|Protocol Violation|0
6922604|NCT00812487|10951285|FG001|Overall Study|Protocol Violation|1
6922605|NCT00812565|10951299|FG000|Overall Study|Did Not Receive Study Medication|1
6922606|NCT00812565|10951300|FG001|Overall Study|Did Not Receive Study Medication|1
6922607|NCT00812565|10951301|FG002|Overall Study|Did Not Receive Study Medication|0
6922608|NCT00812565|10951302|FG003|Overall Study|Did Not Receive Study Medication|0
7037609|NCT01696643|11119599|FG000|Overall Study|Physician Decision|3
6922609|NCT00812565|10951303|FG004|Overall Study|Did Not Receive Study Medication|0
6922610|NCT00812565|10951304|FG005|Overall Study|Did Not Receive Study Medication|0
6922611|NCT00812565|10951305|FG006|Overall Study|Did Not Receive Study Medication|0
7145457|NCT03075891|11303844|FG001|Overall Study|Lost to Follow-up|0
7145458|NCT03075891|11303843|FG000|Overall Study|Pregnancy|3
7145459|NCT03075891|11303844|FG001|Overall Study|Pregnancy|1
7145460|NCT03075891|11303843|FG000|Overall Study|visits not performed (no time)|1
7145461|NCT03075891|11303844|FG001|Overall Study|visits not performed (no time)|0
7145462|NCT03075891|11303843|FG000|Overall Study|Drug abuse relapse issue|0
7145463|NCT03075891|11303844|FG001|Overall Study|Drug abuse relapse issue|1
7145464|NCT03075891|11303843|FG000|Overall Study|Participant requiring study withdrawal|0
7145465|NCT03075891|11303844|FG001|Overall Study|Participant requiring study withdrawal|1
7145466|NCT03075891|11303843|FG000|Overall Study|Adverse event, non-fatal|1
7145467|NCT03075891|11303844|FG001|Overall Study|Adverse event, non-fatal|4
7145468|NCT03075904|11303852|FG000|Overall Study|Physician Decision|3
7145469|NCT03075904|11303852|FG000|Overall Study|Need for Medication not Permitted|1
7145470|NCT03076190|11303858|FG000|Overall Study|Lost to Follow-up|9
7145471|NCT03076190|11303859|FG001|Overall Study|Lost to Follow-up|34
7145472|NCT03076190|11303858|FG000|Overall Study|Excluded from Analysis (zero duration ev|9
7145473|NCT03076190|11303859|FG001|Overall Study|Excluded from Analysis (zero duration ev|7
7145474|NCT03076515|11303885|FG000|Overall Study|DMC decision based on interim analysis|25
7145475|NCT03076515|11303886|FG001|Overall Study|DMC decision based on interim analysis|29
7145476|NCT03076970|11303892|FG000|Washout Period 2|Adverse Event|0
7145477|NCT03076970|11303893|FG001|Washout Period 2|Adverse Event|0
6827293|NCT00124709|10829987|FG001|Overall Study|Adverse Event|0
6827294|NCT00124709|10829986|FG000|Overall Study|Lack of Efficacy|5
6827295|NCT00124709|10829987|FG001|Overall Study|Lack of Efficacy|10
6827296|NCT00124709|10829986|FG000|Overall Study|Protocol Violation|3
6827297|NCT00124709|10829987|FG001|Overall Study|Protocol Violation|5
7037610|NCT01696643|11119600|FG001|Overall Study|Physician Decision|2
7037611|NCT01696643|11119599|FG000|Overall Study|Pregnancy|0
6827298|NCT00124709|10829986|FG000|Overall Study|Withdrawal by Subject|127
6827299|NCT00124709|10829987|FG001|Overall Study|Withdrawal by Subject|136
6827300|NCT00124709|10829986|FG000|Overall Study|Lost to Follow-up|114
6827301|NCT00124709|10829987|FG001|Overall Study|Lost to Follow-up|120
6827302|NCT00124748|10830028|FG000|Overall Study|Adverse Event|8
6827303|NCT00124748|10830029|FG001|Overall Study|Adverse Event|39
6827304|NCT00124748|10830028|FG000|Overall Study|Abnormal laboratory Value|2
6827305|NCT00124748|10830029|FG001|Overall Study|Abnormal laboratory Value|2
6827306|NCT00124748|10830028|FG000|Overall Study|Abnormal Procedure|0
6827307|NCT00124748|10830029|FG001|Overall Study|Abnormal Procedure|1
6827308|NCT00124748|10830028|FG000|Overall Study|Lack of Efficacy|20
7037612|NCT01696643|11119600|FG001|Overall Study|Pregnancy|1
6827309|NCT00124748|10830029|FG001|Overall Study|Lack of Efficacy|41
6827310|NCT00124748|10830028|FG000|Overall Study|No longer requires study drug|1
6827311|NCT00124748|10830029|FG001|Overall Study|No longer requires study drug|1
6827312|NCT00124748|10830028|FG000|Overall Study|Protocol Violation|3
6827313|NCT00124748|10830029|FG001|Overall Study|Protocol Violation|1
6827314|NCT00124748|10830028|FG000|Overall Study|Withdrawal by Subject|5
6827315|NCT00124748|10830029|FG001|Overall Study|Withdrawal by Subject|15
6827316|NCT00124748|10830028|FG000|Overall Study|Lost to Follow-up|2
6827317|NCT00124748|10830029|FG001|Overall Study|Lost to Follow-up|7
6827318|NCT00124748|10830028|FG000|Overall Study|Administrative Problem(Study Terminated)|101
6827319|NCT00124748|10830029|FG001|Overall Study|Administrative Problem(Study Terminated)|174
6827320|NCT00124748|10830028|FG000|Overall Study|Death|1
6827321|NCT00124748|10830029|FG001|Overall Study|Death|3
6827322|NCT00124917|10830035|FG000|Overall Study|Physician Decision|3
6827323|NCT00124943|10830044|FG000|Phase II|Adverse Event|0
7037613|NCT01696643|11119599|FG000|Overall Study|Protocol Violation|7
7037614|NCT01696643|11119600|FG001|Overall Study|Protocol Violation|7
7037615|NCT01696643|11119599|FG000|Overall Study|Study Terminated by Sponsor|286
6827324|NCT00124943|10830045|FG001|Phase II|Adverse Event|2
6827325|NCT00124943|10830046|FG002|Phase II|Adverse Event|0
6827326|NCT00124943|10830047|FG003|Phase II|Adverse Event|1
6827327|NCT00124943|10830044|FG000|Phase II|Protocol Violation|0
6827328|NCT00124943|10830045|FG001|Phase II|Protocol Violation|0
7037616|NCT01696643|11119600|FG001|Overall Study|Study Terminated by Sponsor|294
7037617|NCT01696643|11119599|FG000|Overall Study|Withdrawal by Subject|142
7037618|NCT01696643|11119600|FG001|Overall Study|Withdrawal by Subject|149
7037619|NCT01696643|11119599|FG000|Overall Study|Participant on Restricted Bed Rest|1
7037620|NCT01696643|11119600|FG001|Overall Study|Participant on Restricted Bed Rest|0
7037621|NCT01696643|11119599|FG000|Overall Study|Site Error|2
7037622|NCT01696643|11119600|FG001|Overall Study|Site Error|1
7037623|NCT01696643|11119599|FG000|Overall Study|Participant Incarcerated|0
7037624|NCT01696643|11119600|FG001|Overall Study|Participant Incarcerated|1
7037625|NCT01696643|11119599|FG000|Overall Study|Medical Monitor Decision|0
7037626|NCT01696643|11119600|FG001|Overall Study|Medical Monitor Decision|2
7037627|NCT01696643|11119599|FG000|Overall Study|Participant Did Not Receive Study Drug|2
7037628|NCT01696643|11119600|FG001|Overall Study|Participant Did Not Receive Study Drug|2
7037629|NCT01696695|11119606|FG000|Overall Study|Disease progression|373
7037630|NCT01696695|11119606|FG000|Overall Study|Death|29
6827329|NCT00124943|10830046|FG002|Phase II|Protocol Violation|0
6827330|NCT00124943|10830047|FG003|Phase II|Protocol Violation|1
7037631|NCT01696695|11119606|FG000|Overall Study|Adverse Event|74
7037632|NCT01696695|11119606|FG000|Overall Study|Withdrawal by Subject|92
7037633|NCT01696695|11119606|FG000|Overall Study|Lost to Follow-up|48
7145478|NCT03076970|11303894|FG002|Washout Period 2|Adverse Event|0
7145479|NCT03076970|11303895|FG003|Washout Period 2|Adverse Event|0
7145480|NCT03076970|11303896|FG004|Washout Period 2|Adverse Event|1
7145481|NCT03076970|11303897|FG005|Washout Period 2|Adverse Event|0
7145482|NCT03076970|11303892|FG000|Period 3|Withdrawal by Subject|0
7145483|NCT03076970|11303893|FG001|Period 3|Withdrawal by Subject|0
7145484|NCT03076970|11303894|FG002|Period 3|Withdrawal by Subject|0
7145485|NCT03076970|11303895|FG003|Period 3|Withdrawal by Subject|0
7145486|NCT03076970|11303896|FG004|Period 3|Withdrawal by Subject|0
7145487|NCT03076970|11303897|FG005|Period 3|Withdrawal by Subject|1
7145488|NCT03076970|11303892|FG000|Period 3|Failure to meet I/E criteria|0
7145489|NCT03076970|11303893|FG001|Period 3|Failure to meet I/E criteria|0
7145490|NCT03076970|11303894|FG002|Period 3|Failure to meet I/E criteria|0
7145491|NCT03076970|11303895|FG003|Period 3|Failure to meet I/E criteria|0
7145492|NCT03076970|11303896|FG004|Period 3|Failure to meet I/E criteria|1
7145493|NCT03076970|11303897|FG005|Period 3|Failure to meet I/E criteria|0
7145494|NCT03076996|11303917|FG000|Overall Study|Withdrawal by Subject|2
7145495|NCT03076996|11303917|FG000|Overall Study|Lost to Follow-up|3
7145496|NCT03076996|11303917|FG000|Overall Study|Literacy precluded participation|1
7145497|NCT03077607|11303948|FG000|Period 1 (15 Days)|Adverse Event|1
7145498|NCT03077607|11303949|FG001|Period 1 (15 Days)|Adverse Event|0
7145499|NCT03077607|11303948|FG000|Period 1 (15 Days)|Death|1
7145500|NCT03077607|11303949|FG001|Period 1 (15 Days)|Death|0
7145501|NCT03077607|11303948|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1
7145502|NCT03077607|11303949|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0
7145503|NCT03077607|11303948|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2
7145504|NCT03077607|11303949|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2
7145505|NCT03077646|11303969|FG000|Overall Study|Lost to Follow-up|29
7145506|NCT03077646|11303970|FG001|Overall Study|Lost to Follow-up|30
7145507|NCT03077646|11303971|FG002|Overall Study|Lost to Follow-up|31
7145508|NCT03077659|11303982|FG000|Overall Study|Withdrawal by Subject|0
7145509|NCT03077659|11303983|FG001|Overall Study|Withdrawal by Subject|0
7145510|NCT03077659|11303984|FG002|Overall Study|Withdrawal by Subject|1
7145511|NCT03077711|11303997|FG000|Overall Study|Lost to Follow-up|2
7145512|NCT03077711|11303998|FG001|Overall Study|Lost to Follow-up|2
7145513|NCT03077711|11303997|FG000|Overall Study|noncompliant taking medication|2
7145514|NCT03077711|11303998|FG001|Overall Study|noncompliant taking medication|0
7145515|NCT03077724|11304008|FG000|Overall Study|Lost to Follow-up|5
7145516|NCT03077724|11304009|FG001|Overall Study|Lost to Follow-up|1
7145517|NCT03077724|11304008|FG000|Overall Study|Withdrawal by Subject|3
7145518|NCT03077724|11304009|FG001|Overall Study|Withdrawal by Subject|1
7145519|NCT03077919|11304027|FG000|Overall Study|Lost to Follow-up|4
7145520|NCT03077919|11304028|FG001|Overall Study|Lost to Follow-up|1
7183701|NCT01302847|11383784|FG004|Overall Study|Virologic failure|1
7183702|NCT01302847|11383785|FG005|Overall Study|Virologic failure|1
7183703|NCT01302847|11383786|FG006|Overall Study|Virologic failure|0
7183704|NCT01302847|11383787|FG007|Overall Study|Virologic failure|2
7183705|NCT01302847|11383780|FG000|Overall Study|Severe debilitation, unable to continue|0
7183706|NCT01302847|11383781|FG001|Overall Study|Severe debilitation, unable to continue|0
7183707|NCT01302847|11383782|FG002|Overall Study|Severe debilitation, unable to continue|0
7183708|NCT01302847|11383783|FG003|Overall Study|Severe debilitation, unable to continue|0
7183709|NCT01302847|11383784|FG004|Overall Study|Severe debilitation, unable to continue|0
7183710|NCT01302847|11383785|FG005|Overall Study|Severe debilitation, unable to continue|1
7183711|NCT01302847|11383786|FG006|Overall Study|Severe debilitation, unable to continue|1
7183712|NCT01302847|11383787|FG007|Overall Study|Severe debilitation, unable to continue|0
7183713|NCT01302847|11383780|FG000|Overall Study|Not able to get to clinic|1
7183714|NCT01302847|11383781|FG001|Overall Study|Not able to get to clinic|1
7183715|NCT01302847|11383782|FG002|Overall Study|Not able to get to clinic|0
7183716|NCT01302847|11383783|FG003|Overall Study|Not able to get to clinic|0
7183717|NCT01302847|11383784|FG004|Overall Study|Not able to get to clinic|0
7183718|NCT01302847|11383785|FG005|Overall Study|Not able to get to clinic|0
7183719|NCT01302847|11383786|FG006|Overall Study|Not able to get to clinic|0
7183720|NCT01302847|11383787|FG007|Overall Study|Not able to get to clinic|0
7183721|NCT01302847|11383780|FG000|Overall Study|Site closing|2
7183722|NCT01302847|11383781|FG001|Overall Study|Site closing|2
7183723|NCT01302847|11383782|FG002|Overall Study|Site closing|0
7183724|NCT01302847|11383783|FG003|Overall Study|Site closing|0
7183725|NCT01302847|11383784|FG004|Overall Study|Site closing|0
7183726|NCT01302847|11383785|FG005|Overall Study|Site closing|0
7183727|NCT01302847|11383786|FG006|Overall Study|Site closing|0
7183728|NCT01302847|11383787|FG007|Overall Study|Site closing|0
6922612|NCT00812565|10951306|FG007|Overall Study|Did Not Receive Study Medication|0
6922613|NCT00812565|10951299|FG000|Overall Study|Adverse Event|0
6922614|NCT00812565|10951300|FG001|Overall Study|Adverse Event|0
6922615|NCT00812565|10951301|FG002|Overall Study|Adverse Event|0
6922616|NCT00812565|10951302|FG003|Overall Study|Adverse Event|2
6922617|NCT00812565|10951303|FG004|Overall Study|Adverse Event|0
6922618|NCT00812565|10951304|FG005|Overall Study|Adverse Event|0
6922619|NCT00812565|10951305|FG006|Overall Study|Adverse Event|0
6922620|NCT00812565|10951306|FG007|Overall Study|Adverse Event|1
7183729|NCT01302847|11383780|FG000|Overall Study|Withdrawal by Subject|1
7183730|NCT01302847|11383781|FG001|Overall Study|Withdrawal by Subject|0
6922621|NCT00812565|10951299|FG000|Overall Study|Did Not Come to Study Visit|1
7145521|NCT03078556|11304085|FG000|Treatment Period 1 (4 Days)|Adverse Event|0
7145522|NCT03078556|11304086|FG001|Treatment Period 1 (4 Days)|Adverse Event|1
7145523|NCT03078556|11304087|FG002|Treatment Period 1 (4 Days)|Adverse Event|0
7145524|NCT03078556|11304088|FG003|Treatment Period 1 (4 Days)|Adverse Event|0
7145525|NCT03078556|11304085|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2
7145526|NCT03078556|11304086|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0
7145527|NCT03078556|11304087|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1
7145528|NCT03078556|11304088|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0
7145529|NCT03078556|11304085|FG000|Washout Period 1 (7 Days)|Adverse Event|0
7145530|NCT03078556|11304086|FG001|Washout Period 1 (7 Days)|Adverse Event|1
7145531|NCT03078556|11304087|FG002|Washout Period 1 (7 Days)|Adverse Event|0
7145532|NCT03078556|11304088|FG003|Washout Period 1 (7 Days)|Adverse Event|1
7145533|NCT03078556|11304085|FG000|Washout Period 1 (7 Days)|Physician Decision|0
7145534|NCT03078556|11304086|FG001|Washout Period 1 (7 Days)|Physician Decision|1
7145535|NCT03078556|11304087|FG002|Washout Period 1 (7 Days)|Physician Decision|0
7145536|NCT03078556|11304088|FG003|Washout Period 1 (7 Days)|Physician Decision|0
7145537|NCT03078582|11304115|FG000|Overall Study|Adverse Event|0
7145538|NCT03078582|11304116|FG001|Overall Study|Adverse Event|8
7145539|NCT03078751|11304146|FG000|Overall Study|Adverse Event|4
7145540|NCT03078751|11304147|FG001|Overall Study|Adverse Event|0
7145541|NCT03078751|11304146|FG000|Overall Study|Physician Decision|1
7145542|NCT03078751|11304147|FG001|Overall Study|Physician Decision|0
7145543|NCT03078751|11304146|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0
7145544|NCT03078751|11304147|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23
7145545|NCT03078751|11304146|FG000|Overall Study|Subject/guardian decision|8
7145546|NCT03078751|11304147|FG001|Overall Study|Subject/guardian decision|1
7145547|NCT03078751|11304146|FG000|Overall Study|Untreated|0
7145548|NCT03078751|11304147|FG001|Overall Study|Untreated|4
7145549|NCT03078816|11304153|FG000|Overall Study|Withdrawal by Subject|1
7145550|NCT03078907|11304159|FG000|Overall Study|Adverse Event|2
7145551|NCT03078907|11304160|FG001|Overall Study|Adverse Event|0
7145552|NCT03078907|11304159|FG000|Overall Study|Other|1
7145553|NCT03078907|11304160|FG001|Overall Study|Other|0
7145554|NCT03078907|11304159|FG000|Overall Study|Protocol Violation|0
7145555|NCT03078907|11304160|FG001|Overall Study|Protocol Violation|1
7145556|NCT03080454|11304205|FG000|Baseline|Adverse Event|2
7145557|NCT03080454|11304205|FG000|Anodal Doublestim (5 Days)|Adverse Event|1
7145558|NCT03080454|11304205|FG000|Anodal FU (7 Days)|Lost to Follow-up|4
7145559|NCT03080493|11304214|FG000|Overall Study|Did not provide NRS pain results|1
7145560|NCT03080493|11304215|FG001|Overall Study|Did not provide NRS pain results|0
7145561|NCT03080493|11304214|FG000|Overall Study|Adverse Event|0
7145562|NCT03080493|11304215|FG001|Overall Study|Adverse Event|1
7145563|NCT03080493|11304214|FG000|Overall Study|Randomization error (parity group)|0
7145564|NCT03080493|11304215|FG001|Overall Study|Randomization error (parity group)|1
7145565|NCT03080961|11304221|FG000|Overall Study|Withdrawal by Subject|3
7145566|NCT03081884|11304239|FG000|Overall Study|deferred prostate cancer treatment|1
7145567|NCT03081884|11304239|FG000|Overall Study|metastasis managed with systemic therapy|3
7145568|NCT03082261|11304253|FG000|Overall Study|Death|4
7145569|NCT03082261|11304253|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1
7145570|NCT03082261|11304253|FG000|Overall Study|Insurance denial|1
7145571|NCT03082261|11304253|FG000|Overall Study|Peripheral lead added|1
7145572|NCT03082261|11304253|FG000|Overall Study|Withdrawal by Subject|40
7145573|NCT03082261|11304253|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2
7145574|NCT03082261|11304253|FG000|Overall Study|Subject implanted with device other than study device|1
7145575|NCT03082261|11304253|FG000|Overall Study|Lost to Follow-up|14
7145576|NCT03082261|11304253|FG000|Overall Study|Subject moved to a different state|1
7145577|NCT03082261|11304253|FG000|Overall Study|Subject non-compliance|2
7145578|NCT03082261|11304253|FG000|Overall Study|Subject participation terminated by investigator|9
7145579|NCT03082261|11304253|FG000|Overall Study|Subject participation terminated by sponsor|4
7145580|NCT03082261|11304253|FG000|Overall Study|System explant|19
7145581|NCT03082261|11304253|FG000|Overall Study|Unable to place lead(s)|2
7145582|NCT03082261|11304253|FG000|Overall Study|Unsuccessful trial evaluation period|19
7145583|NCT03082599|11304290|FG000|Overall Study|Lost to Follow-up|1
7145584|NCT03082599|11304291|FG001|Overall Study|Lost to Follow-up|0
7145585|NCT03083132|11304308|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0
7145586|NCT03083132|11304309|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2
7145587|NCT03083132|11304308|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1
7145588|NCT03083132|11304309|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0
7145589|NCT03083132|11304308|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0
7060757|NCT01922102|11157319|FG001|Overall Study|Withdrawal by Subject|3
7145590|NCT03083132|11304309|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1
7145591|NCT03083470|11304329|FG000|Overall Study|Lost to Follow-up|0
7145592|NCT03083470|11304330|FG001|Overall Study|Lost to Follow-up|0
7145593|NCT03083470|11304331|FG002|Overall Study|Lost to Follow-up|0
7145594|NCT03083470|11304332|FG003|Overall Study|Lost to Follow-up|0
7145595|NCT03083470|11304333|FG004|Overall Study|Lost to Follow-up|1
7145596|NCT03083470|11304329|FG000|Overall Study|Withdrawal by Subject|0
7145597|NCT03083470|11304330|FG001|Overall Study|Withdrawal by Subject|0
6922622|NCT00812565|10951300|FG001|Overall Study|Did Not Come to Study Visit|0
6922623|NCT00812565|10951301|FG002|Overall Study|Did Not Come to Study Visit|0
6922624|NCT00812565|10951302|FG003|Overall Study|Did Not Come to Study Visit|0
6922625|NCT00812565|10951303|FG004|Overall Study|Did Not Come to Study Visit|0
6922626|NCT00812565|10951304|FG005|Overall Study|Did Not Come to Study Visit|0
6922627|NCT00812565|10951305|FG006|Overall Study|Did Not Come to Study Visit|0
6922628|NCT00812565|10951306|FG007|Overall Study|Did Not Come to Study Visit|0
6922629|NCT00812565|10951299|FG000|Overall Study|Withdrawal of Consent|1
6922630|NCT00812565|10951300|FG001|Overall Study|Withdrawal of Consent|0
6922631|NCT00812565|10951301|FG002|Overall Study|Withdrawal of Consent|0
6922632|NCT00812565|10951302|FG003|Overall Study|Withdrawal of Consent|0
7145598|NCT03083470|11304331|FG002|Overall Study|Withdrawal by Subject|0
7145599|NCT03083470|11304332|FG003|Overall Study|Withdrawal by Subject|0
7145600|NCT03083470|11304333|FG004|Overall Study|Withdrawal by Subject|1
7145601|NCT03083483|11304348|FG000|Overall Study|Adverse Event|1
7145602|NCT03083483|11304349|FG001|Overall Study|Adverse Event|1
7145603|NCT03083483|11304350|FG002|Overall Study|Adverse Event|1
7145604|NCT03083483|11304348|FG000|Overall Study|Lost to Follow-up|2
7145605|NCT03083483|11304349|FG001|Overall Study|Lost to Follow-up|1
7145606|NCT03083483|11304350|FG002|Overall Study|Lost to Follow-up|1
7145607|NCT03083483|11304348|FG000|Overall Study|technological issues|1
7145608|NCT03083483|11304349|FG001|Overall Study|technological issues|0
7145609|NCT03083483|11304350|FG002|Overall Study|technological issues|1
7145610|NCT03083639|11304360|FG000|Washout Period (at Least 6 Days)|Pregnancy|0
7145611|NCT03083639|11304361|FG001|Washout Period (at Least 6 Days)|Pregnancy|1
7145612|NCT03083639|11304360|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1
7145613|NCT03083639|11304361|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0
7145614|NCT03083847|11304386|FG000|Main|Physician Decision|0
7145615|NCT03083847|11304387|FG001|Main|Physician Decision|0
7145616|NCT03083847|11304388|FG002|Main|Physician Decision|0
7145617|NCT03083847|11304389|FG003|Main|Physician Decision|0
7145618|NCT03083847|11304390|FG004|Main|Physician Decision|0
7145619|NCT03083847|11304391|FG005|Main|Physician Decision|1
7145620|NCT03083847|11304392|FG006|Main|Physician Decision|0
7145621|NCT03083847|11304393|FG007|Main|Physician Decision|0
7145622|NCT03083847|11304394|FG008|Main|Physician Decision|0
7145623|NCT03083847|11304395|FG009|Main|Physician Decision|0
7145624|NCT03083847|11304386|FG000|Main|Pregnancy|0
7145625|NCT03083847|11304387|FG001|Main|Pregnancy|0
7145626|NCT03083847|11304388|FG002|Main|Pregnancy|0
7145627|NCT03083847|11304389|FG003|Main|Pregnancy|0
7145628|NCT03083847|11304390|FG004|Main|Pregnancy|0
7145629|NCT03083847|11304391|FG005|Main|Pregnancy|0
7145630|NCT03083847|11304392|FG006|Main|Pregnancy|0
7145631|NCT03083847|11304393|FG007|Main|Pregnancy|1
7145632|NCT03083847|11304394|FG008|Main|Pregnancy|0
7145633|NCT03083847|11304395|FG009|Main|Pregnancy|0
7145634|NCT03083847|11304386|FG000|Main|Adverse Event|0
7145635|NCT03083847|11304387|FG001|Main|Adverse Event|0
7145636|NCT03083847|11304388|FG002|Main|Adverse Event|0
7145637|NCT03083847|11304389|FG003|Main|Adverse Event|0
7145638|NCT03083847|11304390|FG004|Main|Adverse Event|0
7145639|NCT03083847|11304391|FG005|Main|Adverse Event|0
7145640|NCT03083847|11304392|FG006|Main|Adverse Event|0
7145641|NCT03083847|11304393|FG007|Main|Adverse Event|2
7145642|NCT03083847|11304394|FG008|Main|Adverse Event|0
7145643|NCT03083847|11304395|FG009|Main|Adverse Event|0
7145644|NCT03083847|11304386|FG000|Main|Withdrawal by Subject|0
7145645|NCT03083847|11304387|FG001|Main|Withdrawal by Subject|0
7145646|NCT03083847|11304388|FG002|Main|Withdrawal by Subject|0
7145647|NCT03083847|11304389|FG003|Main|Withdrawal by Subject|0
7145648|NCT03083847|11304390|FG004|Main|Withdrawal by Subject|0
7145649|NCT03083847|11304391|FG005|Main|Withdrawal by Subject|0
7145650|NCT03083847|11304392|FG006|Main|Withdrawal by Subject|1
7145651|NCT03083847|11304393|FG007|Main|Withdrawal by Subject|1
7145652|NCT03083847|11304394|FG008|Main|Withdrawal by Subject|0
7145653|NCT03083847|11304395|FG009|Main|Withdrawal by Subject|0
7145654|NCT03083990|11304425|FG000|Overall Study|Adverse Event|1
7145655|NCT03083990|11304426|FG001|Overall Study|Adverse Event|0
7145656|NCT03084302|11304432|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9
7145657|NCT03084302|11304432|FG000|Overall Study|No valid objective monitor data|6
7145658|NCT03084315|11304439|FG000|Overall Study|Lost to Follow-up|8
7145659|NCT03084315|11304440|FG001|Overall Study|Lost to Follow-up|7
7145660|NCT03084315|11304439|FG000|Overall Study|Withdrawal by Subject|2
7145661|NCT03084315|11304440|FG001|Overall Study|Withdrawal by Subject|2
7145662|NCT03084796|11304452|FG000|Overall Study|Adverse Event|4
7145663|NCT03084796|11304453|FG001|Overall Study|Adverse Event|5
7145664|NCT03084796|11304454|FG002|Overall Study|Adverse Event|6
7145665|NCT03084796|11304455|FG003|Overall Study|Adverse Event|2
7145666|NCT03084796|11304456|FG004|Overall Study|Adverse Event|3
7145667|NCT03084796|11304457|FG005|Overall Study|Adverse Event|5
7145668|NCT03084796|11304452|FG000|Overall Study|Withdrawal by Subject|3
7145669|NCT03084796|11304453|FG001|Overall Study|Withdrawal by Subject|5
7145670|NCT03084796|11304454|FG002|Overall Study|Withdrawal by Subject|2
7145671|NCT03084796|11304455|FG003|Overall Study|Withdrawal by Subject|1
7145672|NCT03084796|11304456|FG004|Overall Study|Withdrawal by Subject|3
7145673|NCT03084796|11304457|FG005|Overall Study|Withdrawal by Subject|0
7145674|NCT03084796|11304452|FG000|Overall Study|Protocol Violation|0
7145675|NCT03084796|11304453|FG001|Overall Study|Protocol Violation|0
7145676|NCT03084796|11304454|FG002|Overall Study|Protocol Violation|1
7145677|NCT03084796|11304455|FG003|Overall Study|Protocol Violation|0
7145678|NCT03084796|11304456|FG004|Overall Study|Protocol Violation|1
7145679|NCT03084796|11304457|FG005|Overall Study|Protocol Violation|1
7145680|NCT03084796|11304452|FG000|Overall Study|Lack of Efficacy|0
7145681|NCT03084796|11304453|FG001|Overall Study|Lack of Efficacy|0
7145682|NCT03084796|11304454|FG002|Overall Study|Lack of Efficacy|1
6922633|NCT00812565|10951303|FG004|Overall Study|Withdrawal of Consent|1
6922634|NCT00812565|10951304|FG005|Overall Study|Withdrawal of Consent|0
6922635|NCT00812565|10951305|FG006|Overall Study|Withdrawal of Consent|0
6922636|NCT00812565|10951306|FG007|Overall Study|Withdrawal of Consent|0
6922637|NCT00812565|10951299|FG000|Overall Study|Reason Not Specified|0
6922638|NCT00812565|10951300|FG001|Overall Study|Reason Not Specified|0
6922639|NCT00812565|10951301|FG002|Overall Study|Reason Not Specified|0
6922640|NCT00812565|10951302|FG003|Overall Study|Reason Not Specified|0
6922641|NCT00812565|10951303|FG004|Overall Study|Reason Not Specified|0
6922642|NCT00812565|10951304|FG005|Overall Study|Reason Not Specified|1
6922643|NCT00812565|10951305|FG006|Overall Study|Reason Not Specified|0
6922644|NCT00812565|10951306|FG007|Overall Study|Reason Not Specified|0
6922645|NCT00812812|10951335|FG000|Overall Study|Adverse Event|2
6922646|NCT00812812|10951336|FG001|Overall Study|Adverse Event|1
6922647|NCT00812812|10951335|FG000|Overall Study|Lack of Efficacy|1
6922648|NCT00812812|10951336|FG001|Overall Study|Lack of Efficacy|0
6922649|NCT00812812|10951335|FG000|Overall Study|Lost to Follow-up|0
6922650|NCT00812812|10951336|FG001|Overall Study|Lost to Follow-up|1
6922651|NCT00812812|10951335|FG000|Overall Study|Withdrawal by Subject|0
6922652|NCT00812812|10951336|FG001|Overall Study|Withdrawal by Subject|2
6922653|NCT00812929|10951370|FG000|Washout Period 1 (7 Days)|Physician Decision|0
6922654|NCT00812929|10951371|FG001|Washout Period 1 (7 Days)|Physician Decision|0
6922655|NCT00812929|10951372|FG002|Washout Period 1 (7 Days)|Physician Decision|1
6922656|NCT00812929|10951373|FG003|Washout Period 1 (7 Days)|Physician Decision|0
6922657|NCT00812929|10951374|FG004|Washout Period 1 (7 Days)|Physician Decision|0
6922658|NCT00812929|10951375|FG005|Washout Period 1 (7 Days)|Physician Decision|0
6922659|NCT00812929|10951376|FG006|Washout Period 1 (7 Days)|Physician Decision|0
6922660|NCT00812929|10951377|FG007|Washout Period 1 (7 Days)|Physician Decision|0
6922661|NCT00812929|10951378|FG008|Washout Period 1 (7 Days)|Physician Decision|0
6922662|NCT00812929|10951379|FG009|Washout Period 1 (7 Days)|Physician Decision|0
6922663|NCT00812929|10951370|FG000|Washout Period 2 (7 Days)|Physician Decision|0
6922664|NCT00812929|10951371|FG001|Washout Period 2 (7 Days)|Physician Decision|0
6922665|NCT00812929|10951372|FG002|Washout Period 2 (7 Days)|Physician Decision|0
6922666|NCT00812929|10951373|FG003|Washout Period 2 (7 Days)|Physician Decision|0
6922667|NCT00812929|10951374|FG004|Washout Period 2 (7 Days)|Physician Decision|0
6922668|NCT00812929|10951375|FG005|Washout Period 2 (7 Days)|Physician Decision|0
6922669|NCT00812929|10951376|FG006|Washout Period 2 (7 Days)|Physician Decision|0
6922670|NCT00812929|10951377|FG007|Washout Period 2 (7 Days)|Physician Decision|0
6922671|NCT00812929|10951378|FG008|Washout Period 2 (7 Days)|Physician Decision|0
6922672|NCT00812929|10951379|FG009|Washout Period 2 (7 Days)|Physician Decision|1
6922673|NCT00812929|10951370|FG000|Washout Period 3 (7 Days)|Adverse Event|0
6922674|NCT00812929|10951371|FG001|Washout Period 3 (7 Days)|Adverse Event|0
6922675|NCT00812929|10951372|FG002|Washout Period 3 (7 Days)|Adverse Event|0
6922676|NCT00812929|10951373|FG003|Washout Period 3 (7 Days)|Adverse Event|0
6922677|NCT00812929|10951374|FG004|Washout Period 3 (7 Days)|Adverse Event|0
6922678|NCT00812929|10951375|FG005|Washout Period 3 (7 Days)|Adverse Event|1
6922679|NCT00812929|10951376|FG006|Washout Period 3 (7 Days)|Adverse Event|0
6922680|NCT00812929|10951377|FG007|Washout Period 3 (7 Days)|Adverse Event|0
6922681|NCT00812929|10951378|FG008|Washout Period 3 (7 Days)|Adverse Event|0
6922682|NCT00812929|10951379|FG009|Washout Period 3 (7 Days)|Adverse Event|0
6922683|NCT00812955|10951400|FG000|Overall Study|Adverse Event|7
6922684|NCT00812955|10951401|FG001|Overall Study|Adverse Event|6
6922685|NCT00812955|10951402|FG002|Overall Study|Adverse Event|3
6922686|NCT00812955|10951403|FG003|Overall Study|Adverse Event|4
6922687|NCT00812955|10951400|FG000|Overall Study|Lost to Follow-up|2
6922688|NCT00812955|10951401|FG001|Overall Study|Lost to Follow-up|1
6922689|NCT00812955|10951402|FG002|Overall Study|Lost to Follow-up|1
6922690|NCT00812955|10951403|FG003|Overall Study|Lost to Follow-up|2
6922691|NCT00812955|10951400|FG000|Overall Study|Withdrawal by Subject|1
6922692|NCT00812955|10951401|FG001|Overall Study|Withdrawal by Subject|0
6922693|NCT00812955|10951402|FG002|Overall Study|Withdrawal by Subject|1
6922694|NCT00812955|10951403|FG003|Overall Study|Withdrawal by Subject|2
6922695|NCT00812955|10951400|FG000|Overall Study|randomized in error|0
6922696|NCT00812955|10951401|FG001|Overall Study|randomized in error|0
6922697|NCT00812955|10951402|FG002|Overall Study|randomized in error|1
6922698|NCT00812955|10951403|FG003|Overall Study|randomized in error|0
6922699|NCT00812968|10951417|FG000|Overall Study|Relapse after erythroid response|6
6922700|NCT00812968|10951417|FG000|Overall Study|Disease progression|1
6922701|NCT00812968|10951417|FG000|Overall Study|No further treatment required|1
6922702|NCT00812968|10951417|FG000|Overall Study|Study closed due to marketing approval|3
6922703|NCT00812981|10951425|FG000|Overall Study|Other|0
6922704|NCT00812981|10951426|FG001|Overall Study|Other|1
7145683|NCT03084796|11304455|FG003|Overall Study|Lack of Efficacy|0
7145684|NCT03084796|11304456|FG004|Overall Study|Lack of Efficacy|1
7145685|NCT03084796|11304457|FG005|Overall Study|Lack of Efficacy|0
7145686|NCT03084796|11304452|FG000|Overall Study|Lost to Follow-up|0
7145687|NCT03084796|11304453|FG001|Overall Study|Lost to Follow-up|0
7145688|NCT03084796|11304454|FG002|Overall Study|Lost to Follow-up|1
7145689|NCT03084796|11304455|FG003|Overall Study|Lost to Follow-up|1
7145690|NCT03084796|11304456|FG004|Overall Study|Lost to Follow-up|3
7145691|NCT03084796|11304457|FG005|Overall Study|Lost to Follow-up|1
7145692|NCT03084796|11304452|FG000|Overall Study|Randomization error|0
6827331|NCT00124943|10830044|FG000|Phase II|Lost to Follow-up|0
7037634|NCT01696695|11119606|FG000|Overall Study|Other|74
7037635|NCT01696695|11119606|FG000|Overall Study|Major Protocol Violation|192
7037636|NCT01696773|11119621|FG000|Days 15-27, Washout|Adverse Event|1
7037637|NCT01696773|11119622|FG001|Days 15-27, Washout|Adverse Event|0
7037638|NCT01696877|11119630|FG000|Overall Study|Adverse Event|0
7037639|NCT01696877|11119631|FG001|Overall Study|Adverse Event|1
7037640|NCT01696929|11119639|FG000|Overall Study|Physician Decision|1
7037641|NCT01696942|11119645|FG000|Overall Study|Withdrawal by Subject|1
7037642|NCT01696942|11119646|FG001|Overall Study|Withdrawal by Subject|0
7037643|NCT01696942|11119645|FG000|Overall Study|Protocol Violation|1
7037644|NCT01696942|11119646|FG001|Overall Study|Protocol Violation|2
7037645|NCT01696942|11119645|FG000|Overall Study|screen failure|0
7037646|NCT01696942|11119646|FG001|Overall Study|screen failure|1
7037647|NCT01696955|11119654|FG000|Main Study|Protocol Violation|1
7037648|NCT01696955|11119655|FG001|Main Study|Protocol Violation|0
7037649|NCT01696955|11119654|FG000|Main Study|Withdrawal by Subject|1
7037650|NCT01696955|11119655|FG001|Main Study|Withdrawal by Subject|1
7060758|NCT01922102|11157320|FG002|Overall Study|Withdrawal by Subject|7
7060759|NCT01922102|11157318|FG000|Overall Study|Physician Decision|0
7060760|NCT01922102|11157319|FG001|Overall Study|Physician Decision|2
7060761|NCT01922102|11157320|FG002|Overall Study|Physician Decision|1
7060762|NCT01922102|11157318|FG000|Overall Study|Adverse Event|1
7060763|NCT01922102|11157319|FG001|Overall Study|Adverse Event|2
7060764|NCT01922102|11157320|FG002|Overall Study|Adverse Event|0
7060765|NCT01922102|11157318|FG000|Overall Study|Lost to Follow-up|1
7060766|NCT01922102|11157319|FG001|Overall Study|Lost to Follow-up|0
7060767|NCT01922102|11157320|FG002|Overall Study|Lost to Follow-up|0
7060768|NCT01922102|11157318|FG000|Overall Study|Administrative problems|0
7060769|NCT01922102|11157319|FG001|Overall Study|Administrative problems|2
7060770|NCT01922102|11157320|FG002|Overall Study|Administrative problems|0
7060771|NCT01922258|11157347|FG000|Overall Study|Lost to Follow-up|1
7060772|NCT01922258|11157348|FG001|Overall Study|Lost to Follow-up|1
7060773|NCT01922258|11157347|FG000|Overall Study|Adverse Event|9
7060774|NCT01922258|11157348|FG001|Overall Study|Adverse Event|2
7060775|NCT01922258|11157347|FG000|Overall Study|Met Withdrawal Criteria|0
7060776|NCT01922258|11157348|FG001|Overall Study|Met Withdrawal Criteria|4
7060777|NCT01922258|11157347|FG000|Overall Study|Withdrawn by the Investigator|1
7060778|NCT01922258|11157348|FG001|Overall Study|Withdrawn by the Investigator|4
7060779|NCT01922258|11157347|FG000|Overall Study|Withdrawal by participant|5
7060780|NCT01922258|11157348|FG001|Overall Study|Withdrawal by participant|5
7060781|NCT01922271|11157356|FG000|WASHOUT Period|Withdrawal by Subject|1
7145693|NCT03084796|11304453|FG001|Overall Study|Randomization error|0
7145694|NCT03084796|11304454|FG002|Overall Study|Randomization error|1
6827332|NCT00124943|10830045|FG001|Phase II|Lost to Follow-up|0
6827333|NCT00124943|10830046|FG002|Phase II|Lost to Follow-up|0
6827334|NCT00124943|10830047|FG003|Phase II|Lost to Follow-up|1
6827335|NCT00124943|10830044|FG000|Phase II|Withdrawal by Subject|0
6827336|NCT00124943|10830045|FG001|Phase II|Withdrawal by Subject|0
6827337|NCT00124943|10830046|FG002|Phase II|Withdrawal by Subject|0
6827338|NCT00124943|10830047|FG003|Phase II|Withdrawal by Subject|2
6827339|NCT00124982|10830059|FG000|Short-term Period|Death|1
6827340|NCT00124982|10830060|FG001|Short-term Period|Death|1
6827341|NCT00124982|10830061|FG002|Short-term Period|Death|0
6827342|NCT00124982|10830059|FG000|Short-term Period|Adverse Event|17
6827343|NCT00124982|10830060|FG001|Short-term Period|Adverse Event|22
6827344|NCT00124982|10830061|FG002|Short-term Period|Adverse Event|0
6827345|NCT00124982|10830059|FG000|Short-term Period|Lack of Efficacy|32
6827346|NCT00124982|10830060|FG001|Short-term Period|Lack of Efficacy|73
6827347|NCT00124982|10830061|FG002|Short-term Period|Lack of Efficacy|0
6827348|NCT00124982|10830059|FG000|Short-term Period|Lost to Follow-up|8
6922705|NCT00813098|10951435|FG000|Overall Study|Adverse Event|2
6922706|NCT00813098|10951436|FG001|Overall Study|Adverse Event|4
6922707|NCT00813098|10951437|FG002|Overall Study|Adverse Event|1
6922708|NCT00813098|10951435|FG000|Overall Study|Withdrawal by Subject|0
6922709|NCT00813098|10951436|FG001|Overall Study|Withdrawal by Subject|1
6922710|NCT00813098|10951437|FG002|Overall Study|Withdrawal by Subject|0
6922711|NCT00813098|10951435|FG000|Overall Study|Inability to complete study procedures|1
6922712|NCT00813098|10951436|FG001|Overall Study|Inability to complete study procedures|0
6922713|NCT00813098|10951437|FG002|Overall Study|Inability to complete study procedures|0
6922714|NCT00813098|10951435|FG000|Overall Study|Lost to Follow-up|0
6922715|NCT00813098|10951436|FG001|Overall Study|Lost to Follow-up|1
6922716|NCT00813098|10951437|FG002|Overall Study|Lost to Follow-up|0
6922717|NCT00813098|10951435|FG000|Overall Study|Protocol Violation|0
6922718|NCT00813098|10951436|FG001|Overall Study|Protocol Violation|0
6922719|NCT00813098|10951437|FG002|Overall Study|Protocol Violation|1
6922720|NCT00813098|10951435|FG000|Overall Study|Principal Investigator decision|0
6922721|NCT00813098|10951436|FG001|Overall Study|Principal Investigator decision|1
6922722|NCT00813098|10951437|FG002|Overall Study|Principal Investigator decision|0
6922723|NCT00813098|10951435|FG000|Overall Study|Withdrew Consent|0
6922724|NCT00813098|10951436|FG001|Overall Study|Withdrew Consent|1
6922725|NCT00813098|10951437|FG002|Overall Study|Withdrew Consent|0
6922726|NCT00813124|10951454|FG000|Overall Study|Death|2
6922727|NCT00813124|10951454|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9
6922728|NCT00813124|10951454|FG000|Overall Study|Withdrawal by Subject|1
6922729|NCT00813150|10951460|FG000|Treatment Period|Adverse Event|16
6922730|NCT00813150|10951461|FG001|Treatment Period|Adverse Event|15
6922731|NCT00813150|10951460|FG000|Treatment Period|Death|2
6922732|NCT00813150|10951461|FG001|Treatment Period|Death|0
6922733|NCT00813150|10951460|FG000|Treatment Period|Progressive disease|1
6922734|NCT00813150|10951461|FG001|Treatment Period|Progressive disease|0
6922735|NCT00813150|10951460|FG000|Treatment Period|Complete response|0
6922736|NCT00813150|10951461|FG001|Treatment Period|Complete response|1
6922737|NCT00813150|10951460|FG000|Treatment Period|Stable disease|1
6922738|NCT00813150|10951461|FG001|Treatment Period|Stable disease|2
6922739|NCT00813150|10951460|FG000|Treatment Period|Protocol Violation|3
6922740|NCT00813150|10951461|FG001|Treatment Period|Protocol Violation|4
6922741|NCT00813150|10951460|FG000|Treatment Period|Withdrawal by Subject|5
6922742|NCT00813150|10951461|FG001|Treatment Period|Withdrawal by Subject|3
6922743|NCT00813150|10951460|FG000|Treatment Period|Non compliance|0
6922744|NCT00813150|10951461|FG001|Treatment Period|Non compliance|1
6922745|NCT00813150|10951460|FG000|Treatment Period|Reason not specified|3
6922746|NCT00813150|10951461|FG001|Treatment Period|Reason not specified|4
6922747|NCT00813150|10951460|FG000|Treatment Period|Data not available|1
6922748|NCT00813150|10951461|FG001|Treatment Period|Data not available|2
6922749|NCT00813150|10951460|FG000|Long Term Follow-up|Death|0
6922750|NCT00813150|10951461|FG001|Long Term Follow-up|Death|4
6922751|NCT00813150|10951460|FG000|Long Term Follow-up|Other|0
6922752|NCT00813150|10951461|FG001|Long Term Follow-up|Other|3
6922753|NCT00813150|10951460|FG000|Long Term Follow-up|Lost to Follow-up|2
6922754|NCT00813150|10951461|FG001|Long Term Follow-up|Lost to Follow-up|0
6922755|NCT00813150|10951460|FG000|Long Term Follow-up|Progression/Relapse|22
6922756|NCT00813150|10951461|FG001|Long Term Follow-up|Progression/Relapse|24
6922757|NCT00813293|10951480|FG000|Overall Study|Intercurrent illness|1
6922758|NCT00813293|10951481|FG001|Overall Study|Intercurrent illness|0
6922759|NCT00813293|10951480|FG000|Overall Study|Adverse Event|0
6922760|NCT00813293|10951481|FG001|Overall Study|Adverse Event|1
6922761|NCT00813358|10951496|FG000|Overall Study|Death|32
6922762|NCT00813358|10951496|FG000|Overall Study|Lost to Follow-up|12
6922763|NCT00813358|10951496|FG000|Overall Study|other endpoints|5
6922764|NCT00813358|10951496|FG000|Overall Study|Withdrawal by Subject|20
6922765|NCT00813488|10951500|FG000|Titration Period 1|Adverse Event|6
6922766|NCT00813488|10951501|FG001|Titration Period 1|Adverse Event|1
6922767|NCT00813488|10951500|FG000|Titration Period 1|Lack of Efficacy|9
6922768|NCT00813488|10951501|FG001|Titration Period 1|Lack of Efficacy|7
6922769|NCT00813488|10951500|FG000|Titration Period 1|Withdrawal by Subject|2
6922770|NCT00813488|10951501|FG001|Titration Period 1|Withdrawal by Subject|2
6922771|NCT00813488|10951500|FG000|Titration Period 1|Protocol Violation|4
6922772|NCT00813488|10951501|FG001|Titration Period 1|Protocol Violation|3
7044740|NCT01756846|11130694|FG001|Overall Study|Withdrawal by Subject|2
7037683|NCT01697319|11119698|FG000|Primary Phase|Withdrawal by Subject|1
7037684|NCT01697319|11119698|FG000|Extension Phase|Terminated by Sponsor|15
7037685|NCT01697345|11119702|FG000|Overall Study|Withdrawal by Subject|1
7037686|NCT01697358|11119723|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6
7145695|NCT03084796|11304455|FG003|Overall Study|Randomization error|0
7145696|NCT03084796|11304456|FG004|Overall Study|Randomization error|0
7145697|NCT03084796|11304457|FG005|Overall Study|Randomization error|0
7145698|NCT03085017|11304473|FG000|Overall Study|Death|0
7145699|NCT03085017|11304474|FG001|Overall Study|Death|3
7145700|NCT03085238|11304480|FG000|Overall Study|Adverse Event|2
7145701|NCT03085238|11304480|FG000|Overall Study|Death|2
7145702|NCT03085758|11304496|FG000|Overall Study|Death|26
7145703|NCT03085758|11304497|FG001|Overall Study|Death|24
7145704|NCT03085758|11304498|FG002|Overall Study|Death|53
7145705|NCT03085758|11304496|FG000|Overall Study|Lost to Follow-up|1
7145706|NCT03085758|11304497|FG001|Overall Study|Lost to Follow-up|1
7145707|NCT03085758|11304498|FG002|Overall Study|Lost to Follow-up|1
7145708|NCT03085758|11304496|FG000|Overall Study|Withdrawal by Subject|2
7145709|NCT03085758|11304497|FG001|Overall Study|Withdrawal by Subject|2
7145710|NCT03085758|11304498|FG002|Overall Study|Withdrawal by Subject|1
7145711|NCT03085758|11304496|FG000|Overall Study|Refusal to recall it up to day 90|0
7145712|NCT03085758|11304497|FG001|Overall Study|Refusal to recall it up to day 90|0
7145713|NCT03085758|11304498|FG002|Overall Study|Refusal to recall it up to day 90|1
7145714|NCT03085758|11304496|FG000|Overall Study|Pt seen by doctor in digestive surgery|0
7145715|NCT03085758|11304497|FG001|Overall Study|Pt seen by doctor in digestive surgery|1
7145716|NCT03085758|11304498|FG002|Overall Study|Pt seen by doctor in digestive surgery|0
7145717|NCT03085797|11304512|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1
7145718|NCT03085797|11304513|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0
7145719|NCT03085797|11304512|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16
7145720|NCT03085797|11304513|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17
7145721|NCT03085797|11304512|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0
7145722|NCT03085797|11304513|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1
7145723|NCT03085914|11304541|FG000|Overall Study|Death|6
7145724|NCT03085914|11304542|FG001|Overall Study|Death|6
7145725|NCT03085914|11304543|FG002|Overall Study|Death|4
7145726|NCT03085914|11304544|FG003|Overall Study|Death|1
7145727|NCT03085914|11304545|FG004|Overall Study|Death|5
7145728|NCT03085914|11304546|FG005|Overall Study|Death|2
7145729|NCT03085914|11304547|FG006|Overall Study|Death|2
7145730|NCT03085914|11304541|FG000|Overall Study|Withdrawal by Subject|1
7145731|NCT03085914|11304542|FG001|Overall Study|Withdrawal by Subject|1
7145732|NCT03085914|11304543|FG002|Overall Study|Withdrawal by Subject|2
7145733|NCT03085914|11304544|FG003|Overall Study|Withdrawal by Subject|2
7145734|NCT03085914|11304545|FG004|Overall Study|Withdrawal by Subject|2
7145735|NCT03085914|11304546|FG005|Overall Study|Withdrawal by Subject|0
7145736|NCT03085914|11304547|FG006|Overall Study|Withdrawal by Subject|1
7145737|NCT03085914|11304541|FG000|Overall Study|Lost to Follow-up|0
7145738|NCT03085914|11304542|FG001|Overall Study|Lost to Follow-up|0
7145739|NCT03085914|11304543|FG002|Overall Study|Lost to Follow-up|1
7145740|NCT03085914|11304544|FG003|Overall Study|Lost to Follow-up|0
7145741|NCT03085914|11304545|FG004|Overall Study|Lost to Follow-up|0
7145742|NCT03085914|11304546|FG005|Overall Study|Lost to Follow-up|1
7145743|NCT03085914|11304547|FG006|Overall Study|Lost to Follow-up|1
7145744|NCT03085914|11304541|FG000|Overall Study|Reason was not specified,|2
7145745|NCT03085914|11304542|FG001|Overall Study|Reason was not specified,|2
7145746|NCT03085914|11304543|FG002|Overall Study|Reason was not specified,|2
7145747|NCT03085914|11304544|FG003|Overall Study|Reason was not specified,|3
7145748|NCT03085914|11304545|FG004|Overall Study|Reason was not specified,|3
7145749|NCT03085914|11304546|FG005|Overall Study|Reason was not specified,|3
7145750|NCT03085914|11304547|FG006|Overall Study|Reason was not specified,|6
7145751|NCT03085914|11304541|FG000|Overall Study|Progressive Disease|0
7145752|NCT03085914|11304542|FG001|Overall Study|Progressive Disease|0
7145753|NCT03085914|11304543|FG002|Overall Study|Progressive Disease|2
7145754|NCT03085914|11304544|FG003|Overall Study|Progressive Disease|2
6827349|NCT00124982|10830060|FG001|Short-term Period|Lost to Follow-up|5
6827350|NCT00124982|10830061|FG002|Short-term Period|Lost to Follow-up|0
6827351|NCT00124982|10830059|FG000|Short-term Period|Withdrawal of Consent|7
6827352|NCT00124982|10830060|FG001|Short-term Period|Withdrawal of Consent|9
6827353|NCT00124982|10830061|FG002|Short-term Period|Withdrawal of Consent|0
6827354|NCT00124982|10830059|FG000|Short-term Period|Poor/Non-compliance|3
7145755|NCT03085914|11304545|FG004|Overall Study|Progressive Disease|1
7145756|NCT03085914|11304546|FG005|Overall Study|Progressive Disease|1
7145757|NCT03085914|11304547|FG006|Overall Study|Progressive Disease|1
7145758|NCT03085914|11304541|FG000|Overall Study|Study Terminated by the Sponsor|0
7145759|NCT03085914|11304542|FG001|Overall Study|Study Terminated by the Sponsor|0
7145760|NCT03085914|11304543|FG002|Overall Study|Study Terminated by the Sponsor|0
7145761|NCT03085914|11304544|FG003|Overall Study|Study Terminated by the Sponsor|1
6827355|NCT00124982|10830060|FG001|Short-term Period|Poor/Non-compliance|1
6827356|NCT00124982|10830061|FG002|Short-term Period|Poor/Non-compliance|0
6827357|NCT00124982|10830059|FG000|Short-term Period|No Longer Meets Study Criteria|1
7145762|NCT03085914|11304545|FG004|Overall Study|Study Terminated by the Sponsor|2
7145763|NCT03085914|11304546|FG005|Overall Study|Study Terminated by the Sponsor|1
7145764|NCT03085914|11304547|FG006|Overall Study|Study Terminated by the Sponsor|0
7145765|NCT03085927|11304568|FG000|Overall Study|Withdrawal by Subject|1
6922773|NCT00813488|10951500|FG000|Titration Period 1|Non-compliance to study medication|4
6922774|NCT00813488|10951501|FG001|Titration Period 1|Non-compliance to study medication|1
6922775|NCT00813488|10951500|FG000|Titration Period 1|Non-compliance to study procedures|2
6922776|NCT00813488|10951501|FG001|Titration Period 1|Non-compliance to study procedures|2
6922777|NCT00813488|10951500|FG000|Titration Period 1|Technical Difficulties|0
6922778|NCT00813488|10951501|FG001|Titration Period 1|Technical Difficulties|1
6922779|NCT00813488|10951500|FG000|Titration Period 2|Adverse Event|2
6922780|NCT00813488|10951501|FG001|Titration Period 2|Adverse Event|3
6922781|NCT00813488|10951500|FG000|Titration Period 2|Lack of Efficacy|8
6922782|NCT00813488|10951501|FG001|Titration Period 2|Lack of Efficacy|4
6922783|NCT00813488|10951500|FG000|Titration Period 2|Protocol Violation|3
6922784|NCT00813488|10951501|FG001|Titration Period 2|Protocol Violation|2
6922785|NCT00813488|10951500|FG000|Titration Period 2|Lost to Follow-up|1
6922786|NCT00813488|10951501|FG001|Titration Period 2|Lost to Follow-up|0
6922787|NCT00813488|10951500|FG000|Titration Period 2|Non-compliance with study procedures|2
6922788|NCT00813488|10951501|FG001|Titration Period 2|Non-compliance with study procedures|1
6922789|NCT00813488|10951500|FG000|Double-blind Treatment Period 1|Adverse Event|1
6922790|NCT00813488|10951501|FG001|Double-blind Treatment Period 1|Adverse Event|1
6922791|NCT00813488|10951500|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0
6922792|NCT00813488|10951501|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1
6922793|NCT00813488|10951500|FG000|Double-blind Treatment Period 1|Protocol Violation|0
6922794|NCT00813488|10951501|FG001|Double-blind Treatment Period 1|Protocol Violation|2
6922795|NCT00813488|10951500|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0
6922796|NCT00813488|10951501|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1
6922797|NCT00813488|10951500|FG000|Double-blind Treatment Period 2|Adverse Event|1
6922798|NCT00813488|10951501|FG001|Double-blind Treatment Period 2|Adverse Event|0
6922799|NCT00813488|10951500|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1
6922800|NCT00813488|10951501|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1
6922801|NCT00813488|10951500|FG000|Double-blind Treatment Period 2|Protocol Violation|2
6922802|NCT00813488|10951501|FG001|Double-blind Treatment Period 2|Protocol Violation|0
6922803|NCT00813488|10951500|FG000|Double-blind Treatment Period 2|Other|1
7145766|NCT03085927|11304569|FG001|Overall Study|Withdrawal by Subject|4
7145767|NCT03085927|11304568|FG000|Overall Study|Lost to Follow-up|3
7145768|NCT03085927|11304569|FG001|Overall Study|Lost to Follow-up|1
7145769|NCT03085927|11304568|FG000|Overall Study|Death|1
7145770|NCT03085927|11304569|FG001|Overall Study|Death|0
7145771|NCT03085927|11304568|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1
7145772|NCT03085927|11304569|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0
7145773|NCT03085927|11304568|FG000|Overall Study|Dyad Became Ineligible|0
7145774|NCT03085927|11304569|FG001|Overall Study|Dyad Became Ineligible|1
7145775|NCT03086018|11304577|FG000|Final Testing for End of Trial|Adverse Event|1
7145776|NCT03086018|11304577|FG000|Final Testing for End of Trial|Withdrawal by Subject|1
7145777|NCT03086057|11304587|FG000|Stage 1: PrEP Uptake|Incarcerated|3
7145778|NCT03086057|11304588|FG001|Stage 1: PrEP Uptake|Incarcerated|1
7145779|NCT03086057|11304589|FG002|Stage 1: PrEP Uptake|Incarcerated|0
7145780|NCT03086057|11304590|FG003|Stage 1: PrEP Uptake|Incarcerated|0
7145781|NCT03086057|11304587|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1
7145782|NCT03086057|11304588|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4
7145783|NCT03086057|11304589|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0
7145784|NCT03086057|11304590|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0
7145785|NCT03086057|11304587|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6
7145786|NCT03086057|11304588|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5
7145787|NCT03086057|11304589|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0
7145788|NCT03086057|11304590|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0
7145789|NCT03086057|11304587|FG000|Stage 1: PrEP Uptake|Death|1
7145790|NCT03086057|11304588|FG001|Stage 1: PrEP Uptake|Death|0
7145791|NCT03086057|11304589|FG002|Stage 1: PrEP Uptake|Death|0
7145792|NCT03086057|11304590|FG003|Stage 1: PrEP Uptake|Death|0
7145793|NCT03086057|11304587|FG000|Stage 2: PrEP Adherence|Incarcerated|0
7145794|NCT03086057|11304588|FG001|Stage 2: PrEP Adherence|Incarcerated|0
7145795|NCT03086057|11304589|FG002|Stage 2: PrEP Adherence|Incarcerated|2
7145796|NCT03086057|11304590|FG003|Stage 2: PrEP Adherence|Incarcerated|0
7145797|NCT03086057|11304587|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0
7145798|NCT03086057|11304588|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0
7145799|NCT03086057|11304589|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1
7145800|NCT03086057|11304590|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0
7145801|NCT03086057|11304587|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0
7145802|NCT03086057|11304588|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0
7145803|NCT03086057|11304589|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3
7145804|NCT03086057|11304590|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2
7145805|NCT03086135|11304600|FG000|Overall Study|Adverse Event|1
7145806|NCT03086135|11304600|FG000|Overall Study|Lost to Follow-up|2
7145807|NCT03086330|11304622|FG000|Overall Study|Withdrawal by Subject|3
7145808|NCT03086330|11304623|FG001|Overall Study|Withdrawal by Subject|2
7145809|NCT03086330|11304622|FG000|Overall Study|Lost to Follow-up|1
7145810|NCT03086330|11304623|FG001|Overall Study|Lost to Follow-up|2
7145811|NCT03086343|11304631|FG000|Overall Study|Adverse Event|7
7145812|NCT03086343|11304632|FG001|Overall Study|Adverse Event|7
7145813|NCT03086343|11304631|FG000|Overall Study|Withdrawal by Subject|10
7145814|NCT03086343|11304632|FG001|Overall Study|Withdrawal by Subject|6
7145815|NCT03086343|11304631|FG000|Overall Study|Lost to Follow-up|3
7145816|NCT03086343|11304632|FG001|Overall Study|Lost to Follow-up|1
7145817|NCT03086343|11304631|FG000|Overall Study|Lack of Efficacy|4
7145818|NCT03086343|11304632|FG001|Overall Study|Lack of Efficacy|6
7145819|NCT03086343|11304631|FG000|Overall Study|Other, not specified|8
7145820|NCT03086343|11304632|FG001|Overall Study|Other, not specified|4
7145821|NCT03086343|11304631|FG000|Overall Study|Missing|0
7145822|NCT03086343|11304632|FG001|Overall Study|Missing|1
7145823|NCT03086447|11304653|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
7145824|NCT03086447|11304654|FG001|Overall Study|No Longer Meets Eligibility Criteria|1
7145825|NCT03086447|11304653|FG000|Overall Study|Lost Lens|2
7145826|NCT03086447|11304654|FG001|Overall Study|Lost Lens|5
7145827|NCT03086447|11304653|FG000|Overall Study|Product quality complaint|0
7145828|NCT03086447|11304654|FG001|Overall Study|Product quality complaint|1
7145829|NCT03086447|11304653|FG000|Overall Study|Lens Damage|1
7145830|NCT03086447|11304654|FG001|Overall Study|Lens Damage|6
7145831|NCT03086447|11304653|FG000|Overall Study|Unsatisfactory Lens Fitting|0
7145832|NCT03086447|11304654|FG001|Overall Study|Unsatisfactory Lens Fitting|1
7145833|NCT03086447|11304653|FG000|Overall Study|Test Article No Longer Available|1
7145834|NCT03086447|11304654|FG001|Overall Study|Test Article No Longer Available|0
7145835|NCT03086447|11304653|FG000|Overall Study|Protocol Violation|2
7145836|NCT03086447|11304654|FG001|Overall Study|Protocol Violation|4
7145837|NCT03086447|11304653|FG000|Overall Study|Lost to Follow-up|0
7145838|NCT03086447|11304654|FG001|Overall Study|Lost to Follow-up|1
7145839|NCT03086447|11304653|FG000|Overall Study|Adverse Event|3
7145840|NCT03086447|11304654|FG001|Overall Study|Adverse Event|0
7145841|NCT03086447|11304653|FG000|Overall Study|Lens Discomfort|2
7145842|NCT03086447|11304654|FG001|Overall Study|Lens Discomfort|1
7145843|NCT03086460|11304660|FG000|Study Participants|Lost to Follow-up|2
7145844|NCT03086460|11304660|FG000|Study Participants|Protocol Violation|1
7145845|NCT03086460|11304660|FG000|Study Participants|Withdrawal by Subject|6
7145846|NCT03086460|11304660|FG000|Treatment A|Lost to Follow-up|1
7145847|NCT03086460|11304660|FG000|Treatment A|Protocol Violation|1
7145848|NCT03086460|11304660|FG000|Treatment A|Withdrawal by Subject|2
7145849|NCT03086460|11304660|FG000|Treatment C|Withdrawal by Subject|2
7145850|NCT03086460|11304660|FG000|Treatment E|Lost to Follow-up|1
7145851|NCT03086460|11304660|FG000|Treatment E|Withdrawal by Subject|3
7145852|NCT03086551|11304677|FG000|First Intervention|Failure to meet inclusion criterion|1
7145853|NCT03086551|11304678|FG001|First Intervention|Failure to meet inclusion criterion|0
7145854|NCT03086551|11304677|FG000|First Intervention|Lost to Follow-up|0
7145855|NCT03086551|11304678|FG001|First Intervention|Lost to Follow-up|1
7145856|NCT03086551|11304677|FG000|Washout|Lost to Follow-up|1
7145857|NCT03086551|11304678|FG001|Washout|Lost to Follow-up|2
7145858|NCT03086551|11304677|FG000|Washout|Withdrawal by Subject|2
7145859|NCT03086551|11304678|FG001|Washout|Withdrawal by Subject|1
7145860|NCT03087513|11304704|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2
7145861|NCT03087643|11304728|FG000|Overall Study|Withdrawal by Subject|2
7145862|NCT03087643|11304729|FG001|Overall Study|Withdrawal by Subject|4
7145863|NCT03087643|11304728|FG000|Overall Study|Death|2
7145864|NCT03087643|11304729|FG001|Overall Study|Death|2
7145865|NCT03087786|11304737|FG000|Overall Study|Withdrawal by Subject|2
7145866|NCT03087786|11304738|FG001|Overall Study|Withdrawal by Subject|0
7145867|NCT03087851|11304747|FG000|Overall Study|Withdraw on medical grounds|0
7145868|NCT03087851|11304748|FG001|Overall Study|Withdraw on medical grounds|1
7145869|NCT03087851|11304749|FG002|Overall Study|Withdraw on medical grounds|2
7145870|NCT03088917|11304796|FG000|Overall Study|In care/cured elsewhere|15
6922804|NCT00813488|10951501|FG001|Double-blind Treatment Period 2|Other|0
6922805|NCT00813488|10951500|FG000|Open-label Extension|Adverse Event|1
6922806|NCT00813488|10951501|FG001|Open-label Extension|Adverse Event|2
6922807|NCT00813488|10951500|FG000|Open-label Extension|Lack of Efficacy|3
6922808|NCT00813488|10951501|FG001|Open-label Extension|Lack of Efficacy|0
6922809|NCT00813488|10951500|FG000|Open-label Extension|Withdrawal by Subject|0
6922810|NCT00813488|10951501|FG001|Open-label Extension|Withdrawal by Subject|2
6922811|NCT00813488|10951500|FG000|Open-label Extension|Protocol Violation|1
6922812|NCT00813488|10951501|FG001|Open-label Extension|Protocol Violation|2
6922813|NCT00813488|10951500|FG000|Open-label Extension|Non-compliance study medication|4
6922814|NCT00813488|10951501|FG001|Open-label Extension|Non-compliance study medication|0
6922815|NCT00813488|10951500|FG000|Open-label Extension|Non-compliance study procedures|2
6922816|NCT00813488|10951501|FG001|Open-label Extension|Non-compliance study procedures|1
6922817|NCT00813488|10951500|FG000|Open-label Extension|Other|1
6922818|NCT00813488|10951501|FG001|Open-label Extension|Other|0
6922819|NCT00813592|10951511|FG000|Overall Study|Disease assessment was not completed per|2
6922820|NCT00813709|10951519|FG000|Double Blind Period|Adverse Event|4
6922821|NCT00813709|10951520|FG001|Double Blind Period|Adverse Event|1
6922822|NCT00813709|10951521|FG002|Double Blind Period|Adverse Event|4
6922823|NCT00813709|10951522|FG003|Double Blind Period|Adverse Event|0
6922824|NCT00813709|10951523|FG004|Double Blind Period|Adverse Event|0
6922825|NCT00813709|10951524|FG005|Double Blind Period|Adverse Event|0
6922826|NCT00813709|10951519|FG000|Double Blind Period|Lost to Follow-up|3
6922827|NCT00813709|10951520|FG001|Double Blind Period|Lost to Follow-up|2
6922828|NCT00813709|10951521|FG002|Double Blind Period|Lost to Follow-up|2
6922829|NCT00813709|10951522|FG003|Double Blind Period|Lost to Follow-up|0
6922830|NCT00813709|10951523|FG004|Double Blind Period|Lost to Follow-up|0
6922831|NCT00813709|10951524|FG005|Double Blind Period|Lost to Follow-up|0
6922832|NCT00813709|10951519|FG000|Double Blind Period|Switched to open label phase|9
6922833|NCT00813709|10951520|FG001|Double Blind Period|Switched to open label phase|26
6922834|NCT00813709|10951521|FG002|Double Blind Period|Switched to open label phase|18
6922835|NCT00813709|10951522|FG003|Double Blind Period|Switched to open label phase|0
6922836|NCT00813709|10951523|FG004|Double Blind Period|Switched to open label phase|0
6922837|NCT00813709|10951524|FG005|Double Blind Period|Switched to open label phase|0
6922838|NCT00813709|10951519|FG000|Double Blind Period|Randomized but not treated|1
6922839|NCT00813709|10951520|FG001|Double Blind Period|Randomized but not treated|3
6922840|NCT00813709|10951521|FG002|Double Blind Period|Randomized but not treated|1
7145871|NCT03088917|11304796|FG000|Overall Study|Refuse re-evaluation|13
7145872|NCT03088917|11304796|FG000|Overall Study|Contact not established|13
7145873|NCT03088917|11304796|FG000|Overall Study|Severe comorbidity/short life expectancy|5
7145874|NCT03088917|11304796|FG000|Overall Study|Moved outside study region|50
7145875|NCT03089047|11304804|FG000|Overall Study|Lost to Follow-up|1
7145876|NCT03089047|11304805|FG001|Overall Study|Lost to Follow-up|0
7145877|NCT03089216|11304815|FG000|Overall Study|Adverse Event|0
7145878|NCT03089216|11304816|FG001|Overall Study|Adverse Event|0
7145879|NCT03089216|11304817|FG002|Overall Study|Adverse Event|0
7145880|NCT03089216|11304818|FG003|Overall Study|Adverse Event|1
7145881|NCT03089580|11304832|FG000|Overall Study|Lost to Follow-up|2
7145882|NCT03089697|11304840|FG000|Overall Study|Adverse Event|1
7145883|NCT03089697|11304841|FG001|Overall Study|Adverse Event|2
7145884|NCT03089697|11304840|FG000|Overall Study|Withdrawal by Subject|1
7145885|NCT03089697|11304841|FG001|Overall Study|Withdrawal by Subject|0
7145886|NCT03089944|11304861|FG000|Overall Study|Lost to Follow-up|8
6922841|NCT00813709|10951522|FG003|Double Blind Period|Randomized but not treated|0
6922842|NCT00813709|10951523|FG004|Double Blind Period|Randomized but not treated|0
6922843|NCT00813709|10951524|FG005|Double Blind Period|Randomized but not treated|0
6922844|NCT00813709|10951519|FG000|Double Blind Period|Other|14
7145887|NCT03089944|11304861|FG000|Overall Study|Withdrew Consent|2
7145888|NCT03089944|11304861|FG000|Overall Study|Adverse Event|1
7145889|NCT03089944|11304861|FG000|Overall Study|Other|1
7145890|NCT03090100|11304867|FG000|Overall Study|Adverse Event|9
7145891|NCT03090100|11304868|FG001|Overall Study|Adverse Event|11
7145892|NCT03090100|11304867|FG000|Overall Study|Pregnancy|1
7145893|NCT03090100|11304868|FG001|Overall Study|Pregnancy|1
7145894|NCT03090100|11304867|FG000|Overall Study|Lack of Efficacy|2
7145895|NCT03090100|11304868|FG001|Overall Study|Lack of Efficacy|7
7145896|NCT03090100|11304867|FG000|Overall Study|Lost to Follow-up|2
7145897|NCT03090100|11304868|FG001|Overall Study|Lost to Follow-up|2
7145898|NCT03090100|11304867|FG000|Overall Study|Withdrawal by Subject|7
7145899|NCT03090100|11304868|FG001|Overall Study|Withdrawal by Subject|19
7145900|NCT03090100|11304867|FG000|Overall Study|Protocol Violation|2
7145901|NCT03090100|11304868|FG001|Overall Study|Protocol Violation|6
7145902|NCT03090100|11304867|FG000|Overall Study|Non-compliance|2
7145903|NCT03090100|11304868|FG001|Overall Study|Non-compliance|0
7145904|NCT03090100|11304867|FG000|Overall Study|Other|2
7145905|NCT03090100|11304868|FG001|Overall Study|Other|2
7145906|NCT03091348|11304903|FG000|Overall Study|Lost to Follow-up|2
7145907|NCT03091348|11304904|FG001|Overall Study|Lost to Follow-up|1
7145908|NCT03091400|11304917|FG000|Washout - 2 Weeks|Withdrawal by Subject|1
7145909|NCT03091400|11304918|FG001|Washout - 2 Weeks|Withdrawal by Subject|0
7145910|NCT03091439|11304926|FG000|Overall Study|Study Terminated by the Sponsor|1
7145911|NCT03091439|11304927|FG001|Overall Study|Study Terminated by the Sponsor|0
7145912|NCT03091738|11304952|FG000|Overall Study|Adverse Event|1
7145913|NCT03091738|11304952|FG000|Overall Study|Lost to Follow-up|1
7145914|NCT03091777|11304963|FG000|Overall Study|Pregnancy|2
7145915|NCT03091777|11304964|FG001|Overall Study|Pregnancy|1
7145916|NCT03091777|11304965|FG002|Overall Study|Pregnancy|0
7145917|NCT03091777|11304963|FG000|Overall Study|Adverse Event|2
7145918|NCT03091777|11304964|FG001|Overall Study|Adverse Event|1
7145919|NCT03091777|11304965|FG002|Overall Study|Adverse Event|4
7145920|NCT03091777|11304963|FG000|Overall Study|Withdrawal by Subject|4
7145921|NCT03091777|11304964|FG001|Overall Study|Withdrawal by Subject|2
7145922|NCT03091777|11304965|FG002|Overall Study|Withdrawal by Subject|6
7145923|NCT03091777|11304963|FG000|Overall Study|Protocol Violation|2
7145924|NCT03091777|11304964|FG001|Overall Study|Protocol Violation|1
7145925|NCT03091777|11304965|FG002|Overall Study|Protocol Violation|1
7145926|NCT03091777|11304963|FG000|Overall Study|Lost to Follow-up|12
7145927|NCT03091777|11304964|FG001|Overall Study|Lost to Follow-up|14
7145928|NCT03091777|11304965|FG002|Overall Study|Lost to Follow-up|7
7145929|NCT03091777|11304963|FG000|Overall Study|Lack of Efficacy|0
7145930|NCT03091777|11304964|FG001|Overall Study|Lack of Efficacy|0
7145931|NCT03091777|11304965|FG002|Overall Study|Lack of Efficacy|5
7145932|NCT03091777|11304963|FG000|Overall Study|Noncompliance with study drug|2
7145933|NCT03091777|11304964|FG001|Overall Study|Noncompliance with study drug|3
7145934|NCT03091777|11304965|FG002|Overall Study|Noncompliance with study drug|1
7145935|NCT03091777|11304963|FG000|Overall Study|Physician Decision|1
7145936|NCT03091777|11304964|FG001|Overall Study|Physician Decision|0
7145937|NCT03091777|11304965|FG002|Overall Study|Physician Decision|1
7145938|NCT03091777|11304963|FG000|Overall Study|Abnormal Laboratory Value|7
7145939|NCT03091777|11304964|FG001|Overall Study|Abnormal Laboratory Value|11
7145940|NCT03091777|11304965|FG002|Overall Study|Abnormal Laboratory Value|12
7145941|NCT03091920|11304976|FG000|Overall Study|Adverse Event|0
7145942|NCT03091920|11304977|FG001|Overall Study|Adverse Event|1
7145943|NCT03091920|11304978|FG002|Overall Study|Adverse Event|0
7145944|NCT03092375|11305009|FG000|Overall Study|Lack of Efficacy|0
7145945|NCT03092375|11305010|FG001|Overall Study|Lack of Efficacy|1
7145946|NCT03092375|11305011|FG002|Overall Study|Lack of Efficacy|1
7037687|NCT01697358|11119724|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0
7037688|NCT01697358|11119723|FG000|Period I: Randomization to 6 Months|Physician Decision|4
7037689|NCT01697358|11119724|FG001|Period I: Randomization to 6 Months|Physician Decision|0
7037690|NCT01697358|11119723|FG000|Period I: Randomization to 6 Months|Adverse Event|1
7037691|NCT01697358|11119724|FG001|Period I: Randomization to 6 Months|Adverse Event|1
7037692|NCT01697358|11119723|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2
7037693|NCT01697358|11119724|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0
7037694|NCT01697358|11119723|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3
7145947|NCT03092375|11305012|FG003|Overall Study|Lack of Efficacy|0
7145948|NCT03092479|11305031|FG000|Overall Study|Lost to Follow-up|3
7145949|NCT03092479|11305032|FG001|Overall Study|Lost to Follow-up|2
7145950|NCT03092479|11305031|FG000|Overall Study|Withdrawal by Subject|4
7145951|NCT03092479|11305032|FG001|Overall Study|Withdrawal by Subject|0
7145952|NCT03092726|11305040|FG000|Overall Study|Adverse Event|3
7145953|NCT03092726|11305041|FG001|Overall Study|Adverse Event|10
7145954|NCT03092726|11305040|FG000|Overall Study|Lack of Efficacy|0
7145955|NCT03092726|11305041|FG001|Overall Study|Lack of Efficacy|1
7145956|NCT03092726|11305040|FG000|Overall Study|Lost to Follow-up|1
7145957|NCT03092726|11305041|FG001|Overall Study|Lost to Follow-up|0
7145958|NCT03092726|11305040|FG000|Overall Study|Withdrawal by Subject|5
7145959|NCT03092726|11305041|FG001|Overall Study|Withdrawal by Subject|3
7145960|NCT03092752|11305047|FG000|Overall Study|Aged <40 years|14209
7145961|NCT03092752|11305047|FG000|Overall Study|At least one claim with T2DM|61299
7145962|NCT03092752|11305047|FG000|Overall Study|Having no claim of study drugs|29282
7145963|NCT03092752|11305047|FG000|Overall Study|Average hospital visit interval >92 days|10779
7145964|NCT03092752|11305047|FG000|Overall Study|<6 month history|245900
7145965|NCT03092791|11305076|FG000|Overall Study|Lost to Follow-up|0
7145966|NCT03092791|11305077|FG001|Overall Study|Lost to Follow-up|0
7145967|NCT03092791|11305078|FG002|Overall Study|Lost to Follow-up|0
7145968|NCT03092791|11305079|FG003|Overall Study|Lost to Follow-up|0
7145969|NCT03092791|11305080|FG004|Overall Study|Lost to Follow-up|0
7145970|NCT03092791|11305081|FG005|Overall Study|Lost to Follow-up|0
7145971|NCT03092791|11305082|FG006|Overall Study|Lost to Follow-up|1
7145972|NCT03092791|11305083|FG007|Overall Study|Lost to Follow-up|0
7145973|NCT03092791|11305076|FG000|Overall Study|Withdrawal of Consent|0
7145974|NCT03092791|11305077|FG001|Overall Study|Withdrawal of Consent|0
7145975|NCT03092791|11305078|FG002|Overall Study|Withdrawal of Consent|0
7145976|NCT03092791|11305079|FG003|Overall Study|Withdrawal of Consent|0
7145977|NCT03092791|11305080|FG004|Overall Study|Withdrawal of Consent|4
7145978|NCT03092791|11305081|FG005|Overall Study|Withdrawal of Consent|12
7145979|NCT03092791|11305082|FG006|Overall Study|Withdrawal of Consent|6
7145980|NCT03092791|11305083|FG007|Overall Study|Withdrawal of Consent|4
7145981|NCT03092791|11305076|FG000|Overall Study|Study Termination|0
7145982|NCT03092791|11305077|FG001|Overall Study|Study Termination|0
7145983|NCT03092791|11305078|FG002|Overall Study|Study Termination|0
7145984|NCT03092791|11305079|FG003|Overall Study|Study Termination|0
7145985|NCT03092791|11305080|FG004|Overall Study|Study Termination|55
7145986|NCT03092791|11305081|FG005|Overall Study|Study Termination|46
7145987|NCT03092791|11305082|FG006|Overall Study|Study Termination|53
7145988|NCT03092791|11305083|FG007|Overall Study|Study Termination|55
7145989|NCT03092791|11305076|FG000|Overall Study|Death|0
7145990|NCT03092791|11305077|FG001|Overall Study|Death|0
7145991|NCT03092791|11305078|FG002|Overall Study|Death|0
7145992|NCT03092791|11305079|FG003|Overall Study|Death|0
7145993|NCT03092791|11305080|FG004|Overall Study|Death|0
7145994|NCT03092791|11305081|FG005|Overall Study|Death|1
7145995|NCT03092791|11305082|FG006|Overall Study|Death|0
7145996|NCT03092791|11305083|FG007|Overall Study|Death|1
7145997|NCT03092791|11305076|FG000|Overall Study|Reason Not Specified|0
7145998|NCT03092791|11305077|FG001|Overall Study|Reason Not Specified|0
7145999|NCT03092791|11305078|FG002|Overall Study|Reason Not Specified|0
7146000|NCT03092791|11305079|FG003|Overall Study|Reason Not Specified|0
7146001|NCT03092791|11305080|FG004|Overall Study|Reason Not Specified|1
7146002|NCT03092791|11305081|FG005|Overall Study|Reason Not Specified|1
7146003|NCT03092791|11305082|FG006|Overall Study|Reason Not Specified|0
7146004|NCT03092791|11305083|FG007|Overall Study|Reason Not Specified|0
7146005|NCT03093181|11305143|FG000|Overall Study|Withdrawal by Subject|2
7146006|NCT03093181|11305144|FG001|Overall Study|Withdrawal by Subject|1
7146007|NCT03093181|11305145|FG002|Overall Study|Withdrawal by Subject|2
7037695|NCT01697358|11119724|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12
7037696|NCT01697358|11119723|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8
7037697|NCT01697358|11119724|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10
7037698|NCT01697358|11119723|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
7037699|NCT01697358|11119724|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
7037700|NCT01697358|11119723|FG000|Period II: 6-24M Long-term Follow-up|Death|1
7037701|NCT01697358|11119724|FG001|Period II: 6-24M Long-term Follow-up|Death|1
7037702|NCT01697358|11119723|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0
7037703|NCT01697358|11119724|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3
7037704|NCT01697358|11119723|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34
7037705|NCT01697358|11119724|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26
7037706|NCT01697449|11119730|FG000|Overall Study|Disease progression|47
7037707|NCT01697449|11119730|FG000|Overall Study|Adverse Event|7
7037708|NCT01697449|11119730|FG000|Overall Study|Lost to Follow-up|5
7037709|NCT01697449|11119730|FG000|Overall Study|Withdrawal by Subject|2
7037710|NCT01697449|11119730|FG000|Overall Study|Physician Decision|1
7037711|NCT01697449|11119730|FG000|Overall Study|Death|2
7037712|NCT01697449|11119730|FG000|Overall Study|Other|1
7037713|NCT01697449|11119730|FG000|Overall Study|Missing|25
7037714|NCT01697462|11119737|FG000|Overall Study|Disease Progression|1
7037715|NCT01697462|11119737|FG000|Overall Study|Adverse Event|6
7037716|NCT01697462|11119737|FG000|Overall Study|Lost to Follow-up|21
7037717|NCT01697462|11119737|FG000|Overall Study|Withdrawal by Subject|12
7037718|NCT01697462|11119737|FG000|Overall Study|Investigator Decision|21
7037719|NCT01697462|11119737|FG000|Overall Study|Death|1
7037720|NCT01697462|11119737|FG000|Overall Study|Other|10
7146008|NCT03093181|11305143|FG000|Overall Study|Other (Not specified)|1
7146009|NCT03093181|11305144|FG001|Overall Study|Other (Not specified)|0
6897070|NCT00636441|10915729|FG004|Overall Study|Late, ineligible|0
7037721|NCT01697462|11119737|FG000|Overall Study|Missing|5
7037722|NCT01697501|11119741|FG000|Overall Study|Protocol Violation|2
7146010|NCT03093181|11305145|FG002|Overall Study|Other (Not specified)|0
7146011|NCT03093181|11305143|FG000|Overall Study|Adverse Event|0
7146012|NCT03093181|11305144|FG001|Overall Study|Adverse Event|1
7146013|NCT03093181|11305145|FG002|Overall Study|Adverse Event|0
7146014|NCT03093181|11305143|FG000|Overall Study|Other (Protocol violation)|0
7146015|NCT03093181|11305144|FG001|Overall Study|Other (Protocol violation)|0
7146016|NCT03093181|11305145|FG002|Overall Study|Other (Protocol violation)|1
7183731|NCT01302847|11383782|FG002|Overall Study|Withdrawal by Subject|0
7183732|NCT01302847|11383783|FG003|Overall Study|Withdrawal by Subject|0
7146017|NCT03093324|11305168|FG000|Overall Study|Adverse Event|4
7146018|NCT03093324|11305169|FG001|Overall Study|Adverse Event|15
7146019|NCT03093324|11305168|FG000|Overall Study|Lost to Follow-up|1
7146020|NCT03093324|11305169|FG001|Overall Study|Lost to Follow-up|0
7146021|NCT03093324|11305168|FG000|Overall Study|Protocol Deviation|2
7146022|NCT03093324|11305169|FG001|Overall Study|Protocol Deviation|2
7146023|NCT03093324|11305168|FG000|Overall Study|Withdrawal by Subject|2
7146024|NCT03093324|11305169|FG001|Overall Study|Withdrawal by Subject|2
7146025|NCT03093415|11305178|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17
7146026|NCT03093415|11305179|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36
7146027|NCT03093415|11305180|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0
7146028|NCT03093415|11305178|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40
7146029|NCT03093415|11305179|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0
7146030|NCT03093415|11305180|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0
7146031|NCT03093415|11305178|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28
7146032|NCT03093415|11305179|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6
7146033|NCT03093415|11305180|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0
7146034|NCT03093415|11305178|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0
7146035|NCT03093415|11305179|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12
7146036|NCT03093415|11305180|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0
7146037|NCT03093415|11305178|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18
7146038|NCT03093415|11305179|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12
7146039|NCT03093415|11305180|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0
6922845|NCT00813709|10951520|FG001|Double Blind Period|Other|9
6922846|NCT00813709|10951521|FG002|Double Blind Period|Other|6
6922847|NCT00813709|10951522|FG003|Double Blind Period|Other|0
6922848|NCT00813709|10951523|FG004|Double Blind Period|Other|0
6922849|NCT00813709|10951524|FG005|Double Blind Period|Other|0
6922850|NCT00813709|10951519|FG000|Open Label Period|Adverse Event|0
6922851|NCT00813709|10951520|FG001|Open Label Period|Adverse Event|0
6922852|NCT00813709|10951521|FG002|Open Label Period|Adverse Event|0
6922853|NCT00813709|10951522|FG003|Open Label Period|Adverse Event|5
6922854|NCT00813709|10951523|FG004|Open Label Period|Adverse Event|4
6922855|NCT00813709|10951524|FG005|Open Label Period|Adverse Event|3
6922856|NCT00813709|10951519|FG000|Open Label Period|Lack of Efficacy|0
6922857|NCT00813709|10951520|FG001|Open Label Period|Lack of Efficacy|0
6922858|NCT00813709|10951521|FG002|Open Label Period|Lack of Efficacy|0
6922859|NCT00813709|10951522|FG003|Open Label Period|Lack of Efficacy|3
6922860|NCT00813709|10951523|FG004|Open Label Period|Lack of Efficacy|1
6922861|NCT00813709|10951524|FG005|Open Label Period|Lack of Efficacy|1
6922862|NCT00813709|10951519|FG000|Open Label Period|Randomized but not treated|0
6922863|NCT00813709|10951520|FG001|Open Label Period|Randomized but not treated|0
6922864|NCT00813709|10951521|FG002|Open Label Period|Randomized but not treated|0
6922865|NCT00813709|10951522|FG003|Open Label Period|Randomized but not treated|1
6922866|NCT00813709|10951523|FG004|Open Label Period|Randomized but not treated|0
6922867|NCT00813709|10951524|FG005|Open Label Period|Randomized but not treated|1
6922868|NCT00813709|10951519|FG000|Open Label Period|Other|0
6922869|NCT00813709|10951520|FG001|Open Label Period|Other|0
6922870|NCT00813709|10951521|FG002|Open Label Period|Other|0
6922871|NCT00813709|10951522|FG003|Open Label Period|Other|11
6922872|NCT00813709|10951523|FG004|Open Label Period|Other|5
6922873|NCT00813709|10951524|FG005|Open Label Period|Other|6
6922874|NCT00813748|10951555|FG000|Skin Test Substudy|Physician Decision|0
6922875|NCT00813748|10951556|FG001|Skin Test Substudy|Physician Decision|1
6922876|NCT00813761|10951566|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2
6922877|NCT00813761|10951567|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
6922878|NCT00813761|10951568|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
7146040|NCT03093415|11305178|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4
7146041|NCT03093415|11305179|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4
7146042|NCT03093415|11305180|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0
7146043|NCT03093415|11305178|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15
7146044|NCT03093415|11305179|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32
7146045|NCT03093415|11305180|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0
7146046|NCT03093415|11305178|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5
7146047|NCT03093415|11305179|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3
7146048|NCT03093415|11305180|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0
6922879|NCT00813761|10951569|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
6922880|NCT00813761|10951566|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
6922881|NCT00813761|10951567|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
6922882|NCT00813761|10951568|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3
6922883|NCT00813761|10951569|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1
6922884|NCT00813761|10951566|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
6922885|NCT00813761|10951567|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
6922886|NCT00813761|10951568|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
6922887|NCT00813761|10951569|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0
7037723|NCT01697579|11119759|FG000|Base Study-Cycle 1|Adverse Event|1
7037724|NCT01697579|11119760|FG001|Base Study-Cycle 1|Adverse Event|0
7037725|NCT01697579|11119761|FG002|Base Study-Cycle 1|Adverse Event|0
7037726|NCT01697579|11119762|FG003|Base Study-Cycle 1|Adverse Event|0
7037727|NCT01697579|11119763|FG004|Base Study-Cycle 1|Adverse Event|0
7037728|NCT01697579|11119764|FG005|Base Study-Cycle 1|Adverse Event|0
7037729|NCT01697579|11119765|FG006|Base Study-Cycle 1|Adverse Event|0
7037730|NCT01697579|11119759|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1
7146049|NCT03093415|11305178|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4
7146050|NCT03093415|11305179|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2
7146051|NCT03093415|11305180|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0
7146052|NCT03093415|11305178|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9
7146053|NCT03093415|11305179|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3
7146054|NCT03093415|11305180|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0
7146055|NCT03093415|11305178|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1
7146056|NCT03093415|11305179|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8
7146057|NCT03093415|11305180|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3
7146058|NCT03093454|11305190|FG000|Overall Study|Withdrawal by Subject|1
7146059|NCT03093454|11305191|FG001|Overall Study|Withdrawal by Subject|1
7146060|NCT03093454|11305190|FG000|Overall Study|Scheduling conflict|3
7146061|NCT03093454|11305191|FG001|Overall Study|Scheduling conflict|1
7146062|NCT03093454|11305190|FG000|Overall Study|Physician Decision|2
7146063|NCT03093454|11305191|FG001|Overall Study|Physician Decision|1
7146064|NCT03093870|11305209|FG000|Overall Study|Withdrawal by Subject|2
7146065|NCT03093870|11305210|FG001|Overall Study|Withdrawal by Subject|6
7146066|NCT03093870|11305211|FG002|Overall Study|Withdrawal by Subject|5
7146067|NCT03093870|11305209|FG000|Overall Study|Death|1
7146068|NCT03093870|11305210|FG001|Overall Study|Death|35
7146069|NCT03093870|11305211|FG002|Overall Study|Death|35
7146070|NCT03093870|11305209|FG000|Overall Study|Radiographic disease progression|10
7146071|NCT03093870|11305210|FG001|Overall Study|Radiographic disease progression|0
7146072|NCT03093870|11305211|FG002|Overall Study|Radiographic disease progression|0
7146073|NCT03093870|11305209|FG000|Overall Study|Clinical disease progression|1
7146074|NCT03093870|11305210|FG001|Overall Study|Clinical disease progression|0
7146075|NCT03093870|11305211|FG002|Overall Study|Clinical disease progression|0
7146076|NCT03093870|11305209|FG000|Overall Study|Physician Decision|2
7146077|NCT03093870|11305210|FG001|Overall Study|Physician Decision|0
7146078|NCT03093870|11305211|FG002|Overall Study|Physician Decision|0
7146079|NCT03093870|11305209|FG000|Overall Study|Adverse Event|7
7146080|NCT03093870|11305210|FG001|Overall Study|Adverse Event|0
7146081|NCT03093870|11305211|FG002|Overall Study|Adverse Event|0
7146082|NCT03093870|11305209|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1
7146083|NCT03093870|11305210|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0
7146084|NCT03093870|11305211|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0
7146085|NCT03093870|11305209|FG000|Overall Study|Lost to Follow-up|0
7146086|NCT03093870|11305210|FG001|Overall Study|Lost to Follow-up|0
7146087|NCT03093870|11305211|FG002|Overall Study|Lost to Follow-up|1
7146088|NCT03094195|11305222|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12
7146089|NCT03094195|11305223|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10
7146090|NCT03094195|11305224|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11
7146091|NCT03094195|11305225|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
7146092|NCT03094195|11305226|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
7146093|NCT03094195|11305227|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
7146094|NCT03094195|11305228|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
7146095|NCT03094195|11305229|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
7146096|NCT03094195|11305222|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3
7146097|NCT03094195|11305223|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2
7146098|NCT03094195|11305224|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1
7146099|NCT03094195|11305225|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0
7146100|NCT03094195|11305226|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0
7146101|NCT03094195|11305227|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0
7146102|NCT03094195|11305228|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0
7146103|NCT03094195|11305229|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0
7146104|NCT03094195|11305222|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0
7146105|NCT03094195|11305223|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0
7146106|NCT03094195|11305224|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1
7146107|NCT03094195|11305225|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0
7146108|NCT03094195|11305226|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0
7146109|NCT03094195|11305227|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0
7146110|NCT03094195|11305228|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0
7146111|NCT03094195|11305229|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0
7037731|NCT01697579|11119760|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
7146112|NCT03094195|11305222|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
7037732|NCT01697579|11119761|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
7146113|NCT03094195|11305223|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1
7146114|NCT03094195|11305224|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1
7146115|NCT03094195|11305225|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
7146116|NCT03094195|11305226|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
7146117|NCT03094195|11305227|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
7146118|NCT03094195|11305228|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
7146119|NCT03094195|11305229|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
7146120|NCT03094611|11305253|FG000|Overall Study|Lack of Efficacy|1
7146121|NCT03094611|11305253|FG000|Overall Study|Stem Cell Transplant|1
7146122|NCT03095027|11305276|FG000|Period 2, Second Week of Wear|Adverse Event|1
7146123|NCT03095027|11305277|FG001|Period 2, Second Week of Wear|Adverse Event|0
7146124|NCT03095118|11305292|FG000|Overall Study|Adverse Event|1
7146125|NCT03095118|11305292|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1
7146126|NCT03095508|11305298|FG000|Overall Study|Adverse Event|0
7037733|NCT01697579|11119762|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
7037734|NCT01697579|11119763|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
7037735|NCT01697579|11119764|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
7037736|NCT01697579|11119765|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
7037737|NCT01697579|11119759|FG000|Base Study-Cycle 1|Protocol Violation|0
7037738|NCT01697579|11119760|FG001|Base Study-Cycle 1|Protocol Violation|0
7037739|NCT01697579|11119761|FG002|Base Study-Cycle 1|Protocol Violation|0
7146127|NCT03095508|11305299|FG001|Overall Study|Adverse Event|1
7146128|NCT03095521|11305307|FG000|Overall Study|Withdrawal by Subject|0
7146129|NCT03095521|11305308|FG001|Overall Study|Withdrawal by Subject|1
7146130|NCT03095521|11305307|FG000|Overall Study|Lost to Follow-up|0
7146131|NCT03095521|11305308|FG001|Overall Study|Lost to Follow-up|1
7146132|NCT03095599|11305316|FG000|Overall Study|Withdrawal by Subject|1
7146133|NCT03095599|11305317|FG001|Overall Study|Withdrawal by Subject|0
7146134|NCT03095599|11305316|FG000|Overall Study|Lost to Follow-up|1
7146135|NCT03095599|11305317|FG001|Overall Study|Lost to Follow-up|0
7146136|NCT03095599|11305316|FG000|Overall Study|Withdrawal prior to vaccination|1
7146137|NCT03095599|11305317|FG001|Overall Study|Withdrawal prior to vaccination|0
7146138|NCT03095651|11305362|FG000|Overall Study|Lost to Follow-up|1
7146139|NCT03095651|11305363|FG001|Overall Study|Lost to Follow-up|1
7146140|NCT03095651|11305364|FG002|Overall Study|Lost to Follow-up|0
7146141|NCT03095651|11305365|FG003|Overall Study|Lost to Follow-up|1
7146142|NCT03095651|11305366|FG004|Overall Study|Lost to Follow-up|0
7146143|NCT03095651|11305367|FG005|Overall Study|Lost to Follow-up|0
7146144|NCT03095651|11305368|FG006|Overall Study|Lost to Follow-up|0
7146145|NCT03095651|11305369|FG007|Overall Study|Lost to Follow-up|0
7146146|NCT03095651|11305362|FG000|Overall Study|Withdrawal by Subject|0
7146147|NCT03095651|11305363|FG001|Overall Study|Withdrawal by Subject|0
7146148|NCT03095651|11305364|FG002|Overall Study|Withdrawal by Subject|0
7146149|NCT03095651|11305365|FG003|Overall Study|Withdrawal by Subject|0
6922888|NCT00813761|10951566|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0
6922889|NCT00813761|10951567|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0
6922890|NCT00813761|10951568|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3
6922891|NCT00813761|10951569|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0
6922892|NCT00813761|10951566|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
6922893|NCT00813761|10951567|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
6922894|NCT00813761|10951568|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5
6922895|NCT00813761|10951569|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
6922896|NCT00813761|10951566|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
6922897|NCT00813761|10951567|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1
6922898|NCT00813761|10951568|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
6922899|NCT00813761|10951569|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
6922900|NCT00813761|10951566|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2
6922901|NCT00813761|10951567|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3
6922902|NCT00813761|10951568|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
6922903|NCT00813761|10951569|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
6922904|NCT00813761|10951566|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3
6922905|NCT00813761|10951567|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0
6922906|NCT00813761|10951568|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2
6922907|NCT00813761|10951569|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1
6922908|NCT00813761|10951566|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
6922909|NCT00813761|10951567|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
6922910|NCT00813761|10951568|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
6922911|NCT00813761|10951569|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
6922912|NCT00813761|10951566|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
7037740|NCT01697579|11119762|FG003|Base Study-Cycle 1|Protocol Violation|0
7146150|NCT03095651|11305366|FG004|Overall Study|Withdrawal by Subject|0
7146151|NCT03095651|11305367|FG005|Overall Study|Withdrawal by Subject|1
7146152|NCT03095651|11305368|FG006|Overall Study|Withdrawal by Subject|0
7146153|NCT03095651|11305369|FG007|Overall Study|Withdrawal by Subject|0
7146154|NCT03096314|11305397|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9
7146155|NCT03096314|11305398|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12
7146156|NCT03096483|11305425|FG000|Overall Study|Withdrawal by site|1
7146157|NCT03096847|11305453|FG000|Overall Study|Other|2
7146158|NCT03096847|11305454|FG001|Overall Study|Other|1
7146159|NCT03096847|11305455|FG002|Overall Study|Other|2
7146160|NCT03096847|11305453|FG000|Overall Study|Lost to Follow-up|1
7146161|NCT03096847|11305454|FG001|Overall Study|Lost to Follow-up|0
7146162|NCT03096847|11305455|FG002|Overall Study|Lost to Follow-up|1
7146163|NCT03096847|11305453|FG000|Overall Study|Death|6
7146164|NCT03096847|11305454|FG001|Overall Study|Death|0
7146165|NCT03096847|11305455|FG002|Overall Study|Death|2
7146166|NCT03096847|11305453|FG000|Overall Study|Protocol Violation|3
7146167|NCT03096847|11305454|FG001|Overall Study|Protocol Violation|0
7146168|NCT03096847|11305455|FG002|Overall Study|Protocol Violation|6
7146169|NCT03096847|11305453|FG000|Overall Study|Physician Decision|12
7146170|NCT03096847|11305454|FG001|Overall Study|Physician Decision|2
7146171|NCT03096847|11305455|FG002|Overall Study|Physician Decision|8
7146172|NCT03096847|11305453|FG000|Overall Study|Withdrawal by Subject|24
7146173|NCT03096847|11305454|FG001|Overall Study|Withdrawal by Subject|1
7146174|NCT03096847|11305455|FG002|Overall Study|Withdrawal by Subject|12
6827358|NCT00124982|10830060|FG001|Short-term Period|No Longer Meets Study Criteria|2
6827359|NCT00124982|10830061|FG002|Short-term Period|No Longer Meets Study Criteria|0
6827360|NCT00124982|10830059|FG000|Short-term Period|Participant Decision|1
6827361|NCT00124982|10830060|FG001|Short-term Period|Participant Decision|0
6827362|NCT00124982|10830061|FG002|Short-term Period|Participant Decision|0
6827363|NCT00124982|10830059|FG000|Short-term Period|Participant Chose Own Doctor|0
6827364|NCT00124982|10830060|FG001|Short-term Period|Participant Chose Own Doctor|1
6827365|NCT00124982|10830061|FG002|Short-term Period|Participant Chose Own Doctor|0
6827366|NCT00124982|10830059|FG000|Short-term Period|Investigator Decision-No Specific AE|1
6827367|NCT00124982|10830060|FG001|Short-term Period|Investigator Decision-No Specific AE|0
6827368|NCT00124982|10830061|FG002|Short-term Period|Investigator Decision-No Specific AE|0
6827369|NCT00124982|10830059|FG000|Short-term Period|Participant Had Lymphopenia|1
6827370|NCT00124982|10830060|FG001|Short-term Period|Participant Had Lymphopenia|0
6827371|NCT00124982|10830061|FG002|Short-term Period|Participant Had Lymphopenia|0
6827372|NCT00124982|10830059|FG000|Long-term Period|Death|0
6827373|NCT00124982|10830060|FG001|Long-term Period|Death|0
6827374|NCT00124982|10830061|FG002|Long-term Period|Death|1
6827375|NCT00124982|10830059|FG000|Long-term Period|Adverse Event|0
6827376|NCT00124982|10830060|FG001|Long-term Period|Adverse Event|0
6827377|NCT00124982|10830061|FG002|Long-term Period|Adverse Event|17
6827378|NCT00124982|10830059|FG000|Long-term Period|Lack of Efficacy|0
6827379|NCT00124982|10830060|FG001|Long-term Period|Lack of Efficacy|0
6827380|NCT00124982|10830061|FG002|Long-term Period|Lack of Efficacy|46
6827381|NCT00124982|10830059|FG000|Long-term Period|Lost to Follow-up|0
6827382|NCT00124982|10830060|FG001|Long-term Period|Lost to Follow-up|0
6827383|NCT00124982|10830061|FG002|Long-term Period|Lost to Follow-up|4
6827384|NCT00124982|10830059|FG000|Long-term Period|Withdrawal by Subject|0
6827385|NCT00124982|10830060|FG001|Long-term Period|Withdrawal by Subject|0
6827386|NCT00124982|10830061|FG002|Long-term Period|Withdrawal by Subject|16
6827387|NCT00124982|10830059|FG000|Long-term Period|Pregnancy|0
6827388|NCT00124982|10830060|FG001|Long-term Period|Pregnancy|0
6827389|NCT00124982|10830061|FG002|Long-term Period|Pregnancy|1
6827390|NCT00124982|10830059|FG000|Long-term Period|Poor/Non-compliance|0
6827391|NCT00124982|10830060|FG001|Long-term Period|Poor/Non-compliance|0
6827392|NCT00124982|10830061|FG002|Long-term Period|Poor/Non-compliance|2
6827393|NCT00124982|10830059|FG000|Long-term Period|Administrative Reason by Sponsor|0
6827394|NCT00124982|10830060|FG001|Long-term Period|Administrative Reason by Sponsor|0
6827395|NCT00124982|10830061|FG002|Long-term Period|Administrative Reason by Sponsor|1
6827396|NCT00124982|10830059|FG000|Long-term Period|Neurologist Recommendation|0
6827397|NCT00124982|10830060|FG001|Long-term Period|Neurologist Recommendation|0
6827398|NCT00124982|10830061|FG002|Long-term Period|Neurologist Recommendation|1
6827399|NCT00125138|10830083|FG000|Overall Study|Adverse Event|1
7037741|NCT01697579|11119763|FG004|Base Study-Cycle 1|Protocol Violation|3
7037742|NCT01697579|11119764|FG005|Base Study-Cycle 1|Protocol Violation|0
7037743|NCT01697579|11119765|FG006|Base Study-Cycle 1|Protocol Violation|0
7037744|NCT01697579|11119759|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0
7037745|NCT01697579|11119760|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1
7037746|NCT01697579|11119761|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0
7037747|NCT01697579|11119762|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0
7037748|NCT01697579|11119763|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0
7037749|NCT01697579|11119764|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0
7037750|NCT01697579|11119765|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0
7037751|NCT01697579|11119759|FG000|Base Study-Cycle 1|Technical Problems|0
7037752|NCT01697579|11119760|FG001|Base Study-Cycle 1|Technical Problems|0
7037753|NCT01697579|11119761|FG002|Base Study-Cycle 1|Technical Problems|1
7037754|NCT01697579|11119762|FG003|Base Study-Cycle 1|Technical Problems|1
7037755|NCT01697579|11119763|FG004|Base Study-Cycle 1|Technical Problems|0
7037756|NCT01697579|11119764|FG005|Base Study-Cycle 1|Technical Problems|0
7037757|NCT01697579|11119765|FG006|Base Study-Cycle 1|Technical Problems|0
7037758|NCT01697579|11119759|FG000|Optional Extension-Cycles 2-6|Death|0
7037759|NCT01697579|11119760|FG001|Optional Extension-Cycles 2-6|Death|0
7037760|NCT01697579|11119761|FG002|Optional Extension-Cycles 2-6|Death|0
7037761|NCT01697579|11119762|FG003|Optional Extension-Cycles 2-6|Death|0
7037762|NCT01697579|11119763|FG004|Optional Extension-Cycles 2-6|Death|0
7037763|NCT01697579|11119764|FG005|Optional Extension-Cycles 2-6|Death|0
7037764|NCT01697579|11119765|FG006|Optional Extension-Cycles 2-6|Death|2
7037765|NCT01697579|11119759|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
7037766|NCT01697579|11119760|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
7037767|NCT01697579|11119761|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
7037768|NCT01697579|11119762|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
7037769|NCT01697579|11119763|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
7037770|NCT01697579|11119764|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1
7037771|NCT01697579|11119765|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5
6827400|NCT00125138|10830084|FG001|Overall Study|Adverse Event|0
6827401|NCT00125138|10830085|FG002|Overall Study|Adverse Event|3
7146175|NCT03096847|11305453|FG000|Overall Study|Adverse Event|72
7146176|NCT03096847|11305454|FG001|Overall Study|Adverse Event|6
7146177|NCT03096847|11305455|FG002|Overall Study|Adverse Event|28
7146178|NCT03096847|11305453|FG000|Overall Study|Progressive disease|97
7146179|NCT03096847|11305454|FG001|Overall Study|Progressive disease|10
7146180|NCT03096847|11305455|FG002|Overall Study|Progressive disease|78
7146181|NCT03096847|11305453|FG000|Overall Study|Non-compliance with study medication|1
7146182|NCT03096847|11305454|FG001|Overall Study|Non-compliance with study medication|0
7146183|NCT03096847|11305455|FG002|Overall Study|Non-compliance with study medication|0
7146184|NCT03096847|11305453|FG000|Overall Study|New therapy for study indication|1
7146185|NCT03096847|11305454|FG001|Overall Study|New therapy for study indication|0
7146186|NCT03096847|11305455|FG002|Overall Study|New therapy for study indication|1
7146187|NCT03097029|11305482|FG000|Overall Study|Withdrawal by Subject|1
7146188|NCT03097133|11305488|FG000|Overall Study|Lost to Follow-up|3
7146189|NCT03097133|11305489|FG001|Overall Study|Lost to Follow-up|2
7146190|NCT03097133|11305488|FG000|Overall Study|Withdrawal by Subject|2
7146191|NCT03097133|11305489|FG001|Overall Study|Withdrawal by Subject|5
7146192|NCT03097133|11305488|FG000|Overall Study|Discontinued DB, not entered FU Phase|21
7146193|NCT03097133|11305489|FG001|Overall Study|Discontinued DB, not entered FU Phase|25
7146194|NCT03097133|11305488|FG000|Overall Study|Other|3
7146195|NCT03097133|11305489|FG001|Overall Study|Other|2
7146196|NCT03097133|11305488|FG000|Overall Study|Adverse Event|1
7146197|NCT03097133|11305489|FG001|Overall Study|Adverse Event|0
7146198|NCT03097289|11305495|FG000|Overall Study|Adverse Event|1
7146199|NCT03097289|11305495|FG000|Overall Study|Equipment failure|2
7146200|NCT03097289|11305495|FG000|Overall Study|Collected platelet product unusable|3
7037772|NCT01697579|11119759|FG000|Optional Extension-Cycles 2-6|Physician Decision|0
7037773|NCT01697579|11119760|FG001|Optional Extension-Cycles 2-6|Physician Decision|0
7037774|NCT01697579|11119761|FG002|Optional Extension-Cycles 2-6|Physician Decision|0
7037775|NCT01697579|11119762|FG003|Optional Extension-Cycles 2-6|Physician Decision|0
7037776|NCT01697579|11119763|FG004|Optional Extension-Cycles 2-6|Physician Decision|0
7037777|NCT01697579|11119764|FG005|Optional Extension-Cycles 2-6|Physician Decision|7
7037778|NCT01697579|11119765|FG006|Optional Extension-Cycles 2-6|Physician Decision|11
7037779|NCT01697579|11119759|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0
7037780|NCT01697579|11119760|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0
7146201|NCT03097315|11305500|FG000|Overall Study|Withdrawal by Subject|1
7146202|NCT03097588|11305534|FG000|Overall Study|Adverse Event|1
7146203|NCT03097614|11305538|FG000|Overall Study|Adverse Event|3
7146204|NCT03097861|11305563|FG000|Overall Study|Adverse Event|3
7146205|NCT03097861|11305564|FG001|Overall Study|Adverse Event|8
7146206|NCT03097861|11305565|FG002|Overall Study|Adverse Event|4
7146207|NCT03097861|11305563|FG000|Overall Study|Investigator Decision|0
7146208|NCT03097861|11305564|FG001|Overall Study|Investigator Decision|1
7146209|NCT03097861|11305565|FG002|Overall Study|Investigator Decision|0
7146210|NCT03097861|11305563|FG000|Overall Study|Lost to Follow-up|0
7037781|NCT01697579|11119761|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0
7037782|NCT01697579|11119762|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0
7037783|NCT01697579|11119763|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0
7037784|NCT01697579|11119764|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0
7037785|NCT01697579|11119765|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4
7037786|NCT01697579|11119759|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0
7037787|NCT01697579|11119760|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0
7037788|NCT01697579|11119761|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0
7037789|NCT01697579|11119762|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0
7037790|NCT01697579|11119763|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0
7037791|NCT01697579|11119764|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1
7037792|NCT01697579|11119765|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2
7037793|NCT01697579|11119759|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
7037794|NCT01697579|11119760|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
7146211|NCT03097861|11305564|FG001|Overall Study|Lost to Follow-up|7
7146212|NCT03097861|11305565|FG002|Overall Study|Lost to Follow-up|1
7146213|NCT03097861|11305563|FG000|Overall Study|Withdrawal by Subject|1
7146214|NCT03097861|11305564|FG001|Overall Study|Withdrawal by Subject|5
7146215|NCT03097861|11305565|FG002|Overall Study|Withdrawal by Subject|3
7146216|NCT03097861|11305563|FG000|Overall Study|Reason not provided|3
7146217|NCT03097861|11305564|FG001|Overall Study|Reason not provided|1
7146218|NCT03097861|11305565|FG002|Overall Study|Reason not provided|1
7146219|NCT03098030|11305579|FG000|Overall Study|Death|10
7146220|NCT03098030|11305580|FG001|Overall Study|Death|156
7146221|NCT03098030|11305581|FG002|Overall Study|Death|156
7146222|NCT03098030|11305582|FG003|Overall Study|Death|82
7146223|NCT03098030|11305579|FG000|Overall Study|Withdrawal by Subject|0
7146224|NCT03098030|11305580|FG001|Overall Study|Withdrawal by Subject|7
7146225|NCT03098030|11305581|FG002|Overall Study|Withdrawal by Subject|8
7037795|NCT01697579|11119761|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
7037796|NCT01697579|11119762|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
7146226|NCT03098030|11305582|FG003|Overall Study|Withdrawal by Subject|2
7146227|NCT03098030|11305579|FG000|Overall Study|Lost to Follow-up|0
7146228|NCT03098030|11305580|FG001|Overall Study|Lost to Follow-up|0
7146229|NCT03098030|11305581|FG002|Overall Study|Lost to Follow-up|2
7146230|NCT03098030|11305582|FG003|Overall Study|Lost to Follow-up|1
7146231|NCT03098433|11305615|FG000|Overall Study|Withdrawal by Subject|10
7146232|NCT03098550|11305623|FG000|Overall Study|Disease Progression|30
7146233|NCT03098550|11305624|FG001|Overall Study|Disease Progression|19
7146234|NCT03098550|11305625|FG002|Overall Study|Disease Progression|41
7146235|NCT03098550|11305623|FG000|Overall Study|Study Drug Toxicity|2
7146236|NCT03098550|11305624|FG001|Overall Study|Study Drug Toxicity|1
7146237|NCT03098550|11305625|FG002|Overall Study|Study Drug Toxicity|0
7146238|NCT03098550|11305623|FG000|Overall Study|Death|1
7146239|NCT03098550|11305624|FG001|Overall Study|Death|0
7146240|NCT03098550|11305625|FG002|Overall Study|Death|0
7146241|NCT03098550|11305623|FG000|Overall Study|Adverse Event unrelated to Study Drug|6
7146242|NCT03098550|11305624|FG001|Overall Study|Adverse Event unrelated to Study Drug|0
7146243|NCT03098550|11305625|FG002|Overall Study|Adverse Event unrelated to Study Drug|1
7146244|NCT03098550|11305623|FG000|Overall Study|Administrative reason by sponsor|0
7146245|NCT03098550|11305624|FG001|Overall Study|Administrative reason by sponsor|0
7146246|NCT03098550|11305625|FG002|Overall Study|Administrative reason by sponsor|1
7146247|NCT03098550|11305623|FG000|Overall Study|Other reasons|2
7146248|NCT03098550|11305624|FG001|Overall Study|Other reasons|0
7146249|NCT03098550|11305625|FG002|Overall Study|Other reasons|0
7146250|NCT03098979|11305670|FG000|Overall Study|Adverse Event|1
7146251|NCT03098979|11305671|FG001|Overall Study|Adverse Event|0
7146252|NCT03098979|11305672|FG002|Overall Study|Adverse Event|1
7146253|NCT03098979|11305673|FG003|Overall Study|Adverse Event|4
7146254|NCT03098979|11305674|FG004|Overall Study|Adverse Event|6
7146255|NCT03098979|11305675|FG005|Overall Study|Adverse Event|1
7037797|NCT01697579|11119763|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
7037798|NCT01697579|11119764|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1
7037799|NCT01697579|11119765|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
7037800|NCT01697579|11119759|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
7037801|NCT01697579|11119760|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
7037802|NCT01697579|11119761|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
7037803|NCT01697579|11119762|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
7037804|NCT01697579|11119763|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
7037805|NCT01697579|11119764|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15
7037806|NCT01697579|11119765|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24
7037807|NCT01697579|11119759|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
7037808|NCT01697579|11119760|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
7037809|NCT01697579|11119761|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
7037810|NCT01697579|11119762|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
7037811|NCT01697579|11119763|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
7037812|NCT01697579|11119764|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4
7037813|NCT01697579|11119765|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11
7037814|NCT01697579|11119759|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
7037815|NCT01697579|11119760|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
7037816|NCT01697579|11119761|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
7037817|NCT01697579|11119762|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
7037818|NCT01697579|11119763|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
7037819|NCT01697579|11119764|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
7037820|NCT01697579|11119765|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2
7037821|NCT01697579|11119759|FG000|Optional Extension-Cycles 2-6|Technical Problems|0
7037822|NCT01697579|11119760|FG001|Optional Extension-Cycles 2-6|Technical Problems|0
7037823|NCT01697579|11119761|FG002|Optional Extension-Cycles 2-6|Technical Problems|0
7037824|NCT01697579|11119762|FG003|Optional Extension-Cycles 2-6|Technical Problems|0
7037825|NCT01697579|11119763|FG004|Optional Extension-Cycles 2-6|Technical Problems|0
7037826|NCT01697579|11119764|FG005|Optional Extension-Cycles 2-6|Technical Problems|0
7146256|NCT03098979|11305670|FG000|Overall Study|Withdrawal by Subject|2
7146257|NCT03098979|11305671|FG001|Overall Study|Withdrawal by Subject|1
7146258|NCT03098979|11305672|FG002|Overall Study|Withdrawal by Subject|1
7146259|NCT03098979|11305673|FG003|Overall Study|Withdrawal by Subject|1
7146260|NCT03098979|11305674|FG004|Overall Study|Withdrawal by Subject|2
7146261|NCT03098979|11305675|FG005|Overall Study|Withdrawal by Subject|1
7146262|NCT03098979|11305670|FG000|Overall Study|Death|1
7146263|NCT03098979|11305671|FG001|Overall Study|Death|0
7146264|NCT03098979|11305672|FG002|Overall Study|Death|2
7146265|NCT03098979|11305673|FG003|Overall Study|Death|0
7146266|NCT03098979|11305674|FG004|Overall Study|Death|1
7146267|NCT03098979|11305675|FG005|Overall Study|Death|0
7146268|NCT03098979|11305670|FG000|Overall Study|Physician Decision|2
7146269|NCT03098979|11305671|FG001|Overall Study|Physician Decision|1
7146270|NCT03098979|11305672|FG002|Overall Study|Physician Decision|0
7146271|NCT03098979|11305673|FG003|Overall Study|Physician Decision|0
7146272|NCT03098979|11305674|FG004|Overall Study|Physician Decision|0
7146273|NCT03098979|11305675|FG005|Overall Study|Physician Decision|0
7146274|NCT03098979|11305670|FG000|Overall Study|Non-compliance|0
7146275|NCT03098979|11305671|FG001|Overall Study|Non-compliance|0
7146276|NCT03098979|11305672|FG002|Overall Study|Non-compliance|0
7146277|NCT03098979|11305673|FG003|Overall Study|Non-compliance|0
7146278|NCT03098979|11305674|FG004|Overall Study|Non-compliance|0
7146279|NCT03098979|11305675|FG005|Overall Study|Non-compliance|1
7146280|NCT03098979|11305670|FG000|Overall Study|Protocol Violation|0
7146281|NCT03098979|11305671|FG001|Overall Study|Protocol Violation|0
7146282|NCT03098979|11305672|FG002|Overall Study|Protocol Violation|0
7146283|NCT03098979|11305673|FG003|Overall Study|Protocol Violation|0
7146284|NCT03098979|11305674|FG004|Overall Study|Protocol Violation|0
7146285|NCT03098979|11305675|FG005|Overall Study|Protocol Violation|1
7146286|NCT03099096|11305689|FG000|Overall Study|Adverse Event|1
7146287|NCT03099096|11305689|FG000|Overall Study|Physician Decision|1
7146288|NCT03099161|11305696|FG000|Overall Study|Adverse Event|0
7146289|NCT03099161|11305697|FG001|Overall Study|Adverse Event|0
7146290|NCT03099161|11305698|FG002|Overall Study|Adverse Event|2
7146291|NCT03099161|11305696|FG000|Overall Study|Physician Decision|2
7146292|NCT03099161|11305697|FG001|Overall Study|Physician Decision|0
6922913|NCT00813761|10951567|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
6922914|NCT00813761|10951568|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
6922915|NCT00813761|10951569|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0
6922916|NCT00813761|10951566|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1
6922917|NCT00813761|10951567|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4
6922918|NCT00813761|10951568|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0
6922919|NCT00813761|10951569|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3
6922920|NCT00813761|10951566|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9
6922921|NCT00813761|10951567|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
6922922|NCT00813761|10951568|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6
6922923|NCT00813761|10951569|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
6922924|NCT00813800|10951585|FG000|Overall Study|Screen Failure after Consent|2
6922925|NCT00813800|10951585|FG000|Overall Study|Adverse Event|1
6922926|NCT00813800|10951585|FG000|Overall Study|Worsening of depression|2
6922927|NCT00813800|10951585|FG000|Overall Study|Physician Decision|1
6922928|NCT00813813|10951591|FG000|Overall Study|Withdrawal by Subject|1
6922929|NCT00813813|10951592|FG001|Overall Study|Withdrawal by Subject|1
6922930|NCT00813813|10951591|FG000|Overall Study|Lost to Follow-up|2
6922931|NCT00813813|10951592|FG001|Overall Study|Lost to Follow-up|7
6922932|NCT00813813|10951591|FG000|Overall Study|Other|0
6922933|NCT00813813|10951592|FG001|Overall Study|Other|1
6922934|NCT00813865|10951598|FG000|Overall Study|Failure to Respond|3
6922935|NCT00813865|10951598|FG000|Overall Study|Lost to Follow-up|3
6922936|NCT00813865|10951598|FG000|Overall Study|Withdrawal by Subject|1
6922937|NCT00813904|10951602|FG000|Overall Study|Death|1
6922938|NCT00813917|10951608|FG000|Overall Study|Adverse Event|0
6922939|NCT00813917|10951609|FG001|Overall Study|Adverse Event|1
6922940|NCT00813917|10951608|FG000|Overall Study|Withdrawal by Subject|3
6922941|NCT00813917|10951609|FG001|Overall Study|Withdrawal by Subject|4
6922942|NCT00813917|10951608|FG000|Overall Study|Lost to Follow-up|3
6922943|NCT00813917|10951609|FG001|Overall Study|Lost to Follow-up|1
6922944|NCT00813943|10951618|FG000|Overall Study|Ongoing at cut-off date|5
6922945|NCT00813943|10951619|FG001|Overall Study|Ongoing at cut-off date|5
6922946|NCT00813943|10951620|FG002|Overall Study|Ongoing at cut-off date|3
6922947|NCT00813995|10951637|FG000|Overall Study|Clinical adverse event|9
6922948|NCT00813995|10951638|FG001|Overall Study|Clinical adverse event|3
6922949|NCT00813995|10951637|FG000|Overall Study|Laboratory adverse event|0
6922950|NCT00813995|10951638|FG001|Overall Study|Laboratory adverse event|2
6922951|NCT00813995|10951637|FG000|Overall Study|Lack of Efficacy|1
6922952|NCT00813995|10951638|FG001|Overall Study|Lack of Efficacy|0
6922953|NCT00813995|10951637|FG000|Overall Study|Lost to Follow-up|4
6922954|NCT00813995|10951638|FG001|Overall Study|Lost to Follow-up|2
6922955|NCT00813995|10951637|FG000|Overall Study|Other reason|2
6922956|NCT00813995|10951638|FG001|Overall Study|Other reason|2
6922957|NCT00813995|10951637|FG000|Overall Study|Protocol Violation|3
6922958|NCT00813995|10951638|FG001|Overall Study|Protocol Violation|2
6922959|NCT00813995|10951637|FG000|Overall Study|Subject moved|4
6922960|NCT00813995|10951638|FG001|Overall Study|Subject moved|0
6922961|NCT00813995|10951637|FG000|Overall Study|Withdrawal by Subject|0
6922962|NCT00813995|10951638|FG001|Overall Study|Withdrawal by Subject|5
6922963|NCT00814164|10951659|FG000|Overall Study|Progression|7
6922964|NCT00814164|10951659|FG000|Overall Study|not stated|7
6922965|NCT00814164|10951659|FG000|Overall Study|Death|5
7146293|NCT03099161|11305698|FG002|Overall Study|Physician Decision|0
7146294|NCT03099161|11305696|FG000|Overall Study|Progressive Disease|1
7146295|NCT03099161|11305697|FG001|Overall Study|Progressive Disease|4
7146296|NCT03099161|11305698|FG002|Overall Study|Progressive Disease|1
6922966|NCT00814307|10951692|FG000|Overall Study|Randomized but not treated|1
6922967|NCT00814307|10951693|FG001|Overall Study|Randomized but not treated|0
6922968|NCT00814307|10951694|FG002|Overall Study|Randomized but not treated|0
6922969|NCT00814307|10951695|FG003|Overall Study|Randomized but not treated|0
6922970|NCT00814307|10951692|FG000|Overall Study|Adverse Event|3
6922971|NCT00814307|10951693|FG001|Overall Study|Adverse Event|9
6922972|NCT00814307|10951694|FG002|Overall Study|Adverse Event|3
6922973|NCT00814307|10951695|FG003|Overall Study|Adverse Event|2
6922974|NCT00814307|10951692|FG000|Overall Study|Lack of Efficacy|1
6922975|NCT00814307|10951693|FG001|Overall Study|Lack of Efficacy|1
7146297|NCT03099187|11305708|FG000|Double-blind Treatment|Adverse Event|19
7146298|NCT03099187|11305709|FG001|Double-blind Treatment|Adverse Event|1
7146299|NCT03099187|11305710|FG002|Double-blind Treatment|Adverse Event|0
7146300|NCT03099187|11305711|FG003|Double-blind Treatment|Adverse Event|0
7146301|NCT03099187|11305708|FG000|Double-blind Treatment|Death|1
7146302|NCT03099187|11305709|FG001|Double-blind Treatment|Death|3
7146303|NCT03099187|11305710|FG002|Double-blind Treatment|Death|0
7146304|NCT03099187|11305711|FG003|Double-blind Treatment|Death|0
7146305|NCT03099187|11305708|FG000|Double-blind Treatment|Lack of Efficacy|1
7146306|NCT03099187|11305709|FG001|Double-blind Treatment|Lack of Efficacy|0
7146307|NCT03099187|11305710|FG002|Double-blind Treatment|Lack of Efficacy|0
7146308|NCT03099187|11305711|FG003|Double-blind Treatment|Lack of Efficacy|0
7146309|NCT03099187|11305708|FG000|Double-blind Treatment|Physician Decision|2
7146310|NCT03099187|11305709|FG001|Double-blind Treatment|Physician Decision|1
7146311|NCT03099187|11305710|FG002|Double-blind Treatment|Physician Decision|0
7146312|NCT03099187|11305711|FG003|Double-blind Treatment|Physician Decision|0
7146313|NCT03099187|11305708|FG000|Double-blind Treatment|Withdrawal by Subject|9
7146314|NCT03099187|11305709|FG001|Double-blind Treatment|Withdrawal by Subject|4
7146315|NCT03099187|11305710|FG002|Double-blind Treatment|Withdrawal by Subject|0
7146316|NCT03099187|11305711|FG003|Double-blind Treatment|Withdrawal by Subject|0
7146317|NCT03099187|11305708|FG000|Double-blind Treatment|Lung transplantation|0
7146318|NCT03099187|11305709|FG001|Double-blind Treatment|Lung transplantation|1
7146319|NCT03099187|11305710|FG002|Double-blind Treatment|Lung transplantation|0
7146320|NCT03099187|11305711|FG003|Double-blind Treatment|Lung transplantation|0
7146321|NCT03099187|11305708|FG000|Double-blind Treatment|Non-compliance with study drug|0
7146322|NCT03099187|11305709|FG001|Double-blind Treatment|Non-compliance with study drug|2
7146323|NCT03099187|11305710|FG002|Double-blind Treatment|Non-compliance with study drug|0
7146324|NCT03099187|11305711|FG003|Double-blind Treatment|Non-compliance with study drug|0
7146325|NCT03099187|11305708|FG000|Double-blind Treatment|Disease progression|0
7146326|NCT03099187|11305709|FG001|Double-blind Treatment|Disease progression|1
7146327|NCT03099187|11305710|FG002|Double-blind Treatment|Disease progression|0
7146328|NCT03099187|11305711|FG003|Double-blind Treatment|Disease progression|0
7146329|NCT03099187|11305708|FG000|Double-blind Treatment|Randomization error|0
7146330|NCT03099187|11305709|FG001|Double-blind Treatment|Randomization error|2
7146331|NCT03099187|11305710|FG002|Double-blind Treatment|Randomization error|0
7146332|NCT03099187|11305711|FG003|Double-blind Treatment|Randomization error|0
7146333|NCT03099187|11305708|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1
7146334|NCT03099187|11305709|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1
7146335|NCT03099187|11305710|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0
7146336|NCT03099187|11305711|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0
7146337|NCT03099187|11305708|FG000|12-month Safety Follow-up|Adverse Event|0
7146338|NCT03099187|11305709|FG001|12-month Safety Follow-up|Adverse Event|0
7146339|NCT03099187|11305710|FG002|12-month Safety Follow-up|Adverse Event|5
7146340|NCT03099187|11305711|FG003|12-month Safety Follow-up|Adverse Event|12
7146341|NCT03099187|11305708|FG000|12-month Safety Follow-up|Death|0
7146342|NCT03099187|11305709|FG001|12-month Safety Follow-up|Death|0
7146343|NCT03099187|11305710|FG002|12-month Safety Follow-up|Death|7
7146344|NCT03099187|11305711|FG003|12-month Safety Follow-up|Death|9
7146345|NCT03099187|11305708|FG000|12-month Safety Follow-up|Lung transplantation|0
7146346|NCT03099187|11305709|FG001|12-month Safety Follow-up|Lung transplantation|0
7146347|NCT03099187|11305710|FG002|12-month Safety Follow-up|Lung transplantation|2
7146348|NCT03099187|11305711|FG003|12-month Safety Follow-up|Lung transplantation|1
7146349|NCT03099187|11305708|FG000|12-month Safety Follow-up|Lost to Follow-up|0
7146350|NCT03099187|11305709|FG001|12-month Safety Follow-up|Lost to Follow-up|0
7146351|NCT03099187|11305710|FG002|12-month Safety Follow-up|Lost to Follow-up|1
7146352|NCT03099187|11305711|FG003|12-month Safety Follow-up|Lost to Follow-up|0
7146353|NCT03099187|11305708|FG000|12-month Safety Follow-up|Symptomatic deterioration|0
7146354|NCT03099187|11305709|FG001|12-month Safety Follow-up|Symptomatic deterioration|0
7146355|NCT03099187|11305710|FG002|12-month Safety Follow-up|Symptomatic deterioration|1
7146356|NCT03099187|11305711|FG003|12-month Safety Follow-up|Symptomatic deterioration|1
7146357|NCT03099187|11305708|FG000|12-month Safety Follow-up|Withdrawal by Subject|0
7146358|NCT03099187|11305709|FG001|12-month Safety Follow-up|Withdrawal by Subject|0
7146359|NCT03099187|11305710|FG002|12-month Safety Follow-up|Withdrawal by Subject|3
7146360|NCT03099187|11305711|FG003|12-month Safety Follow-up|Withdrawal by Subject|2
7146361|NCT03099187|11305708|FG000|12-month Safety Follow-up|Due to hospitalization|0
7146362|NCT03099187|11305709|FG001|12-month Safety Follow-up|Due to hospitalization|0
7146363|NCT03099187|11305710|FG002|12-month Safety Follow-up|Due to hospitalization|0
7146364|NCT03099187|11305711|FG003|12-month Safety Follow-up|Due to hospitalization|1
7146365|NCT03099538|11305731|FG000|Overall Study|Lack of Efficacy|3
7146366|NCT03099694|11305744|FG000|Overall Study|Withdrawal by Subject|11
7146367|NCT03099694|11305745|FG001|Overall Study|Withdrawal by Subject|13
7146368|NCT03099694|11305744|FG000|Overall Study|Lost to Follow-up|9
7146369|NCT03099694|11305745|FG001|Overall Study|Lost to Follow-up|5
7146370|NCT03100058|11305761|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
7146371|NCT03100058|11305762|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
7146372|NCT03100058|11305763|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4
7146373|NCT03100058|11305764|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8
7146374|NCT03100058|11305765|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1
7037827|NCT01697579|11119765|FG006|Optional Extension-Cycles 2-6|Technical Problems|1
7037828|NCT01697579|11119759|FG000|Optional Extension-Cycles 2-6|Participant Moved|0
7037829|NCT01697579|11119760|FG001|Optional Extension-Cycles 2-6|Participant Moved|0
7037830|NCT01697579|11119761|FG002|Optional Extension-Cycles 2-6|Participant Moved|0
7037831|NCT01697579|11119762|FG003|Optional Extension-Cycles 2-6|Participant Moved|0
7037832|NCT01697579|11119763|FG004|Optional Extension-Cycles 2-6|Participant Moved|0
7037833|NCT01697579|11119764|FG005|Optional Extension-Cycles 2-6|Participant Moved|0
7037834|NCT01697579|11119765|FG006|Optional Extension-Cycles 2-6|Participant Moved|2
7037835|NCT01697579|11119759|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
7037836|NCT01697579|11119760|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
7037837|NCT01697579|11119761|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
7037838|NCT01697579|11119762|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
7037839|NCT01697579|11119763|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
7037840|NCT01697579|11119764|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6
7037841|NCT01697579|11119765|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4
7037842|NCT01697579|11119759|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0
7037843|NCT01697579|11119760|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0
7037844|NCT01697579|11119761|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0
7037845|NCT01697579|11119762|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0
7037846|NCT01697579|11119763|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0
7037847|NCT01697579|11119764|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0
7037848|NCT01697579|11119765|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1
7037849|NCT01697592|11119803|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1
7037850|NCT01697592|11119804|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
7146375|NCT03100058|11305766|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
7146376|NCT03100058|11305767|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3
7037851|NCT01697592|11119805|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
7037852|NCT01697592|11119806|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
7037853|NCT01697592|11119807|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
7037854|NCT01697592|11119808|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
7037855|NCT01697592|11119809|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
7037856|NCT01697592|11119810|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
7037857|NCT01697592|11119811|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
7037858|NCT01697592|11119812|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
7037859|NCT01697592|11119803|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0
7037860|NCT01697592|11119804|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0
7037861|NCT01697592|11119805|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0
7037862|NCT01697592|11119806|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0
7037863|NCT01697592|11119807|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0
7037864|NCT01697592|11119808|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1
7037865|NCT01697592|11119809|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0
7037866|NCT01697592|11119810|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0
7037867|NCT01697592|11119811|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0
7146377|NCT03100058|11305768|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11
7146378|NCT03100058|11305769|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2
7146379|NCT03100058|11305770|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
7146380|NCT03100058|11305771|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
7146381|NCT03100058|11305772|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
7146382|NCT03100058|11305773|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
7146383|NCT03100058|11305761|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2
7146384|NCT03100058|11305762|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
7146385|NCT03100058|11305763|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3
7146386|NCT03100058|11305764|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
7146387|NCT03100058|11305765|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
7146388|NCT03100058|11305766|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
7146389|NCT03100058|11305767|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
7146390|NCT03100058|11305768|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
7146391|NCT03100058|11305769|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2
7146392|NCT03100058|11305770|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
7146393|NCT03100058|11305771|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
7146394|NCT03100058|11305772|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
7146395|NCT03100058|11305773|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
7146396|NCT03100058|11305761|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
7146397|NCT03100058|11305762|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
7146398|NCT03100058|11305763|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
7146399|NCT03100058|11305764|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
7146400|NCT03100058|11305765|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
7146401|NCT03100058|11305766|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
6922976|NCT00814307|10951694|FG002|Overall Study|Lack of Efficacy|3
6922977|NCT00814307|10951695|FG003|Overall Study|Lack of Efficacy|4
6922978|NCT00814307|10951692|FG000|Overall Study|Other|1
7146402|NCT03100058|11305767|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
7146403|NCT03100058|11305768|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
6827402|NCT00125138|10830086|FG003|Overall Study|Adverse Event|2
6827403|NCT00125138|10830083|FG000|Overall Study|Withdrawal by Subject|2
6827404|NCT00125138|10830084|FG001|Overall Study|Withdrawal by Subject|3
6827405|NCT00125138|10830085|FG002|Overall Study|Withdrawal by Subject|1
7146404|NCT03100058|11305769|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
7146405|NCT03100058|11305770|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
7146406|NCT03100058|11305771|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
7146407|NCT03100058|11305772|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
7146408|NCT03100058|11305773|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
7146409|NCT03100058|11305761|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
7146410|NCT03100058|11305762|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
7146411|NCT03100058|11305763|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
7146412|NCT03100058|11305764|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
7146413|NCT03100058|11305765|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
7146414|NCT03100058|11305766|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
7146415|NCT03100058|11305767|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
7146416|NCT03100058|11305768|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
7146417|NCT03100058|11305769|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
7146418|NCT03100058|11305770|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
7146419|NCT03100058|11305771|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
7146420|NCT03100058|11305772|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
7146421|NCT03100058|11305773|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
7146422|NCT03100058|11305761|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7146423|NCT03100058|11305762|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7146424|NCT03100058|11305763|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7146425|NCT03100058|11305764|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1
7146426|NCT03100058|11305765|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7146427|NCT03100058|11305766|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7146428|NCT03100058|11305767|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7146429|NCT03100058|11305768|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1
7146430|NCT03100058|11305769|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7146431|NCT03100058|11305770|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7146432|NCT03100058|11305771|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7146433|NCT03100058|11305772|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7146434|NCT03100058|11305773|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7146435|NCT03100058|11305761|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7146436|NCT03100058|11305762|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7146437|NCT03100058|11305763|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7146438|NCT03100058|11305764|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1
7146439|NCT03100058|11305765|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7146440|NCT03100058|11305766|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7146441|NCT03100058|11305767|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1
7146442|NCT03100058|11305768|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7146443|NCT03100058|11305769|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7146444|NCT03100058|11305770|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7146445|NCT03100058|11305771|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7146446|NCT03100058|11305772|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7146447|NCT03100058|11305773|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7146448|NCT03100058|11305761|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0
7146449|NCT03100058|11305762|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1
6922979|NCT00814307|10951693|FG001|Overall Study|Other|2
6922980|NCT00814307|10951694|FG002|Overall Study|Other|0
6922981|NCT00814307|10951695|FG003|Overall Study|Other|1
6922982|NCT00814307|10951692|FG000|Overall Study|Protocol Violation|2
6922983|NCT00814307|10951693|FG001|Overall Study|Protocol Violation|8
6922984|NCT00814307|10951694|FG002|Overall Study|Protocol Violation|1
6922985|NCT00814307|10951695|FG003|Overall Study|Protocol Violation|1
6922986|NCT00814307|10951692|FG000|Overall Study|Withdrawal by Subject|4
6922987|NCT00814307|10951693|FG001|Overall Study|Withdrawal by Subject|6
6922988|NCT00814307|10951694|FG002|Overall Study|Withdrawal by Subject|0
6922989|NCT00814307|10951695|FG003|Overall Study|Withdrawal by Subject|2
6922990|NCT00814307|10951692|FG000|Overall Study|Death|0
6922991|NCT00814307|10951693|FG001|Overall Study|Death|1
6922992|NCT00814307|10951694|FG002|Overall Study|Death|0
6922993|NCT00814307|10951695|FG003|Overall Study|Death|0
6922994|NCT00814320|10951709|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1
6922995|NCT00814320|10951710|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0
6922996|NCT00814320|10951709|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0
7146450|NCT03100058|11305763|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0
7146451|NCT03100058|11305764|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0
6922997|NCT00814320|10951710|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2
6922998|NCT00814320|10951709|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0
7146452|NCT03100058|11305765|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0
7146453|NCT03100058|11305766|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0
7146454|NCT03100058|11305767|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0
7146455|NCT03100058|11305768|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0
7146456|NCT03100058|11305769|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0
7146457|NCT03100058|11305770|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0
7146458|NCT03100058|11305771|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0
7146459|NCT03100058|11305772|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0
7037868|NCT01697592|11119812|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0
7037869|NCT01697592|11119803|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1
7037870|NCT01697592|11119804|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0
7037871|NCT01697592|11119805|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0
7037872|NCT01697592|11119806|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0
7037873|NCT01697592|11119807|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0
7037874|NCT01697592|11119808|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0
7146460|NCT03100058|11305773|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0
7146461|NCT03100058|11305761|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1
7146462|NCT03100058|11305762|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7146463|NCT03100058|11305763|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7146464|NCT03100058|11305764|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7146465|NCT03100058|11305765|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7146466|NCT03100058|11305766|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7146467|NCT03100058|11305767|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7146468|NCT03100058|11305768|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7146469|NCT03100058|11305769|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7146470|NCT03100058|11305770|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7146471|NCT03100058|11305771|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7146472|NCT03100058|11305772|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7146473|NCT03100058|11305773|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7146474|NCT03100058|11305761|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7146475|NCT03100058|11305762|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7146476|NCT03100058|11305763|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7146477|NCT03100058|11305764|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7146478|NCT03100058|11305765|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7146479|NCT03100058|11305766|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7146480|NCT03100058|11305767|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1
7146481|NCT03100058|11305768|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7146482|NCT03100058|11305769|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7146483|NCT03100058|11305770|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7146484|NCT03100058|11305771|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7146485|NCT03100058|11305772|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7146486|NCT03100058|11305773|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7146487|NCT03100058|11305761|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7146488|NCT03100058|11305762|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7146489|NCT03100058|11305763|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7146490|NCT03100058|11305764|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7146491|NCT03100058|11305765|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7146492|NCT03100058|11305766|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7146493|NCT03100058|11305767|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7146494|NCT03100058|11305768|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7146495|NCT03100058|11305769|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7146496|NCT03100058|11305770|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7146497|NCT03100058|11305771|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4
7146498|NCT03100058|11305772|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2
7146499|NCT03100058|11305773|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1
7146500|NCT03100058|11305761|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7146501|NCT03100058|11305762|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7146502|NCT03100058|11305763|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7146503|NCT03100058|11305764|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7146504|NCT03100058|11305765|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7146505|NCT03100058|11305766|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7146506|NCT03100058|11305767|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7146507|NCT03100058|11305768|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7146508|NCT03100058|11305769|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7146509|NCT03100058|11305770|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7146510|NCT03100058|11305771|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3
7146511|NCT03100058|11305772|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1
7146512|NCT03100058|11305773|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7146513|NCT03100058|11305761|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7146514|NCT03100058|11305762|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7037875|NCT01697592|11119809|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0
7146515|NCT03100058|11305763|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7146516|NCT03100058|11305764|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7146517|NCT03100058|11305765|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7146518|NCT03100058|11305766|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7146519|NCT03100058|11305767|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7146520|NCT03100058|11305768|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7146521|NCT03100058|11305769|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7146522|NCT03100058|11305770|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4
6827406|NCT00125138|10830086|FG003|Overall Study|Withdrawal by Subject|1
6827407|NCT00125138|10830083|FG000|Overall Study|Lack of Efficacy|0
6827408|NCT00125138|10830084|FG001|Overall Study|Lack of Efficacy|0
6827409|NCT00125138|10830085|FG002|Overall Study|Lack of Efficacy|0
6827410|NCT00125138|10830086|FG003|Overall Study|Lack of Efficacy|1
6827411|NCT00125138|10830083|FG000|Overall Study|Sponsor decision-pt moved to assist care|0
6827412|NCT00125138|10830084|FG001|Overall Study|Sponsor decision-pt moved to assist care|0
6827413|NCT00125138|10830085|FG002|Overall Study|Sponsor decision-pt moved to assist care|0
6827414|NCT00125138|10830086|FG003|Overall Study|Sponsor decision-pt moved to assist care|1
6922999|NCT00814320|10951710|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1
7146523|NCT03100058|11305771|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7
7146524|NCT03100058|11305772|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7146525|NCT03100058|11305773|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2
7146526|NCT03100058|11305761|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7146527|NCT03100058|11305762|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7146528|NCT03100058|11305763|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7146529|NCT03100058|11305764|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7146530|NCT03100058|11305765|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7146531|NCT03100058|11305766|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7037876|NCT01697592|11119810|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0
7037877|NCT01697592|11119811|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0
7037878|NCT01697592|11119812|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0
7037879|NCT01697592|11119803|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
7037880|NCT01697592|11119804|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
7037881|NCT01697592|11119805|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
7146532|NCT03100058|11305767|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7146533|NCT03100058|11305768|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7146534|NCT03100058|11305769|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7146535|NCT03100058|11305770|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7146536|NCT03100058|11305771|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1
7146537|NCT03100058|11305772|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7146538|NCT03100058|11305773|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7146539|NCT03100058|11305761|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7146540|NCT03100058|11305762|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7146541|NCT03100058|11305763|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7146542|NCT03100058|11305764|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7146543|NCT03100058|11305765|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7146544|NCT03100058|11305766|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7146545|NCT03100058|11305767|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7146546|NCT03100058|11305768|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7146547|NCT03100058|11305769|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
6923000|NCT00814320|10951709|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1
6923001|NCT00814320|10951710|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0
6923002|NCT00814320|10951709|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1
6923003|NCT00814320|10951710|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0
6923004|NCT00814320|10951709|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1
6923005|NCT00814320|10951710|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4
6923006|NCT00814320|10951709|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2
6923007|NCT00814320|10951710|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1
7037882|NCT01697592|11119806|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
7037883|NCT01697592|11119807|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
7037884|NCT01697592|11119808|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
7037885|NCT01697592|11119809|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
7037886|NCT01697592|11119810|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
7037887|NCT01697592|11119811|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
7037888|NCT01697592|11119812|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
7037889|NCT01697592|11119803|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0
7037890|NCT01697592|11119804|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2
7037891|NCT01697592|11119805|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1
7037892|NCT01697592|11119806|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2
7037893|NCT01697592|11119807|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0
7060782|NCT01922271|11157357|FG001|WASHOUT Period|Withdrawal by Subject|0
7082210|NCT02139644|11192565|FG003|Treatment Period|Non-compliance|1
7082211|NCT02139644|11192566|FG004|Treatment Period|Non-compliance|0
7082212|NCT02139644|11192567|FG005|Treatment Period|Non-compliance|0
6923008|NCT00814320|10951709|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0
6923009|NCT00814320|10951710|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1
6923010|NCT00814320|10951709|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0
7082213|NCT02139644|11192562|FG000|Treatment Period|Protocol Violation|0
7146548|NCT03100058|11305770|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7146549|NCT03100058|11305771|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7146550|NCT03100058|11305772|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7146551|NCT03100058|11305773|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1
7146552|NCT03100058|11305761|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7146553|NCT03100058|11305762|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7146554|NCT03100058|11305763|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7146555|NCT03100058|11305764|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7146556|NCT03100058|11305765|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7146557|NCT03100058|11305766|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7146558|NCT03100058|11305767|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7146559|NCT03100058|11305768|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7146560|NCT03100058|11305769|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7146561|NCT03100058|11305770|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1
7146562|NCT03100058|11305771|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7146563|NCT03100058|11305772|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7146564|NCT03100058|11305773|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7146565|NCT03100344|11305820|FG000|Overall Study|Adverse Event|0
7146566|NCT03100344|11305821|FG001|Overall Study|Adverse Event|3
7146567|NCT03100344|11305822|FG002|Overall Study|Adverse Event|2
7146568|NCT03100344|11305823|FG003|Overall Study|Adverse Event|3
7146569|NCT03100344|11305820|FG000|Overall Study|Lack of Efficacy|2
7146570|NCT03100344|11305821|FG001|Overall Study|Lack of Efficacy|0
7146571|NCT03100344|11305822|FG002|Overall Study|Lack of Efficacy|0
7146572|NCT03100344|11305823|FG003|Overall Study|Lack of Efficacy|0
7146573|NCT03100344|11305820|FG000|Overall Study|Protocol Violation|1
7146574|NCT03100344|11305821|FG001|Overall Study|Protocol Violation|0
7146575|NCT03100344|11305822|FG002|Overall Study|Protocol Violation|0
7146576|NCT03100344|11305823|FG003|Overall Study|Protocol Violation|0
7146577|NCT03100344|11305820|FG000|Overall Study|Withdrawal by Subject|10
7146578|NCT03100344|11305821|FG001|Overall Study|Withdrawal by Subject|7
7146579|NCT03100344|11305822|FG002|Overall Study|Withdrawal by Subject|4
7146580|NCT03100344|11305823|FG003|Overall Study|Withdrawal by Subject|8
7146581|NCT03100344|11305820|FG000|Overall Study|Lost to Follow-up|1
7146582|NCT03100344|11305821|FG001|Overall Study|Lost to Follow-up|1
7146583|NCT03100344|11305822|FG002|Overall Study|Lost to Follow-up|1
7146584|NCT03100344|11305823|FG003|Overall Study|Lost to Follow-up|1
7146585|NCT03100825|11305838|FG000|Overall Study|Participant/Guardian Decision|7
7146586|NCT03100825|11305838|FG000|Overall Study|Physician Decision|1
7146587|NCT03100838|11305842|FG000|Overall Study|Adverse Event|1
7146588|NCT03100838|11305843|FG001|Overall Study|Adverse Event|0
7146589|NCT03100838|11305844|FG002|Overall Study|Adverse Event|0
7146590|NCT03100838|11305845|FG003|Overall Study|Adverse Event|0
7146591|NCT03100838|11305842|FG000|Overall Study|Physician Decision|1
7146592|NCT03100838|11305843|FG001|Overall Study|Physician Decision|1
7146593|NCT03100838|11305844|FG002|Overall Study|Physician Decision|1
7146594|NCT03100838|11305845|FG003|Overall Study|Physician Decision|1
7146595|NCT03100838|11305842|FG000|Overall Study|Pregnancy|0
7146596|NCT03100838|11305843|FG001|Overall Study|Pregnancy|1
7146597|NCT03100838|11305844|FG002|Overall Study|Pregnancy|0
7146598|NCT03100838|11305845|FG003|Overall Study|Pregnancy|0
7146599|NCT03100838|11305842|FG000|Overall Study|Lost to Follow-up|0
6923011|NCT00814320|10951710|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1
6923012|NCT00814320|10951709|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0
6923013|NCT00814320|10951710|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3
6923014|NCT00814346|10951735|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0
6923015|NCT00814346|10951736|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1
6923016|NCT00814346|10951735|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0
6923017|NCT00814346|10951736|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2
6923018|NCT00814346|10951735|FG000|Open Phase (17 Months)|Adverse Event|5
6923019|NCT00814346|10951736|FG001|Open Phase (17 Months)|Adverse Event|0
6923020|NCT00814346|10951735|FG000|Open Phase (17 Months)|Consent|2
6923021|NCT00814346|10951736|FG001|Open Phase (17 Months)|Consent|0
6923022|NCT00814346|10951735|FG000|Open Phase (17 Months)|Lost to Follow-up|2
6923023|NCT00814346|10951736|FG001|Open Phase (17 Months)|Lost to Follow-up|0
6923024|NCT00814346|10951735|FG000|Open Phase (17 Months)|Not otherwise specified|1
6923025|NCT00814346|10951736|FG001|Open Phase (17 Months)|Not otherwise specified|0
6827415|NCT00125164|10830100|FG000|Overall Study|Adverse Event|0
6827416|NCT00125164|10830101|FG001|Overall Study|Adverse Event|0
6827417|NCT00125164|10830102|FG002|Overall Study|Adverse Event|2
6827418|NCT00125164|10830103|FG003|Overall Study|Adverse Event|4
6827419|NCT00125164|10830100|FG000|Overall Study|Lost to Follow-up|0
6827420|NCT00125164|10830101|FG001|Overall Study|Lost to Follow-up|0
6827421|NCT00125164|10830102|FG002|Overall Study|Lost to Follow-up|1
6827422|NCT00125164|10830103|FG003|Overall Study|Lost to Follow-up|1
6827423|NCT00125164|10830100|FG000|Overall Study|Withdrawal by Subject|2
6827424|NCT00125164|10830101|FG001|Overall Study|Withdrawal by Subject|0
6827425|NCT00125164|10830102|FG002|Overall Study|Withdrawal by Subject|1
7146600|NCT03100838|11305843|FG001|Overall Study|Lost to Follow-up|0
7146601|NCT03100838|11305844|FG002|Overall Study|Lost to Follow-up|1
7146602|NCT03100838|11305845|FG003|Overall Study|Lost to Follow-up|0
7146603|NCT03100942|11305863|FG000|Randomized Treatment Period|Withdrew Consent|4
7146604|NCT03100942|11305864|FG001|Randomized Treatment Period|Withdrew Consent|5
7146605|NCT03100942|11305865|FG002|Randomized Treatment Period|Withdrew Consent|3
7146606|NCT03100942|11305866|FG003|Randomized Treatment Period|Withdrew Consent|3
7146607|NCT03100942|11305867|FG004|Randomized Treatment Period|Withdrew Consent|0
7146608|NCT03100942|11305868|FG005|Randomized Treatment Period|Withdrew Consent|0
7146609|NCT03100942|11305869|FG006|Randomized Treatment Period|Withdrew Consent|0
7146610|NCT03100942|11305863|FG000|Randomized Treatment Period|Adverse Event|5
7146611|NCT03100942|11305864|FG001|Randomized Treatment Period|Adverse Event|2
7146612|NCT03100942|11305865|FG002|Randomized Treatment Period|Adverse Event|1
7146613|NCT03100942|11305866|FG003|Randomized Treatment Period|Adverse Event|0
7146614|NCT03100942|11305867|FG004|Randomized Treatment Period|Adverse Event|0
7037894|NCT01697592|11119808|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0
7037895|NCT01697592|11119809|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1
7037896|NCT01697592|11119810|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0
7037897|NCT01697592|11119811|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0
7037898|NCT01697592|11119812|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1
6923026|NCT00814463|10951755|FG000|Overall Study|Lost to Follow-up|1
7037899|NCT01697592|11119803|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1
7037900|NCT01697592|11119804|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0
7146615|NCT03100942|11305868|FG005|Randomized Treatment Period|Adverse Event|0
7146616|NCT03100942|11305869|FG006|Randomized Treatment Period|Adverse Event|0
7146617|NCT03100942|11305863|FG000|Randomized Treatment Period|Investigator's Discretion|2
7146618|NCT03100942|11305864|FG001|Randomized Treatment Period|Investigator's Discretion|1
7146619|NCT03100942|11305865|FG002|Randomized Treatment Period|Investigator's Discretion|0
7146620|NCT03100942|11305866|FG003|Randomized Treatment Period|Investigator's Discretion|0
7146621|NCT03100942|11305867|FG004|Randomized Treatment Period|Investigator's Discretion|0
7146622|NCT03100942|11305868|FG005|Randomized Treatment Period|Investigator's Discretion|0
7146623|NCT03100942|11305869|FG006|Randomized Treatment Period|Investigator's Discretion|0
7146624|NCT03100942|11305863|FG000|Randomized Treatment Period|Protocol Violation|0
7146625|NCT03100942|11305864|FG001|Randomized Treatment Period|Protocol Violation|1
7146626|NCT03100942|11305865|FG002|Randomized Treatment Period|Protocol Violation|1
7146627|NCT03100942|11305866|FG003|Randomized Treatment Period|Protocol Violation|1
7146628|NCT03100942|11305867|FG004|Randomized Treatment Period|Protocol Violation|0
7146629|NCT03100942|11305868|FG005|Randomized Treatment Period|Protocol Violation|0
6923027|NCT00814489|10951763|FG000|Overall Study|Other|2
6923028|NCT00814489|10951764|FG001|Overall Study|Other|0
6923029|NCT00814489|10951765|FG002|Overall Study|Other|1
6923030|NCT00814502|10951777|FG000|Overall Study|Adverse Event|1
6923031|NCT00814502|10951778|FG001|Overall Study|Adverse Event|0
6923032|NCT00814502|10951777|FG000|Overall Study|Withdrawal by Subject|0
6923033|NCT00814502|10951778|FG001|Overall Study|Withdrawal by Subject|2
6923034|NCT00814580|10951788|FG000|Overall Study|Adverse Event|6
6923035|NCT00814580|10951789|FG001|Overall Study|Adverse Event|15
6923036|NCT00814580|10951788|FG000|Overall Study|Lack of Efficacy|18
6923037|NCT00814580|10951789|FG001|Overall Study|Lack of Efficacy|25
6923038|NCT00814580|10951788|FG000|Overall Study|Protocol Violation|2
6923039|NCT00814580|10951789|FG001|Overall Study|Protocol Violation|0
6923040|NCT00814580|10951788|FG000|Overall Study|Withdrawal by Subject|2
6923041|NCT00814580|10951789|FG001|Overall Study|Withdrawal by Subject|2
6923042|NCT00814580|10951788|FG000|Overall Study|Other|1
7037901|NCT01697592|11119805|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0
7037902|NCT01697592|11119806|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1
7037903|NCT01697592|11119807|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0
7037904|NCT01697592|11119808|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0
7037905|NCT01697592|11119809|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0
7037906|NCT01697592|11119810|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0
7037907|NCT01697592|11119811|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0
7037908|NCT01697592|11119812|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0
7037909|NCT01697592|11119803|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2
7037910|NCT01697592|11119804|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
7037911|NCT01697592|11119805|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
7037912|NCT01697592|11119806|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
7037913|NCT01697592|11119807|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
7037914|NCT01697592|11119808|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
7037915|NCT01697592|11119809|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
7037916|NCT01697592|11119810|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
7037917|NCT01697592|11119811|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
7037918|NCT01697592|11119812|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
7037919|NCT01697592|11119803|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2
7037920|NCT01697592|11119804|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1
7037921|NCT01697592|11119805|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1
7037922|NCT01697592|11119806|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2
7037923|NCT01697592|11119807|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0
7037924|NCT01697592|11119808|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1
7037925|NCT01697592|11119809|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1
7037926|NCT01697592|11119810|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0
7037927|NCT01697592|11119811|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2
7037928|NCT01697592|11119812|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0
7037929|NCT01697696|11119850|FG000|Overall Study|Study terminated by sponsor|0
7146630|NCT03100942|11305869|FG006|Randomized Treatment Period|Protocol Violation|0
7146631|NCT03100942|11305863|FG000|Randomized Treatment Period|Lost to Follow-up|0
7146632|NCT03100942|11305864|FG001|Randomized Treatment Period|Lost to Follow-up|0
7146633|NCT03100942|11305865|FG002|Randomized Treatment Period|Lost to Follow-up|1
7146634|NCT03100942|11305866|FG003|Randomized Treatment Period|Lost to Follow-up|0
7146635|NCT03100942|11305867|FG004|Randomized Treatment Period|Lost to Follow-up|0
7146636|NCT03100942|11305868|FG005|Randomized Treatment Period|Lost to Follow-up|0
7146637|NCT03100942|11305869|FG006|Randomized Treatment Period|Lost to Follow-up|0
7146638|NCT03100942|11305863|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1
7146639|NCT03100942|11305864|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
7146640|NCT03100942|11305865|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
7146641|NCT03100942|11305866|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1
7146642|NCT03100942|11305867|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
7183733|NCT01302847|11383784|FG004|Overall Study|Withdrawal by Subject|1
6923043|NCT00814580|10951789|FG001|Overall Study|Other|3
7146643|NCT03100942|11305868|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
7146644|NCT03100942|11305869|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
7146645|NCT03100942|11305863|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0
7146646|NCT03100942|11305864|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0
7146647|NCT03100942|11305865|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0
7146648|NCT03100942|11305866|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0
7146649|NCT03100942|11305867|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0
7146650|NCT03100942|11305868|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0
7146651|NCT03100942|11305869|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1
7146652|NCT03101020|11305893|FG000|Overall Study|Lack of time to participate|1
7146653|NCT03101020|11305894|FG001|Overall Study|Lack of time to participate|0
7146654|NCT03101020|11305893|FG000|Overall Study|Ran over by a car|0
7146655|NCT03101020|11305894|FG001|Overall Study|Ran over by a car|1
7146656|NCT03101020|11305893|FG000|Overall Study|Withdrawal by Subject|0
7146657|NCT03101020|11305894|FG001|Overall Study|Withdrawal by Subject|2
7146658|NCT03101150|11305924|FG000|Overall Study|Lost to Follow-up|2
7146659|NCT03101150|11305925|FG001|Overall Study|Lost to Follow-up|4
7146660|NCT03101150|11305924|FG000|Overall Study|Miscarriage|3
7146661|NCT03101150|11305925|FG001|Overall Study|Miscarriage|6
7146662|NCT03101241|11305933|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4
7146663|NCT03101241|11305934|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2
7146664|NCT03101241|11305933|FG000|Overall Study|Participant withdrew consent|3
7146665|NCT03101241|11305934|FG001|Overall Study|Participant withdrew consent|1
7146666|NCT03101241|11305933|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2
7146667|NCT03101241|11305934|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0
7146668|NCT03101241|11305933|FG000|Overall Study|Lost to Follow-up|2
7146669|NCT03101241|11305934|FG001|Overall Study|Lost to Follow-up|0
7146670|NCT03101241|11305933|FG000|Overall Study|Lack of Efficacy|0
7146671|NCT03101241|11305934|FG001|Overall Study|Lack of Efficacy|1
7146672|NCT03101241|11305933|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0
7146673|NCT03101241|11305934|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1
7146674|NCT03101267|11305943|FG000|Primary Study Period|Withdrawal by Subject|1
7146675|NCT03101267|11305944|FG001|Primary Study Period|Withdrawal by Subject|2
7146676|NCT03101267|11305945|FG002|Primary Study Period|Withdrawal by Subject|3
7146677|NCT03101267|11305943|FG000|Primary Study Period|Miscellaneous|2
7037930|NCT01697696|11119851|FG001|Overall Study|Study terminated by sponsor|3
7037931|NCT01697696|11119850|FG000|Overall Study|Protocol deviation|1
7037932|NCT01697696|11119851|FG001|Overall Study|Protocol deviation|0
7037933|NCT01697696|11119850|FG000|Overall Study|Physician Decision|1
7037934|NCT01697696|11119851|FG001|Overall Study|Physician Decision|0
7037935|NCT01697696|11119850|FG000|Overall Study|Death|4
7037936|NCT01697696|11119851|FG001|Overall Study|Death|2
7037937|NCT01697696|11119850|FG000|Overall Study|Lost to Follow-up|10
7037938|NCT01697696|11119851|FG001|Overall Study|Lost to Follow-up|7
7037939|NCT01697696|11119850|FG000|Overall Study|Subject/guardian decision|31
7037940|NCT01697696|11119851|FG001|Overall Study|Subject/guardian decision|35
7037941|NCT01697748|11119868|FG000|Overall Study|ineligible skin incision|1
7037942|NCT01697748|11119869|FG001|Overall Study|ineligible skin incision|2
7037943|NCT01697748|11119868|FG000|Overall Study|ineligible uterine incision|4
7037944|NCT01697748|11119869|FG001|Overall Study|ineligible uterine incision|1
7037945|NCT01697748|11119868|FG000|Overall Study|Lost to Follow-up|53
7037946|NCT01697748|11119869|FG001|Overall Study|Lost to Follow-up|65
7037947|NCT01697956|11119877|FG000|Overall Study|Protocol Violation|1
7037948|NCT01697956|11119878|FG001|Overall Study|Protocol Violation|1
7037949|NCT01697969|11119890|FG000|Overall Study|Did not meet inc/exc criteria|3
7037950|NCT01698008|11119897|FG000|Overall Study|Withdrawal by Subject|1
7037951|NCT01698008|11119898|FG001|Overall Study|Withdrawal by Subject|2
7037952|NCT01698268|11119906|FG000|Overall Study|Physician Decision|2
7037953|NCT01698268|11119907|FG001|Overall Study|Physician Decision|1
7037954|NCT01698320|11119915|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24
7037955|NCT01698320|11119916|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
7037956|NCT01698320|11119917|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
7037957|NCT01698320|11119915|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1
7037958|NCT01698320|11119916|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
7037959|NCT01698320|11119917|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
7037960|NCT01698320|11119915|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1
7037961|NCT01698320|11119916|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
7037962|NCT01698320|11119917|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
7037963|NCT01698320|11119915|FG000|Run-In Period (Week -1 to Day 0)|Other|1
7037964|NCT01698320|11119916|FG001|Run-In Period (Week -1 to Day 0)|Other|0
7037965|NCT01698320|11119917|FG002|Run-In Period (Week -1 to Day 0)|Other|0
7037966|NCT01698320|11119915|FG000|12-Week Double-Blind Period|Adverse Event|0
7146678|NCT03101267|11305944|FG001|Primary Study Period|Miscellaneous|0
7146679|NCT03101267|11305945|FG002|Primary Study Period|Miscellaneous|0
7146680|NCT03101293|11305955|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1
7146681|NCT03101293|11305956|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0
7146682|NCT03101358|11305966|FG000|Overall Study|Non-compliance with study schedule|1
7146683|NCT03101358|11305967|FG001|Overall Study|Non-compliance with study schedule|0
7146684|NCT03101358|11305968|FG002|Overall Study|Non-compliance with study schedule|0
7146685|NCT03101358|11305969|FG003|Overall Study|Non-compliance with study schedule|1
7146686|NCT03101358|11305966|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0
7146687|NCT03101358|11305967|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0
7146688|NCT03101358|11305968|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1
7146689|NCT03101358|11305969|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0
7146690|NCT03101358|11305966|FG000|Overall Study|Physician Decision|1
7146691|NCT03101358|11305967|FG001|Overall Study|Physician Decision|0
7146692|NCT03101358|11305968|FG002|Overall Study|Physician Decision|0
7146693|NCT03101358|11305969|FG003|Overall Study|Physician Decision|3
7146694|NCT03101358|11305966|FG000|Overall Study|Adverse Event|0
7146695|NCT03101358|11305967|FG001|Overall Study|Adverse Event|0
7146696|NCT03101358|11305968|FG002|Overall Study|Adverse Event|1
7146697|NCT03101358|11305969|FG003|Overall Study|Adverse Event|0
7146698|NCT03101358|11305966|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0
7146699|NCT03101358|11305967|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0
7146700|NCT03101358|11305968|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0
7146701|NCT03101358|11305969|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1
7146702|NCT03101358|11305966|FG000|Overall Study|Lost to Follow-up|1
7146703|NCT03101358|11305967|FG001|Overall Study|Lost to Follow-up|0
7146704|NCT03101358|11305968|FG002|Overall Study|Lost to Follow-up|0
7146705|NCT03101358|11305969|FG003|Overall Study|Lost to Follow-up|1
7146706|NCT03101371|11305982|FG000|Overall Study|Physician Decision|0
7146707|NCT03101371|11305983|FG001|Overall Study|Physician Decision|1
7146708|NCT03101371|11305982|FG000|Overall Study|Lost to Follow-up|1
7146709|NCT03101371|11305983|FG001|Overall Study|Lost to Follow-up|4
7146710|NCT03101371|11305982|FG000|Overall Study|Did not meet eligibility criteria|2
7146711|NCT03101371|11305983|FG001|Overall Study|Did not meet eligibility criteria|1
7146712|NCT03101462|11305991|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1
7146713|NCT03101462|11305992|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1
7146714|NCT03101514|11305998|FG000|Overall Study|Withdrawal by Subject|4
6827426|NCT00125164|10830103|FG003|Overall Study|Withdrawal by Subject|1
6827427|NCT00125190|10830113|FG000|Overall Study|Subject/Parent Decision|7
6827428|NCT00125190|10830113|FG000|Overall Study|Non-compliance|2
6827429|NCT00125190|10830113|FG000|Overall Study|Adverse Event|1
6827430|NCT00125190|10830113|FG000|Overall Study|Other|1
6827431|NCT00125190|10830113|FG000|Overall Study|Lost to Follow-up|4
6827432|NCT00125242|10830120|FG000|Overall Study|did not qualify|7
6827433|NCT00125242|10830121|FG001|Overall Study|did not qualify|2
6827434|NCT00125359|10830126|FG000|Overall Study|Death|4
6827435|NCT00125359|10830126|FG000|Overall Study|Adverse Event|5
6827436|NCT00125359|10830126|FG000|Overall Study|Physician Decision|14
6827437|NCT00125853|10830199|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3
6827438|NCT00125853|10830200|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7
6827439|NCT00126126|10830230|FG000|Overall Study|Lost to Follow-up|0
6827440|NCT00126126|10830231|FG001|Overall Study|Lost to Follow-up|2
6827441|NCT00126191|10830239|FG000|Overall Study|Physician Decision|0
6827442|NCT00126191|10830240|FG001|Overall Study|Physician Decision|1
6827443|NCT00126191|10830239|FG000|Overall Study|Death|0
6827444|NCT00126191|10830240|FG001|Overall Study|Death|1
6827445|NCT00126425|10830248|FG000|Overall Study|Withdrawal by Subject|17
6827446|NCT00126425|10830249|FG001|Overall Study|Withdrawal by Subject|1
6827447|NCT00126425|10830248|FG000|Overall Study|Lost to Follow-up|8
6827448|NCT00126425|10830249|FG001|Overall Study|Lost to Follow-up|4
6827449|NCT00126425|10830248|FG000|Overall Study|Protocol Violation|9
6827450|NCT00126425|10830249|FG001|Overall Study|Protocol Violation|6
6827451|NCT00126425|10830248|FG000|Overall Study|Adverse Event|1
6827452|NCT00126425|10830249|FG001|Overall Study|Adverse Event|0
6827453|NCT00126425|10830248|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1
6827454|NCT00126425|10830249|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0
6827455|NCT00126425|10830248|FG000|Overall Study|Other|5
6827456|NCT00126425|10830249|FG001|Overall Study|Other|0
6827457|NCT00126438|10830257|FG000|Overall Study|Withdrawal due to adverse event|1
6827458|NCT00126438|10830258|FG001|Overall Study|Withdrawal due to adverse event|0
6827459|NCT00126438|10830257|FG000|Overall Study|Lost to Follow-up|22
6827460|NCT00126438|10830258|FG001|Overall Study|Lost to Follow-up|0
6827461|NCT00126438|10830257|FG000|Overall Study|Protocol Violation|8
6827462|NCT00126438|10830258|FG001|Overall Study|Protocol Violation|8
6827463|NCT00126438|10830257|FG000|Overall Study|Withdrawal by Subject|3
6827464|NCT00126438|10830258|FG001|Overall Study|Withdrawal by Subject|2
6827465|NCT00126490|10830264|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1
6827466|NCT00126503|10830270|FG000|Overall Study|disease progression|23
6827467|NCT00126503|10830271|FG001|Overall Study|disease progression|14
6827468|NCT00126503|10830270|FG000|Overall Study|Withdrawal by Subject|0
6827469|NCT00126503|10830271|FG001|Overall Study|Withdrawal by Subject|1
6827470|NCT00126503|10830270|FG000|Overall Study|alternative therapy|1
6827471|NCT00126503|10830271|FG001|Overall Study|alternative therapy|1
7146715|NCT03101514|11305998|FG000|Overall Study|Protocol Violation|2
7146716|NCT03101514|11305998|FG000|Overall Study|patient's information was incomplete|1
7146717|NCT03101592|11306005|FG000|Overall Study|participant files could not be located|111
7146718|NCT03101592|11306006|FG001|Overall Study|participant files could not be located|170
7146719|NCT03101592|11306007|FG002|Overall Study|participant files could not be located|118
7146720|NCT03102710|11306052|FG000|Overall Study|Dental metal affected MRI scan quality|1
7146721|NCT03102710|11306053|FG001|Overall Study|Dental metal affected MRI scan quality|0
7146722|NCT03102710|11306054|FG002|Overall Study|Dental metal affected MRI scan quality|0
7146723|NCT03102710|11306052|FG000|Overall Study|Technical issues during final MRI scan|0
7146724|NCT03102710|11306053|FG001|Overall Study|Technical issues during final MRI scan|1
7146725|NCT03102710|11306054|FG002|Overall Study|Technical issues during final MRI scan|0
7146726|NCT03102710|11306052|FG000|Overall Study|Nausea during MRI scan|0
7146727|NCT03102710|11306053|FG001|Overall Study|Nausea during MRI scan|1
7146728|NCT03102710|11306054|FG002|Overall Study|Nausea during MRI scan|0
7146729|NCT03102710|11306052|FG000|Overall Study|Subject unable to attend final session|0
7146730|NCT03102710|11306053|FG001|Overall Study|Subject unable to attend final session|1
7146731|NCT03102710|11306054|FG002|Overall Study|Subject unable to attend final session|0
7146732|NCT03102762|11306073|FG000|Overall Study|Lost to Follow-up|1
7146733|NCT03102762|11306074|FG001|Overall Study|Lost to Follow-up|0
7146734|NCT03102918|11306096|FG000|Overall Study|Protocol Violation|1
7146735|NCT03102918|11306097|FG001|Overall Study|Protocol Violation|0
7146736|NCT03103100|11306110|FG000|Overall Study|Adverse Event|1
7037967|NCT01698320|11119916|FG001|12-Week Double-Blind Period|Adverse Event|1
7037968|NCT01698320|11119917|FG002|12-Week Double-Blind Period|Adverse Event|1
7037969|NCT01698320|11119915|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0
7037970|NCT01698320|11119916|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2
7037971|NCT01698320|11119917|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2
7037972|NCT01698320|11119915|FG000|12-Week Double-Blind Period|Protocol Violation|0
7037973|NCT01698320|11119916|FG001|12-Week Double-Blind Period|Protocol Violation|0
7037974|NCT01698320|11119917|FG002|12-Week Double-Blind Period|Protocol Violation|2
7037975|NCT01698320|11119915|FG000|12-Week Double-Blind Period|Pregnancy|0
7037976|NCT01698320|11119916|FG001|12-Week Double-Blind Period|Pregnancy|1
7146737|NCT03103100|11306111|FG001|Overall Study|Adverse Event|0
7146738|NCT03103100|11306112|FG002|Overall Study|Adverse Event|0
7146739|NCT03103100|11306110|FG000|Overall Study|Physician Decision|1
7146740|NCT03103100|11306111|FG001|Overall Study|Physician Decision|0
7146741|NCT03103100|11306112|FG002|Overall Study|Physician Decision|2
7146742|NCT03103503|11306153|FG000|Overall Study|Death|64
7146743|NCT03103503|11306153|FG000|Overall Study|Physician Decision|57
7146744|NCT03103503|11306153|FG000|Overall Study|Withdrawal by Subject|10
7146745|NCT03103503|11306153|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10
7146746|NCT03103503|11306153|FG000|Overall Study|Lost to Follow-up|3
7146747|NCT03103503|11306153|FG000|Overall Study|Study Closure|757
7146748|NCT03103763|11306160|FG000|Overall Study|Death|15
7146749|NCT03103763|11306161|FG001|Overall Study|Death|5
7146750|NCT03103763|11306162|FG002|Overall Study|Death|5
7146751|NCT03103763|11306160|FG000|Overall Study|Withdrawal by Subject|0
7146752|NCT03103763|11306161|FG001|Overall Study|Withdrawal by Subject|3
7146753|NCT03103763|11306162|FG002|Overall Study|Withdrawal by Subject|2
7146754|NCT03103906|11306172|FG000|Overall Study|Adverse Event|2
7146755|NCT03103906|11306173|FG001|Overall Study|Adverse Event|3
7146756|NCT03103906|11306172|FG000|Overall Study|Other|2
7146757|NCT03103906|11306173|FG001|Overall Study|Other|0
7146758|NCT03103919|11306181|FG000|Overall Study|Adverse Event|2
7146759|NCT03103919|11306182|FG001|Overall Study|Adverse Event|2
7146760|NCT03104816|11306242|FG000|Overall Study|Lack of Efficacy|0
7146761|NCT03104816|11306243|FG001|Overall Study|Lack of Efficacy|2
7146762|NCT03104816|11306244|FG002|Overall Study|Lack of Efficacy|0
7146763|NCT03104816|11306242|FG000|Overall Study|Protocol Violation|2
7146764|NCT03104816|11306243|FG001|Overall Study|Protocol Violation|0
7146765|NCT03104816|11306244|FG002|Overall Study|Protocol Violation|2
7183734|NCT01302847|11383785|FG005|Overall Study|Withdrawal by Subject|0
7183735|NCT01302847|11383786|FG006|Overall Study|Withdrawal by Subject|0
7183736|NCT01302847|11383787|FG007|Overall Study|Withdrawal by Subject|1
7183737|NCT01302847|11383780|FG000|Overall Study|Not willing to adhere to requirements|5
7183738|NCT01302847|11383781|FG001|Overall Study|Not willing to adhere to requirements|0
7183739|NCT01302847|11383782|FG002|Overall Study|Not willing to adhere to requirements|0
7183740|NCT01302847|11383783|FG003|Overall Study|Not willing to adhere to requirements|1
7183741|NCT01302847|11383784|FG004|Overall Study|Not willing to adhere to requirements|0
7183742|NCT01302847|11383785|FG005|Overall Study|Not willing to adhere to requirements|0
7183743|NCT01302847|11383786|FG006|Overall Study|Not willing to adhere to requirements|0
7037977|NCT01698320|11119917|FG002|12-Week Double-Blind Period|Pregnancy|1
7183744|NCT01302847|11383787|FG007|Overall Study|Not willing to adhere to requirements|2
7183745|NCT01302847|11383780|FG000|Overall Study|Site unable to contact participant|2
7183746|NCT01302847|11383781|FG001|Overall Study|Site unable to contact participant|1
7183747|NCT01302847|11383782|FG002|Overall Study|Site unable to contact participant|0
7183748|NCT01302847|11383783|FG003|Overall Study|Site unable to contact participant|0
7183749|NCT01302847|11383784|FG004|Overall Study|Site unable to contact participant|0
7183750|NCT01302847|11383785|FG005|Overall Study|Site unable to contact participant|0
7146766|NCT03105297|11306261|FG000|Baseline Phase (Day 1)|Other|21
7146767|NCT03105297|11306261|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1
7146768|NCT03105297|11306261|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7
7146769|NCT03105362|11306272|FG000|Overall Study|Withdrawal by Subject|1
7146770|NCT03105362|11306272|FG000|Overall Study|Lost to Follow-up|1
7146771|NCT03106077|11306296|FG000|Overall Study|Screen Failure|94
7146772|NCT03106077|11306297|FG001|Overall Study|Screen Failure|0
7146773|NCT03106753|11306318|FG000|Overall Study|Withdrawal by Subject|0
7146774|NCT03106753|11306319|FG001|Overall Study|Withdrawal by Subject|1
7146775|NCT03107026|11306343|FG000|Overall Study|Adverse Event|2
7146776|NCT03107026|11306344|FG001|Overall Study|Adverse Event|14
7146777|NCT03107026|11306345|FG002|Overall Study|Adverse Event|23
7146778|NCT03107026|11306343|FG000|Overall Study|Lost to Follow-up|12
7146779|NCT03107026|11306344|FG001|Overall Study|Lost to Follow-up|12
7146780|NCT03107026|11306345|FG002|Overall Study|Lost to Follow-up|13
7146781|NCT03107026|11306343|FG000|Overall Study|Protocol Violation|1
7146782|NCT03107026|11306344|FG001|Overall Study|Protocol Violation|2
7146783|NCT03107026|11306345|FG002|Overall Study|Protocol Violation|0
7146784|NCT03107026|11306343|FG000|Overall Study|Pregnancy|1
7146785|NCT03107026|11306344|FG001|Overall Study|Pregnancy|0
7146786|NCT03107026|11306345|FG002|Overall Study|Pregnancy|0
7146787|NCT03107026|11306343|FG000|Overall Study|Withdrawal by Subject|13
7146788|NCT03107026|11306344|FG001|Overall Study|Withdrawal by Subject|5
7146789|NCT03107026|11306345|FG002|Overall Study|Withdrawal by Subject|17
7146790|NCT03107026|11306343|FG000|Overall Study|non compliance with study visits|1
7146791|NCT03107026|11306344|FG001|Overall Study|non compliance with study visits|2
7146792|NCT03107026|11306345|FG002|Overall Study|non compliance with study visits|0
7146793|NCT03107026|11306343|FG000|Overall Study|non-compliance with study drug|2
7146794|NCT03107026|11306344|FG001|Overall Study|non-compliance with study drug|2
7146795|NCT03107026|11306345|FG002|Overall Study|non-compliance with study drug|3
7146796|NCT03107026|11306343|FG000|Overall Study|Physician Decision|0
7146797|NCT03107026|11306344|FG001|Overall Study|Physician Decision|1
7146798|NCT03107026|11306345|FG002|Overall Study|Physician Decision|0
7146799|NCT03107052|11306356|FG000|Overall Study|Adverse Event|6
7146800|NCT03107052|11306357|FG001|Overall Study|Adverse Event|1
7146801|NCT03107052|11306358|FG002|Overall Study|Adverse Event|2
7146802|NCT03107052|11306356|FG000|Overall Study|Withdrawal by Subject|9
6923044|NCT00814580|10951788|FG000|Overall Study|Did Not Take Drug|2
6923045|NCT00814580|10951789|FG001|Overall Study|Did Not Take Drug|2
6923046|NCT00814632|10951807|FG000|Overall Study|Lack of Efficacy|2
6923047|NCT00814658|10951813|FG000|Overall Study|Lost to Follow-up|0
6923048|NCT00814658|10951814|FG001|Overall Study|Lost to Follow-up|1
6923049|NCT00814658|10951813|FG000|Overall Study|Physician Decision|1
6923050|NCT00814658|10951814|FG001|Overall Study|Physician Decision|0
6923051|NCT00814658|10951813|FG000|Overall Study|Adverse Event|3
6923052|NCT00814658|10951814|FG001|Overall Study|Adverse Event|3
6923053|NCT00814710|10951853|FG000|Overall Study|Adverse Event|1
6923054|NCT00814710|10951854|FG001|Overall Study|Adverse Event|0
6923055|NCT00814710|10951853|FG000|Overall Study|Lost to Follow-up|7
6923056|NCT00814710|10951854|FG001|Overall Study|Lost to Follow-up|3
6923057|NCT00814801|10951878|FG000|Overall Study|Adverse Event|15
6923058|NCT00814801|10951879|FG001|Overall Study|Adverse Event|16
6923059|NCT00814801|10951880|FG002|Overall Study|Adverse Event|19
6923060|NCT00814801|10951878|FG000|Overall Study|Withdrawal by Subject|9
6923061|NCT00814801|10951879|FG001|Overall Study|Withdrawal by Subject|11
6923062|NCT00814801|10951880|FG002|Overall Study|Withdrawal by Subject|14
6923063|NCT00814801|10951878|FG000|Overall Study|Inappropriate as a subject|1
6923064|NCT00814801|10951879|FG001|Overall Study|Inappropriate as a subject|1
6923065|NCT00814801|10951880|FG002|Overall Study|Inappropriate as a subject|1
6923066|NCT00814801|10951878|FG000|Overall Study|Change of patients for CIBIC plus-J|1
6923067|NCT00814801|10951879|FG001|Overall Study|Change of patients for CIBIC plus-J|1
6923068|NCT00814801|10951880|FG002|Overall Study|Change of patients for CIBIC plus-J|0
6923069|NCT00814801|10951878|FG000|Overall Study|Missing or change of caregiver|6
6923070|NCT00814801|10951879|FG001|Overall Study|Missing or change of caregiver|2
6923071|NCT00814801|10951880|FG002|Overall Study|Missing or change of caregiver|4
6923072|NCT00814801|10951878|FG000|Overall Study|Non-compliance|0
6923073|NCT00814801|10951879|FG001|Overall Study|Non-compliance|1
6923074|NCT00814801|10951880|FG002|Overall Study|Non-compliance|1
6923075|NCT00814801|10951878|FG000|Overall Study|Other|2
6923076|NCT00814801|10951879|FG001|Overall Study|Other|6
6923077|NCT00814801|10951880|FG002|Overall Study|Other|4
6923078|NCT00814879|10951890|FG000|By Week 24|Cancer Diagnosis|1
6923079|NCT00814879|10951891|FG001|By Week 24|Cancer Diagnosis|0
6923080|NCT00814879|10951890|FG000|By Week 24|Incarceration|0
6923081|NCT00814879|10951891|FG001|By Week 24|Incarceration|1
6923082|NCT00814879|10951890|FG000|By Week 48|Lost to Follow-up|2
6923083|NCT00814879|10951891|FG001|By Week 48|Lost to Follow-up|2
6923084|NCT00814879|10951890|FG000|By Week 48|Death|0
6923085|NCT00814879|10951891|FG001|By Week 48|Death|1
6923086|NCT00815191|10951928|FG000|Overall Study|Protocol Violation|1
6923087|NCT00815191|10951929|FG001|Overall Study|Protocol Violation|1
6923088|NCT00815295|10951938|FG000|Overall Study|Cetuximab hypersensitivity reaction|0
6923089|NCT00815295|10951939|FG001|Overall Study|Cetuximab hypersensitivity reaction|1
6923090|NCT00815295|10951940|FG002|Overall Study|Cetuximab hypersensitivity reaction|3
6923091|NCT00815308|10951948|FG000|Overall Study|Adverse Event|4
7146803|NCT03107052|11306357|FG001|Overall Study|Withdrawal by Subject|5
7146804|NCT03107052|11306358|FG002|Overall Study|Withdrawal by Subject|8
7146805|NCT03107052|11306356|FG000|Overall Study|Protocol Violation|6
7146806|NCT03107052|11306357|FG001|Overall Study|Protocol Violation|0
7146807|NCT03107052|11306358|FG002|Overall Study|Protocol Violation|3
7146808|NCT03107052|11306356|FG000|Overall Study|Lost to Follow-up|4
7146809|NCT03107052|11306357|FG001|Overall Study|Lost to Follow-up|0
7146810|NCT03107052|11306358|FG002|Overall Study|Lost to Follow-up|1
7146811|NCT03107052|11306356|FG000|Overall Study|Lack of Efficacy|23
7146812|NCT03107052|11306357|FG001|Overall Study|Lack of Efficacy|7
7146813|NCT03107052|11306358|FG002|Overall Study|Lack of Efficacy|4
7146814|NCT03107052|11306356|FG000|Overall Study|Other than specified|4
7146815|NCT03107052|11306357|FG001|Overall Study|Other than specified|2
7146816|NCT03107052|11306358|FG002|Overall Study|Other than specified|0
7146817|NCT03107052|11306356|FG000|Overall Study|Study terminated due to futility|67
7146818|NCT03107052|11306357|FG001|Overall Study|Study terminated due to futility|31
7146819|NCT03107052|11306358|FG002|Overall Study|Study terminated due to futility|23
7146820|NCT03107091|11306366|FG000|Overall Study|Physician Decision|1
7146821|NCT03107377|11306373|FG000|Overall Study|Adverse Event|3
7146822|NCT03107377|11306374|FG001|Overall Study|Adverse Event|3
7146823|NCT03107377|11306373|FG000|Overall Study|Protocol Violation|9
7146824|NCT03107377|11306374|FG001|Overall Study|Protocol Violation|12
7146825|NCT03107377|11306373|FG000|Overall Study|Physician Decision|3
7146826|NCT03107377|11306374|FG001|Overall Study|Physician Decision|6
7146827|NCT03107377|11306373|FG000|Overall Study|Pregnancy|7
7146828|NCT03107377|11306374|FG001|Overall Study|Pregnancy|7
7146829|NCT03107377|11306373|FG000|Overall Study|Withdrawal by Subject|16
7146830|NCT03107377|11306374|FG001|Overall Study|Withdrawal by Subject|22
7146831|NCT03107377|11306373|FG000|Overall Study|Lost to Follow-up|37
7146832|NCT03107377|11306374|FG001|Overall Study|Lost to Follow-up|34
7146833|NCT03107377|11306373|FG000|Overall Study|Other reason not specified|16
7146834|NCT03107377|11306374|FG001|Overall Study|Other reason not specified|15
7146835|NCT03107715|11306382|FG000|Overall Study|did not deliver at the home hospital|4
7146836|NCT03107715|11306383|FG001|Overall Study|did not deliver at the home hospital|6
7146837|NCT03107715|11306382|FG000|Overall Study|infant stillborn|0
7146838|NCT03107715|11306383|FG001|Overall Study|infant stillborn|1
7146839|NCT03107793|11306398|FG000|Induction Period (16 Weeks)|Adverse Event|5
7146840|NCT03107793|11306399|FG001|Induction Period (16 Weeks)|Adverse Event|0
7146841|NCT03107793|11306400|FG002|Induction Period (16 Weeks)|Adverse Event|0
7146842|NCT03107793|11306398|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3
7146843|NCT03107793|11306399|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0
7146844|NCT03107793|11306400|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0
7146845|NCT03107793|11306398|FG000|Induction Period (16 Weeks)|Physician Decision|1
7146846|NCT03107793|11306399|FG001|Induction Period (16 Weeks)|Physician Decision|0
7146847|NCT03107793|11306400|FG002|Induction Period (16 Weeks)|Physician Decision|0
7146848|NCT03107793|11306398|FG000|Induction Period (16 Weeks)|Progressive Disease|1
7146849|NCT03107793|11306399|FG001|Induction Period (16 Weeks)|Progressive Disease|0
7146850|NCT03107793|11306400|FG002|Induction Period (16 Weeks)|Progressive Disease|0
7146851|NCT03107793|11306398|FG000|Maintenance Period (16-48 Week)|Adverse Event|0
7146852|NCT03107793|11306399|FG001|Maintenance Period (16-48 Week)|Adverse Event|6
7146853|NCT03107793|11306400|FG002|Maintenance Period (16-48 Week)|Adverse Event|10
7146854|NCT03107793|11306398|FG000|Maintenance Period (16-48 Week)|Death|0
7146855|NCT03107793|11306399|FG001|Maintenance Period (16-48 Week)|Death|2
7146856|NCT03107793|11306400|FG002|Maintenance Period (16-48 Week)|Death|0
7146857|NCT03107793|11306398|FG000|Maintenance Period (16-48 Week)|Lack of Efficacy|0
7146858|NCT03107793|11306399|FG001|Maintenance Period (16-48 Week)|Lack of Efficacy|21
7146859|NCT03107793|11306400|FG002|Maintenance Period (16-48 Week)|Lack of Efficacy|8
7146860|NCT03107793|11306398|FG000|Maintenance Period (16-48 Week)|Lost to Follow-up|0
7146861|NCT03107793|11306399|FG001|Maintenance Period (16-48 Week)|Lost to Follow-up|1
7146862|NCT03107793|11306400|FG002|Maintenance Period (16-48 Week)|Lost to Follow-up|0
7146863|NCT03107793|11306398|FG000|Maintenance Period (16-48 Week)|Withdrawal by Subject|0
7146864|NCT03107793|11306399|FG001|Maintenance Period (16-48 Week)|Withdrawal by Subject|12
7146865|NCT03107793|11306400|FG002|Maintenance Period (16-48 Week)|Withdrawal by Subject|4
7146866|NCT03107793|11306398|FG000|Maintenance Period (16-48 Week)|Physician Decision|0
7146867|NCT03107793|11306399|FG001|Maintenance Period (16-48 Week)|Physician Decision|1
7146868|NCT03107793|11306400|FG002|Maintenance Period (16-48 Week)|Physician Decision|2
6923092|NCT00815308|10951948|FG000|Overall Study|Withdrawal by Subject|0
6923093|NCT00815308|10951948|FG000|Overall Study|Protocol Violation|6
6923094|NCT00815516|10951978|FG000|Overall Study|Death|3
6923095|NCT00815516|10951979|FG001|Overall Study|Death|1
6923096|NCT00815516|10951978|FG000|Overall Study|Physician Decision|1
6923097|NCT00815516|10951979|FG001|Overall Study|Physician Decision|0
6923098|NCT00815659|10951985|FG000|Overall Study|Adverse Event|9
6923099|NCT00815659|10951985|FG000|Overall Study|Withdrawal by Subject|9
6923100|NCT00815659|10951985|FG000|Overall Study|Lost to Follow-up|4
6923101|NCT00815659|10951985|FG000|Overall Study|Protocol Violation|1
6923102|NCT00815919|10952018|FG000|Overall Study|Unrelated Fungal Infection|1
6923103|NCT00815919|10952018|FG000|Overall Study|AML Relapse|1
6923104|NCT00815919|10952018|FG000|Overall Study|Lack of Efficacy|2
6923105|NCT00816023|10952037|FG000|Overall Study|Lost to Follow-up|1
6923106|NCT00816023|10952038|FG001|Overall Study|Lost to Follow-up|1
6923107|NCT00816023|10952039|FG002|Overall Study|Lost to Follow-up|0
6923108|NCT00816023|10952040|FG003|Overall Study|Lost to Follow-up|0
6923109|NCT00816023|10952037|FG000|Overall Study|Withdrawal by Subject|1
6923110|NCT00816023|10952038|FG001|Overall Study|Withdrawal by Subject|0
6923111|NCT00816023|10952039|FG002|Overall Study|Withdrawal by Subject|0
6923112|NCT00816023|10952040|FG003|Overall Study|Withdrawal by Subject|0
6923113|NCT00816023|10952037|FG000|Overall Study|Physician Decision|0
6923114|NCT00816023|10952038|FG001|Overall Study|Physician Decision|0
6923115|NCT00816023|10952039|FG002|Overall Study|Physician Decision|1
6923116|NCT00816023|10952040|FG003|Overall Study|Physician Decision|0
6923117|NCT00816023|10952037|FG000|Overall Study|assessments complete prior to window|1
6923118|NCT00816023|10952038|FG001|Overall Study|assessments complete prior to window|1
7037978|NCT01698320|11119915|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
7037979|NCT01698320|11119916|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
7037980|NCT01698320|11119917|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2
7037981|NCT01698320|11119915|FG000|12-Week Double-Blind Period|Lost to Follow-up|0
7037982|NCT01698320|11119916|FG001|12-Week Double-Blind Period|Lost to Follow-up|0
7037983|NCT01698320|11119917|FG002|12-Week Double-Blind Period|Lost to Follow-up|4
7037984|NCT01698320|11119915|FG000|40-Week Open-Label Period|Adverse Event|0
7037985|NCT01698320|11119916|FG001|40-Week Open-Label Period|Adverse Event|3
7037986|NCT01698320|11119917|FG002|40-Week Open-Label Period|Adverse Event|2
7037987|NCT01698320|11119915|FG000|40-Week Open-Label Period|Withdrawal by Subject|0
7037988|NCT01698320|11119916|FG001|40-Week Open-Label Period|Withdrawal by Subject|11
7037989|NCT01698320|11119917|FG002|40-Week Open-Label Period|Withdrawal by Subject|7
7037990|NCT01698320|11119915|FG000|40-Week Open-Label Period|Pregnancy|0
7037991|NCT01698320|11119916|FG001|40-Week Open-Label Period|Pregnancy|2
7037992|NCT01698320|11119917|FG002|40-Week Open-Label Period|Pregnancy|1
7037993|NCT01698320|11119915|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
7037994|NCT01698320|11119916|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1
7037995|NCT01698320|11119917|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
7037996|NCT01698320|11119915|FG000|40-Week Open-Label Period|Lost to Follow-up|0
7037997|NCT01698320|11119916|FG001|40-Week Open-Label Period|Lost to Follow-up|2
7037998|NCT01698320|11119917|FG002|40-Week Open-Label Period|Lost to Follow-up|0
7037999|NCT01698554|11119955|FG000|Overall Study|Adverse Event|2
7038000|NCT01698554|11119956|FG001|Overall Study|Adverse Event|5
7038001|NCT01698554|11119957|FG002|Overall Study|Adverse Event|0
7038002|NCT01698554|11119958|FG003|Overall Study|Adverse Event|1
7038003|NCT01698554|11119955|FG000|Overall Study|Lost to Follow-up|1
7038004|NCT01698554|11119956|FG001|Overall Study|Lost to Follow-up|0
7038005|NCT01698554|11119957|FG002|Overall Study|Lost to Follow-up|0
7038006|NCT01698554|11119958|FG003|Overall Study|Lost to Follow-up|0
7038007|NCT01698554|11119955|FG000|Overall Study|Personal Reasons|0
7038008|NCT01698554|11119956|FG001|Overall Study|Personal Reasons|5
7038009|NCT01698554|11119957|FG002|Overall Study|Personal Reasons|1
7038010|NCT01698554|11119958|FG003|Overall Study|Personal Reasons|1
7038011|NCT01698554|11119955|FG000|Overall Study|Protocol Violation|2
7038012|NCT01698554|11119956|FG001|Overall Study|Protocol Violation|0
7038013|NCT01698554|11119957|FG002|Overall Study|Protocol Violation|1
7038014|NCT01698554|11119958|FG003|Overall Study|Protocol Violation|0
7038015|NCT01698554|11119955|FG000|Overall Study|Other Miscellaneous Reasons|1
7038016|NCT01698554|11119956|FG001|Overall Study|Other Miscellaneous Reasons|0
7038017|NCT01698554|11119957|FG002|Overall Study|Other Miscellaneous Reasons|0
7038018|NCT01698554|11119958|FG003|Overall Study|Other Miscellaneous Reasons|0
7038019|NCT01698775|11119987|FG000|Phase A|Adverse Event|2
7038020|NCT01698775|11119988|FG001|Phase A|Adverse Event|1
7038021|NCT01698775|11119987|FG000|Phase A|Death|1
7038022|NCT01698775|11119988|FG001|Phase A|Death|1
7038023|NCT01698775|11119987|FG000|Phase A|Lack of Efficacy|1
7038024|NCT01698775|11119988|FG001|Phase A|Lack of Efficacy|0
7038025|NCT01698775|11119987|FG000|Phase A|Lost to Follow-up|1
7038026|NCT01698775|11119988|FG001|Phase A|Lost to Follow-up|2
7038027|NCT01698775|11119987|FG000|Phase A|Protocol Violation|1
7038028|NCT01698775|11119988|FG001|Phase A|Protocol Violation|0
7038029|NCT01698775|11119987|FG000|Phase A|Withdrawal by Subject|3
7038030|NCT01698775|11119988|FG001|Phase A|Withdrawal by Subject|4
7038031|NCT01698775|11119987|FG000|Phase A|Kidney [transplant]|0
7038032|NCT01698775|11119988|FG001|Phase A|Kidney [transplant]|1
7038033|NCT01698775|11119987|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0
7038034|NCT01698775|11119988|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1
7038035|NCT01698775|11119987|FG000|Phase B|Adverse Event|6
7146869|NCT03107793|11306398|FG000|Maintenance Period (16-48 Week)|Pregnancy|0
6923119|NCT00816023|10952039|FG002|Overall Study|assessments complete prior to window|2
6923120|NCT00816023|10952040|FG003|Overall Study|assessments complete prior to window|1
6923121|NCT00816023|10952037|FG000|Overall Study|Randomized Not Treated|6
6923122|NCT00816023|10952038|FG001|Overall Study|Randomized Not Treated|4
6923123|NCT00816023|10952039|FG002|Overall Study|Randomized Not Treated|6
6923124|NCT00816023|10952040|FG003|Overall Study|Randomized Not Treated|11
6923125|NCT00816036|10952052|FG000|Overall Study|Death|47
6923126|NCT00816036|10952053|FG001|Overall Study|Death|28
6923127|NCT00816036|10952052|FG000|Overall Study|Lost to Follow-up|75
6923128|NCT00816036|10952053|FG001|Overall Study|Lost to Follow-up|57
6923129|NCT00816036|10952052|FG000|Overall Study|Withdrawal by Subject|54
7146870|NCT03107793|11306399|FG001|Maintenance Period (16-48 Week)|Pregnancy|1
7146871|NCT03107793|11306400|FG002|Maintenance Period (16-48 Week)|Pregnancy|1
7146872|NCT03107793|11306398|FG000|Maintenance Period (16-48 Week)|Disease Relapse|0
7146873|NCT03107793|11306399|FG001|Maintenance Period (16-48 Week)|Disease Relapse|2
7146874|NCT03107793|11306400|FG002|Maintenance Period (16-48 Week)|Disease Relapse|1
7146875|NCT03107793|11306398|FG000|Maintenance Period (16-48 Week)|Progressive Disease|0
7146876|NCT03107793|11306399|FG001|Maintenance Period (16-48 Week)|Progressive Disease|0
7146877|NCT03107793|11306400|FG002|Maintenance Period (16-48 Week)|Progressive Disease|1
7146878|NCT03107793|11306398|FG000|Maintenance Period (16-48 Week)|Received A Disallowed Concomitant Treatment|0
7146879|NCT03107793|11306399|FG001|Maintenance Period (16-48 Week)|Received A Disallowed Concomitant Treatment|0
7146880|NCT03107793|11306400|FG002|Maintenance Period (16-48 Week)|Received A Disallowed Concomitant Treatment|1
7146881|NCT03108027|11306407|FG000|Period 1|Subject/Guardian Decision|0
7146882|NCT03108027|11306408|FG001|Period 1|Subject/Guardian Decision|0
7146883|NCT03108027|11306409|FG002|Period 1|Subject/Guardian Decision|0
7146884|NCT03108027|11306410|FG003|Period 1|Subject/Guardian Decision|2
6923130|NCT00816036|10952053|FG001|Overall Study|Withdrawal by Subject|23
7038036|NCT01698775|11119988|FG001|Phase B|Adverse Event|3
7038037|NCT01698775|11119987|FG000|Phase B|Death|0
7038038|NCT01698775|11119988|FG001|Phase B|Death|1
7038039|NCT01698775|11119987|FG000|Phase B|Lack of Efficacy|0
7038040|NCT01698775|11119988|FG001|Phase B|Lack of Efficacy|1
7038041|NCT01698775|11119987|FG000|Phase B|Lost to Follow-up|0
7038042|NCT01698775|11119988|FG001|Phase B|Lost to Follow-up|1
7038043|NCT01698775|11119987|FG000|Phase B|Physician Decision|1
7038044|NCT01698775|11119988|FG001|Phase B|Physician Decision|1
7038045|NCT01698775|11119987|FG000|Phase B|Protocol Violation|1
7038046|NCT01698775|11119988|FG001|Phase B|Protocol Violation|1
7038047|NCT01698775|11119987|FG000|Phase B|Withdrawal by Subject|6
7038048|NCT01698775|11119988|FG001|Phase B|Withdrawal by Subject|2
7038049|NCT01698801|11119998|FG000|Treatment Phase|Adverse Event|4
7038050|NCT01698801|11119998|FG000|Treatment Phase|Protocol Violation|1
7038051|NCT01698801|11119998|FG000|Treatment Phase|Other|4
7038052|NCT01698801|11119998|FG000|Treatment Phase|Withdrawal by Subject|1
7038053|NCT01698801|11119998|FG000|Treatment Phase|Disease progression|1
7038054|NCT01698801|11119998|FG000|Follow Up Phase|Withdrawal by Subject|1
7038055|NCT01698801|11119998|FG000|Follow Up Phase|Death|4
7038056|NCT01698814|11120005|FG000|Overall Study|Adverse Event|0
7038057|NCT01698814|11120006|FG001|Overall Study|Adverse Event|2
7038058|NCT01698814|11120005|FG000|Overall Study|Lost to Follow-up|0
7038059|NCT01698814|11120006|FG001|Overall Study|Lost to Follow-up|1
7038060|NCT01698814|11120005|FG000|Overall Study|Pregnancy|1
7038061|NCT01698814|11120006|FG001|Overall Study|Pregnancy|0
7038062|NCT01698814|11120005|FG000|Overall Study|Randomized in error|1
7038063|NCT01698814|11120006|FG001|Overall Study|Randomized in error|0
7038064|NCT01698879|11120015|FG000|Overall Study|Withdrawal by Subject|1
7038065|NCT01698879|11120016|FG001|Overall Study|Withdrawal by Subject|0
7038066|NCT01698879|11120017|FG002|Overall Study|Withdrawal by Subject|0
7038067|NCT01699022|11120031|FG000|Overall Study|Early discontinuation from the study|3
7038068|NCT01699087|11120036|FG000|Overall Study|Lost to Follow-up|7
7038069|NCT01699087|11120036|FG000|Overall Study|Screen failure (prior to treatment)|15
7038070|NCT01699087|11120036|FG000|Overall Study|Unable to make future visits|2
7038071|NCT01699178|11120043|FG000|Overall Study|Adverse Event|1
7038072|NCT01699178|11120044|FG001|Overall Study|Adverse Event|5
7038073|NCT01699178|11120043|FG000|Overall Study|Lost to Follow-up|1
7038074|NCT01699178|11120044|FG001|Overall Study|Lost to Follow-up|6
7038075|NCT01699178|11120043|FG000|Overall Study|Non-compliance with Study Drug|3
7038076|NCT01699178|11120044|FG001|Overall Study|Non-compliance with Study Drug|1
7038077|NCT01699178|11120043|FG000|Overall Study|Physician Decision|1
7038078|NCT01699178|11120044|FG001|Overall Study|Physician Decision|0
7038079|NCT01699178|11120043|FG000|Overall Study|Withdrawal by Subject|4
7038080|NCT01699178|11120044|FG001|Overall Study|Withdrawal by Subject|12
7038081|NCT01699178|11120043|FG000|Overall Study|Hematocrit >54%|1
7038082|NCT01699178|11120044|FG001|Overall Study|Hematocrit >54%|1
7038083|NCT01699178|11120043|FG000|Overall Study|PSA increase of >1.4 ng/mL|4
7038084|NCT01699178|11120044|FG001|Overall Study|PSA increase of >1.4 ng/mL|3
7038085|NCT01699178|11120043|FG000|Overall Study|ineligible/noncompliant/ subject reason|4
7038086|NCT01699178|11120044|FG001|Overall Study|ineligible/noncompliant/ subject reason|4
7038087|NCT01699503|11120061|FG000|Overall Study|Death|31
7146885|NCT03108027|11306411|FG004|Period 1|Subject/Guardian Decision|0
7146886|NCT03108027|11306412|FG005|Period 1|Subject/Guardian Decision|0
7146887|NCT03108027|11306407|FG000|Period 3|Adverse Event|0
7146888|NCT03108027|11306408|FG001|Period 3|Adverse Event|1
7146889|NCT03108027|11306409|FG002|Period 3|Adverse Event|0
7146890|NCT03108027|11306410|FG003|Period 3|Adverse Event|0
7146891|NCT03108027|11306411|FG004|Period 3|Adverse Event|0
7146892|NCT03108027|11306412|FG005|Period 3|Adverse Event|0
7146893|NCT03108157|11306422|FG000|Overall Study|Protocol Violation|15
7146894|NCT03108157|11306423|FG001|Overall Study|Protocol Violation|4
7038088|NCT01699503|11120062|FG001|Overall Study|Death|40
7038089|NCT01699503|11120061|FG000|Overall Study|Withdrawal by Subject|65
7038090|NCT01699503|11120062|FG001|Overall Study|Withdrawal by Subject|57
7038091|NCT01699503|11120061|FG000|Overall Study|Lost to Follow-up|121
7038092|NCT01699503|11120062|FG001|Overall Study|Lost to Follow-up|117
7146895|NCT03108521|11306458|FG000|Overall Study|Lost to Follow-up|3
6923131|NCT00816166|10952079|FG000|Overall Study|Lost to Follow-up|6
6923132|NCT00816166|10952080|FG001|Overall Study|Lost to Follow-up|10
6923133|NCT00816166|10952079|FG000|Overall Study|Death|4
6923134|NCT00816166|10952080|FG001|Overall Study|Death|2
6923135|NCT00816361|10952097|FG000|Overall Study|Withdrawal by Subject|0
6923136|NCT00816361|10952098|FG001|Overall Study|Withdrawal by Subject|0
6923137|NCT00816361|10952099|FG002|Overall Study|Withdrawal by Subject|0
7038093|NCT01699503|11120061|FG000|Overall Study|Excluded due to quality|783
7038094|NCT01699503|11120062|FG001|Overall Study|Excluded due to quality|791
7038095|NCT01699685|11120087|FG000|Period 1|Adverse Event|1
7038096|NCT01699685|11120088|FG001|Period 1|Adverse Event|1
7038097|NCT01699685|11120087|FG000|Period 1|Medical or ethical, noncompliance|2
7038098|NCT01699685|11120088|FG001|Period 1|Medical or ethical, noncompliance|0
7038099|NCT01699685|11120087|FG000|Period 1|Other|0
7038100|NCT01699685|11120088|FG001|Period 1|Other|1
7038101|NCT01699685|11120087|FG000|Period 1|Patient request|0
7038102|NCT01699685|11120088|FG001|Period 1|Patient request|1
7038103|NCT01699685|11120087|FG000|Period 2|Lost to Follow-up|1
7038104|NCT01699685|11120088|FG001|Period 2|Lost to Follow-up|0
7038105|NCT01699750|11120106|FG000|Overall Study|Withdrew Consent|0
7038106|NCT01699750|11120107|FG001|Overall Study|Withdrew Consent|1
7038107|NCT01699750|11120106|FG000|Overall Study|Other|0
7038108|NCT01699750|11120107|FG001|Overall Study|Other|2
7038109|NCT01699789|11120123|FG000|Overall Study|Withdrawal by Subject|18
7038110|NCT01699789|11120124|FG001|Overall Study|Withdrawal by Subject|23
7038111|NCT01699789|11120123|FG000|Overall Study|Death|1
7038112|NCT01699789|11120124|FG001|Overall Study|Death|2
7038113|NCT01699789|11120123|FG000|Overall Study|Lost to Follow-up|83
7038114|NCT01699789|11120124|FG001|Overall Study|Lost to Follow-up|101
7038115|NCT01699815|11120134|FG000|Overall Study|Protocol Violation|4
7038116|NCT01699815|11120135|FG001|Overall Study|Protocol Violation|7
7038117|NCT01699815|11120134|FG000|Overall Study|record could not be located|1
7038118|NCT01699815|11120135|FG001|Overall Study|record could not be located|0
7038119|NCT01699815|11120134|FG000|Overall Study|Adverse Event|0
7038120|NCT01699815|11120135|FG001|Overall Study|Adverse Event|1
7038121|NCT01699867|11120141|FG000|Overall Study|Screening Failure|3
7038122|NCT01700049|11120149|FG000|Overall Study|Withdrawal by Subject|1
7038123|NCT01700140|11120157|FG000|Overall Study|Use of rescue drugs|3
7038124|NCT01700140|11120158|FG001|Overall Study|Use of rescue drugs|3
7038125|NCT01700140|11120159|FG002|Overall Study|Use of rescue drugs|1
7038126|NCT01700140|11120157|FG000|Overall Study|Discontinuation of radiotherapy|1
7038127|NCT01700140|11120158|FG001|Overall Study|Discontinuation of radiotherapy|0
7038128|NCT01700140|11120159|FG002|Overall Study|Discontinuation of radiotherapy|0
7038129|NCT01700140|11120157|FG000|Overall Study|Use of chemotherapy or surgical therapy|0
7038130|NCT01700140|11120158|FG001|Overall Study|Use of chemotherapy or surgical therapy|1
7038131|NCT01700140|11120159|FG002|Overall Study|Use of chemotherapy or surgical therapy|0
7038132|NCT01700140|11120157|FG000|Overall Study|Aggravation of symptoms|1
7038133|NCT01700140|11120158|FG001|Overall Study|Aggravation of symptoms|0
7038134|NCT01700140|11120159|FG002|Overall Study|Aggravation of symptoms|0
7038135|NCT01700140|11120157|FG000|Overall Study|Adverse Event|0
7038136|NCT01700140|11120158|FG001|Overall Study|Adverse Event|1
7038137|NCT01700140|11120159|FG002|Overall Study|Adverse Event|0
7038138|NCT01700140|11120157|FG000|Overall Study|Inclusion/exclusion criteria deviation|1
7038139|NCT01700140|11120158|FG001|Overall Study|Inclusion/exclusion criteria deviation|4
7038140|NCT01700140|11120159|FG002|Overall Study|Inclusion/exclusion criteria deviation|0
7038141|NCT01700179|11120170|FG000|Overall Study|Physician Decision|2
7038142|NCT01700192|11120176|FG000|Overall Study|Adverse Event|73
7038143|NCT01700192|11120177|FG001|Overall Study|Adverse Event|18
7038144|NCT01700192|11120176|FG000|Overall Study|Lack of Efficacy|1
7038145|NCT01700192|11120177|FG001|Overall Study|Lack of Efficacy|0
7038146|NCT01700192|11120176|FG000|Overall Study|Lost to Follow-up|42
7038147|NCT01700192|11120177|FG001|Overall Study|Lost to Follow-up|29
7038148|NCT01700192|11120176|FG000|Overall Study|Noncompliance with study drug|0
7038149|NCT01700192|11120177|FG001|Overall Study|Noncompliance with study drug|5
7038150|NCT01700192|11120176|FG000|Overall Study|Physician Decision|2
7038151|NCT01700192|11120177|FG001|Overall Study|Physician Decision|3
7038152|NCT01700192|11120176|FG000|Overall Study|Pregnancy|1
7038153|NCT01700192|11120177|FG001|Overall Study|Pregnancy|4
6923138|NCT00816361|10952100|FG003|Overall Study|Withdrawal by Subject|0
6923139|NCT00816361|10952101|FG004|Overall Study|Withdrawal by Subject|1
7038154|NCT01700192|11120176|FG000|Overall Study|Progressive disease|1
7038155|NCT01700192|11120177|FG001|Overall Study|Progressive disease|0
7038156|NCT01700192|11120176|FG000|Overall Study|Protocol Violation|3
7038157|NCT01700192|11120177|FG001|Overall Study|Protocol Violation|4
7038158|NCT01700192|11120176|FG000|Overall Study|Technical problems|0
7038159|NCT01700192|11120177|FG001|Overall Study|Technical problems|1
7038160|NCT01700192|11120176|FG000|Overall Study|Withdrawal by Subject|56
7038161|NCT01700192|11120177|FG001|Overall Study|Withdrawal by Subject|64
7038162|NCT01700192|11120176|FG000|Overall Study|Never received study drug|1
7038163|NCT01700192|11120177|FG001|Overall Study|Never received study drug|0
7038164|NCT01700205|11120185|FG000|Overall Study|Withdrawal by Subject|13
7038165|NCT01700205|11120186|FG001|Overall Study|Withdrawal by Subject|13
7146896|NCT03108521|11306459|FG001|Overall Study|Lost to Follow-up|0
7038166|NCT01700205|11120185|FG000|Overall Study|Protocol Violation|2
7146897|NCT03108521|11306458|FG000|Overall Study|Lack of Efficacy|2
7146898|NCT03108521|11306459|FG001|Overall Study|Lack of Efficacy|0
7146899|NCT03108521|11306458|FG000|Overall Study|Physician Decision|4
7146900|NCT03108521|11306459|FG001|Overall Study|Physician Decision|0
7146901|NCT03108521|11306458|FG000|Overall Study|Adverse Event|3
7146902|NCT03108521|11306459|FG001|Overall Study|Adverse Event|0
7146903|NCT03109184|11306506|FG000|Overall Study|Lost to Follow-up|6
7146904|NCT03109184|11306507|FG001|Overall Study|Lost to Follow-up|6
7146905|NCT03109184|11306506|FG000|Overall Study|Withdrawal by Subject|1
7146906|NCT03109184|11306507|FG001|Overall Study|Withdrawal by Subject|1
7146907|NCT03110029|11306537|FG000|Overall Study|Withdrawal by Subject|1
7146908|NCT03110029|11306538|FG001|Overall Study|Withdrawal by Subject|1
7146909|NCT03110185|11306546|FG000|Overall Study|Death|0
7146910|NCT03110185|11306547|FG001|Overall Study|Death|1
7146911|NCT03110185|11306546|FG000|Overall Study|Withdrawal by Subject|2
7146912|NCT03110185|11306547|FG001|Overall Study|Withdrawal by Subject|7
7146913|NCT03110185|11306546|FG000|Overall Study|Time Constraints|0
7146914|NCT03110185|11306547|FG001|Overall Study|Time Constraints|6
7146915|NCT03110185|11306546|FG000|Overall Study|Conflict with care|5
7146916|NCT03110185|11306547|FG001|Overall Study|Conflict with care|12
7146917|NCT03110185|11306546|FG000|Overall Study|Protocol Violation|1
7146918|NCT03110185|11306547|FG001|Overall Study|Protocol Violation|4
7146919|NCT03110185|11306546|FG000|Overall Study|MRI Incompatible|2
7146920|NCT03110185|11306547|FG001|Overall Study|MRI Incompatible|0
7146921|NCT03110185|11306546|FG000|Overall Study|Patient Refusal|0
7146922|NCT03110185|11306547|FG001|Overall Study|Patient Refusal|1
7146923|NCT03110562|11306578|FG000|Overall Study|Withdrawal by Subject|37
7146924|NCT03110562|11306579|FG001|Overall Study|Withdrawal by Subject|35
7146925|NCT03110562|11306578|FG000|Overall Study|Death|47
7146926|NCT03110562|11306579|FG001|Overall Study|Death|61
7146927|NCT03110562|11306578|FG000|Overall Study|Lost to Follow-up|7
7146928|NCT03110562|11306579|FG001|Overall Study|Lost to Follow-up|6
7146929|NCT03110562|11306578|FG000|Overall Study|Other|2
7146930|NCT03110562|11306579|FG001|Overall Study|Other|1
7146931|NCT03110562|11306578|FG000|Overall Study|Randomized but never treated|0
7146932|NCT03110562|11306579|FG001|Overall Study|Randomized but never treated|3
7146933|NCT03110562|11306578|FG000|Overall Study|Ongoing|102
7146934|NCT03110562|11306579|FG001|Overall Study|Ongoing|101
7146935|NCT03110770|11306606|FG000|Overall Study|Death|1
7146936|NCT03110770|11306607|FG001|Overall Study|Death|0
7146937|NCT03110770|11306608|FG002|Overall Study|Death|0
7146938|NCT03110770|11306609|FG003|Overall Study|Death|1
7146939|NCT03110770|11306610|FG004|Overall Study|Death|0
7146940|NCT03110770|11306606|FG000|Overall Study|Enrolled but did not receive product|0
7146941|NCT03110770|11306607|FG001|Overall Study|Enrolled but did not receive product|0
7146942|NCT03110770|11306608|FG002|Overall Study|Enrolled but did not receive product|0
7146943|NCT03110770|11306609|FG003|Overall Study|Enrolled but did not receive product|8
7146944|NCT03110770|11306610|FG004|Overall Study|Enrolled but did not receive product|7
7146945|NCT03110770|11306606|FG000|Overall Study|Lost to Follow-up|0
7146946|NCT03110770|11306607|FG001|Overall Study|Lost to Follow-up|0
7146947|NCT03110770|11306608|FG002|Overall Study|Lost to Follow-up|0
7146948|NCT03110770|11306609|FG003|Overall Study|Lost to Follow-up|53
7146949|NCT03110770|11306610|FG004|Overall Study|Lost to Follow-up|45
7146950|NCT03110770|11306606|FG000|Overall Study|Investigator Decision|0
7146951|NCT03110770|11306607|FG001|Overall Study|Investigator Decision|0
7146952|NCT03110770|11306608|FG002|Overall Study|Investigator Decision|0
7146953|NCT03110770|11306609|FG003|Overall Study|Investigator Decision|5
7146954|NCT03110770|11306610|FG004|Overall Study|Investigator Decision|3
7146955|NCT03110770|11306606|FG000|Overall Study|Withdrawal by Subject|0
7146956|NCT03110770|11306607|FG001|Overall Study|Withdrawal by Subject|0
7146957|NCT03110770|11306608|FG002|Overall Study|Withdrawal by Subject|0
7146958|NCT03110770|11306609|FG003|Overall Study|Withdrawal by Subject|24
7146959|NCT03110770|11306610|FG004|Overall Study|Withdrawal by Subject|24
7146960|NCT03110770|11306606|FG000|Overall Study|Moved from area|5
7146961|NCT03110770|11306607|FG001|Overall Study|Moved from area|0
7146962|NCT03110770|11306608|FG002|Overall Study|Moved from area|2
7146963|NCT03110770|11306609|FG003|Overall Study|Moved from area|42
7146964|NCT03110770|11306610|FG004|Overall Study|Moved from area|43
7146965|NCT03110770|11306606|FG000|Overall Study|Illness/Injury unrelated to product|0
7146966|NCT03110770|11306607|FG001|Overall Study|Illness/Injury unrelated to product|0
7146967|NCT03110770|11306608|FG002|Overall Study|Illness/Injury unrelated to product|0
7146968|NCT03110770|11306609|FG003|Overall Study|Illness/Injury unrelated to product|0
7038167|NCT01700205|11120186|FG001|Overall Study|Protocol Violation|2
7146969|NCT03110770|11306610|FG004|Overall Study|Illness/Injury unrelated to product|1
7146970|NCT03111108|11306626|FG000|Overall Study|Death|0
7146971|NCT03111108|11306627|FG001|Overall Study|Death|1
7146972|NCT03111108|11306626|FG000|Overall Study|Withdrawal by Subject|1
7146973|NCT03111108|11306627|FG001|Overall Study|Withdrawal by Subject|0
7146974|NCT03113916|11306738|FG000|Overall Study|Withdrawal by Subject|9
7146975|NCT03113916|11306739|FG001|Overall Study|Withdrawal by Subject|7
7146976|NCT03113916|11306738|FG000|Overall Study|Pregnancy|1
7146977|NCT03113916|11306739|FG001|Overall Study|Pregnancy|3
7146978|NCT03113916|11306738|FG000|Overall Study|Lost to Follow-up|1
7146979|NCT03113916|11306739|FG001|Overall Study|Lost to Follow-up|2
7146980|NCT03114488|11306759|FG000|Time Period 2|Withdrawal by Subject|1
7146981|NCT03114488|11306760|FG001|Time Period 2|Withdrawal by Subject|3
7146982|NCT03114657|11306772|FG000|Overall Study|Adverse Event|9
7146983|NCT03114657|11306773|FG001|Overall Study|Adverse Event|6
7146984|NCT03114657|11306772|FG000|Overall Study|Death|4
7146985|NCT03114657|11306773|FG001|Overall Study|Death|0
7146986|NCT03114657|11306772|FG000|Overall Study|Multiple Reasons|1
7146987|NCT03114657|11306773|FG001|Overall Study|Multiple Reasons|2
7146988|NCT03114657|11306772|FG000|Overall Study|Physician Decision|2
7146989|NCT03114657|11306773|FG001|Overall Study|Physician Decision|2
7146990|NCT03114657|11306772|FG000|Overall Study|Study Terminated By Sponsor|355
7146991|NCT03114657|11306773|FG001|Overall Study|Study Terminated By Sponsor|374
7146992|NCT03114657|11306772|FG000|Overall Study|Symptomatic Deterioration|0
7146993|NCT03114657|11306773|FG001|Overall Study|Symptomatic Deterioration|1
7146994|NCT03114657|11306772|FG000|Overall Study|Withdrawal by Subject|28
7146995|NCT03114657|11306773|FG001|Overall Study|Withdrawal by Subject|22
6923140|NCT00816361|10952102|FG005|Overall Study|Withdrawal by Subject|2
7038168|NCT01700387|11120202|FG000|Overall Study|Withdrawal by Subject|1
7038169|NCT01700387|11120203|FG001|Overall Study|Withdrawal by Subject|2
7038170|NCT01700387|11120202|FG000|Overall Study|Adverse Event|1
7038171|NCT01700387|11120203|FG001|Overall Study|Adverse Event|1
7038172|NCT01700387|11120202|FG000|Overall Study|Lost to Follow-up|2
7038173|NCT01700387|11120203|FG001|Overall Study|Lost to Follow-up|1
7038174|NCT01700530|11120229|FG000|Overall Study|Withdrawal by Subject|0
7146996|NCT03114969|11306793|FG000|Overall Study|Lost to Follow-up|0
7146997|NCT03114969|11306794|FG001|Overall Study|Lost to Follow-up|0
7146998|NCT03114969|11306795|FG002|Overall Study|Lost to Follow-up|3
7146999|NCT03114969|11306796|FG003|Overall Study|Lost to Follow-up|2
7147000|NCT03114969|11306797|FG004|Overall Study|Lost to Follow-up|0
7147001|NCT03114969|11306798|FG005|Overall Study|Lost to Follow-up|0
7147002|NCT03114969|11306799|FG006|Overall Study|Lost to Follow-up|0
7147003|NCT03114969|11306800|FG007|Overall Study|Lost to Follow-up|0
7147004|NCT03114969|11306801|FG008|Overall Study|Lost to Follow-up|0
7147005|NCT03114969|11306793|FG000|Overall Study|Adverse Event|0
7147006|NCT03114969|11306794|FG001|Overall Study|Adverse Event|0
7147007|NCT03114969|11306795|FG002|Overall Study|Adverse Event|1
7147008|NCT03114969|11306796|FG003|Overall Study|Adverse Event|0
7147009|NCT03114969|11306797|FG004|Overall Study|Adverse Event|0
7147010|NCT03114969|11306798|FG005|Overall Study|Adverse Event|1
7147011|NCT03114969|11306799|FG006|Overall Study|Adverse Event|1
7038175|NCT01700530|11120230|FG001|Overall Study|Withdrawal by Subject|3
7038176|NCT01700530|11120231|FG002|Overall Study|Withdrawal by Subject|1
7038177|NCT01700621|11120241|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7
7038178|NCT01700621|11120242|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4
7038179|NCT01700621|11120241|FG000|Analyzed for Immunogenicity|Protocol Violation|5
7038180|NCT01700621|11120242|FG001|Analyzed for Immunogenicity|Protocol Violation|1
7038181|NCT01700621|11120241|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1
7147012|NCT03114969|11306800|FG007|Overall Study|Adverse Event|0
7147013|NCT03114969|11306801|FG008|Overall Study|Adverse Event|2
7147014|NCT03115112|11306843|FG000|Overall Study|Adverse Event|5
7038182|NCT01700621|11120242|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2
7147015|NCT03115112|11306844|FG001|Overall Study|Adverse Event|1
7147016|NCT03115112|11306843|FG000|Overall Study|Withdrawal by Subject|4
7147017|NCT03115112|11306844|FG001|Overall Study|Withdrawal by Subject|2
7147018|NCT03115112|11306843|FG000|Overall Study|Lost to Follow-up|0
7147019|NCT03115112|11306844|FG001|Overall Study|Lost to Follow-up|1
7147020|NCT03115112|11306843|FG000|Overall Study|Death|1
7147021|NCT03115112|11306844|FG001|Overall Study|Death|0
6923141|NCT00816361|10952103|FG006|Overall Study|Withdrawal by Subject|0
6923142|NCT00816361|10952104|FG007|Overall Study|Withdrawal by Subject|2
6923143|NCT00816361|10952105|FG008|Overall Study|Withdrawal by Subject|1
6923144|NCT00816361|10952097|FG000|Overall Study|Death|4
6923145|NCT00816361|10952098|FG001|Overall Study|Death|3
6923146|NCT00816361|10952099|FG002|Overall Study|Death|3
6923147|NCT00816361|10952100|FG003|Overall Study|Death|3
6923148|NCT00816361|10952101|FG004|Overall Study|Death|1
6923149|NCT00816361|10952102|FG005|Overall Study|Death|1
6923150|NCT00816361|10952103|FG006|Overall Study|Death|3
6923151|NCT00816361|10952104|FG007|Overall Study|Death|7
6923152|NCT00816361|10952105|FG008|Overall Study|Death|8
6923153|NCT00816361|10952097|FG000|Overall Study|Other|0
6923154|NCT00816361|10952098|FG001|Overall Study|Other|0
6923155|NCT00816361|10952099|FG002|Overall Study|Other|0
6923156|NCT00816361|10952100|FG003|Overall Study|Other|0
6923157|NCT00816361|10952101|FG004|Overall Study|Other|0
6923158|NCT00816361|10952102|FG005|Overall Study|Other|0
6923159|NCT00816361|10952103|FG006|Overall Study|Other|0
6923160|NCT00816361|10952104|FG007|Overall Study|Other|0
6923161|NCT00816361|10952105|FG008|Overall Study|Other|1
6923162|NCT00816400|10952135|FG000|Overall Study|Death|2
6923163|NCT00816400|10952136|FG001|Overall Study|Death|3
6923164|NCT00816400|10952137|FG002|Overall Study|Death|3
6923165|NCT00816400|10952138|FG003|Overall Study|Death|3
6923166|NCT00816400|10952139|FG004|Overall Study|Death|2
6923167|NCT00816400|10952140|FG005|Overall Study|Death|3
6923168|NCT00816400|10952141|FG006|Overall Study|Death|2
6923169|NCT00816400|10952142|FG007|Overall Study|Death|5
6923170|NCT00816400|10952143|FG008|Overall Study|Death|6
6923171|NCT00816400|10952135|FG000|Overall Study|In hospice care at the end of the study|0
6923172|NCT00816400|10952136|FG001|Overall Study|In hospice care at the end of the study|0
6923173|NCT00816400|10952137|FG002|Overall Study|In hospice care at the end of the study|2
6923174|NCT00816400|10952138|FG003|Overall Study|In hospice care at the end of the study|0
6923175|NCT00816400|10952139|FG004|Overall Study|In hospice care at the end of the study|0
6923176|NCT00816400|10952140|FG005|Overall Study|In hospice care at the end of the study|0
6923177|NCT00816400|10952141|FG006|Overall Study|In hospice care at the end of the study|0
6923178|NCT00816400|10952142|FG007|Overall Study|In hospice care at the end of the study|0
6923179|NCT00816400|10952143|FG008|Overall Study|In hospice care at the end of the study|0
6923180|NCT00816556|10952167|FG000|Overall Study|Adverse Event|1
6923181|NCT00816556|10952168|FG001|Overall Study|Adverse Event|1
6923182|NCT00816556|10952169|FG002|Overall Study|Adverse Event|1
6923183|NCT00816556|10952167|FG000|Overall Study|Withdrawal by Subject|1
6923184|NCT00816556|10952168|FG001|Overall Study|Withdrawal by Subject|1
6923185|NCT00816556|10952169|FG002|Overall Study|Withdrawal by Subject|1
6923186|NCT00816556|10952167|FG000|Overall Study|Lost to Follow-up|0
6923187|NCT00816556|10952168|FG001|Overall Study|Lost to Follow-up|0
7038183|NCT01700829|11120273|FG000|Overall Study|Withdrawal by Subject|1
7038184|NCT01700829|11120274|FG001|Overall Study|Withdrawal by Subject|1
7038185|NCT01700959|11120295|FG000|Overall Study|Adverse Event|0
7038186|NCT01700959|11120296|FG001|Overall Study|Adverse Event|1
7038187|NCT01700959|11120297|FG002|Overall Study|Adverse Event|1
7038188|NCT01700959|11120298|FG003|Overall Study|Adverse Event|2
7147022|NCT03115112|11306843|FG000|Overall Study|Pregnancy|1
7147023|NCT03115112|11306844|FG001|Overall Study|Pregnancy|0
7038189|NCT01700959|11120299|FG004|Overall Study|Adverse Event|0
7038190|NCT01700959|11120300|FG005|Overall Study|Adverse Event|2
7038191|NCT01700959|11120295|FG000|Overall Study|Withdrawal by Subject|15
7038192|NCT01700959|11120296|FG001|Overall Study|Withdrawal by Subject|9
7060783|NCT01922349|11157380|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0
7060784|NCT01922349|11157381|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0
7060785|NCT01922349|11157382|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0
7060786|NCT01922349|11157383|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1
7060787|NCT01922739|11157419|FG000|Titration/Adjustment Period|Adverse Event|3
7060788|NCT01922739|11157419|FG000|Titration/Adjustment Period|Withdrawal by Subject|5
7147024|NCT03115112|11306843|FG000|Overall Study|Site closure|1
6923188|NCT00816556|10952169|FG002|Overall Study|Lost to Follow-up|1
6923189|NCT00816595|10952179|FG000|Overall Study|Withdrawal by Subject|2
6923190|NCT00816595|10952180|FG001|Overall Study|Withdrawal by Subject|0
6923191|NCT00817063|10952219|FG000|Overall Study|Adverse Event|32
6923192|NCT00817063|10952220|FG001|Overall Study|Adverse Event|13
6923193|NCT00817063|10952219|FG000|Overall Study|Death|1
6923194|NCT00817063|10952220|FG001|Overall Study|Death|1
6923195|NCT00817063|10952219|FG000|Overall Study|Lack of Efficacy|33
6923196|NCT00817063|10952220|FG001|Overall Study|Lack of Efficacy|86
6923197|NCT00817063|10952219|FG000|Overall Study|Failure to Return|13
6923198|NCT00817063|10952220|FG001|Overall Study|Failure to Return|12
6923199|NCT00817063|10952219|FG000|Overall Study|Violation of Selection at Entry|7
6923200|NCT00817063|10952220|FG001|Overall Study|Violation of Selection at Entry|4
6923201|NCT00817063|10952219|FG000|Overall Study|Protocol Violation|3
6923202|NCT00817063|10952220|FG001|Overall Study|Protocol Violation|8
7147025|NCT03115112|11306844|FG001|Overall Study|Site closure|1
7147026|NCT03115476|11306868|FG000|LP0084-1369|Death|1
7147027|NCT03115476|11306869|FG001|LP0084-1369|Death|0
7147028|NCT03115476|11306870|FG002|LP0084-1369|Death|2
7147029|NCT03115476|11306868|FG000|LP0084-1369|Trial terminated by Sponsor|190
7147030|NCT03115476|11306869|FG001|LP0084-1369|Trial terminated by Sponsor|210
7147031|NCT03115476|11306870|FG002|LP0084-1369|Trial terminated by Sponsor|160
7147032|NCT03116152|11306902|FG000|Overall Study|Disease Progression|49
7147033|NCT03116152|11306903|FG001|Overall Study|Disease Progression|47
7147034|NCT03116152|11306902|FG000|Overall Study|Death|5
7147035|NCT03116152|11306903|FG001|Overall Study|Death|2
7147036|NCT03116152|11306902|FG000|Overall Study|Adverse Event|21
7147037|NCT03116152|11306903|FG001|Overall Study|Adverse Event|7
7147038|NCT03116152|11306902|FG000|Overall Study|Protocol Violation|2
7147039|NCT03116152|11306903|FG001|Overall Study|Protocol Violation|2
7147040|NCT03116152|11306902|FG000|Overall Study|Withdrawal by Subject|0
7147041|NCT03116152|11306903|FG001|Overall Study|Withdrawal by Subject|1
7147042|NCT03116152|11306902|FG000|Overall Study|Physician Decision|3
7060789|NCT01922739|11157419|FG000|Titration/Adjustment Period|Lost to Follow-up|1
7060790|NCT01922739|11157419|FG000|Titration/Adjustment Period|Lack of Efficacy|3
7060791|NCT01922739|11157419|FG000|Open-label Treatment Period|Adverse Event|6
7060792|NCT01922739|11157419|FG000|Open-label Treatment Period|Withdrawal by Subject|14
7060793|NCT01922739|11157419|FG000|Open-label Treatment Period|Noncompliance to study medication|3
7060794|NCT01922739|11157419|FG000|Open-label Treatment Period|Protocol Violation|5
7060795|NCT01922739|11157419|FG000|Open-label Treatment Period|Pregnancy|1
7060796|NCT01922739|11157419|FG000|Open-label Treatment Period|Noncompliance to study procedures|1
7060797|NCT01922739|11157419|FG000|Open-label Treatment Period|Lost to Follow-up|2
7060798|NCT01922739|11157419|FG000|Open-label Treatment Period|Physician Decision|1
7060799|NCT01922739|11157419|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1
7060800|NCT01922934|11157437|FG000|Eligible Patients|Death|0
7060801|NCT01922934|11157438|FG001|Eligible Patients|Death|7
7060802|NCT01922934|11157437|FG000|Eligible Patients|Physician Decision|17
7060803|NCT01922934|11157438|FG001|Eligible Patients|Physician Decision|0
7060804|NCT01922934|11157437|FG000|Eligible Patients|Did not meet inclusion criteria|36
7060805|NCT01922934|11157438|FG001|Eligible Patients|Did not meet inclusion criteria|81
7060806|NCT01922934|11157437|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169
7060807|NCT01922934|11157438|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0
7060808|NCT01922934|11157437|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66
7060809|NCT01922934|11157438|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0
7060810|NCT01922934|11157437|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21
7060811|NCT01922934|11157438|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284
7060812|NCT01923181|11157473|FG000|Overall Study|Protocol Violation|2
7060813|NCT01923181|11157474|FG001|Overall Study|Protocol Violation|2
7060814|NCT01923181|11157475|FG002|Overall Study|Protocol Violation|0
7060815|NCT01923181|11157476|FG003|Overall Study|Protocol Violation|2
7060816|NCT01923181|11157477|FG004|Overall Study|Protocol Violation|2
7060817|NCT01923181|11157478|FG005|Overall Study|Protocol Violation|1
7060818|NCT01923181|11157479|FG006|Overall Study|Protocol Violation|1
7060819|NCT01923181|11157480|FG007|Overall Study|Protocol Violation|2
7060820|NCT01923181|11157481|FG008|Overall Study|Protocol Violation|1
7060821|NCT01923181|11157473|FG000|Overall Study|Withdrawal by Subject|0
7060822|NCT01923181|11157474|FG001|Overall Study|Withdrawal by Subject|1
7060823|NCT01923181|11157475|FG002|Overall Study|Withdrawal by Subject|0
7060824|NCT01923181|11157476|FG003|Overall Study|Withdrawal by Subject|1
7060825|NCT01923181|11157477|FG004|Overall Study|Withdrawal by Subject|4
7060826|NCT01923181|11157478|FG005|Overall Study|Withdrawal by Subject|2
7060827|NCT01923181|11157479|FG006|Overall Study|Withdrawal by Subject|4
7060828|NCT01923181|11157480|FG007|Overall Study|Withdrawal by Subject|3
7060829|NCT01923181|11157481|FG008|Overall Study|Withdrawal by Subject|1
7060830|NCT01923181|11157473|FG000|Overall Study|Other|1
7060831|NCT01923181|11157474|FG001|Overall Study|Other|0
7060832|NCT01923181|11157475|FG002|Overall Study|Other|0
7060833|NCT01923181|11157476|FG003|Overall Study|Other|1
7060834|NCT01923181|11157477|FG004|Overall Study|Other|0
7060835|NCT01923181|11157478|FG005|Overall Study|Other|0
7060836|NCT01923181|11157479|FG006|Overall Study|Other|0
7060837|NCT01923181|11157480|FG007|Overall Study|Other|0
7060838|NCT01923181|11157481|FG008|Overall Study|Other|0
7060839|NCT01923181|11157473|FG000|Overall Study|Lost to Follow-up|0
7060840|NCT01923181|11157474|FG001|Overall Study|Lost to Follow-up|3
7060841|NCT01923181|11157475|FG002|Overall Study|Lost to Follow-up|2
7060842|NCT01923181|11157476|FG003|Overall Study|Lost to Follow-up|1
7147043|NCT03116152|11306903|FG001|Overall Study|Physician Decision|2
7147044|NCT03116152|11306902|FG000|Overall Study|other|11
7147045|NCT03116152|11306903|FG001|Overall Study|other|34
7060843|NCT01923181|11157477|FG004|Overall Study|Lost to Follow-up|2
7060844|NCT01923181|11157478|FG005|Overall Study|Lost to Follow-up|1
7060845|NCT01923181|11157479|FG006|Overall Study|Lost to Follow-up|3
7060846|NCT01923181|11157480|FG007|Overall Study|Lost to Follow-up|3
7060847|NCT01923181|11157481|FG008|Overall Study|Lost to Follow-up|1
7147046|NCT03116698|11306922|FG000|Overall Study|Adverse Event|1
7147047|NCT03116698|11306923|FG001|Overall Study|Adverse Event|1
7147048|NCT03116698|11306924|FG002|Overall Study|Adverse Event|1
7147049|NCT03116698|11306925|FG003|Overall Study|Adverse Event|0
7147050|NCT03116698|11306922|FG000|Overall Study|Withdrawal by Subject|1
7147051|NCT03116698|11306923|FG001|Overall Study|Withdrawal by Subject|4
7147052|NCT03116698|11306924|FG002|Overall Study|Withdrawal by Subject|5
7147053|NCT03116698|11306925|FG003|Overall Study|Withdrawal by Subject|2
7147054|NCT03116698|11306922|FG000|Overall Study|Lost to Follow-up|2
7147055|NCT03116698|11306923|FG001|Overall Study|Lost to Follow-up|0
7147056|NCT03116698|11306924|FG002|Overall Study|Lost to Follow-up|0
7147057|NCT03116698|11306925|FG003|Overall Study|Lost to Follow-up|0
7147058|NCT03116698|11306922|FG000|Overall Study|Physician Decision|1
7147059|NCT03116698|11306923|FG001|Overall Study|Physician Decision|1
7147060|NCT03116698|11306924|FG002|Overall Study|Physician Decision|0
7147061|NCT03116698|11306925|FG003|Overall Study|Physician Decision|0
7147062|NCT03116698|11306922|FG000|Overall Study|Protocol Violation|1
7147063|NCT03116698|11306923|FG001|Overall Study|Protocol Violation|0
7147064|NCT03116698|11306924|FG002|Overall Study|Protocol Violation|0
7147065|NCT03116698|11306925|FG003|Overall Study|Protocol Violation|0
7147066|NCT03116698|11306922|FG000|Overall Study|Death|0
7147067|NCT03116698|11306923|FG001|Overall Study|Death|0
7147068|NCT03116698|11306924|FG002|Overall Study|Death|2
7147069|NCT03116698|11306925|FG003|Overall Study|Death|0
7147070|NCT03116828|11306937|FG000|Overall Study|Adverse Event|1
7147071|NCT03116828|11306938|FG001|Overall Study|Adverse Event|10
7147072|NCT03116828|11306937|FG000|Overall Study|Withdrawal by Subject|4
6923203|NCT00817063|10952219|FG000|Overall Study|Withdrawal by Subject|17
6923204|NCT00817063|10952220|FG001|Overall Study|Withdrawal by Subject|37
6923205|NCT00817063|10952219|FG000|Overall Study|Early Improvement|19
6923206|NCT00817063|10952220|FG001|Overall Study|Early Improvement|4
6923207|NCT00817063|10952219|FG000|Overall Study|Administrative|10
6923208|NCT00817063|10952220|FG001|Overall Study|Administrative|4
6923209|NCT00817063|10952219|FG000|Overall Study|Abnormality of Laboratory Test|2
6923210|NCT00817063|10952220|FG001|Overall Study|Abnormality of Laboratory Test|1
6923211|NCT00817089|10952230|FG000|First Alcohol Challenge|Lost to Follow-up|0
6923212|NCT00817089|10952231|FG001|First Alcohol Challenge|Lost to Follow-up|0
6923213|NCT00817089|10952232|FG002|First Alcohol Challenge|Lost to Follow-up|0
6923214|NCT00817089|10952233|FG003|First Alcohol Challenge|Lost to Follow-up|1
6923215|NCT00817089|10952230|FG000|Second Alcohol Challenge|Lost to Follow-up|0
6923216|NCT00817089|10952231|FG001|Second Alcohol Challenge|Lost to Follow-up|1
6923217|NCT00817089|10952232|FG002|Second Alcohol Challenge|Lost to Follow-up|0
6923218|NCT00817089|10952233|FG003|Second Alcohol Challenge|Lost to Follow-up|0
6923219|NCT00817206|10952249|FG000|Overall Study|Adverse Event|10
6923220|NCT00817206|10952250|FG001|Overall Study|Adverse Event|3
6923221|NCT00817206|10952249|FG000|Overall Study|Protocol Violation|0
6923222|NCT00817206|10952250|FG001|Overall Study|Protocol Violation|2
6923223|NCT00817206|10952249|FG000|Overall Study|Lost to Follow-up|0
6923224|NCT00817206|10952250|FG001|Overall Study|Lost to Follow-up|1
6923225|NCT00817206|10952249|FG000|Overall Study|Death|2
6923226|NCT00817206|10952250|FG001|Overall Study|Death|0
6923227|NCT00817206|10952249|FG000|Overall Study|Withdrawal by Subject|7
7060848|NCT01923285|11157506|FG000|Overall Study|Withdrawal by Subject|7
7060849|NCT01923285|11157507|FG001|Overall Study|Withdrawal by Subject|6
7060850|NCT01923311|11157515|FG000|Overall Study|Pregnancy|1
7060851|NCT01923311|11157516|FG001|Overall Study|Pregnancy|0
7060852|NCT01923311|11157515|FG000|Overall Study|Investigator's Discretion|1
7060853|NCT01923311|11157516|FG001|Overall Study|Investigator's Discretion|0
7060854|NCT01923311|11157515|FG000|Overall Study|Non-Compliance with Study Drug|2
7060855|NCT01923311|11157516|FG001|Overall Study|Non-Compliance with Study Drug|1
7060856|NCT01923311|11157515|FG000|Overall Study|Withdrew Consent|1
7060857|NCT01923311|11157516|FG001|Overall Study|Withdrew Consent|0
7060858|NCT01923311|11157515|FG000|Overall Study|Study Terminated by Sponsor|12
7060859|NCT01923311|11157516|FG001|Overall Study|Study Terminated by Sponsor|0
7060860|NCT01923363|11157523|FG000|Overall Study|Protocol Violation|1
7060861|NCT01923389|11157529|FG000|Overall Study|Protocol Violation|1
7060862|NCT01923389|11157530|FG001|Overall Study|Protocol Violation|0
7060863|NCT01923428|11157541|FG000|Overall Study|Adverse Event|8
7060864|NCT01923428|11157542|FG001|Overall Study|Adverse Event|6
7060865|NCT01923428|11157543|FG002|Overall Study|Adverse Event|3
7060866|NCT01923428|11157544|FG003|Overall Study|Adverse Event|3
7060867|NCT01923428|11157541|FG000|Overall Study|Withdrawal by Subject|5
6923228|NCT00817206|10952250|FG001|Overall Study|Withdrawal by Subject|3
7147073|NCT03116828|11306938|FG001|Overall Study|Withdrawal by Subject|8
7147074|NCT03116828|11306937|FG000|Overall Study|OTHER|3
7147075|NCT03116828|11306938|FG001|Overall Study|OTHER|3
7147076|NCT03117361|11306968|FG000|Overall Study|Progressive disease|5
7147077|NCT03117361|11306968|FG000|Overall Study|Death|1
6923229|NCT00817206|10952249|FG000|Overall Study|Physician Decision|2
6923230|NCT00817206|10952250|FG001|Overall Study|Physician Decision|0
6923231|NCT00817336|10952262|FG000|Overall Study|Withdrawal by Subject|1
6923232|NCT00817336|10952263|FG001|Overall Study|Withdrawal by Subject|1
7060868|NCT01923428|11157542|FG001|Overall Study|Withdrawal by Subject|3
7060869|NCT01923428|11157543|FG002|Overall Study|Withdrawal by Subject|0
7060870|NCT01923428|11157544|FG003|Overall Study|Withdrawal by Subject|4
7060871|NCT01923428|11157541|FG000|Overall Study|Lost to Follow-up|2
7060872|NCT01923428|11157542|FG001|Overall Study|Lost to Follow-up|1
7060873|NCT01923428|11157543|FG002|Overall Study|Lost to Follow-up|5
7147078|NCT03117361|11306968|FG000|Overall Study|Physician Decision|2
7147079|NCT03117361|11306968|FG000|Overall Study|On study treatment at the end of study|1
7147080|NCT03117361|11306968|FG000|Overall Study|Treatment-related adverse event|1
7147081|NCT03117738|11307009|FG000|Overall Study|Withdrawal by Subject|3
7147082|NCT03117738|11307010|FG001|Overall Study|Withdrawal by Subject|1
7147083|NCT03117738|11307009|FG000|Overall Study|Lost to Follow-up|1
7147084|NCT03117738|11307010|FG001|Overall Study|Lost to Follow-up|4
7147085|NCT03118297|11307018|FG000|Overall Study|Lost to Follow-up|0
7147086|NCT03118297|11307019|FG001|Overall Study|Lost to Follow-up|2
7147087|NCT03118518|11307031|FG000|Overall Study|Early Exit after treatment|2
7147088|NCT03118518|11307032|FG001|Overall Study|Early Exit after treatment|8
7147089|NCT03118518|11307031|FG000|Overall Study|Early Exit after randomization but prior to treatment|4
7147090|NCT03118518|11307032|FG001|Overall Study|Early Exit after randomization but prior to treatment|3
7147091|NCT03118739|11307049|FG000|Overall Study|Physician Decision|0
7147092|NCT03118739|11307050|FG001|Overall Study|Physician Decision|1
7147093|NCT03118739|11307049|FG000|Overall Study|Withdrawal by Subject|5
7147094|NCT03118739|11307050|FG001|Overall Study|Withdrawal by Subject|3
7147095|NCT03118739|11307049|FG000|Overall Study|Lost to Follow-up|2
7147096|NCT03118739|11307050|FG001|Overall Study|Lost to Follow-up|0
7147097|NCT03118765|11307061|FG000|Overall Study|Withdrawal by Subject|0
7147098|NCT03118765|11307062|FG001|Overall Study|Withdrawal by Subject|0
7147099|NCT03118765|11307063|FG002|Overall Study|Withdrawal by Subject|1
7147100|NCT03118765|11307064|FG003|Overall Study|Withdrawal by Subject|0
7147101|NCT03118765|11307065|FG004|Overall Study|Withdrawal by Subject|0
7147102|NCT03118765|11307061|FG000|Overall Study|Adverse Event|1
7147103|NCT03118765|11307062|FG001|Overall Study|Adverse Event|1
7147104|NCT03118765|11307063|FG002|Overall Study|Adverse Event|1
7147105|NCT03118765|11307064|FG003|Overall Study|Adverse Event|1
7147106|NCT03118765|11307065|FG004|Overall Study|Adverse Event|1
7060874|NCT01923428|11157544|FG003|Overall Study|Lost to Follow-up|0
7060875|NCT01923428|11157541|FG000|Overall Study|Protocol Violation|3
7060876|NCT01923428|11157542|FG001|Overall Study|Protocol Violation|0
7060877|NCT01923428|11157543|FG002|Overall Study|Protocol Violation|2
7060878|NCT01923428|11157544|FG003|Overall Study|Protocol Violation|1
7060879|NCT01923428|11157541|FG000|Overall Study|Non Compliance to treatment|1
7060880|NCT01923428|11157542|FG001|Overall Study|Non Compliance to treatment|2
7060881|NCT01923428|11157543|FG002|Overall Study|Non Compliance to treatment|0
7060882|NCT01923428|11157544|FG003|Overall Study|Non Compliance to treatment|1
7060883|NCT01923428|11157541|FG000|Overall Study|Lack of Efficacy|0
7060884|NCT01923428|11157542|FG001|Overall Study|Lack of Efficacy|0
7060885|NCT01923428|11157543|FG002|Overall Study|Lack of Efficacy|1
7060886|NCT01923428|11157544|FG003|Overall Study|Lack of Efficacy|1
7060887|NCT01923467|11157554|FG000|Overall Study|Lost to Follow-up|62
7060888|NCT01923467|11157554|FG000|Overall Study|Subject non-interest|479
7147107|NCT03118765|11307061|FG000|Overall Study|Non compliance with Study Procedures|0
7147108|NCT03118765|11307062|FG001|Overall Study|Non compliance with Study Procedures|0
7147109|NCT03118765|11307063|FG002|Overall Study|Non compliance with Study Procedures|0
7147110|NCT03118765|11307064|FG003|Overall Study|Non compliance with Study Procedures|1
7147111|NCT03118765|11307065|FG004|Overall Study|Non compliance with Study Procedures|0
7147112|NCT03118765|11307061|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0
7060889|NCT01923740|11157560|FG000|Overall Study|Lost to Follow-up|4
7060890|NCT01923740|11157561|FG001|Overall Study|Lost to Follow-up|9
7060891|NCT01923740|11157560|FG000|Overall Study|Withdrawal by Subject|2
7060892|NCT01923740|11157561|FG001|Overall Study|Withdrawal by Subject|0
7060893|NCT01923896|11157578|FG000|Overall Study|Adverse Event|1
7060894|NCT01923896|11157579|FG001|Overall Study|Adverse Event|0
7060895|NCT01924182|11157604|FG000|Overall Study|Withdrawal by Subject|1
7060896|NCT01924182|11157605|FG001|Overall Study|Withdrawal by Subject|0
7147113|NCT03118765|11307062|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1
7147114|NCT03118765|11307063|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1
7147115|NCT03118765|11307064|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0
7187153|NCT02561962|11387639|FG008|Overall Study|Withdrawal by Subject|0
6923233|NCT00817414|10952273|FG000|Overall Study|Adverse Event|1
6923234|NCT00817414|10952274|FG001|Overall Study|Adverse Event|1
6923235|NCT00817414|10952275|FG002|Overall Study|Adverse Event|1
6923236|NCT00817414|10952276|FG003|Overall Study|Adverse Event|0
6923237|NCT00817414|10952277|FG004|Overall Study|Adverse Event|0
6923238|NCT00817414|10952273|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0
6923239|NCT00817414|10952274|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1
6923240|NCT00817414|10952275|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2
6923241|NCT00817414|10952276|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4
6923242|NCT00817414|10952277|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0
6923243|NCT00817414|10952273|FG000|Overall Study|Withdrawal by Subject|1
6923244|NCT00817414|10952274|FG001|Overall Study|Withdrawal by Subject|1
6923245|NCT00817414|10952275|FG002|Overall Study|Withdrawal by Subject|0
7060897|NCT01924299|11157613|FG000|Period 2|Withdrawal by Subject|1
7060898|NCT01924299|11157614|FG001|Period 2|Withdrawal by Subject|0
7060899|NCT01924299|11157613|FG000|Period 2|Adverse Event|0
7060900|NCT01924299|11157614|FG001|Period 2|Adverse Event|1
7060901|NCT01924364|11157626|FG000|Overall Study|Physician Decision|3
7147116|NCT03118765|11307065|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0
7147117|NCT03118765|11307061|FG000|Overall Study|COPD Exacerbation|1
7147118|NCT03118765|11307062|FG001|Overall Study|COPD Exacerbation|0
7147119|NCT03118765|11307063|FG002|Overall Study|COPD Exacerbation|0
7147120|NCT03118765|11307064|FG003|Overall Study|COPD Exacerbation|1
7147121|NCT03118765|11307065|FG004|Overall Study|COPD Exacerbation|0
7147122|NCT03118765|11307061|FG000|Overall Study|Lost to Follow-up|1
7147123|NCT03118765|11307062|FG001|Overall Study|Lost to Follow-up|0
7147124|NCT03118765|11307063|FG002|Overall Study|Lost to Follow-up|1
7147125|NCT03118765|11307064|FG003|Overall Study|Lost to Follow-up|0
7147126|NCT03118765|11307065|FG004|Overall Study|Lost to Follow-up|0
7147127|NCT03118765|11307061|FG000|Overall Study|Sponsor Decision|1
7147128|NCT03118765|11307062|FG001|Overall Study|Sponsor Decision|0
7147129|NCT03118765|11307063|FG002|Overall Study|Sponsor Decision|1
7147130|NCT03118765|11307064|FG003|Overall Study|Sponsor Decision|0
7147131|NCT03118765|11307065|FG004|Overall Study|Sponsor Decision|1
7147132|NCT03118934|11307085|FG000|Overall Study|Adverse Event|0
7147133|NCT03118934|11307086|FG001|Overall Study|Adverse Event|0
7147134|NCT03118934|11307087|FG002|Overall Study|Adverse Event|0
7147135|NCT03118934|11307088|FG003|Overall Study|Adverse Event|0
7147136|NCT03118934|11307089|FG004|Overall Study|Adverse Event|0
7147137|NCT03118934|11307090|FG005|Overall Study|Adverse Event|1
7147138|NCT03118934|11307085|FG000|Overall Study|Physician Decision|0
7147139|NCT03118934|11307086|FG001|Overall Study|Physician Decision|0
7147140|NCT03118934|11307087|FG002|Overall Study|Physician Decision|0
7147141|NCT03118934|11307088|FG003|Overall Study|Physician Decision|0
7147142|NCT03118934|11307089|FG004|Overall Study|Physician Decision|0
7147143|NCT03118934|11307090|FG005|Overall Study|Physician Decision|1
7147144|NCT03118934|11307085|FG000|Overall Study|Discontinued prior to exposure|0
7147145|NCT03118934|11307086|FG001|Overall Study|Discontinued prior to exposure|1
7147146|NCT03118934|11307087|FG002|Overall Study|Discontinued prior to exposure|1
7147147|NCT03118934|11307088|FG003|Overall Study|Discontinued prior to exposure|1
7147148|NCT03118934|11307089|FG004|Overall Study|Discontinued prior to exposure|2
7147149|NCT03118934|11307090|FG005|Overall Study|Discontinued prior to exposure|0
7147150|NCT03118947|11307100|FG000|Overall Study|Adverse Event|7
7147151|NCT03118947|11307100|FG000|Overall Study|Death|3
7147152|NCT03118947|11307100|FG000|Overall Study|Lack of Efficacy|4
7147153|NCT03118947|11307100|FG000|Overall Study|Non-compliance with study drug|1
7147154|NCT03118947|11307100|FG000|Overall Study|Protocol Violation|2
7038193|NCT01700959|11120297|FG002|Overall Study|Withdrawal by Subject|12
7038194|NCT01700959|11120298|FG003|Overall Study|Withdrawal by Subject|11
7038195|NCT01700959|11120299|FG004|Overall Study|Withdrawal by Subject|8
7038196|NCT01700959|11120300|FG005|Overall Study|Withdrawal by Subject|12
7038197|NCT01700959|11120295|FG000|Overall Study|Ineligible|2
7038198|NCT01700959|11120296|FG001|Overall Study|Ineligible|1
7038199|NCT01700959|11120297|FG002|Overall Study|Ineligible|2
7038200|NCT01700959|11120298|FG003|Overall Study|Ineligible|0
7060902|NCT01924429|11157652|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3
7038201|NCT01700959|11120299|FG004|Overall Study|Ineligible|0
7038202|NCT01700959|11120300|FG005|Overall Study|Ineligible|1
7038203|NCT01700959|11120295|FG000|Overall Study|Noncompliant|9
7038204|NCT01700959|11120296|FG001|Overall Study|Noncompliant|9
7038205|NCT01700959|11120297|FG002|Overall Study|Noncompliant|17
7038206|NCT01700959|11120298|FG003|Overall Study|Noncompliant|18
7038207|NCT01700959|11120299|FG004|Overall Study|Noncompliant|15
7038208|NCT01700959|11120300|FG005|Overall Study|Noncompliant|9
7038209|NCT01700959|11120295|FG000|Overall Study|Side effects|1
7038210|NCT01700959|11120296|FG001|Overall Study|Side effects|4
7038211|NCT01700959|11120297|FG002|Overall Study|Side effects|8
7038212|NCT01700959|11120298|FG003|Overall Study|Side effects|4
7038213|NCT01700959|11120299|FG004|Overall Study|Side effects|4
7038214|NCT01700959|11120300|FG005|Overall Study|Side effects|1
7044741|NCT01756898|11130713|FG000|Overall Study|Adverse Event|7
7044742|NCT01756898|11130714|FG001|Overall Study|Adverse Event|1
7044743|NCT01756898|11130715|FG002|Overall Study|Adverse Event|0
7044744|NCT01756898|11130716|FG003|Overall Study|Adverse Event|0
7044745|NCT01756898|11130713|FG000|Overall Study|Lack of Efficacy|4
7044746|NCT01756898|11130714|FG001|Overall Study|Lack of Efficacy|7
7044747|NCT01756898|11130715|FG002|Overall Study|Lack of Efficacy|6
7044748|NCT01756898|11130716|FG003|Overall Study|Lack of Efficacy|6
7044749|NCT01756898|11130713|FG000|Overall Study|Lost to Follow-up|2
7044750|NCT01756898|11130714|FG001|Overall Study|Lost to Follow-up|4
7044751|NCT01756898|11130715|FG002|Overall Study|Lost to Follow-up|2
7044752|NCT01756898|11130716|FG003|Overall Study|Lost to Follow-up|3
7044753|NCT01756898|11130713|FG000|Overall Study|Protocol Violation|1
7044754|NCT01756898|11130714|FG001|Overall Study|Protocol Violation|2
7044755|NCT01756898|11130715|FG002|Overall Study|Protocol Violation|2
7044756|NCT01756898|11130716|FG003|Overall Study|Protocol Violation|1
7060903|NCT01924429|11157653|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2
7044757|NCT01756898|11130713|FG000|Overall Study|Withdrew Consent|5
7044758|NCT01756898|11130714|FG001|Overall Study|Withdrew Consent|3
7044759|NCT01756898|11130715|FG002|Overall Study|Withdrew Consent|5
7147155|NCT03118947|11307100|FG000|Overall Study|Withdrawal by Subject|3
7147156|NCT03118947|11307100|FG000|Overall Study|Withdrawal by caregiver|3
7147157|NCT03118947|11307100|FG000|Overall Study|Change in patient's living situation|4
7147158|NCT03118947|11307100|FG000|Overall Study|Lost to Follow-up|2
7147159|NCT03119610|11307150|FG000|Overall Study|Adverse Event|1
7147160|NCT03119610|11307151|FG001|Overall Study|Adverse Event|0
7147161|NCT03119610|11307150|FG000|Overall Study|Lost to Follow-up|0
7147162|NCT03119610|11307151|FG001|Overall Study|Lost to Follow-up|1
7147163|NCT03119688|11307182|FG000|Overall Study|Adverse Event|4
7147164|NCT03119701|11307201|FG000|6-day Dosing|Death|4
7147165|NCT03119701|11307202|FG001|6-day Dosing|Death|1
7147166|NCT03119701|11307201|FG000|6-day Dosing|Adverse Event|3
6923246|NCT00817414|10952276|FG003|Overall Study|Withdrawal by Subject|0
6923247|NCT00817414|10952277|FG004|Overall Study|Withdrawal by Subject|0
6923248|NCT00817414|10952273|FG000|Overall Study|Lost to Follow-up|0
6923249|NCT00817414|10952274|FG001|Overall Study|Lost to Follow-up|0
6923250|NCT00817414|10952275|FG002|Overall Study|Lost to Follow-up|1
6923251|NCT00817414|10952276|FG003|Overall Study|Lost to Follow-up|1
6923252|NCT00817414|10952277|FG004|Overall Study|Lost to Follow-up|1
6923253|NCT00817414|10952273|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0
6923254|NCT00817414|10952274|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0
6923255|NCT00817414|10952275|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0
6923256|NCT00817414|10952276|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7
7147167|NCT03119701|11307202|FG001|6-day Dosing|Adverse Event|0
7147168|NCT03119701|11307201|FG000|6-day Dosing|Physician Decision|0
7147169|NCT03119701|11307202|FG001|6-day Dosing|Physician Decision|1
7147170|NCT03119701|11307201|FG000|6-day Dosing|Withdrawal by Subject|0
6923257|NCT00817414|10952277|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0
7038215|NCT01700985|11120318|FG000|Overall Study|Incarcerated|0
7038216|NCT01700985|11120319|FG001|Overall Study|Incarcerated|1
7038217|NCT01701063|11120356|FG000|Overall Study|Lost to Follow-up|0
7038218|NCT01701063|11120357|FG001|Overall Study|Lost to Follow-up|1
7038219|NCT01701063|11120358|FG002|Overall Study|Lost to Follow-up|0
7038220|NCT01701063|11120356|FG000|Overall Study|Withdrawal by Subject|0
7038221|NCT01701063|11120357|FG001|Overall Study|Withdrawal by Subject|0
7038222|NCT01701063|11120358|FG002|Overall Study|Withdrawal by Subject|1
7038223|NCT01701063|11120356|FG000|Overall Study|Other|0
7038224|NCT01701063|11120357|FG001|Overall Study|Other|0
7038225|NCT01701063|11120358|FG002|Overall Study|Other|1
7038226|NCT01701193|11120397|FG000|Overall Study|Withdrawal by Subject|2
7038227|NCT01701193|11120398|FG001|Overall Study|Withdrawal by Subject|2
7038228|NCT01701193|11120399|FG002|Overall Study|Withdrawal by Subject|1
7038229|NCT01701193|11120400|FG003|Overall Study|Withdrawal by Subject|2
7038230|NCT01701193|11120397|FG000|Overall Study|Adverse Event|1
7038231|NCT01701193|11120398|FG001|Overall Study|Adverse Event|0
7038232|NCT01701193|11120399|FG002|Overall Study|Adverse Event|0
7038233|NCT01701193|11120400|FG003|Overall Study|Adverse Event|0
7038234|NCT01701245|11120415|FG000|Overall Study|Protocol Violation|1
7038235|NCT01701245|11120416|FG001|Overall Study|Protocol Violation|3
7038236|NCT01701245|11120415|FG000|Overall Study|Did not complete the open label period|11
7038237|NCT01701245|11120416|FG001|Overall Study|Did not complete the open label period|12
7038238|NCT01701258|11120426|FG000|Assessment and Scheduling|Found to be Ineligible|57
7038239|NCT01701258|11120427|FG001|Assessment and Scheduling|Found to be Ineligible|0
7038240|NCT01701258|11120428|FG002|Assessment and Scheduling|Found to be Ineligible|0
7038241|NCT01701258|11120429|FG003|Assessment and Scheduling|Found to be Ineligible|0
7038242|NCT01701258|11120430|FG004|Assessment and Scheduling|Found to be Ineligible|0
7038243|NCT01701258|11120431|FG005|Assessment and Scheduling|Found to be Ineligible|0
7038244|NCT01701258|11120432|FG006|Assessment and Scheduling|Found to be Ineligible|0
7038245|NCT01701258|11120433|FG007|Assessment and Scheduling|Found to be Ineligible|0
7038246|NCT01701258|11120434|FG008|Assessment and Scheduling|Found to be Ineligible|0
7038247|NCT01701258|11120435|FG009|Assessment and Scheduling|Found to be Ineligible|0
7038248|NCT01701258|11120436|FG010|Assessment and Scheduling|Found to be Ineligible|0
7038249|NCT01701258|11120437|FG011|Assessment and Scheduling|Found to be Ineligible|0
7038250|NCT01701258|11120438|FG012|Assessment and Scheduling|Found to be Ineligible|0
7038251|NCT01701258|11120426|FG000|Assessment and Scheduling|Lost to Follow-up|10
7038252|NCT01701258|11120427|FG001|Assessment and Scheduling|Lost to Follow-up|0
7038253|NCT01701258|11120428|FG002|Assessment and Scheduling|Lost to Follow-up|0
7038254|NCT01701258|11120429|FG003|Assessment and Scheduling|Lost to Follow-up|0
7038255|NCT01701258|11120430|FG004|Assessment and Scheduling|Lost to Follow-up|0
7038256|NCT01701258|11120431|FG005|Assessment and Scheduling|Lost to Follow-up|0
7038257|NCT01701258|11120432|FG006|Assessment and Scheduling|Lost to Follow-up|0
7038258|NCT01701258|11120433|FG007|Assessment and Scheduling|Lost to Follow-up|0
7038259|NCT01701258|11120434|FG008|Assessment and Scheduling|Lost to Follow-up|0
7038260|NCT01701258|11120435|FG009|Assessment and Scheduling|Lost to Follow-up|0
7038261|NCT01701258|11120436|FG010|Assessment and Scheduling|Lost to Follow-up|0
7038262|NCT01701258|11120437|FG011|Assessment and Scheduling|Lost to Follow-up|0
7038263|NCT01701258|11120438|FG012|Assessment and Scheduling|Lost to Follow-up|0
7038264|NCT01701258|11120426|FG000|Assessment and Scheduling|Withdrawal by Subject|14
7038265|NCT01701258|11120427|FG001|Assessment and Scheduling|Withdrawal by Subject|0
7038266|NCT01701258|11120428|FG002|Assessment and Scheduling|Withdrawal by Subject|0
7038267|NCT01701258|11120429|FG003|Assessment and Scheduling|Withdrawal by Subject|0
7044760|NCT01756898|11130716|FG003|Overall Study|Withdrew Consent|6
7147171|NCT03119701|11307202|FG001|6-day Dosing|Withdrawal by Subject|1
7147172|NCT03119701|11307201|FG000|Mid-term (Final) Follow-up at D90|Death|3
7147173|NCT03119701|11307202|FG001|Mid-term (Final) Follow-up at D90|Death|1
7147174|NCT03120013|11307224|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0
7147175|NCT03120013|11307225|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1
7147176|NCT03120351|11307233|FG000|Overall Study|Physician Decision|1
6923258|NCT00817414|10952273|FG000|Overall Study|Protocol Violation|0
6923259|NCT00817414|10952274|FG001|Overall Study|Protocol Violation|0
6923260|NCT00817414|10952275|FG002|Overall Study|Protocol Violation|0
6923261|NCT00817414|10952276|FG003|Overall Study|Protocol Violation|0
6923262|NCT00817414|10952277|FG004|Overall Study|Protocol Violation|1
6923263|NCT00817479|10952296|FG000|Overall Study|Physician Decision|1
6923264|NCT00817479|10952297|FG001|Overall Study|Physician Decision|1
6923265|NCT00817531|10952303|FG000|Overall Study|Adverse Event|1
6923266|NCT00817531|10952303|FG000|Overall Study|Lack of Efficacy|1
6923267|NCT00817635|10952316|FG000|Overall Study|Adverse Event|1
6923268|NCT00817635|10952317|FG001|Overall Study|Adverse Event|0
6923269|NCT00817635|10952318|FG002|Overall Study|Adverse Event|0
6923270|NCT00817635|10952319|FG003|Overall Study|Adverse Event|1
6923271|NCT00817635|10952320|FG004|Overall Study|Adverse Event|1
6923272|NCT00817635|10952316|FG000|Overall Study|Abnormal Laboratory Value(s)|1
6923273|NCT00817635|10952317|FG001|Overall Study|Abnormal Laboratory Value(s)|1
6923274|NCT00817635|10952318|FG002|Overall Study|Abnormal Laboratory Value(s)|0
6923275|NCT00817635|10952319|FG003|Overall Study|Abnormal Laboratory Value(s)|0
6923276|NCT00817635|10952320|FG004|Overall Study|Abnormal Laboratory Value(s)|1
6923277|NCT00817635|10952316|FG000|Overall Study|Withdrawal by Subject|2
7060904|NCT01924689|11157690|FG000|Overall Study|Death|0
7060905|NCT01924689|11157691|FG001|Overall Study|Death|1
7060906|NCT01924689|11157692|FG002|Overall Study|Death|0
7060907|NCT01924689|11157693|FG003|Overall Study|Death|1
7060908|NCT01924689|11157694|FG004|Overall Study|Death|0
7060909|NCT01924689|11157695|FG005|Overall Study|Death|0
7060910|NCT01924689|11157690|FG000|Overall Study|Disease progression|0
7060911|NCT01924689|11157691|FG001|Overall Study|Disease progression|0
7060912|NCT01924689|11157692|FG002|Overall Study|Disease progression|2
7060913|NCT01924689|11157693|FG003|Overall Study|Disease progression|0
7060914|NCT01924689|11157694|FG004|Overall Study|Disease progression|3
7060915|NCT01924689|11157695|FG005|Overall Study|Disease progression|2
7060916|NCT01924689|11157690|FG000|Overall Study|New therapy or study|3
7060917|NCT01924689|11157691|FG001|Overall Study|New therapy or study|2
7060918|NCT01924689|11157692|FG002|Overall Study|New therapy or study|1
7060919|NCT01924689|11157693|FG003|Overall Study|New therapy or study|4
7060920|NCT01924689|11157694|FG004|Overall Study|New therapy or study|2
7060921|NCT01924689|11157695|FG005|Overall Study|New therapy or study|0
7060922|NCT01924689|11157690|FG000|Overall Study|Withdrawal of consent|0
7060923|NCT01924689|11157691|FG001|Overall Study|Withdrawal of consent|0
7060924|NCT01924689|11157692|FG002|Overall Study|Withdrawal of consent|1
7060925|NCT01924689|11157693|FG003|Overall Study|Withdrawal of consent|1
7060926|NCT01924689|11157694|FG004|Overall Study|Withdrawal of consent|0
7060927|NCT01924689|11157695|FG005|Overall Study|Withdrawal of consent|0
7060928|NCT01924689|11157690|FG000|Overall Study|Other|0
7060929|NCT01924689|11157691|FG001|Overall Study|Other|0
7060930|NCT01924689|11157692|FG002|Overall Study|Other|0
7060931|NCT01924689|11157693|FG003|Overall Study|Other|0
7060932|NCT01924689|11157694|FG004|Overall Study|Other|1
7060933|NCT01924689|11157695|FG005|Overall Study|Other|0
7060934|NCT01924754|11157716|FG000|Overall Study|Lost to Follow-up|1
7060935|NCT01924754|11157717|FG001|Overall Study|Lost to Follow-up|2
7060936|NCT01924754|11157718|FG002|Overall Study|Lost to Follow-up|1
7060937|NCT01924754|11157716|FG000|Overall Study|Pregnancy|0
7060938|NCT01924754|11157717|FG001|Overall Study|Pregnancy|1
7060939|NCT01924754|11157718|FG002|Overall Study|Pregnancy|2
7060940|NCT01924767|11157734|FG000|Overall Study|Adverse Event|1
7060941|NCT01924767|11157735|FG001|Overall Study|Adverse Event|0
7060942|NCT01924767|11157736|FG002|Overall Study|Adverse Event|1
7060943|NCT01924767|11157737|FG003|Overall Study|Adverse Event|0
7060944|NCT01924767|11157738|FG004|Overall Study|Adverse Event|0
7060945|NCT01924806|11157757|FG000|Overall Study|Physician Decision|2
7147177|NCT03120351|11307234|FG001|Overall Study|Physician Decision|1
7147178|NCT03120520|11307244|FG000|Overall Study|Lost to Follow-up|1
7147179|NCT03120520|11307245|FG001|Overall Study|Lost to Follow-up|1
7147180|NCT03120520|11307246|FG002|Overall Study|Lost to Follow-up|1
6923278|NCT00817635|10952317|FG001|Overall Study|Withdrawal by Subject|1
6923279|NCT00817635|10952318|FG002|Overall Study|Withdrawal by Subject|0
6923280|NCT00817635|10952319|FG003|Overall Study|Withdrawal by Subject|1
6923281|NCT00817635|10952320|FG004|Overall Study|Withdrawal by Subject|2
7060946|NCT01924806|11157758|FG001|Overall Study|Physician Decision|1
6923282|NCT00817635|10952316|FG000|Overall Study|Lost to Follow-up|0
7060947|NCT01924845|11157764|FG000|Overall Study|Adverse Event|3
7060948|NCT01924845|11157764|FG000|Overall Study|Withdrawal by Subject|2
7060949|NCT01924845|11157764|FG000|Overall Study|Protocol Violation|1
7060950|NCT01925014|11157799|FG000|Overall Study|Inappropriate enrollment|4
7060951|NCT01925014|11157800|FG001|Overall Study|Inappropriate enrollment|6
7060952|NCT01925014|11157799|FG000|Overall Study|Withdrawal by Subject|5
7060953|NCT01925014|11157800|FG001|Overall Study|Withdrawal by Subject|13
7060954|NCT01925170|11157813|FG000|Overall Study|Unverified cancer status|53
7147181|NCT03120520|11307247|FG003|Overall Study|Lost to Follow-up|1
7147182|NCT03120520|11307244|FG000|Overall Study|Withdrawal by Subject|3
7147183|NCT03120520|11307245|FG001|Overall Study|Withdrawal by Subject|2
7147184|NCT03120520|11307246|FG002|Overall Study|Withdrawal by Subject|3
7147185|NCT03120520|11307247|FG003|Overall Study|Withdrawal by Subject|2
7147186|NCT03120520|11307244|FG000|Overall Study|Other|0
7147187|NCT03120520|11307245|FG001|Overall Study|Other|1
7147188|NCT03120520|11307246|FG002|Overall Study|Other|0
7147189|NCT03120520|11307247|FG003|Overall Study|Other|0
7147190|NCT03121950|11307307|FG000|Overall Study|Withdrawal by Subject|11
7147191|NCT03121950|11307308|FG001|Overall Study|Withdrawal by Subject|2
7147192|NCT03122145|11307318|FG000|Overall Study|Concurrent respiratory disease|3
7147193|NCT03122145|11307319|FG001|Overall Study|Concurrent respiratory disease|0
7183751|NCT01302847|11383786|FG006|Overall Study|Site unable to contact participant|2
7183752|NCT01302847|11383787|FG007|Overall Study|Site unable to contact participant|0
7183753|NCT01287611|11383816|FG000|Overall Study|Lost to Follow-up|29
7183754|NCT01287611|11383817|FG001|Overall Study|Lost to Follow-up|16
6923283|NCT00817635|10952317|FG001|Overall Study|Lost to Follow-up|1
6923284|NCT00817635|10952318|FG002|Overall Study|Lost to Follow-up|0
6923285|NCT00817635|10952319|FG003|Overall Study|Lost to Follow-up|1
6923286|NCT00817635|10952320|FG004|Overall Study|Lost to Follow-up|0
6923287|NCT00817635|10952316|FG000|Overall Study|Administrative Problems|0
6923288|NCT00817635|10952317|FG001|Overall Study|Administrative Problems|0
6923289|NCT00817635|10952318|FG002|Overall Study|Administrative Problems|0
6923290|NCT00817635|10952319|FG003|Overall Study|Administrative Problems|0
7060955|NCT01925183|11157821|FG000|Overall Study|Adverse Event|1
7060956|NCT01925183|11157822|FG001|Overall Study|Adverse Event|0
7060957|NCT01925209|11157832|FG000|Treatment Epoch|Physician Decision|1
7060958|NCT01925209|11157833|FG001|Treatment Epoch|Physician Decision|0
7060959|NCT01925209|11157834|FG002|Treatment Epoch|Physician Decision|0
7060960|NCT01925209|11157835|FG003|Treatment Epoch|Physician Decision|0
7060961|NCT01925209|11157832|FG000|Treatment Epoch|Non-compliance with study treatment|0
7060962|NCT01925209|11157833|FG001|Treatment Epoch|Non-compliance with study treatment|0
6923291|NCT00817635|10952320|FG004|Overall Study|Administrative Problems|1
6923292|NCT00817635|10952316|FG000|Overall Study|Protocol Violation|5
6923293|NCT00817635|10952317|FG001|Overall Study|Protocol Violation|1
6923294|NCT00817635|10952318|FG002|Overall Study|Protocol Violation|3
6923295|NCT00817635|10952319|FG003|Overall Study|Protocol Violation|2
6923296|NCT00817635|10952320|FG004|Overall Study|Protocol Violation|3
6923297|NCT00817778|10952341|FG000|Overall Study|Adverse Event|1
6923298|NCT00817778|10952342|FG001|Overall Study|Adverse Event|0
6923299|NCT00817778|10952341|FG000|Overall Study|Withdrawal by Subject|1
6923300|NCT00817778|10952342|FG001|Overall Study|Withdrawal by Subject|1
6923301|NCT00817778|10952341|FG000|Overall Study|Protocol Violation|0
6923302|NCT00817778|10952342|FG001|Overall Study|Protocol Violation|1
6923303|NCT00817778|10952341|FG000|Overall Study|Study-specific discontinuation criteria|0
6923304|NCT00817778|10952342|FG001|Overall Study|Study-specific discontinuation criteria|1
6923305|NCT00817778|10952341|FG000|Overall Study|Poor venous access|1
6923306|NCT00817778|10952342|FG001|Overall Study|Poor venous access|0
6974635|NCT01189266|11026780|FG000|Overall Study|No treatment|0
6974636|NCT01189266|11026781|FG001|Overall Study|No treatment|0
6974637|NCT01189266|11026782|FG002|Overall Study|No treatment|1
6974638|NCT01189461|11026838|FG000|Overall Study|Lack of Efficacy|13
6974639|NCT01189461|11026838|FG000|Overall Study|Lost to Follow-up|1
6974640|NCT01189461|11026838|FG000|Overall Study|Withdrawal by Subject|6
6974641|NCT01189461|11026838|FG000|Overall Study|Protocol Violation|1
7060963|NCT01925209|11157834|FG002|Treatment Epoch|Non-compliance with study treatment|0
7060964|NCT01925209|11157835|FG003|Treatment Epoch|Non-compliance with study treatment|1
7060965|NCT01925209|11157832|FG000|Treatment Epoch|Death|1
7060966|NCT01925209|11157833|FG001|Treatment Epoch|Death|0
7060967|NCT01925209|11157834|FG002|Treatment Epoch|Death|0
7060968|NCT01925209|11157835|FG003|Treatment Epoch|Death|0
7060969|NCT01925209|11157832|FG000|Treatment Epoch|Protocol deviation|0
7060970|NCT01925209|11157833|FG001|Treatment Epoch|Protocol deviation|0
7060971|NCT01925209|11157834|FG002|Treatment Epoch|Protocol deviation|1
7060972|NCT01925209|11157835|FG003|Treatment Epoch|Protocol deviation|1
7060973|NCT01925209|11157832|FG000|Treatment Epoch|Withdrawal by Subject|4
7060974|NCT01925209|11157833|FG001|Treatment Epoch|Withdrawal by Subject|3
7060975|NCT01925209|11157834|FG002|Treatment Epoch|Withdrawal by Subject|3
6974642|NCT01189461|11026838|FG000|Overall Study|Adverse Event|2
6974643|NCT01189461|11026838|FG000|Overall Study|Did not meet entrance criteria|3
6974644|NCT01189461|11026838|FG000|Overall Study|Other|8
6974645|NCT01189487|11026842|FG000|Overall Study|Lack of Efficacy|2
6974646|NCT01189487|11026842|FG000|Overall Study|Adverse Event|1
6974647|NCT01189500|11026846|FG000|Period 1: TAMOX Alone|Adverse Event|1
6974648|NCT01189500|11026846|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1
6974649|NCT01189604|11026860|FG000|Overall Study|Impossible to visit|0
7183755|NCT01287611|11383816|FG000|Overall Study|Exclusion due to expanded Kerr incision|4
6974650|NCT01189604|11026861|FG001|Overall Study|Impossible to visit|0
6974651|NCT01189604|11026862|FG002|Overall Study|Impossible to visit|0
7060976|NCT01925209|11157835|FG003|Treatment Epoch|Withdrawal by Subject|2
7060977|NCT01925209|11157832|FG000|Treatment Epoch|Adverse Event|3
7183756|NCT01287611|11383817|FG001|Overall Study|Exclusion due to expanded Kerr incision|3
7060978|NCT01925209|11157833|FG001|Treatment Epoch|Adverse Event|5
7060979|NCT01925209|11157834|FG002|Treatment Epoch|Adverse Event|3
7060980|NCT01925209|11157835|FG003|Treatment Epoch|Adverse Event|1
7060981|NCT01925209|11157832|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0
7060982|NCT01925209|11157833|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1
7147194|NCT03122171|11307325|FG000|Overall Study|Withdrawal by Subject|1
7147195|NCT03122184|11307331|FG000|Overall Study|Lost to Follow-up|4
7147196|NCT03122184|11307332|FG001|Overall Study|Lost to Follow-up|6
7147197|NCT03122184|11307331|FG000|Overall Study|Withdrawal by Subject|3
7147198|NCT03122184|11307332|FG001|Overall Study|Withdrawal by Subject|0
7060983|NCT01925209|11157834|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1
7060984|NCT01925209|11157835|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2
7060985|NCT01925209|11157832|FG000|Maintenance Treatment Epoch|Adverse Event|0
7060986|NCT01925209|11157833|FG001|Maintenance Treatment Epoch|Adverse Event|0
7060987|NCT01925209|11157834|FG002|Maintenance Treatment Epoch|Adverse Event|1
7060988|NCT01925209|11157835|FG003|Maintenance Treatment Epoch|Adverse Event|0
7060989|NCT01925209|11157832|FG000|Follow-up|Adverse Event|1
7060990|NCT01925209|11157833|FG001|Follow-up|Adverse Event|4
7060991|NCT01925209|11157834|FG002|Follow-up|Adverse Event|0
7060992|NCT01925209|11157835|FG003|Follow-up|Adverse Event|1
7060993|NCT01925209|11157832|FG000|Follow-up|Physician Decision|0
7060994|NCT01925209|11157833|FG001|Follow-up|Physician Decision|0
7060995|NCT01925209|11157834|FG002|Follow-up|Physician Decision|1
7060996|NCT01925209|11157835|FG003|Follow-up|Physician Decision|0
7060997|NCT01925209|11157832|FG000|Follow-up|Non-compliance with study treatment|0
7060998|NCT01925209|11157833|FG001|Follow-up|Non-compliance with study treatment|0
7060999|NCT01925209|11157834|FG002|Follow-up|Non-compliance with study treatment|0
7061000|NCT01925209|11157835|FG003|Follow-up|Non-compliance with study treatment|1
7061001|NCT01925209|11157832|FG000|Follow-up|Withdrawal by Subject|0
7061002|NCT01925209|11157833|FG001|Follow-up|Withdrawal by Subject|2
7061003|NCT01925209|11157834|FG002|Follow-up|Withdrawal by Subject|0
7061004|NCT01925209|11157835|FG003|Follow-up|Withdrawal by Subject|2
7061005|NCT01925274|11157848|FG000|Overall Study|Death|1
7061006|NCT01925274|11157849|FG001|Overall Study|Death|0
7061007|NCT01925274|11157850|FG002|Overall Study|Death|0
7061008|NCT01925274|11157848|FG000|Overall Study|Lost to Follow-up|0
7061009|NCT01925274|11157849|FG001|Overall Study|Lost to Follow-up|1
7061010|NCT01925274|11157850|FG002|Overall Study|Lost to Follow-up|0
7061011|NCT01925274|11157848|FG000|Overall Study|Withdrawal by Subject|1
7061012|NCT01925274|11157849|FG001|Overall Study|Withdrawal by Subject|2
7061013|NCT01925274|11157850|FG002|Overall Study|Withdrawal by Subject|0
7061014|NCT01925274|11157848|FG000|Overall Study|Study terminated by sponsor|4
7061015|NCT01925274|11157849|FG001|Overall Study|Study terminated by sponsor|0
7061016|NCT01925274|11157850|FG002|Overall Study|Study terminated by sponsor|0
7061017|NCT01925274|11157848|FG000|Overall Study|Protocol amendment|1
7061018|NCT01925274|11157849|FG001|Overall Study|Protocol amendment|3
7061019|NCT01925274|11157850|FG002|Overall Study|Protocol amendment|6
7061020|NCT01925339|11157862|FG000|Overall Study|Adverse Event|2
7061021|NCT01925339|11157863|FG001|Overall Study|Adverse Event|0
7061022|NCT01925417|11157886|FG000|Overall Study|Withdrawal by Subject|2
7061023|NCT01925417|11157886|FG000|Overall Study|Death|1
7061024|NCT01925612|11157905|FG000|Overall Study|Progressive Disease|1
7061025|NCT01925612|11157906|FG001|Overall Study|Progressive Disease|1
7061026|NCT01925612|11157907|FG002|Overall Study|Progressive Disease|1
7061027|NCT01925612|11157908|FG003|Overall Study|Progressive Disease|0
7061028|NCT01925612|11157909|FG004|Overall Study|Progressive Disease|0
7061029|NCT01925612|11157905|FG000|Overall Study|Adverse Event|3
7061030|NCT01925612|11157906|FG001|Overall Study|Adverse Event|3
7061031|NCT01925612|11157907|FG002|Overall Study|Adverse Event|0
7061032|NCT01925612|11157908|FG003|Overall Study|Adverse Event|1
7061033|NCT01925612|11157909|FG004|Overall Study|Adverse Event|2
7061034|NCT01925703|11157925|FG000|Overall Study|Physician Decision|1
7061035|NCT01925703|11157925|FG000|Overall Study|Lost to Follow-up|2
7061036|NCT01925703|11157925|FG000|Overall Study|Discharge prior to full iron repletion|1
7061037|NCT01925768|11157931|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
7061038|NCT01925768|11157932|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7061039|NCT01925768|11157931|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
7061040|NCT01925768|11157932|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2
7061041|NCT01925768|11157931|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5
7061042|NCT01925768|11157932|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
7061043|NCT01925768|11157931|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
7147199|NCT03122184|11307331|FG000|Overall Study|Terminated due to cognitive problem|1
7061044|NCT01925768|11157932|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6
7061045|NCT01925768|11157931|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1
7061046|NCT01925768|11157932|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
7061047|NCT01925768|11157931|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0
7061048|NCT01925768|11157932|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1
7061049|NCT01925768|11157931|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6
7061050|NCT01925768|11157932|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6
7061051|NCT01925768|11157931|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7
7147200|NCT03122184|11307332|FG001|Overall Study|Terminated due to cognitive problem|0
7147201|NCT03122223|11307342|FG000|Overall Study|Withdrawal by Subject|2
7147202|NCT03122223|11307343|FG001|Overall Study|Withdrawal by Subject|2
7147203|NCT03122223|11307344|FG002|Overall Study|Withdrawal by Subject|1
7147204|NCT03122223|11307345|FG003|Overall Study|Withdrawal by Subject|0
7147205|NCT03122223|11307342|FG000|Overall Study|Lost to Follow-up|0
7147206|NCT03122223|11307343|FG001|Overall Study|Lost to Follow-up|2
7147207|NCT03122223|11307344|FG002|Overall Study|Lost to Follow-up|2
7147208|NCT03122223|11307345|FG003|Overall Study|Lost to Follow-up|0
7147209|NCT03122223|11307342|FG000|Overall Study|Participant unable to adhere|1
7147210|NCT03122223|11307343|FG001|Overall Study|Participant unable to adhere|1
7147211|NCT03122223|11307344|FG002|Overall Study|Participant unable to adhere|1
7147212|NCT03122223|11307345|FG003|Overall Study|Participant unable to adhere|0
7147213|NCT03122457|11307355|FG000|Overall Study|Withdrawal by Subject|6
7147214|NCT03122535|11307359|FG000|Overall Study|Lost to Follow-up|68
7147215|NCT03122535|11307360|FG001|Overall Study|Lost to Follow-up|68
7147216|NCT03122535|11307359|FG000|Overall Study|Physician Decision|3
7147217|NCT03122535|11307360|FG001|Overall Study|Physician Decision|3
7147218|NCT03122535|11307359|FG000|Overall Study|Withdrawal by Subject|2
7147219|NCT03122535|11307360|FG001|Overall Study|Withdrawal by Subject|2
7147220|NCT03122548|11307366|FG000|Overall Study|Death|2
7147221|NCT03122548|11307366|FG000|Overall Study|Progression - subject went into hospice|1
7147222|NCT03122548|11307366|FG000|Overall Study|Study Terminated by Sponsor|2
7147223|NCT03122860|11307389|FG000|Overall Study|Discontinued Before Treatment|1
7147224|NCT03122860|11307390|FG001|Overall Study|Discontinued Before Treatment|1
7147225|NCT03122860|11307391|FG002|Overall Study|Discontinued Before Treatment|2
7147226|NCT03122860|11307392|FG003|Overall Study|Discontinued Before Treatment|0
7147227|NCT03122860|11307393|FG004|Overall Study|Discontinued Before Treatment|1
7147228|NCT03122860|11307394|FG005|Overall Study|Discontinued Before Treatment|0
7147229|NCT03122860|11307389|FG000|Overall Study|Adverse Event|1
7147230|NCT03122860|11307390|FG001|Overall Study|Adverse Event|0
7147231|NCT03122860|11307391|FG002|Overall Study|Adverse Event|1
7147232|NCT03122860|11307392|FG003|Overall Study|Adverse Event|1
7061052|NCT01925768|11157932|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9
7061053|NCT01925768|11157931|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2
7061054|NCT01925768|11157932|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1
7061055|NCT01925768|11157931|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0
7061056|NCT01925768|11157932|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1
7061057|NCT01925768|11157931|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5
7061058|NCT01925768|11157932|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1
7061059|NCT01925950|11157953|FG000|Part 2|Withdrawal by Subject|1
7061060|NCT01925950|11157954|FG001|Part 2|Withdrawal by Subject|0
7061061|NCT01925989|11157962|FG000|Period 1|Sponsor Decision|1
7061062|NCT01925989|11157963|FG001|Period 1|Sponsor Decision|1
7061063|NCT01925989|11157964|FG002|Period 1|Sponsor Decision|0
7061064|NCT01925989|11157962|FG000|Period 1|Withdrawal by Subject|0
7061065|NCT01925989|11157963|FG001|Period 1|Withdrawal by Subject|1
7061066|NCT01925989|11157964|FG002|Period 1|Withdrawal by Subject|0
7061067|NCT01926015|11157978|FG000|Overall Study|Withdrawal by parent/guardian|0
7061068|NCT01926015|11157979|FG001|Overall Study|Withdrawal by parent/guardian|1
7061069|NCT01926015|11157978|FG000|Overall Study|Randomized not treated|2
7061070|NCT01926015|11157979|FG001|Overall Study|Randomized not treated|0
7061071|NCT01926028|11157988|FG000|Overall Study|Lost to Follow-up|7
7061072|NCT01926028|11157989|FG001|Overall Study|Lost to Follow-up|6
7061073|NCT01926028|11157990|FG002|Overall Study|Lost to Follow-up|0
7061074|NCT01926028|11157988|FG000|Overall Study|Physician Decision|1
7061075|NCT01926028|11157989|FG001|Overall Study|Physician Decision|5
7061076|NCT01926028|11157990|FG002|Overall Study|Physician Decision|0
7061077|NCT01926028|11157988|FG000|Overall Study|Withdrawal by Subject|9
7061078|NCT01926028|11157989|FG001|Overall Study|Withdrawal by Subject|9
7061079|NCT01926028|11157990|FG002|Overall Study|Withdrawal by Subject|2
7061080|NCT01926028|11157988|FG000|Overall Study|Non compliance or other reasons|4
7061081|NCT01926028|11157989|FG001|Overall Study|Non compliance or other reasons|2
7061082|NCT01926028|11157990|FG002|Overall Study|Non compliance or other reasons|0
7061083|NCT01926119|11157999|FG000|Overall Study|Withdrawal by Subject|1
7061084|NCT01926444|11158007|FG000|Overall Study|Colonoscopy not performed|0
7061085|NCT01926444|11158008|FG001|Overall Study|Colonoscopy not performed|0
7061086|NCT01926444|11158009|FG002|Overall Study|Colonoscopy not performed|4
7061087|NCT01926444|11158010|FG003|Overall Study|Colonoscopy not performed|2
7061088|NCT01926509|11158037|FG000|Overall Study|vital sign met discontinuation criteria|1
7061089|NCT01926509|11158038|FG001|Overall Study|vital sign met discontinuation criteria|0
7061090|NCT01926509|11158039|FG002|Overall Study|vital sign met discontinuation criteria|0
7061091|NCT01926509|11158040|FG003|Overall Study|vital sign met discontinuation criteria|0
7061092|NCT01926626|11158050|FG000|Overall Study|Withdrawal by Subject|15
7147233|NCT03122860|11307393|FG004|Overall Study|Adverse Event|0
6923307|NCT00818168|10952378|FG000|Overall Study|Lack of Efficacy|18
6923308|NCT00818168|10952378|FG000|Overall Study|Pregnancy|2
7061093|NCT01926626|11158050|FG000|Overall Study|Lost to Follow-up|7
6923309|NCT00818168|10952378|FG000|Overall Study|Withdrawal by Subject|16
7061094|NCT01926782|11158060|FG000|Overall Study|Participant moved|2
7061095|NCT01926782|11158061|FG001|Overall Study|Participant moved|0
7061096|NCT01926782|11158062|FG002|Overall Study|Participant moved|1
7061097|NCT01926782|11158063|FG003|Overall Study|Participant moved|1
7147234|NCT03122860|11307394|FG005|Overall Study|Adverse Event|0
7147235|NCT03122860|11307389|FG000|Overall Study|Lost to Follow-up|5
7147236|NCT03122860|11307390|FG001|Overall Study|Lost to Follow-up|2
7061098|NCT01926782|11158064|FG004|Overall Study|Participant moved|0
7061099|NCT01926782|11158065|FG005|Overall Study|Participant moved|3
7061100|NCT01926782|11158060|FG000|Overall Study|Physician Decision|0
7061101|NCT01926782|11158061|FG001|Overall Study|Physician Decision|2
7061102|NCT01926782|11158062|FG002|Overall Study|Physician Decision|1
7061103|NCT01926782|11158063|FG003|Overall Study|Physician Decision|1
7147237|NCT03122860|11307391|FG002|Overall Study|Lost to Follow-up|3
7147238|NCT03122860|11307392|FG003|Overall Study|Lost to Follow-up|3
7147239|NCT03122860|11307393|FG004|Overall Study|Lost to Follow-up|5
7147240|NCT03122860|11307394|FG005|Overall Study|Lost to Follow-up|4
7147241|NCT03122860|11307389|FG000|Overall Study|Subject Non-Compliance|0
7147242|NCT03122860|11307390|FG001|Overall Study|Subject Non-Compliance|0
7147243|NCT03122860|11307391|FG002|Overall Study|Subject Non-Compliance|1
7147244|NCT03122860|11307392|FG003|Overall Study|Subject Non-Compliance|0
7147245|NCT03122860|11307393|FG004|Overall Study|Subject Non-Compliance|0
7147246|NCT03122860|11307394|FG005|Overall Study|Subject Non-Compliance|0
7147247|NCT03122860|11307389|FG000|Overall Study|Withdrawal by Subject|3
7147248|NCT03122860|11307390|FG001|Overall Study|Withdrawal by Subject|2
7147249|NCT03122860|11307391|FG002|Overall Study|Withdrawal by Subject|5
7147250|NCT03122860|11307392|FG003|Overall Study|Withdrawal by Subject|7
7147251|NCT03122860|11307393|FG004|Overall Study|Withdrawal by Subject|9
7147252|NCT03122860|11307394|FG005|Overall Study|Withdrawal by Subject|8
7147253|NCT03123120|11307425|FG000|Overall Study|Lost to Follow-up|0
7147254|NCT03123120|11307426|FG001|Overall Study|Lost to Follow-up|1
7061104|NCT01926782|11158064|FG004|Overall Study|Physician Decision|0
7061105|NCT01926782|11158065|FG005|Overall Study|Physician Decision|0
7061106|NCT01926782|11158060|FG000|Overall Study|Other than specified|2
7061107|NCT01926782|11158061|FG001|Overall Study|Other than specified|3
7061108|NCT01926782|11158062|FG002|Overall Study|Other than specified|5
7061109|NCT01926782|11158063|FG003|Overall Study|Other than specified|12
7061110|NCT01926782|11158064|FG004|Overall Study|Other than specified|4
7061111|NCT01926782|11158065|FG005|Overall Study|Other than specified|11
7061112|NCT01926782|11158060|FG000|Overall Study|Adverse Event|13
7061113|NCT01926782|11158061|FG001|Overall Study|Adverse Event|4
7061114|NCT01926782|11158062|FG002|Overall Study|Adverse Event|17
7061115|NCT01926782|11158063|FG003|Overall Study|Adverse Event|4
7061116|NCT01926782|11158064|FG004|Overall Study|Adverse Event|3
7061117|NCT01926782|11158065|FG005|Overall Study|Adverse Event|14
7061118|NCT01926782|11158060|FG000|Overall Study|Poor compliance to protocol|5
7061119|NCT01926782|11158061|FG001|Overall Study|Poor compliance to protocol|3
7061120|NCT01926782|11158062|FG002|Overall Study|Poor compliance to protocol|8
7061121|NCT01926782|11158063|FG003|Overall Study|Poor compliance to protocol|0
7061122|NCT01926782|11158064|FG004|Overall Study|Poor compliance to protocol|1
7061123|NCT01926782|11158065|FG005|Overall Study|Poor compliance to protocol|6
7061124|NCT01926782|11158060|FG000|Overall Study|Randomized and not treated|0
7061125|NCT01926782|11158061|FG001|Overall Study|Randomized and not treated|0
7061126|NCT01926782|11158062|FG002|Overall Study|Randomized and not treated|0
7061127|NCT01926782|11158063|FG003|Overall Study|Randomized and not treated|1
7061128|NCT01926782|11158064|FG004|Overall Study|Randomized and not treated|0
7061129|NCT01926782|11158065|FG005|Overall Study|Randomized and not treated|0
7061130|NCT01926782|11158060|FG000|Overall Study|Withdrawal by Subject|6
7061131|NCT01926782|11158061|FG001|Overall Study|Withdrawal by Subject|1
7061132|NCT01926782|11158062|FG002|Overall Study|Withdrawal by Subject|8
7061133|NCT01926782|11158063|FG003|Overall Study|Withdrawal by Subject|1
7061134|NCT01926782|11158064|FG004|Overall Study|Withdrawal by Subject|0
7061135|NCT01926782|11158065|FG005|Overall Study|Withdrawal by Subject|5
7061136|NCT01926782|11158060|FG000|Overall Study|Related to study drug administration|0
7061137|NCT01926782|11158061|FG001|Overall Study|Related to study drug administration|0
7061138|NCT01926782|11158062|FG002|Overall Study|Related to study drug administration|0
7061139|NCT01926782|11158063|FG003|Overall Study|Related to study drug administration|0
7061140|NCT01926782|11158064|FG004|Overall Study|Related to study drug administration|0
7061141|NCT01926782|11158065|FG005|Overall Study|Related to study drug administration|2
7061142|NCT01926886|11158080|FG000|Overall Study|Administrative/other|1
7061143|NCT01926886|11158081|FG001|Overall Study|Administrative/other|0
7061144|NCT01926886|11158080|FG000|Overall Study|Adverse event/intercurrent illness|4
7061145|NCT01926886|11158081|FG001|Overall Study|Adverse event/intercurrent illness|0
7061146|NCT01926886|11158080|FG000|Overall Study|Disease progression/recurrence|4
7147255|NCT03123120|11307425|FG000|Overall Study|Withdrawal by Subject|0
7147256|NCT03123120|11307426|FG001|Overall Study|Withdrawal by Subject|1
7147257|NCT03123354|11307441|FG000|Overall Study|Physician Decision|6
7147258|NCT03123471|11307447|FG000|Placebo-controlled Phase|Adverse Event|3
7061147|NCT01926886|11158081|FG001|Overall Study|Disease progression/recurrence|0
7061148|NCT01926886|11158080|FG000|Overall Study|Withdrawal by Subject|15
7061149|NCT01926886|11158081|FG001|Overall Study|Withdrawal by Subject|0
7061150|NCT01926886|11158080|FG000|Overall Study|Failure to return|3
7061151|NCT01926886|11158081|FG001|Overall Study|Failure to return|0
7061152|NCT01926886|11158080|FG000|Overall Study|Recurrence of disease|1
7061153|NCT01926886|11158081|FG001|Overall Study|Recurrence of disease|0
7147259|NCT03123471|11307448|FG001|Placebo-controlled Phase|Adverse Event|8
7147260|NCT03123471|11307447|FG000|Placebo-controlled Phase|Lack of Efficacy|3
7147261|NCT03123471|11307448|FG001|Placebo-controlled Phase|Lack of Efficacy|4
7147262|NCT03123471|11307447|FG000|Placebo-controlled Phase|Withdrawal by Subject|6
7147263|NCT03123471|11307448|FG001|Placebo-controlled Phase|Withdrawal by Subject|16
7147264|NCT03123471|11307447|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3
7147265|NCT03123471|11307448|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0
7147266|NCT03123471|11307447|FG000|Placebo-controlled Phase|Lost to Follow-up|1
7147267|NCT03123471|11307448|FG001|Placebo-controlled Phase|Lost to Follow-up|3
7147268|NCT03123471|11307447|FG000|Placebo-controlled Phase|Protocol Deviation|2
7147269|NCT03123471|11307448|FG001|Placebo-controlled Phase|Protocol Deviation|1
7147270|NCT03123471|11307447|FG000|Placebo-controlled Phase|Miscellaneous|0
7147271|NCT03123471|11307448|FG001|Placebo-controlled Phase|Miscellaneous|1
7147272|NCT03123471|11307447|FG000|Apremilast Extension Phase|Lost to Follow-up|2
7147273|NCT03123471|11307448|FG001|Apremilast Extension Phase|Lost to Follow-up|5
7147274|NCT03123471|11307447|FG000|Apremilast Extension Phase|Adverse Event|1
7147275|NCT03123471|11307448|FG001|Apremilast Extension Phase|Adverse Event|5
7061154|NCT01926886|11158080|FG000|Overall Study|Progression of disease|2
7061155|NCT01926886|11158081|FG001|Overall Study|Progression of disease|0
7061156|NCT01926886|11158080|FG000|Overall Study|Death|1
7061157|NCT01926886|11158081|FG001|Overall Study|Death|0
7061158|NCT01926886|11158080|FG000|Overall Study|Did not cooperate|1
7061159|NCT01926886|11158081|FG001|Overall Study|Did not cooperate|0
7061160|NCT01927055|11158099|FG000|Open-label|Adverse Event|6
7061161|NCT01927055|11158100|FG001|Open-label|Adverse Event|0
7061162|NCT01927055|11158101|FG002|Open-label|Adverse Event|0
7061163|NCT01927055|11158099|FG000|Open-label|Withdrawal by Subject|1
7061164|NCT01927055|11158100|FG001|Open-label|Withdrawal by Subject|0
7061165|NCT01927055|11158101|FG002|Open-label|Withdrawal by Subject|0
7061166|NCT01927055|11158099|FG000|Open-label|Study Stopped|4
7061167|NCT01927055|11158100|FG001|Open-label|Study Stopped|0
7061168|NCT01927055|11158101|FG002|Open-label|Study Stopped|0
7061169|NCT01927055|11158099|FG000|Open-label|Supine Hypertension|4
7061170|NCT01927055|11158100|FG001|Open-label|Supine Hypertension|0
7061171|NCT01927055|11158101|FG002|Open-label|Supine Hypertension|0
7061172|NCT01927055|11158099|FG000|Open-label|Difficulty attending study visits|1
7061173|NCT01927055|11158100|FG001|Open-label|Difficulty attending study visits|0
7061174|NCT01927055|11158101|FG002|Open-label|Difficulty attending study visits|0
7061175|NCT01927055|11158099|FG000|Double-Blind|Adverse Event|0
7061176|NCT01927055|11158100|FG001|Double-Blind|Adverse Event|1
7061177|NCT01927055|11158101|FG002|Double-Blind|Adverse Event|1
7061178|NCT01927055|11158099|FG000|Double-Blind|Protocol Violation|0
7061179|NCT01927055|11158100|FG001|Double-Blind|Protocol Violation|0
7061180|NCT01927055|11158101|FG002|Double-Blind|Protocol Violation|1
7061181|NCT01927055|11158099|FG000|Double-Blind|Withdrawal by Subject|0
7061182|NCT01927055|11158100|FG001|Double-Blind|Withdrawal by Subject|2
7061183|NCT01927055|11158101|FG002|Double-Blind|Withdrawal by Subject|3
7061184|NCT01927055|11158099|FG000|Double-Blind|Study Stopped|0
7061185|NCT01927055|11158100|FG001|Double-Blind|Study Stopped|7
7061186|NCT01927055|11158101|FG002|Double-Blind|Study Stopped|7
7061187|NCT01927055|11158099|FG000|Double-Blind|Supine Hypertension|0
7061188|NCT01927055|11158100|FG001|Double-Blind|Supine Hypertension|0
7061189|NCT01927055|11158101|FG002|Double-Blind|Supine Hypertension|1
7061190|NCT01927055|11158099|FG000|Double-Blind|Extended Vacation|0
7061191|NCT01927055|11158100|FG001|Double-Blind|Extended Vacation|1
7061192|NCT01927055|11158101|FG002|Double-Blind|Extended Vacation|0
7061193|NCT01927341|11158117|FG000|Phase 1b|Lost to Follow-up|1
7061194|NCT01927341|11158118|FG001|Phase 1b|Lost to Follow-up|0
7061195|NCT01927341|11158119|FG002|Phase 1b|Lost to Follow-up|0
7061196|NCT01927341|11158120|FG003|Phase 1b|Lost to Follow-up|0
7061197|NCT01927341|11158121|FG004|Phase 1b|Lost to Follow-up|0
7061198|NCT01927341|11158117|FG000|Phase 1b|Death|2
7061199|NCT01927341|11158118|FG001|Phase 1b|Death|0
7061200|NCT01927341|11158119|FG002|Phase 1b|Death|0
7061201|NCT01927341|11158120|FG003|Phase 1b|Death|0
7061202|NCT01927341|11158121|FG004|Phase 1b|Death|0
7061203|NCT01927341|11158117|FG000|Phase 1b|Follow-up completed|7
7147276|NCT03123471|11307447|FG000|Apremilast Extension Phase|Lack of Efficacy|2
7061204|NCT01927341|11158118|FG001|Phase 1b|Follow-up completed|0
7061205|NCT01927341|11158119|FG002|Phase 1b|Follow-up completed|0
7061206|NCT01927341|11158120|FG003|Phase 1b|Follow-up completed|0
7061207|NCT01927341|11158121|FG004|Phase 1b|Follow-up completed|0
7061208|NCT01927341|11158117|FG000|Phase 2|Lost to Follow-up|0
7061209|NCT01927341|11158118|FG001|Phase 2|Lost to Follow-up|1
7147277|NCT03123471|11307448|FG001|Apremilast Extension Phase|Lack of Efficacy|8
7147278|NCT03123471|11307447|FG000|Apremilast Extension Phase|Withdrawal by Subject|3
7061210|NCT01927341|11158119|FG002|Phase 2|Lost to Follow-up|0
7061211|NCT01927341|11158120|FG003|Phase 2|Lost to Follow-up|0
7061212|NCT01927341|11158121|FG004|Phase 2|Lost to Follow-up|0
7061213|NCT01927341|11158117|FG000|Phase 2|Participant withdrew consent|0
7061214|NCT01927341|11158118|FG001|Phase 2|Participant withdrew consent|2
7061215|NCT01927341|11158119|FG002|Phase 2|Participant withdrew consent|1
7061216|NCT01927341|11158120|FG003|Phase 2|Participant withdrew consent|2
7061217|NCT01927341|11158121|FG004|Phase 2|Participant withdrew consent|3
7061218|NCT01927341|11158117|FG000|Phase 2|Death|0
7061219|NCT01927341|11158118|FG001|Phase 2|Death|4
7147279|NCT03123471|11307448|FG001|Apremilast Extension Phase|Withdrawal by Subject|7
7147280|NCT03123588|11307462|FG000|Overall Study|Study Terminated by Sponsor|2
7147281|NCT03123588|11307463|FG001|Overall Study|Study Terminated by Sponsor|5
7147282|NCT03123588|11307462|FG000|Overall Study|Withdrawal by Subject|1
7147283|NCT03123588|11307463|FG001|Overall Study|Withdrawal by Subject|0
7147284|NCT03123588|11307462|FG000|Overall Study|Adverse Event|1
7147285|NCT03123588|11307463|FG001|Overall Study|Adverse Event|0
7147286|NCT03123588|11307462|FG000|Overall Study|Physician Decision|2
7147287|NCT03123588|11307463|FG001|Overall Study|Physician Decision|1
7147288|NCT03123861|11307487|FG000|Overall Study|Protocol Violation|1
7147289|NCT03123861|11307488|FG001|Overall Study|Protocol Violation|1
7147290|NCT03123861|11307487|FG000|Overall Study|Withdrawal by Subject|2
7147291|NCT03123861|11307488|FG001|Overall Study|Withdrawal by Subject|2
7147292|NCT03123939|11307507|FG000|Overall Study|Lack of Efficacy|6
7147293|NCT03123939|11307507|FG000|Overall Study|Death|5
7147294|NCT03123939|11307507|FG000|Overall Study|Physician Decision|2
7147295|NCT03123939|11307507|FG000|Overall Study|Subject/guardian decision|2
7147296|NCT03123939|11307507|FG000|Overall Study|Lost to Follow-up|1
6827472|NCT00126503|10830270|FG000|Overall Study|other complicating disease|4
7061220|NCT01927341|11158119|FG002|Phase 2|Death|0
7061221|NCT01927341|11158120|FG003|Phase 2|Death|3
7061222|NCT01927341|11158121|FG004|Phase 2|Death|2
7061223|NCT01927341|11158117|FG000|Phase 2|New cancer therapy|0
7061224|NCT01927341|11158118|FG001|Phase 2|New cancer therapy|1
7061225|NCT01927341|11158119|FG002|Phase 2|New cancer therapy|0
7061226|NCT01927341|11158120|FG003|Phase 2|New cancer therapy|4
7061227|NCT01927341|11158121|FG004|Phase 2|New cancer therapy|1
7061228|NCT01927341|11158117|FG000|Phase 2|Disease progression|0
7061229|NCT01927341|11158118|FG001|Phase 2|Disease progression|1
7061230|NCT01927341|11158119|FG002|Phase 2|Disease progression|1
7061231|NCT01927341|11158120|FG003|Phase 2|Disease progression|1
7061232|NCT01927341|11158121|FG004|Phase 2|Disease progression|0
7061233|NCT01927341|11158117|FG000|Phase 2|Follow-up completed|0
7061234|NCT01927341|11158118|FG001|Phase 2|Follow-up completed|6
7061235|NCT01927341|11158119|FG002|Phase 2|Follow-up completed|3
7061236|NCT01927341|11158120|FG003|Phase 2|Follow-up completed|5
7061237|NCT01927341|11158121|FG004|Phase 2|Follow-up completed|2
7061238|NCT01927367|11158139|FG000|Overall Study|Withdrawal by Subject|7
7061239|NCT01927367|11158140|FG001|Overall Study|Withdrawal by Subject|4
7061240|NCT01927367|11158139|FG000|Overall Study|No baseline data|0
7061241|NCT01927367|11158140|FG001|Overall Study|No baseline data|1
7061242|NCT01927497|11158148|FG000|Overall Study|Death|0
7061243|NCT01927497|11158149|FG001|Overall Study|Death|1
7061244|NCT01927497|11158148|FG000|Overall Study|Protocol Violation|2
7061245|NCT01927497|11158149|FG001|Overall Study|Protocol Violation|0
7061246|NCT01927562|11158155|FG000|Overall Study|Lost to Follow-up|30
7061247|NCT01927562|11158155|FG000|Overall Study|Withdrawal by Subject|3
7061248|NCT01927562|11158155|FG000|Overall Study|Physician Decision|5
7061249|NCT01927627|11158167|FG000|Overall Study|Adverse Event|3
7061250|NCT01927627|11158167|FG000|Overall Study|Lack of Efficacy|1
7061251|NCT01927627|11158167|FG000|Overall Study|Financial Concerns|1
7061252|NCT01927757|11158175|FG000|Overall Study|Withdrawal by Subject|14
7061253|NCT01927757|11158175|FG000|Overall Study|Lost to Follow-up|2
7061254|NCT01927757|11158175|FG000|Overall Study|Decision by Sponsor|2
7061255|NCT01927757|11158175|FG000|Overall Study|Other|1
7061256|NCT01927757|11158175|FG000|Overall Study|Ethical Reasons|4
7061257|NCT01927861|11158185|FG000|Extension Phase (104 Weeks)|Adverse Event|0
7061258|NCT01927861|11158186|FG001|Extension Phase (104 Weeks)|Adverse Event|2
7061259|NCT01927861|11158185|FG000|Extension Phase (104 Weeks)|Unclassified|0
7061260|NCT01927861|11158186|FG001|Extension Phase (104 Weeks)|Unclassified|1
7061261|NCT01928225|11158221|FG000|Overall Study|Pregnancy|1
7061262|NCT01928225|11158222|FG001|Overall Study|Pregnancy|0
7061263|NCT01928225|11158221|FG000|Overall Study|basaloid cervical cancer|1
7061264|NCT01928225|11158222|FG001|Overall Study|basaloid cervical cancer|0
7061265|NCT01928225|11158221|FG000|Overall Study|Lost to Follow-up|1
7061266|NCT01928225|11158222|FG001|Overall Study|Lost to Follow-up|3
7061267|NCT01928329|11158240|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1
7061268|NCT01928329|11158241|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3
7147297|NCT03123939|11307507|FG000|Overall Study|New therapy for study indication|1
7147298|NCT03123939|11307507|FG000|Overall Study|Protocol deviation|1
7147299|NCT03123939|11307507|FG000|Overall Study|Progressive disease|18
7147300|NCT03123939|11307507|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4
7183757|NCT01254422|11383827|FG000|Overall Study|Protocol Violation|1
7061269|NCT01928329|11158240|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0
7061270|NCT01928329|11158241|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1
7061271|NCT01928329|11158240|FG000|Overall Study|Adverse Event|5
7061272|NCT01928329|11158241|FG001|Overall Study|Adverse Event|3
7061273|NCT01928329|11158240|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4
7061274|NCT01928329|11158241|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1
7061275|NCT01928329|11158240|FG000|Overall Study|Withdrawal by Subject|1
7061276|NCT01928329|11158241|FG001|Overall Study|Withdrawal by Subject|5
7061277|NCT01928329|11158240|FG000|Overall Study|Physician Decision|1
7061278|NCT01928329|11158241|FG001|Overall Study|Physician Decision|1
7061279|NCT01928381|11158247|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60
7082214|NCT02139644|11192563|FG001|Treatment Period|Protocol Violation|0
7147301|NCT03123939|11307507|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1
7147302|NCT03124108|11307520|FG000|Overall Study|Adverse Event|0
7147303|NCT03124108|11307521|FG001|Overall Study|Adverse Event|1
7147304|NCT03124108|11307522|FG002|Overall Study|Adverse Event|0
7147305|NCT03124199|11307543|FG000|Overall Study|Lost to Follow-up|4
7147306|NCT03124381|11307573|FG000|Overall Study|Lost to Follow-up|1
7147307|NCT03124381|11307574|FG001|Overall Study|Lost to Follow-up|1
7147308|NCT03124381|11307573|FG000|Overall Study|Withdrawal by Subject|6
7147309|NCT03124381|11307574|FG001|Overall Study|Withdrawal by Subject|3
7147310|NCT03124381|11307573|FG000|Overall Study|Protocol Violation|0
7147311|NCT03124381|11307574|FG001|Overall Study|Protocol Violation|1
7147312|NCT03124381|11307573|FG000|Overall Study|Adverse Event|1
7147313|NCT03124381|11307574|FG001|Overall Study|Adverse Event|1
7147314|NCT03124381|11307573|FG000|Overall Study|Non-Compliance with Study Treatment|1
7147315|NCT03124381|11307574|FG001|Overall Study|Non-Compliance with Study Treatment|0
7147316|NCT03124407|11307584|FG000|Overall Study|Lost to Follow-up|1
7147317|NCT03124407|11307585|FG001|Overall Study|Lost to Follow-up|0
6923310|NCT00818168|10952378|FG000|Overall Study|Lost to Follow-up|7
6923311|NCT00818168|10952378|FG000|Overall Study|Adverse Event|19
6923312|NCT00818168|10952378|FG000|Overall Study|Reason for Non-completion Not reported|6
7061280|NCT01928381|11158248|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
7061281|NCT01928381|11158249|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
7061282|NCT01928381|11158250|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
7061283|NCT01928381|11158251|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
7061284|NCT01928381|11158252|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
7061285|NCT01928381|11158253|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
7061286|NCT01928381|11158247|FG000|Part 1 - Pain Training|Pain training criteria not met|29
7061287|NCT01928381|11158248|FG001|Part 1 - Pain Training|Pain training criteria not met|0
7061288|NCT01928381|11158249|FG002|Part 1 - Pain Training|Pain training criteria not met|0
7061289|NCT01928381|11158250|FG003|Part 1 - Pain Training|Pain training criteria not met|0
7061290|NCT01928381|11158251|FG004|Part 1 - Pain Training|Pain training criteria not met|0
7061291|NCT01928381|11158252|FG005|Part 1 - Pain Training|Pain training criteria not met|0
7061292|NCT01928381|11158253|FG006|Part 1 - Pain Training|Pain training criteria not met|0
7061293|NCT01928381|11158247|FG000|Part 1 - Pain Training|Withdrawal by Subject|1
7061294|NCT01928381|11158248|FG001|Part 1 - Pain Training|Withdrawal by Subject|0
7061295|NCT01928381|11158249|FG002|Part 1 - Pain Training|Withdrawal by Subject|0
7061296|NCT01928381|11158250|FG003|Part 1 - Pain Training|Withdrawal by Subject|0
7061297|NCT01928381|11158251|FG004|Part 1 - Pain Training|Withdrawal by Subject|0
7061298|NCT01928381|11158252|FG005|Part 1 - Pain Training|Withdrawal by Subject|0
7061299|NCT01928381|11158253|FG006|Part 1 - Pain Training|Withdrawal by Subject|0
7061300|NCT01928381|11158247|FG000|Part 1 - Pain Training|Lost to Follow-up|4
7061301|NCT01928381|11158248|FG001|Part 1 - Pain Training|Lost to Follow-up|0
7061302|NCT01928381|11158249|FG002|Part 1 - Pain Training|Lost to Follow-up|0
7061303|NCT01928381|11158250|FG003|Part 1 - Pain Training|Lost to Follow-up|0
7061304|NCT01928381|11158251|FG004|Part 1 - Pain Training|Lost to Follow-up|0
7061305|NCT01928381|11158252|FG005|Part 1 - Pain Training|Lost to Follow-up|0
7061306|NCT01928381|11158253|FG006|Part 1 - Pain Training|Lost to Follow-up|0
7061307|NCT01928381|11158247|FG000|Part 1 - Pain Training|Protocol Violation|1
7061308|NCT01928381|11158248|FG001|Part 1 - Pain Training|Protocol Violation|0
7061309|NCT01928381|11158249|FG002|Part 1 - Pain Training|Protocol Violation|0
7061310|NCT01928381|11158250|FG003|Part 1 - Pain Training|Protocol Violation|0
7061311|NCT01928381|11158251|FG004|Part 1 - Pain Training|Protocol Violation|0
7061312|NCT01928381|11158252|FG005|Part 1 - Pain Training|Protocol Violation|0
7061313|NCT01928381|11158253|FG006|Part 1 - Pain Training|Protocol Violation|0
7061314|NCT01928381|11158247|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1
7061315|NCT01928381|11158248|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0
7061316|NCT01928381|11158249|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0
7061317|NCT01928381|11158250|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0
7061318|NCT01928381|11158251|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0
7061319|NCT01928381|11158252|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0
7061320|NCT01928381|11158253|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0
7061321|NCT01928381|11158247|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2
7061322|NCT01928381|11158248|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
7061323|NCT01928381|11158249|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
7061324|NCT01928381|11158250|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
7061325|NCT01928381|11158251|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
7061326|NCT01928381|11158252|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
7147318|NCT03124407|11307586|FG002|Overall Study|Lost to Follow-up|0
7147319|NCT03124407|11307587|FG003|Overall Study|Lost to Follow-up|0
7147320|NCT03124407|11307584|FG000|Overall Study|Adverse Event|0
7147321|NCT03124407|11307585|FG001|Overall Study|Adverse Event|0
7147322|NCT03124407|11307586|FG002|Overall Study|Adverse Event|1
6923313|NCT00818168|10952378|FG000|Overall Study|Participant Moved|2
6923314|NCT00818207|10952384|FG000|Overall Study|Adverse Event|6
7061327|NCT01928381|11158253|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
7061328|NCT01928381|11158247|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1
7061329|NCT01928381|11158248|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
7147323|NCT03124407|11307587|FG003|Overall Study|Adverse Event|0
7038268|NCT01701258|11120430|FG004|Assessment and Scheduling|Withdrawal by Subject|0
7038269|NCT01701258|11120431|FG005|Assessment and Scheduling|Withdrawal by Subject|0
7038270|NCT01701258|11120432|FG006|Assessment and Scheduling|Withdrawal by Subject|0
7038271|NCT01701258|11120433|FG007|Assessment and Scheduling|Withdrawal by Subject|0
7038272|NCT01701258|11120434|FG008|Assessment and Scheduling|Withdrawal by Subject|0
7038273|NCT01701258|11120435|FG009|Assessment and Scheduling|Withdrawal by Subject|0
7038274|NCT01701258|11120436|FG010|Assessment and Scheduling|Withdrawal by Subject|0
7038275|NCT01701258|11120437|FG011|Assessment and Scheduling|Withdrawal by Subject|0
7038276|NCT01701258|11120438|FG012|Assessment and Scheduling|Withdrawal by Subject|0
7038277|NCT01701258|11120426|FG000|Assessment and Scheduling|Investigator Terminated|2
7038278|NCT01701258|11120427|FG001|Assessment and Scheduling|Investigator Terminated|0
7038279|NCT01701258|11120428|FG002|Assessment and Scheduling|Investigator Terminated|0
7038280|NCT01701258|11120429|FG003|Assessment and Scheduling|Investigator Terminated|0
7038281|NCT01701258|11120430|FG004|Assessment and Scheduling|Investigator Terminated|0
7038282|NCT01701258|11120431|FG005|Assessment and Scheduling|Investigator Terminated|0
7038283|NCT01701258|11120432|FG006|Assessment and Scheduling|Investigator Terminated|0
7038284|NCT01701258|11120433|FG007|Assessment and Scheduling|Investigator Terminated|0
7038285|NCT01701258|11120434|FG008|Assessment and Scheduling|Investigator Terminated|0
7038286|NCT01701258|11120435|FG009|Assessment and Scheduling|Investigator Terminated|0
7038287|NCT01701258|11120436|FG010|Assessment and Scheduling|Investigator Terminated|0
7038288|NCT01701258|11120437|FG011|Assessment and Scheduling|Investigator Terminated|0
7038289|NCT01701258|11120438|FG012|Assessment and Scheduling|Investigator Terminated|0
7038290|NCT01701362|11120473|FG000|Overall Study|Adverse events not related to study drug|1
7038291|NCT01701362|11120474|FG001|Overall Study|Adverse events not related to study drug|6
7038292|NCT01701362|11120473|FG000|Overall Study|Adverse events related to study drug|12
7038293|NCT01701362|11120474|FG001|Overall Study|Adverse events related to study drug|10
7061330|NCT01928381|11158249|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
7061331|NCT01928381|11158250|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
7061332|NCT01928381|11158251|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
7061333|NCT01928381|11158252|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
7061334|NCT01928381|11158253|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
7061335|NCT01928381|11158247|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10
7147324|NCT03124459|11307607|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0
7147325|NCT03124459|11307608|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0
7147326|NCT03124459|11307609|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0
7147327|NCT03124459|11307610|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0
7147328|NCT03124459|11307611|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2
7147329|NCT03124459|11307612|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0
7147330|NCT03124459|11307607|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0
7147331|NCT03124459|11307608|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0
7147332|NCT03124459|11307609|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0
7147333|NCT03124459|11307610|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0
7147334|NCT03124459|11307611|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1
7147335|NCT03124459|11307612|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0
7147336|NCT03124459|11307607|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0
7147337|NCT03124459|11307608|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0
7061336|NCT01928381|11158248|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
7061337|NCT01928381|11158249|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
7061338|NCT01928381|11158250|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
7061339|NCT01928381|11158251|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
7061340|NCT01928381|11158252|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
7061341|NCT01928381|11158253|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
7061342|NCT01928381|11158247|FG000|Part 2 - First Intervention|Withdrawal by Subject|0
7061343|NCT01928381|11158248|FG001|Part 2 - First Intervention|Withdrawal by Subject|0
7061344|NCT01928381|11158249|FG002|Part 2 - First Intervention|Withdrawal by Subject|1
7061345|NCT01928381|11158250|FG003|Part 2 - First Intervention|Withdrawal by Subject|0
7061346|NCT01928381|11158251|FG004|Part 2 - First Intervention|Withdrawal by Subject|0
7061347|NCT01928381|11158252|FG005|Part 2 - First Intervention|Withdrawal by Subject|0
7061348|NCT01928381|11158253|FG006|Part 2 - First Intervention|Withdrawal by Subject|0
7061349|NCT01928381|11158247|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0
7147338|NCT03124459|11307609|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0
7147339|NCT03124459|11307610|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11
7147340|NCT03124459|11307611|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12
7147341|NCT03124459|11307612|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0
7147342|NCT03124459|11307607|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0
7038294|NCT01701362|11120473|FG000|Overall Study|Protocol Violation|5
7038295|NCT01701362|11120474|FG001|Overall Study|Protocol Violation|3
7038296|NCT01701362|11120473|FG000|Overall Study|No longer willing to participate|8
7038297|NCT01701362|11120474|FG001|Overall Study|No longer willing to participate|14
7038298|NCT01701362|11120473|FG000|Overall Study|Lost to Follow-up|6
7147343|NCT03124459|11307608|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0
7147344|NCT03124459|11307609|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0
7147345|NCT03124459|11307610|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1
7061350|NCT01928381|11158248|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0
7061351|NCT01928381|11158249|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1
7061352|NCT01928381|11158250|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0
7061353|NCT01928381|11158251|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0
7061354|NCT01928381|11158252|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0
7061355|NCT01928381|11158253|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0
7061356|NCT01928381|11158247|FG000|Part 2 - First Intervention|Eligibility criterion not met|0
7061357|NCT01928381|11158248|FG001|Part 2 - First Intervention|Eligibility criterion not met|0
7061358|NCT01928381|11158249|FG002|Part 2 - First Intervention|Eligibility criterion not met|0
7061359|NCT01928381|11158250|FG003|Part 2 - First Intervention|Eligibility criterion not met|0
7061360|NCT01928381|11158251|FG004|Part 2 - First Intervention|Eligibility criterion not met|0
7061361|NCT01928381|11158252|FG005|Part 2 - First Intervention|Eligibility criterion not met|1
7061362|NCT01928381|11158253|FG006|Part 2 - First Intervention|Eligibility criterion not met|1
7061363|NCT01928381|11158247|FG000|Part 2 - First Intervention|Lost to Follow-up|0
7061364|NCT01928381|11158248|FG001|Part 2 - First Intervention|Lost to Follow-up|0
7061365|NCT01928381|11158249|FG002|Part 2 - First Intervention|Lost to Follow-up|0
7061366|NCT01928381|11158250|FG003|Part 2 - First Intervention|Lost to Follow-up|1
7061367|NCT01928381|11158251|FG004|Part 2 - First Intervention|Lost to Follow-up|0
7061368|NCT01928381|11158252|FG005|Part 2 - First Intervention|Lost to Follow-up|0
7061369|NCT01928381|11158253|FG006|Part 2 - First Intervention|Lost to Follow-up|0
7061370|NCT01928381|11158247|FG000|Washout First Intervention|Protocol Violation|0
7061371|NCT01928381|11158248|FG001|Washout First Intervention|Protocol Violation|0
7061372|NCT01928381|11158249|FG002|Washout First Intervention|Protocol Violation|0
7061373|NCT01928381|11158250|FG003|Washout First Intervention|Protocol Violation|0
7061374|NCT01928381|11158251|FG004|Washout First Intervention|Protocol Violation|1
7061375|NCT01928381|11158252|FG005|Washout First Intervention|Protocol Violation|0
7061376|NCT01928381|11158253|FG006|Washout First Intervention|Protocol Violation|0
7061377|NCT01928381|11158247|FG000|Part 2 - Second Intervention|Lost to Follow-up|0
7061378|NCT01928381|11158248|FG001|Part 2 - Second Intervention|Lost to Follow-up|1
7061379|NCT01928381|11158249|FG002|Part 2 - Second Intervention|Lost to Follow-up|0
7061380|NCT01928381|11158250|FG003|Part 2 - Second Intervention|Lost to Follow-up|1
7061381|NCT01928381|11158251|FG004|Part 2 - Second Intervention|Lost to Follow-up|0
7061382|NCT01928381|11158252|FG005|Part 2 - Second Intervention|Lost to Follow-up|0
7061383|NCT01928381|11158253|FG006|Part 2 - Second Intervention|Lost to Follow-up|0
7061384|NCT01928381|11158247|FG000|Part 2 - Post Third Intervention|Protocol Violation|0
7061385|NCT01928381|11158248|FG001|Part 2 - Post Third Intervention|Protocol Violation|0
7061386|NCT01928381|11158249|FG002|Part 2 - Post Third Intervention|Protocol Violation|1
7061387|NCT01928381|11158250|FG003|Part 2 - Post Third Intervention|Protocol Violation|0
7061388|NCT01928381|11158251|FG004|Part 2 - Post Third Intervention|Protocol Violation|0
7061389|NCT01928381|11158252|FG005|Part 2 - Post Third Intervention|Protocol Violation|0
7061390|NCT01928381|11158253|FG006|Part 2 - Post Third Intervention|Protocol Violation|0
7061391|NCT01928433|11158266|FG000|Overall Study|Adverse Event|5
7061392|NCT01928433|11158267|FG001|Overall Study|Adverse Event|2
7061393|NCT01928433|11158268|FG002|Overall Study|Adverse Event|5
7061394|NCT01928433|11158266|FG000|Overall Study|Protocol Violation|0
7061395|NCT01928433|11158267|FG001|Overall Study|Protocol Violation|0
7061396|NCT01928433|11158268|FG002|Overall Study|Protocol Violation|2
7061397|NCT01928433|11158266|FG000|Overall Study|Lack of Efficacy|5
7061398|NCT01928433|11158267|FG001|Overall Study|Lack of Efficacy|4
7061399|NCT01928433|11158268|FG002|Overall Study|Lack of Efficacy|4
7061400|NCT01928433|11158266|FG000|Overall Study|Withdrawal by Subject|0
7061401|NCT01928433|11158267|FG001|Overall Study|Withdrawal by Subject|4
7061402|NCT01928433|11158268|FG002|Overall Study|Withdrawal by Subject|0
7061403|NCT01928433|11158266|FG000|Overall Study|Negative screening urine culture|7
7061404|NCT01928433|11158267|FG001|Overall Study|Negative screening urine culture|6
7061405|NCT01928433|11158268|FG002|Overall Study|Negative screening urine culture|10
7061406|NCT01928433|11158266|FG000|Overall Study|Lost to Follow-up|0
7061407|NCT01928433|11158267|FG001|Overall Study|Lost to Follow-up|2
7061408|NCT01928433|11158268|FG002|Overall Study|Lost to Follow-up|3
7061409|NCT01928433|11158266|FG000|Overall Study|Other reasons|3
7061410|NCT01928433|11158267|FG001|Overall Study|Other reasons|3
7061411|NCT01928433|11158268|FG002|Overall Study|Other reasons|4
7082215|NCT02139644|11192564|FG002|Treatment Period|Protocol Violation|0
7082216|NCT02139644|11192565|FG003|Treatment Period|Protocol Violation|1
7082217|NCT02139644|11192566|FG004|Treatment Period|Protocol Violation|1
7082218|NCT02139644|11192567|FG005|Treatment Period|Protocol Violation|1
7082219|NCT02139644|11192562|FG000|Treatment Period|Disease progression|0
7147346|NCT03124459|11307611|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4
7147347|NCT03124459|11307612|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0
7147348|NCT03124459|11307607|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0
7082220|NCT02139644|11192563|FG001|Treatment Period|Disease progression|0
7082221|NCT02139644|11192564|FG002|Treatment Period|Disease progression|0
7147349|NCT03124459|11307608|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0
7147350|NCT03124459|11307609|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0
7147351|NCT03124459|11307610|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0
7147352|NCT03124459|11307611|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0
7147353|NCT03124459|11307612|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22
7147354|NCT03124459|11307607|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0
7147355|NCT03124459|11307608|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0
7147356|NCT03124459|11307609|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0
7147357|NCT03124459|11307610|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0
7147358|NCT03124459|11307611|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0
7147359|NCT03124459|11307612|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1
7147360|NCT03124537|11307627|FG000|Overall Study|Lost to Follow-up|3
7147361|NCT03124537|11307628|FG001|Overall Study|Lost to Follow-up|5
6827473|NCT00126503|10830271|FG001|Overall Study|other complicating disease|1
6827474|NCT00126503|10830270|FG000|Overall Study|Death|3
6827475|NCT00126503|10830271|FG001|Overall Study|Death|0
6827476|NCT00126503|10830270|FG000|Overall Study|Adverse Event|13
7147362|NCT03124537|11307627|FG000|Overall Study|App Crash, Incomplete Data|7
7147363|NCT03124537|11307628|FG001|Overall Study|App Crash, Incomplete Data|8
7147364|NCT03124563|11307640|FG000|Overall Study|Lost to Follow-up|1
7147365|NCT03124563|11307641|FG001|Overall Study|Lost to Follow-up|1
7147366|NCT03124563|11307640|FG000|Overall Study|Withdrawal by Subject|1
7147367|NCT03124563|11307641|FG001|Overall Study|Withdrawal by Subject|1
7147368|NCT03124784|11307663|FG000|Overall Study|Adverse Event|1
7147369|NCT03124784|11307663|FG000|Overall Study|Computer/Equip Malfunction|1
7038299|NCT01701362|11120474|FG001|Overall Study|Lost to Follow-up|9
7038300|NCT01701362|11120473|FG000|Overall Study|Insufficient clinical response|6
7038301|NCT01701362|11120474|FG001|Overall Study|Insufficient clinical response|6
7038302|NCT01701362|11120473|FG000|Overall Study|Death|0
7147370|NCT03125200|11307716|FG000|Overall Study|Study Termination|0
6923315|NCT00818207|10952385|FG001|Overall Study|Adverse Event|0
7038303|NCT01701362|11120474|FG001|Overall Study|Death|1
7038304|NCT01701362|11120473|FG000|Overall Study|Randomized but not treated|1
7038305|NCT01701362|11120474|FG001|Overall Study|Randomized but not treated|2
7038306|NCT01701362|11120473|FG000|Overall Study|Reasons other than those mentioned above|3
7038307|NCT01701362|11120474|FG001|Overall Study|Reasons other than those mentioned above|5
7061412|NCT01928472|11158294|FG000|Overall Study|Death|0
7061413|NCT01928472|11158295|FG001|Overall Study|Death|0
7061414|NCT01928472|11158296|FG002|Overall Study|Death|1
7061415|NCT01928472|11158297|FG003|Overall Study|Death|0
7061416|NCT01928472|11158294|FG000|Overall Study|Withdrawal by Subject|4
7061417|NCT01928472|11158295|FG001|Overall Study|Withdrawal by Subject|4
7061418|NCT01928472|11158296|FG002|Overall Study|Withdrawal by Subject|1
7061419|NCT01928472|11158297|FG003|Overall Study|Withdrawal by Subject|2
7061420|NCT01928472|11158294|FG000|Overall Study|Lost to Follow-up|2
7061421|NCT01928472|11158295|FG001|Overall Study|Lost to Follow-up|3
7061422|NCT01928472|11158296|FG002|Overall Study|Lost to Follow-up|4
7061423|NCT01928472|11158297|FG003|Overall Study|Lost to Follow-up|0
7061424|NCT01928472|11158294|FG000|Overall Study|Administrative Reason|2
7061425|NCT01928472|11158295|FG001|Overall Study|Administrative Reason|1
7061426|NCT01928472|11158296|FG002|Overall Study|Administrative Reason|0
7061427|NCT01928472|11158297|FG003|Overall Study|Administrative Reason|0
7061428|NCT01928472|11158294|FG000|Overall Study|Unclassified|0
7061429|NCT01928472|11158295|FG001|Overall Study|Unclassified|0
7061430|NCT01928472|11158296|FG002|Overall Study|Unclassified|1
7061431|NCT01928472|11158297|FG003|Overall Study|Unclassified|0
7061432|NCT01928485|11158310|FG000|Overall Study|Physician Decision|0
7061433|NCT01928485|11158311|FG001|Overall Study|Physician Decision|1
7061434|NCT01928719|11158365|FG000|Overall Study|Lost to Follow-up|26
7061435|NCT01928719|11158366|FG001|Overall Study|Lost to Follow-up|11
7061436|NCT01928719|11158365|FG000|Overall Study|Withdrawal by Subject|22
7061437|NCT01928719|11158366|FG001|Overall Study|Withdrawal by Subject|7
7061438|NCT01928719|11158365|FG000|Overall Study|Protocol Violation|3
7061439|NCT01928719|11158366|FG001|Overall Study|Protocol Violation|1
7061440|NCT01928719|11158365|FG000|Overall Study|Adverse Event|1
7061441|NCT01928719|11158366|FG001|Overall Study|Adverse Event|0
7061442|NCT01928758|11158376|FG000|Overall Study|Lost to Follow-up|14
7061443|NCT01928758|11158377|FG001|Overall Study|Lost to Follow-up|9
7061444|NCT01928758|11158376|FG000|Overall Study|Withdrawal by Subject|5
7061445|NCT01928758|11158377|FG001|Overall Study|Withdrawal by Subject|2
7061446|NCT01928758|11158376|FG000|Overall Study|Adverse Event|3
7061447|NCT01928758|11158377|FG001|Overall Study|Adverse Event|5
7147371|NCT03125200|11307717|FG001|Overall Study|Study Termination|0
7147372|NCT03125200|11307718|FG002|Overall Study|Study Termination|0
6923316|NCT00818207|10952384|FG000|Overall Study|Lost to Follow-up|160
7061448|NCT01928758|11158376|FG000|Overall Study|Protocol Violation|3
7061449|NCT01928758|11158377|FG001|Overall Study|Protocol Violation|4
7061450|NCT01928771|11158387|FG000|Overall Study|Adverse Event|6
7061451|NCT01928771|11158388|FG001|Overall Study|Adverse Event|5
7061452|NCT01928771|11158389|FG002|Overall Study|Adverse Event|1
7061453|NCT01928771|11158387|FG000|Overall Study|Death|2
7061454|NCT01928771|11158388|FG001|Overall Study|Death|2
7147373|NCT03125200|11307719|FG003|Overall Study|Study Termination|1
7147374|NCT03125200|11307720|FG004|Overall Study|Study Termination|1
7147375|NCT03125200|11307721|FG005|Overall Study|Study Termination|2
7147376|NCT03125200|11307722|FG006|Overall Study|Study Termination|1
7147377|NCT03125200|11307716|FG000|Overall Study|Clinical Progression|0
7147378|NCT03125200|11307717|FG001|Overall Study|Clinical Progression|0
7147379|NCT03125200|11307718|FG002|Overall Study|Clinical Progression|0
7147380|NCT03125200|11307719|FG003|Overall Study|Clinical Progression|1
7038308|NCT01701401|11120488|FG000|Overall Study|Randomized But Not Treated|3
7038309|NCT01701401|11120489|FG001|Overall Study|Randomized But Not Treated|1
7038310|NCT01701401|11120490|FG002|Overall Study|Randomized But Not Treated|0
7061455|NCT01928771|11158389|FG002|Overall Study|Death|2
7061456|NCT01928771|11158387|FG000|Overall Study|Lost to Follow-up|5
7061457|NCT01928771|11158388|FG001|Overall Study|Lost to Follow-up|6
7061458|NCT01928771|11158389|FG002|Overall Study|Lost to Follow-up|3
7061459|NCT01928771|11158387|FG000|Overall Study|Withdrawal by Subject|20
7061460|NCT01928771|11158388|FG001|Overall Study|Withdrawal by Subject|15
7061461|NCT01928771|11158389|FG002|Overall Study|Withdrawal by Subject|17
7061462|NCT01928771|11158387|FG000|Overall Study|Study-Specific Withdrawal Criteria|0
7061463|NCT01928771|11158388|FG001|Overall Study|Study-Specific Withdrawal Criteria|1
7061464|NCT01928771|11158389|FG002|Overall Study|Study-Specific Withdrawal Criteria|1
7061465|NCT01928771|11158387|FG000|Overall Study|Other Reasons|9
7061466|NCT01928771|11158388|FG001|Overall Study|Other Reasons|9
7061467|NCT01928771|11158389|FG002|Overall Study|Other Reasons|14
7061468|NCT01928771|11158387|FG000|Overall Study|Severe Non-Compliance to Protocol|4
7061469|NCT01928771|11158388|FG001|Overall Study|Severe Non-Compliance to Protocol|2
7061470|NCT01928771|11158389|FG002|Overall Study|Severe Non-Compliance to Protocol|2
7061471|NCT01928862|11158422|FG000|Overall Study|Lost to Follow-up|1
7061472|NCT01928862|11158423|FG001|Overall Study|Lost to Follow-up|0
7061473|NCT01928862|11158424|FG002|Overall Study|Lost to Follow-up|0
7061474|NCT01928862|11158425|FG003|Overall Study|Lost to Follow-up|0
7061475|NCT01928862|11158426|FG004|Overall Study|Lost to Follow-up|1
7061476|NCT01928927|11158441|FG000|Overall Study|Lost to Follow-up|1
7061477|NCT01928927|11158442|FG001|Overall Study|Lost to Follow-up|0
7061478|NCT01928927|11158441|FG000|Overall Study|Withdrawal by Subject|1
7061479|NCT01928927|11158442|FG001|Overall Study|Withdrawal by Subject|1
7061480|NCT01928940|11158454|FG000|Overall Study|Adverse Event|0
7061481|NCT01928940|11158455|FG001|Overall Study|Adverse Event|1
7061482|NCT01929018|11158464|FG000|Overall Study|Lost to Follow-up|1
7061483|NCT01929018|11158465|FG001|Overall Study|Lost to Follow-up|0
7061484|NCT01929018|11158464|FG000|Overall Study|Hospitalization|0
7061485|NCT01929018|11158465|FG001|Overall Study|Hospitalization|1
7061486|NCT01929031|11158475|FG000|Overall Study|Adverse Event|3
7061487|NCT01929031|11158476|FG001|Overall Study|Adverse Event|1
7061488|NCT01929031|11158477|FG002|Overall Study|Adverse Event|1
7061489|NCT01929031|11158478|FG003|Overall Study|Adverse Event|0
7061490|NCT01929031|11158479|FG004|Overall Study|Adverse Event|0
7061491|NCT01929031|11158480|FG005|Overall Study|Adverse Event|0
7061492|NCT01929031|11158475|FG000|Overall Study|Protocol Violation|1
7061493|NCT01929031|11158476|FG001|Overall Study|Protocol Violation|0
7061494|NCT01929031|11158477|FG002|Overall Study|Protocol Violation|0
7061495|NCT01929031|11158478|FG003|Overall Study|Protocol Violation|0
7061496|NCT01929031|11158479|FG004|Overall Study|Protocol Violation|0
7061497|NCT01929031|11158480|FG005|Overall Study|Protocol Violation|1
7038311|NCT01701401|11120491|FG003|Overall Study|Randomized But Not Treated|1
7038312|NCT01701401|11120488|FG000|Overall Study|Lost to Follow-up|5
7038313|NCT01701401|11120489|FG001|Overall Study|Lost to Follow-up|5
7038314|NCT01701401|11120490|FG002|Overall Study|Lost to Follow-up|1
7038315|NCT01701401|11120491|FG003|Overall Study|Lost to Follow-up|3
7038316|NCT01701401|11120488|FG000|Overall Study|Withdrew Consent|0
7038317|NCT01701401|11120489|FG001|Overall Study|Withdrew Consent|3
7038318|NCT01701401|11120490|FG002|Overall Study|Withdrew Consent|1
7038319|NCT01701401|11120491|FG003|Overall Study|Withdrew Consent|2
7038320|NCT01701401|11120488|FG000|Overall Study|Lack of Efficacy|1
7038321|NCT01701401|11120489|FG001|Overall Study|Lack of Efficacy|0
7038322|NCT01701401|11120490|FG002|Overall Study|Lack of Efficacy|2
7038323|NCT01701401|11120491|FG003|Overall Study|Lack of Efficacy|0
7038324|NCT01701401|11120488|FG000|Overall Study|Adverse Event|1
7038325|NCT01701401|11120489|FG001|Overall Study|Adverse Event|0
7038326|NCT01701401|11120490|FG002|Overall Study|Adverse Event|0
7038327|NCT01701401|11120491|FG003|Overall Study|Adverse Event|0
7038328|NCT01701401|11120488|FG000|Overall Study|Protocol Violation|0
7147381|NCT03125200|11307720|FG004|Overall Study|Clinical Progression|0
6827477|NCT00126503|10830271|FG001|Overall Study|Adverse Event|3
7038329|NCT01701401|11120489|FG001|Overall Study|Protocol Violation|0
7038330|NCT01701401|11120490|FG002|Overall Study|Protocol Violation|1
7038331|NCT01701401|11120491|FG003|Overall Study|Protocol Violation|0
7061498|NCT01929031|11158475|FG000|Overall Study|Reason other than specified above|0
7061499|NCT01929031|11158476|FG001|Overall Study|Reason other than specified above|1
7061500|NCT01929031|11158477|FG002|Overall Study|Reason other than specified above|0
7061501|NCT01929031|11158478|FG003|Overall Study|Reason other than specified above|0
7061502|NCT01929031|11158479|FG004|Overall Study|Reason other than specified above|1
7061503|NCT01929031|11158480|FG005|Overall Study|Reason other than specified above|0
7147382|NCT03125200|11307721|FG005|Overall Study|Clinical Progression|1
7147383|NCT03125200|11307722|FG006|Overall Study|Clinical Progression|0
7147384|NCT03125200|11307716|FG000|Overall Study|Progressive Disease|2
7147385|NCT03125200|11307717|FG001|Overall Study|Progressive Disease|1
7147386|NCT03125200|11307718|FG002|Overall Study|Progressive Disease|2
7147387|NCT03125200|11307719|FG003|Overall Study|Progressive Disease|1
7147388|NCT03125200|11307720|FG004|Overall Study|Progressive Disease|2
7147389|NCT03125200|11307721|FG005|Overall Study|Progressive Disease|0
7147390|NCT03125200|11307722|FG006|Overall Study|Progressive Disease|1
7147391|NCT03125200|11307716|FG000|Overall Study|Lack of Efficacy|0
7147392|NCT03125200|11307717|FG001|Overall Study|Lack of Efficacy|0
7147393|NCT03125200|11307718|FG002|Overall Study|Lack of Efficacy|0
7147394|NCT03125200|11307719|FG003|Overall Study|Lack of Efficacy|1
7147395|NCT03125200|11307720|FG004|Overall Study|Lack of Efficacy|0
6827478|NCT00126503|10830270|FG000|Overall Study|non-compliant|1
6827479|NCT00126503|10830271|FG001|Overall Study|non-compliant|0
6923317|NCT00818207|10952385|FG001|Overall Study|Lost to Follow-up|146
6923318|NCT00818207|10952384|FG000|Overall Study|Multiple reasons|11
6923319|NCT00818207|10952385|FG001|Overall Study|Multiple reasons|12
6923320|NCT00818207|10952384|FG000|Overall Study|Withdrawal by Subject|42
6923321|NCT00818207|10952385|FG001|Overall Study|Withdrawal by Subject|104
6923322|NCT00818207|10952384|FG000|Overall Study|Death|3
6923323|NCT00818207|10952385|FG001|Overall Study|Death|5
6923324|NCT00818246|10952391|FG000|Overall Study|Impossible to match pictures|5
6923325|NCT00818259|10952402|FG000|Part I|Withdrawal by Subject|1
6827480|NCT00126503|10830270|FG000|Overall Study|Physician Decision|2
6827481|NCT00126503|10830271|FG001|Overall Study|Physician Decision|1
6827482|NCT00126555|10830281|FG000|Overall Study|Withdrawal by Subject|1
6827483|NCT00126555|10830281|FG000|Overall Study|Adverse Event|2
6827484|NCT00126555|10830281|FG000|Overall Study|Progressive Disease|3
6827485|NCT00126568|10830297|FG000|Overall Study|Death|2
6827486|NCT00126581|10830304|FG000|Overall Study|Adverse Event|3
6827487|NCT00126581|10830305|FG001|Overall Study|Adverse Event|7
6827488|NCT00126581|10830304|FG000|Overall Study|Death|3
6827489|NCT00126581|10830305|FG001|Overall Study|Death|2
6827490|NCT00126581|10830304|FG000|Overall Study|Withdrawal by Subject|1
6827491|NCT00126581|10830305|FG001|Overall Study|Withdrawal by Subject|4
6827492|NCT00126581|10830304|FG000|Overall Study|Alternative therapy|3
6827493|NCT00126581|10830305|FG001|Overall Study|Alternative therapy|3
6827494|NCT00126581|10830304|FG000|Overall Study|Other illness/MD discretion|3
6827495|NCT00126581|10830305|FG001|Overall Study|Other illness/MD discretion|4
6827496|NCT00126594|10830315|FG000|Overall Study|Ineligible|2
6827497|NCT00126594|10830316|FG001|Overall Study|Ineligible|0
6827498|NCT00126594|10830315|FG000|Overall Study|Withdrawal by Subject|0
6827499|NCT00126594|10830316|FG001|Overall Study|Withdrawal by Subject|4
6827500|NCT00126594|10830315|FG000|Overall Study|Physician Decision|1
6827501|NCT00126594|10830316|FG001|Overall Study|Physician Decision|3
6827502|NCT00126594|10830315|FG000|Overall Study|Adverse Event|7
6827503|NCT00126594|10830316|FG001|Overall Study|Adverse Event|5
6827504|NCT00126594|10830315|FG000|Overall Study|Non-compliance|0
6827505|NCT00126594|10830316|FG001|Overall Study|Non-compliance|1
6827506|NCT00126594|10830315|FG000|Overall Study|Disease Progression|29
6827507|NCT00126594|10830316|FG001|Overall Study|Disease Progression|24
6827508|NCT00127036|10830354|FG000|Overall Study|Insufficient Data for Analysis|6
6827509|NCT00127036|10830355|FG001|Overall Study|Insufficient Data for Analysis|11
7061504|NCT01929044|11158492|FG000|Overall Study|Adverse Event|1
7061505|NCT01929044|11158493|FG001|Overall Study|Adverse Event|0
7061506|NCT01929044|11158492|FG000|Overall Study|Protocol Violation|9
7061507|NCT01929044|11158493|FG001|Overall Study|Protocol Violation|14
7061508|NCT01929044|11158492|FG000|Overall Study|Not Treated|1
7061509|NCT01929044|11158493|FG001|Overall Study|Not Treated|3
7061510|NCT01929083|11158510|FG000|Intervention 1|Lost to Follow-up|2
7061511|NCT01929083|11158511|FG001|Intervention 1|Lost to Follow-up|0
7061512|NCT01929083|11158510|FG000|Intervention 1|Nonadherent to study medications|1
7061513|NCT01929083|11158511|FG001|Intervention 1|Nonadherent to study medications|0
7061514|NCT01929083|11158510|FG000|Intervention 2|Adverse Event|0
7061515|NCT01929083|11158511|FG001|Intervention 2|Adverse Event|1
6827510|NCT00127036|10830354|FG000|Overall Study|Screen Failure|2
6827511|NCT00127036|10830355|FG001|Overall Study|Screen Failure|0
6827512|NCT00127101|10830380|FG000|Base Protocol|Adverse Event|0
6827513|NCT00127101|10830381|FG001|Base Protocol|Adverse Event|2
6827514|NCT00127101|10830382|FG002|Base Protocol|Adverse Event|1
6827515|NCT00127101|10830383|FG003|Base Protocol|Adverse Event|0
6827516|NCT00127101|10830384|FG004|Base Protocol|Adverse Event|0
6827517|NCT00127101|10830385|FG005|Base Protocol|Adverse Event|0
6827518|NCT00127101|10830380|FG000|Base Protocol|Lack of Efficacy|1
6923326|NCT00818259|10952403|FG001|Part I|Withdrawal by Subject|0
7061516|NCT01929109|11158522|FG000|Period 1 (All Groups)|Deviation from protocol|0
6827519|NCT00127101|10830381|FG001|Base Protocol|Lack of Efficacy|0
6827520|NCT00127101|10830382|FG002|Base Protocol|Lack of Efficacy|0
6827521|NCT00127101|10830383|FG003|Base Protocol|Lack of Efficacy|0
6827522|NCT00127101|10830384|FG004|Base Protocol|Lack of Efficacy|2
6827523|NCT00127101|10830385|FG005|Base Protocol|Lack of Efficacy|0
6923327|NCT00818259|10952404|FG002|Part I|Withdrawal by Subject|0
7061517|NCT01929109|11158523|FG001|Period 1 (All Groups)|Deviation from protocol|0
7082222|NCT02139644|11192565|FG003|Treatment Period|Disease progression|1
7147396|NCT03125200|11307721|FG005|Overall Study|Lack of Efficacy|0
7147397|NCT03125200|11307722|FG006|Overall Study|Lack of Efficacy|0
7147398|NCT03125200|11307716|FG000|Overall Study|Toxicity|0
7147399|NCT03125200|11307717|FG001|Overall Study|Toxicity|0
7147400|NCT03125200|11307718|FG002|Overall Study|Toxicity|0
7147401|NCT03125200|11307719|FG003|Overall Study|Toxicity|1
7147402|NCT03125200|11307720|FG004|Overall Study|Toxicity|0
7147403|NCT03125200|11307721|FG005|Overall Study|Toxicity|0
7147404|NCT03125200|11307722|FG006|Overall Study|Toxicity|0
7147405|NCT03125200|11307716|FG000|Overall Study|Consent Withdrawn by Subject|0
7147406|NCT03125200|11307717|FG001|Overall Study|Consent Withdrawn by Subject|1
7147407|NCT03125200|11307718|FG002|Overall Study|Consent Withdrawn by Subject|0
7147408|NCT03125200|11307719|FG003|Overall Study|Consent Withdrawn by Subject|0
7147409|NCT03125200|11307720|FG004|Overall Study|Consent Withdrawn by Subject|1
7147410|NCT03125200|11307721|FG005|Overall Study|Consent Withdrawn by Subject|0
7147411|NCT03125200|11307722|FG006|Overall Study|Consent Withdrawn by Subject|1
7147412|NCT03125395|11307745|FG000|Overall Study|Adverse Event|2
7147413|NCT03125395|11307745|FG000|Overall Study|Withdrawal of consent (not due to AE)|1
7147414|NCT03125395|11307745|FG000|Overall Study|Physician Decision|2
7147415|NCT03125395|11307745|FG000|Overall Study|Commercial drug is available|5
7147416|NCT03125629|11307749|FG000|Overall Study|Withdrawal by Subject|2
7147417|NCT03125629|11307749|FG000|Overall Study|Equipment malfunction|1
7147418|NCT03125915|11307765|FG000|1 Month Follow up|Lost to Follow-up|3
7147419|NCT03125915|11307766|FG001|1 Month Follow up|Lost to Follow-up|3
7147420|NCT03125915|11307767|FG002|1 Month Follow up|Lost to Follow-up|2
7147421|NCT03125915|11307768|FG003|1 Month Follow up|Lost to Follow-up|3
7147422|NCT03125915|11307765|FG000|3 Month Follow-up|Lost to Follow-up|6
7147423|NCT03125915|11307766|FG001|3 Month Follow-up|Lost to Follow-up|4
7147424|NCT03125915|11307767|FG002|3 Month Follow-up|Lost to Follow-up|4
7147425|NCT03125915|11307768|FG003|3 Month Follow-up|Lost to Follow-up|2
7147426|NCT03125915|11307765|FG000|6 Month Follow-up|Lost to Follow-up|7
7147427|NCT03125915|11307766|FG001|6 Month Follow-up|Lost to Follow-up|3
7147428|NCT03125915|11307767|FG002|6 Month Follow-up|Lost to Follow-up|6
7147429|NCT03125915|11307768|FG003|6 Month Follow-up|Lost to Follow-up|3
7147430|NCT03125941|11307780|FG000|Overall Study|did not receive intervention|1
7147431|NCT03125941|11307781|FG001|Overall Study|did not receive intervention|2
7147432|NCT03126227|11307789|FG000|Overall Study|Adverse Event|43
7147433|NCT03126227|11307790|FG001|Overall Study|Adverse Event|4
7147434|NCT03126227|11307789|FG000|Overall Study|Death|0
7147435|NCT03126227|11307790|FG001|Overall Study|Death|1
7147436|NCT03126227|11307789|FG000|Overall Study|Lost to Follow-up|0
7147437|NCT03126227|11307790|FG001|Overall Study|Lost to Follow-up|1
7147438|NCT03126227|11307789|FG000|Overall Study|Physician Decision|2
7147439|NCT03126227|11307790|FG001|Overall Study|Physician Decision|0
7147440|NCT03126227|11307789|FG000|Overall Study|Protocol Violation|1
7147441|NCT03126227|11307790|FG001|Overall Study|Protocol Violation|0
7147442|NCT03126227|11307789|FG000|Overall Study|Withdrawal by Subject|19
7147443|NCT03126227|11307790|FG001|Overall Study|Withdrawal by Subject|3
7147444|NCT03126227|11307789|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8
7147445|NCT03126227|11307790|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1
7147446|NCT03126227|11307789|FG000|Overall Study|Lack of dosing compliance|2
7147447|NCT03126227|11307790|FG001|Overall Study|Lack of dosing compliance|0
7147448|NCT03126227|11307789|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2
7147449|NCT03126227|11307790|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0
7147450|NCT03126227|11307789|FG000|Overall Study|Scheduling conflict|1
7147451|NCT03126227|11307790|FG001|Overall Study|Scheduling conflict|0
7147452|NCT03126344|11307799|FG000|Overall Study|Lost to Follow-up|0
7147453|NCT03126344|11307800|FG001|Overall Study|Lost to Follow-up|0
7147454|NCT03126344|11307801|FG002|Overall Study|Lost to Follow-up|5
7061518|NCT01929109|11158524|FG002|Period 1 (All Groups)|Deviation from protocol|1
7147460|NCT03126786|11307869|FG000|Overall Study|Adverse Event|3
7147461|NCT03126786|11307870|FG001|Overall Study|Adverse Event|0
7147462|NCT03126786|11307869|FG000|Overall Study|Lost to Follow-up|0
7147463|NCT03126786|11307870|FG001|Overall Study|Lost to Follow-up|1
7147464|NCT03126786|11307869|FG000|Overall Study|Withdrawal by Subject|3
7147465|NCT03126786|11307870|FG001|Overall Study|Withdrawal by Subject|1
7147466|NCT03127384|11307904|FG000|Overall Study|Lost to Follow-up|4
7147467|NCT03127384|11307904|FG000|Overall Study|Subject request|2
7147468|NCT03127644|11307922|FG000|Overall Study|Study-specific withdrawal criteria|0
7147469|NCT03127644|11307923|FG001|Overall Study|Study-specific withdrawal criteria|0
7147470|NCT03127644|11307924|FG002|Overall Study|Study-specific withdrawal criteria|2
7147471|NCT03128099|11307962|FG000|Overall Study|High dose task was too long|0
7147472|NCT03128099|11307963|FG001|Overall Study|High dose task was too long|4
7147473|NCT03128099|11307964|FG002|Overall Study|High dose task was too long|0
7147474|NCT03128099|11307962|FG000|Overall Study|Participant got a full time job.|1
7147475|NCT03128099|11307963|FG001|Overall Study|Participant got a full time job.|0
7147476|NCT03128099|11307964|FG002|Overall Study|Participant got a full time job.|0
7147477|NCT03128099|11307962|FG000|Overall Study|Became homeless and lost contact|1
7147478|NCT03128099|11307963|FG001|Overall Study|Became homeless and lost contact|0
7147479|NCT03128099|11307964|FG002|Overall Study|Became homeless and lost contact|0
7147480|NCT03128099|11307962|FG000|Overall Study|Did not complete all the assessments|0
7147481|NCT03128099|11307963|FG001|Overall Study|Did not complete all the assessments|0
7147482|NCT03128099|11307964|FG002|Overall Study|Did not complete all the assessments|1
7147483|NCT03128307|11307970|FG000|Overall Study|Lost to Follow-up|29
7147484|NCT03128307|11307970|FG000|Overall Study|Withdrawal by Subject|5
7147485|NCT03128723|11307978|FG000|Overall Study|Withdrawal by Subject|2
7147486|NCT03128892|11307982|FG000|Overall Study|Withdrawal by Subject|2
7147487|NCT03128892|11307982|FG000|Overall Study|Physician Decision|1
7147488|NCT03130257|11308012|FG000|Overall Study|Withdrawal by Subject|1
7147489|NCT03130257|11308013|FG001|Overall Study|Withdrawal by Subject|0
6923328|NCT00818259|10952405|FG003|Part I|Withdrawal by Subject|0
6923329|NCT00818259|10952406|FG004|Part I|Withdrawal by Subject|0
6923330|NCT00818259|10952407|FG005|Part I|Withdrawal by Subject|0
6923331|NCT00818259|10952408|FG006|Part I|Withdrawal by Subject|0
6923332|NCT00818259|10952409|FG007|Part I|Withdrawal by Subject|0
6923333|NCT00818259|10952410|FG008|Part I|Withdrawal by Subject|0
6923334|NCT00818259|10952402|FG000|Part II|Physician Decision|0
6923335|NCT00818259|10952403|FG001|Part II|Physician Decision|0
6923336|NCT00818259|10952404|FG002|Part II|Physician Decision|1
6923337|NCT00818259|10952405|FG003|Part II|Physician Decision|0
6923338|NCT00818259|10952406|FG004|Part II|Physician Decision|0
6923339|NCT00818259|10952407|FG005|Part II|Physician Decision|0
6923340|NCT00818259|10952408|FG006|Part II|Physician Decision|0
6923341|NCT00818259|10952409|FG007|Part II|Physician Decision|0
6923342|NCT00818259|10952410|FG008|Part II|Physician Decision|0
6923343|NCT00818259|10952402|FG000|Part II|Lack of Efficacy|0
6923344|NCT00818259|10952403|FG001|Part II|Lack of Efficacy|0
6923345|NCT00818259|10952404|FG002|Part II|Lack of Efficacy|0
6923346|NCT00818259|10952405|FG003|Part II|Lack of Efficacy|1
6923347|NCT00818259|10952406|FG004|Part II|Lack of Efficacy|0
6923348|NCT00818259|10952407|FG005|Part II|Lack of Efficacy|0
6923349|NCT00818259|10952408|FG006|Part II|Lack of Efficacy|0
6923350|NCT00818259|10952409|FG007|Part II|Lack of Efficacy|0
6923351|NCT00818259|10952410|FG008|Part II|Lack of Efficacy|0
6923352|NCT00818259|10952402|FG000|Part II|Not Treated|0
6923353|NCT00818259|10952403|FG001|Part II|Not Treated|0
6923354|NCT00818259|10952404|FG002|Part II|Not Treated|0
6923355|NCT00818259|10952405|FG003|Part II|Not Treated|1
6923356|NCT00818259|10952406|FG004|Part II|Not Treated|0
6923357|NCT00818259|10952407|FG005|Part II|Not Treated|0
6923358|NCT00818259|10952408|FG006|Part II|Not Treated|0
6923359|NCT00818259|10952409|FG007|Part II|Not Treated|0
6923360|NCT00818259|10952410|FG008|Part II|Not Treated|0
6923361|NCT00818259|10952402|FG000|Part IV|Physician Decision|0
6923362|NCT00818259|10952403|FG001|Part IV|Physician Decision|0
6923363|NCT00818259|10952404|FG002|Part IV|Physician Decision|0
6923364|NCT00818259|10952405|FG003|Part IV|Physician Decision|0
6923365|NCT00818259|10952406|FG004|Part IV|Physician Decision|0
6923366|NCT00818259|10952407|FG005|Part IV|Physician Decision|1
6923367|NCT00818259|10952408|FG006|Part IV|Physician Decision|0
6923368|NCT00818259|10952409|FG007|Part IV|Physician Decision|0
6923369|NCT00818259|10952410|FG008|Part IV|Physician Decision|0
6923370|NCT00818259|10952402|FG000|Part V|Adverse Event|0
6923371|NCT00818259|10952403|FG001|Part V|Adverse Event|0
7147490|NCT03130257|11308014|FG002|Overall Study|Withdrawal by Subject|2
7147491|NCT03131167|11308048|FG000|Overall Study|Other (Unspecified)|0
7147492|NCT03131167|11308049|FG001|Overall Study|Other (Unspecified)|0
7147493|NCT03131167|11308050|FG002|Overall Study|Other (Unspecified)|0
7147494|NCT03131167|11308051|FG003|Overall Study|Other (Unspecified)|0
7147495|NCT03131167|11308052|FG004|Overall Study|Other (Unspecified)|0
7147496|NCT03131167|11308053|FG005|Overall Study|Other (Unspecified)|1
7147497|NCT03131167|11308054|FG006|Overall Study|Other (Unspecified)|0
7147498|NCT03131167|11308055|FG007|Overall Study|Other (Unspecified)|0
7147499|NCT03131167|11308056|FG008|Overall Study|Other (Unspecified)|0
7147500|NCT03131167|11308057|FG009|Overall Study|Other (Unspecified)|0
7147501|NCT03131167|11308058|FG010|Overall Study|Other (Unspecified)|0
7147502|NCT03131167|11308059|FG011|Overall Study|Other (Unspecified)|0
7147503|NCT03131167|11308060|FG012|Overall Study|Other (Unspecified)|0
7147504|NCT03131453|11308113|FG000|Overall Study|Study terminated by Sponsor|424
7147505|NCT03131453|11308114|FG001|Overall Study|Study terminated by Sponsor|222
7147506|NCT03131453|11308115|FG002|Overall Study|Study terminated by Sponsor|438
7147507|NCT03131453|11308113|FG000|Overall Study|Withdrawal by Subject|18
7147508|NCT03131453|11308114|FG001|Overall Study|Withdrawal by Subject|7
7147509|NCT03131453|11308115|FG002|Overall Study|Withdrawal by Subject|13
7147510|NCT03131453|11308113|FG000|Overall Study|Adverse Event|10
7147511|NCT03131453|11308114|FG001|Overall Study|Adverse Event|3
7147512|NCT03131453|11308115|FG002|Overall Study|Adverse Event|3
7147513|NCT03131453|11308113|FG000|Overall Study|Lost to Follow-up|1
7147514|NCT03131453|11308114|FG001|Overall Study|Lost to Follow-up|0
6923372|NCT00818259|10952404|FG002|Part V|Adverse Event|0
6923373|NCT00818259|10952405|FG003|Part V|Adverse Event|0
6923374|NCT00818259|10952406|FG004|Part V|Adverse Event|0
6923375|NCT00818259|10952407|FG005|Part V|Adverse Event|0
6923376|NCT00818259|10952408|FG006|Part V|Adverse Event|0
6923377|NCT00818259|10952409|FG007|Part V|Adverse Event|1
6923378|NCT00818259|10952410|FG008|Part V|Adverse Event|0
7147515|NCT03131453|11308115|FG002|Overall Study|Lost to Follow-up|1
7147516|NCT03131453|11308113|FG000|Overall Study|Physician Decision|1
7147517|NCT03131453|11308114|FG001|Overall Study|Physician Decision|0
7147518|NCT03131453|11308115|FG002|Overall Study|Physician Decision|1
7147519|NCT03131453|11308113|FG000|Overall Study|Non-compliance with study treatment|1
7147520|NCT03131453|11308114|FG001|Overall Study|Non-compliance with study treatment|0
7147521|NCT03131453|11308115|FG002|Overall Study|Non-compliance with study treatment|0
7147522|NCT03131453|11308113|FG000|Overall Study|Technical problems|1
7147523|NCT03131453|11308114|FG001|Overall Study|Technical problems|0
7147524|NCT03131453|11308115|FG002|Overall Study|Technical problems|0
7147525|NCT03131453|11308113|FG000|Overall Study|Protocol deviation|0
7147526|NCT03131453|11308114|FG001|Overall Study|Protocol deviation|1
7147527|NCT03131453|11308115|FG002|Overall Study|Protocol deviation|0
7147528|NCT03131479|11308128|FG000|Overall Study|Adverse Event|0
7147529|NCT03131479|11308129|FG001|Overall Study|Adverse Event|0
7147530|NCT03131479|11308130|FG002|Overall Study|Adverse Event|1
7147531|NCT03131479|11308131|FG003|Overall Study|Adverse Event|1
7147532|NCT03131479|11308132|FG004|Overall Study|Adverse Event|0
7147533|NCT03131479|11308128|FG000|Overall Study|Subject/Guardian Decision|0
7147534|NCT03131479|11308129|FG001|Overall Study|Subject/Guardian Decision|0
7147535|NCT03131479|11308130|FG002|Overall Study|Subject/Guardian Decision|0
7147536|NCT03131479|11308131|FG003|Overall Study|Subject/Guardian Decision|1
7147537|NCT03131479|11308132|FG004|Overall Study|Subject/Guardian Decision|0
7147538|NCT03131570|11308146|FG000|Overall Study|Adverse Event|1
7147539|NCT03131570|11308147|FG001|Overall Study|Adverse Event|0
7147540|NCT03131596|11308155|FG000|Overall Study|Protocol Violation|3
6923379|NCT00818389|10952450|FG000|Overall Study|Death|1
6923380|NCT00818389|10952451|FG001|Overall Study|Death|3
6923381|NCT00818389|10952450|FG000|Overall Study|ALS Disease Progression|1
6923382|NCT00818389|10952451|FG001|Overall Study|ALS Disease Progression|0
6923383|NCT00818389|10952450|FG000|Overall Study|Withdrawal by Subject|2
6923384|NCT00818389|10952451|FG001|Overall Study|Withdrawal by Subject|2
6923385|NCT00818389|10952450|FG000|Overall Study|Adverse Event|0
6923386|NCT00818389|10952451|FG001|Overall Study|Adverse Event|1
6923387|NCT00818441|10952459|FG000|Overall Study|Death|69
6923388|NCT00818441|10952460|FG001|Overall Study|Death|26
6923389|NCT00818441|10952459|FG000|Overall Study|Other|5
6923390|NCT00818441|10952460|FG001|Overall Study|Other|0
6923391|NCT00818441|10952459|FG000|Overall Study|Lost to Follow-up|2
6923392|NCT00818441|10952460|FG001|Overall Study|Lost to Follow-up|1
6923393|NCT00818441|10952459|FG000|Overall Study|Withdrawal by Subject|2
6923394|NCT00818441|10952460|FG001|Overall Study|Withdrawal by Subject|0
6923395|NCT00818441|10952459|FG000|Overall Study|Adverse Event|0
6923396|NCT00818441|10952460|FG001|Overall Study|Adverse Event|1
6923397|NCT00818441|10952459|FG000|Overall Study|Study terminated by sponsor|11
6923398|NCT00818441|10952460|FG001|Overall Study|Study terminated by sponsor|2
6923399|NCT00818454|10952467|FG000|Treatment Period 1|Adverse Event|0
6923400|NCT00818454|10952468|FG001|Treatment Period 1|Adverse Event|1
6923401|NCT00818454|10952469|FG002|Treatment Period 1|Adverse Event|0
6923402|NCT00818454|10952470|FG003|Treatment Period 1|Adverse Event|0
6923403|NCT00818454|10952467|FG000|Treatment Period 1|Other|3
6923404|NCT00818454|10952468|FG001|Treatment Period 1|Other|0
6923405|NCT00818454|10952469|FG002|Treatment Period 1|Other|0
6923406|NCT00818454|10952470|FG003|Treatment Period 1|Other|0
6923407|NCT00818454|10952467|FG000|Washout Period of 1 Week|Adverse Event|1
6923408|NCT00818454|10952468|FG001|Washout Period of 1 Week|Adverse Event|1
6923409|NCT00818454|10952469|FG002|Washout Period of 1 Week|Adverse Event|0
6923410|NCT00818454|10952470|FG003|Washout Period of 1 Week|Adverse Event|0
6923411|NCT00818454|10952467|FG000|Washout Period of 1 Week|Protocol Violation|2
6923412|NCT00818454|10952468|FG001|Washout Period of 1 Week|Protocol Violation|0
6923413|NCT00818454|10952469|FG002|Washout Period of 1 Week|Protocol Violation|0
6923414|NCT00818454|10952470|FG003|Washout Period of 1 Week|Protocol Violation|0
7147541|NCT03131596|11308156|FG001|Overall Study|Protocol Violation|3
7147542|NCT03131596|11308155|FG000|Overall Study|Lost to Follow-up|3
7147543|NCT03131596|11308156|FG001|Overall Study|Lost to Follow-up|0
7147544|NCT03131648|11308164|FG000|Initial Treatment Period|Not dosed|2
7147545|NCT03131648|11308165|FG001|Initial Treatment Period|Not dosed|2
7147546|NCT03131648|11308166|FG002|Initial Treatment Period|Not dosed|0
7147547|NCT03131648|11308167|FG003|Initial Treatment Period|Not dosed|0
7147548|NCT03131648|11308168|FG004|Initial Treatment Period|Not dosed|0
7147549|NCT03131648|11308169|FG005|Initial Treatment Period|Not dosed|0
7147550|NCT03131648|11308170|FG006|Initial Treatment Period|Not dosed|0
7147551|NCT03131648|11308171|FG007|Initial Treatment Period|Not dosed|0
7147552|NCT03131648|11308164|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51
7147553|NCT03131648|11308165|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18
7147554|NCT03131648|11308166|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0
7147555|NCT03131648|11308167|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0
7147556|NCT03131648|11308168|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0
7147557|NCT03131648|11308169|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0
7147558|NCT03131648|11308170|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0
7061519|NCT01929109|11158525|FG003|Period 1 (All Groups)|Deviation from protocol|0
7061520|NCT01929109|11158526|FG004|Period 1 (All Groups)|Deviation from protocol|0
7082223|NCT02139644|11192566|FG004|Treatment Period|Disease progression|1
7082224|NCT02139644|11192567|FG005|Treatment Period|Disease progression|2
7082225|NCT02139644|11192562|FG000|Treatment Period|Lost to Follow-up|0
7082226|NCT02139644|11192563|FG001|Treatment Period|Lost to Follow-up|0
7082227|NCT02139644|11192564|FG002|Treatment Period|Lost to Follow-up|1
7082228|NCT02139644|11192565|FG003|Treatment Period|Lost to Follow-up|1
7082229|NCT02139644|11192566|FG004|Treatment Period|Lost to Follow-up|1
7082230|NCT02139644|11192567|FG005|Treatment Period|Lost to Follow-up|1
7082231|NCT02139644|11192562|FG000|Treatment Period|Lack of Efficacy|0
7082232|NCT02139644|11192563|FG001|Treatment Period|Lack of Efficacy|0
7082233|NCT02139644|11192564|FG002|Treatment Period|Lack of Efficacy|1
7082234|NCT02139644|11192565|FG003|Treatment Period|Lack of Efficacy|0
7082235|NCT02139644|11192566|FG004|Treatment Period|Lack of Efficacy|1
7082236|NCT02139644|11192567|FG005|Treatment Period|Lack of Efficacy|4
7082237|NCT02139644|11192562|FG000|Treatment Period|Other|0
7082238|NCT02139644|11192563|FG001|Treatment Period|Other|3
7082239|NCT02139644|11192564|FG002|Treatment Period|Other|1
7082240|NCT02139644|11192565|FG003|Treatment Period|Other|1
7082241|NCT02139644|11192566|FG004|Treatment Period|Other|0
7082242|NCT02139644|11192567|FG005|Treatment Period|Other|1
7082243|NCT02139826|11192588|FG000|Overall Study|Adverse Event|1
7082244|NCT02139943|11192608|FG000|Overall Study|Adverse Event|0
7082245|NCT02139943|11192609|FG001|Overall Study|Adverse Event|1
7082246|NCT02139943|11192610|FG002|Overall Study|Adverse Event|2
7082247|NCT02139943|11192608|FG000|Overall Study|Lost to Follow-up|3
7082248|NCT02139943|11192609|FG001|Overall Study|Lost to Follow-up|2
7082249|NCT02139943|11192610|FG002|Overall Study|Lost to Follow-up|2
7082250|NCT02139943|11192608|FG000|Overall Study|Withdrawal by Subject|4
7082251|NCT02139943|11192609|FG001|Overall Study|Withdrawal by Subject|3
7082252|NCT02139943|11192610|FG002|Overall Study|Withdrawal by Subject|0
7082253|NCT02139943|11192608|FG000|Overall Study|Other|0
7082254|NCT02139943|11192609|FG001|Overall Study|Other|0
7082255|NCT02139943|11192610|FG002|Overall Study|Other|1
7082256|NCT02139943|11192608|FG000|Overall Study|Participant wishes to discontinue|2
7082257|NCT02139943|11192609|FG001|Overall Study|Participant wishes to discontinue|0
7082258|NCT02139943|11192610|FG002|Overall Study|Participant wishes to discontinue|0
7082259|NCT02139943|11192608|FG000|Overall Study|Participant in Poor Compliance|1
7082260|NCT02139943|11192609|FG001|Overall Study|Participant in Poor Compliance|0
7082261|NCT02139943|11192610|FG002|Overall Study|Participant in Poor Compliance|1
7082262|NCT02139943|11192608|FG000|Overall Study|eGFR Withdrawal Criteria|0
7082263|NCT02139943|11192609|FG001|Overall Study|eGFR Withdrawal Criteria|0
7082264|NCT02139943|11192610|FG002|Overall Study|eGFR Withdrawal Criteria|1
7082265|NCT02139982|11192632|FG000|Overall Study|Lack of Efficacy|0
7082266|NCT02139982|11192633|FG001|Overall Study|Lack of Efficacy|1
7082267|NCT02139982|11192634|FG002|Overall Study|Lack of Efficacy|0
7082268|NCT02139982|11192635|FG003|Overall Study|Lack of Efficacy|1
7082269|NCT02139982|11192636|FG004|Overall Study|Lack of Efficacy|0
7082270|NCT02139982|11192637|FG005|Overall Study|Lack of Efficacy|0
7082271|NCT02139982|11192638|FG006|Overall Study|Lack of Efficacy|0
7082272|NCT02139982|11192639|FG007|Overall Study|Lack of Efficacy|0
7082273|NCT02139982|11192640|FG008|Overall Study|Lack of Efficacy|0
7082274|NCT02139982|11192641|FG009|Overall Study|Lack of Efficacy|0
7082275|NCT02140060|11192669|FG000|Overall Study|Adverse Event|0
7082276|NCT02140060|11192670|FG001|Overall Study|Adverse Event|0
7082277|NCT02140060|11192671|FG002|Overall Study|Adverse Event|0
7082278|NCT02140060|11192672|FG003|Overall Study|Adverse Event|1
7082279|NCT02140060|11192673|FG004|Overall Study|Adverse Event|1
7082280|NCT02140060|11192674|FG005|Overall Study|Adverse Event|1
7082281|NCT02140060|11192669|FG000|Overall Study|Lack of Efficacy|0
7183758|NCT01254422|11383828|FG001|Overall Study|Protocol Violation|0
7082282|NCT02140060|11192670|FG001|Overall Study|Lack of Efficacy|0
7082283|NCT02140060|11192671|FG002|Overall Study|Lack of Efficacy|0
7082284|NCT02140060|11192672|FG003|Overall Study|Lack of Efficacy|1
7082285|NCT02140060|11192673|FG004|Overall Study|Lack of Efficacy|0
7082286|NCT02140060|11192674|FG005|Overall Study|Lack of Efficacy|0
7061521|NCT01929135|11158543|FG000|Overall Study|Lost to Follow-up|1
7061522|NCT01929135|11158544|FG001|Overall Study|Lost to Follow-up|1
7061523|NCT01929226|11158554|FG000|Overall Study|Lost to Follow-up|4
7061524|NCT01929226|11158555|FG001|Overall Study|Lost to Follow-up|0
7061525|NCT01929226|11158554|FG000|Overall Study|Withdrawal by Subject|1
7061526|NCT01929226|11158555|FG001|Overall Study|Withdrawal by Subject|1
7061527|NCT01929317|11158568|FG000|Dose Increase Effect Verification Phase|Adverse Event|5
7061528|NCT01929317|11158569|FG001|Dose Increase Effect Verification Phase|Adverse Event|1
7061529|NCT01929317|11158568|FG000|Dose Increase Effect Verification Phase|Physician Decision|1
7061530|NCT01929317|11158569|FG001|Dose Increase Effect Verification Phase|Physician Decision|0
7061531|NCT01929317|11158568|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3
7061532|NCT01929317|11158569|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0
7061533|NCT01929317|11158568|FG000|Long-term Phase|Adverse Event|5
7061534|NCT01929317|11158569|FG001|Long-term Phase|Adverse Event|1
7061535|NCT01929317|11158568|FG000|Long-term Phase|Physician Decision|3
7061536|NCT01929317|11158569|FG001|Long-term Phase|Physician Decision|0
7061537|NCT01929317|11158568|FG000|Long-term Phase|Withdrawal by Subject|4
7061538|NCT01929317|11158569|FG001|Long-term Phase|Withdrawal by Subject|0
7061539|NCT01929317|11158568|FG000|Long-term Phase|Protocol Violation|1
7061540|NCT01929317|11158569|FG001|Long-term Phase|Protocol Violation|0
7061541|NCT01929317|11158568|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1
7061542|NCT01929317|11158569|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0
7061543|NCT01929317|11158568|FG000|Long-term Phase|Study Closed/Terminated|5
7061544|NCT01929317|11158569|FG001|Long-term Phase|Study Closed/Terminated|3
7061545|NCT01929343|11158584|FG000|Overall Study|Physician Decision|0
7061546|NCT01929343|11158585|FG001|Overall Study|Physician Decision|2
7147559|NCT03131648|11308171|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0
7147560|NCT03131648|11308164|FG000|Open-label Treatment|Discontinued IMP|0
7147561|NCT03131648|11308165|FG001|Open-label Treatment|Discontinued IMP|0
7147562|NCT03131648|11308166|FG002|Open-label Treatment|Discontinued IMP|0
7147563|NCT03131648|11308167|FG003|Open-label Treatment|Discontinued IMP|0
7147564|NCT03131648|11308168|FG004|Open-label Treatment|Discontinued IMP|0
7147565|NCT03131648|11308169|FG005|Open-label Treatment|Discontinued IMP|0
7147566|NCT03131648|11308170|FG006|Open-label Treatment|Discontinued IMP|112
7147567|NCT03131648|11308171|FG007|Open-label Treatment|Discontinued IMP|0
7147568|NCT03131648|11308164|FG000|Open-label Treatment|Completed Week 50|0
7147569|NCT03131648|11308165|FG001|Open-label Treatment|Completed Week 50|0
7147570|NCT03131648|11308166|FG002|Open-label Treatment|Completed Week 50|0
7147571|NCT03131648|11308167|FG003|Open-label Treatment|Completed Week 50|0
7147572|NCT03131648|11308168|FG004|Open-label Treatment|Completed Week 50|0
7147573|NCT03131648|11308169|FG005|Open-label Treatment|Completed Week 50|0
7147574|NCT03131648|11308170|FG006|Open-label Treatment|Completed Week 50|6
7147575|NCT03131648|11308171|FG007|Open-label Treatment|Completed Week 50|0
7147576|NCT03131648|11308164|FG000|Maintenance Treatment Period|Not dosed|0
7147577|NCT03131648|11308165|FG001|Maintenance Treatment Period|Not dosed|0
7147578|NCT03131648|11308166|FG002|Maintenance Treatment Period|Not dosed|3
7147579|NCT03131648|11308167|FG003|Maintenance Treatment Period|Not dosed|2
7147580|NCT03131648|11308168|FG004|Maintenance Treatment Period|Not dosed|1
7147581|NCT03131648|11308169|FG005|Maintenance Treatment Period|Not dosed|0
7147582|NCT03131648|11308170|FG006|Maintenance Treatment Period|Not dosed|0
7147583|NCT03131648|11308171|FG007|Maintenance Treatment Period|Not dosed|0
7147584|NCT03131648|11308164|FG000|Maintenance Treatment Period|Discontinued IMP|0
7147585|NCT03131648|11308165|FG001|Maintenance Treatment Period|Discontinued IMP|0
7147586|NCT03131648|11308166|FG002|Maintenance Treatment Period|Discontinued IMP|3
7147587|NCT03131648|11308167|FG003|Maintenance Treatment Period|Discontinued IMP|5
7147588|NCT03131648|11308168|FG004|Maintenance Treatment Period|Discontinued IMP|4
7147589|NCT03131648|11308169|FG005|Maintenance Treatment Period|Discontinued IMP|4
7147590|NCT03131648|11308170|FG006|Maintenance Treatment Period|Discontinued IMP|0
7147591|NCT03131648|11308171|FG007|Maintenance Treatment Period|Discontinued IMP|0
7147592|NCT03131648|11308164|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0
7147593|NCT03131648|11308165|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0
7147594|NCT03131648|11308166|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21
7147595|NCT03131648|11308167|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18
7147596|NCT03131648|11308168|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9
7147597|NCT03131648|11308169|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10
7147598|NCT03131648|11308170|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0
7147599|NCT03131648|11308171|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0
7147600|NCT03131648|11308164|FG000|Maintenance Treatment Period|Completed Week 50|0
7147601|NCT03131648|11308165|FG001|Maintenance Treatment Period|Completed Week 50|0
7147602|NCT03131648|11308166|FG002|Maintenance Treatment Period|Completed Week 50|0
7147603|NCT03131648|11308167|FG003|Maintenance Treatment Period|Completed Week 50|0
7147604|NCT03131648|11308168|FG004|Maintenance Treatment Period|Completed Week 50|1
7147605|NCT03131648|11308169|FG005|Maintenance Treatment Period|Completed Week 50|0
7061547|NCT01929343|11158586|FG002|Overall Study|Physician Decision|0
7061548|NCT01929343|11158584|FG000|Overall Study|Withdrawal by Subject|1
7061549|NCT01929343|11158585|FG001|Overall Study|Withdrawal by Subject|0
7061550|NCT01929343|11158586|FG002|Overall Study|Withdrawal by Subject|0
7147606|NCT03131648|11308170|FG006|Maintenance Treatment Period|Completed Week 50|0
7147607|NCT03131648|11308171|FG007|Maintenance Treatment Period|Completed Week 50|0
7147608|NCT03131648|11308164|FG000|Open-label (Short Term Extension)|Discontinued IMP|0
7147609|NCT03131648|11308165|FG001|Open-label (Short Term Extension)|Discontinued IMP|0
7147610|NCT03131648|11308166|FG002|Open-label (Short Term Extension)|Discontinued IMP|0
7147611|NCT03131648|11308167|FG003|Open-label (Short Term Extension)|Discontinued IMP|0
7147612|NCT03131648|11308168|FG004|Open-label (Short Term Extension)|Discontinued IMP|0
7147613|NCT03131648|11308169|FG005|Open-label (Short Term Extension)|Discontinued IMP|0
7147614|NCT03131648|11308170|FG006|Open-label (Short Term Extension)|Discontinued IMP|0
7147615|NCT03131648|11308171|FG007|Open-label (Short Term Extension)|Discontinued IMP|3
7147616|NCT03131687|11308194|FG000|Overall Study|Adverse Event|0
7147617|NCT03131687|11308195|FG001|Overall Study|Adverse Event|1
7147618|NCT03131687|11308196|FG002|Overall Study|Adverse Event|0
7147619|NCT03131687|11308197|FG003|Overall Study|Adverse Event|1
7147620|NCT03131687|11308198|FG004|Overall Study|Adverse Event|2
7147621|NCT03131687|11308199|FG005|Overall Study|Adverse Event|2
7147622|NCT03131687|11308194|FG000|Overall Study|Death|1
7147623|NCT03131687|11308195|FG001|Overall Study|Death|0
7147624|NCT03131687|11308196|FG002|Overall Study|Death|0
7147625|NCT03131687|11308197|FG003|Overall Study|Death|0
7147626|NCT03131687|11308198|FG004|Overall Study|Death|0
7147627|NCT03131687|11308199|FG005|Overall Study|Death|0
7147628|NCT03131687|11308194|FG000|Overall Study|Withdrawal by Subject|3
7147629|NCT03131687|11308195|FG001|Overall Study|Withdrawal by Subject|3
7147630|NCT03131687|11308196|FG002|Overall Study|Withdrawal by Subject|3
7147631|NCT03131687|11308197|FG003|Overall Study|Withdrawal by Subject|1
7147632|NCT03131687|11308198|FG004|Overall Study|Withdrawal by Subject|2
6827524|NCT00127101|10830380|FG000|Base Protocol|Withdrawal by Subject|1
6827525|NCT00127101|10830381|FG001|Base Protocol|Withdrawal by Subject|2
6827526|NCT00127101|10830382|FG002|Base Protocol|Withdrawal by Subject|1
7061551|NCT01929395|11158597|FG000|Overall Study|Did not complete - non-related toxicity|1
7061552|NCT01929395|11158598|FG001|Overall Study|Did not complete - non-related toxicity|0
7061553|NCT01929395|11158599|FG002|Overall Study|Did not complete - non-related toxicity|0
7061554|NCT01929395|11158597|FG000|Overall Study|Withdrawal by Subject|0
7061555|NCT01929395|11158598|FG001|Overall Study|Withdrawal by Subject|1
7061556|NCT01929395|11158599|FG002|Overall Study|Withdrawal by Subject|0
7061557|NCT01929395|11158597|FG000|Overall Study|Screen Fail|0
7061558|NCT01929395|11158598|FG001|Overall Study|Screen Fail|0
7061559|NCT01929395|11158599|FG002|Overall Study|Screen Fail|1
7061560|NCT01929408|11158607|FG000|Overall Study|received HCT as initial treatment|8
7061561|NCT01929681|11158632|FG000|Overall Study|Withdrawal by Subject|1
7061562|NCT01929681|11158633|FG001|Overall Study|Withdrawal by Subject|0
7061563|NCT01929681|11158632|FG000|Overall Study|Physician Decision|1
7061564|NCT01929681|11158633|FG001|Overall Study|Physician Decision|1
7061565|NCT01929707|11158639|FG000|Intervention Period 1|Lost to Follow-up|0
7061566|NCT01929707|11158640|FG001|Intervention Period 1|Lost to Follow-up|0
7061567|NCT01929707|11158641|FG002|Intervention Period 1|Lost to Follow-up|0
7061568|NCT01929707|11158642|FG003|Intervention Period 1|Lost to Follow-up|1
7061569|NCT01929707|11158643|FG004|Intervention Period 1|Lost to Follow-up|0
7061570|NCT01929707|11158644|FG005|Intervention Period 1|Lost to Follow-up|0
7061571|NCT01929707|11158645|FG006|Intervention Period 1|Lost to Follow-up|0
7061572|NCT01929707|11158646|FG007|Intervention Period 1|Lost to Follow-up|0
7061573|NCT01929707|11158639|FG000|Intervention Period 1|Withdrawal by Subject|0
7061574|NCT01929707|11158640|FG001|Intervention Period 1|Withdrawal by Subject|0
7147633|NCT03131687|11308199|FG005|Overall Study|Withdrawal by Subject|1
7147634|NCT03131687|11308194|FG000|Overall Study|Lost to Follow-up|1
7147635|NCT03131687|11308195|FG001|Overall Study|Lost to Follow-up|4
6827527|NCT00127101|10830383|FG003|Base Protocol|Withdrawal by Subject|0
6827528|NCT00127101|10830384|FG004|Base Protocol|Withdrawal by Subject|0
6827529|NCT00127101|10830385|FG005|Base Protocol|Withdrawal by Subject|1
6827530|NCT00127101|10830380|FG000|Continuation Phase|Adverse Event|0
7038332|NCT01701973|11120538|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0
7038333|NCT01701973|11120539|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1
7038334|NCT01701973|11120540|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0
6827531|NCT00127101|10830381|FG001|Continuation Phase|Adverse Event|0
6827532|NCT00127101|10830382|FG002|Continuation Phase|Adverse Event|0
6827533|NCT00127101|10830383|FG003|Continuation Phase|Adverse Event|0
6827534|NCT00127101|10830384|FG004|Continuation Phase|Adverse Event|1
6827535|NCT00127101|10830385|FG005|Continuation Phase|Adverse Event|1
6827536|NCT00127101|10830380|FG000|Continuation Phase|Lack of Efficacy|0
6827537|NCT00127101|10830381|FG001|Continuation Phase|Lack of Efficacy|0
6827538|NCT00127101|10830382|FG002|Continuation Phase|Lack of Efficacy|0
7038335|NCT01701973|11120541|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0
7038336|NCT01701973|11120542|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0
7038337|NCT01701973|11120543|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0
7038338|NCT01701973|11120544|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0
7038339|NCT01701973|11120545|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0
7038340|NCT01702025|11120598|FG000|Overall Study|Equipment failure|1
7038341|NCT01702025|11120599|FG001|Overall Study|Equipment failure|0
7038342|NCT01702025|11120600|FG002|Overall Study|Equipment failure|0
7038343|NCT01702025|11120601|FG003|Overall Study|Equipment failure|0
7061575|NCT01929707|11158641|FG002|Intervention Period 1|Withdrawal by Subject|0
7061576|NCT01929707|11158642|FG003|Intervention Period 1|Withdrawal by Subject|2
7061577|NCT01929707|11158643|FG004|Intervention Period 1|Withdrawal by Subject|0
7061578|NCT01929707|11158644|FG005|Intervention Period 1|Withdrawal by Subject|0
7061579|NCT01929707|11158645|FG006|Intervention Period 1|Withdrawal by Subject|0
7061580|NCT01929707|11158646|FG007|Intervention Period 1|Withdrawal by Subject|0
7061581|NCT01929707|11158639|FG000|Intervention Period 2|Withdrawal by Subject|0
7061582|NCT01929707|11158640|FG001|Intervention Period 2|Withdrawal by Subject|0
7061583|NCT01929707|11158641|FG002|Intervention Period 2|Withdrawal by Subject|0
7061584|NCT01929707|11158642|FG003|Intervention Period 2|Withdrawal by Subject|0
7061585|NCT01929707|11158643|FG004|Intervention Period 2|Withdrawal by Subject|0
7147636|NCT03131687|11308196|FG002|Overall Study|Lost to Follow-up|0
6923415|NCT00818454|10952467|FG000|Washout Period of 1 Week|Other|1
6923416|NCT00818454|10952468|FG001|Washout Period of 1 Week|Other|2
6923417|NCT00818454|10952469|FG002|Washout Period of 1 Week|Other|0
6923418|NCT00818454|10952470|FG003|Washout Period of 1 Week|Other|0
6923419|NCT00818454|10952467|FG000|Treatment Period 2|Other|2
6923420|NCT00818454|10952468|FG001|Treatment Period 2|Other|1
6923421|NCT00818454|10952469|FG002|Treatment Period 2|Other|0
6923422|NCT00818454|10952470|FG003|Treatment Period 2|Other|0
6923423|NCT00818454|10952467|FG000|Treatment Period 3|Adverse Event|0
6923424|NCT00818454|10952468|FG001|Treatment Period 3|Adverse Event|0
6923425|NCT00818454|10952469|FG002|Treatment Period 3|Adverse Event|0
6923426|NCT00818454|10952470|FG003|Treatment Period 3|Adverse Event|1
6923427|NCT00818519|10952482|FG000|Overall Study|Adverse Event|2
6923428|NCT00818519|10952483|FG001|Overall Study|Adverse Event|2
6923429|NCT00818519|10952482|FG000|Overall Study|Lost to Follow-up|4
6923430|NCT00818519|10952483|FG001|Overall Study|Lost to Follow-up|6
6923431|NCT00818519|10952482|FG000|Overall Study|Protocol Violation|2
6923432|NCT00818519|10952483|FG001|Overall Study|Protocol Violation|1
6923433|NCT00818519|10952482|FG000|Overall Study|Pregnancy|0
6923434|NCT00818519|10952483|FG001|Overall Study|Pregnancy|1
6923435|NCT00818519|10952482|FG000|Overall Study|Withdrawal by Subject|4
6923436|NCT00818519|10952483|FG001|Overall Study|Withdrawal by Subject|9
6923437|NCT00818519|10952482|FG000|Overall Study|participant recovered completely|1
6923438|NCT00818519|10952483|FG001|Overall Study|participant recovered completely|0
6923439|NCT00818519|10952482|FG000|Overall Study|participant will leave for long tme|1
6923440|NCT00818519|10952483|FG001|Overall Study|participant will leave for long tme|0
6923441|NCT00818623|10952497|FG000|Overall Study|Adverse Event|1
6923442|NCT00818623|10952498|FG001|Overall Study|Adverse Event|0
6923443|NCT00818623|10952499|FG002|Overall Study|Adverse Event|1
6923444|NCT00818623|10952500|FG003|Overall Study|Adverse Event|0
6923445|NCT00818623|10952501|FG004|Overall Study|Adverse Event|0
6923446|NCT00818623|10952502|FG005|Overall Study|Adverse Event|1
6923447|NCT00818623|10952503|FG006|Overall Study|Adverse Event|0
6923448|NCT00818623|10952504|FG007|Overall Study|Adverse Event|0
6923449|NCT00818623|10952497|FG000|Overall Study|Bad prostate specific antigen response|0
6923450|NCT00818623|10952498|FG001|Overall Study|Bad prostate specific antigen response|3
6923451|NCT00818623|10952499|FG002|Overall Study|Bad prostate specific antigen response|2
6923452|NCT00818623|10952500|FG003|Overall Study|Bad prostate specific antigen response|5
6923453|NCT00818623|10952501|FG004|Overall Study|Bad prostate specific antigen response|0
6923454|NCT00818623|10952502|FG005|Overall Study|Bad prostate specific antigen response|1
6923455|NCT00818623|10952503|FG006|Overall Study|Bad prostate specific antigen response|0
6923456|NCT00818623|10952504|FG007|Overall Study|Bad prostate specific antigen response|0
6923457|NCT00818623|10952497|FG000|Overall Study|Withdrawal by Subject|0
6923458|NCT00818623|10952498|FG001|Overall Study|Withdrawal by Subject|1
6923459|NCT00818623|10952499|FG002|Overall Study|Withdrawal by Subject|1
6923460|NCT00818623|10952500|FG003|Overall Study|Withdrawal by Subject|0
6923461|NCT00818623|10952501|FG004|Overall Study|Withdrawal by Subject|0
6923462|NCT00818623|10952502|FG005|Overall Study|Withdrawal by Subject|1
6923463|NCT00818623|10952503|FG006|Overall Study|Withdrawal by Subject|1
6923464|NCT00818623|10952504|FG007|Overall Study|Withdrawal by Subject|1
6923465|NCT00818623|10952497|FG000|Overall Study|Protocol Violation|1
6923466|NCT00818623|10952498|FG001|Overall Study|Protocol Violation|0
6923467|NCT00818623|10952499|FG002|Overall Study|Protocol Violation|0
6923468|NCT00818623|10952500|FG003|Overall Study|Protocol Violation|0
6923469|NCT00818623|10952501|FG004|Overall Study|Protocol Violation|1
6923470|NCT00818623|10952502|FG005|Overall Study|Protocol Violation|0
6923471|NCT00818623|10952503|FG006|Overall Study|Protocol Violation|1
6923472|NCT00818623|10952504|FG007|Overall Study|Protocol Violation|0
6923473|NCT00818623|10952497|FG000|Overall Study|Need of additional treatment|0
6923474|NCT00818623|10952498|FG001|Overall Study|Need of additional treatment|0
6923475|NCT00818623|10952499|FG002|Overall Study|Need of additional treatment|0
6923476|NCT00818623|10952500|FG003|Overall Study|Need of additional treatment|0
6923477|NCT00818623|10952501|FG004|Overall Study|Need of additional treatment|1
6923478|NCT00818623|10952502|FG005|Overall Study|Need of additional treatment|0
6923479|NCT00818623|10952503|FG006|Overall Study|Need of additional treatment|0
6923480|NCT00818623|10952504|FG007|Overall Study|Need of additional treatment|0
6923481|NCT00818623|10952497|FG000|Overall Study|Lack of trial drug at site|0
6923482|NCT00818623|10952498|FG001|Overall Study|Lack of trial drug at site|0
6923483|NCT00818623|10952499|FG002|Overall Study|Lack of trial drug at site|0
7038344|NCT01702025|11120598|FG000|Overall Study|Adverse Event|1
7061586|NCT01929707|11158644|FG005|Intervention Period 2|Withdrawal by Subject|2
6827539|NCT00127101|10830383|FG003|Continuation Phase|Lack of Efficacy|0
6827540|NCT00127101|10830384|FG004|Continuation Phase|Lack of Efficacy|0
6827541|NCT00127101|10830385|FG005|Continuation Phase|Lack of Efficacy|1
6827542|NCT00127101|10830380|FG000|Continuation Phase|Withdrawal by Subject|0
6827543|NCT00127101|10830381|FG001|Continuation Phase|Withdrawal by Subject|0
6827544|NCT00127101|10830382|FG002|Continuation Phase|Withdrawal by Subject|1
6827545|NCT00127101|10830383|FG003|Continuation Phase|Withdrawal by Subject|0
6827546|NCT00127101|10830384|FG004|Continuation Phase|Withdrawal by Subject|2
6827547|NCT00127101|10830385|FG005|Continuation Phase|Withdrawal by Subject|1
6827548|NCT00127166|10830401|FG000|Period I|Protocol Violation|0
6827549|NCT00127166|10830402|FG001|Period I|Protocol Violation|2
6827550|NCT00127166|10830401|FG000|Period I|Withdrawal by Subject|2
6827551|NCT00127166|10830402|FG001|Period I|Withdrawal by Subject|0
6827552|NCT00127166|10830401|FG000|Period I|Patient did not meet inclusion criteria|1
6827553|NCT00127166|10830402|FG001|Period I|Patient did not meet inclusion criteria|0
6827554|NCT00127166|10830401|FG000|Washout Period|Patient did not meet inclusion criteria|0
6827555|NCT00127166|10830402|FG001|Washout Period|Patient did not meet inclusion criteria|1
6827556|NCT00127166|10830401|FG000|Period II|Withdrawal by Subject|2
6827557|NCT00127166|10830402|FG001|Period II|Withdrawal by Subject|0
6827558|NCT00127166|10830401|FG000|Period II|Patient did not perform Visit 6 exercise|1
6827559|NCT00127166|10830402|FG001|Period II|Patient did not perform Visit 6 exercise|0
6827560|NCT00127192|10830413|FG000|Overall Study|Adverse Event|0
6827561|NCT00127192|10830414|FG001|Overall Study|Adverse Event|1
6827562|NCT00127192|10830415|FG002|Overall Study|Adverse Event|1
6827563|NCT00127192|10830416|FG003|Overall Study|Adverse Event|1
6827564|NCT00127192|10830417|FG004|Overall Study|Adverse Event|0
6827565|NCT00127192|10830413|FG000|Overall Study|Lack of Efficacy|2
6827566|NCT00127192|10830414|FG001|Overall Study|Lack of Efficacy|0
6827567|NCT00127192|10830415|FG002|Overall Study|Lack of Efficacy|0
6827568|NCT00127192|10830416|FG003|Overall Study|Lack of Efficacy|0
6827569|NCT00127192|10830417|FG004|Overall Study|Lack of Efficacy|2
6827570|NCT00127192|10830413|FG000|Overall Study|Withdrawal by Subject|0
6827571|NCT00127192|10830414|FG001|Overall Study|Withdrawal by Subject|0
6827572|NCT00127192|10830415|FG002|Overall Study|Withdrawal by Subject|1
6827573|NCT00127192|10830416|FG003|Overall Study|Withdrawal by Subject|0
6827574|NCT00127192|10830417|FG004|Overall Study|Withdrawal by Subject|3
6827575|NCT00127192|10830413|FG000|Overall Study|Adverse event in pre-treatment period|1
6827576|NCT00127192|10830414|FG001|Overall Study|Adverse event in pre-treatment period|0
6827577|NCT00127192|10830415|FG002|Overall Study|Adverse event in pre-treatment period|0
6827578|NCT00127192|10830416|FG003|Overall Study|Adverse event in pre-treatment period|0
6827579|NCT00127192|10830417|FG004|Overall Study|Adverse event in pre-treatment period|0
6827580|NCT00127205|10830432|FG000|Overall Study|Adverse Event|228
6827581|NCT00127205|10830433|FG001|Overall Study|Adverse Event|387
6827582|NCT00127205|10830434|FG002|Overall Study|Adverse Event|273
6827583|NCT00127205|10830432|FG000|Overall Study|Death|8
6827584|NCT00127205|10830433|FG001|Overall Study|Death|6
6827585|NCT00127205|10830434|FG002|Overall Study|Death|5
6827586|NCT00127205|10830432|FG000|Overall Study|Withdrawal by Subject|318
6827587|NCT00127205|10830433|FG001|Overall Study|Withdrawal by Subject|310
6827588|NCT00127205|10830434|FG002|Overall Study|Withdrawal by Subject|172
6827589|NCT00127205|10830432|FG000|Overall Study|Other-non protocol specified|142
6827590|NCT00127205|10830433|FG001|Overall Study|Other-non protocol specified|129
6827591|NCT00127205|10830434|FG002|Overall Study|Other-non protocol specified|77
6827592|NCT00127205|10830432|FG000|Overall Study|Data not reported|6
7061587|NCT01929707|11158645|FG006|Intervention Period 2|Withdrawal by Subject|0
7061588|NCT01929707|11158646|FG007|Intervention Period 2|Withdrawal by Subject|0
7061589|NCT01929863|11158671|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1
7061590|NCT01929863|11158672|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0
7061591|NCT01929863|11158671|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0
6827593|NCT00127205|10830433|FG001|Overall Study|Data not reported|10
6827594|NCT00127205|10830434|FG002|Overall Study|Data not reported|1
6827595|NCT00127205|10830432|FG000|Overall Study|Progression|127
6827596|NCT00127205|10830433|FG001|Overall Study|Progression|131
6827597|NCT00127205|10830434|FG002|Overall Study|Progression|84
6897071|NCT00636441|10915730|FG005|Overall Study|Late, ineligible|0
6897072|NCT00636441|10915731|FG006|Overall Study|Late, ineligible|1
6897073|NCT00636441|10915725|FG000|Overall Study|Screen Failure|0
6897074|NCT00636441|10915726|FG001|Overall Study|Screen Failure|0
6897075|NCT00636441|10915727|FG002|Overall Study|Screen Failure|0
6897076|NCT00636441|10915728|FG003|Overall Study|Screen Failure|0
6897077|NCT00636441|10915729|FG004|Overall Study|Screen Failure|0
6897078|NCT00636441|10915730|FG005|Overall Study|Screen Failure|0
7038345|NCT01702025|11120599|FG001|Overall Study|Adverse Event|1
7038346|NCT01702025|11120600|FG002|Overall Study|Adverse Event|1
7038347|NCT01702025|11120601|FG003|Overall Study|Adverse Event|0
7038348|NCT01702246|11120629|FG000|Overall Study|Lost to Follow-up|2
7038349|NCT01702246|11120629|FG000|Overall Study|Withdrawal by Subject|2
7038350|NCT01702246|11120629|FG000|Overall Study|Physician Decision|1
7038351|NCT01702298|11120645|FG000|Overall Study|Withdrawal by Subject|1
7038352|NCT01702311|11120651|FG000|Overall Study|Withdrawal by Subject|3
6827598|NCT00127413|10830468|FG000|Overall Study|Lost to Follow-up|6
6827599|NCT00127413|10830469|FG001|Overall Study|Lost to Follow-up|4
6827600|NCT00127413|10830470|FG002|Overall Study|Lost to Follow-up|8
6827601|NCT00127413|10830471|FG003|Overall Study|Lost to Follow-up|2
6827602|NCT00127608|10830502|FG000|Overall Study|VZV DNA negative|1
6827603|NCT00127660|10830510|FG000|Overall Study|Protocol Violation|3
6827604|NCT00127660|10830511|FG001|Overall Study|Protocol Violation|3
6827605|NCT00127660|10830512|FG002|Overall Study|Protocol Violation|5
6827606|NCT00127660|10830513|FG003|Overall Study|Protocol Violation|0
6827607|NCT00127712|10830525|FG000|Overall Study|Adverse Event|3
6827608|NCT00127712|10830526|FG001|Overall Study|Adverse Event|0
6827609|NCT00127712|10830525|FG000|Overall Study|Lack of GI access to continue|2
6827610|NCT00127712|10830526|FG001|Overall Study|Lack of GI access to continue|0
6827611|NCT00127803|10830553|FG000|Overall Study|Adverse Event|2
6827612|NCT00127803|10830554|FG001|Overall Study|Adverse Event|0
6827613|NCT00127803|10830555|FG002|Overall Study|Adverse Event|0
6827614|NCT00127803|10830556|FG003|Overall Study|Adverse Event|0
6827615|NCT00127803|10830553|FG000|Overall Study|Withdrawal by Subject|1
6827616|NCT00127803|10830554|FG001|Overall Study|Withdrawal by Subject|0
6827617|NCT00127803|10830555|FG002|Overall Study|Withdrawal by Subject|0
6827618|NCT00127803|10830556|FG003|Overall Study|Withdrawal by Subject|0
6827619|NCT00127803|10830553|FG000|Overall Study|Lost to Follow-up|0
6827620|NCT00127803|10830554|FG001|Overall Study|Lost to Follow-up|0
6827621|NCT00127803|10830555|FG002|Overall Study|Lost to Follow-up|0
6827622|NCT00127803|10830556|FG003|Overall Study|Lost to Follow-up|1
6827623|NCT00127842|10830566|FG000|Overall Study|Adverse Event|15
6827624|NCT00127842|10830566|FG000|Overall Study|Withdrawal by Subject|3
6827625|NCT00127842|10830566|FG000|Overall Study|Lost to Follow-up|1
6827626|NCT00127842|10830566|FG000|Overall Study|Lack of Efficacy|12
6827627|NCT00127842|10830566|FG000|Overall Study|Noncompliance|2
6827628|NCT00127842|10830566|FG000|Overall Study|Protocol Violation|1
6827629|NCT00127842|10830566|FG000|Overall Study|Other|5
6827630|NCT00127855|10830575|FG000|Primary Vaccination Course|Adverse Event|0
6827631|NCT00127855|10830576|FG001|Primary Vaccination Course|Adverse Event|0
6827632|NCT00127855|10830577|FG002|Primary Vaccination Course|Adverse Event|1
6827633|NCT00127855|10830578|FG003|Primary Vaccination Course|Adverse Event|0
6827634|NCT00127855|10830579|FG004|Primary Vaccination Course|Adverse Event|0
6827635|NCT00127855|10830575|FG000|Primary Vaccination Course|Withdrawal by Subject|1
6827636|NCT00127855|10830576|FG001|Primary Vaccination Course|Withdrawal by Subject|0
6827637|NCT00127855|10830577|FG002|Primary Vaccination Course|Withdrawal by Subject|0
6827638|NCT00127855|10830578|FG003|Primary Vaccination Course|Withdrawal by Subject|0
6827639|NCT00127855|10830579|FG004|Primary Vaccination Course|Withdrawal by Subject|1
6827640|NCT00127855|10830575|FG000|Primary Vaccination Course|Lost to Follow-up|1
6827641|NCT00127855|10830576|FG001|Primary Vaccination Course|Lost to Follow-up|1
6827642|NCT00127855|10830577|FG002|Primary Vaccination Course|Lost to Follow-up|1
6827643|NCT00127855|10830578|FG003|Primary Vaccination Course|Lost to Follow-up|0
6827644|NCT00127855|10830579|FG004|Primary Vaccination Course|Lost to Follow-up|2
6827645|NCT00127855|10830575|FG000|Primary Vaccination Course|Other|0
6923484|NCT00818623|10952500|FG003|Overall Study|Lack of trial drug at site|0
6923485|NCT00818623|10952501|FG004|Overall Study|Lack of trial drug at site|2
6923486|NCT00818623|10952502|FG005|Overall Study|Lack of trial drug at site|0
6923487|NCT00818623|10952503|FG006|Overall Study|Lack of trial drug at site|1
6923488|NCT00818623|10952504|FG007|Overall Study|Lack of trial drug at site|0
6923489|NCT00818623|10952497|FG000|Overall Study|Disease progression|0
6923490|NCT00818623|10952498|FG001|Overall Study|Disease progression|0
6923491|NCT00818623|10952499|FG002|Overall Study|Disease progression|0
6923492|NCT00818623|10952500|FG003|Overall Study|Disease progression|0
6923493|NCT00818623|10952501|FG004|Overall Study|Disease progression|0
6923494|NCT00818623|10952502|FG005|Overall Study|Disease progression|0
6923495|NCT00818623|10952503|FG006|Overall Study|Disease progression|1
6923496|NCT00818623|10952504|FG007|Overall Study|Disease progression|0
6923497|NCT00818649|10952522|FG000|Overall Study|Declining performance status|2
6923498|NCT00818649|10952522|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1
6923499|NCT00818649|10952522|FG000|Overall Study|Adverse Event|1
6923500|NCT00818662|10952531|FG000|Overall Study|Adverse Event|5
6923501|NCT00818662|10952532|FG001|Overall Study|Adverse Event|14
6923502|NCT00818662|10952533|FG002|Overall Study|Adverse Event|4
6923503|NCT00818662|10952534|FG003|Overall Study|Adverse Event|3
6923504|NCT00818662|10952531|FG000|Overall Study|Withdrawal by Subject|5
6923505|NCT00818662|10952532|FG001|Overall Study|Withdrawal by Subject|4
6923506|NCT00818662|10952533|FG002|Overall Study|Withdrawal by Subject|2
6923507|NCT00818662|10952534|FG003|Overall Study|Withdrawal by Subject|2
6923508|NCT00818662|10952531|FG000|Overall Study|Death|1
6923509|NCT00818662|10952532|FG001|Overall Study|Death|3
6923510|NCT00818662|10952533|FG002|Overall Study|Death|0
6923511|NCT00818662|10952534|FG003|Overall Study|Death|0
6827646|NCT00127855|10830576|FG001|Primary Vaccination Course|Other|0
6827647|NCT00127855|10830577|FG002|Primary Vaccination Course|Other|0
6827648|NCT00127855|10830578|FG003|Primary Vaccination Course|Other|0
6827649|NCT00127855|10830579|FG004|Primary Vaccination Course|Other|1
6827650|NCT00127933|10830593|FG000|Overall Study|Randomized but not dosed|1
6827651|NCT00127933|10830594|FG001|Overall Study|Randomized but not dosed|0
6827652|NCT00128102|10830602|FG000|Overall Study|Site Discontinued|3
6827653|NCT00128102|10830603|FG001|Overall Study|Site Discontinued|6
6827654|NCT00128102|10830602|FG000|Overall Study|Other|0
6827655|NCT00128102|10830603|FG001|Overall Study|Other|1
6827656|NCT00128102|10830602|FG000|Overall Study|Progressive Disease|255
6827657|NCT00128102|10830603|FG001|Overall Study|Progressive Disease|285
6827658|NCT00128102|10830602|FG000|Overall Study|Adverse Event|34
6827659|NCT00128102|10830603|FG001|Overall Study|Adverse Event|11
6827660|NCT00128102|10830602|FG000|Overall Study|Death|12
6827661|NCT00128102|10830603|FG001|Overall Study|Death|13
6827662|NCT00128102|10830602|FG000|Overall Study|Physician Decision|3
6827663|NCT00128102|10830603|FG001|Overall Study|Physician Decision|3
6827664|NCT00128102|10830602|FG000|Overall Study|Withdrawal by Subject|19
6827665|NCT00128102|10830603|FG001|Overall Study|Withdrawal by Subject|11
6827666|NCT00128102|10830602|FG000|Overall Study|Protocol Violation|2
6827667|NCT00128102|10830603|FG001|Overall Study|Protocol Violation|2
6827668|NCT00128206|10830723|FG000|Overall Study|Lost to Follow-up|137
6827669|NCT00128206|10830724|FG001|Overall Study|Lost to Follow-up|118
6827670|NCT00128206|10830723|FG000|Overall Study|Adverse Event|0
6827671|NCT00128206|10830724|FG001|Overall Study|Adverse Event|2
7061592|NCT01929863|11158672|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1
7061593|NCT01929863|11158671|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0
7061594|NCT01929863|11158672|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1
7061595|NCT01929876|11158683|FG000|Period 2|Non-Compliance|1
7061596|NCT01929980|11158691|FG000|Overall Study|Physician Decision|1
7061597|NCT01929993|11158697|FG000|Overall Study|Protocol Violation|4
7061598|NCT01929993|11158698|FG001|Overall Study|Protocol Violation|6
7061599|NCT01929993|11158697|FG000|Overall Study|Absent CIN, invasion present or artifact|26
7061600|NCT01929993|11158698|FG001|Overall Study|Absent CIN, invasion present or artifact|22
7061601|NCT01930045|11158704|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0
7061602|NCT01930045|11158705|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0
7061603|NCT01930045|11158706|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0
7061604|NCT01930045|11158707|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0
7061605|NCT01930045|11158708|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0
7061606|NCT01930045|11158709|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1
7061607|NCT01930045|11158704|FG000|Pause (up to 37 Days)|Protocol Violation|0
7061608|NCT01930045|11158705|FG001|Pause (up to 37 Days)|Protocol Violation|0
7061609|NCT01930045|11158706|FG002|Pause (up to 37 Days)|Protocol Violation|0
7061610|NCT01930045|11158707|FG003|Pause (up to 37 Days)|Protocol Violation|0
7061611|NCT01930045|11158708|FG004|Pause (up to 37 Days)|Protocol Violation|0
7061612|NCT01930045|11158709|FG005|Pause (up to 37 Days)|Protocol Violation|1
7061613|NCT01930162|11158733|FG000|Overall Study|Abnormal test procedure result(s)|4
7061614|NCT01930162|11158733|FG000|Overall Study|Death|1
7061615|NCT01930175|11158741|FG000|Core Study|Lost to Follow-up|0
7061616|NCT01930175|11158742|FG001|Core Study|Lost to Follow-up|1
7061617|NCT01930175|11158743|FG002|Core Study|Lost to Follow-up|0
7061618|NCT01930175|11158741|FG000|Core Study|Adverse Event|0
7061619|NCT01930175|11158742|FG001|Core Study|Adverse Event|0
7061620|NCT01930175|11158743|FG002|Core Study|Adverse Event|1
7061621|NCT01930188|11158755|FG000|Overall Study|unclassified|4
7061622|NCT01930188|11158756|FG001|Overall Study|unclassified|5
7061623|NCT01930188|11158757|FG002|Overall Study|unclassified|3
7061624|NCT01930188|11158755|FG000|Overall Study|Missing follow-up information|2
7061625|NCT01930188|11158756|FG001|Overall Study|Missing follow-up information|2
7061626|NCT01930188|11158757|FG002|Overall Study|Missing follow-up information|3
7061627|NCT01930188|11158755|FG000|Overall Study|Lost to Follow-up|5
7061628|NCT01930188|11158756|FG001|Overall Study|Lost to Follow-up|2
7061629|NCT01930188|11158757|FG002|Overall Study|Lost to Follow-up|2
7061630|NCT01930188|11158755|FG000|Overall Study|Death|2
7061631|NCT01930188|11158756|FG001|Overall Study|Death|1
7061632|NCT01930188|11158757|FG002|Overall Study|Death|3
7061633|NCT01930188|11158755|FG000|Overall Study|Withdrawal by Subject|9
7061634|NCT01930188|11158756|FG001|Overall Study|Withdrawal by Subject|11
7061635|NCT01930188|11158757|FG002|Overall Study|Withdrawal by Subject|8
7061636|NCT01930214|11158769|FG000|Overall Study|Death|4
7061637|NCT01930214|11158770|FG001|Overall Study|Death|4
7061638|NCT01930214|11158771|FG002|Overall Study|Death|11
7061639|NCT01930214|11158769|FG000|Overall Study|Lost to Follow-up|12
7061640|NCT01930214|11158770|FG001|Overall Study|Lost to Follow-up|13
7061641|NCT01930214|11158771|FG002|Overall Study|Lost to Follow-up|12
7061642|NCT01930214|11158769|FG000|Overall Study|Voluntary withdrawal of infomed consent|2
7061643|NCT01930214|11158770|FG001|Overall Study|Voluntary withdrawal of infomed consent|4
7061644|NCT01930214|11158771|FG002|Overall Study|Voluntary withdrawal of infomed consent|2
7061645|NCT01930214|11158769|FG000|Overall Study|Physician Decision|2
7061646|NCT01930214|11158770|FG001|Overall Study|Physician Decision|0
7061647|NCT01930214|11158771|FG002|Overall Study|Physician Decision|0
7061648|NCT01930799|11158813|FG000|Overall Study|Withdrawal by Subject|3
6827672|NCT00128492|10830751|FG000|Overall Study|AE unrelated to study|2
6827673|NCT00128492|10830752|FG001|Overall Study|AE unrelated to study|9
6827674|NCT00128492|10830751|FG000|Overall Study|Study drug intolerance (AE)|2
7061649|NCT01930799|11158813|FG000|Overall Study|Lost to Follow-up|5
7061650|NCT01930890|11158821|FG000|Overall Study|Study Termination|14
7061651|NCT01930890|11158822|FG001|Overall Study|Study Termination|28
7061652|NCT01930890|11158823|FG002|Overall Study|Study Termination|13
6827675|NCT00128492|10830752|FG001|Overall Study|Study drug intolerance (AE)|8
6827676|NCT00128492|10830751|FG000|Overall Study|AE related to study|1
6827677|NCT00128492|10830752|FG001|Overall Study|AE related to study|4
6827678|NCT00128492|10830751|FG000|Overall Study|Death|1
6827679|NCT00128492|10830752|FG001|Overall Study|Death|0
6827680|NCT00128492|10830751|FG000|Overall Study|Lost to Follow-up|1
6827681|NCT00128492|10830752|FG001|Overall Study|Lost to Follow-up|5
6827682|NCT00128492|10830751|FG000|Overall Study|Noncompliance|0
6827683|NCT00128492|10830752|FG001|Overall Study|Noncompliance|5
6827684|NCT00128492|10830751|FG000|Overall Study|Personal or administrative|10
6827685|NCT00128492|10830752|FG001|Overall Study|Personal or administrative|22
6827686|NCT00128492|10830751|FG000|Overall Study|Withdrawal by Subject|3
6923512|NCT00818662|10952531|FG000|Overall Study|Physician Decision|1
6923513|NCT00818662|10952532|FG001|Overall Study|Physician Decision|0
6923514|NCT00818662|10952533|FG002|Overall Study|Physician Decision|0
6923515|NCT00818662|10952534|FG003|Overall Study|Physician Decision|0
6923516|NCT00818662|10952531|FG000|Overall Study|Lost to Follow-up|0
6923517|NCT00818662|10952532|FG001|Overall Study|Lost to Follow-up|0
6923518|NCT00818662|10952533|FG002|Overall Study|Lost to Follow-up|0
6923519|NCT00818662|10952534|FG003|Overall Study|Lost to Follow-up|1
6923520|NCT00818662|10952531|FG000|Overall Study|Unwilling or Unable to Participate|4
6923521|NCT00818662|10952532|FG001|Overall Study|Unwilling or Unable to Participate|6
6923522|NCT00818662|10952533|FG002|Overall Study|Unwilling or Unable to Participate|2
6923523|NCT00818662|10952534|FG003|Overall Study|Unwilling or Unable to Participate|4
6923524|NCT00818662|10952531|FG000|Overall Study|Protocol Violation|1
6923525|NCT00818662|10952532|FG001|Overall Study|Protocol Violation|1
6923526|NCT00818662|10952533|FG002|Overall Study|Protocol Violation|0
6923527|NCT00818662|10952534|FG003|Overall Study|Protocol Violation|0
6923528|NCT00818662|10952531|FG000|Overall Study|Requires a Prohibited Medication|1
6923529|NCT00818662|10952532|FG001|Overall Study|Requires a Prohibited Medication|0
6923530|NCT00818662|10952533|FG002|Overall Study|Requires a Prohibited Medication|0
6923531|NCT00818662|10952534|FG003|Overall Study|Requires a Prohibited Medication|0
6923532|NCT00818662|10952531|FG000|Overall Study|Safety Risk|1
6923533|NCT00818662|10952532|FG001|Overall Study|Safety Risk|1
6923534|NCT00818662|10952533|FG002|Overall Study|Safety Risk|0
6923535|NCT00818662|10952534|FG003|Overall Study|Safety Risk|1
6923536|NCT00818662|10952531|FG000|Overall Study|Study Partner Unwilling or Unable|3
6923537|NCT00818662|10952532|FG001|Overall Study|Study Partner Unwilling or Unable|2
6923538|NCT00818662|10952533|FG002|Overall Study|Study Partner Unwilling or Unable|1
6923539|NCT00818662|10952534|FG003|Overall Study|Study Partner Unwilling or Unable|1
6923540|NCT00818662|10952531|FG000|Overall Study|Participant's health declined|0
6923541|NCT00818662|10952532|FG001|Overall Study|Participant's health declined|0
6923542|NCT00818662|10952533|FG002|Overall Study|Participant's health declined|0
6923543|NCT00818662|10952534|FG003|Overall Study|Participant's health declined|1
6923544|NCT00818662|10952531|FG000|Overall Study|Caregiver to pursue other treatment|0
6923545|NCT00818662|10952532|FG001|Overall Study|Caregiver to pursue other treatment|1
6923546|NCT00818662|10952533|FG002|Overall Study|Caregiver to pursue other treatment|0
6923547|NCT00818662|10952534|FG003|Overall Study|Caregiver to pursue other treatment|0
6923548|NCT00818662|10952531|FG000|Overall Study|Moving out of state|0
6923549|NCT00818662|10952532|FG001|Overall Study|Moving out of state|0
6923550|NCT00818662|10952533|FG002|Overall Study|Moving out of state|0
6923551|NCT00818662|10952534|FG003|Overall Study|Moving out of state|1
6923552|NCT00818662|10952531|FG000|Overall Study|Declined move to another study site|1
6923553|NCT00818662|10952532|FG001|Overall Study|Declined move to another study site|0
6923554|NCT00818662|10952533|FG002|Overall Study|Declined move to another study site|0
6923555|NCT00818662|10952534|FG003|Overall Study|Declined move to another study site|0
6923556|NCT00818662|10952531|FG000|Overall Study|Change in living situation|0
6923557|NCT00818662|10952532|FG001|Overall Study|Change in living situation|0
6923558|NCT00818662|10952533|FG002|Overall Study|Change in living situation|0
6923559|NCT00818662|10952534|FG003|Overall Study|Change in living situation|1
6923560|NCT00818662|10952531|FG000|Overall Study|Study partner decision|0
7061653|NCT01930890|11158824|FG003|Overall Study|Study Termination|25
7061654|NCT01930890|11158821|FG000|Overall Study|Death|0
7061655|NCT01930890|11158822|FG001|Overall Study|Death|0
7061656|NCT01930890|11158823|FG002|Overall Study|Death|0
7061657|NCT01930890|11158824|FG003|Overall Study|Death|1
7061658|NCT01930890|11158821|FG000|Overall Study|Investigator Decision|0
6923561|NCT00818662|10952532|FG001|Overall Study|Study partner decision|0
6923562|NCT00818662|10952533|FG002|Overall Study|Study partner decision|0
6923563|NCT00818662|10952534|FG003|Overall Study|Study partner decision|1
6923564|NCT00818662|10952531|FG000|Overall Study|Admitted to long term nursing care|0
6923565|NCT00818662|10952532|FG001|Overall Study|Admitted to long term nursing care|1
6923566|NCT00818662|10952533|FG002|Overall Study|Admitted to long term nursing care|0
6923567|NCT00818662|10952534|FG003|Overall Study|Admitted to long term nursing care|0
6923568|NCT00818753|10952548|FG000|Overall Study|Protocol Violation|1
7061659|NCT01930890|11158822|FG001|Overall Study|Investigator Decision|1
6923569|NCT00818753|10952549|FG001|Overall Study|Protocol Violation|0
6923570|NCT00818753|10952550|FG002|Overall Study|Protocol Violation|0
6923571|NCT00818753|10952548|FG000|Overall Study|Other reason (not specified)|0
6923572|NCT00818753|10952549|FG001|Overall Study|Other reason (not specified)|0
6923573|NCT00818753|10952550|FG002|Overall Study|Other reason (not specified)|1
6827687|NCT00128492|10830752|FG001|Overall Study|Withdrawal by Subject|5
6923574|NCT00818753|10952548|FG000|Overall Study|Randomised and not treated|2
6827688|NCT00128492|10830751|FG000|Overall Study|Pregnancy|0
6827689|NCT00128492|10830752|FG001|Overall Study|Pregnancy|1
6827690|NCT00128661|10830760|FG000|Overall Study|Adverse Event|14
6827691|NCT00128661|10830761|FG001|Overall Study|Adverse Event|11
6827692|NCT00128661|10830760|FG000|Overall Study|Lost to Follow-up|10
6827693|NCT00128661|10830761|FG001|Overall Study|Lost to Follow-up|7
6827694|NCT00128661|10830760|FG000|Overall Study|Withdrawal by Subject|243
6827695|NCT00128661|10830761|FG001|Overall Study|Withdrawal by Subject|232
6827696|NCT00128661|10830760|FG000|Overall Study|Other|7
6827697|NCT00128661|10830761|FG001|Overall Study|Other|8
7061660|NCT01930890|11158823|FG002|Overall Study|Investigator Decision|0
7061661|NCT01930890|11158824|FG003|Overall Study|Investigator Decision|0
6827698|NCT00128830|10830780|FG000|Overall Study|Adverse Event|10
6923575|NCT00818753|10952549|FG001|Overall Study|Randomised and not treated|0
6923576|NCT00818753|10952550|FG002|Overall Study|Randomised and not treated|0
6923577|NCT00818766|10952560|FG000|Overall Study|Could not be Contacted on Day 28|11
6923578|NCT00818766|10952561|FG001|Overall Study|Could not be Contacted on Day 28|10
7038353|NCT01702311|11120652|FG001|Overall Study|Withdrawal by Subject|2
7038354|NCT01702311|11120651|FG000|Overall Study|Discharge less than 24 hours|10
7038355|NCT01702311|11120652|FG001|Overall Study|Discharge less than 24 hours|7
7038356|NCT01702311|11120651|FG000|Overall Study|Physician Decision|3
7038357|NCT01702311|11120652|FG001|Overall Study|Physician Decision|4
7038358|NCT01702363|11120661|FG000|Overall Study|Adverse Event|14
7038359|NCT01702363|11120661|FG000|Overall Study|Lack of Efficacy|4
7038360|NCT01702363|11120661|FG000|Overall Study|Withdrawal by Subject|2
7038361|NCT01702428|11120670|FG000|Overall Study|Adverse Event|2
7038362|NCT01702428|11120671|FG001|Overall Study|Adverse Event|0
7038363|NCT01702428|11120672|FG002|Overall Study|Adverse Event|0
7038364|NCT01702428|11120673|FG003|Overall Study|Adverse Event|0
7038365|NCT01702428|11120670|FG000|Overall Study|Lost to Follow-up|33
7038366|NCT01702428|11120671|FG001|Overall Study|Lost to Follow-up|41
7038367|NCT01702428|11120672|FG002|Overall Study|Lost to Follow-up|37
6923579|NCT00818766|10952560|FG000|Overall Study|Death|1
6923580|NCT00818766|10952561|FG001|Overall Study|Death|0
6923581|NCT00818766|10952560|FG000|Overall Study|Did not Receive Allocated Intervention|3
6923582|NCT00818766|10952561|FG001|Overall Study|Did not Receive Allocated Intervention|0
6923583|NCT00818779|10952569|FG000|Overall Study|Protocol Violation|1
6923584|NCT00818779|10952570|FG001|Overall Study|Protocol Violation|0
6923585|NCT00818779|10952569|FG000|Overall Study|Lost to Follow-up|1
6923586|NCT00818779|10952570|FG001|Overall Study|Lost to Follow-up|0
6923587|NCT00818779|10952569|FG000|Overall Study|Adverse Event|4
6923588|NCT00818779|10952570|FG001|Overall Study|Adverse Event|1
6923589|NCT00818883|10952589|FG000|Overall Study|Adverse Event|28
6923590|NCT00818883|10952590|FG001|Overall Study|Adverse Event|19
6923591|NCT00818883|10952589|FG000|Overall Study|Protocol Violation|2
6923592|NCT00818883|10952590|FG001|Overall Study|Protocol Violation|2
6923593|NCT00818883|10952589|FG000|Overall Study|Lost to Follow-up|3
6923594|NCT00818883|10952590|FG001|Overall Study|Lost to Follow-up|2
6923595|NCT00818883|10952589|FG000|Overall Study|Withdrawal by Subject|16
6923596|NCT00818883|10952590|FG001|Overall Study|Withdrawal by Subject|14
6923597|NCT00818883|10952589|FG000|Overall Study|Lack of Efficacy|0
6923598|NCT00818883|10952590|FG001|Overall Study|Lack of Efficacy|2
6923599|NCT00818883|10952589|FG000|Overall Study|Other|2
6923600|NCT00818883|10952590|FG001|Overall Study|Other|7
6923601|NCT00819013|10952604|FG000|Overall Study|Not meeting continuing study eligibility|2
6923602|NCT00819013|10952605|FG001|Overall Study|Not meeting continuing study eligibility|1
6923603|NCT00819013|10952606|FG002|Overall Study|Not meeting continuing study eligibility|2
6923604|NCT00819013|10952607|FG003|Overall Study|Not meeting continuing study eligibility|1
6923605|NCT00819013|10952604|FG000|Overall Study|Adverse Event|0
6923606|NCT00819013|10952605|FG001|Overall Study|Adverse Event|0
6923607|NCT00819013|10952606|FG002|Overall Study|Adverse Event|1
6923608|NCT00819013|10952607|FG003|Overall Study|Adverse Event|0
6923609|NCT00819013|10952604|FG000|Overall Study|Withdrawal by Subject|1
6923610|NCT00819013|10952605|FG001|Overall Study|Withdrawal by Subject|0
6923611|NCT00819013|10952606|FG002|Overall Study|Withdrawal by Subject|1
6923612|NCT00819013|10952607|FG003|Overall Study|Withdrawal by Subject|0
6923613|NCT00819013|10952604|FG000|Overall Study|Lost to Follow-up|0
7038368|NCT01702428|11120673|FG003|Overall Study|Lost to Follow-up|44
7038369|NCT01702428|11120670|FG000|Overall Study|Parents cannot assist to site|1
7038370|NCT01702428|11120671|FG001|Overall Study|Parents cannot assist to site|0
7038371|NCT01702428|11120672|FG002|Overall Study|Parents cannot assist to site|1
7038372|NCT01702428|11120673|FG003|Overall Study|Parents cannot assist to site|0
6827699|NCT00128830|10830780|FG000|Overall Study|Withdrawal by Subject|14
6923614|NCT00819013|10952605|FG001|Overall Study|Lost to Follow-up|0
7038373|NCT01702428|11120670|FG000|Overall Study|Lost Coverage|0
7038374|NCT01702428|11120671|FG001|Overall Study|Lost Coverage|0
7038375|NCT01702428|11120672|FG002|Overall Study|Lost Coverage|0
7061662|NCT01930890|11158821|FG000|Overall Study|Consent Withdrawn|0
6923615|NCT00819013|10952606|FG002|Overall Study|Lost to Follow-up|1
6923616|NCT00819013|10952607|FG003|Overall Study|Lost to Follow-up|2
6923617|NCT00819013|10952604|FG000|Overall Study|Death|0
6923618|NCT00819013|10952605|FG001|Overall Study|Death|0
6923619|NCT00819013|10952606|FG002|Overall Study|Death|0
7038376|NCT01702428|11120673|FG003|Overall Study|Lost Coverage|1
6827700|NCT00128830|10830780|FG000|Overall Study|Lost to Follow-up|4
7061663|NCT01930890|11158822|FG001|Overall Study|Consent Withdrawn|3
7061664|NCT01930890|11158823|FG002|Overall Study|Consent Withdrawn|0
7061665|NCT01930890|11158824|FG003|Overall Study|Consent Withdrawn|1
7061666|NCT01930890|11158821|FG000|Overall Study|Adverse Event|0
7061667|NCT01930890|11158822|FG001|Overall Study|Adverse Event|1
7061668|NCT01930890|11158823|FG002|Overall Study|Adverse Event|0
7061669|NCT01930890|11158824|FG003|Overall Study|Adverse Event|0
7061670|NCT01931059|11158836|FG000|Day 1|Pregnancy|0
7061671|NCT01931059|11158837|FG001|Day 1|Pregnancy|1
7061672|NCT01931059|11158836|FG000|Day3|Lost to Follow-up|1
7061673|NCT01931059|11158837|FG001|Day3|Lost to Follow-up|0
7061674|NCT01931150|11158851|FG000|Overall Study|Withdrawal by Subject|1
7061675|NCT01931150|11158852|FG001|Overall Study|Withdrawal by Subject|2
7061676|NCT01931202|11158865|FG000|Overall Study|Withdrawal by Subject|0
7061677|NCT01931202|11158866|FG001|Overall Study|Withdrawal by Subject|0
7061678|NCT01931202|11158867|FG002|Overall Study|Withdrawal by Subject|2
7061679|NCT01931202|11158865|FG000|Overall Study|Lost to Follow-up|0
7061680|NCT01931202|11158866|FG001|Overall Study|Lost to Follow-up|5
7061681|NCT01931202|11158867|FG002|Overall Study|Lost to Follow-up|2
7061682|NCT01931397|11158878|FG000|Overall Study|Physician Decision|2
7061683|NCT01931397|11158878|FG000|Overall Study|Withdrawal by Subject|8
7061684|NCT01931397|11158878|FG000|Overall Study|moved out of state|1
7061685|NCT01931462|11158886|FG000|Overall Study|Withdrawal by Subject|1
7061686|NCT01931475|11158892|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20
7061687|NCT01931475|11158893|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10
7061688|NCT01931475|11158892|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1
7061689|NCT01931475|11158893|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0
7061690|NCT01931475|11158892|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16
7061691|NCT01931475|11158893|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12
7061692|NCT01931475|11158892|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2
7061693|NCT01931475|11158893|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3
7061694|NCT01931475|11158892|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0
7061695|NCT01931475|11158893|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1
6827701|NCT00128830|10830780|FG000|Overall Study|Reached a virologic endpoint|29
6827702|NCT00128830|10830780|FG000|Overall Study|Non-compliant|4
6827703|NCT00128830|10830780|FG000|Overall Study|Discontinued or ineligible for study|2
6827704|NCT00128830|10830780|FG000|Overall Study|Other|9
6827705|NCT00129116|10830806|FG000|Primary Phase|Lost to Follow-up|1
6827706|NCT00129116|10830807|FG001|Primary Phase|Lost to Follow-up|1
6827707|NCT00129116|10830808|FG002|Primary Phase|Lost to Follow-up|0
6827708|NCT00129116|10830809|FG003|Primary Phase|Lost to Follow-up|1
6827709|NCT00129116|10830810|FG004|Primary Phase|Lost to Follow-up|1
6827710|NCT00129116|10830806|FG000|Primary Phase|Protocol Violation|0
6827711|NCT00129116|10830807|FG001|Primary Phase|Protocol Violation|1
6827712|NCT00129116|10830808|FG002|Primary Phase|Protocol Violation|0
6827713|NCT00129116|10830809|FG003|Primary Phase|Protocol Violation|0
6827714|NCT00129116|10830810|FG004|Primary Phase|Protocol Violation|0
6827715|NCT00129116|10830806|FG000|Primary Phase|Adverse Event|1
6827716|NCT00129116|10830807|FG001|Primary Phase|Adverse Event|1
6827717|NCT00129116|10830808|FG002|Primary Phase|Adverse Event|0
6827718|NCT00129116|10830809|FG003|Primary Phase|Adverse Event|0
6827719|NCT00129116|10830810|FG004|Primary Phase|Adverse Event|0
6827720|NCT00129116|10830806|FG000|Primary Phase|Withdrawal by Subject|0
6827721|NCT00129116|10830807|FG001|Primary Phase|Withdrawal by Subject|1
6827722|NCT00129116|10830808|FG002|Primary Phase|Withdrawal by Subject|0
6827723|NCT00129116|10830809|FG003|Primary Phase|Withdrawal by Subject|0
6827724|NCT00129116|10830810|FG004|Primary Phase|Withdrawal by Subject|0
6827725|NCT00129116|10830806|FG000|Primary Phase|Other|0
6827726|NCT00129116|10830807|FG001|Primary Phase|Other|0
6827727|NCT00129116|10830808|FG002|Primary Phase|Other|1
6827728|NCT00129116|10830809|FG003|Primary Phase|Other|0
6827729|NCT00129116|10830810|FG004|Primary Phase|Other|0
6827730|NCT00129116|10830806|FG000|Booster Phase|Lost to Follow-up|2
6827731|NCT00129116|10830807|FG001|Booster Phase|Lost to Follow-up|0
6827732|NCT00129116|10830808|FG002|Booster Phase|Lost to Follow-up|0
6827733|NCT00129116|10830809|FG003|Booster Phase|Lost to Follow-up|0
6827734|NCT00129116|10830810|FG004|Booster Phase|Lost to Follow-up|1
6827735|NCT00129129|10830825|FG000|Primary Phase|Adverse Event|2
6827736|NCT00129129|10830826|FG001|Primary Phase|Adverse Event|1
6827737|NCT00129129|10830827|FG002|Primary Phase|Adverse Event|0
6827738|NCT00129129|10830828|FG003|Primary Phase|Adverse Event|0
6827739|NCT00129129|10830829|FG004|Primary Phase|Adverse Event|0
6827740|NCT00129129|10830825|FG000|Primary Phase|Withdrawal by Subject|12
7061696|NCT01931475|11158892|FG000|Period 2: Extension Treatment Phase|Adverse Event|0
7061697|NCT01931475|11158893|FG001|Period 2: Extension Treatment Phase|Adverse Event|8
7061698|NCT01931475|11158892|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1
7061699|NCT01931475|11158893|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0
6827741|NCT00129129|10830826|FG001|Primary Phase|Withdrawal by Subject|10
6827742|NCT00129129|10830827|FG002|Primary Phase|Withdrawal by Subject|0
6827743|NCT00129129|10830828|FG003|Primary Phase|Withdrawal by Subject|0
6827744|NCT00129129|10830829|FG004|Primary Phase|Withdrawal by Subject|0
6827745|NCT00129129|10830825|FG000|Primary Phase|Migration from study area|1
6827746|NCT00129129|10830826|FG001|Primary Phase|Migration from study area|3
6827747|NCT00129129|10830827|FG002|Primary Phase|Migration from study area|0
6827748|NCT00129129|10830828|FG003|Primary Phase|Migration from study area|0
6827749|NCT00129129|10830829|FG004|Primary Phase|Migration from study area|0
6827750|NCT00129129|10830825|FG000|Primary Phase|Lost to Follow-up|8
6827751|NCT00129129|10830826|FG001|Primary Phase|Lost to Follow-up|6
6827752|NCT00129129|10830827|FG002|Primary Phase|Lost to Follow-up|0
6827753|NCT00129129|10830828|FG003|Primary Phase|Lost to Follow-up|0
6827754|NCT00129129|10830829|FG004|Primary Phase|Lost to Follow-up|0
6827755|NCT00129129|10830825|FG000|Primary Phase|Other|2
6827756|NCT00129129|10830826|FG001|Primary Phase|Other|5
6827757|NCT00129129|10830827|FG002|Primary Phase|Other|0
6827758|NCT00129129|10830828|FG003|Primary Phase|Other|0
6827759|NCT00129129|10830829|FG004|Primary Phase|Other|0
6827760|NCT00129129|10830825|FG000|Fourth Dose Phase|Lost to Follow-up|4
6827761|NCT00129129|10830826|FG001|Fourth Dose Phase|Lost to Follow-up|0
6827762|NCT00129129|10830827|FG002|Fourth Dose Phase|Lost to Follow-up|0
6827763|NCT00129129|10830828|FG003|Fourth Dose Phase|Lost to Follow-up|2
6827764|NCT00129129|10830829|FG004|Fourth Dose Phase|Lost to Follow-up|2
6827765|NCT00129129|10830825|FG000|Fourth Dose Phase|Withdrawal by Subject|0
6827766|NCT00129129|10830826|FG001|Fourth Dose Phase|Withdrawal by Subject|0
6827767|NCT00129129|10830827|FG002|Fourth Dose Phase|Withdrawal by Subject|0
6827768|NCT00129129|10830828|FG003|Fourth Dose Phase|Withdrawal by Subject|0
6827769|NCT00129129|10830829|FG004|Fourth Dose Phase|Withdrawal by Subject|1
6827770|NCT00129129|10830825|FG000|Fourth Dose Phase|Migration from study area|0
6827771|NCT00129129|10830826|FG001|Fourth Dose Phase|Migration from study area|0
6827772|NCT00129129|10830827|FG002|Fourth Dose Phase|Migration from study area|0
6827773|NCT00129129|10830828|FG003|Fourth Dose Phase|Migration from study area|0
6923620|NCT00819013|10952607|FG003|Overall Study|Death|1
6923621|NCT00819039|10952620|FG000|Overall Study|Physician Decision|1
6923622|NCT00819039|10952621|FG001|Overall Study|Physician Decision|0
6923623|NCT00819039|10952622|FG002|Overall Study|Physician Decision|1
6923624|NCT00819039|10952620|FG000|Overall Study|Protocol Violation|1
6923625|NCT00819039|10952621|FG001|Overall Study|Protocol Violation|0
6923626|NCT00819039|10952622|FG002|Overall Study|Protocol Violation|0
6923627|NCT00819052|10952634|FG000|Overall Study|Adverse Event|0
6923628|NCT00819052|10952635|FG001|Overall Study|Adverse Event|5
6923629|NCT00819052|10952634|FG000|Overall Study|Protocol Violation|1
6923630|NCT00819052|10952635|FG001|Overall Study|Protocol Violation|2
6923631|NCT00819052|10952634|FG000|Overall Study|Lost to Follow-up|1
6923632|NCT00819052|10952635|FG001|Overall Study|Lost to Follow-up|2
6923633|NCT00819052|10952634|FG000|Overall Study|Withdrawal by Subject|1
6923634|NCT00819052|10952635|FG001|Overall Study|Withdrawal by Subject|2
6923635|NCT00819052|10952634|FG000|Overall Study|Lack of Efficacy|1
6923636|NCT00819052|10952635|FG001|Overall Study|Lack of Efficacy|1
6923637|NCT00819052|10952634|FG000|Overall Study|Pregnancy|1
6923638|NCT00819052|10952635|FG001|Overall Study|Pregnancy|2
6923639|NCT00819052|10952634|FG000|Overall Study|Death or events leading to death|1
6923640|NCT00819052|10952635|FG001|Overall Study|Death or events leading to death|0
6923641|NCT00819091|10952646|FG000|Overall Study|Adverse Event|3
6923642|NCT00819091|10952647|FG001|Overall Study|Adverse Event|5
6923643|NCT00819091|10952646|FG000|Overall Study|Protocol Violation|0
6923644|NCT00819091|10952647|FG001|Overall Study|Protocol Violation|1
6923645|NCT00819091|10952646|FG000|Overall Study|Lost to Follow-up|2
6923646|NCT00819091|10952647|FG001|Overall Study|Lost to Follow-up|0
6923647|NCT00819091|10952646|FG000|Overall Study|Withdrawal by Subject|1
6923648|NCT00819091|10952647|FG001|Overall Study|Withdrawal by Subject|2
6923649|NCT00819091|10952646|FG000|Overall Study|Other|1
6923650|NCT00819091|10952647|FG001|Overall Study|Other|2
6923651|NCT00819156|10952659|FG000|Overall Study|Adverse Event|1
6923652|NCT00819156|10952660|FG001|Overall Study|Adverse Event|4
6923653|NCT00819156|10952661|FG002|Overall Study|Adverse Event|2
6923654|NCT00819156|10952662|FG003|Overall Study|Adverse Event|1
6923655|NCT00819156|10952663|FG004|Overall Study|Adverse Event|2
6923656|NCT00819156|10952664|FG005|Overall Study|Adverse Event|3
6923657|NCT00819156|10952659|FG000|Overall Study|Withdrawal by Subject|0
6923658|NCT00819156|10952660|FG001|Overall Study|Withdrawal by Subject|3
6923659|NCT00819156|10952661|FG002|Overall Study|Withdrawal by Subject|2
6923660|NCT00819156|10952662|FG003|Overall Study|Withdrawal by Subject|0
6923661|NCT00819156|10952663|FG004|Overall Study|Withdrawal by Subject|1
6923662|NCT00819156|10952664|FG005|Overall Study|Withdrawal by Subject|0
6923663|NCT00819156|10952659|FG000|Overall Study|Protocol Violation|1
6923664|NCT00819156|10952660|FG001|Overall Study|Protocol Violation|0
6923665|NCT00819156|10952661|FG002|Overall Study|Protocol Violation|1
6923666|NCT00819156|10952662|FG003|Overall Study|Protocol Violation|0
6923667|NCT00819156|10952663|FG004|Overall Study|Protocol Violation|0
6923668|NCT00819156|10952664|FG005|Overall Study|Protocol Violation|1
6923669|NCT00819156|10952659|FG000|Overall Study|Lost to Follow-up|0
6923670|NCT00819156|10952660|FG001|Overall Study|Lost to Follow-up|1
6923671|NCT00819156|10952661|FG002|Overall Study|Lost to Follow-up|0
6827774|NCT00129129|10830829|FG004|Fourth Dose Phase|Migration from study area|2
6827775|NCT00129129|10830825|FG000|Fourth Dose Phase|Other|0
6827776|NCT00129129|10830826|FG001|Fourth Dose Phase|Other|0
6827777|NCT00129129|10830827|FG002|Fourth Dose Phase|Other|0
6827778|NCT00129129|10830828|FG003|Fourth Dose Phase|Other|1
6923672|NCT00819156|10952662|FG003|Overall Study|Lost to Follow-up|0
6923673|NCT00819156|10952663|FG004|Overall Study|Lost to Follow-up|0
6827779|NCT00129129|10830829|FG004|Fourth Dose Phase|Other|1
6827780|NCT00129129|10830825|FG000|Fourth Dose Phase|Protocol Violation|0
6827781|NCT00129129|10830826|FG001|Fourth Dose Phase|Protocol Violation|0
6827782|NCT00129129|10830827|FG002|Fourth Dose Phase|Protocol Violation|0
6827783|NCT00129129|10830828|FG003|Fourth Dose Phase|Protocol Violation|1
6827784|NCT00129129|10830829|FG004|Fourth Dose Phase|Protocol Violation|0
6827785|NCT00129220|10830852|FG000|Study Period II|Adverse Event|9
6827786|NCT00129220|10830853|FG001|Study Period II|Adverse Event|5
6827787|NCT00129220|10830854|FG002|Study Period II|Adverse Event|7
6827788|NCT00129220|10830852|FG000|Study Period II|Lack of Efficacy|15
6827789|NCT00129220|10830853|FG001|Study Period II|Lack of Efficacy|1
6827790|NCT00129220|10830854|FG002|Study Period II|Lack of Efficacy|28
6827791|NCT00129220|10830852|FG000|Study Period II|Entry Criteria Not Met|2
6827792|NCT00129220|10830853|FG001|Study Period II|Entry Criteria Not Met|0
6827793|NCT00129220|10830854|FG002|Study Period II|Entry Criteria Not Met|2
6827794|NCT00129220|10830852|FG000|Study Period II|Protocol Violation|4
6827795|NCT00129220|10830853|FG001|Study Period II|Protocol Violation|2
6827796|NCT00129220|10830854|FG002|Study Period II|Protocol Violation|1
6827797|NCT00129220|10830852|FG000|Study Period II|Physician Decision|0
6827798|NCT00129220|10830853|FG001|Study Period II|Physician Decision|1
6827799|NCT00129220|10830854|FG002|Study Period II|Physician Decision|0
6827800|NCT00129220|10830852|FG000|Study Period II|Withdrawal by Subject|1
6827801|NCT00129220|10830853|FG001|Study Period II|Withdrawal by Subject|3
6827802|NCT00129220|10830854|FG002|Study Period II|Withdrawal by Subject|4
6827803|NCT00129220|10830852|FG000|Study Period II|Reason Not Specified|2
6827804|NCT00129220|10830853|FG001|Study Period II|Reason Not Specified|0
6827805|NCT00129220|10830854|FG002|Study Period II|Reason Not Specified|5
6827806|NCT00129220|10830852|FG000|Study Period III|Adverse Event|1
6827807|NCT00129220|10830853|FG001|Study Period III|Adverse Event|0
6827808|NCT00129220|10830854|FG002|Study Period III|Adverse Event|3
6827809|NCT00129220|10830852|FG000|Study Period III|Protocol Violation|1
6827810|NCT00129220|10830853|FG001|Study Period III|Protocol Violation|1
6827811|NCT00129220|10830854|FG002|Study Period III|Protocol Violation|2
6827812|NCT00129220|10830852|FG000|Study Period III|Withdrawal by Subject|1
6827813|NCT00129220|10830853|FG001|Study Period III|Withdrawal by Subject|0
6827814|NCT00129220|10830854|FG002|Study Period III|Withdrawal by Subject|3
6827815|NCT00129220|10830852|FG000|Study Period III|Sponsor Decision|1
6827816|NCT00129220|10830853|FG001|Study Period III|Sponsor Decision|0
6827817|NCT00129220|10830854|FG002|Study Period III|Sponsor Decision|0
6827818|NCT00129220|10830852|FG000|Study Period III|Reason Not Specified|9
6827819|NCT00129220|10830853|FG001|Study Period III|Reason Not Specified|0
6827820|NCT00129220|10830854|FG002|Study Period III|Reason Not Specified|2
6827821|NCT00129259|10830875|FG000|Overall Study|Lost to Follow-up|1
6827822|NCT00129259|10830876|FG001|Overall Study|Lost to Follow-up|1
6827823|NCT00129259|10830875|FG000|Overall Study|Withdrawal by Subject|2
6827824|NCT00129259|10830876|FG001|Overall Study|Withdrawal by Subject|1
6827825|NCT00129259|10830875|FG000|Overall Study|Only available minimal phone assessments|0
6827826|NCT00129259|10830876|FG001|Overall Study|Only available minimal phone assessments|1
6827827|NCT00129272|10830884|FG000|Overall Study|Lost to Follow-up|12
6827828|NCT00129272|10830885|FG001|Overall Study|Lost to Follow-up|11
6827829|NCT00129272|10830884|FG000|Overall Study|Withdrawal by Subject|5
6827830|NCT00129272|10830885|FG001|Overall Study|Withdrawal by Subject|11
6827831|NCT00129311|10830910|FG000|Overall Study|Withdrawal by Subject|12
6827832|NCT00129311|10830911|FG001|Overall Study|Withdrawal by Subject|19
6827833|NCT00129376|10830917|FG000|Overall Study|Adverse Event|1
6827834|NCT00129376|10830917|FG000|Overall Study|Lack of Efficacy|1
6827835|NCT00129389|10830923|FG000|Overall Study|Adverse Event|19
6827836|NCT00129389|10830924|FG001|Overall Study|Adverse Event|87
6827837|NCT00129389|10830923|FG000|Overall Study|Death|0
6827838|NCT00129389|10830924|FG001|Overall Study|Death|1
6827839|NCT00129389|10830923|FG000|Overall Study|Lost to Follow-up|2
6827840|NCT00129389|10830924|FG001|Overall Study|Lost to Follow-up|1
6827841|NCT00129389|10830923|FG000|Overall Study|Physician Decision|0
6827842|NCT00129389|10830924|FG001|Overall Study|Physician Decision|4
6827843|NCT00129389|10830923|FG000|Overall Study|Protocol Violation|0
6827844|NCT00129389|10830924|FG001|Overall Study|Protocol Violation|6
6827845|NCT00129389|10830923|FG000|Overall Study|Withdrawal by Subject|9
6827846|NCT00129389|10830924|FG001|Overall Study|Withdrawal by Subject|23
6827847|NCT00129389|10830923|FG000|Overall Study|Relapse|1
6827848|NCT00129389|10830924|FG001|Overall Study|Relapse|0
6827849|NCT00129389|10830923|FG000|Overall Study|Not eligible|1
6827850|NCT00129389|10830924|FG001|Overall Study|Not eligible|2
6827851|NCT00129389|10830923|FG000|Overall Study|Crossed to the other arm|1
6827852|NCT00129389|10830924|FG001|Overall Study|Crossed to the other arm|16
6827853|NCT00129467|10830941|FG000|Received Intervention|Death|1
6827854|NCT00129467|10830942|FG001|Received Intervention|Death|1
6827855|NCT00129467|10830941|FG000|Received Intervention|Cardiac SAE (hypertension)|1
6827856|NCT00129467|10830942|FG001|Received Intervention|Cardiac SAE (hypertension)|1
6827857|NCT00129467|10830941|FG000|Received Intervention|Delirium|2
6827858|NCT00129467|10830942|FG001|Received Intervention|Delirium|0
6827859|NCT00129467|10830941|FG000|Received Intervention|Withdrawal by Subject|1
6827860|NCT00129467|10830942|FG001|Received Intervention|Withdrawal by Subject|0
6827861|NCT00129467|10830941|FG000|Received Intervention|Nausea|1
6827862|NCT00129467|10830942|FG001|Received Intervention|Nausea|0
6827863|NCT00129467|10830941|FG000|Received Intervention|Intolerance to citalopram|0
6827864|NCT00129467|10830942|FG001|Received Intervention|Intolerance to citalopram|1
6827865|NCT00129467|10830941|FG000|Received Intervention|Dizzyness, fatigue|0
6827866|NCT00129467|10830942|FG001|Received Intervention|Dizzyness, fatigue|1
6827867|NCT00129467|10830941|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1
6827868|NCT00129467|10830942|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0
6827869|NCT00129467|10830941|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1
6827870|NCT00129467|10830942|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0
6827871|NCT00129545|10830960|FG000|Overall Study|Death|5
6827872|NCT00129545|10830961|FG001|Overall Study|Death|60
6827873|NCT00129545|10830962|FG002|Overall Study|Death|44
6827874|NCT00129545|10830960|FG000|Overall Study|Withdrawal by Subject|3
6827875|NCT00129545|10830961|FG001|Overall Study|Withdrawal by Subject|18
6827876|NCT00129545|10830962|FG002|Overall Study|Withdrawal by Subject|44
6827877|NCT00129545|10830960|FG000|Overall Study|Lost to Follow-up|2
6827878|NCT00129545|10830961|FG001|Overall Study|Lost to Follow-up|22
6827879|NCT00129545|10830962|FG002|Overall Study|Lost to Follow-up|13
6827880|NCT00129545|10830960|FG000|Overall Study|Physician Decision|0
6827881|NCT00129545|10830961|FG001|Overall Study|Physician Decision|3
6827882|NCT00129545|10830962|FG002|Overall Study|Physician Decision|10
6827883|NCT00129545|10830960|FG000|Overall Study|Device not implanted|16
6827884|NCT00129545|10830961|FG001|Overall Study|Device not implanted|61
6827885|NCT00129545|10830962|FG002|Overall Study|Device not implanted|0
6827886|NCT00129623|10830972|FG000|Overall Study|Adverse Event|3
6827887|NCT00129623|10830973|FG001|Overall Study|Adverse Event|7
6827888|NCT00129623|10830972|FG000|Overall Study|Refused Treatment|5
6827889|NCT00129623|10830973|FG001|Overall Study|Refused Treatment|3
6827890|NCT00129623|10830972|FG000|Overall Study|Failure to Return|1
6827891|NCT00129623|10830973|FG001|Overall Study|Failure to Return|1
6827892|NCT00129623|10830972|FG000|Overall Study|Relocated job out of state|1
6827893|NCT00129623|10830973|FG001|Overall Study|Relocated job out of state|0
6827894|NCT00129623|10830972|FG000|Overall Study|Uncertainty to return|0
6827895|NCT00129623|10830973|FG001|Overall Study|Uncertainty to return|1
6827896|NCT00129649|10830983|FG000|Overall Study|Withdrawal by Subject|76
6827897|NCT00129649|10830984|FG001|Overall Study|Withdrawal by Subject|65
6827898|NCT00129701|10830990|FG000|Overall Study|Withdrawal by Subject|33
6827899|NCT00129766|10831007|FG000|Overall Study|Death|3
6827900|NCT00129766|10831008|FG001|Overall Study|Death|8
6827901|NCT00129766|10831007|FG000|Overall Study|Withdrawal of consent|31
6827902|NCT00129766|10831008|FG001|Overall Study|Withdrawal of consent|30
6827903|NCT00129766|10831007|FG000|Overall Study|Lost to Follow-up|26
6827904|NCT00129766|10831008|FG001|Overall Study|Lost to Follow-up|21
6827905|NCT00129935|10831017|FG000|Overall Study|Adverse Event|18
6827906|NCT00129935|10831018|FG001|Overall Study|Adverse Event|56
6827907|NCT00129935|10831017|FG000|Overall Study|Death|1
6827908|NCT00129935|10831018|FG001|Overall Study|Death|1
6827909|NCT00129935|10831017|FG000|Overall Study|Withdrawal by Subject|7
6923674|NCT00819156|10952664|FG005|Overall Study|Lost to Follow-up|2
6923675|NCT00819156|10952659|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5
6923676|NCT00819156|10952660|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2
6923677|NCT00819156|10952661|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1
6923678|NCT00819156|10952662|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1
6923679|NCT00819156|10952663|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1
6923680|NCT00819156|10952664|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2
6923681|NCT00819156|10952659|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3
6923682|NCT00819156|10952660|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0
6923683|NCT00819156|10952661|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0
6923684|NCT00819156|10952662|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0
6923685|NCT00819156|10952663|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1
6923686|NCT00819156|10952664|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0
6923687|NCT00819156|10952659|FG000|Overall Study|Prostate-specific antigen progression|0
6923688|NCT00819156|10952660|FG001|Overall Study|Prostate-specific antigen progression|0
6923689|NCT00819156|10952661|FG002|Overall Study|Prostate-specific antigen progression|0
6923690|NCT00819156|10952662|FG003|Overall Study|Prostate-specific antigen progression|0
6923691|NCT00819156|10952663|FG004|Overall Study|Prostate-specific antigen progression|1
6923692|NCT00819156|10952664|FG005|Overall Study|Prostate-specific antigen progression|0
6923693|NCT00819234|10952699|FG000|Overall Study|Withdrawal by Subject|8
6827910|NCT00129935|10831018|FG001|Overall Study|Withdrawal by Subject|20
6827911|NCT00129935|10831017|FG000|Overall Study|Protocol Violation|0
6827912|NCT00129935|10831018|FG001|Overall Study|Protocol Violation|4
6827913|NCT00129935|10831017|FG000|Overall Study|Physician Decision|3
6827914|NCT00129935|10831018|FG001|Overall Study|Physician Decision|4
6827915|NCT00129935|10831017|FG000|Overall Study|Recurrence|1
6827916|NCT00129935|10831018|FG001|Overall Study|Recurrence|3
6827917|NCT00129935|10831017|FG000|Overall Study|Second primary|0
6827918|NCT00129935|10831018|FG001|Overall Study|Second primary|1
6827919|NCT00129935|10831017|FG000|Overall Study|Other|3
6827920|NCT00129935|10831018|FG001|Overall Study|Other|2
6827921|NCT00129935|10831017|FG000|Overall Study|Crossed to the other arm|2
6827922|NCT00129935|10831018|FG001|Overall Study|Crossed to the other arm|1
6827923|NCT00129935|10831017|FG000|Overall Study|Incorrect study treatment|1
6827924|NCT00129935|10831018|FG001|Overall Study|Incorrect study treatment|0
6827925|NCT00129961|10831026|FG000|Overall Study|Adverse Event|1
6827926|NCT00129961|10831027|FG001|Overall Study|Adverse Event|0
6827927|NCT00129961|10831026|FG000|Overall Study|Death|1
6827928|NCT00129961|10831027|FG001|Overall Study|Death|1
6827929|NCT00129961|10831026|FG000|Overall Study|Withdrawal by Sponsor|14
6827930|NCT00129961|10831027|FG001|Overall Study|Withdrawal by Sponsor|20
6827931|NCT00129961|10831026|FG000|Overall Study|Physician Decision|1
6827932|NCT00129961|10831027|FG001|Overall Study|Physician Decision|0
6827933|NCT00129961|10831026|FG000|Overall Study|Withdrawal by Subject|2
6827934|NCT00129961|10831027|FG001|Overall Study|Withdrawal by Subject|1
6827935|NCT00129961|10831026|FG000|Overall Study|Missing Record|0
6827936|NCT00129961|10831027|FG001|Overall Study|Missing Record|1
6827937|NCT00129987|10831035|FG000|1st Educational Session|Withdrawal by Subject|141
6827938|NCT00129987|10831036|FG001|1st Educational Session|Withdrawal by Subject|109
6827939|NCT00129987|10831035|FG000|1 Year|Withdrawal by Subject|32
6827940|NCT00129987|10831036|FG001|1 Year|Withdrawal by Subject|21
6827941|NCT00130039|10831044|FG000|Overall Study|Withdrawal by Subject|15
6827942|NCT00130039|10831045|FG001|Overall Study|Withdrawal by Subject|11
6827943|NCT00130039|10831044|FG000|Overall Study|Lost to Follow-up|3
6827944|NCT00130039|10831045|FG001|Overall Study|Lost to Follow-up|1
6827945|NCT00130039|10831044|FG000|Overall Study|Adverse Event|4
6827946|NCT00130039|10831045|FG001|Overall Study|Adverse Event|2
6827947|NCT00130039|10831044|FG000|Overall Study|Physician Decision|3
6827948|NCT00130039|10831045|FG001|Overall Study|Physician Decision|0
6827949|NCT00130039|10831044|FG000|Overall Study|clinical events without follow up MRI|5
6827950|NCT00130039|10831045|FG001|Overall Study|clinical events without follow up MRI|4
6827951|NCT00130208|10831063|FG000|Maintenance Period (26 Weeks)|Adverse Event|10
6827952|NCT00130208|10831064|FG001|Maintenance Period (26 Weeks)|Adverse Event|12
6827953|NCT00130208|10831063|FG000|Maintenance Period (26 Weeks)|Physician Decision|0
6827954|NCT00130208|10831064|FG001|Maintenance Period (26 Weeks)|Physician Decision|2
6827955|NCT00130208|10831063|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8
6827956|NCT00130208|10831064|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11
6827957|NCT00130208|10831063|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5
6827958|NCT00130208|10831064|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4
6827959|NCT00130208|10831063|FG000|Maintenance Period (26 Weeks)|Other|1
6827960|NCT00130208|10831064|FG001|Maintenance Period (26 Weeks)|Other|1
6827961|NCT00130208|10831063|FG000|Washout Period (8 Weeks)|Adverse Event|3
6827962|NCT00130208|10831064|FG001|Washout Period (8 Weeks)|Adverse Event|6
6827963|NCT00130208|10831063|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2
6827964|NCT00130208|10831064|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4
6827965|NCT00130208|10831063|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0
6827966|NCT00130208|10831064|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1
6827967|NCT00130208|10831063|FG000|Washout Period (8 Weeks)|Other|1
6827968|NCT00130208|10831064|FG001|Washout Period (8 Weeks)|Other|1
6827969|NCT00130247|10831072|FG000|Overall Study|Pregnancy|1
6827970|NCT00130247|10831073|FG001|Overall Study|Pregnancy|0
6827971|NCT00130247|10831072|FG000|Overall Study|Post-randomization exclusion|1
6827972|NCT00130247|10831073|FG001|Overall Study|Post-randomization exclusion|2
6827973|NCT00130247|10831072|FG000|Overall Study|Not compliant with DOT|0
6827974|NCT00130247|10831073|FG001|Overall Study|Not compliant with DOT|2
6827975|NCT00130286|10831083|FG000|Overall Study|Withdrawal by Subject|0
6827976|NCT00130286|10831084|FG001|Overall Study|Withdrawal by Subject|1
6827977|NCT00130286|10831085|FG002|Overall Study|Withdrawal by Subject|2
6827978|NCT00130286|10831086|FG003|Overall Study|Withdrawal by Subject|2
6827979|NCT00130286|10831083|FG000|Overall Study|Adverse Event|0
6827980|NCT00130286|10831084|FG001|Overall Study|Adverse Event|0
6827981|NCT00130286|10831085|FG002|Overall Study|Adverse Event|2
6827982|NCT00130286|10831086|FG003|Overall Study|Adverse Event|0
6923694|NCT00819234|10952700|FG001|Overall Study|Withdrawal by Subject|13
6923695|NCT00819234|10952701|FG002|Overall Study|Withdrawal by Subject|6
6923696|NCT00819234|10952702|FG003|Overall Study|Withdrawal by Subject|3
6923697|NCT00819234|10952703|FG004|Overall Study|Withdrawal by Subject|0
6923698|NCT00819234|10952704|FG005|Overall Study|Withdrawal by Subject|4
6923699|NCT00819234|10952705|FG006|Overall Study|Withdrawal by Subject|4
6923700|NCT00819234|10952706|FG007|Overall Study|Withdrawal by Subject|8
6923701|NCT00819234|10952707|FG008|Overall Study|Withdrawal by Subject|5
6827983|NCT00130286|10831083|FG000|Overall Study|Missing lab specimens|0
6827984|NCT00130286|10831084|FG001|Overall Study|Missing lab specimens|2
6827985|NCT00130286|10831085|FG002|Overall Study|Missing lab specimens|0
6827986|NCT00130286|10831086|FG003|Overall Study|Missing lab specimens|0
6827987|NCT00130520|10831096|FG000|Overall Study|Adverse Event|11
6827988|NCT00130520|10831096|FG000|Overall Study|Death|1
6827989|NCT00130520|10831096|FG000|Overall Study|Physician Decision|1
6827990|NCT00130520|10831096|FG000|Overall Study|Withdrawal by Subject|1
6827991|NCT00130520|10831096|FG000|Overall Study|Disease Progression|23
6827992|NCT00130520|10831096|FG000|Overall Study|Protocol non-compliance|1
6827993|NCT00130520|10831096|FG000|Overall Study|Did not meet re-treatment criteria|1
6827994|NCT00130533|10831102|FG000|Overall Study|Withdrawal by Subject|33
6827995|NCT00130533|10831103|FG001|Overall Study|Withdrawal by Subject|6
6827996|NCT00130533|10831102|FG000|Overall Study|Adverse Event|34
6827997|NCT00130533|10831103|FG001|Overall Study|Adverse Event|1
6827998|NCT00130533|10831102|FG000|Overall Study|Disease relapse|9
7061700|NCT01931475|11158892|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0
7061701|NCT01931475|11158893|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9
7061702|NCT01931475|11158892|FG000|Period 2: Extension Treatment Phase|Physician Decision|1
7061703|NCT01931475|11158893|FG001|Period 2: Extension Treatment Phase|Physician Decision|1
7061704|NCT01931475|11158892|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1
7061705|NCT01931475|11158893|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0
7061706|NCT01931475|11158892|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1
7061707|NCT01931475|11158893|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1
7061708|NCT01931566|11158920|FG000|Overall Study|Randomized But Not Treated|6
7061709|NCT01931566|11158921|FG001|Overall Study|Randomized But Not Treated|9
7061710|NCT01931566|11158922|FG002|Overall Study|Randomized But Not Treated|14
7061711|NCT01931566|11158920|FG000|Overall Study|Adverse Event|37
7061712|NCT01931566|11158921|FG001|Overall Study|Adverse Event|167
7061713|NCT01931566|11158922|FG002|Overall Study|Adverse Event|132
7061714|NCT01931566|11158920|FG000|Overall Study|Major Protocol Deviation|5
7061715|NCT01931566|11158921|FG001|Overall Study|Major Protocol Deviation|14
7061716|NCT01931566|11158922|FG002|Overall Study|Major Protocol Deviation|21
7061717|NCT01931566|11158920|FG000|Overall Study|Lost to Follow-up|3
7061718|NCT01931566|11158921|FG001|Overall Study|Lost to Follow-up|26
7061719|NCT01931566|11158922|FG002|Overall Study|Lost to Follow-up|23
7061720|NCT01931566|11158920|FG000|Overall Study|Voluntary Withdrawal|78
7061721|NCT01931566|11158921|FG001|Overall Study|Voluntary Withdrawal|245
7061722|NCT01931566|11158922|FG002|Overall Study|Voluntary Withdrawal|225
7061723|NCT01931566|11158920|FG000|Overall Study|Study Termination|289
7061724|NCT01931566|11158921|FG001|Overall Study|Study Termination|968
7061725|NCT01931566|11158922|FG002|Overall Study|Study Termination|1037
7061726|NCT01931566|11158920|FG000|Overall Study|Reason Not Specified|11
7061727|NCT01931566|11158921|FG001|Overall Study|Reason Not Specified|47
7061728|NCT01931566|11158922|FG002|Overall Study|Reason Not Specified|53
7061729|NCT01931566|11158920|FG000|Overall Study|Missing|0
7061730|NCT01931566|11158921|FG001|Overall Study|Missing|0
7061731|NCT01931566|11158922|FG002|Overall Study|Missing|1
7061732|NCT01931670|11158934|FG000|Treatment Period|Exclusionary Medication Received|1
7061733|NCT01931670|11158935|FG001|Treatment Period|Exclusionary Medication Received|1
7061734|NCT01931670|11158936|FG002|Treatment Period|Exclusionary Medication Received|1
7061735|NCT01931670|11158934|FG000|Treatment Period|Surgery/Invasive Intervention|4
7061736|NCT01931670|11158935|FG001|Treatment Period|Surgery/Invasive Intervention|2
7061737|NCT01931670|11158936|FG002|Treatment Period|Surgery/Invasive Intervention|0
7061738|NCT01931670|11158934|FG000|Treatment Period|Subject Noncompliant|4
7061739|NCT01931670|11158935|FG001|Treatment Period|Subject Noncompliant|9
7061740|NCT01931670|11158936|FG002|Treatment Period|Subject Noncompliant|5
7061741|NCT01931670|11158934|FG000|Treatment Period|Adverse Event|19
7061742|NCT01931670|11158935|FG001|Treatment Period|Adverse Event|8
7061743|NCT01931670|11158936|FG002|Treatment Period|Adverse Event|21
7061744|NCT01931670|11158934|FG000|Treatment Period|Lack of Efficacy|11
7061745|NCT01931670|11158935|FG001|Treatment Period|Lack of Efficacy|2
7061746|NCT01931670|11158936|FG002|Treatment Period|Lack of Efficacy|2
7061747|NCT01931670|11158934|FG000|Treatment Period|Pregnancy|7
7061748|NCT01931670|11158935|FG001|Treatment Period|Pregnancy|2
7061749|NCT01931670|11158936|FG002|Treatment Period|Pregnancy|0
7061750|NCT01931670|11158934|FG000|Treatment Period|Other|8
7061751|NCT01931670|11158935|FG001|Treatment Period|Other|7
7061752|NCT01931670|11158936|FG002|Treatment Period|Other|2
7061753|NCT01931670|11158934|FG000|Treatment Period|Consent Withdrawn by Subject|17
7061754|NCT01931670|11158935|FG001|Treatment Period|Consent Withdrawn by Subject|12
7061755|NCT01931670|11158936|FG002|Treatment Period|Consent Withdrawn by Subject|7
7061756|NCT01931670|11158934|FG000|Treatment Period|Lost to Follow-up|19
6827999|NCT00130533|10831103|FG001|Overall Study|Disease relapse|13
6828000|NCT00130533|10831102|FG000|Overall Study|Interruption of treatment > 3 weeks|11
7038377|NCT01702428|11120670|FG000|Overall Study|Lost Health Plan|3
7038378|NCT01702428|11120671|FG001|Overall Study|Lost Health Plan|5
7038379|NCT01702428|11120672|FG002|Overall Study|Lost Health Plan|0
7038380|NCT01702428|11120673|FG003|Overall Study|Lost Health Plan|2
7038381|NCT01702428|11120670|FG000|Overall Study|Mother transferred care|0
7038382|NCT01702428|11120671|FG001|Overall Study|Mother transferred care|1
7038383|NCT01702428|11120672|FG002|Overall Study|Mother transferred care|0
7038384|NCT01702428|11120673|FG003|Overall Study|Mother transferred care|0
7038385|NCT01702428|11120670|FG000|Overall Study|Parents too busy|1
7061757|NCT01931670|11158935|FG001|Treatment Period|Lost to Follow-up|5
7061758|NCT01931670|11158936|FG002|Treatment Period|Lost to Follow-up|7
7061759|NCT01931670|11158934|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3
7061760|NCT01931670|11158935|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0
7061761|NCT01931670|11158936|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0
7061762|NCT01931670|11158934|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0
7061763|NCT01931670|11158935|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2
7061764|NCT01931670|11158936|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1
7061765|NCT01931670|11158934|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4
6828001|NCT00130533|10831103|FG001|Overall Study|Interruption of treatment > 3 weeks|0
7147637|NCT03131687|11308197|FG003|Overall Study|Lost to Follow-up|1
7038386|NCT01702428|11120671|FG001|Overall Study|Parents too busy|0
7038387|NCT01702428|11120672|FG002|Overall Study|Parents too busy|0
7038388|NCT01702428|11120673|FG003|Overall Study|Parents too busy|0
7038389|NCT01702428|11120670|FG000|Overall Study|Protocol Violation|3
7038390|NCT01702428|11120671|FG001|Overall Study|Protocol Violation|0
7038391|NCT01702428|11120672|FG002|Overall Study|Protocol Violation|1
7038392|NCT01702428|11120673|FG003|Overall Study|Protocol Violation|0
7038393|NCT01702428|11120670|FG000|Overall Study|Withdrawal by Subject|21
7038394|NCT01702428|11120671|FG001|Overall Study|Withdrawal by Subject|23
7038395|NCT01702428|11120672|FG002|Overall Study|Withdrawal by Subject|14
7038396|NCT01702428|11120673|FG003|Overall Study|Withdrawal by Subject|10
7038397|NCT01702454|11120692|FG000|Overall Study|Consent withdrawal|0
7038398|NCT01702454|11120693|FG001|Overall Study|Consent withdrawal|1
7038399|NCT01702454|11120692|FG000|Overall Study|Migrated/moved from study area|0
7038400|NCT01702454|11120693|FG001|Overall Study|Migrated/moved from study area|1
7038401|NCT01702454|11120692|FG000|Overall Study|Lost to Follow-up|3
7038402|NCT01702454|11120693|FG001|Overall Study|Lost to Follow-up|6
7038403|NCT01702519|11120704|FG000|Washout Period|Lost to Follow-up|1
7038404|NCT01702519|11120705|FG001|Washout Period|Lost to Follow-up|0
7038405|NCT01702519|11120704|FG000|Washout Period|Withdrawal by Subject|0
7038406|NCT01702519|11120705|FG001|Washout Period|Withdrawal by Subject|2
7038407|NCT01702532|11120717|FG000|Overall Study|Adverse Event|0
7038408|NCT01702532|11120718|FG001|Overall Study|Adverse Event|1
7038409|NCT01702558|11120730|FG000|Overall Study|Withdrawal by Subject|0
6828002|NCT00130533|10831102|FG000|Overall Study|Death|4
6828003|NCT00130533|10831103|FG001|Overall Study|Death|2
6828004|NCT00130533|10831102|FG000|Overall Study|Protocol Violation|5
6828005|NCT00130533|10831103|FG001|Overall Study|Protocol Violation|1
6828006|NCT00130533|10831102|FG000|Overall Study|Lost to Follow-up|1
6828007|NCT00130533|10831103|FG001|Overall Study|Lost to Follow-up|1
6828008|NCT00130533|10831102|FG000|Overall Study|Sponsor´s decision|2
6828009|NCT00130533|10831103|FG001|Overall Study|Sponsor´s decision|0
6828010|NCT00130533|10831102|FG000|Overall Study|Second Primary Malignancy|0
6828011|NCT00130533|10831103|FG001|Overall Study|Second Primary Malignancy|1
6828012|NCT00130533|10831102|FG000|Overall Study|Other|12
6828013|NCT00130533|10831103|FG001|Overall Study|Other|5
6828014|NCT00130637|10831109|FG000|Overall Study|Adverse Event|2
6828015|NCT00130637|10831109|FG000|Overall Study|Withdrawal by Subject|1
6828016|NCT00130689|10831113|FG000|Overall Study|Progressive Disease|29
6828017|NCT00130689|10831113|FG000|Overall Study|Death|1
6828018|NCT00130689|10831113|FG000|Overall Study|Clinical Deterioration|4
6828019|NCT00130689|10831113|FG000|Overall Study|Withdrawal by Subject|3
6828020|NCT00130689|10831113|FG000|Overall Study|Ineligible|6
6828021|NCT00130728|10831119|FG000|Overall Study|Death|258
6828022|NCT00130728|10831120|FG001|Overall Study|Death|258
6828023|NCT00130728|10831119|FG000|Overall Study|Lost to Follow-up|4
6828024|NCT00130728|10831120|FG001|Overall Study|Lost to Follow-up|0
6828025|NCT00130728|10831119|FG000|Overall Study|Withdrawal by Subject|0
6828026|NCT00130728|10831120|FG001|Overall Study|Withdrawal by Subject|2
6828027|NCT00130793|10831137|FG000|Overall Study|Lost to Follow-up|1
6828028|NCT00130793|10831138|FG001|Overall Study|Lost to Follow-up|4
6828029|NCT00130793|10831137|FG000|Overall Study|Withdrew consent|2
6828030|NCT00130793|10831138|FG001|Overall Study|Withdrew consent|0
6828031|NCT00130832|10831147|FG000|Overall Study|Adverse Event|1
6828032|NCT00130832|10831148|FG001|Overall Study|Adverse Event|1
6828033|NCT00130832|10831147|FG000|Overall Study|Lost to Follow-up|1
6828034|NCT00130832|10831148|FG001|Overall Study|Lost to Follow-up|2
6828035|NCT00130832|10831147|FG000|Overall Study|Protocol Violation|6
6828036|NCT00130832|10831148|FG001|Overall Study|Protocol Violation|8
6828037|NCT00130832|10831147|FG000|Overall Study|Withdrawal by Subject|6
6828038|NCT00130832|10831148|FG001|Overall Study|Withdrawal by Subject|1
6828039|NCT00130832|10831147|FG000|Overall Study|Moved|2
6828040|NCT00130832|10831148|FG001|Overall Study|Moved|2
6828041|NCT00130832|10831147|FG000|Overall Study|Other|0
6828042|NCT00130832|10831148|FG001|Overall Study|Other|3
7038410|NCT01702558|11120731|FG001|Overall Study|Withdrawal by Subject|0
7038411|NCT01702558|11120732|FG002|Overall Study|Withdrawal by Subject|0
7038412|NCT01702558|11120733|FG003|Overall Study|Withdrawal by Subject|12
7038413|NCT01702558|11120734|FG004|Overall Study|Withdrawal by Subject|4
7038414|NCT01702558|11120730|FG000|Overall Study|Lost to Follow-up|0
7038415|NCT01702558|11120731|FG001|Overall Study|Lost to Follow-up|0
7038416|NCT01702558|11120732|FG002|Overall Study|Lost to Follow-up|0
7038417|NCT01702558|11120733|FG003|Overall Study|Lost to Follow-up|3
7038418|NCT01702558|11120734|FG004|Overall Study|Lost to Follow-up|0
6828043|NCT00131248|10831164|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1
6828044|NCT00131248|10831165|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0
6828045|NCT00131352|10831173|FG000|Initial Treatment Period|Adverse Event|1
6828046|NCT00131352|10831174|FG001|Initial Treatment Period|Adverse Event|3
6828047|NCT00131352|10831173|FG000|Initial Treatment Period|Non-compliant|1
6828048|NCT00131352|10831174|FG001|Initial Treatment Period|Non-compliant|2
6828049|NCT00131352|10831173|FG000|Initial Treatment Period|Withdrawal by Subject|1
6828050|NCT00131352|10831174|FG001|Initial Treatment Period|Withdrawal by Subject|1
6828051|NCT00131352|10831173|FG000|Initial Treatment Period|Lack of Efficacy|6
6828052|NCT00131352|10831174|FG001|Initial Treatment Period|Lack of Efficacy|4
6828053|NCT00131352|10831173|FG000|Initial Treatment Period|Other|0
6828054|NCT00131352|10831174|FG001|Initial Treatment Period|Other|2
6828055|NCT00131352|10831173|FG000|Repeat Treatment Period|Adverse Event|1
6828056|NCT00131352|10831174|FG001|Repeat Treatment Period|Adverse Event|0
6828057|NCT00131352|10831173|FG000|Repeat Treatment Period|Other|1
6828058|NCT00131352|10831174|FG001|Repeat Treatment Period|Other|0
6828059|NCT00131365|10831182|FG000|Overall Study|Withdrawal by Subject|1
6828060|NCT00131365|10831182|FG000|Overall Study|Alternative treatment|3
6828061|NCT00131469|10831217|FG000|Overall Study|Withdrawal by Subject|3
6828062|NCT00131469|10831218|FG001|Overall Study|Withdrawal by Subject|4
6828063|NCT00131469|10831217|FG000|Overall Study|Protocol Violation|3
6828064|NCT00131469|10831218|FG001|Overall Study|Protocol Violation|1
6828065|NCT00131469|10831217|FG000|Overall Study|Death|0
6828066|NCT00131469|10831218|FG001|Overall Study|Death|1
6828067|NCT00131469|10831217|FG000|Overall Study|Lost to Follow-up|0
6828068|NCT00131469|10831218|FG001|Overall Study|Lost to Follow-up|1
6828069|NCT00131469|10831217|FG000|Overall Study|scan not analyzable|3
6828070|NCT00131469|10831218|FG001|Overall Study|scan not analyzable|6
6828071|NCT00131508|10831226|FG000|Overall Study|Disease progression|0
6828072|NCT00131508|10831227|FG001|Overall Study|Disease progression|2
6828073|NCT00131508|10831226|FG000|Overall Study|Non-Compliance|2
6828074|NCT00131508|10831227|FG001|Overall Study|Non-Compliance|4
6923702|NCT00819234|10952708|FG009|Overall Study|Withdrawal by Subject|3
6923703|NCT00819234|10952699|FG000|Overall Study|Adverse Event|0
6923704|NCT00819234|10952700|FG001|Overall Study|Adverse Event|0
6923705|NCT00819234|10952701|FG002|Overall Study|Adverse Event|1
6923706|NCT00819234|10952702|FG003|Overall Study|Adverse Event|0
6923707|NCT00819234|10952703|FG004|Overall Study|Adverse Event|0
6923708|NCT00819234|10952704|FG005|Overall Study|Adverse Event|2
6923709|NCT00819234|10952705|FG006|Overall Study|Adverse Event|0
6923710|NCT00819234|10952706|FG007|Overall Study|Adverse Event|0
6923711|NCT00819234|10952707|FG008|Overall Study|Adverse Event|0
6923712|NCT00819234|10952708|FG009|Overall Study|Adverse Event|0
6923713|NCT00819234|10952699|FG000|Overall Study|Physician Decision|0
6923714|NCT00819234|10952700|FG001|Overall Study|Physician Decision|0
6923715|NCT00819234|10952701|FG002|Overall Study|Physician Decision|0
6923716|NCT00819234|10952702|FG003|Overall Study|Physician Decision|1
6923717|NCT00819234|10952703|FG004|Overall Study|Physician Decision|0
6923718|NCT00819234|10952704|FG005|Overall Study|Physician Decision|0
6923719|NCT00819234|10952705|FG006|Overall Study|Physician Decision|0
6923720|NCT00819234|10952706|FG007|Overall Study|Physician Decision|0
6923721|NCT00819234|10952707|FG008|Overall Study|Physician Decision|0
6923722|NCT00819234|10952708|FG009|Overall Study|Physician Decision|2
6923723|NCT00819234|10952699|FG000|Overall Study|Protocol Violation|0
6923724|NCT00819234|10952700|FG001|Overall Study|Protocol Violation|0
6923725|NCT00819234|10952701|FG002|Overall Study|Protocol Violation|1
6923726|NCT00819234|10952702|FG003|Overall Study|Protocol Violation|0
6923727|NCT00819234|10952703|FG004|Overall Study|Protocol Violation|0
6923728|NCT00819234|10952704|FG005|Overall Study|Protocol Violation|0
6923729|NCT00819234|10952705|FG006|Overall Study|Protocol Violation|0
6923730|NCT00819234|10952706|FG007|Overall Study|Protocol Violation|0
6923731|NCT00819234|10952707|FG008|Overall Study|Protocol Violation|0
6923732|NCT00819234|10952708|FG009|Overall Study|Protocol Violation|0
6923733|NCT00819234|10952699|FG000|Overall Study|Lost to Follow-up|2
6923734|NCT00819234|10952700|FG001|Overall Study|Lost to Follow-up|2
6923735|NCT00819234|10952701|FG002|Overall Study|Lost to Follow-up|0
6923736|NCT00819234|10952702|FG003|Overall Study|Lost to Follow-up|2
6923737|NCT00819234|10952703|FG004|Overall Study|Lost to Follow-up|1
6923738|NCT00819234|10952704|FG005|Overall Study|Lost to Follow-up|1
6923739|NCT00819234|10952705|FG006|Overall Study|Lost to Follow-up|1
6923740|NCT00819234|10952706|FG007|Overall Study|Lost to Follow-up|1
6923741|NCT00819234|10952707|FG008|Overall Study|Lost to Follow-up|1
6923742|NCT00819234|10952708|FG009|Overall Study|Lost to Follow-up|2
6923743|NCT00819247|10952766|FG000|Overall Study|Adverse Event|0
6923744|NCT00819247|10952767|FG001|Overall Study|Adverse Event|5
6923745|NCT00819247|10952768|FG002|Overall Study|Adverse Event|3
6923746|NCT00819247|10952766|FG000|Overall Study|Insufficient testosterone response|5
6923747|NCT00819247|10952767|FG001|Overall Study|Insufficient testosterone response|8
6923748|NCT00819247|10952768|FG002|Overall Study|Insufficient testosterone response|10
6923749|NCT00819247|10952766|FG000|Overall Study|Withdrawal by Subject|1
6923750|NCT00819247|10952767|FG001|Overall Study|Withdrawal by Subject|0
6923751|NCT00819247|10952768|FG002|Overall Study|Withdrawal by Subject|0
6923752|NCT00819247|10952766|FG000|Overall Study|Protocol Violation|1
6923753|NCT00819247|10952767|FG001|Overall Study|Protocol Violation|0
6923754|NCT00819247|10952768|FG002|Overall Study|Protocol Violation|1
6923755|NCT00819247|10952766|FG000|Overall Study|Mistakenly withdrawn|0
6923756|NCT00819247|10952767|FG001|Overall Study|Mistakenly withdrawn|1
6923757|NCT00819247|10952768|FG002|Overall Study|Mistakenly withdrawn|0
6923758|NCT00819247|10952766|FG000|Overall Study|Bad prostate-specific antigen response|3
6923759|NCT00819247|10952767|FG001|Overall Study|Bad prostate-specific antigen response|2
6828075|NCT00131508|10831226|FG000|Overall Study|Withdrawal by Subject|1
6828076|NCT00131508|10831227|FG001|Overall Study|Withdrawal by Subject|2
6828077|NCT00131664|10831246|FG000|First Period (First 6 Months)|Lost to Follow-up|7
6828078|NCT00131664|10831247|FG001|First Period (First 6 Months)|Lost to Follow-up|3
6828079|NCT00131664|10831248|FG002|First Period (First 6 Months)|Lost to Follow-up|3
6923760|NCT00819247|10952768|FG002|Overall Study|Bad prostate-specific antigen response|0
6923761|NCT00819247|10952766|FG000|Overall Study|Other|1
6923762|NCT00819247|10952767|FG001|Overall Study|Other|0
6923763|NCT00819247|10952768|FG002|Overall Study|Other|0
6828080|NCT00131664|10831249|FG003|First Period (First 6 Months)|Lost to Follow-up|0
6828081|NCT00131664|10831250|FG004|First Period (First 6 Months)|Lost to Follow-up|0
6828082|NCT00131664|10831251|FG005|First Period (First 6 Months)|Lost to Follow-up|0
6828083|NCT00131664|10831246|FG000|First Period (First 6 Months)|Death|0
6828084|NCT00131664|10831247|FG001|First Period (First 6 Months)|Death|1
6828085|NCT00131664|10831248|FG002|First Period (First 6 Months)|Death|0
6828086|NCT00131664|10831249|FG003|First Period (First 6 Months)|Death|0
6828087|NCT00131664|10831250|FG004|First Period (First 6 Months)|Death|0
6828088|NCT00131664|10831251|FG005|First Period (First 6 Months)|Death|0
6828089|NCT00131664|10831246|FG000|First Period (First 6 Months)|Protocol Violation|2
6828090|NCT00131664|10831247|FG001|First Period (First 6 Months)|Protocol Violation|2
6828091|NCT00131664|10831248|FG002|First Period (First 6 Months)|Protocol Violation|1
6828092|NCT00131664|10831249|FG003|First Period (First 6 Months)|Protocol Violation|0
6828093|NCT00131664|10831250|FG004|First Period (First 6 Months)|Protocol Violation|0
6828094|NCT00131664|10831251|FG005|First Period (First 6 Months)|Protocol Violation|0
6828095|NCT00131664|10831246|FG000|First Period (First 6 Months)|Withdrawal by Subject|4
6828096|NCT00131664|10831247|FG001|First Period (First 6 Months)|Withdrawal by Subject|6
7038419|NCT01702558|11120730|FG000|Overall Study|Death|4
7038420|NCT01702558|11120731|FG001|Overall Study|Death|3
7038421|NCT01702558|11120732|FG002|Overall Study|Death|3
6828097|NCT00131664|10831248|FG002|First Period (First 6 Months)|Withdrawal by Subject|2
6828098|NCT00131664|10831249|FG003|First Period (First 6 Months)|Withdrawal by Subject|0
6828099|NCT00131664|10831250|FG004|First Period (First 6 Months)|Withdrawal by Subject|0
6828100|NCT00131664|10831251|FG005|First Period (First 6 Months)|Withdrawal by Subject|0
6828101|NCT00131664|10831246|FG000|First Period (First 6 Months)|Adverse Event|9
6828102|NCT00131664|10831247|FG001|First Period (First 6 Months)|Adverse Event|4
6828103|NCT00131664|10831248|FG002|First Period (First 6 Months)|Adverse Event|5
6828104|NCT00131664|10831249|FG003|First Period (First 6 Months)|Adverse Event|0
6828105|NCT00131664|10831250|FG004|First Period (First 6 Months)|Adverse Event|0
6828106|NCT00131664|10831251|FG005|First Period (First 6 Months)|Adverse Event|0
6828107|NCT00131664|10831246|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1
6828108|NCT00131664|10831247|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2
6828109|NCT00131664|10831248|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0
6828110|NCT00131664|10831249|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0
6828111|NCT00131664|10831250|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0
6828112|NCT00131664|10831251|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0
6828113|NCT00131664|10831246|FG000|First Period (First 6 Months)|Administrative reasons|2
6828114|NCT00131664|10831247|FG001|First Period (First 6 Months)|Administrative reasons|0
6828115|NCT00131664|10831248|FG002|First Period (First 6 Months)|Administrative reasons|5
6828116|NCT00131664|10831249|FG003|First Period (First 6 Months)|Administrative reasons|0
6828117|NCT00131664|10831250|FG004|First Period (First 6 Months)|Administrative reasons|0
6828118|NCT00131664|10831251|FG005|First Period (First 6 Months)|Administrative reasons|0
6828119|NCT00131664|10831246|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3
6828120|NCT00131664|10831247|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0
6828121|NCT00131664|10831248|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2
6828122|NCT00131664|10831249|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1
6828123|NCT00131664|10831250|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0
6828124|NCT00131664|10831251|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2
6828125|NCT00131664|10831246|FG000|Second Period (Additional Drug Added)|Protocol Violation|0
6828126|NCT00131664|10831247|FG001|Second Period (Additional Drug Added)|Protocol Violation|1
6828127|NCT00131664|10831248|FG002|Second Period (Additional Drug Added)|Protocol Violation|1
6828128|NCT00131664|10831249|FG003|Second Period (Additional Drug Added)|Protocol Violation|0
6828129|NCT00131664|10831250|FG004|Second Period (Additional Drug Added)|Protocol Violation|0
6828130|NCT00131664|10831251|FG005|Second Period (Additional Drug Added)|Protocol Violation|0
6828131|NCT00131664|10831246|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2
6828132|NCT00131664|10831247|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0
6828133|NCT00131664|10831248|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0
6828134|NCT00131664|10831249|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0
6828135|NCT00131664|10831250|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0
6828136|NCT00131664|10831251|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0
6828137|NCT00131664|10831246|FG000|Second Period (Additional Drug Added)|Adverse Event|0
6828138|NCT00131664|10831247|FG001|Second Period (Additional Drug Added)|Adverse Event|1
6828139|NCT00131664|10831248|FG002|Second Period (Additional Drug Added)|Adverse Event|0
6828140|NCT00131664|10831249|FG003|Second Period (Additional Drug Added)|Adverse Event|0
6828141|NCT00131664|10831250|FG004|Second Period (Additional Drug Added)|Adverse Event|0
6828142|NCT00131664|10831251|FG005|Second Period (Additional Drug Added)|Adverse Event|1
6828143|NCT00131664|10831246|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
6828144|NCT00131664|10831247|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
7038422|NCT01702558|11120733|FG003|Overall Study|Death|16
7038423|NCT01702558|11120734|FG004|Overall Study|Death|20
7038424|NCT01702558|11120730|FG000|Overall Study|Safety Follow-Up less than 3 Months|0
6828145|NCT00131664|10831248|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
6828146|NCT00131664|10831249|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1
6828147|NCT00131664|10831250|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
6828148|NCT00131664|10831251|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
6828149|NCT00131664|10831246|FG000|Second Period (Additional Drug Added)|Administrative reasons|4
6828150|NCT00131664|10831247|FG001|Second Period (Additional Drug Added)|Administrative reasons|2
6828151|NCT00131664|10831248|FG002|Second Period (Additional Drug Added)|Administrative reasons|0
6828152|NCT00131664|10831249|FG003|Second Period (Additional Drug Added)|Administrative reasons|0
6828153|NCT00131664|10831250|FG004|Second Period (Additional Drug Added)|Administrative reasons|1
6828154|NCT00131664|10831251|FG005|Second Period (Additional Drug Added)|Administrative reasons|0
6828155|NCT00131911|10831295|FG000|Overall Study|Withdrawal by Subject|1
6828156|NCT00131911|10831296|FG001|Overall Study|Withdrawal by Subject|0
6923764|NCT00819390|10952795|FG000|Overall Study|Lost to Follow-up|1
6923765|NCT00819390|10952796|FG001|Overall Study|Lost to Follow-up|1
6923766|NCT00819390|10952797|FG002|Overall Study|Lost to Follow-up|0
6923767|NCT00819390|10952798|FG003|Overall Study|Lost to Follow-up|0
6923768|NCT00819390|10952795|FG000|Overall Study|Withdrawal by Subject|2
6923769|NCT00819390|10952796|FG001|Overall Study|Withdrawal by Subject|0
6923770|NCT00819390|10952797|FG002|Overall Study|Withdrawal by Subject|0
6923771|NCT00819390|10952798|FG003|Overall Study|Withdrawal by Subject|0
6923772|NCT00819390|10952795|FG000|Overall Study|Adverse Event|0
6923773|NCT00819390|10952796|FG001|Overall Study|Adverse Event|0
6923774|NCT00819390|10952797|FG002|Overall Study|Adverse Event|1
6923775|NCT00819390|10952798|FG003|Overall Study|Adverse Event|0
6923776|NCT00819585|10952832|FG000|Core Study|Adverse Event|2
6923777|NCT00819585|10952833|FG001|Core Study|Adverse Event|1
6923778|NCT00819585|10952834|FG002|Core Study|Adverse Event|1
6923779|NCT00819585|10952835|FG003|Core Study|Adverse Event|4
6923780|NCT00819585|10952836|FG004|Core Study|Adverse Event|1
6923781|NCT00819585|10952837|FG005|Core Study|Adverse Event|0
6923782|NCT00819585|10952838|FG006|Core Study|Adverse Event|2
6923783|NCT00819585|10952839|FG007|Core Study|Adverse Event|0
6923784|NCT00819585|10952840|FG008|Core Study|Adverse Event|0
6923785|NCT00819585|10952841|FG009|Core Study|Adverse Event|0
6923786|NCT00819585|10952842|FG010|Core Study|Adverse Event|0
6923787|NCT00819585|10952832|FG000|Core Study|Abnormal Laboratory Value(s)|2
6923788|NCT00819585|10952833|FG001|Core Study|Abnormal Laboratory Value(s)|0
6923789|NCT00819585|10952834|FG002|Core Study|Abnormal Laboratory Value(s)|0
6923790|NCT00819585|10952835|FG003|Core Study|Abnormal Laboratory Value(s)|0
6923791|NCT00819585|10952836|FG004|Core Study|Abnormal Laboratory Value(s)|0
6923792|NCT00819585|10952837|FG005|Core Study|Abnormal Laboratory Value(s)|0
6923793|NCT00819585|10952838|FG006|Core Study|Abnormal Laboratory Value(s)|0
6923794|NCT00819585|10952839|FG007|Core Study|Abnormal Laboratory Value(s)|0
6923795|NCT00819585|10952840|FG008|Core Study|Abnormal Laboratory Value(s)|0
6923796|NCT00819585|10952841|FG009|Core Study|Abnormal Laboratory Value(s)|0
6923797|NCT00819585|10952842|FG010|Core Study|Abnormal Laboratory Value(s)|0
6923798|NCT00819585|10952832|FG000|Core Study|Unsatisfactory Therapeutic Effect|0
6923799|NCT00819585|10952833|FG001|Core Study|Unsatisfactory Therapeutic Effect|1
6923800|NCT00819585|10952834|FG002|Core Study|Unsatisfactory Therapeutic Effect|0
6923801|NCT00819585|10952835|FG003|Core Study|Unsatisfactory Therapeutic Effect|0
6923802|NCT00819585|10952836|FG004|Core Study|Unsatisfactory Therapeutic Effect|0
6923803|NCT00819585|10952837|FG005|Core Study|Unsatisfactory Therapeutic Effect|0
6923804|NCT00819585|10952838|FG006|Core Study|Unsatisfactory Therapeutic Effect|1
6923805|NCT00819585|10952839|FG007|Core Study|Unsatisfactory Therapeutic Effect|0
6923806|NCT00819585|10952840|FG008|Core Study|Unsatisfactory Therapeutic Effect|0
6923807|NCT00819585|10952841|FG009|Core Study|Unsatisfactory Therapeutic Effect|0
6923808|NCT00819585|10952842|FG010|Core Study|Unsatisfactory Therapeutic Effect|0
6923809|NCT00819585|10952832|FG000|Core Study|Subject No Longer Requires Study Drug|0
6923810|NCT00819585|10952833|FG001|Core Study|Subject No Longer Requires Study Drug|0
6923811|NCT00819585|10952834|FG002|Core Study|Subject No Longer Requires Study Drug|0
6923812|NCT00819585|10952835|FG003|Core Study|Subject No Longer Requires Study Drug|0
6923813|NCT00819585|10952836|FG004|Core Study|Subject No Longer Requires Study Drug|1
6923814|NCT00819585|10952837|FG005|Core Study|Subject No Longer Requires Study Drug|0
6923815|NCT00819585|10952838|FG006|Core Study|Subject No Longer Requires Study Drug|0
6923816|NCT00819585|10952839|FG007|Core Study|Subject No Longer Requires Study Drug|0
6923817|NCT00819585|10952840|FG008|Core Study|Subject No Longer Requires Study Drug|0
6923818|NCT00819585|10952841|FG009|Core Study|Subject No Longer Requires Study Drug|0
6923819|NCT00819585|10952842|FG010|Core Study|Subject No Longer Requires Study Drug|0
6923820|NCT00819585|10952832|FG000|Core Study|Subject Withdrew Consent|0
6923821|NCT00819585|10952833|FG001|Core Study|Subject Withdrew Consent|3
6923822|NCT00819585|10952834|FG002|Core Study|Subject Withdrew Consent|2
6923823|NCT00819585|10952835|FG003|Core Study|Subject Withdrew Consent|1
6923824|NCT00819585|10952836|FG004|Core Study|Subject Withdrew Consent|0
6923825|NCT00819585|10952837|FG005|Core Study|Subject Withdrew Consent|0
6923826|NCT00819585|10952838|FG006|Core Study|Subject Withdrew Consent|3
6923827|NCT00819585|10952839|FG007|Core Study|Subject Withdrew Consent|0
6923828|NCT00819585|10952840|FG008|Core Study|Subject Withdrew Consent|0
6923829|NCT00819585|10952841|FG009|Core Study|Subject Withdrew Consent|0
6828157|NCT00131937|10831301|FG000|Overall Study|Adverse Event|3
6828158|NCT00131937|10831301|FG000|Overall Study|Withdrawal by Subject|2
6828159|NCT00131937|10831301|FG000|Overall Study|Physician Decision|1
6828160|NCT00131937|10831301|FG000|Overall Study|Disease Progression|7
6828161|NCT00131937|10831301|FG000|Overall Study|Alternative therapy|1
6828162|NCT00132028|10831309|FG000|Overall Study|Adverse Event|7
6828163|NCT00132028|10831309|FG000|Overall Study|Death|2
6828164|NCT00132028|10831309|FG000|Overall Study|Lack of Efficacy|11
6828165|NCT00132028|10831309|FG000|Overall Study|Withdrawal by Subject|2
6828166|NCT00132028|10831309|FG000|Overall Study|not eligible|2
6828167|NCT00132028|10831309|FG000|Overall Study|Physician Decision|3
6828168|NCT00132041|10831313|FG000|Baseline|Ineligible|6
7061766|NCT01931670|11158935|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4
7061767|NCT01931670|11158936|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2
7061768|NCT01931670|11158934|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6
7061769|NCT01931670|11158935|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3
7061770|NCT01931670|11158936|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3
7061771|NCT01931670|11158934|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6
7061772|NCT01931670|11158935|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3
7061773|NCT01931670|11158936|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13
7061774|NCT01931670|11158934|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0
7061775|NCT01931670|11158935|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0
7061776|NCT01931670|11158936|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2
7061777|NCT01931735|11158948|FG000|Randomized Phase|Lost to Follow-up|2
7061778|NCT01931735|11158949|FG001|Randomized Phase|Lost to Follow-up|2
7061779|NCT01931735|11158950|FG002|Randomized Phase|Lost to Follow-up|5
7061780|NCT01931735|11158951|FG003|Randomized Phase|Lost to Follow-up|0
7061781|NCT01931735|11158948|FG000|Observational Non-Randomized Phase|Adverse Event|0
7061782|NCT01931735|11158949|FG001|Observational Non-Randomized Phase|Adverse Event|0
7061783|NCT01931735|11158950|FG002|Observational Non-Randomized Phase|Adverse Event|0
7061784|NCT01931735|11158951|FG003|Observational Non-Randomized Phase|Adverse Event|1
7061785|NCT01931735|11158948|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0
7061786|NCT01931735|11158949|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0
7061787|NCT01931735|11158950|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0
7061788|NCT01931735|11158951|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1
7061789|NCT01931839|11158968|FG000|Overall Study|Death|0
7061790|NCT01931839|11158969|FG001|Overall Study|Death|1
7061791|NCT01931839|11158970|FG002|Overall Study|Death|2
7061792|NCT01931839|11158971|FG003|Overall Study|Death|0
7061793|NCT01931839|11158972|FG004|Overall Study|Death|0
7061794|NCT01931839|11158973|FG005|Overall Study|Death|0
7061795|NCT01931839|11158974|FG006|Overall Study|Death|0
7061796|NCT01931839|11158968|FG000|Overall Study|Physician Decision|1
7061797|NCT01931839|11158969|FG001|Overall Study|Physician Decision|0
7061798|NCT01931839|11158970|FG002|Overall Study|Physician Decision|1
7061799|NCT01931839|11158971|FG003|Overall Study|Physician Decision|0
7061800|NCT01931839|11158972|FG004|Overall Study|Physician Decision|0
7061801|NCT01931839|11158973|FG005|Overall Study|Physician Decision|0
7061802|NCT01931839|11158974|FG006|Overall Study|Physician Decision|1
7061803|NCT01931839|11158968|FG000|Overall Study|Withdrawal of consent|0
7061804|NCT01931839|11158969|FG001|Overall Study|Withdrawal of consent|0
7061805|NCT01931839|11158970|FG002|Overall Study|Withdrawal of consent|0
7061806|NCT01931839|11158971|FG003|Overall Study|Withdrawal of consent|0
7061807|NCT01931839|11158972|FG004|Overall Study|Withdrawal of consent|1
6923830|NCT00819585|10952842|FG010|Core Study|Subject Withdrew Consent|0
6923831|NCT00819585|10952832|FG000|Core Study|Lost to Follow-up|2
6923832|NCT00819585|10952833|FG001|Core Study|Lost to Follow-up|1
6923833|NCT00819585|10952834|FG002|Core Study|Lost to Follow-up|2
6923834|NCT00819585|10952835|FG003|Core Study|Lost to Follow-up|0
6923835|NCT00819585|10952836|FG004|Core Study|Lost to Follow-up|1
6923836|NCT00819585|10952837|FG005|Core Study|Lost to Follow-up|1
6923837|NCT00819585|10952838|FG006|Core Study|Lost to Follow-up|1
6923838|NCT00819585|10952839|FG007|Core Study|Lost to Follow-up|0
6923839|NCT00819585|10952840|FG008|Core Study|Lost to Follow-up|0
6923840|NCT00819585|10952841|FG009|Core Study|Lost to Follow-up|0
6923841|NCT00819585|10952842|FG010|Core Study|Lost to Follow-up|0
6923842|NCT00819585|10952832|FG000|Core Study|Administrative Problems|0
6923843|NCT00819585|10952833|FG001|Core Study|Administrative Problems|0
6923844|NCT00819585|10952834|FG002|Core Study|Administrative Problems|0
6923845|NCT00819585|10952835|FG003|Core Study|Administrative Problems|0
6923846|NCT00819585|10952836|FG004|Core Study|Administrative Problems|0
6923847|NCT00819585|10952837|FG005|Core Study|Administrative Problems|0
6923848|NCT00819585|10952838|FG006|Core Study|Administrative Problems|2
7061808|NCT01931839|11158973|FG005|Overall Study|Withdrawal of consent|0
7061809|NCT01931839|11158974|FG006|Overall Study|Withdrawal of consent|0
7061810|NCT01931839|11158968|FG000|Overall Study|Adverse Event|9
6828169|NCT00132041|10831313|FG000|3 Months Post Ablation|Transplant|1
6923849|NCT00819585|10952839|FG007|Core Study|Administrative Problems|0
6923850|NCT00819585|10952840|FG008|Core Study|Administrative Problems|0
6828170|NCT00132041|10831313|FG000|3 Months Post Ablation|Non-Protocol Treatment|2
6828171|NCT00132041|10831313|FG000|6 Months Post Ablation|Withdrawal by Subject|2
6828172|NCT00132041|10831313|FG000|6 Months Post Ablation|Death|2
6828173|NCT00132041|10831313|FG000|6 Months Post Ablation|Transplant|6
6828174|NCT00132041|10831313|FG000|9 Months Post Ablation|Death|1
6828175|NCT00132041|10831313|FG000|9 Months Post Ablation|Transplant|1
6828176|NCT00132041|10831313|FG000|12 Months Post Ablation|Withdrawal by Subject|1
6828177|NCT00132041|10831313|FG000|12 Months Post Ablation|Death|1
6828178|NCT00132041|10831313|FG000|12 Months Post Ablation|Transplant|1
6828179|NCT00132041|10831313|FG000|12 Months Post Ablation|non-protocol Treatment|1
6828180|NCT00132041|10831313|FG000|15 Months Post Ablation|Withdrawal by Subject|1
6828181|NCT00132041|10831313|FG000|15 Months Post Ablation|Death|1
6828182|NCT00132041|10831313|FG000|15 Months Post Ablation|Transplant|5
6828183|NCT00132041|10831313|FG000|15 Months Post Ablation|Non-Protocol Treatment|1
6828184|NCT00132041|10831313|FG000|18 Months Post Ablation|Withdrawal by Subject|1
6828185|NCT00132041|10831313|FG000|18 Months Post Ablation|Transplant|1
6828186|NCT00132041|10831313|FG000|18 Months Post Ablation|Non-Protocol Treatment|3
6828187|NCT00132041|10831313|FG000|18 Months Post Ablation|ExtraHepatic tumor|1
6828188|NCT00132132|10831325|FG000|Overall Study|Lost to Follow-up|7
6828189|NCT00132132|10831326|FG001|Overall Study|Lost to Follow-up|2
6828190|NCT00132301|10831334|FG000|Overall Study|Death|7
6828191|NCT00132301|10831335|FG001|Overall Study|Death|6
6828192|NCT00132301|10831334|FG000|Overall Study|Withdrawal by Subject|5
6828193|NCT00132301|10831335|FG001|Overall Study|Withdrawal by Subject|2
6828194|NCT00132301|10831334|FG000|Overall Study|Physician Decision|1
6828195|NCT00132301|10831335|FG001|Overall Study|Physician Decision|1
6828196|NCT00132301|10831334|FG000|Overall Study|Lost to Follow-up|5
6828197|NCT00132301|10831335|FG001|Overall Study|Lost to Follow-up|3
6828198|NCT00132301|10831334|FG000|Overall Study|Other|1
6828199|NCT00132301|10831335|FG001|Overall Study|Other|1
6828200|NCT00132301|10831334|FG000|Overall Study|Excluded by Data Monitoring Committee|1
6828201|NCT00132301|10831335|FG001|Overall Study|Excluded by Data Monitoring Committee|0
6828202|NCT00132314|10831343|FG000|Overall Study|Lost to Follow-up|70
6828203|NCT00132314|10831344|FG001|Overall Study|Lost to Follow-up|62
6828204|NCT00132314|10831343|FG000|Overall Study|Lacked SSN|1
6828205|NCT00132314|10831344|FG001|Overall Study|Lacked SSN|3
6828206|NCT00132314|10831343|FG000|Overall Study|Refused intervention at baseline|2
6828207|NCT00132314|10831344|FG001|Overall Study|Refused intervention at baseline|7
6923851|NCT00819585|10952841|FG009|Core Study|Administrative Problems|0
6923852|NCT00819585|10952842|FG010|Core Study|Administrative Problems|0
6923853|NCT00819585|10952832|FG000|Core Study|Death|0
6923854|NCT00819585|10952833|FG001|Core Study|Death|0
6923855|NCT00819585|10952834|FG002|Core Study|Death|0
6923856|NCT00819585|10952835|FG003|Core Study|Death|0
6923857|NCT00819585|10952836|FG004|Core Study|Death|0
6923858|NCT00819585|10952837|FG005|Core Study|Death|0
6923859|NCT00819585|10952838|FG006|Core Study|Death|1
6923860|NCT00819585|10952839|FG007|Core Study|Death|0
6923861|NCT00819585|10952840|FG008|Core Study|Death|0
6923862|NCT00819585|10952841|FG009|Core Study|Death|0
6923863|NCT00819585|10952842|FG010|Core Study|Death|0
6923864|NCT00819585|10952832|FG000|Core Study|Protocol Violation|0
6923865|NCT00819585|10952833|FG001|Core Study|Protocol Violation|0
6923866|NCT00819585|10952834|FG002|Core Study|Protocol Violation|1
6923867|NCT00819585|10952835|FG003|Core Study|Protocol Violation|0
6923868|NCT00819585|10952836|FG004|Core Study|Protocol Violation|0
6923869|NCT00819585|10952837|FG005|Core Study|Protocol Violation|1
6923870|NCT00819585|10952838|FG006|Core Study|Protocol Violation|3
6923871|NCT00819585|10952839|FG007|Core Study|Protocol Violation|0
6923872|NCT00819585|10952840|FG008|Core Study|Protocol Violation|0
6923873|NCT00819585|10952841|FG009|Core Study|Protocol Violation|0
6923874|NCT00819585|10952842|FG010|Core Study|Protocol Violation|0
6923875|NCT00819585|10952832|FG000|Extension Study|Abnormal Laboratory Value(s)|0
6923876|NCT00819585|10952833|FG001|Extension Study|Abnormal Laboratory Value(s)|0
6923877|NCT00819585|10952834|FG002|Extension Study|Abnormal Laboratory Value(s)|0
6923878|NCT00819585|10952835|FG003|Extension Study|Abnormal Laboratory Value(s)|0
6923879|NCT00819585|10952836|FG004|Extension Study|Abnormal Laboratory Value(s)|0
6923880|NCT00819585|10952837|FG005|Extension Study|Abnormal Laboratory Value(s)|0
6923881|NCT00819585|10952838|FG006|Extension Study|Abnormal Laboratory Value(s)|0
6923882|NCT00819585|10952839|FG007|Extension Study|Abnormal Laboratory Value(s)|0
6923883|NCT00819585|10952840|FG008|Extension Study|Abnormal Laboratory Value(s)|1
6923884|NCT00819585|10952841|FG009|Extension Study|Abnormal Laboratory Value(s)|0
6923885|NCT00819585|10952842|FG010|Extension Study|Abnormal Laboratory Value(s)|0
6923886|NCT00819585|10952832|FG000|Extension Study|Subject Withdrew Consent|0
6923887|NCT00819585|10952833|FG001|Extension Study|Subject Withdrew Consent|0
6923888|NCT00819585|10952834|FG002|Extension Study|Subject Withdrew Consent|0
6923889|NCT00819585|10952835|FG003|Extension Study|Subject Withdrew Consent|0
6923890|NCT00819585|10952836|FG004|Extension Study|Subject Withdrew Consent|0
6923891|NCT00819585|10952837|FG005|Extension Study|Subject Withdrew Consent|0
6828208|NCT00132496|10831352|FG000|Overall Study|Withdrawal by Subject|1
6828209|NCT00132496|10831353|FG001|Overall Study|Withdrawal by Subject|2
6828210|NCT00132496|10831352|FG000|Overall Study|Physician Decision|1
6828211|NCT00132496|10831353|FG001|Overall Study|Physician Decision|0
6828212|NCT00132678|10831361|FG000|Period II (Open-Label Oral Risperidone)|Death|0
6923892|NCT00819585|10952838|FG006|Extension Study|Subject Withdrew Consent|0
6923893|NCT00819585|10952839|FG007|Extension Study|Subject Withdrew Consent|0
6923894|NCT00819585|10952840|FG008|Extension Study|Subject Withdrew Consent|3
6828213|NCT00132678|10831362|FG001|Period II (Open-Label Oral Risperidone)|Death|0
6828214|NCT00132678|10831363|FG002|Period II (Open-Label Oral Risperidone)|Death|1
6828215|NCT00132678|10831361|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0
6828216|NCT00132678|10831362|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0
6828217|NCT00132678|10831363|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13
6828218|NCT00132678|10831361|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0
6828219|NCT00132678|10831362|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0
6828220|NCT00132678|10831363|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6
6828221|NCT00132678|10831361|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
6828222|NCT00132678|10831362|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
6828223|NCT00132678|10831363|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7
6828224|NCT00132678|10831361|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
6828225|NCT00132678|10831362|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
6828226|NCT00132678|10831363|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14
6828227|NCT00132678|10831361|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
6828228|NCT00132678|10831362|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
6828229|NCT00132678|10831363|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16
6828230|NCT00132678|10831361|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0
6828231|NCT00132678|10831362|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0
6828232|NCT00132678|10831363|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1
6828233|NCT00132678|10831361|FG000|Period III (Open-Label Stabilization)|Death|2
6828234|NCT00132678|10831362|FG001|Period III (Open-Label Stabilization)|Death|0
6828235|NCT00132678|10831363|FG002|Period III (Open-Label Stabilization)|Death|0
6828236|NCT00132678|10831361|FG000|Period III (Open-Label Stabilization)|Adverse Event|12
6828237|NCT00132678|10831362|FG001|Period III (Open-Label Stabilization)|Adverse Event|0
6828238|NCT00132678|10831363|FG002|Period III (Open-Label Stabilization)|Adverse Event|0
6828239|NCT00132678|10831361|FG000|Period III (Open-Label Stabilization)|Non responder|107
6828240|NCT00132678|10831362|FG001|Period III (Open-Label Stabilization)|Non responder|0
6828241|NCT00132678|10831363|FG002|Period III (Open-Label Stabilization)|Non responder|0
6828242|NCT00132678|10831361|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5
6828243|NCT00132678|10831362|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
6828244|NCT00132678|10831363|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
6828245|NCT00132678|10831361|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19
6828246|NCT00132678|10831362|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0
6828247|NCT00132678|10831363|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0
6828248|NCT00132678|10831361|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49
6828249|NCT00132678|10831362|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
6828250|NCT00132678|10831363|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
6828251|NCT00132678|10831361|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1
6828252|NCT00132678|10831362|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0
6828253|NCT00132678|10831363|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0
6828254|NCT00132678|10831361|FG000|Period III (Open-Label Stabilization)|Physician Decision|1
6828255|NCT00132678|10831362|FG001|Period III (Open-Label Stabilization)|Physician Decision|0
6828256|NCT00132678|10831363|FG002|Period III (Open-Label Stabilization)|Physician Decision|0
6828257|NCT00132678|10831361|FG000|Period III (Open-Label Stabilization)|Pregnancy|2
6828258|NCT00132678|10831362|FG001|Period III (Open-Label Stabilization)|Pregnancy|0
6828259|NCT00132678|10831363|FG002|Period III (Open-Label Stabilization)|Pregnancy|0
6828260|NCT00132678|10831361|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1
6828261|NCT00132678|10831362|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1
6828262|NCT00132678|10831363|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0
6828263|NCT00132678|10831361|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
6828264|NCT00132678|10831362|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
6828265|NCT00132678|10831363|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0
6828266|NCT00132678|10831361|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6
6828267|NCT00132678|10831362|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3
6828268|NCT00132678|10831363|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0
6828269|NCT00132678|10831361|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14
6828270|NCT00132678|10831362|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15
6828271|NCT00132678|10831363|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0
6828272|NCT00132678|10831361|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10
6828273|NCT00132678|10831362|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14
6828274|NCT00132678|10831363|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0
6828275|NCT00132678|10831361|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2
6828276|NCT00132678|10831362|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1
6828277|NCT00132678|10831363|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0
6828278|NCT00132678|10831361|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0
6828279|NCT00132678|10831362|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2
6828280|NCT00132678|10831363|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0
7061811|NCT01931839|11158969|FG001|Overall Study|Adverse Event|4
7061812|NCT01931839|11158970|FG002|Overall Study|Adverse Event|1
7061813|NCT01931839|11158971|FG003|Overall Study|Adverse Event|3
7061814|NCT01931839|11158972|FG004|Overall Study|Adverse Event|0
7061815|NCT01931839|11158973|FG005|Overall Study|Adverse Event|0
7061816|NCT01931839|11158974|FG006|Overall Study|Adverse Event|1
7061817|NCT01931839|11158968|FG000|Overall Study|Withdrawal of consent (not due to AE)|11
7061818|NCT01931839|11158969|FG001|Overall Study|Withdrawal of consent (not due to AE)|8
7061819|NCT01931839|11158970|FG002|Overall Study|Withdrawal of consent (not due to AE)|13
7061820|NCT01931839|11158971|FG003|Overall Study|Withdrawal of consent (not due to AE)|3
7061821|NCT01931839|11158972|FG004|Overall Study|Withdrawal of consent (not due to AE)|0
7061822|NCT01931839|11158973|FG005|Overall Study|Withdrawal of consent (not due to AE)|2
7061823|NCT01931839|11158974|FG006|Overall Study|Withdrawal of consent (not due to AE)|2
7061824|NCT01931839|11158968|FG000|Overall Study|Other non-compliance|15
7061825|NCT01931839|11158969|FG001|Overall Study|Other non-compliance|9
6828281|NCT00132691|10831373|FG000|Overall Study|Lost to Follow-up|5
6828282|NCT00132691|10831374|FG001|Overall Study|Lost to Follow-up|8
6828283|NCT00132691|10831373|FG000|Overall Study|Missed 2-year visit|4
6828284|NCT00132691|10831374|FG001|Overall Study|Missed 2-year visit|4
6828285|NCT00132691|10831373|FG000|Overall Study|Death|2
6828286|NCT00132691|10831374|FG001|Overall Study|Death|0
6828287|NCT00132730|10831389|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11
6828288|NCT00132730|10831390|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4
6828289|NCT00132730|10831391|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
6828290|NCT00132730|10831392|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
6828291|NCT00132730|10831393|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
6828292|NCT00132730|10831394|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
6828293|NCT00132730|10831389|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
6828294|NCT00132730|10831390|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
6828295|NCT00132730|10831391|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
6828296|NCT00132730|10831392|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
6828297|NCT00132730|10831393|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
6828298|NCT00132730|10831394|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
6828299|NCT00132730|10831389|FG000|Period II - 12-week Treatment (Base)|Other reasons|11
6828300|NCT00132730|10831390|FG001|Period II - 12-week Treatment (Base)|Other reasons|10
6828301|NCT00132730|10831391|FG002|Period II - 12-week Treatment (Base)|Other reasons|9
6828302|NCT00132730|10831392|FG003|Period II - 12-week Treatment (Base)|Other reasons|13
6828303|NCT00132730|10831393|FG004|Period II - 12-week Treatment (Base)|Other reasons|0
6828304|NCT00132730|10831394|FG005|Period II - 12-week Treatment (Base)|Other reasons|0
6828305|NCT00132730|10831389|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0
6828306|NCT00132730|10831390|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0
6923895|NCT00819585|10952841|FG009|Extension Study|Subject Withdrew Consent|0
6923896|NCT00819585|10952842|FG010|Extension Study|Subject Withdrew Consent|1
6923897|NCT00819585|10952832|FG000|Extension Study|Lost to Follow-up|0
6923898|NCT00819585|10952833|FG001|Extension Study|Lost to Follow-up|0
6923899|NCT00819585|10952834|FG002|Extension Study|Lost to Follow-up|0
6923900|NCT00819585|10952835|FG003|Extension Study|Lost to Follow-up|0
6923901|NCT00819585|10952836|FG004|Extension Study|Lost to Follow-up|0
6923902|NCT00819585|10952837|FG005|Extension Study|Lost to Follow-up|0
6923903|NCT00819585|10952838|FG006|Extension Study|Lost to Follow-up|0
6923904|NCT00819585|10952839|FG007|Extension Study|Lost to Follow-up|0
6923905|NCT00819585|10952840|FG008|Extension Study|Lost to Follow-up|2
6923906|NCT00819585|10952841|FG009|Extension Study|Lost to Follow-up|1
6923907|NCT00819585|10952842|FG010|Extension Study|Lost to Follow-up|1
6923908|NCT00819585|10952832|FG000|Extension Study|Death|0
6923909|NCT00819585|10952833|FG001|Extension Study|Death|0
6923910|NCT00819585|10952834|FG002|Extension Study|Death|0
6923911|NCT00819585|10952835|FG003|Extension Study|Death|0
6923912|NCT00819585|10952836|FG004|Extension Study|Death|0
6923913|NCT00819585|10952837|FG005|Extension Study|Death|0
6923914|NCT00819585|10952838|FG006|Extension Study|Death|0
6923915|NCT00819585|10952839|FG007|Extension Study|Death|0
6923916|NCT00819585|10952840|FG008|Extension Study|Death|2
6923917|NCT00819585|10952841|FG009|Extension Study|Death|0
6923918|NCT00819585|10952842|FG010|Extension Study|Death|0
6923919|NCT00819741|10952885|FG000|Overall Study|Adverse Event|5
6923920|NCT00819741|10952886|FG001|Overall Study|Adverse Event|2
6923921|NCT00819741|10952885|FG000|Overall Study|Lack of Efficacy|0
6923922|NCT00819741|10952886|FG001|Overall Study|Lack of Efficacy|2
6923923|NCT00819741|10952885|FG000|Overall Study|Lost to Follow-up|3
6923924|NCT00819741|10952886|FG001|Overall Study|Lost to Follow-up|1
6923925|NCT00819741|10952885|FG000|Overall Study|Protocol Violation|3
6923926|NCT00819741|10952886|FG001|Overall Study|Protocol Violation|4
6923927|NCT00819741|10952885|FG000|Overall Study|Withdrawal by Subject|2
6923928|NCT00819741|10952886|FG001|Overall Study|Withdrawal by Subject|2
7061826|NCT01931839|11158970|FG002|Overall Study|Other non-compliance|12
7061827|NCT01931839|11158971|FG003|Overall Study|Other non-compliance|3
6923929|NCT00819741|10952885|FG000|Overall Study|Unclassified|6
6923930|NCT00819741|10952886|FG001|Overall Study|Unclassified|0
6923931|NCT00819741|10952885|FG000|Overall Study|Reasons unknown|3
6828307|NCT00132730|10831391|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57
6828308|NCT00132730|10831392|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20
7038425|NCT01702558|11120731|FG001|Overall Study|Safety Follow-Up less than 3 Months|0
6828309|NCT00132730|10831393|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0
6828310|NCT00132730|10831394|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0
6828311|NCT00132730|10831389|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
6828312|NCT00132730|10831390|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
6828313|NCT00132730|10831391|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11
6828314|NCT00132730|10831392|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1
6828315|NCT00132730|10831393|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
6828316|NCT00132730|10831394|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
6828317|NCT00132730|10831389|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
6828318|NCT00132730|10831390|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
6828319|NCT00132730|10831391|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
6828320|NCT00132730|10831392|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1
6828321|NCT00132730|10831393|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
6828322|NCT00132730|10831394|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
6828323|NCT00132730|10831389|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0
6828324|NCT00132730|10831390|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0
6828325|NCT00132730|10831391|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14
6828326|NCT00132730|10831392|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3
6828327|NCT00132730|10831393|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0
6828328|NCT00132730|10831394|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0
6828329|NCT00132730|10831389|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0
6828330|NCT00132730|10831390|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0
6828331|NCT00132730|10831391|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0
6828332|NCT00132730|10831392|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0
6828333|NCT00132730|10831393|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169
6828334|NCT00132730|10831394|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68
6828335|NCT00132730|10831389|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
6828336|NCT00132730|10831390|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
6828337|NCT00132730|10831391|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
6828338|NCT00132730|10831392|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
6828339|NCT00132730|10831393|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3
6828340|NCT00132730|10831394|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
6828341|NCT00132730|10831389|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
6828342|NCT00132730|10831390|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
6828343|NCT00132730|10831391|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
6828344|NCT00132730|10831392|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
6828345|NCT00132730|10831393|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1
6828346|NCT00132730|10831394|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
6828347|NCT00132730|10831389|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0
6828348|NCT00132730|10831390|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0
6828349|NCT00132730|10831391|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0
6828350|NCT00132730|10831392|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0
6828351|NCT00132730|10831393|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6
6828352|NCT00132730|10831394|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0
6828353|NCT00132730|10831389|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0
6828354|NCT00132730|10831390|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0
6828355|NCT00132730|10831391|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0
6828356|NCT00132730|10831392|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0
6828357|NCT00132730|10831393|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7
6828358|NCT00132730|10831394|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2
6828359|NCT00132769|10831410|FG000|Overall Study|Withdrawal by Subject|1
6828360|NCT00132769|10831411|FG001|Overall Study|Withdrawal by Subject|3
6828361|NCT00132769|10831410|FG000|Overall Study|Lack of Efficacy|7
6828362|NCT00132769|10831411|FG001|Overall Study|Lack of Efficacy|6
6828363|NCT00132769|10831410|FG000|Overall Study|Adverse Event|2
6828364|NCT00132769|10831411|FG001|Overall Study|Adverse Event|1
6828365|NCT00132769|10831410|FG000|Overall Study|Protocol Violation|1
6828366|NCT00132769|10831411|FG001|Overall Study|Protocol Violation|1
6828367|NCT00132808|10831420|FG000|Stratum I|Adverse Event|2
6828368|NCT00132808|10831421|FG001|Stratum I|Adverse Event|1
6828369|NCT00132808|10831422|FG002|Stratum I|Adverse Event|0
6828370|NCT00132808|10831420|FG000|Stratum I|Lost to Follow-up|3
6828371|NCT00132808|10831421|FG001|Stratum I|Lost to Follow-up|4
6828372|NCT00132808|10831422|FG002|Stratum I|Lost to Follow-up|1
6828373|NCT00132808|10831420|FG000|Stratum I|Withdrawal by Subject|4
6828374|NCT00132808|10831421|FG001|Stratum I|Withdrawal by Subject|7
7038426|NCT01702558|11120732|FG002|Overall Study|Safety Follow-Up less than 3 Months|2
7038427|NCT01702558|11120733|FG003|Overall Study|Safety Follow-Up less than 3 Months|0
6828375|NCT00132808|10831422|FG002|Stratum I|Withdrawal by Subject|3
6828376|NCT00132808|10831420|FG000|Stratum I|Abnormal test procedure result (s)|0
6828377|NCT00132808|10831421|FG001|Stratum I|Abnormal test procedure result (s)|0
6828378|NCT00132808|10831422|FG002|Stratum I|Abnormal test procedure result (s)|1
6828379|NCT00132808|10831420|FG000|Stratum II|Adverse Event|1
6828380|NCT00132808|10831421|FG001|Stratum II|Adverse Event|2
6828381|NCT00132808|10831422|FG002|Stratum II|Adverse Event|1
6828382|NCT00132808|10831420|FG000|Stratum II|Death|1
6828383|NCT00132808|10831421|FG001|Stratum II|Death|0
6828384|NCT00132808|10831422|FG002|Stratum II|Death|0
6828385|NCT00132808|10831420|FG000|Stratum II|Lost to Follow-up|2
6828386|NCT00132808|10831421|FG001|Stratum II|Lost to Follow-up|2
6828387|NCT00132808|10831422|FG002|Stratum II|Lost to Follow-up|1
6828388|NCT00132808|10831420|FG000|Stratum II|Protocol Violation|0
6828389|NCT00132808|10831421|FG001|Stratum II|Protocol Violation|2
6828390|NCT00132808|10831422|FG002|Stratum II|Protocol Violation|1
6828391|NCT00132808|10831420|FG000|Stratum II|Withdrawal by Subject|4
6828392|NCT00132808|10831421|FG001|Stratum II|Withdrawal by Subject|9
6828393|NCT00132808|10831422|FG002|Stratum II|Withdrawal by Subject|6
6828394|NCT00132873|10831430|FG000|Overall Study|Adverse Event|3
6828395|NCT00132873|10831430|FG000|Overall Study|Lost to Follow-up|1
6828396|NCT00132873|10831430|FG000|Overall Study|Lack of Efficacy|1
6828397|NCT00132873|10831430|FG000|Overall Study|Withdrawal by Subject|3
6828398|NCT00132873|10831430|FG000|Overall Study|Planned Pregnancy|1
6828399|NCT00133705|10831474|FG000|Overall Study|Withdrawal by Subject|2
6828400|NCT00133705|10831475|FG001|Overall Study|Withdrawal by Subject|3
6828401|NCT00133952|10831487|FG000|Overall Study|Adverse Event|1
6828402|NCT00133952|10831488|FG001|Overall Study|Adverse Event|2
6828403|NCT00133952|10831487|FG000|Overall Study|Death|3
6828404|NCT00133952|10831488|FG001|Overall Study|Death|2
6828405|NCT00133952|10831487|FG000|Overall Study|Lost to Follow-up|9
6828406|NCT00133952|10831488|FG001|Overall Study|Lost to Follow-up|14
6828407|NCT00133952|10831487|FG000|Overall Study|Protocol Entry Criteria Exclusion|4
6828408|NCT00133952|10831488|FG001|Overall Study|Protocol Entry Criteria Exclusion|1
6828409|NCT00133952|10831487|FG000|Overall Study|Protocol Violation|1
6828410|NCT00133952|10831488|FG001|Overall Study|Protocol Violation|1
6828411|NCT00133952|10831487|FG000|Overall Study|Withdrawal by Subject|20
6828412|NCT00133952|10831488|FG001|Overall Study|Withdrawal by Subject|4
6828413|NCT00133952|10831487|FG000|Overall Study|Physician Decision|4
6828414|NCT00133952|10831488|FG001|Overall Study|Physician Decision|3
6828415|NCT00133952|10831487|FG000|Overall Study|Sponsor Decision|0
6828416|NCT00133952|10831488|FG001|Overall Study|Sponsor Decision|1
6828417|NCT00133991|10831515|FG000|Overall Study|Death|4
6828418|NCT00134056|10831537|FG000|Randomization|Not eligible for assigned treatment|22
6828419|NCT00134056|10831538|FG001|Randomization|Not eligible for assigned treatment|20
6828420|NCT00134056|10831537|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
6828421|NCT00134056|10831538|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
6828422|NCT00134056|10831537|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81
6828423|NCT00134056|10831538|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67
6828424|NCT00134056|10831537|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20
6828425|NCT00134056|10831538|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21
6828426|NCT00134056|10831537|FG000|Eligible for Protocol Assigned Treatment|Other|55
6828427|NCT00134056|10831538|FG001|Eligible for Protocol Assigned Treatment|Other|56
6828428|NCT00134082|10831547|FG000|Overall Study|Adverse Event|2
6828429|NCT00134082|10831547|FG000|Overall Study|Death|1
6828430|NCT00134563|10831576|FG000|Overall Study|Not treated due to protocol violation|0
6828431|NCT00134563|10831577|FG001|Overall Study|Not treated due to protocol violation|1
6828432|NCT00134563|10831578|FG002|Overall Study|Not treated due to protocol violation|1
6828433|NCT00134563|10831576|FG000|Overall Study|Adverse Event|29
6828434|NCT00134563|10831577|FG001|Overall Study|Adverse Event|37
6828435|NCT00134563|10831578|FG002|Overall Study|Adverse Event|38
6828436|NCT00134563|10831576|FG000|Overall Study|Lack of Efficacy|24
6828437|NCT00134563|10831577|FG001|Overall Study|Lack of Efficacy|14
6828438|NCT00134563|10831578|FG002|Overall Study|Lack of Efficacy|17
6828439|NCT00134563|10831576|FG000|Overall Study|Protocol Violation|3
6828440|NCT00134563|10831577|FG001|Overall Study|Protocol Violation|2
6828441|NCT00134563|10831578|FG002|Overall Study|Protocol Violation|5
6828442|NCT00134563|10831576|FG000|Overall Study|Lost to Follow-up|4
6828443|NCT00134563|10831577|FG001|Overall Study|Lost to Follow-up|0
6828444|NCT00134563|10831578|FG002|Overall Study|Lost to Follow-up|2
6828445|NCT00134563|10831576|FG000|Overall Study|progressive disease|11
6828446|NCT00134563|10831577|FG001|Overall Study|progressive disease|4
6828447|NCT00134563|10831578|FG002|Overall Study|progressive disease|2
6828448|NCT00134563|10831576|FG000|Overall Study|did not wish to continue|33
6828449|NCT00134563|10831577|FG001|Overall Study|did not wish to continue|32
6828450|NCT00134563|10831578|FG002|Overall Study|did not wish to continue|26
6828451|NCT00134563|10831576|FG000|Overall Study|Reason other than above|0
6828452|NCT00134563|10831577|FG001|Overall Study|Reason other than above|2
6828453|NCT00134563|10831578|FG002|Overall Study|Reason other than above|5
6897079|NCT00636441|10915731|FG006|Overall Study|Screen Failure|17
6897080|NCT00636506|10915742|FG000|Overall Study|Lost to Follow-up|8
6897081|NCT00636506|10915742|FG000|Overall Study|Explanted|1
6897082|NCT00636506|10915742|FG000|Overall Study|Withdrawal by Subject|6
6828454|NCT00134719|10831589|FG000|Primary Vaccination Phase|Adverse Event|4
6828455|NCT00134719|10831590|FG001|Primary Vaccination Phase|Adverse Event|0
6828456|NCT00134719|10831591|FG002|Primary Vaccination Phase|Adverse Event|0
6828457|NCT00134719|10831589|FG000|Primary Vaccination Phase|Protocol Violation|1
6828458|NCT00134719|10831590|FG001|Primary Vaccination Phase|Protocol Violation|0
6828459|NCT00134719|10831591|FG002|Primary Vaccination Phase|Protocol Violation|0
6828460|NCT00134719|10831589|FG000|Primary Vaccination Phase|Withdrawal by Subject|2
7061828|NCT01931839|11158972|FG004|Overall Study|Other non-compliance|0
7061829|NCT01931839|11158973|FG005|Overall Study|Other non-compliance|3
7061830|NCT01931839|11158974|FG006|Overall Study|Other non-compliance|0
7061831|NCT01931839|11158968|FG000|Overall Study|Lost to Follow-up|1
7061832|NCT01931839|11158969|FG001|Overall Study|Lost to Follow-up|2
6828461|NCT00134719|10831590|FG001|Primary Vaccination Phase|Withdrawal by Subject|3
6828462|NCT00134719|10831591|FG002|Primary Vaccination Phase|Withdrawal by Subject|2
6828463|NCT00134719|10831589|FG000|Primary Vaccination Phase|Lost to Follow-up|7
6828464|NCT00134719|10831590|FG001|Primary Vaccination Phase|Lost to Follow-up|3
6828465|NCT00134719|10831591|FG002|Primary Vaccination Phase|Lost to Follow-up|3
6828466|NCT00134719|10831589|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1
6828467|NCT00134719|10831590|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3
6828468|NCT00134719|10831591|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1
6828469|NCT00134719|10831589|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1
6828470|NCT00134719|10831590|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
6828471|NCT00134719|10831591|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
6828472|NCT00134784|10831603|FG000|Overall Study|Withdrawal by Subject|2
6828473|NCT00134784|10831604|FG001|Overall Study|Withdrawal by Subject|2
6828474|NCT00134784|10831605|FG002|Overall Study|Withdrawal by Subject|2
6828475|NCT00134784|10831606|FG003|Overall Study|Withdrawal by Subject|1
6828476|NCT00134901|10831615|FG000|Overall Study|Lost to Follow-up|5
6828477|NCT00134901|10831616|FG001|Overall Study|Lost to Follow-up|5
6828478|NCT00134901|10831615|FG000|Overall Study|discontinued intervention|12
6828479|NCT00134901|10831616|FG001|Overall Study|discontinued intervention|10
6828480|NCT00135330|10831646|FG000|Overall Study|Adverse Event|2
6828481|NCT00135330|10831647|FG001|Overall Study|Adverse Event|5
7038428|NCT01702558|11120734|FG004|Overall Study|Safety Follow-Up less than 3 Months|0
7038429|NCT01702558|11120730|FG000|Overall Study|Study Terminated by Sponsor|0
6828482|NCT00135330|10831648|FG002|Overall Study|Adverse Event|1
6828483|NCT00135330|10831646|FG000|Overall Study|Lost to Follow-up|0
6828484|NCT00135330|10831647|FG001|Overall Study|Lost to Follow-up|2
6828485|NCT00135330|10831648|FG002|Overall Study|Lost to Follow-up|3
6828486|NCT00135330|10831646|FG000|Overall Study|Physician Decision|1
6828487|NCT00135330|10831647|FG001|Overall Study|Physician Decision|1
6828488|NCT00135330|10831648|FG002|Overall Study|Physician Decision|0
6828489|NCT00135330|10831646|FG000|Overall Study|Protocol Violation|4
6828490|NCT00135330|10831647|FG001|Overall Study|Protocol Violation|3
6828491|NCT00135330|10831648|FG002|Overall Study|Protocol Violation|3
6828492|NCT00135330|10831646|FG000|Overall Study|Patient Decision|5
6828493|NCT00135330|10831647|FG001|Overall Study|Patient Decision|1
6828494|NCT00135330|10831648|FG002|Overall Study|Patient Decision|4
6828495|NCT00135330|10831646|FG000|Overall Study|Sponsor Decision|0
6828496|NCT00135330|10831647|FG001|Overall Study|Sponsor Decision|1
6828497|NCT00135330|10831648|FG002|Overall Study|Sponsor Decision|0
6828498|NCT00135356|10831658|FG000|Overall Study|Adverse Event|6
6828499|NCT00135356|10831659|FG001|Overall Study|Adverse Event|2
6828500|NCT00135356|10831658|FG000|Overall Study|Lack of Efficacy|2
6828501|NCT00135356|10831659|FG001|Overall Study|Lack of Efficacy|0
6828502|NCT00135356|10831658|FG000|Overall Study|Lost to Follow-up|3
6828503|NCT00135356|10831659|FG001|Overall Study|Lost to Follow-up|1
6828504|NCT00135356|10831658|FG000|Overall Study|Surgery for abdominal fat|1
6828505|NCT00135356|10831659|FG001|Overall Study|Surgery for abdominal fat|0
6828506|NCT00135356|10831658|FG000|Overall Study|Change in antiviral regimen|0
6828507|NCT00135356|10831659|FG001|Overall Study|Change in antiviral regimen|1
6828508|NCT00135356|10831658|FG000|Overall Study|Poor/noncompliance|1
6828509|NCT00135356|10831659|FG001|Overall Study|Poor/noncompliance|1
6828510|NCT00135356|10831658|FG000|Overall Study|No longer meets study criteria|2
6828511|NCT00135356|10831659|FG001|Overall Study|No longer meets study criteria|0
6828512|NCT00135356|10831658|FG000|Overall Study|Withdrawal by Subject|2
6828513|NCT00135356|10831659|FG001|Overall Study|Withdrawal by Subject|4
6828514|NCT00135512|10831665|FG000|Overall Study|Adverse Event|56
6828515|NCT00135512|10831665|FG000|Overall Study|Lack of Efficacy|25
6828516|NCT00135512|10831665|FG000|Overall Study|Other|42
6828517|NCT00135694|10831672|FG000|Overall Study|Adverse Event|17
6828518|NCT00135694|10831673|FG001|Overall Study|Adverse Event|4
6828519|NCT00135694|10831674|FG002|Overall Study|Adverse Event|0
7038430|NCT01702558|11120731|FG001|Overall Study|Study Terminated by Sponsor|1
7038431|NCT01702558|11120732|FG002|Overall Study|Study Terminated by Sponsor|0
7038432|NCT01702558|11120733|FG003|Overall Study|Study Terminated by Sponsor|0
7061833|NCT01931839|11158970|FG002|Overall Study|Lost to Follow-up|4
6828520|NCT00135694|10831672|FG000|Overall Study|Death|14
7038433|NCT01702558|11120734|FG004|Overall Study|Study Terminated by Sponsor|1
7038434|NCT01702558|11120730|FG000|Overall Study|Other|0
6828521|NCT00135694|10831673|FG001|Overall Study|Death|1
6828522|NCT00135694|10831674|FG002|Overall Study|Death|2
6828523|NCT00135694|10831672|FG000|Overall Study|Lost to Follow-up|8
6828524|NCT00135694|10831673|FG001|Overall Study|Lost to Follow-up|7
6828525|NCT00135694|10831674|FG002|Overall Study|Lost to Follow-up|1
6828526|NCT00135694|10831672|FG000|Overall Study|Withdrawal by Subject|41
6828527|NCT00135694|10831673|FG001|Overall Study|Withdrawal by Subject|7
6828528|NCT00135694|10831674|FG002|Overall Study|Withdrawal by Subject|4
6828529|NCT00135694|10831672|FG000|Overall Study|Protocol Violation|19
6828530|NCT00135694|10831673|FG001|Overall Study|Protocol Violation|1
6828531|NCT00135694|10831674|FG002|Overall Study|Protocol Violation|0
6828532|NCT00135694|10831672|FG000|Overall Study|Hepatitis C related reasons|39
6828533|NCT00135694|10831673|FG001|Overall Study|Hepatitis C related reasons|1
6828534|NCT00135694|10831674|FG002|Overall Study|Hepatitis C related reasons|0
6828535|NCT00135694|10831672|FG000|Overall Study|Ineligible for Random assignment|42
6828536|NCT00135694|10831673|FG001|Overall Study|Ineligible for Random assignment|0
6828537|NCT00135694|10831674|FG002|Overall Study|Ineligible for Random assignment|0
6828538|NCT00135707|10831684|FG000|Overall Study|Lost to Follow-up|94
6828539|NCT00135707|10831685|FG001|Overall Study|Lost to Follow-up|89
7038435|NCT01702558|11120731|FG001|Overall Study|Other|0
7038436|NCT01702558|11120732|FG002|Overall Study|Other|0
7038437|NCT01702558|11120733|FG003|Overall Study|Other|16
7038438|NCT01702558|11120734|FG004|Overall Study|Other|17
7038439|NCT01702844|11120747|FG000|Overall Study|Adverse Event|9
7038440|NCT01702844|11120747|FG000|Overall Study|Death|1
7038441|NCT01702844|11120747|FG000|Overall Study|Withdrawal by Subject|3
7038442|NCT01702844|11120747|FG000|Overall Study|Physician Decision|6
7061834|NCT01931839|11158971|FG003|Overall Study|Lost to Follow-up|5
7061835|NCT01931839|11158972|FG004|Overall Study|Lost to Follow-up|0
6828540|NCT00135707|10831684|FG000|Overall Study|Withdrawal by Subject|0
6828541|NCT00135707|10831685|FG001|Overall Study|Withdrawal by Subject|1
6828542|NCT00135707|10831684|FG000|Overall Study|Institutional review board request|1
6828543|NCT00135707|10831685|FG001|Overall Study|Institutional review board request|0
6828544|NCT00136084|10831709|FG000|Overall Study|Death|12
6828545|NCT00136084|10831710|FG001|Overall Study|Death|5
6828546|NCT00136084|10831709|FG000|Overall Study|Unacceptable toxicity|8
6828547|NCT00136084|10831710|FG001|Overall Study|Unacceptable toxicity|11
6828548|NCT00136084|10831709|FG000|Overall Study|Relapse|20
6828549|NCT00136084|10831710|FG001|Overall Study|Relapse|23
6828550|NCT00136084|10831709|FG000|Overall Study|Lost to Follow-up|2
6828551|NCT00136084|10831710|FG001|Overall Study|Lost to Follow-up|0
6828552|NCT00136084|10831709|FG000|Overall Study|No Response|1
6828553|NCT00136084|10831710|FG001|Overall Study|No Response|2
6828554|NCT00136084|10831709|FG000|Overall Study|Withdrawal by Subject|5
6828555|NCT00136084|10831710|FG001|Overall Study|Withdrawal by Subject|1
6828556|NCT00136318|10831735|FG000|Overall Study|Adverse Event|5
6828557|NCT00136318|10831736|FG001|Overall Study|Adverse Event|5
6828558|NCT00136318|10831735|FG000|Overall Study|Withdrawal by Subject|2
6828559|NCT00136318|10831736|FG001|Overall Study|Withdrawal by Subject|2
6828560|NCT00136357|10831745|FG000|Overall Study|Withdrawal by Subject|3
6828561|NCT00136357|10831746|FG001|Overall Study|Withdrawal by Subject|2
6828562|NCT00136604|10831757|FG000|Overall Study|Lost to Follow-up|1
6828563|NCT00136604|10831758|FG001|Overall Study|Lost to Follow-up|0
6828564|NCT00136604|10831759|FG002|Overall Study|Lost to Follow-up|0
6828565|NCT00136604|10831760|FG003|Overall Study|Lost to Follow-up|0
6828566|NCT00136604|10831761|FG004|Overall Study|Lost to Follow-up|1
6828567|NCT00136604|10831757|FG000|Overall Study|Migrated/moved from study area|0
6828568|NCT00136604|10831758|FG001|Overall Study|Migrated/moved from study area|1
6828569|NCT00136604|10831759|FG002|Overall Study|Migrated/moved from study area|0
6828570|NCT00136604|10831760|FG003|Overall Study|Migrated/moved from study area|0
6828571|NCT00136604|10831761|FG004|Overall Study|Migrated/moved from study area|0
6828572|NCT00136916|10831823|FG000|Overall Study|Never received study treatment|3
6828573|NCT00136916|10831824|FG001|Overall Study|Never received study treatment|5
6828574|NCT00136916|10831823|FG000|Overall Study|Death|1
6828575|NCT00136916|10831824|FG001|Overall Study|Death|3
6828576|NCT00136916|10831823|FG000|Overall Study|Adverse Event|27
6828577|NCT00136916|10831824|FG001|Overall Study|Adverse Event|8
6828578|NCT00136916|10831823|FG000|Overall Study|Laboratory abnormality|0
6828579|NCT00136916|10831824|FG001|Overall Study|Laboratory abnormality|1
6828580|NCT00136916|10831823|FG000|Overall Study|Lack of Efficacy|13
6828581|NCT00136916|10831824|FG001|Overall Study|Lack of Efficacy|3
6828582|NCT00136916|10831823|FG000|Overall Study|Lost to Follow-up|12
6828583|NCT00136916|10831824|FG001|Overall Study|Lost to Follow-up|14
6828584|NCT00136916|10831823|FG000|Overall Study|Withdrawal by Subject|44
6828585|NCT00136916|10831824|FG001|Overall Study|Withdrawal by Subject|46
6828586|NCT00136916|10831823|FG000|Overall Study|Other|22
6828587|NCT00136916|10831824|FG001|Overall Study|Other|24
6828588|NCT00136916|10831823|FG000|Overall Study|Discontinued in follow up period|3
6828589|NCT00136916|10831824|FG001|Overall Study|Discontinued in follow up period|0
6828590|NCT00136955|10831832|FG000|Overall Study|Adverse Event|8
6828591|NCT00136955|10831832|FG000|Overall Study|Lost to Follow-up|1
6828592|NCT00136955|10831832|FG000|Overall Study|Withdrawal by Subject|2
6828593|NCT00136955|10831832|FG000|Overall Study|Incl. prog. disease, protocol violation|12
6828594|NCT00137046|10831838|FG000|Overall Study|Death|2
6828595|NCT00137046|10831839|FG001|Overall Study|Death|1
7038443|NCT01702961|11120751|FG000|Overall Study|Additional treatment|3
7038444|NCT01702961|11120751|FG000|Overall Study|Progressive disease|5
7061836|NCT01931839|11158973|FG005|Overall Study|Lost to Follow-up|0
6828596|NCT00137046|10831838|FG000|Overall Study|Adverse Event|16
6828597|NCT00137046|10831839|FG001|Overall Study|Adverse Event|5
6828598|NCT00137046|10831838|FG000|Overall Study|Laboratory Abnormality|2
6828599|NCT00137046|10831839|FG001|Overall Study|Laboratory Abnormality|0
6828600|NCT00137046|10831838|FG000|Overall Study|Lack of Efficacy|13
6828601|NCT00137046|10831839|FG001|Overall Study|Lack of Efficacy|1
6828602|NCT00137046|10831838|FG000|Overall Study|Lost to Follow-up|8
6828603|NCT00137046|10831839|FG001|Overall Study|Lost to Follow-up|24
6828604|NCT00137046|10831838|FG000|Overall Study|Other|23
6828605|NCT00137046|10831839|FG001|Overall Study|Other|19
6828606|NCT00137046|10831838|FG000|Overall Study|Withdrawal by Subject|33
6828607|NCT00137046|10831839|FG001|Overall Study|Withdrawal by Subject|42
6828608|NCT00137046|10831838|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1
6828609|NCT00137046|10831839|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0
6828610|NCT00137046|10831838|FG000|Overall Study|Withdrew prior to study treatment|1
6828611|NCT00137046|10831839|FG001|Overall Study|Withdrew prior to study treatment|1
6828612|NCT00137111|10831853|FG000|Total Therapy|Death|35
6828613|NCT00137111|10831854|FG001|Total Therapy|Death|0
6828614|NCT00137111|10831855|FG002|Total Therapy|Death|0
6828615|NCT00137111|10831856|FG003|Total Therapy|Death|0
6828616|NCT00137111|10831853|FG000|Total Therapy|Non Compliance|5
6828617|NCT00137111|10831854|FG001|Total Therapy|Non Compliance|0
6828618|NCT00137111|10831855|FG002|Total Therapy|Non Compliance|0
6828619|NCT00137111|10831856|FG003|Total Therapy|Non Compliance|0
6828620|NCT00137267|10831865|FG000|Overall Study|Lost to Follow-up|15
6828621|NCT00137267|10831866|FG001|Overall Study|Lost to Follow-up|21
6828622|NCT00137423|10831883|FG000|Overall Study|Adverse Event|7
6828623|NCT00137423|10831884|FG001|Overall Study|Adverse Event|9
6828624|NCT00137423|10831883|FG000|Overall Study|consent withdrawn|1
6828625|NCT00137423|10831884|FG001|Overall Study|consent withdrawn|1
6828626|NCT00137423|10831883|FG000|Overall Study|Lack of Efficacy|31
6828627|NCT00137423|10831884|FG001|Overall Study|Lack of Efficacy|33
6828628|NCT00137423|10831883|FG000|Overall Study|Death|0
6828629|NCT00137423|10831884|FG001|Overall Study|Death|1
6828630|NCT00137436|10831894|FG000|Overall Study|Adverse Event|13
6828631|NCT00137436|10831894|FG000|Overall Study|Death|2
6828632|NCT00137436|10831894|FG000|Overall Study|Lack of Efficacy|17
6828633|NCT00137436|10831894|FG000|Overall Study|Withdrawal by Subject|6
6828634|NCT00137436|10831894|FG000|Overall Study|Other|5
6828635|NCT00137449|10831900|FG000|Overall Study|Disease Progression|8
6828636|NCT00137449|10831901|FG001|Overall Study|Disease Progression|13
6828637|NCT00137449|10831900|FG000|Overall Study|Death|4
6828638|NCT00137449|10831901|FG001|Overall Study|Death|3
6828639|NCT00137449|10831900|FG000|Overall Study|Adverse Event|3
7038445|NCT01702961|11120751|FG000|Overall Study|Relapse|20
7038446|NCT01702961|11120751|FG000|Overall Study|Death|6
7038447|NCT01702961|11120751|FG000|Overall Study|Lost to Follow-up|2
7038448|NCT01702961|11120751|FG000|Overall Study|Ongoing|11
7038449|NCT01702987|11120757|FG000|Overall Study|Withdrawal by Subject|1
7038450|NCT01702987|11120758|FG001|Overall Study|Withdrawal by Subject|0
6828640|NCT00137449|10831901|FG001|Overall Study|Adverse Event|1
6828641|NCT00137449|10831900|FG000|Overall Study|Withdrawal by Subject|1
6828642|NCT00137449|10831901|FG001|Overall Study|Withdrawal by Subject|1
6828643|NCT00137631|10831910|FG000|Overall Study|Lost to Follow-up|37
6828644|NCT00137631|10831911|FG001|Overall Study|Lost to Follow-up|41
6828645|NCT00137839|10831917|FG000|Overall Study|Adverse Event|7
6828646|NCT00137839|10831917|FG000|Overall Study|Physician Decision|7
6828647|NCT00137839|10831917|FG000|Overall Study|Death|8
6828648|NCT00137839|10831917|FG000|Overall Study|Disease Progression|60
6828649|NCT00137839|10831917|FG000|Overall Study|Not Start Treatment|1
6828650|NCT00137839|10831917|FG000|Overall Study|Prolonged Treatment Delay|1
6828651|NCT00138424|10831962|FG000|Overall Study|Physician Decision|0
6828652|NCT00138424|10831963|FG001|Overall Study|Physician Decision|1
6923932|NCT00819741|10952886|FG001|Overall Study|Reasons unknown|3
6923933|NCT00819767|10952894|FG000|Overall Study|Unsatisfactory therapeutic effect|1
6923934|NCT00819767|10952895|FG001|Overall Study|Unsatisfactory therapeutic effect|2
6923935|NCT00819780|10952903|FG000|Overall Study|Did not receive study drug|3
6923936|NCT00819780|10952904|FG001|Overall Study|Did not receive study drug|4
6923937|NCT00819780|10952903|FG000|Overall Study|Still in treatment|25
6828653|NCT00138424|10831964|FG002|Overall Study|Physician Decision|0
6828654|NCT00138424|10831965|FG003|Overall Study|Physician Decision|0
6828655|NCT00138658|10831986|FG000|Overall Study|Adverse Event|23
6828656|NCT00138658|10831986|FG000|Overall Study|Death|1
6828657|NCT00138658|10831986|FG000|Overall Study|Disease Progression|21
6828658|NCT00138658|10831986|FG000|Overall Study|Physician Decision|11
6828659|NCT00138658|10831986|FG000|Overall Study|Withdrawal by Subject|5
6828660|NCT00138671|10831994|FG000|Overall Study|Death|0
6828661|NCT00138671|10831995|FG001|Overall Study|Death|3
6828662|NCT00138671|10831994|FG000|Overall Study|Adverse Event|6
6828663|NCT00138671|10831995|FG001|Overall Study|Adverse Event|3
6923938|NCT00819780|10952904|FG001|Overall Study|Still in treatment|17
6923939|NCT00819910|10952919|FG000|Overall Study|Adverse Event|0
7038451|NCT01703000|11120764|FG000|Overall Study|Death|1
6828664|NCT00138671|10831994|FG000|Overall Study|Lost to Follow-up|1
6828665|NCT00138671|10831995|FG001|Overall Study|Lost to Follow-up|2
6828666|NCT00138671|10831994|FG000|Overall Study|Withdrawal by Subject|3
6828667|NCT00138671|10831995|FG001|Overall Study|Withdrawal by Subject|5
6828668|NCT00138671|10831994|FG000|Overall Study|Other|3
6828669|NCT00138671|10831995|FG001|Overall Study|Other|3
6828670|NCT00139477|10832014|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6
6828671|NCT00139477|10832015|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7
6828672|NCT00139477|10832014|FG000|First Intervention -Baseline to 6Months|Relocation|1
6828673|NCT00139477|10832015|FG001|First Intervention -Baseline to 6Months|Relocation|2
6828674|NCT00139477|10832014|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3
6828675|NCT00139477|10832015|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3
6828676|NCT00139477|10832014|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2
6828677|NCT00139477|10832015|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0
6828678|NCT00139477|10832014|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0
6828679|NCT00139477|10832015|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2
6828680|NCT00139477|10832014|FG000|Second Intervention -6Months to 12Months|Relocation|1
6828681|NCT00139477|10832015|FG001|Second Intervention -6Months to 12Months|Relocation|0
6828682|NCT00139477|10832014|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4
6828683|NCT00139477|10832015|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3
6828684|NCT00139659|10832025|FG000|Overall Study|Adverse Event|12
6828685|NCT00139659|10832026|FG001|Overall Study|Adverse Event|1
6828686|NCT00139659|10832025|FG000|Overall Study|Lack of Efficacy|1
6828687|NCT00139659|10832026|FG001|Overall Study|Lack of Efficacy|1
6828688|NCT00139659|10832025|FG000|Overall Study|Lost to Follow-up|7
6828689|NCT00139659|10832026|FG001|Overall Study|Lost to Follow-up|3
6828690|NCT00139659|10832025|FG000|Overall Study|Reason not Specified|6
6828691|NCT00139659|10832026|FG001|Overall Study|Reason not Specified|3
6828692|NCT00139659|10832025|FG000|Overall Study|Withdrawal by Subject|14
6828693|NCT00139659|10832026|FG001|Overall Study|Withdrawal by Subject|10
6828694|NCT00139737|10832036|FG000|Overall Study|Withdrawal by Subject|190
6828695|NCT00139737|10832036|FG000|Overall Study|Adverse Event|58
6828696|NCT00139737|10832036|FG000|Overall Study|Lack of Efficacy|40
6828697|NCT00139737|10832036|FG000|Overall Study|Lost to Follow-up|8
6828698|NCT00139737|10832036|FG000|Overall Study|Death|3
6828699|NCT00139737|10832036|FG000|Overall Study|Laboratory Abnormality|2
6828700|NCT00139737|10832036|FG000|Overall Study|Protocol Violation|18
6828701|NCT00139737|10832036|FG000|Overall Study|Withdrew During Screening Phase|8
6828702|NCT00139737|10832036|FG000|Overall Study|Did Not Meet Entrance Criteria|1
6828703|NCT00139737|10832036|FG000|Overall Study|Screened, Not Treated|13
6828704|NCT00139776|10832042|FG000|Period I|Did not enter Period II|575
6828705|NCT00139776|10832043|FG001|Period I|Did not enter Period II|0
6828706|NCT00139776|10832044|FG002|Period I|Did not enter Period II|0
6828707|NCT00139776|10832045|FG003|Period I|Did not enter Period II|0
6828708|NCT00139776|10832042|FG000|Period II|Not Randomized into Period III|0
6828709|NCT00139776|10832043|FG001|Period II|Not Randomized into Period III|322
6828710|NCT00139776|10832044|FG002|Period II|Not Randomized into Period III|0
6828711|NCT00139776|10832045|FG003|Period II|Not Randomized into Period III|0
6828712|NCT00139776|10832042|FG000|Period III|Adverse Event|0
6828713|NCT00139776|10832043|FG001|Period III|Adverse Event|0
6828714|NCT00139776|10832044|FG002|Period III|Adverse Event|22
6828715|NCT00139776|10832045|FG003|Period III|Adverse Event|23
6828716|NCT00139776|10832042|FG000|Period III|Other|0
6828717|NCT00139776|10832043|FG001|Period III|Other|0
6828718|NCT00139776|10832044|FG002|Period III|Other|23
6828719|NCT00139776|10832045|FG003|Period III|Other|34
6828720|NCT00139776|10832042|FG000|Period III|Lack of Efficacy|0
6828721|NCT00139776|10832043|FG001|Period III|Lack of Efficacy|0
6828722|NCT00139776|10832044|FG002|Period III|Lack of Efficacy|10
6828723|NCT00139776|10832045|FG003|Period III|Lack of Efficacy|24
6828724|NCT00139776|10832042|FG000|Period III|Lost to Follow-up|0
6828725|NCT00139776|10832043|FG001|Period III|Lost to Follow-up|0
6828726|NCT00139776|10832044|FG002|Period III|Lost to Follow-up|5
6828727|NCT00139776|10832045|FG003|Period III|Lost to Follow-up|4
6828728|NCT00139776|10832042|FG000|Period III|Withdrawal by Subject|0
6828729|NCT00139776|10832043|FG001|Period III|Withdrawal by Subject|0
6828730|NCT00139776|10832044|FG002|Period III|Withdrawal by Subject|16
6828731|NCT00139776|10832045|FG003|Period III|Withdrawal by Subject|21
6828732|NCT00140140|10832064|FG000|Overall Study|Unacceptable toxicity|1
6828733|NCT00140140|10832065|FG001|Overall Study|Unacceptable toxicity|1
6828734|NCT00140140|10832066|FG002|Overall Study|Unacceptable toxicity|2
6828735|NCT00140140|10832064|FG000|Overall Study|Physician Decision|1
6828736|NCT00140140|10832065|FG001|Overall Study|Physician Decision|1
6828737|NCT00140140|10832066|FG002|Overall Study|Physician Decision|0
6828738|NCT00140413|10832127|FG000|Overall Study|Lost to Follow-up|1
6828739|NCT00140413|10832128|FG001|Overall Study|Lost to Follow-up|0
6828740|NCT00140413|10832127|FG000|Overall Study|Withdrawal by Subject|2
6828741|NCT00140413|10832128|FG001|Overall Study|Withdrawal by Subject|0
6828742|NCT00140426|10832137|FG000|Overall Study|Withdrawal by Subject|0
6828743|NCT00140426|10832138|FG001|Overall Study|Withdrawal by Subject|3
6828744|NCT00140855|10832166|FG000|Overall Study|Progressive disease|2
6828745|NCT00141037|10832172|FG000|Overall Study|Physician Decision|1
6828746|NCT00141037|10832173|FG001|Overall Study|Physician Decision|2
6828747|NCT00141037|10832172|FG000|Overall Study|Lost to Follow-up|3
6828748|NCT00141037|10832173|FG001|Overall Study|Lost to Follow-up|1
6828749|NCT00141037|10832172|FG000|Overall Study|Protocol Violation|0
6828750|NCT00141037|10832173|FG001|Overall Study|Protocol Violation|2
6828751|NCT00141037|10832172|FG000|Overall Study|Withdrawal by Subject|2
6828752|NCT00141037|10832173|FG001|Overall Study|Withdrawal by Subject|1
6828753|NCT00141037|10832172|FG000|Overall Study|Other|0
6828754|NCT00141037|10832173|FG001|Overall Study|Other|1
6828755|NCT00141037|10832172|FG000|Overall Study|Moved from area|1
6828756|NCT00141037|10832173|FG001|Overall Study|Moved from area|7
6828757|NCT00141037|10832172|FG000|Overall Study|Graft Failure|3
6828758|NCT00141037|10832173|FG001|Overall Study|Graft Failure|4
6828759|NCT00141102|10832181|FG000|Overall Study|Adverse Event|233
6828760|NCT00141102|10832182|FG001|Overall Study|Adverse Event|305
6828761|NCT00141102|10832181|FG000|Overall Study|Laboratory Abnormality|9
6828762|NCT00141102|10832182|FG001|Overall Study|Laboratory Abnormality|33
6828763|NCT00141102|10832181|FG000|Overall Study|Lack of Efficacy|21
6828764|NCT00141102|10832182|FG001|Overall Study|Lack of Efficacy|26
6828765|NCT00141102|10832181|FG000|Overall Study|Lost to Follow-up|29
6828766|NCT00141102|10832182|FG001|Overall Study|Lost to Follow-up|32
6828767|NCT00141102|10832181|FG000|Overall Study|Other|87
6828768|NCT00141102|10832182|FG001|Overall Study|Other|76
6828769|NCT00141102|10832181|FG000|Overall Study|Withdrawal by Subject|112
6828770|NCT00141102|10832182|FG001|Overall Study|Withdrawal by Subject|142
6828771|NCT00141102|10832181|FG000|Overall Study|Randomized But Did Not Receive Treatment|15
6828772|NCT00141102|10832182|FG001|Overall Study|Randomized But Did Not Receive Treatment|9
6828773|NCT00141102|10832181|FG000|Overall Study|Death|2
6828774|NCT00141102|10832182|FG001|Overall Study|Death|2
6828775|NCT00141219|10832196|FG000|Overall Study|Protocol violations|5
6828776|NCT00141219|10832197|FG001|Overall Study|Protocol violations|4
6828777|NCT00141219|10832196|FG000|Overall Study|Adverse Event|8
6828778|NCT00141219|10832197|FG001|Overall Study|Adverse Event|6
6828779|NCT00141219|10832196|FG000|Overall Study|Lack of Efficacy|5
6828780|NCT00141219|10832197|FG001|Overall Study|Lack of Efficacy|4
6828781|NCT00141219|10832196|FG000|Overall Study|Withdrawal by Subject|6
6828782|NCT00141219|10832197|FG001|Overall Study|Withdrawal by Subject|2
6828783|NCT00141271|10832206|FG000|Overall Study|Adverse Event|31
6828784|NCT00141271|10832207|FG001|Overall Study|Adverse Event|19
6828785|NCT00141271|10832208|FG002|Overall Study|Adverse Event|17
6828786|NCT00141271|10832206|FG000|Overall Study|Laboratory Abnormality|2
6828787|NCT00141271|10832207|FG001|Overall Study|Laboratory Abnormality|1
6828788|NCT00141271|10832208|FG002|Overall Study|Laboratory Abnormality|1
6828789|NCT00141271|10832206|FG000|Overall Study|Lack of Efficacy|7
6828790|NCT00141271|10832207|FG001|Overall Study|Lack of Efficacy|7
6828791|NCT00141271|10832208|FG002|Overall Study|Lack of Efficacy|3
6828792|NCT00141271|10832206|FG000|Overall Study|Lost to Follow-up|15
6828793|NCT00141271|10832207|FG001|Overall Study|Lost to Follow-up|15
6828794|NCT00141271|10832208|FG002|Overall Study|Lost to Follow-up|21
6828795|NCT00141271|10832206|FG000|Overall Study|Withdrawal by Subject|14
6828796|NCT00141271|10832207|FG001|Overall Study|Withdrawal by Subject|9
6828797|NCT00141271|10832208|FG002|Overall Study|Withdrawal by Subject|10
6828798|NCT00141271|10832206|FG000|Overall Study|Other|11
6828799|NCT00141271|10832207|FG001|Overall Study|Other|12
6828800|NCT00141271|10832208|FG002|Overall Study|Other|5
6828801|NCT00141297|10832218|FG000|Overall Study|Adverse Event|0
6828802|NCT00141297|10832219|FG001|Overall Study|Adverse Event|0
6828803|NCT00141297|10832220|FG002|Overall Study|Adverse Event|1
6828804|NCT00141297|10832221|FG003|Overall Study|Adverse Event|0
6828805|NCT00141297|10832222|FG004|Overall Study|Adverse Event|1
6828806|NCT00141297|10832223|FG005|Overall Study|Adverse Event|1
6828807|NCT00141297|10832224|FG006|Overall Study|Adverse Event|0
6828808|NCT00141297|10832225|FG007|Overall Study|Adverse Event|1
7038452|NCT01703065|11120781|FG000|Overall Study|Lack of Efficacy|1
7038453|NCT01703065|11120782|FG001|Overall Study|Lack of Efficacy|0
7038454|NCT01703091|11120791|FG000|Overall Study|Adverse Event|5
7038455|NCT01703091|11120792|FG001|Overall Study|Adverse Event|3
7038456|NCT01703091|11120791|FG000|Overall Study|Physician Decision|2
7038457|NCT01703091|11120792|FG001|Overall Study|Physician Decision|1
7038458|NCT01703091|11120791|FG000|Overall Study|Withdrawal by Subject|1
6828809|NCT00141297|10832226|FG008|Overall Study|Adverse Event|1
6828810|NCT00141297|10832227|FG009|Overall Study|Adverse Event|0
6828811|NCT00141297|10832218|FG000|Overall Study|Death|1
6828812|NCT00141297|10832219|FG001|Overall Study|Death|0
6828813|NCT00141297|10832220|FG002|Overall Study|Death|0
6828814|NCT00141297|10832221|FG003|Overall Study|Death|0
6828815|NCT00141297|10832222|FG004|Overall Study|Death|0
6828816|NCT00141297|10832223|FG005|Overall Study|Death|0
6828817|NCT00141297|10832224|FG006|Overall Study|Death|0
6828818|NCT00141297|10832225|FG007|Overall Study|Death|0
6828819|NCT00141297|10832226|FG008|Overall Study|Death|1
6828820|NCT00141297|10832227|FG009|Overall Study|Death|0
6828821|NCT00141297|10832218|FG000|Overall Study|Withdrawal by Subject|0
7038459|NCT01703091|11120792|FG001|Overall Study|Withdrawal by Subject|0
6828822|NCT00141297|10832219|FG001|Overall Study|Withdrawal by Subject|0
6828823|NCT00141297|10832220|FG002|Overall Study|Withdrawal by Subject|0
6828824|NCT00141297|10832221|FG003|Overall Study|Withdrawal by Subject|0
6828825|NCT00141297|10832222|FG004|Overall Study|Withdrawal by Subject|0
6828826|NCT00141297|10832223|FG005|Overall Study|Withdrawal by Subject|0
6828827|NCT00141297|10832224|FG006|Overall Study|Withdrawal by Subject|0
6828828|NCT00141297|10832225|FG007|Overall Study|Withdrawal by Subject|0
7038460|NCT01703091|11120791|FG000|Overall Study|Sponsor Decision|1
6923940|NCT00819910|10952920|FG001|Overall Study|Adverse Event|0
6923941|NCT00819910|10952921|FG002|Overall Study|Adverse Event|2
6923942|NCT00819910|10952922|FG003|Overall Study|Adverse Event|1
6923943|NCT00819910|10952919|FG000|Overall Study|Withdrawal by Subject|1
6923944|NCT00819910|10952920|FG001|Overall Study|Withdrawal by Subject|1
6923945|NCT00819910|10952921|FG002|Overall Study|Withdrawal by Subject|1
6923946|NCT00819910|10952922|FG003|Overall Study|Withdrawal by Subject|0
6923947|NCT00819910|10952919|FG000|Overall Study|Lost to Follow-up|1
6923948|NCT00819910|10952920|FG001|Overall Study|Lost to Follow-up|0
6923949|NCT00819910|10952921|FG002|Overall Study|Lost to Follow-up|0
6923950|NCT00819910|10952922|FG003|Overall Study|Lost to Follow-up|0
6923951|NCT00820040|10952934|FG000|Overall Study|Death|1
6923952|NCT00820040|10952934|FG000|Overall Study|Sponsor terminated study|1
6923953|NCT00820040|10952934|FG000|Overall Study|Screen failure|1
6923954|NCT00820170|10952943|FG000|Overall Study|Adverse Event|0
6923955|NCT00820170|10952944|FG001|Overall Study|Adverse Event|0
6923956|NCT00820170|10952945|FG002|Overall Study|Adverse Event|0
6923957|NCT00820170|10952946|FG003|Overall Study|Adverse Event|0
6923958|NCT00820170|10952947|FG004|Overall Study|Adverse Event|2
6923959|NCT00820170|10952943|FG000|Overall Study|Progressive Disease|0
6923960|NCT00820170|10952944|FG001|Overall Study|Progressive Disease|0
6923961|NCT00820170|10952945|FG002|Overall Study|Progressive Disease|0
6923962|NCT00820170|10952946|FG003|Overall Study|Progressive Disease|0
6923963|NCT00820170|10952947|FG004|Overall Study|Progressive Disease|2
6923964|NCT00820222|10952966|FG000|Overall Study|Lost to Follow-up|10
6923965|NCT00820222|10952967|FG001|Overall Study|Lost to Follow-up|9
6923966|NCT00820222|10952966|FG000|Overall Study|Withdrawal by Subject|19
6923967|NCT00820222|10952967|FG001|Overall Study|Withdrawal by Subject|21
6923968|NCT00820222|10952966|FG000|Overall Study|Physician Decision|93
6923969|NCT00820222|10952967|FG001|Overall Study|Physician Decision|88
6923970|NCT00820222|10952966|FG000|Overall Study|Sponsor Terminated Study|43
6923971|NCT00820222|10952967|FG001|Overall Study|Sponsor Terminated Study|65
6923972|NCT00820222|10952966|FG000|Overall Study|Unkown|11
6923973|NCT00820222|10952967|FG001|Overall Study|Unkown|7
6923974|NCT00820248|10952988|FG000|Overall Study|No treated|4
6923975|NCT00820248|10952989|FG001|Overall Study|No treated|1
6923976|NCT00820599|10953035|FG000|Overall Study|Death|129
6923977|NCT00820599|10953035|FG000|Overall Study|Withdrawal by Subject|2
6923978|NCT00820755|10953061|FG000|Period 1: Combination Therapy Phase|Adverse Event|77
6923979|NCT00820755|10953062|FG001|Period 1: Combination Therapy Phase|Adverse Event|0
6923980|NCT00820755|10953063|FG002|Period 1: Combination Therapy Phase|Adverse Event|0
6923981|NCT00820755|10953061|FG000|Period 1: Combination Therapy Phase|Death|28
6923982|NCT00820755|10953062|FG001|Period 1: Combination Therapy Phase|Death|0
6923983|NCT00820755|10953063|FG002|Period 1: Combination Therapy Phase|Death|0
6923984|NCT00820755|10953061|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4
6923985|NCT00820755|10953062|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0
6923986|NCT00820755|10953063|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0
6923987|NCT00820755|10953061|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1
6923988|NCT00820755|10953062|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0
6923989|NCT00820755|10953063|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0
6923990|NCT00820755|10953061|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21
6923991|NCT00820755|10953062|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
6923992|NCT00820755|10953063|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
6923993|NCT00820755|10953061|FG000|Period 1: Combination Therapy Phase|Progressive disease|114
6923994|NCT00820755|10953062|FG001|Period 1: Combination Therapy Phase|Progressive disease|0
6923995|NCT00820755|10953063|FG002|Period 1: Combination Therapy Phase|Progressive disease|0
6923996|NCT00820755|10953061|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14
6923997|NCT00820755|10953062|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
6923998|NCT00820755|10953063|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
6923999|NCT00820755|10953061|FG000|Period 1: Combination Therapy Phase|Other|11
6924000|NCT00820755|10953062|FG001|Period 1: Combination Therapy Phase|Other|0
6924001|NCT00820755|10953063|FG002|Period 1: Combination Therapy Phase|Other|0
6924002|NCT00820755|10953061|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0
6924003|NCT00820755|10953062|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
6924004|NCT00820755|10953063|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
6924005|NCT00820898|10953075|FG000|Overall Study|Inelgible - wrong primary site|1
6924006|NCT00821015|10953085|FG000|Overall Study|Lost to Follow-up|12
6924007|NCT00821093|10953100|FG000|Overall Study|Adverse Event|20
6924008|NCT00821093|10953101|FG001|Overall Study|Adverse Event|12
6924009|NCT00821093|10953100|FG000|Overall Study|Withdrawal by Subject|9
6924010|NCT00821093|10953101|FG001|Overall Study|Withdrawal by Subject|13
6924011|NCT00821093|10953100|FG000|Overall Study|Lost to Follow-up|9
6924012|NCT00821093|10953101|FG001|Overall Study|Lost to Follow-up|3
6924013|NCT00821093|10953100|FG000|Overall Study|Protocol deviation|3
6924014|NCT00821093|10953101|FG001|Overall Study|Protocol deviation|6
6924015|NCT00821093|10953100|FG000|Overall Study|Abnormal laboratory value(s)|2
6924016|NCT00821093|10953101|FG001|Overall Study|Abnormal laboratory value(s)|0
6924017|NCT00821093|10953100|FG000|Overall Study|Lack of Efficacy|2
6924018|NCT00821093|10953101|FG001|Overall Study|Lack of Efficacy|2
6924019|NCT00821093|10953100|FG000|Overall Study|Death|2
6828829|NCT00141297|10832226|FG008|Overall Study|Withdrawal by Subject|1
6828830|NCT00141297|10832227|FG009|Overall Study|Withdrawal by Subject|0
6828831|NCT00141297|10832218|FG000|Overall Study|Other|0
6828832|NCT00141297|10832219|FG001|Overall Study|Other|0
6828833|NCT00141297|10832220|FG002|Overall Study|Other|0
6828834|NCT00141297|10832221|FG003|Overall Study|Other|1
6828835|NCT00141297|10832222|FG004|Overall Study|Other|5
6828836|NCT00141297|10832223|FG005|Overall Study|Other|0
6828837|NCT00141297|10832224|FG006|Overall Study|Other|0
6828838|NCT00141297|10832225|FG007|Overall Study|Other|0
6828839|NCT00141297|10832226|FG008|Overall Study|Other|2
6828840|NCT00141297|10832227|FG009|Overall Study|Other|0
6828841|NCT00141297|10832218|FG000|Overall Study|Progressive Disease|2
6828842|NCT00141297|10832219|FG001|Overall Study|Progressive Disease|3
6828843|NCT00141297|10832220|FG002|Overall Study|Progressive Disease|6
6828844|NCT00141297|10832221|FG003|Overall Study|Progressive Disease|2
6828845|NCT00141297|10832222|FG004|Overall Study|Progressive Disease|15
6828846|NCT00141297|10832223|FG005|Overall Study|Progressive Disease|2
6828847|NCT00141297|10832224|FG006|Overall Study|Progressive Disease|3
6828848|NCT00141297|10832225|FG007|Overall Study|Progressive Disease|3
6828849|NCT00141297|10832226|FG008|Overall Study|Progressive Disease|15
6828850|NCT00141297|10832227|FG009|Overall Study|Progressive Disease|6
6828851|NCT00141297|10832218|FG000|Overall Study|Transitioned|0
6828852|NCT00141297|10832219|FG001|Overall Study|Transitioned|0
6828853|NCT00141297|10832220|FG002|Overall Study|Transitioned|0
6828854|NCT00141297|10832221|FG003|Overall Study|Transitioned|0
6828855|NCT00141297|10832222|FG004|Overall Study|Transitioned|1
6828856|NCT00141297|10832223|FG005|Overall Study|Transitioned|0
6828857|NCT00141297|10832224|FG006|Overall Study|Transitioned|0
6828858|NCT00141297|10832225|FG007|Overall Study|Transitioned|0
6828859|NCT00141297|10832226|FG008|Overall Study|Transitioned|0
6828860|NCT00141297|10832227|FG009|Overall Study|Transitioned|0
6828861|NCT00141453|10832262|FG000|Overall Study|Protocol Violation|6
6828862|NCT00141453|10832263|FG001|Overall Study|Protocol Violation|5
6828863|NCT00141518|10832272|FG000|Overall Study|Withdrew Consent Prior to Treatment|1
6828864|NCT00141518|10832273|FG001|Overall Study|Withdrew Consent Prior to Treatment|0
6828865|NCT00141518|10832274|FG002|Overall Study|Withdrew Consent Prior to Treatment|0
6828866|NCT00141518|10832272|FG000|Overall Study|Adverse Event|7
6828867|NCT00141518|10832273|FG001|Overall Study|Adverse Event|5
6828868|NCT00141518|10832274|FG002|Overall Study|Adverse Event|2
6828869|NCT00141518|10832272|FG000|Overall Study|Withdrawal by Subject|2
6828870|NCT00141518|10832273|FG001|Overall Study|Withdrawal by Subject|0
6828871|NCT00141518|10832274|FG002|Overall Study|Withdrawal by Subject|2
6828872|NCT00141518|10832272|FG000|Overall Study|Protocol Violation|1
6828873|NCT00141518|10832273|FG001|Overall Study|Protocol Violation|1
6828874|NCT00141518|10832274|FG002|Overall Study|Protocol Violation|2
6828875|NCT00141518|10832272|FG000|Overall Study|Lack of Efficacy|5
6828876|NCT00141518|10832273|FG001|Overall Study|Lack of Efficacy|0
6828877|NCT00141518|10832274|FG002|Overall Study|Lack of Efficacy|0
6828878|NCT00141726|10832284|FG000|Overall Study|Completed <50% Scheduled Dosing|3
6828879|NCT00141778|10832301|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5
6828880|NCT00141778|10832302|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2
6828881|NCT00141778|10832303|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6
6828882|NCT00141778|10832301|FG000|Started Study Medication|Met safety criteria for discontinuation|2
6828883|NCT00141778|10832302|FG001|Started Study Medication|Met safety criteria for discontinuation|4
6828884|NCT00141778|10832303|FG002|Started Study Medication|Met safety criteria for discontinuation|3
6828885|NCT00141778|10832301|FG000|Started Study Medication|Withdrawal by Subject|0
6828886|NCT00141778|10832302|FG001|Started Study Medication|Withdrawal by Subject|2
6828887|NCT00141778|10832303|FG002|Started Study Medication|Withdrawal by Subject|0
6828888|NCT00141778|10832301|FG000|Started Study Medication|Difficulty Swallowing|0
6828889|NCT00141778|10832302|FG001|Started Study Medication|Difficulty Swallowing|1
6828890|NCT00141778|10832303|FG002|Started Study Medication|Difficulty Swallowing|0
6828891|NCT00141778|10832301|FG000|Started Study Medication|Chest Discomfort|0
6828892|NCT00141778|10832302|FG001|Started Study Medication|Chest Discomfort|0
6828893|NCT00141778|10832303|FG002|Started Study Medication|Chest Discomfort|1
6828894|NCT00141817|10832315|FG000|Overall Study|Protocol Violation|0
6828895|NCT00141817|10832316|FG001|Overall Study|Protocol Violation|0
6828896|NCT00141817|10832317|FG002|Overall Study|Protocol Violation|1
6828897|NCT00141817|10832318|FG003|Overall Study|Protocol Violation|0
6828898|NCT00141817|10832315|FG000|Overall Study|Parent request|1
6828899|NCT00141817|10832316|FG001|Overall Study|Parent request|0
6828900|NCT00141817|10832317|FG002|Overall Study|Parent request|0
6828901|NCT00141817|10832318|FG003|Overall Study|Parent request|0
6828902|NCT00141921|10832328|FG000|Overall Study|Remain on Study|28
6828903|NCT00141921|10832328|FG000|Overall Study|Withdrawal by Subject|42
6828904|NCT00141921|10832328|FG000|Overall Study|Lost to Follow-up|19
6828905|NCT00141921|10832328|FG000|Overall Study|Noncompliance|17
6828906|NCT00141921|10832328|FG000|Overall Study|Disease Progression|7
6828907|NCT00141921|10832328|FG000|Overall Study|Protocol Deviation|7
6828908|NCT00141921|10832328|FG000|Overall Study|Adverse Event|5
6828909|NCT00141921|10832328|FG000|Overall Study|Administrative Decision|2
6828910|NCT00141921|10832328|FG000|Overall Study|Pregnancy|4
6828911|NCT00141921|10832328|FG000|Overall Study|Ineligibility Determined|2
6828912|NCT00141921|10832328|FG000|Overall Study|Other|8
6828913|NCT00142298|10832351|FG000|Overall Study|Adverse Event|10
6828914|NCT00142298|10832352|FG001|Overall Study|Adverse Event|10
6828915|NCT00142298|10832353|FG002|Overall Study|Adverse Event|1
6828916|NCT00142298|10832354|FG003|Overall Study|Adverse Event|5
6828917|NCT00142298|10832355|FG004|Overall Study|Adverse Event|2
6828918|NCT00142298|10832356|FG005|Overall Study|Adverse Event|2
6828919|NCT00142298|10832357|FG006|Overall Study|Adverse Event|0
6828920|NCT00142298|10832358|FG007|Overall Study|Adverse Event|0
6828921|NCT00142298|10832359|FG008|Overall Study|Adverse Event|0
6828922|NCT00142298|10832360|FG009|Overall Study|Adverse Event|0
6828923|NCT00142298|10832351|FG000|Overall Study|Clinical disease progression|1
6828924|NCT00142298|10832352|FG001|Overall Study|Clinical disease progression|0
6828925|NCT00142298|10832353|FG002|Overall Study|Clinical disease progression|0
6828926|NCT00142298|10832354|FG003|Overall Study|Clinical disease progression|0
6828927|NCT00142298|10832355|FG004|Overall Study|Clinical disease progression|0
6828928|NCT00142298|10832356|FG005|Overall Study|Clinical disease progression|0
6828929|NCT00142298|10832357|FG006|Overall Study|Clinical disease progression|0
6828930|NCT00142298|10832358|FG007|Overall Study|Clinical disease progression|0
6828931|NCT00142298|10832359|FG008|Overall Study|Clinical disease progression|0
6828932|NCT00142298|10832360|FG009|Overall Study|Clinical disease progression|0
6828933|NCT00142298|10832351|FG000|Overall Study|Death|1
6828934|NCT00142298|10832352|FG001|Overall Study|Death|1
6828935|NCT00142298|10832353|FG002|Overall Study|Death|1
6828936|NCT00142298|10832354|FG003|Overall Study|Death|0
6828937|NCT00142298|10832355|FG004|Overall Study|Death|0
6828938|NCT00142298|10832356|FG005|Overall Study|Death|6
6828939|NCT00142298|10832357|FG006|Overall Study|Death|0
6828940|NCT00142298|10832358|FG007|Overall Study|Death|0
6828941|NCT00142298|10832359|FG008|Overall Study|Death|0
6828942|NCT00142298|10832360|FG009|Overall Study|Death|0
6828943|NCT00142298|10832351|FG000|Overall Study|Lack of Efficacy|44
6828944|NCT00142298|10832352|FG001|Overall Study|Lack of Efficacy|62
6924020|NCT00821093|10953101|FG001|Overall Study|Death|1
6924021|NCT00821093|10953100|FG000|Overall Study|Abnormal test procedure result(s)|1
6924022|NCT00821093|10953101|FG001|Overall Study|Abnormal test procedure result(s)|1
6924023|NCT00821093|10953100|FG000|Overall Study|Administrative problems|1
6924024|NCT00821093|10953101|FG001|Overall Study|Administrative problems|2
6974652|NCT01189604|11026863|FG003|Overall Study|Impossible to visit|0
6974653|NCT01189604|11026864|FG004|Overall Study|Impossible to visit|0
6974654|NCT01189604|11026865|FG005|Overall Study|Impossible to visit|1
6974655|NCT01189604|11026866|FG006|Overall Study|Impossible to visit|0
6974656|NCT01189604|11026860|FG000|Overall Study|Adverse Event|0
6974657|NCT01189604|11026861|FG001|Overall Study|Adverse Event|1
6974658|NCT01189604|11026862|FG002|Overall Study|Adverse Event|0
6974659|NCT01189604|11026863|FG003|Overall Study|Adverse Event|0
6974660|NCT01189604|11026864|FG004|Overall Study|Adverse Event|2
6974661|NCT01189604|11026865|FG005|Overall Study|Adverse Event|0
6974662|NCT01189604|11026866|FG006|Overall Study|Adverse Event|1
6974663|NCT01189604|11026860|FG000|Overall Study|Withdrawal by Subject|1
6974664|NCT01189604|11026861|FG001|Overall Study|Withdrawal by Subject|0
6974665|NCT01189604|11026862|FG002|Overall Study|Withdrawal by Subject|0
6974666|NCT01189604|11026863|FG003|Overall Study|Withdrawal by Subject|0
6974667|NCT01189604|11026864|FG004|Overall Study|Withdrawal by Subject|0
6974668|NCT01189604|11026865|FG005|Overall Study|Withdrawal by Subject|0
6974669|NCT01189604|11026866|FG006|Overall Study|Withdrawal by Subject|0
6974670|NCT01189812|11026915|FG000|Overall Study|Withdrawal by Subject|2
6974671|NCT01189812|11026916|FG001|Overall Study|Withdrawal by Subject|3
6974672|NCT01189812|11026915|FG000|Overall Study|Adverse Event|1
6974673|NCT01189812|11026916|FG001|Overall Study|Adverse Event|0
6974674|NCT01189812|11026915|FG000|Overall Study|Out of Window|4
6974675|NCT01189812|11026916|FG001|Overall Study|Out of Window|3
6974676|NCT01189812|11026915|FG000|Overall Study|Moved out of State|1
6974677|NCT01189812|11026916|FG001|Overall Study|Moved out of State|2
6974678|NCT01189890|11026924|FG000|Overall Study|Adverse Event|3
6974679|NCT01189890|11026925|FG001|Overall Study|Adverse Event|4
6974680|NCT01189890|11026924|FG000|Overall Study|Lack of Efficacy|7
6974681|NCT01189890|11026925|FG001|Overall Study|Lack of Efficacy|2
6974682|NCT01189890|11026924|FG000|Overall Study|Lost to Follow-up|1
6974683|NCT01189890|11026925|FG001|Overall Study|Lost to Follow-up|7
6974684|NCT01189890|11026924|FG000|Overall Study|Protocol Violation|1
6974685|NCT01189890|11026925|FG001|Overall Study|Protocol Violation|5
6974686|NCT01189890|11026924|FG000|Overall Study|Withdrawal by Subject|15
6974687|NCT01189890|11026925|FG001|Overall Study|Withdrawal by Subject|11
6974688|NCT01189890|11026924|FG000|Overall Study|Non Compliance|0
6974689|NCT01189890|11026925|FG001|Overall Study|Non Compliance|1
6974690|NCT01189890|11026924|FG000|Overall Study|Physician Decision|5
6974691|NCT01189890|11026925|FG001|Overall Study|Physician Decision|4
6974692|NCT01189890|11026924|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5
6974693|NCT01189890|11026925|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5
6974694|NCT01190007|11026931|FG000|Overall Study|Withdrawal by Subject|4
6974695|NCT01190007|11026931|FG000|Overall Study|Adverse Event|8
6974696|NCT01190007|11026931|FG000|Overall Study|Difficulty of visit for complications|1
6974697|NCT01190007|11026931|FG000|Overall Study|Participant was arrested|1
6828945|NCT00142298|10832353|FG002|Overall Study|Lack of Efficacy|9
6828946|NCT00142298|10832354|FG003|Overall Study|Lack of Efficacy|12
6828947|NCT00142298|10832355|FG004|Overall Study|Lack of Efficacy|1
6828948|NCT00142298|10832356|FG005|Overall Study|Lack of Efficacy|0
6828949|NCT00142298|10832357|FG006|Overall Study|Lack of Efficacy|0
6828950|NCT00142298|10832358|FG007|Overall Study|Lack of Efficacy|1
6828951|NCT00142298|10832359|FG008|Overall Study|Lack of Efficacy|0
6828952|NCT00142298|10832360|FG009|Overall Study|Lack of Efficacy|0
6828953|NCT00142298|10832351|FG000|Overall Study|Non-compliance|15
6828954|NCT00142298|10832352|FG001|Overall Study|Non-compliance|13
6828955|NCT00142298|10832353|FG002|Overall Study|Non-compliance|0
6828956|NCT00142298|10832354|FG003|Overall Study|Non-compliance|6
6828957|NCT00142298|10832355|FG004|Overall Study|Non-compliance|1
6828958|NCT00142298|10832356|FG005|Overall Study|Non-compliance|0
6828959|NCT00142298|10832357|FG006|Overall Study|Non-compliance|0
6828960|NCT00142298|10832358|FG007|Overall Study|Non-compliance|3
6828961|NCT00142298|10832359|FG008|Overall Study|Non-compliance|3
6828962|NCT00142298|10832360|FG009|Overall Study|Non-compliance|0
6828963|NCT00142298|10832351|FG000|Overall Study|Patient, Investigator,or Sponsor request|66
6828964|NCT00142298|10832352|FG001|Overall Study|Patient, Investigator,or Sponsor request|60
6828965|NCT00142298|10832353|FG002|Overall Study|Patient, Investigator,or Sponsor request|11
6828966|NCT00142298|10832354|FG003|Overall Study|Patient, Investigator,or Sponsor request|51
6828967|NCT00142298|10832355|FG004|Overall Study|Patient, Investigator,or Sponsor request|4
6828968|NCT00142298|10832356|FG005|Overall Study|Patient, Investigator,or Sponsor request|3
6828969|NCT00142298|10832357|FG006|Overall Study|Patient, Investigator,or Sponsor request|1
6828970|NCT00142298|10832358|FG007|Overall Study|Patient, Investigator,or Sponsor request|4
6828971|NCT00142298|10832359|FG008|Overall Study|Patient, Investigator,or Sponsor request|1
6828972|NCT00142298|10832360|FG009|Overall Study|Patient, Investigator,or Sponsor request|0
6828973|NCT00142298|10832351|FG000|Overall Study|Pregnancy|4
6828974|NCT00142298|10832352|FG001|Overall Study|Pregnancy|4
6828975|NCT00142298|10832353|FG002|Overall Study|Pregnancy|2
6828976|NCT00142298|10832354|FG003|Overall Study|Pregnancy|3
6828977|NCT00142298|10832355|FG004|Overall Study|Pregnancy|0
6828978|NCT00142298|10832356|FG005|Overall Study|Pregnancy|0
6828979|NCT00142298|10832357|FG006|Overall Study|Pregnancy|0
6828980|NCT00142298|10832358|FG007|Overall Study|Pregnancy|0
6828981|NCT00142298|10832359|FG008|Overall Study|Pregnancy|1
6828982|NCT00142298|10832360|FG009|Overall Study|Pregnancy|0
6828983|NCT00142298|10832351|FG000|Overall Study|Virologic breakthrough|19
6828984|NCT00142298|10832352|FG001|Overall Study|Virologic breakthrough|23
6828985|NCT00142298|10832353|FG002|Overall Study|Virologic breakthrough|9
6828986|NCT00142298|10832354|FG003|Overall Study|Virologic breakthrough|7
6828987|NCT00142298|10832355|FG004|Overall Study|Virologic breakthrough|2
6828988|NCT00142298|10832356|FG005|Overall Study|Virologic breakthrough|3
6828989|NCT00142298|10832357|FG006|Overall Study|Virologic breakthrough|3
6828990|NCT00142298|10832358|FG007|Overall Study|Virologic breakthrough|0
6828991|NCT00142298|10832359|FG008|Overall Study|Virologic breakthrough|0
6828992|NCT00142298|10832360|FG009|Overall Study|Virologic breakthrough|0
6828993|NCT00142298|10832351|FG000|Overall Study|Other- not specified|0
6828994|NCT00142298|10832352|FG001|Overall Study|Other- not specified|3
6828995|NCT00142298|10832353|FG002|Overall Study|Other- not specified|0
6828996|NCT00142298|10832354|FG003|Overall Study|Other- not specified|1
6828997|NCT00142298|10832355|FG004|Overall Study|Other- not specified|0
6828998|NCT00142298|10832356|FG005|Overall Study|Other- not specified|0
6828999|NCT00142298|10832357|FG006|Overall Study|Other- not specified|0
6829000|NCT00142298|10832358|FG007|Overall Study|Other- not specified|0
6829001|NCT00142298|10832359|FG008|Overall Study|Other- not specified|0
6829002|NCT00142298|10832360|FG009|Overall Study|Other- not specified|0
6829003|NCT00142298|10832351|FG000|Overall Study|Lost to Follow-up|0
6829004|NCT00142298|10832352|FG001|Overall Study|Lost to Follow-up|0
6829005|NCT00142298|10832353|FG002|Overall Study|Lost to Follow-up|0
6829006|NCT00142298|10832354|FG003|Overall Study|Lost to Follow-up|0
6829007|NCT00142298|10832355|FG004|Overall Study|Lost to Follow-up|0
6829008|NCT00142298|10832356|FG005|Overall Study|Lost to Follow-up|0
6924025|NCT04187989|10953131|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6
6924026|NCT04187989|10953132|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8
6924027|NCT04187989|10953131|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8
6924028|NCT04187989|10953132|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8
6924029|NCT04109118|10953138|FG000|Overall Study|Lost to Follow-up|3
6829009|NCT00142298|10832357|FG006|Overall Study|Lost to Follow-up|2
6829010|NCT00142298|10832358|FG007|Overall Study|Lost to Follow-up|0
6829011|NCT00142298|10832359|FG008|Overall Study|Lost to Follow-up|0
6829012|NCT00142298|10832360|FG009|Overall Study|Lost to Follow-up|0
6829013|NCT00142298|10832351|FG000|Overall Study|Treatment Failure|0
6829014|NCT00142298|10832352|FG001|Overall Study|Treatment Failure|0
6829015|NCT00142298|10832353|FG002|Overall Study|Treatment Failure|0
6829016|NCT00142298|10832354|FG003|Overall Study|Treatment Failure|0
6829017|NCT00142298|10832355|FG004|Overall Study|Treatment Failure|0
6829018|NCT00142298|10832356|FG005|Overall Study|Treatment Failure|2
6829019|NCT00142298|10832357|FG006|Overall Study|Treatment Failure|2
6829020|NCT00142298|10832358|FG007|Overall Study|Treatment Failure|0
6829021|NCT00142298|10832359|FG008|Overall Study|Treatment Failure|0
6829022|NCT00142298|10832360|FG009|Overall Study|Treatment Failure|0
6829023|NCT00142415|10832388|FG000|Overall Study|Physician Decision|0
6829024|NCT00142415|10832389|FG001|Overall Study|Physician Decision|0
6829025|NCT00142415|10832390|FG002|Overall Study|Physician Decision|0
6829026|NCT00142415|10832391|FG003|Overall Study|Physician Decision|0
6829027|NCT00142415|10832392|FG004|Overall Study|Physician Decision|1
6829028|NCT00142415|10832393|FG005|Overall Study|Physician Decision|2
6829029|NCT00142792|10832434|FG000|Overall Study|Death|0
6829030|NCT00142792|10832435|FG001|Overall Study|Death|0
6829031|NCT00142792|10832436|FG002|Overall Study|Death|1
6829032|NCT00142792|10832434|FG000|Overall Study|Withdrawal by Subject|3
6829033|NCT00142792|10832435|FG001|Overall Study|Withdrawal by Subject|2
6829034|NCT00142792|10832436|FG002|Overall Study|Withdrawal by Subject|3
6829035|NCT00142792|10832434|FG000|Overall Study|Lost to Follow-up|8
6829036|NCT00142792|10832435|FG001|Overall Study|Lost to Follow-up|11
6829037|NCT00142792|10832436|FG002|Overall Study|Lost to Follow-up|7
6829038|NCT00142792|10832434|FG000|Overall Study|No category|1
6829039|NCT00142792|10832435|FG001|Overall Study|No category|2
6829040|NCT00142792|10832436|FG002|Overall Study|No category|1
6829041|NCT00142909|10832467|FG000|Randomization|Various Reasons|7
6829042|NCT00142909|10832468|FG001|Randomization|Various Reasons|10
6829043|NCT00142909|10832467|FG000|Medications Begin|Protocol Violation|2
6829044|NCT00142909|10832468|FG001|Medications Begin|Protocol Violation|0
6829045|NCT00142909|10832467|FG000|Medications Begin|Withdrawal by Subject|5
6829046|NCT00142909|10832468|FG001|Medications Begin|Withdrawal by Subject|3
6829047|NCT00142909|10832467|FG000|Medications Begin|Withdrawal by Subject|2
6829048|NCT00142909|10832468|FG001|Medications Begin|Withdrawal by Subject|0
6829049|NCT00142935|10832477|FG000|Overall Study|Other reason|1
6829050|NCT00142935|10832478|FG001|Overall Study|Other reason|1
6829051|NCT00142935|10832479|FG002|Overall Study|Other reason|1
6829052|NCT00142935|10832477|FG000|Overall Study|Lost to Follow-up|2
6829053|NCT00142935|10832478|FG001|Overall Study|Lost to Follow-up|5
6829054|NCT00142935|10832479|FG002|Overall Study|Lost to Follow-up|5
6829055|NCT00142935|10832477|FG000|Overall Study|Death|0
6829056|NCT00142935|10832478|FG001|Overall Study|Death|2
6829057|NCT00142935|10832479|FG002|Overall Study|Death|1
6829058|NCT00143247|10832491|FG000|Overall Study|Death|8
6829059|NCT00143247|10832491|FG000|Overall Study|Adverse Event|19
6829060|NCT00143247|10832491|FG000|Overall Study|Lack of Efficacy|3
6829061|NCT00143247|10832491|FG000|Overall Study|Withdrawal by Subject|55
6829062|NCT00143247|10832491|FG000|Overall Study|Study terminated by sponsor|31
6829063|NCT00143247|10832491|FG000|Overall Study|Protocol Violation|15
6829064|NCT00143247|10832491|FG000|Overall Study|Lost to Follow-up|12
6829065|NCT00143247|10832491|FG000|Overall Study|following inaccurate lab adverse event|1
6829066|NCT00143247|10832491|FG000|Overall Study|Other|12
6829067|NCT00143312|10832495|FG000|Overall Study|Death|11
6829068|NCT00143312|10832495|FG000|Overall Study|Adverse Event|2
6829069|NCT00143312|10832495|FG000|Overall Study|Lost to Follow-up|1
6829070|NCT00143312|10832495|FG000|Overall Study|Other|1
6829071|NCT00143312|10832495|FG000|Overall Study|Withdrawal by Subject|1
6829072|NCT00143390|10832501|FG000|Overall Study|Death|2
6829073|NCT00143390|10832502|FG001|Overall Study|Death|0
6829074|NCT00143390|10832501|FG000|Overall Study|Not meeting entry criteria|2
6829075|NCT00143390|10832502|FG001|Overall Study|Not meeting entry criteria|5
6829076|NCT00143390|10832501|FG000|Overall Study|Withdrawal by Subject|4
6829077|NCT00143390|10832502|FG001|Overall Study|Withdrawal by Subject|4
6829078|NCT00143390|10832501|FG000|Overall Study|Progressive disease|119
6829079|NCT00143390|10832502|FG001|Overall Study|Progressive disease|115
6829080|NCT00143390|10832501|FG000|Overall Study|Protocol Violation|2
6829081|NCT00143390|10832502|FG001|Overall Study|Protocol Violation|0
6829082|NCT00143390|10832501|FG000|Overall Study|Study termination|10
6829083|NCT00143390|10832502|FG001|Overall Study|Study termination|15
6829084|NCT00143390|10832501|FG000|Overall Study|Adverse Event|9
6829085|NCT00143390|10832502|FG001|Overall Study|Adverse Event|8
6829086|NCT00143390|10832501|FG000|Overall Study|Other|1
6829087|NCT00143390|10832502|FG001|Overall Study|Other|2
6829088|NCT00143403|10832510|FG000|Overall Study|Adverse Event|3
6829089|NCT00143403|10832511|FG001|Overall Study|Adverse Event|8
6829090|NCT00143403|10832510|FG000|Overall Study|Death|1
6829091|NCT00143403|10832511|FG001|Overall Study|Death|0
6829092|NCT00143403|10832510|FG000|Overall Study|Withdrawal by Subject|3
6829093|NCT00143403|10832511|FG001|Overall Study|Withdrawal by Subject|12
6829094|NCT00143403|10832510|FG000|Overall Study|Relapse|15
6829095|NCT00143403|10832511|FG001|Overall Study|Relapse|7
6829096|NCT00143403|10832510|FG000|Overall Study|Protocol Violation|2
6829097|NCT00143403|10832511|FG001|Overall Study|Protocol Violation|2
6829098|NCT00143403|10832510|FG000|Overall Study|specified by site|4
6829099|NCT00143403|10832511|FG001|Overall Study|specified by site|9
6829100|NCT00143403|10832510|FG000|Overall Study|Randomized Not Treated|7
6829101|NCT00143403|10832511|FG001|Overall Study|Randomized Not Treated|8
6829102|NCT00143455|10832521|FG000|Cohort 1|Adverse Event|8
6829103|NCT00143455|10832522|FG001|Cohort 1|Adverse Event|4
6829104|NCT00143455|10832523|FG002|Cohort 1|Adverse Event|0
6829105|NCT00143455|10832524|FG003|Cohort 1|Adverse Event|0
6829106|NCT00143455|10832521|FG000|Cohort 1|Death|5
6829107|NCT00143455|10832522|FG001|Cohort 1|Death|2
6829108|NCT00143455|10832523|FG002|Cohort 1|Death|0
6829109|NCT00143455|10832524|FG003|Cohort 1|Death|0
6829110|NCT00143455|10832521|FG000|Cohort 1|Progressive Disease|0
6829111|NCT00143455|10832522|FG001|Cohort 1|Progressive Disease|6
6829112|NCT00143455|10832523|FG002|Cohort 1|Progressive Disease|0
6829113|NCT00143455|10832524|FG003|Cohort 1|Progressive Disease|0
6829114|NCT00143455|10832521|FG000|Cohort 1|Withdrawal by Subject|1
6829115|NCT00143455|10832522|FG001|Cohort 1|Withdrawal by Subject|4
6829116|NCT00143455|10832523|FG002|Cohort 1|Withdrawal by Subject|0
6829117|NCT00143455|10832524|FG003|Cohort 1|Withdrawal by Subject|0
6829118|NCT00143455|10832521|FG000|Cohort 1|Randomized But Not Treated|0
6829119|NCT00143455|10832522|FG001|Cohort 1|Randomized But Not Treated|1
6924030|NCT04045132|10953145|FG000|Overall Study|Lost to Follow-up|3
6924031|NCT04045132|10953146|FG001|Overall Study|Lost to Follow-up|7
6924032|NCT03846219|10953157|FG000|Overall Study|Withdrawal by Subject|3
6924033|NCT03846219|10953158|FG001|Overall Study|Withdrawal by Subject|2
7038461|NCT01703091|11120792|FG001|Overall Study|Sponsor Decision|0
6924034|NCT03846219|10953159|FG002|Overall Study|Withdrawal by Subject|2
6924035|NCT03846219|10953157|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0
6924036|NCT03846219|10953158|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2
6924037|NCT03846219|10953159|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1
6924038|NCT03846219|10953157|FG000|Overall Study|Physician Decision|0
6924039|NCT03846219|10953158|FG001|Overall Study|Physician Decision|0
6924040|NCT03846219|10953159|FG002|Overall Study|Physician Decision|2
6974698|NCT01190020|11026937|FG000|Overall Study|Adverse Event|2
6974699|NCT01190020|11026938|FG001|Overall Study|Adverse Event|0
6974700|NCT01190020|11026937|FG000|Overall Study|Lost to Follow-up|2
6974701|NCT01190020|11026938|FG001|Overall Study|Lost to Follow-up|0
6974702|NCT01190020|11026937|FG000|Overall Study|Withdrawal by Subject|3
6974703|NCT01190020|11026938|FG001|Overall Study|Withdrawal by Subject|0
6974704|NCT01190098|11026959|FG000|Overall Study|Adverse Event|2
6974705|NCT01190098|11026960|FG001|Overall Study|Adverse Event|0
6974706|NCT01190098|11026959|FG000|Overall Study|Patient coomorbidity|0
6974707|NCT01190098|11026960|FG001|Overall Study|Patient coomorbidity|1
6974708|NCT01190098|11026959|FG000|Overall Study|Lack of transportation|1
6974709|NCT01190098|11026960|FG001|Overall Study|Lack of transportation|0
6974710|NCT01190098|11026959|FG000|Overall Study|Other|0
6974711|NCT01190098|11026960|FG001|Overall Study|Other|1
6974712|NCT01190124|11026969|FG000|Overall Study|Death|3
6974713|NCT01190124|11026970|FG001|Overall Study|Death|0
6974714|NCT01190124|11026971|FG002|Overall Study|Death|0
6974715|NCT01190124|11026969|FG000|Overall Study|Therapeutic Failure|12
6974716|NCT01190124|11026970|FG001|Overall Study|Therapeutic Failure|0
6974717|NCT01190124|11026971|FG002|Overall Study|Therapeutic Failure|1
6974718|NCT01190124|11026969|FG000|Overall Study|Lost to Follow-up|2
6974719|NCT01190124|11026970|FG001|Overall Study|Lost to Follow-up|0
6974720|NCT01190124|11026971|FG002|Overall Study|Lost to Follow-up|0
6974721|NCT01190150|11026984|FG000|First Treatment|Withdrawal by Subject|1
6974722|NCT01190150|11026985|FG001|First Treatment|Withdrawal by Subject|0
6974723|NCT01190150|11026984|FG000|Washout|Withdrawal by Subject|0
6974724|NCT01190150|11026985|FG001|Washout|Withdrawal by Subject|1
6974725|NCT01190150|11026984|FG000|Washout|Difficulty in adherence|0
6974726|NCT01190150|11026985|FG001|Washout|Difficulty in adherence|1
6974727|NCT01190176|11026991|FG000|Overall Study|Withdrawal by Subject|1
6974728|NCT01190176|11026991|FG000|Overall Study|Lost to Follow-up|1
6974729|NCT01190189|11026995|FG000|Overall Study|Lost to Follow-up|4
6974730|NCT01190189|11026995|FG000|Overall Study|Withdrawal by Subject|1
6974731|NCT01190189|11026995|FG000|Overall Study|Migrated/moved from study area|1
6974732|NCT01190215|11027001|FG000|Up to Month 6|Lost to Follow-up|2
6829120|NCT00143455|10832523|FG002|Cohort 1|Randomized But Not Treated|0
6829121|NCT00143455|10832524|FG003|Cohort 1|Randomized But Not Treated|0
6829122|NCT00143455|10832521|FG000|Cohort 2|Adverse Event|0
6829123|NCT00143455|10832522|FG001|Cohort 2|Adverse Event|0
6829124|NCT00143455|10832523|FG002|Cohort 2|Adverse Event|42
6829125|NCT00143455|10832524|FG003|Cohort 2|Adverse Event|30
6829126|NCT00143455|10832521|FG000|Cohort 2|No Longer Required Study Treatment|0
6829127|NCT00143455|10832522|FG001|Cohort 2|No Longer Required Study Treatment|0
6829128|NCT00143455|10832523|FG002|Cohort 2|No Longer Required Study Treatment|1
6829129|NCT00143455|10832524|FG003|Cohort 2|No Longer Required Study Treatment|0
6829130|NCT00143455|10832521|FG000|Cohort 2|Protocol Violation|0
6829131|NCT00143455|10832522|FG001|Cohort 2|Protocol Violation|0
6829132|NCT00143455|10832523|FG002|Cohort 2|Protocol Violation|1
6829133|NCT00143455|10832524|FG003|Cohort 2|Protocol Violation|1
6829134|NCT00143455|10832521|FG000|Cohort 2|Lost to Follow-up|0
6829135|NCT00143455|10832522|FG001|Cohort 2|Lost to Follow-up|0
6829136|NCT00143455|10832523|FG002|Cohort 2|Lost to Follow-up|1
6829137|NCT00143455|10832524|FG003|Cohort 2|Lost to Follow-up|4
6829138|NCT00143455|10832521|FG000|Cohort 2|Death|0
6829139|NCT00143455|10832522|FG001|Cohort 2|Death|0
6829140|NCT00143455|10832523|FG002|Cohort 2|Death|20
6829141|NCT00143455|10832524|FG003|Cohort 2|Death|12
6829142|NCT00143455|10832521|FG000|Cohort 2|Progressive Disease|0
6829143|NCT00143455|10832522|FG001|Cohort 2|Progressive Disease|0
6829144|NCT00143455|10832523|FG002|Cohort 2|Progressive Disease|20
6829145|NCT00143455|10832524|FG003|Cohort 2|Progressive Disease|27
6829146|NCT00143455|10832521|FG000|Cohort 2|Withdrawal by Subject|0
6829147|NCT00143455|10832522|FG001|Cohort 2|Withdrawal by Subject|0
6829148|NCT00143455|10832523|FG002|Cohort 2|Withdrawal by Subject|13
6829149|NCT00143455|10832524|FG003|Cohort 2|Withdrawal by Subject|12
6829150|NCT00143455|10832521|FG000|Cohort 2|Other|0
6829151|NCT00143455|10832522|FG001|Cohort 2|Other|0
6829152|NCT00143455|10832523|FG002|Cohort 2|Other|7
6829153|NCT00143455|10832524|FG003|Cohort 2|Other|6
6829154|NCT00143455|10832521|FG000|Cohort 2|Randomized But Not Treated|0
6829155|NCT00143455|10832522|FG001|Cohort 2|Randomized But Not Treated|0
6829156|NCT00143455|10832523|FG002|Cohort 2|Randomized But Not Treated|1
7038462|NCT01703117|11120800|FG000|Overall Study|Adverse Event|4
6829157|NCT00143455|10832524|FG003|Cohort 2|Randomized But Not Treated|1
6829158|NCT00143507|10832538|FG000|Overall Study|Death|572
6829159|NCT00143507|10832539|FG001|Overall Study|Death|547
6829160|NCT00143507|10832538|FG000|Overall Study|Withdrawal by Subject|114
6829161|NCT00143507|10832539|FG001|Overall Study|Withdrawal by Subject|102
6829162|NCT00143507|10832538|FG000|Overall Study|Lost to Follow-up|1
6829163|NCT00143507|10832539|FG001|Overall Study|Lost to Follow-up|0
6829164|NCT00143507|10832538|FG000|Overall Study|Withdrawn by sponsor's decision|0
6829165|NCT00143507|10832539|FG001|Overall Study|Withdrawn by sponsor's decision|3
6829166|NCT00143598|10832547|FG000|Overall Study|Lost to Follow-up|23
6829167|NCT00143598|10832548|FG001|Overall Study|Lost to Follow-up|21
6829168|NCT00143598|10832547|FG000|Overall Study|Withdrawal by Subject|33
6829169|NCT00143598|10832548|FG001|Overall Study|Withdrawal by Subject|37
6829170|NCT00143598|10832547|FG000|Overall Study|Death|36
6829171|NCT00143598|10832548|FG001|Overall Study|Death|36
6829172|NCT00144027|10832573|FG000|Overall Study|Lost to Follow-up|1
6829173|NCT00144027|10832574|FG001|Overall Study|Lost to Follow-up|3
6829174|NCT00144027|10832573|FG000|Overall Study|Withdrawal by Subject|2
6829175|NCT00144027|10832574|FG001|Overall Study|Withdrawal by Subject|2
6829176|NCT00144027|10832573|FG000|Overall Study|did not complete baseline assessment|0
6829177|NCT00144027|10832574|FG001|Overall Study|did not complete baseline assessment|6
6829178|NCT00144170|10832582|FG000|Overall Study|Adverse Event|84
6829179|NCT00144170|10832583|FG001|Overall Study|Adverse Event|41
6829180|NCT00144170|10832582|FG000|Overall Study|Protocol Violation|23
6829181|NCT00144170|10832583|FG001|Overall Study|Protocol Violation|16
6829182|NCT00144170|10832582|FG000|Overall Study|Lost to Follow-up|5
6829183|NCT00144170|10832583|FG001|Overall Study|Lost to Follow-up|10
6829184|NCT00144170|10832582|FG000|Overall Study|Withdrawal by Subject|29
6829185|NCT00144170|10832583|FG001|Overall Study|Withdrawal by Subject|13
6829186|NCT00144170|10832582|FG000|Overall Study|Other reason not defined above|211
6829187|NCT00144170|10832583|FG001|Overall Study|Other reason not defined above|316
6829188|NCT00144300|10832591|FG000|Overall Study|Adverse Event|18
6829189|NCT00144300|10832592|FG001|Overall Study|Adverse Event|16
6829190|NCT00144300|10832591|FG000|Overall Study|Protocol Violation|1
6829191|NCT00144300|10832592|FG001|Overall Study|Protocol Violation|3
6829192|NCT00144300|10832591|FG000|Overall Study|Lost to Follow-up|3
6829193|NCT00144300|10832592|FG001|Overall Study|Lost to Follow-up|0
6829194|NCT00144300|10832591|FG000|Overall Study|Withdrawal by Subject|6
6829195|NCT00144300|10832592|FG001|Overall Study|Withdrawal by Subject|6
6829196|NCT00144300|10832591|FG000|Overall Study|Other reason (not specified)|1
6829197|NCT00144300|10832592|FG001|Overall Study|Other reason (not specified)|3
6829198|NCT00144339|10832600|FG000|Overall Study|Adverse Event|746
6829199|NCT00144339|10832601|FG001|Overall Study|Adverse Event|627
6829200|NCT00144339|10832600|FG000|Overall Study|Protocol Violation|75
6829201|NCT00144339|10832601|FG001|Overall Study|Protocol Violation|48
6829202|NCT00144339|10832600|FG000|Overall Study|Withdrawal by Subject|403
6829203|NCT00144339|10832601|FG001|Overall Study|Withdrawal by Subject|300
6829204|NCT00144339|10832600|FG000|Overall Study|Lost to Follow-up|76
6829205|NCT00144339|10832601|FG001|Overall Study|Lost to Follow-up|64
6829206|NCT00144339|10832600|FG000|Overall Study|Other|58
6829207|NCT00144339|10832601|FG001|Overall Study|Other|60
6829208|NCT00144781|10832620|FG000|Overall Study|Adverse Event|0
6829209|NCT00144781|10832621|FG001|Overall Study|Adverse Event|1
6829210|NCT00144781|10832622|FG002|Overall Study|Adverse Event|0
6829211|NCT00144781|10832623|FG003|Overall Study|Adverse Event|0
6829212|NCT00144781|10832620|FG000|Overall Study|Non-compliant|0
6829213|NCT00144781|10832621|FG001|Overall Study|Non-compliant|1
6829214|NCT00144781|10832622|FG002|Overall Study|Non-compliant|0
6829215|NCT00144781|10832623|FG003|Overall Study|Non-compliant|0
6829216|NCT00145119|10832641|FG000|Overall Study|Death|45
6897083|NCT00636506|10915742|FG000|Overall Study|Procedure aborted|1
6897084|NCT00636610|10915766|FG000|Overall Study|Adverse Event|4
6897085|NCT00636610|10915767|FG001|Overall Study|Adverse Event|4
6897086|NCT00636610|10915766|FG000|Overall Study|Death|6
6897087|NCT00636610|10915767|FG001|Overall Study|Death|3
6897088|NCT00636610|10915766|FG000|Overall Study|Physician decision to withdraw patient|15
6897089|NCT00636610|10915767|FG001|Overall Study|Physician decision to withdraw patient|9
6897090|NCT00636610|10915766|FG000|Overall Study|Subject decision to withdraw|15
6897091|NCT00636610|10915767|FG001|Overall Study|Subject decision to withdraw|11
6897092|NCT00636610|10915766|FG000|Overall Study|Disease progression - radiographic|41
6897093|NCT00636610|10915767|FG001|Overall Study|Disease progression - radiographic|51
6897094|NCT00636610|10915766|FG000|Overall Study|Disease progression - clinical|8
6897095|NCT00636610|10915767|FG001|Overall Study|Disease progression - clinical|3
7061837|NCT01931839|11158974|FG006|Overall Study|Lost to Follow-up|0
7061838|NCT01931839|11158968|FG000|Overall Study|Other|4
7061839|NCT01931839|11158969|FG001|Overall Study|Other|2
6897096|NCT00636610|10915766|FG000|Overall Study|Reason for discontinuation not available|3
6897097|NCT00636610|10915767|FG001|Overall Study|Reason for discontinuation not available|2
6897098|NCT00636636|10915777|FG000|Overall Study|Other reason|4
7061840|NCT01931839|11158970|FG002|Overall Study|Other|6
7061841|NCT01931839|11158971|FG003|Overall Study|Other|0
7061842|NCT01931839|11158972|FG004|Overall Study|Other|0
7061843|NCT01931839|11158973|FG005|Overall Study|Other|0
7061844|NCT01931839|11158974|FG006|Overall Study|Other|0
7061845|NCT01931865|11158994|FG000|Overall Study|Lost to Follow-up|2
7061846|NCT01931865|11158994|FG000|Overall Study|Withdrawal by Subject|2
7061847|NCT01931956|11159014|FG000|Overall Study|Death|42
7061848|NCT01931956|11159015|FG001|Overall Study|Death|7
7061849|NCT01931956|11159016|FG002|Overall Study|Death|379
7061850|NCT01931956|11159017|FG003|Overall Study|Death|96
7061851|NCT01931956|11159014|FG000|Overall Study|Withdrawal by Subject|5
7061852|NCT01931956|11159015|FG001|Overall Study|Withdrawal by Subject|0
7061853|NCT01931956|11159016|FG002|Overall Study|Withdrawal by Subject|70
7061854|NCT01931956|11159017|FG003|Overall Study|Withdrawal by Subject|30
7061855|NCT01931956|11159014|FG000|Overall Study|Lost to Follow-up|2
7061856|NCT01931956|11159015|FG001|Overall Study|Lost to Follow-up|0
7061857|NCT01931956|11159016|FG002|Overall Study|Lost to Follow-up|11
7061858|NCT01931956|11159017|FG003|Overall Study|Lost to Follow-up|7
7061859|NCT01931956|11159014|FG000|Overall Study|Expected|2
7061860|NCT01931956|11159015|FG001|Overall Study|Expected|0
7061861|NCT01931956|11159016|FG002|Overall Study|Expected|6
7061862|NCT01931956|11159017|FG003|Overall Study|Expected|0
7061863|NCT01931956|11159014|FG000|Overall Study|Not due|0
7061864|NCT01931956|11159015|FG001|Overall Study|Not due|0
7061865|NCT01931956|11159016|FG002|Overall Study|Not due|21
7061866|NCT01931956|11159017|FG003|Overall Study|Not due|0
6924041|NCT03606668|10953201|FG000|Overall Study|Screen Failure|1
6924042|NCT03606668|10953201|FG000|Overall Study|Lost to Follow-up|1
6924043|NCT03575897|10953207|FG000|Overall Study|Lost to Follow-up|12
6924044|NCT03575897|10953208|FG001|Overall Study|Lost to Follow-up|13
6924045|NCT03343626|10953222|FG000|Overall Study|Lost to Follow-up|4
6924046|NCT03343626|10953223|FG001|Overall Study|Lost to Follow-up|3
6924047|NCT03343626|10953224|FG002|Overall Study|Lost to Follow-up|2
6924048|NCT03343626|10953225|FG003|Overall Study|Lost to Follow-up|5
6924049|NCT03343626|10953226|FG004|Overall Study|Lost to Follow-up|4
6924050|NCT03343626|10953227|FG005|Overall Study|Lost to Follow-up|4
6924051|NCT03343626|10953228|FG006|Overall Study|Lost to Follow-up|4
6924052|NCT03343626|10953229|FG007|Overall Study|Lost to Follow-up|7
6924053|NCT03343626|10953222|FG000|Overall Study|Withdrawal of Consent|2
6924054|NCT03343626|10953223|FG001|Overall Study|Withdrawal of Consent|1
6924055|NCT03343626|10953224|FG002|Overall Study|Withdrawal of Consent|0
6924056|NCT03343626|10953225|FG003|Overall Study|Withdrawal of Consent|3
6924057|NCT03343626|10953226|FG004|Overall Study|Withdrawal of Consent|3
6924058|NCT03343626|10953227|FG005|Overall Study|Withdrawal of Consent|1
6924059|NCT03343626|10953228|FG006|Overall Study|Withdrawal of Consent|1
6924060|NCT03343626|10953229|FG007|Overall Study|Withdrawal of Consent|2
6924061|NCT03343626|10953222|FG000|Overall Study|Reason not Specified|0
6924062|NCT03343626|10953223|FG001|Overall Study|Reason not Specified|1
6924063|NCT03343626|10953224|FG002|Overall Study|Reason not Specified|0
6924064|NCT03343626|10953225|FG003|Overall Study|Reason not Specified|0
6924065|NCT03343626|10953226|FG004|Overall Study|Reason not Specified|0
6924066|NCT03343626|10953227|FG005|Overall Study|Reason not Specified|0
6924067|NCT03343626|10953228|FG006|Overall Study|Reason not Specified|0
6924068|NCT03343626|10953229|FG007|Overall Study|Reason not Specified|1
6924069|NCT03343626|10953222|FG000|Overall Study|Data Entry Error|0
6924070|NCT03343626|10953223|FG001|Overall Study|Data Entry Error|0
6924071|NCT03343626|10953224|FG002|Overall Study|Data Entry Error|0
6924072|NCT03343626|10953225|FG003|Overall Study|Data Entry Error|0
6924073|NCT03343626|10953226|FG004|Overall Study|Data Entry Error|0
6924074|NCT03343626|10953227|FG005|Overall Study|Data Entry Error|0
6924075|NCT03343626|10953228|FG006|Overall Study|Data Entry Error|0
6924076|NCT03343626|10953229|FG007|Overall Study|Data Entry Error|1
6924077|NCT02807363|10953284|FG000|Dosing Period|Adverse Event|0
6924078|NCT02807363|10953285|FG001|Dosing Period|Adverse Event|1
6924079|NCT02807363|10953286|FG002|Dosing Period|Adverse Event|0
6924080|NCT02807363|10953287|FG003|Dosing Period|Adverse Event|0
6924081|NCT02756403|10953303|FG000|Overall Study|Unable to swallow medication|0
6924082|NCT02756403|10953304|FG001|Overall Study|Unable to swallow medication|1
6924083|NCT02756403|10953305|FG002|Overall Study|Unable to swallow medication|1
6924084|NCT02756403|10953306|FG003|Overall Study|Unable to swallow medication|1
6924085|NCT02756403|10953303|FG000|Overall Study|Did not complete Procedure|0
6924086|NCT02756403|10953304|FG001|Overall Study|Did not complete Procedure|1
6924087|NCT02756403|10953305|FG002|Overall Study|Did not complete Procedure|0
6924088|NCT02756403|10953306|FG003|Overall Study|Did not complete Procedure|0
6924089|NCT02756403|10953303|FG000|Overall Study|Changed Mind About Procedure|0
7061867|NCT01931995|11159042|FG000|First Intervention (1 Day)|Withdrawal by Subject|2
7061868|NCT01931995|11159043|FG001|First Intervention (1 Day)|Withdrawal by Subject|2
6924090|NCT02756403|10953304|FG001|Overall Study|Changed Mind About Procedure|0
6924091|NCT02756403|10953305|FG002|Overall Study|Changed Mind About Procedure|1
6924092|NCT02756403|10953306|FG003|Overall Study|Changed Mind About Procedure|0
7061869|NCT01931995|11159042|FG000|First Intervention (1 Day)|Physician Decision|1
7061870|NCT01931995|11159043|FG001|First Intervention (1 Day)|Physician Decision|1
7061871|NCT01931995|11159042|FG000|First Intervention (1 Day)|Lost to Follow-up|1
7061872|NCT01931995|11159043|FG001|First Intervention (1 Day)|Lost to Follow-up|1
7061873|NCT01932294|11159075|FG000|Overall Study|Death|43
7061874|NCT01932294|11159075|FG000|Overall Study|Lost to Follow-up|8
6924093|NCT02756403|10953303|FG000|Overall Study|Protocol Violation|0
6924094|NCT02756403|10953304|FG001|Overall Study|Protocol Violation|1
6924095|NCT02756403|10953305|FG002|Overall Study|Protocol Violation|0
6924096|NCT02756403|10953306|FG003|Overall Study|Protocol Violation|1
6924097|NCT02751502|10953316|FG000|Overall Study|Lack of funding|4
6974733|NCT01190215|11027002|FG001|Up to Month 6|Lost to Follow-up|0
6974734|NCT01190410|11027010|FG000|Overall Study|Adverse Event|0
6974735|NCT01190410|11027011|FG001|Overall Study|Adverse Event|3
6974736|NCT01190410|11027010|FG000|Overall Study|Lack of Efficacy|0
6974737|NCT01190410|11027011|FG001|Overall Study|Lack of Efficacy|2
6974738|NCT01190410|11027010|FG000|Overall Study|Withdrawal by Subject|0
6974739|NCT01190410|11027011|FG001|Overall Study|Withdrawal by Subject|2
6974740|NCT01190410|11027010|FG000|Overall Study|Administrative decision|1
6974741|NCT01190410|11027011|FG001|Overall Study|Administrative decision|0
6974742|NCT01190410|11027010|FG000|Overall Study|PI discretion|0
6974743|NCT01190410|11027011|FG001|Overall Study|PI discretion|2
6974744|NCT01190436|11027023|FG000|Overall Study|Lost to Follow-up|35
6974745|NCT01190436|11027023|FG000|Overall Study|Other|4
6974746|NCT01190449|11027030|FG000|Overall Study|Ineligible|0
6974747|NCT01190449|11027031|FG001|Overall Study|Ineligible|4
6974748|NCT01190475|11027040|FG000|Overall Study|Withdrawal by Subject|0
6974749|NCT01190475|11027041|FG001|Overall Study|Withdrawal by Subject|0
6974750|NCT01190475|11027042|FG002|Overall Study|Withdrawal by Subject|1
6974751|NCT01190514|11027052|FG000|First Intervention (Period 1)|Adverse Event|1
6974752|NCT01190514|11027053|FG001|First Intervention (Period 1)|Adverse Event|0
6974753|NCT01190514|11027054|FG002|First Intervention (Period 1)|Adverse Event|0
6974754|NCT01190514|11027055|FG003|First Intervention (Period 1)|Adverse Event|0
6974755|NCT01190514|11027052|FG000|Third Intervention (Period 3)|Adverse Event|1
6974756|NCT01190514|11027053|FG001|Third Intervention (Period 3)|Adverse Event|0
6974757|NCT01190514|11027054|FG002|Third Intervention (Period 3)|Adverse Event|0
6974758|NCT01190514|11027055|FG003|Third Intervention (Period 3)|Adverse Event|0
6974759|NCT01190813|11027081|FG000|Overall Study|Lost to Follow-up|1
6974760|NCT01190813|11027082|FG001|Overall Study|Lost to Follow-up|2
6974761|NCT01190813|11027081|FG000|Overall Study|Withdrawal by Subject|2
6974762|NCT01190813|11027082|FG001|Overall Study|Withdrawal by Subject|1
6974763|NCT01190813|11027081|FG000|Overall Study|Refused study treatment after randomized|1
6974764|NCT01190813|11027082|FG001|Overall Study|Refused study treatment after randomized|0
6974765|NCT01190813|11027081|FG000|Overall Study|Adverse Event|0
6974766|NCT01190813|11027082|FG001|Overall Study|Adverse Event|1
6974767|NCT01190839|11027090|FG000|Overall Study|Adverse Event|32
6974768|NCT01190839|11027091|FG001|Overall Study|Adverse Event|41
6974769|NCT01190839|11027090|FG000|Overall Study|Protocol Violation|2
6974770|NCT01190839|11027091|FG001|Overall Study|Protocol Violation|2
6974771|NCT01190839|11027090|FG000|Overall Study|Lost to Follow-up|7
6974772|NCT01190839|11027091|FG001|Overall Study|Lost to Follow-up|1
6974773|NCT01190839|11027090|FG000|Overall Study|Death|1
6974774|NCT01190839|11027091|FG001|Overall Study|Death|0
6974775|NCT01190839|11027090|FG000|Overall Study|Trial stopped by Sponsor|71
6974776|NCT01190839|11027091|FG001|Overall Study|Trial stopped by Sponsor|68
6974777|NCT01190839|11027090|FG000|Overall Study|Undefined|35
6974778|NCT01190839|11027091|FG001|Overall Study|Undefined|31
6974779|NCT01190839|11027090|FG000|Overall Study|Randomized but not treated|2
6974780|NCT01190839|11027091|FG001|Overall Study|Randomized but not treated|4
6974781|NCT01190865|11027099|FG000|Overall Study|Withdrawal by Subject|1
6974782|NCT01190865|11027099|FG000|Overall Study|Non-compliance|2
6974783|NCT01190891|11027122|FG000|Overall Study|Protocol Violation|1
6974784|NCT01190891|11027123|FG001|Overall Study|Protocol Violation|0
6974785|NCT01190891|11027122|FG000|Overall Study|Withdrawal by Subject|5
6974786|NCT01190891|11027123|FG001|Overall Study|Withdrawal by Subject|0
6974787|NCT01190930|11027131|FG000|Induction|Adverse Event|17
6974788|NCT01190930|11027132|FG001|Induction|Adverse Event|0
6974789|NCT01190930|11027133|FG002|Induction|Adverse Event|0
6974790|NCT01190930|11027134|FG003|Induction|Adverse Event|0
6974791|NCT01190930|11027135|FG004|Induction|Adverse Event|0
6974792|NCT01190930|11027136|FG005|Induction|Adverse Event|0
6974793|NCT01190930|11027137|FG006|Induction|Adverse Event|0
6974794|NCT01190930|11027138|FG007|Induction|Adverse Event|0
6974795|NCT01190930|11027139|FG008|Induction|Adverse Event|0
6974796|NCT01190930|11027140|FG009|Induction|Adverse Event|0
6974797|NCT01190930|11027131|FG000|Induction|Death|34
6974798|NCT01190930|11027132|FG001|Induction|Death|0
6974799|NCT01190930|11027133|FG002|Induction|Death|0
6974800|NCT01190930|11027134|FG003|Induction|Death|0
6974801|NCT01190930|11027135|FG004|Induction|Death|0
6974802|NCT01190930|11027136|FG005|Induction|Death|0
6974803|NCT01190930|11027137|FG006|Induction|Death|0
6974804|NCT01190930|11027138|FG007|Induction|Death|0
6974805|NCT01190930|11027139|FG008|Induction|Death|0
6974806|NCT01190930|11027140|FG009|Induction|Death|0
6974807|NCT01190930|11027131|FG000|Induction|Lost to Follow-up|1
6974808|NCT01190930|11027132|FG001|Induction|Lost to Follow-up|0
6974809|NCT01190930|11027133|FG002|Induction|Lost to Follow-up|0
6974810|NCT01190930|11027134|FG003|Induction|Lost to Follow-up|0
6974811|NCT01190930|11027135|FG004|Induction|Lost to Follow-up|0
6974812|NCT01190930|11027136|FG005|Induction|Lost to Follow-up|0
6974813|NCT01190930|11027137|FG006|Induction|Lost to Follow-up|0
6974814|NCT01190930|11027138|FG007|Induction|Lost to Follow-up|0
7061875|NCT01932294|11159075|FG000|Overall Study|VAD Implantation|20
7061876|NCT01932294|11159075|FG000|Overall Study|Heart Transplantation|16
7061877|NCT01932294|11159075|FG000|Overall Study|Transferred to other hospitals|12
7061878|NCT01932437|11159082|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
7061879|NCT01932437|11159083|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
7061880|NCT01932437|11159084|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
7061881|NCT01932437|11159085|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
7061882|NCT01932437|11159086|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
7061883|NCT01932437|11159087|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1
7061884|NCT01932697|11159119|FG000|Overall Study|Received a different amount of tx|1
7061885|NCT01932697|11159120|FG001|Overall Study|Received a different amount of tx|0
7061886|NCT01932697|11159119|FG000|Overall Study|Ineligible|1
7061887|NCT01932697|11159120|FG001|Overall Study|Ineligible|0
7061888|NCT01932762|11159132|FG000|Overall Study|Withdrawal by Subject|1
7061889|NCT01932762|11159133|FG001|Overall Study|Withdrawal by Subject|2
7061890|NCT01932762|11159134|FG002|Overall Study|Withdrawal by Subject|0
7061891|NCT01932762|11159135|FG003|Overall Study|Withdrawal by Subject|0
7061892|NCT01932762|11159132|FG000|Overall Study|Lost to Follow-up|4
7061893|NCT01932762|11159133|FG001|Overall Study|Lost to Follow-up|0
7061894|NCT01932762|11159134|FG002|Overall Study|Lost to Follow-up|0
7061895|NCT01932762|11159135|FG003|Overall Study|Lost to Follow-up|1
7061896|NCT01932762|11159132|FG000|Overall Study|Physician Decision|1
7061897|NCT01932762|11159133|FG001|Overall Study|Physician Decision|0
6829217|NCT00145327|10832665|FG000|Overall Study|Withdrawal by Subject|77
6829218|NCT00145327|10832666|FG001|Overall Study|Withdrawal by Subject|72
6829219|NCT00145327|10832667|FG002|Overall Study|Withdrawal by Subject|164
6829220|NCT00145327|10832665|FG000|Overall Study|Death|26
6829221|NCT00145327|10832666|FG001|Overall Study|Death|18
6829222|NCT00145327|10832667|FG002|Overall Study|Death|30
6829223|NCT00145327|10832665|FG000|Overall Study|Adverse Event|14
6829224|NCT00145327|10832666|FG001|Overall Study|Adverse Event|11
6829225|NCT00145327|10832667|FG002|Overall Study|Adverse Event|22
6829226|NCT00145327|10832665|FG000|Overall Study|Lost to Follow-up|9
6829227|NCT00145327|10832666|FG001|Overall Study|Lost to Follow-up|14
6829228|NCT00145327|10832667|FG002|Overall Study|Lost to Follow-up|14
6829229|NCT00145327|10832665|FG000|Overall Study|Administrative problems|12
6829230|NCT00145327|10832666|FG001|Overall Study|Administrative problems|9
6829231|NCT00145327|10832667|FG002|Overall Study|Administrative problems|13
7061898|NCT01932762|11159134|FG002|Overall Study|Physician Decision|0
7061899|NCT01932762|11159135|FG003|Overall Study|Physician Decision|0
7061900|NCT01932788|11159147|FG000|Overall Study|Protocol Violation|18
7061901|NCT01932788|11159148|FG001|Overall Study|Protocol Violation|0
7061902|NCT01932788|11159147|FG000|Overall Study|Lost to Follow-up|18
7061903|NCT01932788|11159148|FG001|Overall Study|Lost to Follow-up|46
7061904|NCT01932788|11159147|FG000|Overall Study|Lack of Efficacy|2
7038463|NCT01703117|11120801|FG001|Overall Study|Adverse Event|3
7038464|NCT01703117|11120800|FG000|Overall Study|Withdrawal by Subject|0
7061905|NCT01932788|11159148|FG001|Overall Study|Lack of Efficacy|0
7061906|NCT01932788|11159147|FG000|Overall Study|Withdrawal by Subject|0
7061907|NCT01932788|11159148|FG001|Overall Study|Withdrawal by Subject|5
7061908|NCT01932970|11159154|FG000|Overall Study|Withdrawal by Subject|5
7061909|NCT01932970|11159154|FG000|Overall Study|Death|1
7061910|NCT01932970|11159154|FG000|Overall Study|Lost to Follow-up|2
7061911|NCT01932970|11159154|FG000|Overall Study|Protocol Specified Criteria|10
7061912|NCT01932996|11159160|FG000|Overall Study|Protocol Violation|2
7061913|NCT01932996|11159161|FG001|Overall Study|Protocol Violation|0
7061914|NCT01933048|11159169|FG000|Overall Study|Lost to Follow-up|15
7061915|NCT01933048|11159170|FG001|Overall Study|Lost to Follow-up|18
7061916|NCT01933048|11159169|FG000|Overall Study|personal reasons|1
7061917|NCT01933048|11159170|FG001|Overall Study|personal reasons|1
7061918|NCT01933048|11159169|FG000|Overall Study|Protocol Violation|7
7061919|NCT01933048|11159170|FG001|Overall Study|Protocol Violation|8
7061920|NCT01933048|11159169|FG000|Overall Study|Physician Decision|1
7061921|NCT01933048|11159170|FG001|Overall Study|Physician Decision|0
7061922|NCT01933048|11159169|FG000|Overall Study|unknown reasons|1
7061923|NCT01933048|11159170|FG001|Overall Study|unknown reasons|1
7061924|NCT01933113|11159179|FG000|Overall Study|Fractured nonfunctioning lead.|1
7061925|NCT01933217|11159185|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1
7061926|NCT01933217|11159186|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3
7061927|NCT01933217|11159185|FG000|Randomization (4 Weeks)|Lost to Follow-up|1
7061928|NCT01933217|11159186|FG001|Randomization (4 Weeks)|Lost to Follow-up|1
7061929|NCT01933334|11159209|FG000|Overall Study|Adverse Event|5
7061930|NCT01933334|11159210|FG001|Overall Study|Adverse Event|1
7061931|NCT01933334|11159209|FG000|Overall Study|Withdrawal by Subject|0
7061932|NCT01933334|11159210|FG001|Overall Study|Withdrawal by Subject|1
7061933|NCT01933594|11159253|FG000|Overall Study|Lost to Follow-up|1
6829232|NCT00145327|10832665|FG000|Overall Study|Protocol Violation|2
7038465|NCT01703117|11120801|FG001|Overall Study|Withdrawal by Subject|1
7038466|NCT01703208|11120815|FG000|Overall Study|Death|61
7038467|NCT01703208|11120816|FG001|Overall Study|Death|48
7038468|NCT01703208|11120815|FG000|Overall Study|Lack of Efficacy|1
7038469|NCT01703208|11120816|FG001|Overall Study|Lack of Efficacy|2
7038470|NCT01703208|11120815|FG000|Overall Study|Lost to Follow-up|68
7038471|NCT01703208|11120816|FG001|Overall Study|Lost to Follow-up|62
7061934|NCT01933594|11159254|FG001|Overall Study|Lost to Follow-up|0
7061935|NCT01933594|11159255|FG002|Overall Study|Lost to Follow-up|0
7061936|NCT01933594|11159256|FG003|Overall Study|Lost to Follow-up|0
6924098|NCT02285062|10953348|FG000|Overall Study|Withdrawal by Subject|12
6924099|NCT02285062|10953349|FG001|Overall Study|Withdrawal by Subject|17
6924100|NCT02285062|10953348|FG000|Overall Study|Death|58
7038472|NCT01703208|11120815|FG000|Overall Study|Non-Compliance with Study Drug|1
7038473|NCT01703208|11120816|FG001|Overall Study|Non-Compliance with Study Drug|0
6924101|NCT02285062|10953349|FG001|Overall Study|Death|62
6924102|NCT02285062|10953348|FG000|Overall Study|Lost to Follow-up|8
6924103|NCT02285062|10953349|FG001|Overall Study|Lost to Follow-up|5
6924107|NCT01981096|10953361|FG000|Overall Study|Parent illness|1
6924108|NCT01981096|10953362|FG001|Overall Study|Parent illness|0
6924109|NCT01981096|10953361|FG000|Overall Study|Withdrawal by Subject|0
6924110|NCT01981096|10953362|FG001|Overall Study|Withdrawal by Subject|1
6924111|NCT01981096|10953361|FG000|Overall Study|Lost to Follow-up|2
6924112|NCT01981096|10953362|FG001|Overall Study|Lost to Follow-up|0
6924113|NCT01935336|10953372|FG000|Overall Study|Adverse Event|1
6924114|NCT01935336|10953373|FG001|Overall Study|Adverse Event|0
6924115|NCT01935336|10953374|FG002|Overall Study|Adverse Event|0
6924116|NCT01935336|10953375|FG003|Overall Study|Adverse Event|0
6924117|NCT01935336|10953372|FG000|Overall Study|Progressive disease|5
6924118|NCT01935336|10953373|FG001|Overall Study|Progressive disease|3
6924119|NCT01935336|10953374|FG002|Overall Study|Progressive disease|47
6924120|NCT01935336|10953375|FG003|Overall Study|Progressive disease|66
6924121|NCT01712490|10953393|FG000|Overall Study|Ongoing|601
6924122|NCT01712490|10953394|FG001|Overall Study|Ongoing|586
6924123|NCT01712490|10953393|FG000|Overall Study|Other|11
6924124|NCT01712490|10953394|FG001|Overall Study|Other|11
6924125|NCT01712490|10953393|FG000|Overall Study|Withdrawal by Subject|36
6924126|NCT01712490|10953394|FG001|Overall Study|Withdrawal by Subject|44
6924127|NCT01712490|10953393|FG000|Overall Study|Lost to Follow-up|16
6924128|NCT01712490|10953394|FG001|Overall Study|Lost to Follow-up|29
6924129|NCT01702805|10953402|FG000|Overall Study|Data withdrawn prior to hospital discharge|3
6924130|NCT01702805|10953403|FG001|Overall Study|Data withdrawn prior to hospital discharge|7
6924131|NCT01702805|10953402|FG000|Overall Study|Incomplete Follow-up|18
6924132|NCT01702805|10953403|FG001|Overall Study|Incomplete Follow-up|15
6924133|NCT01702805|10953402|FG000|Overall Study|Vital Status Assessment Only|40
6924134|NCT01702805|10953403|FG001|Overall Study|Vital Status Assessment Only|39
6924135|NCT01702805|10953402|FG000|Overall Study|Lost to Follow-up|5
6924136|NCT01702805|10953403|FG001|Overall Study|Lost to Follow-up|5
6924137|NCT01499160|10953409|FG000|Overall Study|Adverse Event|1
6924138|NCT01499160|10953409|FG000|Overall Study|Withdrawal by Subject|1
6924139|NCT01061151|10953451|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2
6924140|NCT01061151|10953452|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
6924141|NCT01061151|10953453|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
6924142|NCT01061151|10953454|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1
6924143|NCT01061151|10953451|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6
6924144|NCT01061151|10953452|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9
6924145|NCT01061151|10953453|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1
6924146|NCT01061151|10953454|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2
6924147|NCT01061151|10953451|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89
6924148|NCT01061151|10953452|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82
6924149|NCT01061151|10953453|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2
6924150|NCT01061151|10953454|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10
6924151|NCT01061151|10953451|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73
6924152|NCT01061151|10953452|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65
6924153|NCT01061151|10953453|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2
6924154|NCT01061151|10953454|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10
6924155|NCT01061151|10953451|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15
6924156|NCT01061151|10953452|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19
6924157|NCT01061151|10953453|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1
6924158|NCT01061151|10953454|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0
6924159|NCT01061151|10953451|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44
6924160|NCT01061151|10953452|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61
6924161|NCT01061151|10953453|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2
6924162|NCT01061151|10953454|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5
6924163|NCT01061151|10953451|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3
6924164|NCT01061151|10953452|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5
6924165|NCT01061151|10953453|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1
6924166|NCT01061151|10953454|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0
6924167|NCT01061151|10953451|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
7038474|NCT01703208|11120815|FG000|Overall Study|Excluded Medication|1
7061937|NCT01933594|11159257|FG004|Overall Study|Lost to Follow-up|1
7061938|NCT01933594|11159258|FG005|Overall Study|Lost to Follow-up|0
7061939|NCT01933594|11159253|FG000|Overall Study|Ineligible for subsequent study step|0
7061940|NCT01933594|11159254|FG001|Overall Study|Ineligible for subsequent study step|0
7061941|NCT01933594|11159255|FG002|Overall Study|Ineligible for subsequent study step|0
7061942|NCT01933594|11159256|FG003|Overall Study|Ineligible for subsequent study step|0
7061943|NCT01933594|11159257|FG004|Overall Study|Ineligible for subsequent study step|1
7061944|NCT01933594|11159258|FG005|Overall Study|Ineligible for subsequent study step|0
7061945|NCT01933672|11159276|FG000|Metformin Run-in Period|Adverse Event|1
7061946|NCT01933672|11159277|FG001|Metformin Run-in Period|Adverse Event|0
7061947|NCT01933672|11159278|FG002|Metformin Run-in Period|Adverse Event|0
7061948|NCT01933672|11159279|FG003|Metformin Run-in Period|Adverse Event|0
7061949|NCT01933672|11159280|FG004|Metformin Run-in Period|Adverse Event|0
7061950|NCT01933672|11159281|FG005|Metformin Run-in Period|Adverse Event|0
7061951|NCT01933672|11159282|FG006|Metformin Run-in Period|Adverse Event|0
7061952|NCT01933672|11159276|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4
7061953|NCT01933672|11159277|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0
7061954|NCT01933672|11159278|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0
7061955|NCT01933672|11159279|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0
7061956|NCT01933672|11159280|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0
7061957|NCT01933672|11159281|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0
7061958|NCT01933672|11159282|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0
7061959|NCT01933672|11159276|FG000|Metformin Run-in Period|Other|5
7061960|NCT01933672|11159277|FG001|Metformin Run-in Period|Other|0
7061961|NCT01933672|11159278|FG002|Metformin Run-in Period|Other|0
7061962|NCT01933672|11159279|FG003|Metformin Run-in Period|Other|0
7061963|NCT01933672|11159280|FG004|Metformin Run-in Period|Other|0
7061964|NCT01933672|11159281|FG005|Metformin Run-in Period|Other|0
7061965|NCT01933672|11159282|FG006|Metformin Run-in Period|Other|0
7061966|NCT01933672|11159276|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0
7061967|NCT01933672|11159277|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0
7061968|NCT01933672|11159278|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0
7061969|NCT01933672|11159279|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0
7061970|NCT01933672|11159280|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1
7061971|NCT01933672|11159281|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0
7061972|NCT01933672|11159282|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0
7061973|NCT01933672|11159276|FG000|First Intervention Period (12-16 Days)|Other|0
7061974|NCT01933672|11159277|FG001|First Intervention Period (12-16 Days)|Other|0
7061975|NCT01933672|11159278|FG002|First Intervention Period (12-16 Days)|Other|1
7061976|NCT01933672|11159279|FG003|First Intervention Period (12-16 Days)|Other|0
7061977|NCT01933672|11159280|FG004|First Intervention Period (12-16 Days)|Other|0
7061978|NCT01933672|11159281|FG005|First Intervention Period (12-16 Days)|Other|1
7061979|NCT01933672|11159282|FG006|First Intervention Period (12-16 Days)|Other|0
7061980|NCT01933672|11159276|FG000|Second Intervention Period (12-16 Days)|Other|0
7061981|NCT01933672|11159277|FG001|Second Intervention Period (12-16 Days)|Other|1
7061982|NCT01933672|11159278|FG002|Second Intervention Period (12-16 Days)|Other|1
7061983|NCT01933672|11159279|FG003|Second Intervention Period (12-16 Days)|Other|0
7061984|NCT01933672|11159280|FG004|Second Intervention Period (12-16 Days)|Other|0
7061985|NCT01933672|11159281|FG005|Second Intervention Period (12-16 Days)|Other|0
7061986|NCT01933672|11159282|FG006|Second Intervention Period (12-16 Days)|Other|0
7061987|NCT01933672|11159276|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
7061988|NCT01933672|11159277|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
7061989|NCT01933672|11159278|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
7061990|NCT01933672|11159279|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1
7061991|NCT01933672|11159280|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
7061992|NCT01933672|11159281|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
7061993|NCT01933672|11159282|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
7061994|NCT01933672|11159276|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
7061995|NCT01933672|11159277|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1
7061996|NCT01933672|11159278|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
7061997|NCT01933672|11159279|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
7061998|NCT01933672|11159280|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
7061999|NCT01933672|11159281|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
7062000|NCT01933672|11159282|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
7062001|NCT01933789|11159313|FG000|Overall Study|Death|0
7062002|NCT01933789|11159314|FG001|Overall Study|Death|0
7062003|NCT01933789|11159315|FG002|Overall Study|Death|0
7062004|NCT01933789|11159316|FG003|Overall Study|Death|0
7062005|NCT01933789|11159317|FG004|Overall Study|Death|21
7062006|NCT01933789|11159318|FG005|Overall Study|Death|32
7062007|NCT01933789|11159319|FG006|Overall Study|Death|0
7062008|NCT01933789|11159320|FG007|Overall Study|Death|0
7062009|NCT01933789|11159321|FG008|Overall Study|Death|0
7062010|NCT01933789|11159313|FG000|Overall Study|Lost to Follow-up|0
7062011|NCT01933789|11159314|FG001|Overall Study|Lost to Follow-up|0
7062012|NCT01933789|11159315|FG002|Overall Study|Lost to Follow-up|0
7062013|NCT01933789|11159316|FG003|Overall Study|Lost to Follow-up|1
7062014|NCT01933789|11159317|FG004|Overall Study|Lost to Follow-up|8
7062015|NCT01933789|11159318|FG005|Overall Study|Lost to Follow-up|9
7062016|NCT01933789|11159319|FG006|Overall Study|Lost to Follow-up|1
7062017|NCT01933789|11159320|FG007|Overall Study|Lost to Follow-up|4
7062018|NCT01933789|11159321|FG008|Overall Study|Lost to Follow-up|0
7062019|NCT01933789|11159313|FG000|Overall Study|Withdrawal by Subject|2
7062020|NCT01933789|11159314|FG001|Overall Study|Withdrawal by Subject|1
7062021|NCT01933789|11159315|FG002|Overall Study|Withdrawal by Subject|0
7062022|NCT01933789|11159316|FG003|Overall Study|Withdrawal by Subject|0
7062023|NCT01933789|11159317|FG004|Overall Study|Withdrawal by Subject|17
7062024|NCT01933789|11159318|FG005|Overall Study|Withdrawal by Subject|16
7062025|NCT01933789|11159319|FG006|Overall Study|Withdrawal by Subject|1
7062026|NCT01933789|11159320|FG007|Overall Study|Withdrawal by Subject|4
7062027|NCT01933789|11159321|FG008|Overall Study|Withdrawal by Subject|0
7062028|NCT01933789|11159313|FG000|Overall Study|Became Ineligible|4
7062029|NCT01933789|11159314|FG001|Overall Study|Became Ineligible|0
7062030|NCT01933789|11159315|FG002|Overall Study|Became Ineligible|0
7062031|NCT01933789|11159316|FG003|Overall Study|Became Ineligible|0
7062032|NCT01933789|11159317|FG004|Overall Study|Became Ineligible|13
7062033|NCT01933789|11159318|FG005|Overall Study|Became Ineligible|10
7062034|NCT01933789|11159319|FG006|Overall Study|Became Ineligible|13
7062035|NCT01933789|11159320|FG007|Overall Study|Became Ineligible|6
7062036|NCT01933789|11159321|FG008|Overall Study|Became Ineligible|0
7062037|NCT01933880|11159343|FG000|Overall Study|Withdrawal by Subject|5
7062038|NCT01933880|11159344|FG001|Overall Study|Withdrawal by Subject|0
7062039|NCT01933880|11159343|FG000|Overall Study|Lack of Efficacy|1
7062040|NCT01933880|11159344|FG001|Overall Study|Lack of Efficacy|0
7062041|NCT01933880|11159343|FG000|Overall Study|Concomitant medication Interference|0
7062042|NCT01933880|11159344|FG001|Overall Study|Concomitant medication Interference|1
7062043|NCT01933880|11159343|FG000|Overall Study|Followup exceeded 4 days to visit window|19
7062044|NCT01933880|11159344|FG001|Overall Study|Followup exceeded 4 days to visit window|0
7062045|NCT01933880|11159343|FG000|Overall Study|Other|4
7062046|NCT01933880|11159344|FG001|Overall Study|Other|0
7062047|NCT01933880|11159343|FG000|Overall Study|Protocol Violation|1
7062048|NCT01933880|11159344|FG001|Overall Study|Protocol Violation|0
7062049|NCT01933919|11159357|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0
7062050|NCT01933919|11159358|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1
7062051|NCT01933919|11159357|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0
7062052|NCT01933919|11159358|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1
7062053|NCT01933919|11159357|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0
7062054|NCT01933919|11159358|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2
7062055|NCT01933919|11159357|FG000|Open-label Long-term Phase|Adverse Event|2
6924168|NCT01061151|10953452|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
6924169|NCT01061151|10953453|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2
6924170|NCT01061151|10953454|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4
6924171|NCT01061151|10953451|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1
6924172|NCT01061151|10953452|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
6924173|NCT01061151|10953453|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
6924174|NCT01061151|10953454|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
6924175|NCT01061151|10953451|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3
6924176|NCT01061151|10953452|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5
6924177|NCT01061151|10953453|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1
6924178|NCT01061151|10953454|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1
6924179|NCT01061151|10953451|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54
6924180|NCT01061151|10953452|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52
6924181|NCT01061151|10953453|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31
6924182|NCT01061151|10953454|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3
6924183|NCT01061151|10953451|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49
6924184|NCT01061151|10953452|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36
6924185|NCT01061151|10953453|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25
6924186|NCT01061151|10953454|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4
6924187|NCT01061151|10953451|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12
7062056|NCT01933919|11159358|FG001|Open-label Long-term Phase|Adverse Event|0
7062057|NCT01933919|11159357|FG000|Open-label Long-term Phase|Withdrawal by Subject|3
7062058|NCT01933919|11159358|FG001|Open-label Long-term Phase|Withdrawal by Subject|4
7062059|NCT01933919|11159357|FG000|Open-label Long-term Phase|Lost to Follow-up|1
7062060|NCT01933919|11159358|FG001|Open-label Long-term Phase|Lost to Follow-up|0
7062061|NCT01933919|11159357|FG000|Open-label Long-term Phase|Other|1
7062062|NCT01933919|11159358|FG001|Open-label Long-term Phase|Other|2
7062063|NCT01934010|11159392|FG000|Overall Study|Adverse Event|1
7062064|NCT01934010|11159393|FG001|Overall Study|Adverse Event|1
7062065|NCT01934010|11159394|FG002|Overall Study|Adverse Event|0
7062066|NCT01934010|11159392|FG000|Overall Study|Withdrawal by Subject|15
7062067|NCT01934010|11159393|FG001|Overall Study|Withdrawal by Subject|6
7062068|NCT01934010|11159394|FG002|Overall Study|Withdrawal by Subject|2
7062069|NCT01934010|11159392|FG000|Overall Study|Lost to Follow-up|7
7062070|NCT01934010|11159393|FG001|Overall Study|Lost to Follow-up|4
7062071|NCT01934010|11159394|FG002|Overall Study|Lost to Follow-up|0
7062072|NCT01934140|11159413|FG000|Persistence Phase (Year 6-10)|Other|24
7062073|NCT01934140|11159414|FG001|Persistence Phase (Year 6-10)|Other|6
7062074|NCT01934140|11159413|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5
7062075|NCT01934140|11159414|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2
7062076|NCT01934140|11159413|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31
7062077|NCT01934140|11159414|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10
7062078|NCT01934140|11159413|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2
7062079|NCT01934140|11159414|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0
7062080|NCT01934140|11159413|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21
7062081|NCT01934140|11159414|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7
7062082|NCT01934140|11159413|FG000|Booster Phase (6 Months)|Lost to Follow-up|1
7062083|NCT01934140|11159414|FG001|Booster Phase (6 Months)|Lost to Follow-up|0
7062084|NCT01934140|11159413|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2
7062085|NCT01934140|11159414|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1
7062086|NCT01934140|11159413|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2
7062087|NCT01934140|11159414|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2
7062088|NCT01934192|11159426|FG000|Overall Study|Protocol Violation|0
7062089|NCT01934192|11159427|FG001|Overall Study|Protocol Violation|0
7062090|NCT01934192|11159428|FG002|Overall Study|Protocol Violation|0
7062091|NCT01934192|11159429|FG003|Overall Study|Protocol Violation|1
7062092|NCT01934192|11159426|FG000|Overall Study|Other: reached stopping criteria|6
7062093|NCT01934192|11159427|FG001|Overall Study|Other: reached stopping criteria|5
7062094|NCT01934192|11159428|FG002|Overall Study|Other: reached stopping criteria|1
7062095|NCT01934192|11159429|FG003|Overall Study|Other: reached stopping criteria|0
7062096|NCT01934192|11159426|FG000|Overall Study|Physician Decision|3
7062097|NCT01934192|11159427|FG001|Overall Study|Physician Decision|2
7062098|NCT01934192|11159428|FG002|Overall Study|Physician Decision|0
7062099|NCT01934192|11159429|FG003|Overall Study|Physician Decision|0
7062100|NCT01934218|11159452|FG000|Double-blind Phase|Adverse Event|8
7062101|NCT01934218|11159453|FG001|Double-blind Phase|Adverse Event|8
7062102|NCT01934218|11159452|FG000|Double-blind Phase|Lack of Efficacy|6
7062103|NCT01934218|11159453|FG001|Double-blind Phase|Lack of Efficacy|7
7062104|NCT01934218|11159452|FG000|Double-blind Phase|Lost to Follow-up|7
7062105|NCT01934218|11159453|FG001|Double-blind Phase|Lost to Follow-up|14
7062106|NCT01934218|11159452|FG000|Double-blind Phase|Physician Decision|1
7062107|NCT01934218|11159453|FG001|Double-blind Phase|Physician Decision|2
7062108|NCT01934218|11159452|FG000|Double-blind Phase|Protocol Violation|4
7062109|NCT01934218|11159453|FG001|Double-blind Phase|Protocol Violation|0
7062110|NCT01934218|11159452|FG000|Double-blind Phase|Withdrawal by Subject|16
7062111|NCT01934218|11159453|FG001|Double-blind Phase|Withdrawal by Subject|13
7062112|NCT01934218|11159452|FG000|Double-blind Phase|Noncompliance with Study Protocol|5
7062113|NCT01934218|11159453|FG001|Double-blind Phase|Noncompliance with Study Protocol|8
7062114|NCT01934218|11159452|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1
7062115|NCT01934218|11159453|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2
7062116|NCT01934218|11159452|FG000|Open-Label Phase|Adverse Event|2
7062117|NCT01934218|11159453|FG001|Open-Label Phase|Adverse Event|4
6924188|NCT01061151|10953452|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11
6924189|NCT01061151|10953453|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2
6924190|NCT01061151|10953454|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0
6924191|NCT01061151|10953451|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28
6924192|NCT01061151|10953452|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26
6924193|NCT01061151|10953453|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15
6924194|NCT01061151|10953454|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5
6924195|NCT01061151|10953451|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5
6924196|NCT01061151|10953452|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8
6924197|NCT01061151|10953453|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1
6924198|NCT01061151|10953454|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3
6924199|NCT00981058|10953476|FG000|Overall Study|Adverse Event|1
6924200|NCT00981058|10953477|FG001|Overall Study|Adverse Event|1
6924201|NCT00981058|10953476|FG000|Overall Study|Progressive Disease|61
6924202|NCT00981058|10953477|FG001|Overall Study|Progressive Disease|49
6924203|NCT00981058|10953476|FG000|Overall Study|Lost to Follow-up|16
6924204|NCT00981058|10953477|FG001|Overall Study|Lost to Follow-up|15
6924205|NCT00981058|10953476|FG000|Overall Study|New Anticancer Therapy|6
6924206|NCT00981058|10953477|FG001|Overall Study|New Anticancer Therapy|6
6924207|NCT00981058|10953476|FG000|Overall Study|Noncompliance|1
6924208|NCT00981058|10953477|FG001|Overall Study|Noncompliance|0
7062118|NCT01934218|11159452|FG000|Open-Label Phase|Lack of Efficacy|1
7062119|NCT01934218|11159453|FG001|Open-Label Phase|Lack of Efficacy|4
7062120|NCT01934218|11159452|FG000|Open-Label Phase|Lost to Follow-up|4
7062121|NCT01934218|11159453|FG001|Open-Label Phase|Lost to Follow-up|2
7062122|NCT01934218|11159452|FG000|Open-Label Phase|Physician Decision|1
7062123|NCT01934218|11159453|FG001|Open-Label Phase|Physician Decision|0
7062124|NCT01934218|11159452|FG000|Open-Label Phase|Protocol Violation|1
7062125|NCT01934218|11159453|FG001|Open-Label Phase|Protocol Violation|0
7062126|NCT01934218|11159452|FG000|Open-Label Phase|Withdrawal by Subject|13
7062127|NCT01934218|11159453|FG001|Open-Label Phase|Withdrawal by Subject|11
6829233|NCT00145327|10832666|FG001|Overall Study|Protocol Violation|0
6829234|NCT00145327|10832667|FG002|Overall Study|Protocol Violation|2
6829235|NCT00145327|10832665|FG000|Overall Study|Abnormal laboratory value(s)|1
6829236|NCT00145327|10832666|FG001|Overall Study|Abnormal laboratory value(s)|0
6829237|NCT00145327|10832667|FG002|Overall Study|Abnormal laboratory value(s)|2
6829238|NCT00145327|10832665|FG000|Overall Study|Missing - not stated|1
6829239|NCT00145327|10832666|FG001|Overall Study|Missing - not stated|0
6829240|NCT00145327|10832667|FG002|Overall Study|Missing - not stated|1
6829241|NCT00145574|10832682|FG000|Double Blind|Adverse Event|0
6829242|NCT00145574|10832683|FG001|Double Blind|Adverse Event|3
6829243|NCT00145574|10832684|FG002|Double Blind|Adverse Event|1
6829244|NCT00145574|10832682|FG000|Double Blind|Withdrawal by Subject|1
6829245|NCT00145574|10832683|FG001|Double Blind|Withdrawal by Subject|1
6829246|NCT00145574|10832684|FG002|Double Blind|Withdrawal by Subject|1
6829247|NCT00145574|10832682|FG000|Double Blind|required restricted medicine|0
6829248|NCT00145574|10832683|FG001|Double Blind|required restricted medicine|1
6829249|NCT00145574|10832684|FG002|Double Blind|required restricted medicine|0
6829250|NCT00145574|10832682|FG000|Open Label Long-term Extension|Adverse Event|0
6829251|NCT00145574|10832683|FG001|Open Label Long-term Extension|Adverse Event|0
6829252|NCT00145574|10832684|FG002|Open Label Long-term Extension|Adverse Event|5
6829253|NCT00145574|10832682|FG000|Open Label Long-term Extension|Lost to Follow-up|0
6829254|NCT00145574|10832683|FG001|Open Label Long-term Extension|Lost to Follow-up|0
6829255|NCT00145574|10832684|FG002|Open Label Long-term Extension|Lost to Follow-up|1
6829256|NCT00145574|10832682|FG000|Open Label Long-term Extension|Withdrawal by Subject|0
6829257|NCT00145574|10832683|FG001|Open Label Long-term Extension|Withdrawal by Subject|0
6829258|NCT00145574|10832684|FG002|Open Label Long-term Extension|Withdrawal by Subject|4
6829259|NCT00145574|10832682|FG000|Open Label Long-term Extension|required restricted medicine|0
6829260|NCT00145574|10832683|FG001|Open Label Long-term Extension|required restricted medicine|0
6829261|NCT00145574|10832684|FG002|Open Label Long-term Extension|required restricted medicine|1
6829262|NCT00145626|10832708|FG000|Overall Study|Did not have NK infusions|2
6829263|NCT00145626|10832708|FG000|Overall Study|Turned 2 years old before treatment|1
6829264|NCT00145626|10832708|FG000|Overall Study|Death|1
6829265|NCT00145626|10832708|FG000|Overall Study|Withdrawal by Subject|1
6829266|NCT00145977|10832730|FG000|Overall Study|Lack of Efficacy|0
6829267|NCT00145977|10832731|FG001|Overall Study|Lack of Efficacy|4
6829268|NCT00145977|10832730|FG000|Overall Study|Lost to Follow-up|1
6829269|NCT00145977|10832731|FG001|Overall Study|Lost to Follow-up|0
6829270|NCT00145977|10832730|FG000|Overall Study|Withdrawal by Subject|1
6829271|NCT00145977|10832731|FG001|Overall Study|Withdrawal by Subject|0
6829272|NCT00146172|10832745|FG000|Overall Study|Adverse Event|0
6829273|NCT00146172|10832746|FG001|Overall Study|Adverse Event|0
6829274|NCT00146172|10832747|FG002|Overall Study|Adverse Event|1
6829275|NCT00146172|10832748|FG003|Overall Study|Adverse Event|1
6829276|NCT00146172|10832749|FG004|Overall Study|Adverse Event|0
6829277|NCT00146172|10832750|FG005|Overall Study|Adverse Event|2
6829278|NCT00146172|10832751|FG006|Overall Study|Adverse Event|3
6829279|NCT00146172|10832752|FG007|Overall Study|Adverse Event|10
6829280|NCT00146172|10832745|FG000|Overall Study|Lost to Follow-up|0
6829281|NCT00146172|10832746|FG001|Overall Study|Lost to Follow-up|0
6829282|NCT00146172|10832747|FG002|Overall Study|Lost to Follow-up|0
6829283|NCT00146172|10832748|FG003|Overall Study|Lost to Follow-up|0
6829284|NCT00146172|10832749|FG004|Overall Study|Lost to Follow-up|0
6829285|NCT00146172|10832750|FG005|Overall Study|Lost to Follow-up|0
6829286|NCT00146172|10832751|FG006|Overall Study|Lost to Follow-up|0
6829287|NCT00146172|10832752|FG007|Overall Study|Lost to Follow-up|1
7062128|NCT01934218|11159452|FG000|Open-Label Phase|Noncompliance with Study Protocol|4
7062129|NCT01934218|11159453|FG001|Open-Label Phase|Noncompliance with Study Protocol|2
7062130|NCT01934218|11159452|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0
7062131|NCT01934218|11159453|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1
7062132|NCT01934335|11159465|FG000|Overall Study|Withdrawal by Subject|1
7062133|NCT01934335|11159466|FG001|Overall Study|Withdrawal by Subject|1
7062134|NCT01934556|11159483|FG000|Overall Study|Withdrawal by Subject|0
7062135|NCT01934556|11159484|FG001|Overall Study|Withdrawal by Subject|1
7062136|NCT01934556|11159485|FG002|Overall Study|Withdrawal by Subject|1
7062137|NCT01934556|11159483|FG000|Overall Study|Lost to Follow-up|4
7062138|NCT01934556|11159484|FG001|Overall Study|Lost to Follow-up|10
7062139|NCT01934556|11159485|FG002|Overall Study|Lost to Follow-up|7
7062140|NCT01934556|11159483|FG000|Overall Study|Death|1
6829288|NCT00146172|10832745|FG000|Overall Study|Disease Progression|2
6829289|NCT00146172|10832746|FG001|Overall Study|Disease Progression|4
6829290|NCT00146172|10832747|FG002|Overall Study|Disease Progression|2
6829291|NCT00146172|10832748|FG003|Overall Study|Disease Progression|5
6829292|NCT00146172|10832749|FG004|Overall Study|Disease Progression|2
6829293|NCT00146172|10832750|FG005|Overall Study|Disease Progression|2
6829294|NCT00146172|10832751|FG006|Overall Study|Disease Progression|1
6829295|NCT00146172|10832752|FG007|Overall Study|Disease Progression|22
6829296|NCT00146172|10832745|FG000|Overall Study|Death|0
6829297|NCT00146172|10832746|FG001|Overall Study|Death|0
6829298|NCT00146172|10832747|FG002|Overall Study|Death|0
6829299|NCT00146172|10832748|FG003|Overall Study|Death|0
6829300|NCT00146172|10832749|FG004|Overall Study|Death|0
6829301|NCT00146172|10832750|FG005|Overall Study|Death|0
7062141|NCT01934556|11159484|FG001|Overall Study|Death|5
6829302|NCT00146172|10832751|FG006|Overall Study|Death|1
6829303|NCT00146172|10832752|FG007|Overall Study|Death|0
6829304|NCT00146172|10832745|FG000|Overall Study|Physician Decision|0
6829305|NCT00146172|10832746|FG001|Overall Study|Physician Decision|0
6829306|NCT00146172|10832747|FG002|Overall Study|Physician Decision|0
6829307|NCT00146172|10832748|FG003|Overall Study|Physician Decision|0
6829308|NCT00146172|10832749|FG004|Overall Study|Physician Decision|0
6829309|NCT00146172|10832750|FG005|Overall Study|Physician Decision|0
6829310|NCT00146172|10832751|FG006|Overall Study|Physician Decision|0
6829311|NCT00146172|10832752|FG007|Overall Study|Physician Decision|1
6829312|NCT00146172|10832745|FG000|Overall Study|Withdrawal by Subject|0
6829313|NCT00146172|10832746|FG001|Overall Study|Withdrawal by Subject|0
6829314|NCT00146172|10832747|FG002|Overall Study|Withdrawal by Subject|0
7038475|NCT01703208|11120816|FG001|Overall Study|Excluded Medication|2
6829315|NCT00146172|10832748|FG003|Overall Study|Withdrawal by Subject|0
6829316|NCT00146172|10832749|FG004|Overall Study|Withdrawal by Subject|0
6829317|NCT00146172|10832750|FG005|Overall Study|Withdrawal by Subject|1
6829318|NCT00146172|10832751|FG006|Overall Study|Withdrawal by Subject|1
6829319|NCT00146172|10832752|FG007|Overall Study|Withdrawal by Subject|4
6829320|NCT00146172|10832745|FG000|Overall Study|Symptomatic Deterioration|1
6829321|NCT00146172|10832746|FG001|Overall Study|Symptomatic Deterioration|0
6829322|NCT00146172|10832747|FG002|Overall Study|Symptomatic Deterioration|1
6829323|NCT00146172|10832748|FG003|Overall Study|Symptomatic Deterioration|0
6829324|NCT00146172|10832749|FG004|Overall Study|Symptomatic Deterioration|1
6829325|NCT00146172|10832750|FG005|Overall Study|Symptomatic Deterioration|2
6829326|NCT00146172|10832751|FG006|Overall Study|Symptomatic Deterioration|0
6829327|NCT00146172|10832752|FG007|Overall Study|Symptomatic Deterioration|2
6829328|NCT00146328|10832781|FG000|Overall Study|Adverse Event|39
6829329|NCT00146328|10832782|FG001|Overall Study|Adverse Event|48
6829330|NCT00146328|10832783|FG002|Overall Study|Adverse Event|79
6829331|NCT00146328|10832781|FG000|Overall Study|Protocol Violation|11
6829332|NCT00146328|10832782|FG001|Overall Study|Protocol Violation|6
6829333|NCT00146328|10832783|FG002|Overall Study|Protocol Violation|12
6829334|NCT00146328|10832781|FG000|Overall Study|Lost to Follow-up|7
6829335|NCT00146328|10832782|FG001|Overall Study|Lost to Follow-up|4
6829336|NCT00146328|10832783|FG002|Overall Study|Lost to Follow-up|7
6829337|NCT00146328|10832781|FG000|Overall Study|Withdrawal by Subject|16
6829338|NCT00146328|10832782|FG001|Overall Study|Withdrawal by Subject|16
6829339|NCT00146328|10832783|FG002|Overall Study|Withdrawal by Subject|22
6829340|NCT00146328|10832781|FG000|Overall Study|Virologic Failure/lack of efficacy|54
6829341|NCT00146328|10832782|FG001|Overall Study|Virologic Failure/lack of efficacy|72
6829342|NCT00146328|10832783|FG002|Overall Study|Virologic Failure/lack of efficacy|142
6829343|NCT00146328|10832781|FG000|Overall Study|Trial ended/site closed|8
6829344|NCT00146328|10832782|FG001|Overall Study|Trial ended/site closed|2
6829345|NCT00146328|10832783|FG002|Overall Study|Trial ended/site closed|19
6829346|NCT00146328|10832781|FG000|Overall Study|Patient decision to end|0
6829347|NCT00146328|10832782|FG001|Overall Study|Patient decision to end|1
6829348|NCT00146328|10832783|FG002|Overall Study|Patient decision to end|6
6829349|NCT00146328|10832781|FG000|Overall Study|Enroll into other trial|2
6829350|NCT00146328|10832782|FG001|Overall Study|Enroll into other trial|4
6829351|NCT00146328|10832783|FG002|Overall Study|Enroll into other trial|2
6829352|NCT00146328|10832781|FG000|Overall Study|Death|0
6829353|NCT00146328|10832782|FG001|Overall Study|Death|1
6829354|NCT00146328|10832783|FG002|Overall Study|Death|1
6829355|NCT00146328|10832781|FG000|Overall Study|Moved|2
6829356|NCT00146328|10832782|FG001|Overall Study|Moved|0
6829357|NCT00146328|10832783|FG002|Overall Study|Moved|0
6829358|NCT00146328|10832781|FG000|Overall Study|Interaction with other medication|2
6829359|NCT00146328|10832782|FG001|Overall Study|Interaction with other medication|0
6829360|NCT00146328|10832783|FG002|Overall Study|Interaction with other medication|1
6829361|NCT00146640|10832793|FG000|Overall Study|Adverse Event|12
6829362|NCT00146640|10832794|FG001|Overall Study|Adverse Event|10
6829363|NCT00146640|10832793|FG000|Overall Study|Medical Reasons|3
6829364|NCT00146640|10832794|FG001|Overall Study|Medical Reasons|0
6829365|NCT00146640|10832793|FG000|Overall Study|Non-Medical Reasons|8
6829366|NCT00146640|10832794|FG001|Overall Study|Non-Medical Reasons|4
6924209|NCT00981058|10953476|FG000|Overall Study|Radiologist Error|0
6924210|NCT00981058|10953477|FG001|Overall Study|Radiologist Error|1
6924211|NCT00981058|10953476|FG000|Overall Study|Randomization Error|1
6924212|NCT00981058|10953477|FG001|Overall Study|Randomization Error|2
6924213|NCT00981058|10953476|FG000|Overall Study|Withdrawal by Subject|25
6924214|NCT00981058|10953477|FG001|Overall Study|Withdrawal by Subject|23
6924215|NCT00981058|10953476|FG000|Overall Study|On study treatment at conclusion|9
6924216|NCT00981058|10953477|FG001|Overall Study|On study treatment at conclusion|0
6924217|NCT00885495|10953485|FG000|Overall Study|Adverse Event|1
6829367|NCT00146757|10832800|FG000|Overall Study|Death|1
6829368|NCT00146757|10832801|FG001|Overall Study|Death|0
6829369|NCT00146757|10832800|FG000|Overall Study|Adverse Event|1
6829370|NCT00146757|10832801|FG001|Overall Study|Adverse Event|0
6829371|NCT00146770|10832809|FG000|Overall Study|Adverse Event|2
6829372|NCT00146770|10832810|FG001|Overall Study|Adverse Event|0
6829373|NCT00146770|10832809|FG000|Overall Study|Pregnancy|1
6829374|NCT00146770|10832810|FG001|Overall Study|Pregnancy|0
6829375|NCT00146770|10832809|FG000|Overall Study|Withdrawal by Subject|2
6829376|NCT00146770|10832810|FG001|Overall Study|Withdrawal by Subject|0
6829377|NCT00146848|10832819|FG000|Pre-randomization|Death|19
6829378|NCT00146848|10832820|FG001|Pre-randomization|Death|0
6829379|NCT00146848|10832821|FG002|Pre-randomization|Death|0
6829380|NCT00146848|10832819|FG000|Pre-randomization|Lost to Follow-up|70
6829381|NCT00146848|10832820|FG001|Pre-randomization|Lost to Follow-up|0
6829382|NCT00146848|10832821|FG002|Pre-randomization|Lost to Follow-up|0
6829383|NCT00146848|10832819|FG000|Pre-randomization|Physician Decision|8
6829384|NCT00146848|10832820|FG001|Pre-randomization|Physician Decision|0
6829385|NCT00146848|10832821|FG002|Pre-randomization|Physician Decision|0
6829386|NCT00146848|10832819|FG000|Pre-randomization|Protocol Violation|172
6829387|NCT00146848|10832820|FG001|Pre-randomization|Protocol Violation|0
6829388|NCT00146848|10832821|FG002|Pre-randomization|Protocol Violation|0
6829389|NCT00146848|10832819|FG000|Pre-randomization|Withdrawal by Subject|40
6829390|NCT00146848|10832820|FG001|Pre-randomization|Withdrawal by Subject|0
6829391|NCT00146848|10832821|FG002|Pre-randomization|Withdrawal by Subject|0
6829392|NCT00146848|10832819|FG000|Post-randomization|Lost to Follow-up|12
6829393|NCT00146848|10832820|FG001|Post-randomization|Lost to Follow-up|15
6829394|NCT00146848|10832821|FG002|Post-randomization|Lost to Follow-up|12
6829395|NCT00146848|10832819|FG000|Post-randomization|Withdrawn|26
6829396|NCT00146848|10832820|FG001|Post-randomization|Withdrawn|32
6829397|NCT00146848|10832821|FG002|Post-randomization|Withdrawn|27
6829398|NCT00147225|10832907|FG000|Overall Study|Withdrawal by Subject|1
6829399|NCT00147225|10832908|FG001|Overall Study|Withdrawal by Subject|0
6829400|NCT00147225|10832909|FG002|Overall Study|Withdrawal by Subject|1
6829401|NCT00147225|10832910|FG003|Overall Study|Withdrawal by Subject|0
6829402|NCT00147225|10832911|FG004|Overall Study|Withdrawal by Subject|0
6829403|NCT00147225|10832912|FG005|Overall Study|Withdrawal by Subject|1
6829404|NCT00147225|10832907|FG000|Overall Study|Adverse Event|0
6829405|NCT00147225|10832908|FG001|Overall Study|Adverse Event|0
6829406|NCT00147225|10832909|FG002|Overall Study|Adverse Event|1
6829407|NCT00147225|10832910|FG003|Overall Study|Adverse Event|1
6829408|NCT00147225|10832911|FG004|Overall Study|Adverse Event|0
6829409|NCT00147225|10832912|FG005|Overall Study|Adverse Event|0
6829410|NCT00147225|10832907|FG000|Overall Study|Screen Failure|0
6829411|NCT00147225|10832908|FG001|Overall Study|Screen Failure|0
6829412|NCT00147225|10832909|FG002|Overall Study|Screen Failure|0
6829413|NCT00147225|10832910|FG003|Overall Study|Screen Failure|0
6829414|NCT00147225|10832911|FG004|Overall Study|Screen Failure|1
6829415|NCT00147225|10832912|FG005|Overall Study|Screen Failure|0
6829416|NCT00147225|10832907|FG000|Overall Study|Chemotherapy Changed|0
6829417|NCT00147225|10832908|FG001|Overall Study|Chemotherapy Changed|0
6829418|NCT00147225|10832909|FG002|Overall Study|Chemotherapy Changed|0
6829419|NCT00147225|10832910|FG003|Overall Study|Chemotherapy Changed|0
6829420|NCT00147225|10832911|FG004|Overall Study|Chemotherapy Changed|0
6829421|NCT00147225|10832912|FG005|Overall Study|Chemotherapy Changed|1
6829422|NCT00147251|10832928|FG000|Recruitment and Enrollment|change in treatment guidelines|24
6829423|NCT00147251|10832929|FG001|Recruitment and Enrollment|change in treatment guidelines|25
6829424|NCT00147498|10832956|FG000|Overall Study|Adverse Event|1
6829425|NCT00147498|10832957|FG001|Overall Study|Adverse Event|6
6829426|NCT00147498|10832958|FG002|Overall Study|Adverse Event|7
6829427|NCT00147498|10832959|FG003|Overall Study|Adverse Event|3
6829428|NCT00147498|10832956|FG000|Overall Study|Lack of Efficacy|1
6829429|NCT00147498|10832957|FG001|Overall Study|Lack of Efficacy|1
6829430|NCT00147498|10832958|FG002|Overall Study|Lack of Efficacy|1
6829431|NCT00147498|10832959|FG003|Overall Study|Lack of Efficacy|8
6829432|NCT00147498|10832956|FG000|Overall Study|Laboratory abnormality|0
6829433|NCT00147498|10832957|FG001|Overall Study|Laboratory abnormality|0
6829434|NCT00147498|10832958|FG002|Overall Study|Laboratory abnormality|2
6829435|NCT00147498|10832959|FG003|Overall Study|Laboratory abnormality|0
6829436|NCT00147498|10832956|FG000|Overall Study|Participant defaulted|0
6829437|NCT00147498|10832957|FG001|Overall Study|Participant defaulted|1
6829438|NCT00147498|10832958|FG002|Overall Study|Participant defaulted|4
6829439|NCT00147498|10832959|FG003|Overall Study|Participant defaulted|3
6829440|NCT00147498|10832956|FG000|Overall Study|Other|1
6829441|NCT00147498|10832957|FG001|Overall Study|Other|1
6924218|NCT00885495|10953486|FG001|Overall Study|Adverse Event|2
6924219|NCT00885495|10953485|FG000|Overall Study|Protocol Violation|0
6924220|NCT00885495|10953486|FG001|Overall Study|Protocol Violation|1
7062142|NCT01934556|11159485|FG002|Overall Study|Death|2
6829442|NCT00147498|10832958|FG002|Overall Study|Other|3
6924221|NCT00885495|10953485|FG000|Overall Study|Withdrawal by Subject|1
6924222|NCT00885495|10953486|FG001|Overall Study|Withdrawal by Subject|0
6924223|NCT00084799|10953499|FG000|Overall Study|Disease Progression|1
6924224|NCT00084799|10953500|FG001|Overall Study|Disease Progression|0
6924225|NCT00821236|10953509|FG000|Overall Study|Lost to Follow-up|3
6924226|NCT00821327|10953517|FG000|Overall Study|Adverse Event|13
6924227|NCT00821327|10953517|FG000|Overall Study|Patient Request|1
6924228|NCT00821327|10953517|FG000|Overall Study|Investigator Request|2
6924229|NCT00821327|10953517|FG000|Overall Study|Sponsor Request|1
6924230|NCT00821327|10953517|FG000|Overall Study|Disease Progression|13
6924231|NCT00821327|10953517|FG000|Overall Study|Other/Unknown|5
6924232|NCT00821431|10953523|FG000|Overall Study|Adverse Event|6
6924233|NCT00821431|10953524|FG001|Overall Study|Adverse Event|3
6924234|NCT00821431|10953523|FG000|Overall Study|Withdrawal by Subject|5
7062143|NCT01934790|11159499|FG000|Treatment|Adverse Event|3
6829443|NCT00147498|10832959|FG003|Overall Study|Other|3
6829444|NCT00147537|10832973|FG000|Phase 1b|Death|0
6829445|NCT00147537|10832974|FG001|Phase 1b|Death|1
6829446|NCT00147537|10832975|FG002|Phase 1b|Death|2
6829447|NCT00147537|10832976|FG003|Phase 1b|Death|1
6829448|NCT00147537|10832977|FG004|Phase 1b|Death|2
6829449|NCT00147537|10832978|FG005|Phase 1b|Death|2
6829450|NCT00147537|10832979|FG006|Phase 1b|Death|1
6829451|NCT00147537|10832980|FG007|Phase 1b|Death|3
6829452|NCT00147537|10832981|FG008|Phase 1b|Death|9
6829453|NCT00147537|10832982|FG009|Phase 1b|Death|0
6829454|NCT00147537|10832983|FG010|Phase 1b|Death|0
6829455|NCT00147537|10832973|FG000|Phase 1b|Lost to Follow-up|2
6829456|NCT00147537|10832974|FG001|Phase 1b|Lost to Follow-up|1
6829457|NCT00147537|10832975|FG002|Phase 1b|Lost to Follow-up|0
6829458|NCT00147537|10832976|FG003|Phase 1b|Lost to Follow-up|0
6829459|NCT00147537|10832977|FG004|Phase 1b|Lost to Follow-up|0
6829460|NCT00147537|10832978|FG005|Phase 1b|Lost to Follow-up|0
6829461|NCT00147537|10832979|FG006|Phase 1b|Lost to Follow-up|2
6829462|NCT00147537|10832980|FG007|Phase 1b|Lost to Follow-up|0
6829463|NCT00147537|10832981|FG008|Phase 1b|Lost to Follow-up|1
6829464|NCT00147537|10832982|FG009|Phase 1b|Lost to Follow-up|0
6829465|NCT00147537|10832983|FG010|Phase 1b|Lost to Follow-up|0
6829466|NCT00147537|10832973|FG000|Phase 1b|Other|0
6829467|NCT00147537|10832974|FG001|Phase 1b|Other|0
6829468|NCT00147537|10832975|FG002|Phase 1b|Other|2
6829469|NCT00147537|10832976|FG003|Phase 1b|Other|1
6829470|NCT00147537|10832977|FG004|Phase 1b|Other|1
6829471|NCT00147537|10832978|FG005|Phase 1b|Other|1
6829472|NCT00147537|10832979|FG006|Phase 1b|Other|14
6829473|NCT00147537|10832980|FG007|Phase 1b|Other|4
6829474|NCT00147537|10832981|FG008|Phase 1b|Other|4
6829475|NCT00147537|10832982|FG009|Phase 1b|Other|0
6829476|NCT00147537|10832983|FG010|Phase 1b|Other|0
6829477|NCT00147537|10832973|FG000|Phase 1b|Withdrawal by Subject|0
6829478|NCT00147537|10832974|FG001|Phase 1b|Withdrawal by Subject|0
6829479|NCT00147537|10832975|FG002|Phase 1b|Withdrawal by Subject|0
6829480|NCT00147537|10832976|FG003|Phase 1b|Withdrawal by Subject|0
6829481|NCT00147537|10832977|FG004|Phase 1b|Withdrawal by Subject|0
6829482|NCT00147537|10832978|FG005|Phase 1b|Withdrawal by Subject|0
6829483|NCT00147537|10832979|FG006|Phase 1b|Withdrawal by Subject|0
6829484|NCT00147537|10832980|FG007|Phase 1b|Withdrawal by Subject|0
6829485|NCT00147537|10832981|FG008|Phase 1b|Withdrawal by Subject|2
6829486|NCT00147537|10832982|FG009|Phase 1b|Withdrawal by Subject|0
6829487|NCT00147537|10832983|FG010|Phase 1b|Withdrawal by Subject|0
6829488|NCT00147537|10832973|FG000|Phase 1b|Randomized but not treated|0
6829489|NCT00147537|10832974|FG001|Phase 1b|Randomized but not treated|0
6829490|NCT00147537|10832975|FG002|Phase 1b|Randomized but not treated|0
6829491|NCT00147537|10832976|FG003|Phase 1b|Randomized but not treated|0
6829492|NCT00147537|10832977|FG004|Phase 1b|Randomized but not treated|0
6829493|NCT00147537|10832978|FG005|Phase 1b|Randomized but not treated|0
6829494|NCT00147537|10832979|FG006|Phase 1b|Randomized but not treated|1
6829495|NCT00147537|10832980|FG007|Phase 1b|Randomized but not treated|0
6829496|NCT00147537|10832981|FG008|Phase 1b|Randomized but not treated|1
6829497|NCT00147537|10832982|FG009|Phase 1b|Randomized but not treated|0
6829498|NCT00147537|10832983|FG010|Phase 1b|Randomized but not treated|0
6829499|NCT00147537|10832973|FG000|Phase 2|Death|0
6829500|NCT00147537|10832974|FG001|Phase 2|Death|0
6829501|NCT00147537|10832975|FG002|Phase 2|Death|0
6829502|NCT00147537|10832976|FG003|Phase 2|Death|0
6829503|NCT00147537|10832977|FG004|Phase 2|Death|0
6829504|NCT00147537|10832978|FG005|Phase 2|Death|0
6829505|NCT00147537|10832979|FG006|Phase 2|Death|0
6829506|NCT00147537|10832980|FG007|Phase 2|Death|0
6829507|NCT00147537|10832981|FG008|Phase 2|Death|0
6829508|NCT00147537|10832982|FG009|Phase 2|Death|85
6829509|NCT00147537|10832983|FG010|Phase 2|Death|31
6829510|NCT00147537|10832973|FG000|Phase 2|Lost to Follow-up|0
6829511|NCT00147537|10832974|FG001|Phase 2|Lost to Follow-up|0
6829512|NCT00147537|10832975|FG002|Phase 2|Lost to Follow-up|0
6829513|NCT00147537|10832976|FG003|Phase 2|Lost to Follow-up|0
6829514|NCT00147537|10832977|FG004|Phase 2|Lost to Follow-up|0
6829515|NCT00147537|10832978|FG005|Phase 2|Lost to Follow-up|0
6829516|NCT00147537|10832979|FG006|Phase 2|Lost to Follow-up|0
6829517|NCT00147537|10832980|FG007|Phase 2|Lost to Follow-up|0
6829518|NCT00147537|10832981|FG008|Phase 2|Lost to Follow-up|0
6829519|NCT00147537|10832982|FG009|Phase 2|Lost to Follow-up|12
6829520|NCT00147537|10832983|FG010|Phase 2|Lost to Follow-up|4
6829521|NCT00147537|10832973|FG000|Phase 2|Other|0
6829522|NCT00147537|10832974|FG001|Phase 2|Other|0
6829523|NCT00147537|10832975|FG002|Phase 2|Other|0
6829524|NCT00147537|10832976|FG003|Phase 2|Other|0
6829525|NCT00147537|10832977|FG004|Phase 2|Other|0
6829526|NCT00147537|10832978|FG005|Phase 2|Other|0
6829527|NCT00147537|10832979|FG006|Phase 2|Other|0
6829528|NCT00147537|10832980|FG007|Phase 2|Other|0
6829529|NCT00147537|10832981|FG008|Phase 2|Other|0
6829530|NCT00147537|10832982|FG009|Phase 2|Other|47
6829531|NCT00147537|10832983|FG010|Phase 2|Other|12
6829532|NCT00147537|10832973|FG000|Phase 2|Withdrawal by Subject|0
6829533|NCT00147537|10832974|FG001|Phase 2|Withdrawal by Subject|0
6829534|NCT00147537|10832975|FG002|Phase 2|Withdrawal by Subject|0
6829535|NCT00147537|10832976|FG003|Phase 2|Withdrawal by Subject|0
6829536|NCT00147537|10832977|FG004|Phase 2|Withdrawal by Subject|0
6829537|NCT00147537|10832978|FG005|Phase 2|Withdrawal by Subject|0
6829538|NCT00147537|10832979|FG006|Phase 2|Withdrawal by Subject|0
6829539|NCT00147537|10832980|FG007|Phase 2|Withdrawal by Subject|0
6829540|NCT00147537|10832981|FG008|Phase 2|Withdrawal by Subject|0
6829541|NCT00147537|10832982|FG009|Phase 2|Withdrawal by Subject|16
6829542|NCT00147537|10832983|FG010|Phase 2|Withdrawal by Subject|4
6829543|NCT00147537|10832973|FG000|Phase 2|Randomized but not treated|0
6829544|NCT00147537|10832974|FG001|Phase 2|Randomized but not treated|0
6829545|NCT00147537|10832975|FG002|Phase 2|Randomized but not treated|0
6829546|NCT00147537|10832976|FG003|Phase 2|Randomized but not treated|0
6829547|NCT00147537|10832977|FG004|Phase 2|Randomized but not treated|0
6829548|NCT00147537|10832978|FG005|Phase 2|Randomized but not treated|0
6829549|NCT00147537|10832979|FG006|Phase 2|Randomized but not treated|0
6829550|NCT00147537|10832980|FG007|Phase 2|Randomized but not treated|0
6829551|NCT00147537|10832981|FG008|Phase 2|Randomized but not treated|0
6829552|NCT00147537|10832982|FG009|Phase 2|Randomized but not treated|1
6829553|NCT00147537|10832983|FG010|Phase 2|Randomized but not treated|1
6829554|NCT00147745|10833031|FG000|Overall Study|Withdrawal by Subject|1
6829555|NCT00147745|10833032|FG001|Overall Study|Withdrawal by Subject|0
6829556|NCT00147745|10833033|FG002|Overall Study|Withdrawal by Subject|0
6829557|NCT00147823|10833043|FG000|Overall Study|Lost to Follow-up|6
6829558|NCT00147823|10833044|FG001|Overall Study|Lost to Follow-up|12
7062144|NCT01934790|11159499|FG000|Treatment|Clinical progression|6
7062145|NCT01934790|11159499|FG000|Treatment|Radiological progression|4
7062146|NCT01934790|11159499|FG000|Treatment|Withdrawal by Subject|2
6829559|NCT00147823|10833043|FG000|Overall Study|Physician Decision|1
6829560|NCT00147823|10833044|FG001|Overall Study|Physician Decision|0
6829561|NCT00147823|10833043|FG000|Overall Study|Withdrawal by Subject|0
6829562|NCT00147823|10833044|FG001|Overall Study|Withdrawal by Subject|1
6829563|NCT00147823|10833043|FG000|Overall Study|Did not receive vitoss due to infection|6
6829564|NCT00147823|10833044|FG001|Overall Study|Did not receive vitoss due to infection|2
6829565|NCT00148109|10833056|FG000|Overall Study|Lack of Efficacy|10
6829566|NCT00148109|10833057|FG001|Overall Study|Lack of Efficacy|18
6829567|NCT00148109|10833056|FG000|Overall Study|Adverse Event|0
6829568|NCT00148109|10833057|FG001|Overall Study|Adverse Event|2
6829569|NCT00148109|10833056|FG000|Overall Study|Withdrawal by Subject|2
6829570|NCT00148109|10833057|FG001|Overall Study|Withdrawal by Subject|0
6829571|NCT00148122|10833063|FG000|Overall Study|Withdrawal by Subject|2
6829572|NCT00148317|10833067|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8
6829573|NCT00148317|10833067|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2
6829574|NCT00148317|10833067|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1
6829575|NCT00148343|10833076|FG000|Overall Study|Withdrawal by Subject|12
6829576|NCT00148343|10833077|FG001|Overall Study|Withdrawal by Subject|7
6829577|NCT00148343|10833076|FG000|Overall Study|Physician Decision|3
6829578|NCT00148343|10833077|FG001|Overall Study|Physician Decision|4
6829579|NCT00148759|10833094|FG000|Overall Study|Withdrawal by Subject|1
6829580|NCT00148759|10833095|FG001|Overall Study|Withdrawal by Subject|1
6829581|NCT00148759|10833094|FG000|Overall Study|Lost to Follow-up|1
6829582|NCT00148759|10833095|FG001|Overall Study|Lost to Follow-up|0
6829583|NCT00148941|10833116|FG000|Overall Study|Lost to Follow-up|17
6829584|NCT00148941|10833117|FG001|Overall Study|Lost to Follow-up|24
6829585|NCT00148941|10833118|FG002|Overall Study|Lost to Follow-up|18
6829586|NCT00148941|10833119|FG003|Overall Study|Lost to Follow-up|22
6829587|NCT00148941|10833116|FG000|Overall Study|Withdrawal by Subject|1
6829588|NCT00148941|10833117|FG001|Overall Study|Withdrawal by Subject|0
6829589|NCT00148941|10833118|FG002|Overall Study|Withdrawal by Subject|1
6829590|NCT00148941|10833119|FG003|Overall Study|Withdrawal by Subject|0
6829591|NCT00148941|10833116|FG000|Overall Study|Other|0
6829592|NCT00148941|10833117|FG001|Overall Study|Other|0
6829593|NCT00148941|10833118|FG002|Overall Study|Other|1
6924235|NCT00821431|10953524|FG001|Overall Study|Withdrawal by Subject|0
6924236|NCT00821431|10953523|FG000|Overall Study|Lost to Follow-up|1
6924237|NCT00821431|10953524|FG001|Overall Study|Lost to Follow-up|0
6924238|NCT00821431|10953523|FG000|Overall Study|Protocol Violation|3
6924239|NCT00821431|10953524|FG001|Overall Study|Protocol Violation|1
6924240|NCT00821431|10953523|FG000|Overall Study|Physician Decision|0
7038476|NCT01703208|11120815|FG000|Overall Study|Site Discontinued Study Participation|23
7038477|NCT01703208|11120816|FG001|Overall Study|Site Discontinued Study Participation|27
7038478|NCT01703208|11120815|FG000|Overall Study|Physician Decision|11
7038479|NCT01703208|11120816|FG001|Overall Study|Physician Decision|13
7062147|NCT01934790|11159499|FG000|Treatment|Study drug never administered|1
6924241|NCT00821431|10953524|FG001|Overall Study|Physician Decision|1
6924242|NCT00821509|10953533|FG000|Overall Study|Withdrawal by Subject|12
6924243|NCT00821509|10953534|FG001|Overall Study|Withdrawal by Subject|11
6924244|NCT00821509|10953535|FG002|Overall Study|Withdrawal by Subject|34
6924245|NCT00821678|10953556|FG000|Overall Study|Withdrawal by Subject|8
6924246|NCT00821678|10953557|FG001|Overall Study|Withdrawal by Subject|0
6924247|NCT00821678|10953556|FG000|Overall Study|Lost to Follow-up|13
6924248|NCT00821678|10953557|FG001|Overall Study|Lost to Follow-up|12
6829594|NCT00148941|10833119|FG003|Overall Study|Other|2
6829595|NCT00149214|10833140|FG000|Overall Study|Adverse Event|12
6829596|NCT00149214|10833141|FG001|Overall Study|Adverse Event|9
6829597|NCT00149214|10833140|FG000|Overall Study|Withdrawal by Subject|4
6924249|NCT00821678|10953556|FG000|Overall Study|Death|0
7038480|NCT01703208|11120815|FG000|Overall Study|Progressive disease|2
7062148|NCT01934790|11159499|FG000|Active Follow up|Death|20
6829598|NCT00149214|10833141|FG001|Overall Study|Withdrawal by Subject|1
6829599|NCT00149214|10833140|FG000|Overall Study|Physician Decision|3
6829600|NCT00149214|10833141|FG001|Overall Study|Physician Decision|3
6829601|NCT00149214|10833140|FG000|Overall Study|Sponsor Decision|0
6829602|NCT00149214|10833141|FG001|Overall Study|Sponsor Decision|1
6829603|NCT00149214|10833140|FG000|Overall Study|Progressive Disease|7
6829604|NCT00149214|10833141|FG001|Overall Study|Progressive Disease|3
6829605|NCT00149396|10833156|FG000|Overall Study|Death|15
6829606|NCT00149396|10833156|FG000|Overall Study|Withdrawal by Subject|1
6829607|NCT00149396|10833156|FG000|Overall Study|Subject noncompliance|2
6829608|NCT00149396|10833156|FG000|Overall Study|other treatment|5
6829609|NCT00149630|10833169|FG000|Overall Study|Incarceration|2
6829610|NCT00149630|10833170|FG001|Overall Study|Incarceration|0
6829611|NCT00149630|10833169|FG000|Overall Study|Treatment Programs|4
6829612|NCT00149630|10833170|FG001|Overall Study|Treatment Programs|5
6829613|NCT00149630|10833169|FG000|Overall Study|Adverse Event|2
6829614|NCT00149630|10833170|FG001|Overall Study|Adverse Event|0
6829615|NCT00149747|10833209|FG000|Overall Study|Death|1
6829616|NCT00149747|10833210|FG001|Overall Study|Death|0
6829617|NCT00149747|10833209|FG000|Overall Study|Withdrawal by Subject|3
6829618|NCT00149747|10833210|FG001|Overall Study|Withdrawal by Subject|3
6829619|NCT00149825|10833230|FG000|Overall Study|Intolerance to medication side effects|1
6829620|NCT00149825|10833231|FG001|Overall Study|Intolerance to medication side effects|2
6829621|NCT00149825|10833230|FG000|Overall Study|Time commitments|2
6829622|NCT00149825|10833231|FG001|Overall Study|Time commitments|1
6829623|NCT00149825|10833230|FG000|Overall Study|Not liking insomnia therapy|1
6829624|NCT00149825|10833231|FG001|Overall Study|Not liking insomnia therapy|0
6829625|NCT00149825|10833230|FG000|Overall Study|Other|1
6829626|NCT00149825|10833231|FG001|Overall Study|Other|0
6829627|NCT00149890|10833254|FG000|Overall Study|Adverse Event|1
6829628|NCT00149890|10833255|FG001|Overall Study|Adverse Event|8
6829629|NCT00149890|10833254|FG000|Overall Study|Lack of Efficacy|8
6829630|NCT00149890|10833255|FG001|Overall Study|Lack of Efficacy|9
6829631|NCT00149890|10833254|FG000|Overall Study|Protocol Violation|1
6829632|NCT00149890|10833255|FG001|Overall Study|Protocol Violation|0
6829633|NCT00149890|10833254|FG000|Overall Study|Lost to Follow-up|1
6829634|NCT00149890|10833255|FG001|Overall Study|Lost to Follow-up|0
6829635|NCT00149890|10833254|FG000|Overall Study|Graft Loss|2
6829636|NCT00149890|10833255|FG001|Overall Study|Graft Loss|1
6829637|NCT00149994|10833263|FG000|Overall Study|Administrative problems:|1
6829638|NCT00149994|10833264|FG001|Overall Study|Administrative problems:|0
6829639|NCT00149994|10833263|FG000|Overall Study|Protocol Violation|0
6829640|NCT00149994|10833264|FG001|Overall Study|Protocol Violation|1
6829641|NCT00150345|10833272|FG000|Overall Study|Death|5
6829642|NCT00150345|10833273|FG001|Overall Study|Death|2
6829643|NCT00150345|10833272|FG000|Overall Study|Adverse Event|8
6829644|NCT00150345|10833273|FG001|Overall Study|Adverse Event|6
6829645|NCT00150345|10833272|FG000|Overall Study|Lack of Efficacy|5
6829646|NCT00150345|10833273|FG001|Overall Study|Lack of Efficacy|4
6829647|NCT00150345|10833272|FG000|Overall Study|Withdrawal by Subject|3
6829648|NCT00150345|10833273|FG001|Overall Study|Withdrawal by Subject|4
6829649|NCT00150345|10833272|FG000|Overall Study|Laboratory abnormality|1
6829650|NCT00150345|10833273|FG001|Overall Study|Laboratory abnormality|2
6829651|NCT00150345|10833272|FG000|Overall Study|Other|12
6829652|NCT00150345|10833273|FG001|Overall Study|Other|14
6829653|NCT00150462|10833291|FG000|Overall Study|Disease Progression or Relapse|3
6829654|NCT00150462|10833292|FG001|Overall Study|Disease Progression or Relapse|1
6829655|NCT00150462|10833293|FG002|Overall Study|Disease Progression or Relapse|2
6829656|NCT00150462|10833294|FG003|Overall Study|Disease Progression or Relapse|1
6829657|NCT00150462|10833295|FG004|Overall Study|Disease Progression or Relapse|2
6829658|NCT00150462|10833296|FG005|Overall Study|Disease Progression or Relapse|2
6829659|NCT00150462|10833297|FG006|Overall Study|Disease Progression or Relapse|3
6829660|NCT00150462|10833298|FG007|Overall Study|Disease Progression or Relapse|5
6829661|NCT00150462|10833299|FG008|Overall Study|Disease Progression or Relapse|5
6829662|NCT00150462|10833300|FG009|Overall Study|Disease Progression or Relapse|3
6829663|NCT00150462|10833301|FG010|Overall Study|Disease Progression or Relapse|2
6829664|NCT00150462|10833291|FG000|Overall Study|Withdrawal by Subject|0
6829665|NCT00150462|10833292|FG001|Overall Study|Withdrawal by Subject|1
6829666|NCT00150462|10833293|FG002|Overall Study|Withdrawal by Subject|1
6829667|NCT00150462|10833294|FG003|Overall Study|Withdrawal by Subject|0
6829668|NCT00150462|10833295|FG004|Overall Study|Withdrawal by Subject|1
6829669|NCT00150462|10833296|FG005|Overall Study|Withdrawal by Subject|2
6829670|NCT00150462|10833297|FG006|Overall Study|Withdrawal by Subject|0
6829671|NCT00150462|10833298|FG007|Overall Study|Withdrawal by Subject|1
6829672|NCT00150462|10833299|FG008|Overall Study|Withdrawal by Subject|0
6829673|NCT00150462|10833300|FG009|Overall Study|Withdrawal by Subject|1
6829674|NCT00150462|10833301|FG010|Overall Study|Withdrawal by Subject|0
6829675|NCT00150462|10833291|FG000|Overall Study|Death|0
6829676|NCT00150462|10833292|FG001|Overall Study|Death|1
6829677|NCT00150462|10833293|FG002|Overall Study|Death|0
6829678|NCT00150462|10833294|FG003|Overall Study|Death|0
6829679|NCT00150462|10833295|FG004|Overall Study|Death|0
6829680|NCT00150462|10833296|FG005|Overall Study|Death|0
6829681|NCT00150462|10833297|FG006|Overall Study|Death|0
6829682|NCT00150462|10833298|FG007|Overall Study|Death|0
6829683|NCT00150462|10833299|FG008|Overall Study|Death|1
6829684|NCT00150462|10833300|FG009|Overall Study|Death|0
6829685|NCT00150462|10833301|FG010|Overall Study|Death|0
6829686|NCT00150462|10833291|FG000|Overall Study|Adverse Event|0
6829687|NCT00150462|10833292|FG001|Overall Study|Adverse Event|0
6829688|NCT00150462|10833293|FG002|Overall Study|Adverse Event|0
6829689|NCT00150462|10833294|FG003|Overall Study|Adverse Event|1
6829690|NCT00150462|10833295|FG004|Overall Study|Adverse Event|0
6829691|NCT00150462|10833296|FG005|Overall Study|Adverse Event|0
6829692|NCT00150462|10833297|FG006|Overall Study|Adverse Event|0
6829693|NCT00150462|10833298|FG007|Overall Study|Adverse Event|2
6829694|NCT00150462|10833299|FG008|Overall Study|Adverse Event|0
6829695|NCT00150462|10833300|FG009|Overall Study|Adverse Event|1
6829696|NCT00150462|10833301|FG010|Overall Study|Adverse Event|0
6829697|NCT00150462|10833291|FG000|Overall Study|Physician Decision|0
6829698|NCT00150462|10833292|FG001|Overall Study|Physician Decision|0
6829699|NCT00150462|10833293|FG002|Overall Study|Physician Decision|1
6829700|NCT00150462|10833294|FG003|Overall Study|Physician Decision|1
6829701|NCT00150462|10833295|FG004|Overall Study|Physician Decision|0
6829702|NCT00150462|10833296|FG005|Overall Study|Physician Decision|0
6829703|NCT00150462|10833297|FG006|Overall Study|Physician Decision|0
6924250|NCT00821678|10953557|FG001|Overall Study|Death|2
6924251|NCT00821873|10953589|FG000|Overall Study|Lost to Follow-up|4
6924252|NCT00822172|10953623|FG000|Overall Study|Adverse Event|10
6924253|NCT00822172|10953624|FG001|Overall Study|Adverse Event|12
6924254|NCT00822172|10953623|FG000|Overall Study|Death|1
6924255|NCT00822172|10953624|FG001|Overall Study|Death|0
6924256|NCT00822172|10953623|FG000|Overall Study|Lost to Follow-up|3
6924257|NCT00822172|10953624|FG001|Overall Study|Lost to Follow-up|1
6924258|NCT00822172|10953623|FG000|Overall Study|Withdrawal by Subject|1
6924259|NCT00822172|10953624|FG001|Overall Study|Withdrawal by Subject|4
6924260|NCT00822172|10953623|FG000|Overall Study|site closed|0
6924261|NCT00822172|10953624|FG001|Overall Study|site closed|1
6924262|NCT00822172|10953623|FG000|Overall Study|Other|0
6924263|NCT00822172|10953624|FG001|Overall Study|Other|1
6924264|NCT00822237|10953653|FG000|Dose 1 Vaccination|Not vaccinated|3
6924265|NCT00822237|10953654|FG001|Dose 1 Vaccination|Not vaccinated|0
6924266|NCT00822237|10953653|FG000|Dose 1 Vaccination|Withdrawal by Subject|13
6924267|NCT00822237|10953654|FG001|Dose 1 Vaccination|Withdrawal by Subject|14
6924268|NCT00822237|10953653|FG000|Dose 1 Vaccination|Lost to Follow-up|9
6924269|NCT00822237|10953654|FG001|Dose 1 Vaccination|Lost to Follow-up|12
6924270|NCT00822237|10953653|FG000|Dose 2 Vaccination|Withdrawal by Subject|2
6924271|NCT00822237|10953654|FG001|Dose 2 Vaccination|Withdrawal by Subject|2
6924272|NCT00822237|10953653|FG000|Dose 2 Vaccination|Lost to Follow-up|2
6924273|NCT00822237|10953654|FG001|Dose 2 Vaccination|Lost to Follow-up|9
6924274|NCT00822692|10953722|FG000|Overall Study|Lost to Follow-up|17
6924275|NCT00822692|10953723|FG001|Overall Study|Lost to Follow-up|25
6924276|NCT00822770|10953740|FG000|Overall Study|Not treated|1
6924277|NCT00822770|10953741|FG001|Overall Study|Not treated|0
6924278|NCT00822770|10953740|FG000|Overall Study|Complication/Incomplete treatment|1
6924279|NCT00822770|10953741|FG001|Overall Study|Complication/Incomplete treatment|0
6924280|NCT00822770|10953740|FG000|Overall Study|Death|1
6924281|NCT00822770|10953741|FG001|Overall Study|Death|1
6924282|NCT00822900|10953749|FG000|Overall Study|Withdrawal by Subject|14
6924283|NCT00822900|10953750|FG001|Overall Study|Withdrawal by Subject|14
6924284|NCT00822900|10953749|FG000|Overall Study|Lost to Follow-up|9
6924285|NCT00822900|10953750|FG001|Overall Study|Lost to Follow-up|9
6924286|NCT00822900|10953749|FG000|Overall Study|Death|83
6924287|NCT00822900|10953750|FG001|Overall Study|Death|69
6924288|NCT00822900|10953749|FG000|Overall Study|Became a ward of the state|2
6924289|NCT00822900|10953750|FG001|Overall Study|Became a ward of the state|1
6924290|NCT00822926|10953758|FG000|Second Injection Visit|Lost to Follow-up|1
6924291|NCT00822926|10953759|FG001|Second Injection Visit|Lost to Follow-up|0
6924292|NCT00822926|10953758|FG000|Second Injection Visit|Withdrawal by Subject|0
6924293|NCT00822926|10953759|FG001|Second Injection Visit|Withdrawal by Subject|1
6924294|NCT00823134|10953790|FG000|Overall Study|Invalid measurement|1
6924295|NCT00823199|10953795|FG000|Overall Study|Withdrawal by Subject|2
6924296|NCT00823212|10953802|FG000|Overall Study|Death|8
6924297|NCT00823212|10953803|FG001|Overall Study|Death|10
6924298|NCT00823212|10953802|FG000|Overall Study|Withdrawal by Subject|6
6924299|NCT00823212|10953803|FG001|Overall Study|Withdrawal by Subject|1
6924300|NCT00823212|10953802|FG000|Overall Study|Incarcerated|0
6924301|NCT00823212|10953803|FG001|Overall Study|Incarcerated|1
6924302|NCT00823212|10953802|FG000|Overall Study|Missed 12-month visit|21
6924303|NCT00823212|10953803|FG001|Overall Study|Missed 12-month visit|21
6924304|NCT00823264|10953813|FG000|Overall Study|Protocol Violation|2
6924305|NCT00823264|10953814|FG001|Overall Study|Protocol Violation|0
6974815|NCT01190930|11027139|FG008|Induction|Lost to Follow-up|0
6974816|NCT01190930|11027140|FG009|Induction|Lost to Follow-up|0
6974817|NCT01190930|11027131|FG000|Induction|Physician Decision|125
6974818|NCT01190930|11027132|FG001|Induction|Physician Decision|3
6974819|NCT01190930|11027133|FG002|Induction|Physician Decision|0
6829704|NCT00150462|10833298|FG007|Overall Study|Physician Decision|0
6829705|NCT00150462|10833299|FG008|Overall Study|Physician Decision|0
6829706|NCT00150462|10833300|FG009|Overall Study|Physician Decision|0
6829707|NCT00150462|10833301|FG010|Overall Study|Physician Decision|0
6974820|NCT01190930|11027134|FG003|Induction|Physician Decision|0
6829708|NCT00150462|10833291|FG000|Overall Study|Other|0
6829709|NCT00150462|10833292|FG001|Overall Study|Other|0
6829710|NCT00150462|10833293|FG002|Overall Study|Other|0
6829711|NCT00150462|10833294|FG003|Overall Study|Other|0
6829712|NCT00150462|10833295|FG004|Overall Study|Other|0
6829713|NCT00150462|10833296|FG005|Overall Study|Other|0
6829714|NCT00150462|10833297|FG006|Overall Study|Other|0
6829715|NCT00150462|10833298|FG007|Overall Study|Other|0
6829716|NCT00150462|10833299|FG008|Overall Study|Other|0
6829717|NCT00150462|10833300|FG009|Overall Study|Other|1
6829718|NCT00150462|10833301|FG010|Overall Study|Other|1
6829719|NCT00150592|10833330|FG000|Overall Study|Adverse Event|4
6829720|NCT00150592|10833331|FG001|Overall Study|Adverse Event|1
6829721|NCT00150592|10833330|FG000|Overall Study|Protocol Violation|1
6829722|NCT00150592|10833331|FG001|Overall Study|Protocol Violation|0
6829723|NCT00150592|10833330|FG000|Overall Study|Withdrawal by Subject|1
6829724|NCT00150592|10833331|FG001|Overall Study|Withdrawal by Subject|2
6829725|NCT00150592|10833330|FG000|Overall Study|Non-compliance|1
6829726|NCT00150592|10833331|FG001|Overall Study|Non-compliance|0
6829727|NCT00150618|10833342|FG000|Overall Study|Adverse Event|2
6829728|NCT00150618|10833343|FG001|Overall Study|Adverse Event|2
6829729|NCT00150618|10833344|FG002|Overall Study|Adverse Event|6
6829730|NCT00150618|10833345|FG003|Overall Study|Adverse Event|9
6829731|NCT00150618|10833346|FG004|Overall Study|Adverse Event|5
6829732|NCT00150618|10833342|FG000|Overall Study|Withdrawal by Subject|6
6829733|NCT00150618|10833343|FG001|Overall Study|Withdrawal by Subject|8
6829734|NCT00150618|10833344|FG002|Overall Study|Withdrawal by Subject|8
6829735|NCT00150618|10833345|FG003|Overall Study|Withdrawal by Subject|4
6829736|NCT00150618|10833346|FG004|Overall Study|Withdrawal by Subject|5
6829737|NCT00150618|10833342|FG000|Overall Study|Lost to Follow-up|4
6829738|NCT00150618|10833343|FG001|Overall Study|Lost to Follow-up|1
6829739|NCT00150618|10833344|FG002|Overall Study|Lost to Follow-up|5
6829740|NCT00150618|10833345|FG003|Overall Study|Lost to Follow-up|8
6829741|NCT00150618|10833346|FG004|Overall Study|Lost to Follow-up|4
6829742|NCT00150618|10833342|FG000|Overall Study|Protocol Violation|1
6829743|NCT00150618|10833343|FG001|Overall Study|Protocol Violation|0
6829744|NCT00150618|10833344|FG002|Overall Study|Protocol Violation|0
6829745|NCT00150618|10833345|FG003|Overall Study|Protocol Violation|0
6829746|NCT00150618|10833346|FG004|Overall Study|Protocol Violation|1
6829747|NCT00150618|10833342|FG000|Overall Study|Lack of Efficacy|1
6829748|NCT00150618|10833343|FG001|Overall Study|Lack of Efficacy|4
6829749|NCT00150618|10833344|FG002|Overall Study|Lack of Efficacy|7
6829750|NCT00150618|10833345|FG003|Overall Study|Lack of Efficacy|4
6829751|NCT00150618|10833346|FG004|Overall Study|Lack of Efficacy|6
6829752|NCT00150618|10833342|FG000|Overall Study|No study meds|0
6829753|NCT00150618|10833343|FG001|Overall Study|No study meds|0
6829754|NCT00150618|10833344|FG002|Overall Study|No study meds|0
6829755|NCT00150618|10833345|FG003|Overall Study|No study meds|0
6829756|NCT00150618|10833346|FG004|Overall Study|No study meds|2
6829757|NCT00150618|10833342|FG000|Overall Study|Physician Decision|0
6829758|NCT00150618|10833343|FG001|Overall Study|Physician Decision|2
6829759|NCT00150618|10833344|FG002|Overall Study|Physician Decision|0
6829760|NCT00150618|10833345|FG003|Overall Study|Physician Decision|0
6829761|NCT00150618|10833346|FG004|Overall Study|Physician Decision|1
6829762|NCT00150618|10833342|FG000|Overall Study|Lack of compliance|2
6829763|NCT00150618|10833343|FG001|Overall Study|Lack of compliance|1
6829764|NCT00150618|10833344|FG002|Overall Study|Lack of compliance|1
6829765|NCT00150618|10833345|FG003|Overall Study|Lack of compliance|0
6829766|NCT00150618|10833346|FG004|Overall Study|Lack of compliance|1
6829767|NCT00150618|10833342|FG000|Overall Study|Abnormal ECG|1
6829768|NCT00150618|10833343|FG001|Overall Study|Abnormal ECG|0
6829769|NCT00150618|10833344|FG002|Overall Study|Abnormal ECG|0
6829770|NCT00150618|10833345|FG003|Overall Study|Abnormal ECG|0
6829771|NCT00150618|10833346|FG004|Overall Study|Abnormal ECG|0
6829772|NCT00150618|10833342|FG000|Overall Study|Sponsor's decision|0
6829773|NCT00150618|10833343|FG001|Overall Study|Sponsor's decision|0
6829774|NCT00150618|10833344|FG002|Overall Study|Sponsor's decision|0
6829775|NCT00150618|10833345|FG003|Overall Study|Sponsor's decision|1
6829776|NCT00150618|10833346|FG004|Overall Study|Sponsor's decision|0
6829777|NCT00150800|10833358|FG000|Overall Study|Adverse Event|89
6829778|NCT00150800|10833358|FG000|Overall Study|Death|18
6829779|NCT00150800|10833358|FG000|Overall Study|Lack of Efficacy|166
6829780|NCT00150800|10833358|FG000|Overall Study|Lost to Follow-up|58
6829781|NCT00150800|10833358|FG000|Overall Study|Subject's choice|90
6829782|NCT00150800|10833358|FG000|Overall Study|No compliance|18
6829783|NCT00150800|10833358|FG000|Overall Study|IP misshandling|1
6829784|NCT00150800|10833358|FG000|Overall Study|Site closure|24
6829785|NCT00150800|10833358|FG000|Overall Study|Protocol non-adherence|2
6829786|NCT00150800|10833358|FG000|Overall Study|Nobody to accompany patient|1
6829787|NCT00150800|10833358|FG000|Overall Study|Distance too long for patient|1
6829788|NCT00150800|10833358|FG000|Overall Study|Neurosurgery|2
6829789|NCT00150800|10833358|FG000|Overall Study|BRV monotherapy|1
6829790|NCT00150800|10833358|FG000|Overall Study|Visit refusal|3
6829791|NCT00150800|10833358|FG000|Overall Study|Sponsor's request|2
6829792|NCT00150800|10833358|FG000|Overall Study|Generalized Epilepsy|1
6829793|NCT00150800|10833358|FG000|Overall Study|Moved from area/country|8
6829794|NCT00150800|10833358|FG000|Overall Study|PI retiring|2
6829795|NCT00150800|10833358|FG000|Overall Study|PI leaving site|2
6829796|NCT00150800|10833358|FG000|Overall Study|Patient insurance|1
6829797|NCT00150800|10833358|FG000|Overall Study|Surgical intervention|4
6829798|NCT00150800|10833358|FG000|Overall Study|Pregnancy planned|1
6829799|NCT00150800|10833358|FG000|Overall Study|PI discontinuation request|1
6829800|NCT00150813|10833363|FG000|Overall Study|Adverse Event|1
6829801|NCT00150813|10833363|FG000|Overall Study|Lack of Efficacy|1
6829802|NCT00150813|10833363|FG000|Overall Study|Lost to Follow-up|5
6829803|NCT00150813|10833363|FG000|Overall Study|Withdrawal by Subject|5
6829804|NCT00150813|10833363|FG000|Overall Study|Remission|3
6829805|NCT00150813|10833363|FG000|Overall Study|Planned pregancy|1
7062149|NCT01934790|11159499|FG000|Active Follow up|Physician Decision|2
7062150|NCT01934790|11159499|FG000|Active Follow up|Progressive disease|1
7062151|NCT01934790|11159499|FG000|Active Follow up|Other reason|1
7062152|NCT01934894|11159505|FG000|Overall Study|Adverse Event|1
7062153|NCT01934894|11159506|FG001|Overall Study|Adverse Event|2
7062154|NCT01934894|11159505|FG000|Overall Study|Death|2
6829806|NCT00150813|10833363|FG000|Overall Study|Switch to commercially available LEV|2
6829807|NCT00150969|10833369|FG000|24 Month Main Study|Adverse Event|3
6829808|NCT00150969|10833370|FG001|24 Month Main Study|Adverse Event|4
6829809|NCT00150969|10833369|FG000|24 Month Main Study|Death|1
6829810|NCT00150969|10833370|FG001|24 Month Main Study|Death|1
6829811|NCT00150969|10833369|FG000|24 Month Main Study|Lack of Efficacy|1
6829812|NCT00150969|10833370|FG001|24 Month Main Study|Lack of Efficacy|8
6829813|NCT00150969|10833369|FG000|24 Month Main Study|Lost to Follow-up|3
6829814|NCT00150969|10833370|FG001|24 Month Main Study|Lost to Follow-up|2
6829815|NCT00150969|10833369|FG000|24 Month Main Study|Protocol Violation|4
6829816|NCT00150969|10833370|FG001|24 Month Main Study|Protocol Violation|2
6829817|NCT00150969|10833369|FG000|24 Month Main Study|Withdrawal by Subject|7
6829818|NCT00150969|10833370|FG001|24 Month Main Study|Withdrawal by Subject|4
6829819|NCT00150969|10833369|FG000|24-48 Month Extension|Withdrawal by Subject|6
6924306|NCT00823472|10953836|FG000|Overall Study|Physician Decision|24
6924307|NCT00823472|10953837|FG001|Overall Study|Physician Decision|28
6924308|NCT00823615|10953843|FG000|Period 2|Lost to Follow-up|2
6924309|NCT00823615|10953844|FG001|Period 2|Lost to Follow-up|0
6924310|NCT00823615|10953843|FG000|Period 2|Time/Job Conflict|1
6924311|NCT00823615|10953844|FG001|Period 2|Time/Job Conflict|2
6924312|NCT00823719|10953852|FG000|Overall Study|Adverse Event|1
6924313|NCT00823719|10953853|FG001|Overall Study|Adverse Event|2
6924314|NCT00823719|10953852|FG000|Overall Study|Physician Decision|1
6924315|NCT00823719|10953853|FG001|Overall Study|Physician Decision|4
6924316|NCT00823719|10953852|FG000|Overall Study|Withdrawal by Subject|0
6924317|NCT00823719|10953853|FG001|Overall Study|Withdrawal by Subject|1
6924318|NCT00823719|10953852|FG000|Overall Study|Disease Progression|4
6924319|NCT00823719|10953853|FG001|Overall Study|Disease Progression|4
6924320|NCT00823823|10953871|FG000|Overall Study|Lost to Follow-up|3
6924321|NCT00823823|10953872|FG001|Overall Study|Lost to Follow-up|1
6924322|NCT00823823|10953871|FG000|Overall Study|Protocol Violation|5
6924323|NCT00823823|10953872|FG001|Overall Study|Protocol Violation|5
6924324|NCT00823836|10953880|FG000|NV and PR/XR Switching Phases|Adverse Event|22
6924325|NCT00823836|10953881|FG001|NV and PR/XR Switching Phases|Adverse Event|21
6924326|NCT00823836|10953880|FG000|NV and PR/XR Switching Phases|Protocol Violation|1
6924327|NCT00823836|10953881|FG001|NV and PR/XR Switching Phases|Protocol Violation|1
6924328|NCT00823836|10953880|FG000|NV and PR/XR Switching Phases|Physician Decision|5
6924329|NCT00823836|10953881|FG001|NV and PR/XR Switching Phases|Physician Decision|2
6924330|NCT00823836|10953880|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4
6924331|NCT00823836|10953881|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5
6924332|NCT00823836|10953880|FG000|Long-term Phase|Adverse Event|3
6924333|NCT00823836|10953881|FG001|Long-term Phase|Adverse Event|2
6924334|NCT00823836|10953880|FG000|Long-term Phase|Physician Decision|1
6924335|NCT00823836|10953881|FG001|Long-term Phase|Physician Decision|2
6924336|NCT00823836|10953880|FG000|Long-term Phase|Withdrawal by Subject|1
6924337|NCT00823836|10953881|FG001|Long-term Phase|Withdrawal by Subject|1
6924338|NCT00823901|10953892|FG000|Overall Study|Adverse Event|1
6924339|NCT00823901|10953893|FG001|Overall Study|Adverse Event|1
6924340|NCT00823901|10953892|FG000|Overall Study|Lack of Efficacy|1
6924341|NCT00823901|10953893|FG001|Overall Study|Lack of Efficacy|0
6924342|NCT00823901|10953892|FG000|Overall Study|Lost to Follow-up|2
6924343|NCT00823901|10953893|FG001|Overall Study|Lost to Follow-up|1
6924344|NCT00823979|10953906|FG000|Overall Study|Lack of Efficacy|13
6924345|NCT00823979|10953907|FG001|Overall Study|Lack of Efficacy|16
6924346|NCT00823979|10953908|FG002|Overall Study|Lack of Efficacy|9
6924347|NCT00823979|10953906|FG000|Overall Study|Lost to Follow-up|2
6924348|NCT00823979|10953907|FG001|Overall Study|Lost to Follow-up|1
6829820|NCT00150969|10833370|FG001|24-48 Month Extension|Withdrawal by Subject|5
6924349|NCT00823979|10953908|FG002|Overall Study|Lost to Follow-up|0
6924350|NCT00823979|10953906|FG000|Overall Study|Withdrawal by Subject|2
6924351|NCT00823979|10953907|FG001|Overall Study|Withdrawal by Subject|3
6924352|NCT00823979|10953908|FG002|Overall Study|Withdrawal by Subject|2
6924353|NCT00823979|10953906|FG000|Overall Study|Protocol Violation|1
6924354|NCT00823979|10953907|FG001|Overall Study|Protocol Violation|1
6924355|NCT00823979|10953908|FG002|Overall Study|Protocol Violation|0
6924356|NCT00823979|10953906|FG000|Overall Study|Pregnancy|0
6924357|NCT00823979|10953907|FG001|Overall Study|Pregnancy|1
7062155|NCT01934894|11159506|FG001|Overall Study|Death|0
7062156|NCT01934894|11159505|FG000|Overall Study|Withdrawal by Subject|0
6829821|NCT00150969|10833369|FG000|24-48 Month Extension|Lack of Efficacy|0
6829822|NCT00150969|10833370|FG001|24-48 Month Extension|Lack of Efficacy|1
6829823|NCT00150969|10833369|FG000|24-48 Month Extension|Adverse Event|1
6829824|NCT00150969|10833370|FG001|24-48 Month Extension|Adverse Event|3
6829825|NCT00150969|10833369|FG000|24-48 Month Extension|Other Reason|81
6829826|NCT00150969|10833370|FG001|24-48 Month Extension|Other Reason|91
6829827|NCT00151281|10833377|FG000|Overall Study|Not evaluable|3
6829828|NCT00151372|10833391|FG000|Overall Study|Death|12
6829829|NCT00151372|10833392|FG001|Overall Study|Death|11
6829830|NCT00151372|10833391|FG000|Overall Study|Lost to Follow-up|5
6829831|NCT00151372|10833392|FG001|Overall Study|Lost to Follow-up|5
6829832|NCT00151372|10833391|FG000|Overall Study|Too sick medically to continue|5
6829833|NCT00151372|10833392|FG001|Overall Study|Too sick medically to continue|6
6829834|NCT00151372|10833391|FG000|Overall Study|Withdrawal by Subject|7
6829835|NCT00151372|10833392|FG001|Overall Study|Withdrawal by Subject|7
6829836|NCT00151411|10833400|FG000|Overall Study|Lost to Follow-up|15
6829837|NCT00151411|10833401|FG001|Overall Study|Lost to Follow-up|19
6829838|NCT00151411|10833400|FG000|Overall Study|Withdrawal by Subject|12
6829839|NCT00151411|10833401|FG001|Overall Study|Withdrawal by Subject|20
6829840|NCT00151411|10833400|FG000|Overall Study|Adverse Event|6
6829841|NCT00151411|10833401|FG001|Overall Study|Adverse Event|0
6829842|NCT00151411|10833400|FG000|Overall Study|Pregnancy|0
6924358|NCT00823979|10953908|FG002|Overall Study|Pregnancy|0
6924359|NCT00823979|10953906|FG000|Overall Study|Adverse Event|0
6924360|NCT00823979|10953907|FG001|Overall Study|Adverse Event|2
6924361|NCT00823979|10953908|FG002|Overall Study|Adverse Event|4
6924362|NCT00823979|10953906|FG000|Overall Study|Other|2
6924363|NCT00823979|10953907|FG001|Overall Study|Other|0
6924364|NCT00823979|10953908|FG002|Overall Study|Other|1
6924365|NCT00823979|10953906|FG000|Overall Study|Randomized but not Treated|4
6924366|NCT00823979|10953907|FG001|Overall Study|Randomized but not Treated|3
6924367|NCT00823979|10953908|FG002|Overall Study|Randomized but not Treated|1
6924368|NCT00823979|10953906|FG000|Overall Study|Study Terminated by Sponsor|5
6924369|NCT00823979|10953907|FG001|Overall Study|Study Terminated by Sponsor|5
6924370|NCT00823979|10953908|FG002|Overall Study|Study Terminated by Sponsor|7
6924371|NCT00824005|10953918|FG000|Overall Study|Death|0
6924372|NCT00824005|10953919|FG001|Overall Study|Death|1
6924373|NCT00824005|10953918|FG000|Overall Study|Lost to Follow-up|0
6924374|NCT00824005|10953919|FG001|Overall Study|Lost to Follow-up|1
6924375|NCT00824161|10953951|FG000|Overall Study|Withdrawal by Subject|1
6924376|NCT00824161|10953951|FG000|Overall Study|Screen Failure|1
6924377|NCT00824265|10953958|FG000|Treatment Phase|Adverse Event,non-fatal|50
6924378|NCT00824265|10953959|FG001|Treatment Phase|Adverse Event,non-fatal|52
6924379|NCT00824265|10953958|FG000|Treatment Phase|Protocol Violation|1
6924380|NCT00824265|10953959|FG001|Treatment Phase|Protocol Violation|0
6924381|NCT00824265|10953958|FG000|Treatment Phase|Lost to Follow-up|1
6924382|NCT00824265|10953959|FG001|Treatment Phase|Lost to Follow-up|1
6924383|NCT00824265|10953958|FG000|Treatment Phase|Physician Decision|6
6924384|NCT00824265|10953959|FG001|Treatment Phase|Physician Decision|12
6924385|NCT00824265|10953958|FG000|Treatment Phase|Withdrawal by Subject|6
6924386|NCT00824265|10953959|FG001|Treatment Phase|Withdrawal by Subject|15
6924387|NCT00824265|10953958|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18
6924388|NCT00824265|10953959|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31
6924389|NCT00824265|10953958|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9
6924390|NCT00824265|10953959|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16
6924391|NCT00824291|10953971|FG000|Overall Study|Adverse Event|15
6924392|NCT00824291|10953972|FG001|Overall Study|Adverse Event|6
6924393|NCT00824291|10953971|FG000|Overall Study|Discontinuation of Study by Sponsor|1
6924394|NCT00824291|10953972|FG001|Overall Study|Discontinuation of Study by Sponsor|2
6924395|NCT00824291|10953971|FG000|Overall Study|Lost to Follow-up|11
6924396|NCT00824291|10953972|FG001|Overall Study|Lost to Follow-up|9
6924397|NCT00824291|10953971|FG000|Overall Study|Non-compliance|1
6924398|NCT00824291|10953972|FG001|Overall Study|Non-compliance|1
6924399|NCT00824291|10953971|FG000|Overall Study|Protocol Violation|4
6924400|NCT00824291|10953972|FG001|Overall Study|Protocol Violation|1
6924401|NCT00824291|10953971|FG000|Overall Study|Withdrawal by Subject|14
6924402|NCT00824291|10953972|FG001|Overall Study|Withdrawal by Subject|8
6924403|NCT00824291|10953971|FG000|Overall Study|Lack of Efficacy|7
6924404|NCT00824291|10953972|FG001|Overall Study|Lack of Efficacy|8
6924405|NCT00824291|10953971|FG000|Overall Study|Participant on prohibited medication|1
6924406|NCT00824291|10953972|FG001|Overall Study|Participant on prohibited medication|0
6924407|NCT00824369|10953984|FG000|Overall Study|Nolonger willing to participate in study|1
6924408|NCT00824369|10953985|FG001|Overall Study|Nolonger willing to participate in study|0
6924409|NCT00824369|10953986|FG002|Overall Study|Nolonger willing to participate in study|1
6924410|NCT00824369|10953987|FG003|Overall Study|Nolonger willing to participate in study|2
6924411|NCT00824369|10953988|FG004|Overall Study|Nolonger willing to participate in study|0
6924412|NCT00824369|10953989|FG005|Overall Study|Nolonger willing to participate in study|1
6924413|NCT00824369|10953984|FG000|Overall Study|Lost to Follow-up|0
6924414|NCT00824369|10953985|FG001|Overall Study|Lost to Follow-up|0
6924415|NCT00824369|10953986|FG002|Overall Study|Lost to Follow-up|0
6924416|NCT00824369|10953987|FG003|Overall Study|Lost to Follow-up|0
6924417|NCT00824369|10953988|FG004|Overall Study|Lost to Follow-up|1
6829843|NCT00151411|10833401|FG001|Overall Study|Pregnancy|4
6829844|NCT00151476|10833410|FG000|FAP Identified Subjects|Protocol Violation|0
6829845|NCT00151476|10833411|FG001|FAP Identified Subjects|Protocol Violation|1
6829846|NCT00151476|10833410|FG000|FAP Analyzed Subjects|Lost to Follow-up|0
6829847|NCT00151476|10833411|FG001|FAP Analyzed Subjects|Lost to Follow-up|2
6829848|NCT00151476|10833410|FG000|FAP Analyzed Subjects|Other study participation|0
6829849|NCT00151476|10833411|FG001|FAP Analyzed Subjects|Other study participation|1
6829850|NCT00151775|10833423|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1
6829851|NCT00151775|10833424|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2
6829852|NCT00151775|10833425|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0
6829853|NCT00151775|10833426|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0
6829854|NCT00151775|10833427|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0
6829855|NCT00151775|10833428|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0
6829856|NCT00151775|10833429|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0
6829857|NCT00151775|10833430|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0
6829858|NCT00151775|10833431|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0
6829859|NCT00151775|10833432|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0
6829860|NCT00151775|10833433|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0
6829861|NCT00151775|10833434|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0
6829862|NCT00151775|10833423|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
6829863|NCT00151775|10833424|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
6829864|NCT00151775|10833425|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
6829865|NCT00151775|10833426|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
6829866|NCT00151775|10833427|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
6829867|NCT00151775|10833428|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
6829868|NCT00151775|10833429|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
6829869|NCT00151775|10833430|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
6829870|NCT00151775|10833431|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
6829871|NCT00151775|10833432|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
6829872|NCT00151775|10833433|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
6829873|NCT00151775|10833434|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
6829874|NCT00151775|10833423|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0
6829875|NCT00151775|10833424|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4
6829876|NCT00151775|10833425|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0
6829877|NCT00151775|10833426|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0
6829878|NCT00151775|10833427|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0
6829879|NCT00151775|10833428|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0
6829880|NCT00151775|10833429|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0
6829881|NCT00151775|10833430|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0
6829882|NCT00151775|10833431|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0
6829883|NCT00151775|10833432|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0
6829884|NCT00151775|10833433|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0
6829885|NCT00151775|10833434|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0
6829886|NCT00151775|10833423|FG000|Period 2 - Double-Blind Dose Response|Other|0
6829887|NCT00151775|10833424|FG001|Period 2 - Double-Blind Dose Response|Other|0
6829888|NCT00151775|10833425|FG002|Period 2 - Double-Blind Dose Response|Other|0
6829889|NCT00151775|10833426|FG003|Period 2 - Double-Blind Dose Response|Other|0
6829890|NCT00151775|10833427|FG004|Period 2 - Double-Blind Dose Response|Other|0
6829891|NCT00151775|10833428|FG005|Period 2 - Double-Blind Dose Response|Other|0
6829892|NCT00151775|10833429|FG006|Period 2 - Double-Blind Dose Response|Other|1
6829893|NCT00151775|10833430|FG007|Period 2 - Double-Blind Dose Response|Other|0
6829894|NCT00151775|10833431|FG008|Period 2 - Double-Blind Dose Response|Other|0
6829895|NCT00151775|10833432|FG009|Period 2 - Double-Blind Dose Response|Other|0
6829896|NCT00151775|10833433|FG010|Period 2 - Double-Blind Dose Response|Other|0
6829897|NCT00151775|10833434|FG011|Period 2 - Double-Blind Dose Response|Other|0
6829898|NCT00151775|10833423|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0
6829899|NCT00151775|10833424|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0
6829900|NCT00151775|10833425|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0
6829901|NCT00151775|10833426|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0
6829902|NCT00151775|10833427|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0
6829903|NCT00151775|10833428|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1
6829904|NCT00151775|10833429|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0
6829905|NCT00151775|10833430|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0
6829906|NCT00151775|10833431|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0
6829907|NCT00151775|10833432|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0
6829908|NCT00151775|10833433|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0
6829909|NCT00151775|10833434|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0
6829910|NCT00151775|10833423|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0
6829911|NCT00151775|10833424|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0
6829912|NCT00151775|10833425|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0
6829913|NCT00151775|10833426|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0
6829914|NCT00151775|10833427|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0
6829915|NCT00151775|10833428|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1
6829916|NCT00151775|10833429|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0
6829917|NCT00151775|10833430|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0
6829918|NCT00151775|10833431|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0
6829919|NCT00151775|10833432|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0
6829920|NCT00151775|10833433|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0
6829921|NCT00151775|10833434|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0
6829922|NCT00151775|10833423|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
6829923|NCT00151775|10833424|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
6829924|NCT00151775|10833425|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
6829925|NCT00151775|10833426|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
6829926|NCT00151775|10833427|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
6829927|NCT00151775|10833428|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
6829928|NCT00151775|10833429|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1
6829929|NCT00151775|10833430|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
6829930|NCT00151775|10833431|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
6829931|NCT00151775|10833432|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
6829932|NCT00151775|10833433|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
6829933|NCT00151775|10833434|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
6829934|NCT00151775|10833423|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
6829935|NCT00151775|10833424|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
6829936|NCT00151775|10833425|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
6924418|NCT00824369|10953989|FG005|Overall Study|Lost to Follow-up|0
6924419|NCT00824382|10954007|FG000|Overall Study|Adverse Event|4
6924420|NCT00824382|10954008|FG001|Overall Study|Adverse Event|1
6924421|NCT00824382|10954009|FG002|Overall Study|Adverse Event|1
6924422|NCT00824382|10954010|FG003|Overall Study|Adverse Event|4
6924423|NCT00824382|10954007|FG000|Overall Study|Protocol Violation|1
6924424|NCT00824382|10954008|FG001|Overall Study|Protocol Violation|0
6924425|NCT00824382|10954009|FG002|Overall Study|Protocol Violation|0
6924426|NCT00824382|10954010|FG003|Overall Study|Protocol Violation|1
6924427|NCT00824382|10954007|FG000|Overall Study|Investigator's decision|0
6924428|NCT00824382|10954008|FG001|Overall Study|Investigator's decision|1
6924429|NCT00824382|10954009|FG002|Overall Study|Investigator's decision|2
6924430|NCT00824382|10954010|FG003|Overall Study|Investigator's decision|0
6924431|NCT00824408|10954027|FG000|Run-in Phase|Progressive disease|4
6924432|NCT00824408|10954028|FG001|Run-in Phase|Progressive disease|4
6924433|NCT00824408|10954029|FG002|Run-in Phase|Progressive disease|0
6924434|NCT00824408|10954030|FG003|Run-in Phase|Progressive disease|0
6924435|NCT00824408|10954031|FG004|Run-in Phase|Progressive disease|0
6924436|NCT00824408|10954027|FG000|Run-in Phase|Adverse Event|1
6924437|NCT00824408|10954028|FG001|Run-in Phase|Adverse Event|1
6924438|NCT00824408|10954029|FG002|Run-in Phase|Adverse Event|0
6924439|NCT00824408|10954030|FG003|Run-in Phase|Adverse Event|0
6924440|NCT00824408|10954031|FG004|Run-in Phase|Adverse Event|0
6924441|NCT00824408|10954027|FG000|Run-in Phase|Refused to continue medication|1
6924442|NCT00824408|10954028|FG001|Run-in Phase|Refused to continue medication|0
6924443|NCT00824408|10954029|FG002|Run-in Phase|Refused to continue medication|0
6924444|NCT00824408|10954030|FG003|Run-in Phase|Refused to continue medication|0
6924445|NCT00824408|10954031|FG004|Run-in Phase|Refused to continue medication|0
6924446|NCT00824408|10954027|FG000|Run-in Phase|Other reason not defined above|0
6924447|NCT00824408|10954028|FG001|Run-in Phase|Other reason not defined above|1
6924448|NCT00824408|10954029|FG002|Run-in Phase|Other reason not defined above|0
6924449|NCT00824408|10954030|FG003|Run-in Phase|Other reason not defined above|0
6924450|NCT00824408|10954031|FG004|Run-in Phase|Other reason not defined above|0
6924451|NCT00824408|10954027|FG000|Randomized Phase|Not treated|0
7062157|NCT01934894|11159506|FG001|Overall Study|Withdrawal by Subject|1
7062158|NCT01934894|11159505|FG000|Overall Study|Progressive Disease|3
7062159|NCT01934894|11159506|FG001|Overall Study|Progressive Disease|2
7062160|NCT01934972|11159517|FG000|Overall Study|Withdrawal by Subject|9
7062161|NCT01934972|11159518|FG001|Overall Study|Withdrawal by Subject|6
7062162|NCT01935700|11159548|FG000|Overall Study|Withdrawal by Subject|1
6829937|NCT00151775|10833426|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
6829938|NCT00151775|10833427|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
6829939|NCT00151775|10833428|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1
6829940|NCT00151775|10833429|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
6829941|NCT00151775|10833430|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
6829942|NCT00151775|10833431|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
6829943|NCT00151775|10833432|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
6829944|NCT00151775|10833433|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
6829945|NCT00151775|10833434|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
6924452|NCT00824408|10954028|FG001|Randomized Phase|Not treated|0
7062163|NCT01935700|11159549|FG001|Overall Study|Withdrawal by Subject|0
7062164|NCT01935700|11159548|FG000|Overall Study|Physician Decision|4
7062165|NCT01935700|11159549|FG001|Overall Study|Physician Decision|0
7062166|NCT01936181|11159581|FG000|Randomised, Double-blind|Adverse Event|27
7062167|NCT01936181|11159582|FG001|Randomised, Double-blind|Adverse Event|21
7062168|NCT01936181|11159583|FG002|Randomised, Double-blind|Adverse Event|0
7062169|NCT01936181|11159584|FG003|Randomised, Double-blind|Adverse Event|0
7062170|NCT01936181|11159581|FG000|Randomised, Double-blind|Protocol Violation|1
7062171|NCT01936181|11159582|FG001|Randomised, Double-blind|Protocol Violation|5
7062172|NCT01936181|11159583|FG002|Randomised, Double-blind|Protocol Violation|0
7062173|NCT01936181|11159584|FG003|Randomised, Double-blind|Protocol Violation|0
7062174|NCT01936181|11159581|FG000|Randomised, Double-blind|Lack of Efficacy|5
7062175|NCT01936181|11159582|FG001|Randomised, Double-blind|Lack of Efficacy|6
7062176|NCT01936181|11159583|FG002|Randomised, Double-blind|Lack of Efficacy|0
7062177|NCT01936181|11159584|FG003|Randomised, Double-blind|Lack of Efficacy|0
7062178|NCT01936181|11159581|FG000|Randomised, Double-blind|Lost to Follow-up|0
7062179|NCT01936181|11159582|FG001|Randomised, Double-blind|Lost to Follow-up|1
7062180|NCT01936181|11159583|FG002|Randomised, Double-blind|Lost to Follow-up|0
7062181|NCT01936181|11159584|FG003|Randomised, Double-blind|Lost to Follow-up|0
7062182|NCT01936181|11159581|FG000|Randomised, Double-blind|Pregnancy|0
7062183|NCT01936181|11159582|FG001|Randomised, Double-blind|Pregnancy|1
7062184|NCT01936181|11159583|FG002|Randomised, Double-blind|Pregnancy|0
7062185|NCT01936181|11159584|FG003|Randomised, Double-blind|Pregnancy|0
7062186|NCT01936181|11159581|FG000|Randomised, Double-blind|Physician Decision|4
7062187|NCT01936181|11159582|FG001|Randomised, Double-blind|Physician Decision|4
7062188|NCT01936181|11159583|FG002|Randomised, Double-blind|Physician Decision|0
7062189|NCT01936181|11159584|FG003|Randomised, Double-blind|Physician Decision|0
7062190|NCT01936181|11159581|FG000|Randomised, Double-blind|Withdrawal by Subject|23
7062191|NCT01936181|11159582|FG001|Randomised, Double-blind|Withdrawal by Subject|26
7062192|NCT01936181|11159583|FG002|Randomised, Double-blind|Withdrawal by Subject|0
7062193|NCT01936181|11159584|FG003|Randomised, Double-blind|Withdrawal by Subject|0
7062194|NCT01936181|11159581|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
7062195|NCT01936181|11159582|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
7062196|NCT01936181|11159583|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
7062197|NCT01936181|11159584|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
6829946|NCT00151775|10833423|FG000|Period 3: Double-blind, Withdrawal|Other|0
6829947|NCT00151775|10833424|FG001|Period 3: Double-blind, Withdrawal|Other|0
6829948|NCT00151775|10833425|FG002|Period 3: Double-blind, Withdrawal|Other|1
6829949|NCT00151775|10833426|FG003|Period 3: Double-blind, Withdrawal|Other|0
6829950|NCT00151775|10833427|FG004|Period 3: Double-blind, Withdrawal|Other|0
6829951|NCT00151775|10833428|FG005|Period 3: Double-blind, Withdrawal|Other|0
6829952|NCT00151775|10833429|FG006|Period 3: Double-blind, Withdrawal|Other|0
6829953|NCT00151775|10833430|FG007|Period 3: Double-blind, Withdrawal|Other|1
6829954|NCT00151775|10833431|FG008|Period 3: Double-blind, Withdrawal|Other|0
6829955|NCT00151775|10833432|FG009|Period 3: Double-blind, Withdrawal|Other|0
6829956|NCT00151775|10833433|FG010|Period 3: Double-blind, Withdrawal|Other|0
6829957|NCT00151775|10833434|FG011|Period 3: Double-blind, Withdrawal|Other|0
6829958|NCT00151775|10833423|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
6829959|NCT00151775|10833424|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
6829960|NCT00151775|10833425|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
6829961|NCT00151775|10833426|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
6829962|NCT00151775|10833427|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
6829963|NCT00151775|10833428|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
6829964|NCT00151775|10833429|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1
6829965|NCT00151775|10833430|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
6829966|NCT00151775|10833431|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
6829967|NCT00151775|10833432|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
6829968|NCT00151775|10833433|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
6829969|NCT00151775|10833434|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
6829970|NCT00151775|10833423|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0
6829971|NCT00151775|10833424|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0
6829972|NCT00151775|10833425|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1
6829973|NCT00151775|10833426|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0
6829974|NCT00151775|10833427|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0
6829975|NCT00151775|10833428|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0
6829976|NCT00151775|10833429|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0
6829977|NCT00151775|10833430|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0
6829978|NCT00151775|10833431|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0
6829979|NCT00151775|10833432|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0
7062198|NCT01936181|11159581|FG000|Transition-extension|Adverse Event|3
7062199|NCT01936181|11159582|FG001|Transition-extension|Adverse Event|0
7062200|NCT01936181|11159583|FG002|Transition-extension|Adverse Event|3
7062201|NCT01936181|11159584|FG003|Transition-extension|Adverse Event|1
7062202|NCT01936181|11159581|FG000|Transition-extension|Lost to Follow-up|3
7062203|NCT01936181|11159582|FG001|Transition-extension|Lost to Follow-up|0
7062204|NCT01936181|11159583|FG002|Transition-extension|Lost to Follow-up|1
6829980|NCT00151775|10833433|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0
6829981|NCT00151775|10833434|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0
6829982|NCT00151775|10833423|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0
6829983|NCT00151775|10833424|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0
6829984|NCT00151775|10833425|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1
6829985|NCT00151775|10833426|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0
6829986|NCT00151775|10833427|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0
6829987|NCT00151775|10833428|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0
6829988|NCT00151775|10833429|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0
6829989|NCT00151775|10833430|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0
6829990|NCT00151775|10833431|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0
6829991|NCT00151775|10833432|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0
6829992|NCT00151775|10833433|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0
6829993|NCT00151775|10833434|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0
6829994|NCT00151775|10833423|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
6829995|NCT00151775|10833424|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
6829996|NCT00151775|10833425|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
6829997|NCT00151775|10833426|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
6829998|NCT00151775|10833427|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
6829999|NCT00151775|10833428|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
6830000|NCT00151775|10833429|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
6830001|NCT00151775|10833430|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
6830002|NCT00151775|10833431|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
6830003|NCT00151775|10833432|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
6830004|NCT00151775|10833433|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
6830005|NCT00151775|10833434|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1
6830006|NCT00151775|10833423|FG000|Period 4: Open Label|Increased blood pressure|0
6924453|NCT00824408|10954029|FG002|Randomized Phase|Not treated|1
6924454|NCT00824408|10954030|FG003|Randomized Phase|Not treated|1
6924455|NCT00824408|10954031|FG004|Randomized Phase|Not treated|1
6924456|NCT00824408|10954027|FG000|Randomized Phase|Progressive disease|0
6924457|NCT00824408|10954028|FG001|Randomized Phase|Progressive disease|0
6924458|NCT00824408|10954029|FG002|Randomized Phase|Progressive disease|25
6924459|NCT00824408|10954030|FG003|Randomized Phase|Progressive disease|36
6924460|NCT00824408|10954031|FG004|Randomized Phase|Progressive disease|34
6924461|NCT00824408|10954027|FG000|Randomized Phase|Adverse Event|0
6924462|NCT00824408|10954028|FG001|Randomized Phase|Adverse Event|0
6924463|NCT00824408|10954029|FG002|Randomized Phase|Adverse Event|4
6924464|NCT00824408|10954030|FG003|Randomized Phase|Adverse Event|5
6924465|NCT00824408|10954031|FG004|Randomized Phase|Adverse Event|5
6924466|NCT00824408|10954027|FG000|Randomized Phase|Refused to continue medication|0
6924467|NCT00824408|10954028|FG001|Randomized Phase|Refused to continue medication|0
6924468|NCT00824408|10954029|FG002|Randomized Phase|Refused to continue medication|2
6924469|NCT00824408|10954030|FG003|Randomized Phase|Refused to continue medication|2
6924470|NCT00824408|10954031|FG004|Randomized Phase|Refused to continue medication|2
6924471|NCT00824408|10954027|FG000|Randomized Phase|Other reason not defined above|0
6924472|NCT00824408|10954028|FG001|Randomized Phase|Other reason not defined above|0
6924473|NCT00824408|10954029|FG002|Randomized Phase|Other reason not defined above|4
6924474|NCT00824408|10954030|FG003|Randomized Phase|Other reason not defined above|2
6924475|NCT00824408|10954031|FG004|Randomized Phase|Other reason not defined above|4
6924476|NCT00824421|10954052|FG000|Overall Study|Adverse Event|6
6924477|NCT00824421|10954053|FG001|Overall Study|Adverse Event|6
6924478|NCT00824421|10954054|FG002|Overall Study|Adverse Event|6
6924479|NCT00824421|10954052|FG000|Overall Study|Death|0
6924480|NCT00824421|10954053|FG001|Overall Study|Death|1
6924481|NCT00824421|10954054|FG002|Overall Study|Death|0
6924482|NCT00824421|10954052|FG000|Overall Study|Lack of Efficacy|5
6924483|NCT00824421|10954053|FG001|Overall Study|Lack of Efficacy|7
6924484|NCT00824421|10954054|FG002|Overall Study|Lack of Efficacy|4
6924485|NCT00824421|10954052|FG000|Overall Study|Lost to Follow-up|2
6924486|NCT00824421|10954053|FG001|Overall Study|Lost to Follow-up|3
6924487|NCT00824421|10954054|FG002|Overall Study|Lost to Follow-up|0
6924488|NCT00824421|10954052|FG000|Overall Study|Pregnancy|1
6924489|NCT00824421|10954053|FG001|Overall Study|Pregnancy|0
6924490|NCT00824421|10954054|FG002|Overall Study|Pregnancy|1
6924491|NCT00824421|10954052|FG000|Overall Study|Withdrawal by Subject|2
6924492|NCT00824421|10954053|FG001|Overall Study|Withdrawal by Subject|3
6924493|NCT00824421|10954054|FG002|Overall Study|Withdrawal by Subject|3
6924494|NCT00824421|10954052|FG000|Overall Study|Randomized but not Treated|1
6924495|NCT00824421|10954053|FG001|Overall Study|Randomized but not Treated|1
6924496|NCT00824421|10954054|FG002|Overall Study|Randomized but not Treated|0
6924497|NCT00824421|10954052|FG000|Overall Study|Other|0
6924498|NCT00824421|10954053|FG001|Overall Study|Other|1
6830007|NCT00151775|10833424|FG001|Period 4: Open Label|Increased blood pressure|0
6924499|NCT00824421|10954054|FG002|Overall Study|Other|0
6924500|NCT00824473|10954103|FG000|Overall Study|Adverse Event|4
6924501|NCT00824473|10954104|FG001|Overall Study|Adverse Event|5
6924502|NCT00824473|10954103|FG000|Overall Study|Lack of Efficacy|2
6924503|NCT00824473|10954104|FG001|Overall Study|Lack of Efficacy|2
6830008|NCT00151775|10833425|FG002|Period 4: Open Label|Increased blood pressure|0
6830009|NCT00151775|10833426|FG003|Period 4: Open Label|Increased blood pressure|0
6830010|NCT00151775|10833427|FG004|Period 4: Open Label|Increased blood pressure|1
6830011|NCT00151775|10833428|FG005|Period 4: Open Label|Increased blood pressure|0
6830012|NCT00151775|10833429|FG006|Period 4: Open Label|Increased blood pressure|0
6830013|NCT00151775|10833430|FG007|Period 4: Open Label|Increased blood pressure|0
6830014|NCT00151775|10833431|FG008|Period 4: Open Label|Increased blood pressure|0
6830015|NCT00151775|10833432|FG009|Period 4: Open Label|Increased blood pressure|1
6830016|NCT00151775|10833433|FG010|Period 4: Open Label|Increased blood pressure|0
6830017|NCT00151775|10833434|FG011|Period 4: Open Label|Increased blood pressure|0
6830018|NCT00151775|10833423|FG000|Period 4: Open Label|Withdrawal by Subject|0
6830019|NCT00151775|10833424|FG001|Period 4: Open Label|Withdrawal by Subject|0
6830020|NCT00151775|10833425|FG002|Period 4: Open Label|Withdrawal by Subject|0
6830021|NCT00151775|10833426|FG003|Period 4: Open Label|Withdrawal by Subject|0
6830022|NCT00151775|10833427|FG004|Period 4: Open Label|Withdrawal by Subject|5
6830023|NCT00151775|10833428|FG005|Period 4: Open Label|Withdrawal by Subject|0
6830024|NCT00151775|10833429|FG006|Period 4: Open Label|Withdrawal by Subject|0
6830025|NCT00151775|10833430|FG007|Period 4: Open Label|Withdrawal by Subject|0
6830026|NCT00151775|10833431|FG008|Period 4: Open Label|Withdrawal by Subject|0
6830027|NCT00151775|10833432|FG009|Period 4: Open Label|Withdrawal by Subject|2
6830028|NCT00151775|10833433|FG010|Period 4: Open Label|Withdrawal by Subject|0
6830029|NCT00151775|10833434|FG011|Period 4: Open Label|Withdrawal by Subject|0
6830030|NCT00151775|10833423|FG000|Period 4: Open Label|Adverse Event|0
6830031|NCT00151775|10833424|FG001|Period 4: Open Label|Adverse Event|0
6830032|NCT00151775|10833425|FG002|Period 4: Open Label|Adverse Event|0
6830033|NCT00151775|10833426|FG003|Period 4: Open Label|Adverse Event|0
6830034|NCT00151775|10833427|FG004|Period 4: Open Label|Adverse Event|1
6924504|NCT00824473|10954103|FG000|Overall Study|Protocol Violation|2
6924505|NCT00824473|10954104|FG001|Overall Study|Protocol Violation|0
6924506|NCT00824473|10954103|FG000|Overall Study|Non-Compliance|4
6924507|NCT00824473|10954104|FG001|Overall Study|Non-Compliance|2
6924508|NCT00824473|10954103|FG000|Overall Study|Withdrawal by Subject|2
6924509|NCT00824473|10954104|FG001|Overall Study|Withdrawal by Subject|3
6924510|NCT00824473|10954103|FG000|Overall Study|Other|1
6924511|NCT00824473|10954104|FG001|Overall Study|Other|1
6924512|NCT00824564|10954126|FG000|Overall Study|Lost to Follow-up|5
6924513|NCT00824564|10954127|FG001|Overall Study|Lost to Follow-up|7
6924514|NCT00824564|10954126|FG000|Overall Study|Withdrawal by Subject|1
6924515|NCT00824564|10954127|FG001|Overall Study|Withdrawal by Subject|1
6924516|NCT00824564|10954126|FG000|Overall Study|Other|1
6924517|NCT00824564|10954127|FG001|Overall Study|Other|2
6924518|NCT00824564|10954126|FG000|Overall Study|Randomized, but not treated|1
6924519|NCT00824564|10954127|FG001|Overall Study|Randomized, but not treated|0
6924520|NCT00824616|10954135|FG000|Overall Study|Adverse Event|2
6924521|NCT00824616|10954136|FG001|Overall Study|Adverse Event|1
6924522|NCT00824616|10954135|FG000|Overall Study|Creatinine/Creatinine Clearance|0
6924523|NCT00824616|10954136|FG001|Overall Study|Creatinine/Creatinine Clearance|2
6924524|NCT00824616|10954135|FG000|Overall Study|Hyperglycemia|1
6924525|NCT00824616|10954136|FG001|Overall Study|Hyperglycemia|1
6924526|NCT00824616|10954135|FG000|Overall Study|Lack of Efficacy|2
6924527|NCT00824616|10954136|FG001|Overall Study|Lack of Efficacy|1
6924528|NCT00824616|10954135|FG000|Overall Study|Lost to Follow-up|0
6924529|NCT00824616|10954136|FG001|Overall Study|Lost to Follow-up|1
6924530|NCT00824616|10954135|FG000|Overall Study|Withdrawal by Subject|1
6924531|NCT00824616|10954136|FG001|Overall Study|Withdrawal by Subject|1
6924532|NCT00824655|10954144|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1
6924533|NCT00824655|10954145|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0
6924534|NCT00824655|10954144|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1
6924535|NCT00824655|10954145|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0
6924536|NCT00824720|10954156|FG000|Overall Study|failed plug insertion|3
6924537|NCT00824720|10954157|FG001|Overall Study|failed plug insertion|1
6924538|NCT00824720|10954158|FG002|Overall Study|failed plug insertion|0
6924539|NCT00824720|10954156|FG000|Overall Study|Protocol Violation|0
6924540|NCT00824720|10954157|FG001|Overall Study|Protocol Violation|0
6924541|NCT00824720|10954158|FG002|Overall Study|Protocol Violation|1
6924542|NCT00824772|10954176|FG000|Overall Study|Withdrawal by Subject|8
6924543|NCT00824850|10954191|FG000|Overall Study|Withdrawal by Subject|0
6924544|NCT00824850|10954192|FG001|Overall Study|Withdrawal by Subject|1
6924545|NCT00824993|10954206|FG000|Overall Study|Withdrawal by Subject|1
6924546|NCT00824993|10954207|FG001|Overall Study|Withdrawal by Subject|1
6924547|NCT00824993|10954206|FG000|Overall Study|Malignancy Relapse|9
6924548|NCT00824993|10954207|FG001|Overall Study|Malignancy Relapse|10
6924549|NCT00824993|10954206|FG000|Overall Study|Rapid Bone Loss|0
6924550|NCT00824993|10954207|FG001|Overall Study|Rapid Bone Loss|1
6924551|NCT00824993|10954206|FG000|Overall Study|Non-Compliant|2
6924552|NCT00824993|10954207|FG001|Overall Study|Non-Compliant|1
6924553|NCT00824993|10954206|FG000|Overall Study|Insurance Issue|2
6924554|NCT00824993|10954207|FG001|Overall Study|Insurance Issue|1
6924555|NCT00824993|10954206|FG000|Overall Study|Death|0
6924556|NCT00824993|10954207|FG001|Overall Study|Death|3
6924557|NCT00825162|10954216|FG000|Overall Study|Withdrawal by Subject|11
7062205|NCT01936181|11159584|FG003|Transition-extension|Lost to Follow-up|2
7062206|NCT01936181|11159581|FG000|Transition-extension|Physician Decision|2
7062207|NCT01936181|11159582|FG001|Transition-extension|Physician Decision|0
7062208|NCT01936181|11159583|FG002|Transition-extension|Physician Decision|0
7062209|NCT01936181|11159584|FG003|Transition-extension|Physician Decision|1
7062210|NCT01936181|11159581|FG000|Transition-extension|Withdrawal by Subject|7
7062211|NCT01936181|11159582|FG001|Transition-extension|Withdrawal by Subject|0
7062212|NCT01936181|11159583|FG002|Transition-extension|Withdrawal by Subject|2
7062213|NCT01936181|11159584|FG003|Transition-extension|Withdrawal by Subject|1
7062214|NCT01936623|11159661|FG000|Overall Study|Lost to Follow-up|0
7062215|NCT01936623|11159662|FG001|Overall Study|Lost to Follow-up|5
7062216|NCT01936649|11159668|FG000|Overall Study|Withdrawal by Subject|4
7062217|NCT01936649|11159668|FG000|Overall Study|Physician Decision|2
7062218|NCT01936649|11159668|FG000|Overall Study|Protocol Violation|2
7062219|NCT01936649|11159668|FG000|Overall Study|Other than specified above|5
7082287|NCT02140164|11192689|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2
7082288|NCT02140411|11192697|FG000|Overall Study|Adverse Event|1
7082289|NCT02140567|11192701|FG000|Overall Study|Problems with recording equipment|6
7082290|NCT02140645|11192721|FG000|Overall Study|Not linked|5489
7082291|NCT02140645|11192722|FG001|Overall Study|Not linked|61654
7082292|NCT02140645|11192723|FG002|Overall Study|Not linked|4236
7082293|NCT02140645|11192724|FG003|Overall Study|Not linked|13833
7082294|NCT02140645|11192725|FG004|Overall Study|Not linked|3286
7082295|NCT02140645|11192726|FG005|Overall Study|Not linked|70896
7082296|NCT02140762|11192737|FG000|Overall Study|Adverse Event|1
7082297|NCT02140762|11192738|FG001|Overall Study|Adverse Event|1
7082298|NCT02140762|11192737|FG000|Overall Study|Lost to Follow-up|9
7082299|NCT02140762|11192738|FG001|Overall Study|Lost to Follow-up|5
7082300|NCT02140762|11192737|FG000|Overall Study|Protocol Violation|1
7082301|NCT02140762|11192738|FG001|Overall Study|Protocol Violation|1
7082302|NCT02140762|11192737|FG000|Overall Study|Withdrawal by Subject|6
7082303|NCT02140762|11192738|FG001|Overall Study|Withdrawal by Subject|4
7082304|NCT02140762|11192737|FG000|Overall Study|Other|0
7082305|NCT02140762|11192738|FG001|Overall Study|Other|1
7082306|NCT02140775|11192751|FG000|Overall Study|Withdrawal by Subject|30
7082307|NCT02140775|11192752|FG001|Overall Study|Withdrawal by Subject|7
7082308|NCT02140970|11192771|FG000|Overall Study|Lost to Follow-up|1
7082309|NCT02140970|11192772|FG001|Overall Study|Lost to Follow-up|2
7082310|NCT02140970|11192771|FG000|Overall Study|Misplaced consent, subject withdrawn|1
7082311|NCT02140970|11192772|FG001|Overall Study|Misplaced consent, subject withdrawn|0
7082312|NCT02140970|11192771|FG000|Overall Study|Did not meet inclusion criteria|0
7082313|NCT02140970|11192772|FG001|Overall Study|Did not meet inclusion criteria|1
7082314|NCT02141204|11192780|FG000|Overall Study|Lost to Follow-up|2
7082315|NCT02141204|11192781|FG001|Overall Study|Lost to Follow-up|1
7082316|NCT02141204|11192780|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1
7082317|NCT02141204|11192781|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2
6830035|NCT00151775|10833428|FG005|Period 4: Open Label|Adverse Event|0
6830036|NCT00151775|10833429|FG006|Period 4: Open Label|Adverse Event|0
6830037|NCT00151775|10833430|FG007|Period 4: Open Label|Adverse Event|0
6830038|NCT00151775|10833431|FG008|Period 4: Open Label|Adverse Event|0
6830039|NCT00151775|10833432|FG009|Period 4: Open Label|Adverse Event|2
6830040|NCT00151775|10833433|FG010|Period 4: Open Label|Adverse Event|0
6830041|NCT00151775|10833434|FG011|Period 4: Open Label|Adverse Event|0
6830042|NCT00151775|10833423|FG000|Period 4: Open Label|Lost to Follow-up|0
6830043|NCT00151775|10833424|FG001|Period 4: Open Label|Lost to Follow-up|0
6830044|NCT00151775|10833425|FG002|Period 4: Open Label|Lost to Follow-up|0
7038481|NCT01703208|11120816|FG001|Overall Study|Progressive disease|2
7038482|NCT01703208|11120815|FG000|Overall Study|Protocol Violation|1
7038483|NCT01703208|11120816|FG001|Overall Study|Protocol Violation|1
7038484|NCT01703208|11120815|FG000|Overall Study|Study Terminated by Sponsor|1710
7038485|NCT01703208|11120816|FG001|Overall Study|Study Terminated by Sponsor|1716
7038486|NCT01703208|11120815|FG000|Overall Study|Withdrawal by Subject|205
7038487|NCT01703208|11120816|FG001|Overall Study|Withdrawal by Subject|209
7038488|NCT01703208|11120815|FG000|Overall Study|Adverse Event|14
7038489|NCT01703208|11120816|FG001|Overall Study|Adverse Event|19
7038490|NCT01703208|11120815|FG000|Overall Study|Technical Problems|0
6830045|NCT00151775|10833426|FG003|Period 4: Open Label|Lost to Follow-up|0
6830046|NCT00151775|10833427|FG004|Period 4: Open Label|Lost to Follow-up|17
7038491|NCT01703208|11120816|FG001|Overall Study|Technical Problems|1
7038492|NCT01703208|11120815|FG000|Overall Study|Protocol Deviation|2
7038493|NCT01703208|11120816|FG001|Overall Study|Protocol Deviation|0
7038494|NCT01703221|11120825|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2
7082318|NCT02141204|11192780|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3
7082319|NCT02141204|11192781|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5
7082320|NCT02141204|11192780|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9
7082321|NCT02141204|11192781|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7
7082322|NCT02141217|11192789|FG000|Overall Study|Adverse Event|1
7082323|NCT02141217|11192790|FG001|Overall Study|Adverse Event|2
7082324|NCT02141217|11192789|FG000|Overall Study|Protocol Violation|1
7082325|NCT02141217|11192790|FG001|Overall Study|Protocol Violation|4
7082326|NCT02141217|11192789|FG000|Overall Study|Withdrawal by Subject|6
6830047|NCT00151775|10833428|FG005|Period 4: Open Label|Lost to Follow-up|0
7038495|NCT01703221|11120826|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4
7038496|NCT01703221|11120827|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0
7038497|NCT01703221|11120825|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2
7038498|NCT01703221|11120826|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0
7038499|NCT01703221|11120827|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1
7038500|NCT01703221|11120825|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1
7038501|NCT01703221|11120826|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0
7038502|NCT01703221|11120827|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0
7038503|NCT01703221|11120825|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2
7038504|NCT01703221|11120826|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
7038505|NCT01703221|11120827|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
7038506|NCT01703221|11120825|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0
7038507|NCT01703221|11120826|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0
7038508|NCT01703221|11120827|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1
7038509|NCT01703221|11120825|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2
7038510|NCT01703221|11120826|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1
7038511|NCT01703221|11120827|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0
7038512|NCT01703221|11120825|FG000|Phase B - (Week 25 to 52)|Adverse Event|2
7038513|NCT01703221|11120826|FG001|Phase B - (Week 25 to 52)|Adverse Event|3
7038514|NCT01703221|11120827|FG002|Phase B - (Week 25 to 52)|Adverse Event|2
7038515|NCT01703221|11120825|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12
7062220|NCT01936870|11159692|FG000|Overall Study|No Visit After Treatment|176
7062221|NCT01936870|11159692|FG000|Overall Study|Protocol Violation|12
7062222|NCT01936870|11159692|FG000|Overall Study|No Drug Administration|1
7062223|NCT01936948|11159717|FG000|Overall Study|no 30-day follow-up data|0
7062224|NCT01936948|11159718|FG001|Overall Study|no 30-day follow-up data|3
7062225|NCT01936948|11159719|FG002|Overall Study|no 30-day follow-up data|3
7038516|NCT01703221|11120826|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10
7038517|NCT01703221|11120827|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3
7038518|NCT01703260|11120844|FG000|Overall Study|Adverse Event|1
7038519|NCT01703260|11120845|FG001|Overall Study|Adverse Event|2
7038520|NCT01703260|11120846|FG002|Overall Study|Adverse Event|2
7038521|NCT01703260|11120844|FG000|Overall Study|Lost to Follow-up|1
7038522|NCT01703260|11120845|FG001|Overall Study|Lost to Follow-up|0
7038523|NCT01703260|11120846|FG002|Overall Study|Lost to Follow-up|0
7038524|NCT01703260|11120844|FG000|Overall Study|Withdrawal by Subject|0
7038525|NCT01703260|11120845|FG001|Overall Study|Withdrawal by Subject|0
7038526|NCT01703260|11120846|FG002|Overall Study|Withdrawal by Subject|1
7038527|NCT01703260|11120844|FG000|Overall Study|Study Termination|1
7038528|NCT01703260|11120845|FG001|Overall Study|Study Termination|2
7038529|NCT01703260|11120846|FG002|Overall Study|Study Termination|0
7038530|NCT01703286|11120854|FG000|Period 1 Including Washout|Withdrawal by Subject|0
7038531|NCT01703286|11120855|FG001|Period 1 Including Washout|Withdrawal by Subject|0
7038532|NCT01703286|11120856|FG002|Period 1 Including Washout|Withdrawal by Subject|0
7038533|NCT01703286|11120857|FG003|Period 1 Including Washout|Withdrawal by Subject|1
7038534|NCT01703286|11120858|FG004|Period 1 Including Washout|Withdrawal by Subject|0
7038535|NCT01703286|11120859|FG005|Period 1 Including Washout|Withdrawal by Subject|1
7038536|NCT01703286|11120854|FG000|Period 2 Including Washout|Adverse Event|0
7038537|NCT01703286|11120855|FG001|Period 2 Including Washout|Adverse Event|0
7038538|NCT01703286|11120856|FG002|Period 2 Including Washout|Adverse Event|0
7038539|NCT01703286|11120857|FG003|Period 2 Including Washout|Adverse Event|1
7038540|NCT01703286|11120858|FG004|Period 2 Including Washout|Adverse Event|0
7038541|NCT01703286|11120859|FG005|Period 2 Including Washout|Adverse Event|0
7038542|NCT01703741|11120904|FG000|Overall Study|Withdrawal by Subject|6
7038543|NCT01703741|11120904|FG000|Overall Study|Adverse Event|2
7038544|NCT01703741|11120904|FG000|Overall Study|Physician Decision|2
7038545|NCT01703741|11120904|FG000|Overall Study|Protocol Violation|1
7038546|NCT01703741|11120904|FG000|Overall Study|Lost to Follow-up|3
7038547|NCT01703741|11120904|FG000|Overall Study|Subject did not want to continue|2
7038548|NCT01703741|11120904|FG000|Overall Study|Subject cannot comply with study visits|1
7038549|NCT01703741|11120904|FG000|Overall Study|Subject started testosterone injections|1
7038550|NCT01703819|11120910|FG000|Overall Study|Adverse Event|0
7038551|NCT01703819|11120911|FG001|Overall Study|Adverse Event|1
7038552|NCT01703819|11120910|FG000|Overall Study|Withdrawal by Subject|0
7038553|NCT01703819|11120911|FG001|Overall Study|Withdrawal by Subject|1
7038554|NCT01703832|11120919|FG000|Overall Study|Withdrawal by Subject|1
7038555|NCT01703832|11120920|FG001|Overall Study|Withdrawal by Subject|0
7038556|NCT01703845|11120928|FG000|Overall Study|Adverse Event|1
7038557|NCT01703845|11120929|FG001|Overall Study|Adverse Event|0
7038558|NCT01703845|11120928|FG000|Overall Study|Protocol Violation|1
7038559|NCT01703845|11120929|FG001|Overall Study|Protocol Violation|0
7038560|NCT01703845|11120928|FG000|Overall Study|other than stated above|1
7038561|NCT01703845|11120929|FG001|Overall Study|other than stated above|0
7038562|NCT01703858|11120940|FG000|Overall Study|Withdrawal by Subject|0
7038563|NCT01703858|11120941|FG001|Overall Study|Withdrawal by Subject|1
7038564|NCT01703858|11120942|FG002|Overall Study|Withdrawal by Subject|0
7038565|NCT01703988|11120959|FG000|Overall Study|Investigator Judgment|0
7038566|NCT01703988|11120960|FG001|Overall Study|Investigator Judgment|0
7038567|NCT01703988|11120961|FG002|Overall Study|Investigator Judgment|0
7038568|NCT01703988|11120962|FG003|Overall Study|Investigator Judgment|1
7038569|NCT01704079|11120975|FG000|Overall Study|Withdrawal by Subject|5
7038570|NCT01704079|11120976|FG001|Overall Study|Withdrawal by Subject|7
7038571|NCT01704079|11120975|FG000|Overall Study|Lost to Follow-up|2
6924558|NCT00825162|10954217|FG001|Overall Study|Withdrawal by Subject|13
6924559|NCT00825162|10954218|FG002|Overall Study|Withdrawal by Subject|3
6924560|NCT00825162|10954216|FG000|Overall Study|Lost to Follow-up|9
6924561|NCT00825162|10954217|FG001|Overall Study|Lost to Follow-up|6
7038572|NCT01704079|11120976|FG001|Overall Study|Lost to Follow-up|5
6830048|NCT00151775|10833429|FG006|Period 4: Open Label|Lost to Follow-up|0
6830049|NCT00151775|10833430|FG007|Period 4: Open Label|Lost to Follow-up|0
6830050|NCT00151775|10833431|FG008|Period 4: Open Label|Lost to Follow-up|0
6830051|NCT00151775|10833432|FG009|Period 4: Open Label|Lost to Follow-up|7
6830052|NCT00151775|10833433|FG010|Period 4: Open Label|Lost to Follow-up|0
6924562|NCT00825162|10954218|FG002|Overall Study|Lost to Follow-up|3
6924563|NCT00825162|10954216|FG000|Overall Study|Physician Decision|2
6924564|NCT00825162|10954217|FG001|Overall Study|Physician Decision|0
6924565|NCT00825162|10954218|FG002|Overall Study|Physician Decision|0
6924566|NCT00825162|10954216|FG000|Overall Study|Move away from the study area|1
6924567|NCT00825162|10954217|FG001|Overall Study|Move away from the study area|0
6924568|NCT00825162|10954218|FG002|Overall Study|Move away from the study area|0
6924569|NCT00825162|10954216|FG000|Overall Study|Unable to attend the study visit|5
6924570|NCT00825162|10954217|FG001|Overall Study|Unable to attend the study visit|2
6924571|NCT00825162|10954218|FG002|Overall Study|Unable to attend the study visit|0
6924572|NCT00825175|10954233|FG000|Overall Study|Withdrawal by Subject|0
6924573|NCT00825175|10954234|FG001|Overall Study|Withdrawal by Subject|5
6924574|NCT00825305|10954251|FG000|Overall Study|Adverse Event|1
6924575|NCT00825305|10954252|FG001|Overall Study|Adverse Event|1
6924576|NCT00825305|10954251|FG000|Overall Study|Withdrawal by Subject|6
6924577|NCT00825305|10954252|FG001|Overall Study|Withdrawal by Subject|12
6924578|NCT00825305|10954251|FG000|Overall Study|Inappropriate inclusion|1
6924579|NCT00825305|10954252|FG001|Overall Study|Inappropriate inclusion|0
6924580|NCT00825305|10954251|FG000|Overall Study|Protocol Violation|9
6924581|NCT00825305|10954252|FG001|Overall Study|Protocol Violation|9
7038573|NCT01704079|11120975|FG000|Overall Study|Adverse Event|4
7038574|NCT01704079|11120976|FG001|Overall Study|Adverse Event|7
7038575|NCT01704079|11120975|FG000|Overall Study|Protocol Violation|1
7038576|NCT01704079|11120976|FG001|Overall Study|Protocol Violation|0
7038577|NCT01704079|11120975|FG000|Overall Study|Subject noncompliance|2
7038578|NCT01704079|11120976|FG001|Overall Study|Subject noncompliance|3
7038579|NCT01704079|11120975|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0
7038580|NCT01704079|11120976|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1
7038581|NCT01704261|11120993|FG000|Overall Study|Withdrawal by Subject|12
7038582|NCT01704261|11120994|FG001|Overall Study|Withdrawal by Subject|15
7038583|NCT01704261|11120993|FG000|Overall Study|Lost to Follow-up|1
7038584|NCT01704261|11120994|FG001|Overall Study|Lost to Follow-up|0
7038585|NCT01704287|11121003|FG000|Initial Treatment Period|Death|139
7038586|NCT01704287|11121004|FG001|Initial Treatment Period|Death|129
7038587|NCT01704287|11121005|FG002|Initial Treatment Period|Death|71
7062226|NCT01936948|11159720|FG003|Overall Study|no 30-day follow-up data|3
7062227|NCT01937117|11159735|FG000|Overall Study|Disease Progression|7
7062228|NCT01937117|11159735|FG000|Overall Study|Physician Decision|4
7062229|NCT01937117|11159735|FG000|Overall Study|Adverse Event|2
6830053|NCT00151775|10833434|FG011|Period 4: Open Label|Lost to Follow-up|0
6830054|NCT00151775|10833423|FG000|Period 4: Open Label|Non-compliance with protocol|0
6830055|NCT00151775|10833424|FG001|Period 4: Open Label|Non-compliance with protocol|0
6830056|NCT00151775|10833425|FG002|Period 4: Open Label|Non-compliance with protocol|0
6830057|NCT00151775|10833426|FG003|Period 4: Open Label|Non-compliance with protocol|0
6830058|NCT00151775|10833427|FG004|Period 4: Open Label|Non-compliance with protocol|4
6830059|NCT00151775|10833428|FG005|Period 4: Open Label|Non-compliance with protocol|0
6830060|NCT00151775|10833429|FG006|Period 4: Open Label|Non-compliance with protocol|0
6830061|NCT00151775|10833430|FG007|Period 4: Open Label|Non-compliance with protocol|0
6830062|NCT00151775|10833431|FG008|Period 4: Open Label|Non-compliance with protocol|0
6897099|NCT00636636|10915778|FG001|Overall Study|Other reason|6
6897100|NCT00636636|10915777|FG000|Overall Study|Adverse Event|19
6897101|NCT00636636|10915778|FG001|Overall Study|Adverse Event|8
6897102|NCT00636636|10915777|FG000|Overall Study|Lack of Efficacy|7
6897103|NCT00636636|10915778|FG001|Overall Study|Lack of Efficacy|12
6897104|NCT00636636|10915777|FG000|Overall Study|Protocol Violation|2
6897105|NCT00636636|10915778|FG001|Overall Study|Protocol Violation|2
6897106|NCT00636636|10915777|FG000|Overall Study|Lost to Follow-up|0
6897107|NCT00636636|10915778|FG001|Overall Study|Lost to Follow-up|1
6897108|NCT00636636|10915777|FG000|Overall Study|Death|0
6897109|NCT00636636|10915778|FG001|Overall Study|Death|1
6897110|NCT00636636|10915777|FG000|Overall Study|Withdrawal by Subject|4
6897111|NCT00636636|10915778|FG001|Overall Study|Withdrawal by Subject|9
6897112|NCT00636675|10915799|FG000|Overall Study|Lost to Follow-up|121
6897113|NCT00636675|10915800|FG001|Overall Study|Lost to Follow-up|31
6897114|NCT00636675|10915799|FG000|Overall Study|Withdrawal by Subject|19
6897115|NCT00636675|10915800|FG001|Overall Study|Withdrawal by Subject|10
6897116|NCT00636792|10915815|FG000|Overall Study|Adverse Event|16
6897117|NCT00636792|10915815|FG000|Overall Study|Physician Decision|7
6830063|NCT00151775|10833432|FG009|Period 4: Open Label|Non-compliance with protocol|4
6830064|NCT00151775|10833433|FG010|Period 4: Open Label|Non-compliance with protocol|0
6830065|NCT00151775|10833434|FG011|Period 4: Open Label|Non-compliance with protocol|0
6830066|NCT00151775|10833423|FG000|Period 4: Open Label|Other|0
6830067|NCT00151775|10833424|FG001|Period 4: Open Label|Other|0
6830068|NCT00151775|10833425|FG002|Period 4: Open Label|Other|0
6830069|NCT00151775|10833426|FG003|Period 4: Open Label|Other|0
6830070|NCT00151775|10833427|FG004|Period 4: Open Label|Other|1
6830071|NCT00151775|10833428|FG005|Period 4: Open Label|Other|0
6830072|NCT00151775|10833429|FG006|Period 4: Open Label|Other|0
6830073|NCT00151775|10833430|FG007|Period 4: Open Label|Other|0
6830074|NCT00151775|10833431|FG008|Period 4: Open Label|Other|0
6830075|NCT00151775|10833432|FG009|Period 4: Open Label|Other|3
6830076|NCT00151775|10833433|FG010|Period 4: Open Label|Other|0
6830077|NCT00151775|10833434|FG011|Period 4: Open Label|Other|0
6830078|NCT00151775|10833423|FG000|Period 4: Open Label|Physician Decision|0
6830079|NCT00151775|10833424|FG001|Period 4: Open Label|Physician Decision|0
6830080|NCT00151775|10833425|FG002|Period 4: Open Label|Physician Decision|0
6830081|NCT00151775|10833426|FG003|Period 4: Open Label|Physician Decision|0
6830082|NCT00151775|10833427|FG004|Period 4: Open Label|Physician Decision|0
6830083|NCT00151775|10833428|FG005|Period 4: Open Label|Physician Decision|0
6830084|NCT00151775|10833429|FG006|Period 4: Open Label|Physician Decision|0
6830085|NCT00151775|10833430|FG007|Period 4: Open Label|Physician Decision|0
6830086|NCT00151775|10833431|FG008|Period 4: Open Label|Physician Decision|0
6830087|NCT00151775|10833432|FG009|Period 4: Open Label|Physician Decision|2
6830088|NCT00151775|10833433|FG010|Period 4: Open Label|Physician Decision|0
6830089|NCT00151775|10833434|FG011|Period 4: Open Label|Physician Decision|0
6830090|NCT00151775|10833423|FG000|Period 4: Open Label|Protocol Violation|0
6830091|NCT00151775|10833424|FG001|Period 4: Open Label|Protocol Violation|0
6830092|NCT00151775|10833425|FG002|Period 4: Open Label|Protocol Violation|0
6830093|NCT00151775|10833426|FG003|Period 4: Open Label|Protocol Violation|0
6830094|NCT00151775|10833427|FG004|Period 4: Open Label|Protocol Violation|1
6830095|NCT00151775|10833428|FG005|Period 4: Open Label|Protocol Violation|0
6830096|NCT00151775|10833429|FG006|Period 4: Open Label|Protocol Violation|0
6830097|NCT00151775|10833430|FG007|Period 4: Open Label|Protocol Violation|0
6830098|NCT00151775|10833431|FG008|Period 4: Open Label|Protocol Violation|0
6830099|NCT00151775|10833432|FG009|Period 4: Open Label|Protocol Violation|0
6830100|NCT00151775|10833433|FG010|Period 4: Open Label|Protocol Violation|0
6830101|NCT00151775|10833434|FG011|Period 4: Open Label|Protocol Violation|0
6830102|NCT00151892|10833489|FG000|Overall Study|Lack of Efficacy|50
6830103|NCT00151892|10833490|FG001|Overall Study|Lack of Efficacy|57
6830104|NCT00151892|10833489|FG000|Overall Study|Patient request|10
6830105|NCT00151892|10833490|FG001|Overall Study|Patient request|7
6830106|NCT00151892|10833489|FG000|Overall Study|Lost to Follow-up|5
6830107|NCT00151892|10833490|FG001|Overall Study|Lost to Follow-up|10
6830108|NCT00151892|10833489|FG000|Overall Study|Adverse Event|6
6830109|NCT00151892|10833490|FG001|Overall Study|Adverse Event|3
6830110|NCT00151892|10833489|FG000|Overall Study|Protocol Violation|3
6830111|NCT00151892|10833490|FG001|Overall Study|Protocol Violation|3
6830112|NCT00151892|10833489|FG000|Overall Study|Non-compliance|0
6830113|NCT00151892|10833490|FG001|Overall Study|Non-compliance|1
6830114|NCT00151892|10833489|FG000|Overall Study|Pregnancy|0
6830115|NCT00151892|10833490|FG001|Overall Study|Pregnancy|1
6830116|NCT00151892|10833489|FG000|Overall Study|Did not return for a visit|1
6830117|NCT00151892|10833490|FG001|Overall Study|Did not return for a visit|0
6924582|NCT00825305|10954251|FG000|Overall Study|Can not be classified|0
6924583|NCT00825305|10954252|FG001|Overall Study|Can not be classified|1
6924584|NCT00825682|10954326|FG000|Overall Study|personal reasons/ inconvenience|13
6924585|NCT00825682|10954327|FG001|Overall Study|personal reasons/ inconvenience|5
6924586|NCT00825812|10954354|FG000|Overall Study|Never entered follow up|0
6924587|NCT00825812|10954355|FG001|Overall Study|Never entered follow up|0
6924588|NCT00825812|10954356|FG002|Overall Study|Never entered follow up|0
6924589|NCT00825812|10954357|FG003|Overall Study|Never entered follow up|1
6924590|NCT00825812|10954354|FG000|Overall Study|Adverse Event|0
6924591|NCT00825812|10954355|FG001|Overall Study|Adverse Event|0
6924592|NCT00825812|10954356|FG002|Overall Study|Adverse Event|0
6924593|NCT00825812|10954357|FG003|Overall Study|Adverse Event|1
6924594|NCT00825812|10954354|FG000|Overall Study|Subject withdrew consent|0
6924595|NCT00825812|10954355|FG001|Overall Study|Subject withdrew consent|0
6924596|NCT00825812|10954356|FG002|Overall Study|Subject withdrew consent|3
6924597|NCT00825812|10954357|FG003|Overall Study|Subject withdrew consent|2
6924598|NCT00825812|10954354|FG000|Overall Study|Non-compliance with protocol|0
6924599|NCT00825812|10954355|FG001|Overall Study|Non-compliance with protocol|0
6924600|NCT00825812|10954356|FG002|Overall Study|Non-compliance with protocol|0
6924601|NCT00825812|10954357|FG003|Overall Study|Non-compliance with protocol|1
6924602|NCT00825812|10954354|FG000|Overall Study|Administrative|0
6924603|NCT00825812|10954355|FG001|Overall Study|Administrative|1
6924604|NCT00825812|10954356|FG002|Overall Study|Administrative|3
6924605|NCT00825812|10954357|FG003|Overall Study|Administrative|5
6830118|NCT00151892|10833489|FG000|Overall Study|Used prohibited corticosteroids|1
6830119|NCT00151892|10833490|FG001|Overall Study|Used prohibited corticosteroids|0
6924606|NCT00825825|10954367|FG000|First Medication Period (14 Days)|Adverse Event|1
6924607|NCT00825825|10954368|FG001|First Medication Period (14 Days)|Adverse Event|0
6830120|NCT00151892|10833489|FG000|Overall Study|Lack of study medication at center|0
6830121|NCT00151892|10833490|FG001|Overall Study|Lack of study medication at center|1
6830122|NCT00151996|10833498|FG000|Overall Study|Adverse Event|3
6830123|NCT00151996|10833499|FG001|Overall Study|Adverse Event|2
6830124|NCT00151996|10833498|FG000|Overall Study|Withdrawal by Subject|1
6830125|NCT00151996|10833499|FG001|Overall Study|Withdrawal by Subject|1
6830126|NCT00151996|10833498|FG000|Overall Study|Protocol Violation|1
6830127|NCT00151996|10833499|FG001|Overall Study|Protocol Violation|2
6830128|NCT00151996|10833498|FG000|Overall Study|Sponsor's decision|0
6830129|NCT00151996|10833499|FG001|Overall Study|Sponsor's decision|2
6830130|NCT00152009|10833509|FG000|Overall Study|Adverse Event|9
6830131|NCT00152009|10833510|FG001|Overall Study|Adverse Event|13
6830132|NCT00152009|10833511|FG002|Overall Study|Adverse Event|20
6830133|NCT00152009|10833512|FG003|Overall Study|Adverse Event|1
6830134|NCT00152009|10833509|FG000|Overall Study|Protocol Violation|3
6830135|NCT00152009|10833510|FG001|Overall Study|Protocol Violation|0
6830136|NCT00152009|10833511|FG002|Overall Study|Protocol Violation|0
6830137|NCT00152009|10833512|FG003|Overall Study|Protocol Violation|1
6830138|NCT00152009|10833509|FG000|Overall Study|Withdrawal by Subject|2
6830139|NCT00152009|10833510|FG001|Overall Study|Withdrawal by Subject|3
6830140|NCT00152009|10833511|FG002|Overall Study|Withdrawal by Subject|4
6830141|NCT00152009|10833512|FG003|Overall Study|Withdrawal by Subject|9
6830142|NCT00152009|10833509|FG000|Overall Study|Lost to Follow-up|2
6830143|NCT00152009|10833510|FG001|Overall Study|Lost to Follow-up|4
6830144|NCT00152009|10833511|FG002|Overall Study|Lost to Follow-up|3
6830145|NCT00152009|10833512|FG003|Overall Study|Lost to Follow-up|3
6830146|NCT00152009|10833509|FG000|Overall Study|Lack of Efficacy|8
6830147|NCT00152009|10833510|FG001|Overall Study|Lack of Efficacy|6
6830148|NCT00152009|10833511|FG002|Overall Study|Lack of Efficacy|7
6830149|NCT00152009|10833512|FG003|Overall Study|Lack of Efficacy|15
6830150|NCT00152009|10833509|FG000|Overall Study|ECG abnormalities|2
6830151|NCT00152009|10833510|FG001|Overall Study|ECG abnormalities|2
7038588|NCT01704287|11121006|FG003|Initial Treatment Period|Death|0
7038589|NCT01704287|11121007|FG004|Initial Treatment Period|Death|0
7038590|NCT01704287|11121003|FG000|Initial Treatment Period|Withdrawal by Subject|3
7038591|NCT01704287|11121004|FG001|Initial Treatment Period|Withdrawal by Subject|2
7038592|NCT01704287|11121005|FG002|Initial Treatment Period|Withdrawal by Subject|4
7038593|NCT01704287|11121006|FG003|Initial Treatment Period|Withdrawal by Subject|0
7038594|NCT01704287|11121007|FG004|Initial Treatment Period|Withdrawal by Subject|0
7038595|NCT01704287|11121003|FG000|Initial Treatment Period|Lost to Follow-up|5
7038596|NCT01704287|11121004|FG001|Initial Treatment Period|Lost to Follow-up|3
7038597|NCT01704287|11121005|FG002|Initial Treatment Period|Lost to Follow-up|0
7038598|NCT01704287|11121006|FG003|Initial Treatment Period|Lost to Follow-up|0
7038599|NCT01704287|11121007|FG004|Initial Treatment Period|Lost to Follow-up|0
7038600|NCT01704287|11121003|FG000|Initial Treatment Period|Switched to Pembrolizumab|0
7038601|NCT01704287|11121004|FG001|Initial Treatment Period|Switched to Pembrolizumab|0
7038602|NCT01704287|11121005|FG002|Initial Treatment Period|Switched to Pembrolizumab|98
7038603|NCT01704287|11121006|FG003|Initial Treatment Period|Switched to Pembrolizumab|0
7038604|NCT01704287|11121007|FG004|Initial Treatment Period|Switched to Pembrolizumab|0
7038605|NCT01704287|11121003|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
7038606|NCT01704287|11121004|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
7038607|NCT01704287|11121005|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
7038608|NCT01704287|11121006|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2
7038609|NCT01704287|11121007|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1
7038610|NCT01704287|11121003|FG000|Switch to Pembrolizumab Treatment Period|Death|0
7038611|NCT01704287|11121004|FG001|Switch to Pembrolizumab Treatment Period|Death|0
7038612|NCT01704287|11121005|FG002|Switch to Pembrolizumab Treatment Period|Death|0
7038613|NCT01704287|11121006|FG003|Switch to Pembrolizumab Treatment Period|Death|35
7038614|NCT01704287|11121007|FG004|Switch to Pembrolizumab Treatment Period|Death|37
7038615|NCT01704287|11121003|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
7038616|NCT01704287|11121004|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
7038617|NCT01704287|11121005|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
7038618|NCT01704287|11121006|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1
7038619|NCT01704287|11121007|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
7038620|NCT01704456|11121028|FG000|Overall Study|Lost to Follow-up|8
7038621|NCT01704456|11121029|FG001|Overall Study|Lost to Follow-up|14
6830152|NCT00152009|10833511|FG002|Overall Study|ECG abnormalities|2
6830153|NCT00152009|10833512|FG003|Overall Study|ECG abnormalities|1
6830154|NCT00152009|10833509|FG000|Overall Study|Sponsor's decision|3
6830155|NCT00152009|10833510|FG001|Overall Study|Sponsor's decision|3
6830156|NCT00152009|10833511|FG002|Overall Study|Sponsor's decision|1
6830157|NCT00152009|10833512|FG003|Overall Study|Sponsor's decision|3
6830158|NCT00152464|10833524|FG000|Overall Study|Adverse Event|3
6830159|NCT00152464|10833525|FG001|Overall Study|Adverse Event|6
6830160|NCT00152464|10833524|FG000|Overall Study|Lost to Follow-up|8
6830161|NCT00152464|10833525|FG001|Overall Study|Lost to Follow-up|4
7038622|NCT01704495|11121039|FG000|Subjects Randomized|Other Reason|3
7038623|NCT01704495|11121040|FG001|Subjects Randomized|Other Reason|2
7038624|NCT01704495|11121041|FG002|Subjects Randomized|Other Reason|3
7038625|NCT01704495|11121042|FG003|Subjects Randomized|Other Reason|2
6830162|NCT00152464|10833524|FG000|Overall Study|Protocol Violation|3
6830163|NCT00152464|10833525|FG001|Overall Study|Protocol Violation|1
6830164|NCT00152464|10833524|FG000|Overall Study|Withdrawal by Subject|21
6830165|NCT00152464|10833525|FG001|Overall Study|Withdrawal by Subject|22
6830166|NCT00152464|10833524|FG000|Overall Study|Atopic dermatitis poorly controlled|0
6830167|NCT00152464|10833525|FG001|Overall Study|Atopic dermatitis poorly controlled|1
6830168|NCT00152464|10833524|FG000|Overall Study|Eczema deterioration|0
6830169|NCT00152464|10833525|FG001|Overall Study|Eczema deterioration|1
6830170|NCT00152464|10833524|FG000|Overall Study|Parent decision|1
6830171|NCT00152464|10833525|FG001|Overall Study|Parent decision|1
6830172|NCT00152464|10833524|FG000|Overall Study|Investigator decision|1
6830173|NCT00152464|10833525|FG001|Overall Study|Investigator decision|0
6830174|NCT00152464|10833524|FG000|Overall Study|Lack of Efficacy|1
6830175|NCT00152464|10833525|FG001|Overall Study|Lack of Efficacy|0
6830176|NCT00152464|10833524|FG000|Overall Study|Eczema poorly controlled|1
6830177|NCT00152464|10833525|FG001|Overall Study|Eczema poorly controlled|0
6830178|NCT00152464|10833524|FG000|Overall Study|Patient relocated|1
6830179|NCT00152464|10833525|FG001|Overall Study|Patient relocated|0
6830180|NCT00152516|10833531|FG000|Overall Study|Adverse Event|18
6830181|NCT00152516|10833531|FG000|Overall Study|Lack and Loss of Efficacy|30
6830182|NCT00152516|10833531|FG000|Overall Study|Lost to Follow-up|5
6830183|NCT00152516|10833531|FG000|Overall Study|Withdrawal by Subject|8
6830184|NCT00152516|10833531|FG000|Overall Study|Protocol Violation|3
6830185|NCT00152516|10833531|FG000|Overall Study|Other: Mother Refused To Cooperate|1
6830186|NCT00152516|10833531|FG000|Overall Study|Other: Given Commercial Drug in Error|2
6830187|NCT00152516|10833531|FG000|Overall Study|Other: Parents Withdrew Consent|2
6830188|NCT00152516|10833531|FG000|Overall Study|Other: Non-Compliance|2
6830189|NCT00152516|10833531|FG000|Overall Study|Other: Primary Care Physician's Decision|1
6830190|NCT00152516|10833531|FG000|Overall Study|Other: Moved Out Of State|1
6924608|NCT00825825|10954369|FG002|First Medication Period (14 Days)|Adverse Event|0
6924609|NCT00825825|10954370|FG003|First Medication Period (14 Days)|Adverse Event|0
6924610|NCT00825825|10954371|FG004|First Medication Period (14 Days)|Adverse Event|0
6924611|NCT00825825|10954372|FG005|First Medication Period (14 Days)|Adverse Event|1
6924612|NCT00825825|10954367|FG000|First Medication Period (14 Days)|Physician Decision|2
6924613|NCT00825825|10954368|FG001|First Medication Period (14 Days)|Physician Decision|0
6924614|NCT00825825|10954369|FG002|First Medication Period (14 Days)|Physician Decision|1
6924615|NCT00825825|10954370|FG003|First Medication Period (14 Days)|Physician Decision|0
6924616|NCT00825825|10954371|FG004|First Medication Period (14 Days)|Physician Decision|0
6924617|NCT00825825|10954372|FG005|First Medication Period (14 Days)|Physician Decision|1
6924618|NCT00825825|10954367|FG000|Second Medication Period (14 Days)|Physician Decision|1
6924619|NCT00825825|10954368|FG001|Second Medication Period (14 Days)|Physician Decision|0
6924620|NCT00825825|10954369|FG002|Second Medication Period (14 Days)|Physician Decision|0
6924621|NCT00825825|10954370|FG003|Second Medication Period (14 Days)|Physician Decision|2
6924622|NCT00825825|10954371|FG004|Second Medication Period (14 Days)|Physician Decision|0
6924623|NCT00825825|10954372|FG005|Second Medication Period (14 Days)|Physician Decision|0
6924624|NCT00825825|10954367|FG000|Second Medication Period (14 Days)|Protocol Violation|1
6924625|NCT00825825|10954368|FG001|Second Medication Period (14 Days)|Protocol Violation|0
6924626|NCT00825825|10954369|FG002|Second Medication Period (14 Days)|Protocol Violation|0
6924627|NCT00825825|10954370|FG003|Second Medication Period (14 Days)|Protocol Violation|0
6924628|NCT00825825|10954371|FG004|Second Medication Period (14 Days)|Protocol Violation|1
6924629|NCT00825825|10954372|FG005|Second Medication Period (14 Days)|Protocol Violation|0
6924630|NCT00825825|10954367|FG000|Third Medication Period (14 Days)|Adverse Event|0
6924631|NCT00825825|10954368|FG001|Third Medication Period (14 Days)|Adverse Event|1
6924632|NCT00825825|10954369|FG002|Third Medication Period (14 Days)|Adverse Event|0
6924633|NCT00825825|10954370|FG003|Third Medication Period (14 Days)|Adverse Event|0
6924634|NCT00825825|10954371|FG004|Third Medication Period (14 Days)|Adverse Event|0
6924635|NCT00825825|10954372|FG005|Third Medication Period (14 Days)|Adverse Event|0
6924636|NCT00825825|10954367|FG000|Third Medication Period (14 Days)|Protocol Violation|0
6830191|NCT00152516|10833531|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1
6830192|NCT00152516|10833531|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1
6830193|NCT00152763|10833539|FG000|Overall Study|Death|4
6830194|NCT00152763|10833540|FG001|Overall Study|Death|1
6830195|NCT00152763|10833541|FG002|Overall Study|Death|2
6830196|NCT00152763|10833542|FG003|Overall Study|Death|1
6830197|NCT00152763|10833539|FG000|Overall Study|Lost to Follow-up|6
6830198|NCT00152763|10833540|FG001|Overall Study|Lost to Follow-up|4
6830199|NCT00152763|10833541|FG002|Overall Study|Lost to Follow-up|2
6830200|NCT00152763|10833542|FG003|Overall Study|Lost to Follow-up|13
6830201|NCT00152971|10833557|FG000|Overall Study|Adverse Event|12
6830202|NCT00152971|10833558|FG001|Overall Study|Adverse Event|10
6830203|NCT00152971|10833559|FG002|Overall Study|Adverse Event|9
6830204|NCT00152971|10833557|FG000|Overall Study|Protocol Violation|10
6830205|NCT00152971|10833558|FG001|Overall Study|Protocol Violation|11
6830206|NCT00152971|10833559|FG002|Overall Study|Protocol Violation|8
6830207|NCT00152971|10833557|FG000|Overall Study|Lost to Follow-up|17
6830208|NCT00152971|10833558|FG001|Overall Study|Lost to Follow-up|14
6830209|NCT00152971|10833559|FG002|Overall Study|Lost to Follow-up|13
6830210|NCT00152971|10833557|FG000|Overall Study|Withdrawal by Subject|9
6830211|NCT00152971|10833558|FG001|Overall Study|Withdrawal by Subject|8
6830212|NCT00152971|10833559|FG002|Overall Study|Withdrawal by Subject|14
6830213|NCT00152971|10833557|FG000|Overall Study|Other|3
6830214|NCT00152971|10833558|FG001|Overall Study|Other|5
6830215|NCT00152971|10833559|FG002|Overall Study|Other|5
6830216|NCT00152971|10833557|FG000|Treatment|Adverse Event|49
6830217|NCT00152971|10833558|FG001|Treatment|Adverse Event|40
6830218|NCT00152971|10833559|FG002|Treatment|Adverse Event|54
6830219|NCT00152971|10833557|FG000|Treatment|Protocol Violation|8
6830220|NCT00152971|10833558|FG001|Treatment|Protocol Violation|6
6830221|NCT00152971|10833559|FG002|Treatment|Protocol Violation|10
6830222|NCT00152971|10833557|FG000|Treatment|Lost to Follow-up|1
6830223|NCT00152971|10833558|FG001|Treatment|Lost to Follow-up|2
6830224|NCT00152971|10833559|FG002|Treatment|Lost to Follow-up|1
6830225|NCT00152971|10833557|FG000|Treatment|Withdrawal by Subject|4
6830226|NCT00152971|10833558|FG001|Treatment|Withdrawal by Subject|4
6830227|NCT00152971|10833559|FG002|Treatment|Withdrawal by Subject|5
6830228|NCT00152971|10833557|FG000|Treatment|Other|9
6830229|NCT00152971|10833558|FG001|Treatment|Other|11
6830230|NCT00152971|10833559|FG002|Treatment|Other|10
6830231|NCT00153062|10833571|FG000|Overall Study|Death|360
6830232|NCT00153062|10833572|FG001|Overall Study|Death|352
6830233|NCT00153062|10833573|FG002|Overall Study|Death|369
6830234|NCT00153062|10833574|FG003|Overall Study|Death|365
6830235|NCT00153062|10833571|FG000|Overall Study|Withdrawal by Subject|14
6830236|NCT00153062|10833572|FG001|Overall Study|Withdrawal by Subject|30
6830237|NCT00153062|10833573|FG002|Overall Study|Withdrawal by Subject|27
6830238|NCT00153062|10833574|FG003|Overall Study|Withdrawal by Subject|28
6830239|NCT00153062|10833571|FG000|Overall Study|Lost to Follow-up|12
6830240|NCT00153062|10833572|FG001|Overall Study|Lost to Follow-up|20
6830241|NCT00153062|10833573|FG002|Overall Study|Lost to Follow-up|15
6830242|NCT00153062|10833574|FG003|Overall Study|Lost to Follow-up|16
6830243|NCT00153062|10833571|FG000|Overall Study|Adverse Event|0
6830244|NCT00153062|10833572|FG001|Overall Study|Adverse Event|1
6830245|NCT00153062|10833573|FG002|Overall Study|Adverse Event|1
6830246|NCT00153062|10833574|FG003|Overall Study|Adverse Event|0
6830247|NCT00153062|10833571|FG000|Overall Study|Protocol Violation|0
6830248|NCT00153062|10833572|FG001|Overall Study|Protocol Violation|2
6830249|NCT00153062|10833573|FG002|Overall Study|Protocol Violation|1
6830250|NCT00153062|10833574|FG003|Overall Study|Protocol Violation|1
6830251|NCT00153062|10833571|FG000|Overall Study|No disposition data available|1
6830252|NCT00153062|10833572|FG001|Overall Study|No disposition data available|1
6830253|NCT00153062|10833573|FG002|Overall Study|No disposition data available|1
6830254|NCT00153062|10833574|FG003|Overall Study|No disposition data available|1
6830255|NCT00153062|10833571|FG000|Overall Study|Other|0
6830256|NCT00153062|10833572|FG001|Overall Study|Other|0
6830257|NCT00153062|10833573|FG002|Overall Study|Other|1
6830258|NCT00153062|10833574|FG003|Overall Study|Other|0
6830259|NCT00153101|10833589|FG000|Overall Study|Lost to Follow-up|14
6830260|NCT00153101|10833590|FG001|Overall Study|Lost to Follow-up|14
7038626|NCT01704495|11121039|FG000|Subjects Randomized|Discontinuation criteria met|4
7038627|NCT01704495|11121040|FG001|Subjects Randomized|Discontinuation criteria met|2
7038628|NCT01704495|11121041|FG002|Subjects Randomized|Discontinuation criteria met|2
7038629|NCT01704495|11121042|FG003|Subjects Randomized|Discontinuation criteria met|0
7038630|NCT01704495|11121039|FG000|Subjects Randomized|Adverse Event|8
7038631|NCT01704495|11121040|FG001|Subjects Randomized|Adverse Event|2
7038632|NCT01704495|11121041|FG002|Subjects Randomized|Adverse Event|0
7062230|NCT01937130|11159743|FG000|Overall Study|Withdrawal by Subject|0
6830261|NCT00153101|10833591|FG002|Overall Study|Lost to Follow-up|12
6830262|NCT00153101|10833592|FG003|Overall Study|Lost to Follow-up|5
6830263|NCT00153101|10833593|FG004|Overall Study|Lost to Follow-up|5
6830264|NCT00153101|10833589|FG000|Overall Study|Withdrawal by Subject|3
6830265|NCT00153101|10833590|FG001|Overall Study|Withdrawal by Subject|4
6830266|NCT00153101|10833591|FG002|Overall Study|Withdrawal by Subject|3
6830267|NCT00153101|10833592|FG003|Overall Study|Withdrawal by Subject|3
6830268|NCT00153101|10833593|FG004|Overall Study|Withdrawal by Subject|5
6830269|NCT00153179|10833623|FG000|Study Visit Day 2|Withdrawal by Subject|1
6830270|NCT00153179|10833624|FG001|Study Visit Day 2|Withdrawal by Subject|0
6830271|NCT00153179|10833625|FG002|Study Visit Day 2|Withdrawal by Subject|2
6830272|NCT00153179|10833626|FG003|Study Visit Day 2|Withdrawal by Subject|2
7062231|NCT01937130|11159744|FG001|Overall Study|Withdrawal by Subject|0
6830273|NCT00153816|10833652|FG000|Overall Study|Death|6
6830274|NCT00153816|10833653|FG001|Overall Study|Death|5
6830275|NCT00153816|10833654|FG002|Overall Study|Death|4
6830276|NCT00153816|10833655|FG003|Overall Study|Death|6
6830277|NCT00153816|10833656|FG004|Overall Study|Death|0
6830278|NCT00153816|10833657|FG005|Overall Study|Death|2
6830279|NCT00153816|10833652|FG000|Overall Study|Lost to Follow-up|7
6830280|NCT00153816|10833653|FG001|Overall Study|Lost to Follow-up|8
7038633|NCT01704495|11121042|FG003|Subjects Randomized|Adverse Event|7
6830281|NCT00153816|10833654|FG002|Overall Study|Lost to Follow-up|5
6830282|NCT00153816|10833655|FG003|Overall Study|Lost to Follow-up|8
6830283|NCT00153816|10833656|FG004|Overall Study|Lost to Follow-up|7
6830284|NCT00153816|10833657|FG005|Overall Study|Lost to Follow-up|9
6830285|NCT00153816|10833652|FG000|Overall Study|Withdrawal by Subject|9
6830286|NCT00153816|10833653|FG001|Overall Study|Withdrawal by Subject|9
7038634|NCT01704495|11121039|FG000|Subjects Randomized|Withdrawal by Subject|5
6830287|NCT00153816|10833654|FG002|Overall Study|Withdrawal by Subject|9
6830288|NCT00153816|10833655|FG003|Overall Study|Withdrawal by Subject|4
6830289|NCT00153816|10833656|FG004|Overall Study|Withdrawal by Subject|1
6830290|NCT00153816|10833657|FG005|Overall Study|Withdrawal by Subject|5
6830291|NCT00153816|10833652|FG000|Overall Study|Follow-up exam not done|8
6830292|NCT00153816|10833653|FG001|Overall Study|Follow-up exam not done|7
6830293|NCT00153816|10833654|FG002|Overall Study|Follow-up exam not done|11
6830294|NCT00153816|10833655|FG003|Overall Study|Follow-up exam not done|10
6830295|NCT00153816|10833656|FG004|Overall Study|Follow-up exam not done|8
6830296|NCT00153816|10833657|FG005|Overall Study|Follow-up exam not done|9
6830297|NCT00153816|10833652|FG000|Overall Study|Follow-up exam done, histology missing|2
6830298|NCT00153816|10833653|FG001|Overall Study|Follow-up exam done, histology missing|3
6830299|NCT00153816|10833654|FG002|Overall Study|Follow-up exam done, histology missing|3
6830300|NCT00153816|10833655|FG003|Overall Study|Follow-up exam done, histology missing|3
6830301|NCT00153816|10833656|FG004|Overall Study|Follow-up exam done, histology missing|1
6830302|NCT00153816|10833657|FG005|Overall Study|Follow-up exam done, histology missing|2
6830303|NCT00153920|10833682|FG000|Overall Study|Adverse Event|9
6830304|NCT00153920|10833682|FG000|Overall Study|Progressive Disease|9
6830305|NCT00153920|10833682|FG000|Overall Study|Physician Decision|3
6830306|NCT00153920|10833682|FG000|Overall Study|Lack of Response|3
6830307|NCT00153920|10833682|FG000|Overall Study|Death|2
6830308|NCT00153920|10833682|FG000|Overall Study|Withdrawal by Subject|1
6830309|NCT00153920|10833682|FG000|Overall Study|Non-Protocol Therapy|1
6830310|NCT00153920|10833682|FG000|Overall Study|Withdrawal of Consent before Trt|1
6830311|NCT00153920|10833682|FG000|Overall Study|Progressive Disease before Trt|1
6830312|NCT00154063|10833692|FG000|Overall Study|Adverse Event|4
6830313|NCT00154063|10833693|FG001|Overall Study|Adverse Event|8
6830314|NCT00154063|10833692|FG000|Overall Study|Protocol Violation|1
6830315|NCT00154063|10833693|FG001|Overall Study|Protocol Violation|1
6830316|NCT00154063|10833692|FG000|Overall Study|Investigator or Sponsor Request|0
6830317|NCT00154063|10833693|FG001|Overall Study|Investigator or Sponsor Request|1
6830318|NCT00154063|10833692|FG000|Overall Study|Withdrawal by Subject|4
6830319|NCT00154063|10833693|FG001|Overall Study|Withdrawal by Subject|9
6830320|NCT00154063|10833692|FG000|Overall Study|Other|3
6830321|NCT00154063|10833693|FG001|Overall Study|Other|3
6830322|NCT00154102|10833705|FG000|Overall Study|investigational study phase ongoing|7
6830323|NCT00154102|10833706|FG001|Overall Study|investigational study phase ongoing|2
6830324|NCT00154284|10833714|FG000|Overall Study|Adverse Event|6
6830325|NCT00154284|10833715|FG001|Overall Study|Adverse Event|9
6830326|NCT00154284|10833714|FG000|Overall Study|Abnormal laboratory value(s)|0
6830327|NCT00154284|10833715|FG001|Overall Study|Abnormal laboratory value(s)|1
6830328|NCT00154284|10833714|FG000|Overall Study|Lack of Efficacy|1
6830329|NCT00154284|10833715|FG001|Overall Study|Lack of Efficacy|2
6830330|NCT00154284|10833714|FG000|Overall Study|Protocol Violation|0
6830331|NCT00154284|10833715|FG001|Overall Study|Protocol Violation|1
6830332|NCT00154297|10833725|FG000|Overall Study|Death|5
6830333|NCT00154297|10833726|FG001|Overall Study|Death|2
6830334|NCT00154297|10833725|FG000|Overall Study|Withdrawal by Subject|0
6830335|NCT00154297|10833726|FG001|Overall Study|Withdrawal by Subject|5
6830336|NCT00154297|10833725|FG000|Overall Study|Lost to Follow-up|3
6924637|NCT00825825|10954368|FG001|Third Medication Period (14 Days)|Protocol Violation|0
6924638|NCT00825825|10954369|FG002|Third Medication Period (14 Days)|Protocol Violation|0
6924639|NCT00825825|10954370|FG003|Third Medication Period (14 Days)|Protocol Violation|0
6924640|NCT00825825|10954371|FG004|Third Medication Period (14 Days)|Protocol Violation|0
6924641|NCT00825825|10954372|FG005|Third Medication Period (14 Days)|Protocol Violation|2
6924642|NCT00825825|10954367|FG000|Third Medication Period (14 Days)|poor data quality|0
6924643|NCT00825825|10954368|FG001|Third Medication Period (14 Days)|poor data quality|1
6924644|NCT00825825|10954369|FG002|Third Medication Period (14 Days)|poor data quality|0
6924645|NCT00825825|10954370|FG003|Third Medication Period (14 Days)|poor data quality|0
6924646|NCT00825825|10954371|FG004|Third Medication Period (14 Days)|poor data quality|0
6924647|NCT00825825|10954372|FG005|Third Medication Period (14 Days)|poor data quality|0
6924648|NCT00825916|10954382|FG000|Overall Study|Lost to Follow-up|4
6924649|NCT00825916|10954383|FG001|Overall Study|Lost to Follow-up|2
6924650|NCT00825916|10954384|FG002|Overall Study|Lost to Follow-up|1
6924651|NCT00825994|10954425|FG000|Overall Study|Withdrawal by Subject|2
6924652|NCT00825994|10954425|FG000|Overall Study|Lost to Follow-up|1
6924653|NCT00825994|10954425|FG000|Overall Study|Protocol Violation|1
6924654|NCT00825994|10954425|FG000|Overall Study|Placebo Responder at V2|1
6924655|NCT00826111|10954443|FG000|Overall Study|Lost to Follow-up|0
6924656|NCT00826111|10954444|FG001|Overall Study|Lost to Follow-up|1
6924657|NCT00826111|10954443|FG000|Overall Study|Protocol Violation|1
6924658|NCT00826111|10954444|FG001|Overall Study|Protocol Violation|0
6924659|NCT00826111|10954443|FG000|Overall Study|Withdrawal by Subject|5
6924660|NCT00826111|10954444|FG001|Overall Study|Withdrawal by Subject|0
6924661|NCT00826111|10954443|FG000|Overall Study|Physician Decision|1
6924662|NCT00826111|10954444|FG001|Overall Study|Physician Decision|1
6924663|NCT00826176|10954470|FG000|Overall Study|Lost to Follow-up|1
6924664|NCT00826176|10954471|FG001|Overall Study|Lost to Follow-up|0
6924665|NCT00826176|10954470|FG000|Overall Study|Subject Withdrew Consent|3
6830337|NCT00154297|10833726|FG001|Overall Study|Lost to Follow-up|0
6830338|NCT00154310|10833734|FG000|Overall Study|Adverse Event|19
6830339|NCT00154310|10833735|FG001|Overall Study|Adverse Event|9
6830340|NCT00154310|10833734|FG000|Overall Study|Lack of Efficacy|5
6830341|NCT00154310|10833735|FG001|Overall Study|Lack of Efficacy|4
6830342|NCT00154310|10833734|FG000|Overall Study|Protocol Violation|4
6830343|NCT00154310|10833735|FG001|Overall Study|Protocol Violation|2
6830344|NCT00154310|10833734|FG000|Overall Study|Withdrawal by Subject|9
6830345|NCT00154310|10833735|FG001|Overall Study|Withdrawal by Subject|3
6830346|NCT00154310|10833734|FG000|Overall Study|Lost to Follow-up|0
6830347|NCT00154310|10833735|FG001|Overall Study|Lost to Follow-up|8
6830348|NCT00154310|10833734|FG000|Overall Study|Administrative problems|0
6830349|NCT00154310|10833735|FG001|Overall Study|Administrative problems|1
6830350|NCT00154310|10833734|FG000|Overall Study|Death|0
6830351|NCT00154310|10833735|FG001|Overall Study|Death|1
6830352|NCT00154375|10833743|FG000|Overall Study|Unsatisfactory therapeutic effect|25
6830353|NCT00154375|10833744|FG001|Overall Study|Unsatisfactory therapeutic effect|26
6830354|NCT00154375|10833743|FG000|Overall Study|Adverse Event|18
6830355|NCT00154375|10833744|FG001|Overall Study|Adverse Event|20
6830356|NCT00154375|10833743|FG000|Overall Study|Withdrawal by Subject|14
6830357|NCT00154375|10833744|FG001|Overall Study|Withdrawal by Subject|10
6830358|NCT00154375|10833743|FG000|Overall Study|Death|5
6830359|NCT00154375|10833744|FG001|Overall Study|Death|13
6830360|NCT00154375|10833743|FG000|Overall Study|Study drug no longer required|5
6830361|NCT00154375|10833744|FG001|Overall Study|Study drug no longer required|3
6830362|NCT00154375|10833743|FG000|Overall Study|Lost to Follow-up|2
6830363|NCT00154375|10833744|FG001|Overall Study|Lost to Follow-up|1
6830364|NCT00154375|10833743|FG000|Overall Study|Abnormal laboratory value(s)|0
6830365|NCT00154375|10833744|FG001|Overall Study|Abnormal laboratory value(s)|2
6830366|NCT00154375|10833743|FG000|Overall Study|Protocol Violation|0
6830367|NCT00154375|10833744|FG001|Overall Study|Protocol Violation|1
6830368|NCT00154375|10833743|FG000|Overall Study|Suspected progression of disease|44
6830369|NCT00154375|10833744|FG001|Overall Study|Suspected progression of disease|30
6830370|NCT00156533|10833790|FG000|Overall Study|Withdrawn - Medication Expiration|0
6830371|NCT00156533|10833791|FG001|Overall Study|Withdrawn - Medication Expiration|2
6830372|NCT00156533|10833792|FG002|Overall Study|Withdrawn - Medication Expiration|1
6830373|NCT00156533|10833793|FG003|Overall Study|Withdrawn - Medication Expiration|0
6830374|NCT00156533|10833790|FG000|Overall Study|Withdrawal by Subject|1
6830375|NCT00156533|10833791|FG001|Overall Study|Withdrawal by Subject|0
6830376|NCT00156533|10833792|FG002|Overall Study|Withdrawal by Subject|0
6830377|NCT00156533|10833793|FG003|Overall Study|Withdrawal by Subject|1
6830378|NCT00156533|10833790|FG000|Overall Study|Failed Screening|1
6830379|NCT00156533|10833791|FG001|Overall Study|Failed Screening|0
6830380|NCT00156533|10833792|FG002|Overall Study|Failed Screening|1
6830381|NCT00156533|10833793|FG003|Overall Study|Failed Screening|1
6830382|NCT00156819|10833812|FG000|Overall Study|Lost to Follow-up|1
6830383|NCT00156819|10833813|FG001|Overall Study|Lost to Follow-up|1
6830384|NCT00156819|10833814|FG002|Overall Study|Lost to Follow-up|3
6830385|NCT00157014|10833853|FG000|Overall Study|Death|4
6830386|NCT00157014|10833854|FG001|Overall Study|Death|2
6830387|NCT00157014|10833855|FG002|Overall Study|Death|1
6830388|NCT00157014|10833856|FG003|Overall Study|Death|1
6830389|NCT00157014|10833853|FG000|Overall Study|Physician Decision|0
6830390|NCT00157014|10833854|FG001|Overall Study|Physician Decision|1
6830391|NCT00157014|10833855|FG002|Overall Study|Physician Decision|0
6830392|NCT00157014|10833856|FG003|Overall Study|Physician Decision|0
6830393|NCT00157014|10833853|FG000|Overall Study|Medications withdrawn on family request|0
6830394|NCT00157014|10833854|FG001|Overall Study|Medications withdrawn on family request|1
6830395|NCT00157014|10833855|FG002|Overall Study|Medications withdrawn on family request|0
6830396|NCT00157014|10833856|FG003|Overall Study|Medications withdrawn on family request|0
6830397|NCT00157014|10833853|FG000|Overall Study|Patient withdrawn by investigator|1
6830398|NCT00157014|10833854|FG001|Overall Study|Patient withdrawn by investigator|0
6830399|NCT00157014|10833855|FG002|Overall Study|Patient withdrawn by investigator|0
6830400|NCT00157014|10833856|FG003|Overall Study|Patient withdrawn by investigator|0
6830401|NCT00157014|10833853|FG000|Overall Study|Patient unable to return in nursing home|1
6830402|NCT00157014|10833854|FG001|Overall Study|Patient unable to return in nursing home|0
6830403|NCT00157014|10833855|FG002|Overall Study|Patient unable to return in nursing home|0
6830404|NCT00157014|10833856|FG003|Overall Study|Patient unable to return in nursing home|0
6830405|NCT00157014|10833853|FG000|Overall Study|Patient would not receive transplant|0
6830406|NCT00157014|10833854|FG001|Overall Study|Patient would not receive transplant|1
6830407|NCT00157014|10833855|FG002|Overall Study|Patient would not receive transplant|0
6830408|NCT00157014|10833856|FG003|Overall Study|Patient would not receive transplant|0
6830409|NCT00157014|10833853|FG000|Overall Study|Withdrawal by Subject|1
6830410|NCT00157014|10833854|FG001|Overall Study|Withdrawal by Subject|0
6830411|NCT00157014|10833855|FG002|Overall Study|Withdrawal by Subject|0
6830412|NCT00157014|10833856|FG003|Overall Study|Withdrawal by Subject|0
6830413|NCT00157157|10833866|FG000|Overall Study|Withdrawal by Subject|6
6830414|NCT00157157|10833866|FG000|Overall Study|Physician Decision|1
6830415|NCT00157157|10833866|FG000|Overall Study|Lost to Follow-up|1
6830416|NCT00157157|10833866|FG000|Overall Study|Enrolled in another study|1
6830417|NCT00157157|10833866|FG000|Overall Study|Met exclusion criteria|1
6830418|NCT00157157|10833866|FG000|Overall Study|Inclusion not met- baseline FVIII value|1
6830419|NCT00157196|10833877|FG000|Overall Study|Ongoing at data cut-off|9
6830420|NCT00157209|10833883|FG000|Overall Study|Ongoing at data cut-off|10
7038635|NCT01704495|11121040|FG001|Subjects Randomized|Withdrawal by Subject|5
7038636|NCT01704495|11121041|FG002|Subjects Randomized|Withdrawal by Subject|5
7038637|NCT01704495|11121042|FG003|Subjects Randomized|Withdrawal by Subject|5
7038638|NCT01704495|11121039|FG000|Subjects Randomized|Protocol Violation|1
7038639|NCT01704495|11121040|FG001|Subjects Randomized|Protocol Violation|1
6830421|NCT00157209|10833884|FG001|Overall Study|Ongoing at data cut-off|0
6897118|NCT00636792|10915815|FG000|Overall Study|Progressive Disease|4
6897119|NCT00636792|10915815|FG000|Overall Study|Withdrawal by Subject|3
6897120|NCT00636792|10915815|FG000|Overall Study|Other|3
6897121|NCT00636818|10915823|FG000|Overall Study|Adverse Event|1
6897122|NCT00636818|10915823|FG000|Overall Study|Lost to Follow-up|2
6897123|NCT00636818|10915823|FG000|Overall Study|Entry Criteria Exclusion|3
6897124|NCT00636818|10915823|FG000|Overall Study|Protocol Violation|1
6897125|NCT00636818|10915823|FG000|Overall Study|Withdrawal by Subject|4
6897126|NCT00636961|10915829|FG000|Period 1|Administrative problems|1
6897127|NCT00636961|10915830|FG001|Period 1|Administrative problems|1
6897128|NCT00636961|10915829|FG000|Period 2|Adverse Event|1
6897129|NCT00636961|10915830|FG001|Period 2|Adverse Event|0
6897130|NCT00636987|10915836|FG000|Overall Study|Death|44
6897131|NCT00636987|10915836|FG000|Overall Study|Explanted|13
6897132|NCT00636987|10915836|FG000|Overall Study|Lost to Follow-up|63
6897133|NCT00636987|10915836|FG000|Overall Study|5 year visit window not complete|69
6897134|NCT00637000|10915846|FG000|Overall Study|Withdrawal by Subject|4
6897135|NCT00637000|10915847|FG001|Overall Study|Withdrawal by Subject|3
6897136|NCT00637156|10915855|FG000|Overall Study|Withdrawal by Subject|0
6897137|NCT00637156|10915856|FG001|Overall Study|Withdrawal by Subject|7
6897138|NCT00637156|10915855|FG000|Overall Study|Death|0
6897139|NCT00637156|10915856|FG001|Overall Study|Death|1
6897140|NCT00637156|10915855|FG000|Overall Study|Lost to Follow-up|10
6897141|NCT00637156|10915856|FG001|Overall Study|Lost to Follow-up|16
6897142|NCT00637195|10915864|FG000|Overall Study|Lost to Follow-up|1
6897143|NCT00637195|10915865|FG001|Overall Study|Lost to Follow-up|0
6897144|NCT00637195|10915864|FG000|Overall Study|Other|2
6897145|NCT00637195|10915865|FG001|Overall Study|Other|0
6897146|NCT00637195|10915864|FG000|Overall Study|Withdrawal by Subject|0
6924666|NCT00826176|10954471|FG001|Overall Study|Subject Withdrew Consent|0
6924667|NCT00826176|10954470|FG000|Overall Study|Administrative|9
6924668|NCT00826176|10954471|FG001|Overall Study|Administrative|0
6924669|NCT00826228|10954486|FG000|Overall Study|Withdrawal by Subject|1
6924670|NCT00826241|10954491|FG000|Overall Study|Withdrawal from Follow-up|1
6924671|NCT00826241|10954491|FG000|Overall Study|Withdrew consent|2
6924672|NCT00826241|10954491|FG000|Overall Study|Death|4
6924673|NCT00826241|10954491|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1
6924674|NCT00826241|10954491|FG000|Overall Study|Non-compliance|1
6924675|NCT00826241|10954491|FG000|Overall Study|Progression of disease|1
6924676|NCT00826241|10954491|FG000|Overall Study|Patient refused follow-up|3
6924677|NCT00826241|10954491|FG000|Overall Study|Lost to Follow-up|9
6924678|NCT00826241|10954491|FG000|Overall Study|Could not obtain records|1
6924679|NCT00826241|10954491|FG000|Overall Study|Screen failure|2
6924680|NCT00826241|10954491|FG000|Overall Study|Pt unable to proceed to registration|1
6924681|NCT00826241|10954491|FG000|Overall Study|Pt opt not to proceed w/trmt|1
6924682|NCT00826267|10954498|FG000|Overall Study|Other Adverse Event|1
6924683|NCT00826267|10954499|FG001|Overall Study|Other Adverse Event|0
6924684|NCT00826267|10954500|FG002|Overall Study|Other Adverse Event|0
6924685|NCT00826280|10954512|FG000|Overall Study|Randomized but drug not received|1
6924686|NCT00826280|10954513|FG001|Overall Study|Randomized but drug not received|0
6924687|NCT00826280|10954514|FG002|Overall Study|Randomized but drug not received|1
6924688|NCT00826280|10954512|FG000|Overall Study|Adverse Event|1
6924689|NCT00826280|10954513|FG001|Overall Study|Adverse Event|3
6924690|NCT00826280|10954514|FG002|Overall Study|Adverse Event|0
6924691|NCT00826280|10954512|FG000|Overall Study|Lost to Follow-up|0
6924692|NCT00826280|10954513|FG001|Overall Study|Lost to Follow-up|1
6924693|NCT00826280|10954514|FG002|Overall Study|Lost to Follow-up|0
6924694|NCT00826280|10954512|FG000|Overall Study|Sponsor discontinued subject or study|1
6924695|NCT00826280|10954513|FG001|Overall Study|Sponsor discontinued subject or study|0
6924696|NCT00826280|10954514|FG002|Overall Study|Sponsor discontinued subject or study|0
6924697|NCT00826280|10954512|FG000|Overall Study|Reversible ischemic defect not present|43
6924698|NCT00826280|10954513|FG001|Overall Study|Reversible ischemic defect not present|40
6924699|NCT00826280|10954514|FG002|Overall Study|Reversible ischemic defect not present|44
6924700|NCT00826280|10954512|FG000|Overall Study|Interpretation Failure|1
6924701|NCT00826280|10954513|FG001|Overall Study|Interpretation Failure|0
6924702|NCT00826280|10954514|FG002|Overall Study|Interpretation Failure|0
6924703|NCT00826280|10954512|FG000|Overall Study|Machine Failure|1
6924704|NCT00826280|10954513|FG001|Overall Study|Machine Failure|1
6924705|NCT00826280|10954514|FG002|Overall Study|Machine Failure|0
6924706|NCT00826280|10954512|FG000|Overall Study|One or more non-interpretable scan|0
6924707|NCT00826280|10954513|FG001|Overall Study|One or more non-interpretable scan|1
7038640|NCT01704495|11121041|FG002|Subjects Randomized|Protocol Violation|2
6897147|NCT00637195|10915865|FG001|Overall Study|Withdrawal by Subject|1
6897148|NCT00637273|10915885|FG000|Overall Study|Adverse Event|11
6897149|NCT00637273|10915886|FG001|Overall Study|Adverse Event|5
6897150|NCT00637273|10915887|FG002|Overall Study|Adverse Event|7
7038641|NCT01704495|11121042|FG003|Subjects Randomized|Protocol Violation|0
7038642|NCT01704495|11121039|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1
7038643|NCT01704495|11121040|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3
7038644|NCT01704495|11121041|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4
6830422|NCT00157248|10833894|FG000|Overall Study|Adverse Event|36
6830423|NCT00157248|10833895|FG001|Overall Study|Adverse Event|25
6830424|NCT00157248|10833896|FG002|Overall Study|Adverse Event|13
6830425|NCT00157248|10833897|FG003|Overall Study|Adverse Event|33
6830426|NCT00157248|10833894|FG000|Overall Study|Protocol Violation|4
6830427|NCT00157248|10833895|FG001|Overall Study|Protocol Violation|0
6830428|NCT00157248|10833896|FG002|Overall Study|Protocol Violation|2
6830429|NCT00157248|10833897|FG003|Overall Study|Protocol Violation|2
6830430|NCT00157248|10833894|FG000|Overall Study|Lost to Follow-up|0
6830431|NCT00157248|10833895|FG001|Overall Study|Lost to Follow-up|1
6830432|NCT00157248|10833896|FG002|Overall Study|Lost to Follow-up|0
6830433|NCT00157248|10833897|FG003|Overall Study|Lost to Follow-up|0
6830434|NCT00157248|10833894|FG000|Overall Study|Withdrawal by Subject|1
6830435|NCT00157248|10833895|FG001|Overall Study|Withdrawal by Subject|4
6830436|NCT00157248|10833896|FG002|Overall Study|Withdrawal by Subject|3
6830437|NCT00157248|10833897|FG003|Overall Study|Withdrawal by Subject|3
6830438|NCT00157248|10833894|FG000|Overall Study|site closures, subject moving|7
6830439|NCT00157248|10833895|FG001|Overall Study|site closures, subject moving|7
6830440|NCT00157248|10833896|FG002|Overall Study|site closures, subject moving|3
6830441|NCT00157248|10833897|FG003|Overall Study|site closures, subject moving|9
6830442|NCT00157755|10833919|FG000|Overall Study|Death|2
6830443|NCT00157755|10833920|FG001|Overall Study|Death|3
6830444|NCT00157755|10833921|FG002|Overall Study|Death|3
6830445|NCT00157755|10833922|FG003|Overall Study|Death|2
6830446|NCT00157755|10833923|FG004|Overall Study|Death|0
6830447|NCT00157755|10833924|FG005|Overall Study|Death|0
6830448|NCT00157755|10833919|FG000|Overall Study|Lost to Follow-up|0
6830449|NCT00157755|10833920|FG001|Overall Study|Lost to Follow-up|0
6830450|NCT00157755|10833921|FG002|Overall Study|Lost to Follow-up|1
6830451|NCT00157755|10833922|FG003|Overall Study|Lost to Follow-up|0
6830452|NCT00157755|10833923|FG004|Overall Study|Lost to Follow-up|0
6830453|NCT00157755|10833924|FG005|Overall Study|Lost to Follow-up|0
6830454|NCT00157755|10833919|FG000|Overall Study|Withdrawal by Subject|0
6830455|NCT00157755|10833920|FG001|Overall Study|Withdrawal by Subject|0
6830456|NCT00157755|10833921|FG002|Overall Study|Withdrawal by Subject|1
6830457|NCT00157755|10833922|FG003|Overall Study|Withdrawal by Subject|1
6830458|NCT00157755|10833923|FG004|Overall Study|Withdrawal by Subject|1
6830459|NCT00157755|10833924|FG005|Overall Study|Withdrawal by Subject|2
6830460|NCT00157755|10833919|FG000|Overall Study|Explant due to infection|0
6830461|NCT00157755|10833920|FG001|Overall Study|Explant due to infection|0
6830462|NCT00157755|10833921|FG002|Overall Study|Explant due to infection|1
6830463|NCT00157755|10833922|FG003|Overall Study|Explant due to infection|0
6830464|NCT00157755|10833923|FG004|Overall Study|Explant due to infection|0
6830465|NCT00157755|10833924|FG005|Overall Study|Explant due to infection|0
6830466|NCT00157755|10833919|FG000|Overall Study|Medical reason|0
6830467|NCT00157755|10833920|FG001|Overall Study|Medical reason|0
6830468|NCT00157755|10833921|FG002|Overall Study|Medical reason|1
6830469|NCT00157755|10833922|FG003|Overall Study|Medical reason|1
6830470|NCT00157755|10833923|FG004|Overall Study|Medical reason|0
6830471|NCT00157755|10833924|FG005|Overall Study|Medical reason|0
6830472|NCT00157755|10833919|FG000|Overall Study|Study site closure|0
6830473|NCT00157755|10833920|FG001|Overall Study|Study site closure|1
6830474|NCT00157755|10833921|FG002|Overall Study|Study site closure|0
6830475|NCT00157755|10833922|FG003|Overall Study|Study site closure|0
6830476|NCT00157755|10833923|FG004|Overall Study|Study site closure|0
6830477|NCT00157755|10833924|FG005|Overall Study|Study site closure|0
6830478|NCT00157755|10833919|FG000|Overall Study|Subject non-compliance|0
6830479|NCT00157755|10833920|FG001|Overall Study|Subject non-compliance|0
6830480|NCT00157755|10833921|FG002|Overall Study|Subject non-compliance|0
6830481|NCT00157755|10833922|FG003|Overall Study|Subject non-compliance|0
6830482|NCT00157755|10833923|FG004|Overall Study|Subject non-compliance|0
6830483|NCT00157755|10833924|FG005|Overall Study|Subject non-compliance|1
6830484|NCT00157755|10833919|FG000|Overall Study|Study completion|0
6830485|NCT00157755|10833920|FG001|Overall Study|Study completion|0
6830486|NCT00157755|10833921|FG002|Overall Study|Study completion|0
6830487|NCT00157755|10833922|FG003|Overall Study|Study completion|0
6830488|NCT00157755|10833923|FG004|Overall Study|Study completion|1
6830489|NCT00157755|10833924|FG005|Overall Study|Study completion|2
6830490|NCT00157820|10833933|FG000|Randomized|Physician Decision|4
6830491|NCT00157820|10833934|FG001|Randomized|Physician Decision|2
6830492|NCT00157820|10833935|FG002|Randomized|Physician Decision|3
6830493|NCT00157820|10833933|FG000|Randomized|Withdrawal by Subject|1
6830494|NCT00157820|10833934|FG001|Randomized|Withdrawal by Subject|2
6830495|NCT00157820|10833935|FG002|Randomized|Withdrawal by Subject|3
6830496|NCT00157820|10833933|FG000|Randomized|Protocol Violation|2
6830497|NCT00157820|10833934|FG001|Randomized|Protocol Violation|1
6830498|NCT00157820|10833935|FG002|Randomized|Protocol Violation|2
6830499|NCT00157820|10833933|FG000|1st 8 Month|Death|7
6830500|NCT00157820|10833934|FG001|1st 8 Month|Death|8
6830501|NCT00157820|10833935|FG002|1st 8 Month|Death|3
6830502|NCT00157820|10833933|FG000|1st 8 Month|Lost to Follow-up|1
6830503|NCT00157820|10833934|FG001|1st 8 Month|Lost to Follow-up|2
6830504|NCT00157820|10833935|FG002|1st 8 Month|Lost to Follow-up|1
6830505|NCT00157820|10833933|FG000|1st 8 Month|Premature cross-over|0
6830506|NCT00157820|10833934|FG001|1st 8 Month|Premature cross-over|2
6830507|NCT00157820|10833935|FG002|1st 8 Month|Premature cross-over|2
6830508|NCT00157820|10833933|FG000|2nd 8 Months|Death|3
6830509|NCT00157820|10833934|FG001|2nd 8 Months|Death|1
6830510|NCT00157820|10833935|FG002|2nd 8 Months|Death|3
6830511|NCT00157820|10833933|FG000|2nd 8 Months|Lost to Follow-up|1
6830512|NCT00157820|10833934|FG001|2nd 8 Months|Lost to Follow-up|5
6830513|NCT00157820|10833935|FG002|2nd 8 Months|Lost to Follow-up|2
6830514|NCT00157820|10833933|FG000|2nd 8 Months|Premature cross-over|1
6830515|NCT00157820|10833934|FG001|2nd 8 Months|Premature cross-over|7
6830516|NCT00157820|10833935|FG002|2nd 8 Months|Premature cross-over|9
6830517|NCT00157950|10833946|FG000|Overall Study|Death|1
6830518|NCT00157950|10833947|FG001|Overall Study|Death|0
6830519|NCT00158054|10833955|FG000|Overall Study|Refused to continue|3
6830520|NCT00158054|10833956|FG001|Overall Study|Refused to continue|0
6830521|NCT00158054|10833955|FG000|Overall Study|Unavailable for follow up|7
6830522|NCT00158054|10833956|FG001|Overall Study|Unavailable for follow up|3
6830523|NCT00158184|10833964|FG000|Overall Study|personal issues|3
6830524|NCT00158184|10833965|FG001|Overall Study|personal issues|1
6830525|NCT00158184|10833964|FG000|Overall Study|failed for follow unit/study rules|2
6830526|NCT00158184|10833965|FG001|Overall Study|failed for follow unit/study rules|0
6830527|NCT00158184|10833964|FG000|Overall Study|Adverse Event|1
6830528|NCT00158184|10833965|FG001|Overall Study|Adverse Event|1
6830529|NCT00158262|10834010|FG000|Overall Study|Lost to Follow-up|1
6830530|NCT00158262|10834011|FG001|Overall Study|Lost to Follow-up|1
6830531|NCT00158600|10834023|FG000|Overall Study|unable to commit time to study|0
6830532|NCT00158600|10834024|FG001|Overall Study|unable to commit time to study|1
6830533|NCT00158600|10834023|FG000|Overall Study|Adverse Event|2
6830534|NCT00158600|10834024|FG001|Overall Study|Adverse Event|1
7038645|NCT01704495|11121042|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3
7038646|NCT01704495|11121039|FG000|Optional Safety Extension|Adverse Event|0
7038647|NCT01704495|11121040|FG001|Optional Safety Extension|Adverse Event|4
6830535|NCT00158600|10834023|FG000|Overall Study|Death|1
6830536|NCT00158600|10834024|FG001|Overall Study|Death|0
6830537|NCT00158600|10834023|FG000|Overall Study|Withdrawal by Subject|2
6830538|NCT00158600|10834024|FG001|Overall Study|Withdrawal by Subject|2
6830539|NCT00158756|10834045|FG000|Overall Study|Withdrawal by Subject|5
6830540|NCT00158756|10834046|FG001|Overall Study|Withdrawal by Subject|0
6830541|NCT00158756|10834047|FG002|Overall Study|Withdrawal by Subject|6
6830542|NCT00158756|10834048|FG003|Overall Study|Withdrawal by Subject|1
6830543|NCT00158756|10834049|FG004|Overall Study|Withdrawal by Subject|3
6830544|NCT00158756|10834045|FG000|Overall Study|Adverse Event|0
6830545|NCT00158756|10834046|FG001|Overall Study|Adverse Event|0
6830546|NCT00158756|10834047|FG002|Overall Study|Adverse Event|1
6924708|NCT00826280|10954514|FG002|Overall Study|One or more non-interpretable scan|1
6924709|NCT00826449|10954524|FG000|Overall Study|Disease Progression|4
6924710|NCT00826449|10954524|FG000|Overall Study|Withdrawal by Subject|1
6924711|NCT00826514|10954531|FG000|Overall Study|Adverse Event|1
6924712|NCT00826514|10954532|FG001|Overall Study|Adverse Event|1
6924713|NCT00826514|10954531|FG000|Overall Study|Lack of Efficacy|0
6924714|NCT00826514|10954532|FG001|Overall Study|Lack of Efficacy|1
6924715|NCT00826514|10954531|FG000|Overall Study|Withdrawal by Subject|2
6924716|NCT00826514|10954532|FG001|Overall Study|Withdrawal by Subject|3
6924717|NCT00826540|10954538|FG000|Overall Study|ineligible|3
6924718|NCT00826540|10954538|FG000|Overall Study|Withdrawal by Subject|1
6924719|NCT00826618|10954542|FG000|Overall Study|Withdrawal by Subject|1
6924720|NCT00826748|10954549|FG000|Overall Study|Withdrawal by Subject|0
6924721|NCT00826748|10954550|FG001|Overall Study|Withdrawal by Subject|0
6924722|NCT00826748|10954551|FG002|Overall Study|Withdrawal by Subject|2
6924723|NCT00826748|10954549|FG000|Overall Study|Physician Decision|0
6924724|NCT00826748|10954550|FG001|Overall Study|Physician Decision|0
6924725|NCT00826748|10954551|FG002|Overall Study|Physician Decision|1
6924726|NCT00826748|10954549|FG000|Overall Study|Samples Did Not pass QC|0
6924727|NCT00826748|10954550|FG001|Overall Study|Samples Did Not pass QC|0
6924728|NCT00826748|10954551|FG002|Overall Study|Samples Did Not pass QC|1
6924729|NCT00826943|10954563|FG000|Overall Study|Withdrawal by Subject|0
6924730|NCT00826943|10954564|FG001|Overall Study|Withdrawal by Subject|0
6924731|NCT00826943|10954565|FG002|Overall Study|Withdrawal by Subject|0
6924732|NCT00826943|10954566|FG003|Overall Study|Withdrawal by Subject|0
6924733|NCT00826943|10954567|FG004|Overall Study|Withdrawal by Subject|1
6830547|NCT00158756|10834048|FG003|Overall Study|Adverse Event|0
6830548|NCT00158756|10834049|FG004|Overall Study|Adverse Event|0
6830549|NCT00158756|10834045|FG000|Overall Study|Serious adverse event|0
6830550|NCT00158756|10834046|FG001|Overall Study|Serious adverse event|0
6830551|NCT00158756|10834047|FG002|Overall Study|Serious adverse event|1
6830552|NCT00158756|10834048|FG003|Overall Study|Serious adverse event|0
6830553|NCT00158756|10834049|FG004|Overall Study|Serious adverse event|0
6830554|NCT00158860|10834063|FG000|Overall Study|Adverse Event|3
6830555|NCT00158860|10834064|FG001|Overall Study|Adverse Event|6
6830556|NCT00158860|10834063|FG000|Overall Study|Lost to Follow-up|11
6830557|NCT00158860|10834064|FG001|Overall Study|Lost to Follow-up|17
6830558|NCT00158860|10834063|FG000|Overall Study|Protocol Violation|8
6830559|NCT00158860|10834064|FG001|Overall Study|Protocol Violation|23
6830560|NCT00158860|10834063|FG000|Overall Study|Withdrawal by Subject|7
6830561|NCT00158860|10834064|FG001|Overall Study|Withdrawal by Subject|17
6830562|NCT00158860|10834063|FG000|Overall Study|MOVING OUT OF STATE|1
6830563|NCT00158860|10834064|FG001|Overall Study|MOVING OUT OF STATE|0
6830564|NCT00158860|10834063|FG000|Overall Study|Pregnancy|3
6830565|NCT00158860|10834064|FG001|Overall Study|Pregnancy|3
6830566|NCT00158860|10834063|FG000|Overall Study|SPONSOR STOPPED STUDY|2
6830567|NCT00158860|10834064|FG001|Overall Study|SPONSOR STOPPED STUDY|2
6830568|NCT00158860|10834063|FG000|Overall Study|SPONSOR REQUEST|0
6830569|NCT00158860|10834064|FG001|Overall Study|SPONSOR REQUEST|1
6830570|NCT00158860|10834063|FG000|Overall Study|Lost to Follow up but returned per GSK|0
6830571|NCT00158860|10834064|FG001|Overall Study|Lost to Follow up but returned per GSK|1
6830572|NCT00158860|10834063|FG000|Overall Study|Closed per sponsor|0
6830573|NCT00158860|10834064|FG001|Overall Study|Closed per sponsor|1
6830574|NCT00159432|10834112|FG000|Overall Study|Adverse Event|1
6830575|NCT00159432|10834112|FG000|Overall Study|Death|1
6830576|NCT00159432|10834112|FG000|Overall Study|Lack of Efficacy|8
6830577|NCT00159822|10834116|FG000|Voriconazole Treatment Period|Lack of Efficacy|3
6830578|NCT00159822|10834116|FG000|Voriconazole Treatment Period|Adverse Event|9
6830579|NCT00159822|10834116|FG000|Voriconazole Treatment Period|Death|4
6830580|NCT00159822|10834116|FG000|Voriconazole Treatment Period|Protocol Violation|2
6830581|NCT00159822|10834116|FG000|Voriconazole Treatment Period|Lost to Follow-up|2
6830582|NCT00159822|10834116|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2
6830583|NCT00159822|10834116|FG000|Post-treatment Follow-up Period|Death|1
6830584|NCT00159822|10834116|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1
6830585|NCT00159822|10834116|FG000|Post-treatment Follow-up Period|Reason unspecified|1
6830586|NCT00159861|10834122|FG000|Core Study - 16 Weeks|Death|3
6830587|NCT00159861|10834123|FG001|Core Study - 16 Weeks|Death|0
6830588|NCT00159861|10834122|FG000|Core Study - 16 Weeks|Adverse Event|12
6830589|NCT00159861|10834123|FG001|Core Study - 16 Weeks|Adverse Event|6
6830590|NCT00159861|10834122|FG000|Core Study - 16 Weeks|Lack of Efficacy|2
6830591|NCT00159861|10834123|FG001|Core Study - 16 Weeks|Lack of Efficacy|3
6830592|NCT00159861|10834122|FG000|Core Study - 16 Weeks|Reason Unspecified|5
6830593|NCT00159861|10834123|FG001|Core Study - 16 Weeks|Reason Unspecified|3
6830594|NCT00159861|10834122|FG000|Core Study - 16 Weeks|Subject Defaulted|1
6830595|NCT00159861|10834123|FG001|Core Study - 16 Weeks|Subject Defaulted|0
6830596|NCT00159861|10834122|FG000|Core Study - 16 Weeks|Randomized but not Treated|2
6830597|NCT00159861|10834123|FG001|Core Study - 16 Weeks|Randomized but not Treated|0
6830598|NCT00159861|10834122|FG000|Extension Study - up to 3 Years|Death|24
6830599|NCT00159861|10834123|FG001|Extension Study - up to 3 Years|Death|28
6830600|NCT00159861|10834122|FG000|Extension Study - up to 3 Years|Adverse Event|14
6830601|NCT00159861|10834123|FG001|Extension Study - up to 3 Years|Adverse Event|14
6830602|NCT00159861|10834122|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5
6830603|NCT00159861|10834123|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1
6830604|NCT00159861|10834122|FG000|Extension Study - up to 3 Years|Reason Unspecified|12
6830605|NCT00159861|10834123|FG001|Extension Study - up to 3 Years|Reason Unspecified|19
6830606|NCT00159861|10834122|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7
6830607|NCT00159861|10834123|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9
6830608|NCT00159874|10834141|FG000|Overall Study|Adverse Event|2
6830609|NCT00159874|10834142|FG001|Overall Study|Adverse Event|2
6830610|NCT00159874|10834143|FG002|Overall Study|Adverse Event|5
6830611|NCT00159874|10834144|FG003|Overall Study|Adverse Event|1
6830612|NCT00159874|10834145|FG004|Overall Study|Adverse Event|1
6924734|NCT00826943|10954568|FG005|Overall Study|Withdrawal by Subject|0
6924735|NCT00827112|10954591|FG000|Overall Study|Adverse Event|2
6924736|NCT00827112|10954592|FG001|Overall Study|Adverse Event|0
6924737|NCT00827112|10954591|FG000|Overall Study|Lack of Efficacy|2
6924738|NCT00827112|10954592|FG001|Overall Study|Lack of Efficacy|0
6924739|NCT00827112|10954591|FG000|Overall Study|Lost to Follow-up|3
6924740|NCT00827112|10954592|FG001|Overall Study|Lost to Follow-up|2
6924741|NCT00827112|10954591|FG000|Overall Study|Pregnancy|0
6924742|NCT00827112|10954592|FG001|Overall Study|Pregnancy|1
6924743|NCT00827112|10954591|FG000|Overall Study|Protocol Violation|0
6924744|NCT00827112|10954592|FG001|Overall Study|Protocol Violation|2
6924745|NCT00827112|10954591|FG000|Overall Study|Withdrawal by Subject|2
6924746|NCT00827112|10954592|FG001|Overall Study|Withdrawal by Subject|1
6924747|NCT00827112|10954591|FG000|Overall Study|Randomized but not treated|5
6924748|NCT00827112|10954592|FG001|Overall Study|Randomized but not treated|3
6924749|NCT00827112|10954591|FG000|Overall Study|Other|1
6924750|NCT00827112|10954592|FG001|Overall Study|Other|3
6924751|NCT00827242|10954600|FG000|Overall Study|Withdrawal by Subject|2
6830613|NCT00159874|10834146|FG005|Overall Study|Adverse Event|2
6830614|NCT00159874|10834147|FG006|Overall Study|Adverse Event|0
6830615|NCT00159874|10834141|FG000|Overall Study|Does Not Meet Entrance Criteria|1
6830616|NCT00159874|10834142|FG001|Overall Study|Does Not Meet Entrance Criteria|0
6830617|NCT00159874|10834143|FG002|Overall Study|Does Not Meet Entrance Criteria|1
6830618|NCT00159874|10834144|FG003|Overall Study|Does Not Meet Entrance Criteria|0
6830619|NCT00159874|10834145|FG004|Overall Study|Does Not Meet Entrance Criteria|0
6830620|NCT00159874|10834146|FG005|Overall Study|Does Not Meet Entrance Criteria|0
6830621|NCT00159874|10834147|FG006|Overall Study|Does Not Meet Entrance Criteria|0
6830622|NCT00159874|10834141|FG000|Overall Study|Lack of Efficacy|2
7038648|NCT01704495|11121041|FG002|Optional Safety Extension|Adverse Event|0
7038649|NCT01704495|11121042|FG003|Optional Safety Extension|Adverse Event|1
7038650|NCT01704495|11121039|FG000|Optional Safety Extension|Other reason|27
6830623|NCT00159874|10834142|FG001|Overall Study|Lack of Efficacy|0
6830624|NCT00159874|10834143|FG002|Overall Study|Lack of Efficacy|1
6830625|NCT00159874|10834144|FG003|Overall Study|Lack of Efficacy|1
6830626|NCT00159874|10834145|FG004|Overall Study|Lack of Efficacy|0
6830627|NCT00159874|10834146|FG005|Overall Study|Lack of Efficacy|3
6830628|NCT00159874|10834147|FG006|Overall Study|Lack of Efficacy|0
6830629|NCT00159874|10834141|FG000|Overall Study|Lost to Follow-up|1
6830630|NCT00159874|10834142|FG001|Overall Study|Lost to Follow-up|0
6830631|NCT00159874|10834143|FG002|Overall Study|Lost to Follow-up|3
6830632|NCT00159874|10834144|FG003|Overall Study|Lost to Follow-up|0
6830633|NCT00159874|10834145|FG004|Overall Study|Lost to Follow-up|1
6830634|NCT00159874|10834146|FG005|Overall Study|Lost to Follow-up|2
6830635|NCT00159874|10834147|FG006|Overall Study|Lost to Follow-up|1
6830636|NCT00159874|10834141|FG000|Overall Study|Other|8
6830637|NCT00159874|10834142|FG001|Overall Study|Other|8
6830638|NCT00159874|10834143|FG002|Overall Study|Other|8
6830639|NCT00159874|10834144|FG003|Overall Study|Other|0
6830640|NCT00159874|10834145|FG004|Overall Study|Other|2
6830641|NCT00159874|10834146|FG005|Overall Study|Other|1
6830642|NCT00159874|10834147|FG006|Overall Study|Other|3
6830643|NCT00159874|10834141|FG000|Overall Study|Protocol Violation|0
6830644|NCT00159874|10834142|FG001|Overall Study|Protocol Violation|5
6830645|NCT00159874|10834143|FG002|Overall Study|Protocol Violation|2
6830646|NCT00159874|10834144|FG003|Overall Study|Protocol Violation|0
6830647|NCT00159874|10834145|FG004|Overall Study|Protocol Violation|0
6830648|NCT00159874|10834146|FG005|Overall Study|Protocol Violation|0
6830649|NCT00159874|10834147|FG006|Overall Study|Protocol Violation|0
6830650|NCT00159874|10834141|FG000|Overall Study|Death|3
6830651|NCT00159874|10834142|FG001|Overall Study|Death|8
6830652|NCT00159874|10834143|FG002|Overall Study|Death|15
6830653|NCT00159874|10834144|FG003|Overall Study|Death|0
6830654|NCT00159874|10834145|FG004|Overall Study|Death|1
6830655|NCT00159874|10834146|FG005|Overall Study|Death|2
6830656|NCT00159874|10834147|FG006|Overall Study|Death|0
6830657|NCT00159874|10834141|FG000|Overall Study|Withdrawal by Subject|2
6830658|NCT00159874|10834142|FG001|Overall Study|Withdrawal by Subject|6
6830659|NCT00159874|10834143|FG002|Overall Study|Withdrawal by Subject|8
6830660|NCT00159874|10834144|FG003|Overall Study|Withdrawal by Subject|4
6830661|NCT00159874|10834145|FG004|Overall Study|Withdrawal by Subject|3
6830662|NCT00159874|10834146|FG005|Overall Study|Withdrawal by Subject|2
6830663|NCT00159874|10834147|FG006|Overall Study|Withdrawal by Subject|1
6830664|NCT00159874|10834141|FG000|Overall Study|Pregnancy|1
6830665|NCT00159874|10834142|FG001|Overall Study|Pregnancy|1
6830666|NCT00159874|10834143|FG002|Overall Study|Pregnancy|0
6830667|NCT00159874|10834144|FG003|Overall Study|Pregnancy|0
6830668|NCT00159874|10834145|FG004|Overall Study|Pregnancy|0
6830669|NCT00159874|10834146|FG005|Overall Study|Pregnancy|0
6830670|NCT00159874|10834147|FG006|Overall Study|Pregnancy|0
6830671|NCT00159913|10834167|FG000|Overall Study|Adverse Event|1
6830672|NCT00159913|10834168|FG001|Overall Study|Adverse Event|0
6830673|NCT00159913|10834169|FG002|Overall Study|Adverse Event|1
6830674|NCT00159913|10834170|FG003|Overall Study|Adverse Event|0
6830675|NCT00159913|10834167|FG000|Overall Study|Withdrawal by Subject|0
6830676|NCT00159913|10834168|FG001|Overall Study|Withdrawal by Subject|0
6830677|NCT00159913|10834169|FG002|Overall Study|Withdrawal by Subject|0
6830678|NCT00159913|10834170|FG003|Overall Study|Withdrawal by Subject|1
6830679|NCT00159913|10834167|FG000|Overall Study|Lost to Follow-up|0
6830680|NCT00159913|10834168|FG001|Overall Study|Lost to Follow-up|0
6830681|NCT00159913|10834169|FG002|Overall Study|Lost to Follow-up|0
6830682|NCT00159913|10834170|FG003|Overall Study|Lost to Follow-up|1
6830683|NCT00159913|10834167|FG000|Overall Study|Protocol Violation|1
6830684|NCT00159913|10834168|FG001|Overall Study|Protocol Violation|0
6830685|NCT00159913|10834169|FG002|Overall Study|Protocol Violation|1
6830686|NCT00159913|10834170|FG003|Overall Study|Protocol Violation|0
6830687|NCT00160199|10834193|FG000|Overall Study|Adverse Event|5
6830688|NCT00160199|10834194|FG001|Overall Study|Adverse Event|14
6830689|NCT00160199|10834193|FG000|Overall Study|Lack of Efficacy|0
6830690|NCT00160199|10834194|FG001|Overall Study|Lack of Efficacy|1
6830691|NCT00160199|10834193|FG000|Overall Study|Lost to Follow-up|7
6830692|NCT00160199|10834194|FG001|Overall Study|Lost to Follow-up|7
6830693|NCT00160199|10834193|FG000|Overall Study|Withdrawal by Subject|4
6830694|NCT00160199|10834194|FG001|Overall Study|Withdrawal by Subject|6
6830695|NCT00160199|10834193|FG000|Overall Study|Administrative|0
6830696|NCT00160199|10834194|FG001|Overall Study|Administrative|1
6830697|NCT00160199|10834193|FG000|Overall Study|Protocol Violation|8
6830698|NCT00160199|10834194|FG001|Overall Study|Protocol Violation|8
6830699|NCT00160251|10834206|FG000|Prior to Amendment 2|Adverse Event|2
6830700|NCT00160251|10834207|FG001|Prior to Amendment 2|Adverse Event|1
6830701|NCT00160251|10834208|FG002|Prior to Amendment 2|Adverse Event|3
6830702|NCT00160251|10834209|FG003|Prior to Amendment 2|Adverse Event|1
6830703|NCT00160251|10834210|FG004|Prior to Amendment 2|Adverse Event|1
7038651|NCT01704495|11121040|FG001|Optional Safety Extension|Other reason|29
6830704|NCT00160251|10834211|FG005|Prior to Amendment 2|Adverse Event|1
6830705|NCT00160251|10834212|FG006|Prior to Amendment 2|Adverse Event|1
6830706|NCT00160251|10834213|FG007|Prior to Amendment 2|Adverse Event|0
6830707|NCT00160251|10834206|FG000|Prior to Amendment 2|Lack of Efficacy|0
6830708|NCT00160251|10834207|FG001|Prior to Amendment 2|Lack of Efficacy|4
6830709|NCT00160251|10834208|FG002|Prior to Amendment 2|Lack of Efficacy|37
6830710|NCT00160251|10834209|FG003|Prior to Amendment 2|Lack of Efficacy|35
6830711|NCT00160251|10834210|FG004|Prior to Amendment 2|Lack of Efficacy|24
6924752|NCT00827242|10954601|FG001|Overall Study|Withdrawal by Subject|4
6924753|NCT00827242|10954600|FG000|Overall Study|Protocol Violation|1
6924754|NCT00827242|10954601|FG001|Overall Study|Protocol Violation|3
6924755|NCT00827242|10954600|FG000|Overall Study|Lost to Follow-up|0
6924756|NCT00827242|10954601|FG001|Overall Study|Lost to Follow-up|3
6924757|NCT00827242|10954600|FG000|Overall Study|Adverse Event Excluding Death|2
6924758|NCT00827242|10954601|FG001|Overall Study|Adverse Event Excluding Death|1
6924759|NCT00827242|10954600|FG000|Overall Study|Entry Criteria Not Met|4
6924760|NCT00827242|10954601|FG001|Overall Study|Entry Criteria Not Met|1
6924761|NCT00827242|10954600|FG000|Overall Study|Physician Decision|2
6924762|NCT00827242|10954601|FG001|Overall Study|Physician Decision|0
6924763|NCT00827242|10954600|FG000|Overall Study|Death|1
6924764|NCT00827242|10954601|FG001|Overall Study|Death|0
6924765|NCT00827242|10954600|FG000|Overall Study|Lack of Efficacy|1
6924766|NCT00827242|10954601|FG001|Overall Study|Lack of Efficacy|0
6924767|NCT00827359|10954611|FG000|Overall Study|Progressive Diseas|19
6924768|NCT00827359|10954611|FG000|Overall Study|Unacceptable Toxicity|5
6924769|NCT00827359|10954611|FG000|Overall Study|Ineligible|1
6924770|NCT00827372|10954615|FG000|Overall Study|Adverse Event|5
6924771|NCT00827372|10954615|FG000|Overall Study|Lack of Efficacy|3
6924772|NCT00827502|10954620|FG000|Overall Study|randomized but not treated|11
6924773|NCT00827502|10954620|FG000|Overall Study|Adverse Event|1
6924774|NCT00827502|10954620|FG000|Overall Study|Lost to Follow-up|4
6924775|NCT00827502|10954620|FG000|Overall Study|Withdrawal by Subject|5
6924776|NCT00827541|10954626|FG000|Overall Study|Exitus|1
6924777|NCT00827541|10954627|FG001|Overall Study|Exitus|8
6924778|NCT00827541|10954626|FG000|Overall Study|Other|1
6924779|NCT00827541|10954627|FG001|Overall Study|Other|3
6924780|NCT00827541|10954626|FG000|Overall Study|Pathogen not susceptible|1
6924781|NCT00827541|10954627|FG001|Overall Study|Pathogen not susceptible|0
6924782|NCT00827541|10954626|FG000|Overall Study|Lack of effectiveness|1
6924783|NCT00827541|10954627|FG001|Overall Study|Lack of effectiveness|0
6924784|NCT00827606|10954635|FG000|Overall Study|Protocol Violation|4
6924785|NCT00827606|10954636|FG001|Overall Study|Protocol Violation|3
6924786|NCT00827606|10954635|FG000|Overall Study|Lost to Follow-up|3
6924787|NCT00827606|10954636|FG001|Overall Study|Lost to Follow-up|1
6924788|NCT00827606|10954635|FG000|Overall Study|Withdrawal by Subject|7
6924789|NCT00827606|10954636|FG001|Overall Study|Withdrawal by Subject|6
6924790|NCT00827606|10954635|FG000|Overall Study|Pregnancy|0
6924791|NCT00827606|10954636|FG001|Overall Study|Pregnancy|1
6924792|NCT00827606|10954635|FG000|Overall Study|Other|5
6924793|NCT00827606|10954636|FG001|Overall Study|Other|13
6924794|NCT00827606|10954635|FG000|Overall Study|LDL below 2.59 mmol/L|4
6924795|NCT00827606|10954636|FG001|Overall Study|LDL below 2.59 mmol/L|12
6924796|NCT00827606|10954635|FG000|Overall Study|Adverse Event|4
6924797|NCT00827606|10954636|FG001|Overall Study|Adverse Event|2
6924798|NCT00827632|10954650|FG000|Overall Study|Lost to Follow-up|8
6924799|NCT00827632|10954651|FG001|Overall Study|Lost to Follow-up|12
6924800|NCT00827632|10954650|FG000|Overall Study|Early withdrawal|14
6924801|NCT00827632|10954651|FG001|Overall Study|Early withdrawal|11
6924802|NCT00827775|10954659|FG000|Overall Study|Withdrawal by Subject|0
6924803|NCT00827775|10954660|FG001|Overall Study|Withdrawal by Subject|5
6830712|NCT00160251|10834211|FG005|Prior to Amendment 2|Lack of Efficacy|55
6830713|NCT00160251|10834212|FG006|Prior to Amendment 2|Lack of Efficacy|0
6830714|NCT00160251|10834213|FG007|Prior to Amendment 2|Lack of Efficacy|0
6830715|NCT00160251|10834206|FG000|Prior to Amendment 2|Lost to Follow-up|0
6830716|NCT00160251|10834207|FG001|Prior to Amendment 2|Lost to Follow-up|0
6830717|NCT00160251|10834208|FG002|Prior to Amendment 2|Lost to Follow-up|1
6830718|NCT00160251|10834209|FG003|Prior to Amendment 2|Lost to Follow-up|0
6830719|NCT00160251|10834210|FG004|Prior to Amendment 2|Lost to Follow-up|1
6830720|NCT00160251|10834211|FG005|Prior to Amendment 2|Lost to Follow-up|1
6830721|NCT00160251|10834212|FG006|Prior to Amendment 2|Lost to Follow-up|0
6830722|NCT00160251|10834213|FG007|Prior to Amendment 2|Lost to Follow-up|0
6830723|NCT00160251|10834206|FG000|Prior to Amendment 2|Withdrawal by Subject|3
6830724|NCT00160251|10834207|FG001|Prior to Amendment 2|Withdrawal by Subject|1
6830725|NCT00160251|10834208|FG002|Prior to Amendment 2|Withdrawal by Subject|3
6897151|NCT00637273|10915885|FG000|Overall Study|Lost to Follow-up|8
6897152|NCT00637273|10915886|FG001|Overall Study|Lost to Follow-up|9
6897153|NCT00637273|10915887|FG002|Overall Study|Lost to Follow-up|13
6897154|NCT00637273|10915885|FG000|Overall Study|Protocol Violation|2
6897155|NCT00637273|10915886|FG001|Overall Study|Protocol Violation|4
6897156|NCT00637273|10915887|FG002|Overall Study|Protocol Violation|1
6897157|NCT00637273|10915885|FG000|Overall Study|Withdrawal of Consent|18
6897158|NCT00637273|10915886|FG001|Overall Study|Withdrawal of Consent|6
6897159|NCT00637273|10915887|FG002|Overall Study|Withdrawal of Consent|18
6897160|NCT00637273|10915885|FG000|Overall Study|Investigator Decision|1
6897161|NCT00637273|10915886|FG001|Overall Study|Investigator Decision|3
6897162|NCT00637273|10915887|FG002|Overall Study|Investigator Decision|1
6897163|NCT00637273|10915885|FG000|Overall Study|Administrative|2
6897164|NCT00637273|10915886|FG001|Overall Study|Administrative|0
6830726|NCT00160251|10834209|FG003|Prior to Amendment 2|Withdrawal by Subject|4
6830727|NCT00160251|10834210|FG004|Prior to Amendment 2|Withdrawal by Subject|2
6830728|NCT00160251|10834211|FG005|Prior to Amendment 2|Withdrawal by Subject|3
6830729|NCT00160251|10834212|FG006|Prior to Amendment 2|Withdrawal by Subject|3
6830730|NCT00160251|10834213|FG007|Prior to Amendment 2|Withdrawal by Subject|0
6830731|NCT00160251|10834206|FG000|Prior to Amendment 2|Noncompliance with protocol|1
6830732|NCT00160251|10834207|FG001|Prior to Amendment 2|Noncompliance with protocol|0
6830733|NCT00160251|10834208|FG002|Prior to Amendment 2|Noncompliance with protocol|0
6830734|NCT00160251|10834209|FG003|Prior to Amendment 2|Noncompliance with protocol|0
6830735|NCT00160251|10834210|FG004|Prior to Amendment 2|Noncompliance with protocol|0
6830736|NCT00160251|10834211|FG005|Prior to Amendment 2|Noncompliance with protocol|0
6830737|NCT00160251|10834212|FG006|Prior to Amendment 2|Noncompliance with protocol|0
6830738|NCT00160251|10834213|FG007|Prior to Amendment 2|Noncompliance with protocol|0
6830739|NCT00160251|10834206|FG000|Prior to Amendment 2|Completed Treatment Phase|3
6830740|NCT00160251|10834207|FG001|Prior to Amendment 2|Completed Treatment Phase|0
6830741|NCT00160251|10834208|FG002|Prior to Amendment 2|Completed Treatment Phase|0
6830742|NCT00160251|10834209|FG003|Prior to Amendment 2|Completed Treatment Phase|0
6830743|NCT00160251|10834210|FG004|Prior to Amendment 2|Completed Treatment Phase|0
6830744|NCT00160251|10834211|FG005|Prior to Amendment 2|Completed Treatment Phase|23
6830745|NCT00160251|10834212|FG006|Prior to Amendment 2|Completed Treatment Phase|0
6830746|NCT00160251|10834213|FG007|Prior to Amendment 2|Completed Treatment Phase|0
6830747|NCT00160251|10834206|FG000|Post-amendment 2|Adverse Event|0
6830748|NCT00160251|10834207|FG001|Post-amendment 2|Adverse Event|0
6830749|NCT00160251|10834208|FG002|Post-amendment 2|Adverse Event|0
6830750|NCT00160251|10834209|FG003|Post-amendment 2|Adverse Event|0
6830751|NCT00160251|10834210|FG004|Post-amendment 2|Adverse Event|0
6830752|NCT00160251|10834211|FG005|Post-amendment 2|Adverse Event|0
6830753|NCT00160251|10834212|FG006|Post-amendment 2|Adverse Event|0
6830754|NCT00160251|10834213|FG007|Post-amendment 2|Adverse Event|20
6830755|NCT00160251|10834206|FG000|Post-amendment 2|Lack of Efficacy|0
6830756|NCT00160251|10834207|FG001|Post-amendment 2|Lack of Efficacy|0
6830757|NCT00160251|10834208|FG002|Post-amendment 2|Lack of Efficacy|0
6830758|NCT00160251|10834209|FG003|Post-amendment 2|Lack of Efficacy|0
6830759|NCT00160251|10834210|FG004|Post-amendment 2|Lack of Efficacy|0
6830760|NCT00160251|10834211|FG005|Post-amendment 2|Lack of Efficacy|0
6830761|NCT00160251|10834212|FG006|Post-amendment 2|Lack of Efficacy|0
6830762|NCT00160251|10834213|FG007|Post-amendment 2|Lack of Efficacy|24
6830763|NCT00160251|10834206|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
6830764|NCT00160251|10834207|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
6830765|NCT00160251|10834208|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
6830766|NCT00160251|10834209|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
6830767|NCT00160251|10834210|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
6830768|NCT00160251|10834211|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
6830769|NCT00160251|10834212|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
6830770|NCT00160251|10834213|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11
6830771|NCT00160524|10834270|FG000|Overall Study|Adverse Event|119
6830772|NCT00160524|10834270|FG000|Overall Study|Adverse Event and Other|94
6830773|NCT00160524|10834270|FG000|Overall Study|Protocol Violation|16
6830774|NCT00160524|10834270|FG000|Overall Study|Protocol Violation and Other|2
6830775|NCT00160524|10834270|FG000|Overall Study|Withdrawal by Subject|141
6830776|NCT00160524|10834270|FG000|Overall Study|Withdrawal by Subject and Other|17
6830777|NCT00160524|10834270|FG000|Overall Study|Physician Decision|27
6830778|NCT00160524|10834270|FG000|Overall Study|Physician Decision and Other|6
6924804|NCT00827827|10954668|FG000|Overall Study|Lost to Follow-up|3
6924805|NCT00827827|10954669|FG001|Overall Study|Lost to Follow-up|0
6924806|NCT00827827|10954668|FG000|Overall Study|Fall at home- hospitalization|1
6924807|NCT00827827|10954669|FG001|Overall Study|Fall at home- hospitalization|0
6924808|NCT00827827|10954668|FG000|Overall Study|Another cerebrovascular accident (CVA)|1
6924809|NCT00827827|10954669|FG001|Overall Study|Another cerebrovascular accident (CVA)|0
6924810|NCT00827827|10954668|FG000|Overall Study|Gout|1
6924811|NCT00827827|10954669|FG001|Overall Study|Gout|0
6924812|NCT00827827|10954668|FG000|Overall Study|Transportation issues|1
6924813|NCT00827827|10954669|FG001|Overall Study|Transportation issues|0
6924814|NCT00827827|10954668|FG000|Overall Study|Burned with water at home|1
6924815|NCT00827827|10954669|FG001|Overall Study|Burned with water at home|0
6924816|NCT00827918|10954679|FG000|Overall Study|Adverse Event|4
6924817|NCT00827918|10954680|FG001|Overall Study|Adverse Event|0
6924818|NCT00827918|10954681|FG002|Overall Study|Adverse Event|0
6924819|NCT00827918|10954679|FG000|Overall Study|Lack of Efficacy|16
6924820|NCT00827918|10954680|FG001|Overall Study|Lack of Efficacy|4
6924821|NCT00827918|10954681|FG002|Overall Study|Lack of Efficacy|15
6924822|NCT00827918|10954679|FG000|Overall Study|Physician Decision|1
6924823|NCT00827918|10954680|FG001|Overall Study|Physician Decision|0
6830779|NCT00160524|10834270|FG000|Overall Study|Lost to Follow-up|13
6830780|NCT00160524|10834270|FG000|Overall Study|Lost to Follow-up and Other|1
6830781|NCT00160524|10834270|FG000|Overall Study|Lack of Efficacy|21
6830782|NCT00160524|10834270|FG000|Overall Study|Lack of Efficacy and Other|1
6830783|NCT00160524|10834270|FG000|Overall Study|Other|20
6830784|NCT00160615|10834276|FG000|Overall Study|Adverse Event|5
6830785|NCT00160615|10834277|FG001|Overall Study|Adverse Event|12
6830786|NCT00160615|10834276|FG000|Overall Study|Withdrawal by Subject|0
6830787|NCT00160615|10834277|FG001|Overall Study|Withdrawal by Subject|2
6830788|NCT00160615|10834276|FG000|Overall Study|Lack of Efficacy|11
6830789|NCT00160615|10834277|FG001|Overall Study|Lack of Efficacy|23
6830790|NCT00160615|10834276|FG000|Overall Study|Patient decision|1
6830791|NCT00160615|10834277|FG001|Overall Study|Patient decision|2
6830792|NCT00160615|10834276|FG000|Overall Study|Investigator decision|1
6830793|NCT00160615|10834277|FG001|Overall Study|Investigator decision|1
6830794|NCT00160615|10834276|FG000|Overall Study|AE agents had to be discontinued (exam.)|0
6830795|NCT00160615|10834277|FG001|Overall Study|AE agents had to be discontinued (exam.)|1
6830796|NCT00160615|10834276|FG000|Overall Study|Switch to surgical treatment|0
6830797|NCT00160615|10834277|FG001|Overall Study|Switch to surgical treatment|2
6830798|NCT00160615|10834276|FG000|Overall Study|Non-compliance was suspected|0
6830799|NCT00160615|10834277|FG001|Overall Study|Non-compliance was suspected|1
6830800|NCT00160615|10834276|FG000|Overall Study|Poor compliance|0
6830801|NCT00160615|10834277|FG001|Overall Study|Poor compliance|1
6830802|NCT00160641|10834285|FG000|Overall Study|Adverse Event|102
6830803|NCT00160641|10834285|FG000|Overall Study|Withdrawal by Subject|87
6830804|NCT00160641|10834285|FG000|Overall Study|Lost to Follow-up|8
6830805|NCT00160641|10834285|FG000|Overall Study|Lack of Efficacy|12
6830806|NCT00160641|10834285|FG000|Overall Study|Protocol Violation|3
6830807|NCT00160641|10834285|FG000|Overall Study|Other|9
6830808|NCT00160654|10834289|FG000|Overall Study|Adverse Event|14
6830809|NCT00160654|10834289|FG000|Overall Study|Lack of Efficacy|4
6830810|NCT00160654|10834289|FG000|Overall Study|Lost to Follow-up|2
6830811|NCT00160654|10834289|FG000|Overall Study|Intake of expired drug|7
6830812|NCT00160654|10834289|FG000|Overall Study|Psychological trauma|1
6830813|NCT00160654|10834289|FG000|Overall Study|Sponsor decision|1
6830814|NCT00160654|10834289|FG000|Overall Study|Patient met exclusion criteria|1
6830815|NCT00160654|10834289|FG000|Overall Study|Patient decision|1
6830816|NCT00160654|10834289|FG000|Overall Study|Poor compliance, dilantin toxicity|1
6830817|NCT00160654|10834289|FG000|Overall Study|Met exclusion criteria|1
6830818|NCT00160667|10834296|FG000|Overall Study|Adverse Event|3
6830819|NCT00160667|10834297|FG001|Overall Study|Adverse Event|1
6830820|NCT00160667|10834298|FG002|Overall Study|Adverse Event|4
6830821|NCT00160667|10834296|FG000|Overall Study|Withdrawal by Subject|2
6830822|NCT00160667|10834297|FG001|Overall Study|Withdrawal by Subject|0
6830823|NCT00160667|10834298|FG002|Overall Study|Withdrawal by Subject|1
6830824|NCT00160667|10834296|FG000|Overall Study|Lack of Efficacy|0
6830825|NCT00160667|10834297|FG001|Overall Study|Lack of Efficacy|1
6830826|NCT00160667|10834298|FG002|Overall Study|Lack of Efficacy|0
6830827|NCT00160667|10834296|FG000|Overall Study|Protocol Violation|0
6830828|NCT00160667|10834297|FG001|Overall Study|Protocol Violation|1
6830829|NCT00160667|10834298|FG002|Overall Study|Protocol Violation|0
6830830|NCT00160667|10834296|FG000|Overall Study|Patient decision|0
6830831|NCT00160667|10834297|FG001|Overall Study|Patient decision|0
6830832|NCT00160667|10834298|FG002|Overall Study|Patient decision|1
6830833|NCT00160680|10834309|FG000|Overall Study|Adverse Event|0
6830834|NCT00160680|10834310|FG001|Overall Study|Adverse Event|1
6830835|NCT00160680|10834309|FG000|Overall Study|Lack of Efficacy|2
6830836|NCT00160680|10834310|FG001|Overall Study|Lack of Efficacy|1
6830837|NCT00160680|10834309|FG000|Overall Study|Lost to Follow-up|3
6830838|NCT00160680|10834310|FG001|Overall Study|Lost to Follow-up|2
6830839|NCT00160680|10834309|FG000|Overall Study|Withdrawal by Subject|4
6830840|NCT00160680|10834310|FG001|Overall Study|Withdrawal by Subject|9
6830841|NCT00160693|10834316|FG000|Overall Study|Adverse Event|97
6830842|NCT00160693|10834316|FG000|Overall Study|Lack of Efficacy|30
6830843|NCT00160693|10834316|FG000|Overall Study|Protocol Violation|24
6830844|NCT00160693|10834316|FG000|Overall Study|Lost to Follow-up|15
6830845|NCT00160693|10834316|FG000|Overall Study|Withdrawal by Subject|54
6830846|NCT00160693|10834316|FG000|Overall Study|Study terminated by sponsor|15
6830847|NCT00160706|10834320|FG000|Overall Study|Adverse Event|53
6830848|NCT00160706|10834320|FG000|Overall Study|Adverse Event and Other Reason|105
6830849|NCT00160706|10834320|FG000|Overall Study|Protocol Violation|3
6830850|NCT00160706|10834320|FG000|Overall Study|Withdrawal by Subject|41
6830851|NCT00160706|10834320|FG000|Overall Study|Withdrawal by Subject and Other|12
6830852|NCT00160706|10834320|FG000|Overall Study|Physician Decision|10
6830853|NCT00160706|10834320|FG000|Overall Study|Physician Decision and Other|3
6830854|NCT00160706|10834320|FG000|Overall Study|Lost to Follow-up|4
6830855|NCT00160706|10834320|FG000|Overall Study|Lost to Follow-up and Other|1
6830856|NCT00160706|10834320|FG000|Overall Study|Lack of Efficacy|42
6830857|NCT00160706|10834320|FG000|Overall Study|Lack of Efficacy and Other|1
6830858|NCT00160706|10834320|FG000|Overall Study|Other Reason|11
6830859|NCT00161213|10834324|FG000|Overall Study|Withdrawal by Subject|1
6830860|NCT00161213|10834324|FG000|Overall Study|Evaluable for toxicity but not response|1
6830861|NCT00161616|10834348|FG000|Overall Study|Withdrawal by Subject|6
6830862|NCT00161616|10834349|FG001|Overall Study|Withdrawal by Subject|5
6830863|NCT00161616|10834348|FG000|Overall Study|Physician Decision|1
6830864|NCT00161616|10834349|FG001|Overall Study|Physician Decision|0
6830865|NCT00161616|10834348|FG000|Overall Study|Death|1
6830866|NCT00161616|10834349|FG001|Overall Study|Death|1
6830867|NCT00161616|10834348|FG000|Overall Study|Lost to Follow-up|17
6830868|NCT00161616|10834349|FG001|Overall Study|Lost to Follow-up|13
6830869|NCT00161616|10834348|FG000|Overall Study|Protocol deviation|1
6830870|NCT00161616|10834349|FG001|Overall Study|Protocol deviation|0
6830871|NCT00162032|10834357|FG000|Overall Study|Lost to Follow-up|4
6830872|NCT00162032|10834358|FG001|Overall Study|Lost to Follow-up|2
6830873|NCT00162032|10834357|FG000|Overall Study|Reason not specified|1
6830874|NCT00162032|10834358|FG001|Overall Study|Reason not specified|0
6830875|NCT00162097|10834373|FG000|Overall Study|Participant no longer met study criteria|0
6830876|NCT00162097|10834374|FG001|Overall Study|Participant no longer met study criteria|0
6830877|NCT00162097|10834375|FG002|Overall Study|Participant no longer met study criteria|0
6830878|NCT00162097|10834376|FG003|Overall Study|Participant no longer met study criteria|1
6830879|NCT00162123|10834400|FG000|Overall Study|Disease progression|27
6830880|NCT00162123|10834401|FG001|Overall Study|Disease progression|19
6830881|NCT00162123|10834402|FG002|Overall Study|Disease progression|10
6830882|NCT00162123|10834403|FG003|Overall Study|Disease progression|4
6830883|NCT00162123|10834404|FG004|Overall Study|Disease progression|8
6830884|NCT00162123|10834405|FG005|Overall Study|Disease progression|3
6830885|NCT00162123|10834406|FG006|Overall Study|Disease progression|1
6830886|NCT00162123|10834407|FG007|Overall Study|Disease progression|0
6830887|NCT00162123|10834400|FG000|Overall Study|Study drug toxicity|6
6830888|NCT00162123|10834401|FG001|Overall Study|Study drug toxicity|1
6830889|NCT00162123|10834402|FG002|Overall Study|Study drug toxicity|5
6830890|NCT00162123|10834403|FG003|Overall Study|Study drug toxicity|0
6830891|NCT00162123|10834404|FG004|Overall Study|Study drug toxicity|4
6830892|NCT00162123|10834405|FG005|Overall Study|Study drug toxicity|1
6830893|NCT00162123|10834406|FG006|Overall Study|Study drug toxicity|1
6830894|NCT00162123|10834407|FG007|Overall Study|Study drug toxicity|0
6830895|NCT00162123|10834400|FG000|Overall Study|Death|3
6830896|NCT00162123|10834401|FG001|Overall Study|Death|3
6830897|NCT00162123|10834402|FG002|Overall Study|Death|1
6830898|NCT00162123|10834403|FG003|Overall Study|Death|1
6830899|NCT00162123|10834404|FG004|Overall Study|Death|1
6830900|NCT00162123|10834405|FG005|Overall Study|Death|1
6830901|NCT00162123|10834406|FG006|Overall Study|Death|0
6830902|NCT00162123|10834407|FG007|Overall Study|Death|0
6830903|NCT00162123|10834400|FG000|Overall Study|Withdrawal by Subject|2
6830904|NCT00162123|10834401|FG001|Overall Study|Withdrawal by Subject|0
6830905|NCT00162123|10834402|FG002|Overall Study|Withdrawal by Subject|2
6830906|NCT00162123|10834403|FG003|Overall Study|Withdrawal by Subject|1
6830907|NCT00162123|10834404|FG004|Overall Study|Withdrawal by Subject|1
6830908|NCT00162123|10834405|FG005|Overall Study|Withdrawal by Subject|2
6830909|NCT00162123|10834406|FG006|Overall Study|Withdrawal by Subject|1
6830910|NCT00162123|10834407|FG007|Overall Study|Withdrawal by Subject|0
6830911|NCT00162123|10834400|FG000|Overall Study|Deterioration without progression|2
6830912|NCT00162123|10834401|FG001|Overall Study|Deterioration without progression|2
6830913|NCT00162123|10834402|FG002|Overall Study|Deterioration without progression|3
6830914|NCT00162123|10834403|FG003|Overall Study|Deterioration without progression|0
6830915|NCT00162123|10834404|FG004|Overall Study|Deterioration without progression|1
6830916|NCT00162123|10834405|FG005|Overall Study|Deterioration without progression|0
6830917|NCT00162123|10834406|FG006|Overall Study|Deterioration without progression|0
6830918|NCT00162123|10834407|FG007|Overall Study|Deterioration without progression|0
6830919|NCT00162123|10834400|FG000|Overall Study|Adverse Event|1
6830920|NCT00162123|10834401|FG001|Overall Study|Adverse Event|2
6830921|NCT00162123|10834402|FG002|Overall Study|Adverse Event|0
6830922|NCT00162123|10834403|FG003|Overall Study|Adverse Event|2
6830923|NCT00162123|10834404|FG004|Overall Study|Adverse Event|1
6830924|NCT00162123|10834405|FG005|Overall Study|Adverse Event|0
6830925|NCT00162123|10834406|FG006|Overall Study|Adverse Event|0
6830926|NCT00162123|10834407|FG007|Overall Study|Adverse Event|0
6830927|NCT00162123|10834400|FG000|Overall Study|Not specified (before treatment)|2
6830928|NCT00162123|10834401|FG001|Overall Study|Not specified (before treatment)|0
6830929|NCT00162123|10834402|FG002|Overall Study|Not specified (before treatment)|0
6830930|NCT00162123|10834403|FG003|Overall Study|Not specified (before treatment)|0
6830931|NCT00162123|10834404|FG004|Overall Study|Not specified (before treatment)|12
6830932|NCT00162123|10834405|FG005|Overall Study|Not specified (before treatment)|1
6830933|NCT00162123|10834406|FG006|Overall Study|Not specified (before treatment)|0
6830934|NCT00162123|10834407|FG007|Overall Study|Not specified (before treatment)|0
6830935|NCT00162123|10834400|FG000|Overall Study|Not specified (after start of treatment)|0
6830936|NCT00162123|10834401|FG001|Overall Study|Not specified (after start of treatment)|0
6830937|NCT00162123|10834402|FG002|Overall Study|Not specified (after start of treatment)|0
6830938|NCT00162123|10834403|FG003|Overall Study|Not specified (after start of treatment)|0
6830939|NCT00162123|10834404|FG004|Overall Study|Not specified (after start of treatment)|3
6830940|NCT00162123|10834405|FG005|Overall Study|Not specified (after start of treatment)|0
6830941|NCT00162123|10834406|FG006|Overall Study|Not specified (after start of treatment)|0
6830942|NCT00162123|10834407|FG007|Overall Study|Not specified (after start of treatment)|0
6830943|NCT00162123|10834400|FG000|Overall Study|Physician Decision|1
6830944|NCT00162123|10834401|FG001|Overall Study|Physician Decision|2
6830945|NCT00162123|10834402|FG002|Overall Study|Physician Decision|0
6830946|NCT00162123|10834403|FG003|Overall Study|Physician Decision|0
6830947|NCT00162123|10834404|FG004|Overall Study|Physician Decision|0
6830948|NCT00162123|10834405|FG005|Overall Study|Physician Decision|1
6830949|NCT00162123|10834406|FG006|Overall Study|Physician Decision|1
6830950|NCT00162123|10834407|FG007|Overall Study|Physician Decision|0
6830951|NCT00162123|10834400|FG000|Overall Study|Tumor assessment only (not treated)|0
6830952|NCT00162123|10834401|FG001|Overall Study|Tumor assessment only (not treated)|0
6830953|NCT00162123|10834402|FG002|Overall Study|Tumor assessment only (not treated)|0
6830954|NCT00162123|10834403|FG003|Overall Study|Tumor assessment only (not treated)|0
6830955|NCT00162123|10834404|FG004|Overall Study|Tumor assessment only (not treated)|0
6830956|NCT00162123|10834405|FG005|Overall Study|Tumor assessment only (not treated)|0
6830957|NCT00162123|10834406|FG006|Overall Study|Tumor assessment only (not treated)|0
6830958|NCT00162123|10834407|FG007|Overall Study|Tumor assessment only (not treated)|1
6830959|NCT00162123|10834400|FG000|Overall Study|Follow-up only (not treated or assessed)|0
6830960|NCT00162123|10834401|FG001|Overall Study|Follow-up only (not treated or assessed)|0
6830961|NCT00162123|10834402|FG002|Overall Study|Follow-up only (not treated or assessed)|0
6830962|NCT00162123|10834403|FG003|Overall Study|Follow-up only (not treated or assessed)|0
6830963|NCT00162123|10834404|FG004|Overall Study|Follow-up only (not treated or assessed)|0
6830964|NCT00162123|10834405|FG005|Overall Study|Follow-up only (not treated or assessed)|0
6830965|NCT00162123|10834406|FG006|Overall Study|Follow-up only (not treated or assessed)|0
6830966|NCT00162123|10834407|FG007|Overall Study|Follow-up only (not treated or assessed)|57
6830967|NCT00162136|10834432|FG000|Overall Study|Adverse Event|1
6830968|NCT00162136|10834432|FG000|Overall Study|Death|1
6830969|NCT00162136|10834432|FG000|Overall Study|Disease Progression/Relapse|23
6830970|NCT00162136|10834432|FG000|Overall Study|Investigator Request|5
6830971|NCT00162136|10834432|FG000|Overall Study|Study Drug Toxicity|4
6830972|NCT00162136|10834432|FG000|Overall Study|Withdrawal by Subject|1
6830973|NCT00162266|10834459|FG000|Double-Blind Period|Adverse Event|5
6830974|NCT00162266|10834460|FG001|Double-Blind Period|Adverse Event|9
6830975|NCT00162266|10834461|FG002|Double-Blind Period|Adverse Event|11
6830976|NCT00162266|10834462|FG003|Double-Blind Period|Adverse Event|0
6830977|NCT00162266|10834459|FG000|Double-Blind Period|Death|0
6830978|NCT00162266|10834460|FG001|Double-Blind Period|Death|1
6830979|NCT00162266|10834461|FG002|Double-Blind Period|Death|0
6830980|NCT00162266|10834462|FG003|Double-Blind Period|Death|0
6830981|NCT00162266|10834459|FG000|Double-Blind Period|Lost to Follow-up|1
6830982|NCT00162266|10834460|FG001|Double-Blind Period|Lost to Follow-up|2
6830983|NCT00162266|10834461|FG002|Double-Blind Period|Lost to Follow-up|0
6830984|NCT00162266|10834462|FG003|Double-Blind Period|Lost to Follow-up|0
6830985|NCT00162266|10834459|FG000|Double-Blind Period|Other Reason|1
6830986|NCT00162266|10834460|FG001|Double-Blind Period|Other Reason|0
6830987|NCT00162266|10834461|FG002|Double-Blind Period|Other Reason|1
6830988|NCT00162266|10834462|FG003|Double-Blind Period|Other Reason|0
6830989|NCT00162266|10834459|FG000|Double-Blind Period|Lack of Efficacy|13
6830990|NCT00162266|10834460|FG001|Double-Blind Period|Lack of Efficacy|17
6830991|NCT00162266|10834461|FG002|Double-Blind Period|Lack of Efficacy|30
6830992|NCT00162266|10834462|FG003|Double-Blind Period|Lack of Efficacy|0
6830993|NCT00162266|10834459|FG000|Double-Blind Period|Withdrawal by Subject|5
6830994|NCT00162266|10834460|FG001|Double-Blind Period|Withdrawal by Subject|2
6830995|NCT00162266|10834461|FG002|Double-Blind Period|Withdrawal by Subject|6
6830996|NCT00162266|10834462|FG003|Double-Blind Period|Withdrawal by Subject|0
6830997|NCT00162266|10834459|FG000|Open-Label Period|Death|0
7038652|NCT01704495|11121041|FG002|Optional Safety Extension|Other reason|30
7038653|NCT01704495|11121042|FG003|Optional Safety Extension|Other reason|28
7038654|NCT01704495|11121039|FG000|Optional Safety Extension|Withdrawal by Subject|2
7038655|NCT01704495|11121040|FG001|Optional Safety Extension|Withdrawal by Subject|0
7038656|NCT01704495|11121041|FG002|Optional Safety Extension|Withdrawal by Subject|1
7038657|NCT01704495|11121042|FG003|Optional Safety Extension|Withdrawal by Subject|2
7038658|NCT01704599|11121061|FG000|Overall Study|Adverse Event|1
7038659|NCT01704651|11121090|FG000|Overall Study|Pre-op withdrawal by subject|1
7038660|NCT01704651|11121091|FG001|Overall Study|Pre-op withdrawal by subject|1
6830998|NCT00162266|10834460|FG001|Open-Label Period|Death|0
6830999|NCT00162266|10834461|FG002|Open-Label Period|Death|0
6831000|NCT00162266|10834462|FG003|Open-Label Period|Death|7
6831001|NCT00162266|10834459|FG000|Open-Label Period|Adverse Event|0
6831002|NCT00162266|10834460|FG001|Open-Label Period|Adverse Event|0
6831003|NCT00162266|10834461|FG002|Open-Label Period|Adverse Event|0
6831004|NCT00162266|10834462|FG003|Open-Label Period|Adverse Event|46
6831005|NCT00162266|10834459|FG000|Open-Label Period|Lack of Efficacy|0
6831006|NCT00162266|10834460|FG001|Open-Label Period|Lack of Efficacy|0
6831007|NCT00162266|10834461|FG002|Open-Label Period|Lack of Efficacy|0
6831008|NCT00162266|10834462|FG003|Open-Label Period|Lack of Efficacy|26
6831009|NCT00162266|10834459|FG000|Open-Label Period|Lost to Follow-up|0
6831010|NCT00162266|10834460|FG001|Open-Label Period|Lost to Follow-up|0
6831011|NCT00162266|10834461|FG002|Open-Label Period|Lost to Follow-up|0
6831012|NCT00162266|10834462|FG003|Open-Label Period|Lost to Follow-up|3
6831013|NCT00162266|10834459|FG000|Open-Label Period|Withdrawal by Subject|0
6831014|NCT00162266|10834460|FG001|Open-Label Period|Withdrawal by Subject|0
6831015|NCT00162266|10834461|FG002|Open-Label Period|Withdrawal by Subject|0
6831016|NCT00162266|10834462|FG003|Open-Label Period|Withdrawal by Subject|31
6831017|NCT00162266|10834459|FG000|Open-Label Period|Administrative Reason By Sponsor|0
6831018|NCT00162266|10834460|FG001|Open-Label Period|Administrative Reason By Sponsor|0
6897165|NCT00637273|10915887|FG002|Overall Study|Administrative|0
6897166|NCT00637273|10915885|FG000|Overall Study|Loss of Glucose Control|1
6897167|NCT00637273|10915886|FG001|Overall Study|Loss of Glucose Control|1
6897168|NCT00637273|10915887|FG002|Overall Study|Loss of Glucose Control|1
6897169|NCT00637377|10915908|FG000|Overall Study|Adverse Event|2
6831019|NCT00162266|10834461|FG002|Open-Label Period|Administrative Reason By Sponsor|0
6831020|NCT00162266|10834462|FG003|Open-Label Period|Administrative Reason By Sponsor|9
6831021|NCT00162266|10834459|FG000|Open-Label Period|Other Reasons|0
6831022|NCT00162266|10834460|FG001|Open-Label Period|Other Reasons|0
6831023|NCT00162266|10834461|FG002|Open-Label Period|Other Reasons|0
6831024|NCT00162266|10834462|FG003|Open-Label Period|Other Reasons|15
6831025|NCT00162981|10834516|FG000|Overall Study|Adverse Event|2
6831026|NCT00162981|10834517|FG001|Overall Study|Adverse Event|5
6831027|NCT00162981|10834516|FG000|Overall Study|Withdrawal by Subject|1
6831028|NCT00162981|10834517|FG001|Overall Study|Withdrawal by Subject|1
6831029|NCT00162981|10834516|FG000|Overall Study|Physician Decision|1
6831030|NCT00162981|10834517|FG001|Overall Study|Physician Decision|0
6831031|NCT00163020|10834525|FG000|Overall Study|Lost to Follow-up|0
6831032|NCT00163020|10834526|FG001|Overall Study|Lost to Follow-up|2
6831033|NCT00163189|10834534|FG000|Overall Study|Other|6
6831034|NCT00163189|10834534|FG000|Overall Study|Lost to Follow-up|1
6831035|NCT00163189|10834534|FG000|Overall Study|Protocol Violation|2
6831036|NCT00163189|10834534|FG000|Overall Study|Death|3
6831037|NCT00163189|10834534|FG000|Overall Study|Adverse Event|6
6831038|NCT00163189|10834534|FG000|Overall Study|Lack of Efficacy|7
6831039|NCT00163189|10834534|FG000|Overall Study|Study terminated by sponsor|11
6831040|NCT00163189|10834534|FG000|Overall Study|Withdrawal by Subject|11
6831041|NCT00163189|10834534|FG000|Overall Study|Did not meet continuation criterion|16
6831042|NCT00163215|10834538|FG000|Overall Study|Lack of Efficacy|3
6831043|NCT00163215|10834538|FG000|Overall Study|Withdrawal by Subject|5
6831044|NCT00163215|10834538|FG000|Overall Study|Other|7
6831045|NCT00163657|10834558|FG000|Overall Study|Death|12
6831046|NCT00163657|10834559|FG001|Overall Study|Death|14
6831047|NCT00163657|10834560|FG002|Overall Study|Death|19
6831048|NCT00163657|10834558|FG000|Overall Study|graft loss|4
6831049|NCT00163657|10834559|FG001|Overall Study|graft loss|1
6831050|NCT00163657|10834560|FG002|Overall Study|graft loss|2
6831051|NCT00163657|10834558|FG000|Overall Study|Withdrawal by Subject|2
6831052|NCT00163657|10834559|FG001|Overall Study|Withdrawal by Subject|3
6831053|NCT00163657|10834560|FG002|Overall Study|Withdrawal by Subject|2
6831054|NCT00163657|10834558|FG000|Overall Study|Physician Decision|0
6831055|NCT00163657|10834559|FG001|Overall Study|Physician Decision|1
6831056|NCT00163657|10834560|FG002|Overall Study|Physician Decision|1
6831057|NCT00163657|10834558|FG000|Overall Study|Non Compliance|1
6831058|NCT00163657|10834559|FG001|Overall Study|Non Compliance|0
6831059|NCT00163657|10834560|FG002|Overall Study|Non Compliance|0
6831060|NCT00163657|10834558|FG000|Overall Study|Lost to Follow-up|1
6831061|NCT00163657|10834559|FG001|Overall Study|Lost to Follow-up|3
6831062|NCT00163657|10834560|FG002|Overall Study|Lost to Follow-up|10
6831063|NCT00163657|10834558|FG000|Overall Study|Other reason|0
6831064|NCT00163657|10834559|FG001|Overall Study|Other reason|1
6831065|NCT00163657|10834560|FG002|Overall Study|Other reason|3
6831066|NCT00165646|10834571|FG000|Overall Study|Adverse Event|1
6831067|NCT00165646|10834572|FG001|Overall Study|Adverse Event|1
6831068|NCT00165646|10834573|FG002|Overall Study|Adverse Event|1
6831069|NCT00165646|10834571|FG000|Overall Study|Lack of Efficacy|1
6831070|NCT00165646|10834572|FG001|Overall Study|Lack of Efficacy|2
6831071|NCT00165646|10834573|FG002|Overall Study|Lack of Efficacy|0
6831072|NCT00165646|10834571|FG000|Overall Study|Withdrawal by Subject|0
6831073|NCT00165646|10834572|FG001|Overall Study|Withdrawal by Subject|2
6831074|NCT00165646|10834573|FG002|Overall Study|Withdrawal by Subject|1
6831075|NCT00165646|10834571|FG000|Overall Study|Physician Decision|2
6831076|NCT00165646|10834572|FG001|Overall Study|Physician Decision|0
6831077|NCT00165646|10834573|FG002|Overall Study|Physician Decision|2
6831078|NCT00165646|10834571|FG000|Overall Study|Protocol Violation|1
6831079|NCT00165646|10834572|FG001|Overall Study|Protocol Violation|0
7038661|NCT01704651|11121090|FG000|Overall Study|Pre-op change in treatment plan|1
7038662|NCT01704651|11121091|FG001|Overall Study|Pre-op change in treatment plan|4
7038663|NCT01704651|11121090|FG000|Overall Study|Nasogastric tube placement in surgery|1
7038664|NCT01704651|11121091|FG001|Overall Study|Nasogastric tube placement in surgery|1
7038665|NCT01704651|11121090|FG000|Overall Study|Post-op did not have laparotomy|2
7038666|NCT01704651|11121091|FG001|Overall Study|Post-op did not have laparotomy|1
7038667|NCT01704755|11121099|FG000|Overall Study|Adverse Event|4
7038668|NCT01704755|11121100|FG001|Overall Study|Adverse Event|1
7038669|NCT01704755|11121099|FG000|Overall Study|Lost to Follow-up|3
7038670|NCT01704755|11121100|FG001|Overall Study|Lost to Follow-up|4
7038671|NCT01704755|11121099|FG000|Overall Study|Withdrew consent|1
7038672|NCT01704755|11121100|FG001|Overall Study|Withdrew consent|1
7038673|NCT01704755|11121099|FG000|Overall Study|Other (not specified)|3
7062232|NCT01937130|11159745|FG002|Overall Study|Withdrawal by Subject|0
7062233|NCT01937130|11159746|FG003|Overall Study|Withdrawal by Subject|1
7062234|NCT01937130|11159743|FG000|Overall Study|Adverse Event|0
7062235|NCT01937130|11159744|FG001|Overall Study|Adverse Event|1
6831080|NCT00165646|10834573|FG002|Overall Study|Protocol Violation|0
6831081|NCT00165672|10834583|FG000|Overall Study|Adverse Event|0
6831082|NCT00165672|10834584|FG001|Overall Study|Adverse Event|1
6831083|NCT00165698|10834592|FG000|Overall Study|Adverse Event|2
6831084|NCT00165698|10834593|FG001|Overall Study|Adverse Event|10
6831085|NCT00165698|10834592|FG000|Overall Study|Lost to Follow-up|2
6831086|NCT00165698|10834593|FG001|Overall Study|Lost to Follow-up|2
6831087|NCT00165698|10834592|FG000|Overall Study|Withdrawal by Subject|2
7062236|NCT01937130|11159745|FG002|Overall Study|Adverse Event|0
7062237|NCT01937130|11159746|FG003|Overall Study|Adverse Event|1
7062238|NCT01937130|11159743|FG000|Overall Study|Death|1
7062239|NCT01937130|11159744|FG001|Overall Study|Death|1
6831088|NCT00165698|10834593|FG001|Overall Study|Withdrawal by Subject|1
6831089|NCT00165698|10834592|FG000|Overall Study|Protocol Violation|1
6831090|NCT00165698|10834593|FG001|Overall Study|Protocol Violation|0
6831091|NCT00165698|10834592|FG000|Overall Study|Not Taken/Lost the medicine|1
6831092|NCT00165698|10834593|FG001|Overall Study|Not Taken/Lost the medicine|2
6831093|NCT00165776|10834603|FG000|Overall Study|Lack of Efficacy|0
6831094|NCT00165776|10834604|FG001|Overall Study|Lack of Efficacy|0
6831095|NCT00165776|10834605|FG002|Overall Study|Lack of Efficacy|0
6924824|NCT00827918|10954681|FG002|Overall Study|Physician Decision|0
6924825|NCT00827918|10954679|FG000|Overall Study|Pregnancy|0
6924826|NCT00827918|10954680|FG001|Overall Study|Pregnancy|1
6924827|NCT00827918|10954681|FG002|Overall Study|Pregnancy|0
6924828|NCT00827918|10954679|FG000|Overall Study|Progressive Disease|1
6924829|NCT00827918|10954680|FG001|Overall Study|Progressive Disease|1
6924830|NCT00827918|10954681|FG002|Overall Study|Progressive Disease|0
6924831|NCT00827918|10954679|FG000|Overall Study|Protocol Violation|0
6924832|NCT00827918|10954680|FG001|Overall Study|Protocol Violation|1
6924833|NCT00827918|10954681|FG002|Overall Study|Protocol Violation|0
6924834|NCT00827918|10954679|FG000|Overall Study|Withdrawal by Subject|6
6924835|NCT00827918|10954680|FG001|Overall Study|Withdrawal by Subject|2
6924836|NCT00827918|10954681|FG002|Overall Study|Withdrawal by Subject|6
6924837|NCT00827931|10954691|FG000|Overall Study|Death|3
6924838|NCT00827931|10954692|FG001|Overall Study|Death|5
6924839|NCT00827931|10954691|FG000|Overall Study|Adverse Event|1
6924840|NCT00827931|10954692|FG001|Overall Study|Adverse Event|0
6924841|NCT00827931|10954691|FG000|Overall Study|Lost to Follow-up|1
6924842|NCT00827931|10954692|FG001|Overall Study|Lost to Follow-up|0
6924843|NCT00827931|10954691|FG000|Overall Study|Withdrawal by Subject|0
7062240|NCT01937130|11159745|FG002|Overall Study|Death|1
7062241|NCT01937130|11159746|FG003|Overall Study|Death|0
7062242|NCT01937130|11159743|FG000|Overall Study|Lost to Follow-up|2
7062243|NCT01937130|11159744|FG001|Overall Study|Lost to Follow-up|0
7062244|NCT01937130|11159745|FG002|Overall Study|Lost to Follow-up|2
7062245|NCT01937130|11159746|FG003|Overall Study|Lost to Follow-up|0
7062246|NCT01937130|11159743|FG000|Overall Study|Physician Decision|0
7062247|NCT01937130|11159744|FG001|Overall Study|Physician Decision|1
7062248|NCT01937130|11159745|FG002|Overall Study|Physician Decision|0
7062249|NCT01937130|11159746|FG003|Overall Study|Physician Decision|0
7062250|NCT01937130|11159743|FG000|Overall Study|Patients unable to swallow|0
7062251|NCT01937130|11159744|FG001|Overall Study|Patients unable to swallow|1
7062252|NCT01937130|11159745|FG002|Overall Study|Patients unable to swallow|0
7062253|NCT01937130|11159746|FG003|Overall Study|Patients unable to swallow|0
7062254|NCT01937130|11159743|FG000|Overall Study|Patient lost to FU due to death|2
7062255|NCT01937130|11159744|FG001|Overall Study|Patient lost to FU due to death|0
7062256|NCT01937130|11159745|FG002|Overall Study|Patient lost to FU due to death|0
7062257|NCT01937130|11159746|FG003|Overall Study|Patient lost to FU due to death|0
7062258|NCT01937299|11159771|FG000|Overall Study|Adverse Event|13
7062259|NCT01937299|11159772|FG001|Overall Study|Adverse Event|0
7038674|NCT01704755|11121100|FG001|Overall Study|Other (not specified)|1
6924844|NCT00827931|10954692|FG001|Overall Study|Withdrawal by Subject|1
6924845|NCT00827931|10954691|FG000|Overall Study|Other|1
6924846|NCT00827931|10954692|FG001|Overall Study|Other|0
6924847|NCT00828009|10954716|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10
6924848|NCT00828009|10954716|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2
6924849|NCT00828009|10954716|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3
6924850|NCT00828009|10954716|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11
6924851|NCT00828009|10954716|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1
6924852|NCT00828009|10954716|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2
6924853|NCT00828009|10954716|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2
7062260|NCT01937299|11159771|FG000|Overall Study|Lack of Efficacy|0
7062261|NCT01937299|11159772|FG001|Overall Study|Lack of Efficacy|4
7062262|NCT01937299|11159771|FG000|Overall Study|Withdrawal by Subject|1
7062263|NCT01937299|11159772|FG001|Overall Study|Withdrawal by Subject|0
7062264|NCT01937312|11159781|FG000|Overall Study|Adverse Event|10
6831096|NCT00165776|10834606|FG003|Overall Study|Lack of Efficacy|1
7038675|NCT01704755|11121099|FG000|Overall Study|Withdrew consent and personal issues|1
7038676|NCT01704755|11121100|FG001|Overall Study|Withdrew consent and personal issues|0
7038677|NCT01704846|11121131|FG000|Treatment Period 2|Withdrawal by Subject|0
7038678|NCT01704846|11121132|FG001|Treatment Period 2|Withdrawal by Subject|1
7038679|NCT01705080|11121150|FG000|Overall Study|Missed visit|10
7038680|NCT01705080|11121151|FG001|Overall Study|Missed visit|4
7038681|NCT01705080|11121152|FG002|Overall Study|Missed visit|1
7038682|NCT01705080|11121150|FG000|Overall Study|Death|4
7038683|NCT01705080|11121151|FG001|Overall Study|Death|4
7062265|NCT01937312|11159782|FG001|Overall Study|Adverse Event|1
7062266|NCT01937312|11159781|FG000|Overall Study|Lack of Efficacy|0
7062267|NCT01937312|11159782|FG001|Overall Study|Lack of Efficacy|1
7062268|NCT01937312|11159781|FG000|Overall Study|Withdrawal of subject prior to treatment|1
6924854|NCT00828009|10954716|FG000|Step 2 - Maintenance Therapy|Progressive disease|12
7062269|NCT01937312|11159782|FG001|Overall Study|Withdrawal of subject prior to treatment|1
7062270|NCT01937351|11159791|FG000|Overall Study|Withdrawal by Subject|4
7062271|NCT01937351|11159792|FG001|Overall Study|Withdrawal by Subject|2
7062272|NCT01937351|11159791|FG000|Overall Study|Death|1
7062273|NCT01937351|11159792|FG001|Overall Study|Death|0
6831097|NCT00165776|10834603|FG000|Overall Study|Withdrawal by Subject|4
6831098|NCT00165776|10834604|FG001|Overall Study|Withdrawal by Subject|1
7038684|NCT01705080|11121152|FG002|Overall Study|Death|6
7038685|NCT01705080|11121150|FG000|Overall Study|Withdrawal by Subject|61
7038686|NCT01705080|11121151|FG001|Overall Study|Withdrawal by Subject|44
7038687|NCT01705080|11121152|FG002|Overall Study|Withdrawal by Subject|9
7038688|NCT01705145|11121160|FG000|Part B|Adverse Event|1
7038689|NCT01705236|11121176|FG000|Overall Study|Lost to Follow-up|1
7038690|NCT01705236|11121176|FG000|Overall Study|Administrative problems|2
7038691|NCT01705236|11121176|FG000|Overall Study|Unsatisfactory therapeutic effect|3
7038692|NCT01705236|11121176|FG000|Overall Study|Protocol Violation|3
7038693|NCT01705236|11121176|FG000|Overall Study|Abnormal test procedure result(s)|4
7038694|NCT01705236|11121176|FG000|Overall Study|Abnormal laboratory value(s)|4
7038695|NCT01705236|11121176|FG000|Overall Study|Withdrawal by Subject|5
7038696|NCT01705236|11121176|FG000|Overall Study|Adverse Event|5
7038697|NCT01705509|11121193|FG000|Inclusion CPET|Screen Failure|5
7038698|NCT01705509|11121193|FG000|Inclusion CPET|Withdrawal by Subject|2
7038699|NCT01705509|11121193|FG000|CPET w/ Ranexa|Screen Failure|2
7038700|NCT01705574|11121199|FG000|Double-Blind Phase|Lost to Follow-up|12
7038701|NCT01705574|11121200|FG001|Double-Blind Phase|Lost to Follow-up|16
7038702|NCT01705574|11121201|FG002|Double-Blind Phase|Lost to Follow-up|0
7038703|NCT01705574|11121202|FG003|Double-Blind Phase|Lost to Follow-up|0
7038704|NCT01705574|11121199|FG000|Double-Blind Phase|Adverse Event|3
7038705|NCT01705574|11121200|FG001|Double-Blind Phase|Adverse Event|10
7038706|NCT01705574|11121201|FG002|Double-Blind Phase|Adverse Event|0
7038707|NCT01705574|11121202|FG003|Double-Blind Phase|Adverse Event|0
7062274|NCT01937351|11159791|FG000|Overall Study|Not treated w device, per protocol fail|4
6831099|NCT00165776|10834605|FG002|Overall Study|Withdrawal by Subject|2
6831100|NCT00165776|10834606|FG003|Overall Study|Withdrawal by Subject|0
6831101|NCT00165776|10834603|FG000|Overall Study|Worsening of Cervical Dystonia|0
6831102|NCT00165776|10834604|FG001|Overall Study|Worsening of Cervical Dystonia|0
6831103|NCT00165776|10834605|FG002|Overall Study|Worsening of Cervical Dystonia|0
6831104|NCT00165776|10834606|FG003|Overall Study|Worsening of Cervical Dystonia|1
6831105|NCT00165789|10834620|FG000|Overall Study|Adverse Event|0
6831106|NCT00165789|10834621|FG001|Overall Study|Adverse Event|3
6831107|NCT00165789|10834622|FG002|Overall Study|Adverse Event|0
6831108|NCT00165789|10834623|FG003|Overall Study|Adverse Event|12
6831109|NCT00165789|10834620|FG000|Overall Study|Withdrawal by Subject|0
6831110|NCT00165789|10834621|FG001|Overall Study|Withdrawal by Subject|1
6831111|NCT00165789|10834622|FG002|Overall Study|Withdrawal by Subject|1
6831112|NCT00165789|10834623|FG003|Overall Study|Withdrawal by Subject|2
6831113|NCT00165841|10834635|FG000|Overall Study|Adverse Event|2
6831114|NCT00165841|10834636|FG001|Overall Study|Adverse Event|3
6831115|NCT00165841|10834635|FG000|Overall Study|Lack of Efficacy|6
6831116|NCT00165841|10834636|FG001|Overall Study|Lack of Efficacy|33
6831117|NCT00165841|10834635|FG000|Overall Study|Lost to Follow-up|4
6831118|NCT00165841|10834636|FG001|Overall Study|Lost to Follow-up|4
6831119|NCT00165841|10834635|FG000|Overall Study|Withdrawal by Subject|7
6831120|NCT00165841|10834636|FG001|Overall Study|Withdrawal by Subject|8
6831121|NCT00165841|10834635|FG000|Overall Study|Physician Decision|1
6831122|NCT00165841|10834636|FG001|Overall Study|Physician Decision|0
6831123|NCT00165841|10834635|FG000|Overall Study|Protocol Violation|6
6831124|NCT00165841|10834636|FG001|Overall Study|Protocol Violation|8
6831125|NCT00165841|10834635|FG000|Overall Study|Other|3
6831126|NCT00165841|10834636|FG001|Overall Study|Other|5
6831127|NCT00165841|10834635|FG000|Overall Study|Medication Noncompliance|1
6831128|NCT00165841|10834636|FG001|Overall Study|Medication Noncompliance|1
6831129|NCT00165984|10834651|FG000|Overall Study|Death|15
6831130|NCT00166114|10834670|FG000|Overall Study|Protocol Violation|2
6831131|NCT00166114|10834671|FG001|Overall Study|Protocol Violation|1
6974821|NCT01190930|11027135|FG004|Induction|Physician Decision|0
6831132|NCT00166114|10834670|FG000|Overall Study|Withdrawal by Subject|10
6831133|NCT00166114|10834671|FG001|Overall Study|Withdrawal by Subject|4
6831134|NCT00166114|10834670|FG000|Overall Study|Adverse Event|2
6831135|NCT00166114|10834671|FG001|Overall Study|Adverse Event|1
6831136|NCT00166296|10834705|FG000|Overall Study|Withdrawal by Subject|1
6831137|NCT00166296|10834706|FG001|Overall Study|Withdrawal by Subject|3
6831138|NCT00166296|10834705|FG000|Overall Study|Adverse Event|2
6974822|NCT01190930|11027136|FG005|Induction|Physician Decision|0
6974823|NCT01190930|11027137|FG006|Induction|Physician Decision|0
6974824|NCT01190930|11027138|FG007|Induction|Physician Decision|0
6974825|NCT01190930|11027139|FG008|Induction|Physician Decision|0
6974826|NCT01190930|11027140|FG009|Induction|Physician Decision|0
6974827|NCT01190930|11027131|FG000|Induction|Withdrawal by Subject|9
6974828|NCT01190930|11027132|FG001|Induction|Withdrawal by Subject|0
6974829|NCT01190930|11027133|FG002|Induction|Withdrawal by Subject|0
6974830|NCT01190930|11027134|FG003|Induction|Withdrawal by Subject|0
6974831|NCT01190930|11027135|FG004|Induction|Withdrawal by Subject|0
6974832|NCT01190930|11027136|FG005|Induction|Withdrawal by Subject|0
6974833|NCT01190930|11027137|FG006|Induction|Withdrawal by Subject|0
6831139|NCT00166296|10834706|FG001|Overall Study|Adverse Event|4
6831140|NCT00166296|10834705|FG000|Overall Study|Lost to Follow-up|4
6831141|NCT00166296|10834706|FG001|Overall Study|Lost to Follow-up|2
6831142|NCT00166439|10834721|FG000|Overall Study|Ineligible|5
6831143|NCT00166517|10834727|FG000|Overall Study|Lost to Follow-up|1
6831144|NCT00166517|10834728|FG001|Overall Study|Lost to Follow-up|0
6831145|NCT00166517|10834727|FG000|Overall Study|Protocol Violation|4
6831146|NCT00166517|10834728|FG001|Overall Study|Protocol Violation|1
6831147|NCT00166517|10834727|FG000|Overall Study|Withdrawal by Subject|0
6831148|NCT00166517|10834728|FG001|Overall Study|Withdrawal by Subject|1
6831149|NCT00166712|10834736|FG000|Overall Study|Death|0
6831150|NCT00166712|10834737|FG001|Overall Study|Death|1
6831151|NCT00166712|10834736|FG000|Overall Study|Adverse Event|1
7062275|NCT01937351|11159792|FG001|Overall Study|Not treated w device, per protocol fail|0
6831152|NCT00166712|10834737|FG001|Overall Study|Adverse Event|0
6831153|NCT00166712|10834736|FG000|Overall Study|Withdrawal by Subject|1
6831154|NCT00166712|10834737|FG001|Overall Study|Withdrawal by Subject|2
6831155|NCT00166712|10834736|FG000|Overall Study|Physician Decision|0
6831156|NCT00166712|10834737|FG001|Overall Study|Physician Decision|2
6924855|NCT00828009|10954716|FG000|Step 2 - Maintenance Therapy|Adverse Event|13
6924856|NCT00828009|10954716|FG000|Step 2 - Maintenance Therapy|Death|1
6924857|NCT00828009|10954716|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4
6924858|NCT00828009|10954716|FG000|Step 2 - Maintenance Therapy|Complicating disease|2
6924859|NCT00828009|10954716|FG000|Step 2 - Maintenance Therapy|Other|1
6924860|NCT00828113|10954750|FG000|Overall Study|Withdrawal by Subject|27
6924861|NCT00828113|10954751|FG001|Overall Study|Withdrawal by Subject|26
6924862|NCT00828113|10954750|FG000|Overall Study|Lost to Follow-up|3
6924863|NCT00828113|10954751|FG001|Overall Study|Lost to Follow-up|5
6924864|NCT00828139|10954761|FG000|Overall Study|Adverse Event|8
6924865|NCT00828139|10954762|FG001|Overall Study|Adverse Event|1
6924866|NCT00828139|10954763|FG002|Overall Study|Adverse Event|10
6924867|NCT00828139|10954764|FG003|Overall Study|Adverse Event|5
6924868|NCT00828139|10954761|FG000|Overall Study|Death|2
6924869|NCT00828139|10954762|FG001|Overall Study|Death|1
6924870|NCT00828139|10954763|FG002|Overall Study|Death|0
7062276|NCT01937364|11159799|FG000|Overall Study|Adverse Event|2
7062277|NCT01937364|11159800|FG001|Overall Study|Adverse Event|1
7062278|NCT01937390|11159806|FG000|Overall Study|Death|2
7062279|NCT01937390|11159806|FG000|Overall Study|Lost to Follow-up|7
7062280|NCT01937390|11159806|FG000|Overall Study|Withdrawal by Subject|5
7062281|NCT01937390|11159806|FG000|Overall Study|Fail to return|21
7062282|NCT01937559|11159823|FG000|Overall Study|Physician Decision|3
7062283|NCT01937559|11159824|FG001|Overall Study|Physician Decision|3
7062284|NCT01937559|11159825|FG002|Overall Study|Physician Decision|0
7062285|NCT01937559|11159823|FG000|Overall Study|Withdrawal by Subject|6
7062286|NCT01937559|11159824|FG001|Overall Study|Withdrawal by Subject|4
7062287|NCT01937559|11159825|FG002|Overall Study|Withdrawal by Subject|0
7062288|NCT01937559|11159823|FG000|Overall Study|screen fail|2
7062289|NCT01937559|11159824|FG001|Overall Study|screen fail|4
7062290|NCT01937559|11159825|FG002|Overall Study|screen fail|0
7062291|NCT01937715|11159853|FG000|Overall Study|Death|0
7062292|NCT01937715|11159854|FG001|Overall Study|Death|0
7062293|NCT01937715|11159855|FG002|Overall Study|Death|0
7062294|NCT01937715|11159856|FG003|Overall Study|Death|1
7062295|NCT01937715|11159857|FG004|Overall Study|Death|0
7062296|NCT01937715|11159853|FG000|Overall Study|Withdrawal by Subject|0
7062297|NCT01937715|11159854|FG001|Overall Study|Withdrawal by Subject|1
7062298|NCT01937715|11159855|FG002|Overall Study|Withdrawal by Subject|0
7062299|NCT01937715|11159856|FG003|Overall Study|Withdrawal by Subject|0
7062300|NCT01937715|11159857|FG004|Overall Study|Withdrawal by Subject|2
7062301|NCT01937715|11159853|FG000|Overall Study|Other|0
7062302|NCT01937715|11159854|FG001|Overall Study|Other|0
7062303|NCT01937715|11159855|FG002|Overall Study|Other|0
7062304|NCT01937715|11159856|FG003|Overall Study|Other|3
6831157|NCT00167245|10834773|FG000|Overall Study|Lost to Follow-up|20
6831158|NCT00167245|10834774|FG001|Overall Study|Lost to Follow-up|31
6831159|NCT00167245|10834773|FG000|Overall Study|Withdrawal by Subject|5
6831160|NCT00167245|10834774|FG001|Overall Study|Withdrawal by Subject|8
6831161|NCT00167245|10834773|FG000|Overall Study|Incarcerated|3
6831162|NCT00167245|10834774|FG001|Overall Study|Incarcerated|2
6831163|NCT00167245|10834773|FG000|Overall Study|Drowsy|1
6831164|NCT00167245|10834774|FG001|Overall Study|Drowsy|0
6831165|NCT00167310|10834785|FG000|Overall Study|Protocol Violation|5
6831166|NCT00167310|10834786|FG001|Overall Study|Protocol Violation|3
6831167|NCT00167310|10834785|FG000|Overall Study|Withdrawal by Subject|3
6831168|NCT00167310|10834786|FG001|Overall Study|Withdrawal by Subject|7
6924871|NCT00828139|10954764|FG003|Overall Study|Death|2
6924872|NCT00828139|10954761|FG000|Overall Study|Refusal unrelated to toxicity|3
6924873|NCT00828139|10954762|FG001|Overall Study|Refusal unrelated to toxicity|4
7062305|NCT01937715|11159857|FG004|Overall Study|Other|0
7062306|NCT01937871|11159872|FG000|Overall Study|Adverse Event|6
7062307|NCT01937871|11159873|FG001|Overall Study|Adverse Event|6
6831169|NCT00167414|10834807|FG000|Overall Study|Death|10
7062308|NCT01937871|11159874|FG002|Overall Study|Adverse Event|2
7062309|NCT01937871|11159872|FG000|Overall Study|Lost to Follow-up|8
7062310|NCT01937871|11159873|FG001|Overall Study|Lost to Follow-up|2
7062311|NCT01937871|11159874|FG002|Overall Study|Lost to Follow-up|4
7062312|NCT01937871|11159872|FG000|Overall Study|Withdrawal by Subject|9
7062313|NCT01937871|11159873|FG001|Overall Study|Withdrawal by Subject|6
7062314|NCT01937871|11159874|FG002|Overall Study|Withdrawal by Subject|4
7062315|NCT01937871|11159872|FG000|Overall Study|Physician Decision|0
7062316|NCT01937871|11159873|FG001|Overall Study|Physician Decision|1
7062317|NCT01937871|11159874|FG002|Overall Study|Physician Decision|0
7062318|NCT01937871|11159872|FG000|Overall Study|Entry Criteria Not Met|1
7062319|NCT01937871|11159873|FG001|Overall Study|Entry Criteria Not Met|2
7062320|NCT01937871|11159874|FG002|Overall Study|Entry Criteria Not Met|1
6831170|NCT00167778|10834824|FG000|Overall Study|Withdrawal by Subject|1
6831171|NCT00168038|10834838|FG000|Overall Study|Adverse Event|1
6831172|NCT00168038|10834838|FG000|Overall Study|Therapy failure|1
6831173|NCT00168064|10834844|FG000|Overall Study|Adverse Event|26
6831174|NCT00168064|10834845|FG001|Overall Study|Adverse Event|22
6831175|NCT00168064|10834844|FG000|Overall Study|Withdrawal by Subject|3
6831176|NCT00168064|10834845|FG001|Overall Study|Withdrawal by Subject|4
6831177|NCT00168064|10834844|FG000|Overall Study|Lack of Efficacy|4
6831178|NCT00168064|10834845|FG001|Overall Study|Lack of Efficacy|4
6831179|NCT00168064|10834844|FG000|Overall Study|Lost to Follow-up|4
6831180|NCT00168064|10834845|FG001|Overall Study|Lost to Follow-up|3
6831181|NCT00168064|10834844|FG000|Overall Study|Non-compliance|2
6831182|NCT00168064|10834845|FG001|Overall Study|Non-compliance|3
6831183|NCT00168064|10834844|FG000|Overall Study|Concurrent Illness|4
6831184|NCT00168064|10834845|FG001|Overall Study|Concurrent Illness|3
6831185|NCT00168064|10834844|FG000|Overall Study|Subject's Best interest|2
6831186|NCT00168064|10834845|FG001|Overall Study|Subject's Best interest|2
6831187|NCT00168064|10834844|FG000|Overall Study|Various|4
6831188|NCT00168064|10834845|FG001|Overall Study|Various|3
6831189|NCT00168103|10834856|FG000|Overall Study|Withdrawal by Subject|1
6831190|NCT00168103|10834857|FG001|Overall Study|Withdrawal by Subject|2
6831191|NCT00168103|10834858|FG002|Overall Study|Withdrawal by Subject|1
6831192|NCT00168103|10834859|FG003|Overall Study|Withdrawal by Subject|0
6831193|NCT00168103|10834856|FG000|Overall Study|Lost to Follow-up|1
6831194|NCT00168103|10834857|FG001|Overall Study|Lost to Follow-up|3
6831195|NCT00168103|10834858|FG002|Overall Study|Lost to Follow-up|0
6831196|NCT00168103|10834859|FG003|Overall Study|Lost to Follow-up|0
6831197|NCT00168805|10834965|FG000|Overall Study|Adverse Event|7
6831198|NCT00168805|10834966|FG001|Overall Study|Adverse Event|11
6831199|NCT00168805|10834967|FG002|Overall Study|Adverse Event|16
6831200|NCT00168805|10834965|FG000|Overall Study|Protocol Violation|12
6831201|NCT00168805|10834966|FG001|Overall Study|Protocol Violation|11
6831202|NCT00168805|10834967|FG002|Overall Study|Protocol Violation|8
6831203|NCT00168805|10834965|FG000|Overall Study|Lost to Follow-up|12
6831204|NCT00168805|10834966|FG001|Overall Study|Lost to Follow-up|17
6831205|NCT00168805|10834967|FG002|Overall Study|Lost to Follow-up|11
6831206|NCT00168805|10834965|FG000|Overall Study|Withdrawal by Subject|16
6831207|NCT00168805|10834966|FG001|Overall Study|Withdrawal by Subject|18
6831208|NCT00168805|10834967|FG002|Overall Study|Withdrawal by Subject|21
6831209|NCT00168805|10834965|FG000|Overall Study|Other|24
6831210|NCT00168805|10834966|FG001|Overall Study|Other|21
6831211|NCT00168805|10834967|FG002|Overall Study|Other|22
6831212|NCT00168805|10834965|FG000|Treatment|Adverse Event|25
6831213|NCT00168805|10834966|FG001|Treatment|Adverse Event|26
6831214|NCT00168805|10834967|FG002|Treatment|Adverse Event|32
6831215|NCT00168805|10834965|FG000|Treatment|Protocol Violation|3
6831216|NCT00168805|10834966|FG001|Treatment|Protocol Violation|5
6831217|NCT00168805|10834967|FG002|Treatment|Protocol Violation|5
6831218|NCT00168805|10834965|FG000|Treatment|Withdrawal by Subject|3
6831219|NCT00168805|10834966|FG001|Treatment|Withdrawal by Subject|7
6831220|NCT00168805|10834967|FG002|Treatment|Withdrawal by Subject|8
6831221|NCT00168805|10834965|FG000|Treatment|Other|18
6831222|NCT00168805|10834966|FG001|Treatment|Other|18
6831223|NCT00168805|10834967|FG002|Treatment|Other|17
6831224|NCT00168818|10834978|FG000|Overall Study|Adverse Event|23
6831225|NCT00168818|10834979|FG001|Overall Study|Adverse Event|29
7038708|NCT01705574|11121199|FG000|Double-Blind Phase|Withdrew Consent|8
7038709|NCT01705574|11121200|FG001|Double-Blind Phase|Withdrew Consent|5
7038710|NCT01705574|11121201|FG002|Double-Blind Phase|Withdrew Consent|0
7038711|NCT01705574|11121202|FG003|Double-Blind Phase|Withdrew Consent|0
7038712|NCT01705574|11121199|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4
7038713|NCT01705574|11121200|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5
7038714|NCT01705574|11121201|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0
7038715|NCT01705574|11121202|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0
7038716|NCT01705574|11121199|FG000|Double-Blind Phase|Pregnancy|1
7038717|NCT01705574|11121200|FG001|Double-Blind Phase|Pregnancy|1
7038718|NCT01705574|11121201|FG002|Double-Blind Phase|Pregnancy|0
7038719|NCT01705574|11121202|FG003|Double-Blind Phase|Pregnancy|0
7038720|NCT01705574|11121199|FG000|Double-Blind Phase|Protocol Violation|1
7038721|NCT01705574|11121200|FG001|Double-Blind Phase|Protocol Violation|0
7062321|NCT01937884|11159887|FG000|Overall Study|Withdrawal by Subject|1
6831226|NCT00168818|10834980|FG002|Overall Study|Adverse Event|31
7062322|NCT01937884|11159888|FG001|Overall Study|Withdrawal by Subject|0
6831227|NCT00168818|10834978|FG000|Overall Study|Protocol Violation|16
6831228|NCT00168818|10834979|FG001|Overall Study|Protocol Violation|11
6831229|NCT00168818|10834980|FG002|Overall Study|Protocol Violation|11
6831230|NCT00168818|10834978|FG000|Overall Study|Lost to Follow-up|13
6831231|NCT00168818|10834979|FG001|Overall Study|Lost to Follow-up|4
6831232|NCT00168818|10834980|FG002|Overall Study|Lost to Follow-up|15
6831233|NCT00168818|10834978|FG000|Overall Study|Withdrawal by Subject|43
6831234|NCT00168818|10834979|FG001|Overall Study|Withdrawal by Subject|41
6831235|NCT00168818|10834980|FG002|Overall Study|Withdrawal by Subject|37
6831236|NCT00168818|10834978|FG000|Overall Study|Other|22
6831237|NCT00168818|10834979|FG001|Overall Study|Other|24
7038722|NCT01705574|11121201|FG002|Double-Blind Phase|Protocol Violation|0
7038723|NCT01705574|11121202|FG003|Double-Blind Phase|Protocol Violation|0
6831238|NCT00168818|10834980|FG002|Overall Study|Other|30
6831239|NCT00168818|10834978|FG000|Treatment|Adverse Event|77
6831240|NCT00168818|10834979|FG001|Treatment|Adverse Event|89
6831241|NCT00168818|10834980|FG002|Treatment|Adverse Event|68
6831242|NCT00168818|10834978|FG000|Treatment|Protocol Violation|8
6831243|NCT00168818|10834979|FG001|Treatment|Protocol Violation|11
6831244|NCT00168818|10834980|FG002|Treatment|Protocol Violation|11
6831245|NCT00168818|10834978|FG000|Treatment|Lost to Follow-up|0
6831246|NCT00168818|10834979|FG001|Treatment|Lost to Follow-up|2
6831247|NCT00168818|10834980|FG002|Treatment|Lost to Follow-up|1
6831248|NCT00168818|10834978|FG000|Treatment|Withdrawal by Subject|25
6831249|NCT00168818|10834979|FG001|Treatment|Withdrawal by Subject|20
6831250|NCT00168818|10834980|FG002|Treatment|Withdrawal by Subject|22
6831251|NCT00168818|10834978|FG000|Treatment|Other|23
6831252|NCT00168818|10834979|FG001|Treatment|Other|29
6831253|NCT00168818|10834980|FG002|Treatment|Other|31
6831254|NCT00168831|10834991|FG000|Overall Study|Adverse Event|36
6831255|NCT00168831|10834992|FG001|Overall Study|Adverse Event|47
6831256|NCT00168831|10834993|FG002|Overall Study|Adverse Event|74
6831257|NCT00168831|10834991|FG000|Overall Study|Lost to Follow-up|5
6831258|NCT00168831|10834992|FG001|Overall Study|Lost to Follow-up|6
6831259|NCT00168831|10834993|FG002|Overall Study|Lost to Follow-up|4
6831260|NCT00168831|10834991|FG000|Overall Study|Withdrawal by Subject|7
6831261|NCT00168831|10834992|FG001|Overall Study|Withdrawal by Subject|14
6831262|NCT00168831|10834993|FG002|Overall Study|Withdrawal by Subject|19
6831263|NCT00168831|10834991|FG000|Overall Study|Protocol Violation|6
6831264|NCT00168831|10834992|FG001|Overall Study|Protocol Violation|11
6831265|NCT00168831|10834993|FG002|Overall Study|Protocol Violation|11
6831266|NCT00168831|10834991|FG000|Overall Study|Other|6
6831267|NCT00168831|10834992|FG001|Overall Study|Other|3
6831268|NCT00168831|10834993|FG002|Overall Study|Other|6
6831269|NCT00168844|10835004|FG000|Overall Study|Adverse Event|31
6831270|NCT00168844|10835005|FG001|Overall Study|Adverse Event|32
6831271|NCT00168844|10835006|FG002|Overall Study|Adverse Event|48
6831272|NCT00168844|10835004|FG000|Overall Study|Lost to Follow-up|4
6831273|NCT00168844|10835005|FG001|Overall Study|Lost to Follow-up|5
6831274|NCT00168844|10835006|FG002|Overall Study|Lost to Follow-up|11
6831275|NCT00168844|10835004|FG000|Overall Study|Withdrawal by Subject|12
6831276|NCT00168844|10835005|FG001|Overall Study|Withdrawal by Subject|9
6831277|NCT00168844|10835006|FG002|Overall Study|Withdrawal by Subject|19
6831278|NCT00168844|10835004|FG000|Overall Study|Protocol Violation|2
6831279|NCT00168844|10835005|FG001|Overall Study|Protocol Violation|2
6831280|NCT00168844|10835006|FG002|Overall Study|Protocol Violation|4
6831281|NCT00168844|10835004|FG000|Overall Study|Other|6
6831282|NCT00168844|10835005|FG001|Overall Study|Other|7
6831283|NCT00168844|10835006|FG002|Overall Study|Other|9
6831284|NCT00169104|10835016|FG000|Overall Study|Withdrawal by Subject|2
6831285|NCT00169104|10835017|FG001|Overall Study|Withdrawal by Subject|0
6831286|NCT00169104|10835016|FG000|Overall Study|Protocol Violation|0
6831287|NCT00169104|10835017|FG001|Overall Study|Protocol Violation|1
6831288|NCT00169104|10835016|FG000|Overall Study|Physician Decision|0
6831289|NCT00169104|10835017|FG001|Overall Study|Physician Decision|1
6831290|NCT00169442|10835030|FG000|Overall Study|Withdrawal by Subject|0
6831291|NCT00169442|10835031|FG001|Overall Study|Withdrawal by Subject|0
6974834|NCT01190930|11027138|FG007|Induction|Withdrawal by Subject|0
6831292|NCT00169442|10835032|FG002|Overall Study|Withdrawal by Subject|1
6831293|NCT00169442|10835033|FG003|Overall Study|Withdrawal by Subject|0
6831294|NCT00169442|10835034|FG004|Overall Study|Withdrawal by Subject|0
6831295|NCT00169442|10835035|FG005|Overall Study|Withdrawal by Subject|0
6831296|NCT00169442|10835030|FG000|Overall Study|Migrated/moved from study area|0
6831297|NCT00169442|10835031|FG001|Overall Study|Migrated/moved from study area|0
6831298|NCT00169442|10835032|FG002|Overall Study|Migrated/moved from study area|0
6831299|NCT00169442|10835033|FG003|Overall Study|Migrated/moved from study area|0
6831300|NCT00169442|10835034|FG004|Overall Study|Migrated/moved from study area|0
6831301|NCT00169442|10835035|FG005|Overall Study|Migrated/moved from study area|2
6831302|NCT00169442|10835030|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0
6831303|NCT00169442|10835031|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0
6831304|NCT00169442|10835032|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0
6831305|NCT00169442|10835033|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0
6831306|NCT00169442|10835034|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1
6831307|NCT00169442|10835035|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0
6831308|NCT00169442|10835030|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0
6831309|NCT00169442|10835031|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1
6974835|NCT01190930|11027139|FG008|Induction|Withdrawal by Subject|0
6974836|NCT01190930|11027140|FG009|Induction|Withdrawal by Subject|0
6974837|NCT01190930|11027131|FG000|Induction|Refusal|235
6831310|NCT00169442|10835032|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0
6831311|NCT00169442|10835033|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0
6831312|NCT00169442|10835034|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0
6831313|NCT00169442|10835035|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0
6831314|NCT00170846|10835065|FG000|Overall Study|Subject withdrew Informed Consent|5
6831315|NCT00170846|10835066|FG001|Overall Study|Subject withdrew Informed Consent|12
6831316|NCT00170846|10835067|FG002|Overall Study|Subject withdrew Informed Consent|8
6924874|NCT00828139|10954763|FG002|Overall Study|Refusal unrelated to toxicity|5
6924875|NCT00828139|10954764|FG003|Overall Study|Refusal unrelated to toxicity|3
6924876|NCT00828139|10954761|FG000|Overall Study|Disease Progression|24
6924877|NCT00828139|10954762|FG001|Overall Study|Disease Progression|33
6924878|NCT00828139|10954763|FG002|Overall Study|Disease Progression|35
6924879|NCT00828139|10954764|FG003|Overall Study|Disease Progression|39
6924880|NCT00828139|10954761|FG000|Overall Study|Other|4
6924881|NCT00828139|10954762|FG001|Overall Study|Other|2
6924882|NCT00828139|10954763|FG002|Overall Study|Other|5
6924883|NCT00828139|10954764|FG003|Overall Study|Other|2
6924884|NCT00828204|10954796|FG000|Main Study: Prior to Study Suspension|Adverse Event|1
6924885|NCT00828204|10954797|FG001|Main Study: Prior to Study Suspension|Adverse Event|0
6924886|NCT00828204|10954796|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2
6924887|NCT00828204|10954797|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0
6924888|NCT00828204|10954796|FG000|Main Study: Prior to Study Suspension|Study Suspension|11
6924889|NCT00828204|10954797|FG001|Main Study: Prior to Study Suspension|Study Suspension|0
6924890|NCT00828204|10954796|FG000|Main Study: After Study Restart|Adverse Event|0
6924891|NCT00828204|10954797|FG001|Main Study: After Study Restart|Adverse Event|2
6924892|NCT00828204|10954796|FG000|Main Study: After Study Restart|Noncompliance|0
6924893|NCT00828204|10954797|FG001|Main Study: After Study Restart|Noncompliance|1
6924894|NCT00828204|10954796|FG000|Extension Study|Lost to Follow-up|0
6924895|NCT00828204|10954797|FG001|Extension Study|Lost to Follow-up|1
6924896|NCT00828204|10954796|FG000|Extension Study|Physician Decision|0
6924897|NCT00828204|10954797|FG001|Extension Study|Physician Decision|2
6924898|NCT00828451|10954831|FG000|Overall Study|Death|2
6924899|NCT00828451|10954831|FG000|Overall Study|Lack of intravenous line|7
6924900|NCT00828451|10954831|FG000|Overall Study|Withdrawal by Subject|1
6924901|NCT00828451|10954831|FG000|Overall Study|Deterioration in clinical status|1
6924902|NCT00828464|10954835|FG000|Overall Study|Withdrawal by Subject|1
6974838|NCT01190930|11027132|FG001|Induction|Refusal|0
6974839|NCT01190930|11027133|FG002|Induction|Refusal|0
6974840|NCT01190930|11027134|FG003|Induction|Refusal|0
6974841|NCT01190930|11027135|FG004|Induction|Refusal|0
6974842|NCT01190930|11027136|FG005|Induction|Refusal|0
6974843|NCT01190930|11027137|FG006|Induction|Refusal|0
6974844|NCT01190930|11027138|FG007|Induction|Refusal|0
6974845|NCT01190930|11027139|FG008|Induction|Refusal|0
7038724|NCT01705574|11121199|FG000|Double-Blind Phase|Randomized but Not Treated|4
7038725|NCT01705574|11121200|FG001|Double-Blind Phase|Randomized but Not Treated|4
7038726|NCT01705574|11121201|FG002|Double-Blind Phase|Randomized but Not Treated|0
7038727|NCT01705574|11121202|FG003|Double-Blind Phase|Randomized but Not Treated|0
7038728|NCT01705574|11121199|FG000|Open-Label Extension Phase|Lost to Follow-up|6
7038729|NCT01705574|11121200|FG001|Open-Label Extension Phase|Lost to Follow-up|0
7038730|NCT01705574|11121201|FG002|Open-Label Extension Phase|Lost to Follow-up|2
7038731|NCT01705574|11121202|FG003|Open-Label Extension Phase|Lost to Follow-up|2
7038732|NCT01705574|11121199|FG000|Open-Label Extension Phase|Withdrew Consent|4
7038733|NCT01705574|11121200|FG001|Open-Label Extension Phase|Withdrew Consent|0
7038734|NCT01705574|11121201|FG002|Open-Label Extension Phase|Withdrew Consent|4
7038735|NCT01705574|11121202|FG003|Open-Label Extension Phase|Withdrew Consent|1
7038736|NCT01705574|11121199|FG000|Open-Label Extension Phase|Adverse Event|3
7038737|NCT01705574|11121200|FG001|Open-Label Extension Phase|Adverse Event|0
7038738|NCT01705574|11121201|FG002|Open-Label Extension Phase|Adverse Event|0
7038739|NCT01705574|11121202|FG003|Open-Label Extension Phase|Adverse Event|1
7038740|NCT01705574|11121199|FG000|Open-Label Extension Phase|Death|2
7038741|NCT01705574|11121200|FG001|Open-Label Extension Phase|Death|0
7038742|NCT01705574|11121201|FG002|Open-Label Extension Phase|Death|1
7038743|NCT01705574|11121202|FG003|Open-Label Extension Phase|Death|0
7038744|NCT01705574|11121199|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0
7038745|NCT01705574|11121200|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0
7044761|NCT01756898|11130713|FG000|Overall Study|Other|0
7062323|NCT01938391|11159971|FG000|6 Month Follow up|Withdrawal by Subject|1
7062324|NCT01938391|11159971|FG000|12 Month Follow up|Physician Decision|1
7062325|NCT01938391|11159971|FG000|12 Month Follow up|Withdrawal by Subject|1
7062326|NCT01938430|11159989|FG000|Overall Study|Randomized but Not Treated|0
7062327|NCT01938430|11159990|FG001|Overall Study|Randomized but Not Treated|0
7062328|NCT01938430|11159991|FG002|Overall Study|Randomized but Not Treated|0
6831317|NCT00170846|10835065|FG000|Overall Study|Lost to Follow-up|6
6831318|NCT00170846|10835066|FG001|Overall Study|Lost to Follow-up|3
6831319|NCT00170846|10835067|FG002|Overall Study|Lost to Follow-up|2
6831320|NCT00170846|10835065|FG000|Overall Study|Death|0
6831321|NCT00170846|10835066|FG001|Overall Study|Death|3
6831322|NCT00170846|10835067|FG002|Overall Study|Death|3
6831323|NCT00170846|10835065|FG000|Overall Study|Reason Missing|0
6831324|NCT00170846|10835066|FG001|Overall Study|Reason Missing|1
6974846|NCT01190930|11027140|FG009|Induction|Refusal|0
6831325|NCT00170846|10835067|FG002|Overall Study|Reason Missing|0
6831326|NCT00170950|10835077|FG000|Overall Study|Death|236
6831327|NCT00170950|10835078|FG001|Overall Study|Death|274
6831328|NCT00170950|10835077|FG000|Overall Study|Withdrawal by Subject|496
6831329|NCT00170950|10835078|FG001|Overall Study|Withdrawal by Subject|498
6831330|NCT00170950|10835077|FG000|Overall Study|Lost to Follow-up|134
6831331|NCT00170950|10835078|FG001|Overall Study|Lost to Follow-up|115
6831332|NCT00170950|10835077|FG000|Overall Study|Missing|2
6831333|NCT00170950|10835078|FG001|Overall Study|Missing|1
6831334|NCT00170950|10835077|FG000|Overall Study|Termination Data Not Recorded|17
6831335|NCT00170950|10835078|FG001|Overall Study|Termination Data Not Recorded|22
6831336|NCT00171054|10835086|FG000|Overall Study|Protocol Violation|1
6831337|NCT00171054|10835087|FG001|Overall Study|Protocol Violation|2
6831338|NCT00171054|10835086|FG000|Overall Study|Patient withdrew consent|1
6831339|NCT00171054|10835087|FG001|Overall Study|Patient withdrew consent|0
6831340|NCT00171054|10835086|FG000|Overall Study|Lost to Follow-up|0
6831341|NCT00171054|10835087|FG001|Overall Study|Lost to Follow-up|1
6831342|NCT00171054|10835086|FG000|Overall Study|Adverse Event|8
6831343|NCT00171054|10835087|FG001|Overall Study|Adverse Event|8
6831344|NCT00171054|10835086|FG000|Overall Study|Condition no longer required study drug|0
6831345|NCT00171054|10835087|FG001|Overall Study|Condition no longer required study drug|1
6897170|NCT00637377|10915909|FG001|Overall Study|Adverse Event|6
6897171|NCT00637377|10915910|FG002|Overall Study|Adverse Event|8
6897172|NCT00637377|10915911|FG003|Overall Study|Adverse Event|9
6897173|NCT00637377|10915908|FG000|Overall Study|Death|1
6897174|NCT00637377|10915909|FG001|Overall Study|Death|3
6897175|NCT00637377|10915910|FG002|Overall Study|Death|2
6897176|NCT00637377|10915911|FG003|Overall Study|Death|1
6897177|NCT00637377|10915908|FG000|Overall Study|Lack of Efficacy|0
6897178|NCT00637377|10915909|FG001|Overall Study|Lack of Efficacy|0
6897179|NCT00637377|10915910|FG002|Overall Study|Lack of Efficacy|1
6897180|NCT00637377|10915911|FG003|Overall Study|Lack of Efficacy|1
6897181|NCT00637377|10915908|FG000|Overall Study|Lost to Follow-up|4
6924903|NCT00828516|10954839|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2
6924904|NCT00828568|10954855|FG000|Randomized|Withdrawal by Subject|1
7038746|NCT01705574|11121201|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1
7038747|NCT01705574|11121202|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0
7038748|NCT01705574|11121199|FG000|Open-Label Extension Phase|Physician Decision|0
7038749|NCT01705574|11121200|FG001|Open-Label Extension Phase|Physician Decision|0
7038750|NCT01705574|11121201|FG002|Open-Label Extension Phase|Physician Decision|2
7038751|NCT01705574|11121202|FG003|Open-Label Extension Phase|Physician Decision|0
7038752|NCT01705574|11121199|FG000|Open-Label Extension Phase|Pregnancy|0
7038753|NCT01705574|11121200|FG001|Open-Label Extension Phase|Pregnancy|0
7038754|NCT01705574|11121201|FG002|Open-Label Extension Phase|Pregnancy|1
7038755|NCT01705574|11121202|FG003|Open-Label Extension Phase|Pregnancy|1
7038756|NCT01705587|11121220|FG000|Overall Study|Withdrawal by Subject|0
7038757|NCT01705587|11121221|FG001|Overall Study|Withdrawal by Subject|1
6924905|NCT00828568|10954856|FG001|Randomized|Withdrawal by Subject|0
6924906|NCT00828568|10954857|FG002|Randomized|Withdrawal by Subject|2
6924907|NCT00828568|10954855|FG000|Treated - Received at Least One Dose|Adverse Event|11
6924908|NCT00828568|10954856|FG001|Treated - Received at Least One Dose|Adverse Event|8
6924909|NCT00828568|10954857|FG002|Treated - Received at Least One Dose|Adverse Event|1
6924910|NCT00828568|10954855|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9
6924911|NCT00828568|10954856|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11
6924912|NCT00828568|10954857|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0
6924913|NCT00828568|10954855|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1
6924914|NCT00828568|10954856|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5
6924915|NCT00828568|10954857|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1
6924916|NCT00828568|10954855|FG000|Treated - Received at Least One Dose|Protocol Violation|9
6924917|NCT00828568|10954856|FG001|Treated - Received at Least One Dose|Protocol Violation|5
6924918|NCT00828568|10954857|FG002|Treated - Received at Least One Dose|Protocol Violation|3
6924919|NCT00828672|10954868|FG000|Study Treatment|Lost to Follow-up|1
6924920|NCT00828672|10954869|FG001|Study Treatment|Lost to Follow-up|0
6924921|NCT00828672|10954868|FG000|Study Treatment|Adverse Event|0
6924922|NCT00828672|10954869|FG001|Study Treatment|Adverse Event|1
6924923|NCT00828672|10954868|FG000|Study Treatment|Complete response, no surgery|1
6924924|NCT00828672|10954869|FG001|Study Treatment|Complete response, no surgery|1
6924925|NCT00828672|10954868|FG000|Post-surgery (<30 Days)|No central review materials|0
6924926|NCT00828672|10954869|FG001|Post-surgery (<30 Days)|No central review materials|1
6924927|NCT00828711|10954878|FG000|Overall Study|Lost to Follow-up|1
6924928|NCT00828711|10954879|FG001|Overall Study|Lost to Follow-up|0
6924929|NCT00828711|10954880|FG002|Overall Study|Lost to Follow-up|0
6924930|NCT00828750|10954888|FG000|Overall Study|Lack of Efficacy|3
6924931|NCT00828750|10954888|FG000|Overall Study|Normal PC Remained While No Treatment|1
6924932|NCT00828945|10954908|FG000|Overall Study|Death|4
7038758|NCT01705652|11121229|FG000|Overall Study|Adverse Event|1
7038759|NCT01705652|11121230|FG001|Overall Study|Adverse Event|0
7038760|NCT01705652|11121229|FG000|Overall Study|Withdrawal by Subject|1
6897182|NCT00637377|10915909|FG001|Overall Study|Lost to Follow-up|1
6897183|NCT00637377|10915910|FG002|Overall Study|Lost to Follow-up|2
6897184|NCT00637377|10915911|FG003|Overall Study|Lost to Follow-up|2
6831346|NCT00171158|10835093|FG000|Core Study|Death|27
6831347|NCT00171158|10835093|FG000|Core Study|Unsatisfactory therapeutic effect|163
6831348|NCT00171158|10835093|FG000|Core Study|Protocol Violation|4
6831349|NCT00171158|10835093|FG000|Core Study|Administrative problems|1
6831350|NCT00171158|10835093|FG000|Core Study|Adverse event, non-fatal|21
6831351|NCT00171158|10835093|FG000|Core Study|Consent withdrawn by subject|6
6831352|NCT00171158|10835093|FG000|Core Study|No longer required drug (BMT)|14
6831353|NCT00171158|10835093|FG000|Core Study|Abnormal Laboratory Values|2
6831354|NCT00171158|10835093|FG000|Core Study|Lost to Follow-up|1
6831355|NCT00171158|10835093|FG000|E2 Extension|Other|7
6831356|NCT00171210|10835099|FG000|Overall Study|Adverse Event|16
6831357|NCT00171210|10835100|FG001|Overall Study|Adverse Event|27
6831358|NCT00171210|10835099|FG000|Overall Study|Abnormal laboratory value(s)|6
6831359|NCT00171210|10835100|FG001|Overall Study|Abnormal laboratory value(s)|3
6831360|NCT00171210|10835099|FG000|Overall Study|Abnormal test procedure result(s)|0
6831361|NCT00171210|10835100|FG001|Overall Study|Abnormal test procedure result(s)|1
6831362|NCT00171210|10835099|FG000|Overall Study|Unsatisfactory therapeutic effect|11
6831363|NCT00171210|10835100|FG001|Overall Study|Unsatisfactory therapeutic effect|15
6831364|NCT00171210|10835099|FG000|Overall Study|Protocol Violation|0
6831365|NCT00171210|10835100|FG001|Overall Study|Protocol Violation|2
6831366|NCT00171210|10835099|FG000|Overall Study|Withdrawal by Subject|32
6831367|NCT00171210|10835100|FG001|Overall Study|Withdrawal by Subject|30
6831368|NCT00171210|10835099|FG000|Overall Study|Lost to Follow-up|1
6831369|NCT00171210|10835100|FG001|Overall Study|Lost to Follow-up|0
6831370|NCT00171210|10835099|FG000|Overall Study|Administrative problems|1
6831371|NCT00171210|10835100|FG001|Overall Study|Administrative problems|1
6831372|NCT00171210|10835099|FG000|Overall Study|Death|2
6831373|NCT00171210|10835100|FG001|Overall Study|Death|3
6831374|NCT00171210|10835099|FG000|Overall Study|Stopped at end of core|0
6831375|NCT00171210|10835100|FG001|Overall Study|Stopped at end of core|32
6831376|NCT00171210|10835099|FG000|Overall Study|Stopped at end of extension 1|0
6831377|NCT00171210|10835100|FG001|Overall Study|Stopped at end of extension 1|1
6831378|NCT00171223|10835109|FG000|Overall Study|Adverse Event (Non-fatal)|6
6831379|NCT00171223|10835110|FG001|Overall Study|Adverse Event (Non-fatal)|5
6831380|NCT00171223|10835111|FG002|Overall Study|Adverse Event (Non-fatal)|19
6831381|NCT00171223|10835109|FG000|Overall Study|Abnormal Laboratory Value (s)|4
6831382|NCT00171223|10835110|FG001|Overall Study|Abnormal Laboratory Value (s)|2
6831383|NCT00171223|10835111|FG002|Overall Study|Abnormal Laboratory Value (s)|3
6831384|NCT00171223|10835109|FG000|Overall Study|Abnormal Procedure|1
6831385|NCT00171223|10835110|FG001|Overall Study|Abnormal Procedure|0
6831386|NCT00171223|10835111|FG002|Overall Study|Abnormal Procedure|0
6831387|NCT00171223|10835109|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57
6831388|NCT00171223|10835110|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43
6831389|NCT00171223|10835111|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52
6831390|NCT00171223|10835109|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2
6831391|NCT00171223|10835110|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4
6831392|NCT00171223|10835111|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2
6831393|NCT00171223|10835109|FG000|Overall Study|Protocol Violation|2
6831394|NCT00171223|10835110|FG001|Overall Study|Protocol Violation|2
6831395|NCT00171223|10835111|FG002|Overall Study|Protocol Violation|3
6831396|NCT00171223|10835109|FG000|Overall Study|Participant Withdrew Consent|12
7062329|NCT01938430|11159992|FG003|Overall Study|Randomized but Not Treated|0
7062330|NCT01938430|11159993|FG004|Overall Study|Randomized but Not Treated|0
7062331|NCT01938430|11159994|FG005|Overall Study|Randomized but Not Treated|0
7062332|NCT01938430|11159995|FG006|Overall Study|Randomized but Not Treated|0
7062333|NCT01938430|11159996|FG007|Overall Study|Randomized but Not Treated|0
7062334|NCT01938430|11159997|FG008|Overall Study|Randomized but Not Treated|0
7062335|NCT01938430|11159998|FG009|Overall Study|Randomized but Not Treated|0
7062336|NCT01938430|11159999|FG010|Overall Study|Randomized but Not Treated|1
7062337|NCT01938430|11160000|FG011|Overall Study|Randomized but Not Treated|0
6831397|NCT00171223|10835110|FG001|Overall Study|Participant Withdrew Consent|21
6831398|NCT00171223|10835111|FG002|Overall Study|Participant Withdrew Consent|15
6831399|NCT00171223|10835109|FG000|Overall Study|Lost to Follow-up|5
6831400|NCT00171223|10835110|FG001|Overall Study|Lost to Follow-up|2
6831401|NCT00171223|10835111|FG002|Overall Study|Lost to Follow-up|3
6831402|NCT00171223|10835109|FG000|Overall Study|Administrative Problems|4
6831403|NCT00171223|10835110|FG001|Overall Study|Administrative Problems|7
6831404|NCT00171223|10835111|FG002|Overall Study|Administrative Problems|6
6831405|NCT00171223|10835109|FG000|Overall Study|Adverse Event (Serious Fatal)|6
6831406|NCT00171223|10835110|FG001|Overall Study|Adverse Event (Serious Fatal)|8
6831407|NCT00171223|10835111|FG002|Overall Study|Adverse Event (Serious Fatal)|9
6924933|NCT00828945|10954908|FG000|Overall Study|Participant was missing|1
6924934|NCT00828945|10954908|FG000|Overall Study|Other|36
6831408|NCT00171223|10835109|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41
6831409|NCT00171223|10835110|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47
6831410|NCT00171223|10835111|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58
7062338|NCT01938430|11160001|FG012|Overall Study|Randomized but Not Treated|0
7062339|NCT01938430|11160002|FG013|Overall Study|Randomized but Not Treated|1
7062340|NCT01938430|11159989|FG000|Overall Study|Adverse Event|0
7062341|NCT01938430|11159990|FG001|Overall Study|Adverse Event|0
6831411|NCT00171249|10835117|FG000|Overall Study|Withdrawal by Subject|2
7038761|NCT01705652|11121230|FG001|Overall Study|Withdrawal by Subject|2
7038762|NCT01705652|11121229|FG000|Overall Study|non-compliance|1
7038763|NCT01705652|11121230|FG001|Overall Study|non-compliance|1
7038764|NCT01705691|11121238|FG000|Overall Study|Death|1
7038765|NCT01705691|11121239|FG001|Overall Study|Death|2
7038766|NCT01705691|11121238|FG000|Overall Study|Withdrawal by Subject|1
7038767|NCT01705691|11121239|FG001|Overall Study|Withdrawal by Subject|2
7038768|NCT01705691|11121238|FG000|Overall Study|Lost to Follow-up|1
7038769|NCT01705691|11121239|FG001|Overall Study|Lost to Follow-up|1
7038770|NCT01705691|11121238|FG000|Overall Study|Other|0
7038771|NCT01705691|11121239|FG001|Overall Study|Other|1
7038772|NCT01705717|11121247|FG000|Overall Study|Adverse Event|2
7038773|NCT01705717|11121248|FG001|Overall Study|Adverse Event|2
7038774|NCT01705717|11121247|FG000|Overall Study|Lack of Efficacy|0
7038775|NCT01705717|11121248|FG001|Overall Study|Lack of Efficacy|1
7038776|NCT01705717|11121247|FG000|Overall Study|Other|0
7038777|NCT01705717|11121248|FG001|Overall Study|Other|2
7038778|NCT01705730|11121253|FG000|Overall Study|Lack of Efficacy|1
7038779|NCT01705730|11121253|FG000|Overall Study|Adverse Event|3
7038780|NCT01705730|11121253|FG000|Overall Study|Lost to Follow-up|1
7038781|NCT01705730|11121253|FG000|Overall Study|Reason not Specified|4
7038782|NCT01706003|11121268|FG000|Overall Study|Withdrawal by Subject|2
7038783|NCT01706003|11121269|FG001|Overall Study|Withdrawal by Subject|0
7038784|NCT01706003|11121268|FG000|Overall Study|Not scheduled|3
7038785|NCT01706003|11121269|FG001|Overall Study|Not scheduled|0
7038786|NCT01706003|11121268|FG000|Overall Study|Lost to Follow-up|6
7038787|NCT01706003|11121269|FG001|Overall Study|Lost to Follow-up|4
7038788|NCT01706146|11121284|FG000|Overall Study|Withdrawal by Subject|1
7038789|NCT01706146|11121284|FG000|Overall Study|Adverse Event|3
7038790|NCT01706146|11121284|FG000|Overall Study|Developed AF and need for antiplatelets|2
7038791|NCT01706159|11121290|FG000|Overall Study|Withdrawal Criteria|2
7038792|NCT01706159|11121291|FG001|Overall Study|Withdrawal Criteria|1
7038793|NCT01706159|11121290|FG000|Overall Study|Unclassified|6
7038794|NCT01706159|11121291|FG001|Overall Study|Unclassified|1
7038795|NCT01706198|11121299|FG000|Overall Study|Adverse Event|12
7038796|NCT01706198|11121300|FG001|Overall Study|Adverse Event|15
7038797|NCT01706198|11121299|FG000|Overall Study|Protocol Violation|7
7038798|NCT01706198|11121300|FG001|Overall Study|Protocol Violation|5
7038799|NCT01706198|11121299|FG000|Overall Study|Other: Subject reached stopping criteria|11
7038800|NCT01706198|11121300|FG001|Overall Study|Other: Subject reached stopping criteria|13
7038801|NCT01706198|11121299|FG000|Overall Study|Lost to Follow-up|97
7038802|NCT01706198|11121300|FG001|Overall Study|Lost to Follow-up|93
7038803|NCT01706198|11121299|FG000|Overall Study|Physician Decision|23
7038804|NCT01706198|11121300|FG001|Overall Study|Physician Decision|37
7038805|NCT01706198|11121299|FG000|Overall Study|Withdrawal by Subject|23
7038806|NCT01706198|11121300|FG001|Overall Study|Withdrawal by Subject|31
7038807|NCT01706250|11121306|FG000|Overall Study|Lost to Follow-up|2
7038808|NCT01706328|11121322|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140
7038809|NCT01706328|11121323|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
7038810|NCT01706328|11121324|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
7038811|NCT01706328|11121322|FG000|2-week Run-in Period|Withdrawal by Subject|15
7038812|NCT01706328|11121323|FG001|2-week Run-in Period|Withdrawal by Subject|0
7038813|NCT01706328|11121324|FG002|2-week Run-in Period|Withdrawal by Subject|0
7038814|NCT01706328|11121322|FG000|2-week Run-in Period|Physician Decision|4
7038815|NCT01706328|11121323|FG001|2-week Run-in Period|Physician Decision|0
7038816|NCT01706328|11121324|FG002|2-week Run-in Period|Physician Decision|0
7038817|NCT01706328|11121322|FG000|2-week Run-in Period|Adverse Event|4
7038818|NCT01706328|11121323|FG001|2-week Run-in Period|Adverse Event|0
7038819|NCT01706328|11121324|FG002|2-week Run-in Period|Adverse Event|0
7038820|NCT01706328|11121322|FG000|2-week Run-in Period|Lost to Follow-up|2
7038821|NCT01706328|11121323|FG001|2-week Run-in Period|Lost to Follow-up|0
7038822|NCT01706328|11121324|FG002|2-week Run-in Period|Lost to Follow-up|0
7038823|NCT01706328|11121322|FG000|12-week Double-blind Treatment Period|Adverse Event|0
7038824|NCT01706328|11121323|FG001|12-week Double-blind Treatment Period|Adverse Event|14
7038825|NCT01706328|11121324|FG002|12-week Double-blind Treatment Period|Adverse Event|16
7062342|NCT01938430|11159991|FG002|Overall Study|Adverse Event|0
7062343|NCT01938430|11159992|FG003|Overall Study|Adverse Event|0
7062344|NCT01938430|11159993|FG004|Overall Study|Adverse Event|0
7062345|NCT01938430|11159994|FG005|Overall Study|Adverse Event|0
7062346|NCT01938430|11159995|FG006|Overall Study|Adverse Event|1
7062347|NCT01938430|11159996|FG007|Overall Study|Adverse Event|0
7062348|NCT01938430|11159997|FG008|Overall Study|Adverse Event|0
7062349|NCT01938430|11159998|FG009|Overall Study|Adverse Event|0
7062350|NCT01938430|11159999|FG010|Overall Study|Adverse Event|0
7062351|NCT01938430|11160000|FG011|Overall Study|Adverse Event|0
7038826|NCT01706328|11121322|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0
6831412|NCT00171249|10835118|FG001|Overall Study|Withdrawal by Subject|0
7038827|NCT01706328|11121323|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4
7038828|NCT01706328|11121324|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4
7038829|NCT01706328|11121322|FG000|12-week Double-blind Treatment Period|Protocol Violation|0
7062352|NCT01938430|11160001|FG012|Overall Study|Adverse Event|0
7062353|NCT01938430|11160002|FG013|Overall Study|Adverse Event|0
7038830|NCT01706328|11121323|FG001|12-week Double-blind Treatment Period|Protocol Violation|4
7038831|NCT01706328|11121324|FG002|12-week Double-blind Treatment Period|Protocol Violation|2
7038832|NCT01706328|11121322|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0
7038833|NCT01706328|11121323|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11
7038834|NCT01706328|11121324|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9
7038835|NCT01706328|11121322|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0
7038836|NCT01706328|11121323|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3
7038837|NCT01706328|11121324|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1
7038838|NCT01706328|11121322|FG000|12-week Double-blind Treatment Period|Physician Decision|0
7038839|NCT01706328|11121323|FG001|12-week Double-blind Treatment Period|Physician Decision|2
7038840|NCT01706328|11121324|FG002|12-week Double-blind Treatment Period|Physician Decision|2
7038841|NCT01706328|11121322|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0
7038842|NCT01706328|11121323|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8
7038843|NCT01706328|11121324|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11
7038844|NCT01706458|11121332|FG000|Overall Study|Physician Decision|3
7038845|NCT01706458|11121333|FG001|Overall Study|Physician Decision|4
7038846|NCT01706536|11121348|FG000|Overall Study|Withdrawal by Subject|1
7038847|NCT01706536|11121349|FG001|Overall Study|Withdrawal by Subject|0
7038848|NCT01706536|11121350|FG002|Overall Study|Withdrawal by Subject|1
7038849|NCT01706536|11121351|FG003|Overall Study|Withdrawal by Subject|0
7038850|NCT01706536|11121352|FG004|Overall Study|Withdrawal by Subject|0
7038851|NCT01706536|11121348|FG000|Overall Study|Adverse Event|2
7038852|NCT01706536|11121349|FG001|Overall Study|Adverse Event|3
7038853|NCT01706536|11121350|FG002|Overall Study|Adverse Event|4
7038854|NCT01706536|11121351|FG003|Overall Study|Adverse Event|3
7038855|NCT01706536|11121352|FG004|Overall Study|Adverse Event|2
7038856|NCT01706536|11121348|FG000|Overall Study|Lack of Efficacy|1
7038857|NCT01706536|11121349|FG001|Overall Study|Lack of Efficacy|0
7038858|NCT01706536|11121350|FG002|Overall Study|Lack of Efficacy|0
7038859|NCT01706536|11121351|FG003|Overall Study|Lack of Efficacy|1
7038860|NCT01706536|11121352|FG004|Overall Study|Lack of Efficacy|0
7038861|NCT01706536|11121348|FG000|Overall Study|non compliance|0
7038862|NCT01706536|11121349|FG001|Overall Study|non compliance|1
7038863|NCT01706536|11121350|FG002|Overall Study|non compliance|0
7038864|NCT01706536|11121351|FG003|Overall Study|non compliance|0
7038865|NCT01706536|11121352|FG004|Overall Study|non compliance|0
7038866|NCT01706575|11121369|FG000|Overall Study|Participant Withdrew Consent|4
7038867|NCT01706575|11121369|FG000|Overall Study|Lost to Follow-up|2
7038868|NCT01706575|11121369|FG000|Overall Study|Started but not Treated|6
7038869|NCT01706770|11121409|FG000|Overall Study|Lost to Follow-up|1
7038870|NCT01706770|11121410|FG001|Overall Study|Lost to Follow-up|0
7038871|NCT01706770|11121409|FG000|Overall Study|Physician Decision|1
7038872|NCT01706770|11121410|FG001|Overall Study|Physician Decision|0
7038873|NCT01706926|11121424|FG000|Overall Study|Lost to Follow-up|0
7038874|NCT01706926|11121425|FG001|Overall Study|Lost to Follow-up|0
7038875|NCT01706926|11121426|FG002|Overall Study|Lost to Follow-up|1
7062354|NCT01938430|11159989|FG000|Overall Study|Death|1
6831413|NCT00171249|10835119|FG002|Overall Study|Withdrawal by Subject|0
6831414|NCT00171249|10835120|FG003|Overall Study|Withdrawal by Subject|6
6831415|NCT00171249|10835121|FG004|Overall Study|Withdrawal by Subject|0
6831416|NCT00171249|10835122|FG005|Overall Study|Withdrawal by Subject|0
6831417|NCT00171249|10835123|FG006|Overall Study|Withdrawal by Subject|0
6831418|NCT00171249|10835117|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44
6831419|NCT00171249|10835118|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3
6831420|NCT00171249|10835119|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5
6831421|NCT00171249|10835120|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70
6831422|NCT00171249|10835121|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3
6831423|NCT00171249|10835122|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31
6831424|NCT00171249|10835123|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1
6831425|NCT00171249|10835117|FG000|Overall Study|Death|7
6831426|NCT00171249|10835118|FG001|Overall Study|Death|1
6831427|NCT00171249|10835119|FG002|Overall Study|Death|0
6831428|NCT00171249|10835120|FG003|Overall Study|Death|4
6831429|NCT00171249|10835121|FG004|Overall Study|Death|0
6831430|NCT00171249|10835122|FG005|Overall Study|Death|3
6831431|NCT00171249|10835123|FG006|Overall Study|Death|1
6831432|NCT00171249|10835117|FG000|Overall Study|Other|10
6831433|NCT00171249|10835118|FG001|Overall Study|Other|0
7062355|NCT01938430|11159990|FG001|Overall Study|Death|2
7062356|NCT01938430|11159991|FG002|Overall Study|Death|2
7062357|NCT01938430|11159992|FG003|Overall Study|Death|1
7062358|NCT01938430|11159993|FG004|Overall Study|Death|0
7062359|NCT01938430|11159994|FG005|Overall Study|Death|0
6831434|NCT00171249|10835119|FG002|Overall Study|Other|0
6831435|NCT00171249|10835120|FG003|Overall Study|Other|43
6831436|NCT00171249|10835121|FG004|Overall Study|Other|0
7038876|NCT01706926|11121427|FG003|Overall Study|Lost to Follow-up|0
7062360|NCT01938430|11159995|FG006|Overall Study|Death|1
7038877|NCT01706926|11121424|FG000|Overall Study|Withdrawal by Subject|2
7062361|NCT01938430|11159996|FG007|Overall Study|Death|1
6831437|NCT00171249|10835122|FG005|Overall Study|Other|2
6831438|NCT00171249|10835123|FG006|Overall Study|Other|0
7062362|NCT01938430|11159997|FG008|Overall Study|Death|2
6831439|NCT00171249|10835117|FG000|Overall Study|No Longer Requires Study Drug|4
6831440|NCT00171249|10835118|FG001|Overall Study|No Longer Requires Study Drug|0
6831441|NCT00171249|10835119|FG002|Overall Study|No Longer Requires Study Drug|0
6831442|NCT00171249|10835120|FG003|Overall Study|No Longer Requires Study Drug|3
6831443|NCT00171249|10835121|FG004|Overall Study|No Longer Requires Study Drug|0
6831444|NCT00171249|10835122|FG005|Overall Study|No Longer Requires Study Drug|5
6831445|NCT00171249|10835123|FG006|Overall Study|No Longer Requires Study Drug|0
6831446|NCT00171249|10835117|FG000|Overall Study|Administrative Problems|1
6831447|NCT00171249|10835118|FG001|Overall Study|Administrative Problems|0
6831448|NCT00171249|10835119|FG002|Overall Study|Administrative Problems|0
6831449|NCT00171249|10835120|FG003|Overall Study|Administrative Problems|2
6831450|NCT00171249|10835121|FG004|Overall Study|Administrative Problems|0
6831451|NCT00171249|10835122|FG005|Overall Study|Administrative Problems|0
6831452|NCT00171249|10835123|FG006|Overall Study|Administrative Problems|0
6831453|NCT00171249|10835117|FG000|Overall Study|Adverse Event|3
6831454|NCT00171249|10835118|FG001|Overall Study|Adverse Event|1
6831455|NCT00171249|10835119|FG002|Overall Study|Adverse Event|0
6831456|NCT00171249|10835120|FG003|Overall Study|Adverse Event|15
6831457|NCT00171249|10835121|FG004|Overall Study|Adverse Event|0
6831458|NCT00171249|10835122|FG005|Overall Study|Adverse Event|2
6831459|NCT00171249|10835123|FG006|Overall Study|Adverse Event|0
6831460|NCT00171249|10835117|FG000|Overall Study|Lost to Follow-up|5
6831461|NCT00171249|10835118|FG001|Overall Study|Lost to Follow-up|0
6831462|NCT00171249|10835119|FG002|Overall Study|Lost to Follow-up|0
6924935|NCT00828984|10954915|FG000|Overall Study|Adverse Event|2
6924936|NCT00828984|10954916|FG001|Overall Study|Adverse Event|3
6924937|NCT00828984|10954917|FG002|Overall Study|Adverse Event|0
6924938|NCT00828984|10954915|FG000|Overall Study|Lost to Follow-up|5
6924939|NCT00828984|10954916|FG001|Overall Study|Lost to Follow-up|3
6924940|NCT00828984|10954917|FG002|Overall Study|Lost to Follow-up|1
6924941|NCT00828984|10954915|FG000|Overall Study|Withdrawal by Subject|4
6924942|NCT00828984|10954916|FG001|Overall Study|Withdrawal by Subject|4
6924943|NCT00828984|10954917|FG002|Overall Study|Withdrawal by Subject|4
7038878|NCT01706926|11121425|FG001|Overall Study|Withdrawal by Subject|0
7038879|NCT01706926|11121426|FG002|Overall Study|Withdrawal by Subject|1
7038880|NCT01706926|11121427|FG003|Overall Study|Withdrawal by Subject|2
7062363|NCT01938430|11159998|FG009|Overall Study|Death|3
6924944|NCT00828984|10954915|FG000|Overall Study|Ineligable|1
6924945|NCT00828984|10954916|FG001|Overall Study|Ineligable|2
6924946|NCT00828984|10954917|FG002|Overall Study|Ineligable|0
6924947|NCT00828984|10954915|FG000|Overall Study|Medical Contraindication|0
6924948|NCT00828984|10954916|FG001|Overall Study|Medical Contraindication|1
6924949|NCT00828984|10954917|FG002|Overall Study|Medical Contraindication|0
6924950|NCT00828984|10954915|FG000|Overall Study|Noncompliant|1
6924951|NCT00828984|10954916|FG001|Overall Study|Noncompliant|2
6924952|NCT00828984|10954917|FG002|Overall Study|Noncompliant|3
6924953|NCT00828984|10954915|FG000|Overall Study|ConMed|1
6924954|NCT00828984|10954916|FG001|Overall Study|ConMed|1
6924955|NCT00828984|10954917|FG002|Overall Study|ConMed|1
6924956|NCT00829010|10954930|FG000|Overall Study|Adverse Event|1
6924957|NCT00829010|10954931|FG001|Overall Study|Adverse Event|0
6924958|NCT00829010|10954932|FG002|Overall Study|Adverse Event|0
6924959|NCT00829010|10954933|FG003|Overall Study|Adverse Event|0
6924960|NCT00829010|10954934|FG004|Overall Study|Adverse Event|0
6924961|NCT00829010|10954930|FG000|Overall Study|Withdrawal by Subject|0
6924962|NCT00829010|10954931|FG001|Overall Study|Withdrawal by Subject|1
6924963|NCT00829010|10954932|FG002|Overall Study|Withdrawal by Subject|1
6924964|NCT00829010|10954933|FG003|Overall Study|Withdrawal by Subject|0
7062364|NCT01938430|11159999|FG010|Overall Study|Death|0
7062365|NCT01938430|11160000|FG011|Overall Study|Death|0
7062366|NCT01938430|11160001|FG012|Overall Study|Death|0
7062367|NCT01938430|11160002|FG013|Overall Study|Death|0
7062368|NCT01938430|11159989|FG000|Overall Study|Investigator's Discretion|0
7062369|NCT01938430|11159990|FG001|Overall Study|Investigator's Discretion|0
7062370|NCT01938430|11159991|FG002|Overall Study|Investigator's Discretion|1
7062371|NCT01938430|11159992|FG003|Overall Study|Investigator's Discretion|0
7062372|NCT01938430|11159993|FG004|Overall Study|Investigator's Discretion|0
7062373|NCT01938430|11159994|FG005|Overall Study|Investigator's Discretion|0
6924965|NCT00829010|10954934|FG004|Overall Study|Withdrawal by Subject|2
6924966|NCT00829010|10954930|FG000|Overall Study|Lost to Follow-up|1
6924967|NCT00829010|10954931|FG001|Overall Study|Lost to Follow-up|0
6924968|NCT00829010|10954932|FG002|Overall Study|Lost to Follow-up|2
7038881|NCT01706926|11121424|FG000|Overall Study|Other|4
6924969|NCT00829010|10954933|FG003|Overall Study|Lost to Follow-up|0
6924970|NCT00829010|10954934|FG004|Overall Study|Lost to Follow-up|0
7038882|NCT01706926|11121425|FG001|Overall Study|Other|4
6831463|NCT00171249|10835120|FG003|Overall Study|Lost to Follow-up|9
6924971|NCT00829010|10954930|FG000|Overall Study|Fatality|5
6924972|NCT00829010|10954931|FG001|Overall Study|Fatality|4
6924973|NCT00829010|10954932|FG002|Overall Study|Fatality|0
6924974|NCT00829010|10954933|FG003|Overall Study|Fatality|3
6924975|NCT00829010|10954934|FG004|Overall Study|Fatality|0
7038883|NCT01706926|11121426|FG002|Overall Study|Other|4
7038884|NCT01706926|11121427|FG003|Overall Study|Other|3
7044762|NCT01756898|11130714|FG001|Overall Study|Other|2
7044763|NCT01756898|11130715|FG002|Overall Study|Other|2
6831464|NCT00171249|10835121|FG004|Overall Study|Lost to Follow-up|0
6831465|NCT00171249|10835122|FG005|Overall Study|Lost to Follow-up|0
6924976|NCT00829010|10954930|FG000|Overall Study|Migrated/Moved from study area|3
6924977|NCT00829010|10954931|FG001|Overall Study|Migrated/Moved from study area|4
6924978|NCT00829010|10954932|FG002|Overall Study|Migrated/Moved from study area|0
6924979|NCT00829010|10954933|FG003|Overall Study|Migrated/Moved from study area|5
6924980|NCT00829010|10954934|FG004|Overall Study|Migrated/Moved from study area|0
6924981|NCT00829166|10954961|FG000|Overall Study|Death|305
6924982|NCT00829166|10954962|FG001|Overall Study|Death|333
6924983|NCT00829166|10954961|FG000|Overall Study|Lost to Follow-up|5
6924984|NCT00829166|10954962|FG001|Overall Study|Lost to Follow-up|4
6924985|NCT00829166|10954961|FG000|Overall Study|Physician's Decision|4
6924986|NCT00829166|10954962|FG001|Overall Study|Physician's Decision|3
6924987|NCT00829166|10954961|FG000|Overall Study|Subject's Decision|41
6924988|NCT00829166|10954962|FG001|Overall Study|Subject's Decision|55
6924989|NCT00829166|10954961|FG000|Overall Study|Sponsor's Decision|137
6924990|NCT00829166|10954962|FG001|Overall Study|Sponsor's Decision|98
6924991|NCT00829166|10954961|FG000|Overall Study|Reason Not Specified|3
6924992|NCT00829166|10954962|FG001|Overall Study|Reason Not Specified|3
6924993|NCT00829179|10954969|FG000|Overall Study|Withdrawal by Subject|1
6924994|NCT00829244|10954975|FG000|Overall Study|Adverse Event|1
6924995|NCT00829244|10954976|FG001|Overall Study|Adverse Event|3
6924996|NCT00829244|10954975|FG000|Overall Study|Protocol Violation|1
6924997|NCT00829244|10954976|FG001|Overall Study|Protocol Violation|0
6924998|NCT00829244|10954975|FG000|Overall Study|Lack of ovarian response to stimulation|9
6924999|NCT00829244|10954976|FG001|Overall Study|Lack of ovarian response to stimulation|5
6925000|NCT00829244|10954975|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1
6925001|NCT00829244|10954976|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6
6925002|NCT00829244|10954975|FG000|Overall Study|No fertilization|2
6925003|NCT00829244|10954976|FG001|Overall Study|No fertilization|2
6925004|NCT00829244|10954975|FG000|Overall Study|All embryos discarded|0
6925005|NCT00829244|10954976|FG001|Overall Study|All embryos discarded|3
6925006|NCT00829244|10954975|FG000|Overall Study|No embryo cleavage|0
6925007|NCT00829244|10954976|FG001|Overall Study|No embryo cleavage|2
6925008|NCT00829283|10954984|FG000|Overall Study|Lost to Follow-up|7
6925009|NCT00829283|10954985|FG001|Overall Study|Lost to Follow-up|25
6925010|NCT00829296|10954993|FG000|Overall Study|Adverse Event|5
6925011|NCT00829296|10954994|FG001|Overall Study|Adverse Event|4
6925012|NCT00829387|10955002|FG000|Overall Study|Withdrawal by Subject|2
6925013|NCT00829387|10955003|FG001|Overall Study|Withdrawal by Subject|3
6925014|NCT00829387|10955002|FG000|Overall Study|Disqualified by PI|1
6925015|NCT00829387|10955003|FG001|Overall Study|Disqualified by PI|0
6925016|NCT00829413|10955009|FG000|Overall Study|No study drug admimnistered|13
6925017|NCT00829413|10955009|FG000|Overall Study|Training Patients|67
6925018|NCT00829413|10955009|FG000|Overall Study|No truth standard procedure available|9
6925019|NCT00829413|10955009|FG000|Overall Study|Technically inadequate truth standard|2
6925020|NCT00829413|10955009|FG000|Overall Study|Indeterminate diagnosis from truth stand|3
6925021|NCT00829439|10955020|FG000|Overall Study|Adverse Event|0
6925022|NCT00829439|10955021|FG001|Overall Study|Adverse Event|0
6925023|NCT00829439|10955022|FG002|Overall Study|Adverse Event|1
6925024|NCT00829439|10955023|FG003|Overall Study|Adverse Event|0
6925025|NCT00829621|10955029|FG000|Overall Study|Death|1
6925026|NCT00829621|10955030|FG001|Overall Study|Death|0
6925027|NCT00829621|10955029|FG000|Overall Study|Lost to Follow-up|3
6925028|NCT00829621|10955030|FG001|Overall Study|Lost to Follow-up|4
6925029|NCT00829829|10955044|FG000|Overall Study|Protocol Violation|0
6925030|NCT00829829|10955045|FG001|Overall Study|Protocol Violation|3
6925031|NCT00829829|10955046|FG002|Overall Study|Protocol Violation|0
6925032|NCT00829829|10955044|FG000|Overall Study|Adverse Event|4
6925033|NCT00829829|10955045|FG001|Overall Study|Adverse Event|4
6925034|NCT00829829|10955046|FG002|Overall Study|Adverse Event|3
6925035|NCT00829829|10955044|FG000|Overall Study|Withdrawal by Subject|8
6925036|NCT00829829|10955045|FG001|Overall Study|Withdrawal by Subject|4
6925037|NCT00829829|10955046|FG002|Overall Study|Withdrawal by Subject|2
6925038|NCT00829829|10955044|FG000|Overall Study|Decision by the Sponsor|1
6925039|NCT00829829|10955045|FG001|Overall Study|Decision by the Sponsor|0
6925040|NCT00829829|10955046|FG002|Overall Study|Decision by the Sponsor|2
6925041|NCT00829829|10955044|FG000|Overall Study|Lost to Follow-up|7
6925042|NCT00829829|10955045|FG001|Overall Study|Lost to Follow-up|3
6925043|NCT00829829|10955046|FG002|Overall Study|Lost to Follow-up|3
6925044|NCT00829829|10955044|FG000|Overall Study|Other than specified above|2
7062374|NCT01938430|11159995|FG006|Overall Study|Investigator's Discretion|0
7062375|NCT01938430|11159996|FG007|Overall Study|Investigator's Discretion|0
7062376|NCT01938430|11159997|FG008|Overall Study|Investigator's Discretion|0
6925045|NCT00829829|10955045|FG001|Overall Study|Other than specified above|2
6925046|NCT00829829|10955046|FG002|Overall Study|Other than specified above|1
6925047|NCT00829933|10955059|FG000|Overall Study|Adverse Event|2
6925048|NCT00829933|10955060|FG001|Overall Study|Adverse Event|3
6925049|NCT00829933|10955061|FG002|Overall Study|Adverse Event|2
6925050|NCT00829933|10955062|FG003|Overall Study|Adverse Event|1
6925051|NCT00829933|10955059|FG000|Overall Study|Death|0
6925052|NCT00829933|10955060|FG001|Overall Study|Death|0
6925053|NCT00829933|10955061|FG002|Overall Study|Death|1
6925054|NCT00829933|10955062|FG003|Overall Study|Death|1
6831466|NCT00171249|10835123|FG006|Overall Study|Lost to Follow-up|0
6831467|NCT00171301|10835134|FG000|Overall Study|Death|1
6831468|NCT00171301|10835135|FG001|Overall Study|Death|2
7038885|NCT01707004|11121464|FG000|Overall Study|Physician Decision|3
7038886|NCT01707030|11121471|FG000|Overall Study|Death|1
6831469|NCT00171301|10835134|FG000|Overall Study|Adverse Event|1
6831470|NCT00171301|10835135|FG001|Overall Study|Adverse Event|2
6831471|NCT00171301|10835134|FG000|Overall Study|Lost to Follow-up|6
6831472|NCT00171301|10835135|FG001|Overall Study|Lost to Follow-up|2
6831473|NCT00171301|10835134|FG000|Overall Study|Protocol Violation|0
6831474|NCT00171301|10835135|FG001|Overall Study|Protocol Violation|2
6831475|NCT00171301|10835134|FG000|Overall Study|Withdrawal by Subject|0
6831476|NCT00171301|10835135|FG001|Overall Study|Withdrawal by Subject|1
6831477|NCT00171314|10835144|FG000|Overall Study|Adverse Event|44
6831478|NCT00171314|10835145|FG001|Overall Study|Adverse Event|41
6831479|NCT00171314|10835144|FG000|Overall Study|Lack of Efficacy|19
7038887|NCT01707030|11121472|FG001|Overall Study|Death|1
6831480|NCT00171314|10835145|FG001|Overall Study|Lack of Efficacy|14
6831481|NCT00171314|10835144|FG000|Overall Study|Withdrawal by Subject|9
6831482|NCT00171314|10835145|FG001|Overall Study|Withdrawal by Subject|6
6831483|NCT00171314|10835144|FG000|Overall Study|Abnormal Test Procedure Results|9
6831484|NCT00171314|10835145|FG001|Overall Study|Abnormal Test Procedure Results|3
6831485|NCT00171314|10835144|FG000|Overall Study|Protocol Violation|3
6831486|NCT00171314|10835145|FG001|Overall Study|Protocol Violation|7
6831487|NCT00171314|10835144|FG000|Overall Study|Administrative Problems|4
6831488|NCT00171314|10835145|FG001|Overall Study|Administrative Problems|3
6831489|NCT00171314|10835144|FG000|Overall Study|Lost to Follow-up|1
6831490|NCT00171314|10835145|FG001|Overall Study|Lost to Follow-up|3
6831491|NCT00171314|10835144|FG000|Overall Study|Death|2
6831492|NCT00171314|10835145|FG001|Overall Study|Death|1
6831493|NCT00171340|10835153|FG000|Overall Study|Adverse Event|46
6831494|NCT00171340|10835154|FG001|Overall Study|Adverse Event|42
6831495|NCT00171340|10835153|FG000|Overall Study|Lack of Efficacy|29
6831496|NCT00171340|10835154|FG001|Overall Study|Lack of Efficacy|41
6831497|NCT00171340|10835153|FG000|Overall Study|Protocol Violation|7
6831498|NCT00171340|10835154|FG001|Overall Study|Protocol Violation|8
6831499|NCT00171340|10835153|FG000|Overall Study|Withdrawal by Subject|22
6831500|NCT00171340|10835154|FG001|Overall Study|Withdrawal by Subject|19
6831501|NCT00171340|10835153|FG000|Overall Study|Lost to Follow-up|0
6831502|NCT00171340|10835154|FG001|Overall Study|Lost to Follow-up|5
6831503|NCT00171340|10835153|FG000|Overall Study|Abnormal Laboratory Results|2
6831504|NCT00171340|10835154|FG001|Overall Study|Abnormal Laboratory Results|0
6831505|NCT00171340|10835153|FG000|Overall Study|Abnormal Test Procedure Results|6
6831506|NCT00171340|10835154|FG001|Overall Study|Abnormal Test Procedure Results|11
6831507|NCT00171340|10835153|FG000|Overall Study|No Longer Required Study Drug|1
6831508|NCT00171340|10835154|FG001|Overall Study|No Longer Required Study Drug|1
6831509|NCT00171340|10835153|FG000|Overall Study|Administrative Problems|5
6831510|NCT00171340|10835154|FG001|Overall Study|Administrative Problems|2
6831511|NCT00171340|10835153|FG000|Overall Study|Death|6
6831512|NCT00171340|10835154|FG001|Overall Study|Death|6
6831513|NCT00171704|10835164|FG000|Overall Study|Adverse Event|24
6831514|NCT00171704|10835165|FG001|Overall Study|Adverse Event|33
7038888|NCT01707030|11121471|FG000|Overall Study|Withdrawal by Subject|2
7062377|NCT01938430|11159998|FG009|Overall Study|Investigator's Discretion|0
7062378|NCT01938430|11159999|FG010|Overall Study|Investigator's Discretion|0
6831515|NCT00171704|10835164|FG000|Overall Study|Disease Progression|14
6831516|NCT00171704|10835165|FG001|Overall Study|Disease Progression|9
7038889|NCT01707030|11121472|FG001|Overall Study|Withdrawal by Subject|3
6831517|NCT00171704|10835164|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1
6831518|NCT00171704|10835165|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0
6831519|NCT00171704|10835164|FG000|Overall Study|Administrative Problems|2
6831520|NCT00171704|10835165|FG001|Overall Study|Administrative Problems|1
6831521|NCT00171704|10835164|FG000|Overall Study|Death|2
7038890|NCT01707030|11121471|FG000|Overall Study|Lost to Follow-up|8
7038891|NCT01707030|11121472|FG001|Overall Study|Lost to Follow-up|13
7038892|NCT01707147|11121505|FG000|Overall Study|Administered Trajenta prior to contract|5
7038893|NCT01707147|11121505|FG000|Overall Study|Patients who have not taken Trajenta|1
7038894|NCT01707147|11121505|FG000|Overall Study|Follow-up failure|17
7038895|NCT01707147|11121505|FG000|Overall Study|Violated inclusion/exclusion criteria|77
7038896|NCT01707290|11121525|FG000|Overall Study|Adverse event (AE)|1
7038897|NCT01707290|11121526|FG001|Overall Study|Adverse event (AE)|0
7038898|NCT01707290|11121525|FG000|Overall Study|Physician Decision|1
7038899|NCT01707290|11121526|FG001|Overall Study|Physician Decision|0
7038900|NCT01707290|11121525|FG000|Overall Study|Lost to Follow-up|3
7038901|NCT01707290|11121526|FG001|Overall Study|Lost to Follow-up|0
7038902|NCT01707290|11121525|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4
7038903|NCT01707290|11121526|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0
7038904|NCT01707290|11121525|FG000|Overall Study|Commercial drug available|60
7038905|NCT01707290|11121526|FG001|Overall Study|Commercial drug available|1
7038906|NCT01707290|11121525|FG000|Overall Study|Other unspecified|17
7038907|NCT01707290|11121526|FG001|Overall Study|Other unspecified|0
7038908|NCT01707667|11121576|FG000|Period 1|expulsion of colonic sensor catheter|1
7044764|NCT01756898|11130716|FG003|Overall Study|Other|0
6831522|NCT00171704|10835165|FG001|Overall Study|Death|2
6831523|NCT00171704|10835164|FG000|Overall Study|Withdrawal by Subject|1
6831524|NCT00171704|10835165|FG001|Overall Study|Withdrawal by Subject|3
6831525|NCT00171704|10835164|FG000|Overall Study|Protocol Violation|0
6831526|NCT00171704|10835165|FG001|Overall Study|Protocol Violation|1
6831527|NCT00171730|10835171|FG000|Overall Study|Adverse Event|3
6831528|NCT00171730|10835171|FG000|Overall Study|Abnormal Laboratory Value(s)|1
6831529|NCT00171730|10835171|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8
6831530|NCT00171730|10835171|FG000|Overall Study|Withdrawal by Subject|3
6831531|NCT00171834|10835188|FG000|Overall Study|Adverse Event|2
6831532|NCT00171834|10835189|FG001|Overall Study|Adverse Event|1
6831533|NCT00171834|10835190|FG002|Overall Study|Adverse Event|3
6831534|NCT00171834|10835191|FG003|Overall Study|Adverse Event|2
7062379|NCT01938430|11160000|FG011|Overall Study|Investigator's Discretion|0
7062380|NCT01938430|11160001|FG012|Overall Study|Investigator's Discretion|0
7062381|NCT01938430|11160002|FG013|Overall Study|Investigator's Discretion|0
7062382|NCT01938430|11159989|FG000|Overall Study|Lack of Efficacy|3
7062383|NCT01938430|11159990|FG001|Overall Study|Lack of Efficacy|1
7062384|NCT01938430|11159991|FG002|Overall Study|Lack of Efficacy|1
7062385|NCT01938430|11159992|FG003|Overall Study|Lack of Efficacy|1
7038909|NCT01707667|11121577|FG001|Period 1|expulsion of colonic sensor catheter|0
7038910|NCT01707693|11121585|FG000|Overall Study Allocation|Withdrawal by Subject|9
7038911|NCT01707693|11121586|FG001|Overall Study Allocation|Withdrawal by Subject|5
7038912|NCT01707693|11121585|FG000|Overall Study Allocation|Protocol Violation|4
7038913|NCT01707693|11121586|FG001|Overall Study Allocation|Protocol Violation|3
7038914|NCT01707693|11121585|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0
7062386|NCT01938430|11159993|FG004|Overall Study|Lack of Efficacy|0
7062387|NCT01938430|11159994|FG005|Overall Study|Lack of Efficacy|0
6831535|NCT00171834|10835192|FG004|Overall Study|Adverse Event|2
6831536|NCT00171834|10835193|FG005|Overall Study|Adverse Event|15
6831537|NCT00171834|10835194|FG006|Overall Study|Adverse Event|1
6831538|NCT00171834|10835188|FG000|Overall Study|Withdrawal by Subject|0
6831539|NCT00171834|10835189|FG001|Overall Study|Withdrawal by Subject|2
6831540|NCT00171834|10835190|FG002|Overall Study|Withdrawal by Subject|0
7038915|NCT01707693|11121586|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3
7062388|NCT01938430|11159995|FG006|Overall Study|Lack of Efficacy|0
7062389|NCT01938430|11159996|FG007|Overall Study|Lack of Efficacy|0
7062390|NCT01938430|11159997|FG008|Overall Study|Lack of Efficacy|1
7062391|NCT01938430|11159998|FG009|Overall Study|Lack of Efficacy|0
7062392|NCT01938430|11159999|FG010|Overall Study|Lack of Efficacy|2
7062393|NCT01938430|11160000|FG011|Overall Study|Lack of Efficacy|1
7062394|NCT01938430|11160001|FG012|Overall Study|Lack of Efficacy|0
7062395|NCT01938430|11160002|FG013|Overall Study|Lack of Efficacy|0
7062396|NCT01938430|11159989|FG000|Overall Study|Lost to Follow-up|0
7062397|NCT01938430|11159990|FG001|Overall Study|Lost to Follow-up|0
7062398|NCT01938430|11159991|FG002|Overall Study|Lost to Follow-up|1
7062399|NCT01938430|11159992|FG003|Overall Study|Lost to Follow-up|0
7062400|NCT01938430|11159993|FG004|Overall Study|Lost to Follow-up|0
7062401|NCT01938430|11159994|FG005|Overall Study|Lost to Follow-up|1
7062402|NCT01938430|11159995|FG006|Overall Study|Lost to Follow-up|0
7062403|NCT01938430|11159996|FG007|Overall Study|Lost to Follow-up|0
7062404|NCT01938430|11159997|FG008|Overall Study|Lost to Follow-up|0
7062405|NCT01938430|11159998|FG009|Overall Study|Lost to Follow-up|0
7062406|NCT01938430|11159999|FG010|Overall Study|Lost to Follow-up|0
7062407|NCT01938430|11160000|FG011|Overall Study|Lost to Follow-up|0
7062408|NCT01938430|11160001|FG012|Overall Study|Lost to Follow-up|0
7062409|NCT01938430|11160002|FG013|Overall Study|Lost to Follow-up|0
7062410|NCT01938430|11159989|FG000|Overall Study|Withdrew Consent|0
7062411|NCT01938430|11159990|FG001|Overall Study|Withdrew Consent|0
7062412|NCT01938430|11159991|FG002|Overall Study|Withdrew Consent|0
7062413|NCT01938430|11159992|FG003|Overall Study|Withdrew Consent|0
7062414|NCT01938430|11159993|FG004|Overall Study|Withdrew Consent|0
7062415|NCT01938430|11159994|FG005|Overall Study|Withdrew Consent|0
7062416|NCT01938430|11159995|FG006|Overall Study|Withdrew Consent|0
7062417|NCT01938430|11159996|FG007|Overall Study|Withdrew Consent|0
7062418|NCT01938430|11159997|FG008|Overall Study|Withdrew Consent|1
7062419|NCT01938430|11159998|FG009|Overall Study|Withdrew Consent|0
7062420|NCT01938430|11159999|FG010|Overall Study|Withdrew Consent|0
7062421|NCT01938430|11160000|FG011|Overall Study|Withdrew Consent|0
7062422|NCT01938430|11160001|FG012|Overall Study|Withdrew Consent|0
7062423|NCT01938430|11160002|FG013|Overall Study|Withdrew Consent|0
7062424|NCT01938573|11160057|FG000|Overall Study|Lack of Efficacy|1
7062425|NCT01938573|11160058|FG001|Overall Study|Lack of Efficacy|0
7062426|NCT01938573|11160057|FG000|Overall Study|Operation at other hospital|1
7062427|NCT01938573|11160058|FG001|Overall Study|Operation at other hospital|0
7062428|NCT01938625|11160065|FG000|Overall Study|Withdrawal by Subject|0
7062429|NCT01938625|11160066|FG001|Overall Study|Withdrawal by Subject|1
7062430|NCT01938625|11160065|FG000|Overall Study|Adverse Event|0
7062431|NCT01938625|11160066|FG001|Overall Study|Adverse Event|1
7038916|NCT01707693|11121585|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0
7038917|NCT01707693|11121586|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2
7062432|NCT01938846|11160084|FG000|Overall Study|Progressive disease|26
7062433|NCT01938846|11160085|FG001|Overall Study|Progressive disease|18
7062434|NCT01938846|11160086|FG002|Overall Study|Progressive disease|16
7062435|NCT01938846|11160084|FG000|Overall Study|Adverse Event|8
6831541|NCT00171834|10835191|FG003|Overall Study|Withdrawal by Subject|1
6831542|NCT00171834|10835192|FG004|Overall Study|Withdrawal by Subject|1
6831543|NCT00171834|10835193|FG005|Overall Study|Withdrawal by Subject|1
6831544|NCT00171834|10835194|FG006|Overall Study|Withdrawal by Subject|0
6831545|NCT00171834|10835188|FG000|Overall Study|Death from study indication|0
6831546|NCT00171834|10835189|FG001|Overall Study|Death from study indication|1
6831547|NCT00171834|10835190|FG002|Overall Study|Death from study indication|0
6831548|NCT00171834|10835191|FG003|Overall Study|Death from study indication|0
6831549|NCT00171834|10835192|FG004|Overall Study|Death from study indication|1
6831550|NCT00171834|10835193|FG005|Overall Study|Death from study indication|0
6831551|NCT00171834|10835194|FG006|Overall Study|Death from study indication|0
6831552|NCT00171834|10835188|FG000|Overall Study|Disease Progression|4
6831553|NCT00171834|10835189|FG001|Overall Study|Disease Progression|8
6831554|NCT00171834|10835190|FG002|Overall Study|Disease Progression|8
6831555|NCT00171834|10835191|FG003|Overall Study|Disease Progression|9
6831556|NCT00171834|10835192|FG004|Overall Study|Disease Progression|2
6831557|NCT00171834|10835193|FG005|Overall Study|Disease Progression|18
6831558|NCT00171834|10835194|FG006|Overall Study|Disease Progression|3
6831559|NCT00171834|10835188|FG000|Overall Study|Treatment Duration Completed|0
6831560|NCT00171834|10835189|FG001|Overall Study|Treatment Duration Completed|0
6925055|NCT00829933|10955059|FG000|Overall Study|Lack of Efficacy|0
6925056|NCT00829933|10955060|FG001|Overall Study|Lack of Efficacy|1
6925057|NCT00829933|10955061|FG002|Overall Study|Lack of Efficacy|0
6925058|NCT00829933|10955062|FG003|Overall Study|Lack of Efficacy|0
6925059|NCT00829933|10955059|FG000|Overall Study|Physician Decision|5
6925060|NCT00829933|10955060|FG001|Overall Study|Physician Decision|7
6925061|NCT00829933|10955061|FG002|Overall Study|Physician Decision|8
6925062|NCT00829933|10955062|FG003|Overall Study|Physician Decision|1
6925063|NCT00829933|10955059|FG000|Overall Study|Pregnancy|0
6925064|NCT00829933|10955060|FG001|Overall Study|Pregnancy|0
6925065|NCT00829933|10955061|FG002|Overall Study|Pregnancy|0
6925066|NCT00829933|10955062|FG003|Overall Study|Pregnancy|2
6925067|NCT00829933|10955059|FG000|Overall Study|Protocol Violation|2
6925068|NCT00829933|10955060|FG001|Overall Study|Protocol Violation|1
6925069|NCT00829933|10955061|FG002|Overall Study|Protocol Violation|0
6925070|NCT00829933|10955062|FG003|Overall Study|Protocol Violation|0
6925071|NCT00829933|10955059|FG000|Overall Study|withdrew before treatment started|5
6925072|NCT00829933|10955060|FG001|Overall Study|withdrew before treatment started|1
6925073|NCT00829933|10955061|FG002|Overall Study|withdrew before treatment started|2
6925074|NCT00829933|10955062|FG003|Overall Study|withdrew before treatment started|9
6925075|NCT00830037|10955083|FG000|Overall Study|Withdrawal by Subject|2
6925076|NCT00830037|10955084|FG001|Overall Study|Withdrawal by Subject|3
6925077|NCT00830037|10955083|FG000|Overall Study|Lost to Follow-up|1
6925078|NCT00830037|10955084|FG001|Overall Study|Lost to Follow-up|2
6925079|NCT00830037|10955083|FG000|Overall Study|Active when terminated by DSMB|15
6925080|NCT00830037|10955084|FG001|Overall Study|Active when terminated by DSMB|14
6925081|NCT00830063|10955094|FG000|Overall Study|Adverse Event|7
6925082|NCT00830063|10955095|FG001|Overall Study|Adverse Event|13
6925083|NCT00830063|10955096|FG002|Overall Study|Adverse Event|16
6925084|NCT00830063|10955097|FG003|Overall Study|Adverse Event|13
6925085|NCT00830063|10955094|FG000|Overall Study|Death|1
6925086|NCT00830063|10955095|FG001|Overall Study|Death|0
6925087|NCT00830063|10955096|FG002|Overall Study|Death|0
6925088|NCT00830063|10955097|FG003|Overall Study|Death|0
6925089|NCT00830063|10955094|FG000|Overall Study|Lost to Follow-up|0
6925090|NCT00830063|10955095|FG001|Overall Study|Lost to Follow-up|0
6925091|NCT00830063|10955096|FG002|Overall Study|Lost to Follow-up|3
6925092|NCT00830063|10955097|FG003|Overall Study|Lost to Follow-up|1
6925093|NCT00830063|10955094|FG000|Overall Study|Preferred Time Entry in Extension Study|119
6925094|NCT00830063|10955095|FG001|Overall Study|Preferred Time Entry in Extension Study|139
6925095|NCT00830063|10955096|FG002|Overall Study|Preferred Time Entry in Extension Study|127
6925096|NCT00830063|10955097|FG003|Overall Study|Preferred Time Entry in Extension Study|126
6925097|NCT00830063|10955094|FG000|Overall Study|Lack of Efficacy|51
6925098|NCT00830063|10955095|FG001|Overall Study|Lack of Efficacy|23
6925099|NCT00830063|10955096|FG002|Overall Study|Lack of Efficacy|25
6925100|NCT00830063|10955097|FG003|Overall Study|Lack of Efficacy|32
6925101|NCT00830063|10955094|FG000|Overall Study|Other|5
6925102|NCT00830063|10955095|FG001|Overall Study|Other|5
6925103|NCT00830063|10955096|FG002|Overall Study|Other|8
6925104|NCT00830063|10955097|FG003|Overall Study|Other|6
6925105|NCT00830063|10955094|FG000|Overall Study|Withdrawal by Subject|16
6925106|NCT00830063|10955095|FG001|Overall Study|Withdrawal by Subject|10
6925107|NCT00830063|10955096|FG002|Overall Study|Withdrawal by Subject|16
6831561|NCT00171834|10835190|FG002|Overall Study|Treatment Duration Completed|1
6925108|NCT00830063|10955097|FG003|Overall Study|Withdrawal by Subject|13
6925109|NCT00830063|10955094|FG000|Overall Study|Protocol Violation|1
6925110|NCT00830063|10955095|FG001|Overall Study|Protocol Violation|0
6925111|NCT00830063|10955096|FG002|Overall Study|Protocol Violation|3
6925112|NCT00830063|10955097|FG003|Overall Study|Protocol Violation|2
6925113|NCT00830063|10955094|FG000|Overall Study|Randomized But Not Treated|0
6925114|NCT00830063|10955095|FG001|Overall Study|Randomized But Not Treated|2
6925115|NCT00830063|10955096|FG002|Overall Study|Randomized But Not Treated|0
6925116|NCT00830063|10955097|FG003|Overall Study|Randomized But Not Treated|2
6925117|NCT00830115|10955116|FG000|Overall Study|Adverse Event|2
6925118|NCT00830115|10955116|FG000|Overall Study|Improvement/recovery|1
6831562|NCT00171834|10835191|FG003|Overall Study|Treatment Duration Completed|0
6831563|NCT00171834|10835192|FG004|Overall Study|Treatment Duration Completed|2
6831564|NCT00171834|10835193|FG005|Overall Study|Treatment Duration Completed|1
6831565|NCT00171834|10835194|FG006|Overall Study|Treatment Duration Completed|0
6831566|NCT00171873|10835226|FG000|Overall Study|Withdrawal by Subject|4
6831567|NCT00171873|10835227|FG001|Overall Study|Withdrawal by Subject|2
6831568|NCT00171873|10835226|FG000|Overall Study|Adverse Event|5
6831569|NCT00171873|10835227|FG001|Overall Study|Adverse Event|0
6831570|NCT00171873|10835226|FG000|Overall Study|Switched to Octreotide|0
6831571|NCT00171873|10835227|FG001|Overall Study|Switched to Octreotide|1
6831572|NCT00171925|10835235|FG000|Overall Study|Adverse Event|10
6831573|NCT00171925|10835236|FG001|Overall Study|Adverse Event|6
6831574|NCT00171925|10835235|FG000|Overall Study|Protocol Violation|1
6831575|NCT00171925|10835236|FG001|Overall Study|Protocol Violation|1
6831576|NCT00171925|10835235|FG000|Overall Study|Withdrawal by Subject|6
6831577|NCT00171925|10835236|FG001|Overall Study|Withdrawal by Subject|9
6831578|NCT00171925|10835235|FG000|Overall Study|Lost to Follow-up|2
6831579|NCT00171925|10835236|FG001|Overall Study|Lost to Follow-up|2
6831580|NCT00171925|10835235|FG000|Overall Study|Administrative problems|10
6831581|NCT00171925|10835236|FG001|Overall Study|Administrative problems|11
6831582|NCT00171925|10835235|FG000|Overall Study|Death|1
6831583|NCT00171925|10835236|FG001|Overall Study|Death|2
6831584|NCT00171951|10835242|FG000|Overall Study|Adverse Event|1
6831585|NCT00171951|10835242|FG000|Overall Study|Abnormal Laboratory Values|2
6831586|NCT00171951|10835242|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3
6831587|NCT00171951|10835242|FG000|Overall Study|Participants Withdrew Consent|3
6831588|NCT00171951|10835242|FG000|Overall Study|New Cancer Therapy|5
6831589|NCT00171951|10835242|FG000|Overall Study|Reason not Specified|2
6831590|NCT00172042|10835251|FG000|Overall Study|Adverse Event|27
6831591|NCT00172042|10835252|FG001|Overall Study|Adverse Event|13
6831592|NCT00172042|10835251|FG000|Overall Study|Abnormal laboratory value(s)|5
6831593|NCT00172042|10835252|FG001|Overall Study|Abnormal laboratory value(s)|1
6831594|NCT00172042|10835251|FG000|Overall Study|Abnormal test procedure(s)|0
6831595|NCT00172042|10835252|FG001|Overall Study|Abnormal test procedure(s)|3
6831596|NCT00172042|10835251|FG000|Overall Study|Unsatisfactory therapeutic effect|13
6831597|NCT00172042|10835252|FG001|Overall Study|Unsatisfactory therapeutic effect|11
6831598|NCT00172042|10835251|FG000|Overall Study|Patient no longer requires study drug|10
6831599|NCT00172042|10835252|FG001|Overall Study|Patient no longer requires study drug|8
6831600|NCT00172042|10835251|FG000|Overall Study|Protocol Violation|8
7062436|NCT01938846|11160085|FG001|Overall Study|Adverse Event|4
7062437|NCT01938846|11160086|FG002|Overall Study|Adverse Event|3
7062438|NCT01938846|11160084|FG000|Overall Study|Withdrawal by Subject|2
7062439|NCT01938846|11160085|FG001|Overall Study|Withdrawal by Subject|2
7062440|NCT01938846|11160086|FG002|Overall Study|Withdrawal by Subject|1
7062441|NCT01938846|11160084|FG000|Overall Study|Other than listed|5
7062442|NCT01938846|11160085|FG001|Overall Study|Other than listed|1
7062443|NCT01938846|11160086|FG002|Overall Study|Other than listed|4
7062444|NCT01939002|11160136|FG000|Overall Study|Adverse Event|13
7062445|NCT01939002|11160137|FG001|Overall Study|Adverse Event|13
7062446|NCT01939002|11160136|FG000|Overall Study|Withdrawal by Subject|5
7062447|NCT01939002|11160137|FG001|Overall Study|Withdrawal by Subject|3
7062448|NCT01939002|11160136|FG000|Overall Study|Other|1
7062449|NCT01939002|11160137|FG001|Overall Study|Other|2
7062450|NCT01939028|11160148|FG000|Overall Study|Withdrawal by Subject|5
7062451|NCT01939028|11160148|FG000|Overall Study|Physician Decision|7
7062452|NCT01939158|11160165|FG000|Overall Study|Adverse Event|1
7062453|NCT01939158|11160166|FG001|Overall Study|Adverse Event|0
7062454|NCT01939158|11160167|FG002|Overall Study|Adverse Event|0
7062455|NCT01939158|11160168|FG003|Overall Study|Adverse Event|0
7062456|NCT01939158|11160165|FG000|Overall Study|Withdrawal by Subject|22
7062457|NCT01939158|11160166|FG001|Overall Study|Withdrawal by Subject|25
7062458|NCT01939158|11160167|FG002|Overall Study|Withdrawal by Subject|15
7062459|NCT01939158|11160168|FG003|Overall Study|Withdrawal by Subject|17
7062460|NCT01939158|11160165|FG000|Overall Study|Migrated/moved from study area|5
7062461|NCT01939158|11160166|FG001|Overall Study|Migrated/moved from study area|7
7062462|NCT01939158|11160167|FG002|Overall Study|Migrated/moved from study area|3
7062463|NCT01939158|11160168|FG003|Overall Study|Migrated/moved from study area|6
7062464|NCT01939158|11160165|FG000|Overall Study|Lost to Follow-up|18
7062465|NCT01939158|11160166|FG001|Overall Study|Lost to Follow-up|17
7062466|NCT01939158|11160167|FG002|Overall Study|Lost to Follow-up|17
7062467|NCT01939158|11160168|FG003|Overall Study|Lost to Follow-up|17
7062468|NCT01939158|11160165|FG000|Overall Study|Death|0
7062469|NCT01939158|11160166|FG001|Overall Study|Death|0
7062470|NCT01939158|11160167|FG002|Overall Study|Death|1
7062471|NCT01939158|11160168|FG003|Overall Study|Death|1
6831601|NCT00172042|10835252|FG001|Overall Study|Protocol Violation|7
6831602|NCT00172042|10835251|FG000|Overall Study|Withdrawal by Subject|37
7062472|NCT01939158|11160165|FG000|Overall Study|No longer meets eligibility criteria|0
7062473|NCT01939158|11160166|FG001|Overall Study|No longer meets eligibility criteria|0
7062474|NCT01939158|11160167|FG002|Overall Study|No longer meets eligibility criteria|1
7062475|NCT01939158|11160168|FG003|Overall Study|No longer meets eligibility criteria|0
7062476|NCT01939158|11160165|FG000|Overall Study|Other|1
6831603|NCT00172042|10835252|FG001|Overall Study|Withdrawal by Subject|25
6831604|NCT00172042|10835251|FG000|Overall Study|Lost to Follow-up|3
6831605|NCT00172042|10835252|FG001|Overall Study|Lost to Follow-up|5
6831606|NCT00172042|10835251|FG000|Overall Study|Administrative problems|13
6831607|NCT00172042|10835252|FG001|Overall Study|Administrative problems|10
6831608|NCT00172042|10835251|FG000|Overall Study|Death|42
6925119|NCT00830128|10955122|FG000|Overall Study|Adverse Event|5
6925120|NCT00830128|10955122|FG000|Overall Study|Lack of Efficacy|7
6925121|NCT00830128|10955122|FG000|Overall Study|Protocol Violation|1
6925122|NCT00830128|10955122|FG000|Overall Study|Withdrawal by Subject|2
6925123|NCT00830128|10955122|FG000|Overall Study|Family obligation|1
6925124|NCT00830128|10955122|FG000|Overall Study|Relocation|1
6925125|NCT00830128|10955122|FG000|Overall Study|Work obligation|1
6925126|NCT00830128|10955122|FG000|Overall Study|Operating a vehicle|1
6925127|NCT00830167|10955128|FG000|Overall Study|Lack of Efficacy|26
6925128|NCT00830167|10955129|FG001|Overall Study|Lack of Efficacy|10
6925129|NCT00830167|10955128|FG000|Overall Study|Adverse Event|8
6925130|NCT00830167|10955129|FG001|Overall Study|Adverse Event|24
6925131|NCT00830167|10955128|FG000|Overall Study|Not meeting entrance criteria|2
6925132|NCT00830167|10955129|FG001|Overall Study|Not meeting entrance criteria|5
6925133|NCT00830167|10955128|FG000|Overall Study|Withdrawal by Subject|2
6925134|NCT00830167|10955129|FG001|Overall Study|Withdrawal by Subject|0
6925135|NCT00830167|10955128|FG000|Overall Study|Lost to Follow-up|0
6925136|NCT00830167|10955129|FG001|Overall Study|Lost to Follow-up|1
6925137|NCT00830167|10955128|FG000|Overall Study|Protocol Violation|0
6925138|NCT00830167|10955129|FG001|Overall Study|Protocol Violation|1
6925139|NCT00830167|10955128|FG000|Overall Study|Other|2
6925140|NCT00830167|10955129|FG001|Overall Study|Other|2
6925141|NCT00830180|10955135|FG000|Overall Study|Adverse Event|6
6925142|NCT00830180|10955135|FG000|Overall Study|Death|11
6925143|NCT00830180|10955135|FG000|Overall Study|Insufficient clinical response|1
6925144|NCT00830180|10955135|FG000|Overall Study|Withdrawal by Subject|5
6925145|NCT00830180|10955135|FG000|Overall Study|Progressive disease|2
6925146|NCT00830180|10955135|FG000|Overall Study|Other - Unspecified|1
6925147|NCT00830375|10955167|FG000|Overall Study|Lost to Follow-up|1
6925148|NCT00830440|10955177|FG000|Overall Study|Protocol Violation|1
6925149|NCT00830440|10955178|FG001|Overall Study|Protocol Violation|0
6925150|NCT00830440|10955177|FG000|Overall Study|Withdrawal by Subject|1
6925151|NCT00830440|10955178|FG001|Overall Study|Withdrawal by Subject|0
6925152|NCT00830440|10955177|FG000|Overall Study|unsuccessful procedure|4
6925153|NCT00830440|10955178|FG001|Overall Study|unsuccessful procedure|0
6925154|NCT00830440|10955177|FG000|Overall Study|Adverse Event|2
6925155|NCT00830440|10955178|FG001|Overall Study|Adverse Event|0
6925156|NCT00830518|10955187|FG000|Overall Study|Progressive Disease|18
6925157|NCT00830518|10955188|FG001|Overall Study|Progressive Disease|8
6925158|NCT00830518|10955187|FG000|Overall Study|Symptomatic Deterioration|4
6925159|NCT00830518|10955188|FG001|Overall Study|Symptomatic Deterioration|1
6925160|NCT00830518|10955187|FG000|Overall Study|Adverse Event|14
6925161|NCT00830518|10955188|FG001|Overall Study|Adverse Event|1
6925162|NCT00830518|10955187|FG000|Overall Study|Withdrawal by Patient|2
6925163|NCT00830518|10955188|FG001|Overall Study|Withdrawal by Patient|0
6925164|NCT00830518|10955187|FG000|Overall Study|Reason not Specified|8
6925165|NCT00830518|10955188|FG001|Overall Study|Reason not Specified|1
6925166|NCT00830765|10955210|FG000|Overall Study|Protocol Violation|3
6925167|NCT00830765|10955211|FG001|Overall Study|Protocol Violation|2
6925168|NCT00830804|10955241|FG000|Overall Study|Lost to Follow-up|4
6925169|NCT00830804|10955241|FG000|Overall Study|Death|1
6925170|NCT00830804|10955241|FG000|Overall Study|Unable to get to clinic|7
6925171|NCT00830804|10955241|FG000|Overall Study|Consent withdrawn|2
6925172|NCT00830804|10955241|FG000|Overall Study|Unwilling to adhere to study requirement|1
6925173|NCT00830869|10955258|FG000|Period 1: Part 1|Symptomatic deterioration|0
6925174|NCT00830869|10955259|FG001|Period 1: Part 1|Symptomatic deterioration|0
6925175|NCT00830869|10955260|FG002|Period 1: Part 1|Symptomatic deterioration|0
6925176|NCT00830869|10955261|FG003|Period 1: Part 1|Symptomatic deterioration|1
6925177|NCT00830869|10955262|FG004|Period 1: Part 1|Symptomatic deterioration|0
6925178|NCT00830869|10955263|FG005|Period 1: Part 1|Symptomatic deterioration|1
6925179|NCT00830869|10955264|FG006|Period 1: Part 1|Symptomatic deterioration|1
6925180|NCT00830869|10955265|FG007|Period 1: Part 1|Symptomatic deterioration|0
6925181|NCT00830869|10955266|FG008|Period 1: Part 1|Symptomatic deterioration|0
6925182|NCT00830869|10955267|FG009|Period 1: Part 1|Symptomatic deterioration|0
6925183|NCT00830869|10955268|FG010|Period 1: Part 1|Symptomatic deterioration|0
6925184|NCT00830869|10955269|FG011|Period 1: Part 1|Symptomatic deterioration|0
6925185|NCT00830869|10955258|FG000|Period 1: Part 1|Withdrawal by Subject|0
6831609|NCT00172042|10835252|FG001|Overall Study|Death|42
6925186|NCT00830869|10955259|FG001|Period 1: Part 1|Withdrawal by Subject|1
6925187|NCT00830869|10955260|FG002|Period 1: Part 1|Withdrawal by Subject|0
6925188|NCT00830869|10955261|FG003|Period 1: Part 1|Withdrawal by Subject|0
6925189|NCT00830869|10955262|FG004|Period 1: Part 1|Withdrawal by Subject|0
6925190|NCT00830869|10955263|FG005|Period 1: Part 1|Withdrawal by Subject|0
6925191|NCT00830869|10955264|FG006|Period 1: Part 1|Withdrawal by Subject|0
6925192|NCT00830869|10955265|FG007|Period 1: Part 1|Withdrawal by Subject|0
6925193|NCT00830869|10955266|FG008|Period 1: Part 1|Withdrawal by Subject|0
6925194|NCT00830869|10955267|FG009|Period 1: Part 1|Withdrawal by Subject|0
6925195|NCT00830869|10955268|FG010|Period 1: Part 1|Withdrawal by Subject|0
6831610|NCT00172185|10835262|FG000|Overall Study|Adverse Event|0
6831611|NCT00172185|10835263|FG001|Overall Study|Adverse Event|1
6831612|NCT00172185|10835264|FG002|Overall Study|Adverse Event|3
6831613|NCT00172185|10835265|FG003|Overall Study|Adverse Event|4
6831614|NCT00172185|10835262|FG000|Overall Study|Physician Decision|0
6831615|NCT00172185|10835263|FG001|Overall Study|Physician Decision|0
6831616|NCT00172185|10835264|FG002|Overall Study|Physician Decision|1
6831617|NCT00172185|10835265|FG003|Overall Study|Physician Decision|0
6831618|NCT00172185|10835262|FG000|Overall Study|SPONSOR Decision|0
6831619|NCT00172185|10835263|FG001|Overall Study|SPONSOR Decision|1
6831620|NCT00172185|10835264|FG002|Overall Study|SPONSOR Decision|0
6831621|NCT00172185|10835265|FG003|Overall Study|SPONSOR Decision|0
6831622|NCT00172185|10835262|FG000|Overall Study|Withdrawal by Subject|0
6831623|NCT00172185|10835263|FG001|Overall Study|Withdrawal by Subject|0
6831624|NCT00172185|10835264|FG002|Overall Study|Withdrawal by Subject|1
6831625|NCT00172185|10835265|FG003|Overall Study|Withdrawal by Subject|0
6831626|NCT00174187|10835281|FG000|Period 1 (up to 3 Years)|Serious adverse event|0
6831627|NCT00174187|10835282|FG001|Period 1 (up to 3 Years)|Serious adverse event|1
6831628|NCT00174187|10835283|FG002|Period 1 (up to 3 Years)|Serious adverse event|0
6831629|NCT00174187|10835281|FG000|Period 1 (up to 3 Years)|Non compliance|0
7038918|NCT01707992|11121596|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8
7038919|NCT01707992|11121597|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13
7038920|NCT01707992|11121598|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9
7038921|NCT01707992|11121599|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0
7038922|NCT01707992|11121600|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0
7038923|NCT01707992|11121601|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0
7038924|NCT01707992|11121596|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10
7038925|NCT01707992|11121597|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3
7038926|NCT01707992|11121598|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2
7038927|NCT01707992|11121599|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
7062477|NCT01939158|11160166|FG001|Overall Study|Other|3
7062478|NCT01939158|11160167|FG002|Overall Study|Other|4
7062479|NCT01939158|11160168|FG003|Overall Study|Other|3
7062480|NCT01939197|11160189|FG000|Overall Study|Withdrawal by Subject|1
7062481|NCT01939197|11160190|FG001|Overall Study|Withdrawal by Subject|0
7062482|NCT01939197|11160191|FG002|Overall Study|Withdrawal by Subject|0
7062483|NCT01939197|11160192|FG003|Overall Study|Withdrawal by Subject|0
7062484|NCT01939197|11160193|FG004|Overall Study|Withdrawal by Subject|1
7062485|NCT01939197|11160194|FG005|Overall Study|Withdrawal by Subject|0
7062486|NCT01939197|11160195|FG006|Overall Study|Withdrawal by Subject|0
7062487|NCT01939197|11160189|FG000|Overall Study|Lost to Follow-up|0
7062488|NCT01939197|11160190|FG001|Overall Study|Lost to Follow-up|1
7062489|NCT01939197|11160191|FG002|Overall Study|Lost to Follow-up|0
7062490|NCT01939197|11160192|FG003|Overall Study|Lost to Follow-up|1
7062491|NCT01939197|11160193|FG004|Overall Study|Lost to Follow-up|3
7062492|NCT01939197|11160194|FG005|Overall Study|Lost to Follow-up|1
7062493|NCT01939197|11160195|FG006|Overall Study|Lost to Follow-up|2
7062494|NCT01939314|11160244|FG000|Overall Study|Withdrawal by Subject|3
7062495|NCT01939314|11160245|FG001|Overall Study|Withdrawal by Subject|1
7062496|NCT01939314|11160244|FG000|Overall Study|Protocol Violation|1
7062497|NCT01939314|11160245|FG001|Overall Study|Protocol Violation|0
7062498|NCT01939314|11160244|FG000|Overall Study|Pregnancy|0
7062499|NCT01939314|11160245|FG001|Overall Study|Pregnancy|1
7062500|NCT01939314|11160244|FG000|Overall Study|Lost to Follow-up|5
7062501|NCT01939314|11160245|FG001|Overall Study|Lost to Follow-up|6
7062502|NCT01939353|11160253|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3
7062503|NCT01939353|11160253|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1
7062504|NCT01939353|11160253|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2
7062505|NCT01939353|11160253|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1
7062506|NCT01939353|11160253|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1
7062507|NCT01939366|11160262|FG000|Overall Study|Adverse Event|8
7062508|NCT01939366|11160263|FG001|Overall Study|Adverse Event|17
7062509|NCT01939366|11160264|FG002|Overall Study|Adverse Event|30
7062510|NCT01939366|11160265|FG003|Overall Study|Adverse Event|8
7062511|NCT01939366|11160266|FG004|Overall Study|Adverse Event|5
7062512|NCT01939366|11160262|FG000|Overall Study|Lack of Efficacy|2
7062513|NCT01939366|11160263|FG001|Overall Study|Lack of Efficacy|1
7062514|NCT01939366|11160264|FG002|Overall Study|Lack of Efficacy|1
7062515|NCT01939366|11160265|FG003|Overall Study|Lack of Efficacy|1
7062516|NCT01939366|11160266|FG004|Overall Study|Lack of Efficacy|3
7062517|NCT01939366|11160262|FG000|Overall Study|Lost to Follow-up|1
7062518|NCT01939366|11160263|FG001|Overall Study|Lost to Follow-up|1
7062519|NCT01939366|11160264|FG002|Overall Study|Lost to Follow-up|0
7062520|NCT01939366|11160265|FG003|Overall Study|Lost to Follow-up|0
7062521|NCT01939366|11160266|FG004|Overall Study|Lost to Follow-up|0
7062522|NCT01939366|11160262|FG000|Overall Study|Withdrawal by Subject|1
7062523|NCT01939366|11160263|FG001|Overall Study|Withdrawal by Subject|0
7062524|NCT01939366|11160264|FG002|Overall Study|Withdrawal by Subject|2
7062525|NCT01939366|11160265|FG003|Overall Study|Withdrawal by Subject|2
6831630|NCT00174187|10835282|FG001|Period 1 (up to 3 Years)|Non compliance|1
6831631|NCT00174187|10835283|FG002|Period 1 (up to 3 Years)|Non compliance|0
7062526|NCT01939366|11160266|FG004|Overall Study|Withdrawal by Subject|3
6831632|NCT00174187|10835281|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0
6831633|NCT00174187|10835282|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1
6831634|NCT00174187|10835283|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0
6831635|NCT00174187|10835281|FG000|Period 1 (up to 3 Years)|Other|0
6831636|NCT00174187|10835282|FG001|Period 1 (up to 3 Years)|Other|1
6831637|NCT00174187|10835283|FG002|Period 1 (up to 3 Years)|Other|0
6831638|NCT00174187|10835281|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0
6831639|NCT00174187|10835282|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0
6831640|NCT00174187|10835283|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2
6831641|NCT00174187|10835281|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0
6831642|NCT00174187|10835282|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0
6831643|NCT00174187|10835283|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3
6831644|NCT00174187|10835281|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0
6831645|NCT00174187|10835282|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0
6831646|NCT00174187|10835283|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2
6831647|NCT00174187|10835281|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0
6831648|NCT00174187|10835282|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0
6831649|NCT00174187|10835283|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1
6831650|NCT00174187|10835281|FG000|Period 2 (After 3 Years)|Other|0
6831651|NCT00174187|10835282|FG001|Period 2 (After 3 Years)|Other|0
6831652|NCT00174187|10835283|FG002|Period 2 (After 3 Years)|Other|5
6831653|NCT00174252|10835291|FG000|Overall Study|Protocol Violation|2
6831654|NCT00174291|10835299|FG000|Overall Study|Lost to Follow-up|1
6831655|NCT00174291|10835300|FG001|Overall Study|Lost to Follow-up|1
6831656|NCT00174291|10835299|FG000|Overall Study|Protocol Violation|0
6831657|NCT00174291|10835300|FG001|Overall Study|Protocol Violation|2
6831658|NCT00174291|10835299|FG000|Overall Study|Study terminated by sponsor|1
6831659|NCT00174291|10835300|FG001|Overall Study|Study terminated by sponsor|0
6831660|NCT00174291|10835299|FG000|Overall Study|Withdrawal by Subject|3
7038928|NCT01707992|11121600|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
7038929|NCT01707992|11121601|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
7038930|NCT01707992|11121596|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88
7038931|NCT01707992|11121597|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68
7038932|NCT01707992|11121598|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154
7038933|NCT01707992|11121599|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
7038934|NCT01707992|11121600|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
7038935|NCT01707992|11121601|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
7038936|NCT01707992|11121596|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1
7038937|NCT01707992|11121597|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
7062527|NCT01939366|11160262|FG000|Overall Study|Inclusion criteria not met|0
7038938|NCT01707992|11121598|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
7038939|NCT01707992|11121599|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
7038940|NCT01707992|11121600|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
7038941|NCT01707992|11121601|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
7038942|NCT01707992|11121596|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12
7038943|NCT01707992|11121597|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5
7038944|NCT01707992|11121598|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9
7038945|NCT01707992|11121599|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0
7038946|NCT01707992|11121600|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0
7038947|NCT01707992|11121601|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0
7038948|NCT01707992|11121596|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10
7038949|NCT01707992|11121597|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4
7038950|NCT01707992|11121598|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9
7038951|NCT01707992|11121599|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
7038952|NCT01707992|11121600|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
7038953|NCT01707992|11121601|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
7038954|NCT01707992|11121596|FG000|Placebo-Controlled Phase (24 Months)|Death|2
7038955|NCT01707992|11121597|FG001|Placebo-Controlled Phase (24 Months)|Death|1
7038956|NCT01707992|11121598|FG002|Placebo-Controlled Phase (24 Months)|Death|1
7038957|NCT01707992|11121599|FG003|Placebo-Controlled Phase (24 Months)|Death|0
7038958|NCT01707992|11121600|FG004|Placebo-Controlled Phase (24 Months)|Death|0
7038959|NCT01707992|11121601|FG005|Placebo-Controlled Phase (24 Months)|Death|0
7038960|NCT01707992|11121596|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2
7038961|NCT01707992|11121597|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1
7038962|NCT01707992|11121598|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6
7038963|NCT01707992|11121599|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
7038964|NCT01707992|11121600|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
7038965|NCT01707992|11121601|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
7038966|NCT01707992|11121596|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11
7038967|NCT01707992|11121597|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9
6831661|NCT00174291|10835300|FG001|Overall Study|Withdrawal by Subject|3
6831662|NCT00174382|10835306|FG000|Overall Study|Death|2
6831663|NCT00174382|10835306|FG000|Overall Study|Adverse Event|19
6831664|NCT00174382|10835306|FG000|Overall Study|Withdrawal by Subject|6
6831665|NCT00174382|10835306|FG000|Overall Study|Protocol Violation|3
6831666|NCT00174382|10835306|FG000|Overall Study|Arrived early for last visit in error|1
6831667|NCT00174382|10835306|FG000|Overall Study|Subject felt pill not effective enough|1
6831668|NCT00174382|10835306|FG000|Overall Study|Lost to Follow-up|1
6831669|NCT00174447|10835310|FG000|Overall Study|Adverse Event|19
6831670|NCT00174447|10835310|FG000|Overall Study|Withdrawal by Subject|15
6831671|NCT00174447|10835310|FG000|Overall Study|Protocol Violation|1
6831672|NCT00174447|10835310|FG000|Overall Study|Lack of Efficacy|1
6831673|NCT00174447|10835310|FG000|Overall Study|Administrative reason/Other|2
6831674|NCT00174460|10835316|FG000|Overall Study|Withdrawal by Subject|0
6831675|NCT00174460|10835317|FG001|Overall Study|Withdrawal by Subject|1
6831676|NCT00174785|10835326|FG000|Overall Study|Adverse Event|293
6925196|NCT00830869|10955269|FG011|Period 1: Part 1|Withdrawal by Subject|0
6925197|NCT00830869|10955258|FG000|Period 1: Part 1|Adverse Event|0
6925198|NCT00830869|10955259|FG001|Period 1: Part 1|Adverse Event|0
6925199|NCT00830869|10955260|FG002|Period 1: Part 1|Adverse Event|0
6925200|NCT00830869|10955261|FG003|Period 1: Part 1|Adverse Event|0
6925201|NCT00830869|10955262|FG004|Period 1: Part 1|Adverse Event|0
6925202|NCT00830869|10955263|FG005|Period 1: Part 1|Adverse Event|1
6925203|NCT00830869|10955264|FG006|Period 1: Part 1|Adverse Event|1
6925204|NCT00830869|10955265|FG007|Period 1: Part 1|Adverse Event|0
6925205|NCT00830869|10955266|FG008|Period 1: Part 1|Adverse Event|0
6925206|NCT00830869|10955267|FG009|Period 1: Part 1|Adverse Event|0
6925207|NCT00830869|10955268|FG010|Period 1: Part 1|Adverse Event|0
6925208|NCT00830869|10955269|FG011|Period 1: Part 1|Adverse Event|0
6925209|NCT00830869|10955258|FG000|Period 1: Part 1|Progressive disease|1
6925210|NCT00830869|10955259|FG001|Period 1: Part 1|Progressive disease|0
6925211|NCT00830869|10955260|FG002|Period 1: Part 1|Progressive disease|1
6925212|NCT00830869|10955261|FG003|Period 1: Part 1|Progressive disease|6
6925213|NCT00830869|10955262|FG004|Period 1: Part 1|Progressive disease|4
6925214|NCT00830869|10955263|FG005|Period 1: Part 1|Progressive disease|4
6925215|NCT00830869|10955264|FG006|Period 1: Part 1|Progressive disease|1
6925216|NCT00830869|10955265|FG007|Period 1: Part 1|Progressive disease|0
6925217|NCT00830869|10955266|FG008|Period 1: Part 1|Progressive disease|0
7062528|NCT01939366|11160263|FG001|Overall Study|Inclusion criteria not met|1
7062529|NCT01939366|11160264|FG002|Overall Study|Inclusion criteria not met|1
7062530|NCT01939366|11160265|FG003|Overall Study|Inclusion criteria not met|0
7062531|NCT01939366|11160266|FG004|Overall Study|Inclusion criteria not met|1
7062532|NCT01939366|11160262|FG000|Overall Study|Other|0
7062533|NCT01939366|11160263|FG001|Overall Study|Other|0
7062534|NCT01939366|11160264|FG002|Overall Study|Other|2
7062535|NCT01939366|11160265|FG003|Overall Study|Other|2
7062536|NCT01939366|11160266|FG004|Overall Study|Other|1
7062537|NCT01939366|11160262|FG000|Overall Study|Protocol Violation|0
7062538|NCT01939366|11160263|FG001|Overall Study|Protocol Violation|0
7062539|NCT01939366|11160264|FG002|Overall Study|Protocol Violation|0
7062540|NCT01939366|11160265|FG003|Overall Study|Protocol Violation|1
7062541|NCT01939366|11160266|FG004|Overall Study|Protocol Violation|0
7062542|NCT01939366|11160262|FG000|Overall Study|Sponsor decision|0
7062543|NCT01939366|11160263|FG001|Overall Study|Sponsor decision|0
7062544|NCT01939366|11160264|FG002|Overall Study|Sponsor decision|0
7062545|NCT01939366|11160265|FG003|Overall Study|Sponsor decision|0
7062546|NCT01939366|11160266|FG004|Overall Study|Sponsor decision|2
7062547|NCT01939366|11160262|FG000|Overall Study|GCP non-compliance at site|2
7062548|NCT01939366|11160263|FG001|Overall Study|GCP non-compliance at site|3
7062549|NCT01939366|11160264|FG002|Overall Study|GCP non-compliance at site|2
7062550|NCT01939366|11160265|FG003|Overall Study|GCP non-compliance at site|3
7062551|NCT01939366|11160266|FG004|Overall Study|GCP non-compliance at site|3
7062552|NCT01939496|11160290|FG000|Overall Study|Adverse Event|2
7062553|NCT01939496|11160291|FG001|Overall Study|Adverse Event|0
7062554|NCT01939496|11160292|FG002|Overall Study|Adverse Event|0
7062555|NCT01939496|11160290|FG000|Overall Study|Lost to Follow-up|1
7062556|NCT01939496|11160291|FG001|Overall Study|Lost to Follow-up|1
7062557|NCT01939496|11160292|FG002|Overall Study|Lost to Follow-up|0
7062558|NCT01939496|11160290|FG000|Overall Study|Physician Decision|1
7062559|NCT01939496|11160291|FG001|Overall Study|Physician Decision|0
7062560|NCT01939496|11160292|FG002|Overall Study|Physician Decision|0
7062561|NCT01939496|11160290|FG000|Overall Study|Protocol Violation|3
7062562|NCT01939496|11160291|FG001|Overall Study|Protocol Violation|0
7062563|NCT01939496|11160292|FG002|Overall Study|Protocol Violation|0
7062564|NCT01939496|11160290|FG000|Overall Study|Withdrawal by Subject|0
7062565|NCT01939496|11160291|FG001|Overall Study|Withdrawal by Subject|1
6831677|NCT00174785|10835327|FG001|Overall Study|Adverse Event|191
6831678|NCT00174785|10835326|FG000|Overall Study|Protocol Violation|14
6831679|NCT00174785|10835327|FG001|Overall Study|Protocol Violation|14
7062566|NCT01939496|11160292|FG002|Overall Study|Withdrawal by Subject|1
7062567|NCT01939496|11160290|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0
7062568|NCT01939496|11160291|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1
7062569|NCT01939496|11160292|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0
7062570|NCT01939496|11160290|FG000|Overall Study|Other|2
7062571|NCT01939496|11160291|FG001|Overall Study|Other|0
7062572|NCT01939496|11160292|FG002|Overall Study|Other|1
6831680|NCT00174785|10835326|FG000|Overall Study|Withdrawal by Subject|173
6831681|NCT00174785|10835327|FG001|Overall Study|Withdrawal by Subject|175
6831682|NCT00174785|10835326|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110
6831683|NCT00174785|10835327|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167
6831684|NCT00174785|10835326|FG000|Overall Study|Prohibited antiarrhythmic medication|39
6831685|NCT00174785|10835327|FG001|Overall Study|Prohibited antiarrhythmic medication|88
6831686|NCT00174785|10835326|FG000|Overall Study|Other prohibited medication|5
6831687|NCT00174785|10835327|FG001|Overall Study|Other prohibited medication|3
6831688|NCT00174785|10835326|FG000|Overall Study|Family request|6
6831689|NCT00174785|10835327|FG001|Overall Study|Family request|8
6831690|NCT00174785|10835326|FG000|Overall Study|Not pre-specified/Not coded|56
6831691|NCT00174785|10835327|FG001|Overall Study|Not pre-specified/Not coded|70
6831692|NCT00174915|10835338|FG000|Overall Study|Lost to Follow-up|19
6831693|NCT00174915|10835339|FG001|Overall Study|Lost to Follow-up|17
6831694|NCT00174915|10835340|FG002|Overall Study|Lost to Follow-up|9
6831695|NCT00174915|10835341|FG003|Overall Study|Lost to Follow-up|17
6831696|NCT00174915|10835342|FG004|Overall Study|Lost to Follow-up|10
6831697|NCT00174915|10835338|FG000|Overall Study|Adverse Event|18
6831698|NCT00174915|10835339|FG001|Overall Study|Adverse Event|16
6831699|NCT00174915|10835340|FG002|Overall Study|Adverse Event|11
6831700|NCT00174915|10835341|FG003|Overall Study|Adverse Event|18
6831701|NCT00174915|10835342|FG004|Overall Study|Adverse Event|5
6831702|NCT00174915|10835338|FG000|Overall Study|Personal Reason(s)|16
7062573|NCT01939548|11160303|FG000|Overall Study|Non compliance|0
7062574|NCT01939548|11160304|FG001|Overall Study|Non compliance|2
7062575|NCT01939548|11160305|FG002|Overall Study|Non compliance|0
7062576|NCT01939548|11160303|FG000|Overall Study|Study Terminated by Sponsor|17
7062577|NCT01939548|11160304|FG001|Overall Study|Study Terminated by Sponsor|19
7062578|NCT01939548|11160305|FG002|Overall Study|Study Terminated by Sponsor|12
7062579|NCT01939548|11160303|FG000|Overall Study|Insufficient Clinical Response|1
7062580|NCT01939548|11160304|FG001|Overall Study|Insufficient Clinical Response|0
7062581|NCT01939548|11160305|FG002|Overall Study|Insufficient Clinical Response|0
7062582|NCT01939548|11160303|FG000|Overall Study|Did Not Meet Entrance Criteria|1
7062583|NCT01939548|11160304|FG001|Overall Study|Did Not Meet Entrance Criteria|0
7062584|NCT01939548|11160305|FG002|Overall Study|Did Not Meet Entrance Criteria|0
7062585|NCT01939548|11160303|FG000|Overall Study|Withdrawal by Subject|4
7062586|NCT01939548|11160304|FG001|Overall Study|Withdrawal by Subject|4
7062587|NCT01939548|11160305|FG002|Overall Study|Withdrawal by Subject|1
7062588|NCT01939548|11160303|FG000|Overall Study|Protocol Violation|7
7062589|NCT01939548|11160304|FG001|Overall Study|Protocol Violation|6
7062590|NCT01939548|11160305|FG002|Overall Study|Protocol Violation|5
7062591|NCT01939548|11160303|FG000|Overall Study|Lost to Follow-up|5
7062592|NCT01939548|11160304|FG001|Overall Study|Lost to Follow-up|5
7062593|NCT01939548|11160305|FG002|Overall Study|Lost to Follow-up|3
7062594|NCT01939548|11160303|FG000|Overall Study|Adverse Event|2
7062595|NCT01939548|11160304|FG001|Overall Study|Adverse Event|9
7062596|NCT01939548|11160305|FG002|Overall Study|Adverse Event|7
7062597|NCT01939548|11160303|FG000|Overall Study|Death|0
7062598|NCT01939548|11160304|FG001|Overall Study|Death|0
7062599|NCT01939548|11160305|FG002|Overall Study|Death|1
7062600|NCT01939548|11160303|FG000|Overall Study|Participant dropped|0
7062601|NCT01939548|11160304|FG001|Overall Study|Participant dropped|0
7062602|NCT01939548|11160305|FG002|Overall Study|Participant dropped|1
7062603|NCT01939548|11160303|FG000|Overall Study|Participant unwilling to continue|0
7062604|NCT01939548|11160304|FG001|Overall Study|Participant unwilling to continue|1
7062605|NCT01939548|11160305|FG002|Overall Study|Participant unwilling to continue|0
7062606|NCT01939548|11160303|FG000|Overall Study|Participant withdrew consent|0
7062607|NCT01939548|11160304|FG001|Overall Study|Participant withdrew consent|2
7062608|NCT01939548|11160305|FG002|Overall Study|Participant withdrew consent|0
7062609|NCT01939548|11160303|FG000|Overall Study|Did not complete follow-up|0
7062610|NCT01939548|11160304|FG001|Overall Study|Did not complete follow-up|1
7062611|NCT01939548|11160305|FG002|Overall Study|Did not complete follow-up|0
7062612|NCT01939899|11160318|FG000|Lead-in Dose Finding Phase|Death|0
7062613|NCT01939899|11160319|FG001|Lead-in Dose Finding Phase|Death|3
7062614|NCT01939899|11160320|FG002|Lead-in Dose Finding Phase|Death|1
7062615|NCT01939899|11160321|FG003|Lead-in Dose Finding Phase|Death|0
7062616|NCT01939899|11160322|FG004|Lead-in Dose Finding Phase|Death|0
7062617|NCT01939899|11160318|FG000|Lead-in Dose Finding Phase|Disease Progression|2
7062618|NCT01939899|11160319|FG001|Lead-in Dose Finding Phase|Disease Progression|4
7062619|NCT01939899|11160320|FG002|Lead-in Dose Finding Phase|Disease Progression|3
7062620|NCT01939899|11160321|FG003|Lead-in Dose Finding Phase|Disease Progression|0
7062621|NCT01939899|11160322|FG004|Lead-in Dose Finding Phase|Disease Progression|0
6831703|NCT00174915|10835339|FG001|Overall Study|Personal Reason(s)|16
6831704|NCT00174915|10835340|FG002|Overall Study|Personal Reason(s)|9
6831705|NCT00174915|10835341|FG003|Overall Study|Personal Reason(s)|9
6831706|NCT00174915|10835342|FG004|Overall Study|Personal Reason(s)|9
6831707|NCT00174915|10835338|FG000|Overall Study|Other|15
7062622|NCT01939899|11160318|FG000|Lead-in Dose Finding Phase|Other|0
7062623|NCT01939899|11160319|FG001|Lead-in Dose Finding Phase|Other|0
7062624|NCT01939899|11160320|FG002|Lead-in Dose Finding Phase|Other|1
7062625|NCT01939899|11160321|FG003|Lead-in Dose Finding Phase|Other|0
7062626|NCT01939899|11160322|FG004|Lead-in Dose Finding Phase|Other|0
7062627|NCT01939899|11160318|FG000|Phase 2|Withdrawal by Subject|0
6831708|NCT00174915|10835339|FG001|Overall Study|Other|8
6831709|NCT00174915|10835340|FG002|Overall Study|Other|6
6831710|NCT00174915|10835341|FG003|Overall Study|Other|5
6831711|NCT00174915|10835342|FG004|Overall Study|Other|3
6831712|NCT00174915|10835338|FG000|Overall Study|Gout Flare|13
6831713|NCT00174915|10835339|FG001|Overall Study|Gout Flare|6
6831714|NCT00174915|10835340|FG002|Overall Study|Gout Flare|8
6831715|NCT00174915|10835341|FG003|Overall Study|Gout Flare|1
6831716|NCT00174915|10835342|FG004|Overall Study|Gout Flare|0
6831717|NCT00174915|10835338|FG000|Overall Study|Protocol Violation|6
6831718|NCT00174915|10835339|FG001|Overall Study|Protocol Violation|3
6831719|NCT00174915|10835340|FG002|Overall Study|Protocol Violation|3
6831720|NCT00174915|10835341|FG003|Overall Study|Protocol Violation|6
6831721|NCT00174915|10835342|FG004|Overall Study|Protocol Violation|3
6831722|NCT00174915|10835338|FG000|Overall Study|Therapeutic Failure|6
6831723|NCT00174915|10835339|FG001|Overall Study|Therapeutic Failure|3
6831724|NCT00174915|10835340|FG002|Overall Study|Therapeutic Failure|2
6831725|NCT00174915|10835341|FG003|Overall Study|Therapeutic Failure|1
6831726|NCT00174915|10835342|FG004|Overall Study|Therapeutic Failure|3
6831727|NCT00174941|10835357|FG000|Overall Study|Adverse Event|1
6831728|NCT00174941|10835358|FG001|Overall Study|Adverse Event|10
6831729|NCT00174941|10835359|FG002|Overall Study|Adverse Event|2
6831730|NCT00174941|10835360|FG003|Overall Study|Adverse Event|13
6925218|NCT00830869|10955267|FG009|Period 1: Part 1|Progressive disease|0
7062628|NCT01939899|11160319|FG001|Phase 2|Withdrawal by Subject|0
7062629|NCT01939899|11160320|FG002|Phase 2|Withdrawal by Subject|0
7062630|NCT01939899|11160321|FG003|Phase 2|Withdrawal by Subject|2
7062631|NCT01939899|11160322|FG004|Phase 2|Withdrawal by Subject|0
7062632|NCT01939899|11160318|FG000|Phase 2|Disease Progression|0
7062633|NCT01939899|11160319|FG001|Phase 2|Disease Progression|0
7062634|NCT01939899|11160320|FG002|Phase 2|Disease Progression|0
7062635|NCT01939899|11160321|FG003|Phase 2|Disease Progression|9
7062636|NCT01939899|11160322|FG004|Phase 2|Disease Progression|1
7062637|NCT01939977|11160348|FG000|Overall Study|Adverse Event|4
7062638|NCT01939977|11160349|FG001|Overall Study|Adverse Event|3
7062639|NCT01939977|11160348|FG000|Overall Study|Lack of Efficacy|3
7062640|NCT01939977|11160349|FG001|Overall Study|Lack of Efficacy|0
7062641|NCT01939977|11160348|FG000|Overall Study|Physician Decision|1
7062642|NCT01939977|11160349|FG001|Overall Study|Physician Decision|1
7062643|NCT01939977|11160348|FG000|Overall Study|Withdrawal by Subject|0
7062644|NCT01939977|11160349|FG001|Overall Study|Withdrawal by Subject|2
7062645|NCT01939977|11160348|FG000|Overall Study|Did not meet inclusion criteria|1
7062646|NCT01939977|11160349|FG001|Overall Study|Did not meet inclusion criteria|0
7062647|NCT01939977|11160348|FG000|Overall Study|Did not receive study medication|0
7062648|NCT01939977|11160349|FG001|Overall Study|Did not receive study medication|1
7062649|NCT01940120|11160355|FG000|Overall Study|Death|40
7062650|NCT01940120|11160355|FG000|Overall Study|Withdrawal by Subject|8
7062651|NCT01940354|11160388|FG000|Overall Study|Withdrawal by Subject|4
7062652|NCT01940354|11160389|FG001|Overall Study|Withdrawal by Subject|2
7062653|NCT01940484|11160395|FG000|Overall Study|Withdrawal by Subject|3
7062654|NCT01940484|11160395|FG000|Overall Study|Underwent transplantation|4
7062655|NCT01940484|11160395|FG000|Overall Study|Death|2
7062656|NCT01940484|11160395|FG000|Overall Study|Adverse Event|1
7062657|NCT01940497|11160401|FG000|Overall Study|Adverse Event/Intercurrent Illness|11
6831731|NCT00174941|10835357|FG000|Overall Study|Protocol Violation|0
6831732|NCT00174941|10835358|FG001|Overall Study|Protocol Violation|1
6831733|NCT00174941|10835359|FG002|Overall Study|Protocol Violation|0
6831734|NCT00174941|10835360|FG003|Overall Study|Protocol Violation|1
6831735|NCT00174941|10835357|FG000|Overall Study|Lost to Follow-up|0
6831736|NCT00174941|10835358|FG001|Overall Study|Lost to Follow-up|3
6831737|NCT00174941|10835359|FG002|Overall Study|Lost to Follow-up|2
6831738|NCT00174941|10835360|FG003|Overall Study|Lost to Follow-up|5
6831739|NCT00174941|10835357|FG000|Overall Study|Personal Reason(s)|0
6831740|NCT00174941|10835358|FG001|Overall Study|Personal Reason(s)|14
6831741|NCT00174941|10835359|FG002|Overall Study|Personal Reason(s)|8
6831742|NCT00174941|10835360|FG003|Overall Study|Personal Reason(s)|22
6831743|NCT00174941|10835357|FG000|Overall Study|Gout Flare|0
6831744|NCT00174941|10835358|FG001|Overall Study|Gout Flare|4
6831745|NCT00174941|10835359|FG002|Overall Study|Gout Flare|4
6831746|NCT00174941|10835360|FG003|Overall Study|Gout Flare|8
6831747|NCT00174941|10835357|FG000|Overall Study|Reason Not Specified|1
6831748|NCT00174941|10835358|FG001|Overall Study|Reason Not Specified|6
6831749|NCT00174941|10835359|FG002|Overall Study|Reason Not Specified|2
6831750|NCT00174941|10835360|FG003|Overall Study|Reason Not Specified|9
6831751|NCT00174954|10835370|FG000|Overall Study|Adverse Event|2
6831752|NCT00174954|10835370|FG000|Overall Study|No tophi found in MRI|1
6831753|NCT00174954|10835370|FG000|Overall Study|Physician Decision|1
7062658|NCT01940497|11160402|FG001|Overall Study|Adverse Event/Intercurrent Illness|8
7062659|NCT01940497|11160401|FG000|Overall Study|Recurrence of Disease Postsurgery|1
7062660|NCT01940497|11160402|FG001|Overall Study|Recurrence of Disease Postsurgery|3
7062661|NCT01940497|11160401|FG000|Overall Study|Violation of Entry Criteria|1
7062662|NCT01940497|11160402|FG001|Overall Study|Violation of Entry Criteria|1
7062663|NCT01940497|11160401|FG000|Overall Study|Refused Treatment|1
7062664|NCT01940497|11160402|FG001|Overall Study|Refused Treatment|3
7062665|NCT01940497|11160401|FG000|Overall Study|Withdrew Consent|6
7062666|NCT01940497|11160402|FG001|Overall Study|Withdrew Consent|2
7038968|NCT01707992|11121598|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10
7062667|NCT01940497|11160401|FG000|Overall Study|Administrative/Other|1
6831754|NCT00174967|10835378|FG000|Overall Study|Adverse Event|1
6831755|NCT00174967|10835379|FG001|Overall Study|Adverse Event|2
6831756|NCT00174967|10835380|FG002|Overall Study|Adverse Event|2
6831757|NCT00174967|10835381|FG003|Overall Study|Adverse Event|1
6831758|NCT00174967|10835378|FG000|Overall Study|Gout Flare|0
6831759|NCT00174967|10835379|FG001|Overall Study|Gout Flare|0
6831760|NCT00174967|10835380|FG002|Overall Study|Gout Flare|0
6831761|NCT00174967|10835381|FG003|Overall Study|Gout Flare|1
6831762|NCT00174967|10835378|FG000|Overall Study|Other|0
6831763|NCT00174967|10835379|FG001|Overall Study|Other|1
6831764|NCT00174967|10835380|FG002|Overall Study|Other|0
6831765|NCT00174967|10835381|FG003|Overall Study|Other|0
6831766|NCT00175019|10835398|FG000|Overall Study|Adverse Event|54
6831767|NCT00175019|10835399|FG001|Overall Study|Adverse Event|22
6831768|NCT00175019|10835400|FG002|Overall Study|Adverse Event|2
6831769|NCT00175019|10835398|FG000|Overall Study|Protocol Violation|6
6831770|NCT00175019|10835399|FG001|Overall Study|Protocol Violation|3
6831771|NCT00175019|10835400|FG002|Overall Study|Protocol Violation|3
6831772|NCT00175019|10835398|FG000|Overall Study|Lost to Follow-up|42
6831773|NCT00175019|10835399|FG001|Overall Study|Lost to Follow-up|39
6831774|NCT00175019|10835400|FG002|Overall Study|Lost to Follow-up|9
6831775|NCT00175019|10835398|FG000|Overall Study|Did not continue under Amendment 4|1
6831776|NCT00175019|10835399|FG001|Overall Study|Did not continue under Amendment 4|1
6831777|NCT00175019|10835400|FG002|Overall Study|Did not continue under Amendment 4|2
6831778|NCT00175019|10835398|FG000|Overall Study|Personal Reason(s)|39
6831779|NCT00175019|10835399|FG001|Overall Study|Personal Reason(s)|31
6831780|NCT00175019|10835400|FG002|Overall Study|Personal Reason(s)|8
6831781|NCT00175019|10835398|FG000|Overall Study|Therapeutic Failure|10
7062668|NCT01940497|11160402|FG001|Overall Study|Administrative/Other|1
7062669|NCT01940705|11160441|FG000|Overall Study|Lost to Follow-up|1
7062670|NCT01940705|11160442|FG001|Overall Study|Lost to Follow-up|3
7062671|NCT01940705|11160443|FG002|Overall Study|Lost to Follow-up|2
7062672|NCT01940705|11160444|FG003|Overall Study|Lost to Follow-up|2
7062673|NCT01940705|11160441|FG000|Overall Study|Withdrawal by Subject|2
7062674|NCT01940705|11160442|FG001|Overall Study|Withdrawal by Subject|2
7062675|NCT01940705|11160443|FG002|Overall Study|Withdrawal by Subject|3
7062676|NCT01940705|11160444|FG003|Overall Study|Withdrawal by Subject|2
7062677|NCT01940705|11160441|FG000|Overall Study|Intervention not given|0
7062678|NCT01940705|11160442|FG001|Overall Study|Intervention not given|3
7062679|NCT01940705|11160443|FG002|Overall Study|Intervention not given|3
7062680|NCT01940705|11160444|FG003|Overall Study|Intervention not given|0
7062681|NCT01940705|11160441|FG000|Overall Study|Withdrawal by team - hearing aid change|1
7062682|NCT01940705|11160442|FG001|Overall Study|Withdrawal by team - hearing aid change|0
7062683|NCT01940705|11160443|FG002|Overall Study|Withdrawal by team - hearing aid change|0
7062684|NCT01940705|11160444|FG003|Overall Study|Withdrawal by team - hearing aid change|0
7062685|NCT01940887|11160459|FG000|Year 1|Protocol Violation|0
7062686|NCT01940887|11160460|FG001|Year 1|Protocol Violation|1
7062687|NCT01940887|11160459|FG000|Year 1|Physician Decision|7
7062688|NCT01940887|11160460|FG001|Year 1|Physician Decision|3
7062689|NCT01940887|11160459|FG000|Year 1|Death|5
7062690|NCT01940887|11160460|FG001|Year 1|Death|3
7062691|NCT01940887|11160459|FG000|Year 1|Adverse Event|7
7062692|NCT01940887|11160460|FG001|Year 1|Adverse Event|6
7062693|NCT01940887|11160459|FG000|Year 1|Withdrawal by Subject|18
7062694|NCT01940887|11160460|FG001|Year 1|Withdrawal by Subject|9
7062695|NCT01940887|11160459|FG000|Year 1|Lost to Follow-up|2
7062696|NCT01940887|11160460|FG001|Year 1|Lost to Follow-up|1
7062697|NCT01940887|11160459|FG000|Year 2|Physician Decision|8
7062698|NCT01940887|11160460|FG001|Year 2|Physician Decision|1
7062699|NCT01940887|11160459|FG000|Year 2|Death|0
7062700|NCT01940887|11160460|FG001|Year 2|Death|2
7062701|NCT01940887|11160459|FG000|Year 2|Sponsor Decision, early termination|192
7062702|NCT01940887|11160460|FG001|Year 2|Sponsor Decision, early termination|203
7062703|NCT01940887|11160459|FG000|Year 2|Adverse Event|8
7062704|NCT01940887|11160460|FG001|Year 2|Adverse Event|2
7062705|NCT01940887|11160459|FG000|Year 2|Withdrawal by Subject|8
7062706|NCT01940887|11160460|FG001|Year 2|Withdrawal by Subject|8
7062707|NCT01940887|11160459|FG000|Year 2|Lost to Follow-up|1
6831782|NCT00175019|10835399|FG001|Overall Study|Therapeutic Failure|38
6831783|NCT00175019|10835400|FG002|Overall Study|Therapeutic Failure|22
6831784|NCT00175019|10835398|FG000|Overall Study|Gout Flare|2
6831785|NCT00175019|10835399|FG001|Overall Study|Gout Flare|3
6831786|NCT00175019|10835400|FG002|Overall Study|Gout Flare|0
6831787|NCT00175019|10835398|FG000|Overall Study|Reason Not Specified|40
6831788|NCT00175019|10835399|FG001|Overall Study|Reason Not Specified|34
6831789|NCT00175019|10835400|FG002|Overall Study|Reason Not Specified|11
6831790|NCT00175825|10835412|FG000|Overall Study|Adverse Event|3
7038969|NCT01707992|11121599|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0
7038970|NCT01707992|11121600|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0
7038971|NCT01707992|11121601|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0
7038972|NCT01707992|11121596|FG000|Active Treatment Phase (24 Months)|Adverse Event|0
7038973|NCT01707992|11121597|FG001|Active Treatment Phase (24 Months)|Adverse Event|0
7038974|NCT01707992|11121598|FG002|Active Treatment Phase (24 Months)|Adverse Event|0
7038975|NCT01707992|11121599|FG003|Active Treatment Phase (24 Months)|Adverse Event|4
6831791|NCT00175825|10835413|FG001|Overall Study|Adverse Event|2
6831792|NCT00175825|10835414|FG002|Overall Study|Adverse Event|1
6831793|NCT00175825|10835415|FG003|Overall Study|Adverse Event|1
6831794|NCT00175825|10835412|FG000|Overall Study|Lost to Follow-up|1
6831795|NCT00175825|10835413|FG001|Overall Study|Lost to Follow-up|2
6831796|NCT00175825|10835414|FG002|Overall Study|Lost to Follow-up|0
6831797|NCT00175825|10835415|FG003|Overall Study|Lost to Follow-up|0
6831798|NCT00175825|10835412|FG000|Overall Study|Withdrawal by Subject|1
6831799|NCT00175825|10835413|FG001|Overall Study|Withdrawal by Subject|0
6831800|NCT00175825|10835414|FG002|Overall Study|Withdrawal by Subject|0
6831801|NCT00175825|10835415|FG003|Overall Study|Withdrawal by Subject|0
6831802|NCT00175877|10835425|FG000|Overall Study|Adverse Event|136
6831803|NCT00175877|10835425|FG000|Overall Study|Withdrawal by Subject|141
6831804|NCT00175877|10835425|FG000|Overall Study|Lost to Follow-up|9
6831805|NCT00175877|10835425|FG000|Overall Study|Lack of Efficacy|26
6831806|NCT00175877|10835425|FG000|Overall Study|Protocol Violation|15
6831807|NCT00175877|10835425|FG000|Overall Study|Other Reason|20
6831808|NCT00175877|10835425|FG000|Overall Study|AE & Other|1
6831809|NCT00175877|10835425|FG000|Overall Study|Withdrawal by subject & Other|1
6831810|NCT00175916|10835429|FG000|Overall Study|Death|19
6831811|NCT00175916|10835429|FG000|Overall Study|Adverse Event|81
6831812|NCT00175916|10835429|FG000|Overall Study|Lack of Efficacy|354
6831813|NCT00175916|10835429|FG000|Overall Study|Lost to Follow-up|17
6831814|NCT00175916|10835429|FG000|Overall Study|Subject Choice|98
6831815|NCT00175916|10835429|FG000|Overall Study|Lack of compliance|8
6831816|NCT00175916|10835429|FG000|Overall Study|Patient cannot record seizures|1
6831817|NCT00175916|10835429|FG000|Overall Study|Sponsor decision|17
6831818|NCT00175916|10835429|FG000|Overall Study|Vigabatrin intake|1
6831819|NCT00175916|10835429|FG000|Overall Study|Suicidal behaviour|1
6831820|NCT00175916|10835429|FG000|Overall Study|Withdrawal by Subject|1
6831821|NCT00175916|10835429|FG000|Overall Study|Seizure - free|4
6831822|NCT00175916|10835429|FG000|Overall Study|Administrative reason|1
6831823|NCT00175916|10835429|FG000|Overall Study|Pregnancy|1
6831824|NCT00175916|10835429|FG000|Overall Study|Patient's request|2
6831825|NCT00175916|10835429|FG000|Overall Study|Treating physiciant's choice|1
6831826|NCT00175916|10835429|FG000|Overall Study|Moved overseas|1
6831827|NCT00175916|10835429|FG000|Overall Study|Loss of job and economic burden|1
6831828|NCT00175916|10835429|FG000|Overall Study|Site was closed|9
6831829|NCT00175916|10835429|FG000|Overall Study|Patient went to prison|1
6831830|NCT00176254|10835450|FG000|Overall Study|Lost to Follow-up|1
6831831|NCT00176462|10835469|FG000|Induction (4 Weeks)|Withdrawal by Subject|0
6831832|NCT00176462|10835470|FG001|Induction (4 Weeks)|Withdrawal by Subject|2
6831833|NCT00176462|10835469|FG000|Induction (4 Weeks)|Death|1
6831834|NCT00176462|10835470|FG001|Induction (4 Weeks)|Death|2
6831835|NCT00176462|10835469|FG000|Induction (4 Weeks)|Lack of Efficacy|0
6831836|NCT00176462|10835470|FG001|Induction (4 Weeks)|Lack of Efficacy|1
6831837|NCT00176462|10835469|FG000|Consolidation (12 Weeks)|Patient moved to another state|0
6831838|NCT00176462|10835470|FG001|Consolidation (12 Weeks)|Patient moved to another state|1
6831839|NCT00176462|10835469|FG000|Consolidation (12 Weeks)|Adverse Event|0
6831840|NCT00176462|10835470|FG001|Consolidation (12 Weeks)|Adverse Event|1
6831841|NCT00176462|10835469|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0
6831842|NCT00176462|10835470|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2
6831843|NCT00176462|10835469|FG000|Consolidation (12 Weeks)|Not documented|0
6831844|NCT00176462|10835470|FG001|Consolidation (12 Weeks)|Not documented|1
6831845|NCT00176462|10835469|FG000|Intensive Continuation (8X8-week Cycles)|Death|1
6831846|NCT00176462|10835470|FG001|Intensive Continuation (8X8-week Cycles)|Death|0
6831847|NCT00176462|10835469|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0
6831848|NCT00176462|10835470|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3
6831849|NCT00176605|10835486|FG000|Overall Study|Withdrawal by Subject|2
6831850|NCT00176644|10835490|FG000|Overall Study|Withdrawal by Subject|1
6831851|NCT00177164|10835587|FG000|Overall Study|Protocol Violation|0
6831852|NCT00177164|10835588|FG001|Overall Study|Protocol Violation|7
6831853|NCT00177164|10835587|FG000|Overall Study|Lost to Follow-up|4
6831854|NCT00177164|10835588|FG001|Overall Study|Lost to Follow-up|5
6831855|NCT00177164|10835587|FG000|Overall Study|increase in alcohol and drug use|1
6831856|NCT00177164|10835588|FG001|Overall Study|increase in alcohol and drug use|2
6831857|NCT00177164|10835587|FG000|Overall Study|Adverse Event|1
6831858|NCT00177164|10835588|FG001|Overall Study|Adverse Event|0
6831859|NCT00177164|10835587|FG000|Overall Study|discharge from hospital|1
6831860|NCT00177164|10835588|FG001|Overall Study|discharge from hospital|0
6831861|NCT00177164|10835587|FG000|Overall Study|Lack of Efficacy|2
6831862|NCT00177164|10835588|FG001|Overall Study|Lack of Efficacy|1
6831863|NCT00177164|10835587|FG000|Overall Study|Pregnancy|0
6831864|NCT00177164|10835588|FG001|Overall Study|Pregnancy|1
6831865|NCT00177216|10835597|FG000|Overall Study|Withdrawal by Subject|6
6831866|NCT00177216|10835598|FG001|Overall Study|Withdrawal by Subject|3
6831867|NCT00177216|10835599|FG002|Overall Study|Withdrawal by Subject|1
6831868|NCT00177294|10835617|FG000|Overall Study|Withdrawal by Subject|7
6831869|NCT00177294|10835618|FG001|Overall Study|Withdrawal by Subject|5
6831870|NCT00177307|10835624|FG000|Overall Study|Withdrawal by Subject|1
6831871|NCT00177671|10835630|FG000|Overall Study|Withdrawal by Subject|5
6831872|NCT00177671|10835631|FG001|Overall Study|Withdrawal by Subject|6
6831873|NCT00177671|10835630|FG000|Overall Study|medical complications|2
6831874|NCT00177671|10835631|FG001|Overall Study|medical complications|0
6831875|NCT00177671|10835630|FG000|Overall Study|Adverse Event|6
6831876|NCT00177671|10835631|FG001|Overall Study|Adverse Event|0
6831877|NCT00177671|10835630|FG000|Overall Study|Physician Decision|12
6831878|NCT00177671|10835631|FG001|Overall Study|Physician Decision|8
6831879|NCT00178126|10835639|FG000|Overall Study|Lost to Follow-up|21
6831880|NCT00178126|10835640|FG001|Overall Study|Lost to Follow-up|21
6831881|NCT00178126|10835639|FG000|Overall Study|did not receive intervention|4
6831882|NCT00178126|10835640|FG001|Overall Study|did not receive intervention|6
6831883|NCT00178256|10835676|FG000|Overall Study|Adverse Event|2
6831884|NCT00178256|10835677|FG001|Overall Study|Adverse Event|0
6831885|NCT00178256|10835678|FG002|Overall Study|Adverse Event|0
6831886|NCT00178256|10835679|FG003|Overall Study|Adverse Event|0
6831887|NCT00178256|10835676|FG000|Overall Study|Death|0
6831888|NCT00178256|10835677|FG001|Overall Study|Death|1
7062708|NCT01940887|11160460|FG001|Year 2|Lost to Follow-up|6
7062709|NCT01940900|11160468|FG000|Overall Study|Physician Decision|4
7062710|NCT01940900|11160469|FG001|Overall Study|Physician Decision|0
7062711|NCT01940900|11160468|FG000|Overall Study|Adverse Event|10
7062712|NCT01940900|11160469|FG001|Overall Study|Adverse Event|15
7062713|NCT01940900|11160468|FG000|Overall Study|Withdrawal by Subject|11
7062714|NCT01940900|11160469|FG001|Overall Study|Withdrawal by Subject|15
7062715|NCT01940900|11160468|FG000|Overall Study|Lost to Follow-up|1
7062716|NCT01940900|11160469|FG001|Overall Study|Lost to Follow-up|0
7062717|NCT01940900|11160468|FG000|Overall Study|Sponsor Decision|1
7062718|NCT01940900|11160469|FG001|Overall Study|Sponsor Decision|0
7062719|NCT01940900|11160468|FG000|Overall Study|subject non-compliance|1
7062720|NCT01940900|11160469|FG001|Overall Study|subject non-compliance|1
7062721|NCT01940900|11160468|FG000|Overall Study|other|1
7062722|NCT01940900|11160469|FG001|Overall Study|other|0
7062723|NCT01940939|11160477|FG000|Overall Study|Withdrawal by Subject|2
7062724|NCT01940939|11160478|FG001|Overall Study|Withdrawal by Subject|8
7062725|NCT01941030|11160486|FG000|Overall Study|Death|3
7062726|NCT01941030|11160487|FG001|Overall Study|Death|2
7062727|NCT01941030|11160486|FG000|Overall Study|Lost to Follow-up|6
7062728|NCT01941030|11160487|FG001|Overall Study|Lost to Follow-up|5
7062729|NCT01941030|11160486|FG000|Overall Study|Withdrawal by Subject|4
7062730|NCT01941030|11160487|FG001|Overall Study|Withdrawal by Subject|6
7062731|NCT01941095|11160493|FG000|Overall Study|Insufficient therapeutic response|13
7062732|NCT01941095|11160493|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2
7062733|NCT01941095|11160493|FG000|Overall Study|Adverse Event|11
7062734|NCT01941095|11160493|FG000|Overall Study|Physician Decision|3
7062735|NCT01941095|11160493|FG000|Overall Study|Withdrawal by Subject|17
7062736|NCT01941095|11160493|FG000|Overall Study|Lost to Follow-up|10
7062737|NCT01941186|11160500|FG000|Follow-up|Lost to Follow-up|1
7062738|NCT01941186|11160501|FG001|Follow-up|Lost to Follow-up|0
7062739|NCT01941498|11160546|FG000|Overall Study|Relocated out of state|1
7062740|NCT01941537|11160567|FG000|Overall Study|Lack of Efficacy|1
7062741|NCT01941537|11160568|FG001|Overall Study|Lack of Efficacy|2
7062742|NCT01941537|11160567|FG000|Overall Study|Lost to Follow-up|1
7062743|NCT01941537|11160568|FG001|Overall Study|Lost to Follow-up|0
7062744|NCT01941537|11160567|FG000|Overall Study|Pregnancy|1
7062745|NCT01941537|11160568|FG001|Overall Study|Pregnancy|0
7062746|NCT01941537|11160567|FG000|Overall Study|Adverse Event|1
7062747|NCT01941537|11160568|FG001|Overall Study|Adverse Event|0
7062748|NCT01941537|11160567|FG000|Overall Study|Withdrawal by Subject|0
7062749|NCT01941537|11160568|FG001|Overall Study|Withdrawal by Subject|1
7062750|NCT01941940|11160613|FG000|Overall Study|Adverse Event|11
7062751|NCT01941940|11160613|FG000|Overall Study|Lost to Follow-up|2
7062752|NCT01941940|11160613|FG000|Overall Study|Physician Decision|2
7062753|NCT01941940|11160613|FG000|Overall Study|Withdrawal by Subject|15
7062754|NCT01941940|11160613|FG000|Overall Study|Death|1
7062755|NCT01941940|11160613|FG000|Overall Study|Other|1
7062756|NCT01941940|11160613|FG000|Overall Study|Other|1
7062757|NCT01942148|11160617|FG000|Overall Study|Adverse Event|4
7062758|NCT01942148|11160617|FG000|Overall Study|Lack of Efficacy|2
7062759|NCT01942148|11160617|FG000|Overall Study|Physician Decision|11
7062760|NCT01942148|11160617|FG000|Overall Study|Protocol Violation|1
7062761|NCT01942148|11160617|FG000|Overall Study|Withdrawal by Subject|8
7062762|NCT01942148|11160617|FG000|Overall Study|Use of the prohibition medicine|1
7062763|NCT01942161|11160624|FG000|Overall Study|Adverse Event|1
7062764|NCT01942161|11160625|FG001|Overall Study|Adverse Event|2
7062765|NCT01942161|11160626|FG002|Overall Study|Adverse Event|5
7062766|NCT01942161|11160624|FG000|Overall Study|Physician Decision|3
7062767|NCT01942161|11160625|FG001|Overall Study|Physician Decision|1
7062768|NCT01942161|11160626|FG002|Overall Study|Physician Decision|0
7062769|NCT01942161|11160624|FG000|Overall Study|Protocol Violation|1
7062770|NCT01942161|11160625|FG001|Overall Study|Protocol Violation|0
7062771|NCT01942161|11160626|FG002|Overall Study|Protocol Violation|0
6831889|NCT00178256|10835678|FG002|Overall Study|Death|0
6831890|NCT00178256|10835679|FG003|Overall Study|Death|1
6831891|NCT00178256|10835676|FG000|Overall Study|Cancer progression|2
6831892|NCT00178256|10835677|FG001|Overall Study|Cancer progression|0
6831893|NCT00178256|10835678|FG002|Overall Study|Cancer progression|0
6831894|NCT00178256|10835679|FG003|Overall Study|Cancer progression|1
7062772|NCT01942161|11160624|FG000|Overall Study|Withdrawal by Subject|3
7062773|NCT01942161|11160625|FG001|Overall Study|Withdrawal by Subject|3
7062774|NCT01942161|11160626|FG002|Overall Study|Withdrawal by Subject|1
6831895|NCT00178399|10835686|FG000|Overall Study|Physician Decision|4
6831896|NCT00178399|10835686|FG000|Overall Study|Withdrawal by Subject|8
6831897|NCT00178399|10835686|FG000|Overall Study|Lost to Follow-up|1
6831898|NCT00178464|10835691|FG000|Overall Study|Withdrawal by Subject|1
6831899|NCT00178464|10835691|FG000|Overall Study|Physician Decision|1
6831900|NCT00178633|10835710|FG000|Overall Study|Lost to Follow-up|6
6831901|NCT00178685|10835734|FG000|Overall Study|Death|3
6831902|NCT00178685|10835735|FG001|Overall Study|Death|3
6831903|NCT00178685|10835736|FG002|Overall Study|Death|6
6831904|NCT00178685|10835734|FG000|Overall Study|Lost to Follow-up|100
6831905|NCT00178685|10835735|FG001|Overall Study|Lost to Follow-up|187
6831906|NCT00178685|10835736|FG002|Overall Study|Lost to Follow-up|183
6831907|NCT00178685|10835734|FG000|Overall Study|Withdrawal by Subject|8
6831908|NCT00178685|10835735|FG001|Overall Study|Withdrawal by Subject|14
6831909|NCT00178685|10835736|FG002|Overall Study|Withdrawal by Subject|7
7038976|NCT01707992|11121600|FG004|Active Treatment Phase (24 Months)|Adverse Event|1
7038977|NCT01707992|11121601|FG005|Active Treatment Phase (24 Months)|Adverse Event|0
7038978|NCT01707992|11121596|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0
7038979|NCT01707992|11121597|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0
7038980|NCT01707992|11121598|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0
7038981|NCT01707992|11121599|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3
7038982|NCT01707992|11121600|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1
7038983|NCT01707992|11121601|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2
7038984|NCT01707992|11121596|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
7062775|NCT01942486|11160634|FG000|Overall Study|Lost to Follow-up|27
7062776|NCT01942590|11160640|FG000|Overall Study|Withdrawal by Subject|0
7062777|NCT01942590|11160641|FG001|Overall Study|Withdrawal by Subject|1
6831910|NCT00179010|10835771|FG000|Overall Study|Muscle probe defective|1
6831911|NCT00179010|10835772|FG001|Overall Study|Muscle probe defective|1
6831912|NCT00179010|10835771|FG000|Overall Study|Failure to place arterial line|0
6831913|NCT00179010|10835772|FG001|Overall Study|Failure to place arterial line|1
6831914|NCT00179309|10835781|FG000|Treatment|Toxicity|2
6831915|NCT00179309|10835782|FG001|Treatment|Toxicity|3
6831916|NCT00179309|10835781|FG000|Treatment|Withdrawal by Subject|1
6831917|NCT00179309|10835782|FG001|Treatment|Withdrawal by Subject|2
6831918|NCT00179309|10835781|FG000|Treatment|Allergy|1
6831919|NCT00179309|10835782|FG001|Treatment|Allergy|0
6831920|NCT00179413|10835790|FG000|Overall Study|Adverse Event|38
6831921|NCT00179413|10835791|FG001|Overall Study|Adverse Event|20
6831922|NCT00179413|10835790|FG000|Overall Study|Withdrawal by Subject|87
6831923|NCT00179413|10835791|FG001|Overall Study|Withdrawal by Subject|95
6831924|NCT00179517|10835807|FG000|Overall Study|Withdrawal by Subject|2
6831925|NCT00179517|10835808|FG001|Overall Study|Withdrawal by Subject|1
7062778|NCT01942590|11160640|FG000|Overall Study|Adverse Event|1
7062779|NCT01942590|11160641|FG001|Overall Study|Adverse Event|0
7062780|NCT01942733|11160696|FG000|Overall Study|Lost to Follow-up|1
7062781|NCT01942733|11160696|FG000|Overall Study|Non-compliance with IMP|1
7062782|NCT01942733|11160696|FG000|Overall Study|Administrative|1
7062783|NCT01942785|11160700|FG000|Overall Study|Adverse Event|2
7062784|NCT01942785|11160700|FG000|Overall Study|Withdrawal by Subject|1
7062785|NCT01942785|11160700|FG000|Overall Study|Protocol Violation|1
7062786|NCT01942993|11160706|FG000|Overall Study|Lost to Follow-up|1
7062787|NCT01942993|11160706|FG000|Overall Study|Physician Decision|1
7062788|NCT01943292|11160738|FG000|Overall Study|Withdrawal by Subject|1
7062789|NCT01943292|11160739|FG001|Overall Study|Withdrawal by Subject|0
7062790|NCT01943292|11160740|FG002|Overall Study|Withdrawal by Subject|0
7062791|NCT01943435|11160757|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4
7062792|NCT01943435|11160758|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12
7062793|NCT01943435|11160759|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3
7062794|NCT01943435|11160757|FG000|Intervention Period|Withdrawal by Subject|3
7062795|NCT01943435|11160758|FG001|Intervention Period|Withdrawal by Subject|3
7062796|NCT01943435|11160759|FG002|Intervention Period|Withdrawal by Subject|4
7062797|NCT01943435|11160757|FG000|2 Month Follow up|Lost to Follow-up|2
7062798|NCT01943435|11160758|FG001|2 Month Follow up|Lost to Follow-up|3
7062799|NCT01943435|11160759|FG002|2 Month Follow up|Lost to Follow-up|0
7062800|NCT01943435|11160757|FG000|6 Month Follow up|Lost to Follow-up|12
7062801|NCT01943435|11160758|FG001|6 Month Follow up|Lost to Follow-up|7
7062802|NCT01943435|11160759|FG002|6 Month Follow up|Lost to Follow-up|15
6831926|NCT00179621|10835817|FG000|Double-Blind Period|Lack of Therapeutic Effect|59
6831927|NCT00179621|10835818|FG001|Double-Blind Period|Lack of Therapeutic Effect|35
6831928|NCT00179621|10835819|FG002|Double-Blind Period|Lack of Therapeutic Effect|19
6831929|NCT00179621|10835820|FG003|Double-Blind Period|Lack of Therapeutic Effect|0
6831930|NCT00179621|10835817|FG000|Double-Blind Period|Adverse Event|2
6831931|NCT00179621|10835818|FG001|Double-Blind Period|Adverse Event|7
6831932|NCT00179621|10835819|FG002|Double-Blind Period|Adverse Event|4
6831933|NCT00179621|10835820|FG003|Double-Blind Period|Adverse Event|0
6831934|NCT00179621|10835817|FG000|Double-Blind Period|Withdrawal by Subject|2
6831935|NCT00179621|10835818|FG001|Double-Blind Period|Withdrawal by Subject|1
6831936|NCT00179621|10835819|FG002|Double-Blind Period|Withdrawal by Subject|3
6831937|NCT00179621|10835820|FG003|Double-Blind Period|Withdrawal by Subject|0
6831938|NCT00179621|10835817|FG000|Double-Blind Period|Death|0
6831939|NCT00179621|10835818|FG001|Double-Blind Period|Death|1
6831940|NCT00179621|10835819|FG002|Double-Blind Period|Death|2
6831941|NCT00179621|10835820|FG003|Double-Blind Period|Death|0
6831942|NCT00179621|10835817|FG000|Double-Blind Period|Protocol Violation|1
6831943|NCT00179621|10835818|FG001|Double-Blind Period|Protocol Violation|0
6831944|NCT00179621|10835819|FG002|Double-Blind Period|Protocol Violation|0
6831945|NCT00179621|10835820|FG003|Double-Blind Period|Protocol Violation|0
6831946|NCT00179621|10835817|FG000|Double-Blind Period|Other|0
6831947|NCT00179621|10835818|FG001|Double-Blind Period|Other|2
6831948|NCT00179621|10835819|FG002|Double-Blind Period|Other|2
6831949|NCT00179621|10835820|FG003|Double-Blind Period|Other|0
6831950|NCT00179621|10835817|FG000|Open-Label Period|Lack of Therapeutic Effect|0
6831951|NCT00179621|10835818|FG001|Open-Label Period|Lack of Therapeutic Effect|19
7062803|NCT01943539|11160793|FG000|Overall Study|Non-compliance with at-home intervention|4
7062804|NCT01943539|11160794|FG001|Overall Study|Non-compliance with at-home intervention|0
7062805|NCT01943552|11160803|FG000|Overall Study|Adverse Event|3
7062806|NCT01943552|11160804|FG001|Overall Study|Adverse Event|2
7062807|NCT01943552|11160803|FG000|Overall Study|Withdrawal by Subject|6
7062808|NCT01943552|11160804|FG001|Overall Study|Withdrawal by Subject|6
7062809|NCT01943552|11160803|FG000|Overall Study|Other Reasons|16
7062810|NCT01943552|11160804|FG001|Overall Study|Other Reasons|17
7062811|NCT01943591|11160825|FG000|Overall Study|Lost to Follow-up|3
7062812|NCT01943591|11160826|FG001|Overall Study|Lost to Follow-up|4
7062813|NCT01943591|11160825|FG000|Overall Study|Death|2
7062814|NCT01943591|11160826|FG001|Overall Study|Death|7
7062815|NCT01943799|11160836|FG000|Overall Study|Lost to Follow-up|0
7062816|NCT01943799|11160837|FG001|Overall Study|Lost to Follow-up|1
7062817|NCT01943799|11160838|FG002|Overall Study|Lost to Follow-up|1
7062818|NCT01943799|11160839|FG003|Overall Study|Lost to Follow-up|0
7062819|NCT01943799|11160836|FG000|Overall Study|Protocol Violation|1
7062820|NCT01943799|11160837|FG001|Overall Study|Protocol Violation|0
7062821|NCT01943799|11160838|FG002|Overall Study|Protocol Violation|0
7062822|NCT01943799|11160839|FG003|Overall Study|Protocol Violation|0
7062823|NCT01943799|11160836|FG000|Overall Study|Withdrawal by Subject|4
7062824|NCT01943799|11160837|FG001|Overall Study|Withdrawal by Subject|2
7062825|NCT01943799|11160838|FG002|Overall Study|Withdrawal by Subject|1
7062826|NCT01943799|11160839|FG003|Overall Study|Withdrawal by Subject|0
7062827|NCT01943851|11160867|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7062828|NCT01943851|11160868|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7062829|NCT01943851|11160869|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7062830|NCT01943851|11160870|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1
7062831|NCT01943851|11160871|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7062832|NCT01943851|11160872|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7062833|NCT01943851|11160873|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1
7062834|NCT01943851|11160874|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1
7062835|NCT01943851|11160875|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1
7062836|NCT01943851|11160876|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7062837|NCT01943851|11160877|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7062838|NCT01943851|11160878|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7062839|NCT01943851|11160879|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7062840|NCT01943851|11160880|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7062841|NCT01943851|11160881|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7062842|NCT01943851|11160882|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7062843|NCT01943851|11160883|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7062844|NCT01943851|11160884|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7062845|NCT01943851|11160867|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7062846|NCT01943851|11160868|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7062847|NCT01943851|11160869|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7062848|NCT01943851|11160870|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7062849|NCT01943851|11160871|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1
7062850|NCT01943851|11160872|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7062851|NCT01943851|11160873|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7062852|NCT01943851|11160874|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1
7062853|NCT01943851|11160875|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7062854|NCT01943851|11160876|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7062855|NCT01943851|11160877|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7062856|NCT01943851|11160878|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7062857|NCT01943851|11160879|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7062858|NCT01943851|11160880|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7062859|NCT01943851|11160881|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7062860|NCT01943851|11160882|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7062861|NCT01943851|11160883|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7062862|NCT01943851|11160884|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7062863|NCT01943851|11160867|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
6831952|NCT00179621|10835819|FG002|Open-Label Period|Lack of Therapeutic Effect|19
6831953|NCT00179621|10835820|FG003|Open-Label Period|Lack of Therapeutic Effect|31
6831954|NCT00179621|10835817|FG000|Open-Label Period|Adverse Event|0
6831955|NCT00179621|10835818|FG001|Open-Label Period|Adverse Event|6
6831956|NCT00179621|10835819|FG002|Open-Label Period|Adverse Event|5
6831957|NCT00179621|10835820|FG003|Open-Label Period|Adverse Event|6
6831958|NCT00179621|10835817|FG000|Open-Label Period|Withdrawal by Subject|0
6831959|NCT00179621|10835818|FG001|Open-Label Period|Withdrawal by Subject|2
6831960|NCT00179621|10835819|FG002|Open-Label Period|Withdrawal by Subject|2
6831961|NCT00179621|10835820|FG003|Open-Label Period|Withdrawal by Subject|2
6831962|NCT00179621|10835817|FG000|Open-Label Period|Death|0
6831963|NCT00179621|10835818|FG001|Open-Label Period|Death|0
6831964|NCT00179621|10835819|FG002|Open-Label Period|Death|1
6831965|NCT00179621|10835820|FG003|Open-Label Period|Death|2
6831966|NCT00179621|10835817|FG000|Open-Label Period|Other|0
6831967|NCT00179621|10835818|FG001|Open-Label Period|Other|1
6831968|NCT00179621|10835819|FG002|Open-Label Period|Other|1
6831969|NCT00179621|10835820|FG003|Open-Label Period|Other|2
6831970|NCT00179647|10835829|FG000|Overall Study|Adverse Event|294
6831971|NCT00179647|10835829|FG000|Overall Study|Lack of Efficacy|478
6831972|NCT00179647|10835829|FG000|Overall Study|Withdrawal by Subject|83
6831973|NCT00179647|10835829|FG000|Overall Study|Lost to Follow-up|4
6831974|NCT00179647|10835829|FG000|Overall Study|Death|94
6831975|NCT00179647|10835829|FG000|Overall Study|Other|960
6831976|NCT00179660|10835833|FG000|Overall Study|Adverse Event|7
6831977|NCT00179660|10835833|FG000|Overall Study|Lack of therapeutic effect|28
6831978|NCT00179660|10835833|FG000|Overall Study|Withdrawal by Subject|2
6831979|NCT00179660|10835833|FG000|Overall Study|Lost to Follow-up|1
6831980|NCT00179660|10835833|FG000|Overall Study|Death|3
6831981|NCT00179660|10835833|FG000|Overall Study|Other - Unspecified|9
6831982|NCT00179673|10835837|FG000|Overall Study|Adverse Event|7
6831983|NCT00179673|10835837|FG000|Overall Study|Lack of Efficacy|15
6831984|NCT00179673|10835837|FG000|Overall Study|Withdrawal by Subject|3
6831985|NCT00179673|10835837|FG000|Overall Study|Death|4
6831986|NCT00179673|10835837|FG000|Overall Study|Other Observations and options|14
6831987|NCT00179959|10835854|FG000|Overall Study|Lost to Follow-up|3
6831988|NCT00179959|10835855|FG001|Overall Study|Lost to Follow-up|1
6925219|NCT00830869|10955268|FG010|Period 1: Part 1|Progressive disease|0
6925220|NCT00830869|10955269|FG011|Period 1: Part 1|Progressive disease|0
6925221|NCT00830869|10955258|FG000|Period 2: Part 2|Protocol Violation|0
6925222|NCT00830869|10955259|FG001|Period 2: Part 2|Protocol Violation|0
6925223|NCT00830869|10955260|FG002|Period 2: Part 2|Protocol Violation|0
6925224|NCT00830869|10955261|FG003|Period 2: Part 2|Protocol Violation|0
6925225|NCT00830869|10955262|FG004|Period 2: Part 2|Protocol Violation|0
6925226|NCT00830869|10955263|FG005|Period 2: Part 2|Protocol Violation|0
6925227|NCT00830869|10955264|FG006|Period 2: Part 2|Protocol Violation|0
6925228|NCT00830869|10955265|FG007|Period 2: Part 2|Protocol Violation|1
6925229|NCT00830869|10955266|FG008|Period 2: Part 2|Protocol Violation|0
6925230|NCT00830869|10955267|FG009|Period 2: Part 2|Protocol Violation|1
7062864|NCT01943851|11160868|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7062865|NCT01943851|11160869|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7062866|NCT01943851|11160870|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7062867|NCT01943851|11160871|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7062868|NCT01943851|11160872|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7062869|NCT01943851|11160873|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7062870|NCT01943851|11160874|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7062871|NCT01943851|11160875|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7062872|NCT01943851|11160876|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7062873|NCT01943851|11160877|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7062874|NCT01943851|11160878|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7062875|NCT01943851|11160879|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7062876|NCT01943851|11160880|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1
7062877|NCT01943851|11160881|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7062878|NCT01943851|11160882|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7062879|NCT01943851|11160883|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7062880|NCT01943851|11160884|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7062881|NCT01943851|11160867|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7062882|NCT01943851|11160868|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7062883|NCT01943851|11160869|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7062884|NCT01943851|11160870|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7062885|NCT01943851|11160871|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7062886|NCT01943851|11160872|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7062887|NCT01943851|11160873|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7062888|NCT01943851|11160874|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7062889|NCT01943851|11160875|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7062890|NCT01943851|11160876|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7062891|NCT01943851|11160877|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7062892|NCT01943851|11160878|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7062893|NCT01943851|11160879|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
6925231|NCT00830869|10955268|FG010|Period 2: Part 2|Protocol Violation|0
6925232|NCT00830869|10955269|FG011|Period 2: Part 2|Protocol Violation|0
7062894|NCT01943851|11160880|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
6831989|NCT00179959|10835854|FG000|Overall Study|Withdrawal by Subject|3
6831990|NCT00179959|10835855|FG001|Overall Study|Withdrawal by Subject|2
6831991|NCT00180479|10835902|FG000|Overall Study|Death|4
6831992|NCT00180479|10835903|FG001|Overall Study|Death|2
6831993|NCT00180479|10835902|FG000|Overall Study|Lost to Follow-up|9
6831994|NCT00180479|10835903|FG001|Overall Study|Lost to Follow-up|7
6831995|NCT00180479|10835902|FG000|Overall Study|Withdrawal by Subject|3
6831996|NCT00180479|10835903|FG001|Overall Study|Withdrawal by Subject|3
6831997|NCT00180479|10835902|FG000|Overall Study|Informed consent not signed|0
6831998|NCT00180479|10835903|FG001|Overall Study|Informed consent not signed|1
6831999|NCT00180674|10835918|FG000|Phase 1, Observation Period|Withdrawal by Subject|4
6832000|NCT00180674|10835918|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1
6832001|NCT00180713|10835945|FG000|Overall Study|Withdrawal by Subject|2
6832002|NCT00180713|10835946|FG001|Overall Study|Withdrawal by Subject|0
6832003|NCT00180713|10835945|FG000|Overall Study|Adverse Event|3
6832004|NCT00180713|10835946|FG001|Overall Study|Adverse Event|3
6832005|NCT00181155|10835952|FG000|Overall Study|Physician Decision|1
6832006|NCT00181155|10835953|FG001|Overall Study|Physician Decision|0
6832007|NCT00181155|10835952|FG000|Overall Study|Withdrawal by Subject|1
6832008|NCT00181155|10835953|FG001|Overall Study|Withdrawal by Subject|0
6832009|NCT00181766|10836017|FG000|Overall Study|Lost to Follow-up|6
6832010|NCT00181766|10836017|FG000|Overall Study|Adverse Event|4
6832011|NCT00181766|10836017|FG000|Overall Study|non-compliance|2
6832012|NCT00181844|10836021|FG000|Signed Consent|Withdrawal by Subject|5
6832013|NCT00181844|10836021|FG000|Signed Consent|Did not meet entrance criteria|7
6832014|NCT00181844|10836021|FG000|Exposed to Study Medication|Adverse Event|10
6832015|NCT00181844|10836021|FG000|Exposed to Study Medication|Lack of Efficacy|2
6832016|NCT00181844|10836021|FG000|Exposed to Study Medication|Non-compliance|2
6832017|NCT00181844|10836021|FG000|Exposed to Study Medication|Withdrawal by Subject|1
6832018|NCT00181844|10836021|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2
6897185|NCT00637377|10915908|FG000|Overall Study|Protocol Violation|2
6897186|NCT00637377|10915909|FG001|Overall Study|Protocol Violation|1
6897187|NCT00637377|10915910|FG002|Overall Study|Protocol Violation|1
6897188|NCT00637377|10915911|FG003|Overall Study|Protocol Violation|0
6897189|NCT00637377|10915908|FG000|Overall Study|Withdrawal by Subject|11
6897190|NCT00637377|10915909|FG001|Overall Study|Withdrawal by Subject|15
6897191|NCT00637377|10915910|FG002|Overall Study|Withdrawal by Subject|13
6897192|NCT00637377|10915911|FG003|Overall Study|Withdrawal by Subject|11
6897193|NCT00637377|10915908|FG000|Overall Study|Other (no further information available)|7
6897194|NCT00637377|10915909|FG001|Overall Study|Other (no further information available)|6
6897195|NCT00637377|10915910|FG002|Overall Study|Other (no further information available)|10
6897196|NCT00637377|10915911|FG003|Overall Study|Other (no further information available)|5
6897197|NCT00637572|10915932|FG000|Overall Study|Adverse Event|1
6897198|NCT00637572|10915933|FG001|Overall Study|Adverse Event|2
6897199|NCT00637572|10915932|FG000|Overall Study|Death|0
6897200|NCT00637572|10915933|FG001|Overall Study|Death|1
6897201|NCT00637572|10915932|FG000|Overall Study|Lost to Follow-up|0
6897202|NCT00637572|10915933|FG001|Overall Study|Lost to Follow-up|1
6897203|NCT00637572|10915932|FG000|Overall Study|Physician Decision|1
6897204|NCT00637572|10915933|FG001|Overall Study|Physician Decision|1
6897205|NCT00637572|10915932|FG000|Overall Study|Withdrawal by Subject|0
6897206|NCT00637572|10915933|FG001|Overall Study|Withdrawal by Subject|2
6897207|NCT00637572|10915932|FG000|Overall Study|Illicit Drug Use|1
6897208|NCT00637572|10915933|FG001|Overall Study|Illicit Drug Use|0
6897209|NCT00638027|10915963|FG000|Overall Study|Adverse Event|0
6897210|NCT00638027|10915964|FG001|Overall Study|Adverse Event|2
6897211|NCT00638157|10915972|FG000|Overall Study|Adverse Event|0
6897212|NCT00638157|10915973|FG001|Overall Study|Adverse Event|1
6897213|NCT00638157|10915972|FG000|Overall Study|Clinical (symptomatic) failure|1
6897214|NCT00638157|10915973|FG001|Overall Study|Clinical (symptomatic) failure|1
6897215|NCT00638157|10915972|FG000|Overall Study|Microbiological failure|1
6897216|NCT00638157|10915973|FG001|Overall Study|Microbiological failure|0
6897217|NCT00638157|10915972|FG000|Overall Study|Lost to Follow-up|1
6897218|NCT00638157|10915973|FG001|Overall Study|Lost to Follow-up|0
6897219|NCT00638157|10915972|FG000|Overall Study|Physician Decision|1
6897220|NCT00638157|10915973|FG001|Overall Study|Physician Decision|0
6897221|NCT00638157|10915972|FG000|Overall Study|Other|1
6897222|NCT00638157|10915973|FG001|Overall Study|Other|2
6897223|NCT00638157|10915972|FG000|Overall Study|Randomized, not treated|2
6897224|NCT00638157|10915973|FG001|Overall Study|Randomized, not treated|0
6897225|NCT00638183|10915980|FG000|Overall Study|Adverse Event|23
6897226|NCT00638183|10915980|FG000|Overall Study|Lack of Efficacy|14
6897227|NCT00638183|10915980|FG000|Overall Study|Physician Decision|9
6897228|NCT00638183|10915980|FG000|Overall Study|Lost to Follow-up|46
6897229|NCT00638183|10915980|FG000|Overall Study|Other reason not defined above|27
6897230|NCT00638235|10915993|FG000|Overall Study|Lost to Follow-up|31
6897231|NCT00638235|10915994|FG001|Overall Study|Lost to Follow-up|3
6897232|NCT00638235|10915995|FG002|Overall Study|Lost to Follow-up|18
6897233|NCT00638235|10915996|FG003|Overall Study|Lost to Follow-up|10
6897234|NCT00638235|10915997|FG004|Overall Study|Lost to Follow-up|13
6897235|NCT00638235|10915998|FG005|Overall Study|Lost to Follow-up|26
6897236|NCT00638235|10915999|FG006|Overall Study|Lost to Follow-up|0
6897237|NCT00638235|10916000|FG007|Overall Study|Lost to Follow-up|1
6897238|NCT00638235|10916001|FG008|Overall Study|Lost to Follow-up|18
6897239|NCT00638378|10916050|FG000|Overall Study|Death|2
6897240|NCT00638378|10916050|FG000|Overall Study|Adverse Event|1
6897241|NCT00638378|10916050|FG000|Overall Study|Disease progression|15
6897242|NCT00638378|10916050|FG000|Overall Study|Physician Decision|4
6897243|NCT00638404|10916056|FG000|Overall Study|Physician Decision|8
6897244|NCT00638404|10916057|FG001|Overall Study|Physician Decision|0
6897245|NCT00638443|10916067|FG000|First Intervention|Adverse Event|2
6832019|NCT00181883|10836025|FG000|Overall Study|Lack of Efficacy|2
6832020|NCT00181883|10836025|FG000|Overall Study|Treatment Limiting AEs|3
6832021|NCT00181883|10836025|FG000|Overall Study|Withdrawal by Subject|4
6832022|NCT00181883|10836025|FG000|Overall Study|Lost to Follow-up|1
6832023|NCT00182078|10836049|FG000|Overall Study|Withdrawal by Subject|1
6832024|NCT00182078|10836050|FG001|Overall Study|Withdrawal by Subject|0
6832025|NCT00182091|10836060|FG000|Overall Study|Withdrawal by Subject|1
6832026|NCT00182091|10836061|FG001|Overall Study|Withdrawal by Subject|0
6832027|NCT00182091|10836062|FG002|Overall Study|Withdrawal by Subject|0
6832028|NCT00182091|10836063|FG003|Overall Study|Withdrawal by Subject|0
6832029|NCT00182325|10836073|FG000|Overall Study|Lost to Follow-up|7
6832030|NCT00182325|10836074|FG001|Overall Study|Lost to Follow-up|7
6832031|NCT00182325|10836073|FG000|Overall Study|Miscarriage|5
6832032|NCT00182325|10836074|FG001|Overall Study|Miscarriage|3
6832033|NCT00182325|10836073|FG000|Overall Study|Did not complete survey|22
6832034|NCT00182325|10836074|FG001|Overall Study|Did not complete survey|43
6832035|NCT00182689|10836082|FG000|Overall Study|Adverse Event|8
6832036|NCT00182689|10836083|FG001|Overall Study|Adverse Event|11
6832037|NCT00182689|10836082|FG000|Overall Study|Withdrawal by Subject|2
6832038|NCT00182689|10836083|FG001|Overall Study|Withdrawal by Subject|2
6832039|NCT00182689|10836082|FG000|Overall Study|Progression|27
6832040|NCT00182689|10836083|FG001|Overall Study|Progression|29
6832041|NCT00182689|10836082|FG000|Overall Study|Death|1
6832042|NCT00182689|10836083|FG001|Overall Study|Death|0
6832043|NCT00182689|10836082|FG000|Overall Study|not protocol specified|0
6832044|NCT00182689|10836083|FG001|Overall Study|not protocol specified|3
6832045|NCT00182689|10836082|FG000|Overall Study|Ineligible|1
6832046|NCT00182689|10836083|FG001|Overall Study|Ineligible|4
6832047|NCT00182689|10836082|FG000|Overall Study|Never received treatment|1
6832048|NCT00182689|10836083|FG001|Overall Study|Never received treatment|0
6832049|NCT00183170|10836138|FG000|First Intervention|Did not complete study|1
6832050|NCT00183170|10836139|FG001|First Intervention|Did not complete study|0
6832051|NCT00183170|10836138|FG000|First Intervention|Did not meet targeted BrAC|1
6832052|NCT00183170|10836139|FG001|First Intervention|Did not meet targeted BrAC|0
6832053|NCT00183170|10836138|FG000|Washout 1 Week|Did not complete study|6
6832054|NCT00183170|10836139|FG001|Washout 1 Week|Did not complete study|8
6832055|NCT00183170|10836138|FG000|Second Intervention|Did not complete study|1
6832056|NCT00183170|10836139|FG001|Second Intervention|Did not complete study|0
6832057|NCT00183170|10836138|FG000|Second Intervention|Did not meet targeted BrAC|0
6832058|NCT00183170|10836139|FG001|Second Intervention|Did not meet targeted BrAC|2
6832059|NCT00183196|10836148|FG000|Overall Study|Withdrawal by Subject|18
6832060|NCT00183196|10836149|FG001|Overall Study|Withdrawal by Subject|11
6832061|NCT00183196|10836150|FG002|Overall Study|Withdrawal by Subject|13
6832062|NCT00183196|10836148|FG000|Overall Study|Adverse Event|1
6832063|NCT00183196|10836149|FG001|Overall Study|Adverse Event|2
6832064|NCT00183196|10836150|FG002|Overall Study|Adverse Event|2
6832065|NCT00183196|10836148|FG000|Overall Study|Legal event|1
6832066|NCT00183196|10836149|FG001|Overall Study|Legal event|1
6832067|NCT00183196|10836150|FG002|Overall Study|Legal event|1
6832068|NCT00183196|10836148|FG000|Overall Study|Required more intensive care|0
6832069|NCT00183196|10836149|FG001|Overall Study|Required more intensive care|1
7062895|NCT01943851|11160881|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7062896|NCT01943851|11160882|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2
7062897|NCT01943851|11160883|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7062898|NCT01943851|11160884|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7062899|NCT01943851|11160867|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7062900|NCT01943851|11160868|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7062901|NCT01943851|11160869|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7062902|NCT01943851|11160870|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7062903|NCT01943851|11160871|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7062904|NCT01943851|11160872|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7062905|NCT01943851|11160873|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7062906|NCT01943851|11160874|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7062907|NCT01943851|11160875|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7062908|NCT01943851|11160876|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7062909|NCT01943851|11160877|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7062910|NCT01943851|11160878|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7062911|NCT01943851|11160879|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
6832070|NCT00183196|10836150|FG002|Overall Study|Required more intensive care|2
6832071|NCT00183248|10836160|FG000|Overall Study|Lost to Follow-up|0
6832072|NCT00183248|10836161|FG001|Overall Study|Lost to Follow-up|1
6832073|NCT00183248|10836160|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1
6832074|NCT00183248|10836161|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0
6832075|NCT00183274|10836167|FG000|Phase 1: Open-Label|Adverse Event|31
6832076|NCT00183274|10836168|FG001|Phase 1: Open-Label|Adverse Event|0
6832077|NCT00183274|10836169|FG002|Phase 1: Open-Label|Adverse Event|0
6832078|NCT00183274|10836170|FG003|Phase 1: Open-Label|Adverse Event|0
6832079|NCT00183274|10836171|FG004|Phase 1: Open-Label|Adverse Event|0
6832080|NCT00183274|10836172|FG005|Phase 1: Open-Label|Adverse Event|0
6832081|NCT00183274|10836167|FG000|Phase 1: Open-Label|Lack of Efficacy|13
6832082|NCT00183274|10836168|FG001|Phase 1: Open-Label|Lack of Efficacy|0
7082327|NCT02141217|11192790|FG001|Overall Study|Withdrawal by Subject|0
6832083|NCT00183274|10836169|FG002|Phase 1: Open-Label|Lack of Efficacy|0
6832084|NCT00183274|10836170|FG003|Phase 1: Open-Label|Lack of Efficacy|0
6832085|NCT00183274|10836171|FG004|Phase 1: Open-Label|Lack of Efficacy|0
7062912|NCT01943851|11160880|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7062913|NCT01943851|11160881|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7062914|NCT01943851|11160882|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4
7062915|NCT01943851|11160883|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3
7062916|NCT01943851|11160884|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1
7062917|NCT01943916|11160929|FG000|Overall Study|Technically invalid images|10
7062918|NCT01943916|11160929|FG000|Overall Study|Enrollment Failure|23
7062919|NCT01943916|11160929|FG000|Overall Study|Pilot Phase exclusion|100
7062920|NCT01943916|11160929|FG000|Overall Study|Quality Assurance Reader Fail|130
7062921|NCT01943916|11160929|FG000|Overall Study|Technical Failure|39
7062922|NCT01943916|11160929|FG000|Overall Study|Protocol Deviation No Biopsy|25
7062923|NCT01943916|11160929|FG000|Overall Study|No Truth Panel Review|38
7062924|NCT01943916|11160929|FG000|Overall Study|Protocol Deviation|1
7082328|NCT02141217|11192789|FG000|Overall Study|Lost to Follow-up|1
7082329|NCT02141217|11192790|FG001|Overall Study|Lost to Follow-up|1
7082330|NCT02141217|11192789|FG000|Overall Study|Physician Decision|1
7082331|NCT02141217|11192790|FG001|Overall Study|Physician Decision|0
7082332|NCT02141217|11192789|FG000|Overall Study|Surgical Intervention|1
7082333|NCT02141217|11192790|FG001|Overall Study|Surgical Intervention|1
7082334|NCT02141295|11192802|FG000|Overall Study|Adverse Event|1
7082335|NCT02141295|11192803|FG001|Overall Study|Adverse Event|18
7082336|NCT02141295|11192804|FG002|Overall Study|Adverse Event|11
7082337|NCT02141295|11192802|FG000|Overall Study|Physician Decision|2
7082338|NCT02141295|11192803|FG001|Overall Study|Physician Decision|19
7082339|NCT02141295|11192804|FG002|Overall Study|Physician Decision|14
7082340|NCT02141295|11192802|FG000|Overall Study|Study terminated by sponsor|0
7082341|NCT02141295|11192803|FG001|Overall Study|Study terminated by sponsor|6
7082342|NCT02141295|11192804|FG002|Overall Study|Study terminated by sponsor|6
7082343|NCT02141295|11192802|FG000|Overall Study|Non-compliance|0
7082344|NCT02141295|11192803|FG001|Overall Study|Non-compliance|1
7082345|NCT02141295|11192804|FG002|Overall Study|Non-compliance|0
7082346|NCT02141295|11192802|FG000|Overall Study|Progressive disease|3
7082347|NCT02141295|11192803|FG001|Overall Study|Progressive disease|32
7082348|NCT02141295|11192804|FG002|Overall Study|Progressive disease|50
7082349|NCT02141295|11192802|FG000|Overall Study|Reason not specified|0
7082350|NCT02141295|11192803|FG001|Overall Study|Reason not specified|9
7082351|NCT02141295|11192804|FG002|Overall Study|Reason not specified|10
7082352|NCT02141295|11192802|FG000|Overall Study|Withdrawal by Subject|0
7082353|NCT02141295|11192803|FG001|Overall Study|Withdrawal by Subject|9
7082354|NCT02141295|11192804|FG002|Overall Study|Withdrawal by Subject|4
7082355|NCT02141360|11192816|FG000|Overall Study|Withdrawal by Subject|6
7082356|NCT02141360|11192817|FG001|Overall Study|Withdrawal by Subject|0
7082357|NCT02141360|11192818|FG002|Overall Study|Withdrawal by Subject|0
7082358|NCT02141360|11192816|FG000|Overall Study|Study Terminated before Visit|1
7082359|NCT02141360|11192817|FG001|Overall Study|Study Terminated before Visit|0
7082360|NCT02141360|11192818|FG002|Overall Study|Study Terminated before Visit|0
7082361|NCT02141399|11192826|FG000|Overall Study|Adverse Event|158
7082362|NCT02141399|11192826|FG000|Overall Study|Lack of Efficacy|62
7082363|NCT02141399|11192826|FG000|Overall Study|Lost to Follow-up|151
7082364|NCT02141399|11192826|FG000|Overall Study|Non-compliance with study drug|18
7082365|NCT02141399|11192826|FG000|Overall Study|Other|45
7082366|NCT02141399|11192826|FG000|Overall Study|Physician Decision|17
7082367|NCT02141399|11192826|FG000|Overall Study|Pregnancy|3
7082368|NCT02141399|11192826|FG000|Overall Study|Protocol Violation|38
7082369|NCT02141399|11192826|FG000|Overall Study|Withdrawal by Subject|238
7082370|NCT02141399|11192826|FG000|Overall Study|Failure to meet eligibility criteria|14
7082371|NCT02141490|11192853|FG000|Overall Study|Screening failures|4
7082372|NCT02141490|11192854|FG001|Overall Study|Screening failures|0
7082373|NCT02141490|11192855|FG002|Overall Study|Screening failures|0
7082374|NCT02141516|11192868|FG000|Overall Study|Adverse Event|0
7082375|NCT02141516|11192869|FG001|Overall Study|Adverse Event|1
7082376|NCT02141516|11192870|FG002|Overall Study|Adverse Event|0
7082377|NCT02141516|11192868|FG000|Overall Study|Lost to Follow-up|0
7082378|NCT02141516|11192869|FG001|Overall Study|Lost to Follow-up|1
7082379|NCT02141516|11192870|FG002|Overall Study|Lost to Follow-up|0
7082380|NCT02141516|11192868|FG000|Overall Study|Other|0
7082381|NCT02141516|11192869|FG001|Overall Study|Other|3
7082382|NCT02141516|11192870|FG002|Overall Study|Other|0
7082383|NCT02141620|11192904|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1
6832086|NCT00183274|10836172|FG005|Phase 1: Open-Label|Lack of Efficacy|0
6925233|NCT00830869|10955258|FG000|Period 2: Part 2|Withdrawal by Subject|0
7082384|NCT02141620|11192905|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0
7082385|NCT02141633|11192913|FG000|Overall Study|Physician Decision|1
7082386|NCT02141633|11192914|FG001|Overall Study|Physician Decision|0
6832087|NCT00183274|10836167|FG000|Phase 1: Open-Label|Protocol Violation|11
7082387|NCT02141659|11192926|FG000|Overall Study|Major Protocol Deviation|0
7082388|NCT02141659|11192927|FG001|Overall Study|Major Protocol Deviation|1
7082389|NCT02141659|11192928|FG002|Overall Study|Major Protocol Deviation|0
7082390|NCT02141659|11192929|FG003|Overall Study|Major Protocol Deviation|0
7082391|NCT02141659|11192930|FG004|Overall Study|Major Protocol Deviation|0
6832088|NCT00183274|10836168|FG001|Phase 1: Open-Label|Protocol Violation|0
6832089|NCT00183274|10836169|FG002|Phase 1: Open-Label|Protocol Violation|0
6832090|NCT00183274|10836170|FG003|Phase 1: Open-Label|Protocol Violation|0
6832091|NCT00183274|10836171|FG004|Phase 1: Open-Label|Protocol Violation|0
6832092|NCT00183274|10836172|FG005|Phase 1: Open-Label|Protocol Violation|0
6832093|NCT00183274|10836167|FG000|Phase 1: Open-Label|Withdrawal by Subject|13
6832094|NCT00183274|10836168|FG001|Phase 1: Open-Label|Withdrawal by Subject|0
6832095|NCT00183274|10836169|FG002|Phase 1: Open-Label|Withdrawal by Subject|0
6832096|NCT00183274|10836170|FG003|Phase 1: Open-Label|Withdrawal by Subject|0
6832097|NCT00183274|10836171|FG004|Phase 1: Open-Label|Withdrawal by Subject|0
6832098|NCT00183274|10836172|FG005|Phase 1: Open-Label|Withdrawal by Subject|0
6832099|NCT00183274|10836167|FG000|Phase 1: Open-Label|Lost to Follow-up|33
6832100|NCT00183274|10836168|FG001|Phase 1: Open-Label|Lost to Follow-up|0
6832101|NCT00183274|10836169|FG002|Phase 1: Open-Label|Lost to Follow-up|0
6832102|NCT00183274|10836170|FG003|Phase 1: Open-Label|Lost to Follow-up|0
6832103|NCT00183274|10836171|FG004|Phase 1: Open-Label|Lost to Follow-up|0
6832104|NCT00183274|10836172|FG005|Phase 1: Open-Label|Lost to Follow-up|0
6832105|NCT00183274|10836167|FG000|Phase 1: Open-Label|Other|9
6832106|NCT00183274|10836168|FG001|Phase 1: Open-Label|Other|0
6832107|NCT00183274|10836169|FG002|Phase 1: Open-Label|Other|0
6832108|NCT00183274|10836170|FG003|Phase 1: Open-Label|Other|0
6832109|NCT00183274|10836171|FG004|Phase 1: Open-Label|Other|0
7062925|NCT01944046|11160940|FG000|Randomized to DB|Adverse Event|5
7062926|NCT01944046|11160941|FG001|Randomized to DB|Adverse Event|2
7062927|NCT01944046|11160940|FG000|Randomized to DB|Clinical Worsening|3
7062928|NCT01944046|11160941|FG001|Randomized to DB|Clinical Worsening|2
7062929|NCT01944046|11160940|FG000|Randomized to DB|Lost to Follow-up|3
7062930|NCT01944046|11160941|FG001|Randomized to DB|Lost to Follow-up|3
7062931|NCT01944046|11160940|FG000|Randomized to DB|Withdrawal by Subject|2
7062932|NCT01944046|11160941|FG001|Randomized to DB|Withdrawal by Subject|4
7062933|NCT01944046|11160940|FG000|Randomized to DB|Physician Decision|1
7062934|NCT01944046|11160941|FG001|Randomized to DB|Physician Decision|2
7062935|NCT01944046|11160940|FG000|Randomized to DB|Did not have baseline ABC-SW|2
7062936|NCT01944046|11160941|FG001|Randomized to DB|Did not have baseline ABC-SW|0
7062937|NCT01944046|11160940|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5
7062938|NCT01944046|11160941|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6
7062939|NCT01944046|11160940|FG000|Open Label Eligible and Consented|Lost to Follow-up|3
7062940|NCT01944046|11160941|FG001|Open Label Eligible and Consented|Lost to Follow-up|5
7062941|NCT01944046|11160940|FG000|Open Label Eligible and Consented|Adverse Event|6
7062942|NCT01944046|11160941|FG001|Open Label Eligible and Consented|Adverse Event|1
7062943|NCT01944046|11160940|FG000|Open Label Eligible and Consented|Clinical Worsening|4
7062944|NCT01944046|11160941|FG001|Open Label Eligible and Consented|Clinical Worsening|2
7062945|NCT01944046|11160940|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1
7062946|NCT01944046|11160941|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0
7062947|NCT01944098|11160953|FG000|Overall Study|Physician Decision|1
7062948|NCT01944098|11160954|FG001|Overall Study|Physician Decision|0
7062949|NCT01944462|11161005|FG000|PPPP Educational Program|Lost to Follow-up|60
7062950|NCT01944631|11161012|FG000|Overall Study|Adverse Event|1
7062951|NCT01944631|11161013|FG001|Overall Study|Adverse Event|0
7062952|NCT01944631|11161012|FG000|Overall Study|Lost to Follow-up|3
7062953|NCT01944631|11161013|FG001|Overall Study|Lost to Follow-up|1
7062954|NCT01944631|11161012|FG000|Overall Study|Withdrawal by Subject|0
7062955|NCT01944631|11161013|FG001|Overall Study|Withdrawal by Subject|1
7062956|NCT01944670|11161028|FG000|Overall Study|Lost to Follow-up|2
7062957|NCT01944722|11161034|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171
7062958|NCT01944722|11161034|FG000|Overall Study|Specimen Shipping Issues|34
7062959|NCT01944722|11161034|FG000|Overall Study|Improper Storage/Transport|5
7062960|NCT01944722|11161034|FG000|Overall Study|Insufficient Volume for Test|1
7062961|NCT01944722|11161034|FG000|Overall Study|Missing Specimens|3
7062962|NCT01944722|11161034|FG000|Overall Study|Specimens Mislabeled|2
7062963|NCT01944722|11161034|FG000|Overall Study|Withdrawal by Subject|8
7062964|NCT01944722|11161034|FG000|Overall Study|NILM Subjects <30 years old|8106
7062965|NCT01944722|11161034|FG000|Overall Study|Unsatisfactory Cytology Result|63
7062966|NCT01944722|11161034|FG000|Overall Study|>ASCUS Cytology|1122
7062967|NCT01944774|11161046|FG000|Overall Study|Withdrawal by Subject|2
7062968|NCT01944774|11161047|FG001|Overall Study|Withdrawal by Subject|3
7062969|NCT01944774|11161048|FG002|Overall Study|Withdrawal by Subject|3
7062970|NCT01944774|11161046|FG000|Overall Study|Adverse Event|3
7062971|NCT01944774|11161047|FG001|Overall Study|Adverse Event|2
7062972|NCT01944774|11161048|FG002|Overall Study|Adverse Event|3
7062973|NCT01944774|11161046|FG000|Overall Study|Lack of Efficacy|1
7062974|NCT01944774|11161047|FG001|Overall Study|Lack of Efficacy|2
7062975|NCT01944774|11161048|FG002|Overall Study|Lack of Efficacy|2
7062976|NCT01944774|11161046|FG000|Overall Study|Lost to Follow-up|0
7062977|NCT01944774|11161047|FG001|Overall Study|Lost to Follow-up|1
6832110|NCT00183274|10836172|FG005|Phase 1: Open-Label|Other|0
6832111|NCT00183274|10836167|FG000|Phase 2: Double-Blind|Relapsed|0
6832112|NCT00183274|10836168|FG001|Phase 2: Double-Blind|Relapsed|8
6832113|NCT00183274|10836169|FG002|Phase 2: Double-Blind|Relapsed|29
6832114|NCT00183274|10836170|FG003|Phase 2: Double-Blind|Relapsed|0
6832115|NCT00183274|10836171|FG004|Phase 2: Double-Blind|Relapsed|0
6832116|NCT00183274|10836172|FG005|Phase 2: Double-Blind|Relapsed|0
6832117|NCT00183274|10836167|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0
6832118|NCT00183274|10836168|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18
6832119|NCT00183274|10836169|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14
6832120|NCT00183274|10836170|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0
6832121|NCT00183274|10836171|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0
6832122|NCT00183274|10836172|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0
6832123|NCT00183274|10836167|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0
6832124|NCT00183274|10836168|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0
6832125|NCT00183274|10836169|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0
6832126|NCT00183274|10836170|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1
6832127|NCT00183274|10836171|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9
6832128|NCT00183274|10836172|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2
6832129|NCT00183274|10836167|FG000|Phase 3: Double-Blind|Relapsed|0
6832130|NCT00183274|10836168|FG001|Phase 3: Double-Blind|Relapsed|0
6832131|NCT00183274|10836169|FG002|Phase 3: Double-Blind|Relapsed|0
6832132|NCT00183274|10836170|FG003|Phase 3: Double-Blind|Relapsed|1
6832133|NCT00183274|10836171|FG004|Phase 3: Double-Blind|Relapsed|11
6832134|NCT00183274|10836172|FG005|Phase 3: Double-Blind|Relapsed|2
6832135|NCT00183391|10836201|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13
6832136|NCT00183391|10836202|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14
6832137|NCT00183391|10836201|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4
6832138|NCT00183391|10836202|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2
6832139|NCT00183430|10836212|FG000|Overall Study|Adverse Event|1
6832140|NCT00183430|10836213|FG001|Overall Study|Adverse Event|0
6925234|NCT00830869|10955259|FG001|Period 2: Part 2|Withdrawal by Subject|0
6925235|NCT00830869|10955260|FG002|Period 2: Part 2|Withdrawal by Subject|0
6925236|NCT00830869|10955261|FG003|Period 2: Part 2|Withdrawal by Subject|0
6925237|NCT00830869|10955262|FG004|Period 2: Part 2|Withdrawal by Subject|0
6925238|NCT00830869|10955263|FG005|Period 2: Part 2|Withdrawal by Subject|0
6925239|NCT00830869|10955264|FG006|Period 2: Part 2|Withdrawal by Subject|0
6925240|NCT00830869|10955265|FG007|Period 2: Part 2|Withdrawal by Subject|1
6925241|NCT00830869|10955266|FG008|Period 2: Part 2|Withdrawal by Subject|2
6925242|NCT00830869|10955267|FG009|Period 2: Part 2|Withdrawal by Subject|1
6925243|NCT00830869|10955268|FG010|Period 2: Part 2|Withdrawal by Subject|0
6925244|NCT00830869|10955269|FG011|Period 2: Part 2|Withdrawal by Subject|1
6925245|NCT00830869|10955258|FG000|Period 2: Part 2|Adverse Event|0
6925246|NCT00830869|10955259|FG001|Period 2: Part 2|Adverse Event|0
6925247|NCT00830869|10955260|FG002|Period 2: Part 2|Adverse Event|0
6925248|NCT00830869|10955261|FG003|Period 2: Part 2|Adverse Event|0
6925249|NCT00830869|10955262|FG004|Period 2: Part 2|Adverse Event|0
6925250|NCT00830869|10955263|FG005|Period 2: Part 2|Adverse Event|0
6925251|NCT00830869|10955264|FG006|Period 2: Part 2|Adverse Event|0
6925252|NCT00830869|10955265|FG007|Period 2: Part 2|Adverse Event|4
6925253|NCT00830869|10955266|FG008|Period 2: Part 2|Adverse Event|3
7062978|NCT01944774|11161048|FG002|Overall Study|Lost to Follow-up|0
7062979|NCT01944839|11161061|FG000|Overall Study|Physician Decision|2
7062980|NCT01944839|11161062|FG001|Overall Study|Physician Decision|2
7062981|NCT01944839|11161061|FG000|Overall Study|Protocol Violation|0
7062982|NCT01944839|11161062|FG001|Overall Study|Protocol Violation|1
7062983|NCT01944839|11161061|FG000|Overall Study|Adverse Event|10
7062984|NCT01944839|11161062|FG001|Overall Study|Adverse Event|5
7062985|NCT01944839|11161061|FG000|Overall Study|Withdrawal by Subject|9
7062986|NCT01944839|11161062|FG001|Overall Study|Withdrawal by Subject|17
7062987|NCT01944839|11161061|FG000|Overall Study|Lost to Follow-up|1
7062988|NCT01944839|11161062|FG001|Overall Study|Lost to Follow-up|0
7062989|NCT01944839|11161061|FG000|Overall Study|Subject non-compliance|0
6832141|NCT00183430|10836212|FG000|Overall Study|Lost to Follow-up|3
6832142|NCT00183430|10836213|FG001|Overall Study|Lost to Follow-up|0
6832143|NCT00183430|10836212|FG000|Overall Study|did not meet inclusion criteria|1
6832144|NCT00183430|10836213|FG001|Overall Study|did not meet inclusion criteria|0
6832145|NCT00183430|10836212|FG000|Overall Study|Withdrawal by Subject|1
6832146|NCT00183430|10836213|FG001|Overall Study|Withdrawal by Subject|0
6832147|NCT00183625|10836260|FG000|Overall Study|Withdrawal by Subject|18
6832148|NCT00183625|10836261|FG001|Overall Study|Withdrawal by Subject|18
6832149|NCT00183625|10836262|FG002|Overall Study|Withdrawal by Subject|19
6832150|NCT00183625|10836263|FG003|Overall Study|Withdrawal by Subject|14
6832151|NCT00183872|10836288|FG000|Overall Study|Death|3
6832152|NCT00183872|10836288|FG000|Overall Study|Adverse Event|9
6832153|NCT00183872|10836288|FG000|Overall Study|Withdrawal by Subject|2
6832154|NCT00183872|10836288|FG000|Overall Study|Drug delayed more than 28 days|2
6832155|NCT00184002|10836292|FG000|Overall Study|Adverse Event|9
6832156|NCT00184002|10836292|FG000|Overall Study|Death|3
6925254|NCT00830869|10955267|FG009|Period 2: Part 2|Adverse Event|2
6925255|NCT00830869|10955268|FG010|Period 2: Part 2|Adverse Event|2
6925256|NCT00830869|10955269|FG011|Period 2: Part 2|Adverse Event|0
6925257|NCT00830869|10955258|FG000|Period 2: Part 2|Symptomatic Deterioration|0
6925258|NCT00830869|10955259|FG001|Period 2: Part 2|Symptomatic Deterioration|0
6925259|NCT00830869|10955260|FG002|Period 2: Part 2|Symptomatic Deterioration|0
7062990|NCT01944839|11161062|FG001|Overall Study|Subject non-compliance|3
7062991|NCT01944969|11161088|FG000|Overall Study|Adverse Event|1
7062992|NCT01944969|11161088|FG000|Overall Study|Lack of Efficacy|1
7062993|NCT01944969|11161088|FG000|Overall Study|Non-compliance with IMP|1
6832157|NCT00184002|10836292|FG000|Overall Study|Physician Decision|1
6832158|NCT00184002|10836292|FG000|Overall Study|Withdrawal by Subject|4
6925260|NCT00830869|10955261|FG003|Period 2: Part 2|Symptomatic Deterioration|0
6925261|NCT00830869|10955262|FG004|Period 2: Part 2|Symptomatic Deterioration|0
6925262|NCT00830869|10955263|FG005|Period 2: Part 2|Symptomatic Deterioration|0
7062994|NCT01944969|11161088|FG000|Overall Study|Administrative or other reasons|23
7062995|NCT01945034|11161097|FG000|Overall Study|Medication Error|0
7062996|NCT01945034|11161098|FG001|Overall Study|Medication Error|1
7062997|NCT01945034|11161099|FG002|Overall Study|Medication Error|0
7062998|NCT01945034|11161097|FG000|Overall Study|Withdrawal by Subject|0
7062999|NCT01945034|11161098|FG001|Overall Study|Withdrawal by Subject|3
7063000|NCT01945034|11161099|FG002|Overall Study|Withdrawal by Subject|1
7063001|NCT01945034|11161097|FG000|Overall Study|Other|0
7063002|NCT01945034|11161098|FG001|Overall Study|Other|1
7063003|NCT01945034|11161099|FG002|Overall Study|Other|3
7063004|NCT01945034|11161097|FG000|Overall Study|Lost to Follow-up|0
7063005|NCT01945034|11161098|FG001|Overall Study|Lost to Follow-up|0
7063006|NCT01945034|11161099|FG002|Overall Study|Lost to Follow-up|2
7063007|NCT01945034|11161097|FG000|Overall Study|Protocol Violation|1
7063008|NCT01945034|11161098|FG001|Overall Study|Protocol Violation|0
7063009|NCT01945034|11161099|FG002|Overall Study|Protocol Violation|1
7063010|NCT01945086|11161110|FG000|Overall Study|Withdrawal by Subject|1
7063011|NCT01945086|11161111|FG001|Overall Study|Withdrawal by Subject|0
7063012|NCT01945086|11161112|FG002|Overall Study|Withdrawal by Subject|1
7063013|NCT01945086|11161110|FG000|Overall Study|Adverse Event|0
7063014|NCT01945086|11161111|FG001|Overall Study|Adverse Event|0
7063015|NCT01945086|11161112|FG002|Overall Study|Adverse Event|1
7063016|NCT01945216|11161138|FG000|Overall Study|Case report forms (CRF) uncollected|52
7063017|NCT01945216|11161138|FG000|Overall Study|Protocol Violation|42
7063018|NCT01945216|11161138|FG000|Overall Study|CRF not assured by investigators|5
7063019|NCT01945242|11161148|FG000|Overall Study|Physician Decision|3
7063020|NCT01945242|11161149|FG001|Overall Study|Physician Decision|3
7063021|NCT01945281|11161158|FG000|Overall Study|Adverse Event|1
7063022|NCT01945281|11161159|FG001|Overall Study|Adverse Event|0
7063023|NCT01945281|11161158|FG000|Overall Study|Death|3
7063024|NCT01945281|11161159|FG001|Overall Study|Death|3
7063025|NCT01945281|11161158|FG000|Overall Study|Physician Decision|1
7063026|NCT01945281|11161159|FG001|Overall Study|Physician Decision|1
7063027|NCT01945281|11161158|FG000|Overall Study|Technical Problems|1
7063028|NCT01945281|11161159|FG001|Overall Study|Technical Problems|0
7063029|NCT01945489|11161182|FG000|Cycle 1|Adverse Event|2
7063030|NCT01945489|11161183|FG001|Cycle 1|Adverse Event|0
7063031|NCT01945489|11161182|FG000|Cycle 1|Lost to Follow-up|4
7063032|NCT01945489|11161183|FG001|Cycle 1|Lost to Follow-up|0
7063033|NCT01945489|11161182|FG000|Cycle 1|Personal Reasons|4
7063034|NCT01945489|11161183|FG001|Cycle 1|Personal Reasons|2
7063035|NCT01945489|11161182|FG000|Cycle 1|Protocol Violation|0
7063036|NCT01945489|11161183|FG001|Cycle 1|Protocol Violation|1
7063037|NCT01945489|11161182|FG000|Cycle 1|Other Miscellaneous Reasons|3
7063038|NCT01945489|11161183|FG001|Cycle 1|Other Miscellaneous Reasons|1
7063039|NCT01945489|11161182|FG000|Cycle 2|Adverse Event|1
7063040|NCT01945489|11161183|FG001|Cycle 2|Adverse Event|0
7063041|NCT01945489|11161182|FG000|Cycle 2|Lost to Follow-up|0
7063042|NCT01945489|11161183|FG001|Cycle 2|Lost to Follow-up|1
7063043|NCT01945580|11161192|FG000|Overall Study|Withdrawal by Subject|13
7063044|NCT01945580|11161193|FG001|Overall Study|Withdrawal by Subject|35
7063045|NCT01945580|11161192|FG000|Overall Study|Physician Decision|3
7063046|NCT01945580|11161193|FG001|Overall Study|Physician Decision|2
7063047|NCT01945580|11161192|FG000|Overall Study|Lost to Follow-up|26
7063048|NCT01945580|11161193|FG001|Overall Study|Lost to Follow-up|39
7063049|NCT01945580|11161192|FG000|Overall Study|Death|7
7063050|NCT01945580|11161193|FG001|Overall Study|Death|2
7063051|NCT01945580|11161192|FG000|Overall Study|Patient moved out of state|0
7063052|NCT01945580|11161193|FG001|Overall Study|Patient moved out of state|1
7063053|NCT01945580|11161192|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1
6832159|NCT00184028|10836296|FG000|Overall Study|Death|1
6832160|NCT00184028|10836296|FG000|Overall Study|Lack of Efficacy|4
6925263|NCT00830869|10955264|FG006|Period 2: Part 2|Symptomatic Deterioration|0
6974847|NCT01190930|11027131|FG000|Induction|Inevaluable|23
7063054|NCT01945580|11161193|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0
7063055|NCT01945580|11161192|FG000|Overall Study|Family illness - unable to return|0
7063056|NCT01945580|11161193|FG001|Overall Study|Family illness - unable to return|1
7063057|NCT01945580|11161192|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0
7063058|NCT01945580|11161193|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1
7063059|NCT01945580|11161192|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0
7063060|NCT01945580|11161193|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1
7063061|NCT01945580|11161192|FG000|Overall Study|Noncompliance with 36 month visit|1
7063062|NCT01945580|11161193|FG001|Overall Study|Noncompliance with 36 month visit|0
7063063|NCT01945580|11161192|FG000|Overall Study|The patient moved.|1
7063064|NCT01945580|11161193|FG001|Overall Study|The patient moved.|0
7063065|NCT01945580|11161192|FG000|Overall Study|No data available|0
7063066|NCT01945580|11161193|FG001|Overall Study|No data available|2
6832161|NCT00184028|10836296|FG000|Overall Study|Adverse Event|2
6832162|NCT00184028|10836296|FG000|Overall Study|Withdrawal by Subject|1
6832163|NCT00184028|10836296|FG000|Overall Study|Non-compliance|2
7063067|NCT01945593|11161207|FG000|Overall Study|Adverse Event|0
7063068|NCT01945593|11161208|FG001|Overall Study|Adverse Event|0
7063069|NCT01945593|11161209|FG002|Overall Study|Adverse Event|0
7063070|NCT01945593|11161210|FG003|Overall Study|Adverse Event|5
7063071|NCT01945593|11161207|FG000|Overall Study|Physician Decision|0
7063072|NCT01945593|11161208|FG001|Overall Study|Physician Decision|0
7063073|NCT01945593|11161209|FG002|Overall Study|Physician Decision|1
7063074|NCT01945593|11161210|FG003|Overall Study|Physician Decision|1
7063075|NCT01945593|11161207|FG000|Overall Study|Withdrawal by Subject|0
7063076|NCT01945593|11161208|FG001|Overall Study|Withdrawal by Subject|2
7063077|NCT01945593|11161209|FG002|Overall Study|Withdrawal by Subject|0
7063078|NCT01945593|11161210|FG003|Overall Study|Withdrawal by Subject|4
7063079|NCT01945593|11161207|FG000|Overall Study|Protocol Violation|0
7063080|NCT01945593|11161208|FG001|Overall Study|Protocol Violation|2
7063081|NCT01945593|11161209|FG002|Overall Study|Protocol Violation|1
7063082|NCT01945593|11161210|FG003|Overall Study|Protocol Violation|3
7063083|NCT01945593|11161207|FG000|Overall Study|Death|0
7063084|NCT01945593|11161208|FG001|Overall Study|Death|0
7063085|NCT01945593|11161209|FG002|Overall Study|Death|1
7063086|NCT01945593|11161210|FG003|Overall Study|Death|0
7063087|NCT01945593|11161207|FG000|Overall Study|Other: Terminated|0
7063088|NCT01945593|11161208|FG001|Overall Study|Other: Terminated|0
7063089|NCT01945593|11161209|FG002|Overall Study|Other: Terminated|0
7063090|NCT01945593|11161210|FG003|Overall Study|Other: Terminated|1
7063091|NCT01945593|11161207|FG000|Overall Study|Other: Surgical Procedure|0
7063092|NCT01945593|11161208|FG001|Overall Study|Other: Surgical Procedure|2
7063093|NCT01945593|11161209|FG002|Overall Study|Other: Surgical Procedure|0
7063094|NCT01945593|11161210|FG003|Overall Study|Other: Surgical Procedure|6
7063095|NCT01945593|11161207|FG000|Overall Study|Other: Screen Failure|0
7063096|NCT01945593|11161208|FG001|Overall Study|Other: Screen Failure|2
7063097|NCT01945593|11161209|FG002|Overall Study|Other: Screen Failure|0
7063098|NCT01945593|11161210|FG003|Overall Study|Other: Screen Failure|0
7063099|NCT01945710|11161232|FG000|Overall Study|Progressive Disease|5
7063100|NCT01945710|11161233|FG001|Overall Study|Progressive Disease|4
7063101|NCT01945710|11161234|FG002|Overall Study|Progressive Disease|3
7063102|NCT01945710|11161235|FG003|Overall Study|Progressive Disease|2
7063103|NCT01945710|11161236|FG004|Overall Study|Progressive Disease|7
7063104|NCT01945710|11161237|FG005|Overall Study|Progressive Disease|3
7063105|NCT01945710|11161238|FG006|Overall Study|Progressive Disease|19
7063106|NCT01945710|11161232|FG000|Overall Study|Adverse Event|0
7063107|NCT01945710|11161233|FG001|Overall Study|Adverse Event|1
7063108|NCT01945710|11161234|FG002|Overall Study|Adverse Event|0
7063109|NCT01945710|11161235|FG003|Overall Study|Adverse Event|0
7063110|NCT01945710|11161236|FG004|Overall Study|Adverse Event|0
7063111|NCT01945710|11161237|FG005|Overall Study|Adverse Event|0
7063112|NCT01945710|11161238|FG006|Overall Study|Adverse Event|0
7063113|NCT01945710|11161232|FG000|Overall Study|Other|2
7063114|NCT01945710|11161233|FG001|Overall Study|Other|0
7063115|NCT01945710|11161234|FG002|Overall Study|Other|3
7063116|NCT01945710|11161235|FG003|Overall Study|Other|1
7063117|NCT01945710|11161236|FG004|Overall Study|Other|1
7063118|NCT01945710|11161237|FG005|Overall Study|Other|0
7063119|NCT01945710|11161238|FG006|Overall Study|Other|4
7063120|NCT01945710|11161232|FG000|Overall Study|Withdrawal by Subject|0
7063121|NCT01945710|11161233|FG001|Overall Study|Withdrawal by Subject|1
7063122|NCT01945710|11161234|FG002|Overall Study|Withdrawal by Subject|1
7063123|NCT01945710|11161235|FG003|Overall Study|Withdrawal by Subject|0
7063124|NCT01945710|11161236|FG004|Overall Study|Withdrawal by Subject|1
7063125|NCT01945710|11161237|FG005|Overall Study|Withdrawal by Subject|0
7063126|NCT01945710|11161238|FG006|Overall Study|Withdrawal by Subject|0
7063127|NCT01945866|11161258|FG000|Overall Study|Eyes did not complete or were dropped|2
7063128|NCT01945866|11161259|FG001|Overall Study|Eyes did not complete or were dropped|0
7063129|NCT01945944|11161268|FG000|Overall Study|Adverse Event|0
7063130|NCT01945944|11161269|FG001|Overall Study|Adverse Event|2
7063131|NCT01945944|11161268|FG000|Overall Study|Physician Decision|1
7063132|NCT01945944|11161269|FG001|Overall Study|Physician Decision|0
7063133|NCT01945944|11161268|FG000|Overall Study|Withdrawal by Subject|0
7063134|NCT01945944|11161269|FG001|Overall Study|Withdrawal by Subject|1
6832164|NCT00184054|10836301|FG000|Overall Study|Adverse Event|1
7063135|NCT01945996|11161294|FG000|Overall Study|Lost to Follow-up|3
7063136|NCT01945996|11161295|FG001|Overall Study|Lost to Follow-up|5
7063137|NCT01946152|11161316|FG000|Overall Study|Adverse Event|1
7063138|NCT01946152|11161317|FG001|Overall Study|Adverse Event|0
7063139|NCT01946152|11161318|FG002|Overall Study|Adverse Event|0
7063140|NCT01946152|11161319|FG003|Overall Study|Adverse Event|0
7063141|NCT01946152|11161316|FG000|Overall Study|Withdrawal by Subject|0
7063142|NCT01946152|11161317|FG001|Overall Study|Withdrawal by Subject|2
7063143|NCT01946152|11161318|FG002|Overall Study|Withdrawal by Subject|0
7063144|NCT01946152|11161319|FG003|Overall Study|Withdrawal by Subject|0
7063145|NCT01946152|11161316|FG000|Overall Study|Progression|0
7063146|NCT01946152|11161317|FG001|Overall Study|Progression|1
7063147|NCT01946152|11161318|FG002|Overall Study|Progression|4
7063148|NCT01946152|11161319|FG003|Overall Study|Progression|7
7063149|NCT01946152|11161316|FG000|Overall Study|Physician Decision|0
6832165|NCT00184093|10836305|FG000|Overall Study|Adverse Event|3
6832166|NCT00184093|10836305|FG000|Overall Study|Lost to Follow-up|3
6832167|NCT00184093|10836305|FG000|Overall Study|Physician Decision|1
6832168|NCT00184093|10836305|FG000|Overall Study|Withdrawal by Subject|2
6832169|NCT00184600|10836329|FG000|Overall Study|Adverse Event|9
7038985|NCT01707992|11121597|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
7038986|NCT01707992|11121598|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
7063150|NCT01946152|11161317|FG001|Overall Study|Physician Decision|0
7063151|NCT01946152|11161318|FG002|Overall Study|Physician Decision|1
7063152|NCT01946152|11161319|FG003|Overall Study|Physician Decision|0
7063153|NCT01946152|11161316|FG000|Overall Study|Second malignancy|0
7063154|NCT01946152|11161317|FG001|Overall Study|Second malignancy|0
7063155|NCT01946152|11161318|FG002|Overall Study|Second malignancy|1
7063156|NCT01946152|11161319|FG003|Overall Study|Second malignancy|0
7063157|NCT01946152|11161316|FG000|Overall Study|Adverse Event|0
7063158|NCT01946152|11161317|FG001|Overall Study|Adverse Event|0
7063159|NCT01946152|11161318|FG002|Overall Study|Adverse Event|0
7063160|NCT01946152|11161319|FG003|Overall Study|Adverse Event|1
7063161|NCT01946165|11161333|FG000|Overall Study|Physician Decision|2
7063162|NCT01946165|11161334|FG001|Overall Study|Physician Decision|0
7063163|NCT01946165|11161333|FG000|Overall Study|Withdrawal by Subject|0
7063164|NCT01946165|11161334|FG001|Overall Study|Withdrawal by Subject|2
7063165|NCT01946178|11161341|FG000|Overall Study|Pregnancy|1
7063166|NCT01946178|11161341|FG000|Overall Study|Lost to Follow-up|1
7063167|NCT01946191|11161351|FG000|Allocation|Did not complete orientation|1
7063168|NCT01946191|11161352|FG001|Allocation|Did not complete orientation|1
7063169|NCT01946191|11161351|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4
7063170|NCT01946191|11161352|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2
7063171|NCT01946191|11161351|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0
7063172|NCT01946191|11161352|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1
7063173|NCT01946191|11161351|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13
7063174|NCT01946191|11161352|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15
7063175|NCT01946282|11161368|FG000|Year 1|Did not return FIT kit|4186
7063176|NCT01946282|11161369|FG001|Year 1|Did not return FIT kit|608
7063177|NCT01946282|11161370|FG002|Year 1|Did not return FIT kit|654
7038987|NCT01707992|11121599|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58
7038988|NCT01707992|11121600|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220
7038989|NCT01707992|11121601|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32
7038990|NCT01707992|11121596|FG000|Active Treatment Phase (24 Months)|Pregnancy|0
7038991|NCT01707992|11121597|FG001|Active Treatment Phase (24 Months)|Pregnancy|0
7038992|NCT01707992|11121598|FG002|Active Treatment Phase (24 Months)|Pregnancy|0
7038993|NCT01707992|11121599|FG003|Active Treatment Phase (24 Months)|Pregnancy|2
7038994|NCT01707992|11121600|FG004|Active Treatment Phase (24 Months)|Pregnancy|5
7038995|NCT01707992|11121601|FG005|Active Treatment Phase (24 Months)|Pregnancy|2
7038996|NCT01707992|11121596|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0
7038997|NCT01707992|11121597|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0
7063178|NCT01946282|11161368|FG000|Year 2|Did not return FIT kit|803
7063179|NCT01946282|11161369|FG001|Year 2|Did not return FIT kit|131
7063180|NCT01946282|11161370|FG002|Year 2|Did not return FIT kit|115
7063181|NCT01946282|11161368|FG000|Year 3|Did not return FIT kit|288
7063182|NCT01946282|11161369|FG001|Year 3|Did not return FIT kit|43
7063183|NCT01946282|11161370|FG002|Year 3|Did not return FIT kit|30
7063184|NCT01946412|11161380|FG000|Overall Study|Adverse Event|1
7063185|NCT01946412|11161380|FG000|Overall Study|Non-Compliance|1
7063186|NCT01946412|11161380|FG000|Overall Study|Continued with commercial Kalydeco|2
7063187|NCT01946412|11161380|FG000|Overall Study|Difficulty in swallowing|1
7063188|NCT01946425|11161388|FG000|Overall Study|Protocol Violation|1
7063189|NCT01946425|11161389|FG001|Overall Study|Protocol Violation|0
7063190|NCT01946425|11161388|FG000|Overall Study|Withdrawal by Subject|1
7063191|NCT01946425|11161389|FG001|Overall Study|Withdrawal by Subject|0
7063192|NCT01946438|11161400|FG000|Overall Study|Adverse Event|0
7063193|NCT01946438|11161401|FG001|Overall Study|Adverse Event|0
7063194|NCT01946438|11161402|FG002|Overall Study|Adverse Event|0
7063195|NCT01946438|11161403|FG003|Overall Study|Adverse Event|1
7063196|NCT01946438|11161400|FG000|Overall Study|Serious Adverse event|1
7063197|NCT01946438|11161401|FG001|Overall Study|Serious Adverse event|0
7063198|NCT01946438|11161402|FG002|Overall Study|Serious Adverse event|0
7063199|NCT01946438|11161403|FG003|Overall Study|Serious Adverse event|0
7063200|NCT01946438|11161400|FG000|Overall Study|Protocol Violation|0
7063201|NCT01946438|11161401|FG001|Overall Study|Protocol Violation|0
7063202|NCT01946438|11161402|FG002|Overall Study|Protocol Violation|1
7063203|NCT01946438|11161403|FG003|Overall Study|Protocol Violation|0
7063204|NCT01946438|11161400|FG000|Overall Study|Withdrawal by Subject|1
7063205|NCT01946438|11161401|FG001|Overall Study|Withdrawal by Subject|0
7063206|NCT01946438|11161402|FG002|Overall Study|Withdrawal by Subject|0
7063207|NCT01946438|11161403|FG003|Overall Study|Withdrawal by Subject|0
7063208|NCT01946529|11161422|FG000|End of Window Therapy (2 Courses)|Physician Decision|0
7063209|NCT01946529|11161423|FG001|End of Window Therapy (2 Courses)|Physician Decision|1
7063210|NCT01946529|11161424|FG002|End of Window Therapy (2 Courses)|Physician Decision|0
7082392|NCT02141659|11192931|FG005|Overall Study|Major Protocol Deviation|0
6832170|NCT00184600|10836330|FG001|Overall Study|Adverse Event|0
6832171|NCT00184600|10836331|FG002|Overall Study|Adverse Event|5
6832172|NCT00184600|10836329|FG000|Overall Study|Death|3
6832173|NCT00184600|10836330|FG001|Overall Study|Death|9
6832174|NCT00184600|10836331|FG002|Overall Study|Death|7
6832175|NCT00184600|10836329|FG000|Overall Study|Lack of Efficacy|3
6832176|NCT00184600|10836330|FG001|Overall Study|Lack of Efficacy|1
6832177|NCT00184600|10836331|FG002|Overall Study|Lack of Efficacy|3
6832178|NCT00184600|10836329|FG000|Overall Study|Lost to Follow-up|4
6832179|NCT00184600|10836330|FG001|Overall Study|Lost to Follow-up|6
6832180|NCT00184600|10836331|FG002|Overall Study|Lost to Follow-up|1
6832181|NCT00184600|10836329|FG000|Overall Study|Protocol Violation|2
6925264|NCT00830869|10955265|FG007|Period 2: Part 2|Symptomatic Deterioration|0
7063211|NCT01946529|11161422|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1
7063212|NCT01946529|11161423|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16
7063213|NCT01946529|11161424|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6
7063214|NCT01946802|11161431|FG000|Overall Study|Death|1
7063215|NCT01946802|11161431|FG000|Overall Study|Withdrawal by Subject|2
7063216|NCT01946802|11161431|FG000|Overall Study|Combined septic shock|1
7063217|NCT01946802|11161431|FG000|Overall Study|Protocol Violation|1
7063218|NCT01946880|11161437|FG000|Overall Study|Lost to Follow-up|1
7063219|NCT01946880|11161438|FG001|Overall Study|Lost to Follow-up|0
7063220|NCT01946880|11161437|FG000|Overall Study|Physician Decision|1
7063221|NCT01946880|11161438|FG001|Overall Study|Physician Decision|1
7063222|NCT01946880|11161437|FG000|Overall Study|Withdrawal by Subject|3
7063223|NCT01946880|11161438|FG001|Overall Study|Withdrawal by Subject|2
7063224|NCT01946880|11161437|FG000|Overall Study|Met Primary Endpoint|1
7063225|NCT01946880|11161438|FG001|Overall Study|Met Primary Endpoint|0
7063226|NCT01946880|11161437|FG000|Overall Study|Personal and Family Issues|1
7038998|NCT01707992|11121598|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0
7063227|NCT01946880|11161438|FG001|Overall Study|Personal and Family Issues|0
7063228|NCT01947127|11161446|FG000|Overall Study|Protocol Violation|18
7063229|NCT01947127|11161447|FG001|Overall Study|Protocol Violation|38
7063230|NCT01947127|11161446|FG000|Overall Study|Withdrawal by Subject|1
7063231|NCT01947127|11161447|FG001|Overall Study|Withdrawal by Subject|1
7063232|NCT01947127|11161446|FG000|Overall Study|Data loss|4
7063233|NCT01947127|11161447|FG001|Overall Study|Data loss|4
7063234|NCT01947283|11161467|FG000|Overall Study|Death|1
7063235|NCT01947283|11161468|FG001|Overall Study|Death|1
7063236|NCT01947283|11161469|FG002|Overall Study|Death|1
7063237|NCT01947283|11161470|FG003|Overall Study|Death|0
7063238|NCT01947283|11161471|FG004|Overall Study|Death|0
7063239|NCT01947283|11161472|FG005|Overall Study|Death|0
7063240|NCT01947283|11161473|FG006|Overall Study|Death|0
7063241|NCT01947283|11161467|FG000|Overall Study|Lost to Follow-up|4
7063242|NCT01947283|11161468|FG001|Overall Study|Lost to Follow-up|6
7063243|NCT01947283|11161469|FG002|Overall Study|Lost to Follow-up|5
7063244|NCT01947283|11161470|FG003|Overall Study|Lost to Follow-up|5
7063245|NCT01947283|11161471|FG004|Overall Study|Lost to Follow-up|0
7063246|NCT01947283|11161472|FG005|Overall Study|Lost to Follow-up|2
7063247|NCT01947283|11161473|FG006|Overall Study|Lost to Follow-up|5
7063248|NCT01947283|11161467|FG000|Overall Study|Withdrawal by Subject|10
7063249|NCT01947283|11161468|FG001|Overall Study|Withdrawal by Subject|8
7063250|NCT01947283|11161469|FG002|Overall Study|Withdrawal by Subject|4
7063251|NCT01947283|11161470|FG003|Overall Study|Withdrawal by Subject|1
7063252|NCT01947283|11161471|FG004|Overall Study|Withdrawal by Subject|0
7063253|NCT01947283|11161472|FG005|Overall Study|Withdrawal by Subject|0
7063254|NCT01947283|11161473|FG006|Overall Study|Withdrawal by Subject|2
7063255|NCT01947283|11161467|FG000|Overall Study|No Clinical Recording|12
7063256|NCT01947283|11161468|FG001|Overall Study|No Clinical Recording|6
7063257|NCT01947283|11161469|FG002|Overall Study|No Clinical Recording|8
7063258|NCT01947283|11161470|FG003|Overall Study|No Clinical Recording|10
7063259|NCT01947283|11161471|FG004|Overall Study|No Clinical Recording|0
7063260|NCT01947283|11161472|FG005|Overall Study|No Clinical Recording|0
7063261|NCT01947283|11161473|FG006|Overall Study|No Clinical Recording|0
7063262|NCT01947283|11161467|FG000|Overall Study|Non-coding Clinical Recording language|0
7063263|NCT01947283|11161468|FG001|Overall Study|Non-coding Clinical Recording language|0
7063264|NCT01947283|11161469|FG002|Overall Study|Non-coding Clinical Recording language|0
7063265|NCT01947283|11161470|FG003|Overall Study|Non-coding Clinical Recording language|1
7063266|NCT01947283|11161471|FG004|Overall Study|Non-coding Clinical Recording language|0
7063267|NCT01947283|11161472|FG005|Overall Study|Non-coding Clinical Recording language|0
7063268|NCT01947283|11161473|FG006|Overall Study|Non-coding Clinical Recording language|0
7063269|NCT01947283|11161467|FG000|Overall Study|Missing Follow-up Assessment|2
7063270|NCT01947283|11161468|FG001|Overall Study|Missing Follow-up Assessment|2
7063271|NCT01947283|11161469|FG002|Overall Study|Missing Follow-up Assessment|3
7063272|NCT01947283|11161470|FG003|Overall Study|Missing Follow-up Assessment|0
7063273|NCT01947283|11161471|FG004|Overall Study|Missing Follow-up Assessment|0
7063274|NCT01947283|11161472|FG005|Overall Study|Missing Follow-up Assessment|2
6832182|NCT00184600|10836330|FG001|Overall Study|Protocol Violation|2
6832183|NCT00184600|10836331|FG002|Overall Study|Protocol Violation|3
6832184|NCT00184600|10836329|FG000|Overall Study|Withdrawal by Subject|20
7044765|NCT01757171|11130749|FG000|Overall Study|Adverse Event|5
7063275|NCT01947283|11161473|FG006|Overall Study|Missing Follow-up Assessment|0
6832185|NCT00184600|10836330|FG001|Overall Study|Withdrawal by Subject|28
6832186|NCT00184600|10836331|FG002|Overall Study|Withdrawal by Subject|12
6832187|NCT00184600|10836329|FG000|Overall Study|Unclassified|4
6832188|NCT00184600|10836330|FG001|Overall Study|Unclassified|5
6832189|NCT00184600|10836331|FG002|Overall Study|Unclassified|3
6832190|NCT00185211|10836358|FG000|Placebo-controlled Study (92012)|Adverse Event|8
7063276|NCT01947283|11161467|FG000|Overall Study|No patients were enrolled in study|0
7063277|NCT01947283|11161468|FG001|Overall Study|No patients were enrolled in study|0
7063278|NCT01947283|11161469|FG002|Overall Study|No patients were enrolled in study|0
7063279|NCT01947283|11161470|FG003|Overall Study|No patients were enrolled in study|0
7063280|NCT01947283|11161471|FG004|Overall Study|No patients were enrolled in study|0
7063281|NCT01947283|11161472|FG005|Overall Study|No patients were enrolled in study|3
7063282|NCT01947283|11161473|FG006|Overall Study|No patients were enrolled in study|1
7063283|NCT01947491|11161503|FG000|Overall Study|Lost to Follow-up|5
7063284|NCT01947491|11161504|FG001|Overall Study|Lost to Follow-up|3
7063285|NCT01947491|11161505|FG002|Overall Study|Lost to Follow-up|1
7063286|NCT01947491|11161506|FG003|Overall Study|Lost to Follow-up|2
7063287|NCT01947491|11161503|FG000|Overall Study|Lack of Efficacy|1
7063288|NCT01947491|11161504|FG001|Overall Study|Lack of Efficacy|0
7063289|NCT01947491|11161505|FG002|Overall Study|Lack of Efficacy|0
7063290|NCT01947491|11161506|FG003|Overall Study|Lack of Efficacy|1
7063291|NCT01947491|11161503|FG000|Overall Study|Protocol Violation|1
7063292|NCT01947491|11161504|FG001|Overall Study|Protocol Violation|0
7063293|NCT01947491|11161505|FG002|Overall Study|Protocol Violation|0
7063294|NCT01947491|11161506|FG003|Overall Study|Protocol Violation|0
7063295|NCT01947491|11161503|FG000|Overall Study|Withdrawal by Subject|1
7063296|NCT01947491|11161504|FG001|Overall Study|Withdrawal by Subject|1
7063297|NCT01947491|11161505|FG002|Overall Study|Withdrawal by Subject|1
7063298|NCT01947491|11161506|FG003|Overall Study|Withdrawal by Subject|0
7063299|NCT01947491|11161503|FG000|Overall Study|Worsening of condition|0
7063300|NCT01947491|11161504|FG001|Overall Study|Worsening of condition|1
7063301|NCT01947491|11161505|FG002|Overall Study|Worsening of condition|0
7063302|NCT01947491|11161506|FG003|Overall Study|Worsening of condition|0
7063303|NCT01947491|11161503|FG000|Overall Study|Adverse Event|0
7063304|NCT01947491|11161504|FG001|Overall Study|Adverse Event|1
7063305|NCT01947491|11161505|FG002|Overall Study|Adverse Event|0
7063306|NCT01947491|11161506|FG003|Overall Study|Adverse Event|2
7063307|NCT01947517|11161518|FG000|Overall Study|Withdrawal by Subject|1
7063308|NCT01947517|11161519|FG001|Overall Study|Withdrawal by Subject|1
7063309|NCT01947582|11161525|FG000|Overall Study|Withdrawal by Subject|1
7063310|NCT01947855|11161545|FG000|Overall Study|Withdrawal by Subject|1
7063311|NCT01947855|11161546|FG001|Overall Study|Withdrawal by Subject|0
7063312|NCT01947855|11161547|FG002|Overall Study|Withdrawal by Subject|0
7063313|NCT01947894|11161558|FG000|Overall Study|Other|3
7063314|NCT01947894|11161559|FG001|Overall Study|Other|4
7063315|NCT01947894|11161560|FG002|Overall Study|Other|3
7063316|NCT01947894|11161558|FG000|Overall Study|Withdrawal by Subject|12
7063317|NCT01947894|11161559|FG001|Overall Study|Withdrawal by Subject|4
7063318|NCT01947894|11161560|FG002|Overall Study|Withdrawal by Subject|1
7063319|NCT01947894|11161558|FG000|Overall Study|Death|12
7063320|NCT01947894|11161559|FG001|Overall Study|Death|1
7063321|NCT01947894|11161560|FG002|Overall Study|Death|0
6832191|NCT00185211|10836359|FG001|Placebo-controlled Study (92012)|Adverse Event|0
6832192|NCT00185211|10836358|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3
6832193|NCT00185211|10836359|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2
6832194|NCT00185211|10836358|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9
6832195|NCT00185211|10836359|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7
6832196|NCT00185211|10836358|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0
6832197|NCT00185211|10836359|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1
6832198|NCT00185211|10836358|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1
6832199|NCT00185211|10836359|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0
6832200|NCT00185211|10836358|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5
6832201|NCT00185211|10836359|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6
6832202|NCT00185211|10836358|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1
6832203|NCT00185211|10836359|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0
6832204|NCT00185211|10836358|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6
6832205|NCT00185211|10836359|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4
6832206|NCT00185211|10836358|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1
6832207|NCT00185211|10836359|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0
6832208|NCT00185211|10836358|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0
6832209|NCT00185211|10836359|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1
6832210|NCT00185211|10836358|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13
6832211|NCT00185211|10836359|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21
6832212|NCT00185211|10836358|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0
6832213|NCT00185211|10836359|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2
6832214|NCT00185380|10836369|FG000|Overall Study|Adverse Event|41
6832215|NCT00185380|10836370|FG001|Overall Study|Adverse Event|43
6832216|NCT00185380|10836371|FG002|Overall Study|Adverse Event|48
6832217|NCT00185380|10836369|FG000|Overall Study|Lost to Follow-up|0
7063322|NCT01947894|11161558|FG000|Overall Study|Physician Decision|2
7063323|NCT01947894|11161559|FG001|Overall Study|Physician Decision|0
7063324|NCT01947894|11161560|FG002|Overall Study|Physician Decision|0
7063325|NCT01947894|11161558|FG000|Overall Study|Adverse Event|5
7063326|NCT01947894|11161559|FG001|Overall Study|Adverse Event|1
7063327|NCT01947894|11161560|FG002|Overall Study|Adverse Event|0
7063328|NCT01947894|11161558|FG000|Overall Study|Switched to other growth hormone brand|53
7063329|NCT01947894|11161559|FG001|Overall Study|Switched to other growth hormone brand|8
7063330|NCT01947894|11161560|FG002|Overall Study|Switched to other growth hormone brand|23
7063331|NCT01948050|11161600|FG000|Overall Study|Withdrawal by Subject|0
7063332|NCT01948050|11161601|FG001|Overall Study|Withdrawal by Subject|1
7063333|NCT01948063|11161609|FG000|Overall Study|Boston MCI halted research protocol|0
7063334|NCT01948063|11161610|FG001|Overall Study|Boston MCI halted research protocol|1
7063335|NCT01948063|11161609|FG000|Overall Study|Discovered an enrollment in other study|0
7063336|NCT01948063|11161610|FG001|Overall Study|Discovered an enrollment in other study|1
7063337|NCT01948063|11161609|FG000|Overall Study|Blood samples were accidentally thawed|1
7063338|NCT01948063|11161610|FG001|Overall Study|Blood samples were accidentally thawed|0
7063339|NCT01948076|11161618|FG000|Overall Study|Withdrawal by Subject|0
7063340|NCT01948076|11161619|FG001|Overall Study|Withdrawal by Subject|1
7063341|NCT01948193|11161631|FG000|Overall Study|Serious event|2
7063342|NCT01948193|11161631|FG000|Overall Study|Lost to Follow-up|7
7063343|NCT01948258|11161636|FG000|Overall Study|Pregnancy|41
7063344|NCT01948258|11161636|FG000|Overall Study|Did not complete by cut-off date|35
7063345|NCT01948258|11161636|FG000|Overall Study|Lost to Follow-up|27
7063346|NCT01948258|11161636|FG000|Overall Study|Withdrawal by SPD|8
7063347|NCT01948258|11161636|FG000|Overall Study|Withdrawal by Subject|6
7063348|NCT01948258|11161636|FG000|Overall Study|Health Care Professional|43
7063349|NCT01948258|11161636|FG000|Overall Study|Removed from statistical analysis|2
7063350|NCT01948427|11161676|FG000|Overall Study|Serious Adverse Event|3
7063351|NCT01948427|11161677|FG001|Overall Study|Serious Adverse Event|0
7063352|NCT01948427|11161678|FG002|Overall Study|Serious Adverse Event|0
7063353|NCT01948427|11161679|FG003|Overall Study|Serious Adverse Event|0
7063354|NCT01948427|11161680|FG004|Overall Study|Serious Adverse Event|1
7063355|NCT01948427|11161676|FG000|Overall Study|Investigator Request|0
7063356|NCT01948427|11161677|FG001|Overall Study|Investigator Request|8
7063357|NCT01948427|11161678|FG002|Overall Study|Investigator Request|0
7063358|NCT01948427|11161679|FG003|Overall Study|Investigator Request|0
7063359|NCT01948427|11161680|FG004|Overall Study|Investigator Request|6
7063360|NCT01948427|11161676|FG000|Overall Study|Lost to Follow-up|1
7063361|NCT01948427|11161677|FG001|Overall Study|Lost to Follow-up|0
7063362|NCT01948427|11161678|FG002|Overall Study|Lost to Follow-up|0
7063363|NCT01948427|11161679|FG003|Overall Study|Lost to Follow-up|0
7063364|NCT01948427|11161680|FG004|Overall Study|Lost to Follow-up|4
7063365|NCT01948427|11161676|FG000|Overall Study|Withdrawal by Subject|2
7063366|NCT01948427|11161677|FG001|Overall Study|Withdrawal by Subject|0
7063367|NCT01948427|11161678|FG002|Overall Study|Withdrawal by Subject|0
7063368|NCT01948427|11161679|FG003|Overall Study|Withdrawal by Subject|0
7063369|NCT01948427|11161680|FG004|Overall Study|Withdrawal by Subject|1
7038999|NCT01707992|11121599|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5
7039000|NCT01707992|11121600|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11
7063370|NCT01948427|11161676|FG000|Overall Study|Other, Not Specified|1
7063371|NCT01948427|11161677|FG001|Overall Study|Other, Not Specified|9
7039001|NCT01707992|11121601|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1
7039002|NCT01707992|11121596|FG000|Active Treatment Phase (24 Months)|Death|0
7039003|NCT01707992|11121597|FG001|Active Treatment Phase (24 Months)|Death|0
7039004|NCT01707992|11121598|FG002|Active Treatment Phase (24 Months)|Death|0
7039005|NCT01707992|11121599|FG003|Active Treatment Phase (24 Months)|Death|2
7039006|NCT01707992|11121600|FG004|Active Treatment Phase (24 Months)|Death|0
7039007|NCT01707992|11121601|FG005|Active Treatment Phase (24 Months)|Death|0
7039008|NCT01707992|11121596|FG000|Active Treatment Phase (24 Months)|Other than specified|0
7039009|NCT01707992|11121597|FG001|Active Treatment Phase (24 Months)|Other than specified|0
7039010|NCT01707992|11121598|FG002|Active Treatment Phase (24 Months)|Other than specified|0
7039011|NCT01707992|11121599|FG003|Active Treatment Phase (24 Months)|Other than specified|1
7039012|NCT01707992|11121600|FG004|Active Treatment Phase (24 Months)|Other than specified|5
7039013|NCT01707992|11121601|FG005|Active Treatment Phase (24 Months)|Other than specified|2
7039014|NCT01707992|11121596|FG000|Active Treatment Phase (24 Months)|Noncompliance|0
7039015|NCT01707992|11121597|FG001|Active Treatment Phase (24 Months)|Noncompliance|0
7063372|NCT01948427|11161678|FG002|Overall Study|Other, Not Specified|0
7063373|NCT01948427|11161679|FG003|Overall Study|Other, Not Specified|0
7063374|NCT01948427|11161680|FG004|Overall Study|Other, Not Specified|2
7063375|NCT01948791|11161705|FG000|Overall Study|Adverse Event|12
6974848|NCT01190930|11027132|FG001|Induction|Inevaluable|1
7063376|NCT01948791|11161705|FG000|Overall Study|Lack of Efficacy|3
7063377|NCT01948791|11161705|FG000|Overall Study|Protocol Violation|2
7063378|NCT01948791|11161705|FG000|Overall Study|Withdrawal by Subject|5
7063379|NCT01948791|11161705|FG000|Overall Study|Lost to Follow-up|6
7063380|NCT01948791|11161705|FG000|Overall Study|Management issues|1
7063381|NCT01948791|11161705|FG000|Overall Study|Others|7
7063382|NCT01948791|11161705|FG000|Overall Study|Screening failure|35
6832218|NCT00185380|10836370|FG001|Overall Study|Lost to Follow-up|4
6832219|NCT00185380|10836371|FG002|Overall Study|Lost to Follow-up|3
6832220|NCT00185380|10836369|FG000|Overall Study|Pregnancy|1
6832221|NCT00185380|10836370|FG001|Overall Study|Pregnancy|4
6832222|NCT00185380|10836371|FG002|Overall Study|Pregnancy|0
6832223|NCT00185380|10836369|FG000|Overall Study|Protocol Violation|2
6832224|NCT00185380|10836370|FG001|Overall Study|Protocol Violation|2
6832225|NCT00185380|10836371|FG002|Overall Study|Protocol Violation|1
6925265|NCT00830869|10955266|FG008|Period 2: Part 2|Symptomatic Deterioration|6
6925266|NCT00830869|10955267|FG009|Period 2: Part 2|Symptomatic Deterioration|3
6925267|NCT00830869|10955268|FG010|Period 2: Part 2|Symptomatic Deterioration|1
6925268|NCT00830869|10955269|FG011|Period 2: Part 2|Symptomatic Deterioration|4
6925269|NCT00830869|10955258|FG000|Period 2: Part 2|Progressive disease|0
6925270|NCT00830869|10955259|FG001|Period 2: Part 2|Progressive disease|0
6925271|NCT00830869|10955260|FG002|Period 2: Part 2|Progressive disease|0
6925272|NCT00830869|10955261|FG003|Period 2: Part 2|Progressive disease|0
6925273|NCT00830869|10955262|FG004|Period 2: Part 2|Progressive disease|0
6925274|NCT00830869|10955263|FG005|Period 2: Part 2|Progressive disease|0
6925275|NCT00830869|10955264|FG006|Period 2: Part 2|Progressive disease|0
6925276|NCT00830869|10955265|FG007|Period 2: Part 2|Progressive disease|14
6925277|NCT00830869|10955266|FG008|Period 2: Part 2|Progressive disease|11
6925278|NCT00830869|10955267|FG009|Period 2: Part 2|Progressive disease|12
6925279|NCT00830869|10955268|FG010|Period 2: Part 2|Progressive disease|8
6925280|NCT00830869|10955269|FG011|Period 2: Part 2|Progressive disease|15
6925281|NCT00830869|10955258|FG000|Period 2: Part 2|Other|0
6925282|NCT00830869|10955259|FG001|Period 2: Part 2|Other|0
6925283|NCT00830869|10955260|FG002|Period 2: Part 2|Other|0
6925284|NCT00830869|10955261|FG003|Period 2: Part 2|Other|0
6925285|NCT00830869|10955262|FG004|Period 2: Part 2|Other|0
6925286|NCT00830869|10955263|FG005|Period 2: Part 2|Other|0
6925287|NCT00830869|10955264|FG006|Period 2: Part 2|Other|0
6925288|NCT00830869|10955265|FG007|Period 2: Part 2|Other|0
6925289|NCT00830869|10955266|FG008|Period 2: Part 2|Other|0
6925290|NCT00830869|10955267|FG009|Period 2: Part 2|Other|1
6925291|NCT00830869|10955268|FG010|Period 2: Part 2|Other|0
6925292|NCT00830869|10955269|FG011|Period 2: Part 2|Other|0
6925293|NCT00830947|10955298|FG000|Overall Study|Lost to Follow-up|4
6925294|NCT00830947|10955299|FG001|Overall Study|Lost to Follow-up|4
6925295|NCT00830960|10955311|FG000|Overall Study|Death|5
6925296|NCT00830960|10955312|FG001|Overall Study|Death|4
6925297|NCT00830960|10955313|FG002|Overall Study|Death|3
6925298|NCT00830960|10955314|FG003|Overall Study|Death|2
6925299|NCT00830960|10955315|FG004|Overall Study|Death|6
6925300|NCT00830960|10955316|FG005|Overall Study|Death|1
6925301|NCT00830960|10955311|FG000|Overall Study|Lost to Follow-up|1
6925302|NCT00830960|10955312|FG001|Overall Study|Lost to Follow-up|1
6925303|NCT00830960|10955313|FG002|Overall Study|Lost to Follow-up|1
6925304|NCT00830960|10955314|FG003|Overall Study|Lost to Follow-up|0
6925305|NCT00830960|10955315|FG004|Overall Study|Lost to Follow-up|0
6925306|NCT00830960|10955316|FG005|Overall Study|Lost to Follow-up|1
6925307|NCT00830960|10955311|FG000|Overall Study|Withdrawal by Subject|19
6925308|NCT00830960|10955312|FG001|Overall Study|Withdrawal by Subject|19
6925309|NCT00830960|10955313|FG002|Overall Study|Withdrawal by Subject|18
6925310|NCT00830960|10955314|FG003|Overall Study|Withdrawal by Subject|23
6925311|NCT00830960|10955315|FG004|Overall Study|Withdrawal by Subject|16
6925312|NCT00830960|10955316|FG005|Overall Study|Withdrawal by Subject|21
6925313|NCT00830960|10955311|FG000|Overall Study|Sponsor Decision|1
6925314|NCT00830960|10955312|FG001|Overall Study|Sponsor Decision|2
6925315|NCT00830960|10955313|FG002|Overall Study|Sponsor Decision|3
6925316|NCT00830960|10955314|FG003|Overall Study|Sponsor Decision|4
6925317|NCT00830960|10955315|FG004|Overall Study|Sponsor Decision|5
6925318|NCT00830960|10955316|FG005|Overall Study|Sponsor Decision|7
6925319|NCT00830960|10955311|FG000|Overall Study|No study drug received|7
7063383|NCT01948830|11161711|FG000|Overall Study|Physician Decision|1
7063384|NCT01948830|11161712|FG001|Overall Study|Physician Decision|3
7063385|NCT01948830|11161711|FG000|Overall Study|Protocol deviation|1
7063386|NCT01948830|11161712|FG001|Overall Study|Protocol deviation|2
7063387|NCT01948830|11161711|FG000|Overall Study|Lost to Follow-up|5
7063388|NCT01948830|11161712|FG001|Overall Study|Lost to Follow-up|4
7063389|NCT01948830|11161711|FG000|Overall Study|Withdrawal by Subject|14
7063390|NCT01948830|11161712|FG001|Overall Study|Withdrawal by Subject|17
7063391|NCT01948830|11161711|FG000|Overall Study|Adverse Event|9
7063392|NCT01948830|11161712|FG001|Overall Study|Adverse Event|2
6925320|NCT00830960|10955312|FG001|Overall Study|No study drug received|2
6832226|NCT00185380|10836369|FG000|Overall Study|Withdrawal by Subject|1
6832227|NCT00185380|10836370|FG001|Overall Study|Withdrawal by Subject|2
6925321|NCT00830960|10955313|FG002|Overall Study|No study drug received|4
6925322|NCT00830960|10955314|FG003|Overall Study|No study drug received|3
6925323|NCT00830960|10955315|FG004|Overall Study|No study drug received|5
6925324|NCT00830960|10955316|FG005|Overall Study|No study drug received|7
6925325|NCT00831129|10955355|FG000|Overall Study|Adverse Event|0
7063393|NCT01948830|11161711|FG000|Overall Study|Death|3
6925326|NCT00831129|10955356|FG001|Overall Study|Adverse Event|1
6925327|NCT00831129|10955355|FG000|Overall Study|9 lost to follow-up reasons uknown|0
6925328|NCT00831129|10955356|FG001|Overall Study|9 lost to follow-up reasons uknown|9
7063394|NCT01948830|11161712|FG001|Overall Study|Death|4
7063395|NCT01948908|11161721|FG000|Overall Study|Protocol Violation|1
6832228|NCT00185380|10836371|FG002|Overall Study|Withdrawal by Subject|0
6832229|NCT00185380|10836369|FG000|Overall Study|Failed insertion|1
6832230|NCT00185380|10836370|FG001|Overall Study|Failed insertion|1
6832231|NCT00185380|10836371|FG002|Overall Study|Failed insertion|2
6832232|NCT00185380|10836369|FG000|Overall Study|Planned pregnancy|9
6832233|NCT00185380|10836370|FG001|Overall Study|Planned pregnancy|12
6832234|NCT00185380|10836371|FG002|Overall Study|Planned pregnancy|12
6832235|NCT00185380|10836369|FG000|Overall Study|No need for contraception|3
6832236|NCT00185380|10836370|FG001|Overall Study|No need for contraception|3
6832237|NCT00185380|10836371|FG002|Overall Study|No need for contraception|3
6832238|NCT00185380|10836369|FG000|Overall Study|Could not attend visits|2
6832239|NCT00185380|10836370|FG001|Overall Study|Could not attend visits|0
6832240|NCT00185380|10836371|FG002|Overall Study|Could not attend visits|4
6832241|NCT00185380|10836369|FG000|Overall Study|personal reason|6
6832242|NCT00185380|10836370|FG001|Overall Study|personal reason|1
6832243|NCT00185380|10836371|FG002|Overall Study|personal reason|1
6832244|NCT00185458|10836379|FG000|Contraception Phase|Adverse Event|37
6832245|NCT00185458|10836379|FG000|Contraception Phase|Lost to Follow-up|10
6832246|NCT00185458|10836379|FG000|Contraception Phase|Protocol Violation|2
6832247|NCT00185458|10836379|FG000|Contraception Phase|Physician Decision|2
6832248|NCT00185458|10836379|FG000|Contraception Phase|Withdrawal by Subject|7
6832249|NCT00185458|10836379|FG000|HRT Phase|Adverse Event|18
6832250|NCT00185458|10836379|FG000|HRT Phase|Lost to Follow-up|4
6832251|NCT00185458|10836379|FG000|HRT Phase|Protocol Violation|2
6832252|NCT00185458|10836379|FG000|HRT Phase|Withdrawal by Subject|3
6832253|NCT00185588|10836395|FG000|Overall Study|Adverse Event|3
6832254|NCT00185588|10836396|FG001|Overall Study|Adverse Event|1
6832255|NCT00185588|10836397|FG002|Overall Study|Adverse Event|4
7063396|NCT01948908|11161722|FG001|Overall Study|Protocol Violation|0
7063397|NCT01948908|11161723|FG002|Overall Study|Protocol Violation|2
7063398|NCT01949051|11161761|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1
7063399|NCT01949051|11161762|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0
7063400|NCT01949051|11161763|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0
7063401|NCT01949051|11161764|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1
7063402|NCT01949051|11161765|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0
7063403|NCT01949051|11161766|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0
7063404|NCT01949051|11161761|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1
7063405|NCT01949051|11161762|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0
6832256|NCT00185588|10836398|FG003|Overall Study|Adverse Event|2
6832257|NCT00185588|10836395|FG000|Overall Study|Lost to Follow-up|0
6832258|NCT00185588|10836396|FG001|Overall Study|Lost to Follow-up|0
6832259|NCT00185588|10836397|FG002|Overall Study|Lost to Follow-up|1
6832260|NCT00185588|10836398|FG003|Overall Study|Lost to Follow-up|2
6832261|NCT00185588|10836395|FG000|Overall Study|Withdrawal by Subject|0
6832262|NCT00185588|10836396|FG001|Overall Study|Withdrawal by Subject|1
7063406|NCT01949051|11161763|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7063407|NCT01949051|11161764|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7063408|NCT01949051|11161765|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7063409|NCT01949051|11161766|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7063410|NCT01949051|11161761|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0
7063411|NCT01949051|11161762|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0
6832263|NCT00185588|10836397|FG002|Overall Study|Withdrawal by Subject|0
6832264|NCT00185588|10836398|FG003|Overall Study|Withdrawal by Subject|0
6832265|NCT00185588|10836395|FG000|Overall Study|Physician Decision|0
6832266|NCT00185588|10836396|FG001|Overall Study|Physician Decision|0
6832267|NCT00185588|10836397|FG002|Overall Study|Physician Decision|1
6832268|NCT00185588|10836398|FG003|Overall Study|Physician Decision|0
6832269|NCT00185614|10836408|FG000|Inter-treatment Period|Physician Decision|1
6832270|NCT00185614|10836408|FG000|Inter-treatment Period|Relapse|2
6832271|NCT00185614|10836408|FG000|Inter-treatment Period|Lack of allogenic donor|1
6832272|NCT00185640|10836412|FG000|Overall Study|Not Eligible|4
6832273|NCT00185640|10836412|FG000|Overall Study|Withdrawal by Subject|3
6832274|NCT00185640|10836412|FG000|Overall Study|Death|138
6832275|NCT00185731|10836424|FG000|Overall Study|Withdrawal by Subject|1
6832276|NCT00185731|10836424|FG000|Overall Study|Not Eligible|1
6832277|NCT00185965|10836441|FG000|Overall Study|Adverse Event|0
6832278|NCT00185965|10836442|FG001|Overall Study|Adverse Event|1
7063412|NCT01949051|11161763|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0
6832279|NCT00186043|10836460|FG000|Overall Study|Lack of Efficacy|1
6832280|NCT00186043|10836461|FG001|Overall Study|Lack of Efficacy|3
6832281|NCT00186043|10836460|FG000|Overall Study|Lost to Follow-up|4
6832282|NCT00186043|10836461|FG001|Overall Study|Lost to Follow-up|6
6832283|NCT00186043|10836460|FG000|Overall Study|Withdrawal by Subject|1
6832284|NCT00186043|10836461|FG001|Overall Study|Withdrawal by Subject|0
6832285|NCT00186043|10836460|FG000|Overall Study|Adverse Event|7
6832286|NCT00186043|10836461|FG001|Overall Study|Adverse Event|3
6832287|NCT00186043|10836460|FG000|Overall Study|Protocol Violation|2
6832288|NCT00186043|10836461|FG001|Overall Study|Protocol Violation|1
7063413|NCT01949051|11161764|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0
7063414|NCT01949051|11161765|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0
6832289|NCT00186121|10836485|FG000|Overall Study|Subject withdrawal (no treatment)|1
6832290|NCT00186121|10836485|FG000|Overall Study|Underwent oophorectomy (no treatment)|1
7063415|NCT01949051|11161766|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1
6832291|NCT00186121|10836485|FG000|Overall Study|Not eligible (no treatment)|1
6832292|NCT00186186|10836489|FG000|Overall Study|Lack of Efficacy|3
6832293|NCT00186186|10836489|FG000|Overall Study|Withdrawal by Subject|3
6832294|NCT00186186|10836489|FG000|Overall Study|Not reported as to reason|2
6832295|NCT00186485|10836500|FG000|Overall Study|Lost to Follow-up|3
6832296|NCT00186537|10836516|FG000|Overall Study|Withdrawal by Subject|4
6832297|NCT00186537|10836517|FG001|Overall Study|Withdrawal by Subject|0
6832298|NCT00186537|10836518|FG002|Overall Study|Withdrawal by Subject|3
6832299|NCT00186537|10836516|FG000|Overall Study|ALT > 1.5 x ULN|3
6832300|NCT00186537|10836517|FG001|Overall Study|ALT > 1.5 x ULN|0
6832301|NCT00186537|10836518|FG002|Overall Study|ALT > 1.5 x ULN|0
6832302|NCT00186628|10836526|FG000|Overall Study|Death|2
6832303|NCT00186628|10836526|FG000|Overall Study|Withdrawal by subject (before treatment)|1
6832304|NCT00186901|10836545|FG000|Overall Study|Pregnancy|6
6832305|NCT00186901|10836546|FG001|Overall Study|Pregnancy|3
6832306|NCT00186901|10836547|FG002|Overall Study|Pregnancy|0
6832307|NCT00186901|10836545|FG000|Overall Study|Lost to Follow-up|6
6832308|NCT00186901|10836546|FG001|Overall Study|Lost to Follow-up|3
6832309|NCT00186901|10836547|FG002|Overall Study|Lost to Follow-up|0
6832310|NCT00186901|10836545|FG000|Overall Study|Bone Mineral Density dropped > 5%|9
6832311|NCT00186901|10836546|FG001|Overall Study|Bone Mineral Density dropped > 5%|7
6832312|NCT00186901|10836547|FG002|Overall Study|Bone Mineral Density dropped > 5%|0
6832313|NCT00186901|10836545|FG000|Overall Study|ALL relapse or second malignancy|1
6832314|NCT00186901|10836546|FG001|Overall Study|ALL relapse or second malignancy|2
6832315|NCT00186901|10836547|FG002|Overall Study|ALL relapse or second malignancy|0
6832316|NCT00186901|10836545|FG000|Overall Study|Withdrawal by Subject|4
6832317|NCT00186901|10836546|FG001|Overall Study|Withdrawal by Subject|5
6832318|NCT00186901|10836547|FG002|Overall Study|Withdrawal by Subject|0
6832319|NCT00186901|10836545|FG000|Overall Study|Open label|3
6832320|NCT00186901|10836546|FG001|Overall Study|Open label|2
6832321|NCT00186901|10836547|FG002|Overall Study|Open label|0
6832322|NCT00186901|10836545|FG000|Overall Study|Limited adherence to study requirements|20
6832323|NCT00186901|10836546|FG001|Overall Study|Limited adherence to study requirements|23
6832324|NCT00186901|10836547|FG002|Overall Study|Limited adherence to study requirements|0
6832325|NCT00186901|10836545|FG000|Overall Study|Bone Mineral Density > 0|0
6832326|NCT00186901|10836546|FG001|Overall Study|Bone Mineral Density > 0|0
6832327|NCT00186901|10836547|FG002|Overall Study|Bone Mineral Density > 0|149
6832328|NCT00187096|10836587|FG000|Overall Study|unacceptable toxicity|0
6832329|NCT00187096|10836588|FG001|Overall Study|unacceptable toxicity|0
6832330|NCT00187096|10836589|FG002|Overall Study|unacceptable toxicity|1
6832331|NCT00187135|10836603|FG000|Visit One|Withdrawal by Subject|1
6832332|NCT00187135|10836604|FG001|Visit One|Withdrawal by Subject|0
6832333|NCT00187135|10836605|FG002|Visit One|Withdrawal by Subject|0
6832334|NCT00187135|10836606|FG003|Visit One|Withdrawal by Subject|0
6832335|NCT00187135|10836607|FG004|Visit One|Withdrawal by Subject|0
6832336|NCT00187135|10836608|FG005|Visit One|Withdrawal by Subject|1
6832337|NCT00187135|10836603|FG000|Visit One|Physician Decision|3
6832338|NCT00187135|10836604|FG001|Visit One|Physician Decision|1
6832339|NCT00187135|10836605|FG002|Visit One|Physician Decision|0
6832340|NCT00187135|10836606|FG003|Visit One|Physician Decision|0
6832341|NCT00187135|10836607|FG004|Visit One|Physician Decision|0
6832342|NCT00187135|10836608|FG005|Visit One|Physician Decision|1
6832343|NCT00187135|10836603|FG000|Visit Two|Death|0
6832344|NCT00187135|10836604|FG001|Visit Two|Death|0
6832345|NCT00187135|10836605|FG002|Visit Two|Death|0
6832346|NCT00187135|10836606|FG003|Visit Two|Death|1
6832347|NCT00187135|10836607|FG004|Visit Two|Death|0
6832348|NCT00187135|10836608|FG005|Visit Two|Death|1
6832349|NCT00187135|10836603|FG000|Visit Two|Physician Decision|1
6832350|NCT00187135|10836604|FG001|Visit Two|Physician Decision|0
6832351|NCT00187135|10836605|FG002|Visit Two|Physician Decision|0
6832352|NCT00187135|10836606|FG003|Visit Two|Physician Decision|0
6832353|NCT00187135|10836607|FG004|Visit Two|Physician Decision|0
6832354|NCT00187135|10836608|FG005|Visit Two|Physician Decision|0
6832355|NCT00187135|10836603|FG000|Visit Two|Withdrawal by Subject|1
6832356|NCT00187135|10836604|FG001|Visit Two|Withdrawal by Subject|1
6832357|NCT00187135|10836605|FG002|Visit Two|Withdrawal by Subject|1
6832358|NCT00187135|10836606|FG003|Visit Two|Withdrawal by Subject|0
6832359|NCT00187135|10836607|FG004|Visit Two|Withdrawal by Subject|1
6832360|NCT00187135|10836608|FG005|Visit Two|Withdrawal by Subject|1
6832361|NCT00187135|10836603|FG000|Visit Two|Study Discontinued|3
6832362|NCT00187135|10836604|FG001|Visit Two|Study Discontinued|2
6832363|NCT00187135|10836605|FG002|Visit Two|Study Discontinued|1
6832364|NCT00187135|10836606|FG003|Visit Two|Study Discontinued|7
6832365|NCT00187135|10836607|FG004|Visit Two|Study Discontinued|5
6832366|NCT00187135|10836608|FG005|Visit Two|Study Discontinued|6
6832367|NCT00187135|10836603|FG000|Visit Three|Death|0
6832368|NCT00187135|10836604|FG001|Visit Three|Death|0
6832369|NCT00187135|10836605|FG002|Visit Three|Death|1
6832370|NCT00187135|10836606|FG003|Visit Three|Death|0
6832371|NCT00187135|10836607|FG004|Visit Three|Death|1
6832372|NCT00187135|10836608|FG005|Visit Three|Death|0
6832373|NCT00187135|10836603|FG000|Visit Three|Withdrawal by Subject|0
6832374|NCT00187135|10836604|FG001|Visit Three|Withdrawal by Subject|1
6832375|NCT00187135|10836605|FG002|Visit Three|Withdrawal by Subject|1
6832376|NCT00187135|10836606|FG003|Visit Three|Withdrawal by Subject|2
6832377|NCT00187135|10836607|FG004|Visit Three|Withdrawal by Subject|0
6832378|NCT00187135|10836608|FG005|Visit Three|Withdrawal by Subject|0
6832379|NCT00187135|10836603|FG000|Visit Three|Study Discontinued|7
6832380|NCT00187135|10836604|FG001|Visit Three|Study Discontinued|6
6832381|NCT00187135|10836605|FG002|Visit Three|Study Discontinued|7
6832382|NCT00187135|10836606|FG003|Visit Three|Study Discontinued|7
6832383|NCT00187135|10836607|FG004|Visit Three|Study Discontinued|7
6832384|NCT00187135|10836608|FG005|Visit Three|Study Discontinued|6
6832385|NCT00187278|10836633|FG000|Overall Study|Protocol Violation|10
6832386|NCT00187278|10836634|FG001|Overall Study|Protocol Violation|13
6832387|NCT00187486|10836657|FG000|Overall Study|Protocol Violation|1
6925329|NCT00831181|10955362|FG000|Overall Study|Adverse Event|12
6925330|NCT00831233|10955369|FG000|Overall Study|Adverse Event|0
6925331|NCT00831233|10955370|FG001|Overall Study|Adverse Event|1
6925332|NCT00831233|10955369|FG000|Overall Study|Protocol Violation|1
6925333|NCT00831233|10955370|FG001|Overall Study|Protocol Violation|0
6925334|NCT00831233|10955369|FG000|Overall Study|Selection Criteria Not Met|2
6925335|NCT00831233|10955370|FG001|Overall Study|Selection Criteria Not Met|0
6925336|NCT00831311|10955395|FG000|Overall Study|Definitive Contraindication|3
6925337|NCT00831311|10955396|FG001|Overall Study|Definitive Contraindication|3
6925338|NCT00831311|10955395|FG000|Overall Study|Lost to Follow-up|3
6925339|NCT00831311|10955396|FG001|Overall Study|Lost to Follow-up|0
6925340|NCT00831311|10955395|FG000|Overall Study|Physician Decision|0
6925341|NCT00831311|10955396|FG001|Overall Study|Physician Decision|1
6925342|NCT00831311|10955395|FG000|Overall Study|Withdrawal by Subject|6
6925343|NCT00831311|10955396|FG001|Overall Study|Withdrawal by Subject|4
6925344|NCT00831389|10955405|FG000|Overall Study|Withdrawal by Subject|0
6925345|NCT00831389|10955406|FG001|Overall Study|Withdrawal by Subject|1
6925346|NCT00831415|10955412|FG000|Overall Study|Adverse Event|14
6925347|NCT00831415|10955412|FG000|Overall Study|Failed to return|3
6925348|NCT00831415|10955412|FG000|Overall Study|Physician Decision|6
6925349|NCT00831415|10955412|FG000|Overall Study|Lost to Follow-up|9
6925350|NCT00831415|10955412|FG000|Overall Study|Protocol Violation|3
6925351|NCT00831415|10955412|FG000|Overall Study|Withdrawal by Subject|35
6925352|NCT00831415|10955412|FG000|Overall Study|Unsatisfactory response - Efficacy|4
6925353|NCT00831415|10955412|FG000|Overall Study|Death|1
6925354|NCT00831441|10955422|FG000|Randomized|Death|82
6925355|NCT00831441|10955423|FG001|Randomized|Death|81
6925356|NCT00831441|10955422|FG000|Randomized|Adverse Event|248
6925357|NCT00831441|10955423|FG001|Randomized|Adverse Event|321
6925358|NCT00831441|10955422|FG000|Randomized|Emergency procedure|2
6925359|NCT00831441|10955423|FG001|Randomized|Emergency procedure|2
6925360|NCT00831441|10955422|FG000|Randomized|Elective procedure|26
6925361|NCT00831441|10955423|FG001|Randomized|Elective procedure|25
6925362|NCT00831441|10955422|FG000|Randomized|Physician Decision|26
6925363|NCT00831441|10955423|FG001|Randomized|Physician Decision|35
6925364|NCT00831441|10955422|FG000|Randomized|No longer met criteria|13
6925365|NCT00831441|10955423|FG001|Randomized|No longer met criteria|19
6925366|NCT00831441|10955422|FG000|Randomized|Withdrawal by Subject|178
6925367|NCT00831441|10955423|FG001|Randomized|Withdrawal by Subject|212
6925368|NCT00831441|10955422|FG000|Randomized|Lost to Follow-up|26
6925369|NCT00831441|10955423|FG001|Randomized|Lost to Follow-up|35
6925370|NCT00831441|10955422|FG000|Randomized|Administrative reason by sponsor|2780
6925371|NCT00831441|10955423|FG001|Randomized|Administrative reason by sponsor|2671
6925372|NCT00831441|10955422|FG000|Randomized|poor/non-compliance|30
6925373|NCT00831441|10955423|FG001|Randomized|poor/non-compliance|38
6925374|NCT00831441|10955422|FG000|Randomized|non-specified|276
6925375|NCT00831441|10955423|FG001|Randomized|non-specified|266
6925376|NCT00831441|10955422|FG000|Follow Up (30 Days)|Withdrawal by Subject|41
6925377|NCT00831441|10955423|FG001|Follow Up (30 Days)|Withdrawal by Subject|34
6925378|NCT00831441|10955422|FG000|Follow Up (30 Days)|Lost to Follow-up|13
6925379|NCT00831441|10955423|FG001|Follow Up (30 Days)|Lost to Follow-up|27
6925380|NCT00831441|10955422|FG000|Follow Up (30 Days)|Death|63
6925381|NCT00831441|10955423|FG001|Follow Up (30 Days)|Death|86
6925382|NCT00831441|10955422|FG000|Follow Up (30 Days)|non-specified|16
6925383|NCT00831441|10955423|FG001|Follow Up (30 Days)|non-specified|26
6925384|NCT00831441|10955422|FG000|Follow Up (30 Days)|missing end of study status|0
6925385|NCT00831441|10955423|FG001|Follow Up (30 Days)|missing end of study status|1
6925386|NCT00831493|10955434|FG000|Overall Study|Intractable nausea and vomiting|1
6925387|NCT00831701|10955449|FG000|Overall Study|Withdrawal by Subject|2
6925388|NCT00831701|10955450|FG001|Overall Study|Withdrawal by Subject|0
6925389|NCT00831701|10955449|FG000|Overall Study|Stone expulsion before first medication|2
6925390|NCT00831701|10955450|FG001|Overall Study|Stone expulsion before first medication|2
6925391|NCT00831701|10955449|FG000|Overall Study|Lost to Follow-up|1
6925392|NCT00831701|10955450|FG001|Overall Study|Lost to Follow-up|3
6925393|NCT00831779|10955477|FG000|Overall Study|Lost to Follow-up|1
6925394|NCT00831779|10955478|FG001|Overall Study|Lost to Follow-up|0
6925395|NCT00831779|10955477|FG000|Overall Study|No longer met criteria|0
6925396|NCT00831779|10955478|FG001|Overall Study|No longer met criteria|1
6925397|NCT00831792|10955484|FG000|Overall Study|Not Eligible|3
6925398|NCT00831792|10955484|FG000|Overall Study|Adverse Event|1
6832388|NCT00187889|10836697|FG000|Overall Study|Withdrawal by Subject|6
6832389|NCT00187889|10836698|FG001|Overall Study|Withdrawal by Subject|4
6925399|NCT00831792|10955484|FG000|Overall Study|Death|1
6925400|NCT00831792|10955484|FG000|Overall Study|Lack of Efficacy|1
6925401|NCT00831844|10955498|FG000|Overall Study|Adverse Event|2
6925402|NCT00831844|10955499|FG001|Overall Study|Adverse Event|0
6925403|NCT00831844|10955500|FG002|Overall Study|Adverse Event|0
6832390|NCT00189202|10836725|FG000|Overall Study|Physician Decision|5
6832391|NCT00189306|10836733|FG000|Treatment Period|Withdrawal by Subject|2
6832392|NCT00189306|10836733|FG000|Treatment Period|Adverse Event|2
6832393|NCT00189306|10836733|FG000|Treatment Period|Protocol Violation|1
6832394|NCT00189306|10836733|FG000|Posttreatment Period|Death|1
6925404|NCT00831844|10955501|FG003|Overall Study|Adverse Event|0
6925405|NCT00831844|10955502|FG004|Overall Study|Adverse Event|1
6925406|NCT00831844|10955503|FG005|Overall Study|Adverse Event|1
6925407|NCT00831844|10955504|FG006|Overall Study|Adverse Event|2
6925408|NCT00831844|10955505|FG007|Overall Study|Adverse Event|0
6925409|NCT00831844|10955506|FG008|Overall Study|Adverse Event|0
6925410|NCT00831844|10955507|FG009|Overall Study|Adverse Event|0
6925411|NCT00831844|10955498|FG000|Overall Study|Death|0
6925412|NCT00831844|10955499|FG001|Overall Study|Death|0
6925413|NCT00831844|10955500|FG002|Overall Study|Death|0
6925414|NCT00831844|10955501|FG003|Overall Study|Death|1
6925415|NCT00831844|10955502|FG004|Overall Study|Death|0
6925416|NCT00831844|10955503|FG005|Overall Study|Death|0
6925417|NCT00831844|10955504|FG006|Overall Study|Death|0
6925418|NCT00831844|10955505|FG007|Overall Study|Death|0
6925419|NCT00831844|10955506|FG008|Overall Study|Death|0
6925420|NCT00831844|10955507|FG009|Overall Study|Death|0
6925421|NCT00831844|10955498|FG000|Overall Study|Lack of Efficacy|8
6925422|NCT00831844|10955499|FG001|Overall Study|Lack of Efficacy|10
6925423|NCT00831844|10955500|FG002|Overall Study|Lack of Efficacy|15
6925424|NCT00831844|10955501|FG003|Overall Study|Lack of Efficacy|8
6925425|NCT00831844|10955502|FG004|Overall Study|Lack of Efficacy|11
6925426|NCT00831844|10955503|FG005|Overall Study|Lack of Efficacy|17
6925427|NCT00831844|10955504|FG006|Overall Study|Lack of Efficacy|8
6925428|NCT00831844|10955505|FG007|Overall Study|Lack of Efficacy|9
6925429|NCT00831844|10955506|FG008|Overall Study|Lack of Efficacy|7
6925430|NCT00831844|10955507|FG009|Overall Study|Lack of Efficacy|0
6925431|NCT00831844|10955498|FG000|Overall Study|Physician Decision|0
6925432|NCT00831844|10955499|FG001|Overall Study|Physician Decision|1
6925433|NCT00831844|10955500|FG002|Overall Study|Physician Decision|3
6925434|NCT00831844|10955501|FG003|Overall Study|Physician Decision|1
6925435|NCT00831844|10955502|FG004|Overall Study|Physician Decision|1
6925436|NCT00831844|10955503|FG005|Overall Study|Physician Decision|1
6925437|NCT00831844|10955504|FG006|Overall Study|Physician Decision|0
6925438|NCT00831844|10955505|FG007|Overall Study|Physician Decision|0
6925439|NCT00831844|10955506|FG008|Overall Study|Physician Decision|1
6925440|NCT00831844|10955507|FG009|Overall Study|Physician Decision|0
6925441|NCT00831844|10955498|FG000|Overall Study|Withdrawal by Subject|0
6925442|NCT00831844|10955499|FG001|Overall Study|Withdrawal by Subject|0
6925443|NCT00831844|10955500|FG002|Overall Study|Withdrawal by Subject|1
6925444|NCT00831844|10955501|FG003|Overall Study|Withdrawal by Subject|0
6925445|NCT00831844|10955502|FG004|Overall Study|Withdrawal by Subject|0
6925446|NCT00831844|10955503|FG005|Overall Study|Withdrawal by Subject|0
6925447|NCT00831844|10955504|FG006|Overall Study|Withdrawal by Subject|0
6925448|NCT00831844|10955505|FG007|Overall Study|Withdrawal by Subject|1
6925449|NCT00831844|10955506|FG008|Overall Study|Withdrawal by Subject|1
6925450|NCT00831844|10955507|FG009|Overall Study|Withdrawal by Subject|0
6925451|NCT00831844|10955498|FG000|Overall Study|Ineligible|0
6925452|NCT00831844|10955499|FG001|Overall Study|Ineligible|1
6925453|NCT00831844|10955500|FG002|Overall Study|Ineligible|1
6925454|NCT00831844|10955501|FG003|Overall Study|Ineligible|0
6925455|NCT00831844|10955502|FG004|Overall Study|Ineligible|1
6925456|NCT00831844|10955503|FG005|Overall Study|Ineligible|0
6925457|NCT00831844|10955504|FG006|Overall Study|Ineligible|0
6925458|NCT00831844|10955505|FG007|Overall Study|Ineligible|0
6925459|NCT00831844|10955506|FG008|Overall Study|Ineligible|0
6925460|NCT00831844|10955507|FG009|Overall Study|Ineligible|0
7063416|NCT01949051|11161761|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0
7039016|NCT01707992|11121598|FG002|Active Treatment Phase (24 Months)|Noncompliance|0
7039017|NCT01707992|11121599|FG003|Active Treatment Phase (24 Months)|Noncompliance|0
7039018|NCT01707992|11121600|FG004|Active Treatment Phase (24 Months)|Noncompliance|4
7039019|NCT01707992|11121601|FG005|Active Treatment Phase (24 Months)|Noncompliance|2
7039020|NCT01707992|11121596|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
7039021|NCT01707992|11121597|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
7063417|NCT01949051|11161762|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1
7063418|NCT01949051|11161763|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0
7063419|NCT01949051|11161764|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0
7063420|NCT01949051|11161765|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0
6925461|NCT00832000|10955538|FG000|Overall Study|Adverse Event|2
6925462|NCT00832000|10955539|FG001|Overall Study|Adverse Event|0
6925463|NCT00832000|10955538|FG000|Overall Study|Withdrawal by Subject|1
6925464|NCT00832000|10955539|FG001|Overall Study|Withdrawal by Subject|0
6925465|NCT00832000|10955538|FG000|Overall Study|No calls to IVR in either period|1
6925466|NCT00832000|10955539|FG001|Overall Study|No calls to IVR in either period|1
6925467|NCT00832000|10955538|FG000|Overall Study|No calls to IVR in period 2|2
6925468|NCT00832000|10955539|FG001|Overall Study|No calls to IVR in period 2|0
6925469|NCT00832078|10955574|FG000|Test Day 1-2 Period|Lack of Efficacy|0
6925470|NCT00832078|10955575|FG001|Test Day 1-2 Period|Lack of Efficacy|2
6925471|NCT00832078|10955574|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1
6925472|NCT00832078|10955575|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0
7063421|NCT01949051|11161766|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0
7063422|NCT01949051|11161761|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
7063423|NCT01949051|11161762|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
7063424|NCT01949051|11161763|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1
7063425|NCT01949051|11161764|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
7063426|NCT01949051|11161765|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
7039022|NCT01707992|11121598|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
7039023|NCT01707992|11121599|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809
7063427|NCT01949051|11161766|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
7063428|NCT01949090|11161779|FG000|Overall Study|Serious Adverse Event|0
7063429|NCT01949090|11161780|FG001|Overall Study|Serious Adverse Event|1
7063430|NCT01949090|11161781|FG002|Overall Study|Serious Adverse Event|2
7063431|NCT01949090|11161782|FG003|Overall Study|Serious Adverse Event|0
7063432|NCT01949090|11161783|FG004|Overall Study|Serious Adverse Event|1
7063433|NCT01949090|11161779|FG000|Overall Study|Withdrawal by Subject|2
7063434|NCT01949090|11161780|FG001|Overall Study|Withdrawal by Subject|0
7063435|NCT01949090|11161781|FG002|Overall Study|Withdrawal by Subject|0
7063436|NCT01949090|11161782|FG003|Overall Study|Withdrawal by Subject|0
7063437|NCT01949090|11161783|FG004|Overall Study|Withdrawal by Subject|1
7063438|NCT01949090|11161779|FG000|Overall Study|Protocol non-compliance|0
6832395|NCT00189306|10836733|FG000|Posttreatment Period|Withdrawal by Subject|2
6832396|NCT00189306|10836733|FG000|Posttreatment Period|Noncompliance|1
6832397|NCT00189306|10836733|FG000|Posttreatment Period|Target lesion excised|1
6832398|NCT00189306|10836733|FG000|Posttreatment Period|Protocol Violation|1
6832399|NCT00189306|10836733|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5
6832400|NCT00189306|10836733|FG000|Posttreatment Period|Local skin reaction/sign|1
6832401|NCT00189306|10836733|FG000|Long-Term Follow-up|Adverse Event|2
6832402|NCT00189306|10836733|FG000|Long-Term Follow-up|Death|4
6832403|NCT00189306|10836733|FG000|Long-Term Follow-up|Withdrawal by Subject|1
6832404|NCT00189306|10836733|FG000|Long-Term Follow-up|Intercurrent disease|2
6832405|NCT00189306|10836733|FG000|Long-Term Follow-up|Lost to Follow-up|9
6832406|NCT00189306|10836733|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20
6832407|NCT00189423|10836739|FG000|Overall Study|Death|746
6832408|NCT00189423|10836740|FG001|Overall Study|Death|747
6832409|NCT00189423|10836739|FG000|Overall Study|Withdrawal by Subject|9
6832410|NCT00189423|10836740|FG001|Overall Study|Withdrawal by Subject|9
6832411|NCT00189423|10836739|FG000|Overall Study|Lost to Follow-up|10
6832412|NCT00189423|10836740|FG001|Overall Study|Lost to Follow-up|10
6832413|NCT00189462|10836757|FG000|Overall Study|Lack of Efficacy|5
6832414|NCT00189462|10836758|FG001|Overall Study|Lack of Efficacy|1
6832415|NCT00189462|10836757|FG000|Overall Study|Lost to Follow-up|18
6832416|NCT00189462|10836758|FG001|Overall Study|Lost to Follow-up|20
6832417|NCT00189488|10836775|FG000|Overall Study|Ineligibility determined|1
6832418|NCT00189488|10836776|FG001|Overall Study|Ineligibility determined|0
6832419|NCT00189488|10836775|FG000|Overall Study|Protocol deviation|2
6832420|NCT00189488|10836776|FG001|Overall Study|Protocol deviation|1
6832421|NCT00189488|10836775|FG000|Overall Study|Adverse Event|2
6832422|NCT00189488|10836776|FG001|Overall Study|Adverse Event|1
6832423|NCT00189488|10836775|FG000|Overall Study|Withdrawal by Subject|2
6832424|NCT00189488|10836776|FG001|Overall Study|Withdrawal by Subject|6
6832425|NCT00189488|10836775|FG000|Overall Study|Disease progression|2
6832426|NCT00189488|10836776|FG001|Overall Study|Disease progression|4
6832427|NCT00189488|10836775|FG000|Overall Study|Administrative Decision|0
6832428|NCT00189488|10836776|FG001|Overall Study|Administrative Decision|2
6832429|NCT00189488|10836775|FG000|Overall Study|Death|5
6832430|NCT00189488|10836776|FG001|Overall Study|Death|8
6832431|NCT00189488|10836775|FG000|Overall Study|Other|1
6832432|NCT00189488|10836776|FG001|Overall Study|Other|0
6832433|NCT00189540|10836785|FG000|Overall Study|Withdrawal by Subject|3
6832434|NCT00189540|10836786|FG001|Overall Study|Withdrawal by Subject|0
6832435|NCT00189540|10836785|FG000|Overall Study|Death|4
6832436|NCT00189540|10836786|FG001|Overall Study|Death|1
6832437|NCT00190671|10836794|FG000|Overall Study|Satisfactory Response|4
6832438|NCT00190671|10836795|FG001|Overall Study|Satisfactory Response|7
6832439|NCT00190671|10836794|FG000|Overall Study|Lack of Efficacy|19
6832440|NCT00190671|10836795|FG001|Overall Study|Lack of Efficacy|24
6832441|NCT00190671|10836794|FG000|Overall Study|Death from Study Disease|1
7039024|NCT01707992|11121600|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243
7039025|NCT01707992|11121601|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174
6832442|NCT00190671|10836795|FG001|Overall Study|Death from Study Disease|1
6832443|NCT00190671|10836794|FG000|Overall Study|Adverse Event|3
6832444|NCT00190671|10836795|FG001|Overall Study|Adverse Event|2
6832445|NCT00190671|10836794|FG000|Overall Study|Clinical Relapse|0
6832446|NCT00190671|10836795|FG001|Overall Study|Clinical Relapse|1
6832447|NCT00190671|10836794|FG000|Overall Study|Death from Study-Drug Toxicity|0
7039026|NCT01707992|11121596|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
7039027|NCT01707992|11121597|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
7039028|NCT01707992|11121598|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
7039029|NCT01707992|11121599|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
7044766|NCT01757171|11130750|FG001|Overall Study|Adverse Event|1
6832448|NCT00190671|10836795|FG001|Overall Study|Death from Study-Drug Toxicity|2
6832449|NCT00190671|10836794|FG000|Overall Study|Death from Other Causes|0
6832450|NCT00190671|10836795|FG001|Overall Study|Death from Other Causes|2
6832451|NCT00190671|10836794|FG000|Overall Study|Protocol Violation|0
6832452|NCT00190671|10836795|FG001|Overall Study|Protocol Violation|1
6832453|NCT00190671|10836794|FG000|Overall Study|Withdrawal by Subject|0
6832454|NCT00190671|10836795|FG001|Overall Study|Withdrawal by Subject|2
6832455|NCT00190684|10836802|FG000|Overall Study|Adverse Event|86
6832456|NCT00190684|10836802|FG000|Overall Study|Satisfactory response|80
6832457|NCT00190684|10836802|FG000|Overall Study|Lack of efficacy|204
6832458|NCT00190684|10836802|FG000|Overall Study|Lost to Follow-up|232
6832459|NCT00190684|10836802|FG000|Overall Study|Patient moved|60
6832460|NCT00190684|10836802|FG000|Overall Study|Patient Decision|432
6832461|NCT00190684|10836802|FG000|Overall Study|Clinical relapse|67
6832462|NCT00190684|10836802|FG000|Overall Study|Sponsor's decision|17
6832463|NCT00190684|10836802|FG000|Overall Study|Physician Decision|84
6832464|NCT00190684|10836802|FG000|Overall Study|Protocol Violation|123
6832465|NCT00190684|10836802|FG000|Overall Study|Study Period III Completed|103
6832466|NCT00190684|10836802|FG000|Overall Study|Study Period V Completed|1
6832467|NCT00190749|10836808|FG000|Overall Study|Lost to Follow-up|8
6832468|NCT00190749|10836809|FG001|Overall Study|Lost to Follow-up|11
6832469|NCT00190749|10836808|FG000|Overall Study|Withdrawal by Subject|10
6832470|NCT00190749|10836809|FG001|Overall Study|Withdrawal by Subject|6
6832471|NCT00190749|10836808|FG000|Overall Study|Protocol Violation|5
6832472|NCT00190749|10836809|FG001|Overall Study|Protocol Violation|4
6832473|NCT00190749|10836808|FG000|Overall Study|Adverse Event|0
6832474|NCT00190749|10836809|FG001|Overall Study|Adverse Event|5
6832475|NCT00190749|10836808|FG000|Overall Study|Lack of Efficacy|2
6832476|NCT00190749|10836809|FG001|Overall Study|Lack of Efficacy|3
6832477|NCT00190749|10836808|FG000|Overall Study|Reason Not Specified|0
6832478|NCT00190749|10836809|FG001|Overall Study|Reason Not Specified|2
6832479|NCT00190749|10836808|FG000|Overall Study|Sponsor Decision|1
6832480|NCT00190749|10836809|FG001|Overall Study|Sponsor Decision|0
6832481|NCT00190775|10836817|FG000|Overall Study|Adverse Event|57
6832482|NCT00190775|10836818|FG001|Overall Study|Adverse Event|22
6832483|NCT00190775|10836817|FG000|Overall Study|Satisfactory Response|1
6832484|NCT00190775|10836818|FG001|Overall Study|Satisfactory Response|0
6832485|NCT00190775|10836817|FG000|Overall Study|Lack of Efficacy|28
6832486|NCT00190775|10836818|FG001|Overall Study|Lack of Efficacy|32
6832487|NCT00190775|10836817|FG000|Overall Study|Lost to Follow-up|31
6832488|NCT00190775|10836818|FG001|Overall Study|Lost to Follow-up|23
6832489|NCT00190775|10836817|FG000|Overall Study|Participant Moved|0
6832490|NCT00190775|10836818|FG001|Overall Study|Participant Moved|1
6832491|NCT00190775|10836817|FG000|Overall Study|Withdrawal by Subject|24
6832492|NCT00190775|10836818|FG001|Overall Study|Withdrawal by Subject|13
6832493|NCT00190775|10836817|FG000|Overall Study|Sponsor Decision|1
6832494|NCT00190775|10836818|FG001|Overall Study|Sponsor Decision|0
6832495|NCT00190775|10836817|FG000|Overall Study|Physician Decision|3
6832496|NCT00190775|10836818|FG001|Overall Study|Physician Decision|0
6832497|NCT00190775|10836817|FG000|Overall Study|Noncompliance|3
6832498|NCT00190775|10836818|FG001|Overall Study|Noncompliance|5
6832499|NCT00190775|10836817|FG000|Overall Study|Protocol Violation|0
6832500|NCT00190775|10836818|FG001|Overall Study|Protocol Violation|1
6832501|NCT00190775|10836817|FG000|Overall Study|Exclusion Criteria Met|1
6832502|NCT00190775|10836818|FG001|Overall Study|Exclusion Criteria Met|3
6832503|NCT00190983|10836831|FG000|Overall Study|Inevaluable (never treated)|2
6832504|NCT00191100|10836837|FG000|Overall Study|Adverse Event|18
6832505|NCT00191100|10836838|FG001|Overall Study|Adverse Event|1
6832506|NCT00191100|10836837|FG000|Overall Study|Lost to Follow-up|2
6832507|NCT00191100|10836838|FG001|Overall Study|Lost to Follow-up|0
6832508|NCT00191100|10836837|FG000|Overall Study|Patient Moved|0
6832509|NCT00191100|10836838|FG001|Overall Study|Patient Moved|1
6832510|NCT00191100|10836837|FG000|Overall Study|Withdrawal by Subject|9
6832511|NCT00191100|10836838|FG001|Overall Study|Withdrawal by Subject|3
6832512|NCT00191100|10836837|FG000|Overall Study|Protocol Entry Criteria Not Met|2
6832513|NCT00191100|10836838|FG001|Overall Study|Protocol Entry Criteria Not Met|1
6832514|NCT00191100|10836837|FG000|Overall Study|Clinical Relapse|2
6832515|NCT00191100|10836838|FG001|Overall Study|Clinical Relapse|1
6832516|NCT00191100|10836837|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1
6832517|NCT00191100|10836838|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2
6832518|NCT00191100|10836837|FG000|Overall Study|Lack of Efficacy, Stable Disease|1
6832519|NCT00191100|10836838|FG001|Overall Study|Lack of Efficacy, Stable Disease|0
6832520|NCT00191100|10836837|FG000|Overall Study|Physician Decision|3
6832521|NCT00191100|10836838|FG001|Overall Study|Physician Decision|1
6832522|NCT00191100|10836837|FG000|Overall Study|Death from Study Drug Toxicity|2
6832523|NCT00191100|10836838|FG001|Overall Study|Death from Study Drug Toxicity|0
6832524|NCT00191100|10836837|FG000|Overall Study|Protocol Violation|1
6832525|NCT00191100|10836838|FG001|Overall Study|Protocol Violation|1
6832526|NCT00191100|10836837|FG000|Overall Study|Death from Other Cause|1
6832527|NCT00191100|10836838|FG001|Overall Study|Death from Other Cause|0
6832528|NCT00191100|10836837|FG000|Overall Study|Reason Not Specified|0
6832529|NCT00191100|10836838|FG001|Overall Study|Reason Not Specified|1
6832530|NCT00191113|10836846|FG000|Core Study|Withdrawal by Subject|25
6832531|NCT00191113|10836847|FG001|Core Study|Withdrawal by Subject|9
6832532|NCT00191113|10836846|FG000|Core Study|Protocol Violation|6
6832533|NCT00191113|10836847|FG001|Core Study|Protocol Violation|2
6832534|NCT00191113|10836846|FG000|Core Study|Lost to Follow-up|3
6832535|NCT00191113|10836847|FG001|Core Study|Lost to Follow-up|0
6832536|NCT00191113|10836846|FG000|Core Study|Adverse Event|0
6832537|NCT00191113|10836847|FG001|Core Study|Adverse Event|2
6832538|NCT00191113|10836846|FG000|Core Study|Lack of Efficacy|0
6832539|NCT00191113|10836847|FG001|Core Study|Lack of Efficacy|2
6832540|NCT00191113|10836846|FG000|Core Study|Death|1
6832541|NCT00191113|10836847|FG001|Core Study|Death|0
6832542|NCT00191139|10836861|FG000|Overall Study|Adverse Event|2
6832543|NCT00191139|10836862|FG001|Overall Study|Adverse Event|6
6832544|NCT00191139|10836861|FG000|Overall Study|Death|2
6832545|NCT00191139|10836862|FG001|Overall Study|Death|0
6832546|NCT00191139|10836861|FG000|Overall Study|Withdrawal by Subject|0
6832547|NCT00191139|10836862|FG001|Overall Study|Withdrawal by Subject|3
6832548|NCT00191139|10836861|FG000|Overall Study|Disease Progression|0
6832549|NCT00191139|10836862|FG001|Overall Study|Disease Progression|1
6832550|NCT00191139|10836861|FG000|Overall Study|Other|1
6832551|NCT00191139|10836862|FG001|Overall Study|Other|2
6832552|NCT00191152|10836870|FG000|Initial Treatment|Adverse Event|43
6832553|NCT00191152|10836871|FG001|Initial Treatment|Adverse Event|67
6832554|NCT00191152|10836870|FG000|Initial Treatment|Physician Decision|40
6832555|NCT00191152|10836871|FG001|Initial Treatment|Physician Decision|31
6925473|NCT00832091|10955583|FG000|Overall Study|Adverse Event|1
6925474|NCT00832091|10955584|FG001|Overall Study|Adverse Event|1
6925475|NCT00832091|10955583|FG000|Overall Study|Protocol Violation|1
6925476|NCT00832091|10955584|FG001|Overall Study|Protocol Violation|0
6925477|NCT00832091|10955583|FG000|Overall Study|Withdrawal by Subject|2
6925478|NCT00832091|10955584|FG001|Overall Study|Withdrawal by Subject|1
6925479|NCT00832091|10955583|FG000|Overall Study|Prohibited Medication|1
6925480|NCT00832091|10955584|FG001|Overall Study|Prohibited Medication|0
6925481|NCT00832117|10955592|FG000|Overall Study|Death|1
6925482|NCT00832117|10955592|FG000|Overall Study|Disease Progression|11
6925483|NCT00832377|10955616|FG000|Overall Study|Protocol Violation|1
6925484|NCT00832416|10955637|FG000|Overall Study|Lack of Efficacy|17
6925485|NCT00832416|10955638|FG001|Overall Study|Lack of Efficacy|15
6925486|NCT00832416|10955639|FG002|Overall Study|Lack of Efficacy|13
6925487|NCT00832416|10955640|FG003|Overall Study|Lack of Efficacy|52
6925488|NCT00832416|10955637|FG000|Overall Study|Withdrawal by Subject|5
6925489|NCT00832416|10955638|FG001|Overall Study|Withdrawal by Subject|7
6925490|NCT00832416|10955639|FG002|Overall Study|Withdrawal by Subject|2
6925491|NCT00832416|10955640|FG003|Overall Study|Withdrawal by Subject|10
6925492|NCT00832416|10955637|FG000|Overall Study|Physician Decision|2
6925493|NCT00832416|10955638|FG001|Overall Study|Physician Decision|12
6925494|NCT00832416|10955639|FG002|Overall Study|Physician Decision|5
6925495|NCT00832416|10955640|FG003|Overall Study|Physician Decision|10
6925496|NCT00832416|10955637|FG000|Overall Study|Administrative|0
6925497|NCT00832416|10955638|FG001|Overall Study|Administrative|0
6925498|NCT00832416|10955639|FG002|Overall Study|Administrative|0
6925499|NCT00832416|10955640|FG003|Overall Study|Administrative|1
6925500|NCT00832416|10955637|FG000|Overall Study|Adverse Event|21
6925501|NCT00832416|10955638|FG001|Overall Study|Adverse Event|19
6925502|NCT00832416|10955639|FG002|Overall Study|Adverse Event|41
6925503|NCT00832416|10955640|FG003|Overall Study|Adverse Event|10
6925504|NCT00832416|10955637|FG000|Overall Study|Death|1
6925505|NCT00832416|10955638|FG001|Overall Study|Death|0
6925506|NCT00832416|10955639|FG002|Overall Study|Death|0
6925507|NCT00832416|10955640|FG003|Overall Study|Death|0
6925508|NCT00832585|10955650|FG000|Overall Study|Withdrawal by Subject|1
6925509|NCT00832585|10955650|FG000|Overall Study|Lost to Follow-up|1
6925510|NCT00832650|10955661|FG000|Overall Study|Randomized but not treated|0
6925511|NCT00832650|10955662|FG001|Overall Study|Randomized but not treated|0
6925512|NCT00832650|10955663|FG002|Overall Study|Randomized but not treated|1
6925513|NCT00832780|10955682|FG000|Overall Study|Death|16
6925514|NCT00832780|10955682|FG000|Overall Study|Lost to Follow-up|4
6925515|NCT00832780|10955682|FG000|Overall Study|no reason given|2
6925516|NCT00832780|10955682|FG000|Overall Study|other complicating condition|2
6925517|NCT00832780|10955682|FG000|Overall Study|Physician Decision|1
6925518|NCT00832819|10955689|FG000|Overall Study|Adverse Event|0
6925519|NCT00832819|10955690|FG001|Overall Study|Adverse Event|1
6832556|NCT00191152|10836870|FG000|Initial Treatment|Withdrawal by Subject|40
6832557|NCT00191152|10836871|FG001|Initial Treatment|Withdrawal by Subject|28
6832558|NCT00191152|10836870|FG000|Initial Treatment|Lost to Follow-up|0
6832559|NCT00191152|10836871|FG001|Initial Treatment|Lost to Follow-up|6
6832560|NCT00191152|10836870|FG000|Initial Treatment|Other|18
6832561|NCT00191152|10836871|FG001|Initial Treatment|Other|21
6925520|NCT00832819|10955691|FG002|Overall Study|Adverse Event|0
6925521|NCT00832819|10955689|FG000|Overall Study|Protocol Violation|0
6925522|NCT00832819|10955690|FG001|Overall Study|Protocol Violation|0
6925523|NCT00832819|10955691|FG002|Overall Study|Protocol Violation|1
6832562|NCT00191152|10836870|FG000|Crossover Treatment|Adverse Event|8
6832563|NCT00191152|10836871|FG001|Crossover Treatment|Adverse Event|8
6832564|NCT00191152|10836870|FG000|Crossover Treatment|Physician Decision|7
6832565|NCT00191152|10836871|FG001|Crossover Treatment|Physician Decision|7
6925524|NCT00832975|10955701|FG000|Overall Study|Lost to Follow-up|7
6925525|NCT00832975|10955701|FG000|Overall Study|Protocol Violation|6
6925526|NCT00832975|10955701|FG000|Overall Study|Death|5
6832566|NCT00191152|10836870|FG000|Crossover Treatment|Withdrawal by Subject|6
6832567|NCT00191152|10836871|FG001|Crossover Treatment|Withdrawal by Subject|9
6832568|NCT00191152|10836870|FG000|Crossover Treatment|Lost to Follow-up|2
6832569|NCT00191152|10836871|FG001|Crossover Treatment|Lost to Follow-up|1
6832570|NCT00191152|10836870|FG000|Crossover Treatment|Other|4
6832571|NCT00191152|10836871|FG001|Crossover Treatment|Other|3
6832572|NCT00191165|10836891|FG000|Overall Study|Adverse Event|2
6832573|NCT00191165|10836892|FG001|Overall Study|Adverse Event|0
6832574|NCT00191165|10836891|FG000|Overall Study|Protocol Violation|0
6832575|NCT00191165|10836892|FG001|Overall Study|Protocol Violation|1
6832576|NCT00191165|10836891|FG000|Overall Study|Participant Moved Away|0
6832577|NCT00191165|10836892|FG001|Overall Study|Participant Moved Away|1
6832578|NCT00191191|10836900|FG000|Overall Study|Entry Criteria Exclusion|2
6832579|NCT00191191|10836901|FG001|Overall Study|Entry Criteria Exclusion|0
6832580|NCT00191191|10836900|FG000|Overall Study|Treated with Another Systemic Agent|1
6832581|NCT00191191|10836901|FG001|Overall Study|Treated with Another Systemic Agent|1
6832582|NCT00191191|10836900|FG000|Overall Study|Adverse Event|11
6832583|NCT00191191|10836901|FG001|Overall Study|Adverse Event|21
6832584|NCT00191191|10836900|FG000|Overall Study|Progressive Disease|84
6832585|NCT00191191|10836901|FG001|Overall Study|Progressive Disease|72
6832586|NCT00191191|10836900|FG000|Overall Study|Toxicity After Dose Reduction|7
6832587|NCT00191191|10836901|FG001|Overall Study|Toxicity After Dose Reduction|8
6832588|NCT00191191|10836900|FG000|Overall Study|Family/Caregiver Decision|5
6832589|NCT00191191|10836901|FG001|Overall Study|Family/Caregiver Decision|7
6832590|NCT00191191|10836900|FG000|Overall Study|Lost to Follow-up|1
6832591|NCT00191191|10836901|FG001|Overall Study|Lost to Follow-up|0
6832592|NCT00191191|10836900|FG000|Overall Study|Physician Decision|3
6832593|NCT00191191|10836901|FG001|Overall Study|Physician Decision|2
6832594|NCT00191191|10836900|FG000|Overall Study|Good Clinical Practice Violation|0
6832595|NCT00191191|10836901|FG001|Overall Study|Good Clinical Practice Violation|1
6832596|NCT00191269|10836909|FG000|Overall Study|Protocol Violation|0
6832597|NCT00191269|10836910|FG001|Overall Study|Protocol Violation|2
6832598|NCT00191269|10836909|FG000|Overall Study|Adverse Event|1
6832599|NCT00191269|10836910|FG001|Overall Study|Adverse Event|4
6832600|NCT00191269|10836909|FG000|Overall Study|Progression of Disease|4
6832601|NCT00191269|10836910|FG001|Overall Study|Progression of Disease|42
6832602|NCT00191269|10836909|FG000|Overall Study|Lack of Efficacy|1
6832603|NCT00191269|10836910|FG001|Overall Study|Lack of Efficacy|5
6832604|NCT00191269|10836909|FG000|Overall Study|Withdrawal by Subject|0
6832605|NCT00191269|10836910|FG001|Overall Study|Withdrawal by Subject|1
6832606|NCT00191269|10836909|FG000|Overall Study|Pathologic Aggrevation|0
6832607|NCT00191269|10836910|FG001|Overall Study|Pathologic Aggrevation|1
6832608|NCT00191269|10836909|FG000|Overall Study|Physician Decision|0
6832609|NCT00191269|10836910|FG001|Overall Study|Physician Decision|3
6832610|NCT00191282|10836919|FG000|Overall Study|Adverse Event|5
6832611|NCT00191282|10836920|FG001|Overall Study|Adverse Event|6
6832612|NCT00191282|10836919|FG000|Overall Study|Death|51
6832613|NCT00191282|10836920|FG001|Overall Study|Death|51
6832614|NCT00191282|10836919|FG000|Overall Study|Lack of Efficacy|11
6832615|NCT00191282|10836920|FG001|Overall Study|Lack of Efficacy|6
6832616|NCT00191282|10836919|FG000|Overall Study|Noncompliance|14
6832617|NCT00191282|10836920|FG001|Overall Study|Noncompliance|17
6832618|NCT00191282|10836919|FG000|Overall Study|Patient moved|11
6832619|NCT00191282|10836920|FG001|Overall Study|Patient moved|14
6832620|NCT00191282|10836919|FG000|Overall Study|Withdrawal by Subject|59
6832621|NCT00191282|10836920|FG001|Overall Study|Withdrawal by Subject|44
6832622|NCT00191282|10836919|FG000|Overall Study|Physician Decision|18
6832623|NCT00191282|10836920|FG001|Overall Study|Physician Decision|15
6832624|NCT00191282|10836919|FG000|Overall Study|Protocol entry criteria not met|14
6832625|NCT00191282|10836920|FG001|Overall Study|Protocol entry criteria not met|9
6832626|NCT00191282|10836919|FG000|Overall Study|Protocol Violation|9
6832627|NCT00191282|10836920|FG001|Overall Study|Protocol Violation|12
6832628|NCT00191282|10836919|FG000|Overall Study|Severity of outcome|2
6832629|NCT00191282|10836920|FG001|Overall Study|Severity of outcome|5
6832630|NCT00191282|10836919|FG000|Overall Study|Sponsor's decision|2
6832631|NCT00191282|10836920|FG001|Overall Study|Sponsor's decision|2
6832632|NCT00191282|10836919|FG000|Overall Study|Lost to Follow-up|24
6832633|NCT00191282|10836920|FG001|Overall Study|Lost to Follow-up|31
6832634|NCT00191308|10836926|FG000|Overall Study|Adverse Event|1
6832635|NCT00191334|10836930|FG000|Overall Study|Adverse Event|4
6832636|NCT00191334|10836930|FG000|Overall Study|Disease Progression or Relapse|8
6832637|NCT00191334|10836930|FG000|Overall Study|Physician Decision|1
6832638|NCT00191334|10836930|FG000|Overall Study|Withdrawal by Subject|4
6832639|NCT00191386|10836934|FG000|Overall Study|Adverse Event|16
6832640|NCT00191386|10836934|FG000|Overall Study|Lost to Follow-up|1
6832641|NCT00191386|10836934|FG000|Overall Study|Entry Criteria Exclusion|3
6832642|NCT00191386|10836934|FG000|Overall Study|Protocol Violation|18
6832643|NCT00191386|10836934|FG000|Overall Study|Withdrawal by Subject|96
6832644|NCT00191386|10836934|FG000|Overall Study|Physician Decision|11
6832645|NCT00191386|10836934|FG000|Overall Study|Lack of Efficacy|15
6832646|NCT00191451|10836941|FG000|Overall Study|Withdrawal by Subject|2
6832647|NCT00191451|10836942|FG001|Overall Study|Withdrawal by Subject|3
6832648|NCT00191451|10836943|FG002|Overall Study|Withdrawal by Subject|5
6832649|NCT00191451|10836941|FG000|Overall Study|Physician Decision|2
6832650|NCT00191451|10836942|FG001|Overall Study|Physician Decision|9
6832651|NCT00191451|10836943|FG002|Overall Study|Physician Decision|6
6832652|NCT00191451|10836941|FG000|Overall Study|Sponsor Decision|1
6832653|NCT00191451|10836942|FG001|Overall Study|Sponsor Decision|0
6832654|NCT00191451|10836943|FG002|Overall Study|Sponsor Decision|0
6832655|NCT00191451|10836941|FG000|Overall Study|Ineligible|0
6832656|NCT00191451|10836942|FG001|Overall Study|Ineligible|1
6832657|NCT00191451|10836943|FG002|Overall Study|Ineligible|0
6832658|NCT00191451|10836941|FG000|Overall Study|Reason Not Specified|2
6832659|NCT00191451|10836942|FG001|Overall Study|Reason Not Specified|1
6832660|NCT00191451|10836943|FG002|Overall Study|Reason Not Specified|3
6832661|NCT00191477|10836953|FG000|Overall Study|Tumor Recurrence|49
6832662|NCT00191477|10836954|FG001|Overall Study|Tumor Recurrence|48
6832663|NCT00191477|10836953|FG000|Overall Study|Death, Study Disease|1
6832664|NCT00191477|10836954|FG001|Overall Study|Death, Study Disease|1
6832665|NCT00191477|10836953|FG000|Overall Study|Death, Other Cause|3
6832666|NCT00191477|10836954|FG001|Overall Study|Death, Other Cause|6
6832667|NCT00191477|10836953|FG000|Overall Study|Lost to Follow-up|23
6832668|NCT00191477|10836954|FG001|Overall Study|Lost to Follow-up|21
6832669|NCT00191477|10836953|FG000|Overall Study|Protocol Violation|1
6832670|NCT00191477|10836954|FG001|Overall Study|Protocol Violation|1
6832671|NCT00191477|10836953|FG000|Overall Study|Treatment Change|2
6832672|NCT00191477|10836954|FG001|Overall Study|Treatment Change|0
6832673|NCT00191477|10836953|FG000|Overall Study|Withdrawal by Subject|2
6832674|NCT00191477|10836954|FG001|Overall Study|Withdrawal by Subject|0
6832675|NCT00191477|10836953|FG000|Overall Study|Other|2
6832676|NCT00191477|10836954|FG001|Overall Study|Other|0
6832677|NCT00191477|10836953|FG000|Overall Study|Not Eligible|41
6832678|NCT00191477|10836954|FG001|Overall Study|Not Eligible|38
6832679|NCT00191477|10836953|FG000|Overall Study|Pathological Specimen Lost|1
6832680|NCT00191477|10836954|FG001|Overall Study|Pathological Specimen Lost|0
7063439|NCT01949090|11161780|FG001|Overall Study|Protocol non-compliance|0
7063440|NCT01949090|11161781|FG002|Overall Study|Protocol non-compliance|0
7063441|NCT01949090|11161782|FG003|Overall Study|Protocol non-compliance|0
7063442|NCT01949090|11161783|FG004|Overall Study|Protocol non-compliance|1
7063443|NCT01949090|11161779|FG000|Overall Study|Lost to Follow-up|2
7063444|NCT01949090|11161780|FG001|Overall Study|Lost to Follow-up|1
7063445|NCT01949090|11161781|FG002|Overall Study|Lost to Follow-up|0
7063446|NCT01949090|11161782|FG003|Overall Study|Lost to Follow-up|1
7063447|NCT01949090|11161783|FG004|Overall Study|Lost to Follow-up|1
7063448|NCT01949116|11161798|FG000|Overall Study|Death|2
6832681|NCT00191477|10836953|FG000|Overall Study|Discontinued Prior to Instillation|13
6832682|NCT00191477|10836954|FG001|Overall Study|Discontinued Prior to Instillation|14
6832683|NCT00191646|10836962|FG000|Overall Study|Toxicity|26
6832684|NCT00191646|10836963|FG001|Overall Study|Toxicity|37
6832685|NCT00191646|10836962|FG000|Overall Study|Disease Progression|5
6832686|NCT00191646|10836963|FG001|Overall Study|Disease Progression|6
6832687|NCT00191646|10836962|FG000|Overall Study|Physician Decision|20
6832688|NCT00191646|10836963|FG001|Overall Study|Physician Decision|11
6832689|NCT00191646|10836962|FG000|Overall Study|Withdrawal by Subject|58
6832690|NCT00191646|10836963|FG001|Overall Study|Withdrawal by Subject|39
6832691|NCT00191646|10836962|FG000|Overall Study|Protocol Violation|5
6832692|NCT00191646|10836963|FG001|Overall Study|Protocol Violation|7
6832693|NCT00191646|10836962|FG000|Overall Study|Death|6
6832694|NCT00191646|10836963|FG001|Overall Study|Death|8
6832695|NCT00191646|10836962|FG000|Overall Study|Other|33
6832696|NCT00191646|10836963|FG001|Overall Study|Other|34
6832697|NCT00191646|10836962|FG000|Overall Study|Missing Data|18
6832698|NCT00191646|10836963|FG001|Overall Study|Missing Data|11
6832699|NCT00191724|10836982|FG000|Overall Study|Adverse Event|0
6832700|NCT00191724|10836983|FG001|Overall Study|Adverse Event|0
6832701|NCT00191724|10836984|FG002|Overall Study|Adverse Event|1
6832702|NCT00191724|10836985|FG003|Overall Study|Adverse Event|0
6832703|NCT00191724|10836986|FG004|Overall Study|Adverse Event|0
6832704|NCT00191724|10836982|FG000|Overall Study|Lost to Follow-up|1
6832705|NCT00191724|10836983|FG001|Overall Study|Lost to Follow-up|1
6832706|NCT00191724|10836984|FG002|Overall Study|Lost to Follow-up|0
6832707|NCT00191724|10836985|FG003|Overall Study|Lost to Follow-up|2
6832708|NCT00191724|10836986|FG004|Overall Study|Lost to Follow-up|3
6832709|NCT00191724|10836982|FG000|Overall Study|Withdrawal by Subject|0
6832710|NCT00191724|10836983|FG001|Overall Study|Withdrawal by Subject|0
6832711|NCT00191724|10836984|FG002|Overall Study|Withdrawal by Subject|0
6832712|NCT00191724|10836985|FG003|Overall Study|Withdrawal by Subject|1
6832713|NCT00191724|10836986|FG004|Overall Study|Withdrawal by Subject|0
6832714|NCT00191789|10836998|FG000|Overall Study|Adverse Event|5
6832715|NCT00191789|10836998|FG000|Overall Study|Patient: Satisfactory Response|5
6832716|NCT00191789|10836998|FG000|Overall Study|Patient/Physician: Satisfactory Response|4
6832717|NCT00191789|10836998|FG000|Overall Study|Withdrawal by Subject|4
6832718|NCT00191789|10836998|FG000|Overall Study|Death - Possibly Study Drug Related|4
6832719|NCT00191789|10836998|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2
6832720|NCT00191789|10836998|FG000|Overall Study|Death - Not Study-Drug Related|1
6897246|NCT00638443|10916068|FG001|First Intervention|Adverse Event|1
6897247|NCT00638456|10916078|FG000|Overall Study|Withdrawal by Subject|6
6897248|NCT00638456|10916079|FG001|Overall Study|Withdrawal by Subject|2
6897249|NCT00638508|10916087|FG000|Overall Study|Physician Decision|5
6897250|NCT00638508|10916088|FG001|Overall Study|Physician Decision|2
7063449|NCT01949116|11161799|FG001|Overall Study|Death|0
6832721|NCT00191815|10837002|FG000|Overall Study|Adverse Event|2
6832722|NCT00191815|10837002|FG000|Overall Study|Disease progression or relapse|24
6925527|NCT00832975|10955701|FG000|Overall Study|Physician Decision|4
6925528|NCT00832975|10955701|FG000|Overall Study|Withdrawal by Subject|3
6925529|NCT00832975|10955701|FG000|Overall Study|Other reasons|14
6925530|NCT00833027|10955705|FG000|Overall Study|Adverse Event|33
6925531|NCT00833027|10955705|FG000|Overall Study|Death|1
6925532|NCT00833027|10955705|FG000|Overall Study|Lack of Efficacy|12
6925533|NCT00833027|10955705|FG000|Overall Study|Lost to Follow-up|24
6925534|NCT00833027|10955705|FG000|Overall Study|Protocol Violation|115
6925535|NCT00833027|10955705|FG000|Overall Study|Withdrawal by Subject|16
6925536|NCT00833027|10955705|FG000|Overall Study|Missing|10
6925537|NCT00833040|10955709|FG000|Overall Study|Adverse Event|0
6925538|NCT00833040|10955710|FG001|Overall Study|Adverse Event|0
6925539|NCT00833040|10955711|FG002|Overall Study|Adverse Event|0
6925540|NCT00833040|10955712|FG003|Overall Study|Adverse Event|0
6925541|NCT00833040|10955713|FG004|Overall Study|Adverse Event|0
6925542|NCT00833040|10955714|FG005|Overall Study|Adverse Event|1
6925543|NCT00833053|10955721|FG000|Overall Study|Adverse Event|4
6925544|NCT00833053|10955722|FG001|Overall Study|Adverse Event|0
6925545|NCT00833053|10955721|FG000|Overall Study|Treatment Failure|3
6925546|NCT00833053|10955722|FG001|Overall Study|Treatment Failure|1
6925547|NCT00833053|10955721|FG000|Overall Study|Withdrawal by Subject|0
6925548|NCT00833053|10955722|FG001|Overall Study|Withdrawal by Subject|1
6925549|NCT00833053|10955721|FG000|Overall Study|Protocol Violation|2
6925550|NCT00833053|10955722|FG001|Overall Study|Protocol Violation|1
6925551|NCT00833092|10955730|FG000|Overall Study|Withdrawal by Subject|2
6925552|NCT00833092|10955731|FG001|Overall Study|Withdrawal by Subject|3
6925553|NCT00833092|10955730|FG000|Overall Study|Protocol Violation|2
6925554|NCT00833092|10955731|FG001|Overall Study|Protocol Violation|1
6925555|NCT00833092|10955730|FG000|Overall Study|Diarrhea|0
6925556|NCT00833092|10955731|FG001|Overall Study|Diarrhea|2
6925557|NCT00833092|10955730|FG000|Overall Study|constipation|0
6925558|NCT00833092|10955731|FG001|Overall Study|constipation|1
6925559|NCT00833105|10955737|FG000|Overall Study|Withdrawal by Subject|1
6925560|NCT00833105|10955737|FG000|Overall Study|Adverse Event|2
6925561|NCT00833248|10955745|FG000|Overall Study|Adverse Event|3
6925562|NCT00833248|10955746|FG001|Overall Study|Adverse Event|0
6925563|NCT00833248|10955745|FG000|Overall Study|Protocol Violation|1
6925564|NCT00833248|10955746|FG001|Overall Study|Protocol Violation|2
6925565|NCT00833248|10955745|FG000|Overall Study|Withdrawal by Subject|0
6925566|NCT00833248|10955746|FG001|Overall Study|Withdrawal by Subject|1
6925567|NCT00833261|10955752|FG000|Overall Study|Withdrawal by Subject|4
6925568|NCT00833417|10955767|FG000|Overall Study|Adverse Event|5
6925569|NCT00833417|10955768|FG001|Overall Study|Adverse Event|16
6925570|NCT00833417|10955767|FG000|Overall Study|Death|1
6925571|NCT00833417|10955768|FG001|Overall Study|Death|3
6925572|NCT00833417|10955767|FG000|Overall Study|Lost to Follow-up|1
6925573|NCT00833417|10955768|FG001|Overall Study|Lost to Follow-up|2
6925574|NCT00833417|10955767|FG000|Overall Study|Physician Decision to Withdraw Patient|3
6925575|NCT00833417|10955768|FG001|Overall Study|Physician Decision to Withdraw Patient|7
6925576|NCT00833417|10955767|FG000|Overall Study|Patient Decision to Withdraw|4
6925577|NCT00833417|10955768|FG001|Overall Study|Patient Decision to Withdraw|23
6925578|NCT00833417|10955767|FG000|Overall Study|Sponsor Decision to Terminate Study|1
6925579|NCT00833417|10955768|FG001|Overall Study|Sponsor Decision to Terminate Study|2
6925580|NCT00833417|10955767|FG000|Overall Study|Disease Progression|18
6925581|NCT00833417|10955768|FG001|Overall Study|Disease Progression|17
6925582|NCT00833417|10955767|FG000|Overall Study|Reason Not Specified|0
6925583|NCT00833417|10955768|FG001|Overall Study|Reason Not Specified|1
6925584|NCT00833469|10955786|FG000|Overall Study|Withdrawal by Subject|1
6925585|NCT00833469|10955786|FG000|Overall Study|Lost to Follow-up|1
6925586|NCT00833482|10955792|FG000|Days 11-20|Adverse Event|0
6925587|NCT00833482|10955793|FG001|Days 11-20|Adverse Event|2
6925588|NCT00833482|10955794|FG002|Days 11-20|Adverse Event|0
6925589|NCT00833482|10955795|FG003|Days 11-20|Adverse Event|0
6925590|NCT00833482|10955796|FG004|Days 11-20|Adverse Event|0
6925591|NCT00833482|10955797|FG005|Days 11-20|Adverse Event|0
6925592|NCT00833482|10955792|FG000|Days 11-20|Withdrawal by Subject|0
6925593|NCT00833482|10955793|FG001|Days 11-20|Withdrawal by Subject|1
6925594|NCT00833482|10955794|FG002|Days 11-20|Withdrawal by Subject|0
6925595|NCT00833482|10955795|FG003|Days 11-20|Withdrawal by Subject|0
6925596|NCT00833482|10955796|FG004|Days 11-20|Withdrawal by Subject|0
6925597|NCT00833482|10955797|FG005|Days 11-20|Withdrawal by Subject|0
6925598|NCT00833482|10955792|FG000|Days 21-30|Adverse Event|0
6925599|NCT00833482|10955793|FG001|Days 21-30|Adverse Event|0
6925600|NCT00833482|10955794|FG002|Days 21-30|Adverse Event|1
6925601|NCT00833482|10955795|FG003|Days 21-30|Adverse Event|0
6925602|NCT00833482|10955796|FG004|Days 21-30|Adverse Event|0
6925603|NCT00833482|10955797|FG005|Days 21-30|Adverse Event|0
6832723|NCT00191815|10837002|FG000|Overall Study|Death|2
6925604|NCT00833482|10955792|FG000|Days 21-30|Withdrawal by Subject|0
6925605|NCT00833482|10955793|FG001|Days 21-30|Withdrawal by Subject|0
6925606|NCT00833482|10955794|FG002|Days 21-30|Withdrawal by Subject|0
6925607|NCT00833482|10955795|FG003|Days 21-30|Withdrawal by Subject|0
6925608|NCT00833482|10955796|FG004|Days 21-30|Withdrawal by Subject|1
6925609|NCT00833482|10955797|FG005|Days 21-30|Withdrawal by Subject|0
6925610|NCT00833547|10955821|FG000|Overall Study|Withdrawal by Subject|2
6832724|NCT00191815|10837002|FG000|Overall Study|Protocol Violation|3
6832725|NCT00191815|10837002|FG000|Overall Study|Physician Decision|2
6832726|NCT00191815|10837002|FG000|Overall Study|Withdrawal by Subject|7
6832727|NCT00191854|10837009|FG000|Overall Study|Death|26
6832728|NCT00191854|10837010|FG001|Overall Study|Death|23
6832729|NCT00191854|10837011|FG002|Overall Study|Death|29
6832730|NCT00191854|10837009|FG000|Overall Study|Lost to Follow-up|7
6832731|NCT00191854|10837010|FG001|Overall Study|Lost to Follow-up|5
6832732|NCT00191854|10837011|FG002|Overall Study|Lost to Follow-up|5
6832733|NCT00191854|10837009|FG000|Overall Study|Withdrawal by Subject|4
6832734|NCT00191854|10837010|FG001|Overall Study|Withdrawal by Subject|2
6832735|NCT00191854|10837011|FG002|Overall Study|Withdrawal by Subject|3
6832736|NCT00191854|10837009|FG000|Overall Study|Sponsor Decision|0
6832737|NCT00191854|10837010|FG001|Overall Study|Sponsor Decision|0
6832738|NCT00191854|10837011|FG002|Overall Study|Sponsor Decision|1
6832739|NCT00191854|10837009|FG000|Overall Study|Screen Failure|0
6832740|NCT00191854|10837010|FG001|Overall Study|Screen Failure|0
6832741|NCT00191854|10837011|FG002|Overall Study|Screen Failure|1
6832742|NCT00191906|10837023|FG000|Study Period II|Adverse Event|0
6832743|NCT00191906|10837024|FG001|Study Period II|Adverse Event|1
6832744|NCT00191906|10837025|FG002|Study Period II|Adverse Event|0
6832745|NCT00191906|10837026|FG003|Study Period II|Adverse Event|0
6832746|NCT00191906|10837023|FG000|Study Period II|Withdrawal by Subject|0
6832747|NCT00191906|10837024|FG001|Study Period II|Withdrawal by Subject|3
6832748|NCT00191906|10837025|FG002|Study Period II|Withdrawal by Subject|0
6832749|NCT00191906|10837026|FG003|Study Period II|Withdrawal by Subject|0
6832750|NCT00191906|10837023|FG000|Study Period II|Parent/Caregiver Decision|0
6832751|NCT00191906|10837024|FG001|Study Period II|Parent/Caregiver Decision|1
6832752|NCT00191906|10837025|FG002|Study Period II|Parent/Caregiver Decision|0
6832753|NCT00191906|10837026|FG003|Study Period II|Parent/Caregiver Decision|0
6832754|NCT00191906|10837023|FG000|Study Period II|Entry Criteria Exclusion|0
6832755|NCT00191906|10837024|FG001|Study Period II|Entry Criteria Exclusion|0
6832756|NCT00191906|10837025|FG002|Study Period II|Entry Criteria Exclusion|1
6832757|NCT00191906|10837026|FG003|Study Period II|Entry Criteria Exclusion|0
6832758|NCT00191906|10837023|FG000|Study Period III|Adverse Event|1
6832759|NCT00191906|10837024|FG001|Study Period III|Adverse Event|0
6832760|NCT00191906|10837025|FG002|Study Period III|Adverse Event|0
6832761|NCT00191906|10837026|FG003|Study Period III|Adverse Event|0
6832762|NCT00191906|10837023|FG000|Study Period III|Lost to Follow-up|0
6832763|NCT00191906|10837024|FG001|Study Period III|Lost to Follow-up|1
6832764|NCT00191906|10837025|FG002|Study Period III|Lost to Follow-up|0
6832765|NCT00191906|10837026|FG003|Study Period III|Lost to Follow-up|0
6832766|NCT00191906|10837023|FG000|Study Period III|Parent/Caregiver Decision|1
6832767|NCT00191906|10837024|FG001|Study Period III|Parent/Caregiver Decision|0
6832768|NCT00191906|10837025|FG002|Study Period III|Parent/Caregiver Decision|0
6832769|NCT00191906|10837026|FG003|Study Period III|Parent/Caregiver Decision|0
6832770|NCT00191906|10837023|FG000|Study Period III|Lack of Efficacy|3
6832771|NCT00191906|10837024|FG001|Study Period III|Lack of Efficacy|3
6832772|NCT00191906|10837025|FG002|Study Period III|Lack of Efficacy|0
6832773|NCT00191906|10837026|FG003|Study Period III|Lack of Efficacy|0
6832774|NCT00191945|10837044|FG000|Double-Blind Acute Treatment|Parent's Decision|3
6832775|NCT00191945|10837045|FG001|Double-Blind Acute Treatment|Parent's Decision|0
6832776|NCT00191945|10837044|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0
6832777|NCT00191945|10837045|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1
6832778|NCT00191945|10837044|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3
6832779|NCT00191945|10837045|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0
6832780|NCT00191945|10837044|FG000|Double-Blind Acute Treatment|Physician Decision|0
6832781|NCT00191945|10837045|FG001|Double-Blind Acute Treatment|Physician Decision|2
6832782|NCT00191984|10837052|FG000|Overall Study|Disease Progression|21
6832783|NCT00191984|10837052|FG000|Overall Study|Adverse Event|4
6832784|NCT00191984|10837052|FG000|Overall Study|Death|2
6832785|NCT00191984|10837052|FG000|Overall Study|Entry Criteria Exclusion|1
6832786|NCT00191984|10837052|FG000|Overall Study|Withdrawal by Subject|7
6832787|NCT00191984|10837052|FG000|Overall Study|Physician Decision|4
6832788|NCT00192023|10837058|FG000|Period III - Double-Blind|Adverse Event|3
6832789|NCT00192023|10837059|FG001|Period III - Double-Blind|Adverse Event|0
6832790|NCT00192023|10837058|FG000|Period III - Double-Blind|Physician Decision|2
6832791|NCT00192023|10837059|FG001|Period III - Double-Blind|Physician Decision|0
6832792|NCT00192023|10837058|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2
6832793|NCT00192023|10837059|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0
6832794|NCT00192023|10837058|FG000|Period IV - Optional Open-Label|Adverse Event|6
6832795|NCT00192023|10837059|FG001|Period IV - Optional Open-Label|Adverse Event|0
6832796|NCT00192023|10837058|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7
6832797|NCT00192023|10837059|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0
6832798|NCT00192023|10837058|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46
6832799|NCT00192023|10837059|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0
6832800|NCT00192023|10837058|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2
6832801|NCT00192023|10837059|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0
6832802|NCT00192023|10837058|FG000|Period IV - Optional Open-Label|Protocol Violation|1
6832803|NCT00192023|10837059|FG001|Period IV - Optional Open-Label|Protocol Violation|0
6832804|NCT00192023|10837058|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4
6832805|NCT00192023|10837059|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0
6832806|NCT00192023|10837058|FG000|Period IV - Optional Open-Label|Physician Decision|9
6832807|NCT00192023|10837059|FG001|Period IV - Optional Open-Label|Physician Decision|0
6832808|NCT00192036|10837065|FG000|Overall Study|Protocol Violation|3
6832809|NCT00192036|10837065|FG000|Overall Study|Adverse Event|6
6832810|NCT00192036|10837065|FG000|Overall Study|Patient/Physician Perception|1
6832811|NCT00192036|10837065|FG000|Overall Study|Objective Tumor Progression|4
6832812|NCT00192036|10837065|FG000|Overall Study|Clinical Disease Progression|1
6832813|NCT00192036|10837065|FG000|Overall Study|Death|1
6832814|NCT00192036|10837065|FG000|Overall Study|Unknown or Not Specified|5
6832815|NCT00192075|10837071|FG000|Overall Study|Disease Progression|23
6832816|NCT00192075|10837072|FG001|Overall Study|Disease Progression|6
6832817|NCT00192075|10837071|FG000|Overall Study|Adverse Event|1
6832818|NCT00192075|10837072|FG001|Overall Study|Adverse Event|3
6832819|NCT00192075|10837071|FG000|Overall Study|Death|0
6832820|NCT00192075|10837072|FG001|Overall Study|Death|1
6925611|NCT00833547|10955822|FG001|Overall Study|Withdrawal by Subject|2
6925612|NCT00833560|10955828|FG000|Overall Study|Toxicity|13
6925613|NCT00833560|10955828|FG000|Overall Study|Adverse Event|11
6925614|NCT00833560|10955828|FG000|Overall Study|Protocol Violation|6
6925615|NCT00833560|10955828|FG000|Overall Study|Lack of Efficacy|4
6925616|NCT00833560|10955828|FG000|Overall Study|Death|2
6925617|NCT00833560|10955828|FG000|Overall Study|Pregression of other disease|1
6925618|NCT00833560|10955828|FG000|Overall Study|Other|5
6925619|NCT00833638|10955835|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1
6925620|NCT00833638|10955836|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2
6925621|NCT00833638|10955837|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0
6925622|NCT00833638|10955835|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3
6925623|NCT00833638|10955836|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2
6925624|NCT00833638|10955837|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1
6925625|NCT00833638|10955835|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
7039030|NCT01707992|11121600|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4
7063450|NCT01949116|11161798|FG000|Overall Study|Lost to Follow-up|1
7063451|NCT01949116|11161799|FG001|Overall Study|Lost to Follow-up|3
7063452|NCT01949116|11161798|FG000|Overall Study|Withdrawal by Subject|5
7063453|NCT01949116|11161799|FG001|Overall Study|Withdrawal by Subject|3
7063454|NCT01949142|11161811|FG000|Overall Study|Withdrawal of consent|1
7063455|NCT01949142|11161812|FG001|Overall Study|Withdrawal of consent|0
7063456|NCT01949142|11161811|FG000|Overall Study|Lost to Follow-up|1
7063457|NCT01949142|11161812|FG001|Overall Study|Lost to Follow-up|1
7063458|NCT01949142|11161811|FG000|Overall Study|Parent changed their mind|1
6832821|NCT00192075|10837071|FG000|Overall Study|Lack of Efficacy|0
7039031|NCT01707992|11121601|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
7039032|NCT01708161|11121631|FG000|Overall Study|Adverse Event|1
7039033|NCT01708161|11121632|FG001|Overall Study|Adverse Event|3
7039034|NCT01708161|11121633|FG002|Overall Study|Adverse Event|4
7039035|NCT01708161|11121634|FG003|Overall Study|Adverse Event|2
7039036|NCT01708161|11121635|FG004|Overall Study|Adverse Event|3
7039037|NCT01708161|11121636|FG005|Overall Study|Adverse Event|0
7039038|NCT01708161|11121631|FG000|Overall Study|Death|0
7039039|NCT01708161|11121632|FG001|Overall Study|Death|0
7039040|NCT01708161|11121633|FG002|Overall Study|Death|0
7039041|NCT01708161|11121634|FG003|Overall Study|Death|1
7039042|NCT01708161|11121635|FG004|Overall Study|Death|0
7039043|NCT01708161|11121636|FG005|Overall Study|Death|1
6925626|NCT00833638|10955836|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2
6925627|NCT00833638|10955837|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
6925628|NCT00833638|10955835|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1
6925629|NCT00833638|10955836|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0
6925630|NCT00833638|10955837|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0
6925631|NCT00833638|10955835|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
6925632|NCT00833638|10955836|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
6925633|NCT00833638|10955837|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
6925634|NCT00833638|10955835|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
6925635|NCT00833638|10955836|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
6925636|NCT00833638|10955837|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2
6925637|NCT00833638|10955835|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
6925638|NCT00833638|10955836|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
6925639|NCT00833638|10955837|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2
6925640|NCT00833638|10955835|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1
6925641|NCT00833638|10955836|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2
6925642|NCT00833638|10955837|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0
6925643|NCT00833638|10955835|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0
7039044|NCT01708161|11121631|FG000|Overall Study|Withdrawal by Subject|0
6832822|NCT00192075|10837072|FG001|Overall Study|Lack of Efficacy|0
7039045|NCT01708161|11121632|FG001|Overall Study|Withdrawal by Subject|1
7063459|NCT01949142|11161812|FG001|Overall Study|Parent changed their mind|0
7063460|NCT01949155|11161821|FG000|Overall Study|Lost to Follow-up|1
6832823|NCT00192075|10837071|FG000|Overall Study|Physician Decision|3
6832824|NCT00192075|10837072|FG001|Overall Study|Physician Decision|0
6832825|NCT00192075|10837071|FG000|Overall Study|Withdrawal by Subject|5
6832826|NCT00192075|10837072|FG001|Overall Study|Withdrawal by Subject|5
6832827|NCT00192075|10837071|FG000|Overall Study|Patient Non-Compliance|0
6832828|NCT00192075|10837072|FG001|Overall Study|Patient Non-Compliance|1
6832829|NCT00192075|10837071|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2
6832830|NCT00192075|10837072|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1
6832831|NCT00192075|10837071|FG000|Overall Study|Other|5
6832832|NCT00192075|10837072|FG001|Overall Study|Other|2
6832833|NCT00192114|10837083|FG000|Overall Study|Objective Tumor Progression|19
6832834|NCT00192114|10837083|FG000|Overall Study|Adverse Event|2
6832835|NCT00192114|10837083|FG000|Overall Study|Clinical Progression|2
6832836|NCT00192114|10837083|FG000|Overall Study|Death|1
6832837|NCT00192296|10837091|FG000|Overall Study|Withdrawal by Subject|0
6832838|NCT00192296|10837092|FG001|Overall Study|Withdrawal by Subject|1
6832839|NCT00192296|10837093|FG002|Overall Study|Withdrawal by Subject|0
6925644|NCT00833638|10955836|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1
6925645|NCT00833638|10955837|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2
6925646|NCT00833690|10955856|FG000|Overall Study|Withdrawal by Subject|1
6925647|NCT00833690|10955857|FG001|Overall Study|Withdrawal by Subject|0
6925648|NCT00833690|10955858|FG002|Overall Study|Withdrawal by Subject|0
6925649|NCT00833690|10955856|FG000|Overall Study|Discontinued study drug|3
6925650|NCT00833690|10955857|FG001|Overall Study|Discontinued study drug|2
6925651|NCT00833690|10955858|FG002|Overall Study|Discontinued study drug|0
6974849|NCT01190930|11027133|FG002|Induction|Inevaluable|0
6974850|NCT01190930|11027134|FG003|Induction|Inevaluable|0
6974851|NCT01190930|11027135|FG004|Induction|Inevaluable|0
6974852|NCT01190930|11027136|FG005|Induction|Inevaluable|0
6974853|NCT01190930|11027137|FG006|Induction|Inevaluable|0
6974854|NCT01190930|11027138|FG007|Induction|Inevaluable|0
6974855|NCT01190930|11027139|FG008|Induction|Inevaluable|0
6974856|NCT01190930|11027140|FG009|Induction|Inevaluable|0
6974857|NCT01190930|11027131|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61
6974858|NCT01190930|11027132|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
6974859|NCT01190930|11027133|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
6974860|NCT01190930|11027134|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
6974861|NCT01190930|11027135|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
6974862|NCT01190930|11027136|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
6974863|NCT01190930|11027137|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
6974864|NCT01190930|11027138|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
6974865|NCT01190930|11027139|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
6974866|NCT01190930|11027140|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
6974867|NCT01190930|11027131|FG000|Induction|High Risk Downs|80
6974868|NCT01190930|11027132|FG001|Induction|High Risk Downs|0
6974869|NCT01190930|11027133|FG002|Induction|High Risk Downs|0
6974870|NCT01190930|11027134|FG003|Induction|High Risk Downs|0
6974871|NCT01190930|11027135|FG004|Induction|High Risk Downs|0
6974872|NCT01190930|11027136|FG005|Induction|High Risk Downs|0
6974873|NCT01190930|11027137|FG006|Induction|High Risk Downs|0
6974874|NCT01190930|11027138|FG007|Induction|High Risk Downs|0
6974875|NCT01190930|11027139|FG008|Induction|High Risk Downs|0
6974876|NCT01190930|11027140|FG009|Induction|High Risk Downs|0
6974877|NCT01190930|11027131|FG000|Induction|Enrollment onto another COG Protocol|1
6974878|NCT01190930|11027132|FG001|Induction|Enrollment onto another COG Protocol|0
6974879|NCT01190930|11027133|FG002|Induction|Enrollment onto another COG Protocol|0
6974880|NCT01190930|11027134|FG003|Induction|Enrollment onto another COG Protocol|0
6974881|NCT01190930|11027135|FG004|Induction|Enrollment onto another COG Protocol|0
6974882|NCT01190930|11027136|FG005|Induction|Enrollment onto another COG Protocol|0
6974883|NCT01190930|11027137|FG006|Induction|Enrollment onto another COG Protocol|0
6974884|NCT01190930|11027138|FG007|Induction|Enrollment onto another COG Protocol|0
6974885|NCT01190930|11027139|FG008|Induction|Enrollment onto another COG Protocol|0
6974886|NCT01190930|11027140|FG009|Induction|Enrollment onto another COG Protocol|0
6974887|NCT01190930|11027131|FG000|Induction|Average Risk|1847
6974888|NCT01190930|11027132|FG001|Induction|Average Risk|0
6974889|NCT01190930|11027133|FG002|Induction|Average Risk|0
6974890|NCT01190930|11027134|FG003|Induction|Average Risk|0
6974891|NCT01190930|11027135|FG004|Induction|Average Risk|0
6974892|NCT01190930|11027136|FG005|Induction|Average Risk|0
6832840|NCT00192296|10837094|FG003|Overall Study|Withdrawal by Subject|0
6832841|NCT00192504|10837108|FG000|Overall Study|Lost to Follow-up|1
6832842|NCT00192504|10837109|FG001|Overall Study|Lost to Follow-up|0
6832843|NCT00192504|10837110|FG002|Overall Study|Lost to Follow-up|0
6832844|NCT00192504|10837111|FG003|Overall Study|Lost to Follow-up|0
6832845|NCT00192504|10837108|FG000|Overall Study|Dosing window missed|0
6832846|NCT00192504|10837109|FG001|Overall Study|Dosing window missed|0
6832847|NCT00192504|10837110|FG002|Overall Study|Dosing window missed|1
6832848|NCT00192504|10837111|FG003|Overall Study|Dosing window missed|0
6832849|NCT00192647|10837123|FG000|Overall Study|Death|1
6832850|NCT00192647|10837124|FG001|Overall Study|Death|1
6974893|NCT01190930|11027137|FG006|Induction|Average Risk|0
6974894|NCT01190930|11027138|FG007|Induction|Average Risk|0
6974895|NCT01190930|11027139|FG008|Induction|Average Risk|0
6832851|NCT00192647|10837123|FG000|Overall Study|Adverse Event|35
6974896|NCT01190930|11027140|FG009|Induction|Average Risk|0
6974897|NCT01190930|11027131|FG000|Induction|High Risk|1227
6832852|NCT00192647|10837124|FG001|Overall Study|Adverse Event|29
6832853|NCT00192647|10837123|FG000|Overall Study|Laboratory Test Abnormality|4
6832854|NCT00192647|10837124|FG001|Overall Study|Laboratory Test Abnormality|2
6832855|NCT00192647|10837123|FG000|Overall Study|Insufficient Therapeutic Response|53
6832856|NCT00192647|10837124|FG001|Overall Study|Insufficient Therapeutic Response|83
6832857|NCT00192647|10837123|FG000|Overall Study|Entry Criteria Violation|6
6832858|NCT00192647|10837124|FG001|Overall Study|Entry Criteria Violation|6
6832859|NCT00192647|10837123|FG000|Overall Study|Protocol Violation|3
6832860|NCT00192647|10837124|FG001|Overall Study|Protocol Violation|1
6832861|NCT00192647|10837123|FG000|Overall Study|Refused Treatment/Did not Cooperate|10
6832862|NCT00192647|10837124|FG001|Overall Study|Refused Treatment/Did not Cooperate|8
6832863|NCT00192647|10837123|FG000|Overall Study|Failure to Return|11
6832864|NCT00192647|10837124|FG001|Overall Study|Failure to Return|13
6832865|NCT00192647|10837123|FG000|Overall Study|Other/Administrative|5
6832866|NCT00192647|10837124|FG001|Overall Study|Other/Administrative|3
6832867|NCT00193050|10837139|FG000|Neoadjuvant Treatment|Lack of Efficacy|2
6832868|NCT00193050|10837139|FG000|Neoadjuvant Treatment|Intercurrent Illness|3
6832869|NCT00193050|10837139|FG000|Neoadjuvant Treatment|Physician Decision|2
6832870|NCT00193050|10837139|FG000|Neoadjuvant Treatment|Adverse Event|2
6832871|NCT00193050|10837139|FG000|Adjuvant|Physician Decision|5
6832872|NCT00193050|10837139|FG000|Adjuvant|Intercurrent Hospitalization|3
6832873|NCT00193050|10837139|FG000|Adjuvant|Lack of Efficacy|2
6832874|NCT00193063|10837144|FG000|Overall Study|Lack of Efficacy|3
6832875|NCT00193063|10837144|FG000|Overall Study|Adverse Event|1
7039046|NCT01708161|11121633|FG002|Overall Study|Withdrawal by Subject|1
7039047|NCT01708161|11121634|FG003|Overall Study|Withdrawal by Subject|0
6832876|NCT00193180|10837159|FG000|Overall Study|Lack of Efficacy|1
6832877|NCT00193180|10837159|FG000|Overall Study|Adverse Event|8
6832878|NCT00193180|10837159|FG000|Overall Study|Protocol Violation|1
6832879|NCT00193206|10837164|FG000|Preoperative Therapy|Lack of Efficacy|2
6832880|NCT00193206|10837164|FG000|Preoperative Therapy|Adverse Event|2
6832881|NCT00193206|10837164|FG000|Preoperative Therapy|Withdrawal by Subject|2
6832882|NCT00193206|10837164|FG000|Preoperative Therapy|False Positive Pregnancy Test|1
6832883|NCT00193206|10837164|FG000|Postoperative Therapy|Withdrawal by Subject|7
6832884|NCT00193206|10837164|FG000|Postoperative Therapy|Physician Decision|3
6832885|NCT00193206|10837164|FG000|Postoperative Therapy|Intercurrent Illness|2
6832886|NCT00193206|10837164|FG000|Postoperative Therapy|Lack of Efficacy|1
6832887|NCT00193206|10837164|FG000|Postoperative Therapy|Protocol Violation|1
6832888|NCT00193609|10837198|FG000|Overall Study|Lack of Efficacy|2
6832889|NCT00193609|10837198|FG000|Overall Study|Adverse Event|2
6832890|NCT00194012|10837204|FG000|Randomized Phase|Lack of Efficacy|8
6832891|NCT00194012|10837205|FG001|Randomized Phase|Lack of Efficacy|18
6832892|NCT00194012|10837204|FG000|Randomized Phase|Study nonadherence|2
6832893|NCT00194012|10837205|FG001|Randomized Phase|Study nonadherence|1
6832894|NCT00194012|10837204|FG000|Randomized Phase|Withdrawal by Subject|3
6832895|NCT00194012|10837205|FG001|Randomized Phase|Withdrawal by Subject|3
6832896|NCT00194012|10837204|FG000|Randomized Phase|Adverse Event|2
6832897|NCT00194012|10837205|FG001|Randomized Phase|Adverse Event|1
6832898|NCT00194012|10837204|FG000|Randomized Phase|Participant reported having a rash|1
6832899|NCT00194012|10837205|FG001|Randomized Phase|Participant reported having a rash|0
6832900|NCT00194012|10837204|FG000|Randomized Phase|Emesis and enuresis|0
6832901|NCT00194012|10837205|FG001|Randomized Phase|Emesis and enuresis|1
6832902|NCT00194012|10837204|FG000|Randomized Phase|Oral/nasal twitching|0
6832903|NCT00194012|10837205|FG001|Randomized Phase|Oral/nasal twitching|1
6832904|NCT00194012|10837204|FG000|Open Label Extension (OLE)|Weight Gain|1
6832905|NCT00194012|10837205|FG001|Open Label Extension (OLE)|Weight Gain|0
6832906|NCT00194012|10837204|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0
6832907|NCT00194012|10837205|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1
6832908|NCT00194012|10837204|FG000|Open Label Extension (OLE)|Lost to Follow-up|3
6832909|NCT00194012|10837205|FG001|Open Label Extension (OLE)|Lost to Follow-up|5
6832910|NCT00194012|10837204|FG000|Open Label Extension (OLE)|Lack of Efficacy|1
6832911|NCT00194012|10837205|FG001|Open Label Extension (OLE)|Lack of Efficacy|0
6832912|NCT00194025|10837217|FG000|Overall Study|Adverse Event|1
6832913|NCT00194025|10837217|FG000|Overall Study|non-adherence with study medication|4
6832914|NCT00194077|10837223|FG000|Overall Study|Lack of Efficacy|22
6832915|NCT00194077|10837224|FG001|Overall Study|Lack of Efficacy|29
6832916|NCT00194077|10837223|FG000|Overall Study|Study nonadherence|1
6832917|NCT00194077|10837224|FG001|Overall Study|Study nonadherence|0
6832918|NCT00194077|10837223|FG000|Overall Study|Withdrawal by Subject|1
6832919|NCT00194077|10837224|FG001|Overall Study|Withdrawal by Subject|1
6832920|NCT00194675|10837275|FG000|Overall Study|Lost to Follow-up|1
6832921|NCT00194675|10837276|FG001|Overall Study|Lost to Follow-up|1
6832922|NCT00194675|10837275|FG000|Overall Study|lack of interest|1
6832923|NCT00194675|10837276|FG001|Overall Study|lack of interest|1
6832924|NCT00194675|10837275|FG000|Overall Study|"withdrew due to edgy feeling"|1
6832925|NCT00194675|10837276|FG001|Overall Study|"withdrew due to edgy feeling"|0
6832926|NCT00194675|10837275|FG000|Overall Study|Protocol Violation|1
6832927|NCT00194675|10837276|FG001|Overall Study|Protocol Violation|0
6832928|NCT00194675|10837275|FG000|Overall Study|Death|1
6832929|NCT00194675|10837276|FG001|Overall Study|Death|0
6832930|NCT00194792|10837288|FG000|Overall Study|Withdrawal by Subject|1
6832931|NCT00194987|10837311|FG000|Overall Study|Withdrawal by Subject|0
7039048|NCT01708161|11121635|FG004|Overall Study|Withdrawal by Subject|0
7039049|NCT01708161|11121636|FG005|Overall Study|Withdrawal by Subject|0
7063461|NCT01949155|11161822|FG001|Overall Study|Lost to Follow-up|0
6832932|NCT00194987|10837312|FG001|Overall Study|Withdrawal by Subject|3
6832933|NCT00195260|10837335|FG000|Part 1: Dose Escalation|Adverse Event|0
6832934|NCT00195260|10837336|FG001|Part 1: Dose Escalation|Adverse Event|1
6925652|NCT00833703|10955868|FG000|Overall Study|Parent(s)/guardian(s)'s request|0
6925653|NCT00833703|10955869|FG001|Overall Study|Parent(s)/guardian(s)'s request|1
6925654|NCT00833755|10955879|FG000|Overall Study|Physician Decision|4
6925655|NCT00833755|10955880|FG001|Overall Study|Physician Decision|4
6925656|NCT00833755|10955881|FG002|Overall Study|Physician Decision|2
6925657|NCT00833755|10955882|FG003|Overall Study|Physician Decision|6
6925658|NCT00833755|10955879|FG000|Overall Study|Subject had scheduling issues|0
6925659|NCT00833755|10955880|FG001|Overall Study|Subject had scheduling issues|1
6925660|NCT00833755|10955881|FG002|Overall Study|Subject had scheduling issues|0
6925661|NCT00833755|10955882|FG003|Overall Study|Subject had scheduling issues|0
6925662|NCT00833794|10955903|FG000|Open-label Phase|Adverse Event|225
6925663|NCT00833794|10955904|FG001|Open-label Phase|Adverse Event|0
6925664|NCT00833794|10955903|FG000|Open-label Phase|Lack of Efficacy|28
6925665|NCT00833794|10955904|FG001|Open-label Phase|Lack of Efficacy|0
6925666|NCT00833794|10955903|FG000|Open-label Phase|Withdrawal by Subject|48
6925667|NCT00833794|10955904|FG001|Open-label Phase|Withdrawal by Subject|0
6925668|NCT00833794|10955903|FG000|Open-label Phase|Physician Decision|20
6925669|NCT00833794|10955904|FG001|Open-label Phase|Physician Decision|0
6925670|NCT00833794|10955903|FG000|Open-label Phase|Administrative reason|1
6925671|NCT00833794|10955904|FG001|Open-label Phase|Administrative reason|0
6925672|NCT00833794|10955903|FG000|Open-label Phase|Protocol Violation|47
6925673|NCT00833794|10955904|FG001|Open-label Phase|Protocol Violation|0
6925674|NCT00833794|10955903|FG000|Open-label Phase|Did not complete wash-out period|12
6925675|NCT00833794|10955904|FG001|Open-label Phase|Did not complete wash-out period|0
6925676|NCT00833794|10955903|FG000|Open-label Phase|enrolled in error (immediately D/C)|1
6925677|NCT00833794|10955904|FG001|Open-label Phase|enrolled in error (immediately D/C)|0
6925678|NCT00833794|10955903|FG000|Double-blind Phase|Adverse Event|44
6925679|NCT00833794|10955904|FG001|Double-blind Phase|Adverse Event|11
6925680|NCT00833794|10955903|FG000|Double-blind Phase|Lack of Efficacy|34
6925681|NCT00833794|10955904|FG001|Double-blind Phase|Lack of Efficacy|22
6925682|NCT00833794|10955903|FG000|Double-blind Phase|Withdrawal by Subject|23
6925683|NCT00833794|10955904|FG001|Double-blind Phase|Withdrawal by Subject|6
6925684|NCT00833794|10955903|FG000|Double-blind Phase|Physician Decision|4
6925685|NCT00833794|10955904|FG001|Double-blind Phase|Physician Decision|7
6925686|NCT00833794|10955903|FG000|Double-blind Phase|Administrative reason|1
6925687|NCT00833794|10955904|FG001|Double-blind Phase|Administrative reason|3
6925688|NCT00833833|10955918|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0
6925689|NCT00833833|10955919|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0
6925690|NCT00833833|10955920|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2
6925691|NCT00833833|10955921|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2
6925692|NCT00833833|10955922|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0
6925693|NCT00833833|10955923|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0
6925694|NCT00833833|10955918|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
6925695|NCT00833833|10955919|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
6925696|NCT00833833|10955920|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
6925697|NCT00833833|10955921|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
6925698|NCT00833833|10955922|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
6925699|NCT00833833|10955923|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
6925700|NCT00833833|10955918|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1
6925701|NCT00833833|10955919|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0
6925702|NCT00833833|10955920|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2
6925703|NCT00833833|10955921|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1
6925704|NCT00833833|10955922|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0
6925705|NCT00833833|10955923|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0
6925706|NCT00833833|10955918|FG000|Phase 1 (as of 01 April 2011)|Death|0
6925707|NCT00833833|10955919|FG001|Phase 1 (as of 01 April 2011)|Death|1
6925708|NCT00833833|10955920|FG002|Phase 1 (as of 01 April 2011)|Death|2
6925709|NCT00833833|10955921|FG003|Phase 1 (as of 01 April 2011)|Death|0
6925710|NCT00833833|10955922|FG004|Phase 1 (as of 01 April 2011)|Death|0
6925711|NCT00833833|10955923|FG005|Phase 1 (as of 01 April 2011)|Death|0
6925712|NCT00833833|10955918|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
6974898|NCT01190930|11027132|FG001|Induction|High Risk|0
7063462|NCT01949155|11161821|FG000|Overall Study|Protocol Violation|1
6832935|NCT00195260|10837337|FG002|Part 1: Dose Escalation|Adverse Event|0
6832936|NCT00195260|10837338|FG003|Part 1: Dose Escalation|Adverse Event|1
6832937|NCT00195260|10837339|FG004|Part 1: Dose Escalation|Adverse Event|1
6832938|NCT00195260|10837340|FG005|Part 1: Dose Escalation|Adverse Event|0
6832939|NCT00195260|10837341|FG006|Part 1: Dose Escalation|Adverse Event|3
6832940|NCT00195260|10837342|FG007|Part 1: Dose Escalation|Adverse Event|0
6832941|NCT00195260|10837343|FG008|Part 1: Dose Escalation|Adverse Event|0
6832942|NCT00195260|10837344|FG009|Part 1: Dose Escalation|Adverse Event|0
6832943|NCT00195260|10837345|FG010|Part 1: Dose Escalation|Adverse Event|0
6832944|NCT00195260|10837335|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0
6832945|NCT00195260|10837336|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0
6832946|NCT00195260|10837337|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0
6832947|NCT00195260|10837338|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0
6832948|NCT00195260|10837339|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2
6832949|NCT00195260|10837340|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0
6832950|NCT00195260|10837341|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0
6832951|NCT00195260|10837342|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1
6832952|NCT00195260|10837343|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0
6832953|NCT00195260|10837344|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0
6832954|NCT00195260|10837345|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0
6925713|NCT00833833|10955919|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
6925714|NCT00833833|10955920|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
6925715|NCT00833833|10955921|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
6925716|NCT00833833|10955922|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
6925717|NCT00833833|10955923|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
6925718|NCT00833833|10955918|FG000|Phase 1 (as of 01 April 2011)|Other|1
6925719|NCT00833833|10955919|FG001|Phase 1 (as of 01 April 2011)|Other|3
6925720|NCT00833833|10955920|FG002|Phase 1 (as of 01 April 2011)|Other|0
6925721|NCT00833833|10955921|FG003|Phase 1 (as of 01 April 2011)|Other|1
6925722|NCT00833833|10955922|FG004|Phase 1 (as of 01 April 2011)|Other|0
6925723|NCT00833833|10955923|FG005|Phase 1 (as of 01 April 2011)|Other|0
6925724|NCT00833833|10955918|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0
6925725|NCT00833833|10955919|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0
6925726|NCT00833833|10955920|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0
6925727|NCT00833833|10955921|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0
6925728|NCT00833833|10955922|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23
6925729|NCT00833833|10955923|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22
6925730|NCT00833833|10955918|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0
6925731|NCT00833833|10955919|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0
6925732|NCT00833833|10955920|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0
6925733|NCT00833833|10955921|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0
6925734|NCT00833833|10955922|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8
6925735|NCT00833833|10955923|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13
6925736|NCT00833833|10955918|FG000|Phase 2 (as of 01 April 2011)|Death|0
6925737|NCT00833833|10955919|FG001|Phase 2 (as of 01 April 2011)|Death|0
6925738|NCT00833833|10955920|FG002|Phase 2 (as of 01 April 2011)|Death|0
6925739|NCT00833833|10955921|FG003|Phase 2 (as of 01 April 2011)|Death|0
6925740|NCT00833833|10955922|FG004|Phase 2 (as of 01 April 2011)|Death|8
6925741|NCT00833833|10955923|FG005|Phase 2 (as of 01 April 2011)|Death|9
6925742|NCT00833833|10955918|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
6925743|NCT00833833|10955919|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
6925744|NCT00833833|10955920|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
6925745|NCT00833833|10955921|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
6925746|NCT00833833|10955922|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7
6925747|NCT00833833|10955923|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6
6925748|NCT00833833|10955918|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
6925749|NCT00833833|10955919|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
6925750|NCT00833833|10955920|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
6925751|NCT00833833|10955921|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
6925752|NCT00833833|10955922|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5
6925753|NCT00833833|10955923|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7
6925754|NCT00833833|10955918|FG000|Phase 2 (as of 01 April 2011)|Other|0
6925755|NCT00833833|10955919|FG001|Phase 2 (as of 01 April 2011)|Other|0
6925756|NCT00833833|10955920|FG002|Phase 2 (as of 01 April 2011)|Other|0
6925757|NCT00833833|10955921|FG003|Phase 2 (as of 01 April 2011)|Other|0
6925758|NCT00833833|10955922|FG004|Phase 2 (as of 01 April 2011)|Other|4
6925759|NCT00833833|10955923|FG005|Phase 2 (as of 01 April 2011)|Other|3
6925760|NCT00833833|10955918|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
6925761|NCT00833833|10955919|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
6925762|NCT00833833|10955920|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
6925763|NCT00833833|10955921|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
6925764|NCT00833833|10955922|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
6925765|NCT00833833|10955923|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1
6925766|NCT00833898|10955945|FG000|Overall Study|Withdrawal by Subject|33
6925767|NCT00833898|10955946|FG001|Overall Study|Withdrawal by Subject|27
6925768|NCT00833898|10955945|FG000|Overall Study|Lost to Follow-up|7
6832955|NCT00195260|10837335|FG000|Part 1: Dose Escalation|Death|0
6832956|NCT00195260|10837336|FG001|Part 1: Dose Escalation|Death|0
6832957|NCT00195260|10837337|FG002|Part 1: Dose Escalation|Death|0
6832958|NCT00195260|10837338|FG003|Part 1: Dose Escalation|Death|0
6925769|NCT00833898|10955946|FG001|Overall Study|Lost to Follow-up|7
6925770|NCT00833898|10955945|FG000|Overall Study|Patient did not receive transplant|0
6925771|NCT00833898|10955946|FG001|Overall Study|Patient did not receive transplant|2
6925772|NCT00833911|10955952|FG000|Titration|Adverse Event|18
6832959|NCT00195260|10837339|FG004|Part 1: Dose Escalation|Death|0
6832960|NCT00195260|10837340|FG005|Part 1: Dose Escalation|Death|0
6832961|NCT00195260|10837341|FG006|Part 1: Dose Escalation|Death|0
6832962|NCT00195260|10837342|FG007|Part 1: Dose Escalation|Death|1
6832963|NCT00195260|10837343|FG008|Part 1: Dose Escalation|Death|0
6832964|NCT00195260|10837344|FG009|Part 1: Dose Escalation|Death|0
6832965|NCT00195260|10837345|FG010|Part 1: Dose Escalation|Death|0
6832966|NCT00195260|10837335|FG000|Part 1: Dose Escalation|Disease Progression|3
6832967|NCT00195260|10837336|FG001|Part 1: Dose Escalation|Disease Progression|2
6832968|NCT00195260|10837337|FG002|Part 1: Dose Escalation|Disease Progression|5
6832969|NCT00195260|10837338|FG003|Part 1: Dose Escalation|Disease Progression|6
6832970|NCT00195260|10837339|FG004|Part 1: Dose Escalation|Disease Progression|4
6832971|NCT00195260|10837340|FG005|Part 1: Dose Escalation|Disease Progression|6
6832972|NCT00195260|10837341|FG006|Part 1: Dose Escalation|Disease Progression|7
6832973|NCT00195260|10837342|FG007|Part 1: Dose Escalation|Disease Progression|4
6832974|NCT00195260|10837343|FG008|Part 1: Dose Escalation|Disease Progression|0
6832975|NCT00195260|10837344|FG009|Part 1: Dose Escalation|Disease Progression|0
6832976|NCT00195260|10837345|FG010|Part 1: Dose Escalation|Disease Progression|0
6832977|NCT00195260|10837335|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1
6832978|NCT00195260|10837336|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1
6832979|NCT00195260|10837337|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1
6832980|NCT00195260|10837338|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0
6832981|NCT00195260|10837339|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0
6832982|NCT00195260|10837340|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1
6832983|NCT00195260|10837341|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0
6832984|NCT00195260|10837342|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0
6832985|NCT00195260|10837343|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0
6832986|NCT00195260|10837344|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0
6832987|NCT00195260|10837345|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0
6832988|NCT00195260|10837335|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
6832989|NCT00195260|10837336|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
6832990|NCT00195260|10837337|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
6832991|NCT00195260|10837338|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
6832992|NCT00195260|10837339|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
6832993|NCT00195260|10837340|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
6832994|NCT00195260|10837341|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
6832995|NCT00195260|10837342|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
6832996|NCT00195260|10837343|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21
6832997|NCT00195260|10837344|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29
6832998|NCT00195260|10837345|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15
6832999|NCT00195260|10837335|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
6833000|NCT00195260|10837336|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
6833001|NCT00195260|10837337|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
6833002|NCT00195260|10837338|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
6833003|NCT00195260|10837339|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
6833004|NCT00195260|10837340|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
6833005|NCT00195260|10837341|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
6833006|NCT00195260|10837342|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
6833007|NCT00195260|10837343|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5
6833008|NCT00195260|10837344|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3
6833009|NCT00195260|10837345|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2
6833010|NCT00195260|10837335|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
6833011|NCT00195260|10837336|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
6833012|NCT00195260|10837337|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
6833013|NCT00195260|10837338|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
6833014|NCT00195260|10837339|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
6833015|NCT00195260|10837340|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
6833016|NCT00195260|10837341|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
6833017|NCT00195260|10837342|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
6833018|NCT00195260|10837343|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1
6833019|NCT00195260|10837344|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2
6833020|NCT00195260|10837345|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3
6833021|NCT00195260|10837335|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
6833022|NCT00195260|10837336|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
6833023|NCT00195260|10837337|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
6833024|NCT00195260|10837338|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
6833025|NCT00195260|10837339|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
6833026|NCT00195260|10837340|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
6833027|NCT00195260|10837341|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
6833028|NCT00195260|10837342|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
6833029|NCT00195260|10837343|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6
6833030|NCT00195260|10837344|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4
6833031|NCT00195260|10837345|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3
6833032|NCT00195273|10837375|FG000|Overall Study|Adverse Event|9
6833033|NCT00195273|10837376|FG001|Overall Study|Adverse Event|9
6833034|NCT00195273|10837375|FG000|Overall Study|Protocol deviation|0
6833035|NCT00195273|10837376|FG001|Overall Study|Protocol deviation|1
6833036|NCT00195273|10837375|FG000|Overall Study|Lack of Efficacy|3
6833037|NCT00195273|10837376|FG001|Overall Study|Lack of Efficacy|1
6833038|NCT00195273|10837375|FG000|Overall Study|Procedural complications|9
6833039|NCT00195273|10837376|FG001|Overall Study|Procedural complications|3
6833040|NCT00195338|10837382|FG000|Overall Study|Lost to Follow-up|2
6833041|NCT00195338|10837382|FG000|Overall Study|Adverse Event|5
6833042|NCT00195338|10837382|FG000|Overall Study|Lack of Efficacy|1
6833043|NCT00195338|10837382|FG000|Overall Study|Early closure of the site|4
6833044|NCT00195351|10837388|FG000|Overall Study|Lost to Follow-up|9
6833045|NCT00195351|10837389|FG001|Overall Study|Lost to Follow-up|9
6833046|NCT00195351|10837388|FG000|Overall Study|Withdrawal by Subject|6
6833047|NCT00195351|10837389|FG001|Overall Study|Withdrawal by Subject|3
6833048|NCT00195351|10837388|FG000|Overall Study|Protocol Deviation|3
6833049|NCT00195351|10837389|FG001|Overall Study|Protocol Deviation|2
6833050|NCT00195351|10837388|FG000|Overall Study|Death|3
6833051|NCT00195351|10837389|FG001|Overall Study|Death|1
6833052|NCT00195351|10837388|FG000|Overall Study|Lack of Efficacy|0
6833053|NCT00195351|10837389|FG001|Overall Study|Lack of Efficacy|1
6833054|NCT00195429|10837401|FG000|Overall Study|Adverse Event|2
6833055|NCT00195429|10837402|FG001|Overall Study|Adverse Event|4
6833056|NCT00195429|10837401|FG000|Overall Study|Lack of Efficacy|2
6833057|NCT00195429|10837402|FG001|Overall Study|Lack of Efficacy|1
6833058|NCT00195429|10837401|FG000|Overall Study|Lost to Follow-up|1
6833059|NCT00195429|10837402|FG001|Overall Study|Lost to Follow-up|0
6833060|NCT00195442|10837408|FG000|Overall Study|Less than expected therapeutic effect|38
6833061|NCT00195442|10837408|FG000|Overall Study|Lost to Follow-up|27
6833062|NCT00195442|10837408|FG000|Overall Study|Switch to other Factor VIII preparation|23
6833063|NCT00195442|10837408|FG000|Overall Study|Intermittent product shortage|21
6833064|NCT00195442|10837408|FG000|Overall Study|Death|7
6833065|NCT00195442|10837408|FG000|Overall Study|No reason specified|4
6833066|NCT00195442|10837408|FG000|Overall Study|Poor cooperation|2
6833067|NCT00195442|10837408|FG000|Overall Study|Other|14
6833068|NCT00195494|10837414|FG000|Year 1|Adverse Event|0
6833069|NCT00195494|10837415|FG001|Year 1|Adverse Event|0
6925773|NCT00833911|10955952|FG000|Titration|Withdrawal by Subject|3
6925774|NCT00833911|10955952|FG000|Maintenance Phase I|Adverse Event|73
6925775|NCT00833911|10955952|FG000|Maintenance Phase I|Withdrawal by Subject|11
6925776|NCT00833911|10955952|FG000|Maintenance Phase I|Physician Decision|10
6925777|NCT00833911|10955952|FG000|Maintenance Phase I|Lack of Efficacy|4
6925778|NCT00833911|10955952|FG000|Maintenance Phase II|Adverse Event|6
6925779|NCT00833911|10955952|FG000|Maintenance Phase II|Physician Decision|2
6925780|NCT00833911|10955952|FG000|Maintenance Phase II|Withdrawal by Subject|1
6925781|NCT00833911|10955952|FG000|Maintenance Phase II|Lack of Efficacy|1
6925782|NCT00833924|10955960|FG000|Overall Study|Death|21
6925783|NCT00833924|10955960|FG000|Overall Study|Conversion|2
6925784|NCT00833924|10955960|FG000|Overall Study|Lost to Follow-up|2
6925785|NCT00833924|10955960|FG000|Overall Study|Withdrawal by Subject|13
6925786|NCT00833924|10955960|FG000|Overall Study|In study follow-up|71
6925787|NCT00833976|10955964|FG000|Overall Study|Withdrawal by Subject|5
6925788|NCT00833976|10955964|FG000|Overall Study|Lost to Follow-up|4
6925789|NCT00833976|10955964|FG000|Overall Study|Did not meet eligibility criteria|41
6925790|NCT00833976|10955964|FG000|Overall Study|Physician Decision|1
6925791|NCT00833989|10955972|FG000|Overall Study|Physician Decision|0
6925792|NCT00833989|10955973|FG001|Overall Study|Physician Decision|0
6925793|NCT00833989|10955974|FG002|Overall Study|Physician Decision|0
6925794|NCT00833989|10955975|FG003|Overall Study|Physician Decision|1
6925795|NCT00833989|10955972|FG000|Overall Study|Withdrawal by Subject|3
6925796|NCT00833989|10955973|FG001|Overall Study|Withdrawal by Subject|0
6925797|NCT00833989|10955974|FG002|Overall Study|Withdrawal by Subject|1
6925798|NCT00833989|10955975|FG003|Overall Study|Withdrawal by Subject|1
6925799|NCT00834041|10955990|FG000|Overall Study|Withdrawal by Subject|1
6925800|NCT00834041|10955991|FG001|Overall Study|Withdrawal by Subject|0
6833070|NCT00195494|10837416|FG002|Year 1|Adverse Event|0
6833071|NCT00195494|10837417|FG003|Year 1|Adverse Event|0
6833072|NCT00195494|10837418|FG004|Year 1|Adverse Event|34
6833073|NCT00195494|10837419|FG005|Year 1|Adverse Event|27
6833074|NCT00195494|10837414|FG000|Year 1|System Toxicity|0
6833075|NCT00195494|10837415|FG001|Year 1|System Toxicity|0
6833076|NCT00195494|10837416|FG002|Year 1|System Toxicity|0
6833077|NCT00195494|10837417|FG003|Year 1|System Toxicity|0
6833078|NCT00195494|10837418|FG004|Year 1|System Toxicity|0
6833079|NCT00195494|10837419|FG005|Year 1|System Toxicity|1
6925801|NCT00834041|10955990|FG000|Overall Study|Lost to Follow-up|0
6925802|NCT00834041|10955991|FG001|Overall Study|Lost to Follow-up|1
6925803|NCT00834080|10955997|FG000|Overall Study|Adverse Event|7
6925804|NCT00834080|10955997|FG000|Overall Study|Lost to Follow-up|7
6925805|NCT00834080|10955997|FG000|Overall Study|Withdrawal by Subject|5
6925806|NCT00834080|10955997|FG000|Overall Study|Other - Pregnancy|1
6833080|NCT00195494|10837414|FG000|Year 1|Lack of Efficacy|0
6833081|NCT00195494|10837415|FG001|Year 1|Lack of Efficacy|0
6833082|NCT00195494|10837416|FG002|Year 1|Lack of Efficacy|0
6833083|NCT00195494|10837417|FG003|Year 1|Lack of Efficacy|0
6833084|NCT00195494|10837418|FG004|Year 1|Lack of Efficacy|24
6833085|NCT00195494|10837419|FG005|Year 1|Lack of Efficacy|9
6833086|NCT00195494|10837414|FG000|Year 1|Compliance|0
6833087|NCT00195494|10837415|FG001|Year 1|Compliance|0
6833088|NCT00195494|10837416|FG002|Year 1|Compliance|0
6833089|NCT00195494|10837417|FG003|Year 1|Compliance|0
6833090|NCT00195494|10837418|FG004|Year 1|Compliance|5
6833091|NCT00195494|10837419|FG005|Year 1|Compliance|1
6833092|NCT00195494|10837414|FG000|Year 1|Lost to Follow-up|0
6833093|NCT00195494|10837415|FG001|Year 1|Lost to Follow-up|0
6833094|NCT00195494|10837416|FG002|Year 1|Lost to Follow-up|0
6833095|NCT00195494|10837417|FG003|Year 1|Lost to Follow-up|0
6833096|NCT00195494|10837418|FG004|Year 1|Lost to Follow-up|1
6833097|NCT00195494|10837419|FG005|Year 1|Lost to Follow-up|0
6833098|NCT00195494|10837414|FG000|Year 1|Missed >4 consecutive doses|0
6833099|NCT00195494|10837415|FG001|Year 1|Missed >4 consecutive doses|0
6833100|NCT00195494|10837416|FG002|Year 1|Missed >4 consecutive doses|0
6833101|NCT00195494|10837417|FG003|Year 1|Missed >4 consecutive doses|0
6833102|NCT00195494|10837418|FG004|Year 1|Missed >4 consecutive doses|3
6833103|NCT00195494|10837419|FG005|Year 1|Missed >4 consecutive doses|2
6833104|NCT00195494|10837414|FG000|Year 1|Protocol deviation|0
6833105|NCT00195494|10837415|FG001|Year 1|Protocol deviation|0
6833106|NCT00195494|10837416|FG002|Year 1|Protocol deviation|0
6833107|NCT00195494|10837417|FG003|Year 1|Protocol deviation|0
6833108|NCT00195494|10837418|FG004|Year 1|Protocol deviation|2
6833109|NCT00195494|10837419|FG005|Year 1|Protocol deviation|3
6833110|NCT00195494|10837414|FG000|Year 1|Physician Decision|0
6833111|NCT00195494|10837415|FG001|Year 1|Physician Decision|0
6833112|NCT00195494|10837416|FG002|Year 1|Physician Decision|0
6833113|NCT00195494|10837417|FG003|Year 1|Physician Decision|0
6833114|NCT00195494|10837418|FG004|Year 1|Physician Decision|1
6833115|NCT00195494|10837419|FG005|Year 1|Physician Decision|0
6833116|NCT00195494|10837414|FG000|Year 1|Withdrawal by Subject|0
6833117|NCT00195494|10837415|FG001|Year 1|Withdrawal by Subject|0
6833118|NCT00195494|10837416|FG002|Year 1|Withdrawal by Subject|0
6833119|NCT00195494|10837417|FG003|Year 1|Withdrawal by Subject|0
6833120|NCT00195494|10837418|FG004|Year 1|Withdrawal by Subject|8
6833121|NCT00195494|10837419|FG005|Year 1|Withdrawal by Subject|9
6833122|NCT00195494|10837414|FG000|Year 1|Protocol Violation|0
6833123|NCT00195494|10837415|FG001|Year 1|Protocol Violation|0
6833124|NCT00195494|10837416|FG002|Year 1|Protocol Violation|0
6833125|NCT00195494|10837417|FG003|Year 1|Protocol Violation|0
6833126|NCT00195494|10837418|FG004|Year 1|Protocol Violation|1
6833127|NCT00195494|10837419|FG005|Year 1|Protocol Violation|1
6833128|NCT00195494|10837414|FG000|Year 2|Adverse Event|3
6833129|NCT00195494|10837415|FG001|Year 2|Adverse Event|7
6833130|NCT00195494|10837416|FG002|Year 2|Adverse Event|5
6833131|NCT00195494|10837417|FG003|Year 2|Adverse Event|9
6833132|NCT00195494|10837418|FG004|Year 2|Adverse Event|0
6833133|NCT00195494|10837419|FG005|Year 2|Adverse Event|0
6833134|NCT00195494|10837414|FG000|Year 2|Lack of Efficacy|0
7039050|NCT01708161|11121631|FG000|Overall Study|Administrative problems|0
7039051|NCT01708161|11121632|FG001|Overall Study|Administrative problems|1
7039052|NCT01708161|11121633|FG002|Overall Study|Administrative problems|0
7039053|NCT01708161|11121634|FG003|Overall Study|Administrative problems|0
7039054|NCT01708161|11121635|FG004|Overall Study|Administrative problems|0
7039055|NCT01708161|11121636|FG005|Overall Study|Administrative problems|0
7039056|NCT01708161|11121631|FG000|Overall Study|Disease progression|3
7039057|NCT01708161|11121632|FG001|Overall Study|Disease progression|5
7039058|NCT01708161|11121633|FG002|Overall Study|Disease progression|5
6833135|NCT00195494|10837415|FG001|Year 2|Lack of Efficacy|1
6833136|NCT00195494|10837416|FG002|Year 2|Lack of Efficacy|7
6833137|NCT00195494|10837417|FG003|Year 2|Lack of Efficacy|7
6833138|NCT00195494|10837418|FG004|Year 2|Lack of Efficacy|0
6833139|NCT00195494|10837419|FG005|Year 2|Lack of Efficacy|0
6833140|NCT00195494|10837414|FG000|Year 2|Compliance|1
7039059|NCT01708161|11121634|FG003|Overall Study|Disease progression|13
7039060|NCT01708161|11121635|FG004|Overall Study|Disease progression|3
7039061|NCT01708161|11121636|FG005|Overall Study|Disease progression|0
7039062|NCT01708174|11121653|FG000|Treatment Period|Withdrawal by Subject|1
7039063|NCT01708174|11121654|FG001|Treatment Period|Withdrawal by Subject|0
7039064|NCT01708174|11121655|FG002|Treatment Period|Withdrawal by Subject|0
7039065|NCT01708174|11121653|FG000|Treatment Period|Progressive disease|0
7039066|NCT01708174|11121654|FG001|Treatment Period|Progressive disease|1
7039067|NCT01708174|11121655|FG002|Treatment Period|Progressive disease|0
7039068|NCT01708174|11121653|FG000|Treatment Period|Death|0
7039069|NCT01708174|11121654|FG001|Treatment Period|Death|0
7039070|NCT01708174|11121655|FG002|Treatment Period|Death|1
7039071|NCT01708174|11121653|FG000|Treatment Period|Adverse Event|0
7039072|NCT01708174|11121654|FG001|Treatment Period|Adverse Event|1
7039073|NCT01708174|11121655|FG002|Treatment Period|Adverse Event|0
7039074|NCT01708187|11121666|FG000|Overall Study|Lost to Follow-up|0
7039075|NCT01708187|11121667|FG001|Overall Study|Lost to Follow-up|1
7039076|NCT01708291|11121704|FG000|Overall Study|fighting|2
7039077|NCT01708291|11121705|FG001|Overall Study|fighting|1
7039078|NCT01708902|11121791|FG000|Overall Study|Adverse Event|3
7039079|NCT01708902|11121792|FG001|Overall Study|Adverse Event|4
7039080|NCT01708902|11121793|FG002|Overall Study|Adverse Event|9
7039081|NCT01708902|11121794|FG003|Overall Study|Adverse Event|2
7039082|NCT01708902|11121795|FG004|Overall Study|Adverse Event|7
7039083|NCT01708902|11121796|FG005|Overall Study|Adverse Event|3
7039084|NCT01708902|11121797|FG006|Overall Study|Adverse Event|5
6833141|NCT00195494|10837415|FG001|Year 2|Compliance|0
6833142|NCT00195494|10837416|FG002|Year 2|Compliance|0
6833143|NCT00195494|10837417|FG003|Year 2|Compliance|2
6833144|NCT00195494|10837418|FG004|Year 2|Compliance|0
6833145|NCT00195494|10837419|FG005|Year 2|Compliance|0
6833146|NCT00195494|10837414|FG000|Year 2|Lost to Follow-up|0
6833147|NCT00195494|10837415|FG001|Year 2|Lost to Follow-up|0
6833148|NCT00195494|10837416|FG002|Year 2|Lost to Follow-up|1
6833149|NCT00195494|10837417|FG003|Year 2|Lost to Follow-up|1
6833150|NCT00195494|10837418|FG004|Year 2|Lost to Follow-up|0
6833151|NCT00195494|10837419|FG005|Year 2|Lost to Follow-up|0
6833152|NCT00195494|10837414|FG000|Year 2|Missed >4 consecutive doses|1
6833153|NCT00195494|10837415|FG001|Year 2|Missed >4 consecutive doses|1
6833154|NCT00195494|10837416|FG002|Year 2|Missed >4 consecutive doses|1
6833155|NCT00195494|10837417|FG003|Year 2|Missed >4 consecutive doses|0
6833156|NCT00195494|10837418|FG004|Year 2|Missed >4 consecutive doses|0
6833157|NCT00195494|10837419|FG005|Year 2|Missed >4 consecutive doses|0
6833158|NCT00195494|10837414|FG000|Year 2|Protocol deviation|0
6833159|NCT00195494|10837415|FG001|Year 2|Protocol deviation|1
6833160|NCT00195494|10837416|FG002|Year 2|Protocol deviation|0
6833161|NCT00195494|10837417|FG003|Year 2|Protocol deviation|0
6833162|NCT00195494|10837418|FG004|Year 2|Protocol deviation|0
6833163|NCT00195494|10837419|FG005|Year 2|Protocol deviation|0
6833164|NCT00195494|10837414|FG000|Year 2|Physician Decision|1
6833165|NCT00195494|10837415|FG001|Year 2|Physician Decision|1
6833166|NCT00195494|10837416|FG002|Year 2|Physician Decision|0
6833167|NCT00195494|10837417|FG003|Year 2|Physician Decision|0
6833168|NCT00195494|10837418|FG004|Year 2|Physician Decision|0
6833169|NCT00195494|10837419|FG005|Year 2|Physician Decision|0
6833170|NCT00195494|10837414|FG000|Year 2|Withdrawal by Subject|1
6833171|NCT00195494|10837415|FG001|Year 2|Withdrawal by Subject|5
6833172|NCT00195494|10837416|FG002|Year 2|Withdrawal by Subject|4
6833173|NCT00195494|10837417|FG003|Year 2|Withdrawal by Subject|3
6833174|NCT00195494|10837418|FG004|Year 2|Withdrawal by Subject|0
6833175|NCT00195494|10837419|FG005|Year 2|Withdrawal by Subject|0
6833176|NCT00195494|10837414|FG000|Year 2|System toxicity|0
6833177|NCT00195494|10837415|FG001|Year 2|System toxicity|0
6833178|NCT00195494|10837416|FG002|Year 2|System toxicity|0
6833179|NCT00195494|10837417|FG003|Year 2|System toxicity|1
6833180|NCT00195494|10837418|FG004|Year 2|System toxicity|0
6833181|NCT00195494|10837419|FG005|Year 2|System toxicity|0
6833182|NCT00195507|10837437|FG000|Overall Study|Adverse Event|24
6833183|NCT00195507|10837438|FG001|Overall Study|Adverse Event|13
6833184|NCT00195507|10837437|FG000|Overall Study|Death|0
6833185|NCT00195507|10837438|FG001|Overall Study|Death|1
6833186|NCT00195507|10837437|FG000|Overall Study|Failed to Return|4
6833187|NCT00195507|10837438|FG001|Overall Study|Failed to Return|3
6833188|NCT00195507|10837437|FG000|Overall Study|Physician Decision|1
6833189|NCT00195507|10837438|FG001|Overall Study|Physician Decision|2
6833190|NCT00195507|10837437|FG000|Overall Study|Lost to Follow-up|3
6833191|NCT00195507|10837438|FG001|Overall Study|Lost to Follow-up|2
6833192|NCT00195507|10837437|FG000|Overall Study|Protocol Violation|5
6833193|NCT00195507|10837438|FG001|Overall Study|Protocol Violation|4
6833194|NCT00195507|10837437|FG000|Overall Study|Lack of Efficacy|40
6833195|NCT00195507|10837438|FG001|Overall Study|Lack of Efficacy|67
6833196|NCT00195507|10837437|FG000|Overall Study|Withdrawal by Subject|16
6925807|NCT00834080|10955997|FG000|Overall Study|Other - False positive tests of the UDS|1
6925808|NCT00834080|10955997|FG000|Overall Study|Physician Decision|1
6925809|NCT00834080|10955997|FG000|Overall Study|Subject Relocated|1
6925810|NCT00834366|10956048|FG000|Treatment Period 1|Adverse Event|1
6925811|NCT00834366|10956049|FG001|Treatment Period 1|Adverse Event|1
6925812|NCT00834834|10956099|FG000|Overall Study|Withdrawal by Subject|4
6833197|NCT00195507|10837438|FG001|Overall Study|Withdrawal by Subject|23
6925813|NCT00834834|10956100|FG001|Overall Study|Withdrawal by Subject|3
6925814|NCT00834899|10956125|FG000|Overall Study|Withdrawal by Subject|1
6925815|NCT00834899|10956126|FG001|Overall Study|Withdrawal by Subject|1
6925816|NCT00834912|10956138|FG000|Treatment Period 1|Adverse Event|0
6925817|NCT00834912|10956139|FG001|Treatment Period 1|Adverse Event|1
6925818|NCT00834912|10956140|FG002|Treatment Period 1|Adverse Event|0
6925819|NCT00834912|10956141|FG003|Treatment Period 1|Adverse Event|1
6925820|NCT00834912|10956142|FG004|Treatment Period 1|Adverse Event|0
6925821|NCT00834912|10956143|FG005|Treatment Period 1|Adverse Event|0
6925822|NCT00834912|10956138|FG000|Treatment Period 2|Withdrawal by Subject|0
6925823|NCT00834912|10956139|FG001|Treatment Period 2|Withdrawal by Subject|0
6925824|NCT00834912|10956140|FG002|Treatment Period 2|Withdrawal by Subject|1
6925825|NCT00834912|10956141|FG003|Treatment Period 2|Withdrawal by Subject|0
6833198|NCT00195507|10837437|FG000|Overall Study|Protocol Deviation|6
6833199|NCT00195507|10837438|FG001|Overall Study|Protocol Deviation|3
6833200|NCT00195650|10837453|FG000|Overall Study|Adverse Event|194
6833201|NCT00195650|10837453|FG000|Overall Study|Lack of Efficacy|99
6925826|NCT00834912|10956142|FG004|Treatment Period 2|Withdrawal by Subject|1
6925827|NCT00834912|10956143|FG005|Treatment Period 2|Withdrawal by Subject|0
6925828|NCT00835068|10956162|FG000|Overall Study|Death|1
6833202|NCT00195650|10837453|FG000|Overall Study|Withdrawal by Subject|67
6833203|NCT00195650|10837453|FG000|Overall Study|Lost to Follow-up|44
6833204|NCT00195650|10837453|FG000|Overall Study|Death|23
6833205|NCT00195650|10837453|FG000|Overall Study|Protocol Violation|15
6833206|NCT00195650|10837453|FG000|Overall Study|Administrative reasons|83
6833207|NCT00195663|10837460|FG000|2-year Double-blind Treatment Period|Adverse Event|21
7063463|NCT01949155|11161822|FG001|Overall Study|Protocol Violation|0
7063464|NCT01949480|11161844|FG000|Overall Study|Physician Decision|5
7063465|NCT01949480|11161845|FG001|Overall Study|Physician Decision|8
7063466|NCT01949532|11161853|FG000|Overall Study|On-study at the Data Cut-off Date|3
7063467|NCT01949532|11161854|FG001|Overall Study|On-study at the Data Cut-off Date|3
7063468|NCT01949662|11161879|FG000|Overall Study|Death|9
7063469|NCT01949662|11161880|FG001|Overall Study|Death|7
7063470|NCT01949662|11161879|FG000|Overall Study|Discharged before an agitation event|8
7063471|NCT01949662|11161880|FG001|Overall Study|Discharged before an agitation event|3
7063472|NCT01949662|11161879|FG000|Overall Study|Dropped out|1
7063473|NCT01949662|11161880|FG001|Overall Study|Dropped out|3
7063474|NCT01949662|11161879|FG000|Overall Study|Ineligible|0
7063475|NCT01949662|11161880|FG001|Overall Study|Ineligible|1
7063476|NCT01949870|11161894|FG000|Overall Study|Lack of Efficacy|2
7063477|NCT01949870|11161894|FG000|Overall Study|Adverse Event|1
7063478|NCT01949870|11161894|FG000|Overall Study|Study termination|1
7063479|NCT01949870|11161894|FG000|Overall Study|Eligibility requirements not fulfilled|2
7063480|NCT01950013|11161901|FG000|Overall Study|Withdrawal by Subject|0
7063481|NCT01950013|11161902|FG001|Overall Study|Withdrawal by Subject|2
7063482|NCT01950013|11161903|FG002|Overall Study|Withdrawal by Subject|0
7063483|NCT01950169|11161932|FG000|Overall Study|Withdrawal by Subject|2
7063484|NCT01950169|11161933|FG001|Overall Study|Withdrawal by Subject|8
6833208|NCT00195663|10837461|FG001|2-year Double-blind Treatment Period|Adverse Event|27
6833209|NCT00195663|10837462|FG002|2-year Double-blind Treatment Period|Adverse Event|32
6833210|NCT00195663|10837460|FG000|2-year Double-blind Treatment Period|Death|0
6833211|NCT00195663|10837461|FG001|2-year Double-blind Treatment Period|Death|2
6833212|NCT00195663|10837462|FG002|2-year Double-blind Treatment Period|Death|0
6833213|NCT00195663|10837460|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0
6833214|NCT00195663|10837461|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0
6833215|NCT00195663|10837462|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1
6833216|NCT00195663|10837460|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15
6833217|NCT00195663|10837461|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18
6833218|NCT00195663|10837462|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12
6833219|NCT00195663|10837460|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47
6833220|NCT00195663|10837461|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52
6833221|NCT00195663|10837462|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13
6833222|NCT00195663|10837460|FG000|2-year Double-blind Treatment Period|Protocol Violation|6
6833223|NCT00195663|10837461|FG001|2-year Double-blind Treatment Period|Protocol Violation|6
6833224|NCT00195663|10837462|FG002|2-year Double-blind Treatment Period|Protocol Violation|4
6833225|NCT00195663|10837460|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0
6833226|NCT00195663|10837461|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1
6833227|NCT00195663|10837462|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0
6833228|NCT00195663|10837460|FG000|2-year Double-blind Treatment Period|Recovery|1
6833229|NCT00195663|10837461|FG001|2-year Double-blind Treatment Period|Recovery|0
6833230|NCT00195663|10837462|FG002|2-year Double-blind Treatment Period|Recovery|1
6833231|NCT00195663|10837460|FG000|2-year Double-blind Treatment Period|Administrative reasons|3
6833232|NCT00195663|10837461|FG001|2-year Double-blind Treatment Period|Administrative reasons|2
6833233|NCT00195663|10837462|FG002|2-year Double-blind Treatment Period|Administrative reasons|9
6833234|NCT00195663|10837460|FG000|Open-Label Extension Period|Adverse Event|21
6833235|NCT00195663|10837461|FG001|Open-Label Extension Period|Adverse Event|32
6833236|NCT00195663|10837462|FG002|Open-Label Extension Period|Adverse Event|36
6833237|NCT00195663|10837460|FG000|Open-Label Extension Period|Lost to Follow-up|9
6833238|NCT00195663|10837461|FG001|Open-Label Extension Period|Lost to Follow-up|2
6833239|NCT00195663|10837462|FG002|Open-Label Extension Period|Lost to Follow-up|6
6833240|NCT00195663|10837460|FG000|Open-Label Extension Period|Recovery|0
6833241|NCT00195663|10837461|FG001|Open-Label Extension Period|Recovery|2
6833242|NCT00195663|10837462|FG002|Open-Label Extension Period|Recovery|2
6833243|NCT00195663|10837460|FG000|Open-Label Extension Period|Protocol Violation|3
6833244|NCT00195663|10837461|FG001|Open-Label Extension Period|Protocol Violation|4
6833245|NCT00195663|10837462|FG002|Open-Label Extension Period|Protocol Violation|4
6833246|NCT00195663|10837460|FG000|Open-Label Extension Period|Death|2
6833247|NCT00195663|10837461|FG001|Open-Label Extension Period|Death|2
6833248|NCT00195663|10837462|FG002|Open-Label Extension Period|Death|2
6833249|NCT00195663|10837460|FG000|Open-Label Extension Period|Withdrawal by Subject|16
6833250|NCT00195663|10837461|FG001|Open-Label Extension Period|Withdrawal by Subject|15
6833251|NCT00195663|10837462|FG002|Open-Label Extension Period|Withdrawal by Subject|22
6833252|NCT00195663|10837460|FG000|Open-Label Extension Period|Lack of Efficacy|14
6833253|NCT00195663|10837461|FG001|Open-Label Extension Period|Lack of Efficacy|6
6833254|NCT00195663|10837462|FG002|Open-Label Extension Period|Lack of Efficacy|12
6833255|NCT00195663|10837460|FG000|Open-Label Extension Period|Administrative reasons|11
7063485|NCT01950169|11161934|FG002|Overall Study|Withdrawal by Subject|1
7063486|NCT01950169|11161932|FG000|Overall Study|Death|1
7063487|NCT01950169|11161933|FG001|Overall Study|Death|0
7063488|NCT01950169|11161934|FG002|Overall Study|Death|0
6833256|NCT00195663|10837461|FG001|Open-Label Extension Period|Administrative reasons|11
7063489|NCT01950273|11161954|FG000|Overall Study|Protocol Violation|1
7063490|NCT01950273|11161955|FG001|Overall Study|Protocol Violation|0
6833257|NCT00195663|10837462|FG002|Open-Label Extension Period|Administrative reasons|13
6833258|NCT00195676|10837480|FG000|Period O - Open-label Treatment|Adverse Event|82
6833259|NCT00195676|10837480|FG000|Period O - Open-label Treatment|Death|6
6833260|NCT00195676|10837480|FG000|Period O - Open-label Treatment|Lack of Efficacy|198
6833261|NCT00195676|10837480|FG000|Period O - Open-label Treatment|Lost to Follow-up|91
6833262|NCT00195676|10837480|FG000|Period O - Open-label Treatment|Protocol Violation|12
6833263|NCT00195676|10837480|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147
6833264|NCT00195676|10837480|FG000|Period O - Open-label Treatment|Administrative reasons|2
6833265|NCT00195676|10837480|FG000|Period O - Open-label Treatment|Other reasons|68
6833266|NCT00195676|10837480|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4
6833267|NCT00195676|10837480|FG000|Period W (Withdrawal) - No Treatment|Death|2
6833268|NCT00195676|10837480|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11
6833269|NCT00195676|10837480|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46
6833270|NCT00195676|10837480|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397
6833271|NCT00195676|10837480|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129
6833272|NCT00195676|10837480|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1
6833273|NCT00195676|10837480|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18
6833274|NCT00195676|10837480|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4
6833275|NCT00195676|10837480|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5
6833276|NCT00195676|10837480|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11
6833277|NCT00195676|10837480|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9
6833278|NCT00195676|10837480|FG000|Period R - Retreatment 16 Weeks|Other reasons|6
6833279|NCT00195715|10837509|FG000|Overall Study|Adverse Event|122
6833280|NCT00195715|10837509|FG000|Overall Study|Withdrawal by Subject|58
6833281|NCT00195715|10837509|FG000|Overall Study|Lost to Follow-up|27
6833282|NCT00195715|10837509|FG000|Overall Study|Protocol Violation|13
6833283|NCT00195715|10837509|FG000|Overall Study|Lack of Efficacy|93
6833284|NCT00195715|10837509|FG000|Overall Study|Pregnancy|14
6833285|NCT00195715|10837509|FG000|Overall Study|Investigative site closure|8
6833286|NCT00195715|10837509|FG000|Overall Study|Subject moved/relocated|7
6833287|NCT00195715|10837509|FG000|Overall Study|Subject non-compliance|6
6833288|NCT00195715|10837509|FG000|Overall Study|Subject started commercial Humira|5
6833289|NCT00195715|10837509|FG000|Overall Study|Subject choice|3
6833290|NCT00195715|10837509|FG000|Overall Study|Loss of response/no improvement|3
6833291|NCT00195715|10837509|FG000|Overall Study|Sponsor stopped study|1
6833292|NCT00195715|10837509|FG000|Overall Study|Administrative reasons|2
6833293|NCT00195715|10837509|FG000|Overall Study|Investigator's decision|2
6833294|NCT00195715|10837509|FG000|Overall Study|Subject wants to get pregnant|4
6833295|NCT00195715|10837509|FG000|Overall Study|Use of prohibited medication|2
7039085|NCT01708902|11121791|FG000|Overall Study|Lack of Efficacy|3
7039086|NCT01708902|11121792|FG001|Overall Study|Lack of Efficacy|1
7039087|NCT01708902|11121793|FG002|Overall Study|Lack of Efficacy|0
7039088|NCT01708902|11121794|FG003|Overall Study|Lack of Efficacy|0
7063491|NCT01950273|11161954|FG000|Overall Study|Withdrawal by Subject|2
7063492|NCT01950273|11161955|FG001|Overall Study|Withdrawal by Subject|0
7063493|NCT01950273|11161954|FG000|Overall Study|Other not defined above|1
7063494|NCT01950273|11161955|FG001|Overall Study|Other not defined above|0
7063495|NCT01950364|11161976|FG000|Overall Study|Adverse Event|3
7063496|NCT01950364|11161977|FG001|Overall Study|Adverse Event|0
7063497|NCT01950364|11161976|FG000|Overall Study|Stem Cell Transplant|2
7063498|NCT01950364|11161977|FG001|Overall Study|Stem Cell Transplant|6
7063499|NCT01950364|11161976|FG000|Overall Study|Disease Progression|5
7063500|NCT01950364|11161977|FG001|Overall Study|Disease Progression|2
7063501|NCT01950364|11161976|FG000|Overall Study|Withdrawal by Subject|0
7063502|NCT01950364|11161977|FG001|Overall Study|Withdrawal by Subject|1
7063503|NCT01950364|11161976|FG000|Overall Study|Protocol Violation|0
7063504|NCT01950364|11161977|FG001|Overall Study|Protocol Violation|1
7063505|NCT01950741|11161987|FG000|Overall Study|Lost to Follow-up|1
7063506|NCT01950741|11161987|FG000|Overall Study|Death|1
7063507|NCT01950741|11161987|FG000|Overall Study|Withdrawal by Subject|1
7082393|NCT02141659|11192926|FG000|Overall Study|Lack of Efficacy|0
7082394|NCT02141659|11192927|FG001|Overall Study|Lack of Efficacy|0
7082395|NCT02141659|11192928|FG002|Overall Study|Lack of Efficacy|0
7082396|NCT02141659|11192929|FG003|Overall Study|Lack of Efficacy|0
7082397|NCT02141659|11192930|FG004|Overall Study|Lack of Efficacy|0
7082398|NCT02141659|11192931|FG005|Overall Study|Lack of Efficacy|1
7082399|NCT02141659|11192926|FG000|Overall Study|Pretreatment Event/ Adverse Event|0
7082400|NCT02141659|11192927|FG001|Overall Study|Pretreatment Event/ Adverse Event|0
7082401|NCT02141659|11192928|FG002|Overall Study|Pretreatment Event/ Adverse Event|0
7082402|NCT02141659|11192929|FG003|Overall Study|Pretreatment Event/ Adverse Event|0
7082403|NCT02141659|11192930|FG004|Overall Study|Pretreatment Event/ Adverse Event|2
6833296|NCT00195715|10837509|FG000|Overall Study|Planned surgery|2
7039089|NCT01708902|11121795|FG004|Overall Study|Lack of Efficacy|0
7039090|NCT01708902|11121796|FG005|Overall Study|Lack of Efficacy|1
7039091|NCT01708902|11121797|FG006|Overall Study|Lack of Efficacy|0
7039092|NCT01708902|11121791|FG000|Overall Study|Non compliance with protocol|0
7039093|NCT01708902|11121792|FG001|Overall Study|Non compliance with protocol|2
7039094|NCT01708902|11121793|FG002|Overall Study|Non compliance with protocol|1
7082404|NCT02141659|11192931|FG005|Overall Study|Pretreatment Event/ Adverse Event|1
7039095|NCT01708902|11121794|FG003|Overall Study|Non compliance with protocol|3
7039096|NCT01708902|11121795|FG004|Overall Study|Non compliance with protocol|0
7039097|NCT01708902|11121796|FG005|Overall Study|Non compliance with protocol|0
7039098|NCT01708902|11121797|FG006|Overall Study|Non compliance with protocol|0
7039099|NCT01708902|11121791|FG000|Overall Study|Lost to Follow-up|2
7039100|NCT01708902|11121792|FG001|Overall Study|Lost to Follow-up|1
7039101|NCT01708902|11121793|FG002|Overall Study|Lost to Follow-up|2
7039102|NCT01708902|11121794|FG003|Overall Study|Lost to Follow-up|2
7039103|NCT01708902|11121795|FG004|Overall Study|Lost to Follow-up|0
7039104|NCT01708902|11121796|FG005|Overall Study|Lost to Follow-up|0
7039105|NCT01708902|11121797|FG006|Overall Study|Lost to Follow-up|1
7039106|NCT01708902|11121791|FG000|Overall Study|Refused to continue trial medication|8
7039107|NCT01708902|11121792|FG001|Overall Study|Refused to continue trial medication|0
7039108|NCT01708902|11121793|FG002|Overall Study|Refused to continue trial medication|4
7039109|NCT01708902|11121794|FG003|Overall Study|Refused to continue trial medication|2
7039110|NCT01708902|11121795|FG004|Overall Study|Refused to continue trial medication|8
7039111|NCT01708902|11121796|FG005|Overall Study|Refused to continue trial medication|1
7039112|NCT01708902|11121797|FG006|Overall Study|Refused to continue trial medication|1
7039113|NCT01708902|11121791|FG000|Overall Study|Other Reason|1
7039114|NCT01708902|11121792|FG001|Overall Study|Other Reason|0
7039115|NCT01708902|11121793|FG002|Overall Study|Other Reason|1
7039116|NCT01708902|11121794|FG003|Overall Study|Other Reason|1
7039117|NCT01708902|11121795|FG004|Overall Study|Other Reason|1
7039118|NCT01708902|11121796|FG005|Overall Study|Other Reason|2
7039119|NCT01708902|11121797|FG006|Overall Study|Other Reason|0
7039120|NCT01708915|11121820|FG000|Overall Study|Adverse Event|1
7039121|NCT01708915|11121821|FG001|Overall Study|Adverse Event|0
7039122|NCT01708915|11121822|FG002|Overall Study|Adverse Event|9
7039123|NCT01708915|11121823|FG003|Overall Study|Adverse Event|13
7039124|NCT01708915|11121820|FG000|Overall Study|Lack of Efficacy|84
7039125|NCT01708915|11121821|FG001|Overall Study|Lack of Efficacy|60
7039126|NCT01708915|11121822|FG002|Overall Study|Lack of Efficacy|35
7039127|NCT01708915|11121823|FG003|Overall Study|Lack of Efficacy|15
7039128|NCT01708915|11121820|FG000|Overall Study|Protocol Violation|0
7039129|NCT01708915|11121821|FG001|Overall Study|Protocol Violation|0
7039130|NCT01708915|11121822|FG002|Overall Study|Protocol Violation|0
7039131|NCT01708915|11121823|FG003|Overall Study|Protocol Violation|1
7039132|NCT01708915|11121820|FG000|Overall Study|Withdrawal by Subject|0
7039133|NCT01708915|11121821|FG001|Overall Study|Withdrawal by Subject|1
7039134|NCT01708915|11121822|FG002|Overall Study|Withdrawal by Subject|2
7039135|NCT01708915|11121823|FG003|Overall Study|Withdrawal by Subject|2
7039136|NCT01708915|11121820|FG000|Overall Study|Other reasons than stated above|1
7039137|NCT01708915|11121821|FG001|Overall Study|Other reasons than stated above|1
7039138|NCT01708915|11121822|FG002|Overall Study|Other reasons than stated above|0
7039139|NCT01708915|11121823|FG003|Overall Study|Other reasons than stated above|2
7039140|NCT01709084|11121849|FG000|Overall Study|Lost to Follow-up|4
7039141|NCT01709084|11121850|FG001|Overall Study|Lost to Follow-up|7
7039142|NCT01709084|11121849|FG000|Overall Study|Withdrawal by Subject|2
7039143|NCT01709084|11121850|FG001|Overall Study|Withdrawal by Subject|2
7039144|NCT01709084|11121849|FG000|Overall Study|Adverse Event|5
7039145|NCT01709084|11121850|FG001|Overall Study|Adverse Event|0
7039146|NCT01709084|11121849|FG000|Overall Study|Other|5
7039147|NCT01709084|11121850|FG001|Overall Study|Other|3
7039148|NCT01709084|11121849|FG000|Overall Study|Participant Reached a Virologic Endpoint|0
7039149|NCT01709084|11121850|FG001|Overall Study|Participant Reached a Virologic Endpoint|1
7039150|NCT01709084|11121849|FG000|Overall Study|Not Treated|0
7039151|NCT01709084|11121850|FG001|Overall Study|Not Treated|2
7039152|NCT01709110|11121858|FG000|Overall Study|Adverse Event|56
7039153|NCT01709110|11121859|FG001|Overall Study|Adverse Event|48
7039154|NCT01709110|11121858|FG000|Overall Study|Death|14
7039155|NCT01709110|11121859|FG001|Overall Study|Death|6
7039156|NCT01709110|11121858|FG000|Overall Study|Lost to Follow-up|7
7039157|NCT01709110|11121859|FG001|Overall Study|Lost to Follow-up|5
7039158|NCT01709110|11121858|FG000|Overall Study|Protocol Violation|4
7039159|NCT01709110|11121859|FG001|Overall Study|Protocol Violation|6
7039160|NCT01709110|11121858|FG000|Overall Study|Withdrawal by Subject|96
7039161|NCT01709110|11121859|FG001|Overall Study|Withdrawal by Subject|89
7039162|NCT01709110|11121858|FG000|Overall Study|Physician Decision|4
7039163|NCT01709110|11121859|FG001|Overall Study|Physician Decision|10
7039164|NCT01709110|11121858|FG000|Overall Study|Sponsor Decision|2
7039165|NCT01709110|11121859|FG001|Overall Study|Sponsor Decision|2
7039166|NCT01709110|11121858|FG000|Overall Study|Lack of Efficacy|1
7039167|NCT01709110|11121859|FG001|Overall Study|Lack of Efficacy|1
7039168|NCT01709110|11121858|FG000|Overall Study|Caregiver Decision|1
7039169|NCT01709110|11121859|FG001|Overall Study|Caregiver Decision|1
7039170|NCT01709149|11121868|FG000|Open-label Lead-in Phase|Adverse Event|109
7039171|NCT01709149|11121869|FG001|Open-label Lead-in Phase|Adverse Event|0
7039172|NCT01709149|11121870|FG002|Open-label Lead-in Phase|Adverse Event|0
7039173|NCT01709149|11121868|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2
7039174|NCT01709149|11121869|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0
7039175|NCT01709149|11121870|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0
7039176|NCT01709149|11121868|FG000|Open-label Lead-in Phase|Death|1
7039177|NCT01709149|11121869|FG001|Open-label Lead-in Phase|Death|0
7039178|NCT01709149|11121870|FG002|Open-label Lead-in Phase|Death|0
7039179|NCT01709149|11121868|FG000|Open-label Lead-in Phase|Protocol Violation|3
7039180|NCT01709149|11121869|FG001|Open-label Lead-in Phase|Protocol Violation|0
7039181|NCT01709149|11121870|FG002|Open-label Lead-in Phase|Protocol Violation|0
7039182|NCT01709149|11121868|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0
7039183|NCT01709149|11121869|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12
7039184|NCT01709149|11121870|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78
7039185|NCT01709149|11121868|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
7039186|NCT01709149|11121869|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7
7039187|NCT01709149|11121870|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12
7039188|NCT01709149|11121868|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0
7039189|NCT01709149|11121869|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2
7039190|NCT01709149|11121870|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5
7039191|NCT01709149|11121868|FG000|Double-blind, Placebo-controlled Phase|Death|0
7039192|NCT01709149|11121869|FG001|Double-blind, Placebo-controlled Phase|Death|2
6833297|NCT00195715|10837509|FG000|Overall Study|Increased infection rate|1
6833298|NCT00195715|10837509|FG000|Overall Study|Ineligible|1
6833299|NCT00195715|10837509|FG000|Overall Study|Colonic stricture|1
6833300|NCT00195715|10837509|FG000|Overall Study|Sponsor discontinued trial|1
6833301|NCT00195715|10837509|FG000|Overall Study|Sponsor discretion - trial ended early|1
6833302|NCT00195819|10837513|FG000|Double-Blind|Withdrawal by Subject|1
6833303|NCT00195819|10837514|FG001|Double-Blind|Withdrawal by Subject|0
6833304|NCT00195819|10837513|FG000|Double-Blind|Moved|1
6833305|NCT00195819|10837514|FG001|Double-Blind|Moved|0
6833306|NCT00195819|10837513|FG000|Open-label|Adverse Event|0
6833307|NCT00195819|10837514|FG001|Open-label|Adverse Event|9
6833308|NCT00195819|10837513|FG000|Open-label|Lack of Efficacy|0
6833309|NCT00195819|10837514|FG001|Open-label|Lack of Efficacy|2
6833310|NCT00195819|10837513|FG000|Open-label|Pregnancy|0
6833311|NCT00195819|10837514|FG001|Open-label|Pregnancy|1
6833312|NCT00195819|10837513|FG000|Open-label|Protocol Violation|0
6925829|NCT00835068|10956163|FG001|Overall Study|Death|0
6925830|NCT00835068|10956162|FG000|Overall Study|Adverse Event|0
6925831|NCT00835068|10956163|FG001|Overall Study|Adverse Event|1
6925832|NCT00835068|10956162|FG000|Overall Study|Other|8
6925833|NCT00835068|10956163|FG001|Overall Study|Other|0
6925834|NCT00835068|10956162|FG000|Overall Study|Withdrawal by Subject|1
6925835|NCT00835068|10956163|FG001|Overall Study|Withdrawal by Subject|0
6925836|NCT00835120|10956169|FG000|Overall Study|Lack of Efficacy|1
6925837|NCT00835120|10956169|FG000|Overall Study|Lost to Follow-up|3
6925838|NCT00835120|10956169|FG000|Overall Study|Adverse Event|2
6925839|NCT00835120|10956169|FG000|Overall Study|Withdrawal by Subject|2
6925840|NCT00835237|10956212|FG000|Overall Study|Lost to Follow-up|4
6925841|NCT00835237|10956213|FG001|Overall Study|Lost to Follow-up|0
6925842|NCT00835237|10956212|FG000|Overall Study|Withdrawal by Subject|2
6925843|NCT00835237|10956213|FG001|Overall Study|Withdrawal by Subject|0
6925844|NCT00835341|10956221|FG000|Overall Study|Lost to Follow-up|3
6925845|NCT00835341|10956222|FG001|Overall Study|Lost to Follow-up|12
6925846|NCT00835380|10956228|FG000|Overall Study|Withdrawal by Subject|2
6925847|NCT00835731|10956247|FG000|Overall Study|Withdrawal by Subject|1
6925848|NCT00835731|10956248|FG001|Overall Study|Withdrawal by Subject|0
6925849|NCT00835731|10956247|FG000|Overall Study|Physician Decision|1
6925850|NCT00835731|10956248|FG001|Overall Study|Physician Decision|1
6925851|NCT00835770|10956256|FG000|Overall Study|MS Relapse|17
6925852|NCT00835770|10956257|FG001|Overall Study|MS Relapse|23
6925853|NCT00835770|10956256|FG000|Overall Study|MS Progression|14
6925854|NCT00835770|10956257|FG001|Overall Study|MS Progression|9
6925855|NCT00835770|10956256|FG000|Overall Study|Adverse Event|113
6925856|NCT00835770|10956257|FG001|Overall Study|Adverse Event|124
6925857|NCT00835770|10956256|FG000|Overall Study|Lost to Follow-up|22
6925858|NCT00835770|10956257|FG001|Overall Study|Lost to Follow-up|19
6925859|NCT00835770|10956256|FG000|Overall Study|Consent Withdrawn|144
6925860|NCT00835770|10956257|FG001|Overall Study|Consent Withdrawn|156
6925861|NCT00835770|10956256|FG000|Overall Study|Investigator Decision|42
6925862|NCT00835770|10956257|FG001|Overall Study|Investigator Decision|42
6925863|NCT00835770|10956256|FG000|Overall Study|Participant Non-Compliance|11
6925864|NCT00835770|10956257|FG001|Overall Study|Participant Non-Compliance|9
6925865|NCT00835770|10956256|FG000|Overall Study|Death|4
6925866|NCT00835770|10956257|FG001|Overall Study|Death|6
6925867|NCT00835770|10956256|FG000|Overall Study|Other|115
6925868|NCT00835770|10956257|FG001|Overall Study|Other|104
6925869|NCT00835770|10956256|FG000|Overall Study|Other|2
6925870|NCT00835770|10956257|FG001|Overall Study|Other|1
6925871|NCT00835978|10956300|FG000|Overall Study|Death|33
6925872|NCT00835978|10956301|FG001|Overall Study|Death|40
6925873|NCT00835978|10956302|FG002|Overall Study|Death|49
6925874|NCT00835978|10956303|FG003|Overall Study|Death|4
6925875|NCT00835978|10956300|FG000|Overall Study|Lost to Follow-up|3
6925876|NCT00835978|10956301|FG001|Overall Study|Lost to Follow-up|4
7039193|NCT01709149|11121870|FG002|Double-blind, Placebo-controlled Phase|Death|0
6833313|NCT00195819|10837514|FG001|Open-label|Protocol Violation|2
6833314|NCT00195819|10837513|FG000|Open-label|Moved|0
6925877|NCT00835978|10956302|FG002|Overall Study|Lost to Follow-up|2
6925878|NCT00835978|10956303|FG003|Overall Study|Lost to Follow-up|1
6925879|NCT00835978|10956300|FG000|Overall Study|Other|5
6833315|NCT00195819|10837514|FG001|Open-label|Moved|1
6833316|NCT00195819|10837513|FG000|Open-label|Withdrawal by Subject|0
6833317|NCT00195819|10837514|FG001|Open-label|Withdrawal by Subject|5
6833318|NCT00196105|10837529|FG000|Overall Study|Lost to Follow-up|4
6833319|NCT00196105|10837530|FG001|Overall Study|Lost to Follow-up|5
6833320|NCT00196105|10837531|FG002|Overall Study|Lost to Follow-up|7
6833321|NCT00196196|10837539|FG000|Overall Study|Withdrawal by Subject|2
6833322|NCT00196196|10837539|FG000|Overall Study|Did not have required condition (hydroce|5
6833323|NCT00196313|10837545|FG000|Overall Study|Protocol Violation|2
6833324|NCT00196313|10837546|FG001|Overall Study|Protocol Violation|3
6833325|NCT00196313|10837545|FG000|Overall Study|Withdrawal by Subject|3
6833326|NCT00196313|10837546|FG001|Overall Study|Withdrawal by Subject|1
6833327|NCT00196313|10837545|FG000|Overall Study|Adverse Event|3
6833328|NCT00196313|10837546|FG001|Overall Study|Adverse Event|1
6833329|NCT00196313|10837545|FG000|Overall Study|Subject Pregnant|1
6833330|NCT00196313|10837546|FG001|Overall Study|Subject Pregnant|1
6833331|NCT00196313|10837545|FG000|Overall Study|Lost to Follow-up|2
6833332|NCT00196313|10837546|FG001|Overall Study|Lost to Follow-up|2
6833333|NCT00196326|10837553|FG000|Overall Study|Did not meet protocol requirements|64
6833334|NCT00196326|10837553|FG000|Overall Study|Non-compliance with the protocol|81
6833335|NCT00196326|10837553|FG000|Overall Study|Physician Decision|3
6833336|NCT00196326|10837553|FG000|Overall Study|Withdrawal by Subject|225
6833337|NCT00196326|10837553|FG000|Overall Study|Adverse Event|253
6833338|NCT00196326|10837553|FG000|Overall Study|Pregnancy|34
6833339|NCT00196326|10837553|FG000|Overall Study|Lost to Follow-up|304
6833340|NCT00196326|10837553|FG000|Overall Study|Other|22
6833341|NCT00196937|10837566|FG000|Overall Study|Serious Adverse Event|1
6833342|NCT00196937|10837567|FG001|Overall Study|Serious Adverse Event|0
6833343|NCT00196937|10837568|FG002|Overall Study|Serious Adverse Event|0
6833344|NCT00196937|10837566|FG000|Overall Study|Non-serious adverse event|1
7039194|NCT01709149|11121868|FG000|Double-blind, Placebo-controlled Phase|not defined|0
7039195|NCT01709149|11121869|FG001|Double-blind, Placebo-controlled Phase|not defined|1
7039196|NCT01709149|11121870|FG002|Double-blind, Placebo-controlled Phase|not defined|2
7039197|NCT01709149|11121868|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7039198|NCT01709149|11121869|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2
6833345|NCT00196937|10837567|FG001|Overall Study|Non-serious adverse event|1
6833346|NCT00196937|10837568|FG002|Overall Study|Non-serious adverse event|1
6833347|NCT00196937|10837566|FG000|Overall Study|Withdrawal by Subject|0
6833348|NCT00196937|10837567|FG001|Overall Study|Withdrawal by Subject|0
6833349|NCT00196937|10837568|FG002|Overall Study|Withdrawal by Subject|2
6833350|NCT00196937|10837566|FG000|Overall Study|Lost to Follow-up|4
6833351|NCT00196937|10837567|FG001|Overall Study|Lost to Follow-up|3
6833352|NCT00196937|10837568|FG002|Overall Study|Lost to Follow-up|3
6833353|NCT00196937|10837566|FG000|Overall Study|Other|3
6833354|NCT00196937|10837567|FG001|Overall Study|Other|1
6833355|NCT00196937|10837568|FG002|Overall Study|Other|1
6833356|NCT00196976|10837591|FG000|Primary Study|Migrated from study area|0
6833357|NCT00196976|10837592|FG001|Primary Study|Migrated from study area|0
6833358|NCT00196976|10837593|FG002|Primary Study|Migrated from study area|0
6833359|NCT00196976|10837594|FG003|Primary Study|Migrated from study area|0
6833360|NCT00196976|10837595|FG004|Primary Study|Migrated from study area|0
6833361|NCT00196976|10837596|FG005|Primary Study|Migrated from study area|0
6833362|NCT00196976|10837597|FG006|Primary Study|Migrated from study area|0
6833363|NCT00196976|10837598|FG007|Primary Study|Migrated from study area|1
6833364|NCT00196976|10837599|FG008|Primary Study|Migrated from study area|0
6833365|NCT00196976|10837600|FG009|Primary Study|Migrated from study area|0
6833366|NCT00196976|10837601|FG010|Primary Study|Migrated from study area|0
6833367|NCT00196976|10837602|FG011|Primary Study|Migrated from study area|0
6833368|NCT00196976|10837603|FG012|Primary Study|Migrated from study area|0
6833369|NCT00196976|10837604|FG013|Primary Study|Migrated from study area|0
6833370|NCT00196976|10837591|FG000|Primary Study|Protocol Violation|0
6833371|NCT00196976|10837592|FG001|Primary Study|Protocol Violation|1
6833372|NCT00196976|10837593|FG002|Primary Study|Protocol Violation|1
6833373|NCT00196976|10837594|FG003|Primary Study|Protocol Violation|0
6833374|NCT00196976|10837595|FG004|Primary Study|Protocol Violation|0
6833375|NCT00196976|10837596|FG005|Primary Study|Protocol Violation|0
6833376|NCT00196976|10837597|FG006|Primary Study|Protocol Violation|0
6833377|NCT00196976|10837598|FG007|Primary Study|Protocol Violation|0
6833378|NCT00196976|10837599|FG008|Primary Study|Protocol Violation|0
6833379|NCT00196976|10837600|FG009|Primary Study|Protocol Violation|0
6833380|NCT00196976|10837601|FG010|Primary Study|Protocol Violation|0
6833381|NCT00196976|10837602|FG011|Primary Study|Protocol Violation|0
6833382|NCT00196976|10837603|FG012|Primary Study|Protocol Violation|0
6833383|NCT00196976|10837604|FG013|Primary Study|Protocol Violation|0
6833384|NCT00196976|10837591|FG000|Primary Study|Withdrawal by Subject|1
6833385|NCT00196976|10837592|FG001|Primary Study|Withdrawal by Subject|0
6833386|NCT00196976|10837593|FG002|Primary Study|Withdrawal by Subject|1
6833387|NCT00196976|10837594|FG003|Primary Study|Withdrawal by Subject|1
6833388|NCT00196976|10837595|FG004|Primary Study|Withdrawal by Subject|2
6833389|NCT00196976|10837596|FG005|Primary Study|Withdrawal by Subject|1
6833390|NCT00196976|10837597|FG006|Primary Study|Withdrawal by Subject|0
6833391|NCT00196976|10837598|FG007|Primary Study|Withdrawal by Subject|0
6833392|NCT00196976|10837599|FG008|Primary Study|Withdrawal by Subject|0
6833393|NCT00196976|10837600|FG009|Primary Study|Withdrawal by Subject|1
6833394|NCT00196976|10837601|FG010|Primary Study|Withdrawal by Subject|0
6833395|NCT00196976|10837602|FG011|Primary Study|Withdrawal by Subject|0
6833396|NCT00196976|10837603|FG012|Primary Study|Withdrawal by Subject|0
6833397|NCT00196976|10837604|FG013|Primary Study|Withdrawal by Subject|0
6833398|NCT00196976|10837591|FG000|Primary Study|Lost to Follow-up|0
6833399|NCT00196976|10837592|FG001|Primary Study|Lost to Follow-up|0
6833400|NCT00196976|10837593|FG002|Primary Study|Lost to Follow-up|0
6833401|NCT00196976|10837594|FG003|Primary Study|Lost to Follow-up|0
6833402|NCT00196976|10837595|FG004|Primary Study|Lost to Follow-up|1
6833403|NCT00196976|10837596|FG005|Primary Study|Lost to Follow-up|1
6833404|NCT00196976|10837597|FG006|Primary Study|Lost to Follow-up|0
6833405|NCT00196976|10837598|FG007|Primary Study|Lost to Follow-up|2
6833406|NCT00196976|10837599|FG008|Primary Study|Lost to Follow-up|0
6833407|NCT00196976|10837600|FG009|Primary Study|Lost to Follow-up|0
6833408|NCT00196976|10837601|FG010|Primary Study|Lost to Follow-up|0
6833409|NCT00196976|10837602|FG011|Primary Study|Lost to Follow-up|0
6833410|NCT00196976|10837603|FG012|Primary Study|Lost to Follow-up|0
6925880|NCT00835978|10956301|FG001|Overall Study|Other|1
6925881|NCT00835978|10956302|FG002|Overall Study|Other|8
6925882|NCT00835978|10956303|FG003|Overall Study|Other|0
6925883|NCT00835978|10956300|FG000|Overall Study|Objective progression or relapse|2
6925884|NCT00835978|10956301|FG001|Overall Study|Objective progression or relapse|0
6925885|NCT00835978|10956302|FG002|Overall Study|Objective progression or relapse|1
6925886|NCT00835978|10956303|FG003|Overall Study|Objective progression or relapse|0
6925887|NCT00835978|10956300|FG000|Overall Study|Adverse Event|1
6925888|NCT00835978|10956301|FG001|Overall Study|Adverse Event|0
6925889|NCT00835978|10956302|FG002|Overall Study|Adverse Event|1
6925890|NCT00835978|10956303|FG003|Overall Study|Adverse Event|0
6925891|NCT00835978|10956300|FG000|Overall Study|Withdrawal by Subject|0
6925892|NCT00835978|10956301|FG001|Overall Study|Withdrawal by Subject|3
6925893|NCT00835978|10956302|FG002|Overall Study|Withdrawal by Subject|0
6925894|NCT00835978|10956303|FG003|Overall Study|Withdrawal by Subject|5
6925895|NCT00835978|10956300|FG000|Overall Study|Study terminated by sponsor|12
6925896|NCT00835978|10956301|FG001|Overall Study|Study terminated by sponsor|8
6925897|NCT00835978|10956302|FG002|Overall Study|Study terminated by sponsor|30
6925898|NCT00835978|10956303|FG003|Overall Study|Study terminated by sponsor|0
6925899|NCT00836095|10956324|FG000|Overall Study|Physician Decision|0
6925900|NCT00836095|10956325|FG001|Overall Study|Physician Decision|3
6925901|NCT00836186|10956331|FG000|Overall Study|Blood could not be drawn|1
7039199|NCT01709149|11121870|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7039200|NCT01709162|11121879|FG000|Overall Study|Disease progression|3
7039201|NCT01709162|11121880|FG001|Overall Study|Disease progression|3
7039202|NCT01709162|11121879|FG000|Overall Study|Study drug toxicity|2
7039203|NCT01709162|11121880|FG001|Overall Study|Study drug toxicity|0
7039204|NCT01709162|11121879|FG000|Overall Study|Administrative reason by sponsor|0
7039205|NCT01709162|11121880|FG001|Overall Study|Administrative reason by sponsor|1
7039206|NCT01709162|11121879|FG000|Overall Study|Other|1
7039207|NCT01709162|11121880|FG001|Overall Study|Other|0
7039208|NCT01709162|11121879|FG000|Overall Study|Withdrawal by Subject|0
7039209|NCT01709162|11121880|FG001|Overall Study|Withdrawal by Subject|1
7039210|NCT01709227|11121888|FG000|Overall Study|Physician Decision|1
7039211|NCT01709227|11121889|FG001|Overall Study|Physician Decision|0
7039212|NCT01709227|11121888|FG000|Overall Study|Pleural Peritoneal communication|0
7039213|NCT01709227|11121889|FG001|Overall Study|Pleural Peritoneal communication|9
7039214|NCT01709305|11121896|FG000|Phase 1|Clinical Adverse Event|80
7039215|NCT01709305|11121897|FG001|Phase 1|Clinical Adverse Event|0
7039216|NCT01709305|11121898|FG002|Phase 1|Clinical Adverse Event|0
7039217|NCT01709305|11121899|FG003|Phase 1|Clinical Adverse Event|0
7039218|NCT01709305|11121900|FG004|Phase 1|Clinical Adverse Event|0
7039219|NCT01709305|11121896|FG000|Phase 1|Death|2
7039220|NCT01709305|11121897|FG001|Phase 1|Death|0
6833411|NCT00196976|10837604|FG013|Primary Study|Lost to Follow-up|0
6833412|NCT00196976|10837591|FG000|Primary Study|Other|0
6833413|NCT00196976|10837592|FG001|Primary Study|Other|0
6833414|NCT00196976|10837593|FG002|Primary Study|Other|2
6833415|NCT00196976|10837594|FG003|Primary Study|Other|0
6833416|NCT00196976|10837595|FG004|Primary Study|Other|0
6833417|NCT00196976|10837596|FG005|Primary Study|Other|0
6833418|NCT00196976|10837597|FG006|Primary Study|Other|0
6833419|NCT00196976|10837598|FG007|Primary Study|Other|0
6833420|NCT00196976|10837599|FG008|Primary Study|Other|0
6833421|NCT00196976|10837600|FG009|Primary Study|Other|0
6833422|NCT00196976|10837601|FG010|Primary Study|Other|0
6833423|NCT00196976|10837602|FG011|Primary Study|Other|0
6833424|NCT00196976|10837603|FG012|Primary Study|Other|0
6833425|NCT00196976|10837604|FG013|Primary Study|Other|0
6833426|NCT00196976|10837591|FG000|Booster Study|Withdrawal by Subject|0
6925902|NCT00836277|10956336|FG000|Overall Study|Not evaluable for response|6
6925903|NCT00836498|10956377|FG000|Overall Study|Adverse Event|1
7039221|NCT01709305|11121898|FG002|Phase 1|Death|0
7039222|NCT01709305|11121899|FG003|Phase 1|Death|0
6833427|NCT00196976|10837592|FG001|Booster Study|Withdrawal by Subject|0
6833428|NCT00196976|10837593|FG002|Booster Study|Withdrawal by Subject|0
6833429|NCT00196976|10837594|FG003|Booster Study|Withdrawal by Subject|0
7039223|NCT01709305|11121900|FG004|Phase 1|Death|0
7039224|NCT01709305|11121896|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13
7039225|NCT01709305|11121897|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0
6833430|NCT00196976|10837595|FG004|Booster Study|Withdrawal by Subject|0
6833431|NCT00196976|10837596|FG005|Booster Study|Withdrawal by Subject|0
6833432|NCT00196976|10837597|FG006|Booster Study|Withdrawal by Subject|0
6833433|NCT00196976|10837598|FG007|Booster Study|Withdrawal by Subject|0
6833434|NCT00196976|10837599|FG008|Booster Study|Withdrawal by Subject|0
6833435|NCT00196976|10837600|FG009|Booster Study|Withdrawal by Subject|0
6833436|NCT00196976|10837601|FG010|Booster Study|Withdrawal by Subject|1
6833437|NCT00196976|10837602|FG011|Booster Study|Withdrawal by Subject|0
6833438|NCT00196976|10837603|FG012|Booster Study|Withdrawal by Subject|0
6833439|NCT00196976|10837604|FG013|Booster Study|Withdrawal by Subject|0
6833440|NCT00196976|10837591|FG000|Booster Study|Lost to Follow-up|0
6833441|NCT00196976|10837592|FG001|Booster Study|Lost to Follow-up|0
6833442|NCT00196976|10837593|FG002|Booster Study|Lost to Follow-up|0
6833443|NCT00196976|10837594|FG003|Booster Study|Lost to Follow-up|0
6833444|NCT00196976|10837595|FG004|Booster Study|Lost to Follow-up|0
6833445|NCT00196976|10837596|FG005|Booster Study|Lost to Follow-up|0
6833446|NCT00196976|10837597|FG006|Booster Study|Lost to Follow-up|0
6833447|NCT00196976|10837598|FG007|Booster Study|Lost to Follow-up|0
6833448|NCT00196976|10837599|FG008|Booster Study|Lost to Follow-up|0
6833449|NCT00196976|10837600|FG009|Booster Study|Lost to Follow-up|0
6833450|NCT00196976|10837601|FG010|Booster Study|Lost to Follow-up|1
6833451|NCT00196976|10837602|FG011|Booster Study|Lost to Follow-up|2
6833452|NCT00196976|10837603|FG012|Booster Study|Lost to Follow-up|0
6833453|NCT00196976|10837604|FG013|Booster Study|Lost to Follow-up|0
6833454|NCT00197002|10837647|FG000|Overall Study|Adverse Event|0
6833455|NCT00197002|10837648|FG001|Overall Study|Adverse Event|1
6833456|NCT00197002|10837649|FG002|Overall Study|Adverse Event|0
6833457|NCT00197002|10837647|FG000|Overall Study|Protocol Violation|1
6833458|NCT00197002|10837648|FG001|Overall Study|Protocol Violation|0
6833459|NCT00197002|10837649|FG002|Overall Study|Protocol Violation|2
6833460|NCT00197002|10837647|FG000|Overall Study|Withdrawal by Subject|9
6833461|NCT00197002|10837648|FG001|Overall Study|Withdrawal by Subject|5
6833462|NCT00197002|10837649|FG002|Overall Study|Withdrawal by Subject|7
6833463|NCT00197002|10837647|FG000|Overall Study|Migrated/moved from study area|3
6833464|NCT00197002|10837648|FG001|Overall Study|Migrated/moved from study area|5
6833465|NCT00197002|10837649|FG002|Overall Study|Migrated/moved from study area|1
6833466|NCT00197002|10837647|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4
6833467|NCT00197002|10837648|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4
6833468|NCT00197002|10837649|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5
6833469|NCT00197002|10837647|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2
6833470|NCT00197002|10837648|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2
6833471|NCT00197002|10837649|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1
6833472|NCT00197002|10837647|FG000|Overall Study|Others|3
6833473|NCT00197002|10837648|FG001|Overall Study|Others|1
6833474|NCT00197002|10837649|FG002|Overall Study|Others|1
6833475|NCT00197015|10837663|FG000|Overall Study|Adverse Event|3
6833476|NCT00197015|10837664|FG001|Overall Study|Adverse Event|0
6833477|NCT00197015|10837665|FG002|Overall Study|Adverse Event|1
6833478|NCT00197015|10837663|FG000|Overall Study|Protocol Violation|0
6833479|NCT00197015|10837664|FG001|Overall Study|Protocol Violation|3
6833480|NCT00197015|10837665|FG002|Overall Study|Protocol Violation|3
6833481|NCT00197015|10837663|FG000|Overall Study|Withdrawal by Subject|17
6833482|NCT00197015|10837664|FG001|Overall Study|Withdrawal by Subject|37
6833483|NCT00197015|10837665|FG002|Overall Study|Withdrawal by Subject|34
6833484|NCT00197015|10837663|FG000|Overall Study|Lost to Follow-up|28
6833485|NCT00197015|10837664|FG001|Overall Study|Lost to Follow-up|46
6833486|NCT00197015|10837665|FG002|Overall Study|Lost to Follow-up|37
6833487|NCT00197015|10837663|FG000|Overall Study|Other|2
6833488|NCT00197015|10837664|FG001|Overall Study|Other|3
6833489|NCT00197015|10837665|FG002|Overall Study|Other|2
6833490|NCT00197028|10837675|FG000|Overall Study|Adverse Event|2
6833491|NCT00197028|10837676|FG001|Overall Study|Adverse Event|2
6833492|NCT00197028|10837675|FG000|Overall Study|Protocol Violation|2
6833493|NCT00197028|10837676|FG001|Overall Study|Protocol Violation|1
6833494|NCT00197028|10837675|FG000|Overall Study|Withdrawal by Subject|8
6833495|NCT00197028|10837676|FG001|Overall Study|Withdrawal by Subject|12
6833496|NCT00197028|10837675|FG000|Overall Study|Lost to Follow-up|1
6833497|NCT00197028|10837676|FG001|Overall Study|Lost to Follow-up|0
6833498|NCT00197028|10837675|FG000|Overall Study|Other|3
6833499|NCT00197028|10837676|FG001|Overall Study|Other|6
6833500|NCT00197054|10837685|FG000|Overall Study|Withdrawal by Subject|9
6833501|NCT00197054|10837686|FG001|Overall Study|Withdrawal by Subject|3
6833502|NCT00197054|10837687|FG002|Overall Study|Withdrawal by Subject|3
6833503|NCT00197054|10837685|FG000|Overall Study|Moved from area|7
6833504|NCT00197054|10837686|FG001|Overall Study|Moved from area|14
6833505|NCT00197054|10837687|FG002|Overall Study|Moved from area|9
6833506|NCT00197054|10837685|FG000|Overall Study|Lost to Follow-up|1
6833507|NCT00197054|10837686|FG001|Overall Study|Lost to Follow-up|4
6833508|NCT00197054|10837687|FG002|Overall Study|Lost to Follow-up|0
6833509|NCT00197106|10837707|FG000|4-Week Run-In Period|Did not meet entry criteria|99
6833510|NCT00197106|10837708|FG001|4-Week Run-In Period|Did not meet entry criteria|0
6833511|NCT00197106|10837709|FG002|4-Week Run-In Period|Did not meet entry criteria|0
6833512|NCT00197106|10837707|FG000|Overall Treatment Period|Lack of Efficacy|0
6833513|NCT00197106|10837708|FG001|Overall Treatment Period|Lack of Efficacy|1
6833514|NCT00197106|10837709|FG002|Overall Treatment Period|Lack of Efficacy|0
6833515|NCT00197106|10837707|FG000|Overall Treatment Period|Lost to Follow-up|0
6833516|NCT00197106|10837708|FG001|Overall Treatment Period|Lost to Follow-up|0
6833517|NCT00197106|10837709|FG002|Overall Treatment Period|Lost to Follow-up|2
6833518|NCT00197106|10837707|FG000|Overall Treatment Period|Protocol Violation|0
6833519|NCT00197106|10837708|FG001|Overall Treatment Period|Protocol Violation|0
6833520|NCT00197106|10837709|FG002|Overall Treatment Period|Protocol Violation|2
6833521|NCT00197106|10837707|FG000|Overall Treatment Period|Withdrawal by Subject|0
6833522|NCT00197106|10837708|FG001|Overall Treatment Period|Withdrawal by Subject|0
6833523|NCT00197106|10837709|FG002|Overall Treatment Period|Withdrawal by Subject|2
6833524|NCT00197145|10837726|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1
6833525|NCT00197145|10837727|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1
6833526|NCT00197145|10837726|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10
6833527|NCT00197145|10837727|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8
6833528|NCT00197145|10837726|FG000|Period 1: Randomized Treatment Phase|Other|2
6833529|NCT00197145|10837727|FG001|Period 1: Randomized Treatment Phase|Other|2
6833530|NCT00197145|10837726|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1
6833531|NCT00197145|10837727|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0
6833532|NCT00197145|10837726|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3
6833533|NCT00197145|10837727|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0
6833534|NCT00197145|10837726|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2
6833535|NCT00197145|10837727|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0
6833536|NCT00197145|10837726|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3
6833537|NCT00197145|10837727|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0
6833538|NCT00197145|10837726|FG000|Period 2 : Open Label Phase|Other|1
6833539|NCT00197145|10837727|FG001|Period 2 : Open Label Phase|Other|0
6833540|NCT00197236|10837746|FG000|Overall Study|Adverse Event|1
6833541|NCT00197236|10837747|FG001|Overall Study|Adverse Event|0
6833542|NCT00197236|10837748|FG002|Overall Study|Adverse Event|1
6833543|NCT00197236|10837746|FG000|Overall Study|Lost to Follow-up|5
6833544|NCT00197236|10837747|FG001|Overall Study|Lost to Follow-up|14
6833545|NCT00197236|10837748|FG002|Overall Study|Lost to Follow-up|6
6833546|NCT00197236|10837746|FG000|Overall Study|Protocol Violation|0
6833547|NCT00197236|10837747|FG001|Overall Study|Protocol Violation|0
6833548|NCT00197236|10837748|FG002|Overall Study|Protocol Violation|1
6833549|NCT00197236|10837746|FG000|Overall Study|Withdrawal by Subject|7
6833550|NCT00197236|10837747|FG001|Overall Study|Withdrawal by Subject|3
6833551|NCT00197236|10837748|FG002|Overall Study|Withdrawal by Subject|11
6833552|NCT00197236|10837746|FG000|Overall Study|Study drug/medication expiration|1
6833553|NCT00197236|10837747|FG001|Overall Study|Study drug/medication expiration|0
6833554|NCT00197236|10837748|FG002|Overall Study|Study drug/medication expiration|3
6833555|NCT00197236|10837746|FG000|Overall Study|Returned out of specified time window|0
6833556|NCT00197236|10837747|FG001|Overall Study|Returned out of specified time window|0
6833557|NCT00197236|10837748|FG002|Overall Study|Returned out of specified time window|1
6833558|NCT00197496|10837786|FG000|Baseline to Discharge|not interested|1
6833559|NCT00197496|10837787|FG001|Baseline to Discharge|not interested|0
6833560|NCT00197496|10837786|FG000|Baseline to Discharge|MRSA|1
6833561|NCT00197496|10837787|FG001|Baseline to Discharge|MRSA|0
6833562|NCT00197496|10837786|FG000|Baseline to Discharge|Physician Decision|0
6833563|NCT00197496|10837787|FG001|Baseline to Discharge|Physician Decision|1
6833564|NCT00197496|10837786|FG000|Baseline to Discharge|Protocol Violation|0
6833565|NCT00197496|10837787|FG001|Baseline to Discharge|Protocol Violation|1
6833566|NCT00197496|10837786|FG000|Follow-up|Lost to Follow-up|2
6833567|NCT00197496|10837787|FG001|Follow-up|Lost to Follow-up|1
6833568|NCT00198029|10837793|FG000|Overall Study|Withdrawal by Subject|4
7039226|NCT01709305|11121898|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0
7039227|NCT01709305|11121899|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0
7039228|NCT01709305|11121900|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0
7039229|NCT01709305|11121896|FG000|Phase 1|Laboratory Adverse Event|16
7039230|NCT01709305|11121897|FG001|Phase 1|Laboratory Adverse Event|0
7039231|NCT01709305|11121898|FG002|Phase 1|Laboratory Adverse Event|0
7039232|NCT01709305|11121899|FG003|Phase 1|Laboratory Adverse Event|0
7039233|NCT01709305|11121900|FG004|Phase 1|Laboratory Adverse Event|0
7039234|NCT01709305|11121896|FG000|Phase 1|Lost to Follow-up|147
7039235|NCT01709305|11121897|FG001|Phase 1|Lost to Follow-up|0
7039236|NCT01709305|11121898|FG002|Phase 1|Lost to Follow-up|0
7039237|NCT01709305|11121899|FG003|Phase 1|Lost to Follow-up|0
7039238|NCT01709305|11121900|FG004|Phase 1|Lost to Follow-up|0
6833569|NCT00198107|10837817|FG000|Double-Blind Period|Adverse Event|1
6833570|NCT00198107|10837818|FG001|Double-Blind Period|Adverse Event|1
6925904|NCT00836498|10956378|FG001|Overall Study|Adverse Event|0
6925905|NCT00836498|10956377|FG000|Overall Study|Lost to Follow-up|1
6925906|NCT00836498|10956378|FG001|Overall Study|Lost to Follow-up|0
6925907|NCT00836498|10956377|FG000|Overall Study|Withdrawal by Subject|2
6925908|NCT00836498|10956378|FG001|Overall Study|Withdrawal by Subject|1
6925909|NCT00836589|10956385|FG000|Overall Study|Lost to Follow-up|246
7039239|NCT01709305|11121896|FG000|Phase 1|Travel, moving, etc.|30
7039240|NCT01709305|11121897|FG001|Phase 1|Travel, moving, etc.|0
6925910|NCT00836589|10956385|FG000|Overall Study|Death|429
7039241|NCT01709305|11121898|FG002|Phase 1|Travel, moving, etc.|0
6833571|NCT00198107|10837819|FG002|Double-Blind Period|Adverse Event|0
6833572|NCT00198107|10837817|FG000|Double-Blind Period|Lack of Efficacy|2
6833573|NCT00198107|10837818|FG001|Double-Blind Period|Lack of Efficacy|0
6833574|NCT00198107|10837819|FG002|Double-Blind Period|Lack of Efficacy|0
6833575|NCT00198107|10837817|FG000|Double-Blind Period|Lost to Follow-up|2
6833576|NCT00198107|10837818|FG001|Double-Blind Period|Lost to Follow-up|1
6833577|NCT00198107|10837819|FG002|Double-Blind Period|Lost to Follow-up|0
6833578|NCT00198107|10837817|FG000|Double-Blind Period|Physician Decision|1
6833579|NCT00198107|10837818|FG001|Double-Blind Period|Physician Decision|0
6833580|NCT00198107|10837819|FG002|Double-Blind Period|Physician Decision|0
6833581|NCT00198107|10837817|FG000|Double-Blind Period|Withdrawal by Subject|0
6833582|NCT00198107|10837818|FG001|Double-Blind Period|Withdrawal by Subject|1
6833583|NCT00198107|10837819|FG002|Double-Blind Period|Withdrawal by Subject|0
6833584|NCT00198107|10837817|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0
6833585|NCT00198107|10837818|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0
6833586|NCT00198107|10837819|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2
6833587|NCT00198133|10837829|FG000|Overall Study|Disease progression|2
6833588|NCT00198133|10837830|FG001|Overall Study|Disease progression|5
6833589|NCT00198133|10837829|FG000|Overall Study|Adverse Event|1
6833590|NCT00198133|10837830|FG001|Overall Study|Adverse Event|3
6833591|NCT00198133|10837829|FG000|Overall Study|Withdrawal by Subject|1
6833592|NCT00198133|10837830|FG001|Overall Study|Withdrawal by Subject|0
6833593|NCT00198133|10837829|FG000|Overall Study|Physician Decision|1
6833594|NCT00198133|10837830|FG001|Overall Study|Physician Decision|0
6833595|NCT00198822|10837839|FG000|Overall Study|Lost to Follow-up|14
6833596|NCT00198822|10837840|FG001|Overall Study|Lost to Follow-up|20
6833597|NCT00198822|10837841|FG002|Overall Study|Lost to Follow-up|21
6833598|NCT00199381|10837849|FG000|Overall Study|Withdrawal by Subject|38
6833599|NCT00199381|10837849|FG000|Overall Study|Adverse Event|73
6833600|NCT00199381|10837849|FG000|Overall Study|Protocol Violation|6
6833601|NCT00199381|10837849|FG000|Overall Study|Lack of Efficacy|27
6833602|NCT00199381|10837849|FG000|Overall Study|Not including due to early termination|37
6833603|NCT00199381|10837849|FG000|Overall Study|Study termination by Sponsor|323
6833604|NCT00199797|10837853|FG000|Overall Study|Progressive Disease|1
6833605|NCT00199797|10837853|FG000|Overall Study|Adverse Event|1
6833606|NCT00199797|10837853|FG000|Overall Study|Physician Decision|1
6833607|NCT00199836|10837858|FG000|Overall Study|Progressive Disease|5
6833608|NCT00199836|10837858|FG000|Overall Study|Death|1
6833609|NCT00199849|10837866|FG000|Overall Study|Unrelated illness or complication|0
6833610|NCT00199849|10837867|FG001|Overall Study|Unrelated illness or complication|1
6833611|NCT00199849|10837868|FG002|Overall Study|Unrelated illness or complication|0
6833612|NCT00199849|10837866|FG000|Overall Study|Progressive disease requiring intervention|0
6833613|NCT00199849|10837867|FG001|Overall Study|Progressive disease requiring intervention|0
6833614|NCT00199849|10837868|FG002|Overall Study|Progressive disease requiring intervention|1
6833615|NCT00199849|10837866|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0
6833616|NCT00199849|10837867|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0
6833617|NCT00199849|10837868|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1
6833618|NCT00199875|10837881|FG000|Overall Study|Withdrawal by Subject|0
6833619|NCT00199875|10837882|FG001|Overall Study|Withdrawal by Subject|0
6833620|NCT00199875|10837883|FG002|Overall Study|Withdrawal by Subject|0
6833621|NCT00199875|10837884|FG003|Overall Study|Withdrawal by Subject|0
6833622|NCT00199875|10837885|FG004|Overall Study|Withdrawal by Subject|1
6833623|NCT00199888|10837897|FG000|Overall Study|Lost to Follow-up|1
6833624|NCT00199901|10837903|FG000|Overall Study|Protocol Violation|2
6833625|NCT00199901|10837904|FG001|Overall Study|Protocol Violation|0
6833626|NCT00199901|10837903|FG000|Overall Study|Withdrawal by Subject|1
6833627|NCT00199901|10837904|FG001|Overall Study|Withdrawal by Subject|0
6833628|NCT00199901|10837903|FG000|Overall Study|Progressive Disease|24
6833629|NCT00199901|10837904|FG001|Overall Study|Progressive Disease|24
6833630|NCT00200057|10837921|FG000|Overall Study|Lack of Efficacy|3
6833631|NCT00200057|10837921|FG000|Overall Study|Exited due to terminal illness of PI|2
6833632|NCT00200057|10837921|FG000|Overall Study|Withdrawal by Subject|1
6833633|NCT00200057|10837921|FG000|Overall Study|Change in medical condition|1
6833634|NCT00200057|10837921|FG000|Overall Study|Infection|1
6833635|NCT00200057|10837921|FG000|Overall Study|Death|1
6833636|NCT00200356|10837949|FG000|Overall Study|Lack of Efficacy|3
6833637|NCT00200356|10837950|FG001|Overall Study|Lack of Efficacy|3
6833638|NCT00200356|10837949|FG000|Overall Study|Protocol Violation|4
6833639|NCT00200356|10837950|FG001|Overall Study|Protocol Violation|4
6833640|NCT00200356|10837949|FG000|Overall Study|Nontreatment|1
6833641|NCT00200356|10837950|FG001|Overall Study|Nontreatment|0
6833642|NCT00200850|10837968|FG000|Overall Study|relocation|1
6833643|NCT00200850|10837969|FG001|Overall Study|relocation|0
6833644|NCT00200850|10837970|FG002|Overall Study|relocation|1
7039242|NCT01709305|11121899|FG003|Phase 1|Travel, moving, etc.|0
7039243|NCT01709305|11121900|FG004|Phase 1|Travel, moving, etc.|0
7039244|NCT01709305|11121896|FG000|Phase 1|Physician Decision|13
6833645|NCT00200850|10837968|FG000|Overall Study|too busy|1
6833646|NCT00200850|10837969|FG001|Overall Study|too busy|0
6833647|NCT00200850|10837970|FG002|Overall Study|too busy|0
6833648|NCT00200850|10837968|FG000|Overall Study|Pregnancy|0
6833649|NCT00200850|10837969|FG001|Overall Study|Pregnancy|0
6833650|NCT00200850|10837970|FG002|Overall Study|Pregnancy|1
6833651|NCT00200850|10837968|FG000|Overall Study|Poor adherence|0
6833652|NCT00200850|10837969|FG001|Overall Study|Poor adherence|0
6833653|NCT00200850|10837970|FG002|Overall Study|Poor adherence|1
6833654|NCT00200850|10837968|FG000|Overall Study|optic neuritis|0
6833655|NCT00200850|10837969|FG001|Overall Study|optic neuritis|0
6833656|NCT00200850|10837970|FG002|Overall Study|optic neuritis|1
6833657|NCT00200850|10837968|FG000|Overall Study|Adverse Event|1
6833658|NCT00200850|10837969|FG001|Overall Study|Adverse Event|1
6833659|NCT00200850|10837970|FG002|Overall Study|Adverse Event|2
6833660|NCT00200967|10837999|FG000|First Treatment Period|Withdrawal by Subject|5
6833661|NCT00200967|10838000|FG001|First Treatment Period|Withdrawal by Subject|1
6833662|NCT00200967|10837999|FG000|First Treatment Period|Pregnancy|1
6833663|NCT00200967|10838000|FG001|First Treatment Period|Pregnancy|0
6833664|NCT00200967|10837999|FG000|Wash-out Period|Lost to Follow-up|0
6833665|NCT00200967|10838000|FG001|Wash-out Period|Lost to Follow-up|1
6833666|NCT00200967|10837999|FG000|Second Treatment Period|Withdrawal by Subject|1
6833667|NCT00200967|10838000|FG001|Second Treatment Period|Withdrawal by Subject|2
6833668|NCT00200967|10837999|FG000|Run-out Period|Lost to Follow-up|1
6833669|NCT00200967|10838000|FG001|Run-out Period|Lost to Follow-up|0
6833670|NCT00201006|10838009|FG000|Overall Study|Withdrawal by Subject|7
6833671|NCT00201006|10838010|FG001|Overall Study|Withdrawal by Subject|2
6833672|NCT00201006|10838011|FG002|Overall Study|Withdrawal by Subject|3
6833673|NCT00201006|10838009|FG000|Overall Study|Adverse Event|1
6833674|NCT00201006|10838010|FG001|Overall Study|Adverse Event|0
6833675|NCT00201006|10838011|FG002|Overall Study|Adverse Event|1
6833676|NCT00201201|10838038|FG000|Overall Study|Death|0
6833677|NCT00201201|10838039|FG001|Overall Study|Death|2
6833678|NCT00201201|10838038|FG000|Overall Study|Withdrawal by Subject|5
6833679|NCT00201201|10838039|FG001|Overall Study|Withdrawal by Subject|5
6897251|NCT00638690|10916105|FG000|Overall Study|Death|655
6897252|NCT00638690|10916106|FG001|Overall Study|Death|335
6897253|NCT00638690|10916105|FG000|Overall Study|Withdrawal by Subject|22
7039245|NCT01709305|11121897|FG001|Phase 1|Physician Decision|0
7039246|NCT01709305|11121898|FG002|Phase 1|Physician Decision|0
7039247|NCT01709305|11121899|FG003|Phase 1|Physician Decision|0
7039248|NCT01709305|11121900|FG004|Phase 1|Physician Decision|0
7039249|NCT01709305|11121896|FG000|Phase 1|Protocol Violation|118
7039250|NCT01709305|11121897|FG001|Phase 1|Protocol Violation|0
7039251|NCT01709305|11121898|FG002|Phase 1|Protocol Violation|0
7039252|NCT01709305|11121899|FG003|Phase 1|Protocol Violation|0
7039253|NCT01709305|11121900|FG004|Phase 1|Protocol Violation|0
6897254|NCT00638690|10916106|FG001|Overall Study|Withdrawal by Subject|5
6897255|NCT00638690|10916105|FG000|Overall Study|Lost to Follow-up|4
6897256|NCT00638690|10916106|FG001|Overall Study|Lost to Follow-up|2
6897257|NCT00638846|10916132|FG000|Overall Study|Adverse Event|0
6897258|NCT00638846|10916133|FG001|Overall Study|Adverse Event|1
6897259|NCT00638846|10916132|FG000|Overall Study|Lost to Follow-up|3
6897260|NCT00638846|10916133|FG001|Overall Study|Lost to Follow-up|2
6897261|NCT00638846|10916132|FG000|Overall Study|lens issue|1
6897262|NCT00638846|10916133|FG001|Overall Study|lens issue|3
6897263|NCT00638963|10916155|FG000|Overall Study|Withdrawal by Subject|1
6897264|NCT00638963|10916156|FG001|Overall Study|Withdrawal by Subject|0
6897265|NCT00638989|10916165|FG000|Overall Study|Lost to Follow-up|0
6897266|NCT00638989|10916166|FG001|Overall Study|Lost to Follow-up|0
6897267|NCT00638989|10916167|FG002|Overall Study|Lost to Follow-up|1
6897268|NCT00639002|10916177|FG000|Overall Study|Death|1
6897269|NCT00639002|10916177|FG000|Overall Study|Adverse Event|1
6897270|NCT00639002|10916177|FG000|Overall Study|Protocol Violation|1
6897271|NCT00639002|10916177|FG000|Overall Study|Disease progression|3
6897272|NCT00639002|10916177|FG000|Overall Study|Physician Decision|6
6897273|NCT00639002|10916177|FG000|Overall Study|Lack of Efficacy|1
6897274|NCT00639223|10916202|FG000|Overall Study|Lost to Follow-up|0
6897275|NCT00639223|10916203|FG001|Overall Study|Lost to Follow-up|2
6897276|NCT00639379|10916209|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2
6897277|NCT00639379|10916210|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0
6897278|NCT00639379|10916209|FG000|Period 1 - 2 Weeks|lens issue|3
6897279|NCT00639379|10916210|FG001|Period 1 - 2 Weeks|lens issue|0
6897280|NCT00639457|10916239|FG000|Overall Study|Withdrawal by Subject|2
6897281|NCT00639457|10916240|FG001|Overall Study|Withdrawal by Subject|3
6897282|NCT00639509|10916246|FG000|Overall Study|Death|1
6897283|NCT00639678|10916254|FG000|Overall Study|Withdrawal by Subject|3
6897284|NCT00639678|10916255|FG001|Overall Study|Withdrawal by Subject|0
6897285|NCT00639678|10916256|FG002|Overall Study|Withdrawal by Subject|4
6897286|NCT00639678|10916257|FG003|Overall Study|Withdrawal by Subject|0
6897287|NCT00639678|10916254|FG000|Overall Study|Lost to Follow-up|1
6897288|NCT00639678|10916255|FG001|Overall Study|Lost to Follow-up|0
6897289|NCT00639678|10916256|FG002|Overall Study|Lost to Follow-up|6
6897290|NCT00639678|10916257|FG003|Overall Study|Lost to Follow-up|0
6897291|NCT00639678|10916254|FG000|Overall Study|Adverse Event|0
6897292|NCT00639678|10916255|FG001|Overall Study|Adverse Event|1
6897293|NCT00639678|10916256|FG002|Overall Study|Adverse Event|0
6897294|NCT00639678|10916257|FG003|Overall Study|Adverse Event|0
6897295|NCT00639678|10916254|FG000|Overall Study|Lack of Compliance|0
6897296|NCT00639678|10916255|FG001|Overall Study|Lack of Compliance|0
6897297|NCT00639678|10916256|FG002|Overall Study|Lack of Compliance|1
7063508|NCT01950819|11161998|FG000|Overall Study|Graft Loss|35
7063509|NCT01950819|11161999|FG001|Overall Study|Graft Loss|30
7063510|NCT01950819|11161998|FG000|Overall Study|Death|29
7063511|NCT01950819|11161999|FG001|Overall Study|Death|34
7063512|NCT01950819|11161998|FG000|Overall Study|Subject / Gardian decision|54
7063513|NCT01950819|11161999|FG001|Overall Study|Subject / Gardian decision|51
7063514|NCT01950819|11161998|FG000|Overall Study|technical problems|2
7063515|NCT01950819|11161999|FG001|Overall Study|technical problems|0
7063516|NCT01950819|11161998|FG000|Overall Study|Pregnancy|0
7063517|NCT01950819|11161999|FG001|Overall Study|Pregnancy|2
7063518|NCT01950819|11161998|FG000|Overall Study|Lost to Follow-up|9
7063519|NCT01950819|11161999|FG001|Overall Study|Lost to Follow-up|17
6833680|NCT00201643|10838072|FG000|Overall Study|Withdrawal by Subject|5
6833681|NCT00201643|10838073|FG001|Overall Study|Withdrawal by Subject|4
6833682|NCT00201851|10838127|FG000|Overall Study|Lost to Follow-up|2
6833683|NCT00201851|10838128|FG001|Overall Study|Lost to Follow-up|1
6833684|NCT00201851|10838129|FG002|Overall Study|Lost to Follow-up|0
6833685|NCT00201851|10838127|FG000|Overall Study|Ineligible post enrollment|6
6833686|NCT00201851|10838128|FG001|Overall Study|Ineligible post enrollment|1
6925911|NCT00836589|10956385|FG000|Overall Study|Withdrawal by Subject or Physician|591
6925912|NCT00836693|10956407|FG000|Overall Study|Adverse Event|4
6925913|NCT00836693|10956408|FG001|Overall Study|Adverse Event|1
6925914|NCT00836693|10956407|FG000|Overall Study|Sponsor Decision|0
6925915|NCT00836693|10956408|FG001|Overall Study|Sponsor Decision|1
6925916|NCT00836693|10956407|FG000|Overall Study|Physician Decision|2
6925917|NCT00836693|10956408|FG001|Overall Study|Physician Decision|0
6925918|NCT00836693|10956407|FG000|Overall Study|Withdrawal by Subject|9
6925919|NCT00836693|10956408|FG001|Overall Study|Withdrawal by Subject|4
6925920|NCT00836693|10956407|FG000|Overall Study|Protocol Violation|1
6925921|NCT00836693|10956408|FG001|Overall Study|Protocol Violation|0
6925922|NCT00836693|10956407|FG000|Overall Study|Lost to Follow-up|1
6925923|NCT00836693|10956408|FG001|Overall Study|Lost to Follow-up|0
6925924|NCT00836745|10956418|FG000|Overall Study|Death|2
6925925|NCT00836745|10956418|FG000|Overall Study|Lost to Follow-up|10
6925926|NCT00836745|10956418|FG000|Overall Study|Adverse Event|3
6925927|NCT00836745|10956418|FG000|Overall Study|Objective progression or relapse|4
6925928|NCT00836745|10956418|FG000|Overall Study|Other|2
6925929|NCT00836810|10956430|FG000|Overall Study|New diagnosis|1
6925930|NCT00836810|10956431|FG001|Overall Study|New diagnosis|0
6925931|NCT00836875|10956439|FG000|Overall Study|Death|3
6925932|NCT00836875|10956440|FG001|Overall Study|Death|2
6925933|NCT00836875|10956439|FG000|Overall Study|Withdrawal by Subject|0
6925934|NCT00836875|10956440|FG001|Overall Study|Withdrawal by Subject|1
6925935|NCT00836927|10956468|FG000|Overall Study|Progressive disease|2
6925936|NCT00836927|10956469|FG001|Overall Study|Progressive disease|0
6925937|NCT00836927|10956470|FG002|Overall Study|Progressive disease|0
6925938|NCT00836927|10956471|FG003|Overall Study|Progressive disease|1
6925939|NCT00836927|10956472|FG004|Overall Study|Progressive disease|1
6925940|NCT00836927|10956468|FG000|Overall Study|Withdrawal by Subject|1
6925941|NCT00836927|10956469|FG001|Overall Study|Withdrawal by Subject|0
6925942|NCT00836927|10956470|FG002|Overall Study|Withdrawal by Subject|0
6925943|NCT00836927|10956471|FG003|Overall Study|Withdrawal by Subject|0
6925944|NCT00836927|10956472|FG004|Overall Study|Withdrawal by Subject|0
6925945|NCT00836953|10956486|FG000|Overall Study|Withdrawal by Subject|1
6925946|NCT00836953|10956486|FG000|Overall Study|Lost to Follow-up|1
6925947|NCT00837096|10956496|FG000|Overall Study|Physician Decision|1
6925948|NCT00837096|10956497|FG001|Overall Study|Physician Decision|1
6925949|NCT00837096|10956496|FG000|Overall Study|Not reported|9
7063520|NCT01951092|11162011|FG000|Overall Study|Lost to Follow-up|10
7063521|NCT01951092|11162011|FG000|Overall Study|Incarceration|1
7063522|NCT01951092|11162011|FG000|Overall Study|Transfer of Care|1
7063523|NCT01951105|11162018|FG000|Overall Study|Adverse Event|0
6833687|NCT00201851|10838129|FG002|Overall Study|Ineligible post enrollment|1
6833688|NCT00202644|10838163|FG000|Overall Study|Adverse Event|12
6833689|NCT00202644|10838164|FG001|Overall Study|Adverse Event|13
6833690|NCT00202644|10838163|FG000|Overall Study|Withdrawal by Subject|8
6833691|NCT00202644|10838164|FG001|Overall Study|Withdrawal by Subject|6
6833692|NCT00202644|10838163|FG000|Overall Study|Lack of Efficacy|6
6833693|NCT00202644|10838164|FG001|Overall Study|Lack of Efficacy|6
6833694|NCT00202644|10838163|FG000|Overall Study|Lost to Follow-up|0
6833695|NCT00202644|10838164|FG001|Overall Study|Lost to Follow-up|1
6833696|NCT00202644|10838163|FG000|Overall Study|Other|9
6833697|NCT00202644|10838164|FG001|Overall Study|Other|1
6833698|NCT00202839|10838177|FG000|Overall Study|Adverse Event|1
6833699|NCT00202839|10838178|FG001|Overall Study|Adverse Event|5
6833700|NCT00202839|10838177|FG000|Overall Study|Physician Decision|12
6833701|NCT00202839|10838178|FG001|Overall Study|Physician Decision|0
6833702|NCT00202839|10838177|FG000|Overall Study|Withdrawal by Subject|6
6833703|NCT00202839|10838178|FG001|Overall Study|Withdrawal by Subject|2
6833704|NCT00202839|10838177|FG000|Overall Study|Protocol Violation|2
6833705|NCT00202839|10838178|FG001|Overall Study|Protocol Violation|1
6833706|NCT00202839|10838177|FG000|Overall Study|Lost to Follow-up|3
6833707|NCT00202839|10838178|FG001|Overall Study|Lost to Follow-up|2
6833708|NCT00203021|10838190|FG000|Overall Study|Death|4
6833709|NCT00203021|10838191|FG001|Overall Study|Death|1
6833710|NCT00203021|10838190|FG000|Overall Study|Adverse Event|10
6833711|NCT00203021|10838191|FG001|Overall Study|Adverse Event|5
6833712|NCT00203021|10838190|FG000|Overall Study|Withdrawal by Subject|45
6833713|NCT00203021|10838191|FG001|Overall Study|Withdrawal by Subject|48
6833714|NCT00203021|10838190|FG000|Overall Study|Lost to Follow-up|9
6833715|NCT00203021|10838191|FG001|Overall Study|Lost to Follow-up|7
6833716|NCT00203021|10838190|FG000|Overall Study|Other than specified|11
6833717|NCT00203021|10838191|FG001|Overall Study|Other than specified|16
6833718|NCT00203047|10838199|FG000|Overall Study|Ongoing: in database - January 29, 2009|131
6833719|NCT00203047|10838200|FG001|Overall Study|Ongoing: in database - January 29, 2009|109
6833720|NCT00203047|10838199|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5
6833721|NCT00203047|10838200|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1
6833722|NCT00203047|10838199|FG000|Overall Study|Withdrawal by Subject|13
7039254|NCT01709305|11121896|FG000|Phase 1|Withdrawal by Subject|218
6833723|NCT00203047|10838200|FG001|Overall Study|Withdrawal by Subject|47
6833724|NCT00203047|10838199|FG000|Overall Study|Teva requested participant withdrawal|1
6833725|NCT00203047|10838200|FG001|Overall Study|Teva requested participant withdrawal|1
6833726|NCT00203047|10838199|FG000|Overall Study|Physician Decision|8
6833727|NCT00203047|10838200|FG001|Overall Study|Physician Decision|7
6833728|NCT00203047|10838199|FG000|Overall Study|Non-compliance|4
6833729|NCT00203047|10838200|FG001|Overall Study|Non-compliance|8
6833730|NCT00203047|10838199|FG000|Overall Study|Protocol Violation|1
6833731|NCT00203047|10838200|FG001|Overall Study|Protocol Violation|0
6833732|NCT00203047|10838199|FG000|Overall Study|Lost to Follow-up|11
6833733|NCT00203047|10838200|FG001|Overall Study|Lost to Follow-up|5
6833734|NCT00203047|10838199|FG000|Overall Study|Adverse Event|8
6833735|NCT00203047|10838200|FG001|Overall Study|Adverse Event|18
6833736|NCT00203047|10838199|FG000|Overall Study|Death|1
6833737|NCT00203047|10838200|FG001|Overall Study|Death|2
6833738|NCT00203047|10838199|FG000|Overall Study|Pregnancy|3
6833739|NCT00203047|10838200|FG001|Overall Study|Pregnancy|0
6833740|NCT00203047|10838199|FG000|Overall Study|Other|5
6833741|NCT00203047|10838200|FG001|Overall Study|Other|5
6833742|NCT00203242|10838228|FG000|Overall Study|Lost to Follow-up|1
6833743|NCT00203268|10838232|FG000|Early Treatment|only treated one headache|2
6833744|NCT00203268|10838232|FG000|Early Treatment|Lost to Follow-up|1
6833745|NCT00203268|10838232|FG000|Early Treatment|Withdrawal by Subject|1
6833746|NCT00203294|10838240|FG000|Overall Study|Withdrawal by Subject|8
6833747|NCT00203294|10838241|FG001|Overall Study|Withdrawal by Subject|13
6833748|NCT00203307|10838249|FG000|First Intervention|Adverse Event|2
6833749|NCT00203307|10838250|FG001|First Intervention|Adverse Event|0
6833750|NCT00203411|10838256|FG000|Follow-up|Progressive Disease|4
6833751|NCT00203424|10838261|FG000|Treatment Period|Withdrawal by Subject|4
6833752|NCT00203424|10838261|FG000|Treatment Period|Adverse Event|5
6833753|NCT00203424|10838261|FG000|Treatment Period|progressive disease|2
6833754|NCT00203424|10838261|FG000|Follow-up Period|Withdrawal by Subject|1
6833755|NCT00203424|10838261|FG000|Follow-up Period|progressive disease|4
6833756|NCT00203424|10838261|FG000|Follow-up Period|Lost to Follow-up|1
6833757|NCT00203476|10838268|FG000|Overall Study|Lost to Follow-up|1
6833758|NCT00203476|10838269|FG001|Overall Study|Lost to Follow-up|0
6833759|NCT00203476|10838270|FG002|Overall Study|Lost to Follow-up|0
6833760|NCT00203476|10838268|FG000|Overall Study|Withdrawal by Subject|0
6833761|NCT00203476|10838269|FG001|Overall Study|Withdrawal by Subject|1
6833762|NCT00203476|10838270|FG002|Overall Study|Withdrawal by Subject|0
6833763|NCT00203502|10838278|FG000|Overall Study|Death|1
6833764|NCT00203892|10838285|FG000|Overall Study|Physician Decision|1
6833765|NCT00203892|10838286|FG001|Overall Study|Physician Decision|2
6833766|NCT00203892|10838287|FG002|Overall Study|Physician Decision|0
6833767|NCT00203892|10838285|FG000|Overall Study|Death|1
6833768|NCT00203892|10838286|FG001|Overall Study|Death|0
6833769|NCT00203892|10838287|FG002|Overall Study|Death|0
6833770|NCT00203996|10838314|FG000|Overall Study|Lost to Follow-up|0
6833771|NCT00203996|10838315|FG001|Overall Study|Lost to Follow-up|0
6833772|NCT00203996|10838316|FG002|Overall Study|Lost to Follow-up|0
6833773|NCT00203996|10838317|FG003|Overall Study|Lost to Follow-up|1
6833774|NCT00203996|10838318|FG004|Overall Study|Lost to Follow-up|0
6833775|NCT00203996|10838319|FG005|Overall Study|Lost to Follow-up|0
6833776|NCT00203996|10838320|FG006|Overall Study|Lost to Follow-up|0
6833777|NCT00203996|10838321|FG007|Overall Study|Lost to Follow-up|0
6833778|NCT00203996|10838322|FG008|Overall Study|Lost to Follow-up|0
6833779|NCT00203996|10838323|FG009|Overall Study|Lost to Follow-up|0
6833780|NCT00203996|10838314|FG000|Overall Study|Protocol Violation|0
6833781|NCT00203996|10838315|FG001|Overall Study|Protocol Violation|0
6833782|NCT00203996|10838316|FG002|Overall Study|Protocol Violation|0
6833783|NCT00203996|10838317|FG003|Overall Study|Protocol Violation|6
6833784|NCT00203996|10838318|FG004|Overall Study|Protocol Violation|1
6833785|NCT00203996|10838319|FG005|Overall Study|Protocol Violation|0
6833786|NCT00203996|10838320|FG006|Overall Study|Protocol Violation|0
6833787|NCT00203996|10838321|FG007|Overall Study|Protocol Violation|0
6833788|NCT00203996|10838322|FG008|Overall Study|Protocol Violation|0
6833789|NCT00203996|10838323|FG009|Overall Study|Protocol Violation|0
6833790|NCT00203996|10838314|FG000|Overall Study|Physician Decision|0
6833791|NCT00203996|10838315|FG001|Overall Study|Physician Decision|0
6833792|NCT00203996|10838316|FG002|Overall Study|Physician Decision|0
6833793|NCT00203996|10838317|FG003|Overall Study|Physician Decision|2
6833794|NCT00203996|10838318|FG004|Overall Study|Physician Decision|0
6833795|NCT00203996|10838319|FG005|Overall Study|Physician Decision|0
6833796|NCT00203996|10838320|FG006|Overall Study|Physician Decision|0
6833797|NCT00203996|10838321|FG007|Overall Study|Physician Decision|0
6833798|NCT00203996|10838322|FG008|Overall Study|Physician Decision|0
6833799|NCT00203996|10838323|FG009|Overall Study|Physician Decision|1
6833800|NCT00203996|10838314|FG000|Overall Study|CPAP machine malfunction|0
6833801|NCT00203996|10838315|FG001|Overall Study|CPAP machine malfunction|0
6833802|NCT00203996|10838316|FG002|Overall Study|CPAP machine malfunction|0
6833803|NCT00203996|10838317|FG003|Overall Study|CPAP machine malfunction|1
6833804|NCT00203996|10838318|FG004|Overall Study|CPAP machine malfunction|0
6833805|NCT00203996|10838319|FG005|Overall Study|CPAP machine malfunction|0
6833806|NCT00203996|10838320|FG006|Overall Study|CPAP machine malfunction|0
6833807|NCT00203996|10838321|FG007|Overall Study|CPAP machine malfunction|0
6833808|NCT00203996|10838322|FG008|Overall Study|CPAP machine malfunction|0
6833809|NCT00203996|10838323|FG009|Overall Study|CPAP machine malfunction|0
6833810|NCT00203996|10838314|FG000|Overall Study|Scheduling issue|0
6833811|NCT00203996|10838315|FG001|Overall Study|Scheduling issue|0
6833812|NCT00203996|10838316|FG002|Overall Study|Scheduling issue|0
6833813|NCT00203996|10838317|FG003|Overall Study|Scheduling issue|0
6833814|NCT00203996|10838318|FG004|Overall Study|Scheduling issue|0
6833815|NCT00203996|10838319|FG005|Overall Study|Scheduling issue|0
6925950|NCT00837096|10956497|FG001|Overall Study|Not reported|8
6925951|NCT00837148|10956503|FG000|Overall Study|Adverse Event|1
6925952|NCT00837148|10956503|FG000|Overall Study|Death|1
6925953|NCT00837161|10956507|FG000|Overall Study|refused hysterectomy|2
6925954|NCT00837213|10956517|FG000|Overall Study|Lost to Follow-up|3
6925955|NCT00837213|10956518|FG001|Overall Study|Lost to Follow-up|2
6925956|NCT00837213|10956517|FG000|Overall Study|Withdrawal by Subject|2
6925957|NCT00837213|10956518|FG001|Overall Study|Withdrawal by Subject|2
6925958|NCT00837213|10956517|FG000|Overall Study|not stated|1
6925959|NCT00837213|10956518|FG001|Overall Study|not stated|1
6925960|NCT00837330|10956530|FG000|Overall Study|Lost to Follow-up|1
6925961|NCT00837330|10956531|FG001|Overall Study|Lost to Follow-up|3
6925962|NCT00837434|10956539|FG000|Overall Study|Physician Decision|3
6925963|NCT00837434|10956540|FG001|Overall Study|Physician Decision|0
6925964|NCT00837434|10956539|FG000|Overall Study|Lost to Follow-up|1
6925965|NCT00837434|10956540|FG001|Overall Study|Lost to Follow-up|1
6925966|NCT00837434|10956539|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1
6925967|NCT00837434|10956540|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0
6925968|NCT00837434|10956539|FG000|Overall Study|Noncompliant|2
6925969|NCT00837434|10956540|FG001|Overall Study|Noncompliant|0
6925970|NCT00837434|10956539|FG000|Overall Study|Baseline assessments not done in time|1
6925971|NCT00837434|10956540|FG001|Overall Study|Baseline assessments not done in time|0
6925972|NCT00837434|10956539|FG000|Overall Study|Unable to obtain study drug|1
6925973|NCT00837434|10956540|FG001|Overall Study|Unable to obtain study drug|0
6925974|NCT00837473|10956551|FG000|Overall Study|Lost to Follow-up|1
6925975|NCT00837473|10956551|FG000|Overall Study|Withdrawal by Subject|2
6925976|NCT00837486|10956557|FG000|Blinded-treatment Phase|Physician Decision|1
6925977|NCT00837486|10956558|FG001|Blinded-treatment Phase|Physician Decision|0
6925978|NCT00837486|10956557|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2
6925979|NCT00837486|10956558|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0
6925980|NCT00837486|10956557|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2
6925981|NCT00837486|10956558|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0
6925982|NCT00837486|10956557|FG000|Long-term Follow-up Phase - Open Label|Death|1
6925983|NCT00837486|10956558|FG001|Long-term Follow-up Phase - Open Label|Death|0
6925984|NCT00837577|10956575|FG000|Double-blind Period|Clinical Adverse Event|1
6925985|NCT00837577|10956576|FG001|Double-blind Period|Clinical Adverse Event|0
6925986|NCT00837577|10956575|FG000|Double-blind Period|Withdrawal by Subject|1
6925987|NCT00837577|10956576|FG001|Double-blind Period|Withdrawal by Subject|0
6925988|NCT00837577|10956575|FG000|Open-label Period|Clinical Adverse Event|2
6925989|NCT00837577|10956576|FG001|Open-label Period|Clinical Adverse Event|2
6925990|NCT00837577|10956575|FG000|Open-label Period|Laboratory Adverse Event|0
6925991|NCT00837577|10956576|FG001|Open-label Period|Laboratory Adverse Event|1
6925992|NCT00837577|10956575|FG000|Open-label Period|Lack of Efficacy|4
6925993|NCT00837577|10956576|FG001|Open-label Period|Lack of Efficacy|3
6925994|NCT00837577|10956575|FG000|Open-label Period|Withdrawal by Subject|1
6925995|NCT00837577|10956576|FG001|Open-label Period|Withdrawal by Subject|2
6925996|NCT00837577|10956575|FG000|Open-label Period|Other Reason|1
6925997|NCT00837577|10956576|FG001|Open-label Period|Other Reason|1
6925998|NCT00837616|10956598|FG000|Overall Study|Withdrawal by Subject|0
6925999|NCT00837616|10956599|FG001|Overall Study|Withdrawal by Subject|1
6926000|NCT00837694|10956611|FG000|Overall Study|Lost to Follow-up|2
6926001|NCT00837694|10956612|FG001|Overall Study|Lost to Follow-up|0
6926002|NCT00837694|10956613|FG002|Overall Study|Lost to Follow-up|2
6926003|NCT00837694|10956614|FG003|Overall Study|Lost to Follow-up|1
6926004|NCT00837694|10956615|FG004|Overall Study|Lost to Follow-up|1
6926005|NCT00837694|10956616|FG005|Overall Study|Lost to Follow-up|1
6926006|NCT00837759|10956630|FG000|Overall Study|Protocol Violation|3
6926007|NCT00837759|10956630|FG000|Overall Study|Lost to Follow-up|1
6926008|NCT00837811|10956637|FG000|Overall Study|Adverse Event|4
6926009|NCT00837811|10956638|FG001|Overall Study|Adverse Event|6
6926010|NCT00837811|10956639|FG002|Overall Study|Adverse Event|0
6926011|NCT00837811|10956637|FG000|Overall Study|Death|1
6926012|NCT00837811|10956638|FG001|Overall Study|Death|1
6833816|NCT00203996|10838320|FG006|Overall Study|Scheduling issue|0
6833817|NCT00203996|10838321|FG007|Overall Study|Scheduling issue|2
6833818|NCT00203996|10838322|FG008|Overall Study|Scheduling issue|0
6833819|NCT00203996|10838323|FG009|Overall Study|Scheduling issue|0
6833820|NCT00205179|10838354|FG000|Overall Study|Death|0
6833821|NCT00205179|10838355|FG001|Overall Study|Death|2
6833822|NCT00205179|10838354|FG000|Overall Study|Physician Decision|1
6833823|NCT00205179|10838355|FG001|Overall Study|Physician Decision|1
6833824|NCT00205179|10838354|FG000|Overall Study|Adverse Event|1
6833825|NCT00205179|10838355|FG001|Overall Study|Adverse Event|1
6833826|NCT00205699|10838401|FG000|Overall Study|Lost to Follow-up|1
6833827|NCT00205699|10838402|FG001|Overall Study|Lost to Follow-up|3
6833828|NCT00205699|10838403|FG002|Overall Study|Lost to Follow-up|5
6833829|NCT00205699|10838401|FG000|Overall Study|Adverse Event|1
6833830|NCT00205699|10838402|FG001|Overall Study|Adverse Event|0
6833831|NCT00205699|10838403|FG002|Overall Study|Adverse Event|0
6833832|NCT00205699|10838401|FG000|Overall Study|Withdrawal by Subject|1
6833833|NCT00205699|10838402|FG001|Overall Study|Withdrawal by Subject|2
6833834|NCT00205699|10838403|FG002|Overall Study|Withdrawal by Subject|1
6833835|NCT00205699|10838401|FG000|Overall Study|Lack of Efficacy|0
6833836|NCT00205699|10838402|FG001|Overall Study|Lack of Efficacy|1
6833837|NCT00205699|10838403|FG002|Overall Study|Lack of Efficacy|0
6833838|NCT00205712|10838416|FG000|Overall Study|Lost to Follow-up|0
6833839|NCT00205712|10838417|FG001|Overall Study|Lost to Follow-up|1
6833840|NCT00205777|10838429|FG000|Core Study (Up to 3 Years)|Adverse Event|260
6833841|NCT00205777|10838430|FG001|Core Study (Up to 3 Years)|Adverse Event|267
6833842|NCT00205777|10838431|FG002|Core Study (Up to 3 Years)|Adverse Event|252
6833843|NCT00205777|10838432|FG003|Core Study (Up to 3 Years)|Adverse Event|232
6833844|NCT00205777|10838433|FG004|Core Study (Up to 3 Years)|Adverse Event|0
6833845|NCT00205777|10838434|FG005|Core Study (Up to 3 Years)|Adverse Event|0
6833846|NCT00205777|10838429|FG000|Core Study (Up to 3 Years)|Death|9
6833847|NCT00205777|10838430|FG001|Core Study (Up to 3 Years)|Death|7
6833848|NCT00205777|10838431|FG002|Core Study (Up to 3 Years)|Death|14
6833849|NCT00205777|10838432|FG003|Core Study (Up to 3 Years)|Death|7
6833850|NCT00205777|10838433|FG004|Core Study (Up to 3 Years)|Death|0
6833851|NCT00205777|10838434|FG005|Core Study (Up to 3 Years)|Death|0
6833852|NCT00205777|10838429|FG000|Core Study (Up to 3 Years)|Failed to return|40
6833853|NCT00205777|10838430|FG001|Core Study (Up to 3 Years)|Failed to return|25
6833854|NCT00205777|10838431|FG002|Core Study (Up to 3 Years)|Failed to return|27
6833855|NCT00205777|10838432|FG003|Core Study (Up to 3 Years)|Failed to return|27
6833856|NCT00205777|10838433|FG004|Core Study (Up to 3 Years)|Failed to return|0
6833857|NCT00205777|10838434|FG005|Core Study (Up to 3 Years)|Failed to return|0
6833858|NCT00205777|10838429|FG000|Core Study (Up to 3 Years)|Other Event|49
6833859|NCT00205777|10838430|FG001|Core Study (Up to 3 Years)|Other Event|52
6833860|NCT00205777|10838431|FG002|Core Study (Up to 3 Years)|Other Event|41
6833861|NCT00205777|10838432|FG003|Core Study (Up to 3 Years)|Other Event|58
6833862|NCT00205777|10838433|FG004|Core Study (Up to 3 Years)|Other Event|0
6833863|NCT00205777|10838434|FG005|Core Study (Up to 3 Years)|Other Event|0
6833864|NCT00205777|10838429|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144
6833865|NCT00205777|10838430|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169
6926013|NCT00837811|10956639|FG002|Overall Study|Death|0
6926014|NCT00837811|10956637|FG000|Overall Study|Lack of Efficacy|0
6926015|NCT00837811|10956638|FG001|Overall Study|Lack of Efficacy|11
6926016|NCT00837811|10956639|FG002|Overall Study|Lack of Efficacy|0
6926017|NCT00837811|10956637|FG000|Overall Study|Lost to Follow-up|1
6926018|NCT00837811|10956638|FG001|Overall Study|Lost to Follow-up|3
6926019|NCT00837811|10956639|FG002|Overall Study|Lost to Follow-up|0
6926020|NCT00837811|10956637|FG000|Overall Study|Physician Decision|0
6926021|NCT00837811|10956638|FG001|Overall Study|Physician Decision|2
6926022|NCT00837811|10956639|FG002|Overall Study|Physician Decision|1
6926023|NCT00837811|10956637|FG000|Overall Study|Withdrawal by Subject|1
6926024|NCT00837811|10956638|FG001|Overall Study|Withdrawal by Subject|9
6926025|NCT00837811|10956639|FG002|Overall Study|Withdrawal by Subject|0
6926026|NCT00837811|10956637|FG000|Overall Study|Sponsor Decision|0
7039255|NCT01709305|11121897|FG001|Phase 1|Withdrawal by Subject|0
6926027|NCT00837811|10956638|FG001|Overall Study|Sponsor Decision|2
6926028|NCT00837811|10956639|FG002|Overall Study|Sponsor Decision|0
6926029|NCT00837876|10956666|FG000|Overall Study|Death|2
6926030|NCT00837876|10956666|FG000|Overall Study|Adverse Event|7
6926031|NCT00837876|10956666|FG000|Overall Study|Physician Decision|1
6926032|NCT00837876|10956666|FG000|Overall Study|Withdrawal by Subject|3
6926033|NCT00837876|10956666|FG000|Overall Study|disease progression|24
6926034|NCT00837967|10956680|FG000|Washout Period of 7 - 14 Days|Adverse Event|2
6926035|NCT00837967|10956681|FG001|Washout Period of 7 - 14 Days|Adverse Event|0
6926036|NCT00838097|10956702|FG000|Overall Study|Ineligibility determined|6
6926037|NCT00838097|10956702|FG000|Overall Study|Adverse Event|2
6926038|NCT00838097|10956702|FG000|Overall Study|Withdrawal by Subject|3
6926039|NCT00838097|10956702|FG000|Overall Study|Requirement for alternative therapy|2
6926040|NCT00838097|10956702|FG000|Overall Study|Physician Decision|4
6833866|NCT00205777|10838431|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149
6833867|NCT00205777|10838432|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162
6833868|NCT00205777|10838433|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0
6926041|NCT00838097|10956702|FG000|Overall Study|Lost to Follow-up|11
6926042|NCT00838097|10956702|FG000|Overall Study|Death|6
6833869|NCT00205777|10838434|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0
6833870|NCT00205777|10838429|FG000|Core Study (Up to 3 Years)|Protocol Violation|53
6833871|NCT00205777|10838430|FG001|Core Study (Up to 3 Years)|Protocol Violation|55
6833872|NCT00205777|10838431|FG002|Core Study (Up to 3 Years)|Protocol Violation|50
6833873|NCT00205777|10838432|FG003|Core Study (Up to 3 Years)|Protocol Violation|42
6833874|NCT00205777|10838433|FG004|Core Study (Up to 3 Years)|Protocol Violation|0
6833875|NCT00205777|10838434|FG005|Core Study (Up to 3 Years)|Protocol Violation|0
6833876|NCT00205777|10838429|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52
6833877|NCT00205777|10838430|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52
6833878|NCT00205777|10838431|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39
6833879|NCT00205777|10838432|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75
6833880|NCT00205777|10838433|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0
6833881|NCT00205777|10838434|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0
6833882|NCT00205777|10838429|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21
6833883|NCT00205777|10838430|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32
6833884|NCT00205777|10838431|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35
6833885|NCT00205777|10838432|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29
6833886|NCT00205777|10838433|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0
6833887|NCT00205777|10838434|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0
6833888|NCT00205777|10838429|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180
6833889|NCT00205777|10838430|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158
6833890|NCT00205777|10838431|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160
6833891|NCT00205777|10838432|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174
6833892|NCT00205777|10838433|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0
6833893|NCT00205777|10838434|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0
6833894|NCT00205777|10838429|FG000|Completed Core Study, Entered SE I|Other Event|52
6833895|NCT00205777|10838430|FG001|Completed Core Study, Entered SE I|Other Event|46
6833896|NCT00205777|10838431|FG002|Completed Core Study, Entered SE I|Other Event|47
6833897|NCT00205777|10838432|FG003|Completed Core Study, Entered SE I|Other Event|50
6833898|NCT00205777|10838433|FG004|Completed Core Study, Entered SE I|Other Event|0
6833899|NCT00205777|10838434|FG005|Completed Core Study, Entered SE I|Other Event|0
6833900|NCT00205777|10838429|FG000|Study Extension I|Adverse Event|57
6833901|NCT00205777|10838430|FG001|Study Extension I|Adverse Event|0
6833902|NCT00205777|10838431|FG002|Study Extension I|Adverse Event|0
6833903|NCT00205777|10838432|FG003|Study Extension I|Adverse Event|61
6833904|NCT00205777|10838433|FG004|Study Extension I|Adverse Event|58
6833905|NCT00205777|10838434|FG005|Study Extension I|Adverse Event|0
6833906|NCT00205777|10838429|FG000|Study Extension I|Death|5
6833907|NCT00205777|10838430|FG001|Study Extension I|Death|0
6833908|NCT00205777|10838431|FG002|Study Extension I|Death|0
6833909|NCT00205777|10838432|FG003|Study Extension I|Death|1
6833910|NCT00205777|10838433|FG004|Study Extension I|Death|2
6833911|NCT00205777|10838434|FG005|Study Extension I|Death|0
6833912|NCT00205777|10838429|FG000|Study Extension I|Withdrawal by Subject|99
6833913|NCT00205777|10838430|FG001|Study Extension I|Withdrawal by Subject|0
6833914|NCT00205777|10838431|FG002|Study Extension I|Withdrawal by Subject|0
6833915|NCT00205777|10838432|FG003|Study Extension I|Withdrawal by Subject|106
6833916|NCT00205777|10838433|FG004|Study Extension I|Withdrawal by Subject|89
6833917|NCT00205777|10838434|FG005|Study Extension I|Withdrawal by Subject|0
6833918|NCT00205777|10838429|FG000|Study Extension I|Protocol Violation|4
6833919|NCT00205777|10838430|FG001|Study Extension I|Protocol Violation|0
6833920|NCT00205777|10838431|FG002|Study Extension I|Protocol Violation|0
6833921|NCT00205777|10838432|FG003|Study Extension I|Protocol Violation|8
6833922|NCT00205777|10838433|FG004|Study Extension I|Protocol Violation|8
6833923|NCT00205777|10838434|FG005|Study Extension I|Protocol Violation|0
6833924|NCT00205777|10838429|FG000|Study Extension I|Lack of Efficacy|0
6833925|NCT00205777|10838430|FG001|Study Extension I|Lack of Efficacy|0
6833926|NCT00205777|10838431|FG002|Study Extension I|Lack of Efficacy|0
6833927|NCT00205777|10838432|FG003|Study Extension I|Lack of Efficacy|1
6833928|NCT00205777|10838433|FG004|Study Extension I|Lack of Efficacy|2
6833929|NCT00205777|10838434|FG005|Study Extension I|Lack of Efficacy|0
6833930|NCT00205777|10838429|FG000|Study Extension I|Failed to return|15
6833931|NCT00205777|10838430|FG001|Study Extension I|Failed to return|0
6833932|NCT00205777|10838431|FG002|Study Extension I|Failed to return|0
6833933|NCT00205777|10838432|FG003|Study Extension I|Failed to return|17
6833934|NCT00205777|10838433|FG004|Study Extension I|Failed to return|13
6833935|NCT00205777|10838434|FG005|Study Extension I|Failed to return|0
6833936|NCT00205777|10838429|FG000|Study Extension I|Other Event|34
6833937|NCT00205777|10838430|FG001|Study Extension I|Other Event|0
6833938|NCT00205777|10838431|FG002|Study Extension I|Other Event|0
6833939|NCT00205777|10838432|FG003|Study Extension I|Other Event|34
6833940|NCT00205777|10838433|FG004|Study Extension I|Other Event|29
6833941|NCT00205777|10838434|FG005|Study Extension I|Other Event|0
6833942|NCT00205777|10838429|FG000|Study Extension I|Withdrawn as per protocol|0
6833943|NCT00205777|10838430|FG001|Study Extension I|Withdrawn as per protocol|0
6833944|NCT00205777|10838431|FG002|Study Extension I|Withdrawn as per protocol|1070
6833945|NCT00205777|10838432|FG003|Study Extension I|Withdrawn as per protocol|0
6833946|NCT00205777|10838433|FG004|Study Extension I|Withdrawn as per protocol|0
6833947|NCT00205777|10838434|FG005|Study Extension I|Withdrawn as per protocol|0
6833948|NCT00205777|10838429|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273
6833949|NCT00205777|10838430|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
6833950|NCT00205777|10838431|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
6833951|NCT00205777|10838432|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240
6833952|NCT00205777|10838433|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258
6833953|NCT00205777|10838434|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
6833954|NCT00205777|10838429|FG000|Study Extension II|Adverse Event|0
6833955|NCT00205777|10838430|FG001|Study Extension II|Adverse Event|0
6833956|NCT00205777|10838431|FG002|Study Extension II|Adverse Event|0
6833957|NCT00205777|10838432|FG003|Study Extension II|Adverse Event|14
6833958|NCT00205777|10838433|FG004|Study Extension II|Adverse Event|0
6833959|NCT00205777|10838434|FG005|Study Extension II|Adverse Event|30
6833960|NCT00205777|10838429|FG000|Study Extension II|Death|0
7063524|NCT01951105|11162019|FG001|Overall Study|Adverse Event|5
6833961|NCT00205777|10838430|FG001|Study Extension II|Death|0
6833962|NCT00205777|10838431|FG002|Study Extension II|Death|0
6833963|NCT00205777|10838432|FG003|Study Extension II|Death|2
6833964|NCT00205777|10838433|FG004|Study Extension II|Death|0
6833965|NCT00205777|10838434|FG005|Study Extension II|Death|5
6833966|NCT00205777|10838429|FG000|Study Extension II|Withdrawal by Subject|0
6833967|NCT00205777|10838430|FG001|Study Extension II|Withdrawal by Subject|0
6833968|NCT00205777|10838431|FG002|Study Extension II|Withdrawal by Subject|0
6833969|NCT00205777|10838432|FG003|Study Extension II|Withdrawal by Subject|35
6833970|NCT00205777|10838433|FG004|Study Extension II|Withdrawal by Subject|0
6833971|NCT00205777|10838434|FG005|Study Extension II|Withdrawal by Subject|59
6833972|NCT00205777|10838429|FG000|Study Extension II|Protocol Violation|0
6833973|NCT00205777|10838430|FG001|Study Extension II|Protocol Violation|0
6833974|NCT00205777|10838431|FG002|Study Extension II|Protocol Violation|0
6833975|NCT00205777|10838432|FG003|Study Extension II|Protocol Violation|1
6833976|NCT00205777|10838433|FG004|Study Extension II|Protocol Violation|0
6833977|NCT00205777|10838434|FG005|Study Extension II|Protocol Violation|10
6833978|NCT00205777|10838429|FG000|Study Extension II|Lack of Efficacy|0
6833979|NCT00205777|10838430|FG001|Study Extension II|Lack of Efficacy|0
6833980|NCT00205777|10838431|FG002|Study Extension II|Lack of Efficacy|0
6833981|NCT00205777|10838432|FG003|Study Extension II|Lack of Efficacy|0
6833982|NCT00205777|10838433|FG004|Study Extension II|Lack of Efficacy|0
6833983|NCT00205777|10838434|FG005|Study Extension II|Lack of Efficacy|1
6833984|NCT00205777|10838429|FG000|Study Extension II|Failed to return|0
6833985|NCT00205777|10838430|FG001|Study Extension II|Failed to return|0
6833986|NCT00205777|10838431|FG002|Study Extension II|Failed to return|0
6833987|NCT00205777|10838432|FG003|Study Extension II|Failed to return|14
6833988|NCT00205777|10838433|FG004|Study Extension II|Failed to return|0
6926043|NCT00838097|10956702|FG000|Overall Study|Protocol-specified criteria|142
6926044|NCT00838110|10956708|FG000|Overall Study|Death|0
6926045|NCT00838110|10956709|FG001|Overall Study|Death|0
6926046|NCT00838110|10956710|FG002|Overall Study|Death|1
6926047|NCT00838110|10956711|FG003|Overall Study|Death|2
6926048|NCT00838110|10956708|FG000|Overall Study|Adverse Event|11
6926049|NCT00838110|10956709|FG001|Overall Study|Adverse Event|10
6926050|NCT00838110|10956710|FG002|Overall Study|Adverse Event|8
6926051|NCT00838110|10956711|FG003|Overall Study|Adverse Event|7
6926052|NCT00838110|10956708|FG000|Overall Study|Withdrawal by Subject|5
6926053|NCT00838110|10956709|FG001|Overall Study|Withdrawal by Subject|6
6926054|NCT00838110|10956710|FG002|Overall Study|Withdrawal by Subject|3
6926055|NCT00838110|10956711|FG003|Overall Study|Withdrawal by Subject|4
6926056|NCT00838110|10956708|FG000|Overall Study|Other|3
6926057|NCT00838110|10956709|FG001|Overall Study|Other|3
6926058|NCT00838110|10956710|FG002|Overall Study|Other|3
6926059|NCT00838110|10956711|FG003|Overall Study|Other|2
6926060|NCT00838110|10956708|FG000|Overall Study|Protocol Violation|0
6926061|NCT00838110|10956709|FG001|Overall Study|Protocol Violation|2
6926062|NCT00838110|10956710|FG002|Overall Study|Protocol Violation|1
6926063|NCT00838110|10956711|FG003|Overall Study|Protocol Violation|1
6926064|NCT00838110|10956708|FG000|Overall Study|Lost to Follow-up|3
6926065|NCT00838110|10956709|FG001|Overall Study|Lost to Follow-up|0
6926066|NCT00838110|10956710|FG002|Overall Study|Lost to Follow-up|0
6926067|NCT00838110|10956711|FG003|Overall Study|Lost to Follow-up|0
6926068|NCT00838110|10956708|FG000|Overall Study|Did not meet eligibility criteria|0
6926069|NCT00838110|10956709|FG001|Overall Study|Did not meet eligibility criteria|0
6926070|NCT00838110|10956710|FG002|Overall Study|Did not meet eligibility criteria|1
6926071|NCT00838110|10956711|FG003|Overall Study|Did not meet eligibility criteria|2
6926072|NCT00838110|10956708|FG000|Overall Study|Randomized but not treated|0
6926073|NCT00838110|10956709|FG001|Overall Study|Randomized but not treated|1
6926074|NCT00838110|10956710|FG002|Overall Study|Randomized but not treated|0
6926075|NCT00838110|10956711|FG003|Overall Study|Randomized but not treated|0
6926076|NCT00838201|10956740|FG000|Overall Study|Investigator decision, or other reasons|2
6926077|NCT00838201|10956741|FG001|Overall Study|Investigator decision, or other reasons|3
7063525|NCT01951105|11162020|FG002|Overall Study|Adverse Event|0
7063526|NCT01951105|11162018|FG000|Overall Study|Lost to Follow-up|0
6833989|NCT00205777|10838434|FG005|Study Extension II|Failed to return|26
6926078|NCT00838201|10956740|FG000|Overall Study|Noncompliance|0
6926079|NCT00838201|10956741|FG001|Overall Study|Noncompliance|1
6833990|NCT00205777|10838429|FG000|Study Extension II|Other Event|0
6833991|NCT00205777|10838430|FG001|Study Extension II|Other Event|0
6833992|NCT00205777|10838431|FG002|Study Extension II|Other Event|0
6833993|NCT00205777|10838432|FG003|Study Extension II|Other Event|12
6833994|NCT00205777|10838433|FG004|Study Extension II|Other Event|0
6833995|NCT00205777|10838434|FG005|Study Extension II|Other Event|20
6833996|NCT00205777|10838429|FG000|Study Extension II|Enrolled but not treated|0
6833997|NCT00205777|10838430|FG001|Study Extension II|Enrolled but not treated|0
6833998|NCT00205777|10838431|FG002|Study Extension II|Enrolled but not treated|0
6833999|NCT00205777|10838432|FG003|Study Extension II|Enrolled but not treated|71
6834000|NCT00205777|10838433|FG004|Study Extension II|Enrolled but not treated|0
6834001|NCT00205777|10838434|FG005|Study Extension II|Enrolled but not treated|131
6834002|NCT00205803|10838451|FG000|Infant Series|Lost to Follow-up|10
6834003|NCT00205803|10838452|FG001|Infant Series|Lost to Follow-up|4
6834004|NCT00205803|10838451|FG000|Infant Series|Withdrawal by Subject|2
6834005|NCT00205803|10838452|FG001|Infant Series|Withdrawal by Subject|5
6834006|NCT00205803|10838451|FG000|Infant Series|Physician Decision|3
6834007|NCT00205803|10838452|FG001|Infant Series|Physician Decision|1
6834008|NCT00205803|10838451|FG000|Infant Series|Protocol Violation|1
6834009|NCT00205803|10838452|FG001|Infant Series|Protocol Violation|0
6834010|NCT00205803|10838451|FG000|Infant Series|Lost Kaiser coverage|0
6834011|NCT00205803|10838452|FG001|Infant Series|Lost Kaiser coverage|1
6834012|NCT00205803|10838451|FG000|Infant Series|Non-compliant|1
6834013|NCT00205803|10838452|FG001|Infant Series|Non-compliant|0
6834014|NCT00205803|10838451|FG000|Infant Series|Sponsor request|1
6834015|NCT00205803|10838452|FG001|Infant Series|Sponsor request|0
6834016|NCT00205803|10838451|FG000|After Infant Series|Adverse Event|1
6834017|NCT00205803|10838452|FG001|After Infant Series|Adverse Event|1
6834018|NCT00205803|10838451|FG000|After Infant Series|Protocol Violation|1
6834019|NCT00205803|10838452|FG001|After Infant Series|Protocol Violation|1
6834020|NCT00205803|10838451|FG000|After Infant Series|Lost to Follow-up|2
6834021|NCT00205803|10838452|FG001|After Infant Series|Lost to Follow-up|1
6834022|NCT00205803|10838451|FG000|After Infant Series|Physician Decision|3
6834023|NCT00205803|10838452|FG001|After Infant Series|Physician Decision|2
6834024|NCT00205803|10838451|FG000|After Infant Series|Withdrawal by Subject|1
6834025|NCT00205803|10838452|FG001|After Infant Series|Withdrawal by Subject|4
6834026|NCT00205803|10838451|FG000|After Infant Series|Other|10
6834027|NCT00205803|10838452|FG001|After Infant Series|Other|4
6834028|NCT00205803|10838451|FG000|Toddler Dose|Lost to Follow-up|2
6834029|NCT00205803|10838452|FG001|Toddler Dose|Lost to Follow-up|3
6834030|NCT00205855|10838476|FG000|Overall Study|Only received temporary implants|16
6834031|NCT00205855|10838476|FG000|Overall Study|Withdrawal by Subject|5
6834032|NCT00205881|10838480|FG000|Overall Study|Withdrawal by Subject|16
6834033|NCT00206076|10838487|FG000|Overall Study|Physician Decision|2
6834034|NCT00206076|10838488|FG001|Overall Study|Physician Decision|0
6834035|NCT00206076|10838487|FG000|Overall Study|Withdrawal by Subject|1
6834036|NCT00206076|10838488|FG001|Overall Study|Withdrawal by Subject|1
6834037|NCT00206102|10838498|FG000|Overall Study|Adverse Event|119
6834038|NCT00206102|10838499|FG001|Overall Study|Adverse Event|82
6834039|NCT00206102|10838498|FG000|Overall Study|Protocol Violation|0
6834040|NCT00206102|10838499|FG001|Overall Study|Protocol Violation|2
6834041|NCT00206102|10838498|FG000|Overall Study|Lack of therapeutic response|16
6834042|NCT00206102|10838499|FG001|Overall Study|Lack of therapeutic response|11
6834043|NCT00206102|10838498|FG000|Overall Study|Lost to Follow-up|95
6834044|NCT00206102|10838499|FG001|Overall Study|Lost to Follow-up|66
6834045|NCT00206102|10838498|FG000|Overall Study|Withdrawal by Subject|118
6834046|NCT00206102|10838499|FG001|Overall Study|Withdrawal by Subject|101
6834047|NCT00206102|10838498|FG000|Overall Study|Study-specific discontinuation criteria|18
6834048|NCT00206102|10838499|FG001|Overall Study|Study-specific discontinuation criteria|17
6834049|NCT00206102|10838498|FG000|Overall Study|None of those categories|42
6834050|NCT00206102|10838499|FG001|Overall Study|None of those categories|36
6834051|NCT00206323|10838507|FG000|Overall Study|Lack of Efficacy|4
6834052|NCT00206323|10838508|FG001|Overall Study|Lack of Efficacy|1
6834053|NCT00206323|10838507|FG000|Overall Study|Adverse Event|1
6834054|NCT00206323|10838508|FG001|Overall Study|Adverse Event|1
6834055|NCT00206323|10838507|FG000|Overall Study|Lost to Follow-up|1
6834056|NCT00206323|10838508|FG001|Overall Study|Lost to Follow-up|1
6834057|NCT00206427|10838518|FG000|Overall Study|Adverse Event|2
6834058|NCT00206440|10838524|FG000|Overall Study|Protocol Violation|1
6834059|NCT00206440|10838525|FG001|Overall Study|Protocol Violation|2
6834060|NCT00206440|10838524|FG000|Overall Study|Adverse Event|4
6834061|NCT00206440|10838525|FG001|Overall Study|Adverse Event|2
6834062|NCT00206518|10838533|FG000|Overall Study|Lack of Efficacy|6
6834063|NCT00206518|10838534|FG001|Overall Study|Lack of Efficacy|4
6834064|NCT00206518|10838533|FG000|Overall Study|Adverse Event|2
6834065|NCT00206518|10838534|FG001|Overall Study|Adverse Event|1
6834066|NCT00206518|10838533|FG000|Overall Study|Physician Decision|1
6834067|NCT00206518|10838534|FG001|Overall Study|Physician Decision|0
6834068|NCT00206518|10838533|FG000|Overall Study|Protocol Violation|1
6834069|NCT00206518|10838534|FG001|Overall Study|Protocol Violation|1
6834070|NCT00206726|10838540|FG000|Overall Study|Delayed recovery of blood counts|1
6834071|NCT00206726|10838540|FG000|Overall Study|Progressive disease or relapsed disease|18
6834072|NCT00206726|10838540|FG000|Overall Study|Placed on new protocol|1
6834073|NCT00206726|10838540|FG000|Overall Study|Bone marrow transplant|1
6834074|NCT00206726|10838540|FG000|Overall Study|Adverse Event|17
6834075|NCT00206726|10838540|FG000|Overall Study|Death|4
6834076|NCT00206726|10838540|FG000|Overall Study|Protocol Violation|1
6834077|NCT00206726|10838540|FG000|Overall Study|Withdrawal by Subject|8
6834078|NCT00207090|10838544|FG000|Overall Study|Study drug toxicity|3
6834079|NCT00207090|10838544|FG000|Overall Study|Chest wall mass larger|1
6834080|NCT00207090|10838544|FG000|Overall Study|Disease progression/relapse|2
6834081|NCT00207090|10838544|FG000|Overall Study|Physician Decision|1
6834082|NCT00207142|10838556|FG000|Induction Phase|Adverse Event|9
6834083|NCT00207142|10838557|FG001|Induction Phase|Adverse Event|0
6834084|NCT00207142|10838558|FG002|Induction Phase|Adverse Event|0
6834085|NCT00207142|10838559|FG003|Induction Phase|Adverse Event|0
6834086|NCT00207142|10838556|FG000|Induction Phase|Death|1
6834087|NCT00207142|10838557|FG001|Induction Phase|Death|0
6834088|NCT00207142|10838558|FG002|Induction Phase|Death|0
6834089|NCT00207142|10838559|FG003|Induction Phase|Death|0
6834090|NCT00207142|10838556|FG000|Induction Phase|Lack of Efficacy|1
6834091|NCT00207142|10838557|FG001|Induction Phase|Lack of Efficacy|0
6834092|NCT00207142|10838558|FG002|Induction Phase|Lack of Efficacy|0
6834093|NCT00207142|10838559|FG003|Induction Phase|Lack of Efficacy|0
6834094|NCT00207142|10838556|FG000|Induction Phase|Lost to Follow-up|5
6834095|NCT00207142|10838557|FG001|Induction Phase|Lost to Follow-up|0
6834096|NCT00207142|10838558|FG002|Induction Phase|Lost to Follow-up|0
6834097|NCT00207142|10838559|FG003|Induction Phase|Lost to Follow-up|0
6834098|NCT00207142|10838556|FG000|Induction Phase|Physician Decision|2
6834099|NCT00207142|10838557|FG001|Induction Phase|Physician Decision|0
6834100|NCT00207142|10838558|FG002|Induction Phase|Physician Decision|0
6834101|NCT00207142|10838559|FG003|Induction Phase|Physician Decision|0
6834102|NCT00207142|10838556|FG000|Induction Phase|Poor/noncompliance|2
6834103|NCT00207142|10838557|FG001|Induction Phase|Poor/noncompliance|0
6834104|NCT00207142|10838558|FG002|Induction Phase|Poor/noncompliance|0
6834105|NCT00207142|10838559|FG003|Induction Phase|Poor/noncompliance|0
6834106|NCT00207142|10838556|FG000|Induction Phase|Pregnancy|1
6834107|NCT00207142|10838557|FG001|Induction Phase|Pregnancy|0
6834108|NCT00207142|10838558|FG002|Induction Phase|Pregnancy|0
6834109|NCT00207142|10838559|FG003|Induction Phase|Pregnancy|0
6834110|NCT00207142|10838556|FG000|Induction Phase|Subject no longer meets study criteria|3
6834111|NCT00207142|10838557|FG001|Induction Phase|Subject no longer meets study criteria|0
6834112|NCT00207142|10838558|FG002|Induction Phase|Subject no longer meets study criteria|0
6834113|NCT00207142|10838559|FG003|Induction Phase|Subject no longer meets study criteria|0
6834114|NCT00207142|10838556|FG000|Induction Phase|Withdrawal by Subject|4
6834115|NCT00207142|10838557|FG001|Induction Phase|Withdrawal by Subject|0
6834116|NCT00207142|10838558|FG002|Induction Phase|Withdrawal by Subject|0
6834117|NCT00207142|10838559|FG003|Induction Phase|Withdrawal by Subject|0
6834118|NCT00207142|10838556|FG000|Induction Phase|Incarceration|1
6834119|NCT00207142|10838557|FG001|Induction Phase|Incarceration|0
6834120|NCT00207142|10838558|FG002|Induction Phase|Incarceration|0
7039256|NCT01709305|11121898|FG002|Phase 1|Withdrawal by Subject|0
6834121|NCT00207142|10838559|FG003|Induction Phase|Incarceration|0
6834122|NCT00207142|10838556|FG000|Induction Phase|Missing lab data|1
6834123|NCT00207142|10838557|FG001|Induction Phase|Missing lab data|0
6834124|NCT00207142|10838558|FG002|Induction Phase|Missing lab data|0
6834125|NCT00207142|10838559|FG003|Induction Phase|Missing lab data|0
6834126|NCT00207142|10838556|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0
6834127|NCT00207142|10838557|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1
6834128|NCT00207142|10838558|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4
6834129|NCT00207142|10838559|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1
6834130|NCT00207142|10838556|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0
6834131|NCT00207142|10838557|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
6834132|NCT00207142|10838558|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
6834133|NCT00207142|10838559|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2
6834134|NCT00207142|10838556|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0
6834135|NCT00207142|10838557|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0
6834136|NCT00207142|10838558|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1
6834137|NCT00207142|10838559|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0
6834138|NCT00207142|10838556|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0
6834139|NCT00207142|10838557|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
6834140|NCT00207142|10838558|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2
6834141|NCT00207142|10838559|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
6834142|NCT00207142|10838556|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0
6834143|NCT00207142|10838557|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2
7039257|NCT01709305|11121899|FG003|Phase 1|Withdrawal by Subject|0
6834144|NCT00207142|10838558|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2
6834145|NCT00207142|10838559|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0
6834146|NCT00207142|10838556|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
6834147|NCT00207142|10838557|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
6834148|NCT00207142|10838558|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1
6834149|NCT00207142|10838559|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
6834150|NCT00207142|10838556|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0
6897298|NCT00639678|10916257|FG003|Overall Study|Lack of Compliance|0
6897299|NCT00639769|10916273|FG000|Overall Study|Death|2
6834151|NCT00207142|10838557|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
6834152|NCT00207142|10838558|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
6834153|NCT00207142|10838559|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1
6834154|NCT00207142|10838556|FG000|Maintenance Phase/Rescue Phase|Death|0
6834155|NCT00207142|10838557|FG001|Maintenance Phase/Rescue Phase|Death|0
6834156|NCT00207142|10838558|FG002|Maintenance Phase/Rescue Phase|Death|0
6834157|NCT00207142|10838559|FG003|Maintenance Phase/Rescue Phase|Death|1
6834158|NCT00207142|10838556|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
6834159|NCT00207142|10838557|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
6834160|NCT00207142|10838558|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
6834161|NCT00207142|10838559|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1
6834162|NCT00207714|10838579|FG000|Overall Study|Adverse Event|6
6834163|NCT00207714|10838580|FG001|Overall Study|Adverse Event|2
6834164|NCT00207714|10838581|FG002|Overall Study|Adverse Event|4
6834165|NCT00207714|10838582|FG003|Overall Study|Adverse Event|3
6834166|NCT00207714|10838583|FG004|Overall Study|Adverse Event|1
6834167|NCT00207714|10838579|FG000|Overall Study|Unsatisfactory therapeutic effect|5
6834168|NCT00207714|10838580|FG001|Overall Study|Unsatisfactory therapeutic effect|3
6834169|NCT00207714|10838581|FG002|Overall Study|Unsatisfactory therapeutic effect|1
6834170|NCT00207714|10838582|FG003|Overall Study|Unsatisfactory therapeutic effect|4
6834171|NCT00207714|10838583|FG004|Overall Study|Unsatisfactory therapeutic effect|4
6834172|NCT00207714|10838579|FG000|Overall Study|Other|3
6834173|NCT00207714|10838580|FG001|Overall Study|Other|2
6834174|NCT00207714|10838581|FG002|Overall Study|Other|5
6834175|NCT00207714|10838582|FG003|Overall Study|Other|1
6834176|NCT00207714|10838583|FG004|Overall Study|Other|0
6834177|NCT00207727|10838607|FG000|Overall Study|Withdrawal by Subject|0
6834178|NCT00207727|10838608|FG001|Overall Study|Withdrawal by Subject|0
6834179|NCT00207727|10838609|FG002|Overall Study|Withdrawal by Subject|0
6834180|NCT00207727|10838610|FG003|Overall Study|Withdrawal by Subject|0
6834181|NCT00207727|10838611|FG004|Overall Study|Withdrawal by Subject|1
6834182|NCT00207727|10838607|FG000|Overall Study|Lost to Follow-up|0
6834183|NCT00207727|10838608|FG001|Overall Study|Lost to Follow-up|1
6834184|NCT00207727|10838609|FG002|Overall Study|Lost to Follow-up|0
6834185|NCT00207727|10838610|FG003|Overall Study|Lost to Follow-up|0
6834186|NCT00207727|10838611|FG004|Overall Study|Lost to Follow-up|0
6834187|NCT00207727|10838607|FG000|Overall Study|Other|38
6834188|NCT00207727|10838608|FG001|Overall Study|Other|41
6834189|NCT00207727|10838609|FG002|Overall Study|Other|41
6834190|NCT00207727|10838610|FG003|Overall Study|Other|37
6834191|NCT00207727|10838611|FG004|Overall Study|Other|33
6834192|NCT00207740|10838627|FG000|Overall Study|Adverse Event|4
6834193|NCT00207740|10838628|FG001|Overall Study|Adverse Event|14
6834194|NCT00207740|10838629|FG002|Overall Study|Adverse Event|14
6834195|NCT00207740|10838630|FG003|Overall Study|Adverse Event|11
6834196|NCT00207740|10838627|FG000|Overall Study|Unsatisfactory therapeutic effect|1
6834197|NCT00207740|10838628|FG001|Overall Study|Unsatisfactory therapeutic effect|0
6834198|NCT00207740|10838629|FG002|Overall Study|Unsatisfactory therapeutic effect|2
6834199|NCT00207740|10838630|FG003|Overall Study|Unsatisfactory therapeutic effect|4
6834200|NCT00207740|10838627|FG000|Overall Study|Lost to Follow-up|0
6834201|NCT00207740|10838628|FG001|Overall Study|Lost to Follow-up|2
6834202|NCT00207740|10838629|FG002|Overall Study|Lost to Follow-up|1
6834203|NCT00207740|10838630|FG003|Overall Study|Lost to Follow-up|1
6834204|NCT00207740|10838627|FG000|Overall Study|Death|0
6834205|NCT00207740|10838628|FG001|Overall Study|Death|0
6834206|NCT00207740|10838629|FG002|Overall Study|Death|0
6834207|NCT00207740|10838630|FG003|Overall Study|Death|1
6834208|NCT00207740|10838627|FG000|Overall Study|Sponsor Directive|22
6834209|NCT00207740|10838628|FG001|Overall Study|Sponsor Directive|15
6834210|NCT00207740|10838629|FG002|Overall Study|Sponsor Directive|16
6834211|NCT00207740|10838630|FG003|Overall Study|Sponsor Directive|21
6834212|NCT00207740|10838627|FG000|Overall Study|Other|2
6834213|NCT00207740|10838628|FG001|Overall Study|Other|10
6834214|NCT00207740|10838629|FG002|Overall Study|Other|7
6834215|NCT00207740|10838630|FG003|Overall Study|Other|5
6834216|NCT00208325|10838671|FG000|Overall Study|Death|18
6834217|NCT00208325|10838672|FG001|Overall Study|Death|19
6834218|NCT00208325|10838673|FG002|Overall Study|Death|7
6834219|NCT00208325|10838674|FG003|Overall Study|Death|5
6834220|NCT00208325|10838671|FG000|Overall Study|Withdrawal by Subject|0
6834221|NCT00208325|10838672|FG001|Overall Study|Withdrawal by Subject|1
6834222|NCT00208325|10838673|FG002|Overall Study|Withdrawal by Subject|0
6834223|NCT00208325|10838674|FG003|Overall Study|Withdrawal by Subject|0
6834224|NCT00208325|10838671|FG000|Overall Study|Revision|4
6834225|NCT00208325|10838672|FG001|Overall Study|Revision|1
6834226|NCT00208325|10838673|FG002|Overall Study|Revision|0
6834227|NCT00208325|10838674|FG003|Overall Study|Revision|4
6834228|NCT00208325|10838671|FG000|Overall Study|Lost to Follow-up|1
6834229|NCT00208325|10838672|FG001|Overall Study|Lost to Follow-up|0
6834230|NCT00208325|10838673|FG002|Overall Study|Lost to Follow-up|2
6834231|NCT00208325|10838674|FG003|Overall Study|Lost to Follow-up|0
6834232|NCT00208325|10838671|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4
6834233|NCT00208325|10838672|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4
6834234|NCT00208325|10838673|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1
6834235|NCT00208325|10838674|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3
6834236|NCT00208325|10838671|FG000|Overall Study|Does not wish to Continue in Study|5
6834237|NCT00208325|10838672|FG001|Overall Study|Does not wish to Continue in Study|8
6834238|NCT00208325|10838673|FG002|Overall Study|Does not wish to Continue in Study|3
7039258|NCT01709305|11121900|FG004|Phase 1|Withdrawal by Subject|0
6834239|NCT00208325|10838674|FG003|Overall Study|Does not wish to Continue in Study|2
6834240|NCT00208325|10838671|FG000|Overall Study|Other|2
6834241|NCT00208325|10838672|FG001|Overall Study|Other|1
6834242|NCT00208325|10838673|FG002|Overall Study|Other|1
6834243|NCT00208325|10838674|FG003|Overall Study|Other|0
6834244|NCT00208325|10838671|FG000|Overall Study|Mis-Randomized|17
6834245|NCT00208325|10838672|FG001|Overall Study|Mis-Randomized|20
6834246|NCT00208325|10838673|FG002|Overall Study|Mis-Randomized|0
6834247|NCT00208325|10838674|FG003|Overall Study|Mis-Randomized|0
6834248|NCT00208767|10838704|FG000|Overall Study|Adverse Event|9
6834249|NCT00208767|10838705|FG001|Overall Study|Adverse Event|1
6834250|NCT00208767|10838704|FG000|Overall Study|Withdrawal by Subject|14
6834251|NCT00208767|10838705|FG001|Overall Study|Withdrawal by Subject|3
6834252|NCT00208767|10838704|FG000|Overall Study|Death|1
6834253|NCT00208767|10838705|FG001|Overall Study|Death|0
6834254|NCT00208767|10838704|FG000|Overall Study|Lost to Follow-up|3
6834255|NCT00208767|10838705|FG001|Overall Study|Lost to Follow-up|3
6834256|NCT00209092|10838727|FG000|Overall Study|Progression of disease|7
6834257|NCT00209092|10838728|FG001|Overall Study|Progression of disease|1
6834258|NCT00209092|10838727|FG000|Overall Study|Adverse Event|0
6834259|NCT00209092|10838728|FG001|Overall Study|Adverse Event|1
6834260|NCT00209092|10838727|FG000|Overall Study|Withdrawal by Subject|1
6834261|NCT00209092|10838728|FG001|Overall Study|Withdrawal by Subject|0
6834262|NCT00209170|10838736|FG000|Overall Study|Adverse Event|0
6834263|NCT00209170|10838737|FG001|Overall Study|Adverse Event|1
6834264|NCT00209170|10838736|FG000|Overall Study|Withdrawal by Subject|2
6834265|NCT00209170|10838737|FG001|Overall Study|Withdrawal by Subject|1
6834266|NCT00209170|10838736|FG000|Overall Study|Lack of Efficacy|0
6834267|NCT00209170|10838737|FG001|Overall Study|Lack of Efficacy|1
6834268|NCT00209274|10838745|FG000|Overall Study|Missed visit|3
6834269|NCT00209274|10838746|FG001|Overall Study|Missed visit|2
6834270|NCT00209274|10838745|FG000|Overall Study|Death|32
6834271|NCT00209274|10838746|FG001|Overall Study|Death|15
6834272|NCT00209274|10838745|FG000|Overall Study|Withdrawal by Subject|30
6834273|NCT00209274|10838746|FG001|Overall Study|Withdrawal by Subject|15
6834274|NCT00209274|10838745|FG000|Overall Study|Randomized not treated (RNT)|6
6834275|NCT00209274|10838746|FG001|Overall Study|Randomized not treated (RNT)|15
6834276|NCT00209339|10838752|FG000|At 12 Months Follow-up|Withdrawal by Subject|8
6834277|NCT00209339|10838752|FG000|At 12 Months Follow-up|Death|1
6834278|NCT00209339|10838752|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6
6834279|NCT00209339|10838752|FG000|At 24 Months Follow-up|Withdrawal by Subject|4
6834280|NCT00209339|10838752|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6
6834281|NCT00209339|10838752|FG000|At 24 Months Follow-up|Death|1
6834282|NCT00209339|10838752|FG000|At 3 Years Follow-up|Withdrawal by Subject|1
6834283|NCT00209339|10838752|FG000|At 4 Years Follow-up|Withdrawal by Subject|4
6834284|NCT00209339|10838752|FG000|At 4 Years Follow-up|Death|1
6834285|NCT00209339|10838752|FG000|At 5 Years Follow-up|Withdrawal by Subject|2
6834286|NCT00209339|10838752|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5
6834287|NCT00209339|10838752|FG000|At 5 Years Follow-up|Death|1
6834288|NCT00209560|10838767|FG000|Overall Study|Lack of Efficacy|1
6834289|NCT00209560|10838768|FG001|Overall Study|Lack of Efficacy|0
6834290|NCT00210106|10838774|FG000|Overall Study|Death|1
6834291|NCT00210106|10838774|FG000|Overall Study|Protocol Violation|13
6834292|NCT00210119|10838779|FG000|Overall Study|Protocol Violation|1
6834293|NCT00210119|10838779|FG000|Overall Study|Withdrawal by Subject|1
6834294|NCT00210184|10838783|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2
6834295|NCT00210626|10838814|FG000|Overall Study|Adverse Event|1
6834296|NCT00210626|10838815|FG001|Overall Study|Adverse Event|2
6834297|NCT00210626|10838814|FG000|Overall Study|Protocol Violation|1
6834298|NCT00210626|10838815|FG001|Overall Study|Protocol Violation|5
6834299|NCT00210626|10838814|FG000|Overall Study|Lost to Follow-up|11
6834300|NCT00210626|10838815|FG001|Overall Study|Lost to Follow-up|11
6834301|NCT00210626|10838814|FG000|Overall Study|Death|1
7039259|NCT01709305|11121896|FG000|Phase 2|Clinical Adverse Event|0
6834302|NCT00210626|10838815|FG001|Overall Study|Death|0
6834303|NCT00210626|10838814|FG000|Overall Study|Withdrawal by Subject|29
6834304|NCT00210626|10838815|FG001|Overall Study|Withdrawal by Subject|20
6834305|NCT00210626|10838814|FG000|Overall Study|Physician Decision|0
6834306|NCT00210626|10838815|FG001|Overall Study|Physician Decision|2
6834307|NCT00210626|10838814|FG000|Overall Study|Sponser Request|1
6834308|NCT00210626|10838815|FG001|Overall Study|Sponser Request|0
6834309|NCT00210626|10838814|FG000|Overall Study|Other|4
6834310|NCT00210626|10838815|FG001|Overall Study|Other|5
6834311|NCT00210639|10838823|FG000|Overall Study|Lost to Follow-up|37
7039260|NCT01709305|11121897|FG001|Phase 2|Clinical Adverse Event|10
6834312|NCT00210639|10838824|FG001|Overall Study|Lost to Follow-up|29
6834313|NCT00210639|10838823|FG000|Overall Study|Withdrawal by Subject|8
6834314|NCT00210639|10838824|FG001|Overall Study|Withdrawal by Subject|1
6834315|NCT00210639|10838823|FG000|Overall Study|Other|18
6834316|NCT00210639|10838824|FG001|Overall Study|Other|12
6834317|NCT00211081|10838830|FG000|Overall Study|Withdrawal by Subject|2
6834318|NCT00211172|10838836|FG000|Overall Study|Died or lost health plan eligibility|39
6834319|NCT00211172|10838837|FG001|Overall Study|Died or lost health plan eligibility|32
6834320|NCT00211185|10838843|FG000|Overall Study|Death|2
6834321|NCT00211185|10838843|FG000|Overall Study|Disease progression|7
6834322|NCT00211185|10838843|FG000|Overall Study|Withdrawal by Subject|6
6834323|NCT00211185|10838843|FG000|Overall Study|Physician Decision|5
6834324|NCT00211237|10838849|FG000|Baseline|Withdrew|1
6834325|NCT00211237|10838850|FG001|Baseline|Withdrew|3
6834326|NCT00211237|10838851|FG002|Baseline|Withdrew|0
6834327|NCT00211237|10838849|FG000|Baseline|Refused random assignment|1
6834328|NCT00211237|10838850|FG001|Baseline|Refused random assignment|0
6834329|NCT00211237|10838851|FG002|Baseline|Refused random assignment|0
6834330|NCT00211237|10838849|FG000|1 Month|Death|2
6834331|NCT00211237|10838850|FG001|1 Month|Death|1
6834332|NCT00211237|10838851|FG002|1 Month|Death|0
6834333|NCT00211237|10838849|FG000|1 Month|Lost to Follow-up|0
6834334|NCT00211237|10838850|FG001|1 Month|Lost to Follow-up|2
6834335|NCT00211237|10838851|FG002|1 Month|Lost to Follow-up|0
6834336|NCT00211237|10838849|FG000|1 Month|Withdrew|0
6834337|NCT00211237|10838850|FG001|1 Month|Withdrew|4
6834338|NCT00211237|10838851|FG002|1 Month|Withdrew|0
6834339|NCT00211237|10838849|FG000|1 Month|Additional surgery needed|1
6834340|NCT00211237|10838850|FG001|1 Month|Additional surgery needed|0
6834341|NCT00211237|10838851|FG002|1 Month|Additional surgery needed|0
6834342|NCT00211237|10838849|FG000|1 Month|Non-medical problem|0
6834343|NCT00211237|10838850|FG001|1 Month|Non-medical problem|2
6834344|NCT00211237|10838851|FG002|1 Month|Non-medical problem|0
6834345|NCT00211237|10838849|FG000|3 Months|Death|7
6834346|NCT00211237|10838850|FG001|3 Months|Death|3
6834347|NCT00211237|10838851|FG002|3 Months|Death|0
6834348|NCT00211237|10838849|FG000|3 Months|Could not comply with protocol|1
6834349|NCT00211237|10838850|FG001|3 Months|Could not comply with protocol|0
6834350|NCT00211237|10838851|FG002|3 Months|Could not comply with protocol|0
6834351|NCT00211237|10838849|FG000|3 Months|Withdrew|0
6834352|NCT00211237|10838850|FG001|3 Months|Withdrew|1
6834353|NCT00211237|10838851|FG002|3 Months|Withdrew|0
6834354|NCT00211237|10838849|FG000|3 Months|Non-medical problem|0
6834355|NCT00211237|10838850|FG001|3 Months|Non-medical problem|0
6926080|NCT00838201|10956740|FG000|Overall Study|Administrative decision|1
6926081|NCT00838201|10956741|FG001|Overall Study|Administrative decision|2
6926082|NCT00838201|10956740|FG000|Overall Study|Disease progression|3
6926083|NCT00838201|10956741|FG001|Overall Study|Disease progression|3
6926084|NCT00838201|10956740|FG000|Overall Study|Consent withdrawn|16
6926085|NCT00838201|10956741|FG001|Overall Study|Consent withdrawn|19
6926086|NCT00838201|10956740|FG000|Overall Study|Lost to Follow-up|4
6926087|NCT00838201|10956741|FG001|Overall Study|Lost to Follow-up|3
6926088|NCT00838201|10956740|FG000|Overall Study|Adverse Event|5
6926089|NCT00838201|10956741|FG001|Overall Study|Adverse Event|9
6926090|NCT00838201|10956740|FG000|Overall Study|Death|11
6926091|NCT00838201|10956741|FG001|Overall Study|Death|13
6926092|NCT00838331|10956747|FG000|Aged Blood Transfusion|Withdrawal by Subject|9
6926093|NCT00838435|10956751|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1
6926094|NCT00838435|10956751|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2
6926095|NCT00838435|10956751|FG000|Part 2 (7 Years)|Adverse Event|2
6926096|NCT00838435|10956751|FG000|Part 2 (7 Years)|Lost to Follow-up|2
6926097|NCT00838435|10956751|FG000|Part 2 (7 Years)|Physician Decision|1
6926098|NCT00838435|10956751|FG000|Part 2 (7 Years)|Sponsor Decision|6
6926099|NCT00838435|10956751|FG000|Part 2 (7 Years)|Withdrawal by Subject|5
6926100|NCT00838513|10956758|FG000|Screening Period|Screen Failure|3
6926101|NCT00838513|10956758|FG000|Extension Treatment Period|Death|1
6926102|NCT00838513|10956758|FG000|Post Treatment Period (Patients Who Disc|Death|1
6926103|NCT00838539|10956774|FG000|Overall Study|Disease Progression|2
6926104|NCT00838539|10956775|FG001|Overall Study|Disease Progression|4
6926105|NCT00838539|10956776|FG002|Overall Study|Disease Progression|3
6926106|NCT00838539|10956777|FG003|Overall Study|Disease Progression|2
6926107|NCT00838539|10956778|FG004|Overall Study|Disease Progression|4
6926108|NCT00838539|10956779|FG005|Overall Study|Disease Progression|2
6926109|NCT00838539|10956780|FG006|Overall Study|Disease Progression|3
6926110|NCT00838539|10956781|FG007|Overall Study|Disease Progression|4
6926111|NCT00838539|10956782|FG008|Overall Study|Disease Progression|4
6926112|NCT00838539|10956783|FG009|Overall Study|Disease Progression|5
6926113|NCT00838539|10956784|FG010|Overall Study|Disease Progression|1
6926114|NCT00838539|10956785|FG011|Overall Study|Disease Progression|4
6926115|NCT00838539|10956774|FG000|Overall Study|Adverse Event|1
6926116|NCT00838539|10956775|FG001|Overall Study|Adverse Event|1
6926117|NCT00838539|10956776|FG002|Overall Study|Adverse Event|1
6926118|NCT00838539|10956777|FG003|Overall Study|Adverse Event|1
6926119|NCT00838539|10956778|FG004|Overall Study|Adverse Event|2
6926120|NCT00838539|10956779|FG005|Overall Study|Adverse Event|1
6926121|NCT00838539|10956780|FG006|Overall Study|Adverse Event|0
6926122|NCT00838539|10956781|FG007|Overall Study|Adverse Event|2
6926123|NCT00838539|10956782|FG008|Overall Study|Adverse Event|0
6834356|NCT00211237|10838851|FG002|3 Months|Non-medical problem|1
6834357|NCT00211237|10838849|FG000|6 Months|Death|6
6834358|NCT00211237|10838850|FG001|6 Months|Death|0
6834359|NCT00211237|10838851|FG002|6 Months|Death|3
6834360|NCT00211237|10838849|FG000|6 Months|Lost to Follow-up|2
6926124|NCT00838539|10956783|FG009|Overall Study|Adverse Event|1
6926125|NCT00838539|10956784|FG010|Overall Study|Adverse Event|2
6926126|NCT00838539|10956785|FG011|Overall Study|Adverse Event|0
6834361|NCT00211237|10838850|FG001|6 Months|Lost to Follow-up|0
6834362|NCT00211237|10838851|FG002|6 Months|Lost to Follow-up|0
6834363|NCT00211237|10838849|FG000|6 Months|Could not comply with protocol|0
7039261|NCT01709305|11121898|FG002|Phase 2|Clinical Adverse Event|10
7039262|NCT01709305|11121899|FG003|Phase 2|Clinical Adverse Event|6
6834364|NCT00211237|10838850|FG001|6 Months|Could not comply with protocol|2
6834365|NCT00211237|10838851|FG002|6 Months|Could not comply with protocol|0
6834366|NCT00211237|10838849|FG000|12 Months|Death|8
6834367|NCT00211237|10838850|FG001|12 Months|Death|2
6834368|NCT00211237|10838851|FG002|12 Months|Death|3
6834369|NCT00211237|10838849|FG000|12 Months|Lost to Follow-up|1
6834370|NCT00211237|10838850|FG001|12 Months|Lost to Follow-up|0
6834371|NCT00211237|10838851|FG002|12 Months|Lost to Follow-up|1
6834372|NCT00211237|10838849|FG000|12 Months|Withdrew|0
6834373|NCT00211237|10838850|FG001|12 Months|Withdrew|0
6834374|NCT00211237|10838851|FG002|12 Months|Withdrew|1
6834375|NCT00211237|10838849|FG000|12 Months|unrelated medical problem|0
6834376|NCT00211237|10838850|FG001|12 Months|unrelated medical problem|0
6834377|NCT00211237|10838851|FG002|12 Months|unrelated medical problem|1
6834378|NCT00211510|10838870|FG000|Overall Study|Physician Decision|3
6834379|NCT00211510|10838871|FG001|Overall Study|Physician Decision|1
6834380|NCT00211510|10838870|FG000|Overall Study|Withdrawal by Subject|3
6834381|NCT00211510|10838871|FG001|Overall Study|Withdrawal by Subject|1
6834382|NCT00211536|10838882|FG000|Overall Study|Withdrawal by Subject|2
6834383|NCT00211536|10838883|FG001|Overall Study|Withdrawal by Subject|2
6834384|NCT00211536|10838882|FG000|Overall Study|Physician Decision|0
6834385|NCT00211536|10838883|FG001|Overall Study|Physician Decision|5
6834386|NCT00211536|10838882|FG000|Overall Study|Adverse Event|2
6834387|NCT00211536|10838883|FG001|Overall Study|Adverse Event|0
6834388|NCT00211757|10838900|FG000|Overall Study|Withdrawal by Subject|1
6834389|NCT00211757|10838901|FG001|Overall Study|Withdrawal by Subject|1
6834390|NCT00211757|10838900|FG000|Overall Study|Lack of Efficacy|0
6834391|NCT00211757|10838901|FG001|Overall Study|Lack of Efficacy|1
6834392|NCT00211809|10838909|FG000|Overall Study|Lack of Efficacy|1
6834393|NCT00211809|10838909|FG000|Overall Study|Lost to Follow-up|2
6834394|NCT00211809|10838909|FG000|Overall Study|Pregnancy|1
6834395|NCT00211809|10838909|FG000|Overall Study|side effects|2
6834396|NCT00211887|10838918|FG000|Overall Study|Adverse Event|8
6834397|NCT00211887|10838919|FG001|Overall Study|Adverse Event|4
6834398|NCT00211887|10838920|FG002|Overall Study|Adverse Event|6
6834399|NCT00211887|10838918|FG000|Overall Study|Death|1
6834400|NCT00211887|10838919|FG001|Overall Study|Death|1
6834401|NCT00211887|10838920|FG002|Overall Study|Death|1
6834402|NCT00211887|10838918|FG000|Overall Study|Lost to Follow-up|28
6834403|NCT00211887|10838919|FG001|Overall Study|Lost to Follow-up|13
6834404|NCT00211887|10838920|FG002|Overall Study|Lost to Follow-up|9
6834405|NCT00211887|10838918|FG000|Overall Study|Non-medical reason|31
6834406|NCT00211887|10838919|FG001|Overall Study|Non-medical reason|14
6834407|NCT00211887|10838920|FG002|Overall Study|Non-medical reason|8
6834408|NCT00211887|10838918|FG000|Overall Study|Other medical reason|15
6834409|NCT00211887|10838919|FG001|Overall Study|Other medical reason|11
6834410|NCT00211887|10838920|FG002|Overall Study|Other medical reason|7
6834411|NCT00211887|10838918|FG000|Overall Study|Side effects|19
6834412|NCT00211887|10838919|FG001|Overall Study|Side effects|13
6834413|NCT00211887|10838920|FG002|Overall Study|Side effects|5
6834414|NCT00212355|10838954|FG000|Overall Study|Adverse Event|1
6834415|NCT00212355|10838954|FG000|Overall Study|Withdrawal by Subject|1
6834416|NCT00212355|10838954|FG000|Overall Study|A change of address|1
6834417|NCT00212758|10838962|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1
6834418|NCT00212758|10838963|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0
6834419|NCT00212758|10838962|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
6834420|NCT00212758|10838963|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
6834421|NCT00213135|10838987|FG000|Overall Study|Adverse Event|9
6834422|NCT00213135|10838988|FG001|Overall Study|Adverse Event|5
6834423|NCT00213135|10838989|FG002|Overall Study|Adverse Event|5
6834424|NCT00213135|10838987|FG000|Overall Study|Lost to Follow-up|11
6834425|NCT00213135|10838988|FG001|Overall Study|Lost to Follow-up|8
6834426|NCT00213135|10838989|FG002|Overall Study|Lost to Follow-up|4
6834427|NCT00213135|10838987|FG000|Overall Study|Protocol Violation|4
6834428|NCT00213135|10838988|FG001|Overall Study|Protocol Violation|4
6834429|NCT00213135|10838989|FG002|Overall Study|Protocol Violation|10
6834430|NCT00213135|10838987|FG000|Overall Study|Death|1
6834431|NCT00213135|10838988|FG001|Overall Study|Death|1
6834432|NCT00213135|10838989|FG002|Overall Study|Death|2
6834433|NCT00213135|10838987|FG000|Overall Study|Disease progression|4
6834434|NCT00213135|10838988|FG001|Overall Study|Disease progression|5
6834435|NCT00213135|10838989|FG002|Overall Study|Disease progression|21
6926127|NCT00838539|10956774|FG000|Overall Study|Withdrawal by Subject|0
7039263|NCT01709305|11121900|FG004|Phase 2|Clinical Adverse Event|11
6834436|NCT00213135|10838987|FG000|Overall Study|Other|21
6834437|NCT00213135|10838988|FG001|Overall Study|Other|12
6834438|NCT00213135|10838989|FG002|Overall Study|Other|15
6834439|NCT00213148|10839001|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1
6834440|NCT00213148|10839002|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0
6834441|NCT00213148|10839003|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2
6834442|NCT00213148|10839004|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2
6834443|NCT00213148|10839005|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1
6834444|NCT00213148|10839001|FG000|Cycle 1 (1 Month)|Adverse Event|0
6834445|NCT00213148|10839002|FG001|Cycle 1 (1 Month)|Adverse Event|0
6834446|NCT00213148|10839003|FG002|Cycle 1 (1 Month)|Adverse Event|1
6834447|NCT00213148|10839004|FG003|Cycle 1 (1 Month)|Adverse Event|0
6834448|NCT00213148|10839005|FG004|Cycle 1 (1 Month)|Adverse Event|0
6834449|NCT00213148|10839001|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4
6834450|NCT00213148|10839002|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0
6834451|NCT00213148|10839003|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8
6834452|NCT00213148|10839004|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5
6834453|NCT00213148|10839005|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8
6834454|NCT00213148|10839001|FG000|Cycle 1 (1 Month)|Protocol Violation|1
6834455|NCT00213148|10839002|FG001|Cycle 1 (1 Month)|Protocol Violation|0
6834456|NCT00213148|10839003|FG002|Cycle 1 (1 Month)|Protocol Violation|1
6834457|NCT00213148|10839004|FG003|Cycle 1 (1 Month)|Protocol Violation|0
6834458|NCT00213148|10839005|FG004|Cycle 1 (1 Month)|Protocol Violation|0
6834459|NCT00213148|10839001|FG000|Cycle 1 (1 Month)|Other|3
6834460|NCT00213148|10839002|FG001|Cycle 1 (1 Month)|Other|0
6834461|NCT00213148|10839003|FG002|Cycle 1 (1 Month)|Other|2
6834462|NCT00213148|10839004|FG003|Cycle 1 (1 Month)|Other|2
6834463|NCT00213148|10839005|FG004|Cycle 1 (1 Month)|Other|7
6834464|NCT00213148|10839001|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
6834465|NCT00213148|10839002|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
6834466|NCT00213148|10839003|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
6834467|NCT00213148|10839004|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1
6834468|NCT00213148|10839005|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
6834469|NCT00213148|10839001|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
6834470|NCT00213148|10839002|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
6834471|NCT00213148|10839003|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
6834472|NCT00213148|10839004|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
6834473|NCT00213148|10839005|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1
6834474|NCT00213148|10839001|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15
6834475|NCT00213148|10839002|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0
6834476|NCT00213148|10839003|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5
6834477|NCT00213148|10839004|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8
6834478|NCT00213148|10839005|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5
6834479|NCT00213148|10839001|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0
6834480|NCT00213148|10839002|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0
6834481|NCT00213148|10839003|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2
6834482|NCT00213148|10839004|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2
6834483|NCT00213148|10839005|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1
6834484|NCT00213148|10839001|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1
6834485|NCT00213148|10839002|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3
6834486|NCT00213148|10839003|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7
6834487|NCT00213148|10839004|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6
6834488|NCT00213148|10839005|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16
6834489|NCT00213148|10839001|FG000|Cycle 2 (1 Month)|Other|2
6834490|NCT00213148|10839002|FG001|Cycle 2 (1 Month)|Other|1
6834491|NCT00213148|10839003|FG002|Cycle 2 (1 Month)|Other|2
6834492|NCT00213148|10839004|FG003|Cycle 2 (1 Month)|Other|8
6834493|NCT00213148|10839005|FG004|Cycle 2 (1 Month)|Other|7
6834494|NCT00213148|10839001|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
6834495|NCT00213148|10839002|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1
6834496|NCT00213148|10839003|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
6834497|NCT00213148|10839004|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
6834498|NCT00213148|10839005|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
6834499|NCT00213148|10839001|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1
6834500|NCT00213148|10839002|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
6834501|NCT00213148|10839003|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
6834502|NCT00213148|10839004|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
6834503|NCT00213148|10839005|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
6834504|NCT00213148|10839001|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10
6834505|NCT00213148|10839002|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1
6834506|NCT00213148|10839003|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3
6834507|NCT00213148|10839004|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3
6834508|NCT00213148|10839005|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6
6834509|NCT00213148|10839001|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0
6834510|NCT00213148|10839002|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2
6834511|NCT00213148|10839003|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0
6834512|NCT00213148|10839004|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0
6834513|NCT00213148|10839005|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1
6834514|NCT00213148|10839001|FG000|Cycle 3 (1 Month)|Other|0
6834515|NCT00213148|10839002|FG001|Cycle 3 (1 Month)|Other|0
6834516|NCT00213148|10839003|FG002|Cycle 3 (1 Month)|Other|1
6834517|NCT00213148|10839004|FG003|Cycle 3 (1 Month)|Other|1
6834518|NCT00213148|10839005|FG004|Cycle 3 (1 Month)|Other|0
6834519|NCT00213980|10839036|FG000|Overall Study|Withdrawal by Subject|3
6834520|NCT00213980|10839037|FG001|Overall Study|Withdrawal by Subject|1
6834521|NCT00213980|10839036|FG000|Overall Study|Adverse Event|1
6834522|NCT00213980|10839037|FG001|Overall Study|Adverse Event|1
6834523|NCT00213980|10839036|FG000|Overall Study|Disease progression|0
6834524|NCT00213980|10839037|FG001|Overall Study|Disease progression|2
6834525|NCT00213980|10839036|FG000|Overall Study|Developed ovarian cancer|1
6834526|NCT00213980|10839037|FG001|Overall Study|Developed ovarian cancer|0
6834527|NCT00213980|10839036|FG000|Overall Study|Failed to obtain all 3 DXAs|1
6834528|NCT00213980|10839037|FG001|Overall Study|Failed to obtain all 3 DXAs|3
6834529|NCT00214019|10839043|FG000|Overall Study|Lost to Follow-up|11
6834530|NCT00214019|10839043|FG000|Overall Study|Withdrawal by Subject|2
6834531|NCT00214019|10839043|FG000|Overall Study|Screen Failed prior to randomization|17
6897300|NCT00639769|10916273|FG000|Overall Study|Adverse Event|7
6897301|NCT00639769|10916273|FG000|Overall Study|Lack of Efficacy|1
6897302|NCT00639769|10916273|FG000|Overall Study|Disease progression|26
6897303|NCT00639769|10916273|FG000|Overall Study|Withdrawal by Subject|4
6897304|NCT00640016|10916285|FG000|Overall Study|Withdrawal by Subject|0
6897305|NCT00640016|10916286|FG001|Overall Study|Withdrawal by Subject|1
6897306|NCT00640016|10916287|FG002|Overall Study|Withdrawal by Subject|0
6897307|NCT00640016|10916288|FG003|Overall Study|Withdrawal by Subject|0
6897308|NCT00640016|10916285|FG000|Overall Study|Study termination|2
6897309|NCT00640016|10916286|FG001|Overall Study|Study termination|1
6897310|NCT00640016|10916287|FG002|Overall Study|Study termination|3
6897311|NCT00640016|10916288|FG003|Overall Study|Study termination|2
6897312|NCT00640016|10916285|FG000|Overall Study|Adverse Event|0
6897313|NCT00640016|10916286|FG001|Overall Study|Adverse Event|0
6897314|NCT00640016|10916287|FG002|Overall Study|Adverse Event|0
6897315|NCT00640016|10916288|FG003|Overall Study|Adverse Event|1
6897316|NCT00640042|10916305|FG000|Enrollment|Did not receive study drug|83
6897317|NCT00640146|10916311|FG000|Overall Study|Adverse Event|2
6897318|NCT00640146|10916312|FG001|Overall Study|Adverse Event|0
6897319|NCT00640146|10916311|FG000|Overall Study|Lost to Follow-up|0
6897320|NCT00640146|10916312|FG001|Overall Study|Lost to Follow-up|1
6897321|NCT00640146|10916311|FG000|Overall Study|Lack of Efficacy|0
6897322|NCT00640146|10916312|FG001|Overall Study|Lack of Efficacy|1
6897323|NCT00640146|10916311|FG000|Overall Study|Withdrawal by Subject|1
6897324|NCT00640146|10916312|FG001|Overall Study|Withdrawal by Subject|1
6897325|NCT00640146|10916311|FG000|Overall Study|Randomized but not treated|1
6897326|NCT00640146|10916312|FG001|Overall Study|Randomized but not treated|3
6897327|NCT00640224|10916322|FG000|Overall Study|Lost to Follow-up|5
6897328|NCT00640224|10916323|FG001|Overall Study|Lost to Follow-up|2
6897329|NCT00640224|10916324|FG002|Overall Study|Lost to Follow-up|0
6897330|NCT00640224|10916325|FG003|Overall Study|Lost to Follow-up|0
6897331|NCT00640224|10916322|FG000|Overall Study|Withdrawal by Subject|1
6897332|NCT00640224|10916323|FG001|Overall Study|Withdrawal by Subject|0
6897333|NCT00640224|10916324|FG002|Overall Study|Withdrawal by Subject|0
6897334|NCT00640224|10916325|FG003|Overall Study|Withdrawal by Subject|0
6897335|NCT00640224|10916322|FG000|Overall Study|Headaches|0
6897336|NCT00640224|10916323|FG001|Overall Study|Headaches|1
6897337|NCT00640224|10916324|FG002|Overall Study|Headaches|0
6897338|NCT00640224|10916325|FG003|Overall Study|Headaches|0
6897339|NCT00640289|10916438|FG000|Overall Study|Death|3
6897340|NCT00640289|10916438|FG000|Overall Study|Withdrawal by Subject|1
6897341|NCT00640289|10916438|FG000|Overall Study|Lost to Follow-up|1
6897342|NCT00640289|10916438|FG000|Overall Study|Data collected under different amendment|2
6897343|NCT00640289|10916438|FG000|Overall Study|Transferred to another center|1
6897344|NCT00640289|10916438|FG000|Overall Study|Missing status|5
6897345|NCT00640315|10916444|FG000|Overall Study|Withdrawal by Subject|0
6897346|NCT00640315|10916445|FG001|Overall Study|Withdrawal by Subject|1
6897347|NCT00640328|10916457|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0
6897348|NCT00640328|10916458|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1
6897349|NCT00640328|10916459|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0
6897350|NCT00640328|10916460|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0
6897351|NCT00640328|10916461|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0
6897352|NCT00640328|10916462|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0
6897353|NCT00640328|10916457|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0
6897354|NCT00640328|10916458|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0
6897355|NCT00640328|10916459|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0
6897356|NCT00640328|10916460|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0
6897357|NCT00640328|10916461|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1
6897358|NCT00640328|10916462|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0
6897359|NCT00640328|10916457|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
6897360|NCT00640328|10916458|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
6897361|NCT00640328|10916459|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1
6897362|NCT00640328|10916460|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
6897363|NCT00640328|10916461|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
6897364|NCT00640328|10916462|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
6897365|NCT00640328|10916457|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
6897366|NCT00640328|10916458|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
6897367|NCT00640328|10916459|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
6897368|NCT00640328|10916460|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
6897369|NCT00640328|10916461|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
6897370|NCT00640328|10916462|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
6834532|NCT00214136|10839078|FG000|Overall Study|Death|5
6834533|NCT00214201|10839084|FG000|Overall Study|Withdrawal by Subject|2
6834534|NCT00214201|10839085|FG001|Overall Study|Withdrawal by Subject|0
6834535|NCT00214201|10839084|FG000|Overall Study|Death|0
6834536|NCT00214201|10839085|FG001|Overall Study|Death|2
6834537|NCT00214383|10839094|FG000|Overall Study|Lost to Follow-up|16
6834538|NCT00214383|10839095|FG001|Overall Study|Lost to Follow-up|26
6834539|NCT00214422|10839104|FG000|Overall Study|Physician Decision|2
6834540|NCT00214422|10839105|FG001|Overall Study|Physician Decision|0
6834541|NCT00214422|10839106|FG002|Overall Study|Physician Decision|0
6834542|NCT00214422|10839104|FG000|Overall Study|Developed esophageal ca|1
6834543|NCT00214422|10839105|FG001|Overall Study|Developed esophageal ca|0
6834544|NCT00214422|10839106|FG002|Overall Study|Developed esophageal ca|0
6834545|NCT00214422|10839104|FG000|Overall Study|Pt taken off study|1
6834546|NCT00214422|10839105|FG001|Overall Study|Pt taken off study|1
6834547|NCT00214422|10839106|FG002|Overall Study|Pt taken off study|0
6834548|NCT00214422|10839104|FG000|Overall Study|Disease progression on study|1
6834549|NCT00214422|10839105|FG001|Overall Study|Disease progression on study|0
6834550|NCT00214422|10839106|FG002|Overall Study|Disease progression on study|0
6834551|NCT00214422|10839104|FG000|Overall Study|Unable to make a radiation treatment|0
6834552|NCT00214422|10839105|FG001|Overall Study|Unable to make a radiation treatment|0
6834553|NCT00214422|10839106|FG002|Overall Study|Unable to make a radiation treatment|1
6834554|NCT00214461|10839122|FG000|Overall Study|Adverse Event|0
6834555|NCT00214461|10839123|FG001|Overall Study|Adverse Event|0
6834556|NCT00214461|10839124|FG002|Overall Study|Adverse Event|1
6834557|NCT00214461|10839125|FG003|Overall Study|Adverse Event|1
6834558|NCT00214461|10839122|FG000|Overall Study|Withdrawal by Subject|0
6834559|NCT00214461|10839123|FG001|Overall Study|Withdrawal by Subject|0
6834560|NCT00214461|10839124|FG002|Overall Study|Withdrawal by Subject|1
6834561|NCT00214461|10839125|FG003|Overall Study|Withdrawal by Subject|0
6834562|NCT00215137|10839198|FG000|Open Label Escitalopram|Lack of Efficacy|1
6926128|NCT00838539|10956775|FG001|Overall Study|Withdrawal by Subject|1
6926129|NCT00838539|10956776|FG002|Overall Study|Withdrawal by Subject|0
6926130|NCT00838539|10956777|FG003|Overall Study|Withdrawal by Subject|0
6926131|NCT00838539|10956778|FG004|Overall Study|Withdrawal by Subject|0
6926132|NCT00838539|10956779|FG005|Overall Study|Withdrawal by Subject|0
6926133|NCT00838539|10956780|FG006|Overall Study|Withdrawal by Subject|0
6926134|NCT00838539|10956781|FG007|Overall Study|Withdrawal by Subject|0
6926135|NCT00838539|10956782|FG008|Overall Study|Withdrawal by Subject|0
6926136|NCT00838539|10956783|FG009|Overall Study|Withdrawal by Subject|1
6926137|NCT00838539|10956784|FG010|Overall Study|Withdrawal by Subject|2
6926138|NCT00838539|10956785|FG011|Overall Study|Withdrawal by Subject|0
6926139|NCT00838539|10956774|FG000|Overall Study|Death|0
6926140|NCT00838539|10956775|FG001|Overall Study|Death|0
7039264|NCT01709305|11121896|FG000|Phase 2|Death|0
6926141|NCT00838539|10956776|FG002|Overall Study|Death|0
6926142|NCT00838539|10956777|FG003|Overall Study|Death|0
6926143|NCT00838539|10956778|FG004|Overall Study|Death|0
6926144|NCT00838539|10956779|FG005|Overall Study|Death|0
6926145|NCT00838539|10956780|FG006|Overall Study|Death|1
6926146|NCT00838539|10956781|FG007|Overall Study|Death|0
6926147|NCT00838539|10956782|FG008|Overall Study|Death|0
6926148|NCT00838539|10956783|FG009|Overall Study|Death|0
6926149|NCT00838539|10956784|FG010|Overall Study|Death|0
6926150|NCT00838539|10956785|FG011|Overall Study|Death|0
6926151|NCT00838539|10956774|FG000|Overall Study|Physician Decision|0
6926152|NCT00838539|10956775|FG001|Overall Study|Physician Decision|0
6926153|NCT00838539|10956776|FG002|Overall Study|Physician Decision|0
6926154|NCT00838539|10956777|FG003|Overall Study|Physician Decision|0
6926155|NCT00838539|10956778|FG004|Overall Study|Physician Decision|0
6926156|NCT00838539|10956779|FG005|Overall Study|Physician Decision|0
6926157|NCT00838539|10956780|FG006|Overall Study|Physician Decision|0
6926158|NCT00838539|10956781|FG007|Overall Study|Physician Decision|0
6926159|NCT00838539|10956782|FG008|Overall Study|Physician Decision|1
6926160|NCT00838539|10956783|FG009|Overall Study|Physician Decision|0
6926161|NCT00838539|10956784|FG010|Overall Study|Physician Decision|0
6926162|NCT00838539|10956785|FG011|Overall Study|Physician Decision|0
6926163|NCT00838539|10956774|FG000|Overall Study|Clinical Progression|0
6926164|NCT00838539|10956775|FG001|Overall Study|Clinical Progression|0
6926165|NCT00838539|10956776|FG002|Overall Study|Clinical Progression|0
6926166|NCT00838539|10956777|FG003|Overall Study|Clinical Progression|0
6926167|NCT00838539|10956778|FG004|Overall Study|Clinical Progression|0
6926168|NCT00838539|10956779|FG005|Overall Study|Clinical Progression|0
6926169|NCT00838539|10956780|FG006|Overall Study|Clinical Progression|1
7039265|NCT01709305|11121897|FG001|Phase 2|Death|0
6834563|NCT00215137|10839199|FG001|Open Label Escitalopram|Lack of Efficacy|0
6834564|NCT00215137|10839200|FG002|Open Label Escitalopram|Lack of Efficacy|0
6834565|NCT00215137|10839198|FG000|Randomization Period|Lost to Follow-up|0
6834566|NCT00215137|10839199|FG001|Randomization Period|Lost to Follow-up|1
6834567|NCT00215137|10839200|FG002|Randomization Period|Lost to Follow-up|0
6834568|NCT00215137|10839198|FG000|Randomization Period|Withdrawal by Subject|0
6926170|NCT00838539|10956781|FG007|Overall Study|Clinical Progression|0
6926171|NCT00838539|10956782|FG008|Overall Study|Clinical Progression|0
6834569|NCT00215137|10839199|FG001|Randomization Period|Withdrawal by Subject|1
6926172|NCT00838539|10956783|FG009|Overall Study|Clinical Progression|0
6834570|NCT00215137|10839200|FG002|Randomization Period|Withdrawal by Subject|0
6834571|NCT00215150|10839208|FG000|Open Label Phase|Lost to Follow-up|7
6834572|NCT00215150|10839208|FG000|Open Label Phase|Withdrawal by Subject|1
6834573|NCT00215150|10839208|FG000|Open Label Phase|Did not complete a post base visit|13
6834574|NCT00215150|10839208|FG000|Open Label Phase|Did not meet randomization criteria|9
6834575|NCT00215150|10839208|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2
6834576|NCT00215150|10839208|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1
6834577|NCT00215150|10839208|FG000|Randomization Phase Placebo|Withdrawal by Subject|1
6834578|NCT00215540|10839219|FG000|Overall Study|Withdrew from study medication|1
6834579|NCT00215540|10839220|FG001|Overall Study|Withdrew from study medication|0
6834580|NCT00215540|10839221|FG002|Overall Study|Withdrew from study medication|0
6834581|NCT00215553|10839236|FG000|Overall Study|Adverse Event|0
6834582|NCT00215553|10839237|FG001|Overall Study|Adverse Event|1
6834583|NCT00215553|10839238|FG002|Overall Study|Adverse Event|2
6834584|NCT00215553|10839239|FG003|Overall Study|Adverse Event|1
6834585|NCT00215553|10839240|FG004|Overall Study|Adverse Event|2
6834586|NCT00215553|10839241|FG005|Overall Study|Adverse Event|6
6834587|NCT00215553|10839242|FG006|Overall Study|Adverse Event|0
6834588|NCT00215644|10839260|FG000|Overall Study|Disease Progression|28
6834589|NCT00215644|10839261|FG001|Overall Study|Disease Progression|10
6834590|NCT00215644|10839260|FG000|Overall Study|Adverse Event|2
6834591|NCT00215644|10839261|FG001|Overall Study|Adverse Event|9
6834592|NCT00215644|10839260|FG000|Overall Study|Death|1
6834593|NCT00215644|10839261|FG001|Overall Study|Death|2
6834594|NCT00215644|10839260|FG000|Overall Study|Withdrawal by Subject|1
6834595|NCT00215644|10839261|FG001|Overall Study|Withdrawal by Subject|0
6834596|NCT00215644|10839260|FG000|Overall Study|Other|3
6834597|NCT00215644|10839261|FG001|Overall Study|Other|15
6834598|NCT00215644|10839260|FG000|Overall Study|Randomized but Not Treated|1
6834599|NCT00215644|10839261|FG001|Overall Study|Randomized but Not Treated|0
6834600|NCT00215657|10839275|FG000|Overall Study|Adverse Event|5
6834601|NCT00215657|10839276|FG001|Overall Study|Adverse Event|1
6834602|NCT00215657|10839277|FG002|Overall Study|Adverse Event|3
6834603|NCT00215657|10839278|FG003|Overall Study|Adverse Event|0
6834604|NCT00215657|10839279|FG004|Overall Study|Adverse Event|3
6834605|NCT00215657|10839280|FG005|Overall Study|Adverse Event|1
6834606|NCT00215657|10839281|FG006|Overall Study|Adverse Event|0
6834607|NCT00215657|10839282|FG007|Overall Study|Adverse Event|3
6834608|NCT00215657|10839275|FG000|Overall Study|Withdrawal by Subject|6
6834609|NCT00215657|10839276|FG001|Overall Study|Withdrawal by Subject|3
6834610|NCT00215657|10839277|FG002|Overall Study|Withdrawal by Subject|3
6834611|NCT00215657|10839278|FG003|Overall Study|Withdrawal by Subject|1
6834612|NCT00215657|10839279|FG004|Overall Study|Withdrawal by Subject|6
6834613|NCT00215657|10839280|FG005|Overall Study|Withdrawal by Subject|1
6834614|NCT00215657|10839281|FG006|Overall Study|Withdrawal by Subject|10
6834615|NCT00215657|10839282|FG007|Overall Study|Withdrawal by Subject|3
6834616|NCT00215657|10839275|FG000|Overall Study|Insuff prostate specific antigen resp|3
6834617|NCT00215657|10839276|FG001|Overall Study|Insuff prostate specific antigen resp|2
6834618|NCT00215657|10839277|FG002|Overall Study|Insuff prostate specific antigen resp|2
6834619|NCT00215657|10839278|FG003|Overall Study|Insuff prostate specific antigen resp|2
6834620|NCT00215657|10839279|FG004|Overall Study|Insuff prostate specific antigen resp|1
6834621|NCT00215657|10839280|FG005|Overall Study|Insuff prostate specific antigen resp|2
6834622|NCT00215657|10839281|FG006|Overall Study|Insuff prostate specific antigen resp|3
6834623|NCT00215657|10839282|FG007|Overall Study|Insuff prostate specific antigen resp|2
6834624|NCT00215657|10839275|FG000|Overall Study|Insufficient testosterone response|5
6834625|NCT00215657|10839276|FG001|Overall Study|Insufficient testosterone response|4
6834626|NCT00215657|10839277|FG002|Overall Study|Insufficient testosterone response|1
6834627|NCT00215657|10839278|FG003|Overall Study|Insufficient testosterone response|12
6834628|NCT00215657|10839279|FG004|Overall Study|Insufficient testosterone response|8
6834629|NCT00215657|10839280|FG005|Overall Study|Insufficient testosterone response|12
6834630|NCT00215657|10839281|FG006|Overall Study|Insufficient testosterone response|4
6834631|NCT00215657|10839282|FG007|Overall Study|Insufficient testosterone response|7
6834632|NCT00215657|10839275|FG000|Overall Study|Other|3
6834633|NCT00215657|10839276|FG001|Overall Study|Other|1
6834634|NCT00215657|10839277|FG002|Overall Study|Other|2
6834635|NCT00215657|10839278|FG003|Overall Study|Other|3
6834636|NCT00215657|10839279|FG004|Overall Study|Other|5
6834637|NCT00215657|10839280|FG005|Overall Study|Other|4
6834638|NCT00215657|10839281|FG006|Overall Study|Other|6
6834639|NCT00215657|10839282|FG007|Overall Study|Other|1
6834640|NCT00215683|10839303|FG000|Overall Study|Adverse Event|15
6834641|NCT00215683|10839304|FG001|Overall Study|Adverse Event|16
6834642|NCT00215683|10839305|FG002|Overall Study|Adverse Event|15
6834643|NCT00215683|10839303|FG000|Overall Study|Lack of Efficacy|5
6834644|NCT00215683|10839304|FG001|Overall Study|Lack of Efficacy|1
6834645|NCT00215683|10839305|FG002|Overall Study|Lack of Efficacy|2
6834646|NCT00215683|10839303|FG000|Overall Study|Lost to Follow-up|0
6834647|NCT00215683|10839304|FG001|Overall Study|Lost to Follow-up|2
6834648|NCT00215683|10839305|FG002|Overall Study|Lost to Follow-up|1
6834649|NCT00215683|10839303|FG000|Overall Study|Withdrawal by Subject|9
6834650|NCT00215683|10839304|FG001|Overall Study|Withdrawal by Subject|4
6834651|NCT00215683|10839305|FG002|Overall Study|Withdrawal by Subject|13
6834652|NCT00215683|10839303|FG000|Overall Study|Physician Decision|0
6834653|NCT00215683|10839304|FG001|Overall Study|Physician Decision|0
6834654|NCT00215683|10839305|FG002|Overall Study|Physician Decision|1
6834655|NCT00215683|10839303|FG000|Overall Study|Difficult to attend visits|0
6834656|NCT00215683|10839304|FG001|Overall Study|Difficult to attend visits|1
6834657|NCT00215683|10839305|FG002|Overall Study|Difficult to attend visits|0
6834658|NCT00215683|10839303|FG000|Overall Study|No study drug available|0
6834659|NCT00215683|10839304|FG001|Overall Study|No study drug available|1
6834660|NCT00215683|10839305|FG002|Overall Study|No study drug available|0
6834661|NCT00215683|10839303|FG000|Overall Study|Intermittent therapy required|0
6834662|NCT00215683|10839304|FG001|Overall Study|Intermittent therapy required|1
6834663|NCT00215683|10839305|FG002|Overall Study|Intermittent therapy required|0
6834664|NCT00215943|10839324|FG000|Overall Study|Disease Progression|3
6834665|NCT00215943|10839325|FG001|Overall Study|Disease Progression|5
6834666|NCT00215943|10839324|FG000|Overall Study|Alternate therapy|0
6834667|NCT00215943|10839325|FG001|Overall Study|Alternate therapy|1
6834668|NCT00215943|10839324|FG000|Overall Study|Adverse Event|3
6834669|NCT00215943|10839325|FG001|Overall Study|Adverse Event|6
6834670|NCT00215943|10839324|FG000|Overall Study|Other disease|0
6834671|NCT00215943|10839325|FG001|Overall Study|Other disease|1
6834672|NCT00215943|10839324|FG000|Overall Study|Other complications|3
6834673|NCT00215943|10839325|FG001|Overall Study|Other complications|1
6834674|NCT00216086|10839342|FG000|Overall Study|Protocol Violation|1
6834675|NCT00216086|10839342|FG000|Overall Study|Diagnosis of Metastatic Disease|1
6834676|NCT00216086|10839342|FG000|Overall Study|Social Reasons|2
6834677|NCT00216203|10839359|FG000|Overall Study|Withdrawal by Subject|2
6834678|NCT00216476|10839380|FG000|Overall Study|Withdrawal by Subject|59
6834679|NCT00216476|10839381|FG001|Overall Study|Withdrawal by Subject|72
6834680|NCT00216476|10839382|FG002|Overall Study|Withdrawal by Subject|9
6834681|NCT00216476|10839380|FG000|Overall Study|Lost to Follow-up|10
6834682|NCT00216476|10839381|FG001|Overall Study|Lost to Follow-up|9
6834683|NCT00216476|10839382|FG002|Overall Study|Lost to Follow-up|1
6834684|NCT00216476|10839380|FG000|Overall Study|Adverse Event|6
6834685|NCT00216476|10839381|FG001|Overall Study|Adverse Event|10
6834686|NCT00216476|10839382|FG002|Overall Study|Adverse Event|1
6834687|NCT00216476|10839380|FG000|Overall Study|Lack of Efficacy|4
6834688|NCT00216476|10839381|FG001|Overall Study|Lack of Efficacy|3
6834689|NCT00216476|10839382|FG002|Overall Study|Lack of Efficacy|0
6834690|NCT00216476|10839380|FG000|Overall Study|Death|2
6834691|NCT00216476|10839381|FG001|Overall Study|Death|0
6834692|NCT00216476|10839382|FG002|Overall Study|Death|0
6834693|NCT00216476|10839380|FG000|Overall Study|Pregnancy|0
6834694|NCT00216476|10839381|FG001|Overall Study|Pregnancy|1
6834695|NCT00216476|10839382|FG002|Overall Study|Pregnancy|1
6834696|NCT00216476|10839380|FG000|Overall Study|Other|0
6834697|NCT00216476|10839381|FG001|Overall Study|Other|0
6834698|NCT00216476|10839382|FG002|Overall Study|Other|1
6834699|NCT00216476|10839380|FG000|Overall Study|Refuses Injection|11
6834700|NCT00216476|10839381|FG001|Overall Study|Refuses Injection|0
6834701|NCT00216476|10839382|FG002|Overall Study|Refuses Injection|0
6926173|NCT00838539|10956784|FG010|Overall Study|Clinical Progression|0
6926174|NCT00838539|10956785|FG011|Overall Study|Clinical Progression|0
6926175|NCT00838539|10956774|FG000|Overall Study|Symptomatic Deterioration|0
6926176|NCT00838539|10956775|FG001|Overall Study|Symptomatic Deterioration|0
6926177|NCT00838539|10956776|FG002|Overall Study|Symptomatic Deterioration|1
6926178|NCT00838539|10956777|FG003|Overall Study|Symptomatic Deterioration|1
6926179|NCT00838539|10956778|FG004|Overall Study|Symptomatic Deterioration|0
6834702|NCT00216476|10839380|FG000|Overall Study|No Further Need for Treatment|3
6834703|NCT00216476|10839381|FG001|Overall Study|No Further Need for Treatment|4
6834704|NCT00216476|10839382|FG002|Overall Study|No Further Need for Treatment|1
6834705|NCT00216476|10839380|FG000|Overall Study|Non-compliance|0
6834706|NCT00216476|10839381|FG001|Overall Study|Non-compliance|4
6834707|NCT00216476|10839382|FG002|Overall Study|Non-compliance|1
6834708|NCT00216476|10839380|FG000|Overall Study|Higher dose/Extra Medication Required|2
6834709|NCT00216476|10839381|FG001|Overall Study|Higher dose/Extra Medication Required|0
6834710|NCT00216476|10839382|FG002|Overall Study|Higher dose/Extra Medication Required|2
6834711|NCT00216476|10839380|FG000|Overall Study|Administrative Reasons|1
6834712|NCT00216476|10839381|FG001|Overall Study|Administrative Reasons|1
6834713|NCT00216476|10839382|FG002|Overall Study|Administrative Reasons|0
6834714|NCT00216476|10839380|FG000|Overall Study|Protocol Deviation|5
6834715|NCT00216476|10839381|FG001|Overall Study|Protocol Deviation|1
6834716|NCT00216476|10839382|FG002|Overall Study|Protocol Deviation|0
6834717|NCT00216476|10839380|FG000|Overall Study|Patient Moved|2
6834718|NCT00216476|10839381|FG001|Overall Study|Patient Moved|2
6834719|NCT00216476|10839382|FG002|Overall Study|Patient Moved|0
6834720|NCT00216671|10839395|FG000|Overall Study|Adverse Event|4
6834721|NCT00216671|10839396|FG001|Overall Study|Adverse Event|9
6834722|NCT00216671|10839395|FG000|Overall Study|Pregnancy|0
6834723|NCT00216671|10839396|FG001|Overall Study|Pregnancy|1
6834724|NCT00216671|10839395|FG000|Overall Study|Withdrawal by Subject|4
6834725|NCT00216671|10839396|FG001|Overall Study|Withdrawal by Subject|2
6834726|NCT00216671|10839395|FG000|Overall Study|Refused Injections|3
6834727|NCT00216671|10839396|FG001|Overall Study|Refused Injections|13
6834728|NCT00216671|10839395|FG000|Overall Study|No Need to Continue Medication|1
6926180|NCT00838539|10956779|FG005|Overall Study|Symptomatic Deterioration|1
6834729|NCT00216671|10839396|FG001|Overall Study|No Need to Continue Medication|1
6834730|NCT00216671|10839395|FG000|Overall Study|Insufficient Response|9
6834731|NCT00216671|10839396|FG001|Overall Study|Insufficient Response|4
6834732|NCT00216671|10839395|FG000|Overall Study|Lost to Follow-up|3
6834733|NCT00216671|10839396|FG001|Overall Study|Lost to Follow-up|5
6834734|NCT00216671|10839395|FG000|Overall Study|Non compliant|2
6834735|NCT00216671|10839396|FG001|Overall Study|Non compliant|2
6834736|NCT00216671|10839395|FG000|Overall Study|Ineligible|0
6834737|NCT00216671|10839396|FG001|Overall Study|Ineligible|2
6834738|NCT00216671|10839395|FG000|Overall Study|Physician Decision|1
6834739|NCT00216671|10839396|FG001|Overall Study|Physician Decision|1
6834740|NCT00216671|10839395|FG000|Overall Study|Protocol Violation|3
6834741|NCT00216671|10839396|FG001|Overall Study|Protocol Violation|5
6834742|NCT00216671|10839395|FG000|Overall Study|Relapse|1
6834743|NCT00216671|10839396|FG001|Overall Study|Relapse|0
6834744|NCT00216671|10839395|FG000|Overall Study|Investigator Illness|0
6834745|NCT00216671|10839396|FG001|Overall Study|Investigator Illness|1
6834746|NCT00216671|10839395|FG000|Overall Study|Patient Moved|0
6834747|NCT00216671|10839396|FG001|Overall Study|Patient Moved|1
6834748|NCT00216671|10839395|FG000|Overall Study|Ineligible, no efficacy data|2
6834749|NCT00216671|10839396|FG001|Overall Study|Ineligible, no efficacy data|2
6834750|NCT00216671|10839395|FG000|Overall Study|Insufficient Response Adverse Event|2
6834751|NCT00216671|10839396|FG001|Overall Study|Insufficient Response Adverse Event|1
6834752|NCT00216736|10839404|FG000|Overall Study|Lost to Follow-up|1
6926181|NCT00838539|10956780|FG006|Overall Study|Symptomatic Deterioration|0
6926182|NCT00838539|10956781|FG007|Overall Study|Symptomatic Deterioration|0
6926183|NCT00838539|10956782|FG008|Overall Study|Symptomatic Deterioration|0
6926184|NCT00838539|10956783|FG009|Overall Study|Symptomatic Deterioration|1
6926185|NCT00838539|10956784|FG010|Overall Study|Symptomatic Deterioration|0
6926186|NCT00838539|10956785|FG011|Overall Study|Symptomatic Deterioration|0
6926187|NCT00838565|10956831|FG000|Overall Study|Withdrawal by Subject|0
6926188|NCT00838565|10956832|FG001|Overall Study|Withdrawal by Subject|0
6926189|NCT00838565|10956833|FG002|Overall Study|Withdrawal by Subject|1
6926190|NCT00838565|10956834|FG003|Overall Study|Withdrawal by Subject|0
6926191|NCT00838565|10956835|FG004|Overall Study|Withdrawal by Subject|0
6926192|NCT00838565|10956836|FG005|Overall Study|Withdrawal by Subject|2
6926193|NCT00838565|10956831|FG000|Overall Study|Other|0
6926194|NCT00838565|10956832|FG001|Overall Study|Other|2
6926195|NCT00838565|10956833|FG002|Overall Study|Other|0
6926196|NCT00838565|10956834|FG003|Overall Study|Other|0
6926197|NCT00838565|10956835|FG004|Overall Study|Other|0
6926198|NCT00838565|10956836|FG005|Overall Study|Other|0
6926199|NCT00838565|10956831|FG000|Overall Study|Randomized but not Treated|0
6926200|NCT00838565|10956832|FG001|Overall Study|Randomized but not Treated|1
6926201|NCT00838565|10956833|FG002|Overall Study|Randomized but not Treated|0
6926202|NCT00838565|10956834|FG003|Overall Study|Randomized but not Treated|0
6926203|NCT00838565|10956835|FG004|Overall Study|Randomized but not Treated|0
6926204|NCT00838565|10956836|FG005|Overall Study|Randomized but not Treated|0
6926205|NCT00838578|10956855|FG000|Overall Study|Protocol Violation|2
6926206|NCT00838682|10956865|FG000|Overall Study|Lost to Follow-up|21
6926207|NCT00838682|10956866|FG001|Overall Study|Lost to Follow-up|14
6926208|NCT00838682|10956865|FG000|Overall Study|detection of exclusion criteria|4
6926209|NCT00838682|10956866|FG001|Overall Study|detection of exclusion criteria|3
6926210|NCT00838682|10956865|FG000|Overall Study|Protocol Violation|0
6926211|NCT00838682|10956866|FG001|Overall Study|Protocol Violation|1
6926212|NCT00838682|10956865|FG000|Overall Study|Withdrawal by Subject|0
6926213|NCT00838682|10956866|FG001|Overall Study|Withdrawal by Subject|1
6926214|NCT00838903|10956885|FG000|Treatment Period (156 Weeks)|Adverse Event|5
6926215|NCT00838903|10956886|FG001|Treatment Period (156 Weeks)|Adverse Event|13
6926216|NCT00838903|10956887|FG002|Treatment Period (156 Weeks)|Adverse Event|17
6926217|NCT00838903|10956888|FG003|Treatment Period (156 Weeks)|Adverse Event|25
6926218|NCT00838903|10956885|FG000|Treatment Period (156 Weeks)|Protocol Violation|1
6926219|NCT00838903|10956886|FG001|Treatment Period (156 Weeks)|Protocol Violation|6
6926220|NCT00838903|10956887|FG002|Treatment Period (156 Weeks)|Protocol Violation|6
6926221|NCT00838903|10956888|FG003|Treatment Period (156 Weeks)|Protocol Violation|5
6926222|NCT00838903|10956885|FG000|Treatment Period (156 Weeks)|Noncompliance|9
6926223|NCT00838903|10956886|FG001|Treatment Period (156 Weeks)|Noncompliance|13
6926224|NCT00838903|10956887|FG002|Treatment Period (156 Weeks)|Noncompliance|12
6926225|NCT00838903|10956888|FG003|Treatment Period (156 Weeks)|Noncompliance|6
6926226|NCT00838903|10956885|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
6926227|NCT00838903|10956886|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
6926228|NCT00838903|10956887|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
6926229|NCT00838903|10956888|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
6926230|NCT00838903|10956885|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4
6834753|NCT00216736|10839405|FG001|Overall Study|Lost to Follow-up|1
6834754|NCT00217022|10839413|FG000|Overall Study|Withdrawal by Subject|1
6834755|NCT00217022|10839414|FG001|Overall Study|Withdrawal by Subject|1
6834756|NCT00217087|10839422|FG000|Overall Study|decided to have esophagectomy|1
6834757|NCT00217087|10839423|FG001|Overall Study|decided to have esophagectomy|2
6926231|NCT00838903|10956886|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16
6974899|NCT01190930|11027133|FG002|Induction|High Risk|0
6834758|NCT00217087|10839422|FG000|Overall Study|completed less than 12 months return|10
6834759|NCT00217087|10839423|FG001|Overall Study|completed less than 12 months return|18
6834760|NCT00217425|10839441|FG000|Overall Study|Never started treatment|2
6834761|NCT00217425|10839441|FG000|Overall Study|Patient ineligible|5
6834762|NCT00217425|10839441|FG000|Overall Study|Lack of Efficacy|13
6834763|NCT00217425|10839441|FG000|Overall Study|Adverse Event|8
6834764|NCT00217425|10839441|FG000|Overall Study|Withdrawal by Subject|4
6834765|NCT00217425|10839441|FG000|Overall Study|Other complicating disease|1
6834766|NCT00217425|10839441|FG000|Overall Study|Other|4
6834767|NCT00217464|10839454|FG000|Overall Study|Progression|15
6834768|NCT00217464|10839454|FG000|Overall Study|Other|2
6834769|NCT00217581|10839479|FG000|Overall Study|Withdrawal by Subject|1
6834770|NCT00217620|10839488|FG000|Overall Study|Adverse Event|2
6834771|NCT00217620|10839488|FG000|Overall Study|Progression|31
6834772|NCT00217620|10839488|FG000|Overall Study|Not Protocol Specified|4
6834773|NCT00217620|10839488|FG000|Overall Study|Ineligible|13
6834774|NCT00217620|10839488|FG000|Overall Study|Never received treatment|1
6834775|NCT00217672|10839496|FG000|Allocation|Ineligible|2
6834776|NCT00217672|10839497|FG001|Allocation|Ineligible|0
6834777|NCT00217672|10839496|FG000|Treatment|disease progression|33
6834778|NCT00217672|10839497|FG001|Treatment|disease progression|4
6834779|NCT00217672|10839496|FG000|Treatment|Adverse Event|18
6926232|NCT00838903|10956887|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15
6926233|NCT00838903|10956888|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13
6926234|NCT00838903|10956885|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20
6926235|NCT00838903|10956886|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55
6926236|NCT00838903|10956887|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56
6926237|NCT00838903|10956888|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53
6926238|NCT00838903|10956885|FG000|Treatment Period (156 Weeks)|Physician Decision|1
6926239|NCT00838903|10956886|FG001|Treatment Period (156 Weeks)|Physician Decision|2
6926240|NCT00838903|10956887|FG002|Treatment Period (156 Weeks)|Physician Decision|1
6926241|NCT00838903|10956888|FG003|Treatment Period (156 Weeks)|Physician Decision|2
6926242|NCT00838903|10956885|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3
6926243|NCT00838903|10956886|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
6926244|NCT00838903|10956887|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
6926245|NCT00838903|10956888|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4
6926246|NCT00838903|10956885|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
6926247|NCT00838903|10956886|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1
6926248|NCT00838903|10956887|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
6926249|NCT00838903|10956888|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
6926250|NCT00838903|10956885|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0
6926251|NCT00838903|10956886|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0
6926252|NCT00838903|10956887|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0
6926253|NCT00838903|10956888|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1
6926254|NCT00838903|10956885|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1
6926255|NCT00838903|10956886|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
6926256|NCT00838903|10956887|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
6926257|NCT00838903|10956888|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
6926258|NCT00838903|10956885|FG000|Treatment Period (156 Weeks)|Pregnancy|0
6926259|NCT00838903|10956886|FG001|Treatment Period (156 Weeks)|Pregnancy|0
6926260|NCT00838903|10956887|FG002|Treatment Period (156 Weeks)|Pregnancy|1
6926261|NCT00838903|10956888|FG003|Treatment Period (156 Weeks)|Pregnancy|0
6926262|NCT00838903|10956885|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
6926263|NCT00838903|10956886|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
6926264|NCT00838903|10956887|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1
6926265|NCT00838903|10956888|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
6926266|NCT00838903|10956885|FG000|Treatment Period (156 Weeks)|Site closed|0
6926267|NCT00838903|10956886|FG001|Treatment Period (156 Weeks)|Site closed|0
6926268|NCT00838903|10956887|FG002|Treatment Period (156 Weeks)|Site closed|1
6926269|NCT00838903|10956888|FG003|Treatment Period (156 Weeks)|Site closed|0
6926270|NCT00838903|10956885|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1
6926271|NCT00838903|10956886|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
6926272|NCT00838903|10956887|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
6926273|NCT00838903|10956888|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
6926274|NCT00838903|10956885|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
6926275|NCT00838903|10956886|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
6926276|NCT00838903|10956887|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
6926277|NCT00838903|10956888|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
6926278|NCT00838903|10956885|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1
6834780|NCT00217672|10839497|FG001|Treatment|Adverse Event|2
6834781|NCT00217672|10839496|FG000|Treatment|reqd treatment not permitted by protocol|6
6834782|NCT00217672|10839497|FG001|Treatment|reqd treatment not permitted by protocol|0
6834783|NCT00217672|10839496|FG000|Treatment|Physician Decision|6
6834784|NCT00217672|10839497|FG001|Treatment|Physician Decision|0
6834785|NCT00217672|10839496|FG000|Treatment|insurance issues|1
6834786|NCT00217672|10839497|FG001|Treatment|insurance issues|1
6834787|NCT00217672|10839496|FG000|Treatment|Death|2
6834788|NCT00217672|10839497|FG001|Treatment|Death|0
6834789|NCT00217672|10839496|FG000|Treatment|secondary malignancy|1
6834790|NCT00217672|10839497|FG001|Treatment|secondary malignancy|0
6834791|NCT00217672|10839496|FG000|Follow-up|Withdrawal by Subject|4
6834792|NCT00217672|10839497|FG001|Follow-up|Withdrawal by Subject|0
6834793|NCT00217672|10839496|FG000|Follow-up|Lost to Follow-up|1
6834794|NCT00217672|10839497|FG001|Follow-up|Lost to Follow-up|0
6834795|NCT00217971|10839510|FG000|Overall Study|Adverse Event|1
6834796|NCT00217971|10839511|FG001|Overall Study|Adverse Event|1
6834797|NCT00217971|10839510|FG000|Overall Study|Lost to Follow-up|15
6834798|NCT00217971|10839511|FG001|Overall Study|Lost to Follow-up|19
6834799|NCT00217971|10839510|FG000|Overall Study|Physician Decision|0
6834800|NCT00217971|10839511|FG001|Overall Study|Physician Decision|1
6834801|NCT00217971|10839510|FG000|Overall Study|Withdrawal by Subject|7
6834802|NCT00217971|10839511|FG001|Overall Study|Withdrawal by Subject|12
6834803|NCT00217971|10839510|FG000|Overall Study|non compliant|1
6834804|NCT00217971|10839511|FG001|Overall Study|non compliant|0
6834805|NCT00218257|10839551|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4
6834806|NCT00218257|10839552|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3
6834807|NCT00218296|10839563|FG000|Overall Study|Lost to Follow-up|9
6834808|NCT00218296|10839564|FG001|Overall Study|Lost to Follow-up|7
6834809|NCT00218296|10839563|FG000|Overall Study|Withdrawal by Subject|36
6834810|NCT00218296|10839564|FG001|Overall Study|Withdrawal by Subject|47
6834811|NCT00218296|10839563|FG000|Overall Study|Randomized but did not enter treatment|66
6834812|NCT00218296|10839564|FG001|Overall Study|Randomized but did not enter treatment|67
6834813|NCT00218543|10839659|FG000|Overall Study|Lost to Follow-up|8
6834814|NCT00218543|10839659|FG000|Overall Study|relocated|1
6834815|NCT00218543|10839659|FG000|Overall Study|Withdrawal by Subject|1
6834816|NCT00218543|10839659|FG000|Overall Study|Physician Decision|3
6834817|NCT00218543|10839659|FG000|Overall Study|Adverse Event|2
6834818|NCT00218634|10839665|FG000|Overall Study|Lost to Follow-up|8
6834819|NCT00218634|10839666|FG001|Overall Study|Lost to Follow-up|15
6834820|NCT00219141|10839678|FG000|Overall Study|Adverse Event|4
6834821|NCT00219141|10839679|FG001|Overall Study|Adverse Event|10
6834822|NCT00219141|10839680|FG002|Overall Study|Adverse Event|5
6834823|NCT00219141|10839678|FG000|Overall Study|Lack of Efficacy|3
6834824|NCT00219141|10839679|FG001|Overall Study|Lack of Efficacy|2
6834825|NCT00219141|10839680|FG002|Overall Study|Lack of Efficacy|0
6834826|NCT00219141|10839678|FG000|Overall Study|Administrative problems|0
6834827|NCT00219141|10839679|FG001|Overall Study|Administrative problems|1
6834828|NCT00219141|10839680|FG002|Overall Study|Administrative problems|0
6834829|NCT00219141|10839678|FG000|Overall Study|Lost to Follow-up|2
6834830|NCT00219141|10839679|FG001|Overall Study|Lost to Follow-up|4
6834831|NCT00219141|10839680|FG002|Overall Study|Lost to Follow-up|1
6834832|NCT00219141|10839678|FG000|Overall Study|Protocol Violation|3
6834833|NCT00219141|10839679|FG001|Overall Study|Protocol Violation|1
6834834|NCT00219141|10839680|FG002|Overall Study|Protocol Violation|1
6834835|NCT00219141|10839678|FG000|Overall Study|Withdrawal by Subject|1
6834836|NCT00219141|10839679|FG001|Overall Study|Withdrawal by Subject|3
6834837|NCT00219141|10839680|FG002|Overall Study|Withdrawal by Subject|5
6834838|NCT00219141|10839678|FG000|Overall Study|Condition no longer requires study drug|1
6834839|NCT00219141|10839679|FG001|Overall Study|Condition no longer requires study drug|0
6834840|NCT00219141|10839680|FG002|Overall Study|Condition no longer requires study drug|0
6834841|NCT00219284|10839690|FG000|Treatment Phase - 16 Weeks|Adverse Event|26
6834842|NCT00219284|10839691|FG001|Treatment Phase - 16 Weeks|Adverse Event|24
6834843|NCT00219284|10839690|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0
6834844|NCT00219284|10839691|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1
6834845|NCT00219284|10839690|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3
6834846|NCT00219284|10839691|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10
6834847|NCT00219284|10839690|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9
6834848|NCT00219284|10839691|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5
6834849|NCT00219284|10839690|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5
6834850|NCT00219284|10839691|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9
6834851|NCT00219284|10839690|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1
6834852|NCT00219284|10839691|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2
6834853|NCT00219284|10839690|FG000|Extension Phase - 8 Weeks|Adverse Event|2
6834854|NCT00219284|10839691|FG001|Extension Phase - 8 Weeks|Adverse Event|3
6834855|NCT00219284|10839690|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0
6834856|NCT00219284|10839691|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2
6834857|NCT00219284|10839690|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0
6834858|NCT00219284|10839691|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2
6834859|NCT00219349|10839697|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6
6834860|NCT00219349|10839697|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2
6834861|NCT00219349|10839697|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2
6834862|NCT00219349|10839697|FG000|Escitalopram Phase|Withdrawal by Subject|3
6834863|NCT00219544|10839701|FG000|Single Blind Treatment Period|Lack of Efficacy|5
6834864|NCT00219544|10839702|FG001|Single Blind Treatment Period|Lack of Efficacy|0
6834865|NCT00219544|10839701|FG000|Single Blind Treatment Period|Adverse Event|9
6834866|NCT00219544|10839702|FG001|Single Blind Treatment Period|Adverse Event|0
6834867|NCT00219544|10839701|FG000|Single Blind Treatment Period|Protocol Violation|4
6834868|NCT00219544|10839702|FG001|Single Blind Treatment Period|Protocol Violation|0
6834869|NCT00219544|10839701|FG000|Single Blind Treatment Period|Lost to Follow-up|2
6834870|NCT00219544|10839702|FG001|Single Blind Treatment Period|Lost to Follow-up|0
6834871|NCT00219544|10839701|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1
6834872|NCT00219544|10839702|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0
6834873|NCT00219544|10839701|FG000|Single Blind Treatment Period|Withdrawal by Subject|1
6834874|NCT00219544|10839702|FG001|Single Blind Treatment Period|Withdrawal by Subject|0
6834875|NCT00219557|10839713|FG000|Phase 1|Lack of Efficacy|3
6834876|NCT00219557|10839714|FG001|Phase 1|Lack of Efficacy|0
6834877|NCT00219557|10839715|FG002|Phase 1|Lack of Efficacy|0
6834878|NCT00219557|10839713|FG000|Phase 1|Adverse Event|2
6834879|NCT00219557|10839714|FG001|Phase 1|Adverse Event|0
6834880|NCT00219557|10839715|FG002|Phase 1|Adverse Event|0
6834881|NCT00219557|10839713|FG000|Phase 1|Withdrawal by Subject|1
6834882|NCT00219557|10839714|FG001|Phase 1|Withdrawal by Subject|0
6834883|NCT00219557|10839715|FG002|Phase 1|Withdrawal by Subject|0
6834884|NCT00219557|10839713|FG000|Phase 1|Started chemotherapy at other institute|1
6834885|NCT00219557|10839714|FG001|Phase 1|Started chemotherapy at other institute|0
6834886|NCT00219557|10839715|FG002|Phase 1|Started chemotherapy at other institute|0
6834887|NCT00219557|10839713|FG000|Phase 2|Lack of Efficacy|0
6834888|NCT00219557|10839714|FG001|Phase 2|Lack of Efficacy|21
6834889|NCT00219557|10839715|FG002|Phase 2|Lack of Efficacy|15
6834890|NCT00219557|10839713|FG000|Phase 2|Adverse Event|0
6834891|NCT00219557|10839714|FG001|Phase 2|Adverse Event|22
6834892|NCT00219557|10839715|FG002|Phase 2|Adverse Event|2
6834893|NCT00219557|10839713|FG000|Phase 2|Death|0
6834894|NCT00219557|10839714|FG001|Phase 2|Death|8
6834895|NCT00219557|10839715|FG002|Phase 2|Death|2
6834896|NCT00219557|10839713|FG000|Phase 2|Other|0
6834897|NCT00219557|10839714|FG001|Phase 2|Other|8
6834898|NCT00219557|10839715|FG002|Phase 2|Other|6
6834899|NCT00219557|10839713|FG000|Phase 2|Withdrawal by Subject|0
6834900|NCT00219557|10839714|FG001|Phase 2|Withdrawal by Subject|9
6834901|NCT00219557|10839715|FG002|Phase 2|Withdrawal by Subject|5
6834902|NCT00219557|10839713|FG000|Phase 2|Treatment not received|0
6834903|NCT00219557|10839714|FG001|Phase 2|Treatment not received|1
6834904|NCT00219557|10839715|FG002|Phase 2|Treatment not received|3
6834905|NCT00220636|10839724|FG000|Overall Study|Withdrawal by Subject|4
6834906|NCT00220701|10839731|FG000|Overall Study|Lost to Follow-up|5
6834907|NCT00220701|10839732|FG001|Overall Study|Lost to Follow-up|4
6834908|NCT00220727|10839740|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1
6834909|NCT00220727|10839741|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0
6834910|NCT00220740|10839751|FG000|Efficacy Period|Entered rescue treatment with placebo|23
6834911|NCT00220740|10839752|FG001|Efficacy Period|Entered rescue treatment with placebo|0
6834912|NCT00220740|10839751|FG000|Efficacy Period|Adverse Event|1
6834913|NCT00220740|10839752|FG001|Efficacy Period|Adverse Event|1
6834914|NCT00220740|10839751|FG000|Efficacy Period|Withdrawal by Subject|1
6834915|NCT00220740|10839752|FG001|Efficacy Period|Withdrawal by Subject|0
6834916|NCT00220740|10839751|FG000|Efficacy Period|Protocol Violation|1
6834917|NCT00220740|10839752|FG001|Efficacy Period|Protocol Violation|0
6834918|NCT00220740|10839751|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0
6834919|NCT00220740|10839752|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45
6834920|NCT00220779|10839763|FG000|Overall Study|Adverse Event|1
6834921|NCT00220779|10839764|FG001|Overall Study|Adverse Event|0
6834922|NCT00220779|10839765|FG002|Overall Study|Adverse Event|0
6834923|NCT00220779|10839763|FG000|Overall Study|Withdrawal by Subject|1
6834924|NCT00220779|10839764|FG001|Overall Study|Withdrawal by Subject|4
6834925|NCT00220779|10839765|FG002|Overall Study|Withdrawal by Subject|1
6834926|NCT00220779|10839763|FG000|Overall Study|Non-compliance|1
6834927|NCT00220779|10839764|FG001|Overall Study|Non-compliance|0
6834928|NCT00220779|10839765|FG002|Overall Study|Non-compliance|0
6834929|NCT00220779|10839763|FG000|Overall Study|Too time consuming|1
6834930|NCT00220779|10839764|FG001|Overall Study|Too time consuming|0
6834931|NCT00220779|10839765|FG002|Overall Study|Too time consuming|0
6834932|NCT00220779|10839763|FG000|Overall Study|Pregnancy|0
6834933|NCT00220779|10839764|FG001|Overall Study|Pregnancy|0
6834934|NCT00220779|10839765|FG002|Overall Study|Pregnancy|2
6834935|NCT00220779|10839763|FG000|Overall Study|Lack of Efficacy|3
6834936|NCT00220779|10839764|FG001|Overall Study|Lack of Efficacy|0
6834937|NCT00220779|10839765|FG002|Overall Study|Lack of Efficacy|1
6834938|NCT00220805|10839775|FG000|Overall Study|Adverse Event|1
6834939|NCT00220805|10839776|FG001|Overall Study|Adverse Event|3
6834940|NCT00220805|10839775|FG000|Overall Study|Withdrawal by Subject|3
6834941|NCT00220805|10839776|FG001|Overall Study|Withdrawal by Subject|0
6834942|NCT00220805|10839775|FG000|Overall Study|Lack of Efficacy|1
6834943|NCT00220805|10839776|FG001|Overall Study|Lack of Efficacy|0
6834944|NCT00220805|10839775|FG000|Overall Study|Develop. of choroidal neovascularization|3
6834945|NCT00220805|10839776|FG001|Overall Study|Develop. of choroidal neovascularization|8
6834946|NCT00221104|10839793|FG000|Overall Study|Adverse Event|1
6834947|NCT00221104|10839794|FG001|Overall Study|Adverse Event|0
6834948|NCT00221104|10839793|FG000|Overall Study|Physician Decision|1
6834949|NCT00221104|10839794|FG001|Overall Study|Physician Decision|0
6834950|NCT00221104|10839793|FG000|Overall Study|Protocol Violation|2
6834951|NCT00221104|10839794|FG001|Overall Study|Protocol Violation|0
6834952|NCT00221104|10839793|FG000|Overall Study|Withdrawal by Subject|42
6834953|NCT00221104|10839794|FG001|Overall Study|Withdrawal by Subject|29
6834954|NCT00221104|10839793|FG000|Overall Study|Others|37
6834955|NCT00221104|10839794|FG001|Overall Study|Others|47
6834956|NCT00221195|10839815|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3
6834957|NCT00221195|10839816|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1
6834958|NCT00221195|10839815|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0
6834959|NCT00221195|10839816|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1
6834960|NCT00221195|10839815|FG000|Washout Period (Months 7-9)|Death|0
6834961|NCT00221195|10839816|FG001|Washout Period (Months 7-9)|Death|1
6834962|NCT00221195|10839815|FG000|Therapy 2 (Months 10-15)|Death|1
7039266|NCT01709305|11121898|FG002|Phase 2|Death|1
7039267|NCT01709305|11121899|FG003|Phase 2|Death|0
6834963|NCT00221195|10839816|FG001|Therapy 2 (Months 10-15)|Death|0
6834964|NCT00221195|10839815|FG000|Therapy 2 (Months 10-15)|Adverse Event|1
6834965|NCT00221195|10839816|FG001|Therapy 2 (Months 10-15)|Adverse Event|0
6834966|NCT00221403|10839849|FG000|Overall Study|Protocol Violation|1
6834967|NCT00221403|10839850|FG001|Overall Study|Protocol Violation|0
6834968|NCT00221403|10839851|FG002|Overall Study|Protocol Violation|0
6834969|NCT00221403|10839849|FG000|Overall Study|Physician Decision|1
6834970|NCT00221403|10839850|FG001|Overall Study|Physician Decision|0
6834971|NCT00221403|10839851|FG002|Overall Study|Physician Decision|0
6834972|NCT00221403|10839849|FG000|Overall Study|Withdrawal by Subject|0
6834973|NCT00221403|10839850|FG001|Overall Study|Withdrawal by Subject|3
6834974|NCT00221403|10839851|FG002|Overall Study|Withdrawal by Subject|0
6834975|NCT00221403|10839849|FG000|Overall Study|Lack of Efficacy|0
6834976|NCT00221403|10839850|FG001|Overall Study|Lack of Efficacy|1
6834977|NCT00221403|10839851|FG002|Overall Study|Lack of Efficacy|0
6834978|NCT00221403|10839849|FG000|Overall Study|Adverse Event|0
6834979|NCT00221403|10839850|FG001|Overall Study|Adverse Event|1
6834980|NCT00221403|10839851|FG002|Overall Study|Adverse Event|0
6834981|NCT00222105|10839859|FG000|Overall Study|Removed due to wrong diagnosis|1
6834982|NCT00222105|10839859|FG000|Overall Study|Withdrawal by Subject|1
6834983|NCT00222105|10839859|FG000|Overall Study|Adverse Event|8
6834984|NCT00222105|10839859|FG000|Overall Study|Treatment delays|2
6834985|NCT00222105|10839859|FG000|Overall Study|Death|2
6834986|NCT00222729|10839872|FG000|Overall Study|Adverse Event|3
6834987|NCT00223080|10839878|FG000|Overall Study|Withdrawal by Subject|253
6834988|NCT00223080|10839879|FG001|Overall Study|Withdrawal by Subject|232
6834989|NCT00223080|10839878|FG000|Overall Study|Required contraindicated med|0
6834990|NCT00223080|10839879|FG001|Overall Study|Required contraindicated med|1
6834991|NCT00223080|10839878|FG000|Overall Study|Non-compliant|7
6834992|NCT00223080|10839879|FG001|Overall Study|Non-compliant|7
6834993|NCT00223080|10839878|FG000|Overall Study|Moved from study area|37
6834994|NCT00223080|10839879|FG001|Overall Study|Moved from study area|47
6834995|NCT00223080|10839878|FG000|Overall Study|Lost to Follow-up|259
6834996|NCT00223080|10839879|FG001|Overall Study|Lost to Follow-up|284
6834997|NCT00223080|10839878|FG000|Overall Study|Death|85
6834998|NCT00223080|10839879|FG001|Overall Study|Death|74
6834999|NCT00223080|10839878|FG000|Overall Study|Other|14
6835000|NCT00223080|10839879|FG001|Overall Study|Other|11
6835001|NCT00223080|10839878|FG000|Overall Study|Reason not provided|141
6835002|NCT00223080|10839879|FG001|Overall Study|Reason not provided|140
6835003|NCT00223080|10839878|FG000|Overall Study|Adverse Event|0
6835004|NCT00223080|10839879|FG001|Overall Study|Adverse Event|1
6835005|NCT00223496|10839903|FG000|Overall Study|screen failure|9
6835006|NCT00223496|10839903|FG000|Overall Study|Lost to Follow-up|4
6835007|NCT00223496|10839903|FG000|Overall Study|Lack of Efficacy|6
6835008|NCT00223496|10839903|FG000|Overall Study|Withdrawal by Subject|1
6835009|NCT00223496|10839903|FG000|Overall Study|Physician Decision|2
6835010|NCT00223795|10839944|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7
6835011|NCT00223795|10839945|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9
6835012|NCT00223795|10839944|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
6835013|NCT00223795|10839945|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
6835014|NCT00223808|10839955|FG000|Overall Study|<5 hrs therapy before discharge|3
6835015|NCT00223808|10839956|FG001|Overall Study|<5 hrs therapy before discharge|5
6835016|NCT00223808|10839957|FG002|Overall Study|<5 hrs therapy before discharge|5
6835017|NCT00223977|10839977|FG000|Overall Study|Adverse Event|7
6835018|NCT00223977|10839978|FG001|Overall Study|Adverse Event|10
6835019|NCT00223977|10839979|FG002|Overall Study|Adverse Event|0
6835020|NCT00223977|10839977|FG000|Overall Study|Protocol Violation|0
6835021|NCT00223977|10839978|FG001|Overall Study|Protocol Violation|0
6835022|NCT00223977|10839979|FG002|Overall Study|Protocol Violation|1
6835023|NCT00223977|10839977|FG000|Overall Study|Withdrawal by Subject|1
6835024|NCT00223977|10839978|FG001|Overall Study|Withdrawal by Subject|1
6835025|NCT00223977|10839979|FG002|Overall Study|Withdrawal by Subject|2
6835026|NCT00223977|10839977|FG000|Overall Study|Other|1
6835027|NCT00223977|10839978|FG001|Overall Study|Other|0
6835028|NCT00223977|10839979|FG002|Overall Study|Other|0
6835029|NCT00223990|10839989|FG000|Overall Study|Moved from area|2
6835030|NCT00223990|10839990|FG001|Overall Study|Moved from area|1
6835031|NCT00223990|10839989|FG000|Overall Study|Withdrawal by Subject|4
6835032|NCT00223990|10839990|FG001|Overall Study|Withdrawal by Subject|8
7039268|NCT01709305|11121900|FG004|Phase 2|Death|0
6835033|NCT00223990|10839989|FG000|Overall Study|Lost to Follow-up|1
6835034|NCT00223990|10839990|FG001|Overall Study|Lost to Follow-up|0
6835035|NCT00224016|10839998|FG000|Titration Period|Withdrawal by Subject|0
6835036|NCT00224016|10839999|FG001|Titration Period|Withdrawal by Subject|1
6835037|NCT00224016|10839998|FG000|Titration Period|Lost to Follow-up|1
6835038|NCT00224016|10839999|FG001|Titration Period|Lost to Follow-up|0
6835039|NCT00224016|10839998|FG000|Maintenance Period|Withdrawal by Subject|2
6835040|NCT00224016|10839999|FG001|Maintenance Period|Withdrawal by Subject|0
6835041|NCT00224016|10839998|FG000|Maintenance Period|Lost to Follow-up|0
6835042|NCT00224016|10839999|FG001|Maintenance Period|Lost to Follow-up|1
6835043|NCT00224029|10840005|FG000|Overall Study|Lost to Follow-up|1
6835044|NCT00224029|10840005|FG000|Overall Study|Withdrawal by Subject|4
6974900|NCT01190930|11027134|FG003|Induction|High Risk|0
7039269|NCT01709305|11121896|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0
7039270|NCT01709305|11121897|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0
7039271|NCT01709305|11121898|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0
7039272|NCT01709305|11121899|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0
7039273|NCT01709305|11121900|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2
7039274|NCT01709305|11121896|FG000|Phase 2|Laboratory Adverse Event|0
7039275|NCT01709305|11121897|FG001|Phase 2|Laboratory Adverse Event|1
7039276|NCT01709305|11121898|FG002|Phase 2|Laboratory Adverse Event|0
7039277|NCT01709305|11121899|FG003|Phase 2|Laboratory Adverse Event|1
7039278|NCT01709305|11121900|FG004|Phase 2|Laboratory Adverse Event|1
7039279|NCT01709305|11121896|FG000|Phase 2|Lost to Follow-up|0
7039280|NCT01709305|11121897|FG001|Phase 2|Lost to Follow-up|10
7039281|NCT01709305|11121898|FG002|Phase 2|Lost to Follow-up|6
7039282|NCT01709305|11121899|FG003|Phase 2|Lost to Follow-up|9
7039283|NCT01709305|11121900|FG004|Phase 2|Lost to Follow-up|5
7039284|NCT01709305|11121896|FG000|Phase 2|Travel, moving, etc.|0
7039285|NCT01709305|11121897|FG001|Phase 2|Travel, moving, etc.|2
7039286|NCT01709305|11121898|FG002|Phase 2|Travel, moving, etc.|3
7039287|NCT01709305|11121899|FG003|Phase 2|Travel, moving, etc.|3
7039288|NCT01709305|11121900|FG004|Phase 2|Travel, moving, etc.|5
7039289|NCT01709305|11121896|FG000|Phase 2|Physician Decision|0
7039290|NCT01709305|11121897|FG001|Phase 2|Physician Decision|2
7039291|NCT01709305|11121898|FG002|Phase 2|Physician Decision|0
7039292|NCT01709305|11121899|FG003|Phase 2|Physician Decision|1
7063527|NCT01951105|11162019|FG001|Overall Study|Lost to Follow-up|1
7063528|NCT01951105|11162020|FG002|Overall Study|Lost to Follow-up|0
7063529|NCT01951105|11162018|FG000|Overall Study|Protocol Violation|1
7063530|NCT01951105|11162019|FG001|Overall Study|Protocol Violation|1
7063531|NCT01951105|11162020|FG002|Overall Study|Protocol Violation|1
7063532|NCT01951105|11162018|FG000|Overall Study|Withdrawal by Subject|0
7063533|NCT01951105|11162019|FG001|Overall Study|Withdrawal by Subject|3
7063534|NCT01951105|11162020|FG002|Overall Study|Withdrawal by Subject|1
7063535|NCT01951157|11162046|FG000|Overall Study|Progressive Disease|12
7063536|NCT01951157|11162047|FG001|Overall Study|Progressive Disease|13
7063537|NCT01951157|11162048|FG002|Overall Study|Progressive Disease|10
7063538|NCT01951157|11162046|FG000|Overall Study|Treatment-unrelated AE|1
7063539|NCT01951157|11162047|FG001|Overall Study|Treatment-unrelated AE|0
7063540|NCT01951157|11162048|FG002|Overall Study|Treatment-unrelated AE|3
7063541|NCT01951157|11162046|FG000|Overall Study|Study Termination|0
7039293|NCT01709305|11121900|FG004|Phase 2|Physician Decision|2
7039294|NCT01709305|11121896|FG000|Phase 2|Protocol Violation|0
7039295|NCT01709305|11121897|FG001|Phase 2|Protocol Violation|19
7039296|NCT01709305|11121898|FG002|Phase 2|Protocol Violation|19
7039297|NCT01709305|11121899|FG003|Phase 2|Protocol Violation|13
7039298|NCT01709305|11121900|FG004|Phase 2|Protocol Violation|9
7039299|NCT01709305|11121896|FG000|Phase 2|Withdrawal by Subject|0
7039300|NCT01709305|11121897|FG001|Phase 2|Withdrawal by Subject|8
7039301|NCT01709305|11121898|FG002|Phase 2|Withdrawal by Subject|6
7039302|NCT01709305|11121899|FG003|Phase 2|Withdrawal by Subject|15
7039303|NCT01709305|11121900|FG004|Phase 2|Withdrawal by Subject|12
7039304|NCT01709383|11121917|FG000|Overall Study|Lost to Follow-up|1
7039305|NCT01709383|11121918|FG001|Overall Study|Lost to Follow-up|0
7039306|NCT01709409|11121928|FG000|Overall Study|Protocol Violation|1
7039307|NCT01709409|11121929|FG001|Overall Study|Protocol Violation|0
7039308|NCT01709500|11121957|FG000|Overall Study|Randomized but not treated|0
7063542|NCT01951157|11162047|FG001|Overall Study|Study Termination|0
7063543|NCT01951157|11162048|FG002|Overall Study|Study Termination|1
7063544|NCT01951157|11162046|FG000|Overall Study|Physician Decision|5
6835045|NCT00224029|10840005|FG000|Overall Study|Other|1
6835046|NCT00224042|10840011|FG000|Overall Study|Adverse Event|2
7063545|NCT01951157|11162047|FG001|Overall Study|Physician Decision|3
6835047|NCT00224042|10840012|FG001|Overall Study|Adverse Event|1
6974901|NCT01190930|11027135|FG004|Induction|High Risk|0
6974902|NCT01190930|11027136|FG005|Induction|High Risk|0
6974903|NCT01190930|11027137|FG006|Induction|High Risk|0
6974904|NCT01190930|11027138|FG007|Induction|High Risk|0
6974905|NCT01190930|11027139|FG008|Induction|High Risk|0
6974906|NCT01190930|11027140|FG009|Induction|High Risk|0
6974907|NCT01190930|11027131|FG000|Induction|Low Risk|443
6974908|NCT01190930|11027132|FG001|Induction|Low Risk|0
6974909|NCT01190930|11027133|FG002|Induction|Low Risk|0
6974910|NCT01190930|11027134|FG003|Induction|Low Risk|0
6974911|NCT01190930|11027135|FG004|Induction|Low Risk|0
6974912|NCT01190930|11027136|FG005|Induction|Low Risk|0
6974913|NCT01190930|11027137|FG006|Induction|Low Risk|0
7039309|NCT01709500|11121958|FG001|Overall Study|Randomized but not treated|1
7039310|NCT01709500|11121957|FG000|Overall Study|Adverse Event|5
7039311|NCT01709500|11121958|FG001|Overall Study|Adverse Event|1
7039312|NCT01709500|11121957|FG000|Overall Study|Poor compliance to protocol|2
7039313|NCT01709500|11121958|FG001|Overall Study|Poor compliance to protocol|1
7039314|NCT01709500|11121957|FG000|Overall Study|Other|3
7039315|NCT01709500|11121958|FG001|Overall Study|Other|1
7039316|NCT01709500|11121957|FG000|Overall Study|Related to IMP administration|1
7039317|NCT01709500|11121958|FG001|Overall Study|Related to IMP administration|0
7039318|NCT01709500|11121957|FG000|Overall Study|Treatment ongoing|156
7039319|NCT01709500|11121958|FG001|Overall Study|Treatment ongoing|78
7039320|NCT01709513|11121967|FG000|Overall Study|Randomized but not treated|0
7039321|NCT01709513|11121968|FG001|Overall Study|Randomized but not treated|1
7039322|NCT01709513|11121969|FG002|Overall Study|Randomized but not treated|0
7039323|NCT01709513|11121967|FG000|Overall Study|Adverse Event|16
7039324|NCT01709513|11121968|FG001|Overall Study|Adverse Event|31
7039325|NCT01709513|11121969|FG002|Overall Study|Adverse Event|23
7039326|NCT01709513|11121967|FG000|Overall Study|Poor compliance to protocol|2
7039327|NCT01709513|11121968|FG001|Overall Study|Poor compliance to protocol|0
7039328|NCT01709513|11121969|FG002|Overall Study|Poor compliance to protocol|0
7039329|NCT01709513|11121967|FG000|Overall Study|Other|3
7039330|NCT01709513|11121968|FG001|Overall Study|Other|11
7039331|NCT01709513|11121969|FG002|Overall Study|Other|7
7039332|NCT01709578|11121983|FG000|Overall Study|Rescued and entered in long term safety|63
7039333|NCT01709578|11121984|FG001|Overall Study|Rescued and entered in long term safety|25
7039334|NCT01709578|11121985|FG002|Overall Study|Rescued and entered in long term safety|26
7039335|NCT01709578|11121983|FG000|Overall Study|Adverse Event|9
7039336|NCT01709578|11121984|FG001|Overall Study|Adverse Event|18
7039337|NCT01709578|11121985|FG002|Overall Study|Adverse Event|17
7039338|NCT01709578|11121983|FG000|Overall Study|Lack of Efficacy|5
7039339|NCT01709578|11121984|FG001|Overall Study|Lack of Efficacy|4
7063546|NCT01951157|11162048|FG002|Overall Study|Physician Decision|2
7063547|NCT01951157|11162046|FG000|Overall Study|Non-treatmentrelated death|2
7063548|NCT01951157|11162047|FG001|Overall Study|Non-treatmentrelated death|2
7063549|NCT01951157|11162048|FG002|Overall Study|Non-treatmentrelated death|2
7063550|NCT01951157|11162046|FG000|Overall Study|No treated|0
7063551|NCT01951157|11162047|FG001|Overall Study|No treated|1
7063552|NCT01951157|11162048|FG002|Overall Study|No treated|0
7063553|NCT01951157|11162046|FG000|Overall Study|Treatment-related AE|2
7063554|NCT01951157|11162047|FG001|Overall Study|Treatment-related AE|0
7063555|NCT01951157|11162048|FG002|Overall Study|Treatment-related AE|4
7063556|NCT01951157|11162046|FG000|Overall Study|Consent withdrawn by subject|0
7063557|NCT01951157|11162047|FG001|Overall Study|Consent withdrawn by subject|1
7063558|NCT01951157|11162048|FG002|Overall Study|Consent withdrawn by subject|3
7063559|NCT01951157|11162046|FG000|Overall Study|Treatment-related death|0
7063560|NCT01951157|11162047|FG001|Overall Study|Treatment-related death|2
7063561|NCT01951157|11162048|FG002|Overall Study|Treatment-related death|0
7063562|NCT01951170|11162057|FG000|Overall Study|Investigator decision|1
7063563|NCT01951261|11162063|FG000|Overall Study|Death|1
7063564|NCT01951261|11162064|FG001|Overall Study|Death|0
7063565|NCT01951261|11162063|FG000|Overall Study|Lost to Follow-up|4
7039340|NCT01709578|11121985|FG002|Overall Study|Lack of Efficacy|2
7039341|NCT01709578|11121983|FG000|Overall Study|Poor compliance to protocol|1
7039342|NCT01709578|11121984|FG001|Overall Study|Poor compliance to protocol|2
7039343|NCT01709578|11121985|FG002|Overall Study|Poor compliance to protocol|1
7039344|NCT01709578|11121983|FG000|Overall Study|Other, not related to safety or efficacy|2
7039345|NCT01709578|11121984|FG001|Overall Study|Other, not related to safety or efficacy|7
7039346|NCT01709578|11121985|FG002|Overall Study|Other, not related to safety or efficacy|5
7039347|NCT01709695|11121995|FG000|Overall Study|Withdrawal by Subject|1
7039348|NCT01709695|11121996|FG001|Overall Study|Withdrawal by Subject|1
6835048|NCT00224042|10840011|FG000|Overall Study|Protocol Violation|0
6835049|NCT00224042|10840012|FG001|Overall Study|Protocol Violation|1
7039349|NCT01709708|11122004|FG000|Overall Study|Protocol Violation|1
7039350|NCT01709708|11122005|FG001|Overall Study|Protocol Violation|2
7039351|NCT01709721|11122015|FG000|Open Label Phase|Withdrawal by Subject|0
7039352|NCT01709721|11122016|FG001|Open Label Phase|Withdrawal by Subject|0
7039353|NCT01709721|11122017|FG002|Open Label Phase|Withdrawal by Subject|5
7039354|NCT01709721|11122015|FG000|Open Label Phase|Adverse Event|0
7039355|NCT01709721|11122016|FG001|Open Label Phase|Adverse Event|0
7039356|NCT01709721|11122017|FG002|Open Label Phase|Adverse Event|8
7063566|NCT01951261|11162064|FG001|Overall Study|Lost to Follow-up|3
7063567|NCT01951261|11162063|FG000|Overall Study|Protocol Violation|4
7063568|NCT01951261|11162064|FG001|Overall Study|Protocol Violation|3
7039357|NCT01709721|11122015|FG000|Open Label Phase|Non-compliance With Study Drug|0
7039358|NCT01709721|11122016|FG001|Open Label Phase|Non-compliance With Study Drug|0
7063569|NCT01951417|11162104|FG000|Overall Study|Withdrawal by Subject|1
7063570|NCT01951417|11162104|FG000|Overall Study|Protocol Violation|2
7063571|NCT01951417|11162104|FG000|Overall Study|Lost to Follow-up|6
7063572|NCT01951573|11162112|FG000|Washout Period|Adverse Event|0
6835050|NCT00224042|10840011|FG000|Overall Study|Physician Decision|0
7039359|NCT01709721|11122017|FG002|Open Label Phase|Non-compliance With Study Drug|3
7039360|NCT01709721|11122015|FG000|Open Label Phase|Investigator Decision|0
7039361|NCT01709721|11122016|FG001|Open Label Phase|Investigator Decision|0
6835051|NCT00224042|10840012|FG001|Overall Study|Physician Decision|1
6835052|NCT00224042|10840011|FG000|Overall Study|Did not meet lab incusion criteria|2
6835053|NCT00224042|10840012|FG001|Overall Study|Did not meet lab incusion criteria|3
6835054|NCT00224042|10840011|FG000|Overall Study|Other|2
6835055|NCT00224042|10840012|FG001|Overall Study|Other|0
6835056|NCT00224055|10840020|FG000|Overall Study|Adverse Event|9
6835057|NCT00224055|10840021|FG001|Overall Study|Adverse Event|3
6835058|NCT00224055|10840020|FG000|Overall Study|Lost to Follow-up|1
6835059|NCT00224055|10840021|FG001|Overall Study|Lost to Follow-up|2
6835060|NCT00224055|10840020|FG000|Overall Study|Protocol Violation|1
6835061|NCT00224055|10840021|FG001|Overall Study|Protocol Violation|1
6835062|NCT00224055|10840020|FG000|Overall Study|Inclusion Violation|3
6835063|NCT00224055|10840021|FG001|Overall Study|Inclusion Violation|6
6835064|NCT00224055|10840020|FG000|Overall Study|Withdrawal by Subject|0
6835065|NCT00224055|10840021|FG001|Overall Study|Withdrawal by Subject|2
6835066|NCT00224055|10840020|FG000|Overall Study|Other|1
6835067|NCT00224055|10840021|FG001|Overall Study|Other|0
6835068|NCT00224107|10840029|FG000|Overall Study|Adverse Event|20
6835069|NCT00224107|10840030|FG001|Overall Study|Adverse Event|6
6835070|NCT00224107|10840029|FG000|Overall Study|Protocol Violation|2
6835071|NCT00224107|10840030|FG001|Overall Study|Protocol Violation|3
6835072|NCT00224107|10840029|FG000|Overall Study|Withdrawal by Subject|1
6835073|NCT00224107|10840030|FG001|Overall Study|Withdrawal by Subject|4
6835074|NCT00224107|10840029|FG000|Overall Study|Lack of Efficacy|2
6835075|NCT00224107|10840030|FG001|Overall Study|Lack of Efficacy|0
6835076|NCT00224107|10840029|FG000|Overall Study|Lost to Follow-up|4
6835077|NCT00224107|10840030|FG001|Overall Study|Lost to Follow-up|0
6835078|NCT00224107|10840029|FG000|Overall Study|Physician Decision|1
6835079|NCT00224107|10840030|FG001|Overall Study|Physician Decision|0
6835080|NCT00224107|10840029|FG000|Overall Study|Other|1
6835081|NCT00224107|10840030|FG001|Overall Study|Other|1
6835082|NCT00224120|10840038|FG000|Overall Study|Adverse Event|10
6835083|NCT00224120|10840039|FG001|Overall Study|Adverse Event|4
6835084|NCT00224120|10840038|FG000|Overall Study|Protocol Violation|1
6835085|NCT00224120|10840039|FG001|Overall Study|Protocol Violation|0
6835086|NCT00224120|10840038|FG000|Overall Study|Withdrawal by Subject|5
6835087|NCT00224120|10840039|FG001|Overall Study|Withdrawal by Subject|10
6835088|NCT00224120|10840038|FG000|Overall Study|Lack of Efficacy|0
6835089|NCT00224120|10840039|FG001|Overall Study|Lack of Efficacy|2
6835090|NCT00224120|10840038|FG000|Overall Study|Lost to Follow-up|2
7039362|NCT01709721|11122017|FG002|Open Label Phase|Investigator Decision|1
7039363|NCT01709721|11122015|FG000|Open Label Phase|Sponsor Decision|0
7039364|NCT01709721|11122016|FG001|Open Label Phase|Sponsor Decision|0
7039365|NCT01709721|11122017|FG002|Open Label Phase|Sponsor Decision|2
7039366|NCT01709721|11122015|FG000|Open Label Phase|Protocol Violation|0
7039367|NCT01709721|11122016|FG001|Open Label Phase|Protocol Violation|0
7039368|NCT01709721|11122017|FG002|Open Label Phase|Protocol Violation|1
7039369|NCT01709721|11122015|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0
7039370|NCT01709721|11122016|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0
7039371|NCT01709721|11122017|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1
7039372|NCT01709721|11122015|FG000|Open Label Phase|Inadequate Pain Control|0
7039373|NCT01709721|11122016|FG001|Open Label Phase|Inadequate Pain Control|0
7039374|NCT01709721|11122017|FG002|Open Label Phase|Inadequate Pain Control|37
7039375|NCT01709721|11122015|FG000|Open Label Phase|Other, Specify in text field in database|0
7039376|NCT01709721|11122016|FG001|Open Label Phase|Other, Specify in text field in database|0
7039377|NCT01709721|11122017|FG002|Open Label Phase|Other, Specify in text field in database|14
7039378|NCT01709721|11122015|FG000|Randomized Phase|Adverse Event|0
7039379|NCT01709721|11122016|FG001|Randomized Phase|Adverse Event|1
7039380|NCT01709721|11122017|FG002|Randomized Phase|Adverse Event|0
7039381|NCT01709721|11122015|FG000|Randomized Phase|Lost to Follow-up|1
7039382|NCT01709721|11122016|FG001|Randomized Phase|Lost to Follow-up|0
7039383|NCT01709721|11122017|FG002|Randomized Phase|Lost to Follow-up|0
7039384|NCT01709721|11122015|FG000|Randomized Phase|Inadequate Pain Control|1
7039385|NCT01709721|11122016|FG001|Randomized Phase|Inadequate Pain Control|2
7039386|NCT01709721|11122017|FG002|Randomized Phase|Inadequate Pain Control|0
7039387|NCT01709721|11122015|FG000|Randomized Phase|Other, Specify text field in database|1
7039388|NCT01709721|11122016|FG001|Randomized Phase|Other, Specify text field in database|3
7039389|NCT01709721|11122017|FG002|Randomized Phase|Other, Specify text field in database|0
7063573|NCT01951573|11162113|FG001|Washout Period|Adverse Event|1
7039390|NCT01709838|11122049|FG000|Overall Study|Withdrawal by Subject|21
7039391|NCT01709838|11122049|FG000|Overall Study|Lost to Follow-up|16
7063574|NCT01951586|11162121|FG000|Overall Study|Death|61
6835091|NCT00224120|10840039|FG001|Overall Study|Lost to Follow-up|3
6835092|NCT00224120|10840038|FG000|Overall Study|Other|4
6835093|NCT00224120|10840039|FG001|Overall Study|Other|5
6835094|NCT00224133|10840045|FG000|Overall Study|Adverse Event|93
6835095|NCT00224133|10840045|FG000|Overall Study|Protocol Violation|6
6835096|NCT00224133|10840045|FG000|Overall Study|Withdrawal by Subject|33
6835097|NCT00224133|10840045|FG000|Overall Study|Lack of Efficacy|58
6835098|NCT00224133|10840045|FG000|Overall Study|Lost to Follow-up|21
6835099|NCT00224133|10840045|FG000|Overall Study|Physician Decision|1
6835100|NCT00224133|10840045|FG000|Overall Study|Other|14
6835101|NCT00224484|10840056|FG000|Overall Study|Serious Adverse Event|1
7039392|NCT01709838|11122049|FG000|Overall Study|Pregnancy|10
7039393|NCT01709838|11122049|FG000|Overall Study|Subject/guardian decision|8
7039394|NCT01709838|11122049|FG000|Overall Study|Adverse Event|4
7039395|NCT01709838|11122049|FG000|Overall Study|Physician Decision|4
7039396|NCT01709838|11122049|FG000|Overall Study|Death|3
7039397|NCT01709838|11122049|FG000|Overall Study|Protocol Violation|1
7039398|NCT01709864|11122057|FG000|Overall Study|Physician Decision|0
6835102|NCT00224484|10840057|FG001|Overall Study|Serious Adverse Event|1
6835103|NCT00224484|10840058|FG002|Overall Study|Serious Adverse Event|0
6835104|NCT00224484|10840056|FG000|Overall Study|Non-Serious Adverse Event|5
6835105|NCT00224484|10840057|FG001|Overall Study|Non-Serious Adverse Event|7
6835106|NCT00224484|10840058|FG002|Overall Study|Non-Serious Adverse Event|3
6835107|NCT00224484|10840056|FG000|Overall Study|Protocol Violation|2
6835108|NCT00224484|10840057|FG001|Overall Study|Protocol Violation|2
6835109|NCT00224484|10840058|FG002|Overall Study|Protocol Violation|0
6835110|NCT00224484|10840056|FG000|Overall Study|Withdrawal by Subject|49
6835111|NCT00224484|10840057|FG001|Overall Study|Withdrawal by Subject|18
6835112|NCT00224484|10840058|FG002|Overall Study|Withdrawal by Subject|16
6835113|NCT00224484|10840056|FG000|Overall Study|Migrated/moved from study area|18
6835114|NCT00224484|10840057|FG001|Overall Study|Migrated/moved from study area|5
6835115|NCT00224484|10840058|FG002|Overall Study|Migrated/moved from study area|5
6835116|NCT00224484|10840056|FG000|Overall Study|Lost to Follow-up|66
6835117|NCT00224484|10840057|FG001|Overall Study|Lost to Follow-up|28
6835118|NCT00224484|10840058|FG002|Overall Study|Lost to Follow-up|36
6835119|NCT00224484|10840056|FG000|Overall Study|Reason not specified|5
6835120|NCT00224484|10840057|FG001|Overall Study|Reason not specified|4
6835121|NCT00224484|10840058|FG002|Overall Study|Reason not specified|2
6835122|NCT00224770|10840072|FG000|Overall Study|Lost to Follow-up|4
6835123|NCT00224770|10840073|FG001|Overall Study|Lost to Follow-up|2
6835124|NCT00224770|10840074|FG002|Overall Study|Lost to Follow-up|0
6897371|NCT00640341|10916486|FG000|Overall Study|Adverse Event|0
6897372|NCT00640341|10916487|FG001|Overall Study|Adverse Event|0
6897373|NCT00640341|10916488|FG002|Overall Study|Adverse Event|1
6897374|NCT00640341|10916486|FG000|Overall Study|Positive Slit Lamp Findings|0
6897375|NCT00640341|10916487|FG001|Overall Study|Positive Slit Lamp Findings|0
6897376|NCT00640341|10916488|FG002|Overall Study|Positive Slit Lamp Findings|1
6897377|NCT00640341|10916486|FG000|Overall Study|Study Related Symptoms/Complaints|2
6897378|NCT00640341|10916487|FG001|Overall Study|Study Related Symptoms/Complaints|1
6897379|NCT00640341|10916488|FG002|Overall Study|Study Related Symptoms/Complaints|2
6897380|NCT00640341|10916486|FG000|Overall Study|Inability to Maintain Wearing Schedule|1
6897381|NCT00640341|10916487|FG001|Overall Study|Inability to Maintain Wearing Schedule|1
6897382|NCT00640341|10916488|FG002|Overall Study|Inability to Maintain Wearing Schedule|0
6897383|NCT00640341|10916486|FG000|Overall Study|Failure to Follow Subject Instructions|1
6897384|NCT00640341|10916487|FG001|Overall Study|Failure to Follow Subject Instructions|0
6897385|NCT00640341|10916488|FG002|Overall Study|Failure to Follow Subject Instructions|0
6897386|NCT00640341|10916486|FG000|Overall Study|Lost to Follow-up|2
6897387|NCT00640341|10916487|FG001|Overall Study|Lost to Follow-up|0
6897388|NCT00640341|10916488|FG002|Overall Study|Lost to Follow-up|0
6897389|NCT00640341|10916486|FG000|Overall Study|Withdrawal by Subject|4
6897390|NCT00640341|10916487|FG001|Overall Study|Withdrawal by Subject|0
6897391|NCT00640341|10916488|FG002|Overall Study|Withdrawal by Subject|1
6897392|NCT00640341|10916486|FG000|Overall Study|Unacceptable Lens Movement|1
6897393|NCT00640341|10916487|FG001|Overall Study|Unacceptable Lens Movement|0
6897394|NCT00640341|10916488|FG002|Overall Study|Unacceptable Lens Movement|0
6897395|NCT00640341|10916486|FG000|Overall Study|Poor fit/Uncomfortable|4
6897396|NCT00640341|10916487|FG001|Overall Study|Poor fit/Uncomfortable|0
6897397|NCT00640341|10916488|FG002|Overall Study|Poor fit/Uncomfortable|0
6897398|NCT00640341|10916486|FG000|Overall Study|Ineligable at Baseline|5
6897399|NCT00640341|10916487|FG001|Overall Study|Ineligable at Baseline|3
6897400|NCT00640341|10916488|FG002|Overall Study|Ineligable at Baseline|2
6897401|NCT00640341|10916486|FG000|Overall Study|Adverse event and positive slit lamp|1
6897402|NCT00640341|10916487|FG001|Overall Study|Adverse event and positive slit lamp|0
7039399|NCT01709864|11122058|FG001|Overall Study|Physician Decision|1
7039400|NCT01709864|11122057|FG000|Overall Study|subject/guardian decision|5
7039401|NCT01709864|11122058|FG001|Overall Study|subject/guardian decision|6
7039402|NCT01709864|11122057|FG000|Overall Study|Lost to Follow-up|1
7039403|NCT01709864|11122058|FG001|Overall Study|Lost to Follow-up|0
6897403|NCT00640341|10916488|FG002|Overall Study|Adverse event and positive slit lamp|0
6897404|NCT00640393|10916496|FG000|Part 1|Lost to Follow-up|2
6897405|NCT00640393|10916497|FG001|Part 1|Lost to Follow-up|0
6897406|NCT00640393|10916498|FG002|Part 1|Lost to Follow-up|0
6897407|NCT00640393|10916496|FG000|Part 1|Withdrawal by Subject|3
6897408|NCT00640393|10916497|FG001|Part 1|Withdrawal by Subject|0
6897409|NCT00640393|10916498|FG002|Part 1|Withdrawal by Subject|0
6897410|NCT00640393|10916496|FG000|Randomization|Withdrawn per protocol|17
6897411|NCT00640393|10916497|FG001|Randomization|Withdrawn per protocol|0
6897412|NCT00640393|10916498|FG002|Randomization|Withdrawn per protocol|0
6897413|NCT00640393|10916496|FG000|Randomization|Never randomized by site|2
6897414|NCT00640393|10916497|FG001|Randomization|Never randomized by site|0
6897415|NCT00640393|10916498|FG002|Randomization|Never randomized by site|0
6897416|NCT00640393|10916496|FG000|Part 2|Lost to Follow-up|0
7039404|NCT01709864|11122057|FG000|Overall Study|non-compliance with study treatment|1
6835125|NCT00224874|10840087|FG000|Overall Study|Withdrawal by Subject|0
6835126|NCT00224874|10840088|FG001|Overall Study|Withdrawal by Subject|0
6835127|NCT00224874|10840089|FG002|Overall Study|Withdrawal by Subject|1
6835128|NCT00224874|10840090|FG003|Overall Study|Withdrawal by Subject|0
6835129|NCT00224887|10840102|FG000|Overall Study|Pregnancy|6
6835130|NCT00224887|10840103|FG001|Overall Study|Pregnancy|6
6835131|NCT00225147|10840136|FG000|Open-label Phase|Lost to Follow-up|0
6835132|NCT00225147|10840137|FG001|Open-label Phase|Lost to Follow-up|0
6835133|NCT00225147|10840138|FG002|Open-label Phase|Lost to Follow-up|0
6835134|NCT00225147|10840139|FG003|Open-label Phase|Lost to Follow-up|4
7039405|NCT01709864|11122058|FG001|Overall Study|non-compliance with study treatment|1
7039406|NCT01709864|11122057|FG000|Overall Study|Adverse Event|0
7039407|NCT01709864|11122058|FG001|Overall Study|Adverse Event|2
7039408|NCT01709864|11122057|FG000|Overall Study|Death|0
7039409|NCT01709864|11122058|FG001|Overall Study|Death|1
7039410|NCT01709903|11122066|FG000|Overall Study|administrative problems|2
7039411|NCT01709903|11122067|FG001|Overall Study|administrative problems|6
7039412|NCT01709903|11122066|FG000|Overall Study|Abnormal test procedure results|1
7039413|NCT01709903|11122067|FG001|Overall Study|Abnormal test procedure results|0
7039414|NCT01709903|11122066|FG000|Overall Study|In ability to use device|1
7039415|NCT01709903|11122067|FG001|Overall Study|In ability to use device|1
7039416|NCT01709903|11122066|FG000|Overall Study|no longer needed study drug|0
7063575|NCT01951586|11162122|FG001|Overall Study|Death|120
7063576|NCT01951586|11162121|FG000|Overall Study|Withdrawal by Subject|8
7063577|NCT01951586|11162122|FG001|Overall Study|Withdrawal by Subject|17
7063578|NCT01951586|11162121|FG000|Overall Study|Lost to Follow-up|0
7063579|NCT01951586|11162122|FG001|Overall Study|Lost to Follow-up|1
7063580|NCT01951586|11162121|FG000|Overall Study|Sponsor Decision|9
7063581|NCT01951586|11162122|FG001|Overall Study|Sponsor Decision|10
7063582|NCT01951625|11162134|FG000|Treatment Period|Protocol Violation|2
7063583|NCT01951625|11162135|FG001|Treatment Period|Protocol Violation|0
7063584|NCT01951625|11162136|FG002|Treatment Period|Protocol Violation|1
7063585|NCT01951625|11162137|FG003|Treatment Period|Protocol Violation|3
7063586|NCT01951625|11162138|FG004|Treatment Period|Protocol Violation|2
7063587|NCT01951625|11162134|FG000|Treatment Period|Physician Decision|0
7063588|NCT01951625|11162135|FG001|Treatment Period|Physician Decision|0
7063589|NCT01951625|11162136|FG002|Treatment Period|Physician Decision|0
7063590|NCT01951625|11162137|FG003|Treatment Period|Physician Decision|0
7063591|NCT01951625|11162138|FG004|Treatment Period|Physician Decision|1
7063592|NCT01951625|11162134|FG000|Treatment Period|Protocol driven decision point|0
7063593|NCT01951625|11162135|FG001|Treatment Period|Protocol driven decision point|5
7063594|NCT01951625|11162136|FG002|Treatment Period|Protocol driven decision point|0
7063595|NCT01951625|11162137|FG003|Treatment Period|Protocol driven decision point|2
7063596|NCT01951625|11162138|FG004|Treatment Period|Protocol driven decision point|1
7063597|NCT01951625|11162134|FG000|Treatment Period|Non compliance with study drug|1
7063598|NCT01951625|11162135|FG001|Treatment Period|Non compliance with study drug|2
7063599|NCT01951625|11162136|FG002|Treatment Period|Non compliance with study drug|2
7063600|NCT01951625|11162137|FG003|Treatment Period|Non compliance with study drug|0
6835135|NCT00225147|10840136|FG000|Open-label Phase|Withdrawal by Subject|0
6835136|NCT00225147|10840137|FG001|Open-label Phase|Withdrawal by Subject|0
6835137|NCT00225147|10840138|FG002|Open-label Phase|Withdrawal by Subject|0
6835138|NCT00225147|10840139|FG003|Open-label Phase|Withdrawal by Subject|6
6835139|NCT00225212|10840151|FG000|Overall Study|Disease progression|2
7039417|NCT01709903|11122067|FG001|Overall Study|no longer needed study drug|1
7039418|NCT01709903|11122066|FG000|Overall Study|Lost to Follow-up|0
6835140|NCT00225212|10840151|FG000|Overall Study|Death|1
6835141|NCT00225212|10840151|FG000|Overall Study|Adverse Event|2
6835142|NCT00225212|10840151|FG000|Overall Study|Intercurrent illness|1
6835143|NCT00225251|10840157|FG000|Overall Study|Withdrawal by Subject|1
6835144|NCT00225251|10840158|FG001|Overall Study|Withdrawal by Subject|1
6835145|NCT00225277|10840166|FG000|Overall Study|Adverse Event|30
6835146|NCT00225277|10840167|FG001|Overall Study|Adverse Event|34
6835147|NCT00225277|10840166|FG000|Overall Study|Lack of Efficacy|4
6835148|NCT00225277|10840167|FG001|Overall Study|Lack of Efficacy|1
6835149|NCT00225277|10840166|FG000|Overall Study|Lost to Follow-up|4
6835150|NCT00225277|10840167|FG001|Overall Study|Lost to Follow-up|6
6835151|NCT00225277|10840166|FG000|Overall Study|Physician Decision|6
6835152|NCT00225277|10840167|FG001|Overall Study|Physician Decision|8
6835153|NCT00225277|10840166|FG000|Overall Study|Protocol Violation|6
6835154|NCT00225277|10840167|FG001|Overall Study|Protocol Violation|3
6835155|NCT00225277|10840166|FG000|Overall Study|Withdrawal by Subject|40
7039419|NCT01709903|11122067|FG001|Overall Study|Lost to Follow-up|2
7039420|NCT01709903|11122066|FG000|Overall Study|Death|2
7039421|NCT01709903|11122067|FG001|Overall Study|Death|0
6835156|NCT00225277|10840167|FG001|Overall Study|Withdrawal by Subject|34
6835157|NCT00225277|10840166|FG000|Overall Study|Other|7
7039422|NCT01709903|11122066|FG000|Overall Study|Protocol Violation|3
7039423|NCT01709903|11122067|FG001|Overall Study|Protocol Violation|2
7063601|NCT01951625|11162138|FG004|Treatment Period|Non compliance with study drug|0
7063602|NCT01951625|11162134|FG000|Treatment Period|Death|3
6835158|NCT00225277|10840167|FG001|Overall Study|Other|9
6835159|NCT00225758|10840195|FG000|Overall Study|Adverse Event|4
6835160|NCT00226499|10840216|FG000|Overall Study|Adverse Event|10
6835161|NCT00226499|10840217|FG001|Overall Study|Adverse Event|6
6835162|NCT00226499|10840218|FG002|Overall Study|Adverse Event|3
6835163|NCT00226499|10840216|FG000|Overall Study|Others|1064
6835164|NCT00226499|10840217|FG001|Overall Study|Others|1066
6835165|NCT00226499|10840218|FG002|Overall Study|Others|356
6835166|NCT00226655|10840237|FG000|Overall Study|Death|13
6835167|NCT00226655|10840237|FG000|Overall Study|Withdrawal by Subject|15
6835168|NCT00226655|10840237|FG000|Overall Study|Adverse Event|35
6835169|NCT00226655|10840237|FG000|Overall Study|Physician Decision|6
6835170|NCT00226655|10840237|FG000|Overall Study|Clinical deterioration|10
6835171|NCT00226811|10840241|FG000|Overall Study|Death|8
6835172|NCT00226811|10840241|FG000|Overall Study|Adverse Event|11
6835173|NCT00226811|10840241|FG000|Overall Study|Lack of Efficacy|55
6835174|NCT00226811|10840241|FG000|Overall Study|Withdrawal by Subject|2
6835175|NCT00226941|10840249|FG000|Overall Study|Withdrawal by subject - toxicity|0
6835176|NCT00226941|10840250|FG001|Overall Study|Withdrawal by subject - toxicity|0
6835177|NCT00226941|10840251|FG002|Overall Study|Withdrawal by subject - toxicity|0
6835178|NCT00226941|10840252|FG003|Overall Study|Withdrawal by subject - toxicity|1
6835179|NCT00226941|10840249|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0
6835180|NCT00226941|10840250|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0
6835181|NCT00226941|10840251|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0
6835182|NCT00226941|10840252|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1
6835183|NCT00227266|10840276|FG000|Overall Study|Withdrawal by Subject|0
6835184|NCT00227266|10840277|FG001|Overall Study|Withdrawal by Subject|0
6835185|NCT00227266|10840278|FG002|Overall Study|Withdrawal by Subject|1
6835186|NCT00227266|10840276|FG000|Overall Study|Protocol Violation|1
6835187|NCT00227266|10840277|FG001|Overall Study|Protocol Violation|0
6835188|NCT00227266|10840278|FG002|Overall Study|Protocol Violation|1
6835189|NCT00227266|10840276|FG000|Overall Study|Excessive weight gain|0
6835190|NCT00227266|10840277|FG001|Overall Study|Excessive weight gain|0
6835191|NCT00227266|10840278|FG002|Overall Study|Excessive weight gain|2
6835192|NCT00227305|10840289|FG000|Overall Study|Adverse Event|40
6926279|NCT00838903|10956886|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
6926280|NCT00838903|10956887|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
6926281|NCT00838903|10956888|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
6926282|NCT00838903|10956885|FG000|Follow-up Period (8 Weeks)|Adverse Event|0
6926283|NCT00838903|10956886|FG001|Follow-up Period (8 Weeks)|Adverse Event|0
6926284|NCT00838903|10956887|FG002|Follow-up Period (8 Weeks)|Adverse Event|3
6926285|NCT00838903|10956888|FG003|Follow-up Period (8 Weeks)|Adverse Event|1
6926286|NCT00838903|10956885|FG000|Follow-up Period (8 Weeks)|Noncompliance|2
6926287|NCT00838903|10956886|FG001|Follow-up Period (8 Weeks)|Noncompliance|8
6926288|NCT00838903|10956887|FG002|Follow-up Period (8 Weeks)|Noncompliance|5
6926289|NCT00838903|10956888|FG003|Follow-up Period (8 Weeks)|Noncompliance|5
6926290|NCT00838903|10956885|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6
6926291|NCT00838903|10956886|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28
6926292|NCT00838903|10956887|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22
6926293|NCT00838903|10956888|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24
6926294|NCT00838903|10956885|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5
6926295|NCT00838903|10956886|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
6926296|NCT00838903|10956887|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12
6926297|NCT00838903|10956888|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
6926298|NCT00838903|10956885|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8
6926299|NCT00838903|10956886|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13
6926300|NCT00838903|10956887|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
6926301|NCT00838903|10956888|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
6926302|NCT00838903|10956885|FG000|Follow-up Period (8 Weeks)|Physician Decision|1
6926303|NCT00838903|10956886|FG001|Follow-up Period (8 Weeks)|Physician Decision|1
6926304|NCT00838903|10956887|FG002|Follow-up Period (8 Weeks)|Physician Decision|1
6926305|NCT00838903|10956888|FG003|Follow-up Period (8 Weeks)|Physician Decision|1
6926306|NCT00838903|10956885|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3
6926307|NCT00838903|10956886|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
6926308|NCT00838903|10956887|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6
6926309|NCT00838903|10956888|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
6926310|NCT00838903|10956885|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0
6926311|NCT00838903|10956886|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1
6926312|NCT00838903|10956887|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0
6926313|NCT00838903|10956888|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0
6926314|NCT00838903|10956885|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
6926315|NCT00838903|10956886|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1
6926316|NCT00838903|10956887|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
6926317|NCT00838903|10956888|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
6926318|NCT00838903|10956885|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
6926319|NCT00838903|10956886|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
6926320|NCT00838903|10956887|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
6926321|NCT00838903|10956888|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1
6835193|NCT00227305|10840289|FG000|Overall Study|Withdrawal by Subject|42
6835194|NCT00227305|10840289|FG000|Overall Study|Lost to Follow-up|33
6835195|NCT00227305|10840289|FG000|Overall Study|Study specific discontinuation|13
6835196|NCT00227305|10840289|FG000|Overall Study|MOVED OUT OF AREA|3
6835197|NCT00227305|10840289|FG000|Overall Study|Lack of Efficacy|7
6835198|NCT00227305|10840289|FG000|Overall Study|Physician Decision|3
6835199|NCT00227305|10840289|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1
6835200|NCT00227305|10840289|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1
6835201|NCT00227305|10840289|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1
6835202|NCT00227344|10840295|FG000|Overall Study|study terminated early|12
6835203|NCT00227344|10840296|FG001|Overall Study|study terminated early|5
6835204|NCT00227370|10840304|FG000|Overall Study|Withdrawal by Subject|1
6835205|NCT00227370|10840305|FG001|Overall Study|Withdrawal by Subject|2
6835206|NCT00227370|10840304|FG000|Overall Study|Death|3
6835207|NCT00227370|10840305|FG001|Overall Study|Death|4
6835208|NCT00227370|10840304|FG000|Overall Study|Adverse Event|6
6835209|NCT00227370|10840305|FG001|Overall Study|Adverse Event|11
6835210|NCT00227370|10840304|FG000|Overall Study|Physician Decision|9
6835211|NCT00227370|10840305|FG001|Overall Study|Physician Decision|6
6835212|NCT00227370|10840304|FG000|Overall Study|Other reasons|2
6835213|NCT00227370|10840305|FG001|Overall Study|Other reasons|1
6835214|NCT00227539|10840311|FG000|Overall Study|Protocol Violation|1
6835215|NCT00227591|10840315|FG000|Overall Study|Withdrawal by Subject|1
6835216|NCT00227721|10840333|FG000|Overall Study|On study, but never treated.|1
6835217|NCT00227877|10840345|FG000|Pre-visit Assessment|Technical difficulties|7
6835218|NCT00227877|10840346|FG001|Pre-visit Assessment|Technical difficulties|3
6835219|NCT00227877|10840347|FG002|Pre-visit Assessment|Technical difficulties|0
6835220|NCT00227877|10840348|FG003|Pre-visit Assessment|Technical difficulties|0
6835221|NCT00227877|10840345|FG000|Post-visit Checklist|Lost to Follow-up|24
6835222|NCT00227877|10840346|FG001|Post-visit Checklist|Lost to Follow-up|13
6835223|NCT00227877|10840347|FG002|Post-visit Checklist|Lost to Follow-up|1
7063603|NCT01951625|11162135|FG001|Treatment Period|Death|2
7063604|NCT01951625|11162136|FG002|Treatment Period|Death|2
7063605|NCT01951625|11162137|FG003|Treatment Period|Death|1
6835224|NCT00227877|10840348|FG003|Post-visit Checklist|Lost to Follow-up|0
6835225|NCT00227877|10840345|FG000|3-months Follow-up|Completed late|135
6835226|NCT00227877|10840346|FG001|3-months Follow-up|Completed late|128
6835227|NCT00227877|10840347|FG002|3-months Follow-up|Completed late|34
6835228|NCT00227877|10840348|FG003|3-months Follow-up|Completed late|8
6835229|NCT00227877|10840345|FG000|3-months Follow-up|Lost to Follow-up|178
6835230|NCT00227877|10840346|FG001|3-months Follow-up|Lost to Follow-up|139
6835231|NCT00227877|10840347|FG002|3-months Follow-up|Lost to Follow-up|18
6835232|NCT00227877|10840348|FG003|3-months Follow-up|Lost to Follow-up|13
6835233|NCT00227877|10840345|FG000|12-months Follow-up|Completed late|78
6835234|NCT00227877|10840346|FG001|12-months Follow-up|Completed late|74
6835235|NCT00227877|10840347|FG002|12-months Follow-up|Completed late|1
6835236|NCT00227877|10840348|FG003|12-months Follow-up|Completed late|0
6835237|NCT00227877|10840345|FG000|12-months Follow-up|Lost to Follow-up|232
6835238|NCT00227877|10840346|FG001|12-months Follow-up|Lost to Follow-up|189
6835239|NCT00227877|10840347|FG002|12-months Follow-up|Lost to Follow-up|30
6835240|NCT00227877|10840348|FG003|12-months Follow-up|Lost to Follow-up|26
6835241|NCT00227903|10840362|FG000|Overall Study|Withdrawal by Subject|2
6835242|NCT00227903|10840363|FG001|Overall Study|Withdrawal by Subject|5
6835243|NCT00227903|10840362|FG000|Overall Study|Subject moved out of area|1
6835244|NCT00227903|10840363|FG001|Overall Study|Subject moved out of area|2
6835245|NCT00227903|10840362|FG000|Overall Study|Lost to Follow-up|1
6835246|NCT00227903|10840363|FG001|Overall Study|Lost to Follow-up|3
6835247|NCT00227903|10840362|FG000|Overall Study|Miscarriage|1
6835248|NCT00227903|10840363|FG001|Overall Study|Miscarriage|0
6835249|NCT00228384|10840380|FG000|Overall Study|Death|9
6835250|NCT00228384|10840381|FG001|Overall Study|Death|3
6835251|NCT00228384|10840380|FG000|Overall Study|Lost to Follow-up|6
6835252|NCT00228384|10840381|FG001|Overall Study|Lost to Follow-up|10
6835253|NCT00228384|10840380|FG000|Overall Study|Surgical Intervention (bypass)|5
6835254|NCT00228384|10840381|FG001|Overall Study|Surgical Intervention (bypass)|5
6835255|NCT00228384|10840380|FG000|Overall Study|Withdrawal by Subject|9
6835256|NCT00228384|10840381|FG001|Overall Study|Withdrawal by Subject|10
6835257|NCT00228384|10840380|FG000|Overall Study|Physician Decision|0
6835258|NCT00228384|10840381|FG001|Overall Study|Physician Decision|1
6835259|NCT00228423|10840389|FG000|Overall Study|Adverse Event|2
6835260|NCT00228423|10840390|FG001|Overall Study|Adverse Event|5
6835261|NCT00228423|10840389|FG000|Overall Study|Withdrawal by Subject|7
6835262|NCT00228423|10840390|FG001|Overall Study|Withdrawal by Subject|3
6835263|NCT00228423|10840389|FG000|Overall Study|Protocol Violation|1
6835264|NCT00228423|10840390|FG001|Overall Study|Protocol Violation|3
6835265|NCT00228423|10840389|FG000|Overall Study|Physician Decision|0
6835266|NCT00228423|10840390|FG001|Overall Study|Physician Decision|1
6926322|NCT00838903|10956885|FG000|Follow-up Period (8 Weeks)|Missing|1
6835267|NCT00228553|10840396|FG000|Overall Study|Adverse Event|112
6835268|NCT00228553|10840396|FG000|Overall Study|Lack of Efficacy|34
6835269|NCT00228553|10840396|FG000|Overall Study|Lost to Follow-up|67
6835270|NCT00228553|10840396|FG000|Overall Study|Physician Decision|48
6835271|NCT00228553|10840396|FG000|Overall Study|Protocol Violation|6
6835272|NCT00228553|10840396|FG000|Overall Study|Withdrawal by Subject|115
6926323|NCT00838903|10956886|FG001|Follow-up Period (8 Weeks)|Missing|2
6835273|NCT00228553|10840396|FG000|Overall Study|Pregnancy|2
6835274|NCT00228553|10840396|FG000|Overall Study|Miscellaneous|46
6835275|NCT00228566|10840400|FG000|Overall Study|Adverse Event|31
6835276|NCT00228566|10840400|FG000|Overall Study|Lack of Efficacy|14
7039424|NCT01709903|11122066|FG000|Overall Study|Lack of Efficacy|3
7039425|NCT01709903|11122067|FG001|Overall Study|Lack of Efficacy|3
6835277|NCT00228566|10840400|FG000|Overall Study|Lost to Follow-up|16
6835278|NCT00228566|10840400|FG000|Overall Study|Physician Decision|5
6835279|NCT00228566|10840400|FG000|Overall Study|Withdrawal by Subject|4
6835280|NCT00228566|10840400|FG000|Overall Study|Miscellaneous|1
6835281|NCT00228813|10840404|FG000|Overall Study|Death|4
6835282|NCT00228917|10840416|FG000|Overall Study|Migrated/moved from study area|0
6835283|NCT00228917|10840417|FG001|Overall Study|Migrated/moved from study area|0
6835284|NCT00228917|10840418|FG002|Overall Study|Migrated/moved from study area|0
6835285|NCT00228917|10840419|FG003|Overall Study|Migrated/moved from study area|0
6835286|NCT00228917|10840420|FG004|Overall Study|Migrated/moved from study area|0
6835287|NCT00228917|10840421|FG005|Overall Study|Migrated/moved from study area|2
6835288|NCT00228917|10840422|FG006|Overall Study|Migrated/moved from study area|0
6835289|NCT00228917|10840423|FG007|Overall Study|Migrated/moved from study area|0
6835290|NCT00229203|10840445|FG000|Overall Study|Progressive disease|18
6835291|NCT00229203|10840446|FG001|Overall Study|Progressive disease|9
6835292|NCT00229203|10840445|FG000|Overall Study|Toxicity|6
6835293|NCT00229203|10840446|FG001|Overall Study|Toxicity|1
6835294|NCT00229203|10840445|FG000|Overall Study|Death|4
6835295|NCT00229203|10840446|FG001|Overall Study|Death|2
6835296|NCT00229203|10840445|FG000|Overall Study|Other|3
6835297|NCT00229203|10840446|FG001|Overall Study|Other|3
6835298|NCT00229203|10840445|FG000|Overall Study|Withdrawal by Subject|1
6835299|NCT00229203|10840446|FG001|Overall Study|Withdrawal by Subject|4
6926324|NCT00838903|10956887|FG002|Follow-up Period (8 Weeks)|Missing|1
6926325|NCT00838903|10956888|FG003|Follow-up Period (8 Weeks)|Missing|1
6974914|NCT01190930|11027138|FG007|Induction|Low Risk|0
6974915|NCT01190930|11027139|FG008|Induction|Low Risk|0
6974916|NCT01190930|11027140|FG009|Induction|Low Risk|0
6974917|NCT01190930|11027131|FG000|Induction|Very High Risk|1012
6974918|NCT01190930|11027132|FG001|Induction|Very High Risk|0
6974919|NCT01190930|11027133|FG002|Induction|Very High Risk|0
6974920|NCT01190930|11027134|FG003|Induction|Very High Risk|0
6974921|NCT01190930|11027135|FG004|Induction|Very High Risk|0
6974922|NCT01190930|11027136|FG005|Induction|Very High Risk|0
6974923|NCT01190930|11027137|FG006|Induction|Very High Risk|0
6974924|NCT01190930|11027138|FG007|Induction|Very High Risk|0
6974925|NCT01190930|11027139|FG008|Induction|Very High Risk|0
6974926|NCT01190930|11027140|FG009|Induction|Very High Risk|0
6974927|NCT01190930|11027131|FG000|Induction|Philadelphia chromosome-positive|99
6974928|NCT01190930|11027132|FG001|Induction|Philadelphia chromosome-positive|0
6974929|NCT01190930|11027133|FG002|Induction|Philadelphia chromosome-positive|0
7039426|NCT01709903|11122066|FG000|Overall Study|Withdrawal by Subject|6
6974930|NCT01190930|11027134|FG003|Induction|Philadelphia chromosome-positive|0
6974931|NCT01190930|11027135|FG004|Induction|Philadelphia chromosome-positive|0
6974932|NCT01190930|11027136|FG005|Induction|Philadelphia chromosome-positive|0
6974933|NCT01190930|11027137|FG006|Induction|Philadelphia chromosome-positive|0
6974934|NCT01190930|11027138|FG007|Induction|Philadelphia chromosome-positive|0
6974935|NCT01190930|11027139|FG008|Induction|Philadelphia chromosome-positive|0
6974936|NCT01190930|11027140|FG009|Induction|Philadelphia chromosome-positive|0
6974937|NCT01190930|11027131|FG000|Induction|Incomplete Induction data|63
6974938|NCT01190930|11027132|FG001|Induction|Incomplete Induction data|0
6974939|NCT01190930|11027133|FG002|Induction|Incomplete Induction data|0
6974940|NCT01190930|11027134|FG003|Induction|Incomplete Induction data|0
6974941|NCT01190930|11027135|FG004|Induction|Incomplete Induction data|0
6974942|NCT01190930|11027136|FG005|Induction|Incomplete Induction data|0
6974943|NCT01190930|11027137|FG006|Induction|Incomplete Induction data|0
6974944|NCT01190930|11027138|FG007|Induction|Incomplete Induction data|0
6974945|NCT01190930|11027139|FG008|Induction|Incomplete Induction data|0
6974946|NCT01190930|11027140|FG009|Induction|Incomplete Induction data|0
6974947|NCT01190930|11027131|FG000|Induction|Progressive disease|0
6974948|NCT01190930|11027132|FG001|Induction|Progressive disease|1
6974949|NCT01190930|11027133|FG002|Induction|Progressive disease|0
6974950|NCT01190930|11027134|FG003|Induction|Progressive disease|0
6835300|NCT00229658|10840460|FG000|Overall Study|Administrative|2
6835301|NCT00229658|10840461|FG001|Overall Study|Administrative|1
6835302|NCT00229658|10840460|FG000|Overall Study|Investigator decision|13
6835303|NCT00229658|10840461|FG001|Overall Study|Investigator decision|10
6835304|NCT00229658|10840460|FG000|Overall Study|Other|80
6835305|NCT00229658|10840461|FG001|Overall Study|Other|60
6835306|NCT00229658|10840460|FG000|Overall Study|Lost to Follow-up|82
6835307|NCT00229658|10840461|FG001|Overall Study|Lost to Follow-up|55
6835308|NCT00229658|10840460|FG000|Overall Study|Serious Adverse Event|2
6835309|NCT00229658|10840461|FG001|Overall Study|Serious Adverse Event|2
6974951|NCT01190930|11027135|FG004|Induction|Progressive disease|0
6974952|NCT01190930|11027136|FG005|Induction|Progressive disease|0
6974953|NCT01190930|11027137|FG006|Induction|Progressive disease|0
6974954|NCT01190930|11027138|FG007|Induction|Progressive disease|0
7039427|NCT01709903|11122067|FG001|Overall Study|Withdrawal by Subject|6
7039428|NCT01709903|11122066|FG000|Overall Study|Adverse Event|11
6974955|NCT01190930|11027139|FG008|Induction|Progressive disease|0
6835310|NCT00229658|10840460|FG000|Overall Study|Withdrawal of consent|46
6835311|NCT00229658|10840461|FG001|Overall Study|Withdrawal of consent|39
6835312|NCT00229723|10840474|FG000|Concomitant Phase|Adverse Event|4
6835313|NCT00229723|10840475|FG001|Concomitant Phase|Adverse Event|2
6835314|NCT00229723|10840476|FG002|Concomitant Phase|Adverse Event|5
6835315|NCT00229723|10840477|FG003|Concomitant Phase|Adverse Event|2
6835316|NCT00229723|10840478|FG004|Concomitant Phase|Adverse Event|0
6835317|NCT00229723|10840479|FG005|Concomitant Phase|Adverse Event|1
6835318|NCT00229723|10840480|FG006|Concomitant Phase|Adverse Event|2
6835319|NCT00229723|10840474|FG000|Concomitant Phase|Objective disease progression|0
6835320|NCT00229723|10840475|FG001|Concomitant Phase|Objective disease progression|0
6835321|NCT00229723|10840476|FG002|Concomitant Phase|Objective disease progression|0
6835322|NCT00229723|10840477|FG003|Concomitant Phase|Objective disease progression|0
6835323|NCT00229723|10840478|FG004|Concomitant Phase|Objective disease progression|0
6835324|NCT00229723|10840479|FG005|Concomitant Phase|Objective disease progression|0
6835325|NCT00229723|10840480|FG006|Concomitant Phase|Objective disease progression|0
6835326|NCT00229723|10840474|FG000|Concomitant Phase|Clinical progression|0
6835327|NCT00229723|10840475|FG001|Concomitant Phase|Clinical progression|0
6835328|NCT00229723|10840476|FG002|Concomitant Phase|Clinical progression|0
6835329|NCT00229723|10840477|FG003|Concomitant Phase|Clinical progression|0
6835330|NCT00229723|10840478|FG004|Concomitant Phase|Clinical progression|0
6835331|NCT00229723|10840479|FG005|Concomitant Phase|Clinical progression|0
6835332|NCT00229723|10840480|FG006|Concomitant Phase|Clinical progression|1
6835333|NCT00229723|10840474|FG000|Concomitant Phase|Lost to Follow-up|0
6835334|NCT00229723|10840475|FG001|Concomitant Phase|Lost to Follow-up|0
6835335|NCT00229723|10840476|FG002|Concomitant Phase|Lost to Follow-up|0
6835336|NCT00229723|10840477|FG003|Concomitant Phase|Lost to Follow-up|0
6835337|NCT00229723|10840478|FG004|Concomitant Phase|Lost to Follow-up|1
6835338|NCT00229723|10840479|FG005|Concomitant Phase|Lost to Follow-up|0
6835339|NCT00229723|10840480|FG006|Concomitant Phase|Lost to Follow-up|0
6835340|NCT00229723|10840474|FG000|Concomitant Phase|Informed consent withdrawn|3
6835341|NCT00229723|10840475|FG001|Concomitant Phase|Informed consent withdrawn|2
6835342|NCT00229723|10840476|FG002|Concomitant Phase|Informed consent withdrawn|0
6835343|NCT00229723|10840477|FG003|Concomitant Phase|Informed consent withdrawn|2
6835344|NCT00229723|10840478|FG004|Concomitant Phase|Informed consent withdrawn|0
6835345|NCT00229723|10840479|FG005|Concomitant Phase|Informed consent withdrawn|0
6835346|NCT00229723|10840480|FG006|Concomitant Phase|Informed consent withdrawn|0
6835347|NCT00229723|10840474|FG000|Concomitant Phase|Severe non-compliance|0
6835348|NCT00229723|10840475|FG001|Concomitant Phase|Severe non-compliance|1
6835349|NCT00229723|10840476|FG002|Concomitant Phase|Severe non-compliance|0
6835350|NCT00229723|10840477|FG003|Concomitant Phase|Severe non-compliance|0
6835351|NCT00229723|10840478|FG004|Concomitant Phase|Severe non-compliance|1
6835352|NCT00229723|10840479|FG005|Concomitant Phase|Severe non-compliance|0
6835353|NCT00229723|10840480|FG006|Concomitant Phase|Severe non-compliance|0
6835354|NCT00229723|10840474|FG000|Concomitant Phase|Other|3
7063606|NCT01951625|11162138|FG004|Treatment Period|Death|2
7063607|NCT01951625|11162134|FG000|Treatment Period|Adverse Event|7
7063608|NCT01951625|11162135|FG001|Treatment Period|Adverse Event|10
7063609|NCT01951625|11162136|FG002|Treatment Period|Adverse Event|9
7063610|NCT01951625|11162137|FG003|Treatment Period|Adverse Event|8
7063611|NCT01951625|11162138|FG004|Treatment Period|Adverse Event|8
7063612|NCT01951625|11162134|FG000|Treatment Period|Withdrawal by Subject|5
7063613|NCT01951625|11162135|FG001|Treatment Period|Withdrawal by Subject|2
7063614|NCT01951625|11162136|FG002|Treatment Period|Withdrawal by Subject|1
7063615|NCT01951625|11162137|FG003|Treatment Period|Withdrawal by Subject|7
7063616|NCT01951625|11162138|FG004|Treatment Period|Withdrawal by Subject|3
7063617|NCT01951625|11162134|FG000|Treatment Period|Lost to Follow-up|1
7063618|NCT01951625|11162135|FG001|Treatment Period|Lost to Follow-up|0
7063619|NCT01951625|11162136|FG002|Treatment Period|Lost to Follow-up|0
7063620|NCT01951625|11162137|FG003|Treatment Period|Lost to Follow-up|1
7063621|NCT01951625|11162138|FG004|Treatment Period|Lost to Follow-up|0
7063622|NCT01951625|11162134|FG000|Follow Up Period|Non-compliance with study drug|1
7063623|NCT01951625|11162135|FG001|Follow Up Period|Non-compliance with study drug|0
7063624|NCT01951625|11162136|FG002|Follow Up Period|Non-compliance with study drug|0
7063625|NCT01951625|11162137|FG003|Follow Up Period|Non-compliance with study drug|0
7063626|NCT01951625|11162138|FG004|Follow Up Period|Non-compliance with study drug|0
7063627|NCT01951625|11162134|FG000|Follow Up Period|Death|1
7063628|NCT01951625|11162135|FG001|Follow Up Period|Death|3
7063629|NCT01951625|11162136|FG002|Follow Up Period|Death|2
7063630|NCT01951625|11162137|FG003|Follow Up Period|Death|2
7063631|NCT01951625|11162138|FG004|Follow Up Period|Death|1
7063632|NCT01951625|11162134|FG000|Follow Up Period|Logistical difficulties|1
7063633|NCT01951625|11162135|FG001|Follow Up Period|Logistical difficulties|2
7063634|NCT01951625|11162136|FG002|Follow Up Period|Logistical difficulties|0
7063635|NCT01951625|11162137|FG003|Follow Up Period|Logistical difficulties|0
7063636|NCT01951625|11162138|FG004|Follow Up Period|Logistical difficulties|0
7063637|NCT01951625|11162134|FG000|Follow Up Period|Adverse Event|0
7063638|NCT01951625|11162135|FG001|Follow Up Period|Adverse Event|3
7063639|NCT01951625|11162136|FG002|Follow Up Period|Adverse Event|2
7063640|NCT01951625|11162137|FG003|Follow Up Period|Adverse Event|3
7063641|NCT01951625|11162138|FG004|Follow Up Period|Adverse Event|5
7063642|NCT01951625|11162134|FG000|Follow Up Period|Withdrawal by Subject|4
6835355|NCT00229723|10840475|FG001|Concomitant Phase|Other|0
6835356|NCT00229723|10840476|FG002|Concomitant Phase|Other|1
6835357|NCT00229723|10840477|FG003|Concomitant Phase|Other|1
6835358|NCT00229723|10840478|FG004|Concomitant Phase|Other|0
6835359|NCT00229723|10840479|FG005|Concomitant Phase|Other|2
6835360|NCT00229723|10840480|FG006|Concomitant Phase|Other|0
6835361|NCT00229723|10840474|FG000|Maintenance Phase|Adverse Event|7
6835362|NCT00229723|10840475|FG001|Maintenance Phase|Adverse Event|2
6835363|NCT00229723|10840476|FG002|Maintenance Phase|Adverse Event|1
6835364|NCT00229723|10840477|FG003|Maintenance Phase|Adverse Event|4
6835365|NCT00229723|10840478|FG004|Maintenance Phase|Adverse Event|7
6835366|NCT00229723|10840479|FG005|Maintenance Phase|Adverse Event|5
6835367|NCT00229723|10840480|FG006|Maintenance Phase|Adverse Event|2
6835368|NCT00229723|10840474|FG000|Maintenance Phase|Objective disease progression|5
6835369|NCT00229723|10840475|FG001|Maintenance Phase|Objective disease progression|5
6835370|NCT00229723|10840476|FG002|Maintenance Phase|Objective disease progression|3
6835371|NCT00229723|10840477|FG003|Maintenance Phase|Objective disease progression|6
6835372|NCT00229723|10840478|FG004|Maintenance Phase|Objective disease progression|2
6835373|NCT00229723|10840479|FG005|Maintenance Phase|Objective disease progression|9
6835374|NCT00229723|10840480|FG006|Maintenance Phase|Objective disease progression|5
6835375|NCT00229723|10840474|FG000|Maintenance Phase|Clinical progression|4
6835376|NCT00229723|10840475|FG001|Maintenance Phase|Clinical progression|1
6835377|NCT00229723|10840476|FG002|Maintenance Phase|Clinical progression|2
6835378|NCT00229723|10840477|FG003|Maintenance Phase|Clinical progression|2
6835379|NCT00229723|10840478|FG004|Maintenance Phase|Clinical progression|1
6835380|NCT00229723|10840479|FG005|Maintenance Phase|Clinical progression|1
6835381|NCT00229723|10840480|FG006|Maintenance Phase|Clinical progression|1
6835382|NCT00229723|10840474|FG000|Maintenance Phase|Lost to Follow-up|0
6835383|NCT00229723|10840475|FG001|Maintenance Phase|Lost to Follow-up|1
6835384|NCT00229723|10840476|FG002|Maintenance Phase|Lost to Follow-up|2
6835385|NCT00229723|10840477|FG003|Maintenance Phase|Lost to Follow-up|2
6835386|NCT00229723|10840478|FG004|Maintenance Phase|Lost to Follow-up|0
6835387|NCT00229723|10840479|FG005|Maintenance Phase|Lost to Follow-up|0
6835388|NCT00229723|10840480|FG006|Maintenance Phase|Lost to Follow-up|1
6835389|NCT00229723|10840474|FG000|Maintenance Phase|Informed consent withdrawn|1
6835390|NCT00229723|10840475|FG001|Maintenance Phase|Informed consent withdrawn|0
6835391|NCT00229723|10840476|FG002|Maintenance Phase|Informed consent withdrawn|0
6835392|NCT00229723|10840477|FG003|Maintenance Phase|Informed consent withdrawn|1
6835393|NCT00229723|10840478|FG004|Maintenance Phase|Informed consent withdrawn|1
6835394|NCT00229723|10840479|FG005|Maintenance Phase|Informed consent withdrawn|1
6835395|NCT00229723|10840480|FG006|Maintenance Phase|Informed consent withdrawn|0
6835396|NCT00229723|10840474|FG000|Maintenance Phase|Severe non-compliance|3
6835397|NCT00229723|10840475|FG001|Maintenance Phase|Severe non-compliance|1
6835398|NCT00229723|10840476|FG002|Maintenance Phase|Severe non-compliance|0
6835399|NCT00229723|10840477|FG003|Maintenance Phase|Severe non-compliance|0
6835400|NCT00229723|10840478|FG004|Maintenance Phase|Severe non-compliance|1
6835401|NCT00229723|10840479|FG005|Maintenance Phase|Severe non-compliance|0
6835402|NCT00229723|10840480|FG006|Maintenance Phase|Severe non-compliance|0
6835403|NCT00229723|10840474|FG000|Maintenance Phase|Other|5
6835404|NCT00229723|10840475|FG001|Maintenance Phase|Other|4
6835405|NCT00229723|10840476|FG002|Maintenance Phase|Other|1
6835406|NCT00229723|10840477|FG003|Maintenance Phase|Other|2
6835407|NCT00229723|10840478|FG004|Maintenance Phase|Other|3
6835408|NCT00229723|10840479|FG005|Maintenance Phase|Other|3
6835409|NCT00229723|10840480|FG006|Maintenance Phase|Other|1
6835410|NCT00230048|10840525|FG000|Overall Study|Lost to Follow-up|13
6835411|NCT00230048|10840526|FG001|Overall Study|Lost to Follow-up|18
6835412|NCT00230178|10840557|FG000|Overall Study|Adverse Event|1
6835413|NCT00230178|10840558|FG001|Overall Study|Adverse Event|5
6835414|NCT00230178|10840559|FG002|Overall Study|Adverse Event|2
6835415|NCT00230178|10840557|FG000|Overall Study|Withdrawal by Subject|0
6835416|NCT00230178|10840558|FG001|Overall Study|Withdrawal by Subject|0
6835417|NCT00230178|10840559|FG002|Overall Study|Withdrawal by Subject|1
6835418|NCT00230178|10840557|FG000|Overall Study|Various other reasons|3
6835419|NCT00230178|10840558|FG001|Overall Study|Various other reasons|2
6835420|NCT00230178|10840559|FG002|Overall Study|Various other reasons|4
6835421|NCT00230282|10840567|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4
6835422|NCT00230282|10840567|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1
6835423|NCT00230282|10840567|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1
6835424|NCT00230282|10840567|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2
6835425|NCT00230971|10840597|FG000|Randomization|No study drug administered|3
6835426|NCT00230971|10840598|FG001|Randomization|No study drug administered|3
6835427|NCT00230971|10840597|FG000|Baseline Participants|Lost to Follow-up|5
6835428|NCT00230971|10840598|FG001|Baseline Participants|Lost to Follow-up|12
6835429|NCT00230971|10840597|FG000|Baseline Participants|Death|6
6835430|NCT00230971|10840598|FG001|Baseline Participants|Death|5
6835431|NCT00230971|10840597|FG000|Baseline Participants|Withdrawal by Subject|7
6835432|NCT00230971|10840598|FG001|Baseline Participants|Withdrawal by Subject|1
6835433|NCT00230971|10840597|FG000|Baseline Participants|Adverse Event|1
6835434|NCT00230971|10840598|FG001|Baseline Participants|Adverse Event|0
6835435|NCT00230971|10840597|FG000|Baseline Participants|No bacteria observed|1
6835436|NCT00230971|10840598|FG001|Baseline Participants|No bacteria observed|0
6835437|NCT00230971|10840597|FG000|Baseline Participants|Failure to return|1
6835438|NCT00230971|10840598|FG001|Baseline Participants|Failure to return|1
6835439|NCT00230971|10840597|FG000|Baseline Participants|Reintervention|1
6835440|NCT00230971|10840598|FG001|Baseline Participants|Reintervention|0
6835441|NCT00231062|10840604|FG000|Overall Study|Physician Decision|6
6835442|NCT00231114|10840610|FG000|Randomized|Withdrawal by Subject|6
6835443|NCT00231114|10840611|FG001|Randomized|Withdrawal by Subject|3
6835444|NCT00231114|10840610|FG000|Treatment Period|Death: Motor Vehicle Accident|1
6835445|NCT00231114|10840611|FG001|Treatment Period|Death: Motor Vehicle Accident|0
6835446|NCT00231114|10840610|FG000|Post-Treatment Period|Lost to Follow-up|6
6835447|NCT00231114|10840611|FG001|Post-Treatment Period|Lost to Follow-up|1
6835448|NCT00231114|10840610|FG000|Post-Treatment Period|Physician Decision|1
6835449|NCT00231114|10840611|FG001|Post-Treatment Period|Physician Decision|0
6835450|NCT00231114|10840610|FG000|Post-Treatment Period|Withdrawal by Subject|1
6835451|NCT00231114|10840611|FG001|Post-Treatment Period|Withdrawal by Subject|0
6835452|NCT00231179|10840621|FG000|Overall Study|Lost to Follow-up|21
6835453|NCT00231179|10840622|FG001|Overall Study|Lost to Follow-up|21
6835454|NCT00231179|10840621|FG000|Overall Study|Withdrawal by Subject|3
6835455|NCT00231179|10840622|FG001|Overall Study|Withdrawal by Subject|3
6835456|NCT00231413|10840644|FG000|Overall Study|Non-serious AE|0
6835457|NCT00231413|10840645|FG001|Overall Study|Non-serious AE|0
6835458|NCT00231413|10840646|FG002|Overall Study|Non-serious AE|1
6835459|NCT00231413|10840647|FG003|Overall Study|Non-serious AE|0
6835460|NCT00231413|10840648|FG004|Overall Study|Non-serious AE|0
6835461|NCT00231413|10840649|FG005|Overall Study|Non-serious AE|0
6835462|NCT00231413|10840650|FG006|Overall Study|Non-serious AE|1
6835463|NCT00231413|10840644|FG000|Overall Study|Withdrawal by Subject|3
6835464|NCT00231413|10840645|FG001|Overall Study|Withdrawal by Subject|1
6835465|NCT00231413|10840646|FG002|Overall Study|Withdrawal by Subject|4
6835466|NCT00231413|10840647|FG003|Overall Study|Withdrawal by Subject|2
6835467|NCT00231413|10840648|FG004|Overall Study|Withdrawal by Subject|2
6835468|NCT00231413|10840649|FG005|Overall Study|Withdrawal by Subject|0
6835469|NCT00231413|10840650|FG006|Overall Study|Withdrawal by Subject|3
6835470|NCT00231413|10840644|FG000|Overall Study|Migrated/moved from study area|0
6835471|NCT00231413|10840645|FG001|Overall Study|Migrated/moved from study area|0
6835472|NCT00231413|10840646|FG002|Overall Study|Migrated/moved from study area|1
6835473|NCT00231413|10840647|FG003|Overall Study|Migrated/moved from study area|0
6835474|NCT00231413|10840648|FG004|Overall Study|Migrated/moved from study area|0
6835475|NCT00231413|10840649|FG005|Overall Study|Migrated/moved from study area|1
6835476|NCT00231413|10840650|FG006|Overall Study|Migrated/moved from study area|0
6835477|NCT00231413|10840644|FG000|Overall Study|Lost to Follow-up|4
6835478|NCT00231413|10840645|FG001|Overall Study|Lost to Follow-up|4
6835479|NCT00231413|10840646|FG002|Overall Study|Lost to Follow-up|1
6835480|NCT00231413|10840647|FG003|Overall Study|Lost to Follow-up|1
6835481|NCT00231413|10840648|FG004|Overall Study|Lost to Follow-up|1
6835482|NCT00231413|10840649|FG005|Overall Study|Lost to Follow-up|4
6835483|NCT00231413|10840650|FG006|Overall Study|Lost to Follow-up|0
6835484|NCT00231413|10840644|FG000|Overall Study|Pregnancy|1
6835485|NCT00231413|10840645|FG001|Overall Study|Pregnancy|0
7039429|NCT01709903|11122067|FG001|Overall Study|Adverse Event|18
7039430|NCT01710020|11122073|FG000|Period 1|Protocol Violation|1
7039431|NCT01710033|11122083|FG000|Stage 2|Adverse Event|0
7039432|NCT01710033|11122084|FG001|Stage 2|Adverse Event|0
7039433|NCT01710033|11122085|FG002|Stage 2|Adverse Event|0
7039434|NCT01710033|11122086|FG003|Stage 2|Adverse Event|0
7039435|NCT01710033|11122087|FG004|Stage 2|Adverse Event|1
7039436|NCT01710046|11122102|FG000|Overall Study|Lost to Follow-up|1
7039437|NCT01710046|11122103|FG001|Overall Study|Lost to Follow-up|0
7039438|NCT01710345|11122144|FG000|Overall Study|Adverse Event|0
6835486|NCT00231413|10840646|FG002|Overall Study|Pregnancy|0
6835487|NCT00231413|10840647|FG003|Overall Study|Pregnancy|0
6835488|NCT00231413|10840648|FG004|Overall Study|Pregnancy|0
6835489|NCT00231413|10840649|FG005|Overall Study|Pregnancy|0
6835490|NCT00231413|10840650|FG006|Overall Study|Pregnancy|0
6835491|NCT00231465|10840666|FG000|Overall Study|Completed only one cycle|1
6835492|NCT00231465|10840666|FG000|Overall Study|Did not have follow up CT scans|1
6835493|NCT00231478|10840672|FG000|Overall Study|Protocol Violation|3
6835494|NCT00231478|10840673|FG001|Overall Study|Protocol Violation|2
6835495|NCT00231478|10840672|FG000|Overall Study|Refused Treatment|1
6835496|NCT00231478|10840673|FG001|Overall Study|Refused Treatment|1
6835497|NCT00231478|10840672|FG000|Overall Study|Withdrawal by Subject|1
6835498|NCT00231478|10840673|FG001|Overall Study|Withdrawal by Subject|0
6835499|NCT00231478|10840672|FG000|Overall Study|Adverse Event|0
6835500|NCT00231478|10840673|FG001|Overall Study|Adverse Event|1
7039439|NCT01710345|11122145|FG001|Overall Study|Adverse Event|2
6835501|NCT00231478|10840672|FG000|Overall Study|Administrative|3
6835502|NCT00231478|10840673|FG001|Overall Study|Administrative|2
6835503|NCT00231777|10840681|FG000|Overall Study|Lost to Follow-up|3
7039440|NCT01710345|11122146|FG002|Overall Study|Adverse Event|0
6835504|NCT00231777|10840682|FG001|Overall Study|Lost to Follow-up|0
6835505|NCT00231777|10840681|FG000|Overall Study|Other|3
6835506|NCT00231777|10840682|FG001|Overall Study|Other|2
6835507|NCT00231816|10840690|FG000|Overall Study|Adverse Event|1
6835508|NCT00231816|10840691|FG001|Overall Study|Adverse Event|0
7039441|NCT01710345|11122144|FG000|Overall Study|Lack of Efficacy|2
7039442|NCT01710345|11122145|FG001|Overall Study|Lack of Efficacy|3
6835509|NCT00231816|10840690|FG000|Overall Study|Lost to Follow-up|8
6835510|NCT00231816|10840691|FG001|Overall Study|Lost to Follow-up|5
6835511|NCT00231816|10840690|FG000|Overall Study|Protocol Violation|2
6835512|NCT00231816|10840691|FG001|Overall Study|Protocol Violation|3
6835513|NCT00231816|10840690|FG000|Overall Study|Withdrawal by Subject|3
6835514|NCT00231816|10840691|FG001|Overall Study|Withdrawal by Subject|3
6835515|NCT00231816|10840690|FG000|Overall Study|Other|2
6835516|NCT00231816|10840691|FG001|Overall Study|Other|1
6835517|NCT00231842|10840698|FG000|Overall Study|Withdrawal by Subject|3
6835518|NCT00231842|10840698|FG000|Overall Study|Did not complete the last 3 cycle|8
6835519|NCT00231894|10840709|FG000|Overall Study|Withdrawal by Subject|1
6835520|NCT00231894|10840710|FG001|Overall Study|Withdrawal by Subject|1
6835521|NCT00232180|10840724|FG000|Double-blind (DB) Phase|Death|186
6835522|NCT00232180|10840725|FG001|Double-blind (DB) Phase|Death|222
6835523|NCT00232180|10840726|FG002|Double-blind (DB) Phase|Death|0
6835524|NCT00232180|10840724|FG000|Double-blind (DB) Phase|Lost to Follow-up|34
6835525|NCT00232180|10840725|FG001|Double-blind (DB) Phase|Lost to Follow-up|28
6835526|NCT00232180|10840726|FG002|Double-blind (DB) Phase|Lost to Follow-up|0
6835527|NCT00232180|10840724|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131
6835528|NCT00232180|10840725|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148
6835529|NCT00232180|10840726|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0
6835530|NCT00232180|10840724|FG000|Double-blind (DB) Phase|Protocol Violation|28
6835531|NCT00232180|10840725|FG001|Double-blind (DB) Phase|Protocol Violation|21
6835532|NCT00232180|10840726|FG002|Double-blind (DB) Phase|Protocol Violation|0
6835533|NCT00232180|10840724|FG000|Double-blind (DB) Phase|Adverse Event|83
6835534|NCT00232180|10840725|FG001|Double-blind (DB) Phase|Adverse Event|100
6835535|NCT00232180|10840726|FG002|Double-blind (DB) Phase|Adverse Event|0
6835536|NCT00232180|10840724|FG000|Double-blind (DB) Phase|Other|70
6835537|NCT00232180|10840725|FG001|Double-blind (DB) Phase|Other|75
6835538|NCT00232180|10840726|FG002|Double-blind (DB) Phase|Other|0
6835539|NCT00232180|10840724|FG000|Double-blind (DB) Phase|Randomized but not treated|3
6835540|NCT00232180|10840725|FG001|Double-blind (DB) Phase|Randomized but not treated|4
6835541|NCT00232180|10840726|FG002|Double-blind (DB) Phase|Randomized but not treated|0
6835542|NCT00232180|10840724|FG000|Double-blind (DB) Phase|Laboratory abnormality|6
6835543|NCT00232180|10840725|FG001|Double-blind (DB) Phase|Laboratory abnormality|7
6835544|NCT00232180|10840726|FG002|Double-blind (DB) Phase|Laboratory abnormality|0
6835545|NCT00232180|10840724|FG000|Open Label Phase|Death|0
6835546|NCT00232180|10840725|FG001|Open Label Phase|Death|0
6835547|NCT00232180|10840726|FG002|Open Label Phase|Death|48
6835548|NCT00232180|10840724|FG000|Open Label Phase|Lost to Follow-up|0
6835549|NCT00232180|10840725|FG001|Open Label Phase|Lost to Follow-up|0
6835550|NCT00232180|10840726|FG002|Open Label Phase|Lost to Follow-up|5
6835551|NCT00232180|10840724|FG000|Open Label Phase|Protocol Violation|0
6835552|NCT00232180|10840725|FG001|Open Label Phase|Protocol Violation|0
6835553|NCT00232180|10840726|FG002|Open Label Phase|Protocol Violation|3
6835554|NCT00232180|10840724|FG000|Open Label Phase|Study terminated by sponsor|0
6835555|NCT00232180|10840725|FG001|Open Label Phase|Study terminated by sponsor|0
6835556|NCT00232180|10840726|FG002|Open Label Phase|Study terminated by sponsor|3
6835557|NCT00232180|10840724|FG000|Open Label Phase|Withdrawal by Subject|0
6835558|NCT00232180|10840725|FG001|Open Label Phase|Withdrawal by Subject|0
6835559|NCT00232180|10840726|FG002|Open Label Phase|Withdrawal by Subject|37
6835560|NCT00232180|10840724|FG000|Open Label Phase|Other|0
6835561|NCT00232180|10840725|FG001|Open Label Phase|Other|0
6835562|NCT00232180|10840726|FG002|Open Label Phase|Other|16
6835563|NCT00232180|10840724|FG000|Open Label Phase|Adverse Event|0
6835564|NCT00232180|10840725|FG001|Open Label Phase|Adverse Event|0
6835565|NCT00232180|10840726|FG002|Open Label Phase|Adverse Event|25
6835566|NCT00232180|10840724|FG000|Open Label Phase|Laboratory abnormality|0
6835567|NCT00232180|10840725|FG001|Open Label Phase|Laboratory abnormality|0
6835568|NCT00232180|10840726|FG002|Open Label Phase|Laboratory abnormality|10
6835569|NCT00232180|10840724|FG000|Open Label Phase|Randomized but not treated|0
6835570|NCT00232180|10840725|FG001|Open Label Phase|Randomized but not treated|0
6835571|NCT00232180|10840726|FG002|Open Label Phase|Randomized but not treated|1
6835572|NCT00232544|10840755|FG000|Overall Study|Lost to Follow-up|20
6835573|NCT00232544|10840756|FG001|Overall Study|Lost to Follow-up|15
6835574|NCT00232557|10840764|FG000|Overall Study|Lost to Follow-up|3
6835575|NCT00232557|10840765|FG001|Overall Study|Lost to Follow-up|5
6835576|NCT00232596|10840786|FG000|6-Week Titration Phase|Adverse Event|6
6835577|NCT00232596|10840787|FG001|6-Week Titration Phase|Adverse Event|19
6835578|NCT00232596|10840786|FG000|6-Week Titration Phase|Failed to Return|2
6835579|NCT00232596|10840787|FG001|6-Week Titration Phase|Failed to Return|1
6835580|NCT00232596|10840786|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1
6835581|NCT00232596|10840787|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2
6835582|NCT00232596|10840786|FG000|6-Week Titration Phase|Protocol Violation|1
6835583|NCT00232596|10840787|FG001|6-Week Titration Phase|Protocol Violation|3
6835584|NCT00232596|10840786|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1
6835585|NCT00232596|10840787|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0
6926326|NCT00838916|10956900|FG000|Treatment Period (156 Weeks)|Adverse Event|50
6835586|NCT00232596|10840786|FG000|6-Week Titration Phase|Other|3
6835587|NCT00232596|10840787|FG001|6-Week Titration Phase|Other|3
6835588|NCT00232596|10840786|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0
6835589|NCT00232596|10840787|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1
6835590|NCT00232596|10840786|FG000|12-Week Maintenance Phase|Adverse Event|7
6835591|NCT00232596|10840787|FG001|12-Week Maintenance Phase|Adverse Event|22
6835592|NCT00232596|10840786|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1
6835593|NCT00232596|10840787|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2
6835594|NCT00232596|10840786|FG000|12-Week Maintenance Phase|Protocol Violation|3
6835595|NCT00232596|10840787|FG001|12-Week Maintenance Phase|Protocol Violation|1
6835596|NCT00232596|10840786|FG000|12-Week Maintenance Phase|Other|1
6835597|NCT00232596|10840787|FG001|12-Week Maintenance Phase|Other|3
6835598|NCT00233064|10840811|FG000|Overall Study|Lost to Follow-up|7
6835599|NCT00233064|10840812|FG001|Overall Study|Lost to Follow-up|7
6835600|NCT00233064|10840811|FG000|Overall Study|Withdrawal by Subject|5
6835601|NCT00233064|10840812|FG001|Overall Study|Withdrawal by Subject|3
6835602|NCT00233064|10840811|FG000|Overall Study|Death|0
6835603|NCT00233064|10840812|FG001|Overall Study|Death|1
6835604|NCT00233064|10840811|FG000|Overall Study|Relocation|0
6835605|NCT00233064|10840812|FG001|Overall Study|Relocation|1
6835606|NCT00233064|10840811|FG000|Overall Study|Protocol Violation|1
6835607|NCT00233064|10840812|FG001|Overall Study|Protocol Violation|0
6835608|NCT00233064|10840811|FG000|Overall Study|Moved to Dom. Republic|1
6835609|NCT00233064|10840812|FG001|Overall Study|Moved to Dom. Republic|0
6926327|NCT00838916|10956901|FG001|Treatment Period (156 Weeks)|Adverse Event|11
6926328|NCT00838916|10956900|FG000|Treatment Period (156 Weeks)|Protocol Violation|12
6926329|NCT00838916|10956901|FG001|Treatment Period (156 Weeks)|Protocol Violation|3
6926330|NCT00838916|10956900|FG000|Treatment Period (156 Weeks)|Noncompliance|21
6926331|NCT00838916|10956901|FG001|Treatment Period (156 Weeks)|Noncompliance|14
6926332|NCT00838916|10956900|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
6926333|NCT00838916|10956901|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
6926334|NCT00838916|10956900|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19
6926335|NCT00838916|10956901|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18
6926336|NCT00838916|10956900|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81
6926337|NCT00838916|10956901|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29
6926338|NCT00838916|10956900|FG000|Treatment Period (156 Weeks)|Physician Decision|6
6926339|NCT00838916|10956901|FG001|Treatment Period (156 Weeks)|Physician Decision|1
6926340|NCT00838916|10956900|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1
6926341|NCT00838916|10956901|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0
6926342|NCT00838916|10956900|FG000|Treatment Period (156 Weeks)|Missing|3
6926343|NCT00838916|10956901|FG001|Treatment Period (156 Weeks)|Missing|1
6926344|NCT00838916|10956900|FG000|Treatment Period (156 Weeks)|Pregnancy|2
6926345|NCT00838916|10956901|FG001|Treatment Period (156 Weeks)|Pregnancy|0
6926346|NCT00838916|10956900|FG000|Follow-up Period (8 Weeks)|Adverse Event|10
6926347|NCT00838916|10956901|FG001|Follow-up Period (8 Weeks)|Adverse Event|5
6926348|NCT00838916|10956900|FG000|Follow-up Period (8 Weeks)|Noncompliance|6
6926349|NCT00838916|10956901|FG001|Follow-up Period (8 Weeks)|Noncompliance|5
6926350|NCT00838916|10956900|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38
6926351|NCT00838916|10956901|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22
6926352|NCT00838916|10956900|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
6926353|NCT00838916|10956901|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
6926354|NCT00838916|10956900|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26
6926355|NCT00838916|10956901|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12
6926356|NCT00838916|10956900|FG000|Follow-up Period (8 Weeks)|Physician Decision|2
6926357|NCT00838916|10956901|FG001|Follow-up Period (8 Weeks)|Physician Decision|0
6926358|NCT00838916|10956900|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2
6926359|NCT00838916|10956901|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
6926360|NCT00838916|10956900|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
6926361|NCT00838916|10956901|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0
6926362|NCT00838916|10956900|FG000|Follow-up Period (8 Weeks)|Missing|3
6926363|NCT00838916|10956901|FG001|Follow-up Period (8 Weeks)|Missing|0
6926364|NCT00838929|10956910|FG000|Overall Study|Protocol Violation|0
6926365|NCT00838929|10956911|FG001|Overall Study|Protocol Violation|1
6926366|NCT00838929|10956912|FG002|Overall Study|Protocol Violation|0
6926367|NCT00838929|10956910|FG000|Overall Study|Disease progression|0
6926368|NCT00838929|10956911|FG001|Overall Study|Disease progression|2
6926369|NCT00838929|10956912|FG002|Overall Study|Disease progression|1
6926370|NCT00839072|10956918|FG000|First Intervention Period|Withdrawal by Subject|1
6926371|NCT00839072|10956919|FG001|First Intervention Period|Withdrawal by Subject|0
6926372|NCT00839072|10956918|FG000|First Intervention Period|Adverse Event|1
6926373|NCT00839072|10956919|FG001|First Intervention Period|Adverse Event|1
6926374|NCT00839072|10956918|FG000|Second Intervention Period|Withdrawal by Subject|1
6926375|NCT00839072|10956919|FG001|Second Intervention Period|Withdrawal by Subject|0
6926376|NCT00839098|10956928|FG000|Overall Study|Withdrawal by Subject|2
6926377|NCT00839098|10956929|FG001|Overall Study|Withdrawal by Subject|1
6926378|NCT00839098|10956930|FG002|Overall Study|Withdrawal by Subject|7
6926379|NCT00839254|10956955|FG000|Overall Study|Protocol Violation|0
6835610|NCT00233324|10840832|FG000|Main Study|Death|68
6835611|NCT00233324|10840833|FG001|Main Study|Death|60
6835612|NCT00233324|10840834|FG002|Main Study|Death|62
6835613|NCT00233324|10840835|FG003|Main Study|Death|47
6835614|NCT00233324|10840832|FG000|Follow up at 18-22 Months Corrected Age|Death|5
6835615|NCT00233324|10840833|FG001|Follow up at 18-22 Months Corrected Age|Death|7
6835616|NCT00233324|10840834|FG002|Follow up at 18-22 Months Corrected Age|Death|5
6835617|NCT00233324|10840835|FG003|Follow up at 18-22 Months Corrected Age|Death|4
6835618|NCT00233324|10840832|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8
6835619|NCT00233324|10840833|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
6835620|NCT00233324|10840834|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13
6835621|NCT00233324|10840835|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
6835622|NCT00233363|10840854|FG000|Overall Study|Adverse Event|1
6835623|NCT00233363|10840855|FG001|Overall Study|Adverse Event|2
6835624|NCT00233363|10840854|FG000|Overall Study|Lack of Efficacy|0
6835625|NCT00233363|10840855|FG001|Overall Study|Lack of Efficacy|2
6835626|NCT00233363|10840854|FG000|Overall Study|Withdrawal by Subject|1
6835627|NCT00233363|10840855|FG001|Overall Study|Withdrawal by Subject|1
6835628|NCT00233363|10840854|FG000|Overall Study|Aggravation of complication|1
6835629|NCT00233363|10840855|FG001|Overall Study|Aggravation of complication|0
6835630|NCT00233389|10840863|FG000|Overall Study|Adverse Event|5
6835631|NCT00233389|10840864|FG001|Overall Study|Adverse Event|5
6835632|NCT00233389|10840863|FG000|Overall Study|Lack of Efficacy|11
6835633|NCT00233389|10840864|FG001|Overall Study|Lack of Efficacy|8
6835634|NCT00233389|10840863|FG000|Overall Study|Lost to Follow-up|1
6835635|NCT00233389|10840864|FG001|Overall Study|Lost to Follow-up|1
6835636|NCT00233389|10840863|FG000|Overall Study|Physician Decision|1
6835637|NCT00233389|10840864|FG001|Overall Study|Physician Decision|0
6835638|NCT00233389|10840863|FG000|Overall Study|Protocol Violation|0
6835639|NCT00233389|10840864|FG001|Overall Study|Protocol Violation|1
6835640|NCT00233389|10840863|FG000|Overall Study|Withdrawal by Subject|0
6835641|NCT00233389|10840864|FG001|Overall Study|Withdrawal by Subject|1
6835642|NCT00233402|10840872|FG000|Overall Study|No pathology data|12
6835643|NCT00233402|10840873|FG001|Overall Study|No pathology data|9
6835644|NCT00233402|10840872|FG000|Overall Study|No Ta/T1|89
6835645|NCT00233402|10840873|FG001|Overall Study|No Ta/T1|94
6835646|NCT00233402|10840872|FG000|Overall Study|Lost to follow up etc|3
6835647|NCT00233402|10840873|FG001|Overall Study|Lost to follow up etc|21
6835648|NCT00233454|10840881|FG000|Overall Study|Death|6
6835649|NCT00233480|10840887|FG000|Overall Study|Underwent status II heart transplant|0
6835650|NCT00233480|10840888|FG001|Overall Study|Underwent status II heart transplant|1
6835651|NCT00233948|10840907|FG000|Overall Study|Adverse Event|1
6835652|NCT00233948|10840908|FG001|Overall Study|Adverse Event|0
6835653|NCT00233948|10840909|FG002|Overall Study|Adverse Event|0
6835654|NCT00233948|10840910|FG003|Overall Study|Adverse Event|0
6835655|NCT00233948|10840911|FG004|Overall Study|Adverse Event|0
6835656|NCT00233948|10840912|FG005|Overall Study|Adverse Event|0
6835657|NCT00233987|10840927|FG000|Overall Study|Withdrawal by Subject|1
6835658|NCT00233987|10840927|FG000|Overall Study|Lack of Efficacy|2
6835659|NCT00233987|10840927|FG000|Overall Study|Reason Under Review|1
6835660|NCT00233987|10840927|FG000|Overall Study|Other - Not Protocol Specified|5
6835661|NCT00233987|10840927|FG000|Overall Study|Eligible but No Treatment Received|2
6835662|NCT00233987|10840927|FG000|Overall Study|Ineligible|4
6835663|NCT00234039|10840931|FG000|Overall Study|Adverse Event|2
6835664|NCT00234039|10840931|FG000|Overall Study|Progression/relapse|34
6835665|NCT00234039|10840931|FG000|Overall Study|Other - Not Protocol Specified|3
6835666|NCT00234039|10840931|FG000|Overall Study|Ineligible|9
6835667|NCT00234039|10840931|FG000|Overall Study|No Protocol Treatment Received|2
6835668|NCT00234052|10840935|FG000|Treatment|Withdrawal by Subject|3
6835669|NCT00234052|10840935|FG000|Treatment|Adverse Event|5
6835670|NCT00234052|10840935|FG000|Treatment|Death|2
6835671|NCT00234052|10840935|FG000|Treatment|Progressive Disease|11
6835672|NCT00234052|10840935|FG000|Follow-up for 5 Years|Death|41
6835673|NCT00234052|10840935|FG000|Follow-up for 5 Years|Lost to Follow-up|1
6835674|NCT00234052|10840935|FG000|Follow-up for 5 Years|Other|7
6835675|NCT00234065|10840941|FG000|Overall Study|Adverse Event|268
6835676|NCT00234065|10840942|FG001|Overall Study|Adverse Event|166
6835677|NCT00234065|10840941|FG000|Overall Study|Withdrawal by Subject|73
6835678|NCT00234065|10840942|FG001|Overall Study|Withdrawal by Subject|56
6835679|NCT00234065|10840941|FG000|Overall Study|Physician Decision|23
6835680|NCT00234065|10840942|FG001|Overall Study|Physician Decision|22
6835681|NCT00234065|10840941|FG000|Overall Study|Not Classified|111
6835682|NCT00234065|10840942|FG001|Overall Study|Not Classified|112
6835683|NCT00234104|10840969|FG000|Overall Study|Adverse Event|4
6835684|NCT00234104|10840970|FG001|Overall Study|Adverse Event|0
6835685|NCT00234104|10840971|FG002|Overall Study|Adverse Event|3
6835686|NCT00234104|10840972|FG003|Overall Study|Adverse Event|5
6835687|NCT00234104|10840969|FG000|Overall Study|Protocol Violation|0
6835688|NCT00234104|10840970|FG001|Overall Study|Protocol Violation|0
6835689|NCT00234104|10840971|FG002|Overall Study|Protocol Violation|0
6835690|NCT00234104|10840972|FG003|Overall Study|Protocol Violation|1
6835691|NCT00234104|10840969|FG000|Overall Study|Physician Decision|0
6835692|NCT00234104|10840970|FG001|Overall Study|Physician Decision|1
6835693|NCT00234104|10840971|FG002|Overall Study|Physician Decision|2
6835694|NCT00234104|10840972|FG003|Overall Study|Physician Decision|2
6835695|NCT00234494|10841015|FG000|Overall Study|Protocol Violation|2
6835696|NCT00234533|10841019|FG000|Overall Study|Withdrawal by Subject|6
6835697|NCT00234533|10841019|FG000|Overall Study|Adverse Event|2
6835698|NCT00234533|10841019|FG000|Overall Study|Enrolled but not treated|3
6835699|NCT00235391|10841050|FG000|Overall Study|Adverse Event|4
6835700|NCT00235391|10841051|FG001|Overall Study|Adverse Event|5
6835701|NCT00235391|10841052|FG002|Overall Study|Adverse Event|10
6835702|NCT00235391|10841053|FG003|Overall Study|Adverse Event|72
6835703|NCT00235391|10841054|FG004|Overall Study|Adverse Event|5
6835704|NCT00235391|10841055|FG005|Overall Study|Adverse Event|2
6835705|NCT00235391|10841050|FG000|Overall Study|Abnormal laboratory value(s)|3
6835706|NCT00235391|10841051|FG001|Overall Study|Abnormal laboratory value(s)|5
6835707|NCT00235391|10841052|FG002|Overall Study|Abnormal laboratory value(s)|4
6835708|NCT00235391|10841053|FG003|Overall Study|Abnormal laboratory value(s)|27
6835709|NCT00235391|10841054|FG004|Overall Study|Abnormal laboratory value(s)|1
6835710|NCT00235391|10841055|FG005|Overall Study|Abnormal laboratory value(s)|2
6835711|NCT00235391|10841050|FG000|Overall Study|Unsatisfactory therapeutic effect|0
6835712|NCT00235391|10841051|FG001|Overall Study|Unsatisfactory therapeutic effect|2
6835713|NCT00235391|10841052|FG002|Overall Study|Unsatisfactory therapeutic effect|2
6835714|NCT00235391|10841053|FG003|Overall Study|Unsatisfactory therapeutic effect|17
6835715|NCT00235391|10841054|FG004|Overall Study|Unsatisfactory therapeutic effect|0
6835716|NCT00235391|10841055|FG005|Overall Study|Unsatisfactory therapeutic effect|0
6835717|NCT00235391|10841050|FG000|Overall Study|Condition no longer requires treatment|3
6835718|NCT00235391|10841051|FG001|Overall Study|Condition no longer requires treatment|0
6835719|NCT00235391|10841052|FG002|Overall Study|Condition no longer requires treatment|0
6835720|NCT00235391|10841053|FG003|Overall Study|Condition no longer requires treatment|11
6835721|NCT00235391|10841054|FG004|Overall Study|Condition no longer requires treatment|1
6835722|NCT00235391|10841055|FG005|Overall Study|Condition no longer requires treatment|0
6835723|NCT00235391|10841050|FG000|Overall Study|Protocol deviation|0
6835724|NCT00235391|10841051|FG001|Overall Study|Protocol deviation|0
6835725|NCT00235391|10841052|FG002|Overall Study|Protocol deviation|1
6835726|NCT00235391|10841053|FG003|Overall Study|Protocol deviation|11
6835727|NCT00235391|10841054|FG004|Overall Study|Protocol deviation|0
6835728|NCT00235391|10841055|FG005|Overall Study|Protocol deviation|0
6835729|NCT00235391|10841050|FG000|Overall Study|Withdrawal by Subject|2
6835730|NCT00235391|10841051|FG001|Overall Study|Withdrawal by Subject|3
6835731|NCT00235391|10841052|FG002|Overall Study|Withdrawal by Subject|3
6835732|NCT00235391|10841053|FG003|Overall Study|Withdrawal by Subject|61
6835733|NCT00235391|10841054|FG004|Overall Study|Withdrawal by Subject|5
6835734|NCT00235391|10841055|FG005|Overall Study|Withdrawal by Subject|0
6835735|NCT00235391|10841050|FG000|Overall Study|Lost to Follow-up|0
6835736|NCT00235391|10841051|FG001|Overall Study|Lost to Follow-up|3
6835737|NCT00235391|10841052|FG002|Overall Study|Lost to Follow-up|3
6835738|NCT00235391|10841053|FG003|Overall Study|Lost to Follow-up|16
6835739|NCT00235391|10841054|FG004|Overall Study|Lost to Follow-up|0
6835740|NCT00235391|10841055|FG005|Overall Study|Lost to Follow-up|0
6835741|NCT00235391|10841050|FG000|Overall Study|Administrative problems|0
6835742|NCT00235391|10841051|FG001|Overall Study|Administrative problems|0
6835743|NCT00235391|10841052|FG002|Overall Study|Administrative problems|0
6835744|NCT00235391|10841053|FG003|Overall Study|Administrative problems|1
6835745|NCT00235391|10841054|FG004|Overall Study|Administrative problems|0
6835746|NCT00235391|10841055|FG005|Overall Study|Administrative problems|0
6835747|NCT00235391|10841050|FG000|Overall Study|Death|0
6835748|NCT00235391|10841051|FG001|Overall Study|Death|0
6835749|NCT00235391|10841052|FG002|Overall Study|Death|1
6835750|NCT00235391|10841053|FG003|Overall Study|Death|4
6835751|NCT00235391|10841054|FG004|Overall Study|Death|0
6835752|NCT00235391|10841055|FG005|Overall Study|Death|0
6835753|NCT00235443|10841070|FG000|Overall Study|Adverse Event|4
6835754|NCT00235443|10841071|FG001|Overall Study|Adverse Event|12
6835755|NCT00235443|10841072|FG002|Overall Study|Adverse Event|17
6835756|NCT00235443|10841073|FG003|Overall Study|Adverse Event|44
6835757|NCT00235443|10841074|FG004|Overall Study|Adverse Event|10
6835758|NCT00235443|10841075|FG005|Overall Study|Adverse Event|15
6835759|NCT00235443|10841070|FG000|Overall Study|Lack of Efficacy|0
6835760|NCT00235443|10841071|FG001|Overall Study|Lack of Efficacy|1
6835761|NCT00235443|10841072|FG002|Overall Study|Lack of Efficacy|5
6835762|NCT00235443|10841073|FG003|Overall Study|Lack of Efficacy|12
6835763|NCT00235443|10841074|FG004|Overall Study|Lack of Efficacy|2
6835764|NCT00235443|10841075|FG005|Overall Study|Lack of Efficacy|9
6835765|NCT00235443|10841070|FG000|Overall Study|Withdrawal by Subject|3
6835766|NCT00235443|10841071|FG001|Overall Study|Withdrawal by Subject|9
6835767|NCT00235443|10841072|FG002|Overall Study|Withdrawal by Subject|25
6835768|NCT00235443|10841073|FG003|Overall Study|Withdrawal by Subject|24
6835769|NCT00235443|10841074|FG004|Overall Study|Withdrawal by Subject|10
6835770|NCT00235443|10841075|FG005|Overall Study|Withdrawal by Subject|12
6835771|NCT00235443|10841070|FG000|Overall Study|Lost to Follow-up|0
6835772|NCT00235443|10841071|FG001|Overall Study|Lost to Follow-up|8
6926380|NCT00839254|10956956|FG001|Overall Study|Protocol Violation|1
6926381|NCT00839254|10956957|FG002|Overall Study|Protocol Violation|1
6926382|NCT00839254|10956958|FG003|Overall Study|Protocol Violation|1
6926383|NCT00839254|10956959|FG004|Overall Study|Protocol Violation|0
6926384|NCT00839254|10956960|FG005|Overall Study|Protocol Violation|0
6926385|NCT00839254|10956961|FG006|Overall Study|Protocol Violation|1
6926386|NCT00839254|10956962|FG007|Overall Study|Protocol Violation|2
6926387|NCT00839254|10956955|FG000|Overall Study|Physician Decision|0
6835773|NCT00235443|10841072|FG002|Overall Study|Lost to Follow-up|6
6835774|NCT00235443|10841073|FG003|Overall Study|Lost to Follow-up|6
6835775|NCT00235443|10841074|FG004|Overall Study|Lost to Follow-up|4
6835776|NCT00235443|10841075|FG005|Overall Study|Lost to Follow-up|3
6835777|NCT00235443|10841070|FG000|Overall Study|Unsatisfactory compliance|0
6835778|NCT00235443|10841071|FG001|Overall Study|Unsatisfactory compliance|2
6835779|NCT00235443|10841072|FG002|Overall Study|Unsatisfactory compliance|3
6835780|NCT00235443|10841073|FG003|Overall Study|Unsatisfactory compliance|4
6835781|NCT00235443|10841074|FG004|Overall Study|Unsatisfactory compliance|1
6835782|NCT00235443|10841075|FG005|Overall Study|Unsatisfactory compliance|0
6835783|NCT00235443|10841070|FG000|Overall Study|Other reasons for premature termination|1
6835784|NCT00235443|10841071|FG001|Overall Study|Other reasons for premature termination|6
6835785|NCT00235443|10841072|FG002|Overall Study|Other reasons for premature termination|6
6835786|NCT00235443|10841073|FG003|Overall Study|Other reasons for premature termination|7
6835787|NCT00235443|10841074|FG004|Overall Study|Other reasons for premature termination|3
6835788|NCT00235443|10841075|FG005|Overall Study|Other reasons for premature termination|6
6897417|NCT00640393|10916497|FG001|Part 2|Lost to Follow-up|2
6897418|NCT00640393|10916498|FG002|Part 2|Lost to Follow-up|2
6897419|NCT00640393|10916496|FG000|Part 2|Withdrawal by Subject|0
6897420|NCT00640393|10916497|FG001|Part 2|Withdrawal by Subject|6
6897421|NCT00640393|10916498|FG002|Part 2|Withdrawal by Subject|1
6897422|NCT00640393|10916496|FG000|Part 2|Non-adherence|0
6897423|NCT00640393|10916497|FG001|Part 2|Non-adherence|1
6897424|NCT00640393|10916498|FG002|Part 2|Non-adherence|0
6926388|NCT00839254|10956956|FG001|Overall Study|Physician Decision|1
6926389|NCT00839254|10956957|FG002|Overall Study|Physician Decision|0
6926390|NCT00839254|10956958|FG003|Overall Study|Physician Decision|0
6926391|NCT00839254|10956959|FG004|Overall Study|Physician Decision|0
6926392|NCT00839254|10956960|FG005|Overall Study|Physician Decision|0
6926393|NCT00839254|10956961|FG006|Overall Study|Physician Decision|0
6926394|NCT00839254|10956962|FG007|Overall Study|Physician Decision|1
6926395|NCT00839254|10956955|FG000|Overall Study|Wrong treatment number allocation|0
6926396|NCT00839254|10956956|FG001|Overall Study|Wrong treatment number allocation|1
6926397|NCT00839254|10956957|FG002|Overall Study|Wrong treatment number allocation|0
6926398|NCT00839254|10956958|FG003|Overall Study|Wrong treatment number allocation|0
6926399|NCT00839254|10956959|FG004|Overall Study|Wrong treatment number allocation|0
6926400|NCT00839254|10956960|FG005|Overall Study|Wrong treatment number allocation|1
6926401|NCT00839254|10956961|FG006|Overall Study|Wrong treatment number allocation|0
6926402|NCT00839254|10956962|FG007|Overall Study|Wrong treatment number allocation|0
6926403|NCT00839254|10956955|FG000|Overall Study|Adverse Event|12
6926404|NCT00839254|10956956|FG001|Overall Study|Adverse Event|6
6926405|NCT00839254|10956957|FG002|Overall Study|Adverse Event|3
6926406|NCT00839254|10956958|FG003|Overall Study|Adverse Event|5
6926407|NCT00839254|10956959|FG004|Overall Study|Adverse Event|2
6926408|NCT00839254|10956960|FG005|Overall Study|Adverse Event|1
6926409|NCT00839254|10956961|FG006|Overall Study|Adverse Event|0
6926410|NCT00839254|10956962|FG007|Overall Study|Adverse Event|1
6926411|NCT00839254|10956955|FG000|Overall Study|Withdrawal by Subject|87
6926412|NCT00839254|10956956|FG001|Overall Study|Withdrawal by Subject|53
6926413|NCT00839254|10956957|FG002|Overall Study|Withdrawal by Subject|54
6926414|NCT00839254|10956958|FG003|Overall Study|Withdrawal by Subject|32
6926415|NCT00839254|10956959|FG004|Overall Study|Withdrawal by Subject|27
6926416|NCT00839254|10956960|FG005|Overall Study|Withdrawal by Subject|15
6926417|NCT00839254|10956961|FG006|Overall Study|Withdrawal by Subject|22
6926418|NCT00839254|10956962|FG007|Overall Study|Withdrawal by Subject|9
6926419|NCT00839254|10956955|FG000|Overall Study|Wrong group allocation|0
6926420|NCT00839254|10956956|FG001|Overall Study|Wrong group allocation|0
6926421|NCT00839254|10956957|FG002|Overall Study|Wrong group allocation|0
6926422|NCT00839254|10956958|FG003|Overall Study|Wrong group allocation|0
6897425|NCT00640393|10916496|FG000|Part 2|Adverse Event|0
6897426|NCT00640393|10916497|FG001|Part 2|Adverse Event|1
6897427|NCT00640393|10916498|FG002|Part 2|Adverse Event|0
6897428|NCT00640510|10916508|FG000|Overall Study|Lack of Efficacy|0
6897429|NCT00640510|10916509|FG001|Overall Study|Lack of Efficacy|1
6897430|NCT00640510|10916508|FG000|Overall Study|Protocol Violation|1
6897431|NCT00640510|10916509|FG001|Overall Study|Protocol Violation|0
6897432|NCT00640510|10916508|FG000|Overall Study|Physician Decision|0
6897433|NCT00640510|10916509|FG001|Overall Study|Physician Decision|1
6897434|NCT00640562|10916517|FG000|Overall Study|Adverse Event|8
6897435|NCT00640562|10916518|FG001|Overall Study|Adverse Event|5
6897436|NCT00640562|10916517|FG000|Overall Study|Lack of Efficacy|1
6897437|NCT00640562|10916518|FG001|Overall Study|Lack of Efficacy|4
6897438|NCT00640562|10916517|FG000|Overall Study|Protocol Violation|2
6897439|NCT00640562|10916518|FG001|Overall Study|Protocol Violation|4
6897440|NCT00640562|10916517|FG000|Overall Study|Withdrawal by Subject|6
6897441|NCT00640562|10916518|FG001|Overall Study|Withdrawal by Subject|10
6897442|NCT00640562|10916517|FG000|Overall Study|Known risperidone intolerance|0
6897443|NCT00640562|10916518|FG001|Overall Study|Known risperidone intolerance|1
6897444|NCT00640562|10916517|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0
6897445|NCT00640562|10916518|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1
6897446|NCT00640562|10916517|FG000|Overall Study|Low study drug dose|0
6897447|NCT00640562|10916518|FG001|Overall Study|Low study drug dose|1
6835789|NCT00235495|10841102|FG000|Overall Study|Death|52
6835790|NCT00235495|10841103|FG001|Overall Study|Death|42
6835791|NCT00235495|10841102|FG000|Overall Study|Withdrawal by Subject|5
6835792|NCT00235495|10841103|FG001|Overall Study|Withdrawal by Subject|3
6835793|NCT00235495|10841102|FG000|Overall Study|Lost to Follow-up|11
6835794|NCT00235495|10841103|FG001|Overall Study|Lost to Follow-up|13
6835795|NCT00235495|10841102|FG000|Overall Study|Visit/assessmen outside window/missing|0
6835796|NCT00235495|10841103|FG001|Overall Study|Visit/assessmen outside window/missing|10
6835797|NCT00235716|10841126|FG000|Overall Study|Death|26
6835798|NCT00235716|10841127|FG001|Overall Study|Death|39
6835799|NCT00235716|10841128|FG002|Overall Study|Death|32
6835800|NCT00235716|10841129|FG003|Overall Study|Death|31
6835801|NCT00235716|10841126|FG000|Overall Study|Withdrawal by Subject|23
6926423|NCT00839254|10956959|FG004|Overall Study|Wrong group allocation|0
6926424|NCT00839254|10956960|FG005|Overall Study|Wrong group allocation|0
6926425|NCT00839254|10956961|FG006|Overall Study|Wrong group allocation|1
6926426|NCT00839254|10956962|FG007|Overall Study|Wrong group allocation|0
6926427|NCT00839254|10956955|FG000|Overall Study|Parents wanted pneumococcal vaccine|1
6926428|NCT00839254|10956956|FG001|Overall Study|Parents wanted pneumococcal vaccine|0
6926429|NCT00839254|10956957|FG002|Overall Study|Parents wanted pneumococcal vaccine|0
6926430|NCT00839254|10956958|FG003|Overall Study|Parents wanted pneumococcal vaccine|0
6926431|NCT00839254|10956959|FG004|Overall Study|Parents wanted pneumococcal vaccine|0
6926432|NCT00839254|10956960|FG005|Overall Study|Parents wanted pneumococcal vaccine|1
6926433|NCT00839254|10956961|FG006|Overall Study|Parents wanted pneumococcal vaccine|0
6926434|NCT00839254|10956962|FG007|Overall Study|Parents wanted pneumococcal vaccine|0
6926435|NCT00839254|10956955|FG000|Overall Study|Withdrawn due to non-compliance|2
6926436|NCT00839254|10956956|FG001|Overall Study|Withdrawn due to non-compliance|0
6926437|NCT00839254|10956957|FG002|Overall Study|Withdrawn due to non-compliance|0
6926438|NCT00839254|10956958|FG003|Overall Study|Withdrawn due to non-compliance|0
6926439|NCT00839254|10956959|FG004|Overall Study|Withdrawn due to non-compliance|0
6926440|NCT00839254|10956960|FG005|Overall Study|Withdrawn due to non-compliance|0
6926441|NCT00839254|10956961|FG006|Overall Study|Withdrawn due to non-compliance|0
6926442|NCT00839254|10956962|FG007|Overall Study|Withdrawn due to non-compliance|0
6926443|NCT00839254|10956955|FG000|Overall Study|Lost to Follow-up|51
6926444|NCT00839254|10956956|FG001|Overall Study|Lost to Follow-up|30
6926445|NCT00839254|10956957|FG002|Overall Study|Lost to Follow-up|32
6926446|NCT00839254|10956958|FG003|Overall Study|Lost to Follow-up|24
6926447|NCT00839254|10956959|FG004|Overall Study|Lost to Follow-up|8
6926448|NCT00839254|10956960|FG005|Overall Study|Lost to Follow-up|8
6926449|NCT00839254|10956961|FG006|Overall Study|Lost to Follow-up|4
6926450|NCT00839254|10956962|FG007|Overall Study|Lost to Follow-up|2
6926451|NCT00839306|10957013|FG000|Overall Study|Adverse Event|3
6926452|NCT00839306|10957014|FG001|Overall Study|Adverse Event|5
6926453|NCT00839306|10957013|FG000|Overall Study|Lost to Follow-up|6
6926454|NCT00839306|10957014|FG001|Overall Study|Lost to Follow-up|9
6926455|NCT00839306|10957013|FG000|Overall Study|Withdrawal by Subject|5
6926456|NCT00839306|10957014|FG001|Overall Study|Withdrawal by Subject|7
6926457|NCT00839306|10957013|FG000|Overall Study|Lack of Efficacy|5
6926458|NCT00839306|10957014|FG001|Overall Study|Lack of Efficacy|4
6926459|NCT00839306|10957013|FG000|Overall Study|Other|6
6926460|NCT00839306|10957014|FG001|Overall Study|Other|18
6926461|NCT00839332|10957045|FG000|Phase 1|Disease Progression|38
6926462|NCT00839332|10957046|FG001|Phase 1|Disease Progression|0
6926463|NCT00839332|10957047|FG002|Phase 1|Disease Progression|0
6926464|NCT00839332|10957045|FG000|Phase 1|Adverse Event|6
6926465|NCT00839332|10957046|FG001|Phase 1|Adverse Event|0
6926466|NCT00839332|10957047|FG002|Phase 1|Adverse Event|0
6926467|NCT00839332|10957045|FG000|Phase 1|Withdrawal by Subject|4
6926468|NCT00839332|10957046|FG001|Phase 1|Withdrawal by Subject|0
6926469|NCT00839332|10957047|FG002|Phase 1|Withdrawal by Subject|0
6926470|NCT00839332|10957045|FG000|Phase 1|Physician Decision|2
6926471|NCT00839332|10957046|FG001|Phase 1|Physician Decision|0
6926472|NCT00839332|10957047|FG002|Phase 1|Physician Decision|0
6926473|NCT00839332|10957045|FG000|Phase 2|Protocol Violation|0
6926474|NCT00839332|10957046|FG001|Phase 2|Protocol Violation|1
6926475|NCT00839332|10957047|FG002|Phase 2|Protocol Violation|0
6926476|NCT00839332|10957045|FG000|Phase 2|Disease Progression|0
6926477|NCT00839332|10957046|FG001|Phase 2|Disease Progression|46
6926478|NCT00839332|10957047|FG002|Phase 2|Disease Progression|21
6926479|NCT00839332|10957045|FG000|Phase 2|Adverse Event|0
6926480|NCT00839332|10957046|FG001|Phase 2|Adverse Event|8
6926481|NCT00839332|10957047|FG002|Phase 2|Adverse Event|6
6926482|NCT00839332|10957045|FG000|Phase 2|Death|0
6926483|NCT00839332|10957046|FG001|Phase 2|Death|4
6926484|NCT00839332|10957047|FG002|Phase 2|Death|2
6926485|NCT00839332|10957045|FG000|Phase 2|Withdrawal by Subject|0
6926486|NCT00839332|10957046|FG001|Phase 2|Withdrawal by Subject|5
6926487|NCT00839332|10957047|FG002|Phase 2|Withdrawal by Subject|8
6926488|NCT00839332|10957045|FG000|Phase 2|Physician Decision|0
6835802|NCT00235716|10841127|FG001|Overall Study|Withdrawal by Subject|19
6926489|NCT00839332|10957046|FG001|Phase 2|Physician Decision|4
6926490|NCT00839332|10957047|FG002|Phase 2|Physician Decision|1
6926491|NCT00839332|10957045|FG000|Phase 2|Lost to Follow-up|0
6926492|NCT00839332|10957046|FG001|Phase 2|Lost to Follow-up|0
6926493|NCT00839332|10957047|FG002|Phase 2|Lost to Follow-up|1
6926494|NCT00839423|10957060|FG000|Overall Study|Adverse Event|4
7063643|NCT01951625|11162135|FG001|Follow Up Period|Withdrawal by Subject|1
7063644|NCT01951625|11162136|FG002|Follow Up Period|Withdrawal by Subject|0
7063645|NCT01951625|11162137|FG003|Follow Up Period|Withdrawal by Subject|5
7063646|NCT01951625|11162138|FG004|Follow Up Period|Withdrawal by Subject|3
7063647|NCT01951625|11162134|FG000|Follow Up Period|Lost to Follow-up|1
7063648|NCT01951625|11162135|FG001|Follow Up Period|Lost to Follow-up|0
7063649|NCT01951625|11162136|FG002|Follow Up Period|Lost to Follow-up|0
7063650|NCT01951625|11162137|FG003|Follow Up Period|Lost to Follow-up|1
7063651|NCT01951625|11162138|FG004|Follow Up Period|Lost to Follow-up|1
7063652|NCT01951638|11162156|FG000|Treatment Period|Protocol Violation|0
7063653|NCT01951638|11162157|FG001|Treatment Period|Protocol Violation|0
7063654|NCT01951638|11162158|FG002|Treatment Period|Protocol Violation|0
7063655|NCT01951638|11162159|FG003|Treatment Period|Protocol Violation|2
7063656|NCT01951638|11162160|FG004|Treatment Period|Protocol Violation|0
7063657|NCT01951638|11162156|FG000|Treatment Period|Protocol-driven decision point|1
7063658|NCT01951638|11162157|FG001|Treatment Period|Protocol-driven decision point|3
7063659|NCT01951638|11162158|FG002|Treatment Period|Protocol-driven decision point|0
7063660|NCT01951638|11162159|FG003|Treatment Period|Protocol-driven decision point|0
7063661|NCT01951638|11162160|FG004|Treatment Period|Protocol-driven decision point|0
7063662|NCT01951638|11162156|FG000|Treatment Period|Logistical difficulties|0
7063663|NCT01951638|11162157|FG001|Treatment Period|Logistical difficulties|1
7063664|NCT01951638|11162158|FG002|Treatment Period|Logistical difficulties|1
7063665|NCT01951638|11162159|FG003|Treatment Period|Logistical difficulties|0
7063666|NCT01951638|11162160|FG004|Treatment Period|Logistical difficulties|0
7063667|NCT01951638|11162156|FG000|Treatment Period|Withdrawal by Subject|9
7063668|NCT01951638|11162157|FG001|Treatment Period|Withdrawal by Subject|6
7063669|NCT01951638|11162158|FG002|Treatment Period|Withdrawal by Subject|4
7063670|NCT01951638|11162159|FG003|Treatment Period|Withdrawal by Subject|5
7063671|NCT01951638|11162160|FG004|Treatment Period|Withdrawal by Subject|4
7063672|NCT01951638|11162156|FG000|Treatment Period|Death|0
7063673|NCT01951638|11162157|FG001|Treatment Period|Death|0
7063674|NCT01951638|11162158|FG002|Treatment Period|Death|0
7063675|NCT01951638|11162159|FG003|Treatment Period|Death|3
7063676|NCT01951638|11162160|FG004|Treatment Period|Death|1
7063677|NCT01951638|11162156|FG000|Treatment Period|Adverse Event|3
7063678|NCT01951638|11162157|FG001|Treatment Period|Adverse Event|4
7063679|NCT01951638|11162158|FG002|Treatment Period|Adverse Event|8
7063680|NCT01951638|11162159|FG003|Treatment Period|Adverse Event|6
7063681|NCT01951638|11162160|FG004|Treatment Period|Adverse Event|5
7063682|NCT01951638|11162156|FG000|Follow-up Period|Protocol Violation|0
7063683|NCT01951638|11162157|FG001|Follow-up Period|Protocol Violation|0
7063684|NCT01951638|11162158|FG002|Follow-up Period|Protocol Violation|0
7063685|NCT01951638|11162159|FG003|Follow-up Period|Protocol Violation|1
7063686|NCT01951638|11162160|FG004|Follow-up Period|Protocol Violation|0
7063687|NCT01951638|11162156|FG000|Follow-up Period|Logistical difficulties|0
7063688|NCT01951638|11162157|FG001|Follow-up Period|Logistical difficulties|2
7063689|NCT01951638|11162158|FG002|Follow-up Period|Logistical difficulties|0
7063690|NCT01951638|11162159|FG003|Follow-up Period|Logistical difficulties|0
7063691|NCT01951638|11162160|FG004|Follow-up Period|Logistical difficulties|1
6835803|NCT00235716|10841128|FG002|Overall Study|Withdrawal by Subject|17
6835804|NCT00235716|10841129|FG003|Overall Study|Withdrawal by Subject|18
6835805|NCT00235716|10841126|FG000|Overall Study|Lost to Follow-up|12
6835806|NCT00235716|10841127|FG001|Overall Study|Lost to Follow-up|7
6835807|NCT00235716|10841128|FG002|Overall Study|Lost to Follow-up|14
6835808|NCT00235716|10841129|FG003|Overall Study|Lost to Follow-up|10
6835809|NCT00235716|10841126|FG000|Overall Study|Adverse Event|1
6835810|NCT00235716|10841127|FG001|Overall Study|Adverse Event|1
6835811|NCT00235716|10841128|FG002|Overall Study|Adverse Event|1
6835812|NCT00235716|10841129|FG003|Overall Study|Adverse Event|0
6835813|NCT00235716|10841126|FG000|Overall Study|Physician Decision|0
6835814|NCT00235716|10841127|FG001|Overall Study|Physician Decision|1
6835815|NCT00235716|10841128|FG002|Overall Study|Physician Decision|1
6835816|NCT00235716|10841129|FG003|Overall Study|Physician Decision|3
6835817|NCT00235755|10841142|FG000|4-Week Titration Phase|Adverse Event|6
6835818|NCT00235755|10841143|FG001|4-Week Titration Phase|Adverse Event|14
6835819|NCT00235755|10841144|FG002|4-Week Titration Phase|Adverse Event|20
6835820|NCT00235755|10841142|FG000|4-Week Titration Phase|Lost to Follow-up|0
6835821|NCT00235755|10841143|FG001|4-Week Titration Phase|Lost to Follow-up|1
6835822|NCT00235755|10841144|FG002|4-Week Titration Phase|Lost to Follow-up|1
6835823|NCT00235755|10841142|FG000|4-Week Titration Phase|Protocol Violation|2
6835824|NCT00235755|10841143|FG001|4-Week Titration Phase|Protocol Violation|2
6835825|NCT00235755|10841144|FG002|4-Week Titration Phase|Protocol Violation|1
6897448|NCT00640562|10916517|FG000|Overall Study|Glycosylated Hemoglobin >8|1
7063692|NCT01951638|11162156|FG000|Follow-up Period|Withdrawal by Subject|1
7063693|NCT01951638|11162157|FG001|Follow-up Period|Withdrawal by Subject|5
7063694|NCT01951638|11162158|FG002|Follow-up Period|Withdrawal by Subject|2
7063695|NCT01951638|11162159|FG003|Follow-up Period|Withdrawal by Subject|1
7063696|NCT01951638|11162160|FG004|Follow-up Period|Withdrawal by Subject|2
7063697|NCT01951638|11162156|FG000|Follow-up Period|Lost to Follow-up|0
7063698|NCT01951638|11162157|FG001|Follow-up Period|Lost to Follow-up|1
7063699|NCT01951638|11162158|FG002|Follow-up Period|Lost to Follow-up|0
7063700|NCT01951638|11162159|FG003|Follow-up Period|Lost to Follow-up|1
7063701|NCT01951638|11162160|FG004|Follow-up Period|Lost to Follow-up|0
6835826|NCT00235755|10841142|FG000|4-Week Titration Phase|Withdrawal by Subject|1
6835827|NCT00235755|10841143|FG001|4-Week Titration Phase|Withdrawal by Subject|2
7039443|NCT01710345|11122146|FG002|Overall Study|Lack of Efficacy|1
7039444|NCT01710345|11122144|FG000|Overall Study|Drug Dosing Error|1
7039445|NCT01710345|11122145|FG001|Overall Study|Drug Dosing Error|0
6835828|NCT00235755|10841144|FG002|4-Week Titration Phase|Withdrawal by Subject|3
6835829|NCT00235755|10841142|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
6835830|NCT00235755|10841143|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
6835831|NCT00235755|10841144|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1
6835832|NCT00235755|10841142|FG000|4-Week Titration Phase|Randomization Occurred in Error|1
6835833|NCT00235755|10841143|FG001|4-Week Titration Phase|Randomization Occurred in Error|0
6835834|NCT00235755|10841144|FG002|4-Week Titration Phase|Randomization Occurred in Error|0
6835835|NCT00235755|10841142|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1
6835836|NCT00235755|10841143|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
6835837|NCT00235755|10841144|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
6835838|NCT00235755|10841142|FG000|12-Week Maintenance Phase|Adverse Event|8
6835839|NCT00235755|10841143|FG001|12-Week Maintenance Phase|Adverse Event|12
6835840|NCT00235755|10841144|FG002|12-Week Maintenance Phase|Adverse Event|26
6835841|NCT00235755|10841142|FG000|12-Week Maintenance Phase|Lost to Follow-up|2
6835842|NCT00235755|10841143|FG001|12-Week Maintenance Phase|Lost to Follow-up|3
6835843|NCT00235755|10841144|FG002|12-Week Maintenance Phase|Lost to Follow-up|0
6835844|NCT00235755|10841142|FG000|12-Week Maintenance Phase|Lack of Efficacy|5
6835845|NCT00235755|10841143|FG001|12-Week Maintenance Phase|Lack of Efficacy|0
6835846|NCT00235755|10841144|FG002|12-Week Maintenance Phase|Lack of Efficacy|0
6835847|NCT00235755|10841142|FG000|12-Week Maintenance Phase|Protocol Violation|0
6835848|NCT00235755|10841143|FG001|12-Week Maintenance Phase|Protocol Violation|4
6835849|NCT00235755|10841144|FG002|12-Week Maintenance Phase|Protocol Violation|2
6835850|NCT00235755|10841142|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0
6835851|NCT00235755|10841143|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8
6835852|NCT00235755|10841144|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3
6835853|NCT00235755|10841142|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1
6835854|NCT00235755|10841143|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
6835855|NCT00235755|10841144|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
6835856|NCT00235872|10841171|FG000|Overall Study|Adverse Event|34
6835857|NCT00235872|10841171|FG000|Overall Study|Death|1
6835858|NCT00235872|10841171|FG000|Overall Study|Lost to Follow-up|1
6926495|NCT00839423|10957061|FG001|Overall Study|Adverse Event|3
6926496|NCT00839423|10957062|FG002|Overall Study|Adverse Event|7
6926497|NCT00839423|10957063|FG003|Overall Study|Adverse Event|16
6926498|NCT00839423|10957060|FG000|Overall Study|Lack of Efficacy|6
6926499|NCT00839423|10957061|FG001|Overall Study|Lack of Efficacy|6
6926500|NCT00839423|10957062|FG002|Overall Study|Lack of Efficacy|3
6926501|NCT00839423|10957063|FG003|Overall Study|Lack of Efficacy|2
6926502|NCT00839423|10957060|FG000|Overall Study|Non-compliance|0
6926503|NCT00839423|10957061|FG001|Overall Study|Non-compliance|0
6926504|NCT00839423|10957062|FG002|Overall Study|Non-compliance|0
7039446|NCT01710345|11122146|FG002|Overall Study|Drug Dosing Error|0
7039447|NCT01710358|11122157|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15
7039448|NCT01710358|11122158|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18
7039449|NCT01710358|11122159|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7
7039450|NCT01710358|11122157|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0
7039451|NCT01710358|11122158|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2
7039452|NCT01710358|11122159|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0
7039453|NCT01710358|11122157|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0
6926505|NCT00839423|10957063|FG003|Overall Study|Non-compliance|1
6926506|NCT00839423|10957060|FG000|Overall Study|Protocol Violation|0
6926507|NCT00839423|10957061|FG001|Overall Study|Protocol Violation|1
6926508|NCT00839423|10957062|FG002|Overall Study|Protocol Violation|2
6926509|NCT00839423|10957063|FG003|Overall Study|Protocol Violation|0
6926510|NCT00839423|10957060|FG000|Overall Study|Withdrawal of consent|4
6926511|NCT00839423|10957061|FG001|Overall Study|Withdrawal of consent|0
6926512|NCT00839423|10957062|FG002|Overall Study|Withdrawal of consent|4
6926513|NCT00839423|10957063|FG003|Overall Study|Withdrawal of consent|1
6926514|NCT00839423|10957060|FG000|Overall Study|Lost to Follow-up|1
6926515|NCT00839423|10957061|FG001|Overall Study|Lost to Follow-up|0
6926516|NCT00839423|10957062|FG002|Overall Study|Lost to Follow-up|1
6926517|NCT00839423|10957063|FG003|Overall Study|Lost to Follow-up|0
6926518|NCT00839423|10957060|FG000|Overall Study|Administrative or other reasons|3
6926519|NCT00839423|10957061|FG001|Overall Study|Administrative or other reasons|0
6926520|NCT00839423|10957062|FG002|Overall Study|Administrative or other reasons|1
6926521|NCT00839423|10957063|FG003|Overall Study|Administrative or other reasons|0
6926522|NCT00839436|10957076|FG000|Overall Study|Developed exclusionary condition|1
6926523|NCT00839436|10957077|FG001|Overall Study|Developed exclusionary condition|0
6926524|NCT00839436|10957078|FG002|Overall Study|Developed exclusionary condition|0
6926525|NCT00839436|10957076|FG000|Overall Study|Withdrawal by Subject|0
6926526|NCT00839436|10957077|FG001|Overall Study|Withdrawal by Subject|1
6926527|NCT00839436|10957078|FG002|Overall Study|Withdrawal by Subject|0
6926528|NCT00839436|10957076|FG000|Overall Study|Study drug no longer available|0
6835859|NCT00235872|10841171|FG000|Overall Study|Withdrawal by Subject|50
6835860|NCT00235872|10841171|FG000|Overall Study|Administrative reason|61
6835861|NCT00235989|10841179|FG000|Core Treatment Period (CT)|Lost to Follow-up|0
6835862|NCT00235989|10841180|FG001|Core Treatment Period (CT)|Lost to Follow-up|0
6835863|NCT00235989|10841181|FG002|Core Treatment Period (CT)|Lost to Follow-up|0
6835864|NCT00235989|10841182|FG003|Core Treatment Period (CT)|Lost to Follow-up|0
6835865|NCT00235989|10841183|FG004|Core Treatment Period (CT)|Lost to Follow-up|0
6835866|NCT00235989|10841184|FG005|Core Treatment Period (CT)|Lost to Follow-up|2
6835867|NCT00235989|10841179|FG000|Extension Treatment Period (ET)|Adverse Event|3
6835868|NCT00235989|10841180|FG001|Extension Treatment Period (ET)|Adverse Event|0
6835869|NCT00235989|10841181|FG002|Extension Treatment Period (ET)|Adverse Event|2
6835870|NCT00235989|10841182|FG003|Extension Treatment Period (ET)|Adverse Event|0
6835871|NCT00235989|10841183|FG004|Extension Treatment Period (ET)|Adverse Event|0
6835872|NCT00235989|10841184|FG005|Extension Treatment Period (ET)|Adverse Event|0
6835873|NCT00235989|10841179|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2
6835874|NCT00235989|10841180|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0
7039454|NCT01710358|11122158|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
7039455|NCT01710358|11122159|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
6835875|NCT00235989|10841181|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1
6835876|NCT00235989|10841182|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0
6835877|NCT00235989|10841183|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0
6835878|NCT00235989|10841184|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0
6835879|NCT00235989|10841179|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1
6835880|NCT00235989|10841180|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1
6835881|NCT00235989|10841181|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1
6835882|NCT00235989|10841182|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4
6835883|NCT00235989|10841183|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0
6835884|NCT00235989|10841184|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0
7039456|NCT01710358|11122157|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15
7039457|NCT01710358|11122158|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1
7039458|NCT01710358|11122159|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3
7039459|NCT01710358|11122157|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
7039460|NCT01710358|11122158|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1
7039461|NCT01710358|11122159|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
6835885|NCT00235989|10841179|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2
6835886|NCT00235989|10841180|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3
6835887|NCT00235989|10841181|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1
6835888|NCT00235989|10841182|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2
6835889|NCT00235989|10841183|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0
6835890|NCT00235989|10841184|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0
6835891|NCT00236080|10841199|FG000|Overall Study|Adverse Event|0
6835892|NCT00236080|10841200|FG001|Overall Study|Adverse Event|0
6835893|NCT00236080|10841201|FG002|Overall Study|Adverse Event|3
6835894|NCT00236080|10841202|FG003|Overall Study|Adverse Event|1
6835895|NCT00236080|10841203|FG004|Overall Study|Adverse Event|0
6835896|NCT00236080|10841199|FG000|Overall Study|Lost to Follow-up|0
6835897|NCT00236080|10841200|FG001|Overall Study|Lost to Follow-up|1
6835898|NCT00236080|10841201|FG002|Overall Study|Lost to Follow-up|0
6835899|NCT00236080|10841202|FG003|Overall Study|Lost to Follow-up|0
6835900|NCT00236080|10841203|FG004|Overall Study|Lost to Follow-up|0
6835901|NCT00236080|10841199|FG000|Overall Study|Physician Decision|1
6835902|NCT00236080|10841200|FG001|Overall Study|Physician Decision|0
6835903|NCT00236080|10841201|FG002|Overall Study|Physician Decision|1
6835904|NCT00236080|10841202|FG003|Overall Study|Physician Decision|1
6835905|NCT00236080|10841203|FG004|Overall Study|Physician Decision|1
6835906|NCT00236080|10841199|FG000|Overall Study|Withdrawal by Subject|1
6835907|NCT00236080|10841200|FG001|Overall Study|Withdrawal by Subject|0
6835908|NCT00236080|10841201|FG002|Overall Study|Withdrawal by Subject|0
6835909|NCT00236080|10841202|FG003|Overall Study|Withdrawal by Subject|0
6835910|NCT00236080|10841203|FG004|Overall Study|Withdrawal by Subject|0
6835911|NCT00236080|10841199|FG000|Overall Study|Miscellaneous|0
6835912|NCT00236080|10841200|FG001|Overall Study|Miscellaneous|0
6835913|NCT00236080|10841201|FG002|Overall Study|Miscellaneous|1
6835914|NCT00236080|10841202|FG003|Overall Study|Miscellaneous|0
6835915|NCT00236080|10841203|FG004|Overall Study|Miscellaneous|0
6835916|NCT00236184|10841217|FG000|Overall Study|Adverse Event|5
6835917|NCT00236184|10841218|FG001|Overall Study|Adverse Event|2
6835918|NCT00236184|10841217|FG000|Overall Study|Lack of Efficacy|0
6835919|NCT00236184|10841218|FG001|Overall Study|Lack of Efficacy|1
6835920|NCT00236184|10841217|FG000|Overall Study|Lost to Follow-up|3
6835921|NCT00236184|10841218|FG001|Overall Study|Lost to Follow-up|4
6835922|NCT00236184|10841217|FG000|Overall Study|Physician Decision|1
6835923|NCT00236184|10841218|FG001|Overall Study|Physician Decision|1
6835924|NCT00236184|10841217|FG000|Overall Study|Withdrawal by Subject|3
6835925|NCT00236184|10841218|FG001|Overall Study|Withdrawal by Subject|0
6835926|NCT00236184|10841217|FG000|Overall Study|Protocol Violation|3
6835927|NCT00236184|10841218|FG001|Overall Study|Protocol Violation|0
6835928|NCT00236184|10841217|FG000|Overall Study|non-compliance with study drug|2
6835929|NCT00236184|10841218|FG001|Overall Study|non-compliance with study drug|1
6835930|NCT00236184|10841217|FG000|Overall Study|other|1
6835931|NCT00236184|10841218|FG001|Overall Study|other|2
6835932|NCT00236197|10841226|FG000|Overall Study|Withdrawal by Subject|3
6835933|NCT00236197|10841227|FG001|Overall Study|Withdrawal by Subject|2
6835934|NCT00236197|10841226|FG000|Overall Study|Lost to Follow-up|1
6835935|NCT00236197|10841227|FG001|Overall Study|Lost to Follow-up|5
6835936|NCT00236197|10841226|FG000|Overall Study|Protocol Violation|0
6835937|NCT00236197|10841227|FG001|Overall Study|Protocol Violation|3
6835938|NCT00236197|10841226|FG000|Overall Study|Medication non-compliance|1
6835939|NCT00236197|10841227|FG001|Overall Study|Medication non-compliance|2
6835940|NCT00236197|10841226|FG000|Overall Study|Other|0
6835941|NCT00236197|10841227|FG001|Overall Study|Other|2
6835942|NCT00236899|10841237|FG000|Overall Study|Adverse Event (Study Related)|1
6835943|NCT00236899|10841238|FG001|Overall Study|Adverse Event (Study Related)|1
6835944|NCT00236899|10841239|FG002|Overall Study|Adverse Event (Study Related)|2
6835945|NCT00236899|10841240|FG003|Overall Study|Adverse Event (Study Related)|1
6835946|NCT00236899|10841237|FG000|Overall Study|Adverse Event (Not Study Related)|3
6835947|NCT00236899|10841238|FG001|Overall Study|Adverse Event (Not Study Related)|3
6835948|NCT00236899|10841239|FG002|Overall Study|Adverse Event (Not Study Related)|4
6835949|NCT00236899|10841240|FG003|Overall Study|Adverse Event (Not Study Related)|7
6835950|NCT00236899|10841237|FG000|Overall Study|Death (Study Disease)|1
6835951|NCT00236899|10841238|FG001|Overall Study|Death (Study Disease)|4
6835952|NCT00236899|10841239|FG002|Overall Study|Death (Study Disease)|0
6835953|NCT00236899|10841240|FG003|Overall Study|Death (Study Disease)|0
6835954|NCT00236899|10841237|FG000|Overall Study|Death (Not Study Related)|2
6835955|NCT00236899|10841238|FG001|Overall Study|Death (Not Study Related)|0
6835956|NCT00236899|10841239|FG002|Overall Study|Death (Not Study Related)|0
6835957|NCT00236899|10841240|FG003|Overall Study|Death (Not Study Related)|0
6835958|NCT00236899|10841237|FG000|Overall Study|Death (Study Drug Toxicity)|1
6835959|NCT00236899|10841238|FG001|Overall Study|Death (Study Drug Toxicity)|0
6835960|NCT00236899|10841239|FG002|Overall Study|Death (Study Drug Toxicity)|0
6835961|NCT00236899|10841240|FG003|Overall Study|Death (Study Drug Toxicity)|0
6835962|NCT00236899|10841237|FG000|Overall Study|Lost to Follow-up|0
6835963|NCT00236899|10841238|FG001|Overall Study|Lost to Follow-up|1
6835964|NCT00236899|10841239|FG002|Overall Study|Lost to Follow-up|0
6835965|NCT00236899|10841240|FG003|Overall Study|Lost to Follow-up|0
6835966|NCT00236899|10841237|FG000|Overall Study|Entry Criteria Exclusion|0
6835967|NCT00236899|10841238|FG001|Overall Study|Entry Criteria Exclusion|1
6835968|NCT00236899|10841239|FG002|Overall Study|Entry Criteria Exclusion|1
6835969|NCT00236899|10841240|FG003|Overall Study|Entry Criteria Exclusion|0
6835970|NCT00236899|10841237|FG000|Overall Study|Protocol Violation|1
6835971|NCT00236899|10841238|FG001|Overall Study|Protocol Violation|0
6835972|NCT00236899|10841239|FG002|Overall Study|Protocol Violation|0
6835973|NCT00236899|10841240|FG003|Overall Study|Protocol Violation|0
6835974|NCT00236899|10841237|FG000|Overall Study|Withdrawal by Subject|6
6835975|NCT00236899|10841238|FG001|Overall Study|Withdrawal by Subject|4
6835976|NCT00236899|10841239|FG002|Overall Study|Withdrawal by Subject|5
6835977|NCT00236899|10841240|FG003|Overall Study|Withdrawal by Subject|2
6835978|NCT00236899|10841237|FG000|Overall Study|Physician Decision|7
6835979|NCT00236899|10841238|FG001|Overall Study|Physician Decision|8
6835980|NCT00236899|10841239|FG002|Overall Study|Physician Decision|7
6835981|NCT00236899|10841240|FG003|Overall Study|Physician Decision|6
6835982|NCT00236899|10841237|FG000|Overall Study|Satisfactory Response|2
6835983|NCT00236899|10841238|FG001|Overall Study|Satisfactory Response|0
6835984|NCT00236899|10841239|FG002|Overall Study|Satisfactory Response|0
6835985|NCT00236899|10841240|FG003|Overall Study|Satisfactory Response|1
6835986|NCT00236899|10841237|FG000|Overall Study|Lack of Efficacy|18
6835987|NCT00236899|10841238|FG001|Overall Study|Lack of Efficacy|18
6835988|NCT00236899|10841239|FG002|Overall Study|Lack of Efficacy|25
6835989|NCT00236899|10841240|FG003|Overall Study|Lack of Efficacy|23
6835990|NCT00237042|10841295|FG000|Treatment|Became ineligible post-randomization|0
6835991|NCT00237042|10841296|FG001|Treatment|Became ineligible post-randomization|1
6835992|NCT00237042|10841297|FG002|Treatment|Became ineligible post-randomization|16
6835993|NCT00237042|10841295|FG000|Treatment|Moved out of state|1
6835994|NCT00237042|10841296|FG001|Treatment|Moved out of state|1
6835995|NCT00237042|10841297|FG002|Treatment|Moved out of state|1
6835996|NCT00237042|10841295|FG000|Treatment|Completed no treatment|5
6835997|NCT00237042|10841296|FG001|Treatment|Completed no treatment|5
6835998|NCT00237042|10841297|FG002|Treatment|Completed no treatment|21
6835999|NCT00237042|10841295|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9
6836000|NCT00237042|10841296|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8
6836001|NCT00237042|10841297|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11
6836002|NCT00237042|10841295|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11
6836003|NCT00237042|10841296|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9
6836004|NCT00237042|10841297|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9
6836005|NCT00237185|10841307|FG000|Core|Adverse Event|3
6836006|NCT00237185|10841308|FG001|Core|Adverse Event|4
6836007|NCT00237185|10841307|FG000|Core|Abnormal laboratory value|0
6836008|NCT00237185|10841308|FG001|Core|Abnormal laboratory value|4
6836009|NCT00237185|10841307|FG000|Core|Abnormal test procedure results|1
6836010|NCT00237185|10841308|FG001|Core|Abnormal test procedure results|0
6836011|NCT00237185|10841307|FG000|Core|Lack of Efficacy|30
6836012|NCT00237185|10841308|FG001|Core|Lack of Efficacy|23
6836013|NCT00237185|10841307|FG000|Core|Protocol Violation|1
6836014|NCT00237185|10841308|FG001|Core|Protocol Violation|1
6836015|NCT00237185|10841307|FG000|Core|Withdrawal by Subject|4
6836016|NCT00237185|10841308|FG001|Core|Withdrawal by Subject|4
6836017|NCT00237185|10841307|FG000|Core|Administrative problems|0
6836018|NCT00237185|10841308|FG001|Core|Administrative problems|1
6836019|NCT00237185|10841307|FG000|Core|Death|4
6836020|NCT00237185|10841308|FG001|Core|Death|0
6836021|NCT00237185|10841307|FG000|Core|Determined ineligible post randomization|1
6836022|NCT00237185|10841308|FG001|Core|Determined ineligible post randomization|0
6836023|NCT00237185|10841307|FG000|Extension|Adverse Event|1
6836024|NCT00237185|10841308|FG001|Extension|Adverse Event|0
6836025|NCT00237185|10841307|FG000|Extension|Abnormal laboratory value|0
6836026|NCT00237185|10841308|FG001|Extension|Abnormal laboratory value|1
6836027|NCT00237185|10841307|FG000|Extension|Lack of Efficacy|9
6836028|NCT00237185|10841308|FG001|Extension|Lack of Efficacy|14
6836029|NCT00237185|10841307|FG000|Extension|Condition no longer required study drug|0
6836030|NCT00237185|10841308|FG001|Extension|Condition no longer required study drug|1
6836031|NCT00237185|10841307|FG000|Extension|Withdrawal by Subject|3
6836032|NCT00237185|10841308|FG001|Extension|Withdrawal by Subject|2
6836033|NCT00237185|10841307|FG000|Extension|Lost to Follow-up|1
6836034|NCT00237185|10841308|FG001|Extension|Lost to Follow-up|0
6836035|NCT00237185|10841307|FG000|Extension|Administrative problems|1
6836036|NCT00237185|10841308|FG001|Extension|Administrative problems|0
6836037|NCT00237185|10841307|FG000|Extension|Death|1
6836038|NCT00237185|10841308|FG001|Extension|Death|1
6836039|NCT00237458|10841314|FG000|Overall Study|Lack of Efficacy|1
6836040|NCT00237458|10841314|FG000|Overall Study|Adverse Event|1
6836041|NCT00237458|10841314|FG000|Overall Study|Withdrawal by Subject|1
6836042|NCT00237692|10841326|FG000|Overall Study|Lost to Follow-up|9
6836043|NCT00237692|10841327|FG001|Overall Study|Lost to Follow-up|3
6836044|NCT00237692|10841328|FG002|Overall Study|Lost to Follow-up|5
6836045|NCT00237692|10841329|FG003|Overall Study|Lost to Follow-up|3
6836046|NCT00237692|10841326|FG000|Overall Study|Death|1
6836047|NCT00237692|10841327|FG001|Overall Study|Death|2
6836048|NCT00237692|10841328|FG002|Overall Study|Death|2
6836049|NCT00237692|10841329|FG003|Overall Study|Death|3
6836050|NCT00237692|10841326|FG000|Overall Study|Excluded - did not meet criteria|4
6836051|NCT00237692|10841327|FG001|Overall Study|Excluded - did not meet criteria|3
6836052|NCT00237692|10841328|FG002|Overall Study|Excluded - did not meet criteria|5
6836053|NCT00237692|10841329|FG003|Overall Study|Excluded - did not meet criteria|9
6836054|NCT00237692|10841326|FG000|Overall Study|Withdrawal by Subject|4
6836055|NCT00237692|10841327|FG001|Overall Study|Withdrawal by Subject|6
6836056|NCT00237692|10841328|FG002|Overall Study|Withdrawal by Subject|10
6836057|NCT00237692|10841329|FG003|Overall Study|Withdrawal by Subject|4
6836058|NCT00237744|10841351|FG000|Overall Study|Withdrawal by Subject|3
6836059|NCT00237744|10841352|FG001|Overall Study|Withdrawal by Subject|1
6836060|NCT00237744|10841353|FG002|Overall Study|Withdrawal by Subject|0
6836061|NCT00237796|10841379|FG000|Overall Study|Baseline and one other ILSS required|10
6836062|NCT00237796|10841380|FG001|Overall Study|Baseline and one other ILSS required|5
6836063|NCT00237809|10841391|FG000|Overall Study|Lost to Follow-up|11
6836064|NCT00237809|10841392|FG001|Overall Study|Lost to Follow-up|10
6836065|NCT00237809|10841393|FG002|Overall Study|Lost to Follow-up|9
6836066|NCT00237809|10841394|FG003|Overall Study|Lost to Follow-up|9
6836067|NCT00238121|10841415|FG000|Overall Study|Withdrawal by Subject|1
6836068|NCT00238121|10841416|FG001|Overall Study|Withdrawal by Subject|1
6836069|NCT00238121|10841415|FG000|Overall Study|Adverse Event|2
6836070|NCT00238121|10841416|FG001|Overall Study|Adverse Event|1
6836071|NCT00238238|10841424|FG000|Overall Study|Withdrawal by Subject|0
6836072|NCT00238238|10841425|FG001|Overall Study|Withdrawal by Subject|3
6836073|NCT00238238|10841426|FG002|Overall Study|Withdrawal by Subject|0
6836074|NCT00238264|10841434|FG000|Overall Study|Death|7
6836075|NCT00238264|10841434|FG000|Overall Study|Lost to Follow-up|18
6836076|NCT00238264|10841434|FG000|Overall Study|Withdrawal by Subject|4
6836077|NCT00238264|10841434|FG000|Overall Study|Ineligible|7
6836078|NCT00238303|10841441|FG000|Overall Study|Withdrawal by Subject|11
6836079|NCT00238303|10841442|FG001|Overall Study|Withdrawal by Subject|1
6836080|NCT00238303|10841443|FG002|Overall Study|Withdrawal by Subject|2
6836081|NCT00238303|10841441|FG000|Overall Study|Death|1
6836082|NCT00238303|10841442|FG001|Overall Study|Death|0
6836083|NCT00238303|10841443|FG002|Overall Study|Death|1
6836084|NCT00238303|10841441|FG000|Overall Study|Other Medical Problems|2
6836085|NCT00238303|10841442|FG001|Overall Study|Other Medical Problems|0
6836086|NCT00238303|10841443|FG002|Overall Study|Other Medical Problems|2
6836087|NCT00238303|10841441|FG000|Overall Study|Poor tolerance of study treatment|1
6836088|NCT00238303|10841442|FG001|Overall Study|Poor tolerance of study treatment|0
6836089|NCT00238303|10841443|FG002|Overall Study|Poor tolerance of study treatment|1
6836090|NCT00238303|10841441|FG000|Overall Study|Adverse Event|0
6836091|NCT00238303|10841442|FG001|Overall Study|Adverse Event|1
6836092|NCT00238303|10841443|FG002|Overall Study|Adverse Event|3
6836093|NCT00238433|10841456|FG000|Overall Study|Screen failure|1
6836094|NCT00238433|10841456|FG000|Overall Study|Lost to Follow-up|1
6836095|NCT00238433|10841456|FG000|Overall Study|Death|1
6836096|NCT00239005|10841469|FG000|Overall Study|Adverse Event|6
6836097|NCT00239005|10841470|FG001|Overall Study|Adverse Event|6
6836098|NCT00239005|10841469|FG000|Overall Study|Withdrawal by Subject|3
6836099|NCT00239005|10841470|FG001|Overall Study|Withdrawal by Subject|4
6836100|NCT00239005|10841469|FG000|Overall Study|Unsatisfactory Therapeutic effect|2
6836101|NCT00239005|10841470|FG001|Overall Study|Unsatisfactory Therapeutic effect|0
6836102|NCT00239005|10841469|FG000|Overall Study|Protocol Violation|1
6836103|NCT00239005|10841470|FG001|Overall Study|Protocol Violation|0
6836104|NCT00239005|10841469|FG000|Overall Study|Subj. cond. no longer needs study drug|0
6836105|NCT00239005|10841470|FG001|Overall Study|Subj. cond. no longer needs study drug|1
6836106|NCT00239005|10841469|FG000|Overall Study|Lost to Follow-up|0
6836107|NCT00239005|10841470|FG001|Overall Study|Lost to Follow-up|1
6836108|NCT00239226|10841480|FG000|Overall Study|permAF during stabilization period|0
6836109|NCT00239226|10841481|FG001|Overall Study|permAF during stabilization period|0
6836110|NCT00239226|10841482|FG002|Overall Study|permAF during stabilization period|0
6836111|NCT00239226|10841483|FG003|Overall Study|permAF during stabilization period|3
6836112|NCT00239226|10841480|FG000|Overall Study|Lost to Follow-up|1
6836113|NCT00239226|10841481|FG001|Overall Study|Lost to Follow-up|0
6836114|NCT00239226|10841482|FG002|Overall Study|Lost to Follow-up|1
6836115|NCT00239226|10841483|FG003|Overall Study|Lost to Follow-up|0
6836116|NCT00239356|10841495|FG000|Overall Study|Lack of Efficacy|1
6836117|NCT00239356|10841496|FG001|Overall Study|Lack of Efficacy|0
6836118|NCT00239356|10841495|FG000|Overall Study|Adverse Event|6
6836119|NCT00239356|10841496|FG001|Overall Study|Adverse Event|0
6836120|NCT00239356|10841495|FG000|Overall Study|Withdrawal by Subject|15
6836121|NCT00239356|10841496|FG001|Overall Study|Withdrawal by Subject|6
6836122|NCT00239356|10841495|FG000|Overall Study|Lost to Follow-up|3
6836123|NCT00239356|10841496|FG001|Overall Study|Lost to Follow-up|0
6836124|NCT00239356|10841495|FG000|Overall Study|poor/non-compliance|2
6836125|NCT00239356|10841496|FG001|Overall Study|poor/non-compliance|0
6836126|NCT00239356|10841495|FG000|Overall Study|Pregnancy|1
6836127|NCT00239356|10841496|FG001|Overall Study|Pregnancy|0
6836128|NCT00239356|10841495|FG000|Overall Study|Administrative reason|0
6836129|NCT00239356|10841496|FG001|Overall Study|Administrative reason|1
6836130|NCT00239356|10841495|FG000|Overall Study|Drug available on market|11
6836131|NCT00239356|10841496|FG001|Overall Study|Drug available on market|2
6836132|NCT00239577|10841506|FG000|Primary Phase|Adverse Event|0
6836133|NCT00239577|10841507|FG001|Primary Phase|Adverse Event|0
6836134|NCT00239577|10841508|FG002|Primary Phase|Adverse Event|1
6836135|NCT00239577|10841509|FG003|Primary Phase|Adverse Event|0
6836136|NCT00239577|10841506|FG000|Primary Phase|Other|5
6836137|NCT00239577|10841507|FG001|Primary Phase|Other|3
6836138|NCT00239577|10841508|FG002|Primary Phase|Other|2
6836139|NCT00239577|10841509|FG003|Primary Phase|Other|0
6836140|NCT00239590|10841521|FG000|Randomized|Lost to Follow-up|0
6836141|NCT00239590|10841522|FG001|Randomized|Lost to Follow-up|1
6836142|NCT00239590|10841521|FG000|Randomized|Withdrawal by Subject|0
6836143|NCT00239590|10841522|FG001|Randomized|Withdrawal by Subject|1
6836144|NCT00239590|10841521|FG000|Completed Study Protocol|Adverse Event|1
6836145|NCT00239590|10841522|FG001|Completed Study Protocol|Adverse Event|1
6836146|NCT00239590|10841521|FG000|Completed Study Protocol|Withdrawal by Subject|0
6836147|NCT00239590|10841522|FG001|Completed Study Protocol|Withdrawal by Subject|1
6836148|NCT00239681|10841545|FG000|Overall Study|Adverse Event|100
6836149|NCT00239681|10841546|FG001|Overall Study|Adverse Event|99
6836150|NCT00239681|10841545|FG000|Overall Study|Withdrawal by Subject|458
6836151|NCT00239681|10841546|FG001|Overall Study|Withdrawal by Subject|489
6836152|NCT00239681|10841545|FG000|Overall Study|Lost to Follow-up|28
6836153|NCT00239681|10841546|FG001|Overall Study|Lost to Follow-up|22
6836154|NCT00239681|10841545|FG000|Overall Study|Protocol Violation|4
6836155|NCT00239681|10841546|FG001|Overall Study|Protocol Violation|4
6836156|NCT00239681|10841545|FG000|Overall Study|Physician Decision|13
6836157|NCT00239681|10841546|FG001|Overall Study|Physician Decision|17
6836158|NCT00239681|10841545|FG000|Overall Study|No information chacked on CaseReportForm|90
6836159|NCT00239681|10841546|FG001|Overall Study|No information chacked on CaseReportForm|84
6897449|NCT00640562|10916518|FG001|Overall Study|Glycosylated Hemoglobin >8|0
6897450|NCT00640601|10916524|FG000|Overall Study|Adverse Event|43
6897451|NCT00640601|10916524|FG000|Overall Study|Withdrawal by Subject|20
6897452|NCT00640601|10916524|FG000|Overall Study|Protocol Violation|6
6897453|NCT00640601|10916524|FG000|Overall Study|Lack of Efficacy|16
6897454|NCT00640601|10916524|FG000|Overall Study|Lost to Follow-up|9
6897455|NCT00640601|10916524|FG000|Overall Study|Physician Decision|8
6897456|NCT00640601|10916524|FG000|Overall Study|treatment naive, combination therapy|10
6897457|NCT00640614|10916530|FG000|Overall Study|Lost to Follow-up|1
6897458|NCT00640614|10916531|FG001|Overall Study|Lost to Follow-up|0
6897459|NCT00640835|10916596|FG000|Overall Study|Adverse Event|5
6897460|NCT00640835|10916597|FG001|Overall Study|Adverse Event|3
6897461|NCT00640835|10916596|FG000|Overall Study|Withdrawal by Subject|12
6897462|NCT00640835|10916597|FG001|Overall Study|Withdrawal by Subject|14
6897463|NCT00640835|10916596|FG000|Overall Study|Physician Decision|10
6897464|NCT00640835|10916597|FG001|Overall Study|Physician Decision|14
6897465|NCT00640835|10916596|FG000|Overall Study|Sponsor's Decision|11
6897466|NCT00640835|10916597|FG001|Overall Study|Sponsor's Decision|7
6897467|NCT00640835|10916596|FG000|Overall Study|Protocol Violation|2
6897468|NCT00640835|10916597|FG001|Overall Study|Protocol Violation|2
6897469|NCT00640835|10916596|FG000|Overall Study|Lost to Follow-up|17
6897470|NCT00640835|10916597|FG001|Overall Study|Lost to Follow-up|13
6836160|NCT00239837|10841558|FG000|Overall Study|Lost to Follow-up|3
6836161|NCT00239837|10841559|FG001|Overall Study|Lost to Follow-up|7
6836162|NCT00239928|10841567|FG000|Overall Study|Lack of Efficacy|1
6836163|NCT00239928|10841567|FG000|Overall Study|Adverse Event|4
6836164|NCT00239928|10841567|FG000|Overall Study|Not need to continue study|3
6836165|NCT00239928|10841567|FG000|Overall Study|Withdrawal by Subject|2
6836166|NCT00240071|10841571|FG000|Overall Study|Withdrawal by Subject|3
6836167|NCT00240097|10841576|FG000|Part I|Adverse Event|1
6836168|NCT00240097|10841576|FG000|Part I|Death|1
6836169|NCT00240097|10841576|FG000|Part I|histology|1
6836170|NCT00240097|10841576|FG000|Part I|unevaluable|1
6836171|NCT00240097|10841576|FG000|Part II|did not continue from Part I|23
6836172|NCT00240110|10841586|FG000|Overall Study|Lost to Follow-up|6
6836173|NCT00240110|10841587|FG001|Overall Study|Lost to Follow-up|7
6836174|NCT00240331|10841601|FG000|Overall Study|Withdrawal by Subject|125
6836175|NCT00240331|10841602|FG001|Overall Study|Withdrawal by Subject|132
6836176|NCT00240331|10841601|FG000|Overall Study|Option selected by investigator|1
6836177|NCT00240331|10841602|FG001|Overall Study|Option selected by investigator|2
6836178|NCT00240994|10841665|FG000|Overall Study|Lost to Follow-up|1
6836179|NCT00240994|10841665|FG000|Overall Study|Protocol Violation|1
6836180|NCT00240994|10841665|FG000|Overall Study|Graft failure|1
6836181|NCT00241280|10841676|FG000|Overall Study|Adverse Event|2
6836182|NCT00241280|10841677|FG001|Overall Study|Adverse Event|6
6836183|NCT00241280|10841676|FG000|Overall Study|Discomfort|11
6836184|NCT00241280|10841677|FG001|Overall Study|Discomfort|16
6836185|NCT00241280|10841676|FG000|Overall Study|Pregnancy|1
6836186|NCT00241280|10841677|FG001|Overall Study|Pregnancy|5
6836187|NCT00241280|10841676|FG000|Overall Study|Lost to Follow-up|5
6836188|NCT00241280|10841677|FG001|Overall Study|Lost to Follow-up|8
6836189|NCT00241280|10841676|FG000|Overall Study|Withdrawal by Subject|7
6836190|NCT00241280|10841677|FG001|Overall Study|Withdrawal by Subject|4
6836191|NCT00241280|10841676|FG000|Overall Study|Protocol Violation|4
6836192|NCT00241280|10841677|FG001|Overall Study|Protocol Violation|10
6836193|NCT00241280|10841676|FG000|Overall Study|Relocation|4
6836194|NCT00241280|10841677|FG001|Overall Study|Relocation|4
6836195|NCT00241280|10841676|FG000|Overall Study|Unsatisfactory Physiological Response|1
6836196|NCT00241280|10841677|FG001|Overall Study|Unsatisfactory Physiological Response|1
6836197|NCT00241280|10841676|FG000|Overall Study|Unsatisfactory Visual Response|1
6836198|NCT00241280|10841677|FG001|Overall Study|Unsatisfactory Visual Response|1
6836199|NCT00241280|10841676|FG000|Overall Study|Diabetic|1
6836200|NCT00241280|10841677|FG001|Overall Study|Diabetic|0
6836201|NCT00241280|10841676|FG000|Overall Study|Subject Ineligible/Dispensed|9
6836202|NCT00241280|10841677|FG001|Overall Study|Subject Ineligible/Dispensed|6
6836203|NCT00241280|10841676|FG000|Overall Study|Dispensed incorrect test article|1
6836204|NCT00241280|10841677|FG001|Overall Study|Dispensed incorrect test article|2
6836205|NCT00241280|10841676|FG000|Overall Study|Unacceptable Fit|0
6836206|NCT00241280|10841677|FG001|Overall Study|Unacceptable Fit|1
6836207|NCT00241280|10841676|FG000|Overall Study|Scheduling Conflict|0
6836208|NCT00241280|10841677|FG001|Overall Study|Scheduling Conflict|2
6836209|NCT00241280|10841676|FG000|Overall Study|History of Ocular Surgery|0
6836210|NCT00241280|10841677|FG001|Overall Study|History of Ocular Surgery|1
6836211|NCT00241280|10841676|FG000|Overall Study|Coating on Lens|1
6836212|NCT00241280|10841677|FG001|Overall Study|Coating on Lens|0
6836213|NCT00241280|10841676|FG000|Overall Study|Excessive Dryness|0
6836214|NCT00241280|10841677|FG001|Overall Study|Excessive Dryness|1
6836215|NCT00241358|10841687|FG000|Overall Study|Determined to be not ineligible|0
6836216|NCT00241358|10841688|FG001|Overall Study|Determined to be not ineligible|1
6836217|NCT00241358|10841689|FG002|Overall Study|Determined to be not ineligible|1
6836218|NCT00241631|10841698|FG000|Run in (2 Weeks)|Physician Decision|3
6836219|NCT00241631|10841699|FG001|Run in (2 Weeks)|Physician Decision|3
6836220|NCT00241631|10841698|FG000|Phase 1 (4 Weeks)|sore throat|1
6836221|NCT00241631|10841699|FG001|Phase 1 (4 Weeks)|sore throat|0
6836222|NCT00241631|10841698|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4
6836223|NCT00241631|10841699|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4
6836224|NCT00241631|10841698|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3
6836225|NCT00241631|10841699|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0
6836226|NCT00241631|10841698|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0
6926529|NCT00839436|10957077|FG001|Overall Study|Study drug no longer available|0
6926530|NCT00839436|10957078|FG002|Overall Study|Study drug no longer available|1
6926531|NCT00839527|10957089|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11
6926532|NCT00839527|10957090|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29
6926533|NCT00839527|10957091|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22
6926534|NCT00839527|10957089|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4
6974956|NCT01190930|11027140|FG009|Induction|Progressive disease|0
6836227|NCT00241631|10841699|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1
6836228|NCT00241644|10841709|FG000|First Efficacy Period (Year 1)|Adverse Event|46
6836229|NCT00241644|10841710|FG001|First Efficacy Period (Year 1)|Adverse Event|45
6836230|NCT00241644|10841711|FG002|First Efficacy Period (Year 1)|Adverse Event|45
6836231|NCT00241644|10841712|FG003|First Efficacy Period (Year 1)|Adverse Event|91
6836232|NCT00241644|10841709|FG000|First Efficacy Period (Year 1)|Protocol Violation|3
6836233|NCT00241644|10841710|FG001|First Efficacy Period (Year 1)|Protocol Violation|5
6836234|NCT00241644|10841711|FG002|First Efficacy Period (Year 1)|Protocol Violation|4
6836235|NCT00241644|10841712|FG003|First Efficacy Period (Year 1)|Protocol Violation|8
6836236|NCT00241644|10841709|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59
6836237|NCT00241644|10841710|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74
6836238|NCT00241644|10841711|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81
6836239|NCT00241644|10841712|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133
6836240|NCT00241644|10841709|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116
6836241|NCT00241644|10841710|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142
6836242|NCT00241644|10841711|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116
6836243|NCT00241644|10841712|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258
6836244|NCT00241644|10841709|FG000|First Efficacy Period (Year 1)|Non-compliance|2
6836245|NCT00241644|10841710|FG001|First Efficacy Period (Year 1)|Non-compliance|1
6836246|NCT00241644|10841711|FG002|First Efficacy Period (Year 1)|Non-compliance|2
6836247|NCT00241644|10841712|FG003|First Efficacy Period (Year 1)|Non-compliance|3
6836248|NCT00241644|10841709|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1
6836249|NCT00241644|10841710|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0
6836250|NCT00241644|10841711|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0
6836251|NCT00241644|10841712|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1
6836252|NCT00241644|10841709|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
6836253|NCT00241644|10841710|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
6836254|NCT00241644|10841711|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1
6836255|NCT00241644|10841712|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
6836256|NCT00241644|10841709|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0
6836257|NCT00241644|10841710|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1
6836258|NCT00241644|10841711|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0
6836259|NCT00241644|10841712|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1
6836260|NCT00241644|10841709|FG000|Second Efficacy Period (Year 2)|Adverse Event|11
6836261|NCT00241644|10841710|FG001|Second Efficacy Period (Year 2)|Adverse Event|9
6836262|NCT00241644|10841711|FG002|Second Efficacy Period (Year 2)|Adverse Event|12
6836263|NCT00241644|10841712|FG003|Second Efficacy Period (Year 2)|Adverse Event|20
6836264|NCT00241644|10841709|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2
6836265|NCT00241644|10841710|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1
6836266|NCT00241644|10841711|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2
6836267|NCT00241644|10841712|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3
6836268|NCT00241644|10841709|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4
6836269|NCT00241644|10841710|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3
6836270|NCT00241644|10841711|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2
6836271|NCT00241644|10841712|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7
6836272|NCT00241644|10841709|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43
6836273|NCT00241644|10841710|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43
6836274|NCT00241644|10841711|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46
6836275|NCT00241644|10841712|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86
6836276|NCT00241644|10841709|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1
6836277|NCT00241644|10841710|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1
6836278|NCT00241644|10841711|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2
6836279|NCT00241644|10841712|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2
6836280|NCT00241839|10841724|FG000|Overall Study|Withdrawal by Subject|18
6836281|NCT00241839|10841725|FG001|Overall Study|Withdrawal by Subject|17
6836282|NCT00241839|10841724|FG000|Overall Study|Adverse Event|1
6836283|NCT00241839|10841725|FG001|Overall Study|Adverse Event|1
6836284|NCT00242216|10841752|FG000|Overall Study|Lost to Follow-up|12
6836285|NCT00242216|10841753|FG001|Overall Study|Lost to Follow-up|17
6836286|NCT00242216|10841752|FG000|Overall Study|Death|4
6836287|NCT00242216|10841753|FG001|Overall Study|Death|2
6836288|NCT00242216|10841752|FG000|Overall Study|Lack of Efficacy|1
6836289|NCT00242216|10841753|FG001|Overall Study|Lack of Efficacy|2
6836290|NCT00242216|10841752|FG000|Overall Study|no medicaiton dispensed|1
6836291|NCT00242216|10841753|FG001|Overall Study|no medicaiton dispensed|1
6836292|NCT00242567|10841772|FG000|Overall Study|Adverse Event|70
6836293|NCT00242567|10841773|FG001|Overall Study|Adverse Event|43
6836294|NCT00242567|10841772|FG000|Overall Study|Disease Progression|17
6836295|NCT00242567|10841773|FG001|Overall Study|Disease Progression|22
6836296|NCT00242567|10841772|FG000|Overall Study|Symptomatic deterioration|9
6836297|NCT00242567|10841773|FG001|Overall Study|Symptomatic deterioration|3
6836298|NCT00242567|10841772|FG000|Overall Study|Lack of Efficacy|2
6836299|NCT00242567|10841773|FG001|Overall Study|Lack of Efficacy|2
6836300|NCT00242567|10841772|FG000|Overall Study|Lost to Follow-up|9
6836301|NCT00242567|10841773|FG001|Overall Study|Lost to Follow-up|19
6836302|NCT00242567|10841772|FG000|Overall Study|Withdrawal by Subject|33
7039462|NCT01710358|11122157|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1
7039463|NCT01710358|11122158|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
6836303|NCT00242567|10841773|FG001|Overall Study|Withdrawal by Subject|28
6836304|NCT00242567|10841772|FG000|Overall Study|Protocol Violation|12
6836305|NCT00242567|10841773|FG001|Overall Study|Protocol Violation|12
6836306|NCT00242567|10841772|FG000|Overall Study|Use of an inhibitor of bone resorption|0
6836307|NCT00242567|10841773|FG001|Overall Study|Use of an inhibitor of bone resorption|2
6836308|NCT00242567|10841772|FG000|Overall Study|Other|14
7039464|NCT01710358|11122159|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
7039465|NCT01710358|11122157|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4
7039466|NCT01710358|11122158|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
7039467|NCT01710358|11122159|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
7039468|NCT01710358|11122157|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15
7039469|NCT01710358|11122158|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5
7039470|NCT01710358|11122159|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12
7039471|NCT01710358|11122157|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
7039472|NCT01710358|11122158|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
7063702|NCT01951638|11162156|FG000|Follow-up Period|Death|1
7063703|NCT01951638|11162157|FG001|Follow-up Period|Death|0
6836309|NCT00242567|10841773|FG001|Overall Study|Other|9
6836310|NCT00242580|10841784|FG000|Overall Study|Adverse Event|3
6836311|NCT00242580|10841785|FG001|Overall Study|Adverse Event|0
6836312|NCT00242580|10841786|FG002|Overall Study|Adverse Event|2
6836313|NCT00242580|10841784|FG000|Overall Study|Unsatisfactory therapeutic effect|4
6836314|NCT00242580|10841785|FG001|Overall Study|Unsatisfactory therapeutic effect|5
6836315|NCT00242580|10841786|FG002|Overall Study|Unsatisfactory therapeutic effect|5
6836316|NCT00242580|10841784|FG000|Overall Study|Protocol Violation|0
6836317|NCT00242580|10841785|FG001|Overall Study|Protocol Violation|0
6836318|NCT00242580|10841786|FG002|Overall Study|Protocol Violation|1
6836319|NCT00242580|10841784|FG000|Overall Study|Subject withdrew consent|2
6836320|NCT00242580|10841785|FG001|Overall Study|Subject withdrew consent|2
6836321|NCT00242580|10841786|FG002|Overall Study|Subject withdrew consent|5
6836322|NCT00242580|10841784|FG000|Overall Study|Lost to Follow-up|0
6836323|NCT00242580|10841785|FG001|Overall Study|Lost to Follow-up|3
6836324|NCT00242580|10841786|FG002|Overall Study|Lost to Follow-up|0
6836325|NCT00242580|10841784|FG000|Overall Study|Death|1
6836326|NCT00242580|10841785|FG001|Overall Study|Death|2
6836327|NCT00242580|10841786|FG002|Overall Study|Death|1
6836328|NCT00242658|10841815|FG000|Overall Study|Lost to Follow-up|22
6836329|NCT00242658|10841816|FG001|Overall Study|Lost to Follow-up|19
6836330|NCT00242710|10841830|FG000|Core Study (up to Year 1)|Adverse Event|30
6836331|NCT00242710|10841831|FG001|Core Study (up to Year 1)|Adverse Event|25
6836332|NCT00242710|10841832|FG002|Core Study (up to Year 1)|Adverse Event|23
6836333|NCT00242710|10841833|FG003|Core Study (up to Year 1)|Adverse Event|14
6836334|NCT00242710|10841830|FG000|Core Study (up to Year 1)|Death|0
6836335|NCT00242710|10841831|FG001|Core Study (up to Year 1)|Death|0
6836336|NCT00242710|10841832|FG002|Core Study (up to Year 1)|Death|1
6836337|NCT00242710|10841833|FG003|Core Study (up to Year 1)|Death|0
6836338|NCT00242710|10841830|FG000|Core Study (up to Year 1)|Physician Decision|0
6836339|NCT00242710|10841831|FG001|Core Study (up to Year 1)|Physician Decision|1
6836340|NCT00242710|10841832|FG002|Core Study (up to Year 1)|Physician Decision|0
6836341|NCT00242710|10841833|FG003|Core Study (up to Year 1)|Physician Decision|1
6836342|NCT00242710|10841830|FG000|Core Study (up to Year 1)|Lost to Follow-up|8
6836343|NCT00242710|10841831|FG001|Core Study (up to Year 1)|Lost to Follow-up|8
6836344|NCT00242710|10841832|FG002|Core Study (up to Year 1)|Lost to Follow-up|7
6836345|NCT00242710|10841833|FG003|Core Study (up to Year 1)|Lost to Follow-up|3
6836346|NCT00242710|10841830|FG000|Core Study (up to Year 1)|Other|6
6836347|NCT00242710|10841831|FG001|Core Study (up to Year 1)|Other|1
6836348|NCT00242710|10841832|FG002|Core Study (up to Year 1)|Other|0
6836349|NCT00242710|10841833|FG003|Core Study (up to Year 1)|Other|2
6836350|NCT00242710|10841830|FG000|Core Study (up to Year 1)|Protocol Violation|2
6836351|NCT00242710|10841831|FG001|Core Study (up to Year 1)|Protocol Violation|9
6836352|NCT00242710|10841832|FG002|Core Study (up to Year 1)|Protocol Violation|1
6836353|NCT00242710|10841833|FG003|Core Study (up to Year 1)|Protocol Violation|3
6836354|NCT00242710|10841830|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27
6836355|NCT00242710|10841831|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16
6836356|NCT00242710|10841832|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15
6836357|NCT00242710|10841833|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6
6836358|NCT00242710|10841830|FG000|Core Study (up to Year 1)|Lack of Efficacy|1
6836359|NCT00242710|10841831|FG001|Core Study (up to Year 1)|Lack of Efficacy|0
6836360|NCT00242710|10841832|FG002|Core Study (up to Year 1)|Lack of Efficacy|0
6836361|NCT00242710|10841833|FG003|Core Study (up to Year 1)|Lack of Efficacy|0
6836362|NCT00242710|10841830|FG000|Core Study (up to Year 1)|Randomized but not Treated|12
6836363|NCT00242710|10841831|FG001|Core Study (up to Year 1)|Randomized but not Treated|4
6836364|NCT00242710|10841832|FG002|Core Study (up to Year 1)|Randomized but not Treated|4
6836365|NCT00242710|10841833|FG003|Core Study (up to Year 1)|Randomized but not Treated|2
6836366|NCT00242710|10841830|FG000|Period Between Core Study and Extension|Adverse Event|2
6836367|NCT00242710|10841831|FG001|Period Between Core Study and Extension|Adverse Event|3
6836368|NCT00242710|10841832|FG002|Period Between Core Study and Extension|Adverse Event|5
6836369|NCT00242710|10841833|FG003|Period Between Core Study and Extension|Adverse Event|2
6836370|NCT00242710|10841830|FG000|Period Between Core Study and Extension|Physician Decision|1
6836371|NCT00242710|10841831|FG001|Period Between Core Study and Extension|Physician Decision|1
6836372|NCT00242710|10841832|FG002|Period Between Core Study and Extension|Physician Decision|0
6836373|NCT00242710|10841833|FG003|Period Between Core Study and Extension|Physician Decision|0
6836374|NCT00242710|10841830|FG000|Period Between Core Study and Extension|Other|24
6836375|NCT00242710|10841831|FG001|Period Between Core Study and Extension|Other|24
6836376|NCT00242710|10841832|FG002|Period Between Core Study and Extension|Other|9
6836377|NCT00242710|10841833|FG003|Period Between Core Study and Extension|Other|11
6836378|NCT00242710|10841830|FG000|Period Between Core Study and Extension|Extension not Available|17
6836379|NCT00242710|10841831|FG001|Period Between Core Study and Extension|Extension not Available|21
6836380|NCT00242710|10841832|FG002|Period Between Core Study and Extension|Extension not Available|8
6836381|NCT00242710|10841833|FG003|Period Between Core Study and Extension|Extension not Available|7
6836382|NCT00242710|10841830|FG000|Period Between Core Study and Extension|Protocol Violation|0
6836383|NCT00242710|10841831|FG001|Period Between Core Study and Extension|Protocol Violation|0
6836384|NCT00242710|10841832|FG002|Period Between Core Study and Extension|Protocol Violation|2
6836385|NCT00242710|10841833|FG003|Period Between Core Study and Extension|Protocol Violation|1
6836386|NCT00242710|10841830|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75
6836387|NCT00242710|10841831|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63
6836388|NCT00242710|10841832|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24
6836389|NCT00242710|10841833|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28
6836390|NCT00242710|10841830|FG000|Study Extension (up to Year 2)|Adverse Event|7
6836391|NCT00242710|10841831|FG001|Study Extension (up to Year 2)|Adverse Event|9
6836392|NCT00242710|10841832|FG002|Study Extension (up to Year 2)|Adverse Event|2
6836393|NCT00242710|10841833|FG003|Study Extension (up to Year 2)|Adverse Event|4
6926535|NCT00839527|10957090|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7
6926536|NCT00839527|10957091|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1
6926537|NCT00839527|10957089|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5
6926538|NCT00839527|10957090|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6
6926539|NCT00839527|10957091|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16
6926540|NCT00839527|10957089|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3
6926541|NCT00839527|10957090|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12
6926542|NCT00839527|10957091|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
6926543|NCT00839527|10957089|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32
6926544|NCT00839527|10957090|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46
6926545|NCT00839527|10957091|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64
6926546|NCT00839527|10957089|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1
6926547|NCT00839527|10957090|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6
6926548|NCT00839527|10957091|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1
6926549|NCT00839527|10957089|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3
6926550|NCT00839527|10957090|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8
6926551|NCT00839527|10957091|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5
6926552|NCT00839527|10957089|FG000|Treatment Period (TP) (156 Weeks)|Missing|0
6926553|NCT00839527|10957090|FG001|Treatment Period (TP) (156 Weeks)|Missing|1
6926554|NCT00839527|10957091|FG002|Treatment Period (TP) (156 Weeks)|Missing|0
6926555|NCT00839527|10957089|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
6926556|NCT00839527|10957090|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
6926557|NCT00839527|10957091|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1
6926558|NCT00839527|10957089|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0
6926559|NCT00839527|10957090|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1
6926560|NCT00839527|10957091|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1
6926561|NCT00839527|10957089|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1
6926562|NCT00839527|10957090|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2
6926563|NCT00839527|10957091|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0
6926564|NCT00839527|10957089|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
6926565|NCT00839527|10957090|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
6926566|NCT00839527|10957091|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1
6926567|NCT00839527|10957089|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
6926568|NCT00839527|10957090|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2
6926569|NCT00839527|10957091|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
6926570|NCT00839527|10957089|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
6926571|NCT00839527|10957090|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
6926572|NCT00839527|10957091|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5
6926573|NCT00839527|10957089|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8
6926574|NCT00839527|10957090|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20
6926575|NCT00839527|10957091|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29
6926576|NCT00839527|10957089|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12
6926577|NCT00839527|10957090|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21
6926578|NCT00839527|10957091|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19
6926579|NCT00839527|10957089|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
6926580|NCT00839527|10957090|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
6926581|NCT00839527|10957091|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
6926582|NCT00839527|10957089|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3
6926583|NCT00839527|10957090|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10
6926584|NCT00839527|10957091|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5
6974957|NCT01190930|11027131|FG000|Induction|No treatment|3
6836394|NCT00242710|10841830|FG000|Study Extension (up to Year 2)|Death|0
6836395|NCT00242710|10841831|FG001|Study Extension (up to Year 2)|Death|0
6836396|NCT00242710|10841832|FG002|Study Extension (up to Year 2)|Death|0
6836397|NCT00242710|10841833|FG003|Study Extension (up to Year 2)|Death|1
6836398|NCT00242710|10841830|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7
6836399|NCT00242710|10841831|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7
6836400|NCT00242710|10841832|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5
7044767|NCT01757171|11130749|FG000|Overall Study|Disease Progression|1
7063704|NCT01951638|11162158|FG002|Follow-up Period|Death|1
6836401|NCT00242710|10841833|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0
6836402|NCT00242710|10841830|FG000|Study Extension (up to Year 2)|Other|3
6836403|NCT00242710|10841831|FG001|Study Extension (up to Year 2)|Other|5
6836404|NCT00242710|10841832|FG002|Study Extension (up to Year 2)|Other|4
6836405|NCT00242710|10841833|FG003|Study Extension (up to Year 2)|Other|3
6836406|NCT00242710|10841830|FG000|Study Extension (up to Year 2)|Protocol Violation|0
6836407|NCT00242710|10841831|FG001|Study Extension (up to Year 2)|Protocol Violation|2
6836408|NCT00242710|10841832|FG002|Study Extension (up to Year 2)|Protocol Violation|0
6836409|NCT00242710|10841833|FG003|Study Extension (up to Year 2)|Protocol Violation|1
7063705|NCT01951638|11162159|FG003|Follow-up Period|Death|4
7063706|NCT01951638|11162160|FG004|Follow-up Period|Death|1
7063707|NCT01951638|11162156|FG000|Follow-up Period|Adverse Event|0
7063708|NCT01951638|11162157|FG001|Follow-up Period|Adverse Event|1
7063709|NCT01951638|11162158|FG002|Follow-up Period|Adverse Event|2
7063710|NCT01951638|11162159|FG003|Follow-up Period|Adverse Event|1
7063711|NCT01951638|11162160|FG004|Follow-up Period|Adverse Event|1
7063712|NCT01951703|11162183|FG000|First Intervention|Withdrawal by Subject|1
7063713|NCT01951703|11162184|FG001|First Intervention|Withdrawal by Subject|0
7063714|NCT01951703|11162183|FG000|First Intervention|Subject was not compliant|1
7063715|NCT01951703|11162184|FG001|First Intervention|Subject was not compliant|1
7063716|NCT01951703|11162183|FG000|First Intervention|Physician Decision|1
7063717|NCT01951703|11162184|FG001|First Intervention|Physician Decision|0
7063718|NCT01951703|11162183|FG000|Second Intervention|Protocol Violation|0
7063719|NCT01951703|11162184|FG001|Second Intervention|Protocol Violation|1
7063720|NCT01951703|11162183|FG000|Second Intervention|Unsatisfactory Lens fitting|0
7063721|NCT01951703|11162184|FG001|Second Intervention|Unsatisfactory Lens fitting|1
7063722|NCT01952015|11162231|FG000|Induction|Protocol Violation|1
7063723|NCT01952015|11162231|FG000|Maintenance|Adverse Event|2
7063724|NCT01952015|11162231|FG000|Treatment Period 3|Physician Decision|9
7063725|NCT01952041|11162249|FG000|Overall Study|Lost to Follow-up|9
7063726|NCT01952041|11162250|FG001|Overall Study|Lost to Follow-up|16
7063727|NCT01952041|11162249|FG000|Overall Study|Withdrawal by Subject|7
7063728|NCT01952041|11162250|FG001|Overall Study|Withdrawal by Subject|5
7063729|NCT01952041|11162249|FG000|Overall Study|Death|1
7063730|NCT01952041|11162250|FG001|Overall Study|Death|0
7063731|NCT01952054|11162256|FG000|Overall Study|Physician Decision|1
7063732|NCT01952080|11162264|FG000|Overall Study|Withdrawal by Subject|0
7063733|NCT01952080|11162265|FG001|Overall Study|Withdrawal by Subject|0
7063734|NCT01952080|11162266|FG002|Overall Study|Withdrawal by Subject|0
7063735|NCT01952080|11162267|FG003|Overall Study|Withdrawal by Subject|1
7063736|NCT01952080|11162264|FG000|Overall Study|Protocol Non-compliance|0
7063737|NCT01952080|11162265|FG001|Overall Study|Protocol Non-compliance|1
7063738|NCT01952080|11162266|FG002|Overall Study|Protocol Non-compliance|0
7063739|NCT01952080|11162267|FG003|Overall Study|Protocol Non-compliance|0
7063740|NCT01952145|11162279|FG000|Overall Study|Protocol Violation|2
7063741|NCT01952145|11162280|FG001|Overall Study|Protocol Violation|1
7063742|NCT01952145|11162279|FG000|Overall Study|Death|0
7063743|NCT01952145|11162280|FG001|Overall Study|Death|1
7063744|NCT01952145|11162279|FG000|Overall Study|Adverse Event|9
6836410|NCT00242710|10841830|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10
6836411|NCT00242710|10841831|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6
6836412|NCT00242710|10841832|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4
7044768|NCT01757171|11130750|FG001|Overall Study|Disease Progression|0
7044769|NCT01757171|11130749|FG000|Overall Study|Hospitalization|1
7044770|NCT01757171|11130750|FG001|Overall Study|Hospitalization|0
7044771|NCT01757171|11130749|FG000|Overall Study|ECOG decline|1
7044772|NCT01757171|11130750|FG001|Overall Study|ECOG decline|0
7044773|NCT01757184|11130758|FG000|Double-blind Period|Adverse Event|1
7044774|NCT01757184|11130759|FG001|Double-blind Period|Adverse Event|0
7044775|NCT01757184|11130760|FG002|Double-blind Period|Adverse Event|0
7044776|NCT01757184|11130761|FG003|Double-blind Period|Adverse Event|0
7044777|NCT01757184|11130758|FG000|Open-label Period|Lost to Follow-up|0
7044778|NCT01757184|11130759|FG001|Open-label Period|Lost to Follow-up|0
7044779|NCT01757184|11130760|FG002|Open-label Period|Lost to Follow-up|2
7044780|NCT01757184|11130761|FG003|Open-label Period|Lost to Follow-up|0
7044781|NCT01757184|11130758|FG000|Open-label Period|Withdrawal by Subject|0
7044782|NCT01757184|11130759|FG001|Open-label Period|Withdrawal by Subject|0
7044783|NCT01757184|11130760|FG002|Open-label Period|Withdrawal by Subject|1
7044784|NCT01757184|11130761|FG003|Open-label Period|Withdrawal by Subject|1
7044785|NCT01757184|11130758|FG000|Open-label Period|Discontinued by Sponsor|0
7044786|NCT01757184|11130759|FG001|Open-label Period|Discontinued by Sponsor|0
7044787|NCT01757184|11130760|FG002|Open-label Period|Discontinued by Sponsor|1
7044788|NCT01757184|11130761|FG003|Open-label Period|Discontinued by Sponsor|2
6836413|NCT00242710|10841833|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1
6836414|NCT00243022|10841845|FG000|Overall Study|Withdrawal by Subject|1
6836415|NCT00243022|10841846|FG001|Overall Study|Withdrawal by Subject|0
6836416|NCT00243022|10841845|FG000|Overall Study|Death|1
6836417|NCT00243022|10841846|FG001|Overall Study|Death|0
6926585|NCT00839527|10957089|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1
6926586|NCT00839527|10957090|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
6926587|NCT00839527|10957091|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
6926588|NCT00839527|10957089|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1
6926589|NCT00839527|10957090|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
6926590|NCT00839527|10957091|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
6926591|NCT00839527|10957089|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
6926592|NCT00839527|10957090|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1
6926593|NCT00839527|10957091|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
6926594|NCT00839527|10957089|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
6926595|NCT00839527|10957090|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0
6926596|NCT00839527|10957091|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
6926597|NCT00839527|10957089|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
6926598|NCT00839527|10957090|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1
6926599|NCT00839527|10957091|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
6926600|NCT00839527|10957089|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0
6926601|NCT00839527|10957090|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
6926602|NCT00839527|10957091|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
6926603|NCT00839800|10957116|FG000|Overall Study|Adverse Event|8
6926604|NCT00839800|10957117|FG001|Overall Study|Adverse Event|12
6926605|NCT00839800|10957116|FG000|Overall Study|Lost to Follow-up|31
6926606|NCT00839800|10957117|FG001|Overall Study|Lost to Follow-up|26
6926607|NCT00839800|10957116|FG000|Overall Study|Withdrawal by Subject|28
6926608|NCT00839800|10957117|FG001|Overall Study|Withdrawal by Subject|34
6926609|NCT00839800|10957116|FG000|Overall Study|Incorrect Enrolment|3
6926610|NCT00839800|10957117|FG001|Overall Study|Incorrect Enrolment|3
6926611|NCT00839800|10957116|FG000|Overall Study|Study-Specific Discontinuation Criteria|6
6926612|NCT00839800|10957117|FG001|Overall Study|Study-Specific Discontinuation Criteria|13
6926613|NCT00839800|10957116|FG000|Overall Study|Safety Reasons|2
6926614|NCT00839800|10957117|FG001|Overall Study|Safety Reasons|1
6926615|NCT00839800|10957116|FG000|Overall Study|Other|8
6926616|NCT00839800|10957117|FG001|Overall Study|Other|14
6926617|NCT00839800|10957116|FG000|Overall Study|Severe Non-Compliance to Protocol|7
6926618|NCT00839800|10957117|FG001|Overall Study|Severe Non-Compliance to Protocol|7
6926619|NCT00839852|10957123|FG000|Overall Study|Adverse Event|10
6926620|NCT00839852|10957123|FG000|Overall Study|Insufficient Therapeutic Response|3
6926621|NCT00839852|10957123|FG000|Overall Study|Protocol Violation|9
6926622|NCT00839852|10957123|FG000|Overall Study|Withdrawal of Consent|16
6926623|NCT00839852|10957123|FG000|Overall Study|Lost to Follow-up|7
6926624|NCT00839852|10957123|FG000|Overall Study|Lack of Compliance While in Jail|1
6926625|NCT00839852|10957123|FG000|Overall Study|Pregnancy|1
6926626|NCT00839917|10957129|FG000|Overall Study|Lost to Follow-up|1
6926627|NCT00839917|10957130|FG001|Overall Study|Lost to Follow-up|0
6926628|NCT00839917|10957129|FG000|Overall Study|Did not receive vaccine|0
6926629|NCT00839917|10957130|FG001|Overall Study|Did not receive vaccine|1
6926630|NCT00839956|10957136|FG000|Overall Study|Adverse Event|2
6926631|NCT00839956|10957136|FG000|Overall Study|Lack of Efficacy|6
6926632|NCT00839956|10957136|FG000|Overall Study|Physician Decision|1
6926633|NCT00839956|10957136|FG000|Overall Study|Withdrawal by Subject|3
6926634|NCT00840034|10957153|FG000|Acute Treatment Phase|Adverse Event|6
6926635|NCT00840034|10957154|FG001|Acute Treatment Phase|Adverse Event|8
6926636|NCT00840034|10957153|FG000|Acute Treatment Phase|Lack of Efficacy|2
6926637|NCT00840034|10957154|FG001|Acute Treatment Phase|Lack of Efficacy|0
7039473|NCT01710358|11122159|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0
6836418|NCT00243022|10841845|FG000|Overall Study|Difficult Travel Distance|0
6836419|NCT00243022|10841846|FG001|Overall Study|Difficult Travel Distance|1
6836420|NCT00243074|10841858|FG000|Overall Study|Ineligible|6
6836421|NCT00243074|10841858|FG000|Overall Study|Adverse Event|6
6836422|NCT00243074|10841858|FG000|Overall Study|Withdrawal by Subject|2
6836423|NCT00243074|10841858|FG000|Overall Study|Lack of Efficacy|36
6836424|NCT00243074|10841858|FG000|Overall Study|Death|2
6836425|NCT00243074|10841858|FG000|Overall Study|not protocol specified|1
6836426|NCT00243074|10841858|FG000|Overall Study|Did not receive any treatment|1
6836427|NCT00243230|10841878|FG000|Double-Blind Period|Adverse Event|0
6836428|NCT00243230|10841879|FG001|Double-Blind Period|Adverse Event|2
6836429|NCT00243230|10841880|FG002|Double-Blind Period|Adverse Event|2
6836430|NCT00243230|10841881|FG003|Double-Blind Period|Adverse Event|0
6836431|NCT00243230|10841878|FG000|Double-Blind Period|Withdrawal by Subject|1
6836432|NCT00243230|10841879|FG001|Double-Blind Period|Withdrawal by Subject|0
6836433|NCT00243230|10841880|FG002|Double-Blind Period|Withdrawal by Subject|0
6836434|NCT00243230|10841881|FG003|Double-Blind Period|Withdrawal by Subject|0
6836435|NCT00243230|10841878|FG000|Double-Blind Period|Protocol Violation|0
6836436|NCT00243230|10841879|FG001|Double-Blind Period|Protocol Violation|0
7063745|NCT01952145|11162280|FG001|Overall Study|Adverse Event|0
7063746|NCT01952145|11162279|FG000|Overall Study|Withdrawal Criteria|16
7063747|NCT01952145|11162280|FG001|Overall Study|Withdrawal Criteria|11
7063748|NCT01952145|11162279|FG000|Overall Study|Unclassified|1
7063749|NCT01952145|11162280|FG001|Overall Study|Unclassified|1
7063750|NCT01952366|11162292|FG000|Overall Study|Death|22
7063751|NCT01952366|11162292|FG000|Overall Study|Withdrawal by Subject|9
7063752|NCT01952665|11162346|FG000|Overall Study|Physician Decision|3
7063753|NCT01952665|11162347|FG001|Overall Study|Physician Decision|2
7063754|NCT01952665|11162346|FG000|Overall Study|Lost to Follow-up|1
7063755|NCT01952665|11162347|FG001|Overall Study|Lost to Follow-up|2
7063756|NCT01952665|11162346|FG000|Overall Study|Adverse Event|2
7063757|NCT01952665|11162347|FG001|Overall Study|Adverse Event|1
7063758|NCT01952665|11162346|FG000|Overall Study|Protocol Violation|0
7063759|NCT01952665|11162347|FG001|Overall Study|Protocol Violation|1
7063760|NCT01952691|11162375|FG000|Overall Study|Lost to Follow-up|2
7063761|NCT01952834|11162379|FG000|Overall Study|Adverse Event|1
7063762|NCT01953003|11162386|FG000|Overall Study|Not treated|0
7063763|NCT01953003|11162387|FG001|Overall Study|Not treated|1
7063764|NCT01953003|11162386|FG000|Overall Study|Progressive disease|35
7063765|NCT01953003|11162387|FG001|Overall Study|Progressive disease|45
7063766|NCT01953003|11162386|FG000|Overall Study|Related Adverse events|7
7063767|NCT01953003|11162387|FG001|Overall Study|Related Adverse events|2
7063768|NCT01953003|11162386|FG000|Overall Study|Non-related adverse events|0
7063769|NCT01953003|11162387|FG001|Overall Study|Non-related adverse events|2
7063770|NCT01953003|11162386|FG000|Overall Study|Protocol Violation|0
7063771|NCT01953003|11162387|FG001|Overall Study|Protocol Violation|1
7063772|NCT01953003|11162386|FG000|Overall Study|Withdrawal by Subject|14
7063773|NCT01953003|11162387|FG001|Overall Study|Withdrawal by Subject|4
7063774|NCT01953224|11162410|FG000|Overall Study|Lost to Follow-up|1
7063775|NCT01953224|11162411|FG001|Overall Study|Lost to Follow-up|1
7063776|NCT01953224|11162410|FG000|Overall Study|Withdrawal by Subject|1
6836437|NCT00243230|10841880|FG002|Double-Blind Period|Protocol Violation|1
6836438|NCT00243230|10841881|FG003|Double-Blind Period|Protocol Violation|0
6836439|NCT00243230|10841878|FG000|Double-Blind Period|Randomized but Not Treated|0
6836440|NCT00243230|10841879|FG001|Double-Blind Period|Randomized but Not Treated|0
6836441|NCT00243230|10841880|FG002|Double-Blind Period|Randomized but Not Treated|2
6836442|NCT00243230|10841881|FG003|Double-Blind Period|Randomized but Not Treated|0
6836443|NCT00243230|10841878|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5
6836444|NCT00243230|10841879|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3
6836445|NCT00243230|10841880|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14
6836446|NCT00243230|10841881|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0
6836447|NCT00243230|10841878|FG000|Open Label Period|Adverse Event|0
6836448|NCT00243230|10841879|FG001|Open Label Period|Adverse Event|0
6836449|NCT00243230|10841880|FG002|Open Label Period|Adverse Event|0
6836450|NCT00243230|10841881|FG003|Open Label Period|Adverse Event|2
6836451|NCT00243230|10841878|FG000|Open Label Period|Treatment Failure - Virologic Failure|0
6836452|NCT00243230|10841879|FG001|Open Label Period|Treatment Failure - Virologic Failure|0
6836453|NCT00243230|10841880|FG002|Open Label Period|Treatment Failure - Virologic Failure|0
6836454|NCT00243230|10841881|FG003|Open Label Period|Treatment Failure - Virologic Failure|13
6836455|NCT00243230|10841878|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0
6836456|NCT00243230|10841879|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0
6836457|NCT00243230|10841880|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0
6836458|NCT00243230|10841881|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1
6836459|NCT00243230|10841878|FG000|Open Label Period|Lost to Follow-up|0
6836460|NCT00243230|10841879|FG001|Open Label Period|Lost to Follow-up|0
6836461|NCT00243230|10841880|FG002|Open Label Period|Lost to Follow-up|0
6836462|NCT00243230|10841881|FG003|Open Label Period|Lost to Follow-up|2
6836463|NCT00243230|10841878|FG000|Open Label Period|Withdrawal by Subject|0
6836464|NCT00243230|10841879|FG001|Open Label Period|Withdrawal by Subject|0
6836465|NCT00243230|10841880|FG002|Open Label Period|Withdrawal by Subject|0
6836466|NCT00243230|10841881|FG003|Open Label Period|Withdrawal by Subject|2
6836467|NCT00243230|10841878|FG000|Open Label Period|Protocol Violation|0
6836468|NCT00243230|10841879|FG001|Open Label Period|Protocol Violation|0
6836469|NCT00243230|10841880|FG002|Open Label Period|Protocol Violation|0
6836470|NCT00243230|10841881|FG003|Open Label Period|Protocol Violation|2
6836471|NCT00243230|10841878|FG000|Open Label Period|Administrative Reason|0
6836472|NCT00243230|10841879|FG001|Open Label Period|Administrative Reason|0
6836473|NCT00243230|10841880|FG002|Open Label Period|Administrative Reason|0
6836474|NCT00243230|10841881|FG003|Open Label Period|Administrative Reason|63
6836475|NCT00243269|10841904|FG000|Overall Study|Protocol Violation|2
6836476|NCT00243269|10841905|FG001|Overall Study|Protocol Violation|1
6836477|NCT00243269|10841906|FG002|Overall Study|Protocol Violation|0
6836478|NCT00243269|10841907|FG003|Overall Study|Protocol Violation|1
6836479|NCT00243269|10841904|FG000|Overall Study|Lost to Follow-up|1
7063777|NCT01953224|11162411|FG001|Overall Study|Withdrawal by Subject|2
7063778|NCT01953328|11162434|FG000|Overall Study|Withdrawal by Subject|0
6836480|NCT00243269|10841905|FG001|Overall Study|Lost to Follow-up|0
6836481|NCT00243269|10841906|FG002|Overall Study|Lost to Follow-up|1
6836482|NCT00243269|10841907|FG003|Overall Study|Lost to Follow-up|3
7063779|NCT01953328|11162435|FG001|Overall Study|Withdrawal by Subject|0
6836483|NCT00243347|10841917|FG000|Overall Study|Lack of Efficacy|4
6836484|NCT00243347|10841917|FG000|Overall Study|Adverse Event|2
6836485|NCT00243347|10841917|FG000|Overall Study|Death|1
6836486|NCT00243347|10841917|FG000|Overall Study|Withdrawal by Subject|5
6836487|NCT00243347|10841917|FG000|Overall Study|Condition worsened|7
6836488|NCT00243386|10841921|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1
6836489|NCT00243386|10841922|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
6836490|NCT00243386|10841923|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
6836491|NCT00243386|10841921|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1
6836492|NCT00243386|10841922|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
6836493|NCT00243386|10841923|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
6836494|NCT00243386|10841921|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2
6836495|NCT00243386|10841922|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0
6836496|NCT00243386|10841923|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0
6836497|NCT00243386|10841921|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1
6836498|NCT00243386|10841922|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
6836499|NCT00243386|10841923|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
6836500|NCT00243386|10841921|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1
6836501|NCT00243386|10841922|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
6836502|NCT00243386|10841923|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
6836503|NCT00243386|10841921|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1
6836504|NCT00243386|10841922|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
6836505|NCT00243386|10841923|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
6836506|NCT00243386|10841921|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
6836507|NCT00243386|10841922|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2
6836508|NCT00243386|10841923|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
6836509|NCT00243386|10841921|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
6836510|NCT00243386|10841922|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1
6836511|NCT00243386|10841923|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
6836512|NCT00243412|10841961|FG000|Overall Study|Death|0
6836513|NCT00243412|10841962|FG001|Overall Study|Death|1
6836514|NCT00243412|10841961|FG000|Overall Study|Adverse Event|4
6836515|NCT00243412|10841962|FG001|Overall Study|Adverse Event|2
6836516|NCT00243412|10841961|FG000|Overall Study|Lost to Follow-up|0
6836517|NCT00243412|10841962|FG001|Overall Study|Lost to Follow-up|1
6836518|NCT00243412|10841961|FG000|Overall Study|Physician Decision|1
6836519|NCT00243412|10841962|FG001|Overall Study|Physician Decision|1
6836520|NCT00243412|10841961|FG000|Overall Study|Withdrawal by Subject|4
6836521|NCT00243412|10841962|FG001|Overall Study|Withdrawal by Subject|5
6836522|NCT00243412|10841961|FG000|Overall Study|Other|1
6836523|NCT00243412|10841962|FG001|Overall Study|Other|1
6836524|NCT00243503|10841968|FG000|Overall Study|Adverse Event|11
6836525|NCT00243503|10841968|FG000|Overall Study|Withdrawal by Subject|1
6836526|NCT00243503|10841968|FG000|Overall Study|Lack of Efficacy|44
6836527|NCT00243503|10841968|FG000|Overall Study|Death|1
6836528|NCT00243503|10841968|FG000|Overall Study|Other|1
6836529|NCT00243659|10841975|FG000|Overall Study|Withdrawal by Subject|1
6836530|NCT00243659|10841976|FG001|Overall Study|Withdrawal by Subject|1
6836531|NCT00243659|10841975|FG000|Overall Study|Protocol Violation|1
6836532|NCT00243659|10841976|FG001|Overall Study|Protocol Violation|2
6836533|NCT00243841|10841985|FG000|Overall Study|Physician Decision|0
6836534|NCT00243841|10841986|FG001|Overall Study|Physician Decision|0
6836535|NCT00243841|10841987|FG002|Overall Study|Physician Decision|1
6836536|NCT00243841|10841988|FG003|Overall Study|Physician Decision|0
6836537|NCT00243841|10841989|FG004|Overall Study|Physician Decision|0
6836538|NCT00243841|10841990|FG005|Overall Study|Physician Decision|2
6836539|NCT00243919|10842009|FG000|Overall Study|Death|3
6836540|NCT00243919|10842010|FG001|Overall Study|Death|4
6836541|NCT00243919|10842011|FG002|Overall Study|Death|6
6836542|NCT00243919|10842009|FG000|Overall Study|Withdrawal by Subject|6
6836543|NCT00243919|10842010|FG001|Overall Study|Withdrawal by Subject|6
6836544|NCT00243919|10842011|FG002|Overall Study|Withdrawal by Subject|2
6836545|NCT00243919|10842009|FG000|Overall Study|Lost to Follow-up|6
6836546|NCT00243919|10842010|FG001|Overall Study|Lost to Follow-up|7
6836547|NCT00243919|10842011|FG002|Overall Study|Lost to Follow-up|3
6836548|NCT00243919|10842009|FG000|Overall Study|Administrative Error|1
6836549|NCT00243919|10842010|FG001|Overall Study|Administrative Error|0
6836550|NCT00243919|10842011|FG002|Overall Study|Administrative Error|0
6836551|NCT00243919|10842009|FG000|Overall Study|Physician Decision|1
6836552|NCT00243919|10842010|FG001|Overall Study|Physician Decision|1
6836553|NCT00243919|10842011|FG002|Overall Study|Physician Decision|0
6836554|NCT00243932|10842022|FG000|Stage 1: Dose Selection|Lost to Follow-up|2
6836555|NCT00243932|10842023|FG001|Stage 1: Dose Selection|Lost to Follow-up|0
6836556|NCT00243932|10842024|FG002|Stage 1: Dose Selection|Lost to Follow-up|0
6836557|NCT00244374|10842054|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105
6836558|NCT00244374|10842055|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
6836559|NCT00244374|10842056|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
6836560|NCT00244374|10842057|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
6836561|NCT00244374|10842058|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
6836562|NCT00244374|10842054|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17
6836563|NCT00244374|10842055|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
6836564|NCT00244374|10842056|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
6836565|NCT00244374|10842057|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
6836566|NCT00244374|10842058|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
6836567|NCT00244374|10842054|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14
6836568|NCT00244374|10842055|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
6836569|NCT00244374|10842056|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
6836570|NCT00244374|10842057|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
6836571|NCT00244374|10842058|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
6836572|NCT00244374|10842054|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1
6836573|NCT00244374|10842055|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
6836574|NCT00244374|10842056|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
6836575|NCT00244374|10842057|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
6836576|NCT00244374|10842058|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
6836577|NCT00244374|10842054|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172
6836578|NCT00244374|10842055|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
6836579|NCT00244374|10842056|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
6836580|NCT00244374|10842057|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
6836581|NCT00244374|10842058|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
6836582|NCT00244374|10842054|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51
6836583|NCT00244374|10842055|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
6836584|NCT00244374|10842056|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
6836585|NCT00244374|10842057|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
6836586|NCT00244374|10842058|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
6836587|NCT00244374|10842054|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34
6836588|NCT00244374|10842055|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
6836589|NCT00244374|10842056|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
6836590|NCT00244374|10842057|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
6836591|NCT00244374|10842058|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
6836592|NCT00244374|10842054|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4
6836593|NCT00244374|10842055|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
6836594|NCT00244374|10842056|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
6836595|NCT00244374|10842057|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
6836596|NCT00244374|10842058|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
6836597|NCT00244374|10842054|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12
6836598|NCT00244374|10842055|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
6836599|NCT00244374|10842056|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
6926638|NCT00840034|10957153|FG000|Acute Treatment Phase|Lost to Follow-up|5
6926639|NCT00840034|10957154|FG001|Acute Treatment Phase|Lost to Follow-up|12
7039474|NCT01710358|11122157|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10
7063780|NCT01953328|11162436|FG002|Overall Study|Withdrawal by Subject|0
6926640|NCT00840034|10957153|FG000|Acute Treatment Phase|Physician Decision|0
6926641|NCT00840034|10957154|FG001|Acute Treatment Phase|Physician Decision|1
6926642|NCT00840034|10957153|FG000|Acute Treatment Phase|Protocol Violation|2
6926643|NCT00840034|10957154|FG001|Acute Treatment Phase|Protocol Violation|4
6926644|NCT00840034|10957153|FG000|Acute Treatment Phase|Withdrawal by Subject|6
6926645|NCT00840034|10957154|FG001|Acute Treatment Phase|Withdrawal by Subject|11
6926646|NCT00840034|10957153|FG000|Taper Phase|Adverse Event|1
6926647|NCT00840034|10957154|FG001|Taper Phase|Adverse Event|0
6926648|NCT00840034|10957153|FG000|Taper Phase|Lost to Follow-up|1
6926649|NCT00840034|10957154|FG001|Taper Phase|Lost to Follow-up|1
6926650|NCT00840034|10957153|FG000|Taper Phase|Withdrawal by Subject|1
6926651|NCT00840034|10957154|FG001|Taper Phase|Withdrawal by Subject|1
6926652|NCT00840060|10957164|FG000|Overall Study|Withdrawal by Subject|1
6926653|NCT00840060|10957165|FG001|Overall Study|Withdrawal by Subject|0
6926654|NCT00840060|10957164|FG000|Overall Study|Change in emotional/behavioral status|0
6926655|NCT00840060|10957165|FG001|Overall Study|Change in emotional/behavioral status|1
6926656|NCT00840086|10957171|FG000|Overall Study|Adverse Event|1
6926657|NCT00840086|10957171|FG000|Overall Study|Protocol Violation|2
6926658|NCT00840086|10957171|FG000|Overall Study|Lost to Follow-up|1
6926659|NCT00840294|10957180|FG000|Overall Study|Withdrawal by Subject|2
7044789|NCT01757197|11130775|FG000|Overall Study|Death|2
7063781|NCT01953328|11162437|FG003|Overall Study|Withdrawal by Subject|0
7063782|NCT01953328|11162438|FG004|Overall Study|Withdrawal by Subject|1
6836600|NCT00244374|10842057|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
6836601|NCT00244374|10842058|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
6836602|NCT00244621|10842077|FG000|Double-blind Treatment Period|Lost to Follow-up|0
6836603|NCT00244621|10842078|FG001|Double-blind Treatment Period|Lost to Follow-up|0
6836604|NCT00244621|10842079|FG002|Double-blind Treatment Period|Lost to Follow-up|1
6836605|NCT00244621|10842077|FG000|Double-blind Treatment Period|Withdrawal by Subject|0
6836606|NCT00244621|10842078|FG001|Double-blind Treatment Period|Withdrawal by Subject|1
6836607|NCT00244621|10842079|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
6836608|NCT00244621|10842077|FG000|Double-blind Treatment Period|Lack of Efficacy|0
6836609|NCT00244621|10842078|FG001|Double-blind Treatment Period|Lack of Efficacy|1
6836610|NCT00244621|10842079|FG002|Double-blind Treatment Period|Lack of Efficacy|0
6836611|NCT00244621|10842077|FG000|Double-blind Treatment Period|Multiple Reasons|2
6836612|NCT00244621|10842078|FG001|Double-blind Treatment Period|Multiple Reasons|1
6836613|NCT00244621|10842079|FG002|Double-blind Treatment Period|Multiple Reasons|1
6836614|NCT00244621|10842077|FG000|Open-label Treatment Period|Lost to Follow-up|0
6836615|NCT00244621|10842078|FG001|Open-label Treatment Period|Lost to Follow-up|1
6836616|NCT00244621|10842079|FG002|Open-label Treatment Period|Lost to Follow-up|0
6836617|NCT00244621|10842077|FG000|Open-label Treatment Period|Withdrawal by Subject|1
6836618|NCT00244621|10842078|FG001|Open-label Treatment Period|Withdrawal by Subject|0
6836619|NCT00244621|10842079|FG002|Open-label Treatment Period|Withdrawal by Subject|0
6836620|NCT00244621|10842077|FG000|Open-label Treatment Period|Adverse Event|0
6836621|NCT00244621|10842078|FG001|Open-label Treatment Period|Adverse Event|0
6836622|NCT00244621|10842079|FG002|Open-label Treatment Period|Adverse Event|1
6836623|NCT00244621|10842077|FG000|Open-label Treatment Period|Moved abroad|0
6836624|NCT00244621|10842078|FG001|Open-label Treatment Period|Moved abroad|0
6836625|NCT00244621|10842079|FG002|Open-label Treatment Period|Moved abroad|1
6836626|NCT00244712|10842089|FG000|Overall Study|Adverse Event|20
6836627|NCT00244712|10842090|FG001|Overall Study|Adverse Event|21
6836628|NCT00244712|10842089|FG000|Overall Study|Protocol-Defined Virologic Failure|8
6836629|NCT00244712|10842090|FG001|Overall Study|Protocol-Defined Virologic Failure|6
6836630|NCT00244712|10842089|FG000|Overall Study|Lack of Compliance|10
6836631|NCT00244712|10842090|FG001|Overall Study|Lack of Compliance|11
6836632|NCT00244712|10842089|FG000|Overall Study|Lost to Follow-up|45
6836633|NCT00244712|10842090|FG001|Overall Study|Lost to Follow-up|52
6836634|NCT00244712|10842089|FG000|Overall Study|Withdrawal by Subject|13
6836635|NCT00244712|10842090|FG001|Overall Study|Withdrawal by Subject|23
6836636|NCT00244712|10842089|FG000|Overall Study|Protocol Violation, disease progression|13
6836637|NCT00244712|10842090|FG001|Overall Study|Protocol Violation, disease progression|11
6836638|NCT00244725|10842100|FG000|Overall Study|Lost to Follow-up|3
6836639|NCT00244725|10842101|FG001|Overall Study|Lost to Follow-up|4
6836640|NCT00244725|10842102|FG002|Overall Study|Lost to Follow-up|9
6836641|NCT00244725|10842103|FG003|Overall Study|Lost to Follow-up|2
6836642|NCT00244725|10842100|FG000|Overall Study|Withdrawal by Subject|9
6836643|NCT00244725|10842101|FG001|Overall Study|Withdrawal by Subject|7
6836644|NCT00244725|10842102|FG002|Overall Study|Withdrawal by Subject|7
6836645|NCT00244725|10842103|FG003|Overall Study|Withdrawal by Subject|8
6836646|NCT00244725|10842100|FG000|Overall Study|Not meet treatment eligibility criteria|1
6836647|NCT00244725|10842101|FG001|Overall Study|Not meet treatment eligibility criteria|2
6836648|NCT00244725|10842102|FG002|Overall Study|Not meet treatment eligibility criteria|0
6836649|NCT00244725|10842103|FG003|Overall Study|Not meet treatment eligibility criteria|0
6836650|NCT00244725|10842100|FG000|Overall Study|Physician Decision|3
6836651|NCT00244725|10842101|FG001|Overall Study|Physician Decision|0
6836652|NCT00244725|10842102|FG002|Overall Study|Physician Decision|1
6836653|NCT00244725|10842103|FG003|Overall Study|Physician Decision|2
6836654|NCT00244725|10842100|FG000|Overall Study|Adverse Events|3
6836655|NCT00244725|10842101|FG001|Overall Study|Adverse Events|1
6836656|NCT00244725|10842102|FG002|Overall Study|Adverse Events|4
6836657|NCT00244725|10842103|FG003|Overall Study|Adverse Events|4
6836658|NCT00244725|10842100|FG000|Overall Study|Withdrwal by participant|1
6836659|NCT00244725|10842101|FG001|Overall Study|Withdrwal by participant|0
6836660|NCT00244725|10842102|FG002|Overall Study|Withdrwal by participant|0
6836661|NCT00244725|10842103|FG003|Overall Study|Withdrwal by participant|1
6836662|NCT00244725|10842100|FG000|Overall Study|Liver function test abnormality|2
6836663|NCT00244725|10842101|FG001|Overall Study|Liver function test abnormality|0
6836664|NCT00244725|10842102|FG002|Overall Study|Liver function test abnormality|0
6836665|NCT00244725|10842103|FG003|Overall Study|Liver function test abnormality|1
6836666|NCT00244725|10842100|FG000|Overall Study|Sponsor withdrew the participant|1
6836667|NCT00244725|10842101|FG001|Overall Study|Sponsor withdrew the participant|0
6836668|NCT00244725|10842102|FG002|Overall Study|Sponsor withdrew the participant|0
6836669|NCT00244725|10842103|FG003|Overall Study|Sponsor withdrew the participant|1
6836670|NCT00244725|10842100|FG000|Overall Study|Mediciation Error|0
6836671|NCT00244725|10842101|FG001|Overall Study|Mediciation Error|1
6836672|NCT00244725|10842102|FG002|Overall Study|Mediciation Error|0
6836673|NCT00244725|10842103|FG003|Overall Study|Mediciation Error|0
6836674|NCT00244725|10842100|FG000|Overall Study|Rehab Refused to allow participantion|0
6836675|NCT00244725|10842101|FG001|Overall Study|Rehab Refused to allow participantion|1
6836676|NCT00244725|10842102|FG002|Overall Study|Rehab Refused to allow participantion|0
6836677|NCT00244725|10842103|FG003|Overall Study|Rehab Refused to allow participantion|0
6836678|NCT00244725|10842100|FG000|Overall Study|Headache|0
6836679|NCT00244725|10842101|FG001|Overall Study|Headache|1
6836680|NCT00244725|10842102|FG002|Overall Study|Headache|0
6836681|NCT00244725|10842103|FG003|Overall Study|Headache|0
6836682|NCT00244725|10842100|FG000|Overall Study|Received prohibited medication|0
6836683|NCT00244725|10842101|FG001|Overall Study|Received prohibited medication|1
6836684|NCT00244725|10842102|FG002|Overall Study|Received prohibited medication|0
6836685|NCT00244725|10842103|FG003|Overall Study|Received prohibited medication|1
6836686|NCT00244725|10842100|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0
6836687|NCT00244725|10842101|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1
6836688|NCT00244725|10842102|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0
6836689|NCT00244725|10842103|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0
6836690|NCT00244725|10842100|FG000|Overall Study|Administrative reason|0
6836691|NCT00244725|10842101|FG001|Overall Study|Administrative reason|0
6836692|NCT00244725|10842102|FG002|Overall Study|Administrative reason|1
7063783|NCT01953328|11162439|FG005|Overall Study|Withdrawal by Subject|0
7063784|NCT01953328|11162440|FG006|Overall Study|Withdrawal by Subject|0
7063785|NCT01953328|11162441|FG007|Overall Study|Withdrawal by Subject|0
7063786|NCT01953328|11162434|FG000|Overall Study|Lost to Follow-up|0
7063787|NCT01953328|11162435|FG001|Overall Study|Lost to Follow-up|0
7063788|NCT01953328|11162436|FG002|Overall Study|Lost to Follow-up|0
7063789|NCT01953328|11162437|FG003|Overall Study|Lost to Follow-up|0
7063790|NCT01953328|11162438|FG004|Overall Study|Lost to Follow-up|1
7063791|NCT01953328|11162439|FG005|Overall Study|Lost to Follow-up|0
7063792|NCT01953328|11162440|FG006|Overall Study|Lost to Follow-up|0
6836693|NCT00244725|10842103|FG003|Overall Study|Administrative reason|0
6836694|NCT00244725|10842100|FG000|Overall Study|Vomit|0
6836695|NCT00244725|10842101|FG001|Overall Study|Vomit|0
6836696|NCT00244725|10842102|FG002|Overall Study|Vomit|1
6836697|NCT00244725|10842103|FG003|Overall Study|Vomit|0
6836698|NCT00244725|10842100|FG000|Overall Study|Failed to follow-up|0
6926660|NCT00840294|10957181|FG001|Overall Study|Withdrawal by Subject|1
6926661|NCT00840294|10957180|FG000|Overall Study|Protocol Violation|1
6926662|NCT00840294|10957181|FG001|Overall Study|Protocol Violation|3
6926663|NCT00840294|10957180|FG000|Overall Study|Illness|0
6926664|NCT00840294|10957181|FG001|Overall Study|Illness|1
6926665|NCT00840450|10957191|FG000|Overall Study|Adverse Event|1
6926666|NCT00840450|10957191|FG000|Overall Study|Lack of Efficacy|2
6926667|NCT00840463|10957197|FG000|Overall Study|Adverse Event|1
6926668|NCT00840463|10957198|FG001|Overall Study|Adverse Event|0
6926669|NCT00840658|10957208|FG000|Overall Study|Death|2
6926670|NCT00840658|10957209|FG001|Overall Study|Death|2
6926671|NCT00840658|10957210|FG002|Overall Study|Death|3
6926672|NCT00840658|10957211|FG003|Overall Study|Death|3
6926673|NCT00840658|10957208|FG000|Overall Study|Lost to Follow-up|3
6926674|NCT00840658|10957209|FG001|Overall Study|Lost to Follow-up|1
6926675|NCT00840658|10957210|FG002|Overall Study|Lost to Follow-up|2
6926676|NCT00840658|10957211|FG003|Overall Study|Lost to Follow-up|1
6926677|NCT00840749|10957227|FG000|Overall Study|Death|1
6926678|NCT00840749|10957228|FG001|Overall Study|Death|2
6926679|NCT00840749|10957227|FG000|Overall Study|not treated on study arm|11
6926680|NCT00840749|10957228|FG001|Overall Study|not treated on study arm|11
6926681|NCT00840749|10957227|FG000|Overall Study|study closed|19
6926682|NCT00840749|10957228|FG001|Overall Study|study closed|14
6926683|NCT00840970|10957234|FG000|Overall Study|Adverse Event|0
6926684|NCT00840970|10957235|FG001|Overall Study|Adverse Event|0
6926685|NCT00840970|10957236|FG002|Overall Study|Adverse Event|1
6926686|NCT00840996|10957248|FG000|Overall Study|Withdrawal by Subject|1
6926687|NCT00840996|10957249|FG001|Overall Study|Withdrawal by Subject|0
6926688|NCT00841100|10957264|FG000|Phase 1 (28 Days)|Adverse Event|1
6926689|NCT00841100|10957264|FG000|Phase 1 (28 Days)|Participant non-compliance|2
6926690|NCT00841321|10957289|FG000|Overall Study|Lost to Follow-up|1
6926691|NCT00841321|10957290|FG001|Overall Study|Lost to Follow-up|1
6926692|NCT00841321|10957289|FG000|Overall Study|Adverse Event|0
6926693|NCT00841321|10957290|FG001|Overall Study|Adverse Event|2
6926694|NCT00841568|10957314|FG000|Overall Study|Adverse Event|1
6926695|NCT00841568|10957314|FG000|Overall Study|Death|1
6926696|NCT00841568|10957314|FG000|Overall Study|Withdrawal by Subject|2
6926697|NCT00841568|10957314|FG000|Overall Study|Creatinine over the withdrawal criteria|1
6926698|NCT00841672|10957324|FG000|Overall Study|Adverse Event|7
6926699|NCT00841672|10957325|FG001|Overall Study|Adverse Event|16
6926700|NCT00841672|10957324|FG000|Overall Study|Abnormal test procedure result(s)|0
6926701|NCT00841672|10957325|FG001|Overall Study|Abnormal test procedure result(s)|1
6926702|NCT00841672|10957324|FG000|Overall Study|Subject withdrew consent|2
7063793|NCT01953328|11162441|FG007|Overall Study|Lost to Follow-up|0
7063794|NCT01953354|11162461|FG000|Overall Study|Withdrawal by Subject|0
7063795|NCT01953354|11162462|FG001|Overall Study|Withdrawal by Subject|1
7063796|NCT01953354|11162461|FG000|Overall Study|Decision of Sponsor|0
6836699|NCT00244725|10842101|FG001|Overall Study|Failed to follow-up|0
6836700|NCT00244725|10842102|FG002|Overall Study|Failed to follow-up|1
6836701|NCT00244725|10842103|FG003|Overall Study|Failed to follow-up|1
6836702|NCT00244751|10842116|FG000|Overall Study|Adverse Event|7
6926703|NCT00841672|10957325|FG001|Overall Study|Subject withdrew consent|4
6926704|NCT00841672|10957324|FG000|Overall Study|Lost to Follow-up|1
6926705|NCT00841672|10957325|FG001|Overall Study|Lost to Follow-up|1
6926706|NCT00841672|10957324|FG000|Overall Study|Administrative problems|9
6836703|NCT00244751|10842117|FG001|Overall Study|Adverse Event|7
6836704|NCT00244751|10842118|FG002|Overall Study|Adverse Event|5
6836705|NCT00244751|10842116|FG000|Overall Study|Lost to Follow-up|0
6836706|NCT00244751|10842117|FG001|Overall Study|Lost to Follow-up|1
6836707|NCT00244751|10842118|FG002|Overall Study|Lost to Follow-up|0
6836708|NCT00244751|10842116|FG000|Overall Study|Protocol Violation|1
6836709|NCT00244751|10842117|FG001|Overall Study|Protocol Violation|0
6836710|NCT00244751|10842118|FG002|Overall Study|Protocol Violation|1
6836711|NCT00244751|10842116|FG000|Overall Study|Withdrawal by Subject|7
6836712|NCT00244751|10842117|FG001|Overall Study|Withdrawal by Subject|5
6836713|NCT00244751|10842118|FG002|Overall Study|Withdrawal by Subject|3
6836714|NCT00244751|10842116|FG000|Overall Study|Elevated liver enzymes|1
6836715|NCT00244751|10842117|FG001|Overall Study|Elevated liver enzymes|0
6836716|NCT00244751|10842118|FG002|Overall Study|Elevated liver enzymes|0
6836717|NCT00244751|10842116|FG000|Overall Study|Lack of compliance with protocol|0
6836718|NCT00244751|10842117|FG001|Overall Study|Lack of compliance with protocol|1
6836719|NCT00244751|10842118|FG002|Overall Study|Lack of compliance with protocol|0
6836720|NCT00244751|10842116|FG000|Overall Study|Safety reasons|0
6836721|NCT00244751|10842117|FG001|Overall Study|Safety reasons|1
6836722|NCT00244751|10842118|FG002|Overall Study|Safety reasons|0
6836723|NCT00244751|10842116|FG000|Overall Study|Participant randomized by mistake|0
6836724|NCT00244751|10842117|FG001|Overall Study|Participant randomized by mistake|0
6836725|NCT00244751|10842118|FG002|Overall Study|Participant randomized by mistake|1
6836726|NCT00244764|10842135|FG000|Overall Study|Adverse Event|37
7063797|NCT01953354|11162462|FG001|Overall Study|Decision of Sponsor|1
7063798|NCT01953354|11162461|FG000|Overall Study|Disease Exacerbation|1
7063799|NCT01953354|11162462|FG001|Overall Study|Disease Exacerbation|0
7063800|NCT01953601|11162493|FG000|Part 1 (Base Study)|Adverse Event|24
7063801|NCT01953601|11162494|FG001|Part 1 (Base Study)|Adverse Event|37
7063802|NCT01953601|11162495|FG002|Part 1 (Base Study)|Adverse Event|15
7063803|NCT01953601|11162493|FG000|Part 1 (Base Study)|Death|2
7063804|NCT01953601|11162494|FG001|Part 1 (Base Study)|Death|0
7063805|NCT01953601|11162495|FG002|Part 1 (Base Study)|Death|3
7063806|NCT01953601|11162493|FG000|Part 1 (Base Study)|Lack of Efficacy|3
7063807|NCT01953601|11162494|FG001|Part 1 (Base Study)|Lack of Efficacy|1
7063808|NCT01953601|11162495|FG002|Part 1 (Base Study)|Lack of Efficacy|4
7063809|NCT01953601|11162493|FG000|Part 1 (Base Study)|Lost to Follow-up|1
7063810|NCT01953601|11162494|FG001|Part 1 (Base Study)|Lost to Follow-up|3
7063811|NCT01953601|11162495|FG002|Part 1 (Base Study)|Lost to Follow-up|6
7063812|NCT01953601|11162493|FG000|Part 1 (Base Study)|Non-compliance with study drug|0
7063813|NCT01953601|11162494|FG001|Part 1 (Base Study)|Non-compliance with study drug|3
7063814|NCT01953601|11162495|FG002|Part 1 (Base Study)|Non-compliance with study drug|1
7063815|NCT01953601|11162493|FG000|Part 1 (Base Study)|Physician Decision|3
7063816|NCT01953601|11162494|FG001|Part 1 (Base Study)|Physician Decision|7
7063817|NCT01953601|11162495|FG002|Part 1 (Base Study)|Physician Decision|4
7063818|NCT01953601|11162493|FG000|Part 1 (Base Study)|Screen failure|1
7063819|NCT01953601|11162494|FG001|Part 1 (Base Study)|Screen failure|0
7063820|NCT01953601|11162495|FG002|Part 1 (Base Study)|Screen failure|1
7063821|NCT01953601|11162493|FG000|Part 1 (Base Study)|Site discontinued study participation|2
7063822|NCT01953601|11162494|FG001|Part 1 (Base Study)|Site discontinued study participation|0
7063823|NCT01953601|11162495|FG002|Part 1 (Base Study)|Site discontinued study participation|0
7063824|NCT01953601|11162493|FG000|Part 1 (Base Study)|Study terminated by sponsor|174
7063825|NCT01953601|11162494|FG001|Part 1 (Base Study)|Study terminated by sponsor|169
7063826|NCT01953601|11162495|FG002|Part 1 (Base Study)|Study terminated by sponsor|179
7063827|NCT01953601|11162493|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7
7063828|NCT01953601|11162494|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8
7063829|NCT01953601|11162495|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10
7063830|NCT01953601|11162493|FG000|Part 1 (Base Study)|Subject moved|2
7063831|NCT01953601|11162494|FG001|Part 1 (Base Study)|Subject moved|2
7063832|NCT01953601|11162495|FG002|Part 1 (Base Study)|Subject moved|1
7063833|NCT01953601|11162493|FG000|Part 1 (Base Study)|Withdrawal by Subject|32
7063834|NCT01953601|11162494|FG001|Part 1 (Base Study)|Withdrawal by Subject|23
7063835|NCT01953601|11162495|FG002|Part 1 (Base Study)|Withdrawal by Subject|22
7063836|NCT01953601|11162493|FG000|Part 2 (Extension Study)|Adverse Event|1
7063837|NCT01953601|11162494|FG001|Part 2 (Extension Study)|Adverse Event|1
6836727|NCT00244764|10842135|FG000|Overall Study|Lost to Follow-up|23
6836728|NCT00244764|10842135|FG000|Overall Study|Withdrawal by Subject|12
6836729|NCT00244764|10842135|FG000|Overall Study|Disease Progression|13
6836730|NCT00244764|10842135|FG000|Overall Study|Protocol Violation|2
6836731|NCT00244764|10842135|FG000|Overall Study|Death|1
6836732|NCT00244764|10842135|FG000|Overall Study|Off Study Medication for >21 Days|1
6836733|NCT00244764|10842135|FG000|Overall Study|Declining Performance Status|1
6836734|NCT00244764|10842135|FG000|Overall Study|Participant was Hospitalized until Death|1
7063838|NCT01953601|11162495|FG002|Part 2 (Extension Study)|Adverse Event|10
7063839|NCT01953601|11162493|FG000|Part 2 (Extension Study)|Death|0
7063840|NCT01953601|11162494|FG001|Part 2 (Extension Study)|Death|3
6836735|NCT00244764|10842135|FG000|Overall Study|Primary Investigator Discretion|2
7063841|NCT01953601|11162495|FG002|Part 2 (Extension Study)|Death|0
7063842|NCT01953601|11162493|FG000|Part 2 (Extension Study)|Lack of Efficacy|2
7063843|NCT01953601|11162494|FG001|Part 2 (Extension Study)|Lack of Efficacy|0
7063844|NCT01953601|11162495|FG002|Part 2 (Extension Study)|Lack of Efficacy|0
6836736|NCT00244764|10842135|FG000|Overall Study|Sponsor Terminated Study|2
6836737|NCT00244764|10842135|FG000|Overall Study|Developed Secondary Malignancy|1
6836738|NCT00244855|10842142|FG000|Overall Study|Withdrawal by Subject|0
6836739|NCT00244855|10842143|FG001|Overall Study|Withdrawal by Subject|1
6836740|NCT00244881|10842151|FG000|Overall Study|Withdrawal by Subject|3
6836741|NCT00244933|10842155|FG000|Overall Study|Not response evaluable|2
6836742|NCT00245011|10842163|FG000|Overall Study|Lack of Efficacy|1
6897471|NCT00640835|10916596|FG000|Overall Study|Other Reason|19
6897472|NCT00640835|10916597|FG001|Overall Study|Other Reason|4
6897473|NCT00640926|10916606|FG000|Overall Study|Adverse Event|2
6897474|NCT00640926|10916607|FG001|Overall Study|Adverse Event|3
6897475|NCT00640926|10916608|FG002|Overall Study|Adverse Event|2
6897476|NCT00640926|10916606|FG000|Overall Study|Lack of Efficacy|0
6897477|NCT00640926|10916607|FG001|Overall Study|Lack of Efficacy|2
6897478|NCT00640926|10916608|FG002|Overall Study|Lack of Efficacy|1
6897479|NCT00640926|10916606|FG000|Overall Study|Protocol Violation|2
6897480|NCT00640926|10916607|FG001|Overall Study|Protocol Violation|0
6897481|NCT00640926|10916608|FG002|Overall Study|Protocol Violation|2
6897482|NCT00640926|10916606|FG000|Overall Study|Lost to Follow-up|3
6897483|NCT00640926|10916607|FG001|Overall Study|Lost to Follow-up|1
6897484|NCT00640926|10916608|FG002|Overall Study|Lost to Follow-up|2
6897485|NCT00640926|10916606|FG000|Overall Study|Withdrawal by Subject|1
6897486|NCT00640926|10916607|FG001|Overall Study|Withdrawal by Subject|0
6897487|NCT00640926|10916608|FG002|Overall Study|Withdrawal by Subject|1
6897488|NCT00641043|10916622|FG000|Overall Study|Adverse Event|6
6897489|NCT00641043|10916623|FG001|Overall Study|Adverse Event|4
6897490|NCT00641043|10916622|FG000|Overall Study|Protocol Violation|2
6897491|NCT00641043|10916623|FG001|Overall Study|Protocol Violation|3
6897492|NCT00641043|10916622|FG000|Overall Study|Lost to Follow-up|3
6897493|NCT00641043|10916623|FG001|Overall Study|Lost to Follow-up|2
6897494|NCT00641043|10916622|FG000|Overall Study|Withdrawal by Subject|4
6897495|NCT00641043|10916623|FG001|Overall Study|Withdrawal by Subject|4
6897496|NCT00641043|10916622|FG000|Overall Study|Other incl. lack of efficacy|4
6897497|NCT00641043|10916623|FG001|Overall Study|Other incl. lack of efficacy|2
6897498|NCT00641056|10916631|FG000|Overall Study|Adverse Event|12
6897499|NCT00641056|10916632|FG001|Overall Study|Adverse Event|2
6897500|NCT00641056|10916631|FG000|Overall Study|Lost to Follow-up|2
6897501|NCT00641056|10916632|FG001|Overall Study|Lost to Follow-up|1
6897502|NCT00641056|10916631|FG000|Overall Study|Physician Decision|3
6897503|NCT00641056|10916632|FG001|Overall Study|Physician Decision|1
6897504|NCT00641056|10916631|FG000|Overall Study|Protocol Violation|2
6897505|NCT00641056|10916632|FG001|Overall Study|Protocol Violation|0
6897506|NCT00641056|10916631|FG000|Overall Study|Entry Criteria Not Met|3
6897507|NCT00641056|10916632|FG001|Overall Study|Entry Criteria Not Met|0
6897508|NCT00641056|10916631|FG000|Overall Study|Subject Decision|6
6897509|NCT00641056|10916632|FG001|Overall Study|Subject Decision|19
6926707|NCT00841672|10957325|FG001|Overall Study|Administrative problems|9
6926708|NCT00841672|10957324|FG000|Overall Study|Misrandomized|1
6926709|NCT00841672|10957325|FG001|Overall Study|Misrandomized|0
6926710|NCT00841672|10957324|FG000|Overall Study|Protocol Deviation|0
6926711|NCT00841672|10957325|FG001|Overall Study|Protocol Deviation|1
6926712|NCT00841763|10957333|FG000|Overall Study|Withdrawal by Subject|60
6926713|NCT00841763|10957334|FG001|Overall Study|Withdrawal by Subject|17
6926714|NCT00841763|10957335|FG002|Overall Study|Withdrawal by Subject|4
6926715|NCT00841763|10957336|FG003|Overall Study|Withdrawal by Subject|1
6926716|NCT00841763|10957333|FG000|Overall Study|Adverse Event|9
6926717|NCT00841763|10957334|FG001|Overall Study|Adverse Event|10
6926718|NCT00841763|10957335|FG002|Overall Study|Adverse Event|3
6926719|NCT00841763|10957336|FG003|Overall Study|Adverse Event|2
6926720|NCT00841763|10957333|FG000|Overall Study|Lost to Follow-up|63
6926721|NCT00841763|10957334|FG001|Overall Study|Lost to Follow-up|25
6926722|NCT00841763|10957335|FG002|Overall Study|Lost to Follow-up|0
6926723|NCT00841763|10957336|FG003|Overall Study|Lost to Follow-up|0
6926724|NCT00841763|10957333|FG000|Overall Study|Protocol Violation|20
6926725|NCT00841763|10957334|FG001|Overall Study|Protocol Violation|3
7039475|NCT01710358|11122158|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16
7082405|NCT02141672|11192948|FG000|Overall Study|Adverse Event|0
6897510|NCT00641056|10916631|FG000|Overall Study|Sponsor Decision|1
6926726|NCT00841763|10957335|FG002|Overall Study|Protocol Violation|1
6926727|NCT00841763|10957336|FG003|Overall Study|Protocol Violation|0
6926728|NCT00841763|10957333|FG000|Overall Study|Administrative Reasons|3
6897511|NCT00641056|10916632|FG001|Overall Study|Sponsor Decision|2
6897512|NCT00641147|10916644|FG000|Completed 4 Months.|Physician Decision|1
6897513|NCT00641147|10916645|FG001|Completed 4 Months.|Physician Decision|0
6897514|NCT00641147|10916644|FG000|Completed 4 Months.|Adverse Event|1
6897515|NCT00641147|10916645|FG001|Completed 4 Months.|Adverse Event|0
6897516|NCT00641147|10916644|FG000|Completed 8 Months.|Physician Decision|2
6897517|NCT00641147|10916645|FG001|Completed 8 Months.|Physician Decision|1
6897518|NCT00641147|10916644|FG000|Completed 8 Months.|non compliance|1
6897519|NCT00641147|10916645|FG001|Completed 8 Months.|non compliance|0
6897520|NCT00641147|10916644|FG000|Completed 8 Months.|Withdrawal by Subject|0
6926729|NCT00841763|10957334|FG001|Overall Study|Administrative Reasons|1
6926730|NCT00841763|10957335|FG002|Overall Study|Administrative Reasons|0
6926731|NCT00841763|10957336|FG003|Overall Study|Administrative Reasons|0
6926732|NCT00841763|10957333|FG000|Overall Study|Unable to Classify|7
6836743|NCT00245037|10842167|FG000|Overall Study|Death|17
6836744|NCT00245050|10842173|FG000|Overall Study|Adverse Event|3
6836745|NCT00245050|10842174|FG001|Overall Study|Adverse Event|2
6836746|NCT00245063|10842182|FG000|Overall Study|Adverse Event|6
6836747|NCT00245063|10842183|FG001|Overall Study|Adverse Event|5
6836748|NCT00245063|10842182|FG000|Overall Study|Death|1
6836749|NCT00245063|10842183|FG001|Overall Study|Death|0
6836750|NCT00245102|10842195|FG000|Overall Study|Not Treated|1
6836751|NCT00245102|10842196|FG001|Overall Study|Not Treated|0
6836752|NCT00245102|10842197|FG002|Overall Study|Not Treated|1
6836753|NCT00245102|10842198|FG003|Overall Study|Not Treated|0
6836754|NCT00245102|10842199|FG004|Overall Study|Not Treated|0
6836755|NCT00245102|10842200|FG005|Overall Study|Not Treated|0
6836756|NCT00245102|10842195|FG000|Overall Study|Protocol Violation|1
6836757|NCT00245102|10842196|FG001|Overall Study|Protocol Violation|0
6836758|NCT00245102|10842197|FG002|Overall Study|Protocol Violation|0
6836759|NCT00245102|10842198|FG003|Overall Study|Protocol Violation|0
6836760|NCT00245102|10842199|FG004|Overall Study|Protocol Violation|0
6836761|NCT00245102|10842200|FG005|Overall Study|Protocol Violation|0
6836762|NCT00245102|10842195|FG000|Overall Study|Death|0
6836763|NCT00245102|10842196|FG001|Overall Study|Death|0
6836764|NCT00245102|10842197|FG002|Overall Study|Death|0
6836765|NCT00245102|10842198|FG003|Overall Study|Death|1
6836766|NCT00245102|10842199|FG004|Overall Study|Death|0
6836767|NCT00245102|10842200|FG005|Overall Study|Death|0
6836768|NCT00245102|10842195|FG000|Overall Study|Adverse Event|4
6836769|NCT00245102|10842196|FG001|Overall Study|Adverse Event|2
6836770|NCT00245102|10842197|FG002|Overall Study|Adverse Event|5
6836771|NCT00245102|10842198|FG003|Overall Study|Adverse Event|1
6836772|NCT00245102|10842199|FG004|Overall Study|Adverse Event|0
6836773|NCT00245102|10842200|FG005|Overall Study|Adverse Event|2
6836774|NCT00245102|10842195|FG000|Overall Study|Decline in performance|0
6836775|NCT00245102|10842196|FG001|Overall Study|Decline in performance|2
6836776|NCT00245102|10842197|FG002|Overall Study|Decline in performance|0
6836777|NCT00245102|10842198|FG003|Overall Study|Decline in performance|1
6836778|NCT00245102|10842199|FG004|Overall Study|Decline in performance|0
6836779|NCT00245102|10842200|FG005|Overall Study|Decline in performance|2
6836780|NCT00245102|10842195|FG000|Overall Study|Participant needed surgery|0
6836781|NCT00245102|10842196|FG001|Overall Study|Participant needed surgery|0
6836782|NCT00245102|10842197|FG002|Overall Study|Participant needed surgery|1
6836783|NCT00245102|10842198|FG003|Overall Study|Participant needed surgery|0
6836784|NCT00245102|10842199|FG004|Overall Study|Participant needed surgery|0
6836785|NCT00245102|10842200|FG005|Overall Study|Participant needed surgery|0
6836786|NCT00245102|10842195|FG000|Overall Study|Clinical progression|1
6836787|NCT00245102|10842196|FG001|Overall Study|Clinical progression|0
6836788|NCT00245102|10842197|FG002|Overall Study|Clinical progression|0
6836789|NCT00245102|10842198|FG003|Overall Study|Clinical progression|0
6836790|NCT00245102|10842199|FG004|Overall Study|Clinical progression|0
6836791|NCT00245102|10842200|FG005|Overall Study|Clinical progression|0
6836792|NCT00245466|10842230|FG000|Overall Study|Adverse Event|2
6836793|NCT00245466|10842231|FG001|Overall Study|Adverse Event|8
6836794|NCT00245466|10842232|FG002|Overall Study|Adverse Event|4
6836795|NCT00245466|10842230|FG000|Overall Study|Low prostate specific antigen suppr|16
6836796|NCT00245466|10842231|FG001|Overall Study|Low prostate specific antigen suppr|14
6836797|NCT00245466|10842232|FG002|Overall Study|Low prostate specific antigen suppr|5
6836798|NCT00245466|10842230|FG000|Overall Study|Insufficient testosterone suppr|12
6836799|NCT00245466|10842231|FG001|Overall Study|Insufficient testosterone suppr|12
6836800|NCT00245466|10842232|FG002|Overall Study|Insufficient testosterone suppr|21
6836801|NCT00245466|10842230|FG000|Overall Study|Insufficient PSA and testosterone suppr|0
6836802|NCT00245466|10842231|FG001|Overall Study|Insufficient PSA and testosterone suppr|0
6836803|NCT00245466|10842232|FG002|Overall Study|Insufficient PSA and testosterone suppr|3
6836804|NCT00245466|10842230|FG000|Overall Study|Withdrawal by Subject|2
6836805|NCT00245466|10842231|FG001|Overall Study|Withdrawal by Subject|2
6836806|NCT00245466|10842232|FG002|Overall Study|Withdrawal by Subject|1
6836807|NCT00245466|10842230|FG000|Overall Study|Lost to Follow-up|3
6836808|NCT00245466|10842231|FG001|Overall Study|Lost to Follow-up|0
6836809|NCT00245466|10842232|FG002|Overall Study|Lost to Follow-up|0
6836810|NCT00245466|10842230|FG000|Overall Study|Disease progression|0
6836811|NCT00245466|10842231|FG001|Overall Study|Disease progression|3
6836812|NCT00245466|10842232|FG002|Overall Study|Disease progression|1
6836813|NCT00245466|10842230|FG000|Overall Study|Protocol Violation|1
6836814|NCT00245466|10842231|FG001|Overall Study|Protocol Violation|2
6836815|NCT00245466|10842232|FG002|Overall Study|Protocol Violation|2
6836816|NCT00245466|10842230|FG000|Overall Study|Death|0
6836817|NCT00245466|10842231|FG001|Overall Study|Death|2
6836818|NCT00245466|10842232|FG002|Overall Study|Death|0
6836819|NCT00245466|10842230|FG000|Overall Study|Administrative reasons|0
6836820|NCT00245466|10842231|FG001|Overall Study|Administrative reasons|1
6836821|NCT00245466|10842232|FG002|Overall Study|Administrative reasons|0
6836822|NCT00245583|10842261|FG000|Overall Study|Lost to Follow-up|1
6836823|NCT00245583|10842262|FG001|Overall Study|Lost to Follow-up|5
6836824|NCT00245583|10842261|FG000|Overall Study|Adverse Event|2
6836825|NCT00245583|10842262|FG001|Overall Study|Adverse Event|1
6836826|NCT00245583|10842261|FG000|Overall Study|Lack of Efficacy|1
6836827|NCT00245583|10842262|FG001|Overall Study|Lack of Efficacy|0
6836828|NCT00245583|10842261|FG000|Overall Study|Withdrawal by Subject|2
6836829|NCT00245583|10842262|FG001|Overall Study|Withdrawal by Subject|3
6836830|NCT00245765|10842280|FG000|Overall Study|Adverse Event|1
6836831|NCT00245765|10842281|FG001|Overall Study|Adverse Event|1
6836832|NCT00245765|10842282|FG002|Overall Study|Adverse Event|0
6836833|NCT00245765|10842280|FG000|Overall Study|Lack of Efficacy|14
6836834|NCT00245765|10842281|FG001|Overall Study|Lack of Efficacy|7
6836835|NCT00245765|10842282|FG002|Overall Study|Lack of Efficacy|0
6836836|NCT00245765|10842280|FG000|Overall Study|Lost to Follow-up|1
6836837|NCT00245765|10842281|FG001|Overall Study|Lost to Follow-up|2
6836838|NCT00245765|10842282|FG002|Overall Study|Lost to Follow-up|0
6836839|NCT00245765|10842280|FG000|Overall Study|Withdrawal by Subject|1
6836840|NCT00245765|10842281|FG001|Overall Study|Withdrawal by Subject|0
6836841|NCT00245765|10842282|FG002|Overall Study|Withdrawal by Subject|3
6836842|NCT00245765|10842280|FG000|Overall Study|Other reason|2
6836843|NCT00245765|10842281|FG001|Overall Study|Other reason|0
6836844|NCT00245765|10842282|FG002|Overall Study|Other reason|1
6836845|NCT00245765|10842280|FG000|Overall Study|Other|13
6836846|NCT00245765|10842281|FG001|Overall Study|Other|4
6836847|NCT00245765|10842282|FG002|Overall Study|Other|4
6836848|NCT00245856|10842290|FG000|Period Two|Withdrawal by Subject|0
6836849|NCT00245856|10842291|FG001|Period Two|Withdrawal by Subject|1
6836850|NCT00246012|10842307|FG000|Overall Study|Adverse Event|0
6836851|NCT00246012|10842308|FG001|Overall Study|Adverse Event|0
6836852|NCT00246012|10842309|FG002|Overall Study|Adverse Event|0
6836853|NCT00246012|10842310|FG003|Overall Study|Adverse Event|0
6836854|NCT00246012|10842311|FG004|Overall Study|Adverse Event|0
6836855|NCT00246012|10842312|FG005|Overall Study|Adverse Event|1
6836856|NCT00246012|10842313|FG006|Overall Study|Adverse Event|0
6836857|NCT00246012|10842314|FG007|Overall Study|Adverse Event|0
6836858|NCT00246012|10842315|FG008|Overall Study|Adverse Event|2
6836859|NCT00246012|10842307|FG000|Overall Study|Withdrawal by Subject|0
6836860|NCT00246012|10842308|FG001|Overall Study|Withdrawal by Subject|0
6836861|NCT00246012|10842309|FG002|Overall Study|Withdrawal by Subject|0
6926733|NCT00841763|10957334|FG001|Overall Study|Unable to Classify|1
6926734|NCT00841763|10957335|FG002|Overall Study|Unable to Classify|0
6926735|NCT00841763|10957336|FG003|Overall Study|Unable to Classify|0
6926736|NCT00841776|10957383|FG000|Overall Study|Lack of Efficacy|0
6926737|NCT00841776|10957384|FG001|Overall Study|Lack of Efficacy|1
6926738|NCT00841776|10957383|FG000|Overall Study|Lost to Follow-up|2
6926739|NCT00841776|10957384|FG001|Overall Study|Lost to Follow-up|1
6926740|NCT00841776|10957383|FG000|Overall Study|Withdrawal by Subject|0
6926741|NCT00841776|10957384|FG001|Overall Study|Withdrawal by Subject|1
6926742|NCT00841906|10957403|FG000|Overall Study|Withdrawal by Subject|2
6926743|NCT00841906|10957404|FG001|Overall Study|Withdrawal by Subject|0
7063845|NCT01953601|11162493|FG000|Part 2 (Extension Study)|Lost to Follow-up|2
7063846|NCT01953601|11162494|FG001|Part 2 (Extension Study)|Lost to Follow-up|1
7063847|NCT01953601|11162495|FG002|Part 2 (Extension Study)|Lost to Follow-up|1
6926744|NCT00842153|10957444|FG000|Overall Study|Adverse Event|0
6926745|NCT00842153|10957445|FG001|Overall Study|Adverse Event|1
6926746|NCT00842153|10957444|FG000|Overall Study|Lost to Follow-up|1
6926747|NCT00842153|10957445|FG001|Overall Study|Lost to Follow-up|2
6926748|NCT00842244|10957455|FG000|Overall Study|Death|3
6926749|NCT00842244|10957455|FG000|Overall Study|Withdrawal by Subject|1
6926750|NCT00842244|10957455|FG000|Overall Study|Other|17
6926751|NCT00842257|10957462|FG000|Overall Study|Adverse Event|1
6926752|NCT00842309|10957472|FG000|Overall Study|Withdrawal by Subject|3
6926753|NCT00842309|10957473|FG001|Overall Study|Withdrawal by Subject|1
6926754|NCT00842348|10957487|FG000|Patients Randomised in Study 726|Did not enter Study 729|59
6926755|NCT00842348|10957488|FG001|Patients Randomised in Study 726|Did not enter Study 729|56
6926756|NCT00842348|10957487|FG000|Study 729|Disease progression/death|19
6926757|NCT00842348|10957488|FG001|Study 729|Disease progression/death|30
6926758|NCT00842348|10957487|FG000|Study 729|Adverse Event|1
6926759|NCT00842348|10957488|FG001|Study 729|Adverse Event|1
6926760|NCT00842348|10957487|FG000|Study 729|Protocol Violation|1
6926761|NCT00842348|10957488|FG001|Study 729|Protocol Violation|1
6926762|NCT00842348|10957487|FG000|Study 729|Withdrawal by Subject|2
6926763|NCT00842348|10957488|FG001|Study 729|Withdrawal by Subject|4
6926764|NCT00842348|10957487|FG000|Study 729|Due to Sponsor stopping the study|1
6926765|NCT00842348|10957488|FG001|Study 729|Due to Sponsor stopping the study|1
6926766|NCT00842348|10957487|FG000|Study 729|Due to non-availability of IP|0
6926767|NCT00842348|10957488|FG001|Study 729|Due to non-availability of IP|1
6926768|NCT00842348|10957487|FG000|Study 729|Sponsor's decision|1
7063848|NCT01953601|11162493|FG000|Part 2 (Extension Study)|Physician Decision|2
6836862|NCT00246012|10842310|FG003|Overall Study|Withdrawal by Subject|0
6836863|NCT00246012|10842311|FG004|Overall Study|Withdrawal by Subject|0
6836864|NCT00246012|10842312|FG005|Overall Study|Withdrawal by Subject|1
6926769|NCT00842348|10957488|FG001|Study 729|Sponsor's decision|0
6926770|NCT00842348|10957487|FG000|Study 729|Surgical resection|1
6926771|NCT00842348|10957488|FG001|Study 729|Surgical resection|0
6926772|NCT00842361|10957500|FG000|Overall Study|Protocol Violation|1
6926773|NCT00842361|10957501|FG001|Overall Study|Protocol Violation|0
6926774|NCT00842361|10957500|FG000|Overall Study|Unclassified|0
7063849|NCT01953601|11162494|FG001|Part 2 (Extension Study)|Physician Decision|0
6836865|NCT00246012|10842313|FG006|Overall Study|Withdrawal by Subject|0
6926775|NCT00842361|10957501|FG001|Overall Study|Unclassified|2
6836866|NCT00246012|10842314|FG007|Overall Study|Withdrawal by Subject|0
6836867|NCT00246012|10842315|FG008|Overall Study|Withdrawal by Subject|0
6836868|NCT00246012|10842307|FG000|Overall Study|Disease progression|3
6836869|NCT00246012|10842308|FG001|Overall Study|Disease progression|1
6836870|NCT00246012|10842309|FG002|Overall Study|Disease progression|2
6836871|NCT00246012|10842310|FG003|Overall Study|Disease progression|3
6836872|NCT00246012|10842311|FG004|Overall Study|Disease progression|3
6836873|NCT00246012|10842312|FG005|Overall Study|Disease progression|25
6836874|NCT00246012|10842313|FG006|Overall Study|Disease progression|30
6836875|NCT00246012|10842314|FG007|Overall Study|Disease progression|27
6836876|NCT00246012|10842315|FG008|Overall Study|Disease progression|26
6836877|NCT00246012|10842307|FG000|Overall Study|Other|0
6836878|NCT00246012|10842308|FG001|Overall Study|Other|0
6836879|NCT00246012|10842309|FG002|Overall Study|Other|0
6836880|NCT00246012|10842310|FG003|Overall Study|Other|0
6836881|NCT00246012|10842311|FG004|Overall Study|Other|0
6836882|NCT00246012|10842312|FG005|Overall Study|Other|0
6836883|NCT00246012|10842313|FG006|Overall Study|Other|0
6836884|NCT00246012|10842314|FG007|Overall Study|Other|1
6836885|NCT00246012|10842315|FG008|Overall Study|Other|0
6836886|NCT00246012|10842307|FG000|Overall Study|Randomly assigned but not treated|0
6836887|NCT00246012|10842308|FG001|Overall Study|Randomly assigned but not treated|0
6836888|NCT00246012|10842309|FG002|Overall Study|Randomly assigned but not treated|0
6836889|NCT00246012|10842310|FG003|Overall Study|Randomly assigned but not treated|0
6836890|NCT00246012|10842311|FG004|Overall Study|Randomly assigned but not treated|0
6836891|NCT00246012|10842312|FG005|Overall Study|Randomly assigned but not treated|1
6836892|NCT00246012|10842313|FG006|Overall Study|Randomly assigned but not treated|1
6836893|NCT00246012|10842314|FG007|Overall Study|Randomly assigned but not treated|0
6836894|NCT00246012|10842315|FG008|Overall Study|Randomly assigned but not treated|0
6836895|NCT00246025|10842341|FG000|Overall Study|Adverse Event|7
6836896|NCT00246025|10842342|FG001|Overall Study|Adverse Event|9
6836897|NCT00246025|10842343|FG002|Overall Study|Adverse Event|9
6836898|NCT00246025|10842344|FG003|Overall Study|Adverse Event|10
6836899|NCT00246025|10842341|FG000|Overall Study|Withdrawal by Subject|3
6836900|NCT00246025|10842342|FG001|Overall Study|Withdrawal by Subject|0
6836901|NCT00246025|10842343|FG002|Overall Study|Withdrawal by Subject|1
6836902|NCT00246025|10842344|FG003|Overall Study|Withdrawal by Subject|2
6836903|NCT00246025|10842341|FG000|Overall Study|unsuitable medical history was found|0
6836904|NCT00246025|10842342|FG001|Overall Study|unsuitable medical history was found|0
6836905|NCT00246025|10842343|FG002|Overall Study|unsuitable medical history was found|0
6926776|NCT00842543|10957511|FG000|Overall Study|Withdrawal by Subject|2
6926777|NCT00842543|10957512|FG001|Overall Study|Withdrawal by Subject|0
6926778|NCT00842543|10957513|FG002|Overall Study|Withdrawal by Subject|3
6926779|NCT00842543|10957514|FG003|Overall Study|Withdrawal by Subject|4
6926780|NCT00842712|10957550|FG000|Safety Run-in Part|Adverse Event|0
6926781|NCT00842712|10957551|FG001|Safety Run-in Part|Adverse Event|1
6926782|NCT00842712|10957552|FG002|Safety Run-in Part|Adverse Event|0
6926783|NCT00842712|10957553|FG003|Safety Run-in Part|Adverse Event|0
6926784|NCT00842712|10957554|FG004|Safety Run-in Part|Adverse Event|0
6926785|NCT00842712|10957555|FG005|Safety Run-in Part|Adverse Event|0
6926786|NCT00842712|10957556|FG006|Safety Run-in Part|Adverse Event|0
6926787|NCT00842712|10957550|FG000|Safety Run-in Part|Progressive disease|3
6926788|NCT00842712|10957551|FG001|Safety Run-in Part|Progressive disease|1
6926789|NCT00842712|10957552|FG002|Safety Run-in Part|Progressive disease|0
6926790|NCT00842712|10957553|FG003|Safety Run-in Part|Progressive disease|1
6926791|NCT00842712|10957554|FG004|Safety Run-in Part|Progressive disease|0
6926792|NCT00842712|10957555|FG005|Safety Run-in Part|Progressive disease|0
6926793|NCT00842712|10957556|FG006|Safety Run-in Part|Progressive disease|0
6926794|NCT00842712|10957550|FG000|Randomized Part|Randomized but not treated|0
6926795|NCT00842712|10957551|FG001|Randomized Part|Randomized but not treated|0
6926796|NCT00842712|10957552|FG002|Randomized Part|Randomized but not treated|0
6926797|NCT00842712|10957553|FG003|Randomized Part|Randomized but not treated|0
6926798|NCT00842712|10957554|FG004|Randomized Part|Randomized but not treated|0
6926799|NCT00842712|10957555|FG005|Randomized Part|Randomized but not treated|1
6926800|NCT00842712|10957556|FG006|Randomized Part|Randomized but not treated|4
6926801|NCT00842712|10957550|FG000|Randomized Part|Ongoing at cut-off date|0
6926802|NCT00842712|10957551|FG001|Randomized Part|Ongoing at cut-off date|0
6926803|NCT00842712|10957552|FG002|Randomized Part|Ongoing at cut-off date|0
6926804|NCT00842712|10957553|FG003|Randomized Part|Ongoing at cut-off date|0
6926805|NCT00842712|10957554|FG004|Randomized Part|Ongoing at cut-off date|0
6926806|NCT00842712|10957555|FG005|Randomized Part|Ongoing at cut-off date|0
6926807|NCT00842712|10957556|FG006|Randomized Part|Ongoing at cut-off date|2
6926808|NCT00842829|10957591|FG000|Dose Titration Period|Adverse Event|11
6926809|NCT00842829|10957592|FG001|Dose Titration Period|Adverse Event|10
6926810|NCT00842829|10957593|FG002|Dose Titration Period|Adverse Event|0
6926811|NCT00842829|10957591|FG000|Dose Titration Period|Lack of Efficacy|4
6926812|NCT00842829|10957592|FG001|Dose Titration Period|Lack of Efficacy|1
6926813|NCT00842829|10957593|FG002|Dose Titration Period|Lack of Efficacy|0
6926814|NCT00842829|10957591|FG000|Dose Titration Period|Unstable persistent cancer pain|1
6836906|NCT00246025|10842344|FG003|Overall Study|unsuitable medical history was found|1
6836907|NCT00246090|10842354|FG000|Overall Study|Adverse Event|25
6836908|NCT00246090|10842354|FG000|Overall Study|Withdrawal by Subject|7
7063850|NCT01953601|11162495|FG002|Part 2 (Extension Study)|Physician Decision|2
7063851|NCT01953601|11162493|FG000|Part 2 (Extension Study)|Site discontinued study participation|0
7063852|NCT01953601|11162494|FG001|Part 2 (Extension Study)|Site discontinued study participation|1
7063853|NCT01953601|11162495|FG002|Part 2 (Extension Study)|Site discontinued study participation|1
7063854|NCT01953601|11162493|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185
7063855|NCT01953601|11162494|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178
6836909|NCT00246090|10842354|FG000|Overall Study|Progressive Disease|212
6836910|NCT00246090|10842354|FG000|Overall Study|Clinical Progression|30
6836911|NCT00246090|10842354|FG000|Overall Study|Physician Decision|11
6836912|NCT00246090|10842354|FG000|Overall Study|Not Otherwise Specified|10
6836913|NCT00246129|10842360|FG000|Overall Study|Lost to Follow-up|1
6836914|NCT00246129|10842361|FG001|Overall Study|Lost to Follow-up|0
6836915|NCT00246129|10842360|FG000|Overall Study|Death|2
6836916|NCT00246129|10842361|FG001|Overall Study|Death|1
6836917|NCT00246129|10842360|FG000|Overall Study|suffered primary non-function|1
6836918|NCT00246129|10842361|FG001|Overall Study|suffered primary non-function|0
6836919|NCT00246129|10842360|FG000|Overall Study|grafts failed|3
6836920|NCT00246129|10842361|FG001|Overall Study|grafts failed|1
6836921|NCT00246259|10842372|FG000|Overall Study|Other|3
6836922|NCT00246259|10842373|FG001|Overall Study|Other|3
6836923|NCT00246259|10842372|FG000|Overall Study|Not stable by Week 18|2
6836924|NCT00246259|10842373|FG001|Overall Study|Not stable by Week 18|1
6836925|NCT00246259|10842372|FG000|Overall Study|Participant non-compliant|4
6836926|NCT00246259|10842373|FG001|Overall Study|Participant non-compliant|9
6836927|NCT00246259|10842372|FG000|Overall Study|Lack of Efficacy|2
6836928|NCT00246259|10842373|FG001|Overall Study|Lack of Efficacy|2
6836929|NCT00246259|10842372|FG000|Overall Study|Investigator withdrew participant|2
6836930|NCT00246259|10842373|FG001|Overall Study|Investigator withdrew participant|0
6836931|NCT00246259|10842372|FG000|Overall Study|Adverse Event|5
6836932|NCT00246259|10842373|FG001|Overall Study|Adverse Event|0
6836933|NCT00246259|10842372|FG000|Overall Study|Lost to Follow-up|3
6836934|NCT00246259|10842373|FG001|Overall Study|Lost to Follow-up|4
6836935|NCT00246259|10842372|FG000|Overall Study|Withdrawal by Subject|5
6836936|NCT00246259|10842373|FG001|Overall Study|Withdrawal by Subject|1
6836937|NCT00246259|10842372|FG000|Overall Study|randomly assigned, not eligible for ITT|2
6836938|NCT00246259|10842373|FG001|Overall Study|randomly assigned, not eligible for ITT|6
6836939|NCT00246324|10842379|FG000|Overall Study|Withdrawal by Subject|1
6836940|NCT00246337|10842392|FG000|Overall Study|Lost to Follow-up|3
6836941|NCT00246337|10842393|FG001|Overall Study|Lost to Follow-up|0
6836942|NCT00246337|10842394|FG002|Overall Study|Lost to Follow-up|0
6836943|NCT00246337|10842395|FG003|Overall Study|Lost to Follow-up|0
6836944|NCT00246337|10842396|FG004|Overall Study|Lost to Follow-up|2
6836945|NCT00246337|10842397|FG005|Overall Study|Lost to Follow-up|2
6836946|NCT00246337|10842398|FG006|Overall Study|Lost to Follow-up|1
6836947|NCT00246337|10842399|FG007|Overall Study|Lost to Follow-up|2
6836948|NCT00246337|10842400|FG008|Overall Study|Lost to Follow-up|0
6836949|NCT00246337|10842392|FG000|Overall Study|Protocol Violation|1
6836950|NCT00246337|10842393|FG001|Overall Study|Protocol Violation|0
6836951|NCT00246337|10842394|FG002|Overall Study|Protocol Violation|0
6836952|NCT00246337|10842395|FG003|Overall Study|Protocol Violation|0
6836953|NCT00246337|10842396|FG004|Overall Study|Protocol Violation|1
6836954|NCT00246337|10842397|FG005|Overall Study|Protocol Violation|0
6836955|NCT00246337|10842398|FG006|Overall Study|Protocol Violation|1
6836956|NCT00246337|10842399|FG007|Overall Study|Protocol Violation|1
6836957|NCT00246337|10842400|FG008|Overall Study|Protocol Violation|0
6836958|NCT00246337|10842392|FG000|Overall Study|Withdrawal by Subject|2
7063856|NCT01953601|11162495|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187
7063857|NCT01953601|11162493|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1
7063858|NCT01953601|11162494|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3
7063859|NCT01953601|11162495|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0
6836959|NCT00246337|10842393|FG001|Overall Study|Withdrawal by Subject|0
6836960|NCT00246337|10842394|FG002|Overall Study|Withdrawal by Subject|0
6836961|NCT00246337|10842395|FG003|Overall Study|Withdrawal by Subject|0
6836962|NCT00246337|10842396|FG004|Overall Study|Withdrawal by Subject|0
6836963|NCT00246337|10842397|FG005|Overall Study|Withdrawal by Subject|0
6836964|NCT00246337|10842398|FG006|Overall Study|Withdrawal by Subject|1
6836965|NCT00246337|10842399|FG007|Overall Study|Withdrawal by Subject|1
6836966|NCT00246337|10842400|FG008|Overall Study|Withdrawal by Subject|0
6836967|NCT00246337|10842392|FG000|Overall Study|Lack of Qualifying Event|8
6836968|NCT00246337|10842393|FG001|Overall Study|Lack of Qualifying Event|2
6836969|NCT00246337|10842394|FG002|Overall Study|Lack of Qualifying Event|1
6836970|NCT00246337|10842395|FG003|Overall Study|Lack of Qualifying Event|1
6836971|NCT00246337|10842396|FG004|Overall Study|Lack of Qualifying Event|1
6836972|NCT00246337|10842397|FG005|Overall Study|Lack of Qualifying Event|3
6836973|NCT00246337|10842398|FG006|Overall Study|Lack of Qualifying Event|3
6836974|NCT00246337|10842399|FG007|Overall Study|Lack of Qualifying Event|2
6836975|NCT00246337|10842400|FG008|Overall Study|Lack of Qualifying Event|5
6836976|NCT00246337|10842392|FG000|Overall Study|Site Terminated|10
6836977|NCT00246337|10842393|FG001|Overall Study|Site Terminated|0
6836978|NCT00246337|10842394|FG002|Overall Study|Site Terminated|0
6836979|NCT00246337|10842395|FG003|Overall Study|Site Terminated|0
6836980|NCT00246337|10842396|FG004|Overall Study|Site Terminated|0
7063860|NCT01953601|11162493|FG000|Part 2 (Extension Study)|Subject moved|0
7063861|NCT01953601|11162494|FG001|Part 2 (Extension Study)|Subject moved|0
7063862|NCT01953601|11162495|FG002|Part 2 (Extension Study)|Subject moved|1
6836981|NCT00246337|10842397|FG005|Overall Study|Site Terminated|7
6836982|NCT00246337|10842398|FG006|Overall Study|Site Terminated|1
6836983|NCT00246337|10842399|FG007|Overall Study|Site Terminated|6
6836984|NCT00246337|10842400|FG008|Overall Study|Site Terminated|2
6836985|NCT00246337|10842392|FG000|Overall Study|Abnormal baseline lab values|7
6836986|NCT00246337|10842393|FG001|Overall Study|Abnormal baseline lab values|0
6836987|NCT00246337|10842394|FG002|Overall Study|Abnormal baseline lab values|2
6836988|NCT00246337|10842395|FG003|Overall Study|Abnormal baseline lab values|0
6836989|NCT00246337|10842396|FG004|Overall Study|Abnormal baseline lab values|0
6836990|NCT00246337|10842397|FG005|Overall Study|Abnormal baseline lab values|2
6836991|NCT00246337|10842398|FG006|Overall Study|Abnormal baseline lab values|2
6836992|NCT00246337|10842399|FG007|Overall Study|Abnormal baseline lab values|0
6836993|NCT00246337|10842400|FG008|Overall Study|Abnormal baseline lab values|4
6836994|NCT00246337|10842392|FG000|Overall Study|Overwhelmed|0
6836995|NCT00246337|10842393|FG001|Overall Study|Overwhelmed|0
6836996|NCT00246337|10842394|FG002|Overall Study|Overwhelmed|0
6836997|NCT00246337|10842395|FG003|Overall Study|Overwhelmed|0
6836998|NCT00246337|10842396|FG004|Overall Study|Overwhelmed|0
6836999|NCT00246337|10842397|FG005|Overall Study|Overwhelmed|1
6837000|NCT00246337|10842398|FG006|Overall Study|Overwhelmed|0
6837001|NCT00246337|10842399|FG007|Overall Study|Overwhelmed|0
6837002|NCT00246337|10842400|FG008|Overall Study|Overwhelmed|0
6837003|NCT00246337|10842392|FG000|Overall Study|Protocol Violator|1
6837004|NCT00246337|10842393|FG001|Overall Study|Protocol Violator|0
6837005|NCT00246337|10842394|FG002|Overall Study|Protocol Violator|0
6837006|NCT00246337|10842395|FG003|Overall Study|Protocol Violator|0
6837007|NCT00246337|10842396|FG004|Overall Study|Protocol Violator|0
6837008|NCT00246337|10842397|FG005|Overall Study|Protocol Violator|0
6837009|NCT00246337|10842398|FG006|Overall Study|Protocol Violator|0
6837010|NCT00246337|10842399|FG007|Overall Study|Protocol Violator|0
6837011|NCT00246337|10842400|FG008|Overall Study|Protocol Violator|0
6837012|NCT00246337|10842392|FG000|Overall Study|Reported as completing trial in error|0
6837013|NCT00246337|10842393|FG001|Overall Study|Reported as completing trial in error|0
6837014|NCT00246337|10842394|FG002|Overall Study|Reported as completing trial in error|0
6837015|NCT00246337|10842395|FG003|Overall Study|Reported as completing trial in error|0
6837016|NCT00246337|10842396|FG004|Overall Study|Reported as completing trial in error|0
6837017|NCT00246337|10842397|FG005|Overall Study|Reported as completing trial in error|0
6837018|NCT00246337|10842398|FG006|Overall Study|Reported as completing trial in error|0
6837019|NCT00246337|10842399|FG007|Overall Study|Reported as completing trial in error|1
6837020|NCT00246337|10842400|FG008|Overall Study|Reported as completing trial in error|0
6837021|NCT00246376|10842425|FG000|Overall Study|Dropped/withdrew during dietary run-in|11
7063863|NCT01953601|11162493|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5
7063864|NCT01953601|11162494|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4
7063865|NCT01953601|11162495|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2
7063866|NCT01953692|11162515|FG000|Overall Study|Adverse Event|5
7063867|NCT01953692|11162516|FG001|Overall Study|Adverse Event|2
7039476|NCT01710358|11122159|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5
7039477|NCT01710358|11122157|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1
7039478|NCT01710358|11122158|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0
7039479|NCT01710358|11122159|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1
7063868|NCT01953692|11162517|FG002|Overall Study|Adverse Event|4
6837022|NCT00246376|10842426|FG001|Overall Study|Dropped/withdrew during dietary run-in|5
6837023|NCT00246376|10842427|FG002|Overall Study|Dropped/withdrew during dietary run-in|4
6837024|NCT00246376|10842428|FG003|Overall Study|Dropped/withdrew during dietary run-in|7
6837025|NCT00246376|10842429|FG004|Overall Study|Dropped/withdrew during dietary run-in|3
6837026|NCT00246376|10842425|FG000|Overall Study|Adverse Event|2
6837027|NCT00246376|10842426|FG001|Overall Study|Adverse Event|3
6837028|NCT00246376|10842427|FG002|Overall Study|Adverse Event|1
6837029|NCT00246376|10842428|FG003|Overall Study|Adverse Event|3
6837030|NCT00246376|10842429|FG004|Overall Study|Adverse Event|1
6837031|NCT00246376|10842425|FG000|Overall Study|Lost to Follow-up|2
6837032|NCT00246376|10842426|FG001|Overall Study|Lost to Follow-up|11
6837033|NCT00246376|10842427|FG002|Overall Study|Lost to Follow-up|11
6837034|NCT00246376|10842428|FG003|Overall Study|Lost to Follow-up|16
6837035|NCT00246376|10842429|FG004|Overall Study|Lost to Follow-up|13
6837036|NCT00246571|10842467|FG000|Overall Study|Adverse Event|7
6837037|NCT00246571|10842468|FG001|Overall Study|Adverse Event|0
6837038|NCT00246571|10842467|FG000|Overall Study|Protocol Violation|0
6837039|NCT00246571|10842468|FG001|Overall Study|Protocol Violation|1
6837040|NCT00246571|10842467|FG000|Overall Study|Withdrawal by Subject|2
6837041|NCT00246571|10842468|FG001|Overall Study|Withdrawal by Subject|3
6837042|NCT00246571|10842467|FG000|Overall Study|Lack of Efficacy|84
6837043|NCT00246571|10842468|FG001|Overall Study|Lack of Efficacy|21
6837044|NCT00246571|10842467|FG000|Overall Study|Death|17
6926815|NCT00842829|10957592|FG001|Dose Titration Period|Unstable persistent cancer pain|0
6926816|NCT00842829|10957593|FG002|Dose Titration Period|Unstable persistent cancer pain|0
7063869|NCT01953692|11162518|FG003|Overall Study|Adverse Event|2
7063870|NCT01953692|11162519|FG004|Overall Study|Adverse Event|1
6837045|NCT00246571|10842468|FG001|Overall Study|Death|3
6837046|NCT00246571|10842467|FG000|Overall Study|Sponsor|0
6837047|NCT00246571|10842468|FG001|Overall Study|Sponsor|1
6837048|NCT00246571|10842467|FG000|Overall Study|Did not meet entrance criteria|2
6837049|NCT00246571|10842468|FG001|Overall Study|Did not meet entrance criteria|1
6837050|NCT00246571|10842467|FG000|Overall Study|Laboratory abnormalities|1
6837051|NCT00246571|10842468|FG001|Overall Study|Laboratory abnormalities|0
6837052|NCT00246571|10842467|FG000|Overall Study|Crossover participants|0
6837053|NCT00246571|10842468|FG001|Overall Study|Crossover participants|74
6837054|NCT00246740|10842476|FG000|Initial Enrollment|Death|1
6837055|NCT00246740|10842477|FG001|Initial Enrollment|Death|0
6837056|NCT00246740|10842476|FG000|Initial Enrollment|Additional surgery scheduled|0
6837057|NCT00246740|10842477|FG001|Initial Enrollment|Additional surgery scheduled|2
6837058|NCT00246740|10842476|FG000|Initial Enrollment|Surgery schedule change|4
6837059|NCT00246740|10842477|FG001|Initial Enrollment|Surgery schedule change|4
6837060|NCT00246740|10842476|FG000|Initial Enrollment|Other|1
6837061|NCT00246740|10842477|FG001|Initial Enrollment|Other|2
6837062|NCT00246753|10842483|FG000|Overall Study|Withdrawal by Subject|2
6837063|NCT00246753|10842483|FG000|Overall Study|Physician Decision|2
6837064|NCT00246753|10842483|FG000|Overall Study|Adverse Event|2
6837065|NCT00246753|10842483|FG000|Overall Study|Unacceptable toxicity|2
6837066|NCT00246805|10842489|FG000|Phase 1|Lost to Follow-up|1
6837067|NCT00246805|10842490|FG001|Phase 1|Lost to Follow-up|0
6837068|NCT00247273|10842498|FG000|Overall Study|Adverse Event|85
6837069|NCT00247273|10842499|FG001|Overall Study|Adverse Event|80
6837070|NCT00247273|10842498|FG000|Overall Study|Physician Decision|6
6837071|NCT00247273|10842499|FG001|Overall Study|Physician Decision|3
6837072|NCT00247273|10842498|FG000|Overall Study|Lost to Follow-up|7
6837073|NCT00247273|10842499|FG001|Overall Study|Lost to Follow-up|7
6837074|NCT00247273|10842498|FG000|Overall Study|Withdrawal by Subject|46
6837075|NCT00247273|10842499|FG001|Overall Study|Withdrawal by Subject|47
6837076|NCT00247273|10842498|FG000|Overall Study|Did not take any study drug|2
6837077|NCT00247273|10842499|FG001|Overall Study|Did not take any study drug|0
6837078|NCT00247416|10842516|FG000|Overall Study|3 patients were found to be ineligible|1
6837079|NCT00247416|10842517|FG001|Overall Study|3 patients were found to be ineligible|2
6837080|NCT00247611|10842527|FG000|Baselined|Completed baseline, never placed on ARVs|8
6837081|NCT00247611|10842528|FG001|Baselined|Completed baseline, never placed on ARVs|5
6837082|NCT00247611|10842527|FG000|Baselined|Completed baseline only|9
6837083|NCT00247611|10842528|FG001|Baselined|Completed baseline only|8
6837084|NCT00247676|10842549|FG000|Overall Study|Death|5
6837085|NCT00247676|10842549|FG000|Overall Study|Adverse Event|11
6837086|NCT00247676|10842549|FG000|Overall Study|Lack of Efficacy|15
6837087|NCT00247676|10842549|FG000|Overall Study|Other|3
6837088|NCT00247676|10842549|FG000|Overall Study|Withdrawal by Subject|2
6837089|NCT00247962|10842555|FG000|Overall Study|Adverse Event|15
6837090|NCT00247962|10842556|FG001|Overall Study|Adverse Event|12
6837091|NCT00247962|10842555|FG000|Overall Study|Lost to Follow-up|3
6837092|NCT00247962|10842556|FG001|Overall Study|Lost to Follow-up|1
6837093|NCT00247962|10842555|FG000|Overall Study|Physician Decision|0
6837094|NCT00247962|10842556|FG001|Overall Study|Physician Decision|1
6837095|NCT00247962|10842555|FG000|Overall Study|Protocol Violation|1
6837096|NCT00247962|10842556|FG001|Overall Study|Protocol Violation|1
6837097|NCT00247962|10842555|FG000|Overall Study|Withdrawal by Subject|3
6837098|NCT00247962|10842556|FG001|Overall Study|Withdrawal by Subject|2
6837099|NCT00247962|10842555|FG000|Overall Study|Lack of Efficacy|4
6837100|NCT00247962|10842556|FG001|Overall Study|Lack of Efficacy|2
6837101|NCT00248040|10842565|FG000|Overall Study|transplantectomy|2
6837102|NCT00248040|10842566|FG001|Overall Study|transplantectomy|1
6837103|NCT00248040|10842567|FG002|Overall Study|transplantectomy|3
6837104|NCT00248040|10842565|FG000|Overall Study|transplant cancelled post treat start|1
6837105|NCT00248040|10842566|FG001|Overall Study|transplant cancelled post treat start|0
6837106|NCT00248040|10842567|FG002|Overall Study|transplant cancelled post treat start|0
6837107|NCT00248040|10842565|FG000|Overall Study|Death|0
6837108|NCT00248040|10842566|FG001|Overall Study|Death|0
6837109|NCT00248040|10842567|FG002|Overall Study|Death|1
6837110|NCT00248170|10842578|FG000|Overall Study|Withdrawal by Subject|71
6837111|NCT00248170|10842579|FG001|Overall Study|Withdrawal by Subject|79
6837112|NCT00248170|10842578|FG000|Overall Study|Protocol Violation|35
6837113|NCT00248170|10842579|FG001|Overall Study|Protocol Violation|30
6837114|NCT00248170|10842578|FG000|Overall Study|Lost to Follow-up|28
6837115|NCT00248170|10842579|FG001|Overall Study|Lost to Follow-up|35
6837116|NCT00248170|10842578|FG000|Overall Study|Disease progression|196
6837117|NCT00248170|10842579|FG001|Overall Study|Disease progression|216
6837118|NCT00248170|10842578|FG000|Overall Study|Death|28
6837119|NCT00248170|10842579|FG001|Overall Study|Death|47
6837120|NCT00248170|10842578|FG000|Overall Study|Adverse Event|311
6837121|NCT00248170|10842579|FG001|Overall Study|Adverse Event|296
6837122|NCT00248170|10842578|FG000|Overall Study|Administrative problems|22
6837123|NCT00248170|10842579|FG001|Overall Study|Administrative problems|25
6837124|NCT00248170|10842578|FG000|Overall Study|Abnormal test procedure(s) result|49
6837125|NCT00248170|10842579|FG001|Overall Study|Abnormal test procedure(s) result|61
6837126|NCT00248170|10842578|FG000|Overall Study|Abnormal laboratory values|4
6837127|NCT00248170|10842579|FG001|Overall Study|Abnormal laboratory values|0
6837128|NCT00248170|10842578|FG000|Overall Study|Protocol deviation|17
6837129|NCT00248170|10842579|FG001|Overall Study|Protocol deviation|19
6837130|NCT00248495|10842585|FG000|Overall Study|Withdrawal by Subject|1
6837131|NCT00248625|10842628|FG000|Overall Study|Withdrawal by Subject|0
6837132|NCT00248625|10842629|FG001|Overall Study|Withdrawal by Subject|2
6837133|NCT00248651|10842649|FG000|Overall Study|Withdrawal by Subject|28
6837134|NCT00248651|10842650|FG001|Overall Study|Withdrawal by Subject|40
6837135|NCT00248651|10842651|FG002|Overall Study|Withdrawal by Subject|32
6837136|NCT00248794|10842671|FG000|Overall Study|Lost to Follow-up|6
6837137|NCT00248794|10842672|FG001|Overall Study|Lost to Follow-up|8
6837138|NCT00248794|10842673|FG002|Overall Study|Lost to Follow-up|3
6837139|NCT00248833|10842705|FG000|Overall Study|Adverse Event|2
6837140|NCT00248833|10842706|FG001|Overall Study|Adverse Event|0
6837141|NCT00248833|10842707|FG002|Overall Study|Adverse Event|0
6837142|NCT00248833|10842705|FG000|Overall Study|Withdrawal by Subject|0
6837143|NCT00248833|10842706|FG001|Overall Study|Withdrawal by Subject|1
6837144|NCT00248833|10842707|FG002|Overall Study|Withdrawal by Subject|1
6837145|NCT00248833|10842705|FG000|Overall Study|Lost to Follow-up|1
6837146|NCT00248833|10842706|FG001|Overall Study|Lost to Follow-up|1
6837147|NCT00248833|10842707|FG002|Overall Study|Lost to Follow-up|1
6837148|NCT00248833|10842705|FG000|Overall Study|Other|0
6837149|NCT00248833|10842706|FG001|Overall Study|Other|1
6837150|NCT00248833|10842707|FG002|Overall Study|Other|0
6837151|NCT00249002|10842717|FG000|Overall Study|Adverse Event|2
6837152|NCT00249002|10842717|FG000|Overall Study|Study cancellation|3
6837153|NCT00249002|10842717|FG000|Overall Study|Other|2
6837154|NCT00249288|10842740|FG000|Overall Study|Lost to Follow-up|3
6837155|NCT00249288|10842741|FG001|Overall Study|Lost to Follow-up|3
6837156|NCT00249288|10842740|FG000|Overall Study|Withdrawal by Subject|2
6837157|NCT00249288|10842741|FG001|Overall Study|Withdrawal by Subject|2
6837158|NCT00249444|10842766|FG000|Overall Study|Lost to Follow-up|2
6837159|NCT00249444|10842767|FG001|Overall Study|Lost to Follow-up|2
6837160|NCT00249444|10842766|FG000|Overall Study|non-compliant|9
6837161|NCT00249444|10842767|FG001|Overall Study|non-compliant|11
6837162|NCT00249444|10842766|FG000|Overall Study|Adverse Event|1
6837163|NCT00249444|10842767|FG001|Overall Study|Adverse Event|1
6837164|NCT00249444|10842766|FG000|Overall Study|life event|0
6837165|NCT00249444|10842767|FG001|Overall Study|life event|1
6837166|NCT00249613|10842795|FG000|12 Month Follow-up|Death|1
6837167|NCT00249613|10842796|FG001|12 Month Follow-up|Death|1
6837168|NCT00249613|10842795|FG000|12 Month Follow-up|Withdrawal by Subject|6
6837169|NCT00249613|10842796|FG001|12 Month Follow-up|Withdrawal by Subject|6
6837170|NCT00249613|10842795|FG000|12 Month Follow-up|Lost to Follow-up|10
6837171|NCT00249613|10842796|FG001|12 Month Follow-up|Lost to Follow-up|8
6837172|NCT00249769|10842808|FG000|Overall Study|Withdrawal by Subject|1
6837173|NCT00249769|10842809|FG001|Overall Study|Withdrawal by Subject|10
6837174|NCT00249769|10842810|FG002|Overall Study|Withdrawal by Subject|6
6837175|NCT00249769|10842808|FG000|Overall Study|Migration from Study Area|1
6837176|NCT00249769|10842809|FG001|Overall Study|Migration from Study Area|3
6837177|NCT00249769|10842810|FG002|Overall Study|Migration from Study Area|14
6837178|NCT00249769|10842808|FG000|Overall Study|Miscellaneous|0
6837179|NCT00249769|10842809|FG001|Overall Study|Miscellaneous|2
6837180|NCT00249769|10842810|FG002|Overall Study|Miscellaneous|2
6837181|NCT00249769|10842808|FG000|Overall Study|Adverse Event|0
6837182|NCT00249769|10842809|FG001|Overall Study|Adverse Event|0
6837183|NCT00249769|10842810|FG002|Overall Study|Adverse Event|1
6837184|NCT00249769|10842808|FG000|Overall Study|Physician Decision|0
6837185|NCT00249769|10842809|FG001|Overall Study|Physician Decision|0
6837186|NCT00249769|10842810|FG002|Overall Study|Physician Decision|2
6837187|NCT00249769|10842808|FG000|Overall Study|Lost to Follow-up|0
6837188|NCT00249769|10842809|FG001|Overall Study|Lost to Follow-up|0
6837189|NCT00249769|10842810|FG002|Overall Study|Lost to Follow-up|3
6926817|NCT00842829|10957591|FG000|Dose Titration Period|Withdrawal by Subject|2
6926818|NCT00842829|10957592|FG001|Dose Titration Period|Withdrawal by Subject|6
6926819|NCT00842829|10957593|FG002|Dose Titration Period|Withdrawal by Subject|0
6926820|NCT00842829|10957591|FG000|Dose Titration Period|Other|5
6926821|NCT00842829|10957592|FG001|Dose Titration Period|Other|4
6926822|NCT00842829|10957593|FG002|Dose Titration Period|Other|0
6926823|NCT00842829|10957591|FG000|Dose Titration Period|Non-compliance to study procedures|1
6926824|NCT00842829|10957592|FG001|Dose Titration Period|Non-compliance to study procedures|1
6926825|NCT00842829|10957593|FG002|Dose Titration Period|Non-compliance to study procedures|0
6926826|NCT00842829|10957591|FG000|Dose Titration Period|Non-compliance to study drug|2
6926827|NCT00842829|10957592|FG001|Dose Titration Period|Non-compliance to study drug|1
6837190|NCT00249795|10842820|FG000|Overall Study|Not treated|16
6837191|NCT00249795|10842821|FG001|Overall Study|Not treated|14
6837192|NCT00249795|10842820|FG000|Overall Study|Symptomatic hypotension|127
6837193|NCT00249795|10842821|FG001|Overall Study|Symptomatic hypotension|64
6837194|NCT00249795|10842820|FG000|Overall Study|Other Serious Adverse Event|84
6837195|NCT00249795|10842821|FG001|Overall Study|Other Serious Adverse Event|93
6837196|NCT00249795|10842820|FG000|Overall Study|Qualifying condition not present|26
6837197|NCT00249795|10842821|FG001|Overall Study|Qualifying condition not present|29
6837198|NCT00249795|10842820|FG000|Overall Study|Withdrawal by Subject|678
6926828|NCT00842829|10957593|FG002|Dose Titration Period|Non-compliance to study drug|0
6837199|NCT00249795|10842821|FG001|Overall Study|Withdrawal by Subject|742
6837200|NCT00249795|10842820|FG000|Overall Study|Thromboembolic / outcome event|39
6837201|NCT00249795|10842821|FG001|Overall Study|Thromboembolic / outcome event|45
6926829|NCT00842829|10957591|FG000|Treatment Period|Adverse Event|0
6926830|NCT00842829|10957592|FG001|Treatment Period|Adverse Event|0
6926831|NCT00842829|10957593|FG002|Treatment Period|Adverse Event|15
6926832|NCT00842829|10957591|FG000|Treatment Period|Lack of Efficacy|0
6926833|NCT00842829|10957592|FG001|Treatment Period|Lack of Efficacy|0
6926834|NCT00842829|10957593|FG002|Treatment Period|Lack of Efficacy|6
6926835|NCT00842829|10957591|FG000|Treatment Period|Unstable persistent cancer pain|0
6926836|NCT00842829|10957592|FG001|Treatment Period|Unstable persistent cancer pain|0
6926837|NCT00842829|10957593|FG002|Treatment Period|Unstable persistent cancer pain|5
6926838|NCT00842829|10957591|FG000|Treatment Period|Withdrawal by Subject|0
6926839|NCT00842829|10957592|FG001|Treatment Period|Withdrawal by Subject|0
6926840|NCT00842829|10957593|FG002|Treatment Period|Withdrawal by Subject|11
6926841|NCT00842829|10957591|FG000|Treatment Period|Consistently >4 BTP episodes daily|0
6926842|NCT00842829|10957592|FG001|Treatment Period|Consistently >4 BTP episodes daily|0
6926843|NCT00842829|10957593|FG002|Treatment Period|Consistently >4 BTP episodes daily|1
6926844|NCT00842829|10957591|FG000|Treatment Period|Protocol Violation|0
6926845|NCT00842829|10957592|FG001|Treatment Period|Protocol Violation|0
6926846|NCT00842829|10957593|FG002|Treatment Period|Protocol Violation|2
6926847|NCT00842829|10957591|FG000|Treatment Period|Other|0
6926848|NCT00842829|10957592|FG001|Treatment Period|Other|0
6926849|NCT00842829|10957593|FG002|Treatment Period|Other|18
6926850|NCT00842829|10957591|FG000|Treatment Period|Non-compliance to study procedures|0
6926851|NCT00842829|10957592|FG001|Treatment Period|Non-compliance to study procedures|0
6926852|NCT00842829|10957593|FG002|Treatment Period|Non-compliance to study procedures|4
6926853|NCT00842829|10957591|FG000|Treatment Period|Unclear completion status|0
6926854|NCT00842829|10957592|FG001|Treatment Period|Unclear completion status|0
6926855|NCT00842829|10957593|FG002|Treatment Period|Unclear completion status|1
6926856|NCT00842829|10957591|FG000|Continuation Period|Adverse Event|0
6926857|NCT00842829|10957592|FG001|Continuation Period|Adverse Event|0
6926858|NCT00842829|10957593|FG002|Continuation Period|Adverse Event|32
6926859|NCT00842829|10957591|FG000|Continuation Period|Lack of Efficacy|0
6926860|NCT00842829|10957592|FG001|Continuation Period|Lack of Efficacy|0
6926861|NCT00842829|10957593|FG002|Continuation Period|Lack of Efficacy|6
6926862|NCT00842829|10957591|FG000|Continuation Period|Unstable persistent cancer pain|0
6926863|NCT00842829|10957592|FG001|Continuation Period|Unstable persistent cancer pain|0
6926864|NCT00842829|10957593|FG002|Continuation Period|Unstable persistent cancer pain|3
6926865|NCT00842829|10957591|FG000|Continuation Period|Withdrawal by Subject|0
6926866|NCT00842829|10957592|FG001|Continuation Period|Withdrawal by Subject|0
6926867|NCT00842829|10957593|FG002|Continuation Period|Withdrawal by Subject|10
6926868|NCT00842829|10957591|FG000|Continuation Period|Other|0
6926869|NCT00842829|10957592|FG001|Continuation Period|Other|0
6926870|NCT00842829|10957593|FG002|Continuation Period|Other|7
6926871|NCT00842829|10957591|FG000|Continuation Period|Non-compliance to study procedures|0
6926872|NCT00842829|10957592|FG001|Continuation Period|Non-compliance to study procedures|0
6926873|NCT00842829|10957593|FG002|Continuation Period|Non-compliance to study procedures|2
6926874|NCT00842829|10957591|FG000|Continuation Period|Non-compliance to study drug|0
6926875|NCT00842829|10957592|FG001|Continuation Period|Non-compliance to study drug|0
6926876|NCT00842829|10957593|FG002|Continuation Period|Non-compliance to study drug|1
6926877|NCT00842985|10957614|FG000|Screening|Did not meet entrance requirements|27
6926878|NCT00842985|10957614|FG000|First Intervention|Withdrawal by Subject|3
6926879|NCT00842985|10957614|FG000|First Intervention|Protocol Violation|3
6926880|NCT00842985|10957614|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2
6926881|NCT00842985|10957614|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2
6926882|NCT00843024|10957625|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79
6926883|NCT00843024|10957626|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74
6926884|NCT00843024|10957627|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
6926885|NCT00843024|10957628|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
6926886|NCT00843024|10957629|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
6926887|NCT00843024|10957630|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
6926888|NCT00843024|10957625|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36
6926889|NCT00843024|10957626|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31
6926890|NCT00843024|10957627|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
6926891|NCT00843024|10957628|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
6926892|NCT00843024|10957629|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
6926893|NCT00843024|10957630|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
6926894|NCT00843024|10957625|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19
6926895|NCT00843024|10957626|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18
6926896|NCT00843024|10957627|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
6926897|NCT00843024|10957628|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
6926898|NCT00843024|10957629|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
6926899|NCT00843024|10957630|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
6926900|NCT00843024|10957625|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4
6926901|NCT00843024|10957626|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5
6926902|NCT00843024|10957627|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0
6926903|NCT00843024|10957628|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0
6837202|NCT00249795|10842820|FG000|Overall Study|Oral anticoagulant required|2
6837203|NCT00249795|10842821|FG001|Overall Study|Oral anticoagulant required|0
6837204|NCT00249795|10842820|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7
6837205|NCT00249795|10842821|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3
6837206|NCT00249795|10842820|FG000|Overall Study|Non-compliance|71
6837207|NCT00249795|10842821|FG001|Overall Study|Non-compliance|69
6837208|NCT00249795|10842820|FG000|Overall Study|Study drug intolerance|3
6837209|NCT00249795|10842821|FG001|Overall Study|Study drug intolerance|3
6837210|NCT00249795|10842820|FG000|Overall Study|Other adverse events (non-serious)|188
6837211|NCT00249795|10842821|FG001|Overall Study|Other adverse events (non-serious)|159
6837212|NCT00249795|10842820|FG000|Overall Study|Physician withdrew consent|71
6837213|NCT00249795|10842821|FG001|Overall Study|Physician withdrew consent|63
6837214|NCT00249795|10842820|FG000|Overall Study|Surgery / procedure|4
6837215|NCT00249795|10842821|FG001|Overall Study|Surgery / procedure|5
6837216|NCT00249795|10842820|FG000|Overall Study|Angiotensin II receptor blocker required|35
6837217|NCT00249795|10842821|FG001|Overall Study|Angiotensin II receptor blocker required|58
6837218|NCT00249795|10842820|FG000|Overall Study|Lightheadedness / dizziness|15
6837219|NCT00249795|10842821|FG001|Overall Study|Lightheadedness / dizziness|11
6837220|NCT00249795|10842820|FG000|Overall Study|Hypotension (non-symptomatic)|5
6837221|NCT00249795|10842821|FG001|Overall Study|Hypotension (non-symptomatic)|5
6837222|NCT00249795|10842820|FG000|Overall Study|Other contraindicated medication|1
6837223|NCT00249795|10842821|FG001|Overall Study|Other contraindicated medication|1
6837224|NCT00249795|10842820|FG000|Overall Study|Event related to cardiac condition|17
6837225|NCT00249795|10842821|FG001|Overall Study|Event related to cardiac condition|16
6837226|NCT00249795|10842820|FG000|Overall Study|Patient not wish to continue after May08|4
6837227|NCT00249795|10842821|FG001|Overall Study|Patient not wish to continue after May08|6
6837228|NCT00249795|10842820|FG000|Overall Study|Site not agree to continue after May08|1
6837229|NCT00249795|10842821|FG001|Overall Study|Site not agree to continue after May08|1
6837230|NCT00249795|10842820|FG000|Overall Study|Lost to Follow-up|0
6837231|NCT00249795|10842821|FG001|Overall Study|Lost to Follow-up|2
6837232|NCT00249795|10842820|FG000|Overall Study|Missing|0
6837233|NCT00249795|10842821|FG001|Overall Study|Missing|1
6837234|NCT00249808|10842827|FG000|Overall Study|Other|27
6837235|NCT00249808|10842827|FG000|Overall Study|Protocol Violation|3
6837236|NCT00249808|10842827|FG000|Overall Study|Lost to Follow-up|8
6837237|NCT00249808|10842827|FG000|Overall Study|Adverse Event|81
6837238|NCT00249808|10842827|FG000|Overall Study|Lack of Efficacy|52
6837239|NCT00249808|10842827|FG000|Overall Study|Did Not Provide Post-Baseline Data|11
6837240|NCT00249821|10842833|FG000|Overall Study|Technical problem|0
6837241|NCT00249821|10842834|FG001|Overall Study|Technical problem|1
6837242|NCT00249834|10842848|FG000|Overall Study|Ovarian stimulation failed|1
6837243|NCT00249834|10842849|FG001|Overall Study|Ovarian stimulation failed|0
6837244|NCT00249834|10842850|FG002|Overall Study|Ovarian stimulation failed|0
6837245|NCT00249834|10842851|FG003|Overall Study|Ovarian stimulation failed|0
6837246|NCT00249834|10842852|FG004|Overall Study|Ovarian stimulation failed|0
6837247|NCT00249834|10842853|FG005|Overall Study|Ovarian stimulation failed|0
6837248|NCT00249834|10842854|FG006|Overall Study|Ovarian stimulation failed|0
6837249|NCT00249834|10842855|FG007|Overall Study|Ovarian stimulation failed|0
6837250|NCT00249834|10842848|FG000|Overall Study|Failure of down-regulation|0
6837251|NCT00249834|10842849|FG001|Overall Study|Failure of down-regulation|0
6837252|NCT00249834|10842850|FG002|Overall Study|Failure of down-regulation|0
6837253|NCT00249834|10842851|FG003|Overall Study|Failure of down-regulation|0
6837254|NCT00249834|10842852|FG004|Overall Study|Failure of down-regulation|0
6837255|NCT00249834|10842853|FG005|Overall Study|Failure of down-regulation|0
6837256|NCT00249834|10842854|FG006|Overall Study|Failure of down-regulation|1
6837257|NCT00249834|10842855|FG007|Overall Study|Failure of down-regulation|0
6837258|NCT00249834|10842848|FG000|Overall Study|Protocol Violation|0
6837259|NCT00249834|10842849|FG001|Overall Study|Protocol Violation|19
6837260|NCT00249834|10842850|FG002|Overall Study|Protocol Violation|14
6837261|NCT00249834|10842851|FG003|Overall Study|Protocol Violation|8
6837262|NCT00249834|10842852|FG004|Overall Study|Protocol Violation|5
6837263|NCT00249834|10842853|FG005|Overall Study|Protocol Violation|2
6837264|NCT00249834|10842854|FG006|Overall Study|Protocol Violation|0
6837265|NCT00249834|10842855|FG007|Overall Study|Protocol Violation|0
6837266|NCT00249873|10842869|FG000|Overall Study|Not treated|7
6837267|NCT00249873|10842870|FG001|Overall Study|Not treated|8
6837268|NCT00249873|10842869|FG000|Overall Study|Significant thrombocytopenia|9
6837269|NCT00249873|10842870|FG001|Overall Study|Significant thrombocytopenia|8
6837270|NCT00249873|10842869|FG000|Overall Study|Severe allergic reaction|8
6837271|NCT00249873|10842870|FG001|Overall Study|Severe allergic reaction|1
6837272|NCT00249873|10842869|FG000|Overall Study|Serious haemorrhagic Adverse Event|74
6837273|NCT00249873|10842870|FG001|Overall Study|Serious haemorrhagic Adverse Event|30
6837274|NCT00249873|10842869|FG000|Overall Study|Other Serious Adverse Event|86
6837275|NCT00249873|10842870|FG001|Overall Study|Other Serious Adverse Event|97
6837276|NCT00249873|10842869|FG000|Overall Study|Qualifying condition not present|20
6837277|NCT00249873|10842870|FG001|Overall Study|Qualifying condition not present|23
6837278|NCT00249873|10842869|FG000|Overall Study|Contraindication to oral anticoagulant|4
6926904|NCT00843024|10957629|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0
6926905|NCT00843024|10957630|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0
6926906|NCT00843024|10957625|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2
6926907|NCT00843024|10957626|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6
6926908|NCT00843024|10957627|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0
6926909|NCT00843024|10957628|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0
6926910|NCT00843024|10957629|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0
6926911|NCT00843024|10957630|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0
6926912|NCT00843024|10957625|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0
6926913|NCT00843024|10957626|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1
6926914|NCT00843024|10957627|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0
6926915|NCT00843024|10957628|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0
6926916|NCT00843024|10957629|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0
6926917|NCT00843024|10957630|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0
6926918|NCT00843024|10957625|FG000|Single-blind Placebo Run-In Phase|Other|0
6926919|NCT00843024|10957626|FG001|Single-blind Placebo Run-In Phase|Other|1
6926920|NCT00843024|10957627|FG002|Single-blind Placebo Run-In Phase|Other|0
6926921|NCT00843024|10957628|FG003|Single-blind Placebo Run-In Phase|Other|0
6926922|NCT00843024|10957629|FG004|Single-blind Placebo Run-In Phase|Other|0
6926923|NCT00843024|10957630|FG005|Single-blind Placebo Run-In Phase|Other|0
6926924|NCT00843024|10957625|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0
6926925|NCT00843024|10957626|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0
6926926|NCT00843024|10957627|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20
6926927|NCT00843024|10957628|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10
6926928|NCT00843024|10957629|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13
6926929|NCT00843024|10957630|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14
6926930|NCT00843024|10957625|FG000|Double-blind Treatment Phase|Lost to Follow-up|0
6926931|NCT00843024|10957626|FG001|Double-blind Treatment Phase|Lost to Follow-up|0
6926932|NCT00843024|10957627|FG002|Double-blind Treatment Phase|Lost to Follow-up|8
6926933|NCT00843024|10957628|FG003|Double-blind Treatment Phase|Lost to Follow-up|4
6926934|NCT00843024|10957629|FG004|Double-blind Treatment Phase|Lost to Follow-up|4
6926935|NCT00843024|10957630|FG005|Double-blind Treatment Phase|Lost to Follow-up|4
6926936|NCT00843024|10957625|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0
6926937|NCT00843024|10957626|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0
6926938|NCT00843024|10957627|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0
6926939|NCT00843024|10957628|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6
6926940|NCT00843024|10957629|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0
6926941|NCT00843024|10957630|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2
6926942|NCT00843024|10957625|FG000|Double-blind Treatment Phase|Protocol Violation|0
6926943|NCT00843024|10957626|FG001|Double-blind Treatment Phase|Protocol Violation|0
6926944|NCT00843024|10957627|FG002|Double-blind Treatment Phase|Protocol Violation|3
6926945|NCT00843024|10957628|FG003|Double-blind Treatment Phase|Protocol Violation|0
6926946|NCT00843024|10957629|FG004|Double-blind Treatment Phase|Protocol Violation|0
6926947|NCT00843024|10957630|FG005|Double-blind Treatment Phase|Protocol Violation|3
7039480|NCT01710358|11122157|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
7039481|NCT01710358|11122158|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
7039482|NCT01710358|11122159|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1
7039483|NCT01710358|11122157|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
7039484|NCT01710358|11122158|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
7039485|NCT01710358|11122159|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1
7039486|NCT01710358|11122157|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
6926948|NCT00843024|10957625|FG000|Double-blind Treatment Phase|Physician Decision|0
6926949|NCT00843024|10957626|FG001|Double-blind Treatment Phase|Physician Decision|0
6926950|NCT00843024|10957627|FG002|Double-blind Treatment Phase|Physician Decision|0
6926951|NCT00843024|10957628|FG003|Double-blind Treatment Phase|Physician Decision|3
6926952|NCT00843024|10957629|FG004|Double-blind Treatment Phase|Physician Decision|1
6926953|NCT00843024|10957630|FG005|Double-blind Treatment Phase|Physician Decision|1
6926954|NCT00843024|10957625|FG000|Double-blind Treatment Phase|Adverse Event|0
6926955|NCT00843024|10957626|FG001|Double-blind Treatment Phase|Adverse Event|0
6926956|NCT00843024|10957627|FG002|Double-blind Treatment Phase|Adverse Event|0
6926957|NCT00843024|10957628|FG003|Double-blind Treatment Phase|Adverse Event|0
6926958|NCT00843024|10957629|FG004|Double-blind Treatment Phase|Adverse Event|1
6926959|NCT00843024|10957630|FG005|Double-blind Treatment Phase|Adverse Event|1
6926960|NCT00843024|10957625|FG000|Double-blind Treatment Phase|Lack of Efficacy|0
6926961|NCT00843024|10957626|FG001|Double-blind Treatment Phase|Lack of Efficacy|0
6926962|NCT00843024|10957627|FG002|Double-blind Treatment Phase|Lack of Efficacy|0
6926963|NCT00843024|10957628|FG003|Double-blind Treatment Phase|Lack of Efficacy|0
6926964|NCT00843024|10957629|FG004|Double-blind Treatment Phase|Lack of Efficacy|1
6926965|NCT00843024|10957630|FG005|Double-blind Treatment Phase|Lack of Efficacy|0
6926966|NCT00843115|10957643|FG000|Overall Study|Death|4
6926967|NCT00843115|10957643|FG000|Overall Study|Adverse Event|30
6926968|NCT00843115|10957643|FG000|Overall Study|Lost to Follow-up|4
6926969|NCT00843115|10957643|FG000|Overall Study|Withdrawal by Subject|17
6926970|NCT00843115|10957643|FG000|Overall Study|Family wanted meds stopped|1
6926971|NCT00843115|10957643|FG000|Overall Study|Family does not want continuation|1
6926972|NCT00843115|10957643|FG000|Overall Study|Patient forgot to take meds|1
6926973|NCT00843115|10957643|FG000|Overall Study|Does not meet entrance criteria|1
6926974|NCT00843115|10957643|FG000|Overall Study|Physician Decision|1
6926975|NCT00843115|10957643|FG000|Overall Study|Family discontinued meds|1
6926976|NCT00843115|10957643|FG000|Overall Study|patient took for 2 days then stopped|1
6926977|NCT00843115|10957643|FG000|Overall Study|patient never took the medication|1
6926978|NCT00843115|10957643|FG000|Overall Study|hospitalized due to deterioration|1
6926979|NCT00843115|10957643|FG000|Overall Study|week 12 not done|1
6926980|NCT00843115|10957643|FG000|Overall Study|Syndrome De Glissement|1
6926981|NCT00843167|10957649|FG000|Treatment Period|Adverse Event|1
6926982|NCT00843167|10957650|FG001|Treatment Period|Adverse Event|5
6926983|NCT00843167|10957649|FG000|Treatment Period|Withdrawal by Subject|2
6926984|NCT00843167|10957650|FG001|Treatment Period|Withdrawal by Subject|3
6926985|NCT00843193|10957671|FG000|Overall Study|Adverse Event|2
6926986|NCT00843193|10957672|FG001|Overall Study|Adverse Event|4
6926987|NCT00843193|10957671|FG000|Overall Study|Lack of Efficacy|1
6926988|NCT00843193|10957672|FG001|Overall Study|Lack of Efficacy|1
6926989|NCT00843193|10957671|FG000|Overall Study|Protocol Violation|1
6926990|NCT00843193|10957672|FG001|Overall Study|Protocol Violation|2
6926991|NCT00843193|10957671|FG000|Overall Study|Lost to Follow-up|1
6926992|NCT00843193|10957672|FG001|Overall Study|Lost to Follow-up|0
6926993|NCT00843193|10957671|FG000|Overall Study|Physician Decision|0
6926994|NCT00843193|10957672|FG001|Overall Study|Physician Decision|1
6926995|NCT00843193|10957671|FG000|Overall Study|Withdrawal by Subject|3
6926996|NCT00843193|10957672|FG001|Overall Study|Withdrawal by Subject|3
6926997|NCT00843284|10957679|FG000|Overall Study|Adverse Event|39
6926998|NCT00843284|10957679|FG000|Overall Study|Lack of Efficacy|5
6926999|NCT00843284|10957679|FG000|Overall Study|Lost to Follow-up|11
6927000|NCT00843284|10957679|FG000|Overall Study|Other|10
6927001|NCT00843284|10957679|FG000|Overall Study|Withdrawal by Subject|4
6927002|NCT00843284|10957679|FG000|Overall Study|Death|3
6927003|NCT00843492|10957722|FG000|Overall Study|Adverse Event|0
6927004|NCT00843492|10957723|FG001|Overall Study|Adverse Event|3
6927005|NCT00843492|10957722|FG000|Overall Study|Lost to Follow-up|4
6927006|NCT00843492|10957723|FG001|Overall Study|Lost to Follow-up|4
6927007|NCT00843492|10957722|FG000|Overall Study|Withdrawal by Subject|0
6927008|NCT00843492|10957723|FG001|Overall Study|Withdrawal by Subject|4
6927009|NCT00843492|10957722|FG000|Overall Study|Immobilization Stopped|1
6927010|NCT00843492|10957723|FG001|Overall Study|Immobilization Stopped|0
6927011|NCT00843492|10957722|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1
6927012|NCT00843492|10957723|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1
6927013|NCT00843492|10957722|FG000|Overall Study|Orthopedic Surgery|0
6927014|NCT00843492|10957723|FG001|Overall Study|Orthopedic Surgery|2
6927015|NCT00843492|10957722|FG000|Overall Study|Visit Not Performed|1
6927016|NCT00843492|10957723|FG001|Overall Study|Visit Not Performed|0
6927017|NCT00843492|10957722|FG000|Overall Study|Deep-vein Thrombosis|1
6927018|NCT00843492|10957723|FG001|Overall Study|Deep-vein Thrombosis|0
6927019|NCT00843518|10957731|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5
6927020|NCT00843518|10957732|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3
6927021|NCT00843518|10957731|FG000|Period 2 (Double-blind Treatment)|Death|0
6927022|NCT00843518|10957732|FG001|Period 2 (Double-blind Treatment)|Death|1
6927023|NCT00843518|10957731|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2
6927024|NCT00843518|10957732|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3
6927025|NCT00843518|10957731|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2
6927026|NCT00843518|10957732|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1
6927027|NCT00843518|10957731|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2
6927028|NCT00843518|10957732|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5
6927029|NCT00843518|10957731|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2
6927030|NCT00843518|10957732|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0
6927031|NCT00843518|10957731|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7
6927032|NCT00843518|10957732|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7
6927033|NCT00843635|10957762|FG000|Overall Study|Adverse Event|2
6927034|NCT00843635|10957763|FG001|Overall Study|Adverse Event|2
6927035|NCT00843635|10957764|FG002|Overall Study|Adverse Event|0
6927036|NCT00843726|10957787|FG000|Overall Study|Death|1
6927037|NCT00843726|10957788|FG001|Overall Study|Death|0
6927038|NCT00843726|10957787|FG000|Overall Study|Withdrawal by Subject|0
6927039|NCT00843726|10957788|FG001|Overall Study|Withdrawal by Subject|1
6927040|NCT00843778|10957795|FG000|Overall Study|Adverse Event|15
6927041|NCT00843778|10957795|FG000|Overall Study|Lack of Efficacy|14
6927042|NCT00843778|10957795|FG000|Overall Study|Loss of efficacy|2
6927043|NCT00843778|10957795|FG000|Overall Study|Withdrawal by Subject|4
6927044|NCT00843843|10957801|FG000|Overall Study|Physician Decision|1
6927045|NCT00843843|10957802|FG001|Overall Study|Physician Decision|1
6927046|NCT00843843|10957801|FG000|Overall Study|Protocol Violation|1
6927047|NCT00843843|10957802|FG001|Overall Study|Protocol Violation|1
6927048|NCT00843856|10957810|FG000|Overall Study|Lost to Follow-up|1
6927049|NCT00843856|10957811|FG001|Overall Study|Lost to Follow-up|2
6927050|NCT00844194|10957837|FG000|Overall Study|Adverse Event|17
6927051|NCT00844194|10957838|FG001|Overall Study|Adverse Event|5
6927052|NCT00844194|10957837|FG000|Overall Study|Protocol Violation|1
6927053|NCT00844194|10957838|FG001|Overall Study|Protocol Violation|1
6927054|NCT00844194|10957837|FG000|Overall Study|Lost to Follow-up|1
7063871|NCT01953692|11162520|FG005|Overall Study|Adverse Event|2
7063872|NCT01953692|11162521|FG006|Overall Study|Adverse Event|0
7063873|NCT01953692|11162522|FG007|Overall Study|Adverse Event|0
7063874|NCT01953692|11162523|FG008|Overall Study|Adverse Event|0
7063875|NCT01953692|11162515|FG000|Overall Study|Clinical Progression|0
7063876|NCT01953692|11162516|FG001|Overall Study|Clinical Progression|15
7063877|NCT01953692|11162517|FG002|Overall Study|Clinical Progression|7
7063878|NCT01953692|11162518|FG003|Overall Study|Clinical Progression|5
7063879|NCT01953692|11162519|FG004|Overall Study|Clinical Progression|0
7063880|NCT01953692|11162520|FG005|Overall Study|Clinical Progression|7
7063881|NCT01953692|11162521|FG006|Overall Study|Clinical Progression|20
7063882|NCT01953692|11162522|FG007|Overall Study|Clinical Progression|3
7063883|NCT01953692|11162523|FG008|Overall Study|Clinical Progression|3
7063884|NCT01953692|11162515|FG000|Overall Study|Death|5
6927055|NCT00844194|10957838|FG001|Overall Study|Lost to Follow-up|1
6927056|NCT00844194|10957837|FG000|Overall Study|Withdrawal by Subject|2
7063885|NCT01953692|11162516|FG001|Overall Study|Death|0
7063886|NCT01953692|11162517|FG002|Overall Study|Death|2
7063887|NCT01953692|11162518|FG003|Overall Study|Death|2
7063888|NCT01953692|11162519|FG004|Overall Study|Death|1
6927057|NCT00844194|10957838|FG001|Overall Study|Withdrawal by Subject|1
6927058|NCT00844194|10957837|FG000|Overall Study|Lack of Efficacy|3
6927059|NCT00844194|10957838|FG001|Overall Study|Lack of Efficacy|0
6927060|NCT00844194|10957837|FG000|Overall Study|Other reason (not specified)|1
6927061|NCT00844194|10957838|FG001|Overall Study|Other reason (not specified)|0
6927062|NCT00844376|10957852|FG000|Period 1: First Intervention|Withdrawal by Subject|1
6927063|NCT00844376|10957853|FG001|Period 1: First Intervention|Withdrawal by Subject|0
6927064|NCT00844415|10957859|FG000|Overall Study|Withdrawal by Subject|1
6927065|NCT00844428|10957864|FG000|Screening Period|Screen Failure|3
6927066|NCT00844428|10957864|FG000|Extension Treatment Period|Death|1
6927067|NCT00844428|10957864|FG000|Post Treatment Period (Patients Who Disc|Death|1
6927068|NCT00844519|10957870|FG000|Overall Study|Withdrawal by Subject|1
6927069|NCT00844519|10957871|FG001|Overall Study|Withdrawal by Subject|1
6927070|NCT00844519|10957870|FG000|Overall Study|Adverse Event|1
6927071|NCT00844519|10957871|FG001|Overall Study|Adverse Event|0
6927072|NCT00844532|10957877|FG000|Overall Study|Death|16
6927073|NCT00844532|10957877|FG000|Overall Study|Withdrawal by Subject|16
6927074|NCT00844532|10957877|FG000|Overall Study|Lost to Follow-up|7
6927075|NCT00844545|10957881|FG000|Treatment Period (26 Weeks)|Adverse Event|1
6927076|NCT00844545|10957881|FG000|Treatment Period (26 Weeks)|Protocol Violation|1
6927077|NCT00844545|10957881|FG000|Extension Treatment Period|Adverse Event|2
6927078|NCT00844545|10957881|FG000|Post Treatment Period|Withdrawal by Subject|1
6927079|NCT00844558|10957888|FG000|Overall Study|Withdrawal by Subject|9
6927080|NCT00844558|10957889|FG001|Overall Study|Withdrawal by Subject|2
6927081|NCT00844558|10957888|FG000|Overall Study|Death|1
6927082|NCT00844558|10957889|FG001|Overall Study|Death|0
6927083|NCT00844558|10957888|FG000|Overall Study|Protocol Violation|1
6927084|NCT00844558|10957889|FG001|Overall Study|Protocol Violation|1
6927085|NCT00844558|10957888|FG000|Overall Study|Lost to Follow-up|0
6927086|NCT00844558|10957889|FG001|Overall Study|Lost to Follow-up|1
6927087|NCT00844558|10957888|FG000|Overall Study|Physician Decision|1
6927088|NCT00844558|10957889|FG001|Overall Study|Physician Decision|0
6927089|NCT00844597|10957906|FG000|Overall Study|Adverse Event|0
6927090|NCT00844597|10957907|FG001|Overall Study|Adverse Event|0
6927091|NCT00844597|10957908|FG002|Overall Study|Adverse Event|0
6927092|NCT00844597|10957909|FG003|Overall Study|Adverse Event|1
6927093|NCT00844597|10957910|FG004|Overall Study|Adverse Event|0
6927094|NCT00844597|10957911|FG005|Overall Study|Adverse Event|0
6927095|NCT00844649|10957929|FG000|Overall Study|Progressive Disease|196
6927096|NCT00844649|10957930|FG001|Overall Study|Progressive Disease|245
6927097|NCT00844649|10957929|FG000|Overall Study|Adverse Event|128
6927098|NCT00844649|10957930|FG001|Overall Study|Adverse Event|73
6927099|NCT00844649|10957929|FG000|Overall Study|Physician Decision|25
6927100|NCT00844649|10957930|FG001|Overall Study|Physician Decision|18
6927101|NCT00844649|10957929|FG000|Overall Study|Protocol Violation|10
7063889|NCT01953692|11162520|FG005|Overall Study|Death|3
7063890|NCT01953692|11162521|FG006|Overall Study|Death|6
6927102|NCT00844649|10957930|FG001|Overall Study|Protocol Violation|6
6927103|NCT00844649|10957929|FG000|Overall Study|Withdrawal by Subject|28
6927104|NCT00844649|10957930|FG001|Overall Study|Withdrawal by Subject|39
7063891|NCT01953692|11162522|FG007|Overall Study|Death|2
6927105|NCT00844649|10957929|FG000|Overall Study|Other|7
6927106|NCT00844649|10957930|FG001|Overall Study|Other|10
6927107|NCT00844649|10957929|FG000|Overall Study|Withdrew prior to starting treatment|11
6927108|NCT00844649|10957930|FG001|Overall Study|Withdrew prior to starting treatment|27
6927109|NCT00844753|10957946|FG000|Overall Study|Lack of Efficacy|1
6927110|NCT00844753|10957947|FG001|Overall Study|Lack of Efficacy|0
6927111|NCT00844753|10957948|FG002|Overall Study|Lack of Efficacy|2
7063892|NCT01953692|11162523|FG008|Overall Study|Death|1
6927112|NCT00844753|10957949|FG003|Overall Study|Lack of Efficacy|2
6927113|NCT00844753|10957946|FG000|Overall Study|Adverse Event|3
7063893|NCT01953692|11162515|FG000|Overall Study|Excluded Medication|1
6927114|NCT00844753|10957947|FG001|Overall Study|Adverse Event|2
6927115|NCT00844753|10957948|FG002|Overall Study|Adverse Event|5
6927116|NCT00844753|10957949|FG003|Overall Study|Adverse Event|5
6927117|NCT00844753|10957946|FG000|Overall Study|Lost to Follow-up|1
6927118|NCT00844753|10957947|FG001|Overall Study|Lost to Follow-up|1
6927119|NCT00844753|10957948|FG002|Overall Study|Lost to Follow-up|0
6927120|NCT00844753|10957949|FG003|Overall Study|Lost to Follow-up|1
6927121|NCT00844753|10957946|FG000|Overall Study|could not swallow medication|2
6927122|NCT00844753|10957947|FG001|Overall Study|could not swallow medication|0
6927123|NCT00844753|10957948|FG002|Overall Study|could not swallow medication|0
6927124|NCT00844753|10957949|FG003|Overall Study|could not swallow medication|0
6927125|NCT00844753|10957946|FG000|Overall Study|Withdrawal by Subject|1
6927126|NCT00844753|10957947|FG001|Overall Study|Withdrawal by Subject|0
6927127|NCT00844753|10957948|FG002|Overall Study|Withdrawal by Subject|0
6927128|NCT00844753|10957949|FG003|Overall Study|Withdrawal by Subject|3
6927129|NCT00844805|10957959|FG000|Treatment Phase|Adverse Event|5
6927130|NCT00844805|10957960|FG001|Treatment Phase|Adverse Event|1
6927131|NCT00844805|10957961|FG002|Treatment Phase|Adverse Event|0
6927132|NCT00844805|10957962|FG003|Treatment Phase|Adverse Event|0
6927133|NCT00844805|10957959|FG000|Treatment Phase|Withdrawal by Subject|3
6927134|NCT00844805|10957960|FG001|Treatment Phase|Withdrawal by Subject|4
6927135|NCT00844805|10957961|FG002|Treatment Phase|Withdrawal by Subject|0
6927136|NCT00844805|10957962|FG003|Treatment Phase|Withdrawal by Subject|0
6927137|NCT00844805|10957959|FG000|Treatment Phase|Noncompliance With Protocol|1
6927138|NCT00844805|10957960|FG001|Treatment Phase|Noncompliance With Protocol|0
6927139|NCT00844805|10957961|FG002|Treatment Phase|Noncompliance With Protocol|0
6927140|NCT00844805|10957962|FG003|Treatment Phase|Noncompliance With Protocol|0
6927141|NCT00844805|10957959|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1
6927142|NCT00844805|10957960|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2
6927143|NCT00844805|10957961|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0
6927144|NCT00844805|10957962|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0
6927145|NCT00844805|10957959|FG000|Follow-Up Phase|Adverse Event|0
6927146|NCT00844805|10957960|FG001|Follow-Up Phase|Adverse Event|0
6927147|NCT00844805|10957961|FG002|Follow-Up Phase|Adverse Event|1
6927148|NCT00844805|10957962|FG003|Follow-Up Phase|Adverse Event|0
6927149|NCT00844805|10957959|FG000|Follow-Up Phase|Withdrawal by Subject|0
6927150|NCT00844805|10957960|FG001|Follow-Up Phase|Withdrawal by Subject|0
6927151|NCT00844805|10957961|FG002|Follow-Up Phase|Withdrawal by Subject|6
6927152|NCT00844805|10957962|FG003|Follow-Up Phase|Withdrawal by Subject|3
6927153|NCT00844805|10957959|FG000|Follow-Up Phase|Noncompliance With Protocol|0
6927154|NCT00844805|10957960|FG001|Follow-Up Phase|Noncompliance With Protocol|0
6927155|NCT00844805|10957961|FG002|Follow-Up Phase|Noncompliance With Protocol|0
6927156|NCT00844805|10957962|FG003|Follow-Up Phase|Noncompliance With Protocol|1
6927157|NCT00844805|10957959|FG000|Follow-Up Phase|Relapse/Recurrence|0
6927158|NCT00844805|10957960|FG001|Follow-Up Phase|Relapse/Recurrence|0
6927159|NCT00844805|10957961|FG002|Follow-Up Phase|Relapse/Recurrence|2
6927160|NCT00844805|10957962|FG003|Follow-Up Phase|Relapse/Recurrence|4
6927161|NCT00844805|10957959|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
6927162|NCT00844805|10957960|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
6927163|NCT00844805|10957961|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
6927164|NCT00844805|10957962|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1
6927165|NCT00844831|10957973|FG000|Overall Study|Withdrawal by Subject|4
6927166|NCT00844831|10957973|FG000|Overall Study|Adverse Event|1
6927167|NCT00844831|10957973|FG000|Overall Study|Physician Decision|1
6927168|NCT00844844|10957981|FG000|Treatment Period (26 Weeks)|Adverse Event|1
6927169|NCT00844844|10957981|FG000|Treatment Period (26 Weeks)|Protocol Violation|1
6927170|NCT00844844|10957981|FG000|Extension Treatment Period|Adverse Event|2
6927171|NCT00844844|10957981|FG000|Post Treatment Period|Withdrawal by Subject|1
6927172|NCT00844857|10957987|FG000|Overall Study|Adverse Event|24
6927173|NCT00844857|10957988|FG001|Overall Study|Adverse Event|5
6927174|NCT00844857|10957987|FG000|Overall Study|Sponsor Decision|1
6927175|NCT00844857|10957988|FG001|Overall Study|Sponsor Decision|1
6927176|NCT00844857|10957987|FG000|Overall Study|Physician Decision|2
6927177|NCT00844857|10957988|FG001|Overall Study|Physician Decision|0
6927178|NCT00844857|10957987|FG000|Overall Study|Parent/Caregiver Decision|6
6927179|NCT00844857|10957988|FG001|Overall Study|Parent/Caregiver Decision|2
6927180|NCT00844857|10957987|FG000|Overall Study|Withdrawal by Subject|8
6927181|NCT00844857|10957988|FG001|Overall Study|Withdrawal by Subject|7
6927182|NCT00844857|10957987|FG000|Overall Study|Protocol Violation|6
6927183|NCT00844857|10957988|FG001|Overall Study|Protocol Violation|0
6927184|NCT00844857|10957987|FG000|Overall Study|Lack of Efficacy|5
6927185|NCT00844857|10957988|FG001|Overall Study|Lack of Efficacy|5
6927186|NCT00844857|10957987|FG000|Overall Study|Clinical Relapse|0
6927187|NCT00844857|10957988|FG001|Overall Study|Clinical Relapse|1
6927188|NCT00844857|10957987|FG000|Overall Study|Entry Criteria Not Met|0
6927189|NCT00844857|10957988|FG001|Overall Study|Entry Criteria Not Met|1
6927190|NCT00844857|10957987|FG000|Overall Study|Lost to Follow-up|2
6927191|NCT00844857|10957988|FG001|Overall Study|Lost to Follow-up|3
6927192|NCT00844857|10957987|FG000|Overall Study|Did Not Take Study Drug|3
6927193|NCT00844857|10957988|FG001|Overall Study|Did Not Take Study Drug|1
6927194|NCT00844857|10957987|FG000|Overall Study|Good Clinical Practice Violations|21
6927195|NCT00844857|10957988|FG001|Overall Study|Good Clinical Practice Violations|11
6974958|NCT01190930|11027132|FG001|Induction|No treatment|0
6974959|NCT01190930|11027133|FG002|Induction|No treatment|0
6974960|NCT01190930|11027134|FG003|Induction|No treatment|0
6974961|NCT01190930|11027135|FG004|Induction|No treatment|0
6974962|NCT01190930|11027136|FG005|Induction|No treatment|0
6974963|NCT01190930|11027137|FG006|Induction|No treatment|0
6974964|NCT01190930|11027138|FG007|Induction|No treatment|0
6974965|NCT01190930|11027139|FG008|Induction|No treatment|0
6974966|NCT01190930|11027140|FG009|Induction|No treatment|0
6974967|NCT01190930|11027131|FG000|Induction|Ineligible|69
6974968|NCT01190930|11027132|FG001|Induction|Ineligible|4
6974969|NCT01190930|11027133|FG002|Induction|Ineligible|0
6974970|NCT01190930|11027134|FG003|Induction|Ineligible|0
6974971|NCT01190930|11027135|FG004|Induction|Ineligible|0
6974972|NCT01190930|11027136|FG005|Induction|Ineligible|0
6974973|NCT01190930|11027137|FG006|Induction|Ineligible|0
6974974|NCT01190930|11027138|FG007|Induction|Ineligible|0
6974975|NCT01190930|11027139|FG008|Induction|Ineligible|0
6974976|NCT01190930|11027140|FG009|Induction|Ineligible|0
6974977|NCT01190930|11027131|FG000|Post Induction Pre-Maintenance|Adverse Event|0
6974978|NCT01190930|11027132|FG001|Post Induction Pre-Maintenance|Adverse Event|0
6974979|NCT01190930|11027133|FG002|Post Induction Pre-Maintenance|Adverse Event|8
6974980|NCT01190930|11027134|FG003|Post Induction Pre-Maintenance|Adverse Event|0
6974981|NCT01190930|11027135|FG004|Post Induction Pre-Maintenance|Adverse Event|0
7039487|NCT01710358|11122158|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1
7039488|NCT01710358|11122159|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
7039489|NCT01710358|11122157|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1
6974982|NCT01190930|11027136|FG005|Post Induction Pre-Maintenance|Adverse Event|0
6974983|NCT01190930|11027137|FG006|Post Induction Pre-Maintenance|Adverse Event|0
6974984|NCT01190930|11027138|FG007|Post Induction Pre-Maintenance|Adverse Event|0
6974985|NCT01190930|11027139|FG008|Post Induction Pre-Maintenance|Adverse Event|0
6974986|NCT01190930|11027140|FG009|Post Induction Pre-Maintenance|Adverse Event|0
6974987|NCT01190930|11027131|FG000|Post Induction Pre-Maintenance|Death|0
6974988|NCT01190930|11027132|FG001|Post Induction Pre-Maintenance|Death|0
6974989|NCT01190930|11027133|FG002|Post Induction Pre-Maintenance|Death|8
6974990|NCT01190930|11027134|FG003|Post Induction Pre-Maintenance|Death|4
6974991|NCT01190930|11027135|FG004|Post Induction Pre-Maintenance|Death|0
6974992|NCT01190930|11027136|FG005|Post Induction Pre-Maintenance|Death|0
6974993|NCT01190930|11027137|FG006|Post Induction Pre-Maintenance|Death|0
6974994|NCT01190930|11027138|FG007|Post Induction Pre-Maintenance|Death|0
6974995|NCT01190930|11027139|FG008|Post Induction Pre-Maintenance|Death|0
6974996|NCT01190930|11027140|FG009|Post Induction Pre-Maintenance|Death|0
6974997|NCT01190930|11027131|FG000|Post Induction Pre-Maintenance|Physician Decision|0
6974998|NCT01190930|11027132|FG001|Post Induction Pre-Maintenance|Physician Decision|2
6974999|NCT01190930|11027133|FG002|Post Induction Pre-Maintenance|Physician Decision|35
6975000|NCT01190930|11027134|FG003|Post Induction Pre-Maintenance|Physician Decision|7
6975001|NCT01190930|11027135|FG004|Post Induction Pre-Maintenance|Physician Decision|5
6975002|NCT01190930|11027136|FG005|Post Induction Pre-Maintenance|Physician Decision|3
6975003|NCT01190930|11027137|FG006|Post Induction Pre-Maintenance|Physician Decision|0
6975004|NCT01190930|11027138|FG007|Post Induction Pre-Maintenance|Physician Decision|0
6975005|NCT01190930|11027139|FG008|Post Induction Pre-Maintenance|Physician Decision|0
6975006|NCT01190930|11027140|FG009|Post Induction Pre-Maintenance|Physician Decision|0
6975007|NCT01190930|11027131|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0
6975008|NCT01190930|11027132|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1
6975009|NCT01190930|11027133|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5
6975010|NCT01190930|11027134|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2
6975011|NCT01190930|11027135|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0
6975012|NCT01190930|11027136|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0
6975013|NCT01190930|11027137|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0
6975014|NCT01190930|11027138|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0
6975015|NCT01190930|11027139|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0
6975016|NCT01190930|11027140|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0
6975017|NCT01190930|11027131|FG000|Post Induction Pre-Maintenance|Refusal|0
6975018|NCT01190930|11027132|FG001|Post Induction Pre-Maintenance|Refusal|2
6975019|NCT01190930|11027133|FG002|Post Induction Pre-Maintenance|Refusal|694
6975020|NCT01190930|11027134|FG003|Post Induction Pre-Maintenance|Refusal|4
6975021|NCT01190930|11027135|FG004|Post Induction Pre-Maintenance|Refusal|0
6975022|NCT01190930|11027136|FG005|Post Induction Pre-Maintenance|Refusal|3
6975023|NCT01190930|11027137|FG006|Post Induction Pre-Maintenance|Refusal|0
6975024|NCT01190930|11027138|FG007|Post Induction Pre-Maintenance|Refusal|0
6975025|NCT01190930|11027139|FG008|Post Induction Pre-Maintenance|Refusal|0
6975026|NCT01190930|11027140|FG009|Post Induction Pre-Maintenance|Refusal|0
6975027|NCT01190930|11027131|FG000|Post Induction Pre-Maintenance|Inevaluable|0
6975028|NCT01190930|11027132|FG001|Post Induction Pre-Maintenance|Inevaluable|0
6975029|NCT01190930|11027133|FG002|Post Induction Pre-Maintenance|Inevaluable|6
6975030|NCT01190930|11027134|FG003|Post Induction Pre-Maintenance|Inevaluable|0
6975031|NCT01190930|11027135|FG004|Post Induction Pre-Maintenance|Inevaluable|0
6975032|NCT01190930|11027136|FG005|Post Induction Pre-Maintenance|Inevaluable|0
6927196|NCT00844883|10957997|FG000|Overall Study|Bridged to liver transplant|3
6927197|NCT00844883|10957997|FG000|Overall Study|Bridged to resection|1
6927198|NCT00844896|10958003|FG000|Overall Study|Lost to Follow-up|12
6927199|NCT00844896|10958004|FG001|Overall Study|Lost to Follow-up|16
6927200|NCT00844896|10958003|FG000|Overall Study|Parents did not have time to complete|0
6927201|NCT00844896|10958004|FG001|Overall Study|Parents did not have time to complete|1
6927202|NCT00845065|10958043|FG000|Overall Study|Adverse Event|3
6927203|NCT00845065|10958044|FG001|Overall Study|Adverse Event|23
6927204|NCT00845065|10958043|FG000|Overall Study|Lack of Efficacy|43
6927205|NCT00845065|10958044|FG001|Overall Study|Lack of Efficacy|21
6927206|NCT00845065|10958043|FG000|Overall Study|Non-Medical Reasons|1
6927207|NCT00845065|10958044|FG001|Overall Study|Non-Medical Reasons|11
6927208|NCT00845182|10958064|FG000|Overall Study|Lost to Follow-up|3
6927209|NCT00845182|10958065|FG001|Overall Study|Lost to Follow-up|3
6927210|NCT00845182|10958066|FG002|Overall Study|Lost to Follow-up|4
6927211|NCT00845182|10958064|FG000|Overall Study|Adverse Event|0
6927212|NCT00845182|10958065|FG001|Overall Study|Adverse Event|1
6927213|NCT00845182|10958066|FG002|Overall Study|Adverse Event|1
6927214|NCT00845182|10958064|FG000|Overall Study|Physician Decision|0
6927215|NCT00845182|10958065|FG001|Overall Study|Physician Decision|0
6927216|NCT00845182|10958066|FG002|Overall Study|Physician Decision|1
6927217|NCT00845429|10958090|FG000|Overall Study|Protocol Violation|5
6927218|NCT00845429|10958091|FG001|Overall Study|Protocol Violation|4
6927219|NCT00845429|10958092|FG002|Overall Study|Protocol Violation|7
6927220|NCT00845429|10958090|FG000|Overall Study|Lost to Follow-up|7
6927221|NCT00845429|10958091|FG001|Overall Study|Lost to Follow-up|9
6927222|NCT00845429|10958092|FG002|Overall Study|Lost to Follow-up|10
6927223|NCT00845429|10958090|FG000|Overall Study|Withdrawal by Subject|2
6927224|NCT00845429|10958091|FG001|Overall Study|Withdrawal by Subject|2
6927225|NCT00845429|10958092|FG002|Overall Study|Withdrawal by Subject|2
6927226|NCT00845429|10958090|FG000|Overall Study|Serious adverse event|0
6927227|NCT00845429|10958091|FG001|Overall Study|Serious adverse event|0
6927228|NCT00845429|10958092|FG002|Overall Study|Serious adverse event|1
6927229|NCT00845520|10958121|FG000|Overall Study|Death|1
6927230|NCT00845520|10958122|FG001|Overall Study|Death|2
6927231|NCT00845520|10958123|FG002|Overall Study|Death|0
6927232|NCT00845520|10958121|FG000|Overall Study|Lost to Follow-up|1
6927233|NCT00845520|10958122|FG001|Overall Study|Lost to Follow-up|0
6927234|NCT00845520|10958123|FG002|Overall Study|Lost to Follow-up|0
6927235|NCT00845520|10958121|FG000|Overall Study|Adverse Event|0
6927236|NCT00845520|10958122|FG001|Overall Study|Adverse Event|0
6927237|NCT00845520|10958123|FG002|Overall Study|Adverse Event|1
6927238|NCT00845650|10958143|FG000|Overall Study|Withdrawal by Subject|0
6927239|NCT00845650|10958144|FG001|Overall Study|Withdrawal by Subject|0
6927240|NCT00845650|10958145|FG002|Overall Study|Withdrawal by Subject|0
6927241|NCT00845650|10958146|FG003|Overall Study|Withdrawal by Subject|0
6927242|NCT00845650|10958147|FG004|Overall Study|Withdrawal by Subject|2
6927243|NCT00845650|10958148|FG005|Overall Study|Withdrawal by Subject|0
6927244|NCT00845650|10958143|FG000|Overall Study|Lost to Follow-up|0
6927245|NCT00845650|10958144|FG001|Overall Study|Lost to Follow-up|0
6927246|NCT00845650|10958145|FG002|Overall Study|Lost to Follow-up|3
6927247|NCT00845650|10958146|FG003|Overall Study|Lost to Follow-up|1
6927248|NCT00845650|10958147|FG004|Overall Study|Lost to Follow-up|0
6927249|NCT00845650|10958148|FG005|Overall Study|Lost to Follow-up|1
6927250|NCT00845650|10958143|FG000|Overall Study|Sponsor hold on dosing|0
6927251|NCT00845650|10958144|FG001|Overall Study|Sponsor hold on dosing|0
6927252|NCT00845650|10958145|FG002|Overall Study|Sponsor hold on dosing|0
6927253|NCT00845650|10958146|FG003|Overall Study|Sponsor hold on dosing|0
6927254|NCT00845650|10958147|FG004|Overall Study|Sponsor hold on dosing|1
6927255|NCT00845650|10958148|FG005|Overall Study|Sponsor hold on dosing|1
6927256|NCT00845650|10958143|FG000|Overall Study|Unable to access IV line|1
6927257|NCT00845650|10958144|FG001|Overall Study|Unable to access IV line|0
6927258|NCT00845650|10958145|FG002|Overall Study|Unable to access IV line|0
6927259|NCT00845650|10958146|FG003|Overall Study|Unable to access IV line|0
6927260|NCT00845650|10958147|FG004|Overall Study|Unable to access IV line|0
6927261|NCT00845650|10958148|FG005|Overall Study|Unable to access IV line|0
6927262|NCT00845676|10958173|FG000|Overall Study|Virologic breakthrough at week 20|1
6927263|NCT00845676|10958173|FG000|Overall Study|Adverse Event|1
6927264|NCT00845728|10958180|FG000|Overall Study|Abnormal laboratory value (s)|2
7063894|NCT01953692|11162516|FG001|Overall Study|Excluded Medication|0
7063895|NCT01953692|11162517|FG002|Overall Study|Excluded Medication|0
7063896|NCT01953692|11162518|FG003|Overall Study|Excluded Medication|0
6927265|NCT00845728|10958181|FG001|Overall Study|Abnormal laboratory value (s)|2
6927266|NCT00845728|10958180|FG000|Overall Study|Patient's inability to use the device|4
6927267|NCT00845728|10958181|FG001|Overall Study|Patient's inability to use the device|6
6927268|NCT00845728|10958180|FG000|Overall Study|Abnormal test procedure result (s)|7
6927269|NCT00845728|10958181|FG001|Overall Study|Abnormal test procedure result (s)|2
6927270|NCT00845728|10958180|FG000|Overall Study|Lost to Follow-up|22
6927271|NCT00845728|10958181|FG001|Overall Study|Lost to Follow-up|13
6927272|NCT00845728|10958180|FG000|Overall Study|Death|24
6927273|NCT00845728|10958181|FG001|Overall Study|Death|26
6927274|NCT00845728|10958180|FG000|Overall Study|Administrative Problems|34
6927275|NCT00845728|10958181|FG001|Overall Study|Administrative Problems|26
7063897|NCT01953692|11162519|FG004|Overall Study|Excluded Medication|0
6927276|NCT00845728|10958180|FG000|Overall Study|Protocol Violation|36
6927277|NCT00845728|10958181|FG001|Overall Study|Protocol Violation|24
6927278|NCT00845728|10958180|FG000|Overall Study|Lack of Efficacy|51
6927279|NCT00845728|10958181|FG001|Overall Study|Lack of Efficacy|39
6927280|NCT00845728|10958180|FG000|Overall Study|Adverse Event|101
6927281|NCT00845728|10958181|FG001|Overall Study|Adverse Event|96
6927282|NCT00845728|10958180|FG000|Overall Study|Withdrawal by Subject|105
6927283|NCT00845728|10958181|FG001|Overall Study|Withdrawal by Subject|108
6927284|NCT00845832|10958190|FG000|Treatment Period|Adverse Event|0
6927285|NCT00845832|10958191|FG001|Treatment Period|Adverse Event|2
6927286|NCT00845832|10958192|FG002|Treatment Period|Adverse Event|0
6927287|NCT00845832|10958190|FG000|Treatment Period|Protocol Violation|1
6927288|NCT00845832|10958191|FG001|Treatment Period|Protocol Violation|1
6927289|NCT00845832|10958192|FG002|Treatment Period|Protocol Violation|0
6927290|NCT00845832|10958190|FG000|Safety Follow-Up|Withdrawal by Subject|1
6927291|NCT00845832|10958191|FG001|Safety Follow-Up|Withdrawal by Subject|0
6927292|NCT00845832|10958192|FG002|Safety Follow-Up|Withdrawal by Subject|0
6927293|NCT00845832|10958190|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0
6927294|NCT00845832|10958191|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0
6927295|NCT00845832|10958192|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7
6927296|NCT00845858|10958203|FG000|Overall Study|Withdrawal by Subject|5
6927297|NCT00845858|10958204|FG001|Overall Study|Withdrawal by Subject|1
6927298|NCT00845858|10958205|FG002|Overall Study|Withdrawal by Subject|1
6927299|NCT00845858|10958203|FG000|Overall Study|Adverse Event|3
6927300|NCT00845858|10958204|FG001|Overall Study|Adverse Event|8
6927301|NCT00845858|10958205|FG002|Overall Study|Adverse Event|4
6927302|NCT00845858|10958203|FG000|Overall Study|Protocol Violation|0
6927303|NCT00845858|10958204|FG001|Overall Study|Protocol Violation|0
6927304|NCT00845858|10958205|FG002|Overall Study|Protocol Violation|1
6927305|NCT00845858|10958203|FG000|Overall Study|not eligible|0
6927306|NCT00845858|10958204|FG001|Overall Study|not eligible|3
6927307|NCT00845858|10958205|FG002|Overall Study|not eligible|2
6927308|NCT00845871|10958216|FG000|Assessment Period|Adverse Event|2
6927309|NCT00845871|10958216|FG000|Assessment Period|Abnormal laboratory values|1
6927310|NCT00845871|10958216|FG000|Assessment Period|Abnormal test procedure results|1
6927311|NCT00845871|10958216|FG000|Assessment Period|Patient withdrew consent|3
6927312|NCT00845897|10958243|FG000|Overall Study|Lost to Follow-up|1
6927313|NCT00845897|10958244|FG001|Overall Study|Lost to Follow-up|1
6927314|NCT00845897|10958245|FG002|Overall Study|Lost to Follow-up|0
6927315|NCT00845897|10958243|FG000|Overall Study|Withdrawal by Subject|0
6927316|NCT00845897|10958244|FG001|Overall Study|Withdrawal by Subject|3
6927317|NCT00845897|10958245|FG002|Overall Study|Withdrawal by Subject|2
6927318|NCT00845897|10958243|FG000|Overall Study|Ulcer did not heal|1
6927319|NCT00845897|10958244|FG001|Overall Study|Ulcer did not heal|0
6927320|NCT00845897|10958245|FG002|Overall Study|Ulcer did not heal|1
6927321|NCT00845897|10958243|FG000|Overall Study|Too ill to participate|0
6927322|NCT00845897|10958244|FG001|Overall Study|Too ill to participate|1
6927323|NCT00845897|10958245|FG002|Overall Study|Too ill to participate|0
6927324|NCT00846027|10958262|FG000|Overall Study|Death|3
6927325|NCT00846027|10958262|FG000|Overall Study|Disease Progression|30
6927326|NCT00846027|10958262|FG000|Overall Study|Toxicity|12
6927327|NCT00846027|10958262|FG000|Overall Study|Patient Decision|7
6927328|NCT00846027|10958262|FG000|Overall Study|Investigator Discretion|29
6927329|NCT00846027|10958262|FG000|Overall Study|Protocol Violation|2
6927330|NCT00846027|10958262|FG000|Overall Study|Subject Not Treated|7
6927331|NCT00846040|10958269|FG000|Baseline: Days 1-5|Withdrawal by Subject|1
6927332|NCT00846040|10958270|FG001|Baseline: Days 1-5|Withdrawal by Subject|0
6927333|NCT00846040|10958271|FG002|Baseline: Days 1-5|Withdrawal by Subject|0
6927334|NCT00846040|10958269|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0
6927335|NCT00846040|10958270|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2
6927336|NCT00846040|10958271|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0
7039490|NCT01710358|11122158|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2
7039491|NCT01710358|11122159|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0
7039492|NCT01710358|11122157|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4
7039493|NCT01710358|11122158|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3
7039494|NCT01710358|11122159|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7
7039495|NCT01710358|11122157|FG000|Rescue Period|Adverse Event|0
7039496|NCT01710358|11122158|FG001|Rescue Period|Adverse Event|15
7039497|NCT01710358|11122159|FG002|Rescue Period|Adverse Event|0
7039498|NCT01710358|11122157|FG000|Rescue Period|Death|0
6927337|NCT00846053|10958282|FG000|Overall Study|Physician Decision|3
7039499|NCT01710358|11122158|FG001|Rescue Period|Death|1
6927338|NCT00846053|10958283|FG001|Overall Study|Physician Decision|0
6927339|NCT00846365|10958313|FG000|Overall Study|Adverse Event|20
6927340|NCT00846365|10958314|FG001|Overall Study|Adverse Event|30
6927341|NCT00846365|10958315|FG002|Overall Study|Adverse Event|11
6927342|NCT00846365|10958313|FG000|Overall Study|Protocol Violation|5
6927343|NCT00846365|10958314|FG001|Overall Study|Protocol Violation|4
6927344|NCT00846365|10958315|FG002|Overall Study|Protocol Violation|0
6927345|NCT00846365|10958313|FG000|Overall Study|Lost to Follow-up|8
6927346|NCT00846365|10958314|FG001|Overall Study|Lost to Follow-up|2
6927347|NCT00846365|10958315|FG002|Overall Study|Lost to Follow-up|5
6927348|NCT00846365|10958313|FG000|Overall Study|Withdrawal by Subject|11
6927349|NCT00846365|10958314|FG001|Overall Study|Withdrawal by Subject|11
6927350|NCT00846365|10958315|FG002|Overall Study|Withdrawal by Subject|9
6927351|NCT00846365|10958313|FG000|Overall Study|Pregnancy|1
6927352|NCT00846365|10958314|FG001|Overall Study|Pregnancy|0
6927353|NCT00846365|10958315|FG002|Overall Study|Pregnancy|0
6927354|NCT00846365|10958313|FG000|Overall Study|Lack of Efficacy|1
6927355|NCT00846365|10958314|FG001|Overall Study|Lack of Efficacy|1
6927356|NCT00846365|10958315|FG002|Overall Study|Lack of Efficacy|2
6927357|NCT00846365|10958313|FG000|Overall Study|Other|9
6927358|NCT00846365|10958314|FG001|Overall Study|Other|1
6927359|NCT00846365|10958315|FG002|Overall Study|Other|6
6927360|NCT00846391|10958326|FG000|Overall Study|Physician Decision|0
6927361|NCT00846391|10958327|FG001|Overall Study|Physician Decision|0
6927362|NCT00846391|10958328|FG002|Overall Study|Physician Decision|1
6927363|NCT00846391|10958326|FG000|Overall Study|Study Terminated by Sponsor|1
6927364|NCT00846391|10958327|FG001|Overall Study|Study Terminated by Sponsor|2
6927365|NCT00846391|10958328|FG002|Overall Study|Study Terminated by Sponsor|2
6927366|NCT00846495|10958343|FG000|Overall Study|Lost to Follow-up|1
6927367|NCT00846495|10958344|FG001|Overall Study|Lost to Follow-up|0
6927368|NCT00846495|10958343|FG000|Overall Study|Adverse Event|5
6927369|NCT00846495|10958344|FG001|Overall Study|Adverse Event|1
6927370|NCT00846495|10958343|FG000|Overall Study|Lack of Efficacy|1
6927371|NCT00846495|10958344|FG001|Overall Study|Lack of Efficacy|2
6927372|NCT00846495|10958343|FG000|Overall Study|Physician Decision|1
6927373|NCT00846495|10958344|FG001|Overall Study|Physician Decision|0
6927374|NCT00846521|10958350|FG000|Overall Study|Withdrawal by Subject|5
6927375|NCT00846521|10958350|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5
6927376|NCT00846521|10958350|FG000|Overall Study|Protocol Violation|1
6927377|NCT00846586|10958374|FG000|Overall Study|Adverse Event|20
6927378|NCT00846586|10958375|FG001|Overall Study|Adverse Event|10
6927379|NCT00846586|10958374|FG000|Overall Study|Subject withdrew consent|8
6927380|NCT00846586|10958375|FG001|Overall Study|Subject withdrew consent|10
6927381|NCT00846586|10958374|FG000|Overall Study|Administrative problems|5
6927382|NCT00846586|10958375|FG001|Overall Study|Administrative problems|4
6927383|NCT00846586|10958374|FG000|Overall Study|Death|2
6927384|NCT00846586|10958375|FG001|Overall Study|Death|0
6927385|NCT00846586|10958374|FG000|Overall Study|Protocol deviation|2
6927386|NCT00846586|10958375|FG001|Overall Study|Protocol deviation|6
6927387|NCT00846586|10958374|FG000|Overall Study|Abnormal test procedure result(s)|1
6927388|NCT00846586|10958375|FG001|Overall Study|Abnormal test procedure result(s)|0
6927389|NCT00846586|10958374|FG000|Overall Study|Lost to Follow-up|1
6927390|NCT00846586|10958375|FG001|Overall Study|Lost to Follow-up|4
6927391|NCT00846586|10958374|FG000|Overall Study|Unsatisfactory therapeutic effect|0
6927392|NCT00846586|10958375|FG001|Overall Study|Unsatisfactory therapeutic effect|1
6927393|NCT00846768|10958392|FG000|Overall Study|Adverse Event|0
6927394|NCT00846768|10958393|FG001|Overall Study|Adverse Event|1
6927395|NCT00846768|10958394|FG002|Overall Study|Adverse Event|0
6927396|NCT00846768|10958395|FG003|Overall Study|Adverse Event|0
6927397|NCT00846807|10958405|FG000|Overall Study|Adverse Event|270
6927398|NCT00846807|10958405|FG000|Overall Study|Lost to Follow-up|94
6927399|NCT00846807|10958405|FG000|Overall Study|Withdrawal by Subject|56
6927400|NCT00846807|10958405|FG000|Overall Study|Non compliant with European label|7
6927401|NCT00846807|10958405|FG000|Overall Study|Switch to other anticoagulants|89
6927402|NCT00846807|10958405|FG000|Overall Study|No prescription after hospital discharge|56
6927403|NCT00846807|10958405|FG000|Overall Study|Other|60
6927404|NCT00846846|10958409|FG000|Overall Study|Death|56
6927405|NCT00846846|10958409|FG000|Overall Study|Withdrawal by Subject|19
6927406|NCT00847015|10958413|FG000|Overall Study|Withdrawal by Subject|1
6927407|NCT00847015|10958413|FG000|Overall Study|declined any surgery|1
6927408|NCT00847015|10958413|FG000|Overall Study|partial cystectomy vs radical cystectomy|1
6927409|NCT00847132|10958419|FG000|Overall Study|Death|1
6927410|NCT00847132|10958420|FG001|Overall Study|Death|1
6927411|NCT00847145|10958434|FG000|Overall Study|AE or Death|0
6927412|NCT00847145|10958435|FG001|Overall Study|AE or Death|1
6927413|NCT00847145|10958436|FG002|Overall Study|AE or Death|1
6927414|NCT00847145|10958437|FG003|Overall Study|AE or Death|0
6927415|NCT00847145|10958438|FG004|Overall Study|AE or Death|0
6927416|NCT00847145|10958439|FG005|Overall Study|AE or Death|0
6927417|NCT00847145|10958440|FG006|Overall Study|AE or Death|0
6927418|NCT00847145|10958441|FG007|Overall Study|AE or Death|0
7063898|NCT01953692|11162520|FG005|Overall Study|Excluded Medication|0
7063899|NCT01953692|11162521|FG006|Overall Study|Excluded Medication|0
6927419|NCT00847145|10958434|FG000|Overall Study|Withdrawal by Subject|3
6927420|NCT00847145|10958435|FG001|Overall Study|Withdrawal by Subject|4
6927421|NCT00847145|10958436|FG002|Overall Study|Withdrawal by Subject|6
6927422|NCT00847145|10958437|FG003|Overall Study|Withdrawal by Subject|1
6927423|NCT00847145|10958438|FG004|Overall Study|Withdrawal by Subject|0
6927424|NCT00847145|10958439|FG005|Overall Study|Withdrawal by Subject|0
6927425|NCT00847145|10958440|FG006|Overall Study|Withdrawal by Subject|1
6927426|NCT00847145|10958441|FG007|Overall Study|Withdrawal by Subject|1
6927427|NCT00847145|10958434|FG000|Overall Study|Lost to Follow-up|3
7063900|NCT01953692|11162522|FG007|Overall Study|Excluded Medication|0
6927428|NCT00847145|10958435|FG001|Overall Study|Lost to Follow-up|1
6927429|NCT00847145|10958436|FG002|Overall Study|Lost to Follow-up|1
6927430|NCT00847145|10958437|FG003|Overall Study|Lost to Follow-up|0
6927431|NCT00847145|10958438|FG004|Overall Study|Lost to Follow-up|4
6927432|NCT00847145|10958439|FG005|Overall Study|Lost to Follow-up|4
6927433|NCT00847145|10958440|FG006|Overall Study|Lost to Follow-up|8
6927434|NCT00847145|10958441|FG007|Overall Study|Lost to Follow-up|2
6927435|NCT00847145|10958434|FG000|Overall Study|Inappropriate enrollment|0
6927436|NCT00847145|10958435|FG001|Overall Study|Inappropriate enrollment|0
6927437|NCT00847145|10958436|FG002|Overall Study|Inappropriate enrollment|0
6927438|NCT00847145|10958437|FG003|Overall Study|Inappropriate enrollment|0
6927439|NCT00847145|10958438|FG004|Overall Study|Inappropriate enrollment|1
6927440|NCT00847145|10958439|FG005|Overall Study|Inappropriate enrollment|0
6927441|NCT00847145|10958440|FG006|Overall Study|Inappropriate enrollment|0
6927442|NCT00847145|10958441|FG007|Overall Study|Inappropriate enrollment|0
6927443|NCT00847145|10958434|FG000|Overall Study|Protocol Violation|0
6927444|NCT00847145|10958435|FG001|Overall Study|Protocol Violation|0
6927445|NCT00847145|10958436|FG002|Overall Study|Protocol Violation|3
6927446|NCT00847145|10958437|FG003|Overall Study|Protocol Violation|0
6927447|NCT00847145|10958438|FG004|Overall Study|Protocol Violation|1
6927448|NCT00847145|10958439|FG005|Overall Study|Protocol Violation|0
6927449|NCT00847145|10958440|FG006|Overall Study|Protocol Violation|0
6927450|NCT00847145|10958441|FG007|Overall Study|Protocol Violation|1
6927451|NCT00847197|10958475|FG000|Overall Study|Adverse Event|21
6927452|NCT00847197|10958476|FG001|Overall Study|Adverse Event|3
6927453|NCT00847197|10958475|FG000|Overall Study|Protocol Violation|0
6927454|NCT00847197|10958476|FG001|Overall Study|Protocol Violation|1
6927455|NCT00847197|10958475|FG000|Overall Study|Withdrawal by Subject|3
6927456|NCT00847197|10958476|FG001|Overall Study|Withdrawal by Subject|1
6927457|NCT00847301|10958500|FG000|Overall Study|Adverse Event|35
6927458|NCT00847301|10958500|FG000|Overall Study|Switch to other anticoagulants|16
6927459|NCT00847301|10958500|FG000|Overall Study|Lost to Follow-up|1
6927460|NCT00847301|10958500|FG000|Overall Study|No prescription after hospital discharge|1
6927461|NCT00847301|10958500|FG000|Overall Study|Other reason not defined above|1
6927462|NCT00847379|10958507|FG000|Overall Study|Study terminated by Sponsor|59
6927463|NCT00847379|10958508|FG001|Overall Study|Study terminated by Sponsor|57
6927464|NCT00847379|10958509|FG002|Overall Study|Study terminated by Sponsor|57
6927465|NCT00847535|10958523|FG000|Overall Study|Withdrawal by Subject|2
6927466|NCT00847535|10958524|FG001|Overall Study|Withdrawal by Subject|1
6927467|NCT00847535|10958525|FG002|Overall Study|Withdrawal by Subject|1
6927468|NCT00847535|10958523|FG000|Overall Study|Lost to Follow-up|0
6927469|NCT00847535|10958524|FG001|Overall Study|Lost to Follow-up|1
6927470|NCT00847535|10958525|FG002|Overall Study|Lost to Follow-up|0
6927471|NCT00847561|10958532|FG000|Overall Study|Withdrawal by Subject|4
6927472|NCT00847561|10958533|FG001|Overall Study|Withdrawal by Subject|3
6927473|NCT00847561|10958532|FG000|Overall Study|Unable to schedule|9
6927474|NCT00847561|10958533|FG001|Overall Study|Unable to schedule|1
6927475|NCT00847613|10958552|FG000|Overall Study|Ongoing at cut-off date|250
6927476|NCT00847613|10958553|FG001|Overall Study|Ongoing at cut-off date|265
6927477|NCT00847613|10958554|FG002|Overall Study|Ongoing at cut-off date|64
6927478|NCT00847613|10958555|FG003|Overall Study|Ongoing at cut-off date|64
6927479|NCT00847613|10958552|FG000|Overall Study|Death|1
6927480|NCT00847613|10958553|FG001|Overall Study|Death|1
6927481|NCT00847613|10958554|FG002|Overall Study|Death|0
6927482|NCT00847613|10958555|FG003|Overall Study|Death|0
6927483|NCT00847613|10958552|FG000|Overall Study|Adverse Event|36
6927484|NCT00847613|10958553|FG001|Overall Study|Adverse Event|26
6927485|NCT00847613|10958554|FG002|Overall Study|Adverse Event|5
6927486|NCT00847613|10958555|FG003|Overall Study|Adverse Event|6
6927487|NCT00847613|10958552|FG000|Overall Study|Lack of Efficacy|7
6927488|NCT00847613|10958553|FG001|Overall Study|Lack of Efficacy|3
6927489|NCT00847613|10958554|FG002|Overall Study|Lack of Efficacy|3
6927490|NCT00847613|10958555|FG003|Overall Study|Lack of Efficacy|1
6927491|NCT00847613|10958552|FG000|Overall Study|Study terminated by Sponsor|1
6927492|NCT00847613|10958553|FG001|Overall Study|Study terminated by Sponsor|0
6927493|NCT00847613|10958554|FG002|Overall Study|Study terminated by Sponsor|2
6927494|NCT00847613|10958555|FG003|Overall Study|Study terminated by Sponsor|1
6927495|NCT00847613|10958552|FG000|Overall Study|Lost to Follow-up|5
6927496|NCT00847613|10958553|FG001|Overall Study|Lost to Follow-up|0
6927497|NCT00847613|10958554|FG002|Overall Study|Lost to Follow-up|0
6927498|NCT00847613|10958555|FG003|Overall Study|Lost to Follow-up|3
6927499|NCT00847613|10958552|FG000|Overall Study|Protocol Violation|6
6927500|NCT00847613|10958553|FG001|Overall Study|Protocol Violation|6
6927501|NCT00847613|10958554|FG002|Overall Study|Protocol Violation|3
6927502|NCT00847613|10958555|FG003|Overall Study|Protocol Violation|1
6927503|NCT00847613|10958552|FG000|Overall Study|Pregnancy|1
6927504|NCT00847613|10958553|FG001|Overall Study|Pregnancy|1
6927505|NCT00847613|10958554|FG002|Overall Study|Pregnancy|0
6927506|NCT00847613|10958555|FG003|Overall Study|Pregnancy|0
6927507|NCT00847613|10958552|FG000|Overall Study|Site closure|1
6927508|NCT00847613|10958553|FG001|Overall Study|Site closure|0
6927509|NCT00847613|10958554|FG002|Overall Study|Site closure|0
6927510|NCT00847613|10958555|FG003|Overall Study|Site closure|1
6927511|NCT00847613|10958552|FG000|Overall Study|Withdrawal by Subject|8
6927512|NCT00847613|10958553|FG001|Overall Study|Withdrawal by Subject|11
6927513|NCT00847613|10958554|FG002|Overall Study|Withdrawal by Subject|2
6927514|NCT00847613|10958555|FG003|Overall Study|Withdrawal by Subject|2
6927515|NCT00847613|10958552|FG000|Overall Study|Participant moved|4
6927516|NCT00847613|10958553|FG001|Overall Study|Participant moved|1
6927517|NCT00847613|10958554|FG002|Overall Study|Participant moved|0
6927518|NCT00847613|10958555|FG003|Overall Study|Participant moved|0
6927519|NCT00847613|10958552|FG000|Overall Study|Sponsor request|0
6927520|NCT00847613|10958553|FG001|Overall Study|Sponsor request|1
6927521|NCT00847613|10958554|FG002|Overall Study|Sponsor request|0
6927522|NCT00847613|10958555|FG003|Overall Study|Sponsor request|0
6927523|NCT00847613|10958552|FG000|Overall Study|Randomized, but not treated|0
6927524|NCT00847613|10958553|FG001|Overall Study|Randomized, but not treated|3
6927525|NCT00847613|10958554|FG002|Overall Study|Randomized, but not treated|0
6927526|NCT00847613|10958555|FG003|Overall Study|Randomized, but not treated|0
6927527|NCT00847613|10958552|FG000|Overall Study|Other|1
6927528|NCT00847613|10958553|FG001|Overall Study|Other|1
7063901|NCT01953692|11162523|FG008|Overall Study|Excluded Medication|0
7063902|NCT01953692|11162515|FG000|Overall Study|Lost to Follow-up|1
7063903|NCT01953692|11162516|FG001|Overall Study|Lost to Follow-up|0
7063904|NCT01953692|11162517|FG002|Overall Study|Lost to Follow-up|3
7063905|NCT01953692|11162518|FG003|Overall Study|Lost to Follow-up|1
7063906|NCT01953692|11162519|FG004|Overall Study|Lost to Follow-up|0
7063907|NCT01953692|11162520|FG005|Overall Study|Lost to Follow-up|1
7063908|NCT01953692|11162521|FG006|Overall Study|Lost to Follow-up|0
7063909|NCT01953692|11162522|FG007|Overall Study|Lost to Follow-up|0
7063910|NCT01953692|11162523|FG008|Overall Study|Lost to Follow-up|0
7063911|NCT01953692|11162515|FG000|Overall Study|Physician Decision|11
7063912|NCT01953692|11162516|FG001|Overall Study|Physician Decision|4
7063913|NCT01953692|11162517|FG002|Overall Study|Physician Decision|2
7063914|NCT01953692|11162518|FG003|Overall Study|Physician Decision|2
7063915|NCT01953692|11162519|FG004|Overall Study|Physician Decision|1
7063916|NCT01953692|11162520|FG005|Overall Study|Physician Decision|2
7063917|NCT01953692|11162521|FG006|Overall Study|Physician Decision|4
7063918|NCT01953692|11162522|FG007|Overall Study|Physician Decision|1
7063919|NCT01953692|11162523|FG008|Overall Study|Physician Decision|0
7063920|NCT01953692|11162515|FG000|Overall Study|Protocol Violation|0
7063921|NCT01953692|11162516|FG001|Overall Study|Protocol Violation|2
7063922|NCT01953692|11162517|FG002|Overall Study|Protocol Violation|1
7063923|NCT01953692|11162518|FG003|Overall Study|Protocol Violation|0
7063924|NCT01953692|11162519|FG004|Overall Study|Protocol Violation|0
7063925|NCT01953692|11162520|FG005|Overall Study|Protocol Violation|0
7063926|NCT01953692|11162521|FG006|Overall Study|Protocol Violation|0
7063927|NCT01953692|11162522|FG007|Overall Study|Protocol Violation|1
7063928|NCT01953692|11162523|FG008|Overall Study|Protocol Violation|0
7063929|NCT01953692|11162515|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
7063930|NCT01953692|11162516|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
7063931|NCT01953692|11162517|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
7063932|NCT01953692|11162518|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
7063933|NCT01953692|11162519|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
7063934|NCT01953692|11162520|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
7063935|NCT01953692|11162521|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
7063936|NCT01953692|11162522|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2
7063937|NCT01953692|11162523|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
7063938|NCT01953692|11162515|FG000|Overall Study|Withdrawal by Subject|4
7063939|NCT01953692|11162516|FG001|Overall Study|Withdrawal by Subject|2
7063940|NCT01953692|11162517|FG002|Overall Study|Withdrawal by Subject|1
7063941|NCT01953692|11162518|FG003|Overall Study|Withdrawal by Subject|2
7063942|NCT01953692|11162519|FG004|Overall Study|Withdrawal by Subject|0
7063943|NCT01953692|11162520|FG005|Overall Study|Withdrawal by Subject|3
7063944|NCT01953692|11162521|FG006|Overall Study|Withdrawal by Subject|2
7063945|NCT01953692|11162522|FG007|Overall Study|Withdrawal by Subject|1
7063946|NCT01953692|11162523|FG008|Overall Study|Withdrawal by Subject|1
7063947|NCT01953783|11162553|FG000|Overall Study|Progressive disease|2
7063948|NCT01953913|11162567|FG000|Overall Study|Disease Progression|349
7063949|NCT01953913|11162567|FG000|Overall Study|Worsening of underlying cancer|22
7063950|NCT01953913|11162567|FG000|Overall Study|Adverse Event|20
7063951|NCT01953913|11162567|FG000|Overall Study|Protocol Violation|6
7063952|NCT01953913|11162567|FG000|Overall Study|Lost to Follow-up|4
7063953|NCT01953913|11162567|FG000|Overall Study|Withdrawal by Subject|32
7063954|NCT01953913|11162567|FG000|Overall Study|Other than listed|108
7063955|NCT01953913|11162567|FG000|Overall Study|Not Treated|1
7063956|NCT01954017|11162574|FG000|Overall Study|Adverse Event|0
7063957|NCT01954017|11162575|FG001|Overall Study|Adverse Event|0
7063958|NCT01954017|11162576|FG002|Overall Study|Adverse Event|1
7063959|NCT01954017|11162574|FG000|Overall Study|Death|2
7063960|NCT01954017|11162575|FG001|Overall Study|Death|1
7063961|NCT01954017|11162576|FG002|Overall Study|Death|1
7063962|NCT01954017|11162574|FG000|Overall Study|Withdrawal by Subject|0
7063963|NCT01954017|11162575|FG001|Overall Study|Withdrawal by Subject|1
7063964|NCT01954017|11162576|FG002|Overall Study|Withdrawal by Subject|0
7063965|NCT01954017|11162574|FG000|Overall Study|Protocol Violation|0
7063966|NCT01954017|11162575|FG001|Overall Study|Protocol Violation|3
7063967|NCT01954017|11162576|FG002|Overall Study|Protocol Violation|2
7063968|NCT01954017|11162574|FG000|Overall Study|Necrotizing enterocolitis|1
7063969|NCT01954017|11162575|FG001|Overall Study|Necrotizing enterocolitis|0
7063970|NCT01954017|11162576|FG002|Overall Study|Necrotizing enterocolitis|1
6927529|NCT00847613|10958554|FG002|Overall Study|Other|2
6927530|NCT00847613|10958555|FG003|Overall Study|Other|0
6927531|NCT00847626|10958583|FG000|Overall Study|Adverse Event|10
6927532|NCT00847626|10958584|FG001|Overall Study|Adverse Event|10
7063971|NCT01954017|11162574|FG000|Overall Study|Enteral intake stopped >7 days|0
7063972|NCT01954017|11162575|FG001|Overall Study|Enteral intake stopped >7 days|1
7063973|NCT01954017|11162576|FG002|Overall Study|Enteral intake stopped >7 days|1
7063974|NCT01954017|11162574|FG000|Overall Study|All other reasons|2
7063975|NCT01954017|11162575|FG001|Overall Study|All other reasons|2
7063976|NCT01954017|11162576|FG002|Overall Study|All other reasons|7
6927533|NCT00847626|10958585|FG002|Overall Study|Adverse Event|6
6927534|NCT00847626|10958586|FG003|Overall Study|Adverse Event|19
6927535|NCT00847626|10958587|FG004|Overall Study|Adverse Event|11
6927536|NCT00847626|10958588|FG005|Overall Study|Adverse Event|22
6927537|NCT00847626|10958589|FG006|Overall Study|Adverse Event|4
6927538|NCT00847626|10958590|FG007|Overall Study|Adverse Event|6
6927539|NCT00847626|10958591|FG008|Overall Study|Adverse Event|3
6927540|NCT00847626|10958592|FG009|Overall Study|Adverse Event|6
6927541|NCT00847626|10958593|FG010|Overall Study|Adverse Event|6
6927542|NCT00847626|10958583|FG000|Overall Study|Protocol Violation|2
6927543|NCT00847626|10958584|FG001|Overall Study|Protocol Violation|1
6927544|NCT00847626|10958585|FG002|Overall Study|Protocol Violation|2
6927545|NCT00847626|10958586|FG003|Overall Study|Protocol Violation|1
6927546|NCT00847626|10958587|FG004|Overall Study|Protocol Violation|1
6927547|NCT00847626|10958588|FG005|Overall Study|Protocol Violation|1
6927548|NCT00847626|10958589|FG006|Overall Study|Protocol Violation|1
6927549|NCT00847626|10958590|FG007|Overall Study|Protocol Violation|1
6927550|NCT00847626|10958591|FG008|Overall Study|Protocol Violation|0
6927551|NCT00847626|10958592|FG009|Overall Study|Protocol Violation|1
6927552|NCT00847626|10958593|FG010|Overall Study|Protocol Violation|1
6927553|NCT00847626|10958583|FG000|Overall Study|Lost to Follow-up|0
6927554|NCT00847626|10958584|FG001|Overall Study|Lost to Follow-up|1
6927555|NCT00847626|10958585|FG002|Overall Study|Lost to Follow-up|1
6927556|NCT00847626|10958586|FG003|Overall Study|Lost to Follow-up|1
6927557|NCT00847626|10958587|FG004|Overall Study|Lost to Follow-up|0
6927558|NCT00847626|10958588|FG005|Overall Study|Lost to Follow-up|3
6927559|NCT00847626|10958589|FG006|Overall Study|Lost to Follow-up|1
6927560|NCT00847626|10958590|FG007|Overall Study|Lost to Follow-up|3
6927561|NCT00847626|10958591|FG008|Overall Study|Lost to Follow-up|1
6927562|NCT00847626|10958592|FG009|Overall Study|Lost to Follow-up|0
6927563|NCT00847626|10958593|FG010|Overall Study|Lost to Follow-up|1
6927564|NCT00847626|10958583|FG000|Overall Study|Withdrawal by Subject|5
6927565|NCT00847626|10958584|FG001|Overall Study|Withdrawal by Subject|5
6927566|NCT00847626|10958585|FG002|Overall Study|Withdrawal by Subject|3
6927567|NCT00847626|10958586|FG003|Overall Study|Withdrawal by Subject|8
6927568|NCT00847626|10958587|FG004|Overall Study|Withdrawal by Subject|12
6927569|NCT00847626|10958588|FG005|Overall Study|Withdrawal by Subject|9
6927570|NCT00847626|10958589|FG006|Overall Study|Withdrawal by Subject|8
7063977|NCT01954056|11162612|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1
7063978|NCT01954056|11162613|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0
7063979|NCT01954082|11162621|FG000|Overall Study|Study Suspension|42
7063980|NCT01954082|11162622|FG001|Overall Study|Study Suspension|36
7063981|NCT01954082|11162621|FG000|Overall Study|Adverse Event|10
7063982|NCT01954082|11162622|FG001|Overall Study|Adverse Event|4
7063983|NCT01954082|11162621|FG000|Overall Study|Intolerance|0
7063984|NCT01954082|11162622|FG001|Overall Study|Intolerance|1
7063985|NCT01954082|11162621|FG000|Overall Study|Non-compliance|6
7063986|NCT01954082|11162622|FG001|Overall Study|Non-compliance|4
7063987|NCT01954082|11162621|FG000|Overall Study|Physician Decision|2
7063988|NCT01954082|11162622|FG001|Overall Study|Physician Decision|0
7063989|NCT01954082|11162621|FG000|Overall Study|Parent Decision|1
7063990|NCT01954082|11162622|FG001|Overall Study|Parent Decision|0
7063991|NCT01954082|11162621|FG000|Overall Study|Withdrawal by Subject|0
7063992|NCT01954082|11162622|FG001|Overall Study|Withdrawal by Subject|1
7063993|NCT01954082|11162621|FG000|Overall Study|Discontinued Early Prior to Transfer|3
7063994|NCT01954082|11162622|FG001|Overall Study|Discontinued Early Prior to Transfer|2
7063995|NCT01954082|11162621|FG000|Overall Study|Redirection of Care|0
7063996|NCT01954082|11162622|FG001|Overall Study|Redirection of Care|2
7063997|NCT01954082|11162621|FG000|Overall Study|Miscalculation of Final Dose Day|0
7063998|NCT01954082|11162622|FG001|Overall Study|Miscalculation of Final Dose Day|3
7063999|NCT01954082|11162621|FG000|Overall Study|Comfort Care|0
7064000|NCT01954082|11162622|FG001|Overall Study|Comfort Care|1
7064001|NCT01954082|11162621|FG000|Overall Study|Infant Moved|0
7064002|NCT01954082|11162622|FG001|Overall Study|Infant Moved|1
7064003|NCT01954082|11162621|FG000|Overall Study|Randomized not Treated|4
7064004|NCT01954082|11162622|FG001|Overall Study|Randomized not Treated|2
7064005|NCT01954121|11162630|FG000|Overall Study|Lack of Efficacy|94
6927571|NCT00847626|10958590|FG007|Overall Study|Withdrawal by Subject|4
6927572|NCT00847626|10958591|FG008|Overall Study|Withdrawal by Subject|4
6927573|NCT00847626|10958592|FG009|Overall Study|Withdrawal by Subject|5
6927574|NCT00847626|10958593|FG010|Overall Study|Withdrawal by Subject|2
6927575|NCT00847626|10958583|FG000|Overall Study|Lack of Efficacy|3
6927576|NCT00847626|10958584|FG001|Overall Study|Lack of Efficacy|1
6927577|NCT00847626|10958585|FG002|Overall Study|Lack of Efficacy|0
6927578|NCT00847626|10958586|FG003|Overall Study|Lack of Efficacy|1
6927579|NCT00847626|10958587|FG004|Overall Study|Lack of Efficacy|2
7064006|NCT01954121|11162631|FG001|Overall Study|Lack of Efficacy|41
6927580|NCT00847626|10958588|FG005|Overall Study|Lack of Efficacy|0
6927581|NCT00847626|10958589|FG006|Overall Study|Lack of Efficacy|6
6927582|NCT00847626|10958590|FG007|Overall Study|Lack of Efficacy|2
6927583|NCT00847626|10958591|FG008|Overall Study|Lack of Efficacy|5
6927584|NCT00847626|10958592|FG009|Overall Study|Lack of Efficacy|1
6927585|NCT00847626|10958593|FG010|Overall Study|Lack of Efficacy|7
6927586|NCT00847626|10958583|FG000|Overall Study|Other|1
6927587|NCT00847626|10958584|FG001|Overall Study|Other|5
6927588|NCT00847626|10958585|FG002|Overall Study|Other|4
6927589|NCT00847626|10958586|FG003|Overall Study|Other|1
6927590|NCT00847626|10958587|FG004|Overall Study|Other|2
6927591|NCT00847626|10958588|FG005|Overall Study|Other|2
6927592|NCT00847626|10958589|FG006|Overall Study|Other|2
6927593|NCT00847626|10958590|FG007|Overall Study|Other|3
6927594|NCT00847626|10958591|FG008|Overall Study|Other|1
6927595|NCT00847626|10958592|FG009|Overall Study|Other|1
6927596|NCT00847626|10958593|FG010|Overall Study|Other|3
6927597|NCT00847665|10958622|FG000|Overall Study|Withdrawal by Subject|1
6927598|NCT00847665|10958623|FG001|Overall Study|Withdrawal by Subject|0
6927599|NCT00847704|10958629|FG000|Overall Study|Withdrawal by Subject|1
6927600|NCT00847730|10958633|FG000|Overall Study|Multiple interruptions in therapy|8
6927601|NCT00847808|10958637|FG000|Overall Study|Adverse Event|7
6927602|NCT00847808|10958637|FG000|Overall Study|Protocol Violation|1
6927603|NCT00847808|10958637|FG000|Overall Study|Lost to Follow-up|1
6927604|NCT00847808|10958637|FG000|Overall Study|Withdrawal by Subject|4
6927605|NCT00847808|10958637|FG000|Overall Study|Participant Reported Lack of Efficacy|1
6927606|NCT00847808|10958637|FG000|Overall Study|Participant Took Excluded Medication|1
6927607|NCT00847886|10958643|FG000|Overall Study|Adverse Event|0
6927608|NCT00847886|10958644|FG001|Overall Study|Adverse Event|1
6927609|NCT00847912|10958652|FG000|Overall Study|Protocol Violation|6
6927610|NCT00847912|10958653|FG001|Overall Study|Protocol Violation|7
6927611|NCT00847912|10958652|FG000|Overall Study|Withdrawal by Subject|3
6927612|NCT00847912|10958653|FG001|Overall Study|Withdrawal by Subject|6
6927613|NCT00848042|10958684|FG000|Overall Study|Death|1
6927614|NCT00848042|10958685|FG001|Overall Study|Death|2
6927615|NCT00848042|10958686|FG002|Overall Study|Death|0
6927616|NCT00848042|10958684|FG000|Overall Study|Other Therapy|3
6927617|NCT00848042|10958685|FG001|Overall Study|Other Therapy|0
6927618|NCT00848042|10958686|FG002|Overall Study|Other Therapy|0
6927619|NCT00848081|10958696|FG000|Overall Study|Adverse Event|6
6927620|NCT00848081|10958697|FG001|Overall Study|Adverse Event|7
6927621|NCT00848081|10958696|FG000|Overall Study|Protocol Violation|8
6927622|NCT00848081|10958697|FG001|Overall Study|Protocol Violation|5
6927623|NCT00848081|10958696|FG000|Overall Study|Lost to Follow-up|1
6927624|NCT00848081|10958697|FG001|Overall Study|Lost to Follow-up|0
6927625|NCT00848081|10958696|FG000|Overall Study|Physician Decision|0
6927626|NCT00848081|10958697|FG001|Overall Study|Physician Decision|3
6927627|NCT00848081|10958696|FG000|Overall Study|Withdrawal by Subject|5
6927628|NCT00848081|10958697|FG001|Overall Study|Withdrawal by Subject|3
6927629|NCT00848107|10958703|FG000|Overall Study|Lost to Follow-up|2
6927630|NCT00848107|10958703|FG000|Overall Study|Withdrawal by Subject|8
6927631|NCT00848107|10958703|FG000|Overall Study|Adverse Event|9
6927632|NCT00848107|10958703|FG000|Overall Study|Death|1
6927633|NCT00848107|10958703|FG000|Overall Study|Pregnancy|1
6927634|NCT00848120|10958707|FG000|Overall Study|Adverse Event|1
6927635|NCT00848198|10958736|FG000|Overall Study|Incomplete Case Report Forms|15
6927636|NCT00848211|10958748|FG000|Overall Study|Protocol Violation|0
6927637|NCT00848211|10958749|FG001|Overall Study|Protocol Violation|1
6927638|NCT00848211|10958750|FG002|Overall Study|Protocol Violation|1
6927639|NCT00848211|10958751|FG003|Overall Study|Protocol Violation|0
6927640|NCT00848211|10958748|FG000|Overall Study|Adverse Event|0
6927641|NCT00848211|10958749|FG001|Overall Study|Adverse Event|0
6927642|NCT00848211|10958750|FG002|Overall Study|Adverse Event|0
6927643|NCT00848211|10958751|FG003|Overall Study|Adverse Event|0
6927644|NCT00848250|10958767|FG000|Overall Study|surgery was completed without cardiopulm|0
6927645|NCT00848250|10958768|FG001|Overall Study|surgery was completed without cardiopulm|1
6927646|NCT00848354|10958777|FG000|Phase 1|Adverse Event|5
6927647|NCT00848354|10958778|FG001|Phase 1|Adverse Event|4
6927648|NCT00848354|10958777|FG000|Phase 1|Discontinuation of study by sponsor|2
6927649|NCT00848354|10958778|FG001|Phase 1|Discontinuation of study by sponsor|1
6927650|NCT00848354|10958777|FG000|Phase 1|Failed to return|0
6927651|NCT00848354|10958778|FG001|Phase 1|Failed to return|1
6927652|NCT00848354|10958777|FG000|Phase 1|Lost to Follow-up|1
6927653|NCT00848354|10958778|FG001|Phase 1|Lost to Follow-up|1
6927654|NCT00848354|10958777|FG000|Phase 1|Unspecified Reason|1
6927655|NCT00848354|10958778|FG001|Phase 1|Unspecified Reason|1
6927656|NCT00848354|10958777|FG000|Phase 1|Protocol Violation|1
6927657|NCT00848354|10958778|FG001|Phase 1|Protocol Violation|1
6927658|NCT00848354|10958777|FG000|Phase 1|Withdrawal by Subject|2
6927659|NCT00848354|10958778|FG001|Phase 1|Withdrawal by Subject|4
6927660|NCT00848354|10958777|FG000|Phase 1|Lack of Efficacy|0
6927661|NCT00848354|10958778|FG001|Phase 1|Lack of Efficacy|1
6927662|NCT00848354|10958777|FG000|Phase 2 Year 1|Adverse Event|7
6927663|NCT00848354|10958778|FG001|Phase 2 Year 1|Adverse Event|2
6927664|NCT00848354|10958777|FG000|Phase 2 Year 1|Death|1
6927665|NCT00848354|10958778|FG001|Phase 2 Year 1|Death|0
6927666|NCT00848354|10958777|FG000|Phase 2 Year 1|Failed to Return|1
6927667|NCT00848354|10958778|FG001|Phase 2 Year 1|Failed to Return|1
6927668|NCT00848354|10958777|FG000|Phase 2 Year 1|Lost to Follow-up|1
6927669|NCT00848354|10958778|FG001|Phase 2 Year 1|Lost to Follow-up|0
6927670|NCT00848354|10958777|FG000|Phase 2 Year 1|Unspecified Reason|3
6927671|NCT00848354|10958778|FG001|Phase 2 Year 1|Unspecified Reason|0
6927672|NCT00848354|10958777|FG000|Phase 2 Year 1|Protocol Violation|4
6927673|NCT00848354|10958778|FG001|Phase 2 Year 1|Protocol Violation|1
6927674|NCT00848354|10958777|FG000|Phase 2 Year 1|Subject Request|1
6927675|NCT00848354|10958778|FG001|Phase 2 Year 1|Subject Request|2
6927676|NCT00848354|10958777|FG000|Phase 2 Year 2|Adverse Event|12
6927677|NCT00848354|10958778|FG001|Phase 2 Year 2|Adverse Event|2
6927678|NCT00848354|10958777|FG000|Phase 2 Year 2|Death|2
6927679|NCT00848354|10958778|FG001|Phase 2 Year 2|Death|0
6927680|NCT00848354|10958777|FG000|Phase 2 Year 2|Failed to return|3
6927681|NCT00848354|10958778|FG001|Phase 2 Year 2|Failed to return|0
6927682|NCT00848354|10958777|FG000|Phase 2 Year 2|Lost to Follow-up|1
6927683|NCT00848354|10958778|FG001|Phase 2 Year 2|Lost to Follow-up|3
6927684|NCT00848354|10958777|FG000|Phase 2 Year 2|Unspecified Reason|1
6927685|NCT00848354|10958778|FG001|Phase 2 Year 2|Unspecified Reason|0
6927686|NCT00848354|10958777|FG000|Phase 2 Year 2|Protocol Violation|1
6927687|NCT00848354|10958778|FG001|Phase 2 Year 2|Protocol Violation|1
6927688|NCT00848354|10958777|FG000|Phase 2 Year 2|Subject Request|1
6927689|NCT00848354|10958778|FG001|Phase 2 Year 2|Subject Request|1
6927690|NCT00848354|10958777|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2
6927691|NCT00848354|10958778|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0
6927692|NCT00848393|10958802|FG000|Overall Study|Protocol Violation|0
6927693|NCT00848393|10958803|FG001|Overall Study|Protocol Violation|0
6927694|NCT00848393|10958804|FG002|Overall Study|Protocol Violation|1
6927695|NCT00848393|10958802|FG000|Overall Study|surgical complications unrelated to stud|0
6927696|NCT00848393|10958803|FG001|Overall Study|surgical complications unrelated to stud|0
6927697|NCT00848393|10958804|FG002|Overall Study|surgical complications unrelated to stud|2
6927698|NCT00848484|10958818|FG000|First Intervention (Treatment Period 1)|Adverse Event|2
6927699|NCT00848484|10958819|FG001|First Intervention (Treatment Period 1)|Adverse Event|1
6927700|NCT00848484|10958818|FG000|First Intervention (Treatment Period 1)|Physician Decision|0
6927701|NCT00848484|10958819|FG001|First Intervention (Treatment Period 1)|Physician Decision|1
6927702|NCT00848484|10958818|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0
6927703|NCT00848484|10958819|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1
6927704|NCT00848484|10958818|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0
6927705|NCT00848484|10958819|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3
6927706|NCT00848484|10958818|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0
6927707|NCT00848484|10958819|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1
6927708|NCT00848497|10958827|FG000|Overall Study|Screen failure|2
6927709|NCT00848497|10958828|FG001|Overall Study|Screen failure|0
6927710|NCT00848497|10958827|FG000|Overall Study|Withdrawal by Subject|0
6927711|NCT00848497|10958828|FG001|Overall Study|Withdrawal by Subject|1
6927712|NCT00848536|10958855|FG000|Overall Study|Adverse Event|2
6927713|NCT00848536|10958856|FG001|Overall Study|Adverse Event|2
6927714|NCT00848536|10958855|FG000|Overall Study|Withdrawal by Subject|0
6927715|NCT00848536|10958856|FG001|Overall Study|Withdrawal by Subject|1
6927716|NCT00848536|10958855|FG000|Overall Study|Protocol Violation|0
6927717|NCT00848536|10958856|FG001|Overall Study|Protocol Violation|1
6927718|NCT00848536|10958855|FG000|Overall Study|Noncompliance|1
6927719|NCT00848536|10958856|FG001|Overall Study|Noncompliance|0
6927720|NCT00848536|10958855|FG000|Overall Study|Inadequate Control of IOP|1
6927721|NCT00848536|10958856|FG001|Overall Study|Inadequate Control of IOP|1
6927722|NCT00848536|10958855|FG000|Overall Study|Patient Moved|0
6927723|NCT00848536|10958856|FG001|Overall Study|Patient Moved|2
6927724|NCT00848549|10958864|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31
6927725|NCT00848549|10958865|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35
6927726|NCT00848549|10958864|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35
6927727|NCT00848549|10958865|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24
6927728|NCT00848549|10958864|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
6927729|NCT00848549|10958865|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
6927730|NCT00848549|10958864|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3
6927731|NCT00848549|10958865|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8
6927732|NCT00848549|10958864|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4
6927733|NCT00848549|10958865|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5
6927734|NCT00848549|10958864|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21
6927735|NCT00848549|10958865|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11
6927736|NCT00848549|10958864|FG000|E2090-E044-310 (Base Study) Disposition|Other|4
6927737|NCT00848549|10958865|FG001|E2090-E044-310 (Base Study) Disposition|Other|3
6927738|NCT00848549|10958864|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24
6927739|NCT00848549|10958865|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34
6927740|NCT00848549|10958864|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2
6927741|NCT00848549|10958865|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1
6927742|NCT00848549|10958864|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1
6927743|NCT00848549|10958865|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2
6927744|NCT00848549|10958864|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8
6927745|NCT00848549|10958865|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12
6927746|NCT00848549|10958864|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
6927747|NCT00848549|10958865|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
6927748|NCT00848549|10958864|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0
6927749|NCT00848549|10958865|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2
6927750|NCT00848549|10958864|FG000|E2090-E044-314 (Extension Study)|Other|5
6927751|NCT00848549|10958865|FG001|E2090-E044-314 (Extension Study)|Other|6
6927752|NCT00848718|10958886|FG000|Overall Study|Adverse Event|2
6927753|NCT00848718|10958887|FG001|Overall Study|Adverse Event|2
6927754|NCT00848718|10958888|FG002|Overall Study|Adverse Event|1
6927755|NCT00848718|10958889|FG003|Overall Study|Adverse Event|1
6927756|NCT00848718|10958890|FG004|Overall Study|Adverse Event|1
6927757|NCT00848718|10958891|FG005|Overall Study|Adverse Event|0
6927758|NCT00848718|10958892|FG006|Overall Study|Adverse Event|0
6927759|NCT00848718|10958893|FG007|Overall Study|Adverse Event|1
6927760|NCT00848718|10958894|FG008|Overall Study|Adverse Event|1
6927761|NCT00848718|10958895|FG009|Overall Study|Adverse Event|0
6927762|NCT00848718|10958896|FG010|Overall Study|Adverse Event|0
6927763|NCT00848718|10958897|FG011|Overall Study|Adverse Event|0
6927764|NCT00848718|10958898|FG012|Overall Study|Adverse Event|2
6927765|NCT00848718|10958886|FG000|Overall Study|Lack of Efficacy|0
6927766|NCT00848718|10958887|FG001|Overall Study|Lack of Efficacy|0
6927767|NCT00848718|10958888|FG002|Overall Study|Lack of Efficacy|1
6927768|NCT00848718|10958889|FG003|Overall Study|Lack of Efficacy|0
6927769|NCT00848718|10958890|FG004|Overall Study|Lack of Efficacy|0
6927770|NCT00848718|10958891|FG005|Overall Study|Lack of Efficacy|0
6927771|NCT00848718|10958892|FG006|Overall Study|Lack of Efficacy|1
6927772|NCT00848718|10958893|FG007|Overall Study|Lack of Efficacy|0
6927773|NCT00848718|10958894|FG008|Overall Study|Lack of Efficacy|0
6927774|NCT00848718|10958895|FG009|Overall Study|Lack of Efficacy|0
6927775|NCT00848718|10958896|FG010|Overall Study|Lack of Efficacy|0
7064007|NCT01954121|11162630|FG000|Overall Study|Protocol Violation|0
7064008|NCT01954121|11162631|FG001|Overall Study|Protocol Violation|2
7064009|NCT01954121|11162630|FG000|Overall Study|Lost to Follow-up|5
7064010|NCT01954121|11162631|FG001|Overall Study|Lost to Follow-up|6
7064011|NCT01954121|11162630|FG000|Overall Study|Withdrawal by Subject|18
7064012|NCT01954121|11162631|FG001|Overall Study|Withdrawal by Subject|12
7064013|NCT01954121|11162630|FG000|Overall Study|Pregnancy|1
7064014|NCT01954121|11162631|FG001|Overall Study|Pregnancy|1
7064015|NCT01954121|11162630|FG000|Overall Study|AE, serious fatal|1
7064016|NCT01954121|11162631|FG001|Overall Study|AE, serious fatal|0
7064017|NCT01954121|11162630|FG000|Overall Study|AE, non-serious non-fatal|5
7064018|NCT01954121|11162631|FG001|Overall Study|AE, non-serious non-fatal|22
7064019|NCT01954121|11162630|FG000|Overall Study|SAE, non-fatal|1
7064020|NCT01954121|11162631|FG001|Overall Study|SAE, non-fatal|4
7064021|NCT01954121|11162630|FG000|Overall Study|Non-compliant with study procedures|1
7064022|NCT01954121|11162631|FG001|Overall Study|Non-compliant with study procedures|0
7064023|NCT01954121|11162630|FG000|Overall Study|Non-compliant patient|1
7064024|NCT01954121|11162631|FG001|Overall Study|Non-compliant patient|1
7064025|NCT01954121|11162630|FG000|Overall Study|Subject did not follow instructions|0
7064026|NCT01954121|11162631|FG001|Overall Study|Subject did not follow instructions|2
7064027|NCT01954251|11162639|FG000|Overall Study|Adverse Event|5
7064028|NCT01954251|11162640|FG001|Overall Study|Adverse Event|7
7064029|NCT01954251|11162639|FG000|Overall Study|Lost to Follow-up|6
7064030|NCT01954251|11162640|FG001|Overall Study|Lost to Follow-up|6
7064031|NCT01954251|11162639|FG000|Overall Study|Withdrawal by Subject|2
7064032|NCT01954251|11162640|FG001|Overall Study|Withdrawal by Subject|6
7064033|NCT01954342|11162668|FG000|Overall Study|Missing data from 13-16week study visit|0
7064034|NCT01954342|11162669|FG001|Overall Study|Missing data from 13-16week study visit|0
7064035|NCT01954342|11162670|FG002|Overall Study|Missing data from 13-16week study visit|0
7064036|NCT01954342|11162671|FG003|Overall Study|Missing data from 13-16week study visit|1
7064037|NCT01954342|11162668|FG000|Overall Study|Miscarriage|0
7064038|NCT01954342|11162669|FG001|Overall Study|Miscarriage|0
7064039|NCT01954342|11162670|FG002|Overall Study|Miscarriage|0
7064040|NCT01954342|11162671|FG003|Overall Study|Miscarriage|3
7064041|NCT01954342|11162668|FG000|Overall Study|Lost to Follow-up|0
7064042|NCT01954342|11162669|FG001|Overall Study|Lost to Follow-up|0
7064043|NCT01954342|11162670|FG002|Overall Study|Lost to Follow-up|0
7064044|NCT01954342|11162671|FG003|Overall Study|Lost to Follow-up|5
7064045|NCT01954342|11162668|FG000|Overall Study|Preterm delivery|0
7064046|NCT01954342|11162669|FG001|Overall Study|Preterm delivery|0
7064047|NCT01954342|11162670|FG002|Overall Study|Preterm delivery|0
6927776|NCT00848718|10958897|FG011|Overall Study|Lack of Efficacy|0
6927777|NCT00848718|10958898|FG012|Overall Study|Lack of Efficacy|0
6927778|NCT00848718|10958886|FG000|Overall Study|Physician Decision|0
6927779|NCT00848718|10958887|FG001|Overall Study|Physician Decision|1
6927780|NCT00848718|10958888|FG002|Overall Study|Physician Decision|0
6927781|NCT00848718|10958889|FG003|Overall Study|Physician Decision|0
7064048|NCT01954342|11162671|FG003|Overall Study|Preterm delivery|3
7064049|NCT01954342|11162668|FG000|Overall Study|Pre-eclampsia|0
7064050|NCT01954342|11162669|FG001|Overall Study|Pre-eclampsia|0
7064051|NCT01954342|11162670|FG002|Overall Study|Pre-eclampsia|0
7064052|NCT01954342|11162671|FG003|Overall Study|Pre-eclampsia|4
7064053|NCT01954342|11162668|FG000|Overall Study|Unreliable Data|0
6927782|NCT00848718|10958890|FG004|Overall Study|Physician Decision|1
6927783|NCT00848718|10958891|FG005|Overall Study|Physician Decision|1
6927784|NCT00848718|10958892|FG006|Overall Study|Physician Decision|0
6927785|NCT00848718|10958893|FG007|Overall Study|Physician Decision|0
6927786|NCT00848718|10958894|FG008|Overall Study|Physician Decision|1
6927787|NCT00848718|10958895|FG009|Overall Study|Physician Decision|2
6927788|NCT00848718|10958896|FG010|Overall Study|Physician Decision|0
6927789|NCT00848718|10958897|FG011|Overall Study|Physician Decision|0
6927790|NCT00848718|10958898|FG012|Overall Study|Physician Decision|1
6927791|NCT00848718|10958886|FG000|Overall Study|Progressive disease before treatment|1
6927792|NCT00848718|10958887|FG001|Overall Study|Progressive disease before treatment|5
6927793|NCT00848718|10958888|FG002|Overall Study|Progressive disease before treatment|1
6927794|NCT00848718|10958889|FG003|Overall Study|Progressive disease before treatment|3
6927795|NCT00848718|10958890|FG004|Overall Study|Progressive disease before treatment|4
6927796|NCT00848718|10958891|FG005|Overall Study|Progressive disease before treatment|4
6927797|NCT00848718|10958892|FG006|Overall Study|Progressive disease before treatment|2
6927798|NCT00848718|10958893|FG007|Overall Study|Progressive disease before treatment|1
6927799|NCT00848718|10958894|FG008|Overall Study|Progressive disease before treatment|2
6927800|NCT00848718|10958895|FG009|Overall Study|Progressive disease before treatment|7
6927801|NCT00848718|10958896|FG010|Overall Study|Progressive disease before treatment|3
6927802|NCT00848718|10958897|FG011|Overall Study|Progressive disease before treatment|6
6927803|NCT00848718|10958898|FG012|Overall Study|Progressive disease before treatment|2
6927804|NCT00848718|10958886|FG000|Overall Study|Protocol Violation|0
6927805|NCT00848718|10958887|FG001|Overall Study|Protocol Violation|1
6927806|NCT00848718|10958888|FG002|Overall Study|Protocol Violation|0
6927807|NCT00848718|10958889|FG003|Overall Study|Protocol Violation|0
6927808|NCT00848718|10958890|FG004|Overall Study|Protocol Violation|0
6927809|NCT00848718|10958891|FG005|Overall Study|Protocol Violation|0
6927810|NCT00848718|10958892|FG006|Overall Study|Protocol Violation|0
6927811|NCT00848718|10958893|FG007|Overall Study|Protocol Violation|1
6927812|NCT00848718|10958894|FG008|Overall Study|Protocol Violation|0
6927813|NCT00848718|10958895|FG009|Overall Study|Protocol Violation|0
6927814|NCT00848718|10958896|FG010|Overall Study|Protocol Violation|0
6927815|NCT00848718|10958897|FG011|Overall Study|Protocol Violation|0
6927816|NCT00848718|10958898|FG012|Overall Study|Protocol Violation|1
6927817|NCT00848718|10958886|FG000|Overall Study|Withdrawal by Subject|1
6927818|NCT00848718|10958887|FG001|Overall Study|Withdrawal by Subject|0
6927819|NCT00848718|10958888|FG002|Overall Study|Withdrawal by Subject|0
6927820|NCT00848718|10958889|FG003|Overall Study|Withdrawal by Subject|1
6927821|NCT00848718|10958890|FG004|Overall Study|Withdrawal by Subject|0
6927822|NCT00848718|10958891|FG005|Overall Study|Withdrawal by Subject|0
6927823|NCT00848718|10958892|FG006|Overall Study|Withdrawal by Subject|0
6927824|NCT00848718|10958893|FG007|Overall Study|Withdrawal by Subject|0
6927825|NCT00848718|10958894|FG008|Overall Study|Withdrawal by Subject|0
6927826|NCT00848718|10958895|FG009|Overall Study|Withdrawal by Subject|0
6927827|NCT00848718|10958896|FG010|Overall Study|Withdrawal by Subject|1
6927828|NCT00848718|10958897|FG011|Overall Study|Withdrawal by Subject|0
6927829|NCT00848718|10958898|FG012|Overall Study|Withdrawal by Subject|0
6927830|NCT00848718|10958886|FG000|Overall Study|Progressive disease during treatment|3
6927831|NCT00848718|10958887|FG001|Overall Study|Progressive disease during treatment|0
6927832|NCT00848718|10958888|FG002|Overall Study|Progressive disease during treatment|3
6927833|NCT00848718|10958889|FG003|Overall Study|Progressive disease during treatment|0
6927834|NCT00848718|10958890|FG004|Overall Study|Progressive disease during treatment|0
6927835|NCT00848718|10958891|FG005|Overall Study|Progressive disease during treatment|0
6927836|NCT00848718|10958892|FG006|Overall Study|Progressive disease during treatment|0
6927837|NCT00848718|10958893|FG007|Overall Study|Progressive disease during treatment|2
6927838|NCT00848718|10958894|FG008|Overall Study|Progressive disease during treatment|0
6927839|NCT00848718|10958895|FG009|Overall Study|Progressive disease during treatment|0
6927840|NCT00848718|10958896|FG010|Overall Study|Progressive disease during treatment|0
6927841|NCT00848718|10958897|FG011|Overall Study|Progressive disease during treatment|0
6927842|NCT00848718|10958898|FG012|Overall Study|Progressive disease during treatment|2
6927843|NCT00848926|10958949|FG000|Treatment Period|Progressive disease|45
6927844|NCT00848926|10958949|FG000|Treatment Period|Adverse Event|20
6927845|NCT00848926|10958949|FG000|Treatment Period|Physician Decision|12
6927846|NCT00848926|10958949|FG000|Treatment Period|Withdrawal by Subject|7
6927847|NCT00848926|10958949|FG000|Follow-up Period|Lost to Follow-up|7
6927848|NCT00848926|10958949|FG000|Follow-up Period|Withdrawal by Subject|3
6927849|NCT00848926|10958949|FG000|Follow-up Period|Other|2
6927850|NCT00848965|10958953|FG000|Overall Study|Adverse Event|1
6927851|NCT00848965|10958953|FG000|Overall Study|Withdrawal by Subject|1
6927852|NCT00849017|10958968|FG000|Treatment Period (156 Weeks)|Adverse Event|5
6927853|NCT00849017|10958969|FG001|Treatment Period (156 Weeks)|Adverse Event|6
6927854|NCT00849017|10958970|FG002|Treatment Period (156 Weeks)|Adverse Event|15
6927855|NCT00849017|10958968|FG000|Treatment Period (156 Weeks)|Noncompliance|3
6927856|NCT00849017|10958969|FG001|Treatment Period (156 Weeks)|Noncompliance|3
6927857|NCT00849017|10958970|FG002|Treatment Period (156 Weeks)|Noncompliance|4
6927858|NCT00849017|10958968|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10
6927859|NCT00849017|10958969|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7
6927860|NCT00849017|10958970|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8
6927861|NCT00849017|10958968|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18
6977204|NCT01205776|11030289|FG000|Overall Study|Withdrawal by Subject|11
6927862|NCT00849017|10958969|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14
6927863|NCT00849017|10958970|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11
6927864|NCT00849017|10958968|FG000|Treatment Period (156 Weeks)|Physician Decision|0
6927865|NCT00849017|10958969|FG001|Treatment Period (156 Weeks)|Physician Decision|2
6927866|NCT00849017|10958970|FG002|Treatment Period (156 Weeks)|Physician Decision|1
7039500|NCT01710358|11122159|FG002|Rescue Period|Death|0
7064054|NCT01954342|11162669|FG001|Overall Study|Unreliable Data|0
7064055|NCT01954342|11162670|FG002|Overall Study|Unreliable Data|0
7064056|NCT01954342|11162671|FG003|Overall Study|Unreliable Data|2
7064057|NCT01954394|11162683|FG000|Overall Study|Enrolled but not treated|1
7064058|NCT01954394|11162684|FG001|Overall Study|Enrolled but not treated|0
7064059|NCT01954394|11162683|FG000|Overall Study|Adverse Event|10
7064060|NCT01954394|11162684|FG001|Overall Study|Adverse Event|23
7064061|NCT01954394|11162683|FG000|Overall Study|Poor compliance to protocol|7
7064062|NCT01954394|11162684|FG001|Overall Study|Poor compliance to protocol|7
6927867|NCT00849017|10958968|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3
6927868|NCT00849017|10958969|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
6927869|NCT00849017|10958970|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
6927870|NCT00849017|10958968|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1
6927871|NCT00849017|10958969|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0
6927872|NCT00849017|10958970|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0
6927873|NCT00849017|10958968|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1
6927874|NCT00849017|10958969|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
6927875|NCT00849017|10958970|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
6927876|NCT00849017|10958968|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1
6927877|NCT00849017|10958969|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0
6927878|NCT00849017|10958970|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0
6927879|NCT00849017|10958968|FG000|Treatment Period (156 Weeks)|Pregnancy|1
6927880|NCT00849017|10958969|FG001|Treatment Period (156 Weeks)|Pregnancy|0
6927881|NCT00849017|10958970|FG002|Treatment Period (156 Weeks)|Pregnancy|1
6927882|NCT00849017|10958968|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
6927883|NCT00849017|10958969|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
6927884|NCT00849017|10958970|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1
6927885|NCT00849017|10958968|FG000|Follow-up Period (8 Weeks)|Adverse Event|1
6927886|NCT00849017|10958969|FG001|Follow-up Period (8 Weeks)|Adverse Event|0
6927887|NCT00849017|10958970|FG002|Follow-up Period (8 Weeks)|Adverse Event|0
7064063|NCT01954394|11162683|FG000|Overall Study|Participant Moved|0
7064064|NCT01954394|11162684|FG001|Overall Study|Participant Moved|4
7064065|NCT01954394|11162683|FG000|Overall Study|Related to Study Drug administration|2
6927888|NCT00849017|10958968|FG000|Follow-up Period (8 Weeks)|Noncompliance|2
6927889|NCT00849017|10958969|FG001|Follow-up Period (8 Weeks)|Noncompliance|1
6927890|NCT00849017|10958970|FG002|Follow-up Period (8 Weeks)|Noncompliance|0
7064066|NCT01954394|11162684|FG001|Overall Study|Related to Study Drug administration|2
7064067|NCT01954394|11162683|FG000|Overall Study|Other than specified above|10
7064068|NCT01954394|11162684|FG001|Overall Study|Other than specified above|21
7064069|NCT01954745|11162705|FG000|Overall Study|Radiological Progression|11
6927891|NCT00849017|10958968|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13
6927892|NCT00849017|10958969|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12
6927893|NCT00849017|10958970|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16
6927894|NCT00849017|10958968|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
6927895|NCT00849017|10958969|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
6927896|NCT00849017|10958970|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4
6927897|NCT00849017|10958968|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
6927898|NCT00849017|10958969|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
6927899|NCT00849017|10958970|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3
6927900|NCT00849017|10958968|FG000|Follow-up Period (8 Weeks)|Physician Decision|0
6927901|NCT00849017|10958969|FG001|Follow-up Period (8 Weeks)|Physician Decision|1
6927902|NCT00849017|10958970|FG002|Follow-up Period (8 Weeks)|Physician Decision|1
7039501|NCT01710358|11122157|FG000|Rescue Period|Lack of Efficacy|0
7039502|NCT01710358|11122158|FG001|Rescue Period|Lack of Efficacy|7
7039503|NCT01710358|11122159|FG002|Rescue Period|Lack of Efficacy|0
7039504|NCT01710358|11122157|FG000|Rescue Period|Withdrawal by Subject|0
7039505|NCT01710358|11122158|FG001|Rescue Period|Withdrawal by Subject|8
7039506|NCT01710358|11122159|FG002|Rescue Period|Withdrawal by Subject|0
7039507|NCT01710501|11122183|FG000|Overall Study|Lost to Follow-up|2
7039508|NCT01710501|11122184|FG001|Overall Study|Lost to Follow-up|0
7039509|NCT01710501|11122185|FG002|Overall Study|Lost to Follow-up|0
7039510|NCT01710514|11122195|FG000|Overall Study|Adverse Event|6
7039511|NCT01710514|11122196|FG001|Overall Study|Adverse Event|7
7039512|NCT01710514|11122195|FG000|Overall Study|Withdrawal by Subject|1
7039513|NCT01710514|11122196|FG001|Overall Study|Withdrawal by Subject|0
7039514|NCT01710527|11122205|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0
7039515|NCT01710527|11122206|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1
7039516|NCT01710657|11122215|FG000|Overall Study|Lost to Follow-up|2
7039517|NCT01710657|11122216|FG001|Overall Study|Lost to Follow-up|0
7039518|NCT01710657|11122217|FG002|Overall Study|Lost to Follow-up|1
6927903|NCT00849017|10958968|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3
6927904|NCT00849017|10958969|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
6927905|NCT00849017|10958970|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
6927906|NCT00849017|10958968|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1
6927907|NCT00849017|10958969|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
6927908|NCT00849017|10958970|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
6927909|NCT00849056|10958984|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13
6927910|NCT00849056|10958985|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11
6927911|NCT00849056|10958984|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3
6927912|NCT00849056|10958985|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6
6927913|NCT00849056|10958984|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3
6927914|NCT00849056|10958985|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3
6927915|NCT00849056|10958984|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
6927916|NCT00849056|10958985|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5
6927917|NCT00849056|10958984|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31
6927918|NCT00849056|10958985|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18
6927919|NCT00849056|10958984|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3
6927920|NCT00849056|10958985|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3
6927921|NCT00849056|10958984|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1
6927922|NCT00849056|10958985|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4
6927923|NCT00849056|10958984|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1
6927924|NCT00849056|10958985|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0
6927925|NCT00849056|10958984|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1
6927926|NCT00849056|10958985|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0
6927927|NCT00849056|10958984|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
6927928|NCT00849056|10958985|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3
6927929|NCT00849056|10958984|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
6927930|NCT00849056|10958985|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
6927931|NCT00849056|10958984|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14
6927932|NCT00849056|10958985|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9
6927933|NCT00849056|10958984|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9
7039519|NCT01710657|11122215|FG000|Overall Study|Protocol Violation|2
7064070|NCT01954745|11162705|FG000|Overall Study|Clinical Progression|5
7064071|NCT01954745|11162705|FG000|Overall Study|Adverse Event|2
7064072|NCT01954745|11162705|FG000|Overall Study|Death|1
7064073|NCT01954771|11162712|FG000|Overall Study|Missing HbA1c of end-point|1
7064074|NCT01954771|11162713|FG001|Overall Study|Missing HbA1c of end-point|1
7064075|NCT01954771|11162714|FG002|Overall Study|Missing HbA1c of end-point|0
7064076|NCT01954771|11162712|FG000|Overall Study|Missing CGMS of end-point|1
7064077|NCT01954771|11162713|FG001|Overall Study|Missing CGMS of end-point|1
7064078|NCT01954771|11162714|FG002|Overall Study|Missing CGMS of end-point|0
7064079|NCT01954771|11162712|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5
7064080|NCT01954771|11162713|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1
7064081|NCT01954771|11162714|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3
7064082|NCT01954927|11162727|FG000|Overall Study|Withdrawal by Subject|3
7064083|NCT01954927|11162728|FG001|Overall Study|Withdrawal by Subject|1
7064084|NCT01955005|11162736|FG000|Overall Study|Withdrawal by Subject|3
7064085|NCT01955005|11162737|FG001|Overall Study|Withdrawal by Subject|5
7064086|NCT01955044|11162746|FG000|Overall Study|Death|1
7064087|NCT01955044|11162747|FG001|Overall Study|Death|1
7064088|NCT01955044|11162748|FG002|Overall Study|Death|0
7064089|NCT01955083|11162758|FG000|Overall Study|Lost to Follow-up|1
7064090|NCT01955083|11162759|FG001|Overall Study|Lost to Follow-up|1
7064091|NCT01955122|11162791|FG000|Overall Study|Physician Decision|5
7064092|NCT01955122|11162792|FG001|Overall Study|Physician Decision|5
7064093|NCT01955161|11162807|FG000|Overall Study|Withdrawal before treatment|2
7064094|NCT01955161|11162808|FG001|Overall Study|Withdrawal before treatment|0
7064095|NCT01955161|11162809|FG002|Overall Study|Withdrawal before treatment|1
7064096|NCT01955161|11162807|FG000|Overall Study|Adverse Event|10
7064097|NCT01955161|11162808|FG001|Overall Study|Adverse Event|14
7064098|NCT01955161|11162809|FG002|Overall Study|Adverse Event|15
7064099|NCT01955161|11162807|FG000|Overall Study|Death|1
7064100|NCT01955161|11162808|FG001|Overall Study|Death|1
7064101|NCT01955161|11162809|FG002|Overall Study|Death|3
7064102|NCT01955161|11162807|FG000|Overall Study|Withdrawal by Subject|9
7064103|NCT01955161|11162808|FG001|Overall Study|Withdrawal by Subject|8
7064104|NCT01955161|11162809|FG002|Overall Study|Withdrawal by Subject|12
7064105|NCT01955161|11162807|FG000|Overall Study|Protocol Violation|2
7064106|NCT01955161|11162808|FG001|Overall Study|Protocol Violation|0
7064107|NCT01955161|11162809|FG002|Overall Study|Protocol Violation|0
7064108|NCT01955161|11162807|FG000|Overall Study|Other reason: physician decision|0
7064109|NCT01955161|11162808|FG001|Overall Study|Other reason: physician decision|1
7064110|NCT01955161|11162809|FG002|Overall Study|Other reason: physician decision|1
7064111|NCT01955161|11162807|FG000|Overall Study|Other reason: disallowed medication|1
7064112|NCT01955161|11162808|FG001|Overall Study|Other reason: disallowed medication|0
7064113|NCT01955161|11162809|FG002|Overall Study|Other reason: disallowed medication|1
7064114|NCT01955161|11162807|FG000|Overall Study|Other reason: caregiver unavailable|1
6927934|NCT00849056|10958985|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7
6927935|NCT00849056|10958984|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
6927936|NCT00849056|10958985|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
6927937|NCT00849056|10958984|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1
6927938|NCT00849056|10958985|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4
6927939|NCT00849056|10958984|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1
6927940|NCT00849056|10958985|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0
6927941|NCT00849108|10958994|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1
6927942|NCT00849108|10958995|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0
6927943|NCT00849108|10958994|FG000|Cohort 2 Efficacy|Adverse Event|0
6927944|NCT00849108|10958995|FG001|Cohort 2 Efficacy|Adverse Event|1
6927945|NCT00849108|10958994|FG000|Cohort 2 Efficacy|Other|0
6927946|NCT00849108|10958995|FG001|Cohort 2 Efficacy|Other|9
6927947|NCT00849147|10959012|FG000|Overall Study|Withdrawal by Subject|1
6927948|NCT00849147|10959012|FG000|Overall Study|Protocol Violation|2
6927949|NCT00849147|10959012|FG000|Overall Study|Disease Relapse/Progression|2
6927950|NCT00849186|10959016|FG000|Overall Study|Adverse Event|2
6927951|NCT00849186|10959016|FG000|Overall Study|Withdrawal by Subject|1
6927952|NCT00849186|10959016|FG000|Overall Study|not treated|6
6927953|NCT00849186|10959016|FG000|Overall Study|Other|1
6927954|NCT00849212|10959021|FG000|Overall Study|Lack of Efficacy|1
6927955|NCT00849212|10959021|FG000|Overall Study|Withdrawal by Subject|3
6927956|NCT00849212|10959021|FG000|Overall Study|Adverse Event|2
6927957|NCT00849212|10959021|FG000|Overall Study|Miscellaneous|1
6927958|NCT00849290|10959032|FG000|Overall Study|Adverse Event|3
6927959|NCT00849290|10959032|FG000|Overall Study|Death|14
6927960|NCT00849290|10959032|FG000|Overall Study|Withdrawal by Subject|11
6927961|NCT00849290|10959032|FG000|Overall Study|Lost to Follow-up|2
7039520|NCT01710657|11122216|FG001|Overall Study|Protocol Violation|2
7039521|NCT01710657|11122217|FG002|Overall Study|Protocol Violation|0
7039522|NCT01710657|11122215|FG000|Overall Study|Adverse Event|14
7039523|NCT01710657|11122216|FG001|Overall Study|Adverse Event|8
7039524|NCT01710657|11122217|FG002|Overall Study|Adverse Event|28
7039525|NCT01710657|11122215|FG000|Overall Study|Withdrawal by Subject|0
7039526|NCT01710657|11122216|FG001|Overall Study|Withdrawal by Subject|1
7039527|NCT01710657|11122217|FG002|Overall Study|Withdrawal by Subject|2
7039528|NCT01710657|11122215|FG000|Overall Study|Lack of Efficacy|0
7039529|NCT01710657|11122216|FG001|Overall Study|Lack of Efficacy|1
7039530|NCT01710657|11122217|FG002|Overall Study|Lack of Efficacy|1
7039531|NCT01710709|11122225|FG000|Overall Study|Lost to Follow-up|29
7039532|NCT01710709|11122225|FG000|Overall Study|Adverse Event|48
7039533|NCT01710709|11122225|FG000|Overall Study|Participant met withdrawal criteria|33
7039534|NCT01710709|11122225|FG000|Overall Study|Participant withdrawn by investigator|2
7039535|NCT01710709|11122225|FG000|Overall Study|Withdrawal by Subject|53
7039536|NCT01710709|11122225|FG000|Overall Study|Protocol Violation|5
7039537|NCT01710709|11122225|FG000|Overall Study|Lack of Efficacy|3
7039538|NCT01710800|11122243|FG000|Overall Study|Withdrawal by Subject|21
7039539|NCT01710800|11122243|FG000|Overall Study|Protocol Violation|1
7039540|NCT01711216|11122280|FG000|Overall Study|Adverse Event|4
7039541|NCT01711216|11122280|FG000|Overall Study|Pregnancy|56
7039542|NCT01711216|11122280|FG000|Overall Study|Withdrawal by Subject|6
7039543|NCT01711216|11122280|FG000|Overall Study|Lost to Follow-up|46
7064115|NCT01955161|11162808|FG001|Overall Study|Other reason: caregiver unavailable|0
7064116|NCT01955161|11162809|FG002|Overall Study|Other reason: caregiver unavailable|0
7064117|NCT01955161|11162807|FG000|Overall Study|Other reason: moved to nursing home|0
7064118|NCT01955161|11162808|FG001|Overall Study|Other reason: moved to nursing home|1
7064119|NCT01955161|11162809|FG002|Overall Study|Other reason: moved to nursing home|0
7039544|NCT01711216|11122280|FG000|Overall Study|variety of other minor reasons|83
7064120|NCT01955161|11162807|FG000|Overall Study|Other reason: insufficient compliance|0
7064121|NCT01955161|11162808|FG001|Overall Study|Other reason: insufficient compliance|0
7064122|NCT01955161|11162809|FG002|Overall Study|Other reason: insufficient compliance|1
7064123|NCT01955161|11162807|FG000|Overall Study|Other reason: primary biliary cirrhosis|1
7064124|NCT01955161|11162808|FG001|Overall Study|Other reason: primary biliary cirrhosis|0
7064125|NCT01955161|11162809|FG002|Overall Study|Other reason: primary biliary cirrhosis|0
7064126|NCT01955161|11162807|FG000|Overall Study|Other reason: patient's will|0
7064127|NCT01955161|11162808|FG001|Overall Study|Other reason: patient's will|0
7064128|NCT01955161|11162809|FG002|Overall Study|Other reason: patient's will|1
7064129|NCT01955707|11162901|FG000|Overall Study|Adverse Event|1
7064130|NCT01955707|11162902|FG001|Overall Study|Adverse Event|2
7064131|NCT01955707|11162901|FG000|Overall Study|Lost to Follow-up|2
7064132|NCT01955707|11162902|FG001|Overall Study|Lost to Follow-up|1
7039545|NCT01711216|11122280|FG000|Overall Study|no reason specified|22
7039546|NCT01711359|11122300|FG000|Treatment Period|Withdrawal by Subject|18
6927962|NCT00849290|10959032|FG000|Overall Study|Protocol Violation|5
6927963|NCT00849290|10959032|FG000|Overall Study|Disease Progression|20
7039547|NCT01711359|11122301|FG001|Treatment Period|Withdrawal by Subject|7
7039548|NCT01711359|11122302|FG002|Treatment Period|Withdrawal by Subject|13
7039549|NCT01711359|11122300|FG000|Treatment Period|Lack of Efficacy|13
7039550|NCT01711359|11122301|FG001|Treatment Period|Lack of Efficacy|2
7039551|NCT01711359|11122302|FG002|Treatment Period|Lack of Efficacy|2
6927964|NCT00849381|10959036|FG000|Overall Study|Adverse Event|1
6927965|NCT00849381|10959036|FG000|Overall Study|Lost to Follow-up|129
6927966|NCT00849381|10959036|FG000|Overall Study|Protocol Violation|5
6927967|NCT00849381|10959036|FG000|Overall Study|Withdrawal by Subject|6
6927968|NCT00849381|10959036|FG000|Overall Study|Other|4
7064133|NCT01955707|11162901|FG000|Overall Study|Withdrawal by Subject|0
6927969|NCT00849472|10959040|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2
6927970|NCT00849472|10959040|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1
6927971|NCT00849472|10959040|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1
6927972|NCT00849472|10959040|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1
6927973|NCT00849472|10959040|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1
6927974|NCT00849472|10959040|FG000|Weekly Paclitaxel|Disease Progression|1
6927975|NCT00849472|10959040|FG000|Weekly Paclitaxel|Adverse Event|11
6927976|NCT00849472|10959040|FG000|Weekly Paclitaxel|Withdrawal by Subject|1
6927977|NCT00849472|10959040|FG000|Weekly Paclitaxel|Physician Decision|3
6927978|NCT00849472|10959040|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52
6927979|NCT00849472|10959040|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4
6927980|NCT00849472|10959040|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1
6927981|NCT00849472|10959040|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1
6927982|NCT00849472|10959040|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19
6927983|NCT00849472|10959040|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5
6927984|NCT00849472|10959040|FG000|Pazopanib Postsurgery Treatment|Moved|1
6927985|NCT00849472|10959040|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1
6927986|NCT00849680|10959053|FG000|Overall Study|Adverse Event|0
6927987|NCT00849680|10959054|FG001|Overall Study|Adverse Event|0
6927988|NCT00849680|10959055|FG002|Overall Study|Adverse Event|0
6927989|NCT00849680|10959056|FG003|Overall Study|Adverse Event|0
6927990|NCT00849680|10959057|FG004|Overall Study|Adverse Event|0
6927991|NCT00849680|10959058|FG005|Overall Study|Adverse Event|0
6927992|NCT00849680|10959059|FG006|Overall Study|Adverse Event|2
6927993|NCT00849680|10959060|FG007|Overall Study|Adverse Event|0
6927994|NCT00849680|10959053|FG000|Overall Study|Lost to Follow-up|7
6927995|NCT00849680|10959054|FG001|Overall Study|Lost to Follow-up|3
6927996|NCT00849680|10959055|FG002|Overall Study|Lost to Follow-up|12
6927997|NCT00849680|10959056|FG003|Overall Study|Lost to Follow-up|11
6927998|NCT00849680|10959057|FG004|Overall Study|Lost to Follow-up|8
6927999|NCT00849680|10959058|FG005|Overall Study|Lost to Follow-up|11
6928000|NCT00849680|10959059|FG006|Overall Study|Lost to Follow-up|12
6928001|NCT00849680|10959060|FG007|Overall Study|Lost to Follow-up|5
6928002|NCT00849680|10959053|FG000|Overall Study|Subject moved|1
6928003|NCT00849680|10959054|FG001|Overall Study|Subject moved|0
6928004|NCT00849680|10959055|FG002|Overall Study|Subject moved|3
6928005|NCT00849680|10959056|FG003|Overall Study|Subject moved|1
6928006|NCT00849680|10959057|FG004|Overall Study|Subject moved|0
6928007|NCT00849680|10959058|FG005|Overall Study|Subject moved|2
6928008|NCT00849680|10959059|FG006|Overall Study|Subject moved|2
6928009|NCT00849680|10959060|FG007|Overall Study|Subject moved|2
6928010|NCT00849680|10959053|FG000|Overall Study|Withdrawal by Subject|2
6928011|NCT00849680|10959054|FG001|Overall Study|Withdrawal by Subject|0
6928012|NCT00849680|10959055|FG002|Overall Study|Withdrawal by Subject|0
6928013|NCT00849680|10959056|FG003|Overall Study|Withdrawal by Subject|2
6928014|NCT00849680|10959057|FG004|Overall Study|Withdrawal by Subject|2
6928015|NCT00849680|10959058|FG005|Overall Study|Withdrawal by Subject|2
6928016|NCT00849680|10959059|FG006|Overall Study|Withdrawal by Subject|1
6928017|NCT00849680|10959060|FG007|Overall Study|Withdrawal by Subject|1
6928018|NCT00849680|10959053|FG000|Overall Study|Subject unable to comply with protocol|1
6928019|NCT00849680|10959054|FG001|Overall Study|Subject unable to comply with protocol|0
6928020|NCT00849680|10959055|FG002|Overall Study|Subject unable to comply with protocol|0
6928021|NCT00849680|10959056|FG003|Overall Study|Subject unable to comply with protocol|0
6928022|NCT00849680|10959057|FG004|Overall Study|Subject unable to comply with protocol|0
6928023|NCT00849680|10959058|FG005|Overall Study|Subject unable to comply with protocol|0
6928024|NCT00849680|10959059|FG006|Overall Study|Subject unable to comply with protocol|0
6928025|NCT00849680|10959060|FG007|Overall Study|Subject unable to comply with protocol|0
6928026|NCT00849693|10959082|FG000|Acute Treatment Phase|Adverse Event|12
6928027|NCT00849693|10959083|FG001|Acute Treatment Phase|Adverse Event|7
6928028|NCT00849693|10959084|FG002|Acute Treatment Phase|Adverse Event|6
6928029|NCT00849693|10959085|FG003|Acute Treatment Phase|Adverse Event|4
6928030|NCT00849693|10959082|FG000|Acute Treatment Phase|Lost to Follow-up|5
6928031|NCT00849693|10959083|FG001|Acute Treatment Phase|Lost to Follow-up|8
6928032|NCT00849693|10959084|FG002|Acute Treatment Phase|Lost to Follow-up|11
6928033|NCT00849693|10959085|FG003|Acute Treatment Phase|Lost to Follow-up|9
6928034|NCT00849693|10959082|FG000|Acute Treatment Phase|Protocol Violation|1
6928035|NCT00849693|10959083|FG001|Acute Treatment Phase|Protocol Violation|5
6928036|NCT00849693|10959084|FG002|Acute Treatment Phase|Protocol Violation|2
6928037|NCT00849693|10959085|FG003|Acute Treatment Phase|Protocol Violation|6
6928038|NCT00849693|10959082|FG000|Acute Treatment Phase|Withdrawal by Subject|5
6928039|NCT00849693|10959083|FG001|Acute Treatment Phase|Withdrawal by Subject|5
6928040|NCT00849693|10959084|FG002|Acute Treatment Phase|Withdrawal by Subject|3
6928041|NCT00849693|10959085|FG003|Acute Treatment Phase|Withdrawal by Subject|8
6928042|NCT00849693|10959082|FG000|Acute Treatment Phase|Parent or caregiver decision|7
6928043|NCT00849693|10959083|FG001|Acute Treatment Phase|Parent or caregiver decision|6
6928044|NCT00849693|10959084|FG002|Acute Treatment Phase|Parent or caregiver decision|7
6928045|NCT00849693|10959085|FG003|Acute Treatment Phase|Parent or caregiver decision|7
6928046|NCT00849693|10959082|FG000|Acute Treatment Phase|Physician Decision|2
6928047|NCT00849693|10959083|FG001|Acute Treatment Phase|Physician Decision|1
6928048|NCT00849693|10959084|FG002|Acute Treatment Phase|Physician Decision|2
6928049|NCT00849693|10959085|FG003|Acute Treatment Phase|Physician Decision|1
6928050|NCT00849693|10959082|FG000|Acute Treatment Phase|Sponsor decision|0
6928051|NCT00849693|10959083|FG001|Acute Treatment Phase|Sponsor decision|0
6928052|NCT00849693|10959084|FG002|Acute Treatment Phase|Sponsor decision|1
6928053|NCT00849693|10959085|FG003|Acute Treatment Phase|Sponsor decision|0
6928054|NCT00849693|10959082|FG000|Acute Treatment Phase|Lack of Efficacy|1
6928055|NCT00849693|10959083|FG001|Acute Treatment Phase|Lack of Efficacy|3
6928056|NCT00849693|10959084|FG002|Acute Treatment Phase|Lack of Efficacy|1
6928057|NCT00849693|10959085|FG003|Acute Treatment Phase|Lack of Efficacy|2
6928058|NCT00849693|10959082|FG000|Extension Phase|Adverse Event|4
6928059|NCT00849693|10959083|FG001|Extension Phase|Adverse Event|6
7064134|NCT01955707|11162902|FG001|Overall Study|Withdrawal by Subject|3
7064135|NCT01955707|11162901|FG000|Overall Study|Death|13
7064136|NCT01955707|11162902|FG001|Overall Study|Death|14
7064137|NCT01955707|11162901|FG000|Overall Study|Other|4
7064138|NCT01955707|11162902|FG001|Overall Study|Other|2
7064139|NCT01955733|11162962|FG000|Period 1|Lost to Follow-up|1
7064140|NCT01955733|11162963|FG001|Period 1|Lost to Follow-up|0
7064141|NCT01955733|11162964|FG002|Period 1|Lost to Follow-up|0
7064142|NCT01955733|11162962|FG000|Period 2|Adverse Event|1
7064143|NCT01955733|11162963|FG001|Period 2|Adverse Event|0
7064144|NCT01955733|11162964|FG002|Period 2|Adverse Event|0
7064145|NCT01955733|11162962|FG000|Period 2|Physician Decision|0
7064146|NCT01955733|11162963|FG001|Period 2|Physician Decision|0
7064147|NCT01955733|11162964|FG002|Period 2|Physician Decision|1
7064148|NCT01955733|11162962|FG000|Period 2|Withdrawal by Subject|1
7064149|NCT01955733|11162963|FG001|Period 2|Withdrawal by Subject|3
7064150|NCT01955733|11162964|FG002|Period 2|Withdrawal by Subject|2
7064151|NCT01955733|11162962|FG000|Period 2|Study terminated by sponsor|8
7064152|NCT01955733|11162963|FG001|Period 2|Study terminated by sponsor|14
7064153|NCT01955733|11162964|FG002|Period 2|Study terminated by sponsor|16
7064154|NCT01955733|11162962|FG000|Period 2|Lost to Follow-up|2
7064155|NCT01955733|11162963|FG001|Period 2|Lost to Follow-up|0
7064156|NCT01955733|11162964|FG002|Period 2|Lost to Follow-up|0
7064157|NCT01955733|11162962|FG000|Period 2|Other not defined above|0
7064158|NCT01955733|11162963|FG001|Period 2|Other not defined above|2
7064159|NCT01955733|11162964|FG002|Period 2|Other not defined above|2
7064160|NCT01956123|11163008|FG000|COS Cycle 2|Protocol Violation|8
7064161|NCT01956123|11163009|FG001|COS Cycle 2|Protocol Violation|3
7064162|NCT01956123|11163010|FG002|COS Cycle 2|Protocol Violation|0
7064163|NCT01956123|11163011|FG003|COS Cycle 2|Protocol Violation|0
7064164|NCT01956123|11163008|FG000|COS Cycle 2|Adverse Event|3
7064165|NCT01956123|11163009|FG001|COS Cycle 2|Adverse Event|4
7064166|NCT01956123|11163010|FG002|COS Cycle 2|Adverse Event|0
7064167|NCT01956123|11163011|FG003|COS Cycle 2|Adverse Event|0
7064168|NCT01956123|11163008|FG000|COS Cycle 2|Personal Reasons|2
7064169|NCT01956123|11163009|FG001|COS Cycle 2|Personal Reasons|0
7064170|NCT01956123|11163010|FG002|COS Cycle 2|Personal Reasons|0
7064171|NCT01956123|11163011|FG003|COS Cycle 2|Personal Reasons|0
7064172|NCT01956123|11163008|FG000|COS Cycle 2|Withdrawal by Subject|1
7064173|NCT01956123|11163009|FG001|COS Cycle 2|Withdrawal by Subject|0
7064174|NCT01956123|11163010|FG002|COS Cycle 2|Withdrawal by Subject|0
7064175|NCT01956123|11163011|FG003|COS Cycle 2|Withdrawal by Subject|0
7064176|NCT01956123|11163008|FG000|COS Cycle 3|Protocol Violation|0
7064177|NCT01956123|11163009|FG001|COS Cycle 3|Protocol Violation|0
7064178|NCT01956123|11163010|FG002|COS Cycle 3|Protocol Violation|2
7064179|NCT01956123|11163011|FG003|COS Cycle 3|Protocol Violation|1
7064180|NCT01956123|11163008|FG000|COS Cycle 3|Adverse Event|0
7064181|NCT01956123|11163009|FG001|COS Cycle 3|Adverse Event|0
7064182|NCT01956123|11163010|FG002|COS Cycle 3|Adverse Event|3
7064183|NCT01956123|11163011|FG003|COS Cycle 3|Adverse Event|0
7064184|NCT01956123|11163008|FG000|COS Cycle 3|Personal Reasons|0
7064185|NCT01956123|11163009|FG001|COS Cycle 3|Personal Reasons|0
7064186|NCT01956123|11163010|FG002|COS Cycle 3|Personal Reasons|1
7064187|NCT01956123|11163011|FG003|COS Cycle 3|Personal Reasons|0
7064188|NCT01956123|11163008|FG000|COS Cycle 3|Withdrawal by Subject|0
7064189|NCT01956123|11163009|FG001|COS Cycle 3|Withdrawal by Subject|0
7064190|NCT01956123|11163010|FG002|COS Cycle 3|Withdrawal by Subject|0
7064191|NCT01956123|11163011|FG003|COS Cycle 3|Withdrawal by Subject|1
7064192|NCT01956240|11163024|FG000|Overall Study|Lost to Follow-up|6
7064193|NCT01956240|11163025|FG001|Overall Study|Lost to Follow-up|20
6928060|NCT00849693|10959084|FG002|Extension Phase|Adverse Event|3
7064194|NCT01956240|11163024|FG000|Overall Study|Adverse Event|17
7064195|NCT01956240|11163025|FG001|Overall Study|Adverse Event|4
7064196|NCT01956773|11163050|FG000|Overall Study|Lost to Follow-up|628
6928061|NCT00849693|10959085|FG003|Extension Phase|Adverse Event|7
7064197|NCT01956773|11163051|FG001|Overall Study|Lost to Follow-up|1
7064198|NCT01957111|11163064|FG000|Overall Study|Withdrawal by Subject|1
7064199|NCT01957111|11163065|FG001|Overall Study|Withdrawal by Subject|1
7064200|NCT01957137|11163071|FG000|Randomized Portion|Adverse Event|1
7064201|NCT01957137|11163071|FG000|Randomized Portion|Withdrawal by Subject|1
7039552|NCT01711359|11122300|FG000|Treatment Period|Adverse Event|8
7039553|NCT01711359|11122301|FG001|Treatment Period|Adverse Event|10
6928062|NCT00849693|10959082|FG000|Extension Phase|Lost to Follow-up|7
6928063|NCT00849693|10959083|FG001|Extension Phase|Lost to Follow-up|5
6928064|NCT00849693|10959084|FG002|Extension Phase|Lost to Follow-up|6
6928065|NCT00849693|10959085|FG003|Extension Phase|Lost to Follow-up|6
6928066|NCT00849693|10959082|FG000|Extension Phase|Protocol Violation|0
6928067|NCT00849693|10959083|FG001|Extension Phase|Protocol Violation|3
6928068|NCT00849693|10959084|FG002|Extension Phase|Protocol Violation|2
6928069|NCT00849693|10959085|FG003|Extension Phase|Protocol Violation|3
6928070|NCT00849693|10959082|FG000|Extension Phase|Withdrawal by Subject|6
6928071|NCT00849693|10959083|FG001|Extension Phase|Withdrawal by Subject|9
6928072|NCT00849693|10959084|FG002|Extension Phase|Withdrawal by Subject|10
6928073|NCT00849693|10959085|FG003|Extension Phase|Withdrawal by Subject|15
6928074|NCT00849693|10959082|FG000|Extension Phase|Parent or caregiver decision|9
6928075|NCT00849693|10959083|FG001|Extension Phase|Parent or caregiver decision|4
6928076|NCT00849693|10959084|FG002|Extension Phase|Parent or caregiver decision|10
6928077|NCT00849693|10959085|FG003|Extension Phase|Parent or caregiver decision|5
6928078|NCT00849693|10959082|FG000|Extension Phase|Physician Decision|1
6928079|NCT00849693|10959083|FG001|Extension Phase|Physician Decision|1
6928080|NCT00849693|10959084|FG002|Extension Phase|Physician Decision|2
7039554|NCT01711359|11122302|FG002|Treatment Period|Adverse Event|24
7064202|NCT01957150|11163085|FG000|Overall Study|Adverse Event|23
7064203|NCT01957150|11163086|FG001|Overall Study|Adverse Event|20
7064204|NCT01957150|11163085|FG000|Overall Study|Withdrawal by Subject|13
7064205|NCT01957150|11163086|FG001|Overall Study|Withdrawal by Subject|17
7064206|NCT01957150|11163085|FG000|Overall Study|Physician Decision|3
7064207|NCT01957150|11163086|FG001|Overall Study|Physician Decision|6
7064208|NCT01957150|11163085|FG000|Overall Study|Lost to Follow-up|4
7064209|NCT01957150|11163086|FG001|Overall Study|Lost to Follow-up|4
7064210|NCT01957150|11163085|FG000|Overall Study|Protocol Violation|1
7064211|NCT01957150|11163086|FG001|Overall Study|Protocol Violation|0
7064212|NCT01957150|11163085|FG000|Overall Study|Lack of Efficacy|11
7064213|NCT01957150|11163086|FG001|Overall Study|Lack of Efficacy|11
7064214|NCT01957163|11163095|FG000|Overall Study|Adverse Event|5
7064215|NCT01957163|11163096|FG001|Overall Study|Adverse Event|2
7064216|NCT01957163|11163097|FG002|Overall Study|Adverse Event|4
7064217|NCT01957163|11163095|FG000|Overall Study|Lack of Efficacy|5
7064218|NCT01957163|11163096|FG001|Overall Study|Lack of Efficacy|4
7064219|NCT01957163|11163097|FG002|Overall Study|Lack of Efficacy|9
7064220|NCT01957163|11163095|FG000|Overall Study|Protocol Violation|1
7064221|NCT01957163|11163096|FG001|Overall Study|Protocol Violation|2
7064222|NCT01957163|11163097|FG002|Overall Study|Protocol Violation|0
7064223|NCT01957163|11163095|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0
7064224|NCT01957163|11163096|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0
7064225|NCT01957163|11163097|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1
7064226|NCT01957163|11163095|FG000|Overall Study|Lost to Follow-up|0
7064227|NCT01957163|11163096|FG001|Overall Study|Lost to Follow-up|1
7064228|NCT01957163|11163097|FG002|Overall Study|Lost to Follow-up|0
7064229|NCT01957163|11163095|FG000|Overall Study|Withdrawal by Subject|4
7064230|NCT01957163|11163096|FG001|Overall Study|Withdrawal by Subject|2
7064231|NCT01957163|11163097|FG002|Overall Study|Withdrawal by Subject|4
7064232|NCT01957202|11163105|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7064233|NCT01957202|11163106|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
7064234|NCT01957202|11163107|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7064235|NCT01957202|11163108|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7064236|NCT01957202|11163109|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7064237|NCT01957202|11163110|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7064238|NCT01957202|11163111|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7064239|NCT01957202|11163112|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7064240|NCT01957202|11163113|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7064241|NCT01957202|11163114|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7064242|NCT01957202|11163115|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7064243|NCT01957202|11163116|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7064244|NCT01957202|11163117|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7064245|NCT01957202|11163118|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7064246|NCT01957202|11163119|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7064247|NCT01957202|11163120|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7064248|NCT01957202|11163121|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
7064249|NCT01957202|11163122|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7064250|NCT01957202|11163105|FG000|Treatment Period 3 (8 Days)|Adverse Event|0
7064251|NCT01957202|11163106|FG001|Treatment Period 3 (8 Days)|Adverse Event|0
7064252|NCT01957202|11163107|FG002|Treatment Period 3 (8 Days)|Adverse Event|0
7064253|NCT01957202|11163108|FG003|Treatment Period 3 (8 Days)|Adverse Event|0
7064254|NCT01957202|11163109|FG004|Treatment Period 3 (8 Days)|Adverse Event|0
7064255|NCT01957202|11163110|FG005|Treatment Period 3 (8 Days)|Adverse Event|0
6928081|NCT00849693|10959085|FG003|Extension Phase|Physician Decision|0
6928082|NCT00849693|10959082|FG000|Extension Phase|Sponsor decision|1
6928083|NCT00849693|10959083|FG001|Extension Phase|Sponsor decision|0
6928084|NCT00849693|10959084|FG002|Extension Phase|Sponsor decision|0
7039555|NCT01711359|11122300|FG000|Treatment Period|Physician Decision|4
6928085|NCT00849693|10959085|FG003|Extension Phase|Sponsor decision|1
6928086|NCT00849693|10959082|FG000|Extension Phase|Lack of Efficacy|2
6928087|NCT00849693|10959083|FG001|Extension Phase|Lack of Efficacy|2
6928088|NCT00849693|10959084|FG002|Extension Phase|Lack of Efficacy|2
6928089|NCT00849693|10959085|FG003|Extension Phase|Lack of Efficacy|1
6928090|NCT00849875|10959114|FG000|Overall Study|Death|28
6928091|NCT00849875|10959114|FG000|Overall Study|Ongoing (unknown completion status)|11
6928092|NCT00849875|10959114|FG000|Overall Study|Others|6
6928093|NCT00849875|10959114|FG000|Overall Study|Lost to Follow-up|2
6928094|NCT00849901|10959128|FG000|Acute Treatment Phase|Adverse Event|9
6928095|NCT00849901|10959129|FG001|Acute Treatment Phase|Adverse Event|1
6928096|NCT00849901|10959130|FG002|Acute Treatment Phase|Adverse Event|3
6928097|NCT00849901|10959128|FG000|Acute Treatment Phase|Lost to Follow-up|2
6928098|NCT00849901|10959129|FG001|Acute Treatment Phase|Lost to Follow-up|4
6928099|NCT00849901|10959130|FG002|Acute Treatment Phase|Lost to Follow-up|1
6928100|NCT00849901|10959128|FG000|Acute Treatment Phase|Protocol Violation|0
6928101|NCT00849901|10959129|FG001|Acute Treatment Phase|Protocol Violation|2
6928102|NCT00849901|10959130|FG002|Acute Treatment Phase|Protocol Violation|1
6928103|NCT00849901|10959128|FG000|Acute Treatment Phase|Withdrawal by Subject|4
6928104|NCT00849901|10959129|FG001|Acute Treatment Phase|Withdrawal by Subject|10
6928105|NCT00849901|10959130|FG002|Acute Treatment Phase|Withdrawal by Subject|4
6928106|NCT00849901|10959128|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11
6928107|NCT00849901|10959129|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5
6928108|NCT00849901|10959130|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4
6928109|NCT00849901|10959128|FG000|Acute Treatment Phase|Physician Decision|1
6928110|NCT00849901|10959129|FG001|Acute Treatment Phase|Physician Decision|1
6928111|NCT00849901|10959130|FG002|Acute Treatment Phase|Physician Decision|1
6928112|NCT00849901|10959128|FG000|Acute Treatment Phase|Sponsor Decision|1
6928113|NCT00849901|10959129|FG001|Acute Treatment Phase|Sponsor Decision|0
6928114|NCT00849901|10959130|FG002|Acute Treatment Phase|Sponsor Decision|0
6928115|NCT00849901|10959128|FG000|Acute Treatment Phase|Lack of Efficacy|2
6928116|NCT00849901|10959129|FG001|Acute Treatment Phase|Lack of Efficacy|3
6928117|NCT00849901|10959130|FG002|Acute Treatment Phase|Lack of Efficacy|2
6928118|NCT00849901|10959128|FG000|Extension Phase|Adverse Event|2
6928119|NCT00849901|10959129|FG001|Extension Phase|Adverse Event|8
6928120|NCT00849901|10959130|FG002|Extension Phase|Adverse Event|4
6928121|NCT00849901|10959128|FG000|Extension Phase|Lost to Follow-up|3
6928122|NCT00849901|10959129|FG001|Extension Phase|Lost to Follow-up|0
6928123|NCT00849901|10959130|FG002|Extension Phase|Lost to Follow-up|1
6928124|NCT00849901|10959128|FG000|Extension Phase|Protocol Violation|2
6928125|NCT00849901|10959129|FG001|Extension Phase|Protocol Violation|2
6928126|NCT00849901|10959130|FG002|Extension Phase|Protocol Violation|4
6928127|NCT00849901|10959128|FG000|Extension Phase|Withdrawal by Subject|7
6928128|NCT00849901|10959129|FG001|Extension Phase|Withdrawal by Subject|6
6928129|NCT00849901|10959130|FG002|Extension Phase|Withdrawal by Subject|3
6928130|NCT00849901|10959128|FG000|Extension Phase|Parent or Caregiver Decision|10
6928131|NCT00849901|10959129|FG001|Extension Phase|Parent or Caregiver Decision|4
6928132|NCT00849901|10959130|FG002|Extension Phase|Parent or Caregiver Decision|4
6928133|NCT00849901|10959128|FG000|Extension Phase|Physician Decision|1
6928134|NCT00849901|10959129|FG001|Extension Phase|Physician Decision|2
6928135|NCT00849901|10959130|FG002|Extension Phase|Physician Decision|0
6928136|NCT00849901|10959128|FG000|Extension Phase|Lack of Efficacy|2
6928137|NCT00849901|10959129|FG001|Extension Phase|Lack of Efficacy|4
6928138|NCT00849901|10959130|FG002|Extension Phase|Lack of Efficacy|1
6975033|NCT01190930|11027137|FG006|Post Induction Pre-Maintenance|Inevaluable|0
6975034|NCT01190930|11027138|FG007|Post Induction Pre-Maintenance|Inevaluable|0
6975035|NCT01190930|11027139|FG008|Post Induction Pre-Maintenance|Inevaluable|0
6975036|NCT01190930|11027140|FG009|Post Induction Pre-Maintenance|Inevaluable|0
6975037|NCT01190930|11027131|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
6975038|NCT01190930|11027132|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1
6975039|NCT01190930|11027133|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
6975040|NCT01190930|11027134|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
6975041|NCT01190930|11027135|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
6975042|NCT01190930|11027136|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
6975043|NCT01190930|11027137|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
6975044|NCT01190930|11027138|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
6975045|NCT01190930|11027139|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
6975046|NCT01190930|11027140|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
6975047|NCT01190930|11027131|FG000|Post Induction Pre-Maintenance|Progressive disease|0
6975048|NCT01190930|11027132|FG001|Post Induction Pre-Maintenance|Progressive disease|0
7039556|NCT01711359|11122301|FG001|Treatment Period|Physician Decision|3
7039557|NCT01711359|11122302|FG002|Treatment Period|Physician Decision|2
7039558|NCT01711359|11122300|FG000|Treatment Period|Death|3
7039559|NCT01711359|11122301|FG001|Treatment Period|Death|0
7039560|NCT01711359|11122302|FG002|Treatment Period|Death|0
7039561|NCT01711359|11122300|FG000|Treatment Period|Entry Criteria Not Met|1
7039562|NCT01711359|11122301|FG001|Treatment Period|Entry Criteria Not Met|0
7039563|NCT01711359|11122302|FG002|Treatment Period|Entry Criteria Not Met|0
7039564|NCT01711359|11122300|FG000|Treatment Period|Sponsor Decision|1
7039565|NCT01711359|11122301|FG001|Treatment Period|Sponsor Decision|0
6928139|NCT00849940|10959144|FG000|Overall Study|Physician Decision|4
6928140|NCT00850070|10959154|FG000|Overall Study|Lack of Efficacy|1
6928141|NCT00850070|10959155|FG001|Overall Study|Lack of Efficacy|1
6928142|NCT00850070|10959154|FG000|Overall Study|Adverse Event|2
6928143|NCT00850070|10959155|FG001|Overall Study|Adverse Event|0
6928144|NCT00850135|10959175|FG000|Overall Study|Physician Decision|1
6928145|NCT00850200|10959181|FG000|Overall Study|Physician Decision|2
6928146|NCT00850200|10959181|FG000|Overall Study|Did not recieve treatment|2
6928147|NCT00850200|10959181|FG000|Overall Study|Withdrawal by Subject|1
6928148|NCT00850343|10959192|FG000|Overall Study|Withdrawal by Subject|11
6928149|NCT00850343|10959193|FG001|Overall Study|Withdrawal by Subject|0
6928150|NCT00850343|10959194|FG002|Overall Study|Withdrawal by Subject|3
6928151|NCT00850343|10959195|FG003|Overall Study|Withdrawal by Subject|2
6928152|NCT00850343|10959192|FG000|Overall Study|Adverse Event|15
6928153|NCT00850343|10959193|FG001|Overall Study|Adverse Event|2
6928154|NCT00850343|10959194|FG002|Overall Study|Adverse Event|6
6928155|NCT00850343|10959195|FG003|Overall Study|Adverse Event|6
6928156|NCT00850343|10959192|FG000|Overall Study|Pregnancy|0
6928157|NCT00850343|10959193|FG001|Overall Study|Pregnancy|0
6928158|NCT00850343|10959194|FG002|Overall Study|Pregnancy|0
6928159|NCT00850343|10959195|FG003|Overall Study|Pregnancy|1
6928160|NCT00850343|10959192|FG000|Overall Study|Lack of Efficacy|17
6928161|NCT00850343|10959193|FG001|Overall Study|Lack of Efficacy|0
6928162|NCT00850343|10959194|FG002|Overall Study|Lack of Efficacy|3
6928163|NCT00850343|10959195|FG003|Overall Study|Lack of Efficacy|2
6928164|NCT00850343|10959192|FG000|Overall Study|Non-compliance with Study Procedures|1
6928165|NCT00850343|10959193|FG001|Overall Study|Non-compliance with Study Procedures|0
6928166|NCT00850343|10959194|FG002|Overall Study|Non-compliance with Study Procedures|1
6928167|NCT00850343|10959195|FG003|Overall Study|Non-compliance with Study Procedures|1
6928168|NCT00850343|10959192|FG000|Overall Study|Physician Decision|2
6928169|NCT00850343|10959193|FG001|Overall Study|Physician Decision|1
6928170|NCT00850343|10959194|FG002|Overall Study|Physician Decision|1
6928171|NCT00850343|10959195|FG003|Overall Study|Physician Decision|1
6928172|NCT00850395|10959205|FG000|Overall Study|Death|1
6928173|NCT00850395|10959205|FG000|Overall Study|Adverse Event|1
6928174|NCT00850395|10959205|FG000|Overall Study|Insufficient clinical response|3
6928175|NCT00850395|10959205|FG000|Overall Study|Other|5
6928176|NCT00850460|10959211|FG000|Overall Study|Lost to Follow-up|4
6928177|NCT00850460|10959212|FG001|Overall Study|Lost to Follow-up|4
6928178|NCT00850499|10959224|FG000|Overall Study|Adverse Event|3
6928179|NCT00850499|10959225|FG001|Overall Study|Adverse Event|1
6928180|NCT00850499|10959224|FG000|Overall Study|Lack of Efficacy|0
6928181|NCT00850499|10959225|FG001|Overall Study|Lack of Efficacy|1
6928182|NCT00850538|10959231|FG000|Overall Study|unable/unwilling to complete MRI|13
6928183|NCT00850538|10959231|FG000|Overall Study|specimen missed due to scheduling error|14
6928184|NCT00850538|10959231|FG000|Overall Study|specimen unusable|7
6928185|NCT00850538|10959231|FG000|Overall Study|Withdrawal by Subject|3
6928186|NCT00850538|10959231|FG000|Overall Study|radiology error|2
7039566|NCT01711359|11122302|FG002|Treatment Period|Sponsor Decision|0
7039567|NCT01711359|11122300|FG000|Treatment Period|Lost to Follow-up|1
7039568|NCT01711359|11122301|FG001|Treatment Period|Lost to Follow-up|1
7039569|NCT01711359|11122302|FG002|Treatment Period|Lost to Follow-up|1
7039570|NCT01711359|11122300|FG000|Treatment Period|Randomized, Not Treated|3
7039571|NCT01711359|11122301|FG001|Treatment Period|Randomized, Not Treated|1
7039572|NCT01711359|11122302|FG002|Treatment Period|Randomized, Not Treated|0
7039573|NCT01711619|11122329|FG000|Overall Study|Early study termination|10
7039574|NCT01711619|11122330|FG001|Overall Study|Early study termination|14
7039575|NCT01711619|11122329|FG000|Overall Study|Withdrawal by Subject|3
7039576|NCT01711619|11122330|FG001|Overall Study|Withdrawal by Subject|7
7039577|NCT01711619|11122329|FG000|Overall Study|Protocol Violation|2
7039578|NCT01711619|11122330|FG001|Overall Study|Protocol Violation|3
7039579|NCT01711619|11122329|FG000|Overall Study|Adverse Event|2
7039580|NCT01711619|11122330|FG001|Overall Study|Adverse Event|0
7039581|NCT01711619|11122329|FG000|Overall Study|Lost to Follow-up|1
7039582|NCT01711619|11122330|FG001|Overall Study|Lost to Follow-up|0
7039583|NCT01711645|11122336|FG000|Overall Study|Withdrawal by Subject|8
7039584|NCT01711645|11122336|FG000|Overall Study|Lost to Follow-up|6
7039585|NCT01711645|11122336|FG000|Overall Study|Physician Decision|5
6928187|NCT00850538|10959231|FG000|Overall Study|Protocol Violation|2
6928188|NCT00850564|10959235|FG000|Overall Study|Withdrawal by Subject|2
6928189|NCT00850759|10959278|FG000|Overall Study|Lost to Follow-up|7
6928190|NCT00850759|10959279|FG001|Overall Study|Lost to Follow-up|5
7039586|NCT01711736|11122351|FG000|Overall Study|Lost to Follow-up|4
7039587|NCT01711736|11122352|FG001|Overall Study|Lost to Follow-up|1
7039588|NCT01711736|11122351|FG000|Overall Study|Withdrawal by Subject|6
7039589|NCT01711736|11122352|FG001|Overall Study|Withdrawal by Subject|6
6928191|NCT00850759|10959280|FG002|Overall Study|Lost to Follow-up|5
6928192|NCT00850759|10959281|FG003|Overall Study|Lost to Follow-up|3
6928193|NCT00850993|10959302|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1
6928194|NCT00850993|10959303|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0
6928195|NCT00850993|10959304|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0
7039590|NCT01711736|11122351|FG000|Overall Study|Migrated/moved from study area|2
7039591|NCT01711736|11122352|FG001|Overall Study|Migrated/moved from study area|1
7039592|NCT01711853|11122359|FG000|Overall Study|Not treated|3
7039593|NCT01711866|11122363|FG000|Overall Study|Noncompliant|3
7039594|NCT01711866|11122363|FG000|Overall Study|Withdrawal by Subject|3
7039595|NCT01711866|11122363|FG000|Overall Study|Adverse Event|2
7039596|NCT01711983|11122371|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32
7039597|NCT01711983|11122371|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26
7039598|NCT01711983|11122371|FG000|36-Month Closure Evaluation|Test Device Removal|2
6837279|NCT00249873|10842870|FG001|Overall Study|Contraindication to oral anticoagulant|8
6928196|NCT00850993|10959305|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1
6928197|NCT00851084|10959325|FG000|Overall Study|Randomized but not treated|1
6928198|NCT00851084|10959326|FG001|Overall Study|Randomized but not treated|0
6928199|NCT00851084|10959325|FG000|Overall Study|Adverse Event|26
6928200|NCT00851084|10959326|FG001|Overall Study|Adverse Event|36
6928201|NCT00851084|10959325|FG000|Overall Study|Disease progression|52
6928202|NCT00851084|10959326|FG001|Overall Study|Disease progression|47
6928203|NCT00851084|10959325|FG000|Overall Study|Poor compliance to protocol|1
6928204|NCT00851084|10959326|FG001|Overall Study|Poor compliance to protocol|1
6928205|NCT00851084|10959325|FG000|Overall Study|Physician Decision|13
6928206|NCT00851084|10959326|FG001|Overall Study|Physician Decision|14
6928207|NCT00851084|10959325|FG000|Overall Study|Consent withdrawn|0
6928208|NCT00851084|10959326|FG001|Overall Study|Consent withdrawn|2
6928209|NCT00851084|10959325|FG000|Overall Study|Withdrawal by Subject|11
6928210|NCT00851084|10959326|FG001|Overall Study|Withdrawal by Subject|12
6928211|NCT00851084|10959325|FG000|Overall Study|Metastatic surgery|6
6837280|NCT00249873|10842869|FG000|Overall Study|Withdrawal by Subject|504
6837281|NCT00249873|10842870|FG001|Overall Study|Withdrawal by Subject|466
6837282|NCT00249873|10842869|FG000|Overall Study|Lost to Follow-up|4
6837283|NCT00249873|10842870|FG001|Overall Study|Lost to Follow-up|7
6837284|NCT00249873|10842869|FG000|Overall Study|Minor bleeding|99
6837285|NCT00249873|10842870|FG001|Overall Study|Minor bleeding|37
6837286|NCT00249873|10842869|FG000|Overall Study|Non-compliance|41
6837287|NCT00249873|10842870|FG001|Overall Study|Non-compliance|46
6837288|NCT00249873|10842869|FG000|Overall Study|Other non serious Adverse Event|112
6837289|NCT00249873|10842870|FG001|Overall Study|Other non serious Adverse Event|108
6837290|NCT00249873|10842869|FG000|Overall Study|Other contraindicated medication|1
6837291|NCT00249873|10842870|FG001|Overall Study|Other contraindicated medication|0
6837292|NCT00249873|10842869|FG000|Overall Study|Patient not wish to continue after May08|3
6837293|NCT00249873|10842870|FG001|Overall Study|Patient not wish to continue after May08|4
6837294|NCT00249873|10842869|FG000|Overall Study|Physician withdrew consent|59
6837295|NCT00249873|10842870|FG001|Overall Study|Physician withdrew consent|60
6837296|NCT00249873|10842869|FG000|Overall Study|Open label clopidogrel required|31
6837297|NCT00249873|10842870|FG001|Overall Study|Open label clopidogrel required|42
6837298|NCT00249873|10842869|FG000|Overall Study|Angiotensin II receptor blocker required|1
6837299|NCT00249873|10842870|FG001|Overall Study|Angiotensin II receptor blocker required|0
6837300|NCT00249873|10842869|FG000|Overall Study|Oral anticoagulant required|159
6837301|NCT00249873|10842870|FG001|Overall Study|Oral anticoagulant required|157
6837302|NCT00249873|10842869|FG000|Overall Study|Study drug intolerance|5
6837303|NCT00249873|10842870|FG001|Overall Study|Study drug intolerance|0
6837304|NCT00249873|10842869|FG000|Overall Study|Surgery/ procedure|9
6837305|NCT00249873|10842870|FG001|Overall Study|Surgery/ procedure|9
6837306|NCT00249873|10842869|FG000|Overall Study|Event related to cardiac condition|12
6837307|NCT00249873|10842870|FG001|Overall Study|Event related to cardiac condition|21
6837308|NCT00249873|10842869|FG000|Overall Study|Thromboembolic/outcome event|82
6837309|NCT00249873|10842870|FG001|Overall Study|Thromboembolic/outcome event|122
6837310|NCT00250276|10842880|FG000|Overall Study|Serious Adverse Event|0
6837311|NCT00250276|10842881|FG001|Overall Study|Serious Adverse Event|0
6837312|NCT00250276|10842882|FG002|Overall Study|Serious Adverse Event|1
6837313|NCT00250276|10842883|FG003|Overall Study|Serious Adverse Event|0
6837314|NCT00250276|10842880|FG000|Overall Study|Non-serious Adverse Event|2
6837315|NCT00250276|10842881|FG001|Overall Study|Non-serious Adverse Event|0
6837316|NCT00250276|10842882|FG002|Overall Study|Non-serious Adverse Event|0
6837317|NCT00250276|10842883|FG003|Overall Study|Non-serious Adverse Event|2
6837318|NCT00250276|10842880|FG000|Overall Study|Protocol Violation|0
6837319|NCT00250276|10842881|FG001|Overall Study|Protocol Violation|1
6837320|NCT00250276|10842882|FG002|Overall Study|Protocol Violation|0
6837321|NCT00250276|10842883|FG003|Overall Study|Protocol Violation|0
6837322|NCT00250276|10842880|FG000|Overall Study|Withdrawal by Subject|1
6837323|NCT00250276|10842881|FG001|Overall Study|Withdrawal by Subject|2
6837324|NCT00250276|10842882|FG002|Overall Study|Withdrawal by Subject|3
6837325|NCT00250276|10842883|FG003|Overall Study|Withdrawal by Subject|2
6837326|NCT00250276|10842880|FG000|Overall Study|Migrated/moved from study area|3
6837327|NCT00250276|10842881|FG001|Overall Study|Migrated/moved from study area|0
6837328|NCT00250276|10842882|FG002|Overall Study|Migrated/moved from study area|2
6837329|NCT00250276|10842883|FG003|Overall Study|Migrated/moved from study area|7
6837330|NCT00250276|10842880|FG000|Overall Study|Lost to Follow-up|11
6837331|NCT00250276|10842881|FG001|Overall Study|Lost to Follow-up|18
6837332|NCT00250276|10842882|FG002|Overall Study|Lost to Follow-up|13
6837333|NCT00250276|10842883|FG003|Overall Study|Lost to Follow-up|8
6928212|NCT00851084|10959326|FG001|Overall Study|Metastatic surgery|6
6928213|NCT00851084|10959325|FG000|Overall Study|Other|7
6928214|NCT00851084|10959326|FG001|Overall Study|Other|1
6928215|NCT00851253|10959336|FG000|Overall Study|Disease Progression|1
6928216|NCT00851253|10959337|FG001|Overall Study|Disease Progression|0
6928217|NCT00851318|10959351|FG000|Overall Study|Withdrawal by Subject|7
6928218|NCT00851318|10959352|FG001|Overall Study|Withdrawal by Subject|1
6928219|NCT00851318|10959353|FG002|Overall Study|Withdrawal by Subject|5
6928220|NCT00851318|10959354|FG003|Overall Study|Withdrawal by Subject|3
6928221|NCT00851318|10959351|FG000|Overall Study|Adverse Event|13
6928222|NCT00851318|10959352|FG001|Overall Study|Adverse Event|2
6928223|NCT00851318|10959353|FG002|Overall Study|Adverse Event|9
6928224|NCT00851318|10959354|FG003|Overall Study|Adverse Event|12
6928225|NCT00851318|10959351|FG000|Overall Study|Pregnancy|0
6928226|NCT00851318|10959352|FG001|Overall Study|Pregnancy|0
6928227|NCT00851318|10959353|FG002|Overall Study|Pregnancy|1
6928228|NCT00851318|10959354|FG003|Overall Study|Pregnancy|1
6928229|NCT00851318|10959351|FG000|Overall Study|Lack of Efficacy|8
6928230|NCT00851318|10959352|FG001|Overall Study|Lack of Efficacy|2
6928231|NCT00851318|10959353|FG002|Overall Study|Lack of Efficacy|4
6928232|NCT00851318|10959354|FG003|Overall Study|Lack of Efficacy|2
6928233|NCT00851318|10959351|FG000|Overall Study|Non-compliance with Study Procedures|2
6928234|NCT00851318|10959352|FG001|Overall Study|Non-compliance with Study Procedures|0
6928235|NCT00851318|10959353|FG002|Overall Study|Non-compliance with Study Procedures|1
6928236|NCT00851318|10959354|FG003|Overall Study|Non-compliance with Study Procedures|0
6928237|NCT00851318|10959351|FG000|Overall Study|Physician Decision|0
6928238|NCT00851318|10959352|FG001|Overall Study|Physician Decision|0
6928239|NCT00851318|10959353|FG002|Overall Study|Physician Decision|1
6928240|NCT00851318|10959354|FG003|Overall Study|Physician Decision|1
7064256|NCT01957202|11163111|FG006|Treatment Period 3 (8 Days)|Adverse Event|0
7064257|NCT01957202|11163112|FG007|Treatment Period 3 (8 Days)|Adverse Event|0
7064258|NCT01957202|11163113|FG008|Treatment Period 3 (8 Days)|Adverse Event|0
7064259|NCT01957202|11163114|FG009|Treatment Period 3 (8 Days)|Adverse Event|0
7064260|NCT01957202|11163115|FG010|Treatment Period 3 (8 Days)|Adverse Event|0
7064261|NCT01957202|11163116|FG011|Treatment Period 3 (8 Days)|Adverse Event|0
7064262|NCT01957202|11163117|FG012|Treatment Period 3 (8 Days)|Adverse Event|0
7064263|NCT01957202|11163118|FG013|Treatment Period 3 (8 Days)|Adverse Event|0
7064264|NCT01957202|11163119|FG014|Treatment Period 3 (8 Days)|Adverse Event|0
7064265|NCT01957202|11163120|FG015|Treatment Period 3 (8 Days)|Adverse Event|0
7064266|NCT01957202|11163121|FG016|Treatment Period 3 (8 Days)|Adverse Event|1
7064267|NCT01957202|11163122|FG017|Treatment Period 3 (8 Days)|Adverse Event|0
7064268|NCT01957215|11163134|FG000|Overall Study|Adverse Event|2
7064269|NCT01957215|11163135|FG001|Overall Study|Adverse Event|2
7064270|NCT01957215|11163134|FG000|Overall Study|Lost to Follow-up|3
7064271|NCT01957215|11163135|FG001|Overall Study|Lost to Follow-up|3
7064272|NCT01957215|11163134|FG000|Overall Study|Protocol Violation|1
7064273|NCT01957215|11163135|FG001|Overall Study|Protocol Violation|2
7064274|NCT01957215|11163134|FG000|Overall Study|Withdrawal by Subject|7
7064275|NCT01957215|11163135|FG001|Overall Study|Withdrawal by Subject|5
7064276|NCT01957397|11163158|FG000|Test Period 1|sudden leakage/small bag|1
7064277|NCT01957397|11163159|FG001|Test Period 1|sudden leakage/small bag|1
7064278|NCT01957397|11163158|FG000|Test Period 1|Withdrawal by Subject|1
7064279|NCT01957397|11163159|FG001|Test Period 1|Withdrawal by Subject|0
7064280|NCT01957397|11163158|FG000|Test Period 2|Adverse Event|0
7064281|NCT01957397|11163159|FG001|Test Period 2|Adverse Event|1
7064282|NCT01957397|11163158|FG000|Test Period 3|Adverse Event|1
7064283|NCT01957397|11163159|FG001|Test Period 3|Adverse Event|2
7064284|NCT01957397|11163158|FG000|Test Period 3|the adhesive did not work|1
7064285|NCT01957397|11163159|FG001|Test Period 3|the adhesive did not work|0
7064286|NCT01957462|11163173|FG000|Test Period 1|Withdrawal by Subject|1
7064287|NCT01957462|11163174|FG001|Test Period 1|Withdrawal by Subject|0
7064288|NCT01957462|11163173|FG000|Test Period 1|Adverse Event|1
7064289|NCT01957462|11163174|FG001|Test Period 1|Adverse Event|0
7082406|NCT02141672|11192949|FG001|Overall Study|Adverse Event|1
7082407|NCT02141672|11192950|FG002|Overall Study|Adverse Event|0
7082408|NCT02141672|11192948|FG000|Overall Study|Death|10
7082409|NCT02141672|11192949|FG001|Overall Study|Death|2
7082410|NCT02141672|11192950|FG002|Overall Study|Death|1
7082411|NCT02141672|11192948|FG000|Overall Study|Lack of Efficacy|0
7082412|NCT02141672|11192949|FG001|Overall Study|Lack of Efficacy|0
7082413|NCT02141672|11192950|FG002|Overall Study|Lack of Efficacy|2
7082414|NCT02141672|11192948|FG000|Overall Study|Lost to Follow-up|1
7082415|NCT02141672|11192949|FG001|Overall Study|Lost to Follow-up|1
7082416|NCT02141672|11192950|FG002|Overall Study|Lost to Follow-up|3
7082417|NCT02141672|11192948|FG000|Overall Study|Physician Decision|1
6928241|NCT00851630|10959384|FG000|Overall Study|Death|2
6928242|NCT00851630|10959385|FG001|Overall Study|Death|1
6928243|NCT00851630|10959384|FG000|Overall Study|Clinical failure|0
7082418|NCT02141672|11192949|FG001|Overall Study|Physician Decision|2
7082419|NCT02141672|11192950|FG002|Overall Study|Physician Decision|5
7082420|NCT02141672|11192948|FG000|Overall Study|Protocol Violation|0
7082421|NCT02141672|11192949|FG001|Overall Study|Protocol Violation|0
7082422|NCT02141672|11192950|FG002|Overall Study|Protocol Violation|1
7082423|NCT02141672|11192948|FG000|Overall Study|Withdrawal by Subject|3
7082424|NCT02141672|11192949|FG001|Overall Study|Withdrawal by Subject|2
6928244|NCT00851630|10959385|FG001|Overall Study|Clinical failure|1
6928245|NCT00851643|10959397|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1
6928246|NCT00851643|10959398|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0
6928247|NCT00851643|10959399|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0
6928248|NCT00851643|10959400|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0
6928249|NCT00851643|10959401|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0
6928250|NCT00851643|10959402|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0
6928251|NCT00851643|10959397|FG000|Base Study (Up to 12 Months)|Other|0
6928252|NCT00851643|10959398|FG001|Base Study (Up to 12 Months)|Other|0
6928253|NCT00851643|10959399|FG002|Base Study (Up to 12 Months)|Other|0
6928254|NCT00851643|10959400|FG003|Base Study (Up to 12 Months)|Other|0
6928255|NCT00851643|10959401|FG004|Base Study (Up to 12 Months)|Other|0
6928256|NCT00851643|10959402|FG005|Base Study (Up to 12 Months)|Other|1
6928257|NCT00851643|10959397|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4
6928258|NCT00851643|10959398|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2
6928259|NCT00851643|10959399|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4
6928260|NCT00851643|10959400|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1
6928261|NCT00851643|10959401|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2
6928262|NCT00851643|10959402|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0
6928263|NCT00851643|10959397|FG000|Extension Study (Up to 36 Months)|Moved|0
6928264|NCT00851643|10959398|FG001|Extension Study (Up to 36 Months)|Moved|2
7064290|NCT01957475|11163180|FG000|Test Period 1|Withdrawal by Subject|1
7064291|NCT01957475|11163181|FG001|Test Period 1|Withdrawal by Subject|0
7064292|NCT01957475|11163180|FG000|Test Period 1|Other|1
7064293|NCT01957475|11163181|FG001|Test Period 1|Other|0
7064294|NCT01957475|11163180|FG000|Test Period 1|Lack of Efficacy|0
7064295|NCT01957475|11163181|FG001|Test Period 1|Lack of Efficacy|1
7064296|NCT01957475|11163180|FG000|Test Period 2|Adverse Event|1
7064297|NCT01957475|11163181|FG001|Test Period 2|Adverse Event|0
7064298|NCT01957488|11163187|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2
7064299|NCT01957488|11163188|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0
7064300|NCT01957488|11163189|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1
7064301|NCT01957488|11163190|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1
7064302|NCT01957488|11163191|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0
7064303|NCT01957488|11163192|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0
7064304|NCT01957488|11163187|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1
7064305|NCT01957488|11163188|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2
7064306|NCT01957488|11163189|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2
7064307|NCT01957488|11163190|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1
7064308|NCT01957488|11163191|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0
7064309|NCT01957488|11163192|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3
7064310|NCT01957488|11163187|FG000|Test Period 1 (2 Weeks)|Adverse Event|0
7064311|NCT01957488|11163188|FG001|Test Period 1 (2 Weeks)|Adverse Event|1
7064312|NCT01957488|11163189|FG002|Test Period 1 (2 Weeks)|Adverse Event|1
7064313|NCT01957488|11163190|FG003|Test Period 1 (2 Weeks)|Adverse Event|0
7064314|NCT01957488|11163191|FG004|Test Period 1 (2 Weeks)|Adverse Event|1
7064315|NCT01957488|11163192|FG005|Test Period 1 (2 Weeks)|Adverse Event|0
7064316|NCT01957488|11163187|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0
7064317|NCT01957488|11163188|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0
7064318|NCT01957488|11163189|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0
7064319|NCT01957488|11163190|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1
7064320|NCT01957488|11163191|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1
7064321|NCT01957488|11163192|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2
7064322|NCT01957488|11163187|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
7064323|NCT01957488|11163188|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
7064324|NCT01957488|11163189|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
7064325|NCT01957488|11163190|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
7064326|NCT01957488|11163191|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1
7064327|NCT01957488|11163192|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
7064328|NCT01957488|11163187|FG000|Test Period 1 (2 Weeks)|screen failure|0
7064329|NCT01957488|11163188|FG001|Test Period 1 (2 Weeks)|screen failure|0
7064330|NCT01957488|11163189|FG002|Test Period 1 (2 Weeks)|screen failure|0
7064331|NCT01957488|11163190|FG003|Test Period 1 (2 Weeks)|screen failure|0
7064332|NCT01957488|11163191|FG004|Test Period 1 (2 Weeks)|screen failure|0
7064333|NCT01957488|11163192|FG005|Test Period 1 (2 Weeks)|screen failure|1
7064334|NCT01957488|11163187|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2
7064335|NCT01957488|11163188|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0
7064336|NCT01957488|11163189|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1
7064337|NCT01957488|11163190|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1
7064338|NCT01957488|11163191|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0
7064339|NCT01957488|11163192|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0
7064340|NCT01957488|11163187|FG000|Test Period 2 (2 Weeks)|Other|1
7064341|NCT01957488|11163188|FG001|Test Period 2 (2 Weeks)|Other|0
7064342|NCT01957488|11163189|FG002|Test Period 2 (2 Weeks)|Other|0
7064343|NCT01957488|11163190|FG003|Test Period 2 (2 Weeks)|Other|0
7064344|NCT01957488|11163191|FG004|Test Period 2 (2 Weeks)|Other|0
7064345|NCT01957488|11163192|FG005|Test Period 2 (2 Weeks)|Other|0
7064346|NCT01957488|11163187|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
6928265|NCT00851643|10959399|FG002|Extension Study (Up to 36 Months)|Moved|1
6928266|NCT00851643|10959400|FG003|Extension Study (Up to 36 Months)|Moved|1
6928267|NCT00851643|10959401|FG004|Extension Study (Up to 36 Months)|Moved|0
6928268|NCT00851643|10959402|FG005|Extension Study (Up to 36 Months)|Moved|1
7064347|NCT01957488|11163188|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1
7064348|NCT01957488|11163189|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
7064349|NCT01957488|11163190|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
7064350|NCT01957488|11163191|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
7064351|NCT01957488|11163192|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
7064352|NCT01957488|11163187|FG000|Test Period 2 (2 Weeks)|Adverse Event|0
7064353|NCT01957488|11163188|FG001|Test Period 2 (2 Weeks)|Adverse Event|0
7064354|NCT01957488|11163189|FG002|Test Period 2 (2 Weeks)|Adverse Event|0
7064355|NCT01957488|11163190|FG003|Test Period 2 (2 Weeks)|Adverse Event|0
7064356|NCT01957488|11163191|FG004|Test Period 2 (2 Weeks)|Adverse Event|2
7064357|NCT01957488|11163192|FG005|Test Period 2 (2 Weeks)|Adverse Event|0
7064358|NCT01957488|11163187|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
7064359|NCT01957488|11163188|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
7064360|NCT01957488|11163189|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
7064361|NCT01957488|11163190|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
7064362|NCT01957488|11163191|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
7064363|NCT01957488|11163192|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1
7064364|NCT01957488|11163187|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1
7064365|NCT01957488|11163188|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
7064366|NCT01957488|11163189|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
7064367|NCT01957488|11163190|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
7064368|NCT01957488|11163191|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
7064369|NCT01957488|11163192|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
7064370|NCT01957488|11163187|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0
7064371|NCT01957488|11163188|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1
7064372|NCT01957488|11163189|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0
7064373|NCT01957488|11163190|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0
7064374|NCT01957488|11163191|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0
7064375|NCT01957488|11163192|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0
7064376|NCT01957553|11163200|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2
7064377|NCT01957553|11163201|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3
7064378|NCT01957553|11163200|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2
7064379|NCT01957553|11163201|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0
7064380|NCT01957553|11163200|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2
7064381|NCT01957553|11163201|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0
7064382|NCT01957553|11163200|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1
7064383|NCT01957553|11163201|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0
7064384|NCT01957553|11163200|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1
7064385|NCT01957553|11163201|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3
7064386|NCT01957553|11163200|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1
7064387|NCT01957553|11163201|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2
7064388|NCT01957553|11163200|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0
7064389|NCT01957553|11163201|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1
7064390|NCT01957553|11163200|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0
7064391|NCT01957553|11163201|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1
7064392|NCT01957553|11163200|FG000|Test Period 2 (21 +- 1 Days)|Other|1
7064393|NCT01957553|11163201|FG001|Test Period 2 (21 +- 1 Days)|Other|0
7064394|NCT01957579|11163211|FG000|Overall Study|Withdrawal of concent|0
7064395|NCT01957579|11163212|FG001|Overall Study|Withdrawal of concent|1
7064396|NCT01957579|11163213|FG002|Overall Study|Withdrawal of concent|0
7064397|NCT01957579|11163214|FG003|Overall Study|Withdrawal of concent|0
7064398|NCT01957579|11163211|FG000|Overall Study|Death|0
7064399|NCT01957579|11163212|FG001|Overall Study|Death|0
7064400|NCT01957579|11163213|FG002|Overall Study|Death|2
7064401|NCT01957579|11163214|FG003|Overall Study|Death|0
7064402|NCT01957644|11163246|FG000|Overall Study|Adverse Event|4
7064403|NCT01957644|11163247|FG001|Overall Study|Adverse Event|2
7064404|NCT01957644|11163248|FG002|Overall Study|Adverse Event|0
7064405|NCT01957644|11163249|FG003|Overall Study|Adverse Event|0
7064406|NCT01957644|11163250|FG004|Overall Study|Adverse Event|1
7064407|NCT01957644|11163246|FG000|Overall Study|Progressive disease / relapse|0
7064408|NCT01957644|11163247|FG001|Overall Study|Progressive disease / relapse|1
7064409|NCT01957644|11163248|FG002|Overall Study|Progressive disease / relapse|0
7064410|NCT01957644|11163249|FG003|Overall Study|Progressive disease / relapse|1
7064411|NCT01957644|11163250|FG004|Overall Study|Progressive disease / relapse|0
7064412|NCT01957644|11163246|FG000|Overall Study|Other reason|1
7064413|NCT01957644|11163247|FG001|Overall Study|Other reason|2
7064414|NCT01957644|11163248|FG002|Overall Study|Other reason|1
7064415|NCT01957644|11163249|FG003|Overall Study|Other reason|1
7064416|NCT01957644|11163250|FG004|Overall Study|Other reason|0
7064417|NCT01957644|11163246|FG000|Overall Study|Withdrawal by Subject|1
7064418|NCT01957644|11163247|FG001|Overall Study|Withdrawal by Subject|0
7064419|NCT01957644|11163248|FG002|Overall Study|Withdrawal by Subject|0
7064420|NCT01957644|11163249|FG003|Overall Study|Withdrawal by Subject|0
6928269|NCT00851721|10959417|FG000|Overall Study|planned surgery|1
6928270|NCT00851721|10959418|FG001|Overall Study|planned surgery|0
6928271|NCT00851721|10959417|FG000|Overall Study|Death|1
6928272|NCT00851721|10959418|FG001|Overall Study|Death|0
7064421|NCT01957644|11163250|FG004|Overall Study|Withdrawal by Subject|0
7064422|NCT01957644|11163246|FG000|Overall Study|Protocol Violation|0
7064423|NCT01957644|11163247|FG001|Overall Study|Protocol Violation|1
7064424|NCT01957644|11163248|FG002|Overall Study|Protocol Violation|0
7064425|NCT01957644|11163249|FG003|Overall Study|Protocol Violation|0
7064426|NCT01957644|11163250|FG004|Overall Study|Protocol Violation|0
7064427|NCT01957709|11163268|FG000|Overall Study|Patient refused to complete post-tx bx|1
7064428|NCT01957787|11163276|FG000|Overall Study|Death|18
7064429|NCT01957787|11163276|FG000|Overall Study|Lost to Follow-up|3
7064430|NCT01957787|11163276|FG000|Overall Study|Withdrawal by Subject|3
7064431|NCT01957787|11163276|FG000|Overall Study|Entered Hospice or Similar Program|2
7064432|NCT01957787|11163276|FG000|Overall Study|Index Tumor(s) Resected|2
7064433|NCT01957787|11163276|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2
7064434|NCT01957787|11163276|FG000|Overall Study|Local therapy, not cryoablation|6
7064435|NCT01957865|11163283|FG000|Overall Study|Found HIV negative|0
7064436|NCT01957865|11163284|FG001|Overall Study|Found HIV negative|0
7064437|NCT01957865|11163285|FG002|Overall Study|Found HIV negative|1
7064438|NCT01957865|11163283|FG000|Overall Study|Lost to Follow-up|0
7064439|NCT01957865|11163284|FG001|Overall Study|Lost to Follow-up|2
7064440|NCT01957865|11163285|FG002|Overall Study|Lost to Follow-up|2
7064441|NCT01958008|11163310|FG000|Overall Study|Worsening of disease under study|0
7064442|NCT01958008|11163311|FG001|Overall Study|Worsening of disease under study|0
7064443|NCT01958008|11163312|FG002|Overall Study|Worsening of disease under study|1
7064444|NCT01958008|11163313|FG003|Overall Study|Worsening of disease under study|0
7064445|NCT01958008|11163310|FG000|Overall Study|Other adverse event|1
7064446|NCT01958008|11163311|FG001|Overall Study|Other adverse event|0
7064447|NCT01958008|11163312|FG002|Overall Study|Other adverse event|0
7064448|NCT01958008|11163313|FG003|Overall Study|Other adverse event|0
7064449|NCT01958060|11163332|FG000|Overall Study|Not treated|2
7064450|NCT01958060|11163333|FG001|Overall Study|Not treated|0
7064451|NCT01958060|11163334|FG002|Overall Study|Not treated|0
7064452|NCT01958060|11163335|FG003|Overall Study|Not treated|0
7064453|NCT01958060|11163336|FG004|Overall Study|Not treated|1
7064454|NCT01958060|11163337|FG005|Overall Study|Not treated|0
7064455|NCT01958125|11163384|FG000|Overall Study|Missing diary data|2
7064456|NCT01958125|11163385|FG001|Overall Study|Missing diary data|6
7064457|NCT01958125|11163384|FG000|Overall Study|No headache attacks|0
7064458|NCT01958125|11163385|FG001|Overall Study|No headache attacks|2
7064459|NCT01958164|11163393|FG000|Overall Study|Adverse Event|0
7064460|NCT01958164|11163394|FG001|Overall Study|Adverse Event|2
7064461|NCT01958164|11163393|FG000|Overall Study|Lost to Follow-up|2
7064462|NCT01958164|11163394|FG001|Overall Study|Lost to Follow-up|3
7064463|NCT01958281|11163403|FG000|Overall Study|Lack of Efficacy|5
7064464|NCT01958281|11163404|FG001|Overall Study|Lack of Efficacy|2
7064465|NCT01958281|11163405|FG002|Overall Study|Lack of Efficacy|0
7064466|NCT01958281|11163403|FG000|Overall Study|Adverse Event|0
7064467|NCT01958281|11163404|FG001|Overall Study|Adverse Event|2
7064468|NCT01958281|11163405|FG002|Overall Study|Adverse Event|0
7064469|NCT01958281|11163403|FG000|Overall Study|Withdrew Consent|1
7064470|NCT01958281|11163404|FG001|Overall Study|Withdrew Consent|0
7064471|NCT01958281|11163405|FG002|Overall Study|Withdrew Consent|0
7064472|NCT01958294|11163414|FG000|Overall Study|Clinical Circumstances|2
7064473|NCT01958437|11163440|FG000|Overall Study|Incidental MRI findings|0
7064474|NCT01958437|11163441|FG001|Overall Study|Incidental MRI findings|0
7064475|NCT01958437|11163442|FG002|Overall Study|Incidental MRI findings|1
7064476|NCT01958437|11163443|FG003|Overall Study|Incidental MRI findings|1
7064477|NCT01958476|11163462|FG000|Overall Study|Parent requested exclusion from analysis|1
7064478|NCT01958476|11163463|FG001|Overall Study|Parent requested exclusion from analysis|0
7064479|NCT01958489|11163469|FG000|Period 2|Adverse Event|0
7064480|NCT01958489|11163470|FG001|Period 2|Adverse Event|1
7064481|NCT01958619|11163494|FG000|Overall Study|Protocol Violation|2
7064482|NCT01958619|11163495|FG001|Overall Study|Protocol Violation|0
7064483|NCT01958619|11163496|FG002|Overall Study|Protocol Violation|1
7064484|NCT01958619|11163497|FG003|Overall Study|Protocol Violation|0
7064485|NCT01958671|11163525|FG000|Overall Study|Adverse Event|1
7064486|NCT01958671|11163526|FG001|Overall Study|Adverse Event|1
7064487|NCT01958671|11163527|FG002|Overall Study|Adverse Event|5
7064488|NCT01958671|11163525|FG000|Overall Study|Death|1
7064489|NCT01958671|11163526|FG001|Overall Study|Death|0
7064490|NCT01958671|11163527|FG002|Overall Study|Death|0
7064491|NCT01958671|11163525|FG000|Overall Study|Excluded medication|0
7064492|NCT01958671|11163526|FG001|Overall Study|Excluded medication|0
7064493|NCT01958671|11163527|FG002|Overall Study|Excluded medication|1
7064494|NCT01958671|11163525|FG000|Overall Study|Hyperglycemia|0
7064495|NCT01958671|11163526|FG001|Overall Study|Hyperglycemia|0
7064496|NCT01958671|11163527|FG002|Overall Study|Hyperglycemia|2
7064497|NCT01958671|11163525|FG000|Overall Study|Lost to Follow-up|7
7064498|NCT01958671|11163526|FG001|Overall Study|Lost to Follow-up|11
7064499|NCT01958671|11163527|FG002|Overall Study|Lost to Follow-up|7
7064500|NCT01958671|11163525|FG000|Overall Study|Non-compliance with study drug|1
6928273|NCT00851721|10959417|FG000|Overall Study|Adverse Event|0
7064501|NCT01958671|11163526|FG001|Overall Study|Non-compliance with study drug|1
6928274|NCT00851721|10959418|FG001|Overall Study|Adverse Event|1
6928275|NCT00851786|10959432|FG000|Overall Study|Withdrawal by Subject|0
6928276|NCT00851786|10959433|FG001|Overall Study|Withdrawal by Subject|1
6928277|NCT00851786|10959432|FG000|Overall Study|Protocol Violation|0
6928278|NCT00851786|10959433|FG001|Overall Study|Protocol Violation|1
6928279|NCT00851786|10959432|FG000|Overall Study|Lost to Follow-up|1
6928280|NCT00851786|10959433|FG001|Overall Study|Lost to Follow-up|0
6928281|NCT00851786|10959432|FG000|Overall Study|Incarceration|1
6928282|NCT00851786|10959433|FG001|Overall Study|Incarceration|0
6928283|NCT00851786|10959432|FG000|Overall Study|Site Closure|1
6928284|NCT00851786|10959433|FG001|Overall Study|Site Closure|0
6928285|NCT00851786|10959432|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2
6928286|NCT00851786|10959433|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0
7064502|NCT01958671|11163527|FG002|Overall Study|Non-compliance with study drug|1
7064503|NCT01958671|11163525|FG000|Overall Study|Pregnancy|0
7064504|NCT01958671|11163526|FG001|Overall Study|Pregnancy|0
7064505|NCT01958671|11163527|FG002|Overall Study|Pregnancy|1
7064506|NCT01958671|11163525|FG000|Overall Study|Protocol Violation|0
7064507|NCT01958671|11163526|FG001|Overall Study|Protocol Violation|1
7064508|NCT01958671|11163527|FG002|Overall Study|Protocol Violation|0
7064509|NCT01958671|11163525|FG000|Overall Study|Study site terminated by sponsor|1
7064510|NCT01958671|11163526|FG001|Overall Study|Study site terminated by sponsor|0
7064511|NCT01958671|11163527|FG002|Overall Study|Study site terminated by sponsor|1
7064512|NCT01958671|11163525|FG000|Overall Study|Participant moved|0
7064513|NCT01958671|11163526|FG001|Overall Study|Participant moved|0
7064514|NCT01958671|11163527|FG002|Overall Study|Participant moved|1
7064515|NCT01958671|11163525|FG000|Overall Study|Withdrawal by Subject|8
7064516|NCT01958671|11163526|FG001|Overall Study|Withdrawal by Subject|10
7064517|NCT01958671|11163527|FG002|Overall Study|Withdrawal by Subject|13
7064518|NCT01958827|11163543|FG000|Overall Study|Adverse Event|3
7064519|NCT01958827|11163543|FG000|Overall Study|Lack of Efficacy|6
7064520|NCT01958827|11163543|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1
7064521|NCT01958918|11163549|FG000|Overall Study|Death|1
7064522|NCT01958918|11163550|FG001|Overall Study|Death|3
7064523|NCT01958918|11163549|FG000|Overall Study|Lost to Follow-up|4
7064524|NCT01958918|11163550|FG001|Overall Study|Lost to Follow-up|7
7064525|NCT01958918|11163549|FG000|Overall Study|Withdrawal by Subject|13
7064526|NCT01958918|11163550|FG001|Overall Study|Withdrawal by Subject|8
7064527|NCT01958918|11163549|FG000|Overall Study|Lack of Efficacy|13
7064528|NCT01958918|11163550|FG001|Overall Study|Lack of Efficacy|10
7064529|NCT01958918|11163549|FG000|Overall Study|Adverse Event|12
7064530|NCT01958918|11163550|FG001|Overall Study|Adverse Event|12
7064531|NCT01958918|11163549|FG000|Overall Study|administrative problems|0
7064532|NCT01958918|11163550|FG001|Overall Study|administrative problems|2
7064533|NCT01959035|11163556|FG000|Overall Study|Adverse Event|5
7064534|NCT01959035|11163556|FG000|Overall Study|Withdrawal by Subject|4
7064535|NCT01959035|11163556|FG000|Overall Study|Lost to Follow-up|1
7064536|NCT01959035|11163556|FG000|Overall Study|Other (no primary reason given)|1
7064537|NCT01959165|11163574|FG000|Overall Study|Adverse Event|0
7064538|NCT01959165|11163575|FG001|Overall Study|Adverse Event|0
7064539|NCT01959165|11163576|FG002|Overall Study|Adverse Event|0
7064540|NCT01959165|11163577|FG003|Overall Study|Adverse Event|1
7064541|NCT01959165|11163574|FG000|Overall Study|Lack of Efficacy|1
7064542|NCT01959165|11163575|FG001|Overall Study|Lack of Efficacy|0
7064543|NCT01959165|11163576|FG002|Overall Study|Lack of Efficacy|0
7064544|NCT01959165|11163577|FG003|Overall Study|Lack of Efficacy|0
7064545|NCT01959165|11163574|FG000|Overall Study|overdose|0
7064546|NCT01959165|11163575|FG001|Overall Study|overdose|0
7064547|NCT01959165|11163576|FG002|Overall Study|overdose|0
7064548|NCT01959165|11163577|FG003|Overall Study|overdose|1
7064549|NCT01959165|11163574|FG000|Overall Study|Welfare recipient|0
7064550|NCT01959165|11163575|FG001|Overall Study|Welfare recipient|1
7064551|NCT01959165|11163576|FG002|Overall Study|Welfare recipient|0
7064552|NCT01959165|11163577|FG003|Overall Study|Welfare recipient|0
7064553|NCT01959230|11163596|FG000|Overall Study|Failure to follow study procedures|0
7064554|NCT01959230|11163597|FG001|Overall Study|Failure to follow study procedures|1
7064555|NCT01959230|11163596|FG000|Overall Study|Administrative reasons|2
7064556|NCT01959230|11163597|FG001|Overall Study|Administrative reasons|0
7064557|NCT01959230|11163596|FG000|Overall Study|Withdrawal by Subject|2
7064558|NCT01959230|11163597|FG001|Overall Study|Withdrawal by Subject|0
7064559|NCT01959243|11163605|FG000|Overall Study|Investigator Decision|3
7064560|NCT01959243|11163606|FG001|Overall Study|Investigator Decision|0
7064561|NCT01959243|11163605|FG000|Overall Study|Adverse Event|5
6928287|NCT00851799|10959442|FG000|Overall Study|Death|1
6928288|NCT00851799|10959443|FG001|Overall Study|Death|0
7064562|NCT01959243|11163606|FG001|Overall Study|Adverse Event|2
7064563|NCT01959243|11163605|FG000|Overall Study|Administrative reasons|2
7064564|NCT01959243|11163606|FG001|Overall Study|Administrative reasons|1
7064565|NCT01959243|11163605|FG000|Overall Study|Lost to Follow-up|3
7064566|NCT01959243|11163606|FG001|Overall Study|Lost to Follow-up|1
6928289|NCT00851799|10959444|FG002|Overall Study|Death|1
6928290|NCT00851799|10959442|FG000|Overall Study|Lost to Follow-up|5
6928291|NCT00851799|10959443|FG001|Overall Study|Lost to Follow-up|3
7064567|NCT01959334|11163614|FG000|Second Dose|Adverse Event|1
7064568|NCT01959334|11163615|FG001|Second Dose|Adverse Event|0
7064569|NCT01959334|11163614|FG000|Third Dose|Adverse Event|0
6928292|NCT00851799|10959444|FG002|Overall Study|Lost to Follow-up|10
6928293|NCT00851799|10959442|FG000|Overall Study|Not able to get to clinic|8
6928294|NCT00851799|10959443|FG001|Overall Study|Not able to get to clinic|5
6928295|NCT00851799|10959444|FG002|Overall Study|Not able to get to clinic|9
6928296|NCT00851799|10959442|FG000|Overall Study|Not willing to adhere to requirements|1
6928297|NCT00851799|10959443|FG001|Overall Study|Not willing to adhere to requirements|2
6928298|NCT00851799|10959444|FG002|Overall Study|Not willing to adhere to requirements|2
6928299|NCT00851799|10959442|FG000|Overall Study|Withdrew consent prior study completion|1
6928300|NCT00851799|10959443|FG001|Overall Study|Withdrew consent prior study completion|2
6928301|NCT00851799|10959444|FG002|Overall Study|Withdrew consent prior study completion|1
6928302|NCT00851799|10959442|FG000|Overall Study|Severe Debilitation|0
6928303|NCT00851799|10959443|FG001|Overall Study|Severe Debilitation|1
6928304|NCT00851799|10959444|FG002|Overall Study|Severe Debilitation|0
6928305|NCT00851799|10959442|FG000|Overall Study|Completed protocol due to pregnancy|0
6928306|NCT00851799|10959443|FG001|Overall Study|Completed protocol due to pregnancy|0
6928307|NCT00851799|10959444|FG002|Overall Study|Completed protocol due to pregnancy|1
6928308|NCT00851877|10959452|FG000|Phase I-1|Death|1
6928309|NCT00851877|10959453|FG001|Phase I-1|Death|0
6928310|NCT00851877|10959454|FG002|Phase I-1|Death|0
6928311|NCT00851877|10959452|FG000|Phase II|Withdrawal by Subject|0
6928312|NCT00851877|10959453|FG001|Phase II|Withdrawal by Subject|0
6928313|NCT00851877|10959454|FG002|Phase II|Withdrawal by Subject|3
6928314|NCT00851890|10959464|FG000|Overall Study|Lost to Follow-up|0
6928315|NCT00851890|10959465|FG001|Overall Study|Lost to Follow-up|1
6928316|NCT00851890|10959466|FG002|Overall Study|Lost to Follow-up|0
6928317|NCT00851890|10959467|FG003|Overall Study|Lost to Follow-up|1
6928318|NCT00851903|10959477|FG000|Overall Study|Withdrawal by Subject|2
6928319|NCT00852202|10959493|FG000|Overall Study|Adverse Event|2
6928320|NCT00852202|10959494|FG001|Overall Study|Adverse Event|3
6928321|NCT00852202|10959495|FG002|Overall Study|Adverse Event|7
6928322|NCT00852202|10959493|FG000|Overall Study|Lack of Efficacy|4
6928323|NCT00852202|10959494|FG001|Overall Study|Lack of Efficacy|1
6928324|NCT00852202|10959495|FG002|Overall Study|Lack of Efficacy|2
6928325|NCT00852202|10959493|FG000|Overall Study|Protocol Violation|2
6928326|NCT00852202|10959494|FG001|Overall Study|Protocol Violation|2
6928327|NCT00852202|10959495|FG002|Overall Study|Protocol Violation|7
6928328|NCT00852202|10959493|FG000|Overall Study|Withdrawal by Subject|3
6928329|NCT00852202|10959494|FG001|Overall Study|Withdrawal by Subject|1
6928330|NCT00852202|10959495|FG002|Overall Study|Withdrawal by Subject|2
6928331|NCT00852202|10959493|FG000|Overall Study|Lost to Follow-up|5
6928332|NCT00852202|10959494|FG001|Overall Study|Lost to Follow-up|5
6928333|NCT00852202|10959495|FG002|Overall Study|Lost to Follow-up|6
6928334|NCT00852202|10959493|FG000|Overall Study|pregnancy,moving away and surgery|1
6928335|NCT00852202|10959494|FG001|Overall Study|pregnancy,moving away and surgery|0
6928336|NCT00852202|10959495|FG002|Overall Study|pregnancy,moving away and surgery|2
6928337|NCT00852397|10959507|FG000|Overall Study|Adverse Event|4
6928338|NCT00852397|10959508|FG001|Overall Study|Adverse Event|6
6928339|NCT00852397|10959509|FG002|Overall Study|Adverse Event|4
6928340|NCT00852397|10959507|FG000|Overall Study|Death|0
6928341|NCT00852397|10959508|FG001|Overall Study|Death|0
7064570|NCT01959334|11163615|FG001|Third Dose|Adverse Event|1
7064571|NCT01959347|11163623|FG000|Overall Study|Protocol Violation|9
7064572|NCT01959347|11163624|FG001|Overall Study|Protocol Violation|7
7064573|NCT01959412|11163630|FG000|Overall Study|Protocol deviation|1
7064574|NCT01959412|11163631|FG001|Overall Study|Protocol deviation|1
7064575|NCT01959412|11163632|FG002|Overall Study|Protocol deviation|0
7064576|NCT01959412|11163633|FG003|Overall Study|Protocol deviation|1
7064577|NCT01959412|11163634|FG004|Overall Study|Protocol deviation|3
7064578|NCT01959412|11163635|FG005|Overall Study|Protocol deviation|0
7064579|NCT01959412|11163630|FG000|Overall Study|Adverse Event|0
7064580|NCT01959412|11163631|FG001|Overall Study|Adverse Event|0
7064581|NCT01959412|11163632|FG002|Overall Study|Adverse Event|0
7064582|NCT01959412|11163633|FG003|Overall Study|Adverse Event|1
7064583|NCT01959412|11163634|FG004|Overall Study|Adverse Event|0
7064584|NCT01959412|11163635|FG005|Overall Study|Adverse Event|0
7064585|NCT01959425|11163651|FG000|Overall Study|Withdrawal by Subject|5
7064586|NCT01959425|11163652|FG001|Overall Study|Withdrawal by Subject|4
7064587|NCT01959425|11163651|FG000|Overall Study|Lost to Follow-up|1
7064588|NCT01959425|11163652|FG001|Overall Study|Lost to Follow-up|0
7064589|NCT01959425|11163651|FG000|Overall Study|Discontinued Subjects|6
6928342|NCT00852397|10959509|FG002|Overall Study|Death|1
6928343|NCT00852397|10959507|FG000|Overall Study|Withdrawal by Subject|4
6928344|NCT00852397|10959508|FG001|Overall Study|Withdrawal by Subject|1
6928345|NCT00852397|10959509|FG002|Overall Study|Withdrawal by Subject|2
6928346|NCT00852397|10959507|FG000|Overall Study|Study terminated by sponsor|2
6928347|NCT00852397|10959508|FG001|Overall Study|Study terminated by sponsor|1
6928348|NCT00852397|10959509|FG002|Overall Study|Study terminated by sponsor|6
6928349|NCT00852397|10959507|FG000|Overall Study|Difficulty in study site visit|1
6928350|NCT00852397|10959508|FG001|Overall Study|Difficulty in study site visit|0
6928351|NCT00852397|10959509|FG002|Overall Study|Difficulty in study site visit|0
6928352|NCT00852397|10959507|FG000|Overall Study|Protocol Violation|0
6928353|NCT00852397|10959508|FG001|Overall Study|Protocol Violation|0
6928354|NCT00852397|10959509|FG002|Overall Study|Protocol Violation|1
6928355|NCT00852475|10959519|FG000|Overall Study|Lost to Follow-up|3
7064590|NCT01959425|11163652|FG001|Overall Study|Discontinued Subjects|4
7064591|NCT01959503|11163673|FG000|Overall Study|Death|2
7064592|NCT01959503|11163674|FG001|Overall Study|Death|1
7064593|NCT01959503|11163673|FG000|Overall Study|Randomized but not treated|1
7064594|NCT01959503|11163674|FG001|Overall Study|Randomized but not treated|1
7064595|NCT01959516|11163680|FG000|Epoch 1|Adverse Event|4
7064596|NCT01959516|11163681|FG001|Epoch 1|Adverse Event|1
6928356|NCT00852475|10959520|FG001|Overall Study|Lost to Follow-up|4
6928357|NCT00852540|10959536|FG000|Overall Study|Adverse Event|10
6928358|NCT00852540|10959537|FG001|Overall Study|Adverse Event|3
7064597|NCT01959516|11163680|FG000|Epoch 1|unsatisfactory therapeutic effect|1
7064598|NCT01959516|11163681|FG001|Epoch 1|unsatisfactory therapeutic effect|0
7064599|NCT01959516|11163680|FG000|Epoch 1|Subject withdrew consent|3
7064600|NCT01959516|11163681|FG001|Epoch 1|Subject withdrew consent|2
7064601|NCT01959516|11163680|FG000|Epoch 1|Administrative problems|1
7064602|NCT01959516|11163681|FG001|Epoch 1|Administrative problems|0
7064603|NCT01959516|11163680|FG000|Epoch 1|Use of prohibited treatment|1
7064604|NCT01959516|11163681|FG001|Epoch 1|Use of prohibited treatment|0
7064605|NCT01959516|11163680|FG000|Epoch 1|Moderate or severe COPD exacerbation|0
7064606|NCT01959516|11163681|FG001|Epoch 1|Moderate or severe COPD exacerbation|1
7064607|NCT01959516|11163680|FG000|Epoch 1|Protocol deviation|0
7064608|NCT01959516|11163681|FG001|Epoch 1|Protocol deviation|1
7064609|NCT01959516|11163680|FG000|Epoch 2|unsatisfactory therapeutic effect|1
7064610|NCT01959516|11163681|FG001|Epoch 2|unsatisfactory therapeutic effect|0
7064611|NCT01959516|11163680|FG000|Epoch 2|Subject withdrew consent|1
7064612|NCT01959516|11163681|FG001|Epoch 2|Subject withdrew consent|0
7064613|NCT01959516|11163680|FG000|Epoch 2|Moderate or severe COPD exacerbation|0
7064614|NCT01959516|11163681|FG001|Epoch 2|Moderate or severe COPD exacerbation|1
7064615|NCT01959529|11163689|FG000|Overall Study|Adverse event (not hypoglycaemia)|0
7064616|NCT01959529|11163690|FG001|Overall Study|Adverse event (not hypoglycaemia)|1
7064617|NCT01959529|11163689|FG000|Overall Study|Lost to Follow-up|4
7064618|NCT01959529|11163690|FG001|Overall Study|Lost to Follow-up|1
7064619|NCT01959529|11163689|FG000|Overall Study|Other|70
7064620|NCT01959529|11163690|FG001|Overall Study|Other|68
7064621|NCT01959529|11163689|FG000|Overall Study|Hypoglycaemia|1
7064622|NCT01959529|11163690|FG001|Overall Study|Hypoglycaemia|1
7064623|NCT01959529|11163689|FG000|Overall Study|Lack of glycaemic control|1
7064624|NCT01959529|11163690|FG001|Overall Study|Lack of glycaemic control|1
7064625|NCT01959581|11163701|FG000|Overall Study|Lost to Follow-up|5
7064626|NCT01959607|11163707|FG000|First Intervention (Day 1)|Withdrawal by Subject|1
7064627|NCT01959607|11163708|FG001|First Intervention (Day 1)|Withdrawal by Subject|1
7064628|NCT01959607|11163709|FG002|First Intervention (Day 1)|Withdrawal by Subject|0
7064629|NCT01959607|11163710|FG003|First Intervention (Day 1)|Withdrawal by Subject|0
7064630|NCT01959672|11163719|FG000|Overall Study|Death|1
7064631|NCT01959698|11163737|FG000|Overall Study|Adverse Event|0
7064632|NCT01959698|11163738|FG001|Overall Study|Adverse Event|0
7064633|NCT01959698|11163739|FG002|Overall Study|Adverse Event|0
7064634|NCT01959698|11163740|FG003|Overall Study|Adverse Event|0
7064635|NCT01959698|11163741|FG004|Overall Study|Adverse Event|0
7064636|NCT01959698|11163742|FG005|Overall Study|Adverse Event|0
7064637|NCT01959698|11163743|FG006|Overall Study|Adverse Event|1
7064638|NCT01959698|11163737|FG000|Overall Study|Physician Decision|1
7064639|NCT01959698|11163738|FG001|Overall Study|Physician Decision|0
7064640|NCT01959698|11163739|FG002|Overall Study|Physician Decision|1
7064641|NCT01959698|11163740|FG003|Overall Study|Physician Decision|2
7064642|NCT01959698|11163741|FG004|Overall Study|Physician Decision|0
7064643|NCT01959698|11163742|FG005|Overall Study|Physician Decision|3
7064644|NCT01959698|11163743|FG006|Overall Study|Physician Decision|3
7064645|NCT01959841|11163763|FG000|Overall Study|Adverse Event|1
7064646|NCT01959841|11163764|FG001|Overall Study|Adverse Event|3
7064647|NCT01959841|11163765|FG002|Overall Study|Adverse Event|2
7064648|NCT01959841|11163763|FG000|Overall Study|Lack of Efficacy|5
7064649|NCT01959841|11163764|FG001|Overall Study|Lack of Efficacy|0
7064650|NCT01959841|11163765|FG002|Overall Study|Lack of Efficacy|0
7064651|NCT01959841|11163763|FG000|Overall Study|Lost to Follow-up|1
7064652|NCT01959841|11163764|FG001|Overall Study|Lost to Follow-up|1
7064653|NCT01959841|11163765|FG002|Overall Study|Lost to Follow-up|0
7064654|NCT01959841|11163763|FG000|Overall Study|Physician Decision|0
7064655|NCT01959841|11163764|FG001|Overall Study|Physician Decision|2
7064656|NCT01959841|11163765|FG002|Overall Study|Physician Decision|3
6928359|NCT00852540|10959536|FG000|Overall Study|Lack of Efficacy|15
7064657|NCT01959841|11163763|FG000|Overall Study|Protocol Violation|16
6928360|NCT00852540|10959537|FG001|Overall Study|Lack of Efficacy|3
7064658|NCT01959841|11163764|FG001|Overall Study|Protocol Violation|23
7064659|NCT01959841|11163765|FG002|Overall Study|Protocol Violation|16
7064660|NCT01959841|11163763|FG000|Overall Study|Withdrawal by Subject|7
7064661|NCT01959841|11163764|FG001|Overall Study|Withdrawal by Subject|7
7064662|NCT01959841|11163765|FG002|Overall Study|Withdrawal by Subject|5
7064663|NCT01959841|11163763|FG000|Overall Study|Clinical laboratory value|2
7064664|NCT01959841|11163764|FG001|Overall Study|Clinical laboratory value|6
7064665|NCT01959841|11163765|FG002|Overall Study|Clinical laboratory value|6
7064666|NCT01959841|11163763|FG000|Overall Study|Platelet count below on day1 or 4|11
7064667|NCT01959841|11163764|FG001|Overall Study|Platelet count below on day1 or 4|15
7064668|NCT01959841|11163765|FG002|Overall Study|Platelet count below on day1 or 4|11
7064669|NCT01959880|11163777|FG000|Overall Study|Withdrawal by Subject|11
6928361|NCT00852540|10959536|FG000|Overall Study|Protocol Violation|1
6928362|NCT00852540|10959537|FG001|Overall Study|Protocol Violation|2
6928363|NCT00852540|10959536|FG000|Overall Study|Lost to Follow-up|2
6928364|NCT00852540|10959537|FG001|Overall Study|Lost to Follow-up|3
7064670|NCT01959880|11163778|FG001|Overall Study|Withdrawal by Subject|13
7064671|NCT01959880|11163779|FG002|Overall Study|Withdrawal by Subject|8
7064672|NCT01959880|11163780|FG003|Overall Study|Withdrawal by Subject|7
7064673|NCT01959880|11163777|FG000|Overall Study|Death|1
7064674|NCT01959880|11163778|FG001|Overall Study|Death|10
7064675|NCT01959880|11163779|FG002|Overall Study|Death|1
7064676|NCT01959880|11163780|FG003|Overall Study|Death|2
7064677|NCT01959880|11163777|FG000|Overall Study|Lost to Follow-up|95
7064678|NCT01959880|11163778|FG001|Overall Study|Lost to Follow-up|18
7064679|NCT01959880|11163779|FG002|Overall Study|Lost to Follow-up|15
7064680|NCT01959880|11163780|FG003|Overall Study|Lost to Follow-up|8
7064681|NCT01959880|11163777|FG000|Overall Study|Explantation w/o study device reimplant.|22
7064682|NCT01959880|11163778|FG001|Overall Study|Explantation w/o study device reimplant.|17
7064683|NCT01959880|11163779|FG002|Overall Study|Explantation w/o study device reimplant.|5
7064684|NCT01959880|11163780|FG003|Overall Study|Explantation w/o study device reimplant.|12
7064685|NCT01959880|11163777|FG000|Overall Study|Study completed early-FDA approved|1003
6837334|NCT00250432|10842900|FG000|Overall Study|Adverse Event|25
6837335|NCT00250432|10842901|FG001|Overall Study|Adverse Event|29
7064686|NCT01959880|11163778|FG001|Overall Study|Study completed early-FDA approved|311
7064687|NCT01959880|11163779|FG002|Overall Study|Study completed early-FDA approved|179
7064688|NCT01959880|11163780|FG003|Overall Study|Study completed early-FDA approved|152
7064689|NCT01959919|11163790|FG000|Overall Study|Did not meet the eligibility criteria|2
7064690|NCT01959932|11163797|FG000|Overall Study|Withdrawal by Subject|1
7064691|NCT01959932|11163798|FG001|Overall Study|Withdrawal by Subject|0
7064692|NCT01959932|11163799|FG002|Overall Study|Withdrawal by Subject|0
7064693|NCT01960114|11163842|FG000|Overall Study|Adverse Event|1
7064694|NCT01960114|11163843|FG001|Overall Study|Adverse Event|0
7064695|NCT01960114|11163842|FG000|Overall Study|Could not swallow study medication|0
7064696|NCT01960114|11163843|FG001|Overall Study|Could not swallow study medication|1
7064697|NCT01960140|11163849|FG000|Period 2 (Days 3-18)|Adverse Event|2
7064698|NCT01960257|11163857|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12
7064699|NCT01960257|11163858|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0
7064700|NCT01960257|11163859|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0
7064701|NCT01960257|11163857|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3
7064702|NCT01960257|11163858|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0
7064703|NCT01960257|11163859|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0
7064704|NCT01960257|11163857|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1
7064705|NCT01960257|11163858|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0
7064706|NCT01960257|11163859|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0
7064707|NCT01960296|11163871|FG000|Overall Study|Postponed surgery|1
7064708|NCT01960296|11163872|FG001|Overall Study|Postponed surgery|0
7064709|NCT01960296|11163871|FG000|Overall Study|Received different procedure|1
7064710|NCT01960296|11163872|FG001|Overall Study|Received different procedure|3
7064711|NCT01960348|11163880|FG000|Overall Study|Adverse event, not serious|2
7064712|NCT01960348|11163881|FG001|Overall Study|Adverse event, not serious|2
7064713|NCT01960348|11163880|FG000|Overall Study|Adverse event, serious fatal|6
7064714|NCT01960348|11163881|FG001|Overall Study|Adverse event, serious fatal|5
7064715|NCT01960348|11163880|FG000|Overall Study|Adverse event, serious non-fatal|0
7064716|NCT01960348|11163881|FG001|Overall Study|Adverse event, serious non-fatal|3
7064717|NCT01960348|11163880|FG000|Overall Study|Withdrawal by Subject|1
7064718|NCT01960348|11163881|FG001|Overall Study|Withdrawal by Subject|11
7064719|NCT01960348|11163880|FG000|Overall Study|Physician Decision|0
7064720|NCT01960348|11163881|FG001|Overall Study|Physician Decision|1
7064721|NCT01960348|11163880|FG000|Overall Study|Protocol Violation|1
7064722|NCT01960348|11163881|FG001|Overall Study|Protocol Violation|0
7064723|NCT01960413|11163902|FG000|Overall Study|Withdrawal by Subject|1
7064724|NCT01960413|11163903|FG001|Overall Study|Withdrawal by Subject|1
7064725|NCT01960413|11163902|FG000|Overall Study|Physician Decision|1
6837336|NCT00250432|10842900|FG000|Overall Study|Lack of Efficacy|2
6837337|NCT00250432|10842901|FG001|Overall Study|Lack of Efficacy|1
6837338|NCT00250432|10842900|FG000|Overall Study|Lost to Follow-up|6
6837339|NCT00250432|10842901|FG001|Overall Study|Lost to Follow-up|5
6837340|NCT00250432|10842900|FG000|Overall Study|Patient Moved|0
6837341|NCT00250432|10842901|FG001|Overall Study|Patient Moved|1
6837342|NCT00250432|10842900|FG000|Overall Study|Protocol Violation|0
6837343|NCT00250432|10842901|FG001|Overall Study|Protocol Violation|3
6837344|NCT00250432|10842900|FG000|Overall Study|Withdrawal by Subject|6
6837345|NCT00250432|10842901|FG001|Overall Study|Withdrawal by Subject|2
6837346|NCT00250432|10842900|FG000|Overall Study|Pt died out of posttherapy report period|6
6837347|NCT00250432|10842901|FG001|Overall Study|Pt died out of posttherapy report period|5
6837348|NCT00250432|10842900|FG000|Overall Study|Pt was considered untreatable|0
6837349|NCT00250432|10842901|FG001|Overall Study|Pt was considered untreatable|1
6837350|NCT00250588|10842928|FG000|Overall Study|Withdrawal by Subject|3
6837351|NCT00250588|10842929|FG001|Overall Study|Withdrawal by Subject|6
6837352|NCT00250588|10842930|FG002|Overall Study|Withdrawal by Subject|0
6837353|NCT00250588|10842928|FG000|Overall Study|Lost to Follow-up|6
6837354|NCT00250588|10842929|FG001|Overall Study|Lost to Follow-up|13
6928365|NCT00852540|10959536|FG000|Overall Study|Investigator Discretion|2
6928366|NCT00852540|10959537|FG001|Overall Study|Investigator Discretion|3
6837355|NCT00250588|10842930|FG002|Overall Study|Lost to Follow-up|13
6837356|NCT00250679|10842941|FG000|Overall Study|Adverse Event|12
6837357|NCT00250679|10842942|FG001|Overall Study|Adverse Event|15
6837358|NCT00250679|10842943|FG002|Overall Study|Adverse Event|16
7064726|NCT01960413|11163903|FG001|Overall Study|Physician Decision|0
7064727|NCT01960413|11163902|FG000|Overall Study|Lost to Follow-up|2
7064728|NCT01960413|11163903|FG001|Overall Study|Lost to Follow-up|0
7064729|NCT01960725|11163920|FG000|Overall Study|Lost to Follow-up|4
7064730|NCT01960725|11163921|FG001|Overall Study|Lost to Follow-up|3
7064731|NCT01960725|11163920|FG000|Overall Study|Withdrawal by Subject|1
7064732|NCT01960725|11163921|FG001|Overall Study|Withdrawal by Subject|0
7064733|NCT01960725|11163920|FG000|Overall Study|unable to obtain blood sample|1
7064734|NCT01960725|11163921|FG001|Overall Study|unable to obtain blood sample|2
7064735|NCT01960790|11163927|FG000|Overall Study|Survey forms could not be recovered|3
7064736|NCT01960790|11163927|FG000|Overall Study|Treat with Humira outside survey period|3
7064737|NCT01960790|11163927|FG000|Overall Study|Transferred to another hospital|4
7064738|NCT01960790|11163927|FG000|Overall Study|Unevaluable for safety|1
7064739|NCT01960816|11163931|FG000|Overall Study|Lost to Follow-up|1
7064740|NCT01960842|11163935|FG000|Overall Study|Adverse Event|1
7064741|NCT01960842|11163935|FG000|Overall Study|Withdrawal by Subject|2
7064742|NCT01960855|11163944|FG000|Overall Study|Subject noncompliant|1
7064743|NCT01960855|11163945|FG001|Overall Study|Subject noncompliant|0
7064744|NCT01960855|11163946|FG002|Overall Study|Subject noncompliant|0
7064745|NCT01960855|11163947|FG003|Overall Study|Subject noncompliant|0
7064746|NCT01960855|11163948|FG004|Overall Study|Subject noncompliant|0
7064747|NCT01960855|11163944|FG000|Overall Study|Adverse Event|2
7064748|NCT01960855|11163945|FG001|Overall Study|Adverse Event|0
7064749|NCT01960855|11163946|FG002|Overall Study|Adverse Event|6
7064750|NCT01960855|11163947|FG003|Overall Study|Adverse Event|2
7064751|NCT01960855|11163948|FG004|Overall Study|Adverse Event|2
7064752|NCT01960855|11163944|FG000|Overall Study|Lack of Efficacy|1
7064753|NCT01960855|11163945|FG001|Overall Study|Lack of Efficacy|1
7064754|NCT01960855|11163946|FG002|Overall Study|Lack of Efficacy|0
7064755|NCT01960855|11163947|FG003|Overall Study|Lack of Efficacy|0
7064756|NCT01960855|11163948|FG004|Overall Study|Lack of Efficacy|0
7064757|NCT01960855|11163944|FG000|Overall Study|Other|2
7064758|NCT01960855|11163945|FG001|Overall Study|Other|1
7064759|NCT01960855|11163946|FG002|Overall Study|Other|1
7064760|NCT01960855|11163947|FG003|Overall Study|Other|1
7064761|NCT01960855|11163948|FG004|Overall Study|Other|0
7064762|NCT01960855|11163944|FG000|Overall Study|Consent withdrawn by subject|3
7064763|NCT01960855|11163945|FG001|Overall Study|Consent withdrawn by subject|1
7064764|NCT01960855|11163946|FG002|Overall Study|Consent withdrawn by subject|2
7064765|NCT01960855|11163947|FG003|Overall Study|Consent withdrawn by subject|1
7064766|NCT01960855|11163948|FG004|Overall Study|Consent withdrawn by subject|1
7064767|NCT01960855|11163944|FG000|Overall Study|Lost to Follow-up|2
7064768|NCT01960855|11163945|FG001|Overall Study|Lost to Follow-up|1
7064769|NCT01960855|11163946|FG002|Overall Study|Lost to Follow-up|0
7064770|NCT01960855|11163947|FG003|Overall Study|Lost to Follow-up|0
7064771|NCT01960855|11163948|FG004|Overall Study|Lost to Follow-up|2
7064772|NCT01960907|11163962|FG000|Overall Study|Death|4
7064773|NCT01960907|11163963|FG001|Overall Study|Death|3
7064774|NCT01960907|11163962|FG000|Overall Study|Withdrawal by Subject|32
7064775|NCT01960907|11163963|FG001|Overall Study|Withdrawal by Subject|42
7064776|NCT01960998|11163974|FG000|Overall Study|Lost to Follow-up|3
7064777|NCT01960998|11163975|FG001|Overall Study|Lost to Follow-up|7
7064778|NCT01960998|11163974|FG000|Overall Study|Death|0
7064779|NCT01960998|11163975|FG001|Overall Study|Death|1
7064780|NCT01960998|11163974|FG000|Overall Study|Withdrawal by Subject|8
7064781|NCT01960998|11163975|FG001|Overall Study|Withdrawal by Subject|2
7064782|NCT01960998|11163974|FG000|Overall Study|lost computer access|0
7064783|NCT01960998|11163975|FG001|Overall Study|lost computer access|1
7064784|NCT01961115|11163990|FG000|Overall Study|Disease Progression|1
7064785|NCT01961115|11163991|FG001|Overall Study|Disease Progression|0
7064786|NCT01961115|11163992|FG002|Overall Study|Disease Progression|3
7064787|NCT01961115|11163990|FG000|Overall Study|Adverse Event|1
7064788|NCT01961115|11163991|FG001|Overall Study|Adverse Event|0
7064789|NCT01961115|11163992|FG002|Overall Study|Adverse Event|1
7064790|NCT01961297|11164010|FG000|Overall Study|unconfirmed diagnosis of SD|2
7064791|NCT01961297|11164011|FG001|Overall Study|unconfirmed diagnosis of SD|1
7064792|NCT01961323|11164017|FG000|Overall Study|Withdrawal by Subject|7
7064793|NCT01961323|11164017|FG000|Overall Study|Lost to Follow-up|8
7064794|NCT01961323|11164017|FG000|Overall Study|screen failure|34
7064795|NCT01961349|11164024|FG000|Overall Study|Withdrawal by Subject|1
7064796|NCT01961349|11164025|FG001|Overall Study|Withdrawal by Subject|4
7064797|NCT01961349|11164026|FG002|Overall Study|Withdrawal by Subject|0
7064798|NCT01961349|11164024|FG000|Overall Study|Adverse Event|0
7064799|NCT01961349|11164025|FG001|Overall Study|Adverse Event|0
7064800|NCT01961349|11164026|FG002|Overall Study|Adverse Event|1
7064801|NCT01961349|11164024|FG000|Overall Study|registration error, personal reason etc|2
7064802|NCT01961349|11164025|FG001|Overall Study|registration error, personal reason etc|2
7064803|NCT01961349|11164026|FG002|Overall Study|registration error, personal reason etc|1
6928367|NCT00852540|10959536|FG000|Overall Study|Withdrawal by Subject|3
6928368|NCT00852540|10959537|FG001|Overall Study|Withdrawal by Subject|1
7064804|NCT01961544|11164038|FG000|Overall Study|Protocol Violation|1
7064805|NCT01961544|11164038|FG000|Overall Study|Withdrawal by Subject|7
7064806|NCT01961544|11164038|FG000|Overall Study|Adverse Event|1
7064807|NCT01961544|11164038|FG000|Overall Study|Physician Decision|2
7064808|NCT01961544|11164038|FG000|Overall Study|Poor Tolerance|1
7064809|NCT01961544|11164038|FG000|Overall Study|Aggravation of Steral Pain|1
7064810|NCT01961609|11164044|FG000|Initiation|Missing|3
7064811|NCT01961609|11164045|FG001|Initiation|Missing|2
7064812|NCT01961609|11164046|FG002|Initiation|Missing|0
7064813|NCT01961609|11164047|FG003|Initiation|Missing|0
7064814|NCT01961609|11164044|FG000|Initiation|Protocol deviation|1
7064815|NCT01961609|11164045|FG001|Initiation|Protocol deviation|0
7064816|NCT01961609|11164046|FG002|Initiation|Protocol deviation|0
7064817|NCT01961609|11164047|FG003|Initiation|Protocol deviation|0
7064818|NCT01961609|11164044|FG000|Initiation|Death|0
7064819|NCT01961609|11164045|FG001|Initiation|Death|1
7064820|NCT01961609|11164046|FG002|Initiation|Death|0
7064821|NCT01961609|11164047|FG003|Initiation|Death|0
7064822|NCT01961609|11164044|FG000|Initiation|Administrative problems|1
7064823|NCT01961609|11164045|FG001|Initiation|Administrative problems|0
7064824|NCT01961609|11164046|FG002|Initiation|Administrative problems|0
7064825|NCT01961609|11164047|FG003|Initiation|Administrative problems|0
7064826|NCT01961609|11164044|FG000|Initiation|Withdrawal by Subject|1
7064827|NCT01961609|11164045|FG001|Initiation|Withdrawal by Subject|2
7064828|NCT01961609|11164046|FG002|Initiation|Withdrawal by Subject|0
7064829|NCT01961609|11164047|FG003|Initiation|Withdrawal by Subject|0
7064830|NCT01961609|11164044|FG000|Initiation|Lack of Efficacy|2
7064831|NCT01961609|11164045|FG001|Initiation|Lack of Efficacy|1
7064832|NCT01961609|11164046|FG002|Initiation|Lack of Efficacy|0
7064833|NCT01961609|11164047|FG003|Initiation|Lack of Efficacy|0
7064834|NCT01961609|11164044|FG000|Initiation|Abnormal lab values|0
7064835|NCT01961609|11164045|FG001|Initiation|Abnormal lab values|1
7064836|NCT01961609|11164046|FG002|Initiation|Abnormal lab values|0
7064837|NCT01961609|11164047|FG003|Initiation|Abnormal lab values|0
7064838|NCT01961609|11164044|FG000|Initiation|Adverse Event|3
7064839|NCT01961609|11164045|FG001|Initiation|Adverse Event|5
7064840|NCT01961609|11164046|FG002|Initiation|Adverse Event|0
7064841|NCT01961609|11164047|FG003|Initiation|Adverse Event|0
7064842|NCT01961609|11164044|FG000|Initiation|Randomized but not treated|1
7064843|NCT01961609|11164045|FG001|Initiation|Randomized but not treated|1
7064844|NCT01961609|11164046|FG002|Initiation|Randomized but not treated|0
7064845|NCT01961609|11164047|FG003|Initiation|Randomized but not treated|0
7064846|NCT01961609|11164044|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1
7064847|NCT01961609|11164045|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0
7064848|NCT01961609|11164046|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3
7064849|NCT01961609|11164047|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0
7064850|NCT01961609|11164044|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3
7064851|NCT01961609|11164045|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0
7064852|NCT01961609|11164046|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1
7064853|NCT01961609|11164047|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0
7064854|NCT01961609|11164044|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0
7064855|NCT01961609|11164045|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1
7064856|NCT01961609|11164046|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1
7064857|NCT01961609|11164047|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0
7064858|NCT01961609|11164044|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13
7064859|NCT01961609|11164045|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4
7064860|NCT01961609|11164046|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10
7064861|NCT01961609|11164047|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0
7064862|NCT01961609|11164044|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6
7064863|NCT01961609|11164045|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6
7064864|NCT01961609|11164046|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3
7064865|NCT01961609|11164047|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0
7064866|NCT01961609|11164044|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
7064867|NCT01961609|11164045|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
7064868|NCT01961609|11164046|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1
7064869|NCT01961609|11164047|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
7064870|NCT01961609|11164044|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7
7064871|NCT01961609|11164045|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5
7064872|NCT01961609|11164046|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0
7064873|NCT01961609|11164047|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4
7064874|NCT01961609|11164044|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
7064875|NCT01961609|11164045|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
7064876|NCT01961609|11164046|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1
7147638|NCT03131687|11308198|FG004|Overall Study|Lost to Follow-up|4
7147639|NCT03131687|11308199|FG005|Overall Study|Lost to Follow-up|2
7147640|NCT03131687|11308194|FG000|Overall Study|Participant Started New Diabetic Drug|1
7147641|NCT03131687|11308195|FG001|Overall Study|Participant Started New Diabetic Drug|0
7183759|NCT01254422|11383827|FG000|Overall Study|Adverse Event|1
6928369|NCT00852540|10959536|FG000|Overall Study|Did Not Receive Study Drug|3
6928370|NCT00852540|10959537|FG001|Overall Study|Did Not Receive Study Drug|3
6928371|NCT00852917|10959590|FG000|Overall Study|Adverse Event|13
6928372|NCT00852917|10959591|FG001|Overall Study|Adverse Event|20
6928373|NCT00852917|10959592|FG002|Overall Study|Adverse Event|35
6928374|NCT00852917|10959593|FG003|Overall Study|Adverse Event|17
6928375|NCT00852917|10959590|FG000|Overall Study|Lack of Efficacy|21
6928376|NCT00852917|10959591|FG001|Overall Study|Lack of Efficacy|11
6928377|NCT00852917|10959592|FG002|Overall Study|Lack of Efficacy|11
6928378|NCT00852917|10959593|FG003|Overall Study|Lack of Efficacy|47
6928379|NCT00852917|10959590|FG000|Overall Study|Withdrawal by Subject|4
6928380|NCT00852917|10959591|FG001|Overall Study|Withdrawal by Subject|8
6928381|NCT00852917|10959592|FG002|Overall Study|Withdrawal by Subject|10
6928382|NCT00852917|10959593|FG003|Overall Study|Withdrawal by Subject|9
6928383|NCT00852917|10959590|FG000|Overall Study|Physician Decision|6
6928384|NCT00852917|10959591|FG001|Overall Study|Physician Decision|7
6928385|NCT00852917|10959592|FG002|Overall Study|Physician Decision|2
6928386|NCT00852917|10959593|FG003|Overall Study|Physician Decision|19
6928387|NCT00852917|10959590|FG000|Overall Study|Death|0
6928388|NCT00852917|10959591|FG001|Overall Study|Death|0
6928389|NCT00852917|10959592|FG002|Overall Study|Death|0
6928390|NCT00852917|10959593|FG003|Overall Study|Death|1
6928391|NCT00852930|10959606|FG000|Overall Study|Withdrawal by Subject|1
6928392|NCT00852930|10959607|FG001|Overall Study|Withdrawal by Subject|1
6928393|NCT00852930|10959608|FG002|Overall Study|Withdrawal by Subject|1
6928394|NCT00852930|10959606|FG000|Overall Study|Physician Decision|0
6928395|NCT00852930|10959607|FG001|Overall Study|Physician Decision|0
6928396|NCT00852930|10959608|FG002|Overall Study|Physician Decision|1
6928397|NCT00852969|10959619|FG000|Overall Study|Adverse Event|0
6928398|NCT00852969|10959620|FG001|Overall Study|Adverse Event|1
6928399|NCT00852969|10959619|FG000|Overall Study|Lost to Follow-up|0
6928400|NCT00852969|10959620|FG001|Overall Study|Lost to Follow-up|1
6928401|NCT00852995|10959631|FG000|Overall Study|Adverse Event|1
6928402|NCT00852995|10959632|FG001|Overall Study|Adverse Event|0
6928403|NCT00852995|10959633|FG002|Overall Study|Adverse Event|4
6928404|NCT00852995|10959634|FG003|Overall Study|Adverse Event|0
6928405|NCT00852995|10959635|FG004|Overall Study|Adverse Event|0
6928406|NCT00852995|10959631|FG000|Overall Study|Lost to Follow-up|0
6928407|NCT00852995|10959632|FG001|Overall Study|Lost to Follow-up|1
6928408|NCT00852995|10959633|FG002|Overall Study|Lost to Follow-up|1
6928409|NCT00852995|10959634|FG003|Overall Study|Lost to Follow-up|0
6928410|NCT00852995|10959635|FG004|Overall Study|Lost to Follow-up|0
6928411|NCT00852995|10959631|FG000|Overall Study|Withdrawal by Subject|4
6928412|NCT00852995|10959632|FG001|Overall Study|Withdrawal by Subject|0
6928413|NCT00852995|10959633|FG002|Overall Study|Withdrawal by Subject|0
6928414|NCT00852995|10959634|FG003|Overall Study|Withdrawal by Subject|1
6928415|NCT00852995|10959635|FG004|Overall Study|Withdrawal by Subject|2
6928416|NCT00852995|10959631|FG000|Overall Study|Non-Compliance|0
6928417|NCT00852995|10959632|FG001|Overall Study|Non-Compliance|0
6928418|NCT00852995|10959633|FG002|Overall Study|Non-Compliance|0
6928419|NCT00852995|10959634|FG003|Overall Study|Non-Compliance|2
6928420|NCT00852995|10959635|FG004|Overall Study|Non-Compliance|0
6928421|NCT00852995|10959631|FG000|Overall Study|Progressive Disease|1
6928422|NCT00852995|10959632|FG001|Overall Study|Progressive Disease|0
6928423|NCT00852995|10959633|FG002|Overall Study|Progressive Disease|0
6928424|NCT00852995|10959634|FG003|Overall Study|Progressive Disease|2
6928425|NCT00852995|10959635|FG004|Overall Study|Progressive Disease|1
6928426|NCT00852995|10959631|FG000|Overall Study|Physician Decision|1
6928427|NCT00852995|10959632|FG001|Overall Study|Physician Decision|0
6928428|NCT00852995|10959633|FG002|Overall Study|Physician Decision|0
6928429|NCT00852995|10959634|FG003|Overall Study|Physician Decision|0
6928430|NCT00852995|10959635|FG004|Overall Study|Physician Decision|0
6928431|NCT00852995|10959631|FG000|Overall Study|Protocol Violation|0
6928432|NCT00852995|10959632|FG001|Overall Study|Protocol Violation|0
6928433|NCT00852995|10959633|FG002|Overall Study|Protocol Violation|0
7064877|NCT01961609|11164047|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
7064878|NCT01961609|11164044|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1
7064879|NCT01961609|11164045|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
7064880|NCT01961609|11164046|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
6928434|NCT00852995|10959634|FG003|Overall Study|Protocol Violation|0
6928435|NCT00852995|10959635|FG004|Overall Study|Protocol Violation|1
6928436|NCT00852995|10959631|FG000|Overall Study|Moved Out of Area|1
6928437|NCT00852995|10959632|FG001|Overall Study|Moved Out of Area|0
6928438|NCT00852995|10959633|FG002|Overall Study|Moved Out of Area|0
6928439|NCT00852995|10959634|FG003|Overall Study|Moved Out of Area|0
6928440|NCT00852995|10959635|FG004|Overall Study|Moved Out of Area|0
6928441|NCT00853021|10959652|FG000|Overall Study|Adverse Event|2
6928442|NCT00853021|10959652|FG000|Overall Study|Withdrawal by Subject|2
6928443|NCT00853021|10959652|FG000|Overall Study|Death|1
6928444|NCT00853047|10959661|FG000|Core Phase|Participant Request|0
6928445|NCT00853047|10959662|FG001|Core Phase|Participant Request|0
6928446|NCT00853047|10959663|FG002|Core Phase|Participant Request|0
6928447|NCT00853047|10959664|FG003|Core Phase|Participant Request|1
6928448|NCT00853047|10959665|FG004|Core Phase|Participant Request|0
6928449|NCT00853047|10959666|FG005|Core Phase|Participant Request|0
6928450|NCT00853047|10959661|FG000|Open-Label Extension Phase|Participant Request|0
6928451|NCT00853047|10959662|FG001|Open-Label Extension Phase|Participant Request|0
6928452|NCT00853047|10959663|FG002|Open-Label Extension Phase|Participant Request|0
6928453|NCT00853047|10959664|FG003|Open-Label Extension Phase|Participant Request|0
6928454|NCT00853047|10959665|FG004|Open-Label Extension Phase|Participant Request|0
6928455|NCT00853047|10959666|FG005|Open-Label Extension Phase|Participant Request|7
6928456|NCT00853047|10959661|FG000|Open-Label Extension Phase|Lost to Follow-up|0
6928457|NCT00853047|10959662|FG001|Open-Label Extension Phase|Lost to Follow-up|0
7064881|NCT01961609|11164047|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
7064882|NCT01961609|11164044|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
7064883|NCT01961609|11164045|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1
7064884|NCT01961609|11164046|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
7064885|NCT01961609|11164047|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
7064886|NCT01961609|11164044|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3
7064887|NCT01961609|11164045|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0
7064888|NCT01961609|11164046|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3
7064889|NCT01961609|11164047|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1
7064890|NCT01961609|11164044|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1
7064891|NCT01961609|11164045|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0
7064892|NCT01961609|11164046|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0
7064893|NCT01961609|11164047|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2
7064894|NCT01961687|11164064|FG000|Overall Study|Lost to Follow-up|19
7064895|NCT01961687|11164064|FG000|Overall Study|Re-operation|17
7064896|NCT01961687|11164064|FG000|Overall Study|Death|7
7064897|NCT01961687|11164064|FG000|Overall Study|Withdrawal by Subject|6
7064898|NCT01961687|11164064|FG000|Overall Study|Adverse Event|6
7064899|NCT01961687|11164064|FG000|Overall Study|Moved to area without study site|2
7064900|NCT01961687|11164064|FG000|Overall Study|Sponsor decision|2
7064901|NCT01961687|11164064|FG000|Overall Study|Physician Decision|1
7064902|NCT01961687|11164064|FG000|Overall Study|Unable to meet follow-up requirements|1
7064903|NCT01961882|11164070|FG000|Overall Study|Adverse Event|3
7064904|NCT01961882|11164071|FG001|Overall Study|Adverse Event|2
7064905|NCT01961882|11164070|FG000|Overall Study|Physician Decision|1
7064906|NCT01961882|11164071|FG001|Overall Study|Physician Decision|0
7064907|NCT01961882|11164070|FG000|Overall Study|Withdrawal by Subject|4
7064908|NCT01961882|11164071|FG001|Overall Study|Withdrawal by Subject|1
7064909|NCT01961882|11164070|FG000|Overall Study|Relapse of AML|39
7064910|NCT01961882|11164071|FG001|Overall Study|Relapse of AML|37
7064911|NCT01961882|11164070|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2
7064912|NCT01961882|11164071|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2
7064913|NCT01961882|11164070|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1
7064914|NCT01961882|11164071|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0
7064915|NCT01962103|11164101|FG000|Phase 1|Adverse Event|4
7064916|NCT01962103|11164102|FG001|Phase 1|Adverse Event|0
7064917|NCT01962103|11164103|FG002|Phase 1|Adverse Event|2
7064918|NCT01962103|11164104|FG003|Phase 1|Adverse Event|1
7064919|NCT01962103|11164105|FG004|Phase 1|Adverse Event|2
7064920|NCT01962103|11164106|FG005|Phase 1|Adverse Event|2
7064921|NCT01962103|11164107|FG006|Phase 1|Adverse Event|0
7064922|NCT01962103|11164108|FG007|Phase 1|Adverse Event|0
7064923|NCT01962103|11164109|FG008|Phase 1|Adverse Event|0
7064924|NCT01962103|11164101|FG000|Phase 1|Progressive Disease|8
7064925|NCT01962103|11164102|FG001|Phase 1|Progressive Disease|6
7064926|NCT01962103|11164103|FG002|Phase 1|Progressive Disease|8
7064927|NCT01962103|11164104|FG003|Phase 1|Progressive Disease|4
7064928|NCT01962103|11164105|FG004|Phase 1|Progressive Disease|5
7064929|NCT01962103|11164106|FG005|Phase 1|Progressive Disease|4
7064930|NCT01962103|11164107|FG006|Phase 1|Progressive Disease|0
7064931|NCT01962103|11164108|FG007|Phase 1|Progressive Disease|0
7064932|NCT01962103|11164109|FG008|Phase 1|Progressive Disease|0
7064933|NCT01962103|11164101|FG000|Phase 1|Withdrawal by Subject|0
7064934|NCT01962103|11164102|FG001|Phase 1|Withdrawal by Subject|0
7064935|NCT01962103|11164103|FG002|Phase 1|Withdrawal by Subject|0
7064936|NCT01962103|11164104|FG003|Phase 1|Withdrawal by Subject|2
7064937|NCT01962103|11164105|FG004|Phase 1|Withdrawal by Subject|0
7064938|NCT01962103|11164106|FG005|Phase 1|Withdrawal by Subject|0
7064939|NCT01962103|11164107|FG006|Phase 1|Withdrawal by Subject|0
7064940|NCT01962103|11164108|FG007|Phase 1|Withdrawal by Subject|0
7064941|NCT01962103|11164109|FG008|Phase 1|Withdrawal by Subject|0
7064942|NCT01962103|11164101|FG000|Phase 1|Withdrawal by Parent/Guardian|0
7064943|NCT01962103|11164102|FG001|Phase 1|Withdrawal by Parent/Guardian|0
7064944|NCT01962103|11164103|FG002|Phase 1|Withdrawal by Parent/Guardian|2
6928458|NCT00853047|10959663|FG002|Open-Label Extension Phase|Lost to Follow-up|0
7064945|NCT01962103|11164104|FG003|Phase 1|Withdrawal by Parent/Guardian|1
7064946|NCT01962103|11164105|FG004|Phase 1|Withdrawal by Parent/Guardian|0
7064947|NCT01962103|11164106|FG005|Phase 1|Withdrawal by Parent/Guardian|0
7064948|NCT01962103|11164107|FG006|Phase 1|Withdrawal by Parent/Guardian|0
7064949|NCT01962103|11164108|FG007|Phase 1|Withdrawal by Parent/Guardian|0
7064950|NCT01962103|11164109|FG008|Phase 1|Withdrawal by Parent/Guardian|0
7064951|NCT01962103|11164101|FG000|Phase 1|Physician Decision|0
7064952|NCT01962103|11164102|FG001|Phase 1|Physician Decision|0
7064953|NCT01962103|11164103|FG002|Phase 1|Physician Decision|0
7064954|NCT01962103|11164104|FG003|Phase 1|Physician Decision|1
6928459|NCT00853047|10959664|FG003|Open-Label Extension Phase|Lost to Follow-up|0
6928460|NCT00853047|10959665|FG004|Open-Label Extension Phase|Lost to Follow-up|0
6928461|NCT00853047|10959666|FG005|Open-Label Extension Phase|Lost to Follow-up|1
6928462|NCT00853047|10959661|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0
6928463|NCT00853047|10959662|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0
6928464|NCT00853047|10959663|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0
6928465|NCT00853047|10959664|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0
6928466|NCT00853047|10959665|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0
6928467|NCT00853047|10959666|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2
6928468|NCT00853047|10959661|FG000|Open-Label Extension Phase|Investigator Decision|0
6928469|NCT00853047|10959662|FG001|Open-Label Extension Phase|Investigator Decision|0
6928470|NCT00853047|10959663|FG002|Open-Label Extension Phase|Investigator Decision|0
6928471|NCT00853047|10959664|FG003|Open-Label Extension Phase|Investigator Decision|0
7064955|NCT01962103|11164105|FG004|Phase 1|Physician Decision|0
7064956|NCT01962103|11164106|FG005|Phase 1|Physician Decision|0
7064957|NCT01962103|11164107|FG006|Phase 1|Physician Decision|0
7064958|NCT01962103|11164108|FG007|Phase 1|Physician Decision|0
6928472|NCT00853047|10959665|FG004|Open-Label Extension Phase|Investigator Decision|0
6928473|NCT00853047|10959666|FG005|Open-Label Extension Phase|Investigator Decision|1
7064959|NCT01962103|11164109|FG008|Phase 1|Physician Decision|0
7064960|NCT01962103|11164101|FG000|Phase 1|Symptomatic Deterioration|3
7064961|NCT01962103|11164102|FG001|Phase 1|Symptomatic Deterioration|2
7064962|NCT01962103|11164103|FG002|Phase 1|Symptomatic Deterioration|2
7064963|NCT01962103|11164104|FG003|Phase 1|Symptomatic Deterioration|2
7064964|NCT01962103|11164105|FG004|Phase 1|Symptomatic Deterioration|1
7064965|NCT01962103|11164106|FG005|Phase 1|Symptomatic Deterioration|1
7064966|NCT01962103|11164107|FG006|Phase 1|Symptomatic Deterioration|0
7064967|NCT01962103|11164108|FG007|Phase 1|Symptomatic Deterioration|0
7064968|NCT01962103|11164109|FG008|Phase 1|Symptomatic Deterioration|0
7064969|NCT01962103|11164101|FG000|Phase 1|Miscellaneous|1
7064970|NCT01962103|11164102|FG001|Phase 1|Miscellaneous|0
7064971|NCT01962103|11164103|FG002|Phase 1|Miscellaneous|0
7064972|NCT01962103|11164104|FG003|Phase 1|Miscellaneous|0
7064973|NCT01962103|11164105|FG004|Phase 1|Miscellaneous|0
7064974|NCT01962103|11164106|FG005|Phase 1|Miscellaneous|0
7064975|NCT01962103|11164107|FG006|Phase 1|Miscellaneous|0
7064976|NCT01962103|11164108|FG007|Phase 1|Miscellaneous|0
7064977|NCT01962103|11164109|FG008|Phase 1|Miscellaneous|0
7064978|NCT01962103|11164101|FG000|Phase 2|Adverse Event|0
7064979|NCT01962103|11164102|FG001|Phase 2|Adverse Event|0
7064980|NCT01962103|11164103|FG002|Phase 2|Adverse Event|0
7064981|NCT01962103|11164104|FG003|Phase 2|Adverse Event|0
7064982|NCT01962103|11164105|FG004|Phase 2|Adverse Event|0
7064983|NCT01962103|11164106|FG005|Phase 2|Adverse Event|0
7064984|NCT01962103|11164107|FG006|Phase 2|Adverse Event|1
7064985|NCT01962103|11164108|FG007|Phase 2|Adverse Event|0
7064986|NCT01962103|11164109|FG008|Phase 2|Adverse Event|3
7064987|NCT01962103|11164101|FG000|Phase 2|Progressive Disease|0
7064988|NCT01962103|11164102|FG001|Phase 2|Progressive Disease|0
7064989|NCT01962103|11164103|FG002|Phase 2|Progressive Disease|0
7064990|NCT01962103|11164104|FG003|Phase 2|Progressive Disease|0
7064991|NCT01962103|11164105|FG004|Phase 2|Progressive Disease|0
7064992|NCT01962103|11164106|FG005|Phase 2|Progressive Disease|0
7064993|NCT01962103|11164107|FG006|Phase 2|Progressive Disease|11
7064994|NCT01962103|11164108|FG007|Phase 2|Progressive Disease|12
7064995|NCT01962103|11164109|FG008|Phase 2|Progressive Disease|11
7064996|NCT01962103|11164101|FG000|Phase 2|Symptomatic Deterioration|0
7064997|NCT01962103|11164102|FG001|Phase 2|Symptomatic Deterioration|0
7064998|NCT01962103|11164103|FG002|Phase 2|Symptomatic Deterioration|0
7064999|NCT01962103|11164104|FG003|Phase 2|Symptomatic Deterioration|0
7065000|NCT01962103|11164105|FG004|Phase 2|Symptomatic Deterioration|0
7065001|NCT01962103|11164106|FG005|Phase 2|Symptomatic Deterioration|0
7065002|NCT01962103|11164107|FG006|Phase 2|Symptomatic Deterioration|2
7065003|NCT01962103|11164108|FG007|Phase 2|Symptomatic Deterioration|2
7065004|NCT01962103|11164109|FG008|Phase 2|Symptomatic Deterioration|0
7065005|NCT01962207|11164133|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2
7065006|NCT01962207|11164134|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1
7065007|NCT01962207|11164135|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5
7065008|NCT01962207|11164136|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2
7065009|NCT01962207|11164133|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2
7065010|NCT01962207|11164134|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0
6837359|NCT00250679|10842941|FG000|Overall Study|Protocol Violation|2
7065011|NCT01962207|11164135|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4
7065012|NCT01962207|11164136|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0
6837360|NCT00250679|10842942|FG001|Overall Study|Protocol Violation|4
6837361|NCT00250679|10842943|FG002|Overall Study|Protocol Violation|3
6837362|NCT00250679|10842941|FG000|Overall Study|Withdrawal by Subject|15
6837363|NCT00250679|10842942|FG001|Overall Study|Withdrawal by Subject|18
6837364|NCT00250679|10842943|FG002|Overall Study|Withdrawal by Subject|15
6837365|NCT00250679|10842941|FG000|Overall Study|Lost to Follow-up|3
6837366|NCT00250679|10842942|FG001|Overall Study|Lost to Follow-up|4
6837367|NCT00250679|10842943|FG002|Overall Study|Lost to Follow-up|2
6837368|NCT00250679|10842941|FG000|Overall Study|Does Not Meet Entry Criteria|1
6837369|NCT00250679|10842942|FG001|Overall Study|Does Not Meet Entry Criteria|4
6928474|NCT00853047|10959661|FG000|Open-Label Extension Phase|Reason Not Specified|0
6928475|NCT00853047|10959662|FG001|Open-Label Extension Phase|Reason Not Specified|0
6928476|NCT00853047|10959663|FG002|Open-Label Extension Phase|Reason Not Specified|0
6928477|NCT00853047|10959664|FG003|Open-Label Extension Phase|Reason Not Specified|0
6928478|NCT00853047|10959665|FG004|Open-Label Extension Phase|Reason Not Specified|0
6928479|NCT00853047|10959666|FG005|Open-Label Extension Phase|Reason Not Specified|6
6928480|NCT00853073|10959683|FG000|Overall Study|Withdrawal by Subject|3
6928481|NCT00853073|10959684|FG001|Overall Study|Withdrawal by Subject|2
6928482|NCT00853099|10959693|FG000|Double-blind Period|Adverse Event|7
6928483|NCT00853099|10959694|FG001|Double-blind Period|Adverse Event|9
6928484|NCT00853099|10959695|FG002|Double-blind Period|Adverse Event|13
6928485|NCT00853099|10959696|FG003|Double-blind Period|Adverse Event|0
6928486|NCT00853099|10959693|FG000|Double-blind Period|Withdrawal by Subject|2
6928487|NCT00853099|10959694|FG001|Double-blind Period|Withdrawal by Subject|3
7065013|NCT01962207|11164133|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4
7065014|NCT01962207|11164134|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5
7065015|NCT01962207|11164135|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18
6837370|NCT00250679|10842943|FG002|Overall Study|Does Not Meet Entry Criteria|2
6837371|NCT00250679|10842941|FG000|Overall Study|Lack of Efficacy|0
7065016|NCT01962207|11164136|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4
7065017|NCT01962207|11164133|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0
7065018|NCT01962207|11164134|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0
7065019|NCT01962207|11164135|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3
7065020|NCT01962207|11164136|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1
7065021|NCT01962207|11164133|FG000|Persistence Phase (5 Years)|Adverse Event|0
7065022|NCT01962207|11164134|FG001|Persistence Phase (5 Years)|Adverse Event|0
7065023|NCT01962207|11164135|FG002|Persistence Phase (5 Years)|Adverse Event|1
7065024|NCT01962207|11164136|FG003|Persistence Phase (5 Years)|Adverse Event|0
7065025|NCT01962207|11164133|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21
7065026|NCT01962207|11164134|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7
7065027|NCT01962207|11164135|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13
7065028|NCT01962207|11164136|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5
7065029|NCT01962298|11164155|FG000|Overall Study|Protocol Violation|1
7065030|NCT01962298|11164156|FG001|Overall Study|Protocol Violation|0
7065031|NCT01962298|11164157|FG002|Overall Study|Protocol Violation|1
7065032|NCT01962298|11164158|FG003|Overall Study|Protocol Violation|1
7065033|NCT01962298|11164159|FG004|Overall Study|Protocol Violation|0
7065034|NCT01962298|11164155|FG000|Overall Study|Data quality insufficient|2
7065035|NCT01962298|11164156|FG001|Overall Study|Data quality insufficient|0
7065036|NCT01962298|11164157|FG002|Overall Study|Data quality insufficient|3
7065037|NCT01962298|11164158|FG003|Overall Study|Data quality insufficient|1
7065038|NCT01962298|11164159|FG004|Overall Study|Data quality insufficient|4
7065039|NCT01962298|11164155|FG000|Overall Study|Insufficient data|0
7065040|NCT01962298|11164156|FG001|Overall Study|Insufficient data|2
7065041|NCT01962298|11164157|FG002|Overall Study|Insufficient data|1
7065042|NCT01962298|11164158|FG003|Overall Study|Insufficient data|0
7065043|NCT01962298|11164159|FG004|Overall Study|Insufficient data|1
7065044|NCT01962298|11164155|FG000|Overall Study|Incorrect data recorded|0
7065045|NCT01962298|11164156|FG001|Overall Study|Incorrect data recorded|1
7065046|NCT01962298|11164157|FG002|Overall Study|Incorrect data recorded|0
7065047|NCT01962298|11164158|FG003|Overall Study|Incorrect data recorded|0
7065048|NCT01962298|11164159|FG004|Overall Study|Incorrect data recorded|0
7065049|NCT01962298|11164155|FG000|Overall Study|Physician Decision|0
7065050|NCT01962298|11164156|FG001|Overall Study|Physician Decision|1
7065051|NCT01962298|11164157|FG002|Overall Study|Physician Decision|0
7065052|NCT01962298|11164158|FG003|Overall Study|Physician Decision|0
7065053|NCT01962298|11164159|FG004|Overall Study|Physician Decision|1
7065054|NCT01962441|11164183|FG000|Randomized Period|Randomized but Never Treated|4
7065055|NCT01962441|11164184|FG001|Randomized Period|Randomized but Never Treated|2
7065056|NCT01962441|11164185|FG002|Randomized Period|Randomized but Never Treated|3
7065057|NCT01962441|11164183|FG000|Randomized Period|Lost to Follow-up|2
7065058|NCT01962441|11164184|FG001|Randomized Period|Lost to Follow-up|4
7065059|NCT01962441|11164185|FG002|Randomized Period|Lost to Follow-up|4
7065060|NCT01962441|11164183|FG000|Randomized Period|Withdrew Consent|3
7065061|NCT01962441|11164184|FG001|Randomized Period|Withdrew Consent|3
7065062|NCT01962441|11164185|FG002|Randomized Period|Withdrew Consent|2
7065063|NCT01962441|11164183|FG000|Randomized Period|Adverse Event|1
7065064|NCT01962441|11164184|FG001|Randomized Period|Adverse Event|1
7065065|NCT01962441|11164185|FG002|Randomized Period|Adverse Event|0
7065066|NCT01962441|11164183|FG000|Randomized Period|Death|0
7065067|NCT01962441|11164184|FG001|Randomized Period|Death|0
7065068|NCT01962441|11164185|FG002|Randomized Period|Death|2
7065069|NCT01962441|11164183|FG000|Randomized Period|Protocol Violation|0
6837372|NCT00250679|10842942|FG001|Overall Study|Lack of Efficacy|1
6837373|NCT00250679|10842943|FG002|Overall Study|Lack of Efficacy|3
6837374|NCT00250679|10842941|FG000|Overall Study|Technical Holter issues|1
6837375|NCT00250679|10842942|FG001|Overall Study|Technical Holter issues|0
6837376|NCT00250679|10842943|FG002|Overall Study|Technical Holter issues|2
6837377|NCT00250679|10842941|FG000|Overall Study|Moved|1
6837378|NCT00250679|10842942|FG001|Overall Study|Moved|1
6837379|NCT00250679|10842943|FG002|Overall Study|Moved|0
6928488|NCT00853099|10959695|FG002|Double-blind Period|Withdrawal by Subject|0
6928489|NCT00853099|10959696|FG003|Double-blind Period|Withdrawal by Subject|0
6928490|NCT00853099|10959693|FG000|Double-blind Period|Lack of Efficacy|14
6928491|NCT00853099|10959694|FG001|Double-blind Period|Lack of Efficacy|17
6928492|NCT00853099|10959695|FG002|Double-blind Period|Lack of Efficacy|16
6928493|NCT00853099|10959696|FG003|Double-blind Period|Lack of Efficacy|0
6928494|NCT00853099|10959693|FG000|Double-blind Period|Other|0
6928495|NCT00853099|10959694|FG001|Double-blind Period|Other|0
6928496|NCT00853099|10959695|FG002|Double-blind Period|Other|1
6928497|NCT00853099|10959696|FG003|Double-blind Period|Other|0
6928498|NCT00853099|10959693|FG000|Double-blind Period|Mistreated with rescue study drug|0
7065070|NCT01962441|11164184|FG001|Randomized Period|Protocol Violation|1
7065071|NCT01962441|11164185|FG002|Randomized Period|Protocol Violation|0
7065072|NCT01962441|11164183|FG000|Retreatment Substudy|Lack of Efficacy|1
7065073|NCT01962441|11164184|FG001|Retreatment Substudy|Lack of Efficacy|0
7065074|NCT01962441|11164185|FG002|Retreatment Substudy|Lack of Efficacy|0
7065075|NCT01962441|11164183|FG000|Retreatment Substudy|Lost to Follow-up|1
7065076|NCT01962441|11164184|FG001|Retreatment Substudy|Lost to Follow-up|0
7065077|NCT01962441|11164185|FG002|Retreatment Substudy|Lost to Follow-up|0
7065078|NCT01962493|11164196|FG000|Overall Study|Adverse Event|1
7065079|NCT01962493|11164197|FG001|Overall Study|Adverse Event|2
7065080|NCT01962493|11164196|FG000|Overall Study|Protocol Violation|0
7065081|NCT01962493|11164197|FG001|Overall Study|Protocol Violation|1
7065082|NCT01962493|11164196|FG000|Overall Study|Withdrawal by Subject|4
7065083|NCT01962493|11164197|FG001|Overall Study|Withdrawal by Subject|2
7065084|NCT01962896|11164239|FG000|Overall Study|Lack of Efficacy|4
7065085|NCT01962922|11164246|FG000|PK Portion Day 7|Withdrawal by Subject|3
7065086|NCT01962922|11164247|FG001|PK Portion Day 7|Withdrawal by Subject|0
7065087|NCT01962922|11164246|FG000|PK Portion Day 7|non-compliance|1
7065088|NCT01962922|11164247|FG001|PK Portion Day 7|non-compliance|0
7065089|NCT01962922|11164246|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4
7065090|NCT01962922|11164247|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3
7065091|NCT01962922|11164246|FG000|Extendion Portion (up to Month 6)|Physician Decision|1
7065092|NCT01962922|11164247|FG001|Extendion Portion (up to Month 6)|Physician Decision|0
7082425|NCT02141672|11192950|FG002|Overall Study|Withdrawal by Subject|5
7082426|NCT02141672|11192948|FG000|Overall Study|refused to follow-up|1
7082427|NCT02141672|11192949|FG001|Overall Study|refused to follow-up|0
7082428|NCT02141672|11192950|FG002|Overall Study|refused to follow-up|1
7082429|NCT02141854|11192963|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25
7082430|NCT02141854|11192964|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7082431|NCT02141854|11192965|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7082432|NCT02141854|11192966|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7082433|NCT02141854|11192967|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7082434|NCT02141854|11192968|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7082435|NCT02141854|11192963|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76
7082436|NCT02141854|11192964|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7082437|NCT02141854|11192965|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7082438|NCT02141854|11192966|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7082439|NCT02141854|11192967|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7082440|NCT02141854|11192968|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7082441|NCT02141854|11192963|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14
7082442|NCT02141854|11192964|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7082443|NCT02141854|11192965|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7082444|NCT02141854|11192966|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7082445|NCT02141854|11192967|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7082446|NCT02141854|11192968|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7082447|NCT02141854|11192963|FG000|Run-In Period (Pre-assignment)|Other|14
7082448|NCT02141854|11192964|FG001|Run-In Period (Pre-assignment)|Other|0
7082449|NCT02141854|11192965|FG002|Run-In Period (Pre-assignment)|Other|0
7082450|NCT02141854|11192966|FG003|Run-In Period (Pre-assignment)|Other|0
7082451|NCT02141854|11192967|FG004|Run-In Period (Pre-assignment)|Other|0
7082452|NCT02141854|11192968|FG005|Run-In Period (Pre-assignment)|Other|0
7082453|NCT02141854|11192963|FG000|Run-In Period (Pre-assignment)|Adverse Event|10
7082454|NCT02141854|11192964|FG001|Run-In Period (Pre-assignment)|Adverse Event|0
7082455|NCT02141854|11192965|FG002|Run-In Period (Pre-assignment)|Adverse Event|0
7082456|NCT02141854|11192966|FG003|Run-In Period (Pre-assignment)|Adverse Event|0
7082457|NCT02141854|11192967|FG004|Run-In Period (Pre-assignment)|Adverse Event|0
7082458|NCT02141854|11192968|FG005|Run-In Period (Pre-assignment)|Adverse Event|0
7082459|NCT02141854|11192963|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9
7082460|NCT02141854|11192964|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7082461|NCT02141854|11192965|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7082462|NCT02141854|11192966|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7183760|NCT01254422|11383828|FG001|Overall Study|Adverse Event|0
6928499|NCT00853099|10959694|FG001|Double-blind Period|Mistreated with rescue study drug|0
6928500|NCT00853099|10959695|FG002|Double-blind Period|Mistreated with rescue study drug|1
6928501|NCT00853099|10959696|FG003|Double-blind Period|Mistreated with rescue study drug|0
6928502|NCT00853099|10959693|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0
6928503|NCT00853099|10959694|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0
6928504|NCT00853099|10959695|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0
6928505|NCT00853099|10959696|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74
6928506|NCT00853099|10959693|FG000|Double-blind + Open-label Periods|Adverse Event|0
6928507|NCT00853099|10959694|FG001|Double-blind + Open-label Periods|Adverse Event|0
7065093|NCT01962987|11164269|FG000|Overall Study|Adverse Event|4
7065094|NCT01962987|11164270|FG001|Overall Study|Adverse Event|4
7065095|NCT01962987|11164271|FG002|Overall Study|Adverse Event|0
7065096|NCT01962987|11164269|FG000|Overall Study|Lost to Follow-up|0
7065097|NCT01962987|11164270|FG001|Overall Study|Lost to Follow-up|0
7065098|NCT01962987|11164271|FG002|Overall Study|Lost to Follow-up|1
7065099|NCT01962987|11164269|FG000|Overall Study|Non compliance with dosing requirements|4
7065100|NCT01962987|11164270|FG001|Overall Study|Non compliance with dosing requirements|2
7065101|NCT01962987|11164271|FG002|Overall Study|Non compliance with dosing requirements|0
7065102|NCT01962987|11164269|FG000|Overall Study|Miscellaneous|1
7065103|NCT01962987|11164270|FG001|Overall Study|Miscellaneous|9
7065104|NCT01962987|11164271|FG002|Overall Study|Miscellaneous|2
7065105|NCT01962987|11164269|FG000|Overall Study|Restricted medication|5
7065106|NCT01962987|11164270|FG001|Overall Study|Restricted medication|1
7065107|NCT01962987|11164271|FG002|Overall Study|Restricted medication|1
7065108|NCT01962987|11164269|FG000|Overall Study|Serious Adverse Event|1
7065109|NCT01962987|11164270|FG001|Overall Study|Serious Adverse Event|0
7065110|NCT01962987|11164271|FG002|Overall Study|Serious Adverse Event|0
7065111|NCT01962987|11164269|FG000|Overall Study|Withdrawal by Subject|11
7065112|NCT01962987|11164270|FG001|Overall Study|Withdrawal by Subject|10
7065113|NCT01962987|11164271|FG002|Overall Study|Withdrawal by Subject|6
7065114|NCT01962987|11164269|FG000|Overall Study|Randomized in Error|4
7065115|NCT01962987|11164270|FG001|Overall Study|Randomized in Error|2
7065116|NCT01962987|11164271|FG002|Overall Study|Randomized in Error|2
7065117|NCT01963117|11164305|FG000|Overall Study|Death|1
7065118|NCT01963260|11164359|FG000|Overall Study|Withdrawal by Subject|2
7065119|NCT01963260|11164360|FG001|Overall Study|Withdrawal by Subject|0
7065120|NCT01963260|11164361|FG002|Overall Study|Withdrawal by Subject|0
7065121|NCT01963260|11164362|FG003|Overall Study|Withdrawal by Subject|1
7065122|NCT01963260|11164363|FG004|Overall Study|Withdrawal by Subject|2
7065123|NCT01963260|11164364|FG005|Overall Study|Withdrawal by Subject|0
7065124|NCT01963260|11164365|FG006|Overall Study|Withdrawal by Subject|0
7065125|NCT01963260|11164366|FG007|Overall Study|Withdrawal by Subject|0
7065126|NCT01963260|11164367|FG008|Overall Study|Withdrawal by Subject|0
7065127|NCT01963260|11164368|FG009|Overall Study|Withdrawal by Subject|0
7065128|NCT01963403|11164399|FG000|Overall Study|Lost to Follow-up|2
7065129|NCT01963403|11164400|FG001|Overall Study|Lost to Follow-up|3
7065130|NCT01963403|11164399|FG000|Overall Study|Implant removal|0
7065131|NCT01963403|11164400|FG001|Overall Study|Implant removal|1
7065132|NCT01963611|11164417|FG000|Overall Study|Adverse Event|1
7065133|NCT01963611|11164418|FG001|Overall Study|Adverse Event|1
7065134|NCT01963611|11164419|FG002|Overall Study|Adverse Event|3
7065135|NCT01963611|11164420|FG003|Overall Study|Adverse Event|4
7065136|NCT01963611|11164421|FG004|Overall Study|Adverse Event|3
7065137|NCT01963611|11164417|FG000|Overall Study|Protocol Violation|0
7065138|NCT01963611|11164418|FG001|Overall Study|Protocol Violation|0
7065139|NCT01963611|11164419|FG002|Overall Study|Protocol Violation|0
7065140|NCT01963611|11164420|FG003|Overall Study|Protocol Violation|1
7065141|NCT01963611|11164421|FG004|Overall Study|Protocol Violation|0
7065142|NCT01963611|11164417|FG000|Overall Study|Lack of Efficacy|0
7065143|NCT01963611|11164418|FG001|Overall Study|Lack of Efficacy|0
7065144|NCT01963611|11164419|FG002|Overall Study|Lack of Efficacy|0
7065145|NCT01963611|11164420|FG003|Overall Study|Lack of Efficacy|1
7065146|NCT01963611|11164421|FG004|Overall Study|Lack of Efficacy|0
7065147|NCT01963611|11164417|FG000|Overall Study|Withdrawal by Subject|3
7065148|NCT01963611|11164418|FG001|Overall Study|Withdrawal by Subject|2
7065149|NCT01963611|11164419|FG002|Overall Study|Withdrawal by Subject|1
7065150|NCT01963611|11164420|FG003|Overall Study|Withdrawal by Subject|1
7065151|NCT01963611|11164421|FG004|Overall Study|Withdrawal by Subject|3
7065152|NCT01963611|11164417|FG000|Overall Study|Other|47
7065153|NCT01963611|11164418|FG001|Overall Study|Other|46
7065154|NCT01963611|11164419|FG002|Overall Study|Other|48
7065155|NCT01963611|11164420|FG003|Overall Study|Other|45
7065156|NCT01963611|11164421|FG004|Overall Study|Other|45
7065157|NCT01963676|11164436|FG000|Overall Study|Withdrawal by Subject|1
7065158|NCT01963676|11164437|FG001|Overall Study|Withdrawal by Subject|0
7065159|NCT01963767|11164445|FG000|Overall Study|Withdrawal by Subject|4
7065160|NCT01963767|11164446|FG001|Overall Study|Withdrawal by Subject|2
7065161|NCT01963767|11164445|FG000|Overall Study|Adverse Event|2
7065162|NCT01963767|11164446|FG001|Overall Study|Adverse Event|0
7065163|NCT01964105|11164504|FG000|Overall Study|Lost to Follow-up|2
7065164|NCT01964105|11164505|FG001|Overall Study|Lost to Follow-up|13
7065165|NCT01964105|11164506|FG002|Overall Study|Lost to Follow-up|0
7065166|NCT01964222|11164516|FG000|Overall Study|Lost to Follow-up|7
7065167|NCT01964222|11164517|FG001|Overall Study|Lost to Follow-up|5
7065168|NCT01964222|11164516|FG000|Overall Study|Withdrawal by Subject|6
7065169|NCT01964222|11164517|FG001|Overall Study|Withdrawal by Subject|6
6928508|NCT00853099|10959695|FG002|Double-blind + Open-label Periods|Adverse Event|0
6928509|NCT00853099|10959696|FG003|Double-blind + Open-label Periods|Adverse Event|47
6928510|NCT00853099|10959693|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0
6928511|NCT00853099|10959694|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0
6928512|NCT00853099|10959695|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0
6928513|NCT00853099|10959696|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20
6928514|NCT00853099|10959693|FG000|Double-blind + Open-label Periods|Other|0
6928515|NCT00853099|10959694|FG001|Double-blind + Open-label Periods|Other|0
6928516|NCT00853099|10959695|FG002|Double-blind + Open-label Periods|Other|0
6928517|NCT00853099|10959696|FG003|Double-blind + Open-label Periods|Other|6
6928518|NCT00853112|10959713|FG000|Overall Study|Randomized but not treated|0
6928519|NCT00853112|10959714|FG001|Overall Study|Randomized but not treated|1
6928520|NCT00853112|10959715|FG002|Overall Study|Randomized but not treated|0
6928521|NCT00853112|10959716|FG003|Overall Study|Randomized but not treated|2
6928522|NCT00853112|10959717|FG004|Overall Study|Randomized but not treated|0
6928523|NCT00853112|10959718|FG005|Overall Study|Randomized but not treated|0
6928524|NCT00853112|10959719|FG006|Overall Study|Randomized but not treated|1
6928525|NCT00853125|10959735|FG000|Overall Study|Study participant's donor was CMV +|1
6928526|NCT00853151|10959744|FG000|Overall Study|Adverse Event|1
6928527|NCT00853151|10959745|FG001|Overall Study|Adverse Event|4
6928528|NCT00853151|10959746|FG002|Overall Study|Adverse Event|2
6928529|NCT00853151|10959747|FG003|Overall Study|Adverse Event|0
6928530|NCT00853151|10959744|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1
6928531|NCT00853151|10959745|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0
6928532|NCT00853151|10959746|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0
6928533|NCT00853151|10959747|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0
6928534|NCT00853151|10959744|FG000|Overall Study|Lost to Follow-up|2
6928535|NCT00853151|10959745|FG001|Overall Study|Lost to Follow-up|0
6928536|NCT00853151|10959746|FG002|Overall Study|Lost to Follow-up|3
6928537|NCT00853151|10959747|FG003|Overall Study|Lost to Follow-up|0
6928538|NCT00853151|10959744|FG000|Overall Study|Death|1
6928539|NCT00853151|10959745|FG001|Overall Study|Death|0
6928540|NCT00853151|10959746|FG002|Overall Study|Death|0
6928541|NCT00853151|10959747|FG003|Overall Study|Death|1
6928542|NCT00853151|10959744|FG000|Overall Study|Protocol Violation|0
6928543|NCT00853151|10959745|FG001|Overall Study|Protocol Violation|0
6928544|NCT00853151|10959746|FG002|Overall Study|Protocol Violation|0
6928545|NCT00853151|10959747|FG003|Overall Study|Protocol Violation|1
6928546|NCT00853151|10959744|FG000|Overall Study|Withdrawal by Subject|5
6928547|NCT00853151|10959745|FG001|Overall Study|Withdrawal by Subject|4
6928548|NCT00853151|10959746|FG002|Overall Study|Withdrawal by Subject|2
6928549|NCT00853151|10959747|FG003|Overall Study|Withdrawal by Subject|1
6928550|NCT00853151|10959744|FG000|Overall Study|Physician Decision|0
6928551|NCT00853151|10959745|FG001|Overall Study|Physician Decision|2
6928552|NCT00853151|10959746|FG002|Overall Study|Physician Decision|1
6928553|NCT00853151|10959747|FG003|Overall Study|Physician Decision|0
6928554|NCT00853151|10959744|FG000|Overall Study|Sponsor Decision|0
6928555|NCT00853151|10959745|FG001|Overall Study|Sponsor Decision|3
6928556|NCT00853151|10959746|FG002|Overall Study|Sponsor Decision|0
6928557|NCT00853151|10959747|FG003|Overall Study|Sponsor Decision|0
6928558|NCT00853242|10959767|FG000|Overall Study|Adverse Event|0
6928559|NCT00853242|10959768|FG001|Overall Study|Adverse Event|1
6928560|NCT00853242|10959769|FG002|Overall Study|Adverse Event|1
6928561|NCT00853242|10959770|FG003|Overall Study|Adverse Event|0
6928562|NCT00853242|10959771|FG004|Overall Study|Adverse Event|3
6928563|NCT00853242|10959772|FG005|Overall Study|Adverse Event|1
6928564|NCT00853242|10959773|FG006|Overall Study|Adverse Event|1
6928565|NCT00853242|10959767|FG000|Overall Study|Noncompliant|0
6928566|NCT00853242|10959768|FG001|Overall Study|Noncompliant|0
6928567|NCT00853242|10959769|FG002|Overall Study|Noncompliant|0
6928568|NCT00853242|10959770|FG003|Overall Study|Noncompliant|0
6928569|NCT00853242|10959771|FG004|Overall Study|Noncompliant|1
6928570|NCT00853242|10959772|FG005|Overall Study|Noncompliant|0
6928571|NCT00853242|10959773|FG006|Overall Study|Noncompliant|0
6928572|NCT00853242|10959767|FG000|Overall Study|Withdrawal by Subject|1
6928573|NCT00853242|10959768|FG001|Overall Study|Withdrawal by Subject|2
6928574|NCT00853242|10959769|FG002|Overall Study|Withdrawal by Subject|0
6928575|NCT00853242|10959770|FG003|Overall Study|Withdrawal by Subject|4
6928576|NCT00853242|10959771|FG004|Overall Study|Withdrawal by Subject|0
6928577|NCT00853242|10959772|FG005|Overall Study|Withdrawal by Subject|0
6928578|NCT00853242|10959773|FG006|Overall Study|Withdrawal by Subject|2
6928579|NCT00853242|10959767|FG000|Overall Study|Other|2
6928580|NCT00853242|10959768|FG001|Overall Study|Other|0
6928581|NCT00853242|10959769|FG002|Overall Study|Other|2
6928582|NCT00853242|10959770|FG003|Overall Study|Other|0
6928583|NCT00853242|10959771|FG004|Overall Study|Other|0
6928584|NCT00853242|10959772|FG005|Overall Study|Other|1
6928585|NCT00853242|10959773|FG006|Overall Study|Other|2
6928586|NCT00853372|10959810|FG000|Overall Study|Death|30
6928587|NCT00853372|10959811|FG001|Overall Study|Death|26
6928588|NCT00853372|10959810|FG000|Overall Study|Lost to Follow-up|1
6928589|NCT00853372|10959811|FG001|Overall Study|Lost to Follow-up|2
6928590|NCT00853372|10959810|FG000|Overall Study|Full Consent Withdrawn|1
6928591|NCT00853372|10959811|FG001|Overall Study|Full Consent Withdrawn|1
6928592|NCT00853385|10959822|FG000|Overall Study|Death|0
6928593|NCT00853385|10959823|FG001|Overall Study|Death|0
6928594|NCT00853385|10959824|FG002|Overall Study|Death|0
6928595|NCT00853385|10959825|FG003|Overall Study|Death|0
6928596|NCT00853385|10959826|FG004|Overall Study|Death|1
6928597|NCT00853385|10959822|FG000|Overall Study|Adverse Event|24
6928598|NCT00853385|10959823|FG001|Overall Study|Adverse Event|24
6928599|NCT00853385|10959824|FG002|Overall Study|Adverse Event|2
6928600|NCT00853385|10959825|FG003|Overall Study|Adverse Event|5
7065170|NCT01964222|11164516|FG000|Overall Study|Screening Failure|2
7065171|NCT01964222|11164517|FG001|Overall Study|Screening Failure|0
7065172|NCT01964300|11164525|FG000|Overall Study|Ineligible after enrollment|0
6928601|NCT00853385|10959826|FG004|Overall Study|Adverse Event|22
6928602|NCT00853385|10959822|FG000|Overall Study|Lack of Efficacy|6
6928603|NCT00853385|10959823|FG001|Overall Study|Lack of Efficacy|7
6928604|NCT00853385|10959824|FG002|Overall Study|Lack of Efficacy|3
6928605|NCT00853385|10959825|FG003|Overall Study|Lack of Efficacy|3
6928606|NCT00853385|10959826|FG004|Overall Study|Lack of Efficacy|6
6928607|NCT00853385|10959822|FG000|Overall Study|Lost to Follow-up|2
6928608|NCT00853385|10959823|FG001|Overall Study|Lost to Follow-up|1
6928609|NCT00853385|10959824|FG002|Overall Study|Lost to Follow-up|0
6928610|NCT00853385|10959825|FG003|Overall Study|Lost to Follow-up|0
7039599|NCT01711983|11122371|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62
6928611|NCT00853385|10959826|FG004|Overall Study|Lost to Follow-up|0
6928612|NCT00853385|10959822|FG000|Overall Study|Withdrawal by Subject|4
6928613|NCT00853385|10959823|FG001|Overall Study|Withdrawal by Subject|2
6928614|NCT00853385|10959824|FG002|Overall Study|Withdrawal by Subject|0
6928615|NCT00853385|10959825|FG003|Overall Study|Withdrawal by Subject|1
6928616|NCT00853385|10959826|FG004|Overall Study|Withdrawal by Subject|1
6928617|NCT00853385|10959822|FG000|Overall Study|Other|18
6928618|NCT00853385|10959823|FG001|Overall Study|Other|9
6928619|NCT00853385|10959824|FG002|Overall Study|Other|4
6928620|NCT00853385|10959825|FG003|Overall Study|Other|4
6928621|NCT00853385|10959826|FG004|Overall Study|Other|12
6928622|NCT00853489|10959850|FG000|Overall Study|Lost to Follow-up|5
6928623|NCT00853489|10959851|FG001|Overall Study|Lost to Follow-up|2
6928624|NCT00853580|10959859|FG000|Overall Study|Lost to Follow-up|3
6928625|NCT00853580|10959860|FG001|Overall Study|Lost to Follow-up|5
6928626|NCT00853580|10959859|FG000|Overall Study|Protocol Violation|2
6928627|NCT00853580|10959860|FG001|Overall Study|Protocol Violation|1
6928628|NCT00853580|10959859|FG000|Overall Study|Withdrawal by Subject|2
6928629|NCT00853580|10959860|FG001|Overall Study|Withdrawal by Subject|8
6928630|NCT00853580|10959859|FG000|Overall Study|Commenced contraindicated therapy|0
6928631|NCT00853580|10959860|FG001|Overall Study|Commenced contraindicated therapy|2
6928632|NCT00853593|10959866|FG000|Overall Study|Subjects did not receive a 4396 lead|12
6928633|NCT00853593|10959866|FG000|Overall Study|Model 4396 lead not attempted|29
6928634|NCT00853593|10959866|FG000|Overall Study|Implant not attempted|4
6928635|NCT00853658|10959898|FG000|Overall Study|Death|713
6928636|NCT00853658|10959899|FG001|Overall Study|Death|768
6928637|NCT00853658|10959900|FG002|Overall Study|Death|753
6928638|NCT00853658|10959898|FG000|Overall Study|Lost to Follow-up|11
6928639|NCT00853658|10959899|FG001|Overall Study|Lost to Follow-up|6
6928640|NCT00853658|10959900|FG002|Overall Study|Lost to Follow-up|11
6928641|NCT00853658|10959898|FG000|Overall Study|H.A. Request|26
6928642|NCT00853658|10959899|FG001|Overall Study|H.A. Request|23
6928643|NCT00853658|10959900|FG002|Overall Study|H.A. Request|19
6928644|NCT00853658|10959898|FG000|Overall Study|IRB request|0
6928645|NCT00853658|10959899|FG001|Overall Study|IRB request|0
6928646|NCT00853658|10959900|FG002|Overall Study|IRB request|2
6928647|NCT00853658|10959898|FG000|Overall Study|Vital Status known (alive) at study end|2
6928648|NCT00853658|10959899|FG001|Overall Study|Vital Status known (alive) at study end|3
6928649|NCT00853658|10959900|FG002|Overall Study|Vital Status known (alive) at study end|3
6928650|NCT00853658|10959898|FG000|Overall Study|Vital Status unknown at study end|1
6928651|NCT00853658|10959899|FG001|Overall Study|Vital Status unknown at study end|1
6928652|NCT00853658|10959900|FG002|Overall Study|Vital Status unknown at study end|0
6928653|NCT00853658|10959898|FG000|Overall Study|Vital Status at study end N/A|8
6928654|NCT00853658|10959899|FG001|Overall Study|Vital Status at study end N/A|10
6928655|NCT00853658|10959900|FG002|Overall Study|Vital Status at study end N/A|10
6928656|NCT00853658|10959898|FG000|Overall Study|Patient's request|21
6928657|NCT00853658|10959899|FG001|Overall Study|Patient's request|17
6928658|NCT00853658|10959900|FG002|Overall Study|Patient's request|11
6928659|NCT00853658|10959898|FG000|Overall Study|Missing study completion information|5
6928660|NCT00853658|10959899|FG001|Overall Study|Missing study completion information|4
6928661|NCT00853658|10959900|FG002|Overall Study|Missing study completion information|6
6928662|NCT00853723|10959915|FG000|Overall Study|Adverse Event|3
6928663|NCT00853723|10959916|FG001|Overall Study|Adverse Event|4
6928664|NCT00853723|10959917|FG002|Overall Study|Adverse Event|1
7039600|NCT01712009|11122378|FG000|Overall Study|Withdrawal by Subject|24
7065173|NCT01964300|11164526|FG001|Overall Study|Ineligible after enrollment|1
6928665|NCT00853723|10959915|FG000|Overall Study|Withdrawal by Subject|2
6928666|NCT00853723|10959916|FG001|Overall Study|Withdrawal by Subject|1
7065174|NCT01964300|11164525|FG000|Overall Study|Adverse Event|1
6928667|NCT00853723|10959917|FG002|Overall Study|Withdrawal by Subject|0
6928668|NCT00853723|10959915|FG000|Overall Study|Protocol Violation|1
6928669|NCT00853723|10959916|FG001|Overall Study|Protocol Violation|2
6928670|NCT00853723|10959917|FG002|Overall Study|Protocol Violation|1
7065175|NCT01964300|11164526|FG001|Overall Study|Adverse Event|1
6928671|NCT00853749|10959930|FG000|Overall Study|Lost to Follow-up|0
6928672|NCT00853749|10959931|FG001|Overall Study|Lost to Follow-up|1
6928673|NCT00853762|10959941|FG000|Overall Study|Premature Termination|16
6928674|NCT00853762|10959942|FG001|Overall Study|Premature Termination|15
6928675|NCT00853762|10959943|FG002|Overall Study|Premature Termination|14
6928676|NCT00853762|10959944|FG003|Overall Study|Premature Termination|21
6928677|NCT00853762|10959941|FG000|Overall Study|Protocol Violation|0
6928678|NCT00853762|10959942|FG001|Overall Study|Protocol Violation|0
6928679|NCT00853762|10959943|FG002|Overall Study|Protocol Violation|0
6928680|NCT00853762|10959944|FG003|Overall Study|Protocol Violation|1
6928681|NCT00853762|10959941|FG000|Overall Study|Withdrawal by Subject|0
6928682|NCT00853762|10959942|FG001|Overall Study|Withdrawal by Subject|0
6928683|NCT00853762|10959943|FG002|Overall Study|Withdrawal by Subject|1
6928684|NCT00853762|10959944|FG003|Overall Study|Withdrawal by Subject|0
6928685|NCT00853762|10959941|FG000|Overall Study|Other|0
6928686|NCT00853762|10959942|FG001|Overall Study|Other|2
6928687|NCT00853762|10959943|FG002|Overall Study|Other|0
6928688|NCT00853762|10959944|FG003|Overall Study|Other|0
6928689|NCT00853762|10959941|FG000|Overall Study|Randomised but not Treated|0
6928690|NCT00853762|10959942|FG001|Overall Study|Randomised but not Treated|2
6928691|NCT00853762|10959943|FG002|Overall Study|Randomised but not Treated|2
6928692|NCT00853762|10959944|FG003|Overall Study|Randomised but not Treated|0
6928693|NCT00853827|10959956|FG000|Single Blind Period (1 Week)|Other|4
6928694|NCT00853827|10959957|FG001|Single Blind Period (1 Week)|Other|0
6928695|NCT00853827|10959956|FG000|Single Blind Period (1 Week)|Adverse Event|9
6928696|NCT00853827|10959957|FG001|Single Blind Period (1 Week)|Adverse Event|0
6928697|NCT00853827|10959956|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3
6928698|NCT00853827|10959957|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0
6928699|NCT00853827|10959956|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1
6928700|NCT00853827|10959957|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0
6928701|NCT00853827|10959956|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9
6928702|NCT00853827|10959957|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0
6928703|NCT00853827|10959956|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1
6928704|NCT00853827|10959957|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0
6928705|NCT00853827|10959956|FG000|Single Blind Period (1 Week)|Protocol Violation|12
6928706|NCT00853827|10959957|FG001|Single Blind Period (1 Week)|Protocol Violation|0
6928707|NCT00853827|10959956|FG000|Double Blind Period (103 Weeks)|Adverse Event|25
6928708|NCT00853827|10959957|FG001|Double Blind Period (103 Weeks)|Adverse Event|14
6928709|NCT00853827|10959956|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0
6928710|NCT00853827|10959957|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3
6928711|NCT00853827|10959956|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1
6928712|NCT00853827|10959957|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0
6928713|NCT00853827|10959956|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3
6928714|NCT00853827|10959957|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1
6928715|NCT00853827|10959956|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2
6928716|NCT00853827|10959957|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1
6928717|NCT00853827|10959956|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19
6928718|NCT00853827|10959957|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18
6928719|NCT00853827|10959956|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8
6928720|NCT00853827|10959957|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10
6928721|NCT00853827|10959956|FG000|Double Blind Period (103 Weeks)|Administrative problems|45
6928722|NCT00853827|10959957|FG001|Double Blind Period (103 Weeks)|Administrative problems|56
6928723|NCT00853827|10959956|FG000|Double Blind Period (103 Weeks)|Death|1
6928724|NCT00853827|10959957|FG001|Double Blind Period (103 Weeks)|Death|6
6928725|NCT00853905|10959973|FG000|Overall Study|Lost to Follow-up|1
6928726|NCT00853905|10959974|FG001|Overall Study|Lost to Follow-up|3
6928727|NCT00853905|10959973|FG000|Overall Study|Withdrawal by Subject|0
6928728|NCT00853905|10959974|FG001|Overall Study|Withdrawal by Subject|1
6928729|NCT00853905|10959973|FG000|Overall Study|never had surgery|1
6928730|NCT00853905|10959974|FG001|Overall Study|never had surgery|0
6928731|NCT00853957|10959985|FG000|Overall Study|Adverse Event|9
6928732|NCT00853957|10959986|FG001|Overall Study|Adverse Event|3
6928733|NCT00853957|10959985|FG000|Overall Study|Unsatisfactory therapeutic effect|0
6928734|NCT00853957|10959986|FG001|Overall Study|Unsatisfactory therapeutic effect|2
6928735|NCT00853957|10959985|FG000|Overall Study|Subject withdrew consent|4
6928736|NCT00853957|10959986|FG001|Overall Study|Subject withdrew consent|5
6928737|NCT00853957|10959985|FG000|Overall Study|Lost to Follow-up|1
6928738|NCT00853957|10959986|FG001|Overall Study|Lost to Follow-up|6
6928739|NCT00853957|10959985|FG000|Overall Study|Protocol deviation|0
6928740|NCT00853957|10959986|FG001|Overall Study|Protocol deviation|3
6928741|NCT00853970|10959994|FG000|Overall Study|Withdrawal by Subject|2
6928742|NCT00853970|10959995|FG001|Overall Study|Withdrawal by Subject|1
6928743|NCT00853970|10959994|FG000|Overall Study|Cancelled surgery|4
7039601|NCT01712009|11122379|FG001|Overall Study|Withdrawal by Subject|15
7039602|NCT01712009|11122380|FG002|Overall Study|Withdrawal by Subject|8
7039603|NCT01712009|11122378|FG000|Overall Study|Lost to Follow-up|2
7039604|NCT01712009|11122379|FG001|Overall Study|Lost to Follow-up|0
7039605|NCT01712009|11122380|FG002|Overall Study|Lost to Follow-up|1
6928744|NCT00853970|10959995|FG001|Overall Study|Cancelled surgery|2
6928745|NCT00854100|10960023|FG000|Overall Study|Inability to complete the study visits|0
6928746|NCT00854100|10960024|FG001|Overall Study|Inability to complete the study visits|0
6928747|NCT00854100|10960025|FG002|Overall Study|Inability to complete the study visits|1
6928748|NCT00854100|10960023|FG000|Overall Study|Lost to Follow-up|2
6928749|NCT00854100|10960024|FG001|Overall Study|Lost to Follow-up|0
6928750|NCT00854100|10960025|FG002|Overall Study|Lost to Follow-up|3
6928751|NCT00854100|10960023|FG000|Overall Study|Withdrawal by Subject|3
6928752|NCT00854100|10960024|FG001|Overall Study|Withdrawal by Subject|1
6928753|NCT00854100|10960025|FG002|Overall Study|Withdrawal by Subject|2
6928754|NCT00854100|10960023|FG000|Overall Study|Protocol Violation|2
6928755|NCT00854100|10960024|FG001|Overall Study|Protocol Violation|4
6928756|NCT00854100|10960025|FG002|Overall Study|Protocol Violation|3
6928757|NCT00854100|10960023|FG000|Overall Study|Adverse Event|2
6928758|NCT00854100|10960024|FG001|Overall Study|Adverse Event|1
6928759|NCT00854100|10960025|FG002|Overall Study|Adverse Event|2
6928760|NCT00854113|10960045|FG000|Overall Study|Adverse Event|0
6928761|NCT00854113|10960046|FG001|Overall Study|Adverse Event|0
6928762|NCT00854113|10960047|FG002|Overall Study|Adverse Event|0
6928763|NCT00854113|10960048|FG003|Overall Study|Adverse Event|0
6928764|NCT00854113|10960049|FG004|Overall Study|Adverse Event|0
6928765|NCT00854113|10960050|FG005|Overall Study|Adverse Event|0
6928766|NCT00854113|10960051|FG006|Overall Study|Adverse Event|0
6928767|NCT00854113|10960052|FG007|Overall Study|Adverse Event|2
6928768|NCT00854113|10960053|FG008|Overall Study|Adverse Event|0
6928769|NCT00854113|10960054|FG009|Overall Study|Adverse Event|0
6928770|NCT00854113|10960055|FG010|Overall Study|Adverse Event|0
6928771|NCT00854113|10960045|FG000|Overall Study|Withdrawal by Subject|0
6928772|NCT00854113|10960046|FG001|Overall Study|Withdrawal by Subject|0
6928773|NCT00854113|10960047|FG002|Overall Study|Withdrawal by Subject|0
6928774|NCT00854113|10960048|FG003|Overall Study|Withdrawal by Subject|0
6928775|NCT00854113|10960049|FG004|Overall Study|Withdrawal by Subject|0
6928776|NCT00854113|10960050|FG005|Overall Study|Withdrawal by Subject|0
6928777|NCT00854113|10960051|FG006|Overall Study|Withdrawal by Subject|0
6928778|NCT00854113|10960052|FG007|Overall Study|Withdrawal by Subject|1
6928779|NCT00854113|10960053|FG008|Overall Study|Withdrawal by Subject|1
6928780|NCT00854113|10960054|FG009|Overall Study|Withdrawal by Subject|0
6928781|NCT00854113|10960055|FG010|Overall Study|Withdrawal by Subject|0
6928782|NCT00854308|10960081|FG000|Overall Study|Disease progression|42
6928783|NCT00854308|10960082|FG001|Overall Study|Disease progression|50
6928784|NCT00854308|10960081|FG000|Overall Study|Adverse Event|8
6928785|NCT00854308|10960082|FG001|Overall Study|Adverse Event|3
6928786|NCT00854308|10960081|FG000|Overall Study|Death|2
6928787|NCT00854308|10960082|FG001|Overall Study|Death|5
6928788|NCT00854308|10960081|FG000|Overall Study|Physician Decision|6
7039606|NCT01712009|11122378|FG000|Overall Study|Decision by Sponsor|12
7039607|NCT01712009|11122379|FG001|Overall Study|Decision by Sponsor|14
7039608|NCT01712009|11122380|FG002|Overall Study|Decision by Sponsor|12
7039609|NCT01712061|11122390|FG000|Overall Study|Adverse Event|4
7039610|NCT01712061|11122391|FG001|Overall Study|Adverse Event|9
6928789|NCT00854308|10960082|FG001|Overall Study|Physician Decision|6
6928790|NCT00854308|10960081|FG000|Overall Study|Withdrawal by Subject|4
6928791|NCT00854308|10960082|FG001|Overall Study|Withdrawal by Subject|2
6928792|NCT00854308|10960081|FG000|Overall Study|Sponsor's decision to terminate study|0
6928793|NCT00854308|10960082|FG001|Overall Study|Sponsor's decision to terminate study|1
6928794|NCT00854360|10960092|FG000|Overall Study|Adverse Event|0
6928795|NCT00854360|10960093|FG001|Overall Study|Adverse Event|1
6928796|NCT00854360|10960094|FG002|Overall Study|Adverse Event|2
6928797|NCT00854360|10960095|FG003|Overall Study|Adverse Event|6
6928798|NCT00854360|10960092|FG000|Overall Study|Withdrawal by Subject|0
6928799|NCT00854360|10960093|FG001|Overall Study|Withdrawal by Subject|0
6928800|NCT00854360|10960094|FG002|Overall Study|Withdrawal by Subject|0
6928801|NCT00854360|10960095|FG003|Overall Study|Withdrawal by Subject|1
6928802|NCT00854360|10960092|FG000|Overall Study|Pregnancy|0
6928803|NCT00854360|10960093|FG001|Overall Study|Pregnancy|1
7065176|NCT01964300|11164525|FG000|Overall Study|Lack of Efficacy|3
7065177|NCT01964300|11164526|FG001|Overall Study|Lack of Efficacy|5
7065178|NCT01964300|11164525|FG000|Overall Study|Withdrawal by Subject|0
7065179|NCT01964300|11164526|FG001|Overall Study|Withdrawal by Subject|1
7065180|NCT01964300|11164525|FG000|Overall Study|To receive alternative therapy|1
7065181|NCT01964300|11164526|FG001|Overall Study|To receive alternative therapy|2
7065182|NCT01964300|11164525|FG000|Overall Study|Enlargement of cyst requiring drainage|1
7065183|NCT01964300|11164526|FG001|Overall Study|Enlargement of cyst requiring drainage|0
7065184|NCT01964300|11164525|FG000|Overall Study|Weight criteria not met|0
7065185|NCT01964300|11164526|FG001|Overall Study|Weight criteria not met|1
7065186|NCT01964326|11164532|FG000|Overall Study|Adverse Event|48
7065187|NCT01964326|11164532|FG000|Overall Study|Death|2
7065188|NCT01964326|11164532|FG000|Overall Study|Protocol Violation|4
6928804|NCT00854360|10960094|FG002|Overall Study|Pregnancy|0
6928805|NCT00854360|10960095|FG003|Overall Study|Pregnancy|0
6928806|NCT00854360|10960092|FG000|Overall Study|Lack of Efficacy|2
6928807|NCT00854360|10960093|FG001|Overall Study|Lack of Efficacy|1
6928808|NCT00854360|10960094|FG002|Overall Study|Lack of Efficacy|0
6928809|NCT00854360|10960095|FG003|Overall Study|Lack of Efficacy|0
6928810|NCT00854360|10960092|FG000|Overall Study|Other|0
7039611|NCT01712061|11122392|FG002|Overall Study|Adverse Event|5
6928811|NCT00854360|10960093|FG001|Overall Study|Other|0
6928812|NCT00854360|10960094|FG002|Overall Study|Other|0
6928813|NCT00854360|10960095|FG003|Overall Study|Other|3
6928814|NCT00854373|10960107|FG000|Overall Study|Withdrawal by Subject|1
6928815|NCT00854373|10960108|FG001|Overall Study|Withdrawal by Subject|3
6928816|NCT00854373|10960107|FG000|Overall Study|Forgot to take study drug|1
6928817|NCT00854373|10960108|FG001|Overall Study|Forgot to take study drug|1
6928818|NCT00854581|10960114|FG000|Induction (Up to Day 21)|Lack of Efficacy|4
6928819|NCT00854581|10960114|FG000|Induction (Up to Day 21)|Death|1
6928820|NCT00854581|10960114|FG000|Induction (Up to Day 21)|Physician Decision|1
6928821|NCT00854581|10960114|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3
6928822|NCT00854607|10960132|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65
6928823|NCT00854620|10960143|FG000|Overall Study|Adverse Event|1
6928824|NCT00854724|10960149|FG000|First Intervention|Withdrawal by Subject|1
6928825|NCT00854724|10960150|FG001|First Intervention|Withdrawal by Subject|1
6928826|NCT00854724|10960149|FG000|Washout|Protocol Violation|1
6928827|NCT00854724|10960150|FG001|Washout|Protocol Violation|0
6928828|NCT00854724|10960149|FG000|Washout|Withdrawal by Subject|0
6928829|NCT00854724|10960150|FG001|Washout|Withdrawal by Subject|1
6928830|NCT00854724|10960149|FG000|Second Intervention|Protocol Violation|1
6928831|NCT00854724|10960150|FG001|Second Intervention|Protocol Violation|0
6928832|NCT00854724|10960149|FG000|Second Intervention|Physician Decision|0
6928833|NCT00854724|10960150|FG001|Second Intervention|Physician Decision|1
6928834|NCT00854828|10960160|FG000|Overall Study|Death|1
6928835|NCT00854828|10960161|FG001|Overall Study|Death|0
6928836|NCT00854828|10960162|FG002|Overall Study|Death|0
6928837|NCT00854828|10960163|FG003|Overall Study|Death|0
6928838|NCT00854828|10960160|FG000|Overall Study|Withdrawal by Subject|1
6928839|NCT00854828|10960161|FG001|Overall Study|Withdrawal by Subject|1
6928840|NCT00854828|10960162|FG002|Overall Study|Withdrawal by Subject|0
6928841|NCT00854828|10960163|FG003|Overall Study|Withdrawal by Subject|9
6928842|NCT00854828|10960160|FG000|Overall Study|Missed 24mo visit|1
6928843|NCT00854828|10960161|FG001|Overall Study|Missed 24mo visit|1
6928844|NCT00854828|10960162|FG002|Overall Study|Missed 24mo visit|8
6928845|NCT00854828|10960163|FG003|Overall Study|Missed 24mo visit|8
6928846|NCT00854906|10960173|FG000|Overall Study|One person had no ocular history|1
6928847|NCT00855062|10960195|FG000|Step1|Early Study Closure|5
6928848|NCT00855062|10960196|FG001|Step1|Early Study Closure|7
6928849|NCT00855062|10960195|FG000|Step1|Adverse Event|1
6928850|NCT00855062|10960196|FG001|Step1|Adverse Event|1
6928851|NCT00855062|10960195|FG000|Step1|Protocol Violation|1
6928852|NCT00855062|10960196|FG001|Step1|Protocol Violation|0
6928853|NCT00855062|10960195|FG000|Step1|Pregnancy|1
6928854|NCT00855062|10960196|FG001|Step1|Pregnancy|0
6928855|NCT00855062|10960195|FG000|Step1|Withdrawal by Subject|2
6928856|NCT00855062|10960196|FG001|Step1|Withdrawal by Subject|3
6928857|NCT00855062|10960195|FG000|Step2|Early Study Closure|6
6928858|NCT00855062|10960196|FG001|Step2|Early Study Closure|2
6928859|NCT00855062|10960195|FG000|Step2|Adverse Event|0
6928860|NCT00855062|10960196|FG001|Step2|Adverse Event|3
6928861|NCT00855062|10960195|FG000|Step2|Initiation of antiretroviral therapy/ART|0
6928862|NCT00855062|10960196|FG001|Step2|Initiation of antiretroviral therapy/ART|1
6928863|NCT00855166|10960204|FG000|Overall Study|Adverse Event|0
6928864|NCT00855166|10960205|FG001|Overall Study|Adverse Event|2
6928865|NCT00855166|10960204|FG000|Overall Study|Death|0
6928866|NCT00855166|10960205|FG001|Overall Study|Death|1
6928867|NCT00855166|10960204|FG000|Overall Study|Withdrawal by Subject|1
6928868|NCT00855166|10960205|FG001|Overall Study|Withdrawal by Subject|4
6928869|NCT00855166|10960204|FG000|Overall Study|Poor/non-compliance|2
6928870|NCT00855166|10960205|FG001|Overall Study|Poor/non-compliance|0
6928871|NCT00855166|10960204|FG000|Overall Study|Administrative reasons by sponsor|1
6928872|NCT00855166|10960205|FG001|Overall Study|Administrative reasons by sponsor|0
6928873|NCT00855166|10960204|FG000|Overall Study|Subject no longer meets study criteria|1
6928874|NCT00855166|10960205|FG001|Overall Study|Subject no longer meets study criteria|1
6928875|NCT00855218|10960215|FG000|Overall Study|Adverse Event|43
6928876|NCT00855218|10960216|FG001|Overall Study|Adverse Event|27
6928877|NCT00855218|10960215|FG000|Overall Study|Withdrawal by Subject|10
6928878|NCT00855218|10960216|FG001|Overall Study|Withdrawal by Subject|6
6928879|NCT00855218|10960215|FG000|Overall Study|Physician Decision|18
6928880|NCT00855218|10960216|FG001|Overall Study|Physician Decision|11
6928881|NCT00855218|10960215|FG000|Overall Study|Lost to Follow-up|0
6928882|NCT00855218|10960216|FG001|Overall Study|Lost to Follow-up|1
6928883|NCT00855218|10960215|FG000|Overall Study|Protocol Violation|5
6928884|NCT00855218|10960216|FG001|Overall Study|Protocol Violation|9
6928885|NCT00855218|10960215|FG000|Overall Study|non-compliant with study drug|3
6928886|NCT00855218|10960216|FG001|Overall Study|non-compliant with study drug|1
6928887|NCT00855218|10960215|FG000|Overall Study|patient convenience|2
6928888|NCT00855218|10960216|FG001|Overall Study|patient convenience|0
6928889|NCT00855218|10960215|FG000|Overall Study|technical problems|2
6928890|NCT00855218|10960216|FG001|Overall Study|technical problems|1
6928891|NCT00855218|10960215|FG000|Overall Study|Still treated with study medication|0
6928892|NCT00855218|10960216|FG001|Overall Study|Still treated with study medication|1
6928893|NCT00855218|10960215|FG000|Overall Study|Untreatable disease progression|54
6928894|NCT00855218|10960216|FG001|Overall Study|Untreatable disease progression|67
6928895|NCT00855218|10960215|FG000|Overall Study|Second malignancy|0
6928896|NCT00855218|10960216|FG001|Overall Study|Second malignancy|1
6928897|NCT00855218|10960215|FG000|Overall Study|Progression measurement proven|7
6928898|NCT00855218|10960216|FG001|Overall Study|Progression measurement proven|15
6928899|NCT00855218|10960215|FG000|Overall Study|Clinical endpoint reached|10
6928900|NCT00855218|10960216|FG001|Overall Study|Clinical endpoint reached|13
6928901|NCT00855309|10960224|FG000|Overall Study|patient never recieved drug|1
6928902|NCT00855309|10960225|FG001|Overall Study|patient never recieved drug|0
6928903|NCT00855335|10960236|FG000|Overall Study|Lost to Follow-up|0
6928904|NCT00855335|10960237|FG001|Overall Study|Lost to Follow-up|0
6928905|NCT00855335|10960238|FG002|Overall Study|Lost to Follow-up|3
6928906|NCT00855335|10960239|FG003|Overall Study|Lost to Follow-up|1
6928907|NCT00855335|10960240|FG004|Overall Study|Lost to Follow-up|0
6928908|NCT00855335|10960236|FG000|Overall Study|Withdrawal by Subject|0
6928909|NCT00855335|10960237|FG001|Overall Study|Withdrawal by Subject|0
6928910|NCT00855335|10960238|FG002|Overall Study|Withdrawal by Subject|0
6928911|NCT00855335|10960239|FG003|Overall Study|Withdrawal by Subject|1
6928912|NCT00855335|10960240|FG004|Overall Study|Withdrawal by Subject|0
6928913|NCT00855335|10960236|FG000|Overall Study|Adverse Event|2
6928914|NCT00855335|10960237|FG001|Overall Study|Adverse Event|0
6928915|NCT00855335|10960238|FG002|Overall Study|Adverse Event|0
6928916|NCT00855335|10960239|FG003|Overall Study|Adverse Event|0
6928917|NCT00855335|10960240|FG004|Overall Study|Adverse Event|0
6928918|NCT00855335|10960236|FG000|Overall Study|Physician Decision|1
6928919|NCT00855335|10960237|FG001|Overall Study|Physician Decision|1
6928920|NCT00855335|10960238|FG002|Overall Study|Physician Decision|0
6928921|NCT00855335|10960239|FG003|Overall Study|Physician Decision|0
6928922|NCT00855335|10960240|FG004|Overall Study|Physician Decision|0
6928923|NCT00855335|10960236|FG000|Overall Study|Other|2
6928924|NCT00855335|10960237|FG001|Overall Study|Other|1
6928925|NCT00855335|10960238|FG002|Overall Study|Other|2
6928926|NCT00855335|10960239|FG003|Overall Study|Other|5
6928927|NCT00855335|10960240|FG004|Overall Study|Other|1
6928928|NCT00855439|10960271|FG000|Overall Study|Withdrawal by Subject|2
6928929|NCT00855439|10960272|FG001|Overall Study|Withdrawal by Subject|0
6928930|NCT00855439|10960271|FG000|Overall Study|Pregnancy|1
6928931|NCT00855439|10960272|FG001|Overall Study|Pregnancy|0
6928932|NCT00855465|10960280|FG000|Treatment Period|Adverse Event|4
6928933|NCT00855465|10960281|FG001|Treatment Period|Adverse Event|2
6928934|NCT00855465|10960280|FG000|Treatment Period|Death|2
6928935|NCT00855465|10960281|FG001|Treatment Period|Death|2
6928936|NCT00855465|10960280|FG000|Treatment Period|Lack of Efficacy|2
6928937|NCT00855465|10960281|FG001|Treatment Period|Lack of Efficacy|1
6928938|NCT00855465|10960280|FG000|Treatment Period|Non-compliance|1
6928939|NCT00855465|10960281|FG001|Treatment Period|Non-compliance|0
6928940|NCT00855465|10960280|FG000|Treatment Period|Protocol Violation|2
7039612|NCT01712061|11122390|FG000|Overall Study|Death|0
7039613|NCT01712061|11122391|FG001|Overall Study|Death|0
7039614|NCT01712061|11122392|FG002|Overall Study|Death|1
7039615|NCT01712061|11122390|FG000|Overall Study|Lost to Follow-up|1
7039616|NCT01712061|11122391|FG001|Overall Study|Lost to Follow-up|0
7039617|NCT01712061|11122392|FG002|Overall Study|Lost to Follow-up|1
7039618|NCT01712061|11122390|FG000|Overall Study|Did Not Meet Entrance Criteria|4
7039619|NCT01712061|11122391|FG001|Overall Study|Did Not Meet Entrance Criteria|6
6928941|NCT00855465|10960281|FG001|Treatment Period|Protocol Violation|0
6928942|NCT00855465|10960280|FG000|Treatment Period|Withdrawal by Subject|2
6928943|NCT00855465|10960281|FG001|Treatment Period|Withdrawal by Subject|0
6928944|NCT00855465|10960280|FG000|Treatment Period|Not treated|1
6928945|NCT00855465|10960281|FG001|Treatment Period|Not treated|0
6928946|NCT00855465|10960280|FG000|Follow-up Period (FUP)|Adverse Event|0
6928947|NCT00855465|10960281|FG001|Follow-up Period (FUP)|Adverse Event|1
6928948|NCT00855465|10960280|FG000|Follow-up Period (FUP)|Death|0
6928949|NCT00855465|10960281|FG001|Follow-up Period (FUP)|Death|1
6928950|NCT00855465|10960280|FG000|Follow-up Period (FUP)|Lost to Follow-up|3
6928951|NCT00855465|10960281|FG001|Follow-up Period (FUP)|Lost to Follow-up|0
6928952|NCT00855465|10960280|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4
6928953|NCT00855465|10960281|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0
6928954|NCT00855465|10960280|FG000|Follow-up Period (FUP)|Missing|1
6928955|NCT00855465|10960281|FG001|Follow-up Period (FUP)|Missing|0
6928956|NCT00855582|10960290|FG000|Overall Study|Adverse Event|2
6928957|NCT00855582|10960291|FG001|Overall Study|Adverse Event|6
6928958|NCT00855582|10960292|FG002|Overall Study|Adverse Event|3
6928959|NCT00855582|10960290|FG000|Overall Study|Death|1
6928960|NCT00855582|10960291|FG001|Overall Study|Death|0
6928961|NCT00855582|10960292|FG002|Overall Study|Death|0
6928962|NCT00855582|10960290|FG000|Overall Study|Lack of Efficacy|1
6928963|NCT00855582|10960291|FG001|Overall Study|Lack of Efficacy|3
6928964|NCT00855582|10960292|FG002|Overall Study|Lack of Efficacy|8
6928965|NCT00855582|10960290|FG000|Overall Study|Lost to Follow-up|1
7039620|NCT01712061|11122392|FG002|Overall Study|Did Not Meet Entrance Criteria|3
6928966|NCT00855582|10960291|FG001|Overall Study|Lost to Follow-up|3
6928967|NCT00855582|10960292|FG002|Overall Study|Lost to Follow-up|1
6928968|NCT00855582|10960290|FG000|Overall Study|Physician Decision|0
6928969|NCT00855582|10960291|FG001|Overall Study|Physician Decision|0
6928970|NCT00855582|10960292|FG002|Overall Study|Physician Decision|1
6928971|NCT00855582|10960290|FG000|Overall Study|Protocol Violation|6
6928972|NCT00855582|10960291|FG001|Overall Study|Protocol Violation|2
7044790|NCT01757275|11130781|FG000|Overall Study|Lost to Follow-up|1
6928973|NCT00855582|10960292|FG002|Overall Study|Protocol Violation|6
6928974|NCT00855582|10960290|FG000|Overall Study|Entry Criteria Not Met|8
6928975|NCT00855582|10960291|FG001|Overall Study|Entry Criteria Not Met|6
6928976|NCT00855582|10960292|FG002|Overall Study|Entry Criteria Not Met|3
6928977|NCT00855582|10960290|FG000|Overall Study|Withdrawal by Subject|7
6928978|NCT00855582|10960291|FG001|Overall Study|Withdrawal by Subject|4
6928979|NCT00855582|10960292|FG002|Overall Study|Withdrawal by Subject|8
6928980|NCT00855595|10960305|FG000|Overall Study|Withdrawal by Subject|1
6928981|NCT00855595|10960306|FG001|Overall Study|Withdrawal by Subject|2
6928982|NCT00855595|10960305|FG000|Overall Study|Lost to Follow-up|3
6928983|NCT00855595|10960306|FG001|Overall Study|Lost to Follow-up|3
6928984|NCT00855595|10960305|FG000|Overall Study|Adverse Event|1
6928985|NCT00855595|10960306|FG001|Overall Study|Adverse Event|1
6928986|NCT00855595|10960305|FG000|Overall Study|patient moved out of state|1
6928987|NCT00855595|10960306|FG001|Overall Study|patient moved out of state|0
6928988|NCT00855595|10960305|FG000|Overall Study|patient left country|0
6928989|NCT00855595|10960306|FG001|Overall Study|patient left country|1
6928990|NCT00855738|10960312|FG000|Overall Study|Lost to Follow-up|2
6928991|NCT00855738|10960312|FG000|Overall Study|Adverse Event|1
6928992|NCT00855738|10960312|FG000|Overall Study|Subject Defaulted|1
6928993|NCT00855738|10960312|FG000|Overall Study|Death|1
6975049|NCT01190930|11027133|FG002|Post Induction Pre-Maintenance|Progressive disease|1
6975050|NCT01190930|11027134|FG003|Post Induction Pre-Maintenance|Progressive disease|0
6975051|NCT01190930|11027135|FG004|Post Induction Pre-Maintenance|Progressive disease|0
6975052|NCT01190930|11027136|FG005|Post Induction Pre-Maintenance|Progressive disease|0
6975053|NCT01190930|11027137|FG006|Post Induction Pre-Maintenance|Progressive disease|0
6975054|NCT01190930|11027138|FG007|Post Induction Pre-Maintenance|Progressive disease|0
6975055|NCT01190930|11027139|FG008|Post Induction Pre-Maintenance|Progressive disease|0
6975056|NCT01190930|11027140|FG009|Post Induction Pre-Maintenance|Progressive disease|0
6975057|NCT01190930|11027131|FG000|Post Induction Pre-Maintenance|Relapse|0
6975058|NCT01190930|11027132|FG001|Post Induction Pre-Maintenance|Relapse|0
6975059|NCT01190930|11027133|FG002|Post Induction Pre-Maintenance|Relapse|1
6975060|NCT01190930|11027134|FG003|Post Induction Pre-Maintenance|Relapse|0
6975061|NCT01190930|11027135|FG004|Post Induction Pre-Maintenance|Relapse|0
6975062|NCT01190930|11027136|FG005|Post Induction Pre-Maintenance|Relapse|0
6975063|NCT01190930|11027137|FG006|Post Induction Pre-Maintenance|Relapse|0
6975064|NCT01190930|11027138|FG007|Post Induction Pre-Maintenance|Relapse|0
6975065|NCT01190930|11027139|FG008|Post Induction Pre-Maintenance|Relapse|0
6975066|NCT01190930|11027140|FG009|Post Induction Pre-Maintenance|Relapse|0
6975067|NCT01190930|11027131|FG000|Maintenance|Adverse Event|0
6975068|NCT01190930|11027132|FG001|Maintenance|Adverse Event|0
6975069|NCT01190930|11027133|FG002|Maintenance|Adverse Event|0
6975070|NCT01190930|11027134|FG003|Maintenance|Adverse Event|0
6975071|NCT01190930|11027135|FG004|Maintenance|Adverse Event|0
6975072|NCT01190930|11027136|FG005|Maintenance|Adverse Event|1
6975073|NCT01190930|11027137|FG006|Maintenance|Adverse Event|1
6975074|NCT01190930|11027138|FG007|Maintenance|Adverse Event|3
6975075|NCT01190930|11027139|FG008|Maintenance|Adverse Event|3
6975076|NCT01190930|11027140|FG009|Maintenance|Adverse Event|0
6975077|NCT01190930|11027131|FG000|Maintenance|Death|0
6975078|NCT01190930|11027132|FG001|Maintenance|Death|0
6975079|NCT01190930|11027133|FG002|Maintenance|Death|0
6975080|NCT01190930|11027134|FG003|Maintenance|Death|1
6975081|NCT01190930|11027135|FG004|Maintenance|Death|0
6975082|NCT01190930|11027136|FG005|Maintenance|Death|0
6975083|NCT01190930|11027137|FG006|Maintenance|Death|2
6975084|NCT01190930|11027138|FG007|Maintenance|Death|2
6975085|NCT01190930|11027139|FG008|Maintenance|Death|2
6975086|NCT01190930|11027140|FG009|Maintenance|Death|2
6975087|NCT01190930|11027131|FG000|Maintenance|Lost to Follow-up|0
6975088|NCT01190930|11027132|FG001|Maintenance|Lost to Follow-up|0
6975089|NCT01190930|11027133|FG002|Maintenance|Lost to Follow-up|0
6975090|NCT01190930|11027134|FG003|Maintenance|Lost to Follow-up|0
6975091|NCT01190930|11027135|FG004|Maintenance|Lost to Follow-up|0
6975092|NCT01190930|11027136|FG005|Maintenance|Lost to Follow-up|0
6975093|NCT01190930|11027137|FG006|Maintenance|Lost to Follow-up|1
6975094|NCT01190930|11027138|FG007|Maintenance|Lost to Follow-up|1
6975095|NCT01190930|11027139|FG008|Maintenance|Lost to Follow-up|1
6975096|NCT01190930|11027140|FG009|Maintenance|Lost to Follow-up|0
6975097|NCT01190930|11027131|FG000|Maintenance|Physician Decision|0
6975098|NCT01190930|11027132|FG001|Maintenance|Physician Decision|1
6975099|NCT01190930|11027133|FG002|Maintenance|Physician Decision|0
6975100|NCT01190930|11027134|FG003|Maintenance|Physician Decision|5
6975101|NCT01190930|11027135|FG004|Maintenance|Physician Decision|9
6975102|NCT01190930|11027136|FG005|Maintenance|Physician Decision|4
6975103|NCT01190930|11027137|FG006|Maintenance|Physician Decision|8
6975104|NCT01190930|11027138|FG007|Maintenance|Physician Decision|8
6975105|NCT01190930|11027139|FG008|Maintenance|Physician Decision|10
6975106|NCT01190930|11027140|FG009|Maintenance|Physician Decision|17
6975107|NCT01190930|11027131|FG000|Maintenance|Withdrawal by Subject|0
6975108|NCT01190930|11027132|FG001|Maintenance|Withdrawal by Subject|0
6975109|NCT01190930|11027133|FG002|Maintenance|Withdrawal by Subject|0
6975110|NCT01190930|11027134|FG003|Maintenance|Withdrawal by Subject|0
6975111|NCT01190930|11027135|FG004|Maintenance|Withdrawal by Subject|0
6975112|NCT01190930|11027136|FG005|Maintenance|Withdrawal by Subject|0
6975113|NCT01190930|11027137|FG006|Maintenance|Withdrawal by Subject|2
6975114|NCT01190930|11027138|FG007|Maintenance|Withdrawal by Subject|1
7039621|NCT01712061|11122390|FG000|Overall Study|Medication Error Without Associated AE|0
7039622|NCT01712061|11122391|FG001|Overall Study|Medication Error Without Associated AE|1
6928994|NCT00855816|10960320|FG000|Overall Study|Withdrawal by Subject|22
6928995|NCT00855816|10960321|FG001|Overall Study|Withdrawal by Subject|15
6928996|NCT00855816|10960320|FG000|Overall Study|Lost to Follow-up|3
6928997|NCT00855816|10960321|FG001|Overall Study|Lost to Follow-up|5
6928998|NCT00855816|10960320|FG000|Overall Study|Death|1
6928999|NCT00855816|10960321|FG001|Overall Study|Death|0
6929000|NCT00855816|10960320|FG000|Overall Study|Became ineligible|0
6929001|NCT00855816|10960321|FG001|Overall Study|Became ineligible|1
6929002|NCT00855894|10960340|FG000|Overall Study|Death|31
6929003|NCT00855894|10960340|FG000|Overall Study|Patient's decision|1
6929004|NCT00855894|10960340|FG000|Overall Study|Disease progression|1
6929005|NCT00855920|10960347|FG000|Overall Study|Protocol Violation|0
6929006|NCT00855920|10960348|FG001|Overall Study|Protocol Violation|0
6929007|NCT00855920|10960349|FG002|Overall Study|Protocol Violation|2
6929008|NCT00855920|10960347|FG000|Overall Study|Adverse Event|2
6929009|NCT00855920|10960348|FG001|Overall Study|Adverse Event|1
6929010|NCT00855920|10960349|FG002|Overall Study|Adverse Event|1
6929011|NCT00855920|10960347|FG000|Overall Study|Lack of Efficacy|2
6929012|NCT00855920|10960348|FG001|Overall Study|Lack of Efficacy|2
6929013|NCT00855920|10960349|FG002|Overall Study|Lack of Efficacy|2
6929014|NCT00855920|10960347|FG000|Overall Study|Withdrawal by Subject|2
6929015|NCT00855920|10960348|FG001|Overall Study|Withdrawal by Subject|3
6929016|NCT00855920|10960349|FG002|Overall Study|Withdrawal by Subject|2
6929017|NCT00855920|10960347|FG000|Overall Study|Lost to Follow-up|1
6929018|NCT00855920|10960348|FG001|Overall Study|Lost to Follow-up|0
6929019|NCT00855920|10960349|FG002|Overall Study|Lost to Follow-up|2
6929020|NCT00855920|10960347|FG000|Overall Study|Death|0
6929021|NCT00855920|10960348|FG001|Overall Study|Death|1
6929022|NCT00855920|10960349|FG002|Overall Study|Death|0
6929023|NCT00855920|10960347|FG000|Overall Study|Decision by the sponsor|0
6929024|NCT00855920|10960348|FG001|Overall Study|Decision by the sponsor|1
6929025|NCT00855920|10960349|FG002|Overall Study|Decision by the sponsor|1
6929026|NCT00855920|10960347|FG000|Overall Study|Other than specified above|1
6929027|NCT00855920|10960348|FG001|Overall Study|Other than specified above|1
6929028|NCT00855920|10960349|FG002|Overall Study|Other than specified above|1
6929029|NCT00855933|10960359|FG000|Overall Study|Withdrawal by Subject|0
6929030|NCT00855933|10960360|FG001|Overall Study|Withdrawal by Subject|1
6929031|NCT00855959|10960366|FG000|Overall Study|Adverse Event|2
6929032|NCT00855959|10960366|FG000|Overall Study|Lost to Follow-up|2
6929033|NCT00855959|10960366|FG000|Overall Study|Withdrawal by Subject|3
6929034|NCT00855959|10960366|FG000|Overall Study|Pregnancy|1
6929035|NCT00855959|10960366|FG000|Overall Study|Incorrect enrolment|1
6929036|NCT00856180|10960380|FG000|Overall Study|Adverse Event|4
6929037|NCT00856180|10960380|FG000|Overall Study|Progressive Disease|16
6929038|NCT00856193|10960386|FG000|Period 2|Abnormal test procedure results|0
6929039|NCT00856193|10960387|FG001|Period 2|Abnormal test procedure results|1
6929040|NCT00856193|10960386|FG000|Period 2|Lost to Follow-up|0
6929041|NCT00856193|10960387|FG001|Period 2|Lost to Follow-up|1
6929042|NCT00856206|10960395|FG000|Overall Study|Protocol Violation|6
6929043|NCT00856206|10960396|FG001|Overall Study|Protocol Violation|18
6929044|NCT00856206|10960395|FG000|Overall Study|Adverse Event|10
6929045|NCT00856206|10960396|FG001|Overall Study|Adverse Event|46
6929046|NCT00856206|10960395|FG000|Overall Study|Lack of Efficacy|1
6929047|NCT00856206|10960396|FG001|Overall Study|Lack of Efficacy|2
6929048|NCT00856206|10960395|FG000|Overall Study|Withdrawal by Subject|15
6929049|NCT00856206|10960396|FG001|Overall Study|Withdrawal by Subject|36
6929050|NCT00856206|10960395|FG000|Overall Study|Lost to Follow-up|13
6929051|NCT00856206|10960396|FG001|Overall Study|Lost to Follow-up|39
6929052|NCT00856206|10960395|FG000|Overall Study|Death|2
6929053|NCT00856206|10960396|FG001|Overall Study|Death|2
6929054|NCT00856206|10960395|FG000|Overall Study|Decision by the Sponsor|4
6929055|NCT00856206|10960396|FG001|Overall Study|Decision by the Sponsor|8
6929056|NCT00856206|10960395|FG000|Overall Study|Other than specified above|3
6929057|NCT00856206|10960396|FG001|Overall Study|Other than specified above|10
6929058|NCT00856245|10960417|FG000|Overall Study|Was not transplanted|5
6929059|NCT00856284|10960424|FG000|Overall Study|Hyperglycemic rescue|231
6929060|NCT00856284|10960425|FG001|Overall Study|Hyperglycemic rescue|201
6929061|NCT00856284|10960426|FG002|Overall Study|Hyperglycemic rescue|235
6929062|NCT00856284|10960424|FG000|Overall Study|Adverse Event|60
6929063|NCT00856284|10960425|FG001|Overall Study|Adverse Event|74
6929064|NCT00856284|10960426|FG002|Overall Study|Adverse Event|82
6929065|NCT00856284|10960424|FG000|Overall Study|Major protocol deviation|24
6929066|NCT00856284|10960425|FG001|Overall Study|Major protocol deviation|16
6929067|NCT00856284|10960426|FG002|Overall Study|Major protocol deviation|15
6929068|NCT00856284|10960424|FG000|Overall Study|Lost to Follow-up|20
6929069|NCT00856284|10960425|FG001|Overall Study|Lost to Follow-up|22
6929070|NCT00856284|10960426|FG002|Overall Study|Lost to Follow-up|28
6929071|NCT00856284|10960424|FG000|Overall Study|Voluntary withdrawal|48
6929072|NCT00856284|10960425|FG001|Overall Study|Voluntary withdrawal|52
6929073|NCT00856284|10960426|FG002|Overall Study|Voluntary withdrawal|62
6929074|NCT00856284|10960424|FG000|Overall Study|Pregnancy|1
6929075|NCT00856284|10960425|FG001|Overall Study|Pregnancy|2
6929076|NCT00856284|10960426|FG002|Overall Study|Pregnancy|0
6929077|NCT00856284|10960424|FG000|Overall Study|Investigator discretion|9
6929078|NCT00856284|10960425|FG001|Overall Study|Investigator discretion|8
6929079|NCT00856284|10960426|FG002|Overall Study|Investigator discretion|10
6929080|NCT00856284|10960424|FG000|Overall Study|Other|15
6929081|NCT00856284|10960425|FG001|Overall Study|Other|17
6929082|NCT00856284|10960426|FG002|Overall Study|Other|14
6929083|NCT00856284|10960424|FG000|Overall Study|Randomized in error|0
6929084|NCT00856284|10960425|FG001|Overall Study|Randomized in error|0
6929085|NCT00856284|10960426|FG002|Overall Study|Randomized in error|1
6929086|NCT00856297|10960439|FG000|Overall Study|Unable to classify|2
6929087|NCT00856297|10960440|FG001|Overall Study|Unable to classify|0
6929088|NCT00856297|10960441|FG002|Overall Study|Unable to classify|0
6929089|NCT00856297|10960442|FG003|Overall Study|Unable to classify|0
6929090|NCT00856297|10960443|FG004|Overall Study|Unable to classify|0
6929091|NCT00856323|10960460|FG000|Overall Study|Withdrawal by Subject|2
6929092|NCT00856349|10960464|FG000|Overall Study|Death|418
6929093|NCT00856349|10960464|FG000|Overall Study|Withdrawal by Subject|116
6929094|NCT00856349|10960464|FG000|Overall Study|Lost to Follow-up|91
6929095|NCT00856349|10960464|FG000|Overall Study|Protocol Violation|38
6929096|NCT00856349|10960464|FG000|Overall Study|Physician Decision|13
6929097|NCT00856349|10960464|FG000|Overall Study|Subject relocation|104
6929098|NCT00856349|10960464|FG000|Overall Study|Device explant|33
6929099|NCT00856349|10960464|FG000|Overall Study|Site closure|78
6929100|NCT00856349|10960464|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130
6929101|NCT00856375|10960472|FG000|Overall Study|Other|0
6929102|NCT00856375|10960473|FG001|Overall Study|Other|1
6929103|NCT00856375|10960472|FG000|Overall Study|Death|32
6929104|NCT00856375|10960473|FG001|Overall Study|Death|30
6929105|NCT00856375|10960472|FG000|Overall Study|Sponsor Terminated Study|7
6929106|NCT00856375|10960473|FG001|Overall Study|Sponsor Terminated Study|7
6929107|NCT00856375|10960472|FG000|Overall Study|Withdrawal by Subject|2
6929108|NCT00856375|10960473|FG001|Overall Study|Withdrawal by Subject|1
6929109|NCT00856375|10960472|FG000|Overall Study|Lost to Follow-up|1
6929110|NCT00856375|10960473|FG001|Overall Study|Lost to Follow-up|2
6929111|NCT00856388|10960479|FG000|Overall Study|Other|1
6929112|NCT00856492|10960491|FG000|Overall Study|Ineligible or withdrew consent|1
6929113|NCT00856492|10960492|FG001|Overall Study|Ineligible or withdrew consent|1
6929114|NCT00856492|10960493|FG002|Overall Study|Ineligible or withdrew consent|2
6929115|NCT00856518|10960506|FG000|Overall Study|Lost to Follow-up|4
6929116|NCT00856518|10960507|FG001|Overall Study|Lost to Follow-up|2
6929117|NCT00856544|10960519|FG000|Overall Study|Randomized but not treated|3
6929118|NCT00856544|10960520|FG001|Overall Study|Randomized but not treated|0
6929119|NCT00856544|10960521|FG002|Overall Study|Randomized but not treated|0
6929120|NCT00856544|10960522|FG003|Overall Study|Randomized but not treated|0
6929121|NCT00856544|10960519|FG000|Overall Study|Death|0
6929122|NCT00856544|10960520|FG001|Overall Study|Death|2
6929123|NCT00856544|10960521|FG002|Overall Study|Death|0
6929124|NCT00856544|10960522|FG003|Overall Study|Death|0
6929125|NCT00856544|10960519|FG000|Overall Study|Adverse Event|20
6929126|NCT00856544|10960520|FG001|Overall Study|Adverse Event|29
6929127|NCT00856544|10960521|FG002|Overall Study|Adverse Event|2
6929128|NCT00856544|10960522|FG003|Overall Study|Adverse Event|3
6929129|NCT00856544|10960519|FG000|Overall Study|Lack of Efficacy|16
6929130|NCT00856544|10960520|FG001|Overall Study|Lack of Efficacy|12
6929131|NCT00856544|10960521|FG002|Overall Study|Lack of Efficacy|3
6929132|NCT00856544|10960522|FG003|Overall Study|Lack of Efficacy|3
6929133|NCT00856544|10960519|FG000|Overall Study|Other|9
6929134|NCT00856544|10960520|FG001|Overall Study|Other|16
6929135|NCT00856544|10960521|FG002|Overall Study|Other|1
6929136|NCT00856544|10960522|FG003|Overall Study|Other|6
6929137|NCT00856544|10960519|FG000|Overall Study|Lost to Follow-up|1
6929138|NCT00856544|10960520|FG001|Overall Study|Lost to Follow-up|2
6929139|NCT00856544|10960521|FG002|Overall Study|Lost to Follow-up|2
6929140|NCT00856544|10960522|FG003|Overall Study|Lost to Follow-up|0
6929141|NCT00856544|10960519|FG000|Overall Study|Withdrawal by Subject|8
6929142|NCT00856544|10960520|FG001|Overall Study|Withdrawal by Subject|5
6929143|NCT00856544|10960521|FG002|Overall Study|Withdrawal by Subject|0
6929144|NCT00856544|10960522|FG003|Overall Study|Withdrawal by Subject|1
6929145|NCT00856557|10960546|FG000|Overall Study|No patients with contextual flags|12
6929146|NCT00856557|10960547|FG001|Overall Study|No patients with contextual flags|16
6929147|NCT00856583|10960555|FG000|Overall Study|Lack of Efficacy|389
6929148|NCT00856583|10960556|FG001|Overall Study|Lack of Efficacy|377
6929149|NCT00856583|10960555|FG000|Overall Study|Serious Adverse Event (SAE)|99
6929150|NCT00856583|10960556|FG001|Overall Study|Serious Adverse Event (SAE)|65
6929151|NCT00856583|10960555|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393
6929152|NCT00856583|10960556|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179
6929153|NCT00856583|10960555|FG000|Overall Study|Non-compliance|305
6929154|NCT00856583|10960556|FG001|Overall Study|Non-compliance|262
6929155|NCT00856583|10960555|FG000|Overall Study|Withdrawal by Subject|1092
6929156|NCT00856583|10960556|FG001|Overall Study|Withdrawal by Subject|919
6929157|NCT00856583|10960555|FG000|Overall Study|Physician Decision|59
6929158|NCT00856583|10960556|FG001|Overall Study|Physician Decision|82
6929159|NCT00856583|10960555|FG000|Overall Study|Pregnancy|14
6929160|NCT00856583|10960556|FG001|Overall Study|Pregnancy|5
6929161|NCT00856583|10960555|FG000|Overall Study|Other|92
6929162|NCT00856583|10960556|FG001|Overall Study|Other|104
6929163|NCT00856583|10960555|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694
6929164|NCT00856583|10960556|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604
6929165|NCT00856609|10960564|FG000|Overall Study|Adverse Event|1
6929166|NCT00856609|10960565|FG001|Overall Study|Adverse Event|0
6929167|NCT00856635|10960573|FG000|Overall Study|Lost to Follow-up|2
6929168|NCT00856635|10960574|FG001|Overall Study|Lost to Follow-up|5
6929169|NCT00856635|10960573|FG000|Overall Study|Pregnancy|1
6929170|NCT00856635|10960574|FG001|Overall Study|Pregnancy|0
6929171|NCT00856635|10960573|FG000|Overall Study|Withdrawal by Subject|3
6929172|NCT00856635|10960574|FG001|Overall Study|Withdrawal by Subject|1
6929173|NCT00856635|10960573|FG000|Overall Study|Serious Adverse Event|1
6929174|NCT00856635|10960574|FG001|Overall Study|Serious Adverse Event|0
6929175|NCT00856635|10960573|FG000|Overall Study|Other|1
6929176|NCT00856635|10960574|FG001|Overall Study|Other|0
6929177|NCT00856635|10960573|FG000|Overall Study|Discontinued at Randomization|2
6929178|NCT00856635|10960574|FG001|Overall Study|Discontinued at Randomization|2
6929179|NCT00856661|10960584|FG000|Overall Study|Death|15
6929180|NCT00856661|10960585|FG001|Overall Study|Death|18
6929181|NCT00856661|10960584|FG000|Overall Study|Protocol Violation|2
6929182|NCT00856661|10960585|FG001|Overall Study|Protocol Violation|1
6929183|NCT00856661|10960584|FG000|Overall Study|Withdrawal by Subject|1
6929184|NCT00856661|10960585|FG001|Overall Study|Withdrawal by Subject|2
6929185|NCT00856661|10960584|FG000|Overall Study|Lost to Follow-up|1
6929186|NCT00856661|10960585|FG001|Overall Study|Lost to Follow-up|3
6929187|NCT00856661|10960584|FG000|Overall Study|Physician Judgement|8
6929188|NCT00856661|10960585|FG001|Overall Study|Physician Judgement|5
6929189|NCT00856778|10960611|FG000|Overall Study|Adverse Event|7
6929190|NCT00856778|10960611|FG000|Overall Study|Withdrawal by Subject|10
6929191|NCT00856778|10960611|FG000|Overall Study|Study deviation|2
6929192|NCT00856778|10960611|FG000|Overall Study|Lost to Follow-up|5
6929193|NCT00856830|10960623|FG000|Irinotecan & Bendamustine|Death|0
6929194|NCT00856830|10960624|FG001|Irinotecan & Bendamustine|Death|0
6929195|NCT00856830|10960625|FG002|Irinotecan & Bendamustine|Death|0
6929196|NCT00856830|10960626|FG003|Irinotecan & Bendamustine|Death|2
6929197|NCT00856830|10960623|FG000|Irinotecan & Bendamustine|Physician Decision|0
6929198|NCT00856830|10960624|FG001|Irinotecan & Bendamustine|Physician Decision|0
6929199|NCT00856830|10960625|FG002|Irinotecan & Bendamustine|Physician Decision|0
6929200|NCT00856830|10960626|FG003|Irinotecan & Bendamustine|Physician Decision|1
6929201|NCT00856843|10960633|FG000|Overall Study|Withdrawal by Subject|1
6929202|NCT00856843|10960634|FG001|Overall Study|Withdrawal by Subject|5
6929203|NCT00856843|10960633|FG000|Overall Study|Lack of Efficacy|1
6929204|NCT00856843|10960634|FG001|Overall Study|Lack of Efficacy|0
6929205|NCT00856856|10960640|FG000|2-year Clinical Follow-up|Lost to Follow-up|1
6929206|NCT00856856|10960640|FG000|4-year Clinical Follow-up|Missed visit|1
6929207|NCT00856908|10960651|FG000|Overall Study|Lost to Follow-up|1
6929208|NCT00856908|10960652|FG001|Overall Study|Lost to Follow-up|0
6929209|NCT00856973|10960661|FG000|Overall Study|Adverse Event|5
6929210|NCT00856973|10960662|FG001|Overall Study|Adverse Event|5
6929211|NCT00856973|10960663|FG002|Overall Study|Adverse Event|3
6929212|NCT00856973|10960661|FG000|Overall Study|Lost to Follow-up|6
6929213|NCT00856973|10960662|FG001|Overall Study|Lost to Follow-up|3
6929214|NCT00856973|10960663|FG002|Overall Study|Lost to Follow-up|5
6929215|NCT00856973|10960661|FG000|Overall Study|Physician Decision|0
6929216|NCT00856973|10960662|FG001|Overall Study|Physician Decision|3
6929217|NCT00856973|10960663|FG002|Overall Study|Physician Decision|1
6929218|NCT00856973|10960661|FG000|Overall Study|Protocol Violation|1
6929219|NCT00856973|10960662|FG001|Overall Study|Protocol Violation|2
6929220|NCT00856973|10960663|FG002|Overall Study|Protocol Violation|1
6929221|NCT00856973|10960661|FG000|Overall Study|Withdrawal by Subject|13
6929222|NCT00856973|10960662|FG001|Overall Study|Withdrawal by Subject|16
6929223|NCT00856973|10960663|FG002|Overall Study|Withdrawal by Subject|15
6929224|NCT00856973|10960661|FG000|Overall Study|Other|11
6929225|NCT00856973|10960662|FG001|Overall Study|Other|12
6929226|NCT00856973|10960663|FG002|Overall Study|Other|13
6929227|NCT00856986|10960680|FG000|Run-in Period, Weeks -12-0|Adverse Event|0
6929228|NCT00856986|10960681|FG001|Run-in Period, Weeks -12-0|Adverse Event|0
6929229|NCT00856986|10960682|FG002|Run-in Period, Weeks -12-0|Adverse Event|0
6929230|NCT00856986|10960683|FG003|Run-in Period, Weeks -12-0|Adverse Event|92
6929231|NCT00856986|10960684|FG004|Run-in Period, Weeks -12-0|Adverse Event|0
6929232|NCT00856986|10960680|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0
6929233|NCT00856986|10960681|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0
6929234|NCT00856986|10960682|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0
6929235|NCT00856986|10960683|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24
6929236|NCT00856986|10960684|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0
6929237|NCT00856986|10960680|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
6929238|NCT00856986|10960681|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
6929239|NCT00856986|10960682|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
6929240|NCT00856986|10960683|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10
6929241|NCT00856986|10960684|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
6929242|NCT00856986|10960680|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0
6929243|NCT00856986|10960681|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0
6929244|NCT00856986|10960682|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0
6929245|NCT00856986|10960683|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11
6929246|NCT00856986|10960684|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0
6929247|NCT00856986|10960680|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0
6929248|NCT00856986|10960681|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0
6929249|NCT00856986|10960682|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0
6929250|NCT00856986|10960683|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6
6929251|NCT00856986|10960684|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0
6929252|NCT00856986|10960680|FG000|Run-in Period, Weeks -12-0|Unclassified|0
6929253|NCT00856986|10960681|FG001|Run-in Period, Weeks -12-0|Unclassified|0
6929254|NCT00856986|10960682|FG002|Run-in Period, Weeks -12-0|Unclassified|0
6929255|NCT00856986|10960683|FG003|Run-in Period, Weeks -12-0|Unclassified|24
6929256|NCT00856986|10960684|FG004|Run-in Period, Weeks -12-0|Unclassified|0
6929257|NCT00856986|10960680|FG000|Main Period, Weeks 0-26|Adverse Event|6
6929258|NCT00856986|10960681|FG001|Main Period, Weeks 0-26|Adverse Event|4
6929259|NCT00856986|10960682|FG002|Main Period, Weeks 0-26|Adverse Event|9
6929260|NCT00856986|10960683|FG003|Main Period, Weeks 0-26|Adverse Event|0
6929261|NCT00856986|10960684|FG004|Main Period, Weeks 0-26|Adverse Event|0
6929262|NCT00856986|10960680|FG000|Main Period, Weeks 0-26|Protocol Violation|4
6929263|NCT00856986|10960681|FG001|Main Period, Weeks 0-26|Protocol Violation|5
6929264|NCT00856986|10960682|FG002|Main Period, Weeks 0-26|Protocol Violation|7
6929265|NCT00856986|10960683|FG003|Main Period, Weeks 0-26|Protocol Violation|0
6929266|NCT00856986|10960684|FG004|Main Period, Weeks 0-26|Protocol Violation|0
6929267|NCT00856986|10960680|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11
6929268|NCT00856986|10960681|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0
6929269|NCT00856986|10960682|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3
6929270|NCT00856986|10960683|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0
6929271|NCT00856986|10960684|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0
6929272|NCT00856986|10960680|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1
6929273|NCT00856986|10960681|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1
6929274|NCT00856986|10960682|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2
6929275|NCT00856986|10960683|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0
6929276|NCT00856986|10960684|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0
6929277|NCT00856986|10960680|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5
6929278|NCT00856986|10960681|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2
6929279|NCT00856986|10960682|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0
6929280|NCT00856986|10960683|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0
6929281|NCT00856986|10960684|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0
6929282|NCT00856986|10960680|FG000|Main Period, Weeks 0-26|Unclassified|7
6929283|NCT00856986|10960681|FG001|Main Period, Weeks 0-26|Unclassified|6
6929284|NCT00856986|10960682|FG002|Main Period, Weeks 0-26|Unclassified|7
6929285|NCT00856986|10960683|FG003|Main Period, Weeks 0-26|Unclassified|0
6929286|NCT00856986|10960684|FG004|Main Period, Weeks 0-26|Unclassified|0
6929287|NCT00856986|10960680|FG000|Extension Period, Weeks 26-52|Adverse Event|3
6929288|NCT00856986|10960681|FG001|Extension Period, Weeks 26-52|Adverse Event|3
6929289|NCT00856986|10960682|FG002|Extension Period, Weeks 26-52|Adverse Event|10
6929290|NCT00856986|10960683|FG003|Extension Period, Weeks 26-52|Adverse Event|0
6929291|NCT00856986|10960684|FG004|Extension Period, Weeks 26-52|Adverse Event|0
6929292|NCT00856986|10960680|FG000|Extension Period, Weeks 26-52|Protocol Violation|6
6929293|NCT00856986|10960681|FG001|Extension Period, Weeks 26-52|Protocol Violation|2
6929294|NCT00856986|10960682|FG002|Extension Period, Weeks 26-52|Protocol Violation|5
6929295|NCT00856986|10960683|FG003|Extension Period, Weeks 26-52|Protocol Violation|0
6929296|NCT00856986|10960684|FG004|Extension Period, Weeks 26-52|Protocol Violation|0
6929297|NCT00856986|10960680|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2
6929298|NCT00856986|10960681|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0
6929299|NCT00856986|10960682|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8
6929300|NCT00856986|10960683|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0
6929301|NCT00856986|10960684|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0
6929302|NCT00856986|10960680|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0
6929303|NCT00856986|10960681|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5
6929304|NCT00856986|10960682|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2
6929305|NCT00856986|10960683|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0
6929306|NCT00856986|10960684|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0
6929307|NCT00856986|10960680|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4
6929308|NCT00856986|10960681|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2
6929309|NCT00856986|10960682|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2
6929310|NCT00856986|10960683|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0
6929311|NCT00856986|10960684|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0
6929312|NCT00856986|10960680|FG000|Extension Period, Weeks 26-52|Unclassified|4
6929313|NCT00856986|10960681|FG001|Extension Period, Weeks 26-52|Unclassified|2
6929314|NCT00856986|10960682|FG002|Extension Period, Weeks 26-52|Unclassified|11
6929315|NCT00856986|10960683|FG003|Extension Period, Weeks 26-52|Unclassified|0
6929316|NCT00856986|10960684|FG004|Extension Period, Weeks 26-52|Unclassified|0
6929317|NCT00856999|10960696|FG000|Overall Study|Withdrawal by Subject|5
6929318|NCT00857207|10960703|FG000|Overall Study|Withdrawal by Subject|13
6929319|NCT00857207|10960704|FG001|Overall Study|Withdrawal by Subject|0
6929320|NCT00857207|10960703|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18
6929321|NCT00857207|10960704|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0
6929322|NCT00857207|10960703|FG000|Overall Study|Subject chose not to participate after signing consent|3
6929323|NCT00857207|10960704|FG001|Overall Study|Subject chose not to participate after signing consent|0
6929324|NCT00857220|10960711|FG000|Overall Study|Adverse Event|35
6929325|NCT00857220|10960711|FG000|Overall Study|Death|1
6929326|NCT00857220|10960711|FG000|Overall Study|Lack of Efficacy|11
6929327|NCT00857220|10960711|FG000|Overall Study|Lost to Follow-up|30
6929328|NCT00857220|10960711|FG000|Overall Study|Physician Decision|4
7065189|NCT01964326|11164532|FG000|Overall Study|Lost to Follow-up|88
7065190|NCT01964326|11164532|FG000|Overall Study|Withdrawal by Subject|87
7065191|NCT01964326|11164532|FG000|Overall Study|Pregnancy|1
7065192|NCT01964326|11164532|FG000|Overall Study|No Longer Meets Eligibility Criteria|1
7065193|NCT01964326|11164532|FG000|Overall Study|Physician Decision|55
7065194|NCT01964326|11164532|FG000|Overall Study|Investigator Discretion|1
7065195|NCT01964326|11164532|FG000|Overall Study|Other|9
7065196|NCT01964326|11164532|FG000|Overall Study|Did not meet eligibility criteria|1
7065197|NCT01964352|11164540|FG000|Overall Study|Adverse Event|13
7065198|NCT01964352|11164541|FG001|Overall Study|Adverse Event|3
7065199|NCT01964352|11164542|FG002|Overall Study|Adverse Event|4
7065200|NCT01964352|11164543|FG003|Overall Study|Adverse Event|3
7065201|NCT01964352|11164540|FG000|Overall Study|Lack of Efficacy|6
7065202|NCT01964352|11164541|FG001|Overall Study|Lack of Efficacy|0
7065203|NCT01964352|11164542|FG002|Overall Study|Lack of Efficacy|0
7065204|NCT01964352|11164543|FG003|Overall Study|Lack of Efficacy|0
7065205|NCT01964352|11164540|FG000|Overall Study|Protocol Violation|2
7065206|NCT01964352|11164541|FG001|Overall Study|Protocol Violation|4
7065207|NCT01964352|11164542|FG002|Overall Study|Protocol Violation|0
7065208|NCT01964352|11164543|FG003|Overall Study|Protocol Violation|2
7065209|NCT01964352|11164540|FG000|Overall Study|Lost to Follow-up|1
7065210|NCT01964352|11164541|FG001|Overall Study|Lost to Follow-up|0
7065211|NCT01964352|11164542|FG002|Overall Study|Lost to Follow-up|0
7065212|NCT01964352|11164543|FG003|Overall Study|Lost to Follow-up|1
7065213|NCT01964352|11164540|FG000|Overall Study|Withdrawal by Subject|4
7065214|NCT01964352|11164541|FG001|Overall Study|Withdrawal by Subject|2
7065215|NCT01964352|11164542|FG002|Overall Study|Withdrawal by Subject|1
7065216|NCT01964352|11164543|FG003|Overall Study|Withdrawal by Subject|0
7065217|NCT01964352|11164540|FG000|Overall Study|Other than stated above|0
7065218|NCT01964352|11164541|FG001|Overall Study|Other than stated above|2
7065219|NCT01964352|11164542|FG002|Overall Study|Other than stated above|1
7065220|NCT01964352|11164543|FG003|Overall Study|Other than stated above|2
7065221|NCT01964378|11164555|FG000|Overall Study|Disc. due to death before first dosing|0
7065222|NCT01964378|11164556|FG001|Overall Study|Disc. due to death before first dosing|1
7065223|NCT01964378|11164555|FG000|Overall Study|Disc. due to AE before first dosing|1
7065224|NCT01964378|11164556|FG001|Overall Study|Disc. due to AE before first dosing|0
7065225|NCT01964378|11164555|FG000|Overall Study|Death|3
7065226|NCT01964378|11164556|FG001|Overall Study|Death|2
7065227|NCT01964378|11164555|FG000|Overall Study|Adverse Event|12
7065228|NCT01964378|11164556|FG001|Overall Study|Adverse Event|5
7065229|NCT01964378|11164555|FG000|Overall Study|Lack of Efficacy|0
7065230|NCT01964378|11164556|FG001|Overall Study|Lack of Efficacy|1
7065231|NCT01964378|11164555|FG000|Overall Study|Protocol Violation|0
7065232|NCT01964378|11164556|FG001|Overall Study|Protocol Violation|1
7065233|NCT01964378|11164555|FG000|Overall Study|Lost to Follow-up|0
7065234|NCT01964378|11164556|FG001|Overall Study|Lost to Follow-up|1
7065235|NCT01964378|11164555|FG000|Overall Study|Withdrawal by Subject|7
7065236|NCT01964378|11164556|FG001|Overall Study|Withdrawal by Subject|5
7065237|NCT01964378|11164555|FG000|Overall Study|Inclusion/exclusion criteria not met|1
7065238|NCT01964378|11164556|FG001|Overall Study|Inclusion/exclusion criteria not met|3
7065239|NCT01964378|11164555|FG000|Overall Study|Other|1
7065240|NCT01964378|11164556|FG001|Overall Study|Other|2
7065241|NCT01964430|11164564|FG000|Overall Study|Adverse Event|71
7065242|NCT01964430|11164565|FG001|Overall Study|Adverse Event|37
7065243|NCT01964430|11164564|FG000|Overall Study|Withdrawal by Subject|36
7065244|NCT01964430|11164565|FG001|Overall Study|Withdrawal by Subject|27
7065245|NCT01964430|11164564|FG000|Overall Study|Death|1
7065246|NCT01964430|11164565|FG001|Overall Study|Death|3
7065247|NCT01964430|11164564|FG000|Overall Study|Protocol Deviation|0
7065248|NCT01964430|11164565|FG001|Overall Study|Protocol Deviation|1
6929329|NCT00857220|10960711|FG000|Overall Study|Protocol Violation|16
7065249|NCT01964430|11164564|FG000|Overall Study|Physician Decision|5
7065250|NCT01964430|11164565|FG001|Overall Study|Physician Decision|4
7065251|NCT01964430|11164564|FG000|Overall Study|Disease Relapse|28
7065252|NCT01964430|11164565|FG001|Overall Study|Disease Relapse|38
7065253|NCT01964430|11164564|FG000|Overall Study|Miscellaneous|1
7065254|NCT01964430|11164565|FG001|Overall Study|Miscellaneous|3
7065255|NCT01964430|11164564|FG000|Overall Study|Randomized but not Treated|3
7065256|NCT01964430|11164565|FG001|Overall Study|Randomized but not Treated|11
7065257|NCT01964521|11164571|FG000|Overall Study|Lost to Follow-up|4
7065258|NCT01964547|11164578|FG000|Overall Study|Adverse Event|8
7065259|NCT01964547|11164579|FG001|Overall Study|Adverse Event|2
7065260|NCT01964547|11164578|FG000|Overall Study|Withdrawal by Subject|4
7065261|NCT01964547|11164579|FG001|Overall Study|Withdrawal by Subject|7
7065262|NCT01964547|11164578|FG000|Overall Study|Lost to Follow-up|0
6929330|NCT00857220|10960711|FG000|Overall Study|Withdrawal by Subject|67
7065263|NCT01964547|11164579|FG001|Overall Study|Lost to Follow-up|1
7065264|NCT01964547|11164578|FG000|Overall Study|Withdrawal by Investigator|0
7065265|NCT01964547|11164579|FG001|Overall Study|Withdrawal by Investigator|1
7065266|NCT01964716|11164587|FG000|Overall Study|Withdrawal by Subject|2
7065267|NCT01964716|11164588|FG001|Overall Study|Withdrawal by Subject|3
7065268|NCT01964716|11164587|FG000|Overall Study|Lost to Follow-up|1
7065269|NCT01964716|11164588|FG001|Overall Study|Lost to Follow-up|2
7065270|NCT01964716|11164587|FG000|Overall Study|No longer met eligibility criteria|1
7065271|NCT01964716|11164588|FG001|Overall Study|No longer met eligibility criteria|1
7065272|NCT01964716|11164587|FG000|Overall Study|Death|1
7065273|NCT01964716|11164588|FG001|Overall Study|Death|0
7065274|NCT01964755|11164602|FG000|Overall Study|Death|2
7065275|NCT01964898|11164608|FG000|Overall Study|ineligible post-randomization|1
7065276|NCT01964898|11164609|FG001|Overall Study|ineligible post-randomization|1
7065277|NCT01964898|11164608|FG000|Overall Study|did not receive the allocated interventi|2
7065278|NCT01964898|11164609|FG001|Overall Study|did not receive the allocated interventi|1
7065279|NCT01964898|11164608|FG000|Overall Study|Lost to Follow-up|3
7065280|NCT01964898|11164609|FG001|Overall Study|Lost to Follow-up|5
7065281|NCT01964898|11164608|FG000|Overall Study|Withdrawal by Subject|1
7065282|NCT01964898|11164609|FG001|Overall Study|Withdrawal by Subject|0
7065283|NCT01964924|11164615|FG000|Trametinib Monotherapy|Progression|19
7065284|NCT01964924|11164616|FG001|Trametinib Monotherapy|Progression|0
7065285|NCT01964950|11164627|FG000|Overall Study|Protocol Violation|25
7065286|NCT01964963|11164634|FG000|Overall Study|Case Report Forms Uncollected|888
7065287|NCT01964963|11164634|FG000|Overall Study|Protocol Deviation|50
7065288|NCT01964963|11164634|FG000|Overall Study|Data Reliability was not Assured|5
7065289|NCT01964976|11164640|FG000|Overall Study|Protocol Violation|31
7065290|NCT01965158|11164664|FG000|Overall Study|Adverse Event|14
7065291|NCT01965158|11164665|FG001|Overall Study|Adverse Event|5
7065292|NCT01965158|11164664|FG000|Overall Study|Withdrawal by Subject|16
7065293|NCT01965158|11164665|FG001|Overall Study|Withdrawal by Subject|24
7065294|NCT01965158|11164664|FG000|Overall Study|Lost to Follow-up|7
7065295|NCT01965158|11164665|FG001|Overall Study|Lost to Follow-up|5
7065296|NCT01965158|11164664|FG000|Overall Study|Protocol Violation|1
7065297|NCT01965158|11164665|FG001|Overall Study|Protocol Violation|1
7065298|NCT01965158|11164664|FG000|Overall Study|Other - Miscellaneous|3
7065299|NCT01965158|11164665|FG001|Overall Study|Other - Miscellaneous|0
7065300|NCT01965262|11164671|FG000|Second Intervention (7 Days)|Discontinued|0
7065301|NCT01965262|11164672|FG001|Second Intervention (7 Days)|Discontinued|1
7065302|NCT01965262|11164671|FG000|Second Intervention (7 Days)|Poor lens fit|0
7065303|NCT01965262|11164672|FG001|Second Intervention (7 Days)|Poor lens fit|9
7065304|NCT01965262|11164671|FG000|Second Intervention (7 Days)|Poor visual acuity|1
7065305|NCT01965262|11164672|FG001|Second Intervention (7 Days)|Poor visual acuity|0
7065306|NCT01965327|11164699|FG000|Overall Study|Physician Decision|2
7065307|NCT01965431|11164712|FG000|Overall Study|Adverse Event|0
7065308|NCT01965431|11164713|FG001|Overall Study|Adverse Event|1
7065309|NCT01965431|11164714|FG002|Overall Study|Adverse Event|0
7065310|NCT01965431|11164715|FG003|Overall Study|Adverse Event|0
7065311|NCT01965431|11164716|FG004|Overall Study|Adverse Event|0
7065312|NCT01965431|11164717|FG005|Overall Study|Adverse Event|0
7065313|NCT01965431|11164712|FG000|Overall Study|Other than stated above|6
7065314|NCT01965431|11164713|FG001|Overall Study|Other than stated above|5
7065315|NCT01965431|11164714|FG002|Overall Study|Other than stated above|6
7065316|NCT01965431|11164715|FG003|Overall Study|Other than stated above|6
7065317|NCT01965431|11164716|FG004|Overall Study|Other than stated above|6
7065318|NCT01965431|11164717|FG005|Overall Study|Other than stated above|6
7065319|NCT01965535|11164729|FG000|Overall Study|Lack of Efficacy|2
7065320|NCT01965535|11164730|FG001|Overall Study|Lack of Efficacy|1
7065321|NCT01965600|11164743|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
7065322|NCT01965600|11164744|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3
7065323|NCT01965600|11164745|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2
7065324|NCT01965600|11164746|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
7065325|NCT01965600|11164743|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
7065326|NCT01965600|11164744|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1
7065327|NCT01965600|11164745|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
7065328|NCT01965600|11164746|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
7065329|NCT01965600|11164743|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1
7065330|NCT01965600|11164744|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
7065331|NCT01965600|11164745|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
7065332|NCT01965600|11164746|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
7065333|NCT01965600|11164743|FG000|Washout Period of Approximately 15 Days|Adverse Event|0
7065334|NCT01965600|11164744|FG001|Washout Period of Approximately 15 Days|Adverse Event|0
7065335|NCT01965600|11164745|FG002|Washout Period of Approximately 15 Days|Adverse Event|0
7065336|NCT01965600|11164746|FG003|Washout Period of Approximately 15 Days|Adverse Event|1
7065337|NCT01965600|11164743|FG000|Second Intervention|Study terminated by Sponsor|0
7065338|NCT01965600|11164744|FG001|Second Intervention|Study terminated by Sponsor|0
7065339|NCT01965600|11164745|FG002|Second Intervention|Study terminated by Sponsor|2
7065340|NCT01965600|11164746|FG003|Second Intervention|Study terminated by Sponsor|2
7039623|NCT01712061|11122392|FG002|Overall Study|Medication Error Without Associated AE|0
7039624|NCT01712061|11122390|FG000|Overall Study|Withdrawal by Subject|1
7039625|NCT01712061|11122391|FG001|Overall Study|Withdrawal by Subject|7
7039626|NCT01712061|11122392|FG002|Overall Study|Withdrawal by Subject|1
7039627|NCT01712061|11122390|FG000|Overall Study|Other|0
7039628|NCT01712061|11122391|FG001|Overall Study|Other|3
7039629|NCT01712061|11122392|FG002|Overall Study|Other|0
7039630|NCT01712074|11122404|FG000|Placebo Run-in Period|Adverse Event|2
7039631|NCT01712074|11122405|FG001|Placebo Run-in Period|Adverse Event|0
7065341|NCT01965652|11164756|FG000|Overall Study|Adverse Event|40
7065342|NCT01965652|11164757|FG001|Overall Study|Adverse Event|37
7065343|NCT01965652|11164756|FG000|Overall Study|Withdrawal by Subject|62
7065344|NCT01965652|11164757|FG001|Overall Study|Withdrawal by Subject|69
7065345|NCT01965652|11164756|FG000|Overall Study|Lost to Follow-up|53
7065346|NCT01965652|11164757|FG001|Overall Study|Lost to Follow-up|40
7065347|NCT01965652|11164756|FG000|Overall Study|Protocol Violation|34
7065348|NCT01965652|11164757|FG001|Overall Study|Protocol Violation|38
6929331|NCT00857220|10960711|FG000|Overall Study|Clinical Hold|6
6929332|NCT00857220|10960711|FG000|Overall Study|Site Closed|5
6929333|NCT00857220|10960711|FG000|Overall Study|Miscellaneous|8
7039632|NCT01712074|11122406|FG002|Placebo Run-in Period|Adverse Event|0
7039633|NCT01712074|11122404|FG000|Placebo Run-in Period|Lost to Follow-up|1
7039634|NCT01712074|11122405|FG001|Placebo Run-in Period|Lost to Follow-up|0
7039635|NCT01712074|11122406|FG002|Placebo Run-in Period|Lost to Follow-up|0
7039636|NCT01712074|11122404|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5
7039637|NCT01712074|11122405|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0
7039638|NCT01712074|11122406|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0
7039639|NCT01712074|11122404|FG000|Placebo Run-in Period|Other|1
7039640|NCT01712074|11122405|FG001|Placebo Run-in Period|Other|0
7039641|NCT01712074|11122406|FG002|Placebo Run-in Period|Other|0
7039642|NCT01712074|11122404|FG000|Placebo Run-in Period|No longer willing to participate|1
7039643|NCT01712074|11122405|FG001|Placebo Run-in Period|No longer willing to participate|0
7039644|NCT01712074|11122406|FG002|Placebo Run-in Period|No longer willing to participate|0
7039645|NCT01712074|11122404|FG000|Double Blind Period|Adverse Event|0
7039646|NCT01712074|11122405|FG001|Double Blind Period|Adverse Event|2
7039647|NCT01712074|11122406|FG002|Double Blind Period|Adverse Event|1
7039648|NCT01712074|11122404|FG000|Double Blind Period|No longer willing to participate|0
7039649|NCT01712074|11122405|FG001|Double Blind Period|No longer willing to participate|2
7039650|NCT01712074|11122406|FG002|Double Blind Period|No longer willing to participate|4
7039651|NCT01712074|11122404|FG000|Double Blind Period|Death|0
7039652|NCT01712074|11122405|FG001|Double Blind Period|Death|1
7039653|NCT01712074|11122406|FG002|Double Blind Period|Death|0
7039654|NCT01712074|11122404|FG000|Double Blind Period|Lost to Follow-up|0
7039655|NCT01712074|11122405|FG001|Double Blind Period|Lost to Follow-up|2
7039656|NCT01712074|11122406|FG002|Double Blind Period|Lost to Follow-up|1
7039657|NCT01712074|11122404|FG000|Double Blind Period|Other|0
7039658|NCT01712074|11122405|FG001|Double Blind Period|Other|4
7039659|NCT01712074|11122406|FG002|Double Blind Period|Other|1
7039660|NCT01712074|11122404|FG000|Double Blind Period|Protocol Violation|0
7039661|NCT01712074|11122405|FG001|Double Blind Period|Protocol Violation|0
7039662|NCT01712074|11122406|FG002|Double Blind Period|Protocol Violation|1
6929334|NCT00857233|10960715|FG000|Overall Study|Adverse Event|24
6929335|NCT00857233|10960715|FG000|Overall Study|Lack of Efficacy|1
6929336|NCT00857233|10960715|FG000|Overall Study|Non-compliance|1
6929337|NCT00857233|10960715|FG000|Overall Study|Withdrawal of Consent|9
6929338|NCT00857233|10960715|FG000|Overall Study|Lost to Follow-up|4
6929339|NCT00857233|10960715|FG000|Overall Study|Nursing Home Placement|14
6929340|NCT00857233|10960715|FG000|Overall Study|Other Reasons|2
6929341|NCT00857246|10960719|FG000|Induction Regimen|Adverse Event|1
6929342|NCT00857246|10960719|FG000|Induction Regimen|disease-related complications|1
6929343|NCT00857246|10960719|FG000|Induction Regimen|Withdrawal by Subject|1
6929344|NCT00857246|10960719|FG000|Surgery (Curative)|disease progression|6
6929345|NCT00857246|10960719|FG000|ChemoRT|Withdrawal by Subject|1
6929346|NCT00857246|10960719|FG000|ChemoRT|Adverse Event|2
6929347|NCT00857259|10960729|FG000|Overall Study|Protocol Violation|1
6929348|NCT00857259|10960730|FG001|Overall Study|Protocol Violation|0
6929349|NCT00857259|10960731|FG002|Overall Study|Protocol Violation|1
6929350|NCT00857311|10960754|FG000|Overall Study|Lost to Follow-up|1
6929351|NCT00857311|10960755|FG001|Overall Study|Lost to Follow-up|0
6929352|NCT00857311|10960756|FG002|Overall Study|Lost to Follow-up|0
6929353|NCT00857311|10960757|FG003|Overall Study|Lost to Follow-up|0
6929354|NCT00857389|10960763|FG000|Overall Study|Did not proceed to transplant|2
7065349|NCT01965652|11164756|FG000|Overall Study|Death|3
6929355|NCT00857415|10960769|FG000|Overall Study|Image acquisition failure|2
6929356|NCT00857415|10960770|FG001|Overall Study|Image acquisition failure|0
6929357|NCT00857415|10960769|FG000|Overall Study|Invalid image or not imaged|3
6929358|NCT00857415|10960770|FG001|Overall Study|Invalid image or not imaged|0
7039663|NCT01712074|11122404|FG000|Double Blind Period|No longer met eligibility criteria|0
7039664|NCT01712074|11122405|FG001|Double Blind Period|No longer met eligibility criteria|3
7039665|NCT01712074|11122406|FG002|Double Blind Period|No longer met eligibility criteria|0
7039666|NCT01712178|11122423|FG000|Overall Study|Withdrew consent due to an adverse event|1
6929359|NCT00857415|10960769|FG000|Overall Study|Subject still living at end of study|110
6929360|NCT00857415|10960770|FG001|Overall Study|Subject still living at end of study|0
6929361|NCT00857415|10960769|FG000|Overall Study|Deceased with no autopsy|2
6929362|NCT00857415|10960770|FG001|Overall Study|Deceased with no autopsy|0
6929363|NCT00857454|10960776|FG000|Overall Study|Withdrawal by Subject|2
6929364|NCT00857454|10960776|FG000|Overall Study|Lost to Follow-up|1
6929365|NCT00857454|10960776|FG000|Overall Study|Adverse Event|2
6929366|NCT00857454|10960776|FG000|Overall Study|Total Testosterone >1050 ng/dL|1
6929367|NCT00857454|10960776|FG000|Overall Study|Total Testosterone <300 ng/dL|8
6929368|NCT00857454|10960776|FG000|Overall Study|MTE09 enrollment criteria not met|6
6929369|NCT00857584|10960832|FG000|Overall Study|Lack of Efficacy|1
6929370|NCT00857584|10960833|FG001|Overall Study|Lack of Efficacy|2
6929371|NCT00857584|10960832|FG000|Overall Study|Adverse Event|2
6929372|NCT00857584|10960833|FG001|Overall Study|Adverse Event|2
6929373|NCT00857584|10960832|FG000|Overall Study|Physician Decision|1
6929374|NCT00857584|10960833|FG001|Overall Study|Physician Decision|1
6929375|NCT00857623|10960841|FG000|Overall Study|Adverse Event|5
6929376|NCT00857623|10960842|FG001|Overall Study|Adverse Event|2
6929377|NCT00857623|10960841|FG000|Overall Study|Study-specific discontinuation criteria|5
6929378|NCT00857623|10960842|FG001|Overall Study|Study-specific discontinuation criteria|3
6929379|NCT00857623|10960841|FG000|Overall Study|Withdrawal by Subject|2
6929380|NCT00857623|10960842|FG001|Overall Study|Withdrawal by Subject|1
6929381|NCT00857623|10960841|FG000|Overall Study|Lack of Efficacy|1
6929382|NCT00857623|10960842|FG001|Overall Study|Lack of Efficacy|1
6929383|NCT00857623|10960841|FG000|Overall Study|Severe non-compliance to protocol|1
6929384|NCT00857623|10960842|FG001|Overall Study|Severe non-compliance to protocol|1
6929385|NCT00857623|10960841|FG000|Overall Study|Intake of prohibited medication|0
6929386|NCT00857623|10960842|FG001|Overall Study|Intake of prohibited medication|1
6929387|NCT00857623|10960841|FG000|Overall Study|Positive for HEP C|0
6929388|NCT00857623|10960842|FG001|Overall Study|Positive for HEP C|1
6929389|NCT00857649|10960850|FG000|Overall Study|Adverse Event|15
6929390|NCT00857649|10960851|FG001|Overall Study|Adverse Event|10
6929391|NCT00857649|10960850|FG000|Overall Study|Non-compliance|1
6929392|NCT00857649|10960851|FG001|Overall Study|Non-compliance|1
6929393|NCT00857649|10960850|FG000|Overall Study|Protocol Violation|2
6929394|NCT00857649|10960851|FG001|Overall Study|Protocol Violation|2
6929395|NCT00857649|10960850|FG000|Overall Study|Withdrawal of Consent|10
6929396|NCT00857649|10960851|FG001|Overall Study|Withdrawal of Consent|7
6929397|NCT00857649|10960850|FG000|Overall Study|Nursing Home Placement|2
6929398|NCT00857649|10960851|FG001|Overall Study|Nursing Home Placement|9
6929399|NCT00857649|10960850|FG000|Overall Study|Other Reasons|1
6929400|NCT00857649|10960851|FG001|Overall Study|Other Reasons|3
6929401|NCT00857766|10960872|FG000|Overall Study|Adverse Event|13
6929402|NCT00857766|10960873|FG001|Overall Study|Adverse Event|12
6929403|NCT00857766|10960872|FG000|Overall Study|Protocol Violation|11
6929404|NCT00857766|10960873|FG001|Overall Study|Protocol Violation|11
6929405|NCT00857766|10960872|FG000|Overall Study|Lost to Follow-up|1
6929406|NCT00857766|10960873|FG001|Overall Study|Lost to Follow-up|0
6929407|NCT00857766|10960872|FG000|Overall Study|Investigator Discretion|2
6929408|NCT00857766|10960873|FG001|Overall Study|Investigator Discretion|3
6929409|NCT00857766|10960872|FG000|Overall Study|Participant Withdrew Consent|4
6929410|NCT00857766|10960873|FG001|Overall Study|Participant Withdrew Consent|4
6929411|NCT00857792|10960879|FG000|Overall Study|inadequate image quality for analysis|12
6929412|NCT00857818|10960885|FG000|Overall Study|Lack of Efficacy|1
6929413|NCT00857818|10960886|FG001|Overall Study|Lack of Efficacy|0
6929414|NCT00857818|10960885|FG000|Overall Study|Adverse Event|3
6929415|NCT00857818|10960886|FG001|Overall Study|Adverse Event|0
6929416|NCT00857818|10960885|FG000|Overall Study|Withdrawal by Subject|0
6929417|NCT00857818|10960886|FG001|Overall Study|Withdrawal by Subject|4
6929418|NCT00857818|10960885|FG000|Overall Study|Sponsor terminated study|6
6929419|NCT00857818|10960886|FG001|Overall Study|Sponsor terminated study|4
6929420|NCT00857818|10960885|FG000|Overall Study|Investigator decision|1
6929421|NCT00857818|10960886|FG001|Overall Study|Investigator decision|0
6929422|NCT00857896|10960904|FG000|Baseline to Week 4|Withdrawal by Subject|1
6929423|NCT00857948|10960913|FG000|Overall Study|Withdrawal by Subject|2
6929424|NCT00857948|10960914|FG001|Overall Study|Withdrawal by Subject|0
6929425|NCT00857948|10960915|FG002|Overall Study|Withdrawal by Subject|0
6929426|NCT00857948|10960916|FG003|Overall Study|Withdrawal by Subject|0
6929427|NCT00857948|10960913|FG000|Overall Study|Protocol Violation|1
6929428|NCT00857948|10960914|FG001|Overall Study|Protocol Violation|0
6929429|NCT00857948|10960915|FG002|Overall Study|Protocol Violation|1
6929430|NCT00857948|10960916|FG003|Overall Study|Protocol Violation|0
6929431|NCT00858117|10960945|FG000|Treatment on Study|Adverse Event|2
6929432|NCT00858117|10960945|FG000|Follow up for 5 Years|Death|4
6929433|NCT00858117|10960945|FG000|Follow up for 5 Years|No further data collected for study|9
6929434|NCT00858143|10960954|FG000|Overall Study|Adverse Event|16
6929435|NCT00858143|10960954|FG000|Overall Study|Lack of Efficacy|4
6929436|NCT00858143|10960954|FG000|Overall Study|Death|7
6929437|NCT00858143|10960954|FG000|Overall Study|Other|23
6929438|NCT00858208|10960958|FG000|Overall Study|Adverse Event|3
6929439|NCT00858208|10960958|FG000|Overall Study|Lost to Follow-up|26
6929440|NCT00858208|10960958|FG000|Overall Study|Participant refused|40
6929441|NCT00858208|10960958|FG000|Overall Study|Other|10
6929442|NCT00858234|10960962|FG000|Overall Study|Adverse Event|6
6929443|NCT00858234|10960962|FG000|Overall Study|Progressive disease|2
6929444|NCT00858234|10960962|FG000|Overall Study|Status unknown|1
6929445|NCT00858247|10960968|FG000|Baseline Assessment|Withdrawal by Subject|1
6929446|NCT00858247|10960969|FG001|Baseline Assessment|Withdrawal by Subject|1
6929447|NCT00858247|10960968|FG000|Baseline Assessment|Poor IV access|1
6929448|NCT00858247|10960969|FG001|Baseline Assessment|Poor IV access|0
6929449|NCT00858247|10960968|FG000|Baseline Assessment|Protocol Violation|0
6929450|NCT00858247|10960969|FG001|Baseline Assessment|Protocol Violation|1
6929451|NCT00858247|10960968|FG000|Week 12 Follow-up|Withdrawal by Subject|0
6929452|NCT00858247|10960969|FG001|Week 12 Follow-up|Withdrawal by Subject|1
6929453|NCT00858364|10960977|FG000|Overall Study|Administrative Decision|3
6929454|NCT00858364|10960978|FG001|Overall Study|Administrative Decision|2
6929455|NCT00858364|10960977|FG000|Overall Study|Adverse Event|5
6929456|NCT00858364|10960978|FG001|Overall Study|Adverse Event|2
6929457|NCT00858364|10960977|FG000|Overall Study|Withdrawal by Subject|44
6929458|NCT00858364|10960978|FG001|Overall Study|Withdrawal by Subject|118
6929459|NCT00858364|10960977|FG000|Overall Study|Ineligibility Determined|1
6929460|NCT00858364|10960978|FG001|Overall Study|Ineligibility Determined|10
6929461|NCT00858364|10960977|FG000|Overall Study|Lost to Follow-up|24
6929462|NCT00858364|10960978|FG001|Overall Study|Lost to Follow-up|54
6929463|NCT00858364|10960977|FG000|Overall Study|Noncompliance|3
6929464|NCT00858364|10960978|FG001|Overall Study|Noncompliance|4
6929465|NCT00858364|10960977|FG000|Overall Study|Protocol Deviation|0
6929466|NCT00858364|10960978|FG001|Overall Study|Protocol Deviation|2
6929467|NCT00858364|10960977|FG000|Overall Study|Other|9
6929468|NCT00858364|10960978|FG001|Overall Study|Other|17
6929469|NCT00858364|10960977|FG000|Overall Study|Missing|1
6929470|NCT00858364|10960978|FG001|Overall Study|Missing|1
6929471|NCT00858364|10960977|FG000|Overall Study|Still on-study|114
6929472|NCT00858364|10960978|FG001|Overall Study|Still on-study|247
6929473|NCT00858403|10960993|FG000|Overall Study|Withdrawal by Subject|1
6929474|NCT00858403|10960993|FG000|Overall Study|Death|3
6929475|NCT00858403|10960993|FG000|Overall Study|Disease Progression|1
6929476|NCT00858442|10960999|FG000|Compression:Start to Finish|Lost to Follow-up|1
6929477|NCT00858442|10961000|FG001|Compression:Start to Finish|Lost to Follow-up|3
6929478|NCT00858637|10961031|FG000|Active Comparison Phase|Adverse Event|14
6929479|NCT00858637|10961032|FG001|Active Comparison Phase|Adverse Event|0
6929480|NCT00858637|10961033|FG002|Active Comparison Phase|Adverse Event|0
6929481|NCT00858637|10961034|FG003|Active Comparison Phase|Adverse Event|9
6929482|NCT00858637|10961035|FG004|Active Comparison Phase|Adverse Event|0
6929483|NCT00858637|10961036|FG005|Active Comparison Phase|Adverse Event|0
6929484|NCT00858637|10961031|FG000|Active Comparison Phase|Death|1
6929485|NCT00858637|10961032|FG001|Active Comparison Phase|Death|0
6929486|NCT00858637|10961033|FG002|Active Comparison Phase|Death|0
6929487|NCT00858637|10961034|FG003|Active Comparison Phase|Death|1
6929488|NCT00858637|10961035|FG004|Active Comparison Phase|Death|0
6929489|NCT00858637|10961036|FG005|Active Comparison Phase|Death|0
6929490|NCT00858637|10961031|FG000|Active Comparison Phase|Physician Decision|1
6929491|NCT00858637|10961032|FG001|Active Comparison Phase|Physician Decision|0
6929492|NCT00858637|10961033|FG002|Active Comparison Phase|Physician Decision|0
6929493|NCT00858637|10961034|FG003|Active Comparison Phase|Physician Decision|1
6929494|NCT00858637|10961035|FG004|Active Comparison Phase|Physician Decision|0
6929495|NCT00858637|10961036|FG005|Active Comparison Phase|Physician Decision|0
6929496|NCT00858637|10961031|FG000|Active Comparison Phase|Withdrawal by Subject|7
6929497|NCT00858637|10961032|FG001|Active Comparison Phase|Withdrawal by Subject|0
6929498|NCT00858637|10961033|FG002|Active Comparison Phase|Withdrawal by Subject|0
6929499|NCT00858637|10961034|FG003|Active Comparison Phase|Withdrawal by Subject|6
6929500|NCT00858637|10961035|FG004|Active Comparison Phase|Withdrawal by Subject|0
6929501|NCT00858637|10961036|FG005|Active Comparison Phase|Withdrawal by Subject|0
6929502|NCT00858637|10961031|FG000|Active Comparison Phase|Other Reasons|1
6929503|NCT00858637|10961032|FG001|Active Comparison Phase|Other Reasons|0
6929504|NCT00858637|10961033|FG002|Active Comparison Phase|Other Reasons|0
6929505|NCT00858637|10961034|FG003|Active Comparison Phase|Other Reasons|1
6929506|NCT00858637|10961035|FG004|Active Comparison Phase|Other Reasons|0
6929507|NCT00858637|10961036|FG005|Active Comparison Phase|Other Reasons|0
6929508|NCT00858637|10961031|FG000|Placebo-controlled Withdrawal Phase|Death|0
6929509|NCT00858637|10961032|FG001|Placebo-controlled Withdrawal Phase|Death|0
6929510|NCT00858637|10961033|FG002|Placebo-controlled Withdrawal Phase|Death|1
6929511|NCT00858637|10961034|FG003|Placebo-controlled Withdrawal Phase|Death|0
6929512|NCT00858637|10961035|FG004|Placebo-controlled Withdrawal Phase|Death|1
6929513|NCT00858637|10961036|FG005|Placebo-controlled Withdrawal Phase|Death|0
6929514|NCT00858637|10961031|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
6929515|NCT00858637|10961032|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
6929516|NCT00858637|10961033|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
6929517|NCT00858637|10961034|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
6929518|NCT00858637|10961035|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
6929519|NCT00858637|10961036|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1
6929520|NCT00858780|10961050|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18
6929521|NCT00858780|10961051|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
6929522|NCT00858780|10961052|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
6975115|NCT01190930|11027139|FG008|Maintenance|Withdrawal by Subject|4
6929523|NCT00858780|10961053|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
6929524|NCT00858780|10961054|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
6929525|NCT00858780|10961050|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
6929526|NCT00858780|10961051|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
6929527|NCT00858780|10961052|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1
6929528|NCT00858780|10961053|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
6929529|NCT00858780|10961054|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
6929530|NCT00858780|10961050|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
6929531|NCT00858780|10961051|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
6929532|NCT00858780|10961052|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
6929533|NCT00858780|10961053|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
6929534|NCT00858780|10961054|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
6929535|NCT00858780|10961050|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0
6929536|NCT00858780|10961051|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1
6929537|NCT00858780|10961052|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0
6929538|NCT00858780|10961053|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0
6929539|NCT00858780|10961054|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0
6929540|NCT00858780|10961050|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
6929541|NCT00858780|10961051|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
6929542|NCT00858780|10961052|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
6929543|NCT00858780|10961053|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
6929544|NCT00858780|10961054|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1
6929545|NCT00858780|10961050|FG000|OL Re-Treatment (Failure to Week 48)|Other|0
6929546|NCT00858780|10961051|FG001|OL Re-Treatment (Failure to Week 48)|Other|0
6929547|NCT00858780|10961052|FG002|OL Re-Treatment (Failure to Week 48)|Other|0
6929548|NCT00858780|10961053|FG003|OL Re-Treatment (Failure to Week 48)|Other|0
6929549|NCT00858780|10961054|FG004|OL Re-Treatment (Failure to Week 48)|Other|1
6929550|NCT00858832|10961066|FG000|Overall Study|became ineligible: delivered vaginally|1
6929551|NCT00858832|10961067|FG001|Overall Study|became ineligible: delivered vaginally|0
6929552|NCT00858832|10961066|FG000|Overall Study|Adverse Event|0
6929553|NCT00858832|10961067|FG001|Overall Study|Adverse Event|1
6929554|NCT00858845|10961075|FG000|Overall Study|Patient underwent heart transplant.|0
6929555|NCT00858845|10961076|FG001|Overall Study|Patient underwent heart transplant.|1
6929556|NCT00858988|10961092|FG000|Analysis|Lactulose unable to be detected in urine|2
6929557|NCT00858988|10961093|FG001|Analysis|Lactulose unable to be detected in urine|1
6929558|NCT00859014|10961099|FG000|Overall Study|Death|4
6929559|NCT00859014|10961099|FG000|Overall Study|Lost to Follow-up|1
6929560|NCT00859222|10961150|FG000|Overall Study|Adverse Event|2
6929561|NCT00859222|10961151|FG001|Overall Study|Adverse Event|3
6929562|NCT00859222|10961152|FG002|Overall Study|Adverse Event|6
6929563|NCT00859222|10961153|FG003|Overall Study|Adverse Event|24
6929564|NCT00859222|10961154|FG004|Overall Study|Adverse Event|15
6929565|NCT00859222|10961150|FG000|Overall Study|DLT|1
6929566|NCT00859222|10961151|FG001|Overall Study|DLT|0
7039667|NCT01712178|11122424|FG001|Overall Study|Withdrew consent due to an adverse event|1
7039668|NCT01712178|11122423|FG000|Overall Study|Serious adverse event/withdrew consent|0
7039669|NCT01712178|11122424|FG001|Overall Study|Serious adverse event/withdrew consent|1
7039670|NCT01712178|11122423|FG000|Overall Study|Lost to Follow-up|0
7039671|NCT01712178|11122424|FG001|Overall Study|Lost to Follow-up|1
7039672|NCT01712204|11122432|FG000|Overall Study|Adverse Event|3
6929567|NCT00859222|10961152|FG002|Overall Study|DLT|0
6929568|NCT00859222|10961153|FG003|Overall Study|DLT|0
6929569|NCT00859222|10961154|FG004|Overall Study|DLT|0
6929570|NCT00859313|10961169|FG000|Overall Study|Lack of Efficacy|2
6929571|NCT00859313|10961169|FG000|Overall Study|Adverse Event|1
6929572|NCT00859313|10961169|FG000|Overall Study|staff error|1
6929573|NCT00859456|10961177|FG000|Overall Study|Adverse Event|3
6929574|NCT00859456|10961177|FG000|Overall Study|Progressive disease|2
6929575|NCT00859456|10961177|FG000|Overall Study|Non-compliance|3
6929576|NCT00859469|10961181|FG000|Overall Study|Adverse Event|2
6929577|NCT00859469|10961181|FG000|Overall Study|Lack of Efficacy|9
6929578|NCT00859469|10961181|FG000|Overall Study|Withdrawal by Subject|1
6929579|NCT00859469|10961181|FG000|Overall Study|Death|16
6975116|NCT01190930|11027140|FG009|Maintenance|Withdrawal by Subject|1
6975117|NCT01190930|11027131|FG000|Maintenance|Refusal|0
6975118|NCT01190930|11027132|FG001|Maintenance|Refusal|1
6975119|NCT01190930|11027133|FG002|Maintenance|Refusal|0
6975120|NCT01190930|11027134|FG003|Maintenance|Refusal|2
6975121|NCT01190930|11027135|FG004|Maintenance|Refusal|0
6975122|NCT01190930|11027136|FG005|Maintenance|Refusal|4
6975123|NCT01190930|11027137|FG006|Maintenance|Refusal|5
6975124|NCT01190930|11027138|FG007|Maintenance|Refusal|17
7039673|NCT01712204|11122433|FG001|Overall Study|Adverse Event|1
6975125|NCT01190930|11027139|FG008|Maintenance|Refusal|13
6975126|NCT01190930|11027140|FG009|Maintenance|Refusal|6
6975127|NCT01190930|11027131|FG000|Maintenance|second malignant neoplasm|0
6975128|NCT01190930|11027132|FG001|Maintenance|second malignant neoplasm|0
6975129|NCT01190930|11027133|FG002|Maintenance|second malignant neoplasm|0
6975130|NCT01190930|11027134|FG003|Maintenance|second malignant neoplasm|1
6975131|NCT01190930|11027135|FG004|Maintenance|second malignant neoplasm|0
6929580|NCT00859547|10961198|FG000|Overall Study|Lost to Follow-up|1
6929581|NCT00859547|10961198|FG000|Overall Study|Parent withdrew consent|1
6929582|NCT00859573|10961204|FG000|Overall Study|Withdrawal by Subject|4
6929583|NCT00859573|10961205|FG001|Overall Study|Withdrawal by Subject|1
6929584|NCT00859573|10961204|FG000|Overall Study|Physician Decision|1
6929585|NCT00859573|10961205|FG001|Overall Study|Physician Decision|1
6929586|NCT00859586|10961211|FG000|Overall Study|Donors|4
6929587|NCT00859638|10961217|FG000|Overall Study|Lost to Follow-up|6
6929588|NCT00859638|10961218|FG001|Overall Study|Lost to Follow-up|1
6929589|NCT00859638|10961217|FG000|Overall Study|Withdrawal by Subject|3
6929590|NCT00859638|10961218|FG001|Overall Study|Withdrawal by Subject|2
6929591|NCT00859638|10961217|FG000|Overall Study|Ill health|1
6929592|NCT00859638|10961218|FG001|Overall Study|Ill health|1
7065350|NCT01965652|11164757|FG001|Overall Study|Death|4
7065351|NCT01965652|11164756|FG000|Overall Study|Other - Miscellaneous|18
7065352|NCT01965652|11164757|FG001|Overall Study|Other - Miscellaneous|21
7065353|NCT01965652|11164756|FG000|Overall Study|Pregnancy|0
6929593|NCT00859898|10961241|FG000|Overall Study|Lack of Efficacy|0
6929594|NCT00859898|10961242|FG001|Overall Study|Lack of Efficacy|1
6929595|NCT00859898|10961243|FG002|Overall Study|Lack of Efficacy|1
6929596|NCT00859898|10961241|FG000|Overall Study|Adverse Event|4
6929597|NCT00859898|10961242|FG001|Overall Study|Adverse Event|9
6929598|NCT00859898|10961243|FG002|Overall Study|Adverse Event|8
6929599|NCT00859898|10961241|FG000|Overall Study|Withdrawal by Subject|11
6929600|NCT00859898|10961242|FG001|Overall Study|Withdrawal by Subject|8
6929601|NCT00859898|10961243|FG002|Overall Study|Withdrawal by Subject|11
6929602|NCT00859898|10961241|FG000|Overall Study|Death|0
6929603|NCT00859898|10961242|FG001|Overall Study|Death|0
6929604|NCT00859898|10961243|FG002|Overall Study|Death|1
6929605|NCT00859898|10961241|FG000|Overall Study|Lost to Follow-up|10
6929606|NCT00859898|10961242|FG001|Overall Study|Lost to Follow-up|11
6929607|NCT00859898|10961243|FG002|Overall Study|Lost to Follow-up|5
6929608|NCT00859898|10961241|FG000|Overall Study|poor/non-compliance|2
6929609|NCT00859898|10961242|FG001|Overall Study|poor/non-compliance|0
6929610|NCT00859898|10961243|FG002|Overall Study|poor/non-compliance|0
6929611|NCT00859898|10961241|FG000|Overall Study|No longer meets criteria|0
6929612|NCT00859898|10961242|FG001|Overall Study|No longer meets criteria|1
6929613|NCT00859898|10961243|FG002|Overall Study|No longer meets criteria|0
6929614|NCT00859898|10961241|FG000|Overall Study|non-specified|1
6929615|NCT00859898|10961242|FG001|Overall Study|non-specified|1
6929616|NCT00859898|10961243|FG002|Overall Study|non-specified|1
6929617|NCT00859937|10961254|FG000|Overall Study|Protocol Violation|1
6929618|NCT00859937|10961255|FG001|Overall Study|Protocol Violation|0
6929619|NCT00860028|10961285|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2
6929620|NCT00860028|10961286|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1
6929621|NCT00860067|10961297|FG000|Overall Study|Lost to Follow-up|46
6929622|NCT00860067|10961298|FG001|Overall Study|Lost to Follow-up|9
6929623|NCT00860067|10961299|FG002|Overall Study|Lost to Follow-up|9
6929624|NCT00860067|10961297|FG000|Overall Study|Withdrawal by Subject|4
6929625|NCT00860067|10961298|FG001|Overall Study|Withdrawal by Subject|0
6929626|NCT00860067|10961299|FG002|Overall Study|Withdrawal by Subject|0
6929627|NCT00860067|10961297|FG000|Overall Study|Pregnancy|1
6929628|NCT00860067|10961298|FG001|Overall Study|Pregnancy|0
6929629|NCT00860067|10961299|FG002|Overall Study|Pregnancy|0
6929630|NCT00860262|10961317|FG000|Overall Study|Adverse Event|9
6929631|NCT00860262|10961318|FG001|Overall Study|Adverse Event|6
6929632|NCT00860262|10961319|FG002|Overall Study|Adverse Event|7
6929633|NCT00860262|10961317|FG000|Overall Study|Protocol Violation|0
6929634|NCT00860262|10961318|FG001|Overall Study|Protocol Violation|1
6929635|NCT00860262|10961319|FG002|Overall Study|Protocol Violation|0
6929636|NCT00860262|10961317|FG000|Overall Study|Lost to Follow-up|2
6929637|NCT00860262|10961318|FG001|Overall Study|Lost to Follow-up|0
6929638|NCT00860262|10961319|FG002|Overall Study|Lost to Follow-up|1
6929639|NCT00860262|10961317|FG000|Overall Study|Withdrawal by Subject|4
6929640|NCT00860262|10961318|FG001|Overall Study|Withdrawal by Subject|8
6929641|NCT00860262|10961319|FG002|Overall Study|Withdrawal by Subject|6
6929642|NCT00860262|10961317|FG000|Overall Study|Lack of Efficacy|0
6929643|NCT00860262|10961318|FG001|Overall Study|Lack of Efficacy|4
6929644|NCT00860262|10961319|FG002|Overall Study|Lack of Efficacy|3
6929645|NCT00860262|10961317|FG000|Overall Study|Other|5
6929646|NCT00860262|10961318|FG001|Overall Study|Other|3
7065354|NCT01965652|11164757|FG001|Overall Study|Pregnancy|1
7065355|NCT01965834|11164780|FG000|Overall Study|Lack of Efficacy|4
6929647|NCT00860262|10961319|FG002|Overall Study|Other|1
6929648|NCT00860405|10961353|FG000|Overall Study|Main reason: Follow-up data not complete|5
6929649|NCT00860405|10961354|FG001|Overall Study|Main reason: Follow-up data not complete|4
6929650|NCT00860470|10961366|FG000|Overall Study|Death|6
6929651|NCT00860470|10961367|FG001|Overall Study|Death|10
6929652|NCT00860470|10961366|FG000|Overall Study|Moved away|8
6929653|NCT00860470|10961367|FG001|Overall Study|Moved away|10
6929654|NCT00860470|10961366|FG000|Overall Study|Lost to Follow-up|34
6929655|NCT00860470|10961367|FG001|Overall Study|Lost to Follow-up|39
6929656|NCT00860574|10961377|FG000|Overall Study|Death|2
6929657|NCT00860574|10961377|FG000|Overall Study|Relapse|1
6929658|NCT00860743|10961387|FG000|Overall Study|Withdrawal by Subject|3
6929659|NCT00860743|10961388|FG001|Overall Study|Withdrawal by Subject|0
7065356|NCT01965860|11164787|FG000|Overall Study|Pregnancy|1
6929660|NCT00860951|10961421|FG000|Overall Study|Withdrawal by Subject|2
6929661|NCT00860951|10961421|FG000|Overall Study|Lost to Follow-up|5
6929662|NCT00861198|10961436|FG000|Overall Study|SpyGlass Failed|5
6929663|NCT00861341|10961444|FG000|Overall Study|Withdrawal by Subject|2
6929664|NCT00861380|10961455|FG000|Overall Study|Withdrawal Information not recorded|8427
6929665|NCT00861380|10961456|FG001|Overall Study|Withdrawal Information not recorded|9112
6929666|NCT00861380|10961457|FG002|Overall Study|Withdrawal Information not recorded|8872
6929667|NCT00861380|10961458|FG003|Overall Study|Withdrawal Information not recorded|3689
6929668|NCT00861380|10961459|FG004|Overall Study|Withdrawal Information not recorded|1812
6929669|NCT00861380|10961460|FG005|Overall Study|Withdrawal Information not recorded|6249
6929670|NCT00861380|10961461|FG006|Overall Study|Withdrawal Information not recorded|3020
6929671|NCT00861471|10961494|FG000|Overall Study|Withdrawal by Subject|1
6929672|NCT00861471|10961494|FG000|Overall Study|Adverse Event|2
6929673|NCT00861471|10961494|FG000|Overall Study|Lack of Efficacy|3
6929674|NCT00861471|10961494|FG000|Overall Study|treatment for lumbar laminectomy|1
6929675|NCT00861471|10961494|FG000|Overall Study|Physician Decision|2
6929676|NCT00861614|10961516|FG000|Overall Study|Disease Progression|182
6929677|NCT00861614|10961517|FG001|Overall Study|Disease Progression|263
6929678|NCT00861614|10961516|FG000|Overall Study|Study Drug Toxicity|79
6929679|NCT00861614|10961517|FG001|Overall Study|Study Drug Toxicity|6
6929680|NCT00861614|10961516|FG000|Overall Study|Death|32
6929681|NCT00861614|10961517|FG001|Overall Study|Death|19
6929682|NCT00861614|10961516|FG000|Overall Study|Adverse Event|27
6929683|NCT00861614|10961517|FG001|Overall Study|Adverse Event|23
6929684|NCT00861614|10961516|FG000|Overall Study|Withdrawal by Subject|34
6929685|NCT00861614|10961517|FG001|Overall Study|Withdrawal by Subject|35
7065357|NCT01965860|11164788|FG001|Overall Study|Pregnancy|0
7065358|NCT01965860|11164789|FG002|Overall Study|Pregnancy|1
7065359|NCT01965860|11164787|FG000|Overall Study|Logistics|1
7065360|NCT01965860|11164788|FG001|Overall Study|Logistics|0
7065361|NCT01965860|11164789|FG002|Overall Study|Logistics|0
7065362|NCT01965938|11164804|FG000|Overall Study|Withdrawal by Subject|1
7065363|NCT01965938|11164805|FG001|Overall Study|Withdrawal by Subject|0
7065364|NCT01966003|11164815|FG000|Overall Study|Death|43
7065365|NCT01966003|11164816|FG001|Overall Study|Death|36
7065366|NCT01966003|11164815|FG000|Overall Study|Protocol Violation|6
7065367|NCT01966003|11164816|FG001|Overall Study|Protocol Violation|4
7065368|NCT01966003|11164815|FG000|Overall Study|Lost to Follow-up|4
7065369|NCT01966003|11164816|FG001|Overall Study|Lost to Follow-up|3
7065370|NCT01966003|11164815|FG000|Overall Study|Physician Decision|12
7065371|NCT01966003|11164816|FG001|Overall Study|Physician Decision|13
7065372|NCT01966003|11164815|FG000|Overall Study|Withdrawal by Subject|29
7065373|NCT01966003|11164816|FG001|Overall Study|Withdrawal by Subject|19
7065374|NCT01966003|11164815|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131
7065375|NCT01966003|11164816|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127
7065376|NCT01966003|11164815|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44
7065377|NCT01966003|11164816|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67
7065378|NCT01966003|11164815|FG000|Overall Study|Other|1
7065379|NCT01966003|11164816|FG001|Overall Study|Other|1
7065380|NCT01966042|11164822|FG000|Overall Study|Death|2
7065381|NCT01966068|11164828|FG000|Overall Study|Withdrawal by Subject|57
7065382|NCT01966068|11164828|FG000|Overall Study|Lost to Follow-up|81
7065383|NCT01966107|11164835|FG000|Overall Study|excluded from FAS|21
7065384|NCT01966107|11164836|FG001|Overall Study|excluded from FAS|20
7065385|NCT01966107|11164835|FG000|Overall Study|discontinued treatment|345
7065386|NCT01966107|11164836|FG001|Overall Study|discontinued treatment|372
6929686|NCT00861614|10961516|FG000|Overall Study|Other|17
6929687|NCT00861614|10961517|FG001|Overall Study|Other|22
6929688|NCT00861692|10961523|FG000|Overall Study|Death|6
6929689|NCT00861744|10961531|FG000|Overall Study|Adverse Event|0
6929690|NCT00861744|10961532|FG001|Overall Study|Adverse Event|0
6929691|NCT00861744|10961533|FG002|Overall Study|Adverse Event|0
6929692|NCT00861744|10961534|FG003|Overall Study|Adverse Event|1
6929693|NCT00861744|10961531|FG000|Overall Study|Lost to Follow-up|7
6929694|NCT00861744|10961532|FG001|Overall Study|Lost to Follow-up|19
6929695|NCT00861744|10961533|FG002|Overall Study|Lost to Follow-up|17
7065387|NCT01966107|11164835|FG000|Overall Study|due to study closure|164
7065388|NCT01966107|11164836|FG001|Overall Study|due to study closure|186
7065389|NCT01966107|11164835|FG000|Overall Study|withdrew from the study|272
7065390|NCT01966107|11164836|FG001|Overall Study|withdrew from the study|303
7065391|NCT01966120|11164844|FG000|Overall Study|Withdrawal by Subject|0
7065392|NCT01966120|11164845|FG001|Overall Study|Withdrawal by Subject|5
7065393|NCT01966120|11164844|FG000|Overall Study|Lost to Follow-up|1
7065394|NCT01966120|11164845|FG001|Overall Study|Lost to Follow-up|1
7065395|NCT01966432|11164892|FG000|Overall Study|Lost to Follow-up|3
6929696|NCT00861744|10961534|FG003|Overall Study|Lost to Follow-up|12
6929697|NCT00861744|10961531|FG000|Overall Study|Withdrawal by Subject|10
6929698|NCT00861744|10961532|FG001|Overall Study|Withdrawal by Subject|6
6929699|NCT00861744|10961533|FG002|Overall Study|Withdrawal by Subject|6
6929700|NCT00861744|10961534|FG003|Overall Study|Withdrawal by Subject|19
6929701|NCT00861744|10961531|FG000|Overall Study|Protocol Violation|0
6929702|NCT00861744|10961532|FG001|Overall Study|Protocol Violation|1
6929703|NCT00861744|10961533|FG002|Overall Study|Protocol Violation|0
6929704|NCT00861744|10961534|FG003|Overall Study|Protocol Violation|0
7065396|NCT01966432|11164893|FG001|Overall Study|Lost to Follow-up|2
6929705|NCT00861744|10961531|FG000|Overall Study|Migration from study area|0
6929706|NCT00861744|10961532|FG001|Overall Study|Migration from study area|3
6929707|NCT00861744|10961533|FG002|Overall Study|Migration from study area|1
6929708|NCT00861744|10961534|FG003|Overall Study|Migration from study area|0
6929709|NCT00861744|10961531|FG000|Overall Study|Blood draws|0
6929710|NCT00861744|10961532|FG001|Overall Study|Blood draws|0
6929711|NCT00861744|10961533|FG002|Overall Study|Blood draws|0
6929712|NCT00861744|10961534|FG003|Overall Study|Blood draws|1
6929713|NCT00861757|10961548|FG000|Overall Study|Adverse Event|1
6929714|NCT00861757|10961549|FG001|Overall Study|Adverse Event|5
6929715|NCT00861757|10961550|FG002|Overall Study|Adverse Event|7
6929716|NCT00861757|10961551|FG003|Overall Study|Adverse Event|2
6929717|NCT00861757|10961548|FG000|Overall Study|Entry Criteria Not Met|1
6929718|NCT00861757|10961549|FG001|Overall Study|Entry Criteria Not Met|2
6929719|NCT00861757|10961550|FG002|Overall Study|Entry Criteria Not Met|1
6929720|NCT00861757|10961551|FG003|Overall Study|Entry Criteria Not Met|1
6929721|NCT00861757|10961548|FG000|Overall Study|Lack of Efficacy|3
6929722|NCT00861757|10961549|FG001|Overall Study|Lack of Efficacy|1
6929723|NCT00861757|10961550|FG002|Overall Study|Lack of Efficacy|0
6929724|NCT00861757|10961551|FG003|Overall Study|Lack of Efficacy|1
6929725|NCT00861757|10961548|FG000|Overall Study|Lost to Follow-up|1
6929726|NCT00861757|10961549|FG001|Overall Study|Lost to Follow-up|0
6929727|NCT00861757|10961550|FG002|Overall Study|Lost to Follow-up|1
6929728|NCT00861757|10961551|FG003|Overall Study|Lost to Follow-up|1
6929729|NCT00861757|10961548|FG000|Overall Study|Physician Decision|0
6929730|NCT00861757|10961549|FG001|Overall Study|Physician Decision|0
6929731|NCT00861757|10961550|FG002|Overall Study|Physician Decision|0
6929732|NCT00861757|10961551|FG003|Overall Study|Physician Decision|1
6929733|NCT00861757|10961548|FG000|Overall Study|Protocol Violation|2
6929734|NCT00861757|10961549|FG001|Overall Study|Protocol Violation|2
6929735|NCT00861757|10961550|FG002|Overall Study|Protocol Violation|4
6929736|NCT00861757|10961551|FG003|Overall Study|Protocol Violation|1
6929737|NCT00861757|10961548|FG000|Overall Study|Withdrawal by Subject|1
6929738|NCT00861757|10961549|FG001|Overall Study|Withdrawal by Subject|5
6929739|NCT00861757|10961550|FG002|Overall Study|Withdrawal by Subject|5
6929740|NCT00861757|10961551|FG003|Overall Study|Withdrawal by Subject|2
6929741|NCT00862082|10961571|FG000|Overall Study|Sponsor decision to terminate the study|5
6929742|NCT00862082|10961572|FG001|Overall Study|Sponsor decision to terminate the study|0
6929743|NCT00862082|10961571|FG000|Overall Study|Withdrawal by Subject|0
6929744|NCT00862082|10961572|FG001|Overall Study|Withdrawal by Subject|1
6929745|NCT00862121|10961587|FG000|Overall Study|Adverse Event|1
6929746|NCT00862121|10961588|FG001|Overall Study|Adverse Event|2
6929747|NCT00862121|10961587|FG000|Overall Study|Lack of Efficacy|0
6929748|NCT00862121|10961588|FG001|Overall Study|Lack of Efficacy|3
6929749|NCT00862121|10961587|FG000|Overall Study|Protocol Violation|0
6929750|NCT00862121|10961588|FG001|Overall Study|Protocol Violation|1
6929751|NCT00862121|10961587|FG000|Overall Study|Exclusion criterion violation|0
6929752|NCT00862121|10961588|FG001|Overall Study|Exclusion criterion violation|1
6929753|NCT00862121|10961587|FG000|Overall Study|Incorrect randomisation|0
6929754|NCT00862121|10961588|FG001|Overall Study|Incorrect randomisation|1
6929755|NCT00862134|10961596|FG000|Overall Study|Death|1
6929756|NCT00862134|10961597|FG001|Overall Study|Death|0
6929757|NCT00862134|10961596|FG000|Overall Study|Physician Decision|0
6929758|NCT00862134|10961597|FG001|Overall Study|Physician Decision|1
6929759|NCT00862134|10961596|FG000|Overall Study|Withdrawal by Subject|1
6929760|NCT00862134|10961597|FG001|Overall Study|Withdrawal by Subject|2
6929761|NCT00862134|10961596|FG000|Overall Study|Sponsor terminated study|5
6929762|NCT00862134|10961597|FG001|Overall Study|Sponsor terminated study|7
6929763|NCT00862134|10961596|FG000|Overall Study|Adverse Event|2
6929764|NCT00862134|10961597|FG001|Overall Study|Adverse Event|2
6929765|NCT00862134|10961596|FG000|Overall Study|Withdrew prior to dosing|2
6929766|NCT00862134|10961597|FG001|Overall Study|Withdrew prior to dosing|0
6929767|NCT00862277|10961611|FG000|Overall Study|Protocol Violation|1
6929768|NCT00862277|10961612|FG001|Overall Study|Protocol Violation|2
6929769|NCT00862277|10961613|FG002|Overall Study|Protocol Violation|5
6929770|NCT00862459|10961628|FG000|Overall Study|Lost to Follow-up|1
6929771|NCT00862459|10961629|FG001|Overall Study|Lost to Follow-up|2
6929772|NCT00862459|10961630|FG002|Overall Study|Lost to Follow-up|2
6929773|NCT00862459|10961628|FG000|Overall Study|Protocol Violation|1
6929774|NCT00862459|10961629|FG001|Overall Study|Protocol Violation|0
6929775|NCT00862459|10961630|FG002|Overall Study|Protocol Violation|0
6929776|NCT00862459|10961628|FG000|Overall Study|Withdrawal by Subject|1
6929777|NCT00862459|10961629|FG001|Overall Study|Withdrawal by Subject|1
6929778|NCT00862459|10961630|FG002|Overall Study|Withdrawal by Subject|3
6929779|NCT00862459|10961628|FG000|Overall Study|Adverse Event|0
6929780|NCT00862459|10961629|FG001|Overall Study|Adverse Event|1
6929781|NCT00862459|10961630|FG002|Overall Study|Adverse Event|0
6929782|NCT00862459|10961628|FG000|Overall Study|Personal reasons|1
6929783|NCT00862459|10961629|FG001|Overall Study|Personal reasons|0
6929784|NCT00862459|10961630|FG002|Overall Study|Personal reasons|0
6929785|NCT00862459|10961628|FG000|Overall Study|Operation|1
6929786|NCT00862459|10961629|FG001|Overall Study|Operation|1
6929787|NCT00862459|10961630|FG002|Overall Study|Operation|0
6929788|NCT00862459|10961628|FG000|Overall Study|Intravenous (IV) site problems|1
6929789|NCT00862459|10961629|FG001|Overall Study|Intravenous (IV) site problems|0
6929790|NCT00862459|10961630|FG002|Overall Study|Intravenous (IV) site problems|1
6929791|NCT00862459|10961628|FG000|Overall Study|Unable to hold still for imaging|0
6929792|NCT00862459|10961629|FG001|Overall Study|Unable to hold still for imaging|1
6929793|NCT00862459|10961630|FG002|Overall Study|Unable to hold still for imaging|0
6929794|NCT00862459|10961628|FG000|Overall Study|Inclusion/exclusion criteria not met|0
6929795|NCT00862459|10961629|FG001|Overall Study|Inclusion/exclusion criteria not met|1
6929796|NCT00862459|10961630|FG002|Overall Study|Inclusion/exclusion criteria not met|0
6929797|NCT00862459|10961628|FG000|Overall Study|Administrative problems|0
6929798|NCT00862459|10961629|FG001|Overall Study|Administrative problems|1
6929799|NCT00862459|10961630|FG002|Overall Study|Administrative problems|0
6929800|NCT00862641|10961673|FG000|Overall Study|Randomized, but drug not received|1
6929801|NCT00862641|10961674|FG001|Overall Study|Randomized, but drug not received|4
6929802|NCT00862641|10961675|FG002|Overall Study|Randomized, but drug not received|1
6929803|NCT00862641|10961676|FG003|Overall Study|Randomized, but drug not received|4
6929804|NCT00862654|10961690|FG000|Overall Study|Lack of Efficacy|1
6929805|NCT00862654|10961691|FG001|Overall Study|Lack of Efficacy|0
6929806|NCT00862654|10961692|FG002|Overall Study|Lack of Efficacy|1
6929807|NCT00862654|10961693|FG003|Overall Study|Lack of Efficacy|0
6929808|NCT00862654|10961690|FG000|Overall Study|Lost to Follow-up|1
6929809|NCT00862654|10961691|FG001|Overall Study|Lost to Follow-up|2
6929810|NCT00862654|10961692|FG002|Overall Study|Lost to Follow-up|1
6929811|NCT00862654|10961693|FG003|Overall Study|Lost to Follow-up|3
6929812|NCT00862654|10961690|FG000|Overall Study|Adverse Event|0
6929813|NCT00862654|10961691|FG001|Overall Study|Adverse Event|1
6929814|NCT00862654|10961692|FG002|Overall Study|Adverse Event|1
6929815|NCT00862654|10961693|FG003|Overall Study|Adverse Event|0
6929816|NCT00862654|10961690|FG000|Overall Study|Pregnancy|1
6929817|NCT00862654|10961691|FG001|Overall Study|Pregnancy|1
6929818|NCT00862654|10961692|FG002|Overall Study|Pregnancy|0
6929819|NCT00862654|10961693|FG003|Overall Study|Pregnancy|0
6929820|NCT00862654|10961690|FG000|Overall Study|Withdrawal by Subject|2
6929821|NCT00862654|10961691|FG001|Overall Study|Withdrawal by Subject|2
6929822|NCT00862654|10961692|FG002|Overall Study|Withdrawal by Subject|2
6929823|NCT00862654|10961693|FG003|Overall Study|Withdrawal by Subject|3
6929824|NCT00862654|10961690|FG000|Overall Study|Subject mistake|0
6929825|NCT00862654|10961691|FG001|Overall Study|Subject mistake|1
6929826|NCT00862654|10961692|FG002|Overall Study|Subject mistake|0
6929827|NCT00862654|10961693|FG003|Overall Study|Subject mistake|0
6929828|NCT00862654|10961690|FG000|Overall Study|Familly constraint|0
6929829|NCT00862654|10961691|FG001|Overall Study|Familly constraint|1
6929830|NCT00862654|10961692|FG002|Overall Study|Familly constraint|0
6929831|NCT00862654|10961693|FG003|Overall Study|Familly constraint|0
6929832|NCT00862654|10961690|FG000|Overall Study|Never used study drugs|1
6929833|NCT00862654|10961691|FG001|Overall Study|Never used study drugs|0
6929834|NCT00862654|10961692|FG002|Overall Study|Never used study drugs|0
6929835|NCT00862654|10961693|FG003|Overall Study|Never used study drugs|0
6929836|NCT00862654|10961690|FG000|Overall Study|Included after end of inclusions|0
6929837|NCT00862654|10961691|FG001|Overall Study|Included after end of inclusions|0
6929838|NCT00862654|10961692|FG002|Overall Study|Included after end of inclusions|1
6929839|NCT00862654|10961693|FG003|Overall Study|Included after end of inclusions|0
6929840|NCT00862719|10961707|FG000|Overall Study|Disease Progression|5
6929841|NCT00862719|10961708|FG001|Overall Study|Disease Progression|0
6929842|NCT00862719|10961709|FG002|Overall Study|Disease Progression|1
6929843|NCT00862719|10961710|FG003|Overall Study|Disease Progression|0
6929844|NCT00862719|10961707|FG000|Overall Study|Death|5
6929845|NCT00862719|10961708|FG001|Overall Study|Death|6
6929846|NCT00862719|10961709|FG002|Overall Study|Death|1
6929847|NCT00862719|10961710|FG003|Overall Study|Death|1
6929848|NCT00862719|10961707|FG000|Overall Study|Engraftment failure|0
6929849|NCT00862719|10961708|FG001|Overall Study|Engraftment failure|0
6929850|NCT00862719|10961709|FG002|Overall Study|Engraftment failure|1
6929851|NCT00862719|10961710|FG003|Overall Study|Engraftment failure|0
6929852|NCT00862719|10961707|FG000|Overall Study|Veno-Occlusive Disease|0
6929853|NCT00862719|10961708|FG001|Overall Study|Veno-Occlusive Disease|0
6929854|NCT00862719|10961709|FG002|Overall Study|Veno-Occlusive Disease|1
6929855|NCT00862719|10961710|FG003|Overall Study|Veno-Occlusive Disease|0
6929856|NCT00862823|10961742|FG000|First Intervention|Withdrawal by Subject|1
6929857|NCT00862823|10961743|FG001|First Intervention|Withdrawal by Subject|1
6929858|NCT00862836|10961748|FG000|Overall Study|Withdrawal by Subject|1
6929859|NCT00862849|10961752|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
6929860|NCT00862849|10961753|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1
6929861|NCT00862849|10961754|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
6929862|NCT00862849|10961755|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
6929863|NCT00862849|10961756|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
6929864|NCT00862849|10961757|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
6929865|NCT00862849|10961752|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0
6929866|NCT00862849|10961753|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1
6929867|NCT00862849|10961754|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0
6929868|NCT00862849|10961755|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0
6929869|NCT00862849|10961756|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0
6929870|NCT00862849|10961757|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0
6929871|NCT00862940|10961767|FG000|Overall Study|Adverse Event|15
6929872|NCT00862940|10961768|FG001|Overall Study|Adverse Event|12
6929873|NCT00862940|10961767|FG000|Overall Study|Lack of Efficacy|1
6929874|NCT00862940|10961768|FG001|Overall Study|Lack of Efficacy|3
6929875|NCT00862940|10961767|FG000|Overall Study|Protocol Violation|2
6929876|NCT00862940|10961768|FG001|Overall Study|Protocol Violation|5
6929877|NCT00862940|10961767|FG000|Overall Study|Withdrawal by Subject|4
6929878|NCT00862940|10961768|FG001|Overall Study|Withdrawal by Subject|6
6929879|NCT00862940|10961767|FG000|Overall Study|Non-compliance|4
6929880|NCT00862940|10961768|FG001|Overall Study|Non-compliance|0
6929881|NCT00862940|10961767|FG000|Overall Study|Lost to Follow-up|0
6929882|NCT00862940|10961768|FG001|Overall Study|Lost to Follow-up|1
6929883|NCT00862940|10961767|FG000|Overall Study|Administrative or other reason(s)|4
6929884|NCT00862940|10961768|FG001|Overall Study|Administrative or other reason(s)|3
6929885|NCT00862979|10961776|FG000|Overall Study|Adverse Event|6
6929886|NCT00862979|10961777|FG001|Overall Study|Adverse Event|3
6929887|NCT00862979|10961776|FG000|Overall Study|Protocol Violation|0
6929888|NCT00862979|10961777|FG001|Overall Study|Protocol Violation|1
6929889|NCT00862979|10961776|FG000|Overall Study|Patient withdrew consent|2
6929890|NCT00862979|10961777|FG001|Overall Study|Patient withdrew consent|1
6929891|NCT00862979|10961776|FG000|Overall Study|Administrative problems|0
6929892|NCT00862979|10961777|FG001|Overall Study|Administrative problems|1
6929893|NCT00862979|10961776|FG000|Overall Study|Death|0
6929894|NCT00862979|10961777|FG001|Overall Study|Death|1
6929895|NCT00862992|10961786|FG000|Overall Study|Adverse Event|2
6929896|NCT00862992|10961787|FG001|Overall Study|Adverse Event|1
6929897|NCT00862992|10961788|FG002|Overall Study|Adverse Event|1
6929898|NCT00862992|10961786|FG000|Overall Study|Physician Decision|1
6929899|NCT00862992|10961787|FG001|Overall Study|Physician Decision|0
6929900|NCT00862992|10961788|FG002|Overall Study|Physician Decision|0
6929901|NCT00862992|10961786|FG000|Overall Study|Withdrawal by Subject|0
6929902|NCT00862992|10961787|FG001|Overall Study|Withdrawal by Subject|0
6929903|NCT00862992|10961788|FG002|Overall Study|Withdrawal by Subject|2
6929904|NCT00863057|10961800|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
6929905|NCT00863057|10961801|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
6929906|NCT00863057|10961802|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0
6929907|NCT00863057|10961803|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
6929908|NCT00863057|10961800|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
6929909|NCT00863057|10961801|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1
6929910|NCT00863057|10961802|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
6929911|NCT00863057|10961803|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
6929912|NCT00863057|10961800|FG000|Period 2 (Weeks 6-10)|Adverse Event|0
6929913|NCT00863057|10961801|FG001|Period 2 (Weeks 6-10)|Adverse Event|1
6929914|NCT00863057|10961802|FG002|Period 2 (Weeks 6-10)|Adverse Event|1
6929915|NCT00863057|10961803|FG003|Period 2 (Weeks 6-10)|Adverse Event|0
6929916|NCT00863057|10961800|FG000|Period 2 (Weeks 6-10)|Physician Decision|0
6929917|NCT00863057|10961801|FG001|Period 2 (Weeks 6-10)|Physician Decision|0
6929918|NCT00863057|10961802|FG002|Period 2 (Weeks 6-10)|Physician Decision|0
6929919|NCT00863057|10961803|FG003|Period 2 (Weeks 6-10)|Physician Decision|1
6929920|NCT00863304|10961861|FG000|Overall Study|Adverse Event|10
6929921|NCT00863304|10961862|FG001|Overall Study|Adverse Event|4
6929922|NCT00863304|10961863|FG002|Overall Study|Adverse Event|14
6929923|NCT00863304|10961864|FG003|Overall Study|Adverse Event|16
6929924|NCT00863304|10961861|FG000|Overall Study|Lost to Follow-up|1
6929925|NCT00863304|10961862|FG001|Overall Study|Lost to Follow-up|5
6929926|NCT00863304|10961863|FG002|Overall Study|Lost to Follow-up|4
6929927|NCT00863304|10961864|FG003|Overall Study|Lost to Follow-up|2
6929928|NCT00863304|10961861|FG000|Overall Study|Lack of Efficacy|57
6929929|NCT00863304|10961862|FG001|Overall Study|Lack of Efficacy|26
6929930|NCT00863304|10961863|FG002|Overall Study|Lack of Efficacy|30
6929931|NCT00863304|10961864|FG003|Overall Study|Lack of Efficacy|28
6929932|NCT00863304|10961861|FG000|Overall Study|Withdrawal by Subject|19
6929933|NCT00863304|10961862|FG001|Overall Study|Withdrawal by Subject|14
6929934|NCT00863304|10961863|FG002|Overall Study|Withdrawal by Subject|20
6929935|NCT00863304|10961864|FG003|Overall Study|Withdrawal by Subject|18
6929936|NCT00863304|10961861|FG000|Overall Study|Other|1
6929937|NCT00863304|10961862|FG001|Overall Study|Other|0
6929938|NCT00863304|10961863|FG002|Overall Study|Other|0
6929939|NCT00863304|10961864|FG003|Overall Study|Other|1
6929940|NCT00863304|10961861|FG000|Overall Study|Protocol Violation|2
6929941|NCT00863304|10961862|FG001|Overall Study|Protocol Violation|6
6929942|NCT00863304|10961863|FG002|Overall Study|Protocol Violation|2
6929943|NCT00863304|10961864|FG003|Overall Study|Protocol Violation|0
6929944|NCT00863304|10961861|FG000|Overall Study|Randomized, but not Treated|3
6929945|NCT00863304|10961862|FG001|Overall Study|Randomized, but not Treated|1
6929946|NCT00863304|10961863|FG002|Overall Study|Randomized, but not Treated|4
6929947|NCT00863304|10961864|FG003|Overall Study|Randomized, but not Treated|1
6929948|NCT00863304|10961861|FG000|Overall Study|Entered extension study|101
6929949|NCT00863304|10961862|FG001|Overall Study|Entered extension study|129
6929950|NCT00863304|10961863|FG002|Overall Study|Entered extension study|113
6929951|NCT00863304|10961864|FG003|Overall Study|Entered extension study|125
6929952|NCT00863317|10961878|FG000|Overall Study|Lost to Follow-up|8
6929953|NCT00863317|10961879|FG001|Overall Study|Lost to Follow-up|9
6929954|NCT00863655|10961910|FG000|Overall Study|Protocol Violation|4
6929955|NCT00863655|10961911|FG001|Overall Study|Protocol Violation|0
6929956|NCT00863655|10961910|FG000|Overall Study|Adverse Event|52
6929957|NCT00863655|10961911|FG001|Overall Study|Adverse Event|8
6929958|NCT00863655|10961910|FG000|Overall Study|Withdrawal by Subject|47
6929959|NCT00863655|10961911|FG001|Overall Study|Withdrawal by Subject|7
6929960|NCT00863655|10961910|FG000|Overall Study|Administrative problems|1
6929961|NCT00863655|10961911|FG001|Overall Study|Administrative problems|0
6929962|NCT00863655|10961910|FG000|Overall Study|Death|7
6929963|NCT00863655|10961911|FG001|Overall Study|Death|1
6929964|NCT00863655|10961910|FG000|Overall Study|New cancer therapy|5
6929965|NCT00863655|10961911|FG001|Overall Study|New cancer therapy|1
6929966|NCT00863655|10961910|FG000|Overall Study|Disease progression|364
6929967|NCT00863655|10961911|FG001|Overall Study|Disease progression|221
6929968|NCT00863655|10961910|FG000|Overall Study|Treatment completed as per protocol|5
6929969|NCT00863655|10961911|FG001|Overall Study|Treatment completed as per protocol|1
6929970|NCT00863681|10961920|FG000|Overall Study|Other|2
6929971|NCT00863681|10961921|FG001|Overall Study|Other|0
6929972|NCT00863681|10961922|FG002|Overall Study|Other|0
6929973|NCT00863681|10961920|FG000|Overall Study|Missing|1
6929974|NCT00863681|10961921|FG001|Overall Study|Missing|0
6929975|NCT00863681|10961922|FG002|Overall Study|Missing|0
6929976|NCT00863681|10961920|FG000|Overall Study|Death|40
6929977|NCT00863681|10961921|FG001|Overall Study|Death|23
6929978|NCT00863681|10961922|FG002|Overall Study|Death|6
6929979|NCT00863681|10961920|FG000|Overall Study|Withdrawal by Subject|12
6929980|NCT00863681|10961921|FG001|Overall Study|Withdrawal by Subject|5
6929981|NCT00863681|10961922|FG002|Overall Study|Withdrawal by Subject|2
6929982|NCT00863681|10961920|FG000|Overall Study|Protocol Violation|2
6929983|NCT00863681|10961921|FG001|Overall Study|Protocol Violation|0
6929984|NCT00863681|10961922|FG002|Overall Study|Protocol Violation|0
6929985|NCT00863681|10961920|FG000|Overall Study|Lost to Follow-up|3
6929986|NCT00863681|10961921|FG001|Overall Study|Lost to Follow-up|0
6929987|NCT00863681|10961922|FG002|Overall Study|Lost to Follow-up|3
6929988|NCT00863681|10961920|FG000|Overall Study|Adverse Event|28
6929989|NCT00863681|10961921|FG001|Overall Study|Adverse Event|10
6929990|NCT00863681|10961922|FG002|Overall Study|Adverse Event|6
6929991|NCT00863681|10961920|FG000|Overall Study|Lack of Efficacy|2
6929992|NCT00863681|10961921|FG001|Overall Study|Lack of Efficacy|2
6929993|NCT00863681|10961922|FG002|Overall Study|Lack of Efficacy|1
6929994|NCT00863681|10961920|FG000|Overall Study|Non-compliance with study drug|1
6929995|NCT00863681|10961921|FG001|Overall Study|Non-compliance with study drug|3
6929996|NCT00863681|10961922|FG002|Overall Study|Non-compliance with study drug|0
6929997|NCT00863707|10961932|FG000|Overall Study|Randomized, but drug not received|4
6929998|NCT00863707|10961933|FG001|Overall Study|Randomized, but drug not received|3
6929999|NCT00863746|10961941|FG000|Treatment|Not treated|4
6930000|NCT00863746|10961942|FG001|Treatment|Not treated|2
6930001|NCT00863746|10961941|FG000|Treatment|Adverse Event|41
6930002|NCT00863746|10961942|FG001|Treatment|Adverse Event|16
6930003|NCT00863746|10961941|FG000|Treatment|non-compliant with study medication|4
6930004|NCT00863746|10961942|FG001|Treatment|non-compliant with study medication|0
6930005|NCT00863746|10961941|FG000|Treatment|Consent withdrawn|15
6930006|NCT00863746|10961942|FG001|Treatment|Consent withdrawn|14
6930007|NCT00863746|10961941|FG000|Treatment|Lost to Follow-up|1
6930008|NCT00863746|10961942|FG001|Treatment|Lost to Follow-up|0
6930009|NCT00863746|10961941|FG000|Treatment|Protocol Violation|5
6930010|NCT00863746|10961942|FG001|Treatment|Protocol Violation|3
7065397|NCT01966432|11164894|FG002|Overall Study|Lost to Follow-up|5
7065398|NCT01966432|11164892|FG000|Overall Study|Withdrawal by Subject|1
7065399|NCT01966432|11164893|FG001|Overall Study|Withdrawal by Subject|3
7065400|NCT01966432|11164894|FG002|Overall Study|Withdrawal by Subject|0
7065401|NCT01966432|11164892|FG000|Overall Study|Subject Incarcerated|0
7065402|NCT01966432|11164893|FG001|Overall Study|Subject Incarcerated|0
7065403|NCT01966432|11164894|FG002|Overall Study|Subject Incarcerated|1
7065404|NCT01966432|11164892|FG000|Overall Study|SBIRT program ended|1
7065405|NCT01966432|11164893|FG001|Overall Study|SBIRT program ended|8
7065406|NCT01966432|11164894|FG002|Overall Study|SBIRT program ended|20
7065407|NCT01966445|11164910|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
7065408|NCT01966445|11164911|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
7065409|NCT01966445|11164912|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
7065410|NCT01966445|11164913|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2
6930011|NCT00863746|10961941|FG000|Treatment|Other|1
6930012|NCT00863746|10961942|FG001|Treatment|Other|0
6930013|NCT00863746|10961941|FG000|Survival Follow up|Death|244
6930014|NCT00863746|10961942|FG001|Survival Follow up|Death|271
6930015|NCT00863746|10961941|FG000|Survival Follow up|Lost to Follow-up|2
6930016|NCT00863746|10961942|FG001|Survival Follow up|Lost to Follow-up|1
6930017|NCT00863746|10961941|FG000|Survival Follow up|Consent Withdrawn|7
6930018|NCT00863746|10961942|FG001|Survival Follow up|Consent Withdrawn|8
6930019|NCT00863772|10961951|FG000|Overall Study|Adverse Event|1
6930020|NCT00863772|10961952|FG001|Overall Study|Adverse Event|4
7065411|NCT01966445|11164914|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
7065412|NCT01966445|11164915|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1
6930021|NCT00863772|10961953|FG002|Overall Study|Adverse Event|0
6930022|NCT00863772|10961951|FG000|Overall Study|Lack of Efficacy|4
6930023|NCT00863772|10961952|FG001|Overall Study|Lack of Efficacy|2
6930024|NCT00863772|10961953|FG002|Overall Study|Lack of Efficacy|4
6930025|NCT00863772|10961951|FG000|Overall Study|Lost to Follow-up|5
6930026|NCT00863772|10961952|FG001|Overall Study|Lost to Follow-up|1
6930027|NCT00863772|10961953|FG002|Overall Study|Lost to Follow-up|1
6930028|NCT00863772|10961951|FG000|Overall Study|Protocol Violation|2
6930029|NCT00863772|10961952|FG001|Overall Study|Protocol Violation|0
6930030|NCT00863772|10961953|FG002|Overall Study|Protocol Violation|2
6930031|NCT00863772|10961951|FG000|Overall Study|Withdrawal by Subject|4
6930032|NCT00863772|10961952|FG001|Overall Study|Withdrawal by Subject|7
6930033|NCT00863772|10961953|FG002|Overall Study|Withdrawal by Subject|5
6930034|NCT00863772|10961951|FG000|Overall Study|Study terminated by sponsor|44
6930035|NCT00863772|10961952|FG001|Overall Study|Study terminated by sponsor|45
6930036|NCT00863772|10961953|FG002|Overall Study|Study terminated by sponsor|36
6930037|NCT00863772|10961951|FG000|Overall Study|Entered extension study|6
6930038|NCT00863772|10961952|FG001|Overall Study|Entered extension study|4
6930039|NCT00863772|10961953|FG002|Overall Study|Entered extension study|9
6930040|NCT00863772|10961951|FG000|Overall Study|Other|1
6930041|NCT00863772|10961952|FG001|Overall Study|Other|2
6930042|NCT00863772|10961953|FG002|Overall Study|Other|4
6930043|NCT00863772|10961951|FG000|Overall Study|Randomized but not Treated|1
6930044|NCT00863772|10961952|FG001|Overall Study|Randomized but not Treated|0
6930045|NCT00863772|10961953|FG002|Overall Study|Randomized but not Treated|0
6930046|NCT00863798|10961964|FG000|Overall Study|Adverse Event|5
6930047|NCT00863798|10961965|FG001|Overall Study|Adverse Event|2
6930048|NCT00863798|10961966|FG002|Overall Study|Adverse Event|4
6930049|NCT00863798|10961964|FG000|Overall Study|Participant failed to return|2
6930050|NCT00863798|10961965|FG001|Overall Study|Participant failed to return|1
6930051|NCT00863798|10961966|FG002|Overall Study|Participant failed to return|0
6930052|NCT00863798|10961964|FG000|Overall Study|Investigator request|1
6930053|NCT00863798|10961965|FG001|Overall Study|Investigator request|2
6930054|NCT00863798|10961966|FG002|Overall Study|Investigator request|1
6930055|NCT00863798|10961964|FG000|Overall Study|Lack of Efficacy|4
6930056|NCT00863798|10961965|FG001|Overall Study|Lack of Efficacy|3
6930057|NCT00863798|10961966|FG002|Overall Study|Lack of Efficacy|6
6930058|NCT00863798|10961964|FG000|Overall Study|Lost to Follow-up|6
6930059|NCT00863798|10961965|FG001|Overall Study|Lost to Follow-up|9
6930060|NCT00863798|10961966|FG002|Overall Study|Lost to Follow-up|5
6930061|NCT00863798|10961964|FG000|Overall Study|Other|2
6930062|NCT00863798|10961965|FG001|Overall Study|Other|3
6930063|NCT00863798|10961966|FG002|Overall Study|Other|1
6930064|NCT00863798|10961964|FG000|Overall Study|Protocol Violation|0
6930065|NCT00863798|10961965|FG001|Overall Study|Protocol Violation|1
6930066|NCT00863798|10961966|FG002|Overall Study|Protocol Violation|1
6930067|NCT00863798|10961964|FG000|Overall Study|Withdrawal by Subject|8
6930068|NCT00863798|10961965|FG001|Overall Study|Withdrawal by Subject|7
6930069|NCT00863798|10961966|FG002|Overall Study|Withdrawal by Subject|4
6930070|NCT00863798|10961964|FG000|Overall Study|Randomized not treated|4
6930071|NCT00863798|10961965|FG001|Overall Study|Randomized not treated|2
6930072|NCT00863798|10961966|FG002|Overall Study|Randomized not treated|3
6930073|NCT00863928|10961976|FG000|Overall Study|Protocol Violation|26
6930074|NCT00863928|10961977|FG001|Overall Study|Protocol Violation|0
6930075|NCT00863928|10961976|FG000|Overall Study|Withdrawal by Subject|3
6930076|NCT00863928|10961977|FG001|Overall Study|Withdrawal by Subject|0
6930077|NCT00863928|10961976|FG000|Overall Study|surgery cancellation|4
6930078|NCT00863928|10961977|FG001|Overall Study|surgery cancellation|0
6930079|NCT00863928|10961976|FG000|Overall Study|medication allergy|3
6930080|NCT00863928|10961977|FG001|Overall Study|medication allergy|0
6930081|NCT00864097|10962004|FG000|Overall Study|Death|0
6930082|NCT00864097|10962005|FG001|Overall Study|Death|1
6930083|NCT00864097|10962006|FG002|Overall Study|Death|0
6930084|NCT00864097|10962007|FG003|Overall Study|Death|0
6930085|NCT00864097|10962004|FG000|Overall Study|Adverse Event|6
6930086|NCT00864097|10962005|FG001|Overall Study|Adverse Event|8
6930087|NCT00864097|10962006|FG002|Overall Study|Adverse Event|11
6930088|NCT00864097|10962007|FG003|Overall Study|Adverse Event|9
6930089|NCT00864097|10962004|FG000|Overall Study|Lack of Efficacy|9
6930090|NCT00864097|10962005|FG001|Overall Study|Lack of Efficacy|3
6930091|NCT00864097|10962006|FG002|Overall Study|Lack of Efficacy|7
6930092|NCT00864097|10962007|FG003|Overall Study|Lack of Efficacy|2
6930093|NCT00864097|10962004|FG000|Overall Study|Lost to Follow-up|0
6930094|NCT00864097|10962005|FG001|Overall Study|Lost to Follow-up|1
6930095|NCT00864097|10962006|FG002|Overall Study|Lost to Follow-up|0
6930096|NCT00864097|10962007|FG003|Overall Study|Lost to Follow-up|1
6930097|NCT00864097|10962004|FG000|Overall Study|Withdrawal by Subject|15
6930098|NCT00864097|10962005|FG001|Overall Study|Withdrawal by Subject|11
6930099|NCT00864097|10962006|FG002|Overall Study|Withdrawal by Subject|11
6930100|NCT00864097|10962007|FG003|Overall Study|Withdrawal by Subject|12
6930101|NCT00864097|10962004|FG000|Overall Study|Protocol Violation|2
6930102|NCT00864097|10962005|FG001|Overall Study|Protocol Violation|1
6930103|NCT00864097|10962006|FG002|Overall Study|Protocol Violation|0
6930104|NCT00864097|10962007|FG003|Overall Study|Protocol Violation|1
6930105|NCT00864097|10962004|FG000|Overall Study|Terminated by sponsor|105
6930106|NCT00864097|10962005|FG001|Overall Study|Terminated by sponsor|112
6930107|NCT00864097|10962006|FG002|Overall Study|Terminated by sponsor|102
6930108|NCT00864097|10962007|FG003|Overall Study|Terminated by sponsor|99
6930109|NCT00864097|10962004|FG000|Overall Study|Randomized but not treated|2
6930110|NCT00864097|10962005|FG001|Overall Study|Randomized but not treated|0
6930111|NCT00864097|10962006|FG002|Overall Study|Randomized but not treated|1
6930112|NCT00864097|10962007|FG003|Overall Study|Randomized but not treated|0
6930113|NCT00864097|10962004|FG000|Overall Study|Other|0
6930114|NCT00864097|10962005|FG001|Overall Study|Other|0
6930115|NCT00864097|10962006|FG002|Overall Study|Other|0
6930116|NCT00864097|10962007|FG003|Overall Study|Other|1
6930117|NCT00864253|10962028|FG000|Overall Study|Adverse Event|56
6930118|NCT00864253|10962029|FG001|Overall Study|Adverse Event|11
6930119|NCT00864253|10962028|FG000|Overall Study|Unrelated Adverse Event|3
6930120|NCT00864253|10962029|FG001|Overall Study|Unrelated Adverse Event|1
6930121|NCT00864253|10962028|FG000|Overall Study|Physician Decision|11
6930122|NCT00864253|10962029|FG001|Overall Study|Physician Decision|15
6930123|NCT00864253|10962028|FG000|Overall Study|Protocol Violation|0
6930124|NCT00864253|10962029|FG001|Overall Study|Protocol Violation|2
6930125|NCT00864253|10962028|FG000|Overall Study|Lost to Follow-up|1
6930126|NCT00864253|10962029|FG001|Overall Study|Lost to Follow-up|1
6930127|NCT00864253|10962028|FG000|Overall Study|Withdrawal by Subject|18
6930128|NCT00864253|10962029|FG001|Overall Study|Withdrawal by Subject|18
6930129|NCT00864253|10962028|FG000|Overall Study|Death|1
6930130|NCT00864253|10962029|FG001|Overall Study|Death|0
6930131|NCT00864253|10962028|FG000|Overall Study|Ongoing|2
6930132|NCT00864253|10962029|FG001|Overall Study|Ongoing|3
6930133|NCT00864253|10962028|FG000|Overall Study|Untreated|7
6930134|NCT00864253|10962029|FG001|Overall Study|Untreated|7
6930135|NCT00864513|10962050|FG000|Overall Study|Withdrawal by Subject|3
6930136|NCT00864682|10962082|FG000|Overall Study|Protocol Violation|2
6930137|NCT00864682|10962083|FG001|Overall Study|Protocol Violation|1
6930138|NCT00864682|10962084|FG002|Overall Study|Protocol Violation|2
6930139|NCT00864721|10962098|FG000|Overall Study|Patient request|11
6930140|NCT00864721|10962098|FG000|Overall Study|Hospitalized|1
6930141|NCT00864721|10962098|FG000|Overall Study|Drug hold/delay more than 4 weeks|1
6930142|NCT00864721|10962098|FG000|Overall Study|Adverse Event|21
6930143|NCT00864851|10962105|FG000|Overall Study|Withdrawal by Subject|0
6930144|NCT00864851|10962106|FG001|Overall Study|Withdrawal by Subject|1
6930145|NCT00864851|10962107|FG002|Overall Study|Withdrawal by Subject|0
6930146|NCT00864851|10962105|FG000|Overall Study|Physician Decision|1
6930147|NCT00864851|10962106|FG001|Overall Study|Physician Decision|0
6930148|NCT00864851|10962107|FG002|Overall Study|Physician Decision|0
6930149|NCT00864851|10962105|FG000|Overall Study|Death|1
6930150|NCT00864851|10962106|FG001|Overall Study|Death|0
6930151|NCT00864851|10962107|FG002|Overall Study|Death|0
6930152|NCT00864851|10962105|FG000|Overall Study|Patient uncooperative|1
6930153|NCT00864851|10962106|FG001|Overall Study|Patient uncooperative|0
6930154|NCT00864851|10962107|FG002|Overall Study|Patient uncooperative|0
6930155|NCT00864916|10962119|FG000|Overall Study|Lost to Follow-up|4
6930156|NCT00864916|10962120|FG001|Overall Study|Lost to Follow-up|4
6930157|NCT00864916|10962119|FG000|Overall Study|Protocol Violation|1
6930158|NCT00864916|10962120|FG001|Overall Study|Protocol Violation|0
6930159|NCT00864916|10962119|FG000|Overall Study|Withdrawal by Subject|1
6930160|NCT00864916|10962120|FG001|Overall Study|Withdrawal by Subject|0
6930161|NCT00865020|10962128|FG000|Overall Study|Withdrawal by Subject|22
6930162|NCT00865020|10962129|FG001|Overall Study|Withdrawal by Subject|16
6930163|NCT00865020|10962128|FG000|Overall Study|Adverse Event|9
6930164|NCT00865020|10962129|FG001|Overall Study|Adverse Event|14
6930165|NCT00865020|10962128|FG000|Overall Study|Abnormal test procedure result(s)|6
6930166|NCT00865020|10962129|FG001|Overall Study|Abnormal test procedure result(s)|8
6930167|NCT00865020|10962128|FG000|Overall Study|Lost to Follow-up|6
6930168|NCT00865020|10962129|FG001|Overall Study|Lost to Follow-up|4
6930169|NCT00865020|10962128|FG000|Overall Study|Protocol deviation|4
6930170|NCT00865020|10962129|FG001|Overall Study|Protocol deviation|1
6930171|NCT00865020|10962128|FG000|Overall Study|Administrative problems|0
6930172|NCT00865020|10962129|FG001|Overall Study|Administrative problems|2
6930173|NCT00865020|10962128|FG000|Overall Study|Abnormal laboratory value(s)|0
6930174|NCT00865020|10962129|FG001|Overall Study|Abnormal laboratory value(s)|1
6930175|NCT00865020|10962128|FG000|Overall Study|Death|0
6930176|NCT00865020|10962129|FG001|Overall Study|Death|1
6930177|NCT00865020|10962128|FG000|Overall Study|Randomized but discontinued|2
6930178|NCT00865020|10962129|FG001|Overall Study|Randomized but discontinued|4
6930179|NCT00865046|10962138|FG000|Overall Study|Lost to Follow-up|1
6930180|NCT00865046|10962139|FG001|Overall Study|Lost to Follow-up|4
6930181|NCT00865046|10962140|FG002|Overall Study|Lost to Follow-up|0
6930182|NCT00865046|10962138|FG000|Overall Study|Death|0
6930183|NCT00865046|10962139|FG001|Overall Study|Death|1
6930184|NCT00865046|10962140|FG002|Overall Study|Death|1
6930185|NCT00865046|10962138|FG000|Overall Study|Withdrawal by Subject|5
6930186|NCT00865046|10962139|FG001|Overall Study|Withdrawal by Subject|0
6930187|NCT00865046|10962140|FG002|Overall Study|Withdrawal by Subject|0
6930188|NCT00865098|10962148|FG000|Overall Study|Progressive disease|1
6930189|NCT00865124|10962155|FG000|Overall Study|Physician Decision|2
6930190|NCT00865124|10962156|FG001|Overall Study|Physician Decision|1
6930191|NCT00865124|10962157|FG002|Overall Study|Physician Decision|0
6930192|NCT00865124|10962155|FG000|Overall Study|Withdrawn consent|2
6930193|NCT00865124|10962156|FG001|Overall Study|Withdrawn consent|0
6930194|NCT00865124|10962157|FG002|Overall Study|Withdrawn consent|0
6930195|NCT00865189|10962167|FG000|Overall Study|Other|1
6930196|NCT00865189|10962168|FG001|Overall Study|Other|2
6930197|NCT00865189|10962167|FG000|Overall Study|Death|4
6930198|NCT00865189|10962168|FG001|Overall Study|Death|11
6930199|NCT00865189|10962167|FG000|Overall Study|Lost to Follow-up|6
6930200|NCT00865189|10962168|FG001|Overall Study|Lost to Follow-up|6
6930201|NCT00865189|10962167|FG000|Overall Study|Withdrawal by Subject|1
6930202|NCT00865189|10962168|FG001|Overall Study|Withdrawal by Subject|0
6930203|NCT00865280|10962186|FG000|Overall Study|Withdrawal by Subject|4
6930204|NCT00865280|10962187|FG001|Overall Study|Withdrawal by Subject|1
6930205|NCT00865280|10962186|FG000|Overall Study|End of Treatment/Lost to Follow-up|0
6930206|NCT00865280|10962187|FG001|Overall Study|End of Treatment/Lost to Follow-up|1
6930207|NCT00865280|10962186|FG000|Overall Study|Adverse Event/Lost to Follow-up|1
6930208|NCT00865280|10962187|FG001|Overall Study|Adverse Event/Lost to Follow-up|0
6930209|NCT00865280|10962186|FG000|Overall Study|Exclusion Condition|1
6930210|NCT00865280|10962187|FG001|Overall Study|Exclusion Condition|0
6930211|NCT00865280|10962186|FG000|Overall Study|Adverse Event|0
6930212|NCT00865280|10962187|FG001|Overall Study|Adverse Event|1
6930213|NCT00865306|10962195|FG000|Controlled Trial|Lost to Follow-up|1
6930214|NCT00865306|10962196|FG001|Controlled Trial|Lost to Follow-up|1
6930215|NCT00865306|10962195|FG000|Controlled Trial|Difficulty commuting|2
6930216|NCT00865306|10962196|FG001|Controlled Trial|Difficulty commuting|0
6930217|NCT00865306|10962195|FG000|Controlled Trial|Improved btw baseline and first session|1
6930218|NCT00865306|10962196|FG001|Controlled Trial|Improved btw baseline and first session|0
6930219|NCT00865306|10962195|FG000|Controlled Trial|Sought treatment for conduct disorder|1
6930220|NCT00865306|10962196|FG001|Controlled Trial|Sought treatment for conduct disorder|0
6930221|NCT00865306|10962195|FG000|Controlled Trial|Withdrawal by Subject|0
6930222|NCT00865306|10962196|FG001|Controlled Trial|Withdrawal by Subject|1
6930223|NCT00865345|10962202|FG000|Overall Study|Withdrawal by Subject|2
6930224|NCT00865566|10962208|FG000|Overall Study|Death|1
6930225|NCT00865566|10962209|FG001|Overall Study|Death|11
6930226|NCT00865566|10962208|FG000|Overall Study|Lost to Follow-up|314
6930227|NCT00865566|10962209|FG001|Overall Study|Lost to Follow-up|315
6930228|NCT00865566|10962208|FG000|Overall Study|Withdrawal by Subject|45
6930229|NCT00865566|10962209|FG001|Overall Study|Withdrawal by Subject|65
6930230|NCT00865566|10962208|FG000|Overall Study|Physician Decision|0
6930231|NCT00865566|10962209|FG001|Overall Study|Physician Decision|1
6930232|NCT00865566|10962208|FG000|Overall Study|Participant relocated|78
6930233|NCT00865566|10962209|FG001|Overall Study|Participant relocated|107
6930234|NCT00865566|10962208|FG000|Overall Study|Participant unable to adhere|27
6930235|NCT00865566|10962209|FG001|Overall Study|Participant unable to adhere|42
6930236|NCT00865566|10962208|FG000|Overall Study|Other; N=245 due to early study closure|154
6930237|NCT00865566|10962209|FG001|Overall Study|Other; N=245 due to early study closure|139
6930238|NCT00865566|10962208|FG000|Overall Study|HIV infection|5
6930239|NCT00865566|10962209|FG001|Overall Study|HIV infection|7
6975132|NCT01190930|11027136|FG005|Maintenance|second malignant neoplasm|1
6975133|NCT01190930|11027137|FG006|Maintenance|second malignant neoplasm|0
6975134|NCT01190930|11027138|FG007|Maintenance|second malignant neoplasm|0
6975135|NCT01190930|11027139|FG008|Maintenance|second malignant neoplasm|1
6975136|NCT01190930|11027140|FG009|Maintenance|second malignant neoplasm|0
6975137|NCT01190930|11027131|FG000|Maintenance|Inevaluable|0
6975138|NCT01190930|11027132|FG001|Maintenance|Inevaluable|0
6975139|NCT01190930|11027133|FG002|Maintenance|Inevaluable|0
6975140|NCT01190930|11027134|FG003|Maintenance|Inevaluable|0
6975141|NCT01190930|11027135|FG004|Maintenance|Inevaluable|0
6975142|NCT01190930|11027136|FG005|Maintenance|Inevaluable|1
6975143|NCT01190930|11027137|FG006|Maintenance|Inevaluable|1
6975144|NCT01190930|11027138|FG007|Maintenance|Inevaluable|1
6975145|NCT01190930|11027139|FG008|Maintenance|Inevaluable|0
6975146|NCT01190930|11027140|FG009|Maintenance|Inevaluable|0
6975147|NCT01190930|11027131|FG000|Maintenance|Enrollment onto another COG Protocol|0
6975148|NCT01190930|11027132|FG001|Maintenance|Enrollment onto another COG Protocol|0
6975149|NCT01190930|11027133|FG002|Maintenance|Enrollment onto another COG Protocol|0
6975150|NCT01190930|11027134|FG003|Maintenance|Enrollment onto another COG Protocol|0
6975151|NCT01190930|11027135|FG004|Maintenance|Enrollment onto another COG Protocol|0
6975152|NCT01190930|11027136|FG005|Maintenance|Enrollment onto another COG Protocol|0
6975153|NCT01190930|11027137|FG006|Maintenance|Enrollment onto another COG Protocol|0
6975154|NCT01190930|11027138|FG007|Maintenance|Enrollment onto another COG Protocol|0
6975155|NCT01190930|11027139|FG008|Maintenance|Enrollment onto another COG Protocol|1
6975156|NCT01190930|11027140|FG009|Maintenance|Enrollment onto another COG Protocol|0
6975157|NCT01190930|11027131|FG000|Maintenance|Relapse|0
6975158|NCT01190930|11027132|FG001|Maintenance|Relapse|0
6975159|NCT01190930|11027133|FG002|Maintenance|Relapse|0
6975160|NCT01190930|11027134|FG003|Maintenance|Relapse|2
6975161|NCT01190930|11027135|FG004|Maintenance|Relapse|0
6975162|NCT01190930|11027136|FG005|Maintenance|Relapse|1
6975163|NCT01190930|11027137|FG006|Maintenance|Relapse|6
6975164|NCT01190930|11027138|FG007|Maintenance|Relapse|13
6975165|NCT01190930|11027139|FG008|Maintenance|Relapse|11
6975166|NCT01190930|11027140|FG009|Maintenance|Relapse|11
6975167|NCT01190930|11027131|FG000|Maintenance|Still on therapy|0
6975168|NCT01190930|11027132|FG001|Maintenance|Still on therapy|8
6975169|NCT01190930|11027133|FG002|Maintenance|Still on therapy|0
6975170|NCT01190930|11027134|FG003|Maintenance|Still on therapy|29
6975171|NCT01190930|11027135|FG004|Maintenance|Still on therapy|0
6975172|NCT01190930|11027136|FG005|Maintenance|Still on therapy|0
6930240|NCT00865709|10962217|FG000|Treatment|Adverse Event|9
6930241|NCT00865709|10962218|FG001|Treatment|Adverse Event|6
6930242|NCT00865709|10962217|FG000|Treatment|Withdrawal by Subject|10
6930243|NCT00865709|10962218|FG001|Treatment|Withdrawal by Subject|7
6930244|NCT00865709|10962217|FG000|Treatment|Physician Decision|3
6930245|NCT00865709|10962218|FG001|Treatment|Physician Decision|2
6930246|NCT00865709|10962217|FG000|Treatment|Surgery|8
6930247|NCT00865709|10962218|FG001|Treatment|Surgery|3
6930248|NCT00865904|10962231|FG000|Overall Study|Randomized but not Treated|2
6930249|NCT00865904|10962232|FG001|Overall Study|Randomized but not Treated|0
6930250|NCT00865904|10962233|FG002|Overall Study|Randomized but not Treated|0
6930251|NCT00865904|10962234|FG003|Overall Study|Randomized but not Treated|1
6930252|NCT00865904|10962235|FG004|Overall Study|Randomized but not Treated|1
6930253|NCT00866047|10962264|FG000|Treatment Period|Progressive disease|13
6930254|NCT00866047|10962264|FG000|Treatment Period|Adverse Event|16
6930255|NCT00866047|10962264|FG000|Treatment Period|Physician Decision|14
6930256|NCT00866047|10962264|FG000|Treatment Period|Withdrawal by Subject|5
6930257|NCT00866047|10962264|FG000|Follow-up Period|Lost to Follow-up|5
6930258|NCT00866177|10962268|FG000|Overall Study|Withdrawal by Subject|1
6930259|NCT00866177|10962268|FG000|Overall Study|Not Treated|151
6930260|NCT00866281|10962274|FG000|Overall Study|Adverse Event|1
6930261|NCT00866281|10962275|FG001|Overall Study|Adverse Event|0
6930262|NCT00866281|10962274|FG000|Overall Study|Withdrawal by participants|3
6930263|NCT00866281|10962275|FG001|Overall Study|Withdrawal by participants|0
6930264|NCT00866281|10962274|FG000|Overall Study|Disease progression|3
6930265|NCT00866281|10962275|FG001|Overall Study|Disease progression|11
6930266|NCT00866281|10962274|FG000|Overall Study|New cancer therapy|0
6930267|NCT00866281|10962275|FG001|Overall Study|New cancer therapy|4
6930268|NCT00866294|10962287|FG000|Overall Study|Adverse Event|12
6930269|NCT00866294|10962288|FG001|Overall Study|Adverse Event|13
6930270|NCT00866294|10962289|FG002|Overall Study|Adverse Event|9
6930271|NCT00866294|10962287|FG000|Overall Study|Lack of Efficacy|7
6930272|NCT00866294|10962288|FG001|Overall Study|Lack of Efficacy|1
6930273|NCT00866294|10962289|FG002|Overall Study|Lack of Efficacy|0
6930274|NCT00866294|10962287|FG000|Overall Study|Protocol Violation|2
6930275|NCT00866294|10962288|FG001|Overall Study|Protocol Violation|0
6930276|NCT00866294|10962289|FG002|Overall Study|Protocol Violation|0
6930277|NCT00866294|10962287|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5
6930278|NCT00866294|10962288|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1
6930279|NCT00866294|10962289|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1
6930280|NCT00866294|10962287|FG000|Overall Study|Lost to Follow-up|1
6930281|NCT00866294|10962288|FG001|Overall Study|Lost to Follow-up|3
6930282|NCT00866294|10962289|FG002|Overall Study|Lost to Follow-up|0
6930283|NCT00866294|10962287|FG000|Overall Study|Physician Decision|6
6930284|NCT00866294|10962288|FG001|Overall Study|Physician Decision|2
6930285|NCT00866294|10962289|FG002|Overall Study|Physician Decision|1
6930286|NCT00866307|10962305|FG000|Induction|Adverse Event|5
6930287|NCT00866307|10962306|FG001|Induction|Adverse Event|0
6930288|NCT00866307|10962307|FG002|Induction|Adverse Event|0
6930289|NCT00866307|10962305|FG000|Induction|Death|2
6930290|NCT00866307|10962306|FG001|Induction|Death|0
6930291|NCT00866307|10962307|FG002|Induction|Death|0
6930292|NCT00866307|10962305|FG000|Induction|Physician Decision|5
6930293|NCT00866307|10962306|FG001|Induction|Physician Decision|0
6930294|NCT00866307|10962307|FG002|Induction|Physician Decision|0
6930295|NCT00866307|10962305|FG000|Induction|Progressive Disease|1
6930296|NCT00866307|10962306|FG001|Induction|Progressive Disease|0
6930297|NCT00866307|10962307|FG002|Induction|Progressive Disease|0
6930298|NCT00866307|10962305|FG000|Induction|Identification of Patients with Day 29 M|3
6930299|NCT00866307|10962306|FG001|Induction|Identification of Patients with Day 29 M|0
6930300|NCT00866307|10962307|FG002|Induction|Identification of Patients with Day 29 M|0
6930301|NCT00866307|10962305|FG000|Induction|Inadequate cytognetic samples th|1
6930302|NCT00866307|10962306|FG001|Induction|Inadequate cytognetic samples th|0
6930303|NCT00866307|10962307|FG002|Induction|Inadequate cytognetic samples th|0
6930304|NCT00866307|10962305|FG000|Induction|Improper post-induction consent|2
6930305|NCT00866307|10962306|FG001|Induction|Improper post-induction consent|0
6930306|NCT00866307|10962307|FG002|Induction|Improper post-induction consent|0
6930307|NCT00866307|10962305|FG000|Induction|Study was closed at the time|1
6930308|NCT00866307|10962306|FG001|Induction|Study was closed at the time|0
6930309|NCT00866307|10962307|FG002|Induction|Study was closed at the time|0
6930310|NCT00866307|10962305|FG000|Consolidation/Maintenance|Adverse Event|0
6930311|NCT00866307|10962306|FG001|Consolidation/Maintenance|Adverse Event|0
6930312|NCT00866307|10962307|FG002|Consolidation/Maintenance|Adverse Event|8
6930313|NCT00866307|10962305|FG000|Consolidation/Maintenance|Death|0
6930314|NCT00866307|10962306|FG001|Consolidation/Maintenance|Death|0
6930315|NCT00866307|10962307|FG002|Consolidation/Maintenance|Death|1
6930316|NCT00866307|10962305|FG000|Consolidation/Maintenance|Physician Decision|0
6930317|NCT00866307|10962306|FG001|Consolidation/Maintenance|Physician Decision|3
6930318|NCT00866307|10962307|FG002|Consolidation/Maintenance|Physician Decision|2
6930319|NCT00866307|10962305|FG000|Consolidation/Maintenance|Withdrawal by Subject|0
6930320|NCT00866307|10962306|FG001|Consolidation/Maintenance|Withdrawal by Subject|1
6930321|NCT00866307|10962307|FG002|Consolidation/Maintenance|Withdrawal by Subject|1
6930322|NCT00866307|10962305|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
6930323|NCT00866307|10962306|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
6930324|NCT00866307|10962307|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2
6930325|NCT00866307|10962305|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0
6930326|NCT00866307|10962306|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3
6930327|NCT00866307|10962307|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1
6930328|NCT00866307|10962305|FG000|Consolidation/Maintenance|Therapy error|0
6930329|NCT00866307|10962306|FG001|Consolidation/Maintenance|Therapy error|1
6930330|NCT00866307|10962307|FG002|Consolidation/Maintenance|Therapy error|0
6930331|NCT00866307|10962305|FG000|Consolidation/Maintenance|Non-compliance|0
6930332|NCT00866307|10962306|FG001|Consolidation/Maintenance|Non-compliance|0
6930333|NCT00866307|10962307|FG002|Consolidation/Maintenance|Non-compliance|1
6930334|NCT00866307|10962305|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0
6930335|NCT00866307|10962306|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1
6930336|NCT00866307|10962307|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0
6930337|NCT00866320|10962313|FG000|Overall Study|Withdrawal by Subject|4
6930338|NCT00866320|10962313|FG000|Overall Study|Death|2
6930339|NCT00866333|10962322|FG000|Overall Study|Withdrawal of consent|0
6930340|NCT00866333|10962323|FG001|Overall Study|Withdrawal of consent|1
6930341|NCT00866333|10962324|FG002|Overall Study|Withdrawal of consent|2
6930342|NCT00866333|10962322|FG000|Overall Study|Reason not Specified|3
6930343|NCT00866333|10962323|FG001|Overall Study|Reason not Specified|1
6930344|NCT00866333|10962324|FG002|Overall Study|Reason not Specified|1
6930345|NCT00866333|10962322|FG000|Overall Study|Study Terminated by Sponsor|2
6930346|NCT00866333|10962323|FG001|Overall Study|Study Terminated by Sponsor|5
6930347|NCT00866333|10962324|FG002|Overall Study|Study Terminated by Sponsor|9
6930348|NCT00866359|10962334|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5
6930349|NCT00866359|10962335|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4
6930350|NCT00866359|10962336|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0
6930351|NCT00866359|10962337|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0
6930352|NCT00866359|10962334|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3
6930353|NCT00866359|10962335|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
6930354|NCT00866359|10962336|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
6930355|NCT00866359|10962337|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
7183761|NCT01254422|11383827|FG000|Overall Study|Serious adverse event|0
6930356|NCT00866359|10962334|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1
6930357|NCT00866359|10962335|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
6930358|NCT00866359|10962336|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
6930359|NCT00866359|10962337|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
6930360|NCT00866359|10962334|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1
6930361|NCT00866359|10962335|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1
6930362|NCT00866359|10962336|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0
6930363|NCT00866359|10962337|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0
6930364|NCT00866359|10962334|FG000|Treatment Phase (Days 1 to 85)|Other|1
6930365|NCT00866359|10962335|FG001|Treatment Phase (Days 1 to 85)|Other|0
6930366|NCT00866359|10962336|FG002|Treatment Phase (Days 1 to 85)|Other|0
6930367|NCT00866359|10962337|FG003|Treatment Phase (Days 1 to 85)|Other|0
6930368|NCT00866359|10962334|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0
6930369|NCT00866359|10962335|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0
6930370|NCT00866359|10962336|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1
6930371|NCT00866359|10962337|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3
6930372|NCT00866606|10962364|FG000|Overall Study|Lost to Follow-up|3
6930373|NCT00866606|10962364|FG000|Overall Study|Adverse Event|1
6930374|NCT00866619|10962372|FG000|Overall Study|Adverse Event|112
6930375|NCT00866619|10962373|FG001|Overall Study|Adverse Event|106
6930376|NCT00866619|10962374|FG002|Overall Study|Adverse Event|47
6930377|NCT00866619|10962375|FG003|Overall Study|Adverse Event|44
6930378|NCT00866619|10962372|FG000|Overall Study|Protocol Violation|2
6930379|NCT00866619|10962373|FG001|Overall Study|Protocol Violation|39
6930380|NCT00866619|10962374|FG002|Overall Study|Protocol Violation|2
6930381|NCT00866619|10962375|FG003|Overall Study|Protocol Violation|17
6930382|NCT00866619|10962372|FG000|Overall Study|Withdrawal by Subject|587
6930383|NCT00866619|10962373|FG001|Overall Study|Withdrawal by Subject|295
6930384|NCT00866619|10962374|FG002|Overall Study|Withdrawal by Subject|272
6930385|NCT00866619|10962375|FG003|Overall Study|Withdrawal by Subject|144
6930386|NCT00866619|10962372|FG000|Overall Study|Lost to Follow-up|1145
6930387|NCT00866619|10962373|FG001|Overall Study|Lost to Follow-up|830
6930388|NCT00866619|10962374|FG002|Overall Study|Lost to Follow-up|568
6930389|NCT00866619|10962375|FG003|Overall Study|Lost to Follow-up|425
6930390|NCT00866658|10962412|FG000|Overall Study|Adverse Event|5
6930391|NCT00866658|10962413|FG001|Overall Study|Adverse Event|14
6930392|NCT00866658|10962412|FG000|Overall Study|Lack of Efficacy|2
6930393|NCT00866658|10962413|FG001|Overall Study|Lack of Efficacy|1
6930394|NCT00866658|10962412|FG000|Overall Study|Withdrawal by Subject|1
6930395|NCT00866658|10962413|FG001|Overall Study|Withdrawal by Subject|0
6930396|NCT00866658|10962412|FG000|Overall Study|Protocol Violation|1
6930397|NCT00866658|10962413|FG001|Overall Study|Protocol Violation|1
6930398|NCT00866658|10962412|FG000|Overall Study|Familial and Personal Reasons|4
6930399|NCT00866658|10962413|FG001|Overall Study|Familial and Personal Reasons|5
6930400|NCT00866697|10962421|FG000|Overall Study|Study closed/terminated|156
6930401|NCT00866697|10962422|FG001|Overall Study|Study closed/terminated|138
6930402|NCT00866697|10962421|FG000|Overall Study|Lost to Follow-up|22
6930403|NCT00866697|10962422|FG001|Overall Study|Lost to Follow-up|28
6930404|NCT00866697|10962421|FG000|Overall Study|Physician Decision|3
6930405|NCT00866697|10962422|FG001|Overall Study|Physician Decision|5
6930406|NCT00866697|10962421|FG000|Overall Study|Withdrawal by Subject|33
6930407|NCT00866697|10962422|FG001|Overall Study|Withdrawal by Subject|57
6930408|NCT00866723|10962428|FG000|Overall Study|Withdrawal by Subject|1
6930409|NCT00866723|10962428|FG000|Overall Study|Disease Progression|4
6930410|NCT00866775|10962438|FG000|Overall Study|Adverse Event|5
6930411|NCT00866775|10962439|FG001|Overall Study|Adverse Event|19
6930412|NCT00866775|10962438|FG000|Overall Study|Death|1
6930413|NCT00866775|10962439|FG001|Overall Study|Death|0
6930414|NCT00866775|10962438|FG000|Overall Study|Lost to Follow-up|0
6930415|NCT00866775|10962439|FG001|Overall Study|Lost to Follow-up|4
6930416|NCT00866775|10962438|FG000|Overall Study|Physician Decision|0
6930417|NCT00866775|10962439|FG001|Overall Study|Physician Decision|3
7065413|NCT01966445|11164916|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
7065414|NCT01966445|11164910|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
7065415|NCT01966445|11164911|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
7065416|NCT01966445|11164912|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
7065417|NCT01966445|11164913|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
7065418|NCT01966445|11164914|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
7065419|NCT01966445|11164915|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
7065420|NCT01966445|11164916|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
7065421|NCT01966445|11164910|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
7065422|NCT01966445|11164911|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1
7065423|NCT01966445|11164912|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1
7065424|NCT01966445|11164913|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
7065425|NCT01966445|11164914|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2
7065426|NCT01966445|11164915|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
7065427|NCT01966445|11164916|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
7065428|NCT01966445|11164910|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
7065429|NCT01966445|11164911|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
7065430|NCT01966445|11164912|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
7065431|NCT01966445|11164913|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
7065432|NCT01966445|11164914|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
7065433|NCT01966445|11164915|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
7065434|NCT01966445|11164916|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3
7065435|NCT01966445|11164910|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
7065436|NCT01966445|11164911|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
7065437|NCT01966445|11164912|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
7065438|NCT01966445|11164913|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
7065439|NCT01966445|11164914|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
7065440|NCT01966445|11164915|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
7065441|NCT01966445|11164916|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2
7065442|NCT01967069|11165035|FG000|Overall Study|Adverse Event|2
7065443|NCT01967069|11165036|FG001|Overall Study|Adverse Event|2
7065444|NCT01967069|11165035|FG000|Overall Study|Lost to Follow-up|5
7065445|NCT01967069|11165036|FG001|Overall Study|Lost to Follow-up|2
7065446|NCT01967069|11165035|FG000|Overall Study|Withdrawal by Subject|1
7065447|NCT01967069|11165036|FG001|Overall Study|Withdrawal by Subject|3
7065448|NCT01967069|11165035|FG000|Overall Study|Lack of Efficacy|0
7065449|NCT01967069|11165036|FG001|Overall Study|Lack of Efficacy|1
7065450|NCT01967134|11165058|FG000|Overall Study|Lost to Follow-up|0
7065451|NCT01967134|11165059|FG001|Overall Study|Lost to Follow-up|1
7065452|NCT01967134|11165060|FG002|Overall Study|Lost to Follow-up|0
7065453|NCT01967147|11165070|FG000|Overall Study|Adverse Event|5
7065454|NCT01967147|11165071|FG001|Overall Study|Adverse Event|2
7065455|NCT01967147|11165070|FG000|Overall Study|Lack of Efficacy|1
7065456|NCT01967147|11165071|FG001|Overall Study|Lack of Efficacy|4
7065457|NCT01967147|11165070|FG000|Overall Study|Lost to Follow-up|1
7065458|NCT01967147|11165071|FG001|Overall Study|Lost to Follow-up|2
7065459|NCT01967147|11165070|FG000|Overall Study|Withdrawal by Subject|2
7065460|NCT01967147|11165071|FG001|Overall Study|Withdrawal by Subject|4
7065461|NCT01967147|11165070|FG000|Overall Study|Non-compliance with Study Drug|0
7065462|NCT01967147|11165071|FG001|Overall Study|Non-compliance with Study Drug|3
7065463|NCT01967147|11165070|FG000|Overall Study|Other|4
7065464|NCT01967147|11165071|FG001|Overall Study|Other|5
6930418|NCT00866775|10962438|FG000|Overall Study|Protocol Violation|3
6930419|NCT00866775|10962439|FG001|Overall Study|Protocol Violation|4
6930420|NCT00866775|10962438|FG000|Overall Study|Withdrawal by Subject|4
6930421|NCT00866775|10962439|FG001|Overall Study|Withdrawal by Subject|4
7065465|NCT01967173|11165086|FG000|Overall Study|Lost to Follow-up|5
7065466|NCT01967173|11165087|FG001|Overall Study|Lost to Follow-up|3
7065467|NCT01967173|11165088|FG002|Overall Study|Lost to Follow-up|2
6930422|NCT00866775|10962438|FG000|Overall Study|met exit criteria|23
6930423|NCT00866775|10962439|FG001|Overall Study|met exit criteria|17
6930424|NCT00866775|10962438|FG000|Overall Study|discontinued due to communication error|0
6930425|NCT00866775|10962439|FG001|Overall Study|discontinued due to communication error|1
6930426|NCT00866788|10962451|FG000|Overall Study|Adverse Event|0
6930427|NCT00866788|10962452|FG001|Overall Study|Adverse Event|2
6930428|NCT00866788|10962453|FG002|Overall Study|Adverse Event|0
6930429|NCT00866788|10962454|FG003|Overall Study|Adverse Event|1
6930430|NCT00866788|10962451|FG000|Overall Study|Lost to Follow-up|1
6930431|NCT00866788|10962452|FG001|Overall Study|Lost to Follow-up|1
6930432|NCT00866788|10962453|FG002|Overall Study|Lost to Follow-up|0
6930433|NCT00866788|10962454|FG003|Overall Study|Lost to Follow-up|2
6930434|NCT00866788|10962451|FG000|Overall Study|Withdrawal by Subject|2
6930435|NCT00866788|10962452|FG001|Overall Study|Withdrawal by Subject|1
6930436|NCT00866788|10962453|FG002|Overall Study|Withdrawal by Subject|0
6930437|NCT00866788|10962454|FG003|Overall Study|Withdrawal by Subject|1
6930438|NCT00866788|10962451|FG000|Overall Study|Pregnancy|0
6930439|NCT00866788|10962452|FG001|Overall Study|Pregnancy|1
6930440|NCT00866788|10962453|FG002|Overall Study|Pregnancy|0
6930441|NCT00866788|10962454|FG003|Overall Study|Pregnancy|0
6930442|NCT00866788|10962451|FG000|Overall Study|Disease progression|3
6930443|NCT00866788|10962452|FG001|Overall Study|Disease progression|1
6930444|NCT00866788|10962453|FG002|Overall Study|Disease progression|1
6930445|NCT00866788|10962454|FG003|Overall Study|Disease progression|0
6930446|NCT00866788|10962451|FG000|Overall Study|Physician Decision|0
6930447|NCT00866788|10962452|FG001|Overall Study|Physician Decision|0
6930448|NCT00866788|10962453|FG002|Overall Study|Physician Decision|1
6930449|NCT00866788|10962454|FG003|Overall Study|Physician Decision|1
6930450|NCT00866814|10962467|FG000|Overall Study|Lost to Follow-up|12
6930451|NCT00866814|10962467|FG000|Overall Study|Adverse Event|2
6930452|NCT00866814|10962467|FG000|Overall Study|Physician Decision|1
6930453|NCT00866814|10962467|FG000|Overall Study|Death|1
6930454|NCT00866814|10962467|FG000|Overall Study|No longer wished to participate|1
6930455|NCT00866814|10962467|FG000|Overall Study|Unable to meet follow-up requirements|2
6930456|NCT00866814|10962467|FG000|Overall Study|Moved to area without study site|1
6930457|NCT00867009|10962486|FG000|Induction Period|Nonserious Adverse Event|5
6930458|NCT00867009|10962486|FG000|Induction Period|Serious Adverse Event|10
6930459|NCT00867009|10962486|FG000|Induction Period|Death due to serious adverse event|6
6930460|NCT00867009|10962486|FG000|Induction Period|Death due to Study Disease|4
6930461|NCT00867009|10962486|FG000|Induction Period|Protocol Violation|1
6930462|NCT00867009|10962486|FG000|Induction Period|Withdrawal by Subject|8
6930463|NCT00867009|10962486|FG000|Induction Period|Physician Decision|3
6930464|NCT00867009|10962486|FG000|Induction Period|Progressive Disease (PD)|25
6930465|NCT00867009|10962486|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4
6930466|NCT00867035|10962492|FG000|Baseline to 1 Hour|Withdrawal by Subject|1
6930467|NCT00867035|10962493|FG001|Baseline to 1 Hour|Withdrawal by Subject|1
6930468|NCT00867035|10962492|FG000|Baseline to 1 Week|Withdrawal by Subject|1
6930469|NCT00867035|10962493|FG001|Baseline to 1 Week|Withdrawal by Subject|0
6930470|NCT00867087|10962499|FG000|Overall Study|Other|1
6930471|NCT00867087|10962499|FG000|Overall Study|Withdrawal by Subject|4
6930472|NCT00867087|10962499|FG000|Overall Study|Death|37
6930473|NCT00867113|10962560|FG000|Treatment Period|Adverse Event|15
6930474|NCT00867113|10962560|FG000|Treatment Period|Death|2
6930475|NCT00867113|10962560|FG000|Treatment Period|Withdrawal by Subject|19
6930476|NCT00867113|10962560|FG000|Treatment Period|Lost to Follow-up|3
6930477|NCT00867113|10962560|FG000|Treatment Period|Administrative problems|1
6930478|NCT00867113|10962560|FG000|Treatment Period|Disease progression/relapse|1
6930479|NCT00867113|10962560|FG000|Treatment Period|Protocol Violation|4
6930480|NCT00867113|10962560|FG000|Post Treatment After Survival Follow-up|Death|1
6930481|NCT00867113|10962560|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1
6930482|NCT00867113|10962560|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5
6930483|NCT00867113|10962560|FG000|Post Treatment After Survival Follow-up|Administrative problems|4
6930484|NCT00867308|10962596|FG000|Overall Study|Death|1
6930485|NCT00867308|10962597|FG001|Overall Study|Death|0
6930486|NCT00867308|10962596|FG000|Overall Study|Adverse Event|1
6930487|NCT00867308|10962597|FG001|Overall Study|Adverse Event|4
6930488|NCT00867308|10962596|FG000|Overall Study|Lack of Efficacy|6
6930489|NCT00867308|10962597|FG001|Overall Study|Lack of Efficacy|12
6930490|NCT00867308|10962596|FG000|Overall Study|Withdrawal by Subject|1
6930491|NCT00867308|10962597|FG001|Overall Study|Withdrawal by Subject|2
6930492|NCT00867334|10962605|FG000|Overall Study|Withdrawal by Subject|0
6930493|NCT00867334|10962606|FG001|Overall Study|Withdrawal by Subject|1
6930494|NCT00867334|10962605|FG000|Overall Study|Withdrawal by Subject|1
6930495|NCT00867334|10962606|FG001|Overall Study|Withdrawal by Subject|0
6930496|NCT00867334|10962605|FG000|Overall Study|Withdrawal by Subject|1
6930497|NCT00867334|10962606|FG001|Overall Study|Withdrawal by Subject|0
6930498|NCT00867360|10962614|FG000|Overall Study|Withdrawal by Subject|1
6930499|NCT00867360|10962615|FG001|Overall Study|Withdrawal by Subject|0
6930500|NCT00867360|10962614|FG000|Overall Study|Physician Decision|0
6930501|NCT00867360|10962615|FG001|Overall Study|Physician Decision|1
6930502|NCT00867490|10962635|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5
6930503|NCT00867490|10962635|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4
6930504|NCT00867490|10962635|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1
6930505|NCT00867490|10962635|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2
6930506|NCT00867490|10962635|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1
6930507|NCT00867503|10962642|FG000|Overall Study|Withdrawal by Subject|1
6930508|NCT00867815|10962666|FG000|Overall Study|Lost to Follow-up|1
6930509|NCT00868166|10962698|FG000|Overall Study|Death|58
6930510|NCT00868166|10962699|FG001|Overall Study|Death|65
6930511|NCT00868166|10962698|FG000|Overall Study|Withdrawal by Subject|33
6930512|NCT00868166|10962699|FG001|Overall Study|Withdrawal by Subject|25
6930513|NCT00868166|10962698|FG000|Overall Study|Protocol Violation|1
6930514|NCT00868166|10962699|FG001|Overall Study|Protocol Violation|0
6930515|NCT00868166|10962698|FG000|Overall Study|Lost to Follow-up|1
6930516|NCT00868166|10962699|FG001|Overall Study|Lost to Follow-up|3
6930517|NCT00868166|10962698|FG000|Overall Study|Adverse Event|9
6930518|NCT00868166|10962699|FG001|Overall Study|Adverse Event|10
6930519|NCT00868166|10962698|FG000|Overall Study|Lack of efficacy, logistics, unwell|9
6930520|NCT00868166|10962699|FG001|Overall Study|Lack of efficacy, logistics, unwell|10
6930521|NCT00868166|10962698|FG000|Overall Study|Non-compliance with IMP|1
6930522|NCT00868166|10962699|FG001|Overall Study|Non-compliance with IMP|1
6930523|NCT00868192|10962705|FG000|Overall Study|Ineligible|4
6930524|NCT00868231|10962730|FG000|Treatment Period 1|Adverse Event|0
6930525|NCT00868231|10962731|FG001|Treatment Period 1|Adverse Event|0
6930526|NCT00868231|10962732|FG002|Treatment Period 1|Adverse Event|0
6930527|NCT00868231|10962733|FG003|Treatment Period 1|Adverse Event|0
6930528|NCT00868231|10962734|FG004|Treatment Period 1|Adverse Event|1
6930529|NCT00868231|10962735|FG005|Treatment Period 1|Adverse Event|0
6930530|NCT00868231|10962730|FG000|Treatment Period 2|Adverse Event|1
6930531|NCT00868231|10962731|FG001|Treatment Period 2|Adverse Event|0
6930532|NCT00868231|10962732|FG002|Treatment Period 2|Adverse Event|0
6930533|NCT00868231|10962733|FG003|Treatment Period 2|Adverse Event|0
6930534|NCT00868231|10962734|FG004|Treatment Period 2|Adverse Event|0
6930535|NCT00868231|10962735|FG005|Treatment Period 2|Adverse Event|0
6930536|NCT00868231|10962730|FG000|Treatment Period 3|Adverse Event|0
6930537|NCT00868231|10962731|FG001|Treatment Period 3|Adverse Event|0
6930538|NCT00868231|10962732|FG002|Treatment Period 3|Adverse Event|1
6930539|NCT00868231|10962733|FG003|Treatment Period 3|Adverse Event|0
6930540|NCT00868231|10962734|FG004|Treatment Period 3|Adverse Event|0
6930541|NCT00868231|10962735|FG005|Treatment Period 3|Adverse Event|0
6930542|NCT00868296|10962745|FG000|Overall Study|Adverse Event|0
6930543|NCT00868296|10962746|FG001|Overall Study|Adverse Event|2
6930544|NCT00868296|10962745|FG000|Overall Study|Withdrawal by Subject|0
6930545|NCT00868296|10962746|FG001|Overall Study|Withdrawal by Subject|1
6930546|NCT00868439|10962781|FG000|Overall Study|Adverse Event|4
6930547|NCT00868439|10962782|FG001|Overall Study|Adverse Event|3
6930548|NCT00868439|10962781|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2
6930549|NCT00868439|10962782|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3
6930550|NCT00868439|10962781|FG000|Overall Study|Death|0
6930551|NCT00868439|10962782|FG001|Overall Study|Death|1
6930552|NCT00868439|10962781|FG000|Overall Study|Protocol Violation|1
6930553|NCT00868439|10962782|FG001|Overall Study|Protocol Violation|1
6930554|NCT00868439|10962781|FG000|Overall Study|Physician Decision|1
6930555|NCT00868439|10962782|FG001|Overall Study|Physician Decision|0
6930556|NCT00868439|10962781|FG000|Overall Study|Withdrawal by Subject|0
6930557|NCT00868439|10962782|FG001|Overall Study|Withdrawal by Subject|1
6930558|NCT00868517|10962801|FG000|Overall Study|Withdrawal by Subject|3
6930559|NCT00868517|10962802|FG001|Overall Study|Withdrawal by Subject|3
6930560|NCT00868517|10962803|FG002|Overall Study|Withdrawal by Subject|2
6930561|NCT00868517|10962801|FG000|Overall Study|Protocol Violation|1
6930562|NCT00868517|10962802|FG001|Overall Study|Protocol Violation|1
6930563|NCT00868517|10962803|FG002|Overall Study|Protocol Violation|0
6930564|NCT00868530|10962811|FG000|Overall Study|Adverse Event|3
6930565|NCT00868530|10962811|FG000|Overall Study|Lost to Follow-up|1
6930566|NCT00868608|10962818|FG000|Overall Study|Withdrawal by Subject|3
6930567|NCT00868608|10962819|FG001|Overall Study|Withdrawal by Subject|1
6930568|NCT00868608|10962820|FG002|Overall Study|Withdrawal by Subject|0
6930569|NCT00868608|10962818|FG000|Overall Study|Lost to Follow-up|3
7065468|NCT01967173|11165089|FG003|Overall Study|Lost to Follow-up|4
7065469|NCT01967173|11165090|FG004|Overall Study|Lost to Follow-up|8
7065470|NCT01967173|11165091|FG005|Overall Study|Lost to Follow-up|12
7065471|NCT01967173|11165092|FG006|Overall Study|Lost to Follow-up|6
7065472|NCT01967173|11165093|FG007|Overall Study|Lost to Follow-up|8
7065473|NCT01967173|11165086|FG000|Overall Study|Physician Decision|2
7065474|NCT01967173|11165087|FG001|Overall Study|Physician Decision|0
7065475|NCT01967173|11165088|FG002|Overall Study|Physician Decision|2
7065476|NCT01967173|11165089|FG003|Overall Study|Physician Decision|1
7065477|NCT01967173|11165090|FG004|Overall Study|Physician Decision|1
6930570|NCT00868608|10962819|FG001|Overall Study|Lost to Follow-up|0
6930571|NCT00868608|10962820|FG002|Overall Study|Lost to Follow-up|1
6930572|NCT00868608|10962818|FG000|Overall Study|Death|16
6930573|NCT00868608|10962819|FG001|Overall Study|Death|2
6930574|NCT00868608|10962820|FG002|Overall Study|Death|4
6930575|NCT00868608|10962818|FG000|Overall Study|Other - Unspecified|1
6930576|NCT00868608|10962819|FG001|Overall Study|Other - Unspecified|0
6930577|NCT00868608|10962820|FG002|Overall Study|Other - Unspecified|0
6930578|NCT00868790|10962858|FG000|Period 1|Adverse Event|1
6930579|NCT00868790|10962859|FG001|Period 1|Adverse Event|0
6930580|NCT00868790|10962860|FG002|Period 1|Adverse Event|0
6930581|NCT00868790|10962861|FG003|Period 1|Adverse Event|0
6930582|NCT00868790|10962862|FG004|Period 1|Adverse Event|0
7065478|NCT01967173|11165091|FG005|Overall Study|Physician Decision|1
7065479|NCT01967173|11165092|FG006|Overall Study|Physician Decision|1
6930583|NCT00868790|10962863|FG005|Period 1|Adverse Event|0
6930584|NCT00868790|10962864|FG006|Period 1|Adverse Event|0
6930585|NCT00868790|10962865|FG007|Period 1|Adverse Event|3
6930586|NCT00868790|10962866|FG008|Period 1|Adverse Event|1
6930587|NCT00868790|10962867|FG009|Period 1|Adverse Event|0
6930588|NCT00868790|10962868|FG010|Period 1|Adverse Event|0
6930589|NCT00868790|10962869|FG011|Period 1|Adverse Event|0
6930590|NCT00868790|10962870|FG012|Period 1|Adverse Event|0
6930591|NCT00868790|10962871|FG013|Period 1|Adverse Event|1
6930592|NCT00868790|10962858|FG000|Period 1|Protocol Violation|1
6930593|NCT00868790|10962859|FG001|Period 1|Protocol Violation|0
6930594|NCT00868790|10962860|FG002|Period 1|Protocol Violation|0
6930595|NCT00868790|10962861|FG003|Period 1|Protocol Violation|0
6930596|NCT00868790|10962862|FG004|Period 1|Protocol Violation|0
6930597|NCT00868790|10962863|FG005|Period 1|Protocol Violation|0
6930598|NCT00868790|10962864|FG006|Period 1|Protocol Violation|0
6930599|NCT00868790|10962865|FG007|Period 1|Protocol Violation|0
6930600|NCT00868790|10962866|FG008|Period 1|Protocol Violation|0
6930601|NCT00868790|10962867|FG009|Period 1|Protocol Violation|0
6930602|NCT00868790|10962868|FG010|Period 1|Protocol Violation|0
6930603|NCT00868790|10962869|FG011|Period 1|Protocol Violation|0
6930604|NCT00868790|10962870|FG012|Period 1|Protocol Violation|0
6930605|NCT00868790|10962871|FG013|Period 1|Protocol Violation|0
6930606|NCT00868790|10962858|FG000|Period 1|Withdrawal by Subject|0
6930607|NCT00868790|10962859|FG001|Period 1|Withdrawal by Subject|1
6930608|NCT00868790|10962860|FG002|Period 1|Withdrawal by Subject|0
6930609|NCT00868790|10962861|FG003|Period 1|Withdrawal by Subject|0
6930610|NCT00868790|10962862|FG004|Period 1|Withdrawal by Subject|0
6930611|NCT00868790|10962863|FG005|Period 1|Withdrawal by Subject|0
6930612|NCT00868790|10962864|FG006|Period 1|Withdrawal by Subject|0
6930613|NCT00868790|10962865|FG007|Period 1|Withdrawal by Subject|0
6930614|NCT00868790|10962866|FG008|Period 1|Withdrawal by Subject|0
6930615|NCT00868790|10962867|FG009|Period 1|Withdrawal by Subject|0
6930616|NCT00868790|10962868|FG010|Period 1|Withdrawal by Subject|0
6930617|NCT00868790|10962869|FG011|Period 1|Withdrawal by Subject|0
6930618|NCT00868790|10962870|FG012|Period 1|Withdrawal by Subject|0
6930619|NCT00868790|10962871|FG013|Period 1|Withdrawal by Subject|1
6930620|NCT00868790|10962858|FG000|Period 1|Abnormal Triglycerides|0
6930621|NCT00868790|10962859|FG001|Period 1|Abnormal Triglycerides|0
6930622|NCT00868790|10962860|FG002|Period 1|Abnormal Triglycerides|0
6930623|NCT00868790|10962861|FG003|Period 1|Abnormal Triglycerides|0
6930624|NCT00868790|10962862|FG004|Period 1|Abnormal Triglycerides|1
6930625|NCT00868790|10962863|FG005|Period 1|Abnormal Triglycerides|0
7039674|NCT01712204|11122432|FG000|Overall Study|Withdrawal by Subject|3
7039675|NCT01712204|11122433|FG001|Overall Study|Withdrawal by Subject|3
7039676|NCT01712204|11122432|FG000|Overall Study|Lost to Follow-up|1
7039677|NCT01712204|11122433|FG001|Overall Study|Lost to Follow-up|0
6930626|NCT00868790|10962864|FG006|Period 1|Abnormal Triglycerides|0
6930627|NCT00868790|10962865|FG007|Period 1|Abnormal Triglycerides|0
6930628|NCT00868790|10962866|FG008|Period 1|Abnormal Triglycerides|0
6930629|NCT00868790|10962867|FG009|Period 1|Abnormal Triglycerides|0
6930630|NCT00868790|10962868|FG010|Period 1|Abnormal Triglycerides|0
6930631|NCT00868790|10962869|FG011|Period 1|Abnormal Triglycerides|0
6930632|NCT00868790|10962870|FG012|Period 1|Abnormal Triglycerides|0
6930633|NCT00868790|10962871|FG013|Period 1|Abnormal Triglycerides|0
6930634|NCT00868790|10962858|FG000|Period 1|Lost to Follow-up|0
6930635|NCT00868790|10962859|FG001|Period 1|Lost to Follow-up|0
6930636|NCT00868790|10962860|FG002|Period 1|Lost to Follow-up|0
6930637|NCT00868790|10962861|FG003|Period 1|Lost to Follow-up|0
6930638|NCT00868790|10962862|FG004|Period 1|Lost to Follow-up|0
6930639|NCT00868790|10962863|FG005|Period 1|Lost to Follow-up|1
6930640|NCT00868790|10962864|FG006|Period 1|Lost to Follow-up|0
6930641|NCT00868790|10962865|FG007|Period 1|Lost to Follow-up|0
6930642|NCT00868790|10962866|FG008|Period 1|Lost to Follow-up|0
6930643|NCT00868790|10962867|FG009|Period 1|Lost to Follow-up|0
6930644|NCT00868790|10962868|FG010|Period 1|Lost to Follow-up|0
6930645|NCT00868790|10962869|FG011|Period 1|Lost to Follow-up|0
6930646|NCT00868790|10962870|FG012|Period 1|Lost to Follow-up|0
6930647|NCT00868790|10962871|FG013|Period 1|Lost to Follow-up|0
6930648|NCT00868790|10962858|FG000|Period 2|Adverse Event|0
6930649|NCT00868790|10962859|FG001|Period 2|Adverse Event|0
6930650|NCT00868790|10962860|FG002|Period 2|Adverse Event|0
6930651|NCT00868790|10962861|FG003|Period 2|Adverse Event|0
7039678|NCT01712204|11122432|FG000|Overall Study|Protocol Violation|1
6930652|NCT00868790|10962862|FG004|Period 2|Adverse Event|0
6930653|NCT00868790|10962863|FG005|Period 2|Adverse Event|0
6930654|NCT00868790|10962864|FG006|Period 2|Adverse Event|0
6930655|NCT00868790|10962865|FG007|Period 2|Adverse Event|0
6930656|NCT00868790|10962866|FG008|Period 2|Adverse Event|1
6930657|NCT00868790|10962867|FG009|Period 2|Adverse Event|0
6930658|NCT00868790|10962868|FG010|Period 2|Adverse Event|0
6930659|NCT00868790|10962869|FG011|Period 2|Adverse Event|0
6930660|NCT00868790|10962870|FG012|Period 2|Adverse Event|0
6930661|NCT00868790|10962871|FG013|Period 2|Adverse Event|0
6930662|NCT00868790|10962858|FG000|Period 2|Lost to Follow-up|0
6930663|NCT00868790|10962859|FG001|Period 2|Lost to Follow-up|1
6930664|NCT00868790|10962860|FG002|Period 2|Lost to Follow-up|0
6930665|NCT00868790|10962861|FG003|Period 2|Lost to Follow-up|0
6930666|NCT00868790|10962862|FG004|Period 2|Lost to Follow-up|0
6930667|NCT00868790|10962863|FG005|Period 2|Lost to Follow-up|1
7039679|NCT01712204|11122433|FG001|Overall Study|Protocol Violation|1
6930668|NCT00868790|10962864|FG006|Period 2|Lost to Follow-up|0
6930669|NCT00868790|10962865|FG007|Period 2|Lost to Follow-up|0
6930670|NCT00868790|10962866|FG008|Period 2|Lost to Follow-up|0
6930671|NCT00868790|10962867|FG009|Period 2|Lost to Follow-up|0
6930672|NCT00868790|10962868|FG010|Period 2|Lost to Follow-up|0
6930673|NCT00868790|10962869|FG011|Period 2|Lost to Follow-up|0
6930674|NCT00868790|10962870|FG012|Period 2|Lost to Follow-up|0
6930675|NCT00868790|10962871|FG013|Period 2|Lost to Follow-up|0
7039680|NCT01712256|11122452|FG000|Overall Study|Lost to Follow-up|1
7039681|NCT01712334|11122456|FG000|Treatment Period 1|Randomized in Error|0
7065480|NCT01967173|11165093|FG007|Overall Study|Physician Decision|0
7065481|NCT01967173|11165086|FG000|Overall Study|Lack of Efficacy|2
7065482|NCT01967173|11165087|FG001|Overall Study|Lack of Efficacy|0
7065483|NCT01967173|11165088|FG002|Overall Study|Lack of Efficacy|2
7065484|NCT01967173|11165089|FG003|Overall Study|Lack of Efficacy|2
7065485|NCT01967173|11165090|FG004|Overall Study|Lack of Efficacy|0
7065486|NCT01967173|11165091|FG005|Overall Study|Lack of Efficacy|1
7065487|NCT01967173|11165092|FG006|Overall Study|Lack of Efficacy|0
7065488|NCT01967173|11165093|FG007|Overall Study|Lack of Efficacy|2
7065489|NCT01967173|11165086|FG000|Overall Study|Pregnancy|0
7065490|NCT01967173|11165087|FG001|Overall Study|Pregnancy|0
7065491|NCT01967173|11165088|FG002|Overall Study|Pregnancy|0
7065492|NCT01967173|11165089|FG003|Overall Study|Pregnancy|0
7065493|NCT01967173|11165090|FG004|Overall Study|Pregnancy|0
7065494|NCT01967173|11165091|FG005|Overall Study|Pregnancy|0
7065495|NCT01967173|11165092|FG006|Overall Study|Pregnancy|1
7065496|NCT01967173|11165093|FG007|Overall Study|Pregnancy|1
7065497|NCT01967173|11165086|FG000|Overall Study|Adverse Event|0
6930676|NCT00868790|10962858|FG000|Period 2|Withdrawal by Subject|0
6930677|NCT00868790|10962859|FG001|Period 2|Withdrawal by Subject|0
6930678|NCT00868790|10962860|FG002|Period 2|Withdrawal by Subject|0
6930679|NCT00868790|10962861|FG003|Period 2|Withdrawal by Subject|0
6930680|NCT00868790|10962862|FG004|Period 2|Withdrawal by Subject|0
6930681|NCT00868790|10962863|FG005|Period 2|Withdrawal by Subject|0
6930682|NCT00868790|10962864|FG006|Period 2|Withdrawal by Subject|0
6930683|NCT00868790|10962865|FG007|Period 2|Withdrawal by Subject|0
6930684|NCT00868790|10962866|FG008|Period 2|Withdrawal by Subject|1
6930685|NCT00868790|10962867|FG009|Period 2|Withdrawal by Subject|0
6930686|NCT00868790|10962868|FG010|Period 2|Withdrawal by Subject|0
6930687|NCT00868790|10962869|FG011|Period 2|Withdrawal by Subject|0
6930688|NCT00868790|10962870|FG012|Period 2|Withdrawal by Subject|0
6930689|NCT00868790|10962871|FG013|Period 2|Withdrawal by Subject|1
6930690|NCT00868790|10962858|FG000|Period 3|Adverse Event|0
6930691|NCT00868790|10962859|FG001|Period 3|Adverse Event|0
6930692|NCT00868790|10962860|FG002|Period 3|Adverse Event|0
6930693|NCT00868790|10962861|FG003|Period 3|Adverse Event|0
6930694|NCT00868790|10962862|FG004|Period 3|Adverse Event|0
6930695|NCT00868790|10962863|FG005|Period 3|Adverse Event|0
6930696|NCT00868790|10962864|FG006|Period 3|Adverse Event|0
6930697|NCT00868790|10962865|FG007|Period 3|Adverse Event|0
6930698|NCT00868790|10962866|FG008|Period 3|Adverse Event|0
6930699|NCT00868790|10962867|FG009|Period 3|Adverse Event|1
6930700|NCT00868790|10962868|FG010|Period 3|Adverse Event|0
6930701|NCT00868790|10962869|FG011|Period 3|Adverse Event|0
6930702|NCT00868790|10962870|FG012|Period 3|Adverse Event|0
6930703|NCT00868790|10962871|FG013|Period 3|Adverse Event|0
6930704|NCT00868790|10962858|FG000|Period 3|Protocol Violation|0
6930705|NCT00868790|10962859|FG001|Period 3|Protocol Violation|0
6930706|NCT00868790|10962860|FG002|Period 3|Protocol Violation|0
6930707|NCT00868790|10962861|FG003|Period 3|Protocol Violation|0
6930708|NCT00868790|10962862|FG004|Period 3|Protocol Violation|0
6930709|NCT00868790|10962863|FG005|Period 3|Protocol Violation|0
6930710|NCT00868790|10962864|FG006|Period 3|Protocol Violation|0
6930711|NCT00868790|10962865|FG007|Period 3|Protocol Violation|0
6930712|NCT00868790|10962866|FG008|Period 3|Protocol Violation|0
6930713|NCT00868790|10962867|FG009|Period 3|Protocol Violation|0
6930714|NCT00868790|10962868|FG010|Period 3|Protocol Violation|1
6930715|NCT00868790|10962869|FG011|Period 3|Protocol Violation|0
6930716|NCT00868790|10962870|FG012|Period 3|Protocol Violation|0
6930717|NCT00868790|10962871|FG013|Period 3|Protocol Violation|0
6930718|NCT00868790|10962858|FG000|Period 3|Study Terminated by Sponsor|0
6930719|NCT00868790|10962859|FG001|Period 3|Study Terminated by Sponsor|0
6930720|NCT00868790|10962860|FG002|Period 3|Study Terminated by Sponsor|0
7065498|NCT01967173|11165087|FG001|Overall Study|Adverse Event|0
6930721|NCT00868790|10962861|FG003|Period 3|Study Terminated by Sponsor|1
6930722|NCT00868790|10962862|FG004|Period 3|Study Terminated by Sponsor|0
6930723|NCT00868790|10962863|FG005|Period 3|Study Terminated by Sponsor|0
6930724|NCT00868790|10962864|FG006|Period 3|Study Terminated by Sponsor|0
6930725|NCT00868790|10962865|FG007|Period 3|Study Terminated by Sponsor|0
6930726|NCT00868790|10962866|FG008|Period 3|Study Terminated by Sponsor|0
6930727|NCT00868790|10962867|FG009|Period 3|Study Terminated by Sponsor|0
6930728|NCT00868790|10962868|FG010|Period 3|Study Terminated by Sponsor|0
6930729|NCT00868790|10962869|FG011|Period 3|Study Terminated by Sponsor|0
6930730|NCT00868790|10962870|FG012|Period 3|Study Terminated by Sponsor|0
6930731|NCT00868790|10962871|FG013|Period 3|Study Terminated by Sponsor|0
7065499|NCT01967173|11165088|FG002|Overall Study|Adverse Event|0
7065500|NCT01967173|11165089|FG003|Overall Study|Adverse Event|0
7065501|NCT01967173|11165090|FG004|Overall Study|Adverse Event|0
6930732|NCT00868790|10962858|FG000|Period 4|Adverse Event|0
6930733|NCT00868790|10962859|FG001|Period 4|Adverse Event|0
6930734|NCT00868790|10962860|FG002|Period 4|Adverse Event|0
6930735|NCT00868790|10962861|FG003|Period 4|Adverse Event|0
6930736|NCT00868790|10962862|FG004|Period 4|Adverse Event|0
7065502|NCT01967173|11165091|FG005|Overall Study|Adverse Event|0
7065503|NCT01967173|11165092|FG006|Overall Study|Adverse Event|0
7065504|NCT01967173|11165093|FG007|Overall Study|Adverse Event|1
7065505|NCT01967173|11165086|FG000|Overall Study|Withdrawal by Subject|15
7065506|NCT01967173|11165087|FG001|Overall Study|Withdrawal by Subject|14
7065507|NCT01967173|11165088|FG002|Overall Study|Withdrawal by Subject|10
7065508|NCT01967173|11165089|FG003|Overall Study|Withdrawal by Subject|7
7065509|NCT01967173|11165090|FG004|Overall Study|Withdrawal by Subject|8
7065510|NCT01967173|11165091|FG005|Overall Study|Withdrawal by Subject|9
7065511|NCT01967173|11165092|FG006|Overall Study|Withdrawal by Subject|10
7065512|NCT01967173|11165093|FG007|Overall Study|Withdrawal by Subject|12
7065513|NCT01967225|11165109|FG000|Overall Study|Adverse Event|3
7065514|NCT01967225|11165110|FG001|Overall Study|Adverse Event|1
6930737|NCT00868790|10962863|FG005|Period 4|Adverse Event|0
6930738|NCT00868790|10962864|FG006|Period 4|Adverse Event|0
6930739|NCT00868790|10962865|FG007|Period 4|Adverse Event|1
6930740|NCT00868790|10962866|FG008|Period 4|Adverse Event|0
6930741|NCT00868790|10962867|FG009|Period 4|Adverse Event|0
6930742|NCT00868790|10962868|FG010|Period 4|Adverse Event|1
6930743|NCT00868790|10962869|FG011|Period 4|Adverse Event|0
6930744|NCT00868790|10962870|FG012|Period 4|Adverse Event|1
6930745|NCT00868790|10962871|FG013|Period 4|Adverse Event|0
6930746|NCT00868790|10962858|FG000|Period 4|Lost to Follow-up|0
6930747|NCT00868790|10962859|FG001|Period 4|Lost to Follow-up|0
6930748|NCT00868790|10962860|FG002|Period 4|Lost to Follow-up|0
6930749|NCT00868790|10962861|FG003|Period 4|Lost to Follow-up|0
6930750|NCT00868790|10962862|FG004|Period 4|Lost to Follow-up|0
6930751|NCT00868790|10962863|FG005|Period 4|Lost to Follow-up|0
6930752|NCT00868790|10962864|FG006|Period 4|Lost to Follow-up|0
6930753|NCT00868790|10962865|FG007|Period 4|Lost to Follow-up|1
6930754|NCT00868790|10962866|FG008|Period 4|Lost to Follow-up|0
6930755|NCT00868790|10962867|FG009|Period 4|Lost to Follow-up|0
6930756|NCT00868790|10962868|FG010|Period 4|Lost to Follow-up|0
6930757|NCT00868790|10962869|FG011|Period 4|Lost to Follow-up|0
6930758|NCT00868790|10962870|FG012|Period 4|Lost to Follow-up|0
6930759|NCT00868790|10962871|FG013|Period 4|Lost to Follow-up|0
6930760|NCT00868790|10962858|FG000|Period 4|Study Terminated by Sponsor|2
6930761|NCT00868790|10962859|FG001|Period 4|Study Terminated by Sponsor|0
6930762|NCT00868790|10962860|FG002|Period 4|Study Terminated by Sponsor|0
6930763|NCT00868790|10962861|FG003|Period 4|Study Terminated by Sponsor|0
6930764|NCT00868790|10962862|FG004|Period 4|Study Terminated by Sponsor|0
6930765|NCT00868790|10962863|FG005|Period 4|Study Terminated by Sponsor|0
6930766|NCT00868790|10962864|FG006|Period 4|Study Terminated by Sponsor|0
6930767|NCT00868790|10962865|FG007|Period 4|Study Terminated by Sponsor|1
6930768|NCT00868790|10962866|FG008|Period 4|Study Terminated by Sponsor|2
6930769|NCT00868790|10962867|FG009|Period 4|Study Terminated by Sponsor|0
6930770|NCT00868790|10962868|FG010|Period 4|Study Terminated by Sponsor|2
6930771|NCT00868790|10962869|FG011|Period 4|Study Terminated by Sponsor|1
6930772|NCT00868790|10962870|FG012|Period 4|Study Terminated by Sponsor|0
6930773|NCT00868790|10962871|FG013|Period 4|Study Terminated by Sponsor|1
6930774|NCT00868790|10962858|FG000|Period 4|Abnormal ALT/AST|0
6930775|NCT00868790|10962859|FG001|Period 4|Abnormal ALT/AST|0
6930776|NCT00868790|10962860|FG002|Period 4|Abnormal ALT/AST|1
6930777|NCT00868790|10962861|FG003|Period 4|Abnormal ALT/AST|0
6930778|NCT00868790|10962862|FG004|Period 4|Abnormal ALT/AST|0
6930779|NCT00868790|10962863|FG005|Period 4|Abnormal ALT/AST|0
6930780|NCT00868790|10962864|FG006|Period 4|Abnormal ALT/AST|0
6930781|NCT00868790|10962865|FG007|Period 4|Abnormal ALT/AST|0
6930782|NCT00868790|10962866|FG008|Period 4|Abnormal ALT/AST|0
6930783|NCT00868790|10962867|FG009|Period 4|Abnormal ALT/AST|0
6930784|NCT00868790|10962868|FG010|Period 4|Abnormal ALT/AST|0
6930785|NCT00868790|10962869|FG011|Period 4|Abnormal ALT/AST|0
6930786|NCT00868790|10962870|FG012|Period 4|Abnormal ALT/AST|0
6930787|NCT00868790|10962871|FG013|Period 4|Abnormal ALT/AST|0
6930788|NCT00868790|10962858|FG000|Post-study|Withdrawal by Subject|0
6930789|NCT00868790|10962859|FG001|Post-study|Withdrawal by Subject|0
6930790|NCT00868790|10962860|FG002|Post-study|Withdrawal by Subject|0
6930791|NCT00868790|10962861|FG003|Post-study|Withdrawal by Subject|0
6930792|NCT00868790|10962862|FG004|Post-study|Withdrawal by Subject|1
6930793|NCT00868790|10962863|FG005|Post-study|Withdrawal by Subject|0
6930794|NCT00868790|10962864|FG006|Post-study|Withdrawal by Subject|0
6930795|NCT00868790|10962865|FG007|Post-study|Withdrawal by Subject|0
6930796|NCT00868790|10962866|FG008|Post-study|Withdrawal by Subject|0
6930797|NCT00868790|10962867|FG009|Post-study|Withdrawal by Subject|0
6930798|NCT00868790|10962868|FG010|Post-study|Withdrawal by Subject|0
6930799|NCT00868790|10962869|FG011|Post-study|Withdrawal by Subject|0
6930800|NCT00868790|10962870|FG012|Post-study|Withdrawal by Subject|0
6930801|NCT00868790|10962871|FG013|Post-study|Withdrawal by Subject|0
7065515|NCT01967225|11165109|FG000|Overall Study|Withdrawal by Subject|2
7065516|NCT01967225|11165110|FG001|Overall Study|Withdrawal by Subject|1
6930802|NCT00868790|10962858|FG000|Post-study|Excluded Medication|0
6930803|NCT00868790|10962859|FG001|Post-study|Excluded Medication|0
6930804|NCT00868790|10962860|FG002|Post-study|Excluded Medication|0
6930805|NCT00868790|10962861|FG003|Post-study|Excluded Medication|0
6930806|NCT00868790|10962862|FG004|Post-study|Excluded Medication|0
6930807|NCT00868790|10962863|FG005|Post-study|Excluded Medication|0
6930808|NCT00868790|10962864|FG006|Post-study|Excluded Medication|0
6930809|NCT00868790|10962865|FG007|Post-study|Excluded Medication|2
6930810|NCT00868790|10962866|FG008|Post-study|Excluded Medication|0
6930811|NCT00868790|10962867|FG009|Post-study|Excluded Medication|1
6930812|NCT00868790|10962868|FG010|Post-study|Excluded Medication|0
6930813|NCT00868790|10962869|FG011|Post-study|Excluded Medication|0
6930814|NCT00868790|10962870|FG012|Post-study|Excluded Medication|0
6930815|NCT00868790|10962871|FG013|Post-study|Excluded Medication|0
6930816|NCT00869024|10962893|FG000|Overall Study|Death|2
6930817|NCT00869024|10962894|FG001|Overall Study|Death|3
6930818|NCT00869024|10962893|FG000|Overall Study|Lost to Follow-up|0
6930819|NCT00869024|10962894|FG001|Overall Study|Lost to Follow-up|1
6930820|NCT00869024|10962893|FG000|Overall Study|Protocol Violation|0
6930821|NCT00869024|10962894|FG001|Overall Study|Protocol Violation|1
6930822|NCT00869050|10962900|FG000|Overall Study|Screen Failure|3
6930823|NCT00869089|10962904|FG000|Overall Study|Lost to Follow-up|1
6930824|NCT00869089|10962904|FG000|Overall Study|Withdrawal by Subject|1
6930825|NCT00869089|10962904|FG000|Overall Study|Screen Fail|1
6930826|NCT00869323|10962945|FG000|Maintenance Therapy|concurrent illness|1
6930827|NCT00869362|10962960|FG000|Overall Study|Death|0
6930828|NCT00869362|10962961|FG001|Overall Study|Death|2
6930829|NCT00869362|10962960|FG000|Overall Study|Lost to Follow-up|1
6930830|NCT00869362|10962961|FG001|Overall Study|Lost to Follow-up|3
6930831|NCT00869401|10962982|FG000|Overall Study|Withdrawal by Subject|0
6930832|NCT00869401|10962983|FG001|Overall Study|Withdrawal by Subject|0
6930833|NCT00869401|10962984|FG002|Overall Study|Withdrawal by Subject|0
6930834|NCT00869401|10962985|FG003|Overall Study|Withdrawal by Subject|5
6930835|NCT00869401|10962986|FG004|Overall Study|Withdrawal by Subject|3
6930836|NCT00869440|10963002|FG000|Overall Study|Withdrawal by Subject|1
6930837|NCT00869440|10963003|FG001|Overall Study|Withdrawal by Subject|0
6930838|NCT00869440|10963004|FG002|Overall Study|Withdrawal by Subject|0
6930839|NCT00869440|10963005|FG003|Overall Study|Withdrawal by Subject|0
6930840|NCT00869440|10963002|FG000|Overall Study|Physician Decision|1
6930841|NCT00869440|10963003|FG001|Overall Study|Physician Decision|1
6930842|NCT00869440|10963004|FG002|Overall Study|Physician Decision|0
6930843|NCT00869440|10963005|FG003|Overall Study|Physician Decision|0
6930844|NCT00869518|10963017|FG000|Overall Study|Lost to Follow-up|1
6930845|NCT00869518|10963018|FG001|Overall Study|Lost to Follow-up|1
6930846|NCT00869557|10963026|FG000|Randomized Phase|Lost to Follow-up|2
6930847|NCT00869557|10963027|FG001|Randomized Phase|Lost to Follow-up|1
6930848|NCT00869557|10963026|FG000|Randomized Phase|Investigator's Discretion|1
6930849|NCT00869557|10963027|FG001|Randomized Phase|Investigator's Discretion|0
6930850|NCT00869557|10963026|FG000|Randomized Phase|Withdrew Consent|0
6930851|NCT00869557|10963027|FG001|Randomized Phase|Withdrew Consent|1
6930852|NCT00869557|10963026|FG000|Extension Phase|Adverse Event|2
6930853|NCT00869557|10963027|FG001|Extension Phase|Adverse Event|2
6930854|NCT00869557|10963026|FG000|Extension Phase|Lack of Efficacy|1
6930855|NCT00869557|10963027|FG001|Extension Phase|Lack of Efficacy|0
6930856|NCT00869557|10963026|FG000|Extension Phase|Lost to Follow-up|3
6930857|NCT00869557|10963027|FG001|Extension Phase|Lost to Follow-up|1
6930858|NCT00869557|10963026|FG000|Extension Phase|Investigator's Discretion|2
6930859|NCT00869557|10963027|FG001|Extension Phase|Investigator's Discretion|0
6930860|NCT00869557|10963026|FG000|Extension Phase|Withdrew Consent|2
6930861|NCT00869557|10963027|FG001|Extension Phase|Withdrew Consent|0
6930862|NCT00869778|10963056|FG000|Overall Study|Adverse Event|2
6930863|NCT00869778|10963057|FG001|Overall Study|Adverse Event|0
6930864|NCT00869778|10963058|FG002|Overall Study|Adverse Event|0
6930865|NCT00869778|10963056|FG000|Overall Study|Withdrawal by Subject|3
6930866|NCT00869778|10963057|FG001|Overall Study|Withdrawal by Subject|4
6930867|NCT00869778|10963058|FG002|Overall Study|Withdrawal by Subject|5
6930868|NCT00869778|10963056|FG000|Overall Study|Pregnancy|1
6930869|NCT00869778|10963057|FG001|Overall Study|Pregnancy|0
6930870|NCT00869778|10963058|FG002|Overall Study|Pregnancy|0
6930871|NCT00869778|10963056|FG000|Overall Study|Protocol Violation|5
6930872|NCT00869778|10963057|FG001|Overall Study|Protocol Violation|3
6930873|NCT00869778|10963058|FG002|Overall Study|Protocol Violation|5
6930874|NCT00869778|10963056|FG000|Overall Study|Unblinding|1
6930875|NCT00869778|10963057|FG001|Overall Study|Unblinding|0
6930876|NCT00869778|10963058|FG002|Overall Study|Unblinding|0
6930877|NCT00869960|10963087|FG000|Overall Study|Lost to Follow-up|2
6930878|NCT00869999|10963091|FG000|Overall Study|Withdrawal by Subject|1
6930879|NCT00869999|10963091|FG000|Overall Study|removed prior to starting therapy|1
6930880|NCT00870103|10963095|FG000|Overall Study|Physician Decision|2
6930881|NCT00870103|10963095|FG000|Overall Study|Lost to Follow-up|2
6930882|NCT00870194|10963101|FG000|Overall Study|Adverse Event|10
6930883|NCT00870194|10963102|FG001|Overall Study|Adverse Event|5
6930884|NCT00870194|10963101|FG000|Overall Study|Lack of Efficacy|0
6930885|NCT00870194|10963102|FG001|Overall Study|Lack of Efficacy|1
6930886|NCT00870194|10963101|FG000|Overall Study|Lost to Follow-up|2
6930887|NCT00870194|10963102|FG001|Overall Study|Lost to Follow-up|0
6930888|NCT00870194|10963101|FG000|Overall Study|Physician Decision|3
6930889|NCT00870194|10963102|FG001|Overall Study|Physician Decision|1
6930890|NCT00870194|10963101|FG000|Overall Study|Protocol Violation|3
6930891|NCT00870194|10963102|FG001|Overall Study|Protocol Violation|3
6930892|NCT00870194|10963101|FG000|Overall Study|Entry Criteria Not Met|1
6930893|NCT00870194|10963102|FG001|Overall Study|Entry Criteria Not Met|2
6930894|NCT00870194|10963101|FG000|Overall Study|Subject Decision|7
6930895|NCT00870194|10963102|FG001|Overall Study|Subject Decision|2
6930896|NCT00870233|10963108|FG000|Overall Study|Withdrawal by Subject|18
6930897|NCT00870233|10963108|FG000|Overall Study|Did not undergo laparotomy|3
6930898|NCT00870233|10963108|FG000|Overall Study|Incompatible internet browser|2
6930899|NCT00870233|10963108|FG000|Overall Study|Death|1
6930900|NCT00870584|10963155|FG000|Overall Study|Adverse Event|3
6930901|NCT00870584|10963156|FG001|Overall Study|Adverse Event|3
6930902|NCT00870584|10963155|FG000|Overall Study|Withdrawal by Subject|6
6930903|NCT00870584|10963156|FG001|Overall Study|Withdrawal by Subject|7
6930904|NCT00870584|10963155|FG000|Overall Study|Lost to Follow-up|5
6930905|NCT00870584|10963156|FG001|Overall Study|Lost to Follow-up|1
6930906|NCT00870584|10963155|FG000|Overall Study|Protocol Deviation|2
6930907|NCT00870584|10963156|FG001|Overall Study|Protocol Deviation|2
6930908|NCT00870727|10963164|FG000|Overall Study|Lost to Follow-up|0
6930909|NCT00870727|10963165|FG001|Overall Study|Lost to Follow-up|1
6930910|NCT00870727|10963164|FG000|Overall Study|Lack of Efficacy|1
6930911|NCT00870727|10963165|FG001|Overall Study|Lack of Efficacy|3
6930912|NCT00870727|10963164|FG000|Overall Study|Adverse Event|0
6930913|NCT00870727|10963165|FG001|Overall Study|Adverse Event|1
6930914|NCT00870740|10963177|FG000|Overall Study|Adverse Event|2
6930915|NCT00870740|10963178|FG001|Overall Study|Adverse Event|1
6930916|NCT00870740|10963179|FG002|Overall Study|Adverse Event|3
6930917|NCT00870740|10963180|FG003|Overall Study|Adverse Event|2
6930918|NCT00870740|10963181|FG004|Overall Study|Adverse Event|1
6930919|NCT00870740|10963182|FG005|Overall Study|Adverse Event|6
6930920|NCT00870740|10963177|FG000|Overall Study|Consent Withdrawn|6
6930921|NCT00870740|10963178|FG001|Overall Study|Consent Withdrawn|3
6930922|NCT00870740|10963179|FG002|Overall Study|Consent Withdrawn|4
6930923|NCT00870740|10963180|FG003|Overall Study|Consent Withdrawn|6
6930924|NCT00870740|10963181|FG004|Overall Study|Consent Withdrawn|6
6930925|NCT00870740|10963182|FG005|Overall Study|Consent Withdrawn|5
6930926|NCT00870740|10963177|FG000|Overall Study|Investigator Decision|2
6930927|NCT00870740|10963178|FG001|Overall Study|Investigator Decision|0
6930928|NCT00870740|10963179|FG002|Overall Study|Investigator Decision|1
6930929|NCT00870740|10963180|FG003|Overall Study|Investigator Decision|0
6930930|NCT00870740|10963181|FG004|Overall Study|Investigator Decision|0
6930931|NCT00870740|10963182|FG005|Overall Study|Investigator Decision|0
6930932|NCT00870740|10963177|FG000|Overall Study|Subject Non-compliance|0
6930933|NCT00870740|10963178|FG001|Overall Study|Subject Non-compliance|0
6930934|NCT00870740|10963179|FG002|Overall Study|Subject Non-compliance|0
6930935|NCT00870740|10963180|FG003|Overall Study|Subject Non-compliance|0
6930936|NCT00870740|10963181|FG004|Overall Study|Subject Non-compliance|0
6930937|NCT00870740|10963182|FG005|Overall Study|Subject Non-compliance|1
6930938|NCT00870740|10963177|FG000|Overall Study|Death|0
6930939|NCT00870740|10963178|FG001|Overall Study|Death|0
6930940|NCT00870740|10963179|FG002|Overall Study|Death|0
6930941|NCT00870740|10963180|FG003|Overall Study|Death|0
6930942|NCT00870740|10963181|FG004|Overall Study|Death|1
6930943|NCT00870740|10963182|FG005|Overall Study|Death|0
6930944|NCT00870740|10963177|FG000|Overall Study|Other|2
6930945|NCT00870740|10963178|FG001|Overall Study|Other|5
6930946|NCT00870740|10963179|FG002|Overall Study|Other|2
6930947|NCT00870740|10963180|FG003|Overall Study|Other|4
6930948|NCT00870740|10963181|FG004|Overall Study|Other|3
6930949|NCT00870740|10963182|FG005|Overall Study|Other|5
6930950|NCT00870870|10963211|FG000|Overall Study|Withdrawal by Subject|0
6930951|NCT00870870|10963212|FG001|Overall Study|Withdrawal by Subject|1
6930952|NCT00870870|10963213|FG002|Overall Study|Withdrawal by Subject|1
6930953|NCT00870870|10963214|FG003|Overall Study|Withdrawal by Subject|3
6930954|NCT00870870|10963211|FG000|Overall Study|Adverse Event|0
6930955|NCT00870870|10963212|FG001|Overall Study|Adverse Event|0
6930956|NCT00870870|10963213|FG002|Overall Study|Adverse Event|2
6930957|NCT00870870|10963214|FG003|Overall Study|Adverse Event|2
6930958|NCT00871000|10963237|FG000|Overall Study|Withdrawal by Subject|1
6930959|NCT00871000|10963238|FG001|Overall Study|Withdrawal by Subject|0
6930960|NCT00871117|10963246|FG000|Overall Study|Lost to Follow-up|5
6930961|NCT00871117|10963247|FG001|Overall Study|Lost to Follow-up|6
6930962|NCT00871117|10963246|FG000|Overall Study|Other|0
6930963|NCT00871117|10963247|FG001|Overall Study|Other|4
6930964|NCT00871169|10963263|FG000|Overall Study|Protocol Violation|1
6930965|NCT00871169|10963263|FG000|Overall Study|Patient did not receive study treatment|2
6930966|NCT00871234|10963267|FG000|Overall Study|Adverse Event|2
6930967|NCT00871234|10963267|FG000|Overall Study|Lost to Follow-up|3
6975173|NCT01190930|11027137|FG006|Maintenance|Still on therapy|0
6975174|NCT01190930|11027138|FG007|Maintenance|Still on therapy|0
6975175|NCT01190930|11027139|FG008|Maintenance|Still on therapy|0
6975176|NCT01190930|11027140|FG009|Maintenance|Still on therapy|0
6975177|NCT01191008|11027164|FG000|Overall Study|Protocol Violation|7
6975178|NCT01191008|11027164|FG000|Overall Study|Lost to Follow-up|8
6975179|NCT01191086|11027168|FG000|Overall Study|Adverse Event|20
6975180|NCT01191086|11027168|FG000|Overall Study|Lack of Efficacy|10
6975181|NCT01191086|11027168|FG000|Overall Study|Lost to Follow-up|4
6975182|NCT01191086|11027168|FG000|Overall Study|Physician Decision|2
6975183|NCT01191086|11027168|FG000|Overall Study|Withdrawal by Subject|24
6975184|NCT01191086|11027168|FG000|Overall Study|Discontinuation criterion met|1
6930968|NCT00871338|10963286|FG000|Prior to Booster|Withdrawal by Subject|1
6930969|NCT00871338|10963287|FG001|Prior to Booster|Withdrawal by Subject|3
6930970|NCT00871338|10963286|FG000|Prior to Booster|Lost to Follow-up|1
6930971|NCT00871338|10963287|FG001|Prior to Booster|Lost to Follow-up|0
6930972|NCT00871377|10963293|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0
6930973|NCT00871377|10963294|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0
6930974|NCT00871377|10963295|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1
6930975|NCT00871377|10963296|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0
6930976|NCT00871377|10963297|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0
7065517|NCT01967225|11165109|FG000|Overall Study|Lack of Efficacy|1
7065518|NCT01967225|11165110|FG001|Overall Study|Lack of Efficacy|1
6930977|NCT00871377|10963298|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0
6930978|NCT00871377|10963293|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0
6930979|NCT00871377|10963294|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0
6930980|NCT00871377|10963295|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0
6930981|NCT00871377|10963296|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0
6930982|NCT00871377|10963297|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0
6930983|NCT00871377|10963298|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1
6930984|NCT00871377|10963293|FG000|Washout (6 Weeks)|Withdrawal by Subject|1
6930985|NCT00871377|10963294|FG001|Washout (6 Weeks)|Withdrawal by Subject|0
6930986|NCT00871377|10963295|FG002|Washout (6 Weeks)|Withdrawal by Subject|0
6930987|NCT00871377|10963296|FG003|Washout (6 Weeks)|Withdrawal by Subject|0
7065519|NCT01967225|11165109|FG000|Overall Study|Switching to other therapy|2
6930988|NCT00871377|10963297|FG004|Washout (6 Weeks)|Withdrawal by Subject|0
6930989|NCT00871377|10963298|FG005|Washout (6 Weeks)|Withdrawal by Subject|0
7039682|NCT01712334|11122457|FG001|Treatment Period 1|Randomized in Error|2
6930990|NCT00871377|10963293|FG000|Washout (6 Weeks)|Withdrawal by Subject|0
6930991|NCT00871377|10963294|FG001|Washout (6 Weeks)|Withdrawal by Subject|0
6930992|NCT00871377|10963295|FG002|Washout (6 Weeks)|Withdrawal by Subject|0
6930993|NCT00871377|10963296|FG003|Washout (6 Weeks)|Withdrawal by Subject|0
6930994|NCT00871377|10963297|FG004|Washout (6 Weeks)|Withdrawal by Subject|0
6930995|NCT00871377|10963298|FG005|Washout (6 Weeks)|Withdrawal by Subject|1
6930996|NCT00871377|10963293|FG000|Third Intervention (10 Weeks)|Death|0
6930997|NCT00871377|10963294|FG001|Third Intervention (10 Weeks)|Death|0
6930998|NCT00871377|10963295|FG002|Third Intervention (10 Weeks)|Death|0
6930999|NCT00871377|10963296|FG003|Third Intervention (10 Weeks)|Death|1
6931000|NCT00871377|10963297|FG004|Third Intervention (10 Weeks)|Death|0
6931001|NCT00871377|10963298|FG005|Third Intervention (10 Weeks)|Death|0
6931002|NCT00871403|10963309|FG000|Combination Treatment Phase|Randomized but Not Treated|1
6931003|NCT00871403|10963310|FG001|Combination Treatment Phase|Randomized but Not Treated|1
6931004|NCT00871403|10963311|FG002|Combination Treatment Phase|Randomized but Not Treated|1
6931005|NCT00871403|10963309|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8
6931006|NCT00871403|10963310|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19
6931007|NCT00871403|10963311|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0
6931008|NCT00871403|10963309|FG000|Combination Treatment Phase|Adverse Event|0
6931009|NCT00871403|10963310|FG001|Combination Treatment Phase|Adverse Event|17
6931010|NCT00871403|10963311|FG002|Combination Treatment Phase|Adverse Event|2
6931011|NCT00871403|10963309|FG000|Combination Treatment Phase|Disease Progression|0
6931012|NCT00871403|10963310|FG001|Combination Treatment Phase|Disease Progression|8
6931013|NCT00871403|10963311|FG002|Combination Treatment Phase|Disease Progression|5
6931014|NCT00871403|10963309|FG000|Combination Treatment Phase|Withdrawal by Subject|0
6931015|NCT00871403|10963310|FG001|Combination Treatment Phase|Withdrawal by Subject|3
6931016|NCT00871403|10963311|FG002|Combination Treatment Phase|Withdrawal by Subject|1
6931017|NCT00871403|10963309|FG000|Combination Treatment Phase|Physician Decision|0
6931018|NCT00871403|10963310|FG001|Combination Treatment Phase|Physician Decision|1
6931019|NCT00871403|10963311|FG002|Combination Treatment Phase|Physician Decision|3
6931020|NCT00871403|10963309|FG000|Monotherapy Treatment Phase|Disease Progression|0
6931021|NCT00871403|10963310|FG001|Monotherapy Treatment Phase|Disease Progression|9
6931022|NCT00871403|10963311|FG002|Monotherapy Treatment Phase|Disease Progression|1
6931023|NCT00871403|10963309|FG000|Monotherapy Treatment Phase|Adverse Event|0
6931024|NCT00871403|10963310|FG001|Monotherapy Treatment Phase|Adverse Event|4
6931025|NCT00871403|10963311|FG002|Monotherapy Treatment Phase|Adverse Event|0
6931026|NCT00871429|10963318|FG000|Overall Study|Lost to Follow-up|6
6931027|NCT00871429|10963318|FG000|Overall Study|Withdrawal by Subject|17
6931028|NCT00871429|10963318|FG000|Overall Study|Questionnaire not completed|1
6931029|NCT00871494|10963326|FG000|Overall Study|Protocol Violation|5
7039683|NCT01712399|11122486|FG000|Overall Study|Lost to Follow-up|1
7039684|NCT01712399|11122486|FG000|Overall Study|Withdrawal by Subject|39
7039685|NCT01712399|11122486|FG000|Overall Study|Death|1
7039686|NCT01712399|11122486|FG000|Overall Study|Adverse Event|11
7039687|NCT01712399|11122486|FG000|Overall Study|Study closure|345
7039688|NCT01712438|11122490|FG000|Overall Study|Not treated with Human-cl rhFVIII|2
6931030|NCT00871494|10963326|FG000|Overall Study|Lack of Efficacy|4
6931031|NCT00871494|10963326|FG000|Overall Study|Adverse Event|4
6931032|NCT00871494|10963326|FG000|Overall Study|Lost to Follow-up|1
6931033|NCT00871572|10963334|FG000|Overall Study|Adverse Event|0
6931034|NCT00871572|10963335|FG001|Overall Study|Adverse Event|2
7065520|NCT01967225|11165110|FG001|Overall Study|Switching to other therapy|0
6931035|NCT00871572|10963336|FG002|Overall Study|Adverse Event|0
6931036|NCT00871572|10963337|FG003|Overall Study|Adverse Event|3
6931037|NCT00871572|10963334|FG000|Overall Study|Investigator Decision|0
6931038|NCT00871572|10963335|FG001|Overall Study|Investigator Decision|1
6931039|NCT00871572|10963336|FG002|Overall Study|Investigator Decision|0
6931040|NCT00871572|10963337|FG003|Overall Study|Investigator Decision|1
6931041|NCT00871572|10963334|FG000|Overall Study|Lost to Follow-up|0
6931042|NCT00871572|10963335|FG001|Overall Study|Lost to Follow-up|1
6931043|NCT00871572|10963336|FG002|Overall Study|Lost to Follow-up|0
6931044|NCT00871572|10963337|FG003|Overall Study|Lost to Follow-up|1
6931045|NCT00871572|10963334|FG000|Overall Study|Protocol Violation|0
6931046|NCT00871572|10963335|FG001|Overall Study|Protocol Violation|0
6931047|NCT00871572|10963336|FG002|Overall Study|Protocol Violation|1
6931048|NCT00871572|10963337|FG003|Overall Study|Protocol Violation|1
6931049|NCT00871572|10963334|FG000|Overall Study|Sponsor Decision|1
6931050|NCT00871572|10963335|FG001|Overall Study|Sponsor Decision|0
6931051|NCT00871572|10963336|FG002|Overall Study|Sponsor Decision|0
6931052|NCT00871572|10963337|FG003|Overall Study|Sponsor Decision|0
6931053|NCT00871572|10963334|FG000|Overall Study|Withdrawal by Subject|1
6931054|NCT00871572|10963335|FG001|Overall Study|Withdrawal by Subject|2
6931055|NCT00871572|10963336|FG002|Overall Study|Withdrawal by Subject|3
6931056|NCT00871572|10963337|FG003|Overall Study|Withdrawal by Subject|1
6931057|NCT00871715|10963365|FG000|Overall Study|Withdrawal by Subject|6
6931058|NCT00871715|10963366|FG001|Overall Study|Withdrawal by Subject|10
6931059|NCT00871715|10963367|FG002|Overall Study|Withdrawal by Subject|15
6931060|NCT00871715|10963365|FG000|Overall Study|Physician Decision|6
6931061|NCT00871715|10963366|FG001|Overall Study|Physician Decision|0
6931062|NCT00871715|10963367|FG002|Overall Study|Physician Decision|2
6931063|NCT00871715|10963365|FG000|Overall Study|Lost to Follow-up|3
6931064|NCT00871715|10963366|FG001|Overall Study|Lost to Follow-up|6
6931065|NCT00871715|10963367|FG002|Overall Study|Lost to Follow-up|9
6931066|NCT00871728|10963376|FG000|Overall Study|Adverse Event|1
6931067|NCT00871728|10963376|FG000|Overall Study|Protocol Violation|7
6931068|NCT00871728|10963376|FG000|Overall Study|Lost to Follow-up|2
6931069|NCT00871728|10963376|FG000|Overall Study|Failed to Visit Hospital|4
6931070|NCT00871728|10963376|FG000|Overall Study|Participant Non-compliance|1
6931071|NCT00871728|10963376|FG000|Overall Study|Withdrawal of Informed Consent|5
6931072|NCT00871741|10963382|FG000|Overall Study|Premature study termination|9
6931073|NCT00871741|10963383|FG001|Overall Study|Premature study termination|7
6931074|NCT00871780|10963389|FG000|Overall Study|Enrolled But Not Treated|6
6931075|NCT00871780|10963389|FG000|Overall Study|Withdrawal by Subject|9
6931076|NCT00871780|10963389|FG000|Overall Study|Adverse Event|6
6931077|NCT00871780|10963389|FG000|Overall Study|Voluntary Discontinuation|4
6931078|NCT00871780|10963389|FG000|Overall Study|Death|1
6931079|NCT00871780|10963389|FG000|Overall Study|Physician Decision|1
6931080|NCT00871858|10963415|FG000|Overall Study|Protocol Violation|3
7065521|NCT01967225|11165109|FG000|Overall Study|Protocol driven decision point|1
7065522|NCT01967225|11165110|FG001|Overall Study|Protocol driven decision point|0
7065523|NCT01967225|11165109|FG000|Overall Study|Logistical difficulties|1
7039689|NCT01712438|11122490|FG000|Overall Study|Ongoing ITI treatment|6
7039690|NCT01712438|11122490|FG000|Overall Study|Violated inclusion & exclusion criteria|4
7039691|NCT01712438|11122490|FG000|Overall Study|Prematurely Discontinued|25
7039692|NCT01712516|11122503|FG000|Overall Study|Technical problems|0
7039693|NCT01712516|11122504|FG001|Overall Study|Technical problems|0
6931081|NCT00871858|10963416|FG001|Overall Study|Protocol Violation|4
6931082|NCT00871858|10963415|FG000|Overall Study|Adverse Event|1
6931083|NCT00871858|10963416|FG001|Overall Study|Adverse Event|1
6931084|NCT00871858|10963415|FG000|Overall Study|Withdrawal by Subject|1
6931085|NCT00871858|10963416|FG001|Overall Study|Withdrawal by Subject|1
6931086|NCT00871858|10963415|FG000|Overall Study|Lost to Follow-up|0
6931087|NCT00871858|10963416|FG001|Overall Study|Lost to Follow-up|1
6931088|NCT00871871|10963424|FG000|Part I|Adverse Event|0
6931089|NCT00871871|10963425|FG001|Part I|Adverse Event|2
6931090|NCT00871871|10963426|FG002|Part I|Adverse Event|0
6931091|NCT00871871|10963427|FG003|Part I|Adverse Event|0
6931092|NCT00871871|10963424|FG000|Part I|Withdrawal by Subject|3
6931093|NCT00871871|10963425|FG001|Part I|Withdrawal by Subject|0
6931094|NCT00871871|10963426|FG002|Part I|Withdrawal by Subject|0
6931095|NCT00871871|10963427|FG003|Part I|Withdrawal by Subject|0
6931096|NCT00871871|10963424|FG000|Part I|Laboratory abnormality|0
7039694|NCT01712516|11122505|FG002|Overall Study|Technical problems|0
7039695|NCT01712516|11122506|FG003|Overall Study|Technical problems|2
6931097|NCT00871871|10963425|FG001|Part I|Laboratory abnormality|1
6931098|NCT00871871|10963426|FG002|Part I|Laboratory abnormality|0
6931099|NCT00871871|10963427|FG003|Part I|Laboratory abnormality|0
6931100|NCT00871871|10963424|FG000|Part II|Lack of Efficacy|0
6931101|NCT00871871|10963425|FG001|Part II|Lack of Efficacy|0
6931102|NCT00871871|10963426|FG002|Part II|Lack of Efficacy|1
6931103|NCT00871871|10963427|FG003|Part II|Lack of Efficacy|0
6931104|NCT00871871|10963424|FG000|Part II|Withdrawal by Subject|0
6931105|NCT00871871|10963425|FG001|Part II|Withdrawal by Subject|0
6931106|NCT00871871|10963426|FG002|Part II|Withdrawal by Subject|2
6931107|NCT00871871|10963427|FG003|Part II|Withdrawal by Subject|1
6931108|NCT00871871|10963424|FG000|Part II|Adverse Event|0
6931109|NCT00871871|10963425|FG001|Part II|Adverse Event|0
6931110|NCT00871871|10963426|FG002|Part II|Adverse Event|1
6931111|NCT00871871|10963427|FG003|Part II|Adverse Event|2
7065524|NCT01967225|11165110|FG001|Overall Study|Logistical difficulties|0
7065525|NCT01967225|11165109|FG000|Overall Study|Protocol Violation|2
7065526|NCT01967225|11165110|FG001|Overall Study|Protocol Violation|0
7065527|NCT01967277|11165120|FG000|Overall Study|Lost to Follow-up|1
7065528|NCT01967277|11165121|FG001|Overall Study|Lost to Follow-up|2
7065529|NCT01967277|11165120|FG000|Overall Study|Unrelated illness|0
7065530|NCT01967277|11165121|FG001|Overall Study|Unrelated illness|1
7065531|NCT01967537|11165155|FG000|Overall Study|Withdrawal by Subject|52
7065532|NCT01967537|11165155|FG000|Overall Study|Refuse treatment|2
7065533|NCT01967537|11165155|FG000|Overall Study|Lost to Follow-up|6
7065534|NCT01967550|11165161|FG000|Overall Study|Withdrawal by Subject|1
6931112|NCT00871871|10963424|FG000|Part II|Protocol Violation|0
6931113|NCT00871871|10963425|FG001|Part II|Protocol Violation|0
6931114|NCT00871871|10963426|FG002|Part II|Protocol Violation|0
6931115|NCT00871871|10963427|FG003|Part II|Protocol Violation|1
6931116|NCT00871923|10963437|FG000|Overall Study|Death|1
6931117|NCT00871923|10963437|FG000|Overall Study|Withdrawal by Subject|1
6931118|NCT00871975|10963441|FG000|Overall Study|Technical difficulty w155-1ith equipment|3
6931119|NCT00871975|10963441|FG000|Overall Study|Catheters could not be inserted|1
6931120|NCT00871975|10963441|FG000|Overall Study|Patient unable to void/insufficient vol|13
6931121|NCT00871975|10963441|FG000|Overall Study|Motion artifact, tracing uninterpretable|5
6931122|NCT00872001|10963447|FG000|Overall Study|Adverse Event|34
6931123|NCT00872001|10963448|FG001|Overall Study|Adverse Event|23
6931124|NCT00872001|10963447|FG000|Overall Study|Protocol Defined Clinical Event|5
6931125|NCT00872001|10963448|FG001|Overall Study|Protocol Defined Clinical Event|7
6931126|NCT00872001|10963447|FG000|Overall Study|Lost to Follow-up|13
6931127|NCT00872001|10963448|FG001|Overall Study|Lost to Follow-up|12
6931128|NCT00872001|10963447|FG000|Overall Study|Withdrawal by Subject|18
6931129|NCT00872001|10963448|FG001|Overall Study|Withdrawal by Subject|30
6931130|NCT00872001|10963447|FG000|Overall Study|Protocol Violation|5
6931131|NCT00872001|10963448|FG001|Overall Study|Protocol Violation|8
6931132|NCT00872001|10963447|FG000|Overall Study|Did Not Meet Protocol Eligibility|38
6931133|NCT00872001|10963448|FG001|Overall Study|Did Not Meet Protocol Eligibility|36
6931134|NCT00872001|10963447|FG000|Overall Study|Administrative|23
6931135|NCT00872001|10963448|FG001|Overall Study|Administrative|15
6931136|NCT00872170|10963471|FG000|Overall Study|Adverse Event|1
6931137|NCT00872170|10963472|FG001|Overall Study|Adverse Event|0
6931138|NCT00872521|10963493|FG000|Completed PAD Induction|Patient choice|0
6931139|NCT00872521|10963494|FG001|Completed PAD Induction|Patient choice|1
6931140|NCT00872521|10963495|FG002|Completed PAD Induction|Patient choice|0
6931141|NCT00872521|10963493|FG000|Completed PAD Induction|Disease progression|0
6931142|NCT00872521|10963494|FG001|Completed PAD Induction|Disease progression|2
6931143|NCT00872521|10963495|FG002|Completed PAD Induction|Disease progression|0
6931144|NCT00872521|10963493|FG000|Completed PAD Induction|Adverse Event|4
6931145|NCT00872521|10963494|FG001|Completed PAD Induction|Adverse Event|0
6931146|NCT00872521|10963495|FG002|Completed PAD Induction|Adverse Event|0
6931147|NCT00872521|10963493|FG000|Completed PAD Induction|Death|1
6931148|NCT00872521|10963494|FG001|Completed PAD Induction|Death|1
6931149|NCT00872521|10963495|FG002|Completed PAD Induction|Death|0
6931150|NCT00872521|10963493|FG000|Primary Endpoint Analysis|Other|1
6931151|NCT00872521|10963494|FG001|Primary Endpoint Analysis|Other|2
6931152|NCT00872521|10963495|FG002|Primary Endpoint Analysis|Other|0
6931153|NCT00872521|10963493|FG000|Primary Endpoint Analysis|Patient choice|0
6931154|NCT00872521|10963494|FG001|Primary Endpoint Analysis|Patient choice|1
6931155|NCT00872521|10963495|FG002|Primary Endpoint Analysis|Patient choice|0
6931156|NCT00872521|10963493|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0
6931157|NCT00872521|10963494|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2
6931158|NCT00872521|10963495|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0
6931159|NCT00872521|10963493|FG000|Primary Endpoint Analysis|Patient response missing|0
6931160|NCT00872521|10963494|FG001|Primary Endpoint Analysis|Patient response missing|0
6931161|NCT00872521|10963495|FG002|Primary Endpoint Analysis|Patient response missing|1
6931162|NCT00872521|10963493|FG000|Completed 3-month Follow up|Other|0
6931163|NCT00872521|10963494|FG001|Completed 3-month Follow up|Other|2
6931164|NCT00872521|10963495|FG002|Completed 3-month Follow up|Other|0
6931165|NCT00872521|10963493|FG000|Completed 3-month Follow up|Physician Decision|0
6931166|NCT00872521|10963494|FG001|Completed 3-month Follow up|Physician Decision|1
6931167|NCT00872521|10963495|FG002|Completed 3-month Follow up|Physician Decision|0
6931168|NCT00872521|10963493|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0
6931169|NCT00872521|10963494|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2
6931170|NCT00872521|10963495|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1
6931171|NCT00872599|10963523|FG000|Second Washout Period|Adverse Event|1
6931172|NCT00872599|10963524|FG001|Second Washout Period|Adverse Event|1
6931173|NCT00872898|10963569|FG000|Part Two - Double Blind|Adverse Event|4
6931174|NCT00872898|10963570|FG001|Part Two - Double Blind|Adverse Event|3
7065535|NCT01967550|11165162|FG001|Overall Study|Withdrawal by Subject|0
7065536|NCT01967550|11165161|FG000|Overall Study|Adverse Event|2
7065537|NCT01967550|11165162|FG001|Overall Study|Adverse Event|0
6931175|NCT00872898|10963569|FG000|Part Two - Double Blind|Lack of Efficacy|1
6931176|NCT00872898|10963570|FG001|Part Two - Double Blind|Lack of Efficacy|0
6931177|NCT00872898|10963569|FG000|Part Two - Double Blind|Protocol Violation|1
6931178|NCT00872898|10963570|FG001|Part Two - Double Blind|Protocol Violation|0
6931179|NCT00872898|10963569|FG000|Part Two - Double Blind|Withdrawal by Subject|3
6931180|NCT00872898|10963570|FG001|Part Two - Double Blind|Withdrawal by Subject|1
6931181|NCT00872898|10963569|FG000|Part Two - Double Blind|Lost to Follow-up|0
6931182|NCT00872898|10963570|FG001|Part Two - Double Blind|Lost to Follow-up|2
6931183|NCT00872898|10963569|FG000|Part Two - Double Blind|Other reasons|2
6931184|NCT00872898|10963570|FG001|Part Two - Double Blind|Other reasons|0
6931185|NCT00872989|10963581|FG000|Overall Study|Adverse Event|7
6931186|NCT00872989|10963582|FG001|Overall Study|Adverse Event|15
6931187|NCT00872989|10963581|FG000|Overall Study|Withdrawal by Subject|8
6931188|NCT00872989|10963582|FG001|Overall Study|Withdrawal by Subject|5
6931189|NCT00872989|10963581|FG000|Overall Study|Progression/relapse|47
6931190|NCT00872989|10963582|FG001|Overall Study|Progression/relapse|35
6931191|NCT00872989|10963581|FG000|Overall Study|Not protocol specified|3
6931192|NCT00872989|10963582|FG001|Overall Study|Not protocol specified|8
6931193|NCT00873015|10963598|FG000|Overall Study|Withdrawal by Subject|0
6931194|NCT00873015|10963599|FG001|Overall Study|Withdrawal by Subject|1
6931195|NCT00873015|10963600|FG002|Overall Study|Withdrawal by Subject|0
6931196|NCT00873015|10963601|FG003|Overall Study|Withdrawal by Subject|0
6931197|NCT00873041|10963613|FG000|Core Study|Adverse Event|2
6931198|NCT00873041|10963614|FG001|Core Study|Adverse Event|3
6931199|NCT00873041|10963615|FG002|Core Study|Adverse Event|1
6931200|NCT00873041|10963613|FG000|Core Study|Withdrawal by Subject|1
6931201|NCT00873041|10963614|FG001|Core Study|Withdrawal by Subject|2
6931202|NCT00873041|10963615|FG002|Core Study|Withdrawal by Subject|2
6931203|NCT00873041|10963613|FG000|Core Study|Lost to Follow-up|3
6931204|NCT00873041|10963614|FG001|Core Study|Lost to Follow-up|1
6931205|NCT00873041|10963615|FG002|Core Study|Lost to Follow-up|0
6931206|NCT00873041|10963613|FG000|Core Study|Abnormal laboratory value|0
6931207|NCT00873041|10963614|FG001|Core Study|Abnormal laboratory value|0
6931208|NCT00873041|10963615|FG002|Core Study|Abnormal laboratory value|1
6931209|NCT00873041|10963613|FG000|Core Study|Protocol deviation|1
6931210|NCT00873041|10963614|FG001|Core Study|Protocol deviation|0
6931211|NCT00873041|10963615|FG002|Core Study|Protocol deviation|1
6931212|NCT00873041|10963613|FG000|Extension Study|Adverse Event|1
6931213|NCT00873041|10963614|FG001|Extension Study|Adverse Event|0
6931214|NCT00873041|10963615|FG002|Extension Study|Adverse Event|1
6931215|NCT00873041|10963613|FG000|Extension Study|Administrative reasons|0
6931216|NCT00873041|10963614|FG001|Extension Study|Administrative reasons|0
6931217|NCT00873041|10963615|FG002|Extension Study|Administrative reasons|1
6931218|NCT00873093|10963635|FG000|Overall Study|Adverse Event|0
6931219|NCT00873093|10963636|FG001|Overall Study|Adverse Event|2
6931220|NCT00873093|10963637|FG002|Overall Study|Adverse Event|0
6931221|NCT00873093|10963638|FG003|Overall Study|Adverse Event|0
6931222|NCT00873093|10963639|FG004|Overall Study|Adverse Event|0
6931223|NCT00873093|10963635|FG000|Overall Study|Death|0
6931224|NCT00873093|10963636|FG001|Overall Study|Death|3
6931225|NCT00873093|10963637|FG002|Overall Study|Death|2
6931226|NCT00873093|10963638|FG003|Overall Study|Death|0
6931227|NCT00873093|10963639|FG004|Overall Study|Death|0
6931228|NCT00873093|10963635|FG000|Overall Study|Physician Decision|0
6931229|NCT00873093|10963636|FG001|Overall Study|Physician Decision|17
6931230|NCT00873093|10963637|FG002|Overall Study|Physician Decision|10
6931231|NCT00873093|10963638|FG003|Overall Study|Physician Decision|10
6931232|NCT00873093|10963639|FG004|Overall Study|Physician Decision|2
6931233|NCT00873093|10963635|FG000|Overall Study|Withdrawal by Subject|1
6931234|NCT00873093|10963636|FG001|Overall Study|Withdrawal by Subject|4
6931235|NCT00873093|10963637|FG002|Overall Study|Withdrawal by Subject|4
6931236|NCT00873093|10963638|FG003|Overall Study|Withdrawal by Subject|0
6931237|NCT00873093|10963639|FG004|Overall Study|Withdrawal by Subject|0
6931238|NCT00873093|10963635|FG000|Overall Study|Ineligible|0
6931239|NCT00873093|10963636|FG001|Overall Study|Ineligible|1
6931240|NCT00873093|10963637|FG002|Overall Study|Ineligible|0
6931241|NCT00873093|10963638|FG003|Overall Study|Ineligible|1
6931242|NCT00873093|10963639|FG004|Overall Study|Ineligible|0
6931243|NCT00873119|10963663|FG000|Overall Study|Patient request|4
6931244|NCT00873119|10963664|FG001|Overall Study|Patient request|2
6931245|NCT00873119|10963663|FG000|Overall Study|Adverse Event|8
6931246|NCT00873119|10963664|FG001|Overall Study|Adverse Event|0
6931247|NCT00873119|10963663|FG000|Overall Study|Progressive disease|26
6931248|NCT00873119|10963664|FG001|Overall Study|Progressive disease|18
6931249|NCT00873119|10963663|FG000|Overall Study|Death|2
6931250|NCT00873119|10963664|FG001|Overall Study|Death|1
6931251|NCT00873119|10963663|FG000|Overall Study|Other|2
6931252|NCT00873119|10963664|FG001|Overall Study|Other|5
6931253|NCT00873119|10963663|FG000|Overall Study|Not treated|2
6931254|NCT00873119|10963664|FG001|Overall Study|Not treated|0
6931255|NCT00873730|10963680|FG000|Overall Study|Protocol Deviation|5
6931256|NCT00873730|10963681|FG001|Overall Study|Protocol Deviation|2
6931257|NCT00873730|10963680|FG000|Overall Study|Adverse Event|0
6931258|NCT00873730|10963681|FG001|Overall Study|Adverse Event|2
6931259|NCT00873730|10963680|FG000|Overall Study|Withdrawal by Subject|0
6931260|NCT00873730|10963681|FG001|Overall Study|Withdrawal by Subject|1
6931261|NCT00873730|10963680|FG000|Overall Study|Sponsor decision|1
6931262|NCT00873730|10963681|FG001|Overall Study|Sponsor decision|0
6931263|NCT00873860|10963704|FG000|Overall Study|Lost to Follow-up|1
6931264|NCT00873860|10963705|FG001|Overall Study|Lost to Follow-up|0
6931265|NCT00873860|10963706|FG002|Overall Study|Lost to Follow-up|0
6931266|NCT00873860|10963707|FG003|Overall Study|Lost to Follow-up|1
6931267|NCT00873860|10963704|FG000|Overall Study|Withdrawal by Subject|1
7065538|NCT01967550|11165161|FG000|Overall Study|Protocol Violation|2
7065539|NCT01967550|11165162|FG001|Overall Study|Protocol Violation|1
7065540|NCT01967550|11165161|FG000|Overall Study|Non Compliance|0
7065541|NCT01967550|11165162|FG001|Overall Study|Non Compliance|1
7065542|NCT01967576|11165168|FG000|Overall Study|Withdrawal by Subject|3
7065543|NCT01967576|11165168|FG000|Overall Study|Progressed/Removed from treatment|1
7065544|NCT01967576|11165168|FG000|Overall Study|Study closing at site|1
7065545|NCT01967576|11165168|FG000|Overall Study|Adverse Event|1
7065546|NCT01967576|11165168|FG000|Overall Study|Refused further treatment|1
6931268|NCT00873860|10963705|FG001|Overall Study|Withdrawal by Subject|0
6931269|NCT00873860|10963706|FG002|Overall Study|Withdrawal by Subject|2
6931270|NCT00873860|10963707|FG003|Overall Study|Withdrawal by Subject|0
6931271|NCT00873860|10963704|FG000|Overall Study|Death|1
6931272|NCT00873860|10963705|FG001|Overall Study|Death|0
6931273|NCT00873860|10963706|FG002|Overall Study|Death|0
6931274|NCT00873860|10963707|FG003|Overall Study|Death|0
6931275|NCT00873860|10963704|FG000|Overall Study|Other|1
6931276|NCT00873860|10963705|FG001|Overall Study|Other|0
6931277|NCT00873860|10963706|FG002|Overall Study|Other|1
6931278|NCT00873860|10963707|FG003|Overall Study|Other|0
6931279|NCT00873912|10963739|FG000|Overall Study|Withdrawal by Subject|1
6931280|NCT00873912|10963740|FG001|Overall Study|Withdrawal by Subject|0
6931281|NCT00873912|10963739|FG000|Overall Study|Lost to Follow-up|2
6931282|NCT00873912|10963740|FG001|Overall Study|Lost to Follow-up|0
6931283|NCT00874029|10963746|FG000|Overall Study|Withdrawal by Subject|10
6931284|NCT00874029|10963746|FG000|Overall Study|Pregnancy|4
6931285|NCT00874029|10963746|FG000|Overall Study|Physician Decision|1
7039696|NCT01712516|11122503|FG000|Overall Study|Lost to Follow-up|0
7039697|NCT01712516|11122504|FG001|Overall Study|Lost to Follow-up|0
6931286|NCT00874029|10963746|FG000|Overall Study|Adverse Event|1
6931287|NCT00874029|10963746|FG000|Overall Study|Lost to Follow-up|5
6931288|NCT00874120|10963766|FG000|First Intervention|Adverse Event|0
6931289|NCT00874120|10963767|FG001|First Intervention|Adverse Event|1
6931290|NCT00874120|10963766|FG000|First Intervention|Withdrawal by Subject|2
6931291|NCT00874120|10963767|FG001|First Intervention|Withdrawal by Subject|0
6931292|NCT00874120|10963766|FG000|First Intervention|Lost to Follow-up|0
6931293|NCT00874120|10963767|FG001|First Intervention|Lost to Follow-up|1
6931294|NCT00874120|10963766|FG000|First Intervention|Protocol Violation|3
6931295|NCT00874120|10963767|FG001|First Intervention|Protocol Violation|0
6931296|NCT00874120|10963766|FG000|First Intervention|positive drug test|1
6931297|NCT00874120|10963767|FG001|First Intervention|positive drug test|0
6931298|NCT00874120|10963766|FG000|Second Intervention|Withdrawal by Subject|1
6931299|NCT00874120|10963767|FG001|Second Intervention|Withdrawal by Subject|0
6931300|NCT00874120|10963766|FG000|Second Intervention|Protocol Violation|1
6931301|NCT00874120|10963767|FG001|Second Intervention|Protocol Violation|0
6931302|NCT00874237|10963773|FG000|Overall Study|Physician Decision|0
6931303|NCT00874237|10963774|FG001|Overall Study|Physician Decision|1
6931304|NCT00874237|10963775|FG002|Overall Study|Physician Decision|0
6931305|NCT00874237|10963776|FG003|Overall Study|Physician Decision|0
6931306|NCT00874237|10963777|FG004|Overall Study|Physician Decision|0
6931307|NCT00874237|10963778|FG005|Overall Study|Physician Decision|0
6931308|NCT00874237|10963773|FG000|Overall Study|Withdrawal by Subject|0
6931309|NCT00874237|10963774|FG001|Overall Study|Withdrawal by Subject|0
6931310|NCT00874237|10963775|FG002|Overall Study|Withdrawal by Subject|1
6931311|NCT00874237|10963776|FG003|Overall Study|Withdrawal by Subject|0
6931312|NCT00874237|10963777|FG004|Overall Study|Withdrawal by Subject|0
6931313|NCT00874237|10963778|FG005|Overall Study|Withdrawal by Subject|0
6931314|NCT00874276|10963795|FG000|Overall Study|Withdrawal by Subject|1
6931315|NCT00874276|10963796|FG001|Overall Study|Withdrawal by Subject|1
6931316|NCT00874432|10963808|FG000|Overall Study|Withdrawal by Subject|1
6931317|NCT00874432|10963809|FG001|Overall Study|Withdrawal by Subject|0
6931318|NCT00874432|10963810|FG002|Overall Study|Withdrawal by Subject|0
6931319|NCT00874432|10963811|FG003|Overall Study|Withdrawal by Subject|0
6931320|NCT00874432|10963808|FG000|Overall Study|Physician Decision|1
6931321|NCT00874432|10963809|FG001|Overall Study|Physician Decision|0
6931322|NCT00874432|10963810|FG002|Overall Study|Physician Decision|0
6931323|NCT00874432|10963811|FG003|Overall Study|Physician Decision|0
6931324|NCT00874432|10963808|FG000|Overall Study|Other|1
7039698|NCT01712516|11122505|FG002|Overall Study|Lost to Follow-up|2
7039699|NCT01712516|11122506|FG003|Overall Study|Lost to Follow-up|1
6931325|NCT00874432|10963809|FG001|Overall Study|Other|2
6931326|NCT00874432|10963810|FG002|Overall Study|Other|8
6931327|NCT00874432|10963811|FG003|Overall Study|Other|3
6931328|NCT00874497|10963825|FG000|Overall Study|Lost to Follow-up|2
6931329|NCT00874497|10963826|FG001|Overall Study|Lost to Follow-up|4
6931330|NCT00874497|10963825|FG000|Overall Study|Adverse Event|9
6931331|NCT00874497|10963826|FG001|Overall Study|Adverse Event|4
6931332|NCT00874497|10963825|FG000|Overall Study|Sponsor Discontinued Trial|7
6931333|NCT00874497|10963826|FG001|Overall Study|Sponsor Discontinued Trial|3
6931334|NCT00874497|10963825|FG000|Overall Study|Met Withdrawal Criteria|4
6931335|NCT00874497|10963826|FG001|Overall Study|Met Withdrawal Criteria|2
6931336|NCT00874497|10963825|FG000|Overall Study|Physician Decision|1
7039700|NCT01712516|11122503|FG000|Overall Study|Death|0
7065547|NCT01967628|11165174|FG000|Overall Study|Withdrawal by Subject|2
6931337|NCT00874497|10963826|FG001|Overall Study|Physician Decision|1
6931338|NCT00874497|10963825|FG000|Overall Study|Withdrawal by Subject|5
6931339|NCT00874497|10963826|FG001|Overall Study|Withdrawal by Subject|4
6931340|NCT00874549|10963845|FG000|Overall Study|Adverse Event|0
6931341|NCT00874549|10963846|FG001|Overall Study|Adverse Event|0
6931342|NCT00874549|10963847|FG002|Overall Study|Adverse Event|1
6931343|NCT00874549|10963848|FG003|Overall Study|Adverse Event|0
6931344|NCT00874549|10963845|FG000|Overall Study|Protocol Violation|1
6931345|NCT00874549|10963846|FG001|Overall Study|Protocol Violation|0
6931346|NCT00874549|10963847|FG002|Overall Study|Protocol Violation|2
6931347|NCT00874549|10963848|FG003|Overall Study|Protocol Violation|1
6931348|NCT00874549|10963845|FG000|Overall Study|Lost to Follow-up|0
6931349|NCT00874549|10963846|FG001|Overall Study|Lost to Follow-up|0
6931350|NCT00874549|10963847|FG002|Overall Study|Lost to Follow-up|1
6931351|NCT00874549|10963848|FG003|Overall Study|Lost to Follow-up|0
6931352|NCT00874549|10963845|FG000|Overall Study|Withdrawal by Subject|0
6931353|NCT00874549|10963846|FG001|Overall Study|Withdrawal by Subject|1
6931354|NCT00874549|10963847|FG002|Overall Study|Withdrawal by Subject|0
6931355|NCT00874549|10963848|FG003|Overall Study|Withdrawal by Subject|1
6931356|NCT00874731|10963864|FG000|Part 1, Day 1: Placebo|Disease Progression|1
6931357|NCT00874731|10963865|FG001|Part 1, Day 1: Placebo|Disease Progression|0
6931358|NCT00874731|10963866|FG002|Part 1, Day 1: Placebo|Disease Progression|0
6931359|NCT00874731|10963864|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0
6931360|NCT00874731|10963865|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0
6931361|NCT00874731|10963866|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3
6931362|NCT00874731|10963864|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0
6931363|NCT00874731|10963865|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0
6931364|NCT00874731|10963866|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19
6931365|NCT00874770|10963878|FG000|Overall Study|Lack of Efficacy|2
6931366|NCT00874770|10963879|FG001|Overall Study|Lack of Efficacy|0
6931367|NCT00874770|10963880|FG002|Overall Study|Lack of Efficacy|0
6931368|NCT00874770|10963881|FG003|Overall Study|Lack of Efficacy|2
6931369|NCT00874770|10963878|FG000|Overall Study|Adverse Event|1
6931370|NCT00874770|10963879|FG001|Overall Study|Adverse Event|1
6931371|NCT00874770|10963880|FG002|Overall Study|Adverse Event|4
6931372|NCT00874770|10963881|FG003|Overall Study|Adverse Event|2
6931373|NCT00874770|10963878|FG000|Overall Study|Lost to Follow-up|1
6931374|NCT00874770|10963879|FG001|Overall Study|Lost to Follow-up|0
6931375|NCT00874770|10963880|FG002|Overall Study|Lost to Follow-up|0
6931376|NCT00874770|10963881|FG003|Overall Study|Lost to Follow-up|1
6931377|NCT00874770|10963878|FG000|Overall Study|Subject no Longer Meets Study Criteria|1
6931378|NCT00874770|10963879|FG001|Overall Study|Subject no Longer Meets Study Criteria|0
6931379|NCT00874770|10963880|FG002|Overall Study|Subject no Longer Meets Study Criteria|0
6931380|NCT00874770|10963881|FG003|Overall Study|Subject no Longer Meets Study Criteria|0
6931381|NCT00874822|10963901|FG000|Overall Study|excluded by criteria|8
6931382|NCT00874848|10963907|FG000|Overall Study|Adverse Event|13
6931383|NCT00874848|10963908|FG001|Overall Study|Adverse Event|2
6931384|NCT00874848|10963907|FG000|Overall Study|Progressive neoplastic disease|38
6931385|NCT00874848|10963908|FG001|Overall Study|Progressive neoplastic disease|18
6931386|NCT00874848|10963907|FG000|Overall Study|Withdrawal by Subject|7
6931387|NCT00874848|10963908|FG001|Overall Study|Withdrawal by Subject|4
6931388|NCT00874848|10963907|FG000|Overall Study|Noncompliance|1
6931389|NCT00874848|10963908|FG001|Overall Study|Noncompliance|1
6931390|NCT00874848|10963907|FG000|Overall Study|Failure to comply with protocol|0
6931391|NCT00874848|10963908|FG001|Overall Study|Failure to comply with protocol|1
6931392|NCT00874848|10963907|FG000|Overall Study|Physician Decision|0
6931393|NCT00874848|10963908|FG001|Overall Study|Physician Decision|2
6931394|NCT00875017|10963929|FG000|First Intervention|Withdrawal by Subject|1
6931395|NCT00875017|10963930|FG001|First Intervention|Withdrawal by Subject|0
6931396|NCT00875017|10963931|FG002|First Intervention|Withdrawal by Subject|1
6931397|NCT00875017|10963932|FG003|First Intervention|Withdrawal by Subject|0
6931398|NCT00875017|10963933|FG004|First Intervention|Withdrawal by Subject|0
6931399|NCT00875017|10963934|FG005|First Intervention|Withdrawal by Subject|0
6931400|NCT00875017|10963929|FG000|First Intervention|Adverse Event|0
6931401|NCT00875017|10963930|FG001|First Intervention|Adverse Event|0
6931402|NCT00875017|10963931|FG002|First Intervention|Adverse Event|0
6931403|NCT00875017|10963932|FG003|First Intervention|Adverse Event|1
6931404|NCT00875017|10963933|FG004|First Intervention|Adverse Event|0
6931405|NCT00875017|10963934|FG005|First Intervention|Adverse Event|0
6931406|NCT00875017|10963929|FG000|First Intervention|Problems collecting rectal effluent|1
6931407|NCT00875017|10963930|FG001|First Intervention|Problems collecting rectal effluent|0
6931408|NCT00875017|10963931|FG002|First Intervention|Problems collecting rectal effluent|0
6931409|NCT00875017|10963932|FG003|First Intervention|Problems collecting rectal effluent|0
6931410|NCT00875017|10963933|FG004|First Intervention|Problems collecting rectal effluent|0
6931411|NCT00875017|10963934|FG005|First Intervention|Problems collecting rectal effluent|0
6931412|NCT00875017|10963929|FG000|First Intervention|Intolerance to nasogastric tube|0
6931413|NCT00875017|10963930|FG001|First Intervention|Intolerance to nasogastric tube|0
6931414|NCT00875017|10963931|FG002|First Intervention|Intolerance to nasogastric tube|0
6931415|NCT00875017|10963932|FG003|First Intervention|Intolerance to nasogastric tube|0
6931416|NCT00875017|10963933|FG004|First Intervention|Intolerance to nasogastric tube|1
6975185|NCT01191086|11027168|FG000|Overall Study|Other|1
6931417|NCT00875017|10963934|FG005|First Intervention|Intolerance to nasogastric tube|0
6931418|NCT00875017|10963929|FG000|Washout|Problem collecting rectal effluent|0
6931419|NCT00875017|10963930|FG001|Washout|Problem collecting rectal effluent|0
6931420|NCT00875017|10963931|FG002|Washout|Problem collecting rectal effluent|1
6931421|NCT00875017|10963932|FG003|Washout|Problem collecting rectal effluent|0
6931422|NCT00875017|10963933|FG004|Washout|Problem collecting rectal effluent|0
6931423|NCT00875017|10963934|FG005|Washout|Problem collecting rectal effluent|0
6931424|NCT00875017|10963929|FG000|Second Intervention|Adverse Event|0
6931425|NCT00875017|10963930|FG001|Second Intervention|Adverse Event|0
6931426|NCT00875017|10963931|FG002|Second Intervention|Adverse Event|0
6931427|NCT00875017|10963932|FG003|Second Intervention|Adverse Event|1
6931428|NCT00875017|10963933|FG004|Second Intervention|Adverse Event|0
6931429|NCT00875017|10963934|FG005|Second Intervention|Adverse Event|0
6931430|NCT00875017|10963929|FG000|Washout|Problems collecting rectal effluent|0
6931431|NCT00875017|10963930|FG001|Washout|Problems collecting rectal effluent|1
6931432|NCT00875017|10963931|FG002|Washout|Problems collecting rectal effluent|0
6931433|NCT00875017|10963932|FG003|Washout|Problems collecting rectal effluent|0
6931434|NCT00875017|10963933|FG004|Washout|Problems collecting rectal effluent|0
6931435|NCT00875017|10963934|FG005|Washout|Problems collecting rectal effluent|0
6931436|NCT00875017|10963929|FG000|Third Intervention|Adverse Event|0
6931437|NCT00875017|10963930|FG001|Third Intervention|Adverse Event|1
6931438|NCT00875017|10963931|FG002|Third Intervention|Adverse Event|1
6931439|NCT00875017|10963932|FG003|Third Intervention|Adverse Event|0
6931440|NCT00875017|10963933|FG004|Third Intervention|Adverse Event|0
6931441|NCT00875017|10963934|FG005|Third Intervention|Adverse Event|0
6931442|NCT00875017|10963929|FG000|Washout|Withdrawal by Subject|0
6931443|NCT00875017|10963930|FG001|Washout|Withdrawal by Subject|0
6931444|NCT00875017|10963931|FG002|Washout|Withdrawal by Subject|0
6931445|NCT00875017|10963932|FG003|Washout|Withdrawal by Subject|0
6931446|NCT00875017|10963933|FG004|Washout|Withdrawal by Subject|1
6931447|NCT00875017|10963934|FG005|Washout|Withdrawal by Subject|0
6931448|NCT00875017|10963929|FG000|Fourth Intervention|Inability to comply with fasting|0
6931449|NCT00875017|10963930|FG001|Fourth Intervention|Inability to comply with fasting|0
6931450|NCT00875017|10963931|FG002|Fourth Intervention|Inability to comply with fasting|0
6931451|NCT00875017|10963932|FG003|Fourth Intervention|Inability to comply with fasting|0
7065548|NCT01967628|11165175|FG001|Overall Study|Withdrawal by Subject|0
7065549|NCT01967628|11165174|FG000|Overall Study|Unable to complete bronchoscopy|4
7065550|NCT01967628|11165175|FG001|Overall Study|Unable to complete bronchoscopy|6
7065551|NCT01967628|11165174|FG000|Overall Study|Lost to Follow-up|1
7065552|NCT01967628|11165175|FG001|Overall Study|Lost to Follow-up|0
7065553|NCT01967628|11165174|FG000|Overall Study|Low protein concentration in sample|20
6931452|NCT00875017|10963933|FG004|Fourth Intervention|Inability to comply with fasting|0
6931453|NCT00875017|10963934|FG005|Fourth Intervention|Inability to comply with fasting|1
6931454|NCT00875056|10963950|FG000|Overall Study|Adverse Event|6
6931455|NCT00875056|10963951|FG001|Overall Study|Adverse Event|1
6931456|NCT00875056|10963952|FG002|Overall Study|Adverse Event|2
6931457|NCT00875056|10963950|FG000|Overall Study|Progressive Disease|14
6931458|NCT00875056|10963951|FG001|Overall Study|Progressive Disease|8
6931459|NCT00875056|10963952|FG002|Overall Study|Progressive Disease|3
6931460|NCT00875056|10963950|FG000|Overall Study|Withdrawal by Subject|3
6931461|NCT00875056|10963951|FG001|Overall Study|Withdrawal by Subject|0
6931462|NCT00875056|10963952|FG002|Overall Study|Withdrawal by Subject|1
6931463|NCT00875420|10964000|FG000|Overall Study|Adverse Event|0
6931464|NCT00875420|10964001|FG001|Overall Study|Adverse Event|1
6931465|NCT00875420|10964002|FG002|Overall Study|Adverse Event|1
6931466|NCT00875420|10964003|FG003|Overall Study|Adverse Event|0
6931467|NCT00875420|10964004|FG004|Overall Study|Adverse Event|0
6931468|NCT00875420|10964000|FG000|Overall Study|Inability to complete study procedures|1
6931469|NCT00875420|10964001|FG001|Overall Study|Inability to complete study procedures|0
6931470|NCT00875420|10964002|FG002|Overall Study|Inability to complete study procedures|1
6931471|NCT00875420|10964003|FG003|Overall Study|Inability to complete study procedures|1
6931472|NCT00875420|10964004|FG004|Overall Study|Inability to complete study procedures|1
6931473|NCT00875420|10964000|FG000|Overall Study|Lost to Follow-up|1
6931474|NCT00875420|10964001|FG001|Overall Study|Lost to Follow-up|0
6931475|NCT00875420|10964002|FG002|Overall Study|Lost to Follow-up|0
6931476|NCT00875420|10964003|FG003|Overall Study|Lost to Follow-up|0
6931477|NCT00875420|10964004|FG004|Overall Study|Lost to Follow-up|0
6931478|NCT00875420|10964000|FG000|Overall Study|Personal reason|0
6931479|NCT00875420|10964001|FG001|Overall Study|Personal reason|0
6931480|NCT00875420|10964002|FG002|Overall Study|Personal reason|0
6931481|NCT00875420|10964003|FG003|Overall Study|Personal reason|0
6931482|NCT00875420|10964004|FG004|Overall Study|Personal reason|1
6931483|NCT00875420|10964000|FG000|Overall Study|Prohibited medication|0
6931484|NCT00875420|10964001|FG001|Overall Study|Prohibited medication|0
6931485|NCT00875420|10964002|FG002|Overall Study|Prohibited medication|0
6931486|NCT00875420|10964003|FG003|Overall Study|Prohibited medication|1
6931487|NCT00875420|10964004|FG004|Overall Study|Prohibited medication|0
6931488|NCT00875420|10964000|FG000|Overall Study|Sponsor decision|0
6931489|NCT00875420|10964001|FG001|Overall Study|Sponsor decision|1
6931490|NCT00875420|10964002|FG002|Overall Study|Sponsor decision|0
6931491|NCT00875420|10964003|FG003|Overall Study|Sponsor decision|0
6931492|NCT00875420|10964004|FG004|Overall Study|Sponsor decision|0
6931493|NCT00875420|10964000|FG000|Overall Study|Withdrawal by Subject|0
6931494|NCT00875420|10964001|FG001|Overall Study|Withdrawal by Subject|0
6931495|NCT00875420|10964002|FG002|Overall Study|Withdrawal by Subject|1
6931496|NCT00875420|10964003|FG003|Overall Study|Withdrawal by Subject|0
6931497|NCT00875420|10964004|FG004|Overall Study|Withdrawal by Subject|0
6931498|NCT00875433|10964016|FG000|Overall Study|Progressive disease|41
6931499|NCT00875433|10964016|FG000|Overall Study|Other Adverse Event|14
6931500|NCT00875433|10964016|FG000|Overall Study|Withdrawal by Subject|2
6931501|NCT00875433|10964016|FG000|Overall Study|Other|3
6931502|NCT00875485|10964022|FG000|Challenge Dose Epoch|Pregnancy|1
6931503|NCT00875485|10964023|FG001|Challenge Dose Epoch|Pregnancy|0
6931504|NCT00875563|10964040|FG000|Overall Study|Death|4
6931505|NCT00875563|10964040|FG000|Overall Study|Withdrawal by Subject|7
6931506|NCT00875563|10964040|FG000|Overall Study|No long-term (3-5 year) consent|6
6931507|NCT00875563|10964040|FG000|Overall Study|Still be eligible for follow-up|7
6837380|NCT00250679|10842941|FG000|Overall Study|Non-compliance|1
6837381|NCT00250679|10842942|FG001|Overall Study|Non-compliance|1
6837382|NCT00250679|10842943|FG002|Overall Study|Non-compliance|0
6837383|NCT00250679|10842941|FG000|Overall Study|various single events: hip surgery,diary|3
6837384|NCT00250679|10842942|FG001|Overall Study|various single events: hip surgery,diary|1
6837385|NCT00250679|10842943|FG002|Overall Study|various single events: hip surgery,diary|1
6837386|NCT00250705|10842951|FG000|Overall Study|Lack of Efficacy|2
6837387|NCT00250835|10842957|FG000|Overall Study|Withdrawal by Subject|1
6837388|NCT00251004|10842969|FG000|Overall Study|Withdrawal by Subject|23
6837389|NCT00251004|10842970|FG001|Overall Study|Withdrawal by Subject|16
6837390|NCT00251004|10842971|FG002|Overall Study|Withdrawal by Subject|14
6837391|NCT00251004|10842969|FG000|Overall Study|Death|9
6837392|NCT00251004|10842970|FG001|Overall Study|Death|10
6837393|NCT00251004|10842971|FG002|Overall Study|Death|8
6837394|NCT00251004|10842969|FG000|Overall Study|Lost to Follow-up|1
6837395|NCT00251004|10842970|FG001|Overall Study|Lost to Follow-up|2
6837396|NCT00251004|10842971|FG002|Overall Study|Lost to Follow-up|1
6837397|NCT00251004|10842969|FG000|Overall Study|Graft Loss|12
6837398|NCT00251004|10842970|FG001|Overall Study|Graft Loss|13
6837399|NCT00251004|10842971|FG002|Overall Study|Graft Loss|8
6837400|NCT00251316|10843005|FG000|Overall Study|Physician Decision|2
6837401|NCT00251316|10843006|FG001|Overall Study|Physician Decision|3
6837402|NCT00251589|10843016|FG000|Overall Study|Adverse Event|5
6837403|NCT00251589|10843017|FG001|Overall Study|Adverse Event|1
6837404|NCT00251589|10843018|FG002|Overall Study|Adverse Event|2
6837405|NCT00251589|10843019|FG003|Overall Study|Adverse Event|1
6837406|NCT00251589|10843016|FG000|Overall Study|Withdrawal by Subject|1
6837407|NCT00251589|10843017|FG001|Overall Study|Withdrawal by Subject|1
6837408|NCT00251589|10843018|FG002|Overall Study|Withdrawal by Subject|0
6837409|NCT00251589|10843019|FG003|Overall Study|Withdrawal by Subject|0
6837410|NCT00251589|10843016|FG000|Overall Study|Discontinued due to progressive disease|9
6837411|NCT00251589|10843017|FG001|Overall Study|Discontinued due to progressive disease|1
6837412|NCT00251589|10843018|FG002|Overall Study|Discontinued due to progressive disease|0
6837413|NCT00251589|10843019|FG003|Overall Study|Discontinued due to progressive disease|1
6837414|NCT00251641|10843031|FG000|Overall Study|Adverse Event|80
6837415|NCT00251641|10843032|FG001|Overall Study|Adverse Event|8
6931508|NCT00875615|10964053|FG000|Overall Study|Withdrawal by Subject|1
6931509|NCT00875667|10964072|FG000|Overall Study|Adverse Event|29
6931510|NCT00875667|10964073|FG001|Overall Study|Adverse Event|10
6931511|NCT00875667|10964072|FG000|Overall Study|Withdrawal by Subject|17
6931512|NCT00875667|10964073|FG001|Overall Study|Withdrawal by Subject|5
6931513|NCT00875667|10964072|FG000|Overall Study|Death|7
6931514|NCT00875667|10964073|FG001|Overall Study|Death|2
6931515|NCT00875667|10964072|FG000|Overall Study|Protocol Violation|2
6931516|NCT00875667|10964073|FG001|Overall Study|Protocol Violation|0
6931517|NCT00875667|10964072|FG000|Overall Study|Disease Progression|100
6931518|NCT00875667|10964073|FG001|Overall Study|Disease Progression|49
6931519|NCT00875667|10964072|FG000|Overall Study|Miscellaneous|12
6931520|NCT00875667|10964073|FG001|Overall Study|Miscellaneous|6
6931521|NCT00875667|10964072|FG000|Overall Study|Randomized but no Study Drug Given|3
6931522|NCT00875667|10964073|FG001|Overall Study|Randomized but no Study Drug Given|1
6931523|NCT00875706|10964082|FG000|Overall Study|Withdrawal by Subject|1
6931524|NCT00875706|10964083|FG001|Overall Study|Withdrawal by Subject|0
6931525|NCT00875706|10964084|FG002|Overall Study|Withdrawal by Subject|0
6931526|NCT00875797|10964094|FG000|Overall Study|Protocol Violation|6
6931527|NCT00875797|10964095|FG001|Overall Study|Protocol Violation|3
6931528|NCT00875810|10964104|FG000|Overall Study|Withdrawal by Subject|1
6931529|NCT00875810|10964104|FG000|Overall Study|Physician Decision|3
6931530|NCT00875810|10964104|FG000|Overall Study|Lost to Follow-up|39
6837416|NCT00251641|10843031|FG000|Overall Study|Lack of Efficacy|2
6837417|NCT00251641|10843032|FG001|Overall Study|Lack of Efficacy|1
6931531|NCT00875810|10964104|FG000|Overall Study|Patient enroled but not implanted|2
6931532|NCT00875810|10964104|FG000|Overall Study|Device explanted|1
6931533|NCT00875979|10964119|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1
6931534|NCT00875979|10964120|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0
6931535|NCT00875979|10964119|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1
6975186|NCT01191190|11027172|FG000|Overall Study|Withdrawal by Subject|1
6931536|NCT00875979|10964120|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0
6931537|NCT00875979|10964119|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1
6931538|NCT00875979|10964120|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0
6931539|NCT00875979|10964119|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0
6931540|NCT00875979|10964120|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6
6931541|NCT00875979|10964119|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0
6931542|NCT00875979|10964120|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37
6931543|NCT00875979|10964119|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0
6931544|NCT00875979|10964120|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3
6931545|NCT00875979|10964119|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0
6931546|NCT00875979|10964120|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3
6931547|NCT00875979|10964119|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0
6931548|NCT00875979|10964120|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3
6931549|NCT00875979|10964119|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0
6931550|NCT00875979|10964120|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1
6931551|NCT00876018|10964129|FG000|Overall Study|Lost to Follow-up|0
6931552|NCT00876018|10964130|FG001|Overall Study|Lost to Follow-up|1
6931553|NCT00876018|10964131|FG002|Overall Study|Lost to Follow-up|1
6931554|NCT00876018|10964129|FG000|Overall Study|Withdrew Consent due to Adverse Event|5
6931555|NCT00876018|10964130|FG001|Overall Study|Withdrew Consent due to Adverse Event|4
6931556|NCT00876018|10964131|FG002|Overall Study|Withdrew Consent due to Adverse Event|2
6931557|NCT00876187|10964146|FG000|Overall Study|Adverse Event|14
6931558|NCT00876187|10964147|FG001|Overall Study|Adverse Event|12
6931559|NCT00876187|10964148|FG002|Overall Study|Adverse Event|19
6931560|NCT00876187|10964149|FG003|Overall Study|Adverse Event|29
6931561|NCT00876187|10964150|FG004|Overall Study|Adverse Event|10
6931562|NCT00876187|10964146|FG000|Overall Study|Lack of Efficacy|59
6931563|NCT00876187|10964147|FG001|Overall Study|Lack of Efficacy|34
6931564|NCT00876187|10964148|FG002|Overall Study|Lack of Efficacy|45
6931565|NCT00876187|10964149|FG003|Overall Study|Lack of Efficacy|34
6931566|NCT00876187|10964150|FG004|Overall Study|Lack of Efficacy|59
6931567|NCT00876187|10964146|FG000|Overall Study|Lost to Follow-up|9
6931568|NCT00876187|10964147|FG001|Overall Study|Lost to Follow-up|10
6931569|NCT00876187|10964148|FG002|Overall Study|Lost to Follow-up|8
6931570|NCT00876187|10964149|FG003|Overall Study|Lost to Follow-up|8
6931571|NCT00876187|10964150|FG004|Overall Study|Lost to Follow-up|11
6931572|NCT00876187|10964146|FG000|Overall Study|Protocol Violation|6
6931573|NCT00876187|10964147|FG001|Overall Study|Protocol Violation|7
7039701|NCT01712516|11122504|FG001|Overall Study|Death|1
7039702|NCT01712516|11122505|FG002|Overall Study|Death|0
7039703|NCT01712516|11122506|FG003|Overall Study|Death|0
7039704|NCT01712516|11122503|FG000|Overall Study|Protocol deviation|1
7065554|NCT01967628|11165175|FG001|Overall Study|Low protein concentration in sample|25
7065555|NCT01967706|11165188|FG000|First Intervention (Day 1)|Withdrawal by Subject|1
7065556|NCT01967706|11165189|FG001|First Intervention (Day 1)|Withdrawal by Subject|0
7065557|NCT01967706|11165190|FG002|First Intervention (Day 1)|Withdrawal by Subject|0
7065558|NCT01967706|11165191|FG003|First Intervention (Day 1)|Withdrawal by Subject|0
7065559|NCT01967719|11165202|FG000|First Intervention (Day 1)|Withdrawal by Subject|0
6931574|NCT00876187|10964148|FG002|Overall Study|Protocol Violation|7
6931575|NCT00876187|10964149|FG003|Overall Study|Protocol Violation|6
6931576|NCT00876187|10964150|FG004|Overall Study|Protocol Violation|3
6931577|NCT00876187|10964146|FG000|Overall Study|Withdrawal by Subject|16
6931578|NCT00876187|10964147|FG001|Overall Study|Withdrawal by Subject|26
6931579|NCT00876187|10964148|FG002|Overall Study|Withdrawal by Subject|32
6931580|NCT00876187|10964149|FG003|Overall Study|Withdrawal by Subject|38
6931581|NCT00876187|10964150|FG004|Overall Study|Withdrawal by Subject|37
6931582|NCT00876187|10964146|FG000|Overall Study|Entered extension study|101
6931583|NCT00876187|10964147|FG001|Overall Study|Entered extension study|120
7039705|NCT01712516|11122504|FG001|Overall Study|Protocol deviation|0
7039706|NCT01712516|11122505|FG002|Overall Study|Protocol deviation|1
7039707|NCT01712516|11122506|FG003|Overall Study|Protocol deviation|0
7039708|NCT01712516|11122503|FG000|Overall Study|Physician Decision|2
7039709|NCT01712516|11122504|FG001|Overall Study|Physician Decision|0
7039710|NCT01712516|11122505|FG002|Overall Study|Physician Decision|0
7039711|NCT01712516|11122506|FG003|Overall Study|Physician Decision|1
7039712|NCT01712516|11122503|FG000|Overall Study|Withdrawal by Subject|3
7039713|NCT01712516|11122504|FG001|Overall Study|Withdrawal by Subject|9
7065560|NCT01967719|11165203|FG001|First Intervention (Day 1)|Withdrawal by Subject|1
7065561|NCT01967719|11165204|FG002|First Intervention (Day 1)|Withdrawal by Subject|0
6931584|NCT00876187|10964148|FG002|Overall Study|Entered extension study|156
6931585|NCT00876187|10964149|FG003|Overall Study|Entered extension study|151
6931586|NCT00876187|10964150|FG004|Overall Study|Entered extension study|144
6931587|NCT00876187|10964146|FG000|Overall Study|Randomized but not treated|3
6931588|NCT00876187|10964147|FG001|Overall Study|Randomized but not treated|1
6931589|NCT00876187|10964148|FG002|Overall Study|Randomized but not treated|3
6931590|NCT00876187|10964149|FG003|Overall Study|Randomized but not treated|2
6931591|NCT00876187|10964150|FG004|Overall Study|Randomized but not treated|3
7039714|NCT01712516|11122505|FG002|Overall Study|Withdrawal by Subject|3
7039715|NCT01712516|11122506|FG003|Overall Study|Withdrawal by Subject|9
7039716|NCT01712685|11122516|FG000|Overall Study|pt declined to participate before trmt|1
6931592|NCT00876187|10964146|FG000|Overall Study|Other|2
6931593|NCT00876187|10964147|FG001|Overall Study|Other|5
6931594|NCT00876187|10964148|FG002|Overall Study|Other|9
6931595|NCT00876187|10964149|FG003|Overall Study|Other|7
6931596|NCT00876187|10964150|FG004|Overall Study|Other|4
6931597|NCT00876265|10964174|FG000|Overall Study|Miscellaneous reasons|4
6931598|NCT00876265|10964174|FG000|Overall Study|Lost to Follow-up|6
6931599|NCT00876265|10964174|FG000|Overall Study|Withdrawal by Subject|2
6931600|NCT00876343|10964183|FG000|Overall Study|Adverse Event|7
6931601|NCT00876343|10964184|FG001|Overall Study|Adverse Event|8
6931602|NCT00876343|10964185|FG002|Overall Study|Adverse Event|2
6931603|NCT00876343|10964183|FG000|Overall Study|Withdrawal by Subject|4
6931604|NCT00876343|10964184|FG001|Overall Study|Withdrawal by Subject|4
6931605|NCT00876343|10964185|FG002|Overall Study|Withdrawal by Subject|3
6931606|NCT00876343|10964183|FG000|Overall Study|Lack of Efficacy|0
6931607|NCT00876343|10964184|FG001|Overall Study|Lack of Efficacy|0
6931608|NCT00876343|10964185|FG002|Overall Study|Lack of Efficacy|1
6931609|NCT00876343|10964183|FG000|Overall Study|Protocol Violation|4
6931610|NCT00876343|10964184|FG001|Overall Study|Protocol Violation|1
6931611|NCT00876343|10964185|FG002|Overall Study|Protocol Violation|1
6931612|NCT00876343|10964183|FG000|Overall Study|Physician Decision|0
6931613|NCT00876343|10964184|FG001|Overall Study|Physician Decision|1
6931614|NCT00876343|10964185|FG002|Overall Study|Physician Decision|1
6931615|NCT00876343|10964183|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
6931616|NCT00876343|10964184|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
6931617|NCT00876343|10964185|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
6931618|NCT00876343|10964183|FG000|Overall Study|Change of residence or other commitments|2
6931619|NCT00876343|10964184|FG001|Overall Study|Change of residence or other commitments|2
6931620|NCT00876343|10964185|FG002|Overall Study|Change of residence or other commitments|3
6931621|NCT00876395|10964195|FG000|Overall Study|Untreated|8
6931622|NCT00876395|10964196|FG001|Overall Study|Untreated|1
6931623|NCT00876395|10964195|FG000|Overall Study|Adverse Event|63
6931624|NCT00876395|10964196|FG001|Overall Study|Adverse Event|11
6931625|NCT00876395|10964195|FG000|Overall Study|Abnormal test procedure result(s)|1
6931626|NCT00876395|10964196|FG001|Overall Study|Abnormal test procedure result(s)|0
6931627|NCT00876395|10964195|FG000|Overall Study|Disease progression|259
6931628|NCT00876395|10964196|FG001|Overall Study|Disease progression|162
6931629|NCT00876395|10964195|FG000|Overall Study|New cancer therapy|25
6931630|NCT00876395|10964196|FG001|Overall Study|New cancer therapy|7
6931631|NCT00876395|10964195|FG000|Overall Study|Protocol Violation|5
6931632|NCT00876395|10964196|FG001|Overall Study|Protocol Violation|2
6931633|NCT00876395|10964195|FG000|Overall Study|Withdrawal by Subject|66
6931634|NCT00876395|10964196|FG001|Overall Study|Withdrawal by Subject|33
6931635|NCT00876395|10964195|FG000|Overall Study|Lost to Follow-up|2
6931636|NCT00876395|10964196|FG001|Overall Study|Lost to Follow-up|0
6931637|NCT00876395|10964195|FG000|Overall Study|Administrative problems|39
6931638|NCT00876395|10964196|FG001|Overall Study|Administrative problems|23
6931639|NCT00876395|10964195|FG000|Overall Study|Death|12
6931640|NCT00876395|10964196|FG001|Overall Study|Death|0
6931641|NCT00876447|10964209|FG000|Overall Study|Other miscellaneous reasons|3
6931642|NCT00876447|10964210|FG001|Overall Study|Other miscellaneous reasons|8
6931643|NCT00876447|10964209|FG000|Overall Study|Site closure|19
6931644|NCT00876447|10964210|FG001|Overall Study|Site closure|14
6931645|NCT00876447|10964209|FG000|Overall Study|Protocol Violation|9
6931646|NCT00876447|10964210|FG001|Overall Study|Protocol Violation|3
6931647|NCT00876447|10964209|FG000|Overall Study|Personal reasons|30
6931648|NCT00876447|10964210|FG001|Overall Study|Personal reasons|28
6931649|NCT00876447|10964209|FG000|Overall Study|Lost to Follow-up|6
6931650|NCT00876447|10964210|FG001|Overall Study|Lost to Follow-up|15
6931651|NCT00876447|10964209|FG000|Overall Study|Pregnancy|4
6931652|NCT00876447|10964210|FG001|Overall Study|Pregnancy|2
6931653|NCT00876447|10964209|FG000|Overall Study|Lack of Efficacy|5
6931654|NCT00876447|10964210|FG001|Overall Study|Lack of Efficacy|3
6931655|NCT00876447|10964209|FG000|Overall Study|Adverse Event|4
6931656|NCT00876447|10964210|FG001|Overall Study|Adverse Event|8
6931657|NCT00876460|10964248|FG000|Combination Therapy Phase|Progressive disease|2
6931658|NCT00876460|10964249|FG001|Combination Therapy Phase|Progressive disease|3
6931659|NCT00876460|10964250|FG002|Combination Therapy Phase|Progressive disease|3
6931660|NCT00876460|10964251|FG003|Combination Therapy Phase|Progressive disease|3
6931661|NCT00876460|10964252|FG004|Combination Therapy Phase|Progressive disease|3
6931662|NCT00876460|10964253|FG005|Combination Therapy Phase|Progressive disease|1
6931663|NCT00876460|10964254|FG006|Combination Therapy Phase|Progressive disease|1
6931664|NCT00876460|10964255|FG007|Combination Therapy Phase|Progressive disease|1
6931665|NCT00876460|10964248|FG000|Combination Therapy Phase|Dose limiting toxicity|0
6931666|NCT00876460|10964249|FG001|Combination Therapy Phase|Dose limiting toxicity|1
6931667|NCT00876460|10964250|FG002|Combination Therapy Phase|Dose limiting toxicity|0
6931668|NCT00876460|10964251|FG003|Combination Therapy Phase|Dose limiting toxicity|1
6931669|NCT00876460|10964252|FG004|Combination Therapy Phase|Dose limiting toxicity|1
6931670|NCT00876460|10964253|FG005|Combination Therapy Phase|Dose limiting toxicity|2
6931671|NCT00876460|10964254|FG006|Combination Therapy Phase|Dose limiting toxicity|2
6931672|NCT00876460|10964255|FG007|Combination Therapy Phase|Dose limiting toxicity|1
6931673|NCT00876460|10964248|FG000|Combination Therapy Phase|Adverse Event|0
6931674|NCT00876460|10964249|FG001|Combination Therapy Phase|Adverse Event|2
6931675|NCT00876460|10964250|FG002|Combination Therapy Phase|Adverse Event|0
6931676|NCT00876460|10964251|FG003|Combination Therapy Phase|Adverse Event|2
6931677|NCT00876460|10964252|FG004|Combination Therapy Phase|Adverse Event|2
6931678|NCT00876460|10964253|FG005|Combination Therapy Phase|Adverse Event|0
6931679|NCT00876460|10964254|FG006|Combination Therapy Phase|Adverse Event|3
6931680|NCT00876460|10964255|FG007|Combination Therapy Phase|Adverse Event|2
6931681|NCT00876460|10964248|FG000|Combination Therapy Phase|Withdrawal by Subject|1
6931682|NCT00876460|10964249|FG001|Combination Therapy Phase|Withdrawal by Subject|1
6931683|NCT00876460|10964250|FG002|Combination Therapy Phase|Withdrawal by Subject|0
6931684|NCT00876460|10964251|FG003|Combination Therapy Phase|Withdrawal by Subject|0
6931685|NCT00876460|10964252|FG004|Combination Therapy Phase|Withdrawal by Subject|1
6931686|NCT00876460|10964253|FG005|Combination Therapy Phase|Withdrawal by Subject|0
6931687|NCT00876460|10964254|FG006|Combination Therapy Phase|Withdrawal by Subject|0
6931688|NCT00876460|10964255|FG007|Combination Therapy Phase|Withdrawal by Subject|0
6931689|NCT00876460|10964248|FG000|Combination Therapy Phase|Other reason not defined above|0
6931690|NCT00876460|10964249|FG001|Combination Therapy Phase|Other reason not defined above|0
6931691|NCT00876460|10964250|FG002|Combination Therapy Phase|Other reason not defined above|0
6931692|NCT00876460|10964251|FG003|Combination Therapy Phase|Other reason not defined above|0
6931693|NCT00876460|10964252|FG004|Combination Therapy Phase|Other reason not defined above|0
6931694|NCT00876460|10964253|FG005|Combination Therapy Phase|Other reason not defined above|0
6931695|NCT00876460|10964254|FG006|Combination Therapy Phase|Other reason not defined above|1
6931696|NCT00876460|10964255|FG007|Combination Therapy Phase|Other reason not defined above|2
6931697|NCT00876460|10964248|FG000|Combination Therapy Phase|Not treated|0
6931698|NCT00876460|10964249|FG001|Combination Therapy Phase|Not treated|0
6931699|NCT00876460|10964250|FG002|Combination Therapy Phase|Not treated|0
6931700|NCT00876460|10964251|FG003|Combination Therapy Phase|Not treated|0
6931701|NCT00876460|10964252|FG004|Combination Therapy Phase|Not treated|0
6931702|NCT00876460|10964253|FG005|Combination Therapy Phase|Not treated|0
6931703|NCT00876460|10964254|FG006|Combination Therapy Phase|Not treated|1
6931704|NCT00876460|10964255|FG007|Combination Therapy Phase|Not treated|0
6931705|NCT00876460|10964248|FG000|Mono Therapy Phase|Progressive disease|0
6931706|NCT00876460|10964249|FG001|Mono Therapy Phase|Progressive disease|0
6931707|NCT00876460|10964250|FG002|Mono Therapy Phase|Progressive disease|0
6931708|NCT00876460|10964251|FG003|Mono Therapy Phase|Progressive disease|0
6931709|NCT00876460|10964252|FG004|Mono Therapy Phase|Progressive disease|2
6931710|NCT00876460|10964253|FG005|Mono Therapy Phase|Progressive disease|0
6931711|NCT00876460|10964254|FG006|Mono Therapy Phase|Progressive disease|1
6931712|NCT00876460|10964255|FG007|Mono Therapy Phase|Progressive disease|3
6931713|NCT00876460|10964248|FG000|Mono Therapy Phase|Withdrawal by Subject|0
6931714|NCT00876460|10964249|FG001|Mono Therapy Phase|Withdrawal by Subject|1
6931715|NCT00876460|10964250|FG002|Mono Therapy Phase|Withdrawal by Subject|0
6931716|NCT00876460|10964251|FG003|Mono Therapy Phase|Withdrawal by Subject|0
6931717|NCT00876460|10964252|FG004|Mono Therapy Phase|Withdrawal by Subject|0
6931718|NCT00876460|10964253|FG005|Mono Therapy Phase|Withdrawal by Subject|0
6931719|NCT00876460|10964254|FG006|Mono Therapy Phase|Withdrawal by Subject|0
6931720|NCT00876460|10964255|FG007|Mono Therapy Phase|Withdrawal by Subject|0
6931721|NCT00876460|10964248|FG000|Mono Therapy Phase|Adverse Event|0
6931722|NCT00876460|10964249|FG001|Mono Therapy Phase|Adverse Event|0
6931723|NCT00876460|10964250|FG002|Mono Therapy Phase|Adverse Event|0
6931724|NCT00876460|10964251|FG003|Mono Therapy Phase|Adverse Event|1
6931725|NCT00876460|10964252|FG004|Mono Therapy Phase|Adverse Event|0
6931726|NCT00876460|10964253|FG005|Mono Therapy Phase|Adverse Event|0
6931727|NCT00876460|10964254|FG006|Mono Therapy Phase|Adverse Event|0
6931728|NCT00876460|10964255|FG007|Mono Therapy Phase|Adverse Event|0
6931729|NCT00876694|10964287|FG000|Overall Study|Adverse Event|10
6931730|NCT00876694|10964288|FG001|Overall Study|Adverse Event|7
6931731|NCT00876694|10964287|FG000|Overall Study|Subject withdrew consent|6
6931732|NCT00876694|10964288|FG001|Overall Study|Subject withdrew consent|4
6931733|NCT00876694|10964287|FG000|Overall Study|Unsatisfactory therapeutic effect|2
6931734|NCT00876694|10964288|FG001|Overall Study|Unsatisfactory therapeutic effect|0
6931735|NCT00876694|10964287|FG000|Overall Study|Abnormal test procedure result(s)|1
6931736|NCT00876694|10964288|FG001|Overall Study|Abnormal test procedure result(s)|0
6931737|NCT00876694|10964287|FG000|Overall Study|Administrative problems|1
6931738|NCT00876694|10964288|FG001|Overall Study|Administrative problems|1
6931739|NCT00876694|10964287|FG000|Overall Study|Death|1
6931740|NCT00876694|10964288|FG001|Overall Study|Death|0
7039717|NCT01712984|11122541|FG000|Overall Study|Adverse Event|0
7039718|NCT01712984|11122542|FG001|Overall Study|Adverse Event|0
6931741|NCT00876733|10964298|FG000|Overall Study|Adverse Event|34
6931742|NCT00876733|10964299|FG001|Overall Study|Adverse Event|20
6931743|NCT00876733|10964300|FG002|Overall Study|Adverse Event|10
6931744|NCT00876733|10964301|FG003|Overall Study|Adverse Event|3
6931745|NCT00876733|10964298|FG000|Overall Study|Lack of Efficacy|17
6931746|NCT00876733|10964299|FG001|Overall Study|Lack of Efficacy|9
6931747|NCT00876733|10964300|FG002|Overall Study|Lack of Efficacy|10
6931748|NCT00876733|10964301|FG003|Overall Study|Lack of Efficacy|1
6931749|NCT00876733|10964298|FG000|Overall Study|Lost to Follow-up|26
6931750|NCT00876733|10964299|FG001|Overall Study|Lost to Follow-up|10
6931751|NCT00876733|10964300|FG002|Overall Study|Lost to Follow-up|3
6931752|NCT00876733|10964301|FG003|Overall Study|Lost to Follow-up|2
6931753|NCT00876733|10964298|FG000|Overall Study|Data not available|14
6931754|NCT00876733|10964299|FG001|Overall Study|Data not available|3
6931755|NCT00876733|10964300|FG002|Overall Study|Data not available|7
6931756|NCT00876733|10964301|FG003|Overall Study|Data not available|1
6931757|NCT00876928|10964326|FG000|Overall Study|Lost to Follow-up|2
6931758|NCT00876928|10964327|FG001|Overall Study|Lost to Follow-up|5
6931759|NCT00876928|10964326|FG000|Overall Study|Hypokalemia-affects insulin secretion|1
6931760|NCT00876928|10964327|FG001|Overall Study|Hypokalemia-affects insulin secretion|0
6931761|NCT00877006|10964358|FG000|Treatment Period|Death|2
6931762|NCT00877006|10964359|FG001|Treatment Period|Death|1
6931763|NCT00877006|10964358|FG000|Treatment Period|Adverse Event|10
6931764|NCT00877006|10964359|FG001|Treatment Period|Adverse Event|3
6931765|NCT00877006|10964358|FG000|Treatment Period|Withdrawal by Subject|2
6931766|NCT00877006|10964359|FG001|Treatment Period|Withdrawal by Subject|3
6931767|NCT00877006|10964358|FG000|Treatment Period|Protocol Violation|1
6931768|NCT00877006|10964359|FG001|Treatment Period|Protocol Violation|0
6931769|NCT00877006|10964358|FG000|Treatment Period|Lost to Follow-up|0
6931770|NCT00877006|10964359|FG001|Treatment Period|Lost to Follow-up|1
6931771|NCT00877006|10964358|FG000|Treatment Period|Disease Progression|1
6931772|NCT00877006|10964359|FG001|Treatment Period|Disease Progression|2
6931773|NCT00877006|10964358|FG000|Treatment Period|Started New Treatment Regimen|2
6931774|NCT00877006|10964359|FG001|Treatment Period|Started New Treatment Regimen|5
6931775|NCT00877006|10964358|FG000|Treatment Period|Other|4
6931776|NCT00877006|10964359|FG001|Treatment Period|Other|4
6931777|NCT00877006|10964358|FG000|Treatment Period|Randomized but Not Treated|3
6931778|NCT00877006|10964359|FG001|Treatment Period|Randomized but Not Treated|8
6931779|NCT00877006|10964358|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12
6931780|NCT00877006|10964359|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19
6931781|NCT00877006|10964358|FG000|Long-Term Follow-up Period|Lost to Follow-up|8
6931782|NCT00877006|10964359|FG001|Long-Term Follow-up Period|Lost to Follow-up|9
6931783|NCT00877006|10964358|FG000|Long-Term Follow-up Period|Death|26
6931784|NCT00877006|10964359|FG001|Long-Term Follow-up Period|Death|18
6931785|NCT00877006|10964358|FG000|Long-Term Follow-up Period|Other|7
6931786|NCT00877006|10964359|FG001|Long-Term Follow-up Period|Other|9
6931787|NCT00877032|10964374|FG000|Overall Study|Did not meet entrance criteria|0
6931788|NCT00877032|10964375|FG001|Overall Study|Did not meet entrance criteria|0
6931789|NCT00877032|10964376|FG002|Overall Study|Did not meet entrance criteria|0
6931790|NCT00877032|10964377|FG003|Overall Study|Did not meet entrance criteria|1
6931791|NCT00877032|10964378|FG004|Overall Study|Did not meet entrance criteria|0
6931792|NCT00877032|10964379|FG005|Overall Study|Did not meet entrance criteria|0
6931793|NCT00877032|10964380|FG006|Overall Study|Did not meet entrance criteria|2
6931794|NCT00877383|10964415|FG000|Overall Study|Adverse Event|13
6931795|NCT00877383|10964416|FG001|Overall Study|Adverse Event|14
6931796|NCT00877383|10964415|FG000|Overall Study|Lost to Follow-up|5
6931797|NCT00877383|10964416|FG001|Overall Study|Lost to Follow-up|3
6931798|NCT00877383|10964415|FG000|Overall Study|Subject withdrew consent|3
6931799|NCT00877383|10964416|FG001|Overall Study|Subject withdrew consent|12
6931800|NCT00877383|10964415|FG000|Overall Study|Subject no longer requires study drug|2
6931801|NCT00877383|10964416|FG001|Overall Study|Subject no longer requires study drug|0
6931802|NCT00877383|10964415|FG000|Overall Study|Administrative problems|2
6931803|NCT00877383|10964416|FG001|Overall Study|Administrative problems|0
6931804|NCT00877383|10964415|FG000|Overall Study|Protocol deviation|2
6931805|NCT00877383|10964416|FG001|Overall Study|Protocol deviation|6
6931806|NCT00877383|10964415|FG000|Overall Study|Unsatisfactory therapeutic effect|1
6931807|NCT00877383|10964416|FG001|Overall Study|Unsatisfactory therapeutic effect|0
6931808|NCT00877383|10964415|FG000|Overall Study|Death|1
6931809|NCT00877383|10964416|FG001|Overall Study|Death|2
6931810|NCT00877487|10964451|FG000|Open-label Treatment Phase|Adverse Event|1
6931811|NCT00877487|10964452|FG001|Open-label Treatment Phase|Adverse Event|0
6931812|NCT00877487|10964451|FG000|Open-label Treatment Phase|Protocol Violation|3
6931813|NCT00877487|10964452|FG001|Open-label Treatment Phase|Protocol Violation|0
6931814|NCT00877487|10964451|FG000|Open-label Treatment Phase|Withdrawal by Subject|1
6931815|NCT00877487|10964452|FG001|Open-label Treatment Phase|Withdrawal by Subject|0
6931816|NCT00877487|10964451|FG000|Open-label Treatment Phase|Lost to Follow-up|1
6931817|NCT00877487|10964452|FG001|Open-label Treatment Phase|Lost to Follow-up|0
6931818|NCT00877487|10964451|FG000|Open-label Treatment Phase|Out of country for business|1
6931819|NCT00877487|10964452|FG001|Open-label Treatment Phase|Out of country for business|0
6931820|NCT00877487|10964451|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5
6931821|NCT00877487|10964452|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45
6931822|NCT00877487|10964451|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0
6931823|NCT00877487|10964452|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1
6931824|NCT00877487|10964451|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0
6931825|NCT00877487|10964452|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1
6931826|NCT00877487|10964451|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1
6931827|NCT00877487|10964452|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0
6931828|NCT00877773|10964467|FG000|Overall Study|Disease Progression|44
6975187|NCT01191268|11027200|FG000|Overall Study|Withdrawal by Subject|19
6975188|NCT01191268|11027201|FG001|Overall Study|Withdrawal by Subject|25
6975189|NCT01191268|11027202|FG002|Overall Study|Withdrawal by Subject|21
6975190|NCT01191268|11027200|FG000|Overall Study|Adverse Event|21
6931829|NCT00877799|10964476|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2
6931830|NCT00877799|10964477|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
6931831|NCT00877799|10964478|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
6931832|NCT00877799|10964479|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
6931833|NCT00877799|10964480|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
6931834|NCT00877799|10964476|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
6931835|NCT00877799|10964477|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
6931836|NCT00877799|10964478|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2
6931837|NCT00877799|10964479|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
6931838|NCT00877799|10964480|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
6931839|NCT00877799|10964476|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
6931840|NCT00877799|10964477|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3
6931841|NCT00877799|10964478|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
6931842|NCT00877799|10964479|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
6931843|NCT00877799|10964480|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
6931844|NCT00877799|10964476|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
6931845|NCT00877799|10964477|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
6931846|NCT00877799|10964478|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
6931847|NCT00877799|10964479|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1
6931848|NCT00877799|10964480|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
6931849|NCT00877799|10964476|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
6931850|NCT00877799|10964477|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
6931851|NCT00877799|10964478|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
6931852|NCT00877799|10964479|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
6931853|NCT00877799|10964480|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
6931854|NCT00877890|10964502|FG000|Overall Study|Adverse Event|6
6931855|NCT00877890|10964503|FG001|Overall Study|Adverse Event|6
6931856|NCT00877890|10964502|FG000|Overall Study|Lost to Follow-up|5
6931857|NCT00877890|10964503|FG001|Overall Study|Lost to Follow-up|5
6931858|NCT00877890|10964502|FG000|Overall Study|Protocol Violation|0
6931859|NCT00877890|10964503|FG001|Overall Study|Protocol Violation|1
6931860|NCT00877890|10964502|FG000|Overall Study|Withdrawal of Consent|6
6931861|NCT00877890|10964503|FG001|Overall Study|Withdrawal of Consent|12
6931862|NCT00877890|10964502|FG000|Overall Study|Investigator Decision|0
6931863|NCT00877890|10964503|FG001|Overall Study|Investigator Decision|2
6931864|NCT00877890|10964502|FG000|Overall Study|Loss of Glucose Control|3
6931865|NCT00877890|10964503|FG001|Overall Study|Loss of Glucose Control|4
6931866|NCT00877929|10964515|FG000|Overall Study|Adverse Event|11
6931867|NCT00877929|10964516|FG001|Overall Study|Adverse Event|20
6931868|NCT00877929|10964515|FG000|Overall Study|Protocol Violation|3
6931869|NCT00877929|10964516|FG001|Overall Study|Protocol Violation|3
6931870|NCT00877929|10964515|FG000|Overall Study|Lost to Follow-up|0
6931871|NCT00877929|10964516|FG001|Overall Study|Lost to Follow-up|1
6931872|NCT00877929|10964515|FG000|Overall Study|Withdrawal by Subject|4
6931873|NCT00877929|10964516|FG001|Overall Study|Withdrawal by Subject|4
6931874|NCT00877929|10964515|FG000|Overall Study|Lack of Efficacy|0
6931875|NCT00877929|10964516|FG001|Overall Study|Lack of Efficacy|1
6931876|NCT00877929|10964515|FG000|Overall Study|Other reason (not specified)|2
6931877|NCT00877929|10964516|FG001|Overall Study|Other reason (not specified)|6
6931878|NCT00878072|10964526|FG000|Overall Study|Withdrew consent|2
6931879|NCT00878189|10964537|FG000|Overall Study|Death|0
6931880|NCT00878189|10964538|FG001|Overall Study|Death|1
6931881|NCT00878189|10964539|FG002|Overall Study|Death|0
6931882|NCT00878189|10964540|FG003|Overall Study|Death|1
6931883|NCT00878189|10964541|FG004|Overall Study|Death|0
6931884|NCT00878189|10964542|FG005|Overall Study|Death|0
6931885|NCT00878189|10964543|FG006|Overall Study|Death|0
6931886|NCT00878189|10964544|FG007|Overall Study|Death|0
6931887|NCT00878189|10964545|FG008|Overall Study|Death|1
6931888|NCT00878189|10964537|FG000|Overall Study|Participant Refused to Follow-up|0
6931889|NCT00878189|10964538|FG001|Overall Study|Participant Refused to Follow-up|0
6931890|NCT00878189|10964539|FG002|Overall Study|Participant Refused to Follow-up|0
6931891|NCT00878189|10964540|FG003|Overall Study|Participant Refused to Follow-up|0
6931892|NCT00878189|10964541|FG004|Overall Study|Participant Refused to Follow-up|0
6931893|NCT00878189|10964542|FG005|Overall Study|Participant Refused to Follow-up|4
6931894|NCT00878189|10964543|FG006|Overall Study|Participant Refused to Follow-up|0
6931895|NCT00878189|10964544|FG007|Overall Study|Participant Refused to Follow-up|0
6931896|NCT00878189|10964545|FG008|Overall Study|Participant Refused to Follow-up|0
6931897|NCT00878189|10964537|FG000|Overall Study|Other|3
6931898|NCT00878189|10964538|FG001|Overall Study|Other|2
6931899|NCT00878189|10964539|FG002|Overall Study|Other|4
6931900|NCT00878189|10964540|FG003|Overall Study|Other|7
6931901|NCT00878189|10964541|FG004|Overall Study|Other|4
6931902|NCT00878189|10964542|FG005|Overall Study|Other|18
6931903|NCT00878189|10964543|FG006|Overall Study|Other|15
6931904|NCT00878189|10964544|FG007|Overall Study|Other|3
6931905|NCT00878189|10964545|FG008|Overall Study|Other|4
6931906|NCT00878189|10964537|FG000|Overall Study|Lost to Follow-up|0
6931907|NCT00878189|10964538|FG001|Overall Study|Lost to Follow-up|0
6931908|NCT00878189|10964539|FG002|Overall Study|Lost to Follow-up|0
6931909|NCT00878189|10964540|FG003|Overall Study|Lost to Follow-up|0
6931910|NCT00878189|10964541|FG004|Overall Study|Lost to Follow-up|0
6931911|NCT00878189|10964542|FG005|Overall Study|Lost to Follow-up|1
6931912|NCT00878189|10964543|FG006|Overall Study|Lost to Follow-up|1
6931913|NCT00878189|10964544|FG007|Overall Study|Lost to Follow-up|0
6931914|NCT00878189|10964545|FG008|Overall Study|Lost to Follow-up|0
6931915|NCT00878189|10964537|FG000|Overall Study|Objection Progression or Relapse|0
6931916|NCT00878189|10964538|FG001|Overall Study|Objection Progression or Relapse|0
6931917|NCT00878189|10964539|FG002|Overall Study|Objection Progression or Relapse|0
6931918|NCT00878189|10964540|FG003|Overall Study|Objection Progression or Relapse|0
6931919|NCT00878189|10964541|FG004|Overall Study|Objection Progression or Relapse|0
6931920|NCT00878189|10964542|FG005|Overall Study|Objection Progression or Relapse|0
6931921|NCT00878189|10964543|FG006|Overall Study|Objection Progression or Relapse|0
6931922|NCT00878189|10964544|FG007|Overall Study|Objection Progression or Relapse|0
6931923|NCT00878189|10964545|FG008|Overall Study|Objection Progression or Relapse|3
6931924|NCT00878215|10964583|FG000|Overall Study|Determined to be ineligible|0
6931925|NCT00878215|10964584|FG001|Overall Study|Determined to be ineligible|10
6931926|NCT00878215|10964585|FG002|Overall Study|Determined to be ineligible|0
6931927|NCT00878215|10964586|FG003|Overall Study|Determined to be ineligible|0
6931928|NCT00878501|10964617|FG000|Overall Study|Adverse Event|11
6931929|NCT00878501|10964618|FG001|Overall Study|Adverse Event|3
6931930|NCT00878501|10964619|FG002|Overall Study|Adverse Event|3
6931931|NCT00878501|10964617|FG000|Overall Study|Lack of Efficacy|2
6931932|NCT00878501|10964618|FG001|Overall Study|Lack of Efficacy|1
6931933|NCT00878501|10964619|FG002|Overall Study|Lack of Efficacy|0
6931934|NCT00878501|10964617|FG000|Overall Study|Withdrawal by Subject|2
6931935|NCT00878501|10964618|FG001|Overall Study|Withdrawal by Subject|1
6931936|NCT00878501|10964619|FG002|Overall Study|Withdrawal by Subject|2
6931937|NCT00878501|10964617|FG000|Overall Study|Protocol Violation|0
6931938|NCT00878501|10964618|FG001|Overall Study|Protocol Violation|0
6931939|NCT00878501|10964619|FG002|Overall Study|Protocol Violation|1
6931940|NCT00878501|10964617|FG000|Overall Study|Incorrect enrolment|1
6931941|NCT00878501|10964618|FG001|Overall Study|Incorrect enrolment|2
6931942|NCT00878501|10964619|FG002|Overall Study|Incorrect enrolment|0
6931943|NCT00878501|10964617|FG000|Overall Study|Intake of prohibited concom. medication|0
6931944|NCT00878501|10964618|FG001|Overall Study|Intake of prohibited concom. medication|0
6931945|NCT00878501|10964619|FG002|Overall Study|Intake of prohibited concom. medication|1
6931946|NCT00878501|10964617|FG000|Overall Study|Mis-randomisation of patient|1
6931947|NCT00878501|10964618|FG001|Overall Study|Mis-randomisation of patient|0
6931948|NCT00878501|10964619|FG002|Overall Study|Mis-randomisation of patient|0
6931949|NCT00878501|10964617|FG000|Overall Study|Administrative|0
6931950|NCT00878501|10964618|FG001|Overall Study|Administrative|0
6931951|NCT00878501|10964619|FG002|Overall Study|Administrative|1
6931952|NCT00878553|10964631|FG000|Sleep Study|Withdrawal by Subject|2
6931953|NCT00878553|10964632|FG001|Sleep Study|Withdrawal by Subject|0
6931954|NCT00878553|10964633|FG002|Sleep Study|Withdrawal by Subject|0
6931955|NCT00878553|10964634|FG003|Sleep Study|Withdrawal by Subject|0
6931956|NCT00878553|10964635|FG004|Sleep Study|Withdrawal by Subject|0
6931957|NCT00878553|10964631|FG000|Sleep Study|Lost to Follow-up|1
6931958|NCT00878553|10964632|FG001|Sleep Study|Lost to Follow-up|0
6931959|NCT00878553|10964633|FG002|Sleep Study|Lost to Follow-up|0
6931960|NCT00878553|10964634|FG003|Sleep Study|Lost to Follow-up|0
6931961|NCT00878553|10964635|FG004|Sleep Study|Lost to Follow-up|0
6931962|NCT00878553|10964631|FG000|Sleep Study|car accident|1
6931963|NCT00878553|10964632|FG001|Sleep Study|car accident|0
6931964|NCT00878553|10964633|FG002|Sleep Study|car accident|0
6931965|NCT00878553|10964634|FG003|Sleep Study|car accident|0
6931966|NCT00878553|10964635|FG004|Sleep Study|car accident|0
6931967|NCT00878553|10964631|FG000|Sleep Study|family emergency|1
6931968|NCT00878553|10964632|FG001|Sleep Study|family emergency|0
6931969|NCT00878553|10964633|FG002|Sleep Study|family emergency|0
6931970|NCT00878553|10964634|FG003|Sleep Study|family emergency|0
6931971|NCT00878553|10964635|FG004|Sleep Study|family emergency|0
6931972|NCT00878553|10964631|FG000|PK Study|Withdrawal by Subject|0
6931973|NCT00878553|10964632|FG001|PK Study|Withdrawal by Subject|0
6931974|NCT00878553|10964633|FG002|PK Study|Withdrawal by Subject|0
6931975|NCT00878553|10964634|FG003|PK Study|Withdrawal by Subject|1
6931976|NCT00878553|10964635|FG004|PK Study|Withdrawal by Subject|0
6931977|NCT00878709|10964663|FG000|Overall Study|Withdrawal by Subject|197
6931978|NCT00878709|10964664|FG001|Overall Study|Withdrawal by Subject|120
6931979|NCT00878709|10964663|FG000|Overall Study|Lost to Follow-up|35
6931980|NCT00878709|10964664|FG001|Overall Study|Lost to Follow-up|33
6931981|NCT00878709|10964663|FG000|Overall Study|Other Reasons|93
6931982|NCT00878709|10964664|FG001|Overall Study|Other Reasons|84
6931983|NCT00878722|10964679|FG000|Overall Study|Progressive disease|3
6931984|NCT00878722|10964680|FG001|Overall Study|Progressive disease|3
6931985|NCT00878722|10964681|FG002|Overall Study|Progressive disease|3
6931986|NCT00878722|10964682|FG003|Overall Study|Progressive disease|7
6931987|NCT00878722|10964683|FG004|Overall Study|Progressive disease|7
6931988|NCT00878722|10964684|FG005|Overall Study|Progressive disease|1
6931989|NCT00878722|10964685|FG006|Overall Study|Progressive disease|4
6931990|NCT00878722|10964686|FG007|Overall Study|Progressive disease|3
6931991|NCT00878722|10964679|FG000|Overall Study|Death|0
6931992|NCT00878722|10964680|FG001|Overall Study|Death|0
6931993|NCT00878722|10964681|FG002|Overall Study|Death|0
6931994|NCT00878722|10964682|FG003|Overall Study|Death|1
6931995|NCT00878722|10964683|FG004|Overall Study|Death|0
6931996|NCT00878722|10964684|FG005|Overall Study|Death|1
6931997|NCT00878722|10964685|FG006|Overall Study|Death|0
6931998|NCT00878722|10964686|FG007|Overall Study|Death|2
6931999|NCT00878722|10964679|FG000|Overall Study|Adverse Event|0
6932000|NCT00878722|10964680|FG001|Overall Study|Adverse Event|0
6932001|NCT00878722|10964681|FG002|Overall Study|Adverse Event|0
6932002|NCT00878722|10964682|FG003|Overall Study|Adverse Event|0
6932003|NCT00878722|10964683|FG004|Overall Study|Adverse Event|0
6932004|NCT00878722|10964684|FG005|Overall Study|Adverse Event|0
6932005|NCT00878722|10964685|FG006|Overall Study|Adverse Event|2
6932006|NCT00878722|10964686|FG007|Overall Study|Adverse Event|0
6932007|NCT00878722|10964679|FG000|Overall Study|Withdrawal by Subject|0
6932008|NCT00878722|10964680|FG001|Overall Study|Withdrawal by Subject|0
6932009|NCT00878722|10964681|FG002|Overall Study|Withdrawal by Subject|0
6932010|NCT00878722|10964682|FG003|Overall Study|Withdrawal by Subject|0
6932011|NCT00878722|10964683|FG004|Overall Study|Withdrawal by Subject|0
6932012|NCT00878722|10964684|FG005|Overall Study|Withdrawal by Subject|0
6932013|NCT00878722|10964685|FG006|Overall Study|Withdrawal by Subject|0
6932014|NCT00878722|10964686|FG007|Overall Study|Withdrawal by Subject|2
6932015|NCT00878722|10964679|FG000|Overall Study|Relapse|0
6932016|NCT00878722|10964680|FG001|Overall Study|Relapse|0
6932017|NCT00878722|10964681|FG002|Overall Study|Relapse|0
6932018|NCT00878722|10964682|FG003|Overall Study|Relapse|1
6932019|NCT00878722|10964683|FG004|Overall Study|Relapse|0
6932020|NCT00878722|10964684|FG005|Overall Study|Relapse|0
6932021|NCT00878722|10964685|FG006|Overall Study|Relapse|0
6932022|NCT00878722|10964686|FG007|Overall Study|Relapse|0
6932023|NCT00878800|10964712|FG000|Overall Study|Adverse Event|0
6932024|NCT00878800|10964713|FG001|Overall Study|Adverse Event|0
6932025|NCT00878800|10964714|FG002|Overall Study|Adverse Event|2
6932026|NCT00878800|10964715|FG003|Overall Study|Adverse Event|0
6932027|NCT00878800|10964716|FG004|Overall Study|Adverse Event|1
6932028|NCT00878800|10964712|FG000|Overall Study|Progressive disease|1
6932029|NCT00878800|10964713|FG001|Overall Study|Progressive disease|5
6932030|NCT00878800|10964714|FG002|Overall Study|Progressive disease|6
6932031|NCT00878800|10964715|FG003|Overall Study|Progressive disease|5
6932032|NCT00878800|10964716|FG004|Overall Study|Progressive disease|13
6932033|NCT00878800|10964712|FG000|Overall Study|Withdrew consent|1
6932034|NCT00878800|10964713|FG001|Overall Study|Withdrew consent|1
6932035|NCT00878800|10964714|FG002|Overall Study|Withdrew consent|0
6932036|NCT00878800|10964715|FG003|Overall Study|Withdrew consent|1
6932037|NCT00878800|10964716|FG004|Overall Study|Withdrew consent|1
6932038|NCT00878800|10964712|FG000|Overall Study|Death|0
6932039|NCT00878800|10964713|FG001|Overall Study|Death|0
6932040|NCT00878800|10964714|FG002|Overall Study|Death|1
6932041|NCT00878800|10964715|FG003|Overall Study|Death|0
6932042|NCT00878800|10964716|FG004|Overall Study|Death|0
6932043|NCT00878800|10964712|FG000|Overall Study|Other|1
6932044|NCT00878800|10964713|FG001|Overall Study|Other|1
6932045|NCT00878800|10964714|FG002|Overall Study|Other|0
6932046|NCT00878800|10964715|FG003|Overall Study|Other|0
6932047|NCT00878800|10964716|FG004|Overall Study|Other|1
6932048|NCT00878995|10964753|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0
6932049|NCT00878995|10964754|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2
6932050|NCT00879229|10964787|FG000|Overall Study|Study terminated by Sponsor|13
6932051|NCT00879229|10964788|FG001|Overall Study|Study terminated by Sponsor|12
6932052|NCT00879229|10964787|FG000|Overall Study|Death|4
6932053|NCT00879229|10964788|FG001|Overall Study|Death|2
6932054|NCT00879229|10964787|FG000|Overall Study|Adverse Event|2
6932055|NCT00879229|10964788|FG001|Overall Study|Adverse Event|0
6932056|NCT00879229|10964787|FG000|Overall Study|Withdrawal by Subject|1
6932057|NCT00879229|10964788|FG001|Overall Study|Withdrawal by Subject|0
6932058|NCT00879229|10964787|FG000|Overall Study|Clinical status did not improve|1
6932059|NCT00879229|10964788|FG001|Overall Study|Clinical status did not improve|0
6932060|NCT00879229|10964787|FG000|Overall Study|Other|1
6932061|NCT00879229|10964788|FG001|Overall Study|Other|0
6932062|NCT00879333|10964805|FG000|Overall Study|Adverse Event|94
6932063|NCT00879333|10964806|FG001|Overall Study|Adverse Event|34
6932064|NCT00879333|10964805|FG000|Overall Study|Abnormal Laboratory Value|1
6932065|NCT00879333|10964806|FG001|Overall Study|Abnormal Laboratory Value|0
6932066|NCT00879333|10964805|FG000|Overall Study|Withdrawal by Subject|20
6932067|NCT00879333|10964806|FG001|Overall Study|Withdrawal by Subject|7
6932068|NCT00879333|10964805|FG000|Overall Study|Lost to Follow-up|2
6932069|NCT00879333|10964806|FG001|Overall Study|Lost to Follow-up|1
6932070|NCT00879333|10964805|FG000|Overall Study|Administrative Problems|2
6932071|NCT00879333|10964806|FG001|Overall Study|Administrative Problems|0
6932072|NCT00879333|10964805|FG000|Overall Study|Death|16
6932073|NCT00879333|10964806|FG001|Overall Study|Death|5
6932074|NCT00879333|10964805|FG000|Overall Study|Disease Progression|292
6932075|NCT00879333|10964806|FG001|Overall Study|Disease Progression|169
6932076|NCT00879333|10964805|FG000|Overall Study|Protocol Violation|1
6932077|NCT00879333|10964806|FG001|Overall Study|Protocol Violation|1
6932078|NCT00879398|10964819|FG000|Overall Study|Visit Stop|399
6932079|NCT00879398|10964819|FG000|Overall Study|Lack of Efficacy|64
6932080|NCT00879398|10964819|FG000|Overall Study|Adverse Event|41
6932081|NCT00879398|10964819|FG000|Overall Study|Other Reasons|171
6932082|NCT00879411|10964823|FG000|Overall Study|lost to follow-up (non-AE)|162
6932083|NCT00879437|10964827|FG000|Overall Study|Protocol Violation|0
6932084|NCT00879437|10964828|FG001|Overall Study|Protocol Violation|1
6932085|NCT00879437|10964827|FG000|Overall Study|Death|1
6932086|NCT00879437|10964828|FG001|Overall Study|Death|0
6932087|NCT00879645|10964840|FG000|Overall Study|Adverse Event|1
6932088|NCT00879645|10964841|FG001|Overall Study|Adverse Event|0
6932089|NCT00879645|10964842|FG002|Overall Study|Adverse Event|0
6932090|NCT00879645|10964843|FG003|Overall Study|Adverse Event|0
6932091|NCT00879658|10964860|FG000|Overall Study|Abnormal laboratory value(s)|3
6932092|NCT00879658|10964861|FG001|Overall Study|Abnormal laboratory value(s)|0
6932093|NCT00879658|10964862|FG002|Overall Study|Abnormal laboratory value(s)|0
6932094|NCT00879658|10964863|FG003|Overall Study|Abnormal laboratory value(s)|1
6932095|NCT00879658|10964864|FG004|Overall Study|Abnormal laboratory value(s)|0
6932096|NCT00879658|10964865|FG005|Overall Study|Abnormal laboratory value(s)|0
6932097|NCT00879658|10964866|FG006|Overall Study|Abnormal laboratory value(s)|0
6932098|NCT00879658|10964860|FG000|Overall Study|Administrative problems|2
6932099|NCT00879658|10964861|FG001|Overall Study|Administrative problems|1
6932100|NCT00879658|10964862|FG002|Overall Study|Administrative problems|0
6932101|NCT00879658|10964863|FG003|Overall Study|Administrative problems|1
6932102|NCT00879658|10964864|FG004|Overall Study|Administrative problems|0
6932103|NCT00879658|10964865|FG005|Overall Study|Administrative problems|0
6932104|NCT00879658|10964866|FG006|Overall Study|Administrative problems|0
6932105|NCT00879658|10964860|FG000|Overall Study|Adverse Event|6
6932106|NCT00879658|10964861|FG001|Overall Study|Adverse Event|4
6932107|NCT00879658|10964862|FG002|Overall Study|Adverse Event|3
6837418|NCT00251641|10843031|FG000|Overall Study|Progression of Disease|0
6837419|NCT00251641|10843032|FG001|Overall Study|Progression of Disease|2
6837420|NCT00251641|10843031|FG000|Overall Study|Lost to Follow-up|3
6837421|NCT00251641|10843032|FG001|Overall Study|Lost to Follow-up|3
6932108|NCT00879658|10964863|FG003|Overall Study|Adverse Event|1
6932109|NCT00879658|10964864|FG004|Overall Study|Adverse Event|2
6932110|NCT00879658|10964865|FG005|Overall Study|Adverse Event|0
6932111|NCT00879658|10964866|FG006|Overall Study|Adverse Event|0
6932112|NCT00879658|10964860|FG000|Overall Study|Protocol Violation|1
6932113|NCT00879658|10964861|FG001|Overall Study|Protocol Violation|0
6932114|NCT00879658|10964862|FG002|Overall Study|Protocol Violation|0
6932115|NCT00879658|10964863|FG003|Overall Study|Protocol Violation|0
6932116|NCT00879658|10964864|FG004|Overall Study|Protocol Violation|0
6932117|NCT00879658|10964865|FG005|Overall Study|Protocol Violation|0
6932118|NCT00879658|10964866|FG006|Overall Study|Protocol Violation|0
6932119|NCT00879658|10964860|FG000|Overall Study|Withdrawal by Subject|3
6932120|NCT00879658|10964861|FG001|Overall Study|Withdrawal by Subject|0
6932121|NCT00879658|10964862|FG002|Overall Study|Withdrawal by Subject|2
6932122|NCT00879658|10964863|FG003|Overall Study|Withdrawal by Subject|0
6932123|NCT00879658|10964864|FG004|Overall Study|Withdrawal by Subject|0
6932124|NCT00879658|10964865|FG005|Overall Study|Withdrawal by Subject|1
6932125|NCT00879658|10964866|FG006|Overall Study|Withdrawal by Subject|0
6932126|NCT00879658|10964860|FG000|Overall Study|Lack of Efficacy|0
6932127|NCT00879658|10964861|FG001|Overall Study|Lack of Efficacy|0
6932128|NCT00879658|10964862|FG002|Overall Study|Lack of Efficacy|2
6932129|NCT00879658|10964863|FG003|Overall Study|Lack of Efficacy|0
6932130|NCT00879658|10964864|FG004|Overall Study|Lack of Efficacy|0
6932131|NCT00879658|10964865|FG005|Overall Study|Lack of Efficacy|0
6932132|NCT00879658|10964866|FG006|Overall Study|Lack of Efficacy|0
6932133|NCT00879658|10964860|FG000|Overall Study|misrandomized (never received study med)|0
6932134|NCT00879658|10964861|FG001|Overall Study|misrandomized (never received study med)|0
6932135|NCT00879658|10964862|FG002|Overall Study|misrandomized (never received study med)|0
6932136|NCT00879658|10964863|FG003|Overall Study|misrandomized (never received study med)|1
6932137|NCT00879658|10964864|FG004|Overall Study|misrandomized (never received study med)|0
6932138|NCT00879658|10964865|FG005|Overall Study|misrandomized (never received study med)|0
6932139|NCT00879658|10964866|FG006|Overall Study|misrandomized (never received study med)|0
6932140|NCT00879684|10964888|FG000|Stage 1: Dose Escalation|Adverse Event|1
6932141|NCT00879684|10964889|FG001|Stage 1: Dose Escalation|Adverse Event|0
6932142|NCT00879684|10964890|FG002|Stage 1: Dose Escalation|Adverse Event|0
6932143|NCT00879684|10964891|FG003|Stage 1: Dose Escalation|Adverse Event|0
6932144|NCT00879684|10964892|FG004|Stage 1: Dose Escalation|Adverse Event|0
6932145|NCT00879684|10964893|FG005|Stage 1: Dose Escalation|Adverse Event|0
6932146|NCT00879684|10964894|FG006|Stage 1: Dose Escalation|Adverse Event|0
6932147|NCT00879684|10964888|FG000|Stage 1: Dose Escalation|Progressive Disease|2
6932148|NCT00879684|10964889|FG001|Stage 1: Dose Escalation|Progressive Disease|3
6932149|NCT00879684|10964890|FG002|Stage 1: Dose Escalation|Progressive Disease|0
6932150|NCT00879684|10964891|FG003|Stage 1: Dose Escalation|Progressive Disease|4
6932151|NCT00879684|10964892|FG004|Stage 1: Dose Escalation|Progressive Disease|3
6932152|NCT00879684|10964893|FG005|Stage 1: Dose Escalation|Progressive Disease|3
6932153|NCT00879684|10964894|FG006|Stage 1: Dose Escalation|Progressive Disease|0
6932154|NCT00879684|10964888|FG000|Stage 1: Dose Escalation|Investigator declined participation|0
6932155|NCT00879684|10964889|FG001|Stage 1: Dose Escalation|Investigator declined participation|0
6932156|NCT00879684|10964890|FG002|Stage 1: Dose Escalation|Investigator declined participation|2
6975191|NCT01191268|11027201|FG001|Overall Study|Adverse Event|13
6932157|NCT00879684|10964891|FG003|Stage 1: Dose Escalation|Investigator declined participation|2
6932158|NCT00879684|10964892|FG004|Stage 1: Dose Escalation|Investigator declined participation|0
6932159|NCT00879684|10964893|FG005|Stage 1: Dose Escalation|Investigator declined participation|0
6932160|NCT00879684|10964894|FG006|Stage 1: Dose Escalation|Investigator declined participation|0
6932161|NCT00879684|10964888|FG000|Stage 1: Dose Escalation|Death|0
6932162|NCT00879684|10964889|FG001|Stage 1: Dose Escalation|Death|0
6932163|NCT00879684|10964890|FG002|Stage 1: Dose Escalation|Death|1
6932164|NCT00879684|10964891|FG003|Stage 1: Dose Escalation|Death|0
6932165|NCT00879684|10964892|FG004|Stage 1: Dose Escalation|Death|0
6932166|NCT00879684|10964893|FG005|Stage 1: Dose Escalation|Death|0
6932167|NCT00879684|10964894|FG006|Stage 1: Dose Escalation|Death|0
6932168|NCT00879684|10964888|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0
6932169|NCT00879684|10964889|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0
6932170|NCT00879684|10964890|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0
6932171|NCT00879684|10964891|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0
6932172|NCT00879684|10964892|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0
6932173|NCT00879684|10964893|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0
6932174|NCT00879684|10964894|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1
6932175|NCT00879684|10964888|FG000|Stage 2: Expanded Cohort|Progressive Disease|0
6932176|NCT00879684|10964889|FG001|Stage 2: Expanded Cohort|Progressive Disease|0
6932177|NCT00879684|10964890|FG002|Stage 2: Expanded Cohort|Progressive Disease|0
6932178|NCT00879684|10964891|FG003|Stage 2: Expanded Cohort|Progressive Disease|0
6932179|NCT00879684|10964892|FG004|Stage 2: Expanded Cohort|Progressive Disease|0
6932180|NCT00879684|10964893|FG005|Stage 2: Expanded Cohort|Progressive Disease|0
6932181|NCT00879684|10964894|FG006|Stage 2: Expanded Cohort|Progressive Disease|11
6932182|NCT00879684|10964888|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0
6932183|NCT00879684|10964889|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0
6932184|NCT00879684|10964890|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0
6932185|NCT00879684|10964891|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0
6932186|NCT00879684|10964892|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0
6932187|NCT00879684|10964893|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0
6932188|NCT00879684|10964894|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1
6932189|NCT00879697|10964915|FG000|Overall Study|Physician Decision|2
6932190|NCT00879697|10964916|FG001|Overall Study|Physician Decision|2
6932191|NCT00879710|10964924|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2
6932192|NCT00879710|10964925|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3
6932193|NCT00879710|10964926|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1
6932194|NCT00879710|10964927|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4
6932195|NCT00879710|10964924|FG000|Phase 1 - 6 Weeks|Adverse Event|0
6932196|NCT00879710|10964925|FG001|Phase 1 - 6 Weeks|Adverse Event|0
6932197|NCT00879710|10964926|FG002|Phase 1 - 6 Weeks|Adverse Event|1
6932198|NCT00879710|10964927|FG003|Phase 1 - 6 Weeks|Adverse Event|0
6932199|NCT00879775|10964937|FG000|Overall Study|Lost to Follow-up|2
6932200|NCT00879775|10964938|FG001|Overall Study|Lost to Follow-up|1
6932201|NCT00879814|10964948|FG000|Overall Study|Adverse Event|0
6932202|NCT00879814|10964949|FG001|Overall Study|Adverse Event|1
6932203|NCT00879814|10964950|FG002|Overall Study|Adverse Event|0
6932204|NCT00879814|10964951|FG003|Overall Study|Adverse Event|0
6932205|NCT00879814|10964948|FG000|Overall Study|Lost to Follow-up|1
6932206|NCT00879814|10964949|FG001|Overall Study|Lost to Follow-up|0
6932207|NCT00879814|10964950|FG002|Overall Study|Lost to Follow-up|0
6932208|NCT00879814|10964951|FG003|Overall Study|Lost to Follow-up|2
6932209|NCT00879814|10964948|FG000|Overall Study|Participant Failed to Return|0
6932210|NCT00879814|10964949|FG001|Overall Study|Participant Failed to Return|0
6932211|NCT00879814|10964950|FG002|Overall Study|Participant Failed to Return|0
6932212|NCT00879814|10964951|FG003|Overall Study|Participant Failed to Return|1
6932213|NCT00879814|10964948|FG000|Overall Study|Withdrawal by Subject|3
6932214|NCT00879814|10964949|FG001|Overall Study|Withdrawal by Subject|1
6932215|NCT00879814|10964950|FG002|Overall Study|Withdrawal by Subject|1
6932216|NCT00879814|10964951|FG003|Overall Study|Withdrawal by Subject|2
6932217|NCT00879814|10964948|FG000|Overall Study|Physician Decision|0
6932218|NCT00879814|10964949|FG001|Overall Study|Physician Decision|0
6932219|NCT00879814|10964950|FG002|Overall Study|Physician Decision|1
7065562|NCT01967719|11165205|FG003|First Intervention (Day 1)|Withdrawal by Subject|1
7065563|NCT01967719|11165202|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0
7065564|NCT01967719|11165203|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1
7065565|NCT01967719|11165204|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0
6932220|NCT00879814|10964951|FG003|Overall Study|Physician Decision|0
6932221|NCT00879814|10964948|FG000|Overall Study|Other|0
6932222|NCT00879814|10964949|FG001|Overall Study|Other|0
6932223|NCT00879814|10964950|FG002|Overall Study|Other|1
6932224|NCT00879814|10964951|FG003|Overall Study|Other|0
6932225|NCT00879879|10964961|FG000|Overall Study|Death|1
6932226|NCT00879879|10964961|FG000|Overall Study|Withdrawal by Subject|1
6932227|NCT00879879|10964961|FG000|Overall Study|Physician Decision|1
6932228|NCT00879970|10964970|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3
6932229|NCT00879970|10964971|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3
6932230|NCT00879970|10964972|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4
6932231|NCT00879970|10964973|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0
6837422|NCT00251641|10843031|FG000|Overall Study|Withdrawal by Subject|6
6837423|NCT00251641|10843032|FG001|Overall Study|Withdrawal by Subject|8
6837424|NCT00251641|10843031|FG000|Overall Study|Protocol Violation|10
6837425|NCT00251641|10843032|FG001|Overall Study|Protocol Violation|2
6837426|NCT00251641|10843031|FG000|Overall Study|Did not Meet protocol Eligibility|2
6837427|NCT00251641|10843032|FG001|Overall Study|Did not Meet protocol Eligibility|1
6837428|NCT00251641|10843031|FG000|Overall Study|Switched Treatment|9
6837429|NCT00251641|10843032|FG001|Overall Study|Switched Treatment|63
6837430|NCT00251693|10843043|FG000|Overall Study|Adverse Event|17
6837431|NCT00251693|10843044|FG001|Overall Study|Adverse Event|9
6837432|NCT00251693|10843045|FG002|Overall Study|Adverse Event|9
6837433|NCT00251693|10843043|FG000|Overall Study|Protocol Violation|2
6837434|NCT00251693|10843044|FG001|Overall Study|Protocol Violation|0
6837435|NCT00251693|10843045|FG002|Overall Study|Protocol Violation|2
6837436|NCT00251693|10843043|FG000|Overall Study|Lost to Follow-up|12
6837437|NCT00251693|10843044|FG001|Overall Study|Lost to Follow-up|7
6837438|NCT00251693|10843045|FG002|Overall Study|Lost to Follow-up|8
6837439|NCT00251693|10843043|FG000|Overall Study|Withdrawal by Subject|11
6837440|NCT00251693|10843044|FG001|Overall Study|Withdrawal by Subject|17
6837441|NCT00251693|10843045|FG002|Overall Study|Withdrawal by Subject|14
6837442|NCT00251693|10843043|FG000|Overall Study|Lack of Efficacy|0
6837443|NCT00251693|10843044|FG001|Overall Study|Lack of Efficacy|1
6837444|NCT00251693|10843045|FG002|Overall Study|Lack of Efficacy|0
6837445|NCT00251693|10843043|FG000|Overall Study|Inclusion/exclusion criteria not met|5
6837446|NCT00251693|10843044|FG001|Overall Study|Inclusion/exclusion criteria not met|3
6837447|NCT00251693|10843045|FG002|Overall Study|Inclusion/exclusion criteria not met|8
6837448|NCT00251693|10843043|FG000|Overall Study|Noncompliant|0
6837449|NCT00251693|10843044|FG001|Overall Study|Noncompliant|0
6837450|NCT00251693|10843045|FG002|Overall Study|Noncompliant|2
6837451|NCT00251693|10843043|FG000|Overall Study|Possible Barrett's esophagus|3
6837452|NCT00251693|10843044|FG001|Overall Study|Possible Barrett's esophagus|5
6837453|NCT00251693|10843045|FG002|Overall Study|Possible Barrett's esophagus|2
6837454|NCT00251693|10843043|FG000|Overall Study|Subject request/subject unavailable|1
6837455|NCT00251693|10843044|FG001|Overall Study|Subject request/subject unavailable|2
6837456|NCT00251693|10843045|FG002|Overall Study|Subject request/subject unavailable|0
6837457|NCT00251693|10843043|FG000|Overall Study|Abnormal laboratory findings|0
6837458|NCT00251693|10843044|FG001|Overall Study|Abnormal laboratory findings|0
6837459|NCT00251693|10843045|FG002|Overall Study|Abnormal laboratory findings|1
6837460|NCT00251719|10843056|FG000|Overall Study|Adverse Event|14
6837461|NCT00251719|10843057|FG001|Overall Study|Adverse Event|8
6837462|NCT00251719|10843058|FG002|Overall Study|Adverse Event|7
6837463|NCT00251719|10843056|FG000|Overall Study|Protocol Violation|1
6837464|NCT00251719|10843057|FG001|Overall Study|Protocol Violation|1
6837465|NCT00251719|10843058|FG002|Overall Study|Protocol Violation|1
6837466|NCT00251719|10843056|FG000|Overall Study|Lost to Follow-up|5
6837467|NCT00251719|10843057|FG001|Overall Study|Lost to Follow-up|11
6837468|NCT00251719|10843058|FG002|Overall Study|Lost to Follow-up|8
6837469|NCT00251719|10843056|FG000|Overall Study|Withdrawal by Subject|14
6837470|NCT00251719|10843057|FG001|Overall Study|Withdrawal by Subject|12
6837471|NCT00251719|10843058|FG002|Overall Study|Withdrawal by Subject|11
6837472|NCT00251719|10843056|FG000|Overall Study|Lack of Efficacy|2
6837473|NCT00251719|10843057|FG001|Overall Study|Lack of Efficacy|1
6837474|NCT00251719|10843058|FG002|Overall Study|Lack of Efficacy|0
6837475|NCT00251719|10843056|FG000|Overall Study|Inclusion/exclusion criteria not met|12
6837476|NCT00251719|10843057|FG001|Overall Study|Inclusion/exclusion criteria not met|6
6837477|NCT00251719|10843058|FG002|Overall Study|Inclusion/exclusion criteria not met|2
6837478|NCT00251719|10843056|FG000|Overall Study|Investigator decision|1
6837479|NCT00251719|10843057|FG001|Overall Study|Investigator decision|1
6837480|NCT00251719|10843058|FG002|Overall Study|Investigator decision|0
6837481|NCT00251719|10843056|FG000|Overall Study|Noncompliance|2
6837482|NCT00251719|10843057|FG001|Overall Study|Noncompliance|3
6837483|NCT00251719|10843058|FG002|Overall Study|Noncompliance|1
6837484|NCT00251719|10843056|FG000|Overall Study|Barrett's esophagus|2
6837485|NCT00251719|10843057|FG001|Overall Study|Barrett's esophagus|2
6837486|NCT00251719|10843058|FG002|Overall Study|Barrett's esophagus|0
6837487|NCT00251745|10843069|FG000|Overall Study|Adverse Event|7
6837488|NCT00251745|10843070|FG001|Overall Study|Adverse Event|9
6837489|NCT00251745|10843071|FG002|Overall Study|Adverse Event|11
6837490|NCT00251745|10843069|FG000|Overall Study|Lost to Follow-up|4
6837491|NCT00251745|10843070|FG001|Overall Study|Lost to Follow-up|2
6837492|NCT00251745|10843071|FG002|Overall Study|Lost to Follow-up|5
6837493|NCT00251745|10843069|FG000|Overall Study|Withdrawal by Subject|13
6837494|NCT00251745|10843070|FG001|Overall Study|Withdrawal by Subject|7
6837495|NCT00251745|10843071|FG002|Overall Study|Withdrawal by Subject|3
6837496|NCT00251745|10843069|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0
6897521|NCT00641147|10916645|FG001|Completed 8 Months.|Withdrawal by Subject|1
6897522|NCT00641147|10916644|FG000|Completed 12 Months.|Physician Decision|1
6897523|NCT00641147|10916645|FG001|Completed 12 Months.|Physician Decision|1
6897524|NCT00641147|10916644|FG000|Completed 12 Months.|Withdrawal by Subject|0
6897525|NCT00641147|10916645|FG001|Completed 12 Months.|Withdrawal by Subject|1
6897526|NCT00641147|10916644|FG000|Completed 16 Months.|Physician Decision|1
6897527|NCT00641147|10916645|FG001|Completed 16 Months.|Physician Decision|0
6837497|NCT00251745|10843070|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6
6837498|NCT00251745|10843071|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5
6837499|NCT00251745|10843069|FG000|Overall Study|Lack of Efficacy|3
6837500|NCT00251745|10843070|FG001|Overall Study|Lack of Efficacy|0
6837501|NCT00251745|10843071|FG002|Overall Study|Lack of Efficacy|0
6837502|NCT00251745|10843069|FG000|Overall Study|Noncompliant|0
6837503|NCT00251745|10843070|FG001|Overall Study|Noncompliant|2
6837504|NCT00251745|10843071|FG002|Overall Study|Noncompliant|2
6837505|NCT00251745|10843069|FG000|Overall Study|Pregnancy|0
6837506|NCT00251745|10843070|FG001|Overall Study|Pregnancy|1
6837507|NCT00251745|10843071|FG002|Overall Study|Pregnancy|0
6837508|NCT00251745|10843069|FG000|Overall Study|Per Subject Request|0
6837509|NCT00251745|10843070|FG001|Overall Study|Per Subject Request|0
6837510|NCT00251745|10843071|FG002|Overall Study|Per Subject Request|1
6837511|NCT00251745|10843069|FG000|Overall Study|Per Investigator Request|1
6837512|NCT00251745|10843070|FG001|Overall Study|Per Investigator Request|0
6837513|NCT00251745|10843071|FG002|Overall Study|Per Investigator Request|0
6837514|NCT00251758|10843082|FG000|Overall Study|Adverse Event|7
6837515|NCT00251758|10843083|FG001|Overall Study|Adverse Event|9
6837516|NCT00251758|10843084|FG002|Overall Study|Adverse Event|11
6837517|NCT00251758|10843082|FG000|Overall Study|Lost to Follow-up|4
6837518|NCT00251758|10843083|FG001|Overall Study|Lost to Follow-up|2
6837519|NCT00251758|10843084|FG002|Overall Study|Lost to Follow-up|5
7065566|NCT01967719|11165205|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0
7065567|NCT01967732|11165217|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
7065568|NCT01967732|11165218|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1
7065569|NCT01967732|11165219|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
7065570|NCT01967732|11165220|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
6837520|NCT00251758|10843082|FG000|Overall Study|Withdrawal by Subject|13
6837521|NCT00251758|10843083|FG001|Overall Study|Withdrawal by Subject|7
6837522|NCT00251758|10843084|FG002|Overall Study|Withdrawal by Subject|3
6837523|NCT00251758|10843082|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0
6837524|NCT00251758|10843083|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6
6837525|NCT00251758|10843084|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5
6837526|NCT00251758|10843082|FG000|Overall Study|Lack of Efficacy|3
6837527|NCT00251758|10843083|FG001|Overall Study|Lack of Efficacy|0
6837528|NCT00251758|10843084|FG002|Overall Study|Lack of Efficacy|0
6837529|NCT00251758|10843082|FG000|Overall Study|Noncompliant|0
6837530|NCT00251758|10843083|FG001|Overall Study|Noncompliant|2
6837531|NCT00251758|10843084|FG002|Overall Study|Noncompliant|2
6837532|NCT00251758|10843082|FG000|Overall Study|Pregnancy|0
6837533|NCT00251758|10843083|FG001|Overall Study|Pregnancy|1
6837534|NCT00251758|10843084|FG002|Overall Study|Pregnancy|0
6837535|NCT00251758|10843082|FG000|Overall Study|Per Subject Request|0
6837536|NCT00251758|10843083|FG001|Overall Study|Per Subject Request|0
6837537|NCT00251758|10843084|FG002|Overall Study|Per Subject Request|1
6837538|NCT00251758|10843082|FG000|Overall Study|Per Investigator Request|1
6837539|NCT00251758|10843083|FG001|Overall Study|Per Investigator Request|0
6837540|NCT00251758|10843084|FG002|Overall Study|Per Investigator Request|0
6837541|NCT00251927|10843107|FG000|Overall Study|Adverse Event|3
6837542|NCT00251927|10843108|FG001|Overall Study|Adverse Event|15
6837543|NCT00251927|10843107|FG000|Overall Study|Lack of Efficacy|22
6837544|NCT00251927|10843108|FG001|Overall Study|Lack of Efficacy|16
6837545|NCT00251927|10843107|FG000|Overall Study|Lost to Follow-up|22
6837546|NCT00251927|10843108|FG001|Overall Study|Lost to Follow-up|8
6837547|NCT00251927|10843107|FG000|Overall Study|Protocol Violation|1
6837548|NCT00251927|10843108|FG001|Overall Study|Protocol Violation|2
6837549|NCT00251927|10843107|FG000|Overall Study|Pregnancy|2
6837550|NCT00251927|10843108|FG001|Overall Study|Pregnancy|0
6837551|NCT00251927|10843107|FG000|Overall Study|Withdrawal by Subject|40
6837552|NCT00251927|10843108|FG001|Overall Study|Withdrawal by Subject|25
6837553|NCT00251927|10843107|FG000|Overall Study|Study-specific discont. achieved|13
6837554|NCT00251927|10843108|FG001|Overall Study|Study-specific discont. achieved|2
6837555|NCT00251927|10843107|FG000|Overall Study|Study procedure non-compliance|5
6837556|NCT00251927|10843108|FG001|Overall Study|Study procedure non-compliance|6
6837557|NCT00251979|10843117|FG000|Overall Study|Protocol Violation|3
6837558|NCT00251979|10843118|FG001|Overall Study|Protocol Violation|5
6837559|NCT00251979|10843117|FG000|Overall Study|Adverse Event|11
6837560|NCT00251979|10843118|FG001|Overall Study|Adverse Event|17
7065571|NCT01967732|11165217|FG000|First Intervention (Day 1)|Poor venous access|0
6837561|NCT00251979|10843117|FG000|Overall Study|Withdrawal by Subject|13
6837562|NCT00251979|10843118|FG001|Overall Study|Withdrawal by Subject|7
6837563|NCT00251979|10843117|FG000|Overall Study|Lost to Follow-up|8
6837564|NCT00251979|10843118|FG001|Overall Study|Lost to Follow-up|6
6837565|NCT00251979|10843117|FG000|Overall Study|Death|3
6837566|NCT00251979|10843118|FG001|Overall Study|Death|5
6837567|NCT00252057|10843126|FG000|Overall Study|Withdrawal by Subject|2
6837568|NCT00252057|10843127|FG001|Overall Study|Withdrawal by Subject|5
6837569|NCT00252057|10843126|FG000|Overall Study|Death|1
6837570|NCT00252057|10843127|FG001|Overall Study|Death|2
6837571|NCT00252057|10843126|FG000|Overall Study|Participant previously enrolled|0
6837572|NCT00252057|10843127|FG001|Overall Study|Participant previously enrolled|1
6837573|NCT00252187|10843135|FG000|Overall Study|Adverse Event|3
6837574|NCT00252187|10843136|FG001|Overall Study|Adverse Event|1
6837575|NCT00252187|10843135|FG000|Overall Study|Withdrawal by Subject|1
6837576|NCT00252187|10843136|FG001|Overall Study|Withdrawal by Subject|0
6837577|NCT00252239|10843146|FG000|Overall Study|Withdrawal by Subject|1
6837578|NCT00252239|10843147|FG001|Overall Study|Withdrawal by Subject|0
6837579|NCT00252239|10843148|FG002|Overall Study|Withdrawal by Subject|0
6837580|NCT00252239|10843149|FG003|Overall Study|Withdrawal by Subject|1
6837581|NCT00252239|10843146|FG000|Overall Study|Lost to Follow-up|0
6837582|NCT00252239|10843147|FG001|Overall Study|Lost to Follow-up|0
6837583|NCT00252239|10843148|FG002|Overall Study|Lost to Follow-up|2
6837584|NCT00252239|10843149|FG003|Overall Study|Lost to Follow-up|0
6837585|NCT00252499|10843166|FG000|Overall Study|Lost to Follow-up|1
6837586|NCT00252499|10843167|FG001|Overall Study|Lost to Follow-up|0
6837587|NCT00252499|10843168|FG002|Overall Study|Lost to Follow-up|0
6837588|NCT00252564|10843193|FG000|Overall Study|Adverse Event|17
6837589|NCT00252564|10843194|FG001|Overall Study|Adverse Event|13
6932232|NCT00879970|10964974|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0
6932233|NCT00879970|10964970|FG000|Period 1 TZD Randomization|Lost to Follow-up|1
6932234|NCT00879970|10964971|FG001|Period 1 TZD Randomization|Lost to Follow-up|0
6932235|NCT00879970|10964972|FG002|Period 1 TZD Randomization|Lost to Follow-up|1
6932236|NCT00879970|10964973|FG003|Period 1 TZD Randomization|Lost to Follow-up|0
6932237|NCT00879970|10964974|FG004|Period 1 TZD Randomization|Lost to Follow-up|0
6932238|NCT00879970|10964970|FG000|Period 1 TZD Randomization|Death|2
6932239|NCT00879970|10964971|FG001|Period 1 TZD Randomization|Death|1
6932240|NCT00879970|10964972|FG002|Period 1 TZD Randomization|Death|0
6932241|NCT00879970|10964973|FG003|Period 1 TZD Randomization|Death|0
6932242|NCT00879970|10964974|FG004|Period 1 TZD Randomization|Death|0
6932243|NCT00879970|10964970|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2
6932244|NCT00879970|10964971|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
6932245|NCT00879970|10964972|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1
6932246|NCT00879970|10964973|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
6932247|NCT00879970|10964974|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
6932248|NCT00879970|10964970|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
6932249|NCT00879970|10964971|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
6932250|NCT00879970|10964972|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
6932251|NCT00879970|10964973|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2
6932252|NCT00879970|10964974|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6
6932253|NCT00879970|10964970|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0
6932254|NCT00879970|10964971|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0
7039719|NCT01712984|11122543|FG002|Overall Study|Adverse Event|1
7039720|NCT01712984|11122541|FG000|Overall Study|Protocol Violation|2
6932255|NCT00879970|10964972|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0
6932256|NCT00879970|10964973|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0
6932257|NCT00879970|10964974|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1
6932258|NCT00879970|10964970|FG000|Period 2 Vitamin D Randomization|Death|0
6932259|NCT00879970|10964971|FG001|Period 2 Vitamin D Randomization|Death|0
6932260|NCT00879970|10964972|FG002|Period 2 Vitamin D Randomization|Death|0
6932261|NCT00879970|10964973|FG003|Period 2 Vitamin D Randomization|Death|2
6932262|NCT00879970|10964974|FG004|Period 2 Vitamin D Randomization|Death|0
6932263|NCT00879996|10964994|FG000|Overall Study|Lost to Follow-up|7
6932264|NCT00879996|10964995|FG001|Overall Study|Lost to Follow-up|6
6932265|NCT00879996|10964994|FG000|Overall Study|non-compliance|6
6932266|NCT00879996|10964995|FG001|Overall Study|non-compliance|4
6932267|NCT00879996|10964994|FG000|Overall Study|Physician Decision|1
6932268|NCT00879996|10964995|FG001|Overall Study|Physician Decision|2
6932269|NCT00879996|10964994|FG000|Overall Study|psychiatric problem|0
6932270|NCT00879996|10964995|FG001|Overall Study|psychiatric problem|1
6932271|NCT00879996|10964994|FG000|Overall Study|put on parole|1
6932272|NCT00879996|10964995|FG001|Overall Study|put on parole|0
6932273|NCT00880009|10965003|FG000|Overall Study|Study terminated by sponsor|14
6932274|NCT00880009|10965003|FG000|Overall Study|Withdrawal by Subject|1
6932275|NCT00880009|10965003|FG000|Overall Study|Protocol Violation|1
6932276|NCT00880048|10965024|FG000|Overall Study|Adverse Event|2
6932277|NCT00880048|10965025|FG001|Overall Study|Adverse Event|3
6932278|NCT00880048|10965026|FG002|Overall Study|Adverse Event|5
6932279|NCT00880048|10965024|FG000|Overall Study|Lack of Efficacy|1
6932280|NCT00880048|10965025|FG001|Overall Study|Lack of Efficacy|2
6932281|NCT00880048|10965026|FG002|Overall Study|Lack of Efficacy|2
6932282|NCT00880048|10965024|FG000|Overall Study|Protocol Violation|4
6932283|NCT00880048|10965025|FG001|Overall Study|Protocol Violation|6
6932284|NCT00880048|10965026|FG002|Overall Study|Protocol Violation|5
6932285|NCT00880048|10965024|FG000|Overall Study|Lost to Follow-up|6
6932286|NCT00880048|10965025|FG001|Overall Study|Lost to Follow-up|6
6932287|NCT00880048|10965026|FG002|Overall Study|Lost to Follow-up|5
6932288|NCT00880048|10965024|FG000|Overall Study|Physician Decision|1
6932289|NCT00880048|10965025|FG001|Overall Study|Physician Decision|1
6837590|NCT00252564|10843193|FG000|Overall Study|Unrelated Complication|2
6837591|NCT00252564|10843194|FG001|Overall Study|Unrelated Complication|1
6837592|NCT00252564|10843193|FG000|Overall Study|Disease Progression|14
6837593|NCT00252564|10843194|FG001|Overall Study|Disease Progression|20
6932290|NCT00880048|10965026|FG002|Overall Study|Physician Decision|7
7039721|NCT01712984|11122542|FG001|Overall Study|Protocol Violation|0
7039722|NCT01712984|11122543|FG002|Overall Study|Protocol Violation|1
7039723|NCT01712984|11122541|FG000|Overall Study|Lost to Follow-up|8
7039724|NCT01712984|11122542|FG001|Overall Study|Lost to Follow-up|10
6837594|NCT00252564|10843193|FG000|Overall Study|Death|0
6837595|NCT00252564|10843194|FG001|Overall Study|Death|3
6837596|NCT00252564|10843193|FG000|Overall Study|Physician Decision|1
6837597|NCT00252564|10843194|FG001|Overall Study|Physician Decision|0
6837598|NCT00252564|10843193|FG000|Overall Study|Lost to Follow-up|1
6837599|NCT00252564|10843194|FG001|Overall Study|Lost to Follow-up|0
6837600|NCT00252564|10843193|FG000|Overall Study|Patient Request|4
6837601|NCT00252564|10843194|FG001|Overall Study|Patient Request|5
6837602|NCT00252564|10843193|FG000|Overall Study|Withdrawal by Subject|0
6837603|NCT00252564|10843194|FG001|Overall Study|Withdrawal by Subject|2
6837604|NCT00252577|10843200|FG000|Overall Study|Lost to Follow-up|20
6837605|NCT00252694|10843237|FG000|Overall Study|Withdrawal by Subject|83
6837606|NCT00252694|10843238|FG001|Overall Study|Withdrawal by Subject|91
6837607|NCT00252694|10843237|FG000|Overall Study|Death|36
6837608|NCT00252694|10843238|FG001|Overall Study|Death|34
6837609|NCT00252694|10843237|FG000|Overall Study|Mostly Lost to Follow Up|8
6837610|NCT00252694|10843238|FG001|Overall Study|Mostly Lost to Follow Up|13
6837611|NCT00252694|10843237|FG000|Overall Study|Patient Moving|17
6837612|NCT00252694|10843238|FG001|Overall Study|Patient Moving|16
6837613|NCT00252720|10843246|FG000|Overall Study|Withdrawal by Subject|95
6837614|NCT00252720|10843247|FG001|Overall Study|Withdrawal by Subject|97
6837615|NCT00252720|10843246|FG000|Overall Study|Death|7
6837616|NCT00252720|10843247|FG001|Overall Study|Death|8
6837617|NCT00252720|10843246|FG000|Overall Study|Moving|23
6837618|NCT00252720|10843247|FG001|Overall Study|Moving|42
6837619|NCT00252720|10843246|FG000|Overall Study|Mainly patients lost to follow-up|7
6837620|NCT00252720|10843247|FG001|Overall Study|Mainly patients lost to follow-up|18
6837621|NCT00252733|10843255|FG000|Overall Study|Withdrawal by Subject|73
6837622|NCT00252733|10843256|FG001|Overall Study|Withdrawal by Subject|67
6837623|NCT00252733|10843255|FG000|Overall Study|Death|7
6837624|NCT00252733|10843256|FG001|Overall Study|Death|5
6837625|NCT00252733|10843255|FG000|Overall Study|Lost to Follow-up|12
6837626|NCT00252733|10843256|FG001|Overall Study|Lost to Follow-up|6
6837627|NCT00252733|10843255|FG000|Overall Study|Multiple Reasons|14
6837628|NCT00252733|10843256|FG001|Overall Study|Multiple Reasons|14
6897528|NCT00641147|10916644|FG000|Completed 16 Months.|Lost to Follow-up|1
6897529|NCT00641147|10916645|FG001|Completed 16 Months.|Lost to Follow-up|0
6897530|NCT00641667|10916666|FG000|Overall Study|Withdrawal by Subject|1
6897531|NCT00641667|10916666|FG000|Overall Study|Adverse Event|1
6897532|NCT00641667|10916666|FG000|Overall Study|Physician Decision|1
6897533|NCT00641667|10916666|FG000|Overall Study|Worsening of underlying disease|3
6897534|NCT00641706|10916672|FG000|Overall Study|Adverse Event|2
6897535|NCT00641706|10916673|FG001|Overall Study|Adverse Event|1
6897536|NCT00641706|10916672|FG000|Overall Study|Withdrawal by Subject|6
6897537|NCT00641706|10916673|FG001|Overall Study|Withdrawal by Subject|1
6897538|NCT00641706|10916672|FG000|Overall Study|Clinical Decline|1
6897539|NCT00641706|10916673|FG001|Overall Study|Clinical Decline|0
6897540|NCT00641706|10916672|FG000|Overall Study|Lead Investigator Decision|0
6897541|NCT00641706|10916673|FG001|Overall Study|Lead Investigator Decision|1
6897542|NCT00641719|10916681|FG000|Overall Study|Lack of Efficacy|1
6897543|NCT00641719|10916682|FG001|Overall Study|Lack of Efficacy|2
6897544|NCT00641719|10916681|FG000|Overall Study|Adverse Event|24
6897545|NCT00641719|10916682|FG001|Overall Study|Adverse Event|29
6897546|NCT00641719|10916681|FG000|Overall Study|Withdrawal by Subject|4
6897547|NCT00641719|10916682|FG001|Overall Study|Withdrawal by Subject|4
6897548|NCT00641719|10916681|FG000|Overall Study|Reason Not Specified|1
6897549|NCT00641719|10916682|FG001|Overall Study|Reason Not Specified|2
6897550|NCT00642018|10916717|FG000|Overall Study|Adverse Event|11
6897551|NCT00642018|10916718|FG001|Overall Study|Adverse Event|36
6897552|NCT00642018|10916717|FG000|Overall Study|Withdrawal by Subject|4
6897553|NCT00642018|10916718|FG001|Overall Study|Withdrawal by Subject|10
6897554|NCT00642018|10916717|FG000|Overall Study|Progressive Disease|13
6897555|NCT00642018|10916718|FG001|Overall Study|Progressive Disease|18
6897556|NCT00642018|10916717|FG000|Overall Study|Physician Decision|0
6897557|NCT00642018|10916718|FG001|Overall Study|Physician Decision|10
6897558|NCT00642018|10916717|FG000|Overall Study|Protocol Violation|0
6897559|NCT00642018|10916718|FG001|Overall Study|Protocol Violation|1
6897560|NCT00642018|10916717|FG000|Overall Study|Death|0
6897561|NCT00642018|10916718|FG001|Overall Study|Death|3
6897562|NCT00642018|10916717|FG000|Overall Study|Entry Criteria Not Met|0
6897563|NCT00642018|10916718|FG001|Overall Study|Entry Criteria Not Met|1
6897564|NCT00642174|10916727|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0
6897565|NCT00642174|10916728|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1
6897566|NCT00642278|10916741|FG000|Overall Study|Adverse Event|2
6897567|NCT00642278|10916742|FG001|Overall Study|Adverse Event|1
6897568|NCT00642278|10916743|FG002|Overall Study|Adverse Event|3
6897569|NCT00642278|10916744|FG003|Overall Study|Adverse Event|1
6897570|NCT00642278|10916745|FG004|Overall Study|Adverse Event|2
6897571|NCT00642278|10916746|FG005|Overall Study|Adverse Event|2
6897572|NCT00642278|10916747|FG006|Overall Study|Adverse Event|0
6897573|NCT00642278|10916741|FG000|Overall Study|Lack of Efficacy|0
6837629|NCT00253370|10843284|FG000|Overall Study|Adverse Event|18
6837630|NCT00253370|10843284|FG000|Overall Study|Disease progression|13
6837631|NCT00253370|10843284|FG000|Overall Study|Death|2
6837632|NCT00253370|10843284|FG000|Overall Study|Withdrawal by Subject|6
6837633|NCT00253370|10843284|FG000|Overall Study|Non-protocol therapy|1
6837634|NCT00253370|10843284|FG000|Overall Study|Physician Decision|1
6837635|NCT00253370|10843284|FG000|Overall Study|Protocol Violation|1
6837636|NCT00253370|10843284|FG000|Overall Study|Abdominal pain due to disease|1
6932291|NCT00880048|10965024|FG000|Overall Study|Withdrawal by Subject|5
6932292|NCT00880048|10965025|FG001|Overall Study|Withdrawal by Subject|8
6932293|NCT00880048|10965026|FG002|Overall Study|Withdrawal by Subject|5
6932294|NCT00880048|10965024|FG000|Overall Study|Study closed/terminated|9
6932295|NCT00880048|10965025|FG001|Overall Study|Study closed/terminated|7
6932296|NCT00880048|10965026|FG002|Overall Study|Study closed/terminated|6
6932297|NCT00880087|10965036|FG000|Overall Study|Lost to Follow-up|0
6932298|NCT00880087|10965037|FG001|Overall Study|Lost to Follow-up|2
6932299|NCT00880100|10965043|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1
6932300|NCT00880100|10965043|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1
6932301|NCT00880100|10965043|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2
6932302|NCT00880165|10965049|FG000|Overall Study|Withdrawal by Subject|27
6932303|NCT00880165|10965050|FG001|Overall Study|Withdrawal by Subject|23
6932304|NCT00880165|10965049|FG000|Overall Study|Not diagnosed with OSA|14
6932305|NCT00880165|10965050|FG001|Overall Study|Not diagnosed with OSA|8
6932306|NCT00880165|10965049|FG000|Overall Study|Required BIPAP or oxygen treatment|12
6932307|NCT00880165|10965050|FG001|Overall Study|Required BIPAP or oxygen treatment|4
6932308|NCT00880165|10965049|FG000|Overall Study|Lost to follow|9
6932309|NCT00880165|10965050|FG001|Overall Study|Lost to follow|15
6932310|NCT00880191|10965058|FG000|Overall Study|Refused further treatment|4
6932311|NCT00880191|10965059|FG001|Overall Study|Refused further treatment|1
6932312|NCT00880191|10965058|FG000|Overall Study|Adverse Event|8
6932313|NCT00880191|10965059|FG001|Overall Study|Adverse Event|6
6932314|NCT00880191|10965058|FG000|Overall Study|Hospitalization/efficacy|1
6932315|NCT00880191|10965059|FG001|Overall Study|Hospitalization/efficacy|1
6932316|NCT00880256|10965069|FG000|Overall Study|Lost to Follow-up|28
6932317|NCT00880269|10965075|FG000|Overall Study|Protocol Violation|1
6932318|NCT00880269|10965076|FG001|Overall Study|Protocol Violation|0
6932319|NCT00880269|10965075|FG000|Overall Study|Disease Progression|13
6932320|NCT00880269|10965076|FG001|Overall Study|Disease Progression|11
6932321|NCT00880269|10965075|FG000|Overall Study|New Cancer Therapy|1
6932322|NCT00880269|10965076|FG001|Overall Study|New Cancer Therapy|0
6932323|NCT00880269|10965075|FG000|Overall Study|Death|4
6932324|NCT00880269|10965076|FG001|Overall Study|Death|2
6932325|NCT00880269|10965075|FG000|Overall Study|Lost to Follow-up|0
6932326|NCT00880269|10965076|FG001|Overall Study|Lost to Follow-up|1
6932327|NCT00880269|10965075|FG000|Overall Study|Withdrawal by Subject|3
6932328|NCT00880269|10965076|FG001|Overall Study|Withdrawal by Subject|4
6932329|NCT00880269|10965075|FG000|Overall Study|Adverse Event|10
6932330|NCT00880269|10965076|FG001|Overall Study|Adverse Event|9
6932331|NCT00880334|10965084|FG000|Randomized Phase|Physician Decision|1
6932332|NCT00880334|10965085|FG001|Randomized Phase|Physician Decision|0
6932333|NCT00880334|10965084|FG000|Randomized Phase|Withdrawal by Subject|2
6932334|NCT00880334|10965085|FG001|Randomized Phase|Withdrawal by Subject|1
6932335|NCT00880334|10965084|FG000|Randomized Phase|Inadequate Labs|1
6932336|NCT00880334|10965085|FG001|Randomized Phase|Inadequate Labs|1
6932337|NCT00880334|10965084|FG000|Randomized Phase|Brain Metastasis|0
6932338|NCT00880334|10965085|FG001|Randomized Phase|Brain Metastasis|1
6932339|NCT00880334|10965084|FG000|Randomized Phase|Crossover Participants|0
6932340|NCT00880334|10965085|FG001|Randomized Phase|Crossover Participants|37
6932341|NCT00880399|10965103|FG000|Overall Study|Adverse Event|4
6932342|NCT00880399|10965104|FG001|Overall Study|Adverse Event|6
6932343|NCT00880399|10965105|FG002|Overall Study|Adverse Event|5
6932344|NCT00880399|10965103|FG000|Overall Study|Lack of Efficacy|1
6932345|NCT00880399|10965104|FG001|Overall Study|Lack of Efficacy|4
6932346|NCT00880399|10965105|FG002|Overall Study|Lack of Efficacy|2
7039725|NCT01712984|11122543|FG002|Overall Study|Lost to Follow-up|1
6932347|NCT00880399|10965103|FG000|Overall Study|Protocol Violation|4
6932348|NCT00880399|10965104|FG001|Overall Study|Protocol Violation|4
6932349|NCT00880399|10965105|FG002|Overall Study|Protocol Violation|6
6932350|NCT00880399|10965103|FG000|Overall Study|Study closed/terminated|3
6932351|NCT00880399|10965104|FG001|Overall Study|Study closed/terminated|7
6932352|NCT00880399|10965105|FG002|Overall Study|Study closed/terminated|4
6932353|NCT00880399|10965103|FG000|Overall Study|Lost to Follow-up|8
6932354|NCT00880399|10965104|FG001|Overall Study|Lost to Follow-up|5
6932355|NCT00880399|10965105|FG002|Overall Study|Lost to Follow-up|3
6932356|NCT00880399|10965103|FG000|Overall Study|Physician Decision|5
6932357|NCT00880399|10965104|FG001|Overall Study|Physician Decision|0
6932358|NCT00880399|10965105|FG002|Overall Study|Physician Decision|3
6932359|NCT00880399|10965103|FG000|Overall Study|Withdrawal by Subject|6
6932360|NCT00880399|10965104|FG001|Overall Study|Withdrawal by Subject|3
6932361|NCT00880399|10965105|FG002|Overall Study|Withdrawal by Subject|3
6932362|NCT00880555|10965127|FG000|Overall Study|Physician Decision|0
6932363|NCT00880555|10965128|FG001|Overall Study|Physician Decision|8
6932364|NCT00880555|10965129|FG002|Overall Study|Physician Decision|0
6932365|NCT00880555|10965130|FG003|Overall Study|Physician Decision|2
6932366|NCT00880555|10965131|FG004|Overall Study|Physician Decision|1
6932367|NCT00880555|10965132|FG005|Overall Study|Physician Decision|0
6932368|NCT00880555|10965127|FG000|Overall Study|Withdrawal by Subject|1
6932369|NCT00880555|10965128|FG001|Overall Study|Withdrawal by Subject|1
6932370|NCT00880555|10965129|FG002|Overall Study|Withdrawal by Subject|0
6932371|NCT00880555|10965130|FG003|Overall Study|Withdrawal by Subject|0
6932372|NCT00880555|10965131|FG004|Overall Study|Withdrawal by Subject|0
6932373|NCT00880555|10965132|FG005|Overall Study|Withdrawal by Subject|0
6932374|NCT00880555|10965127|FG000|Overall Study|Lack of resources (hired rater)|9
6932375|NCT00880555|10965128|FG001|Overall Study|Lack of resources (hired rater)|7
6932376|NCT00880555|10965129|FG002|Overall Study|Lack of resources (hired rater)|5
6932377|NCT00880555|10965130|FG003|Overall Study|Lack of resources (hired rater)|0
6932378|NCT00880555|10965131|FG004|Overall Study|Lack of resources (hired rater)|0
6932379|NCT00880555|10965132|FG005|Overall Study|Lack of resources (hired rater)|0
6932380|NCT00880555|10965127|FG000|Overall Study|Death|0
6932381|NCT00880555|10965128|FG001|Overall Study|Death|0
6932382|NCT00880555|10965129|FG002|Overall Study|Death|0
6932383|NCT00880555|10965130|FG003|Overall Study|Death|0
6932384|NCT00880555|10965131|FG004|Overall Study|Death|0
6932385|NCT00880555|10965132|FG005|Overall Study|Death|1
6932386|NCT00880555|10965127|FG000|Overall Study|Lost to Follow-up|0
6932387|NCT00880555|10965128|FG001|Overall Study|Lost to Follow-up|1
6932388|NCT00880555|10965129|FG002|Overall Study|Lost to Follow-up|0
6932389|NCT00880555|10965130|FG003|Overall Study|Lost to Follow-up|0
6932390|NCT00880555|10965131|FG004|Overall Study|Lost to Follow-up|0
6932391|NCT00880555|10965132|FG005|Overall Study|Lost to Follow-up|0
6932392|NCT00880568|10965152|FG000|Overall Study|Disease progression|3
6932393|NCT00880568|10965153|FG001|Overall Study|Disease progression|3
6932394|NCT00880568|10965154|FG002|Overall Study|Disease progression|3
6932395|NCT00880568|10965155|FG003|Overall Study|Disease progression|1
6932396|NCT00880568|10965156|FG004|Overall Study|Disease progression|3
6932397|NCT00880568|10965157|FG005|Overall Study|Disease progression|3
6932398|NCT00880568|10965158|FG006|Overall Study|Disease progression|5
6932399|NCT00880568|10965159|FG007|Overall Study|Disease progression|0
6932400|NCT00880568|10965160|FG008|Overall Study|Disease progression|3
6932401|NCT00880568|10965152|FG000|Overall Study|Adverse Event|0
6932402|NCT00880568|10965153|FG001|Overall Study|Adverse Event|0
6932403|NCT00880568|10965154|FG002|Overall Study|Adverse Event|0
6932404|NCT00880568|10965155|FG003|Overall Study|Adverse Event|0
6932405|NCT00880568|10965156|FG004|Overall Study|Adverse Event|0
6932406|NCT00880568|10965157|FG005|Overall Study|Adverse Event|0
6932407|NCT00880568|10965158|FG006|Overall Study|Adverse Event|1
6932408|NCT00880568|10965159|FG007|Overall Study|Adverse Event|1
6932409|NCT00880568|10965160|FG008|Overall Study|Adverse Event|0
6932410|NCT00880568|10965152|FG000|Overall Study|Withdrawal by Subject|0
6932411|NCT00880568|10965153|FG001|Overall Study|Withdrawal by Subject|0
6932412|NCT00880568|10965154|FG002|Overall Study|Withdrawal by Subject|0
6932413|NCT00880568|10965155|FG003|Overall Study|Withdrawal by Subject|0
6932414|NCT00880568|10965156|FG004|Overall Study|Withdrawal by Subject|0
6932415|NCT00880568|10965157|FG005|Overall Study|Withdrawal by Subject|0
6932416|NCT00880568|10965158|FG006|Overall Study|Withdrawal by Subject|0
6932417|NCT00880568|10965159|FG007|Overall Study|Withdrawal by Subject|1
6932418|NCT00880568|10965160|FG008|Overall Study|Withdrawal by Subject|0
6932419|NCT00880607|10965191|FG000|Overall Study|Physician Decision|2
6932420|NCT00880607|10965192|FG001|Overall Study|Physician Decision|2
6932421|NCT00880607|10965191|FG000|Overall Study|Protocol Violation|2
6932422|NCT00880607|10965192|FG001|Overall Study|Protocol Violation|1
6932423|NCT00880607|10965191|FG000|Overall Study|surgery did not extend past L1 level|3
6932424|NCT00880607|10965192|FG001|Overall Study|surgery did not extend past L1 level|0
6932425|NCT00880620|10965204|FG000|Overall Study|Adverse Event|4
6932426|NCT00880620|10965205|FG001|Overall Study|Adverse Event|5
6932427|NCT00880620|10965206|FG002|Overall Study|Adverse Event|15
6932428|NCT00880620|10965207|FG003|Overall Study|Adverse Event|15
6932429|NCT00880620|10965204|FG000|Overall Study|Death|0
6932430|NCT00880620|10965205|FG001|Overall Study|Death|0
6932431|NCT00880620|10965206|FG002|Overall Study|Death|1
6932432|NCT00880620|10965207|FG003|Overall Study|Death|0
7039726|NCT01712984|11122541|FG000|Overall Study|Withdrawal by Subject|6
7039727|NCT01712984|11122542|FG001|Overall Study|Withdrawal by Subject|6
6932433|NCT00880620|10965204|FG000|Overall Study|Lack of Efficacy|12
6932434|NCT00880620|10965205|FG001|Overall Study|Lack of Efficacy|4
6932435|NCT00880620|10965206|FG002|Overall Study|Lack of Efficacy|0
6932436|NCT00880620|10965207|FG003|Overall Study|Lack of Efficacy|1
6932437|NCT00880620|10965204|FG000|Overall Study|Lost to Follow-up|0
6932438|NCT00880620|10965205|FG001|Overall Study|Lost to Follow-up|1
6932439|NCT00880620|10965206|FG002|Overall Study|Lost to Follow-up|1
6932440|NCT00880620|10965207|FG003|Overall Study|Lost to Follow-up|0
6932441|NCT00880620|10965204|FG000|Overall Study|Protocol Violation|0
6932442|NCT00880620|10965205|FG001|Overall Study|Protocol Violation|1
6932443|NCT00880620|10965206|FG002|Overall Study|Protocol Violation|0
6932444|NCT00880620|10965207|FG003|Overall Study|Protocol Violation|2
6932445|NCT00880620|10965204|FG000|Overall Study|Withdrawal by Subject|4
6932446|NCT00880620|10965205|FG001|Overall Study|Withdrawal by Subject|3
6932447|NCT00880620|10965206|FG002|Overall Study|Withdrawal by Subject|1
6932448|NCT00880620|10965207|FG003|Overall Study|Withdrawal by Subject|3
6932449|NCT00880620|10965204|FG000|Overall Study|Noncompliance|0
6932450|NCT00880620|10965205|FG001|Overall Study|Noncompliance|0
6932451|NCT00880620|10965206|FG002|Overall Study|Noncompliance|1
6932452|NCT00880620|10965207|FG003|Overall Study|Noncompliance|1
6932453|NCT00880620|10965204|FG000|Overall Study|Other|1
6932454|NCT00880620|10965205|FG001|Overall Study|Other|1
6932455|NCT00880620|10965206|FG002|Overall Study|Other|2
6932456|NCT00880620|10965207|FG003|Overall Study|Other|2
6932457|NCT00880685|10965221|FG000|Memantine 10mg|Lost to Follow-up|2
6932458|NCT00880685|10965221|FG000|Memantine 20mg|Withdrawal by Subject|1
6932459|NCT00880698|10965232|FG000|Overall Study|Death|0
6932460|NCT00880698|10965233|FG001|Overall Study|Death|0
6932461|NCT00880698|10965234|FG002|Overall Study|Death|1
6932462|NCT00880698|10965235|FG003|Overall Study|Death|2
6932463|NCT00880698|10965232|FG000|Overall Study|Lost to Follow-up|1
6932464|NCT00880698|10965233|FG001|Overall Study|Lost to Follow-up|3
6932465|NCT00880698|10965234|FG002|Overall Study|Lost to Follow-up|0
6932466|NCT00880698|10965235|FG003|Overall Study|Lost to Follow-up|1
6932467|NCT00880750|10965249|FG000|First Intervention|Adverse Event|1
6932468|NCT00880750|10965250|FG001|First Intervention|Adverse Event|0
6932469|NCT00880750|10965249|FG000|First Intervention|Unable to collect urine|4
6932470|NCT00880750|10965250|FG001|First Intervention|Unable to collect urine|0
6932471|NCT00880750|10965249|FG000|First Intervention|Non-compliance with meals|0
6932472|NCT00880750|10965250|FG001|First Intervention|Non-compliance with meals|1
6932473|NCT00880750|10965249|FG000|First Intervention|Withdrawal by Subject|2
7065572|NCT01967732|11165218|FG001|First Intervention (Day 1)|Poor venous access|1
7065573|NCT01967732|11165219|FG002|First Intervention (Day 1)|Poor venous access|0
7065574|NCT01967732|11165220|FG003|First Intervention (Day 1)|Poor venous access|0
7065575|NCT01967888|11165243|FG000|Overall Study|Lost to Follow-up|6
7065576|NCT01967888|11165244|FG001|Overall Study|Lost to Follow-up|4
7065577|NCT01967888|11165243|FG000|Overall Study|Withdrawal by Subject|1
7065578|NCT01967888|11165244|FG001|Overall Study|Withdrawal by Subject|1
6932474|NCT00880750|10965250|FG001|First Intervention|Withdrawal by Subject|0
6932475|NCT00880750|10965249|FG000|First Intervention|Lost to Follow-up|2
6932476|NCT00880750|10965250|FG001|First Intervention|Lost to Follow-up|0
7039728|NCT01712984|11122543|FG002|Overall Study|Withdrawal by Subject|7
7039729|NCT01713036|11122551|FG000|Overall Study|Death|1
7039730|NCT01713283|11122565|FG000|Overall Study|Lack of Efficacy|10
7039731|NCT01713283|11122566|FG001|Overall Study|Lack of Efficacy|2
7039732|NCT01713283|11122565|FG000|Overall Study|Lost to Follow-up|1
7039733|NCT01713283|11122566|FG001|Overall Study|Lost to Follow-up|1
7039734|NCT01713348|11122580|FG000|Overall Study|Withdrawal by Subject|3
7039735|NCT01713348|11122581|FG001|Overall Study|Withdrawal by Subject|2
6932477|NCT00880750|10965249|FG000|Second Intervention|Withdrawal by Subject|2
6932478|NCT00880750|10965250|FG001|Second Intervention|Withdrawal by Subject|2
6932479|NCT00880750|10965249|FG000|Second Intervention|Protocol Violation|1
6932480|NCT00880750|10965250|FG001|Second Intervention|Protocol Violation|0
6932481|NCT00880750|10965249|FG000|Second Intervention|Unable to collect urine|1
6932482|NCT00880750|10965250|FG001|Second Intervention|Unable to collect urine|0
6932483|NCT00880763|10965260|FG000|Extension Period (Part 2)|Adverse Event|0
6932484|NCT00880763|10965261|FG001|Extension Period (Part 2)|Adverse Event|0
6932485|NCT00880763|10965262|FG002|Extension Period (Part 2)|Adverse Event|1
6932486|NCT00880763|10965263|FG003|Extension Period (Part 2)|Adverse Event|1
6932487|NCT00880763|10965260|FG000|Extension Period (Part 2)|Withdrawal by Subject|0
6932488|NCT00880763|10965261|FG001|Extension Period (Part 2)|Withdrawal by Subject|2
6932489|NCT00880763|10965262|FG002|Extension Period (Part 2)|Withdrawal by Subject|1
7039736|NCT01713348|11122582|FG002|Overall Study|Withdrawal by Subject|2
7039737|NCT01713348|11122583|FG003|Overall Study|Withdrawal by Subject|0
7039738|NCT01713348|11122580|FG000|Overall Study|Lost to Follow-up|1
7039739|NCT01713348|11122581|FG001|Overall Study|Lost to Follow-up|0
7039740|NCT01713348|11122582|FG002|Overall Study|Lost to Follow-up|0
7039741|NCT01713348|11122583|FG003|Overall Study|Lost to Follow-up|0
7039742|NCT01713530|11122604|FG000|Overall Study|Adverse Event|0
7039743|NCT01713530|11122605|FG001|Overall Study|Adverse Event|5
7039744|NCT01713530|11122604|FG000|Overall Study|Withdrawal criteria|21
7039745|NCT01713530|11122605|FG001|Overall Study|Withdrawal criteria|12
7039746|NCT01713530|11122604|FG000|Overall Study|Unclassified|4
7039747|NCT01713530|11122605|FG001|Overall Study|Unclassified|2
7039748|NCT01713582|11122632|FG000|Overall Study|Disease progression|3
7039749|NCT01713582|11122633|FG001|Overall Study|Disease progression|3
7039750|NCT01713582|11122634|FG002|Overall Study|Disease progression|3
6932490|NCT00880763|10965263|FG003|Extension Period (Part 2)|Withdrawal by Subject|1
6932491|NCT00880763|10965260|FG000|Extension Period (Part 2)|Physician Decision|0
6932492|NCT00880763|10965261|FG001|Extension Period (Part 2)|Physician Decision|1
6932493|NCT00880763|10965262|FG002|Extension Period (Part 2)|Physician Decision|1
6932494|NCT00880763|10965263|FG003|Extension Period (Part 2)|Physician Decision|0
6932495|NCT00880763|10965260|FG000|Extension Period (Part 2)|Lack of Efficacy|0
6932496|NCT00880763|10965261|FG001|Extension Period (Part 2)|Lack of Efficacy|0
6932497|NCT00880763|10965262|FG002|Extension Period (Part 2)|Lack of Efficacy|0
7039751|NCT01713582|11122635|FG003|Overall Study|Disease progression|2
7039752|NCT01713582|11122636|FG004|Overall Study|Disease progression|3
7039753|NCT01713582|11122637|FG005|Overall Study|Disease progression|3
7039754|NCT01713582|11122638|FG006|Overall Study|Disease progression|3
7039755|NCT01713582|11122639|FG007|Overall Study|Disease progression|3
7039756|NCT01713582|11122640|FG008|Overall Study|Disease progression|3
7065579|NCT01967888|11165243|FG000|Overall Study|Did Not Have Transplant|1
7039757|NCT01713582|11122641|FG009|Overall Study|Disease progression|11
7039758|NCT01713582|11122642|FG010|Overall Study|Disease progression|10
7039759|NCT01713582|11122643|FG011|Overall Study|Disease progression|5
7039760|NCT01713582|11122644|FG012|Overall Study|Disease progression|3
7039761|NCT01713582|11122645|FG013|Overall Study|Disease progression|3
7039762|NCT01713582|11122646|FG014|Overall Study|Disease progression|6
7039763|NCT01713582|11122647|FG015|Overall Study|Disease progression|6
7039764|NCT01713582|11122648|FG016|Overall Study|Disease progression|5
7039765|NCT01713582|11122649|FG017|Overall Study|Disease progression|2
7039766|NCT01713582|11122650|FG018|Overall Study|Disease progression|3
7039767|NCT01713582|11122651|FG019|Overall Study|Disease progression|5
6932498|NCT00880763|10965263|FG003|Extension Period (Part 2)|Lack of Efficacy|1
6932499|NCT00880906|10965275|FG000|Overall Study|Lost to Follow-up|0
6932500|NCT00880906|10965276|FG001|Overall Study|Lost to Follow-up|1
6932501|NCT00880906|10965275|FG000|Overall Study|Did not meet criteria following patholog|12
6932502|NCT00880906|10965276|FG001|Overall Study|Did not meet criteria following patholog|6
6932503|NCT00881335|10965313|FG000|Overall Study|Lost to Follow-up|3
6932504|NCT00881335|10965314|FG001|Overall Study|Lost to Follow-up|2
6932505|NCT00881361|10965322|FG000|Overall Study|Terminated prior to surgery|27
6932506|NCT00881361|10965323|FG001|Overall Study|Terminated prior to surgery|7
6932507|NCT00881361|10965324|FG002|Overall Study|Terminated prior to surgery|0
6932508|NCT00881361|10965322|FG000|Overall Study|Ineligible|17
6932509|NCT00881361|10965323|FG001|Overall Study|Ineligible|2
6932510|NCT00881361|10965324|FG002|Overall Study|Ineligible|2
6932511|NCT00881504|10965342|FG000|Overall Study|Withdrawal by Subject|1
6932512|NCT00881530|10965352|FG000|Overall Study|Adverse Event|5
6932513|NCT00881530|10965353|FG001|Overall Study|Adverse Event|1
6932514|NCT00881530|10965354|FG002|Overall Study|Adverse Event|1
6932515|NCT00881530|10965355|FG003|Overall Study|Adverse Event|4
6932516|NCT00881530|10965356|FG004|Overall Study|Adverse Event|10
6932517|NCT00881530|10965357|FG005|Overall Study|Adverse Event|2
6932518|NCT00881530|10965352|FG000|Overall Study|Lack of Efficacy|1
6932519|NCT00881530|10965353|FG001|Overall Study|Lack of Efficacy|0
6932520|NCT00881530|10965354|FG002|Overall Study|Lack of Efficacy|0
6932521|NCT00881530|10965355|FG003|Overall Study|Lack of Efficacy|0
6932522|NCT00881530|10965356|FG004|Overall Study|Lack of Efficacy|1
6932523|NCT00881530|10965357|FG005|Overall Study|Lack of Efficacy|1
6932524|NCT00881530|10965352|FG000|Overall Study|Not compliant with the protocol|0
6932525|NCT00881530|10965353|FG001|Overall Study|Not compliant with the protocol|0
6932526|NCT00881530|10965354|FG002|Overall Study|Not compliant with the protocol|0
6932527|NCT00881530|10965355|FG003|Overall Study|Not compliant with the protocol|0
6932528|NCT00881530|10965356|FG004|Overall Study|Not compliant with the protocol|2
6932529|NCT00881530|10965357|FG005|Overall Study|Not compliant with the protocol|0
6932530|NCT00881530|10965352|FG000|Overall Study|Lost to Follow-up|0
6932531|NCT00881530|10965353|FG001|Overall Study|Lost to Follow-up|1
6932532|NCT00881530|10965354|FG002|Overall Study|Lost to Follow-up|1
6932533|NCT00881530|10965355|FG003|Overall Study|Lost to Follow-up|3
6932534|NCT00881530|10965356|FG004|Overall Study|Lost to Follow-up|1
6932535|NCT00881530|10965357|FG005|Overall Study|Lost to Follow-up|0
7039768|NCT01713582|11122652|FG020|Overall Study|Disease progression|15
7039769|NCT01713582|11122632|FG000|Overall Study|Death|0
7039770|NCT01713582|11122633|FG001|Overall Study|Death|0
7039771|NCT01713582|11122634|FG002|Overall Study|Death|0
7039772|NCT01713582|11122635|FG003|Overall Study|Death|1
7039773|NCT01713582|11122636|FG004|Overall Study|Death|1
7039774|NCT01713582|11122637|FG005|Overall Study|Death|3
7039775|NCT01713582|11122638|FG006|Overall Study|Death|3
7039776|NCT01713582|11122639|FG007|Overall Study|Death|2
7039777|NCT01713582|11122640|FG008|Overall Study|Death|3
7039778|NCT01713582|11122641|FG009|Overall Study|Death|4
7039779|NCT01713582|11122642|FG010|Overall Study|Death|3
7039780|NCT01713582|11122643|FG011|Overall Study|Death|0
7039781|NCT01713582|11122644|FG012|Overall Study|Death|0
7039782|NCT01713582|11122645|FG013|Overall Study|Death|0
7039783|NCT01713582|11122646|FG014|Overall Study|Death|0
7039784|NCT01713582|11122647|FG015|Overall Study|Death|0
7039785|NCT01713582|11122648|FG016|Overall Study|Death|0
7039786|NCT01713582|11122649|FG017|Overall Study|Death|0
7039787|NCT01713582|11122650|FG018|Overall Study|Death|0
6932536|NCT00881530|10965352|FG000|Overall Study|Refused to continue medication|7
6932537|NCT00881530|10965353|FG001|Overall Study|Refused to continue medication|2
6932538|NCT00881530|10965354|FG002|Overall Study|Refused to continue medication|1
6932539|NCT00881530|10965355|FG003|Overall Study|Refused to continue medication|2
7039788|NCT01713582|11122651|FG019|Overall Study|Death|0
7039789|NCT01713582|11122652|FG020|Overall Study|Death|0
7039790|NCT01713582|11122632|FG000|Overall Study|Adverse event-related|0
6932540|NCT00881530|10965356|FG004|Overall Study|Refused to continue medication|0
6932541|NCT00881530|10965357|FG005|Overall Study|Refused to continue medication|0
6932542|NCT00881530|10965352|FG000|Overall Study|Other reason not defined above|1
7039791|NCT01713582|11122633|FG001|Overall Study|Adverse event-related|0
7039792|NCT01713582|11122634|FG002|Overall Study|Adverse event-related|0
7039793|NCT01713582|11122635|FG003|Overall Study|Adverse event-related|0
7039794|NCT01713582|11122636|FG004|Overall Study|Adverse event-related|0
7039795|NCT01713582|11122637|FG005|Overall Study|Adverse event-related|0
7039796|NCT01713582|11122638|FG006|Overall Study|Adverse event-related|0
7039797|NCT01713582|11122639|FG007|Overall Study|Adverse event-related|0
7039798|NCT01713582|11122640|FG008|Overall Study|Adverse event-related|0
7039799|NCT01713582|11122641|FG009|Overall Study|Adverse event-related|1
7039800|NCT01713582|11122642|FG010|Overall Study|Adverse event-related|1
7039801|NCT01713582|11122643|FG011|Overall Study|Adverse event-related|0
7039802|NCT01713582|11122644|FG012|Overall Study|Adverse event-related|0
7039803|NCT01713582|11122645|FG013|Overall Study|Adverse event-related|0
7039804|NCT01713582|11122646|FG014|Overall Study|Adverse event-related|0
7039805|NCT01713582|11122647|FG015|Overall Study|Adverse event-related|0
7039806|NCT01713582|11122648|FG016|Overall Study|Adverse event-related|0
6932543|NCT00881530|10965353|FG001|Overall Study|Other reason not defined above|1
6932544|NCT00881530|10965354|FG002|Overall Study|Other reason not defined above|2
6932545|NCT00881530|10965355|FG003|Overall Study|Other reason not defined above|0
6932546|NCT00881530|10965356|FG004|Overall Study|Other reason not defined above|0
6932547|NCT00881530|10965357|FG005|Overall Study|Other reason not defined above|2
6932548|NCT00881569|10965373|FG000|Overall Study|Disease progression|1
6932549|NCT00881569|10965374|FG001|Overall Study|Disease progression|1
6932550|NCT00881621|10965380|FG000|Overall Study|Physician Decision|34
6932551|NCT00881712|10965396|FG000|Overall Study|Death|1
6932552|NCT00881712|10965397|FG001|Overall Study|Death|0
6932553|NCT00881712|10965398|FG002|Overall Study|Death|0
6932554|NCT00881712|10965396|FG000|Overall Study|Withdrawal by Subject|1
6932555|NCT00881712|10965397|FG001|Overall Study|Withdrawal by Subject|0
6932556|NCT00881712|10965398|FG002|Overall Study|Withdrawal by Subject|0
6932557|NCT00881751|10965408|FG000|Overall Study|Physician Decision|0
6932558|NCT00881751|10965409|FG001|Overall Study|Physician Decision|1
6932559|NCT00881751|10965408|FG000|Overall Study|Adverse Event|0
6932560|NCT00881751|10965409|FG001|Overall Study|Adverse Event|2
6932561|NCT00881751|10965408|FG000|Overall Study|Withdrawal by Subject|0
6932562|NCT00881751|10965409|FG001|Overall Study|Withdrawal by Subject|2
6932563|NCT00881868|10965417|FG000|Overall Study|Adverse Event|0
6932564|NCT00881868|10965418|FG001|Overall Study|Adverse Event|1
6932565|NCT00881868|10965417|FG000|Overall Study|Lost to Follow-up|2
6932566|NCT00881868|10965418|FG001|Overall Study|Lost to Follow-up|1
6932567|NCT00881868|10965417|FG000|Overall Study|Physician Decision|4
6932568|NCT00881868|10965418|FG001|Overall Study|Physician Decision|0
6932569|NCT00881868|10965417|FG000|Overall Study|Protocol Violation|2
6932570|NCT00881868|10965418|FG001|Overall Study|Protocol Violation|0
6932571|NCT00881894|10965426|FG000|Overall Study|Consent withdrawn|0
6932572|NCT00881894|10965427|FG001|Overall Study|Consent withdrawn|1
6932573|NCT00881894|10965426|FG000|Overall Study|Other reasons for premature termination|1
6932574|NCT00881894|10965427|FG001|Overall Study|Other reasons for premature termination|2
6932575|NCT00881959|10965435|FG000|Overall Study|Lost to Follow-up|2
6932576|NCT00881959|10965436|FG001|Overall Study|Lost to Follow-up|4
6932577|NCT00882115|10965446|FG000|Overall Study|Withdrawal by Subject|3
6932578|NCT00882115|10965446|FG000|Overall Study|did not respond to DEP challe|6
6932579|NCT00882362|10965457|FG000|Overall Study|Adverse Event|13
6932580|NCT00882362|10965458|FG001|Overall Study|Adverse Event|10
6932581|NCT00882362|10965457|FG000|Overall Study|Withdrawal by Subject|13
6932582|NCT00882362|10965458|FG001|Overall Study|Withdrawal by Subject|10
6932583|NCT00882362|10965457|FG000|Overall Study|Lack of Efficacy|3
6932584|NCT00882362|10965458|FG001|Overall Study|Lack of Efficacy|0
6932585|NCT00882362|10965457|FG000|Overall Study|Protocol Violation|7
6932586|NCT00882362|10965458|FG001|Overall Study|Protocol Violation|2
6932587|NCT00882362|10965457|FG000|Overall Study|Pregnancy|1
6932588|NCT00882362|10965458|FG001|Overall Study|Pregnancy|0
6932589|NCT00882362|10965457|FG000|Overall Study|Physician Decision|5
6932590|NCT00882362|10965458|FG001|Overall Study|Physician Decision|1
6932591|NCT00882362|10965457|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2
6932592|NCT00882362|10965458|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
6932593|NCT00882362|10965457|FG000|Overall Study|change of residence or other commitments|5
6932594|NCT00882362|10965458|FG001|Overall Study|change of residence or other commitments|0
6932595|NCT00882518|10965466|FG000|Overall Study|Adverse Event|9
6932596|NCT00882518|10965467|FG001|Overall Study|Adverse Event|18
6932597|NCT00882518|10965466|FG000|Overall Study|Withdrawal by Subject|9
6932598|NCT00882518|10965467|FG001|Overall Study|Withdrawal by Subject|13
6932599|NCT00882518|10965466|FG000|Overall Study|Lack of Efficacy|12
6932600|NCT00882518|10965467|FG001|Overall Study|Lack of Efficacy|9
6932601|NCT00882518|10965466|FG000|Overall Study|Severe non-compliance to protocol|3
6932602|NCT00882518|10965467|FG001|Overall Study|Severe non-compliance to protocol|1
6932603|NCT00882518|10965466|FG000|Overall Study|Incorrect enrolment|4
6932604|NCT00882518|10965467|FG001|Overall Study|Incorrect enrolment|2
6932605|NCT00882518|10965466|FG000|Overall Study|Central lab closure for National day|1
6932606|NCT00882518|10965467|FG001|Overall Study|Central lab closure for National day|0
6932607|NCT00882518|10965466|FG000|Overall Study|Allocating random number by mistake|0
6932608|NCT00882518|10965467|FG001|Overall Study|Allocating random number by mistake|1
6932609|NCT00882557|10965475|FG000|Overall Study|Withdrawal by Subject|1
6932610|NCT00882557|10965476|FG001|Overall Study|Withdrawal by Subject|0
7039807|NCT01713582|11122649|FG017|Overall Study|Adverse event-related|0
7039808|NCT01713582|11122650|FG018|Overall Study|Adverse event-related|1
6932611|NCT00882557|10965475|FG000|Overall Study|Trouble with Vein Access|1
6932612|NCT00882557|10965476|FG001|Overall Study|Trouble with Vein Access|0
7039809|NCT01713582|11122651|FG019|Overall Study|Adverse event-related|0
6932613|NCT00882557|10965475|FG000|Overall Study|Randomized Not Treated|0
6932614|NCT00882557|10965476|FG001|Overall Study|Randomized Not Treated|1
6932615|NCT00882583|10965484|FG000|Overall Study|Physician Decision|1
6932616|NCT00882583|10965485|FG001|Overall Study|Physician Decision|0
6932617|NCT00882583|10965484|FG000|Overall Study|Adverse Event|0
6932618|NCT00882583|10965485|FG001|Overall Study|Adverse Event|1
6932619|NCT00882713|10965520|FG000|Overall Study|Adverse Event|2
6932620|NCT00882713|10965520|FG000|Overall Study|Death|3
6932621|NCT00882713|10965520|FG000|Overall Study|Administrative reasons|4
6932622|NCT00882713|10965520|FG000|Overall Study|refused treatment/withdrew consent|4
6932623|NCT00882713|10965520|FG000|Overall Study|Blood transfusion|2
6932624|NCT00882713|10965520|FG000|Overall Study|Insufficient therapeutic response|3
6932625|NCT00882713|10965520|FG000|Overall Study|Failure to return|2
6932626|NCT00882713|10965520|FG000|Overall Study|Other - Reasons|2
6932627|NCT00882908|10965534|FG000|Overall Study|Adverse Event|0
6932628|NCT00882908|10965535|FG001|Overall Study|Adverse Event|0
6932629|NCT00882908|10965536|FG002|Overall Study|Adverse Event|1
6932630|NCT00882908|10965537|FG003|Overall Study|Adverse Event|0
6932631|NCT00882908|10965538|FG004|Overall Study|Adverse Event|1
6932632|NCT00882908|10965534|FG000|Overall Study|Lost to Follow-up|3
6932633|NCT00882908|10965535|FG001|Overall Study|Lost to Follow-up|5
6932634|NCT00882908|10965536|FG002|Overall Study|Lost to Follow-up|3
6932635|NCT00882908|10965537|FG003|Overall Study|Lost to Follow-up|1
6932636|NCT00882908|10965538|FG004|Overall Study|Lost to Follow-up|2
6932637|NCT00882908|10965534|FG000|Overall Study|Protocol Violation|0
6932638|NCT00882908|10965535|FG001|Overall Study|Protocol Violation|1
6932639|NCT00882908|10965536|FG002|Overall Study|Protocol Violation|0
6932640|NCT00882908|10965537|FG003|Overall Study|Protocol Violation|0
6932641|NCT00882908|10965538|FG004|Overall Study|Protocol Violation|0
6932642|NCT00882908|10965534|FG000|Overall Study|Withdrawal by Subject|0
6932643|NCT00882908|10965535|FG001|Overall Study|Withdrawal by Subject|0
6932644|NCT00882908|10965536|FG002|Overall Study|Withdrawal by Subject|3
6932645|NCT00882908|10965537|FG003|Overall Study|Withdrawal by Subject|5
6932646|NCT00882908|10965538|FG004|Overall Study|Withdrawal by Subject|2
6932647|NCT00882908|10965534|FG000|Overall Study|Subject reached a virologic endpoint|0
6932648|NCT00882908|10965535|FG001|Overall Study|Subject reached a virologic endpoint|0
6932649|NCT00882908|10965536|FG002|Overall Study|Subject reached a virologic endpoint|0
6932650|NCT00882908|10965537|FG003|Overall Study|Subject reached a virologic endpoint|0
6932651|NCT00882908|10965538|FG004|Overall Study|Subject reached a virologic endpoint|1
6932652|NCT00882908|10965534|FG000|Overall Study|Study terminated in error|0
6932653|NCT00882908|10965535|FG001|Overall Study|Study terminated in error|0
6932654|NCT00882908|10965536|FG002|Overall Study|Study terminated in error|0
6932655|NCT00882908|10965537|FG003|Overall Study|Study terminated in error|1
6932656|NCT00882908|10965538|FG004|Overall Study|Study terminated in error|0
6932657|NCT00882921|10965551|FG000|Overall Study|Death|2
7039810|NCT01713582|11122652|FG020|Overall Study|Adverse event-related|0
7039811|NCT01713582|11122632|FG000|Overall Study|Adverse event-unrelated|0
7039812|NCT01713582|11122633|FG001|Overall Study|Adverse event-unrelated|0
7039813|NCT01713582|11122634|FG002|Overall Study|Adverse event-unrelated|0
7039814|NCT01713582|11122635|FG003|Overall Study|Adverse event-unrelated|0
7039815|NCT01713582|11122636|FG004|Overall Study|Adverse event-unrelated|0
7039816|NCT01713582|11122637|FG005|Overall Study|Adverse event-unrelated|1
7039817|NCT01713582|11122638|FG006|Overall Study|Adverse event-unrelated|1
7039818|NCT01713582|11122639|FG007|Overall Study|Adverse event-unrelated|1
6932658|NCT00882921|10965551|FG000|Overall Study|Other|3
6932659|NCT00882921|10965551|FG000|Overall Study|Lost to Follow-up|2
6932660|NCT00882921|10965551|FG000|Overall Study|Termination By Investigator|3
6932661|NCT00882921|10965551|FG000|Overall Study|Withdrawal Of Consent|1
6932662|NCT00882999|10965563|FG000|Overall Study|Adverse Event|0
6932663|NCT00882999|10965564|FG001|Overall Study|Adverse Event|0
6932664|NCT00882999|10965565|FG002|Overall Study|Adverse Event|0
6932665|NCT00882999|10965566|FG003|Overall Study|Adverse Event|0
6932666|NCT00882999|10965567|FG004|Overall Study|Adverse Event|1
6932667|NCT00882999|10965568|FG005|Overall Study|Adverse Event|0
6932668|NCT00882999|10965569|FG006|Overall Study|Adverse Event|0
6932669|NCT00882999|10965563|FG000|Overall Study|Death|0
6932670|NCT00882999|10965564|FG001|Overall Study|Death|1
6932671|NCT00882999|10965565|FG002|Overall Study|Death|0
6932672|NCT00882999|10965566|FG003|Overall Study|Death|0
6932673|NCT00882999|10965567|FG004|Overall Study|Death|0
7039819|NCT01713582|11122640|FG008|Overall Study|Adverse event-unrelated|0
7039820|NCT01713582|11122641|FG009|Overall Study|Adverse event-unrelated|0
7039821|NCT01713582|11122642|FG010|Overall Study|Adverse event-unrelated|0
6932674|NCT00882999|10965568|FG005|Overall Study|Death|0
6932675|NCT00882999|10965569|FG006|Overall Study|Death|0
6932676|NCT00882999|10965563|FG000|Overall Study|Withdrawal by Subject|7
6932677|NCT00882999|10965564|FG001|Overall Study|Withdrawal by Subject|6
6932678|NCT00882999|10965565|FG002|Overall Study|Withdrawal by Subject|3
6932679|NCT00882999|10965566|FG003|Overall Study|Withdrawal by Subject|3
6932680|NCT00882999|10965567|FG004|Overall Study|Withdrawal by Subject|6
6932681|NCT00882999|10965568|FG005|Overall Study|Withdrawal by Subject|5
6932682|NCT00882999|10965569|FG006|Overall Study|Withdrawal by Subject|5
6932683|NCT00882999|10965563|FG000|Overall Study|Lost to Follow-up|0
6932684|NCT00882999|10965564|FG001|Overall Study|Lost to Follow-up|1
6932685|NCT00882999|10965565|FG002|Overall Study|Lost to Follow-up|1
6932686|NCT00882999|10965566|FG003|Overall Study|Lost to Follow-up|2
6932687|NCT00882999|10965567|FG004|Overall Study|Lost to Follow-up|1
6932688|NCT00882999|10965568|FG005|Overall Study|Lost to Follow-up|1
6932689|NCT00882999|10965569|FG006|Overall Study|Lost to Follow-up|2
6932690|NCT00882999|10965563|FG000|Overall Study|Physician Decision|1
6932691|NCT00882999|10965564|FG001|Overall Study|Physician Decision|0
6932692|NCT00882999|10965565|FG002|Overall Study|Physician Decision|0
6932693|NCT00882999|10965566|FG003|Overall Study|Physician Decision|0
6932694|NCT00882999|10965567|FG004|Overall Study|Physician Decision|0
6932695|NCT00882999|10965568|FG005|Overall Study|Physician Decision|1
6932696|NCT00882999|10965569|FG006|Overall Study|Physician Decision|1
6932697|NCT00883051|10965597|FG000|Overall Study|Lost to Follow-up|0
6932698|NCT00883051|10965598|FG001|Overall Study|Lost to Follow-up|0
6932699|NCT00883051|10965599|FG002|Overall Study|Lost to Follow-up|0
6932700|NCT00883051|10965600|FG003|Overall Study|Lost to Follow-up|0
6932701|NCT00883051|10965601|FG004|Overall Study|Lost to Follow-up|1
6932702|NCT00883051|10965597|FG000|Overall Study|Did not use study medication|24
6932703|NCT00883051|10965598|FG001|Overall Study|Did not use study medication|22
6932704|NCT00883051|10965599|FG002|Overall Study|Did not use study medication|29
6932705|NCT00883051|10965600|FG003|Overall Study|Did not use study medication|29
6932706|NCT00883051|10965601|FG004|Overall Study|Did not use study medication|17
6932707|NCT00883090|10965613|FG000|Overall Study|Sponsor's decision|1
6932708|NCT00883090|10965613|FG000|Overall Study|Withdrawal by Subject|1
6932709|NCT00883116|10965628|FG000|Overall Study|Adverse event unrelated to study drug|5
6932710|NCT00883116|10965629|FG001|Overall Study|Adverse event unrelated to study drug|10
6932711|NCT00883116|10965628|FG000|Overall Study|Death|6
6932712|NCT00883116|10965629|FG001|Overall Study|Death|2
6932713|NCT00883116|10965628|FG000|Overall Study|Disease progression|130
6932714|NCT00883116|10965629|FG001|Overall Study|Disease progression|128
6932715|NCT00883116|10965628|FG000|Overall Study|Lost to Follow-up|0
6932716|NCT00883116|10965629|FG001|Overall Study|Lost to Follow-up|1
6932717|NCT00883116|10965628|FG000|Overall Study|Maximum clinical benefit|13
6932718|NCT00883116|10965629|FG001|Overall Study|Maximum clinical benefit|46
6932719|NCT00883116|10965628|FG000|Overall Study|Not identified|3
6932720|NCT00883116|10965629|FG001|Overall Study|Not identified|6
6932721|NCT00883116|10965628|FG000|Overall Study|Study drug toxicity|36
6932722|NCT00883116|10965629|FG001|Overall Study|Study drug toxicity|16
6932723|NCT00883116|10965628|FG000|Overall Study|Withdrawal by Subject|14
6932724|NCT00883116|10965629|FG001|Overall Study|Withdrawal by Subject|8
6932725|NCT00883116|10965628|FG000|Overall Study|No longer meets study criteria|2
6932726|NCT00883116|10965629|FG001|Overall Study|No longer meets study criteria|2
6932727|NCT00883129|10965639|FG000|Overall Study|Adverse Event|7
6932728|NCT00883129|10965640|FG001|Overall Study|Adverse Event|15
6932729|NCT00883129|10965639|FG000|Overall Study|Withdrawal by Subject|8
6932730|NCT00883129|10965640|FG001|Overall Study|Withdrawal by Subject|9
6932731|NCT00883129|10965639|FG000|Overall Study|Non-compliance|3
6932732|NCT00883129|10965640|FG001|Overall Study|Non-compliance|6
6932733|NCT00883129|10965639|FG000|Overall Study|Lost to Follow-up|1
6932734|NCT00883129|10965640|FG001|Overall Study|Lost to Follow-up|2
6932735|NCT00883129|10965639|FG000|Overall Study|Death|1
6932736|NCT00883129|10965640|FG001|Overall Study|Death|2
6932737|NCT00883129|10965639|FG000|Overall Study|Defined Treatment Failure|0
6932738|NCT00883129|10965640|FG001|Overall Study|Defined Treatment Failure|2
6932739|NCT00883181|10965663|FG000|Overall Study|Hematological Adverse Event|26
6932740|NCT00883181|10965663|FG000|Overall Study|Non-hematological Adverse Event|55
6932741|NCT00883181|10965663|FG000|Overall Study|Disease Progression|94
6932742|NCT00883181|10965663|FG000|Overall Study|Administrative Reason|24
6932743|NCT00883181|10965663|FG000|Overall Study|Withdrawal by Subject|4
6932744|NCT00883181|10965663|FG000|Overall Study|Death|31
6932745|NCT00883181|10965663|FG000|Overall Study|Other|38
6932746|NCT00883181|10965663|FG000|Overall Study|Protocol Deviation|3
6932747|NCT00883181|10965663|FG000|Overall Study|Noncompliance|3
6975192|NCT01191268|11027202|FG002|Overall Study|Adverse Event|8
6975193|NCT01191268|11027200|FG000|Overall Study|Physician Decision|6
6975194|NCT01191268|11027201|FG001|Overall Study|Physician Decision|8
6975195|NCT01191268|11027202|FG002|Overall Study|Physician Decision|9
6975196|NCT01191268|11027200|FG000|Overall Study|Lost to Follow-up|8
6975197|NCT01191268|11027201|FG001|Overall Study|Lost to Follow-up|5
6975198|NCT01191268|11027202|FG002|Overall Study|Lost to Follow-up|9
6975199|NCT01191268|11027200|FG000|Overall Study|Entry Criteria Not Met|3
6975200|NCT01191268|11027201|FG001|Overall Study|Entry Criteria Not Met|1
6975201|NCT01191268|11027202|FG002|Overall Study|Entry Criteria Not Met|1
6975202|NCT01191268|11027200|FG000|Overall Study|Death|0
6975203|NCT01191268|11027201|FG001|Overall Study|Death|1
6975204|NCT01191268|11027202|FG002|Overall Study|Death|3
6975205|NCT01191268|11027200|FG000|Overall Study|Protocol Violation|1
6975206|NCT01191268|11027201|FG001|Overall Study|Protocol Violation|0
6975207|NCT01191268|11027202|FG002|Overall Study|Protocol Violation|1
6975208|NCT01191268|11027200|FG000|Overall Study|Sponsor Decision|0
6975209|NCT01191268|11027201|FG001|Overall Study|Sponsor Decision|2
6975210|NCT01191268|11027202|FG002|Overall Study|Sponsor Decision|0
6975211|NCT01191762|11027342|FG000|Overall Study|Adverse Event|1
6975212|NCT01191762|11027343|FG001|Overall Study|Adverse Event|0
6975213|NCT01191788|11027351|FG000|Overall Study|Lost to Follow-up|21
6975214|NCT01191788|11027352|FG001|Overall Study|Lost to Follow-up|22
6932748|NCT00883337|10965710|FG000|Core Treatment Period|Adverse Event|9
6932749|NCT00883337|10965711|FG001|Core Treatment Period|Adverse Event|12
6932750|NCT00883337|10965712|FG002|Core Treatment Period|Adverse Event|22
6932751|NCT00883337|10965710|FG000|Core Treatment Period|Lack of Efficacy|7
6932752|NCT00883337|10965711|FG001|Core Treatment Period|Lack of Efficacy|4
6932753|NCT00883337|10965712|FG002|Core Treatment Period|Lack of Efficacy|2
6932754|NCT00883337|10965710|FG000|Core Treatment Period|Lost to Follow-up|1
7039822|NCT01713582|11122643|FG011|Overall Study|Adverse event-unrelated|0
7039823|NCT01713582|11122644|FG012|Overall Study|Adverse event-unrelated|0
7039824|NCT01713582|11122645|FG013|Overall Study|Adverse event-unrelated|1
7039825|NCT01713582|11122646|FG014|Overall Study|Adverse event-unrelated|1
7039826|NCT01713582|11122647|FG015|Overall Study|Adverse event-unrelated|0
7039827|NCT01713582|11122648|FG016|Overall Study|Adverse event-unrelated|0
7039828|NCT01713582|11122649|FG017|Overall Study|Adverse event-unrelated|0
7039829|NCT01713582|11122650|FG018|Overall Study|Adverse event-unrelated|0
7039830|NCT01713582|11122651|FG019|Overall Study|Adverse event-unrelated|0
7039831|NCT01713582|11122652|FG020|Overall Study|Adverse event-unrelated|0
7039832|NCT01713582|11122632|FG000|Overall Study|Withdrawal of consent|0
7039833|NCT01713582|11122633|FG001|Overall Study|Withdrawal of consent|0
7039834|NCT01713582|11122634|FG002|Overall Study|Withdrawal of consent|1
7039835|NCT01713582|11122635|FG003|Overall Study|Withdrawal of consent|0
7039836|NCT01713582|11122636|FG004|Overall Study|Withdrawal of consent|0
7039837|NCT01713582|11122637|FG005|Overall Study|Withdrawal of consent|1
7039838|NCT01713582|11122638|FG006|Overall Study|Withdrawal of consent|0
7039839|NCT01713582|11122639|FG007|Overall Study|Withdrawal of consent|0
7039840|NCT01713582|11122640|FG008|Overall Study|Withdrawal of consent|0
7039841|NCT01713582|11122641|FG009|Overall Study|Withdrawal of consent|1
6932755|NCT00883337|10965711|FG001|Core Treatment Period|Lost to Follow-up|1
6932756|NCT00883337|10965712|FG002|Core Treatment Period|Lost to Follow-up|0
6932757|NCT00883337|10965710|FG000|Core Treatment Period|Withdrawal by Subject|2
6932758|NCT00883337|10965711|FG001|Core Treatment Period|Withdrawal by Subject|2
6932759|NCT00883337|10965712|FG002|Core Treatment Period|Withdrawal by Subject|6
6932760|NCT00883337|10965710|FG000|Core Treatment Period|Wish to be pregnant|1
6932761|NCT00883337|10965711|FG001|Core Treatment Period|Wish to be pregnant|2
6932762|NCT00883337|10965712|FG002|Core Treatment Period|Wish to be pregnant|1
6932763|NCT00883337|10965710|FG000|Core Treatment Period|Poor compliance to protocol|0
6932764|NCT00883337|10965711|FG001|Core Treatment Period|Poor compliance to protocol|0
6932765|NCT00883337|10965712|FG002|Core Treatment Period|Poor compliance to protocol|1
6932766|NCT00883337|10965710|FG000|Core Treatment Period|Other than above|0
6932767|NCT00883337|10965711|FG001|Core Treatment Period|Other than above|1
6932768|NCT00883337|10965712|FG002|Core Treatment Period|Other than above|1
6932769|NCT00883337|10965710|FG000|Extension Treatment Period|Adverse Event|8
6932770|NCT00883337|10965711|FG001|Extension Treatment Period|Adverse Event|5
6932771|NCT00883337|10965712|FG002|Extension Treatment Period|Adverse Event|5
6932772|NCT00883337|10965710|FG000|Extension Treatment Period|Lack of Efficacy|8
6932773|NCT00883337|10965711|FG001|Extension Treatment Period|Lack of Efficacy|8
6932774|NCT00883337|10965712|FG002|Extension Treatment Period|Lack of Efficacy|8
6932775|NCT00883337|10965710|FG000|Extension Treatment Period|Poor compliance to protocol|1
6932776|NCT00883337|10965711|FG001|Extension Treatment Period|Poor compliance to protocol|1
6932777|NCT00883337|10965712|FG002|Extension Treatment Period|Poor compliance to protocol|1
6932778|NCT00883337|10965710|FG000|Extension Treatment Period|Lost to Follow-up|1
6932779|NCT00883337|10965711|FG001|Extension Treatment Period|Lost to Follow-up|0
6932780|NCT00883337|10965712|FG002|Extension Treatment Period|Lost to Follow-up|0
6932781|NCT00883337|10965710|FG000|Extension Treatment Period|Other than above|10
6932782|NCT00883337|10965711|FG001|Extension Treatment Period|Other than above|9
6932783|NCT00883337|10965712|FG002|Extension Treatment Period|Other than above|5
6932784|NCT00883493|10965736|FG000|Overall Study|Adverse Event|11
6932785|NCT00883493|10965737|FG001|Overall Study|Adverse Event|12
6932786|NCT00883493|10965736|FG000|Overall Study|Lack of Efficacy|4
6932787|NCT00883493|10965737|FG001|Overall Study|Lack of Efficacy|3
6932788|NCT00883493|10965736|FG000|Overall Study|Lost to Follow-up|7
6932789|NCT00883493|10965737|FG001|Overall Study|Lost to Follow-up|6
6932790|NCT00883493|10965736|FG000|Overall Study|Withdrawal by Subject|11
6932791|NCT00883493|10965737|FG001|Overall Study|Withdrawal by Subject|20
6932792|NCT00883493|10965736|FG000|Overall Study|Eligibility Criteria not fullfilled|6
6932793|NCT00883493|10965737|FG001|Overall Study|Eligibility Criteria not fullfilled|6
6932794|NCT00883493|10965736|FG000|Overall Study|Study specific disc. criteria|2
7039842|NCT01713582|11122642|FG010|Overall Study|Withdrawal of consent|0
7039843|NCT01713582|11122643|FG011|Overall Study|Withdrawal of consent|0
7039844|NCT01713582|11122644|FG012|Overall Study|Withdrawal of consent|0
7039845|NCT01713582|11122645|FG013|Overall Study|Withdrawal of consent|0
7039846|NCT01713582|11122646|FG014|Overall Study|Withdrawal of consent|0
6932795|NCT00883493|10965737|FG001|Overall Study|Study specific disc. criteria|0
6932796|NCT00883493|10965736|FG000|Overall Study|Other|5
6932797|NCT00883493|10965737|FG001|Overall Study|Other|3
6932798|NCT00883558|10965743|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2
6932799|NCT00883558|10965744|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
6932800|NCT00883558|10965745|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
6932801|NCT00883558|10965743|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
6932802|NCT00883558|10965744|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1
6932803|NCT00883558|10965745|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
6932804|NCT00883558|10965743|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0
6932805|NCT00883558|10965744|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
6932806|NCT00883558|10965745|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
6932807|NCT00883558|10965743|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
6932808|NCT00883558|10965744|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1
6932809|NCT00883558|10965745|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
6932810|NCT00883558|10965743|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
6932811|NCT00883558|10965744|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
6932812|NCT00883558|10965745|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1
6932813|NCT00883688|10965755|FG000|Overall Study|Ineligible|2
6932814|NCT00883740|10965759|FG000|First Intervention|Lost to Follow-up|1
6932815|NCT00883740|10965760|FG001|First Intervention|Lost to Follow-up|0
6932816|NCT00883740|10965759|FG000|First Intervention|No longer willing to participate|2
6932817|NCT00883740|10965760|FG001|First Intervention|No longer willing to participate|0
6932818|NCT00883740|10965759|FG000|First Intervention|Protocol Violation|3
6932819|NCT00883740|10965760|FG001|First Intervention|Protocol Violation|6
6932820|NCT00883740|10965759|FG000|First Intervention|Adverse Event|1
6932821|NCT00883740|10965760|FG001|First Intervention|Adverse Event|2
6932822|NCT00883740|10965759|FG000|Second Intervention|Protocol Violation|1
6932823|NCT00883740|10965760|FG001|Second Intervention|Protocol Violation|0
6932824|NCT00883740|10965759|FG000|Second Intervention|No longer willing to participate|0
6932825|NCT00883740|10965760|FG001|Second Intervention|No longer willing to participate|1
6932826|NCT00883753|10965766|FG000|Overall Study|Adverse Event|37
6932827|NCT00883753|10965766|FG000|Overall Study|Death|2
6932828|NCT00883753|10965766|FG000|Overall Study|Insufficient therapeutic response|16
6932829|NCT00883753|10965766|FG000|Overall Study|Lost to Follow-up|4
6932830|NCT00883753|10965766|FG000|Overall Study|Violation of selection criteria at entry|7
6932831|NCT00883753|10965766|FG000|Overall Study|Protocol Violation|2
6932832|NCT00883753|10965766|FG000|Overall Study|Refused treatment|4
6932833|NCT00883753|10965766|FG000|Overall Study|Withdrew consent|10
6932834|NCT00883753|10965766|FG000|Overall Study|Investigator's decision|17
6932835|NCT00883753|10965766|FG000|Overall Study|Administrative/Other|8
6932836|NCT00883779|10965775|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4
6932837|NCT00883779|10965776|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4
7039847|NCT01713582|11122647|FG015|Overall Study|Withdrawal of consent|0
7039848|NCT01713582|11122648|FG016|Overall Study|Withdrawal of consent|0
7039849|NCT01713582|11122649|FG017|Overall Study|Withdrawal of consent|0
7039850|NCT01713582|11122650|FG018|Overall Study|Withdrawal of consent|1
7039851|NCT01713582|11122651|FG019|Overall Study|Withdrawal of consent|0
7039852|NCT01713582|11122652|FG020|Overall Study|Withdrawal of consent|0
7039853|NCT01713582|11122632|FG000|Overall Study|Lack of Efficacy|0
7039854|NCT01713582|11122633|FG001|Overall Study|Lack of Efficacy|0
7039855|NCT01713582|11122634|FG002|Overall Study|Lack of Efficacy|0
7039856|NCT01713582|11122635|FG003|Overall Study|Lack of Efficacy|0
7039857|NCT01713582|11122636|FG004|Overall Study|Lack of Efficacy|0
7039858|NCT01713582|11122637|FG005|Overall Study|Lack of Efficacy|0
7039859|NCT01713582|11122638|FG006|Overall Study|Lack of Efficacy|0
7039860|NCT01713582|11122639|FG007|Overall Study|Lack of Efficacy|0
7039861|NCT01713582|11122640|FG008|Overall Study|Lack of Efficacy|0
7039862|NCT01713582|11122641|FG009|Overall Study|Lack of Efficacy|1
7039863|NCT01713582|11122642|FG010|Overall Study|Lack of Efficacy|2
7039864|NCT01713582|11122643|FG011|Overall Study|Lack of Efficacy|0
7039865|NCT01713582|11122644|FG012|Overall Study|Lack of Efficacy|0
7039866|NCT01713582|11122645|FG013|Overall Study|Lack of Efficacy|0
7039867|NCT01713582|11122646|FG014|Overall Study|Lack of Efficacy|0
7039868|NCT01713582|11122647|FG015|Overall Study|Lack of Efficacy|0
7039869|NCT01713582|11122648|FG016|Overall Study|Lack of Efficacy|0
7039870|NCT01713582|11122649|FG017|Overall Study|Lack of Efficacy|0
7039871|NCT01713582|11122650|FG018|Overall Study|Lack of Efficacy|0
7039872|NCT01713582|11122651|FG019|Overall Study|Lack of Efficacy|0
7039873|NCT01713582|11122652|FG020|Overall Study|Lack of Efficacy|0
7039874|NCT01713582|11122632|FG000|Overall Study|Withdrawal by Subject|0
7039875|NCT01713582|11122633|FG001|Overall Study|Withdrawal by Subject|0
7039876|NCT01713582|11122634|FG002|Overall Study|Withdrawal by Subject|0
7039877|NCT01713582|11122635|FG003|Overall Study|Withdrawal by Subject|0
7039878|NCT01713582|11122636|FG004|Overall Study|Withdrawal by Subject|0
7039879|NCT01713582|11122637|FG005|Overall Study|Withdrawal by Subject|0
6932838|NCT00883779|10965775|FG000|Primary Study Treatment Phase|Disease progression|75
7039880|NCT01713582|11122638|FG006|Overall Study|Withdrawal by Subject|0
7039881|NCT01713582|11122639|FG007|Overall Study|Withdrawal by Subject|0
7039882|NCT01713582|11122640|FG008|Overall Study|Withdrawal by Subject|0
7039883|NCT01713582|11122641|FG009|Overall Study|Withdrawal by Subject|0
7039884|NCT01713582|11122642|FG010|Overall Study|Withdrawal by Subject|0
6932839|NCT00883779|10965776|FG001|Primary Study Treatment Phase|Disease progression|59
6932840|NCT00883779|10965775|FG000|Primary Study Treatment Phase|Adverse Event|16
7039885|NCT01713582|11122643|FG011|Overall Study|Withdrawal by Subject|0
7039886|NCT01713582|11122644|FG012|Overall Study|Withdrawal by Subject|0
6932841|NCT00883779|10965776|FG001|Primary Study Treatment Phase|Adverse Event|16
6932842|NCT00883779|10965775|FG000|Primary Study Treatment Phase|Death|2
6932843|NCT00883779|10965776|FG001|Primary Study Treatment Phase|Death|3
6932844|NCT00883779|10965775|FG000|Primary Study Treatment Phase|Refused Treatment|5
6932845|NCT00883779|10965776|FG001|Primary Study Treatment Phase|Refused Treatment|4
6932846|NCT00883779|10965775|FG000|Primary Study Treatment Phase|Other|3
6932847|NCT00883779|10965776|FG001|Primary Study Treatment Phase|Other|0
6932848|NCT00883779|10965775|FG000|Post-Study Treatment Phase|Adverse Event|2
6932849|NCT00883779|10965776|FG001|Post-Study Treatment Phase|Adverse Event|3
6932850|NCT00883779|10965775|FG000|Post-Study Treatment Phase|Death|1
6932851|NCT00883779|10965776|FG001|Post-Study Treatment Phase|Death|3
6932852|NCT00883779|10965775|FG000|Post-Study Treatment Phase|Protocol Violation|0
6932853|NCT00883779|10965776|FG001|Post-Study Treatment Phase|Protocol Violation|1
6932854|NCT00883779|10965775|FG000|Post-Study Treatment Phase|Refused Treatment|3
6932855|NCT00883779|10965776|FG001|Post-Study Treatment Phase|Refused Treatment|0
6932856|NCT00883779|10965775|FG000|Post-Study Treatment Phase|Disease progression|103
6932857|NCT00883779|10965776|FG001|Post-Study Treatment Phase|Disease progression|122
6932858|NCT00883779|10965775|FG000|Post-Study Treatment Phase|Other|3
6932859|NCT00883779|10965776|FG001|Post-Study Treatment Phase|Other|0
6932860|NCT00883779|10965775|FG000|Post-Study Treatment Phase|Ongoing in the study|0
6932861|NCT00883779|10965776|FG001|Post-Study Treatment Phase|Ongoing in the study|6
6932862|NCT00883779|10965775|FG000|Off-study Phase|Death|185
6932863|NCT00883779|10965776|FG001|Off-study Phase|Death|174
6932864|NCT00883779|10965775|FG000|Off-study Phase|Refused treatment|1
6932865|NCT00883779|10965776|FG001|Off-study Phase|Refused treatment|1
6932866|NCT00883779|10965775|FG000|Off-study Phase|Failure to return|5
6932867|NCT00883779|10965776|FG001|Off-study Phase|Failure to return|6
6932868|NCT00883779|10965775|FG000|Off-study Phase|Other|18
6932869|NCT00883779|10965776|FG001|Off-study Phase|Other|21
6932870|NCT00884039|10965784|FG000|Overall Study|Withdrawal by Subject|0
6932871|NCT00884039|10965785|FG001|Overall Study|Withdrawal by Subject|1
6932872|NCT00884039|10965784|FG000|Overall Study|Lack of Efficacy|2
6932873|NCT00884039|10965785|FG001|Overall Study|Lack of Efficacy|0
6932874|NCT00884117|10965807|FG000|Overall Study|Adverse Event|2
6932875|NCT00884117|10965807|FG000|Overall Study|Withdrawal by Subject|89
6932876|NCT00884117|10965807|FG000|Overall Study|Death|3
6932877|NCT00884117|10965807|FG000|Overall Study|Lost to Follow-up|143
6932878|NCT00884117|10965807|FG000|Overall Study|Other|12
6932879|NCT00884221|10965826|FG000|Overall Study|Withdrawal by Subject|0
6932880|NCT00884221|10965827|FG001|Overall Study|Withdrawal by Subject|3
6932881|NCT00884221|10965826|FG000|Overall Study|Adverse Event|6
6932882|NCT00884221|10965827|FG001|Overall Study|Adverse Event|3
6932883|NCT00884221|10965826|FG000|Overall Study|Protocol Violation|16
6932884|NCT00884221|10965827|FG001|Overall Study|Protocol Violation|13
6932885|NCT00884221|10965826|FG000|Overall Study|Cancellation of Cycle and Other Reason|12
6932886|NCT00884221|10965827|FG001|Overall Study|Cancellation of Cycle and Other Reason|13
6932887|NCT00884273|10965837|FG000|Overall Study|Adverse Event|0
6932888|NCT00884273|10965838|FG001|Overall Study|Adverse Event|2
6932889|NCT00884273|10965837|FG000|Overall Study|Protocol Violation|1
6932890|NCT00884273|10965838|FG001|Overall Study|Protocol Violation|3
6932891|NCT00884273|10965837|FG000|Overall Study|Practical reasons|1
6932892|NCT00884273|10965838|FG001|Overall Study|Practical reasons|0
6932893|NCT00884286|10965846|FG000|Overall Study|Progressive disease|21
6932894|NCT00884286|10965847|FG001|Overall Study|Progressive disease|28
6932895|NCT00884286|10965846|FG000|Overall Study|Toxicity|4
6932896|NCT00884286|10965847|FG001|Overall Study|Toxicity|1
6932897|NCT00884286|10965846|FG000|Overall Study|Death|2
6932898|NCT00884286|10965847|FG001|Overall Study|Death|2
6932899|NCT00884286|10965846|FG000|Overall Study|Physician Decision|1
6932900|NCT00884286|10965847|FG001|Overall Study|Physician Decision|0
6932901|NCT00884286|10965846|FG000|Overall Study|Septic shock|1
6932902|NCT00884286|10965847|FG001|Overall Study|Septic shock|0
6932903|NCT00884286|10965846|FG000|Overall Study|Thrombus in right auricle|1
6932904|NCT00884286|10965847|FG001|Overall Study|Thrombus in right auricle|0
6932905|NCT00884286|10965846|FG000|Overall Study|Not treated|2
6932906|NCT00884286|10965847|FG001|Overall Study|Not treated|1
6932907|NCT00884286|10965846|FG000|Overall Study|Comprised lung carcinoma|0
6932908|NCT00884286|10965847|FG001|Overall Study|Comprised lung carcinoma|1
6932909|NCT00884312|10965856|FG000|Overall Study|Non-fatal Progressive Disease|0
6932910|NCT00884312|10965857|FG001|Overall Study|Non-fatal Progressive Disease|8
6932911|NCT00884312|10965856|FG000|Overall Study|Fatal Progressive Disease|0
6932912|NCT00884312|10965857|FG001|Overall Study|Fatal Progressive Disease|1
6932913|NCT00884312|10965856|FG000|Overall Study|Non-fatal Adverse Event|1
6932914|NCT00884312|10965857|FG001|Overall Study|Non-fatal Adverse Event|0
6932915|NCT00884312|10965856|FG000|Overall Study|Fatal Adverse Event|1
6932916|NCT00884312|10965857|FG001|Overall Study|Fatal Adverse Event|4
6932917|NCT00884312|10965856|FG000|Overall Study|Withdrawal by Subject|0
6932918|NCT00884312|10965857|FG001|Overall Study|Withdrawal by Subject|6
6932919|NCT00884312|10965856|FG000|Overall Study|Physician Decision|0
6932920|NCT00884312|10965857|FG001|Overall Study|Physician Decision|1
6932921|NCT00884312|10965856|FG000|Overall Study|Other|0
6932922|NCT00884312|10965857|FG001|Overall Study|Other|4
6932923|NCT00884312|10965856|FG000|Overall Study|Did Not Receive Study Drug|0
6932924|NCT00884312|10965857|FG001|Overall Study|Did Not Receive Study Drug|1
6932925|NCT00884325|10965865|FG000|Overall Study|Lost to Follow-up|1
6932926|NCT00884325|10965866|FG001|Overall Study|Lost to Follow-up|2
6932927|NCT00884325|10965865|FG000|Overall Study|Lack of Efficacy|0
6932928|NCT00884325|10965866|FG001|Overall Study|Lack of Efficacy|1
6932929|NCT00884325|10965865|FG000|Overall Study|Withdrawal by Subject|1
6932930|NCT00884325|10965866|FG001|Overall Study|Withdrawal by Subject|1
6932931|NCT00884325|10965865|FG000|Overall Study|Not provided|1
6932932|NCT00884325|10965866|FG001|Overall Study|Not provided|0
6932933|NCT00884377|10965874|FG000|Overall Study|Withdrawal by Subject|1
6932934|NCT00884377|10965875|FG001|Overall Study|Withdrawal by Subject|0
6932935|NCT00884377|10965874|FG000|Overall Study|Could not confirm diagnosis|1
6932936|NCT00884377|10965875|FG001|Overall Study|Could not confirm diagnosis|0
6932937|NCT00884377|10965874|FG000|Overall Study|Physician Decision|0
6932938|NCT00884377|10965875|FG001|Overall Study|Physician Decision|1
6932939|NCT00884390|10965889|FG000|Overall Study|Adverse Event|0
6932940|NCT00884390|10965890|FG001|Overall Study|Adverse Event|1
6932941|NCT00884390|10965889|FG000|Overall Study|Lost to Follow-up|0
6932942|NCT00884390|10965890|FG001|Overall Study|Lost to Follow-up|1
6932943|NCT00884390|10965889|FG000|Overall Study|Physician Decision|2
6932944|NCT00884390|10965890|FG001|Overall Study|Physician Decision|1
6932945|NCT00884390|10965889|FG000|Overall Study|Protocol Violation|4
6932946|NCT00884390|10965890|FG001|Overall Study|Protocol Violation|1
6932947|NCT00884390|10965889|FG000|Overall Study|Withdrawal by Subject|4
6932948|NCT00884390|10965890|FG001|Overall Study|Withdrawal by Subject|1
6932949|NCT00884390|10965889|FG000|Overall Study|Discontinuation of Study by Sponsor|2
6932950|NCT00884390|10965890|FG001|Overall Study|Discontinuation of Study by Sponsor|2
6932951|NCT00884390|10965889|FG000|Overall Study|Other|11
6932952|NCT00884390|10965890|FG001|Overall Study|Other|1
6932953|NCT00884650|10965925|FG000|Overall Study|Did not return complete pain diaries|7
6932954|NCT00884650|10965926|FG001|Overall Study|Did not return complete pain diaries|7
6932955|NCT00884650|10965925|FG000|Overall Study|Admitted Post-Op|1
6932956|NCT00884650|10965926|FG001|Overall Study|Admitted Post-Op|0
6932957|NCT00884650|10965925|FG000|Overall Study|Femoral Stress Fracture|1
6932958|NCT00884650|10965926|FG001|Overall Study|Femoral Stress Fracture|0
6932959|NCT00884650|10965925|FG000|Overall Study|Pain Pump Complication|0
6932960|NCT00884650|10965926|FG001|Overall Study|Pain Pump Complication|1
6932961|NCT00884741|10965936|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157
6932962|NCT00884741|10965937|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0
6932963|NCT00884741|10965938|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0
6932964|NCT00884741|10965939|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0
6932965|NCT00884741|10965936|FG000|Step 1 Registration: Tissue Screening|Death|3
6932966|NCT00884741|10965937|FG001|Step 1 Registration: Tissue Screening|Death|0
6932967|NCT00884741|10965938|FG002|Step 1 Registration: Tissue Screening|Death|0
6932968|NCT00884741|10965939|FG003|Step 1 Registration: Tissue Screening|Death|0
6932969|NCT00884741|10965936|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3
6932970|NCT00884741|10965937|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0
6932971|NCT00884741|10965938|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0
6932972|NCT00884741|10965939|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0
6932973|NCT00884741|10965936|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105
6932974|NCT00884741|10965937|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0
6932975|NCT00884741|10965938|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0
6932976|NCT00884741|10965939|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0
6932977|NCT00884741|10965936|FG000|Step 1 Registration: Tissue Screening|Disease progression|12
6932978|NCT00884741|10965937|FG001|Step 1 Registration: Tissue Screening|Disease progression|0
6932979|NCT00884741|10965938|FG002|Step 1 Registration: Tissue Screening|Disease progression|0
6932980|NCT00884741|10965939|FG003|Step 1 Registration: Tissue Screening|Disease progression|0
6932981|NCT00884741|10965936|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32
6932982|NCT00884741|10965937|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0
6932983|NCT00884741|10965938|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0
6932984|NCT00884741|10965939|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0
6932985|NCT00884741|10965936|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0
6932986|NCT00884741|10965937|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15
6932987|NCT00884741|10965938|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0
6932988|NCT00884741|10965939|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0
6932989|NCT00884741|10965936|FG000|Step 2 Registration: Tissue Analysis|Death|0
6932990|NCT00884741|10965937|FG001|Step 2 Registration: Tissue Analysis|Death|1
6932991|NCT00884741|10965938|FG002|Step 2 Registration: Tissue Analysis|Death|0
6932992|NCT00884741|10965939|FG003|Step 2 Registration: Tissue Analysis|Death|0
6932993|NCT00884741|10965936|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0
6932994|NCT00884741|10965937|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2
6932995|NCT00884741|10965938|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0
6932996|NCT00884741|10965939|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0
6932997|NCT00884741|10965936|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0
6932998|NCT00884741|10965937|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7
6932999|NCT00884741|10965938|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0
6933000|NCT00884741|10965939|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0
6933001|NCT00884741|10965936|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0
6933002|NCT00884741|10965937|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4
6933003|NCT00884741|10965938|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0
6933004|NCT00884741|10965939|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0
6933005|NCT00884741|10965936|FG000|Randomization|Protocol Violation|0
6933006|NCT00884741|10965937|FG001|Randomization|Protocol Violation|0
6933007|NCT00884741|10965938|FG002|Randomization|Protocol Violation|8
6933008|NCT00884741|10965939|FG003|Randomization|Protocol Violation|8
6933009|NCT00884793|10965955|FG000|Overall Study|Withdrawal by Subject|1
6933010|NCT00884832|10965965|FG000|Overall Study|Withdrawal by Subject|0
6933011|NCT00884832|10965966|FG001|Overall Study|Withdrawal by Subject|1
6933012|NCT00884949|10965985|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1
6933013|NCT00884949|10965985|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1
6933014|NCT00885105|10966018|FG000|Overall Study|Withdrawal by Subject|0
6933015|NCT00885105|10966019|FG001|Overall Study|Withdrawal by Subject|8
6933016|NCT00885105|10966018|FG000|Overall Study|Adverse Event|1
6933017|NCT00885105|10966019|FG001|Overall Study|Adverse Event|0
6933018|NCT00885105|10966018|FG000|Overall Study|Protocol Violation|0
6933019|NCT00885105|10966019|FG001|Overall Study|Protocol Violation|2
6933020|NCT00885118|10966030|FG000|Overall Study|Adverse Event|1
6933021|NCT00885118|10966031|FG001|Overall Study|Adverse Event|0
6933022|NCT00885118|10966032|FG002|Overall Study|Adverse Event|0
6933023|NCT00885118|10966033|FG003|Overall Study|Adverse Event|0
6933024|NCT00885118|10966034|FG004|Overall Study|Adverse Event|0
6933025|NCT00885118|10966030|FG000|Overall Study|Withdrawal by Subject|0
6933026|NCT00885118|10966031|FG001|Overall Study|Withdrawal by Subject|0
6933027|NCT00885118|10966032|FG002|Overall Study|Withdrawal by Subject|0
6933028|NCT00885118|10966033|FG003|Overall Study|Withdrawal by Subject|0
6933029|NCT00885118|10966034|FG004|Overall Study|Withdrawal by Subject|1
6933030|NCT00885118|10966030|FG000|Overall Study|Other reason not defined above|0
6933031|NCT00885118|10966031|FG001|Overall Study|Other reason not defined above|0
6933032|NCT00885118|10966032|FG002|Overall Study|Other reason not defined above|1
6933033|NCT00885118|10966033|FG003|Overall Study|Other reason not defined above|0
6933034|NCT00885118|10966034|FG004|Overall Study|Other reason not defined above|0
6933035|NCT00885170|10966052|FG000|Overall Study|Adverse Event|12
6933036|NCT00885170|10966053|FG001|Overall Study|Adverse Event|4
6933037|NCT00885170|10966052|FG000|Overall Study|Excessive bone loss|6
6933038|NCT00885170|10966053|FG001|Overall Study|Excessive bone loss|3
6933039|NCT00885170|10966052|FG000|Overall Study|Lost to Follow-up|2
6933040|NCT00885170|10966053|FG001|Overall Study|Lost to Follow-up|1
6933041|NCT00885170|10966052|FG000|Overall Study|Physician Decision|2
6933042|NCT00885170|10966053|FG001|Overall Study|Physician Decision|1
6933043|NCT00885170|10966052|FG000|Overall Study|Protocol Violation|3
6933044|NCT00885170|10966053|FG001|Overall Study|Protocol Violation|1
6933045|NCT00885170|10966052|FG000|Overall Study|Withdrawal by Subject|13
7039887|NCT01713582|11122645|FG013|Overall Study|Withdrawal by Subject|0
7039888|NCT01713582|11122646|FG014|Overall Study|Withdrawal by Subject|0
6933046|NCT00885170|10966053|FG001|Overall Study|Withdrawal by Subject|13
6933047|NCT00885352|10966061|FG000|Overall Study|Adverse Event|2
6933048|NCT00885352|10966062|FG001|Overall Study|Adverse Event|3
6933049|NCT00885352|10966061|FG000|Overall Study|Lost to Follow-up|2
6933050|NCT00885352|10966062|FG001|Overall Study|Lost to Follow-up|2
6933051|NCT00885352|10966061|FG000|Overall Study|Physician Decision|0
6933052|NCT00885352|10966062|FG001|Overall Study|Physician Decision|3
6933053|NCT00885352|10966061|FG000|Overall Study|Protocol Violation|0
6933054|NCT00885352|10966062|FG001|Overall Study|Protocol Violation|2
6933055|NCT00885352|10966061|FG000|Overall Study|Withdrawal by Subject|1
6933056|NCT00885352|10966062|FG001|Overall Study|Withdrawal by Subject|5
6933057|NCT00885352|10966061|FG000|Overall Study|Contradiction to study medication|0
6933058|NCT00885352|10966062|FG001|Overall Study|Contradiction to study medication|2
6933059|NCT00885352|10966061|FG000|Overall Study|Excluded medication|2
6933060|NCT00885352|10966062|FG001|Overall Study|Excluded medication|2
6933061|NCT00885352|10966061|FG000|Overall Study|Lab abnormalities|1
6933062|NCT00885352|10966062|FG001|Overall Study|Lab abnormalities|1
6933063|NCT00885365|10966070|FG000|4 Weeks ON Treatment|Adverse Event|2
6933064|NCT00885365|10966071|FG001|4 Weeks ON Treatment|Adverse Event|4
6933065|NCT00885365|10966070|FG000|4 Weeks ON Treatment|Protocol Violation|1
6933066|NCT00885365|10966071|FG001|4 Weeks ON Treatment|Protocol Violation|2
6933067|NCT00885365|10966070|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1
6933068|NCT00885365|10966071|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0
6933069|NCT00885378|10966079|FG000|Overall Study|Lack of Efficacy|2
6933070|NCT00885378|10966080|FG001|Overall Study|Lack of Efficacy|2
6933071|NCT00885378|10966079|FG000|Overall Study|Withdrawal by Subject|1
6933072|NCT00885378|10966080|FG001|Overall Study|Withdrawal by Subject|2
6933073|NCT00885378|10966079|FG000|Overall Study|Lost to Follow-up|1
6933074|NCT00885378|10966080|FG001|Overall Study|Lost to Follow-up|2
6933075|NCT00885378|10966079|FG000|Overall Study|Poor/Noncompliance|2
6933076|NCT00885378|10966080|FG001|Overall Study|Poor/Noncompliance|2
6933077|NCT00885378|10966079|FG000|Overall Study|Protocol Violation|2
6933078|NCT00885378|10966080|FG001|Overall Study|Protocol Violation|0
6933079|NCT00885482|10966086|FG000|Overall Study|Pregnancy|1
6933080|NCT00885482|10966086|FG000|Overall Study|Lack of Efficacy|1
6933081|NCT00885482|10966086|FG000|Overall Study|Death|1
6933082|NCT00885482|10966086|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1
6933083|NCT00885534|10966090|FG000|Overall Study|Patient deemed ineligible|1
6933084|NCT00885677|10966104|FG000|Overall Study|Death|40
6933085|NCT00885677|10966105|FG001|Overall Study|Death|34
6933086|NCT00885677|10966104|FG000|Overall Study|Lost to Follow-up|15
6933087|NCT00885677|10966105|FG001|Overall Study|Lost to Follow-up|13
6933088|NCT00885677|10966104|FG000|Overall Study|Protocol Violation|54
6933089|NCT00885677|10966105|FG001|Overall Study|Protocol Violation|54
6933090|NCT00885677|10966104|FG000|Overall Study|premature study closure|41
6933091|NCT00885677|10966105|FG001|Overall Study|premature study closure|44
7039889|NCT01713582|11122647|FG015|Overall Study|Withdrawal by Subject|0
7039890|NCT01713582|11122648|FG016|Overall Study|Withdrawal by Subject|0
7039891|NCT01713582|11122649|FG017|Overall Study|Withdrawal by Subject|1
6933092|NCT00885677|10966104|FG000|Overall Study|device/lead revision or replacement|7
6933093|NCT00885677|10966105|FG001|Overall Study|device/lead revision or replacement|6
6933094|NCT00885677|10966104|FG000|Overall Study|Heart transplantation|1
6933095|NCT00885677|10966105|FG001|Overall Study|Heart transplantation|0
6933096|NCT00885677|10966104|FG000|Overall Study|Inclusion/exclusion not met|25
6933097|NCT00885677|10966105|FG001|Overall Study|Inclusion/exclusion not met|27
6933098|NCT00885703|10966118|FG000|Overall Study|Death|9
6933099|NCT00885703|10966119|FG001|Overall Study|Death|7
6933100|NCT00885703|10966120|FG002|Overall Study|Death|8
6933101|NCT00885703|10966121|FG003|Overall Study|Death|7
6933102|NCT00885703|10966122|FG004|Overall Study|Death|7
6933103|NCT00885703|10966123|FG005|Overall Study|Death|8
6933104|NCT00885703|10966124|FG006|Overall Study|Death|4
6933105|NCT00885703|10966118|FG000|Overall Study|Lost to Follow-up|0
6933106|NCT00885703|10966119|FG001|Overall Study|Lost to Follow-up|0
6933107|NCT00885703|10966120|FG002|Overall Study|Lost to Follow-up|1
6933108|NCT00885703|10966121|FG003|Overall Study|Lost to Follow-up|0
6933109|NCT00885703|10966122|FG004|Overall Study|Lost to Follow-up|0
6933110|NCT00885703|10966123|FG005|Overall Study|Lost to Follow-up|1
6933111|NCT00885703|10966124|FG006|Overall Study|Lost to Follow-up|0
6933112|NCT00885703|10966118|FG000|Overall Study|Withdrawal by Subject|0
6933113|NCT00885703|10966119|FG001|Overall Study|Withdrawal by Subject|0
6933114|NCT00885703|10966120|FG002|Overall Study|Withdrawal by Subject|0
6933115|NCT00885703|10966121|FG003|Overall Study|Withdrawal by Subject|1
6933116|NCT00885703|10966122|FG004|Overall Study|Withdrawal by Subject|3
6933117|NCT00885703|10966123|FG005|Overall Study|Withdrawal by Subject|1
6933118|NCT00885703|10966124|FG006|Overall Study|Withdrawal by Subject|1
6933119|NCT00885703|10966118|FG000|Overall Study|Ineligible (no CM)|1
6933120|NCT00885703|10966119|FG001|Overall Study|Ineligible (no CM)|3
6933121|NCT00885703|10966120|FG002|Overall Study|Ineligible (no CM)|2
6933122|NCT00885703|10966121|FG003|Overall Study|Ineligible (no CM)|1
6933123|NCT00885703|10966122|FG004|Overall Study|Ineligible (no CM)|2
6933124|NCT00885703|10966123|FG005|Overall Study|Ineligible (no CM)|3
6933125|NCT00885703|10966124|FG006|Overall Study|Ineligible (no CM)|1
6933126|NCT00885755|10966151|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1
6933127|NCT00885755|10966152|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0
6933128|NCT00885755|10966153|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0
6933129|NCT00885755|10966151|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16
6933130|NCT00885755|10966152|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0
6933131|NCT00885755|10966153|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0
6933132|NCT00885755|10966151|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1
6933133|NCT00885755|10966152|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
6933134|NCT00885755|10966153|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
6933135|NCT00885755|10966151|FG000|Part I: Trastuzumab+Taxane|Death|0
6933136|NCT00885755|10966152|FG001|Part I: Trastuzumab+Taxane|Death|0
6933137|NCT00885755|10966153|FG002|Part I: Trastuzumab+Taxane|Death|1
6933138|NCT00885755|10966151|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5
6933139|NCT00885755|10966152|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
6933140|NCT00885755|10966153|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
6933141|NCT00885846|10966168|FG000|Overall Study|Withdrawal by Subject|2
6933142|NCT00885846|10966169|FG001|Overall Study|Withdrawal by Subject|5
6933143|NCT00885846|10966170|FG002|Overall Study|Withdrawal by Subject|2
6933144|NCT00886015|10966180|FG000|Overall Study|Death|0
6933145|NCT00886015|10966181|FG001|Overall Study|Death|2
6933146|NCT00886119|10966187|FG000|Period 1|Did not meet inclusion criteria|1
6933147|NCT00886119|10966188|FG001|Period 1|Did not meet inclusion criteria|0
6933148|NCT00886288|10966224|FG000|Overall Study|no respect of the 12 weeks period|657
6933149|NCT00886288|10966225|FG001|Overall Study|no respect of the 12 weeks period|227
6933150|NCT00886288|10966224|FG000|Overall Study|Lost to Follow-up|86
6933151|NCT00886288|10966225|FG001|Overall Study|Lost to Follow-up|0
6933152|NCT00886340|10966235|FG000|Overall Study|Withdrawal by Subject|0
6933153|NCT00886340|10966236|FG001|Overall Study|Withdrawal by Subject|7
6933154|NCT00886379|10966247|FG000|Overall Study|Transferred Schools|0
6933155|NCT00886379|10966248|FG001|Overall Study|Transferred Schools|0
6933156|NCT00886379|10966249|FG002|Overall Study|Transferred Schools|2
6933157|NCT00886379|10966250|FG003|Overall Study|Transferred Schools|1
7039892|NCT01713582|11122650|FG018|Overall Study|Withdrawal by Subject|0
6933158|NCT00886379|10966251|FG004|Overall Study|Transferred Schools|1
6933159|NCT00886379|10966247|FG000|Overall Study|Final blood draw not obtained|3
6933160|NCT00886379|10966248|FG001|Overall Study|Final blood draw not obtained|3
6933161|NCT00886379|10966249|FG002|Overall Study|Final blood draw not obtained|4
6975215|NCT01191801|11027361|FG000|Overall Study|Death|36
6933162|NCT00886379|10966250|FG003|Overall Study|Final blood draw not obtained|2
6933163|NCT00886379|10966251|FG004|Overall Study|Final blood draw not obtained|2
6933164|NCT00886483|10966265|FG000|Overall Study|Lost to Follow-up|0
6933165|NCT00886483|10966266|FG001|Overall Study|Lost to Follow-up|1
6933166|NCT00886483|10966265|FG000|Overall Study|Pursue medications|1
6933167|NCT00886483|10966266|FG001|Overall Study|Pursue medications|2
6933168|NCT00886483|10966265|FG000|Overall Study|Distance to center, poor grades|1
6933169|NCT00886483|10966266|FG001|Overall Study|Distance to center, poor grades|0
6933170|NCT00886587|10966282|FG000|Overall Study|Adverse Event|2
6933171|NCT00886587|10966283|FG001|Overall Study|Adverse Event|1
6933172|NCT00886587|10966282|FG000|Overall Study|Protocol Violation|2
6933173|NCT00886587|10966283|FG001|Overall Study|Protocol Violation|0
6933174|NCT00886587|10966282|FG000|Overall Study|Withdrawal by Subject|0
6933175|NCT00886587|10966283|FG001|Overall Study|Withdrawal by Subject|1
6933176|NCT00886613|10966292|FG000|Overall Study|Protocol deviation (Part B)|1
6933177|NCT00886613|10966293|FG001|Overall Study|Protocol deviation (Part B)|0
6933178|NCT00886613|10966294|FG002|Overall Study|Protocol deviation (Part B)|0
6933179|NCT00886613|10966292|FG000|Overall Study|Lost to follow-up (Part B)|1
6933180|NCT00886613|10966293|FG001|Overall Study|Lost to follow-up (Part B)|0
6933181|NCT00886613|10966294|FG002|Overall Study|Lost to follow-up (Part B)|1
6933182|NCT00886613|10966292|FG000|Overall Study|Subject withdrew consent (Part A)|0
6933183|NCT00886613|10966293|FG001|Overall Study|Subject withdrew consent (Part A)|0
6933184|NCT00886613|10966294|FG002|Overall Study|Subject withdrew consent (Part A)|2
6933185|NCT00886639|10966312|FG000|Overall Study|acute exacerbation|14
6933186|NCT00886639|10966312|FG000|Overall Study|non-compliance|2
6933187|NCT00886743|10966327|FG000|Overall Study|Adverse Event|3
6933188|NCT00886743|10966327|FG000|Overall Study|Other|1
6933189|NCT00886769|10966333|FG000|Overall Study|Unsatisfactory therapeutic effect|6
6933190|NCT00886769|10966334|FG001|Overall Study|Unsatisfactory therapeutic effect|37
6933191|NCT00886795|10966340|FG000|Overall Study|Lack of Efficacy|1
6933192|NCT00886821|10966359|FG000|Stage 2|Adverse Event|0
6933193|NCT00886821|10966360|FG001|Stage 2|Adverse Event|0
6933194|NCT00886821|10966361|FG002|Stage 2|Adverse Event|0
6933195|NCT00886821|10966362|FG003|Stage 2|Adverse Event|0
6933196|NCT00886821|10966363|FG004|Stage 2|Adverse Event|0
6933197|NCT00886821|10966364|FG005|Stage 2|Adverse Event|0
6933198|NCT00886821|10966365|FG006|Stage 2|Adverse Event|0
6933199|NCT00886821|10966366|FG007|Stage 2|Adverse Event|0
6933200|NCT00886821|10966367|FG008|Stage 2|Adverse Event|0
6933201|NCT00886821|10966368|FG009|Stage 2|Adverse Event|0
7065580|NCT01967888|11165244|FG001|Overall Study|Did Not Have Transplant|0
7065581|NCT01967888|11165243|FG000|Overall Study|Research visit not done, data recorded|1
7065582|NCT01967888|11165244|FG001|Overall Study|Research visit not done, data recorded|0
7065583|NCT01967888|11165243|FG000|Overall Study|Subject excluded after randomization|1
7065584|NCT01967888|11165244|FG001|Overall Study|Subject excluded after randomization|0
7065585|NCT01967888|11165243|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0
7065586|NCT01967888|11165244|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1
6933202|NCT00886821|10966369|FG010|Stage 2|Adverse Event|0
6933203|NCT00886821|10966370|FG011|Stage 2|Adverse Event|1
6933204|NCT00886821|10966371|FG012|Stage 2|Adverse Event|3
6933205|NCT00886821|10966372|FG013|Stage 2|Adverse Event|0
6933206|NCT00886821|10966359|FG000|Stage 2|Lost to Follow-up|0
6933207|NCT00886821|10966360|FG001|Stage 2|Lost to Follow-up|0
6933208|NCT00886821|10966361|FG002|Stage 2|Lost to Follow-up|0
6933209|NCT00886821|10966362|FG003|Stage 2|Lost to Follow-up|0
6933210|NCT00886821|10966363|FG004|Stage 2|Lost to Follow-up|0
6933211|NCT00886821|10966364|FG005|Stage 2|Lost to Follow-up|0
6933212|NCT00886821|10966365|FG006|Stage 2|Lost to Follow-up|0
6933213|NCT00886821|10966366|FG007|Stage 2|Lost to Follow-up|0
6933214|NCT00886821|10966367|FG008|Stage 2|Lost to Follow-up|0
6933215|NCT00886821|10966368|FG009|Stage 2|Lost to Follow-up|0
6933216|NCT00886821|10966369|FG010|Stage 2|Lost to Follow-up|0
6933217|NCT00886821|10966370|FG011|Stage 2|Lost to Follow-up|0
6933218|NCT00886821|10966371|FG012|Stage 2|Lost to Follow-up|2
6933219|NCT00886821|10966372|FG013|Stage 2|Lost to Follow-up|1
6933220|NCT00886834|10966418|FG000|Overall Study|Protocol Violation|0
6933221|NCT00886834|10966419|FG001|Overall Study|Protocol Violation|3
6933222|NCT00886938|10966429|FG000|Overall Study|Adverse Event|1
6933223|NCT00886938|10966429|FG000|Overall Study|Withdrawal by Subject|1
6933224|NCT00887068|10966435|FG000|Overall Study|Withdrawal by Subject|2
6933225|NCT00887068|10966436|FG001|Overall Study|Withdrawal by Subject|0
6933226|NCT00887068|10966435|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4
6933227|NCT00887068|10966436|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0
6933228|NCT00887159|10966445|FG000|Overall Study|Disease progression|6
6933229|NCT00887159|10966446|FG001|Overall Study|Disease progression|39
6933230|NCT00887159|10966447|FG002|Overall Study|Disease progression|33
6933231|NCT00887159|10966445|FG000|Overall Study|Adverse Event|3
6933232|NCT00887159|10966446|FG001|Overall Study|Adverse Event|4
6933233|NCT00887159|10966447|FG002|Overall Study|Adverse Event|17
6933234|NCT00887159|10966445|FG000|Overall Study|Death|2
6933235|NCT00887159|10966446|FG001|Overall Study|Death|2
6933236|NCT00887159|10966447|FG002|Overall Study|Death|0
6933237|NCT00887159|10966445|FG000|Overall Study|Withdrawal by Subject|4
6933238|NCT00887159|10966446|FG001|Overall Study|Withdrawal by Subject|4
6933239|NCT00887159|10966447|FG002|Overall Study|Withdrawal by Subject|2
6933240|NCT00887159|10966445|FG000|Overall Study|Alternative therapy|2
6933241|NCT00887159|10966446|FG001|Overall Study|Alternative therapy|0
6933242|NCT00887159|10966447|FG002|Overall Study|Alternative therapy|0
6933243|NCT00887159|10966445|FG000|Overall Study|Physician Decision|1
6933244|NCT00887159|10966446|FG001|Overall Study|Physician Decision|1
6933245|NCT00887159|10966447|FG002|Overall Study|Physician Decision|0
6933246|NCT00887159|10966445|FG000|Overall Study|Sympomatic deterioration|1
6933247|NCT00887159|10966446|FG001|Overall Study|Sympomatic deterioration|0
6933248|NCT00887159|10966447|FG002|Overall Study|Sympomatic deterioration|0
6933249|NCT00887159|10966445|FG000|Overall Study|Treatment delayed|1
6933250|NCT00887159|10966446|FG001|Overall Study|Treatment delayed|1
6933251|NCT00887159|10966447|FG002|Overall Study|Treatment delayed|0
6933252|NCT00887159|10966445|FG000|Overall Study|Pt had PD but was SD when re-measured|0
6933253|NCT00887159|10966446|FG001|Overall Study|Pt had PD but was SD when re-measured|1
6933254|NCT00887159|10966447|FG002|Overall Study|Pt had PD but was SD when re-measured|0
6933255|NCT00887159|10966445|FG000|Overall Study|Received more tx instead of observation|1
6933256|NCT00887159|10966446|FG001|Overall Study|Received more tx instead of observation|0
6933257|NCT00887159|10966447|FG002|Overall Study|Received more tx instead of observation|0
6933258|NCT00887159|10966445|FG000|Overall Study|Ineligible|5
6933259|NCT00887159|10966446|FG001|Overall Study|Ineligible|1
6933260|NCT00887159|10966447|FG002|Overall Study|Ineligible|0
6933261|NCT00887159|10966445|FG000|Overall Study|Never started assigned therapy|3
6933262|NCT00887159|10966446|FG001|Overall Study|Never started assigned therapy|3
6933263|NCT00887159|10966447|FG002|Overall Study|Never started assigned therapy|4
6933264|NCT00887198|10966459|FG000|Randomized Period|Ongoing|42
6933265|NCT00887198|10966460|FG001|Randomized Period|Ongoing|0
6933266|NCT00887198|10966461|FG002|Randomized Period|Ongoing|0
6933267|NCT00887198|10966459|FG000|Randomized Period|Adverse Event|50
6933268|NCT00887198|10966460|FG001|Randomized Period|Adverse Event|33
6933269|NCT00887198|10966461|FG002|Randomized Period|Adverse Event|0
6933270|NCT00887198|10966459|FG000|Randomized Period|Lost to Follow-up|1
6933271|NCT00887198|10966460|FG001|Randomized Period|Lost to Follow-up|0
6933272|NCT00887198|10966461|FG002|Randomized Period|Lost to Follow-up|0
6933273|NCT00887198|10966459|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0
6933274|NCT00887198|10966460|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51
6933275|NCT00887198|10966461|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0
6933276|NCT00887198|10966459|FG000|Randomized Period|Withdrawal by Subject|41
6933277|NCT00887198|10966460|FG001|Randomized Period|Withdrawal by Subject|56
6933278|NCT00887198|10966461|FG002|Randomized Period|Withdrawal by Subject|0
6933279|NCT00887198|10966459|FG000|Randomized Period|Progressive disease|366
6933280|NCT00887198|10966460|FG001|Randomized Period|Progressive disease|370
6933281|NCT00887198|10966461|FG002|Randomized Period|Progressive disease|0
6933282|NCT00887198|10966459|FG000|Randomized Period|Other|42
6933283|NCT00887198|10966460|FG001|Randomized Period|Other|30
6933284|NCT00887198|10966461|FG002|Randomized Period|Other|0
6933285|NCT00887198|10966459|FG000|Randomized Period|Randomized, Not treated|4
6933286|NCT00887198|10966460|FG001|Randomized Period|Randomized, Not treated|2
6933287|NCT00887198|10966461|FG002|Randomized Period|Randomized, Not treated|0
6933288|NCT00887198|10966459|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0
6933289|NCT00887198|10966460|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0
6933290|NCT00887198|10966461|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8
6933291|NCT00887198|10966459|FG000|Cross Over (Placebo to AA)|Ongoing|0
6933292|NCT00887198|10966460|FG001|Cross Over (Placebo to AA)|Ongoing|0
6933293|NCT00887198|10966461|FG002|Cross Over (Placebo to AA)|Ongoing|35
6933294|NCT00887198|10966459|FG000|Cross Over (Placebo to AA)|Adverse Event|0
6933295|NCT00887198|10966460|FG001|Cross Over (Placebo to AA)|Adverse Event|0
6933296|NCT00887198|10966461|FG002|Cross Over (Placebo to AA)|Adverse Event|9
6933297|NCT00887198|10966459|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0
6933298|NCT00887198|10966460|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0
6933299|NCT00887198|10966461|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2
6933300|NCT00887198|10966459|FG000|Cross Over (Placebo to AA)|Progressive disease|0
6933301|NCT00887198|10966460|FG001|Cross Over (Placebo to AA)|Progressive disease|0
6933302|NCT00887198|10966461|FG002|Cross Over (Placebo to AA)|Progressive disease|20
6933303|NCT00887198|10966459|FG000|Cross Over (Placebo to AA)|Other|0
6933304|NCT00887198|10966460|FG001|Cross Over (Placebo to AA)|Other|0
6933305|NCT00887198|10966461|FG002|Cross Over (Placebo to AA)|Other|19
6933306|NCT00887224|10966472|FG000|Open-label Response (OLR) Phase|Adverse Event|46
6933307|NCT00887224|10966473|FG001|Open-label Response (OLR) Phase|Adverse Event|0
6933308|NCT00887224|10966474|FG002|Open-label Response (OLR) Phase|Adverse Event|0
6933309|NCT00887224|10966472|FG000|Open-label Response (OLR) Phase|Failed to return|6
6933310|NCT00887224|10966473|FG001|Open-label Response (OLR) Phase|Failed to return|0
6933311|NCT00887224|10966474|FG002|Open-label Response (OLR) Phase|Failed to return|0
6933312|NCT00887224|10966472|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26
6933313|NCT00887224|10966473|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0
6933314|NCT00887224|10966474|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0
6933315|NCT00887224|10966472|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16
6933316|NCT00887224|10966473|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0
6933317|NCT00887224|10966474|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0
6933318|NCT00887224|10966472|FG000|Open-label Response (OLR) Phase|Other|1
6933319|NCT00887224|10966473|FG001|Open-label Response (OLR) Phase|Other|0
6933320|NCT00887224|10966474|FG002|Open-label Response (OLR) Phase|Other|0
6933321|NCT00887224|10966472|FG000|Open-label Response (OLR) Phase|Protocol Violation|12
6933322|NCT00887224|10966473|FG001|Open-label Response (OLR) Phase|Protocol Violation|0
6933323|NCT00887224|10966474|FG002|Open-label Response (OLR) Phase|Protocol Violation|0
6933324|NCT00887224|10966472|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15
6933325|NCT00887224|10966473|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0
6933326|NCT00887224|10966474|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0
6933327|NCT00887224|10966472|FG000|Open-label Stability (OLS) Phase|Adverse Event|22
6933328|NCT00887224|10966473|FG001|Open-label Stability (OLS) Phase|Adverse Event|0
6933329|NCT00887224|10966474|FG002|Open-label Stability (OLS) Phase|Adverse Event|0
6933330|NCT00887224|10966472|FG000|Open-label Stability (OLS) Phase|Failed to return|3
6933331|NCT00887224|10966473|FG001|Open-label Stability (OLS) Phase|Failed to return|0
6933332|NCT00887224|10966474|FG002|Open-label Stability (OLS) Phase|Failed to return|0
6933333|NCT00887224|10966472|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16
6933334|NCT00887224|10966473|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0
6933335|NCT00887224|10966474|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0
6933336|NCT00887224|10966472|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9
6933337|NCT00887224|10966473|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0
6933338|NCT00887224|10966474|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0
6933339|NCT00887224|10966472|FG000|Open-label Stability (OLS) Phase|Other|1
6933340|NCT00887224|10966473|FG001|Open-label Stability (OLS) Phase|Other|0
6933341|NCT00887224|10966474|FG002|Open-label Stability (OLS) Phase|Other|0
6933342|NCT00887224|10966472|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13
6933343|NCT00887224|10966473|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0
6933344|NCT00887224|10966474|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0
6933345|NCT00887224|10966472|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19
6933346|NCT00887224|10966473|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
6933347|NCT00887224|10966474|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
6933348|NCT00887224|10966472|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28
6933349|NCT00887224|10966473|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0
6933350|NCT00887224|10966474|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0
6933351|NCT00887224|10966472|FG000|OL Taper Phase / OL Follow Up|Failed to return|17
6933352|NCT00887224|10966473|FG001|OL Taper Phase / OL Follow Up|Failed to return|0
6933353|NCT00887224|10966474|FG002|OL Taper Phase / OL Follow Up|Failed to return|0
6933354|NCT00887224|10966472|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10
7039893|NCT01713582|11122651|FG019|Overall Study|Withdrawal by Subject|0
7039894|NCT01713582|11122652|FG020|Overall Study|Withdrawal by Subject|0
7039895|NCT01713582|11122632|FG000|Overall Study|Stopped to receive bone marrow graft|0
7039896|NCT01713582|11122633|FG001|Overall Study|Stopped to receive bone marrow graft|0
7039897|NCT01713582|11122634|FG002|Overall Study|Stopped to receive bone marrow graft|0
6933355|NCT00887224|10966473|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0
6933356|NCT00887224|10966474|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0
6933357|NCT00887224|10966472|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8
6933358|NCT00887224|10966473|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
6933359|NCT00887224|10966474|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
6933360|NCT00887224|10966472|FG000|OL Taper Phase / OL Follow Up|Other|30
6933361|NCT00887224|10966473|FG001|OL Taper Phase / OL Follow Up|Other|0
6933362|NCT00887224|10966474|FG002|OL Taper Phase / OL Follow Up|Other|0
6933363|NCT00887224|10966472|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3
6933364|NCT00887224|10966473|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0
6933365|NCT00887224|10966474|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0
6933366|NCT00887224|10966472|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48
6933367|NCT00887224|10966473|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
6933368|NCT00887224|10966474|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
6933369|NCT00887224|10966472|FG000|Double-blind (DB) Phase|Adverse Event|0
6933370|NCT00887224|10966473|FG001|Double-blind (DB) Phase|Adverse Event|7
6933371|NCT00887224|10966474|FG002|Double-blind (DB) Phase|Adverse Event|2
6933372|NCT00887224|10966472|FG000|Double-blind (DB) Phase|Failed to return|0
6933373|NCT00887224|10966473|FG001|Double-blind (DB) Phase|Failed to return|2
6933374|NCT00887224|10966474|FG002|Double-blind (DB) Phase|Failed to return|2
6933375|NCT00887224|10966472|FG000|Double-blind (DB) Phase|Lack of Efficacy|0
6933376|NCT00887224|10966473|FG001|Double-blind (DB) Phase|Lack of Efficacy|67
6933377|NCT00887224|10966474|FG002|Double-blind (DB) Phase|Lack of Efficacy|33
6933378|NCT00887224|10966472|FG000|Double-blind (DB) Phase|Lost to Follow-up|0
6933379|NCT00887224|10966473|FG001|Double-blind (DB) Phase|Lost to Follow-up|8
6933380|NCT00887224|10966474|FG002|Double-blind (DB) Phase|Lost to Follow-up|8
6933381|NCT00887224|10966472|FG000|Double-blind (DB) Phase|Other|0
6933382|NCT00887224|10966473|FG001|Double-blind (DB) Phase|Other|2
6933383|NCT00887224|10966474|FG002|Double-blind (DB) Phase|Other|0
6933384|NCT00887224|10966472|FG000|Double-blind (DB) Phase|Protocol Violation|0
6933385|NCT00887224|10966473|FG001|Double-blind (DB) Phase|Protocol Violation|8
6933386|NCT00887224|10966474|FG002|Double-blind (DB) Phase|Protocol Violation|5
6933387|NCT00887224|10966472|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0
6933388|NCT00887224|10966473|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6
7039898|NCT01713582|11122635|FG003|Overall Study|Stopped to receive bone marrow graft|0
6933389|NCT00887224|10966474|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12
6933390|NCT00887224|10966472|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0
6933391|NCT00887224|10966473|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5
6933392|NCT00887224|10966474|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0
6933393|NCT00887224|10966472|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0
6933394|NCT00887224|10966473|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5
6933395|NCT00887224|10966474|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4
6933396|NCT00887224|10966472|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0
6933397|NCT00887224|10966473|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6
6933398|NCT00887224|10966474|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0
6933399|NCT00887224|10966472|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0
6933400|NCT00887224|10966473|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
6933401|NCT00887224|10966474|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
6933402|NCT00887224|10966472|FG000|DB Taper Phase / Post Study Follow Up|Other|0
6933403|NCT00887224|10966473|FG001|DB Taper Phase / Post Study Follow Up|Other|11
6933404|NCT00887224|10966474|FG002|DB Taper Phase / Post Study Follow Up|Other|12
6933405|NCT00887224|10966472|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0
6933406|NCT00887224|10966473|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4
6933407|NCT00887224|10966474|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1
6933408|NCT00887224|10966472|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0
6933409|NCT00887224|10966473|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8
6933410|NCT00887224|10966474|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11
6933411|NCT00887289|10966486|FG000|Overall Study|Lack of Efficacy|14
6933412|NCT00887289|10966486|FG000|Overall Study|Adverse Event|27
6933413|NCT00887289|10966486|FG000|Overall Study|Withdrawal by Subject|26
6933414|NCT00887289|10966486|FG000|Overall Study|Lost to Follow-up|8
6933415|NCT00887289|10966486|FG000|Overall Study|Other|20
6933416|NCT00887341|10966492|FG000|Overall Study|Refused treatment|1
6933417|NCT00887341|10966493|FG001|Overall Study|Refused treatment|0
6933418|NCT00887341|10966492|FG000|Overall Study|Withdrawal by Subject|1
6933419|NCT00887341|10966493|FG001|Overall Study|Withdrawal by Subject|1
6933420|NCT00887341|10966492|FG000|Overall Study|Adverse Event|0
6933421|NCT00887341|10966493|FG001|Overall Study|Adverse Event|1
6933422|NCT00887341|10966492|FG000|Overall Study|Lost to Follow-up|0
6933423|NCT00887341|10966493|FG001|Overall Study|Lost to Follow-up|1
6933424|NCT00887354|10966501|FG000|Treatment Phase (Week 0 to Week 26)|Death|0
6933425|NCT00887354|10966502|FG001|Treatment Phase (Week 0 to Week 26)|Death|1
6933426|NCT00887354|10966501|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
6933427|NCT00887354|10966502|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
6933428|NCT00887354|10966501|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2
6933429|NCT00887354|10966502|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1
6933430|NCT00887354|10966501|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14
6933431|NCT00887354|10966502|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8
6933432|NCT00887354|10966501|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
6933433|NCT00887354|10966502|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
6933434|NCT00887354|10966501|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2
6933435|NCT00887354|10966502|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1
6933436|NCT00887354|10966501|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
6933437|NCT00887354|10966502|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
6933438|NCT00887354|10966501|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1
6933439|NCT00887354|10966502|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2
6933440|NCT00887354|10966501|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20
6933441|NCT00887354|10966502|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25
6933442|NCT00887354|10966501|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5
6933443|NCT00887354|10966502|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3
6933444|NCT00887354|10966501|FG000|Open Label Phase (Week 26 to Week 78)|Death|0
6933445|NCT00887354|10966502|FG001|Open Label Phase (Week 26 to Week 78)|Death|2
6933446|NCT00887354|10966501|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0
6933447|NCT00887354|10966502|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1
6933448|NCT00887354|10966501|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1
6933449|NCT00887354|10966502|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2
6933450|NCT00887354|10966501|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1
6933451|NCT00887354|10966502|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0
6933452|NCT00887354|10966501|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
6933453|NCT00887354|10966502|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
6933454|NCT00887432|10966511|FG000|Overall Study|Start Excluded Therapy|3
6933455|NCT00887432|10966512|FG001|Overall Study|Start Excluded Therapy|0
6933456|NCT00887432|10966511|FG000|Overall Study|Did not complete treatment|6
6933457|NCT00887432|10966512|FG001|Overall Study|Did not complete treatment|8
6933458|NCT00887432|10966511|FG000|Overall Study|Protocol Violation|2
6933459|NCT00887432|10966512|FG001|Overall Study|Protocol Violation|3
6933460|NCT00887432|10966511|FG000|Overall Study|Withdrawal by Subject|3
6933461|NCT00887432|10966512|FG001|Overall Study|Withdrawal by Subject|2
6933462|NCT00887432|10966511|FG000|Overall Study|Lost to Follow-up|1
7065587|NCT01967888|11165243|FG000|Overall Study|Subject Unable To Comply With Final Day|0
7065588|NCT01967888|11165244|FG001|Overall Study|Subject Unable To Comply With Final Day|1
7065589|NCT01967940|11165253|FG000|Part 2|Enrolled in Part 2 and Never Treated|0
7065590|NCT01967940|11165254|FG001|Part 2|Enrolled in Part 2 and Never Treated|0
7065591|NCT01967940|11165255|FG002|Part 2|Enrolled in Part 2 and Never Treated|0
7065592|NCT01967940|11165256|FG003|Part 2|Enrolled in Part 2 and Never Treated|1
7065593|NCT01967940|11165253|FG000|Part 2|Adverse Event|0
7065594|NCT01967940|11165254|FG001|Part 2|Adverse Event|0
6933463|NCT00887432|10966512|FG001|Overall Study|Lost to Follow-up|0
6933464|NCT00887432|10966511|FG000|Overall Study|No reason provided|0
6933465|NCT00887432|10966512|FG001|Overall Study|No reason provided|1
6933466|NCT00887484|10966538|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1
6933467|NCT00887484|10966538|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
6933468|NCT00887484|10966538|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1
6933469|NCT00887549|10966556|FG000|Induction Therapy|Adverse Event|8
6933470|NCT00887549|10966556|FG000|Induction Therapy|Physician Decision|1
6933471|NCT00887549|10966556|FG000|Induction Therapy|Progressive Disease|13
6933472|NCT00887549|10966556|FG000|Induction Therapy|Death due to Study Disease|4
6933473|NCT00887549|10966556|FG000|Induction Therapy|Death due to Study Drug Toxicity|1
6933474|NCT00887549|10966556|FG000|Maintenance Therapy|Adverse Event|16
6933475|NCT00887549|10966556|FG000|Maintenance Therapy|Physician Decision|1
6933476|NCT00887549|10966556|FG000|Maintenance Therapy|Progressive Disease|25
6933477|NCT00887549|10966556|FG000|Maintenance Therapy|Death due to adverse event|1
7039899|NCT01713582|11122636|FG004|Overall Study|Stopped to receive bone marrow graft|0
7039900|NCT01713582|11122637|FG005|Overall Study|Stopped to receive bone marrow graft|0
7039901|NCT01713582|11122638|FG006|Overall Study|Stopped to receive bone marrow graft|0
7039902|NCT01713582|11122639|FG007|Overall Study|Stopped to receive bone marrow graft|0
7039903|NCT01713582|11122640|FG008|Overall Study|Stopped to receive bone marrow graft|0
7039904|NCT01713582|11122641|FG009|Overall Study|Stopped to receive bone marrow graft|0
7039905|NCT01713582|11122642|FG010|Overall Study|Stopped to receive bone marrow graft|0
7039906|NCT01713582|11122643|FG011|Overall Study|Stopped to receive bone marrow graft|0
7039907|NCT01713582|11122644|FG012|Overall Study|Stopped to receive bone marrow graft|0
7039908|NCT01713582|11122645|FG013|Overall Study|Stopped to receive bone marrow graft|0
7039909|NCT01713582|11122646|FG014|Overall Study|Stopped to receive bone marrow graft|0
7039910|NCT01713582|11122647|FG015|Overall Study|Stopped to receive bone marrow graft|0
7039911|NCT01713582|11122648|FG016|Overall Study|Stopped to receive bone marrow graft|1
7039912|NCT01713582|11122649|FG017|Overall Study|Stopped to receive bone marrow graft|0
7039913|NCT01713582|11122650|FG018|Overall Study|Stopped to receive bone marrow graft|0
7039914|NCT01713582|11122651|FG019|Overall Study|Stopped to receive bone marrow graft|0
6933478|NCT00887588|10966584|FG000|Core Period|Death|1
6933479|NCT00887588|10966585|FG001|Core Period|Death|1
6933480|NCT00887588|10966584|FG000|Core Period|Lost to Follow-up|3
6933481|NCT00887588|10966585|FG001|Core Period|Lost to Follow-up|1
6933482|NCT00887588|10966584|FG000|Core Period|Withdrawal by Subject|6
6933483|NCT00887588|10966585|FG001|Core Period|Withdrawal by Subject|8
6933484|NCT00887588|10966584|FG000|Core Period|Adverse Event|9
6933485|NCT00887588|10966585|FG001|Core Period|Adverse Event|11
6933486|NCT00887588|10966584|FG000|Extension Period|Adverse Event|4
6933487|NCT00887588|10966585|FG001|Extension Period|Adverse Event|4
6933488|NCT00887588|10966584|FG000|Extension Period|Death|0
6933489|NCT00887588|10966585|FG001|Extension Period|Death|1
6933490|NCT00887588|10966584|FG000|Extension Period|Protocol deviation|1
6933491|NCT00887588|10966585|FG001|Extension Period|Protocol deviation|0
6933492|NCT00887588|10966584|FG000|Extension Period|Lost to Follow-up|1
6933493|NCT00887588|10966585|FG001|Extension Period|Lost to Follow-up|0
6933494|NCT00887679|10966599|FG000|Overall Study|Withdrawal by Subject|1
6933495|NCT00887679|10966599|FG000|Overall Study|Lost to Follow-up|4
6933496|NCT00887679|10966599|FG000|Overall Study|Physician Decision|5
6933497|NCT00887744|10966604|FG000|Overall Study|Adverse Event|3
6933498|NCT00887744|10966604|FG000|Overall Study|Death|1
6933499|NCT00887744|10966604|FG000|Overall Study|Lost to Follow-up|3
6933500|NCT00887744|10966604|FG000|Overall Study|Withdrawal by Subject|18
6933501|NCT00887744|10966604|FG000|Overall Study|Various reasons|9
6933502|NCT00887809|10966610|FG000|Overall Study|Patient Not Treated|3
6933503|NCT00887809|10966611|FG001|Overall Study|Patient Not Treated|0
6933504|NCT00887809|10966610|FG000|Overall Study|Death|1
6933505|NCT00887809|10966611|FG001|Overall Study|Death|0
6933506|NCT00887822|10966619|FG000|Overall Study|Insufficient therapeutic response|53
6933507|NCT00887822|10966620|FG001|Overall Study|Insufficient therapeutic response|55
6933508|NCT00887822|10966619|FG000|Overall Study|Adverse Event|14
6933509|NCT00887822|10966620|FG001|Overall Study|Adverse Event|17
6933510|NCT00887822|10966619|FG000|Overall Study|Failure to return|11
6933511|NCT00887822|10966620|FG001|Overall Study|Failure to return|11
6933512|NCT00887822|10966619|FG000|Overall Study|Refused treatment/Did not cooperate|12
7039915|NCT01713582|11122652|FG020|Overall Study|Stopped to receive bone marrow graft|0
7039916|NCT01713582|11122632|FG000|Overall Study|Disease progression and adverse event|0
7044791|NCT01757275|11130782|FG001|Overall Study|Lost to Follow-up|2
7065595|NCT01967940|11165255|FG002|Part 2|Adverse Event|0
7065596|NCT01967940|11165256|FG003|Part 2|Adverse Event|1
6933513|NCT00887822|10966620|FG001|Overall Study|Refused treatment/Did not cooperate|10
6933514|NCT00887822|10966619|FG000|Overall Study|Administrative/Other than specified|5
6933515|NCT00887822|10966620|FG001|Overall Study|Administrative/Other than specified|4
6933516|NCT00887822|10966619|FG000|Overall Study|Death|2
6933517|NCT00887822|10966620|FG001|Overall Study|Death|3
6933518|NCT00887822|10966619|FG000|Overall Study|Protocol Violation|0
6933519|NCT00887822|10966620|FG001|Overall Study|Protocol Violation|1
6933520|NCT00887822|10966619|FG000|Overall Study|Randomized but not treated|0
6933521|NCT00887822|10966620|FG001|Overall Study|Randomized but not treated|1
6933522|NCT00887913|10966626|FG000|Overall Study|Withdrawal by Subject|6
6933523|NCT00887926|10966634|FG000|Overall Study|Withdrawal by Subject|0
6933524|NCT00887926|10966635|FG001|Overall Study|Withdrawal by Subject|1
6933525|NCT00887926|10966636|FG002|Overall Study|Withdrawal by Subject|0
6933526|NCT00887926|10966637|FG003|Overall Study|Withdrawal by Subject|0
6933527|NCT00887978|10966655|FG000|Overall Study|Adverse Event|18
6933528|NCT00887978|10966656|FG001|Overall Study|Adverse Event|5
6933529|NCT00887978|10966655|FG000|Overall Study|Clinical Worsening|4
6933530|NCT00887978|10966656|FG001|Overall Study|Clinical Worsening|4
6933531|NCT00887978|10966655|FG000|Overall Study|Death|2
6933532|NCT00887978|10966656|FG001|Overall Study|Death|3
6933533|NCT00887978|10966655|FG000|Overall Study|Withdrawal by Subject|1
6933534|NCT00887978|10966656|FG001|Overall Study|Withdrawal by Subject|2
6933535|NCT00887978|10966655|FG000|Overall Study|Lost to Follow-up|0
6933536|NCT00887978|10966656|FG001|Overall Study|Lost to Follow-up|1
6933537|NCT00888134|10966662|FG000|Treatment With Study Drug|Withdrawal by Subject|1
6933538|NCT00888134|10966662|FG000|Follow-up|being followed for long-term survival|1
6933539|NCT00888173|10966667|FG000|Overall Study|Wrong Primary|1
6933540|NCT00888173|10966667|FG000|Overall Study|Ineligible: required test not done|1
6933541|NCT00888238|10966671|FG000|Washout Period After Period 2|Adverse Event|0
6933542|NCT00888238|10966672|FG001|Washout Period After Period 2|Adverse Event|0
6933543|NCT00888238|10966673|FG002|Washout Period After Period 2|Adverse Event|1
6975216|NCT01191801|11027362|FG001|Overall Study|Death|12
6975217|NCT01191801|11027361|FG000|Overall Study|Lack of Efficacy|176
6975218|NCT01191801|11027362|FG001|Overall Study|Lack of Efficacy|258
6975219|NCT01191801|11027361|FG000|Overall Study|Adverse Event|9
6975220|NCT01191801|11027362|FG001|Overall Study|Adverse Event|8
6975221|NCT01191801|11027361|FG000|Overall Study|Protocol Violation|2
6975222|NCT01191801|11027362|FG001|Overall Study|Protocol Violation|4
6975223|NCT01191801|11027361|FG000|Overall Study|Physician Decision|47
6975224|NCT01191801|11027362|FG001|Overall Study|Physician Decision|24
6975225|NCT01191801|11027361|FG000|Overall Study|Withdrawal by Subject|1
6975226|NCT01191801|11027362|FG001|Overall Study|Withdrawal by Subject|4
6975227|NCT01191801|11027361|FG000|Overall Study|Not Provided|45
6975228|NCT01191801|11027362|FG001|Overall Study|Not Provided|27
6975229|NCT01191840|11027379|FG000|Overall Study|withdrew consent|2
6975230|NCT01191840|11027380|FG001|Overall Study|withdrew consent|1
6975231|NCT01191840|11027379|FG000|Overall Study|Subject discontinued treatment|1
6975232|NCT01191840|11027380|FG001|Overall Study|Subject discontinued treatment|2
6975233|NCT01191840|11027379|FG000|Overall Study|Lost to Follow-up|4
6975234|NCT01191840|11027380|FG001|Overall Study|Lost to Follow-up|6
6975235|NCT01191840|11027379|FG000|Overall Study|Non Staph Infection|4
6975236|NCT01191840|11027380|FG001|Overall Study|Non Staph Infection|3
6975237|NCT01191840|11027379|FG000|Overall Study|ineligible at enrollment|1
6975238|NCT01191840|11027380|FG001|Overall Study|ineligible at enrollment|0
6975239|NCT01191840|11027379|FG000|Overall Study|IRB approval lapse|0
6975240|NCT01191840|11027380|FG001|Overall Study|IRB approval lapse|2
6975241|NCT01191840|11027379|FG000|Overall Study|lab error speciation - non Staph infecti|0
6975242|NCT01191840|11027380|FG001|Overall Study|lab error speciation - non Staph infecti|1
6975243|NCT01191840|11027379|FG000|Overall Study|Withdrawal by Subject|2
6975244|NCT01191840|11027380|FG001|Overall Study|Withdrawal by Subject|0
6975245|NCT01191944|11027388|FG000|Overall Study|Adverse Event|11
6975246|NCT01191944|11027389|FG001|Overall Study|Adverse Event|12
6975247|NCT01191944|11027388|FG000|Overall Study|Protocol Violation|1
6975248|NCT01191944|11027389|FG001|Overall Study|Protocol Violation|2
6975249|NCT01191944|11027388|FG000|Overall Study|Withdrawal by Subject|4
6975250|NCT01191944|11027389|FG001|Overall Study|Withdrawal by Subject|2
6975251|NCT01191944|11027388|FG000|Overall Study|Other|1
6975252|NCT01191944|11027389|FG001|Overall Study|Other|3
6975253|NCT01192022|11027399|FG000|Overall Study|Withdrawal of Consent|3
6975254|NCT01192022|11027400|FG001|Overall Study|Withdrawal of Consent|1
6975255|NCT01192022|11027401|FG002|Overall Study|Withdrawal of Consent|0
6975256|NCT01192022|11027402|FG003|Overall Study|Withdrawal of Consent|0
6975257|NCT01192022|11027403|FG004|Overall Study|Withdrawal of Consent|0
6975258|NCT01192022|11027399|FG000|Overall Study|Lost to Follow-up|4
6975259|NCT01192022|11027400|FG001|Overall Study|Lost to Follow-up|2
6975260|NCT01192022|11027401|FG002|Overall Study|Lost to Follow-up|1
6975261|NCT01192022|11027402|FG003|Overall Study|Lost to Follow-up|1
6975262|NCT01192022|11027403|FG004|Overall Study|Lost to Follow-up|0
6975263|NCT01192022|11027399|FG000|Overall Study|Adverse Event|1
6975264|NCT01192022|11027400|FG001|Overall Study|Adverse Event|0
6975265|NCT01192022|11027401|FG002|Overall Study|Adverse Event|0
6975266|NCT01192022|11027402|FG003|Overall Study|Adverse Event|0
6975267|NCT01192022|11027403|FG004|Overall Study|Adverse Event|0
6975268|NCT01192022|11027399|FG000|Overall Study|Fatal Adverse Event|4
6975269|NCT01192022|11027400|FG001|Overall Study|Fatal Adverse Event|6
6975270|NCT01192022|11027401|FG002|Overall Study|Fatal Adverse Event|0
6837637|NCT00253448|10843298|FG000|Overall Study|Withdrawal by Subject|1
6837638|NCT00253630|10843306|FG000|Overall Study|ineligible|2
6837639|NCT00253643|10843314|FG000|Overall Study|Withdrawal by Subject|0
6837640|NCT00253643|10843315|FG001|Overall Study|Withdrawal by Subject|0
6837641|NCT00253643|10843316|FG002|Overall Study|Withdrawal by Subject|1
6837642|NCT00253643|10843317|FG003|Overall Study|Withdrawal by Subject|1
6837643|NCT00253643|10843314|FG000|Overall Study|Non-Compliance|0
6837644|NCT00253643|10843315|FG001|Overall Study|Non-Compliance|0
6837645|NCT00253643|10843316|FG002|Overall Study|Non-Compliance|0
6837646|NCT00253643|10843317|FG003|Overall Study|Non-Compliance|2
6837647|NCT00253747|10843342|FG000|Overall Study|Lost to Follow-up|13
6837648|NCT00253747|10843343|FG001|Overall Study|Lost to Follow-up|14
6837649|NCT00253747|10843342|FG000|Overall Study|Withdrawal by Subject|10
6837650|NCT00253747|10843343|FG001|Overall Study|Withdrawal by Subject|11
6837651|NCT00253747|10843342|FG000|Overall Study|Administrative Discharge (1), Other (2)|1
6837652|NCT00253747|10843343|FG001|Overall Study|Administrative Discharge (1), Other (2)|2
6837653|NCT00254163|10843379|FG000|Overall Study|Adverse Event|29
6837654|NCT00254163|10843380|FG001|Overall Study|Adverse Event|26
6837655|NCT00254163|10843379|FG000|Overall Study|Patient request/withdrew consent|6
6837656|NCT00254163|10843380|FG001|Overall Study|Patient request/withdrew consent|4
6837657|NCT00254163|10843379|FG000|Overall Study|Investigator request|1
6837658|NCT00254163|10843380|FG001|Overall Study|Investigator request|3
6837659|NCT00254163|10843379|FG000|Overall Study|Failed entry|1
6837660|NCT00254163|10843380|FG001|Overall Study|Failed entry|3
6837661|NCT00254163|10843379|FG000|Overall Study|Progressive disease|0
6837662|NCT00254163|10843380|FG001|Overall Study|Progressive disease|1
6933544|NCT00888329|10966681|FG000|Overall Study|Physician Decision|6
6933545|NCT00888329|10966682|FG001|Overall Study|Physician Decision|9
6933546|NCT00888381|10966690|FG000|Overall Study|Lost to Follow-up|0
6933547|NCT00888381|10966691|FG001|Overall Study|Lost to Follow-up|1
6933548|NCT00888433|10966699|FG000|Overall Study|Withdrawal by Subject|1
6933549|NCT00888433|10966700|FG001|Overall Study|Withdrawal by Subject|2
6933550|NCT00888433|10966699|FG000|Overall Study|Missed Visit|2
6933551|NCT00888433|10966700|FG001|Overall Study|Missed Visit|1
6933552|NCT00888615|10966719|FG000|Overall Study|No treatment|2
6933553|NCT00888654|10966727|FG000|Overall Study|Problems swallowing oral meds.|1
6933554|NCT00888654|10966727|FG000|Overall Study|Not enough oral meds before surgery|3
6933555|NCT00888654|10966727|FG000|Overall Study|Surgery aborted|2
6933556|NCT00888654|10966727|FG000|Overall Study|Withdrawal by Subject|1
6933557|NCT00888654|10966727|FG000|Overall Study|Inelig. due to contraindication of med|1
6933558|NCT00888654|10966727|FG000|Overall Study|Change in surg date|1
6933559|NCT00888654|10966727|FG000|Overall Study|Stopped meds due to headaches|1
6933560|NCT00888849|10966733|FG000|Overall Study|Death|4
6933561|NCT00888849|10966734|FG001|Overall Study|Death|7
6933562|NCT00888849|10966733|FG000|Overall Study|Lost to Follow-up|1
6933563|NCT00888849|10966734|FG001|Overall Study|Lost to Follow-up|2
6933564|NCT00888927|10966744|FG000|Overall Study|Adverse Event|0
6933565|NCT00888927|10966745|FG001|Overall Study|Adverse Event|0
6933566|NCT00888927|10966746|FG002|Overall Study|Adverse Event|0
6933567|NCT00888927|10966747|FG003|Overall Study|Adverse Event|1
6933568|NCT00888927|10966744|FG000|Overall Study|Withdrawal of consent|0
6933569|NCT00888927|10966745|FG001|Overall Study|Withdrawal of consent|0
6933570|NCT00888927|10966746|FG002|Overall Study|Withdrawal of consent|0
6933571|NCT00888927|10966747|FG003|Overall Study|Withdrawal of consent|1
6933572|NCT00888940|10966759|FG000|Overall Study|Adverse Event|12
6933573|NCT00888940|10966760|FG001|Overall Study|Adverse Event|3
6933574|NCT00888940|10966759|FG000|Overall Study|Lost to Follow-up|5
6933575|NCT00888940|10966760|FG001|Overall Study|Lost to Follow-up|5
6933576|NCT00888940|10966759|FG000|Overall Study|Randomized Not Treated|11
6933577|NCT00888940|10966760|FG001|Overall Study|Randomized Not Treated|13
6933578|NCT00889005|10966772|FG000|Overall Study|Lost to Follow-up|4
6933579|NCT00889005|10966773|FG001|Overall Study|Lost to Follow-up|2
6933580|NCT00889005|10966772|FG000|Overall Study|Withdrawal by Subject|4
6933581|NCT00889005|10966773|FG001|Overall Study|Withdrawal by Subject|0
6933582|NCT00889252|10966807|FG000|Overall Study|Adverse Event|2
6933583|NCT00889252|10966808|FG001|Overall Study|Adverse Event|4
6933584|NCT00889252|10966807|FG000|Overall Study|Withdrawal by Subject|3
6933585|NCT00889252|10966808|FG001|Overall Study|Withdrawal by Subject|0
6837663|NCT00254163|10843379|FG000|Overall Study|Death|0
6837664|NCT00254163|10843380|FG001|Overall Study|Death|1
6837665|NCT00254163|10843379|FG000|Overall Study|Other|8
6837666|NCT00254163|10843380|FG001|Overall Study|Other|8
6837667|NCT00254293|10843392|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0
6933586|NCT00889252|10966807|FG000|Overall Study|Protocol Violation|2
6933587|NCT00889252|10966808|FG001|Overall Study|Protocol Violation|0
6933588|NCT00889265|10966814|FG000|Overall Study|Adverse Event|1
6933589|NCT00889265|10966814|FG000|Overall Study|Lost to Follow-up|5
6933590|NCT00889265|10966814|FG000|Overall Study|Protocol Violation|1
6933591|NCT00889603|10966836|FG000|Overall Study|Adverse Event|7
6837668|NCT00254293|10843393|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1
6933592|NCT00889603|10966836|FG000|Overall Study|Death|3
6933593|NCT00889603|10966836|FG000|Overall Study|Lost to Follow-up|19
6933594|NCT00889603|10966836|FG000|Overall Study|No longer willing to participant in stud|4
6933595|NCT00889603|10966836|FG000|Overall Study|Other|4
6933596|NCT00889681|10966840|FG000|Overall Study|Not meeting qualification Criteria|2
6933597|NCT00889681|10966840|FG000|Overall Study|Insurance disapproval|1
6933598|NCT00889707|10966846|FG000|Overall Study|Adverse Event|1
6933599|NCT00889707|10966847|FG001|Overall Study|Adverse Event|0
6933600|NCT00889707|10966846|FG000|Overall Study|Withdrawal by Subject|4
6933601|NCT00889707|10966847|FG001|Overall Study|Withdrawal by Subject|3
6933602|NCT00889707|10966846|FG000|Overall Study|Lost to Follow-up|0
6933603|NCT00889707|10966847|FG001|Overall Study|Lost to Follow-up|2
6933604|NCT00889707|10966846|FG000|Overall Study|Lack of Efficacy|2
6933605|NCT00889707|10966847|FG001|Overall Study|Lack of Efficacy|5
6933606|NCT00889720|10966853|FG000|Overall Study|Withdrawal by Subject|4
6933607|NCT00889720|10966853|FG000|Overall Study|Other|4
6933608|NCT00889863|10966861|FG000|Part I: Open Label|Death|1
6933609|NCT00889863|10966862|FG001|Part I: Open Label|Death|0
6933610|NCT00889863|10966861|FG000|Part I: Open Label|Adverse Event|4
6933611|NCT00889863|10966862|FG001|Part I: Open Label|Adverse Event|0
6933612|NCT00889863|10966861|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72
6933613|NCT00889863|10966862|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0
6933614|NCT00889863|10966861|FG000|Part II: Randomized Double Blind|Adverse Event|0
6933615|NCT00889863|10966862|FG001|Part II: Randomized Double Blind|Adverse Event|4
6933616|NCT00889863|10966861|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11
6933617|NCT00889863|10966862|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20
6933618|NCT00889863|10966861|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0
6933619|NCT00889863|10966862|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1
6933620|NCT00889863|10966861|FG000|Part II: Randomized Double Blind|Protocol deviation|0
6933621|NCT00889863|10966862|FG001|Part II: Randomized Double Blind|Protocol deviation|1
6933622|NCT00890045|10966893|FG000|Overall Study|Death|0
6933623|NCT00890045|10966894|FG001|Overall Study|Death|1
6933624|NCT00890045|10966893|FG000|Overall Study|Did not receive HeRO Graft|0
7039917|NCT01713582|11122633|FG001|Overall Study|Disease progression and adverse event|0
7039918|NCT01713582|11122634|FG002|Overall Study|Disease progression and adverse event|0
7039919|NCT01713582|11122635|FG003|Overall Study|Disease progression and adverse event|0
7039920|NCT01713582|11122636|FG004|Overall Study|Disease progression and adverse event|0
7039921|NCT01713582|11122637|FG005|Overall Study|Disease progression and adverse event|0
7039922|NCT01713582|11122638|FG006|Overall Study|Disease progression and adverse event|0
7039923|NCT01713582|11122639|FG007|Overall Study|Disease progression and adverse event|0
6837669|NCT00254293|10843394|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0
6837670|NCT00254293|10843395|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1
6837671|NCT00254293|10843396|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0
6837672|NCT00254293|10843397|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0
7039924|NCT01713582|11122640|FG008|Overall Study|Disease progression and adverse event|0
7039925|NCT01713582|11122641|FG009|Overall Study|Disease progression and adverse event|0
7039926|NCT01713582|11122642|FG010|Overall Study|Disease progression and adverse event|0
7039927|NCT01713582|11122643|FG011|Overall Study|Disease progression and adverse event|0
7039928|NCT01713582|11122644|FG012|Overall Study|Disease progression and adverse event|0
7039929|NCT01713582|11122645|FG013|Overall Study|Disease progression and adverse event|0
7039930|NCT01713582|11122646|FG014|Overall Study|Disease progression and adverse event|0
6933625|NCT00890045|10966894|FG001|Overall Study|Did not receive HeRO Graft|2
6933626|NCT00890045|10966893|FG000|Overall Study|Lost to Follow-up|5
6933627|NCT00890045|10966894|FG001|Overall Study|Lost to Follow-up|7
6933628|NCT00890084|10966900|FG000|Overall Study|Adverse Event|16
6933629|NCT00890084|10966900|FG000|Overall Study|Lost to Follow-up|126
6933630|NCT00890097|10966907|FG000|Overall Study|Adverse Event|21
6933631|NCT00890097|10966908|FG001|Overall Study|Adverse Event|32
6933632|NCT00890097|10966909|FG002|Overall Study|Adverse Event|28
6933633|NCT00890097|10966907|FG000|Overall Study|Decision Unrelated to an Adverse Event|15
6933634|NCT00890097|10966908|FG001|Overall Study|Decision Unrelated to an Adverse Event|12
6933635|NCT00890097|10966909|FG002|Overall Study|Decision Unrelated to an Adverse Event|17
6933636|NCT00890097|10966907|FG000|Overall Study|Withdrew Consent|9
6933637|NCT00890097|10966908|FG001|Overall Study|Withdrew Consent|6
6933638|NCT00890097|10966909|FG002|Overall Study|Withdrew Consent|9
6933639|NCT00890097|10966907|FG000|Overall Study|Lost to Follow-up|5
6933640|NCT00890097|10966908|FG001|Overall Study|Lost to Follow-up|5
6933641|NCT00890097|10966909|FG002|Overall Study|Lost to Follow-up|5
6933642|NCT00890097|10966907|FG000|Overall Study|Noncompliance|0
6933643|NCT00890097|10966908|FG001|Overall Study|Noncompliance|4
6933644|NCT00890097|10966909|FG002|Overall Study|Noncompliance|4
6933645|NCT00890097|10966907|FG000|Overall Study|Sponsor Decision|7
6933646|NCT00890097|10966908|FG001|Overall Study|Sponsor Decision|11
6933647|NCT00890097|10966909|FG002|Overall Study|Sponsor Decision|7
6933648|NCT00890097|10966907|FG000|Overall Study|Did not attend final visit|2
6933649|NCT00890097|10966908|FG001|Overall Study|Did not attend final visit|3
7039931|NCT01713582|11122647|FG015|Overall Study|Disease progression and adverse event|0
7044792|NCT01757275|11130781|FG000|Overall Study|Adverse Event|3
6933650|NCT00890097|10966909|FG002|Overall Study|Did not attend final visit|0
6933651|NCT00890097|10966907|FG000|Overall Study|Subject Decision|3
6933652|NCT00890097|10966908|FG001|Overall Study|Subject Decision|2
6933653|NCT00890097|10966909|FG002|Overall Study|Subject Decision|6
6933654|NCT00890097|10966907|FG000|Overall Study|Randomization Error|2
6933655|NCT00890097|10966908|FG001|Overall Study|Randomization Error|0
6933656|NCT00890097|10966909|FG002|Overall Study|Randomization Error|0
6933657|NCT00890097|10966907|FG000|Overall Study|Failed inclusion criteria|3
6933658|NCT00890097|10966908|FG001|Overall Study|Failed inclusion criteria|4
6933659|NCT00890097|10966909|FG002|Overall Study|Failed inclusion criteria|0
6933660|NCT00890097|10966907|FG000|Overall Study|Transportation|0
6933661|NCT00890097|10966908|FG001|Overall Study|Transportation|2
6933662|NCT00890097|10966909|FG002|Overall Study|Transportation|0
6933663|NCT00890097|10966907|FG000|Overall Study|Subject Moved|0
6933664|NCT00890097|10966908|FG001|Overall Study|Subject Moved|4
6933665|NCT00890097|10966909|FG002|Overall Study|Subject Moved|0
6933666|NCT00890097|10966907|FG000|Overall Study|Protocol Deviation|1
6933667|NCT00890097|10966908|FG001|Overall Study|Protocol Deviation|1
6933668|NCT00890097|10966909|FG002|Overall Study|Protocol Deviation|1
6933669|NCT00890201|10966928|FG000|Overall Study|Protocol Violation|5
6933670|NCT00890201|10966929|FG001|Overall Study|Protocol Violation|56
6933671|NCT00890552|10966947|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1
6933672|NCT00890552|10966947|FG000|On-treatment|Early prog disease/ death|10
6933673|NCT00890695|10966970|FG000|Overall Study|Protocol Violation|1
6933674|NCT00890695|10966971|FG001|Overall Study|Protocol Violation|0
6933675|NCT00890825|10966988|FG000|Overall Study|Withdrawal by Subject|1
6933676|NCT00890825|10966989|FG001|Overall Study|Withdrawal by Subject|0
6933677|NCT00890825|10966988|FG000|Overall Study|Alive at data cut off (DCO)|13
6933678|NCT00890825|10966989|FG001|Overall Study|Alive at data cut off (DCO)|14
6933679|NCT00890929|10966999|FG000|Overall Study|Death before treatment|2
6933680|NCT00890929|10966999|FG000|Overall Study|Withdrawal by Subject|3
6933681|NCT00890929|10966999|FG000|Overall Study|Physician Decision|1
6933682|NCT00891020|10967015|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11
6933683|NCT00891020|10967016|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32
6933684|NCT00891020|10967017|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17
6933685|NCT00891020|10967015|FG000|24 Week Treatment Period|Death|0
6933686|NCT00891020|10967016|FG001|24 Week Treatment Period|Death|2
6933687|NCT00891020|10967017|FG002|24 Week Treatment Period|Death|0
6933688|NCT00891020|10967015|FG000|24 Week Treatment Period|Insufficient therapeutic response|6
6933689|NCT00891020|10967016|FG001|24 Week Treatment Period|Insufficient therapeutic response|9
6933690|NCT00891020|10967017|FG002|24 Week Treatment Period|Insufficient therapeutic response|15
6933691|NCT00891020|10967015|FG000|24 Week Treatment Period|Failure to return|4
6933692|NCT00891020|10967016|FG001|24 Week Treatment Period|Failure to return|5
6933693|NCT00891020|10967017|FG002|24 Week Treatment Period|Failure to return|5
6933694|NCT00891020|10967015|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1
7065597|NCT01967940|11165253|FG000|Part 2|Unknown Reason|0
7065598|NCT01967940|11165254|FG001|Part 2|Unknown Reason|0
7065599|NCT01967940|11165255|FG002|Part 2|Unknown Reason|0
7065600|NCT01967940|11165256|FG003|Part 2|Unknown Reason|1
7065601|NCT01968031|11165269|FG000|Overall Study|Adverse Event|13
7065602|NCT01968031|11165270|FG001|Overall Study|Adverse Event|10
7065603|NCT01968031|11165271|FG002|Overall Study|Adverse Event|22
7065604|NCT01968031|11165269|FG000|Overall Study|Withdrawal by Subject|3
7065605|NCT01968031|11165270|FG001|Overall Study|Withdrawal by Subject|7
7065606|NCT01968031|11165271|FG002|Overall Study|Withdrawal by Subject|3
7065607|NCT01968031|11165269|FG000|Overall Study|Did not meet entry criteria|1
7065608|NCT01968031|11165270|FG001|Overall Study|Did not meet entry criteria|1
7065609|NCT01968031|11165271|FG002|Overall Study|Did not meet entry criteria|1
7065610|NCT01968031|11165269|FG000|Overall Study|Noncompliance|0
7065611|NCT01968031|11165270|FG001|Overall Study|Noncompliance|0
7065612|NCT01968031|11165271|FG002|Overall Study|Noncompliance|2
7065613|NCT01968031|11165269|FG000|Overall Study|Failed inclusion criteria|0
7065614|NCT01968031|11165270|FG001|Overall Study|Failed inclusion criteria|2
7065615|NCT01968031|11165271|FG002|Overall Study|Failed inclusion criteria|0
7065616|NCT01968031|11165269|FG000|Overall Study|Death|0
7065617|NCT01968031|11165270|FG001|Overall Study|Death|0
7065618|NCT01968031|11165271|FG002|Overall Study|Death|1
7065619|NCT01968031|11165269|FG000|Overall Study|Prohibited concomitant medication|1
7065620|NCT01968031|11165270|FG001|Overall Study|Prohibited concomitant medication|0
7065621|NCT01968031|11165271|FG002|Overall Study|Prohibited concomitant medication|0
7065622|NCT01968070|11165303|FG000|Period 1|Withdrawal by Subject|0
6933695|NCT00891020|10967016|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0
6933696|NCT00891020|10967017|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2
6933697|NCT00891020|10967015|FG000|24 Week Treatment Period|Other protocol violation|1
6933698|NCT00891020|10967016|FG001|24 Week Treatment Period|Other protocol violation|1
6933699|NCT00891020|10967017|FG002|24 Week Treatment Period|Other protocol violation|2
6933700|NCT00891020|10967015|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3
7065623|NCT01968070|11165304|FG001|Period 1|Withdrawal by Subject|1
7065624|NCT01968070|11165305|FG002|Period 1|Withdrawal by Subject|0
7065625|NCT01968070|11165306|FG003|Period 1|Withdrawal by Subject|0
7065626|NCT01968070|11165307|FG004|Period 1|Withdrawal by Subject|0
7065627|NCT01968070|11165308|FG005|Period 1|Withdrawal by Subject|0
7065628|NCT01968070|11165309|FG006|Period 1|Withdrawal by Subject|1
7065629|NCT01968070|11165310|FG007|Period 1|Withdrawal by Subject|0
7065630|NCT01968070|11165311|FG008|Period 1|Withdrawal by Subject|0
7065631|NCT01968070|11165312|FG009|Period 1|Withdrawal by Subject|0
7065632|NCT01968070|11165313|FG010|Period 1|Withdrawal by Subject|0
6933701|NCT00891020|10967016|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2
6933702|NCT00891020|10967017|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1
6933703|NCT00891020|10967015|FG000|24 Week Treatment Period|Withdrew consent|6
6933704|NCT00891020|10967016|FG001|24 Week Treatment Period|Withdrew consent|3
6933705|NCT00891020|10967017|FG002|24 Week Treatment Period|Withdrew consent|15
6933706|NCT00891020|10967015|FG000|24 Week Treatment Period|Administrative/Other|5
6933707|NCT00891020|10967016|FG001|24 Week Treatment Period|Administrative/Other|6
6933708|NCT00891020|10967017|FG002|24 Week Treatment Period|Administrative/Other|1
6933709|NCT00891020|10967015|FG000|Long-term Extension Period|Adverse Event|1
6933710|NCT00891020|10967016|FG001|Long-term Extension Period|Adverse Event|11
6933711|NCT00891020|10967017|FG002|Long-term Extension Period|Adverse Event|10
6933712|NCT00891020|10967015|FG000|Long-term Extension Period|Death|0
6933713|NCT00891020|10967016|FG001|Long-term Extension Period|Death|0
6933714|NCT00891020|10967017|FG002|Long-term Extension Period|Death|1
6933715|NCT00891020|10967015|FG000|Long-term Extension Period|Insufficient therapeutic response|3
6933716|NCT00891020|10967016|FG001|Long-term Extension Period|Insufficient therapeutic response|2
6933717|NCT00891020|10967017|FG002|Long-term Extension Period|Insufficient therapeutic response|2
6933718|NCT00891020|10967015|FG000|Long-term Extension Period|Protocol Violation|0
6933719|NCT00891020|10967016|FG001|Long-term Extension Period|Protocol Violation|1
6933720|NCT00891020|10967017|FG002|Long-term Extension Period|Protocol Violation|1
6933721|NCT00891020|10967015|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1
6933722|NCT00891020|10967016|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6
6933723|NCT00891020|10967017|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4
6933724|NCT00891020|10967015|FG000|Long-term Extension Period|Failure to return|0
6933725|NCT00891020|10967016|FG001|Long-term Extension Period|Failure to return|2
6933726|NCT00891020|10967017|FG002|Long-term Extension Period|Failure to return|3
6933727|NCT00891020|10967015|FG000|Long-term Extension Period|Administrative|1
6933728|NCT00891020|10967016|FG001|Long-term Extension Period|Administrative|2
6933729|NCT00891020|10967017|FG002|Long-term Extension Period|Administrative|2
6933730|NCT00891046|10967032|FG000|Overall Study|Protocol Violation|1
6933731|NCT00891046|10967033|FG001|Overall Study|Protocol Violation|1
6933732|NCT00891046|10967034|FG002|Overall Study|Protocol Violation|0
6933733|NCT00891046|10967035|FG003|Overall Study|Protocol Violation|0
6933734|NCT00891046|10967036|FG004|Overall Study|Protocol Violation|1
6933735|NCT00891046|10967032|FG000|Overall Study|Unsatisfactory therapeutic effect|5
6933736|NCT00891046|10967033|FG001|Overall Study|Unsatisfactory therapeutic effect|2
6933737|NCT00891046|10967034|FG002|Overall Study|Unsatisfactory therapeutic effect|19
6933738|NCT00891046|10967035|FG003|Overall Study|Unsatisfactory therapeutic effect|2
6933739|NCT00891046|10967036|FG004|Overall Study|Unsatisfactory therapeutic effect|20
6933740|NCT00891046|10967032|FG000|Overall Study|Administrative problems|0
6933741|NCT00891046|10967033|FG001|Overall Study|Administrative problems|0
6933742|NCT00891046|10967034|FG002|Overall Study|Administrative problems|0
6933743|NCT00891046|10967035|FG003|Overall Study|Administrative problems|0
6933744|NCT00891046|10967036|FG004|Overall Study|Administrative problems|1
6933745|NCT00891046|10967032|FG000|Overall Study|Participant no longer required drug|0
6933746|NCT00891046|10967033|FG001|Overall Study|Participant no longer required drug|2
6933747|NCT00891046|10967034|FG002|Overall Study|Participant no longer required drug|0
6933748|NCT00891046|10967035|FG003|Overall Study|Participant no longer required drug|0
6933749|NCT00891046|10967036|FG004|Overall Study|Participant no longer required drug|1
6933750|NCT00891046|10967032|FG000|Overall Study|Adverse Event|4
6933751|NCT00891046|10967033|FG001|Overall Study|Adverse Event|3
6933752|NCT00891046|10967034|FG002|Overall Study|Adverse Event|2
6933753|NCT00891046|10967035|FG003|Overall Study|Adverse Event|0
6933754|NCT00891046|10967036|FG004|Overall Study|Adverse Event|14
6933755|NCT00891046|10967032|FG000|Overall Study|Withdrawal by Subject|2
6933756|NCT00891046|10967033|FG001|Overall Study|Withdrawal by Subject|1
6933757|NCT00891046|10967034|FG002|Overall Study|Withdrawal by Subject|2
6933758|NCT00891046|10967035|FG003|Overall Study|Withdrawal by Subject|1
6933759|NCT00891046|10967036|FG004|Overall Study|Withdrawal by Subject|1
6933760|NCT00891046|10967032|FG000|Overall Study|Lost to Follow-up|0
6933761|NCT00891046|10967033|FG001|Overall Study|Lost to Follow-up|0
6933762|NCT00891046|10967034|FG002|Overall Study|Lost to Follow-up|0
6933763|NCT00891046|10967035|FG003|Overall Study|Lost to Follow-up|0
6933764|NCT00891046|10967036|FG004|Overall Study|Lost to Follow-up|1
6933765|NCT00891202|10967088|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1
6933766|NCT00891202|10967089|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0
6933767|NCT00891202|10967090|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0
6933768|NCT00891202|10967091|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0
6933769|NCT00891202|10967088|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
6933770|NCT00891202|10967089|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
6933771|NCT00891202|10967090|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4
6933772|NCT00891202|10967091|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
6933773|NCT00891202|10967088|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
6933774|NCT00891202|10967089|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
6933775|NCT00891202|10967090|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1
6933776|NCT00891202|10967091|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
6933777|NCT00891202|10967088|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
6933778|NCT00891202|10967089|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
6933779|NCT00891202|10967090|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2
6933780|NCT00891202|10967091|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5
6933781|NCT00891228|10967102|FG000|Overall Study|Adverse Event|0
6933782|NCT00891228|10967103|FG001|Overall Study|Adverse Event|2
6933783|NCT00891228|10967104|FG002|Overall Study|Adverse Event|3
6933784|NCT00891228|10967102|FG000|Overall Study|Withdrawal by Subject|2
6933785|NCT00891228|10967103|FG001|Overall Study|Withdrawal by Subject|4
6933786|NCT00891228|10967104|FG002|Overall Study|Withdrawal by Subject|5
6933787|NCT00891228|10967102|FG000|Overall Study|Protocol Violation|3
6933788|NCT00891228|10967103|FG001|Overall Study|Protocol Violation|1
6933789|NCT00891228|10967104|FG002|Overall Study|Protocol Violation|2
7039932|NCT01713582|11122648|FG016|Overall Study|Disease progression and adverse event|1
7039933|NCT01713582|11122649|FG017|Overall Study|Disease progression and adverse event|0
7039934|NCT01713582|11122650|FG018|Overall Study|Disease progression and adverse event|0
7039935|NCT01713582|11122651|FG019|Overall Study|Disease progression and adverse event|0
7039936|NCT01713582|11122652|FG020|Overall Study|Disease progression and adverse event|0
7039937|NCT01713686|11122739|FG000|Overall Study|Lost to Follow-up|9
6933790|NCT00891228|10967102|FG000|Overall Study|Physician Decision|2
6933791|NCT00891228|10967103|FG001|Overall Study|Physician Decision|1
6933792|NCT00891228|10967104|FG002|Overall Study|Physician Decision|0
6933793|NCT00891228|10967102|FG000|Overall Study|Lost to Follow-up|4
6933794|NCT00891228|10967103|FG001|Overall Study|Lost to Follow-up|4
6933795|NCT00891228|10967104|FG002|Overall Study|Lost to Follow-up|5
6933796|NCT00891228|10967102|FG000|Overall Study|Pregnancy|0
6933797|NCT00891228|10967103|FG001|Overall Study|Pregnancy|1
6933798|NCT00891228|10967104|FG002|Overall Study|Pregnancy|0
6933799|NCT00891293|10967112|FG000|Overall Study|Adverse Event|2
6933800|NCT00891293|10967112|FG000|Overall Study|Protocol Violation|2
6933801|NCT00891293|10967112|FG000|Overall Study|Laboratory abnormality|4
6933802|NCT00891293|10967112|FG000|Overall Study|Lost to Follow-up|7
6933803|NCT00891293|10967112|FG000|Overall Study|Subject withdrew consent|7
6933804|NCT00891293|10967112|FG000|Overall Study|Sponsor termination|62
6933805|NCT00891371|10967125|FG000|Pre-assignment|Inclusion/exclusion|5
6933806|NCT00891371|10967125|FG000|Pre-assignment|Consent withdrawal|1
6933807|NCT00891371|10967125|FG000|Treatment|Lack of Efficacy|5
6933808|NCT00891371|10967125|FG000|Treatment|Adverse Event|2
6933809|NCT00891371|10967125|FG000|Treatment|Death|1
6933810|NCT00891371|10967125|FG000|Treatment|Lost to Follow-up|1
6933811|NCT00891462|10967141|FG000|Overall Study|Withdrawal by Subject|9
6933812|NCT00891462|10967142|FG001|Overall Study|Withdrawal by Subject|6
6933813|NCT00891462|10967143|FG002|Overall Study|Withdrawal by Subject|7
6933814|NCT00891462|10967141|FG000|Overall Study|Adverse Event|7
6933815|NCT00891462|10967142|FG001|Overall Study|Adverse Event|8
6933816|NCT00891462|10967143|FG002|Overall Study|Adverse Event|7
6933817|NCT00891462|10967141|FG000|Overall Study|Lack of Efficacy|10
6933818|NCT00891462|10967142|FG001|Overall Study|Lack of Efficacy|5
6933819|NCT00891462|10967143|FG002|Overall Study|Lack of Efficacy|1
6933820|NCT00891462|10967141|FG000|Overall Study|COPD exacerbation|7
6933821|NCT00891462|10967142|FG001|Overall Study|COPD exacerbation|4
6933822|NCT00891462|10967143|FG002|Overall Study|COPD exacerbation|1
6933823|NCT00891462|10967141|FG000|Overall Study|Other Reason|2
6933824|NCT00891462|10967142|FG001|Overall Study|Other Reason|5
6933825|NCT00891462|10967143|FG002|Overall Study|Other Reason|3
6933826|NCT00891462|10967141|FG000|Overall Study|Protocol Violation|2
6933827|NCT00891462|10967142|FG001|Overall Study|Protocol Violation|1
6933828|NCT00891462|10967143|FG002|Overall Study|Protocol Violation|3
6933829|NCT00891462|10967141|FG000|Overall Study|Inclusion/exclusion criteria|0
6933830|NCT00891462|10967142|FG001|Overall Study|Inclusion/exclusion criteria|2
6933831|NCT00891462|10967143|FG002|Overall Study|Inclusion/exclusion criteria|2
6933832|NCT00891462|10967141|FG000|Overall Study|Lost to Follow-up|0
6933833|NCT00891462|10967142|FG001|Overall Study|Lost to Follow-up|2
6933834|NCT00891462|10967143|FG002|Overall Study|Lost to Follow-up|0
6933835|NCT00891527|10967153|FG000|Overall Study|Withdrawal by Subject|2
6933836|NCT00891618|10967158|FG000|Overall Study|Withdrawal by Subject|1
6933837|NCT00891657|10967164|FG000|Overall Study|Withdrawal by Subject|1
6933838|NCT00891657|10967165|FG001|Overall Study|Withdrawal by Subject|1
6933839|NCT00891735|10967175|FG000|Overall Study|Adverse Event|2
6933840|NCT00891735|10967176|FG001|Overall Study|Adverse Event|0
6933841|NCT00891735|10967177|FG002|Overall Study|Adverse Event|2
6933842|NCT00891735|10967178|FG003|Overall Study|Adverse Event|0
6933843|NCT00891735|10967175|FG000|Overall Study|Death|8
6933844|NCT00891735|10967176|FG001|Overall Study|Death|5
6933845|NCT00891735|10967177|FG002|Overall Study|Death|4
6933846|NCT00891735|10967178|FG003|Overall Study|Death|5
6933847|NCT00891735|10967175|FG000|Overall Study|Lost to Follow-up|2
6933848|NCT00891735|10967176|FG001|Overall Study|Lost to Follow-up|2
6933849|NCT00891735|10967177|FG002|Overall Study|Lost to Follow-up|2
6933850|NCT00891735|10967178|FG003|Overall Study|Lost to Follow-up|2
6933851|NCT00891735|10967175|FG000|Overall Study|Physician's decision to withdraw patient|1
6975271|NCT01192022|11027402|FG003|Overall Study|Fatal Adverse Event|0
6975272|NCT01192022|11027403|FG004|Overall Study|Fatal Adverse Event|1
6975273|NCT01192022|11027399|FG000|Overall Study|Physician withdrew-patient hardship|1
6975274|NCT01192022|11027400|FG001|Overall Study|Physician withdrew-patient hardship|0
6933852|NCT00891735|10967176|FG001|Overall Study|Physician's decision to withdraw patient|0
6933853|NCT00891735|10967177|FG002|Overall Study|Physician's decision to withdraw patient|0
6933854|NCT00891735|10967178|FG003|Overall Study|Physician's decision to withdraw patient|0
6933855|NCT00891735|10967175|FG000|Overall Study|Patient's decision to withdraw|4
6933856|NCT00891735|10967176|FG001|Overall Study|Patient's decision to withdraw|9
6933857|NCT00891735|10967177|FG002|Overall Study|Patient's decision to withdraw|4
6933858|NCT00891735|10967178|FG003|Overall Study|Patient's decision to withdraw|8
6933859|NCT00891774|10967188|FG000|Overall Study|Lost to Follow-up|5
6933860|NCT00891774|10967188|FG000|Overall Study|Illness (Self/Mother)|3
6933861|NCT00891774|10967188|FG000|Overall Study|Withdrawal by Subject|2
6933862|NCT00891774|10967188|FG000|Overall Study|Protocol Violation|4
6933863|NCT00891813|10967192|FG000|Overall Study|Adverse Event|3
6933864|NCT00891813|10967192|FG000|Overall Study|Withdrawal by Subject|1
6933865|NCT00891813|10967192|FG000|Overall Study|Patient Noncompliance|6
6933866|NCT00891813|10967192|FG000|Overall Study|Protocol Violation|2
6933867|NCT00891839|10967196|FG000|Overall Study|Adverse Event|2
6933868|NCT00891839|10967196|FG000|Overall Study|Withdrawal by Subject|2
6933869|NCT00891839|10967196|FG000|Overall Study|Disease progression|3
6933870|NCT00891930|10967209|FG000|Part 1: Panitumumab +Irinotecan|Death|38
6933871|NCT00891930|10967209|FG000|Part 1: Panitumumab +Irinotecan|Withdrawal by Subject|1
6933872|NCT00891930|10967209|FG000|Part 1: Panitumumab +Irinotecan|Lost to Follow-up|1
6933873|NCT00891930|10967209|FG000|Part 2: Panitumumab + Ganitumab|Death|30
6933874|NCT00891930|10967209|FG000|Part 2: Panitumumab + Ganitumab|Withdrawal by Subject|1
6933875|NCT00892008|10967235|FG000|Overall Study|Death|5
6933876|NCT00892008|10967235|FG000|Overall Study|Lack of Efficacy|3
6933877|NCT00892008|10967235|FG000|Overall Study|Lost to Follow-up|142
6933878|NCT00892008|10967235|FG000|Overall Study|Other|378
6933879|NCT00892008|10967235|FG000|Overall Study|Adverse Event|37
6933880|NCT00892047|10967241|FG000|Overall Study|Adverse Event|2
6933881|NCT00892047|10967242|FG001|Overall Study|Adverse Event|2
6933882|NCT00892047|10967241|FG000|Overall Study|subject burden|2
6933883|NCT00892047|10967242|FG001|Overall Study|subject burden|3
6933884|NCT00892047|10967241|FG000|Overall Study|Lack of Efficacy|0
6933885|NCT00892047|10967242|FG001|Overall Study|Lack of Efficacy|2
6933886|NCT00892099|10967253|FG000|Overall Study|Death|1
6933887|NCT00892099|10967254|FG001|Overall Study|Death|0
6933888|NCT00892099|10967255|FG002|Overall Study|Death|1
6933889|NCT00892099|10967253|FG000|Overall Study|Adverse Event|1
6933890|NCT00892099|10967254|FG001|Overall Study|Adverse Event|0
6933891|NCT00892099|10967255|FG002|Overall Study|Adverse Event|0
6933892|NCT00892099|10967253|FG000|Overall Study|replocated|1
6933893|NCT00892099|10967254|FG001|Overall Study|replocated|0
6933894|NCT00892099|10967255|FG002|Overall Study|replocated|2
6933895|NCT00892099|10967253|FG000|Overall Study|Prolonged hospitalization|1
6933896|NCT00892099|10967254|FG001|Overall Study|Prolonged hospitalization|0
6933897|NCT00892099|10967255|FG002|Overall Study|Prolonged hospitalization|1
6933898|NCT00892099|10967253|FG000|Overall Study|no further details|1
6933899|NCT00892099|10967254|FG001|Overall Study|no further details|0
6933900|NCT00892099|10967255|FG002|Overall Study|no further details|1
6933901|NCT00892099|10967253|FG000|Overall Study|kidney function recovered|0
6933902|NCT00892099|10967254|FG001|Overall Study|kidney function recovered|1
6933903|NCT00892099|10967255|FG002|Overall Study|kidney function recovered|0
6933904|NCT00892099|10967253|FG000|Overall Study|investigator decision|0
6933905|NCT00892099|10967254|FG001|Overall Study|investigator decision|0
6933906|NCT00892099|10967255|FG002|Overall Study|investigator decision|1
6933907|NCT00892099|10967253|FG000|Overall Study|Lost to Follow-up|0
6933908|NCT00892099|10967254|FG001|Overall Study|Lost to Follow-up|0
6933909|NCT00892099|10967255|FG002|Overall Study|Lost to Follow-up|1
6933910|NCT00892151|10967263|FG000|Overall Study|Protocol Violation|1
6933911|NCT00892177|10967270|FG000|Phase II|Ineligible|0
6933912|NCT00892177|10967271|FG001|Phase II|Ineligible|0
6933913|NCT00892177|10967272|FG002|Phase II|Ineligible|0
6933914|NCT00892177|10967273|FG003|Phase II|Ineligible|0
6933915|NCT00892177|10967274|FG004|Phase II|Ineligible|1
6933916|NCT00892177|10967275|FG005|Phase II|Ineligible|1
6933917|NCT00892177|10967270|FG000|Phase II|Withdrawal by Subject|0
6933918|NCT00892177|10967271|FG001|Phase II|Withdrawal by Subject|0
6933919|NCT00892177|10967272|FG002|Phase II|Withdrawal by Subject|0
6933920|NCT00892177|10967273|FG003|Phase II|Withdrawal by Subject|0
6933921|NCT00892177|10967274|FG004|Phase II|Withdrawal by Subject|4
6933922|NCT00892177|10967275|FG005|Phase II|Withdrawal by Subject|1
6933923|NCT00892281|10967292|FG000|Overall Study|Adverse Event|65
6933924|NCT00892281|10967293|FG001|Overall Study|Adverse Event|8
6933925|NCT00892281|10967292|FG000|Overall Study|Lost to Follow-up|81
6933926|NCT00892281|10967293|FG001|Overall Study|Lost to Follow-up|8
6933927|NCT00892281|10967292|FG000|Overall Study|Pregnancy|1
6933928|NCT00892281|10967293|FG001|Overall Study|Pregnancy|0
6933929|NCT00892281|10967292|FG000|Overall Study|Protocol Violation|7
6933930|NCT00892281|10967293|FG001|Overall Study|Protocol Violation|2
6933931|NCT00892281|10967292|FG000|Overall Study|Withdrawal by Subject|86
6933932|NCT00892281|10967293|FG001|Overall Study|Withdrawal by Subject|14
6933933|NCT00892281|10967292|FG000|Overall Study|Subject failed to return for final visit|2
6933934|NCT00892281|10967293|FG001|Overall Study|Subject failed to return for final visit|0
6933935|NCT00892281|10967292|FG000|Overall Study|Subject unable to keep follow-up visits|1
6933936|NCT00892281|10967293|FG001|Overall Study|Subject unable to keep follow-up visits|0
6933937|NCT00892281|10967292|FG000|Overall Study|Final visit completed 4 weeks late|0
6933938|NCT00892281|10967293|FG001|Overall Study|Final visit completed 4 weeks late|1
6933939|NCT00892281|10967292|FG000|Overall Study|Subject completed day after study closed|1
6933940|NCT00892281|10967293|FG001|Overall Study|Subject completed day after study closed|0
6933941|NCT00892281|10967292|FG000|Overall Study|Family emergency|1
6933942|NCT00892281|10967293|FG001|Overall Study|Family emergency|0
6933943|NCT00892281|10967292|FG000|Overall Study|Last visit not done - death in family|1
6933944|NCT00892281|10967293|FG001|Overall Study|Last visit not done - death in family|0
6933945|NCT00892281|10967292|FG000|Overall Study|Did not meet incl/excl criteria|1
6933946|NCT00892281|10967293|FG001|Overall Study|Did not meet incl/excl criteria|0
6933947|NCT00892281|10967292|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1
6933948|NCT00892281|10967293|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0
6933949|NCT00892281|10967292|FG000|Overall Study|Unable to redeem the drug voucher|1
6933950|NCT00892281|10967293|FG001|Overall Study|Unable to redeem the drug voucher|0
6933951|NCT00892281|10967292|FG000|Overall Study|Subject not good candidate for study|1
6933952|NCT00892281|10967293|FG001|Overall Study|Subject not good candidate for study|0
6933953|NCT00892281|10967292|FG000|Overall Study|Subject did not return for any visits|1
6933954|NCT00892281|10967293|FG001|Overall Study|Subject did not return for any visits|0
6933955|NCT00892281|10967292|FG000|Overall Study|Subject missed several visits/lost meds|1
6933956|NCT00892281|10967293|FG001|Overall Study|Subject missed several visits/lost meds|0
6933957|NCT00892281|10967292|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1
6933958|NCT00892281|10967293|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1
6933959|NCT00892281|10967292|FG000|Overall Study|Scheduled for knee replacement|0
6933960|NCT00892281|10967293|FG001|Overall Study|Scheduled for knee replacement|1
6933961|NCT00892281|10967292|FG000|Overall Study|PI complained of inadequate compensation|3
6933962|NCT00892281|10967293|FG001|Overall Study|PI complained of inadequate compensation|0
6933963|NCT00892281|10967292|FG000|Overall Study|Subject lost interest in program|0
6933964|NCT00892281|10967293|FG001|Overall Study|Subject lost interest in program|1
6933965|NCT00892281|10967292|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0
6933966|NCT00892281|10967293|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1
6933967|NCT00892281|10967292|FG000|Overall Study|Death in family|1
6933968|NCT00892281|10967293|FG001|Overall Study|Death in family|0
6933969|NCT00892281|10967292|FG000|Overall Study|Lack of efficacy of study product|2
6933970|NCT00892281|10967293|FG001|Overall Study|Lack of efficacy of study product|0
6933971|NCT00892281|10967292|FG000|Overall Study|Subject not seen by PI at final visit|1
6933972|NCT00892281|10967293|FG001|Overall Study|Subject not seen by PI at final visit|0
6933973|NCT00892281|10967292|FG000|Overall Study|No show Visit 2; prescription not filled|1
6933974|NCT00892281|10967293|FG001|Overall Study|No show Visit 2; prescription not filled|0
6933975|NCT00892281|10967292|FG000|Overall Study|Missed multiple visits|1
6933976|NCT00892281|10967293|FG001|Overall Study|Missed multiple visits|0
6933977|NCT00892281|10967292|FG000|Overall Study|Missed visits rescheduled out of window|1
6933978|NCT00892281|10967293|FG001|Overall Study|Missed visits rescheduled out of window|0
6933979|NCT00892281|10967292|FG000|Overall Study|Non-compliant with visits as scheduled|1
6933980|NCT00892281|10967293|FG001|Overall Study|Non-compliant with visits as scheduled|0
6933981|NCT00892281|10967292|FG000|Overall Study|Subject had history of drug abuse|1
6933982|NCT00892281|10967293|FG001|Overall Study|Subject had history of drug abuse|0
6933983|NCT00892281|10967292|FG000|Overall Study|Rash on hand|1
6933984|NCT00892281|10967293|FG001|Overall Study|Rash on hand|0
6933985|NCT00892281|10967292|FG000|Overall Study|Visit 4 date out of window|1
6933986|NCT00892281|10967293|FG001|Overall Study|Visit 4 date out of window|0
6933987|NCT00892437|10967301|FG000|Randomized Phase|Randomized but not treated|6
6933988|NCT00892437|10967302|FG001|Randomized Phase|Randomized but not treated|0
6933989|NCT00892437|10967301|FG000|Randomized Phase|Adverse Event|2
6933990|NCT00892437|10967302|FG001|Randomized Phase|Adverse Event|2
6933991|NCT00892437|10967301|FG000|Randomized Phase|Lost to Follow-up|1
6933992|NCT00892437|10967302|FG001|Randomized Phase|Lost to Follow-up|3
6933993|NCT00892437|10967301|FG000|Randomized Phase|Investigator's Discretion|1
6933994|NCT00892437|10967302|FG001|Randomized Phase|Investigator's Discretion|0
6933995|NCT00892437|10967301|FG000|Randomized Phase|Withdrew Consent|1
6933996|NCT00892437|10967302|FG001|Randomized Phase|Withdrew Consent|0
6933997|NCT00892437|10967301|FG000|Open-Label Extension Phase|Adverse Event|4
6933998|NCT00892437|10967302|FG001|Open-Label Extension Phase|Adverse Event|2
6933999|NCT00892437|10967301|FG000|Open-Label Extension Phase|Lack of Efficacy|1
6934000|NCT00892437|10967302|FG001|Open-Label Extension Phase|Lack of Efficacy|0
6934001|NCT00892437|10967301|FG000|Open-Label Extension Phase|Lost to Follow-up|3
6934002|NCT00892437|10967302|FG001|Open-Label Extension Phase|Lost to Follow-up|1
6934003|NCT00892437|10967301|FG000|Open-Label Extension Phase|Investigator's Discretion|1
6934004|NCT00892437|10967302|FG001|Open-Label Extension Phase|Investigator's Discretion|0
6934005|NCT00892437|10967301|FG000|Open-Label Extension Phase|Withdrew Consent|3
6934006|NCT00892437|10967302|FG001|Open-Label Extension Phase|Withdrew Consent|1
6934007|NCT00892723|10967339|FG000|Overall Study|Lost to Follow-up|1
6934008|NCT00892723|10967340|FG001|Overall Study|Lost to Follow-up|3
6934009|NCT00892723|10967341|FG002|Overall Study|Lost to Follow-up|1
6934010|NCT00892723|10967339|FG000|Overall Study|Withdrawal by Subject|1
6934011|NCT00892723|10967340|FG001|Overall Study|Withdrawal by Subject|1
6934012|NCT00892723|10967341|FG002|Overall Study|Withdrawal by Subject|1
6934013|NCT00892775|10967384|FG000|Overall Study|Protocol Violation|1
6934014|NCT00892775|10967385|FG001|Overall Study|Protocol Violation|0
6934015|NCT00892775|10967384|FG000|Overall Study|Subject difficulties with blood drawing|1
6934016|NCT00892775|10967385|FG001|Overall Study|Subject difficulties with blood drawing|0
6934017|NCT00892775|10967384|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1
6934018|NCT00892775|10967385|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0
6934019|NCT00892775|10967384|FG000|Overall Study|Migrated/ moved from study area|1
6934020|NCT00892775|10967385|FG001|Overall Study|Migrated/ moved from study area|0
6934021|NCT00892775|10967384|FG000|Overall Study|Withdrawal by Subject|0
6934022|NCT00892775|10967385|FG001|Overall Study|Withdrawal by Subject|1
6934023|NCT00892775|10967384|FG000|Overall Study|Lost to Follow-up|1
6934024|NCT00892775|10967385|FG001|Overall Study|Lost to Follow-up|0
6934025|NCT00892957|10967393|FG000|Between Postoperative Day 1 and Day 14|Death|0
6934026|NCT00892957|10967394|FG001|Between Postoperative Day 1 and Day 14|Death|2
6934027|NCT00892957|10967393|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0
6934028|NCT00892957|10967394|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2
6934029|NCT00893113|10967431|FG000|Overall Study|Lost to Follow-up|4
6934030|NCT00893113|10967432|FG001|Overall Study|Lost to Follow-up|8
6934031|NCT00893113|10967431|FG000|Overall Study|Early Termination|1
6934032|NCT00893113|10967432|FG001|Overall Study|Early Termination|1
6934033|NCT00893113|10967431|FG000|Overall Study|Withdrew Consent|8
6934034|NCT00893113|10967432|FG001|Overall Study|Withdrew Consent|7
6934035|NCT00893464|10967455|FG000|Overall Study|Did not complete therapy/experience PD|0
6934036|NCT00893464|10967456|FG001|Overall Study|Did not complete therapy/experience PD|0
6934037|NCT00893464|10967457|FG002|Overall Study|Did not complete therapy/experience PD|0
6934038|NCT00893464|10967458|FG003|Overall Study|Did not complete therapy/experience PD|0
6934039|NCT00893464|10967459|FG004|Overall Study|Did not complete therapy/experience PD|0
6934040|NCT00893464|10967460|FG005|Overall Study|Did not complete therapy/experience PD|0
6934041|NCT00893464|10967461|FG006|Overall Study|Did not complete therapy/experience PD|2
6934042|NCT00893464|10967462|FG007|Overall Study|Did not complete therapy/experience PD|2
6934043|NCT00893737|10967485|FG000|Overall Study|Adverse Event|4
6934044|NCT00893737|10967485|FG000|Overall Study|Withdrawal by Subject|2
6934045|NCT00893737|10967485|FG000|Overall Study|Lost to Follow-up|6
6934046|NCT00893763|10967491|FG000|Overall Study|extubated|110
6934047|NCT00893763|10967492|FG001|Overall Study|extubated|110
6934048|NCT00893971|10967500|FG000|Overall Study|Physician Decision|3
6934049|NCT00894166|10967533|FG000|Overall Study|Withdrew or Lost to Follow-Up|61
6934050|NCT00894166|10967534|FG001|Overall Study|Withdrew or Lost to Follow-Up|63
6934051|NCT00894166|10967535|FG002|Overall Study|Withdrew or Lost to Follow-Up|62
6934052|NCT00894166|10967536|FG003|Overall Study|Withdrew or Lost to Follow-Up|68
6934053|NCT00894166|10967537|FG004|Overall Study|Withdrew or Lost to Follow-Up|24
6934054|NCT00894166|10967538|FG005|Overall Study|Withdrew or Lost to Follow-Up|16
6934055|NCT00894166|10967539|FG006|Overall Study|Withdrew or Lost to Follow-Up|16
6934056|NCT00894166|10967540|FG007|Overall Study|Withdrew or Lost to Follow-Up|34
6934057|NCT00894166|10967533|FG000|Overall Study|Death|0
6934058|NCT00894166|10967534|FG001|Overall Study|Death|0
6934059|NCT00894166|10967535|FG002|Overall Study|Death|0
6934060|NCT00894166|10967536|FG003|Overall Study|Death|1
6934061|NCT00894166|10967537|FG004|Overall Study|Death|0
6934062|NCT00894166|10967538|FG005|Overall Study|Death|0
6934063|NCT00894166|10967539|FG006|Overall Study|Death|0
6934064|NCT00894166|10967540|FG007|Overall Study|Death|0
6934065|NCT00894322|10967566|FG000|Overall Study|Withdrawal by Subject|1
6934066|NCT00894322|10967567|FG001|Overall Study|Withdrawal by Subject|0
6934067|NCT00894322|10967568|FG002|Overall Study|Withdrawal by Subject|0
6934068|NCT00894361|10967580|FG000|Overall Study|deaths and less than 2 years followup|24
6934069|NCT00894361|10967581|FG001|Overall Study|deaths and less than 2 years followup|64
6934070|NCT00894387|10967591|FG000|Overall Study|Adverse Event|44
6934071|NCT00894387|10967592|FG001|Overall Study|Adverse Event|45
6934072|NCT00894387|10967591|FG000|Overall Study|Abnormal Laboratory values|2
6934073|NCT00894387|10967592|FG001|Overall Study|Abnormal Laboratory values|2
6934074|NCT00894387|10967591|FG000|Overall Study|Unsatisfactory therapeutic effect|0
6934075|NCT00894387|10967592|FG001|Overall Study|Unsatisfactory therapeutic effect|1
6934076|NCT00894387|10967591|FG000|Overall Study|Lost to Follow-up|3
6934077|NCT00894387|10967592|FG001|Overall Study|Lost to Follow-up|5
6934078|NCT00894387|10967591|FG000|Overall Study|Administrative problems|2
6934079|NCT00894387|10967592|FG001|Overall Study|Administrative problems|2
6934080|NCT00894387|10967591|FG000|Overall Study|Death|77
6934081|NCT00894387|10967592|FG001|Overall Study|Death|76
6934082|NCT00894387|10967591|FG000|Overall Study|Protocol Deviation|4
6934083|NCT00894387|10967592|FG001|Overall Study|Protocol Deviation|0
6934084|NCT00894387|10967591|FG000|Overall Study|Patient's request|25
6934085|NCT00894387|10967592|FG001|Overall Study|Patient's request|30
6934086|NCT00894387|10967591|FG000|Overall Study|Other (Missing)|5
6934087|NCT00894387|10967592|FG001|Overall Study|Other (Missing)|3
6934088|NCT00894387|10967591|FG000|Overall Study|Mis-randomized|13
6934089|NCT00894387|10967592|FG001|Overall Study|Mis-randomized|9
6934090|NCT00894387|10967591|FG000|Overall Study|GCP non-compliance|0
6934091|NCT00894387|10967592|FG001|Overall Study|GCP non-compliance|2
6934092|NCT00894413|10967600|FG000|Overall Study|Physician Decision|0
6934093|NCT00894413|10967601|FG001|Overall Study|Physician Decision|2
6934094|NCT00894413|10967600|FG000|Overall Study|Adverse Event|0
6934095|NCT00894413|10967601|FG001|Overall Study|Adverse Event|2
6934096|NCT00894413|10967600|FG000|Overall Study|Withdrawal by Subject|0
6934097|NCT00894413|10967601|FG001|Overall Study|Withdrawal by Subject|4
6934098|NCT00894543|10967643|FG000|Baseline to Week 4|No diary or lost or withdrew|3
6934099|NCT00894543|10967644|FG001|Baseline to Week 4|No diary or lost or withdrew|2
6934100|NCT00894543|10967643|FG000|Week 4 to Week 8|No diary or lost or withdrew|4
6934101|NCT00894543|10967644|FG001|Week 4 to Week 8|No diary or lost or withdrew|2
6934102|NCT00894647|10967652|FG000|Overall Study|Adverse Event|5
6934103|NCT00894647|10967653|FG001|Overall Study|Adverse Event|4
6934104|NCT00894647|10967652|FG000|Overall Study|Withdrawal by Subject|4
6934105|NCT00894647|10967653|FG001|Overall Study|Withdrawal by Subject|4
6934106|NCT00894647|10967652|FG000|Overall Study|Lost to Follow-up|0
6934107|NCT00894647|10967653|FG001|Overall Study|Lost to Follow-up|2
6934108|NCT00894647|10967652|FG000|Overall Study|Non-compliance with study procedures|0
6934109|NCT00894647|10967653|FG001|Overall Study|Non-compliance with study procedures|2
6934110|NCT00894647|10967652|FG000|Overall Study|Other, not due to AE|1
6934111|NCT00894647|10967653|FG001|Overall Study|Other, not due to AE|2
6934112|NCT00894686|10967659|FG000|Overall Study|Withdrawal by Subject|50
6934113|NCT00894686|10967659|FG000|Overall Study|Physician Decision|1
6934114|NCT00894686|10967659|FG000|Overall Study|Other|5
6975275|NCT01192022|11027401|FG002|Overall Study|Physician withdrew-patient hardship|0
6975276|NCT01192022|11027402|FG003|Overall Study|Physician withdrew-patient hardship|0
6975277|NCT01192022|11027403|FG004|Overall Study|Physician withdrew-patient hardship|0
6975278|NCT01192022|11027399|FG000|Overall Study|Patient too sick from chemotherapy|0
6975279|NCT01192022|11027400|FG001|Overall Study|Patient too sick from chemotherapy|1
6975280|NCT01192022|11027401|FG002|Overall Study|Patient too sick from chemotherapy|0
6975281|NCT01192022|11027402|FG003|Overall Study|Patient too sick from chemotherapy|0
6975282|NCT01192022|11027403|FG004|Overall Study|Patient too sick from chemotherapy|0
6975283|NCT01192022|11027399|FG000|Overall Study|Patient needed surgery|0
6975284|NCT01192022|11027400|FG001|Overall Study|Patient needed surgery|1
6975285|NCT01192022|11027401|FG002|Overall Study|Patient needed surgery|0
6975286|NCT01192022|11027402|FG003|Overall Study|Patient needed surgery|0
6975287|NCT01192022|11027403|FG004|Overall Study|Patient needed surgery|0
6975288|NCT01192022|11027399|FG000|Overall Study|Parents did not allow all follow up|0
6975289|NCT01192022|11027400|FG001|Overall Study|Parents did not allow all follow up|0
6975290|NCT01192022|11027401|FG002|Overall Study|Parents did not allow all follow up|0
6975291|NCT01192022|11027402|FG003|Overall Study|Parents did not allow all follow up|1
6975292|NCT01192022|11027403|FG004|Overall Study|Parents did not allow all follow up|0
6975293|NCT01192100|11027414|FG000|Overall Study|Withdrawal by Subject|0
6975294|NCT01192100|11027415|FG001|Overall Study|Withdrawal by Subject|0
6975295|NCT01192100|11027416|FG002|Overall Study|Withdrawal by Subject|0
6975296|NCT01192100|11027417|FG003|Overall Study|Withdrawal by Subject|0
6975297|NCT01192100|11027418|FG004|Overall Study|Withdrawal by Subject|1
6975298|NCT01192100|11027419|FG005|Overall Study|Withdrawal by Subject|0
6975299|NCT01192100|11027414|FG000|Overall Study|Protocol Violation|0
6975300|NCT01192100|11027415|FG001|Overall Study|Protocol Violation|0
6975301|NCT01192100|11027416|FG002|Overall Study|Protocol Violation|0
6975302|NCT01192100|11027417|FG003|Overall Study|Protocol Violation|1
6975303|NCT01192100|11027418|FG004|Overall Study|Protocol Violation|0
6975304|NCT01192100|11027419|FG005|Overall Study|Protocol Violation|0
6975305|NCT01192126|11027429|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1
6975306|NCT01192126|11027430|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0
6975307|NCT01192126|11027429|FG000|First Intervention (1 Week)|Lost to Follow-up|1
6975308|NCT01192126|11027430|FG001|First Intervention (1 Week)|Lost to Follow-up|1
6975309|NCT01192152|11027449|FG000|Period 1|left prematurely (while on treatment B)|0
6975310|NCT01192152|11027450|FG001|Period 1|left prematurely (while on treatment B)|1
6975311|NCT01192152|11027449|FG000|Period 3|family emergency|1
6975312|NCT01192152|11027450|FG001|Period 3|family emergency|0
6975313|NCT01192178|11027460|FG000|Overall Study|Withdrawal by Subject|6
6975314|NCT01192178|11027461|FG001|Overall Study|Withdrawal by Subject|10
6975315|NCT01192178|11027460|FG000|Overall Study|Protocol Violation|10
6975316|NCT01192178|11027461|FG001|Overall Study|Protocol Violation|3
6975317|NCT01192178|11027460|FG000|Overall Study|Physician Decision|2
6975318|NCT01192178|11027461|FG001|Overall Study|Physician Decision|4
6975319|NCT01192178|11027460|FG000|Overall Study|Lost to Follow-up|3
6975320|NCT01192178|11027461|FG001|Overall Study|Lost to Follow-up|3
6975321|NCT01192178|11027460|FG000|Overall Study|Adverse Event|2
6975322|NCT01192178|11027461|FG001|Overall Study|Adverse Event|1
6975323|NCT01192178|11027460|FG000|Overall Study|Lack of Efficacy|1
6975324|NCT01192178|11027461|FG001|Overall Study|Lack of Efficacy|2
6975325|NCT01192191|11027471|FG000|Overall Study|Adverse Event|7
6975326|NCT01192191|11027472|FG001|Overall Study|Adverse Event|12
6975327|NCT01192191|11027471|FG000|Overall Study|Participants Reached Stopping Criteria|3
6975328|NCT01192191|11027472|FG001|Overall Study|Participants Reached Stopping Criteria|2
6975329|NCT01192191|11027471|FG000|Overall Study|Lost to Follow-up|0
6975330|NCT01192191|11027472|FG001|Overall Study|Lost to Follow-up|1
6975331|NCT01192191|11027471|FG000|Overall Study|Withdrawal by Subject|1
6975332|NCT01192191|11027472|FG001|Overall Study|Withdrawal by Subject|6
6975333|NCT01192204|11027480|FG000|Overall Study|could not keep recall appointments|1
6934115|NCT00894803|10967683|FG000|Overall Study|Death|20
6934116|NCT00894803|10967684|FG001|Overall Study|Death|4
6934117|NCT00894803|10967683|FG000|Overall Study|Lost to Follow-up|0
6934118|NCT00894803|10967684|FG001|Overall Study|Lost to Follow-up|1
6934119|NCT00894933|10967690|FG000|Overall Study|Lost to Follow-up|2
6934120|NCT00894933|10967690|FG000|Overall Study|Cancelled Procedure|1
6934121|NCT00894933|10967690|FG000|Overall Study|Did not meeting incl/excl criteria|1
6934122|NCT00895011|10967697|FG000|Overall Study|Withdrawal by Subject|14
6934123|NCT00895011|10967698|FG001|Overall Study|Withdrawal by Subject|7
6934124|NCT00895011|10967699|FG002|Overall Study|Withdrawal by Subject|2
6934125|NCT00895011|10967697|FG000|Overall Study|Lost to Follow-up|5
6934126|NCT00895011|10967698|FG001|Overall Study|Lost to Follow-up|4
6934127|NCT00895011|10967699|FG002|Overall Study|Lost to Follow-up|1
6934128|NCT00895011|10967697|FG000|Overall Study|Protocol Violation|3
6934129|NCT00895011|10967698|FG001|Overall Study|Protocol Violation|1
6934130|NCT00895011|10967699|FG002|Overall Study|Protocol Violation|3
6934131|NCT00895011|10967697|FG000|Overall Study|Adverse Event|1
6934132|NCT00895011|10967698|FG001|Overall Study|Adverse Event|2
6934133|NCT00895011|10967699|FG002|Overall Study|Adverse Event|2
6934134|NCT00895011|10967697|FG000|Overall Study|schedule conflict|1
6934135|NCT00895011|10967698|FG001|Overall Study|schedule conflict|0
6934136|NCT00895011|10967699|FG002|Overall Study|schedule conflict|0
6934137|NCT00895037|10967711|FG000|Overall Study|Death|0
6934138|NCT00895037|10967712|FG001|Overall Study|Death|2
6934139|NCT00895037|10967713|FG002|Overall Study|Death|1
6934140|NCT00895154|10967723|FG000|Overall Study|Lost to Follow-up|1
6934141|NCT00895154|10967724|FG001|Overall Study|Lost to Follow-up|1
6934142|NCT00895154|10967723|FG000|Overall Study|Withdrawal by Subject|0
6934143|NCT00895154|10967724|FG001|Overall Study|Withdrawal by Subject|1
6934144|NCT00895245|10967771|FG000|Overall Study|Lack of Efficacy|6
6934145|NCT00895310|10967775|FG000|Overall Study|Withdrawal by Subject|1
6934146|NCT00895414|10967779|FG000|First Intervention (14 Days)|Withdrawal by Subject|1
6934147|NCT00895414|10967780|FG001|First Intervention (14 Days)|Withdrawal by Subject|0
6934148|NCT00895414|10967779|FG000|First Intervention (14 Days)|Physician Decision|0
6934149|NCT00895414|10967780|FG001|First Intervention (14 Days)|Physician Decision|1
6934150|NCT00895453|10967789|FG000|Overall Study|Lost to Follow-up|25
6934151|NCT00895453|10967790|FG001|Overall Study|Lost to Follow-up|25
6934152|NCT00895453|10967791|FG002|Overall Study|Lost to Follow-up|23
6934153|NCT00895583|10967810|FG000|Overall Study|Adverse Event|28
6934154|NCT00895583|10967811|FG001|Overall Study|Adverse Event|4
6934155|NCT00895583|10967810|FG000|Overall Study|Death|2
6934156|NCT00895583|10967811|FG001|Overall Study|Death|1
6934157|NCT00895583|10967810|FG000|Overall Study|Physician Decision|3
6934158|NCT00895583|10967811|FG001|Overall Study|Physician Decision|1
6934159|NCT00895583|10967810|FG000|Overall Study|Lost to Follow-up|1
6934160|NCT00895583|10967811|FG001|Overall Study|Lost to Follow-up|3
6934161|NCT00895583|10967810|FG000|Overall Study|Protocol Violation|1
6934162|NCT00895583|10967811|FG001|Overall Study|Protocol Violation|0
6934163|NCT00895583|10967810|FG000|Overall Study|Withdrawal by Subject|4
7065633|NCT01968070|11165314|FG011|Period 1|Withdrawal by Subject|0
7065634|NCT01968070|11165315|FG012|Period 1|Withdrawal by Subject|0
7065635|NCT01968070|11165316|FG013|Period 1|Withdrawal by Subject|0
7065636|NCT01968070|11165317|FG014|Period 1|Withdrawal by Subject|0
7065637|NCT01968070|11165318|FG015|Period 1|Withdrawal by Subject|1
7065638|NCT01968070|11165319|FG016|Period 1|Withdrawal by Subject|0
7065639|NCT01968070|11165320|FG017|Period 1|Withdrawal by Subject|0
7065640|NCT01968070|11165303|FG000|Period 1|Protocol Violation|0
7065641|NCT01968070|11165304|FG001|Period 1|Protocol Violation|0
7065642|NCT01968070|11165305|FG002|Period 1|Protocol Violation|0
7065643|NCT01968070|11165306|FG003|Period 1|Protocol Violation|1
7065644|NCT01968070|11165307|FG004|Period 1|Protocol Violation|1
7065645|NCT01968070|11165308|FG005|Period 1|Protocol Violation|0
7065646|NCT01968070|11165309|FG006|Period 1|Protocol Violation|0
7065647|NCT01968070|11165310|FG007|Period 1|Protocol Violation|0
6934164|NCT00895583|10967811|FG001|Overall Study|Withdrawal by Subject|2
6934165|NCT00895583|10967810|FG000|Overall Study|Lack of Efficacy|5
6934166|NCT00895583|10967811|FG001|Overall Study|Lack of Efficacy|0
6934167|NCT00895583|10967810|FG000|Overall Study|Other|0
6934168|NCT00895583|10967811|FG001|Overall Study|Other|1
6934169|NCT00895622|10967820|FG000|Overall Study|Protocol Violation|5
6934170|NCT00895622|10967821|FG001|Overall Study|Protocol Violation|4
6934171|NCT00895622|10967822|FG002|Overall Study|Protocol Violation|4
6934172|NCT00895661|10967838|FG000|Overall Study|Death|1
6934173|NCT00895661|10967838|FG000|Overall Study|reason unknown|2
6934174|NCT00895843|10967880|FG000|Overall Study|Protocol Violation|12
6934175|NCT00895843|10967881|FG001|Overall Study|Protocol Violation|12
6934176|NCT00895895|10967892|FG000|Period 1|Adverse Event|7
6934177|NCT00895895|10967893|FG001|Period 1|Adverse Event|6
6934178|NCT00895895|10967894|FG002|Period 1|Adverse Event|4
6934179|NCT00895895|10967895|FG003|Period 1|Adverse Event|6
6934180|NCT00895895|10967896|FG004|Period 1|Adverse Event|7
6934181|NCT00895895|10967892|FG000|Period 1|Death|0
6934182|NCT00895895|10967893|FG001|Period 1|Death|0
7065648|NCT01968070|11165311|FG008|Period 1|Protocol Violation|0
7065649|NCT01968070|11165312|FG009|Period 1|Protocol Violation|0
7065650|NCT01968070|11165313|FG010|Period 1|Protocol Violation|0
7065651|NCT01968070|11165314|FG011|Period 1|Protocol Violation|0
7065652|NCT01968070|11165315|FG012|Period 1|Protocol Violation|0
6934183|NCT00895895|10967894|FG002|Period 1|Death|0
6934184|NCT00895895|10967895|FG003|Period 1|Death|0
6934185|NCT00895895|10967896|FG004|Period 1|Death|1
6934186|NCT00895895|10967892|FG000|Period 1|discontinued by sponsor|2
6934187|NCT00895895|10967893|FG001|Period 1|discontinued by sponsor|1
6934188|NCT00895895|10967894|FG002|Period 1|discontinued by sponsor|2
6934189|NCT00895895|10967895|FG003|Period 1|discontinued by sponsor|1
6934190|NCT00895895|10967896|FG004|Period 1|discontinued by sponsor|1
6934191|NCT00895895|10967892|FG000|Period 1|failed to return|0
6934192|NCT00895895|10967893|FG001|Period 1|failed to return|0
6934193|NCT00895895|10967894|FG002|Period 1|failed to return|1
6934194|NCT00895895|10967895|FG003|Period 1|failed to return|0
6934195|NCT00895895|10967896|FG004|Period 1|failed to return|1
6934196|NCT00895895|10967892|FG000|Period 1|investigator request|0
6934197|NCT00895895|10967893|FG001|Period 1|investigator request|1
6934198|NCT00895895|10967894|FG002|Period 1|investigator request|0
6934199|NCT00895895|10967895|FG003|Period 1|investigator request|0
6934200|NCT00895895|10967896|FG004|Period 1|investigator request|0
6934201|NCT00895895|10967892|FG000|Period 1|Lost to Follow-up|2
6934202|NCT00895895|10967893|FG001|Period 1|Lost to Follow-up|1
6934203|NCT00895895|10967894|FG002|Period 1|Lost to Follow-up|3
6934204|NCT00895895|10967895|FG003|Period 1|Lost to Follow-up|2
6934205|NCT00895895|10967896|FG004|Period 1|Lost to Follow-up|3
6934206|NCT00895895|10967892|FG000|Period 1|Other|1
6934207|NCT00895895|10967893|FG001|Period 1|Other|2
6934208|NCT00895895|10967894|FG002|Period 1|Other|1
6934209|NCT00895895|10967895|FG003|Period 1|Other|1
6934210|NCT00895895|10967896|FG004|Period 1|Other|1
6934211|NCT00895895|10967892|FG000|Period 1|Protocol Violation|0
6934212|NCT00895895|10967893|FG001|Period 1|Protocol Violation|1
6934213|NCT00895895|10967894|FG002|Period 1|Protocol Violation|0
6934214|NCT00895895|10967895|FG003|Period 1|Protocol Violation|0
6934215|NCT00895895|10967896|FG004|Period 1|Protocol Violation|0
6934216|NCT00895895|10967892|FG000|Period 1|Withdrawal by Subject|6
6934217|NCT00895895|10967893|FG001|Period 1|Withdrawal by Subject|6
6934218|NCT00895895|10967894|FG002|Period 1|Withdrawal by Subject|8
6934219|NCT00895895|10967895|FG003|Period 1|Withdrawal by Subject|2
6934220|NCT00895895|10967896|FG004|Period 1|Withdrawal by Subject|4
6934221|NCT00895895|10967892|FG000|Period 1|unsatisfactory response-efficacy|2
6934222|NCT00895895|10967893|FG001|Period 1|unsatisfactory response-efficacy|0
6934223|NCT00895895|10967894|FG002|Period 1|unsatisfactory response-efficacy|0
6934224|NCT00895895|10967895|FG003|Period 1|unsatisfactory response-efficacy|0
6934225|NCT00895895|10967896|FG004|Period 1|unsatisfactory response-efficacy|0
6934226|NCT00895895|10967892|FG000|Period 1|randomized and not treated|1
6934227|NCT00895895|10967893|FG001|Period 1|randomized and not treated|3
6934228|NCT00895895|10967894|FG002|Period 1|randomized and not treated|1
6934229|NCT00895895|10967895|FG003|Period 1|randomized and not treated|1
6934230|NCT00895895|10967896|FG004|Period 1|randomized and not treated|2
6934231|NCT00895895|10967892|FG000|After Period 1, Prior to Period 2|Adverse Event|0
6934232|NCT00895895|10967893|FG001|After Period 1, Prior to Period 2|Adverse Event|0
6934233|NCT00895895|10967894|FG002|After Period 1, Prior to Period 2|Adverse Event|1
6934234|NCT00895895|10967895|FG003|After Period 1, Prior to Period 2|Adverse Event|0
6934235|NCT00895895|10967896|FG004|After Period 1, Prior to Period 2|Adverse Event|0
6934236|NCT00895895|10967892|FG000|After Period 1, Prior to Period 2|Other|0
6934237|NCT00895895|10967893|FG001|After Period 1, Prior to Period 2|Other|0
6934238|NCT00895895|10967894|FG002|After Period 1, Prior to Period 2|Other|1
6934239|NCT00895895|10967895|FG003|After Period 1, Prior to Period 2|Other|0
6934240|NCT00895895|10967896|FG004|After Period 1, Prior to Period 2|Other|0
6934241|NCT00895895|10967892|FG000|After Period 1, Prior to Period 2|Protocol Violation|0
6934242|NCT00895895|10967893|FG001|After Period 1, Prior to Period 2|Protocol Violation|0
6934243|NCT00895895|10967894|FG002|After Period 1, Prior to Period 2|Protocol Violation|0
6934244|NCT00895895|10967895|FG003|After Period 1, Prior to Period 2|Protocol Violation|0
6934245|NCT00895895|10967896|FG004|After Period 1, Prior to Period 2|Protocol Violation|1
6934246|NCT00895895|10967892|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0
6934247|NCT00895895|10967893|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0
6934248|NCT00895895|10967894|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0
7065653|NCT01968070|11165316|FG013|Period 1|Protocol Violation|0
7065654|NCT01968070|11165317|FG014|Period 1|Protocol Violation|0
7147642|NCT03131687|11308196|FG002|Overall Study|Participant Started New Diabetic Drug|0
6934249|NCT00895895|10967895|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0
6934250|NCT00895895|10967896|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1
6934251|NCT00895895|10967892|FG000|Period 2|Adverse Event|3
6934252|NCT00895895|10967893|FG001|Period 2|Adverse Event|3
6934253|NCT00895895|10967894|FG002|Period 2|Adverse Event|5
6934254|NCT00895895|10967895|FG003|Period 2|Adverse Event|2
6934255|NCT00895895|10967896|FG004|Period 2|Adverse Event|5
6934256|NCT00895895|10967892|FG000|Period 2|Death|0
6934257|NCT00895895|10967893|FG001|Period 2|Death|0
6934258|NCT00895895|10967894|FG002|Period 2|Death|1
6934259|NCT00895895|10967895|FG003|Period 2|Death|0
6934260|NCT00895895|10967896|FG004|Period 2|Death|0
6934261|NCT00895895|10967892|FG000|Period 2|discontinued by sponsor|44
6934262|NCT00895895|10967893|FG001|Period 2|discontinued by sponsor|44
6934263|NCT00895895|10967894|FG002|Period 2|discontinued by sponsor|38
6934264|NCT00895895|10967895|FG003|Period 2|discontinued by sponsor|46
6934265|NCT00895895|10967896|FG004|Period 2|discontinued by sponsor|37
6934266|NCT00895895|10967892|FG000|Period 2|failed to return|2
6934267|NCT00895895|10967893|FG001|Period 2|failed to return|0
6934268|NCT00895895|10967894|FG002|Period 2|failed to return|0
6934269|NCT00895895|10967895|FG003|Period 2|failed to return|0
6934270|NCT00895895|10967896|FG004|Period 2|failed to return|0
6934271|NCT00895895|10967892|FG000|Period 2|investigator request|2
6934272|NCT00895895|10967893|FG001|Period 2|investigator request|0
6934273|NCT00895895|10967894|FG002|Period 2|investigator request|0
6934274|NCT00895895|10967895|FG003|Period 2|investigator request|0
6934275|NCT00895895|10967896|FG004|Period 2|investigator request|0
7065655|NCT01968070|11165318|FG015|Period 1|Protocol Violation|0
7065656|NCT01968070|11165319|FG016|Period 1|Protocol Violation|0
7065657|NCT01968070|11165320|FG017|Period 1|Protocol Violation|0
7065658|NCT01968070|11165303|FG000|Period 1|Lost to Follow-up|0
7065659|NCT01968070|11165304|FG001|Period 1|Lost to Follow-up|0
6934276|NCT00895895|10967892|FG000|Period 2|Lost to Follow-up|1
6934277|NCT00895895|10967893|FG001|Period 2|Lost to Follow-up|2
6934278|NCT00895895|10967894|FG002|Period 2|Lost to Follow-up|1
6934279|NCT00895895|10967895|FG003|Period 2|Lost to Follow-up|1
6934280|NCT00895895|10967896|FG004|Period 2|Lost to Follow-up|0
6934281|NCT00895895|10967892|FG000|Period 2|Other|1
6934282|NCT00895895|10967893|FG001|Period 2|Other|1
6934283|NCT00895895|10967894|FG002|Period 2|Other|3
6934284|NCT00895895|10967895|FG003|Period 2|Other|1
6934285|NCT00895895|10967896|FG004|Period 2|Other|1
6934286|NCT00895895|10967892|FG000|Period 2|Protocol Violation|1
6934287|NCT00895895|10967893|FG001|Period 2|Protocol Violation|0
6934288|NCT00895895|10967894|FG002|Period 2|Protocol Violation|1
6934289|NCT00895895|10967895|FG003|Period 2|Protocol Violation|1
6934290|NCT00895895|10967896|FG004|Period 2|Protocol Violation|1
6934291|NCT00895895|10967892|FG000|Period 2|Withdrawal by Subject|0
6934292|NCT00895895|10967893|FG001|Period 2|Withdrawal by Subject|2
6934293|NCT00895895|10967894|FG002|Period 2|Withdrawal by Subject|0
6934294|NCT00895895|10967895|FG003|Period 2|Withdrawal by Subject|3
6934295|NCT00895895|10967896|FG004|Period 2|Withdrawal by Subject|5
6934296|NCT00895895|10967892|FG000|Period 2|unsatisfactory response-efficacy|2
6934297|NCT00895895|10967893|FG001|Period 2|unsatisfactory response-efficacy|1
6934298|NCT00895895|10967894|FG002|Period 2|unsatisfactory response-efficacy|0
6934299|NCT00895895|10967895|FG003|Period 2|unsatisfactory response-efficacy|0
6934300|NCT00895895|10967896|FG004|Period 2|unsatisfactory response-efficacy|0
7039938|NCT01713686|11122739|FG000|Overall Study|Withdrawal by Subject|6
7039939|NCT01713933|11122762|FG000|Overall Study|Lost to Follow-up|2
7039940|NCT01713933|11122762|FG000|Overall Study|Withdrawal by Subject|3
7039941|NCT01713933|11122762|FG000|Overall Study|Excluded from analysis as a BMI outlier|1
7039942|NCT01713946|11122769|FG000|Overall Study|Death|0
7039943|NCT01713946|11122770|FG001|Overall Study|Death|2
7039944|NCT01713946|11122771|FG002|Overall Study|Death|2
7039945|NCT01713946|11122769|FG000|Overall Study|Adverse Event|19
7039946|NCT01713946|11122770|FG001|Overall Study|Adverse Event|14
7039947|NCT01713946|11122771|FG002|Overall Study|Adverse Event|13
7039948|NCT01713946|11122769|FG000|Overall Study|Withdrawal by Subject|12
7039949|NCT01713946|11122770|FG001|Overall Study|Withdrawal by Subject|12
7039950|NCT01713946|11122771|FG002|Overall Study|Withdrawal by Subject|8
7039951|NCT01713946|11122769|FG000|Overall Study|Lack of Efficacy|8
7039952|NCT01713946|11122770|FG001|Overall Study|Lack of Efficacy|8
6934301|NCT00895947|10967941|FG000|Overall Study|Adverse Event|3
6934302|NCT00895947|10967942|FG001|Overall Study|Adverse Event|4
6934303|NCT00895947|10967941|FG000|Overall Study|Lost to Follow-up|3
6934304|NCT00895947|10967942|FG001|Overall Study|Lost to Follow-up|4
6934305|NCT00895947|10967941|FG000|Overall Study|Protocol Violation|4
6934306|NCT00895947|10967942|FG001|Overall Study|Protocol Violation|2
6934307|NCT00895947|10967941|FG000|Overall Study|Withdrawal by Subject|2
6934308|NCT00895947|10967942|FG001|Overall Study|Withdrawal by Subject|0
6934309|NCT00896051|10967968|FG000|Overall Study|Adverse Event|2
6934310|NCT00896051|10967969|FG001|Overall Study|Adverse Event|1
7039953|NCT01713946|11122771|FG002|Overall Study|Lack of Efficacy|14
7039954|NCT01713946|11122769|FG000|Overall Study|Protocol Violation|2
7039955|NCT01713946|11122770|FG001|Overall Study|Protocol Violation|4
6934311|NCT00896051|10967968|FG000|Overall Study|Lost to Follow-up|3
7039956|NCT01713946|11122771|FG002|Overall Study|Protocol Violation|1
7039957|NCT01713946|11122769|FG000|Overall Study|Lost to Follow-up|0
7039958|NCT01713946|11122770|FG001|Overall Study|Lost to Follow-up|0
6934312|NCT00896051|10967969|FG001|Overall Study|Lost to Follow-up|2
6934313|NCT00896051|10967968|FG000|Overall Study|Withdrawal by Subject|3
6934314|NCT00896051|10967969|FG001|Overall Study|Withdrawal by Subject|2
6934315|NCT00896051|10967968|FG000|Overall Study|Subject noncompliant|1
6934316|NCT00896051|10967969|FG001|Overall Study|Subject noncompliant|3
7039959|NCT01713946|11122771|FG002|Overall Study|Lost to Follow-up|1
7039960|NCT01713946|11122769|FG000|Overall Study|Administrative problems|1
6934317|NCT00896051|10967968|FG000|Overall Study|Other|1
6934318|NCT00896051|10967969|FG001|Overall Study|Other|1
6934319|NCT00896168|10967995|FG000|Overall Study|Adverse Event|4
6934320|NCT00896168|10967996|FG001|Overall Study|Adverse Event|7
6934321|NCT00896168|10967995|FG000|Overall Study|Treatment failure|8
6934322|NCT00896168|10967996|FG001|Overall Study|Treatment failure|10
7039961|NCT01713946|11122770|FG001|Overall Study|Administrative problems|0
7039962|NCT01713946|11122771|FG002|Overall Study|Administrative problems|0
7065660|NCT01968070|11165305|FG002|Period 1|Lost to Follow-up|0
6934323|NCT00896168|10967995|FG000|Overall Study|Lost to Follow-up|1
6934324|NCT00896168|10967996|FG001|Overall Study|Lost to Follow-up|1
6934325|NCT00896168|10967995|FG000|Overall Study|Other|1
6934326|NCT00896168|10967996|FG001|Overall Study|Other|1
6934327|NCT00896233|10968006|FG000|Overall Study|Claustrophobia during MRI|1
6934328|NCT00896337|10968020|FG000|Overall Study|Death|7
6934329|NCT00896337|10968020|FG000|Overall Study|Withdrawal by Subject|7
6934330|NCT00896337|10968020|FG000|Overall Study|Lost to Follow-up|11
6934331|NCT00896363|10968032|FG000|Overall Study|Adverse Event|3
6934332|NCT00896363|10968033|FG001|Overall Study|Adverse Event|4
6934333|NCT00896363|10968034|FG002|Overall Study|Adverse Event|2
6934334|NCT00896363|10968032|FG000|Overall Study|Lack of Efficacy|0
6934335|NCT00896363|10968033|FG001|Overall Study|Lack of Efficacy|2
7065661|NCT01968070|11165306|FG003|Period 1|Lost to Follow-up|1
7065662|NCT01968070|11165307|FG004|Period 1|Lost to Follow-up|0
7065663|NCT01968070|11165308|FG005|Period 1|Lost to Follow-up|0
7065664|NCT01968070|11165309|FG006|Period 1|Lost to Follow-up|0
7065665|NCT01968070|11165310|FG007|Period 1|Lost to Follow-up|0
7065666|NCT01968070|11165311|FG008|Period 1|Lost to Follow-up|0
7065667|NCT01968070|11165312|FG009|Period 1|Lost to Follow-up|0
7065668|NCT01968070|11165313|FG010|Period 1|Lost to Follow-up|0
7065669|NCT01968070|11165314|FG011|Period 1|Lost to Follow-up|0
7065670|NCT01968070|11165315|FG012|Period 1|Lost to Follow-up|0
7065671|NCT01968070|11165316|FG013|Period 1|Lost to Follow-up|0
7065672|NCT01968070|11165317|FG014|Period 1|Lost to Follow-up|0
7065673|NCT01968070|11165318|FG015|Period 1|Lost to Follow-up|0
7065674|NCT01968070|11165319|FG016|Period 1|Lost to Follow-up|0
7065675|NCT01968070|11165320|FG017|Period 1|Lost to Follow-up|0
7065676|NCT01968070|11165303|FG000|Period 1|Adverse Event|0
7065677|NCT01968070|11165304|FG001|Period 1|Adverse Event|0
7065678|NCT01968070|11165305|FG002|Period 1|Adverse Event|0
7147643|NCT03131687|11308197|FG003|Overall Study|Participant Started New Diabetic Drug|0
7147644|NCT03131687|11308198|FG004|Overall Study|Participant Started New Diabetic Drug|0
7147645|NCT03131687|11308199|FG005|Overall Study|Participant Started New Diabetic Drug|0
7147646|NCT03131687|11308194|FG000|Overall Study|Principle Investigator Decision|0
7147647|NCT03131687|11308195|FG001|Overall Study|Principle Investigator Decision|1
7147648|NCT03131687|11308196|FG002|Overall Study|Principle Investigator Decision|0
7147649|NCT03131687|11308197|FG003|Overall Study|Principle Investigator Decision|0
7147650|NCT03131687|11308198|FG004|Overall Study|Principle Investigator Decision|0
7147651|NCT03131687|11308199|FG005|Overall Study|Principle Investigator Decision|0
7147652|NCT03131687|11308194|FG000|Overall Study|Inadvertent Enrollment|0
7147653|NCT03131687|11308195|FG001|Overall Study|Inadvertent Enrollment|0
7147654|NCT03131687|11308196|FG002|Overall Study|Inadvertent Enrollment|0
7147655|NCT03131687|11308197|FG003|Overall Study|Inadvertent Enrollment|1
7147656|NCT03131687|11308198|FG004|Overall Study|Inadvertent Enrollment|0
7147657|NCT03131687|11308199|FG005|Overall Study|Inadvertent Enrollment|0
7147658|NCT03131713|11308228|FG000|Overall Study|Lost to Follow-up|5
7147659|NCT03131713|11308229|FG001|Overall Study|Lost to Follow-up|0
7147660|NCT03131895|11308239|FG000|Washout Period (at Least 5 Days)|Adverse Event|1
7147661|NCT03131895|11308240|FG001|Washout Period (at Least 5 Days)|Adverse Event|0
7147662|NCT03131895|11308241|FG002|Washout Period (at Least 5 Days)|Adverse Event|0
7147663|NCT03131895|11308242|FG003|Washout Period (at Least 5 Days)|Adverse Event|1
7147664|NCT03131895|11308239|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0
7147665|NCT03131895|11308240|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3
7147666|NCT03131895|11308241|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2
7147667|NCT03131895|11308242|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3
7147668|NCT03131895|11308239|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7147669|NCT03131895|11308240|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2
7147670|NCT03131895|11308241|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7147671|NCT03131895|11308242|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1
7147672|NCT03131895|11308239|FG000|Washout Period (at Least 5 Days)|Other|0
7147673|NCT03131895|11308240|FG001|Washout Period (at Least 5 Days)|Other|0
7147674|NCT03131895|11308241|FG002|Washout Period (at Least 5 Days)|Other|2
7147675|NCT03131895|11308242|FG003|Washout Period (at Least 5 Days)|Other|0
7147676|NCT03131895|11308239|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0
7147677|NCT03131895|11308240|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1
7147678|NCT03131895|11308241|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0
6934336|NCT00896363|10968034|FG002|Overall Study|Lack of Efficacy|1
6934337|NCT00896363|10968032|FG000|Overall Study|Withdrawal by Subject|3
6934338|NCT00896363|10968033|FG001|Overall Study|Withdrawal by Subject|5
6934339|NCT00896363|10968034|FG002|Overall Study|Withdrawal by Subject|5
6934340|NCT00896454|10968053|FG000|Overall Study|Death|10
7065679|NCT01968070|11165306|FG003|Period 1|Adverse Event|0
7065680|NCT01968070|11165307|FG004|Period 1|Adverse Event|0
7065681|NCT01968070|11165308|FG005|Period 1|Adverse Event|0
7065682|NCT01968070|11165309|FG006|Period 1|Adverse Event|1
7065683|NCT01968070|11165310|FG007|Period 1|Adverse Event|0
7065684|NCT01968070|11165311|FG008|Period 1|Adverse Event|0
7065685|NCT01968070|11165312|FG009|Period 1|Adverse Event|0
7147679|NCT03131895|11308242|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0
7147680|NCT03131895|11308239|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1
7147681|NCT03131895|11308240|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
6934341|NCT00896454|10968053|FG000|Overall Study|Adverse Event|8
6934342|NCT00896454|10968053|FG000|Overall Study|Disease Progression|5
6934343|NCT00896454|10968053|FG000|Overall Study|Other|4
6934344|NCT00896454|10968053|FG000|Overall Study|Requirement for alternative therapy|3
6934345|NCT00896454|10968053|FG000|Overall Study|Ongoing in study|2
6934346|NCT00896454|10968053|FG000|Overall Study|Withdrawal by Subject|1
6934347|NCT00896480|10968057|FG000|Overall Study|Disease progression/recurrence|21
6934348|NCT00896532|10968072|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6934349|NCT00896532|10968073|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6934350|NCT00896532|10968074|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6934351|NCT00896532|10968075|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1
6934352|NCT00896532|10968076|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6934353|NCT00896532|10968077|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1
6934354|NCT00896532|10968078|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6837673|NCT00254293|10843398|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0
6837674|NCT00254293|10843392|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
6837675|NCT00254293|10843393|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
6837676|NCT00254293|10843394|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1
6837677|NCT00254293|10843395|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
6837678|NCT00254293|10843396|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
6837679|NCT00254293|10843397|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
6837680|NCT00254293|10843398|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
6837681|NCT00254293|10843392|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
6837682|NCT00254293|10843393|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
6934355|NCT00896532|10968079|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6934356|NCT00896532|10968080|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6934357|NCT00896532|10968081|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6934358|NCT00896532|10968082|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6934359|NCT00896532|10968083|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6934360|NCT00896532|10968084|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6934361|NCT00896532|10968085|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6934362|NCT00896532|10968086|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6934363|NCT00896532|10968087|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6934364|NCT00896532|10968088|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6934365|NCT00896532|10968089|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6934366|NCT00896532|10968090|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6934367|NCT00896532|10968091|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6934368|NCT00896532|10968092|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6934369|NCT00896532|10968093|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6934370|NCT00896532|10968094|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6934371|NCT00896532|10968072|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
6934372|NCT00896532|10968073|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2
6934373|NCT00896532|10968074|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
6934374|NCT00896532|10968075|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2
6934375|NCT00896532|10968076|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
6934376|NCT00896532|10968077|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
6934377|NCT00896532|10968078|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
6934378|NCT00896532|10968079|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
6934379|NCT00896532|10968080|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
6934380|NCT00896532|10968081|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
6934381|NCT00896532|10968082|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
6934382|NCT00896532|10968083|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
6934383|NCT00896532|10968084|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
6934384|NCT00896532|10968085|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
6934385|NCT00896532|10968086|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
6934386|NCT00896532|10968087|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
6934387|NCT00896532|10968088|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
6934388|NCT00896532|10968089|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
6934389|NCT00896532|10968090|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
6934390|NCT00896532|10968091|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
6934391|NCT00896532|10968092|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
6934392|NCT00896532|10968093|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
6934393|NCT00896532|10968094|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
6934394|NCT00896532|10968072|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
6934395|NCT00896532|10968073|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3
6934396|NCT00896532|10968074|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
6934397|NCT00896532|10968075|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6
6934398|NCT00896532|10968076|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5
6934399|NCT00896532|10968077|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6
6934400|NCT00896532|10968078|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
6934401|NCT00896532|10968079|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
6934402|NCT00896532|10968080|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
6934403|NCT00896532|10968081|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
6934404|NCT00896532|10968082|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
6934405|NCT00896532|10968083|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
6934406|NCT00896532|10968084|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
6934407|NCT00896532|10968085|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
6934408|NCT00896532|10968086|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
6934409|NCT00896532|10968087|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
6934410|NCT00896532|10968088|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
6934411|NCT00896532|10968089|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
6934412|NCT00896532|10968090|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
6934413|NCT00896532|10968091|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
6934414|NCT00896532|10968092|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
6934415|NCT00896532|10968093|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
6934416|NCT00896532|10968094|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
6934417|NCT00896532|10968072|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6934418|NCT00896532|10968073|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6934419|NCT00896532|10968074|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2
6934420|NCT00896532|10968075|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6934421|NCT00896532|10968076|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1
6934422|NCT00896532|10968077|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6934423|NCT00896532|10968078|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6934424|NCT00896532|10968079|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6934425|NCT00896532|10968080|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6934426|NCT00896532|10968081|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6934427|NCT00896532|10968082|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6934428|NCT00896532|10968083|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6934429|NCT00896532|10968084|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6934430|NCT00896532|10968085|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6934431|NCT00896532|10968086|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6934432|NCT00896532|10968087|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6934433|NCT00896532|10968088|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6934434|NCT00896532|10968089|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6934435|NCT00896532|10968090|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6934436|NCT00896532|10968091|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6934437|NCT00896532|10968092|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6934438|NCT00896532|10968093|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6934439|NCT00896532|10968094|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6934440|NCT00896532|10968072|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1
6934441|NCT00896532|10968073|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0
6934442|NCT00896532|10968074|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0
6934443|NCT00896532|10968075|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1
6934444|NCT00896532|10968076|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0
6934445|NCT00896532|10968077|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0
6934446|NCT00896532|10968078|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0
6934447|NCT00896532|10968079|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0
6934448|NCT00896532|10968080|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0
6934449|NCT00896532|10968081|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0
6934450|NCT00896532|10968082|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0
6934451|NCT00896532|10968083|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0
6934452|NCT00896532|10968084|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0
6934453|NCT00896532|10968085|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0
6934454|NCT00896532|10968086|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0
6934455|NCT00896532|10968087|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0
7039963|NCT01713946|11122769|FG000|Overall Study|Did not continue in Ext|0
7039964|NCT01713946|11122770|FG001|Overall Study|Did not continue in Ext|3
7039965|NCT01713946|11122771|FG002|Overall Study|Did not continue in Ext|0
7039966|NCT01713946|11122769|FG000|Overall Study|Did not continue in Post-Ext. Phase|1
7039967|NCT01713946|11122770|FG001|Overall Study|Did not continue in Post-Ext. Phase|2
7039968|NCT01713946|11122771|FG002|Overall Study|Did not continue in Post-Ext. Phase|0
7039969|NCT01713946|11122769|FG000|Overall Study|Patients never switched to everolimus|0
7039970|NCT01713946|11122770|FG001|Overall Study|Patients never switched to everolimus|0
7039971|NCT01713946|11122771|FG002|Overall Study|Patients never switched to everolimus|5
7039972|NCT01713998|11122800|FG000|Overall Study|Lost to Follow-up|2
7039973|NCT01713998|11122801|FG001|Overall Study|Lost to Follow-up|0
7039974|NCT01713998|11122802|FG002|Overall Study|Lost to Follow-up|2
6934456|NCT00896532|10968088|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0
6934457|NCT00896532|10968089|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0
6934458|NCT00896532|10968090|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0
6934459|NCT00896532|10968091|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0
6934460|NCT00896532|10968092|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0
6934461|NCT00896532|10968093|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0
6934462|NCT00896532|10968094|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0
6934463|NCT00896532|10968072|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6934464|NCT00896532|10968073|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6934465|NCT00896532|10968074|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1
6934466|NCT00896532|10968075|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6934467|NCT00896532|10968076|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6934468|NCT00896532|10968077|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6934469|NCT00896532|10968078|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6934470|NCT00896532|10968079|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6934471|NCT00896532|10968080|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6934472|NCT00896532|10968081|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6934473|NCT00896532|10968082|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6934474|NCT00896532|10968083|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6934475|NCT00896532|10968084|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6934476|NCT00896532|10968085|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6934477|NCT00896532|10968086|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6934478|NCT00896532|10968087|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6934479|NCT00896532|10968088|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6934480|NCT00896532|10968089|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6934481|NCT00896532|10968090|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6934482|NCT00896532|10968091|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6934483|NCT00896532|10968092|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6934484|NCT00896532|10968093|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6934485|NCT00896532|10968094|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6934486|NCT00896532|10968072|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6934487|NCT00896532|10968073|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6934488|NCT00896532|10968074|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1
6934489|NCT00896532|10968075|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6934490|NCT00896532|10968076|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6934491|NCT00896532|10968077|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6934492|NCT00896532|10968078|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6934493|NCT00896532|10968079|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6934494|NCT00896532|10968080|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6934495|NCT00896532|10968081|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6934496|NCT00896532|10968082|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6934497|NCT00896532|10968083|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6934498|NCT00896532|10968084|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6934499|NCT00896532|10968085|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6934500|NCT00896532|10968086|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6934501|NCT00896532|10968087|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6934502|NCT00896532|10968088|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6934503|NCT00896532|10968089|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6934504|NCT00896532|10968090|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6934505|NCT00896532|10968091|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6934506|NCT00896532|10968092|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6934507|NCT00896532|10968093|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6934508|NCT00896532|10968094|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6934509|NCT00896532|10968072|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6934510|NCT00896532|10968073|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6934511|NCT00896532|10968074|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6934512|NCT00896532|10968075|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1
6934513|NCT00896532|10968076|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6934514|NCT00896532|10968077|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6837683|NCT00254293|10843394|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2
6837684|NCT00254293|10843395|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
6837685|NCT00254293|10843396|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
6837686|NCT00254293|10843397|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
6837687|NCT00254293|10843398|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
6837688|NCT00254293|10843392|FG000|LTE Open Label Variable SC Dosing|Death|0
6837689|NCT00254293|10843393|FG001|LTE Open Label Variable SC Dosing|Death|0
6837690|NCT00254293|10843394|FG002|LTE Open Label Variable SC Dosing|Death|1
6837691|NCT00254293|10843395|FG003|LTE Open Label Variable SC Dosing|Death|0
6837692|NCT00254293|10843396|FG004|LTE Open Label Variable SC Dosing|Death|0
6837693|NCT00254293|10843397|FG005|LTE Open Label Variable SC Dosing|Death|0
6837694|NCT00254293|10843398|FG006|LTE Open Label Variable SC Dosing|Death|0
6837695|NCT00254293|10843392|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1
6837696|NCT00254293|10843393|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0
6837697|NCT00254293|10843394|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2
6837698|NCT00254293|10843395|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0
6837699|NCT00254293|10843396|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1
6837700|NCT00254293|10843397|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0
6837701|NCT00254293|10843398|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0
6934515|NCT00896532|10968078|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6934516|NCT00896532|10968079|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6934517|NCT00896532|10968080|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6934518|NCT00896532|10968081|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6934519|NCT00896532|10968082|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6934520|NCT00896532|10968083|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6934521|NCT00896532|10968084|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6934522|NCT00896532|10968085|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6837702|NCT00254293|10843392|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
6837703|NCT00254293|10843393|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
6837704|NCT00254293|10843394|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
6837705|NCT00254293|10843395|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
6837706|NCT00254293|10843396|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1
6837707|NCT00254293|10843397|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
6837708|NCT00254293|10843398|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
6837709|NCT00254293|10843392|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
6837710|NCT00254293|10843393|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
6837711|NCT00254293|10843394|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1
6837712|NCT00254293|10843395|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
6837713|NCT00254293|10843396|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
6837714|NCT00254293|10843397|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
6837715|NCT00254293|10843398|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
6837716|NCT00254293|10843392|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
6837717|NCT00254293|10843393|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
6837718|NCT00254293|10843394|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1
6837719|NCT00254293|10843395|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
6837720|NCT00254293|10843396|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
6837721|NCT00254293|10843397|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
6837722|NCT00254293|10843398|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
6837723|NCT00254293|10843392|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
6837724|NCT00254293|10843393|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
6837725|NCT00254293|10843394|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1
6837726|NCT00254293|10843395|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
6837727|NCT00254293|10843396|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
6837728|NCT00254293|10843397|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
6837729|NCT00254293|10843398|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
6837730|NCT00254293|10843392|FG000|LTE Open Label Variable SC Dosing|Other|0
6837731|NCT00254293|10843393|FG001|LTE Open Label Variable SC Dosing|Other|0
6837732|NCT00254293|10843394|FG002|LTE Open Label Variable SC Dosing|Other|2
6837733|NCT00254293|10843395|FG003|LTE Open Label Variable SC Dosing|Other|0
6837734|NCT00254293|10843396|FG004|LTE Open Label Variable SC Dosing|Other|0
6837735|NCT00254293|10843397|FG005|LTE Open Label Variable SC Dosing|Other|0
6837736|NCT00254293|10843398|FG006|LTE Open Label Variable SC Dosing|Other|0
6837737|NCT00254293|10843392|FG000|LTE Open Label Fixed Dosing|Death|0
6837738|NCT00254293|10843393|FG001|LTE Open Label Fixed Dosing|Death|0
6837739|NCT00254293|10843394|FG002|LTE Open Label Fixed Dosing|Death|0
6837740|NCT00254293|10843395|FG003|LTE Open Label Fixed Dosing|Death|0
6837741|NCT00254293|10843396|FG004|LTE Open Label Fixed Dosing|Death|0
6837742|NCT00254293|10843397|FG005|LTE Open Label Fixed Dosing|Death|0
6837743|NCT00254293|10843398|FG006|LTE Open Label Fixed Dosing|Death|3
6837744|NCT00254293|10843392|FG000|LTE Open Label Fixed Dosing|Adverse Event|0
6837745|NCT00254293|10843393|FG001|LTE Open Label Fixed Dosing|Adverse Event|0
6837746|NCT00254293|10843394|FG002|LTE Open Label Fixed Dosing|Adverse Event|0
6837747|NCT00254293|10843395|FG003|LTE Open Label Fixed Dosing|Adverse Event|0
6837748|NCT00254293|10843396|FG004|LTE Open Label Fixed Dosing|Adverse Event|0
6837749|NCT00254293|10843397|FG005|LTE Open Label Fixed Dosing|Adverse Event|0
6837750|NCT00254293|10843398|FG006|LTE Open Label Fixed Dosing|Adverse Event|1
6837751|NCT00254293|10843392|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0
6837752|NCT00254293|10843393|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0
6837753|NCT00254293|10843394|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0
6934523|NCT00896532|10968086|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6934524|NCT00896532|10968087|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6934525|NCT00896532|10968088|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6934526|NCT00896532|10968089|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6934527|NCT00896532|10968090|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6934528|NCT00896532|10968091|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6934529|NCT00896532|10968092|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6934530|NCT00896532|10968093|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6934531|NCT00896532|10968094|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6934532|NCT00896532|10968072|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0
6934533|NCT00896532|10968073|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1
6934534|NCT00896532|10968074|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0
6934535|NCT00896532|10968075|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1
6934536|NCT00896532|10968076|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1
6934537|NCT00896532|10968077|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0
6934538|NCT00896532|10968078|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0
6934539|NCT00896532|10968079|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0
6934540|NCT00896532|10968080|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0
6934541|NCT00896532|10968081|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0
6934542|NCT00896532|10968082|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0
6934543|NCT00896532|10968083|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0
6934544|NCT00896532|10968084|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0
6934545|NCT00896532|10968085|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0
6934546|NCT00896532|10968086|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0
6934547|NCT00896532|10968087|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0
6934548|NCT00896532|10968088|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0
6934549|NCT00896532|10968089|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0
6934550|NCT00896532|10968090|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0
6934551|NCT00896532|10968091|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0
6934552|NCT00896532|10968092|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0
6934553|NCT00896532|10968093|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0
6934554|NCT00896532|10968094|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0
6934555|NCT00896532|10968072|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6934556|NCT00896532|10968073|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6934557|NCT00896532|10968074|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6934558|NCT00896532|10968075|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6934559|NCT00896532|10968076|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6934560|NCT00896532|10968077|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6934561|NCT00896532|10968078|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6934562|NCT00896532|10968079|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6934563|NCT00896532|10968080|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1
6934564|NCT00896532|10968081|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6934565|NCT00896532|10968082|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6934566|NCT00896532|10968083|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6934567|NCT00896532|10968084|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6934568|NCT00896532|10968085|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6934569|NCT00896532|10968086|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6934570|NCT00896532|10968087|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6934571|NCT00896532|10968088|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6934572|NCT00896532|10968089|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6934573|NCT00896532|10968090|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6934574|NCT00896532|10968091|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6934575|NCT00896532|10968092|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6934576|NCT00896532|10968093|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6934577|NCT00896532|10968094|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6934578|NCT00896532|10968072|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6934579|NCT00896532|10968073|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6934580|NCT00896532|10968074|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6934581|NCT00896532|10968075|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6934582|NCT00896532|10968076|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6934583|NCT00896532|10968077|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6934584|NCT00896532|10968078|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6934585|NCT00896532|10968079|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6934586|NCT00896532|10968080|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6934587|NCT00896532|10968081|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6934588|NCT00896532|10968082|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6934589|NCT00896532|10968083|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6934590|NCT00896532|10968084|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1
6934591|NCT00896532|10968085|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6934592|NCT00896532|10968086|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6934593|NCT00896532|10968087|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6934594|NCT00896532|10968088|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6934595|NCT00896532|10968089|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6934596|NCT00896532|10968090|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7039975|NCT01713998|11122800|FG000|Overall Study|Withdrawal by Subject|1
7039976|NCT01713998|11122801|FG001|Overall Study|Withdrawal by Subject|0
7039977|NCT01713998|11122802|FG002|Overall Study|Withdrawal by Subject|0
7039978|NCT01714063|11122832|FG000|Overall Study|Equipment malfunction|2
7039979|NCT01714310|11122847|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0
7039980|NCT01714310|11122848|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0
7039981|NCT01714310|11122849|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1
7039982|NCT01714310|11122847|FG000|Open Lisdexamfetamine Titration|Adverse Event|0
7039983|NCT01714310|11122848|FG001|Open Lisdexamfetamine Titration|Adverse Event|0
7039984|NCT01714310|11122849|FG002|Open Lisdexamfetamine Titration|Adverse Event|3
7039985|NCT01714310|11122847|FG000|Double Blind Adjunctive Treatment|Adverse Event|1
7039986|NCT01714310|11122848|FG001|Double Blind Adjunctive Treatment|Adverse Event|1
7039987|NCT01714310|11122849|FG002|Double Blind Adjunctive Treatment|Adverse Event|0
7039988|NCT01714310|11122847|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1
7039989|NCT01714310|11122848|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2
6934597|NCT00896532|10968091|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6934598|NCT00896532|10968092|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6934599|NCT00896532|10968093|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6934600|NCT00896532|10968094|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6934601|NCT00896532|10968072|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6934602|NCT00896532|10968073|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6934603|NCT00896532|10968074|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6934604|NCT00896532|10968075|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6934605|NCT00896532|10968076|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6934606|NCT00896532|10968077|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6934607|NCT00896532|10968078|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6934608|NCT00896532|10968079|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6934609|NCT00896532|10968080|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6934610|NCT00896532|10968081|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6934611|NCT00896532|10968082|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1
6934612|NCT00896532|10968083|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6934613|NCT00896532|10968084|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1
6934614|NCT00896532|10968085|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6934615|NCT00896532|10968086|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6934616|NCT00896532|10968087|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6934617|NCT00896532|10968088|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6934618|NCT00896532|10968089|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6934619|NCT00896532|10968090|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6934620|NCT00896532|10968091|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6934621|NCT00896532|10968092|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6934622|NCT00896532|10968093|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6934623|NCT00896532|10968094|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6934624|NCT00896532|10968072|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6934625|NCT00896532|10968073|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6934626|NCT00896532|10968074|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6934627|NCT00896532|10968075|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6934628|NCT00896532|10968076|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6934629|NCT00896532|10968077|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6934630|NCT00896532|10968078|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6934631|NCT00896532|10968079|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6934632|NCT00896532|10968080|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6934633|NCT00896532|10968081|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6934634|NCT00896532|10968082|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6934635|NCT00896532|10968083|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6934636|NCT00896532|10968084|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1
6934637|NCT00896532|10968085|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1
6934638|NCT00896532|10968086|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6934639|NCT00896532|10968087|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6934640|NCT00896532|10968088|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6934641|NCT00896532|10968089|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7039990|NCT01714310|11122849|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0
7039991|NCT01714544|11122897|FG000|Overall Study|Lost to Follow-up|1
7039992|NCT01714544|11122897|FG000|Overall Study|Physician Decision|1
7039993|NCT01714544|11122897|FG000|Overall Study|Withdrawal by Subject|1
6934642|NCT00896532|10968090|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6934643|NCT00896532|10968091|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6934644|NCT00896532|10968092|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6934645|NCT00896532|10968093|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6934646|NCT00896532|10968094|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6934647|NCT00896532|10968072|FG000|Months 24-36: Denosumab Extension Phase|Other|0
6934648|NCT00896532|10968073|FG001|Months 24-36: Denosumab Extension Phase|Other|0
6934649|NCT00896532|10968074|FG002|Months 24-36: Denosumab Extension Phase|Other|0
6934650|NCT00896532|10968075|FG003|Months 24-36: Denosumab Extension Phase|Other|0
6934651|NCT00896532|10968076|FG004|Months 24-36: Denosumab Extension Phase|Other|0
6934652|NCT00896532|10968077|FG005|Months 24-36: Denosumab Extension Phase|Other|0
6934653|NCT00896532|10968078|FG006|Months 24-36: Denosumab Extension Phase|Other|0
6934654|NCT00896532|10968079|FG007|Months 24-36: Denosumab Extension Phase|Other|0
6934655|NCT00896532|10968080|FG008|Months 24-36: Denosumab Extension Phase|Other|0
6934656|NCT00896532|10968081|FG009|Months 24-36: Denosumab Extension Phase|Other|0
6934657|NCT00896532|10968082|FG010|Months 24-36: Denosumab Extension Phase|Other|1
6934658|NCT00896532|10968083|FG011|Months 24-36: Denosumab Extension Phase|Other|2
6934659|NCT00896532|10968084|FG012|Months 24-36: Denosumab Extension Phase|Other|2
6934660|NCT00896532|10968085|FG013|Months 24-36: Denosumab Extension Phase|Other|1
6934661|NCT00896532|10968086|FG014|Months 24-36: Denosumab Extension Phase|Other|0
6934662|NCT00896532|10968087|FG015|Months 24-36: Denosumab Extension Phase|Other|0
6934663|NCT00896532|10968088|FG016|Months 24-36: Denosumab Extension Phase|Other|0
6934664|NCT00896532|10968089|FG017|Months 24-36: Denosumab Extension Phase|Other|0
6934665|NCT00896532|10968090|FG018|Months 24-36: Denosumab Extension Phase|Other|0
6934666|NCT00896532|10968091|FG019|Months 24-36: Denosumab Extension Phase|Other|0
6934667|NCT00896532|10968092|FG020|Months 24-36: Denosumab Extension Phase|Other|0
6934668|NCT00896532|10968093|FG021|Months 24-36: Denosumab Extension Phase|Other|0
6934669|NCT00896532|10968094|FG022|Months 24-36: Denosumab Extension Phase|Other|0
6934670|NCT00896532|10968072|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6934671|NCT00896532|10968073|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6934672|NCT00896532|10968074|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6934673|NCT00896532|10968075|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6934674|NCT00896532|10968076|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6934675|NCT00896532|10968077|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6934676|NCT00896532|10968078|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6934677|NCT00896532|10968079|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6934678|NCT00896532|10968080|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6934679|NCT00896532|10968081|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6934680|NCT00896532|10968082|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6934681|NCT00896532|10968083|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6934682|NCT00896532|10968084|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7039994|NCT01714609|11122903|FG000|Overall Study|Protocol Violation|1
7039995|NCT01714609|11122904|FG001|Overall Study|Protocol Violation|0
6934683|NCT00896532|10968085|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6934684|NCT00896532|10968086|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6934685|NCT00896532|10968087|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1
6934686|NCT00896532|10968088|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3
6934687|NCT00896532|10968089|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6934688|NCT00896532|10968090|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6934689|NCT00896532|10968091|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6934690|NCT00896532|10968092|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6934691|NCT00896532|10968093|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6934692|NCT00896532|10968094|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6934693|NCT00896532|10968072|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
6934694|NCT00896532|10968073|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7039996|NCT01714635|11122913|FG000|Overall Study|Discontinued|1
6837754|NCT00254293|10843395|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0
6837755|NCT00254293|10843396|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0
6837756|NCT00254293|10843397|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0
6837757|NCT00254293|10843398|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3
6837758|NCT00254293|10843392|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0
6837759|NCT00254293|10843393|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0
6837760|NCT00254293|10843394|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0
6837761|NCT00254293|10843395|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0
6837762|NCT00254293|10843396|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0
6837763|NCT00254293|10843397|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0
6837764|NCT00254293|10843398|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1
6837765|NCT00254293|10843392|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
6837766|NCT00254293|10843393|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
6837767|NCT00254293|10843394|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
6837768|NCT00254293|10843395|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
6837769|NCT00254293|10843396|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
7065686|NCT01968070|11165313|FG010|Period 1|Adverse Event|0
7065687|NCT01968070|11165314|FG011|Period 1|Adverse Event|0
7065688|NCT01968070|11165315|FG012|Period 1|Adverse Event|0
7065689|NCT01968070|11165316|FG013|Period 1|Adverse Event|0
7065690|NCT01968070|11165317|FG014|Period 1|Adverse Event|0
7065691|NCT01968070|11165318|FG015|Period 1|Adverse Event|0
7065692|NCT01968070|11165319|FG016|Period 1|Adverse Event|0
7065693|NCT01968070|11165320|FG017|Period 1|Adverse Event|0
7065694|NCT01968070|11165303|FG000|Period 1|Physician Decision|0
7065695|NCT01968070|11165304|FG001|Period 1|Physician Decision|0
7065696|NCT01968070|11165305|FG002|Period 1|Physician Decision|0
7065697|NCT01968070|11165306|FG003|Period 1|Physician Decision|0
7065698|NCT01968070|11165307|FG004|Period 1|Physician Decision|0
7065699|NCT01968070|11165308|FG005|Period 1|Physician Decision|0
7065700|NCT01968070|11165309|FG006|Period 1|Physician Decision|0
7065701|NCT01968070|11165310|FG007|Period 1|Physician Decision|0
7065702|NCT01968070|11165311|FG008|Period 1|Physician Decision|0
7065703|NCT01968070|11165312|FG009|Period 1|Physician Decision|0
7065704|NCT01968070|11165313|FG010|Period 1|Physician Decision|0
7065705|NCT01968070|11165314|FG011|Period 1|Physician Decision|1
7065706|NCT01968070|11165315|FG012|Period 1|Physician Decision|0
7065707|NCT01968070|11165316|FG013|Period 1|Physician Decision|0
7065708|NCT01968070|11165317|FG014|Period 1|Physician Decision|0
7065709|NCT01968070|11165318|FG015|Period 1|Physician Decision|0
7065710|NCT01968070|11165319|FG016|Period 1|Physician Decision|0
7065711|NCT01968070|11165320|FG017|Period 1|Physician Decision|0
7065712|NCT01968070|11165303|FG000|Period 2|Withdrawal by Subject|0
7065713|NCT01968070|11165304|FG001|Period 2|Withdrawal by Subject|0
7065714|NCT01968070|11165305|FG002|Period 2|Withdrawal by Subject|0
7065715|NCT01968070|11165306|FG003|Period 2|Withdrawal by Subject|0
7065716|NCT01968070|11165307|FG004|Period 2|Withdrawal by Subject|1
7065717|NCT01968070|11165308|FG005|Period 2|Withdrawal by Subject|0
7065718|NCT01968070|11165309|FG006|Period 2|Withdrawal by Subject|0
7065719|NCT01968070|11165310|FG007|Period 2|Withdrawal by Subject|0
7065720|NCT01968070|11165311|FG008|Period 2|Withdrawal by Subject|0
7065721|NCT01968070|11165312|FG009|Period 2|Withdrawal by Subject|0
7065722|NCT01968070|11165313|FG010|Period 2|Withdrawal by Subject|0
7065723|NCT01968070|11165314|FG011|Period 2|Withdrawal by Subject|0
7065724|NCT01968070|11165315|FG012|Period 2|Withdrawal by Subject|0
7065725|NCT01968070|11165316|FG013|Period 2|Withdrawal by Subject|0
7065726|NCT01968070|11165317|FG014|Period 2|Withdrawal by Subject|0
7065727|NCT01968070|11165318|FG015|Period 2|Withdrawal by Subject|0
7065728|NCT01968070|11165319|FG016|Period 2|Withdrawal by Subject|0
7065729|NCT01968070|11165320|FG017|Period 2|Withdrawal by Subject|0
7082463|NCT02141854|11192967|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7082464|NCT02141854|11192968|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7082465|NCT02141854|11192963|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6
7082466|NCT02141854|11192964|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7082467|NCT02141854|11192965|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7082468|NCT02141854|11192966|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7082469|NCT02141854|11192967|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7082470|NCT02141854|11192968|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7082471|NCT02141854|11192963|FG000|Treatment Period|Protocol Violation|0
7082472|NCT02141854|11192964|FG001|Treatment Period|Protocol Violation|1
7082473|NCT02141854|11192965|FG002|Treatment Period|Protocol Violation|0
7082474|NCT02141854|11192966|FG003|Treatment Period|Protocol Violation|2
7082475|NCT02141854|11192967|FG004|Treatment Period|Protocol Violation|2
7082476|NCT02141854|11192968|FG005|Treatment Period|Protocol Violation|1
7082477|NCT02141854|11192963|FG000|Treatment Period|Noncompliance|0
7082478|NCT02141854|11192964|FG001|Treatment Period|Noncompliance|0
7082479|NCT02141854|11192965|FG002|Treatment Period|Noncompliance|0
7082480|NCT02141854|11192966|FG003|Treatment Period|Noncompliance|1
7082481|NCT02141854|11192967|FG004|Treatment Period|Noncompliance|0
7082482|NCT02141854|11192968|FG005|Treatment Period|Noncompliance|0
7082483|NCT02141854|11192963|FG000|Treatment Period|Lack of Efficacy|0
7082484|NCT02141854|11192964|FG001|Treatment Period|Lack of Efficacy|0
7082485|NCT02141854|11192965|FG002|Treatment Period|Lack of Efficacy|0
7082486|NCT02141854|11192966|FG003|Treatment Period|Lack of Efficacy|1
7082487|NCT02141854|11192967|FG004|Treatment Period|Lack of Efficacy|1
7082488|NCT02141854|11192968|FG005|Treatment Period|Lack of Efficacy|7
7082489|NCT02141854|11192963|FG000|Treatment Period|Pregnancy|0
7082490|NCT02141854|11192964|FG001|Treatment Period|Pregnancy|1
7082491|NCT02141854|11192965|FG002|Treatment Period|Pregnancy|0
7082492|NCT02141854|11192966|FG003|Treatment Period|Pregnancy|0
7082493|NCT02141854|11192967|FG004|Treatment Period|Pregnancy|0
7082494|NCT02141854|11192968|FG005|Treatment Period|Pregnancy|0
7082495|NCT02141854|11192963|FG000|Treatment Period|Other|0
7082496|NCT02141854|11192964|FG001|Treatment Period|Other|1
7082497|NCT02141854|11192965|FG002|Treatment Period|Other|2
7082498|NCT02141854|11192966|FG003|Treatment Period|Other|0
7082499|NCT02141854|11192967|FG004|Treatment Period|Other|1
7082500|NCT02141854|11192968|FG005|Treatment Period|Other|2
7082501|NCT02141854|11192963|FG000|Treatment Period|Adverse Event|0
7082502|NCT02141854|11192964|FG001|Treatment Period|Adverse Event|2
7082503|NCT02141854|11192965|FG002|Treatment Period|Adverse Event|2
7082504|NCT02141854|11192966|FG003|Treatment Period|Adverse Event|0
7082505|NCT02141854|11192967|FG004|Treatment Period|Adverse Event|2
7065730|NCT01968434|11165441|FG000|Overall Study|Lost to Follow-up|3
7065731|NCT01968434|11165442|FG001|Overall Study|Lost to Follow-up|6
7065732|NCT01968551|11165460|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
7065733|NCT01968551|11165461|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
7065734|NCT01968551|11165462|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0
7065735|NCT01968551|11165460|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0
7065736|NCT01968551|11165461|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1
7065737|NCT01968551|11165462|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0
7065738|NCT01968551|11165460|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1
7065739|NCT01968551|11165461|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1
7065740|NCT01968551|11165462|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3
7065741|NCT01968551|11165460|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0
7065742|NCT01968551|11165461|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0
7065743|NCT01968551|11165462|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2
7065744|NCT01968551|11165460|FG000|Extension Phase|Adverse Event|0
7065745|NCT01968551|11165461|FG001|Extension Phase|Adverse Event|0
7065746|NCT01968551|11165462|FG002|Extension Phase|Adverse Event|2
7065747|NCT01968551|11165460|FG000|Extension Phase|Death|0
7065748|NCT01968551|11165461|FG001|Extension Phase|Death|1
7065749|NCT01968551|11165462|FG002|Extension Phase|Death|0
7065750|NCT01968551|11165460|FG000|Extension Phase|Withdrew Consent|0
7065751|NCT01968551|11165461|FG001|Extension Phase|Withdrew Consent|0
7065752|NCT01968551|11165462|FG002|Extension Phase|Withdrew Consent|1
7065753|NCT01968551|11165460|FG000|Extension Phase|Lost to Follow-up|1
7065754|NCT01968551|11165461|FG001|Extension Phase|Lost to Follow-up|0
7065755|NCT01968551|11165462|FG002|Extension Phase|Lost to Follow-up|1
7065756|NCT01968694|11165476|FG000|Washout (1 Month)|Lost to Follow-up|0
7065757|NCT01968694|11165477|FG001|Washout (1 Month)|Lost to Follow-up|1
7065758|NCT01968707|11165493|FG000|Overall Study|Did not meet treatment day baseline|49
7065759|NCT01968707|11165494|FG001|Overall Study|Did not meet treatment day baseline|12
7065760|NCT01968707|11165495|FG002|Overall Study|Did not meet treatment day baseline|41
7065761|NCT01968707|11165496|FG003|Overall Study|Did not meet treatment day baseline|44
7065762|NCT01968707|11165497|FG004|Overall Study|Did not meet treatment day baseline|36
7065763|NCT01968707|11165498|FG005|Overall Study|Did not meet treatment day baseline|11
7065764|NCT01968707|11165499|FG006|Overall Study|Did not meet treatment day baseline|34
7065765|NCT01968707|11165500|FG007|Overall Study|Did not meet treatment day baseline|35
7065766|NCT01968811|11165533|FG000|Overall Study|Protocol Violation|4
7065767|NCT01968811|11165533|FG000|Overall Study|post op.ref. of subject to other hospita|1
7065768|NCT01968954|11165539|FG000|Overall Study|Adverse Event|6
7065769|NCT01968954|11165540|FG001|Overall Study|Adverse Event|3
7065770|NCT01968954|11165539|FG000|Overall Study|Death|1
7065771|NCT01968954|11165540|FG001|Overall Study|Death|2
7065772|NCT01968954|11165539|FG000|Overall Study|Lost to Follow-up|6
7065773|NCT01968954|11165540|FG001|Overall Study|Lost to Follow-up|4
7065774|NCT01968954|11165539|FG000|Overall Study|Withdrawal by Subject|20
7065775|NCT01968954|11165540|FG001|Overall Study|Withdrawal by Subject|23
7065776|NCT01968954|11165539|FG000|Overall Study|Other|7
7065777|NCT01968954|11165540|FG001|Overall Study|Other|8
7065778|NCT01968954|11165539|FG000|Overall Study|Protocol Violation|0
7065779|NCT01968954|11165540|FG001|Overall Study|Protocol Violation|1
7065780|NCT01968954|11165539|FG000|Overall Study|Did not met inclusion criteria|0
7065781|NCT01968954|11165540|FG001|Overall Study|Did not met inclusion criteria|2
7065782|NCT01968967|11165549|FG000|Treatment Period|Other|22
7065783|NCT01968967|11165550|FG001|Treatment Period|Other|22
7065784|NCT01968967|11165551|FG002|Treatment Period|Other|0
7065785|NCT01968967|11165552|FG003|Treatment Period|Other|0
7065786|NCT01968967|11165553|FG004|Treatment Period|Other|0
7065787|NCT01968967|11165549|FG000|Treatment Period|Withdrawal by Subject|71
7065788|NCT01968967|11165550|FG001|Treatment Period|Withdrawal by Subject|61
7065789|NCT01968967|11165551|FG002|Treatment Period|Withdrawal by Subject|0
7065790|NCT01968967|11165552|FG003|Treatment Period|Withdrawal by Subject|0
7065791|NCT01968967|11165553|FG004|Treatment Period|Withdrawal by Subject|0
7065792|NCT01968967|11165549|FG000|Treatment Period|Did Not Meet Entrance Criteria|2
7065793|NCT01968967|11165550|FG001|Treatment Period|Did Not Meet Entrance Criteria|3
7065794|NCT01968967|11165551|FG002|Treatment Period|Did Not Meet Entrance Criteria|0
7065795|NCT01968967|11165552|FG003|Treatment Period|Did Not Meet Entrance Criteria|0
7065796|NCT01968967|11165553|FG004|Treatment Period|Did Not Meet Entrance Criteria|0
7065797|NCT01968967|11165549|FG000|Treatment Period|Lost to Follow-up|26
7065798|NCT01968967|11165550|FG001|Treatment Period|Lost to Follow-up|31
7065799|NCT01968967|11165551|FG002|Treatment Period|Lost to Follow-up|0
7065800|NCT01968967|11165552|FG003|Treatment Period|Lost to Follow-up|0
7065801|NCT01968967|11165553|FG004|Treatment Period|Lost to Follow-up|0
7065802|NCT01968967|11165549|FG000|Treatment Period|Protocol Violation|1
7065803|NCT01968967|11165550|FG001|Treatment Period|Protocol Violation|2
7065804|NCT01968967|11165551|FG002|Treatment Period|Protocol Violation|0
7065805|NCT01968967|11165552|FG003|Treatment Period|Protocol Violation|0
7065806|NCT01968967|11165553|FG004|Treatment Period|Protocol Violation|0
7065807|NCT01968967|11165549|FG000|Treatment Period|Adverse Event|9
7065808|NCT01968967|11165550|FG001|Treatment Period|Adverse Event|8
7065809|NCT01968967|11165551|FG002|Treatment Period|Adverse Event|0
7065810|NCT01968967|11165552|FG003|Treatment Period|Adverse Event|0
7065811|NCT01968967|11165553|FG004|Treatment Period|Adverse Event|0
7065812|NCT01968967|11165549|FG000|Treatment Period|Death|9
7065813|NCT01968967|11165550|FG001|Treatment Period|Death|2
7065814|NCT01968967|11165551|FG002|Treatment Period|Death|0
7065815|NCT01968967|11165552|FG003|Treatment Period|Death|0
7065816|NCT01968967|11165553|FG004|Treatment Period|Death|0
7065817|NCT01968967|11165549|FG000|Treatment Period|Randomized Not Treated|6
7065818|NCT01968967|11165550|FG001|Treatment Period|Randomized Not Treated|5
6837770|NCT00254293|10843397|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
6837771|NCT00254293|10843398|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3
6837772|NCT00254293|10843392|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0
6837773|NCT00254293|10843393|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0
6837774|NCT00254293|10843394|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0
7065819|NCT01968967|11165551|FG002|Treatment Period|Randomized Not Treated|0
7065820|NCT01968967|11165552|FG003|Treatment Period|Randomized Not Treated|0
7065821|NCT01968967|11165553|FG004|Treatment Period|Randomized Not Treated|0
7065822|NCT01968967|11165549|FG000|Extension Period|Withdrew Consent|0
7065823|NCT01968967|11165550|FG001|Extension Period|Withdrew Consent|0
7065824|NCT01968967|11165551|FG002|Extension Period|Withdrew Consent|2
7065825|NCT01968967|11165552|FG003|Extension Period|Withdrew Consent|0
7065826|NCT01968967|11165553|FG004|Extension Period|Withdrew Consent|5
7065827|NCT01968980|11165569|FG000|Overall Study|Death|0
7065828|NCT01968980|11165570|FG001|Overall Study|Death|1
7065829|NCT01968980|11165569|FG000|Overall Study|Adverse Event|1
7065830|NCT01968980|11165570|FG001|Overall Study|Adverse Event|3
7065831|NCT01968980|11165569|FG000|Overall Study|Does not meet entry criteria|1
7065832|NCT01968980|11165570|FG001|Overall Study|Does not meet entry criteria|3
7065833|NCT01968980|11165569|FG000|Overall Study|Withdrawal by Subject|13
7065834|NCT01968980|11165570|FG001|Overall Study|Withdrawal by Subject|5
7065835|NCT01968980|11165569|FG000|Overall Study|Other unspecified|1
7065836|NCT01968980|11165570|FG001|Overall Study|Other unspecified|2
7065837|NCT01969058|11165579|FG000|Overall Study|Withdrawal by Subject|2
7065838|NCT01969058|11165580|FG001|Overall Study|Withdrawal by Subject|0
7065839|NCT01969058|11165579|FG000|Overall Study|Adverse Event|1
7065840|NCT01969058|11165580|FG001|Overall Study|Adverse Event|0
7065841|NCT01969084|11165588|FG000|Overall Study|Adverse Event|0
7065842|NCT01969084|11165589|FG001|Overall Study|Adverse Event|1
7065843|NCT01969500|11165646|FG000|Overall Study|Death|0
7065844|NCT01969500|11165647|FG001|Overall Study|Death|1
7065845|NCT01969500|11165646|FG000|Overall Study|extended hospitalization|1
7065846|NCT01969500|11165647|FG001|Overall Study|extended hospitalization|1
7065847|NCT01969721|11165666|FG000|Overall Study|Adverse Event|3
7065848|NCT01969721|11165667|FG001|Overall Study|Adverse Event|8
7065849|NCT01969721|11165668|FG002|Overall Study|Adverse Event|3
7065850|NCT01969721|11165669|FG003|Overall Study|Adverse Event|2
7065851|NCT01969721|11165666|FG000|Overall Study|Lack of Efficacy|0
7065852|NCT01969721|11165667|FG001|Overall Study|Lack of Efficacy|0
7065853|NCT01969721|11165668|FG002|Overall Study|Lack of Efficacy|1
7065854|NCT01969721|11165669|FG003|Overall Study|Lack of Efficacy|0
7065855|NCT01969721|11165666|FG000|Overall Study|Non compliant with protocol|1
7065856|NCT01969721|11165667|FG001|Overall Study|Non compliant with protocol|1
7065857|NCT01969721|11165668|FG002|Overall Study|Non compliant with protocol|0
7065858|NCT01969721|11165669|FG003|Overall Study|Non compliant with protocol|2
7065859|NCT01969721|11165666|FG000|Overall Study|Other not defined above|0
7065860|NCT01969721|11165667|FG001|Overall Study|Other not defined above|2
7065861|NCT01969721|11165668|FG002|Overall Study|Other not defined above|0
7065862|NCT01969721|11165669|FG003|Overall Study|Other not defined above|0
7065863|NCT01969721|11165666|FG000|Overall Study|Discontinued during washout periods.|0
7065864|NCT01969721|11165667|FG001|Overall Study|Discontinued during washout periods.|1
7065865|NCT01969721|11165668|FG002|Overall Study|Discontinued during washout periods.|1
7065866|NCT01969721|11165669|FG003|Overall Study|Discontinued during washout periods.|2
7065867|NCT01969799|11165698|FG000|Overall Study|Adverse Event|0
7065868|NCT01969799|11165699|FG001|Overall Study|Adverse Event|1
7065869|NCT01969799|11165698|FG000|Overall Study|Death|16
7065870|NCT01969799|11165699|FG001|Overall Study|Death|11
7065871|NCT01969799|11165698|FG000|Overall Study|Lost to Follow-up|0
6837775|NCT00254293|10843395|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0
6837776|NCT00254293|10843396|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0
7065872|NCT01969799|11165699|FG001|Overall Study|Lost to Follow-up|2
7065873|NCT01969799|11165698|FG000|Overall Study|Physician Decision|1
7065874|NCT01969799|11165699|FG001|Overall Study|Physician Decision|0
7065875|NCT01969851|11165708|FG000|Overall Study|Adverse Event|0
7065876|NCT01969851|11165709|FG001|Overall Study|Adverse Event|0
7065877|NCT01969851|11165710|FG002|Overall Study|Adverse Event|3
7065878|NCT01969851|11165708|FG000|Overall Study|Lack of Efficacy|0
7065879|NCT01969851|11165709|FG001|Overall Study|Lack of Efficacy|3
7065880|NCT01969851|11165710|FG002|Overall Study|Lack of Efficacy|1
7065881|NCT01969851|11165708|FG000|Overall Study|Withdrawal by Subject|1
7065882|NCT01969851|11165709|FG001|Overall Study|Withdrawal by Subject|0
7065883|NCT01969851|11165710|FG002|Overall Study|Withdrawal by Subject|1
7065884|NCT01969851|11165708|FG000|Overall Study|No effective dose in Titration period|0
7065885|NCT01969851|11165709|FG001|Overall Study|No effective dose in Titration period|0
7065886|NCT01969851|11165710|FG002|Overall Study|No effective dose in Titration period|1
7065887|NCT01969851|11165708|FG000|Overall Study|Sponsor decision|0
6837777|NCT00254293|10843397|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0
6837778|NCT00254293|10843398|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1
6837779|NCT00254293|10843392|FG000|LTE Open Label Fixed Dosing|Other|0
6837780|NCT00254293|10843393|FG001|LTE Open Label Fixed Dosing|Other|0
6837781|NCT00254293|10843394|FG002|LTE Open Label Fixed Dosing|Other|0
6837782|NCT00254293|10843395|FG003|LTE Open Label Fixed Dosing|Other|0
6837783|NCT00254293|10843396|FG004|LTE Open Label Fixed Dosing|Other|0
6837784|NCT00254293|10843397|FG005|LTE Open Label Fixed Dosing|Other|0
6837785|NCT00254293|10843398|FG006|LTE Open Label Fixed Dosing|Other|1
6837786|NCT00254397|10843445|FG000|Overall Study|Disease Progression|4
6837787|NCT00254397|10843446|FG001|Overall Study|Disease Progression|1
6837788|NCT00254397|10843447|FG002|Overall Study|Disease Progression|16
6837789|NCT00254397|10843448|FG003|Overall Study|Disease Progression|23
6837790|NCT00254397|10843445|FG000|Overall Study|Non-Compliant|0
6837791|NCT00254397|10843446|FG001|Overall Study|Non-Compliant|0
6837792|NCT00254397|10843447|FG002|Overall Study|Non-Compliant|0
6837793|NCT00254397|10843448|FG003|Overall Study|Non-Compliant|1
6837794|NCT00254397|10843445|FG000|Overall Study|Adverse Event|2
6837795|NCT00254397|10843446|FG001|Overall Study|Adverse Event|0
6837796|NCT00254397|10843447|FG002|Overall Study|Adverse Event|3
6837797|NCT00254397|10843448|FG003|Overall Study|Adverse Event|1
6837798|NCT00254501|10843483|FG000|Overall Study|Lost to Follow-up|1
6837799|NCT00254501|10843484|FG001|Overall Study|Lost to Follow-up|1
6837800|NCT00254540|10843494|FG000|Overall Study|Adverse Event|6
6837801|NCT00254540|10843495|FG001|Overall Study|Adverse Event|7
6837802|NCT00254540|10843494|FG000|Overall Study|Lack of Efficacy|13
6837803|NCT00254540|10843495|FG001|Overall Study|Lack of Efficacy|13
6837804|NCT00254540|10843494|FG000|Overall Study|Death|0
6934695|NCT00896532|10968074|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
6934696|NCT00896532|10968075|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
6934697|NCT00896532|10968076|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
6934698|NCT00896532|10968077|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
6934699|NCT00896532|10968078|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
6934700|NCT00896532|10968079|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
6934701|NCT00896532|10968080|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
6934702|NCT00896532|10968081|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
6934703|NCT00896532|10968082|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
6934704|NCT00896532|10968083|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
6934705|NCT00896532|10968084|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
6934706|NCT00896532|10968085|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
6934707|NCT00896532|10968086|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
6934708|NCT00896532|10968087|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1
6934709|NCT00896532|10968088|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2
6934710|NCT00896532|10968089|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2
6934711|NCT00896532|10968090|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
6934712|NCT00896532|10968091|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
6934713|NCT00896532|10968092|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
6934714|NCT00896532|10968093|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
6934715|NCT00896532|10968094|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
6934716|NCT00896532|10968072|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6934717|NCT00896532|10968073|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6934718|NCT00896532|10968074|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6934719|NCT00896532|10968075|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6934720|NCT00896532|10968076|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6934721|NCT00896532|10968077|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6934722|NCT00896532|10968078|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6934723|NCT00896532|10968079|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6934724|NCT00896532|10968080|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6934725|NCT00896532|10968081|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6934726|NCT00896532|10968082|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6934727|NCT00896532|10968083|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6934728|NCT00896532|10968084|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6934729|NCT00896532|10968085|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6934730|NCT00896532|10968086|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6934731|NCT00896532|10968087|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6934732|NCT00896532|10968088|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1
6934733|NCT00896532|10968089|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6934734|NCT00896532|10968090|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6934735|NCT00896532|10968091|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6934736|NCT00896532|10968092|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6934737|NCT00896532|10968093|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6837805|NCT00254540|10843495|FG001|Overall Study|Death|1
6837806|NCT00254540|10843494|FG000|Overall Study|Laboratory Test Abnormality|0
6934738|NCT00896532|10968094|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6934739|NCT00896532|10968072|FG000|Months 36-48: Romosozumab Retreatment|Other|0
6934740|NCT00896532|10968073|FG001|Months 36-48: Romosozumab Retreatment|Other|0
6934741|NCT00896532|10968074|FG002|Months 36-48: Romosozumab Retreatment|Other|0
6934742|NCT00896532|10968075|FG003|Months 36-48: Romosozumab Retreatment|Other|0
6934743|NCT00896532|10968076|FG004|Months 36-48: Romosozumab Retreatment|Other|0
6934744|NCT00896532|10968077|FG005|Months 36-48: Romosozumab Retreatment|Other|0
6934745|NCT00896532|10968078|FG006|Months 36-48: Romosozumab Retreatment|Other|0
6934746|NCT00896532|10968079|FG007|Months 36-48: Romosozumab Retreatment|Other|0
6934747|NCT00896532|10968080|FG008|Months 36-48: Romosozumab Retreatment|Other|0
6934748|NCT00896532|10968081|FG009|Months 36-48: Romosozumab Retreatment|Other|0
6934749|NCT00896532|10968082|FG010|Months 36-48: Romosozumab Retreatment|Other|0
6934750|NCT00896532|10968083|FG011|Months 36-48: Romosozumab Retreatment|Other|0
6934751|NCT00896532|10968084|FG012|Months 36-48: Romosozumab Retreatment|Other|0
6934752|NCT00896532|10968085|FG013|Months 36-48: Romosozumab Retreatment|Other|0
6934753|NCT00896532|10968086|FG014|Months 36-48: Romosozumab Retreatment|Other|0
6934754|NCT00896532|10968087|FG015|Months 36-48: Romosozumab Retreatment|Other|0
6934755|NCT00896532|10968088|FG016|Months 36-48: Romosozumab Retreatment|Other|0
6934756|NCT00896532|10968089|FG017|Months 36-48: Romosozumab Retreatment|Other|1
6934757|NCT00896532|10968090|FG018|Months 36-48: Romosozumab Retreatment|Other|0
6934758|NCT00896532|10968091|FG019|Months 36-48: Romosozumab Retreatment|Other|0
6934759|NCT00896532|10968092|FG020|Months 36-48: Romosozumab Retreatment|Other|0
6934760|NCT00896532|10968093|FG021|Months 36-48: Romosozumab Retreatment|Other|0
6934761|NCT00896532|10968094|FG022|Months 36-48: Romosozumab Retreatment|Other|0
6934762|NCT00896532|10968072|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6934763|NCT00896532|10968073|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6934764|NCT00896532|10968074|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6934765|NCT00896532|10968075|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6934766|NCT00896532|10968076|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6934767|NCT00896532|10968077|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6934768|NCT00896532|10968078|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6934769|NCT00896532|10968079|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6934770|NCT00896532|10968080|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6934771|NCT00896532|10968081|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6934772|NCT00896532|10968082|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6934773|NCT00896532|10968083|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6934774|NCT00896532|10968084|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6934775|NCT00896532|10968085|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6934776|NCT00896532|10968086|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6934777|NCT00896532|10968087|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6934778|NCT00896532|10968088|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1
6934779|NCT00896532|10968089|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6934780|NCT00896532|10968090|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6934781|NCT00896532|10968091|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6934782|NCT00896532|10968092|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6934783|NCT00896532|10968093|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6934784|NCT00896532|10968094|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6934785|NCT00896532|10968072|FG000|Months 48-72: Follow-on Phase|Death|0
6934786|NCT00896532|10968073|FG001|Months 48-72: Follow-on Phase|Death|0
6934787|NCT00896532|10968074|FG002|Months 48-72: Follow-on Phase|Death|0
6934788|NCT00896532|10968075|FG003|Months 48-72: Follow-on Phase|Death|0
6934789|NCT00896532|10968076|FG004|Months 48-72: Follow-on Phase|Death|0
6934790|NCT00896532|10968077|FG005|Months 48-72: Follow-on Phase|Death|0
6934791|NCT00896532|10968078|FG006|Months 48-72: Follow-on Phase|Death|0
6934792|NCT00896532|10968079|FG007|Months 48-72: Follow-on Phase|Death|0
6934793|NCT00896532|10968080|FG008|Months 48-72: Follow-on Phase|Death|0
6934794|NCT00896532|10968081|FG009|Months 48-72: Follow-on Phase|Death|0
6934795|NCT00896532|10968082|FG010|Months 48-72: Follow-on Phase|Death|0
6934796|NCT00896532|10968083|FG011|Months 48-72: Follow-on Phase|Death|0
6934797|NCT00896532|10968084|FG012|Months 48-72: Follow-on Phase|Death|0
6934798|NCT00896532|10968085|FG013|Months 48-72: Follow-on Phase|Death|0
6934799|NCT00896532|10968086|FG014|Months 48-72: Follow-on Phase|Death|0
6934800|NCT00896532|10968087|FG015|Months 48-72: Follow-on Phase|Death|0
6934801|NCT00896532|10968088|FG016|Months 48-72: Follow-on Phase|Death|0
6934802|NCT00896532|10968089|FG017|Months 48-72: Follow-on Phase|Death|0
6934803|NCT00896532|10968090|FG018|Months 48-72: Follow-on Phase|Death|1
6934804|NCT00896532|10968091|FG019|Months 48-72: Follow-on Phase|Death|0
6934805|NCT00896532|10968092|FG020|Months 48-72: Follow-on Phase|Death|0
6934806|NCT00896532|10968093|FG021|Months 48-72: Follow-on Phase|Death|0
6934807|NCT00896532|10968094|FG022|Months 48-72: Follow-on Phase|Death|0
6934808|NCT00896532|10968072|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6934809|NCT00896532|10968073|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6934810|NCT00896532|10968074|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6934811|NCT00896532|10968075|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6934812|NCT00896532|10968076|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6934813|NCT00896532|10968077|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6934814|NCT00896532|10968078|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6934815|NCT00896532|10968079|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6934816|NCT00896532|10968080|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6934817|NCT00896532|10968081|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6934818|NCT00896532|10968082|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6934819|NCT00896532|10968083|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6934820|NCT00896532|10968084|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6934821|NCT00896532|10968085|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6934822|NCT00896532|10968086|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6934823|NCT00896532|10968087|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6934824|NCT00896532|10968088|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6934825|NCT00896532|10968089|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6934826|NCT00896532|10968090|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6934827|NCT00896532|10968091|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6934828|NCT00896532|10968092|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6934829|NCT00896532|10968093|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1
6934830|NCT00896532|10968094|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6934831|NCT00896532|10968072|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6934832|NCT00896532|10968073|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6934833|NCT00896532|10968074|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6934834|NCT00896532|10968075|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6934835|NCT00896532|10968076|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6934836|NCT00896532|10968077|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6934837|NCT00896532|10968078|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6934838|NCT00896532|10968079|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6934839|NCT00896532|10968080|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6934840|NCT00896532|10968081|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6934841|NCT00896532|10968082|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6934842|NCT00896532|10968083|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6934843|NCT00896532|10968084|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6934844|NCT00896532|10968085|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6934845|NCT00896532|10968086|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6934846|NCT00896532|10968087|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6934847|NCT00896532|10968088|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7039997|NCT01714635|11122914|FG001|Overall Study|Discontinued|0
6934848|NCT00896532|10968089|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6934849|NCT00896532|10968090|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7039998|NCT01714635|11122915|FG002|Overall Study|Discontinued|2
7039999|NCT01714635|11122913|FG000|Overall Study|Missed 6-month exam|1
7065888|NCT01969851|11165709|FG001|Overall Study|Sponsor decision|0
7065889|NCT01969851|11165710|FG002|Overall Study|Sponsor decision|1
7065890|NCT01970007|11165722|FG000|Overall Study|Death|5
7147682|NCT03131895|11308241|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
7040000|NCT01714635|11122914|FG001|Overall Study|Missed 6-month exam|0
7040001|NCT01714635|11122915|FG002|Overall Study|Missed 6-month exam|0
6934850|NCT00896532|10968091|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6934851|NCT00896532|10968092|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6934852|NCT00896532|10968093|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1
6934853|NCT00896532|10968094|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6934854|NCT00896649|10968141|FG000|Overall Study|Physician Decision|1
6934855|NCT00896649|10968141|FG000|Overall Study|Pregnancy|1
6934856|NCT00896649|10968141|FG000|Overall Study|missing documentation|1
6934857|NCT00896649|10968141|FG000|Overall Study|technical difficulties|2
6934858|NCT00897390|10968155|FG000|Overall Study|Adverse Event|2
6934859|NCT00897390|10968155|FG000|Overall Study|No Longer Met Study Criteria|1
6934860|NCT00897390|10968155|FG000|Overall Study|Personal Reasons|1
6934861|NCT00897390|10968155|FG000|Overall Study|Did not Return for the Clinic Visit|2
6934862|NCT00897715|10968182|FG000|Overall Study|Lost to Follow-up|0
6934863|NCT00897715|10968183|FG001|Overall Study|Lost to Follow-up|1
6934864|NCT00897715|10968182|FG000|Overall Study|Physician Decision|1
6934865|NCT00897715|10968183|FG001|Overall Study|Physician Decision|0
6934866|NCT00897715|10968182|FG000|Overall Study|increased risk of infection|1
6934867|NCT00897715|10968183|FG001|Overall Study|increased risk of infection|0
6934868|NCT00898443|10968199|FG000|Overall Study|Withdrawal by Subject|1
6934869|NCT00898443|10968200|FG001|Overall Study|Withdrawal by Subject|0
6934870|NCT00898807|10968214|FG000|Overall Study|Withdrawal by Subject|5
6934871|NCT00898807|10968215|FG001|Overall Study|Withdrawal by Subject|3
7040002|NCT01714687|11122925|FG000|Overall Study|Withdrawal by Subject|1
7040003|NCT01714687|11122926|FG001|Overall Study|Withdrawal by Subject|0
7040004|NCT01714687|11122925|FG000|Overall Study|Lost to Follow-up|2
7065891|NCT01970007|11165722|FG000|Overall Study|Withdrawal by Subject|23
6934872|NCT00898807|10968214|FG000|Overall Study|Family pressure to discontinue|2
6934873|NCT00898807|10968215|FG001|Overall Study|Family pressure to discontinue|2
6934874|NCT00898807|10968214|FG000|Overall Study|Lost to Follow-up|1
6934875|NCT00898807|10968215|FG001|Overall Study|Lost to Follow-up|3
6934876|NCT00898807|10968214|FG000|Overall Study|Death|0
6934877|NCT00898807|10968215|FG001|Overall Study|Death|1
6934878|NCT00899353|10968234|FG000|Overall Study|Adverse Event|2
6934879|NCT00899353|10968234|FG000|Overall Study|Lost to Follow-up|1
6934880|NCT00899353|10968234|FG000|Overall Study|Withdrawal by Subject|2
6934881|NCT00899392|10968257|FG000|Overall Study|Subject didn't finish/partial pilot data|21
6934882|NCT00899392|10968258|FG001|Overall Study|Subject didn't finish/partial pilot data|24
6934883|NCT00899431|10968267|FG000|Overall Study|Physician Decision|1
6934884|NCT00899431|10968268|FG001|Overall Study|Physician Decision|0
6934885|NCT00899431|10968269|FG002|Overall Study|Physician Decision|0
6934886|NCT00899548|10968298|FG000|Overall Study|Physician Decision|3
6934887|NCT00899678|10968322|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6
6934888|NCT00899678|10968323|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0
6934889|NCT00899678|10968324|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0
6934890|NCT00899678|10968322|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17
6934891|NCT00899678|10968323|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
6934892|NCT00899678|10968324|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
6934893|NCT00899678|10968322|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1
6934894|NCT00899678|10968323|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0
6934895|NCT00899678|10968324|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0
6934896|NCT00899678|10968322|FG000|Induction Period (Weeks 0 to 6)|Other reason|1
6934897|NCT00899678|10968323|FG001|Induction Period (Weeks 0 to 6)|Other reason|0
6934898|NCT00899678|10968324|FG002|Induction Period (Weeks 0 to 6)|Other reason|0
6934899|NCT00899678|10968322|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0
6934900|NCT00899678|10968323|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10
6934901|NCT00899678|10968324|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5
6934902|NCT00899678|10968322|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0
6934903|NCT00899678|10968323|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11
6934904|NCT00899678|10968324|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18
6934905|NCT00899678|10968322|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0
6934906|NCT00899678|10968323|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
6934907|NCT00899678|10968324|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
6934908|NCT00899678|10968322|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0
6934909|NCT00899678|10968323|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1
6934910|NCT00899678|10968324|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2
7065892|NCT01970007|11165722|FG000|Overall Study|Lost to Follow-up|24
7065893|NCT01970007|11165722|FG000|Overall Study|"Other endpoint"|3
7065894|NCT01970241|11165737|FG000|Overall Study|Withdrawal by Subject|2
7065895|NCT01970241|11165738|FG001|Overall Study|Withdrawal by Subject|0
7065896|NCT01970241|11165737|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15
7065897|NCT01970241|11165738|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8
7065898|NCT01970371|11165749|FG000|Overall Study|Death|8
7065899|NCT01970371|11165750|FG001|Overall Study|Death|13
7065900|NCT01970371|11165751|FG002|Overall Study|Death|12
7065901|NCT01970371|11165749|FG000|Overall Study|Lost to Follow-up|0
7065902|NCT01970371|11165750|FG001|Overall Study|Lost to Follow-up|0
7065903|NCT01970371|11165751|FG002|Overall Study|Lost to Follow-up|1
7065904|NCT01970397|11165763|FG000|Overall Study|Adverse Event|0
7065905|NCT01970397|11165764|FG001|Overall Study|Adverse Event|1
7065906|NCT01970397|11165763|FG000|Overall Study|Lost to Follow-up|0
7065907|NCT01970397|11165764|FG001|Overall Study|Lost to Follow-up|1
7065908|NCT01970397|11165763|FG000|Overall Study|Personal Reasons|1
7065909|NCT01970397|11165764|FG001|Overall Study|Personal Reasons|2
7065910|NCT01970397|11165763|FG000|Overall Study|Protocol Violation|1
7065911|NCT01970397|11165764|FG001|Overall Study|Protocol Violation|1
7065912|NCT01970475|11165772|FG000|Overall Study|Withdrawal by Subject|11
7065913|NCT01970475|11165773|FG001|Overall Study|Withdrawal by Subject|6
7065914|NCT01970475|11165772|FG000|Overall Study|Adverse Event|7
7065915|NCT01970475|11165773|FG001|Overall Study|Adverse Event|3
7065916|NCT01970475|11165772|FG000|Overall Study|Lost to Follow-up|2
7065917|NCT01970475|11165773|FG001|Overall Study|Lost to Follow-up|2
7065918|NCT01970475|11165772|FG000|Overall Study|Protocol Violation|1
7065919|NCT01970475|11165773|FG001|Overall Study|Protocol Violation|0
7065920|NCT01970488|11165781|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1
7065921|NCT01970488|11165782|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2
6934911|NCT00899678|10968322|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0
6934912|NCT00899678|10968323|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2
6934913|NCT00899678|10968324|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2
7065922|NCT01970488|11165783|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0
7065923|NCT01970488|11165784|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0
7065924|NCT01970488|11165785|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0
7065925|NCT01970488|11165781|FG000|Part 1: Through Week 16|Protocol Violation|1
7065926|NCT01970488|11165782|FG001|Part 1: Through Week 16|Protocol Violation|2
7065927|NCT01970488|11165783|FG002|Part 1: Through Week 16|Protocol Violation|0
7065928|NCT01970488|11165784|FG003|Part 1: Through Week 16|Protocol Violation|0
6934914|NCT00899847|10968347|FG000|Overall Study|Lack of suitable allogeneic donor|2
6934915|NCT00900029|10968358|FG000|Overall Study|Lost to Follow-up|0
6934916|NCT00900029|10968359|FG001|Overall Study|Lost to Follow-up|2
6934917|NCT00900029|10968360|FG002|Overall Study|Lost to Follow-up|1
6934918|NCT00900029|10968361|FG003|Overall Study|Lost to Follow-up|4
6934919|NCT00900029|10968362|FG004|Overall Study|Lost to Follow-up|4
6934920|NCT00900029|10968358|FG000|Overall Study|Withdrawal by Subject|2
6934921|NCT00900029|10968359|FG001|Overall Study|Withdrawal by Subject|2
6934922|NCT00900029|10968360|FG002|Overall Study|Withdrawal by Subject|1
6934923|NCT00900029|10968361|FG003|Overall Study|Withdrawal by Subject|1
6934924|NCT00900029|10968362|FG004|Overall Study|Withdrawal by Subject|1
6934925|NCT00900029|10968358|FG000|Overall Study|Adverse Event|0
6934926|NCT00900029|10968359|FG001|Overall Study|Adverse Event|0
6934927|NCT00900029|10968360|FG002|Overall Study|Adverse Event|1
6934928|NCT00900029|10968361|FG003|Overall Study|Adverse Event|1
6934929|NCT00900029|10968362|FG004|Overall Study|Adverse Event|1
6934930|NCT00900029|10968358|FG000|Overall Study|Death|1
6934931|NCT00900029|10968359|FG001|Overall Study|Death|0
6934932|NCT00900029|10968360|FG002|Overall Study|Death|0
6934933|NCT00900029|10968361|FG003|Overall Study|Death|1
6934934|NCT00900029|10968362|FG004|Overall Study|Death|0
6934935|NCT00900146|10968379|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
6934936|NCT00900146|10968380|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
6934937|NCT00900146|10968381|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5
6934938|NCT00900146|10968382|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1
6934939|NCT00900146|10968383|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9
6934940|NCT00900146|10968379|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2
6934941|NCT00900146|10968380|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
6934942|NCT00900146|10968381|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
6934943|NCT00900146|10968382|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1
6934944|NCT00900146|10968383|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3
6934945|NCT00900146|10968379|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1
6934946|NCT00900146|10968380|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0
6934947|NCT00900146|10968381|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0
6934948|NCT00900146|10968382|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0
6934949|NCT00900146|10968383|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0
6934950|NCT00900146|10968379|FG000|Intermediate: Period III|Withdrawal by Subject|0
6934951|NCT00900146|10968380|FG001|Intermediate: Period III|Withdrawal by Subject|1
6934952|NCT00900146|10968381|FG002|Intermediate: Period III|Withdrawal by Subject|0
6934953|NCT00900146|10968382|FG003|Intermediate: Period III|Withdrawal by Subject|0
6934954|NCT00900146|10968383|FG004|Intermediate: Period III|Withdrawal by Subject|3
6934955|NCT00900146|10968379|FG000|Intermediate: Period III|Lost to Follow-up|2
6934956|NCT00900146|10968380|FG001|Intermediate: Period III|Lost to Follow-up|0
6934957|NCT00900146|10968381|FG002|Intermediate: Period III|Lost to Follow-up|0
6934958|NCT00900146|10968382|FG003|Intermediate: Period III|Lost to Follow-up|0
6934959|NCT00900146|10968383|FG004|Intermediate: Period III|Lost to Follow-up|1
6934960|NCT00900146|10968379|FG000|Intermediate: Period III|Administrative problems|85
6934961|NCT00900146|10968380|FG001|Intermediate: Period III|Administrative problems|92
6934962|NCT00900146|10968381|FG002|Intermediate: Period III|Administrative problems|84
6934963|NCT00900146|10968382|FG003|Intermediate: Period III|Administrative problems|90
6934964|NCT00900146|10968383|FG004|Intermediate: Period III|Administrative problems|163
6934965|NCT00900159|10968397|FG000|Second Intervention|disempanelled for inappropriate behavior|1
6934966|NCT00900159|10968398|FG001|Second Intervention|disempanelled for inappropriate behavior|0
6934967|NCT00900562|10968415|FG000|Overall Study|Progressive disease|9
6934968|NCT00900562|10968416|FG001|Overall Study|Progressive disease|5
6934969|NCT00900562|10968415|FG000|Overall Study|Toxicity|1
6934970|NCT00900562|10968416|FG001|Overall Study|Toxicity|0
6934971|NCT00900562|10968415|FG000|Overall Study|Death|1
6934972|NCT00900562|10968416|FG001|Overall Study|Death|1
6934973|NCT00900562|10968415|FG000|Overall Study|Withdrawal by Subject|0
6934974|NCT00900562|10968416|FG001|Overall Study|Withdrawal by Subject|1
6934975|NCT00900562|10968415|FG000|Overall Study|Unrelated adverse event|1
6934976|NCT00900562|10968416|FG001|Overall Study|Unrelated adverse event|0
6934977|NCT00900601|10968423|FG000|Overall Study|Physician Decision|1
6934978|NCT00900627|10968433|FG000|Overall Study|Condition under investigation worsened|4
6934979|NCT00900627|10968434|FG001|Overall Study|Condition under investigation worsened|0
6934980|NCT00900627|10968435|FG002|Overall Study|Condition under investigation worsened|5
6934981|NCT00900627|10968436|FG003|Overall Study|Condition under investigation worsened|3
6934982|NCT00900627|10968437|FG004|Overall Study|Condition under investigation worsened|0
6934983|NCT00900627|10968438|FG005|Overall Study|Condition under investigation worsened|0
6934984|NCT00900627|10968433|FG000|Overall Study|Withdrawal by Subject|1
6934985|NCT00900627|10968434|FG001|Overall Study|Withdrawal by Subject|0
6934986|NCT00900627|10968435|FG002|Overall Study|Withdrawal by Subject|1
6934987|NCT00900627|10968436|FG003|Overall Study|Withdrawal by Subject|0
6934988|NCT00900627|10968437|FG004|Overall Study|Withdrawal by Subject|1
6934989|NCT00900627|10968438|FG005|Overall Study|Withdrawal by Subject|2
6934990|NCT00900627|10968433|FG000|Overall Study|Adverse Event|1
6934991|NCT00900627|10968434|FG001|Overall Study|Adverse Event|2
6934992|NCT00900627|10968435|FG002|Overall Study|Adverse Event|0
6934993|NCT00900627|10968436|FG003|Overall Study|Adverse Event|3
7040005|NCT01714687|11122926|FG001|Overall Study|Lost to Follow-up|4
7040006|NCT01714726|11122936|FG000|Double-Blinded Induction Period|Subject not in open label period|3
7065929|NCT01970488|11165785|FG004|Part 1: Through Week 16|Protocol Violation|0
7065930|NCT01970488|11165781|FG000|Part 1: Through Week 16|Adverse Event|6
6934994|NCT00900627|10968437|FG004|Overall Study|Adverse Event|0
6934995|NCT00900627|10968438|FG005|Overall Study|Adverse Event|0
6934996|NCT00900627|10968433|FG000|Overall Study|Death|0
6934997|NCT00900627|10968434|FG001|Overall Study|Death|0
6934998|NCT00900627|10968435|FG002|Overall Study|Death|0
6934999|NCT00900627|10968436|FG003|Overall Study|Death|0
7065931|NCT01970488|11165782|FG001|Part 1: Through Week 16|Adverse Event|5
7065932|NCT01970488|11165783|FG002|Part 1: Through Week 16|Adverse Event|0
7065933|NCT01970488|11165784|FG003|Part 1: Through Week 16|Adverse Event|0
7065934|NCT01970488|11165785|FG004|Part 1: Through Week 16|Adverse Event|0
7065935|NCT01970488|11165781|FG000|Part 1: Through Week 16|Withdrawal by Subject|3
7065936|NCT01970488|11165782|FG001|Part 1: Through Week 16|Withdrawal by Subject|2
6935000|NCT00900627|10968437|FG004|Overall Study|Death|28
6935001|NCT00900627|10968438|FG005|Overall Study|Death|24
6935002|NCT00900731|10968463|FG000|Overall Study|Adverse Event|31
6935003|NCT00900731|10968464|FG001|Overall Study|Adverse Event|27
6935004|NCT00900731|10968463|FG000|Overall Study|Withdrawal by Subject|8
6935005|NCT00900731|10968464|FG001|Overall Study|Withdrawal by Subject|7
6935006|NCT00900731|10968463|FG000|Overall Study|Protocol Deviation|8
6935007|NCT00900731|10968464|FG001|Overall Study|Protocol Deviation|11
6935008|NCT00900731|10968463|FG000|Overall Study|Administrative Problems|5
6935009|NCT00900731|10968464|FG001|Overall Study|Administrative Problems|4
6935010|NCT00900731|10968463|FG000|Overall Study|Abnormal Test Procedure Result(s)|3
6935011|NCT00900731|10968464|FG001|Overall Study|Abnormal Test Procedure Result(s)|0
6935012|NCT00900731|10968463|FG000|Overall Study|Abnormal Laboratory Value(s)|2
6935013|NCT00900731|10968464|FG001|Overall Study|Abnormal Laboratory Value(s)|4
6935014|NCT00900731|10968463|FG000|Overall Study|Lost to Follow-up|2
6935015|NCT00900731|10968464|FG001|Overall Study|Lost to Follow-up|3
6935016|NCT00900731|10968463|FG000|Overall Study|Lack of Efficacy|1
6935017|NCT00900731|10968464|FG001|Overall Study|Lack of Efficacy|3
6935018|NCT00900731|10968463|FG000|Overall Study|Death|0
6935019|NCT00900731|10968464|FG001|Overall Study|Death|2
6935020|NCT00900757|10968470|FG000|Overall Study|screen failure|19
7040007|NCT01714726|11122937|FG001|Double-Blinded Induction Period|Subject not in open label period|1
7044793|NCT01757275|11130782|FG001|Overall Study|Adverse Event|3
7065937|NCT01970488|11165783|FG002|Part 1: Through Week 16|Withdrawal by Subject|0
7065938|NCT01970488|11165784|FG003|Part 1: Through Week 16|Withdrawal by Subject|0
7065939|NCT01970488|11165785|FG004|Part 1: Through Week 16|Withdrawal by Subject|0
7065940|NCT01970488|11165781|FG000|Part 1: Through Week 16|Lost to Follow-up|0
7065941|NCT01970488|11165782|FG001|Part 1: Through Week 16|Lost to Follow-up|2
7065942|NCT01970488|11165783|FG002|Part 1: Through Week 16|Lost to Follow-up|0
7065943|NCT01970488|11165784|FG003|Part 1: Through Week 16|Lost to Follow-up|0
7065944|NCT01970488|11165785|FG004|Part 1: Through Week 16|Lost to Follow-up|0
7065945|NCT01970488|11165781|FG000|Part 2: Post Week 16|Physician Decision|0
7065946|NCT01970488|11165782|FG001|Part 2: Post Week 16|Physician Decision|0
7065947|NCT01970488|11165783|FG002|Part 2: Post Week 16|Physician Decision|0
7065948|NCT01970488|11165784|FG003|Part 2: Post Week 16|Physician Decision|0
7065949|NCT01970488|11165785|FG004|Part 2: Post Week 16|Physician Decision|1
7065950|NCT01970488|11165781|FG000|Part 2: Post Week 16|Non-compliance|0
7065951|NCT01970488|11165782|FG001|Part 2: Post Week 16|Non-compliance|0
7065952|NCT01970488|11165783|FG002|Part 2: Post Week 16|Non-compliance|1
7065953|NCT01970488|11165784|FG003|Part 2: Post Week 16|Non-compliance|0
7065954|NCT01970488|11165785|FG004|Part 2: Post Week 16|Non-compliance|0
7065955|NCT01970488|11165781|FG000|Part 2: Post Week 16|Lack of Efficacy|0
7065956|NCT01970488|11165782|FG001|Part 2: Post Week 16|Lack of Efficacy|0
7065957|NCT01970488|11165783|FG002|Part 2: Post Week 16|Lack of Efficacy|2
7065958|NCT01970488|11165784|FG003|Part 2: Post Week 16|Lack of Efficacy|3
7065959|NCT01970488|11165785|FG004|Part 2: Post Week 16|Lack of Efficacy|1
7065960|NCT01970488|11165781|FG000|Part 2: Post Week 16|Adverse Event|0
7065961|NCT01970488|11165782|FG001|Part 2: Post Week 16|Adverse Event|0
7065962|NCT01970488|11165783|FG002|Part 2: Post Week 16|Adverse Event|5
7065963|NCT01970488|11165784|FG003|Part 2: Post Week 16|Adverse Event|1
7065964|NCT01970488|11165785|FG004|Part 2: Post Week 16|Adverse Event|1
7065965|NCT01970488|11165781|FG000|Part 2: Post Week 16|Withdrawal by Subject|0
7065966|NCT01970488|11165782|FG001|Part 2: Post Week 16|Withdrawal by Subject|0
7065967|NCT01970488|11165783|FG002|Part 2: Post Week 16|Withdrawal by Subject|8
7065968|NCT01970488|11165784|FG003|Part 2: Post Week 16|Withdrawal by Subject|3
7065969|NCT01970488|11165785|FG004|Part 2: Post Week 16|Withdrawal by Subject|3
7065970|NCT01970488|11165781|FG000|Part 2: Post Week 16|Lost to Follow-up|0
6935021|NCT00900796|10968474|FG000|Phase 1|Lacked sufficient information|4
6935022|NCT00900796|10968474|FG000|Phase 1|Missing information at Week 16|7
6935023|NCT00900796|10968474|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110
6935024|NCT00900796|10968474|FG000|Phase 2|Lost to Follow-up|5
6935025|NCT00901186|10968495|FG000|Overall Study|Lack of Efficacy|0
6935026|NCT00901186|10968496|FG001|Overall Study|Lack of Efficacy|1
6935027|NCT00901186|10968495|FG000|Overall Study|Abnormal laboratory values|0
6935028|NCT00901186|10968496|FG001|Overall Study|Abnormal laboratory values|1
6935029|NCT00901186|10968495|FG000|Overall Study|Lost to Follow-up|2
6935030|NCT00901186|10968496|FG001|Overall Study|Lost to Follow-up|0
6935031|NCT00901186|10968495|FG000|Overall Study|Adverse Event|2
6935032|NCT00901186|10968496|FG001|Overall Study|Adverse Event|4
6935033|NCT00901186|10968495|FG000|Overall Study|Administration problems|0
6935034|NCT00901186|10968496|FG001|Overall Study|Administration problems|1
6935035|NCT00901186|10968495|FG000|Overall Study|Protocol deviations|5
6935036|NCT00901186|10968496|FG001|Overall Study|Protocol deviations|4
6935037|NCT00901342|10968519|FG000|Overall Study|Adverse Event|1
6935038|NCT00901342|10968519|FG000|Overall Study|Death|4
6935039|NCT00901342|10968519|FG000|Overall Study|Disease progression|1
6935040|NCT00901342|10968519|FG000|Overall Study|Withdrawal by Subject|9
6935041|NCT00901394|10968526|FG000|Overall Study|Physician Decision|1
6935042|NCT00901394|10968527|FG001|Overall Study|Physician Decision|1
6935043|NCT00901394|10968528|FG002|Overall Study|Physician Decision|2
6935044|NCT00901459|10968536|FG000|Overall Study|Withdrawal by Subject|6
6935045|NCT00901485|10968547|FG000|Overall Study|Lack of Efficacy|0
6935046|NCT00901485|10968548|FG001|Overall Study|Lack of Efficacy|2
6935047|NCT00901485|10968547|FG000|Overall Study|Withdrawal by Subject|1
6935048|NCT00901485|10968548|FG001|Overall Study|Withdrawal by Subject|2
6935049|NCT00901576|10968560|FG000|Second Intervention|Withdrawal by Subject|0
6935050|NCT00901576|10968561|FG001|Second Intervention|Withdrawal by Subject|0
6935051|NCT00901576|10968562|FG002|Second Intervention|Withdrawal by Subject|0
6935052|NCT00901576|10968563|FG003|Second Intervention|Withdrawal by Subject|1
6935053|NCT00901576|10968564|FG004|Second Intervention|Withdrawal by Subject|0
6935054|NCT00901576|10968565|FG005|Second Intervention|Withdrawal by Subject|1
6935055|NCT00901576|10968560|FG000|Second Intervention|Physician Decision|1
6935056|NCT00901576|10968561|FG001|Second Intervention|Physician Decision|0
6935057|NCT00901576|10968562|FG002|Second Intervention|Physician Decision|0
6935058|NCT00901576|10968563|FG003|Second Intervention|Physician Decision|0
6935059|NCT00901576|10968564|FG004|Second Intervention|Physician Decision|0
6935060|NCT00901576|10968565|FG005|Second Intervention|Physician Decision|0
6935061|NCT00901628|10968575|FG000|Overall Study|disconnection of catheter|4
6935062|NCT00901628|10968576|FG001|Overall Study|disconnection of catheter|8
6935063|NCT00901628|10968575|FG000|Overall Study|disconnection of drain|0
6935064|NCT00901628|10968576|FG001|Overall Study|disconnection of drain|1
6935065|NCT00901628|10968575|FG000|Overall Study|peroneal nerve palsy|0
6935066|NCT00901628|10968576|FG001|Overall Study|peroneal nerve palsy|1
6935067|NCT00901901|10968584|FG000|Treatment Period|Adverse Event|120
6935068|NCT00901901|10968585|FG001|Treatment Period|Adverse Event|128
6935069|NCT00901901|10968584|FG000|Treatment Period|Withdrawal by Subject|26
6935070|NCT00901901|10968585|FG001|Treatment Period|Withdrawal by Subject|24
6935071|NCT00901901|10968584|FG000|Treatment Period|Physician Decision|2
6935072|NCT00901901|10968585|FG001|Treatment Period|Physician Decision|2
6935073|NCT00901901|10968584|FG000|Treatment Period|Lost to Follow-up|3
6935074|NCT00901901|10968585|FG001|Treatment Period|Lost to Follow-up|5
6935075|NCT00901901|10968584|FG000|Treatment Period|Noncompliance with study medication|4
6935076|NCT00901901|10968585|FG001|Treatment Period|Noncompliance with study medication|1
6935077|NCT00901901|10968584|FG000|Treatment Period|Missing|1
6935078|NCT00901901|10968585|FG001|Treatment Period|Missing|0
6935079|NCT00901901|10968584|FG000|Treatment Period|Never treated|0
6935080|NCT00901901|10968585|FG001|Treatment Period|Never treated|3
6935081|NCT00901901|10968584|FG000|Treatment Period|Protocol driven decision point|0
6935082|NCT00901901|10968585|FG001|Treatment Period|Protocol driven decision point|2
6935083|NCT00901901|10968584|FG000|Treatment Period|Study terminated by sponsor|2
6935084|NCT00901901|10968585|FG001|Treatment Period|Study terminated by sponsor|0
6935085|NCT00901901|10968584|FG000|Treatment Period|Protocol Violation|5
6935086|NCT00901901|10968585|FG001|Treatment Period|Protocol Violation|9
6935087|NCT00901901|10968584|FG000|Treatment Period|Switch to commercial drug|1
6935088|NCT00901901|10968585|FG001|Treatment Period|Switch to commercial drug|1
6935089|NCT00901901|10968584|FG000|Treatment Period|Transfer to treatment continuation study|5
6935090|NCT00901901|10968585|FG001|Treatment Period|Transfer to treatment continuation study|2
6935091|NCT00901901|10968584|FG000|Follow-up Period|Death|181
6935092|NCT00901901|10968585|FG001|Follow-up Period|Death|208
6935093|NCT00901901|10968584|FG000|Follow-up Period|Protocol driven decision point|47
6935094|NCT00901901|10968585|FG001|Follow-up Period|Protocol driven decision point|36
6935095|NCT00901901|10968584|FG000|Follow-up Period|Withdrawal by Subject|6
6935096|NCT00901901|10968585|FG001|Follow-up Period|Withdrawal by Subject|9
6935097|NCT00901901|10968584|FG000|Follow-up Period|Lost to Follow-up|12
6935098|NCT00901901|10968585|FG001|Follow-up Period|Lost to Follow-up|8
6935099|NCT00901901|10968584|FG000|Follow-up Period|Missing|94
6935100|NCT00901901|10968585|FG001|Follow-up Period|Missing|80
6935101|NCT00901927|10968593|FG000|Overall Study|Lack of Efficacy|1
6935102|NCT00901927|10968593|FG000|Overall Study|Protocol Violation|3
6935103|NCT00901927|10968593|FG000|Overall Study|Withdrawal by Subject|2
6935104|NCT00902174|10968632|FG000|Overall Study|Adverse Event|27
6935105|NCT00902174|10968633|FG001|Overall Study|Adverse Event|7
6935106|NCT00902174|10968632|FG000|Overall Study|Lack of Efficacy|1
6935107|NCT00902174|10968633|FG001|Overall Study|Lack of Efficacy|5
6935108|NCT00902174|10968632|FG000|Overall Study|Death|2
6935109|NCT00902174|10968633|FG001|Overall Study|Death|2
6935110|NCT00902174|10968632|FG000|Overall Study|Withdrawal by Subject|2
6935111|NCT00902174|10968633|FG001|Overall Study|Withdrawal by Subject|1
6935112|NCT00902174|10968632|FG000|Overall Study|Abnormal labs|1
6935113|NCT00902174|10968633|FG001|Overall Study|Abnormal labs|1
6935114|NCT00902174|10968632|FG000|Overall Study|Protocol Violation|1
6935115|NCT00902174|10968633|FG001|Overall Study|Protocol Violation|1
6935116|NCT00902174|10968632|FG000|Overall Study|Administration problem|0
6935117|NCT00902174|10968633|FG001|Overall Study|Administration problem|1
6935118|NCT00902265|10968646|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1
7065971|NCT01970488|11165782|FG001|Part 2: Post Week 16|Lost to Follow-up|0
7065972|NCT01970488|11165783|FG002|Part 2: Post Week 16|Lost to Follow-up|1
7065973|NCT01970488|11165784|FG003|Part 2: Post Week 16|Lost to Follow-up|1
7065974|NCT01970488|11165785|FG004|Part 2: Post Week 16|Lost to Follow-up|2
7065975|NCT01970527|11165802|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1
7065976|NCT01970527|11165803|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0
7065977|NCT01970527|11165802|FG000|Treatment|Disease progression|0
7065978|NCT01970527|11165803|FG001|Treatment|Disease progression|1
6837807|NCT00254540|10843495|FG001|Overall Study|Laboratory Test Abnormality|1
6837808|NCT00254566|10843504|FG000|Overall Study|Death|1
6837809|NCT00254566|10843505|FG001|Overall Study|Death|0
6837810|NCT00254566|10843504|FG000|Overall Study|Adverse Event|5
6837811|NCT00254566|10843505|FG001|Overall Study|Adverse Event|4
6837812|NCT00254566|10843504|FG000|Overall Study|Lack of Efficacy|12
6837813|NCT00254566|10843505|FG001|Overall Study|Lack of Efficacy|9
6837814|NCT00254566|10843504|FG000|Overall Study|Other|1
6837815|NCT00254566|10843505|FG001|Overall Study|Other|5
6837816|NCT00254566|10843504|FG000|Overall Study|Withdrawal by Subject|5
6837817|NCT00254566|10843505|FG001|Overall Study|Withdrawal by Subject|6
6837818|NCT00254566|10843504|FG000|Overall Study|Lost to Follow-up|7
6837819|NCT00254566|10843505|FG001|Overall Study|Lost to Follow-up|2
6837820|NCT00254982|10843517|FG000|Overall Study|Other|2
6837821|NCT00254982|10843518|FG001|Overall Study|Other|1
6837822|NCT00254982|10843517|FG000|Overall Study|Lack of Efficacy|5
6837823|NCT00254982|10843518|FG001|Overall Study|Lack of Efficacy|3
6837824|NCT00254982|10843517|FG000|Overall Study|Lost to Follow-up|5
6837825|NCT00254982|10843518|FG001|Overall Study|Lost to Follow-up|3
6837826|NCT00254982|10843517|FG000|Overall Study|Adverse Event|18
6837827|NCT00254982|10843518|FG001|Overall Study|Adverse Event|16
6837828|NCT00254982|10843517|FG000|Overall Study|Withdrawal by Subject|1
6837829|NCT00254982|10843518|FG001|Overall Study|Withdrawal by Subject|1
6837830|NCT00254982|10843517|FG000|Overall Study|Inclusion/exclusion criteria violation|0
6837831|NCT00254982|10843518|FG001|Overall Study|Inclusion/exclusion criteria violation|2
6837832|NCT00254982|10843517|FG000|Overall Study|Protocol deviation|1
6837833|NCT00254982|10843518|FG001|Overall Study|Protocol deviation|1
6837834|NCT00254982|10843517|FG000|Overall Study|Diagnosis of Tuberculosis|1
6837835|NCT00254982|10843518|FG001|Overall Study|Diagnosis of Tuberculosis|1
6837836|NCT00254982|10843517|FG000|Overall Study|Malignancy|0
6837837|NCT00254982|10843518|FG001|Overall Study|Malignancy|2
6837838|NCT00254982|10843517|FG000|Overall Study|Opportunistic infection|1
6837839|NCT00254982|10843518|FG001|Overall Study|Opportunistic infection|0
6837840|NCT00254982|10843517|FG000|Overall Study|Abnormal liver function tests|2
6837841|NCT00254982|10843518|FG001|Overall Study|Abnormal liver function tests|1
6837842|NCT00255008|10843539|FG000|Overall Study|Adverse Event|1
6837843|NCT00255008|10843540|FG001|Overall Study|Adverse Event|1
6837844|NCT00255008|10843541|FG002|Overall Study|Adverse Event|2
6837845|NCT00255008|10843542|FG003|Overall Study|Adverse Event|0
6837846|NCT00255008|10843539|FG000|Overall Study|Lost to Follow-up|1
6837847|NCT00255008|10843540|FG001|Overall Study|Lost to Follow-up|0
6837848|NCT00255008|10843541|FG002|Overall Study|Lost to Follow-up|1
6837849|NCT00255008|10843542|FG003|Overall Study|Lost to Follow-up|2
6837850|NCT00255008|10843539|FG000|Overall Study|Did not meet viral reduction criteria|4
6837851|NCT00255008|10843540|FG001|Overall Study|Did not meet viral reduction criteria|5
6837852|NCT00255008|10843541|FG002|Overall Study|Did not meet viral reduction criteria|0
6837853|NCT00255008|10843542|FG003|Overall Study|Did not meet viral reduction criteria|1
6837854|NCT00255008|10843539|FG000|Overall Study|Withdrew consent|0
6837855|NCT00255008|10843540|FG001|Overall Study|Withdrew consent|0
6837856|NCT00255008|10843541|FG002|Overall Study|Withdrew consent|2
6837857|NCT00255008|10843542|FG003|Overall Study|Withdrew consent|0
6837858|NCT00255008|10843539|FG000|Overall Study|Sponsor request|18
6837859|NCT00255008|10843540|FG001|Overall Study|Sponsor request|3
6837860|NCT00255008|10843541|FG002|Overall Study|Sponsor request|8
6837861|NCT00255008|10843542|FG003|Overall Study|Sponsor request|17
6837862|NCT00255008|10843539|FG000|Overall Study|Adverse lab experience|1
6837863|NCT00255008|10843540|FG001|Overall Study|Adverse lab experience|0
6837864|NCT00255008|10843541|FG002|Overall Study|Adverse lab experience|0
6837865|NCT00255008|10843542|FG003|Overall Study|Adverse lab experience|0
6837866|NCT00255008|10843539|FG000|Overall Study|Other|7
6837867|NCT00255008|10843540|FG001|Overall Study|Other|0
6837868|NCT00255008|10843541|FG002|Overall Study|Other|3
6837869|NCT00255008|10843542|FG003|Overall Study|Other|2
6837870|NCT00255034|10843554|FG000|Overall Study|Withdrawal by Subject|15
6837871|NCT00255034|10843555|FG001|Overall Study|Withdrawal by Subject|38
6935119|NCT00902265|10968646|FG000|Overall Study|Adverse Event|2
6837872|NCT00255047|10843565|FG000|Overall Study|Serious Adverse Events|2
6837873|NCT00255047|10843566|FG001|Overall Study|Serious Adverse Events|1
6837874|NCT00255047|10843567|FG002|Overall Study|Serious Adverse Events|2
6837875|NCT00255047|10843568|FG003|Overall Study|Serious Adverse Events|1
6837876|NCT00255047|10843565|FG000|Overall Study|Adverse Event|0
6837877|NCT00255047|10843566|FG001|Overall Study|Adverse Event|3
6837878|NCT00255047|10843567|FG002|Overall Study|Adverse Event|2
6837879|NCT00255047|10843568|FG003|Overall Study|Adverse Event|1
6837880|NCT00255047|10843565|FG000|Overall Study|Protocol Violation|13
6837881|NCT00255047|10843566|FG001|Overall Study|Protocol Violation|13
6935120|NCT00902265|10968646|FG000|Overall Study|Lack of Efficacy|2
6935121|NCT00902265|10968646|FG000|Overall Study|Protocol Violation|1
6935122|NCT00902278|10968655|FG000|Overall Study|Physician Decision|1
7065979|NCT01970527|11165802|FG000|Treatment|Participant did not tolerate Ipilimumab|0
7065980|NCT01970527|11165803|FG001|Treatment|Participant did not tolerate Ipilimumab|1
7065981|NCT01970527|11165802|FG000|Treatment|Death|0
6935123|NCT00902278|10968656|FG001|Overall Study|Physician Decision|0
6935124|NCT00902278|10968657|FG002|Overall Study|Physician Decision|2
6935125|NCT00902278|10968658|FG003|Overall Study|Physician Decision|0
6935126|NCT00902278|10968659|FG004|Overall Study|Physician Decision|1
6935127|NCT00902278|10968655|FG000|Overall Study|Lost to Follow-up|3
6935128|NCT00902278|10968656|FG001|Overall Study|Lost to Follow-up|2
6935129|NCT00902278|10968657|FG002|Overall Study|Lost to Follow-up|3
6935130|NCT00902278|10968658|FG003|Overall Study|Lost to Follow-up|0
6935131|NCT00902278|10968659|FG004|Overall Study|Lost to Follow-up|1
6935132|NCT00902304|10968674|FG000|Overall Study|Adverse Event|4
6935133|NCT00902304|10968675|FG001|Overall Study|Adverse Event|10
6935134|NCT00902304|10968676|FG002|Overall Study|Adverse Event|25
6935135|NCT00902304|10968674|FG000|Overall Study|Investigator discretion|3
6935136|NCT00902304|10968675|FG001|Overall Study|Investigator discretion|5
6935137|NCT00902304|10968676|FG002|Overall Study|Investigator discretion|13
6935138|NCT00902304|10968674|FG000|Overall Study|Lost to Follow-up|7
6935139|NCT00902304|10968675|FG001|Overall Study|Lost to Follow-up|7
6935140|NCT00902304|10968676|FG002|Overall Study|Lost to Follow-up|7
6935141|NCT00902304|10968674|FG000|Overall Study|Protocol Violation|9
6935142|NCT00902304|10968675|FG001|Overall Study|Protocol Violation|18
6935143|NCT00902304|10968676|FG002|Overall Study|Protocol Violation|20
6935144|NCT00902304|10968674|FG000|Overall Study|Withdrawal by Subject|32
6935145|NCT00902304|10968675|FG001|Overall Study|Withdrawal by Subject|22
6935146|NCT00902304|10968676|FG002|Overall Study|Withdrawal by Subject|43
6935147|NCT00902304|10968674|FG000|Overall Study|includes pregnancy|3
6935148|NCT00902304|10968675|FG001|Overall Study|includes pregnancy|9
6935149|NCT00902304|10968676|FG002|Overall Study|includes pregnancy|2
6935150|NCT00902330|10968687|FG000|Overall Study|Too overwhelmed by treatment|2
6935151|NCT00902330|10968688|FG001|Overall Study|Too overwhelmed by treatment|5
6935152|NCT00902330|10968687|FG000|Overall Study|Adverse Event|1
6935153|NCT00902330|10968688|FG001|Overall Study|Adverse Event|0
6935154|NCT00902330|10968687|FG000|Overall Study|No post baseline data|1
6935155|NCT00902330|10968688|FG001|Overall Study|No post baseline data|0
6935156|NCT00902486|10968701|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
6935157|NCT00902486|10968702|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0
6935158|NCT00902486|10968703|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0
6935159|NCT00902486|10968704|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
6935160|NCT00902486|10968705|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
6935161|NCT00902486|10968706|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2
6935162|NCT00902486|10968701|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1
6935163|NCT00902486|10968702|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
7065982|NCT01970527|11165803|FG001|Treatment|Death|1
7065983|NCT01970527|11165802|FG000|Follow-up Clinic Visit|Disease progression|1
7065984|NCT01970527|11165803|FG001|Follow-up Clinic Visit|Disease progression|1
7065985|NCT01970527|11165802|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0
7065986|NCT01970527|11165803|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1
7065987|NCT01970527|11165802|FG000|Follow-up Clinic Visit|Lost to Follow-up|0
7065988|NCT01970527|11165803|FG001|Follow-up Clinic Visit|Lost to Follow-up|1
7065989|NCT01970540|11165815|FG000|Overall Study|Non-treatment-related AE|0
7065990|NCT01970540|11165816|FG001|Overall Study|Non-treatment-related AE|0
7065991|NCT01970540|11165817|FG002|Overall Study|Non-treatment-related AE|1
7065992|NCT01970540|11165815|FG000|Overall Study|Progressive disease|55
7065993|NCT01970540|11165816|FG001|Overall Study|Progressive disease|23
7065994|NCT01970540|11165817|FG002|Overall Study|Progressive disease|10
7065995|NCT01970540|11165815|FG000|Overall Study|Treatment delay over protocol|0
7065996|NCT01970540|11165816|FG001|Overall Study|Treatment delay over protocol|0
7065997|NCT01970540|11165817|FG002|Overall Study|Treatment delay over protocol|1
6837882|NCT00255047|10843567|FG002|Overall Study|Protocol Violation|16
6935164|NCT00902486|10968703|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
6935165|NCT00902486|10968704|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
6935166|NCT00902486|10968705|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
6935167|NCT00902486|10968706|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2
6837883|NCT00255047|10843568|FG003|Overall Study|Protocol Violation|20
6837884|NCT00255047|10843565|FG000|Overall Study|Lost to Follow-up|9
7065998|NCT01970540|11165815|FG000|Overall Study|Physician Decision|7
7065999|NCT01970540|11165816|FG001|Overall Study|Physician Decision|2
6837885|NCT00255047|10843566|FG001|Overall Study|Lost to Follow-up|8
6935168|NCT00902486|10968701|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
6935169|NCT00902486|10968702|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
6935170|NCT00902486|10968703|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
6935171|NCT00902486|10968704|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
6935172|NCT00902486|10968705|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1
6935173|NCT00902486|10968706|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1
6935174|NCT00902486|10968701|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
6935175|NCT00902486|10968702|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
6935176|NCT00902486|10968703|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
6935177|NCT00902486|10968704|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1
6935178|NCT00902486|10968705|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
6935179|NCT00902486|10968706|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
6935180|NCT00902486|10968701|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
6935181|NCT00902486|10968702|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
6935182|NCT00902486|10968703|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
6935183|NCT00902486|10968704|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1
6935184|NCT00902486|10968705|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
6935185|NCT00902486|10968706|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
6935186|NCT00902486|10968701|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0
6935187|NCT00902486|10968702|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0
6935188|NCT00902486|10968703|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0
6935189|NCT00902486|10968704|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0
6935190|NCT00902486|10968705|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1
6935191|NCT00902486|10968706|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2
6935192|NCT00902486|10968701|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
6935193|NCT00902486|10968702|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
6935194|NCT00902486|10968703|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1
6935195|NCT00902486|10968704|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1
6935196|NCT00902486|10968705|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
6935197|NCT00902486|10968706|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
6935198|NCT00902486|10968701|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
6935199|NCT00902486|10968702|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
6935200|NCT00902486|10968703|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
6935201|NCT00902486|10968704|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
6935202|NCT00902486|10968705|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
6935203|NCT00902486|10968706|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1
6935204|NCT00902486|10968701|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0
6935205|NCT00902486|10968702|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0
6935206|NCT00902486|10968703|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0
7040008|NCT01714726|11122938|FG002|Double-Blinded Induction Period|Subject not in open label period|0
6935207|NCT00902486|10968704|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1
6935208|NCT00902486|10968705|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0
6935209|NCT00902486|10968706|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0
6935210|NCT00902486|10968701|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
6935211|NCT00902486|10968702|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
6935212|NCT00902486|10968703|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1
6935213|NCT00902486|10968704|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
7040009|NCT01714726|11122939|FG003|Double-Blinded Induction Period|Subject not in open label period|0
7040010|NCT01714726|11122936|FG000|Double-Blinded Induction Period|Adverse Event|0
7040011|NCT01714726|11122937|FG001|Double-Blinded Induction Period|Adverse Event|1
7040012|NCT01714726|11122938|FG002|Double-Blinded Induction Period|Adverse Event|0
7066000|NCT01970540|11165817|FG002|Overall Study|Physician Decision|0
6935214|NCT00902486|10968705|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
6935215|NCT00902486|10968706|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
6935216|NCT00902486|10968701|FG000|Follow-up (After Week 24)|Lost to Follow-up|0
6935217|NCT00902486|10968702|FG001|Follow-up (After Week 24)|Lost to Follow-up|0
6935218|NCT00902486|10968703|FG002|Follow-up (After Week 24)|Lost to Follow-up|0
6935219|NCT00902486|10968704|FG003|Follow-up (After Week 24)|Lost to Follow-up|1
6935220|NCT00902486|10968705|FG004|Follow-up (After Week 24)|Lost to Follow-up|0
6935221|NCT00902486|10968706|FG005|Follow-up (After Week 24)|Lost to Follow-up|0
6935222|NCT00902538|10968739|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49
7040013|NCT01714726|11122939|FG003|Double-Blinded Induction Period|Adverse Event|0
7066001|NCT01970540|11165815|FG000|Overall Study|Clinical progression|0
7066002|NCT01970540|11165816|FG001|Overall Study|Clinical progression|1
7066003|NCT01970540|11165817|FG002|Overall Study|Clinical progression|1
7066004|NCT01970540|11165815|FG000|Overall Study|End of study|2
7066005|NCT01970540|11165816|FG001|Overall Study|End of study|0
7066006|NCT01970540|11165817|FG002|Overall Study|End of study|2
7066007|NCT01970540|11165815|FG000|Overall Study|Adverse Event|0
7066008|NCT01970540|11165816|FG001|Overall Study|Adverse Event|2
6935223|NCT00902538|10968740|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
6935224|NCT00902538|10968741|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
6935225|NCT00902538|10968742|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
6935226|NCT00902538|10968743|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
6935227|NCT00902538|10968744|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
6935228|NCT00902538|10968739|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30
6935229|NCT00902538|10968740|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
6935230|NCT00902538|10968741|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
6935231|NCT00902538|10968742|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
6935232|NCT00902538|10968743|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
6935233|NCT00902538|10968744|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
6935234|NCT00902538|10968739|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22
6935235|NCT00902538|10968740|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
6837886|NCT00255047|10843567|FG002|Overall Study|Lost to Follow-up|5
6837887|NCT00255047|10843568|FG003|Overall Study|Lost to Follow-up|6
6935236|NCT00902538|10968741|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
6935237|NCT00902538|10968742|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
6935238|NCT00902538|10968743|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
6837888|NCT00255047|10843565|FG000|Overall Study|Withdrawal by Subject|24
6837889|NCT00255047|10843566|FG001|Overall Study|Withdrawal by Subject|23
6837890|NCT00255047|10843567|FG002|Overall Study|Withdrawal by Subject|25
6837891|NCT00255047|10843568|FG003|Overall Study|Withdrawal by Subject|18
6837892|NCT00255086|10843580|FG000|Overall Study|Adverse Event|1
6837893|NCT00255086|10843581|FG001|Overall Study|Adverse Event|1
6837894|NCT00255086|10843580|FG000|Overall Study|Protocol Violation|1
6837895|NCT00255086|10843581|FG001|Overall Study|Protocol Violation|1
6837896|NCT00255151|10843602|FG000|Overall Study|Adverse Event|10
6837897|NCT00255151|10843603|FG001|Overall Study|Adverse Event|6
6837898|NCT00255151|10843604|FG002|Overall Study|Adverse Event|9
6837899|NCT00255151|10843602|FG000|Overall Study|Lost to Follow-up|4
6837900|NCT00255151|10843603|FG001|Overall Study|Lost to Follow-up|3
6935239|NCT00902538|10968744|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
6935240|NCT00902538|10968739|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13
6935241|NCT00902538|10968740|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
6935242|NCT00902538|10968741|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
6935243|NCT00902538|10968742|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
6935244|NCT00902538|10968743|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
6935245|NCT00902538|10968744|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
6935246|NCT00902538|10968739|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4
6935247|NCT00902538|10968740|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
6935248|NCT00902538|10968741|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
6935249|NCT00902538|10968742|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
6935250|NCT00902538|10968743|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
6935251|NCT00902538|10968744|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
6935252|NCT00902538|10968739|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4
6935253|NCT00902538|10968740|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2
6935254|NCT00902538|10968741|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3
6935255|NCT00902538|10968742|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0
6935256|NCT00902538|10968743|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0
6935257|NCT00902538|10968744|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0
6935258|NCT00902538|10968739|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
6935259|NCT00902538|10968740|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2
6935260|NCT00902538|10968741|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
6935261|NCT00902538|10968742|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
6935262|NCT00902538|10968743|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
6935263|NCT00902538|10968744|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
6935264|NCT00902538|10968739|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1
6935265|NCT00902538|10968740|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
6935266|NCT00902538|10968741|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2
6935267|NCT00902538|10968742|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
6935268|NCT00902538|10968743|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
6935269|NCT00902538|10968744|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
6935270|NCT00902538|10968739|FG000|2-Randomized Double-blind 3 Treatments|Other|2
6935271|NCT00902538|10968740|FG001|2-Randomized Double-blind 3 Treatments|Other|1
6935272|NCT00902538|10968741|FG002|2-Randomized Double-blind 3 Treatments|Other|0
6935273|NCT00902538|10968742|FG003|2-Randomized Double-blind 3 Treatments|Other|0
6935274|NCT00902538|10968743|FG004|2-Randomized Double-blind 3 Treatments|Other|0
6935275|NCT00902538|10968744|FG005|2-Randomized Double-blind 3 Treatments|Other|0
6935276|NCT00902538|10968739|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
6935277|NCT00902538|10968740|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
6837901|NCT00255151|10843604|FG002|Overall Study|Lost to Follow-up|4
7040014|NCT01714726|11122936|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5
7040015|NCT01714726|11122937|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3
7066009|NCT01970540|11165817|FG002|Overall Study|Adverse Event|1
7066010|NCT01970540|11165815|FG000|Overall Study|Treatment-related AE|4
7066011|NCT01970540|11165816|FG001|Overall Study|Treatment-related AE|0
6837902|NCT00255151|10843602|FG000|Overall Study|Withdrawal by Subject|18
6837903|NCT00255151|10843603|FG001|Overall Study|Withdrawal by Subject|17
6837904|NCT00255151|10843604|FG002|Overall Study|Withdrawal by Subject|8
6837905|NCT00255151|10843602|FG000|Overall Study|Noncompliance|0
6837906|NCT00255151|10843603|FG001|Overall Study|Noncompliance|1
6837907|NCT00255151|10843604|FG002|Overall Study|Noncompliance|2
6837908|NCT00255151|10843602|FG000|Overall Study|Subject Request/Subject Unavailable|1
6837909|NCT00255151|10843603|FG001|Overall Study|Subject Request/Subject Unavailable|1
7066012|NCT01970540|11165817|FG002|Overall Study|Treatment-related AE|2
7066013|NCT01970540|11165815|FG000|Overall Study|Withdrawal by Subject|4
7066014|NCT01970540|11165816|FG001|Overall Study|Withdrawal by Subject|0
7066015|NCT01970540|11165817|FG002|Overall Study|Withdrawal by Subject|1
7066016|NCT01970540|11165815|FG000|Overall Study|Clinical deterioration|1
7066017|NCT01970540|11165816|FG001|Overall Study|Clinical deterioration|0
7066018|NCT01970540|11165817|FG002|Overall Study|Clinical deterioration|0
7066019|NCT01970592|11165836|FG000|Overall Study|Withdrawal by Subject|4
7066020|NCT01970592|11165836|FG000|Overall Study|Physician Decision|1
7066021|NCT01970592|11165836|FG000|Overall Study|Adverse Event|1
7066022|NCT01970878|11165848|FG000|Overall Study|Withdrawal by Subject|11
7066023|NCT01970878|11165849|FG001|Overall Study|Withdrawal by Subject|10
7066024|NCT01970878|11165850|FG002|Overall Study|Withdrawal by Subject|14
7066025|NCT01970878|11165851|FG003|Overall Study|Withdrawal by Subject|7
7066026|NCT01970878|11165848|FG000|Overall Study|Lost to Follow-up|1
7066027|NCT01970878|11165849|FG001|Overall Study|Lost to Follow-up|3
7066028|NCT01970878|11165850|FG002|Overall Study|Lost to Follow-up|2
7066029|NCT01970878|11165851|FG003|Overall Study|Lost to Follow-up|4
7066030|NCT01970878|11165848|FG000|Overall Study|Administrative Reasons|1
7066031|NCT01970878|11165849|FG001|Overall Study|Administrative Reasons|0
7066032|NCT01970878|11165850|FG002|Overall Study|Administrative Reasons|0
7066033|NCT01970878|11165851|FG003|Overall Study|Administrative Reasons|4
6837910|NCT00255151|10843604|FG002|Overall Study|Subject Request/Subject Unavailable|2
6837911|NCT00255151|10843602|FG000|Overall Study|Relapse of Erosive Esophagitis|78
6837912|NCT00255151|10843603|FG001|Overall Study|Relapse of Erosive Esophagitis|16
6837913|NCT00255151|10843604|FG002|Overall Study|Relapse of Erosive Esophagitis|12
6837914|NCT00255151|10843602|FG000|Overall Study|Possible Barrett's Esophagus|1
6837915|NCT00255151|10843603|FG001|Overall Study|Possible Barrett's Esophagus|3
7066034|NCT01970878|11165848|FG000|Overall Study|Lack of Efficacy|2
7066035|NCT01970878|11165849|FG001|Overall Study|Lack of Efficacy|1
7066036|NCT01970878|11165850|FG002|Overall Study|Lack of Efficacy|2
7066037|NCT01970878|11165851|FG003|Overall Study|Lack of Efficacy|0
7066038|NCT01970878|11165848|FG000|Overall Study|Adverse Event|12
7066039|NCT01970878|11165849|FG001|Overall Study|Adverse Event|7
7066040|NCT01970878|11165850|FG002|Overall Study|Adverse Event|4
7066041|NCT01970878|11165851|FG003|Overall Study|Adverse Event|3
7066042|NCT01970878|11165848|FG000|Overall Study|Protocol Specified Criteria|10
7066043|NCT01970878|11165849|FG001|Overall Study|Protocol Specified Criteria|4
7066044|NCT01970878|11165850|FG002|Overall Study|Protocol Specified Criteria|3
7066045|NCT01970878|11165851|FG003|Overall Study|Protocol Specified Criteria|6
7066046|NCT01970878|11165848|FG000|Overall Study|Physician Decision|0
7066047|NCT01970878|11165849|FG001|Overall Study|Physician Decision|1
7066048|NCT01970878|11165850|FG002|Overall Study|Physician Decision|1
7066049|NCT01970878|11165851|FG003|Overall Study|Physician Decision|0
7066050|NCT01970878|11165848|FG000|Overall Study|No Completion Status|0
7066051|NCT01970878|11165849|FG001|Overall Study|No Completion Status|1
7066052|NCT01970878|11165850|FG002|Overall Study|No Completion Status|0
7066053|NCT01970878|11165851|FG003|Overall Study|No Completion Status|0
7066054|NCT01970982|11165871|FG000|Overall Study|Withdrawal by Subject|0
7066055|NCT01970982|11165872|FG001|Overall Study|Withdrawal by Subject|0
7066056|NCT01970982|11165873|FG002|Overall Study|Withdrawal by Subject|2
7066057|NCT01970995|11165885|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
7066058|NCT01970995|11165886|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
7066059|NCT01970995|11165887|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
7066060|NCT01970995|11165885|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1
7066061|NCT01970995|11165886|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0
7066062|NCT01970995|11165887|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1
7066063|NCT01971203|11165902|FG000|Overall Study|Protocol Violation|3
7066064|NCT01971203|11165903|FG001|Overall Study|Protocol Violation|2
7066065|NCT01971203|11165902|FG000|Overall Study|Withdrawal by Subject|5
6897574|NCT00642278|10916742|FG001|Overall Study|Lack of Efficacy|1
6897575|NCT00642278|10916743|FG002|Overall Study|Lack of Efficacy|0
6897576|NCT00642278|10916744|FG003|Overall Study|Lack of Efficacy|0
6897577|NCT00642278|10916745|FG004|Overall Study|Lack of Efficacy|0
6897578|NCT00642278|10916746|FG005|Overall Study|Lack of Efficacy|0
6897579|NCT00642278|10916747|FG006|Overall Study|Lack of Efficacy|0
6897580|NCT00642278|10916741|FG000|Overall Study|Lost to Follow-up|5
6897581|NCT00642278|10916742|FG001|Overall Study|Lost to Follow-up|1
6837916|NCT00255151|10843604|FG002|Overall Study|Possible Barrett's Esophagus|8
6837917|NCT00255151|10843602|FG000|Overall Study|Esophageal Stricture|0
6837918|NCT00255151|10843603|FG001|Overall Study|Esophageal Stricture|0
6837919|NCT00255151|10843604|FG002|Overall Study|Esophageal Stricture|1
6837920|NCT00255151|10843602|FG000|Overall Study|Therapeutic Failure|11
6837921|NCT00255151|10843603|FG001|Overall Study|Therapeutic Failure|2
6837922|NCT00255151|10843604|FG002|Overall Study|Therapeutic Failure|3
6837923|NCT00255164|10843615|FG000|Overall Study|Adverse Event|10
6837924|NCT00255164|10843616|FG001|Overall Study|Adverse Event|6
6837925|NCT00255164|10843617|FG002|Overall Study|Adverse Event|9
6837926|NCT00255164|10843615|FG000|Overall Study|Lost to Follow-up|4
6837927|NCT00255164|10843616|FG001|Overall Study|Lost to Follow-up|3
6837928|NCT00255164|10843617|FG002|Overall Study|Lost to Follow-up|4
6837929|NCT00255164|10843615|FG000|Overall Study|Withdrawal by Subject|18
6837930|NCT00255164|10843616|FG001|Overall Study|Withdrawal by Subject|17
6837931|NCT00255164|10843617|FG002|Overall Study|Withdrawal by Subject|8
6837932|NCT00255164|10843615|FG000|Overall Study|Noncompliance|0
6837933|NCT00255164|10843616|FG001|Overall Study|Noncompliance|1
6837934|NCT00255164|10843617|FG002|Overall Study|Noncompliance|2
6837935|NCT00255164|10843615|FG000|Overall Study|Subject Request/Subject Unavailable|1
6837936|NCT00255164|10843616|FG001|Overall Study|Subject Request/Subject Unavailable|1
6935278|NCT00902538|10968741|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2
6935279|NCT00902538|10968742|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
6935280|NCT00902538|10968743|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
6935281|NCT00902538|10968744|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
6935282|NCT00902538|10968739|FG000|3-Single-blind, Single Treatment|Adverse Event|0
6935283|NCT00902538|10968740|FG001|3-Single-blind, Single Treatment|Adverse Event|5
6935284|NCT00902538|10968741|FG002|3-Single-blind, Single Treatment|Adverse Event|0
6935285|NCT00902538|10968742|FG003|3-Single-blind, Single Treatment|Adverse Event|0
6935286|NCT00902538|10968743|FG004|3-Single-blind, Single Treatment|Adverse Event|0
6935287|NCT00902538|10968744|FG005|3-Single-blind, Single Treatment|Adverse Event|0
6935288|NCT00902538|10968739|FG000|3-Single-blind, Single Treatment|Protocol Violation|0
6935289|NCT00902538|10968740|FG001|3-Single-blind, Single Treatment|Protocol Violation|5
6935290|NCT00902538|10968741|FG002|3-Single-blind, Single Treatment|Protocol Violation|0
6935291|NCT00902538|10968742|FG003|3-Single-blind, Single Treatment|Protocol Violation|0
6935292|NCT00902538|10968743|FG004|3-Single-blind, Single Treatment|Protocol Violation|0
6935293|NCT00902538|10968744|FG005|3-Single-blind, Single Treatment|Protocol Violation|0
6935294|NCT00902538|10968739|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0
6935295|NCT00902538|10968740|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4
6935296|NCT00902538|10968741|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0
6935297|NCT00902538|10968742|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0
6935298|NCT00902538|10968743|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0
6935299|NCT00902538|10968744|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0
6935300|NCT00902538|10968739|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0
6935301|NCT00902538|10968740|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1
6935302|NCT00902538|10968741|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0
6935303|NCT00902538|10968742|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0
7066066|NCT01971203|11165903|FG001|Overall Study|Withdrawal by Subject|6
7066067|NCT01971203|11165902|FG000|Overall Study|Adverse Event|1
7066068|NCT01971203|11165903|FG001|Overall Study|Adverse Event|0
7066069|NCT01971346|11165918|FG000|Overall Study|Protocol Violation|3
7066070|NCT01971346|11165918|FG000|Overall Study|Lost to Follow-up|2
7066071|NCT01971346|11165918|FG000|Overall Study|Withdrawal by Subject|2
7066072|NCT01971346|11165918|FG000|Overall Study|Physician Decision|1
7066073|NCT01971476|11165949|FG000|Cohort 1: 2 to <12 Years|Other not defined|3
7066074|NCT01971476|11165950|FG001|Cohort 1: 2 to <12 Years|Other not defined|3
7066075|NCT01971476|11165951|FG002|Cohort 1: 2 to <12 Years|Other not defined|6
7066076|NCT01971476|11165949|FG000|Cohort 2: 12 to <18 Years|Other not defined|6
7066077|NCT01971476|11165950|FG001|Cohort 2: 12 to <18 Years|Other not defined|3
7066078|NCT01971476|11165951|FG002|Cohort 2: 12 to <18 Years|Other not defined|0
7066079|NCT01971476|11165949|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0
6837937|NCT00255164|10843617|FG002|Overall Study|Subject Request/Subject Unavailable|2
6935304|NCT00902538|10968743|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0
6935305|NCT00902538|10968744|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0
6935306|NCT00902538|10968739|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0
7066080|NCT01971476|11165950|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1
7066081|NCT01971476|11165951|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0
6837938|NCT00255164|10843615|FG000|Overall Study|Relapse of Erosive Esophagitis|78
6837939|NCT00255164|10843616|FG001|Overall Study|Relapse of Erosive Esophagitis|16
6837940|NCT00255164|10843617|FG002|Overall Study|Relapse of Erosive Esophagitis|12
6837941|NCT00255164|10843615|FG000|Overall Study|Possible Barrett's Esophagus|1
6837942|NCT00255164|10843616|FG001|Overall Study|Possible Barrett's Esophagus|3
6837943|NCT00255164|10843617|FG002|Overall Study|Possible Barrett's Esophagus|8
6837944|NCT00255164|10843615|FG000|Overall Study|Esophageal Stricture|0
6837945|NCT00255164|10843616|FG001|Overall Study|Esophageal Stricture|0
6935307|NCT00902538|10968740|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0
6935308|NCT00902538|10968741|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0
6935309|NCT00902538|10968742|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3
6935310|NCT00902538|10968743|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1
6935311|NCT00902538|10968744|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1
6935312|NCT00902538|10968739|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
6935313|NCT00902538|10968740|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
6935314|NCT00902538|10968741|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
6935315|NCT00902538|10968742|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3
6935316|NCT00902538|10968743|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1
6935317|NCT00902538|10968744|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
6935318|NCT00902538|10968739|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
6935319|NCT00902538|10968740|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
6935320|NCT00902538|10968741|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
6935321|NCT00902538|10968742|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3
6935322|NCT00902538|10968743|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
6935323|NCT00902538|10968744|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
6935324|NCT00902564|10968756|FG000|Overall Study|Withdrawal by Subject|2
6935325|NCT00902577|10968760|FG000|Overall Study|Withdrawal by Subject|6
6935326|NCT00902577|10968760|FG000|Overall Study|FMISO production failure|2
6935327|NCT00902746|10968783|FG000|Overall Study|Protocol Violation|7
6935328|NCT00902746|10968783|FG000|Overall Study|Withdrawal by Subject|16
6935329|NCT00902746|10968783|FG000|Overall Study|Adverse Event|8
6935330|NCT00902746|10968783|FG000|Overall Study|Lost to Follow-up|3
6935331|NCT00902746|10968783|FG000|Overall Study|Physician Decision|2
6935332|NCT00902850|10968789|FG000|Overall Study|Physician Decision|2
6935333|NCT00902850|10968790|FG001|Overall Study|Physician Decision|2
6935334|NCT00903032|10968798|FG000|Overall Study|Withdrawal by Subject|5
6935335|NCT00903032|10968799|FG001|Overall Study|Withdrawal by Subject|3
6935336|NCT00903032|10968798|FG000|Overall Study|Lost to Follow-up|2
6935337|NCT00903032|10968799|FG001|Overall Study|Lost to Follow-up|2
6975334|NCT01192204|11027481|FG001|Overall Study|could not keep recall appointments|0
6975335|NCT01192295|11027506|FG000|Overall Study|Adverse Event|3
7066082|NCT01971554|11165972|FG000|Overall Study|Lost to Follow-up|1
7066083|NCT01971554|11165973|FG001|Overall Study|Lost to Follow-up|0
7066084|NCT01971554|11165974|FG002|Overall Study|Lost to Follow-up|0
7066085|NCT01971554|11165975|FG003|Overall Study|Lost to Follow-up|0
7066086|NCT01971567|11165987|FG000|Overall Study|Withdrawal by Subject|3
7066087|NCT01971567|11165988|FG001|Overall Study|Withdrawal by Subject|2
7066088|NCT01971567|11165987|FG000|Overall Study|Lost to Follow-up|1
7066089|NCT01971567|11165988|FG001|Overall Study|Lost to Follow-up|0
7066090|NCT01971645|11166013|FG000|Overall Study|Adverse Event|1
7066091|NCT01971645|11166014|FG001|Overall Study|Adverse Event|0
7066092|NCT01971645|11166015|FG002|Overall Study|Adverse Event|0
7066093|NCT01971645|11166013|FG000|Overall Study|Lost to Follow-up|1
7066094|NCT01971645|11166014|FG001|Overall Study|Lost to Follow-up|0
7066095|NCT01971645|11166015|FG002|Overall Study|Lost to Follow-up|1
7066096|NCT01971645|11166013|FG000|Overall Study|Protocol Violation|0
7066097|NCT01971645|11166014|FG001|Overall Study|Protocol Violation|0
7066098|NCT01971645|11166015|FG002|Overall Study|Protocol Violation|1
7066099|NCT01971723|11166025|FG000|Overall Study|Withdrawal by Subject|1
7066100|NCT01971723|11166026|FG001|Overall Study|Withdrawal by Subject|1
7066101|NCT01971723|11166025|FG000|Overall Study|Protocol Violation|1
7066102|NCT01971723|11166026|FG001|Overall Study|Protocol Violation|2
7066103|NCT01972074|11166048|FG000|Overall Study|Adverse Event|4
7066104|NCT01972074|11166049|FG001|Overall Study|Adverse Event|1
7066105|NCT01972074|11166050|FG002|Overall Study|Adverse Event|0
7066106|NCT01972074|11166048|FG000|Overall Study|Lack of Efficacy|1
7066107|NCT01972074|11166049|FG001|Overall Study|Lack of Efficacy|1
7066108|NCT01972074|11166050|FG002|Overall Study|Lack of Efficacy|0
7066109|NCT01972074|11166048|FG000|Overall Study|Lost to Follow-up|0
7066110|NCT01972074|11166049|FG001|Overall Study|Lost to Follow-up|1
7066111|NCT01972074|11166050|FG002|Overall Study|Lost to Follow-up|1
7066112|NCT01972074|11166048|FG000|Overall Study|Withdrawal by Subject|1
7066113|NCT01972074|11166049|FG001|Overall Study|Withdrawal by Subject|1
7066114|NCT01972074|11166050|FG002|Overall Study|Withdrawal by Subject|1
7066115|NCT01972074|11166048|FG000|Overall Study|Scanner Unavailable|0
7066116|NCT01972074|11166049|FG001|Overall Study|Scanner Unavailable|0
7066117|NCT01972074|11166050|FG002|Overall Study|Scanner Unavailable|1
7066118|NCT01972152|11166057|FG000|First Treatment Visit|Lost to Follow-up|0
7066119|NCT01972152|11166058|FG001|First Treatment Visit|Lost to Follow-up|1
7066120|NCT01972152|11166059|FG002|First Treatment Visit|Lost to Follow-up|0
7066121|NCT01972152|11166060|FG003|First Treatment Visit|Lost to Follow-up|0
7066122|NCT01972152|11166061|FG004|First Treatment Visit|Lost to Follow-up|0
7066123|NCT01972152|11166062|FG005|First Treatment Visit|Lost to Follow-up|0
7066124|NCT01972152|11166057|FG000|Second Treatment Visit|Protocol Violation|0
7066125|NCT01972152|11166058|FG001|Second Treatment Visit|Protocol Violation|1
7066126|NCT01972152|11166059|FG002|Second Treatment Visit|Protocol Violation|0
7066127|NCT01972152|11166060|FG003|Second Treatment Visit|Protocol Violation|0
6975336|NCT01192295|11027507|FG001|Overall Study|Adverse Event|7
6975337|NCT01192295|11027506|FG000|Overall Study|Withdrawal by Subject|3
7066128|NCT01972152|11166061|FG004|Second Treatment Visit|Protocol Violation|0
6935338|NCT00903175|10968811|FG000|Period 1 - First Line|Adverse Event|36
6935339|NCT00903175|10968812|FG001|Period 1 - First Line|Adverse Event|50
6935340|NCT00903175|10968811|FG000|Period 1 - First Line|Abnormal lab value(s)|0
6935341|NCT00903175|10968812|FG001|Period 1 - First Line|Abnormal lab value(s)|1
6935342|NCT00903175|10968811|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1
6935343|NCT00903175|10968812|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0
6935344|NCT00903175|10968811|FG000|Period 1 - First Line|Protocol Violation|3
6935345|NCT00903175|10968812|FG001|Period 1 - First Line|Protocol Violation|3
6935346|NCT00903175|10968811|FG000|Period 1 - First Line|Withdrawal by Subject|8
6935347|NCT00903175|10968812|FG001|Period 1 - First Line|Withdrawal by Subject|12
6935348|NCT00903175|10968811|FG000|Period 1 - First Line|Administrative problems|12
6935349|NCT00903175|10968812|FG001|Period 1 - First Line|Administrative problems|13
6935350|NCT00903175|10968811|FG000|Period 1 - First Line|Death|17
6935351|NCT00903175|10968812|FG001|Period 1 - First Line|Death|10
6935352|NCT00903175|10968811|FG000|Period 2 - Second Line|Missing|1
6935353|NCT00903175|10968812|FG001|Period 2 - Second Line|Missing|0
6935354|NCT00903175|10968811|FG000|Period 2 - Second Line|Adverse Event|16
6935355|NCT00903175|10968812|FG001|Period 2 - Second Line|Adverse Event|20
6935356|NCT00903175|10968811|FG000|Period 2 - Second Line|Withdrawal by Subject|7
6935357|NCT00903175|10968812|FG001|Period 2 - Second Line|Withdrawal by Subject|5
6935358|NCT00903175|10968811|FG000|Period 2 - Second Line|Lost to Follow-up|1
6935359|NCT00903175|10968812|FG001|Period 2 - Second Line|Lost to Follow-up|0
7040016|NCT01714726|11122938|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0
7040017|NCT01714726|11122939|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0
6935360|NCT00903175|10968811|FG000|Period 2 - Second Line|Administrative problems|19
6935361|NCT00903175|10968812|FG001|Period 2 - Second Line|Administrative problems|9
6935362|NCT00903175|10968811|FG000|Period 2 - Second Line|Death|5
6935363|NCT00903175|10968812|FG001|Period 2 - Second Line|Death|2
6935364|NCT00903201|10968821|FG000|Overall Study|Adverse Event|1
6935365|NCT00903201|10968822|FG001|Overall Study|Adverse Event|4
6935366|NCT00903201|10968823|FG002|Overall Study|Adverse Event|0
6935367|NCT00903201|10968821|FG000|Overall Study|Protocol Violation|2
6935368|NCT00903201|10968822|FG001|Overall Study|Protocol Violation|1
6935369|NCT00903201|10968823|FG002|Overall Study|Protocol Violation|0
6935370|NCT00903201|10968821|FG000|Overall Study|Lost to Follow-up|0
6935371|NCT00903201|10968822|FG001|Overall Study|Lost to Follow-up|1
6935372|NCT00903201|10968823|FG002|Overall Study|Lost to Follow-up|0
6935373|NCT00903201|10968821|FG000|Overall Study|Physician Decision|1
6935374|NCT00903201|10968822|FG001|Overall Study|Physician Decision|0
6935375|NCT00903201|10968823|FG002|Overall Study|Physician Decision|1
6935376|NCT00903201|10968821|FG000|Overall Study|Withdrawal by Subject|1
6935377|NCT00903201|10968822|FG001|Overall Study|Withdrawal by Subject|0
6935378|NCT00903201|10968823|FG002|Overall Study|Withdrawal by Subject|1
6935379|NCT00903331|10968835|FG000|Overall Study|Death|4
6935380|NCT00903331|10968836|FG001|Overall Study|Death|8
6935381|NCT00903331|10968835|FG000|Overall Study|Withdrawal of consent|1
6935382|NCT00903331|10968836|FG001|Overall Study|Withdrawal of consent|8
6935383|NCT00903331|10968835|FG000|Overall Study|Lung transplant|0
6935384|NCT00903331|10968836|FG001|Overall Study|Lung transplant|2
6935385|NCT00903344|10968844|FG000|Overall Study|Pregnancy|2
6935386|NCT00903344|10968845|FG001|Overall Study|Pregnancy|3
6935387|NCT00903344|10968844|FG000|Overall Study|Lost to Follow-up|3
6935388|NCT00903344|10968845|FG001|Overall Study|Lost to Follow-up|0
6935389|NCT00903357|10968851|FG000|First Intervention|Withdrawal by Subject|5
6935390|NCT00903357|10968852|FG001|First Intervention|Withdrawal by Subject|3
6935391|NCT00903357|10968851|FG000|First Intervention|Flu|0
6935392|NCT00903357|10968852|FG001|First Intervention|Flu|1
6935393|NCT00903357|10968851|FG000|Wash Out Period of 2 Weeks|Flu|0
6935394|NCT00903357|10968852|FG001|Wash Out Period of 2 Weeks|Flu|1
6935395|NCT00903357|10968851|FG000|Second Intervention|Lost to Follow-up|1
6935396|NCT00903357|10968852|FG001|Second Intervention|Lost to Follow-up|0
6935397|NCT00903370|10968864|FG000|Overall Study|Death|13
7040018|NCT01714726|11122936|FG000|Double-Blinded Induction Period|Lost to Follow-up|0
7066129|NCT01972152|11166062|FG005|Second Treatment Visit|Protocol Violation|0
7066130|NCT01972308|11166088|FG000|Overall Study|Withdrawal by Subject|0
7066131|NCT01972308|11166089|FG001|Overall Study|Withdrawal by Subject|1
7066132|NCT01972308|11166088|FG000|Overall Study|Lost to Follow-up|4
7066133|NCT01972308|11166089|FG001|Overall Study|Lost to Follow-up|6
7066134|NCT01972308|11166088|FG000|Overall Study|Death|4
7066135|NCT01972308|11166089|FG001|Overall Study|Death|1
7066136|NCT01972438|11166099|FG000|Baseline-Month 3 Crossover Period|Death|1
7066137|NCT01972438|11166100|FG001|Baseline-Month 3 Crossover Period|Death|0
6935398|NCT00903370|10968865|FG001|Overall Study|Death|10
6935399|NCT00903370|10968864|FG000|Overall Study|Withdrawal by Subject|9
6935400|NCT00903370|10968865|FG001|Overall Study|Withdrawal by Subject|6
6935401|NCT00903370|10968864|FG000|Overall Study|Lost to Follow-up|6
6935402|NCT00903370|10968865|FG001|Overall Study|Lost to Follow-up|8
6935403|NCT00903383|10968875|FG000|Overall Study|Adverse Event|1
6935404|NCT00903383|10968876|FG001|Overall Study|Adverse Event|2
6935405|NCT00903383|10968877|FG002|Overall Study|Adverse Event|3
6935406|NCT00903383|10968878|FG003|Overall Study|Adverse Event|1
6935407|NCT00903383|10968875|FG000|Overall Study|Physician Decision|1
7044794|NCT01757275|11130781|FG000|Overall Study|Withdrawal by Subject|2
7066138|NCT01972438|11166099|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1
7040019|NCT01714726|11122937|FG001|Double-Blinded Induction Period|Lost to Follow-up|2
7040020|NCT01714726|11122938|FG002|Double-Blinded Induction Period|Lost to Follow-up|0
6935408|NCT00903383|10968876|FG001|Overall Study|Physician Decision|2
6935409|NCT00903383|10968877|FG002|Overall Study|Physician Decision|0
6935410|NCT00903383|10968878|FG003|Overall Study|Physician Decision|0
7040021|NCT01714726|11122939|FG003|Double-Blinded Induction Period|Lost to Follow-up|0
7040022|NCT01714726|11122936|FG000|Open-Label Period|Other|0
7040023|NCT01714726|11122937|FG001|Open-Label Period|Other|0
7040024|NCT01714726|11122938|FG002|Open-Label Period|Other|1
7040025|NCT01714726|11122939|FG003|Open-Label Period|Other|3
7040026|NCT01714726|11122936|FG000|Open-Label Period|Adverse Event|0
7040027|NCT01714726|11122937|FG001|Open-Label Period|Adverse Event|0
6935411|NCT00903383|10968875|FG000|Overall Study|Lost to Follow-up|0
6935412|NCT00903383|10968876|FG001|Overall Study|Lost to Follow-up|0
6935413|NCT00903383|10968877|FG002|Overall Study|Lost to Follow-up|0
6935414|NCT00903383|10968878|FG003|Overall Study|Lost to Follow-up|1
6935415|NCT00903383|10968875|FG000|Overall Study|Decision of Sponsor|1
6935416|NCT00903383|10968876|FG001|Overall Study|Decision of Sponsor|0
6935417|NCT00903383|10968877|FG002|Overall Study|Decision of Sponsor|0
6837946|NCT00255164|10843617|FG002|Overall Study|Esophageal Stricture|1
6837947|NCT00255164|10843615|FG000|Overall Study|Therapeutic Failure|11
6837948|NCT00255164|10843616|FG001|Overall Study|Therapeutic Failure|2
6837949|NCT00255164|10843617|FG002|Overall Study|Therapeutic Failure|3
6837950|NCT00255190|10843644|FG000|Overall Study|Adverse Event|17
6837951|NCT00255190|10843645|FG001|Overall Study|Adverse Event|36
6837952|NCT00255190|10843644|FG000|Overall Study|Protocol Violation|2
6837953|NCT00255190|10843645|FG001|Overall Study|Protocol Violation|2
6935418|NCT00903383|10968878|FG003|Overall Study|Decision of Sponsor|0
6935419|NCT00903383|10968875|FG000|Overall Study|Withdrawal by Subject|4
6935420|NCT00903383|10968876|FG001|Overall Study|Withdrawal by Subject|1
6935421|NCT00903383|10968877|FG002|Overall Study|Withdrawal by Subject|0
6935422|NCT00903383|10968878|FG003|Overall Study|Withdrawal by Subject|2
6935423|NCT00903383|10968875|FG000|Overall Study|Patient Decision - Lack of Efficacy|0
6935424|NCT00903383|10968876|FG001|Overall Study|Patient Decision - Lack of Efficacy|1
6935425|NCT00903383|10968877|FG002|Overall Study|Patient Decision - Lack of Efficacy|0
6935426|NCT00903383|10968878|FG003|Overall Study|Patient Decision - Lack of Efficacy|0
6935427|NCT00903383|10968875|FG000|Overall Study|Patient Decision|0
6935428|NCT00903383|10968876|FG001|Overall Study|Patient Decision|0
6935429|NCT00903383|10968877|FG002|Overall Study|Patient Decision|0
6935430|NCT00903383|10968878|FG003|Overall Study|Patient Decision|1
6935431|NCT00903409|10968890|FG000|Overall Study|Adverse Event|11
6935432|NCT00903409|10968891|FG001|Overall Study|Adverse Event|9
6935433|NCT00903409|10968890|FG000|Overall Study|Non-compliance with Protocol|1
6935434|NCT00903409|10968891|FG001|Overall Study|Non-compliance with Protocol|1
6935435|NCT00903409|10968890|FG000|Overall Study|Laboratory Abnormality|2
6935436|NCT00903409|10968891|FG001|Overall Study|Laboratory Abnormality|0
6935437|NCT00903409|10968890|FG000|Overall Study|Withdrawal by Subject|8
6935438|NCT00903409|10968891|FG001|Overall Study|Withdrawal by Subject|8
6935439|NCT00903409|10968890|FG000|Overall Study|Other|2
6935440|NCT00903409|10968891|FG001|Overall Study|Other|3
6935441|NCT00903409|10968890|FG000|Overall Study|Lost to Follow-up|2
6935442|NCT00903409|10968891|FG001|Overall Study|Lost to Follow-up|6
6935443|NCT00903617|10968910|FG000|Overall Study|Adverse Event|0
6935444|NCT00903617|10968911|FG001|Overall Study|Adverse Event|1
6935445|NCT00903617|10968912|FG002|Overall Study|Adverse Event|1
6935446|NCT00903617|10968913|FG003|Overall Study|Adverse Event|0
6935447|NCT00903617|10968910|FG000|Overall Study|Protocol-defined stopping criteria|0
6935448|NCT00903617|10968911|FG001|Overall Study|Protocol-defined stopping criteria|2
6935449|NCT00903617|10968912|FG002|Overall Study|Protocol-defined stopping criteria|0
7040028|NCT01714726|11122938|FG002|Open-Label Period|Adverse Event|1
7040029|NCT01714726|11122939|FG003|Open-Label Period|Adverse Event|0
7040030|NCT01714726|11122936|FG000|Open-Label Period|Withdrawal by Subject|0
7040031|NCT01714726|11122937|FG001|Open-Label Period|Withdrawal by Subject|0
7040032|NCT01714726|11122938|FG002|Open-Label Period|Withdrawal by Subject|9
7040033|NCT01714726|11122939|FG003|Open-Label Period|Withdrawal by Subject|19
7040034|NCT01714726|11122936|FG000|Open-Label Period|Developed specific withdrawal criteria|0
7040035|NCT01714726|11122937|FG001|Open-Label Period|Developed specific withdrawal criteria|0
7040036|NCT01714726|11122938|FG002|Open-Label Period|Developed specific withdrawal criteria|5
7040037|NCT01714726|11122939|FG003|Open-Label Period|Developed specific withdrawal criteria|2
7040038|NCT01714726|11122936|FG000|Open-Label Period|Lost to Follow-up|0
7040039|NCT01714726|11122937|FG001|Open-Label Period|Lost to Follow-up|0
6837954|NCT00255190|10843644|FG000|Overall Study|Lost to Follow-up|10
6935450|NCT00903617|10968913|FG003|Overall Study|Protocol-defined stopping criteria|0
6935451|NCT00903617|10968910|FG000|Overall Study|Lost to Follow-up|2
7040040|NCT01714726|11122938|FG002|Open-Label Period|Lost to Follow-up|3
6837955|NCT00255190|10843645|FG001|Overall Study|Lost to Follow-up|27
6935452|NCT00903617|10968911|FG001|Overall Study|Lost to Follow-up|0
6935453|NCT00903617|10968912|FG002|Overall Study|Lost to Follow-up|1
6935454|NCT00903617|10968913|FG003|Overall Study|Lost to Follow-up|1
6935455|NCT00903617|10968910|FG000|Overall Study|Withdrawal by Subject|1
6935456|NCT00903617|10968911|FG001|Overall Study|Withdrawal by Subject|2
6935457|NCT00903617|10968912|FG002|Overall Study|Withdrawal by Subject|3
6935458|NCT00903617|10968913|FG003|Overall Study|Withdrawal by Subject|0
6837956|NCT00255190|10843644|FG000|Overall Study|Withdrew Consent|17
6837957|NCT00255190|10843645|FG001|Overall Study|Withdrew Consent|48
6837958|NCT00255190|10843644|FG000|Overall Study|Inclusion/Exclusion criteria not met|0
6837959|NCT00255190|10843645|FG001|Overall Study|Inclusion/Exclusion criteria not met|1
6837960|NCT00255190|10843644|FG000|Overall Study|Erosive esophagitis not healed|0
6837961|NCT00255190|10843645|FG001|Overall Study|Erosive esophagitis not healed|20
6837962|NCT00255190|10843644|FG000|Overall Study|Various|4
6837963|NCT00255190|10843645|FG001|Overall Study|Various|23
6837964|NCT00255346|10843656|FG000|Overall Study|Adverse Event|1
6837965|NCT00255346|10843657|FG001|Overall Study|Adverse Event|0
6837966|NCT00255346|10843658|FG002|Overall Study|Adverse Event|0
6837967|NCT00255346|10843659|FG003|Overall Study|Adverse Event|0
6837968|NCT00255346|10843660|FG004|Overall Study|Adverse Event|0
6837969|NCT00255723|10843674|FG000|Overall Study|Adverse Event|1
6837970|NCT00255723|10843675|FG001|Overall Study|Adverse Event|1
6837971|NCT00255723|10843674|FG000|Overall Study|Death|0
6837972|NCT00255723|10843675|FG001|Overall Study|Death|1
6837973|NCT00255723|10843674|FG000|Overall Study|Response Data Not Available|1
6837974|NCT00255723|10843675|FG001|Overall Study|Response Data Not Available|0
6837975|NCT00255840|10843687|FG000|Overall Study|Lost to Follow-up|10
6837976|NCT00255840|10843688|FG001|Overall Study|Lost to Follow-up|14
6837977|NCT00255840|10843687|FG000|Overall Study|Discontinued intervention|53
6837978|NCT00255840|10843688|FG001|Overall Study|Discontinued intervention|56
6837979|NCT00255944|10843696|FG000|Overall Study|Lost to Follow-up|797
6837980|NCT00255944|10843697|FG001|Overall Study|Lost to Follow-up|834
6837981|NCT00256126|10843714|FG000|Overall Study|Adverse Event|1
6837982|NCT00256126|10843715|FG001|Overall Study|Adverse Event|0
6837983|NCT00256126|10843714|FG000|Overall Study|Other|1
6837984|NCT00256126|10843715|FG001|Overall Study|Other|2
6837985|NCT00256204|10843725|FG000|Overall Study|Adverse Event|10
6837986|NCT00256204|10843726|FG001|Overall Study|Adverse Event|14
6837987|NCT00256204|10843727|FG002|Overall Study|Adverse Event|16
6837988|NCT00256204|10843728|FG003|Overall Study|Adverse Event|14
6837989|NCT00256204|10843725|FG000|Overall Study|Death|0
6837990|NCT00256204|10843726|FG001|Overall Study|Death|1
6837991|NCT00256204|10843727|FG002|Overall Study|Death|0
6837992|NCT00256204|10843728|FG003|Overall Study|Death|0
6837993|NCT00256204|10843725|FG000|Overall Study|Lost to Follow-up|1
6837994|NCT00256204|10843726|FG001|Overall Study|Lost to Follow-up|1
6837995|NCT00256204|10843727|FG002|Overall Study|Lost to Follow-up|1
6837996|NCT00256204|10843728|FG003|Overall Study|Lost to Follow-up|2
6837997|NCT00256204|10843725|FG000|Overall Study|Protocol Violation|1
6837998|NCT00256204|10843726|FG001|Overall Study|Protocol Violation|0
6837999|NCT00256204|10843727|FG002|Overall Study|Protocol Violation|2
6838000|NCT00256204|10843728|FG003|Overall Study|Protocol Violation|1
6838001|NCT00256204|10843725|FG000|Overall Study|Physician Decision|0
6838002|NCT00256204|10843726|FG001|Overall Study|Physician Decision|0
6838003|NCT00256204|10843727|FG002|Overall Study|Physician Decision|1
6838004|NCT00256204|10843728|FG003|Overall Study|Physician Decision|2
6838005|NCT00256204|10843725|FG000|Overall Study|Withdrawal by Subject|17
6838006|NCT00256204|10843726|FG001|Overall Study|Withdrawal by Subject|6
6838007|NCT00256204|10843727|FG002|Overall Study|Withdrawal by Subject|7
6838008|NCT00256204|10843728|FG003|Overall Study|Withdrawal by Subject|5
6838009|NCT00256204|10843725|FG000|Overall Study|Need for additional prohibited treatment|38
6838010|NCT00256204|10843726|FG001|Overall Study|Need for additional prohibited treatment|28
6838011|NCT00256204|10843727|FG002|Overall Study|Need for additional prohibited treatment|27
6838012|NCT00256204|10843728|FG003|Overall Study|Need for additional prohibited treatment|25
6838013|NCT00256243|10843745|FG000|Overall Study|Lost to Follow-up|2
6838014|NCT00256243|10843745|FG000|Overall Study|Death|7
6838015|NCT00256243|10843745|FG000|Overall Study|Not treated|1
6838016|NCT00256282|10843750|FG000|Overall Study|Disease progression, relapse during acti|12
6838017|NCT00256282|10843750|FG000|Overall Study|Adverse Event|3
6838018|NCT00256282|10843750|FG000|Overall Study|Physician Decision|1
6838019|NCT00256308|10843754|FG000|Overall Study|Death|2
6838020|NCT00256698|10843773|FG000|Overall Study|Withdrawal by Subject|7
6838021|NCT00256698|10843774|FG001|Overall Study|Withdrawal by Subject|7
6838022|NCT00256698|10843773|FG000|Overall Study|Adverse Event|13
6838023|NCT00256698|10843774|FG001|Overall Study|Adverse Event|6
6838024|NCT00256698|10843773|FG000|Overall Study|Protocol Violation|6
6838025|NCT00256698|10843774|FG001|Overall Study|Protocol Violation|5
6838026|NCT00256698|10843773|FG000|Overall Study|Lost to Follow-up|1
6838027|NCT00256698|10843774|FG001|Overall Study|Lost to Follow-up|3
6838028|NCT00256698|10843773|FG000|Overall Study|disease progression|97
6838029|NCT00256698|10843774|FG001|Overall Study|disease progression|105
6838030|NCT00256698|10843773|FG000|Overall Study|still ongoing at data cut-off|41
6838031|NCT00256698|10843774|FG001|Overall Study|still ongoing at data cut-off|46
6838032|NCT00256698|10843773|FG000|Overall Study|withdrawn due to osteoporosis|1
6838033|NCT00256698|10843774|FG001|Overall Study|withdrawn due to osteoporosis|0
6838034|NCT00256698|10843773|FG000|Overall Study|Prematurely Discontinued|1
6838035|NCT00256698|10843774|FG001|Overall Study|Prematurely Discontinued|0
6838036|NCT00256724|10843782|FG000|Overall Study|Physician Decision|2
6838037|NCT00256724|10843783|FG001|Overall Study|Physician Decision|5
6838038|NCT00256724|10843782|FG000|Overall Study|Protocol Violation|3
6935459|NCT00903630|10968927|FG000|Phase 2|Adverse Event|0
6935460|NCT00903630|10968928|FG001|Phase 2|Adverse Event|0
6935461|NCT00903630|10968929|FG002|Phase 2|Adverse Event|1
6935462|NCT00903682|10968941|FG000|Overall Study|Adverse Event|6
6935463|NCT00903682|10968942|FG001|Overall Study|Adverse Event|13
6935464|NCT00903682|10968941|FG000|Overall Study|Lost to Follow-up|1
6935465|NCT00903682|10968942|FG001|Overall Study|Lost to Follow-up|0
6935466|NCT00903682|10968941|FG000|Overall Study|Withdrawal by Subject|5
6935467|NCT00903682|10968942|FG001|Overall Study|Withdrawal by Subject|0
6935468|NCT00903682|10968941|FG000|Overall Study|Pregnancy|0
6935469|NCT00903682|10968942|FG001|Overall Study|Pregnancy|1
6935470|NCT00903682|10968941|FG000|Overall Study|Subject Reached A Virologic Endpoint|1
6935471|NCT00903682|10968942|FG001|Overall Study|Subject Reached A Virologic Endpoint|1
6935472|NCT00903682|10968941|FG000|Overall Study|Subject Non-Compliant|1
6935473|NCT00903682|10968942|FG001|Overall Study|Subject Non-Compliant|0
6935474|NCT00903682|10968941|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1
6935475|NCT00903682|10968942|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0
6935476|NCT00903682|10968941|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1
6935477|NCT00903682|10968942|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0
6935478|NCT00903695|10968950|FG000|Overall Study|medical exclusion after 1st testing|1
7040041|NCT01714726|11122939|FG003|Open-Label Period|Lost to Follow-up|4
7040042|NCT01714947|11122965|FG000|Part B|Progressive Disease|3
7040043|NCT01715129|11122978|FG000|Overall Study|Adverse Event, fatal|1
7040044|NCT01715129|11122978|FG000|Overall Study|Lack of Efficacy|3
7040045|NCT01715129|11122978|FG000|Overall Study|Protocol Violation|1
7040046|NCT01715129|11122978|FG000|Overall Study|Consent Withdrawn|2
7040047|NCT01715129|11122978|FG000|Overall Study|Lost to Follow-up|1
7040048|NCT01715129|11122978|FG000|Overall Study|Other|1
7040049|NCT01715298|11123000|FG000|Overall Study|Lost to Follow-up|0
7040050|NCT01715298|11123001|FG001|Overall Study|Lost to Follow-up|2
6935479|NCT00903695|10968951|FG001|Overall Study|medical exclusion after 1st testing|0
6935480|NCT00903695|10968950|FG000|Overall Study|lung cancer|1
6935481|NCT00903695|10968951|FG001|Overall Study|lung cancer|0
6935482|NCT00903760|10968961|FG000|Overall Study|Disease Progression/Death|8
6935483|NCT00903760|10968962|FG001|Overall Study|Disease Progression/Death|6
6935484|NCT00903760|10968961|FG000|Overall Study|Stem Cell Transplant|8
6935485|NCT00903760|10968962|FG001|Overall Study|Stem Cell Transplant|4
6935486|NCT00903760|10968961|FG000|Overall Study|Physician Decision|1
6935487|NCT00903760|10968962|FG001|Overall Study|Physician Decision|2
6935488|NCT00903760|10968961|FG000|Overall Study|Death|0
6935489|NCT00903760|10968962|FG001|Overall Study|Death|1
6935490|NCT00903760|10968961|FG000|Overall Study|Lost to Follow-up|1
6935491|NCT00903760|10968962|FG001|Overall Study|Lost to Follow-up|0
6935492|NCT00903760|10968961|FG000|Overall Study|Withdrawal by Subject|1
6935493|NCT00903760|10968962|FG001|Overall Study|Withdrawal by Subject|2
6935494|NCT00903760|10968961|FG000|Overall Study|Off treatment for long period|0
6935495|NCT00903760|10968962|FG001|Overall Study|Off treatment for long period|1
6935496|NCT00903786|10968968|FG000|Overall Study|Physician Decision|6
6935497|NCT00903786|10968968|FG000|Overall Study|Lack of Efficacy|5
6935498|NCT00903786|10968968|FG000|Overall Study|Reason other than lack of efficacy|4
6935499|NCT00903877|10968973|FG000|Overall Study|Did not meet study criteria|33
6935500|NCT00903877|10968973|FG000|Overall Study|Withdrawal by Subject|3
6935501|NCT00903877|10968973|FG000|Overall Study|Adverse Event|2
6935502|NCT00903877|10968973|FG000|Overall Study|Lost to Follow-up|1
6935503|NCT00903877|10968973|FG000|Overall Study|Participation put on hold|4
6935504|NCT00903929|10968977|FG000|Overall Study|Withdrawal by Subject|0
6935505|NCT00903929|10968978|FG001|Overall Study|Withdrawal by Subject|0
6935506|NCT00903929|10968979|FG002|Overall Study|Withdrawal by Subject|1
6935507|NCT00903929|10968980|FG003|Overall Study|Withdrawal by Subject|2
6935508|NCT00903929|10968977|FG000|Overall Study|Adverse Event|0
6935509|NCT00903929|10968978|FG001|Overall Study|Adverse Event|0
6935510|NCT00903929|10968979|FG002|Overall Study|Adverse Event|0
6935511|NCT00903929|10968980|FG003|Overall Study|Adverse Event|1
6935512|NCT00903968|10968987|FG000|Overall Study|Adverse Event|0
6935513|NCT00903968|10968988|FG001|Overall Study|Adverse Event|0
6935514|NCT00903968|10968989|FG002|Overall Study|Adverse Event|0
6935515|NCT00903968|10968990|FG003|Overall Study|Adverse Event|0
6935516|NCT00903968|10968991|FG004|Overall Study|Adverse Event|0
6935517|NCT00903968|10968992|FG005|Overall Study|Adverse Event|0
6935518|NCT00903968|10968993|FG006|Overall Study|Adverse Event|1
6935519|NCT00903968|10968994|FG007|Overall Study|Adverse Event|8
6935520|NCT00903968|10968987|FG000|Overall Study|DLT|0
7040051|NCT01715298|11123000|FG000|Overall Study|Patient/guardian decision|7
6935521|NCT00903968|10968988|FG001|Overall Study|DLT|0
7040052|NCT01715298|11123001|FG001|Overall Study|Patient/guardian decision|9
7040053|NCT01715415|11123009|FG000|Double-blind Treatment|Did Not Receive Study Drug|0
7040054|NCT01715415|11123010|FG001|Double-blind Treatment|Did Not Receive Study Drug|1
6935522|NCT00903968|10968989|FG002|Overall Study|DLT|0
6935523|NCT00903968|10968990|FG003|Overall Study|DLT|0
6935524|NCT00903968|10968991|FG004|Overall Study|DLT|0
6935525|NCT00903968|10968992|FG005|Overall Study|DLT|0
6935526|NCT00903968|10968993|FG006|Overall Study|DLT|2
6935527|NCT00903968|10968994|FG007|Overall Study|DLT|0
6935528|NCT00903968|10968987|FG000|Overall Study|Withdrawal by Subject|1
6935529|NCT00903968|10968988|FG001|Overall Study|Withdrawal by Subject|0
6935530|NCT00903968|10968989|FG002|Overall Study|Withdrawal by Subject|1
6935531|NCT00903968|10968990|FG003|Overall Study|Withdrawal by Subject|0
6935532|NCT00903968|10968991|FG004|Overall Study|Withdrawal by Subject|1
6935533|NCT00903968|10968992|FG005|Overall Study|Withdrawal by Subject|1
6935534|NCT00903968|10968993|FG006|Overall Study|Withdrawal by Subject|0
6935535|NCT00903968|10968994|FG007|Overall Study|Withdrawal by Subject|4
6935536|NCT00903968|10968987|FG000|Overall Study|Non-Compliance|0
6935537|NCT00903968|10968988|FG001|Overall Study|Non-Compliance|0
6935538|NCT00903968|10968989|FG002|Overall Study|Non-Compliance|0
6838039|NCT00256724|10843783|FG001|Overall Study|Protocol Violation|3
6838040|NCT00256750|10843792|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3
6838041|NCT00256750|10843793|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0
6838042|NCT00256750|10843794|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0
6838043|NCT00256750|10843792|FG000|Transplanted Pre-Treatment|Other|2
6838044|NCT00256750|10843793|FG001|Transplanted Pre-Treatment|Other|0
6838045|NCT00256750|10843794|FG002|Transplanted Pre-Treatment|Other|0
6838046|NCT00256750|10843792|FG000|Transplanted Pre-Treatment|Death|1
6838047|NCT00256750|10843793|FG001|Transplanted Pre-Treatment|Death|0
6838048|NCT00256750|10843794|FG002|Transplanted Pre-Treatment|Death|0
6838049|NCT00256750|10843792|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20
6838050|NCT00256750|10843793|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12
6838051|NCT00256750|10843794|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8
6935539|NCT00903968|10968990|FG003|Overall Study|Non-Compliance|0
7066139|NCT01972438|11166100|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0
7066140|NCT01972438|11166099|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0
6935540|NCT00903968|10968991|FG004|Overall Study|Non-Compliance|0
6935541|NCT00903968|10968992|FG005|Overall Study|Non-Compliance|1
6935542|NCT00903968|10968993|FG006|Overall Study|Non-Compliance|0
6935543|NCT00903968|10968994|FG007|Overall Study|Non-Compliance|0
6935544|NCT00903968|10968987|FG000|Overall Study|Physician Decision|0
6935545|NCT00903968|10968988|FG001|Overall Study|Physician Decision|0
6935546|NCT00903968|10968989|FG002|Overall Study|Physician Decision|0
7040055|NCT01715415|11123009|FG000|Double-blind Treatment|Adverse Event|3
7040056|NCT01715415|11123010|FG001|Double-blind Treatment|Adverse Event|0
7040057|NCT01715415|11123009|FG000|Double-blind Treatment|Withdrawal by Subject|1
7040058|NCT01715415|11123010|FG001|Double-blind Treatment|Withdrawal by Subject|1
7040059|NCT01715415|11123009|FG000|Double-blind Treatment|Other|1
7040060|NCT01715415|11123010|FG001|Double-blind Treatment|Other|0
7040061|NCT01715415|11123009|FG000|Open-label Treatment|Adverse Event|0
7040062|NCT01715415|11123010|FG001|Open-label Treatment|Adverse Event|1
7040063|NCT01715415|11123009|FG000|Open-label Treatment|Subject Noncompliant|0
7040064|NCT01715415|11123010|FG001|Open-label Treatment|Subject Noncompliant|1
7040065|NCT01715571|11123017|FG000|Overall Study|Lost to Follow-up|8
7040066|NCT01715805|11123021|FG000|Placebo + ADT Lead-in Period|Adverse Event|41
7040067|NCT01715805|11123022|FG001|Placebo + ADT Lead-in Period|Adverse Event|0
7040068|NCT01715805|11123023|FG002|Placebo + ADT Lead-in Period|Adverse Event|0
7040069|NCT01715805|11123024|FG003|Placebo + ADT Lead-in Period|Adverse Event|0
7040070|NCT01715805|11123021|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6
7040071|NCT01715805|11123022|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
7040072|NCT01715805|11123023|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
7040073|NCT01715805|11123024|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
7040074|NCT01715805|11123021|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74
7040075|NCT01715805|11123022|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0
7040076|NCT01715805|11123023|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0
6935547|NCT00903968|10968990|FG003|Overall Study|Physician Decision|0
6935548|NCT00903968|10968991|FG004|Overall Study|Physician Decision|0
6935549|NCT00903968|10968992|FG005|Overall Study|Physician Decision|1
6935550|NCT00903968|10968993|FG006|Overall Study|Physician Decision|0
6935551|NCT00903968|10968994|FG007|Overall Study|Physician Decision|0
6935552|NCT00903968|10968987|FG000|Overall Study|Progressive Disease|2
6935553|NCT00903968|10968988|FG001|Overall Study|Progressive Disease|3
6935554|NCT00903968|10968989|FG002|Overall Study|Progressive Disease|2
6935555|NCT00903968|10968990|FG003|Overall Study|Progressive Disease|3
6935556|NCT00903968|10968991|FG004|Overall Study|Progressive Disease|3
6935557|NCT00903968|10968992|FG005|Overall Study|Progressive Disease|3
7040077|NCT01715805|11123024|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0
7040078|NCT01715805|11123021|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49
7040079|NCT01715805|11123022|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
7040080|NCT01715805|11123023|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
7066141|NCT01972438|11166100|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1
6935558|NCT00903968|10968993|FG006|Overall Study|Progressive Disease|0
6935559|NCT00903968|10968994|FG007|Overall Study|Progressive Disease|18
6935560|NCT00903968|10968987|FG000|Overall Study|Lack of Efficacy|0
6935561|NCT00903968|10968988|FG001|Overall Study|Lack of Efficacy|0
7040081|NCT01715805|11123024|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
7040082|NCT01715805|11123021|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34
7040083|NCT01715805|11123022|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0
6935562|NCT00903968|10968989|FG002|Overall Study|Lack of Efficacy|0
6935563|NCT00903968|10968990|FG003|Overall Study|Lack of Efficacy|0
6838052|NCT00256750|10843792|FG000|Post-Transplant Treated (12 Months)|Death|3
6935564|NCT00903968|10968991|FG004|Overall Study|Lack of Efficacy|0
6935565|NCT00903968|10968992|FG005|Overall Study|Lack of Efficacy|0
6935566|NCT00903968|10968993|FG006|Overall Study|Lack of Efficacy|0
6935567|NCT00903968|10968994|FG007|Overall Study|Lack of Efficacy|3
6935568|NCT00904033|10969030|FG000|Overall Study|Withdrawal by Subject|1
6935569|NCT00904033|10969031|FG001|Overall Study|Withdrawal by Subject|1
6935570|NCT00904033|10969032|FG002|Overall Study|Withdrawal by Subject|0
6935571|NCT00904033|10969033|FG003|Overall Study|Withdrawal by Subject|0
6935572|NCT00904033|10969030|FG000|Overall Study|Physician Decision|0
6935573|NCT00904033|10969031|FG001|Overall Study|Physician Decision|0
6935574|NCT00904033|10969032|FG002|Overall Study|Physician Decision|1
6935575|NCT00904033|10969033|FG003|Overall Study|Physician Decision|0
6935576|NCT00904033|10969030|FG000|Overall Study|Unable to obtain final blood draw|0
6935577|NCT00904033|10969031|FG001|Overall Study|Unable to obtain final blood draw|0
6935578|NCT00904033|10969032|FG002|Overall Study|Unable to obtain final blood draw|0
6935579|NCT00904033|10969033|FG003|Overall Study|Unable to obtain final blood draw|2
6935580|NCT00904150|10969046|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3
6935581|NCT00904150|10969047|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0
6935582|NCT00904150|10969046|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0
6935583|NCT00904150|10969047|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145
7066142|NCT01972438|11166099|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1
7066143|NCT01972438|11166100|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2
7066144|NCT01972438|11166099|FG000|Months 3-6 Crossover Period|Early Study Closure|0
7066145|NCT01972438|11166100|FG001|Months 3-6 Crossover Period|Early Study Closure|1
7066146|NCT01972438|11166099|FG000|Months 6-12 Study Period|Death|1
7066147|NCT01972438|11166100|FG001|Months 6-12 Study Period|Death|0
7066148|NCT01972438|11166099|FG000|Months 6-12 Study Period|Early Study Closure|2
7066149|NCT01972438|11166100|FG001|Months 6-12 Study Period|Early Study Closure|2
7066150|NCT01972438|11166099|FG000|Post Month 12 Study Period|Early Study Closure|3
7066151|NCT01972438|11166100|FG001|Post Month 12 Study Period|Early Study Closure|4
7066152|NCT01972464|11166110|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2
7066153|NCT01972464|11166111|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3
7066154|NCT01972464|11166110|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1
7066155|NCT01972464|11166111|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0
6935584|NCT00904215|10969053|FG000|Overall Study|Adverse Event|25
6935585|NCT00904215|10969053|FG000|Overall Study|Protocol Violation|10
6935586|NCT00904215|10969053|FG000|Overall Study|Lost to Follow-up|63
6935587|NCT00904215|10969053|FG000|Overall Study|Withdrawal by Subject|9
6935588|NCT00904215|10969053|FG000|Overall Study|Other|28
6935589|NCT00904371|10969061|FG000|Overall Study|Adverse Event|2
6935590|NCT00904371|10969061|FG000|Overall Study|Lost to Follow-up|4
6935591|NCT00904371|10969061|FG000|Overall Study|Discontinued at target blood pressure|2
6935592|NCT00904371|10969061|FG000|Overall Study|Continued with Tritace|1
6935593|NCT00904670|10969081|FG000|Open Label Phase|Withdrawal by Subject|2
6935594|NCT00904670|10969082|FG001|Open Label Phase|Withdrawal by Subject|0
6935595|NCT00904670|10969081|FG000|Open Label Phase|Adverse Event|2
6935596|NCT00904670|10969082|FG001|Open Label Phase|Adverse Event|0
6935597|NCT00904670|10969081|FG000|Open Label Phase|Lack of Efficacy|1
6935598|NCT00904670|10969082|FG001|Open Label Phase|Lack of Efficacy|0
6935599|NCT00904670|10969081|FG000|Open Label Phase|Lost to Follow-up|1
6935600|NCT00904670|10969082|FG001|Open Label Phase|Lost to Follow-up|0
6935601|NCT00904722|10969090|FG000|Overall Study|Physician Decision|1
6935602|NCT00904748|10969094|FG000|Overall Study|Withdrawal by Subject|1
6935603|NCT00904748|10969095|FG001|Overall Study|Withdrawal by Subject|1
6935604|NCT00904748|10969096|FG002|Overall Study|Withdrawal by Subject|1
6935605|NCT00904748|10969097|FG003|Overall Study|Withdrawal by Subject|2
6935606|NCT00904748|10969098|FG004|Overall Study|Withdrawal by Subject|0
6935607|NCT00904748|10969099|FG005|Overall Study|Withdrawal by Subject|0
6935608|NCT00904748|10969094|FG000|Overall Study|Adverse Event|0
6935609|NCT00904748|10969095|FG001|Overall Study|Adverse Event|0
6935610|NCT00904748|10969096|FG002|Overall Study|Adverse Event|0
6935611|NCT00904748|10969097|FG003|Overall Study|Adverse Event|0
6935612|NCT00904748|10969098|FG004|Overall Study|Adverse Event|1
6935613|NCT00904748|10969099|FG005|Overall Study|Adverse Event|0
6935614|NCT00904839|10969146|FG000|Overall Study|Adverse Event|0
6935615|NCT00904839|10969147|FG001|Overall Study|Adverse Event|5
6935616|NCT00904839|10969148|FG002|Overall Study|Adverse Event|4
6935617|NCT00904839|10969146|FG000|Overall Study|Protocol Violation|0
6935618|NCT00904839|10969147|FG001|Overall Study|Protocol Violation|1
6935619|NCT00904839|10969148|FG002|Overall Study|Protocol Violation|1
6935620|NCT00904839|10969146|FG000|Overall Study|Lost to Follow-up|0
6935621|NCT00904839|10969147|FG001|Overall Study|Lost to Follow-up|1
6935622|NCT00904839|10969148|FG002|Overall Study|Lost to Follow-up|2
6935623|NCT00904839|10969146|FG000|Overall Study|Withdrawal by Subject|0
6935624|NCT00904839|10969147|FG001|Overall Study|Withdrawal by Subject|2
6935625|NCT00904839|10969148|FG002|Overall Study|Withdrawal by Subject|0
6935626|NCT00904839|10969146|FG000|Overall Study|Not treated|1
6935627|NCT00904839|10969147|FG001|Overall Study|Not treated|0
6935628|NCT00904839|10969148|FG002|Overall Study|Not treated|1
6935629|NCT00904839|10969146|FG000|Overall Study|Other than above|0
6935630|NCT00904839|10969147|FG001|Overall Study|Other than above|9
6935631|NCT00904839|10969148|FG002|Overall Study|Other than above|7
6935632|NCT00904917|10969163|FG000|Overall Study|Lost to Follow-up|2
6935633|NCT00904917|10969164|FG001|Overall Study|Lost to Follow-up|2
6935634|NCT00904917|10969165|FG002|Overall Study|Lost to Follow-up|2
6935635|NCT00904917|10969166|FG003|Overall Study|Lost to Follow-up|2
6935636|NCT00904969|10969179|FG000|Overall Study|Lost to Follow-up|4
6935637|NCT00904969|10969179|FG000|Overall Study|Withdrawal by Subject|3
6935638|NCT00904969|10969179|FG000|Overall Study|Additional Treatments|11
6935639|NCT00904969|10969179|FG000|Overall Study|Case Aborted; Subject Exited|1
6935640|NCT00904982|10969202|FG000|Overall Study|Withdrawal by Subject|2
6935641|NCT00904982|10969203|FG001|Overall Study|Withdrawal by Subject|0
6935642|NCT00904982|10969204|FG002|Overall Study|Withdrawal by Subject|0
6935643|NCT00904982|10969205|FG003|Overall Study|Withdrawal by Subject|0
6935644|NCT00905021|10969224|FG000|Overall Study|Adverse Event|2
6935645|NCT00905034|10969229|FG000|Overall Study|Withdrawal by Subject|1
6935646|NCT00905255|10969252|FG000|Overall Study|Adverse Event|7
6935647|NCT00905255|10969253|FG001|Overall Study|Adverse Event|5
6935648|NCT00905255|10969252|FG000|Overall Study|Withdrawal by Subject|5
6935649|NCT00905255|10969253|FG001|Overall Study|Withdrawal by Subject|4
6935650|NCT00905255|10969252|FG000|Overall Study|Familial and Personal Reasons|1
6935651|NCT00905255|10969253|FG001|Overall Study|Familial and Personal Reasons|0
6935652|NCT00905307|10969283|FG000|Overall Study|Switched to Open Label Rescue|7
6935653|NCT00905307|10969284|FG001|Overall Study|Switched to Open Label Rescue|17
6935654|NCT00905307|10969285|FG002|Overall Study|Switched to Open Label Rescue|11
6935655|NCT00905307|10969286|FG003|Overall Study|Switched to Open Label Rescue|11
6935656|NCT00905307|10969287|FG004|Overall Study|Switched to Open Label Rescue|4
6935657|NCT00905307|10969288|FG005|Overall Study|Switched to Open Label Rescue|15
6935658|NCT00905307|10969283|FG000|Overall Study|Lost to Follow-up|0
6935659|NCT00905307|10969284|FG001|Overall Study|Lost to Follow-up|0
6935660|NCT00905307|10969285|FG002|Overall Study|Lost to Follow-up|0
6935661|NCT00905307|10969286|FG003|Overall Study|Lost to Follow-up|0
6935662|NCT00905307|10969287|FG004|Overall Study|Lost to Follow-up|1
6935663|NCT00905307|10969288|FG005|Overall Study|Lost to Follow-up|1
6935664|NCT00905307|10969283|FG000|Overall Study|Adverse Event|3
6935665|NCT00905307|10969284|FG001|Overall Study|Adverse Event|4
6935666|NCT00905307|10969285|FG002|Overall Study|Adverse Event|5
6935667|NCT00905307|10969286|FG003|Overall Study|Adverse Event|11
6935668|NCT00905307|10969287|FG004|Overall Study|Adverse Event|3
6935669|NCT00905307|10969288|FG005|Overall Study|Adverse Event|5
6935670|NCT00905307|10969283|FG000|Overall Study|Withdrawal by Subject|5
6935671|NCT00905307|10969284|FG001|Overall Study|Withdrawal by Subject|13
6935672|NCT00905307|10969285|FG002|Overall Study|Withdrawal by Subject|15
6935673|NCT00905307|10969286|FG003|Overall Study|Withdrawal by Subject|11
6935674|NCT00905307|10969287|FG004|Overall Study|Withdrawal by Subject|4
6935675|NCT00905307|10969288|FG005|Overall Study|Withdrawal by Subject|13
6935676|NCT00905307|10969283|FG000|Overall Study|Protocol Violation|1
6935677|NCT00905307|10969284|FG001|Overall Study|Protocol Violation|0
6935678|NCT00905307|10969285|FG002|Overall Study|Protocol Violation|1
6935679|NCT00905307|10969286|FG003|Overall Study|Protocol Violation|0
6935680|NCT00905307|10969287|FG004|Overall Study|Protocol Violation|0
6935681|NCT00905307|10969288|FG005|Overall Study|Protocol Violation|0
6935682|NCT00905307|10969283|FG000|Overall Study|Lack of Efficacy|6
6935683|NCT00905307|10969284|FG001|Overall Study|Lack of Efficacy|3
6935684|NCT00905307|10969285|FG002|Overall Study|Lack of Efficacy|5
6935685|NCT00905307|10969286|FG003|Overall Study|Lack of Efficacy|4
6935686|NCT00905307|10969287|FG004|Overall Study|Lack of Efficacy|4
6935687|NCT00905307|10969288|FG005|Overall Study|Lack of Efficacy|8
6935688|NCT00905359|10969317|FG000|Overall Study|Lost to Follow-up|17
6935689|NCT00905359|10969318|FG001|Overall Study|Lost to Follow-up|10
6935690|NCT00905359|10969317|FG000|Overall Study|Death|2
6935691|NCT00905359|10969318|FG001|Overall Study|Death|0
6935692|NCT00905359|10969317|FG000|Overall Study|Withdrawal consent|5
6935693|NCT00905359|10969318|FG001|Overall Study|Withdrawal consent|6
6935694|NCT00905424|10969326|FG000|Overall Study|Lost to Follow-up|3
6935695|NCT00905424|10969327|FG001|Overall Study|Lost to Follow-up|3
6935696|NCT00905424|10969326|FG000|Overall Study|Withdrawal by Subject|1
6935697|NCT00905424|10969327|FG001|Overall Study|Withdrawal by Subject|2
6935698|NCT00905424|10969326|FG000|Overall Study|Adverse Event|4
6935699|NCT00905424|10969327|FG001|Overall Study|Adverse Event|2
6935700|NCT00905424|10969326|FG000|Overall Study|Non-compliance with study medication|2
6935701|NCT00905424|10969327|FG001|Overall Study|Non-compliance with study medication|0
6935702|NCT00905424|10969326|FG000|Overall Study|Sponsor decision|1
6935703|NCT00905424|10969327|FG001|Overall Study|Sponsor decision|0
6935704|NCT00905424|10969326|FG000|Overall Study|Positive urine drug screen|0
6935705|NCT00905424|10969327|FG001|Overall Study|Positive urine drug screen|1
6935706|NCT00905424|10969326|FG000|Overall Study|Non-adherence to visit schedule|0
6935707|NCT00905424|10969327|FG001|Overall Study|Non-adherence to visit schedule|1
6935708|NCT00905437|10969337|FG000|Overall Study|Adverse Event|3
6935709|NCT00905437|10969338|FG001|Overall Study|Adverse Event|2
6935710|NCT00905437|10969337|FG000|Overall Study|Lost to Follow-up|0
6935711|NCT00905437|10969338|FG001|Overall Study|Lost to Follow-up|1
6935712|NCT00905437|10969337|FG000|Overall Study|Withdrawal by Subject|0
6935713|NCT00905437|10969338|FG001|Overall Study|Withdrawal by Subject|1
6935714|NCT00905437|10969337|FG000|Overall Study|Other|5
6935715|NCT00905437|10969338|FG001|Overall Study|Other|6
6935716|NCT00905489|10969377|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2
6935717|NCT00905489|10969377|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3
6935718|NCT00905489|10969377|FG000|Optional Extension Phase (OEP)|Adverse Event|1
6935719|NCT00905632|10969424|FG000|Overall Study|Adverse Event|0
6935720|NCT00905632|10969425|FG001|Overall Study|Adverse Event|0
6935721|NCT00905632|10969426|FG002|Overall Study|Adverse Event|0
6935722|NCT00905632|10969427|FG003|Overall Study|Adverse Event|0
6935723|NCT00905632|10969428|FG004|Overall Study|Adverse Event|0
6935724|NCT00905632|10969429|FG005|Overall Study|Adverse Event|1
6935725|NCT00905632|10969430|FG006|Overall Study|Adverse Event|4
6935726|NCT00905840|10969466|FG000|Overall Study|Lost to Follow-up|11
6935727|NCT00905840|10969466|FG000|Overall Study|Death|3
6935728|NCT00905840|10969466|FG000|Overall Study|Withdrawal by Subject|1
6935729|NCT00905840|10969466|FG000|Overall Study|Adverse Event|1
6935730|NCT00906087|10969482|FG000|Initial Washout|Withdrawal by Subject|1
6935731|NCT00906087|10969482|FG000|Initial Washout|Physician Decision|1
6935732|NCT00906204|10969509|FG000|Primary Endpoint (Early Safety)|Physician Decision|1
6935733|NCT00906204|10969510|FG001|Primary Endpoint (Early Safety)|Physician Decision|0
6935734|NCT00906204|10969509|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0
6935735|NCT00906204|10969510|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1
6935736|NCT00906204|10969509|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1
6935737|NCT00906204|10969510|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0
6935738|NCT00906204|10969509|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2
6935739|NCT00906204|10969510|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2
6935740|NCT00906204|10969509|FG000|Secondary Endpoints (Long-term Safety)|Death|0
6935741|NCT00906204|10969510|FG001|Secondary Endpoints (Long-term Safety)|Death|1
6935742|NCT00906282|10969520|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2
6935743|NCT00906282|10969520|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10
6935744|NCT00906282|10969520|FG000|Preoperative Chemotherapy|Progressive disease|6
6935745|NCT00906282|10969520|FG000|Preoperative Chemotherapy|Toxicity|1
6935746|NCT00906347|10969527|FG000|Received Study Drug|8 cm prior to initiation of study drug|18
6935747|NCT00906347|10969528|FG001|Received Study Drug|8 cm prior to initiation of study drug|30
6935748|NCT00906347|10969527|FG000|Received Study Drug|Nonreassuring fetal heart rate|13
6935749|NCT00906347|10969528|FG001|Received Study Drug|Nonreassuring fetal heart rate|1
6935750|NCT00906347|10969527|FG000|Received Study Drug|Refused study drug|1
6935751|NCT00906347|10969528|FG001|Received Study Drug|Refused study drug|0
6935752|NCT00906347|10969527|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8
6935753|NCT00906347|10969528|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0
6935754|NCT00906373|10969536|FG000|Overall Study|Withdrawal by Subject|0
6935755|NCT00906373|10969537|FG001|Overall Study|Withdrawal by Subject|5
6935756|NCT00906373|10969536|FG000|Overall Study|Other|0
6935757|NCT00906373|10969537|FG001|Overall Study|Other|1
6935758|NCT00906373|10969536|FG000|Overall Study|Still on treatment at cutoff date|0
6935759|NCT00906373|10969537|FG001|Overall Study|Still on treatment at cutoff date|2
6935760|NCT00906399|10969547|FG000|Year 1|Randomized But Not Treated|0
6935761|NCT00906399|10969548|FG001|Year 1|Randomized But Not Treated|1
6935762|NCT00906399|10969549|FG002|Year 1|Randomized But Not Treated|3
7066156|NCT01972464|11166110|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0
7066157|NCT01972464|11166111|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1
7066158|NCT01972464|11166110|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
7066159|NCT01972464|11166111|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
7066160|NCT01972529|11166131|FG000|Overall Study|Adverse Event|0
7066161|NCT01972529|11166132|FG001|Overall Study|Adverse Event|1
7066162|NCT01972529|11166133|FG002|Overall Study|Adverse Event|0
7066163|NCT01972529|11166134|FG003|Overall Study|Adverse Event|0
7066164|NCT01972529|11166131|FG000|Overall Study|Lost to Follow-up|1
7066165|NCT01972529|11166132|FG001|Overall Study|Lost to Follow-up|0
7066166|NCT01972529|11166133|FG002|Overall Study|Lost to Follow-up|0
7066167|NCT01972529|11166134|FG003|Overall Study|Lost to Follow-up|0
7066168|NCT01972529|11166131|FG000|Overall Study|Participant Choice|0
7066169|NCT01972529|11166132|FG001|Overall Study|Participant Choice|1
7066170|NCT01972529|11166133|FG002|Overall Study|Participant Choice|0
7066171|NCT01972529|11166134|FG003|Overall Study|Participant Choice|0
7066172|NCT01972529|11166131|FG000|Overall Study|Withdrawl of Consent|1
7066173|NCT01972529|11166132|FG001|Overall Study|Withdrawl of Consent|2
7066174|NCT01972529|11166133|FG002|Overall Study|Withdrawl of Consent|0
7066175|NCT01972529|11166134|FG003|Overall Study|Withdrawl of Consent|1
7066176|NCT01972529|11166131|FG000|Overall Study|Other|0
7066177|NCT01972529|11166132|FG001|Overall Study|Other|0
7066178|NCT01972529|11166133|FG002|Overall Study|Other|0
7066179|NCT01972529|11166134|FG003|Overall Study|Other|2
7066180|NCT01972529|11166131|FG000|Overall Study|Not treated|0
7066181|NCT01972529|11166132|FG001|Overall Study|Not treated|1
7066182|NCT01972529|11166133|FG002|Overall Study|Not treated|2
7066183|NCT01972529|11166134|FG003|Overall Study|Not treated|1
7066184|NCT01972568|11166148|FG000|Overall Study|Other events|3
6935763|NCT00906399|10969550|FG003|Year 1|Randomized But Not Treated|0
7066185|NCT01972568|11166149|FG001|Overall Study|Other events|0
7066186|NCT01972568|11166150|FG002|Overall Study|Other events|0
7066187|NCT01972568|11166148|FG000|Overall Study|Lack of Efficacy|0
7066188|NCT01972568|11166149|FG001|Overall Study|Lack of Efficacy|1
6935764|NCT00906399|10969551|FG004|Year 1|Randomized But Not Treated|0
6935765|NCT00906399|10969552|FG005|Year 1|Randomized But Not Treated|0
6935766|NCT00906399|10969553|FG006|Year 1|Randomized But Not Treated|0
6935767|NCT00906399|10969547|FG000|Year 1|Adverse Event|4
6935768|NCT00906399|10969548|FG001|Year 1|Adverse Event|22
6935769|NCT00906399|10969549|FG002|Year 1|Adverse Event|24
6935770|NCT00906399|10969550|FG003|Year 1|Adverse Event|0
6935771|NCT00906399|10969551|FG004|Year 1|Adverse Event|0
6935772|NCT00906399|10969552|FG005|Year 1|Adverse Event|0
6935773|NCT00906399|10969553|FG006|Year 1|Adverse Event|0
6935774|NCT00906399|10969547|FG000|Year 1|Lost to Follow-up|4
6935775|NCT00906399|10969548|FG001|Year 1|Lost to Follow-up|4
6935776|NCT00906399|10969549|FG002|Year 1|Lost to Follow-up|2
6935777|NCT00906399|10969550|FG003|Year 1|Lost to Follow-up|0
6935778|NCT00906399|10969551|FG004|Year 1|Lost to Follow-up|0
6935779|NCT00906399|10969552|FG005|Year 1|Lost to Follow-up|0
6935780|NCT00906399|10969553|FG006|Year 1|Lost to Follow-up|0
6935781|NCT00906399|10969547|FG000|Year 1|Withdrawal by Subject|30
6935782|NCT00906399|10969548|FG001|Year 1|Withdrawal by Subject|32
6935783|NCT00906399|10969549|FG002|Year 1|Withdrawal by Subject|36
6935784|NCT00906399|10969550|FG003|Year 1|Withdrawal by Subject|0
6935785|NCT00906399|10969551|FG004|Year 1|Withdrawal by Subject|0
6935786|NCT00906399|10969552|FG005|Year 1|Withdrawal by Subject|0
6935787|NCT00906399|10969553|FG006|Year 1|Withdrawal by Subject|0
6935788|NCT00906399|10969547|FG000|Year 1|Physician Decision|0
6935789|NCT00906399|10969548|FG001|Year 1|Physician Decision|1
6935790|NCT00906399|10969549|FG002|Year 1|Physician Decision|3
6935791|NCT00906399|10969550|FG003|Year 1|Physician Decision|0
6935792|NCT00906399|10969551|FG004|Year 1|Physician Decision|0
6935793|NCT00906399|10969552|FG005|Year 1|Physician Decision|0
6935794|NCT00906399|10969553|FG006|Year 1|Physician Decision|0
6935795|NCT00906399|10969547|FG000|Year 1|Death|2
6935796|NCT00906399|10969548|FG001|Year 1|Death|1
6935797|NCT00906399|10969549|FG002|Year 1|Death|1
6935798|NCT00906399|10969550|FG003|Year 1|Death|0
6935799|NCT00906399|10969551|FG004|Year 1|Death|0
6935800|NCT00906399|10969552|FG005|Year 1|Death|0
6935801|NCT00906399|10969553|FG006|Year 1|Death|0
6935802|NCT00906399|10969547|FG000|Year 1|Other|4
6935803|NCT00906399|10969548|FG001|Year 1|Other|2
6935804|NCT00906399|10969549|FG002|Year 1|Other|7
6935805|NCT00906399|10969550|FG003|Year 1|Other|0
6935806|NCT00906399|10969551|FG004|Year 1|Other|0
6935807|NCT00906399|10969552|FG005|Year 1|Other|0
6935808|NCT00906399|10969553|FG006|Year 1|Other|0
6935809|NCT00906399|10969547|FG000|Year 2|Adverse Event|0
6935810|NCT00906399|10969548|FG001|Year 2|Adverse Event|0
6935811|NCT00906399|10969549|FG002|Year 2|Adverse Event|0
6935812|NCT00906399|10969550|FG003|Year 2|Adverse Event|9
6935813|NCT00906399|10969551|FG004|Year 2|Adverse Event|8
6935814|NCT00906399|10969552|FG005|Year 2|Adverse Event|11
6935815|NCT00906399|10969553|FG006|Year 2|Adverse Event|6
6935816|NCT00906399|10969547|FG000|Year 2|Lost to Follow-up|0
6935817|NCT00906399|10969548|FG001|Year 2|Lost to Follow-up|0
6935818|NCT00906399|10969549|FG002|Year 2|Lost to Follow-up|0
6935819|NCT00906399|10969550|FG003|Year 2|Lost to Follow-up|1
6935820|NCT00906399|10969551|FG004|Year 2|Lost to Follow-up|4
6935821|NCT00906399|10969552|FG005|Year 2|Lost to Follow-up|2
6935822|NCT00906399|10969553|FG006|Year 2|Lost to Follow-up|4
6935823|NCT00906399|10969547|FG000|Year 2|Withdrawal by Subject|0
6935824|NCT00906399|10969548|FG001|Year 2|Withdrawal by Subject|0
6935825|NCT00906399|10969549|FG002|Year 2|Withdrawal by Subject|0
6935826|NCT00906399|10969550|FG003|Year 2|Withdrawal by Subject|17
6935827|NCT00906399|10969551|FG004|Year 2|Withdrawal by Subject|18
6935828|NCT00906399|10969552|FG005|Year 2|Withdrawal by Subject|27
6935829|NCT00906399|10969553|FG006|Year 2|Withdrawal by Subject|13
6935830|NCT00906399|10969547|FG000|Year 2|Physician Decision|0
6935831|NCT00906399|10969548|FG001|Year 2|Physician Decision|0
6935832|NCT00906399|10969549|FG002|Year 2|Physician Decision|0
6935833|NCT00906399|10969550|FG003|Year 2|Physician Decision|0
6935834|NCT00906399|10969551|FG004|Year 2|Physician Decision|2
6935835|NCT00906399|10969552|FG005|Year 2|Physician Decision|6
6935836|NCT00906399|10969553|FG006|Year 2|Physician Decision|3
6935837|NCT00906399|10969547|FG000|Year 2|Death|0
6935838|NCT00906399|10969548|FG001|Year 2|Death|0
6935839|NCT00906399|10969549|FG002|Year 2|Death|0
6935840|NCT00906399|10969550|FG003|Year 2|Death|1
6935841|NCT00906399|10969551|FG004|Year 2|Death|0
6935842|NCT00906399|10969552|FG005|Year 2|Death|0
6935843|NCT00906399|10969553|FG006|Year 2|Death|3
6935844|NCT00906399|10969547|FG000|Year 2|Other|0
6935845|NCT00906399|10969548|FG001|Year 2|Other|0
6935846|NCT00906399|10969549|FG002|Year 2|Other|0
6935847|NCT00906399|10969550|FG003|Year 2|Other|2
6935848|NCT00906399|10969551|FG004|Year 2|Other|3
6935849|NCT00906399|10969552|FG005|Year 2|Other|1
6935850|NCT00906399|10969553|FG006|Year 2|Other|0
6935851|NCT00906698|10969584|FG000|Overall Study|Dose-limiting toxicity (DLT)|0
6935852|NCT00906698|10969585|FG001|Overall Study|Dose-limiting toxicity (DLT)|6
6935853|NCT00906698|10969586|FG002|Overall Study|Dose-limiting toxicity (DLT)|0
6935854|NCT00906698|10969587|FG003|Overall Study|Dose-limiting toxicity (DLT)|0
6935855|NCT00906698|10969588|FG004|Overall Study|Dose-limiting toxicity (DLT)|1
6935856|NCT00906698|10969589|FG005|Overall Study|Dose-limiting toxicity (DLT)|0
6935857|NCT00906698|10969584|FG000|Overall Study|Adverse Event|0
6935858|NCT00906698|10969585|FG001|Overall Study|Adverse Event|0
6935859|NCT00906698|10969586|FG002|Overall Study|Adverse Event|2
6935860|NCT00906698|10969587|FG003|Overall Study|Adverse Event|0
6935861|NCT00906698|10969588|FG004|Overall Study|Adverse Event|4
6935862|NCT00906698|10969589|FG005|Overall Study|Adverse Event|1
6935863|NCT00906698|10969584|FG000|Overall Study|Disease progression|3
6935864|NCT00906698|10969585|FG001|Overall Study|Disease progression|12
6935865|NCT00906698|10969586|FG002|Overall Study|Disease progression|4
6935866|NCT00906698|10969587|FG003|Overall Study|Disease progression|4
6935867|NCT00906698|10969588|FG004|Overall Study|Disease progression|12
6935868|NCT00906698|10969589|FG005|Overall Study|Disease progression|4
6935869|NCT00906698|10969584|FG000|Overall Study|Withdrawal by Subject|0
6935870|NCT00906698|10969585|FG001|Overall Study|Withdrawal by Subject|0
6935871|NCT00906698|10969586|FG002|Overall Study|Withdrawal by Subject|0
6935872|NCT00906698|10969587|FG003|Overall Study|Withdrawal by Subject|0
6935873|NCT00906698|10969588|FG004|Overall Study|Withdrawal by Subject|1
6935874|NCT00906698|10969589|FG005|Overall Study|Withdrawal by Subject|0
6935875|NCT00906698|10969584|FG000|Overall Study|incl. non compliance, lost to follow-up|0
6935876|NCT00906698|10969585|FG001|Overall Study|incl. non compliance, lost to follow-up|1
6935877|NCT00906698|10969586|FG002|Overall Study|incl. non compliance, lost to follow-up|0
6935878|NCT00906698|10969587|FG003|Overall Study|incl. non compliance, lost to follow-up|0
6935879|NCT00906698|10969588|FG004|Overall Study|incl. non compliance, lost to follow-up|0
7066189|NCT01972568|11166150|FG002|Overall Study|Lack of Efficacy|2
7066190|NCT01972568|11166148|FG000|Overall Study|Protocol Violation|1
7066191|NCT01972568|11166149|FG001|Overall Study|Protocol Violation|2
7066192|NCT01972568|11166150|FG002|Overall Study|Protocol Violation|2
7066193|NCT01972568|11166148|FG000|Overall Study|Withdrawal by Subject|6
7066194|NCT01972568|11166149|FG001|Overall Study|Withdrawal by Subject|3
7066195|NCT01972568|11166150|FG002|Overall Study|Withdrawal by Subject|7
7066196|NCT01972568|11166148|FG000|Overall Study|Lost to Follow-up|1
7066197|NCT01972568|11166149|FG001|Overall Study|Lost to Follow-up|0
7066198|NCT01972568|11166150|FG002|Overall Study|Lost to Follow-up|0
7066199|NCT01972568|11166148|FG000|Overall Study|Adverse Event|5
7066200|NCT01972568|11166149|FG001|Overall Study|Adverse Event|6
7066201|NCT01972568|11166150|FG002|Overall Study|Adverse Event|5
7066202|NCT01972659|11166160|FG000|Overall Study|Protocol Violation|2
7066203|NCT01972659|11166161|FG001|Overall Study|Protocol Violation|2
7066204|NCT01972659|11166160|FG000|Overall Study|problems realted to acceleromyograph|2
7066205|NCT01972659|11166161|FG001|Overall Study|problems realted to acceleromyograph|1
7066206|NCT01972724|11166170|FG000|Double-Blind|Rescue Criteria Met|1
7066207|NCT01972724|11166171|FG001|Double-Blind|Rescue Criteria Met|0
7066208|NCT01972724|11166172|FG002|Double-Blind|Rescue Criteria Met|0
7066209|NCT01972724|11166170|FG000|Double-Blind|Adverse Event|1
7066210|NCT01972724|11166171|FG001|Double-Blind|Adverse Event|0
7066211|NCT01972724|11166172|FG002|Double-Blind|Adverse Event|0
7066212|NCT01972724|11166170|FG000|Double-Blind|Withdrawal of Consent|2
7066213|NCT01972724|11166171|FG001|Double-Blind|Withdrawal of Consent|1
7066214|NCT01972724|11166172|FG002|Double-Blind|Withdrawal of Consent|0
7066215|NCT01972724|11166170|FG000|Double-Blind|Significant Protocol Deviation|5
7066216|NCT01972724|11166171|FG001|Double-Blind|Significant Protocol Deviation|8
7066217|NCT01972724|11166172|FG002|Double-Blind|Significant Protocol Deviation|0
7066218|NCT01972724|11166170|FG000|Open-Label|Withdrew Consent|0
7066219|NCT01972724|11166171|FG001|Open-Label|Withdrew Consent|0
7066220|NCT01972724|11166172|FG002|Open-Label|Withdrew Consent|3
7066221|NCT01972724|11166170|FG000|Open-Label|Significant Protocol Deviation|0
7066222|NCT01972724|11166171|FG001|Open-Label|Significant Protocol Deviation|0
7066223|NCT01972724|11166172|FG002|Open-Label|Significant Protocol Deviation|2
7066224|NCT01972776|11166186|FG000|Part 1|Withdrawal by Subject|0
7066225|NCT01972776|11166187|FG001|Part 1|Withdrawal by Subject|0
7066226|NCT01972776|11166188|FG002|Part 1|Withdrawal by Subject|1
7066227|NCT01972776|11166189|FG003|Part 1|Withdrawal by Subject|0
7066228|NCT01972776|11166190|FG004|Part 1|Withdrawal by Subject|0
7066229|NCT01972776|11166191|FG005|Part 1|Withdrawal by Subject|0
7066230|NCT01972776|11166186|FG000|Part 1|Adverse Event|0
7066231|NCT01972776|11166187|FG001|Part 1|Adverse Event|0
7066232|NCT01972776|11166188|FG002|Part 1|Adverse Event|1
7066233|NCT01972776|11166189|FG003|Part 1|Adverse Event|1
7066234|NCT01972776|11166190|FG004|Part 1|Adverse Event|0
7066235|NCT01972776|11166191|FG005|Part 1|Adverse Event|0
7066236|NCT01972776|11166186|FG000|Part 2|Adverse Event|0
7066237|NCT01972776|11166187|FG001|Part 2|Adverse Event|0
7066238|NCT01972776|11166188|FG002|Part 2|Adverse Event|0
7066239|NCT01972776|11166189|FG003|Part 2|Adverse Event|0
6935880|NCT00906698|10969589|FG005|Overall Study|incl. non compliance, lost to follow-up|0
6935881|NCT00906945|10969641|FG000|Overall Study|Found to be not eligible|0
6935882|NCT00906945|10969642|FG001|Overall Study|Found to be not eligible|0
7066240|NCT01972776|11166190|FG004|Part 2|Adverse Event|3
7066241|NCT01972776|11166191|FG005|Part 2|Adverse Event|0
7066242|NCT01972776|11166186|FG000|Part 2|Administrative problems|0
7066243|NCT01972776|11166187|FG001|Part 2|Administrative problems|0
7066244|NCT01972776|11166188|FG002|Part 2|Administrative problems|0
7066245|NCT01972776|11166189|FG003|Part 2|Administrative problems|0
7066246|NCT01972776|11166190|FG004|Part 2|Administrative problems|10
7066247|NCT01972776|11166191|FG005|Part 2|Administrative problems|7
6935883|NCT00906945|10969643|FG002|Overall Study|Found to be not eligible|0
7066248|NCT01972789|11166207|FG000|Overall Study|Adverse Event|11
7066249|NCT01972789|11166208|FG001|Overall Study|Adverse Event|4
6935884|NCT00906945|10969644|FG003|Overall Study|Found to be not eligible|1
6935885|NCT00906945|10969645|FG004|Overall Study|Found to be not eligible|1
6935886|NCT00906945|10969646|FG005|Overall Study|Found to be not eligible|1
6935887|NCT00906945|10969641|FG000|Overall Study|Physician Decision|0
6935888|NCT00906945|10969642|FG001|Overall Study|Physician Decision|0
6935889|NCT00906945|10969643|FG002|Overall Study|Physician Decision|0
6935890|NCT00906945|10969644|FG003|Overall Study|Physician Decision|0
6935891|NCT00906945|10969645|FG004|Overall Study|Physician Decision|0
6935892|NCT00906945|10969646|FG005|Overall Study|Physician Decision|1
6935893|NCT00906971|10969673|FG000|Overall Study|Withdrawal by Subject|8
6935894|NCT00906971|10969674|FG001|Overall Study|Withdrawal by Subject|2
6935895|NCT00906971|10969673|FG000|Overall Study|Lost to Follow-up|0
6935896|NCT00906971|10969674|FG001|Overall Study|Lost to Follow-up|1
6935897|NCT00907153|10969695|FG000|Overall Study|Lost to Follow-up|1
6935898|NCT00907153|10969696|FG001|Overall Study|Lost to Follow-up|1
6935899|NCT00907153|10969695|FG000|Overall Study|Withdrawal by Subject|1
6935900|NCT00907153|10969696|FG001|Overall Study|Withdrawal by Subject|3
6935901|NCT00907257|10969704|FG000|Overall Study|Adverse Event|0
6935902|NCT00907257|10969705|FG001|Overall Study|Adverse Event|4
6935903|NCT00907257|10969704|FG000|Overall Study|Protocol Violation|1
6935904|NCT00907257|10969705|FG001|Overall Study|Protocol Violation|2
6935905|NCT00907257|10969704|FG000|Overall Study|Lost to Follow-up|3
6935906|NCT00907257|10969705|FG001|Overall Study|Lost to Follow-up|3
6935907|NCT00907257|10969704|FG000|Overall Study|Withdrawal by Subject|1
6935908|NCT00907257|10969705|FG001|Overall Study|Withdrawal by Subject|2
6935909|NCT00907257|10969704|FG000|Overall Study|Per IRB-Subject became vulnerable|1
6935910|NCT00907257|10969705|FG001|Overall Study|Per IRB-Subject became vulnerable|0
6935911|NCT00907257|10969704|FG000|Overall Study|Moved|1
6935912|NCT00907257|10969705|FG001|Overall Study|Moved|0
6935913|NCT00907257|10969704|FG000|Overall Study|Personal Reasons|6
6935914|NCT00907257|10969705|FG001|Overall Study|Personal Reasons|1
6935915|NCT00907296|10969721|FG000|Overall Study|Ineligibility Determined|1
6935916|NCT00907296|10969722|FG001|Overall Study|Ineligibility Determined|0
6935917|NCT00907296|10969723|FG002|Overall Study|Ineligibility Determined|0
6935918|NCT00907296|10969724|FG003|Overall Study|Ineligibility Determined|1
6935919|NCT00907296|10969725|FG004|Overall Study|Ineligibility Determined|0
6935920|NCT00907296|10969726|FG005|Overall Study|Ineligibility Determined|0
6935921|NCT00907296|10969727|FG006|Overall Study|Ineligibility Determined|0
6935922|NCT00907296|10969728|FG007|Overall Study|Ineligibility Determined|1
6935923|NCT00907296|10969729|FG008|Overall Study|Ineligibility Determined|0
6935924|NCT00907296|10969730|FG009|Overall Study|Ineligibility Determined|0
6935925|NCT00907296|10969721|FG000|Overall Study|Protocol Deviation|0
6935926|NCT00907296|10969722|FG001|Overall Study|Protocol Deviation|1
6935927|NCT00907296|10969723|FG002|Overall Study|Protocol Deviation|0
6935928|NCT00907296|10969724|FG003|Overall Study|Protocol Deviation|0
6935929|NCT00907296|10969725|FG004|Overall Study|Protocol Deviation|0
6935930|NCT00907296|10969726|FG005|Overall Study|Protocol Deviation|0
6935931|NCT00907296|10969727|FG006|Overall Study|Protocol Deviation|0
6935932|NCT00907296|10969728|FG007|Overall Study|Protocol Deviation|0
6935933|NCT00907296|10969729|FG008|Overall Study|Protocol Deviation|0
6935934|NCT00907296|10969730|FG009|Overall Study|Protocol Deviation|0
6935935|NCT00907296|10969721|FG000|Overall Study|Noncompliance|1
6935936|NCT00907296|10969722|FG001|Overall Study|Noncompliance|1
6935937|NCT00907296|10969723|FG002|Overall Study|Noncompliance|1
6935938|NCT00907296|10969724|FG003|Overall Study|Noncompliance|0
6935939|NCT00907296|10969725|FG004|Overall Study|Noncompliance|0
6935940|NCT00907296|10969726|FG005|Overall Study|Noncompliance|1
6935941|NCT00907296|10969727|FG006|Overall Study|Noncompliance|0
6935942|NCT00907296|10969728|FG007|Overall Study|Noncompliance|2
6935943|NCT00907296|10969729|FG008|Overall Study|Noncompliance|0
6935944|NCT00907296|10969730|FG009|Overall Study|Noncompliance|0
7066250|NCT01972789|11166207|FG000|Overall Study|Subject withdrew consent|14
7066251|NCT01972789|11166208|FG001|Overall Study|Subject withdrew consent|12
7066252|NCT01972789|11166207|FG000|Overall Study|Lost to Follow-up|4
7066253|NCT01972789|11166208|FG001|Overall Study|Lost to Follow-up|7
7066254|NCT01972789|11166207|FG000|Overall Study|Death|7
7066255|NCT01972789|11166208|FG001|Overall Study|Death|5
7066256|NCT01972789|11166207|FG000|Overall Study|Protocol deviation|1
7066257|NCT01972789|11166208|FG001|Overall Study|Protocol deviation|0
7066258|NCT01972789|11166207|FG000|Overall Study|Physician Decision|3
7066259|NCT01972789|11166208|FG001|Overall Study|Physician Decision|2
6935945|NCT00907296|10969721|FG000|Overall Study|Adverse Event|2
6935946|NCT00907296|10969722|FG001|Overall Study|Adverse Event|0
7066260|NCT01972841|11166220|FG000|Overall Study|Randomized but Never Received Treatment|2
6935947|NCT00907296|10969723|FG002|Overall Study|Adverse Event|0
6935948|NCT00907296|10969724|FG003|Overall Study|Adverse Event|0
6935949|NCT00907296|10969725|FG004|Overall Study|Adverse Event|0
6935950|NCT00907296|10969726|FG005|Overall Study|Adverse Event|0
6935951|NCT00907296|10969727|FG006|Overall Study|Adverse Event|1
6935952|NCT00907296|10969728|FG007|Overall Study|Adverse Event|0
6935953|NCT00907296|10969729|FG008|Overall Study|Adverse Event|0
6935954|NCT00907296|10969730|FG009|Overall Study|Adverse Event|1
6935955|NCT00907296|10969721|FG000|Overall Study|Withdrawal by Subject|7
6935956|NCT00907296|10969722|FG001|Overall Study|Withdrawal by Subject|2
7066261|NCT01972841|11166221|FG001|Overall Study|Randomized but Never Received Treatment|5
6935957|NCT00907296|10969723|FG002|Overall Study|Withdrawal by Subject|1
6935958|NCT00907296|10969724|FG003|Overall Study|Withdrawal by Subject|1
6935959|NCT00907296|10969725|FG004|Overall Study|Withdrawal by Subject|1
6935960|NCT00907296|10969726|FG005|Overall Study|Withdrawal by Subject|5
6935961|NCT00907296|10969727|FG006|Overall Study|Withdrawal by Subject|3
6935962|NCT00907296|10969728|FG007|Overall Study|Withdrawal by Subject|2
6935963|NCT00907296|10969729|FG008|Overall Study|Withdrawal by Subject|4
6935964|NCT00907296|10969730|FG009|Overall Study|Withdrawal by Subject|2
6935965|NCT00907296|10969721|FG000|Overall Study|Lost to Follow-up|9
6935966|NCT00907296|10969722|FG001|Overall Study|Lost to Follow-up|1
6935967|NCT00907296|10969723|FG002|Overall Study|Lost to Follow-up|0
6935968|NCT00907296|10969724|FG003|Overall Study|Lost to Follow-up|2
6935969|NCT00907296|10969725|FG004|Overall Study|Lost to Follow-up|0
6935970|NCT00907296|10969726|FG005|Overall Study|Lost to Follow-up|3
6935971|NCT00907296|10969727|FG006|Overall Study|Lost to Follow-up|2
6935972|NCT00907296|10969728|FG007|Overall Study|Lost to Follow-up|2
6935973|NCT00907296|10969729|FG008|Overall Study|Lost to Follow-up|0
7040084|NCT01715805|11123023|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0
7040085|NCT01715805|11123024|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0
7040086|NCT01715805|11123021|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1
7040087|NCT01715805|11123022|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
6935974|NCT00907296|10969730|FG009|Overall Study|Lost to Follow-up|4
6935975|NCT00907335|10969754|FG000|Overall Study|Withdrawal by Subject|2
6935976|NCT00907335|10969755|FG001|Overall Study|Withdrawal by Subject|0
6935977|NCT00907335|10969754|FG000|Overall Study|Adverse Event|4
6935978|NCT00907335|10969755|FG001|Overall Study|Adverse Event|1
6935979|NCT00907335|10969754|FG000|Overall Study|Lost to Follow-up|2
6935980|NCT00907335|10969755|FG001|Overall Study|Lost to Follow-up|0
6935981|NCT00907374|10969763|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2
6935982|NCT00907374|10969764|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2
6935983|NCT00907478|10969785|FG000|Overall Study|Ineligibility determined|0
6935984|NCT00907478|10969786|FG001|Overall Study|Ineligibility determined|0
6935985|NCT00907478|10969787|FG002|Overall Study|Ineligibility determined|1
6935986|NCT00907478|10969785|FG000|Overall Study|Noncompliance|0
6935987|NCT00907478|10969786|FG001|Overall Study|Noncompliance|0
6935988|NCT00907478|10969787|FG002|Overall Study|Noncompliance|1
6935989|NCT00907478|10969785|FG000|Overall Study|Adverse Event|3
6935990|NCT00907478|10969786|FG001|Overall Study|Adverse Event|1
6935991|NCT00907478|10969787|FG002|Overall Study|Adverse Event|2
6935992|NCT00907478|10969785|FG000|Overall Study|Withdrawal by Subject|8
6935993|NCT00907478|10969786|FG001|Overall Study|Withdrawal by Subject|9
6935994|NCT00907478|10969787|FG002|Overall Study|Withdrawal by Subject|6
6935995|NCT00907478|10969785|FG000|Overall Study|Requirement for alternative therapy|1
6935996|NCT00907478|10969786|FG001|Overall Study|Requirement for alternative therapy|2
6935997|NCT00907478|10969787|FG002|Overall Study|Requirement for alternative therapy|3
6935998|NCT00907478|10969785|FG000|Overall Study|Physician Decision|2
6935999|NCT00907478|10969786|FG001|Overall Study|Physician Decision|0
6936000|NCT00907478|10969787|FG002|Overall Study|Physician Decision|3
6936001|NCT00907478|10969785|FG000|Overall Study|Death|4
6936002|NCT00907478|10969786|FG001|Overall Study|Death|2
6936003|NCT00907478|10969787|FG002|Overall Study|Death|1
6936004|NCT00907478|10969785|FG000|Overall Study|Protocol-specified criteria|5
6936005|NCT00907478|10969786|FG001|Overall Study|Protocol-specified criteria|2
6936006|NCT00907478|10969787|FG002|Overall Study|Protocol-specified criteria|3
6936007|NCT00907478|10969785|FG000|Overall Study|Pregnancy|0
6936008|NCT00907478|10969786|FG001|Overall Study|Pregnancy|1
6936009|NCT00907478|10969787|FG002|Overall Study|Pregnancy|1
6936010|NCT00907478|10969785|FG000|Overall Study|Lost to Follow-up|1
6936011|NCT00907478|10969786|FG001|Overall Study|Lost to Follow-up|0
6936012|NCT00907478|10969787|FG002|Overall Study|Lost to Follow-up|0
6936013|NCT00907478|10969785|FG000|Overall Study|Other|3
6936014|NCT00907478|10969786|FG001|Overall Study|Other|0
6936015|NCT00907478|10969787|FG002|Overall Study|Other|1
6936016|NCT00907517|10969802|FG000|Overall Study|Progressive Disease|3
6936017|NCT00907517|10969803|FG001|Overall Study|Progressive Disease|3
6936018|NCT00907517|10969804|FG002|Overall Study|Progressive Disease|4
6936019|NCT00907517|10969805|FG003|Overall Study|Progressive Disease|4
6936020|NCT00907517|10969806|FG004|Overall Study|Progressive Disease|4
7040088|NCT01715805|11123023|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
6936021|NCT00907517|10969802|FG000|Overall Study|Symptomatic Deterioration|0
6936022|NCT00907517|10969803|FG001|Overall Study|Symptomatic Deterioration|0
6936023|NCT00907517|10969804|FG002|Overall Study|Symptomatic Deterioration|0
6936024|NCT00907517|10969805|FG003|Overall Study|Symptomatic Deterioration|0
6936025|NCT00907517|10969806|FG004|Overall Study|Symptomatic Deterioration|1
6936026|NCT00907621|10969820|FG000|Overall Study|Lost to Follow-up|6
6936027|NCT00907621|10969821|FG001|Overall Study|Lost to Follow-up|3
6936028|NCT00907621|10969820|FG000|Overall Study|intercurrent febrile illness|1
7040089|NCT01715805|11123024|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
6936029|NCT00907621|10969821|FG001|Overall Study|intercurrent febrile illness|1
6936030|NCT00907738|10969832|FG000|Overall Study|Adverse Event|2
6936031|NCT00907738|10969833|FG001|Overall Study|Adverse Event|0
6936032|NCT00907738|10969834|FG002|Overall Study|Adverse Event|1
6936033|NCT00907738|10969835|FG003|Overall Study|Adverse Event|0
6936034|NCT00907738|10969836|FG004|Overall Study|Adverse Event|0
6936035|NCT00907738|10969832|FG000|Overall Study|not specified or withdrew consent|3
6936036|NCT00907738|10969833|FG001|Overall Study|not specified or withdrew consent|0
6936037|NCT00907738|10969834|FG002|Overall Study|not specified or withdrew consent|0
6936038|NCT00907738|10969835|FG003|Overall Study|not specified or withdrew consent|0
6936039|NCT00907738|10969836|FG004|Overall Study|not specified or withdrew consent|0
6936040|NCT00907738|10969832|FG000|Overall Study|Disease progression|8
6936041|NCT00907738|10969833|FG001|Overall Study|Disease progression|1
6936042|NCT00907738|10969834|FG002|Overall Study|Disease progression|6
6936043|NCT00907738|10969835|FG003|Overall Study|Disease progression|4
6936044|NCT00907738|10969836|FG004|Overall Study|Disease progression|2
6936045|NCT00907777|10969854|FG000|Overall Study|Withdrawal by Subject|0
6936046|NCT00907777|10969855|FG001|Overall Study|Withdrawal by Subject|1
6936047|NCT00907803|10969864|FG000|Overall Study|Withdrawal of consent - long commute|1
6936048|NCT00907803|10969865|FG001|Overall Study|Withdrawal of consent - long commute|0
6936049|NCT00907803|10969866|FG002|Overall Study|Withdrawal of consent - long commute|0
6936050|NCT00907803|10969864|FG000|Overall Study|Adverse Event|2
6936051|NCT00907803|10969865|FG001|Overall Study|Adverse Event|0
6936052|NCT00907803|10969866|FG002|Overall Study|Adverse Event|0
6936053|NCT00907803|10969864|FG000|Overall Study|Withdrawal by Subject|0
6936054|NCT00907803|10969865|FG001|Overall Study|Withdrawal by Subject|1
6936055|NCT00907803|10969866|FG002|Overall Study|Withdrawal by Subject|0
6936056|NCT00907803|10969864|FG000|Overall Study|Lost to Follow-up|0
6936057|NCT00907803|10969865|FG001|Overall Study|Lost to Follow-up|1
6936058|NCT00907803|10969866|FG002|Overall Study|Lost to Follow-up|0
6936059|NCT00907803|10969864|FG000|Overall Study|Protocol Violation|0
6936060|NCT00907803|10969865|FG001|Overall Study|Protocol Violation|1
6936061|NCT00907803|10969866|FG002|Overall Study|Protocol Violation|0
6936062|NCT00907881|10969874|FG000|Overall Study|Lost to Follow-up|59
6936063|NCT00907881|10969874|FG000|Overall Study|Noncompliance|5
6936064|NCT00907881|10969874|FG000|Overall Study|Withdrawal by Subject|5
6936065|NCT00907881|10969874|FG000|Overall Study|Protocol Violation|1
6936066|NCT00907881|10969874|FG000|Overall Study|Missing discontinuation information|15
6936067|NCT00908011|10969880|FG000|Overall Study|Withdrawal by Subject|2
6936068|NCT00908011|10969881|FG001|Overall Study|Withdrawal by Subject|2
6936069|NCT00908037|10969894|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0
6936070|NCT00908037|10969895|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0
6936071|NCT00908037|10969896|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0
6936072|NCT00908037|10969897|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0
6936073|NCT00908037|10969898|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1
6936074|NCT00908037|10969899|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0
6936075|NCT00908037|10969900|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3
6936076|NCT00908037|10969901|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0
6936077|NCT00908037|10969902|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1
6936078|NCT00908037|10969903|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0
6936079|NCT00908037|10969904|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0
6936080|NCT00908037|10969905|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0
6936081|NCT00908037|10969894|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
6936082|NCT00908037|10969895|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
6936083|NCT00908037|10969896|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
6936084|NCT00908037|10969897|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
6936085|NCT00908037|10969898|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2
6936086|NCT00908037|10969899|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
6936087|NCT00908037|10969900|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
6936088|NCT00908037|10969901|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
6936089|NCT00908037|10969902|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4
6936090|NCT00908037|10969903|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
6936091|NCT00908037|10969904|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
6936092|NCT00908037|10969905|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
6936093|NCT00908037|10969894|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
6936094|NCT00908037|10969895|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
6936095|NCT00908037|10969896|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
6936096|NCT00908037|10969897|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
7040090|NCT01715805|11123021|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10
7040091|NCT01715805|11123022|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
7040092|NCT01715805|11123023|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
7040093|NCT01715805|11123024|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
7040094|NCT01715805|11123021|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
7040095|NCT01715805|11123022|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
7040096|NCT01715805|11123023|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
7040097|NCT01715805|11123024|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1
7040098|NCT01715805|11123021|FG000|Double-Blind or Continued Treatment|Adverse Event|0
7040099|NCT01715805|11123022|FG001|Double-Blind or Continued Treatment|Adverse Event|3
7040100|NCT01715805|11123023|FG002|Double-Blind or Continued Treatment|Adverse Event|23
7040101|NCT01715805|11123024|FG003|Double-Blind or Continued Treatment|Adverse Event|2
6936097|NCT00908037|10969898|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
6936098|NCT00908037|10969899|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
6936099|NCT00908037|10969900|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
6936100|NCT00908037|10969901|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
6936101|NCT00908037|10969902|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
6936102|NCT00908037|10969903|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
6936103|NCT00908037|10969904|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
6936104|NCT00908037|10969905|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
6936105|NCT00908037|10969894|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
6936106|NCT00908037|10969895|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
6936107|NCT00908037|10969896|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
6936108|NCT00908037|10969897|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
6936109|NCT00908037|10969898|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
6936110|NCT00908037|10969899|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
6936111|NCT00908037|10969900|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
6936112|NCT00908037|10969901|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
6936113|NCT00908037|10969902|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
6936114|NCT00908037|10969903|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
6936115|NCT00908037|10969904|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
6936116|NCT00908037|10969905|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1
6936117|NCT00908037|10969894|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
6936118|NCT00908037|10969895|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
6936119|NCT00908037|10969896|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
6936120|NCT00908037|10969897|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
6936121|NCT00908037|10969898|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
6936122|NCT00908037|10969899|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
6936123|NCT00908037|10969900|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
6936124|NCT00908037|10969901|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
6936125|NCT00908037|10969902|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
6936126|NCT00908037|10969903|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1
6936127|NCT00908037|10969904|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
6936128|NCT00908037|10969905|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2
6936129|NCT00908037|10969894|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
6936130|NCT00908037|10969895|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
6936131|NCT00908037|10969896|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
6936132|NCT00908037|10969897|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
6936133|NCT00908037|10969898|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
6838053|NCT00256750|10843793|FG001|Post-Transplant Treated (12 Months)|Death|2
6838054|NCT00256750|10843794|FG002|Post-Transplant Treated (12 Months)|Death|4
6838055|NCT00256750|10843792|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10
6838056|NCT00256750|10843793|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22
6838057|NCT00256750|10843794|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27
6838058|NCT00256750|10843792|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1
6838059|NCT00256750|10843793|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
6838060|NCT00256750|10843794|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
6838061|NCT00256750|10843792|FG000|Post-Transplant Treated (12 Months)|Other|5
6838062|NCT00256750|10843793|FG001|Post-Transplant Treated (12 Months)|Other|4
6838063|NCT00256750|10843794|FG002|Post-Transplant Treated (12 Months)|Other|2
6838064|NCT00256750|10843792|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0
6838065|NCT00256750|10843793|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3
6838066|NCT00256750|10843794|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5
6838067|NCT00256750|10843792|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2
6838068|NCT00256750|10843793|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0
6838069|NCT00256750|10843794|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0
6838070|NCT00256750|10843792|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7
6838071|NCT00256750|10843793|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3
6838072|NCT00256750|10843794|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6
6838073|NCT00256750|10843792|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5
6838074|NCT00256750|10843793|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1
6838075|NCT00256750|10843794|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0
6838076|NCT00256750|10843792|FG000|Post-Transplant Treated (24 Months)|Death|3
6838077|NCT00256750|10843793|FG001|Post-Transplant Treated (24 Months)|Death|0
6838078|NCT00256750|10843794|FG002|Post-Transplant Treated (24 Months)|Death|0
6838079|NCT00256750|10843792|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4
6838080|NCT00256750|10843793|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3
6838081|NCT00256750|10843794|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2
6838082|NCT00256750|10843792|FG000|Post-Transplant Treated (24 Months)|Other|2
6838083|NCT00256750|10843793|FG001|Post-Transplant Treated (24 Months)|Other|0
6838084|NCT00256750|10843794|FG002|Post-Transplant Treated (24 Months)|Other|1
6936134|NCT00908037|10969899|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
6936135|NCT00908037|10969900|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
6936136|NCT00908037|10969901|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
6936137|NCT00908037|10969902|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
6936138|NCT00908037|10969903|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1
6936139|NCT00908037|10969904|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
6936140|NCT00908037|10969905|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
6936141|NCT00908037|10969894|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
6936142|NCT00908037|10969895|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
6936143|NCT00908037|10969896|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
6936144|NCT00908037|10969897|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
6936145|NCT00908037|10969898|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
6936146|NCT00908037|10969899|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
6936147|NCT00908037|10969900|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
6936148|NCT00908037|10969901|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
6936149|NCT00908037|10969902|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
6936150|NCT00908037|10969903|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
6936151|NCT00908037|10969904|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2
6936152|NCT00908037|10969905|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
6936153|NCT00908037|10969894|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
6936154|NCT00908037|10969895|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
6936155|NCT00908037|10969896|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
6936156|NCT00908037|10969897|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
6936157|NCT00908037|10969898|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
6936158|NCT00908037|10969899|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
6936159|NCT00908037|10969900|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
6936160|NCT00908037|10969901|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
6936161|NCT00908037|10969902|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
6936162|NCT00908037|10969903|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1
6936163|NCT00908037|10969904|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
6936164|NCT00908037|10969905|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
6936165|NCT00908037|10969894|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
6936166|NCT00908037|10969895|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
6936167|NCT00908037|10969896|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
6936168|NCT00908037|10969897|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
6936169|NCT00908037|10969898|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
7040102|NCT01715805|11123021|FG000|Double-Blind or Continued Treatment|Protocol Violation|0
7040103|NCT01715805|11123022|FG001|Double-Blind or Continued Treatment|Protocol Violation|14
7040104|NCT01715805|11123023|FG002|Double-Blind or Continued Treatment|Protocol Violation|12
7040105|NCT01715805|11123024|FG003|Double-Blind or Continued Treatment|Protocol Violation|19
7040106|NCT01715805|11123021|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0
7040107|NCT01715805|11123022|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11
7040108|NCT01715805|11123023|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11
7040109|NCT01715805|11123024|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13
7040110|NCT01715805|11123021|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0
6936170|NCT00908037|10969899|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
6936171|NCT00908037|10969900|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
6936172|NCT00908037|10969901|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
6936173|NCT00908037|10969902|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
6936174|NCT00908037|10969903|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
6936175|NCT00908037|10969904|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2
6936176|NCT00908037|10969905|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
6936177|NCT00908076|10969959|FG000|Overall Study|Lack of Efficacy|1
6936178|NCT00908076|10969960|FG001|Overall Study|Lack of Efficacy|1
6936179|NCT00908115|10969966|FG000|Overall Study|Other|14
6936180|NCT00908141|10969972|FG000|Overall Study|Withdrawal by Subject|0
6936181|NCT00908141|10969973|FG001|Overall Study|Withdrawal by Subject|1
6936182|NCT00908232|10969979|FG000|Cycle 1 to 4|Death|5
6936183|NCT00908232|10969980|FG001|Cycle 1 to 4|Death|0
6936184|NCT00908232|10969981|FG002|Cycle 1 to 4|Death|0
6936185|NCT00908232|10969982|FG003|Cycle 1 to 4|Death|0
6936186|NCT00908232|10969979|FG000|Cycle 1 to 4|Withdrawal by Subject|4
6936187|NCT00908232|10969980|FG001|Cycle 1 to 4|Withdrawal by Subject|0
6936188|NCT00908232|10969981|FG002|Cycle 1 to 4|Withdrawal by Subject|0
6936189|NCT00908232|10969982|FG003|Cycle 1 to 4|Withdrawal by Subject|0
6936190|NCT00908232|10969979|FG000|Cycle 1 to 4|Progressive Disease|6
7040111|NCT01715805|11123022|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7
7040112|NCT01715805|11123023|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10
6936191|NCT00908232|10969980|FG001|Cycle 1 to 4|Progressive Disease|0
6936192|NCT00908232|10969981|FG002|Cycle 1 to 4|Progressive Disease|0
6936193|NCT00908232|10969982|FG003|Cycle 1 to 4|Progressive Disease|0
6936194|NCT00908232|10969979|FG000|Cycle 1 to 4|Adverse Event|12
6936195|NCT00908232|10969980|FG001|Cycle 1 to 4|Adverse Event|0
6936196|NCT00908232|10969981|FG002|Cycle 1 to 4|Adverse Event|0
6936197|NCT00908232|10969982|FG003|Cycle 1 to 4|Adverse Event|0
6936198|NCT00908232|10969979|FG000|Cycle 1 to 4|Other|1
6936199|NCT00908232|10969980|FG001|Cycle 1 to 4|Other|0
6936200|NCT00908232|10969981|FG002|Cycle 1 to 4|Other|0
6936201|NCT00908232|10969982|FG003|Cycle 1 to 4|Other|0
6936202|NCT00908232|10969979|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1
6936203|NCT00908232|10969980|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
6936204|NCT00908232|10969981|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
6936205|NCT00908232|10969982|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
7066262|NCT01972841|11166222|FG002|Overall Study|Randomized but Never Received Treatment|4
7066263|NCT01972841|11166223|FG003|Overall Study|Randomized but Never Received Treatment|2
7066264|NCT01972841|11166224|FG004|Overall Study|Randomized but Never Received Treatment|6
7066265|NCT01972841|11166225|FG005|Overall Study|Randomized but Never Received Treatment|13
7066266|NCT01972841|11166220|FG000|Overall Study|Adverse Event|13
7066267|NCT01972841|11166221|FG001|Overall Study|Adverse Event|8
7066268|NCT01972841|11166222|FG002|Overall Study|Adverse Event|12
7066269|NCT01972841|11166223|FG003|Overall Study|Adverse Event|9
7066270|NCT01972841|11166224|FG004|Overall Study|Adverse Event|21
7066271|NCT01972841|11166225|FG005|Overall Study|Adverse Event|26
7066272|NCT01972841|11166220|FG000|Overall Study|Lack of Efficacy|1
7066273|NCT01972841|11166221|FG001|Overall Study|Lack of Efficacy|0
7066274|NCT01972841|11166222|FG002|Overall Study|Lack of Efficacy|0
7066275|NCT01972841|11166223|FG003|Overall Study|Lack of Efficacy|2
6936206|NCT00908232|10969979|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5
6936207|NCT00908232|10969980|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
6936208|NCT00908232|10969981|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
6936209|NCT00908232|10969982|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
6936210|NCT00908232|10969979|FG000|Randomization (Cycle 5) to Cycle 8|Death|2
6936211|NCT00908232|10969980|FG001|Randomization (Cycle 5) to Cycle 8|Death|0
6936212|NCT00908232|10969981|FG002|Randomization (Cycle 5) to Cycle 8|Death|0
6936213|NCT00908232|10969982|FG003|Randomization (Cycle 5) to Cycle 8|Death|0
6936214|NCT00908232|10969979|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4
6936215|NCT00908232|10969980|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
6936216|NCT00908232|10969981|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1
6936217|NCT00908232|10969982|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
6936218|NCT00908232|10969979|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17
6936219|NCT00908232|10969980|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2
6936220|NCT00908232|10969981|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
6936221|NCT00908232|10969982|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
6936222|NCT00908232|10969979|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2
6936223|NCT00908232|10969980|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
6936224|NCT00908232|10969981|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
6936225|NCT00908232|10969982|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
6936226|NCT00908232|10969979|FG000|Randomization (Cycle 5) to Cycle 8|Other|3
6936227|NCT00908232|10969980|FG001|Randomization (Cycle 5) to Cycle 8|Other|1
6936228|NCT00908232|10969981|FG002|Randomization (Cycle 5) to Cycle 8|Other|0
6936229|NCT00908232|10969982|FG003|Randomization (Cycle 5) to Cycle 8|Other|0
6936230|NCT00908232|10969979|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1
6936231|NCT00908232|10969980|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
6936232|NCT00908232|10969981|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
6936233|NCT00908232|10969982|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
6936234|NCT00908310|10969988|FG000|Overall Study|Death|37
6936235|NCT00908310|10969988|FG000|Overall Study|Withdrawal by Subject|7
6936236|NCT00908310|10969988|FG000|Overall Study|Lost to Follow-up|7
6936237|NCT00908310|10969988|FG000|Overall Study|Screening failure|5
6936238|NCT00908310|10969988|FG000|Overall Study|Other reasons|4
6936239|NCT00908349|10969992|FG000|Overall Study|Adverse Event|10
6936240|NCT00908349|10969992|FG000|Overall Study|Withdrawal by Subject|9
6936241|NCT00908349|10969992|FG000|Overall Study|Physician Decision|5
6936242|NCT00908349|10969992|FG000|Overall Study|Lost to Follow-up|5
6936243|NCT00908349|10969992|FG000|Overall Study|Various|6
6936244|NCT00908375|10969998|FG000|Overall Study|Withdrawal by Subject|2
6936245|NCT00908375|10969999|FG001|Overall Study|Withdrawal by Subject|4
7066276|NCT01972841|11166224|FG004|Overall Study|Lack of Efficacy|4
7066277|NCT01972841|11166225|FG005|Overall Study|Lack of Efficacy|1
7066278|NCT01972841|11166220|FG000|Overall Study|Lost to Follow-up|4
7066279|NCT01972841|11166221|FG001|Overall Study|Lost to Follow-up|2
7183762|NCT01254422|11383828|FG001|Overall Study|Serious adverse event|1
6936246|NCT00908375|10969998|FG000|Overall Study|Lost to Follow-up|8
7066280|NCT01972841|11166222|FG002|Overall Study|Lost to Follow-up|4
7066281|NCT01972841|11166223|FG003|Overall Study|Lost to Follow-up|2
7066282|NCT01972841|11166224|FG004|Overall Study|Lost to Follow-up|9
7066283|NCT01972841|11166225|FG005|Overall Study|Lost to Follow-up|3
7066284|NCT01972841|11166220|FG000|Overall Study|Protocol Violation|2
6936247|NCT00908375|10969999|FG001|Overall Study|Lost to Follow-up|6
6975338|NCT01192295|11027507|FG001|Overall Study|Withdrawal by Subject|4
6975339|NCT01192295|11027506|FG000|Overall Study|Lost to Follow-up|0
6975340|NCT01192295|11027507|FG001|Overall Study|Lost to Follow-up|1
6975341|NCT01192295|11027506|FG000|Overall Study|Lack of Efficacy|0
6975342|NCT01192295|11027507|FG001|Overall Study|Lack of Efficacy|5
6975343|NCT01192295|11027506|FG000|Overall Study|Administrative|4
6975344|NCT01192295|11027507|FG001|Overall Study|Administrative|6
6975345|NCT01192347|11027515|FG000|Overall Study|Death|3
6975346|NCT01192347|11027515|FG000|Overall Study|Lost to Follow-up|3
6975347|NCT01192347|11027515|FG000|Overall Study|Withdrawal by Subject|1
6975348|NCT01192347|11027515|FG000|Overall Study|Adverse Event|1
6975349|NCT01192347|11027515|FG000|Overall Study|Suspected serious adverse drug reaction|1
6975350|NCT01192347|11027515|FG000|Overall Study|Patient seen in different hospital|1
6975351|NCT01192347|11027515|FG000|Overall Study|Patient not visiting hospital regularly|1
6975352|NCT01192347|11027515|FG000|Overall Study|Patient did not show up for visits|1
6975353|NCT01192399|11027519|FG000|Overall Study|Lack of Efficacy|2
6975354|NCT01192412|11027525|FG000|Overall Study|Lost to Follow-up|2
6975355|NCT01192412|11027526|FG001|Overall Study|Lost to Follow-up|1
6975356|NCT01192412|11027525|FG000|Overall Study|Withdrawal by Subject|2
6975357|NCT01192412|11027526|FG001|Overall Study|Withdrawal by Subject|1
6977205|NCT01205776|11030290|FG001|Overall Study|Withdrawal by Subject|34
6977206|NCT01206140|11030314|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1
6977207|NCT01206140|11030315|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0
6977208|NCT01206166|11030323|FG000|Overall Study|No evaluable data|2
6977209|NCT01206166|11030324|FG001|Overall Study|No evaluable data|3
6977210|NCT01206322|11030335|FG000|Overall Study|Adverse Event|0
6977211|NCT01206322|11030336|FG001|Overall Study|Adverse Event|0
6977212|NCT01206322|11030337|FG002|Overall Study|Adverse Event|0
6977213|NCT01206322|11030338|FG003|Overall Study|Adverse Event|1
6977214|NCT01206582|11030397|FG000|Overall Study|Withdrew prior to study|1
6977215|NCT01206582|11030398|FG001|Overall Study|Withdrew prior to study|0
6977216|NCT01206582|11030397|FG000|Overall Study|Discontinued intervention before week 8|1
6977217|NCT01206582|11030398|FG001|Overall Study|Discontinued intervention before week 8|2
6977218|NCT01206764|11030448|FG000|Overall Study|Adverse Event|20
6977219|NCT01206764|11030448|FG000|Overall Study|Abnormal laboratory value|2
6977220|NCT01206764|11030448|FG000|Overall Study|Abnormal test procedure result|1
6977221|NCT01206764|11030448|FG000|Overall Study|Patient withdrew consent|5
6977222|NCT01206764|11030448|FG000|Overall Study|Lost to Follow-up|6
6977223|NCT01206764|11030448|FG000|Overall Study|Death|11
6977224|NCT01206764|11030448|FG000|Overall Study|New cancer therapy|2
6977225|NCT01206764|11030448|FG000|Overall Study|Disease progression|88
6977226|NCT01206764|11030448|FG000|Overall Study|Protocol deviation|3
6977227|NCT01206777|11030452|FG000|Overall Study|Death|1
6977228|NCT01206777|11030452|FG000|Overall Study|Adverse Event|1
6977229|NCT01206816|11030463|FG000|Overall Study|Protocol Violation|0
6977230|NCT01206816|11030464|FG001|Overall Study|Protocol Violation|0
6977231|NCT01206816|11030465|FG002|Overall Study|Protocol Violation|1
6977232|NCT01206816|11030466|FG003|Overall Study|Protocol Violation|0
6977233|NCT01206816|11030467|FG004|Overall Study|Protocol Violation|0
6977234|NCT01206816|11030468|FG005|Overall Study|Protocol Violation|0
6977235|NCT01206816|11030469|FG006|Overall Study|Protocol Violation|0
6977236|NCT01206816|11030463|FG000|Overall Study|Withdrawal by Subject|0
6977237|NCT01206816|11030464|FG001|Overall Study|Withdrawal by Subject|0
6977238|NCT01206816|11030465|FG002|Overall Study|Withdrawal by Subject|1
6977239|NCT01206816|11030466|FG003|Overall Study|Withdrawal by Subject|0
6977240|NCT01206816|11030467|FG004|Overall Study|Withdrawal by Subject|0
6977241|NCT01206816|11030468|FG005|Overall Study|Withdrawal by Subject|0
6977242|NCT01206816|11030469|FG006|Overall Study|Withdrawal by Subject|0
6977243|NCT01206816|11030463|FG000|Overall Study|Progressive disease|3
6977244|NCT01206816|11030464|FG001|Overall Study|Progressive disease|3
6977245|NCT01206816|11030465|FG002|Overall Study|Progressive disease|13
6977246|NCT01206816|11030466|FG003|Overall Study|Progressive disease|3
6977247|NCT01206816|11030467|FG004|Overall Study|Progressive disease|3
6977248|NCT01206816|11030468|FG005|Overall Study|Progressive disease|16
6977249|NCT01206816|11030469|FG006|Overall Study|Progressive disease|3
6977250|NCT01206816|11030463|FG000|Overall Study|Other AE|0
6977251|NCT01206816|11030464|FG001|Overall Study|Other AE|0
6977252|NCT01206816|11030465|FG002|Overall Study|Other AE|4
6977253|NCT01206816|11030466|FG003|Overall Study|Other AE|0
6977254|NCT01206816|11030467|FG004|Overall Study|Other AE|0
6977255|NCT01206816|11030468|FG005|Overall Study|Other AE|3
6977256|NCT01206816|11030469|FG006|Overall Study|Other AE|2
6977257|NCT01206816|11030463|FG000|Overall Study|other than stated above|0
6977258|NCT01206816|11030464|FG001|Overall Study|other than stated above|0
6977259|NCT01206816|11030465|FG002|Overall Study|other than stated above|1
6977260|NCT01206816|11030466|FG003|Overall Study|other than stated above|0
6977261|NCT01206816|11030467|FG004|Overall Study|other than stated above|0
6977262|NCT01206816|11030468|FG005|Overall Study|other than stated above|0
6977263|NCT01206816|11030469|FG006|Overall Study|other than stated above|1
6977264|NCT01207219|11030492|FG000|Overall Study|changed diagnosis during study period|5
6977265|NCT01207219|11030493|FG001|Overall Study|changed diagnosis during study period|3
6977266|NCT01207219|11030494|FG002|Overall Study|changed diagnosis during study period|1
6977267|NCT01207219|11030492|FG000|Overall Study|Lost to Follow-up|6
6936248|NCT00908544|10970020|FG000|Overall Study|Withdrawal by Subject|2
6936249|NCT00908544|10970021|FG001|Overall Study|Withdrawal by Subject|4
6936250|NCT00908544|10970020|FG000|Overall Study|Lack of Efficacy|0
6936251|NCT00908544|10970021|FG001|Overall Study|Lack of Efficacy|1
6936252|NCT00908544|10970020|FG000|Overall Study|Pregnancy|1
6936253|NCT00908544|10970021|FG001|Overall Study|Pregnancy|0
6936254|NCT00908544|10970020|FG000|Overall Study|Relocation abroad|1
6936255|NCT00908544|10970021|FG001|Overall Study|Relocation abroad|1
6936256|NCT00908544|10970020|FG000|Overall Study|Unable to visit sutdy center|1
6936257|NCT00908544|10970021|FG001|Overall Study|Unable to visit sutdy center|0
6936258|NCT00908583|10970027|FG000|Phase 1|Withdrawal by Subject|1
6936259|NCT00908583|10970027|FG000|Phase 1|Adverse Event|4
6936260|NCT00908583|10970027|FG000|Phase 2|Physician Decision|1
6936261|NCT00908583|10970027|FG000|Phase 2|Adverse Event|1
6936262|NCT00908583|10970027|FG000|Phase 3|Adverse Event|2
7066285|NCT01972841|11166221|FG001|Overall Study|Protocol Violation|2
7066286|NCT01972841|11166222|FG002|Overall Study|Protocol Violation|3
7066287|NCT01972841|11166223|FG003|Overall Study|Protocol Violation|5
7066288|NCT01972841|11166224|FG004|Overall Study|Protocol Violation|9
7066289|NCT01972841|11166225|FG005|Overall Study|Protocol Violation|4
7066290|NCT01972841|11166220|FG000|Overall Study|Withdrawal by participants|21
7066291|NCT01972841|11166221|FG001|Overall Study|Withdrawal by participants|27
7066292|NCT01972841|11166222|FG002|Overall Study|Withdrawal by participants|23
7066293|NCT01972841|11166223|FG003|Overall Study|Withdrawal by participants|16
7066294|NCT01972841|11166224|FG004|Overall Study|Withdrawal by participants|33
7066295|NCT01972841|11166225|FG005|Overall Study|Withdrawal by participants|34
7066296|NCT01972841|11166220|FG000|Overall Study|Miscellaneous|0
7066297|NCT01972841|11166221|FG001|Overall Study|Miscellaneous|0
7066298|NCT01972841|11166222|FG002|Overall Study|Miscellaneous|4
7066299|NCT01972841|11166223|FG003|Overall Study|Miscellaneous|1
7066300|NCT01972841|11166224|FG004|Overall Study|Miscellaneous|0
7066301|NCT01972841|11166225|FG005|Overall Study|Miscellaneous|4
7066302|NCT01972841|11166220|FG000|Overall Study|Did not have end of treatment page|0
7066303|NCT01972841|11166221|FG001|Overall Study|Did not have end of treatment page|0
7066304|NCT01972841|11166222|FG002|Overall Study|Did not have end of treatment page|0
7066305|NCT01972841|11166223|FG003|Overall Study|Did not have end of treatment page|0
7066306|NCT01972841|11166224|FG004|Overall Study|Did not have end of treatment page|1
7066307|NCT01972841|11166225|FG005|Overall Study|Did not have end of treatment page|0
7066308|NCT01973218|11166260|FG000|Overall Study|Adverse Event|1
7066309|NCT01973218|11166261|FG001|Overall Study|Adverse Event|0
7066310|NCT01973218|11166260|FG000|Overall Study|Withdrawal by Subject|1
7066311|NCT01973218|11166261|FG001|Overall Study|Withdrawal by Subject|0
7066312|NCT01973231|11166271|FG000|Overall Study|Protocol Violation|1
7066313|NCT01973231|11166272|FG001|Overall Study|Protocol Violation|1
7066314|NCT01973231|11166271|FG000|Overall Study|Lost to Follow-up|1
7066315|NCT01973231|11166272|FG001|Overall Study|Lost to Follow-up|1
7066316|NCT01973231|11166271|FG000|Overall Study|unclassified|2
7066317|NCT01973231|11166272|FG001|Overall Study|unclassified|1
7066318|NCT01973231|11166271|FG000|Overall Study|Withdrawal by Subject|7
7066319|NCT01973231|11166272|FG001|Overall Study|Withdrawal by Subject|9
7066320|NCT01973283|11166278|FG000|Overall Study|Lost to Follow-up|4
7066321|NCT01973387|11166320|FG000|Overall Study|Adverse Event|14
7066322|NCT01973387|11166321|FG001|Overall Study|Adverse Event|4
7066323|NCT01973387|11166320|FG000|Overall Study|Withdrawal by Subject|7
7066324|NCT01973387|11166321|FG001|Overall Study|Withdrawal by Subject|4
7066325|NCT01973387|11166320|FG000|Overall Study|Study terminated by sponsor|63
7066326|NCT01973387|11166321|FG001|Overall Study|Study terminated by sponsor|0
7066327|NCT01973387|11166320|FG000|Overall Study|Progressive disease or relapse|16
7066328|NCT01973387|11166321|FG001|Overall Study|Progressive disease or relapse|5
7066329|NCT01973387|11166320|FG000|Overall Study|Death|4
7066330|NCT01973387|11166321|FG001|Overall Study|Death|3
7066331|NCT01973387|11166320|FG000|Overall Study|Randomized, not treated|2
7066332|NCT01973387|11166321|FG001|Overall Study|Randomized, not treated|2
7066333|NCT01973439|11166337|FG000|Overall Study|Lost samples from one PK Day|2
7066334|NCT01973439|11166337|FG000|Overall Study|Vomiting after commencing once daily|1
7066335|NCT01973439|11166337|FG000|Overall Study|PK curve incomplete|2
7066336|NCT01973491|11166341|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17
7066337|NCT01973491|11166341|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1
7066338|NCT01973491|11166341|FG000|Treatment Period (16 Weeks)|Adverse Event|1
7066339|NCT01973569|11166348|FG000|Overall Study|Adverse Event|9
7066340|NCT01973569|11166349|FG001|Overall Study|Adverse Event|2
7066341|NCT01973569|11166350|FG002|Overall Study|Adverse Event|4
7066342|NCT01973569|11166348|FG000|Overall Study|Protocol Violation|2
7066343|NCT01973569|11166349|FG001|Overall Study|Protocol Violation|1
7066344|NCT01973569|11166350|FG002|Overall Study|Protocol Violation|3
7066345|NCT01973569|11166348|FG000|Overall Study|Withdrawal by Subject|7
7066346|NCT01973569|11166349|FG001|Overall Study|Withdrawal by Subject|5
7066347|NCT01973569|11166350|FG002|Overall Study|Withdrawal by Subject|2
7066348|NCT01973569|11166348|FG000|Overall Study|Invasive dental treatment|3
6936263|NCT00908583|10970027|FG000|Phase 4|Adverse Event|1
6936264|NCT00908583|10970027|FG000|Phase 4|Physician Decision|1
7066349|NCT01973569|11166349|FG001|Overall Study|Invasive dental treatment|5
7066350|NCT01973569|11166350|FG002|Overall Study|Invasive dental treatment|6
7066351|NCT01973569|11166348|FG000|Overall Study|Prohibited concomitant d|1
7066352|NCT01973569|11166349|FG001|Overall Study|Prohibited concomitant d|5
7066353|NCT01973569|11166350|FG002|Overall Study|Prohibited concomitant d|0
7066354|NCT01973569|11166348|FG000|Overall Study|Disease progression|0
7066355|NCT01973569|11166349|FG001|Overall Study|Disease progression|3
7066356|NCT01973569|11166350|FG002|Overall Study|Disease progression|0
7066357|NCT01973569|11166348|FG000|Overall Study|Other|1
7066358|NCT01973569|11166349|FG001|Overall Study|Other|1
7066359|NCT01973569|11166350|FG002|Overall Study|Other|0
7066360|NCT01973569|11166348|FG000|Overall Study|Did not receive study drug|6
7066361|NCT01973569|11166349|FG001|Overall Study|Did not receive study drug|3
7066362|NCT01973569|11166350|FG002|Overall Study|Did not receive study drug|3
7066363|NCT01973595|11166362|FG000|Washout|Withdrawal by Subject|1
7066364|NCT01973595|11166363|FG001|Washout|Withdrawal by Subject|0
7066365|NCT01973595|11166364|FG002|Washout|Withdrawal by Subject|1
7066366|NCT01973595|11166365|FG003|Washout|Withdrawal by Subject|0
7066367|NCT01973998|11166412|FG000|Overall Study|Death|2
7066368|NCT01973998|11166413|FG001|Overall Study|Death|2
7066369|NCT01974141|11166447|FG000|Overall Study|Other Reasons|28
7066370|NCT01974141|11166448|FG001|Overall Study|Other Reasons|18
7066371|NCT01974141|11166447|FG000|Overall Study|Protocol Violation|2
7066372|NCT01974141|11166448|FG001|Overall Study|Protocol Violation|6
7066373|NCT01974141|11166447|FG000|Overall Study|Personal Reasons|21
7066374|NCT01974141|11166448|FG001|Overall Study|Personal Reasons|20
7066375|NCT01974141|11166447|FG000|Overall Study|Lost to Follow-up|38
7066376|NCT01974141|11166448|FG001|Overall Study|Lost to Follow-up|29
6936265|NCT00908583|10970027|FG000|Phase 5|Adverse Event|3
6936266|NCT00908596|10970049|FG000|Overall Study|Other reasons|46
6936267|NCT00908596|10970050|FG001|Overall Study|Other reasons|6
6936268|NCT00908596|10970051|FG002|Overall Study|Other reasons|2
6936269|NCT00908596|10970052|FG003|Overall Study|Other reasons|0
6936270|NCT00908596|10970049|FG000|Overall Study|Lost to Follow-up|0
6936271|NCT00908596|10970050|FG001|Overall Study|Lost to Follow-up|1
6936272|NCT00908596|10970051|FG002|Overall Study|Lost to Follow-up|12
6936273|NCT00908596|10970052|FG003|Overall Study|Lost to Follow-up|4
6936274|NCT00908596|10970049|FG000|Overall Study|Death|0
6936275|NCT00908596|10970050|FG001|Overall Study|Death|5
6936276|NCT00908596|10970051|FG002|Overall Study|Death|57
6936277|NCT00908596|10970052|FG003|Overall Study|Death|32
6936278|NCT00908596|10970049|FG000|Overall Study|Protocol Violation|1
6936279|NCT00908596|10970050|FG001|Overall Study|Protocol Violation|0
6936280|NCT00908596|10970051|FG002|Overall Study|Protocol Violation|0
6936281|NCT00908596|10970052|FG003|Overall Study|Protocol Violation|0
6936282|NCT00908596|10970049|FG000|Overall Study|Withdrawal by Subject|0
6936283|NCT00908596|10970050|FG001|Overall Study|Withdrawal by Subject|1
6936284|NCT00908596|10970051|FG002|Overall Study|Withdrawal by Subject|3
6936285|NCT00908596|10970052|FG003|Overall Study|Withdrawal by Subject|1
6936286|NCT00908895|10970095|FG000|Overall Study|Lost to Follow-up|1
6936287|NCT00908895|10970096|FG001|Overall Study|Lost to Follow-up|3
6936288|NCT00908895|10970095|FG000|Overall Study|algodystrophy|2
6936289|NCT00908895|10970096|FG001|Overall Study|algodystrophy|2
6936290|NCT00908895|10970095|FG000|Overall Study|Adverse Event|1
6936291|NCT00908895|10970096|FG001|Overall Study|Adverse Event|1
6936292|NCT00908960|10970114|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1
6936293|NCT00908960|10970115|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1
6936294|NCT00908960|10970116|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2
6936295|NCT00909038|10970124|FG000|Overall Study|Protocol Violation|187
6936296|NCT00909038|10970124|FG000|Overall Study|Non-evaluable Subjects|230
6936297|NCT00909090|10970134|FG000|Overall Study|Lost to Follow-up|17
6936298|NCT00909090|10970135|FG001|Overall Study|Lost to Follow-up|17
6936299|NCT00909181|10970163|FG000|Overall Study|Lost to Follow-up|39
6936300|NCT00909181|10970164|FG001|Overall Study|Lost to Follow-up|18
6936301|NCT00909181|10970165|FG002|Overall Study|Lost to Follow-up|33
6936302|NCT00909363|10970196|FG000|Overall Study|Withdrawal by Subject|1
7066377|NCT01974141|11166447|FG000|Overall Study|Pregnancy|3
7066378|NCT01974141|11166448|FG001|Overall Study|Pregnancy|3
7066379|NCT01974141|11166447|FG000|Overall Study|Lack of Efficacy|0
7066380|NCT01974141|11166448|FG001|Overall Study|Lack of Efficacy|1
7066381|NCT01974141|11166447|FG000|Overall Study|Adverse Event|4
7066382|NCT01974141|11166448|FG001|Overall Study|Adverse Event|5
7066383|NCT01974323|11166465|FG000|Overall Study|Other Reasons|25
7066384|NCT01974323|11166466|FG001|Overall Study|Other Reasons|28
7066385|NCT01974323|11166465|FG000|Overall Study|Protocol Violation|2
7066386|NCT01974323|11166466|FG001|Overall Study|Protocol Violation|2
7066387|NCT01974323|11166465|FG000|Overall Study|Personal Reasons|15
7066388|NCT01974323|11166466|FG001|Overall Study|Personal Reasons|19
7066389|NCT01974323|11166465|FG000|Overall Study|Lost to Follow-up|45
7066390|NCT01974323|11166466|FG001|Overall Study|Lost to Follow-up|40
7066391|NCT01974323|11166465|FG000|Overall Study|Pregnancy|2
7066392|NCT01974323|11166466|FG001|Overall Study|Pregnancy|1
7066393|NCT01974323|11166465|FG000|Overall Study|Lack of Efficacy|1
6936303|NCT00909363|10970197|FG001|Overall Study|Withdrawal by Subject|0
6936304|NCT00909363|10970198|FG002|Overall Study|Withdrawal by Subject|0
6936305|NCT00909363|10970196|FG000|Overall Study|Lack of Efficacy|1
6936306|NCT00909363|10970197|FG001|Overall Study|Lack of Efficacy|0
6936307|NCT00909363|10970198|FG002|Overall Study|Lack of Efficacy|0
7066394|NCT01974323|11166466|FG001|Overall Study|Lack of Efficacy|1
7066395|NCT01974323|11166465|FG000|Overall Study|Adverse Event|2
7066396|NCT01974323|11166466|FG001|Overall Study|Adverse Event|2
6936308|NCT00909428|10970212|FG000|Overall Study|Lost to Follow-up|13
6936309|NCT00909428|10970213|FG001|Overall Study|Lost to Follow-up|10
6936310|NCT00909428|10970214|FG002|Overall Study|Lost to Follow-up|9
6936311|NCT00909480|10970223|FG000|Overall Study|Adverse Event|5
6936312|NCT00909480|10970224|FG001|Overall Study|Adverse Event|3
7066397|NCT01974752|11166612|FG000|Overall Study|Death|33
7066398|NCT01974752|11166613|FG001|Overall Study|Death|11
7066399|NCT01974752|11166612|FG000|Overall Study|Lost to Follow-up|2
7066400|NCT01974752|11166613|FG001|Overall Study|Lost to Follow-up|0
7066401|NCT01974752|11166612|FG000|Overall Study|Withdrawal by Subject|2
7147683|NCT03131895|11308242|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
7147684|NCT03131999|11308254|FG000|Overall Study|Withdrawal by Subject|0
7147685|NCT03131999|11308255|FG001|Overall Study|Withdrawal by Subject|1
7147686|NCT03132220|11308263|FG000|Overall Study|Lost to Follow-up|17
7147687|NCT03132220|11308264|FG001|Overall Study|Lost to Follow-up|8
7147688|NCT03132220|11308263|FG000|Overall Study|Withdrawal by Subject|1
7147689|NCT03132220|11308264|FG001|Overall Study|Withdrawal by Subject|4
7147690|NCT03133481|11308299|FG000|Overall Study|FC Catheter fell out post operative day1|0
7147691|NCT03133481|11308300|FG001|Overall Study|FC Catheter fell out post operative day1|4
7147692|NCT03133767|11308352|FG000|Overall Study|Lost to Follow-up|38
7147693|NCT03133767|11308353|FG001|Overall Study|Lost to Follow-up|24
7147694|NCT03133767|11308352|FG000|Overall Study|Protocol Violation|0
7147695|NCT03133767|11308353|FG001|Overall Study|Protocol Violation|1
7183763|NCT01254422|11383827|FG000|Overall Study|Lost to Follow-up|1
7183764|NCT01254422|11383828|FG001|Overall Study|Lost to Follow-up|0
7183765|NCT01187433|11383836|FG000|Overall Study|Protocol Violation|6
7183766|NCT01187433|11383837|FG001|Overall Study|Protocol Violation|2
7183767|NCT01187433|11383836|FG000|Overall Study|Withdrawal by Subject|5
7183768|NCT01187433|11383837|FG001|Overall Study|Withdrawal by Subject|2
7187154|NCT02561962|11387631|FG000|Overall Study|Decision by sponsor|0
7187155|NCT02561962|11387632|FG001|Overall Study|Decision by sponsor|0
7187156|NCT02561962|11387633|FG002|Overall Study|Decision by sponsor|0
7187157|NCT02561962|11387634|FG003|Overall Study|Decision by sponsor|0
7187158|NCT02561962|11387635|FG004|Overall Study|Decision by sponsor|1
7187159|NCT02561962|11387636|FG005|Overall Study|Decision by sponsor|1
7187160|NCT02561962|11387637|FG006|Overall Study|Decision by sponsor|0
7187161|NCT02561962|11387638|FG007|Overall Study|Decision by sponsor|3
7187162|NCT02561962|11387639|FG008|Overall Study|Decision by sponsor|0
7187163|NCT02561962|11387631|FG000|Overall Study|Lost to Follow-up|0
7187164|NCT02561962|11387632|FG001|Overall Study|Lost to Follow-up|0
7187165|NCT02561962|11387633|FG002|Overall Study|Lost to Follow-up|0
7187166|NCT02561962|11387634|FG003|Overall Study|Lost to Follow-up|0
7187167|NCT02561962|11387635|FG004|Overall Study|Lost to Follow-up|0
7187168|NCT02561962|11387636|FG005|Overall Study|Lost to Follow-up|1
7187169|NCT02561962|11387637|FG006|Overall Study|Lost to Follow-up|0
7187170|NCT02561962|11387638|FG007|Overall Study|Lost to Follow-up|0
7187171|NCT02561962|11387639|FG008|Overall Study|Lost to Follow-up|0
7187172|NCT02500589|11387661|FG000|Overall Study|Withdrawal by Subject|11
7187173|NCT02500589|11387662|FG001|Overall Study|Withdrawal by Subject|14
7187174|NCT02500589|11387661|FG000|Overall Study|Lost to Follow-up|10
7187175|NCT02500589|11387662|FG001|Overall Study|Lost to Follow-up|12
7187176|NCT02500589|11387661|FG000|Overall Study|Excluded post rand: cognitive impairment|0
7187177|NCT02500589|11387662|FG001|Overall Study|Excluded post rand: cognitive impairment|1
7187178|NCT02500589|11387661|FG000|Overall Study|Death|7
7187179|NCT02500589|11387662|FG001|Overall Study|Death|5
7187180|NCT02474329|11387672|FG000|Overall Study|Withdraw or did not contribute data.|13
7187181|NCT01388491|11387702|FG000|Overall Study|Adverse Event|10
7187182|NCT01388491|11387703|FG001|Overall Study|Adverse Event|9
7187183|NCT01388491|11387702|FG000|Overall Study|Sponsor Request|9
7187184|NCT01388491|11387703|FG001|Overall Study|Sponsor Request|7
7187185|NCT01388491|11387702|FG000|Overall Study|Withdrawal by Subject|6
7187186|NCT01388491|11387703|FG001|Overall Study|Withdrawal by Subject|10
7187187|NCT01388491|11387702|FG000|Overall Study|Lost to Follow-up|4
7187188|NCT01388491|11387703|FG001|Overall Study|Lost to Follow-up|3
7187189|NCT01388491|11387702|FG000|Overall Study|Protocol Violation|2
7187190|NCT01388491|11387703|FG001|Overall Study|Protocol Violation|0
7187191|NCT01388491|11387702|FG000|Overall Study|Noncompliance|2
7187192|NCT01388491|11387703|FG001|Overall Study|Noncompliance|0
7187193|NCT01388491|11387702|FG000|Overall Study|Pregnancy|1
7187194|NCT01388491|11387703|FG001|Overall Study|Pregnancy|0
7187195|NCT01373151|11387716|FG000|Period 1|Lack of Efficacy|3
7187196|NCT01373151|11387717|FG001|Period 1|Lack of Efficacy|0
7187197|NCT01373151|11387718|FG002|Period 1|Lack of Efficacy|0
7187198|NCT01373151|11387719|FG003|Period 1|Lack of Efficacy|0
7187199|NCT01373151|11387720|FG004|Period 1|Lack of Efficacy|1
7187200|NCT01373151|11387721|FG005|Period 1|Lack of Efficacy|0
7187201|NCT01373151|11387722|FG006|Period 1|Lack of Efficacy|0
7187202|NCT01373151|11387716|FG000|Period 1|Adverse Event|0
7187203|NCT01373151|11387717|FG001|Period 1|Adverse Event|0
7187204|NCT01373151|11387718|FG002|Period 1|Adverse Event|1
7187205|NCT01373151|11387719|FG003|Period 1|Adverse Event|0
7187206|NCT01373151|11387720|FG004|Period 1|Adverse Event|4
7187207|NCT01373151|11387721|FG005|Period 1|Adverse Event|3
6936313|NCT00909480|10970223|FG000|Overall Study|Protocol Violation|6
6936314|NCT00909480|10970224|FG001|Overall Study|Protocol Violation|8
7187208|NCT01373151|11387722|FG006|Period 1|Adverse Event|0
7187209|NCT01373151|11387716|FG000|Period 1|Withdrawal by Subject|2
6936315|NCT00909480|10970223|FG000|Overall Study|Withdrawal criteria|9
6936316|NCT00909480|10970224|FG001|Overall Study|Withdrawal criteria|11
6936317|NCT00909480|10970223|FG000|Overall Study|Unclassified|18
6936318|NCT00909480|10970224|FG001|Overall Study|Unclassified|19
6936319|NCT00909532|10970232|FG000|Overall Study|Adverse Event|4
6936320|NCT00909532|10970233|FG001|Overall Study|Adverse Event|1
6936321|NCT00909532|10970232|FG000|Overall Study|Pregnancy|0
6936322|NCT00909532|10970233|FG001|Overall Study|Pregnancy|1
6936323|NCT00909532|10970232|FG000|Overall Study|Prohibited Medication|2
6936324|NCT00909532|10970233|FG001|Overall Study|Prohibited Medication|1
6936325|NCT00909532|10970232|FG000|Overall Study|Withdrawal of Consent|1
6936326|NCT00909532|10970233|FG001|Overall Study|Withdrawal of Consent|1
6936327|NCT00909532|10970232|FG000|Overall Study|Noncompliance with Study Requirements|0
6936328|NCT00909532|10970233|FG001|Overall Study|Noncompliance with Study Requirements|2
6936329|NCT00909532|10970232|FG000|Overall Study|Physician Decision|1
6936330|NCT00909532|10970233|FG001|Overall Study|Physician Decision|0
6936331|NCT00909532|10970232|FG000|Overall Study|Wrong Genotype|1
6936332|NCT00909532|10970233|FG001|Overall Study|Wrong Genotype|0
7066402|NCT01974752|11166613|FG001|Overall Study|Withdrawal by Subject|3
7066403|NCT01974752|11166612|FG000|Overall Study|Other Eligibility Criteria|0
7066404|NCT01974752|11166613|FG001|Overall Study|Other Eligibility Criteria|1
7066405|NCT01974817|11166619|FG000|Overall Study|Death|4
7066406|NCT01974817|11166619|FG000|Overall Study|Lost to Follow-up|2
7066407|NCT01974817|11166619|FG000|Overall Study|Protocol Violation|2
7066408|NCT01974895|11166625|FG000|Overall Study|Protocol Violation|1
7066409|NCT01974895|11166626|FG001|Overall Study|Protocol Violation|0
7066410|NCT01974895|11166625|FG000|Overall Study|Lost to Follow-up|4
7066411|NCT01974895|11166626|FG001|Overall Study|Lost to Follow-up|6
7066412|NCT01974895|11166625|FG000|Overall Study|Withdrawal by Subject|0
7066413|NCT01974895|11166626|FG001|Overall Study|Withdrawal by Subject|1
7066414|NCT01974895|11166625|FG000|Overall Study|Other (Missed Visit)|1
7066415|NCT01974895|11166626|FG001|Overall Study|Other (Missed Visit)|0
7066416|NCT01974895|11166625|FG000|Overall Study|Other (Reason unknown)|9
7066417|NCT01974895|11166626|FG001|Overall Study|Other (Reason unknown)|8
7066418|NCT01975220|11166645|FG000|Test Period 1|Not treated|0
7066419|NCT01975220|11166646|FG001|Test Period 1|Not treated|1
7066420|NCT01975220|11166647|FG002|Test Period 1|Not treated|0
7066421|NCT01975220|11166648|FG003|Test Period 1|Not treated|0
7066422|NCT01975220|11166649|FG004|Test Period 1|Not treated|0
7066423|NCT01975220|11166650|FG005|Test Period 1|Not treated|0
7082506|NCT02141854|11192968|FG005|Treatment Period|Adverse Event|2
7082507|NCT02141854|11192963|FG000|Treatment Period|Withdrawal by Subject|0
7082508|NCT02141854|11192964|FG001|Treatment Period|Withdrawal by Subject|2
7082509|NCT02141854|11192965|FG002|Treatment Period|Withdrawal by Subject|3
7082510|NCT02141854|11192966|FG003|Treatment Period|Withdrawal by Subject|3
7082511|NCT02141854|11192967|FG004|Treatment Period|Withdrawal by Subject|4
7082512|NCT02141854|11192968|FG005|Treatment Period|Withdrawal by Subject|7
7082513|NCT02141854|11192963|FG000|Treatment Period|Disease progression|0
7082514|NCT02141854|11192964|FG001|Treatment Period|Disease progression|2
7082515|NCT02141854|11192965|FG002|Treatment Period|Disease progression|1
7082516|NCT02141854|11192966|FG003|Treatment Period|Disease progression|3
7082517|NCT02141854|11192967|FG004|Treatment Period|Disease progression|0
7082518|NCT02141854|11192968|FG005|Treatment Period|Disease progression|18
7082519|NCT02141854|11192963|FG000|Treatment Period|Lost to Follow-up|0
7082520|NCT02141854|11192964|FG001|Treatment Period|Lost to Follow-up|1
7082521|NCT02141854|11192965|FG002|Treatment Period|Lost to Follow-up|1
7082522|NCT02141854|11192966|FG003|Treatment Period|Lost to Follow-up|1
7082523|NCT02141854|11192967|FG004|Treatment Period|Lost to Follow-up|0
7082524|NCT02141854|11192968|FG005|Treatment Period|Lost to Follow-up|1
7082525|NCT02141984|11192984|FG000|Overall Study|Lack of Efficacy|2
7082526|NCT02141997|11192992|FG000|Overall Study|Adverse Event|0
7082527|NCT02141997|11192993|FG001|Overall Study|Adverse Event|2
7082528|NCT02141997|11192994|FG002|Overall Study|Adverse Event|0
7082529|NCT02141997|11192995|FG003|Overall Study|Adverse Event|1
7082530|NCT02141997|11192992|FG000|Overall Study|Participant noncompliance|1
7082531|NCT02141997|11192993|FG001|Overall Study|Participant noncompliance|0
7082532|NCT02141997|11192994|FG002|Overall Study|Participant noncompliance|0
7082533|NCT02141997|11192995|FG003|Overall Study|Participant noncompliance|0
7082534|NCT02141997|11192992|FG000|Overall Study|Withdrew consent|1
7082535|NCT02141997|11192993|FG001|Overall Study|Withdrew consent|0
7082536|NCT02141997|11192994|FG002|Overall Study|Withdrew consent|3
7082537|NCT02141997|11192995|FG003|Overall Study|Withdrew consent|0
7082538|NCT02141997|11192992|FG000|Overall Study|Other|1
7082539|NCT02141997|11192993|FG001|Overall Study|Other|4
7082540|NCT02141997|11192994|FG002|Overall Study|Other|0
7082541|NCT02141997|11192995|FG003|Overall Study|Other|0
7082542|NCT02142283|11193084|FG000|Overall Study|Death|20
7082543|NCT02142283|11193085|FG001|Overall Study|Death|18
7082544|NCT02142283|11193084|FG000|Overall Study|Withdrawal by Subject|1
7082545|NCT02142283|11193085|FG001|Overall Study|Withdrawal by Subject|3
7082546|NCT02142387|11193106|FG000|Overall Study|<19 years old|49
6936333|NCT00909532|10970232|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1
6936334|NCT00909532|10970233|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0
6936335|NCT00909727|10970260|FG000|Overall Study|Adverse Event|1
6936336|NCT00909727|10970261|FG001|Overall Study|Adverse Event|0
6936337|NCT00909727|10970260|FG000|Overall Study|Wrong Genotype|1
6936338|NCT00909727|10970261|FG001|Overall Study|Wrong Genotype|0
6936339|NCT00909727|10970260|FG000|Overall Study|Withdrawal of Consent|1
6936340|NCT00909727|10970261|FG001|Overall Study|Withdrawal of Consent|0
6936341|NCT00909727|10970260|FG000|Overall Study|Prohibited Medication|1
6936342|NCT00909727|10970261|FG001|Overall Study|Prohibited Medication|0
6936343|NCT00909779|10970269|FG000|Overall Study|Adverse Event|53
6936344|NCT00909779|10970270|FG001|Overall Study|Adverse Event|55
6936345|NCT00909779|10970269|FG000|Overall Study|Lack of Efficacy|7
6936346|NCT00909779|10970270|FG001|Overall Study|Lack of Efficacy|4
6936347|NCT00909779|10970269|FG000|Overall Study|Lost to Follow-up|19
6936348|NCT00909779|10970270|FG001|Overall Study|Lost to Follow-up|15
6936349|NCT00909779|10970269|FG000|Overall Study|Physician Decision|8
6936350|NCT00909779|10970270|FG001|Overall Study|Physician Decision|2
6936351|NCT00909779|10970269|FG000|Overall Study|Protocol Violation|2
6936352|NCT00909779|10970270|FG001|Overall Study|Protocol Violation|5
6936353|NCT00909779|10970269|FG000|Overall Study|Withdrawal by Subject|116
6936354|NCT00909779|10970270|FG001|Overall Study|Withdrawal by Subject|80
6936355|NCT00909779|10970269|FG000|Overall Study|Site Ceasing Operation|2
6936356|NCT00909779|10970270|FG001|Overall Study|Site Ceasing Operation|2
6936357|NCT00909779|10970269|FG000|Overall Study|Medical Monitor Decision|1
6936358|NCT00909779|10970270|FG001|Overall Study|Medical Monitor Decision|0
6936359|NCT00909779|10970269|FG000|Overall Study|Noncompliance|1
7066424|NCT01975246|11166667|FG000|Overall Study|Adverse Event|2
7066425|NCT01975246|11166668|FG001|Overall Study|Adverse Event|1
7066426|NCT01975246|11166667|FG000|Overall Study|Lack of Efficacy|1
7066427|NCT01975246|11166668|FG001|Overall Study|Lack of Efficacy|0
7066428|NCT01975246|11166667|FG000|Overall Study|Protocol Violation|1
7066429|NCT01975246|11166668|FG001|Overall Study|Protocol Violation|0
7066430|NCT01975246|11166667|FG000|Overall Study|Other than stated|0
7066431|NCT01975246|11166668|FG001|Overall Study|Other than stated|1
7066432|NCT01975285|11166676|FG000|Overall Study|Failed Block and follow up|2
7066433|NCT01975285|11166677|FG001|Overall Study|Failed Block and follow up|2
7066434|NCT01975376|11166685|FG000|Overall Study|Adverse Event|5
7066435|NCT01975376|11166686|FG001|Overall Study|Adverse Event|5
7066436|NCT01975376|11166685|FG000|Overall Study|Death|65
7066437|NCT01975376|11166686|FG001|Overall Study|Death|72
7066438|NCT01975376|11166685|FG000|Overall Study|Lost to Follow-up|70
7066439|NCT01975376|11166686|FG001|Overall Study|Lost to Follow-up|66
7066440|NCT01975376|11166685|FG000|Overall Study|Withdrew consent|68
7066441|NCT01975376|11166686|FG001|Overall Study|Withdrew consent|62
7066442|NCT01975376|11166685|FG000|Overall Study|Other|2
7066443|NCT01975376|11166686|FG001|Overall Study|Other|4
7066444|NCT01975376|11166685|FG000|Overall Study|Randomized, Not Treated|16
7066445|NCT01975376|11166686|FG001|Overall Study|Randomized, Not Treated|8
7066446|NCT01975389|11166694|FG000|Overall Study|Adverse Event|10
7066447|NCT01975389|11166695|FG001|Overall Study|Adverse Event|6
7066448|NCT01975389|11166694|FG000|Overall Study|Death|61
7066449|NCT01975389|11166695|FG001|Overall Study|Death|54
7066450|NCT01975389|11166694|FG000|Overall Study|Lost to Follow-up|81
7066451|NCT01975389|11166695|FG001|Overall Study|Lost to Follow-up|86
7066452|NCT01975389|11166694|FG000|Overall Study|Withdrawal by Subject|90
7066453|NCT01975389|11166695|FG001|Overall Study|Withdrawal by Subject|76
7066454|NCT01975389|11166694|FG000|Overall Study|Other|6
7066455|NCT01975389|11166695|FG001|Overall Study|Other|9
7066456|NCT01975389|11166694|FG000|Overall Study|Randomized, not treated|4
7066457|NCT01975389|11166695|FG001|Overall Study|Randomized, not treated|5
7066458|NCT01975428|11166703|FG000|Overall Study|Lost to Follow-up|17
7066459|NCT01975428|11166704|FG001|Overall Study|Lost to Follow-up|4
7066460|NCT01975428|11166703|FG000|Overall Study|Withdrawal by Subject|3
7066461|NCT01975428|11166704|FG001|Overall Study|Withdrawal by Subject|10
7066462|NCT01975675|11166731|FG000|Overall Study|Death|0
7066463|NCT01975675|11166732|FG001|Overall Study|Death|1
7066464|NCT01975675|11166733|FG002|Overall Study|Death|0
7066465|NCT01975675|11166734|FG003|Overall Study|Death|0
7066466|NCT01975701|11166744|FG000|Overall Study|Lost to Follow-up|1
7066467|NCT01975701|11166744|FG000|Overall Study|Death|23
7066468|NCT01975701|11166744|FG000|Overall Study|Physician Decision|1
7066469|NCT01975831|11166757|FG000|Overall Study|Adverse Event|1
7066470|NCT01975831|11166758|FG001|Overall Study|Adverse Event|2
7066471|NCT01975831|11166759|FG002|Overall Study|Adverse Event|2
7066472|NCT01975831|11166760|FG003|Overall Study|Adverse Event|0
7066473|NCT01975831|11166761|FG004|Overall Study|Adverse Event|1
7066474|NCT01975831|11166762|FG005|Overall Study|Adverse Event|1
7066475|NCT01975831|11166763|FG006|Overall Study|Adverse Event|3
7066476|NCT01975831|11166764|FG007|Overall Study|Adverse Event|4
7066477|NCT01975831|11166765|FG008|Overall Study|Adverse Event|1
7066478|NCT01975831|11166757|FG000|Overall Study|Death|1
7066479|NCT01975831|11166758|FG001|Overall Study|Death|1
7066480|NCT01975831|11166759|FG002|Overall Study|Death|0
6936360|NCT00909779|10970270|FG001|Overall Study|Noncompliance|1
6936361|NCT00909779|10970269|FG000|Overall Study|Randomized in error|1
6936362|NCT00909779|10970270|FG001|Overall Study|Randomized in error|1
6936363|NCT00909792|10970278|FG000|Period 1|Did not meet inclusion criteria|0
6936364|NCT00909792|10970279|FG001|Period 1|Did not meet inclusion criteria|1
7066481|NCT01975831|11166760|FG003|Overall Study|Death|0
7066482|NCT01975831|11166761|FG004|Overall Study|Death|1
7066483|NCT01975831|11166762|FG005|Overall Study|Death|0
6936365|NCT00909792|10970278|FG000|Period 2|Biomicroscopy|1
6936366|NCT00909792|10970279|FG001|Period 2|Biomicroscopy|0
6936367|NCT00909792|10970278|FG000|Period 2|Lost to Follow-up|0
6936368|NCT00909792|10970279|FG001|Period 2|Lost to Follow-up|1
6936369|NCT00909844|10970285|FG000|Overall Study|Adverse Event|1
6936370|NCT00909844|10970285|FG000|Overall Study|Withdrawal by Subject|1
6936371|NCT00909844|10970285|FG000|Overall Study|Lost to Follow-up|2
6936372|NCT00909857|10970292|FG000|Overall Study|Withdrawal by Subject|6
6936373|NCT00909857|10970293|FG001|Overall Study|Withdrawal by Subject|10
6936374|NCT00909857|10970292|FG000|Overall Study|Adverse Event|5
6936375|NCT00909857|10970293|FG001|Overall Study|Adverse Event|5
6936376|NCT00909857|10970292|FG000|Overall Study|Lost to Follow-up|2
6936377|NCT00909857|10970293|FG001|Overall Study|Lost to Follow-up|5
6936378|NCT00909857|10970292|FG000|Overall Study|Protocol Violation|2
6936379|NCT00909857|10970293|FG001|Overall Study|Protocol Violation|1
6936380|NCT00909857|10970292|FG000|Overall Study|Pregnancy|1
6936381|NCT00909857|10970293|FG001|Overall Study|Pregnancy|0
6936382|NCT00909857|10970292|FG000|Overall Study|Other|1
6936383|NCT00909857|10970293|FG001|Overall Study|Other|0
6936384|NCT00909857|10970292|FG000|Overall Study|Did not receive study medication|19
6936385|NCT00909857|10970293|FG001|Overall Study|Did not receive study medication|24
6936386|NCT00909870|10970301|FG000|Overall Study|Adverse Event|13
6936387|NCT00909870|10970302|FG001|Overall Study|Adverse Event|7
6936388|NCT00909870|10970301|FG000|Overall Study|Protocol Violation|1
6936389|NCT00909870|10970302|FG001|Overall Study|Protocol Violation|2
6936390|NCT00909870|10970301|FG000|Overall Study|Withdrawal by Subject|5
6936391|NCT00909870|10970302|FG001|Overall Study|Withdrawal by Subject|8
6936392|NCT00909870|10970301|FG000|Overall Study|Lost to Follow-up|3
6936393|NCT00909870|10970302|FG001|Overall Study|Lost to Follow-up|3
7066484|NCT01975831|11166763|FG006|Overall Study|Death|1
7066485|NCT01975831|11166764|FG007|Overall Study|Death|0
7066486|NCT01975831|11166765|FG008|Overall Study|Death|0
7066487|NCT01975831|11166757|FG000|Overall Study|Progressive Disease|1
7066488|NCT01975831|11166758|FG001|Overall Study|Progressive Disease|3
7066489|NCT01975831|11166759|FG002|Overall Study|Progressive Disease|2
7066490|NCT01975831|11166760|FG003|Overall Study|Progressive Disease|4
7066491|NCT01975831|11166761|FG004|Overall Study|Progressive Disease|13
7066492|NCT01975831|11166762|FG005|Overall Study|Progressive Disease|9
7066493|NCT01975831|11166763|FG006|Overall Study|Progressive Disease|10
7066494|NCT01975831|11166764|FG007|Overall Study|Progressive Disease|8
7066495|NCT01975831|11166765|FG008|Overall Study|Progressive Disease|10
7066496|NCT01975831|11166757|FG000|Overall Study|Withdrawal by Subject|0
7066497|NCT01975831|11166758|FG001|Overall Study|Withdrawal by Subject|3
7066498|NCT01975831|11166759|FG002|Overall Study|Withdrawal by Subject|0
7066499|NCT01975831|11166760|FG003|Overall Study|Withdrawal by Subject|0
7066500|NCT01975831|11166761|FG004|Overall Study|Withdrawal by Subject|3
7066501|NCT01975831|11166762|FG005|Overall Study|Withdrawal by Subject|1
7066502|NCT01975831|11166763|FG006|Overall Study|Withdrawal by Subject|1
7066503|NCT01975831|11166764|FG007|Overall Study|Withdrawal by Subject|0
7066504|NCT01975831|11166765|FG008|Overall Study|Withdrawal by Subject|0
7066505|NCT01975831|11166757|FG000|Overall Study|Physician Decision|0
7066506|NCT01975831|11166758|FG001|Overall Study|Physician Decision|0
7066507|NCT01975831|11166759|FG002|Overall Study|Physician Decision|0
7066508|NCT01975831|11166760|FG003|Overall Study|Physician Decision|0
7066509|NCT01975831|11166761|FG004|Overall Study|Physician Decision|0
7066510|NCT01975831|11166762|FG005|Overall Study|Physician Decision|1
7066511|NCT01975831|11166763|FG006|Overall Study|Physician Decision|0
7066512|NCT01975831|11166764|FG007|Overall Study|Physician Decision|1
7066513|NCT01975831|11166765|FG008|Overall Study|Physician Decision|0
7066514|NCT01975831|11166757|FG000|Overall Study|Initiation of Subsequent Therapy|0
7066515|NCT01975831|11166758|FG001|Overall Study|Initiation of Subsequent Therapy|0
7066516|NCT01975831|11166759|FG002|Overall Study|Initiation of Subsequent Therapy|0
7066517|NCT01975831|11166760|FG003|Overall Study|Initiation of Subsequent Therapy|0
7066518|NCT01975831|11166761|FG004|Overall Study|Initiation of Subsequent Therapy|0
7066519|NCT01975831|11166762|FG005|Overall Study|Initiation of Subsequent Therapy|1
7066520|NCT01975831|11166763|FG006|Overall Study|Initiation of Subsequent Therapy|0
7066521|NCT01975831|11166764|FG007|Overall Study|Initiation of Subsequent Therapy|2
7066522|NCT01975831|11166765|FG008|Overall Study|Initiation of Subsequent Therapy|0
7066523|NCT01975831|11166757|FG000|Overall Study|Entered Hospice|0
7066524|NCT01975831|11166758|FG001|Overall Study|Entered Hospice|0
7066525|NCT01975831|11166759|FG002|Overall Study|Entered Hospice|0
7066526|NCT01975831|11166760|FG003|Overall Study|Entered Hospice|0
7066527|NCT01975831|11166761|FG004|Overall Study|Entered Hospice|0
7066528|NCT01975831|11166762|FG005|Overall Study|Entered Hospice|1
7066529|NCT01975831|11166763|FG006|Overall Study|Entered Hospice|0
6936394|NCT00909870|10970301|FG000|Overall Study|Physician Decision|0
6936395|NCT00909870|10970302|FG001|Overall Study|Physician Decision|2
7066530|NCT01975831|11166764|FG007|Overall Study|Entered Hospice|0
7066531|NCT01975831|11166765|FG008|Overall Study|Entered Hospice|0
7066532|NCT01975831|11166757|FG000|Overall Study|Unable to Treat Within Protocol Windows|0
7066533|NCT01975831|11166758|FG001|Overall Study|Unable to Treat Within Protocol Windows|0
6936396|NCT00909870|10970301|FG000|Overall Study|Other|1
6936397|NCT00909870|10970302|FG001|Overall Study|Other|5
6936398|NCT00910000|10970315|FG000|Overall Study|Adverse Event|0
6936399|NCT00910000|10970316|FG001|Overall Study|Adverse Event|3
6936400|NCT00910000|10970317|FG002|Overall Study|Adverse Event|2
6936401|NCT00910000|10970318|FG003|Overall Study|Adverse Event|2
6936402|NCT00910000|10970319|FG004|Overall Study|Adverse Event|0
6936403|NCT00910000|10970320|FG005|Overall Study|Adverse Event|1
6936404|NCT00910000|10970315|FG000|Overall Study|Withdrawal by Subject|0
6936405|NCT00910000|10970316|FG001|Overall Study|Withdrawal by Subject|0
6936406|NCT00910000|10970317|FG002|Overall Study|Withdrawal by Subject|1
6936407|NCT00910000|10970318|FG003|Overall Study|Withdrawal by Subject|0
6936408|NCT00910000|10970319|FG004|Overall Study|Withdrawal by Subject|1
6936409|NCT00910000|10970320|FG005|Overall Study|Withdrawal by Subject|0
6936410|NCT00910039|10970330|FG000|Overall Study|Physician Decision|1
6936411|NCT00910091|10970337|FG000|Pre-assignment|Withdrawal by Subject|0
6936412|NCT00910091|10970338|FG001|Pre-assignment|Withdrawal by Subject|2
6936413|NCT00910091|10970337|FG000|Treatment and Survival|Withdrawal by Subject|3
6936414|NCT00910091|10970338|FG001|Treatment and Survival|Withdrawal by Subject|4
6936415|NCT00910091|10970337|FG000|Treatment and Survival|Adverse Event|1
6936416|NCT00910091|10970338|FG001|Treatment and Survival|Adverse Event|0
6936417|NCT00910247|10970358|FG000|Overall Study|Adverse Event|15
6936418|NCT00910247|10970358|FG000|Overall Study|Death|2
6936419|NCT00910247|10970358|FG000|Overall Study|Lost to Follow-up|10
6936420|NCT00910247|10970358|FG000|Overall Study|Physician Decision|3
6936421|NCT00910247|10970358|FG000|Overall Study|Protocol Violation|10
6936422|NCT00910247|10970358|FG000|Overall Study|Withdrawal by Subject|25
6936423|NCT00910247|10970358|FG000|Overall Study|Not collected|4
6936424|NCT00910273|10970364|FG000|Overall Study|Lack of Efficacy|6
6936425|NCT00910273|10970365|FG001|Overall Study|Lack of Efficacy|9
6936426|NCT00910273|10970364|FG000|Overall Study|Adverse Event|1
6936427|NCT00910273|10970365|FG001|Overall Study|Adverse Event|1
6936428|NCT00910273|10970364|FG000|Overall Study|Withdrawal by Subject|1
6936429|NCT00910273|10970365|FG001|Overall Study|Withdrawal by Subject|0
6936430|NCT00910273|10970364|FG000|Overall Study|Discontinuation of study by sponsor|8
6936431|NCT00910273|10970365|FG001|Overall Study|Discontinuation of study by sponsor|2
7066534|NCT01975831|11166759|FG002|Overall Study|Unable to Treat Within Protocol Windows|0
7066535|NCT01975831|11166760|FG003|Overall Study|Unable to Treat Within Protocol Windows|0
7066536|NCT01975831|11166761|FG004|Overall Study|Unable to Treat Within Protocol Windows|0
7066537|NCT01975831|11166762|FG005|Overall Study|Unable to Treat Within Protocol Windows|0
7066538|NCT01975831|11166763|FG006|Overall Study|Unable to Treat Within Protocol Windows|1
7066539|NCT01975831|11166764|FG007|Overall Study|Unable to Treat Within Protocol Windows|0
7066540|NCT01975831|11166765|FG008|Overall Study|Unable to Treat Within Protocol Windows|1
7066541|NCT01975948|11166816|FG000|Overall Study|Withdrawal by Subject|17
7066542|NCT01975948|11166817|FG001|Overall Study|Withdrawal by Subject|21
7066543|NCT01975948|11166818|FG002|Overall Study|Withdrawal by Subject|7
7066544|NCT01975948|11166819|FG003|Overall Study|Withdrawal by Subject|6
7066545|NCT01976104|11166837|FG000|Overall Study|Adverse Event|0
7066546|NCT01976104|11166838|FG001|Overall Study|Adverse Event|0
7066547|NCT01976104|11166839|FG002|Overall Study|Adverse Event|1
7066548|NCT01976104|11166840|FG003|Overall Study|Adverse Event|0
7066549|NCT01976104|11166837|FG000|Overall Study|Lost to Follow-up|3
7066550|NCT01976104|11166838|FG001|Overall Study|Lost to Follow-up|0
7066551|NCT01976104|11166839|FG002|Overall Study|Lost to Follow-up|1
7066552|NCT01976104|11166840|FG003|Overall Study|Lost to Follow-up|1
7066553|NCT01976104|11166837|FG000|Overall Study|Subject Choice|0
7066554|NCT01976104|11166838|FG001|Overall Study|Subject Choice|1
7066555|NCT01976104|11166839|FG002|Overall Study|Subject Choice|0
7066556|NCT01976104|11166840|FG003|Overall Study|Subject Choice|1
7066557|NCT01976104|11166837|FG000|Overall Study|Withdrawal by Subject|3
7066558|NCT01976104|11166838|FG001|Overall Study|Withdrawal by Subject|0
7066559|NCT01976104|11166839|FG002|Overall Study|Withdrawal by Subject|0
7066560|NCT01976104|11166840|FG003|Overall Study|Withdrawal by Subject|1
7066561|NCT01976104|11166837|FG000|Overall Study|Other|0
7066562|NCT01976104|11166838|FG001|Overall Study|Other|1
7066563|NCT01976104|11166839|FG002|Overall Study|Other|0
7066564|NCT01976104|11166840|FG003|Overall Study|Other|0
7066565|NCT01976299|11166853|FG000|Overall Study|Withdrawal by Subject|3
7066566|NCT01976299|11166854|FG001|Overall Study|Withdrawal by Subject|1
7066567|NCT01976299|11166853|FG000|Overall Study|Death|4
7066568|NCT01976299|11166854|FG001|Overall Study|Death|2
7066569|NCT01976299|11166853|FG000|Overall Study|Lost to Follow-up|7
7066570|NCT01976299|11166854|FG001|Overall Study|Lost to Follow-up|1
7066571|NCT01976299|11166853|FG000|Overall Study|See clarification above in comments|9
7066572|NCT01976299|11166854|FG001|Overall Study|See clarification above in comments|2
7066573|NCT01976312|11166862|FG000|Overall Study|Pregnancy|0
6936432|NCT00910273|10970364|FG000|Overall Study|Protocol Violation|1
7066574|NCT01976312|11166863|FG001|Overall Study|Pregnancy|1
7066575|NCT01976312|11166862|FG000|Overall Study|Lost to Follow-up|2
7066576|NCT01976312|11166863|FG001|Overall Study|Lost to Follow-up|0
7066577|NCT01976312|11166862|FG000|Overall Study|Withdrawal by Subject|7
7066578|NCT01976312|11166863|FG001|Overall Study|Withdrawal by Subject|2
7066579|NCT01976312|11166862|FG000|Overall Study|Adverse Event|6
7066580|NCT01976312|11166863|FG001|Overall Study|Adverse Event|6
6936433|NCT00910273|10970365|FG001|Overall Study|Protocol Violation|0
6936434|NCT00910273|10970364|FG000|Overall Study|Lost to Follow-up|1
6936435|NCT00910273|10970365|FG001|Overall Study|Lost to Follow-up|1
7066581|NCT01976312|11166862|FG000|Overall Study|Protocol Violation|2
7066582|NCT01976312|11166863|FG001|Overall Study|Protocol Violation|0
6936436|NCT00910299|10970373|FG000|Overall Study|Withdrawal by Subject|16
6936437|NCT00910299|10970374|FG001|Overall Study|Withdrawal by Subject|13
6936438|NCT00910299|10970373|FG000|Overall Study|Sponsor Decision|58
6936439|NCT00910299|10970374|FG001|Overall Study|Sponsor Decision|60
6936440|NCT00910299|10970373|FG000|Overall Study|Didn't receive any study drug|2
6936441|NCT00910299|10970374|FG001|Overall Study|Didn't receive any study drug|1
6936442|NCT00910429|10970382|FG000|Overall Study|Death|18
6936443|NCT00910429|10970383|FG001|Overall Study|Death|12
6936444|NCT00910429|10970382|FG000|Overall Study|Withdrawal by Subject|3
6936445|NCT00910429|10970383|FG001|Overall Study|Withdrawal by Subject|2
6936446|NCT00910429|10970382|FG000|Overall Study|Protocol Violation|1
6936447|NCT00910429|10970383|FG001|Overall Study|Protocol Violation|0
6936448|NCT00910429|10970382|FG000|Overall Study|Lost to Follow-up|2
6936449|NCT00910429|10970383|FG001|Overall Study|Lost to Follow-up|1
6936450|NCT00910429|10970382|FG000|Overall Study|Adverse Event|10
6936451|NCT00910429|10970383|FG001|Overall Study|Adverse Event|5
6936452|NCT00910429|10970382|FG000|Overall Study|Drug non-compliance|1
6936453|NCT00910429|10970383|FG001|Overall Study|Drug non-compliance|0
6936454|NCT00910429|10970382|FG000|Overall Study|Lack of Efficacy|4
6936455|NCT00910429|10970383|FG001|Overall Study|Lack of Efficacy|1
6936456|NCT00910624|10970411|FG000|Treatment Phase|Adverse Event|2
6936457|NCT00910624|10970412|FG001|Treatment Phase|Adverse Event|6
6936458|NCT00910624|10970413|FG002|Treatment Phase|Adverse Event|6
6936459|NCT00910624|10970414|FG003|Treatment Phase|Adverse Event|0
6936460|NCT00910624|10970411|FG000|Treatment Phase|Treatment Failure|23
6936461|NCT00910624|10970412|FG001|Treatment Phase|Treatment Failure|10
6936462|NCT00910624|10970413|FG002|Treatment Phase|Treatment Failure|0
7066583|NCT01976338|11166872|FG000|Overall Study|Physician Decision|0
7066584|NCT01976338|11166873|FG001|Overall Study|Physician Decision|1
7066585|NCT01976338|11166872|FG000|Overall Study|Lost to Follow-up|3
7040113|NCT01715805|11123024|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10
7040114|NCT01715805|11123021|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0
7040115|NCT01715805|11123022|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1
7040116|NCT01715805|11123023|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0
7066586|NCT01976338|11166873|FG001|Overall Study|Lost to Follow-up|0
7066587|NCT01976338|11166872|FG000|Overall Study|Withdrawal by Subject|5
6936463|NCT00910624|10970414|FG003|Treatment Phase|Treatment Failure|0
6936464|NCT00910624|10970411|FG000|Treatment Phase|Lost to Follow-up|0
6936465|NCT00910624|10970412|FG001|Treatment Phase|Lost to Follow-up|0
6936466|NCT00910624|10970413|FG002|Treatment Phase|Lost to Follow-up|1
6936467|NCT00910624|10970414|FG003|Treatment Phase|Lost to Follow-up|0
6936468|NCT00910624|10970411|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
6936469|NCT00910624|10970412|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
7066588|NCT01976338|11166873|FG001|Overall Study|Withdrawal by Subject|2
7066589|NCT01976338|11166872|FG000|Overall Study|Adverse Event|5
7066590|NCT01976338|11166873|FG001|Overall Study|Adverse Event|1
7066591|NCT01976364|11166880|FG000|Main Study (36 Months)|Adverse Event|63
7066592|NCT01976364|11166881|FG001|Main Study (36 Months)|Adverse Event|0
7066593|NCT01976364|11166882|FG002|Main Study (36 Months)|Adverse Event|0
7066594|NCT01976364|11166880|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5
7066595|NCT01976364|11166881|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0
7066596|NCT01976364|11166882|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0
7066597|NCT01976364|11166880|FG000|Main Study (36 Months)|Other|13
7066598|NCT01976364|11166881|FG001|Main Study (36 Months)|Other|0
7066599|NCT01976364|11166882|FG002|Main Study (36 Months)|Other|0
7066600|NCT01976364|11166880|FG000|Main Study (36 Months)|No longer met eligibility criteria|2
7066601|NCT01976364|11166881|FG001|Main Study (36 Months)|No longer met eligibility criteria|0
7066602|NCT01976364|11166882|FG002|Main Study (36 Months)|No longer met eligibility criteria|0
7066603|NCT01976364|11166880|FG000|Main Study (36 Months)|Medication error|1
7066604|NCT01976364|11166881|FG001|Main Study (36 Months)|Medication error|0
7066605|NCT01976364|11166882|FG002|Main Study (36 Months)|Medication error|0
7066606|NCT01976364|11166880|FG000|Main Study (36 Months)|Lost to Follow-up|10
7066607|NCT01976364|11166881|FG001|Main Study (36 Months)|Lost to Follow-up|0
7066608|NCT01976364|11166882|FG002|Main Study (36 Months)|Lost to Follow-up|0
7066609|NCT01976364|11166880|FG000|Main Study (36 Months)|Lack of Efficacy|40
7066610|NCT01976364|11166881|FG001|Main Study (36 Months)|Lack of Efficacy|0
7066611|NCT01976364|11166882|FG002|Main Study (36 Months)|Lack of Efficacy|0
7066612|NCT01976364|11166880|FG000|Main Study (36 Months)|Protocol Violation|13
7066613|NCT01976364|11166881|FG001|Main Study (36 Months)|Protocol Violation|0
7066614|NCT01976364|11166882|FG002|Main Study (36 Months)|Protocol Violation|0
7066615|NCT01976364|11166880|FG000|Main Study (36 Months)|Withdrawal by Subject|69
7066616|NCT01976364|11166881|FG001|Main Study (36 Months)|Withdrawal by Subject|0
7066617|NCT01976364|11166882|FG002|Main Study (36 Months)|Withdrawal by Subject|0
7066618|NCT01976364|11166880|FG000|Main Study (36 Months)|Death|5
7066619|NCT01976364|11166881|FG001|Main Study (36 Months)|Death|0
6936470|NCT00910624|10970413|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1
6936471|NCT00910624|10970414|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0
6936472|NCT00910624|10970411|FG000|Treatment Phase|Withdrawal by Subject|2
6936473|NCT00910624|10970412|FG001|Treatment Phase|Withdrawal by Subject|1
6936474|NCT00910624|10970413|FG002|Treatment Phase|Withdrawal by Subject|0
6936475|NCT00910624|10970414|FG003|Treatment Phase|Withdrawal by Subject|0
6936476|NCT00910624|10970411|FG000|Treatment Phase|Non-Compliance With Protocol|0
6936477|NCT00910624|10970412|FG001|Treatment Phase|Non-Compliance With Protocol|1
6936478|NCT00910624|10970413|FG002|Treatment Phase|Non-Compliance With Protocol|1
6936479|NCT00910624|10970414|FG003|Treatment Phase|Non-Compliance With Protocol|0
6936480|NCT00910624|10970411|FG000|Follow-Up Phase|Adverse Event|0
6936481|NCT00910624|10970412|FG001|Follow-Up Phase|Adverse Event|0
6936482|NCT00910624|10970413|FG002|Follow-Up Phase|Adverse Event|1
6936483|NCT00910624|10970414|FG003|Follow-Up Phase|Adverse Event|0
6936484|NCT00910624|10970411|FG000|Follow-Up Phase|Lost to Follow-up|3
6936485|NCT00910624|10970412|FG001|Follow-Up Phase|Lost to Follow-up|1
6936486|NCT00910624|10970413|FG002|Follow-Up Phase|Lost to Follow-up|2
6936487|NCT00910624|10970414|FG003|Follow-Up Phase|Lost to Follow-up|0
6936488|NCT00910624|10970411|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1
6936489|NCT00910624|10970412|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2
6936490|NCT00910624|10970413|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
6936491|NCT00910624|10970414|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
6936492|NCT00910624|10970411|FG000|Follow-Up Phase|Withdrawal by Subject|1
6936493|NCT00910624|10970412|FG001|Follow-Up Phase|Withdrawal by Subject|0
6936494|NCT00910624|10970413|FG002|Follow-Up Phase|Withdrawal by Subject|0
6936495|NCT00910624|10970414|FG003|Follow-Up Phase|Withdrawal by Subject|0
6936496|NCT00910624|10970411|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1
6936497|NCT00910624|10970412|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
6936498|NCT00910624|10970413|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
6936499|NCT00910624|10970414|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
6936500|NCT00910624|10970411|FG000|Follow-Up Phase|Administrative|0
6936501|NCT00910624|10970412|FG001|Follow-Up Phase|Administrative|1
7066620|NCT01976364|11166882|FG002|Main Study (36 Months)|Death|0
6936502|NCT00910624|10970413|FG002|Follow-Up Phase|Administrative|1
6936503|NCT00910624|10970414|FG003|Follow-Up Phase|Administrative|0
6936504|NCT00910663|10970424|FG000|Period 1|Withdrawal by Subject|0
7066621|NCT01976364|11166880|FG000|Sub-study (12 Months)|Lost to Follow-up|0
7066622|NCT01976364|11166881|FG001|Sub-study (12 Months)|Lost to Follow-up|1
7066623|NCT01976364|11166882|FG002|Sub-study (12 Months)|Lost to Follow-up|0
7066624|NCT01976364|11166880|FG000|Sub-study (12 Months)|Withdrawal by Subject|0
7066625|NCT01976364|11166881|FG001|Sub-study (12 Months)|Withdrawal by Subject|0
7066626|NCT01976364|11166882|FG002|Sub-study (12 Months)|Withdrawal by Subject|1
7066627|NCT01976364|11166880|FG000|Sub-study (12 Months)|Protocol Violation|0
7066628|NCT01976364|11166881|FG001|Sub-study (12 Months)|Protocol Violation|1
7066629|NCT01976364|11166882|FG002|Sub-study (12 Months)|Protocol Violation|1
7066630|NCT01976364|11166880|FG000|Sub-study (12 Months)|Adverse Event|0
7066631|NCT01976364|11166881|FG001|Sub-study (12 Months)|Adverse Event|4
7066632|NCT01976364|11166882|FG002|Sub-study (12 Months)|Adverse Event|3
7066633|NCT01976507|11166918|FG000|Overall Study|Adverse Event|6
7066634|NCT01976507|11166918|FG000|Overall Study|ablation not done, drug not given|1
7066635|NCT01976624|11166933|FG000|Overall Study|Participants contraindicated|2
7066636|NCT01976624|11166933|FG000|Overall Study|Participants age less than 19 years|12
7066637|NCT01976663|11166941|FG000|Overall Study|Completed 18 mos but no repeat treatment|24
7066638|NCT01976663|11166941|FG000|Overall Study|Personal Reasons|6
7066639|NCT01976663|11166941|FG000|Overall Study|Withdrawal by Subject|4
7066640|NCT01976663|11166941|FG000|Overall Study|Screen Failure|3
7066641|NCT01976663|11166941|FG000|Overall Study|Adverse Event|2
7066642|NCT01976663|11166941|FG000|Overall Study|Lost to Follow-up|3
7066643|NCT01976728|11166953|FG000|Overall Study|Subject missed multiple doses of IMP|1
7066644|NCT01976728|11166954|FG001|Overall Study|Subject missed multiple doses of IMP|0
7066645|NCT01976728|11166955|FG002|Overall Study|Subject missed multiple doses of IMP|0
7066646|NCT01976728|11166956|FG003|Overall Study|Subject missed multiple doses of IMP|0
7066647|NCT01976741|11166992|FG000|Overall Study|Withdrawal by Subject|1
7066648|NCT01976741|11166993|FG001|Overall Study|Withdrawal by Subject|0
7066649|NCT01976741|11166994|FG002|Overall Study|Withdrawal by Subject|1
7066650|NCT01976741|11166995|FG003|Overall Study|Withdrawal by Subject|1
7066651|NCT01976741|11166996|FG004|Overall Study|Withdrawal by Subject|0
7066652|NCT01976741|11166997|FG005|Overall Study|Withdrawal by Subject|0
7066653|NCT01976741|11166998|FG006|Overall Study|Withdrawal by Subject|1
7066654|NCT01976741|11166999|FG007|Overall Study|Withdrawal by Subject|4
7066655|NCT01976741|11167000|FG008|Overall Study|Withdrawal by Subject|0
7066656|NCT01976741|11167001|FG009|Overall Study|Withdrawal by Subject|0
7066657|NCT01976741|11166992|FG000|Overall Study|Adverse Event|0
7066658|NCT01976741|11166993|FG001|Overall Study|Adverse Event|0
7066659|NCT01976741|11166994|FG002|Overall Study|Adverse Event|2
7066660|NCT01976741|11166995|FG003|Overall Study|Adverse Event|0
7066661|NCT01976741|11166996|FG004|Overall Study|Adverse Event|0
7066662|NCT01976741|11166997|FG005|Overall Study|Adverse Event|0
7066663|NCT01976741|11166998|FG006|Overall Study|Adverse Event|3
7066664|NCT01976741|11166999|FG007|Overall Study|Adverse Event|8
7066665|NCT01976741|11167000|FG008|Overall Study|Adverse Event|1
7066666|NCT01976741|11167001|FG009|Overall Study|Adverse Event|4
6936505|NCT00910663|10970425|FG001|Period 1|Withdrawal by Subject|1
6936506|NCT00910689|10970435|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2
6936507|NCT00910689|10970436|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1
7147696|NCT03134183|11308392|FG000|Overall Study|Withdrawal by Subject|1
7066667|NCT01976806|11167037|FG000|Overall Study|Lost to Follow-up|1
7066668|NCT01976806|11167038|FG001|Overall Study|Lost to Follow-up|4
7066669|NCT01976806|11167037|FG000|Overall Study|Adverse Event|1
7066670|NCT01976806|11167038|FG001|Overall Study|Adverse Event|1
7066671|NCT01976806|11167037|FG000|Overall Study|Withdrawal by Subject|1
7066672|NCT01976806|11167038|FG001|Overall Study|Withdrawal by Subject|1
7066673|NCT01976845|11167056|FG000|Overall Study|Physician Decision|8
7066674|NCT01976845|11167057|FG001|Overall Study|Physician Decision|8
7066675|NCT01976845|11167058|FG002|Overall Study|Physician Decision|3
7066676|NCT01977040|11167090|FG000|Overall Study|Vasa previa not confirmed|2
7066677|NCT01977092|11167100|FG000|Overall Study|Death|3
7066678|NCT01977092|11167101|FG001|Overall Study|Death|4
7066679|NCT01977092|11167100|FG000|Overall Study|Lost to Follow-up|23
7066680|NCT01977092|11167101|FG001|Overall Study|Lost to Follow-up|14
7066681|NCT01977092|11167100|FG000|Overall Study|Withdrawal by Subject|2
7066682|NCT01977092|11167101|FG001|Overall Study|Withdrawal by Subject|1
7066683|NCT01977092|11167100|FG000|Overall Study|In prison|3
7066684|NCT01977092|11167101|FG001|Overall Study|In prison|11
7066685|NCT01977222|11167107|FG000|Overall Study|Withdrawal by Subject|1
7066686|NCT01977352|11167113|FG000|Overall Study|Lost to Follow-up|1
7066687|NCT01977352|11167114|FG001|Overall Study|Lost to Follow-up|2
7066688|NCT01977456|11167120|FG000|Overall Study|Death|5
7066689|NCT01977482|11167130|FG000|Overall Study|Adverse Event|0
7066690|NCT01977482|11167131|FG001|Overall Study|Adverse Event|1
7066691|NCT01977482|11167132|FG002|Overall Study|Adverse Event|1
7066692|NCT01977482|11167133|FG003|Overall Study|Adverse Event|0
7066693|NCT01977482|11167134|FG004|Overall Study|Adverse Event|2
7066694|NCT01977482|11167135|FG005|Overall Study|Adverse Event|0
7066695|NCT01977482|11167130|FG000|Overall Study|Lost to Follow-up|1
7066696|NCT01977482|11167131|FG001|Overall Study|Lost to Follow-up|0
7066697|NCT01977482|11167132|FG002|Overall Study|Lost to Follow-up|0
7066698|NCT01977482|11167133|FG003|Overall Study|Lost to Follow-up|0
7066699|NCT01977482|11167134|FG004|Overall Study|Lost to Follow-up|0
7066700|NCT01977482|11167135|FG005|Overall Study|Lost to Follow-up|0
7066701|NCT01977482|11167130|FG000|Overall Study|Physician Decision|0
7066702|NCT01977482|11167131|FG001|Overall Study|Physician Decision|1
7066703|NCT01977482|11167132|FG002|Overall Study|Physician Decision|0
7066704|NCT01977482|11167133|FG003|Overall Study|Physician Decision|0
7066705|NCT01977482|11167134|FG004|Overall Study|Physician Decision|0
7066706|NCT01977482|11167135|FG005|Overall Study|Physician Decision|0
7066707|NCT01977482|11167130|FG000|Overall Study|Protocol Violation|0
7066708|NCT01977482|11167131|FG001|Overall Study|Protocol Violation|0
7066709|NCT01977482|11167132|FG002|Overall Study|Protocol Violation|1
7066710|NCT01977482|11167133|FG003|Overall Study|Protocol Violation|0
7066711|NCT01977482|11167134|FG004|Overall Study|Protocol Violation|0
7066712|NCT01977482|11167135|FG005|Overall Study|Protocol Violation|0
7066713|NCT01977482|11167130|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0
7066714|NCT01977482|11167131|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3
7066715|NCT01977482|11167132|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2
7066716|NCT01977482|11167133|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1
7066717|NCT01977482|11167134|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0
7066718|NCT01977482|11167135|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0
7066719|NCT01977482|11167130|FG000|Overall Study|Withdrawal by Subject|2
7066720|NCT01977482|11167131|FG001|Overall Study|Withdrawal by Subject|4
7066721|NCT01977482|11167132|FG002|Overall Study|Withdrawal by Subject|1
7066722|NCT01977482|11167133|FG003|Overall Study|Withdrawal by Subject|3
7066723|NCT01977482|11167134|FG004|Overall Study|Withdrawal by Subject|1
7066724|NCT01977482|11167135|FG005|Overall Study|Withdrawal by Subject|5
7066725|NCT01977573|11167167|FG000|Overall Study|Adverse Event|7
7066726|NCT01977573|11167168|FG001|Overall Study|Adverse Event|0
7066727|NCT01977573|11167169|FG002|Overall Study|Adverse Event|2
7066728|NCT01977573|11167170|FG003|Overall Study|Adverse Event|1
7066729|NCT01977573|11167167|FG000|Overall Study|Lost to Follow-up|1
7066730|NCT01977573|11167168|FG001|Overall Study|Lost to Follow-up|0
7066731|NCT01977573|11167169|FG002|Overall Study|Lost to Follow-up|0
7066732|NCT01977573|11167170|FG003|Overall Study|Lost to Follow-up|1
7066733|NCT01977573|11167167|FG000|Overall Study|Physician Decision|1
7066734|NCT01977573|11167168|FG001|Overall Study|Physician Decision|0
7066735|NCT01977573|11167169|FG002|Overall Study|Physician Decision|0
7066736|NCT01977573|11167170|FG003|Overall Study|Physician Decision|0
7066737|NCT01977573|11167167|FG000|Overall Study|Protocol Violation|3
7066738|NCT01977573|11167168|FG001|Overall Study|Protocol Violation|1
7066739|NCT01977573|11167169|FG002|Overall Study|Protocol Violation|0
7066740|NCT01977573|11167170|FG003|Overall Study|Protocol Violation|0
7066741|NCT01977573|11167167|FG000|Overall Study|Reached Defined Stopping Criteria|2
7066742|NCT01977573|11167168|FG001|Overall Study|Reached Defined Stopping Criteria|1
7066743|NCT01977573|11167169|FG002|Overall Study|Reached Defined Stopping Criteria|1
7066744|NCT01977573|11167170|FG003|Overall Study|Reached Defined Stopping Criteria|0
7066745|NCT01977573|11167167|FG000|Overall Study|Withdrawal by Subject|6
7066746|NCT01977573|11167168|FG001|Overall Study|Withdrawal by Subject|1
7066747|NCT01977573|11167169|FG002|Overall Study|Withdrawal by Subject|1
7066748|NCT01977573|11167170|FG003|Overall Study|Withdrawal by Subject|1
7066749|NCT01977612|11167192|FG000|Overall Study|Lost to Follow-up|1
7066750|NCT01977612|11167193|FG001|Overall Study|Lost to Follow-up|1
7066751|NCT01977625|11167199|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3
6936508|NCT00910689|10970437|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5
6936509|NCT00910689|10970438|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10
6936510|NCT00910689|10970435|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3
6936511|NCT00910689|10970436|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4
6936512|NCT00910689|10970437|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1
6936513|NCT00910689|10970438|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3
6936514|NCT00910689|10970435|FG000|Month 2- 4: Treatment Period|Adverse Event|2
6936515|NCT00910689|10970436|FG001|Month 2- 4: Treatment Period|Adverse Event|3
6936516|NCT00910689|10970437|FG002|Month 2- 4: Treatment Period|Adverse Event|2
6936517|NCT00910689|10970438|FG003|Month 2- 4: Treatment Period|Adverse Event|0
6936518|NCT00910689|10970435|FG000|Month 2- 4: Treatment Period|Time Demands|1
6936519|NCT00910689|10970436|FG001|Month 2- 4: Treatment Period|Time Demands|0
6936520|NCT00910689|10970437|FG002|Month 2- 4: Treatment Period|Time Demands|4
6936521|NCT00910689|10970438|FG003|Month 2- 4: Treatment Period|Time Demands|8
6936522|NCT00910689|10970435|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2
6936523|NCT00910689|10970436|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1
6936524|NCT00910689|10970437|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0
6936525|NCT00910689|10970438|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0
6936526|NCT00910689|10970435|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0
6936527|NCT00910689|10970436|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0
6936528|NCT00910689|10970437|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1
6936529|NCT00910689|10970438|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0
6936530|NCT00910689|10970435|FG000|Month 2- 4: Treatment Period|Pregnancy|0
6936531|NCT00910689|10970436|FG001|Month 2- 4: Treatment Period|Pregnancy|2
6936532|NCT00910689|10970437|FG002|Month 2- 4: Treatment Period|Pregnancy|0
6936533|NCT00910689|10970438|FG003|Month 2- 4: Treatment Period|Pregnancy|0
6936534|NCT00910689|10970435|FG000|Month 2- 4: Treatment Period|Protocol Violation|1
6936535|NCT00910689|10970436|FG001|Month 2- 4: Treatment Period|Protocol Violation|0
6936536|NCT00910689|10970437|FG002|Month 2- 4: Treatment Period|Protocol Violation|0
6936537|NCT00910689|10970438|FG003|Month 2- 4: Treatment Period|Protocol Violation|0
6936538|NCT00910689|10970435|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2
6936539|NCT00910689|10970436|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5
6936540|NCT00910689|10970437|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
6936541|NCT00910689|10970438|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
7066752|NCT01977625|11167200|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0
7066753|NCT01977625|11167199|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1
7066754|NCT01977625|11167200|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0
7066755|NCT01977651|11167208|FG000|4 Month Treatment Period|Adverse Event|34
7066756|NCT01977651|11167208|FG000|4 Month Treatment Period|Death|3
7066757|NCT01977651|11167208|FG000|4 Month Treatment Period|Progressive Disease|43
7066758|NCT01977651|11167208|FG000|4 Month Treatment Period|Withdrawal by Subject|17
7066759|NCT01977651|11167208|FG000|4 Month Treatment Period|Physician Decision|4
7066760|NCT01977651|11167208|FG000|1 Year Extension Period|Adverse Event|14
7066761|NCT01977651|11167208|FG000|1 Year Extension Period|Death|10
7066762|NCT01977651|11167208|FG000|1 Year Extension Period|Lost to Follow-up|2
7066763|NCT01977651|11167208|FG000|1 Year Extension Period|Progressive Disease|86
7066764|NCT01977651|11167208|FG000|1 Year Extension Period|Withdrawal by Subject|11
7066765|NCT01977651|11167208|FG000|1 Year Extension Period|Physician Decision|6
7066766|NCT01977651|11167208|FG000|1 Year Extension Period|Miscellaneous|1
7066767|NCT01977651|11167208|FG000|Post 1 Year Extension Period|Adverse Event|5
7066768|NCT01977651|11167208|FG000|Post 1 Year Extension Period|Death|13
7066769|NCT01977651|11167208|FG000|Post 1 Year Extension Period|Progressive Disease|60
7066770|NCT01977651|11167208|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13
7066771|NCT01977651|11167208|FG000|Post 1 Year Extension Period|Physician Decision|4
7066772|NCT01977651|11167208|FG000|Post 1 Year Extension Period|Miscellaneous|49
7066773|NCT01977677|11167215|FG000|Overall Study|Unrelated Adverse Event|0
7066774|NCT01977677|11167216|FG001|Overall Study|Unrelated Adverse Event|0
7066775|NCT01977677|11167217|FG002|Overall Study|Unrelated Adverse Event|1
7066776|NCT01977690|11167227|FG000|Overall Study|Withdrawal by Subject|0
7066777|NCT01977690|11167228|FG001|Overall Study|Withdrawal by Subject|4
7066778|NCT01977794|11167245|FG000|Overall Study|Adverse Event|2
7066779|NCT01977794|11167246|FG001|Overall Study|Adverse Event|2
7066780|NCT01977794|11167245|FG000|Overall Study|Lost to Follow-up|2
7066781|NCT01977794|11167246|FG001|Overall Study|Lost to Follow-up|1
7066782|NCT01977794|11167245|FG000|Overall Study|Protocol Violation|1
7066783|NCT01977794|11167246|FG001|Overall Study|Protocol Violation|0
7066784|NCT01977794|11167245|FG000|Overall Study|Death|1
7066785|NCT01977794|11167246|FG001|Overall Study|Death|1
6936542|NCT00910689|10970435|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1
6936543|NCT00910689|10970436|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0
6936544|NCT00910689|10970437|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2
6936545|NCT00910689|10970438|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4
7066786|NCT01977794|11167245|FG000|Overall Study|Withdrew consent|2
7066787|NCT01977794|11167246|FG001|Overall Study|Withdrew consent|1
7066788|NCT01977794|11167245|FG000|Overall Study|Other|0
7066789|NCT01977794|11167246|FG001|Overall Study|Other|1
7066790|NCT01977820|11167254|FG000|Overall Study|Sponsor terminated the study|1
6936546|NCT00910689|10970435|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0
6936547|NCT00910689|10970436|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
6936548|NCT00910689|10970437|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
6936549|NCT00910689|10970438|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
6936550|NCT00910689|10970435|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1
6936551|NCT00910689|10970436|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1
6936552|NCT00910689|10970437|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0
6936553|NCT00910689|10970438|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0
6936554|NCT00910689|10970435|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0
6936555|NCT00910689|10970436|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0
6936556|NCT00910689|10970437|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2
6936557|NCT00910689|10970438|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0
6936558|NCT00910689|10970435|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0
6936559|NCT00910689|10970436|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0
6936560|NCT00910689|10970437|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1
6936561|NCT00910689|10970438|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1
6936562|NCT00910689|10970435|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3
6936563|NCT00910689|10970436|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0
6936564|NCT00910689|10970437|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1
6936565|NCT00910689|10970438|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2
6936566|NCT00910689|10970435|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2
6936567|NCT00910689|10970436|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4
6936568|NCT00910689|10970437|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2
6936569|NCT00910689|10970438|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2
6936570|NCT00910689|10970435|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1
6936571|NCT00910689|10970436|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0
6936572|NCT00910689|10970437|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0
6936573|NCT00910689|10970438|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0
6936574|NCT00910689|10970435|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2
6936575|NCT00910689|10970436|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
7066791|NCT01977820|11167255|FG001|Overall Study|Sponsor terminated the study|1
7066792|NCT01977846|11167263|FG000|Total Study - Prospective|Death|0
7066793|NCT01977846|11167264|FG001|Total Study - Prospective|Death|1
7066794|NCT01977846|11167263|FG000|Total Study - Prospective|Lost to Follow-up|0
7066795|NCT01977846|11167264|FG001|Total Study - Prospective|Lost to Follow-up|8
7066796|NCT01977846|11167263|FG000|Total Study - Prospective|Withdrawal by Subject|0
7066797|NCT01977846|11167264|FG001|Total Study - Prospective|Withdrawal by Subject|13
7066798|NCT01977846|11167263|FG000|Total Study - Prospective|Not available at time of visit|0
7066799|NCT01977846|11167264|FG001|Total Study - Prospective|Not available at time of visit|5
7066800|NCT01977846|11167263|FG000|Total Study - Prospective|No show|0
7066801|NCT01977846|11167264|FG001|Total Study - Prospective|No show|1
7066802|NCT01977846|11167263|FG000|Total Study - Prospective|Protocol Violation|0
7066803|NCT01977846|11167264|FG001|Total Study - Prospective|Protocol Violation|1
7066804|NCT01977898|11167273|FG000|Overall Study|Non functioning catheter|1
7066805|NCT01977898|11167274|FG001|Overall Study|Non functioning catheter|1
7066806|NCT01977937|11167282|FG000|Overall Study|Withdrawal by Subject|2
7066807|NCT01977937|11167283|FG001|Overall Study|Withdrawal by Subject|1
7066808|NCT01977937|11167282|FG000|Overall Study|Adverse Event|1
7066809|NCT01977937|11167283|FG001|Overall Study|Adverse Event|0
7066810|NCT01977937|11167282|FG000|Overall Study|Physician Decision|0
7066811|NCT01977937|11167283|FG001|Overall Study|Physician Decision|1
7066812|NCT01978093|11167291|FG000|Overall Study|Death|1
7066813|NCT01978093|11167292|FG001|Overall Study|Death|0
7066814|NCT01978093|11167291|FG000|Overall Study|Adverse Event|0
7066815|NCT01978093|11167292|FG001|Overall Study|Adverse Event|5
7066816|NCT01978093|11167291|FG000|Overall Study|Protocol Violation|8
7066817|NCT01978093|11167292|FG001|Overall Study|Protocol Violation|2
7066818|NCT01978093|11167291|FG000|Overall Study|Withdrawal by Subject|29
7066819|NCT01978093|11167292|FG001|Overall Study|Withdrawal by Subject|25
7066820|NCT01978093|11167291|FG000|Overall Study|Lost to Follow-up|11
7066821|NCT01978093|11167292|FG001|Overall Study|Lost to Follow-up|15
7066822|NCT01978093|11167291|FG000|Overall Study|Migrated/moved from study area|11
7066823|NCT01978093|11167292|FG001|Overall Study|Migrated/moved from study area|13
7066824|NCT01978093|11167291|FG000|Overall Study|Loss of kaiser coverage|4
7066825|NCT01978093|11167292|FG001|Overall Study|Loss of kaiser coverage|10
7066826|NCT01978093|11167291|FG000|Overall Study|Lost kaiser health plan unable to contac|1
7066827|NCT01978093|11167292|FG001|Overall Study|Lost kaiser health plan unable to contac|0
7066828|NCT01978093|11167291|FG000|Overall Study|Mother lost custody of child|0
7066829|NCT01978093|11167292|FG001|Overall Study|Mother lost custody of child|1
7066830|NCT01978093|11167291|FG000|Overall Study|Child was in care of grandmother|0
7066831|NCT01978093|11167292|FG001|Overall Study|Child was in care of grandmother|1
7066832|NCT01978093|11167291|FG000|Overall Study|N/A for vaccine administration|0
7066833|NCT01978093|11167292|FG001|Overall Study|N/A for vaccine administration|1
6936576|NCT00910689|10970437|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
7066834|NCT01978119|11167301|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1
7066835|NCT01978119|11167302|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0
6936577|NCT00910689|10970438|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1
6936578|NCT00910689|10970435|FG000|Months 11- 16: Evaluation Period II|Time Demands|2
6936579|NCT00910689|10970436|FG001|Months 11- 16: Evaluation Period II|Time Demands|1
6936580|NCT00910689|10970437|FG002|Months 11- 16: Evaluation Period II|Time Demands|0
6936581|NCT00910689|10970438|FG003|Months 11- 16: Evaluation Period II|Time Demands|0
6936582|NCT00910689|10970435|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0
6936583|NCT00910689|10970436|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0
6936584|NCT00910689|10970437|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0
6936585|NCT00910689|10970438|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1
6936586|NCT00910689|10970435|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0
6936587|NCT00910689|10970436|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2
6936588|NCT00910689|10970437|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1
6936589|NCT00910689|10970438|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0
6936590|NCT00910715|10970451|FG000|Overall Study|Lost to Follow-up|22
6936591|NCT00910715|10970452|FG001|Overall Study|Lost to Follow-up|26
6936592|NCT00910715|10970453|FG002|Overall Study|Lost to Follow-up|0
6936593|NCT00910728|10970472|FG000|Overall Study|Lack of Efficacy|2
6936594|NCT00910728|10970473|FG001|Overall Study|Lack of Efficacy|3
6936595|NCT00910728|10970474|FG002|Overall Study|Lack of Efficacy|1
6936596|NCT00910728|10970475|FG003|Overall Study|Lack of Efficacy|2
6936597|NCT00910728|10970476|FG004|Overall Study|Lack of Efficacy|1
6936598|NCT00910728|10970477|FG005|Overall Study|Lack of Efficacy|0
7066836|NCT01978119|11167301|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
7066837|NCT01978119|11167302|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
7066838|NCT01978119|11167301|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
7066839|NCT01978119|11167302|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
7066840|NCT01978145|11167308|FG000|Treatment Period 1|Adverse Event|1
7066841|NCT01978145|11167309|FG001|Treatment Period 1|Adverse Event|9
7066842|NCT01978145|11167308|FG000|Treatment Period 1|Physician Decision|1
7066843|NCT01978145|11167309|FG001|Treatment Period 1|Physician Decision|0
7066844|NCT01978145|11167308|FG000|Treatment Period 1|Withdrawal by Subject|5
7066845|NCT01978145|11167309|FG001|Treatment Period 1|Withdrawal by Subject|4
7066846|NCT01978145|11167308|FG000|Treatment Period 1|Par. reached defined stopping criteria|2
7066847|NCT01978145|11167309|FG001|Treatment Period 1|Par. reached defined stopping criteria|3
7066848|NCT01978145|11167308|FG000|Washout Period 1|Adverse Event|0
7066849|NCT01978145|11167309|FG001|Washout Period 1|Adverse Event|1
7066850|NCT01978145|11167308|FG000|Washout Period 1|Withdrawal by Subject|1
7066851|NCT01978145|11167309|FG001|Washout Period 1|Withdrawal by Subject|1
7066852|NCT01978145|11167308|FG000|Washout Period 1|Par. reached defined stopping criteria|0
7066853|NCT01978145|11167309|FG001|Washout Period 1|Par. reached defined stopping criteria|1
7066854|NCT01978145|11167308|FG000|Treatment Period 2|Adverse Event|3
7066855|NCT01978145|11167309|FG001|Treatment Period 2|Adverse Event|3
7066856|NCT01978145|11167308|FG000|Treatment Period 2|Protocol Violation|0
7066857|NCT01978145|11167309|FG001|Treatment Period 2|Protocol Violation|1
7066858|NCT01978145|11167308|FG000|Treatment Period 2|Lost to Follow-up|1
7066859|NCT01978145|11167309|FG001|Treatment Period 2|Lost to Follow-up|1
7066860|NCT01978145|11167308|FG000|Treatment Period 2|Withdrawal by Subject|7
7066861|NCT01978145|11167309|FG001|Treatment Period 2|Withdrawal by Subject|4
7066862|NCT01978145|11167308|FG000|Treatment Period 2|Par. reached defined stopping criteria|8
7066863|NCT01978145|11167309|FG001|Treatment Period 2|Par. reached defined stopping criteria|5
7066864|NCT01978184|11167317|FG000|Overall Study|Progressive disease|5
7066865|NCT01978184|11167318|FG001|Overall Study|Progressive disease|5
7066866|NCT01978184|11167317|FG000|Overall Study|Other than PDA|2
7066867|NCT01978184|11167318|FG001|Overall Study|Other than PDA|2
7066868|NCT01978184|11167317|FG000|Overall Study|Physician Decision|0
7066869|NCT01978184|11167318|FG001|Overall Study|Physician Decision|3
7066870|NCT01978184|11167317|FG000|Overall Study|Noncompliance|1
7066871|NCT01978184|11167318|FG001|Overall Study|Noncompliance|2
7066872|NCT01978184|11167317|FG000|Overall Study|Death|1
7066873|NCT01978184|11167318|FG001|Overall Study|Death|0
7066874|NCT01978184|11167317|FG000|Overall Study|Withdrew- toxicities or physical decline|4
7066875|NCT01978184|11167318|FG001|Overall Study|Withdrew- toxicities or physical decline|8
7066876|NCT01978236|11167324|FG000|Overall Study|Discontinued due to study close|2
7066877|NCT01978262|11167328|FG000|Overall Study|Withdrawal by Subject|9
7066878|NCT01978262|11167328|FG000|Overall Study|Lost to Follow-up|2
7066879|NCT01978912|11167396|FG000|Overall Study|Adverse Event|0
7066880|NCT01978912|11167397|FG001|Overall Study|Adverse Event|1
7066881|NCT01978912|11167398|FG002|Overall Study|Adverse Event|0
6936599|NCT00910728|10970478|FG006|Overall Study|Lack of Efficacy|2
6936600|NCT00910728|10970479|FG007|Overall Study|Lack of Efficacy|2
6936601|NCT00910728|10970480|FG008|Overall Study|Lack of Efficacy|2
7066882|NCT01978912|11167399|FG003|Overall Study|Adverse Event|0
7066883|NCT01978912|11167396|FG000|Overall Study|Lost to Follow-up|1
7066884|NCT01978912|11167397|FG001|Overall Study|Lost to Follow-up|1
7066885|NCT01978912|11167398|FG002|Overall Study|Lost to Follow-up|0
7066886|NCT01978912|11167399|FG003|Overall Study|Lost to Follow-up|1
7066887|NCT01978912|11167396|FG000|Overall Study|Withdrawal by Subject|1
7066888|NCT01978912|11167397|FG001|Overall Study|Withdrawal by Subject|0
7066889|NCT01978912|11167398|FG002|Overall Study|Withdrawal by Subject|2
7147697|NCT03134183|11308393|FG001|Overall Study|Withdrawal by Subject|1
6936602|NCT00910728|10970472|FG000|Overall Study|Withdrawal by Subject|0
7040117|NCT01715805|11123024|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3
7040118|NCT01715805|11123021|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
7040119|NCT01715805|11123022|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3
7040120|NCT01715805|11123023|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
7040121|NCT01715805|11123024|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
7066890|NCT01978912|11167399|FG003|Overall Study|Withdrawal by Subject|2
7066891|NCT01978912|11167396|FG000|Overall Study|Lumbar Surgery|1
7066892|NCT01978912|11167397|FG001|Overall Study|Lumbar Surgery|0
7066893|NCT01978912|11167398|FG002|Overall Study|Lumbar Surgery|1
7066894|NCT01978912|11167399|FG003|Overall Study|Lumbar Surgery|0
7066895|NCT01978912|11167396|FG000|Overall Study|Intradiscal Steroid Injection|0
7066896|NCT01978912|11167397|FG001|Overall Study|Intradiscal Steroid Injection|1
7066897|NCT01978912|11167398|FG002|Overall Study|Intradiscal Steroid Injection|0
7066898|NCT01978912|11167399|FG003|Overall Study|Intradiscal Steroid Injection|0
7066899|NCT01979016|11167411|FG000|Overall Study|Withdrawal by Subject|2
7066900|NCT01979016|11167412|FG001|Overall Study|Withdrawal by Subject|0
7066901|NCT01979016|11167411|FG000|Overall Study|Adverse Event|0
7066902|NCT01979016|11167412|FG001|Overall Study|Adverse Event|1
7066903|NCT01979185|11167452|FG000|Period 2|Other|0
7066904|NCT01979185|11167453|FG001|Period 2|Other|1
7066905|NCT01979523|11167488|FG000|Overall Study|Withdrawal by Subject|1
7066906|NCT01979523|11167489|FG001|Overall Study|Withdrawal by Subject|0
7066907|NCT01979614|11167498|FG000|Overall Study|Adverse Event|1
7066908|NCT01979614|11167499|FG001|Overall Study|Adverse Event|1
7040122|NCT01715831|11123032|FG000|Overall Study|Adverse Event|1
7040123|NCT01715857|11123036|FG000|Overall Study|Did Not Meet Eligibility Criteria|96
7066909|NCT01979835|11167505|FG000|Primary Outcome SA Measurment|failed insertion|18
7066910|NCT01979835|11167505|FG000|Follow-up|Lost to Follow-up|32
7066911|NCT01979952|11167511|FG000|Overall Study|Adverse Event|4
7066912|NCT01979952|11167512|FG001|Overall Study|Adverse Event|5
7066913|NCT01979952|11167511|FG000|Overall Study|Protocol Violation|1
7066914|NCT01979952|11167512|FG001|Overall Study|Protocol Violation|0
7066915|NCT01979952|11167511|FG000|Overall Study|Withdrawal by Subject|2
7066916|NCT01979952|11167512|FG001|Overall Study|Withdrawal by Subject|1
7066917|NCT01979952|11167511|FG000|Overall Study|Other than specified above|1
7066918|NCT01979952|11167512|FG001|Overall Study|Other than specified above|0
7066919|NCT01980056|11167521|FG000|Overall Study|Death|1
7066920|NCT01980056|11167522|FG001|Overall Study|Death|1
7066921|NCT01980056|11167523|FG002|Overall Study|Death|0
7066922|NCT01980095|11167537|FG000|Overall Study|Lost to Follow-up|6
7066923|NCT01980095|11167538|FG001|Overall Study|Lost to Follow-up|7
7066924|NCT01980095|11167537|FG000|Overall Study|Withdrawal by Subject|2
7066925|NCT01980095|11167538|FG001|Overall Study|Withdrawal by Subject|3
7066926|NCT01980095|11167537|FG000|Overall Study|Poor compliance|5
7066927|NCT01980095|11167538|FG001|Overall Study|Poor compliance|0
7066928|NCT01980095|11167537|FG000|Overall Study|Safety issue|0
7066929|NCT01980095|11167538|FG001|Overall Study|Safety issue|1
7066930|NCT01980095|11167537|FG000|Overall Study|Study drug discontinued|1
7066931|NCT01980095|11167538|FG001|Overall Study|Study drug discontinued|0
7066932|NCT01980095|11167537|FG000|Overall Study|Randomized by mistake|1
7066933|NCT01980095|11167538|FG001|Overall Study|Randomized by mistake|0
7066934|NCT01980628|11167577|FG000|Overall Study|Adverse Event|12
7066935|NCT01980628|11167577|FG000|Overall Study|Physician Decision|5
7066936|NCT01980628|11167577|FG000|Overall Study|Withdrawal by Subject|4
7040124|NCT01715896|11123047|FG000|Overall Study|Lost to Follow-up|0
7040125|NCT01715896|11123048|FG001|Overall Study|Lost to Follow-up|2
7040126|NCT01715896|11123047|FG000|Overall Study|Withdrawal by Subject|1
7040127|NCT01715896|11123048|FG001|Overall Study|Withdrawal by Subject|4
7040128|NCT01715896|11123047|FG000|Overall Study|Other|2
7040129|NCT01715896|11123048|FG001|Overall Study|Other|5
7040130|NCT01716104|11123100|FG000|Overall Study|Do not meet inclusion criteria|6
7040131|NCT01716104|11123101|FG001|Overall Study|Do not meet inclusion criteria|7
7066937|NCT01980628|11167577|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42
7066938|NCT01980706|11167594|FG000|Overall Study|Withdrawal by Subject|9
7066939|NCT01980706|11167595|FG001|Overall Study|Withdrawal by Subject|6
7066940|NCT01980706|11167596|FG002|Overall Study|Withdrawal by Subject|2
7066941|NCT01980706|11167594|FG000|Overall Study|Adverse Event|1
7066942|NCT01980706|11167595|FG001|Overall Study|Adverse Event|2
7066943|NCT01980706|11167596|FG002|Overall Study|Adverse Event|5
7066944|NCT01980706|11167594|FG000|Overall Study|Lost to Follow-up|3
7066945|NCT01980706|11167595|FG001|Overall Study|Lost to Follow-up|4
7066946|NCT01980706|11167596|FG002|Overall Study|Lost to Follow-up|3
7066947|NCT01980706|11167594|FG000|Overall Study|miscellaneous|4
7066948|NCT01980706|11167595|FG001|Overall Study|miscellaneous|5
6936603|NCT00910728|10970473|FG001|Overall Study|Withdrawal by Subject|0
6936604|NCT00910728|10970474|FG002|Overall Study|Withdrawal by Subject|0
6936605|NCT00910728|10970475|FG003|Overall Study|Withdrawal by Subject|0
6936606|NCT00910728|10970476|FG004|Overall Study|Withdrawal by Subject|3
6936607|NCT00910728|10970477|FG005|Overall Study|Withdrawal by Subject|1
7066949|NCT01980706|11167596|FG002|Overall Study|miscellaneous|3
7066950|NCT01980888|11167615|FG000|Overall Study|Study Terminated by Sponsor|116
7040132|NCT01716156|11123110|FG000|Overall Study|Protocol Violation|1
7040133|NCT01716156|11123111|FG001|Overall Study|Protocol Violation|0
7040134|NCT01716156|11123112|FG002|Overall Study|Protocol Violation|0
7040135|NCT01716156|11123110|FG000|Overall Study|Withdrawal by Subject|0
7040136|NCT01716156|11123111|FG001|Overall Study|Withdrawal by Subject|1
7040137|NCT01716156|11123112|FG002|Overall Study|Withdrawal by Subject|2
7040138|NCT01716156|11123110|FG000|Overall Study|Lost to Follow-up|1
7040139|NCT01716156|11123111|FG001|Overall Study|Lost to Follow-up|0
7040140|NCT01716156|11123112|FG002|Overall Study|Lost to Follow-up|0
7066951|NCT01980888|11167616|FG001|Overall Study|Study Terminated by Sponsor|122
7066952|NCT01980888|11167615|FG000|Overall Study|Withdrew Consent|17
7066953|NCT01980888|11167616|FG001|Overall Study|Withdrew Consent|6
6936608|NCT00910728|10970478|FG006|Overall Study|Withdrawal by Subject|2
6936609|NCT00910728|10970479|FG007|Overall Study|Withdrawal by Subject|0
6936610|NCT00910728|10970480|FG008|Overall Study|Withdrawal by Subject|0
6936611|NCT00910728|10970472|FG000|Overall Study|(not specified)|2
6936612|NCT00910728|10970473|FG001|Overall Study|(not specified)|0
6936613|NCT00910728|10970474|FG002|Overall Study|(not specified)|1
6936614|NCT00910728|10970475|FG003|Overall Study|(not specified)|0
6936615|NCT00910728|10970476|FG004|Overall Study|(not specified)|1
6936616|NCT00910728|10970477|FG005|Overall Study|(not specified)|0
6936617|NCT00910728|10970478|FG006|Overall Study|(not specified)|0
6936618|NCT00910728|10970479|FG007|Overall Study|(not specified)|0
6936619|NCT00910728|10970480|FG008|Overall Study|(not specified)|0
6936620|NCT00910728|10970472|FG000|Overall Study|Adverse Event|2
6936621|NCT00910728|10970473|FG001|Overall Study|Adverse Event|0
6936622|NCT00910728|10970474|FG002|Overall Study|Adverse Event|1
6936623|NCT00910728|10970475|FG003|Overall Study|Adverse Event|1
6936624|NCT00910728|10970476|FG004|Overall Study|Adverse Event|0
6936625|NCT00910728|10970477|FG005|Overall Study|Adverse Event|0
6936626|NCT00910728|10970478|FG006|Overall Study|Adverse Event|2
7066954|NCT01980888|11167615|FG000|Overall Study|Investigator's Discretion|8
7066955|NCT01980888|11167616|FG001|Overall Study|Investigator's Discretion|3
7066956|NCT01980888|11167615|FG000|Overall Study|Non-Compliance with Study Drug|3
7066957|NCT01980888|11167616|FG001|Overall Study|Non-Compliance with Study Drug|2
7066958|NCT01980992|11167629|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0
7066959|NCT01980992|11167630|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3
7066960|NCT01980992|11167629|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
7066961|NCT01980992|11167630|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
7066962|NCT01980992|11167629|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1
7066963|NCT01980992|11167630|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0
7066964|NCT01980992|11167629|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2
7066965|NCT01980992|11167630|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0
7066966|NCT01980992|11167629|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1
7066967|NCT01980992|11167630|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0
7066968|NCT01980992|11167629|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0
7066969|NCT01980992|11167630|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1
7066970|NCT01981109|11167652|FG000|Overall Study|Death|36
7066971|NCT01981109|11167652|FG000|Overall Study|Withdrawal by Subject|40
7066972|NCT01981109|11167652|FG000|Overall Study|Lost to Follow-up|9
7066973|NCT01981109|11167652|FG000|Overall Study|No Discontinuation Documentation|37
7066974|NCT01981109|11167652|FG000|Overall Study|Study Termination|100
7066975|NCT01981109|11167652|FG000|Overall Study|No data available|2
7066976|NCT01981122|11167659|FG000|Overall Study|Withdrawal by Subject|0
7066977|NCT01981122|11167660|FG001|Overall Study|Withdrawal by Subject|2
7066978|NCT01981122|11167659|FG000|Overall Study|Protocol Violation|0
7066979|NCT01981122|11167660|FG001|Overall Study|Protocol Violation|1
7066980|NCT01981122|11167659|FG000|Overall Study|Lost to Follow-up|0
7066981|NCT01981122|11167660|FG001|Overall Study|Lost to Follow-up|1
7066982|NCT01981122|11167659|FG000|Overall Study|Investigator Or Dendreon Discretion|0
7066983|NCT01981122|11167660|FG001|Overall Study|Investigator Or Dendreon Discretion|1
7066984|NCT01981122|11167659|FG000|Overall Study|Death|14
7066985|NCT01981122|11167660|FG001|Overall Study|Death|15
7066986|NCT01981187|11167666|FG000|Overall Study|Participant/guardian decision|2
7066987|NCT01981187|11167666|FG000|Overall Study|Physician Decision|1
7066988|NCT01981187|11167666|FG000|Overall Study|Disease progression|2
7066989|NCT01981187|11167666|FG000|Overall Study|Adverse Event|7
6936627|NCT00910728|10970479|FG007|Overall Study|Adverse Event|1
6936628|NCT00910728|10970480|FG008|Overall Study|Adverse Event|1
6936629|NCT00910858|10970512|FG000|Pharmacokinetic Phase|Adverse Event|1
7040141|NCT01716169|11123124|FG000|Overall Study|Adverse Event|1
7066990|NCT01981356|11167672|FG000|Overall Study|Lost to Follow-up|4
7066991|NCT01981356|11167673|FG001|Overall Study|Lost to Follow-up|1
7066992|NCT01981356|11167672|FG000|Overall Study|Withdrawal by Subject|1
7066993|NCT01981356|11167673|FG001|Overall Study|Withdrawal by Subject|1
6936630|NCT00910858|10970513|FG001|Pharmacokinetic Phase|Adverse Event|0
7040142|NCT01716169|11123124|FG000|Overall Study|Lost to Follow-up|1
7040143|NCT01716169|11123124|FG000|Overall Study|Withdrawal by Subject|1
6936631|NCT00910858|10970514|FG002|Pharmacokinetic Phase|Adverse Event|0
7040144|NCT01716169|11123124|FG000|Overall Study|inconsistent dressing application|1
7066994|NCT01981356|11167672|FG000|Overall Study|Protocol Violation|2
6936632|NCT00910858|10970512|FG000|Monotherapy Phase|Adverse Event|3
6936633|NCT00910858|10970513|FG001|Monotherapy Phase|Adverse Event|2
6936634|NCT00910858|10970514|FG002|Monotherapy Phase|Adverse Event|0
6936635|NCT00910858|10970512|FG000|Monotherapy Phase|Lack of therapeutic effect|9
6936636|NCT00910858|10970513|FG001|Monotherapy Phase|Lack of therapeutic effect|6
6936637|NCT00910858|10970514|FG002|Monotherapy Phase|Lack of therapeutic effect|4
6936638|NCT00910858|10970512|FG000|Monotherapy Phase|Withdrawal by Subject|1
6936639|NCT00910858|10970513|FG001|Monotherapy Phase|Withdrawal by Subject|3
6936640|NCT00910858|10970514|FG002|Monotherapy Phase|Withdrawal by Subject|1
6936641|NCT00910858|10970512|FG000|Monotherapy Phase|Protocol Violation|1
6936642|NCT00910858|10970513|FG001|Monotherapy Phase|Protocol Violation|0
6936643|NCT00910858|10970514|FG002|Monotherapy Phase|Protocol Violation|0
6936644|NCT00910858|10970512|FG000|Monotherapy Phase|Other|3
7040145|NCT01716234|11123161|FG000|Overall Study|Protocol Violation|0
7040146|NCT01716234|11123162|FG001|Overall Study|Protocol Violation|0
7040147|NCT01716234|11123163|FG002|Overall Study|Protocol Violation|0
7066995|NCT01981356|11167673|FG001|Overall Study|Protocol Violation|0
7066996|NCT01981473|11167683|FG000|Overall Study|Incorrect diagnosis of RA|0
7066997|NCT01981473|11167684|FG001|Overall Study|Incorrect diagnosis of RA|0
7066998|NCT01981473|11167685|FG002|Overall Study|Incorrect diagnosis of RA|1
7066999|NCT01981473|11167683|FG000|Overall Study|Received treatment for < 6 months|0
7067000|NCT01981473|11167684|FG001|Overall Study|Received treatment for < 6 months|0
7067001|NCT01981473|11167685|FG002|Overall Study|Received treatment for < 6 months|1
7067002|NCT01981473|11167683|FG000|Overall Study|Received treatment for >24 months|2
7067003|NCT01981473|11167684|FG001|Overall Study|Received treatment for >24 months|0
7067004|NCT01981473|11167685|FG002|Overall Study|Received treatment for >24 months|6
7067005|NCT01981616|11167713|FG000|Overall Study|Adverse Event|0
7067006|NCT01981616|11167714|FG001|Overall Study|Adverse Event|1
7067007|NCT01981616|11167713|FG000|Overall Study|Protocol Violation|1
7067008|NCT01981616|11167714|FG001|Overall Study|Protocol Violation|0
7082547|NCT02142387|11193107|FG001|Overall Study|<19 years old|326
7082548|NCT02142387|11193106|FG000|Overall Study|non-cardiac etiology|504
7082549|NCT02142387|11193107|FG001|Overall Study|non-cardiac etiology|3431
7082550|NCT02142387|11193106|FG000|Overall Study|CPR not performed|74
7082551|NCT02142387|11193107|FG001|Overall Study|CPR not performed|473
7082552|NCT02142387|11193106|FG000|Overall Study|witnessed by paramedic|139
7082553|NCT02142387|11193107|FG001|Overall Study|witnessed by paramedic|917
7082554|NCT02142387|11193106|FG000|Overall Study|incomplete data|1
7082555|NCT02142387|11193107|FG001|Overall Study|incomplete data|9
7082556|NCT02142387|11193106|FG000|Overall Study|occurred not at home|298
7082557|NCT02142387|11193107|FG001|Overall Study|occurred not at home|2474
7082558|NCT02142504|11193116|FG000|Overall Study|Protocol Violation|2
7082559|NCT02142504|11193117|FG001|Overall Study|Protocol Violation|1
7082560|NCT02142504|11193118|FG002|Overall Study|Protocol Violation|2
7082561|NCT02142504|11193116|FG000|Overall Study|Adverse Event|2
7082562|NCT02142504|11193117|FG001|Overall Study|Adverse Event|3
7082563|NCT02142504|11193118|FG002|Overall Study|Adverse Event|4
7082564|NCT02142504|11193116|FG000|Overall Study|Lost to Follow-up|12
7082565|NCT02142504|11193117|FG001|Overall Study|Lost to Follow-up|19
7082566|NCT02142504|11193118|FG002|Overall Study|Lost to Follow-up|17
7082567|NCT02142504|11193116|FG000|Overall Study|Withdrawal by Subject|7
7082568|NCT02142504|11193117|FG001|Overall Study|Withdrawal by Subject|9
7082569|NCT02142504|11193118|FG002|Overall Study|Withdrawal by Subject|11
7082570|NCT02142504|11193116|FG000|Overall Study|Pregnancy|4
7082571|NCT02142504|11193117|FG001|Overall Study|Pregnancy|4
7082572|NCT02142504|11193118|FG002|Overall Study|Pregnancy|2
7082573|NCT02142504|11193116|FG000|Overall Study|Physician Decision|0
7082574|NCT02142504|11193117|FG001|Overall Study|Physician Decision|1
7082575|NCT02142504|11193118|FG002|Overall Study|Physician Decision|3
7082576|NCT02142504|11193116|FG000|Overall Study|Reason Not Specified|4
7082577|NCT02142504|11193117|FG001|Overall Study|Reason Not Specified|5
7082578|NCT02142504|11193118|FG002|Overall Study|Reason Not Specified|4
7082579|NCT02142712|11193134|FG000|Overall Study|Lost to Follow-up|1
7040148|NCT01716234|11123164|FG003|Overall Study|Protocol Violation|1
7082580|NCT02142712|11193135|FG001|Overall Study|Lost to Follow-up|1
7082581|NCT02142712|11193136|FG002|Overall Study|Lost to Follow-up|1
7082582|NCT02142712|11193137|FG003|Overall Study|Lost to Follow-up|0
7082583|NCT02142894|11193146|FG000|Overall Study|Protocol Violation|8
7082584|NCT02143024|11193152|FG000|Overall Study|Lost to Follow-up|1
7082585|NCT02143024|11193153|FG001|Overall Study|Lost to Follow-up|1
7082586|NCT02143024|11193152|FG000|Overall Study|Withdrawal by Subject|1
7082587|NCT02143024|11193153|FG001|Overall Study|Withdrawal by Subject|0
7082588|NCT02143102|11193161|FG000|Overall Study|Lost to Follow-up|11
7082589|NCT02143102|11193162|FG001|Overall Study|Lost to Follow-up|0
6936645|NCT00910858|10970513|FG001|Monotherapy Phase|Other|4
6936646|NCT00910858|10970514|FG002|Monotherapy Phase|Other|2
6936647|NCT00910858|10970512|FG000|Combined Treatment Phase|Lack of therapeutic effect|8
6975358|NCT01192516|11027535|FG000|Overall Study|Lost to Follow-up|7
6975359|NCT01192516|11027536|FG001|Overall Study|Lost to Follow-up|10
6975360|NCT01192516|11027537|FG002|Overall Study|Lost to Follow-up|7
6975361|NCT01192516|11027535|FG000|Overall Study|Withdrawal by Subject|4
6975362|NCT01192516|11027536|FG001|Overall Study|Withdrawal by Subject|4
6975363|NCT01192516|11027537|FG002|Overall Study|Withdrawal by Subject|1
6975364|NCT01192516|11027535|FG000|Overall Study|started new treatment|5
6975365|NCT01192516|11027536|FG001|Overall Study|started new treatment|1
6975366|NCT01192516|11027537|FG002|Overall Study|started new treatment|0
6936648|NCT00910858|10970513|FG001|Combined Treatment Phase|Lack of therapeutic effect|6
6936649|NCT00910858|10970514|FG002|Combined Treatment Phase|Lack of therapeutic effect|3
6936650|NCT00910858|10970512|FG000|Combined Treatment Phase|Withdrawal by Subject|0
6936651|NCT00910858|10970513|FG001|Combined Treatment Phase|Withdrawal by Subject|2
6936652|NCT00910858|10970514|FG002|Combined Treatment Phase|Withdrawal by Subject|0
6936653|NCT00910858|10970512|FG000|Combined Treatment Phase|Protocol Violation|1
6936654|NCT00910858|10970513|FG001|Combined Treatment Phase|Protocol Violation|0
6936655|NCT00910858|10970514|FG002|Combined Treatment Phase|Protocol Violation|0
6936656|NCT00910858|10970512|FG000|Combined Treatment Phase|Other|0
6936657|NCT00910858|10970513|FG001|Combined Treatment Phase|Other|2
6936658|NCT00910858|10970514|FG002|Combined Treatment Phase|Other|1
6936659|NCT00910871|10970530|FG000|Overall Study|Adverse Event|5
6936660|NCT00910871|10970530|FG000|Overall Study|Death|12
6936661|NCT00910871|10970530|FG000|Overall Study|Lost to Follow-up|8
6936662|NCT00910871|10970530|FG000|Overall Study|Protocol Violation|11
6936663|NCT00910871|10970530|FG000|Overall Study|Withdrawal by Subject|12
6936664|NCT00910871|10970530|FG000|Overall Study|Subject didn't meet eligibility criteria|5
6936665|NCT00910871|10970530|FG000|Overall Study|Undefined|1
6936666|NCT00910910|10970536|FG000|Overall Study|Adverse Event|63
6936667|NCT00910910|10970537|FG001|Overall Study|Adverse Event|35
6936668|NCT00910910|10970536|FG000|Overall Study|PD without histologic change|27
6936669|NCT00910910|10970537|FG001|Overall Study|PD without histologic change|23
6936670|NCT00910910|10970536|FG000|Overall Study|PD with histologic change|0
6936671|NCT00910910|10970537|FG001|Overall Study|PD with histologic change|2
6936672|NCT00910910|10970536|FG000|Overall Study|Withdrawal by Subject|7
6936673|NCT00910910|10970537|FG001|Overall Study|Withdrawal by Subject|5
6936674|NCT00910910|10970536|FG000|Overall Study|Lost to Follow-up|2
6936675|NCT00910910|10970537|FG001|Overall Study|Lost to Follow-up|2
6936676|NCT00910910|10970536|FG000|Overall Study|Death|9
6936677|NCT00910910|10970537|FG001|Overall Study|Death|3
6936678|NCT00910910|10970536|FG000|Overall Study|Protocol Violation|2
6936679|NCT00910910|10970537|FG001|Overall Study|Protocol Violation|2
6936680|NCT00910910|10970536|FG000|Overall Study|Completed 13 cycles of treatment|0
6936681|NCT00910910|10970537|FG001|Overall Study|Completed 13 cycles of treatment|118
6936682|NCT00910910|10970536|FG000|Overall Study|Other|114
6936683|NCT00910910|10970537|FG001|Overall Study|Other|32
6936684|NCT00910910|10970536|FG000|Overall Study|Untreated before cycle 1|1
6936685|NCT00910910|10970537|FG001|Overall Study|Untreated before cycle 1|2
6936686|NCT00910962|10970546|FG000|Overall Study|Adverse Event|5
6936687|NCT00910962|10970547|FG001|Overall Study|Adverse Event|20
6936688|NCT00910962|10970548|FG002|Overall Study|Adverse Event|17
6936689|NCT00910962|10970546|FG000|Overall Study|Protocol Violation|1
6936690|NCT00910962|10970547|FG001|Overall Study|Protocol Violation|3
6936691|NCT00910962|10970548|FG002|Overall Study|Protocol Violation|3
6936692|NCT00910962|10970546|FG000|Overall Study|Lost to Follow-up|0
6936693|NCT00910962|10970547|FG001|Overall Study|Lost to Follow-up|3
6936694|NCT00910962|10970548|FG002|Overall Study|Lost to Follow-up|1
6936695|NCT00910962|10970546|FG000|Overall Study|Physician Decision|0
6936696|NCT00910962|10970547|FG001|Overall Study|Physician Decision|6
6936697|NCT00910962|10970548|FG002|Overall Study|Physician Decision|6
6936698|NCT00910962|10970546|FG000|Overall Study|Withdrawal by Subject|25
6936699|NCT00910962|10970547|FG001|Overall Study|Withdrawal by Subject|32
6936700|NCT00910962|10970548|FG002|Overall Study|Withdrawal by Subject|32
6936701|NCT00910962|10970546|FG000|Overall Study|Reached defined stopping criteria|12
6936702|NCT00910962|10970547|FG001|Overall Study|Reached defined stopping criteria|14
6936703|NCT00910962|10970548|FG002|Overall Study|Reached defined stopping criteria|17
6936704|NCT00910988|10970562|FG000|Overall Study|Lost to Follow-up|2
6936705|NCT00910988|10970563|FG001|Overall Study|Lost to Follow-up|4
6936706|NCT00910988|10970564|FG002|Overall Study|Lost to Follow-up|3
6936707|NCT00910988|10970565|FG003|Overall Study|Lost to Follow-up|0
6936708|NCT00911144|10970593|FG000|Overall Study|Withdrawal by Subject|16
6936709|NCT00911144|10970594|FG001|Overall Study|Withdrawal by Subject|5
6936710|NCT00911157|10970602|FG000|Overall Study|Adverse Event|4
6936711|NCT00911157|10970603|FG001|Overall Study|Adverse Event|1
6936712|NCT00911157|10970602|FG000|Overall Study|Withdrawal by Subject|1
6936713|NCT00911157|10970603|FG001|Overall Study|Withdrawal by Subject|1
6936714|NCT00911157|10970602|FG000|Overall Study|Need for prohibited drug (heparin)|1
6936715|NCT00911157|10970603|FG001|Overall Study|Need for prohibited drug (heparin)|0
6936716|NCT00911157|10970602|FG000|Overall Study|Need to treat for lung cancer|1
6936717|NCT00911157|10970603|FG001|Overall Study|Need to treat for lung cancer|0
6936718|NCT00911170|10970611|FG000|Treatment Period|Randomized in error|1
6936719|NCT00911170|10970612|FG001|Treatment Period|Randomized in error|1
6936720|NCT00911170|10970611|FG000|Treatment Period|Ineligibility determined|1
6936721|NCT00911170|10970612|FG001|Treatment Period|Ineligibility determined|3
6936722|NCT00911170|10970611|FG000|Treatment Period|Protocol deviation|1
6936723|NCT00911170|10970612|FG001|Treatment Period|Protocol deviation|2
6936724|NCT00911170|10970611|FG000|Treatment Period|Adverse Event|9
6936725|NCT00911170|10970612|FG001|Treatment Period|Adverse Event|10
6936726|NCT00911170|10970611|FG000|Treatment Period|Withdrawal by Subject|4
6936727|NCT00911170|10970612|FG001|Treatment Period|Withdrawal by Subject|4
6936728|NCT00911170|10970611|FG000|Treatment Period|Disease progression|0
6936729|NCT00911170|10970612|FG001|Treatment Period|Disease progression|2
6936730|NCT00911170|10970611|FG000|Treatment Period|Physician Decision|5
6936731|NCT00911170|10970612|FG001|Treatment Period|Physician Decision|5
6936732|NCT00911170|10970611|FG000|Treatment Period|Lost to Follow-up|0
6936733|NCT00911170|10970612|FG001|Treatment Period|Lost to Follow-up|1
6936734|NCT00911170|10970611|FG000|Treatment Period|Death|6
6936735|NCT00911170|10970612|FG001|Treatment Period|Death|9
6936736|NCT00911170|10970611|FG000|Long Term Follow-Up|Continuing in study|274
6936737|NCT00911170|10970612|FG001|Long Term Follow-Up|Continuing in study|269
6936738|NCT00911170|10970611|FG000|Long Term Follow-Up|Withdrawal by Subject|20
6936739|NCT00911170|10970612|FG001|Long Term Follow-Up|Withdrawal by Subject|21
6936740|NCT00911170|10970611|FG000|Long Term Follow-Up|Physician Decision|5
6936741|NCT00911170|10970612|FG001|Long Term Follow-Up|Physician Decision|4
6936742|NCT00911170|10970611|FG000|Long Term Follow-Up|Lost to Follow-up|8
6936743|NCT00911170|10970612|FG001|Long Term Follow-Up|Lost to Follow-up|7
6936744|NCT00911170|10970611|FG000|Long Term Follow-Up|Death|116
6936745|NCT00911170|10970612|FG001|Long Term Follow-Up|Death|121
6936746|NCT00911300|10970620|FG000|Overall Study|Primary Endpoint Component Occurred|1
6936747|NCT00911300|10970621|FG001|Overall Study|Primary Endpoint Component Occurred|2
6936748|NCT00911300|10970620|FG000|Overall Study|Death|1
6936749|NCT00911300|10970621|FG001|Overall Study|Death|0
6936750|NCT00911300|10970620|FG000|Overall Study|Thrombus Persistant in Second TEE|3
6936751|NCT00911300|10970621|FG001|Overall Study|Thrombus Persistant in Second TEE|7
6936752|NCT00911300|10970620|FG000|Overall Study|Adverse Event|14
6936753|NCT00911300|10970621|FG001|Overall Study|Adverse Event|6
6936754|NCT00911300|10970620|FG000|Overall Study|Protocol Violation|3
6936755|NCT00911300|10970621|FG001|Overall Study|Protocol Violation|2
6936756|NCT00911300|10970620|FG000|Overall Study|Consent Withdrawn|4
6936757|NCT00911300|10970621|FG001|Overall Study|Consent Withdrawn|12
6936758|NCT00911300|10970620|FG000|Overall Study|Coronary Angiography Performed|1
6936759|NCT00911300|10970621|FG001|Overall Study|Coronary Angiography Performed|0
6936760|NCT00911300|10970620|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3
6936761|NCT00911300|10970621|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3
6936762|NCT00911300|10970620|FG000|Overall Study|Received Commercial Treatment|1
6936763|NCT00911300|10970621|FG001|Overall Study|Received Commercial Treatment|0
6936764|NCT00911300|10970620|FG000|Overall Study|Recurrent Tachyarrhythmia|1
6936765|NCT00911300|10970621|FG001|Overall Study|Recurrent Tachyarrhythmia|1
6936766|NCT00911300|10970620|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
6936767|NCT00911300|10970621|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
6936768|NCT00911300|10970620|FG000|Overall Study|Nurse Unavailable in Participant's City|1
6936769|NCT00911300|10970621|FG001|Overall Study|Nurse Unavailable in Participant's City|0
6936770|NCT00911300|10970620|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1
6936771|NCT00911300|10970621|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0
6936772|NCT00911300|10970620|FG000|Overall Study|Participant Could Not Stay in Hospital|0
6936773|NCT00911300|10970621|FG001|Overall Study|Participant Could Not Stay in Hospital|1
6936774|NCT00911300|10970620|FG000|Overall Study|Investigator's Decision; New AF Episode|0
6936775|NCT00911300|10970621|FG001|Overall Study|Investigator's Decision; New AF Episode|1
6936776|NCT00911300|10970620|FG000|Overall Study|International Normalized Ratio Too High|0
6936777|NCT00911300|10970621|FG001|Overall Study|International Normalized Ratio Too High|1
6936778|NCT00911300|10970620|FG000|Overall Study|Participant Refused Hospital Consulation|0
6936779|NCT00911300|10970621|FG001|Overall Study|Participant Refused Hospital Consulation|1
6936780|NCT00911300|10970620|FG000|Overall Study|Underlying Disease (Myocarditis)|0
6936781|NCT00911300|10970621|FG001|Overall Study|Underlying Disease (Myocarditis)|1
6936782|NCT00911300|10970620|FG000|Overall Study|Physician Decision|0
6936783|NCT00911300|10970621|FG001|Overall Study|Physician Decision|1
6936784|NCT00911300|10970620|FG000|Overall Study|Treatment Stopped by Mistake|0
6936785|NCT00911300|10970621|FG001|Overall Study|Treatment Stopped by Mistake|1
6936786|NCT00911300|10970620|FG000|Overall Study|Randomized; No Study Medication Received|0
6936787|NCT00911300|10970621|FG001|Overall Study|Randomized; No Study Medication Received|2
6936788|NCT00911508|10970638|FG000|Overall Study|Lost to Follow-up|27
6936789|NCT00911508|10970639|FG001|Overall Study|Lost to Follow-up|18
6936790|NCT00911508|10970638|FG000|Overall Study|Withdrawal by Subject|79
6936791|NCT00911508|10970639|FG001|Overall Study|Withdrawal by Subject|112
6936792|NCT00911534|10970647|FG000|Overall Study|Adverse Event|4
6936793|NCT00911534|10970648|FG001|Overall Study|Adverse Event|4
6936794|NCT00911534|10970647|FG000|Overall Study|Lost to Follow-up|2
6936795|NCT00911534|10970648|FG001|Overall Study|Lost to Follow-up|4
6936796|NCT00911534|10970647|FG000|Overall Study|Withdrawal by Subject|2
6936797|NCT00911534|10970648|FG001|Overall Study|Withdrawal by Subject|1
6936798|NCT00911534|10970647|FG000|Overall Study|Lack of Efficacy|4
6936799|NCT00911534|10970648|FG001|Overall Study|Lack of Efficacy|1
6936800|NCT00911534|10970647|FG000|Overall Study|Withdrawal of consent|1
6936801|NCT00911534|10970648|FG001|Overall Study|Withdrawal of consent|4
6936802|NCT00911534|10970647|FG000|Overall Study|Other|2
6936803|NCT00911534|10970648|FG001|Overall Study|Other|2
6936804|NCT00911625|10970670|FG000|Overall Study|Lost to Follow-up|7
6936805|NCT00911625|10970671|FG001|Overall Study|Lost to Follow-up|0
6936806|NCT00911768|10970688|FG000|Overall Study|Protocol Violation|5
6936807|NCT00911768|10970689|FG001|Overall Study|Protocol Violation|4
6936808|NCT00911768|10970688|FG000|Overall Study|Withdrawal by Subject|1
6936809|NCT00911768|10970689|FG001|Overall Study|Withdrawal by Subject|0
6936810|NCT00911807|10970698|FG000|Overall Study|Adverse Event|2
6838085|NCT00256750|10843792|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5
6838086|NCT00256750|10843793|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1
6838087|NCT00256750|10843794|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2
6838088|NCT00256750|10843792|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
6838089|NCT00256750|10843793|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0
6838090|NCT00256750|10843794|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
6838091|NCT00256750|10843792|FG000|Post-Transplant Treated (36 Months)|Death|0
6838092|NCT00256750|10843793|FG001|Post-Transplant Treated (36 Months)|Death|2
6838093|NCT00256750|10843794|FG002|Post-Transplant Treated (36 Months)|Death|1
6838094|NCT00256750|10843792|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
6838095|NCT00256750|10843793|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
6838096|NCT00256750|10843794|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1
6838097|NCT00256750|10843792|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4
6838098|NCT00256750|10843793|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1
6838099|NCT00256750|10843794|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0
6838100|NCT00256750|10843792|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0
6838101|NCT00256750|10843793|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1
6838102|NCT00256750|10843794|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0
6838103|NCT00256750|10843792|FG000|Post-Transplant Treated (36 Months)|Other|0
6838104|NCT00256750|10843793|FG001|Post-Transplant Treated (36 Months)|Other|1
6838105|NCT00256750|10843794|FG002|Post-Transplant Treated (36 Months)|Other|1
6838106|NCT00256750|10843792|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13
6838107|NCT00256750|10843793|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11
6897582|NCT00642278|10916743|FG002|Overall Study|Lost to Follow-up|0
6897583|NCT00642278|10916744|FG003|Overall Study|Lost to Follow-up|1
6897584|NCT00642278|10916745|FG004|Overall Study|Lost to Follow-up|0
6897585|NCT00642278|10916746|FG005|Overall Study|Lost to Follow-up|1
6897586|NCT00642278|10916747|FG006|Overall Study|Lost to Follow-up|1
6897587|NCT00642278|10916741|FG000|Overall Study|Physician Decision|0
6897588|NCT00642278|10916742|FG001|Overall Study|Physician Decision|0
6897589|NCT00642278|10916743|FG002|Overall Study|Physician Decision|0
6897590|NCT00642278|10916744|FG003|Overall Study|Physician Decision|1
6897591|NCT00642278|10916745|FG004|Overall Study|Physician Decision|0
6897592|NCT00642278|10916746|FG005|Overall Study|Physician Decision|0
6897593|NCT00642278|10916747|FG006|Overall Study|Physician Decision|0
6897594|NCT00642278|10916741|FG000|Overall Study|Protocol Violation|0
6897595|NCT00642278|10916742|FG001|Overall Study|Protocol Violation|0
6897596|NCT00642278|10916743|FG002|Overall Study|Protocol Violation|1
6897597|NCT00642278|10916744|FG003|Overall Study|Protocol Violation|1
6897598|NCT00642278|10916745|FG004|Overall Study|Protocol Violation|0
6897599|NCT00642278|10916746|FG005|Overall Study|Protocol Violation|1
6897600|NCT00642278|10916747|FG006|Overall Study|Protocol Violation|2
6897601|NCT00642278|10916741|FG000|Overall Study|Withdrawal by Subject|1
6897602|NCT00642278|10916742|FG001|Overall Study|Withdrawal by Subject|1
6897603|NCT00642278|10916743|FG002|Overall Study|Withdrawal by Subject|1
6897604|NCT00642278|10916744|FG003|Overall Study|Withdrawal by Subject|3
6897605|NCT00642278|10916745|FG004|Overall Study|Withdrawal by Subject|6
6897606|NCT00642278|10916746|FG005|Overall Study|Withdrawal by Subject|2
6897607|NCT00642278|10916747|FG006|Overall Study|Withdrawal by Subject|2
6897608|NCT00642278|10916741|FG000|Overall Study|Noncompliance with study drug regimen|0
6897609|NCT00642278|10916742|FG001|Overall Study|Noncompliance with study drug regimen|0
6897610|NCT00642278|10916743|FG002|Overall Study|Noncompliance with study drug regimen|0
6897611|NCT00642278|10916744|FG003|Overall Study|Noncompliance with study drug regimen|1
6897612|NCT00642278|10916745|FG004|Overall Study|Noncompliance with study drug regimen|0
6897613|NCT00642278|10916746|FG005|Overall Study|Noncompliance with study drug regimen|0
6897614|NCT00642278|10916747|FG006|Overall Study|Noncompliance with study drug regimen|0
6897615|NCT00642278|10916741|FG000|Overall Study|Other|2
6897616|NCT00642278|10916742|FG001|Overall Study|Other|1
6897617|NCT00642278|10916743|FG002|Overall Study|Other|0
6897618|NCT00642278|10916744|FG003|Overall Study|Other|1
6897619|NCT00642278|10916745|FG004|Overall Study|Other|0
6897620|NCT00642278|10916746|FG005|Overall Study|Other|1
6897621|NCT00642278|10916747|FG006|Overall Study|Other|0
6897622|NCT00642304|10916763|FG000|Overall Study|Adverse Event|1
6897623|NCT00642304|10916763|FG000|Overall Study|Death|1
6897624|NCT00642304|10916763|FG000|Overall Study|Blood transfusion|2
6897625|NCT00642304|10916763|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1
6897626|NCT00642304|10916763|FG000|Overall Study|Transplantation|1
6897627|NCT00642356|10916769|FG000|Overall Study|Adverse Event|1
6897628|NCT00642356|10916770|FG001|Overall Study|Adverse Event|0
6897629|NCT00642356|10916769|FG000|Overall Study|Protocol Violation|0
6897630|NCT00642356|10916770|FG001|Overall Study|Protocol Violation|3
6897631|NCT00642356|10916769|FG000|Overall Study|Lack of Efficacy|1
6897632|NCT00642356|10916770|FG001|Overall Study|Lack of Efficacy|0
6897633|NCT00642369|10916778|FG000|Overall Study|Adverse Event|2
6897634|NCT00642369|10916779|FG001|Overall Study|Adverse Event|3
6897635|NCT00642369|10916778|FG000|Overall Study|Withdrawal by Subject|1
6897636|NCT00642369|10916779|FG001|Overall Study|Withdrawal by Subject|0
6936811|NCT00911807|10970699|FG001|Overall Study|Adverse Event|1
6936812|NCT00911807|10970700|FG002|Overall Study|Adverse Event|5
6936813|NCT00911807|10970698|FG000|Overall Study|Death|0
6936814|NCT00911807|10970699|FG001|Overall Study|Death|0
6936815|NCT00911807|10970700|FG002|Overall Study|Death|1
6936816|NCT00911807|10970698|FG000|Overall Study|Protocol Violation|6
6936817|NCT00911807|10970699|FG001|Overall Study|Protocol Violation|4
6936818|NCT00911807|10970700|FG002|Overall Study|Protocol Violation|9
6936819|NCT00911807|10970698|FG000|Overall Study|Withdrawal by Subject|8
6936820|NCT00911807|10970699|FG001|Overall Study|Withdrawal by Subject|10
6936821|NCT00911807|10970700|FG002|Overall Study|Withdrawal by Subject|7
6936822|NCT00911807|10970698|FG000|Overall Study|Organizational reasons|1
6936823|NCT00911807|10970699|FG001|Overall Study|Organizational reasons|3
6936824|NCT00911807|10970700|FG002|Overall Study|Organizational reasons|1
6936825|NCT00911820|10970710|FG000|Overall Study|RECIST progression|12
6936826|NCT00911820|10970711|FG001|Overall Study|RECIST progression|8
6936827|NCT00911820|10970710|FG000|Overall Study|Adverse Event|8
6936828|NCT00911820|10970711|FG001|Overall Study|Adverse Event|8
6936829|NCT00911820|10970710|FG000|Overall Study|Clinical Progression|7
6936830|NCT00911820|10970711|FG001|Overall Study|Clinical Progression|5
6936831|NCT00911820|10970710|FG000|Overall Study|Physician Decision|5
6936832|NCT00911820|10970711|FG001|Overall Study|Physician Decision|9
6936833|NCT00911820|10970710|FG000|Overall Study|Decline in Performance Status|4
6936834|NCT00911820|10970711|FG001|Overall Study|Decline in Performance Status|2
6936835|NCT00911820|10970710|FG000|Overall Study|Withdrawal by Subject|3
6936836|NCT00911820|10970711|FG001|Overall Study|Withdrawal by Subject|4
6936837|NCT00911820|10970710|FG000|Overall Study|Death|1
6838108|NCT00256750|10843794|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14
6838109|NCT00256750|10843792|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5
6838110|NCT00256750|10843793|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4
6838111|NCT00256750|10843794|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1
6838112|NCT00256750|10843792|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4
6838113|NCT00256750|10843793|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
6838114|NCT00256750|10843794|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
6838115|NCT00256750|10843792|FG000|Long Term Extension (LTE; 84 Months)|Death|9
6838116|NCT00256750|10843793|FG001|Long Term Extension (LTE; 84 Months)|Death|4
6838117|NCT00256750|10843794|FG002|Long Term Extension (LTE; 84 Months)|Death|4
6838118|NCT00256750|10843792|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6
6936838|NCT00911820|10970711|FG001|Overall Study|Death|2
6936839|NCT00911820|10970710|FG000|Overall Study|Pursue surgery|1
6936840|NCT00911820|10970711|FG001|Overall Study|Pursue surgery|1
6936841|NCT00911820|10970710|FG000|Overall Study|Pursue Radiation|1
6936842|NCT00911820|10970711|FG001|Overall Study|Pursue Radiation|0
6936843|NCT00911820|10970710|FG000|Overall Study|Still on Therapy|2
6936844|NCT00911820|10970711|FG001|Overall Study|Still on Therapy|2
6936845|NCT00911820|10970710|FG000|Overall Study|Pathology Not Confirmed|1
6936846|NCT00911820|10970711|FG001|Overall Study|Pathology Not Confirmed|0
6936847|NCT00911820|10970710|FG000|Overall Study|Withdraw before Receive Treatment|0
6936848|NCT00911820|10970711|FG001|Overall Study|Withdraw before Receive Treatment|2
6936849|NCT00911859|10970720|FG000|Treatment Period|Adverse Event|3
6936850|NCT00911859|10970721|FG001|Treatment Period|Adverse Event|3
6936851|NCT00911859|10970722|FG002|Treatment Period|Adverse Event|7
6936852|NCT00911859|10970720|FG000|Treatment Period|Death|1
6936853|NCT00911859|10970721|FG001|Treatment Period|Death|3
7067009|NCT01981954|11167747|FG000|Titration Period|Protocol Deviation|1
7067010|NCT01981954|11167747|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1
7067011|NCT01982292|11167783|FG000|Overall Study|Adverse Event|2
7067012|NCT01982292|11167784|FG001|Overall Study|Adverse Event|0
7067013|NCT01982292|11167783|FG000|Overall Study|Death|1
7067014|NCT01982292|11167784|FG001|Overall Study|Death|0
7067015|NCT01982292|11167783|FG000|Overall Study|Lost to Follow-up|2
7067016|NCT01982292|11167784|FG001|Overall Study|Lost to Follow-up|0
6936854|NCT00911859|10970722|FG002|Treatment Period|Death|5
6936855|NCT00911859|10970720|FG000|Treatment Period|Lack of Efficacy|1
6936856|NCT00911859|10970721|FG001|Treatment Period|Lack of Efficacy|7
6936857|NCT00911859|10970722|FG002|Treatment Period|Lack of Efficacy|5
6936858|NCT00911859|10970720|FG000|Treatment Period|Physician Decision|3
6936859|NCT00911859|10970721|FG001|Treatment Period|Physician Decision|3
6936860|NCT00911859|10970722|FG002|Treatment Period|Physician Decision|3
6936861|NCT00911859|10970720|FG000|Treatment Period|Withdrawal by Subject|0
6936862|NCT00911859|10970721|FG001|Treatment Period|Withdrawal by Subject|4
6936863|NCT00911859|10970722|FG002|Treatment Period|Withdrawal by Subject|5
6936864|NCT00911859|10970720|FG000|Treatment Period|Did not receive study treatment|0
6936865|NCT00911859|10970721|FG001|Treatment Period|Did not receive study treatment|1
6936866|NCT00911859|10970722|FG002|Treatment Period|Did not receive study treatment|0
7067017|NCT01982292|11167783|FG000|Overall Study|Non-Compliance With Study Treatment|1
6936867|NCT00911859|10970720|FG000|Maintainance Period|Lack of Efficacy|0
6936868|NCT00911859|10970721|FG001|Maintainance Period|Lack of Efficacy|0
6936869|NCT00911859|10970722|FG002|Maintainance Period|Lack of Efficacy|9
6936870|NCT00911859|10970720|FG000|Maintainance Period|Physician Decision|0
6936871|NCT00911859|10970721|FG001|Maintainance Period|Physician Decision|0
6936872|NCT00911859|10970722|FG002|Maintainance Period|Physician Decision|9
6936873|NCT00911859|10970720|FG000|Maintainance Period|Withdrawal by Subject|0
6936874|NCT00911859|10970721|FG001|Maintainance Period|Withdrawal by Subject|0
6936875|NCT00911859|10970722|FG002|Maintainance Period|Withdrawal by Subject|3
6936876|NCT00911859|10970720|FG000|Follow-up Period|Death|5
6936877|NCT00911859|10970721|FG001|Follow-up Period|Death|8
6936878|NCT00911859|10970722|FG002|Follow-up Period|Death|10
6936879|NCT00911859|10970720|FG000|Follow-up Period|Lost to Follow-up|1
6936880|NCT00911859|10970721|FG001|Follow-up Period|Lost to Follow-up|1
6936881|NCT00911859|10970722|FG002|Follow-up Period|Lost to Follow-up|0
6936882|NCT00911859|10970720|FG000|Follow-up Period|Withdrawal by Subject|0
6936883|NCT00911859|10970721|FG001|Follow-up Period|Withdrawal by Subject|4
6936884|NCT00911859|10970722|FG002|Follow-up Period|Withdrawal by Subject|4
6936885|NCT00911859|10970720|FG000|Follow-up Period|Study terminated by sponsor|5
6936886|NCT00911859|10970721|FG001|Follow-up Period|Study terminated by sponsor|33
6936887|NCT00911859|10970722|FG002|Follow-up Period|Study terminated by sponsor|27
6936888|NCT00911937|10970736|FG000|Overall Study|Death|1
6936889|NCT00911937|10970737|FG001|Overall Study|Death|0
6936890|NCT00911937|10970736|FG000|Overall Study|Lost to Follow-up|8
6936891|NCT00911937|10970737|FG001|Overall Study|Lost to Follow-up|5
6936892|NCT00911937|10970736|FG000|Overall Study|Withdrawal by Subject|10
6936893|NCT00911937|10970737|FG001|Overall Study|Withdrawal by Subject|7
6936894|NCT00911937|10970736|FG000|Overall Study|Withdrawn due to pregnancy|1
6936895|NCT00911937|10970737|FG001|Overall Study|Withdrawn due to pregnancy|0
6936896|NCT00911937|10970736|FG000|Overall Study|Adverse Event|11
6936897|NCT00911937|10970737|FG001|Overall Study|Adverse Event|25
6936898|NCT00911937|10970736|FG000|Overall Study|Lack of Efficacy|11
6936899|NCT00911937|10970737|FG001|Overall Study|Lack of Efficacy|6
6936900|NCT00911937|10970736|FG000|Overall Study|Did not meet inclusion criteria|9
6936901|NCT00911937|10970737|FG001|Overall Study|Did not meet inclusion criteria|11
6936902|NCT00911937|10970736|FG000|Overall Study|Protocol Violation|14
6936903|NCT00911937|10970737|FG001|Overall Study|Protocol Violation|23
6936904|NCT00911937|10970736|FG000|Overall Study|Randomized but not treated|13
6936905|NCT00911937|10970737|FG001|Overall Study|Randomized but not treated|13
6936906|NCT00911937|10970736|FG000|Overall Study|Other|9
6936907|NCT00911937|10970737|FG001|Overall Study|Other|5
6936908|NCT00911989|10970743|FG000|Overall Study|Adverse Event|1
6936909|NCT00912015|10970756|FG000|Overall Study|Lack of Efficacy|1
6936910|NCT00912015|10970757|FG001|Overall Study|Lack of Efficacy|0
6936911|NCT00912015|10970758|FG002|Overall Study|Lack of Efficacy|0
6936912|NCT00912015|10970759|FG003|Overall Study|Lack of Efficacy|0
6936913|NCT00912015|10970756|FG000|Overall Study|Withdrawal by Subject|8
6936914|NCT00912015|10970757|FG001|Overall Study|Withdrawal by Subject|8
6936915|NCT00912015|10970758|FG002|Overall Study|Withdrawal by Subject|3
6936916|NCT00912015|10970759|FG003|Overall Study|Withdrawal by Subject|0
6936917|NCT00912015|10970756|FG000|Overall Study|Protocol Violation|1
6936918|NCT00912015|10970757|FG001|Overall Study|Protocol Violation|0
6936919|NCT00912015|10970758|FG002|Overall Study|Protocol Violation|0
6936920|NCT00912015|10970759|FG003|Overall Study|Protocol Violation|1
6936921|NCT00912015|10970756|FG000|Overall Study|Adverse Event|6
6936922|NCT00912015|10970757|FG001|Overall Study|Adverse Event|0
6936923|NCT00912015|10970758|FG002|Overall Study|Adverse Event|0
6936924|NCT00912015|10970759|FG003|Overall Study|Adverse Event|1
6936925|NCT00912028|10970772|FG000|Overall Study|Lost to Follow-up|2
6936926|NCT00912028|10970773|FG001|Overall Study|Lost to Follow-up|3
6936927|NCT00912028|10970774|FG002|Overall Study|Lost to Follow-up|0
6936928|NCT00912028|10970775|FG003|Overall Study|Lost to Follow-up|1
6936929|NCT00912028|10970776|FG004|Overall Study|Lost to Follow-up|3
6936930|NCT00912028|10970772|FG000|Overall Study|Withdrawal by Subject|3
6936931|NCT00912028|10970773|FG001|Overall Study|Withdrawal by Subject|0
6936932|NCT00912028|10970774|FG002|Overall Study|Withdrawal by Subject|0
6936933|NCT00912028|10970775|FG003|Overall Study|Withdrawal by Subject|0
6936934|NCT00912028|10970776|FG004|Overall Study|Withdrawal by Subject|0
6936935|NCT00912093|10970791|FG000|The Controlled Phase|Death|0
6936936|NCT00912093|10970792|FG001|The Controlled Phase|Death|1
6936937|NCT00912093|10970793|FG002|The Controlled Phase|Death|0
6936938|NCT00912093|10970794|FG003|The Controlled Phase|Death|0
6936939|NCT00912093|10970795|FG004|The Controlled Phase|Death|0
6936940|NCT00912093|10970791|FG000|The Controlled Phase|Medical Condition|0
6936941|NCT00912093|10970792|FG001|The Controlled Phase|Medical Condition|1
7040149|NCT01716234|11123165|FG004|Overall Study|Protocol Violation|1
7040150|NCT01716234|11123166|FG005|Overall Study|Protocol Violation|1
7040151|NCT01716234|11123167|FG006|Overall Study|Protocol Violation|0
7040152|NCT01716234|11123161|FG000|Overall Study|Lack of Efficacy|0
7040153|NCT01716234|11123162|FG001|Overall Study|Lack of Efficacy|0
7040154|NCT01716234|11123163|FG002|Overall Study|Lack of Efficacy|0
7040155|NCT01716234|11123164|FG003|Overall Study|Lack of Efficacy|1
7040156|NCT01716234|11123165|FG004|Overall Study|Lack of Efficacy|0
6936942|NCT00912093|10970793|FG002|The Controlled Phase|Medical Condition|0
6936943|NCT00912093|10970794|FG003|The Controlled Phase|Medical Condition|0
6936944|NCT00912093|10970795|FG004|The Controlled Phase|Medical Condition|0
6936945|NCT00912093|10970791|FG000|The Controlled Phase|Lost to Follow-up|0
6936946|NCT00912093|10970792|FG001|The Controlled Phase|Lost to Follow-up|0
6936947|NCT00912093|10970793|FG002|The Controlled Phase|Lost to Follow-up|0
6936948|NCT00912093|10970794|FG003|The Controlled Phase|Lost to Follow-up|0
6936949|NCT00912093|10970795|FG004|The Controlled Phase|Lost to Follow-up|1
6936950|NCT00912197|10970805|FG000|Overall Study|Withdrawal by Subject|3
6936951|NCT00912197|10970806|FG001|Overall Study|Withdrawal by Subject|3
6936952|NCT00912288|10970816|FG000|Overall Study|Death|0
6936953|NCT00912288|10970817|FG001|Overall Study|Death|1
6936954|NCT00912288|10970816|FG000|Overall Study|Adverse Event|1
6936955|NCT00912288|10970817|FG001|Overall Study|Adverse Event|1
6936956|NCT00912288|10970816|FG000|Overall Study|Lost to Follow-up|1
6936957|NCT00912288|10970817|FG001|Overall Study|Lost to Follow-up|0
6936958|NCT00912288|10970816|FG000|Overall Study|Protocol Violation|1
6936959|NCT00912288|10970817|FG001|Overall Study|Protocol Violation|0
6936960|NCT00912288|10970816|FG000|Overall Study|Withdrawal by Subject|3
6936961|NCT00912288|10970817|FG001|Overall Study|Withdrawal by Subject|3
6936962|NCT00912288|10970816|FG000|Overall Study|Study terminated by sponsor|34
6936963|NCT00912288|10970817|FG001|Overall Study|Study terminated by sponsor|35
6936964|NCT00912288|10970816|FG000|Overall Study|Other|1
6936965|NCT00912288|10970817|FG001|Overall Study|Other|0
6936966|NCT00912340|10970839|FG000|Overall Study|Adverse Event|2
6936967|NCT00912340|10970840|FG001|Overall Study|Adverse Event|4
6936968|NCT00912340|10970841|FG002|Overall Study|Adverse Event|0
6936969|NCT00912340|10970839|FG000|Overall Study|Protocol revised to remove arm|0
6936970|NCT00912340|10970840|FG001|Overall Study|Protocol revised to remove arm|0
6936971|NCT00912340|10970841|FG002|Overall Study|Protocol revised to remove arm|4
6936972|NCT00912405|10970849|FG000|Overall Study|Lost to Follow-up|5
6936973|NCT00912509|10970855|FG000|Overall Study|Lost to Follow-up|1
6936974|NCT00912509|10970856|FG001|Overall Study|Lost to Follow-up|0
6936975|NCT00912509|10970855|FG000|Overall Study|Lack of Efficacy|4
6936976|NCT00912509|10970856|FG001|Overall Study|Lack of Efficacy|3
6936977|NCT00912743|10970865|FG000|Overall Study|Adverse Event|3
6936978|NCT00912743|10970866|FG001|Overall Study|Adverse Event|1
6936979|NCT00912743|10970865|FG000|Overall Study|Lack of Efficacy|9
6936980|NCT00912743|10970866|FG001|Overall Study|Lack of Efficacy|18
6936981|NCT00912743|10970865|FG000|Overall Study|Toxicity|0
6936982|NCT00912743|10970866|FG001|Overall Study|Toxicity|1
6936983|NCT00912743|10970865|FG000|Overall Study|End of treatment form was not collected|1
6936984|NCT00912743|10970866|FG001|Overall Study|End of treatment form was not collected|0
6936985|NCT00912782|10970874|FG000|Overall Study|Death|2
6936986|NCT00912782|10970875|FG001|Overall Study|Death|1
6936987|NCT00912782|10970874|FG000|Overall Study|Lost to Follow-up|0
6936988|NCT00912782|10970875|FG001|Overall Study|Lost to Follow-up|1
6936989|NCT00912782|10970874|FG000|Overall Study|Did not receive vascular access type|1
6936990|NCT00912782|10970875|FG001|Overall Study|Did not receive vascular access type|2
6936991|NCT00912782|10970874|FG000|Overall Study|Relocated before study completion|0
7040157|NCT01716234|11123166|FG005|Overall Study|Lack of Efficacy|0
6936992|NCT00912782|10970875|FG001|Overall Study|Relocated before study completion|1
6936993|NCT00912808|10970892|FG000|First Intervention (6 Weeks)|Adverse Event|2
6936994|NCT00912808|10970893|FG001|First Intervention (6 Weeks)|Adverse Event|1
6936995|NCT00912808|10970892|FG000|Washout|Withdrawal by Subject|0
6936996|NCT00912808|10970893|FG001|Washout|Withdrawal by Subject|1
6936997|NCT00912808|10970892|FG000|Second Intervention (6 Weeks)|Adverse Event|0
6936998|NCT00912808|10970893|FG001|Second Intervention (6 Weeks)|Adverse Event|1
6936999|NCT00912808|10970892|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1
6937000|NCT00912808|10970893|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0
6937001|NCT00912912|10970913|FG000|Overall Study|Withdrawal by Subject|1
6937002|NCT00912912|10970913|FG000|Overall Study|Disease Progression|3
6937003|NCT00912964|10970929|FG000|Overall Study|Eligibility criterion not met|1
6937004|NCT00912964|10970930|FG001|Overall Study|Eligibility criterion not met|1
6937005|NCT00912964|10970931|FG002|Overall Study|Eligibility criterion not met|0
6937006|NCT00912964|10970929|FG000|Overall Study|Adverse Event|15
6937007|NCT00912964|10970930|FG001|Overall Study|Adverse Event|18
6937008|NCT00912964|10970931|FG002|Overall Study|Adverse Event|12
6937009|NCT00912964|10970929|FG000|Overall Study|Lack of Efficacy|11
6937010|NCT00912964|10970930|FG001|Overall Study|Lack of Efficacy|4
6937011|NCT00912964|10970931|FG002|Overall Study|Lack of Efficacy|3
6937012|NCT00912964|10970929|FG000|Overall Study|Withdrawal by Subject|20
6937013|NCT00912964|10970930|FG001|Overall Study|Withdrawal by Subject|12
6937014|NCT00912964|10970931|FG002|Overall Study|Withdrawal by Subject|18
6937015|NCT00912964|10970929|FG000|Overall Study|Lost to Follow-up|4
6937016|NCT00912964|10970930|FG001|Overall Study|Lost to Follow-up|3
6937017|NCT00912964|10970931|FG002|Overall Study|Lost to Follow-up|3
6937018|NCT00912964|10970929|FG000|Overall Study|Protocol Violation|5
6937019|NCT00912964|10970930|FG001|Overall Study|Protocol Violation|3
6937020|NCT00912964|10970931|FG002|Overall Study|Protocol Violation|8
6937021|NCT00912964|10970929|FG000|Overall Study|Taking exclusionary medications|7
6937022|NCT00912964|10970930|FG001|Overall Study|Taking exclusionary medications|4
6937023|NCT00912964|10970931|FG002|Overall Study|Taking exclusionary medications|8
6937024|NCT00912964|10970929|FG000|Overall Study|Medical History|1
6937025|NCT00912964|10970930|FG001|Overall Study|Medical History|0
6937026|NCT00912964|10970931|FG002|Overall Study|Medical History|0
6937027|NCT00912964|10970929|FG000|Overall Study|Non-compliance with study procedures|2
6937028|NCT00912964|10970930|FG001|Overall Study|Non-compliance with study procedures|0
7040158|NCT01716234|11123167|FG006|Overall Study|Lack of Efficacy|0
6937029|NCT00912964|10970931|FG002|Overall Study|Non-compliance with study procedures|0
6937030|NCT00912964|10970929|FG000|Overall Study|Violation of exclusion criterion|0
6937031|NCT00912964|10970930|FG001|Overall Study|Violation of exclusion criterion|0
6937032|NCT00912964|10970931|FG002|Overall Study|Violation of exclusion criterion|2
6937033|NCT00912964|10970929|FG000|Overall Study|Randomized but never received study drug|0
6937034|NCT00912964|10970930|FG001|Overall Study|Randomized but never received study drug|1
6937035|NCT00912964|10970931|FG002|Overall Study|Randomized but never received study drug|0
6937036|NCT00913380|10970990|FG000|Clinical Outcomes|Lost to Follow-up|6
6937037|NCT00913380|10970991|FG001|Clinical Outcomes|Lost to Follow-up|6
6937038|NCT00913458|10970997|FG000|Phase 1|Non-Responder|54
6937039|NCT00913458|10970998|FG001|Phase 1|Non-Responder|0
6937040|NCT00913458|10970999|FG002|Phase 1|Non-Responder|0
6937041|NCT00913458|10971000|FG003|Phase 1|Non-Responder|0
6937042|NCT00913458|10971001|FG004|Phase 1|Non-Responder|0
6937043|NCT00913458|10971002|FG005|Phase 1|Non-Responder|0
6937044|NCT00913458|10971003|FG006|Phase 1|Non-Responder|0
6937045|NCT00913458|10970997|FG000|Phase 1|Subject Request|17
6937046|NCT00913458|10970998|FG001|Phase 1|Subject Request|0
6937047|NCT00913458|10970999|FG002|Phase 1|Subject Request|0
6937048|NCT00913458|10971000|FG003|Phase 1|Subject Request|0
6937049|NCT00913458|10971001|FG004|Phase 1|Subject Request|0
6937050|NCT00913458|10971002|FG005|Phase 1|Subject Request|0
6937051|NCT00913458|10971003|FG006|Phase 1|Subject Request|0
6937052|NCT00913458|10970997|FG000|Phase 1|Adverse Event|20
6937053|NCT00913458|10970998|FG001|Phase 1|Adverse Event|0
6937054|NCT00913458|10970999|FG002|Phase 1|Adverse Event|0
6937055|NCT00913458|10971000|FG003|Phase 1|Adverse Event|0
6937056|NCT00913458|10971001|FG004|Phase 1|Adverse Event|0
6937057|NCT00913458|10971002|FG005|Phase 1|Adverse Event|0
6937058|NCT00913458|10971003|FG006|Phase 1|Adverse Event|0
6937059|NCT00913458|10970997|FG000|Phase 1|Lost to Follow-up|2
6937060|NCT00913458|10970998|FG001|Phase 1|Lost to Follow-up|0
6937061|NCT00913458|10970999|FG002|Phase 1|Lost to Follow-up|0
6937062|NCT00913458|10971000|FG003|Phase 1|Lost to Follow-up|0
6937063|NCT00913458|10971001|FG004|Phase 1|Lost to Follow-up|0
6937064|NCT00913458|10971002|FG005|Phase 1|Lost to Follow-up|0
6937065|NCT00913458|10971003|FG006|Phase 1|Lost to Follow-up|0
6937066|NCT00913458|10970997|FG000|Phase 1|Protocol Violation|10
6937067|NCT00913458|10970998|FG001|Phase 1|Protocol Violation|0
6937068|NCT00913458|10970999|FG002|Phase 1|Protocol Violation|0
6937069|NCT00913458|10971000|FG003|Phase 1|Protocol Violation|0
6937070|NCT00913458|10971001|FG004|Phase 1|Protocol Violation|0
6937071|NCT00913458|10971002|FG005|Phase 1|Protocol Violation|0
6937072|NCT00913458|10971003|FG006|Phase 1|Protocol Violation|0
6937073|NCT00913458|10970997|FG000|Phase 1|Sponsor|2
6937074|NCT00913458|10970998|FG001|Phase 1|Sponsor|0
6937075|NCT00913458|10970999|FG002|Phase 1|Sponsor|0
6937076|NCT00913458|10971000|FG003|Phase 1|Sponsor|0
6937077|NCT00913458|10971001|FG004|Phase 1|Sponsor|0
6937078|NCT00913458|10971002|FG005|Phase 1|Sponsor|0
6937079|NCT00913458|10971003|FG006|Phase 1|Sponsor|0
6937080|NCT00913458|10970997|FG000|Phase 1|Unsatisfactory Response per Investigator|7
6937081|NCT00913458|10970998|FG001|Phase 1|Unsatisfactory Response per Investigator|0
6937082|NCT00913458|10970999|FG002|Phase 1|Unsatisfactory Response per Investigator|0
6937083|NCT00913458|10971000|FG003|Phase 1|Unsatisfactory Response per Investigator|0
6937084|NCT00913458|10971001|FG004|Phase 1|Unsatisfactory Response per Investigator|0
6937085|NCT00913458|10971002|FG005|Phase 1|Unsatisfactory Response per Investigator|0
6937086|NCT00913458|10971003|FG006|Phase 1|Unsatisfactory Response per Investigator|0
6937087|NCT00913458|10970997|FG000|Phase 2|Non-Responder|0
6937088|NCT00913458|10970998|FG001|Phase 2|Non-Responder|5
6937089|NCT00913458|10970999|FG002|Phase 2|Non-Responder|7
6937090|NCT00913458|10971000|FG003|Phase 2|Non-Responder|12
6937091|NCT00913458|10971001|FG004|Phase 2|Non-Responder|0
6937092|NCT00913458|10971002|FG005|Phase 2|Non-Responder|0
6937093|NCT00913458|10971003|FG006|Phase 2|Non-Responder|0
6937094|NCT00913458|10970997|FG000|Phase 2|Subject Request|0
6937095|NCT00913458|10970998|FG001|Phase 2|Subject Request|0
6937096|NCT00913458|10970999|FG002|Phase 2|Subject Request|1
6937097|NCT00913458|10971000|FG003|Phase 2|Subject Request|2
6937098|NCT00913458|10971001|FG004|Phase 2|Subject Request|0
6937099|NCT00913458|10971002|FG005|Phase 2|Subject Request|0
6937100|NCT00913458|10971003|FG006|Phase 2|Subject Request|0
6937101|NCT00913458|10970997|FG000|Phase 2|Adverse Event|0
6937102|NCT00913458|10970998|FG001|Phase 2|Adverse Event|3
6937103|NCT00913458|10970999|FG002|Phase 2|Adverse Event|0
6937104|NCT00913458|10971000|FG003|Phase 2|Adverse Event|1
6937105|NCT00913458|10971001|FG004|Phase 2|Adverse Event|0
6937106|NCT00913458|10971002|FG005|Phase 2|Adverse Event|0
6937107|NCT00913458|10971003|FG006|Phase 2|Adverse Event|0
6937108|NCT00913458|10970997|FG000|Phase 2|Lost to Follow-up|0
6937109|NCT00913458|10970998|FG001|Phase 2|Lost to Follow-up|0
6937110|NCT00913458|10970999|FG002|Phase 2|Lost to Follow-up|0
6937111|NCT00913458|10971000|FG003|Phase 2|Lost to Follow-up|1
6937112|NCT00913458|10971001|FG004|Phase 2|Lost to Follow-up|0
6937113|NCT00913458|10971002|FG005|Phase 2|Lost to Follow-up|0
6937114|NCT00913458|10971003|FG006|Phase 2|Lost to Follow-up|0
6937115|NCT00913458|10970997|FG000|Phase 2|Protocol Violation|0
6937116|NCT00913458|10970998|FG001|Phase 2|Protocol Violation|2
6937117|NCT00913458|10970999|FG002|Phase 2|Protocol Violation|0
6937118|NCT00913458|10971000|FG003|Phase 2|Protocol Violation|0
6937119|NCT00913458|10971001|FG004|Phase 2|Protocol Violation|0
6937120|NCT00913458|10971002|FG005|Phase 2|Protocol Violation|0
6937121|NCT00913458|10971003|FG006|Phase 2|Protocol Violation|0
6937122|NCT00913458|10970997|FG000|Phase 2|Unsatisfactory Response per Investigator|0
6937123|NCT00913458|10970998|FG001|Phase 2|Unsatisfactory Response per Investigator|0
6937124|NCT00913458|10970999|FG002|Phase 2|Unsatisfactory Response per Investigator|11
6937125|NCT00913458|10971000|FG003|Phase 2|Unsatisfactory Response per Investigator|17
6937126|NCT00913458|10971001|FG004|Phase 2|Unsatisfactory Response per Investigator|0
6937127|NCT00913458|10971002|FG005|Phase 2|Unsatisfactory Response per Investigator|0
6937128|NCT00913458|10971003|FG006|Phase 2|Unsatisfactory Response per Investigator|0
6937129|NCT00913458|10970997|FG000|Phase 3|Adverse Event|0
6937130|NCT00913458|10970998|FG001|Phase 3|Adverse Event|0
6937131|NCT00913458|10970999|FG002|Phase 3|Adverse Event|0
6937132|NCT00913458|10971000|FG003|Phase 3|Adverse Event|0
6937133|NCT00913458|10971001|FG004|Phase 3|Adverse Event|5
6937134|NCT00913458|10971002|FG005|Phase 3|Adverse Event|4
6937135|NCT00913458|10971003|FG006|Phase 3|Adverse Event|1
6937136|NCT00913458|10970997|FG000|Phase 3|Lost to Follow-up|0
6937137|NCT00913458|10970998|FG001|Phase 3|Lost to Follow-up|0
6937138|NCT00913458|10970999|FG002|Phase 3|Lost to Follow-up|0
6937139|NCT00913458|10971000|FG003|Phase 3|Lost to Follow-up|0
6937140|NCT00913458|10971001|FG004|Phase 3|Lost to Follow-up|2
6937141|NCT00913458|10971002|FG005|Phase 3|Lost to Follow-up|0
6937142|NCT00913458|10971003|FG006|Phase 3|Lost to Follow-up|0
6937143|NCT00913458|10970997|FG000|Phase 3|Non-Responder|0
6937144|NCT00913458|10970998|FG001|Phase 3|Non-Responder|0
6937145|NCT00913458|10970999|FG002|Phase 3|Non-Responder|0
6937146|NCT00913458|10971000|FG003|Phase 3|Non-Responder|0
6937147|NCT00913458|10971001|FG004|Phase 3|Non-Responder|0
6937148|NCT00913458|10971002|FG005|Phase 3|Non-Responder|1
6937149|NCT00913458|10971003|FG006|Phase 3|Non-Responder|3
6937150|NCT00913458|10970997|FG000|Phase 3|Withdrawal by Subject|0
6937151|NCT00913458|10970998|FG001|Phase 3|Withdrawal by Subject|0
6937152|NCT00913458|10970999|FG002|Phase 3|Withdrawal by Subject|0
6937153|NCT00913458|10971000|FG003|Phase 3|Withdrawal by Subject|0
6937154|NCT00913458|10971001|FG004|Phase 3|Withdrawal by Subject|1
6937155|NCT00913458|10971002|FG005|Phase 3|Withdrawal by Subject|2
6937156|NCT00913458|10971003|FG006|Phase 3|Withdrawal by Subject|0
6937157|NCT00913458|10970997|FG000|Phase 3|Unsatisfactory Response per Investigator|0
6937158|NCT00913458|10970998|FG001|Phase 3|Unsatisfactory Response per Investigator|0
6937159|NCT00913458|10970999|FG002|Phase 3|Unsatisfactory Response per Investigator|0
6937160|NCT00913458|10971000|FG003|Phase 3|Unsatisfactory Response per Investigator|0
6937161|NCT00913458|10971001|FG004|Phase 3|Unsatisfactory Response per Investigator|14
6937162|NCT00913458|10971002|FG005|Phase 3|Unsatisfactory Response per Investigator|11
6937163|NCT00913458|10971003|FG006|Phase 3|Unsatisfactory Response per Investigator|4
6937164|NCT00913523|10971032|FG000|Overall Study|Withdrawal by Subject|3
6937165|NCT00913523|10971033|FG001|Overall Study|Withdrawal by Subject|2
6937166|NCT00913523|10971034|FG002|Overall Study|Withdrawal by Subject|2
6937167|NCT00913523|10971032|FG000|Overall Study|Lost to Follow-up|1
6937168|NCT00913523|10971033|FG001|Overall Study|Lost to Follow-up|1
6937169|NCT00913523|10971034|FG002|Overall Study|Lost to Follow-up|1
6937170|NCT00913523|10971032|FG000|Overall Study|Adverse Event|1
6937171|NCT00913523|10971033|FG001|Overall Study|Adverse Event|0
6937172|NCT00913523|10971034|FG002|Overall Study|Adverse Event|0
6937173|NCT00913523|10971032|FG000|Overall Study|Protocol Violation|5
6937174|NCT00913523|10971033|FG001|Overall Study|Protocol Violation|8
6937175|NCT00913523|10971034|FG002|Overall Study|Protocol Violation|8
6937176|NCT00913523|10971032|FG000|Overall Study|Pregnancy|1
6937177|NCT00913523|10971033|FG001|Overall Study|Pregnancy|3
6937178|NCT00913523|10971034|FG002|Overall Study|Pregnancy|0
6937179|NCT00913523|10971032|FG000|Overall Study|Inadequate Number of Tampons Used|7
6937180|NCT00913523|10971033|FG001|Overall Study|Inadequate Number of Tampons Used|2
6937181|NCT00913523|10971034|FG002|Overall Study|Inadequate Number of Tampons Used|3
6937182|NCT00913744|10971061|FG000|Overall Study|Adverse Event|2
6937183|NCT00913744|10971062|FG001|Overall Study|Adverse Event|0
6937184|NCT00913744|10971061|FG000|Overall Study|Withdrawal by Subject|2
6937185|NCT00913744|10971062|FG001|Overall Study|Withdrawal by Subject|1
6937186|NCT00913744|10971061|FG000|Overall Study|Death|1
6937187|NCT00913744|10971062|FG001|Overall Study|Death|0
6937188|NCT00913770|10971071|FG000|Overall Study|Unable to contact|24
6937189|NCT00913770|10971072|FG001|Overall Study|Unable to contact|19
6937190|NCT00913770|10971073|FG002|Overall Study|Unable to contact|13
6937191|NCT00913770|10971071|FG000|Overall Study|Refused|11
6937192|NCT00913770|10971072|FG001|Overall Study|Refused|10
6937193|NCT00913770|10971073|FG002|Overall Study|Refused|8
6937194|NCT00913835|10971083|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2
6937195|NCT00913835|10971084|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3
6937196|NCT00913835|10971083|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1
6937197|NCT00913835|10971084|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0
6937198|NCT00913835|10971083|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4
6937199|NCT00913835|10971084|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3
6937200|NCT00913835|10971083|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
6937201|NCT00913835|10971084|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
6937202|NCT00913835|10971083|FG000|Lip Dox: Olaratumab Monotherapy|Other|0
6937203|NCT00913835|10971084|FG001|Lip Dox: Olaratumab Monotherapy|Other|3
6975367|NCT01192516|11027535|FG000|Overall Study|Unable to follow Actiwatch instructions|4
6975368|NCT01192516|11027536|FG001|Overall Study|Unable to follow Actiwatch instructions|2
6975369|NCT01192516|11027537|FG002|Overall Study|Unable to follow Actiwatch instructions|0
6937204|NCT00913978|10971103|FG000|Overall Study|Surgeon choice|1
6937205|NCT00913978|10971104|FG001|Overall Study|Surgeon choice|3
6937206|NCT00914316|10971141|FG000|Phase 1|Physician Decision|4
6937207|NCT00914316|10971142|FG001|Phase 1|Physician Decision|0
6937208|NCT00914316|10971143|FG002|Phase 1|Physician Decision|1
6937209|NCT00914316|10971144|FG003|Phase 1|Physician Decision|2
6937210|NCT00914316|10971141|FG000|Phase 1|Withdrawal by Subject|0
6937211|NCT00914316|10971142|FG001|Phase 1|Withdrawal by Subject|2
6937212|NCT00914316|10971143|FG002|Phase 1|Withdrawal by Subject|4
6937213|NCT00914316|10971144|FG003|Phase 1|Withdrawal by Subject|0
6937214|NCT00914316|10971141|FG000|Phase 1|Adverse Event|1
6937215|NCT00914316|10971142|FG001|Phase 1|Adverse Event|0
6937216|NCT00914316|10971143|FG002|Phase 1|Adverse Event|0
6937217|NCT00914316|10971144|FG003|Phase 1|Adverse Event|0
6937218|NCT00914316|10971141|FG000|Phase 2|Withdrawal by Subject|1
6937219|NCT00914316|10971142|FG001|Phase 2|Withdrawal by Subject|0
6937220|NCT00914316|10971143|FG002|Phase 2|Withdrawal by Subject|1
6937221|NCT00914316|10971144|FG003|Phase 2|Withdrawal by Subject|0
6937222|NCT00914459|10971156|FG000|Overall Study|Protocol Violation|0
6937223|NCT00914459|10971157|FG001|Overall Study|Protocol Violation|1
6937224|NCT00914459|10971156|FG000|Overall Study|Parent/Legal guardian request|1
6937225|NCT00914459|10971157|FG001|Overall Study|Parent/Legal guardian request|0
6937226|NCT00914589|10971172|FG000|Overall Study|Adverse Event|1
6937227|NCT00914589|10971173|FG001|Overall Study|Adverse Event|0
6937228|NCT00914589|10971174|FG002|Overall Study|Adverse Event|1
6937229|NCT00914589|10971172|FG000|Overall Study|Protocol Violation|8
6937230|NCT00914589|10971173|FG001|Overall Study|Protocol Violation|6
6937231|NCT00914589|10971174|FG002|Overall Study|Protocol Violation|3
6937232|NCT00914589|10971172|FG000|Overall Study|unclassified|16
6937233|NCT00914589|10971173|FG001|Overall Study|unclassified|9
6937234|NCT00914589|10971174|FG002|Overall Study|unclassified|7
6937235|NCT00914589|10971172|FG000|Overall Study|Death|0
6937236|NCT00914589|10971173|FG001|Overall Study|Death|1
6937237|NCT00914589|10971174|FG002|Overall Study|Death|1
6937238|NCT00914628|10971184|FG000|Overall Study|Death|35
6937239|NCT00914628|10971185|FG001|Overall Study|Death|17
6937240|NCT00914628|10971184|FG000|Overall Study|Medical decision|4
6937241|NCT00914628|10971185|FG001|Overall Study|Medical decision|0
6937242|NCT00914628|10971184|FG000|Overall Study|Protocol Violation|1
6937243|NCT00914628|10971185|FG001|Overall Study|Protocol Violation|0
6937244|NCT00914628|10971184|FG000|Overall Study|Lack of Efficacy|1
6937245|NCT00914628|10971185|FG001|Overall Study|Lack of Efficacy|0
6937246|NCT00914628|10971184|FG000|Overall Study|non-randomized|1
6937247|NCT00914628|10971185|FG001|Overall Study|non-randomized|0
6937248|NCT00914628|10971184|FG000|Overall Study|Relapse|1
6937249|NCT00914628|10971185|FG001|Overall Study|Relapse|2
6937250|NCT00914628|10971184|FG000|Overall Study|Study terminated by Sponsor|14
6937251|NCT00914628|10971185|FG001|Overall Study|Study terminated by Sponsor|8
6937252|NCT00914628|10971184|FG000|Overall Study|Patients who did not receive a single dose|7
6937253|NCT00914628|10971185|FG001|Overall Study|Patients who did not receive a single dose|1
6937254|NCT00914732|10971198|FG000|Overall Study|Lost to Follow-up|6
6937255|NCT00914732|10971199|FG001|Overall Study|Lost to Follow-up|7
6937256|NCT00914732|10971200|FG002|Overall Study|Lost to Follow-up|9
6937257|NCT00914732|10971198|FG000|Overall Study|Withdrawal by Subject|3
6937258|NCT00914732|10971199|FG001|Overall Study|Withdrawal by Subject|0
6937259|NCT00914732|10971200|FG002|Overall Study|Withdrawal by Subject|2
6937260|NCT00914732|10971198|FG000|Overall Study|Adverse Event|1
6937261|NCT00914732|10971199|FG001|Overall Study|Adverse Event|0
6937262|NCT00914732|10971200|FG002|Overall Study|Adverse Event|0
6937263|NCT00914810|10971211|FG000|Overall Study|Withdrawal by Subject|1
6937264|NCT00914810|10971212|FG001|Overall Study|Withdrawal by Subject|0
6937265|NCT00914810|10971211|FG000|Overall Study|Relocated out of state|1
6937266|NCT00914810|10971212|FG001|Overall Study|Relocated out of state|0
6937267|NCT00914810|10971211|FG000|Overall Study|Hospitalized and unable to follow up.|0
6937268|NCT00914810|10971212|FG001|Overall Study|Hospitalized and unable to follow up.|1
6937269|NCT00914849|10971220|FG000|Overall Study|Withdrawal by Subject|1
6937270|NCT00914849|10971221|FG001|Overall Study|Withdrawal by Subject|0
6937271|NCT00914849|10971220|FG000|Overall Study|Not eligible|0
6937272|NCT00914849|10971221|FG001|Overall Study|Not eligible|1
6937273|NCT00914927|10971255|FG000|Overall Study|Adverse Event|0
6937274|NCT00914927|10971256|FG001|Overall Study|Adverse Event|0
6937275|NCT00914927|10971257|FG002|Overall Study|Adverse Event|0
6937276|NCT00914927|10971258|FG003|Overall Study|Adverse Event|0
6937277|NCT00914927|10971259|FG004|Overall Study|Adverse Event|1
6937278|NCT00914927|10971260|FG005|Overall Study|Adverse Event|0
6937279|NCT00914927|10971261|FG006|Overall Study|Adverse Event|0
6937280|NCT00914927|10971255|FG000|Overall Study|Withdrawal by Subject|0
6937281|NCT00914927|10971256|FG001|Overall Study|Withdrawal by Subject|1
6937282|NCT00914927|10971257|FG002|Overall Study|Withdrawal by Subject|0
6937283|NCT00914927|10971258|FG003|Overall Study|Withdrawal by Subject|1
6937284|NCT00914927|10971259|FG004|Overall Study|Withdrawal by Subject|0
6937285|NCT00914927|10971260|FG005|Overall Study|Withdrawal by Subject|0
6937286|NCT00914927|10971261|FG006|Overall Study|Withdrawal by Subject|0
6937287|NCT00914927|10971255|FG000|Overall Study|Lost to Follow-up|0
6937288|NCT00914927|10971256|FG001|Overall Study|Lost to Follow-up|0
6937289|NCT00914927|10971257|FG002|Overall Study|Lost to Follow-up|0
6838119|NCT00256750|10843793|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3
6838120|NCT00256750|10843794|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0
6838121|NCT00256750|10843792|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4
6838122|NCT00256750|10843793|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
6838123|NCT00256750|10843794|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
6838124|NCT00256750|10843792|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0
6838125|NCT00256750|10843793|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1
6838126|NCT00256750|10843794|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2
6838127|NCT00256750|10843792|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
6838128|NCT00256750|10843793|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
6937290|NCT00914927|10971258|FG003|Overall Study|Lost to Follow-up|1
6937291|NCT00914927|10971259|FG004|Overall Study|Lost to Follow-up|0
6937292|NCT00914927|10971260|FG005|Overall Study|Lost to Follow-up|0
6937293|NCT00914927|10971261|FG006|Overall Study|Lost to Follow-up|0
6937294|NCT00914927|10971255|FG000|Overall Study|Administrative/Other|2
6937295|NCT00914927|10971256|FG001|Overall Study|Administrative/Other|1
6937296|NCT00914927|10971257|FG002|Overall Study|Administrative/Other|0
6937297|NCT00914927|10971258|FG003|Overall Study|Administrative/Other|0
6937298|NCT00914927|10971259|FG004|Overall Study|Administrative/Other|1
6937299|NCT00914927|10971260|FG005|Overall Study|Administrative/Other|0
6937300|NCT00914927|10971261|FG006|Overall Study|Administrative/Other|0
6937301|NCT00914940|10971286|FG000|D0 to D100 Post-transplant|Death|2
6937302|NCT00914940|10971286|FG000|D101 to 2 Years Post-transplant|Death|8
6937303|NCT00914940|10971286|FG000|2 Years to 5 Years Post-transplant|Death|3
6937304|NCT00914966|10971290|FG000|Step 1: 1500 Units|Withdrawal by Subject|1
6937305|NCT00914966|10971290|FG000|Step 1: 1500 Units|Physician Decision|1
6937306|NCT00914966|10971290|FG000|Step 2: 2000 Units|Withdrawal by Subject|1
6937307|NCT00915005|10971301|FG000|Overall Study|Withdrawal by Subject|4
6937308|NCT00915005|10971302|FG001|Overall Study|Withdrawal by Subject|4
6937309|NCT00915005|10971301|FG000|Overall Study|Patient preferred protons therapy|6
6937310|NCT00915005|10971302|FG001|Overall Study|Patient preferred protons therapy|0
6937311|NCT00915005|10971301|FG000|Overall Study|Insurance denial|3
6937312|NCT00915005|10971302|FG001|Overall Study|Insurance denial|15
6937313|NCT00915018|10971310|FG000|Overall Study|Death|75
6937314|NCT00915018|10971311|FG001|Overall Study|Death|70
6937315|NCT00915018|10971310|FG000|Overall Study|Lost to Follow-up|10
6937316|NCT00915018|10971311|FG001|Overall Study|Lost to Follow-up|5
6937317|NCT00915018|10971310|FG000|Overall Study|Withdrawal by Subject|38
6937318|NCT00915018|10971311|FG001|Overall Study|Withdrawal by Subject|27
6937319|NCT00915018|10971310|FG000|Overall Study|By Sponsor due to Protocol Amendment|92
6937320|NCT00915018|10971311|FG001|Overall Study|By Sponsor due to Protocol Amendment|105
6937321|NCT00915278|10971336|FG000|Overall Study|Death|1
6937322|NCT00915278|10971337|FG001|Overall Study|Death|0
6937323|NCT00915278|10971338|FG002|Overall Study|Death|0
6937324|NCT00915278|10971339|FG003|Overall Study|Death|0
6937325|NCT00915278|10971340|FG004|Overall Study|Death|0
6937326|NCT00915278|10971341|FG005|Overall Study|Death|0
6937327|NCT00915278|10971336|FG000|Overall Study|Lost to Follow-up|0
6937328|NCT00915278|10971337|FG001|Overall Study|Lost to Follow-up|1
6937329|NCT00915278|10971338|FG002|Overall Study|Lost to Follow-up|0
6937330|NCT00915278|10971339|FG003|Overall Study|Lost to Follow-up|0
6937331|NCT00915278|10971340|FG004|Overall Study|Lost to Follow-up|0
6937332|NCT00915278|10971341|FG005|Overall Study|Lost to Follow-up|0
6937333|NCT00915278|10971336|FG000|Overall Study|Withdrawal by Subject|0
6937334|NCT00915278|10971337|FG001|Overall Study|Withdrawal by Subject|1
6937335|NCT00915278|10971338|FG002|Overall Study|Withdrawal by Subject|0
6937336|NCT00915278|10971339|FG003|Overall Study|Withdrawal by Subject|0
6937337|NCT00915278|10971340|FG004|Overall Study|Withdrawal by Subject|1
6937338|NCT00915278|10971341|FG005|Overall Study|Withdrawal by Subject|4
6937339|NCT00915278|10971336|FG000|Overall Study|Adverse Event|4
6937340|NCT00915278|10971337|FG001|Overall Study|Adverse Event|1
6937341|NCT00915278|10971338|FG002|Overall Study|Adverse Event|0
6937342|NCT00915278|10971339|FG003|Overall Study|Adverse Event|0
6937343|NCT00915278|10971340|FG004|Overall Study|Adverse Event|0
6937344|NCT00915278|10971341|FG005|Overall Study|Adverse Event|0
6937345|NCT00915278|10971336|FG000|Overall Study|Progressive disease/clinical progression|0
6937346|NCT00915278|10971337|FG001|Overall Study|Progressive disease/clinical progression|0
6937347|NCT00915278|10971338|FG002|Overall Study|Progressive disease/clinical progression|0
6937348|NCT00915278|10971339|FG003|Overall Study|Progressive disease/clinical progression|3
6937349|NCT00915278|10971340|FG004|Overall Study|Progressive disease/clinical progression|1
6937350|NCT00915278|10971341|FG005|Overall Study|Progressive disease/clinical progression|2
6937351|NCT00915278|10971336|FG000|Overall Study|Infusion related AEs|0
6937352|NCT00915278|10971337|FG001|Overall Study|Infusion related AEs|0
6937353|NCT00915278|10971338|FG002|Overall Study|Infusion related AEs|0
6937354|NCT00915278|10971339|FG003|Overall Study|Infusion related AEs|0
6937355|NCT00915278|10971340|FG004|Overall Study|Infusion related AEs|0
6937356|NCT00915278|10971341|FG005|Overall Study|Infusion related AEs|2
6937357|NCT00915278|10971336|FG000|Overall Study|Admission to hospice|0
6937358|NCT00915278|10971337|FG001|Overall Study|Admission to hospice|0
6937359|NCT00915278|10971338|FG002|Overall Study|Admission to hospice|1
6937360|NCT00915278|10971339|FG003|Overall Study|Admission to hospice|0
6937361|NCT00915278|10971340|FG004|Overall Study|Admission to hospice|0
6937362|NCT00915278|10971341|FG005|Overall Study|Admission to hospice|0
6937363|NCT00915343|10971355|FG000|Part B - Open Label Period|Treatment switch|0
6937364|NCT00915343|10971356|FG001|Part B - Open Label Period|Treatment switch|0
6937365|NCT00915343|10971357|FG002|Part B - Open Label Period|Treatment switch|1
6937366|NCT00915343|10971355|FG000|Part B - Open Label Period|Did not attend the last visit|0
6937367|NCT00915343|10971356|FG001|Part B - Open Label Period|Did not attend the last visit|0
6937368|NCT00915343|10971357|FG002|Part B - Open Label Period|Did not attend the last visit|1
6937369|NCT00915356|10971374|FG000|Overall Study|Withdrawal by Subject|1
6937370|NCT00915356|10971375|FG001|Overall Study|Withdrawal by Subject|0
6937371|NCT00915356|10971376|FG002|Overall Study|Withdrawal by Subject|0
6937372|NCT00915356|10971377|FG003|Overall Study|Withdrawal by Subject|0
6937373|NCT00915356|10971378|FG004|Overall Study|Withdrawal by Subject|0
7040159|NCT01716234|11123161|FG000|Overall Study|Did not meet protocol eligibility|0
7040160|NCT01716234|11123162|FG001|Overall Study|Did not meet protocol eligibility|0
7040161|NCT01716234|11123163|FG002|Overall Study|Did not meet protocol eligibility|1
7040162|NCT01716234|11123164|FG003|Overall Study|Did not meet protocol eligibility|0
7040163|NCT01716234|11123165|FG004|Overall Study|Did not meet protocol eligibility|0
7040164|NCT01716234|11123166|FG005|Overall Study|Did not meet protocol eligibility|4
7040165|NCT01716234|11123167|FG006|Overall Study|Did not meet protocol eligibility|0
7040166|NCT01716234|11123161|FG000|Overall Study|Adverse Event|7
7040167|NCT01716234|11123162|FG001|Overall Study|Adverse Event|10
7040168|NCT01716234|11123163|FG002|Overall Study|Adverse Event|2
7040169|NCT01716234|11123164|FG003|Overall Study|Adverse Event|8
7040170|NCT01716234|11123165|FG004|Overall Study|Adverse Event|3
7040171|NCT01716234|11123166|FG005|Overall Study|Adverse Event|6
7040172|NCT01716234|11123167|FG006|Overall Study|Adverse Event|0
7040173|NCT01716234|11123161|FG000|Overall Study|Withdrawal by Subject|3
7040174|NCT01716234|11123162|FG001|Overall Study|Withdrawal by Subject|0
7040175|NCT01716234|11123163|FG002|Overall Study|Withdrawal by Subject|2
7040176|NCT01716234|11123164|FG003|Overall Study|Withdrawal by Subject|2
7040177|NCT01716234|11123165|FG004|Overall Study|Withdrawal by Subject|1
7040178|NCT01716234|11123166|FG005|Overall Study|Withdrawal by Subject|3
7040179|NCT01716234|11123167|FG006|Overall Study|Withdrawal by Subject|0
7040180|NCT01716520|11123209|FG000|Treatment Period 1 (14 Days)|Adverse Event|1
7040181|NCT01716520|11123210|FG001|Treatment Period 1 (14 Days)|Adverse Event|0
7040182|NCT01716520|11123211|FG002|Treatment Period 1 (14 Days)|Adverse Event|0
7040183|NCT01716520|11123212|FG003|Treatment Period 1 (14 Days)|Adverse Event|0
7040184|NCT01716520|11123213|FG004|Treatment Period 1 (14 Days)|Adverse Event|0
6937374|NCT00915473|10971392|FG000|Screening|Withdrawal by Subject|1
6937375|NCT00915473|10971393|FG001|Screening|Withdrawal by Subject|0
6937376|NCT00915473|10971392|FG000|4-week Follow Up|Lost to Follow-up|1
6937377|NCT00915473|10971393|FG001|4-week Follow Up|Lost to Follow-up|5
6937378|NCT00915525|10971410|FG000|Overall Study|Protocol Violation|9
6937379|NCT00915525|10971411|FG001|Overall Study|Protocol Violation|4
6937380|NCT00915525|10971410|FG000|Overall Study|Withdrawal by Subject|59
6937381|NCT00915525|10971411|FG001|Overall Study|Withdrawal by Subject|21
6937382|NCT00915525|10971410|FG000|Overall Study|Lost to Follow-up|27
6937383|NCT00915525|10971411|FG001|Overall Study|Lost to Follow-up|16
6937384|NCT00915525|10971410|FG000|Overall Study|Pregnancy|2
6937385|NCT00915525|10971411|FG001|Overall Study|Pregnancy|0
6937386|NCT00915525|10971410|FG000|Overall Study|Lack of Efficacy|15
6937387|NCT00915525|10971411|FG001|Overall Study|Lack of Efficacy|32
6937388|NCT00915525|10971410|FG000|Overall Study|Adverse Event|29
6937389|NCT00915525|10971411|FG001|Overall Study|Adverse Event|13
6937390|NCT00915525|10971410|FG000|Overall Study|Missing|12
6937391|NCT00915525|10971411|FG001|Overall Study|Missing|1
6937392|NCT00915525|10971410|FG000|Overall Study|Other Reason|35
6937393|NCT00915525|10971411|FG001|Overall Study|Other Reason|12
6937394|NCT00915525|10971410|FG000|Overall Study|Site Closed|27
6937395|NCT00915525|10971411|FG001|Overall Study|Site Closed|9
6937396|NCT00915525|10971410|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4
6937397|NCT00915525|10971411|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5
7067018|NCT01982292|11167784|FG001|Overall Study|Non-Compliance With Study Treatment|0
7067019|NCT01982292|11167783|FG000|Overall Study|Protocol Deviation|1
7067020|NCT01982292|11167784|FG001|Overall Study|Protocol Deviation|0
7067021|NCT01982292|11167783|FG000|Overall Study|Patient/Guardian Decision|3
7067022|NCT01982292|11167784|FG001|Overall Study|Patient/Guardian Decision|1
7067023|NCT01982292|11167783|FG000|Overall Study|Technical Problems|2
6937398|NCT00915525|10971410|FG000|Overall Study|Study Burden|28
6937399|NCT00915525|10971411|FG001|Overall Study|Study Burden|12
6937400|NCT00915525|10971410|FG000|Overall Study|Non-Compliance|3
6937401|NCT00915525|10971411|FG001|Overall Study|Non-Compliance|1
6937402|NCT00915525|10971410|FG000|Overall Study|Patient Moved|15
6937403|NCT00915525|10971411|FG001|Overall Study|Patient Moved|9
6937404|NCT00915551|10971450|FG000|Overall Study|Withdrawal by Subject|0
6937405|NCT00915551|10971451|FG001|Overall Study|Withdrawal by Subject|1
6937406|NCT00915772|10971497|FG000|Overall Study|Adverse Event|12
6937407|NCT00915772|10971498|FG001|Overall Study|Adverse Event|13
6937408|NCT00915772|10971499|FG002|Overall Study|Adverse Event|11
6937409|NCT00915772|10971497|FG000|Overall Study|Protocol Violation|4
6937410|NCT00915772|10971498|FG001|Overall Study|Protocol Violation|1
6937411|NCT00915772|10971499|FG002|Overall Study|Protocol Violation|2
6937412|NCT00915772|10971497|FG000|Overall Study|Lost to Follow-up|1
6937413|NCT00915772|10971498|FG001|Overall Study|Lost to Follow-up|2
6937414|NCT00915772|10971499|FG002|Overall Study|Lost to Follow-up|2
6937415|NCT00915772|10971497|FG000|Overall Study|Lack of Efficacy|9
6937416|NCT00915772|10971498|FG001|Overall Study|Lack of Efficacy|15
6937417|NCT00915772|10971499|FG002|Overall Study|Lack of Efficacy|3
6937418|NCT00915772|10971497|FG000|Overall Study|Refused to continue trial medication|6
6937419|NCT00915772|10971498|FG001|Overall Study|Refused to continue trial medication|8
6937420|NCT00915772|10971499|FG002|Overall Study|Refused to continue trial medication|4
6937421|NCT00915772|10971497|FG000|Overall Study|Any other reason|4
6937422|NCT00915772|10971498|FG001|Overall Study|Any other reason|7
6937423|NCT00915772|10971499|FG002|Overall Study|Any other reason|7
6937424|NCT00915876|10971537|FG000|Overall Study|Adverse Event|0
6937425|NCT00915876|10971538|FG001|Overall Study|Adverse Event|1
6937426|NCT00916006|10971589|FG000|Overall Study|Adverse Event|1
6937427|NCT00916006|10971590|FG001|Overall Study|Adverse Event|1
6937428|NCT00916006|10971589|FG000|Overall Study|Withdrawal by Subject|2
6937429|NCT00916006|10971590|FG001|Overall Study|Withdrawal by Subject|5
6937430|NCT00916006|10971589|FG000|Overall Study|Protocol Violation|0
6937431|NCT00916006|10971590|FG001|Overall Study|Protocol Violation|1
6937432|NCT00916058|10971610|FG000|Phase 1|Screen Failure|0
6937433|NCT00916058|10971611|FG001|Phase 1|Screen Failure|0
6937434|NCT00916058|10971612|FG002|Phase 1|Screen Failure|0
6937435|NCT00916058|10971613|FG003|Phase 1|Screen Failure|0
6937436|NCT00916058|10971614|FG004|Phase 1|Screen Failure|0
6937437|NCT00916058|10971615|FG005|Phase 1|Screen Failure|1
6937438|NCT00916058|10971616|FG006|Phase 1|Screen Failure|0
6937439|NCT00916058|10971610|FG000|Phase 2|Screen Failure|0
6937440|NCT00916058|10971611|FG001|Phase 2|Screen Failure|0
6937441|NCT00916058|10971612|FG002|Phase 2|Screen Failure|0
6937442|NCT00916058|10971613|FG003|Phase 2|Screen Failure|0
6937443|NCT00916058|10971614|FG004|Phase 2|Screen Failure|0
6937444|NCT00916058|10971615|FG005|Phase 2|Screen Failure|0
6937445|NCT00916058|10971616|FG006|Phase 2|Screen Failure|3
6937446|NCT00916149|10971646|FG000|Overall Study|Lost to Follow-up|3
6937447|NCT00916149|10971647|FG001|Overall Study|Lost to Follow-up|2
6937448|NCT00916149|10971648|FG002|Overall Study|Lost to Follow-up|0
6937449|NCT00916149|10971646|FG000|Overall Study|Unable to place scalp EEG leads|1
6937450|NCT00916149|10971647|FG001|Overall Study|Unable to place scalp EEG leads|0
6937451|NCT00916149|10971648|FG002|Overall Study|Unable to place scalp EEG leads|0
6937452|NCT00916279|10971655|FG000|Overall Study|Death|2
6937453|NCT00916279|10971655|FG000|Overall Study|Lost to Follow-up|2
6937454|NCT00916305|10971664|FG000|Overall Study|Lost to Follow-up|21
6937455|NCT00916305|10971665|FG001|Overall Study|Lost to Follow-up|27
6937456|NCT00916305|10971664|FG000|Overall Study|Withdrawal by Subject|0
6937457|NCT00916305|10971665|FG001|Overall Study|Withdrawal by Subject|1
6937458|NCT00916344|10971671|FG000|Overall Study|Death|2
6937459|NCT00916344|10971671|FG000|Overall Study|ICD upgrade|1
6937460|NCT00916344|10971671|FG000|Overall Study|Drop-out|5
6937461|NCT00916357|10971675|FG000|Period 1|Withdrawal by Subject|1
6937462|NCT00916357|10971676|FG001|Period 1|Withdrawal by Subject|0
6937463|NCT00916357|10971677|FG002|Period 1|Withdrawal by Subject|0
6937464|NCT00916357|10971678|FG003|Period 1|Withdrawal by Subject|0
6937465|NCT00916357|10971679|FG004|Period 1|Withdrawal by Subject|0
6937466|NCT00916357|10971680|FG005|Period 1|Withdrawal by Subject|0
6937467|NCT00916357|10971675|FG000|Period 2|Weight loss > 3 kilograms (kg)|0
6937468|NCT00916357|10971676|FG001|Period 2|Weight loss > 3 kilograms (kg)|0
6937469|NCT00916357|10971677|FG002|Period 2|Weight loss > 3 kilograms (kg)|0
6937470|NCT00916357|10971678|FG003|Period 2|Weight loss > 3 kilograms (kg)|1
6937471|NCT00916357|10971679|FG004|Period 2|Weight loss > 3 kilograms (kg)|0
6937472|NCT00916357|10971680|FG005|Period 2|Weight loss > 3 kilograms (kg)|0
6937473|NCT00916370|10971691|FG000|Overall Study|Death|3
6937474|NCT00916370|10971692|FG001|Overall Study|Death|1
6937475|NCT00916370|10971691|FG000|Overall Study|Withdrawal by Subject|2
6937476|NCT00916370|10971692|FG001|Overall Study|Withdrawal by Subject|0
6937477|NCT00916370|10971691|FG000|Overall Study|Physician Decision|0
6937478|NCT00916370|10971692|FG001|Overall Study|Physician Decision|1
6937479|NCT00916383|10971699|FG000|Overall Study|Adverse Event|1
6937480|NCT00916383|10971699|FG000|Overall Study|Death|1
6937481|NCT00916383|10971699|FG000|Overall Study|Protocol Violation|1
6937482|NCT00916578|10971716|FG000|Overall Study|Physician Decision|2
7067024|NCT01982292|11167784|FG001|Overall Study|Technical Problems|0
6937483|NCT00916578|10971716|FG000|Overall Study|Withdrawal by Subject|3
7067025|NCT01982331|11167792|FG000|Received Vaccination 2|Adverse Event|1
7067026|NCT01982331|11167793|FG001|Received Vaccination 2|Adverse Event|2
6937484|NCT00916578|10971716|FG000|Overall Study|Insurance Denial|2
6937485|NCT00916617|10971724|FG000|Overall Study|Adverse Event|3
6937486|NCT00916617|10971725|FG001|Overall Study|Adverse Event|2
6937487|NCT00916617|10971726|FG002|Overall Study|Adverse Event|6
6937488|NCT00916617|10971727|FG003|Overall Study|Adverse Event|3
6937489|NCT00916617|10971724|FG000|Overall Study|Withdrawal by Subject|3
6937490|NCT00916617|10971725|FG001|Overall Study|Withdrawal by Subject|2
6937491|NCT00916617|10971726|FG002|Overall Study|Withdrawal by Subject|0
6937492|NCT00916617|10971727|FG003|Overall Study|Withdrawal by Subject|1
6937493|NCT00916617|10971724|FG000|Overall Study|Caregiver Request|3
6937494|NCT00916617|10971725|FG001|Overall Study|Caregiver Request|2
6937495|NCT00916617|10971726|FG002|Overall Study|Caregiver Request|1
6937496|NCT00916617|10971727|FG003|Overall Study|Caregiver Request|0
6937497|NCT00916617|10971724|FG000|Overall Study|Physician Decision|1
6937498|NCT00916617|10971725|FG001|Overall Study|Physician Decision|1
6937499|NCT00916617|10971726|FG002|Overall Study|Physician Decision|0
6937500|NCT00916617|10971727|FG003|Overall Study|Physician Decision|0
6937501|NCT00916617|10971724|FG000|Overall Study|Discontinuation of Study by Sponsor|8
6937502|NCT00916617|10971725|FG001|Overall Study|Discontinuation of Study by Sponsor|13
6937503|NCT00916617|10971726|FG002|Overall Study|Discontinuation of Study by Sponsor|3
6937504|NCT00916617|10971727|FG003|Overall Study|Discontinuation of Study by Sponsor|1
6937505|NCT00916617|10971724|FG000|Overall Study|Lost to Follow-up|2
6937506|NCT00916617|10971725|FG001|Overall Study|Lost to Follow-up|1
6937507|NCT00916617|10971726|FG002|Overall Study|Lost to Follow-up|0
6937508|NCT00916617|10971727|FG003|Overall Study|Lost to Follow-up|0
6937509|NCT00916617|10971724|FG000|Overall Study|Lack of Efficacy|1
6937510|NCT00916617|10971725|FG001|Overall Study|Lack of Efficacy|0
6937511|NCT00916617|10971726|FG002|Overall Study|Lack of Efficacy|0
6937512|NCT00916617|10971727|FG003|Overall Study|Lack of Efficacy|0
6937513|NCT00916617|10971724|FG000|Overall Study|Other|2
6937514|NCT00916617|10971725|FG001|Overall Study|Other|0
6937515|NCT00916617|10971726|FG002|Overall Study|Other|0
6937516|NCT00916617|10971727|FG003|Overall Study|Other|2
6937517|NCT00916721|10971743|FG000|Overall Study|Lost to Follow-up|0
7040185|NCT01716520|11123214|FG005|Treatment Period 1 (14 Days)|Adverse Event|0
7040186|NCT01716520|11123209|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
6937518|NCT00916721|10971744|FG001|Overall Study|Lost to Follow-up|1
6937519|NCT00916721|10971743|FG000|Overall Study|Adverse Event|6
6937520|NCT00916721|10971744|FG001|Overall Study|Adverse Event|3
6937521|NCT00916721|10971743|FG000|Overall Study|Withdrawal by Subject|2
6937522|NCT00916721|10971744|FG001|Overall Study|Withdrawal by Subject|2
6937523|NCT00916721|10971743|FG000|Overall Study|Protocol Violation|2
6937524|NCT00916721|10971744|FG001|Overall Study|Protocol Violation|4
6937525|NCT00916929|10971752|FG000|Overall Study|Lost to Follow-up|1
6937526|NCT00916929|10971753|FG001|Overall Study|Lost to Follow-up|3
6937527|NCT00916929|10971752|FG000|Overall Study|Death|5
6937528|NCT00916929|10971753|FG001|Overall Study|Death|10
6937529|NCT00916929|10971752|FG000|Overall Study|Withdrawal by Subject|1
6937530|NCT00916929|10971753|FG001|Overall Study|Withdrawal by Subject|5
6937531|NCT00916929|10971752|FG000|Overall Study|Left ventricular epicardial lead|1
6937532|NCT00916929|10971753|FG001|Overall Study|Left ventricular epicardial lead|2
6937533|NCT00916929|10971752|FG000|Overall Study|Transferred to hospice care|1
6937534|NCT00916929|10971753|FG001|Overall Study|Transferred to hospice care|1
6937535|NCT00916929|10971752|FG000|Overall Study|System explant|1
6937536|NCT00916929|10971753|FG001|Overall Study|System explant|0
6937537|NCT00916929|10971752|FG000|Overall Study|Moved to another state|0
6937538|NCT00916929|10971753|FG001|Overall Study|Moved to another state|1
6937539|NCT00916929|10971752|FG000|Overall Study|Device unable to process impedance data|0
6937540|NCT00916929|10971753|FG001|Overall Study|Device unable to process impedance data|7
6937541|NCT00917124|10971763|FG000|Overall Study|Protocol Violation|4
6937542|NCT00917124|10971764|FG001|Overall Study|Protocol Violation|6
6937543|NCT00917150|10971774|FG000|Overall Study|Adverse Event|12
6937544|NCT00917150|10971775|FG001|Overall Study|Adverse Event|7
6937545|NCT00917150|10971776|FG002|Overall Study|Adverse Event|12
6937546|NCT00917150|10971777|FG003|Overall Study|Adverse Event|11
6937547|NCT00917150|10971774|FG000|Overall Study|Death|1
6937548|NCT00917150|10971775|FG001|Overall Study|Death|4
6937549|NCT00917150|10971776|FG002|Overall Study|Death|3
6937550|NCT00917150|10971777|FG003|Overall Study|Death|2
6937551|NCT00917150|10971774|FG000|Overall Study|Lost to Follow-up|1
6937552|NCT00917150|10971775|FG001|Overall Study|Lost to Follow-up|0
6937553|NCT00917150|10971776|FG002|Overall Study|Lost to Follow-up|4
6937554|NCT00917150|10971777|FG003|Overall Study|Lost to Follow-up|2
6937555|NCT00917150|10971774|FG000|Overall Study|Physician Decision|0
6937556|NCT00917150|10971775|FG001|Overall Study|Physician Decision|2
6937557|NCT00917150|10971776|FG002|Overall Study|Physician Decision|0
6937558|NCT00917150|10971777|FG003|Overall Study|Physician Decision|1
6937559|NCT00917150|10971774|FG000|Overall Study|Protocol Violation|5
6937560|NCT00917150|10971775|FG001|Overall Study|Protocol Violation|5
6937561|NCT00917150|10971776|FG002|Overall Study|Protocol Violation|3
6937562|NCT00917150|10971777|FG003|Overall Study|Protocol Violation|5
6937563|NCT00917150|10971774|FG000|Overall Study|Withdrawal by Subject|15
6937564|NCT00917150|10971775|FG001|Overall Study|Withdrawal by Subject|16
6937565|NCT00917150|10971776|FG002|Overall Study|Withdrawal by Subject|18
6937566|NCT00917150|10971777|FG003|Overall Study|Withdrawal by Subject|11
6937567|NCT00917150|10971774|FG000|Overall Study|Other than specified|3
6937568|NCT00917150|10971775|FG001|Overall Study|Other than specified|3
6937569|NCT00917150|10971776|FG002|Overall Study|Other than specified|2
6937570|NCT00917150|10971777|FG003|Overall Study|Other than specified|2
6937571|NCT00917267|10971789|FG000|Overall Study|Adverse Event|15
6937572|NCT00917267|10971790|FG001|Overall Study|Adverse Event|36
6937573|NCT00917267|10971789|FG000|Overall Study|Physician Decision|2
6937574|NCT00917267|10971790|FG001|Overall Study|Physician Decision|4
6937575|NCT00917267|10971789|FG000|Overall Study|Protocol Violation|9
6937576|NCT00917267|10971790|FG001|Overall Study|Protocol Violation|18
6937577|NCT00917267|10971789|FG000|Overall Study|Withdrawal by Subject|5
6937578|NCT00917267|10971790|FG001|Overall Study|Withdrawal by Subject|12
6937579|NCT00917267|10971789|FG000|Overall Study|Lost to follow up|0
6937580|NCT00917267|10971790|FG001|Overall Study|Lost to follow up|2
6937581|NCT00917267|10971789|FG000|Overall Study|Entry Criteria Not Met|1
6937582|NCT00917267|10971790|FG001|Overall Study|Entry Criteria Not Met|0
6937583|NCT00917267|10971789|FG000|Overall Study|Sponsor Decision|5
6937584|NCT00917267|10971790|FG001|Overall Study|Sponsor Decision|5
6937585|NCT00917267|10971789|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
6937586|NCT00917267|10971790|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
6937587|NCT00917384|10971802|FG000|Overall Study|Lost to Follow-up|4
6937588|NCT00917384|10971803|FG001|Overall Study|Lost to Follow-up|2
6937589|NCT00917384|10971802|FG000|Overall Study|Withdrawal by Subject|10
6937590|NCT00917384|10971803|FG001|Overall Study|Withdrawal by Subject|2
6937591|NCT00917462|10971809|FG000|Overall Study|Clinical Deterioration|1
6937592|NCT00917501|10971815|FG000|Overall Study|Lost to Follow-up|4
6937593|NCT00917501|10971816|FG001|Overall Study|Lost to Follow-up|1
6937594|NCT00917501|10971815|FG000|Overall Study|Withdrawal by Subject|3
6937595|NCT00917501|10971816|FG001|Overall Study|Withdrawal by Subject|1
6937596|NCT00917501|10971815|FG000|Overall Study|Lack of Efficacy|1
6937597|NCT00917501|10971816|FG001|Overall Study|Lack of Efficacy|2
6937598|NCT00917501|10971815|FG000|Overall Study|trouble swollowing capsules|0
6937599|NCT00917501|10971816|FG001|Overall Study|trouble swollowing capsules|1
6937600|NCT00917553|10971824|FG000|Overall Study|Lost to Follow-up|2
6937601|NCT00917553|10971825|FG001|Overall Study|Lost to Follow-up|1
6937602|NCT00917579|10971831|FG000|Washout >= 2 Weeks|Adverse Event|1
6937603|NCT00917579|10971832|FG001|Washout >= 2 Weeks|Adverse Event|0
6937604|NCT00917579|10971831|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1
6937605|NCT00917579|10971832|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0
6937606|NCT00917644|10971838|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1
6937607|NCT00917644|10971839|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0
6937608|NCT00917644|10971838|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1
6937609|NCT00917644|10971839|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0
6937610|NCT00917644|10971838|FG000|Period 2: Second Intervention|family emergency|1
6937611|NCT00917644|10971839|FG001|Period 2: Second Intervention|family emergency|0
6937612|NCT00917852|10971854|FG000|Overall Study|Death|6
6937613|NCT00918138|10971884|FG000|Overall Study|Subject withdrew consent|1
6937614|NCT00918138|10971885|FG001|Overall Study|Subject withdrew consent|1
6937615|NCT00918138|10971884|FG000|Overall Study|Death|1
6937616|NCT00918138|10971885|FG001|Overall Study|Death|0
6937617|NCT00918203|10971893|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1
6937618|NCT00918203|10971894|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1
6937619|NCT00918203|10971895|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0
6937620|NCT00918203|10971893|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2
6937621|NCT00918203|10971894|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8
6937622|NCT00918203|10971895|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0
6937623|NCT00918203|10971893|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2
6937624|NCT00918203|10971894|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1
6937625|NCT00918203|10971895|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0
6937626|NCT00918203|10971893|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1
6937627|NCT00918203|10971894|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0
6937628|NCT00918203|10971895|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0
6937629|NCT00918255|10971914|FG000|Overall Study|Adverse Event|1
6937630|NCT00918255|10971915|FG001|Overall Study|Adverse Event|0
6937631|NCT00918255|10971916|FG002|Overall Study|Adverse Event|0
6937632|NCT00918255|10971914|FG000|Overall Study|Withdrawal by Subject|1
6937633|NCT00918255|10971915|FG001|Overall Study|Withdrawal by Subject|0
6937634|NCT00918255|10971916|FG002|Overall Study|Withdrawal by Subject|2
6937635|NCT00918255|10971914|FG000|Overall Study|Lack of Efficacy|1
6937636|NCT00918255|10971915|FG001|Overall Study|Lack of Efficacy|0
6937637|NCT00918255|10971916|FG002|Overall Study|Lack of Efficacy|0
6937638|NCT00918255|10971914|FG000|Overall Study|Lost to Follow-up|1
6937639|NCT00918255|10971915|FG001|Overall Study|Lost to Follow-up|0
7040187|NCT01716520|11123210|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
7040188|NCT01716520|11123211|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2
6937640|NCT00918255|10971916|FG002|Overall Study|Lost to Follow-up|2
6937641|NCT00918255|10971914|FG000|Overall Study|Exceeded allowed number of interventions|0
6937642|NCT00918255|10971915|FG001|Overall Study|Exceeded allowed number of interventions|0
6937643|NCT00918255|10971916|FG002|Overall Study|Exceeded allowed number of interventions|1
6937644|NCT00918255|10971914|FG000|Overall Study|Non-compliance|1
6937645|NCT00918255|10971915|FG001|Overall Study|Non-compliance|0
6937646|NCT00918255|10971916|FG002|Overall Study|Non-compliance|0
6937647|NCT00918255|10971914|FG000|Overall Study|Investigator discretion|1
6937648|NCT00918255|10971915|FG001|Overall Study|Investigator discretion|0
6937649|NCT00918255|10971916|FG002|Overall Study|Investigator discretion|0
6937650|NCT00918281|10971924|FG000|Overall Study|Physician Decision|29
6937651|NCT00918333|10971933|FG000|Overall Study|Drug not taken per protocol|1
6937652|NCT00918333|10971934|FG001|Overall Study|Drug not taken per protocol|0
6937653|NCT00918333|10971933|FG000|Overall Study|Inadequate amount of drugs provided|1
6937654|NCT00918333|10971934|FG001|Overall Study|Inadequate amount of drugs provided|4
6937655|NCT00918333|10971933|FG000|Overall Study|Ineligible|1
6937656|NCT00918333|10971934|FG001|Overall Study|Ineligible|0
6937657|NCT00918333|10971933|FG000|Overall Study|Withdrawal by Subject|0
6937658|NCT00918333|10971934|FG001|Overall Study|Withdrawal by Subject|1
6937659|NCT00918346|10971943|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0
6937660|NCT00918346|10971944|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1
6937661|NCT00918385|10971955|FG000|Monotherapy|Adverse Event|1
6937662|NCT00918385|10971956|FG001|Monotherapy|Adverse Event|6
6937663|NCT00918385|10971955|FG000|Monotherapy|Complicating illness|1
6937664|NCT00918385|10971956|FG001|Monotherapy|Complicating illness|0
6937665|NCT00918385|10971955|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1
6937666|NCT00918385|10971956|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1
6937667|NCT00918385|10971955|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
6937668|NCT00918385|10971956|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0
6937669|NCT00918385|10971955|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1
6937670|NCT00918385|10971956|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0
6937671|NCT00918385|10971955|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
6937672|NCT00918385|10971956|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7
6937673|NCT00918567|10971966|FG000|Overall Study|Lack of Efficacy|3
6937674|NCT00918567|10971967|FG001|Overall Study|Lack of Efficacy|1
6937675|NCT00918567|10971966|FG000|Overall Study|Withdrawal by Subject|1
6937676|NCT00918567|10971967|FG001|Overall Study|Withdrawal by Subject|1
6937677|NCT00918567|10971966|FG000|Overall Study|Adverse Event|1
6937678|NCT00918567|10971967|FG001|Overall Study|Adverse Event|0
6937679|NCT00918580|10971973|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1
6937680|NCT00918580|10971973|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5
6937681|NCT00918580|10971973|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2
6937682|NCT00918580|10971973|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2
6937683|NCT00918580|10971973|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1
6937684|NCT00918580|10971973|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58
6937685|NCT00918580|10971973|FG000|After 6-month FU to 1-year FU|Failed to Return|2
6937686|NCT00918684|10971984|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16
6937687|NCT00918684|10971984|FG000|Treatment Phase|Lack of Efficacy|6
6937688|NCT00918684|10971984|FG000|Treatment Phase|Lost to Follow-up|2
6937689|NCT00918684|10971984|FG000|Treatment Phase|Physician Decision|8
6937690|NCT00918684|10971984|FG000|Treatment Phase|Protocol Violation|1
6937691|NCT00918684|10971984|FG000|Treatment Phase|Withdrawal by Subject|8
6937692|NCT00918736|10971994|FG000|Overall Study|Withdrawal by Subject|4
6937693|NCT00918749|10972001|FG000|Overall Study|Adverse Event|1
6937694|NCT00918749|10972002|FG001|Overall Study|Adverse Event|0
6937695|NCT00918749|10972003|FG002|Overall Study|Adverse Event|1
6937696|NCT00918749|10972001|FG000|Overall Study|Lost to Follow-up|0
6937697|NCT00918749|10972002|FG001|Overall Study|Lost to Follow-up|0
6937698|NCT00918749|10972003|FG002|Overall Study|Lost to Follow-up|1
6937699|NCT00918749|10972001|FG000|Overall Study|Withdrawal by Subject|5
6937700|NCT00918749|10972002|FG001|Overall Study|Withdrawal by Subject|3
6937701|NCT00918749|10972003|FG002|Overall Study|Withdrawal by Subject|5
6937702|NCT00918749|10972001|FG000|Overall Study|No Study Medication Taken|1
6937703|NCT00918749|10972002|FG001|Overall Study|No Study Medication Taken|0
6937704|NCT00918749|10972003|FG002|Overall Study|No Study Medication Taken|0
6937705|NCT00918879|10972022|FG000|Overall Study|Withdrawal by Subject|4
6937706|NCT00918879|10972023|FG001|Overall Study|Withdrawal by Subject|4
6937707|NCT00918879|10972022|FG000|Overall Study|Lost to Follow-up|1
6937708|NCT00918879|10972023|FG001|Overall Study|Lost to Follow-up|1
6937709|NCT00918879|10972022|FG000|Overall Study|Severe non-compliance to protocol|1
6937710|NCT00918879|10972023|FG001|Overall Study|Severe non-compliance to protocol|1
6937711|NCT00918957|10972035|FG000|Overall Study|Adverse Event|2
6937712|NCT00918957|10972036|FG001|Overall Study|Adverse Event|0
6937713|NCT00918957|10972035|FG000|Overall Study|Withdrawal by Subject|1
6937714|NCT00918957|10972036|FG001|Overall Study|Withdrawal by Subject|0
6937715|NCT00919061|10972046|FG000|Overall Study|Adverse Event|1
6937716|NCT00919061|10972046|FG000|Overall Study|Withdrawal by Subject|1
6937717|NCT00919633|10972101|FG000|Overall Study|Adverse Event|1
6937718|NCT00919633|10972102|FG001|Overall Study|Adverse Event|9
6937719|NCT00919633|10972103|FG002|Overall Study|Adverse Event|12
6937720|NCT00919633|10972104|FG003|Overall Study|Adverse Event|10
6937721|NCT00919633|10972101|FG000|Overall Study|Death|0
6937722|NCT00919633|10972102|FG001|Overall Study|Death|0
6937723|NCT00919633|10972103|FG002|Overall Study|Death|2
6937724|NCT00919633|10972104|FG003|Overall Study|Death|0
6937725|NCT00919633|10972101|FG000|Overall Study|Lack of Efficacy|17
6937726|NCT00919633|10972102|FG001|Overall Study|Lack of Efficacy|3
6937727|NCT00919633|10972103|FG002|Overall Study|Lack of Efficacy|2
6937728|NCT00919633|10972104|FG003|Overall Study|Lack of Efficacy|3
6937729|NCT00919633|10972101|FG000|Overall Study|Withdrawal by Subject|1
6937730|NCT00919633|10972102|FG001|Overall Study|Withdrawal by Subject|2
6937731|NCT00919633|10972103|FG002|Overall Study|Withdrawal by Subject|4
6937732|NCT00919633|10972104|FG003|Overall Study|Withdrawal by Subject|3
6937733|NCT00919633|10972101|FG000|Overall Study|Lost to Follow-up|3
6937734|NCT00919633|10972102|FG001|Overall Study|Lost to Follow-up|1
6937735|NCT00919633|10972103|FG002|Overall Study|Lost to Follow-up|0
6937736|NCT00919633|10972104|FG003|Overall Study|Lost to Follow-up|2
6937737|NCT00919633|10972101|FG000|Overall Study|Withdraw consent post transition to SOC|0
6937738|NCT00919633|10972102|FG001|Overall Study|Withdraw consent post transition to SOC|0
6937739|NCT00919633|10972103|FG002|Overall Study|Withdraw consent post transition to SOC|1
6937740|NCT00919633|10972104|FG003|Overall Study|Withdraw consent post transition to SOC|1
6937741|NCT00919633|10972101|FG000|Overall Study|Protocol Violation|0
6937742|NCT00919633|10972102|FG001|Overall Study|Protocol Violation|0
6937743|NCT00919633|10972103|FG002|Overall Study|Protocol Violation|0
6937744|NCT00919633|10972104|FG003|Overall Study|Protocol Violation|1
6937745|NCT00919633|10972101|FG000|Overall Study|Physician Decision|0
6937746|NCT00919633|10972102|FG001|Overall Study|Physician Decision|0
6937747|NCT00919633|10972103|FG002|Overall Study|Physician Decision|0
6937748|NCT00919633|10972104|FG003|Overall Study|Physician Decision|1
6937749|NCT00919633|10972101|FG000|Overall Study|Request of withdrawal w/o future contact|0
6937750|NCT00919633|10972102|FG001|Overall Study|Request of withdrawal w/o future contact|0
6937751|NCT00919633|10972103|FG002|Overall Study|Request of withdrawal w/o future contact|1
6937752|NCT00919633|10972104|FG003|Overall Study|Request of withdrawal w/o future contact|0
6937753|NCT00919633|10972101|FG000|Overall Study|Viral rebound outside protocol timepoint|0
6937754|NCT00919633|10972102|FG001|Overall Study|Viral rebound outside protocol timepoint|0
6937755|NCT00919633|10972103|FG002|Overall Study|Viral rebound outside protocol timepoint|1
6937756|NCT00919633|10972104|FG003|Overall Study|Viral rebound outside protocol timepoint|0
6937757|NCT00919711|10972116|FG000|Overall Study|Withdrawal by Subject|15
6937758|NCT00919711|10972117|FG001|Overall Study|Withdrawal by Subject|7
6937759|NCT00919711|10972116|FG000|Overall Study|Adverse Event|13
6937760|NCT00919711|10972117|FG001|Overall Study|Adverse Event|3
6937761|NCT00919711|10972116|FG000|Overall Study|Other|1
6937762|NCT00919711|10972117|FG001|Overall Study|Other|2
6937763|NCT00919711|10972116|FG000|Overall Study|Administrative Decision|0
6937764|NCT00919711|10972117|FG001|Overall Study|Administrative Decision|1
6937765|NCT00919711|10972116|FG000|Overall Study|Lost to Follow-up|2
6937766|NCT00919711|10972117|FG001|Overall Study|Lost to Follow-up|0
6937767|NCT00919711|10972116|FG000|Overall Study|Death|1
6937768|NCT00919711|10972117|FG001|Overall Study|Death|0
6937769|NCT00919711|10972116|FG000|Overall Study|Noncompliance|1
6937770|NCT00919711|10972117|FG001|Overall Study|Noncompliance|0
6975370|NCT01192815|11027558|FG000|Overall Study|Withdrawal by Subject|1
6975371|NCT01192815|11027558|FG000|Overall Study|Lack of Efficacy|1
6975372|NCT01193101|11027588|FG000|Overall Study|Adverse Event|0
6975373|NCT01193101|11027589|FG001|Overall Study|Adverse Event|1
6975374|NCT01193101|11027590|FG002|Overall Study|Adverse Event|1
6975375|NCT01193101|11027591|FG003|Overall Study|Adverse Event|3
6975376|NCT01193101|11027588|FG000|Overall Study|Lack of Efficacy|3
6975377|NCT01193101|11027589|FG001|Overall Study|Lack of Efficacy|1
6975378|NCT01193101|11027590|FG002|Overall Study|Lack of Efficacy|0
6975379|NCT01193101|11027591|FG003|Overall Study|Lack of Efficacy|8
6975380|NCT01193101|11027588|FG000|Overall Study|Withdrawal by Subject|2
6975381|NCT01193101|11027589|FG001|Overall Study|Withdrawal by Subject|4
6975382|NCT01193101|11027590|FG002|Overall Study|Withdrawal by Subject|1
6975383|NCT01193101|11027591|FG003|Overall Study|Withdrawal by Subject|1
6975384|NCT01193101|11027588|FG000|Overall Study|Administrative problems|0
6975385|NCT01193101|11027589|FG001|Overall Study|Administrative problems|0
6975386|NCT01193101|11027590|FG002|Overall Study|Administrative problems|1
6975387|NCT01193101|11027591|FG003|Overall Study|Administrative problems|0
6975388|NCT01193101|11027588|FG000|Overall Study|Abnormal test procedure results|0
6975389|NCT01193101|11027589|FG001|Overall Study|Abnormal test procedure results|1
6975390|NCT01193101|11027590|FG002|Overall Study|Abnormal test procedure results|0
6975391|NCT01193101|11027591|FG003|Overall Study|Abnormal test procedure results|0
6975392|NCT01193127|11027614|FG000|Randomized|Surgery Cancelled|0
6975393|NCT01193127|11027615|FG001|Randomized|Surgery Cancelled|0
6975394|NCT01193127|11027616|FG002|Randomized|Surgery Cancelled|0
6975395|NCT01193127|11027617|FG003|Randomized|Surgery Cancelled|1
6975396|NCT01193127|11027614|FG000|Treated|Withdrawal by Subject|0
6975397|NCT01193127|11027615|FG001|Treated|Withdrawal by Subject|0
6975398|NCT01193127|11027616|FG002|Treated|Withdrawal by Subject|0
6975399|NCT01193127|11027617|FG003|Treated|Withdrawal by Subject|1
6975400|NCT01193153|11027629|FG000|Open-label Lead in Period|Lost to Follow-up|32
6975401|NCT01193153|11027630|FG001|Open-label Lead in Period|Lost to Follow-up|0
6975402|NCT01193153|11027629|FG000|Open-label Lead in Period|Pregnancy|1
6975403|NCT01193153|11027630|FG001|Open-label Lead in Period|Pregnancy|0
6975404|NCT01193153|11027629|FG000|Open-label Lead in Period|Withdrawal by Subject|69
6975405|NCT01193153|11027630|FG001|Open-label Lead in Period|Withdrawal by Subject|0
6975406|NCT01193153|11027629|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4
6975407|NCT01193153|11027630|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0
6975408|NCT01193153|11027629|FG000|Open-label Lead in Period|Other|14
6975409|NCT01193153|11027630|FG001|Open-label Lead in Period|Other|0
6975410|NCT01193153|11027629|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47
6975411|NCT01193153|11027630|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0
6975412|NCT01193153|11027629|FG000|Open-label Lead in Period|Adverse Event|41
6975413|NCT01193153|11027630|FG001|Open-label Lead in Period|Adverse Event|0
6975414|NCT01193153|11027629|FG000|Open-label Lead in Period|Death|1
6975415|NCT01193153|11027630|FG001|Open-label Lead in Period|Death|0
6975416|NCT01193153|11027629|FG000|Open-label Lead in Period|Lack of Efficacy|26
6937771|NCT00919854|10972148|FG000|Overall Study|Adverse Event|1
6937772|NCT00919867|10972158|FG000|First Intervention|Withdrawal by Subject|0
6937773|NCT00919867|10972159|FG001|First Intervention|Withdrawal by Subject|0
6937774|NCT00919867|10972160|FG002|First Intervention|Withdrawal by Subject|1
6937775|NCT00919867|10972161|FG003|First Intervention|Withdrawal by Subject|0
6937776|NCT00919867|10972162|FG004|First Intervention|Withdrawal by Subject|0
6937777|NCT00919867|10972163|FG005|First Intervention|Withdrawal by Subject|0
6937778|NCT00919867|10972158|FG000|First Intervention|Physician Decision|0
6937779|NCT00919867|10972159|FG001|First Intervention|Physician Decision|0
6937780|NCT00919867|10972160|FG002|First Intervention|Physician Decision|0
6937781|NCT00919867|10972161|FG003|First Intervention|Physician Decision|0
6937782|NCT00919867|10972162|FG004|First Intervention|Physician Decision|0
6937783|NCT00919867|10972163|FG005|First Intervention|Physician Decision|1
6937784|NCT00920140|10972193|FG000|Phase 1 (Dose Escalation)|Adverse Event|3
6937785|NCT00920140|10972194|FG001|Phase 1 (Dose Escalation)|Adverse Event|3
6937786|NCT00920140|10972195|FG002|Phase 1 (Dose Escalation)|Adverse Event|0
6937787|NCT00920140|10972196|FG003|Phase 1 (Dose Escalation)|Adverse Event|0
6937788|NCT00920140|10972197|FG004|Phase 1 (Dose Escalation)|Adverse Event|0
6937789|NCT00920140|10972193|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2
6937790|NCT00920140|10972194|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4
6937791|NCT00920140|10972195|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0
6937792|NCT00920140|10972196|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0
6937793|NCT00920140|10972197|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0
6937794|NCT00920140|10972193|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
6937795|NCT00920140|10972194|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2
6937796|NCT00920140|10972195|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
6937797|NCT00920140|10972196|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
6937798|NCT00920140|10972197|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
6937799|NCT00920140|10972193|FG000|Phase 2|Adverse Event|0
6937800|NCT00920140|10972194|FG001|Phase 2|Adverse Event|0
6937801|NCT00920140|10972195|FG002|Phase 2|Adverse Event|14
6937802|NCT00920140|10972196|FG003|Phase 2|Adverse Event|2
6937803|NCT00920140|10972197|FG004|Phase 2|Adverse Event|3
6937804|NCT00920140|10972193|FG000|Phase 2|Lack of Efficacy|0
6937805|NCT00920140|10972194|FG001|Phase 2|Lack of Efficacy|0
6937806|NCT00920140|10972195|FG002|Phase 2|Lack of Efficacy|29
6937807|NCT00920140|10972196|FG003|Phase 2|Lack of Efficacy|14
6937808|NCT00920140|10972197|FG004|Phase 2|Lack of Efficacy|5
6937809|NCT00920140|10972193|FG000|Phase 2|Lost to Follow-up|0
6937810|NCT00920140|10972194|FG001|Phase 2|Lost to Follow-up|0
6937811|NCT00920140|10972195|FG002|Phase 2|Lost to Follow-up|0
6937812|NCT00920140|10972196|FG003|Phase 2|Lost to Follow-up|1
6937813|NCT00920140|10972197|FG004|Phase 2|Lost to Follow-up|0
6937814|NCT00920140|10972193|FG000|Phase 2|Physician Decision|0
6937815|NCT00920140|10972194|FG001|Phase 2|Physician Decision|0
6937816|NCT00920140|10972195|FG002|Phase 2|Physician Decision|3
6937817|NCT00920140|10972196|FG003|Phase 2|Physician Decision|3
6937818|NCT00920140|10972197|FG004|Phase 2|Physician Decision|2
6937819|NCT00920140|10972193|FG000|Phase 2|Withdrawal by Subject|0
6937820|NCT00920140|10972194|FG001|Phase 2|Withdrawal by Subject|0
6937821|NCT00920140|10972195|FG002|Phase 2|Withdrawal by Subject|4
6937822|NCT00920140|10972196|FG003|Phase 2|Withdrawal by Subject|2
6937823|NCT00920140|10972197|FG004|Phase 2|Withdrawal by Subject|1
6937824|NCT00920218|10972214|FG000|Overall Study|Serious Adverse Event|2
6937825|NCT00920218|10972215|FG001|Overall Study|Serious Adverse Event|0
6937826|NCT00920218|10972216|FG002|Overall Study|Serious Adverse Event|2
6937827|NCT00920218|10972217|FG003|Overall Study|Serious Adverse Event|1
6937828|NCT00920218|10972214|FG000|Overall Study|Withdrawal by Subject|0
6937829|NCT00920218|10972215|FG001|Overall Study|Withdrawal by Subject|3
6937830|NCT00920218|10972216|FG002|Overall Study|Withdrawal by Subject|2
6937831|NCT00920218|10972217|FG003|Overall Study|Withdrawal by Subject|0
6937832|NCT00920218|10972214|FG000|Overall Study|Migrated/moved from study area|0
6937833|NCT00920218|10972215|FG001|Overall Study|Migrated/moved from study area|0
6937834|NCT00920218|10972216|FG002|Overall Study|Migrated/moved from study area|1
6937835|NCT00920218|10972217|FG003|Overall Study|Migrated/moved from study area|0
6937836|NCT00920218|10972214|FG000|Overall Study|Lost to Follow-up|0
6937837|NCT00920218|10972215|FG001|Overall Study|Lost to Follow-up|1
6937838|NCT00920218|10972216|FG002|Overall Study|Lost to Follow-up|0
6937839|NCT00920218|10972217|FG003|Overall Study|Lost to Follow-up|3
6937840|NCT00920218|10972214|FG000|Overall Study|Transplant failed/malignancy recurrence|0
6937841|NCT00920218|10972215|FG001|Overall Study|Transplant failed/malignancy recurrence|1
6937842|NCT00920218|10972216|FG002|Overall Study|Transplant failed/malignancy recurrence|2
6937843|NCT00920218|10972217|FG003|Overall Study|Transplant failed/malignancy recurrence|3
6937844|NCT00920218|10972214|FG000|Overall Study|Other|0
6937845|NCT00920218|10972215|FG001|Overall Study|Other|0
6937846|NCT00920218|10972216|FG002|Overall Study|Other|1
6937847|NCT00920218|10972217|FG003|Overall Study|Other|0
6937848|NCT00920426|10972254|FG000|ITZ111451|Adverse Event|1
6937849|NCT00920426|10972255|FG001|ITZ111451|Adverse Event|0
6937850|NCT00920426|10972256|FG002|ITZ111451|Adverse Event|0
6937851|NCT00920426|10972257|FG003|ITZ111451|Adverse Event|0
6937852|NCT00920556|10972273|FG000|Overall Study|Adverse Event|16
6937853|NCT00920556|10972273|FG000|Overall Study|Physician Decision|7
6937854|NCT00920556|10972273|FG000|Overall Study|Withdrawal by Subject|1
6937855|NCT00920686|10972311|FG000|Overall Study|Lost to Follow-up|2
6937856|NCT00920686|10972312|FG001|Overall Study|Lost to Follow-up|3
6937857|NCT00920686|10972313|FG002|Overall Study|Lost to Follow-up|1
6937858|NCT00920686|10972311|FG000|Overall Study|Study drug dosing criteria not met|17
6937859|NCT00920686|10972312|FG001|Overall Study|Study drug dosing criteria not met|19
6937860|NCT00920686|10972313|FG002|Overall Study|Study drug dosing criteria not met|12
6937861|NCT00920699|10972328|FG000|Overall Study|Withdrawal by Subject|2
6937862|NCT00920699|10972329|FG001|Overall Study|Withdrawal by Subject|0
6937863|NCT00920699|10972330|FG002|Overall Study|Withdrawal by Subject|2
6937864|NCT00920699|10972328|FG000|Overall Study|no longer met eligibility|0
6937865|NCT00920699|10972329|FG001|Overall Study|no longer met eligibility|1
6937866|NCT00920699|10972330|FG002|Overall Study|no longer met eligibility|0
6937867|NCT00920699|10972328|FG000|Overall Study|Lost to Follow-up|0
6937868|NCT00920699|10972329|FG001|Overall Study|Lost to Follow-up|0
6937869|NCT00920699|10972330|FG002|Overall Study|Lost to Follow-up|2
6937870|NCT00920790|10972338|FG000|Overall Study|aggravation of general condition|14
6937871|NCT00920829|10972346|FG000|Allocation|No post randomization data|3
6937872|NCT00920829|10972347|FG001|Allocation|No post randomization data|1
6937873|NCT00920829|10972348|FG002|Allocation|No post randomization data|0
6937874|NCT00920829|10972349|FG003|Allocation|No post randomization data|2
6937875|NCT00920829|10972346|FG000|Available for Analysis|Withdrawal by Subject|6
6937876|NCT00920829|10972347|FG001|Available for Analysis|Withdrawal by Subject|6
6937877|NCT00920829|10972348|FG002|Available for Analysis|Withdrawal by Subject|6
6937878|NCT00920829|10972349|FG003|Available for Analysis|Withdrawal by Subject|10
6937879|NCT00920829|10972346|FG000|Available for Analysis|Required Medical Treatment|0
6937880|NCT00920829|10972347|FG001|Available for Analysis|Required Medical Treatment|1
6937881|NCT00920829|10972348|FG002|Available for Analysis|Required Medical Treatment|2
6937882|NCT00920829|10972349|FG003|Available for Analysis|Required Medical Treatment|0
6937883|NCT00920829|10972346|FG000|Available for Analysis|Adverse Event|1
6937884|NCT00920829|10972347|FG001|Available for Analysis|Adverse Event|2
6937885|NCT00920829|10972348|FG002|Available for Analysis|Adverse Event|1
6937886|NCT00920829|10972349|FG003|Available for Analysis|Adverse Event|0
6937887|NCT00920829|10972346|FG000|Available for Analysis|Death|1
6937888|NCT00920829|10972347|FG001|Available for Analysis|Death|0
6937889|NCT00920829|10972348|FG002|Available for Analysis|Death|0
6937890|NCT00920829|10972349|FG003|Available for Analysis|Death|0
6937891|NCT00920829|10972346|FG000|Available for Analysis|Protocol Violation|0
6937892|NCT00920829|10972347|FG001|Available for Analysis|Protocol Violation|0
6937893|NCT00920829|10972348|FG002|Available for Analysis|Protocol Violation|1
6937894|NCT00920829|10972349|FG003|Available for Analysis|Protocol Violation|0
6937895|NCT00920829|10972346|FG000|Available for Analysis|Required more treatment|0
6937896|NCT00920829|10972347|FG001|Available for Analysis|Required more treatment|2
6937897|NCT00920829|10972348|FG002|Available for Analysis|Required more treatment|0
6937898|NCT00920829|10972349|FG003|Available for Analysis|Required more treatment|1
6937899|NCT00920855|10972362|FG000|Overall Study|Adverse Event|1
6937900|NCT00920855|10972363|FG001|Overall Study|Adverse Event|1
6937901|NCT00920855|10972364|FG002|Overall Study|Adverse Event|4
6937902|NCT00920855|10972362|FG000|Overall Study|Withdrawal by Subject|2
6937903|NCT00920855|10972363|FG001|Overall Study|Withdrawal by Subject|1
6937904|NCT00920855|10972364|FG002|Overall Study|Withdrawal by Subject|6
6937905|NCT00920855|10972362|FG000|Overall Study|Disease progression|2
6937906|NCT00920855|10972363|FG001|Overall Study|Disease progression|1
6937907|NCT00920855|10972364|FG002|Overall Study|Disease progression|10
6937908|NCT00920855|10972362|FG000|Overall Study|Noncompliance to study medication|0
6937909|NCT00920855|10972363|FG001|Overall Study|Noncompliance to study medication|0
6937910|NCT00920855|10972364|FG002|Overall Study|Noncompliance to study medication|1
6937911|NCT00920855|10972362|FG000|Overall Study|Response plateau; started maintenance|0
6937912|NCT00920855|10972363|FG001|Overall Study|Response plateau; started maintenance|0
6937913|NCT00920855|10972364|FG002|Overall Study|Response plateau; started maintenance|1
6937914|NCT00920907|10972375|FG000|Induction Period|Adverse Event|0
6937915|NCT00920907|10972376|FG001|Induction Period|Adverse Event|2
6937916|NCT00920907|10972375|FG000|Induction Period|Death|1
6937917|NCT00920907|10972376|FG001|Induction Period|Death|1
6937918|NCT00920907|10972375|FG000|Induction Period|Disease Progression|12
6937919|NCT00920907|10972376|FG001|Induction Period|Disease Progression|11
6937920|NCT00920907|10972375|FG000|Induction Period|Study Drug Toxicity|8
6937921|NCT00920907|10972376|FG001|Induction Period|Study Drug Toxicity|6
6937922|NCT00920907|10972375|FG000|Induction Period|No longer meets study criteria|0
6937923|NCT00920907|10972376|FG001|Induction Period|No longer meets study criteria|1
6937924|NCT00920907|10972375|FG000|Induction Period|Withdrawal by Subject|1
6937925|NCT00920907|10972376|FG001|Induction Period|Withdrawal by Subject|1
6937926|NCT00920907|10972375|FG000|Maintenance Period|Disease Progression|3
6937927|NCT00920907|10972376|FG001|Maintenance Period|Disease Progression|7
6937928|NCT00920907|10972375|FG000|Maintenance Period|Administrative (study closure)|7
6937929|NCT00920907|10972376|FG001|Maintenance Period|Administrative (study closure)|2
6937930|NCT00920907|10972375|FG000|Maintenance Period|Study Drug Toxicity|0
6937931|NCT00920907|10972376|FG001|Maintenance Period|Study Drug Toxicity|2
6937932|NCT00920907|10972375|FG000|Maintenance Period|Death|1
6937933|NCT00920907|10972376|FG001|Maintenance Period|Death|1
6937934|NCT00920907|10972375|FG000|Maintenance Period|Withdrawal by Subject|1
6937935|NCT00920907|10972376|FG001|Maintenance Period|Withdrawal by Subject|0
6937936|NCT00920907|10972375|FG000|Maintenance Period|Adverse Event|0
6937937|NCT00920907|10972376|FG001|Maintenance Period|Adverse Event|1
6937938|NCT00921024|10972386|FG000|Overall Study|Lost to Follow-up|2
6937939|NCT00921024|10972387|FG001|Overall Study|Lost to Follow-up|0
6937940|NCT00921024|10972386|FG000|Overall Study|Received concomittant therapy|2
6937941|NCT00921024|10972387|FG001|Overall Study|Received concomittant therapy|0
6937942|NCT00921024|10972386|FG000|Overall Study|Withdrawal by Subject|0
6937943|NCT00921024|10972387|FG001|Overall Study|Withdrawal by Subject|3
6937944|NCT00921557|10972421|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2
6937945|NCT00921557|10972422|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
6937946|NCT00921557|10972423|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
6937947|NCT00921557|10972421|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0
6937948|NCT00921557|10972422|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1
6937949|NCT00921557|10972423|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0
6937950|NCT00921557|10972421|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
6937951|NCT00921557|10972422|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
6937952|NCT00921557|10972423|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1
6937953|NCT00921557|10972421|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1
6937954|NCT00921557|10972422|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0
6937955|NCT00921557|10972423|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0
6937956|NCT00921557|10972421|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2
6937957|NCT00921557|10972422|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
6937958|NCT00921557|10972423|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
6937959|NCT00922116|10972480|FG000|Overall Study|Adverse Event|4
6937960|NCT00922116|10972480|FG000|Overall Study|Death|1
6937961|NCT00922116|10972480|FG000|Overall Study|Lost to Follow-up|1
6937962|NCT00922116|10972480|FG000|Overall Study|Withdrawal by Subject|4
6937963|NCT00922116|10972480|FG000|Overall Study|Other|5
6937964|NCT00922207|10972491|FG000|Overall Study|Adverse Event/Intercurrent Illness|3
6937965|NCT00922207|10972492|FG001|Overall Study|Adverse Event/Intercurrent Illness|0
6937966|NCT00922207|10972493|FG002|Overall Study|Adverse Event/Intercurrent Illness|0
6937967|NCT00922207|10972491|FG000|Overall Study|Insufficient Therapeutic Response|0
6937968|NCT00922207|10972492|FG001|Overall Study|Insufficient Therapeutic Response|0
6937969|NCT00922207|10972493|FG002|Overall Study|Insufficient Therapeutic Response|1
6937970|NCT00922207|10972491|FG000|Overall Study|Violation of Selection Criteria at Entry|0
6937971|NCT00922207|10972492|FG001|Overall Study|Violation of Selection Criteria at Entry|1
6937972|NCT00922207|10972493|FG002|Overall Study|Violation of Selection Criteria at Entry|0
6937973|NCT00922207|10972491|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1
6937974|NCT00922207|10972492|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0
6937975|NCT00922207|10972493|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0
6937976|NCT00922207|10972491|FG000|Overall Study|Withdrew Consent|2
6937977|NCT00922207|10972492|FG001|Overall Study|Withdrew Consent|5
6937978|NCT00922207|10972493|FG002|Overall Study|Withdrew Consent|2
6937979|NCT00922207|10972491|FG000|Overall Study|Abnormality of Laboratory Test|0
6937980|NCT00922207|10972492|FG001|Overall Study|Abnormality of Laboratory Test|1
6937981|NCT00922207|10972493|FG002|Overall Study|Abnormality of Laboratory Test|1
6937982|NCT00922272|10972506|FG000|Open-label Phase|Adverse Event|5
6937983|NCT00922272|10972507|FG001|Open-label Phase|Adverse Event|0
6937984|NCT00922272|10972506|FG000|Open-label Phase|Protocol Violation|1
6937985|NCT00922272|10972507|FG001|Open-label Phase|Protocol Violation|0
6937986|NCT00922272|10972506|FG000|Open-label Phase|Withdrawal by Subject|11
6937987|NCT00922272|10972507|FG001|Open-label Phase|Withdrawal by Subject|0
6937988|NCT00922272|10972506|FG000|Open-label Phase|Failure to meet randomization criteria|1
6937989|NCT00922272|10972507|FG001|Open-label Phase|Failure to meet randomization criteria|0
6937990|NCT00922272|10972506|FG000|Open-label Phase|Withdrawal criteria met|5
6937991|NCT00922272|10972507|FG001|Open-label Phase|Withdrawal criteria met|0
6937992|NCT00922272|10972506|FG000|Double-blind Phase|Adverse Event|1
6937993|NCT00922272|10972507|FG001|Double-blind Phase|Adverse Event|1
6937994|NCT00922272|10972506|FG000|Double-blind Phase|Withdrawal by Subject|1
6937995|NCT00922272|10972507|FG001|Double-blind Phase|Withdrawal by Subject|1
6937996|NCT00922272|10972506|FG000|Double-blind Phase|Lost to Follow-up|2
6937997|NCT00922272|10972507|FG001|Double-blind Phase|Lost to Follow-up|1
6937998|NCT00922272|10972506|FG000|Double-blind Phase|Withdrawal criteria met|1
6937999|NCT00922272|10972507|FG001|Double-blind Phase|Withdrawal criteria met|1
6938000|NCT00922272|10972506|FG000|Double-blind Phase|Noncompliance|1
6938001|NCT00922272|10972507|FG001|Double-blind Phase|Noncompliance|1
6938002|NCT00922272|10972506|FG000|Double-blind Phase|Positive urine drug screen|1
6938003|NCT00922272|10972507|FG001|Double-blind Phase|Positive urine drug screen|1
6938004|NCT00922428|10972515|FG000|Overall Study|retrospective/extremely implausible data|2
7040189|NCT01716520|11123212|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
6938005|NCT00922428|10972515|FG000|Overall Study|no medication use or questionable use|13
6938006|NCT00922441|10972528|FG000|Overall Study|Protocol Violation|0
6938007|NCT00922441|10972529|FG001|Overall Study|Protocol Violation|0
7040190|NCT01716520|11123213|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
6938008|NCT00922441|10972530|FG002|Overall Study|Protocol Violation|2
6938009|NCT00922441|10972528|FG000|Overall Study|Withdrawal by Subject|0
6938010|NCT00922441|10972529|FG001|Overall Study|Withdrawal by Subject|0
7067027|NCT01982331|11167792|FG000|Received Vaccination 2|Withdrawal by Subject|0
7067028|NCT01982331|11167793|FG001|Received Vaccination 2|Withdrawal by Subject|1
7067029|NCT01982331|11167792|FG000|Completed Study (Day 112)|Withdrawal by Subject|2
6938011|NCT00922441|10972530|FG002|Overall Study|Withdrawal by Subject|1
7067030|NCT01982331|11167793|FG001|Completed Study (Day 112)|Withdrawal by Subject|0
7067031|NCT01982435|11167801|FG000|Overall Study|Adverse Event|1
7067032|NCT01982435|11167802|FG001|Overall Study|Adverse Event|0
7067033|NCT01982682|11167816|FG000|Overall Study|Physician Decision|1
7067034|NCT01982773|11167832|FG000|Overall Study|Withdrawal by Subject|1
7067035|NCT01982773|11167833|FG001|Overall Study|Withdrawal by Subject|3
7067036|NCT01982773|11167832|FG000|Overall Study|Lost to Follow-up|7
7067037|NCT01982773|11167833|FG001|Overall Study|Lost to Follow-up|1
6938012|NCT00922480|10972540|FG000|Main Study|Protocol Violation|3
6938013|NCT00922480|10972541|FG001|Main Study|Protocol Violation|6
6938014|NCT00922480|10972540|FG000|Main Study|Adverse Event|6
6938015|NCT00922480|10972541|FG001|Main Study|Adverse Event|7
6938016|NCT00922480|10972540|FG000|Main Study|Lack of Efficacy|3
6938017|NCT00922480|10972541|FG001|Main Study|Lack of Efficacy|0
6938018|NCT00922480|10972540|FG000|Main Study|Withdrawal by Subject|20
6938019|NCT00922480|10972541|FG001|Main Study|Withdrawal by Subject|15
6938020|NCT00922480|10972540|FG000|Main Study|Lost to Follow-up|5
6938021|NCT00922480|10972541|FG001|Main Study|Lost to Follow-up|0
6938022|NCT00922480|10972540|FG000|Main Study|Physician Decision|0
6938023|NCT00922480|10972541|FG001|Main Study|Physician Decision|1
6938024|NCT00922480|10972540|FG000|Extension Study|Protocol Violation|3
6938025|NCT00922480|10972541|FG001|Extension Study|Protocol Violation|0
6938026|NCT00922480|10972540|FG000|Extension Study|Adverse Event|1
6938027|NCT00922480|10972541|FG001|Extension Study|Adverse Event|1
6938028|NCT00922480|10972540|FG000|Extension Study|Withdrawal by Subject|1
6938029|NCT00922480|10972541|FG001|Extension Study|Withdrawal by Subject|1
6938030|NCT00922480|10972540|FG000|Extension Study|Others|0
6938031|NCT00922480|10972541|FG001|Extension Study|Others|1
6938032|NCT00922623|10972549|FG000|Overall Study|Other|4
6938033|NCT00922623|10972549|FG000|Overall Study|Lost to Follow-up|1
6938034|NCT00922636|10972560|FG000|Overall Study|Adverse Event|3
6938035|NCT00922636|10972561|FG001|Overall Study|Adverse Event|3
6938036|NCT00922636|10972562|FG002|Overall Study|Adverse Event|2
6938037|NCT00922636|10972563|FG003|Overall Study|Adverse Event|3
6938038|NCT00922636|10972564|FG004|Overall Study|Adverse Event|2
6938039|NCT00922636|10972560|FG000|Overall Study|Lack of Efficacy|1
6938040|NCT00922636|10972561|FG001|Overall Study|Lack of Efficacy|7
6938041|NCT00922636|10972562|FG002|Overall Study|Lack of Efficacy|3
6938042|NCT00922636|10972563|FG003|Overall Study|Lack of Efficacy|2
6938043|NCT00922636|10972564|FG004|Overall Study|Lack of Efficacy|4
6938044|NCT00922636|10972560|FG000|Overall Study|Sponsor Decision|0
6938045|NCT00922636|10972561|FG001|Overall Study|Sponsor Decision|0
6938046|NCT00922636|10972562|FG002|Overall Study|Sponsor Decision|2
6938047|NCT00922636|10972563|FG003|Overall Study|Sponsor Decision|0
6938048|NCT00922636|10972564|FG004|Overall Study|Sponsor Decision|0
6938049|NCT00922636|10972560|FG000|Overall Study|Withdrawal by Subject|0
6938050|NCT00922636|10972561|FG001|Overall Study|Withdrawal by Subject|0
6938051|NCT00922636|10972562|FG002|Overall Study|Withdrawal by Subject|5
6938052|NCT00922636|10972563|FG003|Overall Study|Withdrawal by Subject|2
6938053|NCT00922636|10972564|FG004|Overall Study|Withdrawal by Subject|4
6938054|NCT00922636|10972560|FG000|Overall Study|Protocol Violation|0
6938055|NCT00922636|10972561|FG001|Overall Study|Protocol Violation|0
6938056|NCT00922636|10972562|FG002|Overall Study|Protocol Violation|2
6938057|NCT00922636|10972563|FG003|Overall Study|Protocol Violation|2
6938058|NCT00922636|10972564|FG004|Overall Study|Protocol Violation|0
6938059|NCT00922636|10972560|FG000|Overall Study|Entry Criteria Not Met|0
6938060|NCT00922636|10972561|FG001|Overall Study|Entry Criteria Not Met|0
6938061|NCT00922636|10972562|FG002|Overall Study|Entry Criteria Not Met|1
6938062|NCT00922636|10972563|FG003|Overall Study|Entry Criteria Not Met|1
6938063|NCT00922636|10972564|FG004|Overall Study|Entry Criteria Not Met|0
6938064|NCT00922636|10972560|FG000|Overall Study|Parent/Caregiver Decision|2
6938065|NCT00922636|10972561|FG001|Overall Study|Parent/Caregiver Decision|4
6938066|NCT00922636|10972562|FG002|Overall Study|Parent/Caregiver Decision|3
6938067|NCT00922636|10972563|FG003|Overall Study|Parent/Caregiver Decision|5
6938068|NCT00922636|10972564|FG004|Overall Study|Parent/Caregiver Decision|2
6938069|NCT00922636|10972560|FG000|Overall Study|Lost to Follow-up|1
6938070|NCT00922636|10972561|FG001|Overall Study|Lost to Follow-up|2
6938071|NCT00922636|10972562|FG002|Overall Study|Lost to Follow-up|2
6938072|NCT00922636|10972563|FG003|Overall Study|Lost to Follow-up|2
6938073|NCT00922636|10972564|FG004|Overall Study|Lost to Follow-up|4
6938074|NCT00922766|10972585|FG000|Overall Study|Death|3
6938075|NCT00922766|10972585|FG000|Overall Study|Withdrawal by Subject|2
6938076|NCT00922766|10972585|FG000|Overall Study|Other|1
6938077|NCT00922766|10972585|FG000|Overall Study|Adverse Event|1
6938078|NCT00922779|10972589|FG000|Overall Study|Adverse Event|67
6938079|NCT00922779|10972589|FG000|Overall Study|Pregnancy|7
6938080|NCT00922779|10972589|FG000|Overall Study|Withdrawal by Subject|308
6938081|NCT00922779|10972589|FG000|Overall Study|Lost to Follow-up|44
7067038|NCT01982812|11167850|FG000|Overall Study|Death|1
6938082|NCT00922779|10972589|FG000|Overall Study|Other|27
6938083|NCT00922779|10972589|FG000|Overall Study|Missing|1874
7067039|NCT01982812|11167851|FG001|Overall Study|Death|5
7067040|NCT01982812|11167850|FG000|Overall Study|Adverse Event|0
6938084|NCT00922935|10972600|FG000|Overall Study|Protocol Violation|0
6938085|NCT00922935|10972601|FG001|Overall Study|Protocol Violation|3
6938086|NCT00922935|10972602|FG002|Overall Study|Protocol Violation|0
6938087|NCT00922935|10972600|FG000|Overall Study|Physician Decision|1
6938088|NCT00922935|10972601|FG001|Overall Study|Physician Decision|1
6938089|NCT00922935|10972602|FG002|Overall Study|Physician Decision|0
6938090|NCT00922935|10972600|FG000|Overall Study|Lost to Follow-up|0
6938091|NCT00922935|10972601|FG001|Overall Study|Lost to Follow-up|1
6938092|NCT00922935|10972602|FG002|Overall Study|Lost to Follow-up|0
6938093|NCT00922974|10972613|FG000|Phase II Component|Protocol Violation|2
6938094|NCT00922974|10972614|FG001|Phase II Component|Protocol Violation|0
6938095|NCT00922974|10972613|FG000|Phase II Component|Not evaluable for treatment review|5
6938096|NCT00922974|10972614|FG001|Phase II Component|Not evaluable for treatment review|0
6938097|NCT00922974|10972613|FG000|Phase III Component|Protocol Violation|8
6938098|NCT00922974|10972614|FG001|Phase III Component|Protocol Violation|6
6938099|NCT00922987|10972622|FG000|Overall Study|Insufficient clinical response|1
6938100|NCT00922987|10972622|FG000|Overall Study|Protocol Violation|2
6938101|NCT00922987|10972622|FG000|Overall Study|Adverse Event|1
6938102|NCT00923078|10972629|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
6938103|NCT00923078|10972630|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
6938104|NCT00923078|10972631|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0
6938105|NCT00923078|10972629|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0
6938106|NCT00923078|10972630|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0
6938107|NCT00923078|10972631|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20
6938108|NCT00923091|10972646|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11
6938109|NCT00923091|10972647|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3
6938110|NCT00923091|10972648|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7
6938111|NCT00923091|10972649|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13
6938112|NCT00923091|10972650|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10
6938113|NCT00923091|10972651|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5
6938114|NCT00923091|10972652|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9
6938115|NCT00923091|10972653|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17
6938116|NCT00923091|10972654|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
6938117|NCT00923091|10972655|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
6938118|NCT00923091|10972656|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
6938119|NCT00923091|10972657|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
6938120|NCT00923091|10972658|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
6938121|NCT00923091|10972646|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4
6938122|NCT00923091|10972647|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
6938123|NCT00923091|10972648|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
6938124|NCT00923091|10972649|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8
6938125|NCT00923091|10972650|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7
6938126|NCT00923091|10972651|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
6938127|NCT00923091|10972652|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
6938128|NCT00923091|10972653|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
6938129|NCT00923091|10972654|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
6938130|NCT00923091|10972655|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
6938131|NCT00923091|10972656|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
6938132|NCT00923091|10972657|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
6938133|NCT00923091|10972658|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
6938134|NCT00923091|10972646|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
6938135|NCT00923091|10972647|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
6938136|NCT00923091|10972648|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
6938137|NCT00923091|10972649|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5
6938138|NCT00923091|10972650|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
6938139|NCT00923091|10972651|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2
6938140|NCT00923091|10972652|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
6938141|NCT00923091|10972653|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3
6938142|NCT00923091|10972654|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
6938143|NCT00923091|10972655|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
6938144|NCT00923091|10972656|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
6938145|NCT00923091|10972657|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
6938146|NCT00923091|10972658|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
6938147|NCT00923091|10972646|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
6938148|NCT00923091|10972647|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
6938149|NCT00923091|10972648|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
6938150|NCT00923091|10972649|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
6938151|NCT00923091|10972650|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
6938152|NCT00923091|10972651|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1
6938153|NCT00923091|10972652|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
6938154|NCT00923091|10972653|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
6938155|NCT00923091|10972654|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
6938156|NCT00923091|10972655|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
6938157|NCT00923091|10972656|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
6938158|NCT00923091|10972657|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
6938159|NCT00923091|10972658|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
6938160|NCT00923091|10972646|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
6938161|NCT00923091|10972647|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
6938162|NCT00923091|10972648|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
6938163|NCT00923091|10972649|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
6938164|NCT00923091|10972650|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
6938165|NCT00923091|10972651|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
6938166|NCT00923091|10972652|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
6938167|NCT00923091|10972653|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
6938168|NCT00923091|10972654|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
6938169|NCT00923091|10972655|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
6938170|NCT00923091|10972656|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
6938171|NCT00923091|10972657|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
6938172|NCT00923091|10972658|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
6938173|NCT00923091|10972646|FG000|Period III (Single-Blind)|Adverse Event|5
6938174|NCT00923091|10972647|FG001|Period III (Single-Blind)|Adverse Event|0
6938175|NCT00923091|10972648|FG002|Period III (Single-Blind)|Adverse Event|0
6938176|NCT00923091|10972649|FG003|Period III (Single-Blind)|Adverse Event|0
6938177|NCT00923091|10972650|FG004|Period III (Single-Blind)|Adverse Event|0
6938178|NCT00923091|10972651|FG005|Period III (Single-Blind)|Adverse Event|0
6938179|NCT00923091|10972652|FG006|Period III (Single-Blind)|Adverse Event|0
6938180|NCT00923091|10972653|FG007|Period III (Single-Blind)|Adverse Event|0
6938181|NCT00923091|10972654|FG008|Period III (Single-Blind)|Adverse Event|0
6938182|NCT00923091|10972655|FG009|Period III (Single-Blind)|Adverse Event|0
6938183|NCT00923091|10972656|FG010|Period III (Single-Blind)|Adverse Event|0
6938184|NCT00923091|10972657|FG011|Period III (Single-Blind)|Adverse Event|0
6938185|NCT00923091|10972658|FG012|Period III (Single-Blind)|Adverse Event|0
6938186|NCT00923091|10972646|FG000|Period III (Single-Blind)|Withdrawal by Subject|10
6938187|NCT00923091|10972647|FG001|Period III (Single-Blind)|Withdrawal by Subject|0
6938188|NCT00923091|10972648|FG002|Period III (Single-Blind)|Withdrawal by Subject|0
6938189|NCT00923091|10972649|FG003|Period III (Single-Blind)|Withdrawal by Subject|0
6938190|NCT00923091|10972650|FG004|Period III (Single-Blind)|Withdrawal by Subject|0
6938191|NCT00923091|10972651|FG005|Period III (Single-Blind)|Withdrawal by Subject|0
6938192|NCT00923091|10972652|FG006|Period III (Single-Blind)|Withdrawal by Subject|0
6938193|NCT00923091|10972653|FG007|Period III (Single-Blind)|Withdrawal by Subject|0
6938194|NCT00923091|10972654|FG008|Period III (Single-Blind)|Withdrawal by Subject|0
6938195|NCT00923091|10972655|FG009|Period III (Single-Blind)|Withdrawal by Subject|0
6938196|NCT00923091|10972656|FG010|Period III (Single-Blind)|Withdrawal by Subject|0
6938197|NCT00923091|10972657|FG011|Period III (Single-Blind)|Withdrawal by Subject|0
6938198|NCT00923091|10972658|FG012|Period III (Single-Blind)|Withdrawal by Subject|0
7040191|NCT01716520|11123214|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
6938199|NCT00923091|10972646|FG000|Period III (Single-Blind)|Protocol Violation|3
6938200|NCT00923091|10972647|FG001|Period III (Single-Blind)|Protocol Violation|0
6938201|NCT00923091|10972648|FG002|Period III (Single-Blind)|Protocol Violation|0
6938202|NCT00923091|10972649|FG003|Period III (Single-Blind)|Protocol Violation|0
6938203|NCT00923091|10972650|FG004|Period III (Single-Blind)|Protocol Violation|0
6938204|NCT00923091|10972651|FG005|Period III (Single-Blind)|Protocol Violation|0
6938205|NCT00923091|10972652|FG006|Period III (Single-Blind)|Protocol Violation|0
6938206|NCT00923091|10972653|FG007|Period III (Single-Blind)|Protocol Violation|0
6938207|NCT00923091|10972654|FG008|Period III (Single-Blind)|Protocol Violation|0
6938208|NCT00923091|10972655|FG009|Period III (Single-Blind)|Protocol Violation|0
6938209|NCT00923091|10972656|FG010|Period III (Single-Blind)|Protocol Violation|0
6938210|NCT00923091|10972657|FG011|Period III (Single-Blind)|Protocol Violation|0
6938211|NCT00923091|10972658|FG012|Period III (Single-Blind)|Protocol Violation|0
6938212|NCT00923091|10972646|FG000|Period III (Single-Blind)|Lost to Follow-up|2
6938213|NCT00923091|10972647|FG001|Period III (Single-Blind)|Lost to Follow-up|0
6938214|NCT00923091|10972648|FG002|Period III (Single-Blind)|Lost to Follow-up|0
6938215|NCT00923091|10972649|FG003|Period III (Single-Blind)|Lost to Follow-up|0
6938216|NCT00923091|10972650|FG004|Period III (Single-Blind)|Lost to Follow-up|0
6938217|NCT00923091|10972651|FG005|Period III (Single-Blind)|Lost to Follow-up|0
6938218|NCT00923091|10972652|FG006|Period III (Single-Blind)|Lost to Follow-up|0
6938219|NCT00923091|10972653|FG007|Period III (Single-Blind)|Lost to Follow-up|0
6938220|NCT00923091|10972654|FG008|Period III (Single-Blind)|Lost to Follow-up|0
6938221|NCT00923091|10972655|FG009|Period III (Single-Blind)|Lost to Follow-up|0
6938222|NCT00923091|10972656|FG010|Period III (Single-Blind)|Lost to Follow-up|0
6938223|NCT00923091|10972657|FG011|Period III (Single-Blind)|Lost to Follow-up|0
6938224|NCT00923091|10972658|FG012|Period III (Single-Blind)|Lost to Follow-up|0
6938225|NCT00923091|10972646|FG000|Period IV (Double-Blind)|Adverse Event|2
6938226|NCT00923091|10972647|FG001|Period IV (Double-Blind)|Adverse Event|0
6938227|NCT00923091|10972648|FG002|Period IV (Double-Blind)|Adverse Event|0
6938228|NCT00923091|10972649|FG003|Period IV (Double-Blind)|Adverse Event|0
6938229|NCT00923091|10972650|FG004|Period IV (Double-Blind)|Adverse Event|0
6938230|NCT00923091|10972651|FG005|Period IV (Double-Blind)|Adverse Event|0
6938231|NCT00923091|10972652|FG006|Period IV (Double-Blind)|Adverse Event|0
6938232|NCT00923091|10972653|FG007|Period IV (Double-Blind)|Adverse Event|0
6938233|NCT00923091|10972654|FG008|Period IV (Double-Blind)|Adverse Event|0
6938234|NCT00923091|10972655|FG009|Period IV (Double-Blind)|Adverse Event|0
6938235|NCT00923091|10972656|FG010|Period IV (Double-Blind)|Adverse Event|0
6938236|NCT00923091|10972657|FG011|Period IV (Double-Blind)|Adverse Event|0
6938237|NCT00923091|10972658|FG012|Period IV (Double-Blind)|Adverse Event|0
6938238|NCT00923091|10972646|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0
6938239|NCT00923091|10972647|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1
6938240|NCT00923091|10972648|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0
6938241|NCT00923091|10972649|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0
6938242|NCT00923091|10972650|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0
6938243|NCT00923091|10972651|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0
6938244|NCT00923091|10972652|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0
6938245|NCT00923091|10972653|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0
6938246|NCT00923091|10972654|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0
6938247|NCT00923091|10972655|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0
6938248|NCT00923091|10972656|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0
6838129|NCT00256750|10843794|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0
6838130|NCT00256750|10843792|FG000|Long Term Extension (LTE; 84 Months)|Other|5
6938249|NCT00923091|10972657|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0
6938250|NCT00923091|10972658|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0
7040192|NCT01716520|11123209|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7040193|NCT01716520|11123210|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
7040194|NCT01716520|11123211|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7040195|NCT01716520|11123212|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7040196|NCT01716520|11123213|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7040197|NCT01716520|11123214|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7040198|NCT01716520|11123209|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0
7040199|NCT01716520|11123210|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1
7040200|NCT01716520|11123211|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0
7040201|NCT01716520|11123212|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0
6938251|NCT00923091|10972646|FG000|Period IV (Double-Blind)|Protocol Violation|0
6938252|NCT00923091|10972647|FG001|Period IV (Double-Blind)|Protocol Violation|1
6938253|NCT00923091|10972648|FG002|Period IV (Double-Blind)|Protocol Violation|0
6938254|NCT00923091|10972649|FG003|Period IV (Double-Blind)|Protocol Violation|0
6938255|NCT00923091|10972650|FG004|Period IV (Double-Blind)|Protocol Violation|0
6938256|NCT00923091|10972651|FG005|Period IV (Double-Blind)|Protocol Violation|0
6938257|NCT00923091|10972652|FG006|Period IV (Double-Blind)|Protocol Violation|0
6938258|NCT00923091|10972653|FG007|Period IV (Double-Blind)|Protocol Violation|0
6938259|NCT00923091|10972654|FG008|Period IV (Double-Blind)|Protocol Violation|0
6938260|NCT00923091|10972655|FG009|Period IV (Double-Blind)|Protocol Violation|0
7040202|NCT01716520|11123213|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0
7040203|NCT01716520|11123214|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0
7040204|NCT01716520|11123209|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
7040205|NCT01716520|11123210|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
7040206|NCT01716520|11123211|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
7040207|NCT01716520|11123212|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
6838131|NCT00256750|10843793|FG001|Long Term Extension (LTE; 84 Months)|Other|4
6838132|NCT00256750|10843794|FG002|Long Term Extension (LTE; 84 Months)|Other|5
6838133|NCT00256854|10843820|FG000|Overall Study|Withdrawal by Subject|2
6838134|NCT00256854|10843821|FG001|Overall Study|Withdrawal by Subject|3
6838135|NCT00256854|10843822|FG002|Overall Study|Withdrawal by Subject|0
6838136|NCT00256854|10843823|FG003|Overall Study|Withdrawal by Subject|0
6838137|NCT00256854|10843824|FG004|Overall Study|Withdrawal by Subject|0
6838138|NCT00256854|10843825|FG005|Overall Study|Withdrawal by Subject|0
6838139|NCT00256854|10843820|FG000|Overall Study|Lack of Efficacy|1
6838140|NCT00256854|10843821|FG001|Overall Study|Lack of Efficacy|0
6838141|NCT00256854|10843822|FG002|Overall Study|Lack of Efficacy|0
6838142|NCT00256854|10843823|FG003|Overall Study|Lack of Efficacy|0
6838143|NCT00256854|10843824|FG004|Overall Study|Lack of Efficacy|0
6838144|NCT00256854|10843825|FG005|Overall Study|Lack of Efficacy|0
6838145|NCT00256854|10843820|FG000|Overall Study|Protocol Violation|0
6838146|NCT00256854|10843821|FG001|Overall Study|Protocol Violation|1
6838147|NCT00256854|10843822|FG002|Overall Study|Protocol Violation|1
6838148|NCT00256854|10843823|FG003|Overall Study|Protocol Violation|1
6838149|NCT00256854|10843824|FG004|Overall Study|Protocol Violation|0
6838150|NCT00256854|10843825|FG005|Overall Study|Protocol Violation|0
6838151|NCT00256854|10843820|FG000|Overall Study|Adverse Event|0
6938261|NCT00923091|10972656|FG010|Period IV (Double-Blind)|Protocol Violation|0
6938262|NCT00923091|10972657|FG011|Period IV (Double-Blind)|Protocol Violation|0
6938263|NCT00923091|10972658|FG012|Period IV (Double-Blind)|Protocol Violation|0
6938264|NCT00923091|10972646|FG000|Period V (Double -Blind)|Withdrawal by Subject|0
7044795|NCT01757275|11130782|FG001|Overall Study|Withdrawal by Subject|4
6938265|NCT00923091|10972647|FG001|Period V (Double -Blind)|Withdrawal by Subject|0
6938266|NCT00923091|10972648|FG002|Period V (Double -Blind)|Withdrawal by Subject|0
6938267|NCT00923091|10972649|FG003|Period V (Double -Blind)|Withdrawal by Subject|0
6938268|NCT00923091|10972650|FG004|Period V (Double -Blind)|Withdrawal by Subject|0
6938269|NCT00923091|10972651|FG005|Period V (Double -Blind)|Withdrawal by Subject|0
6938270|NCT00923091|10972652|FG006|Period V (Double -Blind)|Withdrawal by Subject|0
6938271|NCT00923091|10972653|FG007|Period V (Double -Blind)|Withdrawal by Subject|0
6938272|NCT00923091|10972654|FG008|Period V (Double -Blind)|Withdrawal by Subject|1
6938273|NCT00923091|10972655|FG009|Period V (Double -Blind)|Withdrawal by Subject|0
6938274|NCT00923091|10972656|FG010|Period V (Double -Blind)|Withdrawal by Subject|0
6938275|NCT00923091|10972657|FG011|Period V (Double -Blind)|Withdrawal by Subject|0
6938276|NCT00923091|10972658|FG012|Period V (Double -Blind)|Withdrawal by Subject|1
6938277|NCT00923091|10972646|FG000|Period V (Double -Blind)|Protocol Violation|0
6938278|NCT00923091|10972647|FG001|Period V (Double -Blind)|Protocol Violation|0
6938279|NCT00923091|10972648|FG002|Period V (Double -Blind)|Protocol Violation|0
6938280|NCT00923091|10972649|FG003|Period V (Double -Blind)|Protocol Violation|0
6938281|NCT00923091|10972650|FG004|Period V (Double -Blind)|Protocol Violation|0
6938282|NCT00923091|10972651|FG005|Period V (Double -Blind)|Protocol Violation|0
6938283|NCT00923091|10972652|FG006|Period V (Double -Blind)|Protocol Violation|0
6938284|NCT00923091|10972653|FG007|Period V (Double -Blind)|Protocol Violation|0
6938285|NCT00923091|10972654|FG008|Period V (Double -Blind)|Protocol Violation|0
6938286|NCT00923091|10972655|FG009|Period V (Double -Blind)|Protocol Violation|0
6938287|NCT00923091|10972656|FG010|Period V (Double -Blind)|Protocol Violation|0
6938288|NCT00923091|10972657|FG011|Period V (Double -Blind)|Protocol Violation|0
6938289|NCT00923091|10972658|FG012|Period V (Double -Blind)|Protocol Violation|1
6938290|NCT00923091|10972646|FG000|Period V (Double -Blind)|Lost to Follow-up|0
6938291|NCT00923091|10972647|FG001|Period V (Double -Blind)|Lost to Follow-up|0
6938292|NCT00923091|10972648|FG002|Period V (Double -Blind)|Lost to Follow-up|0
6938293|NCT00923091|10972649|FG003|Period V (Double -Blind)|Lost to Follow-up|0
6938294|NCT00923091|10972650|FG004|Period V (Double -Blind)|Lost to Follow-up|0
6938295|NCT00923091|10972651|FG005|Period V (Double -Blind)|Lost to Follow-up|0
6938296|NCT00923091|10972652|FG006|Period V (Double -Blind)|Lost to Follow-up|0
6938297|NCT00923091|10972653|FG007|Period V (Double -Blind)|Lost to Follow-up|0
6938298|NCT00923091|10972654|FG008|Period V (Double -Blind)|Lost to Follow-up|0
6938299|NCT00923091|10972655|FG009|Period V (Double -Blind)|Lost to Follow-up|0
6938300|NCT00923091|10972656|FG010|Period V (Double -Blind)|Lost to Follow-up|1
6938301|NCT00923091|10972657|FG011|Period V (Double -Blind)|Lost to Follow-up|0
6938302|NCT00923091|10972658|FG012|Period V (Double -Blind)|Lost to Follow-up|0
6938303|NCT00923091|10972646|FG000|Period VI (Open-Label)|Adverse Event|17
6938304|NCT00923091|10972647|FG001|Period VI (Open-Label)|Adverse Event|0
6938305|NCT00923091|10972648|FG002|Period VI (Open-Label)|Adverse Event|4
6938306|NCT00923091|10972649|FG003|Period VI (Open-Label)|Adverse Event|1
6938307|NCT00923091|10972650|FG004|Period VI (Open-Label)|Adverse Event|1
6938308|NCT00923091|10972651|FG005|Period VI (Open-Label)|Adverse Event|0
6938309|NCT00923091|10972652|FG006|Period VI (Open-Label)|Adverse Event|0
6938310|NCT00923091|10972653|FG007|Period VI (Open-Label)|Adverse Event|0
6938311|NCT00923091|10972654|FG008|Period VI (Open-Label)|Adverse Event|0
6938312|NCT00923091|10972655|FG009|Period VI (Open-Label)|Adverse Event|0
6938313|NCT00923091|10972656|FG010|Period VI (Open-Label)|Adverse Event|0
6938314|NCT00923091|10972657|FG011|Period VI (Open-Label)|Adverse Event|0
6938315|NCT00923091|10972658|FG012|Period VI (Open-Label)|Adverse Event|0
6938316|NCT00923091|10972646|FG000|Period VI (Open-Label)|Withdrawal by Subject|15
6938317|NCT00923091|10972647|FG001|Period VI (Open-Label)|Withdrawal by Subject|7
6938318|NCT00923091|10972648|FG002|Period VI (Open-Label)|Withdrawal by Subject|5
6938319|NCT00923091|10972649|FG003|Period VI (Open-Label)|Withdrawal by Subject|0
6938320|NCT00923091|10972650|FG004|Period VI (Open-Label)|Withdrawal by Subject|1
6938321|NCT00923091|10972651|FG005|Period VI (Open-Label)|Withdrawal by Subject|0
6938322|NCT00923091|10972652|FG006|Period VI (Open-Label)|Withdrawal by Subject|0
6938323|NCT00923091|10972653|FG007|Period VI (Open-Label)|Withdrawal by Subject|0
6938324|NCT00923091|10972654|FG008|Period VI (Open-Label)|Withdrawal by Subject|0
6938325|NCT00923091|10972655|FG009|Period VI (Open-Label)|Withdrawal by Subject|0
6938326|NCT00923091|10972656|FG010|Period VI (Open-Label)|Withdrawal by Subject|0
6938327|NCT00923091|10972657|FG011|Period VI (Open-Label)|Withdrawal by Subject|0
6938328|NCT00923091|10972658|FG012|Period VI (Open-Label)|Withdrawal by Subject|0
6938329|NCT00923091|10972646|FG000|Period VI (Open-Label)|Protocol Violation|6
6938330|NCT00923091|10972647|FG001|Period VI (Open-Label)|Protocol Violation|1
6938331|NCT00923091|10972648|FG002|Period VI (Open-Label)|Protocol Violation|3
6938332|NCT00923091|10972649|FG003|Period VI (Open-Label)|Protocol Violation|1
6938333|NCT00923091|10972650|FG004|Period VI (Open-Label)|Protocol Violation|4
7067041|NCT01982812|11167851|FG001|Overall Study|Adverse Event|5
6938334|NCT00923091|10972651|FG005|Period VI (Open-Label)|Protocol Violation|0
6938335|NCT00923091|10972652|FG006|Period VI (Open-Label)|Protocol Violation|0
6938336|NCT00923091|10972653|FG007|Period VI (Open-Label)|Protocol Violation|0
6938337|NCT00923091|10972654|FG008|Period VI (Open-Label)|Protocol Violation|0
6938338|NCT00923091|10972655|FG009|Period VI (Open-Label)|Protocol Violation|0
6938339|NCT00923091|10972656|FG010|Period VI (Open-Label)|Protocol Violation|0
6938340|NCT00923091|10972657|FG011|Period VI (Open-Label)|Protocol Violation|0
6938341|NCT00923091|10972658|FG012|Period VI (Open-Label)|Protocol Violation|0
6938342|NCT00923091|10972646|FG000|Period VI (Open-Label)|Lost to Follow-up|1
6938343|NCT00923091|10972647|FG001|Period VI (Open-Label)|Lost to Follow-up|0
6938344|NCT00923091|10972648|FG002|Period VI (Open-Label)|Lost to Follow-up|1
6938345|NCT00923091|10972649|FG003|Period VI (Open-Label)|Lost to Follow-up|0
6938346|NCT00923091|10972650|FG004|Period VI (Open-Label)|Lost to Follow-up|0
6938347|NCT00923091|10972651|FG005|Period VI (Open-Label)|Lost to Follow-up|0
6938348|NCT00923091|10972652|FG006|Period VI (Open-Label)|Lost to Follow-up|0
6938349|NCT00923091|10972653|FG007|Period VI (Open-Label)|Lost to Follow-up|0
6938350|NCT00923091|10972654|FG008|Period VI (Open-Label)|Lost to Follow-up|0
6938351|NCT00923091|10972655|FG009|Period VI (Open-Label)|Lost to Follow-up|0
6938352|NCT00923091|10972656|FG010|Period VI (Open-Label)|Lost to Follow-up|0
6938353|NCT00923091|10972657|FG011|Period VI (Open-Label)|Lost to Follow-up|0
6938354|NCT00923091|10972658|FG012|Period VI (Open-Label)|Lost to Follow-up|0
6938355|NCT00923091|10972646|FG000|Period VI (Open-Label)|Other Reason|0
6938356|NCT00923091|10972647|FG001|Period VI (Open-Label)|Other Reason|0
6938357|NCT00923091|10972648|FG002|Period VI (Open-Label)|Other Reason|0
6938358|NCT00923091|10972649|FG003|Period VI (Open-Label)|Other Reason|1
6938359|NCT00923091|10972650|FG004|Period VI (Open-Label)|Other Reason|1
6938360|NCT00923091|10972651|FG005|Period VI (Open-Label)|Other Reason|0
6938361|NCT00923091|10972652|FG006|Period VI (Open-Label)|Other Reason|0
6938362|NCT00923091|10972653|FG007|Period VI (Open-Label)|Other Reason|0
6938363|NCT00923091|10972654|FG008|Period VI (Open-Label)|Other Reason|0
6938364|NCT00923091|10972655|FG009|Period VI (Open-Label)|Other Reason|0
6938365|NCT00923091|10972656|FG010|Period VI (Open-Label)|Other Reason|0
6938366|NCT00923091|10972657|FG011|Period VI (Open-Label)|Other Reason|0
6938367|NCT00923091|10972658|FG012|Period VI (Open-Label)|Other Reason|0
6938368|NCT00923130|10972692|FG000|Overall Study|Stopped treatment due to progression|17
6938369|NCT00923130|10972692|FG000|Overall Study|Death|1
6938370|NCT00923130|10972692|FG000|Overall Study|Discontinued treatment due to toxicities|3
6938371|NCT00923130|10972692|FG000|Overall Study|Switched to alternative treatment|2
6938372|NCT00923130|10972692|FG000|Overall Study|Refused further treatment|2
6938373|NCT00923156|10972699|FG000|Overall Study|Adverse Event|0
6938374|NCT00923156|10972700|FG001|Overall Study|Adverse Event|2
6938375|NCT00923156|10972701|FG002|Overall Study|Adverse Event|1
6938376|NCT00923156|10972699|FG000|Overall Study|Abnormal laboratory values|0
6938377|NCT00923156|10972700|FG001|Overall Study|Abnormal laboratory values|0
6938378|NCT00923156|10972701|FG002|Overall Study|Abnormal laboratory values|1
6938379|NCT00923156|10972699|FG000|Overall Study|Withdrawal by Subject|0
6938380|NCT00923156|10972700|FG001|Overall Study|Withdrawal by Subject|1
6938381|NCT00923156|10972701|FG002|Overall Study|Withdrawal by Subject|0
6938382|NCT00923156|10972699|FG000|Overall Study|Death|0
6938383|NCT00923156|10972700|FG001|Overall Study|Death|1
6938384|NCT00923156|10972701|FG002|Overall Study|Death|0
6938385|NCT00923156|10972699|FG000|Overall Study|Lack of Efficacy|0
6938386|NCT00923156|10972700|FG001|Overall Study|Lack of Efficacy|0
6938387|NCT00923156|10972701|FG002|Overall Study|Lack of Efficacy|1
6938388|NCT00923195|10972711|FG000|Overall Study|Death|0
6938389|NCT00923195|10972712|FG001|Overall Study|Death|1
6938390|NCT00923260|10972720|FG000|Overall Study|Lost to Follow-up|1
6938391|NCT00923260|10972721|FG001|Overall Study|Lost to Follow-up|1
6938392|NCT00923273|10972732|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
6938393|NCT00923273|10972733|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
6938394|NCT00923273|10972734|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
6938395|NCT00923273|10972735|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1
6938396|NCT00923273|10972736|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
6938397|NCT00923273|10972732|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
6938398|NCT00923273|10972733|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
6938399|NCT00923273|10972734|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
6938400|NCT00923273|10972735|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6
6938401|NCT00923273|10972736|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
6938402|NCT00923351|10972756|FG000|Overall Study|no apheresis/adequate tumor sample|0
6938403|NCT00923351|10972757|FG001|Overall Study|no apheresis/adequate tumor sample|0
6938404|NCT00923351|10972758|FG002|Overall Study|no apheresis/adequate tumor sample|12
6938405|NCT00923364|10972764|FG000|Overall Study|Death|3
6938406|NCT00923364|10972765|FG001|Overall Study|Death|0
6938407|NCT00923364|10972764|FG000|Overall Study|Did not go to transplant|1
6938408|NCT00923364|10972765|FG001|Overall Study|Did not go to transplant|0
6938409|NCT00923559|10972776|FG000|Overall Study|Lost to Follow-up|2
6938410|NCT00923559|10972777|FG001|Overall Study|Lost to Follow-up|3
6938411|NCT00923845|10972796|FG000|Induction Therapy|Poor performance status|0
6938412|NCT00923845|10972797|FG001|Induction Therapy|Poor performance status|2
6938413|NCT00923936|10972814|FG000|Overall Study|progressive disease on study|2
6938414|NCT00923936|10972815|FG001|Overall Study|progressive disease on study|1
6938415|NCT00923936|10972814|FG000|Overall Study|Adverse Event|2
6938416|NCT00923936|10972815|FG001|Overall Study|Adverse Event|1
6938417|NCT00923936|10972814|FG000|Overall Study|Lost to follow up|2
7040208|NCT01716520|11123213|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
6938418|NCT00923936|10972815|FG001|Overall Study|Lost to follow up|0
6938419|NCT00923936|10972814|FG000|Overall Study|Continuing in follow up period|2
6938420|NCT00923936|10972815|FG001|Overall Study|Continuing in follow up period|1
6938421|NCT00923975|10972827|FG000|Overall Study|Did not meet inclusion criteria|1
6938422|NCT00924287|10972874|FG000|Overall Study|Death|1
6938423|NCT00924313|10972878|FG000|Overall Study|not imaged due to failed tracer imaging|1
6938424|NCT00924404|10972892|FG000|Overall Study|Lost to Follow-up|6
6938425|NCT00924404|10972893|FG001|Overall Study|Lost to Follow-up|4
6938426|NCT00924443|10972899|FG000|Overall Study|Physician Decision|2
6938427|NCT00924443|10972899|FG000|Overall Study|Protocol Violation|1
6938428|NCT00924469|10972905|FG000|Overall Study|Adverse Event|2
6938429|NCT00924469|10972906|FG001|Overall Study|Adverse Event|0
6938430|NCT00924469|10972905|FG000|Overall Study|Withdrawal by Subject|0
6938431|NCT00924469|10972906|FG001|Overall Study|Withdrawal by Subject|1
6938432|NCT00924469|10972905|FG000|Overall Study|Lost to Follow-up|0
6938433|NCT00924469|10972906|FG001|Overall Study|Lost to Follow-up|1
6938434|NCT00924508|10972917|FG000|Overall Study|Withdrawal by Subject|3
6938435|NCT00924560|10972927|FG000|Overall Study|Did Not Meet Protocol Requirements|4
6938436|NCT00924560|10972928|FG001|Overall Study|Did Not Meet Protocol Requirements|2
6938437|NCT00924560|10972929|FG002|Overall Study|Did Not Meet Protocol Requirements|1
6938438|NCT00924560|10972927|FG000|Overall Study|Non Compliance with the Protocol|20
6938439|NCT00924560|10972928|FG001|Overall Study|Non Compliance with the Protocol|15
6938440|NCT00924560|10972929|FG002|Overall Study|Non Compliance with the Protocol|4
7067042|NCT01982942|11167859|FG000|Overall Study|Adverse Event|10
7067043|NCT01982942|11167860|FG001|Overall Study|Adverse Event|5
7067044|NCT01982942|11167859|FG000|Overall Study|Lost to Follow-up|4
7067045|NCT01982942|11167860|FG001|Overall Study|Lost to Follow-up|3
7067046|NCT01982942|11167859|FG000|Overall Study|Multiple sclerosis progression|3
7067047|NCT01982942|11167860|FG001|Overall Study|Multiple sclerosis progression|2
7067048|NCT01982942|11167859|FG000|Overall Study|Wanted to try therapy not permitted|1
7067049|NCT01982942|11167860|FG001|Overall Study|Wanted to try therapy not permitted|0
6938441|NCT00924560|10972927|FG000|Overall Study|Physician Decision|2
6938442|NCT00924560|10972928|FG001|Overall Study|Physician Decision|3
6938443|NCT00924560|10972929|FG002|Overall Study|Physician Decision|4
6938444|NCT00924560|10972927|FG000|Overall Study|Withdrawal by Subject|50
6938445|NCT00924560|10972928|FG001|Overall Study|Withdrawal by Subject|44
6938446|NCT00924560|10972929|FG002|Overall Study|Withdrawal by Subject|18
6938447|NCT00924560|10972927|FG000|Overall Study|Adverse Event|39
6938448|NCT00924560|10972928|FG001|Overall Study|Adverse Event|33
6938449|NCT00924560|10972929|FG002|Overall Study|Adverse Event|0
6938450|NCT00924560|10972927|FG000|Overall Study|Pregnancy|5
6938451|NCT00924560|10972928|FG001|Overall Study|Pregnancy|7
6938452|NCT00924560|10972929|FG002|Overall Study|Pregnancy|1
6938453|NCT00924560|10972927|FG000|Overall Study|Lost to Follow-up|78
6938454|NCT00924560|10972928|FG001|Overall Study|Lost to Follow-up|94
6938455|NCT00924560|10972929|FG002|Overall Study|Lost to Follow-up|45
6938456|NCT00924560|10972927|FG000|Overall Study|Miscellaneous Reasons|13
6938457|NCT00924560|10972928|FG001|Overall Study|Miscellaneous Reasons|10
6938458|NCT00924560|10972929|FG002|Overall Study|Miscellaneous Reasons|10
6938459|NCT00924638|10972956|FG000|Overall Study|Death|3
6938460|NCT00924638|10972957|FG001|Overall Study|Death|2
6938461|NCT00924638|10972956|FG000|Overall Study|Lost to Follow-up|1
6938462|NCT00924638|10972957|FG001|Overall Study|Lost to Follow-up|1
6938463|NCT00924638|10972956|FG000|Overall Study|Withdrawal by Subject|5
6938464|NCT00924638|10972957|FG001|Overall Study|Withdrawal by Subject|7
6938465|NCT00924638|10972956|FG000|Overall Study|Physician Decision|3
6938466|NCT00924638|10972957|FG001|Overall Study|Physician Decision|3
6938467|NCT00924651|10972965|FG000|Overall Study|Chemo started too soon|2
6938468|NCT00924651|10972966|FG001|Overall Study|Chemo started too soon|3
6938469|NCT00924651|10972965|FG000|Overall Study|No Reason|3
6938470|NCT00924651|10972966|FG001|Overall Study|No Reason|7
6938471|NCT00924651|10972965|FG000|Overall Study|Overwhelmed|6
6938472|NCT00924651|10972966|FG001|Overall Study|Overwhelmed|6
6938473|NCT00924651|10972965|FG000|Overall Study|Noncompliant|1
6938474|NCT00924651|10972966|FG001|Overall Study|Noncompliant|4
6938475|NCT00924651|10972965|FG000|Overall Study|Medical|1
6938476|NCT00924651|10972966|FG001|Overall Study|Medical|3
6938477|NCT00924651|10972965|FG000|Overall Study|Changed Mind|10
6938478|NCT00924651|10972966|FG001|Overall Study|Changed Mind|1
6938479|NCT00924651|10972965|FG000|Overall Study|Incomplete Form|2
6938480|NCT00924651|10972966|FG001|Overall Study|Incomplete Form|1
6938481|NCT00924664|10972974|FG000|Overall Study|Adverse Event|23
6938482|NCT00924664|10972975|FG001|Overall Study|Adverse Event|39
6938483|NCT00924664|10972974|FG000|Overall Study|Lack of Efficacy|10
6938484|NCT00924664|10972975|FG001|Overall Study|Lack of Efficacy|15
6938485|NCT00924664|10972974|FG000|Overall Study|Lost to Follow-up|10
6938486|NCT00924664|10972975|FG001|Overall Study|Lost to Follow-up|12
6938487|NCT00924664|10972974|FG000|Overall Study|Withdrawal by Subject|47
7067050|NCT01982942|11167859|FG000|Overall Study|Subject declined future visits|0
6938488|NCT00924664|10972975|FG001|Overall Study|Withdrawal by Subject|71
7067051|NCT01982942|11167860|FG001|Overall Study|Subject declined future visits|1
7067052|NCT01982942|11167859|FG000|Overall Study|Left geographical area|2
6938489|NCT00924664|10972974|FG000|Overall Study|Protocol Violation|2
7067053|NCT01982942|11167860|FG001|Overall Study|Left geographical area|0
6938490|NCT00924664|10972975|FG001|Overall Study|Protocol Violation|5
6938491|NCT00924664|10972974|FG000|Overall Study|Pregnancy|1
7067054|NCT01982942|11167859|FG000|Overall Study|Too many pills|1
7067055|NCT01982942|11167860|FG001|Overall Study|Too many pills|0
7067056|NCT01982942|11167859|FG000|Overall Study|MS Relapse|0
7067057|NCT01982942|11167860|FG001|Overall Study|MS Relapse|1
7067058|NCT01982942|11167859|FG000|Overall Study|Chose to join a stem cell trial|0
7147698|NCT03134222|11308415|FG000|Treatment Period (Up to Week 12)|Adverse Event|4
7147699|NCT03134222|11308416|FG001|Treatment Period (Up to Week 12)|Adverse Event|1
6938492|NCT00924664|10972975|FG001|Overall Study|Pregnancy|1
6938493|NCT00924664|10972974|FG000|Overall Study|Death|0
6938494|NCT00924664|10972975|FG001|Overall Study|Death|2
6938495|NCT00924664|10972974|FG000|Overall Study|Study terminated by sponsor|199
6938496|NCT00924664|10972975|FG001|Overall Study|Study terminated by sponsor|330
6938497|NCT00924664|10972974|FG000|Overall Study|Other|29
6938498|NCT00924664|10972975|FG001|Overall Study|Other|52
6938499|NCT00924664|10972974|FG000|Overall Study|Randomized but not Treated|1
6938500|NCT00924664|10972975|FG001|Overall Study|Randomized but not Treated|0
6938501|NCT00924703|10972981|FG000|Overall Study|Withdrawal by Subject|11
6938502|NCT00924703|10972981|FG000|Overall Study|Physician Decision|5
6938503|NCT00924703|10972981|FG000|Overall Study|Lost to Follow-up|3
6938504|NCT00924703|10972981|FG000|Overall Study|Adverse Event|2
6938505|NCT00924703|10972981|FG000|Overall Study|Withdrawal by Sponsor|1
6938506|NCT00924729|10972987|FG000|Overall Study|insufficient volume for analysis|1
6938507|NCT00924729|10972988|FG001|Overall Study|insufficient volume for analysis|0
6938508|NCT00924729|10972987|FG000|Overall Study|Protocol Violation|1
6938509|NCT00924729|10972988|FG001|Overall Study|Protocol Violation|0
6938510|NCT00924781|10973000|FG000|Overall Study|Study terminated by sponsor|12
6938511|NCT00924781|10973001|FG001|Overall Study|Study terminated by sponsor|10
6938512|NCT00924820|10973017|FG000|Overall Study|Death|2
6938513|NCT00924820|10973017|FG000|Overall Study|Ineligible, Screen Failure|5
6938514|NCT00924898|10973032|FG000|Overall Study|Withdrawal by Subject|2
6938515|NCT00924950|10973041|FG000|Overall Study|Lost to Follow-up|2
6938516|NCT00925002|10973051|FG000|Overall Study|Other|1
6938517|NCT00925002|10973052|FG001|Overall Study|Other|4
6938518|NCT00925002|10973053|FG002|Overall Study|Other|0
6938519|NCT00925002|10973051|FG000|Overall Study|Death|1
6938520|NCT00925002|10973052|FG001|Overall Study|Death|1
6938521|NCT00925002|10973053|FG002|Overall Study|Death|5
6938522|NCT00925002|10973051|FG000|Overall Study|Adverse Event|3
6938523|NCT00925002|10973052|FG001|Overall Study|Adverse Event|1
6938524|NCT00925002|10973053|FG002|Overall Study|Adverse Event|2
6938525|NCT00925002|10973051|FG000|Overall Study|Participant withdrew consent|1
6938526|NCT00925002|10973052|FG001|Overall Study|Participant withdrew consent|3
6938527|NCT00925002|10973053|FG002|Overall Study|Participant withdrew consent|3
6938528|NCT00925015|10973065|FG000|Overall Study|Adverse Event|1
6938529|NCT00925015|10973066|FG001|Overall Study|Adverse Event|2
6938530|NCT00925015|10973067|FG002|Overall Study|Adverse Event|1
6938531|NCT00925015|10973065|FG000|Overall Study|Physician Decision|0
6938532|NCT00925015|10973066|FG001|Overall Study|Physician Decision|1
6938533|NCT00925015|10973067|FG002|Overall Study|Physician Decision|0
6938534|NCT00925015|10973065|FG000|Overall Study|Progressive Disease|7
6938535|NCT00925015|10973066|FG001|Overall Study|Progressive Disease|3
6938536|NCT00925015|10973067|FG002|Overall Study|Progressive Disease|4
6938537|NCT00925015|10973065|FG000|Overall Study|Withdrawal by Subject|0
6938538|NCT00925015|10973066|FG001|Overall Study|Withdrawal by Subject|0
6938539|NCT00925015|10973067|FG002|Overall Study|Withdrawal by Subject|1
6938540|NCT00925132|10973105|FG000|Overall Study|Withdrawal by Subject|2
6938541|NCT00925132|10973106|FG001|Overall Study|Withdrawal by Subject|0
6938542|NCT00925132|10973107|FG002|Overall Study|Withdrawal by Subject|0
7147700|NCT03134222|11308417|FG002|Treatment Period (Up to Week 12)|Adverse Event|0
6938543|NCT00925132|10973108|FG003|Overall Study|Withdrawal by Subject|0
6938544|NCT00925132|10973109|FG004|Overall Study|Withdrawal by Subject|1
6938545|NCT00925132|10973105|FG000|Overall Study|Removed due to disease progression|0
6938546|NCT00925132|10973106|FG001|Overall Study|Removed due to disease progression|0
6938547|NCT00925132|10973107|FG002|Overall Study|Removed due to disease progression|0
6938548|NCT00925132|10973108|FG003|Overall Study|Removed due to disease progression|0
6938549|NCT00925132|10973109|FG004|Overall Study|Removed due to disease progression|4
6938550|NCT00925288|10973117|FG000|Overall Study|Lost to Follow-up|9
6938551|NCT00925288|10973118|FG001|Overall Study|Lost to Follow-up|7
6938552|NCT00925301|10973128|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
6938553|NCT00925301|10973129|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2
6938554|NCT00925301|10973130|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
6938555|NCT00925301|10973131|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
6938556|NCT00925301|10973128|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0
6938557|NCT00925301|10973129|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1
6938558|NCT00925301|10973130|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0
6938559|NCT00925301|10973131|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0
6938560|NCT00925301|10973128|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
6938561|NCT00925301|10973129|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
6938562|NCT00925301|10973130|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1
6938563|NCT00925301|10973131|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
6938564|NCT00925301|10973128|FG000|6-Month Open-label (Stage 2)|Adverse Event|0
6938565|NCT00925301|10973129|FG001|6-Month Open-label (Stage 2)|Adverse Event|0
6938566|NCT00925301|10973130|FG002|6-Month Open-label (Stage 2)|Adverse Event|2
6938567|NCT00925301|10973131|FG003|6-Month Open-label (Stage 2)|Adverse Event|0
6938568|NCT00925301|10973128|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
6938569|NCT00925301|10973129|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
6938570|NCT00925301|10973130|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
6938571|NCT00925301|10973131|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1
6938572|NCT00925301|10973128|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0
6938573|NCT00925301|10973129|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0
6938574|NCT00925301|10973130|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0
6938575|NCT00925301|10973131|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1
6938576|NCT00925301|10973128|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
6938577|NCT00925301|10973129|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
6938578|NCT00925301|10973130|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
6938579|NCT00925301|10973131|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1
6938580|NCT00925353|10973142|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3
6938581|NCT00925522|10973146|FG000|Overall Study|study closed -- business decision|20
6938582|NCT00925587|10973152|FG000|Overall Study|Protocol Specified Criteria|6
6938583|NCT00925587|10973153|FG001|Overall Study|Protocol Specified Criteria|6
6938584|NCT00925587|10973152|FG000|Overall Study|Physician Decision|4
6938585|NCT00925587|10973153|FG001|Overall Study|Physician Decision|1
6938586|NCT00925587|10973152|FG000|Overall Study|Protocol Violation|6
6938587|NCT00925587|10973153|FG001|Overall Study|Protocol Violation|4
6938588|NCT00925587|10973152|FG000|Overall Study|Withdrawal by Subject|9
6938589|NCT00925587|10973153|FG001|Overall Study|Withdrawal by Subject|6
6938590|NCT00925587|10973152|FG000|Overall Study|Death|5
6938591|NCT00925587|10973153|FG001|Overall Study|Death|5
6938592|NCT00925587|10973152|FG000|Overall Study|Adverse Event|6
6938593|NCT00925587|10973153|FG001|Overall Study|Adverse Event|2
6938594|NCT00925587|10973152|FG000|Overall Study|Lost to Follow-up|0
6938595|NCT00925587|10973153|FG001|Overall Study|Lost to Follow-up|1
6938596|NCT00925600|10973161|FG000|Overall Study|Withdrawal by Subject|16
6938597|NCT00925600|10973162|FG001|Overall Study|Withdrawal by Subject|14
6938598|NCT00925600|10973161|FG000|Overall Study|Death|4
6938599|NCT00925600|10973162|FG001|Overall Study|Death|3
6938600|NCT00925600|10973161|FG000|Overall Study|Lost to Follow-up|2
6938601|NCT00925600|10973162|FG001|Overall Study|Lost to Follow-up|2
6938602|NCT00925600|10973161|FG000|Overall Study|Disease Progression|1
6938603|NCT00925600|10973162|FG001|Overall Study|Disease Progression|3
6938604|NCT00925600|10973161|FG000|Overall Study|Administrative Decision|1
6938605|NCT00925600|10973162|FG001|Overall Study|Administrative Decision|1
6938606|NCT00925600|10973161|FG000|Overall Study|Noncompliance|2
6938607|NCT00925600|10973162|FG001|Overall Study|Noncompliance|0
6938608|NCT00925600|10973161|FG000|Overall Study|Ineligibility Determined|2
6938609|NCT00925600|10973162|FG001|Overall Study|Ineligibility Determined|0
6938610|NCT00925600|10973161|FG000|Overall Study|Protocol Deviation|0
6938611|NCT00925600|10973162|FG001|Overall Study|Protocol Deviation|1
6838152|NCT00256854|10843821|FG001|Overall Study|Adverse Event|0
6838153|NCT00256854|10843822|FG002|Overall Study|Adverse Event|2
6838154|NCT00256854|10843823|FG003|Overall Study|Adverse Event|2
6838155|NCT00256854|10843824|FG004|Overall Study|Adverse Event|0
6838156|NCT00256854|10843825|FG005|Overall Study|Adverse Event|1
6838157|NCT00256854|10843820|FG000|Overall Study|Not compliant with the study drug|0
6838158|NCT00256854|10843821|FG001|Overall Study|Not compliant with the study drug|0
6838159|NCT00256854|10843822|FG002|Overall Study|Not compliant with the study drug|0
6838160|NCT00256854|10843823|FG003|Overall Study|Not compliant with the study drug|0
6838161|NCT00256854|10843824|FG004|Overall Study|Not compliant with the study drug|1
6838162|NCT00256854|10843825|FG005|Overall Study|Not compliant with the study drug|0
6838163|NCT00256867|10843848|FG000|Overall Study|Adverse Event|0
6838164|NCT00256867|10843849|FG001|Overall Study|Adverse Event|1
6938612|NCT00925600|10973161|FG000|Overall Study|Requirement for Alternative Therapy|0
6938613|NCT00925600|10973162|FG001|Overall Study|Requirement for Alternative Therapy|1
6938614|NCT00925600|10973161|FG000|Overall Study|Other|3
6938615|NCT00925600|10973162|FG001|Overall Study|Other|1
6938616|NCT00925600|10973161|FG000|Overall Study|Adverse Event|1
6938617|NCT00925600|10973162|FG001|Overall Study|Adverse Event|2
6975417|NCT01193153|11027630|FG001|Open-label Lead in Period|Lack of Efficacy|0
6975418|NCT01193153|11027629|FG000|Open-label Stabilization Period|Adverse Event|9
6975419|NCT01193153|11027630|FG001|Open-label Stabilization Period|Adverse Event|0
6975420|NCT01193153|11027629|FG000|Open-label Stabilization Period|Death|2
6838165|NCT00256867|10843850|FG002|Overall Study|Adverse Event|1
6838166|NCT00256867|10843851|FG003|Overall Study|Adverse Event|1
6838167|NCT00256867|10843852|FG004|Overall Study|Adverse Event|2
6838168|NCT00256867|10843853|FG005|Overall Study|Adverse Event|2
6975421|NCT01193153|11027630|FG001|Open-label Stabilization Period|Death|0
6975422|NCT01193153|11027629|FG000|Open-label Stabilization Period|Lost to Follow-up|10
6975423|NCT01193153|11027630|FG001|Open-label Stabilization Period|Lost to Follow-up|0
6975424|NCT01193153|11027629|FG000|Open-label Stabilization Period|Lack of Efficacy|5
6975425|NCT01193153|11027630|FG001|Open-label Stabilization Period|Lack of Efficacy|0
6975426|NCT01193153|11027629|FG000|Open-label Stabilization Period|Withdrawal by Subject|29
6975427|NCT01193153|11027630|FG001|Open-label Stabilization Period|Withdrawal by Subject|0
6938618|NCT00925704|10973178|FG000|First Intervention|Withdrew consent|0
6938619|NCT00925704|10973179|FG001|First Intervention|Withdrew consent|0
6938620|NCT00925704|10973180|FG002|First Intervention|Withdrew consent|0
6938621|NCT00925704|10973181|FG003|First Intervention|Withdrew consent|1
6938622|NCT00925704|10973182|FG004|First Intervention|Withdrew consent|1
6938623|NCT00925704|10973183|FG005|First Intervention|Withdrew consent|0
6938624|NCT00925704|10973178|FG000|Second Intervention|Withdrawal by Subject|1
6938625|NCT00925704|10973179|FG001|Second Intervention|Withdrawal by Subject|0
6938626|NCT00925704|10973180|FG002|Second Intervention|Withdrawal by Subject|0
6938627|NCT00925704|10973181|FG003|Second Intervention|Withdrawal by Subject|0
6938628|NCT00925704|10973182|FG004|Second Intervention|Withdrawal by Subject|1
6938629|NCT00925704|10973183|FG005|Second Intervention|Withdrawal by Subject|0
6938630|NCT00925704|10973178|FG000|Third Intervention|Withdrew consent|0
6938631|NCT00925704|10973179|FG001|Third Intervention|Withdrew consent|0
6938632|NCT00925704|10973180|FG002|Third Intervention|Withdrew consent|0
6938633|NCT00925704|10973181|FG003|Third Intervention|Withdrew consent|0
6938634|NCT00925704|10973182|FG004|Third Intervention|Withdrew consent|0
6938635|NCT00925704|10973183|FG005|Third Intervention|Withdrew consent|1
6938636|NCT00925769|10973198|FG000|Overall Study|Major toxicity|1
6938637|NCT00925769|10973199|FG001|Overall Study|Major toxicity|0
6938638|NCT00925769|10973200|FG002|Overall Study|Major toxicity|1
6938639|NCT00925769|10973201|FG003|Overall Study|Major toxicity|1
6938640|NCT00925769|10973202|FG004|Overall Study|Major toxicity|0
6938641|NCT00925769|10973203|FG005|Overall Study|Major toxicity|0
6938642|NCT00925769|10973198|FG000|Overall Study|Disease progression|4
6938643|NCT00925769|10973199|FG001|Overall Study|Disease progression|5
6938644|NCT00925769|10973200|FG002|Overall Study|Disease progression|3
6938645|NCT00925769|10973201|FG003|Overall Study|Disease progression|4
6938646|NCT00925769|10973202|FG004|Overall Study|Disease progression|2
6938647|NCT00925769|10973203|FG005|Overall Study|Disease progression|3
6938648|NCT00925769|10973198|FG000|Overall Study|Death|0
6938649|NCT00925769|10973199|FG001|Overall Study|Death|0
6938650|NCT00925769|10973200|FG002|Overall Study|Death|1
6938651|NCT00925769|10973201|FG003|Overall Study|Death|0
6938652|NCT00925769|10973202|FG004|Overall Study|Death|0
6938653|NCT00925769|10973203|FG005|Overall Study|Death|0
6938654|NCT00925769|10973198|FG000|Overall Study|Physician Decision|1
6938655|NCT00925769|10973199|FG001|Overall Study|Physician Decision|0
6938656|NCT00925769|10973200|FG002|Overall Study|Physician Decision|0
6938657|NCT00925769|10973201|FG003|Overall Study|Physician Decision|0
6938658|NCT00925769|10973202|FG004|Overall Study|Physician Decision|0
6938659|NCT00925769|10973203|FG005|Overall Study|Physician Decision|0
6938660|NCT00925769|10973198|FG000|Overall Study|Missing documentation|0
6938661|NCT00925769|10973199|FG001|Overall Study|Missing documentation|1
6938662|NCT00925769|10973200|FG002|Overall Study|Missing documentation|0
6938663|NCT00925769|10973201|FG003|Overall Study|Missing documentation|0
6938664|NCT00925769|10973202|FG004|Overall Study|Missing documentation|0
6938665|NCT00925769|10973203|FG005|Overall Study|Missing documentation|0
6938666|NCT00925769|10973198|FG000|Overall Study|End of study visit not done|0
6938667|NCT00925769|10973199|FG001|Overall Study|End of study visit not done|0
6938668|NCT00925769|10973200|FG002|Overall Study|End of study visit not done|1
6938669|NCT00925769|10973201|FG003|Overall Study|End of study visit not done|0
7067059|NCT01982942|11167860|FG001|Overall Study|Chose to join a stem cell trial|1
7067060|NCT01982942|11167859|FG000|Overall Study|Subject bedridden, rapidly declining|0
7067061|NCT01982942|11167860|FG001|Overall Study|Subject bedridden, rapidly declining|1
7067062|NCT01982955|11167871|FG000|Overall Study|Randomized but not treated|0
7067063|NCT01982955|11167872|FG001|Overall Study|Randomized but not treated|0
7067064|NCT01982955|11167873|FG002|Overall Study|Randomized but not treated|0
7067065|NCT01982955|11167874|FG003|Overall Study|Randomized but not treated|1
7067066|NCT01982955|11167875|FG004|Overall Study|Randomized but not treated|0
7067067|NCT01982955|11167871|FG000|Overall Study|Ongoing|0
7067068|NCT01982955|11167872|FG001|Overall Study|Ongoing|0
7067069|NCT01982955|11167873|FG002|Overall Study|Ongoing|4
7067070|NCT01982955|11167874|FG003|Overall Study|Ongoing|0
7067071|NCT01982955|11167875|FG004|Overall Study|Ongoing|0
7067072|NCT01983111|11167916|FG000|Overall Study|Withdrawal by Subject|8
7067073|NCT01983111|11167917|FG001|Overall Study|Withdrawal by Subject|6
7067074|NCT01983111|11167916|FG000|Overall Study|Adverse Event|4
7067075|NCT01983111|11167917|FG001|Overall Study|Adverse Event|0
7067076|NCT01983111|11167916|FG000|Overall Study|Protocol Violation|0
7067077|NCT01983111|11167917|FG001|Overall Study|Protocol Violation|1
7067078|NCT01983254|11167936|FG000|Overall Study|Death|6
6938670|NCT00925769|10973202|FG004|Overall Study|End of study visit not done|0
6938671|NCT00925769|10973203|FG005|Overall Study|End of study visit not done|0
6938672|NCT00925769|10973198|FG000|Overall Study|Participant is unable to swallow drug|0
6938673|NCT00925769|10973199|FG001|Overall Study|Participant is unable to swallow drug|0
7067079|NCT01983254|11167937|FG001|Overall Study|Death|6
7067080|NCT01983254|11167936|FG000|Overall Study|Lost to Follow-up|17
7067081|NCT01983254|11167937|FG001|Overall Study|Lost to Follow-up|16
6938674|NCT00925769|10973200|FG002|Overall Study|Participant is unable to swallow drug|0
6938675|NCT00925769|10973201|FG003|Overall Study|Participant is unable to swallow drug|1
6938676|NCT00925769|10973202|FG004|Overall Study|Participant is unable to swallow drug|0
7067082|NCT01983254|11167936|FG000|Overall Study|too ill|11
6977268|NCT01207219|11030493|FG001|Overall Study|Lost to Follow-up|8
6938677|NCT00925769|10973203|FG005|Overall Study|Participant is unable to swallow drug|0
6938678|NCT00925769|10973198|FG000|Overall Study|Adverse Event|0
6938679|NCT00925769|10973199|FG001|Overall Study|Adverse Event|0
6938680|NCT00925769|10973200|FG002|Overall Study|Adverse Event|0
6938681|NCT00925769|10973201|FG003|Overall Study|Adverse Event|0
6938682|NCT00925769|10973202|FG004|Overall Study|Adverse Event|1
6938683|NCT00925769|10973203|FG005|Overall Study|Adverse Event|0
6938684|NCT00925899|10973229|FG000|Part 1|Death|1
6938685|NCT00925899|10973230|FG001|Part 1|Death|2
6938686|NCT00925899|10973229|FG000|Part 1|Withdrawal by Subject|10
6938687|NCT00925899|10973230|FG001|Part 1|Withdrawal by Subject|9
6938688|NCT00925990|10973252|FG000|Overall Study|Adverse Event|1
6938689|NCT00925990|10973253|FG001|Overall Study|Adverse Event|3
6938690|NCT00925990|10973252|FG000|Overall Study|Withdrawal by Subject|2
6938691|NCT00925990|10973253|FG001|Overall Study|Withdrawal by Subject|2
6938692|NCT00925990|10973252|FG000|Overall Study|Lost to Follow-up|1
6938693|NCT00925990|10973253|FG001|Overall Study|Lost to Follow-up|3
6938694|NCT00925990|10973252|FG000|Overall Study|Physician Decision|1
6938695|NCT00925990|10973253|FG001|Overall Study|Physician Decision|1
6938696|NCT00925990|10973252|FG000|Overall Study|moved out of state, missed medication|0
6938697|NCT00925990|10973253|FG001|Overall Study|moved out of state, missed medication|2
6938698|NCT00926003|10973262|FG000|Post-Training Evaluation|Withdrawal by Subject|1
6938699|NCT00926003|10973263|FG001|Post-Training Evaluation|Withdrawal by Subject|0
6938700|NCT00926003|10973264|FG002|Post-Training Evaluation|Withdrawal by Subject|0
6938701|NCT00926003|10973262|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1
6938702|NCT00926003|10973263|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0
6938703|NCT00926003|10973264|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0
6938704|NCT00926029|10973275|FG000|Overall Study|Lost to Follow-up|2
6938705|NCT00926029|10973276|FG001|Overall Study|Lost to Follow-up|1
6938706|NCT00926029|10973277|FG002|Overall Study|Lost to Follow-up|1
6938707|NCT00926211|10973304|FG000|Overall Study|Lost to Follow-up|1
6938708|NCT00926237|10973309|FG000|Overall Study|Withdrawal by Subject|2
6938709|NCT00926237|10973310|FG001|Overall Study|Withdrawal by Subject|1
6938710|NCT00926289|10973332|FG000|Overall Study|Adverse Event|9
6938711|NCT00926289|10973333|FG001|Overall Study|Adverse Event|11
6938712|NCT00926289|10973332|FG000|Overall Study|Protocol Violation|8
6938713|NCT00926289|10973333|FG001|Overall Study|Protocol Violation|12
6938714|NCT00926289|10973332|FG000|Overall Study|Lost to Follow-up|3
6938715|NCT00926289|10973333|FG001|Overall Study|Lost to Follow-up|6
6938716|NCT00926289|10973332|FG000|Overall Study|Withdrawal by Subject|4
6938717|NCT00926289|10973333|FG001|Overall Study|Withdrawal by Subject|4
6938718|NCT00926289|10973332|FG000|Overall Study|Other|1
6938719|NCT00926289|10973333|FG001|Overall Study|Other|3
6938720|NCT00926328|10973341|FG000|Overall Study|Lost to Follow-up|12
6938721|NCT00926328|10973342|FG001|Overall Study|Lost to Follow-up|14
6938722|NCT00926367|10973350|FG000|Overall Study|Withdrawal by Subject|0
6938723|NCT00926367|10973351|FG001|Overall Study|Withdrawal by Subject|1
6938724|NCT00926367|10973350|FG000|Overall Study|Lost to Follow-up|1
6938725|NCT00926367|10973351|FG001|Overall Study|Lost to Follow-up|0
6938726|NCT00926367|10973350|FG000|Overall Study|Skin Irritation|1
6938727|NCT00926367|10973351|FG001|Overall Study|Skin Irritation|2
6938728|NCT00926393|10973374|FG000|Overall Study|Withdrawal by Subject|1
6938729|NCT00926393|10973375|FG001|Overall Study|Withdrawal by Subject|2
6938730|NCT00926393|10973374|FG000|Overall Study|Adverse Event|1
6938731|NCT00926393|10973375|FG001|Overall Study|Adverse Event|1
6938732|NCT00926536|10973392|FG000|Overall Study|Physician Decision|1
6938733|NCT00926536|10973393|FG001|Overall Study|Physician Decision|2
6938734|NCT00926783|10973410|FG000|Overall Study|Incomplete CFAE Procedures|3
6938735|NCT00926783|10973411|FG001|Overall Study|Incomplete CFAE Procedures|3
6938736|NCT00926796|10973419|FG000|Overall Study|Did not receive randomized treatment|4
6938737|NCT00926796|10973420|FG001|Overall Study|Did not receive randomized treatment|7
6938738|NCT00926796|10973419|FG000|Overall Study|Ineligible, negative for gonorrhea|57
6938739|NCT00926796|10973420|FG001|Overall Study|Ineligible, negative for gonorrhea|60
6938740|NCT00926796|10973419|FG000|Overall Study|Ineligible, but positive for gonorrhea|1
6938741|NCT00926796|10973420|FG001|Overall Study|Ineligible, but positive for gonorrhea|1
6938742|NCT00926796|10973419|FG000|Overall Study|Adverse Event|7
6938743|NCT00926796|10973420|FG001|Overall Study|Adverse Event|14
6938744|NCT00926796|10973419|FG000|Overall Study|Lost to Follow-up|22
6938745|NCT00926796|10973420|FG001|Overall Study|Lost to Follow-up|13
6938746|NCT00926796|10973419|FG000|Overall Study|Protocol Violation|15
6938747|NCT00926796|10973420|FG001|Overall Study|Protocol Violation|11
6938748|NCT00926796|10973419|FG000|Overall Study|Withdrawal by Subject|1
6938749|NCT00926796|10973420|FG001|Overall Study|Withdrawal by Subject|0
6938750|NCT00927069|10973462|FG000|Week 0 to Week 12|Worsening of psoriasis|1
6938751|NCT00927069|10973463|FG001|Week 0 to Week 12|Worsening of psoriasis|1
6938752|NCT00927069|10973464|FG002|Week 0 to Week 12|Worsening of psoriasis|0
6938753|NCT00927069|10973465|FG003|Week 0 to Week 12|Worsening of psoriasis|0
6938754|NCT00927069|10973462|FG000|Week 12 to Week 24|Lack of Efficacy|0
6938755|NCT00927069|10973463|FG001|Week 12 to Week 24|Lack of Efficacy|0
6938756|NCT00927069|10973464|FG002|Week 12 to Week 24|Lack of Efficacy|2
6938757|NCT00927069|10973465|FG003|Week 12 to Week 24|Lack of Efficacy|3
6938758|NCT00927069|10973462|FG000|Week 12 to Week 24|Lost to Follow-up|0
6938759|NCT00927069|10973463|FG001|Week 12 to Week 24|Lost to Follow-up|0
6938760|NCT00927069|10973464|FG002|Week 12 to Week 24|Lost to Follow-up|1
6938761|NCT00927069|10973465|FG003|Week 12 to Week 24|Lost to Follow-up|0
6938762|NCT00927069|10973462|FG000|Week 12 to Week 24|Withdrawal by Subject|1
6938763|NCT00927069|10973463|FG001|Week 12 to Week 24|Withdrawal by Subject|0
6938764|NCT00927069|10973464|FG002|Week 12 to Week 24|Withdrawal by Subject|0
6938765|NCT00927069|10973465|FG003|Week 12 to Week 24|Withdrawal by Subject|0
6938766|NCT00927069|10973462|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1
6938767|NCT00927069|10973463|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0
6938768|NCT00927069|10973464|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0
6938769|NCT00927069|10973465|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0
6938770|NCT00927082|10973479|FG000|Overall Study|Lost to Follow-up|9
6938771|NCT00927082|10973480|FG001|Overall Study|Lost to Follow-up|8
6938772|NCT00927082|10973481|FG002|Overall Study|Lost to Follow-up|12
6938773|NCT00927082|10973482|FG003|Overall Study|Lost to Follow-up|16
6938774|NCT00927082|10973479|FG000|Overall Study|Withdrawal by Subject|3
6938775|NCT00927082|10973480|FG001|Overall Study|Withdrawal by Subject|2
6938776|NCT00927082|10973481|FG002|Overall Study|Withdrawal by Subject|7
6938777|NCT00927082|10973482|FG003|Overall Study|Withdrawal by Subject|2
6938778|NCT00927082|10973479|FG000|Overall Study|Death|0
6938779|NCT00927082|10973480|FG001|Overall Study|Death|0
6938780|NCT00927082|10973481|FG002|Overall Study|Death|1
6938781|NCT00927082|10973482|FG003|Overall Study|Death|0
6938782|NCT00927082|10973479|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0
6938783|NCT00927082|10973480|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0
6938784|NCT00927082|10973481|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2
6938785|NCT00927082|10973482|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1
6938786|NCT00927095|10973499|FG000|Overall Study|Adverse Event|3
6938787|NCT00927095|10973500|FG001|Overall Study|Adverse Event|1
6938788|NCT00927095|10973501|FG002|Overall Study|Adverse Event|0
6938789|NCT00927095|10973499|FG000|Overall Study|Withdrawal by Subject|2
6938790|NCT00927095|10973500|FG001|Overall Study|Withdrawal by Subject|1
6938791|NCT00927095|10973501|FG002|Overall Study|Withdrawal by Subject|1
6938792|NCT00927095|10973499|FG000|Overall Study|Physician Decision|1
6938793|NCT00927095|10973500|FG001|Overall Study|Physician Decision|2
6938794|NCT00927095|10973501|FG002|Overall Study|Physician Decision|1
6938795|NCT00927186|10973520|FG000|12 Months Primary Study|Adverse Event|5
6938796|NCT00927186|10973521|FG001|12 Months Primary Study|Adverse Event|2
6938797|NCT00927186|10973520|FG000|12 Months Primary Study|Lost to Follow-up|1
6938798|NCT00927186|10973521|FG001|12 Months Primary Study|Lost to Follow-up|0
6938799|NCT00927186|10973520|FG000|12 Months Primary Study|Protocol Violation|0
6938800|NCT00927186|10973521|FG001|12 Months Primary Study|Protocol Violation|1
6938801|NCT00927186|10973520|FG000|12 Months Primary Study|Withdrawal by Subject|1
6938802|NCT00927186|10973521|FG001|12 Months Primary Study|Withdrawal by Subject|1
6938803|NCT00927251|10973530|FG000|Overall Study|Patients not implanted with 4296 lead|8
6938804|NCT00927355|10973547|FG000|Overall Study|Adverse Event|1
6938805|NCT00927355|10973548|FG001|Overall Study|Adverse Event|1
6938806|NCT00927368|10973569|FG000|Overall Study|enrollment in another study|1
6938807|NCT00927368|10973570|FG001|Overall Study|enrollment in another study|1
6938808|NCT00927368|10973571|FG002|Overall Study|enrollment in another study|2
6938809|NCT00927368|10973569|FG000|Overall Study|Lost to Follow-up|4
6938810|NCT00927368|10973570|FG001|Overall Study|Lost to Follow-up|0
6938811|NCT00927368|10973571|FG002|Overall Study|Lost to Follow-up|0
6938812|NCT00927368|10973569|FG000|Overall Study|equipment failure|1
6938813|NCT00927368|10973570|FG001|Overall Study|equipment failure|0
6938814|NCT00927368|10973571|FG002|Overall Study|equipment failure|0
6938815|NCT00927368|10973569|FG000|Overall Study|ineligible post randomization|0
6938816|NCT00927368|10973570|FG001|Overall Study|ineligible post randomization|3
6938817|NCT00927368|10973571|FG002|Overall Study|ineligible post randomization|1
6938818|NCT00927368|10973569|FG000|Overall Study|cancellation of surgery|0
6938819|NCT00927368|10973570|FG001|Overall Study|cancellation of surgery|1
6938820|NCT00927368|10973571|FG002|Overall Study|cancellation of surgery|2
6938821|NCT00927394|10973581|FG000|Overall Study|Adverse Event|14
6938822|NCT00927394|10973582|FG001|Overall Study|Adverse Event|9
6938823|NCT00927394|10973581|FG000|Overall Study|Unsatisfactory therapeutic effect|17
6938824|NCT00927394|10973582|FG001|Overall Study|Unsatisfactory therapeutic effect|23
6938825|NCT00927394|10973581|FG000|Overall Study|Withdrawal by Subject|20
6938826|NCT00927394|10973582|FG001|Overall Study|Withdrawal by Subject|24
6938827|NCT00927394|10973581|FG000|Overall Study|Lost to Follow-up|8
6938828|NCT00927394|10973582|FG001|Overall Study|Lost to Follow-up|14
6938829|NCT00927394|10973581|FG000|Overall Study|Administrative Problem|1
6938830|NCT00927394|10973582|FG001|Overall Study|Administrative Problem|0
6938831|NCT00927394|10973581|FG000|Overall Study|Death|1
6938832|NCT00927394|10973582|FG001|Overall Study|Death|1
6938833|NCT00927394|10973581|FG000|Overall Study|Protocol deviation|16
6938834|NCT00927394|10973582|FG001|Overall Study|Protocol deviation|13
6938835|NCT00927394|10973581|FG000|Overall Study|Randomized in error|0
6938836|NCT00927394|10973582|FG001|Overall Study|Randomized in error|1
6938837|NCT00927472|10973591|FG000|Overall Study|Withdrawal by Subject|10
6938838|NCT00927472|10973592|FG001|Overall Study|Withdrawal by Subject|11
6938839|NCT00927472|10973591|FG000|Overall Study|Lost to Follow-up|1
6938840|NCT00927472|10973592|FG001|Overall Study|Lost to Follow-up|6
6938841|NCT00927472|10973591|FG000|Overall Study|Protocol Violation|0
6938842|NCT00927472|10973592|FG001|Overall Study|Protocol Violation|1
6938843|NCT00927472|10973591|FG000|Overall Study|Post treatment Assessment out of window|0
6938844|NCT00927472|10973592|FG001|Overall Study|Post treatment Assessment out of window|4
6938845|NCT00927485|10973600|FG000|Overall Study|Adverse Event|4
6938846|NCT00927485|10973601|FG001|Overall Study|Adverse Event|2
6938847|NCT00927485|10973600|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2
6938848|NCT00927485|10973601|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2
6938849|NCT00927563|10973607|FG000|Overall Study|Lost to Follow-up|1
6938850|NCT00927563|10973607|FG000|Overall Study|Withdrawal by Subject|1
6938851|NCT00927589|10973619|FG000|Overall Study|Death|1
6938852|NCT00927589|10973619|FG000|Overall Study|Physician Decision|1
6938853|NCT00927589|10973619|FG000|Overall Study|Withdrawal by Subject|3
6938854|NCT00927589|10973619|FG000|Overall Study|Adverse Event|2
6938855|NCT00927589|10973619|FG000|Overall Study|Disease Progression|8
6938856|NCT00927589|10973619|FG000|Overall Study|Non-compliance|1
6938857|NCT00927758|10973623|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
6938858|NCT00927758|10973624|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
6938859|NCT00927758|10973625|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
6938860|NCT00927758|10973626|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
6938861|NCT00927758|10973627|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
6938862|NCT00927758|10973628|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
6938863|NCT00927758|10973623|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
6938864|NCT00927758|10973624|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
6938865|NCT00927758|10973625|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
6938866|NCT00927758|10973626|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
6938867|NCT00927758|10973627|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
6938868|NCT00927758|10973628|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
6938869|NCT00927784|10973638|FG000|Overall Study|Death|1
6938870|NCT00927784|10973639|FG001|Overall Study|Death|0
6938871|NCT00927784|10973638|FG000|Overall Study|Withdrawal by Subject|1
6938872|NCT00927784|10973639|FG001|Overall Study|Withdrawal by Subject|0
6938873|NCT00927810|10973649|FG000|Overall Study|Withdrawal by Subject|0
6938874|NCT00927810|10973650|FG001|Overall Study|Withdrawal by Subject|3
6938875|NCT00927810|10973651|FG002|Overall Study|Withdrawal by Subject|0
6938876|NCT00927810|10973652|FG003|Overall Study|Withdrawal by Subject|1
6938877|NCT00927810|10973649|FG000|Overall Study|Lost to Follow-up|0
6938878|NCT00927810|10973650|FG001|Overall Study|Lost to Follow-up|2
6938879|NCT00927810|10973651|FG002|Overall Study|Lost to Follow-up|1
6938880|NCT00927810|10973652|FG003|Overall Study|Lost to Follow-up|1
6938881|NCT00927810|10973649|FG000|Overall Study|Death|0
6938882|NCT00927810|10973650|FG001|Overall Study|Death|2
6938883|NCT00927810|10973651|FG002|Overall Study|Death|0
6938884|NCT00927810|10973652|FG003|Overall Study|Death|0
6938885|NCT00927810|10973649|FG000|Overall Study|Abnormal laboratory value(s)|0
6938886|NCT00927810|10973650|FG001|Overall Study|Abnormal laboratory value(s)|1
6938887|NCT00927810|10973651|FG002|Overall Study|Abnormal laboratory value(s)|0
6938888|NCT00927810|10973652|FG003|Overall Study|Abnormal laboratory value(s)|0
6938889|NCT00927823|10973670|FG000|Continuous Dosing Period|Death|0
6938890|NCT00927823|10973671|FG001|Continuous Dosing Period|Death|0
6938891|NCT00927823|10973672|FG002|Continuous Dosing Period|Death|6
6938892|NCT00927823|10973673|FG003|Continuous Dosing Period|Death|0
6938893|NCT00927823|10973670|FG000|Continuous Dosing Period|Lost to Follow-up|1
6938894|NCT00927823|10973671|FG001|Continuous Dosing Period|Lost to Follow-up|1
6938895|NCT00927823|10973672|FG002|Continuous Dosing Period|Lost to Follow-up|9
6938896|NCT00927823|10973673|FG003|Continuous Dosing Period|Lost to Follow-up|0
6938897|NCT00927823|10973670|FG000|Continuous Dosing Period|Withdrawal by Subject|1
6938898|NCT00927823|10973671|FG001|Continuous Dosing Period|Withdrawal by Subject|0
6938899|NCT00927823|10973672|FG002|Continuous Dosing Period|Withdrawal by Subject|2
6938900|NCT00927823|10973673|FG003|Continuous Dosing Period|Withdrawal by Subject|2
6938901|NCT00927823|10973670|FG000|Continuous Dosing Period|Other|1
6938902|NCT00927823|10973671|FG001|Continuous Dosing Period|Other|2
6938903|NCT00927823|10973672|FG002|Continuous Dosing Period|Other|9
6938904|NCT00927823|10973673|FG003|Continuous Dosing Period|Other|3
6938905|NCT00927862|10973705|FG000|Overall Study|Missing data needed for endpt analyses|27
6938906|NCT00927862|10973706|FG001|Overall Study|Missing data needed for endpt analyses|45
6938907|NCT00927901|10973725|FG000|Treatment Period 1|Subject withdrew consent|0
6938908|NCT00927901|10973726|FG001|Treatment Period 1|Subject withdrew consent|0
6938909|NCT00927901|10973727|FG002|Treatment Period 1|Subject withdrew consent|1
6938910|NCT00927901|10973728|FG003|Treatment Period 1|Subject withdrew consent|0
6938911|NCT00927901|10973725|FG000|Treatment Period 4|Adverse Event|0
6938912|NCT00927901|10973726|FG001|Treatment Period 4|Adverse Event|0
6938913|NCT00927901|10973727|FG002|Treatment Period 4|Adverse Event|0
6938914|NCT00927901|10973728|FG003|Treatment Period 4|Adverse Event|1
6938915|NCT00927901|10973725|FG000|Treatment Period 4|Subject withdrew consent|0
6938916|NCT00927901|10973726|FG001|Treatment Period 4|Subject withdrew consent|0
6938917|NCT00927901|10973727|FG002|Treatment Period 4|Subject withdrew consent|1
6938918|NCT00927901|10973728|FG003|Treatment Period 4|Subject withdrew consent|0
6938919|NCT00927927|10973756|FG000|Overall Study|Withdrawal by Subject|0
6938920|NCT00927927|10973757|FG001|Overall Study|Withdrawal by Subject|0
6938921|NCT00927927|10973758|FG002|Overall Study|Withdrawal by Subject|0
6938922|NCT00927927|10973759|FG003|Overall Study|Withdrawal by Subject|0
6938923|NCT00927927|10973760|FG004|Overall Study|Withdrawal by Subject|0
6938924|NCT00927927|10973761|FG005|Overall Study|Withdrawal by Subject|0
6938925|NCT00927927|10973762|FG006|Overall Study|Withdrawal by Subject|0
6938926|NCT00927927|10973763|FG007|Overall Study|Withdrawal by Subject|2
6938927|NCT00927927|10973764|FG008|Overall Study|Withdrawal by Subject|0
6938928|NCT00927927|10973765|FG009|Overall Study|Withdrawal by Subject|0
6938929|NCT00927927|10973766|FG010|Overall Study|Withdrawal by Subject|0
6938930|NCT00927927|10973767|FG011|Overall Study|Withdrawal by Subject|2
6938931|NCT00927927|10973768|FG012|Overall Study|Withdrawal by Subject|0
6938932|NCT00927927|10973769|FG013|Overall Study|Withdrawal by Subject|0
6938933|NCT00927927|10973770|FG014|Overall Study|Withdrawal by Subject|0
6938934|NCT00927940|10973802|FG000|Overall Study|Death|1
6938935|NCT00928018|10973813|FG000|Overall Study|Withdrawal by Subject|1
6938936|NCT00928018|10973814|FG001|Overall Study|Withdrawal by Subject|0
6938937|NCT00928057|10973826|FG000|Overall Study|Adverse Event|1
6938938|NCT00928057|10973827|FG001|Overall Study|Adverse Event|2
6938939|NCT00928057|10973826|FG000|Overall Study|Withdrawal by Subject|1
6938940|NCT00928057|10973827|FG001|Overall Study|Withdrawal by Subject|0
6938941|NCT00928057|10973826|FG000|Overall Study|Lost to Follow-up|0
6938942|NCT00928057|10973827|FG001|Overall Study|Lost to Follow-up|1
6938943|NCT00928057|10973826|FG000|Overall Study|Protocol Violation|0
6938944|NCT00928057|10973827|FG001|Overall Study|Protocol Violation|1
6938945|NCT00928070|10973845|FG000|Overall Study|Lost to Follow-up|1
6938946|NCT00928070|10973846|FG001|Overall Study|Lost to Follow-up|2
6938947|NCT00928070|10973845|FG000|Overall Study|Withdrawal by Subject|10
6938948|NCT00928070|10973846|FG001|Overall Study|Withdrawal by Subject|3
6938949|NCT00928070|10973845|FG000|Overall Study|Adverse Event|14
6938950|NCT00928070|10973846|FG001|Overall Study|Adverse Event|26
6938951|NCT00928070|10973845|FG000|Overall Study|Lack of Efficacy|9
6938952|NCT00928070|10973846|FG001|Overall Study|Lack of Efficacy|5
6938953|NCT00928070|10973845|FG000|Overall Study|Did not meet entrance criteria|16
6938954|NCT00928070|10973846|FG001|Overall Study|Did not meet entrance criteria|9
6938955|NCT00928070|10973845|FG000|Overall Study|Protocol Violation|6
6938956|NCT00928070|10973846|FG001|Overall Study|Protocol Violation|5
6938957|NCT00928070|10973845|FG000|Overall Study|Randomized but not treated|2
6938958|NCT00928070|10973846|FG001|Overall Study|Randomized but not treated|2
6938959|NCT00928070|10973845|FG000|Overall Study|Other|5
6938960|NCT00928070|10973846|FG001|Overall Study|Other|5
6938961|NCT00928135|10973914|FG000|Overall Study|Withdrawal by Subject|1
6938962|NCT00928135|10973915|FG001|Overall Study|Withdrawal by Subject|0
6938963|NCT00928187|10973928|FG000|Overall Study|Death|1
6938964|NCT00928187|10973929|FG001|Overall Study|Death|2
6938965|NCT00928187|10973930|FG002|Overall Study|Death|3
6938966|NCT00928187|10973928|FG000|Overall Study|Lost to Follow-up|1
6938967|NCT00928187|10973929|FG001|Overall Study|Lost to Follow-up|2
6938968|NCT00928187|10973930|FG002|Overall Study|Lost to Follow-up|1
6938969|NCT00928187|10973928|FG000|Overall Study|Withdrawal by Subject|0
6938970|NCT00928187|10973929|FG001|Overall Study|Withdrawal by Subject|1
6938971|NCT00928187|10973930|FG002|Overall Study|Withdrawal by Subject|1
6938972|NCT00928187|10973928|FG000|Overall Study|Protocol Violation|0
6938973|NCT00928187|10973929|FG001|Overall Study|Protocol Violation|1
6938974|NCT00928187|10973930|FG002|Overall Study|Protocol Violation|0
6938975|NCT00928252|10973942|FG000|Overall Study|Physician Decision|3
6938976|NCT00928408|10973965|FG000|Overall Study|Other|2
6938977|NCT00928408|10973965|FG000|Overall Study|Withdrawal by Subject|4
6938978|NCT00928408|10973965|FG000|Overall Study|Death|5
6838169|NCT00256867|10843854|FG006|Overall Study|Adverse Event|1
6838170|NCT00256867|10843855|FG007|Overall Study|Adverse Event|4
6838171|NCT00256867|10843848|FG000|Overall Study|Lost to Follow-up|2
6838172|NCT00256867|10843849|FG001|Overall Study|Lost to Follow-up|2
6838173|NCT00256867|10843850|FG002|Overall Study|Lost to Follow-up|2
6838174|NCT00256867|10843851|FG003|Overall Study|Lost to Follow-up|3
6838175|NCT00256867|10843852|FG004|Overall Study|Lost to Follow-up|2
6838176|NCT00256867|10843853|FG005|Overall Study|Lost to Follow-up|0
6838177|NCT00256867|10843854|FG006|Overall Study|Lost to Follow-up|1
6838178|NCT00256867|10843855|FG007|Overall Study|Lost to Follow-up|2
6838179|NCT00256867|10843848|FG000|Overall Study|Protocol Violation|0
6938979|NCT00928408|10973965|FG000|Overall Study|Lost to Follow-up|12
6938980|NCT00928434|10973976|FG000|Overall Study|Adverse Event|14
6938981|NCT00928434|10973977|FG001|Overall Study|Adverse Event|5
6938982|NCT00928434|10973978|FG002|Overall Study|Adverse Event|18
6938983|NCT00928434|10973976|FG000|Overall Study|Protocol Violation|5
6938984|NCT00928434|10973977|FG001|Overall Study|Protocol Violation|0
6938985|NCT00928434|10973978|FG002|Overall Study|Protocol Violation|8
6938986|NCT00928434|10973976|FG000|Overall Study|Physician Decision|2
6938987|NCT00928434|10973977|FG001|Overall Study|Physician Decision|0
6938988|NCT00928434|10973978|FG002|Overall Study|Physician Decision|3
6938989|NCT00928434|10973976|FG000|Overall Study|Lost to Follow-up|1
6938990|NCT00928434|10973977|FG001|Overall Study|Lost to Follow-up|0
6938991|NCT00928434|10973978|FG002|Overall Study|Lost to Follow-up|3
6938992|NCT00928434|10973976|FG000|Overall Study|Withdrawal by Subject|5
6838180|NCT00256867|10843849|FG001|Overall Study|Protocol Violation|0
6838181|NCT00256867|10843850|FG002|Overall Study|Protocol Violation|0
6938993|NCT00928434|10973977|FG001|Overall Study|Withdrawal by Subject|3
6938994|NCT00928434|10973978|FG002|Overall Study|Withdrawal by Subject|2
6938995|NCT00928434|10973976|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10
6938996|NCT00928434|10973977|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4
6938997|NCT00928434|10973978|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7
6938998|NCT00928434|10973976|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2
6938999|NCT00928434|10973977|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1
6939000|NCT00928434|10973978|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1
6939001|NCT00928434|10973976|FG000|Overall Study|Other (not meeting above criteria)|5
6939002|NCT00928434|10973977|FG001|Overall Study|Other (not meeting above criteria)|1
6939003|NCT00928434|10973978|FG002|Overall Study|Other (not meeting above criteria)|2
6939004|NCT00928486|10973994|FG000|Overall Study|Adverse Event|2
6939005|NCT00928486|10973994|FG000|Overall Study|Disease Progression|7
6939006|NCT00928486|10973994|FG000|Overall Study|Withdrawal by Subject|1
6939007|NCT00928512|10974003|FG000|Overall Study|Adverse Event|4
6939008|NCT00928512|10974004|FG001|Overall Study|Adverse Event|3
6939009|NCT00928512|10974005|FG002|Overall Study|Adverse Event|2
6939010|NCT00928512|10974006|FG003|Overall Study|Adverse Event|8
6939011|NCT00928512|10974007|FG004|Overall Study|Adverse Event|6
6939012|NCT00928512|10974003|FG000|Overall Study|Lack of Efficacy|2
6939013|NCT00928512|10974004|FG001|Overall Study|Lack of Efficacy|0
6939014|NCT00928512|10974005|FG002|Overall Study|Lack of Efficacy|4
6939015|NCT00928512|10974006|FG003|Overall Study|Lack of Efficacy|7
6939016|NCT00928512|10974007|FG004|Overall Study|Lack of Efficacy|3
6939017|NCT00928512|10974003|FG000|Overall Study|Protocol Violation|0
6939018|NCT00928512|10974004|FG001|Overall Study|Protocol Violation|1
6939019|NCT00928512|10974005|FG002|Overall Study|Protocol Violation|0
6939020|NCT00928512|10974006|FG003|Overall Study|Protocol Violation|1
6939021|NCT00928512|10974007|FG004|Overall Study|Protocol Violation|3
6939022|NCT00928512|10974003|FG000|Overall Study|Withdrawal by Subject|3
6939023|NCT00928512|10974004|FG001|Overall Study|Withdrawal by Subject|0
6939024|NCT00928512|10974005|FG002|Overall Study|Withdrawal by Subject|3
6939025|NCT00928512|10974006|FG003|Overall Study|Withdrawal by Subject|4
6939026|NCT00928512|10974007|FG004|Overall Study|Withdrawal by Subject|0
6939027|NCT00928512|10974003|FG000|Overall Study|Lost to Follow-up|1
6939028|NCT00928512|10974004|FG001|Overall Study|Lost to Follow-up|1
6939029|NCT00928512|10974005|FG002|Overall Study|Lost to Follow-up|2
6939030|NCT00928512|10974006|FG003|Overall Study|Lost to Follow-up|1
6939031|NCT00928512|10974007|FG004|Overall Study|Lost to Follow-up|3
6939032|NCT00928512|10974003|FG000|Overall Study|Administrative Problems|0
6939033|NCT00928512|10974004|FG001|Overall Study|Administrative Problems|1
6939034|NCT00928512|10974005|FG002|Overall Study|Administrative Problems|0
6939035|NCT00928512|10974006|FG003|Overall Study|Administrative Problems|0
6939036|NCT00928512|10974007|FG004|Overall Study|Administrative Problems|0
6939037|NCT00928564|10974025|FG000|Overall Study|Lost to Follow-up|6
6939038|NCT00928564|10974026|FG001|Overall Study|Lost to Follow-up|0
6939039|NCT00928668|10974039|FG000|Overall Study|Adverse Event|1
6939040|NCT00928668|10974040|FG001|Overall Study|Adverse Event|0
6939041|NCT00928668|10974041|FG002|Overall Study|Adverse Event|0
6939042|NCT00928668|10974042|FG003|Overall Study|Adverse Event|0
6939043|NCT00928668|10974043|FG004|Overall Study|Adverse Event|0
6939044|NCT00928668|10974039|FG000|Overall Study|Protocol Violation|0
6939045|NCT00928668|10974040|FG001|Overall Study|Protocol Violation|0
6939046|NCT00928668|10974041|FG002|Overall Study|Protocol Violation|0
6939047|NCT00928668|10974042|FG003|Overall Study|Protocol Violation|0
6939048|NCT00928668|10974043|FG004|Overall Study|Protocol Violation|1
6939049|NCT00928668|10974039|FG000|Overall Study|Withdrawal by Subject|0
6939050|NCT00928668|10974040|FG001|Overall Study|Withdrawal by Subject|1
6939051|NCT00928668|10974041|FG002|Overall Study|Withdrawal by Subject|1
6939052|NCT00928668|10974042|FG003|Overall Study|Withdrawal by Subject|0
6939053|NCT00928668|10974043|FG004|Overall Study|Withdrawal by Subject|0
6939054|NCT00928668|10974039|FG000|Overall Study|Other reasons not listed above|0
6939055|NCT00928668|10974040|FG001|Overall Study|Other reasons not listed above|0
6939056|NCT00928668|10974041|FG002|Overall Study|Other reasons not listed above|0
6939057|NCT00928668|10974042|FG003|Overall Study|Other reasons not listed above|1
6939058|NCT00928668|10974043|FG004|Overall Study|Other reasons not listed above|0
6939059|NCT00928707|10974069|FG000|Overall Study|Protocol Violation|1
6939060|NCT00928707|10974070|FG001|Overall Study|Protocol Violation|0
6939061|NCT00928746|10974092|FG000|Overall Study|Adverse Event|2
6939062|NCT00928746|10974092|FG000|Overall Study|Protocol Violation|1
6939063|NCT00928746|10974092|FG000|Overall Study|Withdrawal by Subject|1
6939064|NCT00928746|10974092|FG000|Overall Study|Other|2
6939065|NCT00928889|10974113|FG000|Overall Study|Lost to Follow-up|3
6939066|NCT00928889|10974114|FG001|Overall Study|Lost to Follow-up|1
6939067|NCT00928889|10974113|FG000|Overall Study|Protocol Violation|0
6939068|NCT00928889|10974114|FG001|Overall Study|Protocol Violation|1
6939069|NCT00928889|10974113|FG000|Overall Study|Adverse Event|1
6939070|NCT00928889|10974114|FG001|Overall Study|Adverse Event|0
6939071|NCT00928889|10974113|FG000|Overall Study|Other|1
6939072|NCT00928889|10974114|FG001|Overall Study|Other|0
6939073|NCT00929110|10974137|FG000|Overall Study|Adverse Event|40
6939074|NCT00929110|10974138|FG001|Overall Study|Adverse Event|29
6939075|NCT00929110|10974139|FG002|Overall Study|Adverse Event|18
6939076|NCT00929110|10974137|FG000|Overall Study|Subject withdrew consent|40
6939077|NCT00929110|10974138|FG001|Overall Study|Subject withdrew consent|23
6939078|NCT00929110|10974139|FG002|Overall Study|Subject withdrew consent|26
6939079|NCT00929110|10974137|FG000|Overall Study|Unsatisfactory therapeutic effect|20
6939080|NCT00929110|10974138|FG001|Overall Study|Unsatisfactory therapeutic effect|9
6939081|NCT00929110|10974139|FG002|Overall Study|Unsatisfactory therapeutic effect|6
6939082|NCT00929110|10974137|FG000|Overall Study|Lost to Follow-up|7
6939083|NCT00929110|10974138|FG001|Overall Study|Lost to Follow-up|7
6939084|NCT00929110|10974139|FG002|Overall Study|Lost to Follow-up|3
6939085|NCT00929110|10974137|FG000|Overall Study|Protocol deviation|5
6939086|NCT00929110|10974138|FG001|Overall Study|Protocol deviation|2
6939087|NCT00929110|10974139|FG002|Overall Study|Protocol deviation|4
6939088|NCT00929110|10974137|FG000|Overall Study|Administrative problems|4
6939089|NCT00929110|10974138|FG001|Overall Study|Administrative problems|1
6939090|NCT00929110|10974139|FG002|Overall Study|Administrative problems|2
6939091|NCT00929110|10974137|FG000|Overall Study|Death|2
6939092|NCT00929110|10974138|FG001|Overall Study|Death|2
6939093|NCT00929110|10974139|FG002|Overall Study|Death|2
6939094|NCT00929110|10974137|FG000|Overall Study|Abnormal laboratory value(s)|0
6939095|NCT00929110|10974138|FG001|Overall Study|Abnormal laboratory value(s)|1
6939096|NCT00929110|10974139|FG002|Overall Study|Abnormal laboratory value(s)|0
6939097|NCT00929110|10974137|FG000|Overall Study|Abnormal test procedure result(s)|0
6939098|NCT00929110|10974138|FG001|Overall Study|Abnormal test procedure result(s)|1
6939099|NCT00929110|10974139|FG002|Overall Study|Abnormal test procedure result(s)|1
6939100|NCT00929110|10974137|FG000|Overall Study|Patient inability to use the device|0
6939101|NCT00929110|10974138|FG001|Overall Study|Patient inability to use the device|1
6939102|NCT00929110|10974139|FG002|Overall Study|Patient inability to use the device|0
6939103|NCT00929162|10974149|FG000|Overall Study|Adverse Event|8
6939104|NCT00929162|10974150|FG001|Overall Study|Adverse Event|5
6939105|NCT00929162|10974149|FG000|Overall Study|Withdrawal by Subject|3
6939106|NCT00929162|10974150|FG001|Overall Study|Withdrawal by Subject|1
6939107|NCT00929162|10974149|FG000|Overall Study|Protocol Violation|32
6939108|NCT00929162|10974150|FG001|Overall Study|Protocol Violation|30
6939109|NCT00929162|10974149|FG000|Overall Study|Other termination reason|5
6939110|NCT00929162|10974150|FG001|Overall Study|Other termination reason|6
6939111|NCT00929201|10974156|FG000|Period 1|Withdrawal by Subject|0
6939112|NCT00929201|10974157|FG001|Period 1|Withdrawal by Subject|1
6939113|NCT00929240|10974164|FG000|Initial Treatment Phase|Adverse Event|31
6939114|NCT00929240|10974165|FG001|Initial Treatment Phase|Adverse Event|0
6939115|NCT00929240|10974166|FG002|Initial Treatment Phase|Adverse Event|0
6939116|NCT00929240|10974164|FG000|Initial Treatment Phase|Disease progression|41
6939117|NCT00929240|10974165|FG001|Initial Treatment Phase|Disease progression|0
6939118|NCT00929240|10974166|FG002|Initial Treatment Phase|Disease progression|0
6939119|NCT00929240|10974164|FG000|Initial Treatment Phase|Withdrawal by Subject|13
6939120|NCT00929240|10974165|FG001|Initial Treatment Phase|Withdrawal by Subject|0
6939121|NCT00929240|10974166|FG002|Initial Treatment Phase|Withdrawal by Subject|0
6939122|NCT00929240|10974164|FG000|Initial Treatment Phase|Protocol Violation|5
6939123|NCT00929240|10974165|FG001|Initial Treatment Phase|Protocol Violation|0
6939124|NCT00929240|10974166|FG002|Initial Treatment Phase|Protocol Violation|0
6939125|NCT00929240|10974164|FG000|Initial Treatment Phase|Death|2
6939126|NCT00929240|10974165|FG001|Initial Treatment Phase|Death|0
6939127|NCT00929240|10974166|FG002|Initial Treatment Phase|Death|0
6939128|NCT00929240|10974164|FG000|Initial Treatment Phase|Health authority/Study termination|3
6939129|NCT00929240|10974165|FG001|Initial Treatment Phase|Health authority/Study termination|0
6939130|NCT00929240|10974166|FG002|Initial Treatment Phase|Health authority/Study termination|0
6939131|NCT00929240|10974164|FG000|Initial Treatment Phase|Physician Decision|4
6939132|NCT00929240|10974165|FG001|Initial Treatment Phase|Physician Decision|0
6939133|NCT00929240|10974166|FG002|Initial Treatment Phase|Physician Decision|0
6939134|NCT00929240|10974164|FG000|Maintenance Phase|Disease progression|0
6939135|NCT00929240|10974165|FG001|Maintenance Phase|Disease progression|73
6939136|NCT00929240|10974166|FG002|Maintenance Phase|Disease progression|60
6939137|NCT00929240|10974164|FG000|Maintenance Phase|Adverse Event|0
6939138|NCT00929240|10974165|FG001|Maintenance Phase|Adverse Event|9
6939139|NCT00929240|10974166|FG002|Maintenance Phase|Adverse Event|12
6939140|NCT00929240|10974164|FG000|Maintenance Phase|Withdrawal by Subject|0
6939141|NCT00929240|10974165|FG001|Maintenance Phase|Withdrawal by Subject|2
6939142|NCT00929240|10974166|FG002|Maintenance Phase|Withdrawal by Subject|6
6939143|NCT00929240|10974164|FG000|Maintenance Phase|Protocol Violation|0
6939144|NCT00929240|10974165|FG001|Maintenance Phase|Protocol Violation|1
6939145|NCT00929240|10974166|FG002|Maintenance Phase|Protocol Violation|0
6939146|NCT00929240|10974164|FG000|Maintenance Phase|Health authority/Study termination|0
6939147|NCT00929240|10974165|FG001|Maintenance Phase|Health authority/Study termination|1
6939148|NCT00929240|10974166|FG002|Maintenance Phase|Health authority/Study termination|2
6939149|NCT00929240|10974164|FG000|Maintenance Phase|Physician Decision|0
6939150|NCT00929240|10974165|FG001|Maintenance Phase|Physician Decision|2
6939151|NCT00929240|10974166|FG002|Maintenance Phase|Physician Decision|1
6939152|NCT00929240|10974164|FG000|Maintenance Phase|Change of treatment|0
6939153|NCT00929240|10974165|FG001|Maintenance Phase|Change of treatment|4
6939154|NCT00929240|10974166|FG002|Maintenance Phase|Change of treatment|0
6939155|NCT00929240|10974164|FG000|Maintenance Phase|Treatment ongoing at study closure|0
6939156|NCT00929240|10974165|FG001|Maintenance Phase|Treatment ongoing at study closure|0
6939157|NCT00929240|10974166|FG002|Maintenance Phase|Treatment ongoing at study closure|10
6939158|NCT00929240|10974164|FG000|Maintenance Phase|Participant not treated|0
6939159|NCT00929240|10974165|FG001|Maintenance Phase|Participant not treated|2
6939160|NCT00929240|10974166|FG002|Maintenance Phase|Participant not treated|0
6939161|NCT00929526|10974231|FG000|Overall Study|Withdrawal by Subject|1
6939162|NCT00929526|10974232|FG001|Overall Study|Withdrawal by Subject|11
6939163|NCT00929526|10974231|FG000|Overall Study|Lost to Follow-up|8
6939164|NCT00929526|10974232|FG001|Overall Study|Lost to Follow-up|12
6939165|NCT00929526|10974231|FG000|Overall Study|Other|8
6939166|NCT00929526|10974232|FG001|Overall Study|Other|6
6939167|NCT00929643|10974247|FG000|Overall Study|Protocol Violation|2
6939168|NCT00929656|10974253|FG000|Overall Study|Lost to Follow-up|0
6939169|NCT00929656|10974254|FG001|Overall Study|Lost to Follow-up|1
6939170|NCT00929669|10974260|FG000|Overall Study|elevated glucose levels|1
6939171|NCT00929695|10974266|FG000|Overall Study|Death|2
6939172|NCT00929695|10974267|FG001|Overall Study|Death|1
6939173|NCT00929695|10974266|FG000|Overall Study|Withdrawal by Subject|0
6939174|NCT00929695|10974267|FG001|Overall Study|Withdrawal by Subject|2
6939175|NCT00929695|10974266|FG000|Overall Study|discharge home|4
6939176|NCT00929695|10974267|FG001|Overall Study|discharge home|3
6939177|NCT00929695|10974266|FG000|Overall Study|incorrect stratification|2
6939178|NCT00929695|10974267|FG001|Overall Study|incorrect stratification|0
6939179|NCT00929708|10974283|FG000|Overall Study|Protocol Violation|2
6939180|NCT00929708|10974284|FG001|Overall Study|Protocol Violation|1
6939181|NCT00929708|10974285|FG002|Overall Study|Protocol Violation|1
6939182|NCT00929708|10974286|FG003|Overall Study|Protocol Violation|1
6939183|NCT00929708|10974287|FG004|Overall Study|Protocol Violation|1
6939184|NCT00929708|10974283|FG000|Overall Study|Withdrawal by Subject|2
6939185|NCT00929708|10974284|FG001|Overall Study|Withdrawal by Subject|0
6939186|NCT00929708|10974285|FG002|Overall Study|Withdrawal by Subject|0
6939187|NCT00929708|10974286|FG003|Overall Study|Withdrawal by Subject|2
6939188|NCT00929708|10974287|FG004|Overall Study|Withdrawal by Subject|1
6939189|NCT00929708|10974283|FG000|Overall Study|Adverse Event|0
6939190|NCT00929708|10974284|FG001|Overall Study|Adverse Event|0
6939191|NCT00929708|10974285|FG002|Overall Study|Adverse Event|0
6939192|NCT00929708|10974286|FG003|Overall Study|Adverse Event|0
6939193|NCT00929708|10974287|FG004|Overall Study|Adverse Event|3
6939194|NCT00929708|10974283|FG000|Overall Study|Physician Decision|0
6939195|NCT00929708|10974284|FG001|Overall Study|Physician Decision|2
6939196|NCT00929708|10974285|FG002|Overall Study|Physician Decision|2
6939197|NCT00929708|10974286|FG003|Overall Study|Physician Decision|2
6939198|NCT00929708|10974287|FG004|Overall Study|Physician Decision|1
6939199|NCT00929708|10974283|FG000|Overall Study|Lost to Follow-up|0
6939200|NCT00929708|10974284|FG001|Overall Study|Lost to Follow-up|0
6939201|NCT00929708|10974285|FG002|Overall Study|Lost to Follow-up|0
6939202|NCT00929708|10974286|FG003|Overall Study|Lost to Follow-up|1
6939203|NCT00929708|10974287|FG004|Overall Study|Lost to Follow-up|0
6939204|NCT00929734|10974301|FG000|Overall Study|Lost to Follow-up|2
6939205|NCT00929734|10974302|FG001|Overall Study|Lost to Follow-up|1
6939206|NCT00929734|10974301|FG000|Overall Study|Withdrawal by Subject|0
6939207|NCT00929734|10974302|FG001|Overall Study|Withdrawal by Subject|2
6939208|NCT00929864|10974337|FG000|Overall Study|Death|1
6939209|NCT00929864|10974338|FG001|Overall Study|Death|1
6939210|NCT00929864|10974337|FG000|Overall Study|Adverse Event|11
6939211|NCT00929864|10974338|FG001|Overall Study|Adverse Event|30
6939212|NCT00929864|10974337|FG000|Overall Study|Lack of Efficacy|19
6939213|NCT00929864|10974338|FG001|Overall Study|Lack of Efficacy|16
6939214|NCT00929864|10974337|FG000|Overall Study|Lost to Follow-up|7
6939215|NCT00929864|10974338|FG001|Overall Study|Lost to Follow-up|12
6939216|NCT00929864|10974337|FG000|Overall Study|Withdrawal by Subject|20
6939217|NCT00929864|10974338|FG001|Overall Study|Withdrawal by Subject|9
6939218|NCT00929864|10974337|FG000|Overall Study|No longer met criteria|2
6939219|NCT00929864|10974338|FG001|Overall Study|No longer met criteria|1
6939220|NCT00929864|10974337|FG000|Overall Study|Poor or non-compliance|3
6939221|NCT00929864|10974338|FG001|Overall Study|Poor or non-compliance|3
6939222|NCT00929864|10974337|FG000|Overall Study|Pregnancy|0
6939223|NCT00929864|10974338|FG001|Overall Study|Pregnancy|3
6939224|NCT00929864|10974337|FG000|Overall Study|Administrative reason by Sponsor|1
6939225|NCT00929864|10974338|FG001|Overall Study|Administrative reason by Sponsor|1
6939226|NCT00929864|10974337|FG000|Overall Study|Non-specified|2
6939227|NCT00929864|10974338|FG001|Overall Study|Non-specified|7
6975428|NCT01193153|11027629|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35
6975429|NCT01193153|11027630|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0
6975430|NCT01193153|11027629|FG000|Open-label Stabilization Period|Other|8
6975431|NCT01193153|11027630|FG001|Open-label Stabilization Period|Other|0
6975432|NCT01193153|11027629|FG000|Double Blind Relapse Prevention Period|Other|2
6975433|NCT01193153|11027630|FG001|Double Blind Relapse Prevention Period|Other|3
6975434|NCT01193153|11027629|FG000|Double Blind Relapse Prevention Period|Adverse Event|12
6975435|NCT01193153|11027630|FG001|Double Blind Relapse Prevention Period|Adverse Event|3
6975436|NCT01193153|11027629|FG000|Double Blind Relapse Prevention Period|Death|2
6975437|NCT01193153|11027630|FG001|Double Blind Relapse Prevention Period|Death|0
6975438|NCT01193153|11027629|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2
6975439|NCT01193153|11027630|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9
6939228|NCT00929994|10974348|FG000|Overall Study|Withdrawal by Subject|1
6939229|NCT00929994|10974348|FG000|Overall Study|medical issue unrelated to intervention|4
6939230|NCT00929994|10974348|FG000|Overall Study|employment|1
6939231|NCT00930046|10974357|FG000|Overall Study|Wound catheter malfunctioned|1
6939232|NCT00930046|10974358|FG001|Overall Study|Wound catheter malfunctioned|2
6939233|NCT00930059|10974366|FG000|Overall Study|Death|1
6939234|NCT00930059|10974367|FG001|Overall Study|Death|0
6939235|NCT00930059|10974366|FG000|Overall Study|Did not meet entrance criteria|1
6939236|NCT00930059|10974367|FG001|Overall Study|Did not meet entrance criteria|1
6939237|NCT00930059|10974366|FG000|Overall Study|Withdrawal by Subject|3
6939238|NCT00930059|10974367|FG001|Overall Study|Withdrawal by Subject|4
6939239|NCT00930059|10974366|FG000|Overall Study|Other|1
6939240|NCT00930059|10974367|FG001|Overall Study|Other|0
6939241|NCT00930059|10974366|FG000|Overall Study|1 site terminated by sponsor|1
6939242|NCT00930059|10974367|FG001|Overall Study|1 site terminated by sponsor|1
6939243|NCT00930059|10974366|FG000|Overall Study|Adverse Event|1
6939244|NCT00930059|10974367|FG001|Overall Study|Adverse Event|6
6939245|NCT00930176|10974373|FG000|Overall Study|Death|1
6939246|NCT00930553|10974386|FG000|Overall Study|Adverse Event|1
6939247|NCT00930553|10974386|FG000|Overall Study|Lack of Efficacy|7
6939248|NCT00930553|10974386|FG000|Overall Study|Physician Decision|39
6939249|NCT00930553|10974386|FG000|Overall Study|Protocol Violation|1
6939250|NCT00930553|10974386|FG000|Overall Study|Pregnancy|1
6939251|NCT00930553|10974386|FG000|Overall Study|Withdrawal by Subject|88
6939252|NCT00930553|10974386|FG000|Overall Study|Lost to Follow-up|25
6939253|NCT00930553|10974386|FG000|Overall Study|Death|9
6939254|NCT00930553|10974386|FG000|Overall Study|Study terminated by sponsor|24
6939255|NCT00930553|10974386|FG000|Overall Study|Other than specified above|28
6939256|NCT00930644|10974408|FG000|Overall Study|Withdrawal by Subject|4
6939257|NCT00930644|10974408|FG000|Overall Study|Physician Decision|2
6939258|NCT00930644|10974408|FG000|Overall Study|Death|1
6939259|NCT00930644|10974408|FG000|Overall Study|Adverse Event|16
6939260|NCT00930761|10974417|FG000|Overall Study|3 newborns died; 1 mother quit the study|4
6939261|NCT00930761|10974418|FG001|Overall Study|3 newborns died; 1 mother quit the study|0
6939262|NCT00930761|10974417|FG000|Overall Study|less than 3 music therapy sessions|0
6939263|NCT00930761|10974418|FG001|Overall Study|less than 3 music therapy sessions|3
6939264|NCT00930774|10974428|FG000|Overall Study|Withdrawal by Subject|1
6939265|NCT00930774|10974429|FG001|Overall Study|Withdrawal by Subject|9
6939266|NCT00930774|10974430|FG002|Overall Study|Withdrawal by Subject|2
6939267|NCT00930774|10974431|FG003|Overall Study|Withdrawal by Subject|0
6939268|NCT00930813|10974444|FG000|Overall Study|Death|4
6939269|NCT00930813|10974445|FG001|Overall Study|Death|5
6939270|NCT00930813|10974444|FG000|Overall Study|Withdrawal by Subject|2
6939271|NCT00930813|10974445|FG001|Overall Study|Withdrawal by Subject|5
6939272|NCT00930813|10974444|FG000|Overall Study|Lost to Follow-up|2
6939273|NCT00930813|10974445|FG001|Overall Study|Lost to Follow-up|4
6939274|NCT00930930|10974455|FG000|Overall Study|Death|1
6939275|NCT00930930|10974456|FG001|Overall Study|Death|0
6939276|NCT00930930|10974455|FG000|Overall Study|Physician Decision|1
6939277|NCT00930930|10974456|FG001|Overall Study|Physician Decision|0
6939278|NCT00930930|10974455|FG000|Overall Study|Adverse Event|13
6939279|NCT00930930|10974456|FG001|Overall Study|Adverse Event|3
6939280|NCT00930930|10974455|FG000|Overall Study|Withdrawal by Subject|3
6939281|NCT00930930|10974456|FG001|Overall Study|Withdrawal by Subject|1
6939282|NCT00930930|10974455|FG000|Overall Study|Disease progression|2
6939283|NCT00930930|10974456|FG001|Overall Study|Disease progression|3
6939284|NCT00930930|10974455|FG000|Overall Study|excessive lapse btw txs, not eligible|0
6939285|NCT00930930|10974456|FG001|Overall Study|excessive lapse btw txs, not eligible|1
6939286|NCT00930930|10974455|FG000|Overall Study|patients not compliant|1
6939287|NCT00930930|10974456|FG001|Overall Study|patients not compliant|1
6939288|NCT00930969|10974462|FG000|Overall Study|Death|5
6939289|NCT00930969|10974462|FG000|Overall Study|Lost to Follow-up|1
6939290|NCT00930969|10974462|FG000|Overall Study|Physician Decision|13
6939291|NCT00930969|10974462|FG000|Overall Study|Withdrawal by Subject|19
6939292|NCT00930982|10974468|FG000|Overall Study|Adverse Event|19
6939293|NCT00930982|10974469|FG001|Overall Study|Adverse Event|23
6939294|NCT00930982|10974468|FG000|Overall Study|Protocol Violation|1
6939295|NCT00930982|10974469|FG001|Overall Study|Protocol Violation|5
6939296|NCT00930982|10974468|FG000|Overall Study|Withdrawal by Subject|1
6939297|NCT00930982|10974469|FG001|Overall Study|Withdrawal by Subject|1
6939298|NCT00931268|10974486|FG000|Overall Study|Lost to Follow-up|6
6939299|NCT00931307|10974490|FG000|Overall Study|Lack of Efficacy|12
6939300|NCT00931307|10974490|FG000|Overall Study|Biomicroscopy|1
6939301|NCT00931385|10974503|FG000|Overall Study|Adverse Event|2
6939302|NCT00931385|10974504|FG001|Overall Study|Adverse Event|1
6939303|NCT00931385|10974505|FG002|Overall Study|Adverse Event|0
6939304|NCT00931385|10974506|FG003|Overall Study|Adverse Event|3
6939305|NCT00931385|10974503|FG000|Overall Study|Protocol Violation|0
6939306|NCT00931385|10974504|FG001|Overall Study|Protocol Violation|0
6939307|NCT00931385|10974505|FG002|Overall Study|Protocol Violation|1
6939308|NCT00931385|10974506|FG003|Overall Study|Protocol Violation|0
6939309|NCT00931385|10974503|FG000|Overall Study|Withdrawal by Subject|0
6939310|NCT00931385|10974504|FG001|Overall Study|Withdrawal by Subject|1
6939311|NCT00931385|10974505|FG002|Overall Study|Withdrawal by Subject|0
6939312|NCT00931385|10974506|FG003|Overall Study|Withdrawal by Subject|1
6939313|NCT00931385|10974503|FG000|Overall Study|Lost to Follow-up|0
6939314|NCT00931385|10974504|FG001|Overall Study|Lost to Follow-up|0
6939315|NCT00931385|10974505|FG002|Overall Study|Lost to Follow-up|0
6939316|NCT00931385|10974506|FG003|Overall Study|Lost to Follow-up|1
6939317|NCT00931411|10974522|FG000|First Intervention - 42 Days|Adverse Event|2
6939318|NCT00931411|10974523|FG001|First Intervention - 42 Days|Adverse Event|3
6939319|NCT00931411|10974522|FG000|First Intervention - 42 Days|Lost to Follow-up|2
6939320|NCT00931411|10974523|FG001|First Intervention - 42 Days|Lost to Follow-up|0
6939321|NCT00931411|10974522|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0
6939322|NCT00931411|10974523|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1
6939323|NCT00931463|10974535|FG000|Overall Study|Death|8
6939324|NCT00931463|10974536|FG001|Overall Study|Death|4
6939325|NCT00931463|10974535|FG000|Overall Study|Withdrawal by Subject|5
6939326|NCT00931463|10974536|FG001|Overall Study|Withdrawal by Subject|0
6939327|NCT00931463|10974535|FG000|Overall Study|Lost to Follow-up|4
6939328|NCT00931463|10974536|FG001|Overall Study|Lost to Follow-up|1
6939329|NCT00931515|10974564|FG000|Overall Study|Lost to Follow-up|2
6939330|NCT00931515|10974565|FG001|Overall Study|Lost to Follow-up|5
6939331|NCT00931528|10974573|FG000|Overall Study|Protocol Violation|9
6939332|NCT00931528|10974574|FG001|Overall Study|Protocol Violation|12
6939333|NCT00931528|10974573|FG000|Overall Study|Withdrawal by Subject|4
6939334|NCT00931528|10974574|FG001|Overall Study|Withdrawal by Subject|12
6939335|NCT00931528|10974573|FG000|Overall Study|Lost to Follow-up|6
6939336|NCT00931528|10974574|FG001|Overall Study|Lost to Follow-up|13
6939337|NCT00931528|10974573|FG000|Overall Study|Assessment outside of Time Frame|22
6939338|NCT00931528|10974574|FG001|Overall Study|Assessment outside of Time Frame|23
6939339|NCT00931632|10974583|FG000|Overall Study|Withdrawal by Subject|2
6939340|NCT00931632|10974584|FG001|Overall Study|Withdrawal by Subject|3
6939341|NCT00931632|10974583|FG000|Overall Study|Adverse Event|19
6939342|NCT00931632|10974584|FG001|Overall Study|Adverse Event|15
6939343|NCT00931710|10974592|FG000|Overall Study|Adverse Event|16
6939344|NCT00931710|10974593|FG001|Overall Study|Adverse Event|10
6939345|NCT00931710|10974592|FG000|Overall Study|Abnormal test procedure results|2
6939346|NCT00931710|10974593|FG001|Overall Study|Abnormal test procedure results|0
6939347|NCT00931710|10974592|FG000|Overall Study|Unsatisfactory therapeutic effects|5
6939348|NCT00931710|10974593|FG001|Overall Study|Unsatisfactory therapeutic effects|12
6939349|NCT00931710|10974592|FG000|Overall Study|Patient withdrew consent|4
6939350|NCT00931710|10974593|FG001|Overall Study|Patient withdrew consent|9
6838182|NCT00256867|10843851|FG003|Overall Study|Protocol Violation|1
6838183|NCT00256867|10843852|FG004|Overall Study|Protocol Violation|0
6838184|NCT00256867|10843853|FG005|Overall Study|Protocol Violation|1
6838185|NCT00256867|10843854|FG006|Overall Study|Protocol Violation|0
6838186|NCT00256867|10843855|FG007|Overall Study|Protocol Violation|1
6838187|NCT00256867|10843848|FG000|Overall Study|Withdrawal by Subject|0
6838188|NCT00256867|10843849|FG001|Overall Study|Withdrawal by Subject|0
6838189|NCT00256867|10843850|FG002|Overall Study|Withdrawal by Subject|1
6838190|NCT00256867|10843851|FG003|Overall Study|Withdrawal by Subject|1
6838191|NCT00256867|10843852|FG004|Overall Study|Withdrawal by Subject|2
6838192|NCT00256867|10843853|FG005|Overall Study|Withdrawal by Subject|2
6838193|NCT00256867|10843854|FG006|Overall Study|Withdrawal by Subject|3
6838194|NCT00256867|10843855|FG007|Overall Study|Withdrawal by Subject|2
6838195|NCT00256867|10843848|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0
6838196|NCT00256867|10843849|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1
6838197|NCT00256867|10843850|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0
6838198|NCT00256867|10843851|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0
6838199|NCT00256867|10843852|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0
6838200|NCT00256867|10843853|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0
6838201|NCT00256867|10843854|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0
6838202|NCT00256867|10843855|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0
6838203|NCT00256867|10843848|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0
6838204|NCT00256867|10843849|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0
6838205|NCT00256867|10843850|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0
6838206|NCT00256867|10843851|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0
6838207|NCT00256867|10843852|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0
6838208|NCT00256867|10843853|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0
6838209|NCT00256867|10843854|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0
6838210|NCT00256867|10843855|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1
6838211|NCT00256867|10843848|FG000|Overall Study|Investigator's Decision|0
6838212|NCT00256867|10843849|FG001|Overall Study|Investigator's Decision|0
6939351|NCT00931710|10974592|FG000|Overall Study|Lost to Follow-up|6
6939352|NCT00931710|10974593|FG001|Overall Study|Lost to Follow-up|5
6939353|NCT00931710|10974592|FG000|Overall Study|Protocol deviation|1
6939354|NCT00931710|10974593|FG001|Overall Study|Protocol deviation|2
6939355|NCT00931723|10974601|FG000|Overall Study|Withdrawal by Subject|11
6939356|NCT00931723|10974602|FG001|Overall Study|Withdrawal by Subject|13
6939357|NCT00931723|10974601|FG000|Overall Study|Adverse Event|6
6939358|NCT00931723|10974602|FG001|Overall Study|Adverse Event|13
6939359|NCT00931723|10974601|FG000|Overall Study|Lithium found in blood|0
6838213|NCT00256867|10843850|FG002|Overall Study|Investigator's Decision|0
6939360|NCT00931723|10974602|FG001|Overall Study|Lithium found in blood|1
6939361|NCT00931723|10974601|FG000|Overall Study|Condition under investigation worsened|1
6939362|NCT00931723|10974602|FG001|Overall Study|Condition under investigation worsened|2
6939363|NCT00931723|10974601|FG000|Overall Study|Lost to Follow-up|1
6939364|NCT00931723|10974602|FG001|Overall Study|Lost to Follow-up|2
6939365|NCT00931723|10974601|FG000|Overall Study|Study-specific discontinuation criteria|1
6939366|NCT00931723|10974602|FG001|Overall Study|Study-specific discontinuation criteria|1
6939367|NCT00931723|10974601|FG000|Overall Study|Severe non-compliance to protocol|2
6939368|NCT00931723|10974602|FG001|Overall Study|Severe non-compliance to protocol|0
6939369|NCT00931723|10974601|FG000|Overall Study|Safety reasons|0
6939370|NCT00931723|10974602|FG001|Overall Study|Safety reasons|1
6939371|NCT00931723|10974601|FG000|Overall Study|Took prohibited concomitant medication|0
6939372|NCT00931723|10974602|FG001|Overall Study|Took prohibited concomitant medication|1
6939373|NCT00931723|10974601|FG000|Overall Study|Lack or insufficient theraputic response|2
6939374|NCT00931723|10974602|FG001|Overall Study|Lack or insufficient theraputic response|5
6939375|NCT00931723|10974601|FG000|Overall Study|Sponsor decision|1
6939376|NCT00931723|10974602|FG001|Overall Study|Sponsor decision|0
6939377|NCT00931723|10974601|FG000|Overall Study|Late hospital discharge|1
6939378|NCT00931723|10974602|FG001|Overall Study|Late hospital discharge|0
6939379|NCT00931762|10974608|FG000|Overall Study|Abnormal Laboratory Value (s)|2
6939380|NCT00931762|10974608|FG000|Overall Study|Administrative Problems|5
6939381|NCT00931762|10974608|FG000|Overall Study|Death|1
6939382|NCT00931762|10974608|FG000|Overall Study|Disease Progression|3
6939383|NCT00931762|10974608|FG000|Overall Study|Adverse Event (s)|11
6939384|NCT00931762|10974608|FG000|Overall Study|Subject withdrew consent|13
6939385|NCT00931801|10974615|FG000|Overall Study|Adverse Event|0
6939386|NCT00931801|10974616|FG001|Overall Study|Adverse Event|0
6939387|NCT00931801|10974617|FG002|Overall Study|Adverse Event|1
6939388|NCT00931801|10974615|FG000|Overall Study|Lost to Follow-up|0
6939389|NCT00931801|10974616|FG001|Overall Study|Lost to Follow-up|1
6939390|NCT00931801|10974617|FG002|Overall Study|Lost to Follow-up|0
6939391|NCT00931801|10974615|FG000|Overall Study|Withdrawal by Subject|1
6939392|NCT00931801|10974616|FG001|Overall Study|Withdrawal by Subject|0
6939393|NCT00931801|10974617|FG002|Overall Study|Withdrawal by Subject|0
6939394|NCT00931801|10974615|FG000|Overall Study|Confirmed Virologic Failure|0
6939395|NCT00931801|10974616|FG001|Overall Study|Confirmed Virologic Failure|0
6939396|NCT00931801|10974617|FG002|Overall Study|Confirmed Virologic Failure|3
6939397|NCT00931892|10974641|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0
6939398|NCT00931892|10974642|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1
6939399|NCT00931918|10974690|FG000|Overall Study|Adverse Event|4
6939400|NCT00931918|10974691|FG001|Overall Study|Adverse Event|6
6939401|NCT00931918|10974690|FG000|Overall Study|Progressive Disease|2
6939402|NCT00931918|10974691|FG001|Overall Study|Progressive Disease|1
6939403|NCT00931918|10974690|FG000|Overall Study|Symptomatic Deterioration|1
6939404|NCT00931918|10974691|FG001|Overall Study|Symptomatic Deterioration|0
6939405|NCT00931918|10974690|FG000|Overall Study|Withdrawal by Patient|3
6939406|NCT00931918|10974691|FG001|Overall Study|Withdrawal by Patient|4
6939407|NCT00931918|10974690|FG000|Overall Study|Other Reason not Specified|4
6939408|NCT00931918|10974691|FG001|Overall Study|Other Reason not Specified|4
6939409|NCT00931918|10974690|FG000|Overall Study|Did not receive study drug|3
6939410|NCT00931918|10974691|FG001|Overall Study|Did not receive study drug|2
6939411|NCT00931944|10974697|FG000|Overall Study|Adverse Event|4
6939412|NCT00931944|10974697|FG000|Overall Study|W/D Consent (due to ALS progression))|19
6939413|NCT00931944|10974697|FG000|Overall Study|Withdrawal Consent (due to other)|2
6939414|NCT00931944|10974697|FG000|Overall Study|Death|28
6939415|NCT00931944|10974697|FG000|Overall Study|Other|2
6939416|NCT00932113|10974725|FG000|Overall Study|Lost to Follow-up|1
6838214|NCT00256867|10843851|FG003|Overall Study|Investigator's Decision|0
6838215|NCT00256867|10843852|FG004|Overall Study|Investigator's Decision|1
6838216|NCT00256867|10843853|FG005|Overall Study|Investigator's Decision|0
6838217|NCT00256867|10843854|FG006|Overall Study|Investigator's Decision|0
6838218|NCT00256867|10843855|FG007|Overall Study|Investigator's Decision|0
6838219|NCT00256867|10843848|FG000|Overall Study|Non-compliance with study medication|0
6838220|NCT00256867|10843849|FG001|Overall Study|Non-compliance with study medication|0
6838221|NCT00256867|10843850|FG002|Overall Study|Non-compliance with study medication|0
6838222|NCT00256867|10843851|FG003|Overall Study|Non-compliance with study medication|0
6838223|NCT00256867|10843852|FG004|Overall Study|Non-compliance with study medication|0
6939417|NCT00932113|10974726|FG001|Overall Study|Lost to Follow-up|0
6939418|NCT00932126|10974732|FG000|Overall Study|Adverse Event|0
6939419|NCT00932126|10974733|FG001|Overall Study|Adverse Event|0
6939420|NCT00932126|10974734|FG002|Overall Study|Adverse Event|0
6939421|NCT00932126|10974735|FG003|Overall Study|Adverse Event|0
6939422|NCT00932126|10974736|FG004|Overall Study|Adverse Event|0
6939423|NCT00932126|10974737|FG005|Overall Study|Adverse Event|0
6939424|NCT00932126|10974738|FG006|Overall Study|Adverse Event|1
6939425|NCT00932126|10974739|FG007|Overall Study|Adverse Event|2
6939426|NCT00932126|10974732|FG000|Overall Study|Protocol Violation|0
6838224|NCT00256867|10843853|FG005|Overall Study|Non-compliance with study medication|0
6939427|NCT00932126|10974733|FG001|Overall Study|Protocol Violation|0
6939428|NCT00932126|10974734|FG002|Overall Study|Protocol Violation|0
6939429|NCT00932126|10974735|FG003|Overall Study|Protocol Violation|0
6939430|NCT00932126|10974736|FG004|Overall Study|Protocol Violation|1
6939431|NCT00932126|10974737|FG005|Overall Study|Protocol Violation|0
6939432|NCT00932126|10974738|FG006|Overall Study|Protocol Violation|0
6939433|NCT00932126|10974739|FG007|Overall Study|Protocol Violation|0
6939434|NCT00932126|10974732|FG000|Overall Study|Withdrawal by Subject|0
6939435|NCT00932126|10974733|FG001|Overall Study|Withdrawal by Subject|0
6939436|NCT00932126|10974734|FG002|Overall Study|Withdrawal by Subject|1
7067083|NCT01983254|11167937|FG001|Overall Study|too ill|8
7067084|NCT01983293|11167945|FG000|Overall Study|Withdrawal by Subject|29
7067085|NCT01983293|11167946|FG001|Overall Study|Withdrawal by Subject|15
7067086|NCT01983293|11167945|FG000|Overall Study|Missing 12-month visit|3
7067087|NCT01983293|11167946|FG001|Overall Study|Missing 12-month visit|3
7067088|NCT01983293|11167945|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1
7067089|NCT01983293|11167946|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1
6838225|NCT00256867|10843854|FG006|Overall Study|Non-compliance with study medication|0
7067090|NCT01983683|11167972|FG000|Overall Study|Withdrawal by Subject|14
7067091|NCT01983683|11167973|FG001|Overall Study|Withdrawal by Subject|18
7067092|NCT01983683|11167972|FG000|Overall Study|Death|11
7067093|NCT01983683|11167973|FG001|Overall Study|Death|15
7067094|NCT01983683|11167972|FG000|Overall Study|Physician Decision|8
7067095|NCT01983683|11167973|FG001|Overall Study|Physician Decision|9
6838226|NCT00256867|10843855|FG007|Overall Study|Non-compliance with study medication|1
6939437|NCT00932126|10974735|FG003|Overall Study|Withdrawal by Subject|0
6939438|NCT00932126|10974736|FG004|Overall Study|Withdrawal by Subject|0
6939439|NCT00932126|10974737|FG005|Overall Study|Withdrawal by Subject|0
6939440|NCT00932126|10974738|FG006|Overall Study|Withdrawal by Subject|0
6939441|NCT00932126|10974739|FG007|Overall Study|Withdrawal by Subject|1
6939442|NCT00932126|10974732|FG000|Overall Study|Objective progression or relapse|3
6939443|NCT00932126|10974733|FG001|Overall Study|Objective progression or relapse|3
6939444|NCT00932126|10974734|FG002|Overall Study|Objective progression or relapse|2
6939445|NCT00932126|10974735|FG003|Overall Study|Objective progression or relapse|3
6939446|NCT00932126|10974736|FG004|Overall Study|Objective progression or relapse|3
6939447|NCT00932126|10974737|FG005|Overall Study|Objective progression or relapse|3
6939448|NCT00932126|10974738|FG006|Overall Study|Objective progression or relapse|3
6939449|NCT00932126|10974739|FG007|Overall Study|Objective progression or relapse|5
6939450|NCT00932126|10974732|FG000|Overall Study|Other|0
6939451|NCT00932126|10974733|FG001|Overall Study|Other|0
6939452|NCT00932126|10974734|FG002|Overall Study|Other|0
6939453|NCT00932126|10974735|FG003|Overall Study|Other|0
6939454|NCT00932126|10974736|FG004|Overall Study|Other|1
6939455|NCT00932126|10974737|FG005|Overall Study|Other|0
7040209|NCT01716520|11123214|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
7040210|NCT01716520|11123209|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
7040211|NCT01716520|11123210|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
7040212|NCT01716520|11123211|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
7040213|NCT01716520|11123212|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
6838227|NCT00256867|10843848|FG000|Overall Study|Participant travelled Overseas|0
6838228|NCT00256867|10843849|FG001|Overall Study|Participant travelled Overseas|1
6838229|NCT00256867|10843850|FG002|Overall Study|Participant travelled Overseas|0
6838230|NCT00256867|10843851|FG003|Overall Study|Participant travelled Overseas|0
6838231|NCT00256867|10843852|FG004|Overall Study|Participant travelled Overseas|0
6838232|NCT00256867|10843853|FG005|Overall Study|Participant travelled Overseas|0
6838233|NCT00256867|10843854|FG006|Overall Study|Participant travelled Overseas|0
6838234|NCT00256867|10843855|FG007|Overall Study|Participant travelled Overseas|0
6838235|NCT00256867|10843848|FG000|Overall Study|Participant out of assessment window|0
6838236|NCT00256867|10843849|FG001|Overall Study|Participant out of assessment window|0
6838237|NCT00256867|10843850|FG002|Overall Study|Participant out of assessment window|1
6838238|NCT00256867|10843851|FG003|Overall Study|Participant out of assessment window|0
6838239|NCT00256867|10843852|FG004|Overall Study|Participant out of assessment window|0
6838240|NCT00256867|10843853|FG005|Overall Study|Participant out of assessment window|0
6838241|NCT00256867|10843854|FG006|Overall Study|Participant out of assessment window|0
6838242|NCT00256867|10843855|FG007|Overall Study|Participant out of assessment window|0
6838243|NCT00256867|10843848|FG000|Overall Study|Withdrawal by participant|0
6838244|NCT00256867|10843849|FG001|Overall Study|Withdrawal by participant|0
6838245|NCT00256867|10843850|FG002|Overall Study|Withdrawal by participant|0
6838246|NCT00256867|10843851|FG003|Overall Study|Withdrawal by participant|0
6838247|NCT00256867|10843852|FG004|Overall Study|Withdrawal by participant|0
6838248|NCT00256867|10843853|FG005|Overall Study|Withdrawal by participant|1
6838249|NCT00256867|10843854|FG006|Overall Study|Withdrawal by participant|0
6838250|NCT00256867|10843855|FG007|Overall Study|Withdrawal by participant|0
6838251|NCT00256997|10843884|FG000|Overall Study|Protocol Violation|1
7067096|NCT01983683|11167972|FG000|Overall Study|Lost to Follow-up|4
7067097|NCT01983683|11167973|FG001|Overall Study|Lost to Follow-up|8
7067098|NCT01983683|11167972|FG000|Overall Study|Sponsor Decision|1
7067099|NCT01983683|11167973|FG001|Overall Study|Sponsor Decision|1
7067100|NCT01983930|11168026|FG000|Overall Study|Withdrawal by Subject|9
7067101|NCT01983930|11168027|FG001|Overall Study|Withdrawal by Subject|8
7067102|NCT01983930|11168026|FG000|Overall Study|Adverse Event|0
6939456|NCT00932126|10974738|FG006|Overall Study|Other|1
6939457|NCT00932126|10974739|FG007|Overall Study|Other|2
6939458|NCT00932165|10974759|FG000|Overall Study|Lost to Follow-up|1
6939459|NCT00932360|10974782|FG000|Washout (One Week)|Withdrawal by Subject|0
6939460|NCT00932360|10974783|FG001|Washout (One Week)|Withdrawal by Subject|0
6939461|NCT00932360|10974784|FG002|Washout (One Week)|Withdrawal by Subject|0
6939462|NCT00932360|10974785|FG003|Washout (One Week)|Withdrawal by Subject|0
6939463|NCT00932360|10974786|FG004|Washout (One Week)|Withdrawal by Subject|2
6939464|NCT00932360|10974787|FG005|Washout (One Week)|Withdrawal by Subject|0
6939465|NCT00932373|10974812|FG000|Overall Study|Progressive disease|3
6939466|NCT00932373|10974813|FG001|Overall Study|Progressive disease|1
6939467|NCT00932373|10974814|FG002|Overall Study|Progressive disease|0
6939468|NCT00932373|10974815|FG003|Overall Study|Progressive disease|0
6939469|NCT00932373|10974816|FG004|Overall Study|Progressive disease|10
6939470|NCT00932373|10974817|FG005|Overall Study|Progressive disease|1
6939471|NCT00932373|10974818|FG006|Overall Study|Progressive disease|0
6939472|NCT00932373|10974819|FG007|Overall Study|Progressive disease|2
6939473|NCT00932373|10974820|FG008|Overall Study|Progressive disease|1
6939474|NCT00932373|10974821|FG009|Overall Study|Progressive disease|9
6939475|NCT00932373|10974822|FG010|Overall Study|Progressive disease|2
6939476|NCT00932373|10974812|FG000|Overall Study|Adverse Event|0
6939477|NCT00932373|10974813|FG001|Overall Study|Adverse Event|0
6939478|NCT00932373|10974814|FG002|Overall Study|Adverse Event|0
6939479|NCT00932373|10974815|FG003|Overall Study|Adverse Event|0
6939480|NCT00932373|10974816|FG004|Overall Study|Adverse Event|2
6939481|NCT00932373|10974817|FG005|Overall Study|Adverse Event|1
6939482|NCT00932373|10974818|FG006|Overall Study|Adverse Event|0
6939483|NCT00932373|10974819|FG007|Overall Study|Adverse Event|1
6939484|NCT00932373|10974820|FG008|Overall Study|Adverse Event|0
6939485|NCT00932373|10974821|FG009|Overall Study|Adverse Event|2
6939486|NCT00932373|10974822|FG010|Overall Study|Adverse Event|1
6939487|NCT00932373|10974812|FG000|Overall Study|Physician Decision|0
6939488|NCT00932373|10974813|FG001|Overall Study|Physician Decision|0
6939489|NCT00932373|10974814|FG002|Overall Study|Physician Decision|1
6939490|NCT00932373|10974815|FG003|Overall Study|Physician Decision|0
6939491|NCT00932373|10974816|FG004|Overall Study|Physician Decision|2
6939492|NCT00932373|10974817|FG005|Overall Study|Physician Decision|0
6939493|NCT00932373|10974818|FG006|Overall Study|Physician Decision|0
6939494|NCT00932373|10974819|FG007|Overall Study|Physician Decision|0
6939495|NCT00932373|10974820|FG008|Overall Study|Physician Decision|0
6939496|NCT00932373|10974821|FG009|Overall Study|Physician Decision|1
6939497|NCT00932373|10974822|FG010|Overall Study|Physician Decision|0
7067103|NCT01983930|11168027|FG001|Overall Study|Adverse Event|1
7067104|NCT01983969|11168037|FG000|Overall Study|Disease Progression|0
7067105|NCT01983969|11168038|FG001|Overall Study|Disease Progression|1
7067106|NCT01983969|11168039|FG002|Overall Study|Disease Progression|0
7067107|NCT01984164|11168053|FG000|Overall Study|Withdrawal by Subject|4
7067108|NCT01984164|11168054|FG001|Overall Study|Withdrawal by Subject|3
7067109|NCT01984164|11168053|FG000|Overall Study|Adverse Event|5
7067110|NCT01984164|11168054|FG001|Overall Study|Adverse Event|19
7067111|NCT01984164|11168053|FG000|Overall Study|Lost to Follow-up|1
7067112|NCT01984164|11168054|FG001|Overall Study|Lost to Follow-up|3
7067113|NCT01984229|11168062|FG000|Safety Follow-up Period|Adverse Event|1
7067114|NCT01984229|11168063|FG001|Safety Follow-up Period|Adverse Event|1
7067115|NCT01984229|11168062|FG000|Safety Follow-up Period|Lost to Follow-up|1
7067116|NCT01984229|11168063|FG001|Safety Follow-up Period|Lost to Follow-up|0
7067117|NCT01984242|11168078|FG000|Overall Study|Death|52
7067118|NCT01984242|11168079|FG001|Overall Study|Death|50
7067119|NCT01984242|11168080|FG002|Overall Study|Death|52
7067120|NCT01984242|11168078|FG000|Overall Study|Withdrawal by Subject|5
7067121|NCT01984242|11168079|FG001|Overall Study|Withdrawal by Subject|3
6939498|NCT00932373|10974812|FG000|Overall Study|Dose limiting toxicity|0
6939499|NCT00932373|10974813|FG001|Overall Study|Dose limiting toxicity|0
6939500|NCT00932373|10974814|FG002|Overall Study|Dose limiting toxicity|0
6939501|NCT00932373|10974815|FG003|Overall Study|Dose limiting toxicity|0
6939502|NCT00932373|10974816|FG004|Overall Study|Dose limiting toxicity|0
6939503|NCT00932373|10974817|FG005|Overall Study|Dose limiting toxicity|1
7040214|NCT01716520|11123213|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
7040215|NCT01716520|11123214|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
7040216|NCT01716520|11123209|FG000|Treatment Period 2 (14 Days)|Adverse Event|0
7040217|NCT01716520|11123210|FG001|Treatment Period 2 (14 Days)|Adverse Event|0
7040218|NCT01716520|11123211|FG002|Treatment Period 2 (14 Days)|Adverse Event|0
7040219|NCT01716520|11123212|FG003|Treatment Period 2 (14 Days)|Adverse Event|0
7067122|NCT01984242|11168080|FG002|Overall Study|Withdrawal by Subject|10
7067123|NCT01984242|11168078|FG000|Overall Study|Physician Decision|0
7067124|NCT01984242|11168079|FG001|Overall Study|Physician Decision|0
6939504|NCT00932373|10974818|FG006|Overall Study|Dose limiting toxicity|0
6939505|NCT00932373|10974819|FG007|Overall Study|Dose limiting toxicity|0
6939506|NCT00932373|10974820|FG008|Overall Study|Dose limiting toxicity|0
6939507|NCT00932373|10974821|FG009|Overall Study|Dose limiting toxicity|0
6939508|NCT00932373|10974822|FG010|Overall Study|Dose limiting toxicity|0
6939509|NCT00932373|10974812|FG000|Overall Study|Withdrawal by Subject|0
6939510|NCT00932373|10974813|FG001|Overall Study|Withdrawal by Subject|0
6939511|NCT00932373|10974814|FG002|Overall Study|Withdrawal by Subject|0
7067125|NCT01984242|11168080|FG002|Overall Study|Physician Decision|1
6939512|NCT00932373|10974815|FG003|Overall Study|Withdrawal by Subject|0
6939513|NCT00932373|10974816|FG004|Overall Study|Withdrawal by Subject|0
6939514|NCT00932373|10974817|FG005|Overall Study|Withdrawal by Subject|0
6939515|NCT00932373|10974818|FG006|Overall Study|Withdrawal by Subject|0
6939516|NCT00932373|10974819|FG007|Overall Study|Withdrawal by Subject|0
6939517|NCT00932373|10974820|FG008|Overall Study|Withdrawal by Subject|1
6939518|NCT00932373|10974821|FG009|Overall Study|Withdrawal by Subject|0
6939519|NCT00932373|10974822|FG010|Overall Study|Withdrawal by Subject|0
6939520|NCT00932373|10974812|FG000|Overall Study|Clinical progression|0
6939521|NCT00932373|10974813|FG001|Overall Study|Clinical progression|0
6939522|NCT00932373|10974814|FG002|Overall Study|Clinical progression|0
6939523|NCT00932373|10974815|FG003|Overall Study|Clinical progression|0
6939524|NCT00932373|10974816|FG004|Overall Study|Clinical progression|0
6939525|NCT00932373|10974817|FG005|Overall Study|Clinical progression|0
6939526|NCT00932373|10974818|FG006|Overall Study|Clinical progression|1
6939527|NCT00932373|10974819|FG007|Overall Study|Clinical progression|0
6939528|NCT00932373|10974820|FG008|Overall Study|Clinical progression|0
6939529|NCT00932373|10974821|FG009|Overall Study|Clinical progression|0
6939530|NCT00932373|10974822|FG010|Overall Study|Clinical progression|0
6939531|NCT00932373|10974812|FG000|Overall Study|Lack of Efficacy|0
6939532|NCT00932373|10974813|FG001|Overall Study|Lack of Efficacy|0
6939533|NCT00932373|10974814|FG002|Overall Study|Lack of Efficacy|0
6939534|NCT00932373|10974815|FG003|Overall Study|Lack of Efficacy|0
6939535|NCT00932373|10974816|FG004|Overall Study|Lack of Efficacy|0
6939536|NCT00932373|10974817|FG005|Overall Study|Lack of Efficacy|0
6939537|NCT00932373|10974818|FG006|Overall Study|Lack of Efficacy|0
6939538|NCT00932373|10974819|FG007|Overall Study|Lack of Efficacy|0
6939539|NCT00932373|10974820|FG008|Overall Study|Lack of Efficacy|0
6939540|NCT00932373|10974821|FG009|Overall Study|Lack of Efficacy|1
6939541|NCT00932373|10974822|FG010|Overall Study|Lack of Efficacy|0
6939542|NCT00932425|10974865|FG000|Overall Study|Lost to Follow-up|0
6939543|NCT00932425|10974866|FG001|Overall Study|Lost to Follow-up|1
6939544|NCT00932425|10974865|FG000|Overall Study|Withdrawal by Subject|0
6939545|NCT00932425|10974866|FG001|Overall Study|Withdrawal by Subject|1
6939546|NCT00932451|10974883|FG000|Overall Study|Withdrawal by Subject|69
6939547|NCT00932451|10974883|FG000|Overall Study|Lost to Follow-up|22
6939548|NCT00932451|10974883|FG000|Overall Study|Death|726
6939549|NCT00932451|10974883|FG000|Overall Study|Other reasons|5
6939550|NCT00932646|10974915|FG000|Overall Study|Adverse Event|2
6939551|NCT00932646|10974916|FG001|Overall Study|Adverse Event|1
6939552|NCT00932646|10974917|FG002|Overall Study|Adverse Event|1
6939553|NCT00932646|10974918|FG003|Overall Study|Adverse Event|1
6939554|NCT00932646|10974915|FG000|Overall Study|Lost to Follow-up|2
6939555|NCT00932646|10974916|FG001|Overall Study|Lost to Follow-up|1
6939556|NCT00932646|10974917|FG002|Overall Study|Lost to Follow-up|0
6939557|NCT00932646|10974918|FG003|Overall Study|Lost to Follow-up|0
6939558|NCT00932646|10974915|FG000|Overall Study|Withdrawal by Subject|1
6939559|NCT00932646|10974916|FG001|Overall Study|Withdrawal by Subject|1
6939560|NCT00932646|10974917|FG002|Overall Study|Withdrawal by Subject|3
6939561|NCT00932646|10974918|FG003|Overall Study|Withdrawal by Subject|0
6939562|NCT00932698|10974947|FG000|Part 1 (Dose Escalation)|Progressive Disease|3
6939563|NCT00932698|10974948|FG001|Part 1 (Dose Escalation)|Progressive Disease|2
6939564|NCT00932698|10974949|FG002|Part 1 (Dose Escalation)|Progressive Disease|2
6939565|NCT00932698|10974950|FG003|Part 1 (Dose Escalation)|Progressive Disease|2
6939566|NCT00932698|10974951|FG004|Part 1 (Dose Escalation)|Progressive Disease|3
6939567|NCT00932698|10974952|FG005|Part 1 (Dose Escalation)|Progressive Disease|5
6939568|NCT00932698|10974953|FG006|Part 1 (Dose Escalation)|Progressive Disease|2
6939569|NCT00932698|10974954|FG007|Part 1 (Dose Escalation)|Progressive Disease|0
6939570|NCT00932698|10974955|FG008|Part 1 (Dose Escalation)|Progressive Disease|0
6939571|NCT00932698|10974956|FG009|Part 1 (Dose Escalation)|Progressive Disease|0
6939572|NCT00932698|10974957|FG010|Part 1 (Dose Escalation)|Progressive Disease|0
6939573|NCT00932698|10974947|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0
6939574|NCT00932698|10974948|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1
6939575|NCT00932698|10974949|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0
6939576|NCT00932698|10974950|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1
6939577|NCT00932698|10974951|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0
6939578|NCT00932698|10974952|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1
6939579|NCT00932698|10974953|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1
6939580|NCT00932698|10974954|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0
6939581|NCT00932698|10974955|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0
6939582|NCT00932698|10974956|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0
6939583|NCT00932698|10974957|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0
6939584|NCT00932698|10974947|FG000|Part 1 (Dose Escalation)|Adverse Event|0
6939585|NCT00932698|10974948|FG001|Part 1 (Dose Escalation)|Adverse Event|0
6939586|NCT00932698|10974949|FG002|Part 1 (Dose Escalation)|Adverse Event|0
6939587|NCT00932698|10974950|FG003|Part 1 (Dose Escalation)|Adverse Event|0
6939588|NCT00932698|10974951|FG004|Part 1 (Dose Escalation)|Adverse Event|0
6939589|NCT00932698|10974952|FG005|Part 1 (Dose Escalation)|Adverse Event|1
6939590|NCT00932698|10974953|FG006|Part 1 (Dose Escalation)|Adverse Event|0
6939591|NCT00932698|10974954|FG007|Part 1 (Dose Escalation)|Adverse Event|0
6939592|NCT00932698|10974955|FG008|Part 1 (Dose Escalation)|Adverse Event|0
6939593|NCT00932698|10974956|FG009|Part 1 (Dose Escalation)|Adverse Event|0
6939594|NCT00932698|10974957|FG010|Part 1 (Dose Escalation)|Adverse Event|0
6939595|NCT00932698|10974947|FG000|Part 1 (Dose Escalation)|Other|0
6939596|NCT00932698|10974948|FG001|Part 1 (Dose Escalation)|Other|0
6939597|NCT00932698|10974949|FG002|Part 1 (Dose Escalation)|Other|1
6939598|NCT00932698|10974950|FG003|Part 1 (Dose Escalation)|Other|0
6939599|NCT00932698|10974951|FG004|Part 1 (Dose Escalation)|Other|0
6939600|NCT00932698|10974952|FG005|Part 1 (Dose Escalation)|Other|0
6939601|NCT00932698|10974953|FG006|Part 1 (Dose Escalation)|Other|1
6939602|NCT00932698|10974954|FG007|Part 1 (Dose Escalation)|Other|0
6939603|NCT00932698|10974955|FG008|Part 1 (Dose Escalation)|Other|0
6939604|NCT00932698|10974956|FG009|Part 1 (Dose Escalation)|Other|0
6939605|NCT00932698|10974957|FG010|Part 1 (Dose Escalation)|Other|0
6939606|NCT00932698|10974947|FG000|Part 2 (Dose Expansion)|Progressive Disease|0
6939607|NCT00932698|10974948|FG001|Part 2 (Dose Expansion)|Progressive Disease|0
6939608|NCT00932698|10974949|FG002|Part 2 (Dose Expansion)|Progressive Disease|0
6939609|NCT00932698|10974950|FG003|Part 2 (Dose Expansion)|Progressive Disease|0
6939610|NCT00932698|10974951|FG004|Part 2 (Dose Expansion)|Progressive Disease|0
6939611|NCT00932698|10974952|FG005|Part 2 (Dose Expansion)|Progressive Disease|0
6939612|NCT00932698|10974953|FG006|Part 2 (Dose Expansion)|Progressive Disease|0
6939613|NCT00932698|10974954|FG007|Part 2 (Dose Expansion)|Progressive Disease|14
6939614|NCT00932698|10974955|FG008|Part 2 (Dose Expansion)|Progressive Disease|8
6939615|NCT00932698|10974956|FG009|Part 2 (Dose Expansion)|Progressive Disease|3
6939616|NCT00932698|10974957|FG010|Part 2 (Dose Expansion)|Progressive Disease|2
6939617|NCT00932698|10974947|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0
6939618|NCT00932698|10974948|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0
6939619|NCT00932698|10974949|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0
6939620|NCT00932698|10974950|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0
6939621|NCT00932698|10974951|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0
6939622|NCT00932698|10974952|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0
6939623|NCT00932698|10974953|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0
6939624|NCT00932698|10974954|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1
6939625|NCT00932698|10974955|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3
6939626|NCT00932698|10974956|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2
6939627|NCT00932698|10974957|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0
6939628|NCT00932698|10974947|FG000|Part 2 (Dose Expansion)|Adverse Event|0
6939629|NCT00932698|10974948|FG001|Part 2 (Dose Expansion)|Adverse Event|0
6939630|NCT00932698|10974949|FG002|Part 2 (Dose Expansion)|Adverse Event|0
6939631|NCT00932698|10974950|FG003|Part 2 (Dose Expansion)|Adverse Event|0
6939632|NCT00932698|10974951|FG004|Part 2 (Dose Expansion)|Adverse Event|0
6939633|NCT00932698|10974952|FG005|Part 2 (Dose Expansion)|Adverse Event|0
6939634|NCT00932698|10974953|FG006|Part 2 (Dose Expansion)|Adverse Event|0
6939635|NCT00932698|10974954|FG007|Part 2 (Dose Expansion)|Adverse Event|5
6939636|NCT00932698|10974955|FG008|Part 2 (Dose Expansion)|Adverse Event|1
6939637|NCT00932698|10974956|FG009|Part 2 (Dose Expansion)|Adverse Event|1
6939638|NCT00932698|10974957|FG010|Part 2 (Dose Expansion)|Adverse Event|0
6939639|NCT00932893|10974989|FG000|Overall Study|Death|115
6939640|NCT00932893|10974990|FG001|Overall Study|Death|24
6939641|NCT00932893|10974989|FG000|Overall Study|Lost to Follow-up|8
6939642|NCT00932893|10974990|FG001|Overall Study|Lost to Follow-up|0
6939643|NCT00932893|10974989|FG000|Overall Study|Withdrawal by Subject|5
6939644|NCT00932893|10974990|FG001|Overall Study|Withdrawal by Subject|2
6939645|NCT00932893|10974989|FG000|Overall Study|Other|5
6939646|NCT00932893|10974990|FG001|Overall Study|Other|144
6939647|NCT00933166|10974997|FG000|Overall Study|Lost to Follow-up|4
6939648|NCT00933166|10974997|FG000|Overall Study|Lack of Efficacy|9
6939649|NCT00933166|10974997|FG000|Overall Study|Unavailable|4
6939650|NCT00933166|10974997|FG000|Overall Study|Withdrawal by Subject|1
6939651|NCT00933244|10975004|FG000|Overall Study|Withdrawal by Subject|5
6939652|NCT00933244|10975005|FG001|Overall Study|Withdrawal by Subject|1
6939653|NCT00933244|10975006|FG002|Overall Study|Withdrawal by Subject|3
6939654|NCT00933270|10975014|FG000|Overall Study|Withdrawal by Subject|26
6939655|NCT00933270|10975014|FG000|Overall Study|Insufficient Follow-up|10
6939656|NCT00933270|10975014|FG000|Overall Study|Lost to Follow-up|14
6939657|NCT00933270|10975014|FG000|Overall Study|Adverse Event|1
6939658|NCT00933270|10975014|FG000|Overall Study|Missed Visit|2
6939659|NCT00933270|10975014|FG000|Overall Study|Death|24
6939660|NCT00933270|10975014|FG000|Overall Study|Moved or would not return|10
6939661|NCT00933335|10975021|FG000|Overall Study|Lost to Follow-up|1
6939662|NCT00933335|10975022|FG001|Overall Study|Lost to Follow-up|3
6939663|NCT00933335|10975021|FG000|Overall Study|Withdrawal by Subject|0
6939664|NCT00933335|10975022|FG001|Overall Study|Withdrawal by Subject|1
6939665|NCT00933335|10975021|FG000|Overall Study|Progressive Disease|0
6939666|NCT00933335|10975022|FG001|Overall Study|Progressive Disease|11
6939667|NCT00933335|10975021|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0
6939668|NCT00933335|10975022|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1
6939669|NCT00933335|10975021|FG000|Overall Study|Co-morbid Illness|1
6939670|NCT00933335|10975022|FG001|Overall Study|Co-morbid Illness|0
6939671|NCT00933543|10975045|FG000|Overall Study|Adverse Event|2
6939672|NCT00933543|10975046|FG001|Overall Study|Adverse Event|1
6939673|NCT00933543|10975045|FG000|Overall Study|Lost to Follow-up|0
6939674|NCT00933543|10975046|FG001|Overall Study|Lost to Follow-up|1
6939675|NCT00933543|10975045|FG000|Overall Study|Withdrawal by Subject|0
6939676|NCT00933543|10975046|FG001|Overall Study|Withdrawal by Subject|1
6939677|NCT00933543|10975045|FG000|Overall Study|Lack of Efficacy|0
6939678|NCT00933543|10975046|FG001|Overall Study|Lack of Efficacy|3
6939679|NCT00933543|10975045|FG000|Overall Study|Other|1
6939680|NCT00933543|10975046|FG001|Overall Study|Other|1
6939681|NCT00933608|10975054|FG000|Overall Study|Adverse Event|4
6939682|NCT00933608|10975055|FG001|Overall Study|Adverse Event|2
6939683|NCT00933608|10975054|FG000|Overall Study|Physician Decision|1
6939684|NCT00933608|10975055|FG001|Overall Study|Physician Decision|0
6939685|NCT00933686|10975063|FG000|Overall Study|Protocol Violation|0
6939686|NCT00933686|10975064|FG001|Overall Study|Protocol Violation|1
6939687|NCT00933686|10975063|FG000|Overall Study|Lost to Follow-up|2
6939688|NCT00933686|10975064|FG001|Overall Study|Lost to Follow-up|2
6939689|NCT00933686|10975063|FG000|Overall Study|Withdrawal by Subject|6
6939690|NCT00933686|10975064|FG001|Overall Study|Withdrawal by Subject|5
6939691|NCT00933686|10975063|FG000|Overall Study|Adverse Event|1
6939692|NCT00933686|10975064|FG001|Overall Study|Adverse Event|1
6939693|NCT00933686|10975063|FG000|Overall Study|Physician Decision|1
6939694|NCT00933686|10975064|FG001|Overall Study|Physician Decision|0
6939695|NCT00933686|10975063|FG000|Overall Study|Failure to show up at endpoint visits|0
6939696|NCT00933686|10975064|FG001|Overall Study|Failure to show up at endpoint visits|2
6939697|NCT00933933|10975075|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
6939698|NCT00933933|10975076|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20
6939699|NCT00933933|10975077|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
6939700|NCT00933933|10975075|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
6939701|NCT00933933|10975076|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2
6939702|NCT00933933|10975077|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
6939703|NCT00934050|10975107|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1
6939704|NCT00934050|10975108|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0
6939705|NCT00934050|10975109|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0
6939706|NCT00934050|10975110|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1
6939707|NCT00934050|10975111|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0
6939708|NCT00934050|10975112|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0
6939709|NCT00934050|10975107|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
6939710|NCT00934050|10975108|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12
6939711|NCT00934050|10975109|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
6939712|NCT00934050|10975110|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13
6939713|NCT00934050|10975111|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
6939714|NCT00934050|10975112|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
6939715|NCT00934050|10975107|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
6939716|NCT00934050|10975108|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
6939717|NCT00934050|10975109|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1
6939718|NCT00934050|10975110|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
6939719|NCT00934050|10975111|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
6939720|NCT00934050|10975112|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
6939721|NCT00934050|10975107|FG000|Enrolled After 15 Dec 2009|Adverse Event|0
7067126|NCT01984242|11168078|FG000|Overall Study|Lost to Follow-up|4
7067127|NCT01984242|11168079|FG001|Overall Study|Lost to Follow-up|0
7067128|NCT01984242|11168080|FG002|Overall Study|Lost to Follow-up|3
7067129|NCT01984242|11168078|FG000|Overall Study|Sponsor Decision|1
6939722|NCT00934050|10975108|FG001|Enrolled After 15 Dec 2009|Adverse Event|0
6939723|NCT00934050|10975109|FG002|Enrolled After 15 Dec 2009|Adverse Event|0
6939724|NCT00934050|10975110|FG003|Enrolled After 15 Dec 2009|Adverse Event|0
6939725|NCT00934050|10975111|FG004|Enrolled After 15 Dec 2009|Adverse Event|3
6939726|NCT00934050|10975112|FG005|Enrolled After 15 Dec 2009|Adverse Event|0
6939727|NCT00934050|10975107|FG000|Enrolled After 15 Dec 2009|Death|0
6939728|NCT00934050|10975108|FG001|Enrolled After 15 Dec 2009|Death|0
6939729|NCT00934050|10975109|FG002|Enrolled After 15 Dec 2009|Death|0
6939730|NCT00934050|10975110|FG003|Enrolled After 15 Dec 2009|Death|0
6939731|NCT00934050|10975111|FG004|Enrolled After 15 Dec 2009|Death|0
6939732|NCT00934050|10975112|FG005|Enrolled After 15 Dec 2009|Death|1
6939733|NCT00934050|10975107|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0
6939734|NCT00934050|10975108|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0
6939735|NCT00934050|10975109|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0
6939736|NCT00934050|10975110|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0
6939737|NCT00934050|10975111|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0
6939738|NCT00934050|10975112|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1
6939739|NCT00934050|10975107|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
6939740|NCT00934050|10975108|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
6939741|NCT00934050|10975109|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
6939742|NCT00934050|10975110|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
6939743|NCT00934050|10975111|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4
6939744|NCT00934050|10975112|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2
6939745|NCT00934089|10975124|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1
6939746|NCT00934089|10975125|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0
7067130|NCT01984242|11168079|FG001|Overall Study|Sponsor Decision|0
6939747|NCT00934089|10975124|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1
6939748|NCT00934089|10975125|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0
6939749|NCT00934102|10975131|FG000|Period 1, One Night of Wear|Personal Reasons|1
6939750|NCT00934102|10975132|FG001|Period 1, One Night of Wear|Personal Reasons|0
6939751|NCT00934102|10975133|FG002|Period 1, One Night of Wear|Personal Reasons|0
6939752|NCT00934128|10975143|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0
6939753|NCT00934128|10975144|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1
6939754|NCT00934128|10975143|FG000|First Intervention (2 Hours)|Adverse Event|4
6939755|NCT00934128|10975144|FG001|First Intervention (2 Hours)|Adverse Event|1
6939756|NCT00934128|10975143|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1
6838252|NCT00256997|10843885|FG001|Overall Study|Protocol Violation|4
6838253|NCT00256997|10843884|FG000|Overall Study|Lack of Efficacy|1
6838254|NCT00256997|10843885|FG001|Overall Study|Lack of Efficacy|4
6838255|NCT00256997|10843884|FG000|Overall Study|Death|2
6838256|NCT00256997|10843885|FG001|Overall Study|Death|0
6838257|NCT00256997|10843884|FG000|Overall Study|Adverse Event|4
6838258|NCT00256997|10843885|FG001|Overall Study|Adverse Event|0
6939757|NCT00934128|10975144|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0
6939758|NCT00934128|10975143|FG000|Washout Period (1 Hour)|Patient preference|1
6939759|NCT00934128|10975144|FG001|Washout Period (1 Hour)|Patient preference|3
6939760|NCT00934128|10975143|FG000|Washout Period (1 Hour)|Pain|1
6939761|NCT00934128|10975144|FG001|Washout Period (1 Hour)|Pain|0
6939762|NCT00934128|10975143|FG000|Washout Period (1 Hour)|Too tired|1
6939763|NCT00934128|10975144|FG001|Washout Period (1 Hour)|Too tired|0
6939764|NCT00934128|10975143|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4
6939765|NCT00934128|10975144|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2
7067131|NCT01984242|11168080|FG002|Overall Study|Sponsor Decision|0
7067132|NCT01984242|11168078|FG000|Overall Study|Non-Compliance|1
6939766|NCT00934128|10975143|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0
6939767|NCT00934128|10975144|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3
6939768|NCT00934362|10975171|FG000|Overall Study|Adverse Event|1
6939769|NCT00934362|10975172|FG001|Overall Study|Adverse Event|0
6939770|NCT00934440|10975187|FG000|Overall Study|Lost to Follow-up|1
6939771|NCT00934544|10975194|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12
6939772|NCT00934544|10975195|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4
6939773|NCT00934544|10975196|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0
6939774|NCT00934544|10975194|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2
6939775|NCT00934544|10975195|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9
6939776|NCT00934544|10975196|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0
6939777|NCT00934544|10975194|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2
6939778|NCT00934544|10975195|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0
6939779|NCT00934544|10975196|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0
6939780|NCT00934544|10975194|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1
6939781|NCT00934544|10975195|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3
6939782|NCT00934544|10975196|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0
6939783|NCT00934544|10975194|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2
6939784|NCT00934544|10975195|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0
6939785|NCT00934544|10975196|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0
6939786|NCT00934544|10975194|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0
6939787|NCT00934544|10975195|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1
6939788|NCT00934544|10975196|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0
6939789|NCT00934544|10975194|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7
6939790|NCT00934544|10975195|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7
6939791|NCT00934544|10975196|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0
6939792|NCT00934544|10975194|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29
6939793|NCT00934544|10975195|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18
6939794|NCT00934544|10975196|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0
6939795|NCT00934544|10975194|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16
6939796|NCT00934544|10975195|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9
6939797|NCT00934544|10975196|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6
6939798|NCT00934544|10975194|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35
6939799|NCT00934544|10975195|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5
6939800|NCT00934544|10975196|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10
6939801|NCT00934544|10975194|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10
6939802|NCT00934544|10975195|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9
6939803|NCT00934544|10975196|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0
6939804|NCT00934544|10975194|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2
6939805|NCT00934544|10975195|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0
6939806|NCT00934544|10975196|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5
6939807|NCT00934544|10975194|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32
7067133|NCT01984242|11168079|FG001|Overall Study|Non-Compliance|0
6838259|NCT00256997|10843884|FG000|Overall Study|Lost to Follow-up|3
6939808|NCT00934544|10975195|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4
6939809|NCT00934544|10975196|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7
6939810|NCT00934544|10975194|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4
6939811|NCT00934544|10975195|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0
6939812|NCT00934544|10975196|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1
6939813|NCT00934544|10975194|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0
6939814|NCT00934544|10975195|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1
6939815|NCT00934544|10975196|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0
6939816|NCT00934544|10975194|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8
6939817|NCT00934544|10975195|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0
6939818|NCT00934544|10975196|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5
6939819|NCT00934622|10975226|FG000|Overall Study|Lost to Follow-up|7
6939820|NCT00934622|10975226|FG000|Overall Study|2nd Intraoperative exclusion criteria|1
6939821|NCT00934648|10975267|FG000|Overall Study|Failure to return|8
6939822|NCT00934648|10975267|FG000|Overall Study|Withdrawal by Subject|1
6939823|NCT00934661|10975273|FG000|Overall Study|Failure of Combined/Spinal Epidural|1
6939824|NCT00934661|10975274|FG001|Overall Study|Failure of Combined/Spinal Epidural|0
6939825|NCT00934843|10975282|FG000|Overall Study|Protocol Violation|0
6939826|NCT00934843|10975283|FG001|Overall Study|Protocol Violation|1
6939827|NCT00934856|10975295|FG000|Feasibility Part|Progressive disease|4
6939828|NCT00934856|10975296|FG001|Feasibility Part|Progressive disease|4
6939829|NCT00934856|10975297|FG002|Feasibility Part|Progressive disease|2
6939830|NCT00934856|10975298|FG003|Feasibility Part|Progressive disease|3
6939831|NCT00934856|10975299|FG004|Feasibility Part|Progressive disease|0
6939832|NCT00934856|10975300|FG005|Feasibility Part|Progressive disease|0
6939833|NCT00934856|10975295|FG000|Feasibility Part|Physician Decision|0
6939834|NCT00934856|10975296|FG001|Feasibility Part|Physician Decision|0
6939835|NCT00934856|10975297|FG002|Feasibility Part|Physician Decision|1
6939836|NCT00934856|10975298|FG003|Feasibility Part|Physician Decision|0
6939837|NCT00934856|10975299|FG004|Feasibility Part|Physician Decision|0
6939838|NCT00934856|10975300|FG005|Feasibility Part|Physician Decision|0
6939839|NCT00934856|10975295|FG000|Feasibility Part|Adverse Event|1
6939840|NCT00934856|10975296|FG001|Feasibility Part|Adverse Event|1
7040220|NCT01716520|11123213|FG004|Treatment Period 2 (14 Days)|Adverse Event|1
7040221|NCT01716520|11123214|FG005|Treatment Period 2 (14 Days)|Adverse Event|0
7040222|NCT01716520|11123209|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0
7040223|NCT01716520|11123210|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0
7040224|NCT01716520|11123211|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0
7040225|NCT01716520|11123212|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0
7040226|NCT01716520|11123213|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1
7040227|NCT01716520|11123214|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0
7040228|NCT01716520|11123209|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
7040229|NCT01716520|11123210|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
7040230|NCT01716520|11123211|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
7040231|NCT01716520|11123212|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1
7040232|NCT01716520|11123213|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
7040233|NCT01716520|11123214|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
7040234|NCT01716520|11123209|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1
7040235|NCT01716520|11123210|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0
7040236|NCT01716520|11123211|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1
7040237|NCT01716520|11123212|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0
7040238|NCT01716520|11123213|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0
7040239|NCT01716520|11123214|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1
7040240|NCT01716520|11123209|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1
7040241|NCT01716520|11123210|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
7040242|NCT01716520|11123211|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
7040243|NCT01716520|11123212|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
7040244|NCT01716520|11123213|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
7040245|NCT01716520|11123214|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
6939841|NCT00934856|10975297|FG002|Feasibility Part|Adverse Event|0
6939842|NCT00934856|10975298|FG003|Feasibility Part|Adverse Event|1
6939843|NCT00934856|10975299|FG004|Feasibility Part|Adverse Event|0
6939844|NCT00934856|10975300|FG005|Feasibility Part|Adverse Event|2
6939845|NCT00934856|10975295|FG000|Feasibility Part|Withdrawal by Subject|0
6939846|NCT00934856|10975296|FG001|Feasibility Part|Withdrawal by Subject|0
6939847|NCT00934856|10975297|FG002|Feasibility Part|Withdrawal by Subject|0
6939848|NCT00934856|10975298|FG003|Feasibility Part|Withdrawal by Subject|1
6939849|NCT00934856|10975299|FG004|Feasibility Part|Withdrawal by Subject|0
6939850|NCT00934856|10975300|FG005|Feasibility Part|Withdrawal by Subject|1
6939851|NCT00934856|10975295|FG000|Extension Part|Adverse Event|0
6939852|NCT00934856|10975296|FG001|Extension Part|Adverse Event|0
7040246|NCT01716520|11123209|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
7040247|NCT01716520|11123210|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
6939853|NCT00934856|10975297|FG002|Extension Part|Adverse Event|0
6939854|NCT00934856|10975298|FG003|Extension Part|Adverse Event|1
6939855|NCT00934856|10975299|FG004|Extension Part|Adverse Event|4
7067134|NCT01984242|11168080|FG002|Overall Study|Non-Compliance|0
7067135|NCT01984242|11168078|FG000|Overall Study|Study terminated by Sponsor|38
7067136|NCT01984242|11168079|FG001|Overall Study|Study terminated by Sponsor|50
7067137|NCT01984242|11168080|FG002|Overall Study|Study terminated by Sponsor|34
7067138|NCT01984242|11168078|FG000|Overall Study|Disease Progression|0
6939856|NCT00934856|10975300|FG005|Extension Part|Adverse Event|4
6939857|NCT00934856|10975295|FG000|Extension Part|Progressive disease|0
6939858|NCT00934856|10975296|FG001|Extension Part|Progressive disease|0
6939859|NCT00934856|10975297|FG002|Extension Part|Progressive disease|0
6939860|NCT00934856|10975298|FG003|Extension Part|Progressive disease|1
6939861|NCT00934856|10975299|FG004|Extension Part|Progressive disease|0
6939862|NCT00934856|10975300|FG005|Extension Part|Progressive disease|0
6939863|NCT00934856|10975295|FG000|Extension Part|Non-compliance with drug|0
6939864|NCT00934856|10975296|FG001|Extension Part|Non-compliance with drug|0
6939865|NCT00934856|10975297|FG002|Extension Part|Non-compliance with drug|0
6939866|NCT00934856|10975298|FG003|Extension Part|Non-compliance with drug|0
6939867|NCT00934856|10975299|FG004|Extension Part|Non-compliance with drug|0
6939868|NCT00934856|10975300|FG005|Extension Part|Non-compliance with drug|1
6939869|NCT00934947|10975346|FG000|Overall Study|Adverse Event|0
6939870|NCT00934947|10975347|FG001|Overall Study|Adverse Event|2
6939871|NCT00935012|10975355|FG000|Overall Study|Death|19
6939872|NCT00935012|10975355|FG000|Overall Study|Withdrawal by Subject|3
6939873|NCT00935012|10975355|FG000|Overall Study|Other|5
6939874|NCT00935012|10975355|FG000|Overall Study|Adverse Event|2
6939875|NCT00935220|10975368|FG000|Overall Study|Adverse Event|1
6939876|NCT00935220|10975368|FG000|Overall Study|Other reason (not specified)|1
6939877|NCT00935259|10975372|FG000|Period 1|Administrative (scheduling conflict)|1
6939878|NCT00935259|10975373|FG001|Period 1|Administrative (scheduling conflict)|1
6939879|NCT00935272|10975383|FG000|Overall Study|Lost to Follow-up|10
6939880|NCT00935272|10975384|FG001|Overall Study|Lost to Follow-up|3
6939881|NCT00935272|10975383|FG000|Overall Study|Withdrawal by Subject|8
6939882|NCT00935272|10975384|FG001|Overall Study|Withdrawal by Subject|2
6939883|NCT00935272|10975383|FG000|Overall Study|Physician Decision|1
6939884|NCT00935272|10975384|FG001|Overall Study|Physician Decision|0
6939885|NCT00935272|10975383|FG000|Overall Study|Protocol Violation|0
6939886|NCT00935272|10975384|FG001|Overall Study|Protocol Violation|1
6939887|NCT00935493|10975417|FG000|Overall Study|Lost to Follow-up|1
6939888|NCT00935493|10975418|FG001|Overall Study|Lost to Follow-up|1
6939889|NCT00935493|10975419|FG002|Overall Study|Lost to Follow-up|1
6939890|NCT00935493|10975417|FG000|Overall Study|Treatment Discontinued|0
6939891|NCT00935493|10975418|FG001|Overall Study|Treatment Discontinued|1
6939892|NCT00935493|10975419|FG002|Overall Study|Treatment Discontinued|0
6939893|NCT00935532|10975429|FG000|Overall Study|Adverse Event|11
6939894|NCT00935532|10975430|FG001|Overall Study|Adverse Event|6
6939895|NCT00935532|10975429|FG000|Overall Study|Death|1
6939896|NCT00935532|10975430|FG001|Overall Study|Death|0
6939897|NCT00935532|10975429|FG000|Overall Study|Lost to Follow-up|1
6939898|NCT00935532|10975430|FG001|Overall Study|Lost to Follow-up|0
6939899|NCT00935532|10975429|FG000|Overall Study|Physician Decision|1
6939900|NCT00935532|10975430|FG001|Overall Study|Physician Decision|2
6939901|NCT00935532|10975429|FG000|Overall Study|Protocol Violation|2
6939902|NCT00935532|10975430|FG001|Overall Study|Protocol Violation|1
6939903|NCT00935532|10975429|FG000|Overall Study|Subject Decision|2
6939904|NCT00935532|10975430|FG001|Overall Study|Subject Decision|1
6939905|NCT00935532|10975429|FG000|Overall Study|Sponsor Decision|0
6939906|NCT00935532|10975430|FG001|Overall Study|Sponsor Decision|1
6939907|NCT00935532|10975429|FG000|Overall Study|Loss Glucose Control|4
6939908|NCT00935532|10975430|FG001|Overall Study|Loss Glucose Control|0
6939909|NCT00935584|10975438|FG000|Overall Study|Withdrawal by Subject|9
6939910|NCT00935584|10975439|FG001|Overall Study|Withdrawal by Subject|0
6939911|NCT00935584|10975438|FG000|Overall Study|Death|3
6939912|NCT00935584|10975439|FG001|Overall Study|Death|0
6939913|NCT00935584|10975438|FG000|Overall Study|Lost to Follow-up|8
6939914|NCT00935584|10975439|FG001|Overall Study|Lost to Follow-up|0
6939915|NCT00935584|10975438|FG000|Overall Study|No show|9
6939916|NCT00935584|10975439|FG001|Overall Study|No show|0
6939917|NCT00935584|10975438|FG000|Overall Study|Relocated|3
7067139|NCT01984242|11168079|FG001|Overall Study|Disease Progression|0
7067140|NCT01984242|11168080|FG002|Overall Study|Disease Progression|1
6939918|NCT00935584|10975439|FG001|Overall Study|Relocated|0
6939919|NCT00935584|10975438|FG000|Overall Study|Patient changed provider|3
6939920|NCT00935584|10975439|FG001|Overall Study|Patient changed provider|0
6939921|NCT00935584|10975438|FG000|Overall Study|Provider dropped out of study|14
6939922|NCT00935584|10975439|FG001|Overall Study|Provider dropped out of study|4
7067141|NCT01984294|11168099|FG000|Overall Study|Randomized but Never Treated|0
6939923|NCT00935701|10975443|FG000|Overall Study|Failure to Transition to Acupuncture|1
6939924|NCT00935818|10975474|FG000|Overall Study|Withdrawal by Subject|45
6939925|NCT00935818|10975475|FG001|Overall Study|Withdrawal by Subject|50
6939926|NCT00935818|10975474|FG000|Overall Study|Lost to Follow-up|40
6939927|NCT00935818|10975475|FG001|Overall Study|Lost to Follow-up|42
6939928|NCT00935818|10975474|FG000|Overall Study|Adverse Event|6
6939929|NCT00935818|10975475|FG001|Overall Study|Adverse Event|7
6939930|NCT00935818|10975474|FG000|Overall Study|Physician Decision|0
6939931|NCT00935818|10975475|FG001|Overall Study|Physician Decision|1
6939932|NCT00935883|10975492|FG000|Treatment Period|Physician Decision|1
6939933|NCT00935883|10975493|FG001|Treatment Period|Physician Decision|0
6939934|NCT00935883|10975492|FG000|Treatment Period|Withdrawal by Subject|0
6939935|NCT00935883|10975493|FG001|Treatment Period|Withdrawal by Subject|2
6939936|NCT00936065|10975502|FG000|Overall Study|Adverse Event|1
6939937|NCT00936065|10975503|FG001|Overall Study|Adverse Event|0
6939938|NCT00936065|10975504|FG002|Overall Study|Adverse Event|1
6939939|NCT00936065|10975502|FG000|Overall Study|Lack of Efficacy|1
6939940|NCT00936065|10975503|FG001|Overall Study|Lack of Efficacy|0
6939941|NCT00936065|10975504|FG002|Overall Study|Lack of Efficacy|1
6939942|NCT00936065|10975502|FG000|Overall Study|Lost to Follow-up|1
7067142|NCT01984294|11168100|FG001|Overall Study|Randomized but Never Treated|0
7067143|NCT01984294|11168101|FG002|Overall Study|Randomized but Never Treated|1
7067144|NCT01984294|11168099|FG000|Overall Study|Lack of Efficacy|4
6939943|NCT00936065|10975503|FG001|Overall Study|Lost to Follow-up|0
6939944|NCT00936065|10975504|FG002|Overall Study|Lost to Follow-up|0
6939945|NCT00936065|10975502|FG000|Overall Study|Protocol Violation|1
6939946|NCT00936065|10975503|FG001|Overall Study|Protocol Violation|2
6939947|NCT00936065|10975504|FG002|Overall Study|Protocol Violation|1
6939948|NCT00936065|10975502|FG000|Overall Study|Withdrawal by Subject|0
6939949|NCT00936065|10975503|FG001|Overall Study|Withdrawal by Subject|2
6939950|NCT00936065|10975504|FG002|Overall Study|Withdrawal by Subject|4
6975440|NCT01193153|11027629|FG000|Double Blind Relapse Prevention Period|Pregnancy|1
6975441|NCT01193153|11027630|FG001|Double Blind Relapse Prevention Period|Pregnancy|0
6975442|NCT01193153|11027629|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19
6975443|NCT01193153|11027630|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30
6975444|NCT01193153|11027629|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25
6975445|NCT01193153|11027630|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57
6975446|NCT01193153|11027629|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1
6975447|NCT01193153|11027630|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3
7040248|NCT01716520|11123211|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
7067145|NCT01984294|11168100|FG001|Overall Study|Lack of Efficacy|2
6975448|NCT01193218|11027644|FG000|0-12 Weeks|Adverse Event|6
6975449|NCT01193218|11027645|FG001|0-12 Weeks|Adverse Event|0
6975450|NCT01193218|11027646|FG002|0-12 Weeks|Adverse Event|1
6975451|NCT01193218|11027647|FG003|0-12 Weeks|Adverse Event|0
6975452|NCT01193218|11027648|FG004|0-12 Weeks|Adverse Event|0
6975453|NCT01193218|11027649|FG005|0-12 Weeks|Adverse Event|2
6975454|NCT01193218|11027650|FG006|0-12 Weeks|Adverse Event|2
6975455|NCT01193218|11027651|FG007|0-12 Weeks|Adverse Event|0
6975456|NCT01193218|11027644|FG000|0-12 Weeks|Protocol Violation|0
6975457|NCT01193218|11027645|FG001|0-12 Weeks|Protocol Violation|0
6975458|NCT01193218|11027646|FG002|0-12 Weeks|Protocol Violation|0
6975459|NCT01193218|11027647|FG003|0-12 Weeks|Protocol Violation|0
6975460|NCT01193218|11027648|FG004|0-12 Weeks|Protocol Violation|1
6975461|NCT01193218|11027649|FG005|0-12 Weeks|Protocol Violation|1
6975462|NCT01193218|11027650|FG006|0-12 Weeks|Protocol Violation|0
6975463|NCT01193218|11027651|FG007|0-12 Weeks|Protocol Violation|0
6975464|NCT01193218|11027644|FG000|0-12 Weeks|Withdrawal by Subject|3
6975465|NCT01193218|11027645|FG001|0-12 Weeks|Withdrawal by Subject|0
6975466|NCT01193218|11027646|FG002|0-12 Weeks|Withdrawal by Subject|2
6975467|NCT01193218|11027647|FG003|0-12 Weeks|Withdrawal by Subject|0
6975468|NCT01193218|11027648|FG004|0-12 Weeks|Withdrawal by Subject|0
6975469|NCT01193218|11027649|FG005|0-12 Weeks|Withdrawal by Subject|0
6975470|NCT01193218|11027650|FG006|0-12 Weeks|Withdrawal by Subject|1
6975471|NCT01193218|11027651|FG007|0-12 Weeks|Withdrawal by Subject|0
6975472|NCT01193218|11027644|FG000|12-52 Weeks|Adverse Event|1
6975473|NCT01193218|11027645|FG001|12-52 Weeks|Adverse Event|0
6975474|NCT01193218|11027646|FG002|12-52 Weeks|Adverse Event|1
6975475|NCT01193218|11027647|FG003|12-52 Weeks|Adverse Event|2
6975476|NCT01193218|11027648|FG004|12-52 Weeks|Adverse Event|3
6975477|NCT01193218|11027649|FG005|12-52 Weeks|Adverse Event|3
6975478|NCT01193218|11027650|FG006|12-52 Weeks|Adverse Event|1
6975479|NCT01193218|11027651|FG007|12-52 Weeks|Adverse Event|2
6975480|NCT01193218|11027644|FG000|12-52 Weeks|Lack of Efficacy|0
6975481|NCT01193218|11027645|FG001|12-52 Weeks|Lack of Efficacy|0
6975482|NCT01193218|11027646|FG002|12-52 Weeks|Lack of Efficacy|0
6975483|NCT01193218|11027647|FG003|12-52 Weeks|Lack of Efficacy|0
6975484|NCT01193218|11027648|FG004|12-52 Weeks|Lack of Efficacy|0
6975485|NCT01193218|11027649|FG005|12-52 Weeks|Lack of Efficacy|0
6975486|NCT01193218|11027650|FG006|12-52 Weeks|Lack of Efficacy|1
6975487|NCT01193218|11027651|FG007|12-52 Weeks|Lack of Efficacy|0
6975488|NCT01193218|11027644|FG000|12-52 Weeks|Withdrawal by Subject|3
6975489|NCT01193218|11027645|FG001|12-52 Weeks|Withdrawal by Subject|0
6975490|NCT01193218|11027646|FG002|12-52 Weeks|Withdrawal by Subject|3
6975491|NCT01193218|11027647|FG003|12-52 Weeks|Withdrawal by Subject|0
6975492|NCT01193218|11027648|FG004|12-52 Weeks|Withdrawal by Subject|0
6975493|NCT01193218|11027649|FG005|12-52 Weeks|Withdrawal by Subject|2
6975494|NCT01193218|11027650|FG006|12-52 Weeks|Withdrawal by Subject|1
6975495|NCT01193218|11027651|FG007|12-52 Weeks|Withdrawal by Subject|2
6975496|NCT01193218|11027644|FG000|12-52 Weeks|Other reason than above|1
6975497|NCT01193218|11027645|FG001|12-52 Weeks|Other reason than above|0
6975498|NCT01193218|11027646|FG002|12-52 Weeks|Other reason than above|0
6975499|NCT01193218|11027647|FG003|12-52 Weeks|Other reason than above|1
6939951|NCT00936117|10975512|FG000|Overall Study|Adverse Event|7
6939952|NCT00936117|10975512|FG000|Overall Study|Unable to continue oral medication|3
6939953|NCT00936208|10975519|FG000|Overall Study|Protocol Violation|37
6939954|NCT00936208|10975520|FG001|Overall Study|Protocol Violation|22
6939955|NCT00936221|10975528|FG000|Overall Study|Withdrawal by Subject|1
6939956|NCT00936221|10975529|FG001|Overall Study|Withdrawal by Subject|1
6939957|NCT00936611|10975592|FG000|Overall Study|Progressive Disease|3
6939958|NCT00936611|10975592|FG000|Overall Study|New Systemic Therapy|22
7040249|NCT01716520|11123212|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
7040250|NCT01716520|11123213|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
7040251|NCT01716520|11123214|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1
7040252|NCT01716520|11123209|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
7040253|NCT01716520|11123210|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1
6939959|NCT00936611|10975592|FG000|Overall Study|Lost to Follow-up|1
6939960|NCT00936611|10975592|FG000|Overall Study|Withdrawal by Subject|2
6939961|NCT00936611|10975592|FG000|Overall Study|Still on Follow-up|1
6939962|NCT00936611|10975592|FG000|Overall Study|Still on Active Therapy|7
6939963|NCT00936611|10975592|FG000|Overall Study|Ineligible for Study Drug|3
6939964|NCT00936702|10975605|FG000|Overall Study|Disease progression|34
6939965|NCT00936702|10975605|FG000|Overall Study|Adverse Event|8
6939966|NCT00936702|10975605|FG000|Overall Study|Withdrawal by Subject|2
6939967|NCT00936702|10975605|FG000|Overall Study|Alternative Treatment|1
6939968|NCT00936702|10975605|FG000|Overall Study|Other|1
6939969|NCT00936715|10975609|FG000|Overall Study|Investigators Discretion|1
6939970|NCT00936715|10975609|FG000|Overall Study|Protocol Violation|1
6939971|NCT00936715|10975609|FG000|Overall Study|Safety or Tolerability Reasons|4
6939972|NCT00936858|10975617|FG000|Overall Study|Death|3
6939973|NCT00936858|10975617|FG000|Overall Study|Progression|29
6939974|NCT00936858|10975617|FG000|Overall Study|Withdrawal by Subject|5
6939975|NCT00936858|10975617|FG000|Overall Study|Adverse Event|1
6939976|NCT00936858|10975617|FG000|Overall Study|Physician Decision|7
6939977|NCT00936858|10975617|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4
6939978|NCT00936858|10975617|FG000|Overall Study|Lost to Follow-up|1
6939979|NCT00936884|10975624|FG000|Double-blind|Withdrawal by Subject|6
6939980|NCT00936884|10975625|FG001|Double-blind|Withdrawal by Subject|4
6939981|NCT00936884|10975626|FG002|Double-blind|Withdrawal by Subject|0
6939982|NCT00936884|10975624|FG000|Double-blind|Death|2
6939983|NCT00936884|10975625|FG001|Double-blind|Death|1
6939984|NCT00936884|10975626|FG002|Double-blind|Death|0
6939985|NCT00936884|10975624|FG000|Double-blind|Lack of Efficacy|1
6939986|NCT00936884|10975625|FG001|Double-blind|Lack of Efficacy|1
6939987|NCT00936884|10975626|FG002|Double-blind|Lack of Efficacy|0
6939988|NCT00936884|10975624|FG000|Double-blind|Adverse Event|1
6939989|NCT00936884|10975625|FG001|Double-blind|Adverse Event|0
6939990|NCT00936884|10975626|FG002|Double-blind|Adverse Event|0
6939991|NCT00936884|10975624|FG000|Double-blind|Physician Decision|1
6939992|NCT00936884|10975625|FG001|Double-blind|Physician Decision|0
6939993|NCT00936884|10975626|FG002|Double-blind|Physician Decision|0
6939994|NCT00936884|10975624|FG000|Double-blind|No post baseline diary entry|1
6939995|NCT00936884|10975625|FG001|Double-blind|No post baseline diary entry|0
6939996|NCT00936884|10975626|FG002|Double-blind|No post baseline diary entry|0
6939997|NCT00936884|10975624|FG000|Double-blind|Did not receive study drug|0
6939998|NCT00936884|10975625|FG001|Double-blind|Did not receive study drug|1
6939999|NCT00936884|10975626|FG002|Double-blind|Did not receive study drug|0
6940000|NCT00936897|10975635|FG000|Overall Study|Withdrawal by Subject|9
6940001|NCT00936897|10975636|FG001|Overall Study|Withdrawal by Subject|19
6940002|NCT00936897|10975635|FG000|Overall Study|Adverse Event|4
6940003|NCT00936897|10975636|FG001|Overall Study|Adverse Event|13
6940004|NCT00936897|10975635|FG000|Overall Study|Other|3
6940005|NCT00936897|10975636|FG001|Overall Study|Other|9
6940006|NCT00936897|10975635|FG000|Overall Study|Lost to Follow-up|1
6940007|NCT00936897|10975636|FG001|Overall Study|Lost to Follow-up|10
6940008|NCT00936897|10975635|FG000|Overall Study|Administrative Decision|1
6940009|NCT00936897|10975636|FG001|Overall Study|Administrative Decision|2
6940010|NCT00936897|10975635|FG000|Overall Study|Protocol Violation|1
6940011|NCT00936897|10975636|FG001|Overall Study|Protocol Violation|1
6940012|NCT00936897|10975635|FG000|Overall Study|Ineligibility Determined|0
6940013|NCT00936897|10975636|FG001|Overall Study|Ineligibility Determined|3
6940014|NCT00936897|10975635|FG000|Overall Study|Noncompliance|0
6940015|NCT00936897|10975636|FG001|Overall Study|Noncompliance|2
6940016|NCT00936897|10975635|FG000|Overall Study|Death|0
6940017|NCT00936897|10975636|FG001|Overall Study|Death|1
6940018|NCT00936910|10975642|FG000|Overall Study|Lack of Efficacy|3
6940019|NCT00936975|10975647|FG000|Overall Study|Withdrawal by Subject|1
6940020|NCT00936975|10975647|FG000|Overall Study|Disease progression|3
6940021|NCT00936975|10975647|FG000|Overall Study|Post-Tx scan uninterpretable|2
6940022|NCT00937040|10975654|FG000|Overall Study|Adverse Event|5
6940023|NCT00937040|10975655|FG001|Overall Study|Adverse Event|8
6940024|NCT00937040|10975654|FG000|Overall Study|Lost to Follow-up|12
6940025|NCT00937040|10975655|FG001|Overall Study|Lost to Follow-up|12
6940026|NCT00937040|10975654|FG000|Overall Study|Protocol Violation|3
6940027|NCT00937040|10975655|FG001|Overall Study|Protocol Violation|0
6940028|NCT00937040|10975654|FG000|Overall Study|Withdrawal by Subject|13
6940029|NCT00937040|10975655|FG001|Overall Study|Withdrawal by Subject|7
6940030|NCT00937040|10975654|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3
6940031|NCT00937040|10975655|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2
6940032|NCT00937040|10975654|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5
6940033|NCT00937040|10975655|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8
6940034|NCT00937157|10975686|FG000|Overall Study|Pregnancy|1
6940035|NCT00937157|10975686|FG000|Overall Study|Lost to Follow-up|3
6940036|NCT00937326|10975704|FG000|Overall Study|Adverse Event|0
6940037|NCT00937326|10975705|FG001|Overall Study|Adverse Event|3
6838260|NCT00256997|10843885|FG001|Overall Study|Lost to Follow-up|5
6838261|NCT00256997|10843884|FG000|Overall Study|Withdrawal by Subject|13
6838262|NCT00256997|10843885|FG001|Overall Study|Withdrawal by Subject|3
6838263|NCT00256997|10843884|FG000|Overall Study|Started but not treated|2
6838264|NCT00256997|10843885|FG001|Overall Study|Started but not treated|0
6838265|NCT00256997|10843884|FG000|Overall Study|Other|5
6940038|NCT00937326|10975706|FG002|Overall Study|Adverse Event|1
6940039|NCT00937326|10975707|FG003|Overall Study|Adverse Event|1
6940040|NCT00937326|10975708|FG004|Overall Study|Adverse Event|2
6940041|NCT00937326|10975704|FG000|Overall Study|Death|0
6940042|NCT00937326|10975705|FG001|Overall Study|Death|0
6940043|NCT00937326|10975706|FG002|Overall Study|Death|1
7044796|NCT01757275|11130781|FG000|Overall Study|Not treated|3
6838266|NCT00256997|10843885|FG001|Overall Study|Other|8
6940044|NCT00937326|10975707|FG003|Overall Study|Death|0
6940045|NCT00937326|10975708|FG004|Overall Study|Death|0
6940046|NCT00937326|10975704|FG000|Overall Study|Withdrawal by Subject|3
6940047|NCT00937326|10975705|FG001|Overall Study|Withdrawal by Subject|4
6940048|NCT00937326|10975706|FG002|Overall Study|Withdrawal by Subject|1
6940049|NCT00937326|10975707|FG003|Overall Study|Withdrawal by Subject|4
6940050|NCT00937326|10975708|FG004|Overall Study|Withdrawal by Subject|3
6940051|NCT00937326|10975704|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0
6940052|NCT00937326|10975705|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0
6940053|NCT00937326|10975706|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1
6940054|NCT00937326|10975707|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0
6940055|NCT00937326|10975708|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0
6940056|NCT00937391|10975736|FG000|Stage 2|Withdrawal by Subject|1
6940057|NCT00937404|10975753|FG000|Overall Study|Protocol Violation|1
6940058|NCT00937404|10975753|FG000|Overall Study|Withdrawal by Subject|1
6940059|NCT00937495|10975757|FG000|Overall Study|Protocol Violation|2
6940060|NCT00937521|10975769|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0
6940061|NCT00937521|10975770|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0
6940062|NCT00937521|10975771|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2
6940063|NCT00937521|10975772|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0
6940064|NCT00937521|10975773|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0
6940065|NCT00937521|10975774|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0
6940066|NCT00937521|10975775|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1
6940067|NCT00937521|10975776|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0
6940068|NCT00937521|10975769|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
6940069|NCT00937521|10975770|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
6940070|NCT00937521|10975771|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3
6940071|NCT00937521|10975772|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
6940072|NCT00937521|10975773|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
6940073|NCT00937521|10975774|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
6940074|NCT00937521|10975775|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
6940075|NCT00937521|10975776|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
6940076|NCT00937521|10975769|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
6940077|NCT00937521|10975770|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
6940078|NCT00937521|10975771|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
6940079|NCT00937521|10975772|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
6940080|NCT00937521|10975773|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
6940081|NCT00937521|10975774|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
6940082|NCT00937521|10975775|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
6940083|NCT00937521|10975776|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
6940084|NCT00937521|10975769|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
6940085|NCT00937521|10975770|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4
6940086|NCT00937521|10975771|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
6940087|NCT00937521|10975772|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
6838267|NCT00256997|10843884|FG000|Overall Study|End of Study (As Per Sponsor)|12
6838268|NCT00256997|10843885|FG001|Overall Study|End of Study (As Per Sponsor)|24
6838269|NCT00256997|10843884|FG000|Overall Study|Participant Non-compliant|3
6838270|NCT00256997|10843885|FG001|Overall Study|Participant Non-compliant|6
6838271|NCT00256997|10843884|FG000|Overall Study|Investigator Withdrew Participant|2
6838272|NCT00256997|10843885|FG001|Overall Study|Investigator Withdrew Participant|1
6838273|NCT00257010|10843892|FG000|Overall Study|Lack of Efficacy|11
6838274|NCT00257010|10843892|FG000|Overall Study|Lost to Follow-up|53
6838275|NCT00257010|10843892|FG000|Overall Study|Withdrawal by Subject|34
6940088|NCT00937521|10975773|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2
6940089|NCT00937521|10975774|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
6940090|NCT00937521|10975775|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
6940091|NCT00937521|10975776|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
6940092|NCT00937521|10975769|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1
6940093|NCT00937521|10975770|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0
6940094|NCT00937521|10975771|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0
6940095|NCT00937521|10975772|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0
6940096|NCT00937521|10975773|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0
6940097|NCT00937521|10975774|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0
6940098|NCT00937521|10975775|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1
6940099|NCT00937521|10975776|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0
6940100|NCT00937521|10975769|FG000|Booster Phase|Adverse Event|0
6940101|NCT00937521|10975770|FG001|Booster Phase|Adverse Event|0
6940102|NCT00937521|10975771|FG002|Booster Phase|Adverse Event|0
6940103|NCT00937521|10975772|FG003|Booster Phase|Adverse Event|0
6940104|NCT00937521|10975773|FG004|Booster Phase|Adverse Event|0
6940105|NCT00937521|10975774|FG005|Booster Phase|Adverse Event|0
6940106|NCT00937521|10975775|FG006|Booster Phase|Adverse Event|1
6940107|NCT00937521|10975776|FG007|Booster Phase|Adverse Event|0
6940108|NCT00937521|10975769|FG000|Booster Phase|Withdrawal by Subject|1
6940109|NCT00937521|10975770|FG001|Booster Phase|Withdrawal by Subject|0
6940110|NCT00937521|10975771|FG002|Booster Phase|Withdrawal by Subject|0
6940111|NCT00937521|10975772|FG003|Booster Phase|Withdrawal by Subject|1
6940112|NCT00937521|10975773|FG004|Booster Phase|Withdrawal by Subject|0
6940113|NCT00937521|10975774|FG005|Booster Phase|Withdrawal by Subject|0
6940114|NCT00937521|10975775|FG006|Booster Phase|Withdrawal by Subject|0
6940115|NCT00937521|10975776|FG007|Booster Phase|Withdrawal by Subject|2
6940116|NCT00937521|10975769|FG000|Booster Phase|Lost to Follow-up|2
6940117|NCT00937521|10975770|FG001|Booster Phase|Lost to Follow-up|2
6940118|NCT00937521|10975771|FG002|Booster Phase|Lost to Follow-up|4
6940119|NCT00937521|10975772|FG003|Booster Phase|Lost to Follow-up|2
6940120|NCT00937521|10975773|FG004|Booster Phase|Lost to Follow-up|4
6940121|NCT00937521|10975774|FG005|Booster Phase|Lost to Follow-up|4
6940122|NCT00937521|10975775|FG006|Booster Phase|Lost to Follow-up|3
6940123|NCT00937521|10975776|FG007|Booster Phase|Lost to Follow-up|0
6940124|NCT00937521|10975769|FG000|Booster Phase|Administrative Reason|0
6940125|NCT00937521|10975770|FG001|Booster Phase|Administrative Reason|0
6940126|NCT00937521|10975771|FG002|Booster Phase|Administrative Reason|1
6940127|NCT00937521|10975772|FG003|Booster Phase|Administrative Reason|0
6940128|NCT00937521|10975773|FG004|Booster Phase|Administrative Reason|1
6940129|NCT00937521|10975774|FG005|Booster Phase|Administrative Reason|1
6940130|NCT00937521|10975775|FG006|Booster Phase|Administrative Reason|0
6940131|NCT00937521|10975776|FG007|Booster Phase|Administrative Reason|0
6940132|NCT00937521|10975769|FG000|Booster Phase|Protocol Deviation|0
6940133|NCT00937521|10975770|FG001|Booster Phase|Protocol Deviation|0
6940134|NCT00937521|10975771|FG002|Booster Phase|Protocol Deviation|0
6940135|NCT00937521|10975772|FG003|Booster Phase|Protocol Deviation|0
6940136|NCT00937521|10975773|FG004|Booster Phase|Protocol Deviation|0
6940137|NCT00937521|10975774|FG005|Booster Phase|Protocol Deviation|0
6940138|NCT00937521|10975775|FG006|Booster Phase|Protocol Deviation|1
6940139|NCT00937521|10975776|FG007|Booster Phase|Protocol Deviation|0
6940140|NCT00937547|10975812|FG000|Overall Study|misdiagnosis|1
6940141|NCT00937547|10975813|FG001|Overall Study|misdiagnosis|6
6940142|NCT00937547|10975814|FG002|Overall Study|misdiagnosis|7
6940143|NCT00937560|10975822|FG000|Initial Treatment|Death|6
6940144|NCT00937560|10975822|FG000|Initial Treatment|Withdraw consent|3
6940145|NCT00937560|10975822|FG000|Initial Treatment|Adverse Event|1
6940146|NCT00937560|10975822|FG000|Initial Treatment|Lost to Follow-up|1
6940147|NCT00937560|10975822|FG000|Initial Treatment|No end of study page|10
6940148|NCT00937560|10975822|FG000|Maintenance Treatment|Death|12
6940149|NCT00937560|10975822|FG000|Maintenance Treatment|Withdraw consent|5
6940150|NCT00937560|10975822|FG000|Maintenance Treatment|According to protocol|1
6940151|NCT00937768|10975828|FG000|Overall Study|Refused Further Treatment|3
6940152|NCT00937768|10975829|FG001|Overall Study|Refused Further Treatment|2
6940153|NCT00937768|10975828|FG000|Overall Study|Disease Progression|1
6940154|NCT00937768|10975829|FG001|Overall Study|Disease Progression|1
6940155|NCT00937768|10975828|FG000|Overall Study|Alternate Treatment|0
6940156|NCT00937768|10975829|FG001|Overall Study|Alternate Treatment|1
6940157|NCT00937768|10975828|FG000|Overall Study|No Further Funding|4
6940158|NCT00937768|10975829|FG001|Overall Study|No Further Funding|4
6940159|NCT00937833|10975841|FG000|Overall Study|Protocol Violation|1
6940160|NCT00937833|10975842|FG001|Overall Study|Protocol Violation|2
6940161|NCT00937833|10975841|FG000|Overall Study|Procedure delayed; enrollment closed|0
6940162|NCT00937833|10975842|FG001|Overall Study|Procedure delayed; enrollment closed|1
6940163|NCT00937833|10975841|FG000|Overall Study|Lost to Follow-up|10
6940164|NCT00937833|10975842|FG001|Overall Study|Lost to Follow-up|8
6940165|NCT00937833|10975841|FG000|Overall Study|Withdrawal by Subject|4
6940166|NCT00937833|10975842|FG001|Overall Study|Withdrawal by Subject|6
6940167|NCT00937950|10975857|FG000|Overall Study|Withdrawal by Subject|23
6940168|NCT00937950|10975857|FG000|Overall Study|Migrated/moved from study area|27
6940169|NCT00937950|10975857|FG000|Overall Study|Lost to Follow-up|144
6940170|NCT00937950|10975857|FG000|Overall Study|Missing confirmed|4
6940171|NCT00937950|10975857|FG000|Overall Study|Other|18
6940172|NCT00938015|10975861|FG000|Overall Study|Death|2
6940173|NCT00938015|10975861|FG000|Overall Study|Lost to Follow-up|32
6940174|NCT00938015|10975861|FG000|Overall Study|Adverse Event|32
6940175|NCT00938015|10975861|FG000|Overall Study|Non-responder|52
6940176|NCT00938015|10975861|FG000|Overall Study|Reason not related to Etanercept|29
6940177|NCT00938041|10975865|FG000|Overall Study|Lost to Follow-up|6
6940178|NCT00938041|10975865|FG000|Overall Study|Received Alternative Therapy|1
6940179|NCT00938041|10975865|FG000|Overall Study|Progressive Disease|5
6940180|NCT00938041|10975865|FG000|Overall Study|Death|12
6940181|NCT00938041|10975865|FG000|Overall Study|Adrenal Insufficiency|3
6940182|NCT00938327|10975886|FG000|Overall Study|Adverse Event|2
6940183|NCT00938327|10975886|FG000|Overall Study|Protocol Violation|1
6940184|NCT00938327|10975886|FG000|Overall Study|Withdrawal by Subject|4
6940185|NCT00938327|10975886|FG000|Overall Study|Lost to Follow-up|37
6940186|NCT00938327|10975886|FG000|Overall Study|2nd dose received outside of the study|7
6940187|NCT00938327|10975886|FG000|Overall Study|Vaccine not received as out of stock|9
6940188|NCT00938340|10975890|FG000|Overall Study|Withdrawal by Subject|3
6940189|NCT00938340|10975890|FG000|Overall Study|Protocol Violation|1
6940190|NCT00938340|10975890|FG000|Overall Study|Adverse Event|1
6940191|NCT00938366|10975938|FG000|Overall Study|Withdrawal by Subject|1
6940192|NCT00938366|10975939|FG001|Overall Study|Withdrawal by Subject|0
6940193|NCT00938392|10975947|FG000|Overall Study|Adverse Event|0
6940194|NCT00938392|10975948|FG001|Overall Study|Adverse Event|1
6940195|NCT00938392|10975947|FG000|Overall Study|Withdrawal by Subject|0
6940196|NCT00938392|10975948|FG001|Overall Study|Withdrawal by Subject|1
6940197|NCT00938392|10975947|FG000|Overall Study|Lost to Follow-up|2
6940198|NCT00938392|10975948|FG001|Overall Study|Lost to Follow-up|2
6940199|NCT00938431|10975957|FG000|Overall Study|Adverse Event|5
6940200|NCT00938431|10975958|FG001|Overall Study|Adverse Event|8
6940201|NCT00938431|10975959|FG002|Overall Study|Adverse Event|6
6940202|NCT00938431|10975957|FG000|Overall Study|Lack of Efficacy|0
6940203|NCT00938431|10975958|FG001|Overall Study|Lack of Efficacy|1
6940204|NCT00938431|10975959|FG002|Overall Study|Lack of Efficacy|0
6940205|NCT00938431|10975957|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1
6940206|NCT00938431|10975958|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0
6940207|NCT00938431|10975959|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0
6940208|NCT00938431|10975957|FG000|Overall Study|Dosing compliance issue|0
6940209|NCT00938431|10975958|FG001|Overall Study|Dosing compliance issue|0
6940210|NCT00938431|10975959|FG002|Overall Study|Dosing compliance issue|1
6940211|NCT00938431|10975957|FG000|Overall Study|Reached maximum dose early|0
6940212|NCT00938431|10975958|FG001|Overall Study|Reached maximum dose early|0
6940213|NCT00938431|10975959|FG002|Overall Study|Reached maximum dose early|1
6940214|NCT00938470|10975977|FG000|Overall Study|Disease Progression|3
6940215|NCT00938470|10975978|FG001|Overall Study|Disease Progression|0
6940216|NCT00938470|10975977|FG000|Overall Study|Alternate Treatment|1
6940217|NCT00938470|10975978|FG001|Overall Study|Alternate Treatment|0
6940218|NCT00938470|10975977|FG000|Overall Study|Death|3
6940219|NCT00938470|10975978|FG001|Overall Study|Death|2
6940220|NCT00938470|10975977|FG000|Overall Study|Other Reason|0
6940221|NCT00938470|10975978|FG001|Overall Study|Other Reason|1
6940222|NCT00938639|10975995|FG000|Overall Study|Moved away from study area|0
6940223|NCT00938639|10975996|FG001|Overall Study|Moved away from study area|1
6940224|NCT00938639|10975995|FG000|Overall Study|Lost to Follow-up|1
6940225|NCT00938639|10975996|FG001|Overall Study|Lost to Follow-up|2
6940226|NCT00938639|10975995|FG000|Overall Study|Family issues|1
6940227|NCT00938639|10975996|FG001|Overall Study|Family issues|1
6940228|NCT00938639|10975995|FG000|Overall Study|Participant noncompliance|1
6940229|NCT00938639|10975996|FG001|Overall Study|Participant noncompliance|0
6940230|NCT00938717|10976017|FG000|Overall Study|Adverse Event|10
6940231|NCT00938717|10976018|FG001|Overall Study|Adverse Event|41
6940232|NCT00938717|10976017|FG000|Overall Study|Protocol Violation|11
6940233|NCT00938717|10976018|FG001|Overall Study|Protocol Violation|8
6940234|NCT00938717|10976017|FG000|Overall Study|Withdrawal by Subject|26
6940235|NCT00938717|10976018|FG001|Overall Study|Withdrawal by Subject|24
6940236|NCT00938717|10976017|FG000|Overall Study|Lost to Follow-up|13
6940237|NCT00938717|10976018|FG001|Overall Study|Lost to Follow-up|18
6940238|NCT00938717|10976017|FG000|Overall Study|Lack of Efficacy|33
6940239|NCT00938717|10976018|FG001|Overall Study|Lack of Efficacy|15
6940240|NCT00938717|10976017|FG000|Overall Study|Other reason|5
6940241|NCT00938717|10976018|FG001|Overall Study|Other reason|2
6940242|NCT00938860|10976035|FG000|Overall Study|Adverse Event|2
6940243|NCT00938860|10976036|FG001|Overall Study|Adverse Event|1
6940244|NCT00938860|10976035|FG000|Overall Study|Abnormal laboratory values|2
6940245|NCT00938860|10976036|FG001|Overall Study|Abnormal laboratory values|2
6940246|NCT00938860|10976035|FG000|Overall Study|Withdrawal by Subject|11
6940247|NCT00938860|10976036|FG001|Overall Study|Withdrawal by Subject|8
6940248|NCT00938860|10976035|FG000|Overall Study|Lost to Follow-up|4
6940249|NCT00938860|10976036|FG001|Overall Study|Lost to Follow-up|4
6940250|NCT00938860|10976035|FG000|Overall Study|Administration problems|2
6940251|NCT00938860|10976036|FG001|Overall Study|Administration problems|0
6940252|NCT00938860|10976035|FG000|Overall Study|Death|1
6940253|NCT00938860|10976036|FG001|Overall Study|Death|1
6940254|NCT00938860|10976035|FG000|Overall Study|Protocol Violation|3
6940255|NCT00938860|10976036|FG001|Overall Study|Protocol Violation|1
6940256|NCT00938886|10976044|FG000|Overall Study|Death|0
6940257|NCT00938886|10976045|FG001|Overall Study|Death|1
6940258|NCT00938886|10976044|FG000|Overall Study|Withdrawal by Subject|4
6940259|NCT00938886|10976045|FG001|Overall Study|Withdrawal by Subject|7
6940260|NCT00938886|10976044|FG000|Overall Study|Lost to Follow-up|3
6940261|NCT00938886|10976045|FG001|Overall Study|Lost to Follow-up|2
6940262|NCT00938964|10976053|FG000|Overall Study|Death|3
6940263|NCT00938964|10976054|FG001|Overall Study|Death|3
6940264|NCT00938964|10976053|FG000|Overall Study|Lost to Follow-up|2
6940265|NCT00938964|10976054|FG001|Overall Study|Lost to Follow-up|3
6940266|NCT00938964|10976053|FG000|Overall Study|Withdrawal by Subject|22
6940267|NCT00938964|10976054|FG001|Overall Study|Withdrawal by Subject|18
6940268|NCT00938964|10976053|FG000|Overall Study|Found to Meet Exclusion Criteria|3
6940269|NCT00938964|10976054|FG001|Overall Study|Found to Meet Exclusion Criteria|4
6940270|NCT00939003|10976062|FG000|Double-blind Treatment Period|Adverse Event|1
6940271|NCT00939003|10976063|FG001|Double-blind Treatment Period|Adverse Event|1
6940272|NCT00939003|10976062|FG000|Double-blind Treatment Period|Lack of Efficacy|0
6940273|NCT00939003|10976063|FG001|Double-blind Treatment Period|Lack of Efficacy|1
6940274|NCT00939003|10976062|FG000|Double-blind Treatment Period|Pregnancy|0
6940275|NCT00939003|10976063|FG001|Double-blind Treatment Period|Pregnancy|1
6940276|NCT00939003|10976062|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1
6940277|NCT00939003|10976063|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1
6940278|NCT00939003|10976062|FG000|Open-label Treatment Period|Adverse Event|4
6940279|NCT00939003|10976063|FG001|Open-label Treatment Period|Adverse Event|8
6940280|NCT00939003|10976062|FG000|Open-label Treatment Period|Withdrawal by Subject|14
6940281|NCT00939003|10976063|FG001|Open-label Treatment Period|Withdrawal by Subject|7
6940282|NCT00939003|10976062|FG000|Open-label Treatment Period|Lack of Efficacy|6
6940283|NCT00939003|10976063|FG001|Open-label Treatment Period|Lack of Efficacy|9
6940284|NCT00939003|10976062|FG000|Open-label Treatment Period|Pregnancy|1
6940285|NCT00939003|10976063|FG001|Open-label Treatment Period|Pregnancy|1
6940286|NCT00939003|10976062|FG000|Open-label Treatment Period|Exclusion Criteria|1
6940287|NCT00939003|10976063|FG001|Open-label Treatment Period|Exclusion Criteria|0
6940288|NCT00939003|10976062|FG000|Open-label Treatment Period|Site Closure|3
6940289|NCT00939003|10976063|FG001|Open-label Treatment Period|Site Closure|4
6940290|NCT00939029|10976074|FG000|Overall Study|Withdrawal by Subject|3
6940291|NCT00939029|10976075|FG001|Overall Study|Withdrawal by Subject|7
6940292|NCT00939029|10976074|FG000|Overall Study|Lost to Follow-up|3
6940293|NCT00939029|10976075|FG001|Overall Study|Lost to Follow-up|4
6940294|NCT00939029|10976074|FG000|Overall Study|Adverse Event|0
6940295|NCT00939029|10976075|FG001|Overall Study|Adverse Event|1
6940296|NCT00939055|10976083|FG000|Overall Study|Discontinuation prior to procedure|4
6940297|NCT00939055|10976084|FG001|Overall Study|Discontinuation prior to procedure|0
6940298|NCT00939094|10976093|FG000|Overall Study|Adverse Event|9
6940299|NCT00939094|10976094|FG001|Overall Study|Adverse Event|0
6940300|NCT00939094|10976093|FG000|Overall Study|Withdrawal by Subject|1
6940301|NCT00939094|10976094|FG001|Overall Study|Withdrawal by Subject|6
6940302|NCT00939094|10976093|FG000|Overall Study|Lost to Follow-up|1
6940303|NCT00939094|10976094|FG001|Overall Study|Lost to Follow-up|1
6940304|NCT00939094|10976093|FG000|Overall Study|Eligibility criteria not fulfilled|2
6940305|NCT00939094|10976094|FG001|Overall Study|Eligibility criteria not fulfilled|0
6940306|NCT00939094|10976093|FG000|Overall Study|Severe non-compliance to protocol|0
6940307|NCT00939094|10976094|FG001|Overall Study|Severe non-compliance to protocol|1
6940308|NCT00939094|10976093|FG000|Overall Study|Study stopped by sponsor|0
6940309|NCT00939094|10976094|FG001|Overall Study|Study stopped by sponsor|2
6940310|NCT00939094|10976093|FG000|Overall Study|Abnormal ECG findings|1
6940311|NCT00939094|10976094|FG001|Overall Study|Abnormal ECG findings|0
6940312|NCT00939107|10976102|FG000|Overall Study|Lost to Follow-up|14
6940313|NCT00939107|10976103|FG001|Overall Study|Lost to Follow-up|12
6940314|NCT00939185|10976122|FG000|Overall Study|Adverse Event|3
6940315|NCT00939185|10976122|FG000|Overall Study|Lack of Efficacy|1
6940316|NCT00939185|10976122|FG000|Overall Study|Lost to Follow-up|6
6940317|NCT00939185|10976122|FG000|Overall Study|Other|3
6940318|NCT00939185|10976122|FG000|Overall Study|Withdrawal by Subject|2
7067146|NCT01984294|11168101|FG002|Overall Study|Lack of Efficacy|6
7067147|NCT01984294|11168099|FG000|Overall Study|Adverse Event|0
7067148|NCT01984294|11168100|FG001|Overall Study|Adverse Event|1
6940319|NCT00939185|10976122|FG000|Overall Study|Randomized But Did Not Receive Treatment|10
6940320|NCT00939341|10976143|FG000|Overall Study|Adverse Event|15
6940321|NCT00939341|10976143|FG000|Overall Study|Pregnancy|1
6940322|NCT00939341|10976143|FG000|Overall Study|Lost to Follow-up|23
6940323|NCT00939341|10976143|FG000|Overall Study|Withdrawal by Subject|13
6940324|NCT00939341|10976143|FG000|Overall Study|Protocol Violation|6
6940325|NCT00939341|10976143|FG000|Overall Study|Incorrect enrolment|8
6940326|NCT00939393|10976156|FG000|Overall Study|Withdrawal by Subject|1
6940327|NCT00939393|10976157|FG001|Overall Study|Withdrawal by Subject|0
6940328|NCT00939393|10976156|FG000|Overall Study|Lost to Follow-up|3
6940329|NCT00939393|10976157|FG001|Overall Study|Lost to Follow-up|0
6940330|NCT00939484|10976172|FG000|Overall Study|Progression/Relapse|8
6940331|NCT00939484|10976173|FG001|Overall Study|Progression/Relapse|20
6940332|NCT00939484|10976174|FG002|Overall Study|Progression/Relapse|3
6940333|NCT00939510|10976184|FG000|Overall Study|Withdrawal by Subject|1
6940334|NCT00939523|10976188|FG000|Overall Study|Lack of Efficacy|1
6940335|NCT00939523|10976188|FG000|Overall Study|Physician Decision|2
6940336|NCT00939627|10976210|FG000|Overall Study|Disease Progression|16
6940337|NCT00939627|10976211|FG001|Overall Study|Disease Progression|12
6940338|NCT00939627|10976212|FG002|Overall Study|Disease Progression|0
6940339|NCT00939627|10976210|FG000|Overall Study|Adverse Event|6
6940340|NCT00939627|10976211|FG001|Overall Study|Adverse Event|7
6940341|NCT00939627|10976212|FG002|Overall Study|Adverse Event|0
6940342|NCT00939627|10976210|FG000|Overall Study|Death|0
6940343|NCT00939627|10976211|FG001|Overall Study|Death|2
6940344|NCT00939627|10976212|FG002|Overall Study|Death|0
6940345|NCT00939627|10976210|FG000|Overall Study|Withdrawal by Subject|2
6940346|NCT00939627|10976211|FG001|Overall Study|Withdrawal by Subject|4
6940347|NCT00939627|10976212|FG002|Overall Study|Withdrawal by Subject|0
6940348|NCT00939627|10976210|FG000|Overall Study|Other complicating disease|1
6940349|NCT00939627|10976211|FG001|Overall Study|Other complicating disease|1
6940350|NCT00939627|10976212|FG002|Overall Study|Other complicating disease|0
6940351|NCT00939627|10976210|FG000|Overall Study|Not compliant|2
6940352|NCT00939627|10976211|FG001|Overall Study|Not compliant|0
6940353|NCT00939627|10976212|FG002|Overall Study|Not compliant|0
6940354|NCT00939627|10976210|FG000|Overall Study|No off-tx reason given|0
6940355|NCT00939627|10976211|FG001|Overall Study|No off-tx reason given|2
6940356|NCT00939627|10976212|FG002|Overall Study|No off-tx reason given|0
6940357|NCT00939640|10976218|FG000|Overall Study|Physician Decision|1
6940358|NCT00939692|10976234|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1
6940359|NCT00939692|10976235|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0
6940360|NCT00939692|10976234|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0
6940361|NCT00939692|10976235|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1
6940362|NCT00939770|10976265|FG000|Overall Study|Adverse Event|1
6940363|NCT00939770|10976266|FG001|Overall Study|Adverse Event|1
6940364|NCT00939770|10976267|FG002|Overall Study|Adverse Event|0
6940365|NCT00939770|10976268|FG003|Overall Study|Adverse Event|0
6940366|NCT00939770|10976269|FG004|Overall Study|Adverse Event|6
6940367|NCT00939770|10976270|FG005|Overall Study|Adverse Event|2
6940368|NCT00939770|10976271|FG006|Overall Study|Adverse Event|1
6940369|NCT00939770|10976272|FG007|Overall Study|Adverse Event|1
6940370|NCT00939770|10976265|FG000|Overall Study|Lack of Efficacy|4
6940371|NCT00939770|10976266|FG001|Overall Study|Lack of Efficacy|6
6940372|NCT00939770|10976267|FG002|Overall Study|Lack of Efficacy|13
6940373|NCT00939770|10976268|FG003|Overall Study|Lack of Efficacy|9
6940374|NCT00939770|10976269|FG004|Overall Study|Lack of Efficacy|16
6940375|NCT00939770|10976270|FG005|Overall Study|Lack of Efficacy|8
6940376|NCT00939770|10976271|FG006|Overall Study|Lack of Efficacy|11
6940377|NCT00939770|10976272|FG007|Overall Study|Lack of Efficacy|1
6940378|NCT00939770|10976265|FG000|Overall Study|Lost to Follow-up|0
6940379|NCT00939770|10976266|FG001|Overall Study|Lost to Follow-up|0
6940380|NCT00939770|10976267|FG002|Overall Study|Lost to Follow-up|0
6940381|NCT00939770|10976268|FG003|Overall Study|Lost to Follow-up|0
6940382|NCT00939770|10976269|FG004|Overall Study|Lost to Follow-up|1
6940383|NCT00939770|10976270|FG005|Overall Study|Lost to Follow-up|0
6940384|NCT00939770|10976271|FG006|Overall Study|Lost to Follow-up|0
6940385|NCT00939770|10976272|FG007|Overall Study|Lost to Follow-up|0
6940386|NCT00939770|10976265|FG000|Overall Study|Physician Decision|0
6940387|NCT00939770|10976266|FG001|Overall Study|Physician Decision|0
6940388|NCT00939770|10976267|FG002|Overall Study|Physician Decision|2
6940389|NCT00939770|10976268|FG003|Overall Study|Physician Decision|0
6940390|NCT00939770|10976269|FG004|Overall Study|Physician Decision|7
6940391|NCT00939770|10976270|FG005|Overall Study|Physician Decision|1
6940392|NCT00939770|10976271|FG006|Overall Study|Physician Decision|0
6940393|NCT00939770|10976272|FG007|Overall Study|Physician Decision|6
7067149|NCT01984294|11168101|FG002|Overall Study|Adverse Event|0
7067150|NCT01984424|11168126|FG000|Overall Study|Withdrawal by Subject|3
6940394|NCT00939770|10976265|FG000|Overall Study|Protocol Violation|0
6940395|NCT00939770|10976266|FG001|Overall Study|Protocol Violation|0
6940396|NCT00939770|10976267|FG002|Overall Study|Protocol Violation|0
6940397|NCT00939770|10976268|FG003|Overall Study|Protocol Violation|0
6940398|NCT00939770|10976269|FG004|Overall Study|Protocol Violation|1
6940399|NCT00939770|10976270|FG005|Overall Study|Protocol Violation|0
6940400|NCT00939770|10976271|FG006|Overall Study|Protocol Violation|0
6940401|NCT00939770|10976272|FG007|Overall Study|Protocol Violation|0
6940402|NCT00939770|10976265|FG000|Overall Study|Withdrawal by Subject|0
6940403|NCT00939770|10976266|FG001|Overall Study|Withdrawal by Subject|1
6940404|NCT00939770|10976267|FG002|Overall Study|Withdrawal by Subject|5
6940405|NCT00939770|10976268|FG003|Overall Study|Withdrawal by Subject|2
6940406|NCT00939770|10976269|FG004|Overall Study|Withdrawal by Subject|6
6940407|NCT00939770|10976270|FG005|Overall Study|Withdrawal by Subject|0
6940408|NCT00939770|10976271|FG006|Overall Study|Withdrawal by Subject|2
6940409|NCT00939770|10976272|FG007|Overall Study|Withdrawal by Subject|2
6940410|NCT00939783|10976303|FG000|Overall Study|Death|6
6940411|NCT00939783|10976303|FG000|Overall Study|Adverse Event|39
6940412|NCT00939783|10976303|FG000|Overall Study|Study Terminated by Sponsor|498
6940413|NCT00939783|10976303|FG000|Overall Study|Withdrawal by Subject|78
6940414|NCT00939783|10976303|FG000|Overall Study|Other|16
6940415|NCT00939783|10976303|FG000|Overall Study|Lost to Follow-up|8
6940416|NCT00939783|10976303|FG000|Overall Study|Protocol Violation|3
6940417|NCT00939783|10976303|FG000|Overall Study|Enrolled but not treated|1
6940418|NCT00939809|10976311|FG000|Overall Study|Adverse Event|2
6940419|NCT00939809|10976311|FG000|Overall Study|Death|1
6940420|NCT00939822|10976317|FG000|Overall Study|Lost to Follow-up|1
6940421|NCT00939822|10976318|FG001|Overall Study|Lost to Follow-up|0
6940422|NCT00939822|10976317|FG000|Overall Study|withdrew from study due to busy schedule|1
6940423|NCT00939822|10976318|FG001|Overall Study|withdrew from study due to busy schedule|1
6940424|NCT00939822|10976317|FG000|Overall Study|Mental health issues|0
6940425|NCT00939822|10976318|FG001|Overall Study|Mental health issues|2
6940426|NCT00940017|10976350|FG000|Overall Study|did not meet entrance criteria|3
6940427|NCT00940017|10976350|FG000|Overall Study|Adverse Event|1
6940428|NCT00940108|10976358|FG000|Overall Study|Adverse Event|2
6940429|NCT00940108|10976359|FG001|Overall Study|Adverse Event|4
6940430|NCT00940108|10976360|FG002|Overall Study|Adverse Event|0
6940431|NCT00940108|10976361|FG003|Overall Study|Adverse Event|2
6940432|NCT00940108|10976358|FG000|Overall Study|Withdrew Consent|2
6940433|NCT00940108|10976359|FG001|Overall Study|Withdrew Consent|1
6940434|NCT00940108|10976360|FG002|Overall Study|Withdrew Consent|0
6940435|NCT00940108|10976361|FG003|Overall Study|Withdrew Consent|1
6940436|NCT00940108|10976358|FG000|Overall Study|Dose 2 contraindicated|1
6940437|NCT00940108|10976359|FG001|Overall Study|Dose 2 contraindicated|1
6940438|NCT00940108|10976360|FG002|Overall Study|Dose 2 contraindicated|0
6940439|NCT00940108|10976361|FG003|Overall Study|Dose 2 contraindicated|1
6940440|NCT00940108|10976358|FG000|Overall Study|Declined further vaccination|0
6940441|NCT00940108|10976359|FG001|Overall Study|Declined further vaccination|1
6940442|NCT00940108|10976360|FG002|Overall Study|Declined further vaccination|3
6940443|NCT00940108|10976361|FG003|Overall Study|Declined further vaccination|0
6940444|NCT00940108|10976358|FG000|Overall Study|Refused - pyrexia after Dose 1|0
6940445|NCT00940108|10976359|FG001|Overall Study|Refused - pyrexia after Dose 1|1
6940446|NCT00940108|10976360|FG002|Overall Study|Refused - pyrexia after Dose 1|0
6940447|NCT00940108|10976361|FG003|Overall Study|Refused - pyrexia after Dose 1|0
6940448|NCT00940108|10976358|FG000|Overall Study|Viral illness after Dose 1|0
6940449|NCT00940108|10976359|FG001|Overall Study|Viral illness after Dose 1|1
6940450|NCT00940108|10976360|FG002|Overall Study|Viral illness after Dose 1|0
6940451|NCT00940108|10976361|FG003|Overall Study|Viral illness after Dose 1|0
6940452|NCT00940108|10976358|FG000|Overall Study|Diagnosed with H1N1|0
6940453|NCT00940108|10976359|FG001|Overall Study|Diagnosed with H1N1|0
6940454|NCT00940108|10976360|FG002|Overall Study|Diagnosed with H1N1|0
6940455|NCT00940108|10976361|FG003|Overall Study|Diagnosed with H1N1|1
6940456|NCT00940316|10976391|FG000|Reached First Response at 8 Weeks|Adverse Event|2
6940457|NCT00940316|10976392|FG001|Reached First Response at 8 Weeks|Adverse Event|1
6940458|NCT00940316|10976393|FG002|Reached First Response at 8 Weeks|Adverse Event|0
6940459|NCT00940316|10976391|FG000|Reached First Response at 8 Weeks|Progressive disease|1
6940460|NCT00940316|10976392|FG001|Reached First Response at 8 Weeks|Progressive disease|3
6940461|NCT00940316|10976393|FG002|Reached First Response at 8 Weeks|Progressive disease|0
6940462|NCT00940316|10976391|FG000|Moved on to be Treated Cycle 5|Adverse Event|2
6940463|NCT00940316|10976392|FG001|Moved on to be Treated Cycle 5|Adverse Event|0
6940464|NCT00940316|10976393|FG002|Moved on to be Treated Cycle 5|Adverse Event|0
6940465|NCT00940316|10976391|FG000|Treated After Cycle 5|Adverse Event|0
6940466|NCT00940316|10976392|FG001|Treated After Cycle 5|Adverse Event|0
6940467|NCT00940316|10976393|FG002|Treated After Cycle 5|Adverse Event|1
6940468|NCT00940316|10976391|FG000|Treated After Cycle 5|Progressive disease|0
6940469|NCT00940316|10976392|FG001|Treated After Cycle 5|Progressive disease|1
6940470|NCT00940316|10976393|FG002|Treated After Cycle 5|Progressive disease|0
6940471|NCT00940342|10976412|FG000|Overall Study|Adverse Event|0
6940472|NCT00940342|10976413|FG001|Overall Study|Adverse Event|2
6940473|NCT00940342|10976414|FG002|Overall Study|Adverse Event|1
6940474|NCT00940485|10976435|FG000|Overall Study|HBeAb positive at Baseline|3
6940475|NCT00940485|10976436|FG001|Overall Study|HBeAb positive at Baseline|2
6940476|NCT00940485|10976435|FG000|Overall Study|Lost to Follow-up|2
6940477|NCT00940485|10976436|FG001|Overall Study|Lost to Follow-up|3
6940478|NCT00940485|10976435|FG000|Overall Study|Adverse Event|8
6940479|NCT00940485|10976436|FG001|Overall Study|Adverse Event|0
6940480|NCT00940485|10976435|FG000|Overall Study|Withdrawal by Subject|1
6940481|NCT00940485|10976436|FG001|Overall Study|Withdrawal by Subject|1
6940482|NCT00940485|10976435|FG000|Overall Study|Others|1
6940483|NCT00940485|10976436|FG001|Overall Study|Others|1
6940484|NCT00940602|10976471|FG000|Overall Study|Administrative problems|1
6940485|NCT00940602|10976472|FG001|Overall Study|Administrative problems|1
6940486|NCT00940602|10976471|FG000|Overall Study|Patient/guardian decision|13
6940487|NCT00940602|10976472|FG001|Overall Study|Patient/guardian decision|28
6940488|NCT00940602|10976471|FG000|Overall Study|Physician Decision|8
6940489|NCT00940602|10976472|FG001|Overall Study|Physician Decision|5
6940490|NCT00940602|10976471|FG000|Overall Study|Pregnancy|1
6940491|NCT00940602|10976472|FG001|Overall Study|Pregnancy|0
6940492|NCT00940602|10976471|FG000|Overall Study|Protocol Deviation (untreated)|1
6940493|NCT00940602|10976472|FG001|Overall Study|Protocol Deviation (untreated)|0
6940494|NCT00940602|10976471|FG000|Overall Study|Disease progression|8
6940495|NCT00940602|10976472|FG001|Overall Study|Disease progression|2
6940496|NCT00940602|10976471|FG000|Overall Study|Death|38
6940497|NCT00940602|10976472|FG001|Overall Study|Death|19
6940498|NCT00940602|10976471|FG000|Overall Study|Lost to Follow-up|3
6940499|NCT00940602|10976472|FG001|Overall Study|Lost to Follow-up|1
6940500|NCT00940602|10976471|FG000|Overall Study|Patient withdrew consent|26
6940501|NCT00940602|10976472|FG001|Overall Study|Patient withdrew consent|13
6940502|NCT00940602|10976471|FG000|Overall Study|Adverse Event|7
6940503|NCT00940602|10976472|FG001|Overall Study|Adverse Event|2
6940504|NCT00940602|10976471|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43
6940505|NCT00940602|10976472|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5
6975500|NCT01193218|11027648|FG004|12-52 Weeks|Other reason than above|1
6975501|NCT01193218|11027649|FG005|12-52 Weeks|Other reason than above|0
6975502|NCT01193218|11027650|FG006|12-52 Weeks|Other reason than above|0
6975503|NCT01193218|11027651|FG007|12-52 Weeks|Other reason than above|0
6975504|NCT01193244|11027669|FG000|Overall Study|Withdrawal by Subject|79
6975505|NCT01193244|11027670|FG001|Overall Study|Withdrawal by Subject|97
6975506|NCT01193244|11027669|FG000|Overall Study|Other|303
6975507|NCT01193244|11027670|FG001|Overall Study|Other|278
6975508|NCT01193244|11027669|FG000|Overall Study|Lost to Follow-up|6
6975509|NCT01193244|11027670|FG001|Overall Study|Lost to Follow-up|15
6975510|NCT01193257|11027678|FG000|Overall Study|Death|202
6975511|NCT01193257|11027679|FG001|Overall Study|Death|391
6975512|NCT01193257|11027678|FG000|Overall Study|Study termination by sponsor|0
6975513|NCT01193257|11027679|FG001|Overall Study|Study termination by sponsor|3
6975514|NCT01193257|11027678|FG000|Overall Study|Withdrawal by Subject|26
6975515|NCT01193257|11027679|FG001|Overall Study|Withdrawal by Subject|86
6975516|NCT01193257|11027678|FG000|Overall Study|Lost to Follow-up|2
6975517|NCT01193257|11027679|FG001|Overall Study|Lost to Follow-up|3
6975518|NCT01193257|11027678|FG000|Overall Study|Unblinded due to futility|135
6975519|NCT01193257|11027679|FG001|Overall Study|Unblinded due to futility|251
6975520|NCT01193283|11027685|FG000|Overall Study|Death|1
6975521|NCT01193335|11027691|FG000|After Infant Series|Lost to Follow-up|1
6975522|NCT01193335|11027692|FG001|After Infant Series|Lost to Follow-up|2
6975523|NCT01193335|11027691|FG000|After Infant Series|No Longer Met Eligibility Criteria|0
6975524|NCT01193335|11027692|FG001|After Infant Series|No Longer Met Eligibility Criteria|1
6975525|NCT01193335|11027691|FG000|1-Year Follow-up|No Longer Willing to Participate|7
6975526|NCT01193335|11027692|FG001|1-Year Follow-up|No Longer Willing to Participate|9
6975527|NCT01193335|11027691|FG000|1-Year Follow-up|Lost to Follow-up|4
6975528|NCT01193335|11027692|FG001|1-Year Follow-up|Lost to Follow-up|0
6975529|NCT01193335|11027691|FG000|2-Year Follow-up|No Longer Willing to Participate|5
6975530|NCT01193335|11027692|FG001|2-Year Follow-up|No Longer Willing to Participate|6
6975531|NCT01193335|11027691|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2
6975532|NCT01193335|11027692|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2
6975533|NCT01193348|11027714|FG000|Screening Period|Screen Failure|5
6975534|NCT01193348|11027714|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1
6975535|NCT01193348|11027714|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1
6975536|NCT01193348|11027714|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1
6975537|NCT01193348|11027714|FG000|Extension Treatment Period|Physician Decision|1
6975538|NCT01193348|11027714|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2
6975539|NCT01193517|11027726|FG000|Overall Study|Early Progression|1
6975540|NCT01193517|11027727|FG001|Overall Study|Early Progression|0
6975541|NCT01193517|11027728|FG002|Overall Study|Early Progression|0
6975542|NCT01193582|11027741|FG000|Vaccination Series|Withdrawal by Subject|11
6975543|NCT01193582|11027742|FG001|Vaccination Series|Withdrawal by Subject|13
6975544|NCT01193582|11027743|FG002|Vaccination Series|Withdrawal by Subject|8
6975545|NCT01193582|11027744|FG003|Vaccination Series|Withdrawal by Subject|3
6975546|NCT01193582|11027741|FG000|12 Month Follow-up|Death|0
6975547|NCT01193582|11027742|FG001|12 Month Follow-up|Death|0
6975548|NCT01193582|11027743|FG002|12 Month Follow-up|Death|1
6975549|NCT01193582|11027744|FG003|12 Month Follow-up|Death|0
6975550|NCT01193582|11027741|FG000|12 Month Follow-up|Withdrawal by Subject|6
6975551|NCT01193582|11027742|FG001|12 Month Follow-up|Withdrawal by Subject|0
6975552|NCT01193582|11027743|FG002|12 Month Follow-up|Withdrawal by Subject|3
6975553|NCT01193582|11027744|FG003|12 Month Follow-up|Withdrawal by Subject|11
6975554|NCT01193608|11027762|FG000|Overall Study|Other|0
6975555|NCT01193608|11027763|FG001|Overall Study|Other|1
6975556|NCT01193608|11027764|FG002|Overall Study|Other|0
6975557|NCT01193608|11027765|FG003|Overall Study|Other|0
6975558|NCT01193608|11027766|FG004|Overall Study|Other|0
6975559|NCT01193608|11027767|FG005|Overall Study|Other|0
6975560|NCT01193608|11027762|FG000|Overall Study|Withdrawal by Subject|0
6975561|NCT01193608|11027763|FG001|Overall Study|Withdrawal by Subject|1
6975562|NCT01193608|11027764|FG002|Overall Study|Withdrawal by Subject|2
6975563|NCT01193608|11027765|FG003|Overall Study|Withdrawal by Subject|3
6975564|NCT01193608|11027766|FG004|Overall Study|Withdrawal by Subject|3
6975565|NCT01193608|11027767|FG005|Overall Study|Withdrawal by Subject|0
6975566|NCT01193608|11027762|FG000|Overall Study|Lost to Follow-up|0
6975567|NCT01193608|11027763|FG001|Overall Study|Lost to Follow-up|0
6975568|NCT01193608|11027764|FG002|Overall Study|Lost to Follow-up|0
6975569|NCT01193608|11027765|FG003|Overall Study|Lost to Follow-up|0
6975570|NCT01193608|11027766|FG004|Overall Study|Lost to Follow-up|1
6975571|NCT01193608|11027767|FG005|Overall Study|Lost to Follow-up|2
6975572|NCT01193608|11027762|FG000|Overall Study|Adverse Event|0
6975573|NCT01193608|11027763|FG001|Overall Study|Adverse Event|0
6975574|NCT01193608|11027764|FG002|Overall Study|Adverse Event|0
6940506|NCT00940823|10976485|FG000|Overall Study|Death|8
6940507|NCT00940823|10976486|FG001|Overall Study|Death|12
6940508|NCT00940823|10976485|FG000|Overall Study|Lost to Follow-up|27
6940509|NCT00940823|10976486|FG001|Overall Study|Lost to Follow-up|20
6940510|NCT00940875|10976496|FG000|Treatment Phase|Adverse Event|9
6940511|NCT00940875|10976497|FG001|Treatment Phase|Adverse Event|3
6940512|NCT00940875|10976496|FG000|Treatment Phase|Death|3
6940513|NCT00940875|10976497|FG001|Treatment Phase|Death|5
6940514|NCT00940875|10976496|FG000|Treatment Phase|Lack of Efficacy|1
6940515|NCT00940875|10976497|FG001|Treatment Phase|Lack of Efficacy|0
6940516|NCT00940875|10976496|FG000|Treatment Phase|Withdrawal by Subject|3
6940517|NCT00940875|10976497|FG001|Treatment Phase|Withdrawal by Subject|0
6940518|NCT00940875|10976496|FG000|Treatment Phase|Disease progression|9
6940519|NCT00940875|10976497|FG001|Treatment Phase|Disease progression|11
6940520|NCT00940875|10976496|FG000|Treatment Phase|Physician Decision|1
6940521|NCT00940875|10976497|FG001|Treatment Phase|Physician Decision|0
6940522|NCT00940875|10976496|FG000|Post-Study Treatment|Death|0
6940523|NCT00940875|10976497|FG001|Post-Study Treatment|Death|1
6940524|NCT00940875|10976496|FG000|Post-Study Treatment|Disease Progression|0
6940525|NCT00940875|10976497|FG001|Post-Study Treatment|Disease Progression|2
6940526|NCT00940888|10976504|FG000|Overall Study|Unsuccessful Implant|4
6940527|NCT00940888|10976504|FG000|Overall Study|Death|461
6940528|NCT00940888|10976504|FG000|Overall Study|Withdrawn - Non-Death|364
6940529|NCT00940888|10976504|FG000|Overall Study|Lost to Follow-up|6
6940530|NCT00940992|10976526|FG000|Overall Study|Adverse Event|2
6940531|NCT00940992|10976527|FG001|Overall Study|Adverse Event|0
6940532|NCT00940992|10976528|FG002|Overall Study|Adverse Event|1
6940533|NCT00940992|10976526|FG000|Overall Study|subject request|2
6940534|NCT00940992|10976527|FG001|Overall Study|subject request|1
6940535|NCT00940992|10976528|FG002|Overall Study|subject request|0
6940536|NCT00940992|10976526|FG000|Overall Study|Lost to Follow-up|0
6940537|NCT00940992|10976527|FG001|Overall Study|Lost to Follow-up|1
6940538|NCT00940992|10976528|FG002|Overall Study|Lost to Follow-up|1
6940539|NCT00941031|10976551|FG000|Induction Period|Lack of Efficacy|2
6940540|NCT00941031|10976552|FG001|Induction Period|Lack of Efficacy|1
6940541|NCT00941031|10976553|FG002|Induction Period|Lack of Efficacy|0
6940542|NCT00941031|10976554|FG003|Induction Period|Lack of Efficacy|5
6940543|NCT00941031|10976555|FG004|Induction Period|Lack of Efficacy|0
6940544|NCT00941031|10976556|FG005|Induction Period|Lack of Efficacy|0
6940545|NCT00941031|10976557|FG006|Induction Period|Lack of Efficacy|0
6940546|NCT00941031|10976551|FG000|Induction Period|Withdrawal by Subject|1
6940547|NCT00941031|10976552|FG001|Induction Period|Withdrawal by Subject|2
6940548|NCT00941031|10976553|FG002|Induction Period|Withdrawal by Subject|2
6940549|NCT00941031|10976554|FG003|Induction Period|Withdrawal by Subject|2
7040254|NCT01716520|11123211|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
7040255|NCT01716520|11123212|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
7040256|NCT01716520|11123213|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
7040257|NCT01716520|11123214|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
7040258|NCT01716520|11123209|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0
7040259|NCT01716520|11123210|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0
7067151|NCT01984424|11168127|FG001|Overall Study|Withdrawal by Subject|5
7067152|NCT01984424|11168126|FG000|Overall Study|Sponsor Decision|0
7067153|NCT01984424|11168127|FG001|Overall Study|Sponsor Decision|1
7067154|NCT01984424|11168126|FG000|Overall Study|Lost to Follow-up|0
7067155|NCT01984424|11168127|FG001|Overall Study|Lost to Follow-up|1
7067156|NCT01984684|11168139|FG000|Overall Study|Lost to Follow-up|25
7067157|NCT01984684|11168140|FG001|Overall Study|Lost to Follow-up|24
7067158|NCT01984684|11168139|FG000|Overall Study|Adverse Event|8
7040260|NCT01716520|11123211|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0
7040261|NCT01716520|11123212|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0
7040262|NCT01716520|11123213|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0
7040263|NCT01716520|11123214|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2
7040264|NCT01716520|11123209|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
7040265|NCT01716520|11123210|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
7040266|NCT01716520|11123211|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
7040267|NCT01716520|11123212|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
7067159|NCT01984684|11168140|FG001|Overall Study|Adverse Event|12
7067160|NCT01984684|11168139|FG000|Overall Study|Withdrawal by Subject|9
7067161|NCT01984684|11168140|FG001|Overall Study|Withdrawal by Subject|9
7067162|NCT01984684|11168139|FG000|Overall Study|Lack of Efficacy|3
7067163|NCT01984684|11168140|FG001|Overall Study|Lack of Efficacy|6
6940550|NCT00941031|10976555|FG004|Induction Period|Withdrawal by Subject|0
6940551|NCT00941031|10976556|FG005|Induction Period|Withdrawal by Subject|0
6940552|NCT00941031|10976557|FG006|Induction Period|Withdrawal by Subject|0
6940553|NCT00941031|10976551|FG000|Induction Period|Adminstative Problems|1
6940554|NCT00941031|10976552|FG001|Induction Period|Adminstative Problems|1
7040268|NCT01716520|11123213|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
7067164|NCT01984684|11168139|FG000|Overall Study|Physician Decision|4
7067165|NCT01984684|11168140|FG001|Overall Study|Physician Decision|2
6940555|NCT00941031|10976553|FG002|Induction Period|Adminstative Problems|1
6940556|NCT00941031|10976554|FG003|Induction Period|Adminstative Problems|0
6940557|NCT00941031|10976555|FG004|Induction Period|Adminstative Problems|0
6940558|NCT00941031|10976556|FG005|Induction Period|Adminstative Problems|0
7040269|NCT01716520|11123214|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
7040270|NCT01716533|11123226|FG000|Overall Study|Failure of antibiotic treatment to treat|0
7040271|NCT01716533|11123227|FG001|Overall Study|Failure of antibiotic treatment to treat|0
7040272|NCT01716533|11123228|FG002|Overall Study|Failure of antibiotic treatment to treat|5
7040273|NCT01716533|11123229|FG003|Overall Study|Failure of antibiotic treatment to treat|0
7040274|NCT01716533|11123226|FG000|Overall Study|Withdrawal by Subject|0
7040275|NCT01716533|11123227|FG001|Overall Study|Withdrawal by Subject|0
7040276|NCT01716533|11123228|FG002|Overall Study|Withdrawal by Subject|0
7040277|NCT01716533|11123229|FG003|Overall Study|Withdrawal by Subject|5
7040278|NCT01716533|11123226|FG000|Overall Study|Death|0
7040279|NCT01716533|11123227|FG001|Overall Study|Death|0
7040280|NCT01716533|11123228|FG002|Overall Study|Death|0
7040281|NCT01716533|11123229|FG003|Overall Study|Death|2
7040282|NCT01716533|11123226|FG000|Overall Study|Immunosuppressants>14days past 6months|0
7040283|NCT01716533|11123227|FG001|Overall Study|Immunosuppressants>14days past 6months|0
7040284|NCT01716533|11123228|FG002|Overall Study|Immunosuppressants>14days past 6months|0
7040285|NCT01716533|11123229|FG003|Overall Study|Immunosuppressants>14days past 6months|1
7040286|NCT01716559|11123243|FG000|Overall Study|Adverse Event|11
7040287|NCT01716559|11123243|FG000|Overall Study|Death|21
7040288|NCT01716559|11123243|FG000|Overall Study|Withdrawal by Subject|4
7040289|NCT01716559|11123243|FG000|Overall Study|Other withdrawal reason|75
7040290|NCT01716585|11123249|FG000|Double-blind Treatment|Did Not Receive Study Drug|4
7040291|NCT01716585|11123250|FG001|Double-blind Treatment|Did Not Receive Study Drug|1
7040292|NCT01716585|11123249|FG000|Double-blind Treatment|Adverse Event|2
7040293|NCT01716585|11123250|FG001|Double-blind Treatment|Adverse Event|1
7040294|NCT01716585|11123249|FG000|Double-blind Treatment|Withdrawal by Subject|3
7040295|NCT01716585|11123250|FG001|Double-blind Treatment|Withdrawal by Subject|0
7040296|NCT01716585|11123249|FG000|Double-blind Treatment|Lost to Follow-up|2
7040297|NCT01716585|11123250|FG001|Double-blind Treatment|Lost to Follow-up|0
7040298|NCT01716585|11123249|FG000|Double-blind Treatment|Subject Noncompliant|1
7040299|NCT01716585|11123250|FG001|Double-blind Treatment|Subject Noncompliant|0
7040300|NCT01716585|11123249|FG000|Double-blind Treatment|Other|1
7040301|NCT01716585|11123250|FG001|Double-blind Treatment|Other|0
7040302|NCT01716585|11123249|FG000|Open-label Treatment|Adverse Event|0
7040303|NCT01716585|11123250|FG001|Open-label Treatment|Adverse Event|2
7040304|NCT01716585|11123249|FG000|Open-label Treatment|Virologic Failure|0
7040305|NCT01716585|11123250|FG001|Open-label Treatment|Virologic Failure|2
7040306|NCT01716585|11123249|FG000|Open-label Treatment|Withdrawal by Subject|0
7040307|NCT01716585|11123250|FG001|Open-label Treatment|Withdrawal by Subject|3
7040308|NCT01716663|11123257|FG000|Overall Study|Withdrawn prior to procedure|4
7040309|NCT01716663|11123257|FG000|Overall Study|Treated with non-study catheter|2
7040310|NCT01716715|11123263|FG000|Overall Study|Never Treated|2
7040311|NCT01716715|11123264|FG001|Overall Study|Never Treated|4
7040312|NCT01716754|11123276|FG000|Overall Study|Death|0
7040313|NCT01716754|11123277|FG001|Overall Study|Death|0
7040314|NCT01716754|11123278|FG002|Overall Study|Death|0
7040315|NCT01716754|11123279|FG003|Overall Study|Death|1
7040316|NCT01716754|11123276|FG000|Overall Study|Protocol deviation|0
7040317|NCT01716754|11123277|FG001|Overall Study|Protocol deviation|2
7040318|NCT01716754|11123278|FG002|Overall Study|Protocol deviation|7
7040319|NCT01716754|11123279|FG003|Overall Study|Protocol deviation|2
7040320|NCT01716754|11123276|FG000|Overall Study|Non-compliance with study treatment|0
7040321|NCT01716754|11123277|FG001|Overall Study|Non-compliance with study treatment|0
7040322|NCT01716754|11123278|FG002|Overall Study|Non-compliance with study treatment|1
7040323|NCT01716754|11123279|FG003|Overall Study|Non-compliance with study treatment|0
7040324|NCT01716754|11123276|FG000|Overall Study|Physician Decision|1
7040325|NCT01716754|11123277|FG001|Overall Study|Physician Decision|0
7040326|NCT01716754|11123278|FG002|Overall Study|Physician Decision|0
7040327|NCT01716754|11123279|FG003|Overall Study|Physician Decision|0
7040328|NCT01716754|11123276|FG000|Overall Study|Lost to Follow-up|1
7040329|NCT01716754|11123277|FG001|Overall Study|Lost to Follow-up|0
7040330|NCT01716754|11123278|FG002|Overall Study|Lost to Follow-up|0
7040331|NCT01716754|11123279|FG003|Overall Study|Lost to Follow-up|1
7040332|NCT01716754|11123276|FG000|Overall Study|Adverse Event|4
7040333|NCT01716754|11123277|FG001|Overall Study|Adverse Event|2
7040334|NCT01716754|11123278|FG002|Overall Study|Adverse Event|2
7040335|NCT01716754|11123279|FG003|Overall Study|Adverse Event|1
7040336|NCT01716754|11123276|FG000|Overall Study|Withdrawal by Subject|5
7040337|NCT01716754|11123277|FG001|Overall Study|Withdrawal by Subject|0
7040338|NCT01716754|11123278|FG002|Overall Study|Withdrawal by Subject|4
7040339|NCT01716754|11123279|FG003|Overall Study|Withdrawal by Subject|3
7040340|NCT01717040|11123303|FG000|Overall Study|Lost to Follow-up|2
7040341|NCT01717040|11123304|FG001|Overall Study|Lost to Follow-up|3
7040342|NCT01717040|11123303|FG000|Overall Study|Lack of Efficacy|1
7040343|NCT01717040|11123304|FG001|Overall Study|Lack of Efficacy|1
7040344|NCT01717040|11123303|FG000|Overall Study|Adverse Event|1
7040345|NCT01717040|11123304|FG001|Overall Study|Adverse Event|0
7040346|NCT01717040|11123303|FG000|Overall Study|Required Medication Change|0
7040347|NCT01717040|11123304|FG001|Overall Study|Required Medication Change|1
7040348|NCT01717040|11123303|FG000|Overall Study|New Substance Use Disorder|1
7040349|NCT01717040|11123304|FG001|Overall Study|New Substance Use Disorder|0
7040350|NCT01717287|11123320|FG000|Overall Study|Lost to Follow-up|0
7040351|NCT01717287|11123321|FG001|Overall Study|Lost to Follow-up|2
7040352|NCT01717287|11123320|FG000|Overall Study|Protocol Violation|0
7040353|NCT01717287|11123321|FG001|Overall Study|Protocol Violation|1
7040354|NCT01717313|11123329|FG000|Phase A (Weeks 0 to 24)|Death|0
7040355|NCT01717313|11123330|FG001|Phase A (Weeks 0 to 24)|Death|1
7040356|NCT01717313|11123329|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1
7040357|NCT01717313|11123330|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3
7040358|NCT01717313|11123329|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12
7040359|NCT01717313|11123330|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6
7040360|NCT01717313|11123329|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4
7040361|NCT01717313|11123330|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2
7040362|NCT01717313|11123329|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
7040363|NCT01717313|11123330|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
7040364|NCT01717313|11123329|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1
7040365|NCT01717313|11123330|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0
7040366|NCT01717313|11123329|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
7040367|NCT01717313|11123330|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
7040368|NCT01717313|11123329|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7
7040369|NCT01717313|11123330|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9
7040370|NCT01717313|11123329|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1
7040371|NCT01717313|11123330|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3
7040372|NCT01717326|11123356|FG000|Overall Study|Death|0
7040373|NCT01717326|11123357|FG001|Overall Study|Death|0
7040374|NCT01717326|11123358|FG002|Overall Study|Death|0
7040375|NCT01717326|11123359|FG003|Overall Study|Death|0
7040376|NCT01717326|11123360|FG004|Overall Study|Death|0
7040377|NCT01717326|11123361|FG005|Overall Study|Death|0
7040378|NCT01717326|11123362|FG006|Overall Study|Death|0
7040379|NCT01717326|11123363|FG007|Overall Study|Death|0
7040380|NCT01717326|11123364|FG008|Overall Study|Death|0
7040381|NCT01717326|11123365|FG009|Overall Study|Death|0
7040382|NCT01717326|11123366|FG010|Overall Study|Death|1
7040383|NCT01717326|11123367|FG011|Overall Study|Death|0
7040384|NCT01717326|11123368|FG012|Overall Study|Death|0
7040385|NCT01717326|11123369|FG013|Overall Study|Death|0
7040386|NCT01717326|11123370|FG014|Overall Study|Death|0
7040387|NCT01717326|11123371|FG015|Overall Study|Death|0
7040388|NCT01717326|11123372|FG016|Overall Study|Death|0
7040389|NCT01717326|11123373|FG017|Overall Study|Death|0
7040390|NCT01717326|11123374|FG018|Overall Study|Death|0
7040391|NCT01717326|11123375|FG019|Overall Study|Death|0
7040392|NCT01717326|11123356|FG000|Overall Study|Lost to Follow-up|3
7040393|NCT01717326|11123357|FG001|Overall Study|Lost to Follow-up|0
7040394|NCT01717326|11123358|FG002|Overall Study|Lost to Follow-up|0
7040395|NCT01717326|11123359|FG003|Overall Study|Lost to Follow-up|2
7040396|NCT01717326|11123360|FG004|Overall Study|Lost to Follow-up|1
7040397|NCT01717326|11123361|FG005|Overall Study|Lost to Follow-up|0
7040398|NCT01717326|11123362|FG006|Overall Study|Lost to Follow-up|1
7040399|NCT01717326|11123363|FG007|Overall Study|Lost to Follow-up|0
7040400|NCT01717326|11123364|FG008|Overall Study|Lost to Follow-up|0
7040401|NCT01717326|11123365|FG009|Overall Study|Lost to Follow-up|0
7040402|NCT01717326|11123366|FG010|Overall Study|Lost to Follow-up|1
7040403|NCT01717326|11123367|FG011|Overall Study|Lost to Follow-up|0
7040404|NCT01717326|11123368|FG012|Overall Study|Lost to Follow-up|0
7040405|NCT01717326|11123369|FG013|Overall Study|Lost to Follow-up|0
7040406|NCT01717326|11123370|FG014|Overall Study|Lost to Follow-up|0
7067166|NCT01984684|11168139|FG000|Overall Study|Protocol Violation|4
6940559|NCT00941031|10976557|FG006|Induction Period|Adminstative Problems|0
6940560|NCT00941031|10976551|FG000|Induction Period|Adverse Event|1
6940561|NCT00941031|10976552|FG001|Induction Period|Adverse Event|0
6940562|NCT00941031|10976553|FG002|Induction Period|Adverse Event|3
6940563|NCT00941031|10976554|FG003|Induction Period|Adverse Event|2
6940564|NCT00941031|10976555|FG004|Induction Period|Adverse Event|0
6940565|NCT00941031|10976556|FG005|Induction Period|Adverse Event|0
6940566|NCT00941031|10976557|FG006|Induction Period|Adverse Event|0
6940567|NCT00941031|10976551|FG000|Maintenance Period|Withdrawal by Subject|0
6940568|NCT00941031|10976552|FG001|Maintenance Period|Withdrawal by Subject|0
6940569|NCT00941031|10976553|FG002|Maintenance Period|Withdrawal by Subject|0
6940570|NCT00941031|10976554|FG003|Maintenance Period|Withdrawal by Subject|0
7040407|NCT01717326|11123371|FG015|Overall Study|Lost to Follow-up|2
7040408|NCT01717326|11123372|FG016|Overall Study|Lost to Follow-up|1
7040409|NCT01717326|11123373|FG017|Overall Study|Lost to Follow-up|0
7040410|NCT01717326|11123374|FG018|Overall Study|Lost to Follow-up|2
7040411|NCT01717326|11123375|FG019|Overall Study|Lost to Follow-up|3
7040412|NCT01717326|11123356|FG000|Overall Study|Physician Decision|0
7040413|NCT01717326|11123357|FG001|Overall Study|Physician Decision|0
7040414|NCT01717326|11123358|FG002|Overall Study|Physician Decision|0
7040415|NCT01717326|11123359|FG003|Overall Study|Physician Decision|0
7040416|NCT01717326|11123360|FG004|Overall Study|Physician Decision|0
7040417|NCT01717326|11123361|FG005|Overall Study|Physician Decision|0
7040418|NCT01717326|11123362|FG006|Overall Study|Physician Decision|0
7040419|NCT01717326|11123363|FG007|Overall Study|Physician Decision|0
7040420|NCT01717326|11123364|FG008|Overall Study|Physician Decision|0
7040421|NCT01717326|11123365|FG009|Overall Study|Physician Decision|1
7040422|NCT01717326|11123366|FG010|Overall Study|Physician Decision|0
7040423|NCT01717326|11123367|FG011|Overall Study|Physician Decision|0
6940571|NCT00941031|10976555|FG004|Maintenance Period|Withdrawal by Subject|6
6940572|NCT00941031|10976556|FG005|Maintenance Period|Withdrawal by Subject|2
6940573|NCT00941031|10976557|FG006|Maintenance Period|Withdrawal by Subject|13
6940574|NCT00941031|10976551|FG000|Maintenance Period|Administrative Problems|0
6940575|NCT00941031|10976552|FG001|Maintenance Period|Administrative Problems|0
6940576|NCT00941031|10976553|FG002|Maintenance Period|Administrative Problems|0
6940577|NCT00941031|10976554|FG003|Maintenance Period|Administrative Problems|0
6940578|NCT00941031|10976555|FG004|Maintenance Period|Administrative Problems|1
6940579|NCT00941031|10976556|FG005|Maintenance Period|Administrative Problems|0
6940580|NCT00941031|10976557|FG006|Maintenance Period|Administrative Problems|1
6940581|NCT00941031|10976551|FG000|Maintenance Period|Protocol Violation|0
6940582|NCT00941031|10976552|FG001|Maintenance Period|Protocol Violation|0
6940583|NCT00941031|10976553|FG002|Maintenance Period|Protocol Violation|0
6940584|NCT00941031|10976554|FG003|Maintenance Period|Protocol Violation|0
6940585|NCT00941031|10976555|FG004|Maintenance Period|Protocol Violation|0
6940586|NCT00941031|10976556|FG005|Maintenance Period|Protocol Violation|0
6940587|NCT00941031|10976557|FG006|Maintenance Period|Protocol Violation|1
6940588|NCT00941031|10976551|FG000|Maintenance Period|Adverse Event|0
6940589|NCT00941031|10976552|FG001|Maintenance Period|Adverse Event|0
6940590|NCT00941031|10976553|FG002|Maintenance Period|Adverse Event|0
6940591|NCT00941031|10976554|FG003|Maintenance Period|Adverse Event|0
6940592|NCT00941031|10976555|FG004|Maintenance Period|Adverse Event|0
6940593|NCT00941031|10976556|FG005|Maintenance Period|Adverse Event|2
6940594|NCT00941031|10976557|FG006|Maintenance Period|Adverse Event|8
6940595|NCT00941031|10976551|FG000|Maintenance Period|Lost to Follow-up|0
6940596|NCT00941031|10976552|FG001|Maintenance Period|Lost to Follow-up|0
6940597|NCT00941031|10976553|FG002|Maintenance Period|Lost to Follow-up|0
6940598|NCT00941031|10976554|FG003|Maintenance Period|Lost to Follow-up|0
6940599|NCT00941031|10976555|FG004|Maintenance Period|Lost to Follow-up|2
6940600|NCT00941031|10976556|FG005|Maintenance Period|Lost to Follow-up|2
6940601|NCT00941031|10976557|FG006|Maintenance Period|Lost to Follow-up|7
6940602|NCT00941031|10976551|FG000|Maintenance Period|Lack of Efficacy|0
6940603|NCT00941031|10976552|FG001|Maintenance Period|Lack of Efficacy|0
6940604|NCT00941031|10976553|FG002|Maintenance Period|Lack of Efficacy|0
6940605|NCT00941031|10976554|FG003|Maintenance Period|Lack of Efficacy|0
6940606|NCT00941031|10976555|FG004|Maintenance Period|Lack of Efficacy|0
6940607|NCT00941031|10976556|FG005|Maintenance Period|Lack of Efficacy|0
6940608|NCT00941031|10976557|FG006|Maintenance Period|Lack of Efficacy|13
6940609|NCT00941070|10976576|FG000|Overall Study|Patient non-compliant|1
6940610|NCT00941304|10976587|FG000|Overall Study|Lost to Follow-up|1
6940611|NCT00941304|10976588|FG001|Overall Study|Lost to Follow-up|0
6940612|NCT00941304|10976589|FG002|Overall Study|Lost to Follow-up|0
6940613|NCT00941304|10976590|FG003|Overall Study|Lost to Follow-up|0
6940614|NCT00941304|10976591|FG004|Overall Study|Lost to Follow-up|0
6940615|NCT00941330|10976605|FG000|Overall Study|Other|1
6940616|NCT00941330|10976606|FG001|Overall Study|Other|0
6940617|NCT00941330|10976605|FG000|Overall Study|Physician Decision|0
6940618|NCT00941330|10976606|FG001|Overall Study|Physician Decision|2
6940619|NCT00941603|10976618|FG000|Overall Study|Adverse Event|10
6940620|NCT00941603|10976619|FG001|Overall Study|Adverse Event|15
6940621|NCT00941603|10976620|FG002|Overall Study|Adverse Event|5
6940622|NCT00941603|10976621|FG003|Overall Study|Adverse Event|1
6940623|NCT00941603|10976622|FG004|Overall Study|Adverse Event|4
6940624|NCT00941603|10976623|FG005|Overall Study|Adverse Event|0
6940625|NCT00941603|10976618|FG000|Overall Study|Lost to Follow-up|0
6940626|NCT00941603|10976619|FG001|Overall Study|Lost to Follow-up|0
6940627|NCT00941603|10976620|FG002|Overall Study|Lost to Follow-up|0
6940628|NCT00941603|10976621|FG003|Overall Study|Lost to Follow-up|1
6940629|NCT00941603|10976622|FG004|Overall Study|Lost to Follow-up|0
6940630|NCT00941603|10976623|FG005|Overall Study|Lost to Follow-up|2
6940631|NCT00941603|10976618|FG000|Overall Study|Withdrawal by Subject|0
6940632|NCT00941603|10976619|FG001|Overall Study|Withdrawal by Subject|0
6940633|NCT00941603|10976620|FG002|Overall Study|Withdrawal by Subject|0
6940634|NCT00941603|10976621|FG003|Overall Study|Withdrawal by Subject|2
6940635|NCT00941603|10976622|FG004|Overall Study|Withdrawal by Subject|0
6940636|NCT00941603|10976623|FG005|Overall Study|Withdrawal by Subject|1
6940637|NCT00941603|10976618|FG000|Overall Study|Protocol Violation|0
6940638|NCT00941603|10976619|FG001|Overall Study|Protocol Violation|1
6940639|NCT00941603|10976620|FG002|Overall Study|Protocol Violation|0
6940640|NCT00941603|10976621|FG003|Overall Study|Protocol Violation|0
6940641|NCT00941603|10976622|FG004|Overall Study|Protocol Violation|0
6940642|NCT00941603|10976623|FG005|Overall Study|Protocol Violation|0
6940643|NCT00941603|10976618|FG000|Overall Study|Did not meet protocol eligibility|1
6940644|NCT00941603|10976619|FG001|Overall Study|Did not meet protocol eligibility|0
6940645|NCT00941603|10976620|FG002|Overall Study|Did not meet protocol eligibility|0
6940646|NCT00941603|10976621|FG003|Overall Study|Did not meet protocol eligibility|0
6940647|NCT00941603|10976622|FG004|Overall Study|Did not meet protocol eligibility|0
6940648|NCT00941603|10976623|FG005|Overall Study|Did not meet protocol eligibility|0
6940649|NCT00941655|10976639|FG000|Overall Study|received some chemo, 4 and 9 cycles|1
6940650|NCT00941655|10976640|FG001|Overall Study|received some chemo, 4 and 9 cycles|0
6940651|NCT00941655|10976639|FG000|Overall Study|not meet criteria for chemo foll surgery|4
6940652|NCT00941655|10976640|FG001|Overall Study|not meet criteria for chemo foll surgery|0
6940653|NCT00941655|10976639|FG000|Overall Study|progressed while on chemo|0
6940654|NCT00941655|10976640|FG001|Overall Study|progressed while on chemo|2
6940655|NCT00941655|10976639|FG000|Overall Study|refused further treatment|0
6940656|NCT00941655|10976640|FG001|Overall Study|refused further treatment|1
6940657|NCT00941655|10976639|FG000|Overall Study|withdrew consent|0
6940658|NCT00941655|10976640|FG001|Overall Study|withdrew consent|1
6940659|NCT00941655|10976639|FG000|Overall Study|non-compliant|0
6940660|NCT00941655|10976640|FG001|Overall Study|non-compliant|1
6940661|NCT00941720|10976669|FG000|Overall Study|Withdrawal by Subject|1
6940662|NCT00941720|10976669|FG000|Overall Study|Insurance denied participation|11
6940663|NCT00941720|10976669|FG000|Overall Study|ineligible|2
6940664|NCT00941733|10976675|FG000|Overall Study|Death|24
6940665|NCT00941733|10976676|FG001|Overall Study|Death|10
6940666|NCT00941733|10976675|FG000|Overall Study|Withdrawal by Subject|14
6940667|NCT00941733|10976676|FG001|Overall Study|Withdrawal by Subject|6
6940668|NCT00941733|10976675|FG000|Overall Study|Adverse Event|20
6940669|NCT00941733|10976676|FG001|Overall Study|Adverse Event|4
6940670|NCT00941733|10976675|FG000|Overall Study|Lost to Follow-up|1
6940671|NCT00941733|10976676|FG001|Overall Study|Lost to Follow-up|2
6940672|NCT00941733|10976675|FG000|Overall Study|Protocol Violation|15
6940673|NCT00941733|10976676|FG001|Overall Study|Protocol Violation|6
6940674|NCT00941798|10976684|FG000|Overall Study|Withdrawal by Subject|72
6940675|NCT00941798|10976685|FG001|Overall Study|Withdrawal by Subject|74
6940676|NCT00941798|10976684|FG000|Overall Study|Adverse Event|43
6940677|NCT00941798|10976685|FG001|Overall Study|Adverse Event|23
6940678|NCT00941798|10976684|FG000|Overall Study|Lost to Follow-up|29
6940679|NCT00941798|10976685|FG001|Overall Study|Lost to Follow-up|23
6940680|NCT00941798|10976684|FG000|Overall Study|Protocol Violation|17
6940681|NCT00941798|10976685|FG001|Overall Study|Protocol Violation|20
6940682|NCT00941798|10976684|FG000|Overall Study|Administrative problems|13
6940683|NCT00941798|10976685|FG001|Overall Study|Administrative problems|23
6940684|NCT00941798|10976684|FG000|Overall Study|Lack of Efficacy|10
6940685|NCT00941798|10976685|FG001|Overall Study|Lack of Efficacy|17
6940686|NCT00941798|10976684|FG000|Overall Study|Patient's inability to use device|6
6940687|NCT00941798|10976685|FG001|Overall Study|Patient's inability to use device|1
6940688|NCT00941798|10976684|FG000|Overall Study|Abnormal test procedure results|3
6940689|NCT00941798|10976685|FG001|Overall Study|Abnormal test procedure results|1
6940690|NCT00941798|10976684|FG000|Overall Study|Abnormal laboratory values|1
6940691|NCT00941798|10976685|FG001|Overall Study|Abnormal laboratory values|2
6940692|NCT00941798|10976684|FG000|Overall Study|Death|0
6940693|NCT00941798|10976685|FG001|Overall Study|Death|1
6940694|NCT00941863|10976696|FG000|Until Primary Completion Date (PCD)|Adverse Event|1
6940695|NCT00941863|10976697|FG001|Until Primary Completion Date (PCD)|Adverse Event|2
6940696|NCT00941863|10976698|FG002|Until Primary Completion Date (PCD)|Adverse Event|2
6940697|NCT00941863|10976699|FG003|Until Primary Completion Date (PCD)|Adverse Event|1
6940698|NCT00941863|10976700|FG004|Until Primary Completion Date (PCD)|Adverse Event|5
6940699|NCT00941863|10976696|FG000|Until Primary Completion Date (PCD)|Physician Decision|0
6940700|NCT00941863|10976697|FG001|Until Primary Completion Date (PCD)|Physician Decision|0
6940701|NCT00941863|10976698|FG002|Until Primary Completion Date (PCD)|Physician Decision|0
6940702|NCT00941863|10976699|FG003|Until Primary Completion Date (PCD)|Physician Decision|0
6940703|NCT00941863|10976700|FG004|Until Primary Completion Date (PCD)|Physician Decision|1
6940704|NCT00941863|10976696|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
6940705|NCT00941863|10976697|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
6940706|NCT00941863|10976698|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1
6940707|NCT00941863|10976699|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
6940708|NCT00941863|10976700|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8
6940709|NCT00941863|10976696|FG000|Until Primary Completion Date (PCD)|Death|0
6940710|NCT00941863|10976697|FG001|Until Primary Completion Date (PCD)|Death|0
6940711|NCT00941863|10976698|FG002|Until Primary Completion Date (PCD)|Death|1
6940712|NCT00941863|10976699|FG003|Until Primary Completion Date (PCD)|Death|2
6940713|NCT00941863|10976700|FG004|Until Primary Completion Date (PCD)|Death|7
6940714|NCT00941863|10976696|FG000|Until Primary Completion Date (PCD)|Disease progression|6
6940715|NCT00941863|10976697|FG001|Until Primary Completion Date (PCD)|Disease progression|1
6940716|NCT00941863|10976698|FG002|Until Primary Completion Date (PCD)|Disease progression|8
6940717|NCT00941863|10976699|FG003|Until Primary Completion Date (PCD)|Disease progression|14
6940718|NCT00941863|10976700|FG004|Until Primary Completion Date (PCD)|Disease progression|73
6940719|NCT00941863|10976696|FG000|Continued After PCD|Withdrawal by Subject|0
6940720|NCT00941863|10976697|FG001|Continued After PCD|Withdrawal by Subject|0
6940721|NCT00941863|10976698|FG002|Continued After PCD|Withdrawal by Subject|0
6940722|NCT00941863|10976699|FG003|Continued After PCD|Withdrawal by Subject|0
6940723|NCT00941863|10976700|FG004|Continued After PCD|Withdrawal by Subject|1
6940724|NCT00941863|10976696|FG000|Continued After PCD|Disease progression, recurrence, relapse|0
6940725|NCT00941863|10976697|FG001|Continued After PCD|Disease progression, recurrence, relapse|0
6940726|NCT00941863|10976698|FG002|Continued After PCD|Disease progression, recurrence, relapse|0
6940727|NCT00941863|10976699|FG003|Continued After PCD|Disease progression, recurrence, relapse|0
6940728|NCT00941863|10976700|FG004|Continued After PCD|Disease progression, recurrence, relapse|18
6940729|NCT00942084|10976730|FG000|Overall Study|Death|2
6940730|NCT00942162|10976741|FG000|Overall Study|Death|45
6940731|NCT00942162|10976742|FG001|Overall Study|Death|35
6940732|NCT00942162|10976743|FG002|Overall Study|Death|0
6940733|NCT00942162|10976741|FG000|Overall Study|Withdrawal by Subject|7
6940734|NCT00942162|10976742|FG001|Overall Study|Withdrawal by Subject|2
6940735|NCT00942162|10976743|FG002|Overall Study|Withdrawal by Subject|0
6940736|NCT00942162|10976741|FG000|Overall Study|Lost to Follow-up|4
6940737|NCT00942162|10976742|FG001|Overall Study|Lost to Follow-up|0
6940738|NCT00942162|10976743|FG002|Overall Study|Lost to Follow-up|0
6940739|NCT00942162|10976741|FG000|Overall Study|Other|14
6940740|NCT00942162|10976742|FG001|Overall Study|Other|13
6940741|NCT00942162|10976743|FG002|Overall Study|Other|2
6940742|NCT00942175|10976757|FG000|Overall Study|Adverse Event|2
6940743|NCT00942175|10976758|FG001|Overall Study|Adverse Event|1
6940744|NCT00942175|10976759|FG002|Overall Study|Adverse Event|0
6940745|NCT00942175|10976760|FG003|Overall Study|Adverse Event|0
6940746|NCT00942175|10976757|FG000|Overall Study|Protocol Violation|0
6940747|NCT00942175|10976758|FG001|Overall Study|Protocol Violation|1
6940748|NCT00942175|10976759|FG002|Overall Study|Protocol Violation|2
6940749|NCT00942175|10976760|FG003|Overall Study|Protocol Violation|0
6940750|NCT00942175|10976757|FG000|Overall Study|Pregnancy|0
6940751|NCT00942175|10976758|FG001|Overall Study|Pregnancy|0
6940752|NCT00942175|10976759|FG002|Overall Study|Pregnancy|0
6940753|NCT00942175|10976760|FG003|Overall Study|Pregnancy|1
6940754|NCT00942175|10976757|FG000|Overall Study|Elevated Alanine Amino Transferase|0
6940755|NCT00942175|10976758|FG001|Overall Study|Elevated Alanine Amino Transferase|0
6940756|NCT00942175|10976759|FG002|Overall Study|Elevated Alanine Amino Transferase|0
6940757|NCT00942175|10976760|FG003|Overall Study|Elevated Alanine Amino Transferase|1
6940758|NCT00942175|10976757|FG000|Overall Study|Low Platelet Count|0
6940759|NCT00942175|10976758|FG001|Overall Study|Low Platelet Count|2
6940760|NCT00942175|10976759|FG002|Overall Study|Low Platelet Count|0
6940761|NCT00942175|10976760|FG003|Overall Study|Low Platelet Count|0
6940762|NCT00942188|10976782|FG000|Overall Study|Adverse Event|0
6940763|NCT00942188|10976783|FG001|Overall Study|Adverse Event|3
6940764|NCT00942188|10976784|FG002|Overall Study|Adverse Event|2
6940765|NCT00942188|10976785|FG003|Overall Study|Adverse Event|0
6940766|NCT00942188|10976782|FG000|Overall Study|Lack of Efficacy|0
6940767|NCT00942188|10976783|FG001|Overall Study|Lack of Efficacy|0
6940768|NCT00942188|10976784|FG002|Overall Study|Lack of Efficacy|0
6940769|NCT00942188|10976785|FG003|Overall Study|Lack of Efficacy|1
6940770|NCT00942188|10976782|FG000|Overall Study|Protocol Violation|1
6940771|NCT00942188|10976783|FG001|Overall Study|Protocol Violation|1
6940772|NCT00942188|10976784|FG002|Overall Study|Protocol Violation|0
6940773|NCT00942188|10976785|FG003|Overall Study|Protocol Violation|0
6940774|NCT00942188|10976782|FG000|Overall Study|Lost to Follow-up|2
6940775|NCT00942188|10976783|FG001|Overall Study|Lost to Follow-up|1
6940776|NCT00942188|10976784|FG002|Overall Study|Lost to Follow-up|2
6940777|NCT00942188|10976785|FG003|Overall Study|Lost to Follow-up|0
6940778|NCT00942188|10976782|FG000|Overall Study|Withdrawal by Subject|1
6940779|NCT00942188|10976783|FG001|Overall Study|Withdrawal by Subject|3
6940780|NCT00942188|10976784|FG002|Overall Study|Withdrawal by Subject|4
6940781|NCT00942188|10976785|FG003|Overall Study|Withdrawal by Subject|2
6940782|NCT00942188|10976782|FG000|Overall Study|Physician Decision|0
6940783|NCT00942188|10976783|FG001|Overall Study|Physician Decision|0
6940784|NCT00942188|10976784|FG002|Overall Study|Physician Decision|1
6940785|NCT00942188|10976785|FG003|Overall Study|Physician Decision|0
6940786|NCT00942188|10976782|FG000|Overall Study|Sponsor Decision|0
6940787|NCT00942188|10976783|FG001|Overall Study|Sponsor Decision|2
6940788|NCT00942188|10976784|FG002|Overall Study|Sponsor Decision|0
6940789|NCT00942188|10976785|FG003|Overall Study|Sponsor Decision|1
6940790|NCT00942266|10976797|FG000|Overall Study|Withdrawal by Subject|1
6940791|NCT00942266|10976798|FG001|Overall Study|Withdrawal by Subject|0
6940792|NCT00942266|10976797|FG000|Overall Study|Adverse Event|2
6940793|NCT00942266|10976798|FG001|Overall Study|Adverse Event|1
6940794|NCT00942266|10976797|FG000|Overall Study|Disease Progression|38
6940795|NCT00942266|10976798|FG001|Overall Study|Disease Progression|11
6940796|NCT00942266|10976797|FG000|Overall Study|Failure to thrive and pt withdrawal|0
6940797|NCT00942266|10976798|FG001|Overall Study|Failure to thrive and pt withdrawal|1
6940798|NCT00942266|10976797|FG000|Overall Study|Intercurrent illness|0
6940799|NCT00942266|10976798|FG001|Overall Study|Intercurrent illness|1
6940800|NCT00942266|10976797|FG000|Overall Study|Physician Decision|2
6940801|NCT00942266|10976798|FG001|Overall Study|Physician Decision|0
6940802|NCT00942266|10976797|FG000|Overall Study|medical deterioration (pneumonia)|0
6940803|NCT00942266|10976798|FG001|Overall Study|medical deterioration (pneumonia)|1
6940804|NCT00942357|10976847|FG000|Overall Study|Ineligible|37
6940805|NCT00942357|10976848|FG001|Overall Study|Ineligible|40
6940806|NCT00942422|10976854|FG000|Overall Study|Withdrawal by Subject|1
6940807|NCT00942422|10976854|FG000|Overall Study|Death|1
6940808|NCT00942422|10976854|FG000|Overall Study|Progressive diease|1
6940809|NCT00942604|10976899|FG000|Overall Study|Protocol Violation|1
6940810|NCT00942604|10976900|FG001|Overall Study|Protocol Violation|1
6940811|NCT00942604|10976899|FG000|Overall Study|Adverse Event|0
6940812|NCT00942604|10976900|FG001|Overall Study|Adverse Event|1
6940813|NCT00942604|10976899|FG000|Overall Study|Withdrawal by Subject|0
6940814|NCT00942604|10976900|FG001|Overall Study|Withdrawal by Subject|1
6940815|NCT00942604|10976899|FG000|Overall Study|Patient relocation|1
6940816|NCT00942604|10976900|FG001|Overall Study|Patient relocation|1
6940817|NCT00942708|10976906|FG000|Overall Study|Withdrawal by Subject|1
6940818|NCT00942734|10976911|FG000|Overall Study|Adverse Event|2
6940819|NCT00942734|10976911|FG000|Overall Study|Protocol Violation|3
6940820|NCT00942734|10976911|FG000|Overall Study|Disease Progression|2
6940821|NCT00942734|10976911|FG000|Overall Study|Physician Decision|1
6940822|NCT00942968|10976958|FG000|Overall Study|Adverse Event|60
6940823|NCT00942968|10976958|FG000|Overall Study|Death|76
6940824|NCT00942968|10976958|FG000|Overall Study|Protocol Violation|9
6940825|NCT00942968|10976958|FG000|Overall Study|Lost to Follow-up|4
6940826|NCT00942968|10976958|FG000|Overall Study|Withdrawal by Subject|44
6940827|NCT00942968|10976958|FG000|Overall Study|Sponsor request|5
6940828|NCT00942968|10976958|FG000|Overall Study|Physician Decision|11
6940829|NCT00942968|10976958|FG000|Overall Study|Progression of disease|12
6940830|NCT00942968|10976958|FG000|Overall Study|Inferior vena cava filter placement|4
6940831|NCT00942968|10976958|FG000|Overall Study|Pulmonary embolism (PE)|1
6940832|NCT00942968|10976958|FG000|Overall Study|Participant required pancreatic biopsy|1
6940833|NCT00942968|10976958|FG000|Overall Study|Deep vein thrombosis (DVT)|2
6940834|NCT00942994|10976964|FG000|Overall Study|Adverse Event|7
6940835|NCT00942994|10976965|FG001|Overall Study|Adverse Event|4
6940836|NCT00942994|10976964|FG000|Overall Study|Abnormal laboratory value(s)|1
6940837|NCT00942994|10976965|FG001|Overall Study|Abnormal laboratory value(s)|0
6940838|NCT00942994|10976964|FG000|Overall Study|Unsatisfactory therapeutic effect|1
6940839|NCT00942994|10976965|FG001|Overall Study|Unsatisfactory therapeutic effect|1
6940840|NCT00942994|10976964|FG000|Overall Study|Patient withdrew consent|5
6940841|NCT00942994|10976965|FG001|Overall Study|Patient withdrew consent|8
6940842|NCT00942994|10976964|FG000|Overall Study|Lost to Follow-up|1
6940843|NCT00942994|10976965|FG001|Overall Study|Lost to Follow-up|4
6940844|NCT00942994|10976964|FG000|Overall Study|Protocol deviation|1
6940845|NCT00942994|10976965|FG001|Overall Study|Protocol deviation|2
6940846|NCT00943072|10976973|FG000|Overall Study|Adverse Event|0
6940847|NCT00943072|10976974|FG001|Overall Study|Adverse Event|3
6940848|NCT00943072|10976973|FG000|Overall Study|Death|0
6940849|NCT00943072|10976974|FG001|Overall Study|Death|2
6940850|NCT00943072|10976973|FG000|Overall Study|Withdrawal by Subject|3
6940851|NCT00943072|10976974|FG001|Overall Study|Withdrawal by Subject|1
6940852|NCT00943072|10976973|FG000|Overall Study|Protocol Violation|0
6940853|NCT00943072|10976974|FG001|Overall Study|Protocol Violation|1
6940854|NCT00943072|10976973|FG000|Overall Study|Lost to Follow-up|1
6940855|NCT00943072|10976974|FG001|Overall Study|Lost to Follow-up|2
6940856|NCT00943072|10976973|FG000|Overall Study|Lack of Efficacy|0
6940857|NCT00943072|10976974|FG001|Overall Study|Lack of Efficacy|4
6940858|NCT00943072|10976973|FG000|Overall Study|Other|1
6940859|NCT00943072|10976974|FG001|Overall Study|Other|1
6940860|NCT00943111|10976993|FG000|52-Weeks Primary Analysis Period|Adverse Event|2
6940861|NCT00943111|10976994|FG001|52-Weeks Primary Analysis Period|Adverse Event|1
6940862|NCT00943111|10976995|FG002|52-Weeks Primary Analysis Period|Adverse Event|0
6940863|NCT00943111|10976993|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
6940864|NCT00943111|10976994|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1
6940865|NCT00943111|10976995|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
6940866|NCT00943111|10976993|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
6940867|NCT00943111|10976994|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
6940868|NCT00943111|10976995|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51
6940869|NCT00943111|10976993|FG000|5 Years Long-term Treatment Period|Adverse Event|0
6940870|NCT00943111|10976994|FG001|5 Years Long-term Treatment Period|Adverse Event|0
6940871|NCT00943111|10976995|FG002|5 Years Long-term Treatment Period|Adverse Event|9
6940872|NCT00943111|10976993|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0
6940873|NCT00943111|10976994|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0
6940874|NCT00943111|10976995|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8
6940875|NCT00943111|10976993|FG000|5 Years Long-term Treatment Period|Pregnancy|0
6940876|NCT00943111|10976994|FG001|5 Years Long-term Treatment Period|Pregnancy|0
6940877|NCT00943111|10976995|FG002|5 Years Long-term Treatment Period|Pregnancy|4
6940878|NCT00943111|10976993|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0
6940879|NCT00943111|10976994|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0
6940880|NCT00943111|10976995|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1
6940881|NCT00943111|10976993|FG000|5 Years Long-term Treatment Period|Other than specified above|0
6940882|NCT00943111|10976994|FG001|5 Years Long-term Treatment Period|Other than specified above|0
6940883|NCT00943111|10976995|FG002|5 Years Long-term Treatment Period|Other than specified above|2
6940884|NCT00943124|10977002|FG000|Period 1|Withdrawal by Subject|1
6940885|NCT00943124|10977003|FG001|Period 1|Withdrawal by Subject|1
6940886|NCT00943124|10977002|FG000|Period 1|Did Not Follow Study Procedures|1
6940887|NCT00943124|10977003|FG001|Period 1|Did Not Follow Study Procedures|0
6940888|NCT00943124|10977002|FG000|Period 1|Personal Reasons|0
6940889|NCT00943124|10977003|FG001|Period 1|Personal Reasons|1
6940890|NCT00943306|10977040|FG000|Overall Study|Physician Decision|1
6940891|NCT00943306|10977040|FG000|Overall Study|Death|1
6940892|NCT00943306|10977040|FG000|Overall Study|Sponsor decision due to non-compliance|1
6940893|NCT00943319|10977044|FG000|Overall Study|Death|1
6940894|NCT00943384|10977048|FG000|Overall Study|Dispositioned prior to treatment|23
6940895|NCT00943384|10977048|FG000|Overall Study|Treated off protocol-protocol violation|5
6940896|NCT00943384|10977048|FG000|Overall Study|Lost to Follow-up|16
6940897|NCT00943384|10977048|FG000|Overall Study|Withdrawal by Subject|5
6940898|NCT00943579|10977072|FG000|Overall Study|Adverse Event|4
6940899|NCT00943579|10977073|FG001|Overall Study|Adverse Event|3
6940900|NCT00943579|10977072|FG000|Overall Study|Lack of Efficacy|2
6940901|NCT00943579|10977073|FG001|Overall Study|Lack of Efficacy|2
6940902|NCT00943592|10977082|FG000|Overall Study|Death|3
6940903|NCT00943670|10977095|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2
6940904|NCT00943670|10977095|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3
6940905|NCT00943670|10977095|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15
6940906|NCT00943670|10977095|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2
6940907|NCT00943670|10977095|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20
7040424|NCT01717326|11123368|FG012|Overall Study|Physician Decision|0
7040425|NCT01717326|11123369|FG013|Overall Study|Physician Decision|0
7040426|NCT01717326|11123370|FG014|Overall Study|Physician Decision|0
7040427|NCT01717326|11123371|FG015|Overall Study|Physician Decision|0
7040428|NCT01717326|11123372|FG016|Overall Study|Physician Decision|0
7040429|NCT01717326|11123373|FG017|Overall Study|Physician Decision|0
7040430|NCT01717326|11123374|FG018|Overall Study|Physician Decision|0
7040431|NCT01717326|11123375|FG019|Overall Study|Physician Decision|0
7040432|NCT01717326|11123356|FG000|Overall Study|Protocol Violation|0
7040433|NCT01717326|11123357|FG001|Overall Study|Protocol Violation|0
7040434|NCT01717326|11123358|FG002|Overall Study|Protocol Violation|0
7040435|NCT01717326|11123359|FG003|Overall Study|Protocol Violation|0
7040436|NCT01717326|11123360|FG004|Overall Study|Protocol Violation|1
7040437|NCT01717326|11123361|FG005|Overall Study|Protocol Violation|0
7040438|NCT01717326|11123362|FG006|Overall Study|Protocol Violation|0
7040439|NCT01717326|11123363|FG007|Overall Study|Protocol Violation|0
7040440|NCT01717326|11123364|FG008|Overall Study|Protocol Violation|0
6940908|NCT00943670|10977095|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1
6940909|NCT00943670|10977095|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4
6940910|NCT00943670|10977095|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6
6940911|NCT00943670|10977095|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2
6940912|NCT00943670|10977095|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5
6940913|NCT00943735|10977110|FG000|Overall Study|Adverse Event|12
6940914|NCT00943735|10977110|FG000|Overall Study|Withdrawal by Subject|8
6940915|NCT00943735|10977110|FG000|Overall Study|Death|1
6940916|NCT00943735|10977110|FG000|Overall Study|Other|8
6940917|NCT00943735|10977110|FG000|Overall Study|Other|3
6940918|NCT00943761|10977116|FG000|Overall Study|Lost to Follow-up|2
6940919|NCT00943761|10977117|FG001|Overall Study|Lost to Follow-up|0
6940920|NCT00943761|10977116|FG000|Overall Study|Withdrawal by Subject|2
6940921|NCT00943761|10977117|FG001|Overall Study|Withdrawal by Subject|1
6940922|NCT00943787|10977123|FG000|Overall Study|Physician Decision|4
6940923|NCT00943787|10977123|FG000|Overall Study|Withdrawal by Subject|3
6940924|NCT00943826|10977133|FG000|Concurrent Phase|Adverse Event|50
6940925|NCT00943826|10977134|FG001|Concurrent Phase|Adverse Event|27
6940926|NCT00943826|10977133|FG000|Concurrent Phase|Withdrew consent|3
6940927|NCT00943826|10977134|FG001|Concurrent Phase|Withdrew consent|7
6940928|NCT00943826|10977133|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5
6940929|NCT00943826|10977134|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7
6940930|NCT00943826|10977133|FG000|Concurrent Phase|Administrative reasons|2
6940931|NCT00943826|10977134|FG001|Concurrent Phase|Administrative reasons|1
6940932|NCT00943826|10977133|FG000|Concurrent Phase|Protocol Violation|1
6940933|NCT00943826|10977134|FG001|Concurrent Phase|Protocol Violation|0
6940934|NCT00943826|10977133|FG000|Maintenance Phase|Adverse Event|31
6940935|NCT00943826|10977134|FG001|Maintenance Phase|Adverse Event|30
6940936|NCT00943826|10977133|FG000|Maintenance Phase|Withdrew consent|2
6940937|NCT00943826|10977134|FG001|Maintenance Phase|Withdrew consent|4
6940938|NCT00943826|10977133|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6
6940939|NCT00943826|10977134|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3
6940940|NCT00943826|10977133|FG000|Maintenance Phase|Administrative reasons|4
6940941|NCT00943826|10977134|FG001|Maintenance Phase|Administrative reasons|1
6940942|NCT00943826|10977133|FG000|Maintenance Phase|Failure to return|0
6940943|NCT00943826|10977134|FG001|Maintenance Phase|Failure to return|1
6940944|NCT00943826|10977133|FG000|Monotherapy Phase|Adverse Event|42
6940945|NCT00943826|10977134|FG001|Monotherapy Phase|Adverse Event|5
6940946|NCT00943826|10977133|FG000|Monotherapy Phase|Administrative reasons|11
6940947|NCT00943826|10977134|FG001|Monotherapy Phase|Administrative reasons|5
6940948|NCT00943826|10977133|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8
6940949|NCT00943826|10977134|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2
6940950|NCT00943826|10977133|FG000|Monotherapy Phase|Withdrew Consent|2
6940951|NCT00943826|10977134|FG001|Monotherapy Phase|Withdrew Consent|3
6940952|NCT00943826|10977133|FG000|Monotherapy Phase|Failure to return|2
6940953|NCT00943826|10977134|FG001|Monotherapy Phase|Failure to return|1
6940954|NCT00943826|10977133|FG000|After Primary Overall Survival Analysis|Adverse Event|11
6940955|NCT00943826|10977134|FG001|After Primary Overall Survival Analysis|Adverse Event|0
6975575|NCT01193608|11027765|FG003|Overall Study|Adverse Event|0
7040441|NCT01717326|11123365|FG009|Overall Study|Protocol Violation|0
7040442|NCT01717326|11123366|FG010|Overall Study|Protocol Violation|0
7040443|NCT01717326|11123367|FG011|Overall Study|Protocol Violation|0
7040444|NCT01717326|11123368|FG012|Overall Study|Protocol Violation|0
7040445|NCT01717326|11123369|FG013|Overall Study|Protocol Violation|0
6940956|NCT00943826|10977133|FG000|After Primary Overall Survival Analysis|Administrative reasons|10
6940957|NCT00943826|10977134|FG001|After Primary Overall Survival Analysis|Administrative reasons|16
6940958|NCT00943826|10977133|FG000|After Primary Overall Survival Analysis|Progression of Disease|2
6940959|NCT00943826|10977134|FG001|After Primary Overall Survival Analysis|Progression of Disease|4
6940960|NCT00943826|10977133|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4
6940961|NCT00943826|10977134|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0
6940962|NCT00943917|10977177|FG000|Stage I|Adverse Event|1
6940963|NCT00943917|10977178|FG001|Stage I|Adverse Event|2
6940964|NCT00943917|10977179|FG002|Stage I|Adverse Event|2
6940965|NCT00943917|10977180|FG003|Stage I|Adverse Event|0
6940966|NCT00943917|10977181|FG004|Stage I|Adverse Event|0
6940967|NCT00943917|10977182|FG005|Stage I|Adverse Event|0
6940968|NCT00943917|10977183|FG006|Stage I|Adverse Event|0
6940969|NCT00943917|10977184|FG007|Stage I|Adverse Event|0
6940970|NCT00943917|10977185|FG008|Stage I|Adverse Event|0
6940971|NCT00943917|10977186|FG009|Stage I|Adverse Event|0
6940972|NCT00943917|10977187|FG010|Stage I|Adverse Event|0
6940973|NCT00943917|10977188|FG011|Stage I|Adverse Event|0
6940974|NCT00943917|10977189|FG012|Stage I|Adverse Event|0
6940975|NCT00943917|10977190|FG013|Stage I|Adverse Event|0
6940976|NCT00943917|10977191|FG014|Stage I|Adverse Event|0
6940977|NCT00943917|10977177|FG000|Stage I|Lost to Follow-up|0
6940978|NCT00943917|10977178|FG001|Stage I|Lost to Follow-up|0
6940979|NCT00943917|10977179|FG002|Stage I|Lost to Follow-up|1
6940980|NCT00943917|10977180|FG003|Stage I|Lost to Follow-up|0
6940981|NCT00943917|10977181|FG004|Stage I|Lost to Follow-up|0
6940982|NCT00943917|10977182|FG005|Stage I|Lost to Follow-up|0
6940983|NCT00943917|10977183|FG006|Stage I|Lost to Follow-up|0
6940984|NCT00943917|10977184|FG007|Stage I|Lost to Follow-up|0
6940985|NCT00943917|10977185|FG008|Stage I|Lost to Follow-up|0
6940986|NCT00943917|10977186|FG009|Stage I|Lost to Follow-up|0
6940987|NCT00943917|10977187|FG010|Stage I|Lost to Follow-up|0
6940988|NCT00943917|10977188|FG011|Stage I|Lost to Follow-up|0
6940989|NCT00943917|10977189|FG012|Stage I|Lost to Follow-up|0
6940990|NCT00943917|10977190|FG013|Stage I|Lost to Follow-up|0
6940991|NCT00943917|10977191|FG014|Stage I|Lost to Follow-up|0
6940992|NCT00943917|10977177|FG000|Stage I|hyperglycemia|0
6940993|NCT00943917|10977178|FG001|Stage I|hyperglycemia|0
6940994|NCT00943917|10977179|FG002|Stage I|hyperglycemia|1
6940995|NCT00943917|10977180|FG003|Stage I|hyperglycemia|0
6940996|NCT00943917|10977181|FG004|Stage I|hyperglycemia|0
6940997|NCT00943917|10977182|FG005|Stage I|hyperglycemia|0
6940998|NCT00943917|10977183|FG006|Stage I|hyperglycemia|0
6940999|NCT00943917|10977184|FG007|Stage I|hyperglycemia|0
6941000|NCT00943917|10977185|FG008|Stage I|hyperglycemia|0
6941001|NCT00943917|10977186|FG009|Stage I|hyperglycemia|0
6941002|NCT00943917|10977187|FG010|Stage I|hyperglycemia|0
6941003|NCT00943917|10977188|FG011|Stage I|hyperglycemia|0
6941004|NCT00943917|10977189|FG012|Stage I|hyperglycemia|0
6941005|NCT00943917|10977190|FG013|Stage I|hyperglycemia|0
6941006|NCT00943917|10977191|FG014|Stage I|hyperglycemia|0
6941007|NCT00943917|10977177|FG000|Stage I|A1C elevation|1
6941008|NCT00943917|10977178|FG001|Stage I|A1C elevation|0
6941009|NCT00943917|10977179|FG002|Stage I|A1C elevation|0
6941010|NCT00943917|10977180|FG003|Stage I|A1C elevation|0
6941011|NCT00943917|10977181|FG004|Stage I|A1C elevation|0
6941012|NCT00943917|10977182|FG005|Stage I|A1C elevation|0
6941013|NCT00943917|10977183|FG006|Stage I|A1C elevation|0
6941014|NCT00943917|10977184|FG007|Stage I|A1C elevation|0
6941015|NCT00943917|10977185|FG008|Stage I|A1C elevation|0
6941016|NCT00943917|10977186|FG009|Stage I|A1C elevation|0
6941017|NCT00943917|10977187|FG010|Stage I|A1C elevation|0
6941018|NCT00943917|10977188|FG011|Stage I|A1C elevation|0
6941019|NCT00943917|10977189|FG012|Stage I|A1C elevation|0
6941020|NCT00943917|10977190|FG013|Stage I|A1C elevation|0
6941021|NCT00943917|10977191|FG014|Stage I|A1C elevation|0
6941022|NCT00943917|10977177|FG000|Stage I|Withdrawal by Subject|2
6941023|NCT00943917|10977178|FG001|Stage I|Withdrawal by Subject|1
6941024|NCT00943917|10977179|FG002|Stage I|Withdrawal by Subject|2
6941025|NCT00943917|10977180|FG003|Stage I|Withdrawal by Subject|0
6941026|NCT00943917|10977181|FG004|Stage I|Withdrawal by Subject|0
6941027|NCT00943917|10977182|FG005|Stage I|Withdrawal by Subject|0
6941028|NCT00943917|10977183|FG006|Stage I|Withdrawal by Subject|0
6941029|NCT00943917|10977184|FG007|Stage I|Withdrawal by Subject|0
6941030|NCT00943917|10977185|FG008|Stage I|Withdrawal by Subject|0
6941031|NCT00943917|10977186|FG009|Stage I|Withdrawal by Subject|0
6941032|NCT00943917|10977187|FG010|Stage I|Withdrawal by Subject|0
6941033|NCT00943917|10977188|FG011|Stage I|Withdrawal by Subject|0
6941034|NCT00943917|10977189|FG012|Stage I|Withdrawal by Subject|0
6941035|NCT00943917|10977190|FG013|Stage I|Withdrawal by Subject|0
6941036|NCT00943917|10977191|FG014|Stage I|Withdrawal by Subject|0
6941037|NCT00943917|10977177|FG000|Stage II|Adverse Event|0
6941038|NCT00943917|10977178|FG001|Stage II|Adverse Event|0
6941039|NCT00943917|10977179|FG002|Stage II|Adverse Event|0
6941040|NCT00943917|10977180|FG003|Stage II|Adverse Event|0
6941041|NCT00943917|10977181|FG004|Stage II|Adverse Event|0
6941042|NCT00943917|10977182|FG005|Stage II|Adverse Event|1
6941043|NCT00943917|10977183|FG006|Stage II|Adverse Event|3
6941044|NCT00943917|10977184|FG007|Stage II|Adverse Event|0
6941045|NCT00943917|10977185|FG008|Stage II|Adverse Event|1
6941046|NCT00943917|10977186|FG009|Stage II|Adverse Event|0
6941047|NCT00943917|10977187|FG010|Stage II|Adverse Event|0
6941048|NCT00943917|10977188|FG011|Stage II|Adverse Event|0
6838276|NCT00257010|10843892|FG000|Overall Study|Adverse Event|10
6838277|NCT00257010|10843892|FG000|Overall Study|various|11
6838278|NCT00257010|10843892|FG000|Overall Study|no headache reported|9
6838279|NCT00257166|10843898|FG000|Overall Study|Adverse Event|18
6838280|NCT00257166|10843899|FG001|Overall Study|Adverse Event|13
6838281|NCT00257166|10843898|FG000|Overall Study|Laboratory abnormality|1
6838282|NCT00257166|10843899|FG001|Overall Study|Laboratory abnormality|0
6838283|NCT00257166|10843898|FG000|Overall Study|Lost to Follow-up|8
6838284|NCT00257166|10843899|FG001|Overall Study|Lost to Follow-up|1
6838285|NCT00257166|10843898|FG000|Overall Study|Withdrawal by Subject|9
6838286|NCT00257166|10843899|FG001|Overall Study|Withdrawal by Subject|2
6838287|NCT00257166|10843898|FG000|Overall Study|Other|16
6838288|NCT00257166|10843899|FG001|Overall Study|Other|21
6838289|NCT00257166|10843898|FG000|Overall Study|Randomized, but not treated|1
6838290|NCT00257166|10843899|FG001|Overall Study|Randomized, but not treated|0
6838291|NCT00257192|10843907|FG000|Overall Study|Adverse Event|21
6838292|NCT00257192|10843908|FG001|Overall Study|Adverse Event|10
6838293|NCT00257192|10843907|FG000|Overall Study|Laboratory abnormality|1
6838294|NCT00257192|10843908|FG001|Overall Study|Laboratory abnormality|1
6838295|NCT00257192|10843907|FG000|Overall Study|Lost to Follow-up|3
6838296|NCT00257192|10843908|FG001|Overall Study|Lost to Follow-up|3
6838297|NCT00257192|10843907|FG000|Overall Study|Insufficient clinical response|18
6838298|NCT00257192|10843908|FG001|Overall Study|Insufficient clinical response|18
6838299|NCT00257192|10843907|FG000|Overall Study|Withdrawal by Subject|14
6838300|NCT00257192|10843908|FG001|Overall Study|Withdrawal by Subject|2
6838301|NCT00257192|10843907|FG000|Overall Study|Randomized but not treated|0
6838302|NCT00257192|10843908|FG001|Overall Study|Randomized but not treated|1
6838303|NCT00257192|10843907|FG000|Overall Study|Study terminated by sponsor|1
6838304|NCT00257192|10843908|FG001|Overall Study|Study terminated by sponsor|0
6838305|NCT00257192|10843907|FG000|Overall Study|Miscellaneous|0
6838306|NCT00257192|10843908|FG001|Overall Study|Miscellaneous|4
6838307|NCT00257556|10843929|FG000|Overall Study|Adverse Event|1
6838308|NCT00257556|10843930|FG001|Overall Study|Adverse Event|4
6838309|NCT00257556|10843929|FG000|Overall Study|Physician Decision|6
6838310|NCT00257556|10843930|FG001|Overall Study|Physician Decision|0
6838311|NCT00257556|10843929|FG000|Overall Study|Did not meet hCG criterion|3
6838312|NCT00257556|10843930|FG001|Overall Study|Did not meet hCG criterion|0
6838313|NCT00257556|10843929|FG000|Overall Study|other reason|4
6838314|NCT00257556|10843930|FG001|Overall Study|other reason|6
6838315|NCT00257608|10843938|FG000|Chemotherapy Phase|Adverse Event|138
6838316|NCT00257608|10843939|FG001|Chemotherapy Phase|Adverse Event|0
6838317|NCT00257608|10843940|FG002|Chemotherapy Phase|Adverse Event|0
6838318|NCT00257608|10843938|FG000|Chemotherapy Phase|Disease progression|139
6838319|NCT00257608|10843939|FG001|Chemotherapy Phase|Disease progression|0
6838320|NCT00257608|10843940|FG002|Chemotherapy Phase|Disease progression|0
6838321|NCT00257608|10843938|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6
6838322|NCT00257608|10843939|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0
6838323|NCT00257608|10843940|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0
6838324|NCT00257608|10843938|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27
6838325|NCT00257608|10843939|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
6838326|NCT00257608|10843940|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
6838327|NCT00257608|10843938|FG000|Chemotherapy Phase|Patient's decision to discontinue|35
6838328|NCT00257608|10843939|FG001|Chemotherapy Phase|Patient's decision to discontinue|0
6838329|NCT00257608|10843940|FG002|Chemotherapy Phase|Patient's decision to discontinue|0
6838330|NCT00257608|10843938|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3
6838331|NCT00257608|10843939|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0
6838332|NCT00257608|10843940|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0
6838333|NCT00257608|10843938|FG000|Chemotherapy Phase|Physician Decision|28
6838334|NCT00257608|10843939|FG001|Chemotherapy Phase|Physician Decision|0
6838335|NCT00257608|10843940|FG002|Chemotherapy Phase|Physician Decision|0
6838336|NCT00257608|10843938|FG000|Post Chemotherapy Phase|Adverse Event|0
6838337|NCT00257608|10843939|FG001|Post Chemotherapy Phase|Adverse Event|34
6838338|NCT00257608|10843940|FG002|Post Chemotherapy Phase|Adverse Event|38
6838339|NCT00257608|10843938|FG000|Post Chemotherapy Phase|Disease progression|0
6838340|NCT00257608|10843939|FG001|Post Chemotherapy Phase|Disease progression|204
6838341|NCT00257608|10843940|FG002|Post Chemotherapy Phase|Disease progression|168
6838342|NCT00257608|10843938|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0
6838343|NCT00257608|10843939|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4
6838344|NCT00257608|10843940|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5
6838345|NCT00257608|10843938|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0
6838346|NCT00257608|10843939|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
6838347|NCT00257608|10843940|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
6838348|NCT00257608|10843938|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0
6838349|NCT00257608|10843939|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4
6838350|NCT00257608|10843940|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8
6838351|NCT00257608|10843938|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0
6941049|NCT00943917|10977189|FG012|Stage II|Adverse Event|0
6941050|NCT00943917|10977190|FG013|Stage II|Adverse Event|0
6941051|NCT00943917|10977191|FG014|Stage II|Adverse Event|0
7067167|NCT01984684|11168140|FG001|Overall Study|Protocol Violation|2
7067168|NCT01984684|11168139|FG000|Overall Study|Death|0
7067169|NCT01984684|11168140|FG001|Overall Study|Death|1
7067170|NCT01984684|11168139|FG000|Overall Study|Noncompliance with study drug|2
7067171|NCT01984684|11168140|FG001|Overall Study|Noncompliance with study drug|1
7067172|NCT01984684|11168139|FG000|Overall Study|Subject incarcerated|1
7067173|NCT01984684|11168140|FG001|Overall Study|Subject incarcerated|0
7067174|NCT01984684|11168139|FG000|Overall Study|Study drug not available at site|1
7067175|NCT01984684|11168140|FG001|Overall Study|Study drug not available at site|1
7067176|NCT01984684|11168139|FG000|Overall Study|Subject had inadequate IV access|0
7067177|NCT01984684|11168140|FG001|Overall Study|Subject had inadequate IV access|1
7067178|NCT01984697|11168151|FG000|Overall Study|Adverse Event|0
7067179|NCT01984697|11168152|FG001|Overall Study|Adverse Event|0
7067180|NCT01984697|11168153|FG002|Overall Study|Adverse Event|2
7067181|NCT01984697|11168154|FG003|Overall Study|Adverse Event|0
7067182|NCT01984697|11168155|FG004|Overall Study|Adverse Event|0
7067183|NCT01984697|11168151|FG000|Overall Study|Lost to Follow-up|14
7067184|NCT01984697|11168152|FG001|Overall Study|Lost to Follow-up|5
7067185|NCT01984697|11168153|FG002|Overall Study|Lost to Follow-up|10
7067186|NCT01984697|11168154|FG003|Overall Study|Lost to Follow-up|6
7067187|NCT01984697|11168155|FG004|Overall Study|Lost to Follow-up|21
7067188|NCT01984697|11168151|FG000|Overall Study|Physician Decision|3
7067189|NCT01984697|11168152|FG001|Overall Study|Physician Decision|0
7067190|NCT01984697|11168153|FG002|Overall Study|Physician Decision|0
7067191|NCT01984697|11168154|FG003|Overall Study|Physician Decision|1
7067192|NCT01984697|11168155|FG004|Overall Study|Physician Decision|0
7067193|NCT01984697|11168151|FG000|Overall Study|Protocol Violation|8
7067194|NCT01984697|11168152|FG001|Overall Study|Protocol Violation|5
7067195|NCT01984697|11168153|FG002|Overall Study|Protocol Violation|3
7067196|NCT01984697|11168154|FG003|Overall Study|Protocol Violation|2
7067197|NCT01984697|11168155|FG004|Overall Study|Protocol Violation|0
7067198|NCT01984697|11168151|FG000|Overall Study|Withdrawal by Subject|15
7067199|NCT01984697|11168152|FG001|Overall Study|Withdrawal by Subject|21
7067200|NCT01984697|11168153|FG002|Overall Study|Withdrawal by Subject|13
7067201|NCT01984697|11168154|FG003|Overall Study|Withdrawal by Subject|11
7067202|NCT01984697|11168155|FG004|Overall Study|Withdrawal by Subject|13
7067203|NCT01984697|11168151|FG000|Overall Study|Missed last follow-up visit|1
7067204|NCT01984697|11168152|FG001|Overall Study|Missed last follow-up visit|0
7067205|NCT01984697|11168153|FG002|Overall Study|Missed last follow-up visit|0
7067206|NCT01984697|11168154|FG003|Overall Study|Missed last follow-up visit|0
7067207|NCT01984697|11168155|FG004|Overall Study|Missed last follow-up visit|0
7067208|NCT01984697|11168151|FG000|Overall Study|Death|0
7067209|NCT01984697|11168152|FG001|Overall Study|Death|0
7067210|NCT01984697|11168153|FG002|Overall Study|Death|0
7067211|NCT01984697|11168154|FG003|Overall Study|Death|1
7067212|NCT01984697|11168155|FG004|Overall Study|Death|0
7067213|NCT01984697|11168151|FG000|Overall Study|Pregnancy|2
7067214|NCT01984697|11168152|FG001|Overall Study|Pregnancy|0
7067215|NCT01984697|11168153|FG002|Overall Study|Pregnancy|1
7067216|NCT01984697|11168154|FG003|Overall Study|Pregnancy|0
7067217|NCT01984697|11168155|FG004|Overall Study|Pregnancy|1
7067218|NCT01984892|11168167|FG000|Overall Study|Progressive disease|7
7067219|NCT01985126|11168173|FG000|Overall Study|Death|15
7067220|NCT01985126|11168174|FG001|Overall Study|Death|69
7067221|NCT01985126|11168173|FG000|Overall Study|Lost to Follow-up|0
7067222|NCT01985126|11168174|FG001|Overall Study|Lost to Follow-up|8
7067223|NCT01985126|11168173|FG000|Overall Study|Study Terminated By Sponsor|1
7067224|NCT01985126|11168174|FG001|Overall Study|Study Terminated By Sponsor|22
7067225|NCT01985126|11168173|FG000|Overall Study|Withdrawal by Subject|2
7067226|NCT01985126|11168174|FG001|Overall Study|Withdrawal by Subject|7
7067227|NCT01985321|11168182|FG000|Overall Study|Protocol Violation|4
7067228|NCT01985321|11168183|FG001|Overall Study|Protocol Violation|3
7067229|NCT01985321|11168182|FG000|Overall Study|Withdrawal by Subject|1
7067230|NCT01985321|11168183|FG001|Overall Study|Withdrawal by Subject|0
7067231|NCT01985321|11168182|FG000|Overall Study|Lost to Follow-up|5
7067232|NCT01985321|11168183|FG001|Overall Study|Lost to Follow-up|2
7067233|NCT01985321|11168182|FG000|Overall Study|Subject treated wrong type of sore|1
7067234|NCT01985321|11168183|FG001|Overall Study|Subject treated wrong type of sore|0
7067235|NCT01985334|11168197|FG000|Overall Study|Administrative problems|1
7067236|NCT01985334|11168198|FG001|Overall Study|Administrative problems|1
7067237|NCT01985334|11168199|FG002|Overall Study|Administrative problems|0
7067238|NCT01985334|11168200|FG003|Overall Study|Administrative problems|2
7067239|NCT01985334|11168201|FG004|Overall Study|Administrative problems|0
7067240|NCT01985334|11168202|FG005|Overall Study|Administrative problems|1
7067241|NCT01985334|11168203|FG006|Overall Study|Administrative problems|1
7067242|NCT01985334|11168204|FG007|Overall Study|Administrative problems|3
7067243|NCT01985334|11168197|FG000|Overall Study|Death|1
7067244|NCT01985334|11168198|FG001|Overall Study|Death|0
7067245|NCT01985334|11168199|FG002|Overall Study|Death|0
7067246|NCT01985334|11168200|FG003|Overall Study|Death|3
7067247|NCT01985334|11168201|FG004|Overall Study|Death|0
7067248|NCT01985334|11168202|FG005|Overall Study|Death|0
7067249|NCT01985334|11168203|FG006|Overall Study|Death|1
6941052|NCT00943917|10977177|FG000|Stage II|Withdrawal by Subject|0
7067250|NCT01985334|11168204|FG007|Overall Study|Death|2
7067251|NCT01985334|11168197|FG000|Overall Study|Worsening of disease|0
7067252|NCT01985334|11168198|FG001|Overall Study|Worsening of disease|0
7067253|NCT01985334|11168199|FG002|Overall Study|Worsening of disease|0
7067254|NCT01985334|11168200|FG003|Overall Study|Worsening of disease|1
7067255|NCT01985334|11168201|FG004|Overall Study|Worsening of disease|0
7067256|NCT01985334|11168202|FG005|Overall Study|Worsening of disease|3
7067257|NCT01985334|11168203|FG006|Overall Study|Worsening of disease|0
7067258|NCT01985334|11168204|FG007|Overall Study|Worsening of disease|1
7067259|NCT01985334|11168197|FG000|Overall Study|Other|2
7067260|NCT01985334|11168198|FG001|Overall Study|Other|9
7040446|NCT01717326|11123370|FG014|Overall Study|Protocol Violation|0
7040447|NCT01717326|11123371|FG015|Overall Study|Protocol Violation|0
7040448|NCT01717326|11123372|FG016|Overall Study|Protocol Violation|0
7040449|NCT01717326|11123373|FG017|Overall Study|Protocol Violation|0
7040450|NCT01717326|11123374|FG018|Overall Study|Protocol Violation|0
7040451|NCT01717326|11123375|FG019|Overall Study|Protocol Violation|0
7040452|NCT01717326|11123356|FG000|Overall Study|Withdrawal by Subject|0
7040453|NCT01717326|11123357|FG001|Overall Study|Withdrawal by Subject|1
7040454|NCT01717326|11123358|FG002|Overall Study|Withdrawal by Subject|0
7040455|NCT01717326|11123359|FG003|Overall Study|Withdrawal by Subject|0
7067261|NCT01985334|11168199|FG002|Overall Study|Other|7
7067262|NCT01985334|11168200|FG003|Overall Study|Other|17
7067263|NCT01985334|11168201|FG004|Overall Study|Other|4
7067264|NCT01985334|11168202|FG005|Overall Study|Other|8
7067265|NCT01985334|11168203|FG006|Overall Study|Other|4
7067266|NCT01985334|11168204|FG007|Overall Study|Other|7
7067267|NCT01985334|11168197|FG000|Overall Study|Protocol deviation|6
7067268|NCT01985334|11168198|FG001|Overall Study|Protocol deviation|31
7067269|NCT01985334|11168199|FG002|Overall Study|Protocol deviation|25
7067270|NCT01985334|11168200|FG003|Overall Study|Protocol deviation|84
7067271|NCT01985334|11168201|FG004|Overall Study|Protocol deviation|17
7067272|NCT01985334|11168202|FG005|Overall Study|Protocol deviation|47
7067273|NCT01985334|11168203|FG006|Overall Study|Protocol deviation|15
7067274|NCT01985334|11168204|FG007|Overall Study|Protocol deviation|42
7067275|NCT01985334|11168197|FG000|Overall Study|Moderate / severe COPD exacerbation|5
7067276|NCT01985334|11168198|FG001|Overall Study|Moderate / severe COPD exacerbation|14
7067277|NCT01985334|11168199|FG002|Overall Study|Moderate / severe COPD exacerbation|12
7067278|NCT01985334|11168200|FG003|Overall Study|Moderate / severe COPD exacerbation|40
7067279|NCT01985334|11168201|FG004|Overall Study|Moderate / severe COPD exacerbation|6
7067280|NCT01985334|11168202|FG005|Overall Study|Moderate / severe COPD exacerbation|40
7067281|NCT01985334|11168203|FG006|Overall Study|Moderate / severe COPD exacerbation|8
7067282|NCT01985334|11168204|FG007|Overall Study|Moderate / severe COPD exacerbation|19
7067283|NCT01985334|11168197|FG000|Overall Study|Subject withdrawal of consent|3
7067284|NCT01985334|11168198|FG001|Overall Study|Subject withdrawal of consent|6
7067285|NCT01985334|11168199|FG002|Overall Study|Subject withdrawal of consent|2
7067286|NCT01985334|11168200|FG003|Overall Study|Subject withdrawal of consent|28
7067287|NCT01985334|11168201|FG004|Overall Study|Subject withdrawal of consent|4
7067288|NCT01985334|11168202|FG005|Overall Study|Subject withdrawal of consent|19
7067289|NCT01985334|11168203|FG006|Overall Study|Subject withdrawal of consent|0
7067290|NCT01985334|11168204|FG007|Overall Study|Subject withdrawal of consent|20
7067291|NCT01985334|11168197|FG000|Overall Study|Adverse Event|0
7067292|NCT01985334|11168198|FG001|Overall Study|Adverse Event|8
7067293|NCT01985334|11168199|FG002|Overall Study|Adverse Event|2
7067294|NCT01985334|11168200|FG003|Overall Study|Adverse Event|26
7067295|NCT01985334|11168201|FG004|Overall Study|Adverse Event|3
7067296|NCT01985334|11168202|FG005|Overall Study|Adverse Event|18
7067297|NCT01985334|11168203|FG006|Overall Study|Adverse Event|3
6941053|NCT00943917|10977178|FG001|Stage II|Withdrawal by Subject|0
7067298|NCT01985334|11168204|FG007|Overall Study|Adverse Event|15
7067299|NCT01985334|11168197|FG000|Overall Study|Other|4
7067300|NCT01985334|11168198|FG001|Overall Study|Other|2
7067301|NCT01985334|11168199|FG002|Overall Study|Other|3
7067302|NCT01985334|11168200|FG003|Overall Study|Other|10
7067303|NCT01985334|11168201|FG004|Overall Study|Other|1
7067304|NCT01985334|11168202|FG005|Overall Study|Other|6
7067305|NCT01985334|11168203|FG006|Overall Study|Other|2
7067306|NCT01985334|11168204|FG007|Overall Study|Other|2
7067307|NCT01985334|11168197|FG000|Overall Study|Medication non-compliance|0
7067308|NCT01985334|11168198|FG001|Overall Study|Medication non-compliance|4
7067309|NCT01985334|11168199|FG002|Overall Study|Medication non-compliance|1
7067310|NCT01985334|11168200|FG003|Overall Study|Medication non-compliance|6
7067311|NCT01985334|11168201|FG004|Overall Study|Medication non-compliance|2
7067312|NCT01985334|11168202|FG005|Overall Study|Medication non-compliance|3
7040456|NCT01717326|11123360|FG004|Overall Study|Withdrawal by Subject|0
7040457|NCT01717326|11123361|FG005|Overall Study|Withdrawal by Subject|0
7067313|NCT01985334|11168203|FG006|Overall Study|Medication non-compliance|1
7067314|NCT01985334|11168204|FG007|Overall Study|Medication non-compliance|3
7067315|NCT01985334|11168197|FG000|Overall Study|Use of prohibited treatment|1
7067316|NCT01985334|11168198|FG001|Overall Study|Use of prohibited treatment|4
7067317|NCT01985334|11168199|FG002|Overall Study|Use of prohibited treatment|1
7067318|NCT01985334|11168200|FG003|Overall Study|Use of prohibited treatment|2
7067319|NCT01985334|11168201|FG004|Overall Study|Use of prohibited treatment|1
7067320|NCT01985334|11168202|FG005|Overall Study|Use of prohibited treatment|6
7067321|NCT01985334|11168203|FG006|Overall Study|Use of prohibited treatment|2
7067322|NCT01985334|11168204|FG007|Overall Study|Use of prohibited treatment|0
7067323|NCT01985334|11168197|FG000|Overall Study|Investigator decision|0
7067324|NCT01985334|11168198|FG001|Overall Study|Investigator decision|3
7067325|NCT01985334|11168199|FG002|Overall Study|Investigator decision|0
7067326|NCT01985334|11168200|FG003|Overall Study|Investigator decision|7
7067327|NCT01985334|11168201|FG004|Overall Study|Investigator decision|1
7067328|NCT01985334|11168202|FG005|Overall Study|Investigator decision|1
7067329|NCT01985334|11168203|FG006|Overall Study|Investigator decision|0
7067330|NCT01985334|11168204|FG007|Overall Study|Investigator decision|4
7067331|NCT01985334|11168197|FG000|Overall Study|Lost to Follow-up|0
7067332|NCT01985334|11168198|FG001|Overall Study|Lost to Follow-up|2
7067333|NCT01985334|11168199|FG002|Overall Study|Lost to Follow-up|0
7067334|NCT01985334|11168200|FG003|Overall Study|Lost to Follow-up|3
7067335|NCT01985334|11168201|FG004|Overall Study|Lost to Follow-up|1
7067336|NCT01985334|11168202|FG005|Overall Study|Lost to Follow-up|4
7067337|NCT01985334|11168203|FG006|Overall Study|Lost to Follow-up|0
7067338|NCT01985334|11168204|FG007|Overall Study|Lost to Follow-up|3
7067339|NCT01985360|11168238|FG000|Overall Study|Withdrawal by Subject|4
7067340|NCT01985360|11168239|FG001|Overall Study|Withdrawal by Subject|0
7067341|NCT01985360|11168238|FG000|Overall Study|Lost to Follow-up|5
7067342|NCT01985360|11168239|FG001|Overall Study|Lost to Follow-up|3
7067343|NCT01986010|11168327|FG000|Overall Study|Adverse Event|0
7067344|NCT01986010|11168328|FG001|Overall Study|Adverse Event|1
7067345|NCT01986010|11168329|FG002|Overall Study|Adverse Event|0
7067346|NCT01986010|11168330|FG003|Overall Study|Adverse Event|0
7067347|NCT01986010|11168331|FG004|Overall Study|Adverse Event|0
7067348|NCT01986010|11168332|FG005|Overall Study|Adverse Event|0
7067349|NCT01986010|11168333|FG006|Overall Study|Adverse Event|0
7067350|NCT01986010|11168334|FG007|Overall Study|Adverse Event|0
7067351|NCT01986010|11168335|FG008|Overall Study|Adverse Event|0
7067352|NCT01986010|11168336|FG009|Overall Study|Adverse Event|0
7067353|NCT01986010|11168337|FG010|Overall Study|Adverse Event|0
7067354|NCT01986010|11168338|FG011|Overall Study|Adverse Event|0
7067355|NCT01986010|11168339|FG012|Overall Study|Adverse Event|0
7067356|NCT01986010|11168340|FG013|Overall Study|Adverse Event|0
7067357|NCT01986010|11168341|FG014|Overall Study|Adverse Event|0
7067358|NCT01986010|11168342|FG015|Overall Study|Adverse Event|1
7067359|NCT01986010|11168343|FG016|Overall Study|Adverse Event|0
7067360|NCT01986010|11168327|FG000|Overall Study|Lost to Follow-up|2
7067361|NCT01986010|11168328|FG001|Overall Study|Lost to Follow-up|1
7067362|NCT01986010|11168329|FG002|Overall Study|Lost to Follow-up|2
7067363|NCT01986010|11168330|FG003|Overall Study|Lost to Follow-up|2
7067364|NCT01986010|11168331|FG004|Overall Study|Lost to Follow-up|2
7067365|NCT01986010|11168332|FG005|Overall Study|Lost to Follow-up|2
7067366|NCT01986010|11168333|FG006|Overall Study|Lost to Follow-up|0
7067367|NCT01986010|11168334|FG007|Overall Study|Lost to Follow-up|0
7067368|NCT01986010|11168335|FG008|Overall Study|Lost to Follow-up|4
7067369|NCT01986010|11168336|FG009|Overall Study|Lost to Follow-up|2
7067370|NCT01986010|11168337|FG010|Overall Study|Lost to Follow-up|0
7067371|NCT01986010|11168338|FG011|Overall Study|Lost to Follow-up|1
7067372|NCT01986010|11168339|FG012|Overall Study|Lost to Follow-up|1
7067373|NCT01986010|11168340|FG013|Overall Study|Lost to Follow-up|1
7067374|NCT01986010|11168341|FG014|Overall Study|Lost to Follow-up|2
7067375|NCT01986010|11168342|FG015|Overall Study|Lost to Follow-up|0
7067376|NCT01986010|11168343|FG016|Overall Study|Lost to Follow-up|0
7067377|NCT01986010|11168327|FG000|Overall Study|Physician Decision|0
7067378|NCT01986010|11168328|FG001|Overall Study|Physician Decision|0
7067379|NCT01986010|11168329|FG002|Overall Study|Physician Decision|0
7067380|NCT01986010|11168330|FG003|Overall Study|Physician Decision|0
7067381|NCT01986010|11168331|FG004|Overall Study|Physician Decision|0
7067382|NCT01986010|11168332|FG005|Overall Study|Physician Decision|0
7067383|NCT01986010|11168333|FG006|Overall Study|Physician Decision|0
7067384|NCT01986010|11168334|FG007|Overall Study|Physician Decision|0
7067385|NCT01986010|11168335|FG008|Overall Study|Physician Decision|0
7067386|NCT01986010|11168336|FG009|Overall Study|Physician Decision|0
7067387|NCT01986010|11168337|FG010|Overall Study|Physician Decision|0
7067388|NCT01986010|11168338|FG011|Overall Study|Physician Decision|0
7067389|NCT01986010|11168339|FG012|Overall Study|Physician Decision|0
7067390|NCT01986010|11168340|FG013|Overall Study|Physician Decision|0
7067391|NCT01986010|11168341|FG014|Overall Study|Physician Decision|1
7067392|NCT01986010|11168342|FG015|Overall Study|Physician Decision|0
7067393|NCT01986010|11168343|FG016|Overall Study|Physician Decision|0
7067394|NCT01986010|11168327|FG000|Overall Study|Withdrawal by Subject|2
7067395|NCT01986010|11168328|FG001|Overall Study|Withdrawal by Subject|2
7067396|NCT01986010|11168329|FG002|Overall Study|Withdrawal by Subject|3
7067397|NCT01986010|11168330|FG003|Overall Study|Withdrawal by Subject|0
7067398|NCT01986010|11168331|FG004|Overall Study|Withdrawal by Subject|2
7067399|NCT01986010|11168332|FG005|Overall Study|Withdrawal by Subject|4
7067400|NCT01986010|11168333|FG006|Overall Study|Withdrawal by Subject|0
7067401|NCT01986010|11168334|FG007|Overall Study|Withdrawal by Subject|0
7067402|NCT01986010|11168335|FG008|Overall Study|Withdrawal by Subject|0
7067403|NCT01986010|11168336|FG009|Overall Study|Withdrawal by Subject|0
7067404|NCT01986010|11168337|FG010|Overall Study|Withdrawal by Subject|0
7067405|NCT01986010|11168338|FG011|Overall Study|Withdrawal by Subject|2
7067406|NCT01986010|11168339|FG012|Overall Study|Withdrawal by Subject|0
7067407|NCT01986010|11168340|FG013|Overall Study|Withdrawal by Subject|1
7067408|NCT01986010|11168341|FG014|Overall Study|Withdrawal by Subject|2
7067409|NCT01986010|11168342|FG015|Overall Study|Withdrawal by Subject|0
7067410|NCT01986010|11168343|FG016|Overall Study|Withdrawal by Subject|0
7067411|NCT01986010|11168327|FG000|Overall Study|Status Not Recorded|2
7067412|NCT01986010|11168328|FG001|Overall Study|Status Not Recorded|4
7067413|NCT01986010|11168329|FG002|Overall Study|Status Not Recorded|2
7067414|NCT01986010|11168330|FG003|Overall Study|Status Not Recorded|0
7067415|NCT01986010|11168331|FG004|Overall Study|Status Not Recorded|1
7067416|NCT01986010|11168332|FG005|Overall Study|Status Not Recorded|2
7067417|NCT01986010|11168333|FG006|Overall Study|Status Not Recorded|0
7067418|NCT01986010|11168334|FG007|Overall Study|Status Not Recorded|0
7067419|NCT01986010|11168335|FG008|Overall Study|Status Not Recorded|2
7067420|NCT01986010|11168336|FG009|Overall Study|Status Not Recorded|1
7067421|NCT01986010|11168337|FG010|Overall Study|Status Not Recorded|7
7067422|NCT01986010|11168338|FG011|Overall Study|Status Not Recorded|7
7067423|NCT01986010|11168339|FG012|Overall Study|Status Not Recorded|9
7067424|NCT01986010|11168340|FG013|Overall Study|Status Not Recorded|9
7067425|NCT01986010|11168341|FG014|Overall Study|Status Not Recorded|5
7067426|NCT01986010|11168342|FG015|Overall Study|Status Not Recorded|10
7067427|NCT01986010|11168343|FG016|Overall Study|Status Not Recorded|4
7067428|NCT01986062|11168391|FG000|Overall Study|Lost to Follow-up|1
7067429|NCT01986062|11168392|FG001|Overall Study|Lost to Follow-up|0
7067430|NCT01986062|11168391|FG000|Overall Study|Withdrawal by Subject|0
7067431|NCT01986062|11168392|FG001|Overall Study|Withdrawal by Subject|1
7067432|NCT01986140|11168400|FG000|Overall Study|Withdrawal by Subject|31
7067433|NCT01986140|11168401|FG001|Overall Study|Withdrawal by Subject|25
7067434|NCT01986140|11168400|FG000|Overall Study|alternative treatment|1
7067435|NCT01986140|11168401|FG001|Overall Study|alternative treatment|1
7067436|NCT01986140|11168400|FG000|Overall Study|found not eligible|3
7067437|NCT01986140|11168401|FG001|Overall Study|found not eligible|0
7067438|NCT01986140|11168400|FG000|Overall Study|Adverse Event|0
7067439|NCT01986140|11168401|FG001|Overall Study|Adverse Event|1
7067440|NCT01986140|11168400|FG000|Overall Study|progression disease|0
7067441|NCT01986140|11168401|FG001|Overall Study|progression disease|1
7067442|NCT01986231|11168407|FG000|Overall Study|Adverse Event|1
7067443|NCT01986348|11168415|FG000|Overall Study|Death|8
7067444|NCT01986348|11168416|FG001|Overall Study|Death|22
7067445|NCT01986348|11168417|FG002|Overall Study|Death|10
7067446|NCT01986348|11168418|FG003|Overall Study|Death|21
7067447|NCT01986348|11168415|FG000|Overall Study|Lost to Follow-up|0
7067448|NCT01986348|11168416|FG001|Overall Study|Lost to Follow-up|0
7067449|NCT01986348|11168417|FG002|Overall Study|Lost to Follow-up|0
7067450|NCT01986348|11168418|FG003|Overall Study|Lost to Follow-up|2
7067451|NCT01986348|11168415|FG000|Overall Study|Physician Decision|0
7067452|NCT01986348|11168416|FG001|Overall Study|Physician Decision|0
7067453|NCT01986348|11168417|FG002|Overall Study|Physician Decision|0
7067454|NCT01986348|11168418|FG003|Overall Study|Physician Decision|1
7067455|NCT01986348|11168415|FG000|Overall Study|Progressive Disease|0
7067456|NCT01986348|11168416|FG001|Overall Study|Progressive Disease|0
7067457|NCT01986348|11168417|FG002|Overall Study|Progressive Disease|2
7067458|NCT01986348|11168418|FG003|Overall Study|Progressive Disease|0
7067459|NCT01986348|11168415|FG000|Overall Study|Withdrawal by Participant|0
7067460|NCT01986348|11168416|FG001|Overall Study|Withdrawal by Participant|1
7067461|NCT01986348|11168417|FG002|Overall Study|Withdrawal by Participant|2
7067462|NCT01986348|11168418|FG003|Overall Study|Withdrawal by Participant|1
7067463|NCT01986348|11168415|FG000|Overall Study|Study Terminated by Sponsor|0
7067464|NCT01986348|11168416|FG001|Overall Study|Study Terminated by Sponsor|0
7067465|NCT01986348|11168417|FG002|Overall Study|Study Terminated by Sponsor|0
7067466|NCT01986348|11168418|FG003|Overall Study|Study Terminated by Sponsor|3
7067467|NCT01986348|11168415|FG000|Overall Study|Other-unspecified|0
7067468|NCT01986348|11168416|FG001|Overall Study|Other-unspecified|1
7067469|NCT01986348|11168417|FG002|Overall Study|Other-unspecified|0
7067470|NCT01986348|11168418|FG003|Overall Study|Other-unspecified|2
7067471|NCT01986647|11168444|FG000|Overall Study|Lost to Follow-up|4
7067472|NCT01986647|11168445|FG001|Overall Study|Lost to Follow-up|1
7067473|NCT01986647|11168446|FG002|Overall Study|Lost to Follow-up|4
7067474|NCT01986647|11168447|FG003|Overall Study|Lost to Follow-up|4
7067475|NCT01986647|11168444|FG000|Overall Study|Withdrawal by Subject|1
7067476|NCT01986647|11168445|FG001|Overall Study|Withdrawal by Subject|3
7067477|NCT01986647|11168446|FG002|Overall Study|Withdrawal by Subject|2
7067478|NCT01986647|11168447|FG003|Overall Study|Withdrawal by Subject|3
7067479|NCT01986647|11168444|FG000|Overall Study|Health|5
7067480|NCT01986647|11168445|FG001|Overall Study|Health|3
7067481|NCT01986647|11168446|FG002|Overall Study|Health|6
7067482|NCT01986647|11168447|FG003|Overall Study|Health|4
7067483|NCT01986829|11168483|FG000|Overall Study|Death|1
7067484|NCT01986855|11168493|FG000|Overall Study|Adverse Event|1
7067485|NCT01986855|11168494|FG001|Overall Study|Adverse Event|0
7067486|NCT01986855|11168495|FG002|Overall Study|Adverse Event|0
7067487|NCT01986855|11168493|FG000|Overall Study|Death|3
7067488|NCT01986855|11168494|FG001|Overall Study|Death|4
7067489|NCT01986855|11168495|FG002|Overall Study|Death|4
7067490|NCT01986855|11168493|FG000|Overall Study|Lost to Follow-up|2
7067491|NCT01986855|11168494|FG001|Overall Study|Lost to Follow-up|1
7067492|NCT01986855|11168495|FG002|Overall Study|Lost to Follow-up|0
7067493|NCT01986855|11168493|FG000|Overall Study|Screen Failure|0
7067494|NCT01986855|11168494|FG001|Overall Study|Screen Failure|1
7067495|NCT01986855|11168495|FG002|Overall Study|Screen Failure|0
7067496|NCT01986855|11168493|FG000|Overall Study|Participant Moved|0
7067497|NCT01986855|11168494|FG001|Overall Study|Participant Moved|0
7067498|NCT01986855|11168495|FG002|Overall Study|Participant Moved|2
7067499|NCT01986855|11168493|FG000|Overall Study|Withdrawal by Subject|7
7067500|NCT01986855|11168494|FG001|Overall Study|Withdrawal by Subject|8
7067501|NCT01986855|11168495|FG002|Overall Study|Withdrawal by Subject|5
7067502|NCT01986881|11168506|FG000|Overall Study|Death|228
7067503|NCT01986881|11168507|FG001|Overall Study|Death|233
7067504|NCT01986881|11168508|FG002|Overall Study|Death|247
7067505|NCT01986881|11168506|FG000|Overall Study|Lost to Follow-up|51
7067506|NCT01986881|11168507|FG001|Overall Study|Lost to Follow-up|44
7067507|NCT01986881|11168508|FG002|Overall Study|Lost to Follow-up|55
7067508|NCT01986881|11168506|FG000|Overall Study|Physician Decision|7
7067509|NCT01986881|11168507|FG001|Overall Study|Physician Decision|4
7067510|NCT01986881|11168508|FG002|Overall Study|Physician Decision|6
7067511|NCT01986881|11168506|FG000|Overall Study|Study Site Terminated by Sponsor|2
7067512|NCT01986881|11168507|FG001|Overall Study|Study Site Terminated by Sponsor|2
7067513|NCT01986881|11168508|FG002|Overall Study|Study Site Terminated by Sponsor|3
7067514|NCT01986881|11168506|FG000|Overall Study|Withdrawal by Subject|41
7067515|NCT01986881|11168507|FG001|Overall Study|Withdrawal by Subject|60
7067516|NCT01986881|11168508|FG002|Overall Study|Withdrawal by Subject|45
7067517|NCT01986881|11168506|FG000|Overall Study|Subject Moved|0
7067518|NCT01986881|11168507|FG001|Overall Study|Subject Moved|1
7067519|NCT01986881|11168508|FG002|Overall Study|Subject Moved|0
7067520|NCT01986881|11168506|FG000|Overall Study|Other|1
7067521|NCT01986881|11168507|FG001|Overall Study|Other|2
7067522|NCT01986881|11168508|FG002|Overall Study|Other|2
7067523|NCT01986907|11168539|FG000|Overall Study|Adverse Event|11
7067524|NCT01986907|11168539|FG000|Overall Study|Unsatisfactory therapeutic effect|24
7067525|NCT01986907|11168539|FG000|Overall Study|Protocol Violation|4
7067526|NCT01986907|11168539|FG000|Overall Study|Withdrawal by Subject|76
7067527|NCT01986907|11168539|FG000|Overall Study|Lost to Follow-up|38
7067528|NCT01986907|11168539|FG000|Overall Study|Death|9
7067529|NCT01986920|11168546|FG000|A- 101 25%|Withdrawal by Subject|1
7067530|NCT01986920|11168547|FG001|A- 101 25%|Withdrawal by Subject|0
7067531|NCT01986920|11168548|FG002|A- 101 25%|Withdrawal by Subject|0
7067532|NCT01986920|11168549|FG003|A- 101 25%|Withdrawal by Subject|0
7067533|NCT01986920|11168546|FG000|A-101 32.5%|Withdrawal by Subject|0
7067534|NCT01986920|11168547|FG001|A-101 32.5%|Withdrawal by Subject|1
7067535|NCT01986920|11168548|FG002|A-101 32.5%|Withdrawal by Subject|0
7067536|NCT01986920|11168549|FG003|A-101 32.5%|Withdrawal by Subject|0
7067537|NCT01986920|11168546|FG000|A-101 40%|Withdrawal by Subject|0
6941054|NCT00943917|10977179|FG002|Stage II|Withdrawal by Subject|0
6941055|NCT00943917|10977180|FG003|Stage II|Withdrawal by Subject|0
6941056|NCT00943917|10977181|FG004|Stage II|Withdrawal by Subject|0
6941057|NCT00943917|10977182|FG005|Stage II|Withdrawal by Subject|1
6941058|NCT00943917|10977183|FG006|Stage II|Withdrawal by Subject|0
6941059|NCT00943917|10977184|FG007|Stage II|Withdrawal by Subject|0
6941060|NCT00943917|10977185|FG008|Stage II|Withdrawal by Subject|0
6941061|NCT00943917|10977186|FG009|Stage II|Withdrawal by Subject|0
6941062|NCT00943917|10977187|FG010|Stage II|Withdrawal by Subject|0
6941063|NCT00943917|10977188|FG011|Stage II|Withdrawal by Subject|0
6941064|NCT00943917|10977189|FG012|Stage II|Withdrawal by Subject|0
6941065|NCT00943917|10977190|FG013|Stage II|Withdrawal by Subject|0
6941066|NCT00943917|10977191|FG014|Stage II|Withdrawal by Subject|0
6941067|NCT00943917|10977177|FG000|Stage II|Pregnancy|0
6941068|NCT00943917|10977178|FG001|Stage II|Pregnancy|0
6941069|NCT00943917|10977179|FG002|Stage II|Pregnancy|0
6941070|NCT00943917|10977180|FG003|Stage II|Pregnancy|0
6941071|NCT00943917|10977181|FG004|Stage II|Pregnancy|0
6941072|NCT00943917|10977182|FG005|Stage II|Pregnancy|1
6941073|NCT00943917|10977183|FG006|Stage II|Pregnancy|0
6941074|NCT00943917|10977184|FG007|Stage II|Pregnancy|0
6941075|NCT00943917|10977185|FG008|Stage II|Pregnancy|0
6941076|NCT00943917|10977186|FG009|Stage II|Pregnancy|0
6941077|NCT00943917|10977187|FG010|Stage II|Pregnancy|0
6941078|NCT00943917|10977188|FG011|Stage II|Pregnancy|0
6941079|NCT00943917|10977189|FG012|Stage II|Pregnancy|0
6941080|NCT00943917|10977190|FG013|Stage II|Pregnancy|0
6941081|NCT00943917|10977191|FG014|Stage II|Pregnancy|0
6941082|NCT00943917|10977177|FG000|Stage II Continuation|Adverse Event|0
6941083|NCT00943917|10977178|FG001|Stage II Continuation|Adverse Event|0
6941084|NCT00943917|10977179|FG002|Stage II Continuation|Adverse Event|0
7067538|NCT01986920|11168547|FG001|A-101 40%|Withdrawal by Subject|0
7067539|NCT01986920|11168548|FG002|A-101 40%|Withdrawal by Subject|1
7067540|NCT01986920|11168549|FG003|A-101 40%|Withdrawal by Subject|0
6941085|NCT00943917|10977180|FG003|Stage II Continuation|Adverse Event|0
6941086|NCT00943917|10977181|FG004|Stage II Continuation|Adverse Event|0
6941087|NCT00943917|10977182|FG005|Stage II Continuation|Adverse Event|0
6941088|NCT00943917|10977183|FG006|Stage II Continuation|Adverse Event|0
7067541|NCT01986920|11168546|FG000|Placebo|Withdrawal by Subject|0
7067542|NCT01986920|11168547|FG001|Placebo|Withdrawal by Subject|0
7067543|NCT01986920|11168548|FG002|Placebo|Withdrawal by Subject|0
7067544|NCT01986920|11168549|FG003|Placebo|Withdrawal by Subject|1
7067545|NCT01986985|11168568|FG000|Overall Study|Withdrawal by Subject|4
7067546|NCT01986985|11168568|FG000|Overall Study|Scan not completed due to malfunction|3
6941089|NCT00943917|10977184|FG007|Stage II Continuation|Adverse Event|0
6941090|NCT00943917|10977185|FG008|Stage II Continuation|Adverse Event|0
6941091|NCT00943917|10977186|FG009|Stage II Continuation|Adverse Event|0
6941092|NCT00943917|10977187|FG010|Stage II Continuation|Adverse Event|0
6941093|NCT00943917|10977188|FG011|Stage II Continuation|Adverse Event|1
6941094|NCT00943917|10977189|FG012|Stage II Continuation|Adverse Event|2
6941095|NCT00943917|10977190|FG013|Stage II Continuation|Adverse Event|1
6941096|NCT00943917|10977191|FG014|Stage II Continuation|Adverse Event|1
6941097|NCT00943917|10977177|FG000|Stage II Continuation|Withdrawal by Subject|0
6941098|NCT00943917|10977178|FG001|Stage II Continuation|Withdrawal by Subject|0
6941099|NCT00943917|10977179|FG002|Stage II Continuation|Withdrawal by Subject|0
6941100|NCT00943917|10977180|FG003|Stage II Continuation|Withdrawal by Subject|0
6941101|NCT00943917|10977181|FG004|Stage II Continuation|Withdrawal by Subject|0
6941102|NCT00943917|10977182|FG005|Stage II Continuation|Withdrawal by Subject|0
6941103|NCT00943917|10977183|FG006|Stage II Continuation|Withdrawal by Subject|0
6941104|NCT00943917|10977184|FG007|Stage II Continuation|Withdrawal by Subject|0
6941105|NCT00943917|10977185|FG008|Stage II Continuation|Withdrawal by Subject|0
6941106|NCT00943917|10977186|FG009|Stage II Continuation|Withdrawal by Subject|0
6941107|NCT00943917|10977187|FG010|Stage II Continuation|Withdrawal by Subject|0
6941108|NCT00943917|10977188|FG011|Stage II Continuation|Withdrawal by Subject|0
6941109|NCT00943917|10977189|FG012|Stage II Continuation|Withdrawal by Subject|0
6941110|NCT00943917|10977190|FG013|Stage II Continuation|Withdrawal by Subject|1
6941111|NCT00943917|10977191|FG014|Stage II Continuation|Withdrawal by Subject|3
6941112|NCT00943917|10977177|FG000|Stage II Continuation|Protocol Violation|0
6941113|NCT00943917|10977178|FG001|Stage II Continuation|Protocol Violation|0
6941114|NCT00943917|10977179|FG002|Stage II Continuation|Protocol Violation|0
6941115|NCT00943917|10977180|FG003|Stage II Continuation|Protocol Violation|0
6941116|NCT00943917|10977181|FG004|Stage II Continuation|Protocol Violation|0
6941117|NCT00943917|10977182|FG005|Stage II Continuation|Protocol Violation|0
6941118|NCT00943917|10977183|FG006|Stage II Continuation|Protocol Violation|0
6941119|NCT00943917|10977184|FG007|Stage II Continuation|Protocol Violation|0
6941120|NCT00943917|10977185|FG008|Stage II Continuation|Protocol Violation|0
6941121|NCT00943917|10977186|FG009|Stage II Continuation|Protocol Violation|1
6941122|NCT00943917|10977187|FG010|Stage II Continuation|Protocol Violation|0
6941123|NCT00943917|10977188|FG011|Stage II Continuation|Protocol Violation|1
6941124|NCT00943917|10977189|FG012|Stage II Continuation|Protocol Violation|0
6941125|NCT00943917|10977190|FG013|Stage II Continuation|Protocol Violation|0
6941126|NCT00943917|10977191|FG014|Stage II Continuation|Protocol Violation|0
6941127|NCT00943917|10977177|FG000|Stage II Continuation|hypoglycemia|0
6941128|NCT00943917|10977178|FG001|Stage II Continuation|hypoglycemia|0
6941129|NCT00943917|10977179|FG002|Stage II Continuation|hypoglycemia|0
6941130|NCT00943917|10977180|FG003|Stage II Continuation|hypoglycemia|0
6941131|NCT00943917|10977181|FG004|Stage II Continuation|hypoglycemia|0
6941132|NCT00943917|10977182|FG005|Stage II Continuation|hypoglycemia|0
6941133|NCT00943917|10977183|FG006|Stage II Continuation|hypoglycemia|0
6941134|NCT00943917|10977184|FG007|Stage II Continuation|hypoglycemia|0
6941135|NCT00943917|10977185|FG008|Stage II Continuation|hypoglycemia|0
6941136|NCT00943917|10977186|FG009|Stage II Continuation|hypoglycemia|0
6941137|NCT00943917|10977187|FG010|Stage II Continuation|hypoglycemia|0
6941138|NCT00943917|10977188|FG011|Stage II Continuation|hypoglycemia|0
6941139|NCT00943917|10977189|FG012|Stage II Continuation|hypoglycemia|1
6941140|NCT00943917|10977190|FG013|Stage II Continuation|hypoglycemia|0
6941141|NCT00943917|10977191|FG014|Stage II Continuation|hypoglycemia|0
6941142|NCT00943917|10977177|FG000|Stage II Continuation|A1C elevation|0
6941143|NCT00943917|10977178|FG001|Stage II Continuation|A1C elevation|0
7067547|NCT01987102|11168583|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2
7067548|NCT01987102|11168584|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2
7067549|NCT01987102|11168583|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1
7067550|NCT01987102|11168584|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2
7067551|NCT01987102|11168583|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1
7067552|NCT01987102|11168584|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0
7067553|NCT01987102|11168583|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0
7067554|NCT01987102|11168584|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1
6941144|NCT00943917|10977179|FG002|Stage II Continuation|A1C elevation|0
6941145|NCT00943917|10977180|FG003|Stage II Continuation|A1C elevation|0
6941146|NCT00943917|10977181|FG004|Stage II Continuation|A1C elevation|0
6941147|NCT00943917|10977182|FG005|Stage II Continuation|A1C elevation|0
6941148|NCT00943917|10977183|FG006|Stage II Continuation|A1C elevation|0
6941149|NCT00943917|10977184|FG007|Stage II Continuation|A1C elevation|0
6941150|NCT00943917|10977185|FG008|Stage II Continuation|A1C elevation|0
6941151|NCT00943917|10977186|FG009|Stage II Continuation|A1C elevation|0
6941152|NCT00943917|10977187|FG010|Stage II Continuation|A1C elevation|0
6941153|NCT00943917|10977188|FG011|Stage II Continuation|A1C elevation|0
6941154|NCT00943917|10977189|FG012|Stage II Continuation|A1C elevation|0
6941155|NCT00943917|10977190|FG013|Stage II Continuation|A1C elevation|1
6941156|NCT00943917|10977191|FG014|Stage II Continuation|A1C elevation|0
6941157|NCT00944034|10977257|FG000|Overall Study|Inappropriate enrollment|0
6941158|NCT00944034|10977258|FG001|Overall Study|Inappropriate enrollment|1
7040458|NCT01717326|11123362|FG006|Overall Study|Withdrawal by Subject|0
7067555|NCT01987102|11168583|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0
7067556|NCT01987102|11168584|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1
7067557|NCT01987102|11168583|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0
6941159|NCT00944034|10977259|FG002|Overall Study|Inappropriate enrollment|0
6941160|NCT00944034|10977260|FG003|Overall Study|Inappropriate enrollment|1
6941161|NCT00944034|10977261|FG004|Overall Study|Inappropriate enrollment|2
6941162|NCT00944034|10977262|FG005|Overall Study|Inappropriate enrollment|1
6941163|NCT00944034|10977263|FG006|Overall Study|Inappropriate enrollment|0
6941164|NCT00944034|10977264|FG007|Overall Study|Inappropriate enrollment|0
6941165|NCT00944034|10977265|FG008|Overall Study|Inappropriate enrollment|1
6941166|NCT00944034|10977266|FG009|Overall Study|Inappropriate enrollment|1
6941167|NCT00944034|10977267|FG010|Overall Study|Inappropriate enrollment|0
6941168|NCT00944034|10977268|FG011|Overall Study|Inappropriate enrollment|0
6941169|NCT00944034|10977257|FG000|Overall Study|Withdrawal by Subject|3
6941170|NCT00944034|10977258|FG001|Overall Study|Withdrawal by Subject|2
6941171|NCT00944034|10977259|FG002|Overall Study|Withdrawal by Subject|6
6941172|NCT00944034|10977260|FG003|Overall Study|Withdrawal by Subject|2
6941173|NCT00944034|10977261|FG004|Overall Study|Withdrawal by Subject|5
6941174|NCT00944034|10977262|FG005|Overall Study|Withdrawal by Subject|8
6941175|NCT00944034|10977263|FG006|Overall Study|Withdrawal by Subject|2
6941176|NCT00944034|10977264|FG007|Overall Study|Withdrawal by Subject|2
6941177|NCT00944034|10977265|FG008|Overall Study|Withdrawal by Subject|3
6941178|NCT00944034|10977266|FG009|Overall Study|Withdrawal by Subject|4
6941179|NCT00944034|10977267|FG010|Overall Study|Withdrawal by Subject|0
6941180|NCT00944034|10977268|FG011|Overall Study|Withdrawal by Subject|4
6941181|NCT00944034|10977257|FG000|Overall Study|Lost to Follow-up|0
6941182|NCT00944034|10977258|FG001|Overall Study|Lost to Follow-up|4
6941183|NCT00944034|10977259|FG002|Overall Study|Lost to Follow-up|2
6941184|NCT00944034|10977260|FG003|Overall Study|Lost to Follow-up|0
6941185|NCT00944034|10977261|FG004|Overall Study|Lost to Follow-up|5
6941186|NCT00944034|10977262|FG005|Overall Study|Lost to Follow-up|7
6941187|NCT00944034|10977263|FG006|Overall Study|Lost to Follow-up|0
6941188|NCT00944034|10977264|FG007|Overall Study|Lost to Follow-up|1
6941189|NCT00944034|10977265|FG008|Overall Study|Lost to Follow-up|5
6941190|NCT00944034|10977266|FG009|Overall Study|Lost to Follow-up|1
6941191|NCT00944034|10977267|FG010|Overall Study|Lost to Follow-up|1
6941192|NCT00944034|10977268|FG011|Overall Study|Lost to Follow-up|0
6941193|NCT00944034|10977257|FG000|Overall Study|Death|0
6941194|NCT00944034|10977258|FG001|Overall Study|Death|0
6941195|NCT00944034|10977259|FG002|Overall Study|Death|1
6941196|NCT00944034|10977260|FG003|Overall Study|Death|0
6941197|NCT00944034|10977261|FG004|Overall Study|Death|0
6941198|NCT00944034|10977262|FG005|Overall Study|Death|0
6941199|NCT00944034|10977263|FG006|Overall Study|Death|0
6941200|NCT00944034|10977264|FG007|Overall Study|Death|0
6941201|NCT00944034|10977265|FG008|Overall Study|Death|0
6941202|NCT00944034|10977266|FG009|Overall Study|Death|0
6941203|NCT00944034|10977267|FG010|Overall Study|Death|0
6941204|NCT00944034|10977268|FG011|Overall Study|Death|0
6941205|NCT00944034|10977257|FG000|Overall Study|Protocol Violation|2
6941206|NCT00944034|10977258|FG001|Overall Study|Protocol Violation|0
6941207|NCT00944034|10977259|FG002|Overall Study|Protocol Violation|0
6941208|NCT00944034|10977260|FG003|Overall Study|Protocol Violation|1
6941209|NCT00944034|10977261|FG004|Overall Study|Protocol Violation|2
6941210|NCT00944034|10977262|FG005|Overall Study|Protocol Violation|3
6941211|NCT00944034|10977263|FG006|Overall Study|Protocol Violation|0
6941212|NCT00944034|10977264|FG007|Overall Study|Protocol Violation|1
6941213|NCT00944034|10977265|FG008|Overall Study|Protocol Violation|1
6941214|NCT00944034|10977266|FG009|Overall Study|Protocol Violation|4
6941215|NCT00944034|10977267|FG010|Overall Study|Protocol Violation|0
6941216|NCT00944034|10977268|FG011|Overall Study|Protocol Violation|0
6941217|NCT00944034|10977257|FG000|Overall Study|Unable to classify|0
6941218|NCT00944034|10977258|FG001|Overall Study|Unable to classify|0
6941219|NCT00944034|10977259|FG002|Overall Study|Unable to classify|0
6941220|NCT00944034|10977260|FG003|Overall Study|Unable to classify|0
6941221|NCT00944034|10977261|FG004|Overall Study|Unable to classify|0
6941222|NCT00944034|10977262|FG005|Overall Study|Unable to classify|1
6941223|NCT00944034|10977263|FG006|Overall Study|Unable to classify|1
6941224|NCT00944034|10977264|FG007|Overall Study|Unable to classify|1
6941225|NCT00944034|10977265|FG008|Overall Study|Unable to classify|0
6941226|NCT00944034|10977266|FG009|Overall Study|Unable to classify|0
6941227|NCT00944034|10977267|FG010|Overall Study|Unable to classify|0
6941228|NCT00944034|10977268|FG011|Overall Study|Unable to classify|0
6941229|NCT00944034|10977257|FG000|Overall Study|Administrative reason|0
6941230|NCT00944034|10977258|FG001|Overall Study|Administrative reason|0
6941231|NCT00944034|10977259|FG002|Overall Study|Administrative reason|0
6941232|NCT00944034|10977260|FG003|Overall Study|Administrative reason|0
6941233|NCT00944034|10977261|FG004|Overall Study|Administrative reason|0
6941234|NCT00944034|10977262|FG005|Overall Study|Administrative reason|0
6941235|NCT00944034|10977263|FG006|Overall Study|Administrative reason|1
6941236|NCT00944034|10977264|FG007|Overall Study|Administrative reason|0
6941237|NCT00944034|10977265|FG008|Overall Study|Administrative reason|0
6941238|NCT00944034|10977266|FG009|Overall Study|Administrative reason|0
6941239|NCT00944034|10977267|FG010|Overall Study|Administrative reason|0
6941240|NCT00944034|10977268|FG011|Overall Study|Administrative reason|0
7040459|NCT01717326|11123363|FG007|Overall Study|Withdrawal by Subject|0
7040460|NCT01717326|11123364|FG008|Overall Study|Withdrawal by Subject|0
7040461|NCT01717326|11123365|FG009|Overall Study|Withdrawal by Subject|1
7040462|NCT01717326|11123366|FG010|Overall Study|Withdrawal by Subject|0
6941241|NCT00944125|10977324|FG000|3 to 6 Months|Withdrawal by Subject|0
6941242|NCT00944125|10977325|FG001|3 to 6 Months|Withdrawal by Subject|2
6941243|NCT00944125|10977324|FG000|6 Months to Study Completion|Withdrawal by Subject|0
6941244|NCT00944125|10977325|FG001|6 Months to Study Completion|Withdrawal by Subject|2
6941245|NCT00944645|10977347|FG000|Period 2|Adverse Event|1
6941246|NCT00944645|10977348|FG001|Period 2|Adverse Event|0
6941247|NCT00944645|10977347|FG000|Period 2|Lost to Follow-up|0
6941248|NCT00944645|10977348|FG001|Period 2|Lost to Follow-up|3
6941249|NCT00944645|10977347|FG000|Period 2|Withdrawal by Subject|7
6941250|NCT00944645|10977348|FG001|Period 2|Withdrawal by Subject|6
6941251|NCT00944658|10977356|FG000|Treatment 12 Weeks|Adverse Event|0
6941252|NCT00944658|10977357|FG001|Treatment 12 Weeks|Adverse Event|2
6941253|NCT00944697|10977384|FG000|Overall Study|Withdrawal by Subject|1
6941254|NCT00944697|10977385|FG001|Overall Study|Withdrawal by Subject|1
6941255|NCT00944697|10977384|FG000|Overall Study|Adverse Event|0
6941256|NCT00944697|10977385|FG001|Overall Study|Adverse Event|3
6941257|NCT00944697|10977384|FG000|Overall Study|Administrative|1
6941258|NCT00944697|10977385|FG001|Overall Study|Administrative|1
6941259|NCT00945191|10977436|FG000|Overall Study|Did not achieve a complete response|18
6941260|NCT00945191|10977436|FG000|Overall Study|Participant relocated to another state|1
6941261|NCT00945191|10977436|FG000|Overall Study|Disease progression|3
6941262|NCT00945191|10977436|FG000|Overall Study|Serious adverse event or adverse event|1
6941263|NCT00945191|10977436|FG000|Overall Study|Investigator's discretion|1
6941264|NCT00945243|10977440|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3
6941265|NCT00945321|10977491|FG000|Period 1|Adverse Event|0
6941266|NCT00945321|10977492|FG001|Period 1|Adverse Event|0
6941267|NCT00945321|10977493|FG002|Period 1|Adverse Event|0
6941268|NCT00945321|10977494|FG003|Period 1|Adverse Event|0
6941269|NCT00945321|10977495|FG004|Period 1|Adverse Event|1
6941270|NCT00945321|10977496|FG005|Period 1|Adverse Event|0
6941271|NCT00945321|10977491|FG000|Period 4|Lost to Follow-up|0
6941272|NCT00945321|10977492|FG001|Period 4|Lost to Follow-up|0
6941273|NCT00945321|10977493|FG002|Period 4|Lost to Follow-up|0
6941274|NCT00945321|10977494|FG003|Period 4|Lost to Follow-up|0
6941275|NCT00945321|10977495|FG004|Period 4|Lost to Follow-up|0
6941276|NCT00945321|10977496|FG005|Period 4|Lost to Follow-up|1
6941277|NCT00945477|10977523|FG000|Overall Study|Adverse Event|3
7040463|NCT01717326|11123367|FG011|Overall Study|Withdrawal by Subject|0
7040464|NCT01717326|11123368|FG012|Overall Study|Withdrawal by Subject|1
7040465|NCT01717326|11123369|FG013|Overall Study|Withdrawal by Subject|0
7040466|NCT01717326|11123370|FG014|Overall Study|Withdrawal by Subject|0
7040467|NCT01717326|11123371|FG015|Overall Study|Withdrawal by Subject|1
7040468|NCT01717326|11123372|FG016|Overall Study|Withdrawal by Subject|0
7040469|NCT01717326|11123373|FG017|Overall Study|Withdrawal by Subject|0
7040470|NCT01717326|11123374|FG018|Overall Study|Withdrawal by Subject|2
7040471|NCT01717326|11123375|FG019|Overall Study|Withdrawal by Subject|3
7040472|NCT01717391|11123417|FG000|Overall Study|Withdrawal by Subject|5
7040473|NCT01717391|11123417|FG000|Overall Study|Physician Decision|1
7067558|NCT01987102|11168584|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1
6941278|NCT00945477|10977523|FG000|Overall Study|Lack of Efficacy|2
6941279|NCT00945477|10977523|FG000|Overall Study|Withdrawal by Subject|1
6941280|NCT00945555|10977528|FG000|Overall Study|Referred to another hospital|5
6941281|NCT00945555|10977528|FG000|Overall Study|Worsening condition, intensive care unit|1
6941282|NCT00945555|10977528|FG000|Overall Study|Withdrawal by Subject|2
6941283|NCT00945555|10977528|FG000|Overall Study|Participant continued treatment at home|1
6941284|NCT00945555|10977528|FG000|Overall Study|Death|18
6941285|NCT00945555|10977528|FG000|Overall Study|Other|1
6941286|NCT00945659|10977546|FG000|Overall Study|Lost to Follow-up|7
6941287|NCT00945659|10977547|FG001|Overall Study|Lost to Follow-up|20
6941288|NCT00945659|10977548|FG002|Overall Study|Lost to Follow-up|17
6941289|NCT00945815|10977575|FG000|Overall Study|Death|3
6941290|NCT00945815|10977575|FG000|Overall Study|Not protocol specified|1
6941291|NCT00945815|10977575|FG000|Overall Study|Ineligible|3
6941292|NCT00945815|10977575|FG000|Overall Study|Did not begin protocol therapy|1
7040474|NCT01717391|11123417|FG000|Overall Study|FLT technical failure|3
7040475|NCT01717456|11123425|FG000|End of Treatment|Physician Decision|0
7040476|NCT01717456|11123426|FG001|End of Treatment|Physician Decision|1
7067559|NCT01987232|11168615|FG000|Overall Study|Ongoing in Study|0
7067560|NCT01987232|11168616|FG001|Overall Study|Ongoing in Study|0
6941293|NCT00945893|10977590|FG000|Overall Study|Lost to Follow-up|2
6941294|NCT00945893|10977591|FG001|Overall Study|Lost to Follow-up|8
6941295|NCT00945893|10977590|FG000|Overall Study|Withdrawal of consent|1
6941296|NCT00945893|10977591|FG001|Overall Study|Withdrawal of consent|2
6941297|NCT00945906|10977601|FG000|Overall Study|Withdrawal by Subject|1
6941298|NCT00945906|10977601|FG000|Overall Study|Did not want to return for last visit|2
6941299|NCT00945906|10977601|FG000|Overall Study|Unable to return for last visit|2
6941300|NCT00945906|10977601|FG000|Overall Study|Moved to another country|2
6941301|NCT00945945|10977607|FG000|Overall Study|Adverse Event|15
6941302|NCT00945945|10977608|FG001|Overall Study|Adverse Event|35
6941303|NCT00945945|10977607|FG000|Overall Study|Withdrawal by Subject|7
6941304|NCT00945945|10977608|FG001|Overall Study|Withdrawal by Subject|10
6941305|NCT00945945|10977607|FG000|Overall Study|Lost to Follow-up|4
6941306|NCT00945945|10977608|FG001|Overall Study|Lost to Follow-up|5
6941307|NCT00945945|10977607|FG000|Overall Study|Lack of Efficacy|6
6941308|NCT00945945|10977608|FG001|Overall Study|Lack of Efficacy|2
6941309|NCT00945945|10977607|FG000|Overall Study|Protocol Violation|4
6941310|NCT00945945|10977608|FG001|Overall Study|Protocol Violation|2
6941311|NCT00945945|10977607|FG000|Overall Study|Entry Criteria Not Met|0
6941312|NCT00945945|10977608|FG001|Overall Study|Entry Criteria Not Met|1
6975576|NCT01193608|11027766|FG004|Overall Study|Adverse Event|1
6975577|NCT01193608|11027767|FG005|Overall Study|Adverse Event|0
6975578|NCT01193660|11027789|FG000|Overall Study|Withdrawal by Subject|2
6975579|NCT01193660|11027790|FG001|Overall Study|Withdrawal by Subject|3
6975580|NCT01193660|11027791|FG002|Overall Study|Withdrawal by Subject|1
6975581|NCT01193660|11027789|FG000|Overall Study|Death|1
6975582|NCT01193660|11027790|FG001|Overall Study|Death|0
6975583|NCT01193660|11027791|FG002|Overall Study|Death|0
6975584|NCT01193660|11027789|FG000|Overall Study|Physician Decision|1
6975585|NCT01193660|11027790|FG001|Overall Study|Physician Decision|0
6975586|NCT01193660|11027791|FG002|Overall Study|Physician Decision|1
6975587|NCT01193686|11027801|FG000|Overall Study|Withdrawal by Subject|4
6975588|NCT01193686|11027802|FG001|Overall Study|Withdrawal by Subject|1
6975589|NCT01193686|11027801|FG000|Overall Study|Removed by Investigators; unable to matc|3
6975590|NCT01193686|11027802|FG001|Overall Study|Removed by Investigators; unable to matc|0
6975591|NCT01193920|11027840|FG000|Overall Study|Withdrawal by Subject|1
6975592|NCT01193920|11027841|FG001|Overall Study|Withdrawal by Subject|0
6975593|NCT01193920|11027842|FG002|Overall Study|Withdrawal by Subject|5
6975594|NCT01193920|11027843|FG003|Overall Study|Withdrawal by Subject|1
6975595|NCT01193920|11027844|FG004|Overall Study|Withdrawal by Subject|3
6975596|NCT01193920|11027845|FG005|Overall Study|Withdrawal by Subject|1
6975597|NCT01193920|11027846|FG006|Overall Study|Withdrawal by Subject|3
6975598|NCT01193920|11027847|FG007|Overall Study|Withdrawal by Subject|0
6975599|NCT01193920|11027848|FG008|Overall Study|Withdrawal by Subject|1
6975600|NCT01193920|11027849|FG009|Overall Study|Withdrawal by Subject|0
6975601|NCT01193920|11027840|FG000|Overall Study|Lost to Follow-up|1
6975602|NCT01193920|11027841|FG001|Overall Study|Lost to Follow-up|0
6975603|NCT01193920|11027842|FG002|Overall Study|Lost to Follow-up|1
6975604|NCT01193920|11027843|FG003|Overall Study|Lost to Follow-up|1
6975605|NCT01193920|11027844|FG004|Overall Study|Lost to Follow-up|3
6975606|NCT01193920|11027845|FG005|Overall Study|Lost to Follow-up|3
6975607|NCT01193920|11027846|FG006|Overall Study|Lost to Follow-up|1
6975608|NCT01193920|11027847|FG007|Overall Study|Lost to Follow-up|0
6975609|NCT01193920|11027848|FG008|Overall Study|Lost to Follow-up|2
6975610|NCT01193920|11027849|FG009|Overall Study|Lost to Follow-up|3
6975611|NCT01193920|11027840|FG000|Overall Study|Protocol Violation|1
6975612|NCT01193920|11027841|FG001|Overall Study|Protocol Violation|0
6975613|NCT01193920|11027842|FG002|Overall Study|Protocol Violation|0
6975614|NCT01193920|11027843|FG003|Overall Study|Protocol Violation|0
6975615|NCT01193920|11027844|FG004|Overall Study|Protocol Violation|0
6975616|NCT01193920|11027845|FG005|Overall Study|Protocol Violation|0
6975617|NCT01193920|11027846|FG006|Overall Study|Protocol Violation|0
6975618|NCT01193920|11027847|FG007|Overall Study|Protocol Violation|0
6975619|NCT01193920|11027848|FG008|Overall Study|Protocol Violation|0
6975620|NCT01193920|11027849|FG009|Overall Study|Protocol Violation|0
6975621|NCT01193920|11027840|FG000|Overall Study|Death|0
6975622|NCT01193920|11027841|FG001|Overall Study|Death|0
6975623|NCT01193920|11027842|FG002|Overall Study|Death|0
6975624|NCT01193920|11027843|FG003|Overall Study|Death|1
6975625|NCT01193920|11027844|FG004|Overall Study|Death|0
6975626|NCT01193920|11027845|FG005|Overall Study|Death|0
6975627|NCT01193920|11027846|FG006|Overall Study|Death|2
6975628|NCT01193920|11027847|FG007|Overall Study|Death|3
6975629|NCT01193920|11027848|FG008|Overall Study|Death|2
6975630|NCT01193920|11027849|FG009|Overall Study|Death|4
6975631|NCT01193920|11027840|FG000|Overall Study|Unable to classify|0
6975632|NCT01193920|11027841|FG001|Overall Study|Unable to classify|0
6975633|NCT01193920|11027842|FG002|Overall Study|Unable to classify|0
6975634|NCT01193920|11027843|FG003|Overall Study|Unable to classify|1
6975635|NCT01193920|11027844|FG004|Overall Study|Unable to classify|0
6975636|NCT01193920|11027845|FG005|Overall Study|Unable to classify|0
6975637|NCT01193920|11027846|FG006|Overall Study|Unable to classify|0
6975638|NCT01193920|11027847|FG007|Overall Study|Unable to classify|1
6975639|NCT01193920|11027848|FG008|Overall Study|Unable to classify|0
6975640|NCT01193920|11027849|FG009|Overall Study|Unable to classify|0
6975641|NCT01194154|11027883|FG000|Overall Study|Adverse Event|12
6975642|NCT01194154|11027884|FG001|Overall Study|Adverse Event|7
6975643|NCT01194154|11027883|FG000|Overall Study|Lost to Follow-up|2
6975644|NCT01194154|11027884|FG001|Overall Study|Lost to Follow-up|3
6975645|NCT01194154|11027883|FG000|Overall Study|Protocol Violation|0
6975646|NCT01194154|11027884|FG001|Overall Study|Protocol Violation|1
6975647|NCT01194154|11027883|FG000|Overall Study|Withdrawal by Subject|5
6975648|NCT01194154|11027884|FG001|Overall Study|Withdrawal by Subject|6
6975649|NCT01194154|11027883|FG000|Overall Study|Blood pressure increase|5
6975650|NCT01194154|11027884|FG001|Overall Study|Blood pressure increase|3
6975651|NCT01194154|11027883|FG000|Overall Study|Hemoglobin decrease|0
6975652|NCT01194154|11027884|FG001|Overall Study|Hemoglobin decrease|1
6941313|NCT00946088|10977625|FG000|Overall Study|Withdrawal by Subject|0
6941314|NCT00946088|10977626|FG001|Overall Study|Withdrawal by Subject|1
6941315|NCT00946101|10977636|FG000|Overall Study|Lost to Follow-up|2
6941316|NCT00946101|10977637|FG001|Overall Study|Lost to Follow-up|1
6941317|NCT00946101|10977636|FG000|Overall Study|Withdrawal of consent|2
6941318|NCT00946101|10977637|FG001|Overall Study|Withdrawal of consent|0
6941319|NCT00946101|10977636|FG000|Overall Study|Physician Decision|0
6941320|NCT00946101|10977637|FG001|Overall Study|Physician Decision|1
6941321|NCT00946114|10977649|FG000|Overall Study|Death|5
6941322|NCT00946114|10977650|FG001|Overall Study|Death|2
6941323|NCT00946114|10977649|FG000|Overall Study|Other|1
6941324|NCT00946114|10977650|FG001|Overall Study|Other|0
6941325|NCT00946114|10977649|FG000|Overall Study|Withdrawal by Subject|2
6941326|NCT00946114|10977650|FG001|Overall Study|Withdrawal by Subject|0
6941327|NCT00946153|10977661|FG000|Phase 2|Adverse Event|0
6941328|NCT00946153|10977662|FG001|Phase 2|Adverse Event|0
6941329|NCT00946153|10977663|FG002|Phase 2|Adverse Event|0
6941330|NCT00946153|10977664|FG003|Phase 2|Adverse Event|0
6941331|NCT00946153|10977665|FG004|Phase 2|Adverse Event|6
6941332|NCT00946153|10977661|FG000|Phase 2|Need more reduction of dose|0
6941333|NCT00946153|10977662|FG001|Phase 2|Need more reduction of dose|0
6941334|NCT00946153|10977663|FG002|Phase 2|Need more reduction of dose|0
6941335|NCT00946153|10977664|FG003|Phase 2|Need more reduction of dose|0
6941336|NCT00946153|10977665|FG004|Phase 2|Need more reduction of dose|2
6941337|NCT00946153|10977661|FG000|Phase 2|Physician Decision|0
6941338|NCT00946153|10977662|FG001|Phase 2|Physician Decision|0
6941339|NCT00946153|10977663|FG002|Phase 2|Physician Decision|0
6941340|NCT00946153|10977664|FG003|Phase 2|Physician Decision|0
6941341|NCT00946153|10977665|FG004|Phase 2|Physician Decision|1
6941342|NCT00946153|10977661|FG000|Phase 2|14 days washout for recovery due to AE|0
6941343|NCT00946153|10977662|FG001|Phase 2|14 days washout for recovery due to AE|0
6941344|NCT00946153|10977663|FG002|Phase 2|14 days washout for recovery due to AE|0
6941345|NCT00946153|10977664|FG003|Phase 2|14 days washout for recovery due to AE|0
6941346|NCT00946153|10977665|FG004|Phase 2|14 days washout for recovery due to AE|4
6941347|NCT00946192|10977685|FG000|Overall Study|Lost to Follow-up|6
6941348|NCT00946192|10977686|FG001|Overall Study|Lost to Follow-up|11
6941349|NCT00946192|10977687|FG002|Overall Study|Lost to Follow-up|9
6941350|NCT00946192|10977685|FG000|Overall Study|Withdrawal by Subject|10
6941351|NCT00946192|10977686|FG001|Overall Study|Withdrawal by Subject|7
6941352|NCT00946192|10977687|FG002|Overall Study|Withdrawal by Subject|3
6941353|NCT00946192|10977685|FG000|Overall Study|Did not start medication|2
6941354|NCT00946192|10977686|FG001|Overall Study|Did not start medication|0
6941355|NCT00946192|10977687|FG002|Overall Study|Did not start medication|0
6941356|NCT00946296|10977710|FG000|Overall Study|Physician Decision|3
6941357|NCT00946296|10977711|FG001|Overall Study|Physician Decision|0
6941358|NCT00946309|10977719|FG000|Overall Study|Protocol Violation|1
6941359|NCT00946309|10977720|FG001|Overall Study|Protocol Violation|0
6941360|NCT00946309|10977719|FG000|Overall Study|Lost to Follow-up|0
6941361|NCT00946309|10977720|FG001|Overall Study|Lost to Follow-up|1
6941362|NCT00946309|10977719|FG000|Overall Study|Procedure cancelled/discontinued|0
6941363|NCT00946309|10977720|FG001|Overall Study|Procedure cancelled/discontinued|3
6941364|NCT00946322|10977727|FG000|Pre-treatment|participant failure to follow up|1
6941365|NCT00946322|10977727|FG000|Post-treatment|participant failure to follow up|2
6941366|NCT00946530|10977753|FG000|Overall Study|Withdrawal by Subject|0
6941367|NCT00946530|10977754|FG001|Overall Study|Withdrawal by Subject|3
6941368|NCT00946530|10977755|FG002|Overall Study|Withdrawal by Subject|0
6941369|NCT00946530|10977756|FG003|Overall Study|Withdrawal by Subject|3
6941370|NCT00946530|10977753|FG000|Overall Study|Physician Decision|1
6941371|NCT00946530|10977754|FG001|Overall Study|Physician Decision|1
6941372|NCT00946530|10977755|FG002|Overall Study|Physician Decision|1
6941373|NCT00946530|10977756|FG003|Overall Study|Physician Decision|1
6941374|NCT00946647|10977775|FG000|Phase 1 Part|Adverse Event|2
6941375|NCT00946647|10977776|FG001|Phase 1 Part|Adverse Event|5
6941376|NCT00946647|10977777|FG002|Phase 1 Part|Adverse Event|3
6941377|NCT00946647|10977778|FG003|Phase 1 Part|Adverse Event|0
6941378|NCT00946647|10977779|FG004|Phase 1 Part|Adverse Event|0
6941379|NCT00946647|10977775|FG000|Phase 1 Part|Disease progression|3
6941380|NCT00946647|10977776|FG001|Phase 1 Part|Disease progression|6
6941381|NCT00946647|10977777|FG002|Phase 1 Part|Disease progression|1
6941382|NCT00946647|10977778|FG003|Phase 1 Part|Disease progression|0
6941383|NCT00946647|10977779|FG004|Phase 1 Part|Disease progression|0
6941384|NCT00946647|10977775|FG000|Phase 1 Part|Withdrawal by Subject|1
6941385|NCT00946647|10977776|FG001|Phase 1 Part|Withdrawal by Subject|4
6941386|NCT00946647|10977777|FG002|Phase 1 Part|Withdrawal by Subject|3
6941387|NCT00946647|10977778|FG003|Phase 1 Part|Withdrawal by Subject|0
6941388|NCT00946647|10977779|FG004|Phase 1 Part|Withdrawal by Subject|0
6941389|NCT00946647|10977775|FG000|Phase 1 Part|Abnormal values|0
6941390|NCT00946647|10977776|FG001|Phase 1 Part|Abnormal values|2
6941391|NCT00946647|10977777|FG002|Phase 1 Part|Abnormal values|0
6941392|NCT00946647|10977778|FG003|Phase 1 Part|Abnormal values|0
6941393|NCT00946647|10977779|FG004|Phase 1 Part|Abnormal values|0
6941394|NCT00946647|10977775|FG000|Phase 1 Part|Reason missing|0
6941395|NCT00946647|10977776|FG001|Phase 1 Part|Reason missing|1
6941396|NCT00946647|10977777|FG002|Phase 1 Part|Reason missing|0
6941397|NCT00946647|10977778|FG003|Phase 1 Part|Reason missing|0
6941398|NCT00946647|10977779|FG004|Phase 1 Part|Reason missing|0
6941399|NCT00946647|10977775|FG000|Phase ll Part|Untreated|0
6941400|NCT00946647|10977776|FG001|Phase ll Part|Untreated|0
6941401|NCT00946647|10977777|FG002|Phase ll Part|Untreated|0
6941402|NCT00946647|10977778|FG003|Phase ll Part|Untreated|0
6941403|NCT00946647|10977779|FG004|Phase ll Part|Untreated|2
6941404|NCT00946647|10977775|FG000|Phase ll Part|Adverse Event|0
6941405|NCT00946647|10977776|FG001|Phase ll Part|Adverse Event|0
6941406|NCT00946647|10977777|FG002|Phase ll Part|Adverse Event|0
6941407|NCT00946647|10977778|FG003|Phase ll Part|Adverse Event|10
6941408|NCT00946647|10977779|FG004|Phase ll Part|Adverse Event|6
6941409|NCT00946647|10977775|FG000|Phase ll Part|Withdrawal by Subject|0
6941410|NCT00946647|10977776|FG001|Phase ll Part|Withdrawal by Subject|0
6941411|NCT00946647|10977777|FG002|Phase ll Part|Withdrawal by Subject|0
6941412|NCT00946647|10977778|FG003|Phase ll Part|Withdrawal by Subject|8
6941413|NCT00946647|10977779|FG004|Phase ll Part|Withdrawal by Subject|6
6941414|NCT00946647|10977775|FG000|Phase ll Part|Administrative problems|0
6941415|NCT00946647|10977776|FG001|Phase ll Part|Administrative problems|0
6941416|NCT00946647|10977777|FG002|Phase ll Part|Administrative problems|0
6941417|NCT00946647|10977778|FG003|Phase ll Part|Administrative problems|3
6941418|NCT00946647|10977779|FG004|Phase ll Part|Administrative problems|8
6941419|NCT00946647|10977775|FG000|Phase ll Part|Death|0
6941420|NCT00946647|10977776|FG001|Phase ll Part|Death|0
6941421|NCT00946647|10977777|FG002|Phase ll Part|Death|0
6941422|NCT00946647|10977778|FG003|Phase ll Part|Death|7
6941423|NCT00946647|10977779|FG004|Phase ll Part|Death|4
6941424|NCT00946647|10977775|FG000|Phase ll Part|Disease progression|0
6941425|NCT00946647|10977776|FG001|Phase ll Part|Disease progression|0
6941426|NCT00946647|10977777|FG002|Phase ll Part|Disease progression|0
6941427|NCT00946647|10977778|FG003|Phase ll Part|Disease progression|6
6941428|NCT00946647|10977779|FG004|Phase ll Part|Disease progression|14
6941429|NCT00946647|10977775|FG000|Phase ll Part|Protocol Violation|0
6941430|NCT00946647|10977776|FG001|Phase ll Part|Protocol Violation|0
6941431|NCT00946647|10977777|FG002|Phase ll Part|Protocol Violation|0
6941432|NCT00946647|10977778|FG003|Phase ll Part|Protocol Violation|4
6941433|NCT00946647|10977779|FG004|Phase ll Part|Protocol Violation|2
6941434|NCT00946647|10977775|FG000|Phase ll Part|Subj cond no longer required study drug|0
6941435|NCT00946647|10977776|FG001|Phase ll Part|Subj cond no longer required study drug|0
6941436|NCT00946647|10977777|FG002|Phase ll Part|Subj cond no longer required study drug|0
6941437|NCT00946647|10977778|FG003|Phase ll Part|Subj cond no longer required study drug|2
6941438|NCT00946647|10977779|FG004|Phase ll Part|Subj cond no longer required study drug|0
6941439|NCT00946712|10977794|FG000|Overall Study|Adverse Event|118
6941440|NCT00946712|10977795|FG001|Overall Study|Adverse Event|124
6941441|NCT00946712|10977794|FG000|Overall Study|Disease progression|308
6941442|NCT00946712|10977795|FG001|Overall Study|Disease progression|404
6941443|NCT00946712|10977794|FG000|Overall Study|Death|21
6941444|NCT00946712|10977795|FG001|Overall Study|Death|22
6941445|NCT00946712|10977794|FG000|Overall Study|No treatment given|25
6941446|NCT00946712|10977795|FG001|Overall Study|No treatment given|29
6941447|NCT00946712|10977794|FG000|Overall Study|Other reasons|61
6941448|NCT00946712|10977795|FG001|Overall Study|Other reasons|73
6941449|NCT00946712|10977794|FG000|Overall Study|On Treatment|0
6941450|NCT00946712|10977795|FG001|Overall Study|On Treatment|4
6941451|NCT00946712|10977794|FG000|Overall Study|Ineligible|14
6941452|NCT00946712|10977795|FG001|Overall Study|Ineligible|6
6941453|NCT00946881|10977802|FG000|First Treatment|Withdrawal by Subject|1
6941454|NCT00946881|10977802|FG000|First Treatment|Patient relocated to another state|1
6941455|NCT00946881|10977802|FG000|Retreatment|Withdrawal by Subject|1
6941456|NCT00946920|10977829|FG000|Overall Study|Withdrawal by Subject|28
6941457|NCT00946920|10977830|FG001|Overall Study|Withdrawal by Subject|15
6941458|NCT00946920|10977829|FG000|Overall Study|Lost to Follow-up|2
6941459|NCT00946920|10977830|FG001|Overall Study|Lost to Follow-up|2
6941460|NCT00946920|10977829|FG000|Overall Study|Physician Decision|5
6941461|NCT00946920|10977830|FG001|Overall Study|Physician Decision|2
6941462|NCT00946920|10977829|FG000|Overall Study|Adverse Event|41
6941463|NCT00946920|10977830|FG001|Overall Study|Adverse Event|14
6941464|NCT00946920|10977829|FG000|Overall Study|Protocol Violation|16
6941465|NCT00946920|10977830|FG001|Overall Study|Protocol Violation|8
6941466|NCT00946920|10977829|FG000|Overall Study|Miscellaneous reasons|18
6941467|NCT00946920|10977830|FG001|Overall Study|Miscellaneous reasons|3
6941468|NCT00946998|10977838|FG000|Overall Study|Exited prior to first outcome assessment|5
6941469|NCT00946998|10977839|FG001|Overall Study|Exited prior to first outcome assessment|3
6941470|NCT00947115|10977848|FG000|Overall Study|Missed reporting interval|3
6941471|NCT00947115|10977849|FG001|Overall Study|Missed reporting interval|4
6941472|NCT00947115|10977850|FG002|Overall Study|Missed reporting interval|2
6941473|NCT00947115|10977848|FG000|Overall Study|Physician Decision|0
6941474|NCT00947115|10977849|FG001|Overall Study|Physician Decision|2
6941475|NCT00947115|10977850|FG002|Overall Study|Physician Decision|0
6941476|NCT00947115|10977848|FG000|Overall Study|Death|0
6941477|NCT00947115|10977849|FG001|Overall Study|Death|1
6941478|NCT00947115|10977850|FG002|Overall Study|Death|1
6941479|NCT00947115|10977848|FG000|Overall Study|Migrated from study area|2
6941480|NCT00947115|10977849|FG001|Overall Study|Migrated from study area|0
6941481|NCT00947115|10977850|FG002|Overall Study|Migrated from study area|0
6941482|NCT00947115|10977848|FG000|Overall Study|Withdrawal by Subject|1
6941483|NCT00947115|10977849|FG001|Overall Study|Withdrawal by Subject|3
6941484|NCT00947115|10977850|FG002|Overall Study|Withdrawal by Subject|4
6941485|NCT00947115|10977848|FG000|Overall Study|Lost to Follow-up|11
6941486|NCT00947115|10977849|FG001|Overall Study|Lost to Follow-up|12
6941487|NCT00947115|10977850|FG002|Overall Study|Lost to Follow-up|8
6941488|NCT00947154|10977858|FG000|Overall Study|Lost to Follow-up|1
6941489|NCT00947193|10977867|FG000|Overall Study|Lost to Follow-up|1
6941490|NCT00947193|10977868|FG001|Overall Study|Lost to Follow-up|0
6941491|NCT00947193|10977867|FG000|Overall Study|Withdrawal by Subject|1
6941492|NCT00947193|10977868|FG001|Overall Study|Withdrawal by Subject|0
6941493|NCT00947193|10977867|FG000|Overall Study|Factor VIII >1%|1
6941494|NCT00947193|10977868|FG001|Overall Study|Factor VIII >1%|0
6941495|NCT00947349|10977925|FG000|Triple Treatment Combination Period|Adverse Event|0
6941496|NCT00947349|10977926|FG001|Triple Treatment Combination Period|Adverse Event|1
6941497|NCT00947349|10977927|FG002|Triple Treatment Combination Period|Adverse Event|0
6941498|NCT00947349|10977928|FG003|Triple Treatment Combination Period|Adverse Event|0
6941499|NCT00947349|10977925|FG000|Overall Study Standard of Care|Lack of Efficacy|0
6941500|NCT00947349|10977926|FG001|Overall Study Standard of Care|Lack of Efficacy|0
6941501|NCT00947349|10977927|FG002|Overall Study Standard of Care|Lack of Efficacy|1
6941502|NCT00947349|10977928|FG003|Overall Study Standard of Care|Lack of Efficacy|1
6941503|NCT00947349|10977925|FG000|Overall Study Standard of Care|Withdrawal by Subject|0
6941504|NCT00947349|10977926|FG001|Overall Study Standard of Care|Withdrawal by Subject|0
6941505|NCT00947349|10977927|FG002|Overall Study Standard of Care|Withdrawal by Subject|1
6941506|NCT00947349|10977928|FG003|Overall Study Standard of Care|Withdrawal by Subject|0
6941507|NCT00947349|10977925|FG000|Overall Study Standard of Care|Other|0
6941508|NCT00947349|10977926|FG001|Overall Study Standard of Care|Other|0
6941509|NCT00947349|10977927|FG002|Overall Study Standard of Care|Other|0
6941510|NCT00947349|10977928|FG003|Overall Study Standard of Care|Other|1
6941511|NCT00947427|10977958|FG000|Overall Study|Withdrawal by Subject|1
6941512|NCT00947427|10977959|FG001|Overall Study|Withdrawal by Subject|3
6941513|NCT00947427|10977958|FG000|Overall Study|Protocol Violation|0
6941514|NCT00947427|10977959|FG001|Overall Study|Protocol Violation|1
6941515|NCT00947531|10977976|FG000|Overall Study|Withdrawal by Subject|10
6941516|NCT00947531|10977977|FG001|Overall Study|Withdrawal by Subject|7
6941517|NCT00947531|10977976|FG000|Overall Study|Administrative Reason|0
6941518|NCT00947531|10977977|FG001|Overall Study|Administrative Reason|1
6941519|NCT00947531|10977976|FG000|Overall Study|Adverse Event|2
6941520|NCT00947531|10977977|FG001|Overall Study|Adverse Event|2
6941521|NCT00947531|10977976|FG000|Overall Study|Lack of Efficacy|1
6941522|NCT00947531|10977977|FG001|Overall Study|Lack of Efficacy|0
6941523|NCT00947531|10977976|FG000|Overall Study|Other|1
6941524|NCT00947531|10977977|FG001|Overall Study|Other|1
6941525|NCT00947544|10977983|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1
6941526|NCT00947544|10977984|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0
6941527|NCT00947856|10978023|FG000|Treatment Period|Progressive Disease|33
6941528|NCT00947856|10978024|FG001|Treatment Period|Progressive Disease|12
6941529|NCT00947856|10978023|FG000|Treatment Period|Adverse Event|15
6941530|NCT00947856|10978024|FG001|Treatment Period|Adverse Event|9
6941531|NCT00947856|10978023|FG000|Treatment Period|Physician Decision|14
6941532|NCT00947856|10978024|FG001|Treatment Period|Physician Decision|6
6941533|NCT00947856|10978023|FG000|Treatment Period|Study Stopped by Sponsor|4
6941534|NCT00947856|10978024|FG001|Treatment Period|Study Stopped by Sponsor|4
6941535|NCT00947856|10978023|FG000|Treatment Period|Withdrawal by Subject|12
6941536|NCT00947856|10978024|FG001|Treatment Period|Withdrawal by Subject|1
6941537|NCT00947856|10978023|FG000|Follow-up Period|Study Stopped by Sponsor|40
6941538|NCT00947856|10978024|FG001|Follow-up Period|Study Stopped by Sponsor|20
6941539|NCT00947856|10978023|FG000|Follow-up Period|Re-enrolled for Retreatment|2
6941540|NCT00947856|10978024|FG001|Follow-up Period|Re-enrolled for Retreatment|3
6941541|NCT00947856|10978023|FG000|Follow-up Period|Lost to Follow-up|7
6941542|NCT00947856|10978024|FG001|Follow-up Period|Lost to Follow-up|0
6941543|NCT00947856|10978023|FG000|Follow-up Period|Patient unavailable for site visits|1
6941544|NCT00947856|10978024|FG001|Follow-up Period|Patient unavailable for site visits|0
6941545|NCT00947856|10978023|FG000|Follow-up Period|Withdrawal by Subject|1
6941546|NCT00947856|10978024|FG001|Follow-up Period|Withdrawal by Subject|0
6941547|NCT00947882|10978043|FG000|Overall Study|Adverse Event|0
6941548|NCT00947882|10978044|FG001|Overall Study|Adverse Event|1
6941549|NCT00947882|10978045|FG002|Overall Study|Adverse Event|4
6941550|NCT00947882|10978046|FG003|Overall Study|Adverse Event|4
6941551|NCT00947882|10978043|FG000|Overall Study|Withdrawal by Subject|2
6941552|NCT00947882|10978044|FG001|Overall Study|Withdrawal by Subject|0
6941553|NCT00947882|10978045|FG002|Overall Study|Withdrawal by Subject|8
6941554|NCT00947882|10978046|FG003|Overall Study|Withdrawal by Subject|2
6941555|NCT00947882|10978043|FG000|Overall Study|Protocol Violation|0
6941556|NCT00947882|10978044|FG001|Overall Study|Protocol Violation|0
6941557|NCT00947882|10978045|FG002|Overall Study|Protocol Violation|1
6941558|NCT00947882|10978046|FG003|Overall Study|Protocol Violation|0
6941559|NCT00947882|10978043|FG000|Overall Study|Lost to Follow-up|0
6941560|NCT00947882|10978044|FG001|Overall Study|Lost to Follow-up|2
6941561|NCT00947882|10978045|FG002|Overall Study|Lost to Follow-up|1
6941562|NCT00947882|10978046|FG003|Overall Study|Lost to Follow-up|0
6941563|NCT00947882|10978043|FG000|Overall Study|Other/Unknown|10
6941564|NCT00947882|10978044|FG001|Overall Study|Other/Unknown|13
6941565|NCT00947882|10978045|FG002|Overall Study|Other/Unknown|3
6941566|NCT00947882|10978046|FG003|Overall Study|Other/Unknown|6
6941567|NCT00947882|10978043|FG000|Overall Study|Trial Terminated by Sponsor|62
6941568|NCT00947882|10978044|FG001|Overall Study|Trial Terminated by Sponsor|61
6941569|NCT00947882|10978045|FG002|Overall Study|Trial Terminated by Sponsor|62
6941570|NCT00947882|10978046|FG003|Overall Study|Trial Terminated by Sponsor|70
6941571|NCT00948025|10978059|FG000|Phase 1 (Pilot Phase)|Adverse Event|1
6941572|NCT00948025|10978060|FG001|Phase 1 (Pilot Phase)|Adverse Event|1
6941573|NCT00948025|10978059|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7
6941574|NCT00948025|10978060|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1
6941575|NCT00948025|10978059|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1
6941576|NCT00948025|10978060|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1
6941577|NCT00948064|10978070|FG000|Phase I|No treatment received|1
6941578|NCT00948064|10978071|FG001|Phase I|No treatment received|0
6941579|NCT00948064|10978072|FG002|Phase I|No treatment received|0
6941580|NCT00948064|10978070|FG000|Phase II|Physician Decision|0
6941581|NCT00948064|10978071|FG001|Phase II|Physician Decision|0
6941582|NCT00948064|10978072|FG002|Phase II|Physician Decision|1
6941583|NCT00948064|10978070|FG000|Phase II|Withdrawal by Subject|0
6941584|NCT00948064|10978071|FG001|Phase II|Withdrawal by Subject|1
6941585|NCT00948064|10978072|FG002|Phase II|Withdrawal by Subject|0
6941586|NCT00948155|10978096|FG000|First Intervention 21 Days|Lost to Follow-up|2
6941587|NCT00948155|10978097|FG001|First Intervention 21 Days|Lost to Follow-up|2
6941588|NCT00948155|10978096|FG000|Washout 14 Days|Lost to Follow-up|1
6941589|NCT00948155|10978097|FG001|Washout 14 Days|Lost to Follow-up|2
6941590|NCT00948246|10978105|FG000|Overall Study|Lost to Follow-up|11
6941591|NCT00948246|10978105|FG000|Overall Study|Adverse Event|11
6941592|NCT00948246|10978105|FG000|Overall Study|Death|1
6941593|NCT00948246|10978105|FG000|Overall Study|Withdrawal by Subject|1
6941594|NCT00948389|10978123|FG000|Overall Study|Disease Progression/Relapse/Death|3
6941595|NCT00948389|10978124|FG001|Overall Study|Disease Progression/Relapse/Death|3
6941596|NCT00948389|10978125|FG002|Overall Study|Disease Progression/Relapse/Death|7
6941597|NCT00948389|10978126|FG003|Overall Study|Disease Progression/Relapse/Death|8
6941598|NCT00948389|10978127|FG004|Overall Study|Disease Progression/Relapse/Death|1
6941599|NCT00948389|10978123|FG000|Overall Study|Thrombocytopenia, Grade 4|2
6941600|NCT00948389|10978124|FG001|Overall Study|Thrombocytopenia, Grade 4|0
6941601|NCT00948389|10978125|FG002|Overall Study|Thrombocytopenia, Grade 4|0
6941602|NCT00948389|10978126|FG003|Overall Study|Thrombocytopenia, Grade 4|1
6941603|NCT00948389|10978127|FG004|Overall Study|Thrombocytopenia, Grade 4|0
6941604|NCT00948389|10978123|FG000|Overall Study|Both Progression and Toxicity|1
6941605|NCT00948389|10978124|FG001|Overall Study|Both Progression and Toxicity|0
6941606|NCT00948389|10978125|FG002|Overall Study|Both Progression and Toxicity|0
6941607|NCT00948389|10978126|FG003|Overall Study|Both Progression and Toxicity|0
6941608|NCT00948389|10978127|FG004|Overall Study|Both Progression and Toxicity|0
6941609|NCT00948428|10978144|FG000|Overall Study|Withdrawal by Subject|6
6941610|NCT00948428|10978145|FG001|Overall Study|Withdrawal by Subject|12
6941611|NCT00948428|10978146|FG002|Overall Study|Withdrawal by Subject|7
6941612|NCT00948428|10978144|FG000|Overall Study|Adverse Event|6
6941613|NCT00948428|10978145|FG001|Overall Study|Adverse Event|3
6941614|NCT00948428|10978146|FG002|Overall Study|Adverse Event|0
6941615|NCT00948428|10978144|FG000|Overall Study|Lost to Follow-up|2
6941616|NCT00948428|10978145|FG001|Overall Study|Lost to Follow-up|1
6941617|NCT00948428|10978146|FG002|Overall Study|Lost to Follow-up|1
6941618|NCT00948428|10978144|FG000|Overall Study|Death|2
6941619|NCT00948428|10978145|FG001|Overall Study|Death|0
6941620|NCT00948428|10978146|FG002|Overall Study|Death|0
6941621|NCT00948428|10978144|FG000|Overall Study|Intercurrent Illness|1
6941622|NCT00948428|10978145|FG001|Overall Study|Intercurrent Illness|0
6941623|NCT00948428|10978146|FG002|Overall Study|Intercurrent Illness|0
6941624|NCT00948428|10978144|FG000|Overall Study|Non-compliance|1
6941625|NCT00948428|10978145|FG001|Overall Study|Non-compliance|2
6941626|NCT00948428|10978146|FG002|Overall Study|Non-compliance|0
6941627|NCT00948441|10978156|FG000|Overall Study|no longer meet inclusion criteria|1
6941628|NCT00948441|10978157|FG001|Overall Study|no longer meet inclusion criteria|4
6941629|NCT00948506|10978167|FG000|Overall Study|Withdrawal by Subject|3
6941630|NCT00948506|10978168|FG001|Overall Study|Withdrawal by Subject|1
6941631|NCT00948675|10978188|FG000|Overall Study|Lost to Follow-up|1
6941632|NCT00948675|10978189|FG001|Overall Study|Lost to Follow-up|0
6941633|NCT00948688|10978195|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1
6941634|NCT00948688|10978196|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0
6941635|NCT00948688|10978195|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1
6941636|NCT00948688|10978196|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0
6941637|NCT00948688|10978195|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0
6941638|NCT00948688|10978196|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1
6941639|NCT00948766|10978205|FG000|Core Study|Adverse Event|73
6941640|NCT00948766|10978206|FG001|Core Study|Adverse Event|51
6941641|NCT00948766|10978205|FG000|Core Study|Unsatisfactory Therapeutic Effect|13
6941642|NCT00948766|10978206|FG001|Core Study|Unsatisfactory Therapeutic Effect|14
6941643|NCT00948766|10978205|FG000|Core Study|Patient Withdrew Consent|27
6941644|NCT00948766|10978206|FG001|Core Study|Patient Withdrew Consent|46
6941645|NCT00948766|10978205|FG000|Core Study|Lost to Follow-up|3
6941646|NCT00948766|10978206|FG001|Core Study|Lost to Follow-up|2
6941647|NCT00948766|10978205|FG000|Core Study|Administrative Problems|2
6941648|NCT00948766|10978206|FG001|Core Study|Administrative Problems|2
6941649|NCT00948766|10978205|FG000|Core Study|Death|1
6941650|NCT00948766|10978206|FG001|Core Study|Death|1
6941651|NCT00948766|10978205|FG000|Core Study|Protocol Deviation|8
6941652|NCT00948766|10978206|FG001|Core Study|Protocol Deviation|10
6941653|NCT00948766|10978205|FG000|Extension Study|Adverse Event|43
6941654|NCT00948766|10978206|FG001|Extension Study|Adverse Event|0
6941655|NCT00948766|10978205|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2
6941656|NCT00948766|10978206|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0
6941657|NCT00948766|10978205|FG000|Extension Study|Study Drug No Longer Required|1
6941658|NCT00948766|10978206|FG001|Extension Study|Study Drug No Longer Required|0
6941659|NCT00948766|10978205|FG000|Extension Study|Patient Withdrew Consent|32
6941660|NCT00948766|10978206|FG001|Extension Study|Patient Withdrew Consent|0
6941661|NCT00948766|10978205|FG000|Extension Study|Lost to Follow-up|8
6941662|NCT00948766|10978206|FG001|Extension Study|Lost to Follow-up|0
6941663|NCT00948766|10978205|FG000|Extension Study|Administrative Problems|1
6941664|NCT00948766|10978206|FG001|Extension Study|Administrative Problems|0
6941665|NCT00948766|10978205|FG000|Extension Study|Death|4
6941666|NCT00948766|10978206|FG001|Extension Study|Death|0
6941667|NCT00948818|10978221|FG000|Overall Study|Adverse Event|10
6941668|NCT00948818|10978222|FG001|Overall Study|Adverse Event|32
6941669|NCT00948818|10978221|FG000|Overall Study|Protocol Violation|9
6941670|NCT00948818|10978222|FG001|Overall Study|Protocol Violation|10
6941671|NCT00948818|10978221|FG000|Overall Study|Withdrawal by Subject|25
6941672|NCT00948818|10978222|FG001|Overall Study|Withdrawal by Subject|25
6941673|NCT00948818|10978221|FG000|Overall Study|Lost to Follow-up|10
6941674|NCT00948818|10978222|FG001|Overall Study|Lost to Follow-up|17
6941675|NCT00948818|10978221|FG000|Overall Study|Lack of Efficacy|4
6941676|NCT00948818|10978222|FG001|Overall Study|Lack of Efficacy|5
6941677|NCT00948818|10978221|FG000|Overall Study|Other Reason|4
6941678|NCT00948818|10978222|FG001|Overall Study|Other Reason|5
6941679|NCT00948857|10978233|FG000|Overall Study|Lost to Follow-up|1
6941680|NCT00948857|10978234|FG001|Overall Study|Lost to Follow-up|0
6941681|NCT00948896|10978248|FG000|Randomization to 24 Months of Age|Death|1
6941682|NCT00948896|10978249|FG001|Randomization to 24 Months of Age|Death|0
6941683|NCT00948896|10978250|FG002|Randomization to 24 Months of Age|Death|0
6941684|NCT00948896|10978251|FG003|Randomization to 24 Months of Age|Death|0
6941685|NCT00948896|10978252|FG004|Randomization to 24 Months of Age|Death|2
6941686|NCT00948896|10978253|FG005|Randomization to 24 Months of Age|Death|1
6941687|NCT00948896|10978254|FG006|Randomization to 24 Months of Age|Death|2
6941688|NCT00948896|10978255|FG007|Randomization to 24 Months of Age|Death|1
6941689|NCT00948896|10978248|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3
6941690|NCT00948896|10978249|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5
6941691|NCT00948896|10978250|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4
6941692|NCT00948896|10978251|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4
6941693|NCT00948896|10978252|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0
6941694|NCT00948896|10978253|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1
6941695|NCT00948896|10978254|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0
6941696|NCT00948896|10978255|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0
6941697|NCT00948896|10978248|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4
6941698|NCT00948896|10978249|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4
6941699|NCT00948896|10978250|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2
6941700|NCT00948896|10978251|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5
6941701|NCT00948896|10978252|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0
6941702|NCT00948896|10978253|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0
6941703|NCT00948896|10978254|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1
6941704|NCT00948896|10978255|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0
6941705|NCT00948896|10978248|FG000|Randomization to 24 Months of Age|Protocol Violation|0
6941706|NCT00948896|10978249|FG001|Randomization to 24 Months of Age|Protocol Violation|1
6941707|NCT00948896|10978250|FG002|Randomization to 24 Months of Age|Protocol Violation|0
6941708|NCT00948896|10978251|FG003|Randomization to 24 Months of Age|Protocol Violation|1
6941709|NCT00948896|10978252|FG004|Randomization to 24 Months of Age|Protocol Violation|0
6941710|NCT00948896|10978253|FG005|Randomization to 24 Months of Age|Protocol Violation|0
6941711|NCT00948896|10978254|FG006|Randomization to 24 Months of Age|Protocol Violation|1
6941712|NCT00948896|10978255|FG007|Randomization to 24 Months of Age|Protocol Violation|1
6941713|NCT00948896|10978248|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0
6941714|NCT00948896|10978249|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3
6941715|NCT00948896|10978250|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3
6941716|NCT00948896|10978251|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1
6941717|NCT00948896|10978252|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0
6941718|NCT00948896|10978253|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2
6941719|NCT00948896|10978254|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0
6941720|NCT00948896|10978255|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0
6941721|NCT00948896|10978248|FG000|24 Months of Age to 36 Months of Age|Death|0
6941722|NCT00948896|10978249|FG001|24 Months of Age to 36 Months of Age|Death|2
6941723|NCT00948896|10978250|FG002|24 Months of Age to 36 Months of Age|Death|2
6941724|NCT00948896|10978251|FG003|24 Months of Age to 36 Months of Age|Death|0
6941725|NCT00948896|10978252|FG004|24 Months of Age to 36 Months of Age|Death|0
6941726|NCT00948896|10978253|FG005|24 Months of Age to 36 Months of Age|Death|1
6941727|NCT00948896|10978254|FG006|24 Months of Age to 36 Months of Age|Death|0
6941728|NCT00948896|10978255|FG007|24 Months of Age to 36 Months of Age|Death|0
6941729|NCT00948896|10978248|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
6941730|NCT00948896|10978249|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
6941731|NCT00948896|10978250|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
6941732|NCT00948896|10978251|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
6941733|NCT00948896|10978252|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
6941734|NCT00948896|10978253|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
6941735|NCT00948896|10978254|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
6941736|NCT00948896|10978255|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
6941737|NCT00948896|10978248|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2
6941738|NCT00948896|10978249|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
6941739|NCT00948896|10978250|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
6941740|NCT00948896|10978251|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
6941741|NCT00948896|10978252|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
6941742|NCT00948896|10978253|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
6941743|NCT00948896|10978254|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
6941744|NCT00948896|10978255|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
6941745|NCT00948896|10978248|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0
6941746|NCT00948896|10978249|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0
6941747|NCT00948896|10978250|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1
6941748|NCT00948896|10978251|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0
6941749|NCT00948896|10978252|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0
6941750|NCT00948896|10978253|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1
6941751|NCT00948896|10978254|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0
6941752|NCT00948896|10978255|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0
6941753|NCT00948896|10978248|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
6941754|NCT00948896|10978249|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
6941755|NCT00948896|10978250|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
6941756|NCT00948896|10978251|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1
6941757|NCT00948896|10978252|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
6941758|NCT00948896|10978253|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
6941759|NCT00948896|10978254|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
6941760|NCT00948896|10978255|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
6941761|NCT00948922|10978280|FG000|Overall Study|Did not start study treatment|2
6941762|NCT00948922|10978281|FG001|Overall Study|Did not start study treatment|5
6941763|NCT00948922|10978282|FG002|Overall Study|Did not start study treatment|0
6941764|NCT00948922|10978280|FG000|Overall Study|Withdrawal by Subject|0
6941765|NCT00948922|10978281|FG001|Overall Study|Withdrawal by Subject|2
6941766|NCT00948922|10978282|FG002|Overall Study|Withdrawal by Subject|1
6941767|NCT00948922|10978280|FG000|Overall Study|Death|3
6941768|NCT00948922|10978281|FG001|Overall Study|Death|0
6941769|NCT00948922|10978282|FG002|Overall Study|Death|0
6941770|NCT00948922|10978280|FG000|Overall Study|Disease progression|0
6941771|NCT00948922|10978281|FG001|Overall Study|Disease progression|1
6941772|NCT00948922|10978282|FG002|Overall Study|Disease progression|0
6941773|NCT00948922|10978280|FG000|Overall Study|Insurance issues|1
6941774|NCT00948922|10978281|FG001|Overall Study|Insurance issues|0
6941775|NCT00948922|10978282|FG002|Overall Study|Insurance issues|0
6941776|NCT00948922|10978280|FG000|Overall Study|Transplant eligibility issues|2
6941777|NCT00948922|10978281|FG001|Overall Study|Transplant eligibility issues|3
6941778|NCT00948922|10978282|FG002|Overall Study|Transplant eligibility issues|0
6941779|NCT00948922|10978280|FG000|Overall Study|Not evaluable at time of analysis|0
6941780|NCT00948922|10978281|FG001|Overall Study|Not evaluable at time of analysis|3
6941781|NCT00948922|10978282|FG002|Overall Study|Not evaluable at time of analysis|0
6941782|NCT00948974|10978300|FG000|Overall Study|Lost to Follow-up|23
6941783|NCT00948974|10978301|FG001|Overall Study|Lost to Follow-up|20
6941784|NCT00949117|10978318|FG000|Overall Study|Lack of Efficacy|2
6941785|NCT00949117|10978319|FG001|Overall Study|Lack of Efficacy|3
6941786|NCT00949117|10978318|FG000|Overall Study|Protocol Violation|1
6941787|NCT00949117|10978319|FG001|Overall Study|Protocol Violation|1
6941788|NCT00949117|10978318|FG000|Overall Study|Adverse Event|0
6941789|NCT00949117|10978319|FG001|Overall Study|Adverse Event|1
6941790|NCT00949325|10978331|FG000|Overall Study|Adverse Event|0
6941791|NCT00949325|10978332|FG001|Overall Study|Adverse Event|2
6941792|NCT00949325|10978333|FG002|Overall Study|Adverse Event|0
6941793|NCT00949533|10978351|FG000|Overall Study|Lost to Follow-up|0
6941794|NCT00949533|10978352|FG001|Overall Study|Lost to Follow-up|1
6941795|NCT00949650|10978360|FG000|Overall Study|Progressive disease|188
6941796|NCT00949650|10978361|FG001|Overall Study|Progressive disease|19
6941797|NCT00949650|10978360|FG000|Overall Study|Completed 6 courses of chemotherapy|0
6941798|NCT00949650|10978361|FG001|Overall Study|Completed 6 courses of chemotherapy|60
6941799|NCT00949650|10978360|FG000|Overall Study|Other Adverse Event (AE)|28
6941800|NCT00949650|10978361|FG001|Overall Study|Other Adverse Event (AE)|17
6941801|NCT00949650|10978360|FG000|Overall Study|Protocol Violation|1
6941802|NCT00949650|10978361|FG001|Overall Study|Protocol Violation|4
6941803|NCT00949650|10978360|FG000|Overall Study|Refusal to continue medication|7
6941804|NCT00949650|10978361|FG001|Overall Study|Refusal to continue medication|11
6941805|NCT00949650|10978360|FG000|Overall Study|Not treated|1
6941806|NCT00949650|10978361|FG001|Overall Study|Not treated|4
6941807|NCT00949650|10978360|FG000|Overall Study|Other not specified above|5
6941808|NCT00949650|10978361|FG001|Overall Study|Other not specified above|0
6941809|NCT00949702|10978371|FG000|Overall Study|Death|40
6941810|NCT00949702|10978371|FG000|Overall Study|Disease progression|7
6941811|NCT00949702|10978371|FG000|Overall Study|Withdrawal of consent|1
6941812|NCT00949715|10978377|FG000|Overall Study|Physician Decision|1
6941813|NCT00949715|10978378|FG001|Overall Study|Physician Decision|0
6941814|NCT00949715|10978377|FG000|Overall Study|Lost to Follow-up|1
6941815|NCT00949715|10978378|FG001|Overall Study|Lost to Follow-up|0
6941816|NCT00949715|10978377|FG000|Overall Study|Missing 24 month LVEF measurement|2
6941817|NCT00949715|10978378|FG001|Overall Study|Missing 24 month LVEF measurement|0
6941818|NCT00949884|10978386|FG000|Overall Study|Adverse Event|14
6941819|NCT00949884|10978387|FG001|Overall Study|Adverse Event|3
6941820|NCT00949884|10978388|FG002|Overall Study|Adverse Event|12
6941821|NCT00949884|10978386|FG000|Overall Study|Did not meet inclusion/exclusion|2
6941822|NCT00949884|10978387|FG001|Overall Study|Did not meet inclusion/exclusion|1
6941823|NCT00949884|10978388|FG002|Overall Study|Did not meet inclusion/exclusion|3
6941824|NCT00949884|10978386|FG000|Overall Study|Lost to Follow-up|7
6941825|NCT00949884|10978387|FG001|Overall Study|Lost to Follow-up|5
6941826|NCT00949884|10978388|FG002|Overall Study|Lost to Follow-up|5
6941827|NCT00949884|10978386|FG000|Overall Study|Physician Decision|5
6941828|NCT00949884|10978387|FG001|Overall Study|Physician Decision|0
6941829|NCT00949884|10978388|FG002|Overall Study|Physician Decision|6
6941830|NCT00949884|10978386|FG000|Overall Study|Treatment non-compliance|5
6941831|NCT00949884|10978387|FG001|Overall Study|Treatment non-compliance|0
6941832|NCT00949884|10978388|FG002|Overall Study|Treatment non-compliance|8
6941833|NCT00949884|10978386|FG000|Overall Study|Withdrawal by Subject|13
6941834|NCT00949884|10978387|FG001|Overall Study|Withdrawal by Subject|4
6941835|NCT00949884|10978388|FG002|Overall Study|Withdrawal by Subject|16
6941836|NCT00949884|10978386|FG000|Overall Study|Lack of Efficacy|4
6941837|NCT00949884|10978387|FG001|Overall Study|Lack of Efficacy|2
6941838|NCT00949884|10978388|FG002|Overall Study|Lack of Efficacy|7
6941839|NCT00949884|10978386|FG000|Overall Study|Study terminated by sponsor|0
6941840|NCT00949884|10978387|FG001|Overall Study|Study terminated by sponsor|0
6941841|NCT00949884|10978388|FG002|Overall Study|Study terminated by sponsor|1
6941842|NCT00949910|10978397|FG000|Overall Study|Progressive Disease|3750
6941843|NCT00949910|10978397|FG000|Overall Study|Symptomatic Deterioration|1088
6941844|NCT00949910|10978397|FG000|Overall Study|Lost to Follow-up|100
6941845|NCT00949910|10978397|FG000|Overall Study|Study Drug-Related Adverse Event|315
6941846|NCT00949910|10978397|FG000|Overall Study|Participant Refusal|390
6941847|NCT00949910|10978397|FG000|Overall Study|Death Due to Malignant Disease|456
6941848|NCT00949910|10978397|FG000|Overall Study|Death Due to Progression/Deterioration|4
6941849|NCT00949910|10978397|FG000|Overall Study|Death Due to Adverse Event|115
6941850|NCT00949910|10978397|FG000|Overall Study|Death Due to Toxicity|3
6941851|NCT00949910|10978397|FG000|Overall Study|Death from Unknown Cause|5
6941852|NCT00949910|10978397|FG000|Overall Study|Unspecified Progression/Deterioration|13
6941853|NCT00949910|10978397|FG000|Overall Study|Switched to Compassionate/Other Use|174
6941854|NCT00949910|10978397|FG000|Overall Study|Switched to Commercial Treatment|4
6941855|NCT00949910|10978397|FG000|Overall Study|Violation of Eligibility|23
6941856|NCT00949910|10978397|FG000|Overall Study|Logistical Reasons|13
6941857|NCT00949910|10978397|FG000|Overall Study|Non-Compliance|10
6941858|NCT00949910|10978397|FG000|Overall Study|Prolonged Dosing Interruption|4
6941859|NCT00949910|10978397|FG000|Overall Study|Adverse Event|83
6941860|NCT00949910|10978397|FG000|Overall Study|Serious Adverse Event|6
6941861|NCT00949910|10978397|FG000|Overall Study|Physician/Participant Decision|7
6941862|NCT00949910|10978397|FG000|Overall Study|Other|4
6941863|NCT00949910|10978397|FG000|Overall Study|No Data|9
6941864|NCT00949975|10978405|FG000|Overall Study|Voluntary discontinuation|6
6941865|NCT00949975|10978406|FG001|Overall Study|Voluntary discontinuation|5
6941866|NCT00949975|10978407|FG002|Overall Study|Voluntary discontinuation|3
6941867|NCT00949975|10978408|FG003|Overall Study|Voluntary discontinuation|6
6941868|NCT00949975|10978405|FG000|Overall Study|Adverse Event|11
6941869|NCT00949975|10978406|FG001|Overall Study|Adverse Event|11
6941870|NCT00949975|10978407|FG002|Overall Study|Adverse Event|10
6941871|NCT00949975|10978408|FG003|Overall Study|Adverse Event|10
6941872|NCT00949975|10978405|FG000|Overall Study|Safety reason|0
6941873|NCT00949975|10978406|FG001|Overall Study|Safety reason|1
6941874|NCT00949975|10978407|FG002|Overall Study|Safety reason|0
6941875|NCT00949975|10978408|FG003|Overall Study|Safety reason|0
6941876|NCT00949975|10978405|FG000|Overall Study|Study-specific criteria|0
6941877|NCT00949975|10978406|FG001|Overall Study|Study-specific criteria|1
6941878|NCT00949975|10978407|FG002|Overall Study|Study-specific criteria|1
6941879|NCT00949975|10978408|FG003|Overall Study|Study-specific criteria|0
6941880|NCT00949975|10978405|FG000|Overall Study|Incorrect enrolment|5
6941881|NCT00949975|10978406|FG001|Overall Study|Incorrect enrolment|10
6941882|NCT00949975|10978407|FG002|Overall Study|Incorrect enrolment|4
6941883|NCT00949975|10978408|FG003|Overall Study|Incorrect enrolment|7
6941884|NCT00949975|10978405|FG000|Overall Study|Severe non-compliance|3
6941885|NCT00949975|10978406|FG001|Overall Study|Severe non-compliance|1
6941886|NCT00949975|10978407|FG002|Overall Study|Severe non-compliance|0
6941887|NCT00949975|10978408|FG003|Overall Study|Severe non-compliance|2
6941888|NCT00949975|10978405|FG000|Overall Study|Lost to Follow-up|1
6941889|NCT00949975|10978406|FG001|Overall Study|Lost to Follow-up|0
6941890|NCT00949975|10978407|FG002|Overall Study|Lost to Follow-up|1
6941891|NCT00949975|10978408|FG003|Overall Study|Lost to Follow-up|3
6941892|NCT00949975|10978405|FG000|Overall Study|Other|1
6941893|NCT00949975|10978406|FG001|Overall Study|Other|0
6941894|NCT00949975|10978407|FG002|Overall Study|Other|0
6941895|NCT00949975|10978408|FG003|Overall Study|Other|0
6941896|NCT00950170|10978418|FG000|Overall Study|Parent/Legal Guardian Request|1
6941897|NCT00950170|10978418|FG000|Overall Study|Adverse Event|2
6941898|NCT00950170|10978418|FG000|Overall Study|Discontinuation of Study by Sponsor|1
6941899|NCT00950248|10978451|FG000|Year 1: Baseline|Withdrawal by Subject|6
6941900|NCT00950248|10978452|FG001|Year 1: Baseline|Withdrawal by Subject|0
6941901|NCT00950248|10978453|FG002|Year 1: Baseline|Withdrawal by Subject|0
6941902|NCT00950248|10978451|FG000|Year 1: Baseline|worsening of symptoms|2
6941903|NCT00950248|10978452|FG001|Year 1: Baseline|worsening of symptoms|0
6941904|NCT00950248|10978453|FG002|Year 1: Baseline|worsening of symptoms|0
6941905|NCT00950248|10978451|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0
6941906|NCT00950248|10978452|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2
6941907|NCT00950248|10978453|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4
6941908|NCT00950248|10978451|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0
6941909|NCT00950248|10978452|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3
6941910|NCT00950248|10978453|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0
6941911|NCT00950248|10978451|FG000|Year 2&3 Treatment Randomization|Death|0
6941912|NCT00950248|10978452|FG001|Year 2&3 Treatment Randomization|Death|0
6941913|NCT00950248|10978453|FG002|Year 2&3 Treatment Randomization|Death|1
6941914|NCT00950248|10978451|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0
6941915|NCT00950248|10978452|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1
6941916|NCT00950248|10978453|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0
6941917|NCT00950300|10978462|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6
6941918|NCT00950300|10978463|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15
6941919|NCT00950300|10978462|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1
6941920|NCT00950300|10978463|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3
6941921|NCT00950300|10978462|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3
6941922|NCT00950300|10978463|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0
6941923|NCT00950300|10978462|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2
6941924|NCT00950300|10978463|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1
6941925|NCT00950300|10978462|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1
6941926|NCT00950300|10978463|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0
6941927|NCT00950300|10978462|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4
6941928|NCT00950300|10978463|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5
6941929|NCT00950300|10978462|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2
6941930|NCT00950300|10978463|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1
6941931|NCT00950300|10978462|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12
6941932|NCT00950300|10978463|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11
6941933|NCT00950300|10978462|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10
6941934|NCT00950300|10978463|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5
6941935|NCT00950300|10978462|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1
6941936|NCT00950300|10978463|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1
6941937|NCT00950300|10978462|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3
6941938|NCT00950300|10978463|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4
6941939|NCT00950300|10978462|FG000|TFFU Period|Death|4
6941940|NCT00950300|10978463|FG001|TFFU Period|Death|1
6941941|NCT00950300|10978462|FG000|TFFU Period|Refused Treatment|10
6941942|NCT00950300|10978463|FG001|TFFU Period|Refused Treatment|11
6941943|NCT00950300|10978462|FG000|TFFU Period|Failure to Return|16
6941944|NCT00950300|10978463|FG001|TFFU Period|Failure to Return|16
6941945|NCT00950300|10978462|FG000|TFFU Period|Recurrence of Disease|63
6941946|NCT00950300|10978463|FG001|TFFU Period|Recurrence of Disease|72
6941947|NCT00950300|10978462|FG000|TFFU Period|Other|4
6941948|NCT00950300|10978463|FG001|TFFU Period|Other|3
6941949|NCT00950300|10978462|FG000|SFU Period|Death|44
6941950|NCT00950300|10978463|FG001|SFU Period|Death|42
6941951|NCT00950300|10978462|FG000|SFU Period|Lost to Follow-up|30
6941952|NCT00950300|10978463|FG001|SFU Period|Lost to Follow-up|28
6941953|NCT00950300|10978462|FG000|SFU Period|Withdrawal by Subject|4
6941954|NCT00950300|10978463|FG001|SFU Period|Withdrawal by Subject|8
6941955|NCT00950599|10978496|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0
6941956|NCT00950599|10978497|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0
6941957|NCT00950599|10978498|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0
6941958|NCT00950599|10978499|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1
6975653|NCT01194154|11027883|FG000|Overall Study|Hemoglobin increase|12
6941959|NCT00950599|10978500|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0
6941960|NCT00950599|10978501|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0
6941961|NCT00950599|10978502|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0
6941962|NCT00950599|10978503|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0
6941963|NCT00950599|10978504|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0
6941964|NCT00950599|10978505|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0
6941965|NCT00950599|10978496|FG000|Double-Blind Treatment Period|Adverse Event|0
6941966|NCT00950599|10978497|FG001|Double-Blind Treatment Period|Adverse Event|1
6941967|NCT00950599|10978498|FG002|Double-Blind Treatment Period|Adverse Event|1
7067561|NCT01987232|11168617|FG002|Overall Study|Ongoing in Study|0
7067562|NCT01987232|11168618|FG003|Overall Study|Ongoing in Study|1
7067563|NCT01987232|11168619|FG004|Overall Study|Ongoing in Study|0
7067564|NCT01987427|11168695|FG000|Overall Study|Adverse Event|4
7067565|NCT01987427|11168696|FG001|Overall Study|Adverse Event|2
7067566|NCT01987427|11168697|FG002|Overall Study|Adverse Event|8
6941968|NCT00950599|10978499|FG003|Double-Blind Treatment Period|Adverse Event|1
6941969|NCT00950599|10978500|FG004|Double-Blind Treatment Period|Adverse Event|1
6941970|NCT00950599|10978501|FG005|Double-Blind Treatment Period|Adverse Event|1
6941971|NCT00950599|10978502|FG006|Double-Blind Treatment Period|Adverse Event|0
6941972|NCT00950599|10978503|FG007|Double-Blind Treatment Period|Adverse Event|0
6941973|NCT00950599|10978504|FG008|Double-Blind Treatment Period|Adverse Event|0
6941974|NCT00950599|10978505|FG009|Double-Blind Treatment Period|Adverse Event|0
6941975|NCT00950599|10978496|FG000|Double-Blind Treatment Period|Lack of Efficacy|2
6941976|NCT00950599|10978497|FG001|Double-Blind Treatment Period|Lack of Efficacy|5
6941977|NCT00950599|10978498|FG002|Double-Blind Treatment Period|Lack of Efficacy|5
6941978|NCT00950599|10978499|FG003|Double-Blind Treatment Period|Lack of Efficacy|7
6941979|NCT00950599|10978500|FG004|Double-Blind Treatment Period|Lack of Efficacy|3
6941980|NCT00950599|10978501|FG005|Double-Blind Treatment Period|Lack of Efficacy|6
6941981|NCT00950599|10978502|FG006|Double-Blind Treatment Period|Lack of Efficacy|0
6941982|NCT00950599|10978503|FG007|Double-Blind Treatment Period|Lack of Efficacy|1
6941983|NCT00950599|10978504|FG008|Double-Blind Treatment Period|Lack of Efficacy|0
6941984|NCT00950599|10978505|FG009|Double-Blind Treatment Period|Lack of Efficacy|0
6941985|NCT00950599|10978496|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
6941986|NCT00950599|10978497|FG001|Double-Blind Treatment Period|Lost to Follow-up|0
6941987|NCT00950599|10978498|FG002|Double-Blind Treatment Period|Lost to Follow-up|0
6941988|NCT00950599|10978499|FG003|Double-Blind Treatment Period|Lost to Follow-up|1
6941989|NCT00950599|10978500|FG004|Double-Blind Treatment Period|Lost to Follow-up|1
6941990|NCT00950599|10978501|FG005|Double-Blind Treatment Period|Lost to Follow-up|2
6941991|NCT00950599|10978502|FG006|Double-Blind Treatment Period|Lost to Follow-up|0
6941992|NCT00950599|10978503|FG007|Double-Blind Treatment Period|Lost to Follow-up|1
6941993|NCT00950599|10978504|FG008|Double-Blind Treatment Period|Lost to Follow-up|0
6941994|NCT00950599|10978505|FG009|Double-Blind Treatment Period|Lost to Follow-up|0
6941995|NCT00950599|10978496|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1
6941996|NCT00950599|10978497|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1
7067567|NCT01987427|11168695|FG000|Overall Study|Lost to Follow-up|6
7067568|NCT01987427|11168696|FG001|Overall Study|Lost to Follow-up|6
7067569|NCT01987427|11168697|FG002|Overall Study|Lost to Follow-up|9
7067570|NCT01987427|11168695|FG000|Overall Study|Withdrawal by Subject|2
7067571|NCT01987427|11168696|FG001|Overall Study|Withdrawal by Subject|1
7067572|NCT01987427|11168697|FG002|Overall Study|Withdrawal by Subject|3
7067573|NCT01987427|11168695|FG000|Overall Study|Lack of Efficacy|1
7067574|NCT01987427|11168696|FG001|Overall Study|Lack of Efficacy|0
7067575|NCT01987427|11168697|FG002|Overall Study|Lack of Efficacy|0
7067576|NCT01987427|11168695|FG000|Overall Study|Other|1
7067577|NCT01987427|11168696|FG001|Overall Study|Other|1
7067578|NCT01987427|11168697|FG002|Overall Study|Other|0
7067579|NCT01987453|11168708|FG000|Overall Study|Death|0
7067580|NCT01987453|11168709|FG001|Overall Study|Death|0
7067581|NCT01987453|11168710|FG002|Overall Study|Death|1
7067582|NCT01987453|11168708|FG000|Overall Study|Lack of Efficacy|1
7067583|NCT01987453|11168709|FG001|Overall Study|Lack of Efficacy|12
7067584|NCT01987453|11168710|FG002|Overall Study|Lack of Efficacy|0
7067585|NCT01987479|11168722|FG000|Overall Study|Protocol Violation|1
7067586|NCT01987479|11168722|FG000|Overall Study|Physician Decision|2
7067587|NCT01987479|11168722|FG000|Overall Study|Participant/legal guardian decision|1
7067588|NCT01987479|11168722|FG000|Overall Study|Other|5
7067589|NCT01987479|11168722|FG000|Overall Study|Lost to Follow-up|1
7067590|NCT01987479|11168722|FG000|Overall Study|Adverse Event|7
7067591|NCT01987505|11168728|FG000|Overall Study|Other|9
7067592|NCT01987505|11168728|FG000|Overall Study|Withdrawal by Subject|2
7067593|NCT01987505|11168728|FG000|Overall Study|Other Reason|2
7067594|NCT01987505|11168728|FG000|Overall Study|Lost to Follow-up|15
7067595|NCT01987505|11168728|FG000|Overall Study|Investigator Decision|2
7067596|NCT01987505|11168728|FG000|Overall Study|Death|4
7067597|NCT01987557|11168737|FG000|Overall Study|Protocol Violation|1
7067598|NCT01987557|11168738|FG001|Overall Study|Protocol Violation|0
7067599|NCT01987557|11168739|FG002|Overall Study|Protocol Violation|1
7067600|NCT01987557|11168737|FG000|Overall Study|Withdrawal by Subject|2
7067601|NCT01987557|11168738|FG001|Overall Study|Withdrawal by Subject|1
7067602|NCT01987557|11168739|FG002|Overall Study|Withdrawal by Subject|2
6941997|NCT00950599|10978498|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0
6941998|NCT00950599|10978499|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0
6941999|NCT00950599|10978500|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0
6942000|NCT00950599|10978501|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0
6942001|NCT00950599|10978502|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0
6942002|NCT00950599|10978503|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1
6942003|NCT00950599|10978504|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0
6942004|NCT00950599|10978505|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0
6942005|NCT00950599|10978496|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0
6942006|NCT00950599|10978497|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0
6942007|NCT00950599|10978498|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0
6942008|NCT00950599|10978499|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0
6942009|NCT00950599|10978500|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1
6942010|NCT00950599|10978501|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1
6942011|NCT00950599|10978502|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0
6942012|NCT00950599|10978503|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0
6942013|NCT00950599|10978504|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0
6942014|NCT00950599|10978505|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0
6942015|NCT00950599|10978496|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4
6942016|NCT00950599|10978497|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3
6942017|NCT00950599|10978498|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3
6942018|NCT00950599|10978499|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1
6942019|NCT00950599|10978500|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1
6942020|NCT00950599|10978501|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2
6942021|NCT00950599|10978502|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0
6942022|NCT00950599|10978503|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3
6942023|NCT00950599|10978504|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0
6942024|NCT00950599|10978505|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0
6942025|NCT00950599|10978496|FG000|Follow-Up Period|Adverse Event|0
6942026|NCT00950599|10978497|FG001|Follow-Up Period|Adverse Event|0
6942027|NCT00950599|10978498|FG002|Follow-Up Period|Adverse Event|0
6942028|NCT00950599|10978499|FG003|Follow-Up Period|Adverse Event|0
6942029|NCT00950599|10978500|FG004|Follow-Up Period|Adverse Event|0
6942030|NCT00950599|10978501|FG005|Follow-Up Period|Adverse Event|0
6942031|NCT00950599|10978502|FG006|Follow-Up Period|Adverse Event|0
6942032|NCT00950599|10978503|FG007|Follow-Up Period|Adverse Event|0
6942033|NCT00950599|10978504|FG008|Follow-Up Period|Adverse Event|1
6942034|NCT00950599|10978505|FG009|Follow-Up Period|Adverse Event|0
6942035|NCT00950599|10978496|FG000|Follow-Up Period|Lack of Efficacy|0
6942036|NCT00950599|10978497|FG001|Follow-Up Period|Lack of Efficacy|0
6942037|NCT00950599|10978498|FG002|Follow-Up Period|Lack of Efficacy|0
6942038|NCT00950599|10978499|FG003|Follow-Up Period|Lack of Efficacy|0
6942039|NCT00950599|10978500|FG004|Follow-Up Period|Lack of Efficacy|0
6942040|NCT00950599|10978501|FG005|Follow-Up Period|Lack of Efficacy|0
6942041|NCT00950599|10978502|FG006|Follow-Up Period|Lack of Efficacy|0
6942042|NCT00950599|10978503|FG007|Follow-Up Period|Lack of Efficacy|0
6942043|NCT00950599|10978504|FG008|Follow-Up Period|Lack of Efficacy|3
6942044|NCT00950599|10978505|FG009|Follow-Up Period|Lack of Efficacy|0
6942045|NCT00950599|10978496|FG000|Follow-Up Period|Lost to Follow-up|0
6942046|NCT00950599|10978497|FG001|Follow-Up Period|Lost to Follow-up|0
6942047|NCT00950599|10978498|FG002|Follow-Up Period|Lost to Follow-up|0
6942048|NCT00950599|10978499|FG003|Follow-Up Period|Lost to Follow-up|0
6942049|NCT00950599|10978500|FG004|Follow-Up Period|Lost to Follow-up|0
6942050|NCT00950599|10978501|FG005|Follow-Up Period|Lost to Follow-up|0
6942051|NCT00950599|10978502|FG006|Follow-Up Period|Lost to Follow-up|0
6942052|NCT00950599|10978503|FG007|Follow-Up Period|Lost to Follow-up|0
6942053|NCT00950599|10978504|FG008|Follow-Up Period|Lost to Follow-up|5
6942054|NCT00950599|10978505|FG009|Follow-Up Period|Lost to Follow-up|1
6942055|NCT00950599|10978496|FG000|Follow-Up Period|Physician Decision|0
6942056|NCT00950599|10978497|FG001|Follow-Up Period|Physician Decision|0
6942057|NCT00950599|10978498|FG002|Follow-Up Period|Physician Decision|0
6942058|NCT00950599|10978499|FG003|Follow-Up Period|Physician Decision|0
6942059|NCT00950599|10978500|FG004|Follow-Up Period|Physician Decision|0
6942060|NCT00950599|10978501|FG005|Follow-Up Period|Physician Decision|0
6942061|NCT00950599|10978502|FG006|Follow-Up Period|Physician Decision|0
6942062|NCT00950599|10978503|FG007|Follow-Up Period|Physician Decision|0
6942063|NCT00950599|10978504|FG008|Follow-Up Period|Physician Decision|1
6942064|NCT00950599|10978505|FG009|Follow-Up Period|Physician Decision|0
6942065|NCT00950599|10978496|FG000|Follow-Up Period|Poor/Noncompliance|0
6942066|NCT00950599|10978497|FG001|Follow-Up Period|Poor/Noncompliance|0
6942067|NCT00950599|10978498|FG002|Follow-Up Period|Poor/Noncompliance|0
6942068|NCT00950599|10978499|FG003|Follow-Up Period|Poor/Noncompliance|0
6942069|NCT00950599|10978500|FG004|Follow-Up Period|Poor/Noncompliance|0
6942070|NCT00950599|10978501|FG005|Follow-Up Period|Poor/Noncompliance|0
6942071|NCT00950599|10978502|FG006|Follow-Up Period|Poor/Noncompliance|0
6942072|NCT00950599|10978503|FG007|Follow-Up Period|Poor/Noncompliance|0
6942073|NCT00950599|10978504|FG008|Follow-Up Period|Poor/Noncompliance|1
6942074|NCT00950599|10978505|FG009|Follow-Up Period|Poor/Noncompliance|0
6942075|NCT00950599|10978496|FG000|Follow-Up Period|Subject withdrew Consent|0
6942076|NCT00950599|10978497|FG001|Follow-Up Period|Subject withdrew Consent|0
6942077|NCT00950599|10978498|FG002|Follow-Up Period|Subject withdrew Consent|0
6942078|NCT00950599|10978499|FG003|Follow-Up Period|Subject withdrew Consent|0
6942079|NCT00950599|10978500|FG004|Follow-Up Period|Subject withdrew Consent|0
6942080|NCT00950599|10978501|FG005|Follow-Up Period|Subject withdrew Consent|0
6942081|NCT00950599|10978502|FG006|Follow-Up Period|Subject withdrew Consent|0
6942082|NCT00950599|10978503|FG007|Follow-Up Period|Subject withdrew Consent|0
6942083|NCT00950599|10978504|FG008|Follow-Up Period|Subject withdrew Consent|2
6942084|NCT00950599|10978505|FG009|Follow-Up Period|Subject withdrew Consent|1
6942085|NCT00950651|10978539|FG000|Overall Study|Adverse Event|17
6942086|NCT00950651|10978540|FG001|Overall Study|Adverse Event|20
6942087|NCT00950651|10978539|FG000|Overall Study|Death|1
6942088|NCT00950651|10978540|FG001|Overall Study|Death|0
6942089|NCT00950651|10978539|FG000|Overall Study|Lack of Efficacy|2
6942090|NCT00950651|10978540|FG001|Overall Study|Lack of Efficacy|2
6942091|NCT00950651|10978539|FG000|Overall Study|Protocol Violation|3
6942092|NCT00950651|10978540|FG001|Overall Study|Protocol Violation|4
6942093|NCT00950651|10978539|FG000|Overall Study|Withdrawal by Subject|8
6942094|NCT00950651|10978540|FG001|Overall Study|Withdrawal by Subject|9
6942095|NCT00950664|10978548|FG000|First Intervention|Lost to Follow-up|1
6942096|NCT00950664|10978549|FG001|First Intervention|Lost to Follow-up|3
6942097|NCT00950664|10978548|FG000|First Intervention|Withdrawal by Subject|2
6942098|NCT00950664|10978549|FG001|First Intervention|Withdrawal by Subject|2
6942099|NCT00950742|10978561|FG000|Overall Study|Other Adverse Event|1
6942100|NCT00950742|10978562|FG001|Overall Study|Other Adverse Event|0
6942101|NCT00950742|10978561|FG000|Overall Study|Withdrawal by Subject|3
6942102|NCT00950742|10978562|FG001|Overall Study|Withdrawal by Subject|0
6942103|NCT00950742|10978561|FG000|Overall Study|Progressive Disease|6
6942104|NCT00950742|10978562|FG001|Overall Study|Progressive Disease|2
6942105|NCT00950742|10978561|FG000|Overall Study|Dose limiting toxicity|6
6942106|NCT00950742|10978562|FG001|Overall Study|Dose limiting toxicity|0
6942107|NCT00950755|10978572|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
6942108|NCT00950755|10978572|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1
6942109|NCT00950755|10978572|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27
6942110|NCT00950755|10978572|FG000|Dosimetric and Therapeutic Treatment|Death|1
6942111|NCT00950755|10978572|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1
6942112|NCT00950755|10978572|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1
6942113|NCT00950755|10978572|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6
6942114|NCT00950755|10978572|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1
6942115|NCT00950755|10978572|FG000|Long-Term Follow-Up|Lost to Follow-up|1
6942116|NCT00950755|10978572|FG000|Long-Term Follow-Up|Death|8
6942117|NCT00950807|10978576|FG000|Treatment Period 1|Lack of Efficacy|1
6942118|NCT00950807|10978577|FG001|Treatment Period 1|Lack of Efficacy|0
6942119|NCT00950807|10978578|FG002|Treatment Period 1|Lack of Efficacy|0
6942120|NCT00950807|10978579|FG003|Treatment Period 1|Lack of Efficacy|0
6942121|NCT00950807|10978580|FG004|Treatment Period 1|Lack of Efficacy|0
6942122|NCT00950807|10978581|FG005|Treatment Period 1|Lack of Efficacy|1
6942123|NCT00950807|10978582|FG006|Treatment Period 1|Lack of Efficacy|0
6942124|NCT00950807|10978583|FG007|Treatment Period 1|Lack of Efficacy|0
6942125|NCT00950807|10978584|FG008|Treatment Period 1|Lack of Efficacy|0
6942126|NCT00950807|10978585|FG009|Treatment Period 1|Lack of Efficacy|0
6942127|NCT00950807|10978576|FG000|Treatment Period 1|Protocol Violation|1
6942128|NCT00950807|10978577|FG001|Treatment Period 1|Protocol Violation|0
6942129|NCT00950807|10978578|FG002|Treatment Period 1|Protocol Violation|0
6942130|NCT00950807|10978579|FG003|Treatment Period 1|Protocol Violation|0
6942131|NCT00950807|10978580|FG004|Treatment Period 1|Protocol Violation|0
6942132|NCT00950807|10978581|FG005|Treatment Period 1|Protocol Violation|0
6942133|NCT00950807|10978582|FG006|Treatment Period 1|Protocol Violation|0
6942134|NCT00950807|10978583|FG007|Treatment Period 1|Protocol Violation|0
6942135|NCT00950807|10978584|FG008|Treatment Period 1|Protocol Violation|0
6942136|NCT00950807|10978585|FG009|Treatment Period 1|Protocol Violation|0
6942137|NCT00950807|10978576|FG000|Treatment Period 1|Lost to Follow-up|0
6942138|NCT00950807|10978577|FG001|Treatment Period 1|Lost to Follow-up|0
6942139|NCT00950807|10978578|FG002|Treatment Period 1|Lost to Follow-up|1
6942140|NCT00950807|10978579|FG003|Treatment Period 1|Lost to Follow-up|0
6942141|NCT00950807|10978580|FG004|Treatment Period 1|Lost to Follow-up|0
6942142|NCT00950807|10978581|FG005|Treatment Period 1|Lost to Follow-up|0
6942143|NCT00950807|10978582|FG006|Treatment Period 1|Lost to Follow-up|0
6942144|NCT00950807|10978583|FG007|Treatment Period 1|Lost to Follow-up|0
6942145|NCT00950807|10978584|FG008|Treatment Period 1|Lost to Follow-up|0
6942146|NCT00950807|10978585|FG009|Treatment Period 1|Lost to Follow-up|0
6942147|NCT00950807|10978576|FG000|Treatment Period 1|Withdrawal by Subject|1
6942148|NCT00950807|10978577|FG001|Treatment Period 1|Withdrawal by Subject|0
6942149|NCT00950807|10978578|FG002|Treatment Period 1|Withdrawal by Subject|0
6942150|NCT00950807|10978579|FG003|Treatment Period 1|Withdrawal by Subject|0
6942151|NCT00950807|10978580|FG004|Treatment Period 1|Withdrawal by Subject|1
6942152|NCT00950807|10978581|FG005|Treatment Period 1|Withdrawal by Subject|0
6942153|NCT00950807|10978582|FG006|Treatment Period 1|Withdrawal by Subject|0
6942154|NCT00950807|10978583|FG007|Treatment Period 1|Withdrawal by Subject|0
6942155|NCT00950807|10978584|FG008|Treatment Period 1|Withdrawal by Subject|1
6942156|NCT00950807|10978585|FG009|Treatment Period 1|Withdrawal by Subject|0
6942157|NCT00950807|10978576|FG000|Treatment Period 1|Adverse Event|0
6942158|NCT00950807|10978577|FG001|Treatment Period 1|Adverse Event|0
6942159|NCT00950807|10978578|FG002|Treatment Period 1|Adverse Event|0
6942160|NCT00950807|10978579|FG003|Treatment Period 1|Adverse Event|0
6942161|NCT00950807|10978580|FG004|Treatment Period 1|Adverse Event|0
6942162|NCT00950807|10978581|FG005|Treatment Period 1|Adverse Event|1
6942163|NCT00950807|10978582|FG006|Treatment Period 1|Adverse Event|0
6942164|NCT00950807|10978583|FG007|Treatment Period 1|Adverse Event|0
6942165|NCT00950807|10978584|FG008|Treatment Period 1|Adverse Event|0
6942166|NCT00950807|10978585|FG009|Treatment Period 1|Adverse Event|0
6942167|NCT00950807|10978576|FG000|Washout Period 1|Lack of Efficacy|0
6942168|NCT00950807|10978577|FG001|Washout Period 1|Lack of Efficacy|0
6942169|NCT00950807|10978578|FG002|Washout Period 1|Lack of Efficacy|0
6942170|NCT00950807|10978579|FG003|Washout Period 1|Lack of Efficacy|0
6942171|NCT00950807|10978580|FG004|Washout Period 1|Lack of Efficacy|0
6942172|NCT00950807|10978581|FG005|Washout Period 1|Lack of Efficacy|0
6942173|NCT00950807|10978582|FG006|Washout Period 1|Lack of Efficacy|1
6942174|NCT00950807|10978583|FG007|Washout Period 1|Lack of Efficacy|0
6942175|NCT00950807|10978584|FG008|Washout Period 1|Lack of Efficacy|0
6942176|NCT00950807|10978585|FG009|Washout Period 1|Lack of Efficacy|0
6942177|NCT00950807|10978576|FG000|Washout Period 1|Withdrawal by Subject|0
6942178|NCT00950807|10978577|FG001|Washout Period 1|Withdrawal by Subject|0
6942179|NCT00950807|10978578|FG002|Washout Period 1|Withdrawal by Subject|0
6942180|NCT00950807|10978579|FG003|Washout Period 1|Withdrawal by Subject|0
6942181|NCT00950807|10978580|FG004|Washout Period 1|Withdrawal by Subject|0
6942182|NCT00950807|10978581|FG005|Washout Period 1|Withdrawal by Subject|0
6942183|NCT00950807|10978582|FG006|Washout Period 1|Withdrawal by Subject|0
6942184|NCT00950807|10978583|FG007|Washout Period 1|Withdrawal by Subject|0
6942185|NCT00950807|10978584|FG008|Washout Period 1|Withdrawal by Subject|1
6942186|NCT00950807|10978585|FG009|Washout Period 1|Withdrawal by Subject|0
6942187|NCT00950807|10978576|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3
6942188|NCT00950807|10978577|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0
6942189|NCT00950807|10978578|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0
6942190|NCT00950807|10978579|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0
6942191|NCT00950807|10978580|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0
6942192|NCT00950807|10978581|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0
6942193|NCT00950807|10978582|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1
6942194|NCT00950807|10978583|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1
6942195|NCT00950807|10978584|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0
6942196|NCT00950807|10978585|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0
6942197|NCT00950807|10978576|FG000|Washout Period 1|Adverse Event|2
6942198|NCT00950807|10978577|FG001|Washout Period 1|Adverse Event|0
6942199|NCT00950807|10978578|FG002|Washout Period 1|Adverse Event|0
6942200|NCT00950807|10978579|FG003|Washout Period 1|Adverse Event|1
6942201|NCT00950807|10978580|FG004|Washout Period 1|Adverse Event|1
6942202|NCT00950807|10978581|FG005|Washout Period 1|Adverse Event|0
6942203|NCT00950807|10978582|FG006|Washout Period 1|Adverse Event|0
6942204|NCT00950807|10978583|FG007|Washout Period 1|Adverse Event|0
6942205|NCT00950807|10978584|FG008|Washout Period 1|Adverse Event|0
6942206|NCT00950807|10978585|FG009|Washout Period 1|Adverse Event|0
6942207|NCT00950807|10978576|FG000|Treatment Period 2|Lack of Efficacy|1
6942208|NCT00950807|10978577|FG001|Treatment Period 2|Lack of Efficacy|0
6942209|NCT00950807|10978578|FG002|Treatment Period 2|Lack of Efficacy|0
6942210|NCT00950807|10978579|FG003|Treatment Period 2|Lack of Efficacy|0
6942211|NCT00950807|10978580|FG004|Treatment Period 2|Lack of Efficacy|0
6942212|NCT00950807|10978581|FG005|Treatment Period 2|Lack of Efficacy|0
6942213|NCT00950807|10978582|FG006|Treatment Period 2|Lack of Efficacy|0
6942214|NCT00950807|10978583|FG007|Treatment Period 2|Lack of Efficacy|0
6942215|NCT00950807|10978584|FG008|Treatment Period 2|Lack of Efficacy|0
6942216|NCT00950807|10978585|FG009|Treatment Period 2|Lack of Efficacy|0
6942217|NCT00950807|10978576|FG000|Treatment Period 2|Withdrawal by Subject|0
6942218|NCT00950807|10978577|FG001|Treatment Period 2|Withdrawal by Subject|0
6942219|NCT00950807|10978578|FG002|Treatment Period 2|Withdrawal by Subject|0
6942220|NCT00950807|10978579|FG003|Treatment Period 2|Withdrawal by Subject|0
6942221|NCT00950807|10978580|FG004|Treatment Period 2|Withdrawal by Subject|0
6942222|NCT00950807|10978581|FG005|Treatment Period 2|Withdrawal by Subject|0
6942223|NCT00950807|10978582|FG006|Treatment Period 2|Withdrawal by Subject|1
6942224|NCT00950807|10978583|FG007|Treatment Period 2|Withdrawal by Subject|2
6942225|NCT00950807|10978584|FG008|Treatment Period 2|Withdrawal by Subject|0
6942226|NCT00950807|10978585|FG009|Treatment Period 2|Withdrawal by Subject|0
6942227|NCT00950807|10978576|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1
6942228|NCT00950807|10978577|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0
6942229|NCT00950807|10978578|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0
6942230|NCT00950807|10978579|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0
6942231|NCT00950807|10978580|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0
6942232|NCT00950807|10978581|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0
6942233|NCT00950807|10978582|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0
6975654|NCT01194154|11027884|FG001|Overall Study|Hemoglobin increase|3
6942234|NCT00950807|10978583|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0
6942235|NCT00950807|10978584|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0
6942236|NCT00950807|10978585|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0
6942237|NCT00950807|10978576|FG000|Treatment Period 2|Adverse Event|0
6942238|NCT00950807|10978577|FG001|Treatment Period 2|Adverse Event|1
6942239|NCT00950807|10978578|FG002|Treatment Period 2|Adverse Event|0
6942240|NCT00950807|10978579|FG003|Treatment Period 2|Adverse Event|1
6942241|NCT00950807|10978580|FG004|Treatment Period 2|Adverse Event|0
6942242|NCT00950807|10978581|FG005|Treatment Period 2|Adverse Event|1
6942243|NCT00950807|10978582|FG006|Treatment Period 2|Adverse Event|0
6942244|NCT00950807|10978583|FG007|Treatment Period 2|Adverse Event|1
6942245|NCT00950807|10978584|FG008|Treatment Period 2|Adverse Event|0
6942246|NCT00950807|10978585|FG009|Treatment Period 2|Adverse Event|0
6942247|NCT00950807|10978576|FG000|Washout Period 2|Lack of Efficacy|1
6942248|NCT00950807|10978577|FG001|Washout Period 2|Lack of Efficacy|0
6942249|NCT00950807|10978578|FG002|Washout Period 2|Lack of Efficacy|0
6942250|NCT00950807|10978579|FG003|Washout Period 2|Lack of Efficacy|0
6942251|NCT00950807|10978580|FG004|Washout Period 2|Lack of Efficacy|0
6942252|NCT00950807|10978581|FG005|Washout Period 2|Lack of Efficacy|0
6942253|NCT00950807|10978582|FG006|Washout Period 2|Lack of Efficacy|0
6942254|NCT00950807|10978583|FG007|Washout Period 2|Lack of Efficacy|0
6942255|NCT00950807|10978584|FG008|Washout Period 2|Lack of Efficacy|0
6942256|NCT00950807|10978585|FG009|Washout Period 2|Lack of Efficacy|0
6942257|NCT00950807|10978576|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0
6942258|NCT00950807|10978577|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1
6942259|NCT00950807|10978578|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0
6942260|NCT00950807|10978579|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0
6942261|NCT00950807|10978580|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1
6942262|NCT00950807|10978581|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0
6942263|NCT00950807|10978582|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1
6942264|NCT00950807|10978583|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1
6942265|NCT00950807|10978584|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0
6942266|NCT00950807|10978585|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0
6942267|NCT00950807|10978576|FG000|Washout Period 2|Adverse Event|3
6942268|NCT00950807|10978577|FG001|Washout Period 2|Adverse Event|0
6942269|NCT00950807|10978578|FG002|Washout Period 2|Adverse Event|0
6942270|NCT00950807|10978579|FG003|Washout Period 2|Adverse Event|1
6942271|NCT00950807|10978580|FG004|Washout Period 2|Adverse Event|0
6942272|NCT00950807|10978581|FG005|Washout Period 2|Adverse Event|0
6942273|NCT00950807|10978582|FG006|Washout Period 2|Adverse Event|0
6942274|NCT00950807|10978583|FG007|Washout Period 2|Adverse Event|0
6942275|NCT00950807|10978584|FG008|Washout Period 2|Adverse Event|0
6942276|NCT00950807|10978585|FG009|Washout Period 2|Adverse Event|0
6942277|NCT00950807|10978576|FG000|Treatment Period 3|Withdrawal by Subject|0
6942278|NCT00950807|10978577|FG001|Treatment Period 3|Withdrawal by Subject|0
6942279|NCT00950807|10978578|FG002|Treatment Period 3|Withdrawal by Subject|0
6942280|NCT00950807|10978579|FG003|Treatment Period 3|Withdrawal by Subject|0
6942281|NCT00950807|10978580|FG004|Treatment Period 3|Withdrawal by Subject|0
6942282|NCT00950807|10978581|FG005|Treatment Period 3|Withdrawal by Subject|0
6942283|NCT00950807|10978582|FG006|Treatment Period 3|Withdrawal by Subject|0
6942284|NCT00950807|10978583|FG007|Treatment Period 3|Withdrawal by Subject|0
6942285|NCT00950807|10978584|FG008|Treatment Period 3|Withdrawal by Subject|0
6942286|NCT00950807|10978585|FG009|Treatment Period 3|Withdrawal by Subject|1
6942287|NCT00950807|10978576|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1
6942288|NCT00950807|10978577|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0
6942289|NCT00950807|10978578|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0
6942290|NCT00950807|10978579|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0
6942291|NCT00950807|10978580|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0
6942292|NCT00950807|10978581|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0
6942293|NCT00950807|10978582|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0
6942294|NCT00950807|10978583|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1
6942295|NCT00950807|10978584|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0
6942296|NCT00950807|10978585|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0
6942297|NCT00950807|10978576|FG000|Treatment Period 3|Adverse Event|0
7067603|NCT01987557|11168737|FG000|Overall Study|Adverse Event|0
6942298|NCT00950807|10978577|FG001|Treatment Period 3|Adverse Event|0
6942299|NCT00950807|10978578|FG002|Treatment Period 3|Adverse Event|0
6942300|NCT00950807|10978579|FG003|Treatment Period 3|Adverse Event|0
6942301|NCT00950807|10978580|FG004|Treatment Period 3|Adverse Event|0
6942302|NCT00950807|10978581|FG005|Treatment Period 3|Adverse Event|0
6942303|NCT00950807|10978582|FG006|Treatment Period 3|Adverse Event|1
6942304|NCT00950807|10978583|FG007|Treatment Period 3|Adverse Event|0
6942305|NCT00950807|10978584|FG008|Treatment Period 3|Adverse Event|0
6942306|NCT00950807|10978585|FG009|Treatment Period 3|Adverse Event|0
6942307|NCT00950859|10978624|FG000|Overall Study|Adverse Event|3
6942308|NCT00950859|10978625|FG001|Overall Study|Adverse Event|3
6942309|NCT00950859|10978624|FG000|Overall Study|Insufficient Viral Load Response|12
6942310|NCT00950859|10978625|FG001|Overall Study|Insufficient Viral Load Response|3
6942311|NCT00950859|10978624|FG000|Overall Study|Protocol Violation|1
6942312|NCT00950859|10978625|FG001|Overall Study|Protocol Violation|1
6942313|NCT00950859|10978624|FG000|Overall Study|Lost to Follow-up|0
6942314|NCT00950859|10978625|FG001|Overall Study|Lost to Follow-up|3
6942315|NCT00950872|10978631|FG000|Overall Study|Withdrawal by Subject|1
6942316|NCT00950872|10978631|FG000|Overall Study|Did not have surgery|2
6942317|NCT00950911|10978637|FG000|Overall Study|Adverse Event|0
6942318|NCT00950911|10978638|FG001|Overall Study|Adverse Event|2
6942319|NCT00950911|10978637|FG000|Overall Study|Death|4
6942320|NCT00950911|10978638|FG001|Overall Study|Death|6
6942321|NCT00950911|10978637|FG000|Overall Study|Disease progression|2
6942322|NCT00950911|10978638|FG001|Overall Study|Disease progression|2
6942323|NCT00950911|10978637|FG000|Overall Study|Consent withdrawn|1
6942324|NCT00950911|10978638|FG001|Overall Study|Consent withdrawn|3
6942325|NCT00950911|10978637|FG000|Overall Study|Administrative decision|3
6942326|NCT00950911|10978638|FG001|Overall Study|Administrative decision|1
6942327|NCT00950911|10978637|FG000|Overall Study|Ineligibility determined|1
6942328|NCT00950911|10978638|FG001|Overall Study|Ineligibility determined|0
6942329|NCT00950911|10978637|FG000|Overall Study|Noncompliance|1
6942330|NCT00950911|10978638|FG001|Overall Study|Noncompliance|0
6942331|NCT00950911|10978637|FG000|Overall Study|Poor performance status|0
6942332|NCT00950911|10978638|FG001|Overall Study|Poor performance status|1
6942333|NCT00950950|10978646|FG000|Overall Study|Adverse Event|1
6942334|NCT00950950|10978647|FG001|Overall Study|Adverse Event|0
6942335|NCT00950950|10978646|FG000|Overall Study|Withdrawal by Subject|0
6942336|NCT00950950|10978647|FG001|Overall Study|Withdrawal by Subject|1
6942337|NCT00950963|10978656|FG000|Overall Study|Lost to Follow-up|29
6942338|NCT00950963|10978657|FG001|Overall Study|Lost to Follow-up|24
6942339|NCT00951015|10978667|FG000|Randomization Phase 96 Week|Adverse Event|1
6942340|NCT00951015|10978668|FG001|Randomization Phase 96 Week|Adverse Event|1
6942341|NCT00951015|10978669|FG002|Randomization Phase 96 Week|Adverse Event|2
6942342|NCT00951015|10978670|FG003|Randomization Phase 96 Week|Adverse Event|5
6942343|NCT00951015|10978671|FG004|Randomization Phase 96 Week|Adverse Event|0
6942344|NCT00951015|10978667|FG000|Randomization Phase 96 Week|Lack of Efficacy|1
6942345|NCT00951015|10978668|FG001|Randomization Phase 96 Week|Lack of Efficacy|1
6942346|NCT00951015|10978669|FG002|Randomization Phase 96 Week|Lack of Efficacy|0
6942347|NCT00951015|10978670|FG003|Randomization Phase 96 Week|Lack of Efficacy|0
6942348|NCT00951015|10978671|FG004|Randomization Phase 96 Week|Lack of Efficacy|0
6942349|NCT00951015|10978667|FG000|Randomization Phase 96 Week|Protocol Violation|1
6942350|NCT00951015|10978668|FG001|Randomization Phase 96 Week|Protocol Violation|1
6942351|NCT00951015|10978669|FG002|Randomization Phase 96 Week|Protocol Violation|1
6942352|NCT00951015|10978670|FG003|Randomization Phase 96 Week|Protocol Violation|0
6942353|NCT00951015|10978671|FG004|Randomization Phase 96 Week|Protocol Violation|0
6942354|NCT00951015|10978667|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
6942355|NCT00951015|10978668|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
6942356|NCT00951015|10978669|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
6942357|NCT00951015|10978670|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1
6942358|NCT00951015|10978671|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
6942359|NCT00951015|10978667|FG000|Randomization Phase 96 Week|Lost to Follow-up|0
7040477|NCT01717456|11123425|FG000|End of Treatment|Lost to Follow-up|0
7040478|NCT01717456|11123426|FG001|End of Treatment|Lost to Follow-up|1
7040479|NCT01717456|11123425|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
7040480|NCT01717456|11123426|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
7040481|NCT01717638|11123450|FG000|Overall Study|Lost to Follow-up|0
7040482|NCT01717638|11123451|FG001|Overall Study|Lost to Follow-up|0
7040483|NCT01717638|11123452|FG002|Overall Study|Lost to Follow-up|0
7040484|NCT01717638|11123453|FG003|Overall Study|Lost to Follow-up|0
7040485|NCT01717638|11123454|FG004|Overall Study|Lost to Follow-up|0
7040486|NCT01717638|11123455|FG005|Overall Study|Lost to Follow-up|1
7040487|NCT01717638|11123456|FG006|Overall Study|Lost to Follow-up|0
7040488|NCT01717638|11123457|FG007|Overall Study|Lost to Follow-up|0
7040489|NCT01717638|11123458|FG008|Overall Study|Lost to Follow-up|0
7040490|NCT01717638|11123459|FG009|Overall Study|Lost to Follow-up|0
6942360|NCT00951015|10978668|FG001|Randomization Phase 96 Week|Lost to Follow-up|3
6942361|NCT00951015|10978669|FG002|Randomization Phase 96 Week|Lost to Follow-up|1
6942362|NCT00951015|10978670|FG003|Randomization Phase 96 Week|Lost to Follow-up|2
6942363|NCT00951015|10978671|FG004|Randomization Phase 96 Week|Lost to Follow-up|0
6942364|NCT00951015|10978667|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2
6942365|NCT00951015|10978668|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1
6942366|NCT00951015|10978669|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1
6942367|NCT00951015|10978670|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2
6942368|NCT00951015|10978671|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0
6942369|NCT00951015|10978667|FG000|Open-label Phase|Adverse Event|0
6942370|NCT00951015|10978668|FG001|Open-label Phase|Adverse Event|0
6942371|NCT00951015|10978669|FG002|Open-label Phase|Adverse Event|0
6942372|NCT00951015|10978670|FG003|Open-label Phase|Adverse Event|0
6942373|NCT00951015|10978671|FG004|Open-label Phase|Adverse Event|3
6942374|NCT00951015|10978667|FG000|Open-label Phase|Lack of Efficacy|0
6942375|NCT00951015|10978668|FG001|Open-label Phase|Lack of Efficacy|0
6942376|NCT00951015|10978669|FG002|Open-label Phase|Lack of Efficacy|0
7040491|NCT01717638|11123460|FG010|Overall Study|Lost to Follow-up|0
6942377|NCT00951015|10978670|FG003|Open-label Phase|Lack of Efficacy|0
7040492|NCT01717638|11123461|FG011|Overall Study|Lost to Follow-up|0
7040493|NCT01717638|11123462|FG012|Overall Study|Lost to Follow-up|0
6942378|NCT00951015|10978671|FG004|Open-label Phase|Lack of Efficacy|1
6942379|NCT00951015|10978667|FG000|Open-label Phase|Protocol Violation|0
6942380|NCT00951015|10978668|FG001|Open-label Phase|Protocol Violation|0
6942381|NCT00951015|10978669|FG002|Open-label Phase|Protocol Violation|0
6942382|NCT00951015|10978670|FG003|Open-label Phase|Protocol Violation|0
6942383|NCT00951015|10978671|FG004|Open-label Phase|Protocol Violation|12
6942384|NCT00951015|10978667|FG000|Open-label Phase|Lost to Follow-up|0
6942385|NCT00951015|10978668|FG001|Open-label Phase|Lost to Follow-up|0
6942386|NCT00951015|10978669|FG002|Open-label Phase|Lost to Follow-up|0
6942387|NCT00951015|10978670|FG003|Open-label Phase|Lost to Follow-up|0
6942388|NCT00951015|10978671|FG004|Open-label Phase|Lost to Follow-up|12
6942389|NCT00951015|10978667|FG000|Open-label Phase|Withdrawal by Subject|0
6942390|NCT00951015|10978668|FG001|Open-label Phase|Withdrawal by Subject|0
6942391|NCT00951015|10978669|FG002|Open-label Phase|Withdrawal by Subject|0
6942392|NCT00951015|10978670|FG003|Open-label Phase|Withdrawal by Subject|0
6942393|NCT00951015|10978671|FG004|Open-label Phase|Withdrawal by Subject|14
6942394|NCT00951015|10978667|FG000|Open-label Phase|Physician Decision|0
6942395|NCT00951015|10978668|FG001|Open-label Phase|Physician Decision|0
6942396|NCT00951015|10978669|FG002|Open-label Phase|Physician Decision|0
6942397|NCT00951015|10978670|FG003|Open-label Phase|Physician Decision|0
6942398|NCT00951015|10978671|FG004|Open-label Phase|Physician Decision|8
6942399|NCT00951041|10978696|FG000|Overall Study|Withdrawal by Subject|1
6942400|NCT00951041|10978697|FG001|Overall Study|Withdrawal by Subject|1
6942401|NCT00951041|10978696|FG000|Overall Study|Lost to Follow-up|1
6942402|NCT00951041|10978697|FG001|Overall Study|Lost to Follow-up|0
6942403|NCT00951041|10978696|FG000|Overall Study|Other|3
6942404|NCT00951041|10978697|FG001|Overall Study|Other|0
6942405|NCT00951080|10978706|FG000|Overall Study|Adverse Event|3
6942406|NCT00951080|10978707|FG001|Overall Study|Adverse Event|3
6942407|NCT00951080|10978706|FG000|Overall Study|Lost to Follow-up|0
6942408|NCT00951080|10978707|FG001|Overall Study|Lost to Follow-up|1
6942409|NCT00951080|10978706|FG000|Overall Study|Physician Decision|4
6942410|NCT00951080|10978707|FG001|Overall Study|Physician Decision|1
6942411|NCT00951080|10978706|FG000|Overall Study|Other|19
6942412|NCT00951080|10978707|FG001|Overall Study|Other|22
6942413|NCT00951171|10978721|FG000|Overall Study|Adverse Event|2
6942414|NCT00951171|10978722|FG001|Overall Study|Adverse Event|0
6942415|NCT00951275|10978728|FG000|Overall Study|Administrative Reason|1
6942416|NCT00951275|10978728|FG000|Overall Study|Adverse Event|7
6942417|NCT00951275|10978728|FG000|Overall Study|Withdrawal by Subject|4
6942418|NCT00951275|10978728|FG000|Overall Study|Protocol Violation|1
6942419|NCT00951379|10978734|FG000|Overall Study|Adverse Event|4
6942420|NCT00951379|10978735|FG001|Overall Study|Adverse Event|1
6942421|NCT00951379|10978734|FG000|Overall Study|Withdrawal by Subject|1
6942422|NCT00951379|10978735|FG001|Overall Study|Withdrawal by Subject|0
6942423|NCT00951379|10978734|FG000|Overall Study|Noncompliance|1
6942424|NCT00951379|10978735|FG001|Overall Study|Noncompliance|0
6942425|NCT00951379|10978734|FG000|Overall Study|Disease Progression|0
6942426|NCT00951379|10978735|FG001|Overall Study|Disease Progression|1
6942427|NCT00951483|10978751|FG000|Overall Study|Physician Decision|4
6942428|NCT00951483|10978752|FG001|Overall Study|Physician Decision|0
6942429|NCT00951483|10978751|FG000|Overall Study|Withdrawal by Subject|15
6942430|NCT00951483|10978752|FG001|Overall Study|Withdrawal by Subject|0
6942431|NCT00951496|10978763|FG000|Overall Study|Did not initiate study treatment|10
6942432|NCT00951496|10978764|FG001|Overall Study|Did not initiate study treatment|8
6942433|NCT00951496|10978765|FG002|Overall Study|Did not initiate study treatment|13
6942434|NCT00951509|10978776|FG000|Overall Study|Withdrawal by Subject|2
6942435|NCT00951665|10978798|FG000|Phase 1b|Adverse Event|2
6942436|NCT00951665|10978799|FG001|Phase 1b|Adverse Event|1
6942437|NCT00951665|10978800|FG002|Phase 1b|Adverse Event|0
6942438|NCT00951665|10978801|FG003|Phase 1b|Adverse Event|1
6942439|NCT00951665|10978802|FG004|Phase 1b|Adverse Event|0
6942440|NCT00951665|10978803|FG005|Phase 1b|Adverse Event|0
6942441|NCT00951665|10978798|FG000|Phase 1b|Death|1
6942442|NCT00951665|10978799|FG001|Phase 1b|Death|0
6942443|NCT00951665|10978800|FG002|Phase 1b|Death|2
6942444|NCT00951665|10978801|FG003|Phase 1b|Death|0
6942445|NCT00951665|10978802|FG004|Phase 1b|Death|0
6942446|NCT00951665|10978803|FG005|Phase 1b|Death|0
6942447|NCT00951665|10978798|FG000|Phase 1b|Physician Decision|4
6942448|NCT00951665|10978799|FG001|Phase 1b|Physician Decision|0
6942449|NCT00951665|10978800|FG002|Phase 1b|Physician Decision|1
6942450|NCT00951665|10978801|FG003|Phase 1b|Physician Decision|0
6942451|NCT00951665|10978802|FG004|Phase 1b|Physician Decision|0
6942452|NCT00951665|10978803|FG005|Phase 1b|Physician Decision|0
6942453|NCT00951665|10978798|FG000|Phase 1b|Withdrawal by Subject|0
6942454|NCT00951665|10978799|FG001|Phase 1b|Withdrawal by Subject|1
6942455|NCT00951665|10978800|FG002|Phase 1b|Withdrawal by Subject|0
6942456|NCT00951665|10978801|FG003|Phase 1b|Withdrawal by Subject|0
6942457|NCT00951665|10978802|FG004|Phase 1b|Withdrawal by Subject|0
6942458|NCT00951665|10978803|FG005|Phase 1b|Withdrawal by Subject|0
6942459|NCT00951665|10978798|FG000|Phase 1b|Disease Progression|13
6942460|NCT00951665|10978799|FG001|Phase 1b|Disease Progression|2
6942461|NCT00951665|10978800|FG002|Phase 1b|Disease Progression|14
6942462|NCT00951665|10978801|FG003|Phase 1b|Disease Progression|0
6942463|NCT00951665|10978802|FG004|Phase 1b|Disease Progression|0
6942464|NCT00951665|10978803|FG005|Phase 1b|Disease Progression|0
6942465|NCT00951665|10978798|FG000|Phase 1b|Protocol Violation|2
6942466|NCT00951665|10978799|FG001|Phase 1b|Protocol Violation|0
6942467|NCT00951665|10978800|FG002|Phase 1b|Protocol Violation|0
6942468|NCT00951665|10978801|FG003|Phase 1b|Protocol Violation|0
6942469|NCT00951665|10978802|FG004|Phase 1b|Protocol Violation|0
6942470|NCT00951665|10978803|FG005|Phase 1b|Protocol Violation|0
6942471|NCT00951665|10978798|FG000|Phase 2a|Adverse Event|0
6942472|NCT00951665|10978799|FG001|Phase 2a|Adverse Event|0
6942473|NCT00951665|10978800|FG002|Phase 2a|Adverse Event|0
6942474|NCT00951665|10978801|FG003|Phase 2a|Adverse Event|0
6942475|NCT00951665|10978802|FG004|Phase 2a|Adverse Event|2
6942476|NCT00951665|10978803|FG005|Phase 2a|Adverse Event|0
6942477|NCT00951665|10978798|FG000|Phase 2a|Death|0
6942478|NCT00951665|10978799|FG001|Phase 2a|Death|0
6942479|NCT00951665|10978800|FG002|Phase 2a|Death|0
6942480|NCT00951665|10978801|FG003|Phase 2a|Death|0
6942481|NCT00951665|10978802|FG004|Phase 2a|Death|1
6942482|NCT00951665|10978803|FG005|Phase 2a|Death|1
6942483|NCT00951665|10978798|FG000|Phase 2a|Lost to Follow-up|0
6942484|NCT00951665|10978799|FG001|Phase 2a|Lost to Follow-up|0
6942485|NCT00951665|10978800|FG002|Phase 2a|Lost to Follow-up|0
6942486|NCT00951665|10978801|FG003|Phase 2a|Lost to Follow-up|0
6942487|NCT00951665|10978802|FG004|Phase 2a|Lost to Follow-up|1
6942488|NCT00951665|10978803|FG005|Phase 2a|Lost to Follow-up|0
6942489|NCT00951665|10978798|FG000|Phase 2a|Physician Decision|0
6942490|NCT00951665|10978799|FG001|Phase 2a|Physician Decision|0
6942491|NCT00951665|10978800|FG002|Phase 2a|Physician Decision|0
6942492|NCT00951665|10978801|FG003|Phase 2a|Physician Decision|0
6942493|NCT00951665|10978802|FG004|Phase 2a|Physician Decision|0
6942494|NCT00951665|10978803|FG005|Phase 2a|Physician Decision|1
6942495|NCT00951665|10978798|FG000|Phase 2a|Withdrawal by Subject|0
6942496|NCT00951665|10978799|FG001|Phase 2a|Withdrawal by Subject|0
6942497|NCT00951665|10978800|FG002|Phase 2a|Withdrawal by Subject|0
6942498|NCT00951665|10978801|FG003|Phase 2a|Withdrawal by Subject|0
6942499|NCT00951665|10978802|FG004|Phase 2a|Withdrawal by Subject|2
6942500|NCT00951665|10978803|FG005|Phase 2a|Withdrawal by Subject|0
6942501|NCT00951665|10978798|FG000|Phase 2a|Disease Progression|0
6942502|NCT00951665|10978799|FG001|Phase 2a|Disease Progression|0
6942503|NCT00951665|10978800|FG002|Phase 2a|Disease Progression|0
6942504|NCT00951665|10978801|FG003|Phase 2a|Disease Progression|0
6942505|NCT00951665|10978802|FG004|Phase 2a|Disease Progression|6
7040494|NCT01717638|11123450|FG000|Overall Study|Father in hospital|0
7040495|NCT01717638|11123451|FG001|Overall Study|Father in hospital|0
7040496|NCT01717638|11123452|FG002|Overall Study|Father in hospital|0
7040497|NCT01717638|11123453|FG003|Overall Study|Father in hospital|0
7040498|NCT01717638|11123454|FG004|Overall Study|Father in hospital|0
7040499|NCT01717638|11123455|FG005|Overall Study|Father in hospital|0
7040500|NCT01717638|11123456|FG006|Overall Study|Father in hospital|0
7040501|NCT01717638|11123457|FG007|Overall Study|Father in hospital|0
7040502|NCT01717638|11123458|FG008|Overall Study|Father in hospital|0
7040503|NCT01717638|11123459|FG009|Overall Study|Father in hospital|0
7040504|NCT01717638|11123460|FG010|Overall Study|Father in hospital|0
7040505|NCT01717638|11123461|FG011|Overall Study|Father in hospital|0
7040506|NCT01717638|11123462|FG012|Overall Study|Father in hospital|1
7040507|NCT01717638|11123450|FG000|Overall Study|Withdrawal by Subject|0
6942506|NCT00951665|10978803|FG005|Phase 2a|Disease Progression|5
6975655|NCT01194154|11027883|FG000|Overall Study|Skipping of CERA treatment at two visits|3
6975656|NCT01194154|11027884|FG001|Overall Study|Skipping of CERA treatment at two visits|0
6975657|NCT01194154|11027883|FG000|Overall Study|Treatment with prohibited medication|4
6975658|NCT01194154|11027884|FG001|Overall Study|Treatment with prohibited medication|5
6975659|NCT01194154|11027883|FG000|Overall Study|Other|4
6975660|NCT01194154|11027884|FG001|Overall Study|Other|0
6975661|NCT01194154|11027883|FG000|Overall Study|Did not receive study medication|2
6975662|NCT01194154|11027884|FG001|Overall Study|Did not receive study medication|4
6975663|NCT01194245|11027897|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5
6975664|NCT01194245|11027898|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
6975665|NCT01194245|11027899|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
6975666|NCT01194245|11027900|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
6975667|NCT01194245|11027901|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
6975668|NCT01194245|11027897|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3
6975669|NCT01194245|11027898|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0
6975670|NCT01194245|11027899|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0
6975671|NCT01194245|11027900|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0
6975672|NCT01194245|11027901|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0
7040508|NCT01717638|11123451|FG001|Overall Study|Withdrawal by Subject|1
7040509|NCT01717638|11123452|FG002|Overall Study|Withdrawal by Subject|1
6975673|NCT01194245|11027897|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3
6975674|NCT01194245|11027898|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0
6975675|NCT01194245|11027899|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0
6975676|NCT01194245|11027900|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0
6975677|NCT01194245|11027901|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0
6975678|NCT01194245|11027897|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7
7040510|NCT01717638|11123453|FG003|Overall Study|Withdrawal by Subject|0
7040511|NCT01717638|11123454|FG004|Overall Study|Withdrawal by Subject|1
6942507|NCT00951912|10978866|FG000|Overall Study|Lack of Efficacy|1
7040512|NCT01717638|11123455|FG005|Overall Study|Withdrawal by Subject|0
7040513|NCT01717638|11123456|FG006|Overall Study|Withdrawal by Subject|2
7040514|NCT01717638|11123457|FG007|Overall Study|Withdrawal by Subject|1
6942508|NCT00951912|10978867|FG001|Overall Study|Lack of Efficacy|0
6942509|NCT00951912|10978868|FG002|Overall Study|Lack of Efficacy|0
6942510|NCT00951912|10978866|FG000|Overall Study|Adverse Event|0
6942511|NCT00951912|10978867|FG001|Overall Study|Adverse Event|1
6942512|NCT00951912|10978868|FG002|Overall Study|Adverse Event|1
6942513|NCT00951912|10978866|FG000|Overall Study|Lost to Follow-up|2
6942514|NCT00951912|10978867|FG001|Overall Study|Lost to Follow-up|2
6942515|NCT00951912|10978868|FG002|Overall Study|Lost to Follow-up|0
6942516|NCT00951912|10978866|FG000|Overall Study|Physician Decision|1
6942517|NCT00951912|10978867|FG001|Overall Study|Physician Decision|0
6942518|NCT00951912|10978868|FG002|Overall Study|Physician Decision|1
6942519|NCT00951912|10978866|FG000|Overall Study|Withdrawal by Subject|1
6942520|NCT00951912|10978867|FG001|Overall Study|Withdrawal by Subject|1
6942521|NCT00951912|10978868|FG002|Overall Study|Withdrawal by Subject|0
6942522|NCT00951912|10978866|FG000|Overall Study|Other:Depression|1
6942523|NCT00951912|10978867|FG001|Overall Study|Other:Depression|0
6942524|NCT00951912|10978868|FG002|Overall Study|Other:Depression|0
6942525|NCT00951912|10978866|FG000|Overall Study|Other: Colon cancer|1
6942526|NCT00951912|10978867|FG001|Overall Study|Other: Colon cancer|0
6942527|NCT00951912|10978868|FG002|Overall Study|Other: Colon cancer|0
6942528|NCT00951912|10978866|FG000|Overall Study|Other: Stroke|0
6942529|NCT00951912|10978867|FG001|Overall Study|Other: Stroke|1
6942530|NCT00951912|10978868|FG002|Overall Study|Other: Stroke|0
6942531|NCT00952068|10978876|FG000|Overall Study|Adverse Event|3
6942532|NCT00952068|10978876|FG000|Overall Study|Withdrawal by Subject|4
6942533|NCT00952276|10978920|FG000|Overall Study|Withdrawal by Subject|1
6942534|NCT00952276|10978921|FG001|Overall Study|Withdrawal by Subject|0
6942535|NCT00952276|10978922|FG002|Overall Study|Withdrawal by Subject|0
6942536|NCT00952276|10978923|FG003|Overall Study|Withdrawal by Subject|1
6942537|NCT00952276|10978924|FG004|Overall Study|Withdrawal by Subject|0
6942538|NCT00952289|10978938|FG000|All Participants|Death|9
6942539|NCT00952289|10978939|FG001|All Participants|Death|9
6942540|NCT00952289|10978938|FG000|All Participants|Adverse Event|8
6942541|NCT00952289|10978939|FG001|All Participants|Adverse Event|8
6942542|NCT00952289|10978938|FG000|All Participants|Disease progression|3
6942543|NCT00952289|10978939|FG001|All Participants|Disease progression|12
6942544|NCT00952289|10978938|FG000|All Participants|Withdrawal by Subject|1
6942545|NCT00952289|10978939|FG001|All Participants|Withdrawal by Subject|10
6942546|NCT00952289|10978938|FG000|All Participants|Data lost during site relocation|0
6942547|NCT00952289|10978939|FG001|All Participants|Data lost during site relocation|1
6942548|NCT00952289|10978938|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0
6942549|NCT00952289|10978939|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19
6942550|NCT00952289|10978938|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0
6942551|NCT00952289|10978939|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15
6942552|NCT00952289|10978938|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0
6942553|NCT00952289|10978939|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11
6942554|NCT00952289|10978938|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0
6942555|NCT00952289|10978939|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2
6942556|NCT00952289|10978938|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0
6942557|NCT00952289|10978939|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7
6942558|NCT00952341|10978963|FG000|Cycle 1|Adverse Event|4
6942559|NCT00952341|10978964|FG001|Cycle 1|Adverse Event|1
6942560|NCT00952341|10978963|FG000|Cycle 1|Withdrawal by Subject|3
6942561|NCT00952341|10978964|FG001|Cycle 1|Withdrawal by Subject|8
6942562|NCT00952341|10978963|FG000|Cycle 1|Protocol Violation|2
6942563|NCT00952341|10978964|FG001|Cycle 1|Protocol Violation|1
6942564|NCT00952341|10978963|FG000|Cycle 1|Lost to Follow-up|11
6942565|NCT00952341|10978964|FG001|Cycle 1|Lost to Follow-up|2
6942566|NCT00952341|10978963|FG000|Cycle 1|Physician Decision|0
6942567|NCT00952341|10978964|FG001|Cycle 1|Physician Decision|1
6942568|NCT00952341|10978963|FG000|Cycle 2|Withdrawal by Subject|1
6942569|NCT00952341|10978964|FG001|Cycle 2|Withdrawal by Subject|1
6942570|NCT00952341|10978963|FG000|Cycle 2|Protocol Violation|1
6942571|NCT00952341|10978964|FG001|Cycle 2|Protocol Violation|0
6942572|NCT00952341|10978963|FG000|Cycle 2|Lost to Follow-up|6
6942573|NCT00952341|10978964|FG001|Cycle 2|Lost to Follow-up|9
6942574|NCT00952341|10978963|FG000|Cycle 2|Physician Decision|1
7040515|NCT01717638|11123458|FG008|Overall Study|Withdrawal by Subject|2
7040516|NCT01717638|11123459|FG009|Overall Study|Withdrawal by Subject|1
6942575|NCT00952341|10978964|FG001|Cycle 2|Physician Decision|1
6942576|NCT00952341|10978963|FG000|Cycle 2|Progressive Disease|0
6942577|NCT00952341|10978964|FG001|Cycle 2|Progressive Disease|1
6942578|NCT00952367|10978970|FG000|Overall Study|Withdrawal by Subject|2
6942579|NCT00952367|10978970|FG000|Overall Study|Noncoordination|1
6942580|NCT00952367|10978970|FG000|Overall Study|Protocol Violation|3
6942581|NCT00952380|10978979|FG000|Overall Study|Other|0
6942582|NCT00952380|10978980|FG001|Overall Study|Other|0
6942583|NCT00952380|10978981|FG002|Overall Study|Other|0
6942584|NCT00952380|10978982|FG003|Overall Study|Other|0
6942585|NCT00952380|10978983|FG004|Overall Study|Other|1
6942586|NCT00952380|10978979|FG000|Overall Study|Withdrawal by Subject|0
6942587|NCT00952380|10978980|FG001|Overall Study|Withdrawal by Subject|0
6942588|NCT00952380|10978981|FG002|Overall Study|Withdrawal by Subject|1
6942589|NCT00952380|10978982|FG003|Overall Study|Withdrawal by Subject|0
6942590|NCT00952380|10978983|FG004|Overall Study|Withdrawal by Subject|2
6942591|NCT00952380|10978979|FG000|Overall Study|Adverse Event|0
6942592|NCT00952380|10978980|FG001|Overall Study|Adverse Event|1
6942593|NCT00952380|10978981|FG002|Overall Study|Adverse Event|0
6942594|NCT00952380|10978982|FG003|Overall Study|Adverse Event|0
6942595|NCT00952380|10978983|FG004|Overall Study|Adverse Event|3
6942596|NCT00952380|10978979|FG000|Overall Study|Physician Decision|0
6942597|NCT00952380|10978980|FG001|Overall Study|Physician Decision|0
6942598|NCT00952380|10978981|FG002|Overall Study|Physician Decision|1
6942599|NCT00952380|10978982|FG003|Overall Study|Physician Decision|2
6942600|NCT00952380|10978983|FG004|Overall Study|Physician Decision|0
6942601|NCT00952380|10978979|FG000|Overall Study|Non-compliant to protocol|0
6942602|NCT00952380|10978980|FG001|Overall Study|Non-compliant to protocol|0
6942603|NCT00952380|10978981|FG002|Overall Study|Non-compliant to protocol|0
6942604|NCT00952380|10978982|FG003|Overall Study|Non-compliant to protocol|1
6942605|NCT00952380|10978983|FG004|Overall Study|Non-compliant to protocol|0
6942606|NCT00952419|10979007|FG000|Overall Study|Adverse Event|2
6942607|NCT00952419|10979008|FG001|Overall Study|Adverse Event|0
6942608|NCT00952419|10979009|FG002|Overall Study|Adverse Event|0
6942609|NCT00952419|10979007|FG000|Overall Study|Protocol Violation|3
6942610|NCT00952419|10979008|FG001|Overall Study|Protocol Violation|7
6942611|NCT00952419|10979009|FG002|Overall Study|Protocol Violation|0
6942612|NCT00952419|10979007|FG000|Overall Study|Withdrawal by Subject|1
6942613|NCT00952419|10979008|FG001|Overall Study|Withdrawal by Subject|3
6942614|NCT00952419|10979009|FG002|Overall Study|Withdrawal by Subject|0
6942615|NCT00952484|10979020|FG000|Overall Study|Withdrawal by Subject|0
6942616|NCT00952484|10979021|FG001|Overall Study|Withdrawal by Subject|1
6942617|NCT00952484|10979022|FG002|Overall Study|Withdrawal by Subject|0
6942618|NCT00952523|10979031|FG000|Overall Study|Withdrawal by Subject|7
6942619|NCT00952588|10979039|FG000|Overall Study|Death|28
6942620|NCT00952588|10979040|FG001|Overall Study|Death|13
6942621|NCT00952588|10979039|FG000|Overall Study|Withdrawal by Subject|2
6942622|NCT00952588|10979040|FG001|Overall Study|Withdrawal by Subject|5
6942623|NCT00952588|10979039|FG000|Overall Study|Adverse Event|2
6942624|NCT00952588|10979040|FG001|Overall Study|Adverse Event|3
6942625|NCT00952588|10979039|FG000|Overall Study|Lost to Follow-up|2
6942626|NCT00952588|10979040|FG001|Overall Study|Lost to Follow-up|0
6942627|NCT00952588|10979039|FG000|Overall Study|Physician Decision|0
6942628|NCT00952588|10979040|FG001|Overall Study|Physician Decision|1
6942629|NCT00952588|10979039|FG000|Overall Study|Lack of Efficacy|2
6942630|NCT00952588|10979040|FG001|Overall Study|Lack of Efficacy|2
6942631|NCT00952614|10979046|FG000|Overall Study|Death|3
6942632|NCT00952614|10979046|FG000|Overall Study|Lost to Follow-up|3
6942633|NCT00952614|10979046|FG000|Overall Study|other reason|1
6942634|NCT00952705|10979061|FG000|Overall Study|Lost to Follow-up|24
6942635|NCT00952705|10979062|FG001|Overall Study|Lost to Follow-up|8
6942636|NCT00952705|10979063|FG002|Overall Study|Lost to Follow-up|9
6942637|NCT00952705|10979061|FG000|Overall Study|Withdrawal by Subject|2
6942638|NCT00952705|10979062|FG001|Overall Study|Withdrawal by Subject|1
6942639|NCT00952705|10979063|FG002|Overall Study|Withdrawal by Subject|1
6942640|NCT00952705|10979061|FG000|Overall Study|Death|2
6942641|NCT00952705|10979062|FG001|Overall Study|Death|0
6942642|NCT00952705|10979063|FG002|Overall Study|Death|0
6942643|NCT00952705|10979061|FG000|Overall Study|Incarcerated post dose|5
6942644|NCT00952705|10979062|FG001|Overall Study|Incarcerated post dose|0
6942645|NCT00952705|10979063|FG002|Overall Study|Incarcerated post dose|0
6942646|NCT00952705|10979061|FG000|Overall Study|Exclusion criteria not met pre dose|0
6942647|NCT00952705|10979062|FG001|Overall Study|Exclusion criteria not met pre dose|1
6942648|NCT00952705|10979063|FG002|Overall Study|Exclusion criteria not met pre dose|0
6942649|NCT00952731|10979088|FG000|Overall Study|Drug supply expired|1
6942650|NCT00952731|10979089|FG001|Overall Study|Drug supply expired|0
6942651|NCT00952822|10979095|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
6942652|NCT00952822|10979096|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1
6942653|NCT00952822|10979097|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
6942654|NCT00952822|10979098|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
6942655|NCT00952822|10979095|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
6942656|NCT00952822|10979096|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
6942657|NCT00952822|10979097|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1
6942658|NCT00952822|10979098|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
6942659|NCT00952848|10979109|FG000|Overall Study|Withdrawal by Subject|4
6942660|NCT00953017|10979117|FG000|Overall Study|DId not show up for colonoscopy|4
6942661|NCT00953017|10979118|FG001|Overall Study|DId not show up for colonoscopy|4
6942662|NCT00953017|10979119|FG002|Overall Study|DId not show up for colonoscopy|5
6942663|NCT00953017|10979120|FG003|Overall Study|DId not show up for colonoscopy|4
6942664|NCT00953017|10979117|FG000|Overall Study|Incomplete data|1
6942665|NCT00953017|10979118|FG001|Overall Study|Incomplete data|1
6942666|NCT00953017|10979119|FG002|Overall Study|Incomplete data|0
6942667|NCT00953017|10979120|FG003|Overall Study|Incomplete data|0
6942668|NCT00953017|10979117|FG000|Overall Study|Procedure incomplete due to pain/looping|0
6942669|NCT00953017|10979118|FG001|Overall Study|Procedure incomplete due to pain/looping|1
6942670|NCT00953017|10979119|FG002|Overall Study|Procedure incomplete due to pain/looping|0
6942671|NCT00953017|10979120|FG003|Overall Study|Procedure incomplete due to pain/looping|1
6942672|NCT00953017|10979117|FG000|Overall Study|Brown stool prior to procedure|0
6942673|NCT00953017|10979118|FG001|Overall Study|Brown stool prior to procedure|0
6942674|NCT00953017|10979119|FG002|Overall Study|Brown stool prior to procedure|1
6942675|NCT00953017|10979120|FG003|Overall Study|Brown stool prior to procedure|0
6942676|NCT00953043|10979132|FG000|Overall Study|Withdrawal by Subject|4
6942677|NCT00953043|10979133|FG001|Overall Study|Withdrawal by Subject|0
6942678|NCT00953043|10979132|FG000|Overall Study|Physician Decision|0
6942679|NCT00953043|10979133|FG001|Overall Study|Physician Decision|2
6942680|NCT00953056|10979145|FG000|Overall Study|Withdrew Consent|0
6942681|NCT00953056|10979146|FG001|Overall Study|Withdrew Consent|0
6942682|NCT00953056|10979147|FG002|Overall Study|Withdrew Consent|0
6942683|NCT00953056|10979148|FG003|Overall Study|Withdrew Consent|0
6942684|NCT00953056|10979149|FG004|Overall Study|Withdrew Consent|2
6942685|NCT00953056|10979150|FG005|Overall Study|Withdrew Consent|3
6942686|NCT00953056|10979145|FG000|Overall Study|Serious Adverse Event|0
6942687|NCT00953056|10979146|FG001|Overall Study|Serious Adverse Event|0
6942688|NCT00953056|10979147|FG002|Overall Study|Serious Adverse Event|0
6942689|NCT00953056|10979148|FG003|Overall Study|Serious Adverse Event|0
6942690|NCT00953056|10979149|FG004|Overall Study|Serious Adverse Event|0
6942691|NCT00953056|10979150|FG005|Overall Study|Serious Adverse Event|1
6942692|NCT00953147|10979182|FG000|Overall Study|Adverse Event|8
6942693|NCT00953147|10979183|FG001|Overall Study|Adverse Event|16
6942694|NCT00953147|10979184|FG002|Overall Study|Adverse Event|6
6942695|NCT00953147|10979182|FG000|Overall Study|Protocol Violation|2
6942696|NCT00953147|10979183|FG001|Overall Study|Protocol Violation|8
6942697|NCT00953147|10979184|FG002|Overall Study|Protocol Violation|4
6942698|NCT00953147|10979182|FG000|Overall Study|Withdrawal by Subject|13
6942699|NCT00953147|10979183|FG001|Overall Study|Withdrawal by Subject|15
6942700|NCT00953147|10979184|FG002|Overall Study|Withdrawal by Subject|12
6942701|NCT00953147|10979182|FG000|Overall Study|Lost to Follow-up|8
6942702|NCT00953147|10979183|FG001|Overall Study|Lost to Follow-up|9
6942703|NCT00953147|10979184|FG002|Overall Study|Lost to Follow-up|4
6942704|NCT00953147|10979182|FG000|Overall Study|Physician Decision|2
6942705|NCT00953147|10979183|FG001|Overall Study|Physician Decision|7
6942706|NCT00953147|10979184|FG002|Overall Study|Physician Decision|3
6942707|NCT00953147|10979182|FG000|Overall Study|Other|4
6942708|NCT00953147|10979183|FG001|Overall Study|Other|11
6942709|NCT00953147|10979184|FG002|Overall Study|Other|13
6942710|NCT00953160|10979192|FG000|Overall Study|Lost to Follow-up|23
6942711|NCT00953160|10979192|FG000|Overall Study|Withdrawal by Subject|4
6942712|NCT00953225|10979234|FG000|Overall Study|Withdrawal by Subject|2
6942713|NCT00953225|10979235|FG001|Overall Study|Withdrawal by Subject|0
6942714|NCT00953407|10979253|FG000|Overall Study|Failed inclusion criteria|1
6942715|NCT00953407|10979254|FG001|Overall Study|Failed inclusion criteria|1
6942716|NCT00953407|10979255|FG002|Overall Study|Failed inclusion criteria|1
6942717|NCT00953407|10979256|FG003|Overall Study|Failed inclusion criteria|1
6942718|NCT00953407|10979257|FG004|Overall Study|Failed inclusion criteria|1
6942719|NCT00953407|10979253|FG000|Overall Study|Lost to Follow-up|0
6942720|NCT00953407|10979254|FG001|Overall Study|Lost to Follow-up|0
6942721|NCT00953407|10979255|FG002|Overall Study|Lost to Follow-up|0
6942722|NCT00953407|10979256|FG003|Overall Study|Lost to Follow-up|1
6942723|NCT00953407|10979257|FG004|Overall Study|Lost to Follow-up|0
6942724|NCT00953524|10979273|FG000|Overall Study|Adverse Event|2
6942725|NCT00953524|10979274|FG001|Overall Study|Adverse Event|0
6942726|NCT00953524|10979275|FG002|Overall Study|Adverse Event|1
6942727|NCT00953524|10979276|FG003|Overall Study|Adverse Event|2
6942728|NCT00953524|10979273|FG000|Overall Study|Protocol Violation|18
6942729|NCT00953524|10979274|FG001|Overall Study|Protocol Violation|10
6942730|NCT00953524|10979275|FG002|Overall Study|Protocol Violation|11
7040517|NCT01717638|11123460|FG010|Overall Study|Withdrawal by Subject|0
7040518|NCT01717638|11123461|FG011|Overall Study|Withdrawal by Subject|0
7040519|NCT01717638|11123462|FG012|Overall Study|Withdrawal by Subject|18
7040520|NCT01717768|11123515|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
6942731|NCT00953524|10979276|FG003|Overall Study|Protocol Violation|6
6942732|NCT00953524|10979273|FG000|Overall Study|Lost to Follow-up|0
6942733|NCT00953524|10979274|FG001|Overall Study|Lost to Follow-up|1
6942734|NCT00953524|10979275|FG002|Overall Study|Lost to Follow-up|1
6942735|NCT00953524|10979276|FG003|Overall Study|Lost to Follow-up|0
6942736|NCT00953524|10979273|FG000|Overall Study|Withdrawal by Subject|2
6942737|NCT00953524|10979274|FG001|Overall Study|Withdrawal by Subject|4
6942738|NCT00953524|10979275|FG002|Overall Study|Withdrawal by Subject|1
6942739|NCT00953524|10979276|FG003|Overall Study|Withdrawal by Subject|0
6942740|NCT00953576|10979288|FG000|Overall Study|Adverse Event|0
6942741|NCT00953576|10979289|FG001|Overall Study|Adverse Event|1
6942742|NCT00953576|10979288|FG000|Overall Study|Ineligible after Consent|2
6942743|NCT00953576|10979289|FG001|Overall Study|Ineligible after Consent|0
6942744|NCT00953667|10979311|FG000|Overall Study|Lost to Follow-up|11
6942745|NCT00953667|10979311|FG000|Overall Study|Physician Decision|35
6942746|NCT00953667|10979311|FG000|Overall Study|Withdrawal by Subject|63
7040521|NCT01717768|11123516|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1
7040522|NCT01717768|11123517|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7040523|NCT01717768|11123518|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
6942747|NCT00953667|10979311|FG000|Overall Study|Adverse Event|10
6942748|NCT00953667|10979311|FG000|Overall Study|poor venous access,unable to draw blood|4
6942749|NCT00953706|10979317|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2
6942750|NCT00953706|10979318|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3
6942751|NCT00953706|10979319|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
6942752|NCT00953706|10979320|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
6942753|NCT00953706|10979317|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
6942754|NCT00953706|10979318|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1
6942755|NCT00953706|10979319|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
6942756|NCT00953706|10979320|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
6942757|NCT00953706|10979317|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
6942758|NCT00953706|10979318|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2
6942759|NCT00953706|10979319|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
6942760|NCT00953706|10979320|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
6942761|NCT00953706|10979317|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
6942762|NCT00953706|10979318|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1
6942763|NCT00953706|10979319|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
6942764|NCT00953706|10979320|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
6942765|NCT00953706|10979317|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
6942766|NCT00953706|10979318|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1
6942767|NCT00953706|10979319|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
6942768|NCT00953706|10979320|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
6942769|NCT00953706|10979317|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0
6942770|NCT00953706|10979318|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0
6942771|NCT00953706|10979319|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0
6942772|NCT00953706|10979320|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2
6942773|NCT00953706|10979317|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
6942774|NCT00953706|10979318|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
6942775|NCT00953706|10979319|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
6942776|NCT00953706|10979320|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1
6942777|NCT00953706|10979317|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
6942778|NCT00953706|10979318|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
6942779|NCT00953706|10979319|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
6942780|NCT00953706|10979320|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1
6942781|NCT00953706|10979317|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
6942782|NCT00953706|10979318|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
6942783|NCT00953706|10979319|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4
6942784|NCT00953706|10979320|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25
6942785|NCT00953706|10979317|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
6942786|NCT00953706|10979318|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
7040524|NCT01717768|11123519|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7040525|NCT01717768|11123520|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7040526|NCT01717768|11123521|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7040527|NCT01717768|11123522|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7040528|NCT01717768|11123523|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7040529|NCT01717768|11123524|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7040530|NCT01717768|11123525|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7040531|NCT01717768|11123526|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7040532|NCT01717768|11123515|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7040533|NCT01717768|11123516|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7040534|NCT01717768|11123517|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7040535|NCT01717768|11123518|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7040536|NCT01717768|11123519|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7040537|NCT01717768|11123520|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7040538|NCT01717768|11123521|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7040539|NCT01717768|11123522|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7040540|NCT01717768|11123523|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7040541|NCT01717768|11123524|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7040542|NCT01717768|11123525|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7040543|NCT01717768|11123526|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1
7040544|NCT01717768|11123515|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7040545|NCT01717768|11123516|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7040546|NCT01717768|11123517|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7044797|NCT01757275|11130782|FG001|Overall Study|Not treated|4
7040547|NCT01717768|11123518|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7040548|NCT01717768|11123519|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7040549|NCT01717768|11123520|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7040550|NCT01717768|11123521|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7040551|NCT01717768|11123522|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2
7040552|NCT01717768|11123523|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7040553|NCT01717768|11123524|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7040554|NCT01717768|11123525|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7040555|NCT01717768|11123526|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7040556|NCT01717768|11123515|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7040557|NCT01717768|11123516|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7040558|NCT01717768|11123517|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7040559|NCT01717768|11123518|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7040560|NCT01717768|11123519|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7040561|NCT01717768|11123520|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7040562|NCT01717768|11123521|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7040563|NCT01717768|11123522|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7040564|NCT01717768|11123523|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7040565|NCT01717768|11123524|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1
7040566|NCT01717768|11123525|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7040567|NCT01717768|11123526|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7040568|NCT01717859|11123552|FG000|Overall Study|Adverse Event|5
7040569|NCT01717859|11123552|FG000|Overall Study|Moved out of state|1
7040570|NCT01717859|11123552|FG000|Overall Study|Patient concerned about mental health|1
7040571|NCT01717859|11123552|FG000|Overall Study|Lost to Follow-up|1
7040572|NCT01717859|11123552|FG000|Overall Study|Withdrawal by Subject|2
7040573|NCT01717976|11123591|FG000|Overall Study|Protocol Violation|0
7040574|NCT01717976|11123592|FG001|Overall Study|Protocol Violation|1
7040575|NCT01717989|11123598|FG000|Overall Study|Ineligibility determined|6
7040576|NCT01717989|11123598|FG000|Overall Study|Protocol deviation|6
7040577|NCT01717989|11123598|FG000|Overall Study|Withdrawal by Subject|11
7040578|NCT01717989|11123598|FG000|Overall Study|Physician Decision|2
7040579|NCT01717989|11123598|FG000|Overall Study|Lost to Follow-up|11
7040580|NCT01717989|11123598|FG000|Overall Study|Death|439
7040581|NCT01717989|11123598|FG000|Overall Study|Protocol-specified criteria|551
7040582|NCT01717989|11123598|FG000|Overall Study|Other|40
7040583|NCT01718353|11123628|FG000|Overall Study|Lost to Follow-up|0
7040584|NCT01718353|11123629|FG001|Overall Study|Lost to Follow-up|1
7040585|NCT01718353|11123628|FG000|Overall Study|Principal Investigator's Decision|10
7040586|NCT01718353|11123629|FG001|Overall Study|Principal Investigator's Decision|4
7040587|NCT01718353|11123628|FG000|Overall Study|Randomized but not treated|2
7040588|NCT01718353|11123629|FG001|Overall Study|Randomized but not treated|0
7040589|NCT01718483|11123639|FG000|Overall Study|Withdrawal by Subject|14
7040590|NCT01718483|11123640|FG001|Overall Study|Withdrawal by Subject|12
7040591|NCT01718483|11123639|FG000|Overall Study|Adverse Event|5
7040592|NCT01718483|11123640|FG001|Overall Study|Adverse Event|12
7040593|NCT01718483|11123639|FG000|Overall Study|Lost to Follow-up|8
7040594|NCT01718483|11123640|FG001|Overall Study|Lost to Follow-up|3
7040595|NCT01718483|11123639|FG000|Overall Study|Protocol Violation|4
7040596|NCT01718483|11123640|FG001|Overall Study|Protocol Violation|2
7040597|NCT01718483|11123639|FG000|Overall Study|Other|1
7040598|NCT01718483|11123640|FG001|Overall Study|Other|4
7040599|NCT01718483|11123639|FG000|Overall Study|Pregnancy|1
7040600|NCT01718483|11123640|FG001|Overall Study|Pregnancy|1
7040601|NCT01718483|11123639|FG000|Overall Study|Lack of Efficacy|1
7040602|NCT01718483|11123640|FG001|Overall Study|Lack of Efficacy|0
7040603|NCT01718509|11123648|FG000|Overall Study|Lost to Follow-up|18
7040604|NCT01718509|11123649|FG001|Overall Study|Lost to Follow-up|15
7040605|NCT01718509|11123648|FG000|Overall Study|Withdrawal by Subject|7
7040606|NCT01718509|11123649|FG001|Overall Study|Withdrawal by Subject|13
7040607|NCT01718509|11123648|FG000|Overall Study|Adverse Event|5
7040608|NCT01718509|11123649|FG001|Overall Study|Adverse Event|7
7040609|NCT01718509|11123648|FG000|Overall Study|Other|13
7040610|NCT01718509|11123649|FG001|Overall Study|Other|11
7040611|NCT01718509|11123648|FG000|Overall Study|Protocol Violation|4
7040612|NCT01718509|11123649|FG001|Overall Study|Protocol Violation|2
7040613|NCT01718509|11123648|FG000|Overall Study|Lack of Efficacy|1
7040614|NCT01718509|11123649|FG001|Overall Study|Lack of Efficacy|0
7040615|NCT01718535|11123672|FG000|Overall Study|Bidirectional Sequencing not possible|1
7040616|NCT01718535|11123673|FG001|Overall Study|Bidirectional Sequencing not possible|0
7040617|NCT01718535|11123674|FG002|Overall Study|Bidirectional Sequencing not possible|0
7040618|NCT01718535|11123675|FG003|Overall Study|Bidirectional Sequencing not possible|1
7040619|NCT01718535|11123676|FG004|Overall Study|Bidirectional Sequencing not possible|0
7040620|NCT01718535|11123677|FG005|Overall Study|Bidirectional Sequencing not possible|0
7040621|NCT01718535|11123678|FG006|Overall Study|Bidirectional Sequencing not possible|0
7040622|NCT01718535|11123679|FG007|Overall Study|Bidirectional Sequencing not possible|0
7040623|NCT01718535|11123680|FG008|Overall Study|Bidirectional Sequencing not possible|0
7040624|NCT01718535|11123681|FG009|Overall Study|Bidirectional Sequencing not possible|0
7040625|NCT01719003|11123725|FG000|Overall Study|Non compliant with protocol|1
7040626|NCT01719003|11123726|FG001|Overall Study|Non compliant with protocol|1
7040627|NCT01719003|11123727|FG002|Overall Study|Non compliant with protocol|0
7040628|NCT01719003|11123728|FG003|Overall Study|Non compliant with protocol|1
7040629|NCT01719003|11123729|FG004|Overall Study|Non compliant with protocol|2
7040630|NCT01719003|11123730|FG005|Overall Study|Non compliant with protocol|1
7040631|NCT01719003|11123731|FG006|Overall Study|Non compliant with protocol|2
7040632|NCT01719003|11123732|FG007|Overall Study|Non compliant with protocol|3
7040633|NCT01719003|11123733|FG008|Overall Study|Non compliant with protocol|0
7040634|NCT01719003|11123725|FG000|Overall Study|Adverse Event|6
7067604|NCT01987557|11168738|FG001|Overall Study|Adverse Event|2
7067605|NCT01987557|11168739|FG002|Overall Study|Adverse Event|0
7067606|NCT01987596|11168758|FG000|Overall Study|Physician Decision|1
7067607|NCT01987596|11168759|FG001|Overall Study|Physician Decision|0
7067608|NCT01987596|11168758|FG000|Overall Study|Progressive Disease; missing all period|0
7067609|NCT01987596|11168759|FG001|Overall Study|Progressive Disease; missing all period|1
6942787|NCT00953706|10979319|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1
6942788|NCT00953706|10979320|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2
6942789|NCT00953706|10979317|FG000|Part B (96-Week Open-Label Extension)|Other|0
6942790|NCT00953706|10979318|FG001|Part B (96-Week Open-Label Extension)|Other|0
6942791|NCT00953706|10979319|FG002|Part B (96-Week Open-Label Extension)|Other|0
6942792|NCT00953706|10979320|FG003|Part B (96-Week Open-Label Extension)|Other|2
6942793|NCT00953745|10979341|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1
6942794|NCT00953745|10979342|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0
6942795|NCT00953745|10979341|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2
6942796|NCT00953745|10979342|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0
6942797|NCT00953745|10979341|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3
6942798|NCT00953745|10979342|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0
6942799|NCT00953745|10979341|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1
6942800|NCT00953745|10979342|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0
6942801|NCT00953745|10979341|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6
6942802|NCT00953745|10979342|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0
6942803|NCT00953745|10979341|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1
6942804|NCT00953745|10979342|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0
6942805|NCT00953927|10979379|FG000|Overall Study|Lost to Follow-up|61
6942806|NCT00953927|10979380|FG001|Overall Study|Lost to Follow-up|65
6942807|NCT00953927|10979379|FG000|Overall Study|Withdrawal by Subject|36
6942808|NCT00953927|10979380|FG001|Overall Study|Withdrawal by Subject|25
6942809|NCT00953927|10979379|FG000|Overall Study|Death|7
6942810|NCT00953927|10979380|FG001|Overall Study|Death|4
6942811|NCT00953927|10979379|FG000|Overall Study|Other study discontinuation|1
6942812|NCT00953927|10979380|FG001|Overall Study|Other study discontinuation|1
6942813|NCT00954122|10979390|FG000|Overall Study|Withdrawal by Subject|5
6942814|NCT00954122|10979390|FG000|Overall Study|Adverse Event|1
6942815|NCT00954122|10979390|FG000|Overall Study|Safety Reason|1
6942816|NCT00954174|10979399|FG000|Overall Study|Adverse Event|28
6942817|NCT00954174|10979400|FG001|Overall Study|Adverse Event|23
6942818|NCT00954174|10979401|FG002|Overall Study|Adverse Event|4
6942819|NCT00954174|10979402|FG003|Overall Study|Adverse Event|9
6942820|NCT00954174|10979399|FG000|Overall Study|Death|4
6942821|NCT00954174|10979400|FG001|Overall Study|Death|2
6942822|NCT00954174|10979401|FG002|Overall Study|Death|0
6942823|NCT00954174|10979402|FG003|Overall Study|Death|0
6942824|NCT00954174|10979399|FG000|Overall Study|Lack of Efficacy|32
6942825|NCT00954174|10979400|FG001|Overall Study|Lack of Efficacy|22
6942826|NCT00954174|10979401|FG002|Overall Study|Lack of Efficacy|8
6942827|NCT00954174|10979402|FG003|Overall Study|Lack of Efficacy|6
6942828|NCT00954174|10979399|FG000|Overall Study|Withdrawal by Subject|14
6942829|NCT00954174|10979400|FG001|Overall Study|Withdrawal by Subject|10
6942830|NCT00954174|10979401|FG002|Overall Study|Withdrawal by Subject|4
6942831|NCT00954174|10979402|FG003|Overall Study|Withdrawal by Subject|3
6942832|NCT00954174|10979399|FG000|Overall Study|Medical Reason|4
6942833|NCT00954174|10979400|FG001|Overall Study|Medical Reason|2
6942834|NCT00954174|10979401|FG002|Overall Study|Medical Reason|1
6942835|NCT00954174|10979402|FG003|Overall Study|Medical Reason|0
6942836|NCT00954174|10979399|FG000|Overall Study|Ineligible|40
6942837|NCT00954174|10979400|FG001|Overall Study|Ineligible|47
6942838|NCT00954174|10979401|FG002|Overall Study|Ineligible|7
6942839|NCT00954174|10979402|FG003|Overall Study|Ineligible|4
6942840|NCT00954174|10979399|FG000|Overall Study|Never Treated|4
6942841|NCT00954174|10979400|FG001|Overall Study|Never Treated|17
6942842|NCT00954174|10979401|FG002|Overall Study|Never Treated|0
6942843|NCT00954174|10979402|FG003|Overall Study|Never Treated|3
6942844|NCT00954421|10979424|FG000|Screening|screen failures|3
6942845|NCT00954421|10979424|FG000|6 Months of DBS|Withdrawal by Subject|1
6942846|NCT00954421|10979424|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1
7040635|NCT01719003|11123726|FG001|Overall Study|Adverse Event|5
7040636|NCT01719003|11123727|FG002|Overall Study|Adverse Event|4
7067610|NCT01987609|11168771|FG000|Overall Study|Adverse Event|1
6942847|NCT00954447|10979432|FG000|Overall Study|Adverse Event|33
7040637|NCT01719003|11123728|FG003|Overall Study|Adverse Event|3
6942848|NCT00954447|10979433|FG001|Overall Study|Adverse Event|25
6942849|NCT00954447|10979432|FG000|Overall Study|Lack of Efficacy|17
6942850|NCT00954447|10979433|FG001|Overall Study|Lack of Efficacy|3
6942851|NCT00954447|10979432|FG000|Overall Study|Protocol Violation|5
6942852|NCT00954447|10979433|FG001|Overall Study|Protocol Violation|7
6942853|NCT00954447|10979432|FG000|Overall Study|Lost to Follow-up|8
6942854|NCT00954447|10979433|FG001|Overall Study|Lost to Follow-up|14
6942855|NCT00954447|10979432|FG000|Overall Study|Withdrawal by Subject|26
6942856|NCT00954447|10979433|FG001|Overall Study|Withdrawal by Subject|21
6942857|NCT00954447|10979432|FG000|Overall Study|Other|21
6942858|NCT00954447|10979433|FG001|Overall Study|Other|18
6942859|NCT00954512|10979445|FG000|Overall Study|Withdrawal by Subject|0
6942860|NCT00954512|10979446|FG001|Overall Study|Withdrawal by Subject|0
6942861|NCT00954512|10979447|FG002|Overall Study|Withdrawal by Subject|0
6942862|NCT00954512|10979448|FG003|Overall Study|Withdrawal by Subject|0
6942863|NCT00954512|10979449|FG004|Overall Study|Withdrawal by Subject|0
7067611|NCT01987765|11168789|FG000|Overall Study|Protocol Violation|65
7067612|NCT01987765|11168789|FG000|Overall Study|Lost to Follow-up|37
6942864|NCT00954512|10979450|FG005|Overall Study|Withdrawal by Subject|1
6942865|NCT00954512|10979445|FG000|Overall Study|Adverse Event|0
6942866|NCT00954512|10979446|FG001|Overall Study|Adverse Event|0
6942867|NCT00954512|10979447|FG002|Overall Study|Adverse Event|0
6942868|NCT00954512|10979448|FG003|Overall Study|Adverse Event|0
6942869|NCT00954512|10979449|FG004|Overall Study|Adverse Event|1
6942870|NCT00954512|10979450|FG005|Overall Study|Adverse Event|2
6942871|NCT00954512|10979445|FG000|Overall Study|Physician Decision|0
6942872|NCT00954512|10979446|FG001|Overall Study|Physician Decision|1
6942873|NCT00954512|10979447|FG002|Overall Study|Physician Decision|0
6942874|NCT00954512|10979448|FG003|Overall Study|Physician Decision|1
6942875|NCT00954512|10979449|FG004|Overall Study|Physician Decision|0
6942876|NCT00954512|10979450|FG005|Overall Study|Physician Decision|0
6942877|NCT00954512|10979445|FG000|Overall Study|Symptomatic Deterioration|0
6942878|NCT00954512|10979446|FG001|Overall Study|Symptomatic Deterioration|1
6942879|NCT00954512|10979447|FG002|Overall Study|Symptomatic Deterioration|0
6942880|NCT00954512|10979448|FG003|Overall Study|Symptomatic Deterioration|0
6942881|NCT00954512|10979449|FG004|Overall Study|Symptomatic Deterioration|2
6942882|NCT00954512|10979450|FG005|Overall Study|Symptomatic Deterioration|0
6942883|NCT00954512|10979445|FG000|Overall Study|Progression of Disease|2
6942884|NCT00954512|10979446|FG001|Overall Study|Progression of Disease|1
6942885|NCT00954512|10979447|FG002|Overall Study|Progression of Disease|0
6942886|NCT00954512|10979448|FG003|Overall Study|Progression of Disease|1
6942887|NCT00954512|10979449|FG004|Overall Study|Progression of Disease|1
6942888|NCT00954512|10979450|FG005|Overall Study|Progression of Disease|1
6942889|NCT00954538|10979465|FG000|Part III|Withdrawal by Subject|0
6942890|NCT00954538|10979466|FG001|Part III|Withdrawal by Subject|0
6942891|NCT00954538|10979467|FG002|Part III|Withdrawal by Subject|0
6942892|NCT00954538|10979468|FG003|Part III|Withdrawal by Subject|0
6942893|NCT00954538|10979469|FG004|Part III|Withdrawal by Subject|1
6942894|NCT00954538|10979470|FG005|Part III|Withdrawal by Subject|0
6942895|NCT00954707|10979483|FG000|Overall Study|Death|34
6942896|NCT00954707|10979483|FG000|Overall Study|Withdrawal by Subject|100
6942897|NCT00954707|10979483|FG000|Overall Study|Lost to Follow-up|33
6942898|NCT00954733|10979487|FG000|Overall Study|blood gas machine did not work|1
6942899|NCT00954941|10979497|FG000|Overall Study|Received treatment at home|1
6942900|NCT00954941|10979498|FG001|Overall Study|Received treatment at home|0
6942901|NCT00954941|10979497|FG000|Overall Study|Withdrawal by Subject|1
6942902|NCT00954941|10979498|FG001|Overall Study|Withdrawal by Subject|0
6942903|NCT00954941|10979497|FG000|Overall Study|Insurance Denial|2
6942904|NCT00954941|10979498|FG001|Overall Study|Insurance Denial|2
6942905|NCT00954941|10979497|FG000|Overall Study|Physician Decision|2
6942906|NCT00954941|10979498|FG001|Overall Study|Physician Decision|2
6942907|NCT00954941|10979497|FG000|Overall Study|Ineligible|2
6942908|NCT00954941|10979498|FG001|Overall Study|Ineligible|2
6942909|NCT00954941|10979497|FG000|Overall Study|Adverse Event|0
6942910|NCT00954941|10979498|FG001|Overall Study|Adverse Event|1
6942911|NCT00955110|10979528|FG000|Qualification Phase|Did not meet eligibility criteria|24
6942912|NCT00955110|10979528|FG000|Treatment Phase|Adverse Event|2
6942913|NCT00955110|10979528|FG000|Treatment Phase|Administrative reasons|2
6942914|NCT00955110|10979528|FG000|Treatment Phase|Non-compliance with study restrictions|1
6942915|NCT00955110|10979528|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1
6942916|NCT00955279|10979584|FG000|Overall Study|Other|0
6942917|NCT00955279|10979585|FG001|Overall Study|Other|0
6942918|NCT00955279|10979586|FG002|Overall Study|Other|3
6942919|NCT00955279|10979584|FG000|Overall Study|Death|1
6942920|NCT00955279|10979585|FG001|Overall Study|Death|1
6942921|NCT00955279|10979586|FG002|Overall Study|Death|1
6942922|NCT00955279|10979584|FG000|Overall Study|Lost to Follow-up|0
6942923|NCT00955279|10979585|FG001|Overall Study|Lost to Follow-up|3
6942924|NCT00955279|10979586|FG002|Overall Study|Lost to Follow-up|1
6942925|NCT00955279|10979584|FG000|Overall Study|Withdrawal by Subject|2
6942926|NCT00955279|10979585|FG001|Overall Study|Withdrawal by Subject|0
7067613|NCT01987817|11168795|FG000|Overall Study|Adverse Event|4
6942927|NCT00955279|10979586|FG002|Overall Study|Withdrawal by Subject|3
6942928|NCT00955305|10979596|FG000|Overall Study|Disease progression|39
6942929|NCT00955305|10979597|FG001|Overall Study|Disease progression|41
6942930|NCT00955305|10979596|FG000|Overall Study|Adverse Event|22
6942931|NCT00955305|10979597|FG001|Overall Study|Adverse Event|22
6942932|NCT00955305|10979596|FG000|Overall Study|Death|2
6942933|NCT00955305|10979597|FG001|Overall Study|Death|1
6942934|NCT00955305|10979596|FG000|Overall Study|Withdrawal by Subject|5
6942935|NCT00955305|10979597|FG001|Overall Study|Withdrawal by Subject|4
6942936|NCT00955305|10979596|FG000|Overall Study|Alternative therapy|4
6942937|NCT00955305|10979597|FG001|Overall Study|Alternative therapy|0
6942938|NCT00955305|10979596|FG000|Overall Study|Other complicating disease|2
6942939|NCT00955305|10979597|FG001|Overall Study|Other complicating disease|4
6942940|NCT00955305|10979596|FG000|Overall Study|Physician Decision|1
6942941|NCT00955305|10979597|FG001|Overall Study|Physician Decision|0
6942942|NCT00955305|10979596|FG000|Overall Study|Continued presence of residual disease|0
6942943|NCT00955305|10979597|FG001|Overall Study|Continued presence of residual disease|1
6942944|NCT00955305|10979596|FG000|Overall Study|Functional decline|2
6942945|NCT00955305|10979597|FG001|Overall Study|Functional decline|0
6942946|NCT00955305|10979596|FG000|Overall Study|Maximum response achieved|0
6942947|NCT00955305|10979597|FG001|Overall Study|Maximum response achieved|1
6942948|NCT00955305|10979596|FG000|Overall Study|Lost to Follow-up|0
6942949|NCT00955305|10979597|FG001|Overall Study|Lost to Follow-up|1
6942950|NCT00955305|10979596|FG000|Overall Study|No off-treatment reason submitted|1
6942951|NCT00955305|10979597|FG001|Overall Study|No off-treatment reason submitted|0
6942952|NCT00955305|10979596|FG000|Overall Study|Never started protocol treatment|5
6942953|NCT00955305|10979597|FG001|Overall Study|Never started protocol treatment|5
6942954|NCT00955305|10979596|FG000|Overall Study|Ineligible|5
6942955|NCT00955305|10979597|FG001|Overall Study|Ineligible|7
6942956|NCT00955357|10979605|FG000|Titration Phase|Adverse Event|9
6942957|NCT00955357|10979606|FG001|Titration Phase|Adverse Event|46
6942958|NCT00955357|10979605|FG000|Titration Phase|Lack of Efficacy|0
6942959|NCT00955357|10979606|FG001|Titration Phase|Lack of Efficacy|2
6942960|NCT00955357|10979605|FG000|Titration Phase|Protocol Violation|3
6942961|NCT00955357|10979606|FG001|Titration Phase|Protocol Violation|7
6942962|NCT00955357|10979605|FG000|Titration Phase|Lost to Follow-up|1
6942963|NCT00955357|10979606|FG001|Titration Phase|Lost to Follow-up|3
6942964|NCT00955357|10979605|FG000|Titration Phase|Withdrawal by Subject|3
6942965|NCT00955357|10979606|FG001|Titration Phase|Withdrawal by Subject|5
6942966|NCT00955357|10979605|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0
6942967|NCT00955357|10979606|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1
6942968|NCT00955357|10979605|FG000|Titration Phase|Study medication not tolerated|0
6942969|NCT00955357|10979606|FG001|Titration Phase|Study medication not tolerated|1
6942970|NCT00955357|10979605|FG000|Titration Phase|Non compliance to study procedures|0
6942971|NCT00955357|10979606|FG001|Titration Phase|Non compliance to study procedures|1
6942972|NCT00955357|10979605|FG000|Maintenance Phase|Adverse Event|3
6942973|NCT00955357|10979606|FG001|Maintenance Phase|Adverse Event|23
6942974|NCT00955357|10979605|FG000|Maintenance Phase|Lack of Efficacy|0
6942975|NCT00955357|10979606|FG001|Maintenance Phase|Lack of Efficacy|4
6942976|NCT00955357|10979605|FG000|Maintenance Phase|Protocol Violation|2
6942977|NCT00955357|10979606|FG001|Maintenance Phase|Protocol Violation|6
6942978|NCT00955357|10979605|FG000|Maintenance Phase|Lost to Follow-up|2
6942979|NCT00955357|10979606|FG001|Maintenance Phase|Lost to Follow-up|7
6942980|NCT00955357|10979605|FG000|Maintenance Phase|Withdrawal by Subject|4
6942981|NCT00955357|10979606|FG001|Maintenance Phase|Withdrawal by Subject|4
6942982|NCT00955357|10979605|FG000|Maintenance Phase|Patient moving out of area|0
6942983|NCT00955357|10979606|FG001|Maintenance Phase|Patient moving out of area|1
6942984|NCT00955357|10979605|FG000|Maintenance Phase|Non compliance to study procedures|1
6942985|NCT00955357|10979606|FG001|Maintenance Phase|Non compliance to study procedures|0
6942986|NCT00955409|10979622|FG000|Overall Study|Lack of Efficacy|1
6942987|NCT00955409|10979623|FG001|Overall Study|Lack of Efficacy|0
6942988|NCT00955409|10979624|FG002|Overall Study|Lack of Efficacy|0
6942989|NCT00955409|10979625|FG003|Overall Study|Lack of Efficacy|0
6942990|NCT00955409|10979626|FG004|Overall Study|Lack of Efficacy|0
6942991|NCT00955409|10979627|FG005|Overall Study|Lack of Efficacy|0
6942992|NCT00955409|10979628|FG006|Overall Study|Lack of Efficacy|0
6942993|NCT00955409|10979629|FG007|Overall Study|Lack of Efficacy|0
6942994|NCT00955409|10979630|FG008|Overall Study|Lack of Efficacy|0
6942995|NCT00955409|10979631|FG009|Overall Study|Lack of Efficacy|0
6942996|NCT00955409|10979622|FG000|Overall Study|Withdrawal by Subject|1
6942997|NCT00955409|10979623|FG001|Overall Study|Withdrawal by Subject|0
6942998|NCT00955409|10979624|FG002|Overall Study|Withdrawal by Subject|5
6942999|NCT00955409|10979625|FG003|Overall Study|Withdrawal by Subject|2
6943000|NCT00955409|10979626|FG004|Overall Study|Withdrawal by Subject|0
6943001|NCT00955409|10979627|FG005|Overall Study|Withdrawal by Subject|0
6943002|NCT00955409|10979628|FG006|Overall Study|Withdrawal by Subject|2
6943003|NCT00955409|10979629|FG007|Overall Study|Withdrawal by Subject|0
6943004|NCT00955409|10979630|FG008|Overall Study|Withdrawal by Subject|1
6943005|NCT00955409|10979631|FG009|Overall Study|Withdrawal by Subject|0
6943006|NCT00955409|10979622|FG000|Overall Study|Caregiver Request|2
6943007|NCT00955409|10979623|FG001|Overall Study|Caregiver Request|0
6943008|NCT00955409|10979624|FG002|Overall Study|Caregiver Request|6
6943009|NCT00955409|10979625|FG003|Overall Study|Caregiver Request|5
6943010|NCT00955409|10979626|FG004|Overall Study|Caregiver Request|0
6943011|NCT00955409|10979627|FG005|Overall Study|Caregiver Request|2
6943012|NCT00955409|10979628|FG006|Overall Study|Caregiver Request|3
6943013|NCT00955409|10979629|FG007|Overall Study|Caregiver Request|1
6943014|NCT00955409|10979630|FG008|Overall Study|Caregiver Request|3
6943015|NCT00955409|10979631|FG009|Overall Study|Caregiver Request|0
6943016|NCT00955409|10979622|FG000|Overall Study|Investigator Request|0
6943017|NCT00955409|10979623|FG001|Overall Study|Investigator Request|0
6943018|NCT00955409|10979624|FG002|Overall Study|Investigator Request|1
6943019|NCT00955409|10979625|FG003|Overall Study|Investigator Request|0
6943020|NCT00955409|10979626|FG004|Overall Study|Investigator Request|0
6943021|NCT00955409|10979627|FG005|Overall Study|Investigator Request|0
6943022|NCT00955409|10979628|FG006|Overall Study|Investigator Request|0
6943023|NCT00955409|10979629|FG007|Overall Study|Investigator Request|0
6943024|NCT00955409|10979630|FG008|Overall Study|Investigator Request|0
6943025|NCT00955409|10979631|FG009|Overall Study|Investigator Request|0
6943026|NCT00955409|10979622|FG000|Overall Study|Discontinuation of Study by Sponsor|0
6943027|NCT00955409|10979623|FG001|Overall Study|Discontinuation of Study by Sponsor|0
6943028|NCT00955409|10979624|FG002|Overall Study|Discontinuation of Study by Sponsor|0
6943029|NCT00955409|10979625|FG003|Overall Study|Discontinuation of Study by Sponsor|0
6943030|NCT00955409|10979626|FG004|Overall Study|Discontinuation of Study by Sponsor|0
6943031|NCT00955409|10979627|FG005|Overall Study|Discontinuation of Study by Sponsor|0
6943032|NCT00955409|10979628|FG006|Overall Study|Discontinuation of Study by Sponsor|0
6943033|NCT00955409|10979629|FG007|Overall Study|Discontinuation of Study by Sponsor|1
6943034|NCT00955409|10979630|FG008|Overall Study|Discontinuation of Study by Sponsor|0
6943035|NCT00955409|10979631|FG009|Overall Study|Discontinuation of Study by Sponsor|0
6943036|NCT00955409|10979622|FG000|Overall Study|Lost to Follow-up|0
6943037|NCT00955409|10979623|FG001|Overall Study|Lost to Follow-up|0
6943038|NCT00955409|10979624|FG002|Overall Study|Lost to Follow-up|1
6943039|NCT00955409|10979625|FG003|Overall Study|Lost to Follow-up|0
6943040|NCT00955409|10979626|FG004|Overall Study|Lost to Follow-up|0
6943041|NCT00955409|10979627|FG005|Overall Study|Lost to Follow-up|0
6943042|NCT00955409|10979628|FG006|Overall Study|Lost to Follow-up|1
6943043|NCT00955409|10979629|FG007|Overall Study|Lost to Follow-up|0
6943044|NCT00955409|10979630|FG008|Overall Study|Lost to Follow-up|0
6943045|NCT00955409|10979631|FG009|Overall Study|Lost to Follow-up|0
6943046|NCT00955409|10979622|FG000|Overall Study|Failed to Return|2
6943047|NCT00955409|10979623|FG001|Overall Study|Failed to Return|0
6943048|NCT00955409|10979624|FG002|Overall Study|Failed to Return|0
6943049|NCT00955409|10979625|FG003|Overall Study|Failed to Return|0
6943050|NCT00955409|10979626|FG004|Overall Study|Failed to Return|0
6943051|NCT00955409|10979627|FG005|Overall Study|Failed to Return|0
6943052|NCT00955409|10979628|FG006|Overall Study|Failed to Return|0
6943053|NCT00955409|10979629|FG007|Overall Study|Failed to Return|2
6943054|NCT00955409|10979630|FG008|Overall Study|Failed to Return|0
6943055|NCT00955409|10979631|FG009|Overall Study|Failed to Return|0
6943056|NCT00955409|10979622|FG000|Overall Study|Adverse Event (AE)|2
6943057|NCT00955409|10979623|FG001|Overall Study|Adverse Event (AE)|0
6943058|NCT00955409|10979624|FG002|Overall Study|Adverse Event (AE)|0
6943059|NCT00955409|10979625|FG003|Overall Study|Adverse Event (AE)|0
6943060|NCT00955409|10979626|FG004|Overall Study|Adverse Event (AE)|0
6943061|NCT00955409|10979627|FG005|Overall Study|Adverse Event (AE)|1
6943062|NCT00955409|10979628|FG006|Overall Study|Adverse Event (AE)|2
6943063|NCT00955409|10979629|FG007|Overall Study|Adverse Event (AE)|0
6943064|NCT00955409|10979630|FG008|Overall Study|Adverse Event (AE)|2
6943065|NCT00955409|10979631|FG009|Overall Study|Adverse Event (AE)|0
6943066|NCT00955409|10979622|FG000|Overall Study|Reason not Specified|2
6943067|NCT00955409|10979623|FG001|Overall Study|Reason not Specified|1
6943068|NCT00955409|10979624|FG002|Overall Study|Reason not Specified|13
6943069|NCT00955409|10979625|FG003|Overall Study|Reason not Specified|1
6943070|NCT00955409|10979626|FG004|Overall Study|Reason not Specified|2
6943071|NCT00955409|10979627|FG005|Overall Study|Reason not Specified|0
6943072|NCT00955409|10979628|FG006|Overall Study|Reason not Specified|16
6943073|NCT00955409|10979629|FG007|Overall Study|Reason not Specified|0
6943074|NCT00955409|10979630|FG008|Overall Study|Reason not Specified|8
6943075|NCT00955409|10979631|FG009|Overall Study|Reason not Specified|1
6943076|NCT00955474|10979659|FG000|Overall Study|Physician Decision|7
6943077|NCT00955474|10979660|FG001|Overall Study|Physician Decision|5
6943078|NCT00955617|10979700|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2
6943079|NCT00955617|10979701|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1
6943080|NCT00955617|10979700|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0
6943081|NCT00955617|10979701|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1
6943082|NCT00955617|10979700|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0
6943083|NCT00955617|10979701|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1
6943084|NCT00955617|10979700|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1
7067614|NCT01987817|11168796|FG001|Overall Study|Adverse Event|0
7067615|NCT01987817|11168795|FG000|Overall Study|Withdrawal by Subject|1
7067616|NCT01987817|11168796|FG001|Overall Study|Withdrawal by Subject|1
7067617|NCT01987817|11168795|FG000|Overall Study|Physician Decision|1
7067618|NCT01987817|11168796|FG001|Overall Study|Physician Decision|0
7067619|NCT01987830|11168803|FG000|Overall Study|Never received baseline scan|1
6943085|NCT00955617|10979701|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0
6943086|NCT00955682|10979709|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1
6943087|NCT00955682|10979710|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1
6943088|NCT00955708|10979724|FG000|Overall Study|Death|269
6943089|NCT00955708|10979724|FG000|Overall Study|Lost to Follow-up|72
6943090|NCT00955708|10979724|FG000|Overall Study|Physician Decision|36
6943091|NCT00955708|10979724|FG000|Overall Study|Protocol Violation|134
6943092|NCT00955708|10979724|FG000|Overall Study|Registry Conclusion|186
6943093|NCT00955708|10979724|FG000|Overall Study|Product removed from service|94
6943094|NCT00955708|10979724|FG000|Overall Study|Patient Refused to participate further|116
6943095|NCT00955708|10979724|FG000|Overall Study|Closure of study location|60
6943096|NCT00955708|10979724|FG000|Overall Study|Patient changed care provider/moved|91
6943097|NCT00955721|10979730|FG000|Overall Study|Physician Decision|1
6943098|NCT00955721|10979731|FG001|Overall Study|Physician Decision|0
6943099|NCT00955721|10979730|FG000|Overall Study|Death|1
6943100|NCT00955721|10979731|FG001|Overall Study|Death|0
6943101|NCT00955721|10979730|FG000|Overall Study|Withdrawal by Subject|1
6943102|NCT00955721|10979731|FG001|Overall Study|Withdrawal by Subject|0
6943103|NCT00955825|10979749|FG000|Overall Study|Adverse Event|15
6943104|NCT00955825|10979750|FG001|Overall Study|Adverse Event|2
6943105|NCT00955825|10979749|FG000|Overall Study|Withdrawal by Subject|4
6943106|NCT00955825|10979750|FG001|Overall Study|Withdrawal by Subject|6
6943107|NCT00955825|10979749|FG000|Overall Study|Any other reason not above-mentioned|7
6943108|NCT00955825|10979750|FG001|Overall Study|Any other reason not above-mentioned|9
6943109|NCT00955955|10979789|FG000|Overall Study|Lost to Follow-up|2
6943110|NCT00955955|10979790|FG001|Overall Study|Lost to Follow-up|0
6943111|NCT00955955|10979791|FG002|Overall Study|Lost to Follow-up|0
6943112|NCT00955968|10979807|FG000|Overall Study|Death|2
6943113|NCT00955968|10979808|FG001|Overall Study|Death|4
6943114|NCT00955968|10979807|FG000|Overall Study|Withdrawal by Subject|35
6943115|NCT00955968|10979808|FG001|Overall Study|Withdrawal by Subject|31
6943116|NCT00955968|10979807|FG000|Overall Study|Lost to Follow-up|45
6943117|NCT00955968|10979808|FG001|Overall Study|Lost to Follow-up|39
6943118|NCT00955968|10979807|FG000|Overall Study|Site closed|55
6943119|NCT00955968|10979808|FG001|Overall Study|Site closed|52
6943120|NCT00956293|10979842|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0
6943121|NCT00956293|10979843|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0
6943122|NCT00956293|10979844|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1
6943123|NCT00956293|10979842|FG000|Main Period (Pre-randomization)|Death|0
6943124|NCT00956293|10979843|FG001|Main Period (Pre-randomization)|Death|0
6943125|NCT00956293|10979844|FG002|Main Period (Pre-randomization)|Death|1
6943126|NCT00956293|10979842|FG000|Main Period (Pre-randomization)|Protocol Violation|0
6943127|NCT00956293|10979843|FG001|Main Period (Pre-randomization)|Protocol Violation|0
6943128|NCT00956293|10979844|FG002|Main Period (Pre-randomization)|Protocol Violation|1
6943129|NCT00956293|10979842|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0
6943130|NCT00956293|10979843|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0
6943131|NCT00956293|10979844|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2
6943132|NCT00956293|10979842|FG000|Main Period (Pre-randomization)|Administrative problems|0
6943133|NCT00956293|10979843|FG001|Main Period (Pre-randomization)|Administrative problems|0
6943134|NCT00956293|10979844|FG002|Main Period (Pre-randomization)|Administrative problems|6
6943135|NCT00956293|10979842|FG000|Main Period (Pre-randomization)|Graft loss|0
6943136|NCT00956293|10979843|FG001|Main Period (Pre-randomization)|Graft loss|0
6943137|NCT00956293|10979844|FG002|Main Period (Pre-randomization)|Graft loss|7
6943138|NCT00956293|10979842|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0
6943139|NCT00956293|10979843|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0
6943140|NCT00956293|10979844|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12
6943141|NCT00956293|10979842|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0
6943142|NCT00956293|10979843|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0
6943143|NCT00956293|10979844|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20
6943144|NCT00956293|10979842|FG000|Main Period (Pre-randomization)|Adverse Event|0
6943145|NCT00956293|10979843|FG001|Main Period (Pre-randomization)|Adverse Event|0
6943146|NCT00956293|10979844|FG002|Main Period (Pre-randomization)|Adverse Event|36
6943147|NCT00956293|10979842|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0
6943148|NCT00956293|10979843|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0
6943149|NCT00956293|10979844|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44
6943150|NCT00956293|10979842|FG000|Main Period (Randomization)|Abnormal laboratory value|0
6943151|NCT00956293|10979843|FG001|Main Period (Randomization)|Abnormal laboratory value|2
6943152|NCT00956293|10979844|FG002|Main Period (Randomization)|Abnormal laboratory value|0
6943153|NCT00956293|10979842|FG000|Main Period (Randomization)|Lack of Efficacy|1
6943154|NCT00956293|10979843|FG001|Main Period (Randomization)|Lack of Efficacy|10
6943155|NCT00956293|10979844|FG002|Main Period (Randomization)|Lack of Efficacy|0
6943156|NCT00956293|10979842|FG000|Main Period (Randomization)|Adverse Event|0
6943157|NCT00956293|10979843|FG001|Main Period (Randomization)|Adverse Event|15
6943158|NCT00956293|10979844|FG002|Main Period (Randomization)|Adverse Event|0
6943159|NCT00956293|10979842|FG000|Follow-up Period|Follow-up period was terminated.|20
6943160|NCT00956293|10979843|FG001|Follow-up Period|Follow-up period was terminated.|32
6943161|NCT00956293|10979844|FG002|Follow-up Period|Follow-up period was terminated.|0
6943162|NCT00956592|10979869|FG000|Overall Study|Protocol Violation|1
6943163|NCT00956592|10979870|FG001|Overall Study|Protocol Violation|3
6943164|NCT00956813|10979909|FG000|Flaxseed and Placebo|Withdrawal by Subject|5
6943165|NCT00956813|10979910|FG001|Flaxseed and Placebo|Withdrawal by Subject|4
6943166|NCT00956813|10979909|FG000|Flaxseed and Placebo|Ineligible|3
6943167|NCT00956813|10979910|FG001|Flaxseed and Placebo|Ineligible|1
6943168|NCT00956839|10979920|FG000|Overall Study|Lost to Follow-up|3
6943169|NCT00956839|10979921|FG001|Overall Study|Lost to Follow-up|0
6943170|NCT00956839|10979922|FG002|Overall Study|Lost to Follow-up|3
6943171|NCT00956943|10979943|FG000|Overall Study|Lost to Follow-up|9
6943172|NCT00956943|10979944|FG001|Overall Study|Lost to Follow-up|10
6943173|NCT00957008|10979954|FG000|Overall Study|Withdrawal by Subject|13
6943174|NCT00957008|10979955|FG001|Overall Study|Withdrawal by Subject|10
6943175|NCT00957008|10979956|FG002|Overall Study|Withdrawal by Subject|12
6943176|NCT00957008|10979957|FG003|Overall Study|Withdrawal by Subject|16
6943177|NCT00957008|10979954|FG000|Overall Study|Lost to Follow-up|3
6943178|NCT00957008|10979955|FG001|Overall Study|Lost to Follow-up|1
6943179|NCT00957008|10979956|FG002|Overall Study|Lost to Follow-up|3
6943180|NCT00957008|10979957|FG003|Overall Study|Lost to Follow-up|4
6943181|NCT00957008|10979954|FG000|Overall Study|Physician Decision|1
6943182|NCT00957008|10979955|FG001|Overall Study|Physician Decision|0
6943183|NCT00957008|10979956|FG002|Overall Study|Physician Decision|1
6943184|NCT00957008|10979957|FG003|Overall Study|Physician Decision|1
6943185|NCT00957008|10979954|FG000|Overall Study|Relocated; Family conflict|4
6943186|NCT00957008|10979955|FG001|Overall Study|Relocated; Family conflict|1
6943187|NCT00957008|10979956|FG002|Overall Study|Relocated; Family conflict|1
6943188|NCT00957008|10979957|FG003|Overall Study|Relocated; Family conflict|3
6975679|NCT01194245|11027898|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
6975680|NCT01194245|11027899|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
6975681|NCT01194245|11027900|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
6975682|NCT01194245|11027901|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
6975683|NCT01194245|11027897|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
6975684|NCT01194245|11027898|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
6975685|NCT01194245|11027899|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
6975686|NCT01194245|11027900|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
6975687|NCT01194245|11027901|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1
6975688|NCT01194245|11027897|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
6975689|NCT01194245|11027898|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
6975690|NCT01194245|11027899|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
6975691|NCT01194245|11027900|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
6975692|NCT01194245|11027901|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
6975693|NCT01194258|11027910|FG000|Titration Period|Withdrawal by Subject|6
6975694|NCT01194258|11027911|FG001|Titration Period|Withdrawal by Subject|0
6975695|NCT01194258|11027912|FG002|Titration Period|Withdrawal by Subject|0
6975696|NCT01194258|11027913|FG003|Titration Period|Withdrawal by Subject|0
6975697|NCT01194258|11027914|FG004|Titration Period|Withdrawal by Subject|0
6975698|NCT01194258|11027910|FG000|Titration Period|Lost to Follow-up|2
7040638|NCT01719003|11123729|FG004|Overall Study|Adverse Event|4
7040639|NCT01719003|11123730|FG005|Overall Study|Adverse Event|3
7040640|NCT01719003|11123731|FG006|Overall Study|Adverse Event|6
7040641|NCT01719003|11123732|FG007|Overall Study|Adverse Event|5
7040642|NCT01719003|11123733|FG008|Overall Study|Adverse Event|0
7040643|NCT01719003|11123725|FG000|Overall Study|Lost to Follow-up|0
7040644|NCT01719003|11123726|FG001|Overall Study|Lost to Follow-up|6
7040645|NCT01719003|11123727|FG002|Overall Study|Lost to Follow-up|7
7040646|NCT01719003|11123728|FG003|Overall Study|Lost to Follow-up|2
7040647|NCT01719003|11123729|FG004|Overall Study|Lost to Follow-up|3
7040648|NCT01719003|11123730|FG005|Overall Study|Lost to Follow-up|4
7040649|NCT01719003|11123731|FG006|Overall Study|Lost to Follow-up|3
7040650|NCT01719003|11123732|FG007|Overall Study|Lost to Follow-up|2
7040651|NCT01719003|11123733|FG008|Overall Study|Lost to Follow-up|2
7040652|NCT01719003|11123725|FG000|Overall Study|Refusal to continue, not due to AE|2
7040653|NCT01719003|11123726|FG001|Overall Study|Refusal to continue, not due to AE|5
7040654|NCT01719003|11123727|FG002|Overall Study|Refusal to continue, not due to AE|4
7040655|NCT01719003|11123728|FG003|Overall Study|Refusal to continue, not due to AE|4
7040656|NCT01719003|11123729|FG004|Overall Study|Refusal to continue, not due to AE|4
6975699|NCT01194258|11027911|FG001|Titration Period|Lost to Follow-up|0
6975700|NCT01194258|11027912|FG002|Titration Period|Lost to Follow-up|0
6975701|NCT01194258|11027913|FG003|Titration Period|Lost to Follow-up|0
6975702|NCT01194258|11027914|FG004|Titration Period|Lost to Follow-up|0
6975703|NCT01194258|11027910|FG000|Titration Period|Titration failure|3
6975704|NCT01194258|11027911|FG001|Titration Period|Titration failure|0
6975705|NCT01194258|11027912|FG002|Titration Period|Titration failure|0
6975706|NCT01194258|11027913|FG003|Titration Period|Titration failure|0
6975707|NCT01194258|11027914|FG004|Titration Period|Titration failure|0
6975708|NCT01194258|11027910|FG000|Period 1 (12 Weeks)|Death|0
6975709|NCT01194258|11027911|FG001|Period 1 (12 Weeks)|Death|0
6975710|NCT01194258|11027912|FG002|Period 1 (12 Weeks)|Death|0
7040657|NCT01719003|11123730|FG005|Overall Study|Refusal to continue, not due to AE|3
7040658|NCT01719003|11123731|FG006|Overall Study|Refusal to continue, not due to AE|8
7040659|NCT01719003|11123732|FG007|Overall Study|Refusal to continue, not due to AE|7
7040660|NCT01719003|11123733|FG008|Overall Study|Refusal to continue, not due to AE|1
7040661|NCT01719003|11123725|FG000|Overall Study|Reason other than those specified|0
6943189|NCT00957021|10979971|FG000|Overall Study|Death|5
6943190|NCT00957021|10979971|FG000|Overall Study|Lost to Follow-up|8
6943191|NCT00957021|10979971|FG000|Overall Study|Withdrawal by Subject|34
6943192|NCT00957021|10979971|FG000|Overall Study|No 2 yr ROM data|35
6943193|NCT00957021|10979971|FG000|Overall Study|Revised study component by 2 yr visit|8
6943194|NCT00957021|10979971|FG000|Overall Study|Site Termination by the 2 yr visit|16
6943195|NCT00957021|10979971|FG000|Overall Study|Surgery Cancelled|9
6943196|NCT00957021|10979971|FG000|Overall Study|Termination due to language issue|2
6943197|NCT00957229|10980004|FG000|Study Start|Adverse Event|0
6943198|NCT00957229|10980005|FG001|Study Start|Adverse Event|3
6943199|NCT00957229|10980004|FG000|Study Start|Disease Progression|1
6943200|NCT00957229|10980005|FG001|Study Start|Disease Progression|0
6943201|NCT00957229|10980004|FG000|Reallocated to or Continued Vismodegib|Death|1
6943202|NCT00957229|10980005|FG001|Reallocated to or Continued Vismodegib|Death|1
6943203|NCT00957229|10980004|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2
6943204|NCT00957229|10980005|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1
6943205|NCT00957268|10980027|FG000|Overall Study|Voluntary Withdrawal|0
6943206|NCT00957268|10980028|FG001|Overall Study|Voluntary Withdrawal|0
6943207|NCT00957268|10980029|FG002|Overall Study|Voluntary Withdrawal|1
6943208|NCT00957268|10980030|FG003|Overall Study|Voluntary Withdrawal|0
6943209|NCT00957268|10980031|FG004|Overall Study|Voluntary Withdrawal|0
6943210|NCT00957372|10980059|FG000|PART I|Lost to Follow-up|0
6943211|NCT00957372|10980060|FG001|PART I|Lost to Follow-up|0
6943212|NCT00957372|10980061|FG002|PART I|Lost to Follow-up|1
6943213|NCT00957372|10980062|FG003|PART I|Lost to Follow-up|0
6943214|NCT00957372|10980059|FG000|PART II|Withdrawal by Subject|0
6943215|NCT00957372|10980060|FG001|PART II|Withdrawal by Subject|0
6943216|NCT00957372|10980061|FG002|PART II|Withdrawal by Subject|0
6943217|NCT00957372|10980062|FG003|PART II|Withdrawal by Subject|8
6943218|NCT00957372|10980059|FG000|PART II|Physician Decision|0
6943219|NCT00957372|10980060|FG001|PART II|Physician Decision|0
6943220|NCT00957372|10980061|FG002|PART II|Physician Decision|0
6943221|NCT00957372|10980062|FG003|PART II|Physician Decision|1
6943222|NCT00957372|10980059|FG000|PART II|Pregnancy|0
6943223|NCT00957372|10980060|FG001|PART II|Pregnancy|0
6943224|NCT00957372|10980061|FG002|PART II|Pregnancy|0
6943225|NCT00957372|10980062|FG003|PART II|Pregnancy|1
6943226|NCT00957372|10980059|FG000|PART II|Not Know|0
6943227|NCT00957372|10980060|FG001|PART II|Not Know|0
6943228|NCT00957372|10980061|FG002|PART II|Not Know|0
6943229|NCT00957372|10980062|FG003|PART II|Not Know|20
6943230|NCT00957372|10980059|FG000|PART II|Adverse Event|0
6943231|NCT00957372|10980060|FG001|PART II|Adverse Event|0
6943232|NCT00957372|10980061|FG002|PART II|Adverse Event|0
6943233|NCT00957372|10980062|FG003|PART II|Adverse Event|10
6943234|NCT00957372|10980059|FG000|PART II|Patient non-compliance|0
6943235|NCT00957372|10980060|FG001|PART II|Patient non-compliance|0
6943236|NCT00957372|10980061|FG002|PART II|Patient non-compliance|0
6943237|NCT00957372|10980062|FG003|PART II|Patient non-compliance|4
6943238|NCT00957424|10980078|FG000|Overall Study|Lost to Follow-up|19
6943239|NCT00957424|10980078|FG000|Overall Study|Protocol Violation|3
6943240|NCT00957424|10980078|FG000|Overall Study|Withdrawal by Subject|1
6943241|NCT00957528|10980085|FG000|Overall Study|Protocol Violation|0
6943242|NCT00957528|10980086|FG001|Overall Study|Protocol Violation|1
6943243|NCT00957528|10980087|FG002|Overall Study|Protocol Violation|0
6943244|NCT00957528|10980085|FG000|Overall Study|Withdrawal by Subject|0
6943245|NCT00957528|10980086|FG001|Overall Study|Withdrawal by Subject|0
6943246|NCT00957528|10980087|FG002|Overall Study|Withdrawal by Subject|1
6943247|NCT00957580|10980098|FG000|Overall Study|Ongoing at data cut-off|0
6943248|NCT00957580|10980099|FG001|Overall Study|Ongoing at data cut-off|1
6943249|NCT00957580|10980100|FG002|Overall Study|Ongoing at data cut-off|0
6943250|NCT00957580|10980098|FG000|Overall Study|Enrolled but not treated|0
6943251|NCT00957580|10980099|FG001|Overall Study|Enrolled but not treated|1
6943252|NCT00957580|10980100|FG002|Overall Study|Enrolled but not treated|0
6943253|NCT00957658|10980132|FG000|Overall Study|Death|1
6943254|NCT00957658|10980132|FG000|Overall Study|Lost to Follow-up|4
6943255|NCT00957658|10980132|FG000|Overall Study|Withdrawal by Subject|12
6943256|NCT00957658|10980132|FG000|Overall Study|Revision|1
6943257|NCT00957658|10980132|FG000|Overall Study|Incomplete 2 yr data|28
6943258|NCT00957658|10980132|FG000|Overall Study|Site termination|10
6943259|NCT00957658|10980132|FG000|Overall Study|unwilling/unable to return|2
6943260|NCT00957658|10980132|FG000|Overall Study|surgery cancelled|2
6943261|NCT00957658|10980132|FG000|Overall Study|Protocol Violation|5
6943262|NCT00957723|10980161|FG000|Overall Study|Death|3
6943263|NCT00957723|10980161|FG000|Overall Study|Revision/ Removal of Study Implant|3
6943264|NCT00957723|10980161|FG000|Overall Study|Lost to Follow-up|8
6943265|NCT00957723|10980161|FG000|Overall Study|Withdrawal by Subject|24
6943266|NCT00957723|10980161|FG000|Overall Study|Investigative Site Terminated|61
6943267|NCT00957723|10980161|FG000|Overall Study|Intercurrent Illness|2
6943268|NCT00957723|10980161|FG000|Overall Study|2yr ROM Data Not Evaluable|12
6943269|NCT00957801|10980171|FG000|Overall Study|Withdrawal by Subject|0
6943270|NCT00957801|10980172|FG001|Overall Study|Withdrawal by Subject|0
6943271|NCT00957801|10980173|FG002|Overall Study|Withdrawal by Subject|0
6943272|NCT00957801|10980174|FG003|Overall Study|Withdrawal by Subject|1
6943273|NCT00957853|10980187|FG000|Overall Study|Withdrawal by Subject|1
6943274|NCT00957853|10980188|FG001|Overall Study|Withdrawal by Subject|0
6943275|NCT00957853|10980189|FG002|Overall Study|Withdrawal by Subject|0
6943276|NCT00957905|10980199|FG000|Part B|Not Treated|0
6943277|NCT00957905|10980200|FG001|Part B|Not Treated|1
6943278|NCT00957905|10980199|FG000|Part B|Physician Decision|0
6943279|NCT00957905|10980200|FG001|Part B|Physician Decision|1
6943280|NCT00957905|10980199|FG000|Part B|Death|0
6943281|NCT00957905|10980200|FG001|Part B|Death|1
6943282|NCT00957905|10980199|FG000|Part B|Protocol Violation|0
6943283|NCT00957905|10980200|FG001|Part B|Protocol Violation|1
6943284|NCT00957931|10980206|FG000|Overall Study|Death|4
6943285|NCT00957944|10980212|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0
6943286|NCT00957944|10980213|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1
6943287|NCT00957996|10980221|FG000|Overall Study|Death|4
6943288|NCT00957996|10980222|FG001|Overall Study|Death|10
7067620|NCT01987895|11168809|FG000|Overall Study|Withdrawal by Subject|12
6943289|NCT00957996|10980221|FG000|Overall Study|Lost to Follow-up|4
6943290|NCT00957996|10980222|FG001|Overall Study|Lost to Follow-up|7
6943291|NCT00957996|10980221|FG000|Overall Study|Withdrawal by Subject|9
6943292|NCT00957996|10980222|FG001|Overall Study|Withdrawal by Subject|2
6943293|NCT00957996|10980221|FG000|Overall Study|Adverse Event|2
7067621|NCT01987895|11168810|FG001|Overall Study|Withdrawal by Subject|7
7067622|NCT01987895|11168809|FG000|Overall Study|Physician Decision|8
6943294|NCT00957996|10980222|FG001|Overall Study|Adverse Event|1
6943295|NCT00957996|10980221|FG000|Overall Study|Physician Decision|1
6943296|NCT00957996|10980222|FG001|Overall Study|Physician Decision|1
6943297|NCT00957996|10980221|FG000|Overall Study|Influenza-related complication|0
6943298|NCT00957996|10980222|FG001|Overall Study|Influenza-related complication|1
6943299|NCT00957996|10980221|FG000|Overall Study|Missing|1
6943300|NCT00957996|10980222|FG001|Overall Study|Missing|0
6943301|NCT00957996|10980221|FG000|Overall Study|Noncompliance; Protocol Deviations|5
6943302|NCT00957996|10980222|FG001|Overall Study|Noncompliance; Protocol Deviations|6
6943303|NCT00958009|10980230|FG000|Overall Study|Adverse Event|1
6943304|NCT00958009|10980230|FG000|Overall Study|Subject found device difficult to use|1
6943305|NCT00958074|10980245|FG000|Overall Study|Withdrawal by Subject|0
6943306|NCT00958074|10980246|FG001|Overall Study|Withdrawal by Subject|1
6943307|NCT00958126|10980260|FG000|Overall Study|Serious Adverse Event|0
6943308|NCT00958126|10980261|FG001|Overall Study|Serious Adverse Event|2
6943309|NCT00958126|10980262|FG002|Overall Study|Serious Adverse Event|0
6943310|NCT00958126|10980263|FG003|Overall Study|Serious Adverse Event|0
6943311|NCT00958126|10980264|FG004|Overall Study|Serious Adverse Event|0
6943312|NCT00958126|10980265|FG005|Overall Study|Serious Adverse Event|0
6943313|NCT00958126|10980266|FG006|Overall Study|Serious Adverse Event|1
6943314|NCT00958126|10980267|FG007|Overall Study|Serious Adverse Event|0
6943315|NCT00958126|10980260|FG000|Overall Study|Withdrawal by Subject|0
6943316|NCT00958126|10980261|FG001|Overall Study|Withdrawal by Subject|2
6943317|NCT00958126|10980262|FG002|Overall Study|Withdrawal by Subject|0
6943318|NCT00958126|10980263|FG003|Overall Study|Withdrawal by Subject|0
6943319|NCT00958126|10980264|FG004|Overall Study|Withdrawal by Subject|0
6943320|NCT00958126|10980265|FG005|Overall Study|Withdrawal by Subject|0
6943321|NCT00958126|10980266|FG006|Overall Study|Withdrawal by Subject|0
6943322|NCT00958126|10980267|FG007|Overall Study|Withdrawal by Subject|0
6943323|NCT00958126|10980260|FG000|Overall Study|Moved away from study area|0
6943324|NCT00958126|10980261|FG001|Overall Study|Moved away from study area|0
6943325|NCT00958126|10980262|FG002|Overall Study|Moved away from study area|1
6943326|NCT00958126|10980263|FG003|Overall Study|Moved away from study area|1
6943327|NCT00958126|10980264|FG004|Overall Study|Moved away from study area|0
6943328|NCT00958126|10980265|FG005|Overall Study|Moved away from study area|0
6943329|NCT00958126|10980266|FG006|Overall Study|Moved away from study area|0
6943330|NCT00958126|10980267|FG007|Overall Study|Moved away from study area|0
6943331|NCT00958126|10980260|FG000|Overall Study|Lost to Follow-up|1
6943332|NCT00958126|10980261|FG001|Overall Study|Lost to Follow-up|5
6943333|NCT00958126|10980262|FG002|Overall Study|Lost to Follow-up|9
6943334|NCT00958126|10980263|FG003|Overall Study|Lost to Follow-up|8
6943335|NCT00958126|10980264|FG004|Overall Study|Lost to Follow-up|0
6943336|NCT00958126|10980265|FG005|Overall Study|Lost to Follow-up|0
6943337|NCT00958126|10980266|FG006|Overall Study|Lost to Follow-up|0
6943338|NCT00958126|10980267|FG007|Overall Study|Lost to Follow-up|0
6943339|NCT00958126|10980260|FG000|Overall Study|Sponsor/Investigator decision|0
6943340|NCT00958126|10980261|FG001|Overall Study|Sponsor/Investigator decision|0
6943341|NCT00958126|10980262|FG002|Overall Study|Sponsor/Investigator decision|0
7067623|NCT01987895|11168810|FG001|Overall Study|Physician Decision|10
6943342|NCT00958126|10980263|FG003|Overall Study|Sponsor/Investigator decision|1
6943343|NCT00958126|10980264|FG004|Overall Study|Sponsor/Investigator decision|0
6943344|NCT00958126|10980265|FG005|Overall Study|Sponsor/Investigator decision|0
6943345|NCT00958126|10980266|FG006|Overall Study|Sponsor/Investigator decision|0
6943346|NCT00958126|10980267|FG007|Overall Study|Sponsor/Investigator decision|0
6943347|NCT00958126|10980260|FG000|Overall Study|Other Reason|0
6943348|NCT00958126|10980261|FG001|Overall Study|Other Reason|0
6943349|NCT00958126|10980262|FG002|Overall Study|Other Reason|0
6943350|NCT00958126|10980263|FG003|Overall Study|Other Reason|1
6943351|NCT00958126|10980264|FG004|Overall Study|Other Reason|0
6943352|NCT00958126|10980265|FG005|Overall Study|Other Reason|1
6943353|NCT00958126|10980266|FG006|Overall Study|Other Reason|0
6943354|NCT00958126|10980267|FG007|Overall Study|Other Reason|0
6943355|NCT00958165|10980289|FG000|Overall Study|Lost to Follow-up|5
6943356|NCT00958165|10980289|FG000|Overall Study|Not eligible|9
6943357|NCT00958191|10980293|FG000|Overall Study|Death|4
6943358|NCT00958191|10980293|FG000|Overall Study|Lost to Follow-up|5
6943359|NCT00958191|10980293|FG000|Overall Study|Inadequate 5 yr x-ray quality|10
6943360|NCT00958191|10980293|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21
6943361|NCT00958191|10980293|FG000|Overall Study|Revision of study device|4
6943362|NCT00958191|10980293|FG000|Overall Study|Site termination|11
6943363|NCT00958191|10980293|FG000|Overall Study|No 5 yr x-rays|56
6943364|NCT00958217|10980301|FG000|Overall Study|Death|2
6943365|NCT00958217|10980302|FG001|Overall Study|Death|1
6943366|NCT00958217|10980301|FG000|Overall Study|Withdrawal by Subject|4
6943367|NCT00958217|10980302|FG001|Overall Study|Withdrawal by Subject|3
6943368|NCT00958217|10980301|FG000|Overall Study|Lost to Follow-up|17
6943369|NCT00958217|10980302|FG001|Overall Study|Lost to Follow-up|19
6943370|NCT00958217|10980301|FG000|Overall Study|Moved out of area|1
6943371|NCT00958217|10980302|FG001|Overall Study|Moved out of area|1
6943372|NCT00958217|10980301|FG000|Overall Study|Inpatient hospitalization|0
6943373|NCT00958217|10980302|FG001|Overall Study|Inpatient hospitalization|1
6943374|NCT00958243|10980315|FG000|Overall Study|Withdrawal by Subject|0
6943375|NCT00958243|10980316|FG001|Overall Study|Withdrawal by Subject|1
6943376|NCT00958243|10980317|FG002|Overall Study|Withdrawal by Subject|3
6943377|NCT00958243|10980318|FG003|Overall Study|Withdrawal by Subject|1
6943378|NCT00958243|10980319|FG004|Overall Study|Withdrawal by Subject|1
6943379|NCT00958243|10980320|FG005|Overall Study|Withdrawal by Subject|5
6943380|NCT00958243|10980315|FG000|Overall Study|Lost to Follow-up|2
6943381|NCT00958243|10980316|FG001|Overall Study|Lost to Follow-up|5
6943382|NCT00958243|10980317|FG002|Overall Study|Lost to Follow-up|11
6943383|NCT00958243|10980318|FG003|Overall Study|Lost to Follow-up|2
6943384|NCT00958243|10980319|FG004|Overall Study|Lost to Follow-up|8
6943385|NCT00958243|10980320|FG005|Overall Study|Lost to Follow-up|5
6943386|NCT00958256|10980340|FG000|Overall Study|Adverse Event|3
6943387|NCT00958360|10980381|FG000|Overall Study|Withdrawal by Subject|3
6943388|NCT00958360|10980382|FG001|Overall Study|Withdrawal by Subject|1
6943389|NCT00958360|10980381|FG000|Overall Study|Death|6
6943390|NCT00958360|10980382|FG001|Overall Study|Death|7
6943391|NCT00958360|10980381|FG000|Overall Study|Physician Decision|2
6943392|NCT00958360|10980382|FG001|Overall Study|Physician Decision|1
6943393|NCT00958360|10980381|FG000|Overall Study|Lost to Follow-up|0
6943394|NCT00958360|10980382|FG001|Overall Study|Lost to Follow-up|1
6943395|NCT00958412|10980388|FG000|Overall Study|Study prematurely terminated|18
6943396|NCT00958438|10980395|FG000|Overall Study|Protocol Violation|3
6943397|NCT00958438|10980396|FG001|Overall Study|Protocol Violation|2
6943398|NCT00958438|10980397|FG002|Overall Study|Protocol Violation|2
6943399|NCT00958438|10980395|FG000|Overall Study|Withdrawal by Subject|4
6943400|NCT00958438|10980396|FG001|Overall Study|Withdrawal by Subject|2
6943401|NCT00958438|10980397|FG002|Overall Study|Withdrawal by Subject|1
6943402|NCT00958438|10980395|FG000|Overall Study|Adverse Event|0
6943403|NCT00958438|10980396|FG001|Overall Study|Adverse Event|3
6943404|NCT00958438|10980397|FG002|Overall Study|Adverse Event|0
6943405|NCT00958438|10980395|FG000|Overall Study|Physician Decision|1
6943406|NCT00958438|10980396|FG001|Overall Study|Physician Decision|0
6943407|NCT00958438|10980397|FG002|Overall Study|Physician Decision|1
6943408|NCT00958438|10980395|FG000|Overall Study|Other than specified above|2
6943409|NCT00958438|10980396|FG001|Overall Study|Other than specified above|3
6943410|NCT00958438|10980397|FG002|Overall Study|Other than specified above|2
6943411|NCT00958568|10980428|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80
6943412|NCT00958568|10980429|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
6943413|NCT00958568|10980430|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
6943414|NCT00958568|10980431|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
6943415|NCT00958568|10980428|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44
6943416|NCT00958568|10980429|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
6943417|NCT00958568|10980430|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
6943418|NCT00958568|10980431|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
6943419|NCT00958568|10980428|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34
6943420|NCT00958568|10980429|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
6943421|NCT00958568|10980430|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
6943422|NCT00958568|10980431|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
6943423|NCT00958568|10980428|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39
6943424|NCT00958568|10980429|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
6943425|NCT00958568|10980430|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
6943426|NCT00958568|10980431|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
6943427|NCT00958568|10980428|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14
6943428|NCT00958568|10980429|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
6943429|NCT00958568|10980430|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
6943430|NCT00958568|10980431|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
6943431|NCT00958568|10980428|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13
6943432|NCT00958568|10980429|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
6943433|NCT00958568|10980430|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
6943434|NCT00958568|10980431|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
6943435|NCT00958568|10980428|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4
6943436|NCT00958568|10980429|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
6943437|NCT00958568|10980430|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
6943438|NCT00958568|10980431|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
6943439|NCT00958568|10980428|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8
6943440|NCT00958568|10980429|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
6943441|NCT00958568|10980430|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
6943442|NCT00958568|10980431|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
6943443|NCT00958568|10980428|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1
6943444|NCT00958568|10980429|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
6943445|NCT00958568|10980430|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
6943446|NCT00958568|10980431|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
6943447|NCT00958568|10980428|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
6943448|NCT00958568|10980429|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62
6943449|NCT00958568|10980430|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
6943450|NCT00958568|10980431|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
6943451|NCT00958568|10980428|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
6943452|NCT00958568|10980429|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30
6943453|NCT00958568|10980430|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
6943454|NCT00958568|10980431|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
6943455|NCT00958568|10980428|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
6943456|NCT00958568|10980429|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28
6943457|NCT00958568|10980430|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
6943458|NCT00958568|10980431|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
6943459|NCT00958568|10980428|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
6943460|NCT00958568|10980429|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41
6943461|NCT00958568|10980430|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
6943462|NCT00958568|10980431|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
6943463|NCT00958568|10980428|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
6943464|NCT00958568|10980429|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24
6943465|NCT00958568|10980430|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
6943466|NCT00958568|10980431|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
6943467|NCT00958568|10980428|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
6943468|NCT00958568|10980429|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9
6943469|NCT00958568|10980430|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
6943470|NCT00958568|10980431|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
6943471|NCT00958568|10980428|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
6943472|NCT00958568|10980429|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6
6943473|NCT00958568|10980430|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
6943474|NCT00958568|10980431|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
6943475|NCT00958568|10980428|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
6943476|NCT00958568|10980429|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5
6943477|NCT00958568|10980430|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
6943478|NCT00958568|10980431|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
6943479|NCT00958568|10980428|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
6943480|NCT00958568|10980429|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4
6943481|NCT00958568|10980430|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
6943482|NCT00958568|10980431|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
6943483|NCT00958568|10980428|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
6943484|NCT00958568|10980429|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1
6943485|NCT00958568|10980430|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
6943486|NCT00958568|10980431|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
6943487|NCT00958568|10980428|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
6943488|NCT00958568|10980429|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1
6943489|NCT00958568|10980430|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
6943490|NCT00958568|10980431|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
6943491|NCT00958568|10980428|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
6943492|NCT00958568|10980429|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
6943493|NCT00958568|10980430|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24
6943494|NCT00958568|10980431|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63
6943495|NCT00958568|10980428|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
6943496|NCT00958568|10980429|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
6943497|NCT00958568|10980430|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19
6943498|NCT00958568|10980431|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10
6943499|NCT00958568|10980428|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
6943500|NCT00958568|10980429|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
6943501|NCT00958568|10980430|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16
6943502|NCT00958568|10980431|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15
6943503|NCT00958568|10980428|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
6943504|NCT00958568|10980429|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
6943505|NCT00958568|10980430|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11
6943506|NCT00958568|10980431|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5
6943507|NCT00958568|10980428|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
6943508|NCT00958568|10980429|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
6943509|NCT00958568|10980430|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3
6943510|NCT00958568|10980431|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8
6943511|NCT00958568|10980428|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
6943512|NCT00958568|10980429|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
6943513|NCT00958568|10980430|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5
6943514|NCT00958568|10980431|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4
6943515|NCT00958568|10980428|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
6943516|NCT00958568|10980429|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
6943517|NCT00958568|10980430|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2
6943518|NCT00958568|10980431|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1
6943519|NCT00958568|10980428|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
6943520|NCT00958568|10980429|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
6943521|NCT00958568|10980430|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1
6943522|NCT00958568|10980431|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
6943523|NCT00958568|10980428|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
6943524|NCT00958568|10980429|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
6943525|NCT00958568|10980430|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1
6943526|NCT00958568|10980431|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
6943527|NCT00958711|10980460|FG000|Overall Study|Withdrawal by Subject|0
6943528|NCT00958711|10980461|FG001|Overall Study|Withdrawal by Subject|4
6943529|NCT00958711|10980460|FG000|Overall Study|Physician Decision|5
6943530|NCT00958711|10980461|FG001|Overall Study|Physician Decision|7
6943531|NCT00958711|10980460|FG000|Overall Study|Lost to Follow-up|4
6943532|NCT00958711|10980461|FG001|Overall Study|Lost to Follow-up|1
6943533|NCT00958711|10980460|FG000|Overall Study|Other|2
6943534|NCT00958711|10980461|FG001|Overall Study|Other|5
6943535|NCT00958711|10980460|FG000|Overall Study|Death|1
6943536|NCT00958711|10980461|FG001|Overall Study|Death|2
6943537|NCT00958711|10980460|FG000|Overall Study|Adverse Event|1
6943538|NCT00958711|10980461|FG001|Overall Study|Adverse Event|2
6943539|NCT00958724|10980467|FG000|Overall Study|Disease Progression|6
6943540|NCT00958776|10980473|FG000|Overall Study|Adverse Event|0
6943541|NCT00958776|10980474|FG001|Overall Study|Adverse Event|1
6943542|NCT00958776|10980473|FG000|Overall Study|Physician Decision|1
6943543|NCT00958776|10980474|FG001|Overall Study|Physician Decision|0
6943544|NCT00958776|10980473|FG000|Overall Study|Lost to Follow-up|2
6943545|NCT00958776|10980474|FG001|Overall Study|Lost to Follow-up|6
6943546|NCT00958776|10980473|FG000|Overall Study|Withdrawal by Subject|7
6943547|NCT00958776|10980474|FG001|Overall Study|Withdrawal by Subject|16
6943548|NCT00958776|10980473|FG000|Overall Study|Protocol Violation|1
6943549|NCT00958776|10980474|FG001|Overall Study|Protocol Violation|1
6943550|NCT00958776|10980473|FG000|Overall Study|Death|2
6943551|NCT00958776|10980474|FG001|Overall Study|Death|1
6943552|NCT00958776|10980473|FG000|Overall Study|Noncompliance; Protocol Deviations|2
6943553|NCT00958776|10980474|FG001|Overall Study|Noncompliance; Protocol Deviations|3
6943554|NCT00958776|10980473|FG000|Overall Study|Missing|1
6943555|NCT00958776|10980474|FG001|Overall Study|Missing|1
6943556|NCT00958789|10980481|FG000|Overall Study|Death|5
6943557|NCT00958789|10980481|FG000|Overall Study|Lost to Follow-up|14
6943558|NCT00958789|10980481|FG000|Overall Study|Withdrawal by Subject|17
6943559|NCT00958789|10980481|FG000|Overall Study|No 2 yr. Knee Society Score data|4
6943560|NCT00958789|10980481|FG000|Overall Study|2 yr. Knee Society Score not calculable|1
6943561|NCT00958789|10980481|FG000|Overall Study|Subject terminated|2
6943562|NCT00958789|10980481|FG000|Overall Study|Revision|7
6943563|NCT00958828|10980490|FG000|Period 1, 1 Week of Wear|Randomization break|0
6943564|NCT00958828|10980491|FG001|Period 1, 1 Week of Wear|Randomization break|1
6943565|NCT00958828|10980490|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0
6943566|NCT00958828|10980491|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1
6943567|NCT00958841|10980497|FG000|Overall Study|Abnormal laboratory value(s)|1
6943568|NCT00958841|10980497|FG000|Overall Study|Abnormal test procedure result(s)|3
6943569|NCT00958841|10980497|FG000|Overall Study|Administrative problems|1
6943570|NCT00958841|10980497|FG000|Overall Study|Adverse Event|8
6943571|NCT00958841|10980497|FG000|Overall Study|New cancer therapy|5
6943572|NCT00958841|10980497|FG000|Overall Study|Withdrawal by Subject|1
6943573|NCT00958841|10980497|FG000|Overall Study|Unsatisfactory therapeutic effect|22
6943574|NCT00958841|10980497|FG000|Overall Study|Completed M6/did not enter extension|27
6943575|NCT00958841|10980497|FG000|Overall Study|Discontinued prior to M*|28
6943576|NCT00958880|10980513|FG000|Overall Study|Lost to Follow-up|2
6943577|NCT00958880|10980514|FG001|Overall Study|Lost to Follow-up|2
6943578|NCT00959049|10980540|FG000|Overall Study|Adverse Event|1
6943579|NCT00959049|10980541|FG001|Overall Study|Adverse Event|0
6943580|NCT00959049|10980542|FG002|Overall Study|Adverse Event|0
6943581|NCT00959049|10980543|FG003|Overall Study|Adverse Event|0
6943582|NCT00959049|10980544|FG004|Overall Study|Adverse Event|0
6943583|NCT00959049|10980545|FG005|Overall Study|Adverse Event|0
6943584|NCT00959049|10980540|FG000|Overall Study|Lost to Follow-up|17
6943585|NCT00959049|10980541|FG001|Overall Study|Lost to Follow-up|5
6943586|NCT00959049|10980542|FG002|Overall Study|Lost to Follow-up|1
6943587|NCT00959049|10980543|FG003|Overall Study|Lost to Follow-up|10
6943588|NCT00959049|10980544|FG004|Overall Study|Lost to Follow-up|9
6943589|NCT00959049|10980545|FG005|Overall Study|Lost to Follow-up|1
6943590|NCT00959049|10980540|FG000|Overall Study|Contraindicated medication|0
6943591|NCT00959049|10980541|FG001|Overall Study|Contraindicated medication|0
6943592|NCT00959049|10980542|FG002|Overall Study|Contraindicated medication|0
6943593|NCT00959049|10980543|FG003|Overall Study|Contraindicated medication|1
6943594|NCT00959049|10980544|FG004|Overall Study|Contraindicated medication|0
6943595|NCT00959049|10980545|FG005|Overall Study|Contraindicated medication|0
6943596|NCT00959049|10980540|FG000|Overall Study|Withdrawal by Subject|0
6943597|NCT00959049|10980541|FG001|Overall Study|Withdrawal by Subject|2
6943598|NCT00959049|10980542|FG002|Overall Study|Withdrawal by Subject|0
6943599|NCT00959049|10980543|FG003|Overall Study|Withdrawal by Subject|0
6943600|NCT00959049|10980544|FG004|Overall Study|Withdrawal by Subject|0
6943601|NCT00959049|10980545|FG005|Overall Study|Withdrawal by Subject|0
6943602|NCT00959192|10980583|FG000|Overall Study|Adverse Event|1
6943603|NCT00959192|10980584|FG001|Overall Study|Adverse Event|1
6943604|NCT00959192|10980585|FG002|Overall Study|Adverse Event|1
6943605|NCT00959192|10980586|FG003|Overall Study|Adverse Event|0
6943606|NCT00959192|10980583|FG000|Overall Study|Investigator Request|1
6943607|NCT00959192|10980584|FG001|Overall Study|Investigator Request|0
6943608|NCT00959192|10980585|FG002|Overall Study|Investigator Request|0
6943609|NCT00959192|10980586|FG003|Overall Study|Investigator Request|0
6943610|NCT00959192|10980583|FG000|Overall Study|Caregiver Request|0
6943611|NCT00959192|10980584|FG001|Overall Study|Caregiver Request|0
6943612|NCT00959192|10980585|FG002|Overall Study|Caregiver Request|2
6943613|NCT00959192|10980586|FG003|Overall Study|Caregiver Request|1
6943614|NCT00959374|10980597|FG000|Overall Study|Withdrawal by Subject|2
6943615|NCT00959374|10980597|FG000|Overall Study|Lost to Follow-up|14
6943616|NCT00959374|10980597|FG000|Overall Study|Death|1
6943617|NCT00959374|10980597|FG000|Overall Study|Protocol Violation|1
6943618|NCT00959374|10980597|FG000|Overall Study|Implant Removed/Not Replaced|4
6943619|NCT00959374|10980597|FG000|Overall Study|Physician Decision|1
6943620|NCT00959647|10980605|FG000|Overall Study|Adverse Event|2
6943621|NCT00959647|10980605|FG000|Overall Study|Progressive disease|6
6943622|NCT00959647|10980605|FG000|Overall Study|Study terminated by sponsor|4
6943623|NCT00959647|10980605|FG000|Overall Study|Withdrawal by Subject|7
6943624|NCT00959699|10980628|FG000|Treatment Period|Adverse Event|3
6943625|NCT00959699|10980629|FG001|Treatment Period|Adverse Event|13
6943626|NCT00959699|10980628|FG000|Treatment Period|Lack of Efficacy|15
6943627|NCT00959699|10980629|FG001|Treatment Period|Lack of Efficacy|6
6943628|NCT00959699|10980628|FG000|Treatment Period|Lost to Follow-up|0
6943629|NCT00959699|10980629|FG001|Treatment Period|Lost to Follow-up|1
6943630|NCT00959699|10980628|FG000|Treatment Period|Withdrawal by Subject|1
6943631|NCT00959699|10980629|FG001|Treatment Period|Withdrawal by Subject|3
6943632|NCT00959699|10980628|FG000|Treatment Period|Non-Compliance with Protocol|0
6943633|NCT00959699|10980629|FG001|Treatment Period|Non-Compliance with Protocol|1
6943634|NCT00959699|10980628|FG000|Treatment Period|Did not receive treatment|0
6943635|NCT00959699|10980629|FG001|Treatment Period|Did not receive treatment|1
6943636|NCT00959699|10980628|FG000|Treatment Period|Futility/crossover to boceprevir|4
6943637|NCT00959699|10980629|FG001|Treatment Period|Futility/crossover to boceprevir|0
6943638|NCT00959699|10980628|FG000|Follow-up Period|Lost to Follow-up|3
6943639|NCT00959699|10980629|FG001|Follow-up Period|Lost to Follow-up|2
6943640|NCT00959699|10980628|FG000|Follow-up Period|Withdrawal by Subject|3
6943641|NCT00959699|10980629|FG001|Follow-up Period|Withdrawal by Subject|4
6943642|NCT00959751|10980638|FG000|Overall Study|Lost to Follow-up|2
6943643|NCT00959751|10980639|FG001|Overall Study|Lost to Follow-up|3
6943644|NCT00959751|10980638|FG000|Overall Study|Consent Withdrawn|0
6943645|NCT00959751|10980639|FG001|Overall Study|Consent Withdrawn|1
6943646|NCT00959751|10980638|FG000|Overall Study|Non-compliance to Study Procedures|0
6943647|NCT00959751|10980639|FG001|Overall Study|Non-compliance to Study Procedures|1
6943648|NCT00959751|10980638|FG000|Overall Study|No migraine headache without aura|7
6943649|NCT00959751|10980639|FG001|Overall Study|No migraine headache without aura|7
6943650|NCT00959894|10980665|FG000|Overall Study|Lost to Follow-up|10
6943651|NCT00959894|10980665|FG000|Overall Study|Adverse Event|3
6943652|NCT00959894|10980665|FG000|Overall Study|Withdrawal by Subject|1
6943653|NCT00959894|10980665|FG000|Overall Study|Need for contraindicated medication|1
6943654|NCT00959894|10980665|FG000|Overall Study|Subject moved out of town|1
6943655|NCT00959907|10980672|FG000|Overall Study|Protocol Violation|0
6943656|NCT00959907|10980673|FG001|Overall Study|Protocol Violation|1
6943657|NCT00959907|10980672|FG000|Overall Study|Adverse Event|1
6943658|NCT00959907|10980673|FG001|Overall Study|Adverse Event|0
6943659|NCT00959907|10980672|FG000|Overall Study|Withdrawal by Subject|2
6943660|NCT00959907|10980673|FG001|Overall Study|Withdrawal by Subject|0
6943661|NCT00959946|10980698|FG000|Overall Study|Adverse Event|0
6943662|NCT00959946|10980699|FG001|Overall Study|Adverse Event|0
6943663|NCT00959946|10980700|FG002|Overall Study|Adverse Event|2
6943664|NCT00959946|10980701|FG003|Overall Study|Adverse Event|1
6943665|NCT00959946|10980702|FG004|Overall Study|Adverse Event|0
6943666|NCT00959946|10980703|FG005|Overall Study|Adverse Event|1
6943667|NCT00959946|10980704|FG006|Overall Study|Adverse Event|0
6943668|NCT00959946|10980705|FG007|Overall Study|Adverse Event|0
6943669|NCT00959946|10980698|FG000|Overall Study|Death|0
6943670|NCT00959946|10980699|FG001|Overall Study|Death|0
6943671|NCT00959946|10980700|FG002|Overall Study|Death|0
6943672|NCT00959946|10980701|FG003|Overall Study|Death|0
6943673|NCT00959946|10980702|FG004|Overall Study|Death|0
6943674|NCT00959946|10980703|FG005|Overall Study|Death|1
6943675|NCT00959946|10980704|FG006|Overall Study|Death|0
6943676|NCT00959946|10980705|FG007|Overall Study|Death|0
6943677|NCT00959946|10980698|FG000|Overall Study|Disease Progression|2
6943678|NCT00959946|10980699|FG001|Overall Study|Disease Progression|4
6943679|NCT00959946|10980700|FG002|Overall Study|Disease Progression|2
6943680|NCT00959946|10980701|FG003|Overall Study|Disease Progression|4
6943681|NCT00959946|10980702|FG004|Overall Study|Disease Progression|4
6943682|NCT00959946|10980703|FG005|Overall Study|Disease Progression|6
6943683|NCT00959946|10980704|FG006|Overall Study|Disease Progression|2
6943684|NCT00959946|10980705|FG007|Overall Study|Disease Progression|2
6943685|NCT00959946|10980698|FG000|Overall Study|Withdrawal by Subject|0
6943686|NCT00959946|10980699|FG001|Overall Study|Withdrawal by Subject|0
6943687|NCT00959946|10980700|FG002|Overall Study|Withdrawal by Subject|0
6943688|NCT00959946|10980701|FG003|Overall Study|Withdrawal by Subject|0
6943689|NCT00959946|10980702|FG004|Overall Study|Withdrawal by Subject|0
6943690|NCT00959946|10980703|FG005|Overall Study|Withdrawal by Subject|1
6943691|NCT00959946|10980704|FG006|Overall Study|Withdrawal by Subject|0
6943692|NCT00959946|10980705|FG007|Overall Study|Withdrawal by Subject|0
6943693|NCT00960011|10980747|FG000|Overall Study|Death|5
6943694|NCT00960011|10980748|FG001|Overall Study|Death|0
6943695|NCT00960011|10980747|FG000|Overall Study|Lost to Follow-up|6
6943696|NCT00960011|10980748|FG001|Overall Study|Lost to Follow-up|2
6943697|NCT00960063|10980791|FG000|Overall Study|Adverse Event|1
6943698|NCT00960063|10980792|FG001|Overall Study|Adverse Event|0
6943699|NCT00960063|10980793|FG002|Overall Study|Adverse Event|0
6943700|NCT00960063|10980791|FG000|Overall Study|Progression of Disease|0
6943701|NCT00960063|10980792|FG001|Overall Study|Progression of Disease|0
6943702|NCT00960063|10980793|FG002|Overall Study|Progression of Disease|3
6943703|NCT00960076|10980803|FG000|Overall Study|Adverse Event|1
6943704|NCT00960076|10980804|FG001|Overall Study|Adverse Event|7
6943705|NCT00960076|10980803|FG000|Overall Study|No longer met study criteria|1
6943706|NCT00960076|10980804|FG001|Overall Study|No longer met study criteria|5
6943707|NCT00960076|10980803|FG000|Overall Study|Withdrawal by Subject|1
6943708|NCT00960076|10980804|FG001|Overall Study|Withdrawal by Subject|2
6943709|NCT00960076|10980803|FG000|Overall Study|Lost to Follow-up|3
7067624|NCT01987895|11168809|FG000|Overall Study|Death|7
7067625|NCT01987895|11168810|FG001|Overall Study|Death|7
7067626|NCT01987895|11168809|FG000|Overall Study|Lost to Follow-up|3
7067627|NCT01987895|11168810|FG001|Overall Study|Lost to Follow-up|5
7067628|NCT01987895|11168809|FG000|Overall Study|randomized before giving IC|0
7067629|NCT01987895|11168810|FG001|Overall Study|randomized before giving IC|1
7067630|NCT01987908|11168816|FG000|Placebo Lead-in Period|Adverse Event|2
7067631|NCT01987908|11168817|FG001|Placebo Lead-in Period|Adverse Event|0
7067632|NCT01987908|11168818|FG002|Placebo Lead-in Period|Adverse Event|0
7067633|NCT01987908|11168816|FG000|Placebo Lead-in Period|Physician Decision|2
7067634|NCT01987908|11168817|FG001|Placebo Lead-in Period|Physician Decision|0
7067635|NCT01987908|11168818|FG002|Placebo Lead-in Period|Physician Decision|0
7067636|NCT01987908|11168816|FG000|Placebo Lead-in Period|Withdrawal by Subject|1
7067637|NCT01987908|11168817|FG001|Placebo Lead-in Period|Withdrawal by Subject|0
7067638|NCT01987908|11168818|FG002|Placebo Lead-in Period|Withdrawal by Subject|0
7067639|NCT01987908|11168816|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4
7067640|NCT01987908|11168817|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
7067641|NCT01987908|11168818|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
7067642|NCT01987908|11168816|FG000|Treatment Period|Adverse Event|0
7067643|NCT01987908|11168817|FG001|Treatment Period|Adverse Event|1
7067644|NCT01987908|11168818|FG002|Treatment Period|Adverse Event|1
6943710|NCT00960076|10980804|FG001|Overall Study|Lost to Follow-up|3
6943711|NCT00960076|10980803|FG000|Overall Study|Severe non-compliance to protocol|1
6943712|NCT00960076|10980804|FG001|Overall Study|Severe non-compliance to protocol|2
6943713|NCT00960076|10980803|FG000|Overall Study|Hyperglycemia|1
6943714|NCT00960076|10980804|FG001|Overall Study|Hyperglycemia|5
6943715|NCT00960076|10980803|FG000|Overall Study|Did not attend the termination visit|0
7067645|NCT01987908|11168816|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
7067646|NCT01987908|11168817|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2
7067647|NCT01987908|11168818|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
6943716|NCT00960076|10980804|FG001|Overall Study|Did not attend the termination visit|1
6943717|NCT00960115|10980812|FG000|Overall Study|Ongoing treatment at data cut-off date|19
6943718|NCT00960115|10980813|FG001|Overall Study|Ongoing treatment at data cut-off date|15
6943719|NCT00960193|10980819|FG000|14 Day Washout Period|Withdrawal by Subject|1
7067648|NCT01987908|11168816|FG000|Post-Treatment Observation Period|Other: Bad Veins|0
7067649|NCT01987908|11168817|FG001|Post-Treatment Observation Period|Other: Bad Veins|1
6943720|NCT00960206|10980829|FG000|Overall Study|Death|7
6943721|NCT00960206|10980830|FG001|Overall Study|Death|4
6943722|NCT00960206|10980831|FG002|Overall Study|Death|1
6943723|NCT00960206|10980829|FG000|Overall Study|Unwilling/Unable to return|1
6943724|NCT00960206|10980830|FG001|Overall Study|Unwilling/Unable to return|2
6943725|NCT00960206|10980831|FG002|Overall Study|Unwilling/Unable to return|0
6943726|NCT00960206|10980829|FG000|Overall Study|Lost to Follow-up|8
6943727|NCT00960206|10980830|FG001|Overall Study|Lost to Follow-up|14
6943728|NCT00960206|10980831|FG002|Overall Study|Lost to Follow-up|8
6943729|NCT00960206|10980829|FG000|Overall Study|Withdrawal by Subject|2
6943730|NCT00960206|10980830|FG001|Overall Study|Withdrawal by Subject|4
6943731|NCT00960206|10980831|FG002|Overall Study|Withdrawal by Subject|0
6943732|NCT00960206|10980829|FG000|Overall Study|Revision of study component|2
6943733|NCT00960206|10980830|FG001|Overall Study|Revision of study component|2
6943734|NCT00960206|10980831|FG002|Overall Study|Revision of study component|2
6943735|NCT00960206|10980829|FG000|Overall Study|Missing 10 year data|20
6943736|NCT00960206|10980830|FG001|Overall Study|Missing 10 year data|1
6943737|NCT00960206|10980831|FG002|Overall Study|Missing 10 year data|1
6943738|NCT00960323|10980840|FG000|Atorvastatin Alone|Withdrawal by Subject|1
6943739|NCT00960375|10980850|FG000|Overall Study|Lost to Follow-up|20
6943740|NCT00960375|10980851|FG001|Overall Study|Lost to Follow-up|22
6943741|NCT00960440|10980861|FG000|Overall Study|Death|0
6943742|NCT00960440|10980862|FG001|Overall Study|Death|0
6943743|NCT00960440|10980863|FG002|Overall Study|Death|0
6943744|NCT00960440|10980864|FG003|Overall Study|Death|1
6943745|NCT00960440|10980861|FG000|Overall Study|Adverse Event|12
6943746|NCT00960440|10980862|FG001|Overall Study|Adverse Event|12
6943747|NCT00960440|10980863|FG002|Overall Study|Adverse Event|4
6943748|NCT00960440|10980864|FG003|Overall Study|Adverse Event|4
6943749|NCT00960440|10980861|FG000|Overall Study|Lack of Efficacy|2
6943750|NCT00960440|10980862|FG001|Overall Study|Lack of Efficacy|5
6943751|NCT00960440|10980863|FG002|Overall Study|Lack of Efficacy|3
6943752|NCT00960440|10980864|FG003|Overall Study|Lack of Efficacy|8
6943753|NCT00960440|10980861|FG000|Overall Study|Protocol Violation|2
6943754|NCT00960440|10980862|FG001|Overall Study|Protocol Violation|8
6943755|NCT00960440|10980863|FG002|Overall Study|Protocol Violation|3
6943756|NCT00960440|10980864|FG003|Overall Study|Protocol Violation|4
6943757|NCT00960440|10980861|FG000|Overall Study|Withdrawal by Subject|9
6943758|NCT00960440|10980862|FG001|Overall Study|Withdrawal by Subject|5
6943759|NCT00960440|10980863|FG002|Overall Study|Withdrawal by Subject|2
6943760|NCT00960440|10980864|FG003|Overall Study|Withdrawal by Subject|1
7067650|NCT01987908|11168818|FG002|Post-Treatment Observation Period|Other: Bad Veins|0
7067651|NCT01987960|11168844|FG000|Period 1|Adverse Event|24
7067652|NCT01987960|11168845|FG001|Period 1|Adverse Event|0
7067653|NCT01987960|11168846|FG002|Period 1|Adverse Event|0
7067654|NCT01987960|11168847|FG003|Period 1|Adverse Event|0
7067655|NCT01987960|11168844|FG000|Period 1|Lack of Efficacy|4
7067656|NCT01987960|11168845|FG001|Period 1|Lack of Efficacy|0
7067657|NCT01987960|11168846|FG002|Period 1|Lack of Efficacy|0
7067658|NCT01987960|11168847|FG003|Period 1|Lack of Efficacy|0
7067659|NCT01987960|11168844|FG000|Period 1|Non-compliance with IMP|6
7067660|NCT01987960|11168845|FG001|Period 1|Non-compliance with IMP|0
7067661|NCT01987960|11168846|FG002|Period 1|Non-compliance with IMP|0
7067662|NCT01987960|11168847|FG003|Period 1|Non-compliance with IMP|0
7067663|NCT01987960|11168844|FG000|Period 1|Protocol Violation|12
7067664|NCT01987960|11168845|FG001|Period 1|Protocol Violation|0
7067665|NCT01987960|11168846|FG002|Period 1|Protocol Violation|0
7067666|NCT01987960|11168847|FG003|Period 1|Protocol Violation|0
7067667|NCT01987960|11168844|FG000|Period 1|Withdrawal by Subject|21
7067668|NCT01987960|11168845|FG001|Period 1|Withdrawal by Subject|0
7067669|NCT01987960|11168846|FG002|Period 1|Withdrawal by Subject|0
7067670|NCT01987960|11168847|FG003|Period 1|Withdrawal by Subject|0
7067671|NCT01987960|11168844|FG000|Period 1|Lost to Follow-up|40
7067672|NCT01987960|11168845|FG001|Period 1|Lost to Follow-up|0
7067673|NCT01987960|11168846|FG002|Period 1|Lost to Follow-up|0
7067674|NCT01987960|11168847|FG003|Period 1|Lost to Follow-up|0
7067675|NCT01987960|11168844|FG000|Period 1|administrative or other reason|75
7067676|NCT01987960|11168845|FG001|Period 1|administrative or other reason|0
7067677|NCT01987960|11168846|FG002|Period 1|administrative or other reason|0
7067678|NCT01987960|11168847|FG003|Period 1|administrative or other reason|0
7067679|NCT01987960|11168844|FG000|Period 1|Withdrawal of consent before treatment|4
7067680|NCT01987960|11168845|FG001|Period 1|Withdrawal of consent before treatment|0
6943761|NCT00960440|10980861|FG000|Overall Study|Other|1
6943762|NCT00960440|10980862|FG001|Overall Study|Other|1
6943763|NCT00960440|10980863|FG002|Overall Study|Other|1
6943764|NCT00960440|10980864|FG003|Overall Study|Other|0
6943765|NCT00960531|10980899|FG000|Overall Study|Lack of Efficacy|1
6943766|NCT00960531|10980900|FG001|Overall Study|Lack of Efficacy|0
7067681|NCT01987960|11168846|FG002|Period 1|Withdrawal of consent before treatment|0
6943767|NCT00960531|10980901|FG002|Overall Study|Lack of Efficacy|0
7067682|NCT01987960|11168847|FG003|Period 1|Withdrawal of consent before treatment|0
7067683|NCT01987960|11168844|FG000|Period 2|Adverse Event|0
6943768|NCT00960531|10980902|FG003|Overall Study|Lack of Efficacy|0
6943769|NCT00960531|10980903|FG004|Overall Study|Lack of Efficacy|0
6943770|NCT00960531|10980904|FG005|Overall Study|Lack of Efficacy|0
6943771|NCT00960531|10980905|FG006|Overall Study|Lack of Efficacy|0
6943772|NCT00960531|10980906|FG007|Overall Study|Lack of Efficacy|0
6943773|NCT00960531|10980907|FG008|Overall Study|Lack of Efficacy|0
6943774|NCT00960531|10980908|FG009|Overall Study|Lack of Efficacy|0
6943775|NCT00960531|10980899|FG000|Overall Study|Withdrawal by Subject|1
6943776|NCT00960531|10980900|FG001|Overall Study|Withdrawal by Subject|0
6943777|NCT00960531|10980901|FG002|Overall Study|Withdrawal by Subject|5
6943778|NCT00960531|10980902|FG003|Overall Study|Withdrawal by Subject|2
7067684|NCT01987960|11168845|FG001|Period 2|Adverse Event|0
7067685|NCT01987960|11168846|FG002|Period 2|Adverse Event|1
7067686|NCT01987960|11168847|FG003|Period 2|Adverse Event|0
7067687|NCT01987960|11168844|FG000|Period 2|Withdrawal by Subject|0
7067688|NCT01987960|11168845|FG001|Period 2|Withdrawal by Subject|0
7067689|NCT01987960|11168846|FG002|Period 2|Withdrawal by Subject|1
7067690|NCT01987960|11168847|FG003|Period 2|Withdrawal by Subject|0
7067691|NCT01987960|11168844|FG000|Period 2|Administrative or other reason|0
7067692|NCT01987960|11168845|FG001|Period 2|Administrative or other reason|5
7067693|NCT01987960|11168846|FG002|Period 2|Administrative or other reason|7
7067694|NCT01987960|11168847|FG003|Period 2|Administrative or other reason|0
7067695|NCT01987960|11168844|FG000|Period 3|Adverse Event|0
7067696|NCT01987960|11168845|FG001|Period 3|Adverse Event|0
7067697|NCT01987960|11168846|FG002|Period 3|Adverse Event|0
7067698|NCT01987960|11168847|FG003|Period 3|Adverse Event|7
6943779|NCT00960531|10980903|FG004|Overall Study|Withdrawal by Subject|0
6943780|NCT00960531|10980904|FG005|Overall Study|Withdrawal by Subject|0
6943781|NCT00960531|10980905|FG006|Overall Study|Withdrawal by Subject|2
6943782|NCT00960531|10980906|FG007|Overall Study|Withdrawal by Subject|0
6943783|NCT00960531|10980907|FG008|Overall Study|Withdrawal by Subject|1
6943784|NCT00960531|10980908|FG009|Overall Study|Withdrawal by Subject|0
6943785|NCT00960531|10980899|FG000|Overall Study|Caregiver Request|2
6943786|NCT00960531|10980900|FG001|Overall Study|Caregiver Request|0
6943787|NCT00960531|10980901|FG002|Overall Study|Caregiver Request|6
6943788|NCT00960531|10980902|FG003|Overall Study|Caregiver Request|5
6943789|NCT00960531|10980903|FG004|Overall Study|Caregiver Request|0
6943790|NCT00960531|10980904|FG005|Overall Study|Caregiver Request|2
6943791|NCT00960531|10980905|FG006|Overall Study|Caregiver Request|3
6943792|NCT00960531|10980906|FG007|Overall Study|Caregiver Request|1
6943793|NCT00960531|10980907|FG008|Overall Study|Caregiver Request|3
6943794|NCT00960531|10980908|FG009|Overall Study|Caregiver Request|0
6943795|NCT00960531|10980899|FG000|Overall Study|Investigator Request|0
6943796|NCT00960531|10980900|FG001|Overall Study|Investigator Request|0
6943797|NCT00960531|10980901|FG002|Overall Study|Investigator Request|1
6943798|NCT00960531|10980902|FG003|Overall Study|Investigator Request|0
6943799|NCT00960531|10980903|FG004|Overall Study|Investigator Request|0
6943800|NCT00960531|10980904|FG005|Overall Study|Investigator Request|0
6943801|NCT00960531|10980905|FG006|Overall Study|Investigator Request|0
6943802|NCT00960531|10980906|FG007|Overall Study|Investigator Request|0
6943803|NCT00960531|10980907|FG008|Overall Study|Investigator Request|0
6943804|NCT00960531|10980908|FG009|Overall Study|Investigator Request|0
6943805|NCT00960531|10980899|FG000|Overall Study|Discontinuation of Study by Sponsor|0
6943806|NCT00960531|10980900|FG001|Overall Study|Discontinuation of Study by Sponsor|0
6943807|NCT00960531|10980901|FG002|Overall Study|Discontinuation of Study by Sponsor|0
6943808|NCT00960531|10980902|FG003|Overall Study|Discontinuation of Study by Sponsor|0
6943809|NCT00960531|10980903|FG004|Overall Study|Discontinuation of Study by Sponsor|0
6943810|NCT00960531|10980904|FG005|Overall Study|Discontinuation of Study by Sponsor|0
6943811|NCT00960531|10980905|FG006|Overall Study|Discontinuation of Study by Sponsor|0
6943812|NCT00960531|10980906|FG007|Overall Study|Discontinuation of Study by Sponsor|1
6943813|NCT00960531|10980907|FG008|Overall Study|Discontinuation of Study by Sponsor|0
6943814|NCT00960531|10980908|FG009|Overall Study|Discontinuation of Study by Sponsor|0
6943815|NCT00960531|10980899|FG000|Overall Study|Lost to Follow-up|0
6943816|NCT00960531|10980900|FG001|Overall Study|Lost to Follow-up|0
6943817|NCT00960531|10980901|FG002|Overall Study|Lost to Follow-up|1
6943818|NCT00960531|10980902|FG003|Overall Study|Lost to Follow-up|0
6943819|NCT00960531|10980903|FG004|Overall Study|Lost to Follow-up|0
6943820|NCT00960531|10980904|FG005|Overall Study|Lost to Follow-up|0
6943821|NCT00960531|10980905|FG006|Overall Study|Lost to Follow-up|1
6943822|NCT00960531|10980906|FG007|Overall Study|Lost to Follow-up|0
6943823|NCT00960531|10980907|FG008|Overall Study|Lost to Follow-up|0
7067699|NCT01987960|11168844|FG000|Period 3|Non-compliance with IMP|0
7067700|NCT01987960|11168845|FG001|Period 3|Non-compliance with IMP|0
7067701|NCT01987960|11168846|FG002|Period 3|Non-compliance with IMP|0
7067702|NCT01987960|11168847|FG003|Period 3|Non-compliance with IMP|1
6943824|NCT00960531|10980908|FG009|Overall Study|Lost to Follow-up|0
6943825|NCT00960531|10980899|FG000|Overall Study|Failed to Return|2
6943826|NCT00960531|10980900|FG001|Overall Study|Failed to Return|0
6943827|NCT00960531|10980901|FG002|Overall Study|Failed to Return|0
7147701|NCT03134222|11308418|FG003|Treatment Period (Up to Week 12)|Adverse Event|0
6943828|NCT00960531|10980902|FG003|Overall Study|Failed to Return|0
7183769|NCT01150045|11383847|FG000|Overall Study|Protocol Violation|0
6943829|NCT00960531|10980903|FG004|Overall Study|Failed to Return|0
6943830|NCT00960531|10980904|FG005|Overall Study|Failed to Return|0
6943831|NCT00960531|10980905|FG006|Overall Study|Failed to Return|0
6943832|NCT00960531|10980906|FG007|Overall Study|Failed to Return|2
6943833|NCT00960531|10980907|FG008|Overall Study|Failed to Return|0
7067703|NCT01987960|11168844|FG000|Period 3|Protocol Violation|0
6943834|NCT00960531|10980908|FG009|Overall Study|Failed to Return|0
7040662|NCT01719003|11123726|FG001|Overall Study|Reason other than those specified|0
7040663|NCT01719003|11123727|FG002|Overall Study|Reason other than those specified|2
7040664|NCT01719003|11123728|FG003|Overall Study|Reason other than those specified|3
7040665|NCT01719003|11123729|FG004|Overall Study|Reason other than those specified|4
7040666|NCT01719003|11123730|FG005|Overall Study|Reason other than those specified|1
7040667|NCT01719003|11123731|FG006|Overall Study|Reason other than those specified|0
7040668|NCT01719003|11123732|FG007|Overall Study|Reason other than those specified|3
7040669|NCT01719003|11123733|FG008|Overall Study|Reason other than those specified|1
7040670|NCT01719003|11123725|FG000|Overall Study|Lack of Efficacy|0
7040671|NCT01719003|11123726|FG001|Overall Study|Lack of Efficacy|0
7040672|NCT01719003|11123727|FG002|Overall Study|Lack of Efficacy|0
7040673|NCT01719003|11123728|FG003|Overall Study|Lack of Efficacy|0
7040674|NCT01719003|11123729|FG004|Overall Study|Lack of Efficacy|0
6943835|NCT00960531|10980899|FG000|Overall Study|Adverse Event (AE)|2
6943836|NCT00960531|10980900|FG001|Overall Study|Adverse Event (AE)|0
6943837|NCT00960531|10980901|FG002|Overall Study|Adverse Event (AE)|0
6943838|NCT00960531|10980902|FG003|Overall Study|Adverse Event (AE)|0
6943839|NCT00960531|10980903|FG004|Overall Study|Adverse Event (AE)|0
7040675|NCT01719003|11123730|FG005|Overall Study|Lack of Efficacy|0
7040676|NCT01719003|11123731|FG006|Overall Study|Lack of Efficacy|1
7040677|NCT01719003|11123732|FG007|Overall Study|Lack of Efficacy|0
7040678|NCT01719003|11123733|FG008|Overall Study|Lack of Efficacy|0
7040679|NCT01719172|11123752|FG000|Overall Study|Lost to Follow-up|1
7040680|NCT01719172|11123752|FG000|Overall Study|Death|1
7040681|NCT01719224|11123756|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4
7040682|NCT01719224|11123757|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2
7044798|NCT01757288|11130791|FG000|Overall Study|Consent withdrawal|0
7044799|NCT01757288|11130792|FG001|Overall Study|Consent withdrawal|4
7044800|NCT01757288|11130793|FG002|Overall Study|Consent withdrawal|4
7044801|NCT01757288|11130791|FG000|Overall Study|Patient off study, IRB hold.|0
7044802|NCT01757288|11130792|FG001|Overall Study|Patient off study, IRB hold.|0
7044803|NCT01757288|11130793|FG002|Overall Study|Patient off study, IRB hold.|1
7044804|NCT01757288|11130791|FG000|Overall Study|Patient death prior to starting treatment|0
7044805|NCT01757288|11130792|FG001|Overall Study|Patient death prior to starting treatment|0
7044806|NCT01757288|11130793|FG002|Overall Study|Patient death prior to starting treatment|1
7044807|NCT01757288|11130791|FG000|Overall Study|Wrong medication administered|0
7044808|NCT01757288|11130792|FG001|Overall Study|Wrong medication administered|1
7044809|NCT01757288|11130793|FG002|Overall Study|Wrong medication administered|0
7044810|NCT01757288|11130791|FG000|Overall Study|Liver metastasis identified at CT simulation|0
7044811|NCT01757288|11130792|FG001|Overall Study|Liver metastasis identified at CT simulation|1
7044812|NCT01757288|11130793|FG002|Overall Study|Liver metastasis identified at CT simulation|0
7044813|NCT01757288|11130791|FG000|Overall Study|Not meeting protocol constraints|0
7044814|NCT01757288|11130792|FG001|Overall Study|Not meeting protocol constraints|1
7044815|NCT01757288|11130793|FG002|Overall Study|Not meeting protocol constraints|1
7044816|NCT01757288|11130791|FG000|Overall Study|Multiple missed appointments|0
7044817|NCT01757288|11130792|FG001|Overall Study|Multiple missed appointments|1
7044818|NCT01757288|11130793|FG002|Overall Study|Multiple missed appointments|0
7044819|NCT01757288|11130791|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0
7044820|NCT01757288|11130792|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0
7044821|NCT01757288|11130793|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1
7044822|NCT01757288|11130791|FG000|Overall Study|>2 weeks treatment break|0
7044823|NCT01757288|11130792|FG001|Overall Study|>2 weeks treatment break|0
7044824|NCT01757288|11130793|FG002|Overall Study|>2 weeks treatment break|1
7044825|NCT01757392|11130813|FG000|Overall Study|Withdrawal by Subject|1
7044826|NCT01757392|11130813|FG000|Overall Study|Screen Fail|3
6943840|NCT00960531|10980904|FG005|Overall Study|Adverse Event (AE)|1
6943841|NCT00960531|10980905|FG006|Overall Study|Adverse Event (AE)|2
6943842|NCT00960531|10980906|FG007|Overall Study|Adverse Event (AE)|0
6943843|NCT00960531|10980907|FG008|Overall Study|Adverse Event (AE)|2
6943844|NCT00960531|10980908|FG009|Overall Study|Adverse Event (AE)|0
6943845|NCT00960531|10980899|FG000|Overall Study|Reason not Specified|2
6943846|NCT00960531|10980900|FG001|Overall Study|Reason not Specified|1
6943847|NCT00960531|10980901|FG002|Overall Study|Reason not Specified|13
6943848|NCT00960531|10980902|FG003|Overall Study|Reason not Specified|1
6943849|NCT00960531|10980903|FG004|Overall Study|Reason not Specified|2
7044827|NCT01757405|11130819|FG000|Overall Study|Lost to Follow-up|1
7044828|NCT01757405|11130820|FG001|Overall Study|Lost to Follow-up|1
7044829|NCT01757405|11130819|FG000|Overall Study|Withdrawal by Subject|0
7044830|NCT01757405|11130820|FG001|Overall Study|Withdrawal by Subject|1
7067704|NCT01987960|11168845|FG001|Period 3|Protocol Violation|0
7067705|NCT01987960|11168846|FG002|Period 3|Protocol Violation|0
7067706|NCT01987960|11168847|FG003|Period 3|Protocol Violation|6
7067707|NCT01987960|11168844|FG000|Period 3|Withdrawal by Subject|0
7067708|NCT01987960|11168845|FG001|Period 3|Withdrawal by Subject|0
7067709|NCT01987960|11168846|FG002|Period 3|Withdrawal by Subject|0
7067710|NCT01987960|11168847|FG003|Period 3|Withdrawal by Subject|9
7067711|NCT01987960|11168844|FG000|Period 3|Lost to Follow-up|0
7067712|NCT01987960|11168845|FG001|Period 3|Lost to Follow-up|0
6943850|NCT00960531|10980904|FG005|Overall Study|Reason not Specified|0
6943851|NCT00960531|10980905|FG006|Overall Study|Reason not Specified|16
6943852|NCT00960531|10980906|FG007|Overall Study|Reason not Specified|0
6943853|NCT00960531|10980907|FG008|Overall Study|Reason not Specified|8
6943854|NCT00960531|10980908|FG009|Overall Study|Reason not Specified|1
6943855|NCT00960570|10980934|FG000|21 Day Washout Period|Adverse Event|1
6943856|NCT00960570|10980934|FG000|21 Day Washout Period|Withdrawal by Subject|1
6943857|NCT00960570|10980934|FG000|1 Day Period Between Dosing|Adverse Event|2
6943858|NCT00960570|10980934|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1
6943859|NCT00960661|10980952|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6
6943860|NCT00960661|10980953|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
6943861|NCT00960661|10980954|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
6943862|NCT00960661|10980952|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4
6943863|NCT00960661|10980953|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
6943864|NCT00960661|10980954|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
6943865|NCT00960661|10980952|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331
6943866|NCT00960661|10980953|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
6943867|NCT00960661|10980954|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
6943868|NCT00960661|10980952|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47
6943869|NCT00960661|10980953|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
6943870|NCT00960661|10980954|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
6943871|NCT00960661|10980952|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8
6943872|NCT00960661|10980953|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
6943873|NCT00960661|10980954|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
6943874|NCT00960661|10980952|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3
6943875|NCT00960661|10980953|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
6943876|NCT00960661|10980954|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
6943877|NCT00960661|10980952|FG000|Interventional Phase|Adverse Event|0
6943878|NCT00960661|10980953|FG001|Interventional Phase|Adverse Event|17
6943879|NCT00960661|10980954|FG002|Interventional Phase|Adverse Event|8
6943880|NCT00960661|10980952|FG000|Interventional Phase|Death|0
6943881|NCT00960661|10980953|FG001|Interventional Phase|Death|1
6943882|NCT00960661|10980954|FG002|Interventional Phase|Death|0
6943883|NCT00960661|10980952|FG000|Interventional Phase|Lost to Follow-up|0
6943884|NCT00960661|10980953|FG001|Interventional Phase|Lost to Follow-up|0
6943885|NCT00960661|10980954|FG002|Interventional Phase|Lost to Follow-up|2
6943886|NCT00960661|10980952|FG000|Interventional Phase|entry criteria not met|0
6943887|NCT00960661|10980953|FG001|Interventional Phase|entry criteria not met|3
6943888|NCT00960661|10980954|FG002|Interventional Phase|entry criteria not met|0
6943889|NCT00960661|10980952|FG000|Interventional Phase|Protocol Violation|0
6943890|NCT00960661|10980953|FG001|Interventional Phase|Protocol Violation|7
6943891|NCT00960661|10980954|FG002|Interventional Phase|Protocol Violation|2
6943892|NCT00960661|10980952|FG000|Interventional Phase|Withdrawal by Subject|0
6943893|NCT00960661|10980953|FG001|Interventional Phase|Withdrawal by Subject|18
6943894|NCT00960661|10980954|FG002|Interventional Phase|Withdrawal by Subject|29
6943895|NCT00960661|10980952|FG000|Interventional Phase|Physician Decision|0
6943896|NCT00960661|10980953|FG001|Interventional Phase|Physician Decision|3
6943897|NCT00960661|10980954|FG002|Interventional Phase|Physician Decision|5
6943898|NCT00960661|10980952|FG000|Interventional Phase|sponsor decision|0
6943899|NCT00960661|10980953|FG001|Interventional Phase|sponsor decision|1
6943900|NCT00960661|10980954|FG002|Interventional Phase|sponsor decision|0
6943901|NCT00960661|10980952|FG000|Interventional Phase|Lack of Efficacy|0
6943902|NCT00960661|10980953|FG001|Interventional Phase|Lack of Efficacy|2
6943903|NCT00960661|10980954|FG002|Interventional Phase|Lack of Efficacy|0
6943904|NCT00960687|10980960|FG000|Washout Period of 7 Days|Adverse Event|3
6943905|NCT00960687|10980961|FG001|Washout Period of 7 Days|Adverse Event|2
6943906|NCT00960687|10980960|FG000|Washout Period of 7 Days|Withdrawal by Subject|1
6943907|NCT00960687|10980961|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
6943908|NCT00960804|10980979|FG000|Overall Study|Adverse Event|1
6943909|NCT00960804|10980980|FG001|Overall Study|Adverse Event|0
6943910|NCT00960804|10980981|FG002|Overall Study|Adverse Event|0
6943911|NCT00960804|10980979|FG000|Overall Study|Withdrawal by Subject|1
6943912|NCT00960804|10980980|FG001|Overall Study|Withdrawal by Subject|0
6943913|NCT00960804|10980981|FG002|Overall Study|Withdrawal by Subject|0
6943914|NCT00960804|10980979|FG000|Overall Study|Study terminated by the sponsor|5
6943915|NCT00960804|10980980|FG001|Overall Study|Study terminated by the sponsor|4
6943916|NCT00960804|10980981|FG002|Overall Study|Study terminated by the sponsor|10
6943917|NCT00960843|10980991|FG000|Overall Study|Lost to Follow-up|2
6943918|NCT00960843|10980992|FG001|Overall Study|Lost to Follow-up|0
6943919|NCT00960843|10980991|FG000|Overall Study|Protocol Violation|0
6943920|NCT00960843|10980992|FG001|Overall Study|Protocol Violation|4
6943921|NCT00960843|10980991|FG000|Overall Study|Repeated needle dislodgment|0
6943922|NCT00960843|10980992|FG001|Overall Study|Repeated needle dislodgment|1
6943923|NCT00960856|10980998|FG000|Washout Period of 7 Days|Withdrawal by Subject|0
6943924|NCT00960856|10980999|FG001|Washout Period of 7 Days|Withdrawal by Subject|2
6943925|NCT00960856|10981000|FG002|Washout Period of 7 Days|Withdrawal by Subject|0
6943926|NCT00960856|10981001|FG003|Washout Period of 7 Days|Withdrawal by Subject|0
6943927|NCT00960856|10980998|FG000|Washout Period of 7 Days|Adverse Event|0
6943928|NCT00960856|10980999|FG001|Washout Period of 7 Days|Adverse Event|0
6943929|NCT00960856|10981000|FG002|Washout Period of 7 Days|Adverse Event|1
6943930|NCT00960856|10981001|FG003|Washout Period of 7 Days|Adverse Event|0
6943931|NCT00960869|10981013|FG000|Overall Study|Adverse Event|17
6943932|NCT00960869|10981014|FG001|Overall Study|Adverse Event|26
6943933|NCT00960869|10981013|FG000|Overall Study|Withdrawal by Subject|16
6943934|NCT00960869|10981014|FG001|Overall Study|Withdrawal by Subject|14
6943935|NCT00960869|10981013|FG000|Overall Study|Lost to Follow-up|1
6943936|NCT00960869|10981014|FG001|Overall Study|Lost to Follow-up|4
6943937|NCT00960869|10981013|FG000|Overall Study|Misc|19
6943938|NCT00960869|10981014|FG001|Overall Study|Misc|18
6943939|NCT00960934|10981026|FG000|Overall Study|Adverse Event|2
6943940|NCT00960934|10981027|FG001|Overall Study|Adverse Event|3
6943941|NCT00960934|10981028|FG002|Overall Study|Adverse Event|3
6943942|NCT00960934|10981029|FG003|Overall Study|Adverse Event|2
6943943|NCT00960934|10981030|FG004|Overall Study|Adverse Event|4
6943944|NCT00960934|10981031|FG005|Overall Study|Adverse Event|3
6943945|NCT00960934|10981026|FG000|Overall Study|Lack of Efficacy|1
6943946|NCT00960934|10981027|FG001|Overall Study|Lack of Efficacy|0
6943947|NCT00960934|10981028|FG002|Overall Study|Lack of Efficacy|0
6943948|NCT00960934|10981029|FG003|Overall Study|Lack of Efficacy|0
6943949|NCT00960934|10981030|FG004|Overall Study|Lack of Efficacy|0
6943950|NCT00960934|10981031|FG005|Overall Study|Lack of Efficacy|0
6943951|NCT00960934|10981026|FG000|Overall Study|Lost to Follow-up|0
6943952|NCT00960934|10981027|FG001|Overall Study|Lost to Follow-up|1
6943953|NCT00960934|10981028|FG002|Overall Study|Lost to Follow-up|0
6943954|NCT00960934|10981029|FG003|Overall Study|Lost to Follow-up|0
6943955|NCT00960934|10981030|FG004|Overall Study|Lost to Follow-up|0
6943956|NCT00960934|10981031|FG005|Overall Study|Lost to Follow-up|0
6943957|NCT00960934|10981026|FG000|Overall Study|Other|2
6943958|NCT00960934|10981027|FG001|Overall Study|Other|1
6943959|NCT00960934|10981028|FG002|Overall Study|Other|5
6943960|NCT00960934|10981029|FG003|Overall Study|Other|4
6943961|NCT00960934|10981030|FG004|Overall Study|Other|2
6943962|NCT00960934|10981031|FG005|Overall Study|Other|2
6943963|NCT00960934|10981026|FG000|Overall Study|Physician Decision|0
6943964|NCT00960934|10981027|FG001|Overall Study|Physician Decision|1
6943965|NCT00960934|10981028|FG002|Overall Study|Physician Decision|0
6943966|NCT00960934|10981029|FG003|Overall Study|Physician Decision|0
6943967|NCT00960934|10981030|FG004|Overall Study|Physician Decision|0
6943968|NCT00960934|10981031|FG005|Overall Study|Physician Decision|0
6943969|NCT00960934|10981026|FG000|Overall Study|Progressive Disease|1
6943970|NCT00960934|10981027|FG001|Overall Study|Progressive Disease|1
6943971|NCT00960934|10981028|FG002|Overall Study|Progressive Disease|0
6943972|NCT00960934|10981029|FG003|Overall Study|Progressive Disease|0
6943973|NCT00960934|10981030|FG004|Overall Study|Progressive Disease|1
6943974|NCT00960934|10981031|FG005|Overall Study|Progressive Disease|1
6943975|NCT00960934|10981026|FG000|Overall Study|Protocol Violation|3
6943976|NCT00960934|10981027|FG001|Overall Study|Protocol Violation|4
7067713|NCT01987960|11168846|FG002|Period 3|Lost to Follow-up|0
7067714|NCT01987960|11168847|FG003|Period 3|Lost to Follow-up|5
7067715|NCT01987960|11168844|FG000|Period 3|Administrative or other reason|0
7067716|NCT01987960|11168845|FG001|Period 3|Administrative or other reason|0
7067717|NCT01987960|11168846|FG002|Period 3|Administrative or other reason|0
7067718|NCT01987960|11168847|FG003|Period 3|Administrative or other reason|43
7067719|NCT01987986|11168861|FG000|Overall Study|Lost to Follow-up|1
7067720|NCT01987986|11168862|FG001|Overall Study|Lost to Follow-up|0
6943977|NCT00960934|10981028|FG002|Overall Study|Protocol Violation|0
6943978|NCT00960934|10981029|FG003|Overall Study|Protocol Violation|3
6943979|NCT00960934|10981030|FG004|Overall Study|Protocol Violation|3
6943980|NCT00960934|10981031|FG005|Overall Study|Protocol Violation|2
6943981|NCT00960934|10981026|FG000|Overall Study|Withdrawal by Subject|5
6943982|NCT00960934|10981027|FG001|Overall Study|Withdrawal by Subject|6
6943983|NCT00960934|10981028|FG002|Overall Study|Withdrawal by Subject|4
6943984|NCT00960934|10981029|FG003|Overall Study|Withdrawal by Subject|5
6943985|NCT00960934|10981030|FG004|Overall Study|Withdrawal by Subject|5
6943986|NCT00960934|10981031|FG005|Overall Study|Withdrawal by Subject|7
6943987|NCT00960934|10981026|FG000|Overall Study|Study Terminated by Sponsor|50
7067721|NCT01987986|11168863|FG002|Overall Study|Lost to Follow-up|0
7067722|NCT01987986|11168864|FG003|Overall Study|Lost to Follow-up|0
7067723|NCT01987986|11168861|FG000|Overall Study|Adverse Event|1
7067724|NCT01987986|11168862|FG001|Overall Study|Adverse Event|0
7067725|NCT01987986|11168863|FG002|Overall Study|Adverse Event|2
7067726|NCT01987986|11168864|FG003|Overall Study|Adverse Event|0
7067727|NCT01988012|11168874|FG000|Overall Study|Adverse Event|5
7067728|NCT01988012|11168874|FG000|Overall Study|Insufficient Therapeutic Response|3
7067729|NCT01988012|11168874|FG000|Overall Study|Patient Withdrawal of Consent|4
7067730|NCT01988012|11168874|FG000|Overall Study|Lost to Follow-up|1
6943988|NCT00960934|10981027|FG001|Overall Study|Study Terminated by Sponsor|46
6943989|NCT00960934|10981028|FG002|Overall Study|Study Terminated by Sponsor|52
6943990|NCT00960934|10981029|FG003|Overall Study|Study Terminated by Sponsor|50
6943991|NCT00960934|10981030|FG004|Overall Study|Study Terminated by Sponsor|49
6943992|NCT00960934|10981031|FG005|Overall Study|Study Terminated by Sponsor|49
7067731|NCT01988012|11168874|FG000|Overall Study|Physician Decision|1
6943993|NCT00960986|10981049|FG000|Period 1 (Screening and Washout)|Adverse Event|1
6943994|NCT00960986|10981050|FG001|Period 1 (Screening and Washout)|Adverse Event|2
6975711|NCT01194258|11027913|FG003|Period 1 (12 Weeks)|Death|0
7067732|NCT01988012|11168874|FG000|Overall Study|Protocol Violation|1
7067733|NCT01988090|11168880|FG000|Start Treament After Randomization|Withdrawal by Subject|2
7067734|NCT01988090|11168881|FG001|Start Treament After Randomization|Withdrawal by Subject|3
7067735|NCT01988090|11168880|FG000|Start Treament After Randomization|Protocol Violation|0
7067736|NCT01988090|11168881|FG001|Start Treament After Randomization|Protocol Violation|1
7067737|NCT01988090|11168880|FG000|Complete Study After Start|Withdrawal by Subject|2
7067738|NCT01988090|11168881|FG001|Complete Study After Start|Withdrawal by Subject|0
7067739|NCT01988090|11168880|FG000|Complete Study After Start|Protocol Violation|1
7067740|NCT01988090|11168881|FG001|Complete Study After Start|Protocol Violation|1
7067741|NCT01988103|11168890|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3
7067742|NCT01988103|11168891|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10
7067743|NCT01988103|11168892|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6
7067744|NCT01988103|11168893|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0
7067745|NCT01988103|11168894|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0
7067746|NCT01988103|11168890|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1
7067747|NCT01988103|11168891|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2
7067748|NCT01988103|11168892|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2
7067749|NCT01988103|11168893|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0
7067750|NCT01988103|11168894|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0
7067751|NCT01988103|11168890|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8
6943995|NCT00960986|10981051|FG002|Period 1 (Screening and Washout)|Adverse Event|1
6943996|NCT00960986|10981052|FG003|Period 1 (Screening and Washout)|Adverse Event|1
6943997|NCT00960986|10981049|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0
6943998|NCT00960986|10981050|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0
6943999|NCT00960986|10981051|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2
6944000|NCT00960986|10981052|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1
6944001|NCT00960986|10981049|FG000|Period 1 (Screening and Washout)|Protocol Violation|1
6944002|NCT00960986|10981050|FG001|Period 1 (Screening and Washout)|Protocol Violation|0
6944003|NCT00960986|10981051|FG002|Period 1 (Screening and Washout)|Protocol Violation|0
6944004|NCT00960986|10981052|FG003|Period 1 (Screening and Washout)|Protocol Violation|0
6944005|NCT00960986|10981049|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1
7040683|NCT01719380|11123783|FG000|Overall Study|Adverse Event|0
7040684|NCT01719380|11123784|FG001|Overall Study|Adverse Event|0
7040685|NCT01719380|11123785|FG002|Overall Study|Adverse Event|1
7040686|NCT01719380|11123786|FG003|Overall Study|Adverse Event|2
6944006|NCT00960986|10981050|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2
6944007|NCT00960986|10981051|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1
6944008|NCT00960986|10981052|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1
6944009|NCT00960986|10981049|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17
6944010|NCT00960986|10981050|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15
6944011|NCT00960986|10981051|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10
6944012|NCT00960986|10981052|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12
6944013|NCT00960986|10981049|FG000|Period 3 (7-week Therapy Period)|Death|0
6944014|NCT00960986|10981050|FG001|Period 3 (7-week Therapy Period)|Death|0
6944015|NCT00960986|10981051|FG002|Period 3 (7-week Therapy Period)|Death|1
6944016|NCT00960986|10981052|FG003|Period 3 (7-week Therapy Period)|Death|0
6944017|NCT00960986|10981049|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
6944018|NCT00960986|10981050|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
6944019|NCT00960986|10981051|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1
6944020|NCT00960986|10981052|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
6944021|NCT00960986|10981049|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10
6944022|NCT00960986|10981050|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4
6944023|NCT00960986|10981051|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3
6944024|NCT00960986|10981052|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11
6944025|NCT00960986|10981049|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
6944026|NCT00960986|10981050|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
6944027|NCT00960986|10981051|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4
6944028|NCT00960986|10981052|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
6944029|NCT00960986|10981049|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
6944030|NCT00960986|10981050|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2
6944031|NCT00960986|10981051|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
6944032|NCT00960986|10981052|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0
6944033|NCT00960999|10981064|FG000|Overall Study|Withdrawal by Subject|1
6944034|NCT00960999|10981065|FG001|Overall Study|Withdrawal by Subject|0
6944035|NCT00960999|10981064|FG000|Overall Study|Protocol Violation|5
6944036|NCT00960999|10981065|FG001|Overall Study|Protocol Violation|2
6944037|NCT00960999|10981064|FG000|Overall Study|RT dose constraints not met|2
6944038|NCT00960999|10981065|FG001|Overall Study|RT dose constraints not met|0
6944039|NCT00961116|10981080|FG000|Washout Period of 7 Days|Adverse Event|1
6944040|NCT00961116|10981081|FG001|Washout Period of 7 Days|Adverse Event|1
6944041|NCT00961116|10981080|FG000|Washout Period of 7 Days|Withdrawal by Subject|1
6944042|NCT00961116|10981081|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
6944043|NCT00961116|10981080|FG000|Washout Period of 7 Days|Protocol Violation|0
6944044|NCT00961116|10981081|FG001|Washout Period of 7 Days|Protocol Violation|1
6944045|NCT00961181|10981088|FG000|Overall Study|Death|2
6944046|NCT00961181|10981088|FG000|Overall Study|Withdrawal by Subject|2
6944047|NCT00961181|10981088|FG000|Overall Study|Lost to Follow-up|1
6944048|NCT00961220|10981092|FG000|Overall Study|Adverse Event|3
6944049|NCT00961220|10981092|FG000|Overall Study|Lack of Efficacy|1
6944050|NCT00961220|10981092|FG000|Overall Study|No IV access for O6BG|1
6944051|NCT00961220|10981092|FG000|Overall Study|O6BG no longer supplied|1
6944052|NCT00961220|10981092|FG000|Overall Study|Complete Response prior to 12 courses|1
6944053|NCT00961259|10981109|FG000|Washout Period of 7 Days|due to concomitant medication used|0
6944054|NCT00961259|10981110|FG001|Washout Period of 7 Days|due to concomitant medication used|1
6944055|NCT00961259|10981111|FG002|Washout Period of 7 Days|due to concomitant medication used|0
7067752|NCT01988103|11168891|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4
7067753|NCT01988103|11168892|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1
7067754|NCT01988103|11168893|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0
6944056|NCT00961298|10981120|FG000|Two Week Placebo Run in|Withdrawal by Subject|1
6944057|NCT00961298|10981120|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2
6944058|NCT00961298|10981120|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1
6944059|NCT00961350|10981130|FG000|Overall Study|Adverse Event|18
6944060|NCT00961350|10981131|FG001|Overall Study|Adverse Event|33
6944061|NCT00961350|10981130|FG000|Overall Study|Withdrawal by Subject|10
6944062|NCT00961350|10981131|FG001|Overall Study|Withdrawal by Subject|10
6944063|NCT00961350|10981130|FG000|Overall Study|Lost to Follow-up|3
6944064|NCT00961350|10981131|FG001|Overall Study|Lost to Follow-up|3
6944065|NCT00961350|10981130|FG000|Overall Study|Misc|16
6944066|NCT00961350|10981131|FG001|Overall Study|Misc|21
6944067|NCT00961415|10981148|FG000|Induction Treatment Phase|Withdrawal by Subject|11
6944068|NCT00961415|10981149|FG001|Induction Treatment Phase|Withdrawal by Subject|0
6944069|NCT00961415|10981150|FG002|Induction Treatment Phase|Withdrawal by Subject|0
6944070|NCT00961415|10981148|FG000|Induction Treatment Phase|Death|77
6944071|NCT00961415|10981149|FG001|Induction Treatment Phase|Death|0
6944072|NCT00961415|10981150|FG002|Induction Treatment Phase|Death|0
6944073|NCT00961415|10981148|FG000|Induction Treatment Phase|Protocol Violation|1
6944074|NCT00961415|10981149|FG001|Induction Treatment Phase|Protocol Violation|0
6944075|NCT00961415|10981150|FG002|Induction Treatment Phase|Protocol Violation|0
6944076|NCT00961415|10981148|FG000|Induction Treatment Phase|Physician Decision|2
6944077|NCT00961415|10981149|FG001|Induction Treatment Phase|Physician Decision|0
6944078|NCT00961415|10981150|FG002|Induction Treatment Phase|Physician Decision|0
6944079|NCT00961415|10981148|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27
6944080|NCT00961415|10981149|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0
6944081|NCT00961415|10981150|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0
6944082|NCT00961415|10981148|FG000|Induction Treatment Phase|Other Reason|5
6944083|NCT00961415|10981149|FG001|Induction Treatment Phase|Other Reason|0
6944084|NCT00961415|10981150|FG002|Induction Treatment Phase|Other Reason|0
6944085|NCT00961415|10981148|FG000|Maintenance Treatment Phase|Death|0
6944086|NCT00961415|10981149|FG001|Maintenance Treatment Phase|Death|42
6944087|NCT00961415|10981150|FG002|Maintenance Treatment Phase|Death|34
6944088|NCT00961415|10981148|FG000|Maintenance Treatment Phase|Investigators decision|0
6944089|NCT00961415|10981149|FG001|Maintenance Treatment Phase|Investigators decision|2
6944090|NCT00961415|10981150|FG002|Maintenance Treatment Phase|Investigators decision|0
6944091|NCT00961415|10981148|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0
6944092|NCT00961415|10981149|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3
6944093|NCT00961415|10981150|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8
6944094|NCT00961415|10981148|FG000|Maintenance Treatment Phase|Other reason|0
6944095|NCT00961415|10981149|FG001|Maintenance Treatment Phase|Other reason|1
6944096|NCT00961415|10981150|FG002|Maintenance Treatment Phase|Other reason|3
6944097|NCT00961571|10981177|FG000|Overall Study|Physician Decision|39
6975712|NCT01194258|11027914|FG004|Period 1 (12 Weeks)|Death|1
6975713|NCT01194258|11027910|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0
6975714|NCT01194258|11027911|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0
7067755|NCT01988103|11168894|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0
7067756|NCT01988103|11168890|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0
7067757|NCT01988103|11168891|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6
7067758|NCT01988103|11168892|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3
7067759|NCT01988103|11168893|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3
7067760|NCT01988103|11168894|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2
7067761|NCT01988103|11168890|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0
7067762|NCT01988103|11168891|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1
6975715|NCT01194258|11027912|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0
6975716|NCT01194258|11027913|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0
6975717|NCT01194258|11027914|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2
7067763|NCT01988103|11168892|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2
7067764|NCT01988103|11168893|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0
7067765|NCT01988103|11168894|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0
7067766|NCT01988103|11168890|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0
7067767|NCT01988103|11168891|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5
7067768|NCT01988103|11168892|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4
6944098|NCT00961636|10981184|FG000|Overall Study|Adverse Event|35
6944099|NCT00961636|10981185|FG001|Overall Study|Adverse Event|54
6944100|NCT00961636|10981186|FG002|Overall Study|Adverse Event|13
6944101|NCT00961636|10981184|FG000|Overall Study|Flushing Symptoms|29
6944102|NCT00961636|10981185|FG001|Overall Study|Flushing Symptoms|46
6944103|NCT00961636|10981186|FG002|Overall Study|Flushing Symptoms|3
6944104|NCT00961636|10981184|FG000|Overall Study|Lost to Follow-up|2
6944105|NCT00961636|10981185|FG001|Overall Study|Lost to Follow-up|3
6944106|NCT00961636|10981186|FG002|Overall Study|Lost to Follow-up|1
6944107|NCT00961636|10981184|FG000|Overall Study|Physician Decision|3
6944108|NCT00961636|10981185|FG001|Overall Study|Physician Decision|1
6944109|NCT00961636|10981186|FG002|Overall Study|Physician Decision|1
6944110|NCT00961636|10981184|FG000|Overall Study|Protocol Violation|9
6838352|NCT00257608|10843939|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0
6838353|NCT00257608|10843940|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1
6838354|NCT00257608|10843938|FG000|Post Chemotherapy Phase|Lost to Follow-up|0
6838355|NCT00257608|10843939|FG001|Post Chemotherapy Phase|Lost to Follow-up|0
6838356|NCT00257608|10843940|FG002|Post Chemotherapy Phase|Lost to Follow-up|1
6838357|NCT00257608|10843938|FG000|Post Chemotherapy Phase|Physician Decision|0
6838358|NCT00257608|10843939|FG001|Post Chemotherapy Phase|Physician Decision|8
6838359|NCT00257608|10843940|FG002|Post Chemotherapy Phase|Physician Decision|11
6838360|NCT00257608|10843938|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
6838361|NCT00257608|10843939|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1
6838362|NCT00257608|10843940|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
6838363|NCT00257608|10843938|FG000|Post Chemotherapy Phase|Not treated|0
6838364|NCT00257608|10843939|FG001|Post Chemotherapy Phase|Not treated|4
6838365|NCT00257608|10843940|FG002|Post Chemotherapy Phase|Not treated|7
6838366|NCT00257660|10843955|FG000|Overall Study|Lack of Efficacy|5
6838367|NCT00257660|10843956|FG001|Overall Study|Lack of Efficacy|23
6838368|NCT00257660|10843955|FG000|Overall Study|Withdrawal by Subject|2
6838369|NCT00257660|10843956|FG001|Overall Study|Withdrawal by Subject|0
6838370|NCT00257660|10843955|FG000|Overall Study|Lost to Follow-up|1
6838371|NCT00257660|10843956|FG001|Overall Study|Lost to Follow-up|0
6838372|NCT00257660|10843955|FG000|Overall Study|PI & Subject Schedule Conflicts|1
6838373|NCT00257660|10843956|FG001|Overall Study|PI & Subject Schedule Conflicts|0
6838374|NCT00257660|10843955|FG000|Overall Study|No longer wanted to do blood draws|1
6838375|NCT00257660|10843956|FG001|Overall Study|No longer wanted to do blood draws|0
7067769|NCT01988103|11168893|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0
7067770|NCT01988103|11168894|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1
7067771|NCT01988103|11168890|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0
7067772|NCT01988103|11168891|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1
7067773|NCT01988103|11168892|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2
7067774|NCT01988103|11168893|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0
7067775|NCT01988103|11168894|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2
7067776|NCT01988402|11168941|FG000|Overall Study|Adverse Event|1
7067777|NCT01988402|11168942|FG001|Overall Study|Adverse Event|2
7067778|NCT01988402|11168941|FG000|Overall Study|Withdrawal by Subject|1
7067779|NCT01988402|11168942|FG001|Overall Study|Withdrawal by Subject|0
7082590|NCT02143141|11193170|FG000|Overall Study|pain scores at 24 hours not collected|1
6838376|NCT00257725|10843987|FG000|Overall Study|Adverse Event|3
6838377|NCT00257920|10844003|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0
6838378|NCT00257920|10844004|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1
6838379|NCT00257920|10844003|FG000|Period: Second Intervention|Other|2
6838380|NCT00257920|10844004|FG001|Period: Second Intervention|Other|1
6838381|NCT00258154|10844037|FG000|Overall Study|Adverse Event|1
6944111|NCT00961636|10981185|FG001|Overall Study|Protocol Violation|5
6944112|NCT00961636|10981186|FG002|Overall Study|Protocol Violation|1
6944113|NCT00961636|10981184|FG000|Overall Study|Withdrawal by Subject|29
6944114|NCT00961636|10981185|FG001|Overall Study|Withdrawal by Subject|22
7082591|NCT02143141|11193171|FG001|Overall Study|pain scores at 24 hours not collected|0
7082592|NCT02143583|11193184|FG000|Overall Study|Withdrawal by Subject|1
7082593|NCT02143583|11193185|FG001|Overall Study|Withdrawal by Subject|0
7082594|NCT02143583|11193186|FG002|Overall Study|Withdrawal by Subject|1
7082595|NCT02143583|11193184|FG000|Overall Study|husband illness|0
7082596|NCT02143583|11193185|FG001|Overall Study|husband illness|0
7082597|NCT02143583|11193186|FG002|Overall Study|husband illness|1
7082598|NCT02143713|11193211|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1
7082599|NCT02143713|11193212|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2
7082600|NCT02143713|11193213|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5
7082601|NCT02143713|11193214|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4
7082602|NCT02143713|11193211|FG000|Treatment Period (6 Months)|Adverse Event|7
6838382|NCT00258154|10844038|FG001|Overall Study|Adverse Event|0
6838383|NCT00258154|10844037|FG000|Overall Study|Lost to Follow-up|0
6838384|NCT00258154|10844038|FG001|Overall Study|Lost to Follow-up|1
6944115|NCT00961636|10981186|FG002|Overall Study|Withdrawal by Subject|13
6944116|NCT00961649|10981198|FG000|Overall Study|Adverse Event|4
6838385|NCT00258154|10844037|FG000|Overall Study|Protocol Violation|2
6944117|NCT00961649|10981199|FG001|Overall Study|Adverse Event|0
6944118|NCT00961649|10981200|FG002|Overall Study|Adverse Event|0
6944119|NCT00961649|10981201|FG003|Overall Study|Adverse Event|2
6944120|NCT00961649|10981198|FG000|Overall Study|Inadequate control of IOP|0
6944121|NCT00961649|10981199|FG001|Overall Study|Inadequate control of IOP|0
6944122|NCT00961649|10981200|FG002|Overall Study|Inadequate control of IOP|0
6944123|NCT00961649|10981201|FG003|Overall Study|Inadequate control of IOP|1
6944124|NCT00961649|10981198|FG000|Overall Study|Patient has travel plans during holidays|0
6944125|NCT00961649|10981199|FG001|Overall Study|Patient has travel plans during holidays|0
6944126|NCT00961649|10981200|FG002|Overall Study|Patient has travel plans during holidays|1
6944127|NCT00961649|10981201|FG003|Overall Study|Patient has travel plans during holidays|0
6944128|NCT00961649|10981198|FG000|Overall Study|Patient left to Mexico-family emergency|1
6944129|NCT00961649|10981199|FG001|Overall Study|Patient left to Mexico-family emergency|0
6944130|NCT00961649|10981200|FG002|Overall Study|Patient left to Mexico-family emergency|0
6944131|NCT00961649|10981201|FG003|Overall Study|Patient left to Mexico-family emergency|0
6944132|NCT00961649|10981198|FG000|Overall Study|Study terminated by sponsor|4
6944133|NCT00961649|10981199|FG001|Overall Study|Study terminated by sponsor|4
6944134|NCT00961649|10981200|FG002|Overall Study|Study terminated by sponsor|4
6944135|NCT00961649|10981201|FG003|Overall Study|Study terminated by sponsor|1
6944136|NCT00961896|10981227|FG000|Overall Study|Abnormal laboratory value|0
6944137|NCT00961896|10981228|FG001|Overall Study|Abnormal laboratory value|0
6944138|NCT00961896|10981229|FG002|Overall Study|Abnormal laboratory value|1
6944139|NCT00961961|10981244|FG000|Phase I|Withdrawal by Subject|7
6944140|NCT00961961|10981245|FG001|Phase I|Withdrawal by Subject|0
6944141|NCT00961961|10981246|FG002|Phase I|Withdrawal by Subject|0
6944142|NCT00961961|10981247|FG003|Phase I|Withdrawal by Subject|0
6944143|NCT00961961|10981244|FG000|Phase I|Lost to Follow-up|10
6944144|NCT00961961|10981245|FG001|Phase I|Lost to Follow-up|0
6944145|NCT00961961|10981246|FG002|Phase I|Lost to Follow-up|0
6944146|NCT00961961|10981247|FG003|Phase I|Lost to Follow-up|0
6944147|NCT00961961|10981244|FG000|Phase I|Lack of Efficacy|94
6944148|NCT00961961|10981245|FG001|Phase I|Lack of Efficacy|0
6944149|NCT00961961|10981246|FG002|Phase I|Lack of Efficacy|0
6944150|NCT00961961|10981247|FG003|Phase I|Lack of Efficacy|0
6944151|NCT00961961|10981244|FG000|Phase I|Adverse Event|7
6944152|NCT00961961|10981245|FG001|Phase I|Adverse Event|0
6944153|NCT00961961|10981246|FG002|Phase I|Adverse Event|0
6944154|NCT00961961|10981247|FG003|Phase I|Adverse Event|0
6944155|NCT00961961|10981244|FG000|Phase I|Physician Decision|8
6944156|NCT00961961|10981245|FG001|Phase I|Physician Decision|0
6944157|NCT00961961|10981246|FG002|Phase I|Physician Decision|0
6944158|NCT00961961|10981247|FG003|Phase I|Physician Decision|0
6944159|NCT00961961|10981244|FG000|Phase II|Lost to Follow-up|0
6944160|NCT00961961|10981245|FG001|Phase II|Lost to Follow-up|0
6944161|NCT00961961|10981246|FG002|Phase II|Lost to Follow-up|10
6944162|NCT00961961|10981247|FG003|Phase II|Lost to Follow-up|7
6944163|NCT00961961|10981244|FG000|Phase II|Adverse Event|0
6944164|NCT00961961|10981245|FG001|Phase II|Adverse Event|0
6944165|NCT00961961|10981246|FG002|Phase II|Adverse Event|0
6944166|NCT00961961|10981247|FG003|Phase II|Adverse Event|1
6944167|NCT00961961|10981244|FG000|Phase II|Physician Decision|0
6944168|NCT00961961|10981245|FG001|Phase II|Physician Decision|0
6944169|NCT00961961|10981246|FG002|Phase II|Physician Decision|1
6944170|NCT00961961|10981247|FG003|Phase II|Physician Decision|0
6944171|NCT00961961|10981244|FG000|Phase II|Withdrawal by Subject|0
6944172|NCT00961961|10981245|FG001|Phase II|Withdrawal by Subject|0
6944173|NCT00961961|10981246|FG002|Phase II|Withdrawal by Subject|1
6944174|NCT00961961|10981247|FG003|Phase II|Withdrawal by Subject|0
6944175|NCT00962013|10981274|FG000|Overall Study|Did not have surgery|1
6944176|NCT00962013|10981274|FG000|Overall Study|Death|8
6944177|NCT00962013|10981274|FG000|Overall Study|Lost to Follow-up|12
6944178|NCT00962013|10981274|FG000|Overall Study|Unable/Unwilling to return|6
6944179|NCT00962013|10981274|FG000|Overall Study|Withdrawal by Subject|8
6944180|NCT00962013|10981274|FG000|Overall Study|Removal of study device|3
6944181|NCT00962013|10981274|FG000|Overall Study|Site Termination|24
6944182|NCT00962013|10981274|FG000|Overall Study|No 5 year evaluation|6
6944183|NCT00962091|10981316|FG000|Overall Study|Withdrawal by Subject|1
6944184|NCT00962091|10981317|FG001|Overall Study|Withdrawal by Subject|2
6944185|NCT00962091|10981318|FG002|Overall Study|Withdrawal by Subject|1
6944186|NCT00962091|10981319|FG003|Overall Study|Withdrawal by Subject|1
6944187|NCT00962091|10981320|FG004|Overall Study|Withdrawal by Subject|0
6944188|NCT00962091|10981321|FG005|Overall Study|Withdrawal by Subject|1
6944189|NCT00962091|10981322|FG006|Overall Study|Withdrawal by Subject|0
6944190|NCT00962091|10981316|FG000|Overall Study|Adverse Event|0
6944191|NCT00962091|10981317|FG001|Overall Study|Adverse Event|0
6944192|NCT00962091|10981318|FG002|Overall Study|Adverse Event|0
6944193|NCT00962091|10981319|FG003|Overall Study|Adverse Event|0
6944194|NCT00962091|10981320|FG004|Overall Study|Adverse Event|0
6944195|NCT00962091|10981321|FG005|Overall Study|Adverse Event|0
6944196|NCT00962091|10981322|FG006|Overall Study|Adverse Event|1
6944197|NCT00962104|10981348|FG000|Overall Study|Adverse Event|10
6944198|NCT00962104|10981349|FG001|Overall Study|Adverse Event|3
6944199|NCT00962104|10981348|FG000|Overall Study|Entry Criteria Not Met|1
6944200|NCT00962104|10981349|FG001|Overall Study|Entry Criteria Not Met|2
6944201|NCT00962104|10981348|FG000|Overall Study|Lack of Efficacy|0
6944202|NCT00962104|10981349|FG001|Overall Study|Lack of Efficacy|1
6944203|NCT00962104|10981348|FG000|Overall Study|Lost to Follow-up|10
6944204|NCT00962104|10981349|FG001|Overall Study|Lost to Follow-up|4
6944205|NCT00962104|10981348|FG000|Overall Study|Physician Decision|1
6944206|NCT00962104|10981349|FG001|Overall Study|Physician Decision|0
6944207|NCT00962104|10981348|FG000|Overall Study|Protocol Violation|6
6944208|NCT00962104|10981349|FG001|Overall Study|Protocol Violation|8
6944209|NCT00962104|10981348|FG000|Overall Study|Sponsor Decision|0
6944210|NCT00962104|10981349|FG001|Overall Study|Sponsor Decision|1
6944211|NCT00962104|10981348|FG000|Overall Study|Withdrawal by Subject|10
6944212|NCT00962104|10981349|FG001|Overall Study|Withdrawal by Subject|6
6944213|NCT00962104|10981348|FG000|Overall Study|Other|2
6944214|NCT00962104|10981349|FG001|Overall Study|Other|0
6944215|NCT00962208|10981357|FG000|Overall Study|Could not achieve good vision|9
6944216|NCT00962208|10981358|FG001|Overall Study|Could not achieve good vision|0
6944217|NCT00962208|10981357|FG000|Overall Study|Contraindicated to continue study|5
6944218|NCT00962208|10981358|FG001|Overall Study|Contraindicated to continue study|1
6944219|NCT00962208|10981357|FG000|Overall Study|Lost to Follow-up|0
6944220|NCT00962208|10981358|FG001|Overall Study|Lost to Follow-up|9
6944221|NCT00962247|10981364|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4
6944222|NCT00962247|10981364|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1
6944223|NCT00962390|10981374|FG000|Overall Study|Adverse Event|0
6944224|NCT00962390|10981375|FG001|Overall Study|Adverse Event|0
6944225|NCT00962390|10981376|FG002|Overall Study|Adverse Event|3
6944226|NCT00962390|10981377|FG003|Overall Study|Adverse Event|1
6944227|NCT00962390|10981374|FG000|Overall Study|Lost to Follow-up|2
6944228|NCT00962390|10981375|FG001|Overall Study|Lost to Follow-up|2
6944229|NCT00962390|10981376|FG002|Overall Study|Lost to Follow-up|0
6944230|NCT00962390|10981377|FG003|Overall Study|Lost to Follow-up|0
6944231|NCT00962390|10981374|FG000|Overall Study|Protocol Violation|1
6944232|NCT00962390|10981375|FG001|Overall Study|Protocol Violation|0
6944233|NCT00962390|10981376|FG002|Overall Study|Protocol Violation|0
7067780|NCT01988662|11168956|FG000|Overall Study|Subject/guardian decision|1
7067781|NCT01988662|11168957|FG001|Overall Study|Subject/guardian decision|1
6944234|NCT00962390|10981377|FG003|Overall Study|Protocol Violation|0
6944235|NCT00962390|10981374|FG000|Overall Study|Withdrawal by Subject|1
6944236|NCT00962390|10981375|FG001|Overall Study|Withdrawal by Subject|1
6944237|NCT00962390|10981376|FG002|Overall Study|Withdrawal by Subject|1
6944238|NCT00962390|10981377|FG003|Overall Study|Withdrawal by Subject|0
6944239|NCT00962585|10981391|FG000|Overall Study|Adverse Event|0
6944240|NCT00962585|10981392|FG001|Overall Study|Adverse Event|2
6944241|NCT00962585|10981393|FG002|Overall Study|Adverse Event|1
6944242|NCT00962585|10981394|FG003|Overall Study|Adverse Event|0
6944243|NCT00962585|10981391|FG000|Overall Study|Lost to Follow-up|3
6944244|NCT00962585|10981392|FG001|Overall Study|Lost to Follow-up|0
6944245|NCT00962585|10981393|FG002|Overall Study|Lost to Follow-up|1
6944246|NCT00962585|10981394|FG003|Overall Study|Lost to Follow-up|0
6944247|NCT00962585|10981391|FG000|Overall Study|Protocol Violation|0
6944248|NCT00962585|10981392|FG001|Overall Study|Protocol Violation|0
6944249|NCT00962585|10981393|FG002|Overall Study|Protocol Violation|1
6944250|NCT00962585|10981394|FG003|Overall Study|Protocol Violation|0
6944251|NCT00962585|10981391|FG000|Overall Study|Withdrawal by Subject|1
6944252|NCT00962585|10981392|FG001|Overall Study|Withdrawal by Subject|0
6944253|NCT00962585|10981393|FG002|Overall Study|Withdrawal by Subject|0
6944254|NCT00962585|10981394|FG003|Overall Study|Withdrawal by Subject|0
6944255|NCT00962585|10981391|FG000|Overall Study|Withdrew Consent|2
7067782|NCT01988662|11168956|FG000|Overall Study|Adverse Event|3
7067783|NCT01988662|11168957|FG001|Overall Study|Adverse Event|1
7067784|NCT01988779|11168966|FG000|Overall Study|Withdrawal by Subject|2
7067785|NCT01988779|11168967|FG001|Overall Study|Withdrawal by Subject|2
7067786|NCT01988779|11168966|FG000|Overall Study|Protocol Violation|1
7067787|NCT01988779|11168967|FG001|Overall Study|Protocol Violation|0
7067788|NCT01989156|11169005|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0
7067789|NCT01989156|11169006|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
7067790|NCT01989156|11169007|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3
7067791|NCT01989156|11169005|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0
7067792|NCT01989156|11169006|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0
6944256|NCT00962585|10981392|FG001|Overall Study|Withdrew Consent|0
6944257|NCT00962585|10981393|FG002|Overall Study|Withdrew Consent|0
6944258|NCT00962585|10981394|FG003|Overall Study|Withdrew Consent|0
6944259|NCT00962650|10981415|FG000|Overall Study|Transgastric DP was not completed|2
6944260|NCT00962741|10981419|FG000|Overall Study|Failed to return|3
6944261|NCT00962741|10981419|FG000|Overall Study|Lost to Follow-up|2
6944262|NCT00962741|10981419|FG000|Overall Study|Withdrawal by Subject|1
6944263|NCT00962741|10981419|FG000|Overall Study|Lack of Efficacy|1
7067793|NCT01989156|11169007|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1
6944264|NCT00962741|10981419|FG000|Overall Study|drug ineffective+prohibited drug taken|1
6944265|NCT00962780|10981438|FG000|Overall Study|Death|0
6944266|NCT00962780|10981439|FG001|Overall Study|Death|1
6944267|NCT00962780|10981438|FG000|Overall Study|Protocol Violation|9
6944268|NCT00962780|10981439|FG001|Overall Study|Protocol Violation|4
6944269|NCT00962780|10981438|FG000|Overall Study|Withdrawal by Subject|1
6944270|NCT00962780|10981439|FG001|Overall Study|Withdrawal by Subject|8
6944271|NCT00962780|10981438|FG000|Overall Study|Other|0
6944272|NCT00962780|10981439|FG001|Overall Study|Other|1
6944273|NCT00963235|10981511|FG000|Overall Study|Withdrawal by Subject|22
6944274|NCT00963235|10981511|FG000|Overall Study|Lost to Follow-up|14
6944275|NCT00963235|10981511|FG000|Overall Study|Failed to return|9
6944276|NCT00963235|10981511|FG000|Overall Study|Protocol Violation|7
6944277|NCT00963235|10981511|FG000|Overall Study|Adverse Event|5
6944278|NCT00963235|10981511|FG000|Overall Study|Physician Decision|2
6944279|NCT00963235|10981511|FG000|Overall Study|Other|1
6944280|NCT00963547|10981549|FG000|Overall Study|Adverse Event|0
6944281|NCT00963547|10981550|FG001|Overall Study|Adverse Event|1
6944282|NCT00963547|10981551|FG002|Overall Study|Adverse Event|0
6944283|NCT00963547|10981552|FG003|Overall Study|Adverse Event|1
6944284|NCT00963547|10981553|FG004|Overall Study|Adverse Event|0
6944285|NCT00963547|10981554|FG005|Overall Study|Adverse Event|0
6944286|NCT00963547|10981555|FG006|Overall Study|Adverse Event|0
6944287|NCT00963547|10981549|FG000|Overall Study|Physician Decision|1
6944288|NCT00963547|10981550|FG001|Overall Study|Physician Decision|1
7067794|NCT01989156|11169005|FG000|Confinement Period (Population at Day 5)|Adverse Event|0
7067795|NCT01989156|11169006|FG001|Confinement Period (Population at Day 5)|Adverse Event|0
7067796|NCT01989156|11169007|FG002|Confinement Period (Population at Day 5)|Adverse Event|1
7067797|NCT01989156|11169005|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2
7067798|NCT01989156|11169006|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2
7067799|NCT01989156|11169007|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2
7067800|NCT01989156|11169005|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3
7067801|NCT01989156|11169006|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2
7067802|NCT01989156|11169007|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0
7067803|NCT01989156|11169005|FG000|End of Study (Population at Day 90)|Physician Decision|1
7067804|NCT01989156|11169006|FG001|End of Study (Population at Day 90)|Physician Decision|0
7067805|NCT01989156|11169007|FG002|End of Study (Population at Day 90)|Physician Decision|1
7067806|NCT01989156|11169005|FG000|End of Study (Population at Day 90)|Moved out of state|1
7067807|NCT01989156|11169006|FG001|End of Study (Population at Day 90)|Moved out of state|0
7067808|NCT01989156|11169007|FG002|End of Study (Population at Day 90)|Moved out of state|0
7067809|NCT01989156|11169005|FG000|End of Study (Population at Day 90)|Employment Conflict|0
7067810|NCT01989156|11169006|FG001|End of Study (Population at Day 90)|Employment Conflict|1
7067811|NCT01989156|11169007|FG002|End of Study (Population at Day 90)|Employment Conflict|0
7067812|NCT01989169|11169017|FG000|Period 2|Adverse Event|0
7067813|NCT01989169|11169018|FG001|Period 2|Adverse Event|1
7067814|NCT01989208|11169033|FG000|200 mg (7 Days)|Protocol Violation|0
7067815|NCT01989208|11169034|FG001|200 mg (7 Days)|Protocol Violation|1
7067816|NCT01989455|11169061|FG000|Overall Study|Adverse Event|0
7067817|NCT01989455|11169062|FG001|Overall Study|Adverse Event|1
7067818|NCT01989455|11169063|FG002|Overall Study|Adverse Event|0
6944289|NCT00963547|10981551|FG002|Overall Study|Physician Decision|0
6944290|NCT00963547|10981552|FG003|Overall Study|Physician Decision|0
6944291|NCT00963547|10981553|FG004|Overall Study|Physician Decision|0
6944292|NCT00963547|10981554|FG005|Overall Study|Physician Decision|0
6944293|NCT00963547|10981555|FG006|Overall Study|Physician Decision|0
6944294|NCT00963547|10981549|FG000|Overall Study|Progressive Disease|3
6944295|NCT00963547|10981550|FG001|Overall Study|Progressive Disease|8
6944296|NCT00963547|10981551|FG002|Overall Study|Progressive Disease|9
6944297|NCT00963547|10981552|FG003|Overall Study|Progressive Disease|5
6944298|NCT00963547|10981553|FG004|Overall Study|Progressive Disease|0
6944299|NCT00963547|10981554|FG005|Overall Study|Progressive Disease|0
6944300|NCT00963547|10981555|FG006|Overall Study|Progressive Disease|0
6944301|NCT00963547|10981549|FG000|Overall Study|Withdrawal by Subject|0
6944302|NCT00963547|10981550|FG001|Overall Study|Withdrawal by Subject|0
6944303|NCT00963547|10981551|FG002|Overall Study|Withdrawal by Subject|3
6944304|NCT00963547|10981552|FG003|Overall Study|Withdrawal by Subject|0
6944305|NCT00963547|10981553|FG004|Overall Study|Withdrawal by Subject|0
6944306|NCT00963547|10981554|FG005|Overall Study|Withdrawal by Subject|0
6944307|NCT00963547|10981555|FG006|Overall Study|Withdrawal by Subject|0
6944308|NCT00963547|10981549|FG000|Overall Study|Reason Unknown|0
6944309|NCT00963547|10981550|FG001|Overall Study|Reason Unknown|1
6944310|NCT00963547|10981551|FG002|Overall Study|Reason Unknown|0
6944311|NCT00963547|10981552|FG003|Overall Study|Reason Unknown|0
6944312|NCT00963547|10981553|FG004|Overall Study|Reason Unknown|0
6944313|NCT00963547|10981554|FG005|Overall Study|Reason Unknown|0
6944314|NCT00963547|10981555|FG006|Overall Study|Reason Unknown|0
6944315|NCT00963807|10981599|FG000|Overall Study|Physician Decision|2
7067819|NCT01989455|11169064|FG003|Overall Study|Adverse Event|0
7067820|NCT01989455|11169065|FG004|Overall Study|Adverse Event|0
6944316|NCT00963807|10981599|FG000|Overall Study|Reaction to study chemotherapy regimen|1
6944317|NCT00963807|10981599|FG000|Overall Study|Disease progression|15
7067821|NCT01989455|11169061|FG000|Overall Study|Withdrawal by Subject|0
6944318|NCT00963820|10981605|FG000|Dose Escalation Phase|Progressive Disease|3
6944319|NCT00963820|10981606|FG001|Dose Escalation Phase|Progressive Disease|3
6944320|NCT00963820|10981607|FG002|Dose Escalation Phase|Progressive Disease|3
6944321|NCT00963820|10981608|FG003|Dose Escalation Phase|Progressive Disease|3
6944322|NCT00963820|10981609|FG004|Dose Escalation Phase|Progressive Disease|4
6944323|NCT00963820|10981610|FG005|Dose Escalation Phase|Progressive Disease|3
6944324|NCT00963820|10981611|FG006|Dose Escalation Phase|Progressive Disease|3
6944325|NCT00963820|10981612|FG007|Dose Escalation Phase|Progressive Disease|2
6944326|NCT00963820|10981613|FG008|Dose Escalation Phase|Progressive Disease|0
6944327|NCT00963820|10981614|FG009|Dose Escalation Phase|Progressive Disease|0
6944328|NCT00963820|10981615|FG010|Dose Escalation Phase|Progressive Disease|0
6944329|NCT00963820|10981616|FG011|Dose Escalation Phase|Progressive Disease|0
6944330|NCT00963820|10981605|FG000|Dose Escalation Phase|Adverse Event|0
6944331|NCT00963820|10981606|FG001|Dose Escalation Phase|Adverse Event|0
6944332|NCT00963820|10981607|FG002|Dose Escalation Phase|Adverse Event|0
6944333|NCT00963820|10981608|FG003|Dose Escalation Phase|Adverse Event|0
6944334|NCT00963820|10981609|FG004|Dose Escalation Phase|Adverse Event|0
6944335|NCT00963820|10981610|FG005|Dose Escalation Phase|Adverse Event|0
6944336|NCT00963820|10981611|FG006|Dose Escalation Phase|Adverse Event|3
6944337|NCT00963820|10981612|FG007|Dose Escalation Phase|Adverse Event|1
6944338|NCT00963820|10981613|FG008|Dose Escalation Phase|Adverse Event|0
6944339|NCT00963820|10981614|FG009|Dose Escalation Phase|Adverse Event|0
6944340|NCT00963820|10981615|FG010|Dose Escalation Phase|Adverse Event|0
6944341|NCT00963820|10981616|FG011|Dose Escalation Phase|Adverse Event|0
6944342|NCT00963820|10981605|FG000|Dose Escalation Phase|Withdrawal by Subject|0
6944343|NCT00963820|10981606|FG001|Dose Escalation Phase|Withdrawal by Subject|0
6944344|NCT00963820|10981607|FG002|Dose Escalation Phase|Withdrawal by Subject|0
6944345|NCT00963820|10981608|FG003|Dose Escalation Phase|Withdrawal by Subject|0
6944346|NCT00963820|10981609|FG004|Dose Escalation Phase|Withdrawal by Subject|0
6944347|NCT00963820|10981610|FG005|Dose Escalation Phase|Withdrawal by Subject|0
6944348|NCT00963820|10981611|FG006|Dose Escalation Phase|Withdrawal by Subject|1
6944349|NCT00963820|10981612|FG007|Dose Escalation Phase|Withdrawal by Subject|2
6944350|NCT00963820|10981613|FG008|Dose Escalation Phase|Withdrawal by Subject|0
6944351|NCT00963820|10981614|FG009|Dose Escalation Phase|Withdrawal by Subject|0
6944352|NCT00963820|10981615|FG010|Dose Escalation Phase|Withdrawal by Subject|0
6944353|NCT00963820|10981616|FG011|Dose Escalation Phase|Withdrawal by Subject|0
6944354|NCT00963820|10981605|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
6944355|NCT00963820|10981606|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
6944356|NCT00963820|10981607|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
6944357|NCT00963820|10981608|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
6944358|NCT00963820|10981609|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
6944359|NCT00963820|10981610|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
6944360|NCT00963820|10981611|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
6944361|NCT00963820|10981612|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
6944362|NCT00963820|10981613|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
6944363|NCT00963820|10981614|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
6944364|NCT00963820|10981615|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
6944365|NCT00963820|10981616|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
6944366|NCT00963820|10981605|FG000|Expansion Phase|Progressive Disease|0
6944367|NCT00963820|10981606|FG001|Expansion Phase|Progressive Disease|0
6944368|NCT00963820|10981607|FG002|Expansion Phase|Progressive Disease|0
6944369|NCT00963820|10981608|FG003|Expansion Phase|Progressive Disease|0
6944370|NCT00963820|10981609|FG004|Expansion Phase|Progressive Disease|0
6944371|NCT00963820|10981610|FG005|Expansion Phase|Progressive Disease|0
6944372|NCT00963820|10981611|FG006|Expansion Phase|Progressive Disease|0
6944373|NCT00963820|10981612|FG007|Expansion Phase|Progressive Disease|0
6944374|NCT00963820|10981613|FG008|Expansion Phase|Progressive Disease|8
6944375|NCT00963820|10981614|FG009|Expansion Phase|Progressive Disease|6
6944376|NCT00963820|10981615|FG010|Expansion Phase|Progressive Disease|4
6944377|NCT00963820|10981616|FG011|Expansion Phase|Progressive Disease|2
6944378|NCT00963820|10981605|FG000|Expansion Phase|Adverse Event|0
6944379|NCT00963820|10981606|FG001|Expansion Phase|Adverse Event|0
6944380|NCT00963820|10981607|FG002|Expansion Phase|Adverse Event|0
6944381|NCT00963820|10981608|FG003|Expansion Phase|Adverse Event|0
6944382|NCT00963820|10981609|FG004|Expansion Phase|Adverse Event|0
6944383|NCT00963820|10981610|FG005|Expansion Phase|Adverse Event|0
6944384|NCT00963820|10981611|FG006|Expansion Phase|Adverse Event|0
6944385|NCT00963820|10981612|FG007|Expansion Phase|Adverse Event|0
6944386|NCT00963820|10981613|FG008|Expansion Phase|Adverse Event|1
6944387|NCT00963820|10981614|FG009|Expansion Phase|Adverse Event|3
6944388|NCT00963820|10981615|FG010|Expansion Phase|Adverse Event|0
6944389|NCT00963820|10981616|FG011|Expansion Phase|Adverse Event|0
6944390|NCT00963820|10981605|FG000|Expansion Phase|Withdrawal by Subject|0
6944391|NCT00963820|10981606|FG001|Expansion Phase|Withdrawal by Subject|0
6944392|NCT00963820|10981607|FG002|Expansion Phase|Withdrawal by Subject|0
6944393|NCT00963820|10981608|FG003|Expansion Phase|Withdrawal by Subject|0
6944394|NCT00963820|10981609|FG004|Expansion Phase|Withdrawal by Subject|0
6944395|NCT00963820|10981610|FG005|Expansion Phase|Withdrawal by Subject|0
7067822|NCT01989455|11169062|FG001|Overall Study|Withdrawal by Subject|1
7067823|NCT01989455|11169063|FG002|Overall Study|Withdrawal by Subject|0
7067824|NCT01989455|11169064|FG003|Overall Study|Withdrawal by Subject|0
7067825|NCT01989455|11169065|FG004|Overall Study|Withdrawal by Subject|0
7067826|NCT01989455|11169061|FG000|Overall Study|Technical problems with infusion|0
7067827|NCT01989455|11169062|FG001|Overall Study|Technical problems with infusion|0
7067828|NCT01989455|11169063|FG002|Overall Study|Technical problems with infusion|1
7067829|NCT01989455|11169064|FG003|Overall Study|Technical problems with infusion|0
7082603|NCT02143713|11193212|FG001|Treatment Period (6 Months)|Adverse Event|8
6944396|NCT00963820|10981611|FG006|Expansion Phase|Withdrawal by Subject|0
6944397|NCT00963820|10981612|FG007|Expansion Phase|Withdrawal by Subject|0
6944398|NCT00963820|10981613|FG008|Expansion Phase|Withdrawal by Subject|1
6944399|NCT00963820|10981614|FG009|Expansion Phase|Withdrawal by Subject|0
6944400|NCT00963820|10981615|FG010|Expansion Phase|Withdrawal by Subject|1
6944401|NCT00963820|10981616|FG011|Expansion Phase|Withdrawal by Subject|1
6944402|NCT00963820|10981605|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0
6944403|NCT00963820|10981606|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0
6944404|NCT00963820|10981607|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0
6944405|NCT00963820|10981608|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0
6944406|NCT00963820|10981609|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0
6944407|NCT00963820|10981610|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0
6944408|NCT00963820|10981611|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0
6944409|NCT00963820|10981612|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0
6944410|NCT00963820|10981613|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0
6944411|NCT00963820|10981614|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0
6944412|NCT00963820|10981615|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0
6944413|NCT00963820|10981616|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1
6944414|NCT00963924|10981652|FG000|Overall Study|Adverse Event|1
6944415|NCT00963924|10981653|FG001|Overall Study|Adverse Event|0
6944416|NCT00963924|10981652|FG000|Overall Study|Withdrawal by Subject|0
6944417|NCT00963924|10981653|FG001|Overall Study|Withdrawal by Subject|1
6944418|NCT00963924|10981652|FG000|Overall Study|Changed antipsychotic|0
6944419|NCT00963924|10981653|FG001|Overall Study|Changed antipsychotic|1
6944420|NCT00963924|10981652|FG000|Overall Study|Lost to Follow-up|0
6944421|NCT00963924|10981653|FG001|Overall Study|Lost to Follow-up|1
6944422|NCT00963937|10981664|FG000|Overall Study|Protocol Violation|1
6944423|NCT00963937|10981665|FG001|Overall Study|Protocol Violation|1
6944424|NCT00963937|10981666|FG002|Overall Study|Protocol Violation|0
6944425|NCT00963937|10981664|FG000|Overall Study|Physician Decision|18
6944426|NCT00963937|10981665|FG001|Overall Study|Physician Decision|10
6944427|NCT00963937|10981666|FG002|Overall Study|Physician Decision|4
6944428|NCT00964028|10981683|FG000|Overall Study|Withdrawal by Subject|0
6944429|NCT00964028|10981684|FG001|Overall Study|Withdrawal by Subject|1
6944430|NCT00964158|10981697|FG000|Overall Study|Lost to Follow-up|0
6944431|NCT00964158|10981698|FG001|Overall Study|Lost to Follow-up|1
6944432|NCT00964158|10981699|FG002|Overall Study|Lost to Follow-up|2
6944433|NCT00964158|10981697|FG000|Overall Study|Withdrawal by Subject|0
6944434|NCT00964158|10981698|FG001|Overall Study|Withdrawal by Subject|0
6944435|NCT00964158|10981699|FG002|Overall Study|Withdrawal by Subject|6
6944436|NCT00964223|10981710|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
6944437|NCT00964366|10981726|FG000|Overall Study|Did not qualify at Day 1|1
6944438|NCT00964366|10981727|FG001|Overall Study|Did not qualify at Day 1|0
6944439|NCT00964366|10981726|FG000|Overall Study|Withdrawal by Subject|0
6944440|NCT00964366|10981727|FG001|Overall Study|Withdrawal by Subject|1
6944441|NCT00964392|10981735|FG000|Overall Study|Withdrawal by Subject|4
6944442|NCT00964392|10981736|FG001|Overall Study|Withdrawal by Subject|6
6944443|NCT00964392|10981735|FG000|Overall Study|Lost to Follow-up|4
6944444|NCT00964392|10981736|FG001|Overall Study|Lost to Follow-up|10
6944445|NCT00964392|10981735|FG000|Overall Study|Early Termination, non-study arrhythmia|1
6944446|NCT00964392|10981736|FG001|Overall Study|Early Termination, non-study arrhythmia|6
6944447|NCT00964392|10981735|FG000|Overall Study|Not completed|44
6944448|NCT00964392|10981736|FG001|Overall Study|Not completed|168
6944449|NCT00964678|10981781|FG000|Overall Study|Physician Decision|4
6944450|NCT00964743|10981786|FG000|Overall Study|Neither patient completed 8 weeks of tre|2
6944451|NCT00964782|10981792|FG000|Overall Study|Lost to Follow-up|1
6944452|NCT00964782|10981793|FG001|Overall Study|Lost to Follow-up|0
6944453|NCT00964795|10981801|FG000|Overall Study|Withdrawal by Subject|79
6944454|NCT00964795|10981801|FG000|Overall Study|Adverse Event|12
6944455|NCT00964795|10981801|FG000|Overall Study|Death|14
6944456|NCT00964795|10981801|FG000|Overall Study|Lost to Follow-up|7
6944457|NCT00964795|10981801|FG000|Overall Study|Termination of Study by Sponsor|169
6944458|NCT00964795|10981801|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3
6944459|NCT00964795|10981801|FG000|Overall Study|Other|23
6944460|NCT00964860|10981808|FG000|Overall Study|Withdrawal by Subject|0
6944461|NCT00964860|10981809|FG001|Overall Study|Withdrawal by Subject|1
6944462|NCT00964886|10981819|FG000|Overall Study|Lost to Follow-up|2
6944463|NCT00964886|10981820|FG001|Overall Study|Lost to Follow-up|2
6944464|NCT00964886|10981821|FG002|Overall Study|Lost to Follow-up|6
6944465|NCT00964886|10981822|FG003|Overall Study|Lost to Follow-up|4
6944466|NCT00964886|10981819|FG000|Overall Study|Withdrawal by Subject|6
6944467|NCT00964886|10981820|FG001|Overall Study|Withdrawal by Subject|2
6944468|NCT00964886|10981821|FG002|Overall Study|Withdrawal by Subject|5
6944469|NCT00964886|10981822|FG003|Overall Study|Withdrawal by Subject|3
6944470|NCT00964886|10981819|FG000|Overall Study|Adverse Event|3
6944471|NCT00964886|10981820|FG001|Overall Study|Adverse Event|1
6944472|NCT00964886|10981821|FG002|Overall Study|Adverse Event|5
6944473|NCT00964886|10981822|FG003|Overall Study|Adverse Event|2
6944474|NCT00964886|10981819|FG000|Overall Study|Protocol Violation|0
6944475|NCT00964886|10981820|FG001|Overall Study|Protocol Violation|2
6944476|NCT00964886|10981821|FG002|Overall Study|Protocol Violation|0
6944477|NCT00964886|10981822|FG003|Overall Study|Protocol Violation|0
6944478|NCT00965081|10981838|FG000|Overall Study|Adverse Event|14
6944479|NCT00965081|10981839|FG001|Overall Study|Adverse Event|9
6944480|NCT00965081|10981838|FG000|Overall Study|Lack of Efficacy|2
6944481|NCT00965081|10981839|FG001|Overall Study|Lack of Efficacy|5
6944482|NCT00965081|10981838|FG000|Overall Study|Lost to Follow-up|4
6944483|NCT00965081|10981839|FG001|Overall Study|Lost to Follow-up|5
6944484|NCT00965081|10981838|FG000|Overall Study|Physician Decision|2
7067830|NCT01989455|11169065|FG004|Overall Study|Technical problems with infusion|1
7067831|NCT01989468|11169084|FG000|Overall Study|Adverse Event|10
7067832|NCT01989468|11169085|FG001|Overall Study|Adverse Event|15
7067833|NCT01989468|11169086|FG002|Overall Study|Adverse Event|4
7067834|NCT01989468|11169087|FG003|Overall Study|Adverse Event|5
7067835|NCT01989468|11169088|FG004|Overall Study|Adverse Event|4
7067836|NCT01989468|11169084|FG000|Overall Study|Lack of Efficacy|11
7067837|NCT01989468|11169085|FG001|Overall Study|Lack of Efficacy|11
7067838|NCT01989468|11169086|FG002|Overall Study|Lack of Efficacy|7
7067839|NCT01989468|11169087|FG003|Overall Study|Lack of Efficacy|4
7067840|NCT01989468|11169088|FG004|Overall Study|Lack of Efficacy|2
6944485|NCT00965081|10981839|FG001|Overall Study|Physician Decision|0
6944486|NCT00965081|10981838|FG000|Overall Study|Protocol Violation|2
6944487|NCT00965081|10981839|FG001|Overall Study|Protocol Violation|5
6944488|NCT00965081|10981838|FG000|Overall Study|Sponsor Decision|1
6944489|NCT00965081|10981839|FG001|Overall Study|Sponsor Decision|0
6944490|NCT00965081|10981838|FG000|Overall Study|Withdrawal by Subject|4
6944491|NCT00965081|10981839|FG001|Overall Study|Withdrawal by Subject|7
6944492|NCT00965081|10981838|FG000|Overall Study|Switched to Rescue Arm|5
6944493|NCT00965081|10981839|FG001|Overall Study|Switched to Rescue Arm|12
6944494|NCT00965094|10981848|FG000|Overall Study|Adverse Event|5
6944495|NCT00965094|10981849|FG001|Overall Study|Adverse Event|0
6944496|NCT00965094|10981848|FG000|Overall Study|Lost to Follow-up|0
6944497|NCT00965094|10981849|FG001|Overall Study|Lost to Follow-up|1
6944498|NCT00965185|10981858|FG000|Overall Study|Lost to Follow-up|2
6944499|NCT00965185|10981859|FG001|Overall Study|Lost to Follow-up|0
6944500|NCT00965185|10981858|FG000|Overall Study|Withdrawal by Subject|0
6944501|NCT00965185|10981859|FG001|Overall Study|Withdrawal by Subject|1
7067841|NCT01989468|11169084|FG000|Overall Study|Lost to Follow-up|5
7067842|NCT01989468|11169085|FG001|Overall Study|Lost to Follow-up|2
7067843|NCT01989468|11169086|FG002|Overall Study|Lost to Follow-up|0
7067844|NCT01989468|11169087|FG003|Overall Study|Lost to Follow-up|1
7067845|NCT01989468|11169088|FG004|Overall Study|Lost to Follow-up|1
7067846|NCT01989468|11169084|FG000|Overall Study|Physician Decision|4
7067847|NCT01989468|11169085|FG001|Overall Study|Physician Decision|1
7067848|NCT01989468|11169086|FG002|Overall Study|Physician Decision|0
7067849|NCT01989468|11169087|FG003|Overall Study|Physician Decision|1
6944502|NCT00965263|10981885|FG000|Overall Study|Physician Decision|2
6944503|NCT00965263|10981886|FG001|Overall Study|Physician Decision|0
7067850|NCT01989468|11169088|FG004|Overall Study|Physician Decision|0
7067851|NCT01989468|11169084|FG000|Overall Study|Pregnancy|0
7067852|NCT01989468|11169085|FG001|Overall Study|Pregnancy|1
7067853|NCT01989468|11169086|FG002|Overall Study|Pregnancy|0
7067854|NCT01989468|11169087|FG003|Overall Study|Pregnancy|0
6944504|NCT00965263|10981885|FG000|Overall Study|Family emergency|0
6944505|NCT00965263|10981886|FG001|Overall Study|Family emergency|1
6944506|NCT00965263|10981885|FG000|Overall Study|Protocol Violation|0
6944507|NCT00965263|10981886|FG001|Overall Study|Protocol Violation|2
6944508|NCT00965341|10981912|FG000|Overall Study|Withdrew consent|1
6944509|NCT00965341|10981913|FG001|Overall Study|Withdrew consent|5
6944510|NCT00965341|10981912|FG000|Overall Study|Lost to Follow-up|1
6944511|NCT00965341|10981913|FG001|Overall Study|Lost to Follow-up|0
6944512|NCT00965341|10981912|FG000|Overall Study|Transportation issues|4
6944513|NCT00965341|10981913|FG001|Overall Study|Transportation issues|3
6944514|NCT00965419|10981919|FG000|Open Label Treatment for Responders|Adverse Event|33
6944515|NCT00965419|10981919|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1
6944516|NCT00965419|10981919|FG000|Open Label Treatment for Responders|Protocol Violation|21
6944517|NCT00965419|10981919|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27
6944518|NCT00965419|10981919|FG000|Open Label Treatment for Responders|Physician Decision|6
6944519|NCT00965419|10981919|FG000|Open Label Treatment for Responders|Sponsor Decision|5
6944520|NCT00965419|10981919|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41
6944521|NCT00965419|10981919|FG000|Open Label Treatment for Responders|Lack of Efficacy|67
7067855|NCT01989468|11169088|FG004|Overall Study|Pregnancy|0
7067856|NCT01989468|11169084|FG000|Overall Study|Technical Problems|3
7067857|NCT01989468|11169085|FG001|Overall Study|Technical Problems|1
6944522|NCT00965419|10981919|FG000|Open Label Treatment for Responders|Lost to Follow-up|46
6944523|NCT00965419|10981919|FG000|Follow-up Phase|Adverse Event|9
6944524|NCT00965419|10981919|FG000|Follow-up Phase|Protocol Violation|4
6944525|NCT00965419|10981919|FG000|Follow-up Phase|Withdrawal by Subject|8
6944526|NCT00965419|10981919|FG000|Follow-up Phase|Physician Decision|4
6944527|NCT00965419|10981919|FG000|Follow-up Phase|Parent/Caregiver Decision|9
6944528|NCT00965419|10981919|FG000|Follow-up Phase|Lack of Efficacy|28
6944529|NCT00965458|10981926|FG000|Overall Study|Adverse Event|1
6944530|NCT00965458|10981927|FG001|Overall Study|Adverse Event|0
7067858|NCT01989468|11169086|FG002|Overall Study|Technical Problems|3
7067859|NCT01989468|11169087|FG003|Overall Study|Technical Problems|1
7067860|NCT01989468|11169088|FG004|Overall Study|Technical Problems|0
6944531|NCT00965458|10981926|FG000|Overall Study|Lost to Follow-up|1
6944532|NCT00965458|10981927|FG001|Overall Study|Lost to Follow-up|3
6944533|NCT00965458|10981926|FG000|Overall Study|Withdrawal by Subject|0
6944534|NCT00965458|10981927|FG001|Overall Study|Withdrawal by Subject|1
6944535|NCT00965484|10981935|FG000|Overall Study|Protocol Violation|1
6944536|NCT00965484|10981935|FG000|Overall Study|Withdrawal by Subject|1
6944537|NCT00965497|10981939|FG000|Overall Study|Physician Decision|1
6944538|NCT00965523|10981943|FG000|Study 221|Progressive Disease|4
6944539|NCT00965523|10981943|FG000|Study 221|Physician Decision|3
6944540|NCT00965523|10981943|FG000|Study 224|Progressive Disease|5
6944541|NCT00965523|10981943|FG000|Study 224|Physician Decision|1
6944542|NCT00965562|10981950|FG000|Overall Study|Lost to Follow-up|1
6944543|NCT00965562|10981951|FG001|Overall Study|Lost to Follow-up|2
6944544|NCT00965562|10981952|FG002|Overall Study|Lost to Follow-up|3
6944545|NCT00965562|10981950|FG000|Overall Study|Withdrawal by Subject|2
6944546|NCT00965562|10981951|FG001|Overall Study|Withdrawal by Subject|2
6944547|NCT00965562|10981952|FG002|Overall Study|Withdrawal by Subject|0
7067861|NCT01989468|11169084|FG000|Overall Study|Subject Guardian Decision|11
7067862|NCT01989468|11169085|FG001|Overall Study|Subject Guardian Decision|6
7067863|NCT01989468|11169086|FG002|Overall Study|Subject Guardian Decision|4
7067864|NCT01989468|11169087|FG003|Overall Study|Subject Guardian Decision|4
7067865|NCT01989468|11169088|FG004|Overall Study|Subject Guardian Decision|1
7067866|NCT01989468|11169084|FG000|Overall Study|Death|3
7067867|NCT01989468|11169085|FG001|Overall Study|Death|0
7067868|NCT01989468|11169086|FG002|Overall Study|Death|1
7067869|NCT01989468|11169087|FG003|Overall Study|Death|0
7067870|NCT01989468|11169088|FG004|Overall Study|Death|0
7067871|NCT01989546|11169101|FG000|Overall Study|Clinical Progression|1
7067872|NCT01989546|11169101|FG000|Overall Study|Disease progression on study|8
7067873|NCT01989572|11169111|FG000|Overall Study|Lack of Efficacy|35
7067874|NCT01989572|11169112|FG001|Overall Study|Lack of Efficacy|48
6944548|NCT00965575|10981963|FG000|Overall Study|subject unwillingness to swallow study c|1
6944549|NCT00965575|10981964|FG001|Overall Study|subject unwillingness to swallow study c|0
6944550|NCT00965718|10981972|FG000|Overall Study|Withdrawal by Subject|4
6944551|NCT00965731|10981978|FG000|Overall Study|Death|0
6944552|NCT00965731|10981979|FG001|Overall Study|Death|4
6944553|NCT00965731|10981978|FG000|Overall Study|Withdrawal by Subject|0
6944554|NCT00965731|10981979|FG001|Overall Study|Withdrawal by Subject|1
6944555|NCT00965731|10981978|FG000|Overall Study|Other|7
6944556|NCT00965731|10981979|FG001|Overall Study|Other|15
6944557|NCT00965848|10981990|FG000|Overall Study|Protocol Violation|3
6944558|NCT00965848|10981991|FG001|Overall Study|Protocol Violation|0
6944559|NCT00965848|10981992|FG002|Overall Study|Protocol Violation|1
6944560|NCT00965848|10981990|FG000|Overall Study|Death|11
6944561|NCT00965848|10981991|FG001|Overall Study|Death|1
6944562|NCT00965848|10981992|FG002|Overall Study|Death|5
6944563|NCT00965848|10981990|FG000|Overall Study|Lost to Follow-up|0
6944564|NCT00965848|10981991|FG001|Overall Study|Lost to Follow-up|0
6944565|NCT00965848|10981992|FG002|Overall Study|Lost to Follow-up|1
6944566|NCT00965848|10981990|FG000|Overall Study|Withdrawal by Subject|1
6944567|NCT00965848|10981991|FG001|Overall Study|Withdrawal by Subject|0
6944568|NCT00965848|10981992|FG002|Overall Study|Withdrawal by Subject|0
6944569|NCT00965848|10981990|FG000|Overall Study|Indeterminate Clinical Outcome|2
6944570|NCT00965848|10981991|FG001|Overall Study|Indeterminate Clinical Outcome|0
6944571|NCT00965848|10981992|FG002|Overall Study|Indeterminate Clinical Outcome|1
6944572|NCT00965848|10981990|FG000|Overall Study|Not Clinically Evaluable|7
6944573|NCT00965848|10981991|FG001|Overall Study|Not Clinically Evaluable|1
6944574|NCT00965848|10981992|FG002|Overall Study|Not Clinically Evaluable|1
6944575|NCT00965848|10981990|FG000|Overall Study|Other|5
6944576|NCT00965848|10981991|FG001|Overall Study|Other|0
6944577|NCT00965848|10981992|FG002|Overall Study|Other|1
6944578|NCT00966264|10982036|FG000|Overall Study|Lost to Follow-up|4
6944579|NCT00966264|10982037|FG001|Overall Study|Lost to Follow-up|3
6944580|NCT00966277|10982045|FG000|Overall Study|Withdrawal by Subject|3
6944581|NCT00966277|10982046|FG001|Overall Study|Withdrawal by Subject|0
6944582|NCT00966277|10982045|FG000|Overall Study|Ineligible|1
6944583|NCT00966277|10982046|FG001|Overall Study|Ineligible|3
6944584|NCT00966277|10982045|FG000|Overall Study|Treatment Plan Changed|0
6944585|NCT00966277|10982046|FG001|Overall Study|Treatment Plan Changed|1
6944586|NCT00966355|10982055|FG000|Overall Study|non-variceal bleeding on endoscopy|68
6944587|NCT00966355|10982056|FG001|Overall Study|non-variceal bleeding on endoscopy|70
6944588|NCT00966355|10982057|FG002|Overall Study|non-variceal bleeding on endoscopy|71
6944589|NCT00966355|10982055|FG000|Overall Study|newly diagnosed advanced HCC|11
6944590|NCT00966355|10982056|FG001|Overall Study|newly diagnosed advanced HCC|12
6944591|NCT00966355|10982057|FG002|Overall Study|newly diagnosed advanced HCC|10
6944592|NCT00966355|10982055|FG000|Overall Study|Lost to Follow-up|5
7067875|NCT01989572|11169113|FG002|Overall Study|Lack of Efficacy|48
7067876|NCT01989572|11169114|FG003|Overall Study|Lack of Efficacy|43
7067877|NCT01989572|11169115|FG004|Overall Study|Lack of Efficacy|71
7067878|NCT01989572|11169116|FG005|Overall Study|Lack of Efficacy|79
7067879|NCT01989572|11169111|FG000|Overall Study|Adverse Event|2
6944593|NCT00966355|10982056|FG001|Overall Study|Lost to Follow-up|4
6944594|NCT00966355|10982057|FG002|Overall Study|Lost to Follow-up|3
7067880|NCT01989572|11169112|FG001|Overall Study|Adverse Event|1
7067881|NCT01989572|11169113|FG002|Overall Study|Adverse Event|3
6944595|NCT00966693|10982113|FG000|Overall Study|Adverse Event|0
6944596|NCT00966693|10982114|FG001|Overall Study|Adverse Event|0
6944597|NCT00966693|10982115|FG002|Overall Study|Adverse Event|1
6944598|NCT00966693|10982116|FG003|Overall Study|Adverse Event|2
6944599|NCT00966693|10982113|FG000|Overall Study|Death|0
6944600|NCT00966693|10982114|FG001|Overall Study|Death|0
6944601|NCT00966693|10982115|FG002|Overall Study|Death|1
6944602|NCT00966693|10982116|FG003|Overall Study|Death|0
6944603|NCT00966693|10982113|FG000|Overall Study|Withdrawal by Subject|1
6944604|NCT00966693|10982114|FG001|Overall Study|Withdrawal by Subject|0
6944605|NCT00966693|10982115|FG002|Overall Study|Withdrawal by Subject|0
6944606|NCT00966693|10982116|FG003|Overall Study|Withdrawal by Subject|5
6944607|NCT00966693|10982113|FG000|Overall Study|Disease Progression|0
6944608|NCT00966693|10982114|FG001|Overall Study|Disease Progression|0
6944609|NCT00966693|10982115|FG002|Overall Study|Disease Progression|1
6944610|NCT00966693|10982116|FG003|Overall Study|Disease Progression|16
6944611|NCT00966719|10982128|FG000|Overall Study|Lost to Follow-up|6
6944612|NCT00966719|10982129|FG001|Overall Study|Lost to Follow-up|11
6944613|NCT00966875|10982161|FG000|Part A|Adverse Event|2
6944614|NCT00966875|10982162|FG001|Part A|Adverse Event|1
6944615|NCT00966875|10982163|FG002|Part A|Adverse Event|0
6944616|NCT00966875|10982164|FG003|Part A|Adverse Event|1
6944617|NCT00966875|10982165|FG004|Part A|Adverse Event|0
6944618|NCT00966875|10982166|FG005|Part A|Adverse Event|1
7067882|NCT01989572|11169114|FG003|Overall Study|Adverse Event|0
7067883|NCT01989572|11169115|FG004|Overall Study|Adverse Event|3
7067884|NCT01989572|11169116|FG005|Overall Study|Adverse Event|0
7067885|NCT01989572|11169111|FG000|Overall Study|Death|0
7067886|NCT01989572|11169112|FG001|Overall Study|Death|0
7067887|NCT01989572|11169113|FG002|Overall Study|Death|0
7067888|NCT01989572|11169114|FG003|Overall Study|Death|0
7067889|NCT01989572|11169115|FG004|Overall Study|Death|1
7067890|NCT01989572|11169116|FG005|Overall Study|Death|0
7067891|NCT01989572|11169111|FG000|Overall Study|Withdrawal by Subject|4
7067892|NCT01989572|11169112|FG001|Overall Study|Withdrawal by Subject|1
7067893|NCT01989572|11169113|FG002|Overall Study|Withdrawal by Subject|5
7067894|NCT01989572|11169114|FG003|Overall Study|Withdrawal by Subject|1
7067895|NCT01989572|11169115|FG004|Overall Study|Withdrawal by Subject|12
7067896|NCT01989572|11169116|FG005|Overall Study|Withdrawal by Subject|4
7067897|NCT01989572|11169111|FG000|Overall Study|complicating disease|1
7067898|NCT01989572|11169112|FG001|Overall Study|complicating disease|1
7067899|NCT01989572|11169113|FG002|Overall Study|complicating disease|2
7067900|NCT01989572|11169114|FG003|Overall Study|complicating disease|0
7067901|NCT01989572|11169115|FG004|Overall Study|complicating disease|1
7067902|NCT01989572|11169116|FG005|Overall Study|complicating disease|0
7067903|NCT01989572|11169111|FG000|Overall Study|error|2
7067904|NCT01989572|11169112|FG001|Overall Study|error|1
7067905|NCT01989572|11169113|FG002|Overall Study|error|1
7067906|NCT01989572|11169114|FG003|Overall Study|error|1
7067907|NCT01989572|11169115|FG004|Overall Study|error|1
7067908|NCT01989572|11169116|FG005|Overall Study|error|1
7067909|NCT01989572|11169111|FG000|Overall Study|maximum dose reached|0
7067910|NCT01989572|11169112|FG001|Overall Study|maximum dose reached|1
7067911|NCT01989572|11169113|FG002|Overall Study|maximum dose reached|0
7067912|NCT01989572|11169114|FG003|Overall Study|maximum dose reached|0
7067913|NCT01989572|11169115|FG004|Overall Study|maximum dose reached|1
7067914|NCT01989572|11169116|FG005|Overall Study|maximum dose reached|0
7067915|NCT01989572|11169111|FG000|Overall Study|unknown/not specify|3
7067916|NCT01989572|11169112|FG001|Overall Study|unknown/not specify|4
7067917|NCT01989572|11169113|FG002|Overall Study|unknown/not specify|1
7067918|NCT01989572|11169114|FG003|Overall Study|unknown/not specify|3
7067919|NCT01989572|11169115|FG004|Overall Study|unknown/not specify|3
6944619|NCT00966875|10982167|FG006|Part A|Adverse Event|0
6944620|NCT00966875|10982168|FG007|Part A|Adverse Event|3
6944621|NCT00966875|10982169|FG008|Part A|Adverse Event|3
6944622|NCT00966875|10982161|FG000|Part A|Entry Criteria|0
6944623|NCT00966875|10982162|FG001|Part A|Entry Criteria|0
6944624|NCT00966875|10982163|FG002|Part A|Entry Criteria|0
6944625|NCT00966875|10982164|FG003|Part A|Entry Criteria|0
6944626|NCT00966875|10982165|FG004|Part A|Entry Criteria|0
7067920|NCT01989572|11169116|FG005|Overall Study|unknown/not specify|5
7067921|NCT01989572|11169111|FG000|Overall Study|not start protocol therapy|5
7067922|NCT01989572|11169112|FG001|Overall Study|not start protocol therapy|1
7067923|NCT01989572|11169113|FG002|Overall Study|not start protocol therapy|2
7067924|NCT01989572|11169114|FG003|Overall Study|not start protocol therapy|3
7067925|NCT01989572|11169115|FG004|Overall Study|not start protocol therapy|4
7067926|NCT01989572|11169116|FG005|Overall Study|not start protocol therapy|18
7067927|NCT01989572|11169111|FG000|Overall Study|alternative therapy|3
7067928|NCT01989572|11169112|FG001|Overall Study|alternative therapy|0
7067929|NCT01989572|11169113|FG002|Overall Study|alternative therapy|0
7147702|NCT03134222|11308419|FG004|Treatment Period (Up to Week 12)|Adverse Event|0
6944627|NCT00966875|10982166|FG005|Part A|Entry Criteria|2
6944628|NCT00966875|10982167|FG006|Part A|Entry Criteria|0
6944629|NCT00966875|10982168|FG007|Part A|Entry Criteria|0
6944630|NCT00966875|10982169|FG008|Part A|Entry Criteria|0
6944631|NCT00966875|10982161|FG000|Part A|Lack of Efficacy|0
6944632|NCT00966875|10982162|FG001|Part A|Lack of Efficacy|1
6944633|NCT00966875|10982163|FG002|Part A|Lack of Efficacy|0
7067930|NCT01989572|11169114|FG003|Overall Study|alternative therapy|0
6944634|NCT00966875|10982164|FG003|Part A|Lack of Efficacy|0
6944635|NCT00966875|10982165|FG004|Part A|Lack of Efficacy|0
6944636|NCT00966875|10982166|FG005|Part A|Lack of Efficacy|0
6944637|NCT00966875|10982167|FG006|Part A|Lack of Efficacy|4
6944638|NCT00966875|10982168|FG007|Part A|Lack of Efficacy|0
6944639|NCT00966875|10982169|FG008|Part A|Lack of Efficacy|0
6944640|NCT00966875|10982161|FG000|Part A|Lost to Follow-up|2
6944641|NCT00966875|10982162|FG001|Part A|Lost to Follow-up|0
6944642|NCT00966875|10982163|FG002|Part A|Lost to Follow-up|0
6944643|NCT00966875|10982164|FG003|Part A|Lost to Follow-up|0
6944644|NCT00966875|10982165|FG004|Part A|Lost to Follow-up|0
6944645|NCT00966875|10982166|FG005|Part A|Lost to Follow-up|1
6944646|NCT00966875|10982167|FG006|Part A|Lost to Follow-up|0
6944647|NCT00966875|10982168|FG007|Part A|Lost to Follow-up|0
6944648|NCT00966875|10982169|FG008|Part A|Lost to Follow-up|0
6944649|NCT00966875|10982161|FG000|Part A|Parent/Caregiver Decision|0
6944650|NCT00966875|10982162|FG001|Part A|Parent/Caregiver Decision|0
6944651|NCT00966875|10982163|FG002|Part A|Parent/Caregiver Decision|0
6944652|NCT00966875|10982164|FG003|Part A|Parent/Caregiver Decision|1
6944653|NCT00966875|10982165|FG004|Part A|Parent/Caregiver Decision|0
6944654|NCT00966875|10982166|FG005|Part A|Parent/Caregiver Decision|0
6944655|NCT00966875|10982167|FG006|Part A|Parent/Caregiver Decision|0
6944656|NCT00966875|10982168|FG007|Part A|Parent/Caregiver Decision|0
6944657|NCT00966875|10982169|FG008|Part A|Parent/Caregiver Decision|0
6944658|NCT00966875|10982161|FG000|Part A|Physician Decision|0
6944659|NCT00966875|10982162|FG001|Part A|Physician Decision|0
6944660|NCT00966875|10982163|FG002|Part A|Physician Decision|0
6944661|NCT00966875|10982164|FG003|Part A|Physician Decision|0
6944662|NCT00966875|10982165|FG004|Part A|Physician Decision|1
6944663|NCT00966875|10982166|FG005|Part A|Physician Decision|0
6944664|NCT00966875|10982167|FG006|Part A|Physician Decision|1
6944665|NCT00966875|10982168|FG007|Part A|Physician Decision|0
6944666|NCT00966875|10982169|FG008|Part A|Physician Decision|2
6944667|NCT00966875|10982161|FG000|Part A|Sponsor Decision|0
6944668|NCT00966875|10982162|FG001|Part A|Sponsor Decision|0
6944669|NCT00966875|10982163|FG002|Part A|Sponsor Decision|1
6944670|NCT00966875|10982164|FG003|Part A|Sponsor Decision|0
6944671|NCT00966875|10982165|FG004|Part A|Sponsor Decision|1
6944672|NCT00966875|10982166|FG005|Part A|Sponsor Decision|0
6944673|NCT00966875|10982167|FG006|Part A|Sponsor Decision|0
6944674|NCT00966875|10982168|FG007|Part A|Sponsor Decision|2
6944675|NCT00966875|10982169|FG008|Part A|Sponsor Decision|1
6944676|NCT00966875|10982161|FG000|Part A|Withdrawal by Subject|2
6944677|NCT00966875|10982162|FG001|Part A|Withdrawal by Subject|2
6944678|NCT00966875|10982163|FG002|Part A|Withdrawal by Subject|1
6944679|NCT00966875|10982164|FG003|Part A|Withdrawal by Subject|1
6944680|NCT00966875|10982165|FG004|Part A|Withdrawal by Subject|3
6944681|NCT00966875|10982166|FG005|Part A|Withdrawal by Subject|0
6944682|NCT00966875|10982167|FG006|Part A|Withdrawal by Subject|5
6944683|NCT00966875|10982168|FG007|Part A|Withdrawal by Subject|1
6944684|NCT00966875|10982169|FG008|Part A|Withdrawal by Subject|1
6944685|NCT00966875|10982161|FG000|Part A|Protocol Violation|0
6944686|NCT00966875|10982162|FG001|Part A|Protocol Violation|0
6944687|NCT00966875|10982163|FG002|Part A|Protocol Violation|0
6944688|NCT00966875|10982164|FG003|Part A|Protocol Violation|0
6944689|NCT00966875|10982165|FG004|Part A|Protocol Violation|0
7067931|NCT01989572|11169115|FG004|Overall Study|alternative therapy|1
7067932|NCT01989572|11169116|FG005|Overall Study|alternative therapy|3
7067933|NCT01989689|11169136|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0
7067934|NCT01989689|11169137|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2
7067935|NCT01989689|11169136|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0
7067936|NCT01989689|11169137|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1
7067937|NCT01989754|11169147|FG000|Overall Study|Withdrawal by Subject|10
7067938|NCT01989754|11169148|FG001|Overall Study|Withdrawal by Subject|14
7067939|NCT01989754|11169147|FG000|Overall Study|Lost to Follow-up|28
7067940|NCT01989754|11169148|FG001|Overall Study|Lost to Follow-up|20
7067941|NCT01989754|11169147|FG000|Overall Study|Closed Site|1
6944690|NCT00966875|10982166|FG005|Part A|Protocol Violation|0
6944691|NCT00966875|10982167|FG006|Part A|Protocol Violation|2
6944692|NCT00966875|10982168|FG007|Part A|Protocol Violation|1
6944693|NCT00966875|10982169|FG008|Part A|Protocol Violation|1
6944694|NCT00966875|10982161|FG000|Part B|Adverse Event|0
7067942|NCT01989754|11169148|FG001|Overall Study|Closed Site|1
7067943|NCT01990261|11169176|FG000|Overall Study|Death Before Treatment Start|2
6944695|NCT00966875|10982162|FG001|Part B|Adverse Event|1
6944696|NCT00966875|10982163|FG002|Part B|Adverse Event|1
6944697|NCT00966875|10982164|FG003|Part B|Adverse Event|0
6944698|NCT00966875|10982165|FG004|Part B|Adverse Event|1
6944699|NCT00966875|10982166|FG005|Part B|Adverse Event|0
6944700|NCT00966875|10982167|FG006|Part B|Adverse Event|5
6944701|NCT00966875|10982168|FG007|Part B|Adverse Event|2
6944702|NCT00966875|10982169|FG008|Part B|Adverse Event|2
6944703|NCT00966875|10982161|FG000|Part B|Death|0
6944704|NCT00966875|10982162|FG001|Part B|Death|0
6944705|NCT00966875|10982163|FG002|Part B|Death|1
6944706|NCT00966875|10982164|FG003|Part B|Death|0
6944707|NCT00966875|10982165|FG004|Part B|Death|0
6944708|NCT00966875|10982166|FG005|Part B|Death|0
6944709|NCT00966875|10982167|FG006|Part B|Death|0
6944710|NCT00966875|10982168|FG007|Part B|Death|1
6944711|NCT00966875|10982169|FG008|Part B|Death|0
6944712|NCT00966875|10982161|FG000|Part B|Lack of Efficacy|2
6944713|NCT00966875|10982162|FG001|Part B|Lack of Efficacy|1
6944714|NCT00966875|10982163|FG002|Part B|Lack of Efficacy|1
6944715|NCT00966875|10982164|FG003|Part B|Lack of Efficacy|1
6944716|NCT00966875|10982165|FG004|Part B|Lack of Efficacy|2
6944717|NCT00966875|10982166|FG005|Part B|Lack of Efficacy|3
6944718|NCT00966875|10982167|FG006|Part B|Lack of Efficacy|12
6944719|NCT00966875|10982168|FG007|Part B|Lack of Efficacy|9
6944720|NCT00966875|10982169|FG008|Part B|Lack of Efficacy|6
6944721|NCT00966875|10982161|FG000|Part B|Lost to Follow-up|0
6944722|NCT00966875|10982162|FG001|Part B|Lost to Follow-up|0
6944723|NCT00966875|10982163|FG002|Part B|Lost to Follow-up|0
6944724|NCT00966875|10982164|FG003|Part B|Lost to Follow-up|1
6944725|NCT00966875|10982165|FG004|Part B|Lost to Follow-up|0
6944726|NCT00966875|10982166|FG005|Part B|Lost to Follow-up|0
6944727|NCT00966875|10982167|FG006|Part B|Lost to Follow-up|0
6944728|NCT00966875|10982168|FG007|Part B|Lost to Follow-up|0
6944729|NCT00966875|10982169|FG008|Part B|Lost to Follow-up|1
6944730|NCT00966875|10982161|FG000|Part B|Physician Decision|0
6944731|NCT00966875|10982162|FG001|Part B|Physician Decision|0
6944732|NCT00966875|10982163|FG002|Part B|Physician Decision|1
6944733|NCT00966875|10982164|FG003|Part B|Physician Decision|0
6944734|NCT00966875|10982165|FG004|Part B|Physician Decision|2
6944735|NCT00966875|10982166|FG005|Part B|Physician Decision|1
6944736|NCT00966875|10982167|FG006|Part B|Physician Decision|0
6944737|NCT00966875|10982168|FG007|Part B|Physician Decision|0
6944738|NCT00966875|10982169|FG008|Part B|Physician Decision|2
6944739|NCT00966875|10982161|FG000|Part B|Sponsor Decision|1
6944740|NCT00966875|10982162|FG001|Part B|Sponsor Decision|0
6944741|NCT00966875|10982163|FG002|Part B|Sponsor Decision|0
6944742|NCT00966875|10982164|FG003|Part B|Sponsor Decision|0
6944743|NCT00966875|10982165|FG004|Part B|Sponsor Decision|0
6944744|NCT00966875|10982166|FG005|Part B|Sponsor Decision|1
6944745|NCT00966875|10982167|FG006|Part B|Sponsor Decision|0
6944746|NCT00966875|10982168|FG007|Part B|Sponsor Decision|2
6944747|NCT00966875|10982169|FG008|Part B|Sponsor Decision|1
6944748|NCT00966875|10982161|FG000|Part B|Withdrawal by Subject|2
6944749|NCT00966875|10982162|FG001|Part B|Withdrawal by Subject|1
6944750|NCT00966875|10982163|FG002|Part B|Withdrawal by Subject|2
6944751|NCT00966875|10982164|FG003|Part B|Withdrawal by Subject|1
6944752|NCT00966875|10982165|FG004|Part B|Withdrawal by Subject|2
6944753|NCT00966875|10982166|FG005|Part B|Withdrawal by Subject|1
6944754|NCT00966875|10982167|FG006|Part B|Withdrawal by Subject|4
6944755|NCT00966875|10982168|FG007|Part B|Withdrawal by Subject|5
6944756|NCT00966875|10982169|FG008|Part B|Withdrawal by Subject|5
6944757|NCT00966875|10982161|FG000|Part B|Entry Criteria|0
6944758|NCT00966875|10982162|FG001|Part B|Entry Criteria|0
6944759|NCT00966875|10982163|FG002|Part B|Entry Criteria|0
6944760|NCT00966875|10982164|FG003|Part B|Entry Criteria|0
6944761|NCT00966875|10982165|FG004|Part B|Entry Criteria|0
6944762|NCT00966875|10982166|FG005|Part B|Entry Criteria|0
6944763|NCT00966875|10982167|FG006|Part B|Entry Criteria|1
6944764|NCT00966875|10982168|FG007|Part B|Entry Criteria|0
6944765|NCT00966875|10982169|FG008|Part B|Entry Criteria|1
6944766|NCT00966940|10982244|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2
6944767|NCT00966940|10982245|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0
6944768|NCT00966940|10982244|FG000|Period 1, First 6 Weeks|Protocol Violation|1
6944769|NCT00966940|10982245|FG001|Period 1, First 6 Weeks|Protocol Violation|0
6944770|NCT00967005|10982253|FG000|Overall Study|Lost to Follow-up|7
6944771|NCT00967005|10982254|FG001|Overall Study|Lost to Follow-up|10
6944772|NCT00967018|10982260|FG000|Overall Study|Adverse Event|2
7067944|NCT01990261|11169176|FG000|Overall Study|Death due to Disease Progression (PD)|10
7067945|NCT01990261|11169176|FG000|Overall Study|Death From other Causes|1
7067946|NCT01990261|11169176|FG000|Overall Study|Disease Progression (PD)|8
7067947|NCT01990261|11169176|FG000|Overall Study|PD Before Treatment Start|1
7067948|NCT01990261|11169176|FG000|Overall Study|Dossier not Approved|1
7067949|NCT01990261|11169176|FG000|Overall Study|Lost to Follow-up|2
7067950|NCT01990300|11169180|FG000|Overall Study|Case Report Forms Uncollected|89
7067951|NCT01990300|11169180|FG000|Overall Study|Protocol Deviation|53
7067952|NCT01990313|11169184|FG000|Overall Study|Lost to Follow-up|1
7067953|NCT01990339|11169188|FG000|Overall Study|Data Not Available|49
6944773|NCT00967018|10982260|FG000|Overall Study|Physician Decision|7
6944774|NCT00967018|10982260|FG000|Overall Study|Lost to Follow-up|2
6944775|NCT00967018|10982260|FG000|Overall Study|Withdrawal by Subject|1
6944776|NCT00967018|10982260|FG000|Overall Study|Miscellaneous Reasons|9
6944777|NCT00967226|10982270|FG000|Overall Study|Adverse Event|0
6944778|NCT00967226|10982271|FG001|Overall Study|Adverse Event|5
6944779|NCT00967226|10982270|FG000|Overall Study|Protocol Violation|2
7067954|NCT01990339|11169188|FG000|Overall Study|Voluntary Withdrawal|1402
7067955|NCT01990339|11169188|FG000|Overall Study|Lost to Follow-up|861
6944780|NCT00967226|10982271|FG001|Overall Study|Protocol Violation|0
6944781|NCT00967226|10982270|FG000|Overall Study|Physician Decision|0
6944782|NCT00967226|10982271|FG001|Overall Study|Physician Decision|1
6944783|NCT00967330|10982303|FG000|Overall Study|Protocol Violation|3
6944784|NCT00967330|10982304|FG001|Overall Study|Protocol Violation|4
6944785|NCT00967330|10982303|FG000|Overall Study|Regular|10
6944786|NCT00967330|10982304|FG001|Overall Study|Regular|3
6944787|NCT00967330|10982303|FG000|Overall Study|Withdrawal by Subject|6
6944788|NCT00967330|10982304|FG001|Overall Study|Withdrawal by Subject|0
6944789|NCT00967330|10982303|FG000|Overall Study|Lost to Follow-up|1
6944790|NCT00967330|10982304|FG001|Overall Study|Lost to Follow-up|1
6944791|NCT00967330|10982303|FG000|Overall Study|Death|102
6944792|NCT00967330|10982304|FG001|Overall Study|Death|51
6944793|NCT00967330|10982303|FG000|Overall Study|Severe protocol deviation|0
6944794|NCT00967330|10982304|FG001|Overall Study|Severe protocol deviation|1
6944795|NCT00967343|10982310|FG000|Overall Study|Study termination by sponsor|12
6944796|NCT00967343|10982310|FG000|Overall Study|Death|24
6944797|NCT00967343|10982310|FG000|Overall Study|Relapse|1
6944798|NCT00967343|10982310|FG000|Overall Study|Lost to Follow-up|1
6944799|NCT00967499|10982338|FG000|Overall Study|Adverse Event|0
6944800|NCT00967499|10982339|FG001|Overall Study|Adverse Event|1
6944801|NCT00967499|10982338|FG000|Overall Study|Protocol Violation|1
6944802|NCT00967499|10982339|FG001|Overall Study|Protocol Violation|0
6944803|NCT00967499|10982338|FG000|Overall Study|Sponsor Decision|1
6944804|NCT00967499|10982339|FG001|Overall Study|Sponsor Decision|0
6944805|NCT00967499|10982338|FG000|Overall Study|Randomized but not treated|63
6944806|NCT00967499|10982339|FG001|Overall Study|Randomized but not treated|59
6975718|NCT01194258|11027910|FG000|Period 2 (12 Weeks)|Adverse Event|0
6975719|NCT01194258|11027911|FG001|Period 2 (12 Weeks)|Adverse Event|1
6975720|NCT01194258|11027912|FG002|Period 2 (12 Weeks)|Adverse Event|0
6975721|NCT01194258|11027913|FG003|Period 2 (12 Weeks)|Adverse Event|0
6975722|NCT01194258|11027914|FG004|Period 2 (12 Weeks)|Adverse Event|0
6975723|NCT01194258|11027910|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0
6975724|NCT01194258|11027911|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1
6975725|NCT01194258|11027912|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1
6975726|NCT01194258|11027913|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0
6975727|NCT01194258|11027914|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0
6975728|NCT01194271|11027925|FG000|Overall Study|Withdrawal by Subject|1
6975729|NCT01194271|11027925|FG000|Overall Study|Ineligible, Screen Failure|1
6975730|NCT01194271|11027925|FG000|Overall Study|Death|1
6975731|NCT01194414|11027940|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11
6975732|NCT01194414|11027941|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8
6975733|NCT01194414|11027942|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
6975734|NCT01194414|11027943|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
6975735|NCT01194414|11027940|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9
6975736|NCT01194414|11027941|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5
6975737|NCT01194414|11027942|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
6975738|NCT01194414|11027943|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
6975739|NCT01194414|11027940|FG000|24 Weeks Double Blind Period|Protocol Violation|5
6975740|NCT01194414|11027941|FG001|24 Weeks Double Blind Period|Protocol Violation|3
6975741|NCT01194414|11027942|FG002|24 Weeks Double Blind Period|Protocol Violation|0
6975742|NCT01194414|11027943|FG003|24 Weeks Double Blind Period|Protocol Violation|0
6975743|NCT01194414|11027940|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
6975744|NCT01194414|11027941|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5
6975745|NCT01194414|11027942|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
6975746|NCT01194414|11027943|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
6975747|NCT01194414|11027940|FG000|24 Weeks Double Blind Period|Pregnancy|2
6975748|NCT01194414|11027941|FG001|24 Weeks Double Blind Period|Pregnancy|2
6975749|NCT01194414|11027942|FG002|24 Weeks Double Blind Period|Pregnancy|0
6975750|NCT01194414|11027943|FG003|24 Weeks Double Blind Period|Pregnancy|0
6975751|NCT01194414|11027940|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2
6975752|NCT01194414|11027941|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1
6975753|NCT01194414|11027942|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0
6975754|NCT01194414|11027943|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0
6975755|NCT01194414|11027940|FG000|24 Weeks Double Blind Period|Other|0
6975756|NCT01194414|11027941|FG001|24 Weeks Double Blind Period|Other|1
6975757|NCT01194414|11027942|FG002|24 Weeks Double Blind Period|Other|0
6975758|NCT01194414|11027943|FG003|24 Weeks Double Blind Period|Other|0
6975759|NCT01194414|11027940|FG000|24 Weeks Double Blind Period|Adverse Event|28
6975760|NCT01194414|11027941|FG001|24 Weeks Double Blind Period|Adverse Event|40
6975761|NCT01194414|11027942|FG002|24 Weeks Double Blind Period|Adverse Event|0
6975762|NCT01194414|11027943|FG003|24 Weeks Double Blind Period|Adverse Event|0
6975763|NCT01194414|11027940|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2
6975764|NCT01194414|11027941|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1
6975765|NCT01194414|11027942|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
6975766|NCT01194414|11027943|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
6975767|NCT01194414|11027940|FG000|24 Weeks Double Blind Period|Death|0
6975768|NCT01194414|11027941|FG001|24 Weeks Double Blind Period|Death|1
6975769|NCT01194414|11027942|FG002|24 Weeks Double Blind Period|Death|0
6975770|NCT01194414|11027943|FG003|24 Weeks Double Blind Period|Death|0
6975771|NCT01194414|11027940|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3
6975772|NCT01194414|11027941|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5
6975773|NCT01194414|11027942|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0
6975774|NCT01194414|11027943|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0
6975775|NCT01194414|11027940|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20
6975776|NCT01194414|11027941|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14
6975777|NCT01194414|11027942|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1
6944807|NCT00967616|10982356|FG000|Overall Study|Adverse Event or Serious Adverse Event|2
6944808|NCT00967616|10982357|FG001|Overall Study|Adverse Event or Serious Adverse Event|17
6944809|NCT00967616|10982356|FG000|Overall Study|Death|0
6944810|NCT00967616|10982357|FG001|Overall Study|Death|3
6944811|NCT00967616|10982356|FG000|Overall Study|Withdrawal by Subject|8
6944812|NCT00967616|10982357|FG001|Overall Study|Withdrawal by Subject|4
6944813|NCT00967616|10982356|FG000|Overall Study|Progressive Disease|31
6944814|NCT00967616|10982357|FG001|Overall Study|Progressive Disease|18
6944815|NCT00967616|10982356|FG000|Overall Study|Other|8
6944816|NCT00967616|10982357|FG001|Overall Study|Other|8
6944817|NCT00967616|10982356|FG000|Overall Study|Protocol Violation|1
6944818|NCT00967616|10982357|FG001|Overall Study|Protocol Violation|0
6944819|NCT00967668|10982366|FG000|Overall Study|Withdrawal by Subject|13
6944820|NCT00967668|10982367|FG001|Overall Study|Withdrawal by Subject|8
6944821|NCT00967668|10982368|FG002|Overall Study|Withdrawal by Subject|8
6944822|NCT00967668|10982366|FG000|Overall Study|Death|0
6944823|NCT00967668|10982367|FG001|Overall Study|Death|2
6944824|NCT00967668|10982368|FG002|Overall Study|Death|4
6944825|NCT00967668|10982366|FG000|Overall Study|Removed due to behavior|1
6944826|NCT00967668|10982367|FG001|Overall Study|Removed due to behavior|1
6944827|NCT00967668|10982368|FG002|Overall Study|Removed due to behavior|2
6944828|NCT00967668|10982366|FG000|Overall Study|Refused Year 2|11
6944829|NCT00967668|10982367|FG001|Overall Study|Refused Year 2|6
6944830|NCT00967668|10982368|FG002|Overall Study|Refused Year 2|4
6944831|NCT00967668|10982366|FG000|Overall Study|Lost to follow-up at 12-mo|27
6944832|NCT00967668|10982367|FG001|Overall Study|Lost to follow-up at 12-mo|29
6944833|NCT00967668|10982368|FG002|Overall Study|Lost to follow-up at 12-mo|26
6944834|NCT00967668|10982366|FG000|Overall Study|Lost to Follow-up|15
6944835|NCT00967668|10982367|FG001|Overall Study|Lost to Follow-up|9
6944836|NCT00967668|10982368|FG002|Overall Study|Lost to Follow-up|16
6944837|NCT00967668|10982366|FG000|Overall Study|Refused 12-mo assessment|3
6944838|NCT00967668|10982367|FG001|Overall Study|Refused 12-mo assessment|1
6944839|NCT00967668|10982368|FG002|Overall Study|Refused 12-mo assessment|9
6944840|NCT00967668|10982366|FG000|Overall Study|Pregnancy|1
6944841|NCT00967668|10982367|FG001|Overall Study|Pregnancy|0
6944842|NCT00967668|10982368|FG002|Overall Study|Pregnancy|0
6944843|NCT00967694|10982379|FG000|Overall Study|Withdrawal by Subject|6
6944844|NCT00967798|10982385|FG000|Overall Study|Withdrawal by Subject|5
7067956|NCT01990495|11169194|FG000|Overall Study|Physician Decision|5
7067957|NCT01990495|11169195|FG001|Overall Study|Physician Decision|4
7067958|NCT01990534|11169203|FG000|Overall Study|Death|22
7067959|NCT01990534|11169203|FG000|Overall Study|Progressive disease|3
7067960|NCT01990534|11169203|FG000|Overall Study|Protocol Violation|1
7067961|NCT01990534|11169203|FG000|Overall Study|Withdrawal of Informed Consent|2
7067962|NCT01990534|11169203|FG000|Overall Study|Symptomatic Deterioration|1
7067963|NCT01990534|11169203|FG000|Overall Study|Withdrawal by Subject|3
7067964|NCT01990534|11169203|FG000|Overall Study|Reason not Specified|2
7067965|NCT01990534|11169203|FG000|Overall Study|Lost to Follow-up|1
7067966|NCT01990560|11169207|FG000|Overall Study|Withdrawal by Subject|1
7067967|NCT01990573|11169214|FG000|Overall Study|Physician Decision|0
7067968|NCT01990573|11169215|FG001|Overall Study|Physician Decision|0
7067969|NCT01990573|11169216|FG002|Overall Study|Physician Decision|1
7067970|NCT01990612|11169226|FG000|Overall Study|Lost to Follow-up|2
7067971|NCT01990612|11169227|FG001|Overall Study|Lost to Follow-up|1
6944845|NCT00967798|10982386|FG001|Overall Study|Withdrawal by Subject|2
6944846|NCT00967798|10982385|FG000|Overall Study|Lost to Follow-up|4
6944847|NCT00967798|10982386|FG001|Overall Study|Lost to Follow-up|1
6944848|NCT00968253|10982428|FG000|Overall Study|Death|0
6944849|NCT00968253|10982429|FG001|Overall Study|Death|0
6944850|NCT00968253|10982430|FG002|Overall Study|Death|2
6944851|NCT00968253|10982428|FG000|Overall Study|Withdrawal by Subject|0
6944852|NCT00968253|10982429|FG001|Overall Study|Withdrawal by Subject|0
6944853|NCT00968253|10982430|FG002|Overall Study|Withdrawal by Subject|1
6944854|NCT00968253|10982428|FG000|Overall Study|Disease Progression|0
6944855|NCT00968253|10982429|FG001|Overall Study|Disease Progression|3
6944856|NCT00968253|10982430|FG002|Overall Study|Disease Progression|3
6944857|NCT00968253|10982428|FG000|Overall Study|Adverse Event|0
6944858|NCT00968253|10982429|FG001|Overall Study|Adverse Event|0
6944859|NCT00968253|10982430|FG002|Overall Study|Adverse Event|1
6944860|NCT00968526|10982450|FG000|Overall Study|Adverse Event|2
6944861|NCT00968526|10982451|FG001|Overall Study|Adverse Event|0
6944862|NCT00968526|10982450|FG000|Overall Study|Migrated/moved from study area|1
6944863|NCT00968526|10982451|FG001|Overall Study|Migrated/moved from study area|0
6944864|NCT00968539|10982468|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1
6944865|NCT00968539|10982469|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0
6944866|NCT00968617|10982476|FG000|Overall Study|Study terminated by sponsor|6
6944867|NCT00968669|10982484|FG000|Overall Study|Lost to Follow-up|5
6944868|NCT00968669|10982485|FG001|Overall Study|Lost to Follow-up|2
6944869|NCT00968669|10982486|FG002|Overall Study|Lost to Follow-up|1
6944870|NCT00968669|10982487|FG003|Overall Study|Lost to Follow-up|4
6944871|NCT00968669|10982484|FG000|Overall Study|Withdrawal by Subject|9
7067972|NCT01990612|11169226|FG000|Overall Study|Withdrawal by Subject|5
7067973|NCT01990612|11169227|FG001|Overall Study|Withdrawal by Subject|2
7067974|NCT01990664|11169235|FG000|Overall Study|Lost to Follow-up|2
7067975|NCT01990664|11169236|FG001|Overall Study|Lost to Follow-up|6
6944872|NCT00968669|10982485|FG001|Overall Study|Withdrawal by Subject|7
6944873|NCT00968669|10982486|FG002|Overall Study|Withdrawal by Subject|5
6944874|NCT00968669|10982487|FG003|Overall Study|Withdrawal by Subject|3
6944875|NCT00968669|10982484|FG000|Overall Study|Pregnancy|0
6944876|NCT00968669|10982485|FG001|Overall Study|Pregnancy|0
6944877|NCT00968669|10982486|FG002|Overall Study|Pregnancy|2
6944878|NCT00968669|10982487|FG003|Overall Study|Pregnancy|0
6944879|NCT00968669|10982484|FG000|Overall Study|AE|1
6944880|NCT00968669|10982485|FG001|Overall Study|AE|0
6944881|NCT00968669|10982486|FG002|Overall Study|AE|0
6944882|NCT00968669|10982487|FG003|Overall Study|AE|0
6944883|NCT00968669|10982484|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
6944884|NCT00968669|10982485|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
6944885|NCT00968669|10982486|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
6944886|NCT00968669|10982487|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1
6944887|NCT00968669|10982484|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1
6944888|NCT00968669|10982485|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
6944889|NCT00968669|10982486|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
6944890|NCT00968669|10982487|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
6944891|NCT00968669|10982484|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1
6944892|NCT00968669|10982485|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
6944893|NCT00968669|10982486|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
6944894|NCT00968669|10982487|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
6944895|NCT00968669|10982484|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
6944896|NCT00968669|10982485|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
6944897|NCT00968669|10982486|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1
6944898|NCT00968669|10982487|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
6944899|NCT00968669|10982484|FG000|Overall Study|EARLY WITHDRAWAL|0
6944900|NCT00968669|10982485|FG001|Overall Study|EARLY WITHDRAWAL|1
6944901|NCT00968669|10982486|FG002|Overall Study|EARLY WITHDRAWAL|0
6944902|NCT00968669|10982487|FG003|Overall Study|EARLY WITHDRAWAL|0
6944903|NCT00968669|10982484|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0
6944904|NCT00968669|10982485|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0
6944905|NCT00968669|10982486|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1
6944906|NCT00968669|10982487|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0
6944907|NCT00968669|10982484|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1
6944908|NCT00968669|10982485|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0
6944909|NCT00968669|10982486|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0
6944910|NCT00968669|10982487|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0
6944911|NCT00968669|10982484|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
6944912|NCT00968669|10982485|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1
6944913|NCT00968669|10982486|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
6944914|NCT00968669|10982487|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
6944915|NCT00968669|10982484|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
6944916|NCT00968669|10982485|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1
6944917|NCT00968669|10982486|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
6944918|NCT00968669|10982487|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
6944919|NCT00968669|10982484|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
6944920|NCT00968669|10982485|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1
6944921|NCT00968669|10982486|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
6944922|NCT00968669|10982487|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
6944923|NCT00968669|10982484|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0
6944924|NCT00968669|10982485|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1
6944925|NCT00968669|10982486|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0
6944926|NCT00968669|10982487|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0
6944927|NCT00968669|10982484|FG000|Overall Study|SPONSOR DECISION|0
6944928|NCT00968669|10982485|FG001|Overall Study|SPONSOR DECISION|1
6944929|NCT00968669|10982486|FG002|Overall Study|SPONSOR DECISION|0
6944930|NCT00968669|10982487|FG003|Overall Study|SPONSOR DECISION|0
6944931|NCT00968669|10982484|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
6944932|NCT00968669|10982485|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
6944933|NCT00968669|10982486|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1
7040687|NCT01719380|11123787|FG004|Overall Study|Adverse Event|0
7040688|NCT01719380|11123788|FG005|Overall Study|Adverse Event|1
6944934|NCT00968669|10982487|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
6944935|NCT00968669|10982484|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
6944936|NCT00968669|10982485|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1
6944937|NCT00968669|10982486|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
6944938|NCT00968669|10982487|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
6944939|NCT00968669|10982484|FG000|Overall Study|SUBJECT INCARCERATED|0
6944940|NCT00968669|10982485|FG001|Overall Study|SUBJECT INCARCERATED|1
6944941|NCT00968669|10982486|FG002|Overall Study|SUBJECT INCARCERATED|0
6944942|NCT00968669|10982487|FG003|Overall Study|SUBJECT INCARCERATED|0
6944943|NCT00968669|10982484|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
6944944|NCT00968669|10982485|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1
6944945|NCT00968669|10982486|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
6944946|NCT00968669|10982487|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
7040689|NCT01719380|11123789|FG006|Overall Study|Adverse Event|0
6944947|NCT00968669|10982484|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
6944948|NCT00968669|10982485|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
6944949|NCT00968669|10982486|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
6944950|NCT00968669|10982487|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1
6944951|NCT00968708|10982499|FG000|Overall Study|Adverse Event|169
6944952|NCT00968708|10982500|FG001|Overall Study|Adverse Event|150
6944953|NCT00968708|10982499|FG000|Overall Study|Major Protocol Deviation|0
6944954|NCT00968708|10982500|FG001|Overall Study|Major Protocol Deviation|1
6944955|NCT00968708|10982499|FG000|Overall Study|Lost to Follow-up|19
6944956|NCT00968708|10982500|FG001|Overall Study|Lost to Follow-up|11
6944957|NCT00968708|10982499|FG000|Overall Study|Voluntary Withdrawal|104
6944958|NCT00968708|10982500|FG001|Overall Study|Voluntary Withdrawal|101
6944959|NCT00968708|10982499|FG000|Overall Study|Investigator Discretion|0
6944960|NCT00968708|10982500|FG001|Overall Study|Investigator Discretion|1
6944961|NCT00968708|10982499|FG000|Overall Study|Other|26
6944962|NCT00968708|10982500|FG001|Overall Study|Other|34
6944963|NCT00968799|10982506|FG000|Overall Study|Advanced disease, HIPEC not applicable|2
6944964|NCT00968812|10982513|FG000|Overall Study|Adverse Event|30
6944965|NCT00968812|10982514|FG001|Overall Study|Adverse Event|46
6944966|NCT00968812|10982515|FG002|Overall Study|Adverse Event|33
6944967|NCT00968812|10982513|FG000|Overall Study|Death|2
6944968|NCT00968812|10982514|FG001|Overall Study|Death|2
6944969|NCT00968812|10982515|FG002|Overall Study|Death|1
6944970|NCT00968812|10982513|FG000|Overall Study|Lack of Efficacy|9
6944971|NCT00968812|10982514|FG001|Overall Study|Lack of Efficacy|7
6944972|NCT00968812|10982515|FG002|Overall Study|Lack of Efficacy|16
6944973|NCT00968812|10982513|FG000|Overall Study|Lost to Follow-up|17
6944974|NCT00968812|10982514|FG001|Overall Study|Lost to Follow-up|12
7067976|NCT01990664|11169235|FG000|Overall Study|Withdrawal by Subject|2
7067977|NCT01990664|11169236|FG001|Overall Study|Withdrawal by Subject|3
7067978|NCT01990664|11169235|FG000|Overall Study|Protocol Violation|1
7067979|NCT01990664|11169236|FG001|Overall Study|Protocol Violation|0
7067980|NCT01990664|11169235|FG000|Overall Study|Lens Discomfort|1
6944975|NCT00968812|10982515|FG002|Overall Study|Lost to Follow-up|11
6944976|NCT00968812|10982513|FG000|Overall Study|Physician Decision|8
6944977|NCT00968812|10982514|FG001|Overall Study|Physician Decision|5
6944978|NCT00968812|10982515|FG002|Overall Study|Physician Decision|9
6944979|NCT00968812|10982513|FG000|Overall Study|Protocol Violation|7
6944980|NCT00968812|10982514|FG001|Overall Study|Protocol Violation|4
6944981|NCT00968812|10982515|FG002|Overall Study|Protocol Violation|3
6944982|NCT00968812|10982513|FG000|Overall Study|Withdrawal by Subject|17
6944983|NCT00968812|10982514|FG001|Overall Study|Withdrawal by Subject|23
6944984|NCT00968812|10982515|FG002|Overall Study|Withdrawal by Subject|25
6944985|NCT00968812|10982513|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9
6944986|NCT00968812|10982514|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13
6944987|NCT00968812|10982515|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7
6944988|NCT00968812|10982513|FG000|Overall Study|Noncompliance with study drug|4
6944989|NCT00968812|10982514|FG001|Overall Study|Noncompliance with study drug|1
6944990|NCT00968812|10982515|FG002|Overall Study|Noncompliance with study drug|6
6944991|NCT00968812|10982513|FG000|Overall Study|Unable to take rescue therapy|12
6944992|NCT00968812|10982514|FG001|Overall Study|Unable to take rescue therapy|12
6944993|NCT00968812|10982515|FG002|Overall Study|Unable to take rescue therapy|17
6944994|NCT00968812|10982513|FG000|Overall Study|Other|25
6944995|NCT00968812|10982514|FG001|Overall Study|Other|37
6944996|NCT00968812|10982515|FG002|Overall Study|Other|40
6944997|NCT00968968|10982546|FG000|Overall Study|Study closed/terminated|10
6944998|NCT00968968|10982547|FG001|Overall Study|Study closed/terminated|10
6944999|NCT00968968|10982546|FG000|Overall Study|Protocol defined stopping criteria|3
6945000|NCT00968968|10982547|FG001|Overall Study|Protocol defined stopping criteria|1
6945001|NCT00968968|10982546|FG000|Overall Study|Withdrawal by Subject|2
6945002|NCT00968968|10982547|FG001|Overall Study|Withdrawal by Subject|0
6945003|NCT00968968|10982546|FG000|Overall Study|Physician Decision|1
6945004|NCT00968968|10982547|FG001|Overall Study|Physician Decision|2
6945005|NCT00968968|10982546|FG000|Overall Study|Lost to Follow-up|0
6945006|NCT00968968|10982547|FG001|Overall Study|Lost to Follow-up|1
6945007|NCT00968981|10982557|FG000|Overall Study|Adverse Event|2
6945008|NCT00968981|10982558|FG001|Overall Study|Adverse Event|0
6945009|NCT00968981|10982559|FG002|Overall Study|Adverse Event|0
6945010|NCT00968981|10982557|FG000|Overall Study|Disease Progression|14
6945011|NCT00968981|10982558|FG001|Overall Study|Disease Progression|16
6945012|NCT00968981|10982559|FG002|Overall Study|Disease Progression|13
6945013|NCT00968981|10982557|FG000|Overall Study|Lost to Follow-up|0
6945014|NCT00968981|10982558|FG001|Overall Study|Lost to Follow-up|0
6945015|NCT00968981|10982559|FG002|Overall Study|Lost to Follow-up|1
6945016|NCT00968981|10982557|FG000|Overall Study|Physician Decision|5
6945017|NCT00968981|10982558|FG001|Overall Study|Physician Decision|3
6945018|NCT00968981|10982559|FG002|Overall Study|Physician Decision|5
6945019|NCT00968981|10982557|FG000|Overall Study|Withdrawal by Subject|1
6945020|NCT00968981|10982558|FG001|Overall Study|Withdrawal by Subject|3
6945021|NCT00968981|10982559|FG002|Overall Study|Withdrawal by Subject|3
6945022|NCT00969124|10982568|FG000|Overall Study|Protocol Violation|2
6945023|NCT00969124|10982568|FG000|Overall Study|Inadequate bowel preparation|15
7067981|NCT01990664|11169236|FG001|Overall Study|Lens Discomfort|1
7067982|NCT01990664|11169235|FG000|Overall Study|Lens Handling Difficulties|1
6945024|NCT00969124|10982568|FG000|Overall Study|Inability to reach cecum|9
6945025|NCT00969124|10982568|FG000|Overall Study|Previously unrecognized disease|3
6945026|NCT00969124|10982568|FG000|Overall Study|Technical error|1
6945027|NCT00969150|10982575|FG000|Overall Study|Adverse Event|4
6945028|NCT00969150|10982576|FG001|Overall Study|Adverse Event|14
6945029|NCT00969150|10982575|FG000|Overall Study|Lack of Efficacy|1
6945030|NCT00969150|10982576|FG001|Overall Study|Lack of Efficacy|1
6945031|NCT00969150|10982575|FG000|Overall Study|Protocol Violation|9
6945032|NCT00969150|10982576|FG001|Overall Study|Protocol Violation|12
6945033|NCT00969150|10982575|FG000|Overall Study|Withdrawal by Subject|13
6945034|NCT00969150|10982576|FG001|Overall Study|Withdrawal by Subject|9
6945035|NCT00969150|10982575|FG000|Overall Study|Lost to Follow-up|5
6945036|NCT00969150|10982576|FG001|Overall Study|Lost to Follow-up|4
6945037|NCT00969150|10982575|FG000|Overall Study|Other reasons|1
6945038|NCT00969150|10982576|FG001|Overall Study|Other reasons|0
6945039|NCT00969228|10982584|FG000|Overall Study|Adverse Event|1
6945040|NCT00969228|10982585|FG001|Overall Study|Adverse Event|0
6945041|NCT00969228|10982584|FG000|Overall Study|Withdrawal by Subject|4
6945042|NCT00969228|10982585|FG001|Overall Study|Withdrawal by Subject|0
6945043|NCT00969228|10982584|FG000|Overall Study|Porcine circovirus detection in vaccine|38
6945044|NCT00969228|10982585|FG001|Overall Study|Porcine circovirus detection in vaccine|14
6945045|NCT00969280|10982593|FG000|Overall Study|Protocol Violation|2
6945046|NCT00969280|10982594|FG001|Overall Study|Protocol Violation|1
6945047|NCT00969280|10982593|FG000|Overall Study|Withdrawal by Subject|0
6945048|NCT00969280|10982594|FG001|Overall Study|Withdrawal by Subject|1
6945049|NCT00969280|10982593|FG000|Overall Study|infection of influenza A(H1N1)|0
6945050|NCT00969280|10982594|FG001|Overall Study|infection of influenza A(H1N1)|1
6945051|NCT00969332|10982600|FG000|Overall Study|Physician Decision|8
6945052|NCT00969332|10982600|FG000|Overall Study|Withdrawal by Subject|3
6945053|NCT00969436|10982608|FG000|Overall Study|Protocol Violation|1
6945054|NCT00969436|10982609|FG001|Overall Study|Protocol Violation|3
6945055|NCT00969436|10982610|FG002|Overall Study|Protocol Violation|0
6945056|NCT00969436|10982608|FG000|Overall Study|Migrated/moved from study area|12
6945057|NCT00969436|10982609|FG001|Overall Study|Migrated/moved from study area|10
6945058|NCT00969436|10982610|FG002|Overall Study|Migrated/moved from study area|2
6945059|NCT00969436|10982608|FG000|Overall Study|Father - serious health problem|0
6945060|NCT00969436|10982609|FG001|Overall Study|Father - serious health problem|0
6945061|NCT00969436|10982610|FG002|Overall Study|Father - serious health problem|1
6945062|NCT00969436|10982608|FG000|Overall Study|Parents personal problem|0
6945063|NCT00969436|10982609|FG001|Overall Study|Parents personal problem|0
6945064|NCT00969436|10982610|FG002|Overall Study|Parents personal problem|1
6945065|NCT00969436|10982608|FG000|Overall Study|Subject eliminated (other vaccine)|1
6945066|NCT00969436|10982609|FG001|Overall Study|Subject eliminated (other vaccine)|0
6945067|NCT00969436|10982610|FG002|Overall Study|Subject eliminated (other vaccine)|0
6945068|NCT00969436|10982608|FG000|Overall Study|Withdrawal by Subject|3
6945069|NCT00969436|10982609|FG001|Overall Study|Withdrawal by Subject|0
6945070|NCT00969436|10982610|FG002|Overall Study|Withdrawal by Subject|2
6945071|NCT00969436|10982608|FG000|Overall Study|Lost to Follow-up|8
6945072|NCT00969436|10982609|FG001|Overall Study|Lost to Follow-up|8
6945073|NCT00969436|10982610|FG002|Overall Study|Lost to Follow-up|5
6945074|NCT00969540|10982624|FG000|Overall Study|Lost to Follow-up|1
6945075|NCT00969540|10982625|FG001|Overall Study|Lost to Follow-up|1
6945076|NCT00969553|10982652|FG000|Overall Study|Progressive disease (PD)|2
6945077|NCT00969553|10982653|FG001|Overall Study|Progressive disease (PD)|2
6945078|NCT00969553|10982654|FG002|Overall Study|Progressive disease (PD)|6
6945079|NCT00969553|10982655|FG003|Overall Study|Progressive disease (PD)|9
6945080|NCT00969553|10982656|FG004|Overall Study|Progressive disease (PD)|2
6945081|NCT00969553|10982657|FG005|Overall Study|Progressive disease (PD)|4
6945082|NCT00969553|10982658|FG006|Overall Study|Progressive disease (PD)|2
6945083|NCT00969553|10982659|FG007|Overall Study|Progressive disease (PD)|12
6945084|NCT00969553|10982660|FG008|Overall Study|Progressive disease (PD)|3
6945085|NCT00969553|10982652|FG000|Overall Study|Dose limiting Toxicity (DLT)|0
6945086|NCT00969553|10982653|FG001|Overall Study|Dose limiting Toxicity (DLT)|0
6945087|NCT00969553|10982654|FG002|Overall Study|Dose limiting Toxicity (DLT)|0
6945088|NCT00969553|10982655|FG003|Overall Study|Dose limiting Toxicity (DLT)|0
6945089|NCT00969553|10982656|FG004|Overall Study|Dose limiting Toxicity (DLT)|1
6945090|NCT00969553|10982657|FG005|Overall Study|Dose limiting Toxicity (DLT)|0
6945091|NCT00969553|10982658|FG006|Overall Study|Dose limiting Toxicity (DLT)|0
6945092|NCT00969553|10982659|FG007|Overall Study|Dose limiting Toxicity (DLT)|0
6945093|NCT00969553|10982660|FG008|Overall Study|Dose limiting Toxicity (DLT)|0
6945094|NCT00969553|10982652|FG000|Overall Study|Other Adverse Event|0
7040690|NCT01719380|11123790|FG007|Overall Study|Adverse Event|1
6945095|NCT00969553|10982653|FG001|Overall Study|Other Adverse Event|0
6945096|NCT00969553|10982654|FG002|Overall Study|Other Adverse Event|0
6945097|NCT00969553|10982655|FG003|Overall Study|Other Adverse Event|1
6945098|NCT00969553|10982656|FG004|Overall Study|Other Adverse Event|0
6945099|NCT00969553|10982657|FG005|Overall Study|Other Adverse Event|0
6945100|NCT00969553|10982658|FG006|Overall Study|Other Adverse Event|1
6945101|NCT00969553|10982659|FG007|Overall Study|Other Adverse Event|0
6945102|NCT00969553|10982660|FG008|Overall Study|Other Adverse Event|0
6945103|NCT00969553|10982652|FG000|Overall Study|Refused cont. medication|1
7040691|NCT01719380|11123791|FG008|Overall Study|Adverse Event|4
6945104|NCT00969553|10982653|FG001|Overall Study|Refused cont. medication|1
6945105|NCT00969553|10982654|FG002|Overall Study|Refused cont. medication|0
6945106|NCT00969553|10982655|FG003|Overall Study|Refused cont. medication|2
6945107|NCT00969553|10982656|FG004|Overall Study|Refused cont. medication|0
6945108|NCT00969553|10982657|FG005|Overall Study|Refused cont. medication|0
6945109|NCT00969553|10982658|FG006|Overall Study|Refused cont. medication|0
6945110|NCT00969553|10982659|FG007|Overall Study|Refused cont. medication|1
6945111|NCT00969553|10982660|FG008|Overall Study|Refused cont. medication|0
6945112|NCT00969553|10982652|FG000|Overall Study|Not specified above|0
6945113|NCT00969553|10982653|FG001|Overall Study|Not specified above|0
6945114|NCT00969553|10982654|FG002|Overall Study|Not specified above|0
7067983|NCT01990664|11169236|FG001|Overall Study|Lens Handling Difficulties|0
7067984|NCT01990664|11169235|FG000|Overall Study|Unsatisfactory Visual Response|0
7067985|NCT01990664|11169236|FG001|Overall Study|Unsatisfactory Visual Response|1
7067986|NCT01990742|11169262|FG000|Overall Study|Withdrawal by facility|407
7067987|NCT01990742|11169263|FG001|Overall Study|Withdrawal by facility|1083
7067988|NCT01990742|11169262|FG000|Overall Study|Facility closed|0
7067989|NCT01990742|11169263|FG001|Overall Study|Facility closed|270
7067990|NCT01990768|11169272|FG000|Intervention Started|Found to be ineligible|14
7067991|NCT01990768|11169273|FG001|Intervention Started|Found to be ineligible|13
7067992|NCT01990768|11169274|FG002|Intervention Started|Found to be ineligible|11
7067993|NCT01990768|11169272|FG000|Intervention Started|Study drug issue or kit malfunction|9
7067994|NCT01990768|11169273|FG001|Intervention Started|Study drug issue or kit malfunction|6
7067995|NCT01990768|11169274|FG002|Intervention Started|Study drug issue or kit malfunction|7
7067996|NCT01990768|11169272|FG000|Intervention Started|Patient became ineligible due to vitals|5
7067997|NCT01990768|11169273|FG001|Intervention Started|Patient became ineligible due to vitals|5
7067998|NCT01990768|11169274|FG002|Intervention Started|Patient became ineligible due to vitals|2
7067999|NCT01990768|11169272|FG000|Intervention Started|Not enough time for EMS to enroll|4
7068000|NCT01990768|11169273|FG001|Intervention Started|Not enough time for EMS to enroll|3
7068001|NCT01990768|11169274|FG002|Intervention Started|Not enough time for EMS to enroll|0
7068002|NCT01990768|11169272|FG000|Intervention Started|Patient care priority|1
7068003|NCT01990768|11169273|FG001|Intervention Started|Patient care priority|2
7068004|NCT01990768|11169274|FG002|Intervention Started|Patient care priority|3
7068005|NCT01990768|11169272|FG000|Intervention Started|IV lost|2
7068006|NCT01990768|11169273|FG001|Intervention Started|IV lost|2
7068007|NCT01990768|11169274|FG002|Intervention Started|IV lost|2
7068008|NCT01990768|11169272|FG000|Intervention Started|Required CPR|1
7068009|NCT01990768|11169273|FG001|Intervention Started|Required CPR|1
7068010|NCT01990768|11169274|FG002|Intervention Started|Required CPR|0
7068011|NCT01990768|11169272|FG000|Intervention Started|Seizure or hx of seizure|0
7068012|NCT01990768|11169273|FG001|Intervention Started|Seizure or hx of seizure|0
7068013|NCT01990768|11169274|FG002|Intervention Started|Seizure or hx of seizure|2
7068014|NCT01990768|11169272|FG000|Intervention Started|Discovered to be pregnant|0
7068015|NCT01990768|11169273|FG001|Intervention Started|Discovered to be pregnant|1
7068016|NCT01990768|11169274|FG002|Intervention Started|Discovered to be pregnant|0
6838386|NCT00258154|10844038|FG001|Overall Study|Protocol Violation|1
6838387|NCT00258154|10844037|FG000|Overall Study|Withdrawal by Subject|3
6838388|NCT00258154|10844038|FG001|Overall Study|Withdrawal by Subject|4
6838389|NCT00258154|10844037|FG000|Overall Study|Patient Moved|3
7068017|NCT01990768|11169272|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4
7068018|NCT01990768|11169273|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11
7068019|NCT01990768|11169274|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10
7068020|NCT01990768|11169272|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4
7068021|NCT01990768|11169273|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3
7068022|NCT01990768|11169274|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4
7068023|NCT01990768|11169272|FG000|Prehospital Study Drug Infusion|Required CPR|2
7068024|NCT01990768|11169273|FG001|Prehospital Study Drug Infusion|Required CPR|6
7068025|NCT01990768|11169274|FG002|Prehospital Study Drug Infusion|Required CPR|0
7068026|NCT01990768|11169272|FG000|Prehospital Study Drug Infusion|Other safety concern|2
7068027|NCT01990768|11169273|FG001|Prehospital Study Drug Infusion|Other safety concern|1
7068028|NCT01990768|11169274|FG002|Prehospital Study Drug Infusion|Other safety concern|1
7068029|NCT01990768|11169272|FG000|Prehospital Study Drug Infusion|Death|3
7068030|NCT01990768|11169273|FG001|Prehospital Study Drug Infusion|Death|1
7068031|NCT01990768|11169274|FG002|Prehospital Study Drug Infusion|Death|1
7068032|NCT01990768|11169272|FG000|Prehospital Study Drug Infusion|Discharged|2
7068033|NCT01990768|11169273|FG001|Prehospital Study Drug Infusion|Discharged|1
7068034|NCT01990768|11169274|FG002|Prehospital Study Drug Infusion|Discharged|0
7068035|NCT01990768|11169272|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1
7068036|NCT01990768|11169273|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0
7068037|NCT01990768|11169274|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0
7068038|NCT01990768|11169272|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0
7068039|NCT01990768|11169273|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0
6838390|NCT00258154|10844038|FG001|Overall Study|Patient Moved|1
6945115|NCT00969553|10982655|FG003|Overall Study|Not specified above|4
6945116|NCT00969553|10982656|FG004|Overall Study|Not specified above|0
7068040|NCT01990768|11169274|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1
6945117|NCT00969553|10982657|FG005|Overall Study|Not specified above|0
6945118|NCT00969553|10982658|FG006|Overall Study|Not specified above|1
6945119|NCT00969553|10982659|FG007|Overall Study|Not specified above|1
6945120|NCT00969553|10982660|FG008|Overall Study|Not specified above|0
6945121|NCT00969618|10982688|FG000|Overall Study|Adverse Event|29
6945122|NCT00969618|10982688|FG000|Overall Study|Entry Criteria Not Met|3
6945123|NCT00969618|10982688|FG000|Overall Study|Lack of Efficacy|2
6945124|NCT00969618|10982688|FG000|Overall Study|Lost to Follow-up|7
6945125|NCT00969618|10982688|FG000|Overall Study|Physician Decision|1
6945126|NCT00969618|10982688|FG000|Overall Study|Protocol Violation|9
6945127|NCT00969618|10982688|FG000|Overall Study|Withdrawal by Subject|27
6945128|NCT00969709|10982696|FG000|Overall Study|Adverse Event|3
6945129|NCT00969709|10982697|FG001|Overall Study|Adverse Event|13
6945130|NCT00969709|10982698|FG002|Overall Study|Adverse Event|26
6945131|NCT00969709|10982699|FG003|Overall Study|Adverse Event|12
6945132|NCT00969709|10982696|FG000|Overall Study|Lack of Efficacy|7
6945133|NCT00969709|10982697|FG001|Overall Study|Lack of Efficacy|4
6945134|NCT00969709|10982698|FG002|Overall Study|Lack of Efficacy|1
6945135|NCT00969709|10982699|FG003|Overall Study|Lack of Efficacy|3
6945136|NCT00969709|10982696|FG000|Overall Study|Protocol Violation|9
6945137|NCT00969709|10982697|FG001|Overall Study|Protocol Violation|5
6945138|NCT00969709|10982698|FG002|Overall Study|Protocol Violation|9
6945139|NCT00969709|10982699|FG003|Overall Study|Protocol Violation|10
6945140|NCT00969709|10982696|FG000|Overall Study|Withdrawal by Subject|9
6945141|NCT00969709|10982697|FG001|Overall Study|Withdrawal by Subject|12
6945142|NCT00969709|10982698|FG002|Overall Study|Withdrawal by Subject|11
6945143|NCT00969709|10982699|FG003|Overall Study|Withdrawal by Subject|23
6945144|NCT00969709|10982696|FG000|Overall Study|Lost to Follow-up|10
6945145|NCT00969709|10982697|FG001|Overall Study|Lost to Follow-up|14
6945146|NCT00969709|10982698|FG002|Overall Study|Lost to Follow-up|8
6945147|NCT00969709|10982699|FG003|Overall Study|Lost to Follow-up|15
6945148|NCT00969709|10982696|FG000|Overall Study|Other reasons|0
6945149|NCT00969709|10982697|FG001|Overall Study|Other reasons|0
6945150|NCT00969709|10982698|FG002|Overall Study|Other reasons|3
7068041|NCT01990768|11169272|FG000|Prehospital Study Drug Infusion|Unknown if completed|1
7068042|NCT01990768|11169273|FG001|Prehospital Study Drug Infusion|Unknown if completed|4
7068043|NCT01990768|11169274|FG002|Prehospital Study Drug Infusion|Unknown if completed|2
7068044|NCT01990768|11169272|FG000|In-Hospital Study Drug Infusion|Discharged|19
7068045|NCT01990768|11169273|FG001|In-Hospital Study Drug Infusion|Discharged|18
7068046|NCT01990768|11169274|FG002|In-Hospital Study Drug Infusion|Discharged|13
7068047|NCT01990768|11169272|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14
7068048|NCT01990768|11169273|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17
7068049|NCT01990768|11169274|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10
7068050|NCT01990768|11169272|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13
7068051|NCT01990768|11169273|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7
7068052|NCT01990768|11169274|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12
7068053|NCT01990768|11169272|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12
7068054|NCT01990768|11169273|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11
6945151|NCT00969709|10982699|FG003|Overall Study|Other reasons|0
6945152|NCT00969761|10982725|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
6945153|NCT00969761|10982726|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
6945154|NCT00969761|10982727|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
6945155|NCT00969761|10982728|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
6945156|NCT00969761|10982729|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
6945157|NCT00969761|10982730|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
6945158|NCT00969761|10982731|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
6945159|NCT00969761|10982732|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
6945160|NCT00969761|10982733|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
6945161|NCT00969761|10982734|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
6945162|NCT00969761|10982735|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
6945163|NCT00969761|10982736|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
6945164|NCT00969761|10982725|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
6945165|NCT00969761|10982726|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
6945166|NCT00969761|10982727|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1
6945167|NCT00969761|10982728|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
6945168|NCT00969761|10982729|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
6945169|NCT00969761|10982730|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
6945170|NCT00969761|10982731|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
6945171|NCT00969761|10982732|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
6945172|NCT00969761|10982733|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
6945173|NCT00969761|10982734|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
6945174|NCT00969761|10982735|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
6945175|NCT00969761|10982736|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
6945176|NCT00969761|10982725|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
6945177|NCT00969761|10982726|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
6945178|NCT00969761|10982727|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1
6945179|NCT00969761|10982728|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
6945180|NCT00969761|10982729|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
6945181|NCT00969761|10982730|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
6945182|NCT00969761|10982731|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
6945183|NCT00969761|10982732|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
6945184|NCT00969761|10982733|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
6945185|NCT00969761|10982734|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
6945186|NCT00969761|10982735|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
6945187|NCT00969761|10982736|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
6945188|NCT00969761|10982725|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
6945189|NCT00969761|10982726|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
6945190|NCT00969761|10982727|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
6945191|NCT00969761|10982728|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
6945192|NCT00969761|10982729|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
6945193|NCT00969761|10982730|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
6945194|NCT00969761|10982731|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
6945195|NCT00969761|10982732|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
6945196|NCT00969761|10982733|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1
6945197|NCT00969761|10982734|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
6945198|NCT00969761|10982735|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
6945199|NCT00969761|10982736|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
6945200|NCT00969761|10982725|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
6945201|NCT00969761|10982726|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
6945202|NCT00969761|10982727|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10
6945203|NCT00969761|10982728|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
7068055|NCT01990768|11169274|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6
7068056|NCT01990768|11169272|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11
7068057|NCT01990768|11169273|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4
7068058|NCT01990768|11169274|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7
7068059|NCT01990768|11169272|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8
7068060|NCT01990768|11169273|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9
7068061|NCT01990768|11169274|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17
7068062|NCT01990768|11169272|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5
7068063|NCT01990768|11169273|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5
7068064|NCT01990768|11169274|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4
7068065|NCT01990768|11169272|FG000|In-Hospital Study Drug Infusion|Required CPR|3
7068066|NCT01990768|11169273|FG001|In-Hospital Study Drug Infusion|Required CPR|7
7068067|NCT01990768|11169274|FG002|In-Hospital Study Drug Infusion|Required CPR|1
7068068|NCT01990768|11169272|FG000|In-Hospital Study Drug Infusion|Other safety concern|4
7068069|NCT01990768|11169273|FG001|In-Hospital Study Drug Infusion|Other safety concern|2
7068070|NCT01990768|11169274|FG002|In-Hospital Study Drug Infusion|Other safety concern|3
7068071|NCT01990768|11169272|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4
7068072|NCT01990768|11169273|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0
7068073|NCT01990768|11169274|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3
7068074|NCT01990768|11169272|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1
7068075|NCT01990768|11169273|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1
7068076|NCT01990768|11169274|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1
7068077|NCT01990768|11169272|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1
7068078|NCT01990768|11169273|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1
7068079|NCT01990768|11169274|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0
7068080|NCT01990768|11169272|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0
7068081|NCT01990768|11169273|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1
7068082|NCT01990768|11169274|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2
7068083|NCT01990768|11169272|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0
7068084|NCT01990768|11169273|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0
7068085|NCT01990768|11169274|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1
7068086|NCT01990768|11169272|FG000|6-Month Follow-up|Withdrawal by Subject|25
7068087|NCT01990768|11169273|FG001|6-Month Follow-up|Withdrawal by Subject|25
7068088|NCT01990768|11169274|FG002|6-Month Follow-up|Withdrawal by Subject|26
7068089|NCT01990768|11169272|FG000|6-Month Follow-up|Calls unreturned or refused contact|4
7068090|NCT01990768|11169273|FG001|6-Month Follow-up|Calls unreturned or refused contact|15
7068091|NCT01990768|11169274|FG002|6-Month Follow-up|Calls unreturned or refused contact|20
7068092|NCT01990768|11169272|FG000|6-Month Follow-up|No contact information|5
7068093|NCT01990768|11169273|FG001|6-Month Follow-up|No contact information|6
7068094|NCT01990768|11169274|FG002|6-Month Follow-up|No contact information|5
7068095|NCT01990768|11169272|FG000|6-Month Follow-up|Homeless|4
7068096|NCT01990768|11169273|FG001|6-Month Follow-up|Homeless|3
7068097|NCT01990768|11169274|FG002|6-Month Follow-up|Homeless|6
7068098|NCT01990768|11169272|FG000|6-Month Follow-up|Prisoner at time of enrollment|0
6945204|NCT00969761|10982729|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
6945205|NCT00969761|10982730|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
6945206|NCT00969761|10982731|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
6945207|NCT00969761|10982732|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6
6945208|NCT00969761|10982733|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9
6945209|NCT00969761|10982734|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
6945210|NCT00969761|10982735|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
6945211|NCT00969761|10982736|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
6945212|NCT00969761|10982725|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
6945213|NCT00969761|10982726|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
6945214|NCT00969761|10982727|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
6945215|NCT00969761|10982728|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2
6945216|NCT00969761|10982729|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1
6945217|NCT00969761|10982730|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
6945218|NCT00969761|10982731|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
6945219|NCT00969761|10982732|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
6945220|NCT00969761|10982733|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2
6945221|NCT00969761|10982734|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
6945222|NCT00969761|10982735|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
6945223|NCT00969761|10982736|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
6945224|NCT00970268|10982801|FG000|Overall Study|Withdrawal by Subject|12
6945225|NCT00970268|10982802|FG001|Overall Study|Withdrawal by Subject|19
6945226|NCT00970268|10982801|FG000|Overall Study|Adverse Event|15
6945227|NCT00970268|10982802|FG001|Overall Study|Adverse Event|12
6945228|NCT00970268|10982801|FG000|Overall Study|Lack of Efficacy|3
6945229|NCT00970268|10982802|FG001|Overall Study|Lack of Efficacy|6
6945230|NCT00970268|10982801|FG000|Overall Study|Protocol Violation|4
6945231|NCT00970268|10982802|FG001|Overall Study|Protocol Violation|7
6945232|NCT00970268|10982801|FG000|Overall Study|Other Reason|3
6945233|NCT00970268|10982802|FG001|Overall Study|Other Reason|1
6945234|NCT00970268|10982801|FG000|Overall Study|COPD Exacerbation|4
6945235|NCT00970268|10982802|FG001|Overall Study|COPD Exacerbation|2
6945236|NCT00970268|10982801|FG000|Overall Study|Lost to Follow-up|1
6945237|NCT00970268|10982802|FG001|Overall Study|Lost to Follow-up|2
6945238|NCT00970268|10982801|FG000|Overall Study|Inclusion/Exclusion Criteria|1
7068099|NCT01990768|11169273|FG001|6-Month Follow-up|Prisoner at time of enrollment|0
7068100|NCT01990768|11169274|FG002|6-Month Follow-up|Prisoner at time of enrollment|1
7068101|NCT01990768|11169272|FG000|6-Month Follow-up|Prisoner at time of follow-up|0
7068102|NCT01990768|11169273|FG001|6-Month Follow-up|Prisoner at time of follow-up|2
7068103|NCT01990768|11169274|FG002|6-Month Follow-up|Prisoner at time of follow-up|0
7068104|NCT01990768|11169272|FG000|6-Month Follow-up|Patient at psychiatric hospital|1
7068105|NCT01990768|11169273|FG001|6-Month Follow-up|Patient at psychiatric hospital|0
7068106|NCT01990768|11169274|FG002|6-Month Follow-up|Patient at psychiatric hospital|0
7068107|NCT01990859|11169379|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5
6945239|NCT00970268|10982802|FG001|Overall Study|Inclusion/Exclusion Criteria|0
6945240|NCT00970281|10982816|FG000|Overall Study|Lack of Efficacy|1
6945241|NCT00970281|10982817|FG001|Overall Study|Lack of Efficacy|14
7068108|NCT01990859|11169379|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17
7068109|NCT01990950|11169388|FG000|Overall Study|Death|3
7068110|NCT01990950|11169388|FG000|Overall Study|Lost to Follow-up|2
7068111|NCT01990950|11169388|FG000|Overall Study|Withdrawal by Subject|6
7068112|NCT01991197|11169394|FG000|Overall Study|Lost to Follow-up|1
7068113|NCT01991197|11169395|FG001|Overall Study|Lost to Follow-up|1
7068114|NCT01991197|11169394|FG000|Overall Study|Physician Decision|0
7068115|NCT01991197|11169395|FG001|Overall Study|Physician Decision|2
7068116|NCT01991197|11169394|FG000|Overall Study|Withdrawal by Subject|2
7068117|NCT01991197|11169395|FG001|Overall Study|Withdrawal by Subject|0
7068118|NCT01991314|11169408|FG000|Overall Study|Adverse Event|5
7068119|NCT01991314|11169409|FG001|Overall Study|Adverse Event|1
7068120|NCT01991314|11169408|FG000|Overall Study|Lost to Follow-up|6
7068121|NCT01991314|11169409|FG001|Overall Study|Lost to Follow-up|10
7068122|NCT01991470|11169415|FG000|Enlite 1 Period|Withdrawal by Subject|18
7068123|NCT01991470|11169415|FG000|Enlite 1 Period|Adverse Event|1
7068124|NCT01991470|11169415|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1
7068125|NCT01991470|11169415|FG000|Enlite 3 Period|Lost to Follow-up|1
7068126|NCT01991470|11169415|FG000|Enlite 3 Period|Physician Decision|2
7068127|NCT01991470|11169415|FG000|Enlite 3 Period|Physician Decision|8
6945242|NCT00970281|10982816|FG000|Overall Study|Withdrawal by Subject|0
6945243|NCT00970281|10982817|FG001|Overall Study|Withdrawal by Subject|1
6945244|NCT00970281|10982816|FG000|Overall Study|Physician Decision|1
6945245|NCT00970281|10982817|FG001|Overall Study|Physician Decision|1
7068128|NCT01991470|11169415|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1
7068129|NCT01991483|11169431|FG000|Dose Level 600 mg|Withdrawal by Subject|0
7068130|NCT01991483|11169432|FG001|Dose Level 600 mg|Withdrawal by Subject|0
7068131|NCT01991483|11169433|FG002|Dose Level 600 mg|Withdrawal by Subject|1
7068132|NCT01991483|11169434|FG003|Dose Level 600 mg|Withdrawal by Subject|0
6945246|NCT00970294|10982823|FG000|Overall Study|Physician Decision|4
6945247|NCT00970294|10982823|FG000|Overall Study|Withdrawal by Subject|1
6945248|NCT00970307|10982830|FG000|Overall Study|Serious Adverse Event|1
6945249|NCT00970307|10982831|FG001|Overall Study|Serious Adverse Event|0
6945250|NCT00970307|10982832|FG002|Overall Study|Serious Adverse Event|0
6945251|NCT00970307|10982830|FG000|Overall Study|Withdrawal by Subject|2
6945252|NCT00970307|10982831|FG001|Overall Study|Withdrawal by Subject|3
6945253|NCT00970307|10982832|FG002|Overall Study|Withdrawal by Subject|2
6945254|NCT00970359|10982861|FG000|Overall Study|Not Treated|4
6945255|NCT00970489|10982867|FG000|Overall Study|Death/Withdrew/Criteria Violation|54
6945256|NCT00970489|10982868|FG001|Overall Study|Death/Withdrew/Criteria Violation|41
6945257|NCT00970502|10982874|FG000|Overall Study|Withdrawal by Subject|1
6945258|NCT00970593|10982889|FG000|Overall Study|Adverse Event|1
6945259|NCT00970593|10982890|FG001|Overall Study|Adverse Event|1
6945260|NCT00970593|10982891|FG002|Overall Study|Adverse Event|0
6945261|NCT00970593|10982892|FG003|Overall Study|Adverse Event|0
6945262|NCT00970593|10982893|FG004|Overall Study|Adverse Event|0
6945263|NCT00970593|10982894|FG005|Overall Study|Adverse Event|0
6945264|NCT00970593|10982895|FG006|Overall Study|Adverse Event|0
6945265|NCT00970593|10982889|FG000|Overall Study|Discontinuation of study by sponsor|0
6945266|NCT00970593|10982890|FG001|Overall Study|Discontinuation of study by sponsor|0
6945267|NCT00970593|10982891|FG002|Overall Study|Discontinuation of study by sponsor|5
6945268|NCT00970593|10982892|FG003|Overall Study|Discontinuation of study by sponsor|0
6945269|NCT00970593|10982893|FG004|Overall Study|Discontinuation of study by sponsor|0
6945270|NCT00970593|10982894|FG005|Overall Study|Discontinuation of study by sponsor|0
6945271|NCT00970593|10982895|FG006|Overall Study|Discontinuation of study by sponsor|2
6945272|NCT00970593|10982889|FG000|Overall Study|Withdrawal by Subject|0
6945273|NCT00970593|10982890|FG001|Overall Study|Withdrawal by Subject|0
6945274|NCT00970593|10982891|FG002|Overall Study|Withdrawal by Subject|1
6945275|NCT00970593|10982892|FG003|Overall Study|Withdrawal by Subject|0
6945276|NCT00970593|10982893|FG004|Overall Study|Withdrawal by Subject|0
6945277|NCT00970593|10982894|FG005|Overall Study|Withdrawal by Subject|0
6945278|NCT00970593|10982895|FG006|Overall Study|Withdrawal by Subject|0
6945279|NCT00970632|10982918|FG000|Overall Study|Adverse Event|2
6945280|NCT00970632|10982919|FG001|Overall Study|Adverse Event|2
6945281|NCT00970632|10982920|FG002|Overall Study|Adverse Event|1
6945282|NCT00970632|10982918|FG000|Overall Study|Lack of Efficacy|3
6945283|NCT00970632|10982919|FG001|Overall Study|Lack of Efficacy|0
6945284|NCT00970632|10982920|FG002|Overall Study|Lack of Efficacy|0
6945285|NCT00970632|10982918|FG000|Overall Study|Lost to Follow-up|3
6945286|NCT00970632|10982919|FG001|Overall Study|Lost to Follow-up|0
6945287|NCT00970632|10982920|FG002|Overall Study|Lost to Follow-up|2
6945288|NCT00970632|10982918|FG000|Overall Study|Protocol Violation|8
6945289|NCT00970632|10982919|FG001|Overall Study|Protocol Violation|5
6945290|NCT00970632|10982920|FG002|Overall Study|Protocol Violation|8
6945291|NCT00970632|10982918|FG000|Overall Study|Withdrawal by Subject|7
6945292|NCT00970632|10982919|FG001|Overall Study|Withdrawal by Subject|6
6945293|NCT00970632|10982920|FG002|Overall Study|Withdrawal by Subject|4
6945294|NCT00970632|10982918|FG000|Overall Study|Entry criteria not met|0
6945295|NCT00970632|10982919|FG001|Overall Study|Entry criteria not met|2
6945296|NCT00970632|10982920|FG002|Overall Study|Entry criteria not met|2
6945297|NCT00970632|10982918|FG000|Overall Study|Sponsor decision|1
6945298|NCT00970632|10982919|FG001|Overall Study|Sponsor decision|0
6945299|NCT00970632|10982920|FG002|Overall Study|Sponsor decision|1
6945300|NCT00970684|10982928|FG000|Overall Study|Lack of Efficacy|5
6945301|NCT00970684|10982928|FG000|Overall Study|Adverse Event|4
6945302|NCT00970684|10982928|FG000|Overall Study|Withdrawal by Subject|1
6945303|NCT00970944|10982952|FG000|Overall Study|Death|1
6945304|NCT00970944|10982953|FG001|Overall Study|Death|0
6945305|NCT00970944|10982952|FG000|Overall Study|Physician Decision|0
6945306|NCT00970944|10982953|FG001|Overall Study|Physician Decision|2
6945307|NCT00971048|10982964|FG000|Overall Study|Protocol Violation|1
6945308|NCT00971048|10982965|FG001|Overall Study|Protocol Violation|2
6945309|NCT00971048|10982966|FG002|Overall Study|Protocol Violation|0
6945310|NCT00971048|10982967|FG003|Overall Study|Protocol Violation|1
6945311|NCT00971048|10982964|FG000|Overall Study|Adverse Event|0
6945312|NCT00971048|10982965|FG001|Overall Study|Adverse Event|0
6945313|NCT00971048|10982966|FG002|Overall Study|Adverse Event|1
6945314|NCT00971048|10982967|FG003|Overall Study|Adverse Event|0
6945315|NCT00971048|10982964|FG000|Overall Study|Physician Decision|0
6945316|NCT00971048|10982965|FG001|Overall Study|Physician Decision|0
6945317|NCT00971048|10982966|FG002|Overall Study|Physician Decision|0
6945318|NCT00971048|10982967|FG003|Overall Study|Physician Decision|1
6945319|NCT00971178|10982982|FG000|Overall Study|Lost to Follow-up|2
6945320|NCT00971178|10982983|FG001|Overall Study|Lost to Follow-up|2
6945321|NCT00971178|10982984|FG002|Overall Study|Lost to Follow-up|2
6945322|NCT00971204|10982992|FG000|Overall Study|Did not meet all criteria-not treated|14
6945323|NCT00971204|10982992|FG000|Overall Study|Lost to Follow-up|10
6945324|NCT00971243|10983001|FG000|Double Blind Period|Adverse Event|2
6945325|NCT00971243|10983002|FG001|Double Blind Period|Adverse Event|3
6945326|NCT00971243|10983003|FG002|Double Blind Period|Adverse Event|2
6945327|NCT00971243|10983004|FG003|Double Blind Period|Adverse Event|2
6945328|NCT00971243|10983005|FG004|Double Blind Period|Adverse Event|3
6945329|NCT00971243|10983001|FG000|Double Blind Period|Lost to Follow-up|0
6945330|NCT00971243|10983002|FG001|Double Blind Period|Lost to Follow-up|1
6945331|NCT00971243|10983003|FG002|Double Blind Period|Lost to Follow-up|1
6945332|NCT00971243|10983004|FG003|Double Blind Period|Lost to Follow-up|0
6945333|NCT00971243|10983005|FG004|Double Blind Period|Lost to Follow-up|1
6945334|NCT00971243|10983001|FG000|Double Blind Period|Physician Decision|10
6945335|NCT00971243|10983002|FG001|Double Blind Period|Physician Decision|6
6945336|NCT00971243|10983003|FG002|Double Blind Period|Physician Decision|7
6945337|NCT00971243|10983004|FG003|Double Blind Period|Physician Decision|6
6945338|NCT00971243|10983005|FG004|Double Blind Period|Physician Decision|7
6945339|NCT00971243|10983001|FG000|Double Blind Period|Protocol Violation|2
6945340|NCT00971243|10983002|FG001|Double Blind Period|Protocol Violation|0
6945341|NCT00971243|10983003|FG002|Double Blind Period|Protocol Violation|3
6945342|NCT00971243|10983004|FG003|Double Blind Period|Protocol Violation|2
6945343|NCT00971243|10983005|FG004|Double Blind Period|Protocol Violation|2
6945344|NCT00971243|10983001|FG000|Double Blind Period|Withdrawal by Subject|4
6945345|NCT00971243|10983002|FG001|Double Blind Period|Withdrawal by Subject|1
6945346|NCT00971243|10983003|FG002|Double Blind Period|Withdrawal by Subject|4
6945347|NCT00971243|10983004|FG003|Double Blind Period|Withdrawal by Subject|4
6945348|NCT00971243|10983005|FG004|Double Blind Period|Withdrawal by Subject|4
6945349|NCT00971243|10983001|FG000|Double Blind Period|Other reasons|1
6945350|NCT00971243|10983002|FG001|Double Blind Period|Other reasons|0
6945351|NCT00971243|10983003|FG002|Double Blind Period|Other reasons|2
6945352|NCT00971243|10983004|FG003|Double Blind Period|Other reasons|0
6945353|NCT00971243|10983005|FG004|Double Blind Period|Other reasons|1
6945354|NCT00971243|10983001|FG000|Open-label Period|Adverse Event|1
6945355|NCT00971243|10983002|FG001|Open-label Period|Adverse Event|0
6945356|NCT00971243|10983003|FG002|Open-label Period|Adverse Event|1
6945357|NCT00971243|10983004|FG003|Open-label Period|Adverse Event|1
6945358|NCT00971243|10983005|FG004|Open-label Period|Adverse Event|0
6945359|NCT00971243|10983001|FG000|Open-label Period|Physician Decision|5
6945360|NCT00971243|10983002|FG001|Open-label Period|Physician Decision|9
6945361|NCT00971243|10983003|FG002|Open-label Period|Physician Decision|3
6945362|NCT00971243|10983004|FG003|Open-label Period|Physician Decision|7
6945363|NCT00971243|10983005|FG004|Open-label Period|Physician Decision|2
6945364|NCT00971243|10983001|FG000|Open-label Period|Protocol Violation|1
6945365|NCT00971243|10983002|FG001|Open-label Period|Protocol Violation|1
7040692|NCT01719380|11123792|FG009|Overall Study|Adverse Event|3
7040693|NCT01719380|11123783|FG000|Overall Study|Death|0
7040694|NCT01719380|11123784|FG001|Overall Study|Death|1
7040695|NCT01719380|11123785|FG002|Overall Study|Death|0
6945366|NCT00971243|10983003|FG002|Open-label Period|Protocol Violation|1
7068133|NCT01991483|11169431|FG000|Dose Level 600 mg|Physician Decision|0
7068134|NCT01991483|11169432|FG001|Dose Level 600 mg|Physician Decision|0
7068135|NCT01991483|11169433|FG002|Dose Level 600 mg|Physician Decision|1
7068136|NCT01991483|11169434|FG003|Dose Level 600 mg|Physician Decision|0
6945367|NCT00971243|10983004|FG003|Open-label Period|Protocol Violation|0
7068137|NCT01991483|11169431|FG000|Dose Level 1000 mg|Protocol Violation|0
7068138|NCT01991483|11169432|FG001|Dose Level 1000 mg|Protocol Violation|0
7068139|NCT01991483|11169433|FG002|Dose Level 1000 mg|Protocol Violation|0
7068140|NCT01991483|11169434|FG003|Dose Level 1000 mg|Protocol Violation|1
7068141|NCT01991743|11169464|FG000|Overall Study|external cephalic version not performed|0
7068142|NCT01991743|11169465|FG001|Overall Study|external cephalic version not performed|0
7068143|NCT01991743|11169466|FG002|Overall Study|external cephalic version not performed|1
7068144|NCT01991743|11169467|FG003|Overall Study|external cephalic version not performed|0
7068145|NCT01991795|11169479|FG000|Overall Study|Lost to Follow-up|6
7068146|NCT01991795|11169480|FG001|Overall Study|Lost to Follow-up|4
7068147|NCT01991795|11169479|FG000|Overall Study|Withdrawal by Subject|117
7068148|NCT01991795|11169480|FG001|Overall Study|Withdrawal by Subject|94
7068149|NCT01991795|11169479|FG000|Overall Study|Site prematurely closed by sponsor|26
7068150|NCT01991795|11169480|FG001|Overall Study|Site prematurely closed by sponsor|25
7068151|NCT01991977|11169510|FG000|Overall Study|Withdrew prior to receiving treatment|7
7068152|NCT01991977|11169510|FG000|Overall Study|Withdrew after start of treatment|5
7068153|NCT01992094|11169539|FG000|Overall Study|ADMINISTRATIVE REASON|6
7068154|NCT01992094|11169540|FG001|Overall Study|ADMINISTRATIVE REASON|7
7068155|NCT01992094|11169541|FG002|Overall Study|ADMINISTRATIVE REASON|1
7068156|NCT01992094|11169539|FG000|Overall Study|Adverse Event|1
7068157|NCT01992094|11169540|FG001|Overall Study|Adverse Event|0
7068158|NCT01992094|11169541|FG002|Overall Study|Adverse Event|0
7068159|NCT01992094|11169539|FG000|Overall Study|Death|5
7068160|NCT01992094|11169540|FG001|Overall Study|Death|5
7068161|NCT01992094|11169541|FG002|Overall Study|Death|2
7068162|NCT01992094|11169539|FG000|Overall Study|Lost to Follow-up|26
7040696|NCT01719380|11123786|FG003|Overall Study|Death|0
7040697|NCT01719380|11123787|FG004|Overall Study|Death|0
7068163|NCT01992094|11169540|FG001|Overall Study|Lost to Follow-up|9
7068164|NCT01992094|11169541|FG002|Overall Study|Lost to Follow-up|13
7068165|NCT01992094|11169539|FG000|Overall Study|OTHER|4
7068166|NCT01992094|11169540|FG001|Overall Study|OTHER|0
7068167|NCT01992094|11169541|FG002|Overall Study|OTHER|0
6945368|NCT00971243|10983005|FG004|Open-label Period|Protocol Violation|1
6945369|NCT00971243|10983001|FG000|Open-label Period|Withdrawal by Subject|1
6945370|NCT00971243|10983002|FG001|Open-label Period|Withdrawal by Subject|0
7040698|NCT01719380|11123788|FG005|Overall Study|Death|0
6945371|NCT00971243|10983003|FG002|Open-label Period|Withdrawal by Subject|0
6945372|NCT00971243|10983004|FG003|Open-label Period|Withdrawal by Subject|2
6945373|NCT00971243|10983005|FG004|Open-label Period|Withdrawal by Subject|1
6945374|NCT00971243|10983001|FG000|Open-label Period|Other reason|0
6945375|NCT00971243|10983002|FG001|Open-label Period|Other reason|0
6945376|NCT00971243|10983003|FG002|Open-label Period|Other reason|0
6945377|NCT00971243|10983004|FG003|Open-label Period|Other reason|0
6945378|NCT00971243|10983005|FG004|Open-label Period|Other reason|2
6945379|NCT00971321|10983032|FG000|Up to Month 7|Withdrawal by Subject|1
6945380|NCT00971321|10983033|FG001|Up to Month 7|Withdrawal by Subject|0
6945381|NCT00971321|10983032|FG000|Up to Month 7|Migrated/moved from study area|3
6945382|NCT00971321|10983033|FG001|Up to Month 7|Migrated/moved from study area|2
6945383|NCT00971321|10983032|FG000|Up to Month 11-12|Withdrawal by Subject|2
6945384|NCT00971321|10983033|FG001|Up to Month 11-12|Withdrawal by Subject|1
6945385|NCT00971321|10983032|FG000|Up to Month 11-12|Migrated/moved from study area|2
6945386|NCT00971321|10983033|FG001|Up to Month 11-12|Migrated/moved from study area|2
6945387|NCT00971321|10983032|FG000|Up to Month 11-12|Lost to Follow-up|1
6945388|NCT00971321|10983033|FG001|Up to Month 11-12|Lost to Follow-up|0
6945389|NCT00971425|10983041|FG000|Overall Study|Adverse Event|1
6945390|NCT00971425|10983042|FG001|Overall Study|Adverse Event|1
6945391|NCT00971425|10983041|FG000|Overall Study|Withdrawal by Subject|0
6945392|NCT00971425|10983042|FG001|Overall Study|Withdrawal by Subject|1
6945393|NCT00971932|10983093|FG000|Overall Study|Withdrawal by Subject|1
6945394|NCT00971932|10983093|FG000|Overall Study|Investigator's decision|2
6945395|NCT00971932|10983093|FG000|Overall Study|Ongoing|4
6945396|NCT00971945|10983097|FG000|Overall Study|Progressive Disease|3
6945397|NCT00971945|10983097|FG000|Overall Study|Change in treatment policy|1
6945398|NCT00971945|10983097|FG000|Overall Study|Other reasons|2
6945399|NCT00971997|10983101|FG000|Overall Study|Adverse Event|2
6945400|NCT00971997|10983101|FG000|Overall Study|Death|1
6945401|NCT00971997|10983101|FG000|Overall Study|Protocol Violation|4
6945402|NCT00971997|10983101|FG000|Overall Study|Withdrawal by Subject|5
6945403|NCT00971997|10983101|FG000|Overall Study|Physician Decision|7
6945404|NCT00972153|10983115|FG000|Overall Study|Equipment malfunction during case|0
6945405|NCT00972153|10983116|FG001|Overall Study|Equipment malfunction during case|1
6945406|NCT00972153|10983117|FG002|Overall Study|Equipment malfunction during case|0
6945407|NCT00972244|10983134|FG000|Overall Study|Incorrect Enrolment|1
6945408|NCT00972244|10983135|FG001|Overall Study|Incorrect Enrolment|0
6945409|NCT00972244|10983136|FG002|Overall Study|Incorrect Enrolment|0
6945410|NCT00972244|10983137|FG003|Overall Study|Incorrect Enrolment|0
6945411|NCT00972244|10983138|FG004|Overall Study|Incorrect Enrolment|0
6945412|NCT00972244|10983134|FG000|Overall Study|Adverse Event|0
6945413|NCT00972244|10983135|FG001|Overall Study|Adverse Event|1
6945414|NCT00972244|10983136|FG002|Overall Study|Adverse Event|1
6945415|NCT00972244|10983137|FG003|Overall Study|Adverse Event|0
6945416|NCT00972244|10983138|FG004|Overall Study|Adverse Event|0
6945417|NCT00972244|10983134|FG000|Overall Study|Subject No Longer Meets Study Criteria|2
6945418|NCT00972244|10983135|FG001|Overall Study|Subject No Longer Meets Study Criteria|2
6945419|NCT00972244|10983136|FG002|Overall Study|Subject No Longer Meets Study Criteria|0
6945420|NCT00972244|10983137|FG003|Overall Study|Subject No Longer Meets Study Criteria|0
6945421|NCT00972244|10983138|FG004|Overall Study|Subject No Longer Meets Study Criteria|5
6945422|NCT00972244|10983134|FG000|Overall Study|Withdrawal by Subject|1
6945423|NCT00972244|10983135|FG001|Overall Study|Withdrawal by Subject|2
6945424|NCT00972244|10983136|FG002|Overall Study|Withdrawal by Subject|1
6945425|NCT00972244|10983137|FG003|Overall Study|Withdrawal by Subject|0
6945426|NCT00972244|10983138|FG004|Overall Study|Withdrawal by Subject|1
6945427|NCT00972244|10983134|FG000|Overall Study|Safety|0
6945428|NCT00972244|10983135|FG001|Overall Study|Safety|0
6945429|NCT00972244|10983136|FG002|Overall Study|Safety|0
6945430|NCT00972244|10983137|FG003|Overall Study|Safety|0
6945431|NCT00972244|10983138|FG004|Overall Study|Safety|1
6945432|NCT00972244|10983134|FG000|Overall Study|Death|1
6945433|NCT00972244|10983135|FG001|Overall Study|Death|0
6945434|NCT00972244|10983136|FG002|Overall Study|Death|0
6945435|NCT00972244|10983137|FG003|Overall Study|Death|0
6945436|NCT00972244|10983138|FG004|Overall Study|Death|0
6945437|NCT00972244|10983134|FG000|Overall Study|Various|0
6945438|NCT00972244|10983135|FG001|Overall Study|Various|0
6945439|NCT00972244|10983136|FG002|Overall Study|Various|0
6945440|NCT00972244|10983137|FG003|Overall Study|Various|0
6945441|NCT00972244|10983138|FG004|Overall Study|Various|2
6945442|NCT00972283|10983152|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31
6945443|NCT00972283|10983153|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9
6945444|NCT00972283|10983152|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3
6945445|NCT00972283|10983153|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0
6945446|NCT00972283|10983152|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23
6945447|NCT00972283|10983153|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12
6945448|NCT00972283|10983152|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8
6945449|NCT00972283|10983153|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2
6945450|NCT00972283|10983152|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72
6945451|NCT00972283|10983153|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17
6945452|NCT00972283|10983152|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4
6945453|NCT00972283|10983153|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0
6945454|NCT00972283|10983152|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
6945455|NCT00972283|10983153|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
6945456|NCT00972283|10983152|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5
6945457|NCT00972283|10983153|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0
6945458|NCT00972283|10983152|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6
6945459|NCT00972283|10983153|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2
6945460|NCT00972283|10983152|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11
6945461|NCT00972283|10983153|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5
6945462|NCT00972322|10983161|FG000|Overall Study|Adverse Event|2
6945463|NCT00972322|10983162|FG001|Overall Study|Adverse Event|1
6945464|NCT00972322|10983161|FG000|Overall Study|Positive drug screen|0
6945465|NCT00972322|10983162|FG001|Overall Study|Positive drug screen|1
6945466|NCT00972322|10983161|FG000|Overall Study|Lost to Follow-up|0
6945467|NCT00972322|10983162|FG001|Overall Study|Lost to Follow-up|1
6945468|NCT00972322|10983161|FG000|Overall Study|Consistently high glucose values|1
6945469|NCT00972322|10983162|FG001|Overall Study|Consistently high glucose values|0
6945470|NCT00972504|10983194|FG000|Overall Study|Adverse Event|2
6945471|NCT00972504|10983194|FG000|Overall Study|Investigator discretion|1
6945472|NCT00972517|10983204|FG000|Overall Study|Adverse Event|0
6945473|NCT00972517|10983205|FG001|Overall Study|Adverse Event|0
6945474|NCT00972517|10983206|FG002|Overall Study|Adverse Event|0
6945475|NCT00972517|10983207|FG003|Overall Study|Adverse Event|1
6945476|NCT00972517|10983208|FG004|Overall Study|Adverse Event|0
6945477|NCT00972517|10983209|FG005|Overall Study|Adverse Event|0
6945478|NCT00972517|10983204|FG000|Overall Study|Withdrawal by Subject|0
6945479|NCT00972517|10983205|FG001|Overall Study|Withdrawal by Subject|1
6945480|NCT00972517|10983206|FG002|Overall Study|Withdrawal by Subject|0
6945481|NCT00972517|10983207|FG003|Overall Study|Withdrawal by Subject|2
6945482|NCT00972517|10983208|FG004|Overall Study|Withdrawal by Subject|1
6945483|NCT00972517|10983209|FG005|Overall Study|Withdrawal by Subject|0
6945484|NCT00972543|10983240|FG000|Overall Study|Adverse Event|1
6945485|NCT00972543|10983241|FG001|Overall Study|Adverse Event|0
6945486|NCT00972543|10983240|FG000|Overall Study|Early study termination by sponsor|4
6945487|NCT00972543|10983241|FG001|Overall Study|Early study termination by sponsor|1
6945488|NCT00972595|10983247|FG000|Period 1|Adverse Event|1
6945489|NCT00972595|10983248|FG001|Period 1|Adverse Event|0
6945490|NCT00972777|10983274|FG000|Overall Study|Adverse Event|3
6945491|NCT00972777|10983275|FG001|Overall Study|Adverse Event|2
6945492|NCT00972777|10983274|FG000|Overall Study|Lost to Follow-up|0
6945493|NCT00972777|10983275|FG001|Overall Study|Lost to Follow-up|4
6945494|NCT00972777|10983274|FG000|Overall Study|Withdrawal by Subject|4
6945495|NCT00972777|10983275|FG001|Overall Study|Withdrawal by Subject|5
6945496|NCT00972777|10983274|FG000|Overall Study|Physician Decision|4
6945497|NCT00972777|10983275|FG001|Overall Study|Physician Decision|0
6945498|NCT00972777|10983274|FG000|Overall Study|Protocol Violation|0
6945499|NCT00972777|10983275|FG001|Overall Study|Protocol Violation|2
6945500|NCT00972777|10983274|FG000|Overall Study|Screening Failure|2
6945501|NCT00972777|10983275|FG001|Overall Study|Screening Failure|1
7068168|NCT01992094|11169539|FG000|Overall Study|Protocol Violation|1
7068169|NCT01992094|11169540|FG001|Overall Study|Protocol Violation|0
7068170|NCT01992094|11169541|FG002|Overall Study|Protocol Violation|1
7068171|NCT01992094|11169539|FG000|Overall Study|Withdrawal by Subject|7
7068172|NCT01992094|11169540|FG001|Overall Study|Withdrawal by Subject|3
7068173|NCT01992094|11169541|FG002|Overall Study|Withdrawal by Subject|4
7068174|NCT01992107|11169568|FG000|Overall Study|Administrative reasons|2
7068175|NCT01992107|11169569|FG001|Overall Study|Administrative reasons|0
7068176|NCT01992107|11169570|FG002|Overall Study|Administrative reasons|0
7068177|NCT01992107|11169568|FG000|Overall Study|Adverse Event|0
7068178|NCT01992107|11169569|FG001|Overall Study|Adverse Event|1
7068179|NCT01992107|11169570|FG002|Overall Study|Adverse Event|0
7068180|NCT01992107|11169568|FG000|Overall Study|Lost to Follow-up|46
7068181|NCT01992107|11169569|FG001|Overall Study|Lost to Follow-up|22
7068182|NCT01992107|11169570|FG002|Overall Study|Lost to Follow-up|26
7068183|NCT01992107|11169568|FG000|Overall Study|noncompliance and were unavailable|7
7068184|NCT01992107|11169569|FG001|Overall Study|noncompliance and were unavailable|3
7068185|NCT01992107|11169570|FG002|Overall Study|noncompliance and were unavailable|2
7068186|NCT01992107|11169568|FG000|Overall Study|Withdrawal by Subject|13
7068187|NCT01992107|11169569|FG001|Overall Study|Withdrawal by Subject|7
7068188|NCT01992107|11169570|FG002|Overall Study|Withdrawal by Subject|8
7068189|NCT01992159|11169599|FG000|Overall Study|Withdrawal by Subject|4
7068190|NCT01992159|11169600|FG001|Overall Study|Withdrawal by Subject|7
7068191|NCT01992159|11169601|FG002|Overall Study|Withdrawal by Subject|0
7068192|NCT01992159|11169602|FG003|Overall Study|Withdrawal by Subject|3
7068193|NCT01992159|11169599|FG000|Overall Study|Adverse Event|0
6945502|NCT00972777|10983274|FG000|Overall Study|Missed visit|1
6945503|NCT00972777|10983275|FG001|Overall Study|Missed visit|0
6945504|NCT00972816|10983289|FG000|Overall Study|Adverse Event|0
6945505|NCT00972816|10983290|FG001|Overall Study|Adverse Event|0
7068194|NCT01992159|11169600|FG001|Overall Study|Adverse Event|1
7068195|NCT01992159|11169601|FG002|Overall Study|Adverse Event|0
7068196|NCT01992159|11169602|FG003|Overall Study|Adverse Event|1
7068197|NCT01992159|11169599|FG000|Overall Study|Death|0
7068198|NCT01992159|11169600|FG001|Overall Study|Death|0
6945506|NCT00972816|10983291|FG002|Overall Study|Adverse Event|1
6945507|NCT00972816|10983292|FG003|Overall Study|Adverse Event|0
6945508|NCT00972816|10983293|FG004|Overall Study|Adverse Event|0
6945509|NCT00972816|10983294|FG005|Overall Study|Adverse Event|0
6945510|NCT00972816|10983295|FG006|Overall Study|Adverse Event|0
6945511|NCT00972816|10983296|FG007|Overall Study|Adverse Event|0
6945512|NCT00972816|10983289|FG000|Overall Study|Withdrawal by Subject|4
7068199|NCT01992159|11169601|FG002|Overall Study|Death|1
6945513|NCT00972816|10983290|FG001|Overall Study|Withdrawal by Subject|2
6945514|NCT00972816|10983291|FG002|Overall Study|Withdrawal by Subject|1
6945515|NCT00972816|10983292|FG003|Overall Study|Withdrawal by Subject|3
6945516|NCT00972816|10983293|FG004|Overall Study|Withdrawal by Subject|0
6945517|NCT00972816|10983294|FG005|Overall Study|Withdrawal by Subject|1
6945518|NCT00972816|10983295|FG006|Overall Study|Withdrawal by Subject|1
6945519|NCT00972816|10983296|FG007|Overall Study|Withdrawal by Subject|2
6945520|NCT00972816|10983289|FG000|Overall Study|Lost to Follow-up|11
6945521|NCT00972816|10983290|FG001|Overall Study|Lost to Follow-up|9
6945522|NCT00972816|10983291|FG002|Overall Study|Lost to Follow-up|7
6945523|NCT00972816|10983292|FG003|Overall Study|Lost to Follow-up|5
6945524|NCT00972816|10983293|FG004|Overall Study|Lost to Follow-up|11
6945525|NCT00972816|10983294|FG005|Overall Study|Lost to Follow-up|10
6945526|NCT00972816|10983295|FG006|Overall Study|Lost to Follow-up|7
6945527|NCT00972816|10983296|FG007|Overall Study|Lost to Follow-up|7
6945528|NCT00972816|10983289|FG000|Overall Study|Inappropriate enrolment|0
6945529|NCT00972816|10983290|FG001|Overall Study|Inappropriate enrolment|0
6945530|NCT00972816|10983291|FG002|Overall Study|Inappropriate enrolment|0
6945531|NCT00972816|10983292|FG003|Overall Study|Inappropriate enrolment|0
6945532|NCT00972816|10983293|FG004|Overall Study|Inappropriate enrolment|0
6945533|NCT00972816|10983294|FG005|Overall Study|Inappropriate enrolment|0
6945534|NCT00972816|10983295|FG006|Overall Study|Inappropriate enrolment|2
6945535|NCT00972816|10983296|FG007|Overall Study|Inappropriate enrolment|0
6945536|NCT00972816|10983289|FG000|Overall Study|Unable to classify|2
6945537|NCT00972816|10983290|FG001|Overall Study|Unable to classify|0
6945538|NCT00972816|10983291|FG002|Overall Study|Unable to classify|0
6945539|NCT00972816|10983292|FG003|Overall Study|Unable to classify|0
6945540|NCT00972816|10983293|FG004|Overall Study|Unable to classify|1
6945541|NCT00972816|10983294|FG005|Overall Study|Unable to classify|0
6945542|NCT00972816|10983295|FG006|Overall Study|Unable to classify|0
6945543|NCT00972816|10983296|FG007|Overall Study|Unable to classify|0
6945544|NCT00973102|10983320|FG000|Overall Study|Protocol Violation|1
6945545|NCT00973102|10983321|FG001|Overall Study|Protocol Violation|0
6945546|NCT00973102|10983320|FG000|Overall Study|Prisoner|0
6945547|NCT00973102|10983321|FG001|Overall Study|Prisoner|1
6945548|NCT00973349|10983343|FG000|Overall Study|Adverse Event|0
6945549|NCT00973349|10983344|FG001|Overall Study|Adverse Event|0
6945550|NCT00973349|10983345|FG002|Overall Study|Adverse Event|0
6945551|NCT00973349|10983346|FG003|Overall Study|Adverse Event|0
6945552|NCT00973349|10983347|FG004|Overall Study|Adverse Event|1
7068200|NCT01992159|11169602|FG003|Overall Study|Death|0
7068201|NCT01992536|11169667|FG000|Overall Study|Administrative Reason|0
7068202|NCT01992536|11169668|FG001|Overall Study|Administrative Reason|0
7068203|NCT01992536|11169669|FG002|Overall Study|Administrative Reason|0
7068204|NCT01992536|11169670|FG003|Overall Study|Administrative Reason|0
7068205|NCT01992536|11169671|FG004|Overall Study|Administrative Reason|0
7068206|NCT01992536|11169672|FG005|Overall Study|Administrative Reason|0
7068207|NCT01992536|11169673|FG006|Overall Study|Administrative Reason|7
7068208|NCT01992536|11169674|FG007|Overall Study|Administrative Reason|0
7068209|NCT01992536|11169675|FG008|Overall Study|Administrative Reason|0
7068210|NCT01992536|11169676|FG009|Overall Study|Administrative Reason|0
7068211|NCT01992536|11169667|FG000|Overall Study|Lost to Follow-up|4
7068212|NCT01992536|11169668|FG001|Overall Study|Lost to Follow-up|2
7068213|NCT01992536|11169669|FG002|Overall Study|Lost to Follow-up|1
7068214|NCT01992536|11169670|FG003|Overall Study|Lost to Follow-up|0
7068215|NCT01992536|11169671|FG004|Overall Study|Lost to Follow-up|0
7068216|NCT01992536|11169672|FG005|Overall Study|Lost to Follow-up|1
7068217|NCT01992536|11169673|FG006|Overall Study|Lost to Follow-up|0
7068218|NCT01992536|11169674|FG007|Overall Study|Lost to Follow-up|0
7068219|NCT01992536|11169675|FG008|Overall Study|Lost to Follow-up|1
6945553|NCT00973349|10983348|FG005|Overall Study|Adverse Event|0
6945554|NCT00973349|10983349|FG006|Overall Study|Adverse Event|0
6945555|NCT00973349|10983350|FG007|Overall Study|Adverse Event|0
7068220|NCT01992536|11169676|FG009|Overall Study|Lost to Follow-up|1
7068221|NCT01992536|11169667|FG000|Overall Study|Withdrawal by Subject|0
7068222|NCT01992536|11169668|FG001|Overall Study|Withdrawal by Subject|1
7068223|NCT01992536|11169669|FG002|Overall Study|Withdrawal by Subject|0
7068224|NCT01992536|11169670|FG003|Overall Study|Withdrawal by Subject|2
7068225|NCT01992536|11169671|FG004|Overall Study|Withdrawal by Subject|0
7068226|NCT01992536|11169672|FG005|Overall Study|Withdrawal by Subject|0
7068227|NCT01992536|11169673|FG006|Overall Study|Withdrawal by Subject|0
6945556|NCT00973349|10983351|FG008|Overall Study|Adverse Event|1
7068228|NCT01992536|11169674|FG007|Overall Study|Withdrawal by Subject|0
6945557|NCT00973349|10983352|FG009|Overall Study|Adverse Event|0
6945558|NCT00973349|10983353|FG010|Overall Study|Adverse Event|0
6945559|NCT00973349|10983354|FG011|Overall Study|Adverse Event|0
7068229|NCT01992536|11169675|FG008|Overall Study|Withdrawal by Subject|0
6945560|NCT00973349|10983355|FG012|Overall Study|Adverse Event|0
6945561|NCT00973349|10983356|FG013|Overall Study|Adverse Event|0
6945562|NCT00973349|10983357|FG014|Overall Study|Adverse Event|1
6945563|NCT00973349|10983358|FG015|Overall Study|Adverse Event|0
6945564|NCT00973349|10983343|FG000|Overall Study|Withdrawal by Subject|1
6945565|NCT00973349|10983344|FG001|Overall Study|Withdrawal by Subject|2
6945566|NCT00973349|10983345|FG002|Overall Study|Withdrawal by Subject|2
6945567|NCT00973349|10983346|FG003|Overall Study|Withdrawal by Subject|3
6945568|NCT00973349|10983347|FG004|Overall Study|Withdrawal by Subject|2
6945569|NCT00973349|10983348|FG005|Overall Study|Withdrawal by Subject|0
6945570|NCT00973349|10983349|FG006|Overall Study|Withdrawal by Subject|2
6945571|NCT00973349|10983350|FG007|Overall Study|Withdrawal by Subject|2
6945572|NCT00973349|10983351|FG008|Overall Study|Withdrawal by Subject|0
6945573|NCT00973349|10983352|FG009|Overall Study|Withdrawal by Subject|2
6945574|NCT00973349|10983353|FG010|Overall Study|Withdrawal by Subject|0
6945575|NCT00973349|10983354|FG011|Overall Study|Withdrawal by Subject|1
6945576|NCT00973349|10983355|FG012|Overall Study|Withdrawal by Subject|0
7068230|NCT01992536|11169676|FG009|Overall Study|Withdrawal by Subject|0
7068231|NCT01992549|11169718|FG000|Overall Study|Lost to Follow-up|2
7068232|NCT01992549|11169718|FG000|Overall Study|Serious Adverse Event|1
7068233|NCT01992549|11169718|FG000|Overall Study|Product Switch to Extend Half Life|1
7068234|NCT01992757|11169728|FG000|Overall Study|2 patients excluded due to FFP given.|2
7068235|NCT01993017|11169748|FG000|Overall Study|Death|23
7068236|NCT01993017|11169749|FG001|Overall Study|Death|26
7068237|NCT01993017|11169750|FG002|Overall Study|Death|18
7068238|NCT01993017|11169748|FG000|Overall Study|Could not be contacted|43
7068239|NCT01993017|11169749|FG001|Overall Study|Could not be contacted|42
7068240|NCT01993017|11169750|FG002|Overall Study|Could not be contacted|38
7068241|NCT01993017|11169748|FG000|Overall Study|Dropped out|19
7068242|NCT01993017|11169749|FG001|Overall Study|Dropped out|6
7068243|NCT01993017|11169750|FG002|Overall Study|Dropped out|11
7068244|NCT01993017|11169748|FG000|Overall Study|Other reasons|17
7068245|NCT01993017|11169749|FG001|Overall Study|Other reasons|11
7068246|NCT01993017|11169750|FG002|Overall Study|Other reasons|7
7068247|NCT01993017|11169748|FG000|Overall Study|Ineligible after randomization|4
7068248|NCT01993017|11169749|FG001|Overall Study|Ineligible after randomization|5
7068249|NCT01993017|11169750|FG002|Overall Study|Ineligible after randomization|5
7068250|NCT01993030|11169761|FG000|Overall Study|Adverse Event|0
7068251|NCT01993030|11169762|FG001|Overall Study|Adverse Event|4
7068252|NCT01993186|11169791|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1
7068253|NCT01993186|11169792|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0
7068254|NCT01993186|11169791|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1
7068255|NCT01993186|11169792|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0
7068256|NCT01993186|11169791|FG000|Open-Label Extension Period|Other, Not Specified|0
7068257|NCT01993186|11169792|FG001|Open-Label Extension Period|Other, Not Specified|1
7068258|NCT01993186|11169791|FG000|Open-Label Extension Period|Adverse Event|1
7068259|NCT01993186|11169792|FG001|Open-Label Extension Period|Adverse Event|0
7068260|NCT01993186|11169791|FG000|Open-Label Extension Period|Principal Investigator Decision|1
7068261|NCT01993186|11169792|FG001|Open-Label Extension Period|Principal Investigator Decision|0
7068262|NCT01993186|11169791|FG000|Open-Label Extension Period|Withdrawal by Subject|4
7068263|NCT01993186|11169792|FG001|Open-Label Extension Period|Withdrawal by Subject|5
7068264|NCT01993186|11169791|FG000|Open-Label Extension Period|Subject Non-Compliance|1
7068265|NCT01993186|11169792|FG001|Open-Label Extension Period|Subject Non-Compliance|0
7068266|NCT01993329|11169809|FG000|Period 2|Adverse Event|0
7068267|NCT01993329|11169810|FG001|Period 2|Adverse Event|0
7068268|NCT01993329|11169811|FG002|Period 2|Adverse Event|0
7068269|NCT01993329|11169812|FG003|Period 2|Adverse Event|0
7068270|NCT01993329|11169813|FG004|Period 2|Adverse Event|0
7068271|NCT01993329|11169814|FG005|Period 2|Adverse Event|1
7068272|NCT01993329|11169809|FG000|Wash-out|Personal reasons|0
7068273|NCT01993329|11169810|FG001|Wash-out|Personal reasons|1
7068274|NCT01993329|11169811|FG002|Wash-out|Personal reasons|0
7068275|NCT01993329|11169812|FG003|Wash-out|Personal reasons|0
7068276|NCT01993329|11169813|FG004|Wash-out|Personal reasons|0
7068277|NCT01993329|11169814|FG005|Wash-out|Personal reasons|0
7068278|NCT01993615|11169828|FG000|Overall Study|Death|1
7068279|NCT01993615|11169829|FG001|Overall Study|Death|0
7068280|NCT01993667|11169837|FG000|Overall Study|Insufficient data to analyze|16
7068281|NCT01993667|11169838|FG001|Overall Study|Insufficient data to analyze|16
7068282|NCT01993667|11169837|FG000|Overall Study|Insufficient altitude reached|3
7068283|NCT01993667|11169838|FG001|Overall Study|Insufficient altitude reached|1
7068284|NCT01993667|11169837|FG000|Overall Study|Lost to Follow-up|2
7068285|NCT01993667|11169838|FG001|Overall Study|Lost to Follow-up|2
7068286|NCT01993823|11169846|FG000|Overall Study|Requested by the patient|6
6945577|NCT00973349|10983356|FG013|Overall Study|Withdrawal by Subject|0
6945578|NCT00973349|10983357|FG014|Overall Study|Withdrawal by Subject|0
7068287|NCT01993823|11169847|FG001|Overall Study|Requested by the patient|11
7068288|NCT01993823|11169846|FG000|Overall Study|Protocol Violation|0
7068289|NCT01993823|11169847|FG001|Overall Study|Protocol Violation|1
7068290|NCT01993823|11169846|FG000|Overall Study|Lost to Follow-up|1
7068291|NCT01993823|11169847|FG001|Overall Study|Lost to Follow-up|4
7068292|NCT01993836|11169856|FG000|Overall Study|Surgery Cancelled|3
7068293|NCT01993836|11169857|FG001|Overall Study|Surgery Cancelled|0
6945579|NCT00973349|10983358|FG015|Overall Study|Withdrawal by Subject|0
6945580|NCT00973349|10983343|FG000|Overall Study|Lost to Follow-up|3
6945581|NCT00973349|10983344|FG001|Overall Study|Lost to Follow-up|1
6945582|NCT00973349|10983345|FG002|Overall Study|Lost to Follow-up|2
6945583|NCT00973349|10983346|FG003|Overall Study|Lost to Follow-up|2
6945584|NCT00973349|10983347|FG004|Overall Study|Lost to Follow-up|1
6945585|NCT00973349|10983348|FG005|Overall Study|Lost to Follow-up|3
6945586|NCT00973349|10983349|FG006|Overall Study|Lost to Follow-up|0
6945587|NCT00973349|10983350|FG007|Overall Study|Lost to Follow-up|1
7068294|NCT01993836|11169858|FG002|Overall Study|Surgery Cancelled|0
7068295|NCT01993836|11169856|FG000|Overall Study|Physician Decision|2
6945588|NCT00973349|10983351|FG008|Overall Study|Lost to Follow-up|2
6945589|NCT00973349|10983352|FG009|Overall Study|Lost to Follow-up|1
6945590|NCT00973349|10983353|FG010|Overall Study|Lost to Follow-up|0
6945591|NCT00973349|10983354|FG011|Overall Study|Lost to Follow-up|1
6945592|NCT00973349|10983355|FG012|Overall Study|Lost to Follow-up|0
6945593|NCT00973349|10983356|FG013|Overall Study|Lost to Follow-up|0
6945594|NCT00973349|10983357|FG014|Overall Study|Lost to Follow-up|0
6945595|NCT00973349|10983358|FG015|Overall Study|Lost to Follow-up|1
6945596|NCT00973349|10983343|FG000|Overall Study|Inappropriate enrolment|0
6945597|NCT00973349|10983344|FG001|Overall Study|Inappropriate enrolment|0
6945598|NCT00973349|10983345|FG002|Overall Study|Inappropriate enrolment|1
6945599|NCT00973349|10983346|FG003|Overall Study|Inappropriate enrolment|0
6945600|NCT00973349|10983347|FG004|Overall Study|Inappropriate enrolment|0
6945601|NCT00973349|10983348|FG005|Overall Study|Inappropriate enrolment|0
6945602|NCT00973349|10983349|FG006|Overall Study|Inappropriate enrolment|0
6945603|NCT00973349|10983350|FG007|Overall Study|Inappropriate enrolment|0
6945604|NCT00973349|10983351|FG008|Overall Study|Inappropriate enrolment|0
6945605|NCT00973349|10983352|FG009|Overall Study|Inappropriate enrolment|2
6945606|NCT00973349|10983353|FG010|Overall Study|Inappropriate enrolment|0
6945607|NCT00973349|10983354|FG011|Overall Study|Inappropriate enrolment|0
6945608|NCT00973349|10983355|FG012|Overall Study|Inappropriate enrolment|1
6945609|NCT00973349|10983356|FG013|Overall Study|Inappropriate enrolment|0
6945610|NCT00973349|10983357|FG014|Overall Study|Inappropriate enrolment|1
6945611|NCT00973349|10983358|FG015|Overall Study|Inappropriate enrolment|1
6945612|NCT00973349|10983343|FG000|Overall Study|Protocol Violation|0
6945613|NCT00973349|10983344|FG001|Overall Study|Protocol Violation|0
6945614|NCT00973349|10983345|FG002|Overall Study|Protocol Violation|0
6945615|NCT00973349|10983346|FG003|Overall Study|Protocol Violation|0
6945616|NCT00973349|10983347|FG004|Overall Study|Protocol Violation|0
6945617|NCT00973349|10983348|FG005|Overall Study|Protocol Violation|0
6945618|NCT00973349|10983349|FG006|Overall Study|Protocol Violation|0
6945619|NCT00973349|10983350|FG007|Overall Study|Protocol Violation|0
6945620|NCT00973349|10983351|FG008|Overall Study|Protocol Violation|1
6945621|NCT00973349|10983352|FG009|Overall Study|Protocol Violation|0
6945622|NCT00973349|10983353|FG010|Overall Study|Protocol Violation|0
6945623|NCT00973349|10983354|FG011|Overall Study|Protocol Violation|0
6945624|NCT00973349|10983355|FG012|Overall Study|Protocol Violation|0
6945625|NCT00973349|10983356|FG013|Overall Study|Protocol Violation|0
6945626|NCT00973349|10983357|FG014|Overall Study|Protocol Violation|0
6945627|NCT00973349|10983358|FG015|Overall Study|Protocol Violation|0
6945628|NCT00973349|10983343|FG000|Overall Study|Unable to classify|0
6945629|NCT00973349|10983344|FG001|Overall Study|Unable to classify|0
6945630|NCT00973349|10983345|FG002|Overall Study|Unable to classify|0
6945631|NCT00973349|10983346|FG003|Overall Study|Unable to classify|0
6945632|NCT00973349|10983347|FG004|Overall Study|Unable to classify|1
6945633|NCT00973349|10983348|FG005|Overall Study|Unable to classify|1
6945634|NCT00973349|10983349|FG006|Overall Study|Unable to classify|0
6945635|NCT00973349|10983350|FG007|Overall Study|Unable to classify|0
6945636|NCT00973349|10983351|FG008|Overall Study|Unable to classify|0
7068296|NCT01993836|11169857|FG001|Overall Study|Physician Decision|1
7068297|NCT01993836|11169858|FG002|Overall Study|Physician Decision|0
6945637|NCT00973349|10983352|FG009|Overall Study|Unable to classify|1
6945638|NCT00973349|10983353|FG010|Overall Study|Unable to classify|0
6945639|NCT00973349|10983354|FG011|Overall Study|Unable to classify|0
6945640|NCT00973349|10983355|FG012|Overall Study|Unable to classify|0
7068298|NCT01993836|11169856|FG000|Overall Study|Death|0
7068299|NCT01993836|11169857|FG001|Overall Study|Death|2
7068300|NCT01993836|11169858|FG002|Overall Study|Death|0
7068301|NCT01993836|11169856|FG000|Overall Study|Withdrawal by Subject|12
7068302|NCT01993836|11169857|FG001|Overall Study|Withdrawal by Subject|10
7068303|NCT01993836|11169858|FG002|Overall Study|Withdrawal by Subject|5
7068304|NCT01993888|11169889|FG000|Overall Study|Death|1
7068305|NCT01993888|11169890|FG001|Overall Study|Death|1
7068306|NCT01993888|11169889|FG000|Overall Study|Lost to Follow-up|1
7068307|NCT01993888|11169890|FG001|Overall Study|Lost to Follow-up|1
6945641|NCT00973349|10983356|FG013|Overall Study|Unable to classify|0
6945642|NCT00973349|10983357|FG014|Overall Study|Unable to classify|0
6945643|NCT00973349|10983358|FG015|Overall Study|Unable to classify|0
6945644|NCT00973362|10983386|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25
6945645|NCT00973362|10983387|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0
6945646|NCT00973362|10983386|FG000|Baseline Evaluation|No colposcopy visit|62
7068308|NCT01993888|11169889|FG000|Overall Study|Withdrawal by Subject|0
7068309|NCT01993888|11169890|FG001|Overall Study|Withdrawal by Subject|1
7068310|NCT01993927|11169896|FG000|Overall Study|Case Report Forms Uncollected|18
7068311|NCT01993927|11169896|FG000|Overall Study|Protocol Violation|11
6945647|NCT00973362|10983387|FG001|Baseline Evaluation|No colposcopy visit|0
6945648|NCT00973362|10983386|FG000|Baseline Evaluation|Inevaluable|686
6945649|NCT00973362|10983387|FG001|Baseline Evaluation|Inevaluable|223
6945650|NCT00973362|10983386|FG000|3-Year Follow-up|Lost to Follow-up|17
6945651|NCT00973362|10983387|FG001|3-Year Follow-up|Lost to Follow-up|0
6945652|NCT00973479|10983398|FG000|Overall Study|Lost to Follow-up|0
6945653|NCT00973479|10983399|FG001|Overall Study|Lost to Follow-up|3
6945654|NCT00973479|10983398|FG000|Overall Study|Death|2
6945655|NCT00973479|10983399|FG001|Overall Study|Death|2
6945656|NCT00973479|10983398|FG000|Overall Study|Withdrawal by Subject|15
6945657|NCT00973479|10983399|FG001|Overall Study|Withdrawal by Subject|16
6945658|NCT00973479|10983398|FG000|Overall Study|Lack of Efficacy|5
6945659|NCT00973479|10983399|FG001|Overall Study|Lack of Efficacy|7
6945660|NCT00973479|10983398|FG000|Overall Study|Adverse Event|12
6945661|NCT00973479|10983399|FG001|Overall Study|Adverse Event|32
6945662|NCT00973479|10983398|FG000|Overall Study|Protocol Violation|2
6945663|NCT00973479|10983399|FG001|Overall Study|Protocol Violation|2
6945664|NCT00973479|10983398|FG000|Overall Study|Other|1
6945665|NCT00973479|10983399|FG001|Overall Study|Other|7
6945666|NCT00973622|10983409|FG000|Overall Study|did not attend MRI|14
6945667|NCT00973622|10983410|FG001|Overall Study|did not attend MRI|3
6945668|NCT00973622|10983409|FG000|Overall Study|did not pass MRI screen|6
6945669|NCT00973622|10983410|FG001|Overall Study|did not pass MRI screen|0
6945670|NCT00973622|10983409|FG000|Overall Study|did not complete rTMS sessions|11
6945671|NCT00973622|10983410|FG001|Overall Study|did not complete rTMS sessions|2
6945672|NCT00973674|10983418|FG000|Overall Study|Protocol Violation|2
6945673|NCT00973674|10983419|FG001|Overall Study|Protocol Violation|0
6945674|NCT00973700|10983431|FG000|Overall Study|Withdrawal by Subject|2
6945675|NCT00973700|10983432|FG001|Overall Study|Withdrawal by Subject|2
6945676|NCT00973700|10983433|FG002|Overall Study|Withdrawal by Subject|8
6945677|NCT00973700|10983434|FG003|Overall Study|Withdrawal by Subject|4
6945678|NCT00973700|10983435|FG004|Overall Study|Withdrawal by Subject|4
6945679|NCT00973700|10983431|FG000|Overall Study|Lost to Follow-up|5
6945680|NCT00973700|10983432|FG001|Overall Study|Lost to Follow-up|0
6945681|NCT00973700|10983433|FG002|Overall Study|Lost to Follow-up|1
6945682|NCT00973700|10983434|FG003|Overall Study|Lost to Follow-up|8
6945683|NCT00973700|10983435|FG004|Overall Study|Lost to Follow-up|5
6945684|NCT00973700|10983431|FG000|Overall Study|Inappropriate enrolment|0
6945685|NCT00973700|10983432|FG001|Overall Study|Inappropriate enrolment|0
6945686|NCT00973700|10983433|FG002|Overall Study|Inappropriate enrolment|0
6945687|NCT00973700|10983434|FG003|Overall Study|Inappropriate enrolment|4
6945688|NCT00973700|10983435|FG004|Overall Study|Inappropriate enrolment|0
6945689|NCT00973700|10983431|FG000|Overall Study|Unable to Classify|0
6945690|NCT00973700|10983432|FG001|Overall Study|Unable to Classify|0
6945691|NCT00973700|10983433|FG002|Overall Study|Unable to Classify|1
6945692|NCT00973700|10983434|FG003|Overall Study|Unable to Classify|2
6945693|NCT00973700|10983435|FG004|Overall Study|Unable to Classify|1
6945694|NCT00973765|10983472|FG000|Overall Study|Lost to Follow-up|8
6945695|NCT00973765|10983473|FG001|Overall Study|Lost to Follow-up|14
6975778|NCT01194414|11027943|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6
6975779|NCT01194414|11027940|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9
6975780|NCT01194414|11027941|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11
6975781|NCT01194414|11027942|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2
6975782|NCT01194414|11027943|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3
6975783|NCT01194414|11027940|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4
6975784|NCT01194414|11027941|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3
6975785|NCT01194414|11027942|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2
6975786|NCT01194414|11027943|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1
6975787|NCT01194414|11027940|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3
6975788|NCT01194414|11027941|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5
6975789|NCT01194414|11027942|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
6975790|NCT01194414|11027943|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
7068312|NCT01993940|11169902|FG000|Overall Study|Adverse Event|16
7068313|NCT01993940|11169903|FG001|Overall Study|Adverse Event|11
7068314|NCT01993940|11169902|FG000|Overall Study|Withdrawal by Subject|15
7068315|NCT01993940|11169903|FG001|Overall Study|Withdrawal by Subject|19
7068316|NCT01993940|11169902|FG000|Overall Study|Lost to Follow-up|2
7068317|NCT01993940|11169903|FG001|Overall Study|Lost to Follow-up|5
7068318|NCT01993940|11169902|FG000|Overall Study|Protocol Violation|5
7068319|NCT01993940|11169903|FG001|Overall Study|Protocol Violation|8
7068320|NCT01993940|11169902|FG000|Overall Study|Death|1
7068321|NCT01993940|11169903|FG001|Overall Study|Death|0
7068322|NCT01993940|11169902|FG000|Overall Study|Other - Miscellaneous|1
7068323|NCT01993940|11169903|FG001|Overall Study|Other - Miscellaneous|1
6975791|NCT01194414|11027940|FG000|72 Weeks Open Label Extension|Pregnancy|1
6975792|NCT01194414|11027941|FG001|72 Weeks Open Label Extension|Pregnancy|3
6975793|NCT01194414|11027942|FG002|72 Weeks Open Label Extension|Pregnancy|1
7068324|NCT01994226|11169927|FG000|Overall Study|Protocol Violation|13
7068325|NCT01994226|11169928|FG001|Overall Study|Protocol Violation|10
7068326|NCT01994226|11169927|FG000|Overall Study|Early Cessation of treatment|6
7068327|NCT01994226|11169928|FG001|Overall Study|Early Cessation of treatment|11
6945696|NCT00973921|10983479|FG000|Overall Study|IVUS results were not available|9
6945697|NCT00973973|10983485|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1
6945698|NCT00973973|10983486|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3
6945699|NCT00973973|10983485|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1
6945700|NCT00973973|10983486|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0
6945701|NCT00973973|10983485|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1
6945702|NCT00973973|10983486|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3
6945703|NCT00973973|10983485|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1
6945704|NCT00973973|10983486|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0
6945705|NCT00973973|10983485|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1
6945706|NCT00973973|10983486|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1
6945707|NCT00973973|10983485|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1
6945708|NCT00973973|10983486|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1
6945709|NCT00973973|10983485|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1
6945710|NCT00973973|10983486|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2
6945711|NCT00973973|10983485|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1
6945712|NCT00973973|10983486|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0
6945713|NCT00973973|10983485|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1
6945714|NCT00973973|10983486|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0
6945715|NCT00973973|10983485|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1
6945716|NCT00973973|10983486|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3
6945717|NCT00973973|10983485|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1
6945718|NCT00973973|10983486|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0
6945719|NCT00973973|10983485|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1
6945720|NCT00973973|10983486|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0
6945721|NCT00974090|10983505|FG000|Period 1: Double Blind Period|Adverse Event|2
6945722|NCT00974090|10983506|FG001|Period 1: Double Blind Period|Adverse Event|1
6945723|NCT00974090|10983505|FG000|Period 1: Double Blind Period|Physician Decision|1
6945724|NCT00974090|10983506|FG001|Period 1: Double Blind Period|Physician Decision|0
6945725|NCT00974090|10983505|FG000|Period 2: Open-label Period|Adverse Event|4
6945726|NCT00974090|10983506|FG001|Period 2: Open-label Period|Adverse Event|6
6945727|NCT00974090|10983505|FG000|Period 2: Open-label Period|Lack of Efficacy|3
6945728|NCT00974090|10983506|FG001|Period 2: Open-label Period|Lack of Efficacy|1
6945729|NCT00974090|10983505|FG000|Period 2: Open-label Period|Physician Decision|0
6945730|NCT00974090|10983506|FG001|Period 2: Open-label Period|Physician Decision|3
6945731|NCT00974090|10983505|FG000|Period 2: Open-label Period|Withdrawal by Subject|1
6945732|NCT00974090|10983506|FG001|Period 2: Open-label Period|Withdrawal by Subject|0
6945733|NCT00974220|10983525|FG000|Treatment Period 1|Adverse Event|2
6945734|NCT00974220|10983526|FG001|Treatment Period 1|Adverse Event|1
6945735|NCT00974220|10983525|FG000|Treatment Period 1|noncompliant subjects|0
6945736|NCT00974220|10983526|FG001|Treatment Period 1|noncompliant subjects|1
6945737|NCT00974233|10983532|FG000|Induction Chemoimmunotherapy|Death|2
6945738|NCT00974233|10983532|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5
6945739|NCT00974233|10983532|FG000|Induction Chemoimmunotherapy|Adverse Event|7
6945740|NCT00974233|10983532|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1
6945741|NCT00974233|10983532|FG000|Maintenance Lenalidomide|Lack of Efficacy|5
6945742|NCT00974233|10983532|FG000|Maintenance Lenalidomide|Adverse Event|8
6945743|NCT00974259|10983551|FG000|Overall Study|Technically inadequate PbtO2 recordings|2
6945744|NCT00974259|10983552|FG001|Overall Study|Technically inadequate PbtO2 recordings|1
6945745|NCT00974311|10983560|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5
6945746|NCT00974311|10983561|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2
6945747|NCT00974311|10983560|FG000|DB Phase (up to 24 Months)|Death|561
6945748|NCT00974311|10983561|FG001|DB Phase (up to 24 Months)|Death|298
6945749|NCT00974311|10983560|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16
6945750|NCT00974311|10983561|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7
6945751|NCT00974311|10983560|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108
6945752|NCT00974311|10983561|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42
6945753|NCT00974311|10983560|FG000|DB Phase (up to 24 Months)|Other|1
6945754|NCT00974311|10983561|FG001|DB Phase (up to 24 Months)|Other|0
6945755|NCT00974311|10983560|FG000|OLE Phase (up to 77 Months)|Death|14
7040699|NCT01719380|11123789|FG006|Overall Study|Death|0
7040700|NCT01719380|11123790|FG007|Overall Study|Death|0
7040701|NCT01719380|11123791|FG008|Overall Study|Death|3
7040702|NCT01719380|11123792|FG009|Overall Study|Death|3
7040703|NCT01719380|11123783|FG000|Overall Study|Participant/Guardian Decision|0
7040704|NCT01719380|11123784|FG001|Overall Study|Participant/Guardian Decision|0
7040705|NCT01719380|11123785|FG002|Overall Study|Participant/Guardian Decision|1
7040706|NCT01719380|11123786|FG003|Overall Study|Participant/Guardian Decision|0
7040707|NCT01719380|11123787|FG004|Overall Study|Participant/Guardian Decision|0
7040708|NCT01719380|11123788|FG005|Overall Study|Participant/Guardian Decision|0
7040709|NCT01719380|11123789|FG006|Overall Study|Participant/Guardian Decision|0
7040710|NCT01719380|11123790|FG007|Overall Study|Participant/Guardian Decision|0
7040711|NCT01719380|11123791|FG008|Overall Study|Participant/Guardian Decision|2
6945756|NCT00974311|10983561|FG001|OLE Phase (up to 77 Months)|Death|21
6945757|NCT00974311|10983560|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78
6945758|NCT00974311|10983561|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26
6945759|NCT00974311|10983560|FG000|OLE Phase (up to 77 Months)|Other|15
6945760|NCT00974311|10983561|FG001|OLE Phase (up to 77 Months)|Other|2
6945761|NCT00974311|10983560|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2
6945762|NCT00974311|10983561|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1
6945763|NCT00974675|10983634|FG000|Overall Study|Adverse Event|2
6945764|NCT00974675|10983635|FG001|Overall Study|Adverse Event|1
6945765|NCT00974675|10983636|FG002|Overall Study|Adverse Event|1
6945766|NCT00974675|10983637|FG003|Overall Study|Adverse Event|1
6945767|NCT00974675|10983634|FG000|Overall Study|Physician Decision|0
6945768|NCT00974675|10983635|FG001|Overall Study|Physician Decision|0
6945769|NCT00974675|10983636|FG002|Overall Study|Physician Decision|1
6945770|NCT00974675|10983637|FG003|Overall Study|Physician Decision|0
6945771|NCT00974675|10983634|FG000|Overall Study|Participant on holiday; unable to attend|0
6945772|NCT00974675|10983635|FG001|Overall Study|Participant on holiday; unable to attend|0
6945773|NCT00974675|10983636|FG002|Overall Study|Participant on holiday; unable to attend|0
6945774|NCT00974675|10983637|FG003|Overall Study|Participant on holiday; unable to attend|1
6945775|NCT00974974|10983658|FG000|IR CD-LD Dose Adjustment|Adverse Event|0
6945776|NCT00974974|10983659|FG001|IR CD-LD Dose Adjustment|Adverse Event|3
6945777|NCT00974974|10983658|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0
6945778|NCT00974974|10983659|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1
6945779|NCT00974974|10983658|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0
6945780|NCT00974974|10983659|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1
6945781|NCT00974974|10983658|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0
6945782|NCT00974974|10983659|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7
6945783|NCT00974974|10983658|FG000|IR CD-LD Dose Adjustment|Various|0
6945784|NCT00974974|10983659|FG001|IR CD-LD Dose Adjustment|Various|9
6945785|NCT00974974|10983658|FG000|IPX066 Dose Conversion|Adverse Event|23
6945786|NCT00974974|10983659|FG001|IPX066 Dose Conversion|Adverse Event|0
6945787|NCT00974974|10983658|FG000|IPX066 Dose Conversion|Death|2
6945788|NCT00974974|10983659|FG001|IPX066 Dose Conversion|Death|0
6945789|NCT00974974|10983658|FG000|IPX066 Dose Conversion|Lack of Efficacy|13
6945790|NCT00974974|10983659|FG001|IPX066 Dose Conversion|Lack of Efficacy|0
6945791|NCT00974974|10983658|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12
6945792|NCT00974974|10983659|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0
6945793|NCT00974974|10983658|FG000|IPX066 Dose Conversion|Various|3
6945794|NCT00974974|10983659|FG001|IPX066 Dose Conversion|Various|0
6945795|NCT00974974|10983658|FG000|IPX066 Dose Conversion|Protocol Violation|4
6945796|NCT00974974|10983659|FG001|IPX066 Dose Conversion|Protocol Violation|0
6945797|NCT00974974|10983658|FG000|Maintenance - Double Blind Treatment|Adverse Event|3
6945798|NCT00974974|10983659|FG001|Maintenance - Double Blind Treatment|Adverse Event|3
6945799|NCT00974974|10983658|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1
6945800|NCT00974974|10983659|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1
6945801|NCT00974974|10983658|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0
6945802|NCT00974974|10983659|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1
7068328|NCT01994291|11169937|FG000|Overall Study|Adverse Event|4
7068329|NCT01994291|11169938|FG001|Overall Study|Adverse Event|1
7068330|NCT01994291|11169939|FG002|Overall Study|Adverse Event|3
7068331|NCT01994291|11169937|FG000|Overall Study|Lost to Follow-up|1
7068332|NCT01994291|11169938|FG001|Overall Study|Lost to Follow-up|1
7068333|NCT01994291|11169939|FG002|Overall Study|Lost to Follow-up|0
7068334|NCT01994291|11169937|FG000|Overall Study|Does not meet entrance criteria|1
7068335|NCT01994291|11169938|FG001|Overall Study|Does not meet entrance criteria|0
7068336|NCT01994291|11169939|FG002|Overall Study|Does not meet entrance criteria|0
7068337|NCT01994291|11169937|FG000|Overall Study|Medication error without associated AE|1
7068338|NCT01994291|11169938|FG001|Overall Study|Medication error without associated AE|0
7068339|NCT01994291|11169939|FG002|Overall Study|Medication error without associated AE|1
7068340|NCT01994291|11169937|FG000|Overall Study|Protocol Violation|1
7068341|NCT01994291|11169938|FG001|Overall Study|Protocol Violation|0
7068342|NCT01994291|11169939|FG002|Overall Study|Protocol Violation|0
7068343|NCT01994291|11169937|FG000|Overall Study|Withdrawal by Subject|6
7068344|NCT01994291|11169938|FG001|Overall Study|Withdrawal by Subject|3
7068345|NCT01994291|11169939|FG002|Overall Study|Withdrawal by Subject|5
7068346|NCT01994291|11169937|FG000|Overall Study|Other|1
7068347|NCT01994291|11169938|FG001|Overall Study|Other|2
7068348|NCT01994291|11169939|FG002|Overall Study|Other|0
7068349|NCT01994395|11169950|FG000|Overall Study|Withdrawal by Subject|1
7068350|NCT01994395|11169951|FG001|Overall Study|Withdrawal by Subject|2
7068351|NCT01994590|11169972|FG000|Overall Study|Adverse Event|1
7068352|NCT01994590|11169972|FG000|Overall Study|Trial Terminated|1
7068353|NCT01994629|11169978|FG000|Overall Study|Withdrawal by Subject|1
7068354|NCT01994629|11169979|FG001|Overall Study|Withdrawal by Subject|0
6945803|NCT00974974|10983658|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2
7068355|NCT01994629|11169978|FG000|Overall Study|Lost to Follow-up|0
7068356|NCT01994629|11169979|FG001|Overall Study|Lost to Follow-up|3
7068357|NCT01994720|11169987|FG000|Overall Study|Withdrawal by Subject|46
7068358|NCT01994720|11169988|FG001|Overall Study|Withdrawal by Subject|56
7068359|NCT01994837|11170018|FG000|Overall Study|Progressive disease per protocol|23
6945804|NCT00974974|10983659|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2
6945805|NCT00974974|10983658|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0
6945806|NCT00974974|10983659|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1
6945807|NCT00974974|10983658|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5
6945808|NCT00974974|10983659|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2
6945809|NCT00974974|10983658|FG000|Maintenance - Double Blind Treatment|Various|4
6945810|NCT00974974|10983659|FG001|Maintenance - Double Blind Treatment|Various|0
6945811|NCT00975000|10983667|FG000|Overall Study|Other|1
6945812|NCT00975000|10983668|FG001|Overall Study|Other|0
6945813|NCT00975000|10983667|FG000|Overall Study|Adverse Event|1
6945814|NCT00975000|10983668|FG001|Overall Study|Adverse Event|1
6945815|NCT00975000|10983667|FG000|Overall Study|Withdrawal by Subject|2
6945816|NCT00975000|10983668|FG001|Overall Study|Withdrawal by Subject|2
6945817|NCT00975000|10983667|FG000|Overall Study|Lost to Follow-up|0
6945818|NCT00975000|10983668|FG001|Overall Study|Lost to Follow-up|1
6945819|NCT00975000|10983667|FG000|Overall Study|Protocol-specified Criteria|1
6945820|NCT00975000|10983668|FG001|Overall Study|Protocol-specified Criteria|0
6945821|NCT00975000|10983667|FG000|Overall Study|Non-compliance|0
6945822|NCT00975000|10983668|FG001|Overall Study|Non-compliance|1
6945823|NCT00975130|10983674|FG000|Study Part 1|Adverse Event|150
6945824|NCT00975130|10983675|FG001|Study Part 1|Adverse Event|0
6945825|NCT00975130|10983676|FG002|Study Part 1|Adverse Event|0
6945826|NCT00975130|10983674|FG000|Study Part 1|Lost to Follow-up|19
6945827|NCT00975130|10983675|FG001|Study Part 1|Lost to Follow-up|0
6945828|NCT00975130|10983676|FG002|Study Part 1|Lost to Follow-up|0
6945829|NCT00975130|10983674|FG000|Study Part 1|Withdrawal by Subject|61
6945830|NCT00975130|10983675|FG001|Study Part 1|Withdrawal by Subject|0
6945831|NCT00975130|10983676|FG002|Study Part 1|Withdrawal by Subject|0
6945832|NCT00975130|10983674|FG000|Study Part 1|Protocol Violation|13
6945833|NCT00975130|10983675|FG001|Study Part 1|Protocol Violation|0
6945834|NCT00975130|10983676|FG002|Study Part 1|Protocol Violation|0
7068360|NCT01994837|11170018|FG000|Overall Study|Adv event related to progressive disease|3
7068361|NCT01994837|11170018|FG000|Overall Study|Fatal progressive disease|2
6945835|NCT00975130|10983674|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9
7068362|NCT01994837|11170018|FG000|Overall Study|Adverse event not related to progression|1
7068363|NCT01994837|11170018|FG000|Overall Study|Chose palliative care|1
7068364|NCT01994837|11170018|FG000|Overall Study|Proceeded to transplant|1
7068365|NCT01994837|11170018|FG000|Overall Study|Removed from study due to no response|1
7068366|NCT01994850|11170022|FG000|Overall Study|Physician Decision|1
7068367|NCT01994850|11170022|FG000|Overall Study|Withdrawal by Subject|1
7068368|NCT01994863|11170026|FG000|Period 1|Adverse Event|4
7068369|NCT01994863|11170027|FG001|Period 1|Adverse Event|0
7068370|NCT01994863|11170026|FG000|Period 1|Withdrawal by Subject|1
7068371|NCT01994863|11170027|FG001|Period 1|Withdrawal by Subject|0
7068372|NCT01994863|11170026|FG000|Period 1|Trial stopped by sponsor|1
7068373|NCT01994863|11170027|FG001|Period 1|Trial stopped by sponsor|3
7068374|NCT01994863|11170026|FG000|Period 1|Lack of Efficacy|1
7068375|NCT01994863|11170027|FG001|Period 1|Lack of Efficacy|0
7068376|NCT01994863|11170026|FG000|Period 2|Adverse Event|0
7068377|NCT01994863|11170027|FG001|Period 2|Adverse Event|1
7068378|NCT01994863|11170026|FG000|Period 2|Lack of Efficacy|0
7068379|NCT01994863|11170027|FG001|Period 2|Lack of Efficacy|2
7068380|NCT01994863|11170026|FG000|Period 2|Withdrawal by Subject|1
7068381|NCT01994863|11170027|FG001|Period 2|Withdrawal by Subject|1
7068382|NCT01994876|11170033|FG000|Test Period 1|Withdrawal by Subject|0
7068383|NCT01994876|11170034|FG001|Test Period 1|Withdrawal by Subject|1
7068384|NCT01994876|11170033|FG000|Test Period 1|Adverse Event|0
6945836|NCT00975130|10983675|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0
6945837|NCT00975130|10983676|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0
6945838|NCT00975130|10983674|FG000|Study Part 1|Administrative|4
7068385|NCT01994876|11170034|FG001|Test Period 1|Adverse Event|1
7068386|NCT01994876|11170033|FG000|Test Period 2|Adverse Event|1
7068387|NCT01994876|11170034|FG001|Test Period 2|Adverse Event|0
7068388|NCT01994876|11170033|FG000|Test Period 2|Protocol Violation|0
7068389|NCT01994876|11170034|FG001|Test Period 2|Protocol Violation|1
7068390|NCT01994889|11170045|FG000|Overall Study|Adverse Event|5
7068391|NCT01994889|11170046|FG001|Overall Study|Adverse Event|12
7068392|NCT01994889|11170047|FG002|Overall Study|Adverse Event|11
7068393|NCT01994889|11170045|FG000|Overall Study|Cardiac Device Implantation|0
7068394|NCT01994889|11170046|FG001|Overall Study|Cardiac Device Implantation|2
7068395|NCT01994889|11170047|FG002|Overall Study|Cardiac Device Implantation|0
7068396|NCT01994889|11170045|FG000|Overall Study|Organ Transplantation|1
7068397|NCT01994889|11170046|FG001|Overall Study|Organ Transplantation|5
7068398|NCT01994889|11170047|FG002|Overall Study|Organ Transplantation|5
7068399|NCT01994889|11170045|FG000|Overall Study|No longer willing to participate|8
7068400|NCT01994889|11170046|FG001|Overall Study|No longer willing to participate|17
7068401|NCT01994889|11170047|FG002|Overall Study|No longer willing to participate|37
7068402|NCT01994889|11170045|FG000|Overall Study|Lost to Follow-up|0
6945839|NCT00975130|10983675|FG001|Study Part 1|Administrative|0
6945840|NCT00975130|10983676|FG002|Study Part 1|Administrative|0
6945841|NCT00975130|10983674|FG000|Study Part 1|Withdrew Consent|24
7068403|NCT01994889|11170046|FG001|Overall Study|Lost to Follow-up|1
7068404|NCT01994889|11170047|FG002|Overall Study|Lost to Follow-up|0
7068405|NCT01994889|11170045|FG000|Overall Study|Protocol Violation|0
7068406|NCT01994889|11170046|FG001|Overall Study|Protocol Violation|1
7068407|NCT01994889|11170047|FG002|Overall Study|Protocol Violation|1
7068408|NCT01994889|11170045|FG000|Overall Study|Death|14
7068409|NCT01994889|11170046|FG001|Overall Study|Death|25
7068410|NCT01994889|11170047|FG002|Overall Study|Death|38
7068411|NCT01994902|11170054|FG000|Test Period 1|Withdrawal by Subject|3
7068412|NCT01994902|11170055|FG001|Test Period 1|Withdrawal by Subject|0
6945842|NCT00975130|10983675|FG001|Study Part 1|Withdrew Consent|0
6945843|NCT00975130|10983676|FG002|Study Part 1|Withdrew Consent|0
6945844|NCT00975130|10983674|FG000|Study Part 2|Adverse Event|0
6945845|NCT00975130|10983675|FG001|Study Part 2|Adverse Event|14
6945846|NCT00975130|10983676|FG002|Study Part 2|Adverse Event|7
7068413|NCT01994902|11170054|FG000|Test Period 1|device deficiency with adverse event|0
7068414|NCT01994902|11170055|FG001|Test Period 1|device deficiency with adverse event|1
7068415|NCT01994902|11170054|FG000|Test Period 1|Adverse Event|2
7068416|NCT01994902|11170055|FG001|Test Period 1|Adverse Event|1
7068417|NCT01994902|11170054|FG000|Test Period 1|Lack of Efficacy|0
7068418|NCT01994902|11170055|FG001|Test Period 1|Lack of Efficacy|1
7068419|NCT01994902|11170054|FG000|Test Period 1|bag too small|1
7068420|NCT01994902|11170055|FG001|Test Period 1|bag too small|0
7068421|NCT01994902|11170054|FG000|Test Period 2|Withdrawal by Subject|0
7068422|NCT01994902|11170055|FG001|Test Period 2|Withdrawal by Subject|2
7068423|NCT01994902|11170054|FG000|Test Period 2|Lack of Efficacy|0
7068424|NCT01994902|11170055|FG001|Test Period 2|Lack of Efficacy|1
7068425|NCT01994902|11170054|FG000|Test Period 2|Other|0
7068426|NCT01994902|11170055|FG001|Test Period 2|Other|3
7068427|NCT01994954|11170063|FG000|Overall Study|Death|1
7068428|NCT01994954|11170064|FG001|Overall Study|Death|0
7068429|NCT01994954|11170063|FG000|Overall Study|Withdrawal by Subject|9
7068430|NCT01994954|11170064|FG001|Overall Study|Withdrawal by Subject|14
7068431|NCT01994954|11170063|FG000|Overall Study|Physician Decision|2
7068432|NCT01994954|11170064|FG001|Overall Study|Physician Decision|2
7068433|NCT01994954|11170063|FG000|Overall Study|Lost to Follow-up|8
7068434|NCT01994954|11170064|FG001|Overall Study|Lost to Follow-up|10
7068435|NCT01994954|11170063|FG000|Overall Study|6 Month Follow-up Not Complete|5
7068436|NCT01994954|11170064|FG001|Overall Study|6 Month Follow-up Not Complete|4
7068437|NCT01995071|11170118|FG000|Overall Study|Adverse Event|0
7068438|NCT01995071|11170119|FG001|Overall Study|Adverse Event|0
7068439|NCT01995071|11170120|FG002|Overall Study|Adverse Event|0
7068440|NCT01995071|11170121|FG003|Overall Study|Adverse Event|0
7068441|NCT01995071|11170122|FG004|Overall Study|Adverse Event|0
7068442|NCT01995071|11170123|FG005|Overall Study|Adverse Event|0
7068443|NCT01995071|11170124|FG006|Overall Study|Adverse Event|1
7068444|NCT01995071|11170125|FG007|Overall Study|Adverse Event|0
7068445|NCT01995071|11170126|FG008|Overall Study|Adverse Event|0
7068446|NCT01995071|11170127|FG009|Overall Study|Adverse Event|0
7068447|NCT01995071|11170128|FG010|Overall Study|Adverse Event|0
7068448|NCT01995071|11170129|FG011|Overall Study|Adverse Event|0
7068449|NCT01995071|11170118|FG000|Overall Study|Moved|0
7068450|NCT01995071|11170119|FG001|Overall Study|Moved|0
7068451|NCT01995071|11170120|FG002|Overall Study|Moved|1
7068452|NCT01995071|11170121|FG003|Overall Study|Moved|0
7068453|NCT01995071|11170122|FG004|Overall Study|Moved|1
7068454|NCT01995071|11170123|FG005|Overall Study|Moved|0
7068455|NCT01995071|11170124|FG006|Overall Study|Moved|0
7068456|NCT01995071|11170125|FG007|Overall Study|Moved|0
7068457|NCT01995071|11170126|FG008|Overall Study|Moved|0
7068458|NCT01995071|11170127|FG009|Overall Study|Moved|0
7068459|NCT01995071|11170128|FG010|Overall Study|Moved|1
7068460|NCT01995071|11170129|FG011|Overall Study|Moved|0
7068461|NCT01995071|11170118|FG000|Overall Study|Lost to Follow-up|1
7068462|NCT01995071|11170119|FG001|Overall Study|Lost to Follow-up|0
7068463|NCT01995071|11170120|FG002|Overall Study|Lost to Follow-up|0
7068464|NCT01995071|11170121|FG003|Overall Study|Lost to Follow-up|0
7068465|NCT01995071|11170122|FG004|Overall Study|Lost to Follow-up|0
7068466|NCT01995071|11170123|FG005|Overall Study|Lost to Follow-up|0
7068467|NCT01995071|11170124|FG006|Overall Study|Lost to Follow-up|0
7068468|NCT01995071|11170125|FG007|Overall Study|Lost to Follow-up|1
7068469|NCT01995071|11170126|FG008|Overall Study|Lost to Follow-up|1
7068470|NCT01995071|11170127|FG009|Overall Study|Lost to Follow-up|0
7068471|NCT01995071|11170128|FG010|Overall Study|Lost to Follow-up|0
7068472|NCT01995071|11170129|FG011|Overall Study|Lost to Follow-up|0
7068473|NCT01995071|11170118|FG000|Overall Study|Incarcerated|0
7068474|NCT01995071|11170119|FG001|Overall Study|Incarcerated|0
7068475|NCT01995071|11170120|FG002|Overall Study|Incarcerated|0
7068476|NCT01995071|11170121|FG003|Overall Study|Incarcerated|0
7068477|NCT01995071|11170122|FG004|Overall Study|Incarcerated|0
7068478|NCT01995071|11170123|FG005|Overall Study|Incarcerated|0
6945847|NCT00975130|10983674|FG000|Study Part 2|Lost to Follow-up|0
7068479|NCT01995071|11170124|FG006|Overall Study|Incarcerated|0
7068480|NCT01995071|11170125|FG007|Overall Study|Incarcerated|1
7068481|NCT01995071|11170126|FG008|Overall Study|Incarcerated|0
7068482|NCT01995071|11170127|FG009|Overall Study|Incarcerated|0
7068483|NCT01995071|11170128|FG010|Overall Study|Incarcerated|0
7147703|NCT03134222|11308415|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1
7068484|NCT01995071|11170129|FG011|Overall Study|Incarcerated|0
7082604|NCT02143713|11193213|FG002|Treatment Period (6 Months)|Adverse Event|8
6945848|NCT00975130|10983675|FG001|Study Part 2|Lost to Follow-up|0
6945849|NCT00975130|10983676|FG002|Study Part 2|Lost to Follow-up|1
6945850|NCT00975130|10983674|FG000|Study Part 2|Withdrawal by Subject|0
6945851|NCT00975130|10983675|FG001|Study Part 2|Withdrawal by Subject|13
6945852|NCT00975130|10983676|FG002|Study Part 2|Withdrawal by Subject|5
6945853|NCT00975130|10983674|FG000|Study Part 2|Withdrew Consent|0
6945854|NCT00975130|10983675|FG001|Study Part 2|Withdrew Consent|6
6945855|NCT00975130|10983676|FG002|Study Part 2|Withdrew Consent|2
6945856|NCT00975130|10983674|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0
6945857|NCT00975130|10983675|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4
6945858|NCT00975130|10983676|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1
6945859|NCT00975130|10983674|FG000|Study Part 2|Administrative|0
6945860|NCT00975130|10983675|FG001|Study Part 2|Administrative|1
6945861|NCT00975130|10983676|FG002|Study Part 2|Administrative|0
6945862|NCT00975130|10983674|FG000|Study Part 2|Protocol Violation|0
6945863|NCT00975130|10983675|FG001|Study Part 2|Protocol Violation|0
6945864|NCT00975130|10983676|FG002|Study Part 2|Protocol Violation|1
6945865|NCT00975143|10983691|FG000|Overall Study|Adverse Event|19
6945866|NCT00975143|10983692|FG001|Overall Study|Adverse Event|15
6945867|NCT00975143|10983691|FG000|Overall Study|Withdrawal by Subject|15
6945868|NCT00975143|10983692|FG001|Overall Study|Withdrawal by Subject|15
6945869|NCT00975143|10983691|FG000|Overall Study|Lost to Follow-up|20
6945870|NCT00975143|10983692|FG001|Overall Study|Lost to Follow-up|16
6945871|NCT00975143|10983691|FG000|Overall Study|Non-compliance|5
6945872|NCT00975143|10983692|FG001|Overall Study|Non-compliance|8
6945873|NCT00975143|10983691|FG000|Overall Study|Physician Decision|1
6945874|NCT00975143|10983692|FG001|Overall Study|Physician Decision|2
6945875|NCT00975143|10983691|FG000|Overall Study|Details not available|10
6945876|NCT00975143|10983692|FG001|Overall Study|Details not available|4
6945877|NCT00975156|10983700|FG000|Overall Study|Protocol Violation|0
6945878|NCT00975156|10983701|FG001|Overall Study|Protocol Violation|1
6945879|NCT00975195|10983713|FG000|Overall Study|Adverse Event|108
6945880|NCT00975195|10983714|FG001|Overall Study|Adverse Event|101
6945881|NCT00975195|10983713|FG000|Overall Study|Lack of Efficacy|6
6945882|NCT00975195|10983714|FG001|Overall Study|Lack of Efficacy|6
6945883|NCT00975195|10983713|FG000|Overall Study|Protocol Violation|27
6945884|NCT00975195|10983714|FG001|Overall Study|Protocol Violation|23
6945885|NCT00975195|10983713|FG000|Overall Study|Lost to Follow-up|9
6945886|NCT00975195|10983714|FG001|Overall Study|Lost to Follow-up|7
6945887|NCT00975195|10983713|FG000|Overall Study|Withdrawal by Subject|48
6945888|NCT00975195|10983714|FG001|Overall Study|Withdrawal by Subject|61
6945889|NCT00975195|10983713|FG000|Overall Study|Other reason not defined above|29
6945890|NCT00975195|10983714|FG001|Overall Study|Other reason not defined above|33
6945891|NCT00975195|10983713|FG000|Overall Study|Not treated|1
6945892|NCT00975195|10983714|FG001|Overall Study|Not treated|2
6945893|NCT00975221|10983722|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2
6945894|NCT00975221|10983723|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3
6945895|NCT00975221|10983722|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1
7068485|NCT01995136|11170170|FG000|Overall Study|Change in residence|1
7068486|NCT01995201|11170176|FG000|From Baseline Until Week 24|Adverse Event|4
7068487|NCT01995201|11170177|FG001|From Baseline Until Week 24|Adverse Event|15
7068488|NCT01995201|11170178|FG002|From Baseline Until Week 24|Adverse Event|0
7068489|NCT01995201|11170179|FG003|From Baseline Until Week 24|Adverse Event|0
7068490|NCT01995201|11170180|FG004|From Baseline Until Week 24|Adverse Event|0
7068491|NCT01995201|11170181|FG005|From Baseline Until Week 24|Adverse Event|0
7068492|NCT01995201|11170182|FG006|From Baseline Until Week 24|Adverse Event|0
7068493|NCT01995201|11170176|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
7068494|NCT01995201|11170177|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3
7068495|NCT01995201|11170178|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
7068496|NCT01995201|11170179|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
7068497|NCT01995201|11170180|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
7068498|NCT01995201|11170181|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
7068499|NCT01995201|11170182|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
7068500|NCT01995201|11170176|FG000|From Baseline Until Week 24|Death|0
7068501|NCT01995201|11170177|FG001|From Baseline Until Week 24|Death|1
7068502|NCT01995201|11170178|FG002|From Baseline Until Week 24|Death|0
7068503|NCT01995201|11170179|FG003|From Baseline Until Week 24|Death|0
7068504|NCT01995201|11170180|FG004|From Baseline Until Week 24|Death|0
7068505|NCT01995201|11170181|FG005|From Baseline Until Week 24|Death|0
7068506|NCT01995201|11170182|FG006|From Baseline Until Week 24|Death|0
7068507|NCT01995201|11170176|FG000|From Baseline Until Week 24|Lack of Efficacy|2
7068508|NCT01995201|11170177|FG001|From Baseline Until Week 24|Lack of Efficacy|5
7068509|NCT01995201|11170178|FG002|From Baseline Until Week 24|Lack of Efficacy|0
7068510|NCT01995201|11170179|FG003|From Baseline Until Week 24|Lack of Efficacy|0
6945896|NCT00975221|10983723|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0
6945897|NCT00975221|10983722|FG000|Titration Phase (Weeks 1-12)|Other|0
6945898|NCT00975221|10983723|FG001|Titration Phase (Weeks 1-12)|Other|1
6945899|NCT00975221|10983722|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0
6945900|NCT00975221|10983723|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1
6945901|NCT00975221|10983722|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
6945902|NCT00975221|10983723|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
6945903|NCT00975221|10983722|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1
6945904|NCT00975221|10983723|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0
6945905|NCT00975286|10983733|FG000|Overall Study|Adverse Event|9
6945906|NCT00975286|10983734|FG001|Overall Study|Adverse Event|19
6945907|NCT00975286|10983733|FG000|Overall Study|Protocol Violation|1
6945908|NCT00975286|10983734|FG001|Overall Study|Protocol Violation|2
6945909|NCT00975286|10983733|FG000|Overall Study|Withdrawal by Subject|0
6945910|NCT00975286|10983734|FG001|Overall Study|Withdrawal by Subject|2
6945911|NCT00975286|10983733|FG000|Overall Study|Familial and Personal Reasons|2
6945912|NCT00975286|10983734|FG001|Overall Study|Familial and Personal Reasons|2
6945913|NCT00975286|10983733|FG000|Overall Study|Poor Compliance to Protocol|0
6945914|NCT00975286|10983734|FG001|Overall Study|Poor Compliance to Protocol|2
6945915|NCT00975286|10983733|FG000|Overall Study|Sponsor Decision|0
6945916|NCT00975286|10983734|FG001|Overall Study|Sponsor Decision|2
6945917|NCT00975416|10983742|FG000|Overall Study|early discharge from tx|3
7068511|NCT01995201|11170180|FG004|From Baseline Until Week 24|Lack of Efficacy|0
7068512|NCT01995201|11170181|FG005|From Baseline Until Week 24|Lack of Efficacy|0
7068513|NCT01995201|11170182|FG006|From Baseline Until Week 24|Lack of Efficacy|0
7068514|NCT01995201|11170176|FG000|From Baseline Until Week 24|Lost to Follow-up|2
7068515|NCT01995201|11170177|FG001|From Baseline Until Week 24|Lost to Follow-up|3
7068516|NCT01995201|11170178|FG002|From Baseline Until Week 24|Lost to Follow-up|0
7068517|NCT01995201|11170179|FG003|From Baseline Until Week 24|Lost to Follow-up|0
7068518|NCT01995201|11170180|FG004|From Baseline Until Week 24|Lost to Follow-up|0
7068519|NCT01995201|11170181|FG005|From Baseline Until Week 24|Lost to Follow-up|0
7068520|NCT01995201|11170182|FG006|From Baseline Until Week 24|Lost to Follow-up|0
7068521|NCT01995201|11170176|FG000|From Baseline Until Week 24|Withdrawal by Subject|2
7068522|NCT01995201|11170177|FG001|From Baseline Until Week 24|Withdrawal by Subject|8
7068523|NCT01995201|11170178|FG002|From Baseline Until Week 24|Withdrawal by Subject|0
7068524|NCT01995201|11170179|FG003|From Baseline Until Week 24|Withdrawal by Subject|0
7068525|NCT01995201|11170180|FG004|From Baseline Until Week 24|Withdrawal by Subject|0
7068526|NCT01995201|11170181|FG005|From Baseline Until Week 24|Withdrawal by Subject|0
7068527|NCT01995201|11170182|FG006|From Baseline Until Week 24|Withdrawal by Subject|0
7068528|NCT01995201|11170176|FG000|From Baseline Until Week 24|Physician Decision|0
7068529|NCT01995201|11170177|FG001|From Baseline Until Week 24|Physician Decision|2
7068530|NCT01995201|11170178|FG002|From Baseline Until Week 24|Physician Decision|0
7068531|NCT01995201|11170179|FG003|From Baseline Until Week 24|Physician Decision|0
7068532|NCT01995201|11170180|FG004|From Baseline Until Week 24|Physician Decision|0
7068533|NCT01995201|11170181|FG005|From Baseline Until Week 24|Physician Decision|0
7068534|NCT01995201|11170182|FG006|From Baseline Until Week 24|Physician Decision|0
7068535|NCT01995201|11170176|FG000|From Baseline Until Week 24|Protocol Violation|0
7068536|NCT01995201|11170177|FG001|From Baseline Until Week 24|Protocol Violation|9
7068537|NCT01995201|11170178|FG002|From Baseline Until Week 24|Protocol Violation|0
7068538|NCT01995201|11170179|FG003|From Baseline Until Week 24|Protocol Violation|0
7068539|NCT01995201|11170180|FG004|From Baseline Until Week 24|Protocol Violation|0
7068540|NCT01995201|11170181|FG005|From Baseline Until Week 24|Protocol Violation|0
7068541|NCT01995201|11170182|FG006|From Baseline Until Week 24|Protocol Violation|0
7068542|NCT01995201|11170176|FG000|From Week 24 Until Week 48|Adverse Event|0
7068543|NCT01995201|11170177|FG001|From Week 24 Until Week 48|Adverse Event|0
7068544|NCT01995201|11170178|FG002|From Week 24 Until Week 48|Adverse Event|2
7068545|NCT01995201|11170179|FG003|From Week 24 Until Week 48|Adverse Event|1
7068546|NCT01995201|11170180|FG004|From Week 24 Until Week 48|Adverse Event|1
7068547|NCT01995201|11170181|FG005|From Week 24 Until Week 48|Adverse Event|3
7068548|NCT01995201|11170182|FG006|From Week 24 Until Week 48|Adverse Event|1
7068549|NCT01995201|11170176|FG000|From Week 24 Until Week 48|Death|0
7068550|NCT01995201|11170177|FG001|From Week 24 Until Week 48|Death|0
7068551|NCT01995201|11170178|FG002|From Week 24 Until Week 48|Death|0
7068552|NCT01995201|11170179|FG003|From Week 24 Until Week 48|Death|0
7068553|NCT01995201|11170180|FG004|From Week 24 Until Week 48|Death|0
7068554|NCT01995201|11170181|FG005|From Week 24 Until Week 48|Death|2
7068555|NCT01995201|11170182|FG006|From Week 24 Until Week 48|Death|0
7068556|NCT01995201|11170176|FG000|From Week 24 Until Week 48|Lack of Efficacy|0
7068557|NCT01995201|11170177|FG001|From Week 24 Until Week 48|Lack of Efficacy|0
7068558|NCT01995201|11170178|FG002|From Week 24 Until Week 48|Lack of Efficacy|1
7068559|NCT01995201|11170179|FG003|From Week 24 Until Week 48|Lack of Efficacy|0
7068560|NCT01995201|11170180|FG004|From Week 24 Until Week 48|Lack of Efficacy|0
7068561|NCT01995201|11170181|FG005|From Week 24 Until Week 48|Lack of Efficacy|2
7068562|NCT01995201|11170182|FG006|From Week 24 Until Week 48|Lack of Efficacy|1
7068563|NCT01995201|11170176|FG000|From Week 24 Until Week 48|Lost to Follow-up|0
7068564|NCT01995201|11170177|FG001|From Week 24 Until Week 48|Lost to Follow-up|0
7068565|NCT01995201|11170178|FG002|From Week 24 Until Week 48|Lost to Follow-up|0
7068566|NCT01995201|11170179|FG003|From Week 24 Until Week 48|Lost to Follow-up|0
7068567|NCT01995201|11170180|FG004|From Week 24 Until Week 48|Lost to Follow-up|1
7068568|NCT01995201|11170181|FG005|From Week 24 Until Week 48|Lost to Follow-up|1
6945918|NCT00975416|10983743|FG001|Overall Study|early discharge from tx|5
6945919|NCT00975481|10983750|FG000|Second Intervention Period|Adverse Event|2
6945920|NCT00975481|10983751|FG001|Second Intervention Period|Adverse Event|1
6945921|NCT00975481|10983752|FG002|Second Intervention Period|Adverse Event|0
6945922|NCT00975481|10983753|FG003|Second Intervention Period|Adverse Event|0
6945923|NCT00975481|10983754|FG004|Second Intervention Period|Adverse Event|0
6945924|NCT00975481|10983755|FG005|Second Intervention Period|Adverse Event|0
6945925|NCT00975481|10983750|FG000|Second Intervention Period|Withdrawal by Subject|0
6945926|NCT00975481|10983751|FG001|Second Intervention Period|Withdrawal by Subject|0
6945927|NCT00975481|10983752|FG002|Second Intervention Period|Withdrawal by Subject|1
6945928|NCT00975481|10983753|FG003|Second Intervention Period|Withdrawal by Subject|0
6945929|NCT00975481|10983754|FG004|Second Intervention Period|Withdrawal by Subject|0
6945930|NCT00975481|10983755|FG005|Second Intervention Period|Withdrawal by Subject|0
6945931|NCT00975481|10983750|FG000|Fourth Intervention Period|Withdrawal by Subject|0
6945932|NCT00975481|10983751|FG001|Fourth Intervention Period|Withdrawal by Subject|0
6945933|NCT00975481|10983752|FG002|Fourth Intervention Period|Withdrawal by Subject|1
6945934|NCT00975481|10983753|FG003|Fourth Intervention Period|Withdrawal by Subject|1
6945935|NCT00975481|10983754|FG004|Fourth Intervention Period|Withdrawal by Subject|0
6945936|NCT00975481|10983755|FG005|Fourth Intervention Period|Withdrawal by Subject|0
6945937|NCT00975481|10983750|FG000|Fifth Intervention Period|Withdrawal by Subject|0
6945938|NCT00975481|10983751|FG001|Fifth Intervention Period|Withdrawal by Subject|0
6945939|NCT00975481|10983752|FG002|Fifth Intervention Period|Withdrawal by Subject|0
6945940|NCT00975481|10983753|FG003|Fifth Intervention Period|Withdrawal by Subject|0
6945941|NCT00975481|10983754|FG004|Fifth Intervention Period|Withdrawal by Subject|1
6945942|NCT00975481|10983755|FG005|Fifth Intervention Period|Withdrawal by Subject|0
6945943|NCT00975507|10983775|FG000|Overall Study|Adverse Event|1
6945944|NCT00975507|10983776|FG001|Overall Study|Adverse Event|0
6945945|NCT00975507|10983775|FG000|Overall Study|Lost to Follow-up|7
6945946|NCT00975507|10983776|FG001|Overall Study|Lost to Follow-up|1
6945947|NCT00975507|10983775|FG000|Overall Study|Protocol Violation|2
6945948|NCT00975507|10983776|FG001|Overall Study|Protocol Violation|0
6945949|NCT00975507|10983775|FG000|Overall Study|Withdrawal by Subject|10
6945950|NCT00975507|10983776|FG001|Overall Study|Withdrawal by Subject|3
6945951|NCT00975585|10983786|FG000|Overall Study|Adverse Event|0
6945952|NCT00975585|10983787|FG001|Overall Study|Adverse Event|4
6945953|NCT00975585|10983786|FG000|Overall Study|Lost to Follow-up|3
6945954|NCT00975585|10983787|FG001|Overall Study|Lost to Follow-up|5
6945955|NCT00975585|10983786|FG000|Overall Study|Withdrawal by Subject|2
6945956|NCT00975585|10983787|FG001|Overall Study|Withdrawal by Subject|1
6945957|NCT00975585|10983786|FG000|Overall Study|Lens issue|2
6945958|NCT00975585|10983787|FG001|Overall Study|Lens issue|2
6945959|NCT00975676|10983831|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6
6945960|NCT00975676|10983832|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8
6945961|NCT00975689|10983845|FG000|Overall Study|Adverse Event|0
6945962|NCT00975689|10983846|FG001|Overall Study|Adverse Event|3
7068569|NCT01995201|11170182|FG006|From Week 24 Until Week 48|Lost to Follow-up|0
7068570|NCT01995201|11170176|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0
7068571|NCT01995201|11170177|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0
7068572|NCT01995201|11170178|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1
7068573|NCT01995201|11170179|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0
7068574|NCT01995201|11170180|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1
7068575|NCT01995201|11170181|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0
7068576|NCT01995201|11170182|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0
7068577|NCT01995201|11170176|FG000|From Week 24 Until Week 48|Physician Decision|0
7068578|NCT01995201|11170177|FG001|From Week 24 Until Week 48|Physician Decision|0
7068579|NCT01995201|11170178|FG002|From Week 24 Until Week 48|Physician Decision|0
7068580|NCT01995201|11170179|FG003|From Week 24 Until Week 48|Physician Decision|0
7068581|NCT01995201|11170180|FG004|From Week 24 Until Week 48|Physician Decision|1
7068582|NCT01995201|11170181|FG005|From Week 24 Until Week 48|Physician Decision|0
7068583|NCT01995201|11170182|FG006|From Week 24 Until Week 48|Physician Decision|0
7068584|NCT01995201|11170176|FG000|From Week 24 Until Week 48|Protocol Violation|0
7068585|NCT01995201|11170177|FG001|From Week 24 Until Week 48|Protocol Violation|0
7068586|NCT01995201|11170178|FG002|From Week 24 Until Week 48|Protocol Violation|1
7068587|NCT01995201|11170179|FG003|From Week 24 Until Week 48|Protocol Violation|0
7068588|NCT01995201|11170180|FG004|From Week 24 Until Week 48|Protocol Violation|2
7068589|NCT01995201|11170181|FG005|From Week 24 Until Week 48|Protocol Violation|0
7068590|NCT01995201|11170182|FG006|From Week 24 Until Week 48|Protocol Violation|0
7068591|NCT01995266|11170203|FG000|Overall Study|Death|1
7068592|NCT01995266|11170203|FG000|Overall Study|Lack of Efficacy|6
7068593|NCT01995266|11170203|FG000|Overall Study|Adverse Event|2
7068594|NCT01995357|11170207|FG000|Period 5|Lack of Efficacy|1
7068595|NCT01995357|11170208|FG001|Period 5|Lack of Efficacy|0
6945963|NCT00975689|10983845|FG000|Overall Study|Withdrawal by Subject|1
6945964|NCT00975689|10983846|FG001|Overall Study|Withdrawal by Subject|0
6945965|NCT00975689|10983845|FG000|Overall Study|Physician Decision|1
6945966|NCT00975689|10983846|FG001|Overall Study|Physician Decision|0
7068596|NCT01995357|11170209|FG002|Period 5|Lack of Efficacy|0
7068597|NCT01995357|11170210|FG003|Period 5|Lack of Efficacy|0
7068598|NCT01995357|11170211|FG004|Period 5|Lack of Efficacy|0
7068599|NCT01995357|11170212|FG005|Period 5|Lack of Efficacy|0
7068600|NCT01995357|11170207|FG000|Period 5|Adverse Event|1
6945967|NCT00975715|10983854|FG000|Titration Period|Adverse Event|6
6945968|NCT00975715|10983855|FG001|Titration Period|Adverse Event|0
6945969|NCT00975715|10983854|FG000|Titration Period|Protocol Violation|1
6945970|NCT00975715|10983855|FG001|Titration Period|Protocol Violation|0
6945971|NCT00975715|10983854|FG000|Maintenance Period|Adverse Event|2
6945972|NCT00975715|10983855|FG001|Maintenance Period|Adverse Event|1
6945973|NCT00975780|10983863|FG000|Follow Up|Death|88
6945974|NCT00975780|10983864|FG001|Follow Up|Death|122
6945975|NCT00975780|10983863|FG000|Follow Up|Facility Withdrawal|7
6945976|NCT00975780|10983864|FG001|Follow Up|Facility Withdrawal|23
6945977|NCT00975780|10983863|FG000|Follow Up|Discharged from Facility|7
6945978|NCT00975780|10983864|FG001|Follow Up|Discharged from Facility|12
6945979|NCT00975806|10983873|FG000|Overall Study|Adverse Event|2
6945980|NCT00975806|10983874|FG001|Overall Study|Adverse Event|1
6945981|NCT00975806|10983875|FG002|Overall Study|Adverse Event|2
6945982|NCT00975806|10983873|FG000|Overall Study|Disease Progression|1
6945983|NCT00975806|10983874|FG001|Overall Study|Disease Progression|5
6945984|NCT00975806|10983875|FG002|Overall Study|Disease Progression|1
6945985|NCT00975806|10983873|FG000|Overall Study|Withdrawal by Subject|1
6945986|NCT00975806|10983874|FG001|Overall Study|Withdrawal by Subject|0
6945987|NCT00975806|10983875|FG002|Overall Study|Withdrawal by Subject|0
6945988|NCT00975806|10983873|FG000|Overall Study|Death|0
6945989|NCT00975806|10983874|FG001|Overall Study|Death|1
6945990|NCT00975806|10983875|FG002|Overall Study|Death|0
6945991|NCT00975806|10983873|FG000|Overall Study|Physician decision and disease related|1
6945992|NCT00975806|10983874|FG001|Overall Study|Physician decision and disease related|0
6945993|NCT00975806|10983875|FG002|Overall Study|Physician decision and disease related|1
6945994|NCT00975884|10983887|FG000|Overall Study|Adverse Event|1
6945995|NCT00975884|10983888|FG001|Overall Study|Adverse Event|0
7068601|NCT01995357|11170208|FG001|Period 5|Adverse Event|0
7068602|NCT01995357|11170209|FG002|Period 5|Adverse Event|1
7068603|NCT01995357|11170210|FG003|Period 5|Adverse Event|0
7068604|NCT01995357|11170211|FG004|Period 5|Adverse Event|0
7068605|NCT01995357|11170212|FG005|Period 5|Adverse Event|0
7068606|NCT01995461|11170228|FG000|Overall Study|Death|1
7068607|NCT01995461|11170228|FG000|Overall Study|Lost to Follow-up|2
7068608|NCT01995461|11170228|FG000|Overall Study|Withdrawal by Subject|2
7068609|NCT01995513|11170241|FG000|Open Label Treatment Period|Other|9
7068610|NCT01995513|11170242|FG001|Open Label Treatment Period|Other|0
7068611|NCT01995513|11170243|FG002|Open Label Treatment Period|Other|0
7068612|NCT01995513|11170241|FG000|Open Label Treatment Period|Withdrawal by Subject|14
7068613|NCT01995513|11170242|FG001|Open Label Treatment Period|Withdrawal by Subject|0
7068614|NCT01995513|11170243|FG002|Open Label Treatment Period|Withdrawal by Subject|0
7068615|NCT01995513|11170241|FG000|Open Label Treatment Period|Protocol Violation|1
7068616|NCT01995513|11170242|FG001|Open Label Treatment Period|Protocol Violation|0
7068617|NCT01995513|11170243|FG002|Open Label Treatment Period|Protocol Violation|0
7068618|NCT01995513|11170241|FG000|Open Label Treatment Period|Disease Progression|64
7068619|NCT01995513|11170242|FG001|Open Label Treatment Period|Disease Progression|0
7068620|NCT01995513|11170243|FG002|Open Label Treatment Period|Disease Progression|0
7068621|NCT01995513|11170241|FG000|Open Label Treatment Period|No PSA response at week 13|43
7068622|NCT01995513|11170242|FG001|Open Label Treatment Period|No PSA response at week 13|0
7068623|NCT01995513|11170243|FG002|Open Label Treatment Period|No PSA response at week 13|0
7068624|NCT01995513|11170241|FG000|Open Label Treatment Period|Adverse Event|35
7068625|NCT01995513|11170242|FG001|Open Label Treatment Period|Adverse Event|0
7068626|NCT01995513|11170243|FG002|Open Label Treatment Period|Adverse Event|0
7068627|NCT01995513|11170241|FG000|Open Label Treatment Period|Death|8
7068628|NCT01995513|11170242|FG001|Open Label Treatment Period|Death|0
7068629|NCT01995513|11170243|FG002|Open Label Treatment Period|Death|0
7068630|NCT01995513|11170241|FG000|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|84
7068631|NCT01995513|11170242|FG001|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
7068632|NCT01995513|11170243|FG002|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
7068633|NCT01995513|11170241|FG000|Double Blind Treatment Period|Adverse Event|0
7068634|NCT01995513|11170242|FG001|Double Blind Treatment Period|Adverse Event|12
7068635|NCT01995513|11170243|FG002|Double Blind Treatment Period|Adverse Event|5
7068636|NCT01995513|11170241|FG000|Double Blind Treatment Period|Other|0
7068637|NCT01995513|11170242|FG001|Double Blind Treatment Period|Other|1
7068638|NCT01995513|11170243|FG002|Double Blind Treatment Period|Other|2
7068639|NCT01995513|11170241|FG000|Double Blind Treatment Period|Withdrawal by Subject|0
7068640|NCT01995513|11170242|FG001|Double Blind Treatment Period|Withdrawal by Subject|4
7068641|NCT01995513|11170243|FG002|Double Blind Treatment Period|Withdrawal by Subject|6
7068642|NCT01995513|11170241|FG000|Double Blind Treatment Period|Death|0
7068643|NCT01995513|11170242|FG001|Double Blind Treatment Period|Death|0
7068644|NCT01995513|11170243|FG002|Double Blind Treatment Period|Death|1
7068645|NCT01995513|11170241|FG000|Double Blind Treatment Period|Disease Progression|0
7068646|NCT01995513|11170242|FG001|Double Blind Treatment Period|Disease Progression|82
7068647|NCT01995513|11170243|FG002|Double Blind Treatment Period|Disease Progression|93
7068648|NCT01995513|11170241|FG000|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
7068649|NCT01995513|11170242|FG001|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|27
6945996|NCT00975884|10983887|FG000|Overall Study|Lost to Follow-up|5
6945997|NCT00975884|10983888|FG001|Overall Study|Lost to Follow-up|3
6945998|NCT00975884|10983887|FG000|Overall Study|Withdrawal by Subject|9
6945999|NCT00975884|10983888|FG001|Overall Study|Withdrawal by Subject|9
6946000|NCT00975884|10983887|FG000|Overall Study|Other|1
6946001|NCT00975884|10983888|FG001|Overall Study|Other|3
6946002|NCT00975923|10983906|FG000|Overall Study|Withdrawal by Subject|0
7068650|NCT01995513|11170243|FG002|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|18
7068651|NCT01995526|11170253|FG000|Overall Study|Physician Decision|1
7068652|NCT01995539|11170257|FG000|Overall Study|Screening Failure|1
7068653|NCT01995539|11170257|FG000|Overall Study|Withdrawal by Investigator|15
7068654|NCT01995539|11170257|FG000|Overall Study|Withdrawal by Subject|11
7068655|NCT01995539|11170257|FG000|Overall Study|Lost to Follow-up|5
7068656|NCT01995539|11170257|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1
7068657|NCT01995552|11170261|FG000|Overall Study|Protocol Violation|1
7068658|NCT01995552|11170261|FG000|Overall Study|Lack of Efficacy|15
7068659|NCT01995552|11170261|FG000|Overall Study|Death|1
7068660|NCT01995825|11170269|FG000|Overall Study|Withdrawal by Subject|1
7068661|NCT01995825|11170270|FG001|Overall Study|Withdrawal by Subject|0
7068662|NCT01995838|11170283|FG000|Overall Study|Lost to Follow-up|0
7068663|NCT01995838|11170284|FG001|Overall Study|Lost to Follow-up|1
7068664|NCT01995838|11170285|FG002|Overall Study|Lost to Follow-up|0
7068665|NCT01995838|11170286|FG003|Overall Study|Lost to Follow-up|0
7068666|NCT01995838|11170287|FG004|Overall Study|Lost to Follow-up|0
7068667|NCT01995838|11170288|FG005|Overall Study|Lost to Follow-up|0
7068668|NCT01995838|11170289|FG006|Overall Study|Lost to Follow-up|1
7068669|NCT01995838|11170283|FG000|Overall Study|Participant choice|2
7068670|NCT01995838|11170284|FG001|Overall Study|Participant choice|0
7068671|NCT01995838|11170285|FG002|Overall Study|Participant choice|0
7068672|NCT01995838|11170286|FG003|Overall Study|Participant choice|0
7068673|NCT01995838|11170287|FG004|Overall Study|Participant choice|0
7068674|NCT01995838|11170288|FG005|Overall Study|Participant choice|1
7068675|NCT01995838|11170289|FG006|Overall Study|Participant choice|1
7068676|NCT01995838|11170283|FG000|Overall Study|Adverse Event|0
7068677|NCT01995838|11170284|FG001|Overall Study|Adverse Event|0
7068678|NCT01995838|11170285|FG002|Overall Study|Adverse Event|0
7068679|NCT01995838|11170286|FG003|Overall Study|Adverse Event|0
7068680|NCT01995838|11170287|FG004|Overall Study|Adverse Event|0
7068681|NCT01995838|11170288|FG005|Overall Study|Adverse Event|0
7068682|NCT01995838|11170289|FG006|Overall Study|Adverse Event|1
7068683|NCT01995838|11170283|FG000|Overall Study|Withdrawal by Subject|0
7068684|NCT01995838|11170284|FG001|Overall Study|Withdrawal by Subject|0
7068685|NCT01995838|11170285|FG002|Overall Study|Withdrawal by Subject|0
7068686|NCT01995838|11170286|FG003|Overall Study|Withdrawal by Subject|0
7068687|NCT01995838|11170287|FG004|Overall Study|Withdrawal by Subject|1
7068688|NCT01995838|11170288|FG005|Overall Study|Withdrawal by Subject|0
7068689|NCT01995838|11170289|FG006|Overall Study|Withdrawal by Subject|0
7068690|NCT01995838|11170283|FG000|Overall Study|Other|3
7068691|NCT01995838|11170284|FG001|Overall Study|Other|1
7068692|NCT01995838|11170285|FG002|Overall Study|Other|0
7068693|NCT01995838|11170286|FG003|Overall Study|Other|2
7068694|NCT01995838|11170287|FG004|Overall Study|Other|1
7068695|NCT01995838|11170288|FG005|Overall Study|Other|1
7068696|NCT01995838|11170289|FG006|Overall Study|Other|2
7068697|NCT01996033|11170306|FG000|Overall Study|Death|1
7068698|NCT01996033|11170306|FG000|Overall Study|Physician Decision|1
7068699|NCT01996033|11170306|FG000|Overall Study|Withdrawal by Subject|4
7068700|NCT01996033|11170306|FG000|Overall Study|Lost to Follow-up|3
7068701|NCT01996241|11170312|FG000|Overall Study|Lost to Follow-up|252
7068702|NCT01996241|11170313|FG001|Overall Study|Lost to Follow-up|235
6838391|NCT00258440|10844071|FG000|Overall Study|Withdrawal by Subject|0
6838392|NCT00258440|10844072|FG001|Overall Study|Withdrawal by Subject|0
6838393|NCT00258440|10844073|FG002|Overall Study|Withdrawal by Subject|1
6838394|NCT00258674|10844084|FG000|Overall Study|Death|32
6838395|NCT00258674|10844085|FG001|Overall Study|Death|53
7068703|NCT01996254|11170323|FG000|Overall Study|Change in Eligibility|0
7068704|NCT01996254|11170324|FG001|Overall Study|Change in Eligibility|2
7068705|NCT01996254|11170325|FG002|Overall Study|Change in Eligibility|0
7068706|NCT01996254|11170323|FG000|Overall Study|Withdrawal by Subject|0
6838396|NCT00258674|10844086|FG002|Overall Study|Death|34
6838397|NCT00258856|10844116|FG000|Overall Study|Lost to Follow-up|1
6838398|NCT00258856|10844117|FG001|Overall Study|Lost to Follow-up|0
6838399|NCT00258856|10844118|FG002|Overall Study|Lost to Follow-up|2
6838400|NCT00258856|10844119|FG003|Overall Study|Lost to Follow-up|0
6838401|NCT00258856|10844116|FG000|Overall Study|Non-compliance|2
6838402|NCT00258856|10844117|FG001|Overall Study|Non-compliance|0
6838403|NCT00258856|10844118|FG002|Overall Study|Non-compliance|0
6838404|NCT00258856|10844119|FG003|Overall Study|Non-compliance|1
6838405|NCT00258895|10844142|FG000|Overall Study|Lost to Follow-up|3
6838406|NCT00258895|10844143|FG001|Overall Study|Lost to Follow-up|1
6838407|NCT00258895|10844142|FG000|Overall Study|Protocol Violation|6
6946003|NCT00975923|10983907|FG001|Overall Study|Withdrawal by Subject|1
6838408|NCT00258895|10844143|FG001|Overall Study|Protocol Violation|2
6838409|NCT00258895|10844142|FG000|Overall Study|Withdrawal by Subject|1
6838410|NCT00258895|10844143|FG001|Overall Study|Withdrawal by Subject|0
6838411|NCT00258960|10844153|FG000|Overall Study|Death|2
7068707|NCT01996254|11170324|FG001|Overall Study|Withdrawal by Subject|3
7068708|NCT01996254|11170325|FG002|Overall Study|Withdrawal by Subject|4
7068709|NCT01996254|11170323|FG000|Overall Study|Lost to Follow-up|1
7068710|NCT01996254|11170324|FG001|Overall Study|Lost to Follow-up|0
6946004|NCT00975975|10983914|FG000|Overall Study|Death|6
6946005|NCT00976027|10983920|FG000|Overall Study|Serious Adverse Event|36
6946006|NCT00976027|10983921|FG001|Overall Study|Serious Adverse Event|17
6946007|NCT00976027|10983920|FG000|Overall Study|Adverse Event|0
6946008|NCT00976027|10983921|FG001|Overall Study|Adverse Event|2
6946009|NCT00976027|10983920|FG000|Overall Study|Protocol Violation|60
6946010|NCT00976027|10983921|FG001|Overall Study|Protocol Violation|27
6946011|NCT00976027|10983920|FG000|Overall Study|Lost to Follow-up|208
6946012|NCT00976027|10983921|FG001|Overall Study|Lost to Follow-up|103
6946013|NCT00976027|10983920|FG000|Overall Study|Withdrawal by Subject|107
7068711|NCT01996254|11170325|FG002|Overall Study|Lost to Follow-up|4
7068712|NCT01996319|11170337|FG000|Overall Study|Protocol Violation|1
7068713|NCT01996319|11170338|FG001|Overall Study|Protocol Violation|0
7068714|NCT01996319|11170337|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5
7068715|NCT01996319|11170338|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1
7068716|NCT01996319|11170337|FG000|Overall Study|Adverse Event|2
7068717|NCT01996319|11170338|FG001|Overall Study|Adverse Event|2
7068718|NCT01996332|11170344|FG000|Overall Study|Adverse Event|117
7068719|NCT01996332|11170344|FG000|Overall Study|Lack of Efficacy|1245
7068720|NCT01996332|11170344|FG000|Overall Study|Death|264
7068721|NCT01996332|11170344|FG000|Overall Study|Protocol Violation|9
7068722|NCT01996332|11170344|FG000|Overall Study|Withdrawal by Subject|71
7068723|NCT01996332|11170344|FG000|Overall Study|Other|20
7068724|NCT01996332|11170344|FG000|Overall Study|Clinical Deterioration|28
7068725|NCT01996332|11170344|FG000|Overall Study|Physician Decision|17
7068726|NCT01996332|11170344|FG000|Overall Study|Lost to Follow-up|34
7068727|NCT01996592|11170348|FG000|Overall Study|no response to text/no diary entry|32
7068728|NCT01996592|11170348|FG000|Overall Study|change in surgical date|4
7068729|NCT01996592|11170348|FG000|Overall Study|Withdrawal by Subject|5
7068730|NCT01996592|11170348|FG000|Overall Study|change in mode of delivery|4
7068731|NCT01996709|11170384|FG000|Overall Study|Withdrawal by Subject|1
7068732|NCT01996709|11170385|FG001|Overall Study|Withdrawal by Subject|0
7068733|NCT01996709|11170384|FG000|Overall Study|Lost to Follow-up|3
7068734|NCT01996709|11170385|FG001|Overall Study|Lost to Follow-up|0
7068735|NCT01996709|11170384|FG000|Overall Study|Subject Non-Compliant|1
7068736|NCT01996709|11170385|FG001|Overall Study|Subject Non-Compliant|0
7068737|NCT01996709|11170384|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0
7068738|NCT01996709|11170385|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1
7068739|NCT01996748|11170397|FG000|Overall Study|Personal reason|1
7068740|NCT01996748|11170398|FG001|Overall Study|Personal reason|0
7068741|NCT01996748|11170397|FG000|Overall Study|Physician Decision|2
7068742|NCT01996748|11170398|FG001|Overall Study|Physician Decision|0
7068743|NCT01996748|11170397|FG000|Overall Study|Adverse Event|1
7068744|NCT01996748|11170398|FG001|Overall Study|Adverse Event|4
7068745|NCT01996748|11170397|FG000|Overall Study|Withdrawal by Subject|0
7068746|NCT01996748|11170398|FG001|Overall Study|Withdrawal by Subject|1
7068747|NCT01996748|11170397|FG000|Overall Study|Lost to Follow-up|4
7068748|NCT01996748|11170398|FG001|Overall Study|Lost to Follow-up|1
7068749|NCT01996826|11170417|FG000|Overall Study|Lost to Follow-up|6
7068750|NCT01996826|11170418|FG001|Overall Study|Lost to Follow-up|2
7068751|NCT01996826|11170417|FG000|Overall Study|Physician Decision|1
7068752|NCT01996826|11170418|FG001|Overall Study|Physician Decision|1
7068753|NCT01996904|11170439|FG000|Overall Study|Lost to Follow-up|38
7068754|NCT01996904|11170440|FG001|Overall Study|Lost to Follow-up|27
7068755|NCT01997281|11170482|FG000|Overall Study|Withdrawal by Subject|1
7068756|NCT01997281|11170483|FG001|Overall Study|Withdrawal by Subject|0
7068757|NCT01997333|11170491|FG000|Randomization and Treatment|Disease Progression|70
7068758|NCT01997333|11170492|FG001|Randomization and Treatment|Disease Progression|159
7068759|NCT01997333|11170491|FG000|Randomization and Treatment|Adverse Event|10
7068760|NCT01997333|11170492|FG001|Randomization and Treatment|Adverse Event|32
7068761|NCT01997333|11170491|FG000|Randomization and Treatment|Physician Decision|0
7068762|NCT01997333|11170492|FG001|Randomization and Treatment|Physician Decision|4
7068763|NCT01997333|11170491|FG000|Randomization and Treatment|Withdrawal by Subject|6
7068764|NCT01997333|11170492|FG001|Randomization and Treatment|Withdrawal by Subject|3
7068765|NCT01997333|11170491|FG000|Randomization and Treatment|Did not receive treatment|17
7068766|NCT01997333|11170492|FG001|Randomization and Treatment|Did not receive treatment|5
7068767|NCT01997333|11170491|FG000|Survival Follow up|Withdrawal by Subject|15
7068768|NCT01997333|11170492|FG001|Survival Follow up|Withdrawal by Subject|6
7068769|NCT01997333|11170491|FG000|Survival Follow up|Lost to Follow-up|0
7147704|NCT03134222|11308416|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1
7147705|NCT03134222|11308417|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1
7147706|NCT03134222|11308418|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0
7147707|NCT03134222|11308419|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0
7147708|NCT03134222|11308415|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0
7147709|NCT03134222|11308416|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1
7147710|NCT03134222|11308417|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0
7147711|NCT03134222|11308418|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0
6946014|NCT00976027|10983921|FG001|Overall Study|Withdrawal by Subject|66
6946015|NCT00976209|10983933|FG000|Treatment Period 1|Protocol Violation|1
6946016|NCT00976209|10983934|FG001|Treatment Period 1|Protocol Violation|0
6946017|NCT00976209|10983933|FG000|Treatment Period 1|Lost to Follow-up|2
6946018|NCT00976209|10983934|FG001|Treatment Period 1|Lost to Follow-up|0
6946019|NCT00976209|10983933|FG000|Treatment Period 1|Other|0
6946020|NCT00976209|10983934|FG001|Treatment Period 1|Other|1
6946021|NCT00976209|10983933|FG000|Wash-out Period|Adverse Event|1
6946022|NCT00976209|10983934|FG001|Wash-out Period|Adverse Event|2
6946023|NCT00976209|10983933|FG000|Wash-out Period|Lost to Follow-up|1
6946024|NCT00976209|10983934|FG001|Wash-out Period|Lost to Follow-up|0
6946025|NCT00976209|10983933|FG000|Wash-out Period|Protocol Violation|1
6946026|NCT00976209|10983934|FG001|Wash-out Period|Protocol Violation|0
6946027|NCT00976209|10983933|FG000|Wash-out Period|Other|1
6946028|NCT00976209|10983934|FG001|Wash-out Period|Other|0
6946029|NCT00976209|10983933|FG000|Treatment Period 2|Withdrawal by Subject|0
6946030|NCT00976209|10983934|FG001|Treatment Period 2|Withdrawal by Subject|1
6946031|NCT00976209|10983933|FG000|Treatment Period 2|Lost to Follow-up|0
7068770|NCT01997333|11170492|FG001|Survival Follow up|Lost to Follow-up|6
7068771|NCT01997333|11170491|FG000|Survival Follow up|Various|1
7068772|NCT01997333|11170492|FG001|Survival Follow up|Various|2
7068773|NCT01997892|11170556|FG000|Overall Study|Physician Decision|2
7068774|NCT01997892|11170556|FG000|Overall Study|Lost to Follow-up|6
7068775|NCT01997892|11170556|FG000|Overall Study|Death|14
7068776|NCT01997892|11170556|FG000|Overall Study|Renal transplant|8
7068777|NCT01997892|11170556|FG000|Overall Study|Other|3
7068778|NCT01997892|11170556|FG000|Overall Study|Study completion data not recorded|35
7068779|NCT01998243|11170571|FG000|Overall Study|Pregnancy|0
7068780|NCT01998243|11170572|FG001|Overall Study|Pregnancy|1
7068781|NCT01998243|11170571|FG000|Overall Study|Protocol Violation|5
7068782|NCT01998243|11170572|FG001|Overall Study|Protocol Violation|2
7068783|NCT01998243|11170571|FG000|Overall Study|Withdrawal by Subject|3
7068784|NCT01998243|11170572|FG001|Overall Study|Withdrawal by Subject|4
7068785|NCT01998399|11170595|FG000|Overall Study|Lost to Follow-up|1
7068786|NCT01998399|11170596|FG001|Overall Study|Lost to Follow-up|3
7068787|NCT01998399|11170595|FG000|Overall Study|Death|4
7068788|NCT01998399|11170596|FG001|Overall Study|Death|2
7068789|NCT01998399|11170595|FG000|Overall Study|Study stopped before dosing completed|3
7068790|NCT01998399|11170596|FG001|Overall Study|Study stopped before dosing completed|3
7068791|NCT01998399|11170595|FG000|Overall Study|Withdrawal by Subject|0
7068792|NCT01998399|11170596|FG001|Overall Study|Withdrawal by Subject|1
7068793|NCT01998477|11170617|FG000|Overall Study|Lost to Follow-up|4
7068794|NCT01998477|11170618|FG001|Overall Study|Lost to Follow-up|5
7068795|NCT01998477|11170617|FG000|Overall Study|Withdrawal by Subject|6
7068796|NCT01998477|11170618|FG001|Overall Study|Withdrawal by Subject|0
7068797|NCT01998581|11170651|FG000|Overall Study|Refused repeat treatment|20
7068798|NCT01998581|11170652|FG001|Overall Study|Refused repeat treatment|4
7068799|NCT01998581|11170651|FG000|Overall Study|Protocol Violation|1
7068800|NCT01998581|11170652|FG001|Overall Study|Protocol Violation|0
7068801|NCT01998581|11170651|FG000|Overall Study|Withdrawal by Subject|8
7068802|NCT01998581|11170652|FG001|Overall Study|Withdrawal by Subject|1
7068803|NCT01998581|11170651|FG000|Overall Study|Lost to Follow-up|12
7068804|NCT01998581|11170652|FG001|Overall Study|Lost to Follow-up|4
7068805|NCT01998581|11170651|FG000|Overall Study|Adverse Event|1
7068806|NCT01998581|11170652|FG001|Overall Study|Adverse Event|1
7068807|NCT01998581|11170651|FG000|Overall Study|Other reasons|3
7068808|NCT01998581|11170652|FG001|Overall Study|Other reasons|2
7068809|NCT01998581|11170651|FG000|Overall Study|Randomized but withdrew before treatment|1
7068810|NCT01998581|11170652|FG001|Overall Study|Randomized but withdrew before treatment|0
7068811|NCT01998633|11170661|FG000|Overall Study|Death|1
7068812|NCT01998737|11170671|FG000|Overall Study|Corrupted database|23
7068813|NCT01998737|11170672|FG001|Overall Study|Corrupted database|0
7068814|NCT01998880|11170680|FG000|Overall Study|Adverse Events or Intercurrent Illness|16
7068815|NCT01998880|11170681|FG001|Overall Study|Adverse Events or Intercurrent Illness|16
7068816|NCT01998880|11170680|FG000|Overall Study|Disease Progression|1
7068817|NCT01998880|11170681|FG001|Overall Study|Disease Progression|8
7068818|NCT01998880|11170680|FG000|Overall Study|Withdrew Consent|2
7068819|NCT01998880|11170681|FG001|Overall Study|Withdrew Consent|1
7068820|NCT01998880|11170680|FG000|Overall Study|Death|3
7068821|NCT01998880|11170681|FG001|Overall Study|Death|6
7068822|NCT01998880|11170680|FG000|Overall Study|Insufficient Therapeutic Response|1
7068823|NCT01998880|11170681|FG001|Overall Study|Insufficient Therapeutic Response|5
7068824|NCT01998880|11170680|FG000|Overall Study|Administrative/Other|1
7068825|NCT01998880|11170681|FG001|Overall Study|Administrative/Other|1
7068826|NCT01998880|11170680|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1
7068827|NCT01998880|11170681|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0
7068828|NCT01998880|11170680|FG000|Overall Study|Violation of Selection Criteria at Entry|0
7068829|NCT01998880|11170681|FG001|Overall Study|Violation of Selection Criteria at Entry|1
7068830|NCT01998880|11170680|FG000|Overall Study|Did Not Receive Treatment|3
7068831|NCT01998880|11170681|FG001|Overall Study|Did Not Receive Treatment|2
7068832|NCT01998893|11170687|FG000|Overall Study|Adverse Event|2
7068833|NCT01998893|11170687|FG000|Overall Study|Death|1
7068834|NCT01998893|11170687|FG000|Overall Study|Lost to Follow-up|8
7068835|NCT01998893|11170687|FG000|Overall Study|Physician Decision|2
7068836|NCT01998893|11170687|FG000|Overall Study|Protocol Violation|2
7068837|NCT01998893|11170687|FG000|Overall Study|Withdrawal by Subject|1
6946032|NCT00976209|10983934|FG001|Treatment Period 2|Lost to Follow-up|1
6946033|NCT00976274|10983946|FG000|Overall Study|Lost to Follow-up|5
6946034|NCT00976274|10983947|FG001|Overall Study|Lost to Follow-up|5
6946035|NCT00976274|10983946|FG000|Overall Study|Withdrawal by Subject|1
6946036|NCT00976274|10983947|FG001|Overall Study|Withdrawal by Subject|1
6946037|NCT00976274|10983946|FG000|Overall Study|Physician Decision|1
6946038|NCT00976274|10983947|FG001|Overall Study|Physician Decision|2
6946039|NCT00976391|10983968|FG000|Treatment Period (52 Weeks)|Adverse Event|16
6946040|NCT00976391|10983969|FG001|Treatment Period (52 Weeks)|Adverse Event|2
6946041|NCT00976391|10983968|FG000|Treatment Period (52 Weeks)|Protocol Violation|1
6946042|NCT00976391|10983969|FG001|Treatment Period (52 Weeks)|Protocol Violation|1
6946043|NCT00976391|10983968|FG000|Treatment Period (52 Weeks)|Noncompliance|4
6946044|NCT00976391|10983969|FG001|Treatment Period (52 Weeks)|Noncompliance|4
6946045|NCT00976391|10983968|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10
6946046|NCT00976391|10983969|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8
6946047|NCT00976391|10983968|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9
6946048|NCT00976391|10983969|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19
7068838|NCT01998893|11170687|FG000|Overall Study|Transformation to high-grade lymphoma|1
7068839|NCT01998906|11170694|FG000|Overall Study|Participants ongoing in follow-up|77
7068840|NCT01998906|11170695|FG001|Overall Study|Participants ongoing in follow-up|60
7068841|NCT01998906|11170696|FG002|Overall Study|Participants ongoing in follow-up|58
7068842|NCT01998906|11170694|FG000|Overall Study|Death|21
7068843|NCT01998906|11170695|FG001|Overall Study|Death|30
7068844|NCT01998906|11170696|FG002|Overall Study|Death|17
7068845|NCT01998906|11170694|FG000|Overall Study|Lack of Efficacy|10
7068846|NCT01998906|11170695|FG001|Overall Study|Lack of Efficacy|9
7068847|NCT01998906|11170696|FG002|Overall Study|Lack of Efficacy|8
7068848|NCT01998906|11170694|FG000|Overall Study|Failure to return|0
7068849|NCT01998906|11170695|FG001|Overall Study|Failure to return|2
7068850|NCT01998906|11170696|FG002|Overall Study|Failure to return|4
7068851|NCT01998906|11170694|FG000|Overall Study|Violation of Selection Criteria|0
7068852|NCT01998906|11170695|FG001|Overall Study|Violation of Selection Criteria|0
7068853|NCT01998906|11170696|FG002|Overall Study|Violation of Selection Criteria|1
7068854|NCT01998906|11170694|FG000|Overall Study|Withdrawal by Subject|1
7068855|NCT01998906|11170695|FG001|Overall Study|Withdrawal by Subject|4
7068856|NCT01998906|11170696|FG002|Overall Study|Withdrawal by Subject|3
7068857|NCT01998906|11170694|FG000|Overall Study|Administrative/Other|2
7068858|NCT01998906|11170695|FG001|Overall Study|Administrative/Other|1
7068859|NCT01998906|11170696|FG002|Overall Study|Administrative/Other|3
7068860|NCT01998906|11170694|FG000|Overall Study|Other|3
7068861|NCT01998906|11170695|FG001|Overall Study|Other|8
7068862|NCT01998906|11170696|FG002|Overall Study|Other|4
7068863|NCT01998919|11170709|FG000|Overall Study|Death|2
7068864|NCT01998919|11170710|FG001|Overall Study|Death|2
7068865|NCT01998919|11170709|FG000|Overall Study|Adverse Event|0
7068866|NCT01998919|11170710|FG001|Overall Study|Adverse Event|5
7068867|NCT01998919|11170709|FG000|Overall Study|Disease progression|31
7068868|NCT01998919|11170710|FG001|Overall Study|Disease progression|22
7068869|NCT01998919|11170709|FG000|Overall Study|Withdrawal by Subject|2
7068870|NCT01998919|11170710|FG001|Overall Study|Withdrawal by Subject|4
7068871|NCT01998919|11170709|FG000|Overall Study|Lost to Follow-up|2
7068872|NCT01998919|11170710|FG001|Overall Study|Lost to Follow-up|0
7068873|NCT01998919|11170709|FG000|Overall Study|Other|5
7068874|NCT01998919|11170710|FG001|Overall Study|Other|2
7068875|NCT01998958|11170723|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0
7068876|NCT01998958|11170724|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1
7068877|NCT01998958|11170725|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0
7068878|NCT01998958|11170726|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0
7068879|NCT01998958|11170727|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0
7068880|NCT01998958|11170728|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0
7068881|NCT01998958|11170729|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0
7068882|NCT01998958|11170730|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0
7068883|NCT01998958|11170731|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0
7068884|NCT01998958|11170732|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0
7068885|NCT01998958|11170733|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0
7068886|NCT01998958|11170734|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0
7068887|NCT01998958|11170735|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0
7068888|NCT01998958|11170736|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0
7068889|NCT01998958|11170737|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0
7068890|NCT01998958|11170738|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0
7068891|NCT01998958|11170739|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0
7068892|NCT01998958|11170740|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0
7068893|NCT01998958|11170741|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0
7068894|NCT01998958|11170742|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0
7068895|NCT01998958|11170743|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0
7068896|NCT01998958|11170744|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0
6946049|NCT00976391|10983968|FG000|Treatment Period (52 Weeks)|Physician Decision|1
7068897|NCT01998958|11170745|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0
7068898|NCT01998958|11170746|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0
7068899|NCT01998958|11170747|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0
7068900|NCT01998958|11170748|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0
7068901|NCT01998958|11170749|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0
6946050|NCT00976391|10983969|FG001|Treatment Period (52 Weeks)|Physician Decision|1
6946051|NCT00976391|10983968|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0
6946052|NCT00976391|10983969|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4
6946053|NCT00976391|10983968|FG000|Treatment Period (52 Weeks)|Pregnancy|1
6946054|NCT00976391|10983969|FG001|Treatment Period (52 Weeks)|Pregnancy|0
6946055|NCT00976391|10983968|FG000|Follow-up Period (8 Weeks)|Adverse Event|3
6946056|NCT00976391|10983969|FG001|Follow-up Period (8 Weeks)|Adverse Event|1
7068902|NCT01998958|11170750|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0
7068903|NCT01998958|11170751|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0
7068904|NCT01998958|11170752|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0
7068905|NCT01998958|11170753|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0
7068906|NCT01998958|11170754|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0
7068907|NCT01998958|11170723|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0
7068908|NCT01998958|11170724|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1
7068909|NCT01998958|11170725|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0
7068910|NCT01998958|11170726|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0
7068911|NCT01998958|11170727|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0
7068912|NCT01998958|11170728|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0
7068913|NCT01998958|11170729|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0
7068914|NCT01998958|11170730|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0
7068915|NCT01998958|11170731|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0
7068916|NCT01998958|11170732|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0
7068917|NCT01998958|11170733|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0
7068918|NCT01998958|11170734|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0
7068919|NCT01998958|11170735|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0
7068920|NCT01998958|11170736|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0
7068921|NCT01998958|11170737|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0
7068922|NCT01998958|11170738|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0
7068923|NCT01998958|11170739|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0
7068924|NCT01998958|11170740|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0
7068925|NCT01998958|11170741|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0
7068926|NCT01998958|11170742|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0
7068927|NCT01998958|11170743|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0
7068928|NCT01998958|11170744|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0
7068929|NCT01998958|11170745|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0
7068930|NCT01998958|11170746|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0
7068931|NCT01998958|11170747|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0
7068932|NCT01998958|11170748|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0
7068933|NCT01998958|11170749|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0
7068934|NCT01998958|11170750|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0
7068935|NCT01998958|11170751|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0
7068936|NCT01998958|11170752|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0
7068937|NCT01998958|11170753|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0
7068938|NCT01998958|11170754|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0
7068939|NCT01998958|11170723|FG000|Period 1 (Panel A and B)|Adverse Event|0
7068940|NCT01998958|11170724|FG001|Period 1 (Panel A and B)|Adverse Event|1
7068941|NCT01998958|11170725|FG002|Period 1 (Panel A and B)|Adverse Event|0
7068942|NCT01998958|11170726|FG003|Period 1 (Panel A and B)|Adverse Event|0
7068943|NCT01998958|11170727|FG004|Period 1 (Panel A and B)|Adverse Event|0
7068944|NCT01998958|11170728|FG005|Period 1 (Panel A and B)|Adverse Event|0
7068945|NCT01998958|11170729|FG006|Period 1 (Panel A and B)|Adverse Event|0
7068946|NCT01998958|11170730|FG007|Period 1 (Panel A and B)|Adverse Event|0
7068947|NCT01998958|11170731|FG008|Period 1 (Panel A and B)|Adverse Event|0
7068948|NCT01998958|11170732|FG009|Period 1 (Panel A and B)|Adverse Event|0
7068949|NCT01998958|11170733|FG010|Period 1 (Panel A and B)|Adverse Event|0
7068950|NCT01998958|11170734|FG011|Period 1 (Panel A and B)|Adverse Event|0
7068951|NCT01998958|11170735|FG012|Period 1 (Panel A and B)|Adverse Event|0
7068952|NCT01998958|11170736|FG013|Period 1 (Panel A and B)|Adverse Event|0
7068953|NCT01998958|11170737|FG014|Period 1 (Panel A and B)|Adverse Event|0
7068954|NCT01998958|11170738|FG015|Period 1 (Panel A and B)|Adverse Event|0
7068955|NCT01998958|11170739|FG016|Period 1 (Panel A and B)|Adverse Event|0
7068956|NCT01998958|11170740|FG017|Period 1 (Panel A and B)|Adverse Event|0
7068957|NCT01998958|11170741|FG018|Period 1 (Panel A and B)|Adverse Event|0
7068958|NCT01998958|11170742|FG019|Period 1 (Panel A and B)|Adverse Event|0
7068959|NCT01998958|11170743|FG020|Period 1 (Panel A and B)|Adverse Event|0
6946057|NCT00976391|10983968|FG000|Follow-up Period (8 Weeks)|Noncompliance|2
7068960|NCT01998958|11170744|FG021|Period 1 (Panel A and B)|Adverse Event|0
7068961|NCT01998958|11170745|FG022|Period 1 (Panel A and B)|Adverse Event|0
7068962|NCT01998958|11170746|FG023|Period 1 (Panel A and B)|Adverse Event|0
7068963|NCT01998958|11170747|FG024|Period 1 (Panel A and B)|Adverse Event|0
7068964|NCT01998958|11170748|FG025|Period 1 (Panel A and B)|Adverse Event|0
7068965|NCT01998958|11170749|FG026|Period 1 (Panel A and B)|Adverse Event|0
7068966|NCT01998958|11170750|FG027|Period 1 (Panel A and B)|Adverse Event|0
7068967|NCT01998958|11170751|FG028|Period 1 (Panel A and B)|Adverse Event|0
7068968|NCT01998958|11170752|FG029|Period 1 (Panel A and B)|Adverse Event|0
7068969|NCT01998958|11170753|FG030|Period 1 (Panel A and B)|Adverse Event|0
7068970|NCT01998958|11170754|FG031|Period 1 (Panel A and B)|Adverse Event|0
7068971|NCT01998958|11170723|FG000|Period 1 (Panel A and B)|Other|1
7068972|NCT01998958|11170724|FG001|Period 1 (Panel A and B)|Other|0
7068973|NCT01998958|11170725|FG002|Period 1 (Panel A and B)|Other|0
7068974|NCT01998958|11170726|FG003|Period 1 (Panel A and B)|Other|0
6946058|NCT00976391|10983969|FG001|Follow-up Period (8 Weeks)|Noncompliance|2
6946059|NCT00976391|10983968|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14
6946060|NCT00976391|10983969|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12
7068975|NCT01998958|11170727|FG004|Period 1 (Panel A and B)|Other|0
7068976|NCT01998958|11170728|FG005|Period 1 (Panel A and B)|Other|0
7068977|NCT01998958|11170729|FG006|Period 1 (Panel A and B)|Other|0
7068978|NCT01998958|11170730|FG007|Period 1 (Panel A and B)|Other|0
7068979|NCT01998958|11170731|FG008|Period 1 (Panel A and B)|Other|0
7068980|NCT01998958|11170732|FG009|Period 1 (Panel A and B)|Other|0
7068981|NCT01998958|11170733|FG010|Period 1 (Panel A and B)|Other|0
7068982|NCT01998958|11170734|FG011|Period 1 (Panel A and B)|Other|0
7068983|NCT01998958|11170735|FG012|Period 1 (Panel A and B)|Other|0
7068984|NCT01998958|11170736|FG013|Period 1 (Panel A and B)|Other|0
7068985|NCT01998958|11170737|FG014|Period 1 (Panel A and B)|Other|0
7068986|NCT01998958|11170738|FG015|Period 1 (Panel A and B)|Other|0
7068987|NCT01998958|11170739|FG016|Period 1 (Panel A and B)|Other|0
7068988|NCT01998958|11170740|FG017|Period 1 (Panel A and B)|Other|0
7068989|NCT01998958|11170741|FG018|Period 1 (Panel A and B)|Other|0
7068990|NCT01998958|11170742|FG019|Period 1 (Panel A and B)|Other|0
7068991|NCT01998958|11170743|FG020|Period 1 (Panel A and B)|Other|0
7068992|NCT01998958|11170744|FG021|Period 1 (Panel A and B)|Other|0
7068993|NCT01998958|11170745|FG022|Period 1 (Panel A and B)|Other|0
7068994|NCT01998958|11170746|FG023|Period 1 (Panel A and B)|Other|0
7068995|NCT01998958|11170747|FG024|Period 1 (Panel A and B)|Other|0
7068996|NCT01998958|11170748|FG025|Period 1 (Panel A and B)|Other|0
7068997|NCT01998958|11170749|FG026|Period 1 (Panel A and B)|Other|0
7068998|NCT01998958|11170750|FG027|Period 1 (Panel A and B)|Other|0
7068999|NCT01998958|11170751|FG028|Period 1 (Panel A and B)|Other|0
7069000|NCT01998958|11170752|FG029|Period 1 (Panel A and B)|Other|0
7069001|NCT01998958|11170753|FG030|Period 1 (Panel A and B)|Other|0
7069002|NCT01998958|11170754|FG031|Period 1 (Panel A and B)|Other|0
7069003|NCT01998958|11170723|FG000|Period 2 (Panel A and B)|Adverse Event|0
7069004|NCT01998958|11170724|FG001|Period 2 (Panel A and B)|Adverse Event|0
7069005|NCT01998958|11170725|FG002|Period 2 (Panel A and B)|Adverse Event|0
7069006|NCT01998958|11170726|FG003|Period 2 (Panel A and B)|Adverse Event|0
7069007|NCT01998958|11170727|FG004|Period 2 (Panel A and B)|Adverse Event|0
7069008|NCT01998958|11170728|FG005|Period 2 (Panel A and B)|Adverse Event|0
7069009|NCT01998958|11170729|FG006|Period 2 (Panel A and B)|Adverse Event|0
7069010|NCT01998958|11170730|FG007|Period 2 (Panel A and B)|Adverse Event|0
7069011|NCT01998958|11170731|FG008|Period 2 (Panel A and B)|Adverse Event|0
7069012|NCT01998958|11170732|FG009|Period 2 (Panel A and B)|Adverse Event|0
7069013|NCT01998958|11170733|FG010|Period 2 (Panel A and B)|Adverse Event|1
7069014|NCT01998958|11170734|FG011|Period 2 (Panel A and B)|Adverse Event|0
7069015|NCT01998958|11170735|FG012|Period 2 (Panel A and B)|Adverse Event|0
7069016|NCT01998958|11170736|FG013|Period 2 (Panel A and B)|Adverse Event|0
7069017|NCT01998958|11170737|FG014|Period 2 (Panel A and B)|Adverse Event|1
7069018|NCT01998958|11170738|FG015|Period 2 (Panel A and B)|Adverse Event|0
7069019|NCT01998958|11170739|FG016|Period 2 (Panel A and B)|Adverse Event|0
7069020|NCT01998958|11170740|FG017|Period 2 (Panel A and B)|Adverse Event|0
7069021|NCT01998958|11170741|FG018|Period 2 (Panel A and B)|Adverse Event|0
7069022|NCT01998958|11170742|FG019|Period 2 (Panel A and B)|Adverse Event|0
7069023|NCT01998958|11170743|FG020|Period 2 (Panel A and B)|Adverse Event|0
7069024|NCT01998958|11170744|FG021|Period 2 (Panel A and B)|Adverse Event|0
7069025|NCT01998958|11170745|FG022|Period 2 (Panel A and B)|Adverse Event|0
7069026|NCT01998958|11170746|FG023|Period 2 (Panel A and B)|Adverse Event|0
7069027|NCT01998958|11170747|FG024|Period 2 (Panel A and B)|Adverse Event|0
7069028|NCT01998958|11170748|FG025|Period 2 (Panel A and B)|Adverse Event|0
7069029|NCT01998958|11170749|FG026|Period 2 (Panel A and B)|Adverse Event|0
7069030|NCT01998958|11170750|FG027|Period 2 (Panel A and B)|Adverse Event|0
7069031|NCT01998958|11170751|FG028|Period 2 (Panel A and B)|Adverse Event|0
7069032|NCT01998958|11170752|FG029|Period 2 (Panel A and B)|Adverse Event|0
7069033|NCT01998958|11170753|FG030|Period 2 (Panel A and B)|Adverse Event|0
7069034|NCT01998958|11170754|FG031|Period 2 (Panel A and B)|Adverse Event|0
7069035|NCT01998958|11170723|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0
7069036|NCT01998958|11170724|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0
7069037|NCT01998958|11170725|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0
7069038|NCT01998958|11170726|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0
7069039|NCT01998958|11170727|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0
6946061|NCT00976391|10983968|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6
7069040|NCT01998958|11170728|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0
7069041|NCT01998958|11170729|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0
7069042|NCT01998958|11170730|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0
7069043|NCT01998958|11170731|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0
7069044|NCT01998958|11170732|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0
7069045|NCT01998958|11170733|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0
7069046|NCT01998958|11170734|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0
7069047|NCT01998958|11170735|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0
7069048|NCT01998958|11170736|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0
7069049|NCT01998958|11170737|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1
7069050|NCT01998958|11170738|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0
7069051|NCT01998958|11170739|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0
7082605|NCT02143713|11193214|FG003|Treatment Period (6 Months)|Adverse Event|9
6946062|NCT00976391|10983969|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8
6946063|NCT00976391|10983968|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
7069052|NCT01998958|11170740|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0
7069053|NCT01998958|11170741|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1
7069054|NCT01998958|11170742|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0
7069055|NCT01998958|11170743|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0
7069056|NCT01998958|11170744|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0
7069057|NCT01998958|11170745|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0
7069058|NCT01998958|11170746|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0
7069059|NCT01998958|11170747|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0
7069060|NCT01998958|11170748|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0
7069061|NCT01998958|11170749|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0
7069062|NCT01998958|11170750|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0
7069063|NCT01998958|11170751|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0
7069064|NCT01998958|11170752|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0
7069065|NCT01998958|11170753|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0
7069066|NCT01998958|11170754|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0
7069067|NCT01998958|11170723|FG000|Open Label Phase (Optional)|Adverse Event|0
7069068|NCT01998958|11170724|FG001|Open Label Phase (Optional)|Adverse Event|0
7069069|NCT01998958|11170725|FG002|Open Label Phase (Optional)|Adverse Event|0
7069070|NCT01998958|11170726|FG003|Open Label Phase (Optional)|Adverse Event|0
7069071|NCT01998958|11170727|FG004|Open Label Phase (Optional)|Adverse Event|0
7069072|NCT01998958|11170728|FG005|Open Label Phase (Optional)|Adverse Event|0
7069073|NCT01998958|11170729|FG006|Open Label Phase (Optional)|Adverse Event|0
7069074|NCT01998958|11170730|FG007|Open Label Phase (Optional)|Adverse Event|0
7069075|NCT01998958|11170731|FG008|Open Label Phase (Optional)|Adverse Event|0
7069076|NCT01998958|11170732|FG009|Open Label Phase (Optional)|Adverse Event|0
7069077|NCT01998958|11170733|FG010|Open Label Phase (Optional)|Adverse Event|0
7069078|NCT01998958|11170734|FG011|Open Label Phase (Optional)|Adverse Event|0
7069079|NCT01998958|11170735|FG012|Open Label Phase (Optional)|Adverse Event|0
7069080|NCT01998958|11170736|FG013|Open Label Phase (Optional)|Adverse Event|0
7069081|NCT01998958|11170737|FG014|Open Label Phase (Optional)|Adverse Event|0
7069082|NCT01998958|11170738|FG015|Open Label Phase (Optional)|Adverse Event|0
7069083|NCT01998958|11170739|FG016|Open Label Phase (Optional)|Adverse Event|0
7069084|NCT01998958|11170740|FG017|Open Label Phase (Optional)|Adverse Event|0
7069085|NCT01998958|11170741|FG018|Open Label Phase (Optional)|Adverse Event|0
7069086|NCT01998958|11170742|FG019|Open Label Phase (Optional)|Adverse Event|0
7069087|NCT01998958|11170743|FG020|Open Label Phase (Optional)|Adverse Event|0
7069088|NCT01998958|11170744|FG021|Open Label Phase (Optional)|Adverse Event|0
7069089|NCT01998958|11170745|FG022|Open Label Phase (Optional)|Adverse Event|0
7069090|NCT01998958|11170746|FG023|Open Label Phase (Optional)|Adverse Event|1
7069091|NCT01998958|11170747|FG024|Open Label Phase (Optional)|Adverse Event|0
7069092|NCT01998958|11170748|FG025|Open Label Phase (Optional)|Adverse Event|0
7069093|NCT01998958|11170749|FG026|Open Label Phase (Optional)|Adverse Event|0
7069094|NCT01998958|11170750|FG027|Open Label Phase (Optional)|Adverse Event|0
7069095|NCT01998958|11170751|FG028|Open Label Phase (Optional)|Adverse Event|0
7069096|NCT01998958|11170752|FG029|Open Label Phase (Optional)|Adverse Event|0
7069097|NCT01998958|11170753|FG030|Open Label Phase (Optional)|Adverse Event|0
7069098|NCT01998958|11170754|FG031|Open Label Phase (Optional)|Adverse Event|0
7069099|NCT01998958|11170723|FG000|Open Label Phase (Optional)|Other|0
7069100|NCT01998958|11170724|FG001|Open Label Phase (Optional)|Other|0
7069101|NCT01998958|11170725|FG002|Open Label Phase (Optional)|Other|0
7069102|NCT01998958|11170726|FG003|Open Label Phase (Optional)|Other|0
7069103|NCT01998958|11170727|FG004|Open Label Phase (Optional)|Other|0
7069104|NCT01998958|11170728|FG005|Open Label Phase (Optional)|Other|0
7069105|NCT01998958|11170729|FG006|Open Label Phase (Optional)|Other|0
7069106|NCT01998958|11170730|FG007|Open Label Phase (Optional)|Other|0
7069107|NCT01998958|11170731|FG008|Open Label Phase (Optional)|Other|0
7069108|NCT01998958|11170732|FG009|Open Label Phase (Optional)|Other|0
7069109|NCT01998958|11170733|FG010|Open Label Phase (Optional)|Other|0
7069110|NCT01998958|11170734|FG011|Open Label Phase (Optional)|Other|0
7069111|NCT01998958|11170735|FG012|Open Label Phase (Optional)|Other|0
7069112|NCT01998958|11170736|FG013|Open Label Phase (Optional)|Other|0
7069113|NCT01998958|11170737|FG014|Open Label Phase (Optional)|Other|0
7069114|NCT01998958|11170738|FG015|Open Label Phase (Optional)|Other|0
7069115|NCT01998958|11170739|FG016|Open Label Phase (Optional)|Other|0
7069116|NCT01998958|11170740|FG017|Open Label Phase (Optional)|Other|0
7069117|NCT01998958|11170741|FG018|Open Label Phase (Optional)|Other|0
7069118|NCT01998958|11170742|FG019|Open Label Phase (Optional)|Other|0
7069119|NCT01998958|11170743|FG020|Open Label Phase (Optional)|Other|0
7069120|NCT01998958|11170744|FG021|Open Label Phase (Optional)|Other|0
7069121|NCT01998958|11170745|FG022|Open Label Phase (Optional)|Other|5
7069122|NCT01998958|11170746|FG023|Open Label Phase (Optional)|Other|1
7069123|NCT01998958|11170747|FG024|Open Label Phase (Optional)|Other|0
7069124|NCT01998958|11170748|FG025|Open Label Phase (Optional)|Other|0
7069125|NCT01998958|11170749|FG026|Open Label Phase (Optional)|Other|0
7069126|NCT01998958|11170750|FG027|Open Label Phase (Optional)|Other|0
7069127|NCT01998958|11170751|FG028|Open Label Phase (Optional)|Other|0
7069128|NCT01998958|11170752|FG029|Open Label Phase (Optional)|Other|0
7069129|NCT01998958|11170753|FG030|Open Label Phase (Optional)|Other|0
7069130|NCT01998958|11170754|FG031|Open Label Phase (Optional)|Other|0
7069131|NCT01998958|11170723|FG000|Open Label Phase (Optional)|Lost to Follow-up|0
6946064|NCT00976391|10983969|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7
6946065|NCT00976391|10983968|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
6946066|NCT00976391|10983969|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
6946067|NCT00976456|10983988|FG000|Overall Study|Adverse Event|17
6946068|NCT00976456|10983989|FG001|Overall Study|Adverse Event|22
6946069|NCT00976456|10983988|FG000|Overall Study|Death|7
6946070|NCT00976456|10983989|FG001|Overall Study|Death|9
6946071|NCT00976456|10983988|FG000|Overall Study|Lack of Efficacy|5
6946072|NCT00976456|10983989|FG001|Overall Study|Lack of Efficacy|2
6946073|NCT00976456|10983988|FG000|Overall Study|Withdrawal by Subject|3
6946074|NCT00976456|10983989|FG001|Overall Study|Withdrawal by Subject|1
6946075|NCT00976456|10983988|FG000|Overall Study|screening failure, unknown|11
6946076|NCT00976456|10983989|FG001|Overall Study|screening failure, unknown|4
6946077|NCT00976482|10983995|FG000|Overall Study|Death|208
6946078|NCT00976482|10983995|FG000|Overall Study|Withdrawal by Subject|45
6946079|NCT00976482|10983995|FG000|Overall Study|Center terminated|1
6946080|NCT00976482|10983995|FG000|Overall Study|Protocol Violation|5
6946081|NCT00976495|10984002|FG000|Overall Study|Withdrawal by Subject|0
6946082|NCT00976495|10984003|FG001|Overall Study|Withdrawal by Subject|1
6946083|NCT00976495|10984004|FG002|Overall Study|Withdrawal by Subject|0
6946084|NCT00976508|10984014|FG000|Overall Study|Death|7
6946085|NCT00976508|10984015|FG001|Overall Study|Death|1
6946086|NCT00976508|10984014|FG000|Overall Study|Lost to Follow-up|1
6946087|NCT00976508|10984015|FG001|Overall Study|Lost to Follow-up|0
6946088|NCT00976508|10984014|FG000|Overall Study|Withdrawal by Subject|1
6946089|NCT00976508|10984015|FG001|Overall Study|Withdrawal by Subject|0
6946090|NCT00976508|10984014|FG000|Overall Study|Disease Progression|4
6946091|NCT00976508|10984015|FG001|Overall Study|Disease Progression|4
6946092|NCT00976508|10984014|FG000|Overall Study|Subject Enrolled in Hospice|1
6946093|NCT00976508|10984015|FG001|Overall Study|Subject Enrolled in Hospice|0
6946094|NCT00976508|10984014|FG000|Overall Study|Terminated by the Sponsor|0
6946095|NCT00976508|10984015|FG001|Overall Study|Terminated by the Sponsor|1
6946096|NCT00976560|10984044|FG000|Overall Study|Adverse Event|5
7069132|NCT01998958|11170724|FG001|Open Label Phase (Optional)|Lost to Follow-up|0
7069133|NCT01998958|11170725|FG002|Open Label Phase (Optional)|Lost to Follow-up|0
7069134|NCT01998958|11170726|FG003|Open Label Phase (Optional)|Lost to Follow-up|0
7069135|NCT01998958|11170727|FG004|Open Label Phase (Optional)|Lost to Follow-up|0
7069136|NCT01998958|11170728|FG005|Open Label Phase (Optional)|Lost to Follow-up|0
7069137|NCT01998958|11170729|FG006|Open Label Phase (Optional)|Lost to Follow-up|0
7069138|NCT01998958|11170730|FG007|Open Label Phase (Optional)|Lost to Follow-up|0
7069139|NCT01998958|11170731|FG008|Open Label Phase (Optional)|Lost to Follow-up|0
7069140|NCT01998958|11170732|FG009|Open Label Phase (Optional)|Lost to Follow-up|0
7069141|NCT01998958|11170733|FG010|Open Label Phase (Optional)|Lost to Follow-up|0
7069142|NCT01998958|11170734|FG011|Open Label Phase (Optional)|Lost to Follow-up|0
7069143|NCT01998958|11170735|FG012|Open Label Phase (Optional)|Lost to Follow-up|0
7069144|NCT01998958|11170736|FG013|Open Label Phase (Optional)|Lost to Follow-up|0
7069145|NCT01998958|11170737|FG014|Open Label Phase (Optional)|Lost to Follow-up|0
7069146|NCT01998958|11170738|FG015|Open Label Phase (Optional)|Lost to Follow-up|0
7069147|NCT01998958|11170739|FG016|Open Label Phase (Optional)|Lost to Follow-up|0
7069148|NCT01998958|11170740|FG017|Open Label Phase (Optional)|Lost to Follow-up|0
7069149|NCT01998958|11170741|FG018|Open Label Phase (Optional)|Lost to Follow-up|0
7069150|NCT01998958|11170742|FG019|Open Label Phase (Optional)|Lost to Follow-up|0
7069151|NCT01998958|11170743|FG020|Open Label Phase (Optional)|Lost to Follow-up|0
7069152|NCT01998958|11170744|FG021|Open Label Phase (Optional)|Lost to Follow-up|0
7069153|NCT01998958|11170745|FG022|Open Label Phase (Optional)|Lost to Follow-up|1
7069154|NCT01998958|11170746|FG023|Open Label Phase (Optional)|Lost to Follow-up|0
7069155|NCT01998958|11170747|FG024|Open Label Phase (Optional)|Lost to Follow-up|0
7069156|NCT01998958|11170748|FG025|Open Label Phase (Optional)|Lost to Follow-up|0
7069157|NCT01998958|11170749|FG026|Open Label Phase (Optional)|Lost to Follow-up|0
7069158|NCT01998958|11170750|FG027|Open Label Phase (Optional)|Lost to Follow-up|0
7069159|NCT01998958|11170751|FG028|Open Label Phase (Optional)|Lost to Follow-up|0
7069160|NCT01998958|11170752|FG029|Open Label Phase (Optional)|Lost to Follow-up|0
7069161|NCT01998958|11170753|FG030|Open Label Phase (Optional)|Lost to Follow-up|0
7069162|NCT01998958|11170754|FG031|Open Label Phase (Optional)|Lost to Follow-up|0
7069163|NCT01998958|11170723|FG000|Open Label Phase (Optional)|Lack of Efficacy|0
7069164|NCT01998958|11170724|FG001|Open Label Phase (Optional)|Lack of Efficacy|0
7069165|NCT01998958|11170725|FG002|Open Label Phase (Optional)|Lack of Efficacy|0
7069166|NCT01998958|11170726|FG003|Open Label Phase (Optional)|Lack of Efficacy|0
7069167|NCT01998958|11170727|FG004|Open Label Phase (Optional)|Lack of Efficacy|0
7069168|NCT01998958|11170728|FG005|Open Label Phase (Optional)|Lack of Efficacy|0
7069169|NCT01998958|11170729|FG006|Open Label Phase (Optional)|Lack of Efficacy|0
7069170|NCT01998958|11170730|FG007|Open Label Phase (Optional)|Lack of Efficacy|0
7069171|NCT01998958|11170731|FG008|Open Label Phase (Optional)|Lack of Efficacy|0
6946097|NCT00976560|10984045|FG001|Overall Study|Adverse Event|5
7069172|NCT01998958|11170732|FG009|Open Label Phase (Optional)|Lack of Efficacy|0
7069173|NCT01998958|11170733|FG010|Open Label Phase (Optional)|Lack of Efficacy|0
7069174|NCT01998958|11170734|FG011|Open Label Phase (Optional)|Lack of Efficacy|0
7069175|NCT01998958|11170735|FG012|Open Label Phase (Optional)|Lack of Efficacy|0
7069176|NCT01998958|11170736|FG013|Open Label Phase (Optional)|Lack of Efficacy|0
7069177|NCT01998958|11170737|FG014|Open Label Phase (Optional)|Lack of Efficacy|0
7069178|NCT01998958|11170738|FG015|Open Label Phase (Optional)|Lack of Efficacy|0
7069179|NCT01998958|11170739|FG016|Open Label Phase (Optional)|Lack of Efficacy|0
7069180|NCT01998958|11170740|FG017|Open Label Phase (Optional)|Lack of Efficacy|0
7069181|NCT01998958|11170741|FG018|Open Label Phase (Optional)|Lack of Efficacy|0
7069182|NCT01998958|11170742|FG019|Open Label Phase (Optional)|Lack of Efficacy|0
7069183|NCT01998958|11170743|FG020|Open Label Phase (Optional)|Lack of Efficacy|0
7069184|NCT01998958|11170744|FG021|Open Label Phase (Optional)|Lack of Efficacy|1
7069185|NCT01998958|11170745|FG022|Open Label Phase (Optional)|Lack of Efficacy|2
7069186|NCT01998958|11170746|FG023|Open Label Phase (Optional)|Lack of Efficacy|0
7069187|NCT01998958|11170747|FG024|Open Label Phase (Optional)|Lack of Efficacy|0
7069188|NCT01998958|11170748|FG025|Open Label Phase (Optional)|Lack of Efficacy|0
7069189|NCT01998958|11170749|FG026|Open Label Phase (Optional)|Lack of Efficacy|0
7069190|NCT01998958|11170750|FG027|Open Label Phase (Optional)|Lack of Efficacy|0
7069191|NCT01998958|11170751|FG028|Open Label Phase (Optional)|Lack of Efficacy|0
7069192|NCT01998958|11170752|FG029|Open Label Phase (Optional)|Lack of Efficacy|0
7069193|NCT01998958|11170753|FG030|Open Label Phase (Optional)|Lack of Efficacy|0
7069194|NCT01998958|11170754|FG031|Open Label Phase (Optional)|Lack of Efficacy|0
7069195|NCT01998958|11170723|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0
7069196|NCT01998958|11170724|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0
7069197|NCT01998958|11170725|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0
7069198|NCT01998958|11170726|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0
7069199|NCT01998958|11170727|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0
7069200|NCT01998958|11170728|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0
7069201|NCT01998958|11170729|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0
7069202|NCT01998958|11170730|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0
7069203|NCT01998958|11170731|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0
7069204|NCT01998958|11170732|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0
7069205|NCT01998958|11170733|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0
7069206|NCT01998958|11170734|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0
7069207|NCT01998958|11170735|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0
7069208|NCT01998958|11170736|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0
7069209|NCT01998958|11170737|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0
7069210|NCT01998958|11170738|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0
7069211|NCT01998958|11170739|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0
7069212|NCT01998958|11170740|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0
7069213|NCT01998958|11170741|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0
7069214|NCT01998958|11170742|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0
7069215|NCT01998958|11170743|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0
7069216|NCT01998958|11170744|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2
7069217|NCT01998958|11170745|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1
7069218|NCT01998958|11170746|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2
7069219|NCT01998958|11170747|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0
7069220|NCT01998958|11170748|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0
7069221|NCT01998958|11170749|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0
7069222|NCT01998958|11170750|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0
7069223|NCT01998958|11170751|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0
7069224|NCT01998958|11170752|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0
7069225|NCT01998958|11170753|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0
7069226|NCT01998958|11170754|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0
7069227|NCT01998984|11170808|FG000|Overall Study|Adverse Event|0
7069228|NCT01998984|11170809|FG001|Overall Study|Adverse Event|0
7069229|NCT01998984|11170810|FG002|Overall Study|Adverse Event|0
7069230|NCT01998984|11170811|FG003|Overall Study|Adverse Event|1
7069231|NCT01998984|11170808|FG000|Overall Study|Lost to Follow-up|0
7069232|NCT01998984|11170809|FG001|Overall Study|Lost to Follow-up|1
7069233|NCT01998984|11170810|FG002|Overall Study|Lost to Follow-up|0
7069234|NCT01998984|11170811|FG003|Overall Study|Lost to Follow-up|1
7069235|NCT01998984|11170808|FG000|Overall Study|Withdrawal by Subject|0
7069236|NCT01998984|11170809|FG001|Overall Study|Withdrawal by Subject|0
7069237|NCT01998984|11170810|FG002|Overall Study|Withdrawal by Subject|1
7069238|NCT01998984|11170811|FG003|Overall Study|Withdrawal by Subject|0
7069239|NCT01998984|11170808|FG000|Overall Study|Other|0
7069240|NCT01998984|11170809|FG001|Overall Study|Other|0
7069241|NCT01998984|11170810|FG002|Overall Study|Other|0
7069242|NCT01998984|11170811|FG003|Overall Study|Other|1
7069243|NCT01999114|11170826|FG000|Overall Study|Adverse Event|8
7069244|NCT01999114|11170827|FG001|Overall Study|Adverse Event|7
7069245|NCT01999114|11170828|FG002|Overall Study|Adverse Event|2
7069246|NCT01999114|11170829|FG003|Overall Study|Adverse Event|2
7069247|NCT01999114|11170830|FG004|Overall Study|Adverse Event|1
7069248|NCT01999114|11170826|FG000|Overall Study|Withdrawal by Subject|0
7069249|NCT01999114|11170827|FG001|Overall Study|Withdrawal by Subject|0
7069250|NCT01999114|11170828|FG002|Overall Study|Withdrawal by Subject|1
7069251|NCT01999114|11170829|FG003|Overall Study|Withdrawal by Subject|0
7069252|NCT01999114|11170830|FG004|Overall Study|Withdrawal by Subject|1
7069253|NCT01999114|11170826|FG000|Overall Study|Lost to Follow-up|0
7069254|NCT01999114|11170827|FG001|Overall Study|Lost to Follow-up|0
7069255|NCT01999114|11170828|FG002|Overall Study|Lost to Follow-up|1
7069256|NCT01999114|11170829|FG003|Overall Study|Lost to Follow-up|0
7069257|NCT01999114|11170830|FG004|Overall Study|Lost to Follow-up|0
7069258|NCT01999114|11170826|FG000|Overall Study|Administrative|0
7069259|NCT01999114|11170827|FG001|Overall Study|Administrative|0
7069260|NCT01999114|11170828|FG002|Overall Study|Administrative|1
7069261|NCT01999114|11170829|FG003|Overall Study|Administrative|1
7069262|NCT01999114|11170830|FG004|Overall Study|Administrative|2
7069263|NCT01999218|11170876|FG000|Overall Study|Hyperglycemia|18
7069264|NCT01999218|11170877|FG001|Overall Study|Hyperglycemia|17
7069265|NCT01999218|11170878|FG002|Overall Study|Hyperglycemia|17
6946098|NCT00976560|10984044|FG000|Overall Study|Lack of Efficacy|3
6946099|NCT00976560|10984045|FG001|Overall Study|Lack of Efficacy|5
6946100|NCT00976560|10984044|FG000|Overall Study|Protocol Violation|1
6946101|NCT00976560|10984045|FG001|Overall Study|Protocol Violation|0
6946102|NCT00976560|10984044|FG000|Overall Study|Lost to Follow-up|1
6946103|NCT00976560|10984045|FG001|Overall Study|Lost to Follow-up|0
6946104|NCT00976560|10984044|FG000|Overall Study|Physician Decision|2
6946105|NCT00976560|10984045|FG001|Overall Study|Physician Decision|0
6946106|NCT00976560|10984044|FG000|Overall Study|Withdrawal by Subject|2
6946107|NCT00976560|10984045|FG001|Overall Study|Withdrawal by Subject|3
6946108|NCT00976573|10984053|FG000|Overall Study|Ineligible|0
6946109|NCT00976573|10984054|FG001|Overall Study|Ineligible|1
6946110|NCT00976573|10984053|FG000|Overall Study|Cancel prior to receiving treatment|4
6946111|NCT00976573|10984054|FG001|Overall Study|Cancel prior to receiving treatment|2
6946112|NCT00976677|10984080|FG000|Overall Study|Adverse Event|1
6946113|NCT00976677|10984081|FG001|Overall Study|Adverse Event|0
6946114|NCT00976677|10984080|FG000|Overall Study|Withdrawal by Subject|0
6946115|NCT00976677|10984081|FG001|Overall Study|Withdrawal by Subject|2
6946116|NCT00976677|10984080|FG000|Overall Study|Disease progression|1
6946117|NCT00976677|10984081|FG001|Overall Study|Disease progression|1
6946118|NCT00976677|10984080|FG000|Overall Study|Trial unblinded|2
6946119|NCT00976677|10984081|FG001|Overall Study|Trial unblinded|2
6946120|NCT00976677|10984080|FG000|Overall Study|Unknown/Missing|1
6946121|NCT00976677|10984081|FG001|Overall Study|Unknown/Missing|0
6946122|NCT00976703|10984089|FG000|Overall Study|Physician Decision|1
6946123|NCT00976703|10984090|FG001|Overall Study|Physician Decision|1
6946124|NCT00976703|10984089|FG000|Overall Study|ineligible for study|2
6946125|NCT00976703|10984090|FG001|Overall Study|ineligible for study|2
6946126|NCT00976716|10984096|FG000|Overall Study|Adverse Event|1
6946127|NCT00976820|10984105|FG000|Overall Study|Lost to Follow-up|5
6946128|NCT00976820|10984106|FG001|Overall Study|Lost to Follow-up|16
6946129|NCT00976820|10984107|FG002|Overall Study|Lost to Follow-up|2
6946130|NCT00976820|10984108|FG003|Overall Study|Lost to Follow-up|3
6946131|NCT00976820|10984105|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1
6946132|NCT00976820|10984106|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0
6946133|NCT00976820|10984107|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1
6946134|NCT00976820|10984108|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0
6946135|NCT00976820|10984105|FG000|Overall Study|Withdrawal by Subject|2
6946136|NCT00976820|10984106|FG001|Overall Study|Withdrawal by Subject|4
6946137|NCT00976820|10984107|FG002|Overall Study|Withdrawal by Subject|1
6946138|NCT00976820|10984108|FG003|Overall Study|Withdrawal by Subject|4
6946139|NCT00976898|10984159|FG000|Overall Study|Protocol Violation|1
6946140|NCT00976898|10984159|FG000|Overall Study|Adverse Event|1
6946141|NCT00976898|10984159|FG000|Overall Study|Physician Decision|1
6946142|NCT00976898|10984159|FG000|Overall Study|Liver Transplant|1
6946143|NCT00976898|10984159|FG000|Overall Study|Progressive Disease|1
6946144|NCT00976937|10984165|FG000|Overall Study|Adverse Event|4
6946145|NCT00976937|10984166|FG001|Overall Study|Adverse Event|5
6946146|NCT00976937|10984165|FG000|Overall Study|Lost to Follow-up|2
6946147|NCT00976937|10984166|FG001|Overall Study|Lost to Follow-up|1
6946148|NCT00976937|10984165|FG000|Overall Study|Withdrawal by Subject|5
6946149|NCT00976937|10984166|FG001|Overall Study|Withdrawal by Subject|3
6946150|NCT00976937|10984165|FG000|Overall Study|Poor compliance to protocol|3
6946151|NCT00976937|10984166|FG001|Overall Study|Poor compliance to protocol|0
6946152|NCT00976937|10984165|FG000|Overall Study|Personal and Familial Reason|2
6946153|NCT00976937|10984166|FG001|Overall Study|Personal and Familial Reason|2
6946154|NCT00976950|10984172|FG000|Overall Study|Adverse Event|3
6946155|NCT00976950|10984172|FG000|Overall Study|Events with no relationship to Aptivus|3
6946156|NCT00976989|10984179|FG000|Overall Study|Violation of Selection Criteria at Entry|1
6946157|NCT00976989|10984180|FG001|Overall Study|Violation of Selection Criteria at Entry|0
6946158|NCT00976989|10984181|FG002|Overall Study|Violation of Selection Criteria at Entry|1
6946159|NCT00976989|10984179|FG000|Overall Study|Death|5
6946160|NCT00976989|10984180|FG001|Overall Study|Death|7
6946161|NCT00976989|10984181|FG002|Overall Study|Death|10
6946162|NCT00976989|10984179|FG000|Overall Study|Refused Treatment|4
6946163|NCT00976989|10984180|FG001|Overall Study|Refused Treatment|3
6946164|NCT00976989|10984181|FG002|Overall Study|Refused Treatment|5
6946165|NCT00976989|10984179|FG000|Overall Study|Failure to Return|2
6946166|NCT00976989|10984180|FG001|Overall Study|Failure to Return|1
7069266|NCT01999218|11170876|FG000|Overall Study|Lack of Efficacy|1
7069267|NCT01999218|11170877|FG001|Overall Study|Lack of Efficacy|0
7069268|NCT01999218|11170878|FG002|Overall Study|Lack of Efficacy|1
7040712|NCT01719380|11123792|FG009|Overall Study|Participant/Guardian Decision|2
7040713|NCT01719380|11123783|FG000|Overall Study|Physician Decision|0
7040714|NCT01719380|11123784|FG001|Overall Study|Physician Decision|0
7040715|NCT01719380|11123785|FG002|Overall Study|Physician Decision|2
7040716|NCT01719380|11123786|FG003|Overall Study|Physician Decision|0
7040717|NCT01719380|11123787|FG004|Overall Study|Physician Decision|0
7040718|NCT01719380|11123788|FG005|Overall Study|Physician Decision|0
7040719|NCT01719380|11123789|FG006|Overall Study|Physician Decision|0
7040720|NCT01719380|11123790|FG007|Overall Study|Physician Decision|0
7040721|NCT01719380|11123791|FG008|Overall Study|Physician Decision|1
7040722|NCT01719380|11123792|FG009|Overall Study|Physician Decision|1
7040723|NCT01719380|11123783|FG000|Overall Study|Lack of Efficacy|2
7040724|NCT01719380|11123784|FG001|Overall Study|Lack of Efficacy|6
7040725|NCT01719380|11123785|FG002|Overall Study|Lack of Efficacy|5
7040726|NCT01719380|11123786|FG003|Overall Study|Lack of Efficacy|6
7040727|NCT01719380|11123787|FG004|Overall Study|Lack of Efficacy|3
7040728|NCT01719380|11123788|FG005|Overall Study|Lack of Efficacy|7
7040729|NCT01719380|11123789|FG006|Overall Study|Lack of Efficacy|10
6946167|NCT00976989|10984181|FG002|Overall Study|Failure to Return|0
6946168|NCT00976989|10984179|FG000|Overall Study|Recurrence of Disease|0
6946169|NCT00976989|10984180|FG001|Overall Study|Recurrence of Disease|1
6946170|NCT00976989|10984181|FG002|Overall Study|Recurrence of Disease|0
6946171|NCT00976989|10984179|FG000|Overall Study|Other|1
6946172|NCT00976989|10984180|FG001|Overall Study|Other|0
6946173|NCT00976989|10984181|FG002|Overall Study|Other|1
6946174|NCT00977080|10984193|FG000|Overall Study|Adverse Event|2
6946175|NCT00977080|10984194|FG001|Overall Study|Adverse Event|7
6946176|NCT00977080|10984195|FG002|Overall Study|Adverse Event|7
6946177|NCT00977080|10984196|FG003|Overall Study|Adverse Event|7
6946178|NCT00977080|10984193|FG000|Overall Study|Withdrawal by Subject|1
6946179|NCT00977080|10984194|FG001|Overall Study|Withdrawal by Subject|5
6946180|NCT00977080|10984195|FG002|Overall Study|Withdrawal by Subject|1
6946181|NCT00977080|10984196|FG003|Overall Study|Withdrawal by Subject|5
6946182|NCT00977080|10984193|FG000|Overall Study|Protocol Violation|7
6946183|NCT00977080|10984194|FG001|Overall Study|Protocol Violation|3
6946184|NCT00977080|10984195|FG002|Overall Study|Protocol Violation|4
6946185|NCT00977080|10984196|FG003|Overall Study|Protocol Violation|3
6946186|NCT00977080|10984193|FG000|Overall Study|Noncompliance|0
6946187|NCT00977080|10984194|FG001|Overall Study|Noncompliance|2
6946188|NCT00977080|10984195|FG002|Overall Study|Noncompliance|1
6946189|NCT00977080|10984196|FG003|Overall Study|Noncompliance|0
6946190|NCT00977080|10984193|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
6946191|NCT00977080|10984194|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
6946192|NCT00977080|10984195|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
6946193|NCT00977080|10984196|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1
6946194|NCT00977080|10984193|FG000|Overall Study|Required kidney transplantation|1
6946195|NCT00977080|10984194|FG001|Overall Study|Required kidney transplantation|3
6946196|NCT00977080|10984195|FG002|Overall Study|Required kidney transplantation|3
6946197|NCT00977080|10984196|FG003|Overall Study|Required kidney transplantation|1
6946198|NCT00977080|10984193|FG000|Overall Study|Travel for family reasons|1
6946199|NCT00977080|10984194|FG001|Overall Study|Travel for family reasons|0
6946200|NCT00977080|10984195|FG002|Overall Study|Travel for family reasons|0
6946201|NCT00977080|10984196|FG003|Overall Study|Travel for family reasons|0
6946202|NCT00977106|10984208|FG000|Overall Study|Adverse Event|5
6946203|NCT00977106|10984209|FG001|Overall Study|Adverse Event|6
6946204|NCT00977106|10984208|FG000|Overall Study|Withdrawal by Subject|2
6946205|NCT00977106|10984209|FG001|Overall Study|Withdrawal by Subject|2
6946206|NCT00977106|10984208|FG000|Overall Study|Lack of Efficacy|2
6946207|NCT00977106|10984209|FG001|Overall Study|Lack of Efficacy|2
6946208|NCT00977106|10984208|FG000|Overall Study|Protocol Violation|0
6946209|NCT00977106|10984209|FG001|Overall Study|Protocol Violation|1
6946210|NCT00977106|10984208|FG000|Overall Study|Other|1
6946211|NCT00977106|10984209|FG001|Overall Study|Other|0
6946212|NCT00977197|10984239|FG000|Overall Study|Withdrawal by Subject|3
6946213|NCT00977197|10984240|FG001|Overall Study|Withdrawal by Subject|4
6946214|NCT00977197|10984239|FG000|Overall Study|Adverse Event|3
6946215|NCT00977197|10984240|FG001|Overall Study|Adverse Event|1
6946216|NCT00977197|10984239|FG000|Overall Study|Lack of Efficacy|1
6946217|NCT00977197|10984240|FG001|Overall Study|Lack of Efficacy|0
6946218|NCT00977197|10984239|FG000|Overall Study|Lost to Follow-up|1
6946219|NCT00977197|10984240|FG001|Overall Study|Lost to Follow-up|3
6946220|NCT00977197|10984239|FG000|Overall Study|Nonadherence|1
6946221|NCT00977197|10984240|FG001|Overall Study|Nonadherence|1
6946222|NCT00977314|10984248|FG000|Overall Study|Withdrawal by Subject|1
6946223|NCT00977314|10984249|FG001|Overall Study|Withdrawal by Subject|0
6946224|NCT00977314|10984248|FG000|Overall Study|Physician Decision|1
6946225|NCT00977314|10984249|FG001|Overall Study|Physician Decision|0
6946226|NCT00977379|10984257|FG000|Overall Study|Withdrawal by Subject|1
7040730|NCT01719380|11123790|FG007|Overall Study|Lack of Efficacy|6
7040731|NCT01719380|11123791|FG008|Overall Study|Lack of Efficacy|39
6946227|NCT00977379|10984258|FG001|Overall Study|Withdrawal by Subject|1
6946228|NCT00977379|10984257|FG000|Overall Study|Death|7
6946229|NCT00977379|10984258|FG001|Overall Study|Death|9
6946230|NCT00977379|10984257|FG000|Overall Study|Premature Study Termination|4
6946231|NCT00977379|10984258|FG001|Overall Study|Premature Study Termination|0
6946232|NCT00977379|10984257|FG000|Overall Study|Participant Moving House|0
6946233|NCT00977379|10984258|FG001|Overall Study|Participant Moving House|1
6946234|NCT00977379|10984257|FG000|Overall Study|Randomization Error|0
6946235|NCT00977379|10984258|FG001|Overall Study|Randomization Error|1
6946236|NCT00977431|10984269|FG000|Overall Study|Other than listed|1
6946237|NCT00977431|10984270|FG001|Overall Study|Other than listed|0
6946238|NCT00977431|10984271|FG002|Overall Study|Other than listed|0
6946239|NCT00977431|10984272|FG003|Overall Study|Other than listed|0
6946240|NCT00977431|10984273|FG004|Overall Study|Other than listed|2
6946241|NCT00977431|10984269|FG000|Overall Study|Protocol Violation|0
6946242|NCT00977431|10984270|FG001|Overall Study|Protocol Violation|0
6946243|NCT00977431|10984271|FG002|Overall Study|Protocol Violation|1
6946244|NCT00977431|10984272|FG003|Overall Study|Protocol Violation|0
6946245|NCT00977431|10984273|FG004|Overall Study|Protocol Violation|0
6946246|NCT00977431|10984269|FG000|Overall Study|Adverse Event|3
6946247|NCT00977431|10984270|FG001|Overall Study|Adverse Event|0
6946248|NCT00977431|10984271|FG002|Overall Study|Adverse Event|4
6946249|NCT00977431|10984272|FG003|Overall Study|Adverse Event|0
6946250|NCT00977431|10984273|FG004|Overall Study|Adverse Event|6
6946251|NCT00977431|10984269|FG000|Overall Study|Dose-limiting toxicity (DLT)|1
6946252|NCT00977431|10984270|FG001|Overall Study|Dose-limiting toxicity (DLT)|0
6946253|NCT00977431|10984271|FG002|Overall Study|Dose-limiting toxicity (DLT)|1
6946254|NCT00977431|10984272|FG003|Overall Study|Dose-limiting toxicity (DLT)|0
6946255|NCT00977431|10984273|FG004|Overall Study|Dose-limiting toxicity (DLT)|0
6946256|NCT00977431|10984269|FG000|Overall Study|Progressive disease|2
6946257|NCT00977431|10984270|FG001|Overall Study|Progressive disease|6
6946258|NCT00977431|10984271|FG002|Overall Study|Progressive disease|1
6946259|NCT00977431|10984272|FG003|Overall Study|Progressive disease|3
6946260|NCT00977431|10984273|FG004|Overall Study|Progressive disease|5
6946261|NCT00977470|10984291|FG000|Overall Study|Lack of Efficacy|32
6946262|NCT00977470|10984292|FG001|Overall Study|Lack of Efficacy|30
6946263|NCT00977470|10984291|FG000|Overall Study|Physician Decision|2
6946264|NCT00977470|10984292|FG001|Overall Study|Physician Decision|0
6946265|NCT00977470|10984291|FG000|Overall Study|Adverse Event|1
6946266|NCT00977470|10984292|FG001|Overall Study|Adverse Event|2
6946267|NCT00977470|10984291|FG000|Overall Study|Protocol Violation|1
6946268|NCT00977470|10984292|FG001|Overall Study|Protocol Violation|0
6946269|NCT00977470|10984291|FG000|Overall Study|Withdrawal by Subject|0
6946270|NCT00977470|10984292|FG001|Overall Study|Withdrawal by Subject|2
6946271|NCT00977470|10984291|FG000|Overall Study|Death|0
6946272|NCT00977470|10984292|FG001|Overall Study|Death|2
6946273|NCT00977470|10984291|FG000|Overall Study|clinical decline|0
6946274|NCT00977470|10984292|FG001|Overall Study|clinical decline|1
6946275|NCT00977470|10984291|FG000|Overall Study|prolonged recovery post-surgery|0
6946276|NCT00977470|10984292|FG001|Overall Study|prolonged recovery post-surgery|1
6946277|NCT00977470|10984291|FG000|Overall Study|Still on-study|2
6946278|NCT00977470|10984292|FG001|Overall Study|Still on-study|0
6946279|NCT00977548|10984298|FG000|Overall Study|Ineligible|4
6946280|NCT00977548|10984298|FG000|Overall Study|Adverse Event|8
6946281|NCT00977548|10984298|FG000|Overall Study|Withdrawal by Subject|1
6946282|NCT00977561|10984304|FG000|Overall Study|Death|3
6946283|NCT00977561|10984305|FG001|Overall Study|Death|2
6946284|NCT00977561|10984304|FG000|Overall Study|Study terminated|0
6946285|NCT00977561|10984305|FG001|Overall Study|Study terminated|2
6946286|NCT00977561|10984304|FG000|Overall Study|Other|2
6946287|NCT00977561|10984305|FG001|Overall Study|Other|0
6946288|NCT00977613|10984313|FG000|Overall Study|Lost to Follow-up|16
6946289|NCT00977665|10984319|FG000|Overall Study|Withdrawal by Subject|1
6946290|NCT00977665|10984320|FG001|Overall Study|Withdrawal by Subject|3
6946291|NCT00977665|10984319|FG000|Overall Study|Physician Decision|2
6946292|NCT00977665|10984320|FG001|Overall Study|Physician Decision|1
6946293|NCT00977665|10984319|FG000|Overall Study|Sponsor requested withdrawal|0
6946294|NCT00977665|10984320|FG001|Overall Study|Sponsor requested withdrawal|1
6946295|NCT00977665|10984319|FG000|Overall Study|Lost to Follow-up|1
6946296|NCT00977665|10984320|FG001|Overall Study|Lost to Follow-up|0
6946297|NCT00977665|10984319|FG000|Overall Study|Death|3
6946298|NCT00977665|10984320|FG001|Overall Study|Death|2
6946299|NCT00977665|10984319|FG000|Overall Study|Adverse Event|14
6946300|NCT00977665|10984320|FG001|Overall Study|Adverse Event|7
6946301|NCT00977665|10984319|FG000|Overall Study|Treatment failure|0
6946302|NCT00977665|10984320|FG001|Overall Study|Treatment failure|1
6946303|NCT00977938|10984352|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132
6946304|NCT00977938|10984353|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116
6946305|NCT00977938|10984354|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13
6946306|NCT00977938|10984355|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20
6946307|NCT00977938|10984352|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88
6946308|NCT00977938|10984353|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91
6946309|NCT00977938|10984354|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30
6946310|NCT00977938|10984355|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37
6946311|NCT00977938|10984352|FG000|Treatment (12-30 mo. Post Procedure)|Other|17
6946312|NCT00977938|10984353|FG001|Treatment (12-30 mo. Post Procedure)|Other|18
6946313|NCT00977938|10984354|FG002|Treatment (12-30 mo. Post Procedure)|Other|3
6946314|NCT00977938|10984355|FG003|Treatment (12-30 mo. Post Procedure)|Other|4
7040732|NCT01719380|11123792|FG009|Overall Study|Lack of Efficacy|42
6946315|NCT00977938|10984352|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9
6946316|NCT00977938|10984353|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12
6946317|NCT00977938|10984354|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2
6946318|NCT00977938|10984355|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0
6946319|NCT00977938|10984352|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34
6946320|NCT00977938|10984353|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42
6946321|NCT00977938|10984354|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10
6946322|NCT00977938|10984355|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3
6946323|NCT00977938|10984352|FG000|Observation (30-33 mo. Post Procedure)|Other|8
6946324|NCT00977938|10984353|FG001|Observation (30-33 mo. Post Procedure)|Other|4
6946325|NCT00977938|10984354|FG002|Observation (30-33 mo. Post Procedure)|Other|0
6946326|NCT00977938|10984355|FG003|Observation (30-33 mo. Post Procedure)|Other|0
6946327|NCT00978029|10984370|FG000|Overall Study|Adverse Event|1
6946328|NCT00978029|10984371|FG001|Overall Study|Adverse Event|2
6946329|NCT00978029|10984372|FG002|Overall Study|Adverse Event|5
6946330|NCT00978029|10984370|FG000|Overall Study|Withdrawal by Subject|0
6946331|NCT00978029|10984371|FG001|Overall Study|Withdrawal by Subject|0
6946332|NCT00978029|10984372|FG002|Overall Study|Withdrawal by Subject|1
6946333|NCT00978029|10984370|FG000|Overall Study|Protocol Violation|0
6946334|NCT00978029|10984371|FG001|Overall Study|Protocol Violation|1
6946335|NCT00978029|10984372|FG002|Overall Study|Protocol Violation|0
6946336|NCT00978042|10984382|FG000|Initial Treatment Period|Treated in Error|0
6946337|NCT00978042|10984383|FG001|Initial Treatment Period|Treated in Error|3
6946338|NCT00978042|10984382|FG000|Initial Treatment Period|Ineligibility|1
6946339|NCT00978042|10984383|FG001|Initial Treatment Period|Ineligibility|0
6946340|NCT00978042|10984382|FG000|Initial Treatment Period|Lost to Follow-up|21
6946341|NCT00978042|10984383|FG001|Initial Treatment Period|Lost to Follow-up|3
6946342|NCT00978042|10984382|FG000|Initial Treatment Period|Adverse Event|2
6946343|NCT00978042|10984383|FG001|Initial Treatment Period|Adverse Event|0
6946344|NCT00978042|10984382|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2
6946345|NCT00978042|10984383|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0
6946346|NCT00978042|10984382|FG000|Initial Treatment Period|Consent withdrawn|22
6946347|NCT00978042|10984383|FG001|Initial Treatment Period|Consent withdrawn|9
6946348|NCT00978042|10984382|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13
6946349|NCT00978042|10984383|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0
6946350|NCT00978068|10984391|FG000|Overall Study|Were Awaiting Initiation of ART|2
6946351|NCT00978068|10984392|FG001|Overall Study|Were Awaiting Initiation of ART|2
6946352|NCT00978068|10984391|FG000|Overall Study|Death|1
6946353|NCT00978068|10984392|FG001|Overall Study|Death|2
6946354|NCT00978068|10984391|FG000|Overall Study|Lost to Follow-up|1
6946355|NCT00978068|10984392|FG001|Overall Study|Lost to Follow-up|2
6946356|NCT00978068|10984391|FG000|Overall Study|Physician Decision|0
6946357|NCT00978068|10984392|FG001|Overall Study|Physician Decision|1
6946358|NCT00978068|10984391|FG000|Overall Study|Unable to Comply with Study|0
6946359|NCT00978068|10984392|FG001|Overall Study|Unable to Comply with Study|2
6946360|NCT00978120|10984406|FG000|Overall Study|Death|0
6946361|NCT00978120|10984407|FG001|Overall Study|Death|0
6946362|NCT00978120|10984408|FG002|Overall Study|Death|0
6946363|NCT00978120|10984409|FG003|Overall Study|Death|1
6946364|NCT00978120|10984406|FG000|Overall Study|Lost to Follow-up|0
6946365|NCT00978120|10984407|FG001|Overall Study|Lost to Follow-up|0
6946366|NCT00978120|10984408|FG002|Overall Study|Lost to Follow-up|3
6946367|NCT00978120|10984409|FG003|Overall Study|Lost to Follow-up|0
6946368|NCT00978120|10984406|FG000|Overall Study|Withdrawal by Subject|2
6946369|NCT00978120|10984407|FG001|Overall Study|Withdrawal by Subject|0
6946370|NCT00978120|10984408|FG002|Overall Study|Withdrawal by Subject|0
7069269|NCT01999218|11170876|FG000|Overall Study|Lost to Follow-up|22
6946371|NCT00978120|10984409|FG003|Overall Study|Withdrawal by Subject|0
6946372|NCT00978120|10984406|FG000|Overall Study|Moved out of state|0
6946373|NCT00978120|10984407|FG001|Overall Study|Moved out of state|0
7040733|NCT01719380|11123783|FG000|Overall Study|Progressive Disease|0
7040734|NCT01719380|11123784|FG001|Overall Study|Progressive Disease|0
7040735|NCT01719380|11123785|FG002|Overall Study|Progressive Disease|0
7040736|NCT01719380|11123786|FG003|Overall Study|Progressive Disease|0
7040737|NCT01719380|11123787|FG004|Overall Study|Progressive Disease|0
7040738|NCT01719380|11123788|FG005|Overall Study|Progressive Disease|0
7040739|NCT01719380|11123789|FG006|Overall Study|Progressive Disease|0
7040740|NCT01719380|11123790|FG007|Overall Study|Progressive Disease|0
7040741|NCT01719380|11123791|FG008|Overall Study|Progressive Disease|1
6946374|NCT00978120|10984408|FG002|Overall Study|Moved out of state|0
6946375|NCT00978120|10984409|FG003|Overall Study|Moved out of state|1
6946376|NCT00978250|10984427|FG000|Overall Study|Late determination of ineligibility|0
6946377|NCT00978250|10984428|FG001|Overall Study|Late determination of ineligibility|1
6946378|NCT00978250|10984429|FG002|Overall Study|Late determination of ineligibility|0
6946379|NCT00978250|10984430|FG003|Overall Study|Late determination of ineligibility|1
7040742|NCT01719380|11123792|FG009|Overall Study|Progressive Disease|0
6946380|NCT00978341|10984442|FG000|Washout Period of 2 Weeks|Adverse Event|1
6946381|NCT00978341|10984443|FG001|Washout Period of 2 Weeks|Adverse Event|0
6946382|NCT00978380|10984450|FG000|Overall Study|Protocol Violation|2
7040743|NCT01719757|11123842|FG000|Overall Study|Adverse Event|38
6946383|NCT00978380|10984450|FG000|Overall Study|Withdrawal criteria|9
6946384|NCT00978380|10984450|FG000|Overall Study|Unclassified|8
6946385|NCT00978432|10984458|FG000|Overall Study|Withdrawal by Subject|0
6946386|NCT00978432|10984459|FG001|Overall Study|Withdrawal by Subject|0
6946387|NCT00978432|10984460|FG002|Overall Study|Withdrawal by Subject|1
6946388|NCT00978432|10984458|FG000|Overall Study|Lack of Efficacy|1
6946389|NCT00978432|10984459|FG001|Overall Study|Lack of Efficacy|1
6946390|NCT00978432|10984460|FG002|Overall Study|Lack of Efficacy|3
6946391|NCT00978432|10984458|FG000|Overall Study|Adverse Event|2
6946392|NCT00978432|10984459|FG001|Overall Study|Adverse Event|0
7069270|NCT01999218|11170877|FG001|Overall Study|Lost to Follow-up|17
7069271|NCT01999218|11170878|FG002|Overall Study|Lost to Follow-up|18
7069272|NCT01999218|11170876|FG000|Overall Study|Non-Compliance With Study Drug|6
7069273|NCT01999218|11170877|FG001|Overall Study|Non-Compliance With Study Drug|4
7069274|NCT01999218|11170878|FG002|Overall Study|Non-Compliance With Study Drug|1
7069275|NCT01999218|11170876|FG000|Overall Study|Physician Decision|1
7069276|NCT01999218|11170877|FG001|Overall Study|Physician Decision|4
7069277|NCT01999218|11170878|FG002|Overall Study|Physician Decision|6
7069278|NCT01999218|11170876|FG000|Overall Study|Protocol Violation|4
7069279|NCT01999218|11170877|FG001|Overall Study|Protocol Violation|5
7069280|NCT01999218|11170878|FG002|Overall Study|Protocol Violation|4
7069281|NCT01999218|11170876|FG000|Overall Study|Screen failure|0
7069282|NCT01999218|11170877|FG001|Overall Study|Screen failure|1
7069283|NCT01999218|11170878|FG002|Overall Study|Screen failure|0
7069284|NCT01999218|11170876|FG000|Overall Study|Study Terminated By Sponsor|7
7069285|NCT01999218|11170877|FG001|Overall Study|Study Terminated By Sponsor|5
7069286|NCT01999218|11170878|FG002|Overall Study|Study Terminated By Sponsor|12
7069287|NCT01999218|11170876|FG000|Overall Study|Participant moves|2
7069288|NCT01999218|11170877|FG001|Overall Study|Participant moves|5
7069289|NCT01999218|11170878|FG002|Overall Study|Participant moves|3
7069290|NCT01999218|11170876|FG000|Overall Study|Withdrawal by Subject|28
7069291|NCT01999218|11170877|FG001|Overall Study|Withdrawal by Subject|29
7069292|NCT01999218|11170878|FG002|Overall Study|Withdrawal by Subject|34
7069293|NCT01999218|11170876|FG000|Overall Study|Creatinine/eGFR|0
6838412|NCT00258960|10844153|FG000|Overall Study|Disease Progression|7
6838413|NCT00258960|10844153|FG000|Overall Study|Adverse Event|4
6946393|NCT00978432|10984460|FG002|Overall Study|Adverse Event|1
6946394|NCT00978627|10984483|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4
6946395|NCT00978627|10984484|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3
6946396|NCT00978627|10984483|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2
6946397|NCT00978627|10984484|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0
6946398|NCT00978627|10984483|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8
6946399|NCT00978627|10984484|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6
6946400|NCT00978627|10984483|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7
6946401|NCT00978627|10984484|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5
6946402|NCT00978627|10984483|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25
6946403|NCT00978627|10984484|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12
6946404|NCT00978627|10984483|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3
6946405|NCT00978627|10984484|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0
6946406|NCT00978627|10984483|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4
6946407|NCT00978627|10984484|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1
6946408|NCT00978627|10984483|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2
6946409|NCT00978627|10984484|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1
6946410|NCT00978627|10984483|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12
6946411|NCT00978627|10984484|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7
6946412|NCT00978731|10984494|FG000|Overall Study|Death|4
6946413|NCT00978731|10984495|FG001|Overall Study|Death|1
6946414|NCT00978731|10984496|FG002|Overall Study|Death|1
6946415|NCT00978731|10984497|FG003|Overall Study|Death|0
6946416|NCT00978731|10984494|FG000|Overall Study|Lost to Follow-up|0
6946417|NCT00978731|10984495|FG001|Overall Study|Lost to Follow-up|0
6946418|NCT00978731|10984496|FG002|Overall Study|Lost to Follow-up|0
6946419|NCT00978731|10984497|FG003|Overall Study|Lost to Follow-up|1
6946420|NCT00978731|10984494|FG000|Overall Study|Adverse Event|5
6946421|NCT00978731|10984495|FG001|Overall Study|Adverse Event|2
6946422|NCT00978731|10984496|FG002|Overall Study|Adverse Event|0
6946423|NCT00978731|10984497|FG003|Overall Study|Adverse Event|0
6946424|NCT00978731|10984494|FG000|Overall Study|Participant's request|1
6946425|NCT00978731|10984495|FG001|Overall Study|Participant's request|0
6946426|NCT00978731|10984496|FG002|Overall Study|Participant's request|0
6946427|NCT00978731|10984497|FG003|Overall Study|Participant's request|0
6838414|NCT00258960|10844153|FG000|Overall Study|Physician Decision|1
6838415|NCT00258960|10844153|FG000|Overall Study|Withdrawal by Subject|1
6838416|NCT00258960|10844153|FG000|Overall Study|Mistake|2
6838417|NCT00259012|10844159|FG000|Overall Study|Adverse Event|0
6946428|NCT00978731|10984494|FG000|Overall Study|Administrative reason|3
6946429|NCT00978731|10984495|FG001|Overall Study|Administrative reason|3
7069294|NCT01999218|11170877|FG001|Overall Study|Creatinine/eGFR|0
7069295|NCT01999218|11170878|FG002|Overall Study|Creatinine/eGFR|1
7069296|NCT01999218|11170876|FG000|Overall Study|Death|7
7069297|NCT01999218|11170877|FG001|Overall Study|Death|1
7069298|NCT01999218|11170878|FG002|Overall Study|Death|2
7069299|NCT01999218|11170876|FG000|Overall Study|Excluded Medication|1
6946430|NCT00978731|10984496|FG002|Overall Study|Administrative reason|1
6946431|NCT00978731|10984497|FG003|Overall Study|Administrative reason|0
6946432|NCT00978731|10984494|FG000|Overall Study|Deterioration without progression|0
6946433|NCT00978731|10984495|FG001|Overall Study|Deterioration without progression|1
6946434|NCT00978731|10984496|FG002|Overall Study|Deterioration without progression|0
6946435|NCT00978731|10984497|FG003|Overall Study|Deterioration without progression|0
6946436|NCT00978731|10984494|FG000|Overall Study|Disease progression/relapse|5
6946437|NCT00978731|10984495|FG001|Overall Study|Disease progression/relapse|4
6946438|NCT00978731|10984496|FG002|Overall Study|Disease progression/relapse|2
6946439|NCT00978731|10984497|FG003|Overall Study|Disease progression/relapse|2
6946440|NCT00978731|10984494|FG000|Overall Study|Study closure|3
6946441|NCT00978731|10984495|FG001|Overall Study|Study closure|4
6946442|NCT00978731|10984496|FG002|Overall Study|Study closure|1
6946443|NCT00978731|10984497|FG003|Overall Study|Study closure|1
6946444|NCT00978731|10984494|FG000|Overall Study|No response|1
6946445|NCT00978731|10984495|FG001|Overall Study|No response|0
6946446|NCT00978731|10984496|FG002|Overall Study|No response|0
6946447|NCT00978731|10984497|FG003|Overall Study|No response|0
6946448|NCT00978757|10984513|FG000|Overall Study|Physician Decision|1
6946449|NCT00978757|10984514|FG001|Overall Study|Physician Decision|3
6946450|NCT00979134|10984551|FG000|Overall Study|Disease progression|18
6946451|NCT00979134|10984552|FG001|Overall Study|Disease progression|2
6946452|NCT00979134|10984553|FG002|Overall Study|Disease progression|5
6946453|NCT00979134|10984551|FG000|Overall Study|Adverse Event|0
6946454|NCT00979134|10984552|FG001|Overall Study|Adverse Event|0
6946455|NCT00979134|10984553|FG002|Overall Study|Adverse Event|2
6946456|NCT00979134|10984551|FG000|Overall Study|Withdrawal by Subject|1
6946457|NCT00979134|10984552|FG001|Overall Study|Withdrawal by Subject|1
6946458|NCT00979134|10984553|FG002|Overall Study|Withdrawal by Subject|2
6946459|NCT00979134|10984551|FG000|Overall Study|Lost to Follow-up|2
6946460|NCT00979134|10984552|FG001|Overall Study|Lost to Follow-up|2
6946461|NCT00979134|10984553|FG002|Overall Study|Lost to Follow-up|0
6946462|NCT00979134|10984551|FG000|Overall Study|Death|4
6946463|NCT00979134|10984552|FG001|Overall Study|Death|0
6946464|NCT00979134|10984553|FG002|Overall Study|Death|26
6946465|NCT00979134|10984551|FG000|Overall Study|Other|8
6946466|NCT00979134|10984552|FG001|Overall Study|Other|1
6946467|NCT00979134|10984553|FG002|Overall Study|Other|5
6975794|NCT01194414|11027943|FG003|72 Weeks Open Label Extension|Pregnancy|1
6975795|NCT01194414|11027940|FG000|72 Weeks Open Label Extension|Other|2
6975796|NCT01194414|11027941|FG001|72 Weeks Open Label Extension|Other|1
6975797|NCT01194414|11027942|FG002|72 Weeks Open Label Extension|Other|0
6975798|NCT01194414|11027943|FG003|72 Weeks Open Label Extension|Other|0
6975799|NCT01194414|11027940|FG000|72 Weeks Open Label Extension|Protocol Violation|0
6975800|NCT01194414|11027941|FG001|72 Weeks Open Label Extension|Protocol Violation|0
6975801|NCT01194414|11027942|FG002|72 Weeks Open Label Extension|Protocol Violation|0
6975802|NCT01194414|11027943|FG003|72 Weeks Open Label Extension|Protocol Violation|1
6975803|NCT01194414|11027940|FG000|72 Weeks Open Label Extension|Adverse Event|35
6975804|NCT01194414|11027941|FG001|72 Weeks Open Label Extension|Adverse Event|21
6975805|NCT01194414|11027942|FG002|72 Weeks Open Label Extension|Adverse Event|2
6975806|NCT01194414|11027943|FG003|72 Weeks Open Label Extension|Adverse Event|12
6975807|NCT01194414|11027940|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
6975808|NCT01194414|11027941|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
6975809|NCT01194414|11027942|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
6975810|NCT01194414|11027943|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
6975811|NCT01194414|11027940|FG000|72 Weeks Open Label Extension|Death|1
6975812|NCT01194414|11027941|FG001|72 Weeks Open Label Extension|Death|2
6975813|NCT01194414|11027942|FG002|72 Weeks Open Label Extension|Death|0
6975814|NCT01194414|11027943|FG003|72 Weeks Open Label Extension|Death|2
6975815|NCT01194440|11027955|FG000|Baseline (First Dose)|Reason not specified|4
6975816|NCT01194440|11027955|FG000|Baseline (First Dose)|Lack of Efficacy|1
6975817|NCT01194440|11027955|FG000|Baseline (First Dose)|Change in therapy|1
6975818|NCT01194440|11027955|FG000|Baseline (First Dose)|Adverse Event|1
6975819|NCT01194440|11027955|FG000|6-months (2nd Dose)|Change in therapy|4
6975820|NCT01194531|11027996|FG000|Overall Study|Withdrawal by Subject|1
6975821|NCT01194531|11027997|FG001|Overall Study|Withdrawal by Subject|0
6975822|NCT01194531|11027996|FG000|Overall Study|Protocol Violation|4
6975823|NCT01194531|11027997|FG001|Overall Study|Protocol Violation|1
6975824|NCT01194531|11027996|FG000|Overall Study|Physician Decision|0
6975825|NCT01194531|11027997|FG001|Overall Study|Physician Decision|2
6975826|NCT01194804|11028008|FG000|Overall Study|Withdrawal by Subject|1
7069300|NCT01999218|11170877|FG001|Overall Study|Excluded Medication|1
7069301|NCT01999218|11170878|FG002|Overall Study|Excluded Medication|2
7069302|NCT01999218|11170876|FG000|Overall Study|Adverse Event|9
7069303|NCT01999218|11170877|FG001|Overall Study|Adverse Event|7
7069304|NCT01999218|11170878|FG002|Overall Study|Adverse Event|7
7069305|NCT01999218|11170876|FG000|Overall Study|Treated but excluded at 1 trial site|3
7069306|NCT01999218|11170877|FG001|Overall Study|Treated but excluded at 1 trial site|5
7069307|NCT01999218|11170878|FG002|Overall Study|Treated but excluded at 1 trial site|2
7183770|NCT01150045|11383848|FG001|Overall Study|Protocol Violation|1
7069308|NCT01999322|11170907|FG000|Overall Study|Adverse Event|1
7069309|NCT01999322|11170908|FG001|Overall Study|Adverse Event|0
7069310|NCT01999335|11170919|FG000|Overall Study|Discontinued before receiving treatment|0
7069311|NCT01999335|11170920|FG001|Overall Study|Discontinued before receiving treatment|0
7069312|NCT01999335|11170921|FG002|Overall Study|Discontinued before receiving treatment|0
7069313|NCT01999335|11170922|FG003|Overall Study|Discontinued before receiving treatment|0
7147712|NCT03134222|11308419|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0
7147713|NCT03134222|11308415|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0
7147714|NCT03134222|11308416|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1
7147715|NCT03134222|11308417|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1
7147716|NCT03134222|11308418|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0
7147717|NCT03134222|11308419|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0
7147718|NCT03134222|11308415|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0
7147719|NCT03134222|11308416|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2
7147720|NCT03134222|11308417|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0
7147721|NCT03134222|11308418|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0
7147722|NCT03134222|11308419|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1
7147723|NCT03134222|11308415|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2
7147724|NCT03134222|11308416|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
7147725|NCT03134222|11308417|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
7147726|NCT03134222|11308418|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
7147727|NCT03134222|11308419|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
7147728|NCT03134222|11308415|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
7147729|NCT03134222|11308416|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
7147730|NCT03134222|11308417|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
7147731|NCT03134222|11308418|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1
7147732|NCT03134222|11308419|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
7147733|NCT03134222|11308415|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
7147734|NCT03134222|11308416|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1
7147735|NCT03134222|11308417|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
7147736|NCT03134222|11308418|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
7147737|NCT03134222|11308419|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
7147738|NCT03134599|11308452|FG000|Week 1|Lost to Follow-up|0
7147739|NCT03134599|11308453|FG001|Week 1|Lost to Follow-up|0
7147740|NCT03134599|11308454|FG002|Week 1|Lost to Follow-up|0
7147741|NCT03134599|11308455|FG003|Week 1|Lost to Follow-up|0
7147742|NCT03134599|11308456|FG004|Week 1|Lost to Follow-up|1
7147743|NCT03134599|11308457|FG005|Week 1|Lost to Follow-up|0
7147744|NCT03134599|11308452|FG000|Week 2|Lost to Follow-up|1
7147745|NCT03134599|11308453|FG001|Week 2|Lost to Follow-up|0
7147746|NCT03134599|11308454|FG002|Week 2|Lost to Follow-up|0
7147747|NCT03134599|11308455|FG003|Week 2|Lost to Follow-up|1
7147748|NCT03134599|11308456|FG004|Week 2|Lost to Follow-up|1
7147749|NCT03134599|11308457|FG005|Week 2|Lost to Follow-up|0
7147750|NCT03134599|11308452|FG000|Week 3|Lost to Follow-up|0
7147751|NCT03134599|11308453|FG001|Week 3|Lost to Follow-up|0
7147752|NCT03134599|11308454|FG002|Week 3|Lost to Follow-up|0
7147753|NCT03134599|11308455|FG003|Week 3|Lost to Follow-up|1
7147754|NCT03134599|11308456|FG004|Week 3|Lost to Follow-up|0
7147755|NCT03134599|11308457|FG005|Week 3|Lost to Follow-up|1
7147756|NCT03134911|11308480|FG000|Overall Study|Screen failure|31
7147757|NCT03134911|11308480|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3
7147758|NCT03135028|11308563|FG000|Overall Study|Death|6
7147759|NCT03135028|11308563|FG000|Overall Study|Study Terminated by Sponsor|2
7147760|NCT03135028|11308563|FG000|Overall Study|Withdrew Consent|1
7147761|NCT03135210|11308569|FG000|Overall Study|Death|0
7147762|NCT03135210|11308570|FG001|Overall Study|Death|1
7147763|NCT03135431|11308587|FG000|Overall Study|Study Surgeon not available|2
7147764|NCT03135431|11308588|FG001|Overall Study|Study Surgeon not available|0
7147765|NCT03135522|11308596|FG000|Overall Study|Adverse Event|1
7147766|NCT03135522|11308597|FG001|Overall Study|Adverse Event|0
7147767|NCT03135548|11308610|FG000|Overall Study|Lost to Follow-up|3
7147768|NCT03135548|11308611|FG001|Overall Study|Lost to Follow-up|0
7147769|NCT03135548|11308612|FG002|Overall Study|Lost to Follow-up|0
7147770|NCT03135548|11308610|FG000|Overall Study|Withdrawal by Subject|2
7147771|NCT03135548|11308611|FG001|Overall Study|Withdrawal by Subject|2
7147772|NCT03135548|11308612|FG002|Overall Study|Withdrawal by Subject|1
7147773|NCT03135548|11308610|FG000|Overall Study|Other than listed|0
7147774|NCT03135548|11308611|FG001|Overall Study|Other than listed|2
7147775|NCT03135548|11308612|FG002|Overall Study|Other than listed|2
7147776|NCT03135899|11308628|FG000|Overall Study|Failed spirometry,unable to repeat visit|0
7147777|NCT03135899|11308629|FG001|Overall Study|Failed spirometry,unable to repeat visit|0
7147778|NCT03135899|11308630|FG002|Overall Study|Failed spirometry,unable to repeat visit|0
7147779|NCT03135899|11308631|FG003|Overall Study|Failed spirometry,unable to repeat visit|0
7147780|NCT03135899|11308632|FG004|Overall Study|Failed spirometry,unable to repeat visit|0
7147781|NCT03135899|11308633|FG005|Overall Study|Failed spirometry,unable to repeat visit|0
7147782|NCT03135899|11308634|FG006|Overall Study|Failed spirometry,unable to repeat visit|1
7147783|NCT03135899|11308635|FG007|Overall Study|Failed spirometry,unable to repeat visit|0
7147784|NCT03135899|11308628|FG000|Overall Study|Withdrawal by Subject|0
7147785|NCT03135899|11308629|FG001|Overall Study|Withdrawal by Subject|0
7147786|NCT03135899|11308630|FG002|Overall Study|Withdrawal by Subject|0
7069314|NCT01999335|11170923|FG004|Overall Study|Discontinued before receiving treatment|2
7069315|NCT01999465|11170959|FG000|Overall Study|Lost to Follow-up|0
7069316|NCT01999465|11170960|FG001|Overall Study|Lost to Follow-up|2
7069317|NCT01999465|11170959|FG000|Overall Study|Protocol Violation|0
7069318|NCT01999465|11170960|FG001|Overall Study|Protocol Violation|1
7069319|NCT01999868|11170991|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0
7069320|NCT01999868|11170992|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0
7069321|NCT01999868|11170993|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5
7069322|NCT01999868|11170991|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1
7069323|NCT01999868|11170992|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1
7069324|NCT01999868|11170993|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0
7069325|NCT01999868|11170991|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3
7069326|NCT01999868|11170992|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4
7069327|NCT01999868|11170993|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0
7069328|NCT01999868|11170991|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0
7069329|NCT01999868|11170992|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1
7069330|NCT01999868|11170993|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0
7069331|NCT01999868|11170991|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0
7069332|NCT01999868|11170992|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2
7069333|NCT01999868|11170993|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0
7069334|NCT01999868|11170991|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1
7069335|NCT01999868|11170992|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2
7069336|NCT01999868|11170993|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0
7069337|NCT01999868|11170991|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8
7069338|NCT01999868|11170992|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1
7069339|NCT01999868|11170993|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0
7069340|NCT01999868|11170991|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1
7069341|NCT01999868|11170992|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0
7069342|NCT01999868|11170993|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0
7069343|NCT01999868|11170991|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4
7069344|NCT01999868|11170992|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0
7069345|NCT01999868|11170993|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0
7069346|NCT01999868|11170991|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0
7069347|NCT01999868|11170992|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1
7069348|NCT01999868|11170993|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0
7069349|NCT01999868|11170991|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0
7069350|NCT01999868|11170992|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1
7069351|NCT01999868|11170993|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0
7069352|NCT01999868|11170991|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1
7069353|NCT01999868|11170992|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2
7069354|NCT01999868|11170993|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0
7069355|NCT01999868|11170991|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10
7069356|NCT01999868|11170992|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19
7069357|NCT01999868|11170993|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0
7069358|NCT01999868|11170991|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0
7069359|NCT01999868|11170992|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2
7069360|NCT01999868|11170993|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0
7069361|NCT01999868|11170991|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12
7069362|NCT01999868|11170992|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4
7069363|NCT01999868|11170993|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0
7069364|NCT01999894|11171001|FG000|Overall Study|Adverse Event|9
7069365|NCT01999894|11171001|FG000|Overall Study|Lack of Efficacy|5
7069366|NCT01999894|11171001|FG000|Overall Study|Protocol Violation|1
7069367|NCT01999894|11171001|FG000|Overall Study|Withdrawal by Subject|7
7069368|NCT01999894|11171001|FG000|Overall Study|Lost to Follow-up|10
7069369|NCT01999894|11171001|FG000|Overall Study|Other Reason|3
7069370|NCT01999894|11171001|FG000|Overall Study|Inclusion/exclusion criteria not met|1
7069371|NCT01999946|11171018|FG000|Overall Study|Participant not released from jail|2
7069372|NCT01999946|11171019|FG001|Overall Study|Participant not released from jail|2
7069373|NCT01999946|11171020|FG002|Overall Study|Participant not released from jail|0
7069374|NCT01999946|11171018|FG000|Overall Study|Not included in primary outcome analysis|0
7069375|NCT01999946|11171019|FG001|Overall Study|Not included in primary outcome analysis|0
7069376|NCT01999946|11171020|FG002|Overall Study|Not included in primary outcome analysis|79
7069377|NCT01999972|11171033|FG000|Dose Escalation Part|Participant refused further follow-up|1
7069378|NCT01999972|11171034|FG001|Dose Escalation Part|Participant refused further follow-up|0
7069379|NCT01999972|11171035|FG002|Dose Escalation Part|Participant refused further follow-up|1
7069380|NCT01999972|11171036|FG003|Dose Escalation Part|Participant refused further follow-up|1
7069381|NCT01999972|11171037|FG004|Dose Escalation Part|Participant refused further follow-up|0
7069382|NCT01999972|11171038|FG005|Dose Escalation Part|Participant refused further follow-up|0
7069383|NCT01999972|11171033|FG000|Dose Escalation Part|Death|0
7069384|NCT01999972|11171034|FG001|Dose Escalation Part|Death|1
7069385|NCT01999972|11171035|FG002|Dose Escalation Part|Death|0
7069386|NCT01999972|11171036|FG003|Dose Escalation Part|Death|0
7069387|NCT01999972|11171037|FG004|Dose Escalation Part|Death|0
7069388|NCT01999972|11171038|FG005|Dose Escalation Part|Death|0
7069389|NCT01999972|11171033|FG000|Dose Escalation Part|Enrolled but not treated|0
7069390|NCT01999972|11171034|FG001|Dose Escalation Part|Enrolled but not treated|0
7069391|NCT01999972|11171035|FG002|Dose Escalation Part|Enrolled but not treated|1
7069392|NCT01999972|11171036|FG003|Dose Escalation Part|Enrolled but not treated|1
7069393|NCT01999972|11171037|FG004|Dose Escalation Part|Enrolled but not treated|0
7069394|NCT01999972|11171038|FG005|Dose Escalation Part|Enrolled but not treated|0
7069395|NCT01999972|11171033|FG000|Dose Escalation Part|Disease progression|3
7069396|NCT01999972|11171034|FG001|Dose Escalation Part|Disease progression|2
7069397|NCT01999972|11171035|FG002|Dose Escalation Part|Disease progression|3
7069398|NCT01999972|11171036|FG003|Dose Escalation Part|Disease progression|6
7069399|NCT01999972|11171037|FG004|Dose Escalation Part|Disease progression|0
7069400|NCT01999972|11171038|FG005|Dose Escalation Part|Disease progression|0
7069401|NCT01999972|11171033|FG000|Dose Escalation Part|Adverse Event|0
7069402|NCT01999972|11171034|FG001|Dose Escalation Part|Adverse Event|0
7069403|NCT01999972|11171035|FG002|Dose Escalation Part|Adverse Event|0
7069404|NCT01999972|11171036|FG003|Dose Escalation Part|Adverse Event|2
7069405|NCT01999972|11171037|FG004|Dose Escalation Part|Adverse Event|0
7069406|NCT01999972|11171038|FG005|Dose Escalation Part|Adverse Event|0
7069407|NCT01999972|11171033|FG000|Dose Escalation Part|Global deterioration of health status|1
7069408|NCT01999972|11171034|FG001|Dose Escalation Part|Global deterioration of health status|0
7069409|NCT01999972|11171035|FG002|Dose Escalation Part|Global deterioration of health status|0
7069410|NCT01999972|11171036|FG003|Dose Escalation Part|Global deterioration of health status|1
7069411|NCT01999972|11171037|FG004|Dose Escalation Part|Global deterioration of health status|0
7069412|NCT01999972|11171038|FG005|Dose Escalation Part|Global deterioration of health status|0
7069413|NCT01999972|11171033|FG000|Dose Expansion Part|Death|0
7069414|NCT01999972|11171034|FG001|Dose Expansion Part|Death|0
7069415|NCT01999972|11171035|FG002|Dose Expansion Part|Death|0
7069416|NCT01999972|11171036|FG003|Dose Expansion Part|Death|0
7069417|NCT01999972|11171037|FG004|Dose Expansion Part|Death|2
7069418|NCT01999972|11171038|FG005|Dose Expansion Part|Death|1
7069419|NCT01999972|11171033|FG000|Dose Expansion Part|Disease progression|0
7069420|NCT01999972|11171034|FG001|Dose Expansion Part|Disease progression|0
7069421|NCT01999972|11171035|FG002|Dose Expansion Part|Disease progression|0
7069422|NCT01999972|11171036|FG003|Dose Expansion Part|Disease progression|0
7069423|NCT01999972|11171037|FG004|Dose Expansion Part|Disease progression|9
7069424|NCT01999972|11171038|FG005|Dose Expansion Part|Disease progression|3
7069425|NCT01999972|11171033|FG000|Dose Expansion Part|Sponsor decision|0
7069426|NCT01999972|11171034|FG001|Dose Expansion Part|Sponsor decision|0
7069427|NCT01999972|11171035|FG002|Dose Expansion Part|Sponsor decision|0
7069428|NCT01999972|11171036|FG003|Dose Expansion Part|Sponsor decision|0
7069429|NCT01999972|11171037|FG004|Dose Expansion Part|Sponsor decision|1
7069430|NCT01999972|11171038|FG005|Dose Expansion Part|Sponsor decision|0
7069431|NCT01999972|11171033|FG000|Dose Expansion Part|Adverse Event|0
7069432|NCT01999972|11171034|FG001|Dose Expansion Part|Adverse Event|0
7069433|NCT01999972|11171035|FG002|Dose Expansion Part|Adverse Event|0
7069434|NCT01999972|11171036|FG003|Dose Expansion Part|Adverse Event|0
7069435|NCT01999972|11171037|FG004|Dose Expansion Part|Adverse Event|4
7069436|NCT01999972|11171038|FG005|Dose Expansion Part|Adverse Event|2
7069437|NCT01999972|11171033|FG000|Dose Expansion Part|Participant's non-compliance|0
7069438|NCT01999972|11171034|FG001|Dose Expansion Part|Participant's non-compliance|0
7069439|NCT01999972|11171035|FG002|Dose Expansion Part|Participant's non-compliance|0
7069440|NCT01999972|11171036|FG003|Dose Expansion Part|Participant's non-compliance|0
7069441|NCT01999972|11171037|FG004|Dose Expansion Part|Participant's non-compliance|0
7069442|NCT01999972|11171038|FG005|Dose Expansion Part|Participant's non-compliance|1
7069443|NCT01999972|11171033|FG000|Dose Expansion Part|Participant refused further follow-up|0
7069444|NCT01999972|11171034|FG001|Dose Expansion Part|Participant refused further follow-up|0
7069445|NCT01999972|11171035|FG002|Dose Expansion Part|Participant refused further follow-up|0
7069446|NCT01999972|11171036|FG003|Dose Expansion Part|Participant refused further follow-up|0
7069447|NCT01999972|11171037|FG004|Dose Expansion Part|Participant refused further follow-up|4
7069448|NCT01999972|11171038|FG005|Dose Expansion Part|Participant refused further follow-up|0
7069449|NCT01999972|11171033|FG000|Dose Expansion Part|Changed to standard of care|0
7069450|NCT01999972|11171034|FG001|Dose Expansion Part|Changed to standard of care|0
7069451|NCT01999972|11171035|FG002|Dose Expansion Part|Changed to standard of care|0
7069452|NCT01999972|11171036|FG003|Dose Expansion Part|Changed to standard of care|0
7069453|NCT01999972|11171037|FG004|Dose Expansion Part|Changed to standard of care|1
7069454|NCT01999972|11171038|FG005|Dose Expansion Part|Changed to standard of care|0
7069455|NCT02000440|11171075|FG000|Overall Study|Adverse Event|3
7069456|NCT02000440|11171075|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1
7069457|NCT02000531|11171081|FG000|Overall Study|Lost to Follow-up|1
7069458|NCT02000531|11171082|FG001|Overall Study|Lost to Follow-up|0
7069459|NCT02000531|11171081|FG000|Overall Study|Discontinued due to data cut-off|3
7069460|NCT02000531|11171082|FG001|Overall Study|Discontinued due to data cut-off|8
7069461|NCT02000752|11171099|FG000|Overall Study|Dystocic delivery|19
7069462|NCT02000752|11171100|FG001|Overall Study|Dystocic delivery|8
7069463|NCT02000752|11171099|FG000|Overall Study|Shift Changes|12
7069464|NCT02000752|11171100|FG001|Overall Study|Shift Changes|5
7069465|NCT02000817|11171110|FG000|Overall Study|Withdrawal by Subject|2
7069466|NCT02000817|11171111|FG001|Overall Study|Withdrawal by Subject|0
7069467|NCT02000817|11171112|FG002|Overall Study|Withdrawal by Subject|0
7069468|NCT02000817|11171113|FG003|Overall Study|Withdrawal by Subject|0
7069469|NCT02000817|11171110|FG000|Overall Study|Adverse Event|0
7069470|NCT02000817|11171111|FG001|Overall Study|Adverse Event|1
7069471|NCT02000817|11171112|FG002|Overall Study|Adverse Event|0
7069472|NCT02000817|11171113|FG003|Overall Study|Adverse Event|0
7069473|NCT02000817|11171110|FG000|Overall Study|Lost to Follow-up|0
7069474|NCT02000817|11171111|FG001|Overall Study|Lost to Follow-up|0
7069475|NCT02000817|11171112|FG002|Overall Study|Lost to Follow-up|1
7069476|NCT02000817|11171113|FG003|Overall Study|Lost to Follow-up|0
7069477|NCT02000921|11171138|FG000|Overall Study|Withdrawal by Subject|3
7069478|NCT02000921|11171139|FG001|Overall Study|Withdrawal by Subject|10
7069479|NCT02000921|11171140|FG002|Overall Study|Withdrawal by Subject|5
7069480|NCT02000921|11171138|FG000|Overall Study|Lost to Follow-up|2
7069481|NCT02000921|11171139|FG001|Overall Study|Lost to Follow-up|4
7069482|NCT02000921|11171140|FG002|Overall Study|Lost to Follow-up|5
7069483|NCT02000921|11171138|FG000|Overall Study|Physician Decision|0
7069484|NCT02000921|11171139|FG001|Overall Study|Physician Decision|2
7069485|NCT02000921|11171140|FG002|Overall Study|Physician Decision|0
7069486|NCT02001051|11171167|FG000|Overall Study|Deemed not eligible following enrollment|0
7069487|NCT02001051|11171168|FG001|Overall Study|Deemed not eligible following enrollment|1
7069488|NCT02001064|11171176|FG000|Overall Study|Withdrawal by Subject|2
7069489|NCT02001064|11171177|FG001|Overall Study|Withdrawal by Subject|1
7069490|NCT02001181|11171185|FG000|Overall Study|Adverse Event|0
7069491|NCT02001181|11171186|FG001|Overall Study|Adverse Event|2
7069492|NCT02001181|11171185|FG000|Overall Study|Lost to Follow-up|1
7069493|NCT02001181|11171186|FG001|Overall Study|Lost to Follow-up|0
7069494|NCT02001181|11171185|FG000|Overall Study|Withdrawal by Subject|0
7069495|NCT02001181|11171186|FG001|Overall Study|Withdrawal by Subject|1
7069496|NCT02001194|11171196|FG000|Intervention Period (13 Weeks)|No longer interested|1
7069497|NCT02001194|11171197|FG001|Intervention Period (13 Weeks)|No longer interested|0
7069498|NCT02001194|11171198|FG002|Intervention Period (13 Weeks)|No longer interested|2
7069499|NCT02001194|11171199|FG003|Intervention Period (13 Weeks)|No longer interested|2
7069500|NCT02001194|11171196|FG000|Follow-Up Period (13 Weeks)|No longer interested|3
7069501|NCT02001194|11171197|FG001|Follow-Up Period (13 Weeks)|No longer interested|2
7069502|NCT02001194|11171198|FG002|Follow-Up Period (13 Weeks)|No longer interested|1
7069503|NCT02001194|11171199|FG003|Follow-Up Period (13 Weeks)|No longer interested|0
7069504|NCT02001558|11171211|FG000|Overall Study|Lost to Follow-up|8
7069505|NCT02001558|11171212|FG001|Overall Study|Lost to Follow-up|14
7069506|NCT02001688|11171221|FG000|Overall Study|Withdrawal by Subject|0
7069507|NCT02001688|11171222|FG001|Overall Study|Withdrawal by Subject|0
7069508|NCT02001688|11171223|FG002|Overall Study|Withdrawal by Subject|1
7069509|NCT02001688|11171221|FG000|Overall Study|Adverse Event|0
7069510|NCT02001688|11171222|FG001|Overall Study|Adverse Event|1
7069511|NCT02001688|11171223|FG002|Overall Study|Adverse Event|0
7069512|NCT02001987|11171241|FG000|Core Study Period (24 Weeks)|Adverse Event|9
7069513|NCT02001987|11171241|FG000|Core Study Period (24 Weeks)|Death|1
7069514|NCT02001987|11171241|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2
7069515|NCT02001987|11171241|FG000|Core Study Period (24 Weeks)|Physician Decision|1
7069516|NCT02001987|11171241|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4
7069517|NCT02001987|11171241|FG000|Core Study Period (24 Weeks)|Protocol Violation|3
7069518|NCT02001987|11171241|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3
7069519|NCT02001987|11171241|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2
7069520|NCT02001987|11171241|FG000|LTE Period (52 Weeks)|Physician Decision|2
7069521|NCT02001987|11171241|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1
7069522|NCT02001987|11171241|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1
7069523|NCT02001987|11171241|FG000|LTE Period (52 Weeks)|Other|3
7069524|NCT02002091|11171252|FG000|Screening|Lost to Follow-up|10
7069525|NCT02002091|11171253|FG001|Screening|Lost to Follow-up|12
7069526|NCT02002091|11171252|FG000|Screening|Death|3
7069527|NCT02002091|11171253|FG001|Screening|Death|2
7069528|NCT02002182|11171290|FG000|Overall Study|Withdraw from study|3
7069529|NCT02002182|11171291|FG001|Overall Study|Withdraw from study|1
7069530|NCT02002182|11171290|FG000|Overall Study|Health Reasons|1
7069531|NCT02002182|11171291|FG001|Overall Study|Health Reasons|0
7069532|NCT02002182|11171290|FG000|Overall Study|Death|1
7069533|NCT02002182|11171291|FG001|Overall Study|Death|0
7069534|NCT02002221|11171308|FG000|Overall Study|Adverse Event|2
7069535|NCT02002221|11171309|FG001|Overall Study|Adverse Event|1
7069536|NCT02002221|11171308|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7069537|NCT02002221|11171309|FG001|Overall Study|Unsatisfactory therapeutic effect|1
7069538|NCT02002221|11171308|FG000|Overall Study|Patient withdrew consent|0
7069539|NCT02002221|11171309|FG001|Overall Study|Patient withdrew consent|1
7069540|NCT02002533|11171332|FG000|Overall Study|Withdrawal by Subject|6
6946468|NCT00979407|10984581|FG000|Overall Study|Withdrawal by Subject|3
6946469|NCT00979407|10984582|FG001|Overall Study|Withdrawal by Subject|4
6946470|NCT00979407|10984581|FG000|Overall Study|Lost to Follow-up|3
6946471|NCT00979407|10984582|FG001|Overall Study|Lost to Follow-up|3
6946472|NCT00979420|10984594|FG000|Overall Study|Adverse Event|1
6946473|NCT00979420|10984595|FG001|Overall Study|Adverse Event|0
6946474|NCT00979420|10984596|FG002|Overall Study|Adverse Event|0
6946475|NCT00979420|10984597|FG003|Overall Study|Adverse Event|0
6946476|NCT00979420|10984594|FG000|Overall Study|Lack of Efficacy|3
6946477|NCT00979420|10984595|FG001|Overall Study|Lack of Efficacy|0
6946478|NCT00979420|10984596|FG002|Overall Study|Lack of Efficacy|1
6946479|NCT00979420|10984597|FG003|Overall Study|Lack of Efficacy|1
6946480|NCT00979420|10984594|FG000|Overall Study|Other reasons not related to Viramune|3
6946481|NCT00979420|10984595|FG001|Overall Study|Other reasons not related to Viramune|0
6946482|NCT00979420|10984596|FG002|Overall Study|Other reasons not related to Viramune|0
6946483|NCT00979420|10984597|FG003|Overall Study|Other reasons not related to Viramune|1
6946484|NCT00979576|10984617|FG000|Combination Treatment Phase|Progressive disease|3
6946485|NCT00979576|10984618|FG001|Combination Treatment Phase|Progressive disease|1
6946486|NCT00979576|10984619|FG002|Combination Treatment Phase|Progressive disease|5
6946487|NCT00979576|10984617|FG000|Combination Treatment Phase|Dose limiting toxicity|0
6946488|NCT00979576|10984618|FG001|Combination Treatment Phase|Dose limiting toxicity|3
6946489|NCT00979576|10984619|FG002|Combination Treatment Phase|Dose limiting toxicity|2
6946490|NCT00979576|10984617|FG000|Combination Treatment Phase|Adverse Event|0
6946491|NCT00979576|10984618|FG001|Combination Treatment Phase|Adverse Event|2
6946492|NCT00979576|10984619|FG002|Combination Treatment Phase|Adverse Event|2
6946493|NCT00979576|10984617|FG000|Combination Followed by Monotherapy|Progressive Disease|0
6946494|NCT00979576|10984618|FG001|Combination Followed by Monotherapy|Progressive Disease|2
6946495|NCT00979576|10984619|FG002|Combination Followed by Monotherapy|Progressive Disease|1
6946496|NCT00979602|10984630|FG000|Overall Study|Serious Adverse Event|5
7069541|NCT02002533|11171333|FG001|Overall Study|Withdrawal by Subject|13
7069542|NCT02002533|11171332|FG000|Overall Study|Protocol Violation|0
7069543|NCT02002533|11171333|FG001|Overall Study|Protocol Violation|1
7069544|NCT02002533|11171332|FG000|Overall Study|Adverse Event|0
7069545|NCT02002533|11171333|FG001|Overall Study|Adverse Event|3
7069546|NCT02002533|11171332|FG000|Overall Study|Lost to Follow-up|0
7069547|NCT02002533|11171333|FG001|Overall Study|Lost to Follow-up|1
7069548|NCT02002689|11171350|FG000|Overall Study|Disease Progression|7
7069549|NCT02002689|11171350|FG000|Overall Study|Adverse Event|3
7082606|NCT02143713|11193211|FG000|Treatment Period (6 Months)|Lost to Follow-up|3
7082607|NCT02143713|11193212|FG001|Treatment Period (6 Months)|Lost to Follow-up|0
7082608|NCT02143713|11193213|FG002|Treatment Period (6 Months)|Lost to Follow-up|4
7082609|NCT02143713|11193214|FG003|Treatment Period (6 Months)|Lost to Follow-up|3
7082610|NCT02143713|11193211|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2
7082611|NCT02143713|11193212|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0
7082612|NCT02143713|11193213|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0
7082613|NCT02143713|11193214|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2
7082614|NCT02143713|11193211|FG000|Treatment Period (6 Months)|Pregnancy|0
7082615|NCT02143713|11193212|FG001|Treatment Period (6 Months)|Pregnancy|2
7082616|NCT02143713|11193213|FG002|Treatment Period (6 Months)|Pregnancy|2
7082617|NCT02143713|11193214|FG003|Treatment Period (6 Months)|Pregnancy|0
7082618|NCT02143713|11193211|FG000|Treatment Period (6 Months)|Non-compliance|1
7082619|NCT02143713|11193212|FG001|Treatment Period (6 Months)|Non-compliance|0
7082620|NCT02143713|11193213|FG002|Treatment Period (6 Months)|Non-compliance|0
7082621|NCT02143713|11193214|FG003|Treatment Period (6 Months)|Non-compliance|3
7082622|NCT02143713|11193211|FG000|Treatment Period (6 Months)|Other|3
7082623|NCT02143713|11193212|FG001|Treatment Period (6 Months)|Other|0
7082624|NCT02143713|11193213|FG002|Treatment Period (6 Months)|Other|3
7082625|NCT02143713|11193214|FG003|Treatment Period (6 Months)|Other|2
7082626|NCT02143713|11193211|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
7082627|NCT02143713|11193212|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
7082628|NCT02143713|11193213|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
7082629|NCT02143713|11193214|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4
7082630|NCT02143713|11193211|FG000|Treatment Period (6 Months)|Exclusionary Medication|2
7082631|NCT02143713|11193212|FG001|Treatment Period (6 Months)|Exclusionary Medication|0
7082632|NCT02143713|11193213|FG002|Treatment Period (6 Months)|Exclusionary Medication|0
7082633|NCT02143713|11193214|FG003|Treatment Period (6 Months)|Exclusionary Medication|0
7082634|NCT02143713|11193211|FG000|Treatment Period (6 Months)|Lack of Efficacy|1
7082635|NCT02143713|11193212|FG001|Treatment Period (6 Months)|Lack of Efficacy|0
6946497|NCT00979602|10984631|FG001|Overall Study|Serious Adverse Event|3
6946498|NCT00979602|10984630|FG000|Overall Study|Protocol Violation|3
6946499|NCT00979602|10984631|FG001|Overall Study|Protocol Violation|0
6946500|NCT00979602|10984630|FG000|Overall Study|Withdrawal by Subject|31
7082636|NCT02143713|11193213|FG002|Treatment Period (6 Months)|Lack of Efficacy|0
7082637|NCT02143713|11193214|FG003|Treatment Period (6 Months)|Lack of Efficacy|1
7082638|NCT02143713|11193211|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4
7082639|NCT02143713|11193212|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7
7069550|NCT02002884|11171394|FG000|Main Period (MP)|Other|0
7069551|NCT02002884|11171395|FG001|Main Period (MP)|Other|3
7069552|NCT02002884|11171396|FG002|Main Period (MP)|Other|3
7069553|NCT02002884|11171397|FG003|Main Period (MP)|Other|0
7069554|NCT02002884|11171394|FG000|Main Period (MP)|Adverse Event|0
7069555|NCT02002884|11171395|FG001|Main Period (MP)|Adverse Event|1
7069556|NCT02002884|11171396|FG002|Main Period (MP)|Adverse Event|1
7069557|NCT02002884|11171397|FG003|Main Period (MP)|Adverse Event|0
7069558|NCT02002884|11171394|FG000|Main Period (MP)|Withdrawal by Subject|6
7069559|NCT02002884|11171395|FG001|Main Period (MP)|Withdrawal by Subject|2
7069560|NCT02002884|11171396|FG002|Main Period (MP)|Withdrawal by Subject|2
7069561|NCT02002884|11171397|FG003|Main Period (MP)|Withdrawal by Subject|0
7069562|NCT02002884|11171394|FG000|Main Period (MP)|Lost to Follow-up|0
7069563|NCT02002884|11171395|FG001|Main Period (MP)|Lost to Follow-up|0
7069564|NCT02002884|11171396|FG002|Main Period (MP)|Lost to Follow-up|2
7069565|NCT02002884|11171397|FG003|Main Period (MP)|Lost to Follow-up|0
7069566|NCT02002884|11171394|FG000|Open-Label Extension Period (OLEX)|Other|0
7069567|NCT02002884|11171395|FG001|Open-Label Extension Period (OLEX)|Other|0
7069568|NCT02002884|11171396|FG002|Open-Label Extension Period (OLEX)|Other|0
7069569|NCT02002884|11171397|FG003|Open-Label Extension Period (OLEX)|Other|24
6946501|NCT00979602|10984631|FG001|Overall Study|Withdrawal by Subject|25
7069570|NCT02002884|11171394|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0
7069571|NCT02002884|11171395|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0
7069572|NCT02002884|11171396|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0
7069573|NCT02002884|11171397|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1
7069574|NCT02002884|11171394|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0
7069575|NCT02002884|11171395|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0
7069576|NCT02002884|11171396|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0
7069577|NCT02002884|11171397|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5
7069578|NCT02002884|11171394|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0
7069579|NCT02002884|11171395|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0
7069580|NCT02002884|11171396|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0
7069581|NCT02002884|11171397|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10
7069582|NCT02002884|11171394|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0
7069583|NCT02002884|11171395|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0
7069584|NCT02002884|11171396|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0
7069585|NCT02002884|11171397|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10
7069586|NCT02002975|11171411|FG000|Overall Study|Case Report Forms Uncollected|135
7069587|NCT02002975|11171411|FG000|Overall Study|Protocol Deviation|437
7069588|NCT02003014|11171415|FG000|Overall Study|Case report forms uncollected|9
7069589|NCT02003014|11171415|FG000|Overall Study|Treatment started after contract period|1
7069590|NCT02003014|11171415|FG000|Overall Study|Patient did not visit the study site|5
6946502|NCT00979602|10984630|FG000|Overall Study|Lost to Follow-up|100
6946503|NCT00979602|10984631|FG001|Overall Study|Lost to Follow-up|96
6946504|NCT00979602|10984630|FG000|Overall Study|Migrated/moved from study area|3
6946505|NCT00979602|10984631|FG001|Overall Study|Migrated/moved from study area|6
6946506|NCT00979602|10984630|FG000|Overall Study|Others|3
6946507|NCT00979602|10984631|FG001|Overall Study|Others|3
6946508|NCT00979628|10984661|FG000|Overall Study|received regimen < 24 hours|7
6946509|NCT00979628|10984662|FG001|Overall Study|received regimen < 24 hours|6
6946510|NCT00979628|10984663|FG002|Overall Study|received regimen < 24 hours|5
6946511|NCT00979628|10984661|FG000|Overall Study|received steroids|1
6946512|NCT00979628|10984662|FG001|Overall Study|received steroids|1
6946513|NCT00979628|10984663|FG002|Overall Study|received steroids|0
6946514|NCT00979628|10984661|FG000|Overall Study|transferred to ICU|1
6946515|NCT00979628|10984662|FG001|Overall Study|transferred to ICU|2
6946516|NCT00979628|10984663|FG002|Overall Study|transferred to ICU|1
6946517|NCT00979654|10984674|FG000|Overall Study|Lost to Follow-up|1
6946518|NCT00979654|10984674|FG000|Overall Study|Withdrawal by Subject|22
6946519|NCT00979654|10984674|FG000|Overall Study|Death|1
6946520|NCT00979654|10984674|FG000|Overall Study|Lack of Efficacy|6
6946521|NCT00979654|10984674|FG000|Overall Study|Adverse Event|1
6946522|NCT00979654|10984674|FG000|Overall Study|Adverse Event of Diverticulitis|1
6946523|NCT00979654|10984674|FG000|Overall Study|Per Principal Investigator's Discretion|1
6946524|NCT00979654|10984674|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1
6946525|NCT00979654|10984674|FG000|Overall Study|Serious Adverse Event|1
6946526|NCT00979654|10984674|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1
6946527|NCT00979953|10984728|FG000|Overall Study|Adverse Event|5
6946528|NCT00979953|10984729|FG001|Overall Study|Adverse Event|2
6946529|NCT00979953|10984730|FG002|Overall Study|Adverse Event|17
6946530|NCT00979953|10984731|FG003|Overall Study|Adverse Event|4
6946531|NCT00979953|10984728|FG000|Overall Study|Lack of Efficacy|1
6946532|NCT00979953|10984729|FG001|Overall Study|Lack of Efficacy|2
6946533|NCT00979953|10984730|FG002|Overall Study|Lack of Efficacy|0
6946534|NCT00979953|10984731|FG003|Overall Study|Lack of Efficacy|0
6946535|NCT00979953|10984728|FG000|Overall Study|Lost to Follow-up|1
7069591|NCT02003014|11171415|FG000|Overall Study|Investigator's transfer|4
7069592|NCT02003183|11171430|FG000|Overall Study|Lost to Follow-up|0
7069593|NCT02003183|11171431|FG001|Overall Study|Lost to Follow-up|2
6946536|NCT00979953|10984729|FG001|Overall Study|Lost to Follow-up|1
6946537|NCT00979953|10984730|FG002|Overall Study|Lost to Follow-up|1
6946538|NCT00979953|10984731|FG003|Overall Study|Lost to Follow-up|0
6946539|NCT00979953|10984728|FG000|Overall Study|Withdrawal by Subject|0
6946540|NCT00979953|10984729|FG001|Overall Study|Withdrawal by Subject|0
6946541|NCT00979953|10984730|FG002|Overall Study|Withdrawal by Subject|2
6946542|NCT00979953|10984731|FG003|Overall Study|Withdrawal by Subject|1
6946543|NCT00979953|10984728|FG000|Overall Study|Protocol Violation|1
6946544|NCT00979953|10984729|FG001|Overall Study|Protocol Violation|0
6946545|NCT00979953|10984730|FG002|Overall Study|Protocol Violation|2
6946546|NCT00979953|10984731|FG003|Overall Study|Protocol Violation|2
6946547|NCT00979992|10984741|FG000|Overall Study|Ineligible - inadequate pathology|1
6946548|NCT00979992|10984741|FG000|Overall Study|Ineligible - wrong cell type|2
6946549|NCT00979992|10984741|FG000|Overall Study|Refused - Never Treated|2
6946550|NCT00980005|10984747|FG000|Overall Study|Withdrawal by Subject|6
6946551|NCT00980005|10984748|FG001|Overall Study|Withdrawal by Subject|17
6946552|NCT00980005|10984747|FG000|Overall Study|Lost to Follow-up|37
6946553|NCT00980005|10984748|FG001|Overall Study|Lost to Follow-up|43
6946554|NCT00980005|10984747|FG000|Overall Study|Other|4
6946555|NCT00980005|10984748|FG001|Overall Study|Other|3
6946556|NCT00980018|10984758|FG000|Overall Study|Adverse Event|8
6946557|NCT00980018|10984758|FG000|Overall Study|Patient withdrew consent|3
6946558|NCT00980018|10984758|FG000|Overall Study|Lost to Follow-up|1
6946559|NCT00980044|10984765|FG000|Overall Study|Withdrawal by Subject|5
6946560|NCT00980044|10984766|FG001|Overall Study|Withdrawal by Subject|7
6946561|NCT00980044|10984767|FG002|Overall Study|Withdrawal by Subject|3
6946562|NCT00980044|10984765|FG000|Overall Study|Protocol Violation|0
6946563|NCT00980044|10984766|FG001|Overall Study|Protocol Violation|0
6946564|NCT00980044|10984767|FG002|Overall Study|Protocol Violation|2
6946565|NCT00980057|10984780|FG000|Overall Study|Death|13
6946566|NCT00980057|10984781|FG001|Overall Study|Death|3
6946567|NCT00980057|10984780|FG000|Overall Study|Adverse Event|0
6946568|NCT00980057|10984781|FG001|Overall Study|Adverse Event|1
6946569|NCT00980057|10984780|FG000|Overall Study|Physician Decision|4
6946570|NCT00980057|10984781|FG001|Overall Study|Physician Decision|0
6946571|NCT00980057|10984780|FG000|Overall Study|Lost to Follow-up|1
6946572|NCT00980057|10984781|FG001|Overall Study|Lost to Follow-up|0
6946573|NCT00980057|10984780|FG000|Overall Study|Withdrawal by Subject|1
6946574|NCT00980057|10984781|FG001|Overall Study|Withdrawal by Subject|1
6946575|NCT00980148|10984790|FG000|Overall Study|Discharged from facility|89
6946576|NCT00980148|10984791|FG001|Overall Study|Discharged from facility|96
6946577|NCT00980148|10984790|FG000|Overall Study|Received other antichlamydia treatment|20
6946578|NCT00980148|10984791|FG001|Overall Study|Received other antichlamydia treatment|14
6946579|NCT00980148|10984790|FG000|Overall Study|Negative for chlamydia at enrollment|12
6946580|NCT00980148|10984791|FG001|Overall Study|Negative for chlamydia at enrollment|9
6946581|NCT00980148|10984790|FG000|Overall Study|Various other reasons|8
6946582|NCT00980148|10984791|FG001|Overall Study|Various other reasons|9
6946583|NCT00980174|10984799|FG000|Overall Study|Withdrawal by Subject|1
6946584|NCT00980174|10984800|FG001|Overall Study|Withdrawal by Subject|4
6946585|NCT00980174|10984799|FG000|Overall Study|Adverse Event|0
6946586|NCT00980174|10984800|FG001|Overall Study|Adverse Event|3
6946587|NCT00980174|10984799|FG000|Overall Study|Ineligibility determined|2
6946588|NCT00980174|10984800|FG001|Overall Study|Ineligibility determined|1
6946589|NCT00980174|10984799|FG000|Overall Study|Death|1
6946590|NCT00980174|10984800|FG001|Overall Study|Death|1
6946591|NCT00980174|10984799|FG000|Overall Study|Other|0
6946592|NCT00980174|10984800|FG001|Overall Study|Other|1
6946593|NCT00980200|10984806|FG000|7-day Treatment Period 1|Withdrawal by Subject|0
6946594|NCT00980200|10984807|FG001|7-day Treatment Period 1|Withdrawal by Subject|1
6946595|NCT00980200|10984808|FG002|7-day Treatment Period 1|Withdrawal by Subject|0
6946596|NCT00980200|10984809|FG003|7-day Treatment Period 1|Withdrawal by Subject|0
6946597|NCT00980200|10984810|FG004|7-day Treatment Period 1|Withdrawal by Subject|0
6946598|NCT00980200|10984806|FG000|7-day Treatment Period 3|Lack of Efficacy|0
6946599|NCT00980200|10984807|FG001|7-day Treatment Period 3|Lack of Efficacy|1
6946600|NCT00980200|10984808|FG002|7-day Treatment Period 3|Lack of Efficacy|0
6946601|NCT00980200|10984809|FG003|7-day Treatment Period 3|Lack of Efficacy|0
6946602|NCT00980200|10984810|FG004|7-day Treatment Period 3|Lack of Efficacy|1
6946603|NCT00980330|10984838|FG000|Overall Study|Adverse Event|0
6946604|NCT00980330|10984839|FG001|Overall Study|Adverse Event|0
6946605|NCT00980330|10984840|FG002|Overall Study|Adverse Event|0
6946606|NCT00980330|10984841|FG003|Overall Study|Adverse Event|1
6946607|NCT00980330|10984842|FG004|Overall Study|Adverse Event|0
6946608|NCT00980330|10984843|FG005|Overall Study|Adverse Event|0
6946609|NCT00980330|10984844|FG006|Overall Study|Adverse Event|0
6946610|NCT00980330|10984838|FG000|Overall Study|Lost to Follow-up|1
6946611|NCT00980330|10984839|FG001|Overall Study|Lost to Follow-up|1
6946612|NCT00980330|10984840|FG002|Overall Study|Lost to Follow-up|4
6946613|NCT00980330|10984841|FG003|Overall Study|Lost to Follow-up|2
6946614|NCT00980330|10984842|FG004|Overall Study|Lost to Follow-up|1
6946615|NCT00980330|10984843|FG005|Overall Study|Lost to Follow-up|1
6946616|NCT00980330|10984844|FG006|Overall Study|Lost to Follow-up|2
6946617|NCT00980330|10984838|FG000|Overall Study|Withdrawal by Subject|2
6946618|NCT00980330|10984839|FG001|Overall Study|Withdrawal by Subject|4
6946619|NCT00980330|10984840|FG002|Overall Study|Withdrawal by Subject|4
6946620|NCT00980330|10984841|FG003|Overall Study|Withdrawal by Subject|1
6946621|NCT00980330|10984842|FG004|Overall Study|Withdrawal by Subject|3
6946622|NCT00980330|10984843|FG005|Overall Study|Withdrawal by Subject|2
6946623|NCT00980330|10984844|FG006|Overall Study|Withdrawal by Subject|5
6946624|NCT00980330|10984838|FG000|Overall Study|(not specified)|2
6946625|NCT00980330|10984839|FG001|Overall Study|(not specified)|0
6946626|NCT00980330|10984840|FG002|Overall Study|(not specified)|0
6946627|NCT00980330|10984841|FG003|Overall Study|(not specified)|1
6946628|NCT00980330|10984842|FG004|Overall Study|(not specified)|1
6946629|NCT00980330|10984843|FG005|Overall Study|(not specified)|1
6946630|NCT00980330|10984844|FG006|Overall Study|(not specified)|0
6946631|NCT00980343|10984863|FG000|Overall Study|no tumor at surgery - treatment effect|1
6946632|NCT00980343|10984864|FG001|Overall Study|no tumor at surgery - treatment effect|3
6946633|NCT00980655|10984896|FG000|Overall Study|Adverse Event|13
6946634|NCT00980655|10984897|FG001|Overall Study|Adverse Event|31
6946635|NCT00980655|10984896|FG000|Overall Study|Death|0
6946636|NCT00980655|10984897|FG001|Overall Study|Death|7
6946637|NCT00980655|10984896|FG000|Overall Study|Protocol Violation|2
6946638|NCT00980655|10984897|FG001|Overall Study|Protocol Violation|7
6946639|NCT00980655|10984896|FG000|Overall Study|Withdrawal by Subject|0
6946640|NCT00980655|10984897|FG001|Overall Study|Withdrawal by Subject|4
6946641|NCT00980655|10984896|FG000|Overall Study|Lost to Follow-up|0
6946642|NCT00980655|10984897|FG001|Overall Study|Lost to Follow-up|1
6946643|NCT00980655|10984896|FG000|Overall Study|Parent/legal guardian request|1
6946644|NCT00980655|10984897|FG001|Overall Study|Parent/legal guardian request|0
6946645|NCT00980655|10984896|FG000|Overall Study|Other|0
6946646|NCT00980655|10984897|FG001|Overall Study|Other|1
6946647|NCT00980798|10984950|FG000|Overall Study|Adverse Event|7
6946648|NCT00980798|10984951|FG001|Overall Study|Adverse Event|36
6946649|NCT00980798|10984950|FG000|Overall Study|Lack of Efficacy|16
6946650|NCT00980798|10984951|FG001|Overall Study|Lack of Efficacy|5
6946651|NCT00980798|10984950|FG000|Overall Study|Lost to Follow-up|0
6946652|NCT00980798|10984951|FG001|Overall Study|Lost to Follow-up|1
6946653|NCT00980798|10984950|FG000|Overall Study|Physician Decision|2
6946654|NCT00980798|10984951|FG001|Overall Study|Physician Decision|1
6946655|NCT00980798|10984950|FG000|Overall Study|Withdrawal by Subject|8
6946656|NCT00980798|10984951|FG001|Overall Study|Withdrawal by Subject|11
6946657|NCT00980798|10984950|FG000|Overall Study|Other|0
6946658|NCT00980798|10984951|FG001|Overall Study|Other|1
6946659|NCT00980980|10984960|FG000|Overall Study|Withdrawal by Hospital|0
6946660|NCT00980980|10984961|FG001|Overall Study|Withdrawal by Hospital|1
6946661|NCT00980980|10984962|FG002|Overall Study|Withdrawal by Hospital|0
6946662|NCT00981019|10984973|FG000|Overall Study|Did not respond|65
6946663|NCT00981019|10984973|FG000|Overall Study|Did not match target population|94
6946664|NCT00981019|10984973|FG000|Overall Study|Inadvertent exclusion|239
6946665|NCT00981019|10984973|FG000|Overall Study|Hit the survey after closure|79
6946666|NCT00981084|10984988|FG000|Post Intervention (Data Analysis)|poor effort|1
6946667|NCT00981084|10984989|FG001|Post Intervention (Data Analysis)|poor effort|1
6946668|NCT00981084|10984988|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1
6946669|NCT00981084|10984989|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0
6946670|NCT00981149|10984999|FG000|Overall Study|Lost to Follow-up|1
6946671|NCT00981149|10985000|FG001|Overall Study|Lost to Follow-up|2
6946672|NCT00981149|10984999|FG000|Overall Study|Withdrawal by Subject|1
6946673|NCT00981149|10985000|FG001|Overall Study|Withdrawal by Subject|1
6946674|NCT00981175|10985009|FG000|Primary Dose Vaccination|Adverse Event|1
6946675|NCT00981175|10985010|FG001|Primary Dose Vaccination|Adverse Event|0
6946676|NCT00981175|10985009|FG000|Primary Dose Vaccination|Protocol Violation|0
6946677|NCT00981175|10985010|FG001|Primary Dose Vaccination|Protocol Violation|1
6946678|NCT00981175|10985009|FG000|Primary Dose Vaccination|Lost to Follow-up|2
6946679|NCT00981175|10985010|FG001|Primary Dose Vaccination|Lost to Follow-up|1
6946680|NCT00981175|10985009|FG000|Booster Dose Vaccination|Lost to Follow-up|2
6946681|NCT00981175|10985010|FG001|Booster Dose Vaccination|Lost to Follow-up|3
6946682|NCT00981292|10985072|FG000|Day 1|Protocol Violation|1
6946683|NCT00981292|10985073|FG001|Day 1|Protocol Violation|0
6946684|NCT00981292|10985074|FG002|Day 1|Protocol Violation|0
6946685|NCT00981292|10985075|FG003|Day 1|Protocol Violation|0
6946686|NCT00981292|10985076|FG004|Day 1|Protocol Violation|0
6946687|NCT00981292|10985077|FG005|Day 1|Protocol Violation|2
6946688|NCT00981292|10985072|FG000|Day 2|Protocol Violation|2
6946689|NCT00981292|10985073|FG001|Day 2|Protocol Violation|0
6946690|NCT00981292|10985074|FG002|Day 2|Protocol Violation|0
6946691|NCT00981292|10985075|FG003|Day 2|Protocol Violation|0
6946692|NCT00981292|10985076|FG004|Day 2|Protocol Violation|0
6946693|NCT00981292|10985077|FG005|Day 2|Protocol Violation|0
6946694|NCT00981292|10985072|FG000|Day 3|Protocol Violation|0
7040744|NCT01719757|11123842|FG000|Overall Study|Withdrawal by Subject|15
6946695|NCT00981292|10985073|FG001|Day 3|Protocol Violation|0
6946696|NCT00981292|10985074|FG002|Day 3|Protocol Violation|0
6946697|NCT00981292|10985075|FG003|Day 3|Protocol Violation|0
6946698|NCT00981292|10985076|FG004|Day 3|Protocol Violation|0
6946699|NCT00981292|10985077|FG005|Day 3|Protocol Violation|1
6946700|NCT00981409|10985100|FG000|Overall Study|Adverse Event|4
6946701|NCT00981409|10985101|FG001|Overall Study|Adverse Event|0
6946702|NCT00981409|10985100|FG000|Overall Study|Protocol Violation|0
6946703|NCT00981409|10985101|FG001|Overall Study|Protocol Violation|1
6946704|NCT00981409|10985100|FG000|Overall Study|Prostate Cancer Treatment before Trial|2
6946705|NCT00981409|10985101|FG001|Overall Study|Prostate Cancer Treatment before Trial|0
6946706|NCT00981461|10985122|FG000|Overall Study|Lost to Follow-up|5
6946707|NCT00981461|10985123|FG001|Overall Study|Lost to Follow-up|2
6946708|NCT00981526|10985142|FG000|Overall Study|Withdrawal by Subject|0
6946709|NCT00981526|10985143|FG001|Overall Study|Withdrawal by Subject|2
6946710|NCT00981526|10985142|FG000|Overall Study|Physician Decision|4
6946711|NCT00981526|10985143|FG001|Overall Study|Physician Decision|4
6946712|NCT00981578|10985151|FG000|Overall Study|Death|1
6946713|NCT00981578|10985151|FG000|Overall Study|Withdrawal by Subject|2
6946714|NCT00981682|10985181|FG000|Overall Study|Adverse Event|48
6946715|NCT00981682|10985181|FG000|Overall Study|Withdrawal by Subject|52
6946716|NCT00981682|10985181|FG000|Overall Study|Lost to Follow-up|14
6946717|NCT00981682|10985181|FG000|Overall Study|Lack of Efficacy|13
6946718|NCT00981682|10985181|FG000|Overall Study|Protocol Violation|6
6946719|NCT00981682|10985181|FG000|Overall Study|administrative|9
6946720|NCT00981747|10985185|FG000|Losartan|Withdrawal by Subject|1
6946721|NCT00981747|10985185|FG000|Losartan|Death|1
6946722|NCT00981747|10985185|FG000|Placebo Oral Tablet|Withdrawal by Subject|1
6946723|NCT00981799|10985199|FG000|Overall Study|Adverse Event|1
6946724|NCT00981799|10985200|FG001|Overall Study|Adverse Event|1
6946725|NCT00981799|10985201|FG002|Overall Study|Adverse Event|0
6946726|NCT00981799|10985202|FG003|Overall Study|Adverse Event|0
6946727|NCT00982020|10985245|FG000|Overall Study|Adverse Event|19
6946728|NCT00982020|10985246|FG001|Overall Study|Adverse Event|15
6946729|NCT00982020|10985245|FG000|Overall Study|Withdrawal by Subject|11
6946730|NCT00982020|10985246|FG001|Overall Study|Withdrawal by Subject|14
6946731|NCT00982020|10985245|FG000|Overall Study|Lost to Follow-up|5
6946732|NCT00982020|10985246|FG001|Overall Study|Lost to Follow-up|11
6946733|NCT00982020|10985245|FG000|Overall Study|Lack of Efficacy|10
6946734|NCT00982020|10985246|FG001|Overall Study|Lack of Efficacy|4
6946735|NCT00982020|10985245|FG000|Overall Study|Parent/Caregiver Decision|5
6946736|NCT00982020|10985246|FG001|Overall Study|Parent/Caregiver Decision|5
6946737|NCT00982020|10985245|FG000|Overall Study|Treatment Non-compliance|3
6946738|NCT00982020|10985246|FG001|Overall Study|Treatment Non-compliance|6
6946739|NCT00982020|10985245|FG000|Overall Study|Physician Decision|2
6946740|NCT00982020|10985246|FG001|Overall Study|Physician Decision|5
6946741|NCT00982020|10985245|FG000|Overall Study|Entry Criteria Not Met|2
6946742|NCT00982020|10985246|FG001|Overall Study|Entry Criteria Not Met|1
6946743|NCT00982020|10985245|FG000|Overall Study|Protocol Violation|0
6946744|NCT00982020|10985246|FG001|Overall Study|Protocol Violation|2
6946745|NCT00982020|10985245|FG000|Overall Study|Clinical Relapse|0
6946746|NCT00982020|10985246|FG001|Overall Study|Clinical Relapse|1
6946747|NCT00982137|10985279|FG000|Overall Study|Lost to Follow-up|0
6946748|NCT00982137|10985280|FG001|Overall Study|Lost to Follow-up|0
6946749|NCT00982137|10985281|FG002|Overall Study|Lost to Follow-up|0
6946750|NCT00982137|10985282|FG003|Overall Study|Lost to Follow-up|1
6946751|NCT00982137|10985279|FG000|Overall Study|Withdrawal by Subject|0
6946752|NCT00982137|10985280|FG001|Overall Study|Withdrawal by Subject|1
6946753|NCT00982137|10985281|FG002|Overall Study|Withdrawal by Subject|0
6946754|NCT00982137|10985282|FG003|Overall Study|Withdrawal by Subject|0
6946755|NCT00982228|10985320|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12
6946756|NCT00982228|10985321|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2
6946757|NCT00982228|10985320|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2
6946758|NCT00982228|10985321|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0
6946759|NCT00982228|10985320|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11
6946760|NCT00982228|10985321|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2
6946761|NCT00982228|10985320|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15
6946762|NCT00982228|10985321|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3
6946763|NCT00982228|10985320|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28
6946764|NCT00982228|10985321|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13
6946765|NCT00982228|10985320|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3
6946766|NCT00982228|10985321|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2
6946767|NCT00982228|10985320|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1
6946768|NCT00982228|10985321|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0
6946769|NCT00982228|10985320|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1
6946770|NCT00982228|10985321|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2
6946771|NCT00982228|10985320|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5
6946772|NCT00982228|10985321|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0
6946773|NCT00982228|10985320|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11
6946774|NCT00982228|10985321|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1
6946775|NCT00982280|10985327|FG000|Observation Period|Not eligible to be dosed|19
6946776|NCT00982280|10985327|FG000|Titration and Optimal Dose Period|Adverse Event|5
6946777|NCT00982280|10985327|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2
6946778|NCT00982280|10985327|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1
6946779|NCT00982280|10985327|FG000|Maintenance Period|Adverse Event|1
6946780|NCT00982319|10985334|FG000|Overall Study|Surgery date change|1
6946781|NCT00982319|10985335|FG001|Overall Study|Surgery date change|0
6946782|NCT00982319|10985334|FG000|Overall Study|Preop values out of acceptable range|1
6946783|NCT00982319|10985335|FG001|Overall Study|Preop values out of acceptable range|1
6946784|NCT00982319|10985334|FG000|Overall Study|Pregnancy|0
6946785|NCT00982319|10985335|FG001|Overall Study|Pregnancy|1
6975827|NCT01194830|11028014|FG000|Overall Study|Adverse Event|3
6946786|NCT00982410|10985359|FG000|3-month Follow-up Assessment|Could not reach to schedule|8
6946787|NCT00982410|10985360|FG001|3-month Follow-up Assessment|Could not reach to schedule|9
6946788|NCT00982410|10985359|FG000|3-month Follow-up Assessment|Scheduled, no-show|1
6946789|NCT00982410|10985360|FG001|3-month Follow-up Assessment|Scheduled, no-show|2
6946790|NCT00982410|10985359|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0
6946791|NCT00982410|10985360|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2
6946792|NCT00982410|10985359|FG000|6-month Follow-up Assessment|Could not reach to schedule|5
6946793|NCT00982410|10985360|FG001|6-month Follow-up Assessment|Could not reach to schedule|7
6946794|NCT00982410|10985359|FG000|6-month Follow-up Assessment|participant no transportation|1
6946795|NCT00982410|10985360|FG001|6-month Follow-up Assessment|participant no transportation|0
6946796|NCT00982410|10985359|FG000|6-month Follow-up Assessment|incarceration|0
6946797|NCT00982410|10985360|FG001|6-month Follow-up Assessment|incarceration|2
6946798|NCT00982410|10985359|FG000|6-month Follow-up Assessment|patent surgery|0
6946799|NCT00982410|10985360|FG001|6-month Follow-up Assessment|patent surgery|1
7069594|NCT02003365|11171444|FG000|Overall Study|Lost to Follow-up|0
7069595|NCT02003365|11171445|FG001|Overall Study|Lost to Follow-up|0
7069596|NCT02003365|11171446|FG002|Overall Study|Lost to Follow-up|1
7069597|NCT02003391|11171456|FG000|Overall Study|Withdrawal by Subject|2
7069598|NCT02003391|11171457|FG001|Overall Study|Withdrawal by Subject|1
7069599|NCT02003391|11171456|FG000|Overall Study|Protocol Violation|0
7069600|NCT02003391|11171457|FG001|Overall Study|Protocol Violation|1
7069601|NCT02003391|11171456|FG000|Overall Study|Adverse Event|1
7069602|NCT02003391|11171457|FG001|Overall Study|Adverse Event|0
7069603|NCT02003534|11171478|FG000|Overall Study|Lost to Follow-up|47
7069604|NCT02003573|11171485|FG000|Overall Study|Progressive disease|2
7069605|NCT02003573|11171486|FG001|Overall Study|Progressive disease|0
7069606|NCT02003573|11171487|FG002|Overall Study|Progressive disease|1
7069607|NCT02003573|11171485|FG000|Overall Study|Other Adverse event|0
7069608|NCT02003573|11171486|FG001|Overall Study|Other Adverse event|1
7069609|NCT02003573|11171487|FG002|Overall Study|Other Adverse event|1
6946800|NCT00982410|10985359|FG000|6-month Follow-up Assessment|scheduled, no-show|0
6946801|NCT00982410|10985360|FG001|6-month Follow-up Assessment|scheduled, no-show|1
6946802|NCT00982410|10985359|FG000|12-month Follow-up Assessment|Death|0
6946803|NCT00982410|10985360|FG001|12-month Follow-up Assessment|Death|2
6946804|NCT00982410|10985359|FG000|12-month Follow-up Assessment|could not reach to schedule|6
6946805|NCT00982410|10985360|FG001|12-month Follow-up Assessment|could not reach to schedule|5
6946806|NCT00982410|10985359|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0
6946807|NCT00982410|10985360|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1
6946808|NCT00982410|10985359|FG000|12-month Follow-up Assessment|incarceration|2
6946809|NCT00982410|10985360|FG001|12-month Follow-up Assessment|incarceration|1
6946810|NCT00982410|10985359|FG000|12-month Follow-up Assessment|scheduled, no-show|1
6946811|NCT00982410|10985360|FG001|12-month Follow-up Assessment|scheduled, no-show|0
6946812|NCT00982488|10985382|FG000|Overall Study|Administrative reason by sponsor|81
6946813|NCT00982488|10985383|FG001|Overall Study|Administrative reason by sponsor|3
6946814|NCT00982488|10985384|FG002|Overall Study|Administrative reason by sponsor|11
6946815|NCT00982488|10985385|FG003|Overall Study|Administrative reason by sponsor|0
6946816|NCT00982488|10985386|FG004|Overall Study|Administrative reason by sponsor|0
6946817|NCT00982488|10985382|FG000|Overall Study|Adverse event unrelated to study drug|5
6946818|NCT00982488|10985383|FG001|Overall Study|Adverse event unrelated to study drug|1
6946819|NCT00982488|10985384|FG002|Overall Study|Adverse event unrelated to study drug|0
6946820|NCT00982488|10985385|FG003|Overall Study|Adverse event unrelated to study drug|0
6946821|NCT00982488|10985386|FG004|Overall Study|Adverse event unrelated to study drug|0
6946822|NCT00982488|10985382|FG000|Overall Study|Death|11
6946823|NCT00982488|10985383|FG001|Overall Study|Death|0
6946824|NCT00982488|10985384|FG002|Overall Study|Death|2
6946825|NCT00982488|10985385|FG003|Overall Study|Death|0
6946826|NCT00982488|10985386|FG004|Overall Study|Death|0
6946827|NCT00982488|10985382|FG000|Overall Study|Disease progression|30
6946828|NCT00982488|10985383|FG001|Overall Study|Disease progression|5
6946829|NCT00982488|10985384|FG002|Overall Study|Disease progression|10
6946830|NCT00982488|10985385|FG003|Overall Study|Disease progression|1
6946831|NCT00982488|10985386|FG004|Overall Study|Disease progression|1
6946832|NCT00982488|10985382|FG000|Overall Study|Lost to Follow-up|1
6946833|NCT00982488|10985383|FG001|Overall Study|Lost to Follow-up|0
6946834|NCT00982488|10985384|FG002|Overall Study|Lost to Follow-up|0
6946835|NCT00982488|10985385|FG003|Overall Study|Lost to Follow-up|0
6946836|NCT00982488|10985386|FG004|Overall Study|Lost to Follow-up|0
6946837|NCT00982488|10985382|FG000|Overall Study|Maximum clinical benefit|1
6946838|NCT00982488|10985383|FG001|Overall Study|Maximum clinical benefit|1
6946839|NCT00982488|10985384|FG002|Overall Study|Maximum clinical benefit|1
6946840|NCT00982488|10985385|FG003|Overall Study|Maximum clinical benefit|0
6946841|NCT00982488|10985386|FG004|Overall Study|Maximum clinical benefit|0
6946842|NCT00982488|10985382|FG000|Overall Study|Other|15
6946843|NCT00982488|10985383|FG001|Overall Study|Other|1
7040745|NCT01719757|11123842|FG000|Overall Study|Lost to Follow-up|20
7040746|NCT01719757|11123842|FG000|Overall Study|Protocol Violation|1
7069610|NCT02003573|11171485|FG000|Overall Study|Refuse to take trial medication|0
7040747|NCT01719757|11123842|FG000|Overall Study|well controlled pain|27
7069611|NCT02003573|11171486|FG001|Overall Study|Refuse to take trial medication|1
7069612|NCT02003573|11171487|FG002|Overall Study|Refuse to take trial medication|1
6946844|NCT00982488|10985384|FG002|Overall Study|Other|3
6946845|NCT00982488|10985385|FG003|Overall Study|Other|1
6946846|NCT00982488|10985386|FG004|Overall Study|Other|0
6946847|NCT00982488|10985382|FG000|Overall Study|Poor compliance/noncompliance|0
6946848|NCT00982488|10985383|FG001|Overall Study|Poor compliance/noncompliance|1
6946849|NCT00982488|10985384|FG002|Overall Study|Poor compliance/noncompliance|0
6946850|NCT00982488|10985385|FG003|Overall Study|Poor compliance/noncompliance|0
6946851|NCT00982488|10985386|FG004|Overall Study|Poor compliance/noncompliance|0
6946852|NCT00982488|10985382|FG000|Overall Study|Stem cell transplant|2
6946853|NCT00982488|10985383|FG001|Overall Study|Stem cell transplant|0
6946854|NCT00982488|10985384|FG002|Overall Study|Stem cell transplant|0
6946855|NCT00982488|10985385|FG003|Overall Study|Stem cell transplant|1
6946856|NCT00982488|10985386|FG004|Overall Study|Stem cell transplant|0
6946857|NCT00982488|10985382|FG000|Overall Study|Study drug toxicity|34
6946858|NCT00982488|10985383|FG001|Overall Study|Study drug toxicity|1
6946859|NCT00982488|10985384|FG002|Overall Study|Study drug toxicity|6
6946860|NCT00982488|10985385|FG003|Overall Study|Study drug toxicity|0
6946861|NCT00982488|10985386|FG004|Overall Study|Study drug toxicity|0
6946862|NCT00982488|10985382|FG000|Overall Study|Withdrawal by Subject|5
6946863|NCT00982488|10985383|FG001|Overall Study|Withdrawal by Subject|1
6946864|NCT00982488|10985384|FG002|Overall Study|Withdrawal by Subject|1
6946865|NCT00982488|10985385|FG003|Overall Study|Withdrawal by Subject|0
6946866|NCT00982488|10985386|FG004|Overall Study|Withdrawal by Subject|0
6946867|NCT00982644|10985418|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20
6946868|NCT00982644|10985419|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5
6946869|NCT00982644|10985418|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7
6946870|NCT00982644|10985419|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2
6946871|NCT00982644|10985418|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46
6946872|NCT00982644|10985419|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18
6946873|NCT00982644|10985418|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9
6946874|NCT00982644|10985419|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5
6946875|NCT00982644|10985418|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84
6946876|NCT00982644|10985419|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30
6946877|NCT00982644|10985418|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12
6946878|NCT00982644|10985419|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5
6946879|NCT00982644|10985418|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3
6946880|NCT00982644|10985419|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1
6946881|NCT00982644|10985418|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2
6946882|NCT00982644|10985419|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4
6946883|NCT00982644|10985418|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6
6946884|NCT00982644|10985419|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3
6946885|NCT00982644|10985418|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23
6946886|NCT00982644|10985419|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7
6946887|NCT00982657|10985429|FG000|Overall Study|Death|1
6946888|NCT00982657|10985430|FG001|Overall Study|Death|0
6946889|NCT00982657|10985431|FG002|Overall Study|Death|1
6946890|NCT00982657|10985432|FG003|Overall Study|Death|1
6946891|NCT00982657|10985429|FG000|Overall Study|Withdrawal by Subject|0
6946892|NCT00982657|10985430|FG001|Overall Study|Withdrawal by Subject|0
6946893|NCT00982657|10985431|FG002|Overall Study|Withdrawal by Subject|1
6946894|NCT00982657|10985432|FG003|Overall Study|Withdrawal by Subject|3
6946895|NCT00982657|10985429|FG000|Overall Study|Other|0
6946896|NCT00982657|10985430|FG001|Overall Study|Other|0
6946897|NCT00982657|10985431|FG002|Overall Study|Other|0
6946898|NCT00982657|10985432|FG003|Overall Study|Other|4
6946899|NCT00982657|10985429|FG000|Overall Study|On going at date of cut-off|0
6946900|NCT00982657|10985430|FG001|Overall Study|On going at date of cut-off|0
6946901|NCT00982657|10985431|FG002|Overall Study|On going at date of cut-off|0
6946902|NCT00982657|10985432|FG003|Overall Study|On going at date of cut-off|1
6946903|NCT00982735|10985452|FG000|Overall Study|Lost to Follow-up|6
6946904|NCT00982735|10985452|FG000|Overall Study|Patient ineligible for trial|224
6946905|NCT00982878|10985510|FG000|Overall Study|Physician Decision|1
6946906|NCT00982930|10985514|FG000|Overall Study|Adverse Event|1
6946907|NCT00982930|10985514|FG000|Overall Study|Withdrawal by Subject|1
6946908|NCT00982930|10985514|FG000|Overall Study|Administrative Problems|2
6946909|NCT00983073|10985518|FG000|Titration and Optimal Dose Period|Adverse Event|19
6946910|NCT00983073|10985518|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11
6946911|NCT00983073|10985518|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5
6946912|NCT00983073|10985518|FG000|Titration and Optimal Dose Period|Non-Compliance|1
6946913|NCT00983073|10985518|FG000|Titration and Optimal Dose Period|Other reason|4
6946914|NCT00983073|10985518|FG000|Maintenance Period|Adverse Event|5
6946915|NCT00983073|10985518|FG000|Maintenance Period|Withdrawal by Subject|2
6946916|NCT00983073|10985518|FG000|Maintenance Period|Lack of Efficacy|2
6946917|NCT00983073|10985518|FG000|Maintenance Period|Other Reason|7
6946918|NCT00983294|10985546|FG000|14 Day Washout Period|Withdrawal by Subject|2
6946919|NCT00983294|10985546|FG000|Colchicine With Azithromycin|Adverse Event|1
6946920|NCT00983372|10985565|FG000|14 Day Washout Period|Withdrawal by Subject|1
6946921|NCT00983372|10985565|FG000|Diltiazem ER Alone|missed diltiazem dose|2
6946922|NCT00983372|10985565|FG000|Diltiazem ER Alone|Adverse Event|1
6946923|NCT00983385|10985572|FG000|Observation Period|Not eligible to be dosed|20
6946924|NCT00983385|10985572|FG000|Observation Period|Not Evaluable due to Non Compliance|12
6946925|NCT00983476|10985594|FG000|Overall Study|Did not receive intervention|17
6946926|NCT00983476|10985595|FG001|Overall Study|Did not receive intervention|22
6946927|NCT00983476|10985596|FG002|Overall Study|Did not receive intervention|0
6946928|NCT00983515|10985623|FG000|Ritonavir Alone|liver panel out of range|6
6946929|NCT00983515|10985623|FG000|Colchicine With Ritonavir|Lost to Follow-up|1
6946930|NCT00983528|10985630|FG000|Overall Study|Death|4
6946931|NCT00983528|10985630|FG000|Overall Study|Lost to Follow-up|1
6946932|NCT00983528|10985630|FG000|Overall Study|Study Terminated|1
6946933|NCT00983580|10985640|FG000|Overall Study|Cancel Prior to treatment|1
6946934|NCT00983580|10985641|FG001|Overall Study|Cancel Prior to treatment|3
6946935|NCT00983580|10985640|FG000|Overall Study|Protocol Violation|1
6946936|NCT00983580|10985641|FG001|Overall Study|Protocol Violation|1
6946937|NCT00983580|10985640|FG000|Overall Study|Ineligible|3
6946938|NCT00983580|10985641|FG001|Overall Study|Ineligible|0
6946939|NCT00983619|10985660|FG000|Overall Study|Lost to Follow-up|0
6946940|NCT00983619|10985661|FG001|Overall Study|Lost to Follow-up|1
6946941|NCT00983619|10985662|FG002|Overall Study|Lost to Follow-up|0
6946942|NCT00983619|10985663|FG003|Overall Study|Lost to Follow-up|0
6946943|NCT00983619|10985664|FG004|Overall Study|Lost to Follow-up|0
6946944|NCT00983619|10985665|FG005|Overall Study|Lost to Follow-up|2
6946945|NCT00983619|10985666|FG006|Overall Study|Lost to Follow-up|0
6946946|NCT00983619|10985667|FG007|Overall Study|Lost to Follow-up|0
6946947|NCT00983619|10985668|FG008|Overall Study|Lost to Follow-up|0
7040748|NCT01719783|11123850|FG000|Dose 2|Physician Decision|1
7040749|NCT01719783|11123851|FG001|Dose 2|Physician Decision|0
7040750|NCT01719861|11123877|FG000|Cycle 1|Death|4
7040751|NCT01719861|11123877|FG000|Cycle 2|Death|1
7069613|NCT02003573|11171485|FG000|Overall Study|Other than specified|1
7069614|NCT02003573|11171486|FG001|Overall Study|Other than specified|2
7069615|NCT02003573|11171487|FG002|Overall Study|Other than specified|3
7069616|NCT02003638|11171508|FG000|Overall Study|Withdrawal by Subject|1
7069617|NCT02003638|11171509|FG001|Overall Study|Withdrawal by Subject|0
7069618|NCT02003898|11171515|FG000|Overall Study|Death|3
7069619|NCT02003898|11171515|FG000|Overall Study|Lost to Follow-up|12
7069620|NCT02003898|11171515|FG000|Overall Study|Withdrawal by Subject|52
7069621|NCT02003963|11171530|FG000|Overall Study|Lost to Follow-up|2
7069622|NCT02003963|11171531|FG001|Overall Study|Lost to Follow-up|1
7069623|NCT02004093|11171541|FG000|Overall Study|Death|2
7069624|NCT02004093|11171542|FG001|Overall Study|Death|1
7069625|NCT02004093|11171541|FG000|Overall Study|Lack of Efficacy|66
7069626|NCT02004093|11171542|FG001|Overall Study|Lack of Efficacy|62
7069627|NCT02004093|11171541|FG000|Overall Study|Protocol Violation|0
7069628|NCT02004093|11171542|FG001|Overall Study|Protocol Violation|1
7069629|NCT02004093|11171541|FG000|Overall Study|Lost to Follow-up|0
7069630|NCT02004093|11171542|FG001|Overall Study|Lost to Follow-up|1
7069631|NCT02004093|11171541|FG000|Overall Study|Withdrawal by Subject|3
7069632|NCT02004093|11171542|FG001|Overall Study|Withdrawal by Subject|7
7069633|NCT02004093|11171541|FG000|Overall Study|Other|3
7069634|NCT02004093|11171542|FG001|Overall Study|Other|1
7069635|NCT02004236|11171564|FG000|Overall Study|Lack of Efficacy|0
7069636|NCT02004236|11171565|FG001|Overall Study|Lack of Efficacy|0
7069637|NCT02004236|11171566|FG002|Overall Study|Lack of Efficacy|16
7069638|NCT02004262|11171581|FG000|Overall Study|Death|67
7069639|NCT02004262|11171582|FG001|Overall Study|Death|64
7069640|NCT02004262|11171583|FG002|Overall Study|Death|66
7069641|NCT02004262|11171584|FG003|Overall Study|Death|28
7069642|NCT02004262|11171585|FG004|Overall Study|Death|29
7069643|NCT02004262|11171586|FG005|Overall Study|Death|22
7069644|NCT02004262|11171581|FG000|Overall Study|Withdrawal by Subject|1
7069645|NCT02004262|11171582|FG001|Overall Study|Withdrawal by Subject|0
7069646|NCT02004262|11171583|FG002|Overall Study|Withdrawal by Subject|4
6946948|NCT00983619|10985669|FG009|Overall Study|Lost to Follow-up|0
6946949|NCT00983619|10985670|FG010|Overall Study|Lost to Follow-up|0
6946950|NCT00983619|10985671|FG011|Overall Study|Lost to Follow-up|2
7044831|NCT01757691|11130851|FG000|Overall Study|Administrative problems|2
7044832|NCT01757691|11130852|FG001|Overall Study|Administrative problems|0
7044967|NCT01760954|11131187|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
7044968|NCT01760954|11131188|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
7044969|NCT01760954|11131189|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4
7069647|NCT02004262|11171584|FG003|Overall Study|Withdrawal by Subject|0
6946951|NCT00983619|10985660|FG000|Overall Study|Withdrawal by Subject|2
6946952|NCT00983619|10985661|FG001|Overall Study|Withdrawal by Subject|1
7069648|NCT02004262|11171585|FG004|Overall Study|Withdrawal by Subject|1
7069649|NCT02004262|11171586|FG005|Overall Study|Withdrawal by Subject|3
7069650|NCT02004262|11171581|FG000|Overall Study|Lost to Follow-up|1
7069651|NCT02004262|11171582|FG001|Overall Study|Lost to Follow-up|1
7069652|NCT02004262|11171583|FG002|Overall Study|Lost to Follow-up|0
6946953|NCT00983619|10985662|FG002|Overall Study|Withdrawal by Subject|1
6946954|NCT00983619|10985663|FG003|Overall Study|Withdrawal by Subject|3
7044970|NCT01760954|11131190|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9
7044971|NCT01760954|11131187|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4
7044972|NCT01760954|11131188|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7
7069653|NCT02004262|11171584|FG003|Overall Study|Lost to Follow-up|0
6946955|NCT00983619|10985664|FG004|Overall Study|Withdrawal by Subject|1
6946956|NCT00983619|10985665|FG005|Overall Study|Withdrawal by Subject|23
6946957|NCT00983619|10985666|FG006|Overall Study|Withdrawal by Subject|0
6946958|NCT00983619|10985667|FG007|Overall Study|Withdrawal by Subject|0
6946959|NCT00983619|10985668|FG008|Overall Study|Withdrawal by Subject|0
6946960|NCT00983619|10985669|FG009|Overall Study|Withdrawal by Subject|0
6946961|NCT00983619|10985670|FG010|Overall Study|Withdrawal by Subject|1
6946962|NCT00983619|10985671|FG011|Overall Study|Withdrawal by Subject|1
6946963|NCT00983619|10985660|FG000|Overall Study|Death|0
6946964|NCT00983619|10985661|FG001|Overall Study|Death|2
6946965|NCT00983619|10985662|FG002|Overall Study|Death|2
6946966|NCT00983619|10985663|FG003|Overall Study|Death|1
6946967|NCT00983619|10985664|FG004|Overall Study|Death|2
6946968|NCT00983619|10985665|FG005|Overall Study|Death|30
6946969|NCT00983619|10985666|FG006|Overall Study|Death|1
6946970|NCT00983619|10985667|FG007|Overall Study|Death|0
6946971|NCT00983619|10985668|FG008|Overall Study|Death|1
6946972|NCT00983619|10985669|FG009|Overall Study|Death|2
6946973|NCT00983619|10985670|FG010|Overall Study|Death|9
6946974|NCT00983619|10985671|FG011|Overall Study|Death|8
6946975|NCT00983619|10985660|FG000|Overall Study|Other|1
6946976|NCT00983619|10985661|FG001|Overall Study|Other|0
6946977|NCT00983619|10985662|FG002|Overall Study|Other|0
6946978|NCT00983619|10985663|FG003|Overall Study|Other|1
6946979|NCT00983619|10985664|FG004|Overall Study|Other|0
6946980|NCT00983619|10985665|FG005|Overall Study|Other|12
6946981|NCT00983619|10985666|FG006|Overall Study|Other|2
6946982|NCT00983619|10985667|FG007|Overall Study|Other|2
6946983|NCT00983619|10985668|FG008|Overall Study|Other|0
6946984|NCT00983619|10985669|FG009|Overall Study|Other|1
6946985|NCT00983619|10985670|FG010|Overall Study|Other|1
6946986|NCT00983619|10985671|FG011|Overall Study|Other|0
6946987|NCT00983749|10985719|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1
6946988|NCT00983749|10985720|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3
6946989|NCT00983827|10985730|FG000|Overall Study|Withdrawal by Subject|1
6946990|NCT00983853|10985740|FG000|Overall Study|Lost to Follow-up|1
6946991|NCT00983853|10985741|FG001|Overall Study|Lost to Follow-up|1
6946992|NCT00983853|10985742|FG002|Overall Study|Lost to Follow-up|2
6946993|NCT00983853|10985743|FG003|Overall Study|Lost to Follow-up|2
6946994|NCT00983853|10985744|FG004|Overall Study|Lost to Follow-up|2
6946995|NCT00983853|10985745|FG005|Overall Study|Lost to Follow-up|1
6946996|NCT00983853|10985740|FG000|Overall Study|Withdrawal by Subject|0
6946997|NCT00983853|10985741|FG001|Overall Study|Withdrawal by Subject|0
6946998|NCT00983853|10985742|FG002|Overall Study|Withdrawal by Subject|1
6946999|NCT00983853|10985743|FG003|Overall Study|Withdrawal by Subject|0
6947000|NCT00983853|10985744|FG004|Overall Study|Withdrawal by Subject|1
6947001|NCT00983853|10985745|FG005|Overall Study|Withdrawal by Subject|0
6947002|NCT00983853|10985740|FG000|Overall Study|Unable to come to study follow-up visits|0
6947003|NCT00983853|10985741|FG001|Overall Study|Unable to come to study follow-up visits|1
6947004|NCT00983853|10985742|FG002|Overall Study|Unable to come to study follow-up visits|0
6947005|NCT00983853|10985743|FG003|Overall Study|Unable to come to study follow-up visits|0
6947006|NCT00983853|10985744|FG004|Overall Study|Unable to come to study follow-up visits|0
6947007|NCT00983853|10985745|FG005|Overall Study|Unable to come to study follow-up visits|0
6947008|NCT00983892|10985763|FG000|Overall Study|Withdrawal by Subject|10
6947009|NCT00983892|10985764|FG001|Overall Study|Withdrawal by Subject|12
6975828|NCT01194830|11028015|FG001|Overall Study|Adverse Event|2
6975829|NCT01194830|11028014|FG000|Overall Study|Protocol Violation|5
6975830|NCT01194830|11028015|FG001|Overall Study|Protocol Violation|4
6975831|NCT01194830|11028014|FG000|Overall Study|Lost to Follow-up|9
6975832|NCT01194830|11028015|FG001|Overall Study|Lost to Follow-up|7
6975833|NCT01194830|11028014|FG000|Overall Study|Withdrawal by Subject|2
6975834|NCT01194830|11028015|FG001|Overall Study|Withdrawal by Subject|1
6975835|NCT01194830|11028014|FG000|Overall Study|Lack of Efficacy|1
6975836|NCT01194830|11028015|FG001|Overall Study|Lack of Efficacy|1
6975837|NCT01194830|11028014|FG000|Overall Study|Non-compliance issues|4
6975838|NCT01194830|11028015|FG001|Overall Study|Non-compliance issues|4
6975839|NCT01194830|11028014|FG000|Overall Study|Other Reason|12
6975840|NCT01194830|11028015|FG001|Overall Study|Other Reason|8
6975841|NCT01194869|11028021|FG000|Overall Study|Disease Progression|2
6975842|NCT01194869|11028021|FG000|Overall Study|Toxicity|2
6975843|NCT01194973|11028025|FG000|Screening Period|Screen Failure|3
6975844|NCT01194973|11028025|FG000|26 Week Treatment Period|Adverse Event|1
6975845|NCT01194973|11028025|FG000|26 Week Treatment Period|Lack of Efficacy|1
6975846|NCT01194973|11028025|FG000|26 Week Treatment Period|Pregnancy|1
6975847|NCT01194999|11028029|FG000|Overall Study|Lost to Follow-up|17
6975848|NCT01195090|11028045|FG000|Overall Study|Adverse Event|1
6975849|NCT01195090|11028046|FG001|Overall Study|Adverse Event|2
6975850|NCT01195090|11028045|FG000|Overall Study|Lost to Follow-up|2
6975851|NCT01195090|11028046|FG001|Overall Study|Lost to Follow-up|2
6975852|NCT01195090|11028045|FG000|Overall Study|Protocol Violation|3
6975853|NCT01195090|11028046|FG001|Overall Study|Protocol Violation|4
6975854|NCT01195103|11028055|FG000|Overall Study|Withdrawal by Subject|1
6975855|NCT01195103|11028056|FG001|Overall Study|Withdrawal by Subject|0
6975856|NCT01195103|11028057|FG002|Overall Study|Withdrawal by Subject|0
6975857|NCT01195272|11028074|FG000|Overall Study|Adverse Event|1
6975858|NCT01195272|11028074|FG000|Overall Study|Lack of Efficacy|3
6947010|NCT00983905|10985770|FG000|Theophylline Alone|Adverse Event|1
6947011|NCT00983905|10985770|FG000|Colchicine Alone|Adverse Event|2
6947012|NCT00983918|10985781|FG000|Overall Study|conversion to open cholecystectomy|0
6947013|NCT00983918|10985782|FG001|Overall Study|conversion to open cholecystectomy|2
6947014|NCT00983918|10985783|FG002|Overall Study|conversion to open cholecystectomy|2
6947015|NCT00983918|10985784|FG003|Overall Study|conversion to open cholecystectomy|2
6947016|NCT00983931|10985794|FG000|14 Day Washout Period|Physician Decision|1
6947017|NCT00983957|10985800|FG000|Overall Study|Adverse Event|1
6947018|NCT00983957|10985800|FG000|Overall Study|Personal Reasons|1
6947019|NCT00984009|10985824|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1
6947020|NCT00984022|10985833|FG000|Overall Study|Lost to Follow-up|10
6947021|NCT00984022|10985834|FG001|Overall Study|Lost to Follow-up|14
6947022|NCT00984061|10985840|FG000|Clarithromycin Alone|Protocol Violation|1
6947023|NCT00984126|10985851|FG000|Overall Study|Protocol Violation|0
6947024|NCT00984126|10985852|FG001|Overall Study|Protocol Violation|0
6947025|NCT00984126|10985853|FG002|Overall Study|Protocol Violation|1
6947026|NCT00984126|10985854|FG003|Overall Study|Protocol Violation|2
6947027|NCT00984126|10985851|FG000|Overall Study|Adverse Event|0
6947028|NCT00984126|10985852|FG001|Overall Study|Adverse Event|0
6947029|NCT00984126|10985853|FG002|Overall Study|Adverse Event|0
7069654|NCT02004262|11171585|FG004|Overall Study|Lost to Follow-up|0
7069655|NCT02004262|11171586|FG005|Overall Study|Lost to Follow-up|0
7040752|NCT01720043|11123891|FG000|Overall Study|Withdrawal by Subject|1
7040753|NCT01720069|11123898|FG000|Overall Study|Could not use e-diary correctly|0
7040754|NCT01720069|11123899|FG001|Overall Study|Could not use e-diary correctly|1
7040755|NCT01720069|11123900|FG002|Overall Study|Could not use e-diary correctly|1
6947030|NCT00984126|10985854|FG003|Overall Study|Adverse Event|2
6947031|NCT00984126|10985851|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7
6947032|NCT00984126|10985852|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7
6947033|NCT00984126|10985853|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3
6947034|NCT00984126|10985854|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46
6947035|NCT00984126|10985851|FG000|Overall Study|Withdrawal criteria|0
6947036|NCT00984126|10985852|FG001|Overall Study|Withdrawal criteria|1
6947037|NCT00984126|10985853|FG002|Overall Study|Withdrawal criteria|3
6947038|NCT00984126|10985854|FG003|Overall Study|Withdrawal criteria|9
6947039|NCT00984165|10985881|FG000|Overall Study|Death on study|2
6947040|NCT00984165|10985882|FG001|Overall Study|Death on study|0
6947041|NCT00984165|10985883|FG002|Overall Study|Death on study|0
6947042|NCT00984165|10985884|FG003|Overall Study|Death on study|0
6947043|NCT00984165|10985881|FG000|Overall Study|Disease progression on study|5
6947044|NCT00984165|10985882|FG001|Overall Study|Disease progression on study|1
6947045|NCT00984165|10985883|FG002|Overall Study|Disease progression on study|0
6947046|NCT00984165|10985884|FG003|Overall Study|Disease progression on study|0
6947047|NCT00984165|10985881|FG000|Overall Study|Death of recipient|0
6947048|NCT00984165|10985882|FG001|Overall Study|Death of recipient|0
7040756|NCT01720069|11123898|FG000|Overall Study|Randomised without baseline values|0
7040757|NCT01720069|11123899|FG001|Overall Study|Randomised without baseline values|0
7040758|NCT01720069|11123900|FG002|Overall Study|Randomised without baseline values|1
7040759|NCT01720069|11123898|FG000|Overall Study|Adverse Event|0
7040760|NCT01720069|11123899|FG001|Overall Study|Adverse Event|0
7040761|NCT01720069|11123900|FG002|Overall Study|Adverse Event|1
7040762|NCT01720069|11123898|FG000|Overall Study|Lack of Efficacy|0
7040763|NCT01720069|11123899|FG001|Overall Study|Lack of Efficacy|4
7040764|NCT01720069|11123900|FG002|Overall Study|Lack of Efficacy|0
7040765|NCT01720069|11123898|FG000|Overall Study|Treatment period withdrawal criteria met|4
7040766|NCT01720069|11123899|FG001|Overall Study|Treatment period withdrawal criteria met|8
7040767|NCT01720069|11123900|FG002|Overall Study|Treatment period withdrawal criteria met|9
7040768|NCT01720069|11123898|FG000|Overall Study|Withdrawal by Subject|0
7040769|NCT01720069|11123899|FG001|Overall Study|Withdrawal by Subject|2
7040770|NCT01720069|11123900|FG002|Overall Study|Withdrawal by Subject|1
7040771|NCT01720069|11123898|FG000|Overall Study|OCS bursts occured, discontinued in line|1
7069656|NCT02004262|11171581|FG000|Overall Study|Study Terminated by Sponsor|4
6947049|NCT00984165|10985883|FG002|Overall Study|Death of recipient|0
6947050|NCT00984165|10985884|FG003|Overall Study|Death of recipient|1
6947051|NCT00984165|10985881|FG000|Overall Study|New protocol|0
6947052|NCT00984165|10985882|FG001|Overall Study|New protocol|0
6947053|NCT00984165|10985883|FG002|Overall Study|New protocol|0
6947054|NCT00984165|10985884|FG003|Overall Study|New protocol|1
6947055|NCT00984165|10985881|FG000|Overall Study|P+/donor pair removed from protocol|0
6947056|NCT00984165|10985882|FG001|Overall Study|P+/donor pair removed from protocol|0
6947057|NCT00984165|10985883|FG002|Overall Study|P+/donor pair removed from protocol|0
6947058|NCT00984165|10985884|FG003|Overall Study|P+/donor pair removed from protocol|1
6947059|NCT00984165|10985881|FG000|Overall Study|removed with a pair recipient|0
6947060|NCT00984165|10985882|FG001|Overall Study|removed with a pair recipient|0
6947061|NCT00984165|10985883|FG002|Overall Study|removed with a pair recipient|0
6947062|NCT00984165|10985884|FG003|Overall Study|removed with a pair recipient|1
6947063|NCT00984204|10985895|FG000|Overall Study|Death|1
6947064|NCT00984204|10985895|FG000|Overall Study|Lost to Follow-up|4
6947065|NCT00984204|10985895|FG000|Overall Study|Lack of Efficacy|10
6947066|NCT00984256|10985901|FG000|Overall Study|Withdrawal by Subject|0
6947067|NCT00984256|10985902|FG001|Overall Study|Withdrawal by Subject|1
6947068|NCT00984282|10985919|FG000|Double Blind Treatment|Adverse Event|40
6947069|NCT00984282|10985920|FG001|Double Blind Treatment|Adverse Event|6
6947070|NCT00984282|10985919|FG000|Double Blind Treatment|Progression, recurrence or relapse|25
6947071|NCT00984282|10985920|FG001|Double Blind Treatment|Progression, recurrence or relapse|3
6947072|NCT00984282|10985919|FG000|Double Blind Treatment|Physician Decision|1
6947073|NCT00984282|10985920|FG001|Double Blind Treatment|Physician Decision|2
6947074|NCT00984282|10985919|FG000|Double Blind Treatment|Noncompliance with study medication|3
6947075|NCT00984282|10985920|FG001|Double Blind Treatment|Noncompliance with study medication|0
6947076|NCT00984282|10985919|FG000|Double Blind Treatment|Progression by clinical judgment|2
6947077|NCT00984282|10985920|FG001|Double Blind Treatment|Progression by clinical judgment|0
6947078|NCT00984282|10985919|FG000|Double Blind Treatment|Withdrawal by Subject|13
6947079|NCT00984282|10985920|FG001|Double Blind Treatment|Withdrawal by Subject|18
6947080|NCT00984282|10985919|FG000|Double Blind Treatment|Lost to Follow-up|3
6947081|NCT00984282|10985920|FG001|Double Blind Treatment|Lost to Follow-up|0
6947082|NCT00984282|10985919|FG000|Double Blind Treatment|Death|8
6947083|NCT00984282|10985920|FG001|Double Blind Treatment|Death|4
6947084|NCT00984282|10985919|FG000|Double Blind Treatment|Not treated|0
6947085|NCT00984282|10985920|FG001|Double Blind Treatment|Not treated|1
6947086|NCT00984282|10985919|FG000|Double Blind Treatment|Switched to commercial drug|6
6947087|NCT00984282|10985920|FG001|Double Blind Treatment|Switched to commercial drug|1
6947088|NCT00984282|10985919|FG000|Double Blind Treatment|protocol driven decision point|1
7069657|NCT02004262|11171582|FG001|Overall Study|Study Terminated by Sponsor|3
7069658|NCT02004262|11171583|FG002|Overall Study|Study Terminated by Sponsor|2
7069659|NCT02004262|11171584|FG003|Overall Study|Study Terminated by Sponsor|1
7069660|NCT02004262|11171585|FG004|Overall Study|Study Terminated by Sponsor|1
6947089|NCT00984282|10985920|FG001|Double Blind Treatment|protocol driven decision point|1
6947090|NCT00984282|10985919|FG000|Double Blind Treatment|Radiological and clinical progression|0
6947091|NCT00984282|10985920|FG001|Double Blind Treatment|Radiological and clinical progression|1
6947092|NCT00984282|10985919|FG000|Double Blind Treatment|Transferred to treat. continuation study|2
6947093|NCT00984282|10985920|FG001|Double Blind Treatment|Transferred to treat. continuation study|1
6947094|NCT00984282|10985919|FG000|Open-label Treatment|Adverse Event|20
6947095|NCT00984282|10985920|FG001|Open-label Treatment|Adverse Event|30
6947096|NCT00984282|10985919|FG000|Open-label Treatment|Withdrawal by Subject|6
6947097|NCT00984282|10985920|FG001|Open-label Treatment|Withdrawal by Subject|21
6947098|NCT00984282|10985919|FG000|Open-label Treatment|Death|7
6947099|NCT00984282|10985920|FG001|Open-label Treatment|Death|15
6947100|NCT00984282|10985919|FG000|Open-label Treatment|Progression, recurrence or relapse|40
6947101|NCT00984282|10985920|FG001|Open-label Treatment|Progression, recurrence or relapse|82
6947102|NCT00984282|10985919|FG000|Open-label Treatment|Lost to Follow-up|1
6947103|NCT00984282|10985920|FG001|Open-label Treatment|Lost to Follow-up|1
6947104|NCT00984282|10985919|FG000|Open-label Treatment|Patient convenience|1
6947105|NCT00984282|10985920|FG001|Open-label Treatment|Patient convenience|0
6947106|NCT00984282|10985919|FG000|Open-label Treatment|Non-compliant with study medication|1
6947107|NCT00984282|10985920|FG001|Open-label Treatment|Non-compliant with study medication|0
6947108|NCT00984282|10985919|FG000|Open-label Treatment|Target lesion removed|0
6947109|NCT00984282|10985920|FG001|Open-label Treatment|Target lesion removed|1
6947110|NCT00984282|10985919|FG000|Open-label Treatment|Protocol driven decision point|1
6947111|NCT00984282|10985920|FG001|Open-label Treatment|Protocol driven decision point|1
6947112|NCT00984282|10985919|FG000|Open-label Treatment|Transferred to treat. continuation study|2
6947113|NCT00984282|10985920|FG001|Open-label Treatment|Transferred to treat. continuation study|3
6947114|NCT00984282|10985919|FG000|Open-label Treatment|Switched to commercial drug|6
6947115|NCT00984282|10985920|FG001|Open-label Treatment|Switched to commercial drug|7
6947116|NCT00984282|10985919|FG000|Open-label Treatment|Physician Decision|1
6947117|NCT00984282|10985920|FG001|Open-label Treatment|Physician Decision|0
6947118|NCT00984282|10985919|FG000|Long Term Follow-up|Withdrawal by Subject|8
6947119|NCT00984282|10985920|FG001|Long Term Follow-up|Withdrawal by Subject|14
6947120|NCT00984282|10985919|FG000|Long Term Follow-up|Death|27
6947121|NCT00984282|10985920|FG001|Long Term Follow-up|Death|68
7069661|NCT02004262|11171586|FG005|Overall Study|Study Terminated by Sponsor|5
6947122|NCT00984282|10985919|FG000|Long Term Follow-up|Lost to Follow-up|3
6947123|NCT00984282|10985920|FG001|Long Term Follow-up|Lost to Follow-up|6
6947124|NCT00984282|10985919|FG000|Long Term Follow-up|Protocol driven decision point|25
6947125|NCT00984282|10985920|FG001|Long Term Follow-up|Protocol driven decision point|26
6947126|NCT00984282|10985919|FG000|Long Term Follow-up|Transferred to treat. continuation study|2
6947127|NCT00984282|10985920|FG001|Long Term Follow-up|Transferred to treat. continuation study|3
6947128|NCT00984282|10985919|FG000|Long Term Follow-up|Switched to commercial drug|4
6947129|NCT00984282|10985920|FG001|Long Term Follow-up|Switched to commercial drug|2
6947130|NCT00984282|10985919|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0
6947131|NCT00984282|10985920|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1
6947132|NCT00984295|10985931|FG000|Overall Study|Lost to Follow-up|31
6947133|NCT00984295|10985932|FG001|Overall Study|Lost to Follow-up|12
6947134|NCT00984295|10985933|FG002|Overall Study|Lost to Follow-up|13
6947135|NCT00984295|10985931|FG000|Overall Study|Protocol Violation|2
6947136|NCT00984295|10985932|FG001|Overall Study|Protocol Violation|1
6947137|NCT00984295|10985933|FG002|Overall Study|Protocol Violation|4
6947138|NCT00984295|10985931|FG000|Overall Study|Withdrawal by Subject|18
6947139|NCT00984295|10985932|FG001|Overall Study|Withdrawal by Subject|9
6947140|NCT00984295|10985933|FG002|Overall Study|Withdrawal by Subject|12
6947141|NCT00984295|10985931|FG000|Overall Study|CAE - discontinued test vaccine|0
6947142|NCT00984295|10985932|FG001|Overall Study|CAE - discontinued test vaccine|1
6947143|NCT00984295|10985933|FG002|Overall Study|CAE - discontinued test vaccine|3
6947144|NCT00984295|10985931|FG000|Overall Study|Missed one or more blood samplings|3
6947145|NCT00984295|10985932|FG001|Overall Study|Missed one or more blood samplings|7
6947146|NCT00984295|10985933|FG002|Overall Study|Missed one or more blood samplings|2
6947147|NCT00984295|10985931|FG000|Overall Study|Incomplete safety follow-up|11
6947148|NCT00984295|10985932|FG001|Overall Study|Incomplete safety follow-up|2
6947149|NCT00984295|10985933|FG002|Overall Study|Incomplete safety follow-up|3
6947150|NCT00984542|10985971|FG000|Overall Study|disease progression|19
6947151|NCT00984542|10985971|FG000|Overall Study|toxicity|7
6947152|NCT00984542|10985971|FG000|Overall Study|Death|7
6947153|NCT00984542|10985971|FG000|Overall Study|complicating disease|3
6947154|NCT00984542|10985971|FG000|Overall Study|Withdrawal by Subject|3
6947155|NCT00984542|10985971|FG000|Overall Study|clinical deterioration|2
6947156|NCT00984568|10985978|FG000|Overall Study|Withdrawal by Subject|1
6947157|NCT00984568|10985979|FG001|Overall Study|Withdrawal by Subject|2
6947158|NCT00984568|10985978|FG000|Overall Study|Lack of Efficacy|2
6947159|NCT00984568|10985979|FG001|Overall Study|Lack of Efficacy|0
6947160|NCT00984568|10985978|FG000|Overall Study|Adverse Event|2
6947161|NCT00984568|10985979|FG001|Overall Study|Adverse Event|0
6947162|NCT00984568|10985978|FG000|Overall Study|Did Not Meet Randomization Criteria|1
6947163|NCT00984568|10985979|FG001|Overall Study|Did Not Meet Randomization Criteria|0
6947164|NCT00984568|10985978|FG000|Overall Study|Lost to Follow-up|0
6947165|NCT00984568|10985979|FG001|Overall Study|Lost to Follow-up|1
6947166|NCT00984568|10985978|FG000|Overall Study|Opportunistic Infection|1
6947167|NCT00984568|10985979|FG001|Overall Study|Opportunistic Infection|0
6947168|NCT00984568|10985978|FG000|Overall Study|Unknown Reason|1
6947169|NCT00984568|10985979|FG001|Overall Study|Unknown Reason|3
6947170|NCT00984594|10985987|FG000|Overall Study|Lost to Follow-up|1
6947171|NCT00984594|10985988|FG001|Overall Study|Lost to Follow-up|0
6947172|NCT00984594|10985987|FG000|Overall Study|Withdrawal by Subject|0
6947173|NCT00984594|10985988|FG001|Overall Study|Withdrawal by Subject|1
6947174|NCT00984620|10985998|FG000|Overall Study|Adverse Event|5
6947175|NCT00984620|10985999|FG001|Overall Study|Adverse Event|5
6947176|NCT00984620|10985998|FG000|Overall Study|Lost to Follow-up|1
6947177|NCT00984620|10985999|FG001|Overall Study|Lost to Follow-up|1
6947178|NCT00984620|10985998|FG000|Overall Study|Withdrawal by Subject|0
6947179|NCT00984620|10985999|FG001|Overall Study|Withdrawal by Subject|2
6947180|NCT00984620|10985998|FG000|Overall Study|reason other than listed above|0
6947181|NCT00984620|10985999|FG001|Overall Study|reason other than listed above|4
6947182|NCT00984659|10986011|FG000|2-week Run-in Period|Adverse Event|8
6947183|NCT00984659|10986012|FG001|2-week Run-in Period|Adverse Event|0
6947184|NCT00984659|10986013|FG002|2-week Run-in Period|Adverse Event|0
6947185|NCT00984659|10986014|FG003|2-week Run-in Period|Adverse Event|0
6947186|NCT00984659|10986011|FG000|2-week Run-in Period|Protocol Violation|5
6947187|NCT00984659|10986012|FG001|2-week Run-in Period|Protocol Violation|0
6947188|NCT00984659|10986013|FG002|2-week Run-in Period|Protocol Violation|0
6947189|NCT00984659|10986014|FG003|2-week Run-in Period|Protocol Violation|0
6947190|NCT00984659|10986011|FG000|2-week Run-in Period|Study Closed/Terminated|2
6947191|NCT00984659|10986012|FG001|2-week Run-in Period|Study Closed/Terminated|0
6947192|NCT00984659|10986013|FG002|2-week Run-in Period|Study Closed/Terminated|0
6947193|NCT00984659|10986014|FG003|2-week Run-in Period|Study Closed/Terminated|0
6947194|NCT00984659|10986011|FG000|2-week Run-in Period|Lost to Follow-up|3
6947195|NCT00984659|10986012|FG001|2-week Run-in Period|Lost to Follow-up|0
6947196|NCT00984659|10986013|FG002|2-week Run-in Period|Lost to Follow-up|0
6947197|NCT00984659|10986014|FG003|2-week Run-in Period|Lost to Follow-up|0
6947198|NCT00984659|10986011|FG000|2-week Run-in Period|Physician Decision|10
6947199|NCT00984659|10986012|FG001|2-week Run-in Period|Physician Decision|0
6947200|NCT00984659|10986013|FG002|2-week Run-in Period|Physician Decision|0
6947201|NCT00984659|10986014|FG003|2-week Run-in Period|Physician Decision|0
6947202|NCT00984659|10986011|FG000|2-week Run-in Period|Withdrawal by Subject|10
6947203|NCT00984659|10986012|FG001|2-week Run-in Period|Withdrawal by Subject|0
6947204|NCT00984659|10986013|FG002|2-week Run-in Period|Withdrawal by Subject|0
6947205|NCT00984659|10986014|FG003|2-week Run-in Period|Withdrawal by Subject|0
6947206|NCT00984659|10986011|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14
6947207|NCT00984659|10986012|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0
6947208|NCT00984659|10986013|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0
6947209|NCT00984659|10986014|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0
6947210|NCT00984659|10986011|FG000|6-week Double-blind Treatment Period|Adverse Event|0
6947211|NCT00984659|10986012|FG001|6-week Double-blind Treatment Period|Adverse Event|3
6947212|NCT00984659|10986013|FG002|6-week Double-blind Treatment Period|Adverse Event|3
6947213|NCT00984659|10986014|FG003|6-week Double-blind Treatment Period|Adverse Event|7
6947214|NCT00984659|10986011|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0
6947215|NCT00984659|10986012|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2
6947216|NCT00984659|10986013|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0
6947217|NCT00984659|10986014|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1
6947218|NCT00984659|10986011|FG000|6-week Double-blind Treatment Period|Protocol Violation|0
6947219|NCT00984659|10986012|FG001|6-week Double-blind Treatment Period|Protocol Violation|0
6947220|NCT00984659|10986013|FG002|6-week Double-blind Treatment Period|Protocol Violation|0
6947221|NCT00984659|10986014|FG003|6-week Double-blind Treatment Period|Protocol Violation|4
6947222|NCT00984659|10986011|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0
7040772|NCT01720069|11123899|FG001|Overall Study|OCS bursts occured, discontinued in line|0
7040773|NCT01720069|11123900|FG002|Overall Study|OCS bursts occured, discontinued in line|0
7040774|NCT01720069|11123898|FG000|Overall Study|Non-compliance on using e-diary|0
7040775|NCT01720069|11123899|FG001|Overall Study|Non-compliance on using e-diary|0
7040776|NCT01720069|11123900|FG002|Overall Study|Non-compliance on using e-diary|1
7040777|NCT01720069|11123898|FG000|Overall Study|Lost to Follow-up|0
7040778|NCT01720069|11123899|FG001|Overall Study|Lost to Follow-up|0
7040779|NCT01720069|11123900|FG002|Overall Study|Lost to Follow-up|1
7040780|NCT01720225|11123914|FG000|Overall Study|Withdrawal by Subject|0
7040781|NCT01720225|11123915|FG001|Overall Study|Withdrawal by Subject|1
7040782|NCT01720225|11123914|FG000|Overall Study|Did not complete 2 cycles of therapy|3
7040783|NCT01720225|11123915|FG001|Overall Study|Did not complete 2 cycles of therapy|0
7040784|NCT01720264|11123934|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1
6947223|NCT00984659|10986012|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0
6947224|NCT00984659|10986013|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1
6947225|NCT00984659|10986014|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0
6947226|NCT00984659|10986011|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0
6947227|NCT00984659|10986012|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1
6947228|NCT00984659|10986013|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7
6947229|NCT00984659|10986014|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1
6947230|NCT00984867|10986036|FG000|Overall Study|Adverse Event|3
6947231|NCT00984867|10986037|FG001|Overall Study|Adverse Event|7
6947232|NCT00984867|10986036|FG000|Overall Study|Death|1
6947233|NCT00984867|10986037|FG001|Overall Study|Death|0
6947234|NCT00984867|10986036|FG000|Overall Study|Withdrawal by Subject|13
6947235|NCT00984867|10986037|FG001|Overall Study|Withdrawal by Subject|4
6947236|NCT00984867|10986036|FG000|Overall Study|Lost to Follow-up|3
6947237|NCT00984867|10986037|FG001|Overall Study|Lost to Follow-up|4
6947238|NCT00984867|10986036|FG000|Overall Study|Poor/non-compliance|0
6947239|NCT00984867|10986037|FG001|Overall Study|Poor/non-compliance|1
6947240|NCT00984867|10986036|FG000|Overall Study|Subject no longer meets study criteria|1
6947241|NCT00984867|10986037|FG001|Overall Study|Subject no longer meets study criteria|1
6947242|NCT00984867|10986036|FG000|Overall Study|site closing|1
6947243|NCT00984867|10986037|FG001|Overall Study|site closing|0
6947244|NCT00984867|10986036|FG000|Overall Study|lack of efficacy and subject compliance|1
6947245|NCT00984867|10986037|FG001|Overall Study|lack of efficacy and subject compliance|0
6947246|NCT00985088|10986062|FG000|Overall Study|Serious Adverse Event|1
6947247|NCT00985088|10986063|FG001|Overall Study|Serious Adverse Event|1
6947248|NCT00985088|10986064|FG002|Overall Study|Serious Adverse Event|0
6947249|NCT00985088|10986065|FG003|Overall Study|Serious Adverse Event|0
6947250|NCT00985088|10986066|FG004|Overall Study|Serious Adverse Event|0
6947251|NCT00985088|10986067|FG005|Overall Study|Serious Adverse Event|0
6947252|NCT00985088|10986068|FG006|Overall Study|Serious Adverse Event|0
6947253|NCT00985088|10986069|FG007|Overall Study|Serious Adverse Event|1
6947254|NCT00985088|10986062|FG000|Overall Study|Adverse Event|0
6947255|NCT00985088|10986063|FG001|Overall Study|Adverse Event|0
6947256|NCT00985088|10986064|FG002|Overall Study|Adverse Event|1
6947257|NCT00985088|10986065|FG003|Overall Study|Adverse Event|0
6947258|NCT00985088|10986066|FG004|Overall Study|Adverse Event|0
6947259|NCT00985088|10986067|FG005|Overall Study|Adverse Event|0
6947260|NCT00985088|10986068|FG006|Overall Study|Adverse Event|0
6947261|NCT00985088|10986069|FG007|Overall Study|Adverse Event|0
6947262|NCT00985088|10986062|FG000|Overall Study|Withdrawal by Subject|4
6947263|NCT00985088|10986063|FG001|Overall Study|Withdrawal by Subject|0
6947264|NCT00985088|10986064|FG002|Overall Study|Withdrawal by Subject|0
6947265|NCT00985088|10986065|FG003|Overall Study|Withdrawal by Subject|1
6947266|NCT00985088|10986066|FG004|Overall Study|Withdrawal by Subject|3
6947267|NCT00985088|10986067|FG005|Overall Study|Withdrawal by Subject|2
6947268|NCT00985088|10986068|FG006|Overall Study|Withdrawal by Subject|1
6947269|NCT00985088|10986069|FG007|Overall Study|Withdrawal by Subject|2
6947270|NCT00985088|10986062|FG000|Overall Study|Migrated/moved from study area|0
6947271|NCT00985088|10986063|FG001|Overall Study|Migrated/moved from study area|0
7040785|NCT01720264|11123934|FG000|Post-transplant (Day 16) to 1 Year|Death|8
7040786|NCT01720264|11123934|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4
6947272|NCT00985088|10986064|FG002|Overall Study|Migrated/moved from study area|1
6947273|NCT00985088|10986065|FG003|Overall Study|Migrated/moved from study area|0
6947274|NCT00985088|10986066|FG004|Overall Study|Migrated/moved from study area|0
6947275|NCT00985088|10986067|FG005|Overall Study|Migrated/moved from study area|0
6947276|NCT00985088|10986068|FG006|Overall Study|Migrated/moved from study area|0
6947277|NCT00985088|10986069|FG007|Overall Study|Migrated/moved from study area|1
6947278|NCT00985088|10986062|FG000|Overall Study|Lost to Follow-up|6
6947279|NCT00985088|10986063|FG001|Overall Study|Lost to Follow-up|1
6947280|NCT00985088|10986064|FG002|Overall Study|Lost to Follow-up|2
6947281|NCT00985088|10986065|FG003|Overall Study|Lost to Follow-up|6
6947282|NCT00985088|10986066|FG004|Overall Study|Lost to Follow-up|6
6947283|NCT00985088|10986067|FG005|Overall Study|Lost to Follow-up|5
6947284|NCT00985088|10986068|FG006|Overall Study|Lost to Follow-up|3
6947285|NCT00985088|10986069|FG007|Overall Study|Lost to Follow-up|2
6947286|NCT00985114|10986099|FG000|Overall Study|Adverse Event|1
6947287|NCT00985114|10986100|FG001|Overall Study|Adverse Event|0
6947288|NCT00985114|10986099|FG000|Overall Study|Withdrawal by Subject|0
6947289|NCT00985114|10986100|FG001|Overall Study|Withdrawal by Subject|2
6947290|NCT00985153|10986114|FG000|Overall Study|Lost to Follow-up|16
6947291|NCT00985153|10986115|FG001|Overall Study|Lost to Follow-up|19
6947292|NCT00985153|10986116|FG002|Overall Study|Lost to Follow-up|17
6947293|NCT00985153|10986117|FG003|Overall Study|Lost to Follow-up|20
6947294|NCT00985153|10986114|FG000|Overall Study|Protocol Violation|3
6947295|NCT00985153|10986115|FG001|Overall Study|Protocol Violation|2
6947296|NCT00985153|10986116|FG002|Overall Study|Protocol Violation|4
6947297|NCT00985153|10986117|FG003|Overall Study|Protocol Violation|3
6947298|NCT00985153|10986114|FG000|Overall Study|Withdrawal by Subject|6
6947299|NCT00985153|10986115|FG001|Overall Study|Withdrawal by Subject|11
6947300|NCT00985153|10986116|FG002|Overall Study|Withdrawal by Subject|11
6947301|NCT00985153|10986117|FG003|Overall Study|Withdrawal by Subject|10
6947302|NCT00985153|10986114|FG000|Overall Study|Missed One or More Bleeds|7
6947303|NCT00985153|10986115|FG001|Overall Study|Missed One or More Bleeds|7
6947304|NCT00985153|10986116|FG002|Overall Study|Missed One or More Bleeds|8
6947305|NCT00985153|10986117|FG003|Overall Study|Missed One or More Bleeds|10
6947306|NCT00985153|10986114|FG000|Overall Study|Incomplete Safety Follow-up|3
6947307|NCT00985153|10986115|FG001|Overall Study|Incomplete Safety Follow-up|5
6947308|NCT00985153|10986116|FG002|Overall Study|Incomplete Safety Follow-up|4
6947309|NCT00985153|10986117|FG003|Overall Study|Incomplete Safety Follow-up|4
6947310|NCT00985166|10986130|FG000|Overall Study|Lost to Follow-up|3
6947311|NCT00985166|10986131|FG001|Overall Study|Lost to Follow-up|2
6947312|NCT00985166|10986132|FG002|Overall Study|Lost to Follow-up|2
6947313|NCT00985166|10986130|FG000|Overall Study|Withdrawal by Subject|3
6947314|NCT00985166|10986131|FG001|Overall Study|Withdrawal by Subject|2
6947315|NCT00985166|10986132|FG002|Overall Study|Withdrawal by Subject|0
6947316|NCT00985166|10986130|FG000|Overall Study|Test not done|2
6947317|NCT00985166|10986131|FG001|Overall Study|Test not done|0
6947318|NCT00985166|10986132|FG002|Overall Study|Test not done|4
6947319|NCT00985166|10986130|FG000|Overall Study|Other|1
6947320|NCT00985166|10986131|FG001|Overall Study|Other|0
6947321|NCT00985166|10986132|FG002|Overall Study|Other|1
6947322|NCT00985192|10986142|FG000|Overall Study|Withdrawal by Subject|1
6947323|NCT00985192|10986142|FG000|Overall Study|Disease Progression|1
6947324|NCT00985192|10986142|FG000|Overall Study|Determined to be Ineligible During Trial|2
6947325|NCT00985231|10986148|FG000|Overall Study|ineligible|1
6947326|NCT00985231|10986149|FG001|Overall Study|ineligible|0
6947327|NCT00985231|10986148|FG000|Overall Study|Protocol Violation|1
6947328|NCT00985231|10986149|FG001|Overall Study|Protocol Violation|0
6947329|NCT00985231|10986148|FG000|Overall Study|Withdrawal by Subject|1
6947330|NCT00985231|10986149|FG001|Overall Study|Withdrawal by Subject|0
7069662|NCT02004353|11171609|FG000|Overall Study|Voluntary participation|1334
7040787|NCT01720446|11123988|FG000|Overall Study|Lost to Follow-up|12
6947331|NCT00985231|10986148|FG000|Overall Study|Lost to Follow-up|0
6947332|NCT00985231|10986149|FG001|Overall Study|Lost to Follow-up|1
6947333|NCT00985231|10986148|FG000|Overall Study|Study related symptoms & complaints|0
6947334|NCT00985231|10986149|FG001|Overall Study|Study related symptoms & complaints|2
6947335|NCT00985426|10986161|FG000|Overall Study|Adverse Event|0
7069663|NCT02004847|11171646|FG000|Overall Study|Protocol Violation|1
6947336|NCT00985426|10986162|FG001|Overall Study|Adverse Event|1
6947337|NCT00985426|10986161|FG000|Overall Study|Subject Non-Compliance|3
6947338|NCT00985426|10986162|FG001|Overall Study|Subject Non-Compliance|3
6947339|NCT00985426|10986161|FG000|Overall Study|Withdrawal by Subject|12
6947340|NCT00985426|10986162|FG001|Overall Study|Withdrawal by Subject|16
6947341|NCT00985426|10986161|FG000|Overall Study|Lost to Follow-up|8
6947342|NCT00985426|10986162|FG001|Overall Study|Lost to Follow-up|10
6947343|NCT00985426|10986161|FG000|Overall Study|Death|7
6947344|NCT00985426|10986162|FG001|Overall Study|Death|3
6947345|NCT00985426|10986161|FG000|Overall Study|Protocol Violation|2
6947346|NCT00985426|10986162|FG001|Overall Study|Protocol Violation|0
6947347|NCT00985426|10986161|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11
6947348|NCT00985426|10986162|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11
6947349|NCT00985439|10986172|FG000|Overall Study|Adverse Event|0
6947350|NCT00985439|10986173|FG001|Overall Study|Adverse Event|0
6947351|NCT00985439|10986174|FG002|Overall Study|Adverse Event|1
6947352|NCT00985439|10986175|FG003|Overall Study|Adverse Event|0
7040788|NCT01720446|11123989|FG001|Overall Study|Lost to Follow-up|6
7040789|NCT01720446|11123990|FG002|Overall Study|Lost to Follow-up|16
7040790|NCT01720446|11123991|FG003|Overall Study|Lost to Follow-up|16
7040791|NCT01720446|11123988|FG000|Overall Study|Withdrawal by Subject|2
7040792|NCT01720446|11123989|FG001|Overall Study|Withdrawal by Subject|5
7040793|NCT01720446|11123990|FG002|Overall Study|Withdrawal by Subject|4
7040794|NCT01720446|11123991|FG003|Overall Study|Withdrawal by Subject|4
7040795|NCT01720524|11124006|FG000|Part A|Insufficient Clinical Response|2
7040796|NCT01720524|11124007|FG001|Part A|Insufficient Clinical Response|4
6947353|NCT00985465|10986187|FG000|Overall Study|Withdrawal by Subject|1
6947354|NCT00985465|10986188|FG001|Overall Study|Withdrawal by Subject|2
6947355|NCT00985465|10986187|FG000|Overall Study|Considered to be part of the other group|0
6947356|NCT00985465|10986188|FG001|Overall Study|Considered to be part of the other group|1
6947357|NCT00985491|10986195|FG000|Overall Study|Adverse Event|8
6947358|NCT00985491|10986195|FG000|Overall Study|device migration|7
6947359|NCT00985491|10986195|FG000|Overall Study|Withdrawal by Subject|1
6947360|NCT00985491|10986195|FG000|Overall Study|implant failure|3
6947361|NCT00985504|10986202|FG000|Acute Treatment Period|Adverse Event|3
6947362|NCT00985504|10986203|FG001|Acute Treatment Period|Adverse Event|4
6947363|NCT00985504|10986202|FG000|Acute Treatment Period|Entry Criteria Not Met|1
6947364|NCT00985504|10986203|FG001|Acute Treatment Period|Entry Criteria Not Met|2
6947365|NCT00985504|10986202|FG000|Acute Treatment Period|Protocol Violation|2
6947366|NCT00985504|10986203|FG001|Acute Treatment Period|Protocol Violation|0
6947367|NCT00985504|10986202|FG000|Acute Treatment Period|Sponsor Decision|0
6947368|NCT00985504|10986203|FG001|Acute Treatment Period|Sponsor Decision|1
6947369|NCT00985504|10986202|FG000|Acute Treatment Period|Withdrawal by Subject|9
6947370|NCT00985504|10986203|FG001|Acute Treatment Period|Withdrawal by Subject|5
6947371|NCT00985504|10986202|FG000|Optimization Period|Adverse Event|7
6947372|NCT00985504|10986203|FG001|Optimization Period|Adverse Event|9
6947373|NCT00985504|10986202|FG000|Optimization Period|Death|0
6947374|NCT00985504|10986203|FG001|Optimization Period|Death|1
6947375|NCT00985504|10986202|FG000|Optimization Period|Lack of Efficacy|5
6947376|NCT00985504|10986203|FG001|Optimization Period|Lack of Efficacy|3
6947377|NCT00985504|10986202|FG000|Optimization Period|Lost to Follow-up|0
6947378|NCT00985504|10986203|FG001|Optimization Period|Lost to Follow-up|1
6947379|NCT00985504|10986202|FG000|Optimization Period|Physician Decision|1
6947380|NCT00985504|10986203|FG001|Optimization Period|Physician Decision|0
6947381|NCT00985504|10986202|FG000|Optimization Period|Protocol Violation|3
6947382|NCT00985504|10986203|FG001|Optimization Period|Protocol Violation|1
6947383|NCT00985504|10986202|FG000|Optimization Period|Withdrawal by Subject|10
6947384|NCT00985504|10986203|FG001|Optimization Period|Withdrawal by Subject|8
6947385|NCT00985621|10986237|FG000|Overall Study|Adverse Event|2
6947386|NCT00985621|10986238|FG001|Overall Study|Adverse Event|3
6947387|NCT00985621|10986239|FG002|Overall Study|Adverse Event|4
6947388|NCT00985621|10986240|FG003|Overall Study|Adverse Event|16
6947389|NCT00985621|10986237|FG000|Overall Study|Lack of Efficacy|10
6947390|NCT00985621|10986238|FG001|Overall Study|Lack of Efficacy|6
6947391|NCT00985621|10986239|FG002|Overall Study|Lack of Efficacy|5
6947392|NCT00985621|10986240|FG003|Overall Study|Lack of Efficacy|12
6947393|NCT00985621|10986237|FG000|Overall Study|Lost to Follow-up|2
6947394|NCT00985621|10986238|FG001|Overall Study|Lost to Follow-up|3
6947395|NCT00985621|10986239|FG002|Overall Study|Lost to Follow-up|4
6947396|NCT00985621|10986240|FG003|Overall Study|Lost to Follow-up|4
6947397|NCT00985621|10986237|FG000|Overall Study|Study Terminated by Sponsor|89
6947398|NCT00985621|10986238|FG001|Overall Study|Study Terminated by Sponsor|108
6947399|NCT00985621|10986239|FG002|Overall Study|Study Terminated by Sponsor|99
6947400|NCT00985621|10986240|FG003|Overall Study|Study Terminated by Sponsor|92
6947401|NCT00985621|10986237|FG000|Overall Study|Protocol Violation|1
6947402|NCT00985621|10986238|FG001|Overall Study|Protocol Violation|1
6947403|NCT00985621|10986239|FG002|Overall Study|Protocol Violation|1
6947404|NCT00985621|10986240|FG003|Overall Study|Protocol Violation|0
6947405|NCT00985621|10986237|FG000|Overall Study|Withdrawal by Subject|8
6947406|NCT00985621|10986238|FG001|Overall Study|Withdrawal by Subject|10
6947407|NCT00985621|10986239|FG002|Overall Study|Withdrawal by Subject|8
6947408|NCT00985621|10986240|FG003|Overall Study|Withdrawal by Subject|12
6947409|NCT00985621|10986237|FG000|Overall Study|Other|1
6947410|NCT00985621|10986238|FG001|Overall Study|Other|0
6947411|NCT00985621|10986239|FG002|Overall Study|Other|0
6947412|NCT00985621|10986240|FG003|Overall Study|Other|0
6947413|NCT00985621|10986237|FG000|Overall Study|Randomized but not Treated|1
6947414|NCT00985621|10986238|FG001|Overall Study|Randomized but not Treated|0
6947415|NCT00985621|10986239|FG002|Overall Study|Randomized but not Treated|2
6947416|NCT00985621|10986240|FG003|Overall Study|Randomized but not Treated|1
6947417|NCT00985673|10986258|FG000|Overall Study|Lost to Follow-up|6
6947418|NCT00985673|10986259|FG001|Overall Study|Lost to Follow-up|7
6947419|NCT00985673|10986260|FG002|Overall Study|Lost to Follow-up|6
6947420|NCT00985673|10986261|FG003|Overall Study|Lost to Follow-up|10
6947421|NCT00985673|10986262|FG004|Overall Study|Lost to Follow-up|5
6947422|NCT00985673|10986263|FG005|Overall Study|Lost to Follow-up|3
6947423|NCT00985673|10986258|FG000|Overall Study|Withdrawal by Subject|0
6947424|NCT00985673|10986259|FG001|Overall Study|Withdrawal by Subject|4
6947425|NCT00985673|10986260|FG002|Overall Study|Withdrawal by Subject|5
6947426|NCT00985673|10986261|FG003|Overall Study|Withdrawal by Subject|2
6947427|NCT00985673|10986262|FG004|Overall Study|Withdrawal by Subject|2
6947428|NCT00985673|10986263|FG005|Overall Study|Withdrawal by Subject|3
6947429|NCT00985673|10986258|FG000|Overall Study|Other|1
6947430|NCT00985673|10986259|FG001|Overall Study|Other|0
6947431|NCT00985673|10986260|FG002|Overall Study|Other|1
6947432|NCT00985673|10986261|FG003|Overall Study|Other|0
6947433|NCT00985673|10986262|FG004|Overall Study|Other|1
6947434|NCT00985673|10986263|FG005|Overall Study|Other|0
6947435|NCT00985686|10986282|FG000|Overall Study|Lost to Follow-up|1
6947436|NCT00985686|10986283|FG001|Overall Study|Lost to Follow-up|1
6947437|NCT00985686|10986284|FG002|Overall Study|Lost to Follow-up|0
6947438|NCT00985686|10986285|FG003|Overall Study|Lost to Follow-up|2
6947439|NCT00985712|10986295|FG000|Overall Study|Adverse Event|0
6947440|NCT00985712|10986296|FG001|Overall Study|Adverse Event|1
6947441|NCT00985712|10986295|FG000|Overall Study|Lost to Follow-up|2
6947442|NCT00985712|10986296|FG001|Overall Study|Lost to Follow-up|2
6947443|NCT00985712|10986295|FG000|Overall Study|Protocol Violation|0
6947444|NCT00985712|10986296|FG001|Overall Study|Protocol Violation|1
6947445|NCT00985712|10986295|FG000|Overall Study|Withdrawal by Subject|4
6947446|NCT00985712|10986296|FG001|Overall Study|Withdrawal by Subject|1
6947447|NCT00985712|10986295|FG000|Overall Study|Sponsor decision|0
6947448|NCT00985712|10986296|FG001|Overall Study|Sponsor decision|2
6947449|NCT00985725|10986304|FG000|Overall Study|Adverse Event|4
6947450|NCT00985725|10986305|FG001|Overall Study|Adverse Event|1
6947451|NCT00985725|10986304|FG000|Overall Study|Protocol Violation|1
6947452|NCT00985725|10986305|FG001|Overall Study|Protocol Violation|3
6947453|NCT00985725|10986304|FG000|Overall Study|Withdrawal by Subject|4
6947454|NCT00985725|10986305|FG001|Overall Study|Withdrawal by Subject|4
6947455|NCT00985725|10986304|FG000|Overall Study|Lost to Follow-up|1
6947456|NCT00985725|10986305|FG001|Overall Study|Lost to Follow-up|1
6947457|NCT00985725|10986304|FG000|Overall Study|Lack of Efficacy|0
6947458|NCT00985725|10986305|FG001|Overall Study|Lack of Efficacy|1
6947459|NCT00985725|10986304|FG000|Overall Study|Non-compliance|1
6947460|NCT00985725|10986305|FG001|Overall Study|Non-compliance|2
6947461|NCT00985725|10986304|FG000|Overall Study|Out-of-window visits|0
6947462|NCT00985725|10986305|FG001|Overall Study|Out-of-window visits|1
6947463|NCT00985751|10986316|FG000|Overall Study|Adverse Event|0
6947464|NCT00985751|10986317|FG001|Overall Study|Adverse Event|0
6947465|NCT00985751|10986318|FG002|Overall Study|Adverse Event|0
6947466|NCT00985751|10986319|FG003|Overall Study|Adverse Event|0
6947467|NCT00985751|10986320|FG004|Overall Study|Adverse Event|1
6947468|NCT00985790|10986337|FG000|Overall Study|Withdrawal by Subject|1
6947469|NCT00985790|10986338|FG001|Overall Study|Withdrawal by Subject|1
6947470|NCT00985790|10986337|FG000|Overall Study|Lost to Follow-up|6
6947471|NCT00985790|10986338|FG001|Overall Study|Lost to Follow-up|7
6947472|NCT00985946|10986358|FG000|Overall Study|Lost to Follow-up|6
6947473|NCT00985946|10986358|FG000|Overall Study|Withdrawal by Subject|1
6947474|NCT00985959|10986365|FG000|Overall Study|Adverse Event|0
6947475|NCT00985959|10986366|FG001|Overall Study|Adverse Event|0
6947476|NCT00985959|10986367|FG002|Overall Study|Adverse Event|19
6947477|NCT00985959|10986365|FG000|Overall Study|Withdrawal by Subject|0
6947478|NCT00985959|10986366|FG001|Overall Study|Withdrawal by Subject|0
6947479|NCT00985959|10986367|FG002|Overall Study|Withdrawal by Subject|8
6947480|NCT00985959|10986365|FG000|Overall Study|Progressive disease|1
6947481|NCT00985959|10986366|FG001|Overall Study|Progressive disease|2
6947482|NCT00985959|10986367|FG002|Overall Study|Progressive disease|8
6947483|NCT00985959|10986365|FG000|Overall Study|Unrecovered toxicity|0
6947484|NCT00985959|10986366|FG001|Overall Study|Unrecovered toxicity|0
6947485|NCT00985959|10986367|FG002|Overall Study|Unrecovered toxicity|7
6947486|NCT00985959|10986365|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2
6947487|NCT00985959|10986366|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0
6947488|NCT00985959|10986367|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2
6947489|NCT00985959|10986365|FG000|Overall Study|Complete response observed over 2 cycles|0
6947490|NCT00985959|10986366|FG001|Overall Study|Complete response observed over 2 cycles|1
6947491|NCT00985959|10986367|FG002|Overall Study|Complete response observed over 2 cycles|4
6947492|NCT00985959|10986365|FG000|Overall Study|Other|0
6947493|NCT00985959|10986366|FG001|Overall Study|Other|0
6947494|NCT00985959|10986367|FG002|Overall Study|Other|11
6947495|NCT00985985|10986385|FG000|Overall Study|Adverse Event|4
6947496|NCT00985985|10986386|FG001|Overall Study|Adverse Event|2
6947497|NCT00985985|10986387|FG002|Overall Study|Adverse Event|2
6947498|NCT00985985|10986388|FG003|Overall Study|Adverse Event|2
6947499|NCT00985985|10986385|FG000|Overall Study|Lost to Follow-up|4
6947500|NCT00985985|10986386|FG001|Overall Study|Lost to Follow-up|11
6947501|NCT00985985|10986387|FG002|Overall Study|Lost to Follow-up|2
6947502|NCT00985985|10986388|FG003|Overall Study|Lost to Follow-up|3
6947503|NCT00985985|10986385|FG000|Overall Study|Protocol Violation|1
6947504|NCT00985985|10986386|FG001|Overall Study|Protocol Violation|2
6947505|NCT00985985|10986387|FG002|Overall Study|Protocol Violation|0
6947506|NCT00985985|10986388|FG003|Overall Study|Protocol Violation|1
6947507|NCT00985985|10986385|FG000|Overall Study|Lack of Efficacy|5
6947508|NCT00985985|10986386|FG001|Overall Study|Lack of Efficacy|6
6947509|NCT00985985|10986387|FG002|Overall Study|Lack of Efficacy|1
6947510|NCT00985985|10986388|FG003|Overall Study|Lack of Efficacy|3
6947511|NCT00985985|10986385|FG000|Overall Study|Withdrawal by Subject|4
6947512|NCT00985985|10986386|FG001|Overall Study|Withdrawal by Subject|2
6947513|NCT00985985|10986387|FG002|Overall Study|Withdrawal by Subject|2
6947514|NCT00985985|10986388|FG003|Overall Study|Withdrawal by Subject|2
6947515|NCT00985985|10986385|FG000|Overall Study|Other Reason|6
6947516|NCT00985985|10986386|FG001|Overall Study|Other Reason|1
6947517|NCT00985985|10986387|FG002|Overall Study|Other Reason|4
6947518|NCT00985985|10986388|FG003|Overall Study|Other Reason|2
6947519|NCT00986102|10986407|FG000|Overall Study|Lost to Follow-up|0
6947520|NCT00986102|10986408|FG001|Overall Study|Lost to Follow-up|1
6947521|NCT00986102|10986409|FG002|Overall Study|Lost to Follow-up|0
6947522|NCT00986102|10986410|FG003|Overall Study|Lost to Follow-up|1
7069664|NCT02004847|11171647|FG001|Overall Study|Protocol Violation|1
7069665|NCT02004873|11171662|FG000|Overall Study|Implant unsuccessful|6
7069666|NCT02004873|11171662|FG000|Overall Study|Awaiting 6-month visit|390
6947523|NCT00986102|10986407|FG000|Overall Study|Withdrawal by Subject|1
6947524|NCT00986102|10986408|FG001|Overall Study|Withdrawal by Subject|1
6947525|NCT00986102|10986409|FG002|Overall Study|Withdrawal by Subject|0
6947526|NCT00986102|10986410|FG003|Overall Study|Withdrawal by Subject|0
6947527|NCT00986154|10986422|FG000|Overall Study|Death|136
6947528|NCT00986154|10986423|FG001|Overall Study|Death|127
6947529|NCT00986154|10986422|FG000|Overall Study|Lost to Follow-up|7
6947530|NCT00986154|10986423|FG001|Overall Study|Lost to Follow-up|4
6947531|NCT00986154|10986422|FG000|Overall Study|Withdrawal by Subject|32
6947532|NCT00986154|10986423|FG001|Overall Study|Withdrawal by Subject|33
6947533|NCT00986154|10986422|FG000|Overall Study|investigator/subject decide not continue|6
6947534|NCT00986154|10986423|FG001|Overall Study|investigator/subject decide not continue|3
6947535|NCT00986154|10986422|FG000|Overall Study|never received study drug|25
6947536|NCT00986154|10986423|FG001|Overall Study|never received study drug|27
6947537|NCT00986180|10986431|FG000|Overall Study|Adverse Event|21
6947538|NCT00986180|10986432|FG001|Overall Study|Adverse Event|23
6947539|NCT00986180|10986431|FG000|Overall Study|Lack of Efficacy|4
6947540|NCT00986180|10986432|FG001|Overall Study|Lack of Efficacy|3
6947541|NCT00986180|10986431|FG000|Overall Study|Lost to Follow-up|5
6947542|NCT00986180|10986432|FG001|Overall Study|Lost to Follow-up|7
6947543|NCT00986180|10986431|FG000|Overall Study|Physician Decision|1
6947544|NCT00986180|10986432|FG001|Overall Study|Physician Decision|3
6947545|NCT00986180|10986431|FG000|Overall Study|Protocol Violation|2
6947546|NCT00986180|10986432|FG001|Overall Study|Protocol Violation|0
6947547|NCT00986180|10986431|FG000|Overall Study|Withdrawal by Subject|1
6947548|NCT00986180|10986432|FG001|Overall Study|Withdrawal by Subject|9
6947549|NCT00986180|10986431|FG000|Overall Study|Miscellanies|10
6947550|NCT00986180|10986432|FG001|Overall Study|Miscellanies|11
6947551|NCT00986232|10986442|FG000|Overall Study|Adverse Event|1
6947552|NCT00986232|10986443|FG001|Overall Study|Adverse Event|2
6947553|NCT00986232|10986444|FG002|Overall Study|Adverse Event|3
6947554|NCT00986232|10986445|FG003|Overall Study|Adverse Event|0
6947555|NCT00986232|10986442|FG000|Overall Study|Lost to Follow-up|19
6947556|NCT00986232|10986443|FG001|Overall Study|Lost to Follow-up|12
6947557|NCT00986232|10986444|FG002|Overall Study|Lost to Follow-up|12
6947558|NCT00986232|10986445|FG003|Overall Study|Lost to Follow-up|7
6947559|NCT00986232|10986442|FG000|Overall Study|Protocol Violation|2
6947560|NCT00986232|10986443|FG001|Overall Study|Protocol Violation|3
6947561|NCT00986232|10986444|FG002|Overall Study|Protocol Violation|0
6947562|NCT00986232|10986445|FG003|Overall Study|Protocol Violation|1
6947563|NCT00986232|10986442|FG000|Overall Study|Withdrawal by Subject|13
6947564|NCT00986232|10986443|FG001|Overall Study|Withdrawal by Subject|16
6947565|NCT00986232|10986444|FG002|Overall Study|Withdrawal by Subject|12
6947566|NCT00986232|10986445|FG003|Overall Study|Withdrawal by Subject|3
6947567|NCT00986232|10986442|FG000|Overall Study|Missed one or more bleeds|13
6947568|NCT00986232|10986443|FG001|Overall Study|Missed one or more bleeds|10
6947569|NCT00986232|10986444|FG002|Overall Study|Missed one or more bleeds|6
6947570|NCT00986232|10986445|FG003|Overall Study|Missed one or more bleeds|7
6947571|NCT00986232|10986442|FG000|Overall Study|Incomplete safety follow-up|3
6947572|NCT00986232|10986443|FG001|Overall Study|Incomplete safety follow-up|7
6947573|NCT00986232|10986444|FG002|Overall Study|Incomplete safety follow-up|2
6947574|NCT00986232|10986445|FG003|Overall Study|Incomplete safety follow-up|2
6947575|NCT00986245|10986461|FG000|First Intervention|Poor compliance|8
6947576|NCT00986245|10986462|FG001|First Intervention|Poor compliance|4
6947577|NCT00986245|10986461|FG000|First Intervention|Lack of Efficacy|1
6947578|NCT00986245|10986462|FG001|First Intervention|Lack of Efficacy|2
6947579|NCT00986245|10986461|FG000|First Intervention|Withdrawal by Subject|0
6947580|NCT00986245|10986462|FG001|First Intervention|Withdrawal by Subject|1
6947581|NCT00986245|10986461|FG000|First Intervention|Protocol Violation|0
6947582|NCT00986245|10986462|FG001|First Intervention|Protocol Violation|1
6947583|NCT00986245|10986461|FG000|First Intervention|Out of indication|1
6947584|NCT00986245|10986462|FG001|First Intervention|Out of indication|0
6947585|NCT00986245|10986461|FG000|Second Intervention|Poor compliance|1
6947586|NCT00986245|10986462|FG001|Second Intervention|Poor compliance|0
6947587|NCT00986245|10986461|FG000|Second Intervention|Lost to Follow-up|1
6947588|NCT00986245|10986462|FG001|Second Intervention|Lost to Follow-up|0
6947589|NCT00986245|10986461|FG000|Second Intervention|Protocol Violation|0
6947590|NCT00986245|10986462|FG001|Second Intervention|Protocol Violation|1
6947591|NCT00986258|10986473|FG000|Observation Period|Not eligible to be dosed|11
6947592|NCT00986258|10986473|FG000|Titration and Optimal Dose Period|Adverse Event|15
6947593|NCT00986258|10986473|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3
6947594|NCT00986258|10986473|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3
6947595|NCT00986258|10986473|FG000|Titration and Optimal Dose Period|Non-Compliance|1
6947596|NCT00986258|10986473|FG000|Titration and Optimal Dose Period|Other|1
6947597|NCT00986258|10986473|FG000|Maintenance Period|Adverse Event|5
6947598|NCT00986258|10986473|FG000|Maintenance Period|Lack of Efficacy|2
6947599|NCT00986258|10986473|FG000|Maintenance Period|Withdrawal by Subject|2
6947600|NCT00986349|10986487|FG000|Overall Study|Unsuccessful implant procedure|3
6947601|NCT00986349|10986487|FG000|Overall Study|Adverse Event|2
6947602|NCT00986349|10986487|FG000|Overall Study|Physician Decision|1
6947603|NCT00986349|10986487|FG000|Overall Study|device migration|1
6947604|NCT00986362|10986502|FG000|Overall Study|Death|2
6947605|NCT00986362|10986503|FG001|Overall Study|Death|0
6947606|NCT00986362|10986502|FG000|Overall Study|Lost to Follow-up|0
6947607|NCT00986362|10986503|FG001|Overall Study|Lost to Follow-up|1
6947608|NCT00986427|10986523|FG000|Overall Study|Lost to Follow-up|2
6947609|NCT00986427|10986524|FG001|Overall Study|Lost to Follow-up|0
6947610|NCT00986427|10986523|FG000|Overall Study|Lack of Efficacy|1
6947611|NCT00986427|10986524|FG001|Overall Study|Lack of Efficacy|0
6947612|NCT00986427|10986523|FG000|Overall Study|Withdrawal by Subject|1
6947613|NCT00986427|10986524|FG001|Overall Study|Withdrawal by Subject|0
6947614|NCT00986440|10986536|FG000|Overall Study|Progressive disease|27
6947615|NCT00986440|10986537|FG001|Overall Study|Progressive disease|37
6947616|NCT00986440|10986536|FG000|Overall Study|Serious adverse event or adverse event|9
6947617|NCT00986440|10986537|FG001|Overall Study|Serious adverse event or adverse event|2
6947618|NCT00986440|10986536|FG000|Overall Study|Withdrawal by Subject|1
6947619|NCT00986440|10986537|FG001|Overall Study|Withdrawal by Subject|2
6947620|NCT00986440|10986536|FG000|Overall Study|Screen failure (not dosed)|4
6947621|NCT00986440|10986537|FG001|Overall Study|Screen failure (not dosed)|2
6947622|NCT00986479|10986551|FG000|Period 1|Improved mood|1
6947623|NCT00986479|10986552|FG001|Period 1|Improved mood|0
6947624|NCT00986479|10986551|FG000|Period 1|Administrative reasons|1
6947625|NCT00986479|10986552|FG001|Period 1|Administrative reasons|0
6947626|NCT00986570|10986568|FG000|Overall Study|Lost to Follow-up|6
6947627|NCT00986570|10986568|FG000|Overall Study|Potential bias for objective assessment|1
6947628|NCT00986674|10986585|FG000|Overall Study|Lack of Efficacy|28
6947629|NCT00986674|10986586|FG001|Overall Study|Lack of Efficacy|25
6947630|NCT00986674|10986587|FG002|Overall Study|Lack of Efficacy|23
6947631|NCT00986674|10986585|FG000|Overall Study|Adverse Event|4
6947632|NCT00986674|10986586|FG001|Overall Study|Adverse Event|8
6947633|NCT00986674|10986587|FG002|Overall Study|Adverse Event|9
6947634|NCT00986674|10986585|FG000|Overall Study|Death|5
6947635|NCT00986674|10986586|FG001|Overall Study|Death|0
6947636|NCT00986674|10986587|FG002|Overall Study|Death|4
6947637|NCT00986674|10986585|FG000|Overall Study|Withdrawal by Subject|6
6947638|NCT00986674|10986586|FG001|Overall Study|Withdrawal by Subject|2
6947639|NCT00986674|10986587|FG002|Overall Study|Withdrawal by Subject|1
6947640|NCT00986674|10986585|FG000|Overall Study|alternative therapy|0
6947641|NCT00986674|10986586|FG001|Overall Study|alternative therapy|0
6947642|NCT00986674|10986587|FG002|Overall Study|alternative therapy|1
6947643|NCT00986674|10986585|FG000|Overall Study|not start protocol therapy|4
6947644|NCT00986674|10986586|FG001|Overall Study|not start protocol therapy|3
6947645|NCT00986674|10986587|FG002|Overall Study|not start protocol therapy|1
6947646|NCT00986674|10986585|FG000|Overall Study|unknown/not specify|0
6947647|NCT00986674|10986586|FG001|Overall Study|unknown/not specify|7
6947648|NCT00986674|10986587|FG002|Overall Study|unknown/not specify|9
6947649|NCT00986830|10986595|FG000|Overall Study|Death|1
6947650|NCT00986830|10986595|FG000|Overall Study|Lost to Follow-up|1
6947651|NCT00986830|10986595|FG000|Overall Study|Lack of Efficacy|1
6947652|NCT00986830|10986595|FG000|Overall Study|Unable to access sinus with device|5
6947653|NCT00986921|10986610|FG000|Overall Study|Physician Decision|1
6947654|NCT00986921|10986611|FG001|Overall Study|Physician Decision|0
6947655|NCT00986973|10986620|FG000|Overall Study|Withdrawn by study team|1
6947656|NCT00986986|10986627|FG000|Overall Study|Lost to Follow-up|0
6947657|NCT00986986|10986628|FG001|Overall Study|Lost to Follow-up|1
6947658|NCT00987337|10986638|FG000|Overall Study|Adverse Event|10
6947659|NCT00987337|10986639|FG001|Overall Study|Adverse Event|9
6947660|NCT00987337|10986640|FG002|Overall Study|Adverse Event|8
6947661|NCT00987337|10986638|FG000|Overall Study|Insufficient Virologic Response|10
6947662|NCT00987337|10986639|FG001|Overall Study|Insufficient Virologic Response|7
6947663|NCT00987337|10986640|FG002|Overall Study|Insufficient Virologic Response|12
6947664|NCT00987337|10986638|FG000|Overall Study|Virologic Breakthrough|2
6947665|NCT00987337|10986639|FG001|Overall Study|Virologic Breakthrough|2
6947666|NCT00987337|10986640|FG002|Overall Study|Virologic Breakthrough|8
6947667|NCT00987337|10986638|FG000|Overall Study|Lost to Follow-up|10
6947668|NCT00987337|10986639|FG001|Overall Study|Lost to Follow-up|6
6947669|NCT00987337|10986640|FG002|Overall Study|Lost to Follow-up|2
6947670|NCT00987337|10986638|FG000|Overall Study|Withdrawal by Subject|6
6947671|NCT00987337|10986639|FG001|Overall Study|Withdrawal by Subject|9
6947672|NCT00987337|10986640|FG002|Overall Study|Withdrawal by Subject|9
6947673|NCT00987337|10986638|FG000|Overall Study|Other|0
6947674|NCT00987337|10986639|FG001|Overall Study|Other|2
6947675|NCT00987337|10986640|FG002|Overall Study|Other|5
6947676|NCT00987337|10986638|FG000|Overall Study|Protocol Violation|1
6947677|NCT00987337|10986639|FG001|Overall Study|Protocol Violation|0
6947678|NCT00987337|10986640|FG002|Overall Study|Protocol Violation|2
6947679|NCT00987337|10986638|FG000|Overall Study|Participant Relapsed|18
6947680|NCT00987337|10986639|FG001|Overall Study|Participant Relapsed|20
6947681|NCT00987337|10986640|FG002|Overall Study|Participant Relapsed|5
6947682|NCT00987389|10986652|FG000|Overall Study|Ineligible|0
6947683|NCT00987389|10986653|FG001|Overall Study|Ineligible|3
6947684|NCT00987389|10986654|FG002|Overall Study|Ineligible|0
6947685|NCT00987389|10986655|FG003|Overall Study|Ineligible|0
6947686|NCT00987389|10986652|FG000|Overall Study|Lost to Follow-up|4
6947687|NCT00987389|10986653|FG001|Overall Study|Lost to Follow-up|1
6947688|NCT00987389|10986654|FG002|Overall Study|Lost to Follow-up|3
6947689|NCT00987389|10986655|FG003|Overall Study|Lost to Follow-up|1
6947690|NCT00987389|10986652|FG000|Overall Study|Withdrawal by Subject|4
6947691|NCT00987389|10986653|FG001|Overall Study|Withdrawal by Subject|3
6947692|NCT00987389|10986654|FG002|Overall Study|Withdrawal by Subject|2
7069667|NCT02004873|11171662|FG000|Overall Study|Missed 6-month visit|4
6947693|NCT00987389|10986655|FG003|Overall Study|Withdrawal by Subject|1
6947694|NCT00987389|10986652|FG000|Overall Study|Withdrawn from Treatment|0
6947695|NCT00987389|10986653|FG001|Overall Study|Withdrawn from Treatment|1
6947696|NCT00987389|10986654|FG002|Overall Study|Withdrawn from Treatment|0
6947697|NCT00987389|10986655|FG003|Overall Study|Withdrawn from Treatment|0
6947698|NCT00987389|10986652|FG000|Overall Study|Multiple different reasons|1
6947699|NCT00987389|10986653|FG001|Overall Study|Multiple different reasons|0
6947700|NCT00987389|10986654|FG002|Overall Study|Multiple different reasons|3
6947701|NCT00987389|10986655|FG003|Overall Study|Multiple different reasons|1
6947702|NCT00987402|10986665|FG000|Overall Study|Insufficient data entry|86
6947703|NCT00987402|10986666|FG001|Overall Study|Insufficient data entry|98
6947704|NCT00987467|10986681|FG000|Overall Study|Lost to Follow-up|2
6947705|NCT00987623|10986700|FG000|Overall Study|Lost to Follow-up|2
6947706|NCT00987623|10986701|FG001|Overall Study|Lost to Follow-up|1
6947707|NCT00987623|10986700|FG000|Overall Study|Time/job conflict|2
6947708|NCT00987623|10986701|FG001|Overall Study|Time/job conflict|0
6947709|NCT00987623|10986700|FG000|Overall Study|Discomfort|1
6947710|NCT00987623|10986701|FG001|Overall Study|Discomfort|0
6947711|NCT00987623|10986700|FG000|Overall Study|Biomicroscopy|0
6947712|NCT00987623|10986701|FG001|Overall Study|Biomicroscopy|1
6947713|NCT00987623|10986700|FG000|Overall Study|Influenza|0
6947714|NCT00987623|10986701|FG001|Overall Study|Influenza|1
6947715|NCT00987831|10986719|FG000|Overall Study|Never flared in 12 months|1
6947716|NCT00987831|10986720|FG001|Overall Study|Never flared in 12 months|0
6947717|NCT00987831|10986721|FG002|Overall Study|Never flared in 12 months|0
6947718|NCT00987831|10986719|FG000|Overall Study|Lost to Follow-up|0
6947719|NCT00987831|10986720|FG001|Overall Study|Lost to Follow-up|3
6947720|NCT00987831|10986721|FG002|Overall Study|Lost to Follow-up|0
6947721|NCT00987935|10986739|FG000|Overall Study|Progressive disease|3
6947722|NCT00987935|10986740|FG001|Overall Study|Progressive disease|2
6947723|NCT00987935|10986741|FG002|Overall Study|Progressive disease|3
6947724|NCT00987935|10986742|FG003|Overall Study|Progressive disease|2
6947725|NCT00987935|10986743|FG004|Overall Study|Progressive disease|5
6947726|NCT00987935|10986744|FG005|Overall Study|Progressive disease|3
6947727|NCT00987935|10986745|FG006|Overall Study|Progressive disease|9
6947728|NCT00987935|10986746|FG007|Overall Study|Progressive disease|48
6947729|NCT00987935|10986747|FG008|Overall Study|Progressive disease|23
6947730|NCT00987935|10986739|FG000|Overall Study|Adverse Event|0
6947731|NCT00987935|10986740|FG001|Overall Study|Adverse Event|1
6947732|NCT00987935|10986741|FG002|Overall Study|Adverse Event|0
6947733|NCT00987935|10986742|FG003|Overall Study|Adverse Event|1
6947734|NCT00987935|10986743|FG004|Overall Study|Adverse Event|1
6947735|NCT00987935|10986744|FG005|Overall Study|Adverse Event|0
6947736|NCT00987935|10986745|FG006|Overall Study|Adverse Event|2
6947737|NCT00987935|10986746|FG007|Overall Study|Adverse Event|10
6947738|NCT00987935|10986747|FG008|Overall Study|Adverse Event|6
6947739|NCT00987935|10986739|FG000|Overall Study|Refused to continue taking trial med.|1
6947740|NCT00987935|10986740|FG001|Overall Study|Refused to continue taking trial med.|0
6947741|NCT00987935|10986741|FG002|Overall Study|Refused to continue taking trial med.|0
6947742|NCT00987935|10986742|FG003|Overall Study|Refused to continue taking trial med.|0
6947743|NCT00987935|10986743|FG004|Overall Study|Refused to continue taking trial med.|1
6947744|NCT00987935|10986744|FG005|Overall Study|Refused to continue taking trial med.|0
6947745|NCT00987935|10986745|FG006|Overall Study|Refused to continue taking trial med.|4
6947746|NCT00987935|10986746|FG007|Overall Study|Refused to continue taking trial med.|4
6947747|NCT00987935|10986747|FG008|Overall Study|Refused to continue taking trial med.|2
6947748|NCT00987935|10986739|FG000|Overall Study|Reason other than those specified above|0
6947749|NCT00987935|10986740|FG001|Overall Study|Reason other than those specified above|0
6947750|NCT00987935|10986741|FG002|Overall Study|Reason other than those specified above|0
6947751|NCT00987935|10986742|FG003|Overall Study|Reason other than those specified above|0
6947752|NCT00987935|10986743|FG004|Overall Study|Reason other than those specified above|0
6947753|NCT00987935|10986744|FG005|Overall Study|Reason other than those specified above|0
6947754|NCT00987935|10986745|FG006|Overall Study|Reason other than those specified above|0
6947755|NCT00987935|10986746|FG007|Overall Study|Reason other than those specified above|0
6947756|NCT00987935|10986747|FG008|Overall Study|Reason other than those specified above|1
6947757|NCT00988065|10986814|FG000|Overall Study|Adverse Event|4
6947758|NCT00988065|10986815|FG001|Overall Study|Adverse Event|10
6947759|NCT00988065|10986816|FG002|Overall Study|Adverse Event|2
6947760|NCT00988065|10986814|FG000|Overall Study|Lost to Follow-up|1
6947761|NCT00988065|10986815|FG001|Overall Study|Lost to Follow-up|2
6947762|NCT00988065|10986816|FG002|Overall Study|Lost to Follow-up|2
6947763|NCT00988065|10986814|FG000|Overall Study|Subject withdrew consent|3
6947764|NCT00988065|10986815|FG001|Overall Study|Subject withdrew consent|5
6947765|NCT00988065|10986816|FG002|Overall Study|Subject withdrew consent|2
7040797|NCT01720524|11124006|FG000|Part A|Adverse Event|2
6947766|NCT00988065|10986814|FG000|Overall Study|Noncompliance with protocol|5
6947767|NCT00988065|10986815|FG001|Overall Study|Noncompliance with protocol|6
6947768|NCT00988065|10986816|FG002|Overall Study|Noncompliance with protocol|9
7069668|NCT02004873|11171662|FG000|Overall Study|Death|23
6947769|NCT00988091|10986826|FG000|Double-blind Period|Withdrawal by Subject|15
6947770|NCT00988091|10986827|FG001|Double-blind Period|Withdrawal by Subject|13
6947771|NCT00988091|10986826|FG000|Double-blind Period|Lost to Follow-up|12
6947772|NCT00988091|10986827|FG001|Double-blind Period|Lost to Follow-up|14
6947773|NCT00988091|10986826|FG000|Double-blind Period|Other|8
6947774|NCT00988091|10986827|FG001|Double-blind Period|Other|8
6947775|NCT00988091|10986826|FG000|Double-blind Period|Adverse Event|6
6947776|NCT00988091|10986827|FG001|Double-blind Period|Adverse Event|9
6947777|NCT00988091|10986826|FG000|Double-blind Period|Use of exclusionary medication|2
6947778|NCT00988091|10986827|FG001|Double-blind Period|Use of exclusionary medication|3
6947779|NCT00988091|10986826|FG000|Open-label Period|Adverse Event|4
6947780|NCT00988091|10986827|FG001|Open-label Period|Adverse Event|7
6947781|NCT00988091|10986826|FG000|Open-label Period|Use of exclusionary medication|1
6947782|NCT00988091|10986827|FG001|Open-label Period|Use of exclusionary medication|1
6947783|NCT00988091|10986826|FG000|Open-label Period|Protocol Violation|1
6947784|NCT00988091|10986827|FG001|Open-label Period|Protocol Violation|1
6947785|NCT00988091|10986826|FG000|Open-label Period|Withdrawal by Subject|10
6947786|NCT00988091|10986827|FG001|Open-label Period|Withdrawal by Subject|16
6947787|NCT00988091|10986826|FG000|Open-label Period|Lost to Follow-up|3
6947788|NCT00988091|10986827|FG001|Open-label Period|Lost to Follow-up|5
6947789|NCT00988091|10986826|FG000|Open-label Period|Other|2
6947790|NCT00988091|10986827|FG001|Open-label Period|Other|3
6947791|NCT00988117|10986834|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1
6947792|NCT00988117|10986834|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2
6947793|NCT00988169|10986861|FG000|Overall Study|Withdrawal by Subject|1
6947794|NCT00988208|10986867|FG000|Overall Study|Adverse Event|71
6947795|NCT00988208|10986868|FG001|Overall Study|Adverse Event|122
6947796|NCT00988208|10986867|FG000|Overall Study|Disease Progression|103
6947797|NCT00988208|10986868|FG001|Overall Study|Disease Progression|89
6947798|NCT00988208|10986867|FG000|Overall Study|Withdrawal by Subject|50
6947799|NCT00988208|10986868|FG001|Overall Study|Withdrawal by Subject|57
6947800|NCT00988208|10986867|FG000|Overall Study|Death|9
6947801|NCT00988208|10986868|FG001|Overall Study|Death|15
6947802|NCT00988208|10986867|FG000|Overall Study|Lost to Follow-up|2
6947803|NCT00988208|10986868|FG001|Overall Study|Lost to Follow-up|3
6947804|NCT00988208|10986867|FG000|Overall Study|Protocol Violation|9
6947805|NCT00988208|10986868|FG001|Overall Study|Protocol Violation|2
6947806|NCT00988208|10986867|FG000|Overall Study|Sponsor Decision|102
6947807|NCT00988208|10986868|FG001|Overall Study|Sponsor Decision|78
6947808|NCT00988208|10986867|FG000|Overall Study|Clinical Progression|17
6947809|NCT00988208|10986868|FG001|Overall Study|Clinical Progression|16
6947810|NCT00988208|10986867|FG000|Overall Study|Biochemical Progression|21
6947811|NCT00988208|10986868|FG001|Overall Study|Biochemical Progression|7
6947812|NCT00988208|10986867|FG000|Overall Study|Clinical Deterioration|7
6947813|NCT00988208|10986868|FG001|Overall Study|Clinical Deterioration|14
6947814|NCT00988208|10986867|FG000|Overall Study|Subject Decision/Investigator Discretion|32
6947815|NCT00988208|10986868|FG001|Overall Study|Subject Decision/Investigator Discretion|32
6947816|NCT00988208|10986867|FG000|Overall Study|Other|8
6947817|NCT00988208|10986868|FG001|Overall Study|Other|3
6947818|NCT00988221|10986877|FG000|Part I|Adverse Event|0
6947819|NCT00988221|10986878|FG001|Part I|Adverse Event|1
6947820|NCT00988221|10986879|FG002|Part I|Adverse Event|2
6947821|NCT00988221|10986880|FG003|Part I|Adverse Event|0
6947822|NCT00988221|10986877|FG000|Part I|Insufficient Therapeutic Response|4
6947823|NCT00988221|10986878|FG001|Part I|Insufficient Therapeutic Response|6
6947824|NCT00988221|10986879|FG002|Part I|Insufficient Therapeutic Response|5
6947825|NCT00988221|10986880|FG003|Part I|Insufficient Therapeutic Response|0
6947826|NCT00988221|10986877|FG000|Part I|Refused Treatment|0
6947827|NCT00988221|10986878|FG001|Part I|Refused Treatment|2
6947828|NCT00988221|10986879|FG002|Part I|Refused Treatment|1
6947829|NCT00988221|10986880|FG003|Part I|Refused Treatment|0
6947830|NCT00988221|10986877|FG000|Part I|Lost to Follow-up|0
6947831|NCT00988221|10986878|FG001|Part I|Lost to Follow-up|1
6947832|NCT00988221|10986879|FG002|Part I|Lost to Follow-up|0
6947833|NCT00988221|10986880|FG003|Part I|Lost to Follow-up|0
6947834|NCT00988221|10986877|FG000|Part II|Adverse Event|1
6947835|NCT00988221|10986878|FG001|Part II|Adverse Event|0
6947836|NCT00988221|10986879|FG002|Part II|Adverse Event|0
6947837|NCT00988221|10986880|FG003|Part II|Adverse Event|1
6947838|NCT00988221|10986877|FG000|Part II|Withdrawal by Subject|0
6947839|NCT00988221|10986878|FG001|Part II|Withdrawal by Subject|0
6947840|NCT00988221|10986879|FG002|Part II|Withdrawal by Subject|2
6947841|NCT00988221|10986880|FG003|Part II|Withdrawal by Subject|2
6947842|NCT00988221|10986877|FG000|Part II|Reason not Specified|0
6947843|NCT00988221|10986878|FG001|Part II|Reason not Specified|0
6947844|NCT00988221|10986879|FG002|Part II|Reason not Specified|1
6947845|NCT00988221|10986880|FG003|Part II|Reason not Specified|0
6947846|NCT00988221|10986877|FG000|Part III|Adverse Event|1
6947847|NCT00988221|10986878|FG001|Part III|Adverse Event|0
6947848|NCT00988221|10986879|FG002|Part III|Adverse Event|1
6947849|NCT00988221|10986880|FG003|Part III|Adverse Event|0
6947850|NCT00988221|10986877|FG000|Part III|Insufficient Therapeutic Response|0
6947851|NCT00988221|10986878|FG001|Part III|Insufficient Therapeutic Response|1
6947852|NCT00988221|10986879|FG002|Part III|Insufficient Therapeutic Response|1
6947853|NCT00988221|10986880|FG003|Part III|Insufficient Therapeutic Response|0
6947854|NCT00988221|10986877|FG000|Part III|Refused Treatment|0
6947855|NCT00988221|10986878|FG001|Part III|Refused Treatment|0
6947856|NCT00988221|10986879|FG002|Part III|Refused Treatment|1
6947857|NCT00988221|10986880|FG003|Part III|Refused Treatment|0
6947858|NCT00988351|10986918|FG000|Overall Study|Withdrawal by Subject|8
6947859|NCT00988351|10986919|FG001|Overall Study|Withdrawal by Subject|0
6947860|NCT00988351|10986918|FG000|Overall Study|Lost to Follow-up|6
6947861|NCT00988351|10986919|FG001|Overall Study|Lost to Follow-up|9
6947862|NCT00988351|10986918|FG000|Overall Study|not using CPAP|5
6947863|NCT00988351|10986919|FG001|Overall Study|not using CPAP|3
6947864|NCT00988429|10986928|FG000|Overall Study|Adverse Event|9
6947865|NCT00988429|10986929|FG001|Overall Study|Adverse Event|21
6947866|NCT00988429|10986930|FG002|Overall Study|Adverse Event|45
6947867|NCT00988429|10986928|FG000|Overall Study|Lack of Efficacy|0
6947868|NCT00988429|10986929|FG001|Overall Study|Lack of Efficacy|0
6947869|NCT00988429|10986930|FG002|Overall Study|Lack of Efficacy|1
6947870|NCT00988429|10986928|FG000|Overall Study|Non-Compliance with Study Drug|5
6947871|NCT00988429|10986929|FG001|Overall Study|Non-Compliance with Study Drug|1
6947872|NCT00988429|10986930|FG002|Overall Study|Non-Compliance with Study Drug|3
6947873|NCT00988429|10986928|FG000|Overall Study|Physician Decision|1
6947874|NCT00988429|10986929|FG001|Overall Study|Physician Decision|0
6947875|NCT00988429|10986930|FG002|Overall Study|Physician Decision|3
6947876|NCT00988429|10986928|FG000|Overall Study|Pregnancy|2
6947877|NCT00988429|10986929|FG001|Overall Study|Pregnancy|1
6947878|NCT00988429|10986930|FG002|Overall Study|Pregnancy|0
6947879|NCT00988429|10986928|FG000|Overall Study|Protocol Violation|4
6947880|NCT00988429|10986929|FG001|Overall Study|Protocol Violation|3
6947881|NCT00988429|10986930|FG002|Overall Study|Protocol Violation|3
6947882|NCT00988429|10986928|FG000|Overall Study|Withdrawal by Subject|7
6947883|NCT00988429|10986929|FG001|Overall Study|Withdrawal by Subject|7
6947884|NCT00988429|10986930|FG002|Overall Study|Withdrawal by Subject|12
6947885|NCT00988429|10986928|FG000|Overall Study|Administrative Reasons|1
6947886|NCT00988429|10986929|FG001|Overall Study|Administrative Reasons|2
6947887|NCT00988429|10986930|FG002|Overall Study|Administrative Reasons|1
6947888|NCT00988429|10986928|FG000|Overall Study|other reasons|8
6947889|NCT00988429|10986929|FG001|Overall Study|other reasons|8
6947890|NCT00988429|10986930|FG002|Overall Study|other reasons|1
6975859|NCT01195363|11028080|FG000|Overall Study|Lost to Follow-up|7
6975860|NCT01195363|11028081|FG001|Overall Study|Lost to Follow-up|4
6975861|NCT01195363|11028080|FG000|Overall Study|Adverse Event|3
6975862|NCT01195363|11028081|FG001|Overall Study|Adverse Event|1
6975863|NCT01195363|11028080|FG000|Overall Study|Lack of Efficacy|0
6975864|NCT01195363|11028081|FG001|Overall Study|Lack of Efficacy|4
6975865|NCT01195363|11028080|FG000|Overall Study|incarceration|1
6975866|NCT01195363|11028081|FG001|Overall Study|incarceration|0
6975867|NCT01195415|11028087|FG000|Overall Study|No repeat biopsy due to progression|2
6975868|NCT01195545|11028095|FG000|Overall Study|Protocol Violation|4
6975869|NCT01195623|11028120|FG000|Overall Study|Lost to Follow-up|35
6975870|NCT01195623|11028121|FG001|Overall Study|Lost to Follow-up|37
6975871|NCT01195636|11028129|FG000|First Intervention (3 Weeks)|Adverse Event|2
6975872|NCT01195636|11028130|FG001|First Intervention (3 Weeks)|Adverse Event|3
6975873|NCT01195636|11028129|FG000|First Intervention (3 Weeks)|Protocol Violation|1
6975874|NCT01195636|11028130|FG001|First Intervention (3 Weeks)|Protocol Violation|0
6975875|NCT01195636|11028129|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1
6975876|NCT01195636|11028130|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0
6975877|NCT01195636|11028129|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1
6975878|NCT01195636|11028130|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0
6975879|NCT01195636|11028129|FG000|Washout Period (2 Weeks)|Adverse Event|1
6975880|NCT01195636|11028130|FG001|Washout Period (2 Weeks)|Adverse Event|1
6975881|NCT01195636|11028129|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1
6975882|NCT01195636|11028130|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2
6975883|NCT01195636|11028129|FG000|Second Intervention (3 Weeks)|Adverse Event|1
6975884|NCT01195636|11028130|FG001|Second Intervention (3 Weeks)|Adverse Event|1
6975885|NCT01195636|11028129|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0
6975886|NCT01195636|11028130|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1
6975887|NCT01195662|11028139|FG000|Double Blind Treatment Period|Adverse Event|4
6975888|NCT01195662|11028140|FG001|Double Blind Treatment Period|Adverse Event|1
6975889|NCT01195662|11028141|FG002|Double Blind Treatment Period|Adverse Event|2
6975890|NCT01195662|11028139|FG000|Double Blind Treatment Period|Withdrawal by Subject|6
6975891|NCT01195662|11028140|FG001|Double Blind Treatment Period|Withdrawal by Subject|4
6975892|NCT01195662|11028141|FG002|Double Blind Treatment Period|Withdrawal by Subject|4
6975893|NCT01195662|11028139|FG000|Double Blind Treatment Period|Lost to Follow-up|3
6975894|NCT01195662|11028140|FG001|Double Blind Treatment Period|Lost to Follow-up|2
6975895|NCT01195662|11028141|FG002|Double Blind Treatment Period|Lost to Follow-up|3
6975896|NCT01195662|11028139|FG000|Double Blind Treatment Period|Administrative reason|2
6975897|NCT01195662|11028140|FG001|Double Blind Treatment Period|Administrative reason|1
6975898|NCT01195662|11028141|FG002|Double Blind Treatment Period|Administrative reason|1
6975899|NCT01195662|11028139|FG000|Double Blind Treatment Period|Requested discontinue treatment|1
6975900|NCT01195662|11028140|FG001|Double Blind Treatment Period|Requested discontinue treatment|0
6975901|NCT01195662|11028141|FG002|Double Blind Treatment Period|Requested discontinue treatment|1
6947891|NCT00988442|10986941|FG000|Overall Study|Death|1
6947892|NCT00988442|10986942|FG001|Overall Study|Death|2
6947893|NCT00988442|10986941|FG000|Overall Study|Lost to Follow-up|0
6947894|NCT00988442|10986942|FG001|Overall Study|Lost to Follow-up|1
6947895|NCT00988442|10986941|FG000|Overall Study|Early Study Closure|29
6947896|NCT00988442|10986942|FG001|Overall Study|Early Study Closure|25
6947897|NCT00988533|10986951|FG000|Overall Study|Lost to Follow-up|3
6947898|NCT00988559|10986959|FG000|Overall Study|Withdrawal by Subject|1
6947899|NCT00988559|10986960|FG001|Overall Study|Withdrawal by Subject|1
6947900|NCT00988559|10986961|FG002|Overall Study|Withdrawal by Subject|0
6947901|NCT00988559|10986962|FG003|Overall Study|Withdrawal by Subject|1
6947902|NCT00988559|10986959|FG000|Overall Study|Pregnancy|0
6947903|NCT00988559|10986960|FG001|Overall Study|Pregnancy|1
6947904|NCT00988559|10986961|FG002|Overall Study|Pregnancy|1
6947905|NCT00988559|10986962|FG003|Overall Study|Pregnancy|0
6947906|NCT00988559|10986959|FG000|Overall Study|Lost to Follow-up|0
6947907|NCT00988559|10986960|FG001|Overall Study|Lost to Follow-up|0
6947908|NCT00988559|10986961|FG002|Overall Study|Lost to Follow-up|1
6947909|NCT00988559|10986962|FG003|Overall Study|Lost to Follow-up|0
6947910|NCT00988598|10986974|FG000|Overall Study|Withdrawal by Subject|2
6947911|NCT00988598|10986975|FG001|Overall Study|Withdrawal by Subject|0
6947912|NCT00988637|10986983|FG000|Overall Study|Lost to Follow-up|2
6947913|NCT00988637|10986984|FG001|Overall Study|Lost to Follow-up|1
6947914|NCT00988637|10986983|FG000|Overall Study|Withdrawal by Subject|1
6947915|NCT00988637|10986984|FG001|Overall Study|Withdrawal by Subject|1
6947916|NCT00988637|10986983|FG000|Overall Study|non-compliance with study drug|0
6947917|NCT00988637|10986984|FG001|Overall Study|non-compliance with study drug|1
6947918|NCT00988858|10986997|FG000|Overall Study|Adverse Event|7
6947919|NCT00988858|10986997|FG000|Overall Study|Death|1
6947920|NCT00988858|10986997|FG000|Overall Study|Physician Decision|1
6947921|NCT00988858|10986997|FG000|Overall Study|Sponsor Decision|1
6947922|NCT00988884|10987003|FG000|Overall Study|Adverse Event|0
6947923|NCT00988884|10987004|FG001|Overall Study|Adverse Event|1
6947924|NCT00988884|10987003|FG000|Overall Study|Lost to Follow-up|20
6947925|NCT00988884|10987004|FG001|Overall Study|Lost to Follow-up|16
6947926|NCT00988884|10987003|FG000|Overall Study|Protocol Violation|0
6947927|NCT00988884|10987004|FG001|Overall Study|Protocol Violation|1
6947928|NCT00988884|10987003|FG000|Overall Study|Withdrawal by Subject|15
6947929|NCT00988884|10987004|FG001|Overall Study|Withdrawal by Subject|18
6947930|NCT00989092|10987029|FG000|Overall Study|Physician Decision|9
6947931|NCT00989092|10987030|FG001|Overall Study|Physician Decision|6
6947932|NCT00989092|10987029|FG000|Overall Study|Adverse Event|20
6947933|NCT00989092|10987030|FG001|Overall Study|Adverse Event|1
6947934|NCT00989092|10987029|FG000|Overall Study|Chemotherapy initiated|12
6947935|NCT00989092|10987030|FG001|Overall Study|Chemotherapy initiated|4
6947936|NCT00989092|10987029|FG000|Overall Study|Withdrawal by Subject|17
6947937|NCT00989092|10987030|FG001|Overall Study|Withdrawal by Subject|9
6947938|NCT00989092|10987029|FG000|Overall Study|Death|14
6947939|NCT00989092|10987030|FG001|Overall Study|Death|2
6947940|NCT00989092|10987029|FG000|Overall Study|Ineligibility determined|3
6947941|NCT00989092|10987030|FG001|Overall Study|Ineligibility determined|3
6947942|NCT00989092|10987029|FG000|Overall Study|Lost to Follow-up|6
6947943|NCT00989092|10987030|FG001|Overall Study|Lost to Follow-up|2
6947944|NCT00989092|10987029|FG000|Overall Study|Other|3
6947945|NCT00989092|10987030|FG001|Overall Study|Other|1
6947946|NCT00989092|10987029|FG000|Overall Study|Protocol deviation|2
6947947|NCT00989092|10987030|FG001|Overall Study|Protocol deviation|0
6947948|NCT00989092|10987029|FG000|Overall Study|Erythropoietin therapy initiated|2
6947949|NCT00989092|10987030|FG001|Overall Study|Erythropoietin therapy initiated|0
6947950|NCT00989092|10987029|FG000|Overall Study|Did not receive study drug|2
6947951|NCT00989092|10987030|FG001|Overall Study|Did not receive study drug|0
6947952|NCT00989196|10987048|FG000|Treatment Period|Lost to Follow-up|1
6947953|NCT00989196|10987049|FG001|Treatment Period|Lost to Follow-up|0
6947954|NCT00989235|10987057|FG000|Overall Study|Death|0
6947955|NCT00989235|10987058|FG001|Overall Study|Death|1
6947956|NCT00989235|10987057|FG000|Overall Study|Adverse Event|0
6947957|NCT00989235|10987058|FG001|Overall Study|Adverse Event|1
6947958|NCT00989235|10987057|FG000|Overall Study|Lack of Efficacy|1
6947959|NCT00989235|10987058|FG001|Overall Study|Lack of Efficacy|0
6947960|NCT00989235|10987057|FG000|Overall Study|Withdrawal of Consent|1
6947961|NCT00989235|10987058|FG001|Overall Study|Withdrawal of Consent|1
6947962|NCT00989235|10987057|FG000|Overall Study|Desire to Become Pregnant|1
6947963|NCT00989235|10987058|FG001|Overall Study|Desire to Become Pregnant|0
6947964|NCT00989235|10987057|FG000|Overall Study|Randomized by Mistake|0
6947965|NCT00989235|10987058|FG001|Overall Study|Randomized by Mistake|2
6947966|NCT00989235|10987057|FG000|Overall Study|Lost to Follow-up|0
6947967|NCT00989235|10987058|FG001|Overall Study|Lost to Follow-up|1
6947968|NCT00989261|10987069|FG000|Overall Study|Still in follow up|12
6947969|NCT00989261|10987070|FG001|Overall Study|Still in follow up|21
6947970|NCT00989261|10987069|FG000|Overall Study|Withdrawal by Subject|0
6947971|NCT00989261|10987070|FG001|Overall Study|Withdrawal by Subject|1
6947972|NCT00989261|10987069|FG000|Overall Study|Lost to Follow-up|3
6947973|NCT00989261|10987070|FG001|Overall Study|Lost to Follow-up|0
6947974|NCT00989287|10987078|FG000|Overall Study|Adverse Event|1
6947975|NCT00989287|10987079|FG001|Overall Study|Adverse Event|0
6947976|NCT00989287|10987078|FG000|Overall Study|Lost to Follow-up|0
6947977|NCT00989287|10987079|FG001|Overall Study|Lost to Follow-up|1
6947978|NCT00989573|10987101|FG000|Overall Study|Adverse Event|8
6947979|NCT00989573|10987102|FG001|Overall Study|Adverse Event|12
6947980|NCT00989573|10987103|FG002|Overall Study|Adverse Event|4
6947981|NCT00989573|10987101|FG000|Overall Study|Physician Decision|0
6947982|NCT00989573|10987102|FG001|Overall Study|Physician Decision|2
6947983|NCT00989573|10987103|FG002|Overall Study|Physician Decision|0
6947984|NCT00989573|10987101|FG000|Overall Study|Protocol Violation|1
6947985|NCT00989573|10987102|FG001|Overall Study|Protocol Violation|1
6947986|NCT00989573|10987103|FG002|Overall Study|Protocol Violation|1
6947987|NCT00989573|10987101|FG000|Overall Study|Withdrawal by Subject|4
6947988|NCT00989573|10987102|FG001|Overall Study|Withdrawal by Subject|7
6947989|NCT00989573|10987103|FG002|Overall Study|Withdrawal by Subject|3
6947990|NCT00989664|10987127|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1
6947991|NCT00989664|10987127|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2
6947992|NCT00989664|10987127|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49
6947993|NCT00989664|10987127|FG000|Dosimetric and Therapeutic Treatment|Death|1
6947994|NCT00989664|10987127|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7
6947995|NCT00989664|10987127|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1
6947996|NCT00989664|10987127|FG000|Long-Term Follow-Up|Death|3
6947997|NCT00989781|10987143|FG000|Ovarian Response to hCG|Lost to Follow-up|3
6947998|NCT00989781|10987144|FG001|Ovarian Response to hCG|Lost to Follow-up|2
6947999|NCT00989833|10987154|FG000|Overall Study|Lost to Follow-up|0
6948000|NCT00989833|10987155|FG001|Overall Study|Lost to Follow-up|1
6948001|NCT00989833|10987156|FG002|Overall Study|Lost to Follow-up|0
6948002|NCT00989833|10987154|FG000|Overall Study|Protocol Violation|1
6948003|NCT00989833|10987155|FG001|Overall Study|Protocol Violation|2
6948004|NCT00989833|10987156|FG002|Overall Study|Protocol Violation|1
6948005|NCT00989833|10987154|FG000|Overall Study|Withdrawal by Subject|0
6948006|NCT00989833|10987155|FG001|Overall Study|Withdrawal by Subject|0
6948007|NCT00989833|10987156|FG002|Overall Study|Withdrawal by Subject|1
6948008|NCT00989833|10987154|FG000|Overall Study|Incorrectly randomized|1
6948009|NCT00989833|10987155|FG001|Overall Study|Incorrectly randomized|0
6948010|NCT00989833|10987156|FG002|Overall Study|Incorrectly randomized|0
6948011|NCT00989950|10987172|FG000|Randomized Phase|Protocol Violation|1
6948012|NCT00989950|10987173|FG001|Randomized Phase|Protocol Violation|0
6948013|NCT00989950|10987174|FG002|Randomized Phase|Protocol Violation|0
6948014|NCT00989950|10987175|FG003|Randomized Phase|Protocol Violation|0
6948015|NCT00989950|10987172|FG000|Randomized Phase|Adverse Event|0
6948016|NCT00989950|10987173|FG001|Randomized Phase|Adverse Event|1
6948017|NCT00989950|10987174|FG002|Randomized Phase|Adverse Event|0
6948018|NCT00989950|10987175|FG003|Randomized Phase|Adverse Event|0
6948019|NCT00989963|10987188|FG000|Overall Study|Adverse Event|1
6948020|NCT00989963|10987189|FG001|Overall Study|Adverse Event|1
6948021|NCT00989963|10987190|FG002|Overall Study|Adverse Event|1
6948022|NCT00990093|10987211|FG000|Test Period 1 (1-14 Days)|Adverse Event|1
6948023|NCT00990093|10987212|FG001|Test Period 1 (1-14 Days)|Adverse Event|0
6948024|NCT00990093|10987211|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2
6948025|NCT00990093|10987212|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0
6948026|NCT00990093|10987211|FG000|Test Period 1 (1-14 Days)|Other|1
6948027|NCT00990093|10987212|FG001|Test Period 1 (1-14 Days)|Other|0
6948028|NCT00990093|10987211|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0
6948029|NCT00990093|10987212|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2
6948030|NCT00990093|10987211|FG000|Test Period 2 (15-28 Days)|Adverse Event|1
6948031|NCT00990093|10987212|FG001|Test Period 2 (15-28 Days)|Adverse Event|0
6948032|NCT00990093|10987211|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1
6948033|NCT00990093|10987212|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0
6948034|NCT00990093|10987211|FG000|Test Period 2 (15-28 Days)|Other|0
6948035|NCT00990093|10987212|FG001|Test Period 2 (15-28 Days)|Other|1
6948036|NCT00990106|10987220|FG000|Overall Study|"too busy to continue"|1
6948037|NCT00990106|10987221|FG001|Overall Study|"too busy to continue"|2
6948038|NCT00990106|10987220|FG000|Overall Study|Lost to Follow-up|1
6948039|NCT00990106|10987221|FG001|Overall Study|Lost to Follow-up|3
6948040|NCT00990106|10987220|FG000|Overall Study|Withdrawal by Subject|2
6948041|NCT00990106|10987221|FG001|Overall Study|Withdrawal by Subject|1
6948042|NCT00990106|10987220|FG000|Overall Study|opted for open label prazosin|1
6948043|NCT00990106|10987221|FG001|Overall Study|opted for open label prazosin|1
6948044|NCT00990106|10987220|FG000|Overall Study|relocation/deployment|4
6948045|NCT00990106|10987221|FG001|Overall Study|relocation/deployment|1
6948046|NCT00990106|10987220|FG000|Overall Study|started exclusionary medication|0
6948047|NCT00990106|10987221|FG001|Overall Study|started exclusionary medication|1
6948048|NCT00990106|10987220|FG000|Overall Study|planned major surgery|0
6948049|NCT00990106|10987221|FG001|Overall Study|planned major surgery|1
6948050|NCT00990106|10987220|FG000|Overall Study|scheduling conflicts|0
6948051|NCT00990106|10987221|FG001|Overall Study|scheduling conflicts|2
6948052|NCT00990184|10987227|FG000|Overall Study|Physician Decision|1
6948053|NCT00990249|10987242|FG000|Overall Study|Disease Progression|8
6948054|NCT00990249|10987242|FG000|Overall Study|Non-Compliance|1
6948055|NCT00990249|10987242|FG000|Overall Study|Death|2
6948056|NCT00990249|10987242|FG000|Overall Study|Not treated|2
6948057|NCT00990314|10987255|FG000|Overall Study|Death|2
6948058|NCT00990314|10987255|FG000|Overall Study|Adverse Event|2
6948059|NCT00990314|10987255|FG000|Overall Study|Withdrawal by Subject|3
6948060|NCT00990314|10987255|FG000|Overall Study|Non-Compliance|1
6948061|NCT00990314|10987255|FG000|Overall Study|Physician Decision|3
6948062|NCT00990314|10987255|FG000|Overall Study|Lack of Efficacy|1
6948063|NCT00990340|10987261|FG000|First 14-day Treatment|Not Compliant|2
6948064|NCT00990340|10987262|FG001|First 14-day Treatment|Not Compliant|1
6948065|NCT00990340|10987261|FG000|First 14-day Treatment|Lost to Follow-up|2
6948066|NCT00990340|10987262|FG001|First 14-day Treatment|Lost to Follow-up|1
6948067|NCT00990340|10987261|FG000|First 14-day Treatment|Protocol Violation|2
6948068|NCT00990340|10987262|FG001|First 14-day Treatment|Protocol Violation|2
6948069|NCT00990652|10987290|FG000|Pre-surgical Bortezomib|Adverse Event|1
6948070|NCT00990652|10987290|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1
6948071|NCT00990665|10987295|FG000|Overall Study|Unsuccessful Implant|8
6948072|NCT00990665|10987295|FG000|Overall Study|Death|29
6948073|NCT00990665|10987295|FG000|Overall Study|Heart Transplant|1
6948074|NCT00990665|10987295|FG000|Overall Study|Withdrawal by Subject|6
7069669|NCT02004873|11171662|FG000|Overall Study|Withdrawal by Subject|1
7069670|NCT02004886|11171673|FG000|Overall Study|Adverse Event|0
7069671|NCT02004886|11171674|FG001|Overall Study|Adverse Event|1
7069672|NCT02004886|11171675|FG002|Overall Study|Adverse Event|0
7069673|NCT02004886|11171676|FG003|Overall Study|Adverse Event|0
7069674|NCT02004886|11171673|FG000|Overall Study|Unable to attend future visits|1
7069675|NCT02004886|11171674|FG001|Overall Study|Unable to attend future visits|0
7069676|NCT02004886|11171675|FG002|Overall Study|Unable to attend future visits|0
7069677|NCT02004886|11171676|FG003|Overall Study|Unable to attend future visits|0
7069678|NCT02005029|11171705|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1
7069679|NCT02005029|11171706|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0
7069680|NCT02005211|11171737|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
7069681|NCT02005211|11171738|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
7069682|NCT02005211|11171739|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
7069683|NCT02005211|11171740|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
7069684|NCT02005211|11171741|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1
7069685|NCT02005211|11171742|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
7069686|NCT02005211|11171743|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
7069687|NCT02005250|11171768|FG000|Overall Study|Lost to Follow-up|15
7069688|NCT02005250|11171769|FG001|Overall Study|Lost to Follow-up|5
7069689|NCT02005276|11171779|FG000|Overall Study|No longer interested|5
7069690|NCT02005276|11171780|FG001|Overall Study|No longer interested|2
7069691|NCT02005276|11171781|FG002|Overall Study|No longer interested|3
7069692|NCT02005276|11171782|FG003|Overall Study|No longer interested|3
7069693|NCT02005484|11171807|FG000|Overall Study|Death|1
7069694|NCT02005484|11171807|FG000|Overall Study|Disease progression|1
7069695|NCT02005484|11171807|FG000|Overall Study|Changed to a Different Study|1
7069696|NCT02005484|11171807|FG000|Overall Study|Sponsor decision|1
7069697|NCT02005562|11171830|FG000|Overall Study|Death|2
7069698|NCT02005562|11171831|FG001|Overall Study|Death|2
7069699|NCT02005562|11171830|FG000|Overall Study|Graft loss|7
7069700|NCT02005562|11171831|FG001|Overall Study|Graft loss|6
7069701|NCT02005562|11171830|FG000|Overall Study|Withdrawal by Subject|2
7069702|NCT02005562|11171831|FG001|Overall Study|Withdrawal by Subject|2
7069703|NCT02005562|11171830|FG000|Overall Study|No transplant|1
7069704|NCT02005562|11171831|FG001|Overall Study|No transplant|4
7069705|NCT02005562|11171830|FG000|Overall Study|Physician Decision|0
7069706|NCT02005562|11171831|FG001|Overall Study|Physician Decision|1
7069707|NCT02005627|11171848|FG000|Overall Study|Lost to Follow-up|1
7069708|NCT02005627|11171849|FG001|Overall Study|Lost to Follow-up|2
6948075|NCT00990665|10987295|FG000|Overall Study|Lost to Follow-up|1
6948076|NCT00990665|10987295|FG000|Overall Study|System Explant|3
6948077|NCT00990704|10987303|FG000|Overall Study|Adverse Event|1
6948078|NCT00990704|10987304|FG001|Overall Study|Adverse Event|1
6948079|NCT00990704|10987303|FG000|Overall Study|Physician Decision|0
6948080|NCT00990704|10987304|FG001|Overall Study|Physician Decision|1
6948081|NCT00990821|10987337|FG000|Overall Study|Withdrawal by Subject|0
6948082|NCT00990821|10987338|FG001|Overall Study|Withdrawal by Subject|2
6948083|NCT00990821|10987339|FG002|Overall Study|Withdrawal by Subject|0
6948084|NCT00990821|10987340|FG003|Overall Study|Withdrawal by Subject|0
6948085|NCT00990821|10987341|FG004|Overall Study|Withdrawal by Subject|3
6948086|NCT00990821|10987342|FG005|Overall Study|Withdrawal by Subject|3
6948087|NCT00990821|10987343|FG006|Overall Study|Withdrawal by Subject|1
6948088|NCT00990821|10987344|FG007|Overall Study|Withdrawal by Subject|0
6948089|NCT00990821|10987345|FG008|Overall Study|Withdrawal by Subject|0
6948090|NCT00990821|10987346|FG009|Overall Study|Withdrawal by Subject|1
6948091|NCT00990821|10987347|FG010|Overall Study|Withdrawal by Subject|3
6948092|NCT00990821|10987348|FG011|Overall Study|Withdrawal by Subject|5
7069709|NCT02005627|11171848|FG000|Overall Study|Withdrawal by Subject|1
7069710|NCT02005627|11171849|FG001|Overall Study|Withdrawal by Subject|2
7069711|NCT02005692|11171869|FG000|Overall Study|Protocol Violation|1
7069712|NCT02005692|11171869|FG000|Overall Study|Withdrawal by Subject|1
6948093|NCT00990821|10987349|FG012|Overall Study|Withdrawal by Subject|2
6948094|NCT00990821|10987350|FG013|Overall Study|Withdrawal by Subject|1
6948095|NCT00991276|10987426|FG000|First Intervention Period|Adverse Event|0
6948096|NCT00991276|10987427|FG001|First Intervention Period|Adverse Event|1
6948097|NCT00991276|10987428|FG002|First Intervention Period|Adverse Event|0
6948098|NCT00991276|10987429|FG003|First Intervention Period|Adverse Event|1
6948099|NCT00991276|10987430|FG004|First Intervention Period|Adverse Event|0
6948100|NCT00991276|10987431|FG005|First Intervention Period|Adverse Event|0
6948101|NCT00991276|10987426|FG000|First Intervention Period|Protocol Violation|0
6948102|NCT00991276|10987427|FG001|First Intervention Period|Protocol Violation|0
6948103|NCT00991276|10987428|FG002|First Intervention Period|Protocol Violation|0
6948104|NCT00991276|10987429|FG003|First Intervention Period|Protocol Violation|0
6948105|NCT00991276|10987430|FG004|First Intervention Period|Protocol Violation|2
6948106|NCT00991276|10987431|FG005|First Intervention Period|Protocol Violation|0
6948107|NCT00991276|10987426|FG000|First Intervention Period|Insufficient clinical response|0
6948108|NCT00991276|10987427|FG001|First Intervention Period|Insufficient clinical response|0
6948109|NCT00991276|10987428|FG002|First Intervention Period|Insufficient clinical response|0
6948110|NCT00991276|10987429|FG003|First Intervention Period|Insufficient clinical response|0
6948111|NCT00991276|10987430|FG004|First Intervention Period|Insufficient clinical response|1
6948112|NCT00991276|10987431|FG005|First Intervention Period|Insufficient clinical response|0
6948113|NCT00991276|10987426|FG000|First Intervention Period|Other|0
6948114|NCT00991276|10987427|FG001|First Intervention Period|Other|0
6948115|NCT00991276|10987428|FG002|First Intervention Period|Other|0
6948116|NCT00991276|10987429|FG003|First Intervention Period|Other|1
6948117|NCT00991276|10987430|FG004|First Intervention Period|Other|1
6948118|NCT00991276|10987431|FG005|First Intervention Period|Other|0
6948119|NCT00991276|10987426|FG000|First Intervention Period|Withdrawal by Subject|0
6948120|NCT00991276|10987427|FG001|First Intervention Period|Withdrawal by Subject|1
6948121|NCT00991276|10987428|FG002|First Intervention Period|Withdrawal by Subject|0
6948122|NCT00991276|10987429|FG003|First Intervention Period|Withdrawal by Subject|1
6948123|NCT00991276|10987430|FG004|First Intervention Period|Withdrawal by Subject|0
6948124|NCT00991276|10987431|FG005|First Intervention Period|Withdrawal by Subject|1
6948125|NCT00991276|10987426|FG000|First Intervention Period|Lost to Follow-up|0
6948126|NCT00991276|10987427|FG001|First Intervention Period|Lost to Follow-up|1
6948127|NCT00991276|10987428|FG002|First Intervention Period|Lost to Follow-up|0
6948128|NCT00991276|10987429|FG003|First Intervention Period|Lost to Follow-up|1
6948129|NCT00991276|10987430|FG004|First Intervention Period|Lost to Follow-up|0
6948130|NCT00991276|10987431|FG005|First Intervention Period|Lost to Follow-up|0
6948131|NCT00991276|10987426|FG000|Second Intervention Period|Adverse Event|0
6948132|NCT00991276|10987427|FG001|Second Intervention Period|Adverse Event|2
6948133|NCT00991276|10987428|FG002|Second Intervention Period|Adverse Event|0
6948134|NCT00991276|10987429|FG003|Second Intervention Period|Adverse Event|1
6948135|NCT00991276|10987430|FG004|Second Intervention Period|Adverse Event|1
6948136|NCT00991276|10987431|FG005|Second Intervention Period|Adverse Event|0
6948137|NCT00991276|10987426|FG000|Second Intervention Period|Protocol Violation|1
6948138|NCT00991276|10987427|FG001|Second Intervention Period|Protocol Violation|0
6948139|NCT00991276|10987428|FG002|Second Intervention Period|Protocol Violation|0
6948140|NCT00991276|10987429|FG003|Second Intervention Period|Protocol Violation|0
6948141|NCT00991276|10987430|FG004|Second Intervention Period|Protocol Violation|0
6948142|NCT00991276|10987431|FG005|Second Intervention Period|Protocol Violation|0
6948143|NCT00991276|10987426|FG000|Second Intervention Period|Other|0
6948144|NCT00991276|10987427|FG001|Second Intervention Period|Other|0
6948145|NCT00991276|10987428|FG002|Second Intervention Period|Other|0
6948146|NCT00991276|10987429|FG003|Second Intervention Period|Other|1
6948147|NCT00991276|10987430|FG004|Second Intervention Period|Other|0
6948148|NCT00991276|10987431|FG005|Second Intervention Period|Other|1
6948149|NCT00991276|10987426|FG000|Third Intervention Period|Protocol Violation|1
6948150|NCT00991276|10987427|FG001|Third Intervention Period|Protocol Violation|0
6948151|NCT00991276|10987428|FG002|Third Intervention Period|Protocol Violation|0
6948152|NCT00991276|10987429|FG003|Third Intervention Period|Protocol Violation|0
6948153|NCT00991276|10987430|FG004|Third Intervention Period|Protocol Violation|0
6948154|NCT00991276|10987431|FG005|Third Intervention Period|Protocol Violation|0
6948155|NCT00991276|10987426|FG000|Third Intervention Period|Other|0
6948156|NCT00991276|10987427|FG001|Third Intervention Period|Other|0
6948157|NCT00991276|10987428|FG002|Third Intervention Period|Other|0
6948158|NCT00991276|10987429|FG003|Third Intervention Period|Other|0
6948159|NCT00991276|10987430|FG004|Third Intervention Period|Other|0
6948160|NCT00991276|10987431|FG005|Third Intervention Period|Other|1
6948161|NCT00991276|10987426|FG000|Third Intervention Period|Adverse Event|0
6948162|NCT00991276|10987427|FG001|Third Intervention Period|Adverse Event|0
6948163|NCT00991276|10987428|FG002|Third Intervention Period|Adverse Event|1
6948164|NCT00991276|10987429|FG003|Third Intervention Period|Adverse Event|0
6948165|NCT00991276|10987430|FG004|Third Intervention Period|Adverse Event|0
6948166|NCT00991276|10987431|FG005|Third Intervention Period|Adverse Event|0
6948167|NCT00991276|10987426|FG000|Third Intervention Period|Withdrawal by Subject|0
6948168|NCT00991276|10987427|FG001|Third Intervention Period|Withdrawal by Subject|0
6948169|NCT00991276|10987428|FG002|Third Intervention Period|Withdrawal by Subject|0
6948170|NCT00991276|10987429|FG003|Third Intervention Period|Withdrawal by Subject|1
6948171|NCT00991276|10987430|FG004|Third Intervention Period|Withdrawal by Subject|0
6948172|NCT00991276|10987431|FG005|Third Intervention Period|Withdrawal by Subject|0
6948173|NCT00991289|10987440|FG000|Overall Study|Adverse Event|1
6948174|NCT00991289|10987440|FG000|Overall Study|Physician Decision|2
6948175|NCT00991289|10987440|FG000|Overall Study|Withdrawal by Subject|3
6948176|NCT00991289|10987440|FG000|Overall Study|Lost to Follow-up|4
6948177|NCT00991289|10987440|FG000|Overall Study|Protocol Violation|2
6948178|NCT00991302|10987446|FG000|Overall Study|Death|0
6948179|NCT00991302|10987447|FG001|Overall Study|Death|1
6948180|NCT00991302|10987446|FG000|Overall Study|Lost to Follow-up|14
6948181|NCT00991302|10987447|FG001|Overall Study|Lost to Follow-up|12
6948182|NCT00991341|10987455|FG000|Overall Study|no surgery w/in 30 days of randomization|11
6948183|NCT00991341|10987456|FG001|Overall Study|no surgery w/in 30 days of randomization|18
6948184|NCT00991341|10987455|FG000|Overall Study|Death|3
6948185|NCT00991341|10987456|FG001|Overall Study|Death|0
6948186|NCT00991341|10987455|FG000|Overall Study|no RBCs received 96hrs after randomized|186
6948187|NCT00991341|10987456|FG001|Overall Study|no RBCs received 96hrs after randomized|155
6948188|NCT00991341|10987455|FG000|Overall Study|Physician Decision|1
6948189|NCT00991341|10987456|FG001|Overall Study|Physician Decision|2
6948190|NCT00991341|10987455|FG000|Overall Study|Withdrawal by Subject|3
6948191|NCT00991341|10987456|FG001|Overall Study|Withdrawal by Subject|4
6948192|NCT00991406|10987462|FG000|Overall Study|One participant did not respond to FES.|1
6948193|NCT00991510|10987481|FG000|Period I (Days 1-14)|Adverse Event|1
6948194|NCT00991510|10987482|FG001|Period I (Days 1-14)|Adverse Event|0
6948195|NCT00991510|10987481|FG000|Period III (Days 29-112)|Adverse Event|1
6948196|NCT00991510|10987482|FG001|Period III (Days 29-112)|Adverse Event|1
6948197|NCT00991939|10987505|FG000|Overall Study|Lost to Follow-up|0
6948198|NCT00991939|10987506|FG001|Overall Study|Lost to Follow-up|1
6948199|NCT00991939|10987505|FG000|Overall Study|Withdrawal by Subject|1
6948200|NCT00991939|10987506|FG001|Overall Study|Withdrawal by Subject|0
6948201|NCT00991939|10987505|FG000|Overall Study|Entire study terminated|4
6948202|NCT00991939|10987506|FG001|Overall Study|Entire study terminated|1
6948203|NCT00991952|10987516|FG000|Overall Study|Adverse Event|0
6948204|NCT00991952|10987517|FG001|Overall Study|Adverse Event|1
6948205|NCT00992017|10987523|FG000|Overall Study|Lost to Follow-up|2
6948206|NCT00992017|10987523|FG000|Overall Study|Withdrawal by Subject|2
6948207|NCT00992017|10987523|FG000|Overall Study|Unable to get to clinic|5
6948208|NCT00992017|10987523|FG000|Overall Study|Not adhere to study requirements|1
6948209|NCT00992056|10987534|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1
6948210|NCT00992056|10987535|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2
6948211|NCT00992056|10987534|FG000|Washout Period (2 Weeks)|Physician Decision|1
6948212|NCT00992056|10987535|FG001|Washout Period (2 Weeks)|Physician Decision|0
6948213|NCT00992108|10987543|FG000|Overall Study|Lost to Follow-up|0
6948214|NCT00992108|10987544|FG001|Overall Study|Lost to Follow-up|1
6948215|NCT00992186|10987550|FG000|Overall Study|Withdrawal by Subject|2
6948216|NCT00992186|10987550|FG000|Overall Study|Protocol Violation|1
6948217|NCT00992186|10987550|FG000|Overall Study|Physician Decision|1
6948218|NCT00992186|10987550|FG000|Overall Study|Adverse Event|9
6948219|NCT00992186|10987550|FG000|Overall Study|Progressive Disease|30
6948220|NCT00992186|10987550|FG000|Overall Study|Refusal To Receive Study Agent|3
6948221|NCT00992225|10987555|FG000|Overall Study|Entry Criteria Not Met|8
6948222|NCT00992225|10987555|FG000|Overall Study|Adverse Event|2
6948223|NCT00992394|10987603|FG000|Overall Study|Lack of Efficacy|6
6948224|NCT00992394|10987604|FG001|Overall Study|Lack of Efficacy|3
6948225|NCT00992394|10987603|FG000|Overall Study|Adverse Event|4
6948226|NCT00992394|10987604|FG001|Overall Study|Adverse Event|5
6948227|NCT00992394|10987603|FG000|Overall Study|Withdrawal by Subject|8
6948228|NCT00992394|10987604|FG001|Overall Study|Withdrawal by Subject|2
6948229|NCT00992394|10987603|FG000|Overall Study|Physician Decision|1
6948230|NCT00992394|10987604|FG001|Overall Study|Physician Decision|0
6948231|NCT00992394|10987603|FG000|Overall Study|Protocol Violation|2
6948232|NCT00992394|10987604|FG001|Overall Study|Protocol Violation|4
6948233|NCT00992394|10987603|FG000|Overall Study|Lost to Follow-up|2
6948234|NCT00992394|10987604|FG001|Overall Study|Lost to Follow-up|0
6948235|NCT00992394|10987603|FG000|Overall Study|Other event|1
6948236|NCT00992394|10987604|FG001|Overall Study|Other event|0
6948237|NCT00992407|10987612|FG000|Overall Study|Protocol Violation|2
6948238|NCT00992407|10987613|FG001|Overall Study|Protocol Violation|1
6948239|NCT00992407|10987612|FG000|Overall Study|Lost to Follow-up|3
6948240|NCT00992407|10987613|FG001|Overall Study|Lost to Follow-up|3
6948241|NCT00992407|10987612|FG000|Overall Study|Adverse Event|3
6948242|NCT00992407|10987613|FG001|Overall Study|Adverse Event|2
6948243|NCT00992407|10987612|FG000|Overall Study|protocol Violation & Adverse events|2
6948244|NCT00992407|10987613|FG001|Overall Study|protocol Violation & Adverse events|4
6948245|NCT00992407|10987612|FG000|Overall Study|Other|2
6948246|NCT00992407|10987613|FG001|Overall Study|Other|0
6948247|NCT00992407|10987612|FG000|Overall Study|Loss of follow-up & Adverse events|2
6948248|NCT00992407|10987613|FG001|Overall Study|Loss of follow-up & Adverse events|1
6948249|NCT00992407|10987612|FG000|Overall Study|Study medication not administered|17
6948250|NCT00992407|10987613|FG001|Overall Study|Study medication not administered|13
6948251|NCT00992446|10987631|FG000|Overall Study|Disease Progression|1
6948252|NCT00992446|10987631|FG000|Overall Study|Withdrawal by Subject|2
6948253|NCT00992446|10987631|FG000|Overall Study|Maintenance Therapy Screen Fail|5
6948254|NCT00992459|10987637|FG000|Overall Study|Withdrawal by Subject|0
6948255|NCT00992459|10987638|FG001|Overall Study|Withdrawal by Subject|1
6948256|NCT00992459|10987637|FG000|Overall Study|Adverse Event|1
6948257|NCT00992459|10987638|FG001|Overall Study|Adverse Event|0
6948258|NCT00992511|10987648|FG000|Overall Study|Migrated/moved from study area|1
6948259|NCT00992511|10987649|FG001|Overall Study|Migrated/moved from study area|0
6948260|NCT00992511|10987650|FG002|Overall Study|Migrated/moved from study area|1
6948261|NCT00992511|10987651|FG003|Overall Study|Migrated/moved from study area|2
6948262|NCT00992511|10987648|FG000|Overall Study|Lost to Follow-up|1
6948263|NCT00992511|10987649|FG001|Overall Study|Lost to Follow-up|0
6948264|NCT00992511|10987650|FG002|Overall Study|Lost to Follow-up|0
6948265|NCT00992511|10987651|FG003|Overall Study|Lost to Follow-up|2
6948266|NCT00992511|10987648|FG000|Overall Study|Withdrawal by Subject|0
6948267|NCT00992511|10987649|FG001|Overall Study|Withdrawal by Subject|0
6948268|NCT00992511|10987650|FG002|Overall Study|Withdrawal by Subject|1
6948269|NCT00992511|10987651|FG003|Overall Study|Withdrawal by Subject|1
6948270|NCT00992589|10987661|FG000|Open-Label Phase|Adverse Event|4
6948271|NCT00992589|10987662|FG001|Open-Label Phase|Adverse Event|0
6948272|NCT00992589|10987663|FG002|Open-Label Phase|Adverse Event|0
6948273|NCT00992589|10987664|FG003|Open-Label Phase|Adverse Event|0
6948274|NCT00992589|10987661|FG000|Open-Label Phase|Withdrawal by Subject|20
6948275|NCT00992589|10987662|FG001|Open-Label Phase|Withdrawal by Subject|0
6948276|NCT00992589|10987663|FG002|Open-Label Phase|Withdrawal by Subject|0
6948277|NCT00992589|10987664|FG003|Open-Label Phase|Withdrawal by Subject|0
6948278|NCT00992589|10987661|FG000|Open-Label Phase|Lost to Follow-up|1
6948279|NCT00992589|10987662|FG001|Open-Label Phase|Lost to Follow-up|0
6948280|NCT00992589|10987663|FG002|Open-Label Phase|Lost to Follow-up|0
6948281|NCT00992589|10987664|FG003|Open-Label Phase|Lost to Follow-up|0
6948282|NCT00992589|10987661|FG000|Open-Label Phase|Protocol Violation|3
6948283|NCT00992589|10987662|FG001|Open-Label Phase|Protocol Violation|0
6948284|NCT00992589|10987663|FG002|Open-Label Phase|Protocol Violation|0
6948285|NCT00992589|10987664|FG003|Open-Label Phase|Protocol Violation|0
6948286|NCT00992589|10987661|FG000|Open-Label Phase|Physician Decision|4
6948287|NCT00992589|10987662|FG001|Open-Label Phase|Physician Decision|0
6948288|NCT00992589|10987663|FG002|Open-Label Phase|Physician Decision|0
6948289|NCT00992589|10987664|FG003|Open-Label Phase|Physician Decision|0
6948290|NCT00992589|10987661|FG000|Open-Label Phase|Other|45
6948291|NCT00992589|10987662|FG001|Open-Label Phase|Other|0
6948292|NCT00992589|10987663|FG002|Open-Label Phase|Other|0
6948293|NCT00992589|10987664|FG003|Open-Label Phase|Other|0
6948294|NCT00992589|10987661|FG000|Double-Blind Phase|Adverse Event|0
6948295|NCT00992589|10987662|FG001|Double-Blind Phase|Adverse Event|6
6948296|NCT00992589|10987663|FG002|Double-Blind Phase|Adverse Event|2
6948297|NCT00992589|10987664|FG003|Double-Blind Phase|Adverse Event|3
6948298|NCT00992589|10987661|FG000|Double-Blind Phase|Withdrawal by Subject|0
6948299|NCT00992589|10987662|FG001|Double-Blind Phase|Withdrawal by Subject|6
6948300|NCT00992589|10987663|FG002|Double-Blind Phase|Withdrawal by Subject|5
6948301|NCT00992589|10987664|FG003|Double-Blind Phase|Withdrawal by Subject|2
6948302|NCT00992589|10987661|FG000|Double-Blind Phase|Lost to Follow-up|0
6948303|NCT00992589|10987662|FG001|Double-Blind Phase|Lost to Follow-up|0
6948304|NCT00992589|10987663|FG002|Double-Blind Phase|Lost to Follow-up|0
6948305|NCT00992589|10987664|FG003|Double-Blind Phase|Lost to Follow-up|2
6948306|NCT00992589|10987661|FG000|Double-Blind Phase|Other|0
6948307|NCT00992589|10987662|FG001|Double-Blind Phase|Other|1
6948308|NCT00992589|10987663|FG002|Double-Blind Phase|Other|6
6948309|NCT00992589|10987664|FG003|Double-Blind Phase|Other|3
6948310|NCT00992784|10987702|FG000|Overall Study|Adverse Event|2
6948311|NCT00992784|10987703|FG001|Overall Study|Adverse Event|1
6948312|NCT00992784|10987704|FG002|Overall Study|Adverse Event|0
6948313|NCT00992784|10987702|FG000|Overall Study|Withdrawal by Subject|1
6948314|NCT00992784|10987703|FG001|Overall Study|Withdrawal by Subject|1
6948315|NCT00992784|10987704|FG002|Overall Study|Withdrawal by Subject|1
6948316|NCT00992836|10987712|FG000|Overall Study|Lost to Follow-up|1
6948317|NCT00992836|10987712|FG000|Overall Study|Withdrawal by Subject|2
6948318|NCT00992836|10987712|FG000|Overall Study|Protocol Violation|2
6948319|NCT00992992|10987731|FG000|Overall Study|Lost to Follow-up|3
6948320|NCT00992992|10987731|FG000|Overall Study|Death|16
6948321|NCT00992992|10987731|FG000|Overall Study|GlaxoSmithKline Closed the Study|2
6948322|NCT00992992|10987731|FG000|Overall Study|Sponsor Closed the Study|4
6948323|NCT00993031|10987737|FG000|Overall Study|Death|0
6948324|NCT00993031|10987738|FG001|Overall Study|Death|1
6948325|NCT00993031|10987737|FG000|Overall Study|Physician Decision|0
6948326|NCT00993031|10987738|FG001|Overall Study|Physician Decision|2
6948327|NCT00993031|10987737|FG000|Overall Study|Withdrawal by Subject|3
6948328|NCT00993031|10987738|FG001|Overall Study|Withdrawal by Subject|3
6948329|NCT00993031|10987737|FG000|Overall Study|Lost to Follow-up|19
6948330|NCT00993031|10987738|FG001|Overall Study|Lost to Follow-up|13
6948331|NCT00993044|10987748|FG000|Irinotecan 50 mg|Physician Decision|1
6948332|NCT00993148|10987753|FG000|Overall Study|Lost to Follow-up|2
6948333|NCT00993148|10987753|FG000|Overall Study|never initiated treatment|1
6948334|NCT00993265|10987792|FG000|Overall Study|Adverse Event|1
6948335|NCT00993265|10987793|FG001|Overall Study|Adverse Event|0
6948336|NCT00993265|10987792|FG000|Overall Study|Changed dose of concomitant drug|2
6948337|NCT00993265|10987793|FG001|Overall Study|Changed dose of concomitant drug|0
6948338|NCT00993265|10987792|FG000|Overall Study|Non-compliant with study medication|1
6948339|NCT00993265|10987793|FG001|Overall Study|Non-compliant with study medication|0
6948340|NCT00993291|10987799|FG000|Overall Study|Withdrawal by Subject|1
6948341|NCT00993317|10987805|FG000|Overall Study|Adverse Event|2
6948342|NCT00993317|10987806|FG001|Overall Study|Adverse Event|4
6948343|NCT00993317|10987805|FG000|Overall Study|Lack of Efficacy|18
6948344|NCT00993317|10987806|FG001|Overall Study|Lack of Efficacy|18
6948345|NCT00993317|10987805|FG000|Overall Study|Withdrawal by Subject|0
6948346|NCT00993317|10987806|FG001|Overall Study|Withdrawal by Subject|2
6948347|NCT00993317|10987805|FG000|Overall Study|Investigator's opinion|0
6948348|NCT00993317|10987806|FG001|Overall Study|Investigator's opinion|1
6948349|NCT00993317|10987805|FG000|Overall Study|Early study termination at the site|1
6948350|NCT00993317|10987806|FG001|Overall Study|Early study termination at the site|0
6948351|NCT00993421|10987819|FG000|Overall Study|Adverse Event|2
6948352|NCT00993421|10987820|FG001|Overall Study|Adverse Event|7
6948353|NCT00993421|10987821|FG002|Overall Study|Adverse Event|6
6948354|NCT00993421|10987822|FG003|Overall Study|Adverse Event|9
6948355|NCT00993421|10987823|FG004|Overall Study|Adverse Event|5
6948356|NCT00993421|10987824|FG005|Overall Study|Adverse Event|7
6948357|NCT00993421|10987825|FG006|Overall Study|Adverse Event|1
6948358|NCT00993421|10987819|FG000|Overall Study|Sponsor Decision|36
6948359|NCT00993421|10987820|FG001|Overall Study|Sponsor Decision|31
6948360|NCT00993421|10987821|FG002|Overall Study|Sponsor Decision|28
6948361|NCT00993421|10987822|FG003|Overall Study|Sponsor Decision|30
6948362|NCT00993421|10987823|FG004|Overall Study|Sponsor Decision|38
6948363|NCT00993421|10987824|FG005|Overall Study|Sponsor Decision|30
6948364|NCT00993421|10987825|FG006|Overall Study|Sponsor Decision|29
6948365|NCT00993421|10987819|FG000|Overall Study|Lost to Follow-up|3
6948366|NCT00993421|10987820|FG001|Overall Study|Lost to Follow-up|5
6948367|NCT00993421|10987821|FG002|Overall Study|Lost to Follow-up|5
6948368|NCT00993421|10987822|FG003|Overall Study|Lost to Follow-up|0
6948369|NCT00993421|10987823|FG004|Overall Study|Lost to Follow-up|0
6948370|NCT00993421|10987824|FG005|Overall Study|Lost to Follow-up|0
6948371|NCT00993421|10987825|FG006|Overall Study|Lost to Follow-up|6
6948372|NCT00993421|10987819|FG000|Overall Study|Withdrawal by Subject|3
6948373|NCT00993421|10987820|FG001|Overall Study|Withdrawal by Subject|2
6948374|NCT00993421|10987821|FG002|Overall Study|Withdrawal by Subject|3
6948375|NCT00993421|10987822|FG003|Overall Study|Withdrawal by Subject|3
6948376|NCT00993421|10987823|FG004|Overall Study|Withdrawal by Subject|3
6948377|NCT00993421|10987824|FG005|Overall Study|Withdrawal by Subject|5
6948378|NCT00993421|10987825|FG006|Overall Study|Withdrawal by Subject|3
6948379|NCT00993421|10987819|FG000|Overall Study|Death|0
6948380|NCT00993421|10987820|FG001|Overall Study|Death|0
6948381|NCT00993421|10987821|FG002|Overall Study|Death|0
6948382|NCT00993421|10987822|FG003|Overall Study|Death|0
6948383|NCT00993421|10987823|FG004|Overall Study|Death|0
6948384|NCT00993421|10987824|FG005|Overall Study|Death|0
6948385|NCT00993421|10987825|FG006|Overall Study|Death|1
6948386|NCT00993421|10987819|FG000|Overall Study|Entry Criteria Exclusion|0
6948387|NCT00993421|10987820|FG001|Overall Study|Entry Criteria Exclusion|0
6948388|NCT00993421|10987821|FG002|Overall Study|Entry Criteria Exclusion|1
6948389|NCT00993421|10987822|FG003|Overall Study|Entry Criteria Exclusion|3
6948390|NCT00993421|10987823|FG004|Overall Study|Entry Criteria Exclusion|0
6948391|NCT00993421|10987824|FG005|Overall Study|Entry Criteria Exclusion|1
6948392|NCT00993421|10987825|FG006|Overall Study|Entry Criteria Exclusion|0
6948393|NCT00993421|10987819|FG000|Overall Study|Physician Decision|0
6948394|NCT00993421|10987820|FG001|Overall Study|Physician Decision|0
6948395|NCT00993421|10987821|FG002|Overall Study|Physician Decision|0
6948396|NCT00993421|10987822|FG003|Overall Study|Physician Decision|0
6948397|NCT00993421|10987823|FG004|Overall Study|Physician Decision|0
6948398|NCT00993421|10987824|FG005|Overall Study|Physician Decision|1
6948399|NCT00993421|10987825|FG006|Overall Study|Physician Decision|1
6948400|NCT00993421|10987819|FG000|Overall Study|Protocol Violation|0
6948401|NCT00993421|10987820|FG001|Overall Study|Protocol Violation|0
6948402|NCT00993421|10987821|FG002|Overall Study|Protocol Violation|0
6948403|NCT00993421|10987822|FG003|Overall Study|Protocol Violation|0
6948404|NCT00993421|10987823|FG004|Overall Study|Protocol Violation|0
6948405|NCT00993421|10987824|FG005|Overall Study|Protocol Violation|2
6948406|NCT00993421|10987825|FG006|Overall Study|Protocol Violation|1
6948407|NCT00993473|10987843|FG000|Overall Study|Adverse Event|0
6948408|NCT00993473|10987844|FG001|Overall Study|Adverse Event|2
6948409|NCT00993473|10987843|FG000|Overall Study|Protocol Violation|1
6948410|NCT00993473|10987844|FG001|Overall Study|Protocol Violation|2
6948411|NCT00993473|10987843|FG000|Overall Study|Lost to Follow-up|1
6948412|NCT00993473|10987844|FG001|Overall Study|Lost to Follow-up|0
6948413|NCT00993473|10987843|FG000|Overall Study|Withdrawal by Subject|1
6948414|NCT00993473|10987844|FG001|Overall Study|Withdrawal by Subject|5
6948415|NCT00993473|10987843|FG000|Overall Study|Technical problem with CGM device|0
6948416|NCT00993473|10987844|FG001|Overall Study|Technical problem with CGM device|1
6948417|NCT00993473|10987843|FG000|Overall Study|Family event|1
6948418|NCT00993473|10987844|FG001|Overall Study|Family event|0
6948419|NCT00993499|10987856|FG000|Run-in Period (8 Days)|Adverse Event|0
6948420|NCT00993499|10987857|FG001|Run-in Period (8 Days)|Adverse Event|1
6948421|NCT00993499|10987858|FG002|Run-in Period (8 Days)|Adverse Event|0
6948422|NCT00993499|10987859|FG003|Run-in Period (8 Days)|Adverse Event|0
6948423|NCT00993499|10987860|FG004|Run-in Period (8 Days)|Adverse Event|0
6948424|NCT00993499|10987861|FG005|Run-in Period (8 Days)|Adverse Event|0
6948425|NCT00993499|10987856|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1
6948426|NCT00993499|10987857|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
6948427|NCT00993499|10987858|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
6948428|NCT00993499|10987859|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
6948429|NCT00993499|10987860|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
6948430|NCT00993499|10987861|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
6948431|NCT00993499|10987856|FG000|Run-in Period (8 Days)|Consent withdrawn|0
6948432|NCT00993499|10987857|FG001|Run-in Period (8 Days)|Consent withdrawn|1
6948433|NCT00993499|10987858|FG002|Run-in Period (8 Days)|Consent withdrawn|0
6948434|NCT00993499|10987859|FG003|Run-in Period (8 Days)|Consent withdrawn|0
6948435|NCT00993499|10987860|FG004|Run-in Period (8 Days)|Consent withdrawn|0
6948436|NCT00993499|10987861|FG005|Run-in Period (8 Days)|Consent withdrawn|0
6948437|NCT00993499|10987856|FG000|Run-in Period (8 Days)|Progressive disease|0
6948438|NCT00993499|10987857|FG001|Run-in Period (8 Days)|Progressive disease|1
6948439|NCT00993499|10987858|FG002|Run-in Period (8 Days)|Progressive disease|1
6948440|NCT00993499|10987859|FG003|Run-in Period (8 Days)|Progressive disease|0
6948441|NCT00993499|10987860|FG004|Run-in Period (8 Days)|Progressive disease|0
6948442|NCT00993499|10987861|FG005|Run-in Period (8 Days)|Progressive disease|0
6948443|NCT00993499|10987856|FG000|Discontinued Before Starting Course 3|Progressive Disease|2
6948444|NCT00993499|10987857|FG001|Discontinued Before Starting Course 3|Progressive Disease|2
6948445|NCT00993499|10987858|FG002|Discontinued Before Starting Course 3|Progressive Disease|0
6948446|NCT00993499|10987859|FG003|Discontinued Before Starting Course 3|Progressive Disease|0
6948447|NCT00993499|10987860|FG004|Discontinued Before Starting Course 3|Progressive Disease|0
6948448|NCT00993499|10987861|FG005|Discontinued Before Starting Course 3|Progressive Disease|0
6948449|NCT00993499|10987856|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2
6948450|NCT00993499|10987857|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2
6948451|NCT00993499|10987858|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0
6948452|NCT00993499|10987859|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0
6948453|NCT00993499|10987860|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0
6948454|NCT00993499|10987861|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0
6948455|NCT00993499|10987856|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
6948456|NCT00993499|10987857|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
6948457|NCT00993499|10987858|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
6948458|NCT00993499|10987859|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
6948459|NCT00993499|10987860|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
6948460|NCT00993499|10987861|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
6948461|NCT00993499|10987856|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0
6948462|NCT00993499|10987857|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0
6948463|NCT00993499|10987858|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2
6948464|NCT00993499|10987859|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0
6948465|NCT00993499|10987860|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0
6948466|NCT00993499|10987861|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0
6948467|NCT00993499|10987856|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0
6948468|NCT00993499|10987857|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1
6948469|NCT00993499|10987858|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0
6948470|NCT00993499|10987859|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0
6948471|NCT00993499|10987860|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0
6948472|NCT00993499|10987861|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0
6948473|NCT00993499|10987856|FG000|Discontinued After Starting Course 3|Progressive Disease|6
6948474|NCT00993499|10987857|FG001|Discontinued After Starting Course 3|Progressive Disease|4
6948475|NCT00993499|10987858|FG002|Discontinued After Starting Course 3|Progressive Disease|3
6948476|NCT00993499|10987859|FG003|Discontinued After Starting Course 3|Progressive Disease|1
6948477|NCT00993499|10987860|FG004|Discontinued After Starting Course 3|Progressive Disease|3
6948478|NCT00993499|10987861|FG005|Discontinued After Starting Course 3|Progressive Disease|3
6948479|NCT00993499|10987856|FG000|Discontinued After Starting Course 3|DLT|1
6948480|NCT00993499|10987857|FG001|Discontinued After Starting Course 3|DLT|0
6948481|NCT00993499|10987858|FG002|Discontinued After Starting Course 3|DLT|2
6948482|NCT00993499|10987859|FG003|Discontinued After Starting Course 3|DLT|1
6948483|NCT00993499|10987860|FG004|Discontinued After Starting Course 3|DLT|0
6948484|NCT00993499|10987861|FG005|Discontinued After Starting Course 3|DLT|0
6948485|NCT00993499|10987856|FG000|Discontinued After Starting Course 3|Other adverse event|1
6948486|NCT00993499|10987857|FG001|Discontinued After Starting Course 3|Other adverse event|0
6948487|NCT00993499|10987858|FG002|Discontinued After Starting Course 3|Other adverse event|1
6948488|NCT00993499|10987859|FG003|Discontinued After Starting Course 3|Other adverse event|0
6948489|NCT00993499|10987860|FG004|Discontinued After Starting Course 3|Other adverse event|0
6948490|NCT00993499|10987861|FG005|Discontinued After Starting Course 3|Other adverse event|0
6948491|NCT00993616|10987875|FG000|Overall Study|No tumor at entry|1
6948492|NCT00993616|10987875|FG000|Overall Study|Never treated|1
6948493|NCT00993668|10987903|FG000|Single-Blind Period|Adverse Event|1
6948494|NCT00993668|10987904|FG001|Single-Blind Period|Adverse Event|1
6948495|NCT00993668|10987903|FG000|Single-Blind Period|Lack of Efficacy|0
6948496|NCT00993668|10987904|FG001|Single-Blind Period|Lack of Efficacy|1
6948497|NCT00993668|10987903|FG000|Single-Blind Period|Lost to Follow-up|3
6948498|NCT00993668|10987904|FG001|Single-Blind Period|Lost to Follow-up|1
6948499|NCT00993668|10987903|FG000|Open-Label Period|Adverse Event|9
6948500|NCT00993668|10987904|FG001|Open-Label Period|Adverse Event|8
6948501|NCT00993668|10987903|FG000|Open-Label Period|Lack of Efficacy|4
6948502|NCT00993668|10987904|FG001|Open-Label Period|Lack of Efficacy|3
6948503|NCT00993668|10987903|FG000|Open-Label Period|Withdrawal by Subject|4
6948504|NCT00993668|10987904|FG001|Open-Label Period|Withdrawal by Subject|3
6948505|NCT00993668|10987903|FG000|Open-Label Period|Lost to Follow-up|6
6948506|NCT00993668|10987904|FG001|Open-Label Period|Lost to Follow-up|1
6948507|NCT00993915|10987937|FG000|Overall Study|Insufficient clinical response|3
6948508|NCT00993915|10987937|FG000|Overall Study|Withdrawal by Subject|2
6948509|NCT00993915|10987937|FG000|Overall Study|Other|1
7069713|NCT02005692|11171869|FG000|Overall Study|Discharged earlier than anticipated|5
7069714|NCT02005887|11171876|FG000|Overall Study|Protocol Violation|0
7069715|NCT02005887|11171877|FG001|Overall Study|Protocol Violation|2
7069716|NCT02006121|11171898|FG000|Double Blind Phase|Adverse Event|6
7069717|NCT02006121|11171899|FG001|Double Blind Phase|Adverse Event|0
7069718|NCT02006121|11171898|FG000|Double Blind Phase|Lack of Efficacy|1
7069719|NCT02006121|11171899|FG001|Double Blind Phase|Lack of Efficacy|16
7069720|NCT02006121|11171898|FG000|Double Blind Phase|Withdrawal by Subject|3
7069721|NCT02006121|11171899|FG001|Double Blind Phase|Withdrawal by Subject|4
6948510|NCT00993915|10987937|FG000|Overall Study|Ongoing|3
6948511|NCT00993928|10987943|FG000|Overall Study|Withdrawal by Subject|4
6948512|NCT00993928|10987944|FG001|Overall Study|Withdrawal by Subject|7
6948513|NCT00993928|10987943|FG000|Overall Study|ineligible|1
6948514|NCT00993928|10987944|FG001|Overall Study|ineligible|0
6948515|NCT00993954|10987956|FG000|Overall Study|Protocol Violation|21
6948516|NCT00993954|10987957|FG001|Overall Study|Protocol Violation|2
6948517|NCT00993967|10987963|FG000|Overall Study|Adverse Event|8
6948518|NCT00993967|10987963|FG000|Overall Study|Death|1
6948519|NCT00993967|10987963|FG000|Overall Study|Lost to Follow-up|14
6948520|NCT00993967|10987963|FG000|Overall Study|Withdrawal by Subject|36
6948521|NCT00993967|10987963|FG000|Overall Study|Protocol Violation|2
6948522|NCT00994110|10987969|FG000|Overall Study|Withdrawal by Subject|9
6948523|NCT00994110|10987970|FG001|Overall Study|Withdrawal by Subject|9
6948524|NCT00994110|10987969|FG000|Overall Study|Not Treated|4
6948525|NCT00994110|10987970|FG001|Overall Study|Not Treated|8
6948526|NCT00994110|10987969|FG000|Overall Study|Adverse Event|1
6948527|NCT00994110|10987970|FG001|Overall Study|Adverse Event|0
6948528|NCT00994110|10987969|FG000|Overall Study|Patient not resected|41
6948529|NCT00994110|10987970|FG001|Overall Study|Patient not resected|52
6948530|NCT00994110|10987969|FG000|Overall Study|Pt not eligible|10
6948531|NCT00994110|10987970|FG001|Overall Study|Pt not eligible|5
6975902|NCT01195662|11028139|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1
6975903|NCT01195662|11028140|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5
6975904|NCT01195662|11028141|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2
6975905|NCT01195662|11028139|FG000|Double Blind Treatment Period|Lack of Efficacy|2
6975906|NCT01195662|11028140|FG001|Double Blind Treatment Period|Lack of Efficacy|0
6975907|NCT01195662|11028141|FG002|Double Blind Treatment Period|Lack of Efficacy|0
6975908|NCT01195662|11028139|FG000|Double Blind Treatment Period|Non-specified|3
6975909|NCT01195662|11028140|FG001|Double Blind Treatment Period|Non-specified|0
6975910|NCT01195662|11028141|FG002|Double Blind Treatment Period|Non-specified|0
6975911|NCT01195662|11028139|FG000|Double Blind Treatment Period|Missing disposition information|0
6975912|NCT01195662|11028140|FG001|Double Blind Treatment Period|Missing disposition information|1
6975913|NCT01195662|11028141|FG002|Double Blind Treatment Period|Missing disposition information|1
6975914|NCT01195662|11028139|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2
6975915|NCT01195662|11028140|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0
6975916|NCT01195662|11028141|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1
6975917|NCT01195662|11028139|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1
6975918|NCT01195662|11028140|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
6975919|NCT01195662|11028141|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
6975920|NCT01195675|11028150|FG000|Overall Study|Adverse Event|1
6975921|NCT01195675|11028150|FG000|Overall Study|Withdrawal by Subject|2
6975922|NCT01195831|11028233|FG000|Overall Study|Lost to Follow-up|2
6975923|NCT01195831|11028234|FG001|Overall Study|Lost to Follow-up|4
6975924|NCT01195831|11028233|FG000|Overall Study|Withdrawal by Subject|2
6975925|NCT01195831|11028234|FG001|Overall Study|Withdrawal by Subject|2
6975926|NCT01195831|11028233|FG000|Overall Study|Adverse Event|4
6975927|NCT01195831|11028234|FG001|Overall Study|Adverse Event|2
7069722|NCT02006121|11171898|FG000|Double Blind Phase|Non-compliance with study drug|1
6975928|NCT01195831|11028233|FG000|Overall Study|Protocol Violation|0
6975929|NCT01195831|11028234|FG001|Overall Study|Protocol Violation|2
6975930|NCT01195844|11028240|FG000|Overall Study|Fecal sample not collected|40
6975931|NCT01195948|11028270|FG000|Overall Study|Lost to Follow-up|0
6975932|NCT01195948|11028271|FG001|Overall Study|Lost to Follow-up|1
6975933|NCT01195948|11028272|FG002|Overall Study|Lost to Follow-up|2
6975934|NCT01196026|11028289|FG000|Overall Study|Withdrawal by Subject|1
6975935|NCT01196026|11028290|FG001|Overall Study|Withdrawal by Subject|4
6975936|NCT01196026|11028291|FG002|Overall Study|Withdrawal by Subject|0
6975937|NCT01196026|11028292|FG003|Overall Study|Withdrawal by Subject|0
6948532|NCT00994214|10988011|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0
6948533|NCT00994214|10988012|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1
6948534|NCT00994214|10988013|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0
6948535|NCT00994214|10988014|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0
6948536|NCT00994214|10988011|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
6948537|NCT00994214|10988012|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
6948538|NCT00994214|10988013|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
6948539|NCT00994214|10988014|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1
6948540|NCT00994214|10988011|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1
6948541|NCT00994214|10988012|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
6948542|NCT00994214|10988013|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
6948543|NCT00994214|10988014|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
6948544|NCT00994214|10988011|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
6948545|NCT00994214|10988012|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12
6948546|NCT00994214|10988013|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
6948547|NCT00994214|10988014|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14
6948548|NCT00994214|10988011|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
6948549|NCT00994214|10988012|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
6948550|NCT00994214|10988013|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
6948551|NCT00994214|10988014|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1
6948552|NCT00994214|10988011|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4
6948553|NCT00994214|10988012|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3
6948554|NCT00994214|10988013|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
6948555|NCT00994214|10988014|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
6948556|NCT00994240|10988044|FG000|Overall Study|Lost to Follow-up|3
6948557|NCT00994240|10988045|FG001|Overall Study|Lost to Follow-up|2
6948558|NCT00994240|10988044|FG000|Overall Study|Withdrawal by Subject|1
6948559|NCT00994240|10988045|FG001|Overall Study|Withdrawal by Subject|0
6948560|NCT00994240|10988044|FG000|Overall Study|study termination|2
6948561|NCT00994240|10988045|FG001|Overall Study|study termination|3
6948562|NCT00994279|10988053|FG000|Overall Study|Withdrawal by Subject|2
6948563|NCT00994279|10988054|FG001|Overall Study|Withdrawal by Subject|2
6948564|NCT00994279|10988053|FG000|Overall Study|Toxicity|1
6948565|NCT00994279|10988054|FG001|Overall Study|Toxicity|0
6948566|NCT00994279|10988053|FG000|Overall Study|Multiple reasons|1
6948567|NCT00994279|10988054|FG001|Overall Study|Multiple reasons|3
6948568|NCT00994422|10988075|FG000|Overall Study|Lost to Follow-up|7
6948569|NCT00994422|10988076|FG001|Overall Study|Lost to Follow-up|1
6948570|NCT00994448|10988086|FG000|Overall Study|Adverse Event|1
6948571|NCT00994448|10988087|FG001|Overall Study|Adverse Event|0
6948572|NCT00994448|10988086|FG000|Overall Study|Lost to Follow-up|5
6948573|NCT00994448|10988087|FG001|Overall Study|Lost to Follow-up|1
6948574|NCT00994448|10988086|FG000|Overall Study|Withdrawal by Subject|1
6948575|NCT00994448|10988087|FG001|Overall Study|Withdrawal by Subject|1
6948576|NCT00994448|10988086|FG000|Overall Study|Physician Decision|1
6948577|NCT00994448|10988087|FG001|Overall Study|Physician Decision|0
6948578|NCT00994461|10988096|FG000|Overall Study|Adverse Event|2
6948579|NCT00994461|10988097|FG001|Overall Study|Adverse Event|1
6948580|NCT00994461|10988098|FG002|Overall Study|Adverse Event|0
6948581|NCT00994643|10988113|FG000|Overall Study|Withdrawal by Subject|1
6948582|NCT00994682|10988119|FG000|Double Bilnd|Withdrawal by Subject|5
6948583|NCT00994682|10988120|FG001|Double Bilnd|Withdrawal by Subject|6
6948584|NCT00994682|10988119|FG000|Double Bilnd|Lost to Follow-up|3
6948585|NCT00994682|10988120|FG001|Double Bilnd|Lost to Follow-up|3
6948586|NCT00994682|10988119|FG000|Double Bilnd|Adverse Event|1
6948587|NCT00994682|10988120|FG001|Double Bilnd|Adverse Event|0
6948588|NCT00994682|10988119|FG000|Pioglitazone Open Label|Withdrawal by Subject|4
6948589|NCT00994682|10988120|FG001|Pioglitazone Open Label|Withdrawal by Subject|4
6948590|NCT00994682|10988119|FG000|Pioglitazone Open Label|Lost to Follow-up|3
6948591|NCT00994682|10988120|FG001|Pioglitazone Open Label|Lost to Follow-up|2
6948592|NCT00994682|10988119|FG000|Pioglitazone Open Label|Physician Decision|6
6948593|NCT00994682|10988120|FG001|Pioglitazone Open Label|Physician Decision|1
6948594|NCT00994890|10988151|FG000|Overall Study|Adverse Event|13
6948595|NCT00994890|10988152|FG001|Overall Study|Adverse Event|9
6948596|NCT00994890|10988153|FG002|Overall Study|Adverse Event|11
6948597|NCT00994890|10988151|FG000|Overall Study|Lack of Efficacy|0
6948598|NCT00994890|10988152|FG001|Overall Study|Lack of Efficacy|0
6948599|NCT00994890|10988153|FG002|Overall Study|Lack of Efficacy|1
6948600|NCT00994890|10988151|FG000|Overall Study|Lost to Follow-up|6
6948601|NCT00994890|10988152|FG001|Overall Study|Lost to Follow-up|1
6948602|NCT00994890|10988153|FG002|Overall Study|Lost to Follow-up|3
6948603|NCT00994890|10988151|FG000|Overall Study|No longer willing to participate|8
6948604|NCT00994890|10988152|FG001|Overall Study|No longer willing to participate|5
6948605|NCT00994890|10988153|FG002|Overall Study|No longer willing to participate|13
6948606|NCT00994890|10988151|FG000|Overall Study|Protocol Violation|2
6948607|NCT00994890|10988152|FG001|Overall Study|Protocol Violation|4
6948608|NCT00994890|10988153|FG002|Overall Study|Protocol Violation|0
6948609|NCT00994890|10988151|FG000|Overall Study|Study terminated by sponsor|199
6948610|NCT00994890|10988152|FG001|Overall Study|Study terminated by sponsor|201
6948611|NCT00994890|10988153|FG002|Overall Study|Study terminated by sponsor|197
6948612|NCT00994890|10988151|FG000|Overall Study|Randomized, but not treated|1
6948613|NCT00994890|10988152|FG001|Overall Study|Randomized, but not treated|0
6948614|NCT00994890|10988153|FG002|Overall Study|Randomized, but not treated|0
6948615|NCT00994890|10988151|FG000|Overall Study|Other|2
6948616|NCT00994890|10988152|FG001|Overall Study|Other|2
7069723|NCT02006121|11171899|FG001|Double Blind Phase|Non-compliance with study drug|3
7069724|NCT02006121|11171898|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1
7069725|NCT02006121|11171899|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0
7069726|NCT02006121|11171898|FG000|Double Blind Phase|Inconvenience of infusion system|0
7069727|NCT02006121|11171899|FG001|Double Blind Phase|Inconvenience of infusion system|1
7069728|NCT02006121|11171898|FG000|Open Label Phase|Adverse Event|15
7069729|NCT02006121|11171899|FG001|Open Label Phase|Adverse Event|0
7069730|NCT02006121|11171898|FG000|Open Label Phase|Lack of Efficacy|2
7069731|NCT02006121|11171899|FG001|Open Label Phase|Lack of Efficacy|0
7069732|NCT02006121|11171898|FG000|Open Label Phase|Protocol Violation|2
7069733|NCT02006121|11171899|FG001|Open Label Phase|Protocol Violation|0
7069734|NCT02006121|11171898|FG000|Open Label Phase|Withdrawal by Subject|3
6948617|NCT00994890|10988153|FG002|Overall Study|Other|1
6948618|NCT00995007|10988168|FG000|Overall Study|Withdrew consent|1
6948619|NCT00995007|10988169|FG001|Overall Study|Withdrew consent|0
6948620|NCT00995007|10988168|FG000|Overall Study|Refused further treatment|8
6948621|NCT00995007|10988169|FG001|Overall Study|Refused further treatment|2
6948622|NCT00995007|10988168|FG000|Overall Study|Toxicity|8
6948623|NCT00995007|10988169|FG001|Overall Study|Toxicity|0
6948624|NCT00995020|10988186|FG000|Overall Study|margin analysis not performed|2
6948625|NCT00995020|10988187|FG001|Overall Study|margin analysis not performed|5
6948626|NCT00995020|10988186|FG000|Overall Study|specimen fragmentation, thermal damage|1
6948627|NCT00995020|10988187|FG001|Overall Study|specimen fragmentation, thermal damage|2
6948628|NCT00995085|10988204|FG000|Overall Study|Withdrawal by Subject|5
6948629|NCT00995345|10988218|FG000|Overall Study|Withdrawal by Subject|4
6948630|NCT00995345|10988219|FG001|Overall Study|Withdrawal by Subject|2
6948631|NCT00995345|10988220|FG002|Overall Study|Withdrawal by Subject|1
6948632|NCT00995345|10988221|FG003|Overall Study|Withdrawal by Subject|3
6948633|NCT00995345|10988222|FG004|Overall Study|Withdrawal by Subject|1
6948634|NCT00995345|10988218|FG000|Overall Study|Adverse Event|3
6948635|NCT00995345|10988219|FG001|Overall Study|Adverse Event|1
6948636|NCT00995345|10988220|FG002|Overall Study|Adverse Event|2
6948637|NCT00995345|10988221|FG003|Overall Study|Adverse Event|0
6948638|NCT00995345|10988222|FG004|Overall Study|Adverse Event|1
6948639|NCT00995345|10988218|FG000|Overall Study|Lost to Follow-up|2
6948640|NCT00995345|10988219|FG001|Overall Study|Lost to Follow-up|2
6948641|NCT00995345|10988220|FG002|Overall Study|Lost to Follow-up|2
6948642|NCT00995345|10988221|FG003|Overall Study|Lost to Follow-up|1
6948643|NCT00995345|10988222|FG004|Overall Study|Lost to Follow-up|0
6948644|NCT00995345|10988218|FG000|Overall Study|all other reasons combined|2
6948645|NCT00995345|10988219|FG001|Overall Study|all other reasons combined|2
6948646|NCT00995345|10988220|FG002|Overall Study|all other reasons combined|2
6948647|NCT00995345|10988221|FG003|Overall Study|all other reasons combined|1
6948648|NCT00995345|10988222|FG004|Overall Study|all other reasons combined|3
6948649|NCT00995371|10988236|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
6948650|NCT00995371|10988237|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
6948651|NCT00995410|10988245|FG000|Overall Study|Adverse Event|51
6948652|NCT00995410|10988245|FG000|Overall Study|Withdrawal by Subject|7
6948653|NCT00995410|10988245|FG000|Overall Study|Lost to Follow-up|2
6948654|NCT00995410|10988245|FG000|Overall Study|Misc|28
6948655|NCT00995436|10988252|FG000|Overall Study|Withdrawal by Subject|2
6948656|NCT00995436|10988253|FG001|Overall Study|Withdrawal by Subject|5
6948657|NCT00995436|10988254|FG002|Overall Study|Withdrawal by Subject|0
6948658|NCT00995488|10988284|FG000|Overall Study|Withdrawal by Subject|1
6948659|NCT00995553|10988323|FG000|Overall Study|Withdrawal by Subject|2
6948660|NCT00995553|10988324|FG001|Overall Study|Withdrawal by Subject|6
6948661|NCT00995566|10988330|FG000|Overall Study|Adverse Event|2
6948662|NCT00995566|10988330|FG000|Overall Study|Early study termination|52
6948663|NCT00995670|10988337|FG000|Overall Study|Failed arterial cannulation|1
6948664|NCT00995670|10988338|FG001|Overall Study|Failed arterial cannulation|0
7069735|NCT02006121|11171899|FG001|Open Label Phase|Withdrawal by Subject|0
7069736|NCT02006121|11171898|FG000|Open Label Phase|Non-compliance with study drug|3
7069737|NCT02006121|11171899|FG001|Open Label Phase|Non-compliance with study drug|0
6948665|NCT00995670|10988339|FG002|Overall Study|Failed arterial cannulation|3
6948666|NCT00995709|10988350|FG000|Overall Study|Adverse Event|4
6948667|NCT00995709|10988351|FG001|Overall Study|Adverse Event|2
6948668|NCT00995709|10988352|FG002|Overall Study|Adverse Event|0
6948669|NCT00995709|10988350|FG000|Overall Study|Lack of Efficacy|0
6948670|NCT00995709|10988351|FG001|Overall Study|Lack of Efficacy|1
6948671|NCT00995709|10988352|FG002|Overall Study|Lack of Efficacy|4
6948672|NCT00995709|10988350|FG000|Overall Study|Withdrawal by Subject|0
6948673|NCT00995709|10988351|FG001|Overall Study|Withdrawal by Subject|4
6948674|NCT00995709|10988352|FG002|Overall Study|Withdrawal by Subject|1
6948675|NCT00995709|10988350|FG000|Overall Study|Lost to Follow-up|1
6948676|NCT00995709|10988351|FG001|Overall Study|Lost to Follow-up|0
6948677|NCT00995709|10988352|FG002|Overall Study|Lost to Follow-up|0
6948678|NCT00995709|10988350|FG000|Overall Study|Death|0
6948679|NCT00995709|10988351|FG001|Overall Study|Death|1
6948680|NCT00995709|10988352|FG002|Overall Study|Death|0
6948681|NCT00995709|10988350|FG000|Overall Study|Protocol Violation|2
6948682|NCT00995709|10988351|FG001|Overall Study|Protocol Violation|1
6948683|NCT00995709|10988352|FG002|Overall Study|Protocol Violation|0
6948684|NCT00995774|10988375|FG000|Training Period 2|Withdrawal by Subject|2
6948685|NCT00995774|10988376|FG001|Training Period 2|Withdrawal by Subject|0
6948686|NCT00995865|10988385|FG000|Overall Study|Protocol Violation|2
6948687|NCT00995865|10988386|FG001|Overall Study|Protocol Violation|0
6948688|NCT00995865|10988387|FG002|Overall Study|Protocol Violation|0
6948689|NCT00995865|10988385|FG000|Overall Study|Lost to Follow-up|0
6948690|NCT00995865|10988386|FG001|Overall Study|Lost to Follow-up|0
6948691|NCT00995865|10988387|FG002|Overall Study|Lost to Follow-up|1
6948692|NCT00995930|10988418|FG000|Overall Study|Protocol deviation|2
6948693|NCT00995930|10988419|FG001|Overall Study|Protocol deviation|5
6948694|NCT00995930|10988418|FG000|Overall Study|Death|0
6948695|NCT00995930|10988419|FG001|Overall Study|Death|1
6948696|NCT00995930|10988418|FG000|Overall Study|Administrative problems|4
6948697|NCT00995930|10988419|FG001|Overall Study|Administrative problems|2
6948698|NCT00995930|10988418|FG000|Overall Study|Lost to Follow-up|1
6948699|NCT00995930|10988419|FG001|Overall Study|Lost to Follow-up|2
6948700|NCT00995930|10988418|FG000|Overall Study|Withdrawal by Subject|3
6948701|NCT00995930|10988419|FG001|Overall Study|Withdrawal by Subject|4
6948702|NCT00995930|10988418|FG000|Overall Study|Adverse Event|11
6948703|NCT00995930|10988419|FG001|Overall Study|Adverse Event|14
6948704|NCT00996034|10988426|FG000|Overall Study|Lost to Follow-up|2
6948705|NCT00996034|10988426|FG000|Overall Study|withdrawn by PI|1
6948706|NCT00996125|10988432|FG000|Overall Study|Adverse Event|0
6948707|NCT00996125|10988433|FG001|Overall Study|Adverse Event|2
6948708|NCT00996125|10988432|FG000|Overall Study|Lost to Follow-up|1
6948709|NCT00996125|10988433|FG001|Overall Study|Lost to Follow-up|6
6948710|NCT00996125|10988432|FG000|Overall Study|Withdrawal by Subject|4
6948711|NCT00996125|10988433|FG001|Overall Study|Withdrawal by Subject|3
6948712|NCT00996203|10988448|FG000|Overall Study|Adverse Event|3
6948713|NCT00996203|10988448|FG000|Overall Study|Lost to Follow-up|1
6948714|NCT00996203|10988448|FG000|Overall Study|Lack of Efficacy|1
6948715|NCT00996203|10988448|FG000|Overall Study|Protocol Violation|2
6948716|NCT00996216|10988453|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1
6948717|NCT00996216|10988453|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3
6948718|NCT00996216|10988453|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1
6948719|NCT00996281|10988460|FG000|Overall Study|Adverse Event|75
6948720|NCT00996281|10988461|FG001|Overall Study|Adverse Event|37
6948721|NCT00996281|10988460|FG000|Overall Study|Major Protocol Deviation|6
6948722|NCT00996281|10988461|FG001|Overall Study|Major Protocol Deviation|7
6948723|NCT00996281|10988460|FG000|Overall Study|Lost to Follow-up|14
6948724|NCT00996281|10988461|FG001|Overall Study|Lost to Follow-up|16
6948725|NCT00996281|10988460|FG000|Overall Study|Withdrawal by Subject|31
7069738|NCT02006472|11171956|FG000|Period 1 (Through Week 26)|Protocol Violation|1
7069739|NCT02006472|11171957|FG001|Period 1 (Through Week 26)|Protocol Violation|1
7069740|NCT02006472|11171958|FG002|Period 1 (Through Week 26)|Protocol Violation|1
7069741|NCT02006472|11171959|FG003|Period 1 (Through Week 26)|Protocol Violation|1
6948726|NCT00996281|10988461|FG001|Overall Study|Withdrawal by Subject|20
6948727|NCT00996281|10988460|FG000|Overall Study|Lack of Efficacy|0
6948728|NCT00996281|10988461|FG001|Overall Study|Lack of Efficacy|2
6948729|NCT00996281|10988460|FG000|Overall Study|Other|5
6948730|NCT00996281|10988461|FG001|Overall Study|Other|7
6948731|NCT00996307|10988471|FG000|Overall Study|Adverse Event|0
6948732|NCT00996307|10988472|FG001|Overall Study|Adverse Event|1
6948733|NCT00996307|10988473|FG002|Overall Study|Adverse Event|0
6948734|NCT00996307|10988474|FG003|Overall Study|Adverse Event|0
6948735|NCT00996307|10988471|FG000|Overall Study|Withdrawal by Subject|3
6948736|NCT00996307|10988472|FG001|Overall Study|Withdrawal by Subject|2
6948737|NCT00996307|10988473|FG002|Overall Study|Withdrawal by Subject|5
6948738|NCT00996307|10988474|FG003|Overall Study|Withdrawal by Subject|5
6948739|NCT00996307|10988471|FG000|Overall Study|Lost to Follow-up|13
6948740|NCT00996307|10988472|FG001|Overall Study|Lost to Follow-up|13
6948741|NCT00996307|10988473|FG002|Overall Study|Lost to Follow-up|7
6948742|NCT00996307|10988474|FG003|Overall Study|Lost to Follow-up|15
6948743|NCT00996307|10988471|FG000|Overall Study|Administrative reason|0
6948744|NCT00996307|10988472|FG001|Overall Study|Administrative reason|1
6948745|NCT00996307|10988473|FG002|Overall Study|Administrative reason|0
6948746|NCT00996307|10988474|FG003|Overall Study|Administrative reason|0
6948747|NCT00996307|10988471|FG000|Overall Study|Unable to classify|4
6948748|NCT00996307|10988472|FG001|Overall Study|Unable to classify|0
7069742|NCT02006472|11171960|FG004|Period 1 (Through Week 26)|Protocol Violation|0
6948749|NCT00996307|10988473|FG002|Overall Study|Unable to classify|2
6948750|NCT00996307|10988474|FG003|Overall Study|Unable to classify|1
6948751|NCT00996437|10988526|FG000|Overall Study|Death|1
6948752|NCT00996437|10988527|FG001|Overall Study|Death|0
6948753|NCT00996437|10988526|FG000|Overall Study|Dropped|2
6948754|NCT00996437|10988527|FG001|Overall Study|Dropped|2
6948755|NCT00996437|10988526|FG000|Overall Study|Missed|2
6948756|NCT00996437|10988527|FG001|Overall Study|Missed|5
6948757|NCT00996476|10988538|FG000|Overall Study|Withdrawal by Subject|1
6948758|NCT00996476|10988539|FG001|Overall Study|Withdrawal by Subject|2
6948759|NCT00996476|10988540|FG002|Overall Study|Withdrawal by Subject|1
6948760|NCT00996476|10988541|FG003|Overall Study|Withdrawal by Subject|0
6948761|NCT00996476|10988542|FG004|Overall Study|Withdrawal by Subject|1
6948762|NCT00996476|10988538|FG000|Overall Study|Adverse Event|0
6948763|NCT00996476|10988539|FG001|Overall Study|Adverse Event|1
6948764|NCT00996476|10988540|FG002|Overall Study|Adverse Event|0
6948765|NCT00996476|10988541|FG003|Overall Study|Adverse Event|0
6948766|NCT00996476|10988542|FG004|Overall Study|Adverse Event|1
6948767|NCT00996489|10988559|FG000|Overall Study|Device failure|45
6948768|NCT00996489|10988559|FG000|Overall Study|Discontinued|116
6948769|NCT00996580|10988563|FG000|Overall Study|Adverse Event|466
6948770|NCT00996580|10988563|FG000|Overall Study|Lost to Follow-up|480
6948771|NCT00996580|10988563|FG000|Overall Study|Noncompliance with the protocol|137
6948772|NCT00996580|10988563|FG000|Overall Study|Physician Decision|5
6948773|NCT00996580|10988563|FG000|Overall Study|Pregnancy|68
6948774|NCT00996580|10988563|FG000|Overall Study|Protocol Violation|16
6948775|NCT00996580|10988563|FG000|Overall Study|Sponsor requested participant withdrawal|35
6948776|NCT00996580|10988563|FG000|Overall Study|Withdrawal by Subject|217
6948777|NCT00996580|10988563|FG000|Overall Study|Other|29
6948778|NCT00996593|10988570|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7
6948779|NCT00996593|10988570|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3
6948780|NCT00996593|10988570|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22
6948781|NCT00996593|10988570|FG000|Dosimetric and Therapeutic Treatment|Death|1
6948782|NCT00996593|10988570|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6
6948783|NCT00996593|10988570|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3
6948784|NCT00996593|10988570|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1
6948785|NCT00996593|10988570|FG000|Long-Term Follow-Up|Withdrawal by Subject|2
6948786|NCT00996593|10988570|FG000|Long-Term Follow-Up|Site Closed|1
6948787|NCT00996606|10988574|FG000|Overall Study|Adverse Event or Intercurrent Illness|2
6948788|NCT00996606|10988574|FG000|Overall Study|Insufficient Therapeutic Response|2
6948789|NCT00996606|10988574|FG000|Overall Study|Protocol Violation|1
6948790|NCT00996606|10988574|FG000|Overall Study|Withdrawal by Subject|3
6948791|NCT00996632|10988580|FG000|Overall Study|Physician Decision|0
6948792|NCT00996632|10988581|FG001|Overall Study|Physician Decision|0
6948793|NCT00996658|10988589|FG000|Overall Study|Adverse Event|2
6948794|NCT00996658|10988590|FG001|Overall Study|Adverse Event|5
6948795|NCT00996658|10988589|FG000|Overall Study|Protocol Violation|0
6948796|NCT00996658|10988590|FG001|Overall Study|Protocol Violation|1
6948797|NCT00996658|10988589|FG000|Overall Study|Lost to Follow-up|2
6948798|NCT00996658|10988590|FG001|Overall Study|Lost to Follow-up|5
6948799|NCT00996658|10988589|FG000|Overall Study|Non-compliance issues|3
6948800|NCT00996658|10988590|FG001|Overall Study|Non-compliance issues|3
6948801|NCT00996658|10988589|FG000|Overall Study|Other|9
6948802|NCT00996658|10988590|FG001|Overall Study|Other|7
6948803|NCT00996736|10988598|FG000|Overall Study|Death|1
6948804|NCT00996736|10988599|FG001|Overall Study|Death|1
6948805|NCT00996736|10988598|FG000|Overall Study|Lost to Follow-up|15
6948806|NCT00996736|10988599|FG001|Overall Study|Lost to Follow-up|14
6948807|NCT00996736|10988598|FG000|Overall Study|Visit not within 3-month window|5
6948808|NCT00996736|10988599|FG001|Overall Study|Visit not within 3-month window|3
6948809|NCT00996801|10988620|FG000|Overall Study|Adverse Event|6
6948810|NCT00996801|10988621|FG001|Overall Study|Adverse Event|4
6948811|NCT00996801|10988622|FG002|Overall Study|Adverse Event|12
6948812|NCT00996801|10988623|FG003|Overall Study|Adverse Event|17
6948813|NCT00996801|10988624|FG004|Overall Study|Adverse Event|31
6948814|NCT00996801|10988625|FG005|Overall Study|Adverse Event|3
6948815|NCT00996801|10988620|FG000|Overall Study|Lack of Efficacy|3
6948816|NCT00996801|10988621|FG001|Overall Study|Lack of Efficacy|0
6948817|NCT00996801|10988622|FG002|Overall Study|Lack of Efficacy|1
6948818|NCT00996801|10988623|FG003|Overall Study|Lack of Efficacy|3
6948819|NCT00996801|10988624|FG004|Overall Study|Lack of Efficacy|0
6948820|NCT00996801|10988625|FG005|Overall Study|Lack of Efficacy|1
7069743|NCT02006472|11171956|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0
7069744|NCT02006472|11171957|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0
7069745|NCT02006472|11171958|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1
7069746|NCT02006472|11171959|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0
7069747|NCT02006472|11171960|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0
6948821|NCT00996801|10988620|FG000|Overall Study|Lost to Follow-up|0
6948822|NCT00996801|10988621|FG001|Overall Study|Lost to Follow-up|0
6948823|NCT00996801|10988622|FG002|Overall Study|Lost to Follow-up|0
6948824|NCT00996801|10988623|FG003|Overall Study|Lost to Follow-up|3
6948825|NCT00996801|10988624|FG004|Overall Study|Lost to Follow-up|3
6948826|NCT00996801|10988625|FG005|Overall Study|Lost to Follow-up|2
6948827|NCT00996801|10988620|FG000|Overall Study|Physician Decision|0
6948828|NCT00996801|10988621|FG001|Overall Study|Physician Decision|0
6948829|NCT00996801|10988622|FG002|Overall Study|Physician Decision|0
6948830|NCT00996801|10988623|FG003|Overall Study|Physician Decision|1
6948831|NCT00996801|10988624|FG004|Overall Study|Physician Decision|0
6948832|NCT00996801|10988625|FG005|Overall Study|Physician Decision|0
6948833|NCT00996801|10988620|FG000|Overall Study|Progressive Disease|0
6948834|NCT00996801|10988621|FG001|Overall Study|Progressive Disease|1
6948835|NCT00996801|10988622|FG002|Overall Study|Progressive Disease|0
6948836|NCT00996801|10988623|FG003|Overall Study|Progressive Disease|0
7069748|NCT02006472|11171956|FG000|Period 1 (Through Week 26)|Noncompliance|2
7069749|NCT02006472|11171957|FG001|Period 1 (Through Week 26)|Noncompliance|1
7069750|NCT02006472|11171958|FG002|Period 1 (Through Week 26)|Noncompliance|1
7069751|NCT02006472|11171959|FG003|Period 1 (Through Week 26)|Noncompliance|0
7069752|NCT02006472|11171960|FG004|Period 1 (Through Week 26)|Noncompliance|0
6948837|NCT00996801|10988624|FG004|Overall Study|Progressive Disease|0
6948838|NCT00996801|10988625|FG005|Overall Study|Progressive Disease|0
6948839|NCT00996801|10988620|FG000|Overall Study|Protocol Violation|3
6948840|NCT00996801|10988621|FG001|Overall Study|Protocol Violation|4
6948841|NCT00996801|10988622|FG002|Overall Study|Protocol Violation|1
6948842|NCT00996801|10988623|FG003|Overall Study|Protocol Violation|2
6948843|NCT00996801|10988624|FG004|Overall Study|Protocol Violation|3
6948844|NCT00996801|10988625|FG005|Overall Study|Protocol Violation|4
6948845|NCT00996801|10988620|FG000|Overall Study|Study Terminated by Sponsor|0
6948846|NCT00996801|10988621|FG001|Overall Study|Study Terminated by Sponsor|1
6948847|NCT00996801|10988622|FG002|Overall Study|Study Terminated by Sponsor|0
6948848|NCT00996801|10988623|FG003|Overall Study|Study Terminated by Sponsor|0
6948849|NCT00996801|10988624|FG004|Overall Study|Study Terminated by Sponsor|46
6948850|NCT00996801|10988625|FG005|Overall Study|Study Terminated by Sponsor|0
6948851|NCT00996801|10988620|FG000|Overall Study|Withdrawal by Subject|8
6948852|NCT00996801|10988621|FG001|Overall Study|Withdrawal by Subject|6
6948853|NCT00996801|10988622|FG002|Overall Study|Withdrawal by Subject|9
6948854|NCT00996801|10988623|FG003|Overall Study|Withdrawal by Subject|5
6948855|NCT00996801|10988624|FG004|Overall Study|Withdrawal by Subject|5
6948856|NCT00996801|10988625|FG005|Overall Study|Withdrawal by Subject|9
6948857|NCT00996840|10988646|FG000|Overall Study|Adverse Event|0
6948858|NCT00996840|10988647|FG001|Overall Study|Adverse Event|1
6948859|NCT00996840|10988648|FG002|Overall Study|Adverse Event|0
6948860|NCT00996840|10988649|FG003|Overall Study|Adverse Event|0
6948861|NCT00996840|10988650|FG004|Overall Study|Adverse Event|0
6948862|NCT00996840|10988646|FG000|Overall Study|Physician Decision|0
6948863|NCT00996840|10988647|FG001|Overall Study|Physician Decision|0
6948864|NCT00996840|10988648|FG002|Overall Study|Physician Decision|1
6948865|NCT00996840|10988649|FG003|Overall Study|Physician Decision|1
6948866|NCT00996840|10988650|FG004|Overall Study|Physician Decision|2
6948867|NCT00996840|10988646|FG000|Overall Study|Withdrawal by Subject|1
6948868|NCT00996840|10988647|FG001|Overall Study|Withdrawal by Subject|1
6948869|NCT00996840|10988648|FG002|Overall Study|Withdrawal by Subject|0
6948870|NCT00996840|10988649|FG003|Overall Study|Withdrawal by Subject|0
6948871|NCT00996840|10988650|FG004|Overall Study|Withdrawal by Subject|0
6948872|NCT00996892|10988666|FG000|Dose-Escalation Stage 1|Adverse Event|0
6948873|NCT00996892|10988667|FG001|Dose-Escalation Stage 1|Adverse Event|0
6948874|NCT00996892|10988668|FG002|Dose-Escalation Stage 1|Adverse Event|0
6948875|NCT00996892|10988669|FG003|Dose-Escalation Stage 1|Adverse Event|2
6948876|NCT00996892|10988670|FG004|Dose-Escalation Stage 1|Adverse Event|0
6948877|NCT00996892|10988671|FG005|Dose-Escalation Stage 1|Adverse Event|0
6948878|NCT00996892|10988672|FG006|Dose-Escalation Stage 1|Adverse Event|1
6948879|NCT00996892|10988673|FG007|Dose-Escalation Stage 1|Adverse Event|0
6948880|NCT00996892|10988674|FG008|Dose-Escalation Stage 1|Adverse Event|0
6948881|NCT00996892|10988675|FG009|Dose-Escalation Stage 1|Adverse Event|0
6948882|NCT00996892|10988676|FG010|Dose-Escalation Stage 1|Adverse Event|0
6948883|NCT00996892|10988677|FG011|Dose-Escalation Stage 1|Adverse Event|0
6948884|NCT00996892|10988678|FG012|Dose-Escalation Stage 1|Adverse Event|0
6948885|NCT00996892|10988679|FG013|Dose-Escalation Stage 1|Adverse Event|0
6948886|NCT00996892|10988680|FG014|Dose-Escalation Stage 1|Adverse Event|0
6948887|NCT00996892|10988681|FG015|Dose-Escalation Stage 1|Adverse Event|0
6948888|NCT00996892|10988682|FG016|Dose-Escalation Stage 1|Adverse Event|0
6948889|NCT00996892|10988683|FG017|Dose-Escalation Stage 1|Adverse Event|0
6948890|NCT00996892|10988684|FG018|Dose-Escalation Stage 1|Adverse Event|0
6948891|NCT00996892|10988685|FG019|Dose-Escalation Stage 1|Adverse Event|0
6948892|NCT00996892|10988666|FG000|Dose-Escalation Stage 1|Death|1
6948893|NCT00996892|10988667|FG001|Dose-Escalation Stage 1|Death|0
6948894|NCT00996892|10988668|FG002|Dose-Escalation Stage 1|Death|0
6948895|NCT00996892|10988669|FG003|Dose-Escalation Stage 1|Death|0
6948896|NCT00996892|10988670|FG004|Dose-Escalation Stage 1|Death|0
6948897|NCT00996892|10988671|FG005|Dose-Escalation Stage 1|Death|1
6948898|NCT00996892|10988672|FG006|Dose-Escalation Stage 1|Death|0
6948899|NCT00996892|10988673|FG007|Dose-Escalation Stage 1|Death|0
6948900|NCT00996892|10988674|FG008|Dose-Escalation Stage 1|Death|0
6948901|NCT00996892|10988675|FG009|Dose-Escalation Stage 1|Death|0
6948902|NCT00996892|10988676|FG010|Dose-Escalation Stage 1|Death|0
6948903|NCT00996892|10988677|FG011|Dose-Escalation Stage 1|Death|0
6948904|NCT00996892|10988678|FG012|Dose-Escalation Stage 1|Death|0
7069753|NCT02006472|11171956|FG000|Period 1 (Through Week 26)|Other|1
6948905|NCT00996892|10988679|FG013|Dose-Escalation Stage 1|Death|0
6948906|NCT00996892|10988680|FG014|Dose-Escalation Stage 1|Death|0
6948907|NCT00996892|10988681|FG015|Dose-Escalation Stage 1|Death|0
6948908|NCT00996892|10988682|FG016|Dose-Escalation Stage 1|Death|0
6948909|NCT00996892|10988683|FG017|Dose-Escalation Stage 1|Death|0
6948910|NCT00996892|10988684|FG018|Dose-Escalation Stage 1|Death|0
6948911|NCT00996892|10988685|FG019|Dose-Escalation Stage 1|Death|0
6948912|NCT00996892|10988666|FG000|Dose-Escalation Stage 1|Physician Decision|1
6948913|NCT00996892|10988667|FG001|Dose-Escalation Stage 1|Physician Decision|0
6948914|NCT00996892|10988668|FG002|Dose-Escalation Stage 1|Physician Decision|0
6948915|NCT00996892|10988669|FG003|Dose-Escalation Stage 1|Physician Decision|1
6948916|NCT00996892|10988670|FG004|Dose-Escalation Stage 1|Physician Decision|0
6948917|NCT00996892|10988671|FG005|Dose-Escalation Stage 1|Physician Decision|1
6948918|NCT00996892|10988672|FG006|Dose-Escalation Stage 1|Physician Decision|2
6948919|NCT00996892|10988673|FG007|Dose-Escalation Stage 1|Physician Decision|0
6948920|NCT00996892|10988674|FG008|Dose-Escalation Stage 1|Physician Decision|0
6948921|NCT00996892|10988675|FG009|Dose-Escalation Stage 1|Physician Decision|0
6948922|NCT00996892|10988676|FG010|Dose-Escalation Stage 1|Physician Decision|0
6948923|NCT00996892|10988677|FG011|Dose-Escalation Stage 1|Physician Decision|0
6948924|NCT00996892|10988678|FG012|Dose-Escalation Stage 1|Physician Decision|0
6948925|NCT00996892|10988679|FG013|Dose-Escalation Stage 1|Physician Decision|0
6948926|NCT00996892|10988680|FG014|Dose-Escalation Stage 1|Physician Decision|0
6948927|NCT00996892|10988681|FG015|Dose-Escalation Stage 1|Physician Decision|0
6948928|NCT00996892|10988682|FG016|Dose-Escalation Stage 1|Physician Decision|0
6948929|NCT00996892|10988683|FG017|Dose-Escalation Stage 1|Physician Decision|0
6948930|NCT00996892|10988684|FG018|Dose-Escalation Stage 1|Physician Decision|0
6948931|NCT00996892|10988685|FG019|Dose-Escalation Stage 1|Physician Decision|0
6948932|NCT00996892|10988666|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0
6948933|NCT00996892|10988667|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1
6948934|NCT00996892|10988668|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0
6948935|NCT00996892|10988669|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2
6948936|NCT00996892|10988670|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1
6948937|NCT00996892|10988671|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1
6948938|NCT00996892|10988672|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1
6948939|NCT00996892|10988673|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0
6948940|NCT00996892|10988674|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0
6948941|NCT00996892|10988675|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0
6948942|NCT00996892|10988676|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0
6948943|NCT00996892|10988677|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0
6948944|NCT00996892|10988678|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0
6948945|NCT00996892|10988679|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0
6948946|NCT00996892|10988680|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0
6948947|NCT00996892|10988681|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0
6948948|NCT00996892|10988682|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0
6948949|NCT00996892|10988683|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0
6948950|NCT00996892|10988684|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0
6948951|NCT00996892|10988685|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0
6948952|NCT00996892|10988666|FG000|Dose-Escalation Stage 1|Disease Progression|2
6948953|NCT00996892|10988667|FG001|Dose-Escalation Stage 1|Disease Progression|2
6948954|NCT00996892|10988668|FG002|Dose-Escalation Stage 1|Disease Progression|3
6948955|NCT00996892|10988669|FG003|Dose-Escalation Stage 1|Disease Progression|4
6948956|NCT00996892|10988670|FG004|Dose-Escalation Stage 1|Disease Progression|10
6948957|NCT00996892|10988671|FG005|Dose-Escalation Stage 1|Disease Progression|7
6948958|NCT00996892|10988672|FG006|Dose-Escalation Stage 1|Disease Progression|0
6948959|NCT00996892|10988673|FG007|Dose-Escalation Stage 1|Disease Progression|0
6948960|NCT00996892|10988674|FG008|Dose-Escalation Stage 1|Disease Progression|0
6948961|NCT00996892|10988675|FG009|Dose-Escalation Stage 1|Disease Progression|0
6948962|NCT00996892|10988676|FG010|Dose-Escalation Stage 1|Disease Progression|0
6948963|NCT00996892|10988677|FG011|Dose-Escalation Stage 1|Disease Progression|0
6948964|NCT00996892|10988678|FG012|Dose-Escalation Stage 1|Disease Progression|0
6948965|NCT00996892|10988679|FG013|Dose-Escalation Stage 1|Disease Progression|0
6948966|NCT00996892|10988680|FG014|Dose-Escalation Stage 1|Disease Progression|0
6948967|NCT00996892|10988681|FG015|Dose-Escalation Stage 1|Disease Progression|0
6948968|NCT00996892|10988682|FG016|Dose-Escalation Stage 1|Disease Progression|0
6948969|NCT00996892|10988683|FG017|Dose-Escalation Stage 1|Disease Progression|0
6948970|NCT00996892|10988684|FG018|Dose-Escalation Stage 1|Disease Progression|0
6948971|NCT00996892|10988685|FG019|Dose-Escalation Stage 1|Disease Progression|0
6948972|NCT00996892|10988666|FG000|Dose-Escalation Stage 1A|Adverse Event|0
6948973|NCT00996892|10988667|FG001|Dose-Escalation Stage 1A|Adverse Event|0
6948974|NCT00996892|10988668|FG002|Dose-Escalation Stage 1A|Adverse Event|0
6948975|NCT00996892|10988669|FG003|Dose-Escalation Stage 1A|Adverse Event|0
6948976|NCT00996892|10988670|FG004|Dose-Escalation Stage 1A|Adverse Event|0
7069754|NCT02006472|11171957|FG001|Period 1 (Through Week 26)|Other|5
7069755|NCT02006472|11171958|FG002|Period 1 (Through Week 26)|Other|0
7069756|NCT02006472|11171959|FG003|Period 1 (Through Week 26)|Other|2
7069757|NCT02006472|11171960|FG004|Period 1 (Through Week 26)|Other|3
7069758|NCT02006472|11171956|FG000|Period 1 (Through Week 26)|Adverse Event|5
6948977|NCT00996892|10988671|FG005|Dose-Escalation Stage 1A|Adverse Event|0
6948978|NCT00996892|10988672|FG006|Dose-Escalation Stage 1A|Adverse Event|0
6948979|NCT00996892|10988673|FG007|Dose-Escalation Stage 1A|Adverse Event|0
6948980|NCT00996892|10988674|FG008|Dose-Escalation Stage 1A|Adverse Event|0
6948981|NCT00996892|10988675|FG009|Dose-Escalation Stage 1A|Adverse Event|0
6948982|NCT00996892|10988676|FG010|Dose-Escalation Stage 1A|Adverse Event|1
6948983|NCT00996892|10988677|FG011|Dose-Escalation Stage 1A|Adverse Event|0
6948984|NCT00996892|10988678|FG012|Dose-Escalation Stage 1A|Adverse Event|0
6948985|NCT00996892|10988679|FG013|Dose-Escalation Stage 1A|Adverse Event|1
7069759|NCT02006472|11171957|FG001|Period 1 (Through Week 26)|Adverse Event|6
6948986|NCT00996892|10988680|FG014|Dose-Escalation Stage 1A|Adverse Event|0
6948987|NCT00996892|10988681|FG015|Dose-Escalation Stage 1A|Adverse Event|0
6948988|NCT00996892|10988682|FG016|Dose-Escalation Stage 1A|Adverse Event|0
6948989|NCT00996892|10988683|FG017|Dose-Escalation Stage 1A|Adverse Event|0
6948990|NCT00996892|10988684|FG018|Dose-Escalation Stage 1A|Adverse Event|0
6948991|NCT00996892|10988685|FG019|Dose-Escalation Stage 1A|Adverse Event|0
6948992|NCT00996892|10988666|FG000|Dose-Escalation Stage 1A|Death|0
6948993|NCT00996892|10988667|FG001|Dose-Escalation Stage 1A|Death|0
6948994|NCT00996892|10988668|FG002|Dose-Escalation Stage 1A|Death|0
6948995|NCT00996892|10988669|FG003|Dose-Escalation Stage 1A|Death|0
6948996|NCT00996892|10988670|FG004|Dose-Escalation Stage 1A|Death|0
6948997|NCT00996892|10988671|FG005|Dose-Escalation Stage 1A|Death|0
6948998|NCT00996892|10988672|FG006|Dose-Escalation Stage 1A|Death|0
7069760|NCT02006472|11171958|FG002|Period 1 (Through Week 26)|Adverse Event|11
7069761|NCT02006472|11171959|FG003|Period 1 (Through Week 26)|Adverse Event|11
7069762|NCT02006472|11171960|FG004|Period 1 (Through Week 26)|Adverse Event|14
7069763|NCT02006472|11171956|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3
7069764|NCT02006472|11171957|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9
7069765|NCT02006472|11171958|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3
7069766|NCT02006472|11171959|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0
7069767|NCT02006472|11171960|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3
7069768|NCT02006472|11171956|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1
7069769|NCT02006472|11171957|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0
7069770|NCT02006472|11171958|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0
7069771|NCT02006472|11171959|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1
7069772|NCT02006472|11171960|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1
7069773|NCT02006472|11171956|FG000|Period 2 (Through Week 52)|Noncompliance|1
7069774|NCT02006472|11171957|FG001|Period 2 (Through Week 52)|Noncompliance|0
7069775|NCT02006472|11171958|FG002|Period 2 (Through Week 52)|Noncompliance|0
6948999|NCT00996892|10988673|FG007|Dose-Escalation Stage 1A|Death|0
6949000|NCT00996892|10988674|FG008|Dose-Escalation Stage 1A|Death|0
6949001|NCT00996892|10988675|FG009|Dose-Escalation Stage 1A|Death|2
6949002|NCT00996892|10988676|FG010|Dose-Escalation Stage 1A|Death|0
6949003|NCT00996892|10988677|FG011|Dose-Escalation Stage 1A|Death|1
6949004|NCT00996892|10988678|FG012|Dose-Escalation Stage 1A|Death|1
6949005|NCT00996892|10988679|FG013|Dose-Escalation Stage 1A|Death|0
6949006|NCT00996892|10988680|FG014|Dose-Escalation Stage 1A|Death|0
6949007|NCT00996892|10988681|FG015|Dose-Escalation Stage 1A|Death|0
6949008|NCT00996892|10988682|FG016|Dose-Escalation Stage 1A|Death|0
6949009|NCT00996892|10988683|FG017|Dose-Escalation Stage 1A|Death|0
6949010|NCT00996892|10988684|FG018|Dose-Escalation Stage 1A|Death|0
6949011|NCT00996892|10988685|FG019|Dose-Escalation Stage 1A|Death|0
6949012|NCT00996892|10988666|FG000|Dose-Escalation Stage 1A|Physician Decision|0
6949013|NCT00996892|10988667|FG001|Dose-Escalation Stage 1A|Physician Decision|0
6949014|NCT00996892|10988668|FG002|Dose-Escalation Stage 1A|Physician Decision|0
6949015|NCT00996892|10988669|FG003|Dose-Escalation Stage 1A|Physician Decision|0
6949016|NCT00996892|10988670|FG004|Dose-Escalation Stage 1A|Physician Decision|0
6949017|NCT00996892|10988671|FG005|Dose-Escalation Stage 1A|Physician Decision|0
6949018|NCT00996892|10988672|FG006|Dose-Escalation Stage 1A|Physician Decision|0
6949019|NCT00996892|10988673|FG007|Dose-Escalation Stage 1A|Physician Decision|1
6949020|NCT00996892|10988674|FG008|Dose-Escalation Stage 1A|Physician Decision|0
6949021|NCT00996892|10988675|FG009|Dose-Escalation Stage 1A|Physician Decision|0
6949022|NCT00996892|10988676|FG010|Dose-Escalation Stage 1A|Physician Decision|0
6949023|NCT00996892|10988677|FG011|Dose-Escalation Stage 1A|Physician Decision|0
6949024|NCT00996892|10988678|FG012|Dose-Escalation Stage 1A|Physician Decision|0
6949025|NCT00996892|10988679|FG013|Dose-Escalation Stage 1A|Physician Decision|0
6949026|NCT00996892|10988680|FG014|Dose-Escalation Stage 1A|Physician Decision|0
6949027|NCT00996892|10988681|FG015|Dose-Escalation Stage 1A|Physician Decision|0
6949028|NCT00996892|10988682|FG016|Dose-Escalation Stage 1A|Physician Decision|0
6949029|NCT00996892|10988683|FG017|Dose-Escalation Stage 1A|Physician Decision|0
7069776|NCT02006472|11171959|FG003|Period 2 (Through Week 52)|Noncompliance|0
7069777|NCT02006472|11171960|FG004|Period 2 (Through Week 52)|Noncompliance|0
7069778|NCT02006472|11171956|FG000|Period 2 (Through Week 52)|Adverse Event|1
7069779|NCT02006472|11171957|FG001|Period 2 (Through Week 52)|Adverse Event|4
7069780|NCT02006472|11171958|FG002|Period 2 (Through Week 52)|Adverse Event|5
7069781|NCT02006472|11171959|FG003|Period 2 (Through Week 52)|Adverse Event|1
7069782|NCT02006472|11171960|FG004|Period 2 (Through Week 52)|Adverse Event|1
7069783|NCT02006472|11171956|FG000|Period 2 (Through Week 52)|Other|0
7069784|NCT02006472|11171957|FG001|Period 2 (Through Week 52)|Other|1
7069785|NCT02006472|11171958|FG002|Period 2 (Through Week 52)|Other|0
7069786|NCT02006472|11171959|FG003|Period 2 (Through Week 52)|Other|1
7069787|NCT02006472|11171960|FG004|Period 2 (Through Week 52)|Other|0
7069788|NCT02006472|11171956|FG000|Period 2 (Through Week 52)|Not treated|0
7069789|NCT02006472|11171957|FG001|Period 2 (Through Week 52)|Not treated|0
7069790|NCT02006472|11171958|FG002|Period 2 (Through Week 52)|Not treated|2
7069791|NCT02006472|11171959|FG003|Period 2 (Through Week 52)|Not treated|0
7069792|NCT02006472|11171960|FG004|Period 2 (Through Week 52)|Not treated|0
6949030|NCT00996892|10988684|FG018|Dose-Escalation Stage 1A|Physician Decision|0
6949031|NCT00996892|10988685|FG019|Dose-Escalation Stage 1A|Physician Decision|0
6949032|NCT00996892|10988666|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0
6949033|NCT00996892|10988667|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0
6949034|NCT00996892|10988668|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0
6949035|NCT00996892|10988669|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0
6949036|NCT00996892|10988670|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0
6949037|NCT00996892|10988671|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0
6949038|NCT00996892|10988672|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0
6949039|NCT00996892|10988673|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0
6949040|NCT00996892|10988674|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0
6949041|NCT00996892|10988675|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1
6949042|NCT00996892|10988676|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1
6949043|NCT00996892|10988677|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1
6949044|NCT00996892|10988678|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1
6949045|NCT00996892|10988679|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0
6949046|NCT00996892|10988680|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0
6949047|NCT00996892|10988681|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0
6949048|NCT00996892|10988682|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0
6949049|NCT00996892|10988683|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0
6949050|NCT00996892|10988684|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0
6949051|NCT00996892|10988685|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0
6949052|NCT00996892|10988666|FG000|Dose-Escalation Stage 1A|Disease Progression|0
6949053|NCT00996892|10988667|FG001|Dose-Escalation Stage 1A|Disease Progression|0
6949054|NCT00996892|10988668|FG002|Dose-Escalation Stage 1A|Disease Progression|0
6949055|NCT00996892|10988669|FG003|Dose-Escalation Stage 1A|Disease Progression|0
6949056|NCT00996892|10988670|FG004|Dose-Escalation Stage 1A|Disease Progression|0
6949057|NCT00996892|10988671|FG005|Dose-Escalation Stage 1A|Disease Progression|0
6949058|NCT00996892|10988672|FG006|Dose-Escalation Stage 1A|Disease Progression|0
6949059|NCT00996892|10988673|FG007|Dose-Escalation Stage 1A|Disease Progression|2
6949060|NCT00996892|10988674|FG008|Dose-Escalation Stage 1A|Disease Progression|3
6949061|NCT00996892|10988675|FG009|Dose-Escalation Stage 1A|Disease Progression|1
6949062|NCT00996892|10988676|FG010|Dose-Escalation Stage 1A|Disease Progression|5
7069793|NCT02006472|11171956|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2
7069794|NCT02006472|11171957|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1
7069795|NCT02006472|11171958|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2
6949063|NCT00996892|10988677|FG011|Dose-Escalation Stage 1A|Disease Progression|7
6949064|NCT00996892|10988678|FG012|Dose-Escalation Stage 1A|Disease Progression|6
6949065|NCT00996892|10988679|FG013|Dose-Escalation Stage 1A|Disease Progression|4
6949066|NCT00996892|10988680|FG014|Dose-Escalation Stage 1A|Disease Progression|0
6949067|NCT00996892|10988681|FG015|Dose-Escalation Stage 1A|Disease Progression|0
6949068|NCT00996892|10988682|FG016|Dose-Escalation Stage 1A|Disease Progression|0
6949069|NCT00996892|10988683|FG017|Dose-Escalation Stage 1A|Disease Progression|0
6949070|NCT00996892|10988684|FG018|Dose-Escalation Stage 1A|Disease Progression|0
6949071|NCT00996892|10988685|FG019|Dose-Escalation Stage 1A|Disease Progression|0
6949072|NCT00996892|10988666|FG000|Dose-Escalation Stage 1B|Physician Decision|0
6949073|NCT00996892|10988667|FG001|Dose-Escalation Stage 1B|Physician Decision|0
6949074|NCT00996892|10988668|FG002|Dose-Escalation Stage 1B|Physician Decision|0
6949075|NCT00996892|10988669|FG003|Dose-Escalation Stage 1B|Physician Decision|0
6949076|NCT00996892|10988670|FG004|Dose-Escalation Stage 1B|Physician Decision|0
6949077|NCT00996892|10988671|FG005|Dose-Escalation Stage 1B|Physician Decision|0
6949078|NCT00996892|10988672|FG006|Dose-Escalation Stage 1B|Physician Decision|0
6949079|NCT00996892|10988673|FG007|Dose-Escalation Stage 1B|Physician Decision|0
6949080|NCT00996892|10988674|FG008|Dose-Escalation Stage 1B|Physician Decision|0
6949081|NCT00996892|10988675|FG009|Dose-Escalation Stage 1B|Physician Decision|0
6949082|NCT00996892|10988676|FG010|Dose-Escalation Stage 1B|Physician Decision|0
6949083|NCT00996892|10988677|FG011|Dose-Escalation Stage 1B|Physician Decision|0
6949084|NCT00996892|10988678|FG012|Dose-Escalation Stage 1B|Physician Decision|0
6949085|NCT00996892|10988679|FG013|Dose-Escalation Stage 1B|Physician Decision|0
6949086|NCT00996892|10988680|FG014|Dose-Escalation Stage 1B|Physician Decision|0
6949087|NCT00996892|10988681|FG015|Dose-Escalation Stage 1B|Physician Decision|0
6949088|NCT00996892|10988682|FG016|Dose-Escalation Stage 1B|Physician Decision|0
6949089|NCT00996892|10988683|FG017|Dose-Escalation Stage 1B|Physician Decision|2
6949090|NCT00996892|10988684|FG018|Dose-Escalation Stage 1B|Physician Decision|0
6949091|NCT00996892|10988685|FG019|Dose-Escalation Stage 1B|Physician Decision|0
6949092|NCT00996892|10988666|FG000|Dose-Escalation Stage 1B|Disease Progression|0
6949093|NCT00996892|10988667|FG001|Dose-Escalation Stage 1B|Disease Progression|0
6949094|NCT00996892|10988668|FG002|Dose-Escalation Stage 1B|Disease Progression|0
6949095|NCT00996892|10988669|FG003|Dose-Escalation Stage 1B|Disease Progression|0
6949096|NCT00996892|10988670|FG004|Dose-Escalation Stage 1B|Disease Progression|0
6949097|NCT00996892|10988671|FG005|Dose-Escalation Stage 1B|Disease Progression|0
6949098|NCT00996892|10988672|FG006|Dose-Escalation Stage 1B|Disease Progression|0
6949099|NCT00996892|10988673|FG007|Dose-Escalation Stage 1B|Disease Progression|0
6949100|NCT00996892|10988674|FG008|Dose-Escalation Stage 1B|Disease Progression|0
6949101|NCT00996892|10988675|FG009|Dose-Escalation Stage 1B|Disease Progression|0
7069796|NCT02006472|11171959|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0
7069797|NCT02006472|11171960|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0
7069798|NCT02006472|11171956|FG000|Period 2 (Through Week 52)|Sponsor decision|0
6949102|NCT00996892|10988676|FG010|Dose-Escalation Stage 1B|Disease Progression|0
6949103|NCT00996892|10988677|FG011|Dose-Escalation Stage 1B|Disease Progression|0
6949104|NCT00996892|10988678|FG012|Dose-Escalation Stage 1B|Disease Progression|0
6949105|NCT00996892|10988679|FG013|Dose-Escalation Stage 1B|Disease Progression|0
6949106|NCT00996892|10988680|FG014|Dose-Escalation Stage 1B|Disease Progression|4
6949107|NCT00996892|10988681|FG015|Dose-Escalation Stage 1B|Disease Progression|3
6949108|NCT00996892|10988682|FG016|Dose-Escalation Stage 1B|Disease Progression|3
6949109|NCT00996892|10988683|FG017|Dose-Escalation Stage 1B|Disease Progression|3
6949110|NCT00996892|10988684|FG018|Dose-Escalation Stage 1B|Disease Progression|0
6949111|NCT00996892|10988685|FG019|Dose-Escalation Stage 1B|Disease Progression|0
6949112|NCT00996892|10988666|FG000|Expansion Stage 2|Adverse Event|0
6949113|NCT00996892|10988667|FG001|Expansion Stage 2|Adverse Event|0
6949114|NCT00996892|10988668|FG002|Expansion Stage 2|Adverse Event|0
6949115|NCT00996892|10988669|FG003|Expansion Stage 2|Adverse Event|0
6949116|NCT00996892|10988670|FG004|Expansion Stage 2|Adverse Event|0
6949117|NCT00996892|10988671|FG005|Expansion Stage 2|Adverse Event|0
6949118|NCT00996892|10988672|FG006|Expansion Stage 2|Adverse Event|0
6949119|NCT00996892|10988673|FG007|Expansion Stage 2|Adverse Event|0
6949120|NCT00996892|10988674|FG008|Expansion Stage 2|Adverse Event|0
6949121|NCT00996892|10988675|FG009|Expansion Stage 2|Adverse Event|0
6949122|NCT00996892|10988676|FG010|Expansion Stage 2|Adverse Event|0
6949123|NCT00996892|10988677|FG011|Expansion Stage 2|Adverse Event|0
6949124|NCT00996892|10988678|FG012|Expansion Stage 2|Adverse Event|0
6949125|NCT00996892|10988679|FG013|Expansion Stage 2|Adverse Event|0
6949126|NCT00996892|10988680|FG014|Expansion Stage 2|Adverse Event|0
6949127|NCT00996892|10988681|FG015|Expansion Stage 2|Adverse Event|0
6949128|NCT00996892|10988682|FG016|Expansion Stage 2|Adverse Event|0
6949129|NCT00996892|10988683|FG017|Expansion Stage 2|Adverse Event|0
6949130|NCT00996892|10988684|FG018|Expansion Stage 2|Adverse Event|3
6949131|NCT00996892|10988685|FG019|Expansion Stage 2|Adverse Event|0
6949132|NCT00996892|10988666|FG000|Expansion Stage 2|Death|0
6949133|NCT00996892|10988667|FG001|Expansion Stage 2|Death|0
6949134|NCT00996892|10988668|FG002|Expansion Stage 2|Death|0
6949135|NCT00996892|10988669|FG003|Expansion Stage 2|Death|0
6949136|NCT00996892|10988670|FG004|Expansion Stage 2|Death|0
6949137|NCT00996892|10988671|FG005|Expansion Stage 2|Death|0
6949138|NCT00996892|10988672|FG006|Expansion Stage 2|Death|0
6949139|NCT00996892|10988673|FG007|Expansion Stage 2|Death|0
6949140|NCT00996892|10988674|FG008|Expansion Stage 2|Death|0
6949141|NCT00996892|10988675|FG009|Expansion Stage 2|Death|0
6949142|NCT00996892|10988676|FG010|Expansion Stage 2|Death|0
6949143|NCT00996892|10988677|FG011|Expansion Stage 2|Death|0
6949144|NCT00996892|10988678|FG012|Expansion Stage 2|Death|0
6949145|NCT00996892|10988679|FG013|Expansion Stage 2|Death|0
6949146|NCT00996892|10988680|FG014|Expansion Stage 2|Death|0
6949147|NCT00996892|10988681|FG015|Expansion Stage 2|Death|0
6949148|NCT00996892|10988682|FG016|Expansion Stage 2|Death|0
6949149|NCT00996892|10988683|FG017|Expansion Stage 2|Death|0
6949150|NCT00996892|10988684|FG018|Expansion Stage 2|Death|2
6949151|NCT00996892|10988685|FG019|Expansion Stage 2|Death|0
6949152|NCT00996892|10988666|FG000|Expansion Stage 2|Physician Decision|0
6949153|NCT00996892|10988667|FG001|Expansion Stage 2|Physician Decision|0
7069799|NCT02006472|11171957|FG001|Period 2 (Through Week 52)|Sponsor decision|0
6949154|NCT00996892|10988668|FG002|Expansion Stage 2|Physician Decision|0
6949155|NCT00996892|10988669|FG003|Expansion Stage 2|Physician Decision|0
6949156|NCT00996892|10988670|FG004|Expansion Stage 2|Physician Decision|0
6949157|NCT00996892|10988671|FG005|Expansion Stage 2|Physician Decision|0
6949158|NCT00996892|10988672|FG006|Expansion Stage 2|Physician Decision|0
6949159|NCT00996892|10988673|FG007|Expansion Stage 2|Physician Decision|0
6949160|NCT00996892|10988674|FG008|Expansion Stage 2|Physician Decision|0
6949161|NCT00996892|10988675|FG009|Expansion Stage 2|Physician Decision|0
6949162|NCT00996892|10988676|FG010|Expansion Stage 2|Physician Decision|0
6949163|NCT00996892|10988677|FG011|Expansion Stage 2|Physician Decision|0
6949164|NCT00996892|10988678|FG012|Expansion Stage 2|Physician Decision|0
6949165|NCT00996892|10988679|FG013|Expansion Stage 2|Physician Decision|0
6949166|NCT00996892|10988680|FG014|Expansion Stage 2|Physician Decision|0
7069800|NCT02006472|11171958|FG002|Period 2 (Through Week 52)|Sponsor decision|1
7069801|NCT02006472|11171959|FG003|Period 2 (Through Week 52)|Sponsor decision|0
7069802|NCT02006472|11171960|FG004|Period 2 (Through Week 52)|Sponsor decision|0
6949167|NCT00996892|10988681|FG015|Expansion Stage 2|Physician Decision|0
6949168|NCT00996892|10988682|FG016|Expansion Stage 2|Physician Decision|0
6949169|NCT00996892|10988683|FG017|Expansion Stage 2|Physician Decision|0
6949170|NCT00996892|10988684|FG018|Expansion Stage 2|Physician Decision|1
6949171|NCT00996892|10988685|FG019|Expansion Stage 2|Physician Decision|0
7069803|NCT02006576|11171980|FG000|Overall Study|Withdrawal by Subject|4
6949172|NCT00996892|10988666|FG000|Expansion Stage 2|Withdrawal by Subject|0
6949173|NCT00996892|10988667|FG001|Expansion Stage 2|Withdrawal by Subject|0
6949174|NCT00996892|10988668|FG002|Expansion Stage 2|Withdrawal by Subject|0
6949175|NCT00996892|10988669|FG003|Expansion Stage 2|Withdrawal by Subject|0
6949176|NCT00996892|10988670|FG004|Expansion Stage 2|Withdrawal by Subject|0
6949177|NCT00996892|10988671|FG005|Expansion Stage 2|Withdrawal by Subject|0
6949178|NCT00996892|10988672|FG006|Expansion Stage 2|Withdrawal by Subject|0
6949179|NCT00996892|10988673|FG007|Expansion Stage 2|Withdrawal by Subject|0
6949180|NCT00996892|10988674|FG008|Expansion Stage 2|Withdrawal by Subject|0
6949181|NCT00996892|10988675|FG009|Expansion Stage 2|Withdrawal by Subject|0
6949182|NCT00996892|10988676|FG010|Expansion Stage 2|Withdrawal by Subject|0
6949183|NCT00996892|10988677|FG011|Expansion Stage 2|Withdrawal by Subject|0
6949184|NCT00996892|10988678|FG012|Expansion Stage 2|Withdrawal by Subject|0
6949185|NCT00996892|10988679|FG013|Expansion Stage 2|Withdrawal by Subject|0
6949186|NCT00996892|10988680|FG014|Expansion Stage 2|Withdrawal by Subject|0
6949187|NCT00996892|10988681|FG015|Expansion Stage 2|Withdrawal by Subject|0
6949188|NCT00996892|10988682|FG016|Expansion Stage 2|Withdrawal by Subject|0
6949189|NCT00996892|10988683|FG017|Expansion Stage 2|Withdrawal by Subject|0
6949190|NCT00996892|10988684|FG018|Expansion Stage 2|Withdrawal by Subject|1
6949191|NCT00996892|10988685|FG019|Expansion Stage 2|Withdrawal by Subject|0
6949192|NCT00996892|10988666|FG000|Expansion Stage 2|Disease Progression|0
6949193|NCT00996892|10988667|FG001|Expansion Stage 2|Disease Progression|0
6949194|NCT00996892|10988668|FG002|Expansion Stage 2|Disease Progression|0
6949195|NCT00996892|10988669|FG003|Expansion Stage 2|Disease Progression|0
6949196|NCT00996892|10988670|FG004|Expansion Stage 2|Disease Progression|0
6949197|NCT00996892|10988671|FG005|Expansion Stage 2|Disease Progression|0
6949198|NCT00996892|10988672|FG006|Expansion Stage 2|Disease Progression|0
6949199|NCT00996892|10988673|FG007|Expansion Stage 2|Disease Progression|0
6949200|NCT00996892|10988674|FG008|Expansion Stage 2|Disease Progression|0
6949201|NCT00996892|10988675|FG009|Expansion Stage 2|Disease Progression|0
6949202|NCT00996892|10988676|FG010|Expansion Stage 2|Disease Progression|0
6949203|NCT00996892|10988677|FG011|Expansion Stage 2|Disease Progression|0
6949204|NCT00996892|10988678|FG012|Expansion Stage 2|Disease Progression|0
6949205|NCT00996892|10988679|FG013|Expansion Stage 2|Disease Progression|0
6949206|NCT00996892|10988680|FG014|Expansion Stage 2|Disease Progression|0
6949207|NCT00996892|10988681|FG015|Expansion Stage 2|Disease Progression|0
6949208|NCT00996892|10988682|FG016|Expansion Stage 2|Disease Progression|0
6949209|NCT00996892|10988683|FG017|Expansion Stage 2|Disease Progression|0
6949210|NCT00996892|10988684|FG018|Expansion Stage 2|Disease Progression|28
6949211|NCT00996892|10988685|FG019|Expansion Stage 2|Disease Progression|0
6949212|NCT00996892|10988666|FG000|Expansion Stage 2A|Adverse Event|0
6949213|NCT00996892|10988667|FG001|Expansion Stage 2A|Adverse Event|0
6949214|NCT00996892|10988668|FG002|Expansion Stage 2A|Adverse Event|0
6949215|NCT00996892|10988669|FG003|Expansion Stage 2A|Adverse Event|0
6949216|NCT00996892|10988670|FG004|Expansion Stage 2A|Adverse Event|0
6949217|NCT00996892|10988671|FG005|Expansion Stage 2A|Adverse Event|0
6949218|NCT00996892|10988672|FG006|Expansion Stage 2A|Adverse Event|0
6949219|NCT00996892|10988673|FG007|Expansion Stage 2A|Adverse Event|0
6949220|NCT00996892|10988674|FG008|Expansion Stage 2A|Adverse Event|0
6949221|NCT00996892|10988675|FG009|Expansion Stage 2A|Adverse Event|0
6949222|NCT00996892|10988676|FG010|Expansion Stage 2A|Adverse Event|0
6949223|NCT00996892|10988677|FG011|Expansion Stage 2A|Adverse Event|0
6949224|NCT00996892|10988678|FG012|Expansion Stage 2A|Adverse Event|0
6949225|NCT00996892|10988679|FG013|Expansion Stage 2A|Adverse Event|0
6949226|NCT00996892|10988680|FG014|Expansion Stage 2A|Adverse Event|0
6949227|NCT00996892|10988681|FG015|Expansion Stage 2A|Adverse Event|0
6949228|NCT00996892|10988682|FG016|Expansion Stage 2A|Adverse Event|0
6949229|NCT00996892|10988683|FG017|Expansion Stage 2A|Adverse Event|0
6949230|NCT00996892|10988684|FG018|Expansion Stage 2A|Adverse Event|0
6949231|NCT00996892|10988685|FG019|Expansion Stage 2A|Adverse Event|8
6949232|NCT00996892|10988666|FG000|Expansion Stage 2A|Physician Decision|0
6949233|NCT00996892|10988667|FG001|Expansion Stage 2A|Physician Decision|0
6949234|NCT00996892|10988668|FG002|Expansion Stage 2A|Physician Decision|0
6949235|NCT00996892|10988669|FG003|Expansion Stage 2A|Physician Decision|0
6949236|NCT00996892|10988670|FG004|Expansion Stage 2A|Physician Decision|0
6949237|NCT00996892|10988671|FG005|Expansion Stage 2A|Physician Decision|0
6949238|NCT00996892|10988672|FG006|Expansion Stage 2A|Physician Decision|0
6949239|NCT00996892|10988673|FG007|Expansion Stage 2A|Physician Decision|0
6949240|NCT00996892|10988674|FG008|Expansion Stage 2A|Physician Decision|0
6949241|NCT00996892|10988675|FG009|Expansion Stage 2A|Physician Decision|0
6949242|NCT00996892|10988676|FG010|Expansion Stage 2A|Physician Decision|0
6949243|NCT00996892|10988677|FG011|Expansion Stage 2A|Physician Decision|0
6949244|NCT00996892|10988678|FG012|Expansion Stage 2A|Physician Decision|0
6949245|NCT00996892|10988679|FG013|Expansion Stage 2A|Physician Decision|0
6949246|NCT00996892|10988680|FG014|Expansion Stage 2A|Physician Decision|0
6949247|NCT00996892|10988681|FG015|Expansion Stage 2A|Physician Decision|0
6949248|NCT00996892|10988682|FG016|Expansion Stage 2A|Physician Decision|0
6949249|NCT00996892|10988683|FG017|Expansion Stage 2A|Physician Decision|0
6949250|NCT00996892|10988684|FG018|Expansion Stage 2A|Physician Decision|0
6949251|NCT00996892|10988685|FG019|Expansion Stage 2A|Physician Decision|2
6949252|NCT00996892|10988666|FG000|Expansion Stage 2A|Withdrawal by Subject|0
6949253|NCT00996892|10988667|FG001|Expansion Stage 2A|Withdrawal by Subject|0
6949254|NCT00996892|10988668|FG002|Expansion Stage 2A|Withdrawal by Subject|0
6949255|NCT00996892|10988669|FG003|Expansion Stage 2A|Withdrawal by Subject|0
6949256|NCT00996892|10988670|FG004|Expansion Stage 2A|Withdrawal by Subject|0
6949257|NCT00996892|10988671|FG005|Expansion Stage 2A|Withdrawal by Subject|0
6949258|NCT00996892|10988672|FG006|Expansion Stage 2A|Withdrawal by Subject|0
6949259|NCT00996892|10988673|FG007|Expansion Stage 2A|Withdrawal by Subject|0
6949260|NCT00996892|10988674|FG008|Expansion Stage 2A|Withdrawal by Subject|0
6949261|NCT00996892|10988675|FG009|Expansion Stage 2A|Withdrawal by Subject|0
6949262|NCT00996892|10988676|FG010|Expansion Stage 2A|Withdrawal by Subject|0
6949263|NCT00996892|10988677|FG011|Expansion Stage 2A|Withdrawal by Subject|0
6949264|NCT00996892|10988678|FG012|Expansion Stage 2A|Withdrawal by Subject|0
6949265|NCT00996892|10988679|FG013|Expansion Stage 2A|Withdrawal by Subject|0
6949266|NCT00996892|10988680|FG014|Expansion Stage 2A|Withdrawal by Subject|0
6949267|NCT00996892|10988681|FG015|Expansion Stage 2A|Withdrawal by Subject|0
6949268|NCT00996892|10988682|FG016|Expansion Stage 2A|Withdrawal by Subject|0
6949269|NCT00996892|10988683|FG017|Expansion Stage 2A|Withdrawal by Subject|0
6949270|NCT00996892|10988684|FG018|Expansion Stage 2A|Withdrawal by Subject|0
6949271|NCT00996892|10988685|FG019|Expansion Stage 2A|Withdrawal by Subject|4
6949272|NCT00996892|10988666|FG000|Expansion Stage 2A|Disease Progression|0
6949273|NCT00996892|10988667|FG001|Expansion Stage 2A|Disease Progression|0
6949274|NCT00996892|10988668|FG002|Expansion Stage 2A|Disease Progression|0
6949275|NCT00996892|10988669|FG003|Expansion Stage 2A|Disease Progression|0
6949276|NCT00996892|10988670|FG004|Expansion Stage 2A|Disease Progression|0
6949277|NCT00996892|10988671|FG005|Expansion Stage 2A|Disease Progression|0
6949278|NCT00996892|10988672|FG006|Expansion Stage 2A|Disease Progression|0
6949279|NCT00996892|10988673|FG007|Expansion Stage 2A|Disease Progression|0
6949280|NCT00996892|10988674|FG008|Expansion Stage 2A|Disease Progression|0
6949281|NCT00996892|10988675|FG009|Expansion Stage 2A|Disease Progression|0
6949282|NCT00996892|10988676|FG010|Expansion Stage 2A|Disease Progression|0
6949283|NCT00996892|10988677|FG011|Expansion Stage 2A|Disease Progression|0
6949284|NCT00996892|10988678|FG012|Expansion Stage 2A|Disease Progression|0
6949285|NCT00996892|10988679|FG013|Expansion Stage 2A|Disease Progression|0
6949286|NCT00996892|10988680|FG014|Expansion Stage 2A|Disease Progression|0
6949287|NCT00996892|10988681|FG015|Expansion Stage 2A|Disease Progression|0
6949288|NCT00996892|10988682|FG016|Expansion Stage 2A|Disease Progression|0
6949289|NCT00996892|10988683|FG017|Expansion Stage 2A|Disease Progression|0
6949290|NCT00996892|10988684|FG018|Expansion Stage 2A|Disease Progression|0
6949291|NCT00996892|10988685|FG019|Expansion Stage 2A|Disease Progression|31
6949292|NCT00996918|10988751|FG000|Overall Study|Lack of Efficacy|1
6949293|NCT00996918|10988752|FG001|Overall Study|Lack of Efficacy|1
6949294|NCT00996918|10988753|FG002|Overall Study|Lack of Efficacy|2
6949295|NCT00996918|10988754|FG003|Overall Study|Lack of Efficacy|2
6949296|NCT00996918|10988755|FG004|Overall Study|Lack of Efficacy|0
6949297|NCT00996918|10988751|FG000|Overall Study|Adverse Event|2
6949298|NCT00996918|10988752|FG001|Overall Study|Adverse Event|5
6949299|NCT00996918|10988753|FG002|Overall Study|Adverse Event|2
6949300|NCT00996918|10988754|FG003|Overall Study|Adverse Event|6
6949301|NCT00996918|10988755|FG004|Overall Study|Adverse Event|0
6949302|NCT00996918|10988751|FG000|Overall Study|Withdrawal by Subject|1
6949303|NCT00996918|10988752|FG001|Overall Study|Withdrawal by Subject|4
6949304|NCT00996918|10988753|FG002|Overall Study|Withdrawal by Subject|3
6949305|NCT00996918|10988754|FG003|Overall Study|Withdrawal by Subject|3
6949306|NCT00996918|10988755|FG004|Overall Study|Withdrawal by Subject|2
6949307|NCT00996918|10988751|FG000|Overall Study|Physician Decision|1
6949308|NCT00996918|10988752|FG001|Overall Study|Physician Decision|0
6949309|NCT00996918|10988753|FG002|Overall Study|Physician Decision|0
6949310|NCT00996918|10988754|FG003|Overall Study|Physician Decision|0
6949311|NCT00996918|10988755|FG004|Overall Study|Physician Decision|0
6949312|NCT00996918|10988751|FG000|Overall Study|Discontinuation of Study by Sponsor|31
6949313|NCT00996918|10988752|FG001|Overall Study|Discontinuation of Study by Sponsor|54
6949314|NCT00996918|10988753|FG002|Overall Study|Discontinuation of Study by Sponsor|30
6949315|NCT00996918|10988754|FG003|Overall Study|Discontinuation of Study by Sponsor|45
6949316|NCT00996918|10988755|FG004|Overall Study|Discontinuation of Study by Sponsor|2
6949317|NCT00996918|10988751|FG000|Overall Study|Loss of Caregiver|0
6949318|NCT00996918|10988752|FG001|Overall Study|Loss of Caregiver|1
6949319|NCT00996918|10988753|FG002|Overall Study|Loss of Caregiver|0
6949320|NCT00996918|10988754|FG003|Overall Study|Loss of Caregiver|0
6949321|NCT00996918|10988755|FG004|Overall Study|Loss of Caregiver|0
6949322|NCT00996918|10988751|FG000|Overall Study|Other|3
6949323|NCT00996918|10988752|FG001|Overall Study|Other|1
6949324|NCT00996918|10988753|FG002|Overall Study|Other|0
6949325|NCT00996918|10988754|FG003|Overall Study|Other|0
6949326|NCT00996918|10988755|FG004|Overall Study|Other|0
6949327|NCT00996944|10988774|FG000|Double-blind Treatment Period|Adverse Event|2
6949328|NCT00996944|10988775|FG001|Double-blind Treatment Period|Adverse Event|1
6949329|NCT00996944|10988774|FG000|Double-blind Treatment Period|Protocol Violation|1
6949330|NCT00996944|10988775|FG001|Double-blind Treatment Period|Protocol Violation|0
6949331|NCT00996944|10988774|FG000|Double-blind Treatment Period|Study Closed/Terminated|6
6949332|NCT00996944|10988775|FG001|Double-blind Treatment Period|Study Closed/Terminated|5
6949333|NCT00996944|10988774|FG000|Double-blind Treatment Period|Withdrawal by Subject|1
6949334|NCT00996944|10988775|FG001|Double-blind Treatment Period|Withdrawal by Subject|1
6949335|NCT00996944|10988774|FG000|Long-term Treatment Period|Study Closed/Terminated|12
6949336|NCT00996944|10988775|FG001|Long-term Treatment Period|Study Closed/Terminated|5
6949337|NCT00996996|10988783|FG000|Overall Study|Progressive Disease|10
6949338|NCT00996996|10988783|FG000|Overall Study|Non-compliance|8
6949339|NCT00996996|10988783|FG000|Overall Study|Lost to Follow-up|9
6949340|NCT00996996|10988783|FG000|Overall Study|Death|5
6949341|NCT00996996|10988783|FG000|Overall Study|Did Not Receive Study Medications|1
6949342|NCT00997035|10988789|FG000|3-week Followup Visit|Lost to Follow-up|9
6949343|NCT00997035|10988790|FG001|3-week Followup Visit|Lost to Follow-up|6
6949344|NCT00997035|10988789|FG000|3-month Follow-up Visit|Lost to Follow-up|12
6949345|NCT00997035|10988790|FG001|3-month Follow-up Visit|Lost to Follow-up|6
6949346|NCT00997126|10988817|FG000|Overall Study|Physician Decision|7
6949347|NCT00997126|10988818|FG001|Overall Study|Physician Decision|11
6949348|NCT00997243|10988843|FG000|Overall Study|Early termination of study by sponsor|7
6949349|NCT00997321|10988849|FG000|Overall Study|did not undergo sedation after enrollmen|0
6949350|NCT00997321|10988850|FG001|Overall Study|did not undergo sedation after enrollmen|3
6949351|NCT00997334|10988862|FG000|Overall Study|still on therapy|12
6949352|NCT00997334|10988862|FG000|Overall Study|Adverse Event|3
6949353|NCT00997334|10988862|FG000|Overall Study|Patient non-compliance|1
6949354|NCT00997334|10988862|FG000|Overall Study|Withdrawal by Subject|3
6949355|NCT00997334|10988862|FG000|Overall Study|Death|2
6949356|NCT00997334|10988862|FG000|Overall Study|Urgent Palliative Care|2
6949357|NCT00997334|10988862|FG000|Overall Study|No lesion amenable|1
6949358|NCT00997334|10988862|FG000|Overall Study|Ineligible|1
6949359|NCT00997373|10988868|FG000|Overall Study|Withdrawal by Subject|5
6949360|NCT00997373|10988869|FG001|Overall Study|Withdrawal by Subject|0
6949361|NCT00997373|10988868|FG000|Overall Study|wrong tumor type|4
6949362|NCT00997373|10988869|FG001|Overall Study|wrong tumor type|0
6949363|NCT00997373|10988868|FG000|Overall Study|could not have hysterectomy|6
6949364|NCT00997373|10988869|FG001|Overall Study|could not have hysterectomy|0
6949365|NCT00997438|10988883|FG000|Overall Study|Blood draw difficulty|2
6949366|NCT00997438|10988884|FG001|Overall Study|Blood draw difficulty|0
6949367|NCT00997438|10988885|FG002|Overall Study|Blood draw difficulty|1
6949368|NCT00997438|10988883|FG000|Overall Study|Withdrawal by Subject|1
6949369|NCT00997438|10988884|FG001|Overall Study|Withdrawal by Subject|1
6949370|NCT00997438|10988885|FG002|Overall Study|Withdrawal by Subject|0
6949371|NCT00997438|10988883|FG000|Overall Study|Exclusion criteria at visit 1|2
6949372|NCT00997438|10988884|FG001|Overall Study|Exclusion criteria at visit 1|2
6949373|NCT00997438|10988885|FG002|Overall Study|Exclusion criteria at visit 1|3
6949374|NCT00997503|10988894|FG000|Overall Study|Death|53
6949375|NCT00997503|10988894|FG000|Overall Study|Withdrawal by Subject|76
6949376|NCT00997503|10988894|FG000|Overall Study|Lost to Follow-up|33
6949377|NCT00997503|10988894|FG000|Overall Study|Adverse Event|3
6949378|NCT00997503|10988894|FG000|Overall Study|Physician Decision|10
6949379|NCT00997503|10988894|FG000|Overall Study|Missed 12-month follow-up|85
6949380|NCT00997503|10988894|FG000|Overall Study|Other reason|13
6949381|NCT00997893|10988952|FG000|Overall Study|Adverse Event|1
6949382|NCT00997893|10988953|FG001|Overall Study|Adverse Event|0
6949383|NCT00997893|10988954|FG002|Overall Study|Adverse Event|0
6949384|NCT00997893|10988952|FG000|Overall Study|Unable to meet study timelines|1
6949385|NCT00997893|10988953|FG001|Overall Study|Unable to meet study timelines|0
6949386|NCT00997893|10988954|FG002|Overall Study|Unable to meet study timelines|0
6949387|NCT00997893|10988952|FG000|Overall Study|Pain/pain meds during Visit 4|0
6949388|NCT00997893|10988953|FG001|Overall Study|Pain/pain meds during Visit 4|1
6949389|NCT00997893|10988954|FG002|Overall Study|Pain/pain meds during Visit 4|0
6949390|NCT00997984|10988970|FG000|Overall Study|Adverse Event|1
6949391|NCT00997984|10988971|FG001|Overall Study|Adverse Event|8
6949392|NCT00997984|10988972|FG002|Overall Study|Adverse Event|8
6949393|NCT00997984|10988970|FG000|Overall Study|Protocol Violation|1
6949394|NCT00997984|10988971|FG001|Overall Study|Protocol Violation|3
6949395|NCT00997984|10988972|FG002|Overall Study|Protocol Violation|0
6949396|NCT00997984|10988970|FG000|Overall Study|Withdrawal by Subject|6
6949397|NCT00997984|10988971|FG001|Overall Study|Withdrawal by Subject|9
6949398|NCT00997984|10988972|FG002|Overall Study|Withdrawal by Subject|5
6949399|NCT00997984|10988970|FG000|Overall Study|Lost to Follow-up|8
6949400|NCT00997984|10988971|FG001|Overall Study|Lost to Follow-up|5
6949401|NCT00997984|10988972|FG002|Overall Study|Lost to Follow-up|4
6949402|NCT00997984|10988970|FG000|Overall Study|Lack of Efficacy|20
6949403|NCT00997984|10988971|FG001|Overall Study|Lack of Efficacy|6
6949404|NCT00997984|10988972|FG002|Overall Study|Lack of Efficacy|3
6949405|NCT00997984|10988970|FG000|Overall Study|Met exclusion criteria|1
6949406|NCT00997984|10988971|FG001|Overall Study|Met exclusion criteria|0
6949407|NCT00997984|10988972|FG002|Overall Study|Met exclusion criteria|0
6949408|NCT00997984|10988970|FG000|Overall Study|non-compliance|0
6949409|NCT00997984|10988971|FG001|Overall Study|non-compliance|2
6949410|NCT00997984|10988972|FG002|Overall Study|non-compliance|3
6949411|NCT00997984|10988970|FG000|Overall Study|Wrong medication dispensed|0
6949412|NCT00997984|10988971|FG001|Overall Study|Wrong medication dispensed|1
6949413|NCT00997984|10988972|FG002|Overall Study|Wrong medication dispensed|0
6949414|NCT00997984|10988970|FG000|Overall Study|Suicidal ideation|0
6949415|NCT00997984|10988971|FG001|Overall Study|Suicidal ideation|0
6949416|NCT00997984|10988972|FG002|Overall Study|Suicidal ideation|1
6949417|NCT00997984|10988970|FG000|Overall Study|Work schedule|0
6949418|NCT00997984|10988971|FG001|Overall Study|Work schedule|0
6949419|NCT00997984|10988972|FG002|Overall Study|Work schedule|2
6949420|NCT00998296|10989015|FG000|Overall Study|Progressive disease|0
6949421|NCT00998296|10989016|FG001|Overall Study|Progressive disease|1
6949422|NCT00998296|10989017|FG002|Overall Study|Progressive disease|0
6949423|NCT00998296|10989018|FG003|Overall Study|Progressive disease|0
6949424|NCT00998296|10989019|FG004|Overall Study|Progressive disease|0
6949425|NCT00998296|10989020|FG005|Overall Study|Progressive disease|0
6949426|NCT00998296|10989021|FG006|Overall Study|Progressive disease|1
6949427|NCT00998296|10989022|FG007|Overall Study|Progressive disease|0
6949428|NCT00998296|10989023|FG008|Overall Study|Progressive disease|0
6949429|NCT00998296|10989024|FG009|Overall Study|Progressive disease|14
6949430|NCT00998296|10989025|FG010|Overall Study|Progressive disease|5
6949431|NCT00998296|10989015|FG000|Overall Study|Dose limiting or dose reducing toxicity|0
6949432|NCT00998296|10989016|FG001|Overall Study|Dose limiting or dose reducing toxicity|0
6949433|NCT00998296|10989017|FG002|Overall Study|Dose limiting or dose reducing toxicity|0
6949434|NCT00998296|10989018|FG003|Overall Study|Dose limiting or dose reducing toxicity|0
6949435|NCT00998296|10989019|FG004|Overall Study|Dose limiting or dose reducing toxicity|1
6949436|NCT00998296|10989020|FG005|Overall Study|Dose limiting or dose reducing toxicity|0
6949437|NCT00998296|10989021|FG006|Overall Study|Dose limiting or dose reducing toxicity|0
6949438|NCT00998296|10989022|FG007|Overall Study|Dose limiting or dose reducing toxicity|2
6949439|NCT00998296|10989023|FG008|Overall Study|Dose limiting or dose reducing toxicity|2
6949440|NCT00998296|10989024|FG009|Overall Study|Dose limiting or dose reducing toxicity|0
6949441|NCT00998296|10989025|FG010|Overall Study|Dose limiting or dose reducing toxicity|0
6949442|NCT00998296|10989015|FG000|Overall Study|Other adverse event|0
6949443|NCT00998296|10989016|FG001|Overall Study|Other adverse event|0
6949444|NCT00998296|10989017|FG002|Overall Study|Other adverse event|0
6949445|NCT00998296|10989018|FG003|Overall Study|Other adverse event|0
6949446|NCT00998296|10989019|FG004|Overall Study|Other adverse event|1
6949447|NCT00998296|10989020|FG005|Overall Study|Other adverse event|0
6949448|NCT00998296|10989021|FG006|Overall Study|Other adverse event|0
6949449|NCT00998296|10989022|FG007|Overall Study|Other adverse event|0
6949450|NCT00998296|10989023|FG008|Overall Study|Other adverse event|0
6949451|NCT00998296|10989024|FG009|Overall Study|Other adverse event|1
6949452|NCT00998296|10989025|FG010|Overall Study|Other adverse event|2
6949453|NCT00998296|10989015|FG000|Overall Study|Refused to continue taking trial med.|0
6949454|NCT00998296|10989016|FG001|Overall Study|Refused to continue taking trial med.|0
6949455|NCT00998296|10989017|FG002|Overall Study|Refused to continue taking trial med.|0
6949456|NCT00998296|10989018|FG003|Overall Study|Refused to continue taking trial med.|0
6949457|NCT00998296|10989019|FG004|Overall Study|Refused to continue taking trial med.|0
6949458|NCT00998296|10989020|FG005|Overall Study|Refused to continue taking trial med.|0
6949459|NCT00998296|10989021|FG006|Overall Study|Refused to continue taking trial med.|0
6949460|NCT00998296|10989022|FG007|Overall Study|Refused to continue taking trial med.|0
6949461|NCT00998296|10989023|FG008|Overall Study|Refused to continue taking trial med.|0
6949462|NCT00998296|10989024|FG009|Overall Study|Refused to continue taking trial med.|2
6949463|NCT00998296|10989025|FG010|Overall Study|Refused to continue taking trial med.|0
6949464|NCT00998296|10989015|FG000|Overall Study|Reason other than those specified above|0
6949465|NCT00998296|10989016|FG001|Overall Study|Reason other than those specified above|0
6949466|NCT00998296|10989017|FG002|Overall Study|Reason other than those specified above|0
6949467|NCT00998296|10989018|FG003|Overall Study|Reason other than those specified above|0
6949468|NCT00998296|10989019|FG004|Overall Study|Reason other than those specified above|0
6949469|NCT00998296|10989020|FG005|Overall Study|Reason other than those specified above|0
6949470|NCT00998296|10989021|FG006|Overall Study|Reason other than those specified above|0
6949471|NCT00998296|10989022|FG007|Overall Study|Reason other than those specified above|0
6949472|NCT00998296|10989023|FG008|Overall Study|Reason other than those specified above|0
6949473|NCT00998296|10989024|FG009|Overall Study|Reason other than those specified above|1
6949474|NCT00998296|10989025|FG010|Overall Study|Reason other than those specified above|0
6949475|NCT00998309|10989054|FG000|Overall Study|Protocol Violation|4
6949476|NCT00998335|10989108|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0
6949477|NCT00998335|10989109|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2
6949478|NCT00998400|10989134|FG000|Overall Study|Lack of interest/motivation|1
6949479|NCT00998400|10989135|FG001|Overall Study|Lack of interest/motivation|2
6949480|NCT00998400|10989134|FG000|Overall Study|Logistical problems|1
6949481|NCT00998400|10989135|FG001|Overall Study|Logistical problems|0
6949482|NCT00998764|10989178|FG000|Overall Study|Lack of Efficacy|3
6949483|NCT00998764|10989179|FG001|Overall Study|Lack of Efficacy|6
6949484|NCT00998764|10989178|FG000|Overall Study|Adverse Event|17
6949485|NCT00998764|10989179|FG001|Overall Study|Adverse Event|12
6949486|NCT00998764|10989178|FG000|Overall Study|Withdrawal by Subject|19
6949487|NCT00998764|10989179|FG001|Overall Study|Withdrawal by Subject|25
6949488|NCT00998764|10989178|FG000|Overall Study|Physician Decision|3
6949489|NCT00998764|10989179|FG001|Overall Study|Physician Decision|3
6949490|NCT00998764|10989178|FG000|Overall Study|Death|3
6949491|NCT00998764|10989179|FG001|Overall Study|Death|1
6949492|NCT00998764|10989178|FG000|Overall Study|Discontinuation of Study by Sponsor|164
6949493|NCT00998764|10989179|FG001|Overall Study|Discontinuation of Study by Sponsor|217
6949494|NCT00998764|10989178|FG000|Overall Study|Protocol Violation|0
6949495|NCT00998764|10989179|FG001|Overall Study|Protocol Violation|1
6949496|NCT00998764|10989178|FG000|Overall Study|Failed to Return|1
6949497|NCT00998764|10989179|FG001|Overall Study|Failed to Return|1
6949498|NCT00998764|10989178|FG000|Overall Study|Lost to Follow-up|1
6949499|NCT00998764|10989179|FG001|Overall Study|Lost to Follow-up|1
6949500|NCT00998764|10989178|FG000|Overall Study|Loss of Caregiver|0
6949501|NCT00998764|10989179|FG001|Overall Study|Loss of Caregiver|3
6949502|NCT00998764|10989178|FG000|Overall Study|Other|4
6949503|NCT00998764|10989179|FG001|Overall Study|Other|4
6949504|NCT00998764|10989178|FG000|Overall Study|Recurrent Episode of vasogenic edema|1
6949505|NCT00998764|10989179|FG001|Overall Study|Recurrent Episode of vasogenic edema|0
6949506|NCT00998790|10989187|FG000|Overall Study|Withdrawal by Subject|21
6949507|NCT00998881|10989197|FG000|Overall Study|Adverse Event|2
6949508|NCT00998881|10989198|FG001|Overall Study|Adverse Event|2
6949509|NCT00998881|10989197|FG000|Overall Study|Lack of Efficacy|1
6949510|NCT00998881|10989198|FG001|Overall Study|Lack of Efficacy|0
6949511|NCT00998881|10989197|FG000|Overall Study|Physician Decision|3
6949512|NCT00998881|10989198|FG001|Overall Study|Physician Decision|0
6949513|NCT00998881|10989197|FG000|Overall Study|Withdrawal by Subject|1
6949514|NCT00998881|10989198|FG001|Overall Study|Withdrawal by Subject|0
6949515|NCT00998881|10989197|FG000|Overall Study|Personal matter|1
6949516|NCT00998881|10989198|FG001|Overall Study|Personal matter|0
6949517|NCT00998946|10989204|FG000|Overall Study|Lost to Follow-up|1
6949518|NCT00998946|10989204|FG000|Overall Study|Withdrawal by Subject|1
6949519|NCT00998946|10989204|FG000|Overall Study|Death|2
6949520|NCT00998946|10989204|FG000|Overall Study|Reason Unspecified|3
6949521|NCT00998946|10989204|FG000|Overall Study|Enrolled but not Dosed|2
6975938|NCT01196026|11028293|FG004|Overall Study|Withdrawal by Subject|0
6975939|NCT01196026|11028294|FG005|Overall Study|Withdrawal by Subject|0
6975940|NCT01196026|11028289|FG000|Overall Study|Lost to Follow-up|0
6975941|NCT01196026|11028290|FG001|Overall Study|Lost to Follow-up|3
6975942|NCT01196026|11028291|FG002|Overall Study|Lost to Follow-up|0
6975943|NCT01196026|11028292|FG003|Overall Study|Lost to Follow-up|0
6975944|NCT01196026|11028293|FG004|Overall Study|Lost to Follow-up|1
6975945|NCT01196026|11028294|FG005|Overall Study|Lost to Follow-up|0
6975946|NCT01196026|11028289|FG000|Overall Study|Other|0
6975947|NCT01196026|11028290|FG001|Overall Study|Other|1
6975948|NCT01196026|11028291|FG002|Overall Study|Other|0
6975949|NCT01196026|11028292|FG003|Overall Study|Other|0
6975950|NCT01196026|11028293|FG004|Overall Study|Other|0
6975951|NCT01196026|11028294|FG005|Overall Study|Other|0
6975952|NCT01196052|11028310|FG000|Overall Study|Adverse Event|9
6975953|NCT01196052|11028310|FG000|Overall Study|Lost to Follow-up|1
6975954|NCT01196052|11028310|FG000|Overall Study|Noncompliance to Protocol Requirements|2
6975955|NCT01196052|11028310|FG000|Overall Study|Reason not Specified|5
6975956|NCT01196052|11028310|FG000|Overall Study|Withdrawal by Subject|6
6975957|NCT01196078|11028316|FG000|Overall Study|Withdrawal by Subject|3
6975958|NCT01196078|11028317|FG001|Overall Study|Withdrawal by Subject|5
6975959|NCT01196078|11028316|FG000|Overall Study|Adverse Event|4
6975960|NCT01196078|11028317|FG001|Overall Study|Adverse Event|4
6975961|NCT01196078|11028316|FG000|Overall Study|Protocol Violation|2
6975962|NCT01196078|11028317|FG001|Overall Study|Protocol Violation|1
6975963|NCT01196078|11028316|FG000|Overall Study|Lack of Efficacy|17
6975964|NCT01196078|11028317|FG001|Overall Study|Lack of Efficacy|23
6975965|NCT01196078|11028316|FG000|Overall Study|Lost to Follow-up|1
6975966|NCT01196078|11028317|FG001|Overall Study|Lost to Follow-up|0
6975967|NCT01196078|11028316|FG000|Overall Study|Death|6
6975968|NCT01196078|11028317|FG001|Overall Study|Death|4
6975969|NCT01196091|11028326|FG000|Overall Study|Adverse Event|22
6975970|NCT01196091|11028327|FG001|Overall Study|Adverse Event|27
6975971|NCT01196091|11028328|FG002|Overall Study|Adverse Event|26
6975972|NCT01196091|11028326|FG000|Overall Study|Death|3
6975973|NCT01196091|11028327|FG001|Overall Study|Death|2
6975974|NCT01196091|11028328|FG002|Overall Study|Death|2
6975975|NCT01196091|11028326|FG000|Overall Study|Entry Criteria Not Met|11
6975976|NCT01196091|11028327|FG001|Overall Study|Entry Criteria Not Met|11
6975977|NCT01196091|11028328|FG002|Overall Study|Entry Criteria Not Met|10
6975978|NCT01196091|11028326|FG000|Overall Study|Lack of Efficacy|15
6975979|NCT01196091|11028327|FG001|Overall Study|Lack of Efficacy|12
6975980|NCT01196091|11028328|FG002|Overall Study|Lack of Efficacy|17
6975981|NCT01196091|11028326|FG000|Overall Study|Lost to Follow-up|5
6975982|NCT01196091|11028327|FG001|Overall Study|Lost to Follow-up|5
6975983|NCT01196091|11028328|FG002|Overall Study|Lost to Follow-up|6
6975984|NCT01196091|11028326|FG000|Overall Study|Parent/Caregiver Decision|0
6975985|NCT01196091|11028327|FG001|Overall Study|Parent/Caregiver Decision|0
6975986|NCT01196091|11028328|FG002|Overall Study|Parent/Caregiver Decision|1
6975987|NCT01196091|11028326|FG000|Overall Study|Withdrawal by Subject|16
6975988|NCT01196091|11028327|FG001|Overall Study|Withdrawal by Subject|19
6975989|NCT01196091|11028328|FG002|Overall Study|Withdrawal by Subject|22
6975990|NCT01196091|11028326|FG000|Overall Study|Physician Decision|3
7069804|NCT02006576|11171981|FG001|Overall Study|Withdrawal by Subject|6
7069805|NCT02006576|11171982|FG002|Overall Study|Withdrawal by Subject|2
7069806|NCT02006576|11171980|FG000|Overall Study|Death|0
7069807|NCT02006576|11171981|FG001|Overall Study|Death|0
7069808|NCT02006576|11171982|FG002|Overall Study|Death|1
7069809|NCT02006576|11171980|FG000|Overall Study|Lost to Follow-up|1
7069810|NCT02006576|11171981|FG001|Overall Study|Lost to Follow-up|0
7069811|NCT02006576|11171982|FG002|Overall Study|Lost to Follow-up|1
6975991|NCT01196091|11028327|FG001|Overall Study|Physician Decision|3
6975992|NCT01196091|11028328|FG002|Overall Study|Physician Decision|4
6975993|NCT01196091|11028326|FG000|Overall Study|Protocol Violation|1
6975994|NCT01196091|11028327|FG001|Overall Study|Protocol Violation|3
6975995|NCT01196091|11028328|FG002|Overall Study|Protocol Violation|3
7069812|NCT02006576|11171980|FG000|Overall Study|Screen Failure, too sick, other|13
6975996|NCT01196091|11028326|FG000|Overall Study|Sponsor Decision|6
6975997|NCT01196091|11028327|FG001|Overall Study|Sponsor Decision|5
6975998|NCT01196091|11028328|FG002|Overall Study|Sponsor Decision|4
6975999|NCT01196091|11028326|FG000|Overall Study|Excluded Site|5
6976000|NCT01196091|11028327|FG001|Overall Study|Excluded Site|11
6949522|NCT00998985|10989222|FG000|Overall Study|Withdrawal by Subject|0
6949523|NCT00998985|10989223|FG001|Overall Study|Withdrawal by Subject|0
6949524|NCT00998985|10989224|FG002|Overall Study|Withdrawal by Subject|0
6949525|NCT00998985|10989225|FG003|Overall Study|Withdrawal by Subject|0
6949526|NCT00998985|10989226|FG004|Overall Study|Withdrawal by Subject|0
6949527|NCT00998985|10989227|FG005|Overall Study|Withdrawal by Subject|0
6949528|NCT00998985|10989228|FG006|Overall Study|Withdrawal by Subject|0
7069813|NCT02006576|11171981|FG001|Overall Study|Screen Failure, too sick, other|1
6949529|NCT00998985|10989229|FG007|Overall Study|Withdrawal by Subject|0
6949530|NCT00998985|10989230|FG008|Overall Study|Withdrawal by Subject|1
6949531|NCT00998985|10989231|FG009|Overall Study|Withdrawal by Subject|0
6949532|NCT00998985|10989232|FG010|Overall Study|Withdrawal by Subject|0
6949533|NCT00998985|10989233|FG011|Overall Study|Withdrawal by Subject|0
6949534|NCT00998985|10989234|FG012|Overall Study|Withdrawal by Subject|0
6949535|NCT00998985|10989235|FG013|Overall Study|Withdrawal by Subject|0
6949536|NCT00998985|10989222|FG000|Overall Study|Protocol Violation|0
6949537|NCT00998985|10989223|FG001|Overall Study|Protocol Violation|0
6949538|NCT00998985|10989224|FG002|Overall Study|Protocol Violation|0
6949539|NCT00998985|10989225|FG003|Overall Study|Protocol Violation|0
6949540|NCT00998985|10989226|FG004|Overall Study|Protocol Violation|0
6949541|NCT00998985|10989227|FG005|Overall Study|Protocol Violation|1
6949542|NCT00998985|10989228|FG006|Overall Study|Protocol Violation|0
6949543|NCT00998985|10989229|FG007|Overall Study|Protocol Violation|0
6949544|NCT00998985|10989230|FG008|Overall Study|Protocol Violation|0
6949545|NCT00998985|10989231|FG009|Overall Study|Protocol Violation|0
6949546|NCT00998985|10989232|FG010|Overall Study|Protocol Violation|0
6949547|NCT00998985|10989233|FG011|Overall Study|Protocol Violation|0
6949548|NCT00998985|10989234|FG012|Overall Study|Protocol Violation|0
6949549|NCT00998985|10989235|FG013|Overall Study|Protocol Violation|0
6949550|NCT00999167|10989360|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4
6949551|NCT00999167|10989361|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
6949552|NCT00999167|10989362|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
6949553|NCT00999167|10989360|FG000|Part A: Open Label Safety run-in|Adverse Event|3
6949554|NCT00999167|10989361|FG001|Part A: Open Label Safety run-in|Adverse Event|0
6949555|NCT00999167|10989362|FG002|Part A: Open Label Safety run-in|Adverse Event|0
6949556|NCT00999167|10989360|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0
6949557|NCT00999167|10989361|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19
6949558|NCT00999167|10989362|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16
6949559|NCT00999167|10989360|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0
6949560|NCT00999167|10989361|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7
6949561|NCT00999167|10989362|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4
6949562|NCT00999167|10989360|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0
6949563|NCT00999167|10989361|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6
6949564|NCT00999167|10989362|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1
6949565|NCT00999167|10989360|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0
6949566|NCT00999167|10989361|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1
6949567|NCT00999167|10989362|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0
6949568|NCT00999167|10989360|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0
6949569|NCT00999167|10989361|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1
6949570|NCT00999167|10989362|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0
6949571|NCT00999167|10989360|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
6949572|NCT00999167|10989361|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1
6949573|NCT00999167|10989362|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
6949574|NCT00999466|10989375|FG000|Main Part|Withdrawal by Subject|0
6949575|NCT00999466|10989376|FG001|Main Part|Withdrawal by Subject|0
6949576|NCT00999466|10989377|FG002|Main Part|Withdrawal by Subject|2
6949577|NCT00999466|10989375|FG000|Main Part|Adverse Event|0
6949578|NCT00999466|10989376|FG001|Main Part|Adverse Event|4
6949579|NCT00999466|10989377|FG002|Main Part|Adverse Event|2
6949580|NCT00999518|10989390|FG000|Overall Study|Adverse Event|1
6949581|NCT00999518|10989391|FG001|Overall Study|Adverse Event|6
6949582|NCT00999518|10989392|FG002|Overall Study|Adverse Event|3
6949583|NCT00999518|10989393|FG003|Overall Study|Adverse Event|1
6949584|NCT00999518|10989394|FG004|Overall Study|Adverse Event|2
6949585|NCT00999518|10989390|FG000|Overall Study|Lack of Efficacy|2
6949586|NCT00999518|10989391|FG001|Overall Study|Lack of Efficacy|0
6949587|NCT00999518|10989392|FG002|Overall Study|Lack of Efficacy|0
6949588|NCT00999518|10989393|FG003|Overall Study|Lack of Efficacy|2
6949589|NCT00999518|10989394|FG004|Overall Study|Lack of Efficacy|2
6949590|NCT00999518|10989390|FG000|Overall Study|Lost to Follow-up|0
6949591|NCT00999518|10989391|FG001|Overall Study|Lost to Follow-up|0
6949592|NCT00999518|10989392|FG002|Overall Study|Lost to Follow-up|0
6949593|NCT00999518|10989393|FG003|Overall Study|Lost to Follow-up|4
6949594|NCT00999518|10989394|FG004|Overall Study|Lost to Follow-up|1
6949595|NCT00999518|10989390|FG000|Overall Study|Did not meet entrance criteria|0
6949596|NCT00999518|10989391|FG001|Overall Study|Did not meet entrance criteria|0
7069814|NCT02006576|11171982|FG002|Overall Study|Screen Failure, too sick, other|13
6949597|NCT00999518|10989392|FG002|Overall Study|Did not meet entrance criteria|0
7069815|NCT02006628|11171992|FG000|Overall Study|Adverse Event|1
7069816|NCT02006628|11171993|FG001|Overall Study|Adverse Event|1
7069817|NCT02006628|11171992|FG000|Overall Study|Withdrawal by Subject|2
7069818|NCT02006628|11171993|FG001|Overall Study|Withdrawal by Subject|1
7069819|NCT02006641|11172002|FG000|Overall Study|Withdrawal before treatment|2
7069820|NCT02006641|11172003|FG001|Overall Study|Withdrawal before treatment|5
7069821|NCT02006641|11172004|FG002|Overall Study|Withdrawal before treatment|3
6949598|NCT00999518|10989393|FG003|Overall Study|Did not meet entrance criteria|0
6949599|NCT00999518|10989394|FG004|Overall Study|Did not meet entrance criteria|1
6949600|NCT00999518|10989390|FG000|Overall Study|Study terminated by sponsor|10
6949601|NCT00999518|10989391|FG001|Overall Study|Study terminated by sponsor|6
6949602|NCT00999518|10989392|FG002|Overall Study|Study terminated by sponsor|5
6949603|NCT00999518|10989393|FG003|Overall Study|Study terminated by sponsor|5
6949604|NCT00999518|10989394|FG004|Overall Study|Study terminated by sponsor|9
6949605|NCT00999518|10989390|FG000|Overall Study|Pregnancy|0
6949606|NCT00999518|10989391|FG001|Overall Study|Pregnancy|0
6949607|NCT00999518|10989392|FG002|Overall Study|Pregnancy|1
6949608|NCT00999518|10989393|FG003|Overall Study|Pregnancy|0
6949609|NCT00999518|10989394|FG004|Overall Study|Pregnancy|0
6949610|NCT00999518|10989390|FG000|Overall Study|Protocol Violation|0
6949611|NCT00999518|10989391|FG001|Overall Study|Protocol Violation|1
6949612|NCT00999518|10989392|FG002|Overall Study|Protocol Violation|0
6949613|NCT00999518|10989393|FG003|Overall Study|Protocol Violation|0
6949614|NCT00999518|10989394|FG004|Overall Study|Protocol Violation|2
6949615|NCT00999518|10989390|FG000|Overall Study|Withdrawal by Subject|5
6949616|NCT00999518|10989391|FG001|Overall Study|Withdrawal by Subject|4
6949617|NCT00999518|10989392|FG002|Overall Study|Withdrawal by Subject|10
6949618|NCT00999518|10989393|FG003|Overall Study|Withdrawal by Subject|6
6949619|NCT00999518|10989394|FG004|Overall Study|Withdrawal by Subject|1
6949620|NCT00999518|10989390|FG000|Overall Study|Other|5
6949621|NCT00999518|10989391|FG001|Overall Study|Other|7
6949622|NCT00999518|10989392|FG002|Overall Study|Other|1
6949623|NCT00999518|10989393|FG003|Overall Study|Other|4
6949624|NCT00999518|10989394|FG004|Overall Study|Other|5
6949625|NCT00999518|10989390|FG000|Overall Study|Randomized but not Treated|1
6949626|NCT00999518|10989391|FG001|Overall Study|Randomized but not Treated|1
6949627|NCT00999518|10989392|FG002|Overall Study|Randomized but not Treated|2
6949628|NCT00999518|10989393|FG003|Overall Study|Randomized but not Treated|0
6949629|NCT00999518|10989394|FG004|Overall Study|Randomized but not Treated|1
6949630|NCT00999544|10989410|FG000|Overall Study|Withdrawal by Subject|1
6949631|NCT00999596|10989443|FG000|Overall Study|Statistical population not required|101
6949632|NCT00999661|10989448|FG000|Overall Study|Lost to Follow-up|59
6949633|NCT00999661|10989448|FG000|Overall Study|Adverse Event|1
6949634|NCT00999661|10989448|FG000|Overall Study|Withdrawal by Subject|1
6949635|NCT00999661|10989448|FG000|Overall Study|Not meeting eligibility criteria|9
6949636|NCT00999687|10989452|FG000|First Intervention|Withdrawal by Subject|1
6949637|NCT00999687|10989452|FG000|Second Intervention|Withdrawal by Subject|2
6949638|NCT00999687|10989452|FG000|Second Intervention|Lack of Efficacy|1
6949639|NCT00999713|10989460|FG000|Overall Study|Physician Decision|2
6949640|NCT00999713|10989461|FG001|Overall Study|Physician Decision|0
6949641|NCT00999908|10989476|FG000|Treatment Period 1|Subject withdrew consent|2
6949642|NCT00999908|10989477|FG001|Treatment Period 1|Subject withdrew consent|0
6949643|NCT00999908|10989478|FG002|Treatment Period 1|Subject withdrew consent|0
6949644|NCT00999908|10989476|FG000|Treatment Period 2|Protocol Violation|1
6949645|NCT00999908|10989477|FG001|Treatment Period 2|Protocol Violation|0
6949646|NCT00999908|10989478|FG002|Treatment Period 2|Protocol Violation|0
6949647|NCT00999921|10989488|FG000|Overall Study|Lost to Follow-up|10
6949648|NCT00999921|10989489|FG001|Overall Study|Lost to Follow-up|19
6949649|NCT01000025|10989500|FG000|Overall Study|Adverse Event|43
6949650|NCT01000025|10989501|FG001|Overall Study|Adverse Event|2
6949651|NCT01000025|10989500|FG000|Overall Study|Withdrawal by Subject|13
6949652|NCT01000025|10989501|FG001|Overall Study|Withdrawal by Subject|8
6949653|NCT01000025|10989500|FG000|Overall Study|Death|23
6949654|NCT01000025|10989501|FG001|Overall Study|Death|13
6949655|NCT01000025|10989500|FG000|Overall Study|Lack of Efficacy|363
6949656|NCT01000025|10989501|FG001|Overall Study|Lack of Efficacy|208
6949657|NCT01000025|10989500|FG000|Overall Study|Intercurrent Illness|26
6949658|NCT01000025|10989501|FG001|Overall Study|Intercurrent Illness|7
6949659|NCT01000051|10989509|FG000|Overall Study|Withdrawal by Subject|1
6949660|NCT01000051|10989510|FG001|Overall Study|Withdrawal by Subject|1
6949661|NCT01000051|10989509|FG000|Overall Study|Disease Progression|1
6949662|NCT01000051|10989510|FG001|Overall Study|Disease Progression|0
6949663|NCT01000051|10989509|FG000|Overall Study|Serious noncompliance|1
6949664|NCT01000051|10989510|FG001|Overall Study|Serious noncompliance|0
6949665|NCT01000064|10989516|FG000|Overall Study|Withdrawal by Subject|1
6949666|NCT01000064|10989517|FG001|Overall Study|Withdrawal by Subject|1
6949667|NCT01000155|10989526|FG000|Overall Study|Withdrawal by Subject|1
6949668|NCT01000155|10989526|FG000|Overall Study|Adverse Event|1
6949669|NCT01000311|10989548|FG000|Overall Study|Adverse Event|2
6949670|NCT01000311|10989549|FG001|Overall Study|Adverse Event|5
6949671|NCT01000311|10989548|FG000|Overall Study|Withdrawal by Subject|16
6949672|NCT01000311|10989549|FG001|Overall Study|Withdrawal by Subject|24
6949673|NCT01000311|10989548|FG000|Overall Study|Lost to Follow-up|15
6949674|NCT01000311|10989549|FG001|Overall Study|Lost to Follow-up|24
6949675|NCT01000311|10989548|FG000|Overall Study|Protocol Violation|1
6949676|NCT01000311|10989549|FG001|Overall Study|Protocol Violation|2
6949677|NCT01000311|10989548|FG000|Overall Study|Inappropriate enrollment|2
6949678|NCT01000311|10989549|FG001|Overall Study|Inappropriate enrollment|0
6949679|NCT01000311|10989548|FG000|Overall Study|Administrative reason|9
6949680|NCT01000311|10989549|FG001|Overall Study|Administrative reason|15
6949681|NCT01000337|10989562|FG000|Overall Study|Lost to Follow-up|4
6949682|NCT01000337|10989563|FG001|Overall Study|Lost to Follow-up|3
6949683|NCT01000376|10989571|FG000|Cycle 1 Day 1|Adverse Event|1
6949684|NCT01000376|10989572|FG001|Cycle 1 Day 1|Adverse Event|0
6949685|NCT01000376|10989571|FG000|Cycle 1 Day 1|Progressive Disease|1
6949686|NCT01000376|10989572|FG001|Cycle 1 Day 1|Progressive Disease|0
6949687|NCT01000480|10989578|FG000|Induction Phase|Adverse Event|2
6949688|NCT01000480|10989578|FG000|Induction Phase|Lost to Follow-up|1
6949689|NCT01000480|10989578|FG000|Induction Phase|Physician Decision|1
6949690|NCT01000480|10989578|FG000|Induction Phase|Entry Criteria Not Met|3
6949691|NCT01000480|10989578|FG000|Concurrent Therapy Phase|Adverse Event|4
6949692|NCT01000480|10989578|FG000|Concurrent Therapy Phase|Protocol Violation|2
6949693|NCT01000480|10989578|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3
6949694|NCT01000480|10989578|FG000|Concurrent Therapy Phase|Physician Decision|1
6949695|NCT01000493|10989584|FG000|Overall Study|Adverse Event|3
6949696|NCT01000493|10989585|FG001|Overall Study|Adverse Event|6
6949697|NCT01000493|10989584|FG000|Overall Study|Lack of Efficacy|1
6949698|NCT01000493|10989585|FG001|Overall Study|Lack of Efficacy|1
6949699|NCT01000493|10989584|FG000|Overall Study|Protocol Violation|1
6949700|NCT01000493|10989585|FG001|Overall Study|Protocol Violation|8
6949701|NCT01000493|10989584|FG000|Overall Study|Study closed/terminated|25
6949702|NCT01000493|10989585|FG001|Overall Study|Study closed/terminated|23
6949703|NCT01000493|10989584|FG000|Overall Study|Lost to Follow-up|5
6949704|NCT01000493|10989585|FG001|Overall Study|Lost to Follow-up|9
6949705|NCT01000493|10989584|FG000|Overall Study|Physician Decision|1
6949706|NCT01000493|10989585|FG001|Overall Study|Physician Decision|1
6949707|NCT01000493|10989584|FG000|Overall Study|Withdrawal by Subject|3
6949708|NCT01000493|10989585|FG001|Overall Study|Withdrawal by Subject|7
6949709|NCT01000506|10989595|FG000|Overall Study|Adverse Event|6
6949710|NCT01000506|10989596|FG001|Overall Study|Adverse Event|5
6949711|NCT01000506|10989597|FG002|Overall Study|Adverse Event|8
6949712|NCT01000506|10989598|FG003|Overall Study|Adverse Event|9
6949713|NCT01000506|10989595|FG000|Overall Study|Lack of Efficacy|8
6949714|NCT01000506|10989596|FG001|Overall Study|Lack of Efficacy|6
6949715|NCT01000506|10989597|FG002|Overall Study|Lack of Efficacy|4
6949716|NCT01000506|10989598|FG003|Overall Study|Lack of Efficacy|4
6949717|NCT01000506|10989595|FG000|Overall Study|Protocol Violation|1
6949718|NCT01000506|10989596|FG001|Overall Study|Protocol Violation|1
6949719|NCT01000506|10989597|FG002|Overall Study|Protocol Violation|0
6949720|NCT01000506|10989598|FG003|Overall Study|Protocol Violation|0
6949721|NCT01000506|10989595|FG000|Overall Study|Lost to Follow-up|1
6949722|NCT01000506|10989596|FG001|Overall Study|Lost to Follow-up|1
6949723|NCT01000506|10989597|FG002|Overall Study|Lost to Follow-up|4
6949724|NCT01000506|10989598|FG003|Overall Study|Lost to Follow-up|0
6949725|NCT01000506|10989595|FG000|Overall Study|Physician Decision|1
6949726|NCT01000506|10989596|FG001|Overall Study|Physician Decision|3
6949727|NCT01000506|10989597|FG002|Overall Study|Physician Decision|3
6949728|NCT01000506|10989598|FG003|Overall Study|Physician Decision|3
6949729|NCT01000506|10989595|FG000|Overall Study|Withdrawal by Subject|11
6949730|NCT01000506|10989596|FG001|Overall Study|Withdrawal by Subject|8
6949731|NCT01000506|10989597|FG002|Overall Study|Withdrawal by Subject|2
6949732|NCT01000506|10989598|FG003|Overall Study|Withdrawal by Subject|7
6949733|NCT01000610|10989608|FG000|Overall Study|Adverse Event|1
6949734|NCT01000610|10989608|FG000|Overall Study|Lost to Follow-up|4
6949735|NCT01000610|10989608|FG000|Overall Study|Treatment failure|1
6949736|NCT01000636|10989612|FG000|Overall Study|Withdrawal by Subject|1
6949737|NCT01000636|10989612|FG000|Overall Study|Adverse Event|1
6949738|NCT01000649|10989620|FG000|Overall Study|Adverse Event|5
6949739|NCT01000649|10989621|FG001|Overall Study|Adverse Event|1
6949740|NCT01000649|10989622|FG002|Overall Study|Adverse Event|2
6949741|NCT01000649|10989623|FG003|Overall Study|Adverse Event|4
6949742|NCT01000649|10989620|FG000|Overall Study|Lost to Follow-up|0
6949743|NCT01000649|10989621|FG001|Overall Study|Lost to Follow-up|2
6949744|NCT01000649|10989622|FG002|Overall Study|Lost to Follow-up|0
6949745|NCT01000649|10989623|FG003|Overall Study|Lost to Follow-up|2
6949746|NCT01000727|10989645|FG000|Overall Study|Lost to Follow-up|41
6949747|NCT01000727|10989646|FG001|Overall Study|Lost to Follow-up|43
6949748|NCT01000727|10989645|FG000|Overall Study|Withdrawal by Subject|111
6949749|NCT01000727|10989646|FG001|Overall Study|Withdrawal by Subject|109
6949750|NCT01000727|10989645|FG000|Overall Study|Study closed/terminated|23
6949751|NCT01000727|10989646|FG001|Overall Study|Study closed/terminated|24
6949752|NCT01000805|10989656|FG000|Overall Study|Adverse Event|21
6949753|NCT01000805|10989657|FG001|Overall Study|Adverse Event|9
6949754|NCT01000805|10989656|FG000|Overall Study|Lack of Efficacy|5
6949755|NCT01000805|10989657|FG001|Overall Study|Lack of Efficacy|16
6949756|NCT01000805|10989656|FG000|Overall Study|Lost to Follow-up|16
6949757|NCT01000805|10989657|FG001|Overall Study|Lost to Follow-up|21
6949758|NCT01000805|10989656|FG000|Overall Study|Physician Decision|0
6949759|NCT01000805|10989657|FG001|Overall Study|Physician Decision|1
6949760|NCT01000805|10989656|FG000|Overall Study|Protocol Violation|12
6949761|NCT01000805|10989657|FG001|Overall Study|Protocol Violation|8
6949762|NCT01000805|10989656|FG000|Overall Study|Withdrawal by Subject|16
6949763|NCT01000805|10989657|FG001|Overall Study|Withdrawal by Subject|6
6949764|NCT01000805|10989656|FG000|Overall Study|Sponsor Decision|0
6949765|NCT01000805|10989657|FG001|Overall Study|Sponsor Decision|1
6949766|NCT01000961|10989673|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0
6949767|NCT01000961|10989674|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1
6949768|NCT01000961|10989673|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0
6949769|NCT01000961|10989674|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1
6949770|NCT01000974|10989685|FG000|Primary Vaccination Phase|Withdrawal by Subject|109
6949771|NCT01000974|10989686|FG001|Primary Vaccination Phase|Withdrawal by Subject|17
6949772|NCT01000974|10989687|FG002|Primary Vaccination Phase|Withdrawal by Subject|21
6949773|NCT01000974|10989685|FG000|Primary Vaccination Phase|Lost to Follow-up|171
6949774|NCT01000974|10989686|FG001|Primary Vaccination Phase|Lost to Follow-up|19
6949775|NCT01000974|10989687|FG002|Primary Vaccination Phase|Lost to Follow-up|26
6949776|NCT01000974|10989685|FG000|Primary Vaccination Phase|Protocol Violation|40
6949777|NCT01000974|10989686|FG001|Primary Vaccination Phase|Protocol Violation|3
6949778|NCT01000974|10989687|FG002|Primary Vaccination Phase|Protocol Violation|2
6949779|NCT01000974|10989685|FG000|Primary Vaccination Phase|Adverse Event|14
6949780|NCT01000974|10989686|FG001|Primary Vaccination Phase|Adverse Event|2
6949781|NCT01000974|10989687|FG002|Primary Vaccination Phase|Adverse Event|2
6949782|NCT01000974|10989685|FG000|Primary Vaccination Phase|Other|4
6949783|NCT01000974|10989686|FG001|Primary Vaccination Phase|Other|9
6949784|NCT01000974|10989687|FG002|Primary Vaccination Phase|Other|12
6949785|NCT01000974|10989685|FG000|Booster Vaccination Phase|Protocol Violation|0
6949786|NCT01000974|10989686|FG001|Booster Vaccination Phase|Protocol Violation|0
6949787|NCT01000974|10989687|FG002|Booster Vaccination Phase|Protocol Violation|2
6949788|NCT01000974|10989685|FG000|Booster Vaccination Phase|Withdrawal by Subject|3
6949789|NCT01000974|10989686|FG001|Booster Vaccination Phase|Withdrawal by Subject|1
6949790|NCT01000974|10989687|FG002|Booster Vaccination Phase|Withdrawal by Subject|1
6949791|NCT01000974|10989685|FG000|Booster Vaccination Phase|Lost to Follow-up|40
6949792|NCT01000974|10989686|FG001|Booster Vaccination Phase|Lost to Follow-up|5
6949793|NCT01000974|10989687|FG002|Booster Vaccination Phase|Lost to Follow-up|7
6949794|NCT01000974|10989685|FG000|Booster Vaccination Phase|Other|24
6949795|NCT01000974|10989686|FG001|Booster Vaccination Phase|Other|6
6949796|NCT01000974|10989687|FG002|Booster Vaccination Phase|Other|4
6949797|NCT01001104|10989733|FG000|Overall Study|Adverse Event|2
6949798|NCT01001104|10989734|FG001|Overall Study|Adverse Event|1
6949799|NCT01001104|10989735|FG002|Overall Study|Adverse Event|0
6949800|NCT01001104|10989736|FG003|Overall Study|Adverse Event|0
6949801|NCT01001104|10989733|FG000|Overall Study|Lost to Follow-up|0
6949802|NCT01001104|10989734|FG001|Overall Study|Lost to Follow-up|0
6949803|NCT01001104|10989735|FG002|Overall Study|Lost to Follow-up|1
6949804|NCT01001104|10989736|FG003|Overall Study|Lost to Follow-up|0
6949805|NCT01001104|10989733|FG000|Overall Study|Entry Criteria Not Met|0
6949806|NCT01001104|10989734|FG001|Overall Study|Entry Criteria Not Met|0
6949807|NCT01001104|10989735|FG002|Overall Study|Entry Criteria Not Met|0
6949808|NCT01001104|10989736|FG003|Overall Study|Entry Criteria Not Met|1
6949809|NCT01001104|10989733|FG000|Overall Study|Withdrawal by Subject|0
6949810|NCT01001104|10989734|FG001|Overall Study|Withdrawal by Subject|0
6949811|NCT01001104|10989735|FG002|Overall Study|Withdrawal by Subject|0
6949812|NCT01001104|10989736|FG003|Overall Study|Withdrawal by Subject|2
6949813|NCT01001169|10989751|FG000|Overall Study|Withdrawal by Subject|2
6949814|NCT01001169|10989752|FG001|Overall Study|Withdrawal by Subject|1
6949815|NCT01001208|10989785|FG000|Overall Study|Adverse Event|10
6949816|NCT01001208|10989786|FG001|Overall Study|Adverse Event|5
6949817|NCT01001208|10989785|FG000|Overall Study|Lost to Follow-up|5
6949818|NCT01001208|10989786|FG001|Overall Study|Lost to Follow-up|9
6949819|NCT01001208|10989785|FG000|Overall Study|Physician Decision|1
6949820|NCT01001208|10989786|FG001|Overall Study|Physician Decision|0
6949821|NCT01001208|10989785|FG000|Overall Study|Withdrawal by Subject|4
6949822|NCT01001208|10989786|FG001|Overall Study|Withdrawal by Subject|5
6949823|NCT01001208|10989785|FG000|Overall Study|Ineligibility Determined|4
6949824|NCT01001208|10989786|FG001|Overall Study|Ineligibility Determined|2
6949825|NCT01001208|10989785|FG000|Overall Study|Noncompliance|4
6949826|NCT01001208|10989786|FG001|Overall Study|Noncompliance|7
6949827|NCT01001208|10989785|FG000|Overall Study|Disease Progression|0
6949828|NCT01001208|10989786|FG001|Overall Study|Disease Progression|3
6949829|NCT01001208|10989785|FG000|Overall Study|Other|0
6949830|NCT01001208|10989786|FG001|Overall Study|Other|2
7069822|NCT02006641|11172002|FG000|Overall Study|Adverse Event|15
7069823|NCT02006641|11172003|FG001|Overall Study|Adverse Event|11
6949831|NCT01001221|10989796|FG000|Overall Study|Adverse Event|1
6949832|NCT01001221|10989797|FG001|Overall Study|Adverse Event|2
6949833|NCT01001221|10989798|FG002|Overall Study|Adverse Event|0
6949834|NCT01001221|10989799|FG003|Overall Study|Adverse Event|2
6949835|NCT01001221|10989800|FG004|Overall Study|Adverse Event|0
6949836|NCT01001221|10989796|FG000|Overall Study|Disease progression|3
6949837|NCT01001221|10989797|FG001|Overall Study|Disease progression|2
6949838|NCT01001221|10989798|FG002|Overall Study|Disease progression|2
6949839|NCT01001221|10989799|FG003|Overall Study|Disease progression|4
6949840|NCT01001221|10989800|FG004|Overall Study|Disease progression|0
6949841|NCT01001221|10989796|FG000|Overall Study|Other|1
7069824|NCT02006641|11172004|FG002|Overall Study|Adverse Event|15
7069825|NCT02006641|11172002|FG000|Overall Study|Protocol Violation|0
7069826|NCT02006641|11172003|FG001|Overall Study|Protocol Violation|2
7069827|NCT02006641|11172004|FG002|Overall Study|Protocol Violation|2
7069828|NCT02006641|11172002|FG000|Overall Study|Lost to Follow-up|0
7069829|NCT02006641|11172003|FG001|Overall Study|Lost to Follow-up|1
7069830|NCT02006641|11172004|FG002|Overall Study|Lost to Follow-up|0
7069831|NCT02006641|11172002|FG000|Overall Study|Withdrawal by Subject|7
7069832|NCT02006641|11172003|FG001|Overall Study|Withdrawal by Subject|12
7069833|NCT02006641|11172004|FG002|Overall Study|Withdrawal by Subject|11
7069834|NCT02006641|11172002|FG000|Overall Study|Other reason: patient didn't show up|1
7069835|NCT02006641|11172003|FG001|Overall Study|Other reason: patient didn't show up|0
7069836|NCT02006641|11172004|FG002|Overall Study|Other reason: patient didn't show up|0
7069837|NCT02006641|11172002|FG000|Overall Study|Other reason:patient didn't want to come|0
7069838|NCT02006641|11172003|FG001|Overall Study|Other reason:patient didn't want to come|0
7069839|NCT02006641|11172004|FG002|Overall Study|Other reason:patient didn't want to come|1
7069840|NCT02006641|11172002|FG000|Overall Study|Other reason: patient has moved|1
7069841|NCT02006641|11172003|FG001|Overall Study|Other reason: patient has moved|0
7069842|NCT02006641|11172004|FG002|Overall Study|Other reason: patient has moved|1
7069843|NCT02006641|11172002|FG000|Overall Study|Other reason: caregiver in hospital|0
7069844|NCT02006641|11172003|FG001|Overall Study|Other reason: caregiver in hospital|1
7069845|NCT02006641|11172004|FG002|Overall Study|Other reason: caregiver in hospital|0
7069846|NCT02006641|11172002|FG000|Overall Study|Other reason: patient's wife has died|0
7069847|NCT02006641|11172003|FG001|Overall Study|Other reason: patient's wife has died|0
7069848|NCT02006641|11172004|FG002|Overall Study|Other reason: patient's wife has died|1
7069849|NCT02006641|11172002|FG000|Overall Study|Other reason: hospitalisation|0
7069850|NCT02006641|11172003|FG001|Overall Study|Other reason: hospitalisation|1
7069851|NCT02006641|11172004|FG002|Overall Study|Other reason: hospitalisation|0
7069852|NCT02006641|11172002|FG000|Overall Study|Other reason: caregiver impossibility|0
7069853|NCT02006641|11172003|FG001|Overall Study|Other reason: caregiver impossibility|0
7069854|NCT02006641|11172004|FG002|Overall Study|Other reason: caregiver impossibility|1
7069855|NCT02006641|11172002|FG000|Overall Study|Other reason: protocol non-compliance|0
7069856|NCT02006641|11172003|FG001|Overall Study|Other reason: protocol non-compliance|0
7069857|NCT02006641|11172004|FG002|Overall Study|Other reason: protocol non-compliance|1
7069858|NCT02006654|11172014|FG000|Overall Study|Withdrawal before treatment|4
7069859|NCT02006654|11172015|FG001|Overall Study|Withdrawal before treatment|2
7069860|NCT02006654|11172014|FG000|Overall Study|Adverse Event|16
7069861|NCT02006654|11172015|FG001|Overall Study|Adverse Event|17
7069862|NCT02006654|11172014|FG000|Overall Study|Death|1
7069863|NCT02006654|11172015|FG001|Overall Study|Death|0
7069864|NCT02006654|11172014|FG000|Overall Study|Withdrawal by Subject|14
7069865|NCT02006654|11172015|FG001|Overall Study|Withdrawal by Subject|12
7069866|NCT02006654|11172014|FG000|Overall Study|Protocol Violation|5
7069867|NCT02006654|11172015|FG001|Overall Study|Protocol Violation|8
7069868|NCT02006654|11172014|FG000|Overall Study|Lost to Follow-up|1
7069869|NCT02006654|11172015|FG001|Overall Study|Lost to Follow-up|0
7069870|NCT02006654|11172014|FG000|Overall Study|patient's will|2
7069871|NCT02006654|11172015|FG001|Overall Study|patient's will|1
7069872|NCT02006654|11172014|FG000|Overall Study|insufficient compliance|1
7069873|NCT02006654|11172015|FG001|Overall Study|insufficient compliance|0
7069874|NCT02006654|11172014|FG000|Overall Study|worsening cognitive condition|0
7069875|NCT02006654|11172015|FG001|Overall Study|worsening cognitive condition|1
7069876|NCT02006654|11172014|FG000|Overall Study|faecal incontinence|0
7069877|NCT02006654|11172015|FG001|Overall Study|faecal incontinence|1
7069878|NCT02006654|11172014|FG000|Overall Study|mood disorder|0
7069879|NCT02006654|11172015|FG001|Overall Study|mood disorder|1
7069880|NCT02006654|11172014|FG000|Overall Study|disallowed medication|1
7069881|NCT02006654|11172015|FG001|Overall Study|disallowed medication|0
7069882|NCT02006654|11172014|FG000|Overall Study|moving out of state|0
7069883|NCT02006654|11172015|FG001|Overall Study|moving out of state|1
7069884|NCT02006667|11172022|FG000|Overall Study|Adverse Event|3
7069885|NCT02006667|11172022|FG000|Overall Study|Death|2
7069886|NCT02006667|11172022|FG000|Overall Study|Withdrawal by Subject|1
7069887|NCT02006693|11172028|FG000|Overall Study|No Reason Specified|6
7069888|NCT02006693|11172029|FG001|Overall Study|No Reason Specified|8
7069889|NCT02006693|11172028|FG000|Overall Study|Another Glaucoma-related Surgery|12
7069890|NCT02006693|11172029|FG001|Overall Study|Another Glaucoma-related Surgery|1
7069891|NCT02006693|11172028|FG000|Overall Study|XEN Implant Explantation|0
7069892|NCT02006693|11172029|FG001|Overall Study|XEN Implant Explantation|1
7069893|NCT02006693|11172028|FG000|Overall Study|Death|2
7069894|NCT02006693|11172029|FG001|Overall Study|Death|2
7069895|NCT02006693|11172028|FG000|Overall Study|Lost to Follow-up|4
7069896|NCT02006693|11172029|FG001|Overall Study|Lost to Follow-up|1
7069897|NCT02006693|11172028|FG000|Overall Study|Patient Decision|4
7069898|NCT02006693|11172029|FG001|Overall Study|Patient Decision|0
7069899|NCT02006706|11172035|FG000|Overall Study|Lost to Follow-up|1
7069900|NCT02006719|11172041|FG000|Overall Study|Withdrawal by Subject|10
7069901|NCT02006719|11172042|FG001|Overall Study|Withdrawal by Subject|2
7069902|NCT02006719|11172041|FG000|Overall Study|Lost to Follow-up|5
7069903|NCT02006719|11172042|FG001|Overall Study|Lost to Follow-up|1
7069904|NCT02006719|11172041|FG000|Overall Study|Protocol Violation|2
7069905|NCT02006719|11172042|FG001|Overall Study|Protocol Violation|0
7069906|NCT02006719|11172041|FG000|Overall Study|Adverse Event|1
7069907|NCT02006719|11172042|FG001|Overall Study|Adverse Event|1
7069908|NCT02006719|11172041|FG000|Overall Study|Other/Unknown|0
7069909|NCT02006719|11172042|FG001|Overall Study|Other/Unknown|1
7069910|NCT02006732|11172052|FG000|Overall Study|Adverse Event|10
7069911|NCT02006732|11172053|FG001|Overall Study|Adverse Event|7
7069912|NCT02006732|11172054|FG002|Overall Study|Adverse Event|4
7069913|NCT02006732|11172055|FG003|Overall Study|Adverse Event|2
7069914|NCT02006732|11172052|FG000|Overall Study|Lack of Efficacy|6
7069915|NCT02006732|11172053|FG001|Overall Study|Lack of Efficacy|3
7069916|NCT02006732|11172054|FG002|Overall Study|Lack of Efficacy|1
7069917|NCT02006732|11172055|FG003|Overall Study|Lack of Efficacy|1
7069918|NCT02006732|11172052|FG000|Overall Study|Protocol Violation|1
7069919|NCT02006732|11172053|FG001|Overall Study|Protocol Violation|1
7069920|NCT02006732|11172054|FG002|Overall Study|Protocol Violation|0
7069921|NCT02006732|11172055|FG003|Overall Study|Protocol Violation|0
7069922|NCT02006732|11172052|FG000|Overall Study|Lost to Follow-up|0
7069923|NCT02006732|11172053|FG001|Overall Study|Lost to Follow-up|1
7069924|NCT02006732|11172054|FG002|Overall Study|Lost to Follow-up|0
7069925|NCT02006732|11172055|FG003|Overall Study|Lost to Follow-up|0
7069926|NCT02006732|11172052|FG000|Overall Study|Withdrawal by Subject|3
7069927|NCT02006732|11172053|FG001|Overall Study|Withdrawal by Subject|0
7069928|NCT02006732|11172054|FG002|Overall Study|Withdrawal by Subject|4
7069929|NCT02006732|11172055|FG003|Overall Study|Withdrawal by Subject|1
7069930|NCT02006758|11172065|FG000|Overall Study|Protocol Violation|1
7069931|NCT02006758|11172065|FG000|Overall Study|Death|1
7069932|NCT02006758|11172065|FG000|Overall Study|Lost to Follow-up|4
7069933|NCT02006758|11172065|FG000|Overall Study|Withdrawal by Subject|4
7069934|NCT02006758|11172065|FG000|Overall Study|Procedurally excluded|1
7069935|NCT02006758|11172065|FG000|Overall Study|Other|2
7069936|NCT02006979|11172100|FG000|Overall Study|Withdrawal by Subject|1
7069937|NCT02006979|11172101|FG001|Overall Study|Withdrawal by Subject|1
7069938|NCT02006979|11172100|FG000|Overall Study|Protocol Violation|0
7069939|NCT02006979|11172101|FG001|Overall Study|Protocol Violation|1
7069940|NCT02007070|11172107|FG000|Overall Study|Adverse Event|4
7069941|NCT02007070|11172107|FG000|Overall Study|Clinical Progression|4
7069942|NCT02007070|11172107|FG000|Overall Study|Death|1
7069943|NCT02007070|11172107|FG000|Overall Study|Protocol Violation|2
7069944|NCT02007070|11172107|FG000|Overall Study|Physician Decision|1
7069945|NCT02007070|11172107|FG000|Overall Study|Progressive Disease|21
7069946|NCT02007096|11172113|FG000|Overall Study|medication not available|2
7069947|NCT02007096|11172114|FG001|Overall Study|medication not available|0
7069948|NCT02007096|11172113|FG000|Overall Study|did not inject saline|0
7069949|NCT02007096|11172114|FG001|Overall Study|did not inject saline|3
7069950|NCT02007096|11172113|FG000|Overall Study|did not follow postoperative protocol|8
7069951|NCT02007096|11172114|FG001|Overall Study|did not follow postoperative protocol|11
7069952|NCT02007096|11172113|FG000|Overall Study|converted to open surgery|1
7069953|NCT02007096|11172114|FG001|Overall Study|converted to open surgery|1
7069954|NCT02007096|11172113|FG000|Overall Study|no mesh placed|0
7069955|NCT02007096|11172114|FG001|Overall Study|no mesh placed|1
7069956|NCT02007109|11172120|FG000|Overall Study|Diary not returned or excluded|102
7069957|NCT02007109|11172120|FG000|Overall Study|Excluded - Age<7yo|9
7069958|NCT02007252|11172133|FG000|Overall Study|Administrative problems|3
7069959|NCT02007252|11172134|FG001|Overall Study|Administrative problems|7
7069960|NCT02007252|11172133|FG000|Overall Study|Abnormal laboratory value(s)|1
7069961|NCT02007252|11172134|FG001|Overall Study|Abnormal laboratory value(s)|0
7069962|NCT02007252|11172133|FG000|Overall Study|Adverse Event|7
7069963|NCT02007252|11172134|FG001|Overall Study|Adverse Event|4
7069964|NCT02007278|11172142|FG000|Overall Study|Failure to comply with an eligibility|0
7069965|NCT02007278|11172143|FG001|Overall Study|Failure to comply with an eligibility|1
7069966|NCT02007278|11172142|FG000|Overall Study|Ingestion of drugs not allowed in study|0
7069967|NCT02007278|11172143|FG001|Overall Study|Ingestion of drugs not allowed in study|1
7069968|NCT02007278|11172142|FG000|Overall Study|Incorrect medication administration|1
7069969|NCT02007278|11172143|FG001|Overall Study|Incorrect medication administration|0
7069970|NCT02007278|11172142|FG000|Overall Study|Mis-randomization|1
7069971|NCT02007278|11172143|FG001|Overall Study|Mis-randomization|1
7069972|NCT02007434|11172177|FG000|Overall Study|Lost to Follow-up|0
7069973|NCT02007434|11172178|FG001|Overall Study|Lost to Follow-up|1
7069974|NCT02007434|11172179|FG002|Overall Study|Lost to Follow-up|0
7069975|NCT02007434|11172180|FG003|Overall Study|Lost to Follow-up|0
7069976|NCT02007434|11172181|FG004|Overall Study|Lost to Follow-up|0
7069977|NCT02007434|11172182|FG005|Overall Study|Lost to Follow-up|0
7069978|NCT02007434|11172183|FG006|Overall Study|Lost to Follow-up|0
7069979|NCT02007434|11172184|FG007|Overall Study|Lost to Follow-up|0
7069980|NCT02007434|11172177|FG000|Overall Study|Non-compliance|1
7069981|NCT02007434|11172178|FG001|Overall Study|Non-compliance|0
7069982|NCT02007434|11172179|FG002|Overall Study|Non-compliance|1
7069983|NCT02007434|11172180|FG003|Overall Study|Non-compliance|0
7069984|NCT02007434|11172181|FG004|Overall Study|Non-compliance|0
7069985|NCT02007434|11172182|FG005|Overall Study|Non-compliance|0
7147787|NCT03135899|11308631|FG003|Overall Study|Withdrawal by Subject|0
7147788|NCT03135899|11308632|FG004|Overall Study|Withdrawal by Subject|0
7069986|NCT02007434|11172183|FG006|Overall Study|Non-compliance|0
7069987|NCT02007434|11172184|FG007|Overall Study|Non-compliance|0
7069988|NCT02007577|11172205|FG000|Overall Study|Adverse Event|1
7069989|NCT02007577|11172206|FG001|Overall Study|Adverse Event|0
7069990|NCT02007577|11172205|FG000|Overall Study|Withdrawal by Subject|0
7069991|NCT02007577|11172206|FG001|Overall Study|Withdrawal by Subject|1
7069992|NCT02007720|11172214|FG000|Overall Study|Withdrawal by Subject|9
7069993|NCT02007720|11172215|FG001|Overall Study|Withdrawal by Subject|11
7069994|NCT02007720|11172214|FG000|Overall Study|study terminated by sponsor|58
7069995|NCT02007720|11172215|FG001|Overall Study|study terminated by sponsor|54
7069996|NCT02007720|11172214|FG000|Overall Study|technical problem|4
7069997|NCT02007720|11172215|FG001|Overall Study|technical problem|2
7069998|NCT02007720|11172214|FG000|Overall Study|patient followd less than 165 days|11
7069999|NCT02007720|11172215|FG001|Overall Study|patient followd less than 165 days|5
7070000|NCT02007954|11172226|FG000|Overall Study|Received liver transplant|3
7070001|NCT02007954|11172226|FG000|Overall Study|Switch in treatment modality|2
7070002|NCT02007954|11172226|FG000|Overall Study|Disease progression and unrelated AE|1
7070003|NCT02007954|11172226|FG000|Overall Study|Death|1
7070004|NCT02008227|11172245|FG000|Overall Study|Lost to Follow-up|7
6949842|NCT01001221|10989797|FG001|Overall Study|Other|1
6949843|NCT01001221|10989798|FG002|Overall Study|Other|0
6949844|NCT01001221|10989799|FG003|Overall Study|Other|0
6949845|NCT01001221|10989800|FG004|Overall Study|Other|0
6949846|NCT01001221|10989796|FG000|Overall Study|Not treated; protocol exclusion|0
6949847|NCT01001221|10989797|FG001|Overall Study|Not treated; protocol exclusion|0
6949848|NCT01001221|10989798|FG002|Overall Study|Not treated; protocol exclusion|1
6949849|NCT01001221|10989799|FG003|Overall Study|Not treated; protocol exclusion|0
6949850|NCT01001221|10989800|FG004|Overall Study|Not treated; protocol exclusion|0
6949851|NCT01001299|10989811|FG000|Overall Study|Insufficient Therapeutic Response|20
6949852|NCT01001299|10989811|FG000|Overall Study|Adverse event or Intercurrent Illness|1
6949853|NCT01001299|10989811|FG000|Overall Study|Death|1
6949854|NCT01001299|10989811|FG000|Overall Study|Began Taking Commercially Available Drug|2
6949855|NCT01001299|10989811|FG000|Overall Study|Withdrew Consent|1
6949856|NCT01001325|10989817|FG000|Overall Study|Lost to Follow-up|16
6949857|NCT01001325|10989818|FG001|Overall Study|Lost to Follow-up|10
6949858|NCT01001325|10989817|FG000|Overall Study|Protocol Violation|2
6949859|NCT01001325|10989818|FG001|Overall Study|Protocol Violation|0
6949860|NCT01001377|10989826|FG000|Overall Study|Ineligibility determined|2
6949861|NCT01001377|10989827|FG001|Overall Study|Ineligibility determined|0
6949862|NCT01001377|10989826|FG000|Overall Study|Withdrawal by Subject|19
6949863|NCT01001377|10989827|FG001|Overall Study|Withdrawal by Subject|20
6949864|NCT01001377|10989826|FG000|Overall Study|Lost to Follow-up|14
6949865|NCT01001377|10989827|FG001|Overall Study|Lost to Follow-up|17
6949866|NCT01001377|10989826|FG000|Overall Study|Death|391
6949867|NCT01001377|10989827|FG001|Overall Study|Death|384
6949868|NCT01001429|10989844|FG000|Overall Study|surgery cancelled|0
6949869|NCT01001429|10989845|FG001|Overall Study|surgery cancelled|1
6949870|NCT01001494|10989915|FG000|Overall Study|Adverse Event|8
6949871|NCT01001494|10989916|FG001|Overall Study|Adverse Event|4
6949872|NCT01001494|10989917|FG002|Overall Study|Adverse Event|6
6949873|NCT01001494|10989915|FG000|Overall Study|Protocol Violation|0
6949874|NCT01001494|10989916|FG001|Overall Study|Protocol Violation|1
6949875|NCT01001494|10989917|FG002|Overall Study|Protocol Violation|1
6949876|NCT01001494|10989915|FG000|Overall Study|Lost to Follow-up|2
6949877|NCT01001494|10989916|FG001|Overall Study|Lost to Follow-up|0
6949878|NCT01001494|10989917|FG002|Overall Study|Lost to Follow-up|1
6949879|NCT01001494|10989915|FG000|Overall Study|Withdrawal by Subject|9
6949880|NCT01001494|10989916|FG001|Overall Study|Withdrawal by Subject|7
6949881|NCT01001494|10989917|FG002|Overall Study|Withdrawal by Subject|17
6949882|NCT01001494|10989915|FG000|Overall Study|COPD exacerbation|3
6949883|NCT01001494|10989916|FG001|Overall Study|COPD exacerbation|4
6949884|NCT01001494|10989917|FG002|Overall Study|COPD exacerbation|5
6949885|NCT01001494|10989915|FG000|Overall Study|Lack of Efficacy|2
6949886|NCT01001494|10989916|FG001|Overall Study|Lack of Efficacy|0
6949887|NCT01001494|10989917|FG002|Overall Study|Lack of Efficacy|8
6949888|NCT01001494|10989915|FG000|Overall Study|Other|0
6949889|NCT01001494|10989916|FG001|Overall Study|Other|1
6949890|NCT01001494|10989917|FG002|Overall Study|Other|3
6949891|NCT01001520|10989925|FG000|Medication Period 1|Withdrawal by Subject|2
7070005|NCT02008227|11172246|FG001|Overall Study|Lost to Follow-up|9
7070006|NCT02008227|11172245|FG000|Overall Study|Death|494
7070007|NCT02008227|11172246|FG001|Overall Study|Death|485
6949892|NCT01001520|10989926|FG001|Medication Period 1|Withdrawal by Subject|2
6949893|NCT01001520|10989925|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0
6949894|NCT01001520|10989926|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3
6949895|NCT01001520|10989925|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0
6949896|NCT01001520|10989926|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2
6949897|NCT01001520|10989925|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2
6949898|NCT01001520|10989926|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0
6949899|NCT01001520|10989925|FG000|Washout Period|Withdrawal by Subject|2
6949900|NCT01001520|10989926|FG001|Washout Period|Withdrawal by Subject|1
6949901|NCT01001520|10989925|FG000|Medication Period 2|Withdrawal by Subject|0
6949902|NCT01001520|10989926|FG001|Medication Period 2|Withdrawal by Subject|3
6949903|NCT01001572|10989955|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32
6949904|NCT01001572|10989956|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
6949905|NCT01001572|10989957|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
6949906|NCT01001572|10989955|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11
6949907|NCT01001572|10989956|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0
6949908|NCT01001572|10989957|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0
6949909|NCT01001572|10989955|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96
6949910|NCT01001572|10989956|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
6949911|NCT01001572|10989957|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
6949912|NCT01001572|10989955|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7
6949913|NCT01001572|10989956|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
6949914|NCT01001572|10989957|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
6949915|NCT01001572|10989955|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1
6949916|NCT01001572|10989956|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
6949917|NCT01001572|10989957|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
6949918|NCT01001572|10989955|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4
6949919|NCT01001572|10989956|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
6949920|NCT01001572|10989957|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
6949921|NCT01001572|10989955|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82
6949922|NCT01001572|10989956|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0
6949923|NCT01001572|10989957|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0
6949924|NCT01001572|10989955|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45
6949925|NCT01001572|10989956|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
6949926|NCT01001572|10989957|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
6949927|NCT01001572|10989955|FG000|Double-Blind Treatment Phase|Adverse Event|0
6949928|NCT01001572|10989956|FG001|Double-Blind Treatment Phase|Adverse Event|2
6949929|NCT01001572|10989957|FG002|Double-Blind Treatment Phase|Adverse Event|2
6949930|NCT01001572|10989955|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0
6949931|NCT01001572|10989956|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8
6949932|NCT01001572|10989957|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13
6949933|NCT01001572|10989955|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
6949934|NCT01001572|10989956|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
6949935|NCT01001572|10989957|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1
6949936|NCT01001572|10989955|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
6949937|NCT01001572|10989956|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
6949938|NCT01001572|10989957|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1
6949939|NCT01001572|10989955|FG000|Double-Blind Treatment Phase|Protocol deviation|0
6949940|NCT01001572|10989956|FG001|Double-Blind Treatment Phase|Protocol deviation|0
6949941|NCT01001572|10989957|FG002|Double-Blind Treatment Phase|Protocol deviation|1
7070008|NCT02008227|11172245|FG000|Overall Study|Withdrawal by Subject|67
7070009|NCT02008227|11172246|FG001|Overall Study|Withdrawal by Subject|36
7070010|NCT02008227|11172245|FG000|Overall Study|Study Terminated By Sponsor|44
6949942|NCT01001572|10989955|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0
6949943|NCT01001572|10989956|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0
6949944|NCT01001572|10989957|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1
6949945|NCT01001598|10989963|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1
6949946|NCT01001598|10989963|FG000|Overall Study|Adverse Event|1
6949947|NCT01001702|10989967|FG000|Overall Study|Lost to Follow-up|7
6949948|NCT01001702|10989967|FG000|Overall Study|Adverse Event|7
6949949|NCT01001702|10989967|FG000|Overall Study|Sponsor Discontinued Study|4
6949950|NCT01001702|10989967|FG000|Overall Study|Subject met Withdrawal Criteria|22
6949951|NCT01001702|10989967|FG000|Overall Study|Investigator withdrew Subject|10
6949952|NCT01001702|10989967|FG000|Overall Study|Withdrawal by Subject|19
6949953|NCT01001702|10989967|FG000|Overall Study|Lack of Efficacy per Investigator|3
6949954|NCT01001767|10989973|FG000|Overall Study|no baseline study performed|1
6949955|NCT01001767|10989974|FG001|Overall Study|no baseline study performed|0
6949956|NCT01001767|10989973|FG000|Overall Study|Protocol Violation|1
6949957|NCT01001767|10989974|FG001|Overall Study|Protocol Violation|0
6949958|NCT01001767|10989973|FG000|Overall Study|Lost to Follow-up|1
6949959|NCT01001767|10989974|FG001|Overall Study|Lost to Follow-up|0
6949960|NCT01001767|10989973|FG000|Overall Study|Physician Decision|1
6949961|NCT01001767|10989974|FG001|Overall Study|Physician Decision|0
6949962|NCT01001832|10989995|FG000|Short-term Period|Adverse Event|2
6949963|NCT01001832|10989996|FG001|Short-term Period|Adverse Event|3
6949964|NCT01001832|10989995|FG000|Long-term Period|Adverse Event|2
6949965|NCT01001832|10989996|FG001|Long-term Period|Adverse Event|1
6949966|NCT01001832|10989995|FG000|Long-term Period|Withdrawal by Subject|1
6949967|NCT01001832|10989996|FG001|Long-term Period|Withdrawal by Subject|0
6949968|NCT01001832|10989995|FG000|Long-term Period|Lack of Efficacy|0
6949969|NCT01001832|10989996|FG001|Long-term Period|Lack of Efficacy|2
6949970|NCT01001832|10989995|FG000|Long-term Period|Other|1
6949971|NCT01001832|10989996|FG001|Long-term Period|Other|2
6949972|NCT01001832|10989995|FG000|Follow-up Period|Withdrawal by Subject|1
6949973|NCT01001832|10989996|FG001|Follow-up Period|Withdrawal by Subject|0
6949974|NCT01001832|10989995|FG000|Follow-up Period|Follow-up no longer required /protocol|15
6949975|NCT01001832|10989996|FG001|Follow-up Period|Follow-up no longer required /protocol|20
6949976|NCT01001832|10989995|FG000|Follow-up Period|Other|2
6949977|NCT01001832|10989996|FG001|Follow-up Period|Other|1
6949978|NCT01001910|10990005|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6
6949979|NCT01001988|10990018|FG000|Overall Study|Protocol Violation|84
6949980|NCT01001988|10990018|FG000|Overall Study|Withdrawal by Subject|18
6949981|NCT01001988|10990018|FG000|Overall Study|Lost to Follow-up|15
6949982|NCT01002105|10990024|FG000|Overall Study|Lost to Follow-up|10
6949983|NCT01002105|10990025|FG001|Overall Study|Lost to Follow-up|16
6949984|NCT01002105|10990024|FG000|Overall Study|non compliance|5
6949985|NCT01002105|10990025|FG001|Overall Study|non compliance|3
6949986|NCT01002105|10990024|FG000|Overall Study|condition worsened|4
6949987|NCT01002105|10990025|FG001|Overall Study|condition worsened|2
6949988|NCT01002339|10990050|FG000|Overall Study|Withdrawal by Subject|0
6949989|NCT01002339|10990051|FG001|Overall Study|Withdrawal by Subject|1
6949990|NCT01002339|10990052|FG002|Overall Study|Withdrawal by Subject|0
6949991|NCT01002339|10990050|FG000|Overall Study|Incorrect treatment assignment|0
6949992|NCT01002339|10990051|FG001|Overall Study|Incorrect treatment assignment|0
6949993|NCT01002339|10990052|FG002|Overall Study|Incorrect treatment assignment|1
6949994|NCT01002339|10990050|FG000|Overall Study|Protocol Violation|0
6949995|NCT01002339|10990051|FG001|Overall Study|Protocol Violation|0
6949996|NCT01002339|10990052|FG002|Overall Study|Protocol Violation|2
7070011|NCT02008227|11172246|FG001|Overall Study|Study Terminated By Sponsor|83
7070012|NCT02008318|11172255|FG000|Overall Study|Adverse Event|4
6949997|NCT01002339|10990050|FG000|Overall Study|Lung cancer detected before transplant|0
6949998|NCT01002339|10990051|FG001|Overall Study|Lung cancer detected before transplant|0
6949999|NCT01002339|10990052|FG002|Overall Study|Lung cancer detected before transplant|1
6950000|NCT01002339|10990050|FG000|Overall Study|Randomized. Not transplanted|0
6950001|NCT01002339|10990051|FG001|Overall Study|Randomized. Not transplanted|0
6950002|NCT01002339|10990052|FG002|Overall Study|Randomized. Not transplanted|1
7070013|NCT02008318|11172256|FG001|Overall Study|Adverse Event|0
7070014|NCT02008318|11172255|FG000|Overall Study|Physician Decision|2
7070015|NCT02008318|11172256|FG001|Overall Study|Physician Decision|0
7070016|NCT02008318|11172255|FG000|Overall Study|Progressive Disease|2
7070017|NCT02008318|11172256|FG001|Overall Study|Progressive Disease|0
7070018|NCT02008318|11172255|FG000|Overall Study|Protocol Violation|1
7070019|NCT02008318|11172256|FG001|Overall Study|Protocol Violation|1
7070020|NCT02008318|11172255|FG000|Overall Study|Withdrawal by Subject|3
7070021|NCT02008318|11172256|FG001|Overall Study|Withdrawal by Subject|0
7070022|NCT02008526|11172268|FG000|Overall Study|Death|0
7070023|NCT02008526|11172269|FG001|Overall Study|Death|2
7070024|NCT02008526|11172270|FG002|Overall Study|Death|1
7070025|NCT02008526|11172268|FG000|Overall Study|Withdrawal by Subject|3
7070026|NCT02008526|11172269|FG001|Overall Study|Withdrawal by Subject|3
7070027|NCT02008526|11172270|FG002|Overall Study|Withdrawal by Subject|2
6950003|NCT01002482|10990073|FG000|Overall Study|Withdrawal by Subject|14
6950004|NCT01002482|10990074|FG001|Overall Study|Withdrawal by Subject|21
6950005|NCT01002482|10990073|FG000|Overall Study|Included twice|1
6950006|NCT01002482|10990074|FG001|Overall Study|Included twice|0
6950007|NCT01002547|10990083|FG000|Overall Study|Withdrawal by Subject|4
6950008|NCT01002547|10990084|FG001|Overall Study|Withdrawal by Subject|0
6950009|NCT01002547|10990085|FG002|Overall Study|Withdrawal by Subject|5
6950010|NCT01002547|10990083|FG000|Overall Study|Lost to Follow-up|2
6950011|NCT01002547|10990084|FG001|Overall Study|Lost to Follow-up|1
6950012|NCT01002547|10990085|FG002|Overall Study|Lost to Follow-up|1
6950013|NCT01002547|10990083|FG000|Overall Study|Physician Decision|1
6950014|NCT01002547|10990084|FG001|Overall Study|Physician Decision|0
6950015|NCT01002547|10990085|FG002|Overall Study|Physician Decision|0
6950016|NCT01002547|10990083|FG000|Overall Study|Death|0
6950017|NCT01002547|10990084|FG001|Overall Study|Death|2
6950018|NCT01002547|10990085|FG002|Overall Study|Death|2
6950019|NCT01002547|10990083|FG000|Overall Study|Adverse Event|1
6950020|NCT01002547|10990084|FG001|Overall Study|Adverse Event|0
6950021|NCT01002547|10990085|FG002|Overall Study|Adverse Event|0
6950022|NCT01002573|10990095|FG000|Overall Study|Subject did not receive at least 1 dose|11
6950023|NCT01002573|10990096|FG001|Overall Study|Subject did not receive at least 1 dose|7
7070028|NCT02008526|11172268|FG000|Overall Study|Lost to Follow-up|5
7070029|NCT02008526|11172269|FG001|Overall Study|Lost to Follow-up|9
7070030|NCT02008526|11172270|FG002|Overall Study|Lost to Follow-up|6
7070031|NCT02008565|11172282|FG000|Overall Study|Protocol Violation|1
7070032|NCT02008565|11172283|FG001|Overall Study|Protocol Violation|1
7070033|NCT02008565|11172284|FG002|Overall Study|Protocol Violation|2
7070034|NCT02008565|11172285|FG003|Overall Study|Protocol Violation|0
7070035|NCT02008773|11172319|FG000|Overall Study|Adverse Event|3
7070036|NCT02008773|11172320|FG001|Overall Study|Adverse Event|3
7070037|NCT02008773|11172321|FG002|Overall Study|Adverse Event|1
7070038|NCT02008773|11172322|FG003|Overall Study|Adverse Event|2
7070039|NCT02008773|11172319|FG000|Overall Study|Medication Non-compliance|2
7070040|NCT02008773|11172320|FG001|Overall Study|Medication Non-compliance|1
7070041|NCT02008773|11172321|FG002|Overall Study|Medication Non-compliance|3
7070042|NCT02008773|11172322|FG003|Overall Study|Medication Non-compliance|2
7070043|NCT02008773|11172319|FG000|Overall Study|Withdrawal by Subject|8
7070044|NCT02008773|11172320|FG001|Overall Study|Withdrawal by Subject|4
6950024|NCT01002742|10990104|FG000|Overall Study|Determined to be ineligible|0
6950025|NCT01002742|10990105|FG001|Overall Study|Determined to be ineligible|1
6950026|NCT01002989|10990115|FG000|Overall Study|exclusion criteria, no consent|5
7070045|NCT02008773|11172321|FG002|Overall Study|Withdrawal by Subject|7
7070046|NCT02008773|11172322|FG003|Overall Study|Withdrawal by Subject|6
7070047|NCT02008773|11172319|FG000|Overall Study|Lost to Follow-up|0
7070048|NCT02008773|11172320|FG001|Overall Study|Lost to Follow-up|1
7070049|NCT02008773|11172321|FG002|Overall Study|Lost to Follow-up|3
7070050|NCT02008773|11172322|FG003|Overall Study|Lost to Follow-up|2
7070051|NCT02008877|11172330|FG000|Overall Study|Inevaluable|0
7070052|NCT02008877|11172331|FG001|Overall Study|Inevaluable|1
7070053|NCT02008877|11172332|FG002|Overall Study|Inevaluable|0
7070054|NCT02008890|11172344|FG000|Period 1|Withdrawal by Subject|7
7070055|NCT02008890|11172345|FG001|Period 1|Withdrawal by Subject|7
7070056|NCT02008890|11172346|FG002|Period 1|Withdrawal by Subject|5
7070057|NCT02008890|11172347|FG003|Period 1|Withdrawal by Subject|0
7070058|NCT02008890|11172348|FG004|Period 1|Withdrawal by Subject|0
7070059|NCT02008890|11172344|FG000|Period 1|Pregnancy|1
7070060|NCT02008890|11172345|FG001|Period 1|Pregnancy|0
7070061|NCT02008890|11172346|FG002|Period 1|Pregnancy|0
7070062|NCT02008890|11172347|FG003|Period 1|Pregnancy|0
7070063|NCT02008890|11172348|FG004|Period 1|Pregnancy|0
7070064|NCT02008890|11172344|FG000|Period 1|Physician Decision|1
7070065|NCT02008890|11172345|FG001|Period 1|Physician Decision|0
7070066|NCT02008890|11172346|FG002|Period 1|Physician Decision|1
7070067|NCT02008890|11172347|FG003|Period 1|Physician Decision|0
7070068|NCT02008890|11172348|FG004|Period 1|Physician Decision|0
7070069|NCT02008890|11172344|FG000|Period 1|Adverse Event|6
7070070|NCT02008890|11172345|FG001|Period 1|Adverse Event|8
7070071|NCT02008890|11172346|FG002|Period 1|Adverse Event|6
7070072|NCT02008890|11172347|FG003|Period 1|Adverse Event|0
7070073|NCT02008890|11172348|FG004|Period 1|Adverse Event|0
7070074|NCT02008890|11172344|FG000|Period 2|Adverse Event|12
7070075|NCT02008890|11172345|FG001|Period 2|Adverse Event|7
7070076|NCT02008890|11172346|FG002|Period 2|Adverse Event|0
7070077|NCT02008890|11172347|FG003|Period 2|Adverse Event|5
7070078|NCT02008890|11172348|FG004|Period 2|Adverse Event|5
7070079|NCT02008890|11172344|FG000|Period 2|Withdrawal by Subject|11
7070080|NCT02008890|11172345|FG001|Period 2|Withdrawal by Subject|8
7070081|NCT02008890|11172346|FG002|Period 2|Withdrawal by Subject|0
7070082|NCT02008890|11172347|FG003|Period 2|Withdrawal by Subject|7
7070083|NCT02008890|11172348|FG004|Period 2|Withdrawal by Subject|2
7070084|NCT02008890|11172344|FG000|Period 2|Physician Decision|4
7070085|NCT02008890|11172345|FG001|Period 2|Physician Decision|0
7070086|NCT02008890|11172346|FG002|Period 2|Physician Decision|0
7070087|NCT02008890|11172347|FG003|Period 2|Physician Decision|2
7070088|NCT02008890|11172348|FG004|Period 2|Physician Decision|1
7070089|NCT02008890|11172344|FG000|Period 2|Lost to Follow-up|0
7070090|NCT02008890|11172345|FG001|Period 2|Lost to Follow-up|0
7070091|NCT02008890|11172346|FG002|Period 2|Lost to Follow-up|1
7070092|NCT02008890|11172347|FG003|Period 2|Lost to Follow-up|0
7070093|NCT02008890|11172348|FG004|Period 2|Lost to Follow-up|0
7070094|NCT02008890|11172344|FG000|Extension Period|Withdrawal by Subject|3
7070095|NCT02008890|11172345|FG001|Extension Period|Withdrawal by Subject|2
7070096|NCT02008890|11172346|FG002|Extension Period|Withdrawal by Subject|0
7070097|NCT02008890|11172347|FG003|Extension Period|Withdrawal by Subject|4
6838418|NCT00259012|10844160|FG001|Overall Study|Adverse Event|1
6838419|NCT00259012|10844159|FG000|Overall Study|Withdrawal by Subject|1
7070098|NCT02008890|11172348|FG004|Extension Period|Withdrawal by Subject|2
7070099|NCT02008890|11172344|FG000|Extension Period|Lost to Follow-up|1
7070100|NCT02008890|11172345|FG001|Extension Period|Lost to Follow-up|0
7070101|NCT02008890|11172346|FG002|Extension Period|Lost to Follow-up|0
7070102|NCT02008890|11172347|FG003|Extension Period|Lost to Follow-up|0
7070103|NCT02008890|11172348|FG004|Extension Period|Lost to Follow-up|0
7070104|NCT02008890|11172344|FG000|Extension Period|Adverse Event|1
7070105|NCT02008890|11172345|FG001|Extension Period|Adverse Event|3
7070106|NCT02008890|11172346|FG002|Extension Period|Adverse Event|0
7070107|NCT02008890|11172347|FG003|Extension Period|Adverse Event|0
7070108|NCT02008890|11172348|FG004|Extension Period|Adverse Event|2
7070109|NCT02008916|11172366|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0
7070110|NCT02008916|11172367|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1
7070111|NCT02008916|11172368|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3
7070112|NCT02008916|11172366|FG000|Week 16 - 156|Adverse Event|4
7070113|NCT02008916|11172367|FG001|Week 16 - 156|Adverse Event|2
7070114|NCT02008916|11172368|FG002|Week 16 - 156|Adverse Event|3
7070115|NCT02008916|11172366|FG000|Week 16 - 156|Withdrawal by Subject|7
6838420|NCT00259012|10844160|FG001|Overall Study|Withdrawal by Subject|0
7070116|NCT02008916|11172367|FG001|Week 16 - 156|Withdrawal by Subject|3
7070117|NCT02008916|11172368|FG002|Week 16 - 156|Withdrawal by Subject|5
6838421|NCT00259012|10844159|FG000|Overall Study|Physician Decision|0
7070118|NCT02008916|11172366|FG000|Week 16 - 156|No longer requires treatment|0
7070119|NCT02008916|11172367|FG001|Week 16 - 156|No longer requires treatment|1
7070120|NCT02008916|11172368|FG002|Week 16 - 156|No longer requires treatment|0
7070121|NCT02008916|11172366|FG000|Week 16 - 156|Lost to Follow-up|5
7070122|NCT02008916|11172367|FG001|Week 16 - 156|Lost to Follow-up|0
7070123|NCT02008916|11172368|FG002|Week 16 - 156|Lost to Follow-up|0
6950027|NCT01003184|10990164|FG000|Overall Study|Adverse Event|12
6950028|NCT01003184|10990165|FG001|Overall Study|Adverse Event|5
6950029|NCT01003184|10990164|FG000|Overall Study|Lost to Follow-up|1
6950030|NCT01003184|10990165|FG001|Overall Study|Lost to Follow-up|0
6950031|NCT01003184|10990164|FG000|Overall Study|Loss of glucose control|1
6950032|NCT01003184|10990165|FG001|Overall Study|Loss of glucose control|1
6950033|NCT01003184|10990164|FG000|Overall Study|Protocol Violation|3
6950034|NCT01003184|10990165|FG001|Overall Study|Protocol Violation|0
6950035|NCT01003184|10990164|FG000|Overall Study|Withdrawal by Subject|1
6950036|NCT01003184|10990165|FG001|Overall Study|Withdrawal by Subject|6
6950037|NCT01003184|10990164|FG000|Overall Study|Physician Decision|1
6950038|NCT01003184|10990165|FG001|Overall Study|Physician Decision|0
6950039|NCT01003210|10990173|FG000|Overall Study|Lost to Follow-up|1
6950040|NCT01003210|10990174|FG001|Overall Study|Lost to Follow-up|3
6950041|NCT01003249|10990180|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1
6950042|NCT01003249|10990181|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1
6950043|NCT01003249|10990180|FG000|First Intervention (4 Weeks)|Non-Serious Event|1
6950044|NCT01003249|10990181|FG001|First Intervention (4 Weeks)|Non-Serious Event|1
6950045|NCT01003249|10990180|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0
6950046|NCT01003249|10990181|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1
6950047|NCT01003249|10990180|FG000|Second Intervention (4 Weeks)|Adverse Event|1
6950048|NCT01003249|10990181|FG001|Second Intervention (4 Weeks)|Adverse Event|0
6950049|NCT01003639|10990227|FG000|Overall Study|Lost to Follow-up|6
6950050|NCT01003639|10990228|FG001|Overall Study|Lost to Follow-up|9
6950051|NCT01003639|10990227|FG000|Overall Study|Withdrawal by Subject|9
6950052|NCT01003639|10990228|FG001|Overall Study|Withdrawal by Subject|5
6950053|NCT01003639|10990227|FG000|Overall Study|Lack of Efficacy|1
6950054|NCT01003639|10990228|FG001|Overall Study|Lack of Efficacy|6
6950055|NCT01003639|10990227|FG000|Overall Study|Adverse Event|0
6950056|NCT01003639|10990228|FG001|Overall Study|Adverse Event|1
6950057|NCT01003639|10990227|FG000|Overall Study|Protocol Violation|0
6950058|NCT01003639|10990228|FG001|Overall Study|Protocol Violation|1
6950059|NCT01003639|10990227|FG000|Overall Study|Physician Decision|1
6950060|NCT01003639|10990228|FG001|Overall Study|Physician Decision|0
6950061|NCT01003886|10990238|FG000|Overall Study|Lack of Efficacy|5
6950062|NCT01003886|10990238|FG000|Overall Study|Lost to Follow-up|169
6950063|NCT01003886|10990238|FG000|Overall Study|Withdrawal by Subject|39
6950064|NCT01003886|10990238|FG000|Overall Study|Other|14
6950065|NCT01003886|10990238|FG000|Overall Study|Adverse Event|3
6950066|NCT01003899|10990242|FG000|Overall Study|Other Adverse Event|8
6950067|NCT01003899|10990242|FG000|Overall Study|Not entered|4
6950068|NCT01003899|10990242|FG000|Overall Study|Not treated|1
6950069|NCT01003899|10990242|FG000|Overall Study|Progressive disease|34
6950070|NCT01003990|10990253|FG000|Overall Study|Adverse Event|8
6950071|NCT01003990|10990254|FG001|Overall Study|Adverse Event|5
6950072|NCT01003990|10990255|FG002|Overall Study|Adverse Event|11
6950073|NCT01003990|10990253|FG000|Overall Study|Death|0
6950074|NCT01003990|10990254|FG001|Overall Study|Death|8
6950075|NCT01003990|10990255|FG002|Overall Study|Death|1
6950076|NCT01003990|10990253|FG000|Overall Study|Lack of Efficacy|10
6950077|NCT01003990|10990254|FG001|Overall Study|Lack of Efficacy|2
6950078|NCT01003990|10990255|FG002|Overall Study|Lack of Efficacy|3
6950079|NCT01003990|10990253|FG000|Overall Study|Lost to Follow-up|30
6950080|NCT01003990|10990254|FG001|Overall Study|Lost to Follow-up|12
6950081|NCT01003990|10990255|FG002|Overall Study|Lost to Follow-up|7
6950082|NCT01003990|10990253|FG000|Overall Study|Reasons Not Identified|14
6950083|NCT01003990|10990254|FG001|Overall Study|Reasons Not Identified|13
6950084|NCT01003990|10990255|FG002|Overall Study|Reasons Not Identified|8
7070124|NCT02008916|11172366|FG000|Week 16 - 156|Lack of Efficacy|3
7070125|NCT02008916|11172367|FG001|Week 16 - 156|Lack of Efficacy|5
7070126|NCT02008916|11172368|FG002|Week 16 - 156|Lack of Efficacy|2
7070127|NCT02008916|11172366|FG000|Week 16 - 156|Pregnancy|0
7070128|NCT02008916|11172367|FG001|Week 16 - 156|Pregnancy|1
7070129|NCT02008916|11172368|FG002|Week 16 - 156|Pregnancy|0
7070130|NCT02008916|11172366|FG000|Week 16 - 156|Physician Decision|0
7070131|NCT02008916|11172367|FG001|Week 16 - 156|Physician Decision|1
7070132|NCT02008916|11172368|FG002|Week 16 - 156|Physician Decision|0
7070133|NCT02009046|11172386|FG000|Overall Study|Lost to Follow-up|256
7070134|NCT02009046|11172387|FG001|Overall Study|Lost to Follow-up|206
7082640|NCT02143713|11193213|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
7082641|NCT02143713|11193214|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10
7082642|NCT02143713|11193211|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0
7082643|NCT02143713|11193212|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0
7082644|NCT02143713|11193213|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1
7082645|NCT02143713|11193214|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0
7082646|NCT02143713|11193211|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3
7082647|NCT02143713|11193212|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8
7082648|NCT02143713|11193213|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11
7082649|NCT02143713|11193214|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8
6950085|NCT01003990|10990253|FG000|Overall Study|Poor/Non-compliance|4
6950086|NCT01003990|10990254|FG001|Overall Study|Poor/Non-compliance|3
6950087|NCT01003990|10990255|FG002|Overall Study|Poor/Non-compliance|2
6950088|NCT01003990|10990253|FG000|Overall Study|Pregnancy|10
6950089|NCT01003990|10990254|FG001|Overall Study|Pregnancy|2
7070135|NCT02009163|11172401|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48
7070136|NCT02009163|11172402|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
7070137|NCT02009163|11172403|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
7070138|NCT02009163|11172401|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29
7070139|NCT02009163|11172402|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0
7070140|NCT02009163|11172403|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0
6950090|NCT01003990|10990255|FG002|Overall Study|Pregnancy|4
6950091|NCT01003990|10990253|FG000|Overall Study|No Longer Met Study Criteria|4
6950092|NCT01003990|10990254|FG001|Overall Study|No Longer Met Study Criteria|1
6950093|NCT01003990|10990255|FG002|Overall Study|No Longer Met Study Criteria|0
6950094|NCT01003990|10990253|FG000|Overall Study|Subject Withdrew Consent|12
6950095|NCT01003990|10990254|FG001|Overall Study|Subject Withdrew Consent|5
6950096|NCT01003990|10990255|FG002|Overall Study|Subject Withdrew Consent|7
6950097|NCT01004003|10990272|FG000|Overall Study|Progressive disease|2
6950098|NCT01004003|10990273|FG001|Overall Study|Progressive disease|1
6950099|NCT01004003|10990274|FG002|Overall Study|Progressive disease|1
6950100|NCT01004003|10990275|FG003|Overall Study|Progressive disease|0
6950101|NCT01004003|10990276|FG004|Overall Study|Progressive disease|2
6950102|NCT01004003|10990277|FG005|Overall Study|Progressive disease|1
6950103|NCT01004003|10990278|FG006|Overall Study|Progressive disease|1
6950104|NCT01004003|10990279|FG007|Overall Study|Progressive disease|39
6950105|NCT01004003|10990280|FG008|Overall Study|Progressive disease|22
6950106|NCT01004003|10990272|FG000|Overall Study|Adverse Event|4
6950107|NCT01004003|10990273|FG001|Overall Study|Adverse Event|2
6950108|NCT01004003|10990274|FG002|Overall Study|Adverse Event|3
6950109|NCT01004003|10990275|FG003|Overall Study|Adverse Event|3
6950110|NCT01004003|10990276|FG004|Overall Study|Adverse Event|2
6950111|NCT01004003|10990277|FG005|Overall Study|Adverse Event|2
6950112|NCT01004003|10990278|FG006|Overall Study|Adverse Event|7
6950113|NCT01004003|10990279|FG007|Overall Study|Adverse Event|21
6950114|NCT01004003|10990280|FG008|Overall Study|Adverse Event|6
6950115|NCT01004003|10990272|FG000|Overall Study|Refused to continue taking trial med.|0
6950116|NCT01004003|10990273|FG001|Overall Study|Refused to continue taking trial med.|0
6950117|NCT01004003|10990274|FG002|Overall Study|Refused to continue taking trial med.|0
6950118|NCT01004003|10990275|FG003|Overall Study|Refused to continue taking trial med.|0
6950119|NCT01004003|10990276|FG004|Overall Study|Refused to continue taking trial med.|0
6950120|NCT01004003|10990277|FG005|Overall Study|Refused to continue taking trial med.|0
6950121|NCT01004003|10990278|FG006|Overall Study|Refused to continue taking trial med.|0
6950122|NCT01004003|10990279|FG007|Overall Study|Refused to continue taking trial med.|0
6950123|NCT01004003|10990280|FG008|Overall Study|Refused to continue taking trial med.|2
6950124|NCT01004003|10990272|FG000|Overall Study|Other|0
6950125|NCT01004003|10990273|FG001|Overall Study|Other|0
6950126|NCT01004003|10990274|FG002|Overall Study|Other|0
6950127|NCT01004003|10990275|FG003|Overall Study|Other|0
6950128|NCT01004003|10990276|FG004|Overall Study|Other|0
6950129|NCT01004003|10990277|FG005|Overall Study|Other|1
6950130|NCT01004003|10990278|FG006|Overall Study|Other|0
6950131|NCT01004003|10990279|FG007|Overall Study|Other|0
6950132|NCT01004003|10990280|FG008|Overall Study|Other|0
6950133|NCT01004146|10990341|FG000|Overall Study|Withdrawal by Subject|4
6950134|NCT01004146|10990342|FG001|Overall Study|Withdrawal by Subject|5
6950135|NCT01004159|10990348|FG000|Overall Study|Adverse Event|2
6950136|NCT01004159|10990348|FG000|Overall Study|Disease Progression|18
6950137|NCT01004172|10990352|FG000|Overall Study|Progressive Disease in CNS Only|16
6950138|NCT01004172|10990352|FG000|Overall Study|Progressive Disease in Non-CNS Only|16
6950139|NCT01004172|10990352|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2
6950140|NCT01004172|10990352|FG000|Overall Study|Adverse Event|1
6950141|NCT01004172|10990352|FG000|Overall Study|Physician Decision|1
6950142|NCT01004172|10990352|FG000|Overall Study|Symptomatic Deterioration|2
6950143|NCT01004185|10990359|FG000|Overall Study|Adverse Event|1
6950144|NCT01004185|10990360|FG001|Overall Study|Adverse Event|1
6950145|NCT01004185|10990359|FG000|Overall Study|Lost to Follow-up|0
6950146|NCT01004185|10990360|FG001|Overall Study|Lost to Follow-up|1
6950147|NCT01004185|10990359|FG000|Overall Study|Lack of Efficacy|2
6950148|NCT01004185|10990360|FG001|Overall Study|Lack of Efficacy|1
6950149|NCT01004185|10990359|FG000|Overall Study|Sponsor Terminated Study|4
6950150|NCT01004185|10990360|FG001|Overall Study|Sponsor Terminated Study|5
6950151|NCT01004185|10990359|FG000|Overall Study|Withdrawal by Subject|2
6950152|NCT01004185|10990360|FG001|Overall Study|Withdrawal by Subject|1
6950153|NCT01004250|10990366|FG000|Induction Therapy Period|Adverse Event|10
6950154|NCT01004250|10990366|FG000|Induction Therapy Period|Entry Criteria Not Met|1
7070141|NCT02009163|11172401|FG000|Open-label Period (Non-randomized)|Adverse Event|22
6950155|NCT01004250|10990366|FG000|Induction Therapy Period|Withdrawal by Subject|2
6950156|NCT01004250|10990366|FG000|Induction Therapy Period|Physician Decision|2
6950157|NCT01004250|10990366|FG000|Maintenance Therapy Period|Adverse Event|15
6950158|NCT01004250|10990366|FG000|Maintenance Therapy Period|Lost to Follow-up|1
6950159|NCT01004250|10990366|FG000|Maintenance Therapy Period|Protocol Violation|1
6950160|NCT01004250|10990366|FG000|Maintenance Therapy Period|Withdrawal by Subject|5
6950161|NCT01004250|10990366|FG000|Maintenance Therapy Period|Physician Decision|4
6950162|NCT01004250|10990366|FG000|Follow-Up (FU) Period|Lost to Follow-up|1
6976001|NCT01196091|11028328|FG002|Overall Study|Excluded Site|8
6950163|NCT01004406|10990384|FG000|Overall Study|Withdrawal by Subject|2
6950164|NCT01004406|10990385|FG001|Overall Study|Withdrawal by Subject|0
6950165|NCT01004406|10990384|FG000|Overall Study|Lost to Follow-up|1
6950166|NCT01004406|10990385|FG001|Overall Study|Lost to Follow-up|0
6950167|NCT01004432|10990391|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20
6950168|NCT01004432|10990392|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
6950169|NCT01004432|10990393|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
6950170|NCT01004432|10990394|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
6950171|NCT01004432|10990395|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
6950172|NCT01004432|10990391|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29
6950173|NCT01004432|10990392|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
6950174|NCT01004432|10990393|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
6950175|NCT01004432|10990394|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
6950176|NCT01004432|10990395|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
6950177|NCT01004432|10990391|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17
6950178|NCT01004432|10990392|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
6950179|NCT01004432|10990393|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
6950180|NCT01004432|10990394|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
6950181|NCT01004432|10990395|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
6950182|NCT01004432|10990391|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15
6950183|NCT01004432|10990392|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
6950184|NCT01004432|10990393|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
6950185|NCT01004432|10990394|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
6950186|NCT01004432|10990395|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
6950187|NCT01004432|10990391|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2
6950188|NCT01004432|10990392|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
6950189|NCT01004432|10990393|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
6950190|NCT01004432|10990394|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
6950191|NCT01004432|10990395|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
6950192|NCT01004432|10990391|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
6950193|NCT01004432|10990392|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1
6950194|NCT01004432|10990393|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5
6950195|NCT01004432|10990394|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6
6950196|NCT01004432|10990395|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
6950197|NCT01004432|10990391|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
6950198|NCT01004432|10990392|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
6950199|NCT01004432|10990393|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
6950200|NCT01004432|10990394|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4
6950201|NCT01004432|10990395|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
6950202|NCT01004432|10990391|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
6950203|NCT01004432|10990392|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1
6950204|NCT01004432|10990393|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4
6950205|NCT01004432|10990394|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7
6950206|NCT01004432|10990395|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
6950207|NCT01004432|10990391|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
6950208|NCT01004432|10990392|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
6950209|NCT01004432|10990393|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
6950210|NCT01004432|10990394|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1
6950211|NCT01004432|10990395|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
6950212|NCT01004432|10990391|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
6950213|NCT01004432|10990392|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2
6950214|NCT01004432|10990393|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24
6950215|NCT01004432|10990394|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37
6950216|NCT01004432|10990395|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
6950217|NCT01004432|10990391|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
6950218|NCT01004432|10990392|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
6950219|NCT01004432|10990393|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1
6950220|NCT01004432|10990394|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
6950221|NCT01004432|10990395|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
6950222|NCT01004432|10990391|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0
6950223|NCT01004432|10990392|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0
6950224|NCT01004432|10990393|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0
6950225|NCT01004432|10990394|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0
6950226|NCT01004432|10990395|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2
6950227|NCT01004432|10990391|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0
6950228|NCT01004432|10990392|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0
6950229|NCT01004432|10990393|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0
6950230|NCT01004432|10990394|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0
6950231|NCT01004432|10990395|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4
6950232|NCT01004432|10990391|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
6950233|NCT01004432|10990392|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
6950234|NCT01004432|10990393|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
6950235|NCT01004432|10990394|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
6950236|NCT01004432|10990395|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2
6950237|NCT01004432|10990391|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
6950238|NCT01004432|10990392|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
6950239|NCT01004432|10990393|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
6950240|NCT01004432|10990394|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
6950241|NCT01004432|10990395|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10
6950242|NCT01004614|10990413|FG000|Washout|Withdrawal by Subject|0
7070142|NCT02009163|11172402|FG001|Open-label Period (Non-randomized)|Adverse Event|0
7070143|NCT02009163|11172403|FG002|Open-label Period (Non-randomized)|Adverse Event|0
7070144|NCT02009163|11172401|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20
7070145|NCT02009163|11172402|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0
7070146|NCT02009163|11172403|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0
7070147|NCT02009163|11172401|FG000|Open-label Period (Non-randomized)|Protocol Violation|10
7070148|NCT02009163|11172402|FG001|Open-label Period (Non-randomized)|Protocol Violation|0
7070149|NCT02009163|11172403|FG002|Open-label Period (Non-randomized)|Protocol Violation|0
7070150|NCT02009163|11172401|FG000|Open-label Period (Non-randomized)|Pregnancy|1
7070151|NCT02009163|11172402|FG001|Open-label Period (Non-randomized)|Pregnancy|0
6950243|NCT01004614|10990414|FG001|Washout|Withdrawal by Subject|1
6950244|NCT01004614|10990415|FG002|Washout|Withdrawal by Subject|0
6950245|NCT01004614|10990416|FG003|Washout|Withdrawal by Subject|0
6950246|NCT01004822|10990473|FG000|Overall Study|Objective progression or relapse|3
6950247|NCT01004822|10990474|FG001|Overall Study|Objective progression or relapse|3
6950248|NCT01004822|10990475|FG002|Overall Study|Objective progression or relapse|0
6950249|NCT01004822|10990476|FG003|Overall Study|Objective progression or relapse|1
6950250|NCT01004822|10990477|FG004|Overall Study|Objective progression or relapse|2
6950251|NCT01004822|10990478|FG005|Overall Study|Objective progression or relapse|2
6950252|NCT01004822|10990479|FG006|Overall Study|Objective progression or relapse|1
6950253|NCT01004822|10990480|FG007|Overall Study|Objective progression or relapse|4
6950254|NCT01004822|10990473|FG000|Overall Study|Global deterioration of health status|0
6950255|NCT01004822|10990474|FG001|Overall Study|Global deterioration of health status|0
6950256|NCT01004822|10990475|FG002|Overall Study|Global deterioration of health status|0
6950257|NCT01004822|10990476|FG003|Overall Study|Global deterioration of health status|1
6950258|NCT01004822|10990477|FG004|Overall Study|Global deterioration of health status|0
6950259|NCT01004822|10990478|FG005|Overall Study|Global deterioration of health status|0
6950260|NCT01004822|10990479|FG006|Overall Study|Global deterioration of health status|1
6950261|NCT01004822|10990480|FG007|Overall Study|Global deterioration of health status|0
6950262|NCT01004822|10990473|FG000|Overall Study|No longer willing to continue|0
6950263|NCT01004822|10990474|FG001|Overall Study|No longer willing to continue|0
6950264|NCT01004822|10990475|FG002|Overall Study|No longer willing to continue|0
6950265|NCT01004822|10990476|FG003|Overall Study|No longer willing to continue|1
6950266|NCT01004822|10990477|FG004|Overall Study|No longer willing to continue|2
6950267|NCT01004822|10990478|FG005|Overall Study|No longer willing to continue|1
6950268|NCT01004822|10990479|FG006|Overall Study|No longer willing to continue|1
6950269|NCT01004822|10990480|FG007|Overall Study|No longer willing to continue|0
6950270|NCT01004822|10990473|FG000|Overall Study|Adverse Event|0
6950271|NCT01004822|10990474|FG001|Overall Study|Adverse Event|0
6950272|NCT01004822|10990475|FG002|Overall Study|Adverse Event|0
6950273|NCT01004822|10990476|FG003|Overall Study|Adverse Event|0
6950274|NCT01004822|10990477|FG004|Overall Study|Adverse Event|0
6950275|NCT01004822|10990478|FG005|Overall Study|Adverse Event|0
6950276|NCT01004822|10990479|FG006|Overall Study|Adverse Event|1
6950277|NCT01004822|10990480|FG007|Overall Study|Adverse Event|1
6950278|NCT01004822|10990473|FG000|Overall Study|Other|0
6950279|NCT01004822|10990474|FG001|Overall Study|Other|0
6950280|NCT01004822|10990475|FG002|Overall Study|Other|4
6950281|NCT01004822|10990476|FG003|Overall Study|Other|1
6950282|NCT01004822|10990477|FG004|Overall Study|Other|0
6950283|NCT01004822|10990478|FG005|Overall Study|Other|1
6950284|NCT01004822|10990479|FG006|Overall Study|Other|0
6950285|NCT01004822|10990480|FG007|Overall Study|Other|0
6950286|NCT01004848|10990502|FG000|Overall Study|Lost to Follow-up|55
6950287|NCT01004848|10990503|FG001|Overall Study|Lost to Follow-up|45
6950288|NCT01005251|10990526|FG000|Overall Study|Withdrawal by Subject|2
6950289|NCT01005251|10990527|FG001|Overall Study|Withdrawal by Subject|5
6950290|NCT01005251|10990528|FG002|Overall Study|Withdrawal by Subject|3
6950291|NCT01005251|10990529|FG003|Overall Study|Withdrawal by Subject|4
6950292|NCT01005251|10990530|FG004|Overall Study|Withdrawal by Subject|9
6950293|NCT01005251|10990526|FG000|Overall Study|Eligibility criteria not fulfilled|4
6950294|NCT01005251|10990527|FG001|Overall Study|Eligibility criteria not fulfilled|0
6950295|NCT01005251|10990528|FG002|Overall Study|Eligibility criteria not fulfilled|4
6950296|NCT01005251|10990529|FG003|Overall Study|Eligibility criteria not fulfilled|1
6950297|NCT01005251|10990530|FG004|Overall Study|Eligibility criteria not fulfilled|0
7070152|NCT02009163|11172403|FG002|Open-label Period (Non-randomized)|Pregnancy|0
7070153|NCT02009163|11172401|FG000|Open-label Period (Non-randomized)|Other|13
7070154|NCT02009163|11172402|FG001|Open-label Period (Non-randomized)|Other|0
7070155|NCT02009163|11172403|FG002|Open-label Period (Non-randomized)|Other|0
7070156|NCT02009163|11172401|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0
7070157|NCT02009163|11172402|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25
7070158|NCT02009163|11172403|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9
7070159|NCT02009163|11172401|FG000|Randomized-withdrawal Period|Lost to Follow-up|0
7070160|NCT02009163|11172402|FG001|Randomized-withdrawal Period|Lost to Follow-up|13
7070161|NCT02009163|11172403|FG002|Randomized-withdrawal Period|Lost to Follow-up|6
7070162|NCT02009163|11172401|FG000|Randomized-withdrawal Period|Adverse Event|0
7070163|NCT02009163|11172402|FG001|Randomized-withdrawal Period|Adverse Event|0
7070164|NCT02009163|11172403|FG002|Randomized-withdrawal Period|Adverse Event|6
7070165|NCT02009163|11172401|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0
7070166|NCT02009163|11172402|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40
7070167|NCT02009163|11172403|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5
7070168|NCT02009163|11172401|FG000|Randomized-withdrawal Period|Protocol Violation|0
7070169|NCT02009163|11172402|FG001|Randomized-withdrawal Period|Protocol Violation|1
7070170|NCT02009163|11172403|FG002|Randomized-withdrawal Period|Protocol Violation|2
7070171|NCT02009163|11172401|FG000|Randomized-withdrawal Period|Pregnancy|0
7070172|NCT02009163|11172402|FG001|Randomized-withdrawal Period|Pregnancy|0
7070173|NCT02009163|11172403|FG002|Randomized-withdrawal Period|Pregnancy|2
7070174|NCT02009163|11172401|FG000|Randomized-withdrawal Period|Other|0
7070175|NCT02009163|11172402|FG001|Randomized-withdrawal Period|Other|9
7070176|NCT02009163|11172403|FG002|Randomized-withdrawal Period|Other|5
7070177|NCT02009332|11172419|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0
7070178|NCT02009332|11172420|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1
7070179|NCT02009332|11172421|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0
7070180|NCT02009332|11172422|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0
7070181|NCT02009332|11172423|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0
7070182|NCT02009332|11172424|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0
7070183|NCT02009332|11172419|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0
7070184|NCT02009332|11172420|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0
7070185|NCT02009332|11172421|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0
7070186|NCT02009332|11172422|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0
7070187|NCT02009332|11172423|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1
7070188|NCT02009332|11172424|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0
7070189|NCT02009332|11172419|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0
7070190|NCT02009332|11172420|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0
7070191|NCT02009332|11172421|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0
7070192|NCT02009332|11172422|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0
7070193|NCT02009332|11172423|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0
7070194|NCT02009332|11172424|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1
7070195|NCT02009397|11172438|FG000|Overall Study|Protocol Violation|6
7070196|NCT02009397|11172438|FG000|Overall Study|Death|8
7070197|NCT02009397|11172438|FG000|Overall Study|Lost to Follow-up|6
7070198|NCT02009696|11172451|FG000|Overall Study|Withdrawal by Subject|2
6950298|NCT01005251|10990526|FG000|Overall Study|Adverse Event|2
6950299|NCT01005251|10990527|FG001|Overall Study|Adverse Event|6
6950300|NCT01005251|10990528|FG002|Overall Study|Adverse Event|8
6950301|NCT01005251|10990529|FG003|Overall Study|Adverse Event|5
6950302|NCT01005251|10990530|FG004|Overall Study|Adverse Event|4
6950303|NCT01005251|10990526|FG000|Overall Study|Protocol Violation|1
6950304|NCT01005251|10990527|FG001|Overall Study|Protocol Violation|0
6950305|NCT01005251|10990528|FG002|Overall Study|Protocol Violation|0
6950306|NCT01005251|10990529|FG003|Overall Study|Protocol Violation|0
6950307|NCT01005251|10990530|FG004|Overall Study|Protocol Violation|2
6950308|NCT01005251|10990526|FG000|Overall Study|Developed study-specific withdrawal crit|2
6950309|NCT01005251|10990527|FG001|Overall Study|Developed study-specific withdrawal crit|0
6950310|NCT01005251|10990528|FG002|Overall Study|Developed study-specific withdrawal crit|3
6950311|NCT01005251|10990529|FG003|Overall Study|Developed study-specific withdrawal crit|0
6950312|NCT01005251|10990530|FG004|Overall Study|Developed study-specific withdrawal crit|1
6950313|NCT01005251|10990526|FG000|Overall Study|Lost to Follow-up|1
6950314|NCT01005251|10990527|FG001|Overall Study|Lost to Follow-up|4
6950315|NCT01005251|10990528|FG002|Overall Study|Lost to Follow-up|2
6950316|NCT01005251|10990529|FG003|Overall Study|Lost to Follow-up|0
6950317|NCT01005251|10990530|FG004|Overall Study|Lost to Follow-up|0
6950318|NCT01005251|10990526|FG000|Overall Study|Physician Decision|0
7070199|NCT02009722|11172457|FG000|Overall Study|Protocol Violation|1
7070200|NCT02009722|11172458|FG001|Overall Study|Protocol Violation|2
7070201|NCT02009722|11172457|FG000|Overall Study|Did not receive intervention|0
7070202|NCT02009722|11172458|FG001|Overall Study|Did not receive intervention|1
7070203|NCT02009865|11172466|FG000|Overall Study|Adverse Event|0
7070204|NCT02009865|11172467|FG001|Overall Study|Adverse Event|2
7070205|NCT02009865|11172466|FG000|Overall Study|Protocol Violation|0
6950319|NCT01005251|10990527|FG001|Overall Study|Physician Decision|0
6950320|NCT01005251|10990528|FG002|Overall Study|Physician Decision|0
6950321|NCT01005251|10990529|FG003|Overall Study|Physician Decision|0
6950322|NCT01005251|10990530|FG004|Overall Study|Physician Decision|2
6950323|NCT01005251|10990526|FG000|Overall Study|Patient moved|1
6950324|NCT01005251|10990527|FG001|Overall Study|Patient moved|0
6950325|NCT01005251|10990528|FG002|Overall Study|Patient moved|0
6950326|NCT01005251|10990529|FG003|Overall Study|Patient moved|0
6950327|NCT01005251|10990530|FG004|Overall Study|Patient moved|0
6950328|NCT01005251|10990526|FG000|Overall Study|Wrong drug dispensed|0
6950329|NCT01005251|10990527|FG001|Overall Study|Wrong drug dispensed|1
6950330|NCT01005251|10990528|FG002|Overall Study|Wrong drug dispensed|0
6950331|NCT01005251|10990529|FG003|Overall Study|Wrong drug dispensed|0
6950332|NCT01005251|10990530|FG004|Overall Study|Wrong drug dispensed|0
6950333|NCT01005251|10990526|FG000|Overall Study|Randomized in error|0
6950334|NCT01005251|10990527|FG001|Overall Study|Randomized in error|0
6950335|NCT01005251|10990528|FG002|Overall Study|Randomized in error|1
6950336|NCT01005251|10990529|FG003|Overall Study|Randomized in error|1
6950337|NCT01005251|10990530|FG004|Overall Study|Randomized in error|0
6950338|NCT01005251|10990526|FG000|Overall Study|Lack of Efficacy|0
6950339|NCT01005251|10990527|FG001|Overall Study|Lack of Efficacy|0
6950340|NCT01005251|10990528|FG002|Overall Study|Lack of Efficacy|1
6950341|NCT01005251|10990529|FG003|Overall Study|Lack of Efficacy|1
6950342|NCT01005251|10990530|FG004|Overall Study|Lack of Efficacy|0
6950343|NCT01005316|10990554|FG000|Overall Study|Adverse Event|0
6950344|NCT01005316|10990555|FG001|Overall Study|Adverse Event|0
6950345|NCT01005316|10990556|FG002|Overall Study|Adverse Event|0
6950346|NCT01005316|10990557|FG003|Overall Study|Adverse Event|1
6950347|NCT01005316|10990554|FG000|Overall Study|Death|20
6950348|NCT01005316|10990555|FG001|Overall Study|Death|5
6950349|NCT01005316|10990556|FG002|Overall Study|Death|1
6950350|NCT01005316|10990557|FG003|Overall Study|Death|15
6950351|NCT01005316|10990554|FG000|Overall Study|Study Termination|5
6950352|NCT01005316|10990555|FG001|Overall Study|Study Termination|63
6950353|NCT01005316|10990556|FG002|Overall Study|Study Termination|9
6950354|NCT01005316|10990557|FG003|Overall Study|Study Termination|85
6950355|NCT01005316|10990554|FG000|Overall Study|Lost to Follow-up|1
6950356|NCT01005316|10990555|FG001|Overall Study|Lost to Follow-up|3
6950357|NCT01005316|10990556|FG002|Overall Study|Lost to Follow-up|0
6950358|NCT01005316|10990557|FG003|Overall Study|Lost to Follow-up|2
6950359|NCT01005316|10990554|FG000|Overall Study|Physician Decision|6
6950360|NCT01005316|10990555|FG001|Overall Study|Physician Decision|0
6950361|NCT01005316|10990556|FG002|Overall Study|Physician Decision|0
6950362|NCT01005316|10990557|FG003|Overall Study|Physician Decision|0
6950363|NCT01005316|10990554|FG000|Overall Study|Sponsor Decision|6
6950364|NCT01005316|10990555|FG001|Overall Study|Sponsor Decision|3
6950365|NCT01005316|10990556|FG002|Overall Study|Sponsor Decision|0
6950366|NCT01005316|10990557|FG003|Overall Study|Sponsor Decision|0
6950367|NCT01005316|10990554|FG000|Overall Study|Withdrawal by Subject|1
6950368|NCT01005316|10990555|FG001|Overall Study|Withdrawal by Subject|1
6950369|NCT01005316|10990556|FG002|Overall Study|Withdrawal by Subject|0
6950370|NCT01005316|10990557|FG003|Overall Study|Withdrawal by Subject|2
6950371|NCT01005316|10990554|FG000|Overall Study|Consented to Another Study|2
6950372|NCT01005316|10990555|FG001|Overall Study|Consented to Another Study|0
6950373|NCT01005316|10990556|FG002|Overall Study|Consented to Another Study|0
6950374|NCT01005316|10990557|FG003|Overall Study|Consented to Another Study|0
6950375|NCT01005316|10990554|FG000|Overall Study|Delisted|8
6950376|NCT01005316|10990555|FG001|Overall Study|Delisted|0
6950377|NCT01005316|10990556|FG002|Overall Study|Delisted|0
6950378|NCT01005316|10990557|FG003|Overall Study|Delisted|0
6950379|NCT01005316|10990554|FG000|Overall Study|Transferred Care|1
6950380|NCT01005316|10990555|FG001|Overall Study|Transferred Care|0
6950381|NCT01005316|10990556|FG002|Overall Study|Transferred Care|1
6950382|NCT01005316|10990557|FG003|Overall Study|Transferred Care|3
6950383|NCT01005316|10990554|FG000|Overall Study|Retransplanted|0
6950384|NCT01005316|10990555|FG001|Overall Study|Retransplanted|1
6950385|NCT01005316|10990556|FG002|Overall Study|Retransplanted|0
6950386|NCT01005316|10990557|FG003|Overall Study|Retransplanted|0
6950387|NCT01005329|10990568|FG000|Overall Study|Ineligible or received no protocol trt.|4
6950388|NCT01005602|10990613|FG000|Overall Study|Excluded due to unreliable clinical data|1
6950389|NCT01005602|10990614|FG001|Overall Study|Excluded due to unreliable clinical data|0
6950390|NCT01005680|10990629|FG000|Overall Study|Lost to Follow-up|4
6950391|NCT01005680|10990630|FG001|Overall Study|Lost to Follow-up|6
6950392|NCT01005680|10990629|FG000|Overall Study|Withdrawal by Subject|1
6950393|NCT01005680|10990630|FG001|Overall Study|Withdrawal by Subject|4
6950394|NCT01005680|10990629|FG000|Overall Study|Physician Decision|1
6950395|NCT01005680|10990630|FG001|Overall Study|Physician Decision|1
6950396|NCT01005719|10990646|FG000|Period 1|Adverse Event|0
6950397|NCT01005719|10990647|FG001|Period 1|Adverse Event|0
6950398|NCT01005719|10990648|FG002|Period 1|Adverse Event|0
6950399|NCT01005719|10990649|FG003|Period 1|Adverse Event|1
6950400|NCT01005719|10990650|FG004|Period 1|Adverse Event|0
6950401|NCT01005719|10990651|FG005|Period 1|Adverse Event|0
6950402|NCT01005719|10990646|FG000|Period 1|Delay in completing study procedures|0
6950403|NCT01005719|10990647|FG001|Period 1|Delay in completing study procedures|0
6950404|NCT01005719|10990648|FG002|Period 1|Delay in completing study procedures|0
6950405|NCT01005719|10990649|FG003|Period 1|Delay in completing study procedures|0
6950406|NCT01005719|10990650|FG004|Period 1|Delay in completing study procedures|0
6950407|NCT01005719|10990651|FG005|Period 1|Delay in completing study procedures|1
6950408|NCT01005719|10990646|FG000|Period 2|Adverse Event|0
6950409|NCT01005719|10990647|FG001|Period 2|Adverse Event|0
6950410|NCT01005719|10990648|FG002|Period 2|Adverse Event|0
6950411|NCT01005719|10990649|FG003|Period 2|Adverse Event|0
6950412|NCT01005719|10990650|FG004|Period 2|Adverse Event|1
6950413|NCT01005719|10990651|FG005|Period 2|Adverse Event|1
6950414|NCT01005732|10990660|FG000|Overall Study|Lost to Follow-up|10
6950415|NCT01005732|10990660|FG000|Overall Study|Death|1
6950416|NCT01005875|10990677|FG000|Overall Study|Death|3
6950417|NCT01005901|10990694|FG000|Overall Study|Withdrawal by Subject|38
6950418|NCT01005901|10990695|FG001|Overall Study|Withdrawal by Subject|14
6950419|NCT01005901|10990694|FG000|Overall Study|Adverse Event|30
6950420|NCT01005901|10990695|FG001|Overall Study|Adverse Event|16
6950421|NCT01005901|10990694|FG000|Overall Study|Administrative problems|21
6950422|NCT01005901|10990695|FG001|Overall Study|Administrative problems|13
6950423|NCT01005901|10990694|FG000|Overall Study|Unsatisfactory therapeutic effect|5
6950424|NCT01005901|10990695|FG001|Overall Study|Unsatisfactory therapeutic effect|5
6950425|NCT01005901|10990694|FG000|Overall Study|Protocol Violation|4
6950426|NCT01005901|10990695|FG001|Overall Study|Protocol Violation|3
6950427|NCT01005901|10990694|FG000|Overall Study|Death|2
6950428|NCT01005901|10990695|FG001|Overall Study|Death|3
6950429|NCT01005901|10990694|FG000|Overall Study|Lost to Follow-up|1
6950430|NCT01005901|10990695|FG001|Overall Study|Lost to Follow-up|2
6950431|NCT01005901|10990694|FG000|Overall Study|Patient's inability to use the device|1
6950432|NCT01005901|10990695|FG001|Overall Study|Patient's inability to use the device|1
6950433|NCT01005901|10990694|FG000|Overall Study|No longer requires study drug|0
6950434|NCT01005901|10990695|FG001|Overall Study|No longer requires study drug|1
6950435|NCT01005966|10990701|FG000|Treatment Period 1 (14 Days)|Adverse Event|1
6950436|NCT01005966|10990702|FG001|Treatment Period 1 (14 Days)|Adverse Event|0
6950437|NCT01005966|10990703|FG002|Treatment Period 1 (14 Days)|Adverse Event|0
6950438|NCT01005966|10990704|FG003|Treatment Period 1 (14 Days)|Adverse Event|0
6950439|NCT01005966|10990705|FG004|Treatment Period 1 (14 Days)|Adverse Event|0
6950440|NCT01005966|10990701|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1
6950441|NCT01005966|10990702|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0
6950442|NCT01005966|10990703|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1
6950443|NCT01005966|10990704|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0
6950444|NCT01005966|10990705|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0
6950445|NCT01005966|10990701|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0
6950446|NCT01005966|10990702|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0
6950447|NCT01005966|10990703|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0
6950448|NCT01005966|10990704|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1
6950449|NCT01005966|10990705|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0
6950450|NCT01005966|10990701|FG000|Treatment Period 2 (14 Days)|Adverse Event|0
6950451|NCT01005966|10990702|FG001|Treatment Period 2 (14 Days)|Adverse Event|1
6950452|NCT01005966|10990703|FG002|Treatment Period 2 (14 Days)|Adverse Event|1
6950453|NCT01005966|10990704|FG003|Treatment Period 2 (14 Days)|Adverse Event|0
6950454|NCT01005966|10990705|FG004|Treatment Period 2 (14 Days)|Adverse Event|0
6950455|NCT01005966|10990701|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0
6950456|NCT01005966|10990702|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0
6950457|NCT01005966|10990703|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0
6950458|NCT01005966|10990704|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1
6950459|NCT01005966|10990705|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0
6950460|NCT01005966|10990701|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
6950461|NCT01005966|10990702|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
6950462|NCT01005966|10990703|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1
6950463|NCT01005966|10990704|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
6950464|NCT01005966|10990705|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
6950465|NCT01005966|10990701|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0
6950466|NCT01005966|10990702|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1
6950467|NCT01005966|10990703|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0
6950468|NCT01005966|10990704|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0
6950469|NCT01005966|10990705|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1
6950470|NCT01005966|10990701|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0
6950471|NCT01005966|10990702|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1
6950472|NCT01005966|10990703|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0
6950473|NCT01005966|10990704|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0
6950474|NCT01005966|10990705|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0
6950475|NCT01005966|10990701|FG000|Treatment Period 4 (14 Days)|Other Reason|0
6950476|NCT01005966|10990702|FG001|Treatment Period 4 (14 Days)|Other Reason|0
6950477|NCT01005966|10990703|FG002|Treatment Period 4 (14 Days)|Other Reason|0
6950478|NCT01005966|10990704|FG003|Treatment Period 4 (14 Days)|Other Reason|0
6950479|NCT01005966|10990705|FG004|Treatment Period 4 (14 Days)|Other Reason|1
6950480|NCT01006122|10990722|FG000|First Double-blind Intervention Period|Lost to Follow-up|0
6950481|NCT01006122|10990723|FG001|First Double-blind Intervention Period|Lost to Follow-up|2
6950482|NCT01006122|10990722|FG000|First Double-blind Intervention Period|Protocol Violation|1
6950483|NCT01006122|10990723|FG001|First Double-blind Intervention Period|Protocol Violation|1
6950484|NCT01006122|10990722|FG000|First Double-blind Intervention Period|Pregnancy|0
6950485|NCT01006122|10990723|FG001|First Double-blind Intervention Period|Pregnancy|1
6950486|NCT01006122|10990722|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9
6950487|NCT01006122|10990723|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8
6950488|NCT01006122|10990722|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1
6950489|NCT01006122|10990723|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0
6950490|NCT01006122|10990722|FG000|First Double-blind Intervention Period|Lack of Efficacy|2
6950491|NCT01006122|10990723|FG001|First Double-blind Intervention Period|Lack of Efficacy|1
6950492|NCT01006122|10990722|FG000|First Double-blind Intervention Period|Other|3
6950493|NCT01006122|10990723|FG001|First Double-blind Intervention Period|Other|0
6950494|NCT01006122|10990722|FG000|First Double-blind Intervention Period|Adverse Event|0
6950495|NCT01006122|10990723|FG001|First Double-blind Intervention Period|Adverse Event|4
6950496|NCT01006122|10990722|FG000|Second Double-blind Intervention Period|Adverse Event|1
6950497|NCT01006122|10990723|FG001|Second Double-blind Intervention Period|Adverse Event|1
6950498|NCT01006122|10990722|FG000|Second Double-blind Intervention Period|Protocol Violation|1
6950499|NCT01006122|10990723|FG001|Second Double-blind Intervention Period|Protocol Violation|0
6950500|NCT01006122|10990722|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0
6950501|NCT01006122|10990723|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3
6950502|NCT01006122|10990722|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0
6950503|NCT01006122|10990723|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2
6950504|NCT01006122|10990722|FG000|Second Double-blind Intervention Period|Death|0
6950505|NCT01006122|10990723|FG001|Second Double-blind Intervention Period|Death|1
6950506|NCT01006135|10990729|FG000|Overall Study|Adverse Event|22
6950507|NCT01006135|10990729|FG000|Overall Study|Protocol Violation|14
6950508|NCT01006135|10990729|FG000|Overall Study|Lost to Follow-up|32
6950509|NCT01006135|10990729|FG000|Overall Study|Other|72
6950510|NCT01006291|10990749|FG000|Overall Study|Adverse Event|2
6950511|NCT01006291|10990750|FG001|Overall Study|Adverse Event|1
6950512|NCT01006291|10990751|FG002|Overall Study|Adverse Event|2
6950513|NCT01006291|10990749|FG000|Overall Study|Lack of Efficacy|2
6950514|NCT01006291|10990750|FG001|Overall Study|Lack of Efficacy|2
6950515|NCT01006291|10990751|FG002|Overall Study|Lack of Efficacy|1
6950516|NCT01006291|10990749|FG000|Overall Study|Protocol Violation|3
6950517|NCT01006291|10990750|FG001|Overall Study|Protocol Violation|3
6950518|NCT01006291|10990751|FG002|Overall Study|Protocol Violation|3
6950519|NCT01006291|10990749|FG000|Overall Study|Withdrawal criteria|5
6950520|NCT01006291|10990750|FG001|Overall Study|Withdrawal criteria|4
6950521|NCT01006291|10990751|FG002|Overall Study|Withdrawal criteria|4
6950522|NCT01006291|10990749|FG000|Overall Study|Other|14
6950523|NCT01006291|10990750|FG001|Overall Study|Other|14
6950524|NCT01006291|10990751|FG002|Overall Study|Other|17
6950525|NCT01006356|10990759|FG000|Overall Study|Adverse Event|6
6950526|NCT01006356|10990759|FG000|Overall Study|Physician Decision|1
6950527|NCT01006356|10990759|FG000|Overall Study|Paticipants did not cooperate|6
6950528|NCT01006356|10990759|FG000|Overall Study|Withdrawal by Subject|1
6950529|NCT01006356|10990759|FG000|Overall Study|Choice by participants|2
6950530|NCT01006356|10990759|FG000|Overall Study|Protocol Violation|3
6950531|NCT01006356|10990759|FG000|Overall Study|Other|23
6950532|NCT01006590|10990782|FG000|Overall Study|Adverse Event|2
6950533|NCT01006590|10990783|FG001|Overall Study|Adverse Event|3
6950534|NCT01006590|10990782|FG000|Overall Study|Death|1
6950535|NCT01006590|10990783|FG001|Overall Study|Death|1
6950536|NCT01006590|10990782|FG000|Overall Study|Lost to Follow-up|1
6950537|NCT01006590|10990783|FG001|Overall Study|Lost to Follow-up|1
6950538|NCT01006590|10990782|FG000|Overall Study|Protocol Violation|1
6950539|NCT01006590|10990783|FG001|Overall Study|Protocol Violation|0
6950540|NCT01006590|10990782|FG000|Overall Study|Withdrawal by Subject|4
6950541|NCT01006590|10990783|FG001|Overall Study|Withdrawal by Subject|2
6950542|NCT01006590|10990782|FG000|Overall Study|Study specific discontinuation criteria|16
6950543|NCT01006590|10990783|FG001|Overall Study|Study specific discontinuation criteria|23
6950544|NCT01006590|10990782|FG000|Overall Study|Other|3
6950545|NCT01006590|10990783|FG001|Overall Study|Other|2
6950546|NCT01006603|10990791|FG000|Overall Study|Withdrawal by Subject|17
6950547|NCT01006603|10990792|FG001|Overall Study|Withdrawal by Subject|19
6950548|NCT01006603|10990791|FG000|Overall Study|Lost to Follow-up|0
6950549|NCT01006603|10990792|FG001|Overall Study|Lost to Follow-up|1
6950550|NCT01006603|10990791|FG000|Overall Study|Safety reason|1
6950551|NCT01006603|10990792|FG001|Overall Study|Safety reason|1
6950552|NCT01006603|10990791|FG000|Overall Study|Protocol Violation|1
6950553|NCT01006603|10990792|FG001|Overall Study|Protocol Violation|3
6950554|NCT01006603|10990791|FG000|Overall Study|Incorrect enrolment|0
6950555|NCT01006603|10990792|FG001|Overall Study|Incorrect enrolment|2
6950556|NCT01006603|10990791|FG000|Overall Study|Adverse Event|15
7040798|NCT01720524|11124007|FG001|Part A|Adverse Event|2
7040799|NCT01720524|11124006|FG000|Part A|Death|2
7040800|NCT01720524|11124007|FG001|Part A|Death|1
7040801|NCT01720524|11124006|FG000|Part A|Lost to Follow-up|0
7040802|NCT01720524|11124007|FG001|Part A|Lost to Follow-up|1
7040803|NCT01720524|11124006|FG000|Part A|Missed 28 day follow-up visit|1
7040804|NCT01720524|11124007|FG001|Part A|Missed 28 day follow-up visit|1
7040805|NCT01720524|11124006|FG000|Part A|Withdrawal by Subject|0
7040806|NCT01720524|11124007|FG001|Part A|Withdrawal by Subject|1
6950557|NCT01006603|10990792|FG001|Overall Study|Adverse Event|7
6950558|NCT01006603|10990791|FG000|Overall Study|Death|1
6950559|NCT01006603|10990792|FG001|Overall Study|Death|1
7040807|NCT01720524|11124006|FG000|Part A|Other|0
6950560|NCT01006603|10990791|FG000|Overall Study|Study specific discontinuation criteria|33
6950561|NCT01006603|10990792|FG001|Overall Study|Study specific discontinuation criteria|34
6950562|NCT01006603|10990791|FG000|Overall Study|Other|3
6950563|NCT01006603|10990792|FG001|Overall Study|Other|7
6950564|NCT01006616|10990802|FG000|Period 1 (6 Months)|Adverse Event|10
6950565|NCT01006616|10990803|FG001|Period 1 (6 Months)|Adverse Event|31
6950566|NCT01006616|10990804|FG002|Period 1 (6 Months)|Adverse Event|37
6950567|NCT01006616|10990805|FG003|Period 1 (6 Months)|Adverse Event|9
6950568|NCT01006616|10990802|FG000|Period 1 (6 Months)|Lack of Efficacy|3
6950569|NCT01006616|10990803|FG001|Period 1 (6 Months)|Lack of Efficacy|4
6950570|NCT01006616|10990804|FG002|Period 1 (6 Months)|Lack of Efficacy|0
6950571|NCT01006616|10990805|FG003|Period 1 (6 Months)|Lack of Efficacy|4
6950572|NCT01006616|10990802|FG000|Period 1 (6 Months)|Lost to Follow-up|0
6950573|NCT01006616|10990803|FG001|Period 1 (6 Months)|Lost to Follow-up|0
6950574|NCT01006616|10990804|FG002|Period 1 (6 Months)|Lost to Follow-up|1
6950575|NCT01006616|10990805|FG003|Period 1 (6 Months)|Lost to Follow-up|0
6950576|NCT01006616|10990802|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6
6950577|NCT01006616|10990803|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5
6950578|NCT01006616|10990804|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2
6950579|NCT01006616|10990805|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3
6950580|NCT01006616|10990802|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0
6950581|NCT01006616|10990803|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3
6950582|NCT01006616|10990804|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1
6950583|NCT01006616|10990805|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2
6950584|NCT01006616|10990802|FG000|Period 1 (6 Months)|Withdrawal by Subject|2
6950585|NCT01006616|10990803|FG001|Period 1 (6 Months)|Withdrawal by Subject|2
6950586|NCT01006616|10990804|FG002|Period 1 (6 Months)|Withdrawal by Subject|2
6950587|NCT01006616|10990805|FG003|Period 1 (6 Months)|Withdrawal by Subject|0
6950588|NCT01006616|10990802|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
6950589|NCT01006616|10990803|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7
6950590|NCT01006616|10990804|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
6950591|NCT01006616|10990805|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
6950592|NCT01006616|10990802|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0
6950593|NCT01006616|10990803|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2
6950594|NCT01006616|10990804|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2
6950595|NCT01006616|10990805|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3
6950596|NCT01006616|10990802|FG000|Period 1 (6 Months)|Not Treated|0
6950597|NCT01006616|10990803|FG001|Period 1 (6 Months)|Not Treated|0
6950598|NCT01006616|10990804|FG002|Period 1 (6 Months)|Not Treated|1
6950599|NCT01006616|10990805|FG003|Period 1 (6 Months)|Not Treated|1
6950600|NCT01006616|10990802|FG000|Period 2 (18 Months)|Adverse Event|6
6950601|NCT01006616|10990803|FG001|Period 2 (18 Months)|Adverse Event|6
6950602|NCT01006616|10990804|FG002|Period 2 (18 Months)|Adverse Event|6
6950603|NCT01006616|10990805|FG003|Period 2 (18 Months)|Adverse Event|4
6950604|NCT01006616|10990802|FG000|Period 2 (18 Months)|Lack of Efficacy|0
6950605|NCT01006616|10990803|FG001|Period 2 (18 Months)|Lack of Efficacy|0
6950606|NCT01006616|10990804|FG002|Period 2 (18 Months)|Lack of Efficacy|1
6950607|NCT01006616|10990805|FG003|Period 2 (18 Months)|Lack of Efficacy|2
6950608|NCT01006616|10990802|FG000|Period 2 (18 Months)|Lost to Follow-up|2
6950609|NCT01006616|10990803|FG001|Period 2 (18 Months)|Lost to Follow-up|0
6950610|NCT01006616|10990804|FG002|Period 2 (18 Months)|Lost to Follow-up|0
6950611|NCT01006616|10990805|FG003|Period 2 (18 Months)|Lost to Follow-up|0
6950612|NCT01006616|10990802|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
6950613|NCT01006616|10990803|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0
6950614|NCT01006616|10990804|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
6950615|NCT01006616|10990805|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2
6950616|NCT01006616|10990802|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0
6950617|NCT01006616|10990803|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6
6950618|NCT01006616|10990804|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1
6950619|NCT01006616|10990805|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2
6950620|NCT01006616|10990802|FG000|Period 2 (18 Months)|Withdrawal by Subject|1
6950621|NCT01006616|10990803|FG001|Period 2 (18 Months)|Withdrawal by Subject|4
6950622|NCT01006616|10990804|FG002|Period 2 (18 Months)|Withdrawal by Subject|0
6950623|NCT01006616|10990805|FG003|Period 2 (18 Months)|Withdrawal by Subject|1
6950624|NCT01006616|10990802|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0
6950625|NCT01006616|10990803|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1
6950626|NCT01006616|10990804|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0
6950627|NCT01006616|10990805|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1
6950628|NCT01006616|10990802|FG000|Period 2 (18 Months)|Study Terminated|63
6950629|NCT01006616|10990803|FG001|Period 2 (18 Months)|Study Terminated|46
6950630|NCT01006616|10990804|FG002|Period 2 (18 Months)|Study Terminated|44
6950631|NCT01006616|10990805|FG003|Period 2 (18 Months)|Study Terminated|70
6950632|NCT01006629|10990815|FG000|Overall Study|Adverse Event|1
6950633|NCT01006629|10990815|FG000|Overall Study|Parent refused to continue participation|1
6950634|NCT01006629|10990815|FG000|Overall Study|Parent unable to perform site visit|4
6950635|NCT01006707|10990828|FG000|Study Session 1|Lost to Follow-up|2
6950636|NCT01006707|10990829|FG001|Study Session 1|Lost to Follow-up|0
6950637|NCT01006707|10990830|FG002|Study Session 1|Lost to Follow-up|0
6950638|NCT01006707|10990828|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3
6950639|NCT01006707|10990829|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0
6950640|NCT01006707|10990830|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0
6950641|NCT01006889|10990838|FG000|Overall Study|Withdrawal by Subject|3
6950642|NCT01006980|10990856|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1
6950643|NCT01006980|10990857|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45
6950644|NCT01006980|10990856|FG000|Vemurafenib and Dacarbazine|Adverse Event|25
6950645|NCT01006980|10990857|FG001|Vemurafenib and Dacarbazine|Adverse Event|5
6950646|NCT01006980|10990856|FG000|Vemurafenib and Dacarbazine|Death|13
6950647|NCT01006980|10990857|FG001|Vemurafenib and Dacarbazine|Death|12
6950648|NCT01006980|10990856|FG000|Vemurafenib and Dacarbazine|Progression|257
6950649|NCT01006980|10990857|FG001|Vemurafenib and Dacarbazine|Progression|218
6950650|NCT01006980|10990856|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4
6950651|NCT01006980|10990857|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6
6950652|NCT01006980|10990856|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9
6950653|NCT01006980|10990857|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6
6950654|NCT01006980|10990856|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2
6950655|NCT01006980|10990857|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3
6950656|NCT01006980|10990856|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26
6950657|NCT01006980|10990857|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43
6950658|NCT01006980|10990856|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0
6950659|NCT01006980|10990857|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4
6950660|NCT01006980|10990856|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0
6950661|NCT01006980|10990857|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4
6950662|NCT01006980|10990856|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0
6950663|NCT01006980|10990857|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65
6950664|NCT01006980|10990856|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0
6950665|NCT01006980|10990857|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1
6950666|NCT01006980|10990856|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0
6950667|NCT01006980|10990857|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10
6950668|NCT01007032|10990868|FG000|Overall Study|On Study Treatment at Cut-off Date|0
6950669|NCT01007032|10990869|FG001|Overall Study|On Study Treatment at Cut-off Date|1
6950670|NCT01007032|10990870|FG002|Overall Study|On Study Treatment at Cut-off Date|1
6950671|NCT01007032|10990871|FG003|Overall Study|On Study Treatment at Cut-off Date|0
6950672|NCT01007032|10990868|FG000|Overall Study|Withdrawal by Subject|0
6950673|NCT01007032|10990869|FG001|Overall Study|Withdrawal by Subject|0
6950674|NCT01007032|10990870|FG002|Overall Study|Withdrawal by Subject|0
6950675|NCT01007032|10990871|FG003|Overall Study|Withdrawal by Subject|1
6950676|NCT01007123|10990910|FG000|Overall Study|Adverse Event|3
6950677|NCT01007123|10990911|FG001|Overall Study|Adverse Event|4
6950678|NCT01007123|10990912|FG002|Overall Study|Adverse Event|7
6950679|NCT01007123|10990913|FG003|Overall Study|Adverse Event|1
6950680|NCT01007123|10990910|FG000|Overall Study|Lack of Efficacy|1
6950681|NCT01007123|10990911|FG001|Overall Study|Lack of Efficacy|0
6950682|NCT01007123|10990912|FG002|Overall Study|Lack of Efficacy|1
6950683|NCT01007123|10990913|FG003|Overall Study|Lack of Efficacy|4
6950684|NCT01007123|10990910|FG000|Overall Study|Protocol Violation|1
6950685|NCT01007123|10990911|FG001|Overall Study|Protocol Violation|1
6950686|NCT01007123|10990912|FG002|Overall Study|Protocol Violation|2
6950687|NCT01007123|10990913|FG003|Overall Study|Protocol Violation|1
6950688|NCT01007123|10990910|FG000|Overall Study|Withdrawal by Subject|1
6950689|NCT01007123|10990911|FG001|Overall Study|Withdrawal by Subject|0
6950690|NCT01007123|10990912|FG002|Overall Study|Withdrawal by Subject|1
6950691|NCT01007123|10990913|FG003|Overall Study|Withdrawal by Subject|0
6950692|NCT01007123|10990910|FG000|Overall Study|Lost to Follow-up|0
6950693|NCT01007123|10990911|FG001|Overall Study|Lost to Follow-up|1
6950694|NCT01007123|10990912|FG002|Overall Study|Lost to Follow-up|0
6950695|NCT01007123|10990913|FG003|Overall Study|Lost to Follow-up|0
6950696|NCT01007149|10990946|FG000|Overall Study|Administrative problems|0
6950697|NCT01007149|10990947|FG001|Overall Study|Administrative problems|1
6950698|NCT01007253|10990953|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1
6950699|NCT01007253|10990954|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0
6950700|NCT01007253|10990955|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0
6950701|NCT01007253|10990956|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0
6950702|NCT01007396|10990966|FG000|Overall Study|Lost to Follow-up|47
6950703|NCT01007435|10990974|FG000|Overall Study|Adverse Event|16
6950704|NCT01007435|10990975|FG001|Overall Study|Adverse Event|25
6950705|NCT01007435|10990976|FG002|Overall Study|Adverse Event|47
6950706|NCT01007435|10990977|FG003|Overall Study|Adverse Event|31
6950707|NCT01007435|10990974|FG000|Overall Study|Death|2
6950708|NCT01007435|10990975|FG001|Overall Study|Death|4
6950709|NCT01007435|10990976|FG002|Overall Study|Death|2
6950710|NCT01007435|10990977|FG003|Overall Study|Death|1
6950711|NCT01007435|10990974|FG000|Overall Study|Insufficient Therapeutic Response|21
6950712|NCT01007435|10990975|FG001|Overall Study|Insufficient Therapeutic Response|7
6950713|NCT01007435|10990976|FG002|Overall Study|Insufficient Therapeutic Response|2
6950714|NCT01007435|10990977|FG003|Overall Study|Insufficient Therapeutic Response|9
6950715|NCT01007435|10990974|FG000|Overall Study|Violation of Selection Criteria at Entry|3
6950716|NCT01007435|10990975|FG001|Overall Study|Violation of Selection Criteria at Entry|5
6950717|NCT01007435|10990976|FG002|Overall Study|Violation of Selection Criteria at Entry|2
6950718|NCT01007435|10990977|FG003|Overall Study|Violation of Selection Criteria at Entry|0
6950719|NCT01007435|10990974|FG000|Overall Study|Other Protocol Violation|2
6950720|NCT01007435|10990975|FG001|Overall Study|Other Protocol Violation|0
6950721|NCT01007435|10990976|FG002|Overall Study|Other Protocol Violation|1
6950722|NCT01007435|10990977|FG003|Overall Study|Other Protocol Violation|0
6950723|NCT01007435|10990974|FG000|Overall Study|Refused Treatment|13
6950724|NCT01007435|10990975|FG001|Overall Study|Refused Treatment|13
6950725|NCT01007435|10990976|FG002|Overall Study|Refused Treatment|5
6950726|NCT01007435|10990977|FG003|Overall Study|Refused Treatment|8
6950727|NCT01007435|10990974|FG000|Overall Study|Failure to Return|5
6950728|NCT01007435|10990975|FG001|Overall Study|Failure to Return|4
6950729|NCT01007435|10990976|FG002|Overall Study|Failure to Return|3
6950730|NCT01007435|10990977|FG003|Overall Study|Failure to Return|6
6950731|NCT01007435|10990974|FG000|Overall Study|Reason not Specified|1
6950732|NCT01007435|10990975|FG001|Overall Study|Reason not Specified|1
6950733|NCT01007435|10990976|FG002|Overall Study|Reason not Specified|2
6950734|NCT01007435|10990977|FG003|Overall Study|Reason not Specified|1
6950735|NCT01007448|10990989|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1
6950736|NCT01007448|10990990|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0
6950737|NCT01007448|10990989|FG000|Overall Study|Staph Skin Infection Flare|1
6950738|NCT01007448|10990990|FG001|Overall Study|Staph Skin Infection Flare|0
6950739|NCT01007448|10990989|FG000|Overall Study|Participant Leaving the Country|1
6950740|NCT01007448|10990990|FG001|Overall Study|Participant Leaving the Country|0
6950741|NCT01007448|10990989|FG000|Overall Study|Participant Given Prohibited Medication|1
6950742|NCT01007448|10990990|FG001|Overall Study|Participant Given Prohibited Medication|0
6950743|NCT01007448|10990989|FG000|Overall Study|Progressive Disease|1
6950744|NCT01007448|10990990|FG001|Overall Study|Progressive Disease|2
6950745|NCT01007448|10990989|FG000|Overall Study|Lack of Efficacy|2
6950746|NCT01007448|10990990|FG001|Overall Study|Lack of Efficacy|0
6950747|NCT01007448|10990989|FG000|Overall Study|Withdrawal by Subject|2
6950748|NCT01007448|10990990|FG001|Overall Study|Withdrawal by Subject|3
6950749|NCT01007448|10990989|FG000|Overall Study|Adverse Event|1
6950750|NCT01007448|10990990|FG001|Overall Study|Adverse Event|4
6950751|NCT01007552|10991000|FG000|Overall Study|Withdrawal by Subject|1
6950752|NCT01007812|10991026|FG000|Period 1, One Week|Lost to Follow-up|0
6950753|NCT01007812|10991027|FG001|Period 1, One Week|Lost to Follow-up|1
6950754|NCT01007812|10991026|FG000|Period 1, One Week|Discomfort|1
6950755|NCT01007812|10991027|FG001|Period 1, One Week|Discomfort|0
6950756|NCT01007838|10991037|FG000|Overall Study|Withdrawal by Subject|1
6950757|NCT01007838|10991038|FG001|Overall Study|Withdrawal by Subject|0
6950758|NCT01007838|10991039|FG002|Overall Study|Withdrawal by Subject|0
6950759|NCT01007838|10991040|FG003|Overall Study|Withdrawal by Subject|0
6950760|NCT01007838|10991037|FG000|Overall Study|Physician Decision|1
6950761|NCT01007838|10991038|FG001|Overall Study|Physician Decision|0
6950762|NCT01007838|10991039|FG002|Overall Study|Physician Decision|0
6950763|NCT01007838|10991040|FG003|Overall Study|Physician Decision|0
6950764|NCT01007838|10991037|FG000|Overall Study|Started home haemodialysis|1
6950765|NCT01007838|10991038|FG001|Overall Study|Started home haemodialysis|0
6950766|NCT01007838|10991039|FG002|Overall Study|Started home haemodialysis|0
6950767|NCT01007838|10991040|FG003|Overall Study|Started home haemodialysis|0
6950768|NCT01007916|10991050|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1
6950769|NCT01007916|10991051|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0
6950770|NCT01007916|10991050|FG000|Period 2, 4 Weeks of Wear|Relocation|1
6950771|NCT01007916|10991051|FG001|Period 2, 4 Weeks of Wear|Relocation|0
6950772|NCT01007942|10991059|FG000|Overall Study|Adverse Event|29
6950773|NCT01007942|10991060|FG001|Overall Study|Adverse Event|14
6950774|NCT01007942|10991059|FG000|Overall Study|Abnormal test procedure|0
6950775|NCT01007942|10991060|FG001|Overall Study|Abnormal test procedure|1
6950776|NCT01007942|10991059|FG000|Overall Study|Disease progression|217
6950777|NCT01007942|10991060|FG001|Overall Study|Disease progression|242
6950778|NCT01007942|10991059|FG000|Overall Study|New cancer therapy|5
6950779|NCT01007942|10991060|FG001|Overall Study|New cancer therapy|1
6950780|NCT01007942|10991059|FG000|Overall Study|Protocol Violation|1
6950781|NCT01007942|10991060|FG001|Overall Study|Protocol Violation|1
6950782|NCT01007942|10991059|FG000|Overall Study|Withdrawal by Subject|19
6950783|NCT01007942|10991060|FG001|Overall Study|Withdrawal by Subject|14
6950784|NCT01007942|10991059|FG000|Overall Study|Lost to Follow-up|1
6950785|NCT01007942|10991060|FG001|Overall Study|Lost to Follow-up|0
6950786|NCT01007942|10991059|FG000|Overall Study|Administrative problems|2
6950787|NCT01007942|10991060|FG001|Overall Study|Administrative problems|0
6950788|NCT01007942|10991059|FG000|Overall Study|Death|3
6950789|NCT01007942|10991060|FG001|Overall Study|Death|2
6950790|NCT01007942|10991059|FG000|Overall Study|Patients untreated|4
6950791|NCT01007942|10991060|FG001|Overall Study|Patients untreated|3
6950792|NCT01008150|10991101|FG000|Overall Study|did not receive study drug|1
6950793|NCT01008150|10991102|FG001|Overall Study|did not receive study drug|1
6950794|NCT01008150|10991103|FG002|Overall Study|did not receive study drug|1
6950795|NCT01008150|10991104|FG003|Overall Study|did not receive study drug|0
6950796|NCT01008410|10991139|FG000|Overall Study|Adverse Event|13
6950797|NCT01008410|10991140|FG001|Overall Study|Adverse Event|7
6950798|NCT01008410|10991139|FG000|Overall Study|Withdrawal by Subject|6
6950799|NCT01008410|10991140|FG001|Overall Study|Withdrawal by Subject|2
6950800|NCT01008410|10991139|FG000|Overall Study|Lost to Follow-up|1
6950801|NCT01008410|10991140|FG001|Overall Study|Lost to Follow-up|0
6950802|NCT01008410|10991139|FG000|Overall Study|Noncompliance|1
6950803|NCT01008410|10991140|FG001|Overall Study|Noncompliance|0
6950804|NCT01008410|10991139|FG000|Overall Study|Low Cortisol|2
6950805|NCT01008410|10991140|FG001|Overall Study|Low Cortisol|0
6950806|NCT01008410|10991139|FG000|Overall Study|Lack of Efficacy|2
6950807|NCT01008410|10991140|FG001|Overall Study|Lack of Efficacy|6
6950808|NCT01008410|10991139|FG000|Overall Study|Met Exclusion Criterion|0
6950809|NCT01008410|10991140|FG001|Overall Study|Met Exclusion Criterion|1
6950810|NCT01008423|10991148|FG000|Overall Study|Adverse Event|13
6950811|NCT01008423|10991149|FG001|Overall Study|Adverse Event|6
6950812|NCT01008423|10991148|FG000|Overall Study|Withdrawal by Subject|4
6950813|NCT01008423|10991149|FG001|Overall Study|Withdrawal by Subject|7
6950814|NCT01008423|10991148|FG000|Overall Study|Lost to Follow-up|0
6950815|NCT01008423|10991149|FG001|Overall Study|Lost to Follow-up|2
6950816|NCT01008423|10991148|FG000|Overall Study|Low Cortisol|0
6950817|NCT01008423|10991149|FG001|Overall Study|Low Cortisol|1
6950818|NCT01008423|10991148|FG000|Overall Study|Lack of Efficacy|0
6950819|NCT01008423|10991149|FG001|Overall Study|Lack of Efficacy|5
6950820|NCT01008423|10991148|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1
6950821|NCT01008423|10991149|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0
6950822|NCT01008423|10991148|FG000|Overall Study|Personal Conflict|1
6950823|NCT01008423|10991149|FG001|Overall Study|Personal Conflict|0
6950824|NCT01008423|10991148|FG000|Overall Study|Other|0
6950825|NCT01008423|10991149|FG001|Overall Study|Other|1
6950826|NCT01008449|10991157|FG000|Overall Study|Lost to Follow-up|29
6950827|NCT01008449|10991158|FG001|Overall Study|Lost to Follow-up|19
6950828|NCT01008475|10991175|FG000|Overall Study|Ongoing treatment at data cut-off date|0
6950829|NCT01008475|10991176|FG001|Overall Study|Ongoing treatment at data cut-off date|0
6950830|NCT01008475|10991177|FG002|Overall Study|Ongoing treatment at data cut-off date|0
6950831|NCT01008475|10991178|FG003|Overall Study|Ongoing treatment at data cut-off date|0
6950832|NCT01008475|10991179|FG004|Overall Study|Ongoing treatment at data cut-off date|5
6950833|NCT01008475|10991180|FG005|Overall Study|Ongoing treatment at data cut-off date|6
6950834|NCT01008475|10991181|FG006|Overall Study|Ongoing treatment at data cut-off date|4
6950835|NCT01008553|10991197|FG000|Period 1 (Titration Period)|Physician Decision|2
6950836|NCT01008553|10991198|FG001|Period 1 (Titration Period)|Physician Decision|0
6950837|NCT01008553|10991199|FG002|Period 1 (Titration Period)|Physician Decision|0
6950838|NCT01008553|10991197|FG000|Period 1 (Titration Period)|Adverse Event|33
6950839|NCT01008553|10991198|FG001|Period 1 (Titration Period)|Adverse Event|0
6950840|NCT01008553|10991199|FG002|Period 1 (Titration Period)|Adverse Event|0
6950841|NCT01008553|10991197|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6
6950842|NCT01008553|10991198|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0
6950843|NCT01008553|10991199|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0
6950844|NCT01008553|10991197|FG000|Period 1 (Titration Period)|Determined to increase dosage|3
6950845|NCT01008553|10991198|FG001|Period 1 (Titration Period)|Determined to increase dosage|0
6950846|NCT01008553|10991199|FG002|Period 1 (Titration Period)|Determined to increase dosage|0
6950847|NCT01008553|10991197|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50
6950848|NCT01008553|10991198|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
6950849|NCT01008553|10991199|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
6950850|NCT01008553|10991197|FG000|Period 1 (Titration Period)|Not appropriate for this study|1
6950851|NCT01008553|10991198|FG001|Period 1 (Titration Period)|Not appropriate for this study|0
6950852|NCT01008553|10991199|FG002|Period 1 (Titration Period)|Not appropriate for this study|0
6950853|NCT01008553|10991197|FG000|Period 2 (Double-Blind Period)|Physician Decision|0
6950854|NCT01008553|10991198|FG001|Period 2 (Double-Blind Period)|Physician Decision|1
6950855|NCT01008553|10991199|FG002|Period 2 (Double-Blind Period)|Physician Decision|2
6950856|NCT01008553|10991197|FG000|Period 2 (Double-Blind Period)|Adverse Event|0
6950857|NCT01008553|10991198|FG001|Period 2 (Double-Blind Period)|Adverse Event|14
6950858|NCT01008553|10991199|FG002|Period 2 (Double-Blind Period)|Adverse Event|4
6950859|NCT01008553|10991197|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
6950860|NCT01008553|10991198|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
6950861|NCT01008553|10991199|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
6950862|NCT01008553|10991197|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
6950863|NCT01008553|10991198|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1
6950864|NCT01008553|10991199|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
6950865|NCT01008553|10991197|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
6950866|NCT01008553|10991198|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1
6950867|NCT01008553|10991199|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4
6950868|NCT01008553|10991197|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
6950869|NCT01008553|10991198|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
6950870|NCT01008553|10991199|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3
6950871|NCT01008553|10991197|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
6950872|NCT01008553|10991198|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
6950873|NCT01008553|10991199|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
6950874|NCT01008553|10991197|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
6950875|NCT01008553|10991198|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18
6950876|NCT01008553|10991199|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35
6950877|NCT01008618|10991220|FG000|Period 1 (Titration Period)|Physician Decision|2
6950878|NCT01008618|10991221|FG001|Period 1 (Titration Period)|Physician Decision|0
6950879|NCT01008618|10991222|FG002|Period 1 (Titration Period)|Physician Decision|0
6950880|NCT01008618|10991220|FG000|Period 1 (Titration Period)|Adverse Event|33
6950881|NCT01008618|10991221|FG001|Period 1 (Titration Period)|Adverse Event|0
6950882|NCT01008618|10991222|FG002|Period 1 (Titration Period)|Adverse Event|0
6950883|NCT01008618|10991220|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11
6950884|NCT01008618|10991221|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0
6950885|NCT01008618|10991222|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0
6950886|NCT01008618|10991220|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20
6950887|NCT01008618|10991221|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
6950888|NCT01008618|10991222|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
6950889|NCT01008618|10991220|FG000|Period 1 (Titration Period)|Aggravated symptom|2
6950890|NCT01008618|10991221|FG001|Period 1 (Titration Period)|Aggravated symptom|0
6950891|NCT01008618|10991222|FG002|Period 1 (Titration Period)|Aggravated symptom|0
6950892|NCT01008618|10991220|FG000|Period 2 (Double-Blind Period)|Adverse Event|0
6950893|NCT01008618|10991221|FG001|Period 2 (Double-Blind Period)|Adverse Event|11
6950894|NCT01008618|10991222|FG002|Period 2 (Double-Blind Period)|Adverse Event|2
6950895|NCT01008618|10991220|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
6950896|NCT01008618|10991221|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3
6950897|NCT01008618|10991222|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
6950898|NCT01008618|10991220|FG000|Period 2 (Double-Blind Period)|Physician Decision|0
6950899|NCT01008618|10991221|FG001|Period 2 (Double-Blind Period)|Physician Decision|1
6950900|NCT01008618|10991222|FG002|Period 2 (Double-Blind Period)|Physician Decision|0
6950901|NCT01008618|10991220|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
6950902|NCT01008618|10991221|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
7070206|NCT02009865|11172467|FG001|Overall Study|Protocol Violation|2
7070207|NCT02009865|11172466|FG000|Overall Study|Withdrawal by Subject|1
7070208|NCT02009865|11172467|FG001|Overall Study|Withdrawal by Subject|1
7070209|NCT02009878|11172476|FG000|Overall Study|Participant Met Withdrawal Criteria|0
6950903|NCT01008618|10991222|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3
6950904|NCT01008618|10991220|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
6950905|NCT01008618|10991221|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
6950906|NCT01008618|10991222|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
6950907|NCT01008618|10991220|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
6950908|NCT01008618|10991221|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21
6950909|NCT01008618|10991222|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29
6950910|NCT01008618|10991220|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0
6950911|NCT01008618|10991221|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0
6950912|NCT01008618|10991222|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1
6950913|NCT01008696|10991233|FG000|Overall Study|Participant's evasion of hospital visit|5
6950914|NCT01008696|10991234|FG001|Overall Study|Participant's evasion of hospital visit|4
6950915|NCT01008696|10991233|FG000|Overall Study|Withdrawal by Subject|2
6950916|NCT01008696|10991234|FG001|Overall Study|Withdrawal by Subject|4
6950917|NCT01008696|10991233|FG000|Overall Study|Physician Decision|5
6950918|NCT01008696|10991234|FG001|Overall Study|Physician Decision|1
6950919|NCT01008696|10991233|FG000|Overall Study|Adverse Event|1
6950920|NCT01008696|10991234|FG001|Overall Study|Adverse Event|0
6950921|NCT01008696|10991233|FG000|Overall Study|Participants' non-cooperation|2
6950922|NCT01008696|10991234|FG001|Overall Study|Participants' non-cooperation|3
6950923|NCT01008696|10991233|FG000|Overall Study|Other|2
6950924|NCT01008696|10991234|FG001|Overall Study|Other|3
6950925|NCT01008696|10991233|FG000|Overall Study|Other|0
6950926|NCT01008696|10991234|FG001|Overall Study|Other|2
6950927|NCT01008748|10991250|FG000|Overall Study|Lost to Follow-up|80
6838422|NCT00259012|10844160|FG001|Overall Study|Physician Decision|1
6838423|NCT00259012|10844159|FG000|Overall Study|Lost to Follow-up|0
6838424|NCT00259012|10844160|FG001|Overall Study|Lost to Follow-up|1
6838425|NCT00259012|10844159|FG000|Overall Study|Protocol Violation|1
6838426|NCT00259012|10844160|FG001|Overall Study|Protocol Violation|1
6838427|NCT00259272|10844183|FG000|Overall Study|Adverse Event|2
6838428|NCT00259272|10844184|FG001|Overall Study|Adverse Event|1
6838429|NCT00259272|10844185|FG002|Overall Study|Adverse Event|0
6838430|NCT00259272|10844186|FG003|Overall Study|Adverse Event|3
6838431|NCT00259272|10844183|FG000|Overall Study|Lack of Efficacy|5
6838432|NCT00259272|10844184|FG001|Overall Study|Lack of Efficacy|1
6838433|NCT00259272|10844185|FG002|Overall Study|Lack of Efficacy|2
6838434|NCT00259272|10844186|FG003|Overall Study|Lack of Efficacy|6
6838435|NCT00259272|10844183|FG000|Overall Study|Physician Decision|1
6838436|NCT00259272|10844184|FG001|Overall Study|Physician Decision|2
6838437|NCT00259272|10844185|FG002|Overall Study|Physician Decision|1
6838438|NCT00259272|10844186|FG003|Overall Study|Physician Decision|3
6838439|NCT00259272|10844183|FG000|Overall Study|Protocol Violation|2
6838440|NCT00259272|10844184|FG001|Overall Study|Protocol Violation|0
6838441|NCT00259272|10844185|FG002|Overall Study|Protocol Violation|0
6838442|NCT00259272|10844186|FG003|Overall Study|Protocol Violation|1
6838443|NCT00259272|10844183|FG000|Overall Study|Sponsor Decision|0
6838444|NCT00259272|10844184|FG001|Overall Study|Sponsor Decision|1
6838445|NCT00259272|10844185|FG002|Overall Study|Sponsor Decision|0
6838446|NCT00259272|10844186|FG003|Overall Study|Sponsor Decision|0
6838447|NCT00259272|10844183|FG000|Overall Study|Withdrawal by Subject|4
6838448|NCT00259272|10844184|FG001|Overall Study|Withdrawal by Subject|2
6838449|NCT00259272|10844185|FG002|Overall Study|Withdrawal by Subject|2
6838450|NCT00259272|10844186|FG003|Overall Study|Withdrawal by Subject|7
6838451|NCT00259272|10844183|FG000|Overall Study|Lost to Follow-up|1
6838452|NCT00259272|10844184|FG001|Overall Study|Lost to Follow-up|0
6838453|NCT00259272|10844185|FG002|Overall Study|Lost to Follow-up|0
6838454|NCT00259272|10844186|FG003|Overall Study|Lost to Follow-up|1
6838455|NCT00259298|10844205|FG000|Overall Study|Withdrawal by Subject|1
6838456|NCT00259298|10844205|FG000|Overall Study|Physician Decision|2
6838457|NCT00259610|10844213|FG000|Overall Study|Withdrawal by Subject|33
6838458|NCT00259610|10844214|FG001|Overall Study|Withdrawal by Subject|25
6838459|NCT00259610|10844215|FG002|Overall Study|Withdrawal by Subject|29
6838460|NCT00259610|10844216|FG003|Overall Study|Withdrawal by Subject|19
6838461|NCT00259610|10844213|FG000|Overall Study|Lost to Follow-up|19
6838462|NCT00259610|10844214|FG001|Overall Study|Lost to Follow-up|8
6838463|NCT00259610|10844215|FG002|Overall Study|Lost to Follow-up|18
6838464|NCT00259610|10844216|FG003|Overall Study|Lost to Follow-up|15
6838465|NCT00259610|10844213|FG000|Overall Study|Physician Decision|6
6838466|NCT00259610|10844214|FG001|Overall Study|Physician Decision|4
6838467|NCT00259610|10844215|FG002|Overall Study|Physician Decision|7
6838468|NCT00259610|10844216|FG003|Overall Study|Physician Decision|2
6838469|NCT00259610|10844213|FG000|Overall Study|Death|1
6950928|NCT01008748|10991250|FG000|Overall Study|Other|1
6950929|NCT01008904|10991254|FG000|Overall Study|Lost to Follow-up|1
6950930|NCT01008904|10991254|FG000|Overall Study|Adverse Event|2
6950931|NCT01008904|10991254|FG000|Overall Study|unexpected unrelated surgery|1
6950932|NCT01008943|10991258|FG000|Overall Study|Withdrawal by Subject|1
6950933|NCT01008995|10991268|FG000|Controlled Period|Adverse Event|1
6950934|NCT01008995|10991269|FG001|Controlled Period|Adverse Event|2
6950935|NCT01008995|10991270|FG002|Controlled Period|Adverse Event|0
6950936|NCT01008995|10991271|FG003|Controlled Period|Adverse Event|0
6950937|NCT01008995|10991268|FG000|Controlled Period|Other|2
6950938|NCT01008995|10991269|FG001|Controlled Period|Other|1
6950939|NCT01008995|10991270|FG002|Controlled Period|Other|0
6950940|NCT01008995|10991271|FG003|Controlled Period|Other|0
6950941|NCT01008995|10991268|FG000|After Controlled Period|Adverse Event|0
6950942|NCT01008995|10991269|FG001|After Controlled Period|Adverse Event|0
6950943|NCT01008995|10991270|FG002|After Controlled Period|Adverse Event|1
6950944|NCT01008995|10991271|FG003|After Controlled Period|Adverse Event|1
6950945|NCT01008995|10991268|FG000|After Controlled Period|Other|0
6950946|NCT01008995|10991269|FG001|After Controlled Period|Other|0
6950947|NCT01008995|10991270|FG002|After Controlled Period|Other|1
6950948|NCT01008995|10991271|FG003|After Controlled Period|Other|0
6950949|NCT01009034|10991279|FG000|Overall Study|Lost to Follow-up|2
6950950|NCT01009034|10991279|FG000|Overall Study|Withdrawal by Subject|2
6950951|NCT01009047|10991285|FG000|Overall Study|Adverse Event|5
6950952|NCT01009047|10991286|FG001|Overall Study|Adverse Event|0
7070210|NCT02009878|11172477|FG001|Overall Study|Participant Met Withdrawal Criteria|1
7070211|NCT02009878|11172478|FG002|Overall Study|Participant Met Withdrawal Criteria|0
7070212|NCT02009930|11172486|FG000|Overall Study|withdrawn|5
7070213|NCT02010255|11172554|FG000|Overall Study|Death|0
7070214|NCT02010255|11172555|FG001|Overall Study|Death|1
7070215|NCT02010255|11172556|FG002|Overall Study|Death|4
7070216|NCT02010255|11172557|FG003|Overall Study|Death|4
7070217|NCT02010255|11172558|FG004|Overall Study|Death|2
7070218|NCT02010255|11172559|FG005|Overall Study|Death|0
7070219|NCT02010255|11172560|FG006|Overall Study|Death|1
7070220|NCT02010255|11172561|FG007|Overall Study|Death|1
7070221|NCT02010255|11172562|FG008|Overall Study|Death|1
7070222|NCT02010255|11172563|FG009|Overall Study|Death|0
7070223|NCT02010255|11172564|FG010|Overall Study|Death|1
7070224|NCT02010255|11172565|FG011|Overall Study|Death|1
7070225|NCT02010255|11172566|FG012|Overall Study|Death|0
7070226|NCT02010255|11172567|FG013|Overall Study|Death|0
7070227|NCT02010255|11172554|FG000|Overall Study|Lack of Efficacy|4
7070228|NCT02010255|11172555|FG001|Overall Study|Lack of Efficacy|1
7070229|NCT02010255|11172556|FG002|Overall Study|Lack of Efficacy|2
7070230|NCT02010255|11172557|FG003|Overall Study|Lack of Efficacy|1
7070231|NCT02010255|11172558|FG004|Overall Study|Lack of Efficacy|1
7070232|NCT02010255|11172559|FG005|Overall Study|Lack of Efficacy|0
6950953|NCT01009047|10991285|FG000|Overall Study|Lost to Follow-up|0
6950954|NCT01009047|10991286|FG001|Overall Study|Lost to Follow-up|2
6950955|NCT01009047|10991285|FG000|Overall Study|Lack of Efficacy|4
6950956|NCT01009047|10991286|FG001|Overall Study|Lack of Efficacy|11
6950957|NCT01009047|10991285|FG000|Overall Study|Withdrawal by consent|16
7070233|NCT02010255|11172560|FG006|Overall Study|Lack of Efficacy|0
7070234|NCT02010255|11172561|FG007|Overall Study|Lack of Efficacy|0
6950958|NCT01009047|10991286|FG001|Overall Study|Withdrawal by consent|11
6950959|NCT01009047|10991285|FG000|Overall Study|Other|3
6950960|NCT01009047|10991286|FG001|Overall Study|Other|2
6950961|NCT01009060|10991294|FG000|Overall Study|Adverse Event|1
6950962|NCT01009060|10991295|FG001|Overall Study|Adverse Event|2
6950963|NCT01009060|10991294|FG000|Overall Study|Protocol Violation|0
6950964|NCT01009060|10991295|FG001|Overall Study|Protocol Violation|1
6950965|NCT01009060|10991294|FG000|Overall Study|Lost to Follow-up|1
6950966|NCT01009060|10991295|FG001|Overall Study|Lost to Follow-up|0
6950967|NCT01009060|10991294|FG000|Overall Study|Physician Decision|1
6950968|NCT01009060|10991295|FG001|Overall Study|Physician Decision|1
6950969|NCT01009060|10991294|FG000|Overall Study|Withdrawal by Subject|1
6950970|NCT01009060|10991295|FG001|Overall Study|Withdrawal by Subject|1
6950971|NCT01009086|10991308|FG000|Overall Study|Lack of Efficacy|16
6950972|NCT01009086|10991309|FG001|Overall Study|Lack of Efficacy|15
6950973|NCT01009086|10991310|FG002|Overall Study|Lack of Efficacy|9
6950974|NCT01009086|10991308|FG000|Overall Study|Lost to Follow-up|4
6950975|NCT01009086|10991309|FG001|Overall Study|Lost to Follow-up|5
6950976|NCT01009086|10991310|FG002|Overall Study|Lost to Follow-up|3
6950977|NCT01009086|10991308|FG000|Overall Study|Adverse Event|12
6950978|NCT01009086|10991309|FG001|Overall Study|Adverse Event|11
6950979|NCT01009086|10991310|FG002|Overall Study|Adverse Event|8
6950980|NCT01009086|10991308|FG000|Overall Study|Withdrawal by Subject|9
6950981|NCT01009086|10991309|FG001|Overall Study|Withdrawal by Subject|11
6950982|NCT01009086|10991310|FG002|Overall Study|Withdrawal by Subject|13
6950983|NCT01009086|10991308|FG000|Overall Study|Other|3
6950984|NCT01009086|10991309|FG001|Overall Study|Other|5
6950985|NCT01009086|10991310|FG002|Overall Study|Other|1
6950986|NCT01009099|10991325|FG000|Overall Study|Lost to Follow-up|1
6950987|NCT01009099|10991326|FG001|Overall Study|Lost to Follow-up|0
6950988|NCT01009099|10991325|FG000|Overall Study|Physician Decision|3
6950989|NCT01009099|10991326|FG001|Overall Study|Physician Decision|2
6950990|NCT01009099|10991325|FG000|Overall Study|Withdrawal by Subject|1
6950991|NCT01009099|10991326|FG001|Overall Study|Withdrawal by Subject|1
6950992|NCT01009099|10991325|FG000|Overall Study|Death|0
6950993|NCT01009099|10991326|FG001|Overall Study|Death|1
6950994|NCT01009203|10991341|FG000|Overall Study|Withdrawal by Subject|1
6950995|NCT01009203|10991341|FG000|Overall Study|Adverse Event|5
6950996|NCT01009203|10991341|FG000|Overall Study|Treatment-unrelated death|1
6950997|NCT01009281|10991345|FG000|Overall Study|Administrative problems|7
6950998|NCT01009346|10991362|FG000|Overall Study|Adverse Event|4
6950999|NCT01009463|10991371|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373
6951000|NCT01009463|10991372|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
6951001|NCT01009463|10991373|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
6951002|NCT01009463|10991374|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
6951003|NCT01009463|10991375|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
6951004|NCT01009463|10991371|FG000|4-week, Open-label Run-In Period|Adverse Event|10
6951005|NCT01009463|10991372|FG001|4-week, Open-label Run-In Period|Adverse Event|0
6951006|NCT01009463|10991373|FG002|4-week, Open-label Run-In Period|Adverse Event|0
6951007|NCT01009463|10991374|FG003|4-week, Open-label Run-In Period|Adverse Event|0
6951008|NCT01009463|10991375|FG004|4-week, Open-label Run-In Period|Adverse Event|0
6951009|NCT01009463|10991371|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6
6951010|NCT01009463|10991372|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0
6951011|NCT01009463|10991373|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0
6951012|NCT01009463|10991374|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0
6951013|NCT01009463|10991375|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0
6951014|NCT01009463|10991371|FG000|4-week, Open-label Run-In Period|Physician Decision|10
6951015|NCT01009463|10991372|FG001|4-week, Open-label Run-In Period|Physician Decision|0
6951016|NCT01009463|10991373|FG002|4-week, Open-label Run-In Period|Physician Decision|0
6951017|NCT01009463|10991374|FG003|4-week, Open-label Run-In Period|Physician Decision|0
6951018|NCT01009463|10991375|FG004|4-week, Open-label Run-In Period|Physician Decision|0
6951019|NCT01009463|10991371|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50
6951020|NCT01009463|10991372|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0
6951021|NCT01009463|10991373|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0
6951022|NCT01009463|10991374|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0
6951023|NCT01009463|10991375|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0
6951024|NCT01009463|10991371|FG000|52-week, Double-blind Treatment Period|Adverse Event|0
6951025|NCT01009463|10991372|FG001|52-week, Double-blind Treatment Period|Adverse Event|22
6951026|NCT01009463|10991373|FG002|52-week, Double-blind Treatment Period|Adverse Event|25
6951027|NCT01009463|10991374|FG003|52-week, Double-blind Treatment Period|Adverse Event|29
6951028|NCT01009463|10991375|FG004|52-week, Double-blind Treatment Period|Adverse Event|31
6951029|NCT01009463|10991371|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
6951030|NCT01009463|10991372|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34
6951031|NCT01009463|10991373|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18
6951032|NCT01009463|10991374|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17
6951033|NCT01009463|10991375|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
6951034|NCT01009463|10991371|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0
6951035|NCT01009463|10991372|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24
6951036|NCT01009463|10991373|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16
6951037|NCT01009463|10991374|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11
6951038|NCT01009463|10991375|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18
6951039|NCT01009463|10991371|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0
6951040|NCT01009463|10991372|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8
6951041|NCT01009463|10991373|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7
6951042|NCT01009463|10991374|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8
6951043|NCT01009463|10991375|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7
6951044|NCT01009463|10991371|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
6951045|NCT01009463|10991372|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
6951046|NCT01009463|10991373|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14
6951047|NCT01009463|10991374|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
6951048|NCT01009463|10991375|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
6951049|NCT01009463|10991371|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
6951050|NCT01009463|10991372|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2
6951051|NCT01009463|10991373|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
6951052|NCT01009463|10991374|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
6951053|NCT01009463|10991375|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
6951054|NCT01009463|10991371|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0
6951055|NCT01009463|10991372|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11
6951056|NCT01009463|10991373|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7
6951057|NCT01009463|10991374|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6
6951058|NCT01009463|10991375|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5
6951059|NCT01009463|10991371|FG000|52-week, Double-blind Treatment Period|Physician Decision|0
6951060|NCT01009463|10991372|FG001|52-week, Double-blind Treatment Period|Physician Decision|4
6951061|NCT01009463|10991373|FG002|52-week, Double-blind Treatment Period|Physician Decision|6
6951062|NCT01009463|10991374|FG003|52-week, Double-blind Treatment Period|Physician Decision|6
6951063|NCT01009463|10991375|FG004|52-week, Double-blind Treatment Period|Physician Decision|8
6951064|NCT01009515|10991386|FG000|Overall Study|Withdrawal by Subject|3
6951065|NCT01009554|10991392|FG000|Overall Study|Adverse Event|1
6951066|NCT01009554|10991393|FG001|Overall Study|Adverse Event|1
6951067|NCT01009554|10991392|FG000|Overall Study|Withdrawal by Subject|1
6951068|NCT01009554|10991393|FG001|Overall Study|Withdrawal by Subject|3
6951069|NCT01009554|10991392|FG000|Overall Study|Noncompliant with Study Product|0
6951070|NCT01009554|10991393|FG001|Overall Study|Noncompliant with Study Product|3
6951071|NCT01009580|10991401|FG000|Overall Study|Adverse Event|4
6951072|NCT01009580|10991402|FG001|Overall Study|Adverse Event|4
6951073|NCT01009580|10991401|FG000|Overall Study|Lack of Efficacy|0
6951074|NCT01009580|10991402|FG001|Overall Study|Lack of Efficacy|1
6951075|NCT01009580|10991401|FG000|Overall Study|Protocol Violation|2
6951076|NCT01009580|10991402|FG001|Overall Study|Protocol Violation|3
6951077|NCT01009580|10991401|FG000|Overall Study|Withdrawal Criteria|4
6951078|NCT01009580|10991402|FG001|Overall Study|Withdrawal Criteria|6
6951079|NCT01009580|10991401|FG000|Overall Study|Unclassified|17
6951080|NCT01009580|10991402|FG001|Overall Study|Unclassified|21
6951081|NCT01009645|10991421|FG000|Overall Study|Lost to Follow-up|2
6951082|NCT01009645|10991422|FG001|Overall Study|Lost to Follow-up|8
6951083|NCT01009645|10991423|FG002|Overall Study|Lost to Follow-up|4
6951084|NCT01009645|10991424|FG003|Overall Study|Lost to Follow-up|5
6976002|NCT01196091|11028326|FG000|Overall Study|Randomized, No Study Drug Received|1
6976003|NCT01196091|11028327|FG001|Overall Study|Randomized, No Study Drug Received|0
6976004|NCT01196091|11028328|FG002|Overall Study|Randomized, No Study Drug Received|1
6976005|NCT01196104|11028343|FG000|Overall Study|Lost to Follow-up|1
6976006|NCT01196104|11028344|FG001|Overall Study|Lost to Follow-up|0
6976007|NCT01196104|11028343|FG000|Overall Study|Physician Decision|0
6976008|NCT01196104|11028344|FG001|Overall Study|Physician Decision|1
6976009|NCT01196104|11028343|FG000|Overall Study|Withdrawal by Subject|3
6976010|NCT01196104|11028344|FG001|Overall Study|Withdrawal by Subject|3
6976011|NCT01196104|11028343|FG000|Overall Study|Various|0
7070235|NCT02010255|11172562|FG008|Overall Study|Lack of Efficacy|0
7070236|NCT02010255|11172563|FG009|Overall Study|Lack of Efficacy|0
7070237|NCT02010255|11172564|FG010|Overall Study|Lack of Efficacy|1
7070238|NCT02010255|11172565|FG011|Overall Study|Lack of Efficacy|0
7070239|NCT02010255|11172566|FG012|Overall Study|Lack of Efficacy|0
7070240|NCT02010255|11172567|FG013|Overall Study|Lack of Efficacy|0
7070241|NCT02010255|11172554|FG000|Overall Study|Withdrew Consent|1
7070242|NCT02010255|11172555|FG001|Overall Study|Withdrew Consent|0
7070243|NCT02010255|11172556|FG002|Overall Study|Withdrew Consent|0
7070244|NCT02010255|11172557|FG003|Overall Study|Withdrew Consent|1
7070245|NCT02010255|11172558|FG004|Overall Study|Withdrew Consent|0
7070246|NCT02010255|11172559|FG005|Overall Study|Withdrew Consent|0
6976012|NCT01196104|11028344|FG001|Overall Study|Various|1
6976013|NCT01196416|11028380|FG000|Overall Study|Withdrawal by Subject|2
7070247|NCT02010255|11172560|FG006|Overall Study|Withdrew Consent|0
7070248|NCT02010255|11172561|FG007|Overall Study|Withdrew Consent|0
7070249|NCT02010255|11172562|FG008|Overall Study|Withdrew Consent|0
6951085|NCT01009814|10991450|FG000|Overall Study|No longer met study criteria|1
6951086|NCT01009814|10991451|FG001|Overall Study|No longer met study criteria|1
6951087|NCT01009814|10991452|FG002|Overall Study|No longer met study criteria|0
7070250|NCT02010255|11172563|FG009|Overall Study|Withdrew Consent|0
7070251|NCT02010255|11172564|FG010|Overall Study|Withdrew Consent|0
7070252|NCT02010255|11172565|FG011|Overall Study|Withdrew Consent|0
7070253|NCT02010255|11172566|FG012|Overall Study|Withdrew Consent|0
7070254|NCT02010255|11172567|FG013|Overall Study|Withdrew Consent|0
7070255|NCT02010255|11172554|FG000|Overall Study|Adverse Event|1
7070256|NCT02010255|11172555|FG001|Overall Study|Adverse Event|0
7070257|NCT02010255|11172556|FG002|Overall Study|Adverse Event|0
7070258|NCT02010255|11172557|FG003|Overall Study|Adverse Event|0
7070259|NCT02010255|11172558|FG004|Overall Study|Adverse Event|0
7070260|NCT02010255|11172559|FG005|Overall Study|Adverse Event|0
7070261|NCT02010255|11172560|FG006|Overall Study|Adverse Event|0
7070262|NCT02010255|11172561|FG007|Overall Study|Adverse Event|0
7070263|NCT02010255|11172562|FG008|Overall Study|Adverse Event|0
7070264|NCT02010255|11172563|FG009|Overall Study|Adverse Event|0
7070265|NCT02010255|11172564|FG010|Overall Study|Adverse Event|0
7070266|NCT02010255|11172565|FG011|Overall Study|Adverse Event|0
7070267|NCT02010255|11172566|FG012|Overall Study|Adverse Event|0
7070268|NCT02010255|11172567|FG013|Overall Study|Adverse Event|0
7070269|NCT02010255|11172554|FG000|Overall Study|Lost to Follow-up|0
7070270|NCT02010255|11172555|FG001|Overall Study|Lost to Follow-up|0
6951088|NCT01009814|10991453|FG003|Overall Study|No longer met study criteria|0
6951089|NCT01009814|10991454|FG004|Overall Study|No longer met study criteria|0
6951090|NCT01009840|10991470|FG000|Overall Study|Lost to Follow-up|1
6951091|NCT01009840|10991470|FG000|Overall Study|Adverse Event|4
6951092|NCT01009840|10991470|FG000|Overall Study|Subject Met Withdrawal Criteria|7
6951093|NCT01009840|10991470|FG000|Overall Study|Subject was Withdrawn by Investigator|1
6951094|NCT01009840|10991470|FG000|Overall Study|Subject Withdrew Consent to Participate|1
6951095|NCT01009983|10991487|FG000|Overall Study|necessary scans not completed|1
6951096|NCT01010061|10991506|FG000|Overall Study|Adverse Events or Intercurrent Illness|33
6951097|NCT01010061|10991507|FG001|Overall Study|Adverse Events or Intercurrent Illness|16
6951098|NCT01010061|10991506|FG000|Overall Study|Disease Progression|2
6951099|NCT01010061|10991507|FG001|Overall Study|Disease Progression|8
6951100|NCT01010061|10991506|FG000|Overall Study|Withdrew Consent|5
6951101|NCT01010061|10991507|FG001|Overall Study|Withdrew Consent|1
6951102|NCT01010061|10991506|FG000|Overall Study|Death|3
6951103|NCT01010061|10991507|FG001|Overall Study|Death|6
6951104|NCT01010061|10991506|FG000|Overall Study|Administrative/Other|0
6951105|NCT01010061|10991507|FG001|Overall Study|Administrative/Other|1
6951106|NCT01010061|10991506|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2
6951107|NCT01010061|10991507|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0
6951108|NCT01010061|10991506|FG000|Overall Study|Insufficient Therapeutic Response|1
6951109|NCT01010061|10991507|FG001|Overall Study|Insufficient Therapeutic Response|5
6951110|NCT01010061|10991506|FG000|Overall Study|Violation of Selection Criteria|0
6951111|NCT01010061|10991507|FG001|Overall Study|Violation of Selection Criteria|1
6951112|NCT01010061|10991506|FG000|Overall Study|Did Not Receive Treatment|2
6951113|NCT01010061|10991507|FG001|Overall Study|Did Not Receive Treatment|2
6951114|NCT01010126|10991521|FG000|Overall Study|Withdrawal by Subject|1
6951115|NCT01010126|10991522|FG001|Overall Study|Withdrawal by Subject|0
6951116|NCT01010126|10991523|FG002|Overall Study|Withdrawal by Subject|1
6951117|NCT01010126|10991524|FG003|Overall Study|Withdrawal by Subject|0
6951118|NCT01010126|10991525|FG004|Overall Study|Withdrawal by Subject|3
6951119|NCT01010126|10991526|FG005|Overall Study|Withdrawal by Subject|0
6951120|NCT01010204|10991542|FG000|Overall Study|Lost to Follow-up|2
6951121|NCT01010204|10991543|FG001|Overall Study|Lost to Follow-up|2
6951122|NCT01010204|10991542|FG000|Overall Study|Adverse Event|1
6951123|NCT01010204|10991543|FG001|Overall Study|Adverse Event|3
6951124|NCT01010204|10991542|FG000|Overall Study|Withdrawal by Subject|2
6951125|NCT01010204|10991543|FG001|Overall Study|Withdrawal by Subject|3
6951126|NCT01010204|10991542|FG000|Overall Study|psychiatric hospitalization|2
6951127|NCT01010204|10991543|FG001|Overall Study|psychiatric hospitalization|1
6951128|NCT01010217|10991554|FG000|Overall Study|Lost to Follow-up|4
6951129|NCT01010217|10991555|FG001|Overall Study|Lost to Follow-up|5
6951130|NCT01010217|10991556|FG002|Overall Study|Lost to Follow-up|1
7070271|NCT02010255|11172556|FG002|Overall Study|Lost to Follow-up|1
7070272|NCT02010255|11172557|FG003|Overall Study|Lost to Follow-up|0
7070273|NCT02010255|11172558|FG004|Overall Study|Lost to Follow-up|1
7070274|NCT02010255|11172559|FG005|Overall Study|Lost to Follow-up|0
7070275|NCT02010255|11172560|FG006|Overall Study|Lost to Follow-up|0
7070276|NCT02010255|11172561|FG007|Overall Study|Lost to Follow-up|0
7070277|NCT02010255|11172562|FG008|Overall Study|Lost to Follow-up|0
7070278|NCT02010255|11172563|FG009|Overall Study|Lost to Follow-up|0
7070279|NCT02010255|11172564|FG010|Overall Study|Lost to Follow-up|0
7070280|NCT02010255|11172565|FG011|Overall Study|Lost to Follow-up|0
7070281|NCT02010255|11172566|FG012|Overall Study|Lost to Follow-up|0
7070282|NCT02010255|11172567|FG013|Overall Study|Lost to Follow-up|0
6951131|NCT01010217|10991557|FG003|Overall Study|Lost to Follow-up|0
7070283|NCT02010255|11172554|FG000|Overall Study|Randomized but Not Treated|0
7070284|NCT02010255|11172555|FG001|Overall Study|Randomized but Not Treated|0
7070285|NCT02010255|11172556|FG002|Overall Study|Randomized but Not Treated|0
6951132|NCT01010217|10991558|FG004|Overall Study|Lost to Follow-up|0
6951133|NCT01010217|10991554|FG000|Overall Study|Withdrawal by Subject|1
6951134|NCT01010217|10991555|FG001|Overall Study|Withdrawal by Subject|0
6951135|NCT01010217|10991556|FG002|Overall Study|Withdrawal by Subject|0
6951136|NCT01010217|10991557|FG003|Overall Study|Withdrawal by Subject|0
6951137|NCT01010217|10991558|FG004|Overall Study|Withdrawal by Subject|0
6951138|NCT01010217|10991554|FG000|Overall Study|Physician Decision|0
6951139|NCT01010217|10991555|FG001|Overall Study|Physician Decision|0
6951140|NCT01010217|10991556|FG002|Overall Study|Physician Decision|0
6951141|NCT01010217|10991557|FG003|Overall Study|Physician Decision|6
6951142|NCT01010217|10991558|FG004|Overall Study|Physician Decision|3
6951143|NCT01010230|10991572|FG000|Overall Study|Withdrawal by Subject|6
6951144|NCT01010230|10991573|FG001|Overall Study|Withdrawal by Subject|5
6951145|NCT01010230|10991572|FG000|Overall Study|Lost to Follow-up|4
6951146|NCT01010230|10991573|FG001|Overall Study|Lost to Follow-up|2
6951147|NCT01010503|10991605|FG000|Overall Study|Adverse Event|1
6951148|NCT01010503|10991605|FG000|Overall Study|Death|1
6951149|NCT01010633|10991627|FG000|Overall Study|Adverse Event|1
6951150|NCT01010633|10991628|FG001|Overall Study|Adverse Event|1
6951151|NCT01010633|10991627|FG000|Overall Study|Protocol Violation|1
6951152|NCT01010633|10991628|FG001|Overall Study|Protocol Violation|2
6951153|NCT01010633|10991627|FG000|Overall Study|Withdrawal by Subject|2
6951154|NCT01010633|10991628|FG001|Overall Study|Withdrawal by Subject|1
6951155|NCT01010633|10991627|FG000|Overall Study|Investigator decision|0
6951156|NCT01010633|10991628|FG001|Overall Study|Investigator decision|1
6951157|NCT01010750|10991640|FG000|Second Intervention|Adverse Event|0
6951158|NCT01010750|10991641|FG001|Second Intervention|Adverse Event|1
6951159|NCT01010750|10991642|FG002|Second Intervention|Adverse Event|0
6951160|NCT01010750|10991643|FG003|Second Intervention|Adverse Event|0
6951161|NCT01010750|10991644|FG004|Second Intervention|Adverse Event|0
6951162|NCT01010750|10991645|FG005|Second Intervention|Adverse Event|0
6951163|NCT01010776|10991662|FG000|Main Phase|Withdrawal by Subject|14
6951164|NCT01010776|10991662|FG000|Main Phase|Lack of Efficacy|8
6951165|NCT01010776|10991662|FG000|Main Phase|Adverse Event|7
6951166|NCT01010776|10991662|FG000|Main Phase|Lost to Follow-up|6
6951167|NCT01010776|10991662|FG000|Main Phase|Non-compliance to study medication|5
6951168|NCT01010776|10991662|FG000|Main Phase|Selection failure|2
6951169|NCT01010776|10991662|FG000|Main Phase|Inform consent withdrawal|1
6951170|NCT01010776|10991662|FG000|Main Phase|Other|1
6951171|NCT01010776|10991662|FG000|Main Phase|Did not received study medication|5
6951172|NCT01010776|10991662|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15
6951173|NCT01010776|10991662|FG000|Extension Phase|Other|3
6951174|NCT01010867|10991681|FG000|Overall Study|< 50% adherence to probiotic|1
6951175|NCT01010971|10991721|FG000|Overall Study|Adverse Event|2
6951176|NCT01010971|10991722|FG001|Overall Study|Adverse Event|4
6951177|NCT01010971|10991723|FG002|Overall Study|Adverse Event|3
6951178|NCT01010971|10991721|FG000|Overall Study|Withdrawal by Subject|0
6951179|NCT01010971|10991722|FG001|Overall Study|Withdrawal by Subject|2
6951180|NCT01010971|10991723|FG002|Overall Study|Withdrawal by Subject|5
6951181|NCT01010971|10991721|FG000|Overall Study|Lost to Follow-up|0
6951182|NCT01010971|10991722|FG001|Overall Study|Lost to Follow-up|2
6951183|NCT01010971|10991723|FG002|Overall Study|Lost to Follow-up|3
6951184|NCT01010971|10991721|FG000|Overall Study|Other|1
6951185|NCT01010971|10991722|FG001|Overall Study|Other|0
6951186|NCT01010971|10991723|FG002|Overall Study|Other|2
6951187|NCT01011049|10991740|FG000|Overall Study|Protocol Violation|0
6951188|NCT01011049|10991741|FG001|Overall Study|Protocol Violation|0
6951189|NCT01011049|10991742|FG002|Overall Study|Protocol Violation|2
6951190|NCT01011049|10991743|FG003|Overall Study|Protocol Violation|0
6951191|NCT01011049|10991740|FG000|Overall Study|Lost to Follow-up|1
6951192|NCT01011049|10991741|FG001|Overall Study|Lost to Follow-up|2
6951193|NCT01011049|10991742|FG002|Overall Study|Lost to Follow-up|1
6951194|NCT01011049|10991743|FG003|Overall Study|Lost to Follow-up|0
6951195|NCT01011049|10991740|FG000|Overall Study|Withdrawal by Subject|0
6951196|NCT01011049|10991741|FG001|Overall Study|Withdrawal by Subject|0
7070286|NCT02010255|11172557|FG003|Overall Study|Randomized but Not Treated|0
7070287|NCT02010255|11172558|FG004|Overall Study|Randomized but Not Treated|0
6951197|NCT01011049|10991742|FG002|Overall Study|Withdrawal by Subject|1
6951198|NCT01011049|10991743|FG003|Overall Study|Withdrawal by Subject|0
6951199|NCT01011153|10991760|FG000|Overall Study|Less than 78 cases completed|8
6951200|NCT01011153|10991761|FG001|Overall Study|Less than 78 cases completed|11
6951201|NCT01011153|10991762|FG002|Overall Study|Less than 78 cases completed|9
6951202|NCT01011283|10991808|FG000|Overall Study|Adverse Event|4
6951203|NCT01011283|10991809|FG001|Overall Study|Adverse Event|2
6951204|NCT01011283|10991808|FG000|Overall Study|Progressive Disease|0
6951205|NCT01011283|10991809|FG001|Overall Study|Progressive Disease|2
6951206|NCT01011283|10991808|FG000|Overall Study|Terminated by Sponsor|5
6951207|NCT01011283|10991809|FG001|Overall Study|Terminated by Sponsor|5
6951208|NCT01011283|10991808|FG000|Overall Study|Other|2
7070288|NCT02010255|11172559|FG005|Overall Study|Randomized but Not Treated|0
7070289|NCT02010255|11172560|FG006|Overall Study|Randomized but Not Treated|0
6951209|NCT01011283|10991809|FG001|Overall Study|Other|2
6951210|NCT01011309|10991818|FG000|Overall Study|Adverse Event|2
6951211|NCT01011309|10991819|FG001|Overall Study|Adverse Event|1
6951212|NCT01011309|10991820|FG002|Overall Study|Adverse Event|2
6951213|NCT01011309|10991818|FG000|Overall Study|Lack of Efficacy|0
6951214|NCT01011309|10991819|FG001|Overall Study|Lack of Efficacy|1
6951215|NCT01011309|10991820|FG002|Overall Study|Lack of Efficacy|0
6951216|NCT01011309|10991818|FG000|Overall Study|Protocol Violation|0
6951217|NCT01011309|10991819|FG001|Overall Study|Protocol Violation|1
6951218|NCT01011309|10991820|FG002|Overall Study|Protocol Violation|3
6951219|NCT01011335|10991832|FG000|Overall Study|Lost to Follow-up|0
6951220|NCT01011335|10991833|FG001|Overall Study|Lost to Follow-up|0
6951221|NCT01011335|10991834|FG002|Overall Study|Lost to Follow-up|1
6951222|NCT01011335|10991835|FG003|Overall Study|Lost to Follow-up|1
6951223|NCT01011335|10991836|FG004|Overall Study|Lost to Follow-up|1
6951224|NCT01011335|10991837|FG005|Overall Study|Lost to Follow-up|1
6951225|NCT01011335|10991838|FG006|Overall Study|Lost to Follow-up|2
6951226|NCT01011335|10991839|FG007|Overall Study|Lost to Follow-up|2
6951227|NCT01011335|10991840|FG008|Overall Study|Lost to Follow-up|1
6951228|NCT01011335|10991841|FG009|Overall Study|Lost to Follow-up|0
6951229|NCT01011335|10991842|FG010|Overall Study|Lost to Follow-up|0
6951230|NCT01011335|10991843|FG011|Overall Study|Lost to Follow-up|1
6951231|NCT01011335|10991844|FG012|Overall Study|Lost to Follow-up|2
6951232|NCT01011335|10991832|FG000|Overall Study|Protocol Violation|0
6951233|NCT01011335|10991833|FG001|Overall Study|Protocol Violation|1
6951234|NCT01011335|10991834|FG002|Overall Study|Protocol Violation|0
6951235|NCT01011335|10991835|FG003|Overall Study|Protocol Violation|0
6951236|NCT01011335|10991836|FG004|Overall Study|Protocol Violation|0
6951237|NCT01011335|10991837|FG005|Overall Study|Protocol Violation|0
6951238|NCT01011335|10991838|FG006|Overall Study|Protocol Violation|0
6951239|NCT01011335|10991839|FG007|Overall Study|Protocol Violation|0
6951240|NCT01011335|10991840|FG008|Overall Study|Protocol Violation|0
6951241|NCT01011335|10991841|FG009|Overall Study|Protocol Violation|0
6951242|NCT01011335|10991842|FG010|Overall Study|Protocol Violation|0
6951243|NCT01011335|10991843|FG011|Overall Study|Protocol Violation|0
6951244|NCT01011335|10991844|FG012|Overall Study|Protocol Violation|0
6951245|NCT01011335|10991832|FG000|Overall Study|Moved/deployed or no booster|1
6951246|NCT01011335|10991833|FG001|Overall Study|Moved/deployed or no booster|0
6951247|NCT01011335|10991834|FG002|Overall Study|Moved/deployed or no booster|0
6951248|NCT01011335|10991835|FG003|Overall Study|Moved/deployed or no booster|1
6951249|NCT01011335|10991836|FG004|Overall Study|Moved/deployed or no booster|0
6951250|NCT01011335|10991837|FG005|Overall Study|Moved/deployed or no booster|0
6951251|NCT01011335|10991838|FG006|Overall Study|Moved/deployed or no booster|1
6951252|NCT01011335|10991839|FG007|Overall Study|Moved/deployed or no booster|0
6951253|NCT01011335|10991840|FG008|Overall Study|Moved/deployed or no booster|1
6951254|NCT01011335|10991841|FG009|Overall Study|Moved/deployed or no booster|0
6951255|NCT01011335|10991842|FG010|Overall Study|Moved/deployed or no booster|2
6951256|NCT01011335|10991843|FG011|Overall Study|Moved/deployed or no booster|0
6951257|NCT01011335|10991844|FG012|Overall Study|Moved/deployed or no booster|0
6951258|NCT01011335|10991832|FG000|Overall Study|Adverse Event|0
6951259|NCT01011335|10991833|FG001|Overall Study|Adverse Event|0
6951260|NCT01011335|10991834|FG002|Overall Study|Adverse Event|0
6951261|NCT01011335|10991835|FG003|Overall Study|Adverse Event|0
6951262|NCT01011335|10991836|FG004|Overall Study|Adverse Event|0
6951263|NCT01011335|10991837|FG005|Overall Study|Adverse Event|0
6951264|NCT01011335|10991838|FG006|Overall Study|Adverse Event|0
6951265|NCT01011335|10991839|FG007|Overall Study|Adverse Event|0
6951266|NCT01011335|10991840|FG008|Overall Study|Adverse Event|0
6951267|NCT01011335|10991841|FG009|Overall Study|Adverse Event|0
6951268|NCT01011335|10991842|FG010|Overall Study|Adverse Event|4
6951269|NCT01011335|10991843|FG011|Overall Study|Adverse Event|0
6951270|NCT01011335|10991844|FG012|Overall Study|Adverse Event|1
6951271|NCT01011387|10991881|FG000|Overall Study|Withdrawal by Subject|3
6951272|NCT01011387|10991881|FG000|Overall Study|Adverse Event|2
6951273|NCT01011387|10991881|FG000|Overall Study|Protocol Violation|1
6951274|NCT01011439|10991901|FG000|Overall Study|Death|37
6951275|NCT01011439|10991901|FG000|Overall Study|Lost to Follow-up|4
6951276|NCT01011439|10991901|FG000|Overall Study|Withdrawal by Subject|1
6951277|NCT01011439|10991901|FG000|Overall Study|Sponsor's decision|15
6951278|NCT01011465|10991914|FG000|Overall Study|Withdrawal by Subject|2
6951279|NCT01011465|10991915|FG001|Overall Study|Withdrawal by Subject|1
6951280|NCT01011465|10991916|FG002|Overall Study|Withdrawal by Subject|0
6951281|NCT01011465|10991917|FG003|Overall Study|Withdrawal by Subject|0
6951282|NCT01011465|10991918|FG004|Overall Study|Withdrawal by Subject|1
6951283|NCT01011465|10991919|FG005|Overall Study|Withdrawal by Subject|0
6951284|NCT01011465|10991920|FG006|Overall Study|Withdrawal by Subject|1
6951285|NCT01011465|10991921|FG007|Overall Study|Withdrawal by Subject|0
6951286|NCT01011556|10991941|FG000|Overall Study|Adverse Event|1
6951287|NCT01011556|10991942|FG001|Overall Study|Adverse Event|3
6951288|NCT01011556|10991943|FG002|Overall Study|Adverse Event|2
6951289|NCT01011556|10991944|FG003|Overall Study|Adverse Event|1
6951290|NCT01011556|10991941|FG000|Overall Study|Lost to Follow-up|1
6951291|NCT01011556|10991942|FG001|Overall Study|Lost to Follow-up|0
6951292|NCT01011556|10991943|FG002|Overall Study|Lost to Follow-up|0
6951293|NCT01011556|10991944|FG003|Overall Study|Lost to Follow-up|0
6951294|NCT01011556|10991941|FG000|Overall Study|Physician Decision|1
6951295|NCT01011556|10991942|FG001|Overall Study|Physician Decision|0
6951296|NCT01011556|10991943|FG002|Overall Study|Physician Decision|0
6951297|NCT01011556|10991944|FG003|Overall Study|Physician Decision|1
6951298|NCT01011556|10991941|FG000|Overall Study|Protocol Violation|0
6951299|NCT01011556|10991942|FG001|Overall Study|Protocol Violation|1
6951300|NCT01011556|10991943|FG002|Overall Study|Protocol Violation|0
6951301|NCT01011556|10991944|FG003|Overall Study|Protocol Violation|0
6951302|NCT01011556|10991941|FG000|Overall Study|Withdrawal by Subject|1
6951303|NCT01011556|10991942|FG001|Overall Study|Withdrawal by Subject|2
6951304|NCT01011556|10991943|FG002|Overall Study|Withdrawal by Subject|4
6951305|NCT01011556|10991944|FG003|Overall Study|Withdrawal by Subject|4
6951306|NCT01011556|10991941|FG000|Overall Study|Sponsor decision|0
6951307|NCT01011556|10991942|FG001|Overall Study|Sponsor decision|1
6951308|NCT01011556|10991943|FG002|Overall Study|Sponsor decision|1
6951309|NCT01011556|10991944|FG003|Overall Study|Sponsor decision|2
6951310|NCT01011556|10991941|FG000|Overall Study|Inclusion/exclusion criteria not met|2
6951311|NCT01011556|10991942|FG001|Overall Study|Inclusion/exclusion criteria not met|1
6951312|NCT01011556|10991943|FG002|Overall Study|Inclusion/exclusion criteria not met|3
6951313|NCT01011556|10991944|FG003|Overall Study|Inclusion/exclusion criteria not met|5
6951314|NCT01011673|10991959|FG000|Randomized|Secondary headache|2
6951315|NCT01011673|10991960|FG001|Randomized|Secondary headache|1
6951316|NCT01011673|10991959|FG000|24 Hour Follow-up|Lost to Follow-up|3
6951317|NCT01011673|10991960|FG001|24 Hour Follow-up|Lost to Follow-up|3
6951318|NCT01011738|10991969|FG000|Overall Study|Death|12
6951319|NCT01011738|10991970|FG001|Overall Study|Death|3
6951320|NCT01011738|10991971|FG002|Overall Study|Death|0
6951321|NCT01011738|10991969|FG000|Overall Study|Unknown reasons|312
6951322|NCT01011738|10991970|FG001|Overall Study|Unknown reasons|291
6951323|NCT01011738|10991971|FG002|Overall Study|Unknown reasons|17
6951324|NCT01011868|10992003|FG000|After Week 18 Follow-up|Adverse Event|8
6951325|NCT01011868|10992004|FG001|After Week 18 Follow-up|Adverse Event|6
6951326|NCT01011868|10992005|FG002|After Week 18 Follow-up|Adverse Event|13
6951327|NCT01011868|10992003|FG000|After Week 18 Follow-up|Lack of Efficacy|1
6951328|NCT01011868|10992004|FG001|After Week 18 Follow-up|Lack of Efficacy|0
6951329|NCT01011868|10992005|FG002|After Week 18 Follow-up|Lack of Efficacy|0
6951330|NCT01011868|10992003|FG000|After Week 18 Follow-up|Protocol Violation|1
6951331|NCT01011868|10992004|FG001|After Week 18 Follow-up|Protocol Violation|1
6951332|NCT01011868|10992005|FG002|After Week 18 Follow-up|Protocol Violation|1
6951333|NCT01011868|10992003|FG000|After Week 18 Follow-up|Lost to Follow-up|5
6951334|NCT01011868|10992004|FG001|After Week 18 Follow-up|Lost to Follow-up|3
6951335|NCT01011868|10992005|FG002|After Week 18 Follow-up|Lost to Follow-up|0
7070290|NCT02010255|11172561|FG007|Overall Study|Randomized but Not Treated|0
7070291|NCT02010255|11172562|FG008|Overall Study|Randomized but Not Treated|0
7070292|NCT02010255|11172563|FG009|Overall Study|Randomized but Not Treated|0
7070293|NCT02010255|11172564|FG010|Overall Study|Randomized but Not Treated|0
7070294|NCT02010255|11172565|FG011|Overall Study|Randomized but Not Treated|0
7070295|NCT02010255|11172566|FG012|Overall Study|Randomized but Not Treated|0
7070296|NCT02010255|11172567|FG013|Overall Study|Randomized but Not Treated|1
7070297|NCT02010567|11172636|FG000|Overall Study|Adverse Event|0
7070298|NCT02010567|11172637|FG001|Overall Study|Adverse Event|0
7070299|NCT02010567|11172638|FG002|Overall Study|Adverse Event|1
7070300|NCT02010567|11172639|FG003|Overall Study|Adverse Event|0
7070301|NCT02010567|11172640|FG004|Overall Study|Adverse Event|1
7070302|NCT02010632|11172650|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1
7070303|NCT02010632|11172651|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0
7070304|NCT02010684|11172663|FG000|Overall Study|Lost to Follow-up|8
7070305|NCT02010684|11172664|FG001|Overall Study|Lost to Follow-up|18
7070306|NCT02010684|11172663|FG000|Overall Study|Withdrawal by Subject|4
7070307|NCT02010684|11172664|FG001|Overall Study|Withdrawal by Subject|5
7070308|NCT02010775|11172688|FG000|Overall Study|Adverse Event|0
7070309|NCT02010775|11172689|FG001|Overall Study|Adverse Event|0
7070310|NCT02010775|11172690|FG002|Overall Study|Adverse Event|0
7070311|NCT02010775|11172691|FG003|Overall Study|Adverse Event|0
7070312|NCT02010775|11172692|FG004|Overall Study|Adverse Event|1
7070313|NCT02010775|11172688|FG000|Overall Study|Pregnancy|0
7070314|NCT02010775|11172689|FG001|Overall Study|Pregnancy|0
7070315|NCT02010775|11172690|FG002|Overall Study|Pregnancy|2
7070316|NCT02010775|11172691|FG003|Overall Study|Pregnancy|0
7070317|NCT02010775|11172692|FG004|Overall Study|Pregnancy|0
7070318|NCT02010775|11172688|FG000|Overall Study|Lost to Follow-up|2
7070319|NCT02010775|11172689|FG001|Overall Study|Lost to Follow-up|0
7070320|NCT02010775|11172690|FG002|Overall Study|Lost to Follow-up|0
7070321|NCT02010775|11172691|FG003|Overall Study|Lost to Follow-up|1
7070322|NCT02010775|11172692|FG004|Overall Study|Lost to Follow-up|1
7070323|NCT02010775|11172688|FG000|Overall Study|Personal Reasons|3
7070324|NCT02010775|11172689|FG001|Overall Study|Personal Reasons|3
7070325|NCT02010775|11172690|FG002|Overall Study|Personal Reasons|1
6951336|NCT01011868|10992003|FG000|After Week 18 Follow-up|Withdrawal by Subject|6
6951337|NCT01011868|10992004|FG001|After Week 18 Follow-up|Withdrawal by Subject|3
6951338|NCT01011868|10992005|FG002|After Week 18 Follow-up|Withdrawal by Subject|0
6951339|NCT01011868|10992003|FG000|After Week 18 Follow-up|Other reason not defined above|2
6951340|NCT01011868|10992004|FG001|After Week 18 Follow-up|Other reason not defined above|3
6951341|NCT01011868|10992005|FG002|After Week 18 Follow-up|Other reason not defined above|12
6951342|NCT01011868|10992003|FG000|After Week 78 Follow-up|Adverse Event|14
6951343|NCT01011868|10992004|FG001|After Week 78 Follow-up|Adverse Event|18
6951344|NCT01011868|10992005|FG002|After Week 78 Follow-up|Adverse Event|21
6951345|NCT01011868|10992003|FG000|After Week 78 Follow-up|Lack of Efficacy|4
6951346|NCT01011868|10992004|FG001|After Week 78 Follow-up|Lack of Efficacy|0
6951347|NCT01011868|10992005|FG002|After Week 78 Follow-up|Lack of Efficacy|0
6951348|NCT01011868|10992003|FG000|After Week 78 Follow-up|Protocol Violation|9
6951349|NCT01011868|10992004|FG001|After Week 78 Follow-up|Protocol Violation|1
6951350|NCT01011868|10992005|FG002|After Week 78 Follow-up|Protocol Violation|2
6951351|NCT01011868|10992003|FG000|After Week 78 Follow-up|Lost to Follow-up|11
6951352|NCT01011868|10992004|FG001|After Week 78 Follow-up|Lost to Follow-up|6
6951353|NCT01011868|10992005|FG002|After Week 78 Follow-up|Lost to Follow-up|4
6951354|NCT01011868|10992003|FG000|After Week 78 Follow-up|Withdrawal by Subject|9
6951355|NCT01011868|10992004|FG001|After Week 78 Follow-up|Withdrawal by Subject|8
6951356|NCT01011868|10992005|FG002|After Week 78 Follow-up|Withdrawal by Subject|1
6951357|NCT01011868|10992003|FG000|After Week 78 Follow-up|Other reason not defined above|5
6951358|NCT01011868|10992004|FG001|After Week 78 Follow-up|Other reason not defined above|5
6951359|NCT01011868|10992005|FG002|After Week 78 Follow-up|Other reason not defined above|16
6951360|NCT01011907|10992019|FG000|Overall Study|Withdrawal by Subject|13
6951361|NCT01011907|10992020|FG001|Overall Study|Withdrawal by Subject|11
6951362|NCT01011907|10992019|FG000|Overall Study|Adverse Event|1
6951363|NCT01011907|10992020|FG001|Overall Study|Adverse Event|4
6951364|NCT01011933|10992026|FG000|Overall Study|Wrong cell type|1
6951365|NCT01011933|10992026|FG000|Overall Study|Improper pre-protocol Rx|1
6951366|NCT01011933|10992026|FG000|Overall Study|Inadequate pathology|1
6951367|NCT01011933|10992026|FG000|Overall Study|Never treated|1
6951368|NCT01011946|10992036|FG000|Overall Study|Transferred to another hospital|2
6951369|NCT01011946|10992036|FG000|Overall Study|No pathological lab value|1
6951370|NCT01012037|10992043|FG000|Overall Study|Adverse Event|0
6951371|NCT01012037|10992044|FG001|Overall Study|Adverse Event|8
6951372|NCT01012037|10992045|FG002|Overall Study|Adverse Event|3
6951373|NCT01012037|10992043|FG000|Overall Study|Protocol Violation|0
7070326|NCT02010775|11172691|FG003|Overall Study|Personal Reasons|2
6951374|NCT01012037|10992044|FG001|Overall Study|Protocol Violation|3
7070327|NCT02010775|11172692|FG004|Overall Study|Personal Reasons|4
7070328|NCT02011113|11172717|FG000|Overall Study|Adverse Event|4
7070329|NCT02011113|11172717|FG000|Overall Study|Disease Progression (DP)|16
7070330|NCT02011113|11172717|FG000|Overall Study|Death|1
6951375|NCT01012037|10992045|FG002|Overall Study|Protocol Violation|5
6951376|NCT01012037|10992043|FG000|Overall Study|Withdrawal by Subject|0
6951377|NCT01012037|10992044|FG001|Overall Study|Withdrawal by Subject|4
6951378|NCT01012037|10992045|FG002|Overall Study|Withdrawal by Subject|1
6951379|NCT01012037|10992043|FG000|Overall Study|Other reason (not specified)|1
6951380|NCT01012037|10992044|FG001|Overall Study|Other reason (not specified)|1
6951381|NCT01012037|10992045|FG002|Overall Study|Other reason (not specified)|1
6951382|NCT01012219|10992061|FG000|Period 1|Withdrawal by Subject|1
6951383|NCT01012219|10992061|FG000|Period 2|Withdrawal by Subject|1
6951384|NCT01012258|10992083|FG000|Overall Study|Death|14
6951385|NCT01012258|10992083|FG000|Overall Study|Lost to Follow-up|1
6951386|NCT01012258|10992083|FG000|Overall Study|Adverse Event|1
6951387|NCT01012258|10992083|FG000|Overall Study|Progressive Disease (PD)|18
6951388|NCT01012258|10992083|FG000|Overall Study|Symptomatic Deterioration|1
6951389|NCT01012258|10992083|FG000|Overall Study|Another Anti-cancer Drug Received|1
6951390|NCT01012258|10992083|FG000|Overall Study|Another Tumor Discovered|1
6951391|NCT01012258|10992083|FG000|Overall Study|Ongoing|29
6951392|NCT01012323|10992097|FG000|Overall Study|Investigator Judgment|1
6951393|NCT01012440|10992134|FG000|Overall Study|Withdrawal by Subject|2
6951394|NCT01012622|10992142|FG000|Overall Study|Withdrawal by Subject|6
6951395|NCT01012622|10992142|FG000|Overall Study|Lost to Follow-up|5
6951396|NCT01012622|10992142|FG000|Overall Study|Adverse Event|7
6951397|NCT01012622|10992142|FG000|Overall Study|non-compliance with the drug|9
6951398|NCT01012622|10992142|FG000|Overall Study|Other|1
6951399|NCT01012622|10992142|FG000|Overall Study|screening failure|1
6951400|NCT01012622|10992142|FG000|Overall Study|withdrawal of consent by a parent|2
6951401|NCT01012713|10992160|FG000|Overall Study|Lack of Efficacy|3
6951402|NCT01012739|10992165|FG000|Treatment Period 1|Adverse Event|0
6951403|NCT01012739|10992166|FG001|Treatment Period 1|Adverse Event|0
6951404|NCT01012739|10992167|FG002|Treatment Period 1|Adverse Event|0
6951405|NCT01012739|10992168|FG003|Treatment Period 1|Adverse Event|1
6951406|NCT01012739|10992165|FG000|Treatment Period 2|Abnormal test procedure results|0
7070331|NCT02011113|11172717|FG000|Overall Study|Insufficient effect of Pomalidomide|1
7070332|NCT02011113|11172717|FG000|Overall Study|Investigator's judgement- DP|3
7070333|NCT02011113|11172717|FG000|Overall Study|Study terminated by sponsor|11
6951407|NCT01012739|10992166|FG001|Treatment Period 2|Abnormal test procedure results|0
6951408|NCT01012739|10992167|FG002|Treatment Period 2|Abnormal test procedure results|0
6951409|NCT01012739|10992168|FG003|Treatment Period 2|Abnormal test procedure results|1
6951410|NCT01012765|10992179|FG000|Treatment Period 1|Adverse Event|1
6951411|NCT01012765|10992180|FG001|Treatment Period 1|Adverse Event|0
7070334|NCT02011386|11172722|FG000|Overall Study|Non-compliance|2
6951412|NCT01012765|10992181|FG002|Treatment Period 1|Adverse Event|1
6951413|NCT01012765|10992182|FG003|Treatment Period 1|Adverse Event|0
6951414|NCT01012765|10992183|FG004|Treatment Period 1|Adverse Event|0
6951415|NCT01012765|10992184|FG005|Treatment Period 1|Adverse Event|0
6951416|NCT01012765|10992179|FG000|Treatment Period 1|Withdrawal by Subject|2
7070335|NCT02011386|11172722|FG000|Overall Study|Lack of Efficacy|3
7070336|NCT02011893|11172778|FG000|Enrollment to Randomization|Adverse Event|2
7070337|NCT02011893|11172779|FG001|Enrollment to Randomization|Adverse Event|0
6951417|NCT01012765|10992180|FG001|Treatment Period 1|Withdrawal by Subject|0
6951418|NCT01012765|10992181|FG002|Treatment Period 1|Withdrawal by Subject|0
6951419|NCT01012765|10992182|FG003|Treatment Period 1|Withdrawal by Subject|0
6951420|NCT01012765|10992183|FG004|Treatment Period 1|Withdrawal by Subject|0
6951421|NCT01012765|10992184|FG005|Treatment Period 1|Withdrawal by Subject|0
6951422|NCT01012765|10992179|FG000|Treatment Period 1|Administrative problems|0
6951423|NCT01012765|10992180|FG001|Treatment Period 1|Administrative problems|0
6951424|NCT01012765|10992181|FG002|Treatment Period 1|Administrative problems|1
6951425|NCT01012765|10992182|FG003|Treatment Period 1|Administrative problems|1
6951426|NCT01012765|10992183|FG004|Treatment Period 1|Administrative problems|1
6951427|NCT01012765|10992184|FG005|Treatment Period 1|Administrative problems|0
6951428|NCT01012765|10992179|FG000|Treatment Period 1|Protocol Violation|0
6951429|NCT01012765|10992180|FG001|Treatment Period 1|Protocol Violation|0
6951430|NCT01012765|10992181|FG002|Treatment Period 1|Protocol Violation|0
6951431|NCT01012765|10992182|FG003|Treatment Period 1|Protocol Violation|2
6951432|NCT01012765|10992183|FG004|Treatment Period 1|Protocol Violation|1
6951433|NCT01012765|10992184|FG005|Treatment Period 1|Protocol Violation|0
6951434|NCT01012765|10992179|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0
6951435|NCT01012765|10992180|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0
6951436|NCT01012765|10992181|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0
6951437|NCT01012765|10992182|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0
6951438|NCT01012765|10992183|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1
6951439|NCT01012765|10992184|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0
6951440|NCT01012765|10992179|FG000|Treatment Period 2|Withdrawal by Subject|1
6951441|NCT01012765|10992180|FG001|Treatment Period 2|Withdrawal by Subject|0
6951442|NCT01012765|10992181|FG002|Treatment Period 2|Withdrawal by Subject|1
6951443|NCT01012765|10992182|FG003|Treatment Period 2|Withdrawal by Subject|0
6951444|NCT01012765|10992183|FG004|Treatment Period 2|Withdrawal by Subject|1
6951445|NCT01012765|10992184|FG005|Treatment Period 2|Withdrawal by Subject|0
6951446|NCT01012765|10992179|FG000|Treatment Period 2|Abnormal laboratory value(s)|0
6951447|NCT01012765|10992180|FG001|Treatment Period 2|Abnormal laboratory value(s)|0
6951448|NCT01012765|10992181|FG002|Treatment Period 2|Abnormal laboratory value(s)|0
6951449|NCT01012765|10992182|FG003|Treatment Period 2|Abnormal laboratory value(s)|0
6951450|NCT01012765|10992183|FG004|Treatment Period 2|Abnormal laboratory value(s)|0
6951451|NCT01012765|10992184|FG005|Treatment Period 2|Abnormal laboratory value(s)|1
6951452|NCT01012765|10992179|FG000|Treatment Period 2|Adverse Event|0
6951453|NCT01012765|10992180|FG001|Treatment Period 2|Adverse Event|1
6951454|NCT01012765|10992181|FG002|Treatment Period 2|Adverse Event|1
6951455|NCT01012765|10992182|FG003|Treatment Period 2|Adverse Event|0
6951456|NCT01012765|10992183|FG004|Treatment Period 2|Adverse Event|0
6951457|NCT01012765|10992184|FG005|Treatment Period 2|Adverse Event|0
6951458|NCT01012765|10992179|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0
6951459|NCT01012765|10992180|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1
6951460|NCT01012765|10992181|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1
6951461|NCT01012765|10992182|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0
6951462|NCT01012765|10992183|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0
6951463|NCT01012765|10992184|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0
6951464|NCT01012947|10992206|FG000|Overall Study|Lost to Follow-up|131
6951465|NCT01012947|10992207|FG001|Overall Study|Lost to Follow-up|135
6951466|NCT01012947|10992208|FG002|Overall Study|Lost to Follow-up|130
6951467|NCT01012947|10992209|FG003|Overall Study|Lost to Follow-up|118
6951468|NCT01012947|10992210|FG004|Overall Study|Lost to Follow-up|142
6951469|NCT01012973|10992224|FG000|Overall Study|Adverse Event|5
6951470|NCT01012973|10992225|FG001|Overall Study|Adverse Event|5
6951471|NCT01012973|10992224|FG000|Overall Study|Lack of Efficacy|0
6951472|NCT01012973|10992225|FG001|Overall Study|Lack of Efficacy|5
6951473|NCT01012973|10992224|FG000|Overall Study|Lost to Follow-up|1
6951474|NCT01012973|10992225|FG001|Overall Study|Lost to Follow-up|0
6951475|NCT01012973|10992224|FG000|Overall Study|(Overseas travel - indefinite period)|1
6951476|NCT01012973|10992225|FG001|Overall Study|(Overseas travel - indefinite period)|0
6951477|NCT01012973|10992224|FG000|Overall Study|Increase in vis. acuity, never injected|0
6951478|NCT01012973|10992225|FG001|Overall Study|Increase in vis. acuity, never injected|1
6951479|NCT01012973|10992224|FG000|Overall Study|Protocol Violation|5
6951480|NCT01012973|10992225|FG001|Overall Study|Protocol Violation|2
6951481|NCT01012973|10992224|FG000|Overall Study|Withdrawal by Subject|4
6951482|NCT01012973|10992225|FG001|Overall Study|Withdrawal by Subject|6
6951483|NCT01012999|10992235|FG000|Overall Study|Protocol Violation|1
6951484|NCT01013207|10992252|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6
7070338|NCT02011893|11172780|FG002|Enrollment to Randomization|Adverse Event|0
7070339|NCT02011893|11172778|FG000|Enrollment to Randomization|Physician Decision|10
7070340|NCT02011893|11172779|FG001|Enrollment to Randomization|Physician Decision|0
7070341|NCT02011893|11172780|FG002|Enrollment to Randomization|Physician Decision|0
7070342|NCT02011893|11172778|FG000|Enrollment to Randomization|Withdrawal by Subject|21
7070343|NCT02011893|11172779|FG001|Enrollment to Randomization|Withdrawal by Subject|0
6951485|NCT01013285|10992258|FG000|Overall Study|Death|48
6951486|NCT01013285|10992259|FG001|Overall Study|Death|89
6951487|NCT01013350|10992266|FG000|Overall Study|Lost to Follow-up|15
6951488|NCT01013350|10992267|FG001|Overall Study|Lost to Follow-up|95
6951489|NCT01013350|10992266|FG000|Overall Study|Adverse Event|0
6951490|NCT01013350|10992267|FG001|Overall Study|Adverse Event|1
6951491|NCT01013350|10992266|FG000|Overall Study|Physician Decision|4
6951492|NCT01013350|10992267|FG001|Overall Study|Physician Decision|20
6951493|NCT01013350|10992266|FG000|Overall Study|Withdrawal by Subject|15
6951494|NCT01013350|10992267|FG001|Overall Study|Withdrawal by Subject|38
6951495|NCT01013350|10992266|FG000|Overall Study|Death|3
6951496|NCT01013350|10992267|FG001|Overall Study|Death|5
6951497|NCT01013350|10992266|FG000|Overall Study|Participant entered interventional study|0
6951498|NCT01013350|10992267|FG001|Overall Study|Participant entered interventional study|8
6951499|NCT01013350|10992266|FG000|Overall Study|Other|1
6951500|NCT01013350|10992267|FG001|Overall Study|Other|25
6951501|NCT01013597|10992274|FG000|Overall Study|Withdrawal by Subject|1
6951502|NCT01013740|10992280|FG000|Overall Study|Lost to Follow-up|3
6951503|NCT01013740|10992281|FG001|Overall Study|Lost to Follow-up|5
6951504|NCT01013740|10992280|FG000|Overall Study|Physician Decision|2
6951505|NCT01013740|10992281|FG001|Overall Study|Physician Decision|0
6951506|NCT01013740|10992280|FG000|Overall Study|Withdrawal by Subject|2
6951507|NCT01013740|10992281|FG001|Overall Study|Withdrawal by Subject|10
6951508|NCT01013740|10992280|FG000|Overall Study|study close / terminated : done in error|2
6951509|NCT01013740|10992281|FG001|Overall Study|study close / terminated : done in error|1
6951510|NCT01013740|10992280|FG000|Overall Study|Missing|2
6951511|NCT01013740|10992281|FG001|Overall Study|Missing|1
6951512|NCT01013740|10992280|FG000|Overall Study|Ongoing: Study records not completed|0
6951513|NCT01013740|10992281|FG001|Overall Study|Ongoing: Study records not completed|2
6951514|NCT01013753|10992289|FG000|Overall Study|Adverse Event|8
6951515|NCT01013753|10992289|FG000|Overall Study|Protocol Violation|3
6951516|NCT01013753|10992289|FG000|Overall Study|Lost to Follow-up|1
6951517|NCT01013753|10992289|FG000|Overall Study|Withdrawal by Subject|2
6951518|NCT01013753|10992289|FG000|Overall Study|Other|2
6951519|NCT01013792|10992305|FG000|Overall Study|Study suspended|2
6951520|NCT01013792|10992306|FG001|Overall Study|Study suspended|1
6951521|NCT01013792|10992305|FG000|Overall Study|Adverse Event|0
6951522|NCT01013792|10992306|FG001|Overall Study|Adverse Event|3
6951523|NCT01013792|10992305|FG000|Overall Study|Lost to Follow-up|0
6951524|NCT01013792|10992306|FG001|Overall Study|Lost to Follow-up|1
6951525|NCT01013870|10992327|FG000|Overall Study|Lost to Follow-up|1
6951526|NCT01013870|10992328|FG001|Overall Study|Lost to Follow-up|3
6951527|NCT01013883|10992336|FG000|Overall Study|Lost to Follow-up|2
6951528|NCT01013883|10992337|FG001|Overall Study|Lost to Follow-up|2
6951529|NCT01013961|10992345|FG000|Overall Study|Adverse Event|2
6951530|NCT01013961|10992346|FG001|Overall Study|Adverse Event|2
6951531|NCT01013961|10992345|FG000|Overall Study|Withdrawal by Subject|1
6951532|NCT01013961|10992346|FG001|Overall Study|Withdrawal by Subject|0
6951533|NCT01013961|10992345|FG000|Overall Study|Physician Decision|0
6951534|NCT01013961|10992346|FG001|Overall Study|Physician Decision|1
6951535|NCT01014013|10992354|FG000|Overall Study|Inclusion/Exclusion criteria not met|1
6951536|NCT01014013|10992355|FG001|Overall Study|Inclusion/Exclusion criteria not met|3
6951537|NCT01014013|10992354|FG000|Overall Study|Clinical adverse experience|4
6951538|NCT01014013|10992355|FG001|Overall Study|Clinical adverse experience|2
6951539|NCT01014013|10992354|FG000|Overall Study|Laboratory adverse experience|1
6951540|NCT01014013|10992355|FG001|Overall Study|Laboratory adverse experience|1
6951541|NCT01014013|10992354|FG000|Overall Study|Protocol Violation|1
6951542|NCT01014013|10992355|FG001|Overall Study|Protocol Violation|3
6951543|NCT01014013|10992354|FG000|Overall Study|Withdrawal by Subject|7
6951544|NCT01014013|10992355|FG001|Overall Study|Withdrawal by Subject|4
6951545|NCT01014013|10992354|FG000|Overall Study|Clinical/microbiologic failure|1
6951546|NCT01014013|10992355|FG001|Overall Study|Clinical/microbiologic failure|2
6951547|NCT01014013|10992354|FG000|Overall Study|Pathogen culture = no growth|26
6951548|NCT01014013|10992355|FG001|Overall Study|Pathogen culture = no growth|34
6951549|NCT01014013|10992354|FG000|Overall Study|Negative urine culture|2
6951550|NCT01014013|10992355|FG001|Overall Study|Negative urine culture|0
6951551|NCT01014013|10992354|FG000|Overall Study|Pathogen resistant|7
6951552|NCT01014013|10992355|FG001|Overall Study|Pathogen resistant|4
6951553|NCT01014013|10992354|FG000|Overall Study|Physician Decision|0
6951554|NCT01014013|10992355|FG001|Overall Study|Physician Decision|1
6951555|NCT01014013|10992354|FG000|Overall Study|Another antibiotic therapy required|0
6951556|NCT01014013|10992355|FG001|Overall Study|Another antibiotic therapy required|1
6951557|NCT01014013|10992354|FG000|Overall Study|Appendectomy|1
6951558|NCT01014013|10992355|FG001|Overall Study|Appendectomy|0
6951559|NCT01014013|10992354|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0
6951560|NCT01014013|10992355|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1
6951561|NCT01014143|10992400|FG000|Second Intervention|Lost to Follow-up|2
6951562|NCT01014143|10992401|FG001|Second Intervention|Lost to Follow-up|0
6951563|NCT01014143|10992402|FG002|Second Intervention|Lost to Follow-up|0
6951564|NCT01014208|10992421|FG000|Overall Study|Lost to Follow-up|2
6951565|NCT01014208|10992422|FG001|Overall Study|Lost to Follow-up|5
6951566|NCT01014208|10992421|FG000|Overall Study|Participant Withdrew Consent|12
6951567|NCT01014208|10992422|FG001|Overall Study|Participant Withdrew Consent|12
7070344|NCT02011893|11172780|FG002|Enrollment to Randomization|Withdrawal by Subject|0
6951568|NCT01014208|10992421|FG000|Overall Study|Did Not Receive Study Drug|2
6951569|NCT01014208|10992422|FG001|Overall Study|Did Not Receive Study Drug|0
6951570|NCT01014208|10992421|FG000|Overall Study|Study Closed/terminated|78
6951571|NCT01014208|10992422|FG001|Overall Study|Study Closed/terminated|83
6951572|NCT01014442|10992447|FG000|Overall Study|Adverse Event|0
6951573|NCT01014442|10992448|FG001|Overall Study|Adverse Event|8
6951574|NCT01014442|10992447|FG000|Overall Study|Withdrawal by Subject|4
6951575|NCT01014442|10992448|FG001|Overall Study|Withdrawal by Subject|4
6951576|NCT01014442|10992447|FG000|Overall Study|Protocol Violation|2
6951577|NCT01014442|10992448|FG001|Overall Study|Protocol Violation|5
6951578|NCT01014442|10992447|FG000|Overall Study|Lack of Compliance|0
6951579|NCT01014442|10992448|FG001|Overall Study|Lack of Compliance|1
6951580|NCT01014442|10992447|FG000|Overall Study|Unspecified Reason|1
6951581|NCT01014442|10992448|FG001|Overall Study|Unspecified Reason|1
6951582|NCT01014533|10992469|FG000|Overall Study|Protocol Violation|3
6951583|NCT01014533|10992470|FG001|Overall Study|Protocol Violation|2
6951584|NCT01014533|10992469|FG000|Overall Study|Withdrawal by Subject|2
6951585|NCT01014533|10992470|FG001|Overall Study|Withdrawal by Subject|0
6951586|NCT01014533|10992469|FG000|Overall Study|unable to come to appointment|0
6951587|NCT01014533|10992470|FG001|Overall Study|unable to come to appointment|3
6951588|NCT01014585|10992481|FG000|Overall Study|Adverse Event|0
6951589|NCT01014585|10992482|FG001|Overall Study|Adverse Event|2
6951590|NCT01014585|10992483|FG002|Overall Study|Adverse Event|0
6951591|NCT01014585|10992484|FG003|Overall Study|Adverse Event|3
6951592|NCT01014585|10992481|FG000|Overall Study|Withdrawal by Subject|2
6951593|NCT01014585|10992482|FG001|Overall Study|Withdrawal by Subject|0
6951594|NCT01014585|10992483|FG002|Overall Study|Withdrawal by Subject|1
6951595|NCT01014585|10992484|FG003|Overall Study|Withdrawal by Subject|3
6951596|NCT01014585|10992481|FG000|Overall Study|Lost to Follow-up|0
6951597|NCT01014585|10992482|FG001|Overall Study|Lost to Follow-up|0
6951598|NCT01014585|10992483|FG002|Overall Study|Lost to Follow-up|0
6951599|NCT01014585|10992484|FG003|Overall Study|Lost to Follow-up|2
6951600|NCT01014585|10992481|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18
6951601|NCT01014585|10992482|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23
6951602|NCT01014585|10992483|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
6951603|NCT01014585|10992484|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
6951604|NCT01014624|10992496|FG000|Overall Study|Adverse Event|0
6951605|NCT01014624|10992497|FG001|Overall Study|Adverse Event|1
6951606|NCT01014624|10992496|FG000|Overall Study|Protocol Violation|1
6951607|NCT01014624|10992497|FG001|Overall Study|Protocol Violation|0
6951608|NCT01014624|10992496|FG000|Overall Study|Withdrawal by Subject|1
6951609|NCT01014624|10992497|FG001|Overall Study|Withdrawal by Subject|0
6951610|NCT01014689|10992507|FG000|Overall Study|Lack of Efficacy|0
6951611|NCT01014689|10992508|FG001|Overall Study|Lack of Efficacy|1
6951612|NCT01014689|10992507|FG000|Overall Study|Adverse Event|3
6951613|NCT01014689|10992508|FG001|Overall Study|Adverse Event|0
6951614|NCT01014689|10992507|FG000|Overall Study|Withdrawal by Subject|5
6951615|NCT01014689|10992508|FG001|Overall Study|Withdrawal by Subject|4
6951616|NCT01014689|10992507|FG000|Overall Study|Protocol Violation|1
6951617|NCT01014689|10992508|FG001|Overall Study|Protocol Violation|1
6951618|NCT01014689|10992507|FG000|Overall Study|Lost to Follow-up|3
6951619|NCT01014689|10992508|FG001|Overall Study|Lost to Follow-up|7
6951620|NCT01014689|10992507|FG000|Overall Study|Pregnancy|1
6951621|NCT01014689|10992508|FG001|Overall Study|Pregnancy|0
6976014|NCT01196429|11028386|FG000|Overall Study|Ineligible - inadequate pathology|1
6976015|NCT01196429|11028387|FG001|Overall Study|Ineligible - inadequate pathology|0
6976016|NCT01196429|11028386|FG000|Overall Study|Ineligible - wrong cell type|1
6976017|NCT01196429|11028387|FG001|Overall Study|Ineligible - wrong cell type|0
6976018|NCT01196429|11028386|FG000|Overall Study|Refused - Never Treated|1
6976019|NCT01196429|11028387|FG001|Overall Study|Refused - Never Treated|0
6976020|NCT01196741|11028406|FG000|Overall Study|Disease progression|34
6976021|NCT01196741|11028407|FG001|Overall Study|Disease progression|14
6976022|NCT01196741|11028406|FG000|Overall Study|Adverse Event|10
6976023|NCT01196741|11028407|FG001|Overall Study|Adverse Event|6
6976024|NCT01196741|11028406|FG000|Overall Study|Serious Adverse Event|3
6976025|NCT01196741|11028407|FG001|Overall Study|Serious Adverse Event|1
6976026|NCT01196741|11028406|FG000|Overall Study|Dose limiting Adverse Event|2
6976027|NCT01196741|11028407|FG001|Overall Study|Dose limiting Adverse Event|1
6976028|NCT01196741|11028406|FG000|Overall Study|Withdrawal by Subject|3
6976029|NCT01196741|11028407|FG001|Overall Study|Withdrawal by Subject|0
6976030|NCT01196741|11028406|FG000|Overall Study|Other reason|3
6976031|NCT01196741|11028407|FG001|Overall Study|Other reason|3
6976032|NCT01196741|11028406|FG000|Overall Study|Other|3
6976033|NCT01196741|11028407|FG001|Overall Study|Other|2
6976034|NCT01196741|11028406|FG000|Overall Study|Protocol Violation|2
6976035|NCT01196741|11028407|FG001|Overall Study|Protocol Violation|1
6976036|NCT01196975|11028469|FG000|Overall Study|Adverse Event|2
6976037|NCT01196975|11028470|FG001|Overall Study|Adverse Event|2
6976038|NCT01196975|11028471|FG002|Overall Study|Adverse Event|0
6976039|NCT01196975|11028472|FG003|Overall Study|Adverse Event|0
6976040|NCT01196975|11028473|FG004|Overall Study|Adverse Event|2
6976041|NCT01196975|11028469|FG000|Overall Study|Withdrawal by Subject|2
6976042|NCT01196975|11028470|FG001|Overall Study|Withdrawal by Subject|1
6976043|NCT01196975|11028471|FG002|Overall Study|Withdrawal by Subject|0
6976044|NCT01196975|11028472|FG003|Overall Study|Withdrawal by Subject|1
6951622|NCT01014910|10992540|FG000|Overall Study|Withdrawal by Subject|0
6951623|NCT01014910|10992541|FG001|Overall Study|Withdrawal by Subject|2
6951624|NCT01014975|10992618|FG000|Overall Study|Withdrawal by Subject|1
6951625|NCT01014975|10992619|FG001|Overall Study|Withdrawal by Subject|0
6951626|NCT01014975|10992620|FG002|Overall Study|Withdrawal by Subject|1
6951627|NCT01014975|10992618|FG000|Overall Study|Death|3
6951628|NCT01014975|10992619|FG001|Overall Study|Death|3
6951629|NCT01014975|10992620|FG002|Overall Study|Death|4
6951630|NCT01014975|10992618|FG000|Overall Study|Lost to Follow-up|0
6951631|NCT01014975|10992619|FG001|Overall Study|Lost to Follow-up|0
6951632|NCT01014975|10992620|FG002|Overall Study|Lost to Follow-up|1
6951633|NCT01014988|10992634|FG000|Overall Study|Adverse Event|20
6951634|NCT01014988|10992635|FG001|Overall Study|Adverse Event|0
6951635|NCT01014988|10992636|FG002|Overall Study|Adverse Event|1
6951636|NCT01014988|10992637|FG003|Overall Study|Adverse Event|0
6951637|NCT01014988|10992638|FG004|Overall Study|Adverse Event|1
6951638|NCT01014988|10992639|FG005|Overall Study|Adverse Event|3
6951639|NCT01014988|10992634|FG000|Overall Study|Lost to Follow-up|1
6951640|NCT01014988|10992635|FG001|Overall Study|Lost to Follow-up|0
6951641|NCT01014988|10992636|FG002|Overall Study|Lost to Follow-up|1
6951642|NCT01014988|10992637|FG003|Overall Study|Lost to Follow-up|0
6951643|NCT01014988|10992638|FG004|Overall Study|Lost to Follow-up|0
6951644|NCT01014988|10992639|FG005|Overall Study|Lost to Follow-up|0
6951645|NCT01014988|10992634|FG000|Overall Study|Physician Decision|1
6951646|NCT01014988|10992635|FG001|Overall Study|Physician Decision|0
6951647|NCT01014988|10992636|FG002|Overall Study|Physician Decision|0
6951648|NCT01014988|10992637|FG003|Overall Study|Physician Decision|0
6951649|NCT01014988|10992638|FG004|Overall Study|Physician Decision|0
6951650|NCT01014988|10992639|FG005|Overall Study|Physician Decision|0
6951651|NCT01014988|10992634|FG000|Overall Study|Withdrawal by Subject|1
6951652|NCT01014988|10992635|FG001|Overall Study|Withdrawal by Subject|0
6951653|NCT01014988|10992636|FG002|Overall Study|Withdrawal by Subject|0
6951654|NCT01014988|10992637|FG003|Overall Study|Withdrawal by Subject|0
6951655|NCT01014988|10992638|FG004|Overall Study|Withdrawal by Subject|0
6951656|NCT01014988|10992639|FG005|Overall Study|Withdrawal by Subject|0
6951657|NCT01015118|10992663|FG000|Overall Study|Protocol Violation|5
6951658|NCT01015118|10992664|FG001|Overall Study|Protocol Violation|6
6951659|NCT01015118|10992663|FG000|Overall Study|Withdrawal by Subject|103
6951660|NCT01015118|10992664|FG001|Overall Study|Withdrawal by Subject|27
6951661|NCT01015118|10992663|FG000|Overall Study|Other Adverse Event (AE)|141
6951662|NCT01015118|10992664|FG001|Overall Study|Other Adverse Event (AE)|33
6951663|NCT01015118|10992663|FG000|Overall Study|Worsening or AE of underlying disease|5
6951664|NCT01015118|10992664|FG001|Overall Study|Worsening or AE of underlying disease|4
6951665|NCT01015118|10992663|FG000|Overall Study|Progressive disease|364
6951666|NCT01015118|10992664|FG001|Overall Study|Progressive disease|229
6951667|NCT01015118|10992663|FG000|Overall Study|Not treated|9
6951668|NCT01015118|10992664|FG001|Overall Study|Not treated|5
6951669|NCT01015118|10992663|FG000|Overall Study|Other than stated above|42
6951670|NCT01015118|10992664|FG001|Overall Study|Other than stated above|23
6951671|NCT01015131|10992670|FG000|Overall Study|Physician Decision|1
6951672|NCT01015131|10992670|FG000|Overall Study|Protocol Violation|1
6951673|NCT01015131|10992670|FG000|Overall Study|Withdrawal by Subject|2
6951674|NCT01015131|10992670|FG000|Overall Study|Other Protocol Specified Criteria|4
6951675|NCT01015287|10992682|FG000|Overall Study|Death|21
6951676|NCT01015287|10992683|FG001|Overall Study|Death|16
6951677|NCT01015287|10992682|FG000|Overall Study|Adverse Event|1
6951678|NCT01015287|10992683|FG001|Overall Study|Adverse Event|0
6951679|NCT01015287|10992682|FG000|Overall Study|Sponsor Decision|3
6951680|NCT01015287|10992683|FG001|Overall Study|Sponsor Decision|7
6951681|NCT01015287|10992682|FG000|Overall Study|Physician Decision|19
6951682|NCT01015287|10992683|FG001|Overall Study|Physician Decision|21
6951683|NCT01015287|10992682|FG000|Overall Study|Withdrawal by Subject|14
6951684|NCT01015287|10992683|FG001|Overall Study|Withdrawal by Subject|19
6951685|NCT01015287|10992682|FG000|Overall Study|Entry Criteria not Met|11
6951686|NCT01015287|10992683|FG001|Overall Study|Entry Criteria not Met|14
6951687|NCT01015287|10992682|FG000|Overall Study|Lost to Follow-up|2
6951688|NCT01015287|10992683|FG001|Overall Study|Lost to Follow-up|1
6951689|NCT01015287|10992682|FG000|Overall Study|Protocol Violation|1
6951690|NCT01015287|10992683|FG001|Overall Study|Protocol Violation|1
6951691|NCT01015560|10992721|FG000|Overall Study|Adverse Event|1
6951692|NCT01015560|10992721|FG000|Overall Study|Not protocol specified|1
6951693|NCT01015560|10992721|FG000|Overall Study|Withdrawal by Subject|1
6951694|NCT01015612|10992734|FG000|Overall Study|Death|113
6951695|NCT01015612|10992734|FG000|Overall Study|Withdrawal by Subject|40
7147789|NCT03135899|11308633|FG005|Overall Study|Withdrawal by Subject|2
6951696|NCT01015638|10992740|FG000|Overall Study|Withdrawal by Subject|1
6951697|NCT01015638|10992741|FG001|Overall Study|Withdrawal by Subject|0
6951698|NCT01015677|10992750|FG000|Overall Study|Adverse Event|0
6951699|NCT01015677|10992751|FG001|Overall Study|Adverse Event|1
6951700|NCT01015677|10992752|FG002|Overall Study|Adverse Event|0
6951701|NCT01015677|10992750|FG000|Overall Study|Lack of Efficacy|0
6951702|NCT01015677|10992751|FG001|Overall Study|Lack of Efficacy|1
6951703|NCT01015677|10992752|FG002|Overall Study|Lack of Efficacy|0
6951704|NCT01015677|10992750|FG000|Overall Study|Protocol Violation|0
6951705|NCT01015677|10992751|FG001|Overall Study|Protocol Violation|1
6951706|NCT01015677|10992752|FG002|Overall Study|Protocol Violation|0
6951707|NCT01015677|10992750|FG000|Overall Study|Withdrawal by Subject|1
6951708|NCT01015677|10992751|FG001|Overall Study|Withdrawal by Subject|1
6951709|NCT01015677|10992752|FG002|Overall Study|Withdrawal by Subject|0
6951710|NCT01015703|10992765|FG000|Overall Study|Withdrawal by Subject|0
6951711|NCT01015703|10992766|FG001|Overall Study|Withdrawal by Subject|1
6951712|NCT01015703|10992767|FG002|Overall Study|Withdrawal by Subject|0
6951713|NCT01015703|10992768|FG003|Overall Study|Withdrawal by Subject|0
6951714|NCT01015703|10992769|FG004|Overall Study|Withdrawal by Subject|0
6951715|NCT01015703|10992765|FG000|Overall Study|Adverse Event|1
6951716|NCT01015703|10992766|FG001|Overall Study|Adverse Event|0
6951717|NCT01015703|10992767|FG002|Overall Study|Adverse Event|0
6951718|NCT01015703|10992768|FG003|Overall Study|Adverse Event|0
6951719|NCT01015703|10992769|FG004|Overall Study|Adverse Event|0
6951720|NCT01015703|10992765|FG000|Overall Study|Protocol Violation|1
6951721|NCT01015703|10992766|FG001|Overall Study|Protocol Violation|0
6951722|NCT01015703|10992767|FG002|Overall Study|Protocol Violation|0
6951723|NCT01015703|10992768|FG003|Overall Study|Protocol Violation|0
6951724|NCT01015703|10992769|FG004|Overall Study|Protocol Violation|0
6951725|NCT01015768|10992781|FG000|Overall Study|Some subject data unuseable|4
6951726|NCT01015768|10992782|FG001|Overall Study|Some subject data unuseable|4
6951727|NCT01015820|10992814|FG000|Overall Study|Suboptimal measurements|1
6951728|NCT01015820|10992815|FG001|Overall Study|Suboptimal measurements|0
6951729|NCT01016015|10992826|FG000|Overall Study|Not Treated|3
6951730|NCT01016015|10992826|FG000|Overall Study|Withdrawal by Subject|1
6951731|NCT01016015|10992826|FG000|Overall Study|Adverse Event|15
6951732|NCT01016067|10992832|FG000|Overall Study|Lost to Follow-up|1
6951733|NCT01016067|10992833|FG001|Overall Study|Lost to Follow-up|2
6951734|NCT01016067|10992832|FG000|Overall Study|Physician Decision|1
6951735|NCT01016067|10992833|FG001|Overall Study|Physician Decision|1
6951736|NCT01016067|10992832|FG000|Overall Study|Withdrew due to Relocation|0
6951737|NCT01016067|10992833|FG001|Overall Study|Withdrew due to Relocation|1
6951738|NCT01016132|10992848|FG000|Overall Study|Discomfort|1
6951739|NCT01016262|10992855|FG000|Double-blind Phase|Adverse Event|0
6951740|NCT01016262|10992856|FG001|Double-blind Phase|Adverse Event|0
6951741|NCT01016262|10992857|FG002|Double-blind Phase|Adverse Event|1
6951742|NCT01016262|10992858|FG003|Double-blind Phase|Adverse Event|0
6951743|NCT01016262|10992859|FG004|Double-blind Phase|Adverse Event|0
6951744|NCT01016262|10992860|FG005|Double-blind Phase|Adverse Event|0
6951745|NCT01016262|10992855|FG000|Double-blind Phase|Lack of Efficacy|1
6951746|NCT01016262|10992856|FG001|Double-blind Phase|Lack of Efficacy|0
6951747|NCT01016262|10992857|FG002|Double-blind Phase|Lack of Efficacy|5
6951748|NCT01016262|10992858|FG003|Double-blind Phase|Lack of Efficacy|0
6951749|NCT01016262|10992859|FG004|Double-blind Phase|Lack of Efficacy|0
6951750|NCT01016262|10992860|FG005|Double-blind Phase|Lack of Efficacy|0
6951751|NCT01016262|10992855|FG000|Double-blind Phase|Disease Progression|0
6951752|NCT01016262|10992856|FG001|Double-blind Phase|Disease Progression|1
6951753|NCT01016262|10992857|FG002|Double-blind Phase|Disease Progression|2
6951754|NCT01016262|10992858|FG003|Double-blind Phase|Disease Progression|0
6951755|NCT01016262|10992859|FG004|Double-blind Phase|Disease Progression|0
6951756|NCT01016262|10992860|FG005|Double-blind Phase|Disease Progression|0
6951757|NCT01016262|10992855|FG000|Double-blind Phase|Withdrawal of Informed Consent|0
6951758|NCT01016262|10992856|FG001|Double-blind Phase|Withdrawal of Informed Consent|0
6951759|NCT01016262|10992857|FG002|Double-blind Phase|Withdrawal of Informed Consent|1
6951760|NCT01016262|10992858|FG003|Double-blind Phase|Withdrawal of Informed Consent|0
6951761|NCT01016262|10992859|FG004|Double-blind Phase|Withdrawal of Informed Consent|0
6951762|NCT01016262|10992860|FG005|Double-blind Phase|Withdrawal of Informed Consent|0
6951763|NCT01016262|10992855|FG000|Open-Label Phase|Adverse Event|0
6951764|NCT01016262|10992856|FG001|Open-Label Phase|Adverse Event|0
6951765|NCT01016262|10992857|FG002|Open-Label Phase|Adverse Event|0
6951766|NCT01016262|10992858|FG003|Open-Label Phase|Adverse Event|1
6951767|NCT01016262|10992859|FG004|Open-Label Phase|Adverse Event|0
6951768|NCT01016262|10992860|FG005|Open-Label Phase|Adverse Event|0
6951769|NCT01016262|10992855|FG000|Open-Label Phase|Lost to Follow-up|0
6951770|NCT01016262|10992856|FG001|Open-Label Phase|Lost to Follow-up|0
6951771|NCT01016262|10992857|FG002|Open-Label Phase|Lost to Follow-up|0
6951772|NCT01016262|10992858|FG003|Open-Label Phase|Lost to Follow-up|0
6951773|NCT01016262|10992859|FG004|Open-Label Phase|Lost to Follow-up|1
6951774|NCT01016262|10992860|FG005|Open-Label Phase|Lost to Follow-up|0
6951775|NCT01016262|10992855|FG000|Open-Label Phase|Lack of Efficacy|0
6951776|NCT01016262|10992856|FG001|Open-Label Phase|Lack of Efficacy|0
6951777|NCT01016262|10992857|FG002|Open-Label Phase|Lack of Efficacy|0
6951778|NCT01016262|10992858|FG003|Open-Label Phase|Lack of Efficacy|1
6951779|NCT01016262|10992859|FG004|Open-Label Phase|Lack of Efficacy|0
6951780|NCT01016262|10992860|FG005|Open-Label Phase|Lack of Efficacy|0
6951781|NCT01016262|10992855|FG000|Open-Label Phase|Withdrawal of Informed Consent|0
6951782|NCT01016262|10992856|FG001|Open-Label Phase|Withdrawal of Informed Consent|0
6951783|NCT01016262|10992857|FG002|Open-Label Phase|Withdrawal of Informed Consent|0
6951784|NCT01016262|10992858|FG003|Open-Label Phase|Withdrawal of Informed Consent|0
6951785|NCT01016262|10992859|FG004|Open-Label Phase|Withdrawal of Informed Consent|1
6951786|NCT01016262|10992860|FG005|Open-Label Phase|Withdrawal of Informed Consent|0
6951787|NCT01016600|10992929|FG000|Overall Study|Did not start treatment|1
6951788|NCT01016600|10992930|FG001|Overall Study|Did not start treatment|0
6951789|NCT01016600|10992931|FG002|Overall Study|Did not start treatment|0
7070345|NCT02011893|11172778|FG000|Enrollment to Randomization|Screening Failure|29
7070346|NCT02011893|11172779|FG001|Enrollment to Randomization|Screening Failure|0
7070347|NCT02011893|11172780|FG002|Enrollment to Randomization|Screening Failure|0
7070348|NCT02011893|11172778|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9
7070349|NCT02011893|11172779|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
7070350|NCT02011893|11172780|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
7070351|NCT02011893|11172778|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2
7070352|NCT02011893|11172779|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0
7070353|NCT02011893|11172780|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0
7070354|NCT02011893|11172778|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
7070355|NCT02011893|11172779|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
7070356|NCT02011893|11172780|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1
7070357|NCT02011893|11172778|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
7070358|NCT02011893|11172779|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
7070359|NCT02011893|11172780|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2
7070360|NCT02011893|11172778|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
7070361|NCT02011893|11172779|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
7070362|NCT02011893|11172780|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1
6951790|NCT01016600|10992932|FG003|Overall Study|Did not start treatment|0
6951791|NCT01016912|10993027|FG000|End of Treatment Period|Lack of Efficacy|0
6951792|NCT01016912|10993028|FG001|End of Treatment Period|Lack of Efficacy|1
6951793|NCT01016912|10993029|FG002|End of Treatment Period|Lack of Efficacy|0
6951794|NCT01016912|10993030|FG003|End of Treatment Period|Lack of Efficacy|4
6951795|NCT01016912|10993031|FG004|End of Treatment Period|Lack of Efficacy|4
6951796|NCT01016912|10993027|FG000|End of Treatment Period|Adverse Event|0
6951797|NCT01016912|10993028|FG001|End of Treatment Period|Adverse Event|1
6951798|NCT01016912|10993029|FG002|End of Treatment Period|Adverse Event|1
6951799|NCT01016912|10993030|FG003|End of Treatment Period|Adverse Event|0
6951800|NCT01016912|10993031|FG004|End of Treatment Period|Adverse Event|0
6951801|NCT01016912|10993027|FG000|End of Treatment Period|Completed double-blind period only|0
6951802|NCT01016912|10993028|FG001|End of Treatment Period|Completed double-blind period only|1
6951803|NCT01016912|10993029|FG002|End of Treatment Period|Completed double-blind period only|0
6951804|NCT01016912|10993030|FG003|End of Treatment Period|Completed double-blind period only|0
6951805|NCT01016912|10993031|FG004|End of Treatment Period|Completed double-blind period only|0
6951806|NCT01016912|10993027|FG000|Follow-up Period|Other reason|0
6951807|NCT01016912|10993028|FG001|Follow-up Period|Other reason|0
6951808|NCT01016912|10993029|FG002|Follow-up Period|Other reason|1
6951809|NCT01016912|10993030|FG003|Follow-up Period|Other reason|1
6951810|NCT01016912|10993031|FG004|Follow-up Period|Other reason|0
6951811|NCT01016964|10993070|FG000|Overall Study|Lost to Follow-up|3
6951812|NCT01016964|10993071|FG001|Overall Study|Lost to Follow-up|3
6951813|NCT01016977|10993079|FG000|Overall Study|Lost to Follow-up|1
6951814|NCT01016977|10993080|FG001|Overall Study|Lost to Follow-up|0
6951815|NCT01016977|10993079|FG000|Overall Study|Withdrawal by Subject|2
6951816|NCT01016977|10993080|FG001|Overall Study|Withdrawal by Subject|2
6951817|NCT01017029|10993097|FG000|Overall Study|Lost to Follow-up|1
6951818|NCT01017029|10993098|FG001|Overall Study|Lost to Follow-up|0
6951819|NCT01017029|10993097|FG000|Overall Study|Administrative problem|0
6951820|NCT01017029|10993098|FG001|Overall Study|Administrative problem|1
6951821|NCT01017029|10993097|FG000|Overall Study|Death|3
6951822|NCT01017029|10993098|FG001|Overall Study|Death|1
6951823|NCT01017120|10993115|FG000|Overall Study|Adverse Event|9
6951824|NCT01017120|10993116|FG001|Overall Study|Adverse Event|0
6951825|NCT01017120|10993115|FG000|Overall Study|Lost to Follow-up|13
6951826|NCT01017120|10993116|FG001|Overall Study|Lost to Follow-up|11
6951827|NCT01017120|10993115|FG000|Overall Study|Lack of Efficacy|1
6951828|NCT01017120|10993116|FG001|Overall Study|Lack of Efficacy|0
6951829|NCT01017120|10993115|FG000|Overall Study|Withdrawal by Subject|39
6951830|NCT01017120|10993116|FG001|Overall Study|Withdrawal by Subject|21
6951831|NCT01017120|10993115|FG000|Overall Study|Pregnancy|1
6951832|NCT01017120|10993116|FG001|Overall Study|Pregnancy|1
6951833|NCT01017120|10993115|FG000|Overall Study|Did Not Meet Eligibility Criteria|1
6951834|NCT01017120|10993116|FG001|Overall Study|Did Not Meet Eligibility Criteria|0
6951835|NCT01017120|10993115|FG000|Overall Study|Relocated Out of Town|0
6951836|NCT01017120|10993116|FG001|Overall Study|Relocated Out of Town|2
6951837|NCT01017120|10993115|FG000|Overall Study|Protocol Violation|1
6951838|NCT01017120|10993116|FG001|Overall Study|Protocol Violation|0
6951839|NCT01017120|10993115|FG000|Overall Study|Parent Unable to Provide Transportation|1
6951840|NCT01017120|10993116|FG001|Overall Study|Parent Unable to Provide Transportation|0
6951841|NCT01017146|10993124|FG000|Overall Study|Adverse Event|11
6951842|NCT01017146|10993125|FG001|Overall Study|Adverse Event|1
6951843|NCT01017146|10993124|FG000|Overall Study|Lost to Follow-up|14
6951844|NCT01017146|10993125|FG001|Overall Study|Lost to Follow-up|14
6951845|NCT01017146|10993124|FG000|Overall Study|Noncompliance with Study Product|1
6951846|NCT01017146|10993125|FG001|Overall Study|Noncompliance with Study Product|1
6951847|NCT01017146|10993124|FG000|Overall Study|Withdrawal by Subject|32
6951848|NCT01017146|10993125|FG001|Overall Study|Withdrawal by Subject|16
6951849|NCT01017146|10993124|FG000|Overall Study|Relocation|0
6951850|NCT01017146|10993125|FG001|Overall Study|Relocation|4
6951851|NCT01017146|10993124|FG000|Overall Study|Pregnancy|2
6951852|NCT01017146|10993125|FG001|Overall Study|Pregnancy|1
6951853|NCT01017146|10993124|FG000|Overall Study|Protocol Violation|2
6951854|NCT01017146|10993125|FG001|Overall Study|Protocol Violation|0
6951855|NCT01017146|10993124|FG000|Overall Study|Took Excluded Medication|2
6951856|NCT01017146|10993125|FG001|Overall Study|Took Excluded Medication|0
6951857|NCT01017146|10993124|FG000|Overall Study|Did Not Meet Eligibility Criteria|1
6951858|NCT01017146|10993125|FG001|Overall Study|Did Not Meet Eligibility Criteria|2
6951859|NCT01017146|10993124|FG000|Overall Study|Change in Work Situation|1
6951860|NCT01017146|10993125|FG001|Overall Study|Change in Work Situation|0
6951861|NCT01017549|10993163|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1
6951862|NCT01017549|10993163|FG000|One-year Follow-up|Lost to Follow-up|2
6951863|NCT01017549|10993163|FG000|One-year Follow-up|Withdrawal by Subject|5
6951864|NCT01017549|10993163|FG000|5 Year Follow-up|Lost to Follow-up|9
6951865|NCT01017549|10993163|FG000|5 Year Follow-up|Mastectomy|3
6951866|NCT01017575|10993172|FG000|Overall Study|Lack of Efficacy|0
6951867|NCT01017575|10993173|FG001|Overall Study|Lack of Efficacy|1
6951868|NCT01017575|10993174|FG002|Overall Study|Lack of Efficacy|0
6951869|NCT01017575|10993175|FG003|Overall Study|Lack of Efficacy|1
6951870|NCT01017575|10993176|FG004|Overall Study|Lack of Efficacy|1
6951871|NCT01017575|10993172|FG000|Overall Study|Adverse Event|0
6951872|NCT01017575|10993173|FG001|Overall Study|Adverse Event|1
6951873|NCT01017575|10993174|FG002|Overall Study|Adverse Event|0
6951874|NCT01017575|10993175|FG003|Overall Study|Adverse Event|0
6951875|NCT01017575|10993176|FG004|Overall Study|Adverse Event|2
6951876|NCT01017575|10993172|FG000|Overall Study|Withdrawal by Subject|1
6951877|NCT01017575|10993173|FG001|Overall Study|Withdrawal by Subject|0
6951878|NCT01017575|10993174|FG002|Overall Study|Withdrawal by Subject|0
6951879|NCT01017575|10993175|FG003|Overall Study|Withdrawal by Subject|0
6951880|NCT01017575|10993176|FG004|Overall Study|Withdrawal by Subject|0
6951881|NCT01017601|10993190|FG000|Overall Study|Disease Progression|12
6951882|NCT01017601|10993191|FG001|Overall Study|Disease Progression|12
6951883|NCT01017601|10993190|FG000|Overall Study|Withdrawal by Subject|0
6951884|NCT01017601|10993191|FG001|Overall Study|Withdrawal by Subject|1
6951885|NCT01017731|10993201|FG000|Overall Study|Lost to Follow-up|2
6951886|NCT01017731|10993201|FG000|Overall Study|Withdrawal by Subject|3
6951887|NCT01017731|10993201|FG000|Overall Study|Physician Decision|2
6951888|NCT01017731|10993201|FG000|Overall Study|Adverse Event|1
6951889|NCT01017874|10993208|FG000|Overall Study|Withdrawal by Subject|23
6951890|NCT01017874|10993209|FG001|Overall Study|Withdrawal by Subject|20
6951891|NCT01017874|10993208|FG000|Overall Study|Sponsor decision|3
6951892|NCT01017874|10993209|FG001|Overall Study|Sponsor decision|1
6951893|NCT01017874|10993208|FG000|Overall Study|Lost to Follow-up|3
6951894|NCT01017874|10993209|FG001|Overall Study|Lost to Follow-up|2
6951895|NCT01017874|10993208|FG000|Overall Study|Physician Decision|1
6951896|NCT01017874|10993209|FG001|Overall Study|Physician Decision|3
6951897|NCT01017952|10993219|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356
6951898|NCT01017952|10993220|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
6951899|NCT01017952|10993221|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
6951900|NCT01017952|10993222|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
6951901|NCT01017952|10993223|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
6951902|NCT01017952|10993219|FG000|4-week, Open-label Run-In Period|Adverse Event|23
6951903|NCT01017952|10993220|FG001|4-week, Open-label Run-In Period|Adverse Event|0
6951904|NCT01017952|10993221|FG002|4-week, Open-label Run-In Period|Adverse Event|0
6951905|NCT01017952|10993222|FG003|4-week, Open-label Run-In Period|Adverse Event|0
6951906|NCT01017952|10993223|FG004|4-week, Open-label Run-In Period|Adverse Event|0
6951907|NCT01017952|10993219|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1
6951908|NCT01017952|10993220|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
6951909|NCT01017952|10993221|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
6951910|NCT01017952|10993222|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
6951911|NCT01017952|10993223|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
6951912|NCT01017952|10993219|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6
6951913|NCT01017952|10993220|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0
6951914|NCT01017952|10993221|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0
6951915|NCT01017952|10993222|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0
6951916|NCT01017952|10993223|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0
6951917|NCT01017952|10993219|FG000|4-week, Open-label Run-In Period|Physician Decision|10
6951918|NCT01017952|10993220|FG001|4-week, Open-label Run-In Period|Physician Decision|0
6951919|NCT01017952|10993221|FG002|4-week, Open-label Run-In Period|Physician Decision|0
6951920|NCT01017952|10993222|FG003|4-week, Open-label Run-In Period|Physician Decision|0
6951921|NCT01017952|10993223|FG004|4-week, Open-label Run-In Period|Physician Decision|0
6951922|NCT01017952|10993219|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63
6951923|NCT01017952|10993220|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0
6951924|NCT01017952|10993221|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0
6951925|NCT01017952|10993222|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0
6951926|NCT01017952|10993223|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0
6951927|NCT01017952|10993219|FG000|52-week, Double-blind Treatment Period|Adverse Event|0
6951928|NCT01017952|10993220|FG001|52-week, Double-blind Treatment Period|Adverse Event|25
6951929|NCT01017952|10993221|FG002|52-week, Double-blind Treatment Period|Adverse Event|32
6951930|NCT01017952|10993222|FG003|52-week, Double-blind Treatment Period|Adverse Event|35
6951931|NCT01017952|10993223|FG004|52-week, Double-blind Treatment Period|Adverse Event|30
6951932|NCT01017952|10993219|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
6951933|NCT01017952|10993220|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30
6951934|NCT01017952|10993221|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
6951935|NCT01017952|10993222|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
6951936|NCT01017952|10993223|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
6951937|NCT01017952|10993219|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0
6951938|NCT01017952|10993220|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35
6951939|NCT01017952|10993221|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14
6951940|NCT01017952|10993222|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16
6951941|NCT01017952|10993223|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14
6951942|NCT01017952|10993219|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0
6951943|NCT01017952|10993220|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7
6951944|NCT01017952|10993221|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11
6951945|NCT01017952|10993222|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9
6951946|NCT01017952|10993223|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8
6951947|NCT01017952|10993219|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
6951948|NCT01017952|10993220|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
6951949|NCT01017952|10993221|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
6951950|NCT01017952|10993222|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12
6951951|NCT01017952|10993223|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
6951952|NCT01017952|10993219|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
6951953|NCT01017952|10993220|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
6951954|NCT01017952|10993221|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
6951955|NCT01017952|10993222|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
6951956|NCT01017952|10993223|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
6951957|NCT01017952|10993219|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0
6951958|NCT01017952|10993220|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6
6951959|NCT01017952|10993221|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8
6951960|NCT01017952|10993222|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6
6951961|NCT01017952|10993223|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10
6951962|NCT01017952|10993219|FG000|52-week, Double-blind Treatment Period|Physician Decision|0
6951963|NCT01017952|10993220|FG001|52-week, Double-blind Treatment Period|Physician Decision|10
6951964|NCT01017952|10993221|FG002|52-week, Double-blind Treatment Period|Physician Decision|8
6951965|NCT01017952|10993222|FG003|52-week, Double-blind Treatment Period|Physician Decision|9
6951966|NCT01017952|10993223|FG004|52-week, Double-blind Treatment Period|Physician Decision|7
6951967|NCT01018030|10993236|FG000|Overall Study|Adverse Event|10
6951968|NCT01018030|10993237|FG001|Overall Study|Adverse Event|5
6951969|NCT01018030|10993238|FG002|Overall Study|Adverse Event|5
6951970|NCT01018030|10993236|FG000|Overall Study|Withdrawal by Subject|2
6951971|NCT01018030|10993237|FG001|Overall Study|Withdrawal by Subject|2
6951972|NCT01018030|10993238|FG002|Overall Study|Withdrawal by Subject|4
6951973|NCT01018030|10993236|FG000|Overall Study|Lost to Follow-up|2
6951974|NCT01018030|10993237|FG001|Overall Study|Lost to Follow-up|0
6951975|NCT01018030|10993238|FG002|Overall Study|Lost to Follow-up|3
6951976|NCT01018030|10993236|FG000|Overall Study|Protocol Violation|2
6951977|NCT01018030|10993237|FG001|Overall Study|Protocol Violation|1
6951978|NCT01018030|10993238|FG002|Overall Study|Protocol Violation|0
6951979|NCT01018030|10993236|FG000|Overall Study|Physician Decision|1
6951980|NCT01018030|10993237|FG001|Overall Study|Physician Decision|0
6951981|NCT01018030|10993238|FG002|Overall Study|Physician Decision|1
6951982|NCT01018030|10993236|FG000|Overall Study|Lack of Efficacy|1
6951983|NCT01018030|10993237|FG001|Overall Study|Lack of Efficacy|0
6951984|NCT01018030|10993238|FG002|Overall Study|Lack of Efficacy|0
6951985|NCT01018030|10993236|FG000|Overall Study|Did Not Receive Study Drug|1
6951986|NCT01018030|10993237|FG001|Overall Study|Did Not Receive Study Drug|3
7070363|NCT02011945|11172788|FG000|Overall Study|Participant requested to Discontinue|0
7070364|NCT02011945|11172789|FG001|Overall Study|Participant requested to Discontinue|1
7070365|NCT02011945|11172790|FG002|Overall Study|Participant requested to Discontinue|1
7070366|NCT02011945|11172788|FG000|Overall Study|Adverse Event unrelated to Drug|0
7070367|NCT02011945|11172789|FG001|Overall Study|Adverse Event unrelated to Drug|2
7070368|NCT02011945|11172790|FG002|Overall Study|Adverse Event unrelated to Drug|1
7070369|NCT02011945|11172788|FG000|Overall Study|Study Drug Toxicity|0
7070370|NCT02011945|11172789|FG001|Overall Study|Study Drug Toxicity|0
7070371|NCT02011945|11172790|FG002|Overall Study|Study Drug Toxicity|1
7070372|NCT02011945|11172788|FG000|Overall Study|Treatment Failure|0
7070373|NCT02011945|11172789|FG001|Overall Study|Treatment Failure|7
7070374|NCT02011945|11172790|FG002|Overall Study|Treatment Failure|6
7070375|NCT02011945|11172788|FG000|Overall Study|No Longer Meets Study Criteria|1
6951987|NCT01018030|10993238|FG002|Overall Study|Did Not Receive Study Drug|0
6951988|NCT01018186|10993301|FG000|2-week Run-in Period|Protocol Violation|1
6951989|NCT01018186|10993302|FG001|2-week Run-in Period|Protocol Violation|0
6951990|NCT01018186|10993303|FG002|2-week Run-in Period|Protocol Violation|0
6951991|NCT01018186|10993304|FG003|2-week Run-in Period|Protocol Violation|0
6951992|NCT01018186|10993301|FG000|2-week Run-in Period|Lost to Follow-up|2
6951993|NCT01018186|10993302|FG001|2-week Run-in Period|Lost to Follow-up|0
6951994|NCT01018186|10993303|FG002|2-week Run-in Period|Lost to Follow-up|0
6951995|NCT01018186|10993304|FG003|2-week Run-in Period|Lost to Follow-up|0
6951996|NCT01018186|10993301|FG000|2-week Run-in Period|Physician Decision|3
6951997|NCT01018186|10993302|FG001|2-week Run-in Period|Physician Decision|0
6951998|NCT01018186|10993303|FG002|2-week Run-in Period|Physician Decision|0
6951999|NCT01018186|10993304|FG003|2-week Run-in Period|Physician Decision|0
6952000|NCT01018186|10993301|FG000|2-week Run-in Period|Withdrawal by Subject|11
6952001|NCT01018186|10993302|FG001|2-week Run-in Period|Withdrawal by Subject|0
6952002|NCT01018186|10993303|FG002|2-week Run-in Period|Withdrawal by Subject|0
6952003|NCT01018186|10993304|FG003|2-week Run-in Period|Withdrawal by Subject|0
6952004|NCT01018186|10993301|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97
6952005|NCT01018186|10993302|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0
6952006|NCT01018186|10993303|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0
6952007|NCT01018186|10993304|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0
6952008|NCT01018186|10993301|FG000|52-week Double-blind Treatment Period|Adverse Event|0
6952009|NCT01018186|10993302|FG001|52-week Double-blind Treatment Period|Adverse Event|5
6952010|NCT01018186|10993303|FG002|52-week Double-blind Treatment Period|Adverse Event|3
6952011|NCT01018186|10993304|FG003|52-week Double-blind Treatment Period|Adverse Event|6
6952012|NCT01018186|10993301|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0
6952013|NCT01018186|10993302|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1
6952014|NCT01018186|10993303|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4
6952015|NCT01018186|10993304|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1
6952016|NCT01018186|10993301|FG000|52-week Double-blind Treatment Period|Protocol Violation|0
6952017|NCT01018186|10993302|FG001|52-week Double-blind Treatment Period|Protocol Violation|8
6952018|NCT01018186|10993303|FG002|52-week Double-blind Treatment Period|Protocol Violation|8
6952019|NCT01018186|10993304|FG003|52-week Double-blind Treatment Period|Protocol Violation|2
6952020|NCT01018186|10993301|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
6952021|NCT01018186|10993302|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14
6952022|NCT01018186|10993303|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16
6952023|NCT01018186|10993304|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
6952024|NCT01018186|10993301|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0
6952025|NCT01018186|10993302|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1
6952026|NCT01018186|10993303|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3
6952027|NCT01018186|10993304|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4
6952028|NCT01018186|10993301|FG000|52-week Double-blind Treatment Period|Physician Decision|0
6952029|NCT01018186|10993302|FG001|52-week Double-blind Treatment Period|Physician Decision|1
6952030|NCT01018186|10993303|FG002|52-week Double-blind Treatment Period|Physician Decision|0
6952031|NCT01018186|10993304|FG003|52-week Double-blind Treatment Period|Physician Decision|3
6952032|NCT01018186|10993301|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0
6952033|NCT01018186|10993302|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10
6952034|NCT01018186|10993303|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7
6952035|NCT01018186|10993304|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9
7070376|NCT02011945|11172789|FG001|Overall Study|No Longer Meets Study Criteria|0
7070377|NCT02011945|11172790|FG002|Overall Study|No Longer Meets Study Criteria|0
7070378|NCT02011945|11172788|FG000|Overall Study|Proceeded to stem cell transplant|0
7070379|NCT02011945|11172789|FG001|Overall Study|Proceeded to stem cell transplant|0
7070380|NCT02011945|11172790|FG002|Overall Study|Proceeded to stem cell transplant|1
7070381|NCT02011945|11172788|FG000|Overall Study|Sub-Optimal Response to dasatinib|1
7070382|NCT02011945|11172789|FG001|Overall Study|Sub-Optimal Response to dasatinib|0
7070383|NCT02011945|11172790|FG002|Overall Study|Sub-Optimal Response to dasatinib|0
6952036|NCT01018264|10993318|FG000|Overall Study|Withdrawal by Subject|1
6952037|NCT01018264|10993319|FG001|Overall Study|Withdrawal by Subject|0
6952038|NCT01018264|10993318|FG000|Overall Study|Lost to Follow-up|0
6952039|NCT01018264|10993319|FG001|Overall Study|Lost to Follow-up|1
6952040|NCT01018394|10993327|FG000|Overall Study|Withdrawal by Subject|5
6952041|NCT01018394|10993328|FG001|Overall Study|Withdrawal by Subject|5
6952042|NCT01018394|10993327|FG000|Overall Study|Lost to Follow-up|4
6952043|NCT01018394|10993328|FG001|Overall Study|Lost to Follow-up|3
6952044|NCT01018511|10993364|FG000|Overall Study|Not fulfilling eligibility criteria|6
6952045|NCT01018511|10993365|FG001|Overall Study|Not fulfilling eligibility criteria|7
6952046|NCT01018511|10993366|FG002|Overall Study|Not fulfilling eligibility criteria|7
6952047|NCT01018511|10993367|FG003|Overall Study|Not fulfilling eligibility criteria|3
6952048|NCT01018511|10993364|FG000|Overall Study|Adverse Event|5
6952049|NCT01018511|10993365|FG001|Overall Study|Adverse Event|9
6952050|NCT01018511|10993366|FG002|Overall Study|Adverse Event|13
7070384|NCT02012218|11172812|FG000|Overall Study|Withdrawal by Subject|1
7070385|NCT02012218|11172813|FG001|Overall Study|Withdrawal by Subject|0
6952051|NCT01018511|10993367|FG003|Overall Study|Adverse Event|10
6952052|NCT01018511|10993364|FG000|Overall Study|Lack of Efficacy|4
6952053|NCT01018511|10993365|FG001|Overall Study|Lack of Efficacy|1
6952054|NCT01018511|10993366|FG002|Overall Study|Lack of Efficacy|1
6952055|NCT01018511|10993367|FG003|Overall Study|Lack of Efficacy|2
6952056|NCT01018511|10993364|FG000|Overall Study|Withdrawal by Subject|6
6952057|NCT01018511|10993365|FG001|Overall Study|Withdrawal by Subject|5
6952058|NCT01018511|10993366|FG002|Overall Study|Withdrawal by Subject|11
6952059|NCT01018511|10993367|FG003|Overall Study|Withdrawal by Subject|9
6952060|NCT01018511|10993364|FG000|Overall Study|Lost to Follow-up|0
6952061|NCT01018511|10993365|FG001|Overall Study|Lost to Follow-up|0
6952062|NCT01018511|10993366|FG002|Overall Study|Lost to Follow-up|1
6952063|NCT01018511|10993367|FG003|Overall Study|Lost to Follow-up|0
6952064|NCT01018511|10993364|FG000|Overall Study|Protocol Violation|5
6952065|NCT01018511|10993365|FG001|Overall Study|Protocol Violation|8
6952066|NCT01018511|10993366|FG002|Overall Study|Protocol Violation|7
6952067|NCT01018511|10993367|FG003|Overall Study|Protocol Violation|9
6952068|NCT01018511|10993364|FG000|Overall Study|Miscellaneous|0
6952069|NCT01018511|10993365|FG001|Overall Study|Miscellaneous|2
6952070|NCT01018511|10993366|FG002|Overall Study|Miscellaneous|0
6952071|NCT01018511|10993367|FG003|Overall Study|Miscellaneous|0
6952072|NCT01018680|10993385|FG000|Overall Study|Adverse Event|23
6952073|NCT01018680|10993386|FG001|Overall Study|Adverse Event|40
6952074|NCT01018680|10993385|FG000|Overall Study|Withdrawal by Subject|10
6952075|NCT01018680|10993386|FG001|Overall Study|Withdrawal by Subject|10
6952076|NCT01018680|10993385|FG000|Overall Study|Protocol Violation|5
6952077|NCT01018680|10993386|FG001|Overall Study|Protocol Violation|8
6952078|NCT01018680|10993385|FG000|Overall Study|Sponsor Decision|6
6952079|NCT01018680|10993386|FG001|Overall Study|Sponsor Decision|7
6952080|NCT01018680|10993385|FG000|Overall Study|Lack of Efficacy|8
6952081|NCT01018680|10993386|FG001|Overall Study|Lack of Efficacy|2
6952082|NCT01018680|10993385|FG000|Overall Study|Lost to Follow-up|5
6952083|NCT01018680|10993386|FG001|Overall Study|Lost to Follow-up|3
6952084|NCT01018680|10993385|FG000|Overall Study|Entry Criteria Not Met|1
6952085|NCT01018680|10993386|FG001|Overall Study|Entry Criteria Not Met|4
6952086|NCT01018680|10993385|FG000|Overall Study|Physician Decision|3
6952087|NCT01018680|10993386|FG001|Overall Study|Physician Decision|1
6952088|NCT01018732|10993395|FG000|Overall Study|Lost to Follow-up|0
6952089|NCT01018732|10993396|FG001|Overall Study|Lost to Follow-up|0
6952090|NCT01018732|10993397|FG002|Overall Study|Lost to Follow-up|3
6952091|NCT01018732|10993395|FG000|Overall Study|Protocol Violation|1
6952092|NCT01018732|10993396|FG001|Overall Study|Protocol Violation|1
6952093|NCT01018732|10993397|FG002|Overall Study|Protocol Violation|0
6952094|NCT01018732|10993395|FG000|Overall Study|Inappropriate Enrollment|0
6952095|NCT01018732|10993396|FG001|Overall Study|Inappropriate Enrollment|1
6952096|NCT01018732|10993397|FG002|Overall Study|Inappropriate Enrollment|0
6952097|NCT01018732|10993395|FG000|Overall Study|Unable to Classify|0
6952098|NCT01018732|10993396|FG001|Overall Study|Unable to Classify|0
6952099|NCT01018732|10993397|FG002|Overall Study|Unable to Classify|1
6952100|NCT01018862|10993408|FG000|Overall Study|Adverse Event|2
6952101|NCT01018862|10993409|FG001|Overall Study|Adverse Event|0
6952102|NCT01018862|10993410|FG002|Overall Study|Adverse Event|6
6952103|NCT01018862|10993408|FG000|Overall Study|Lack of Efficacy|1
6952104|NCT01018862|10993409|FG001|Overall Study|Lack of Efficacy|0
6952105|NCT01018862|10993410|FG002|Overall Study|Lack of Efficacy|2
6952106|NCT01018862|10993408|FG000|Overall Study|Lost to Follow-up|3
6952107|NCT01018862|10993409|FG001|Overall Study|Lost to Follow-up|1
6952108|NCT01018862|10993410|FG002|Overall Study|Lost to Follow-up|0
6952109|NCT01018862|10993408|FG000|Overall Study|Protocol Violation|1
6952110|NCT01018862|10993409|FG001|Overall Study|Protocol Violation|3
6952111|NCT01018862|10993410|FG002|Overall Study|Protocol Violation|3
6952112|NCT01018862|10993408|FG000|Overall Study|Withdrawal by Subject|1
6952113|NCT01018862|10993409|FG001|Overall Study|Withdrawal by Subject|2
6952114|NCT01018862|10993410|FG002|Overall Study|Withdrawal by Subject|1
6952115|NCT01018862|10993408|FG000|Overall Study|administrative problems|5
6952116|NCT01018862|10993409|FG001|Overall Study|administrative problems|4
6952117|NCT01018862|10993410|FG002|Overall Study|administrative problems|4
6952118|NCT01018953|10993418|FG000|Overall Study|Adverse Event|2
6952119|NCT01018953|10993418|FG000|Overall Study|Withdrawal by Subject|1
6952120|NCT01018953|10993418|FG000|Overall Study|Study termination by sponsor|5
6952121|NCT01018979|10993425|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3
6952122|NCT01018979|10993426|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9
6952123|NCT01018979|10993425|FG000|Overall Study|Not received at least one dose|0
6952124|NCT01018979|10993426|FG001|Overall Study|Not received at least one dose|1
6952125|NCT01018992|10993437|FG000|Overall Study|Adverse Event|8
6952126|NCT01018992|10993438|FG001|Overall Study|Adverse Event|3
6952127|NCT01018992|10993437|FG000|Overall Study|Withdrawal by Subject|3
6952128|NCT01018992|10993438|FG001|Overall Study|Withdrawal by Subject|8
6952129|NCT01018992|10993437|FG000|Overall Study|Protocol Violation|0
6952130|NCT01018992|10993438|FG001|Overall Study|Protocol Violation|4
6952131|NCT01018992|10993437|FG000|Overall Study|Lost to Follow-up|5
6952132|NCT01018992|10993438|FG001|Overall Study|Lost to Follow-up|1
6952133|NCT01019135|10993447|FG000|Overall Study|Did not receive allocated intervention|12
6952134|NCT01019135|10993448|FG001|Overall Study|Did not receive allocated intervention|6
6952135|NCT01019135|10993449|FG002|Overall Study|Did not receive allocated intervention|25
7070386|NCT02012218|11172814|FG002|Overall Study|Withdrawal by Subject|1
7070387|NCT02012218|11172815|FG003|Overall Study|Withdrawal by Subject|1
7070388|NCT02012218|11172816|FG004|Overall Study|Withdrawal by Subject|1
7070389|NCT02012218|11172812|FG000|Overall Study|Adverse Event|1
7070390|NCT02012218|11172813|FG001|Overall Study|Adverse Event|0
7070391|NCT02012218|11172814|FG002|Overall Study|Adverse Event|0
7070392|NCT02012218|11172815|FG003|Overall Study|Adverse Event|1
7070393|NCT02012218|11172816|FG004|Overall Study|Adverse Event|0
7070394|NCT02012218|11172812|FG000|Overall Study|Lost to Follow-up|0
7070395|NCT02012218|11172813|FG001|Overall Study|Lost to Follow-up|1
7070396|NCT02012218|11172814|FG002|Overall Study|Lost to Follow-up|1
7070397|NCT02012218|11172815|FG003|Overall Study|Lost to Follow-up|0
7070398|NCT02012218|11172816|FG004|Overall Study|Lost to Follow-up|0
7070399|NCT02012218|11172812|FG000|Overall Study|Protocol Specified|1
7070400|NCT02012218|11172813|FG001|Overall Study|Protocol Specified|0
7070401|NCT02012218|11172814|FG002|Overall Study|Protocol Specified|0
7070402|NCT02012218|11172815|FG003|Overall Study|Protocol Specified|0
7070403|NCT02012218|11172816|FG004|Overall Study|Protocol Specified|0
7070404|NCT02012218|11172812|FG000|Overall Study|Protocol Deviation|1
7070405|NCT02012218|11172813|FG001|Overall Study|Protocol Deviation|0
7070406|NCT02012218|11172814|FG002|Overall Study|Protocol Deviation|0
7070407|NCT02012218|11172815|FG003|Overall Study|Protocol Deviation|0
7070408|NCT02012218|11172816|FG004|Overall Study|Protocol Deviation|0
7070409|NCT02012452|11172857|FG000|Overall Study|Lost to Follow-up|2
7070410|NCT02012452|11172858|FG001|Overall Study|Lost to Follow-up|1
7070411|NCT02012452|11172857|FG000|Overall Study|Withdrawal by Subject|4
7070412|NCT02012452|11172858|FG001|Overall Study|Withdrawal by Subject|0
7070413|NCT02012491|11172866|FG000|Overall Study|Lost to Follow-up|1
7070414|NCT02012491|11172867|FG001|Overall Study|Lost to Follow-up|0
7070415|NCT02012491|11172866|FG000|Overall Study|Protocol Violation|0
7070416|NCT02012491|11172867|FG001|Overall Study|Protocol Violation|1
7070417|NCT02012491|11172866|FG000|Overall Study|Withdrawal by Subject|1
7070418|NCT02012491|11172867|FG001|Overall Study|Withdrawal by Subject|0
7070419|NCT02012686|11172896|FG000|Overall Study|muscle contraction|0
7070420|NCT02012686|11172897|FG001|Overall Study|muscle contraction|1
7070421|NCT02012686|11172896|FG000|Overall Study|electrocardiography monitoring noise|0
7070422|NCT02012686|11172897|FG001|Overall Study|electrocardiography monitoring noise|1
7070423|NCT02012959|11172903|FG000|Treatment Phase A|Adverse Event|2
7070424|NCT02012959|11172904|FG001|Treatment Phase A|Adverse Event|0
7070425|NCT02012959|11172905|FG002|Treatment Phase A|Adverse Event|0
7070426|NCT02012959|11172906|FG003|Treatment Phase A|Adverse Event|0
7070427|NCT02012959|11172907|FG004|Treatment Phase A|Adverse Event|0
7070428|NCT02013037|11172917|FG000|Overall Study|Death|6
7070429|NCT02013037|11172917|FG000|Overall Study|Withdrawal by Subject|1
7070430|NCT02013037|11172917|FG000|Overall Study|Awaiting Transplantation|7
7070431|NCT02013037|11172917|FG000|Overall Study|Transplanted without DSA|2
7070432|NCT02013206|11172950|FG000|Overall Study|Progressive disease (PD)|14
7070433|NCT02013206|11172951|FG001|Overall Study|Progressive disease (PD)|17
7070434|NCT02013206|11172950|FG000|Overall Study|Symptomatic deterioration|3
7070435|NCT02013206|11172951|FG001|Overall Study|Symptomatic deterioration|1
7070436|NCT02013206|11172950|FG000|Overall Study|Adverse Event|1
7070437|NCT02013206|11172951|FG001|Overall Study|Adverse Event|0
7070438|NCT02013206|11172950|FG000|Overall Study|Patient refusal|2
7070439|NCT02013206|11172951|FG001|Overall Study|Patient refusal|0
7070440|NCT02013206|11172950|FG000|Overall Study|Patient non-compliance|1
7070441|NCT02013206|11172951|FG001|Overall Study|Patient non-compliance|0
7070442|NCT02013206|11172950|FG000|Overall Study|Death|1
7070443|NCT02013206|11172951|FG001|Overall Study|Death|2
7070444|NCT02013206|11172950|FG000|Overall Study|Other reasons off treatment|5
7070445|NCT02013206|11172951|FG001|Overall Study|Other reasons off treatment|2
7070446|NCT02013375|11172974|FG000|Overall Study|Did not engraft|1
7070447|NCT02013375|11172974|FG000|Overall Study|Did not engraft|1
7070448|NCT02013388|11172987|FG000|Overall Study|work emergency|1
7070449|NCT02013388|11172988|FG001|Overall Study|work emergency|0
7070450|NCT02013388|11172989|FG002|Overall Study|work emergency|0
7070451|NCT02013388|11172990|FG003|Overall Study|work emergency|0
7070452|NCT02013388|11172991|FG004|Overall Study|work emergency|1
7070453|NCT02013388|11172992|FG005|Overall Study|work emergency|0
7070454|NCT02013388|11172993|FG006|Overall Study|work emergency|0
7070455|NCT02013388|11172994|FG007|Overall Study|work emergency|0
7070456|NCT02013531|11173016|FG000|Overall Study|Lost to Follow-up|3
7070457|NCT02013531|11173016|FG000|Overall Study|Met Withdrawal Criteria|1
7070458|NCT02013531|11173016|FG000|Overall Study|Withdrawal by Subject|1
7147790|NCT03135899|11308634|FG006|Overall Study|Withdrawal by Subject|0
7070459|NCT02013544|11173022|FG000|Overall Study|Adverse Event|5
7070460|NCT02013544|11173023|FG001|Overall Study|Adverse Event|5
7070461|NCT02013544|11173022|FG000|Overall Study|Lost to Follow-up|2
7070462|NCT02013544|11173023|FG001|Overall Study|Lost to Follow-up|3
7070463|NCT02013544|11173022|FG000|Overall Study|Withdrawal by Subject|2
7070464|NCT02013544|11173023|FG001|Overall Study|Withdrawal by Subject|8
7070465|NCT02013544|11173022|FG000|Overall Study|Physician Decision|0
7070466|NCT02013544|11173023|FG001|Overall Study|Physician Decision|1
7070467|NCT02013544|11173022|FG000|Overall Study|Entry criteria not met/non-compliance|2
7070468|NCT02013544|11173023|FG001|Overall Study|Entry criteria not met/non-compliance|3
7070469|NCT02013609|11173029|FG000|Overall Study|Withdrawal by Subject|9
7070470|NCT02013609|11173029|FG000|Overall Study|Lost to Follow-up|3
7070471|NCT02013609|11173029|FG000|Overall Study|Adverse Event|3
7070472|NCT02013609|11173029|FG000|Overall Study|Met Withdrawal Criteria|3
7070473|NCT02013622|11173033|FG000|Overall Study|Lost to Follow-up|10
7070474|NCT02013622|11173033|FG000|Overall Study|Adverse Event|3
7070475|NCT02013622|11173033|FG000|Overall Study|Met Withdrawal Criteria|3
7070476|NCT02013622|11173033|FG000|Overall Study|Withdrawal by Subject|6
7070477|NCT02013622|11173033|FG000|Overall Study|Protocol Deviation|1
7070478|NCT02013622|11173033|FG000|Overall Study|Lack of Efficacy|1
6952136|NCT01019135|10993447|FG000|Overall Study|Did not attend CR|8
6952137|NCT01019135|10993448|FG001|Overall Study|Did not attend CR|13
6952138|NCT01019135|10993449|FG002|Overall Study|Did not attend CR|6
6952139|NCT01019252|10993459|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2
6952140|NCT01019252|10993460|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0
6952141|NCT01019252|10993459|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1
6952142|NCT01019252|10993460|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0
6952143|NCT01019252|10993459|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0
6952144|NCT01019252|10993460|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2
6952145|NCT01019252|10993459|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0
6952146|NCT01019252|10993460|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5
6952147|NCT01019317|10993466|FG000|Overall Study|Not Eligible|4
6952148|NCT01019369|10993472|FG000|Overall Study|Lost to Follow-up|10
6952149|NCT01019369|10993473|FG001|Overall Study|Lost to Follow-up|6
6952150|NCT01019369|10993472|FG000|Overall Study|Withdrawal by Subject|0
6952151|NCT01019369|10993473|FG001|Overall Study|Withdrawal by Subject|1
6952152|NCT01019486|10993483|FG000|Overall Study|Withdrawal by Subject|1
6952153|NCT01019486|10993484|FG001|Overall Study|Withdrawal by Subject|1
6952154|NCT01019486|10993485|FG002|Overall Study|Withdrawal by Subject|1
6952155|NCT01019694|10993497|FG000|Overall Study|Adverse Event|12
6952156|NCT01019694|10993498|FG001|Overall Study|Adverse Event|16
6952157|NCT01019694|10993499|FG002|Overall Study|Adverse Event|19
6952158|NCT01019694|10993497|FG000|Overall Study|Protocol Violation|2
6952159|NCT01019694|10993498|FG001|Overall Study|Protocol Violation|6
6952160|NCT01019694|10993499|FG002|Overall Study|Protocol Violation|4
6952161|NCT01019694|10993497|FG000|Overall Study|Lost to Follow-up|5
6952162|NCT01019694|10993498|FG001|Overall Study|Lost to Follow-up|3
6952163|NCT01019694|10993499|FG002|Overall Study|Lost to Follow-up|3
6952164|NCT01019694|10993497|FG000|Overall Study|Withdrawal by Subject|4
6952165|NCT01019694|10993498|FG001|Overall Study|Withdrawal by Subject|6
6952166|NCT01019694|10993499|FG002|Overall Study|Withdrawal by Subject|12
6952167|NCT01019694|10993497|FG000|Overall Study|Not treated|0
6952168|NCT01019694|10993498|FG001|Overall Study|Not treated|2
6952169|NCT01019694|10993499|FG002|Overall Study|Not treated|3
6952170|NCT01019694|10993497|FG000|Overall Study|Other reason (not specified)|1
6952171|NCT01019694|10993498|FG001|Overall Study|Other reason (not specified)|5
6952172|NCT01019694|10993499|FG002|Overall Study|Other reason (not specified)|6
6952173|NCT01020019|10993538|FG000|Overall Study|Lost to Follow-up|21
6952174|NCT01020019|10993539|FG001|Overall Study|Lost to Follow-up|18
6952175|NCT01020019|10993538|FG000|Overall Study|Adverse Event|1
6952176|NCT01020019|10993539|FG001|Overall Study|Adverse Event|5
6952177|NCT01020019|10993538|FG000|Overall Study|not interested in treatment|4
7070479|NCT02013674|11173039|FG000|Overall Study|Death|0
7070480|NCT02013674|11173040|FG001|Overall Study|Death|1
7070481|NCT02013674|11173039|FG000|Overall Study|Lost to Follow-up|1
7070482|NCT02013674|11173040|FG001|Overall Study|Lost to Follow-up|0
7070483|NCT02013687|11173050|FG000|Overall Study|Lost to Follow-up|0
7070484|NCT02013687|11173051|FG001|Overall Study|Lost to Follow-up|0
7070485|NCT02013687|11173052|FG002|Overall Study|Lost to Follow-up|1
7070486|NCT02013687|11173053|FG003|Overall Study|Lost to Follow-up|0
7070487|NCT02013687|11173050|FG000|Overall Study|Protocol Violation|0
7070488|NCT02013687|11173051|FG001|Overall Study|Protocol Violation|0
7070489|NCT02013687|11173052|FG002|Overall Study|Protocol Violation|0
7070490|NCT02013687|11173053|FG003|Overall Study|Protocol Violation|1
7070491|NCT02013687|11173050|FG000|Overall Study|Withdrawal by Subject|0
7070492|NCT02013687|11173051|FG001|Overall Study|Withdrawal by Subject|0
7070493|NCT02013687|11173052|FG002|Overall Study|Withdrawal by Subject|0
7070494|NCT02013687|11173053|FG003|Overall Study|Withdrawal by Subject|1
7070495|NCT02013687|11173050|FG000|Overall Study|Missed visits due to patient travel|0
7070496|NCT02013687|11173051|FG001|Overall Study|Missed visits due to patient travel|0
7070497|NCT02013687|11173052|FG002|Overall Study|Missed visits due to patient travel|1
7070498|NCT02013687|11173053|FG003|Overall Study|Missed visits due to patient travel|0
7070499|NCT02013765|11173067|FG000|Overall Study|Trial was terminated by sponsor|1
6952178|NCT01020019|10993539|FG001|Overall Study|not interested in treatment|4
6952179|NCT01020019|10993538|FG000|Overall Study|moving|0
7070500|NCT02013778|11173071|FG000|Overall Study|Death|4
6952180|NCT01020019|10993539|FG001|Overall Study|moving|2
6952181|NCT01020123|10993552|FG000|Main Period|Withdrawal by Subject|6
6952182|NCT01020123|10993553|FG001|Main Period|Withdrawal by Subject|5
6952183|NCT01020123|10993554|FG002|Main Period|Withdrawal by Subject|3
6952184|NCT01020123|10993555|FG003|Main Period|Withdrawal by Subject|1
7070501|NCT02013778|11173071|FG000|Overall Study|Withdrawal by Subject|1
7070502|NCT02013778|11173071|FG000|Overall Study|Physician Decision|1
7070503|NCT02013778|11173071|FG000|Overall Study|Adverse Event|1
7070504|NCT02013791|11173084|FG000|Period 1|Lost to Follow-up|0
7070505|NCT02013791|11173085|FG001|Period 1|Lost to Follow-up|0
7070506|NCT02013791|11173086|FG002|Period 1|Lost to Follow-up|0
6952185|NCT01020123|10993556|FG004|Main Period|Withdrawal by Subject|6
6952186|NCT01020123|10993557|FG005|Main Period|Withdrawal by Subject|3
6952187|NCT01020123|10993558|FG006|Main Period|Withdrawal by Subject|2
6952188|NCT01020123|10993552|FG000|Main Period|Eligibility Criteria not fullfilled|0
6952189|NCT01020123|10993553|FG001|Main Period|Eligibility Criteria not fullfilled|1
6952190|NCT01020123|10993554|FG002|Main Period|Eligibility Criteria not fullfilled|0
6952191|NCT01020123|10993555|FG003|Main Period|Eligibility Criteria not fullfilled|0
6952192|NCT01020123|10993556|FG004|Main Period|Eligibility Criteria not fullfilled|1
6952193|NCT01020123|10993557|FG005|Main Period|Eligibility Criteria not fullfilled|0
6952194|NCT01020123|10993558|FG006|Main Period|Eligibility Criteria not fullfilled|0
6952195|NCT01020123|10993552|FG000|Main Period|Adverse Event|5
6952196|NCT01020123|10993553|FG001|Main Period|Adverse Event|2
6952197|NCT01020123|10993554|FG002|Main Period|Adverse Event|2
6952198|NCT01020123|10993555|FG003|Main Period|Adverse Event|1
6952199|NCT01020123|10993556|FG004|Main Period|Adverse Event|1
6952200|NCT01020123|10993557|FG005|Main Period|Adverse Event|2
6952201|NCT01020123|10993558|FG006|Main Period|Adverse Event|1
6952202|NCT01020123|10993552|FG000|Main Period|Protocol Violation|4
6952203|NCT01020123|10993553|FG001|Main Period|Protocol Violation|4
6952204|NCT01020123|10993554|FG002|Main Period|Protocol Violation|2
6952205|NCT01020123|10993555|FG003|Main Period|Protocol Violation|5
6952206|NCT01020123|10993556|FG004|Main Period|Protocol Violation|2
6952207|NCT01020123|10993557|FG005|Main Period|Protocol Violation|3
6952208|NCT01020123|10993558|FG006|Main Period|Protocol Violation|2
6952209|NCT01020123|10993552|FG000|Main Period|Lost to Follow-up|0
6952210|NCT01020123|10993553|FG001|Main Period|Lost to Follow-up|2
6952211|NCT01020123|10993554|FG002|Main Period|Lost to Follow-up|0
7070507|NCT02013791|11173087|FG003|Period 1|Lost to Follow-up|1
7070508|NCT02013791|11173088|FG004|Period 1|Lost to Follow-up|0
7070509|NCT02013791|11173089|FG005|Period 1|Lost to Follow-up|0
7070510|NCT02013791|11173090|FG006|Period 1|Lost to Follow-up|1
7070511|NCT02013791|11173091|FG007|Period 1|Lost to Follow-up|1
7070512|NCT02013791|11173092|FG008|Period 1|Lost to Follow-up|0
7070513|NCT02013791|11173084|FG000|Period 1|Other Miscellaneous Reasons|0
6952212|NCT01020123|10993555|FG003|Main Period|Lost to Follow-up|0
6952213|NCT01020123|10993556|FG004|Main Period|Lost to Follow-up|0
6952214|NCT01020123|10993557|FG005|Main Period|Lost to Follow-up|0
6952215|NCT01020123|10993558|FG006|Main Period|Lost to Follow-up|0
6952216|NCT01020123|10993552|FG000|Main Period|Unclasified|2
6952217|NCT01020123|10993553|FG001|Main Period|Unclasified|0
7070514|NCT02013791|11173085|FG001|Period 1|Other Miscellaneous Reasons|2
7070515|NCT02013791|11173086|FG002|Period 1|Other Miscellaneous Reasons|0
7070516|NCT02013791|11173087|FG003|Period 1|Other Miscellaneous Reasons|0
7070517|NCT02013791|11173088|FG004|Period 1|Other Miscellaneous Reasons|0
7070518|NCT02013791|11173089|FG005|Period 1|Other Miscellaneous Reasons|0
7070519|NCT02013791|11173090|FG006|Period 1|Other Miscellaneous Reasons|0
7070520|NCT02013791|11173091|FG007|Period 1|Other Miscellaneous Reasons|0
7070521|NCT02013791|11173092|FG008|Period 1|Other Miscellaneous Reasons|0
7070522|NCT02013817|11173113|FG000|Overall Study|Adverse Event|12
7070523|NCT02013817|11173113|FG000|Overall Study|Withdrawal by Subject|4
7070524|NCT02013817|11173113|FG000|Overall Study|Death|2
7070525|NCT02013817|11173113|FG000|Overall Study|Other|9
6952218|NCT01020123|10993554|FG002|Main Period|Unclasified|1
6952219|NCT01020123|10993555|FG003|Main Period|Unclasified|0
6952220|NCT01020123|10993556|FG004|Main Period|Unclasified|1
6952221|NCT01020123|10993557|FG005|Main Period|Unclasified|3
6952222|NCT01020123|10993558|FG006|Main Period|Unclasified|6
6952223|NCT01020123|10993552|FG000|Extention Period|Withdrawal by Subject|2
6952224|NCT01020123|10993553|FG001|Extention Period|Withdrawal by Subject|1
6952225|NCT01020123|10993554|FG002|Extention Period|Withdrawal by Subject|1
6952226|NCT01020123|10993555|FG003|Extention Period|Withdrawal by Subject|0
6952227|NCT01020123|10993556|FG004|Extention Period|Withdrawal by Subject|0
6952228|NCT01020123|10993557|FG005|Extention Period|Withdrawal by Subject|0
6952229|NCT01020123|10993558|FG006|Extention Period|Withdrawal by Subject|0
6952230|NCT01020123|10993552|FG000|Extention Period|Adverse Event|0
6952231|NCT01020123|10993553|FG001|Extention Period|Adverse Event|0
6952232|NCT01020123|10993554|FG002|Extention Period|Adverse Event|0
6952233|NCT01020123|10993555|FG003|Extention Period|Adverse Event|1
6952234|NCT01020123|10993556|FG004|Extention Period|Adverse Event|0
6952235|NCT01020123|10993557|FG005|Extention Period|Adverse Event|0
6952236|NCT01020123|10993558|FG006|Extention Period|Adverse Event|0
6952237|NCT01020123|10993552|FG000|Extention Period|Protocol Violation|1
6952238|NCT01020123|10993553|FG001|Extention Period|Protocol Violation|1
7070526|NCT02013830|11173117|FG000|Overall Study|Adverse Event|3
7070527|NCT02013830|11173117|FG000|Overall Study|Death|1
7070528|NCT02013830|11173117|FG000|Overall Study|Insufficient therapeutic response|25
7070529|NCT02013830|11173117|FG000|Overall Study|Refused treatment|1
7070530|NCT02014116|11173138|FG000|Overall Study|Progressive Disease|3
7070531|NCT02014116|11173139|FG001|Overall Study|Progressive Disease|4
7070532|NCT02014116|11173140|FG002|Overall Study|Progressive Disease|2
7070533|NCT02014116|11173141|FG003|Overall Study|Progressive Disease|6
7070534|NCT02014116|11173142|FG004|Overall Study|Progressive Disease|1
7070535|NCT02014116|11173143|FG005|Overall Study|Progressive Disease|13
7070536|NCT02014116|11173144|FG006|Overall Study|Progressive Disease|1
7070537|NCT02014116|11173145|FG007|Overall Study|Progressive Disease|3
6952239|NCT01020123|10993554|FG002|Extention Period|Protocol Violation|1
6952240|NCT01020123|10993555|FG003|Extention Period|Protocol Violation|0
6952241|NCT01020123|10993556|FG004|Extention Period|Protocol Violation|0
6952242|NCT01020123|10993557|FG005|Extention Period|Protocol Violation|0
6952243|NCT01020123|10993558|FG006|Extention Period|Protocol Violation|1
6952244|NCT01020123|10993552|FG000|Extention Period|Lost to Follow-up|0
6952245|NCT01020123|10993553|FG001|Extention Period|Lost to Follow-up|0
6952246|NCT01020123|10993554|FG002|Extention Period|Lost to Follow-up|0
6952247|NCT01020123|10993555|FG003|Extention Period|Lost to Follow-up|0
6952248|NCT01020123|10993556|FG004|Extention Period|Lost to Follow-up|0
6952249|NCT01020123|10993557|FG005|Extention Period|Lost to Follow-up|2
6952250|NCT01020123|10993558|FG006|Extention Period|Lost to Follow-up|0
6952251|NCT01020305|10993575|FG000|Overall Study|Adverse Event|2
6952252|NCT01020435|10993581|FG000|Overall Study|Lost to Follow-up|0
6952253|NCT01020435|10993582|FG001|Overall Study|Lost to Follow-up|1
6952254|NCT01020448|10993589|FG000|Pre-assignment|Adverse Event|6
6952255|NCT01020448|10993589|FG000|Pre-assignment|Withdrawal by Subject|5
6952256|NCT01020448|10993589|FG000|Pre-assignment|Does Not Meet Entry Criteria|2
6952257|NCT01020448|10993589|FG000|Treatment|Adverse Event|11
6952258|NCT01020448|10993589|FG000|Treatment|Consent Withdrawn|3
6952259|NCT01020448|10993589|FG000|Treatment|Disease Progression|2
6952260|NCT01020448|10993589|FG000|Treatment|Lack of Efficacy|8
6952261|NCT01020448|10993589|FG000|Treatment|Lost to Follow-up|2
6952262|NCT01020474|10993596|FG000|Overall Study|Adverse Event|4
6952263|NCT01020474|10993597|FG001|Overall Study|Adverse Event|4
6952264|NCT01020474|10993596|FG000|Overall Study|Protocol Violation|0
6952265|NCT01020474|10993597|FG001|Overall Study|Protocol Violation|2
6952266|NCT01020474|10993596|FG000|Overall Study|Withdrawal by Subject|5
6952267|NCT01020474|10993597|FG001|Overall Study|Withdrawal by Subject|7
6952268|NCT01020474|10993596|FG000|Overall Study|Other Reasons|1
6952269|NCT01020474|10993597|FG001|Overall Study|Other Reasons|1
6952270|NCT01020474|10993596|FG000|Overall Study|Insufficient Clinical Response|0
6952271|NCT01020474|10993597|FG001|Overall Study|Insufficient Clinical Response|3
6952272|NCT01020487|10993606|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0
6952273|NCT01020487|10993607|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2
6952274|NCT01020487|10993608|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1
6952275|NCT01020487|10993606|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
6952276|NCT01020487|10993607|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
6952277|NCT01020487|10993608|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1
6952278|NCT01020487|10993606|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
6952279|NCT01020487|10993607|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
6952280|NCT01020487|10993608|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3
6952281|NCT01020487|10993606|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0
6952282|NCT01020487|10993607|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0
6952283|NCT01020487|10993608|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1
6952284|NCT01020487|10993606|FG000|Part 2 Open-label Period|Adverse Event|0
6952285|NCT01020487|10993607|FG001|Part 2 Open-label Period|Adverse Event|4
6952286|NCT01020487|10993608|FG002|Part 2 Open-label Period|Adverse Event|1
6952287|NCT01020526|10993618|FG000|Overall Study|Withdrawal by Subject|5
6952288|NCT01020526|10993618|FG000|Overall Study|Other reasons|3
6952289|NCT01020526|10993618|FG000|Overall Study|Insufficient clinical response|3
6952290|NCT01020526|10993618|FG000|Overall Study|Lost to Follow-up|1
6952291|NCT01020526|10993618|FG000|Overall Study|Adverse Event|2
6952292|NCT01020747|10993633|FG000|Overall Study|Withdrawal by Subject|1
6952293|NCT01020773|10993640|FG000|Overall Study|Withdrawal by Subject|4
6952294|NCT01020773|10993641|FG001|Overall Study|Withdrawal by Subject|3
6952295|NCT01020786|10993647|FG000|Induction Period|Entry Criteria Not Met|2
6952296|NCT01020786|10993647|FG000|Induction Period|Adverse Event|10
6952297|NCT01020786|10993647|FG000|Induction Period|Progressive Disease|31
6952298|NCT01020786|10993647|FG000|Induction Period|Investigator Decision|3
6952299|NCT01020786|10993647|FG000|Induction Period|Withdrawal by Subject|3
6952300|NCT01020786|10993647|FG000|Maintenance Period|Adverse Event|8
6952301|NCT01020786|10993647|FG000|Maintenance Period|Progressive Disease|43
6952302|NCT01020786|10993647|FG000|Maintenance Period|Withdrawal by Subject|8
6952303|NCT01020786|10993647|FG000|Maintenance Period|Sponsor Decision|1
6952304|NCT01020799|10993655|FG000|Overall Study|Adverse Event|4
6952305|NCT01020799|10993656|FG001|Overall Study|Adverse Event|3
6952306|NCT01020799|10993657|FG002|Overall Study|Adverse Event|2
6952307|NCT01020799|10993655|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4
6952308|NCT01020799|10993656|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3
6952309|NCT01020799|10993657|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0
6952310|NCT01020799|10993655|FG000|Overall Study|Protocol Violation|3
6952311|NCT01020799|10993656|FG001|Overall Study|Protocol Violation|2
6952312|NCT01020799|10993657|FG002|Overall Study|Protocol Violation|0
6952313|NCT01020799|10993655|FG000|Overall Study|Withdrawal by Subject|2
6952314|NCT01020799|10993656|FG001|Overall Study|Withdrawal by Subject|2
7040808|NCT01720524|11124007|FG001|Part A|Other|1
7040809|NCT01720524|11124006|FG000|Part A|Lost to Follow-up|0
6952315|NCT01020799|10993657|FG002|Overall Study|Withdrawal by Subject|3
6952316|NCT01020799|10993655|FG000|Overall Study|Lost to Follow-up|6
7040810|NCT01720524|11124007|FG001|Part A|Lost to Follow-up|1
6952317|NCT01020799|10993656|FG001|Overall Study|Lost to Follow-up|4
6952318|NCT01020799|10993657|FG002|Overall Study|Lost to Follow-up|2
6952319|NCT01020812|10993665|FG000|Overall Study|Physician Decision|1
6952320|NCT01020812|10993665|FG000|Overall Study|Withdrawal by Subject|1
6952321|NCT01020812|10993665|FG000|Overall Study|Protocol Violation|1
6952322|NCT01020838|10993669|FG000|Overall Study|Death|90
6952323|NCT01020838|10993669|FG000|Overall Study|Adverse Event|1
6952324|NCT01020838|10993669|FG000|Overall Study|Withdrawal by Subject|9
6952325|NCT01020838|10993669|FG000|Overall Study|Lost to Follow-up|6
6952326|NCT01020838|10993669|FG000|Overall Study|Most common: Study ended by sponsor|77
6952327|NCT01020877|10993684|FG000|Second Intervention|Withdrawal by Subject|1
6952328|NCT01020877|10993685|FG001|Second Intervention|Withdrawal by Subject|0
6952329|NCT01020981|10993693|FG000|Overall Study|Did not return mailed survey|74
6952330|NCT01020981|10993694|FG001|Overall Study|Did not return mailed survey|58
6952331|NCT01020981|10993693|FG000|Overall Study|Survey returned undeliverable|8
6952332|NCT01020981|10993694|FG001|Overall Study|Survey returned undeliverable|32
6952333|NCT01020981|10993693|FG000|Overall Study|Participant declined to complete survey|2
6952334|NCT01020981|10993694|FG001|Overall Study|Participant declined to complete survey|0
6952335|NCT01021007|10993704|FG000|Overall Study|Lost to Follow-up|1
6952336|NCT01021007|10993705|FG001|Overall Study|Lost to Follow-up|1
6952337|NCT01021007|10993704|FG000|Overall Study|Adverse Event|1
6952338|NCT01021007|10993705|FG001|Overall Study|Adverse Event|3
6952339|NCT01021020|10993711|FG000|Period I|Protocol Violation|1
6952340|NCT01021020|10993711|FG000|Period I|Withdrawal by Subject|1
6952341|NCT01021020|10993711|FG000|14 Day Washout Period A|Physician Decision|1
6976045|NCT01196975|11028473|FG004|Overall Study|Withdrawal by Subject|0
6976046|NCT01196975|11028469|FG000|Overall Study|Lost to Follow-up|11
6976047|NCT01196975|11028470|FG001|Overall Study|Lost to Follow-up|6
6976048|NCT01196975|11028471|FG002|Overall Study|Lost to Follow-up|5
6976049|NCT01196975|11028472|FG003|Overall Study|Lost to Follow-up|5
6976050|NCT01196975|11028473|FG004|Overall Study|Lost to Follow-up|11
6976051|NCT01196988|11028512|FG000|Overall Study|Adverse Event|1
6976052|NCT01196988|11028513|FG001|Overall Study|Adverse Event|2
6976053|NCT01196988|11028514|FG002|Overall Study|Adverse Event|0
6976054|NCT01196988|11028515|FG003|Overall Study|Adverse Event|0
6976055|NCT01196988|11028512|FG000|Overall Study|Withdrawal by Subject|5
6976056|NCT01196988|11028513|FG001|Overall Study|Withdrawal by Subject|1
6976057|NCT01196988|11028514|FG002|Overall Study|Withdrawal by Subject|4
6976058|NCT01196988|11028515|FG003|Overall Study|Withdrawal by Subject|0
6976059|NCT01196988|11028512|FG000|Overall Study|Lost to Follow-up|16
6976060|NCT01196988|11028513|FG001|Overall Study|Lost to Follow-up|29
6976061|NCT01196988|11028514|FG002|Overall Study|Lost to Follow-up|21
7070538|NCT02014116|11173146|FG008|Overall Study|Progressive Disease|7
7070539|NCT02014116|11173138|FG000|Overall Study|Adverse Event|0
6976062|NCT01196988|11028515|FG003|Overall Study|Lost to Follow-up|1
6976063|NCT01196988|11028512|FG000|Overall Study|Other|2
6976064|NCT01196988|11028513|FG001|Overall Study|Other|0
6976065|NCT01196988|11028514|FG002|Overall Study|Other|0
6976066|NCT01196988|11028515|FG003|Overall Study|Other|0
6976067|NCT01197300|11028528|FG000|Overall Study|Lost to Follow-up|0
6976068|NCT01197300|11028529|FG001|Overall Study|Lost to Follow-up|1
6976069|NCT01197300|11028528|FG000|Overall Study|Protocol Violation|0
6976070|NCT01197300|11028529|FG001|Overall Study|Protocol Violation|1
6976071|NCT01197378|11028546|FG000|Overall Study|Adverse Event|3
6976072|NCT01197378|11028546|FG000|Overall Study|Withdrawal by Subject|1
6976073|NCT01197378|11028546|FG000|Overall Study|Physician Decision|1
6976074|NCT01197378|11028546|FG000|Overall Study|Other|2
6976075|NCT01197417|11028552|FG000|Overall Study|Physician Decision|3
6976076|NCT01197417|11028553|FG001|Overall Study|Physician Decision|2
6976077|NCT01197417|11028552|FG000|Overall Study|Withdrawal by Subject|2
6976078|NCT01197417|11028553|FG001|Overall Study|Withdrawal by Subject|4
6976079|NCT01197417|11028552|FG000|Overall Study|Site miscommunication|0
6976080|NCT01197417|11028553|FG001|Overall Study|Site miscommunication|1
6976081|NCT01197417|11028552|FG000|Overall Study|Subject transferred to intensive care|0
6976082|NCT01197417|11028553|FG001|Overall Study|Subject transferred to intensive care|1
6976083|NCT01197417|11028552|FG000|Overall Study|Not consented in time to receive drug|0
6976084|NCT01197417|11028553|FG001|Overall Study|Not consented in time to receive drug|1
6976085|NCT01197417|11028552|FG000|Overall Study|Hypotension|1
6976086|NCT01197417|11028553|FG001|Overall Study|Hypotension|2
7070540|NCT02014116|11173139|FG001|Overall Study|Adverse Event|0
7070541|NCT02014116|11173140|FG002|Overall Study|Adverse Event|0
6976087|NCT01197417|11028552|FG000|Overall Study|Found to be ineligible|2
6976088|NCT01197417|11028553|FG001|Overall Study|Found to be ineligible|5
6976089|NCT01197417|11028552|FG000|Overall Study|No 25-hour magnesium level|0
6976090|NCT01197417|11028553|FG001|Overall Study|No 25-hour magnesium level|2
6976091|NCT01197508|11028581|FG000|Overall Study|Withdrawal by Subject|8
6976092|NCT01197508|11028582|FG001|Overall Study|Withdrawal by Subject|7
6976093|NCT01197508|11028583|FG002|Overall Study|Withdrawal by Subject|15
6976094|NCT01197508|11028584|FG003|Overall Study|Withdrawal by Subject|4
6976095|NCT01197508|11028581|FG000|Overall Study|Eligiblity criteria not fulfilled|0
6976096|NCT01197508|11028582|FG001|Overall Study|Eligiblity criteria not fulfilled|0
6976097|NCT01197508|11028583|FG002|Overall Study|Eligiblity criteria not fulfilled|2
7070542|NCT02014116|11173141|FG003|Overall Study|Adverse Event|0
7070543|NCT02014116|11173142|FG004|Overall Study|Adverse Event|1
6952342|NCT01021137|10993731|FG000|Overall Study|Lost to Follow-up|9
6952343|NCT01021137|10993732|FG001|Overall Study|Lost to Follow-up|4
6952344|NCT01021137|10993733|FG002|Overall Study|Lost to Follow-up|2
6952345|NCT01021137|10993734|FG003|Overall Study|Lost to Follow-up|6
6952346|NCT01021137|10993731|FG000|Overall Study|Withdrawal by Subject|1
6952347|NCT01021137|10993732|FG001|Overall Study|Withdrawal by Subject|0
6952348|NCT01021137|10993733|FG002|Overall Study|Withdrawal by Subject|0
6952349|NCT01021137|10993734|FG003|Overall Study|Withdrawal by Subject|3
6952350|NCT01021215|10993747|FG000|Overall Study|Lost to Follow-up|3
6952351|NCT01021215|10993748|FG001|Overall Study|Lost to Follow-up|0
6976098|NCT01197508|11028584|FG003|Overall Study|Eligiblity criteria not fulfilled|0
6976099|NCT01197508|11028581|FG000|Overall Study|Adverse Event|10
6976100|NCT01197508|11028582|FG001|Overall Study|Adverse Event|13
6976101|NCT01197508|11028583|FG002|Overall Study|Adverse Event|23
6976102|NCT01197508|11028584|FG003|Overall Study|Adverse Event|3
6976103|NCT01197508|11028581|FG000|Overall Study|Severe non-compliance to protocol|0
6976104|NCT01197508|11028582|FG001|Overall Study|Severe non-compliance to protocol|3
6976105|NCT01197508|11028583|FG002|Overall Study|Severe non-compliance to protocol|1
6976106|NCT01197508|11028584|FG003|Overall Study|Severe non-compliance to protocol|3
6976107|NCT01197508|11028581|FG000|Overall Study|Condition under investigation worsened|1
6976108|NCT01197508|11028582|FG001|Overall Study|Condition under investigation worsened|1
6976109|NCT01197508|11028583|FG002|Overall Study|Condition under investigation worsened|1
6976110|NCT01197508|11028584|FG003|Overall Study|Condition under investigation worsened|1
6976111|NCT01197508|11028581|FG000|Overall Study|Lack of Efficacy|1
6976112|NCT01197508|11028582|FG001|Overall Study|Lack of Efficacy|2
6976113|NCT01197508|11028583|FG002|Overall Study|Lack of Efficacy|2
6976114|NCT01197508|11028584|FG003|Overall Study|Lack of Efficacy|1
6976115|NCT01197508|11028581|FG000|Overall Study|Study-specific withdrawal criteria|0
6976116|NCT01197508|11028582|FG001|Overall Study|Study-specific withdrawal criteria|0
6976117|NCT01197508|11028583|FG002|Overall Study|Study-specific withdrawal criteria|1
6976118|NCT01197508|11028584|FG003|Overall Study|Study-specific withdrawal criteria|2
6976119|NCT01197508|11028581|FG000|Overall Study|Lost to Follow-up|1
6976120|NCT01197508|11028582|FG001|Overall Study|Lost to Follow-up|1
6976121|NCT01197508|11028583|FG002|Overall Study|Lost to Follow-up|2
6976122|NCT01197508|11028584|FG003|Overall Study|Lost to Follow-up|0
6976123|NCT01197508|11028581|FG000|Overall Study|Other|2
6976124|NCT01197508|11028582|FG001|Overall Study|Other|3
6976125|NCT01197508|11028583|FG002|Overall Study|Other|2
6976126|NCT01197508|11028584|FG003|Overall Study|Other|2
6976127|NCT01197521|11028597|FG000|Overall Study|Not reported|24
6976128|NCT01197521|11028598|FG001|Overall Study|Not reported|25
6976129|NCT01197521|11028599|FG002|Overall Study|Not reported|21
6976130|NCT01197521|11028597|FG000|Overall Study|Enrolment in long term extension|42
6976131|NCT01197521|11028598|FG001|Overall Study|Enrolment in long term extension|36
6976132|NCT01197521|11028599|FG002|Overall Study|Enrolment in long term extension|87
6976133|NCT01197521|11028597|FG000|Overall Study|Severe non-compliance to protocol|1
6976134|NCT01197521|11028598|FG001|Overall Study|Severe non-compliance to protocol|3
6976135|NCT01197521|11028599|FG002|Overall Study|Severe non-compliance to protocol|3
6976136|NCT01197521|11028597|FG000|Overall Study|Lack of therapeutic response|2
6976137|NCT01197521|11028598|FG001|Overall Study|Lack of therapeutic response|3
6976138|NCT01197521|11028599|FG002|Overall Study|Lack of therapeutic response|4
6976139|NCT01197521|11028597|FG000|Overall Study|Dev. of study specific discont. criteria|6
6976140|NCT01197521|11028598|FG001|Overall Study|Dev. of study specific discont. criteria|16
6976141|NCT01197521|11028599|FG002|Overall Study|Dev. of study specific discont. criteria|2
6976142|NCT01197521|11028597|FG000|Overall Study|Lost to Follow-up|3
6976143|NCT01197521|11028598|FG001|Overall Study|Lost to Follow-up|2
6976144|NCT01197521|11028599|FG002|Overall Study|Lost to Follow-up|2
6976145|NCT01197521|11028597|FG000|Overall Study|Adverse Event|25
6976146|NCT01197521|11028598|FG001|Overall Study|Adverse Event|28
6976147|NCT01197521|11028599|FG002|Overall Study|Adverse Event|24
6976148|NCT01197534|11028613|FG000|Overall Study|Not reported|16
6976149|NCT01197534|11028614|FG001|Overall Study|Not reported|10
6976150|NCT01197534|11028615|FG002|Overall Study|Not reported|16
6976151|NCT01197534|11028613|FG000|Overall Study|Enrolment in long term extension|57
6976152|NCT01197534|11028614|FG001|Overall Study|Enrolment in long term extension|66
6976153|NCT01197534|11028615|FG002|Overall Study|Enrolment in long term extension|119
6976154|NCT01197534|11028613|FG000|Overall Study|Severe non-compliance to protocol|3
6976155|NCT01197534|11028614|FG001|Overall Study|Severe non-compliance to protocol|4
6976156|NCT01197534|11028615|FG002|Overall Study|Severe non-compliance to protocol|1
6976157|NCT01197534|11028613|FG000|Overall Study|Lack of therapeutic response|9
6976158|NCT01197534|11028614|FG001|Overall Study|Lack of therapeutic response|4
6976159|NCT01197534|11028615|FG002|Overall Study|Lack of therapeutic response|9
6976160|NCT01197534|11028613|FG000|Overall Study|Dev. of study specific discont. criteria|13
6976161|NCT01197534|11028614|FG001|Overall Study|Dev. of study specific discont. criteria|6
6976162|NCT01197534|11028615|FG002|Overall Study|Dev. of study specific discont. criteria|2
6976163|NCT01197534|11028613|FG000|Overall Study|Lost to Follow-up|1
6976164|NCT01197534|11028614|FG001|Overall Study|Lost to Follow-up|4
6976165|NCT01197534|11028615|FG002|Overall Study|Lost to Follow-up|2
6976166|NCT01197534|11028613|FG000|Overall Study|Adverse Event|35
6976167|NCT01197534|11028614|FG001|Overall Study|Adverse Event|36
6976168|NCT01197534|11028615|FG002|Overall Study|Adverse Event|24
6952352|NCT04161131|10993759|FG000|Overall Study|Ineligible|2
6952353|NCT04161131|10993759|FG000|Overall Study|Lost to Follow-up|4
6952354|NCT04102501|10993765|FG000|Overall Study|Withdrawal by Subject|7
6952355|NCT04102501|10993766|FG001|Overall Study|Withdrawal by Subject|9
6952356|NCT04102501|10993765|FG000|Overall Study|Adverse Event|1
6952357|NCT04102501|10993766|FG001|Overall Study|Adverse Event|3
6952358|NCT03398356|10993809|FG000|Before Treatment|Lost to Follow-up|1
6952359|NCT03398356|10993810|FG001|Before Treatment|Lost to Follow-up|2
6952360|NCT03398356|10993811|FG002|Before Treatment|Lost to Follow-up|0
6952361|NCT03398356|10993809|FG000|Before Treatment|drug intolerance|2
6952362|NCT03398356|10993810|FG001|Before Treatment|drug intolerance|1
6952363|NCT03398356|10993811|FG002|Before Treatment|drug intolerance|0
6952364|NCT03398356|10993809|FG000|Before Treatment|Withdrawal by Subject|0
6952365|NCT03398356|10993810|FG001|Before Treatment|Withdrawal by Subject|5
6952366|NCT03398356|10993811|FG002|Before Treatment|Withdrawal by Subject|0
6952367|NCT03398356|10993809|FG000|Before Treatment|Physician Decision|0
6952368|NCT03398356|10993810|FG001|Before Treatment|Physician Decision|0
6952369|NCT03398356|10993811|FG002|Before Treatment|Physician Decision|11
6952370|NCT03398356|10993809|FG000|After 6 Weeks of Treatment|Physician Decision|0
6952371|NCT03398356|10993810|FG001|After 6 Weeks of Treatment|Physician Decision|2
6952372|NCT03398356|10993811|FG002|After 6 Weeks of Treatment|Physician Decision|0
6952373|NCT03365791|10993819|FG000|Overall Study|Adverse Event|5
6952374|NCT03365791|10993819|FG000|Overall Study|Death|1
6952375|NCT03365791|10993819|FG000|Overall Study|Lost to Follow-up|1
6952376|NCT03365791|10993819|FG000|Overall Study|Physician Decision|9
6952377|NCT03365791|10993819|FG000|Overall Study|Progressive disease|51
6952378|NCT03365791|10993819|FG000|Overall Study|Subject/guardian decision|5
6952379|NCT03350750|10993826|FG000|Overall Study|Death|1
6952380|NCT03350750|10993827|FG001|Overall Study|Death|1
6952381|NCT02819440|10993846|FG000|Overall Study|Adverse Event|3
6952382|NCT02819440|10993847|FG001|Overall Study|Adverse Event|1
6952383|NCT02819440|10993846|FG000|Overall Study|Lost to Follow-up|1
6952384|NCT02819440|10993847|FG001|Overall Study|Lost to Follow-up|3
6952385|NCT02819440|10993846|FG000|Overall Study|Withdrawal by Subject|9
6952386|NCT02819440|10993847|FG001|Overall Study|Withdrawal by Subject|8
6952387|NCT02782741|10993855|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0
6952388|NCT02782741|10993856|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4
6952389|NCT02782741|10993855|FG000|Blinded Treatment Period: up to Week 49|Other|0
6952390|NCT02782741|10993856|FG001|Blinded Treatment Period: up to Week 49|Other|1
7147791|NCT03135899|11308635|FG007|Overall Study|Withdrawal by Subject|0
6952391|NCT02782741|10993855|FG000|Open-label Long-term: Week 50 to 145|Adverse Event|2
6952392|NCT02782741|10993856|FG001|Open-label Long-term: Week 50 to 145|Adverse Event|1
6952393|NCT02782741|10993855|FG000|Open-label Long-term: Week 50 to 145|Other|1
6952394|NCT02782741|10993856|FG001|Open-label Long-term: Week 50 to 145|Other|0
6952395|NCT02782741|10993855|FG000|Open-label Long-term: Week 50 to 145|Ongoing|48
6952396|NCT02782741|10993856|FG001|Open-label Long-term: Week 50 to 145|Ongoing|43
6952401|NCT02647359|10993877|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0
6952402|NCT02647359|10993878|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1
6952403|NCT02647359|10993877|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4
6952404|NCT02647359|10993878|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0
6952405|NCT02647359|10993877|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2
6952406|NCT02647359|10993878|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1
6952407|NCT02647359|10993877|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8
6952408|NCT02647359|10993878|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3
6952409|NCT02647359|10993877|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1
6952410|NCT02647359|10993878|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0
6952411|NCT02647359|10993877|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7
6952412|NCT02647359|10993878|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4
6952413|NCT02485691|10993890|FG000|Overall Study|Adverse Event|25
6952414|NCT02485691|10993891|FG001|Overall Study|Adverse Event|11
6952415|NCT02485691|10993890|FG000|Overall Study|Poor compliance to protocol|0
6952416|NCT02485691|10993891|FG001|Overall Study|Poor compliance to protocol|1
6952417|NCT02485691|10993890|FG000|Overall Study|Disease progression|57
6952418|NCT02485691|10993891|FG001|Overall Study|Disease progression|92
6952419|NCT02485691|10993890|FG000|Overall Study|Investigator's decision|23
6952420|NCT02485691|10993891|FG001|Overall Study|Investigator's decision|5
6952421|NCT02485691|10993890|FG000|Overall Study|Participant's request|13
6952422|NCT02485691|10993891|FG001|Overall Study|Participant's request|6
6952423|NCT02485691|10993890|FG000|Overall Study|Other reason|8
6952424|NCT02485691|10993891|FG001|Overall Study|Other reason|9
6952425|NCT02485691|10993890|FG000|Overall Study|Randomized and not treated|3
6952426|NCT02485691|10993891|FG001|Overall Study|Randomized and not treated|2
6952427|NCT02201251|10993900|FG000|Overall Study|Adverse Event|1
6952428|NCT02201251|10993901|FG001|Overall Study|Adverse Event|1
6952429|NCT02201251|10993900|FG000|Overall Study|Protocol Violation|1
6952430|NCT02201251|10993901|FG001|Overall Study|Protocol Violation|0
6952431|NCT02201251|10993900|FG000|Overall Study|Noncompliance with Study Drug|0
6952432|NCT02201251|10993901|FG001|Overall Study|Noncompliance with Study Drug|1
6952433|NCT02201251|10993900|FG000|Overall Study|Withdrawal by Subject|2
6952434|NCT02201251|10993901|FG001|Overall Study|Withdrawal by Subject|1
6976169|NCT01197560|11028632|FG000|Overall Study|Adverse Event|6
6976170|NCT01197560|11028633|FG001|Overall Study|Adverse Event|8
6976171|NCT01197560|11028632|FG000|Overall Study|Death|3
6976172|NCT01197560|11028633|FG001|Overall Study|Death|5
6976173|NCT01197560|11028632|FG000|Overall Study|Withdrawal by Subject|1
6976174|NCT01197560|11028633|FG001|Overall Study|Withdrawal by Subject|1
6976175|NCT01197560|11028632|FG000|Overall Study|Disease progression|40
6976176|NCT01197560|11028633|FG001|Overall Study|Disease progression|35
6976177|NCT01197560|11028632|FG000|Overall Study|Miscellaneous|4
6976178|NCT01197560|11028633|FG001|Overall Study|Miscellaneous|3
6976179|NCT01197560|11028632|FG000|Overall Study|Missing|0
6976180|NCT01197560|11028633|FG001|Overall Study|Missing|1
6976181|NCT01197755|11028667|FG000|Overall Study|Adverse Event|8
6976182|NCT01197755|11028668|FG001|Overall Study|Adverse Event|10
6976183|NCT01197755|11028669|FG002|Overall Study|Adverse Event|10
6976184|NCT01197755|11028667|FG000|Overall Study|Study-specific discontinuation criteria|2
6976185|NCT01197755|11028668|FG001|Overall Study|Study-specific discontinuation criteria|1
6976186|NCT01197755|11028669|FG002|Overall Study|Study-specific discontinuation criteria|0
6976187|NCT01197755|11028667|FG000|Overall Study|Entered the long-term extension study|18
6976188|NCT01197755|11028668|FG001|Overall Study|Entered the long-term extension study|21
6976189|NCT01197755|11028669|FG002|Overall Study|Entered the long-term extension study|35
6976190|NCT01197755|11028667|FG000|Overall Study|Lack of therapeutic response|0
6976191|NCT01197755|11028668|FG001|Overall Study|Lack of therapeutic response|7
6976192|NCT01197755|11028669|FG002|Overall Study|Lack of therapeutic response|4
6976193|NCT01197755|11028667|FG000|Overall Study|Severe non-compliance to the protocol|2
6976194|NCT01197755|11028668|FG001|Overall Study|Severe non-compliance to the protocol|1
6976195|NCT01197755|11028669|FG002|Overall Study|Severe non-compliance to the protocol|2
6976196|NCT01197755|11028667|FG000|Overall Study|Withdrawal by Subject|1
6976197|NCT01197755|11028668|FG001|Overall Study|Withdrawal by Subject|0
6976198|NCT01197755|11028669|FG002|Overall Study|Withdrawal by Subject|0
6976199|NCT01197755|11028667|FG000|Overall Study|Lost to Follow-up|0
6976200|NCT01197755|11028668|FG001|Overall Study|Lost to Follow-up|0
6976201|NCT01197755|11028669|FG002|Overall Study|Lost to Follow-up|1
6976202|NCT01197755|11028667|FG000|Overall Study|eg, change in circumstances|7
6976203|NCT01197755|11028668|FG001|Overall Study|eg, change in circumstances|3
6976204|NCT01197755|11028669|FG002|Overall Study|eg, change in circumstances|2
6976205|NCT01197794|11028686|FG000|Overall Study|Adverse Event|3
6976206|NCT01197794|11028687|FG001|Overall Study|Adverse Event|2
6976207|NCT01197794|11028688|FG002|Overall Study|Adverse Event|4
6976208|NCT01197794|11028689|FG003|Overall Study|Adverse Event|4
6976209|NCT01197794|11028690|FG004|Overall Study|Adverse Event|4
6976210|NCT01197794|11028691|FG005|Overall Study|Adverse Event|2
6976211|NCT01197794|11028692|FG006|Overall Study|Adverse Event|3
6976212|NCT01197794|11028686|FG000|Overall Study|Protocol Violation|0
6976213|NCT01197794|11028687|FG001|Overall Study|Protocol Violation|0
6976214|NCT01197794|11028688|FG002|Overall Study|Protocol Violation|0
6976215|NCT01197794|11028689|FG003|Overall Study|Protocol Violation|0
6976216|NCT01197794|11028690|FG004|Overall Study|Protocol Violation|2
6976217|NCT01197794|11028691|FG005|Overall Study|Protocol Violation|0
6976218|NCT01197794|11028692|FG006|Overall Study|Protocol Violation|1
7070544|NCT02014116|11173143|FG005|Overall Study|Adverse Event|0
7070545|NCT02014116|11173144|FG006|Overall Study|Adverse Event|0
7070546|NCT02014116|11173145|FG007|Overall Study|Adverse Event|1
7070547|NCT02014116|11173146|FG008|Overall Study|Adverse Event|0
7070548|NCT02014116|11173138|FG000|Overall Study|Lost to Follow-up|0
7070549|NCT02014116|11173139|FG001|Overall Study|Lost to Follow-up|0
7070550|NCT02014116|11173140|FG002|Overall Study|Lost to Follow-up|0
7070551|NCT02014116|11173141|FG003|Overall Study|Lost to Follow-up|0
7070552|NCT02014116|11173142|FG004|Overall Study|Lost to Follow-up|0
7070553|NCT02014116|11173143|FG005|Overall Study|Lost to Follow-up|1
7070554|NCT02014116|11173144|FG006|Overall Study|Lost to Follow-up|0
7070555|NCT02014116|11173145|FG007|Overall Study|Lost to Follow-up|0
6976219|NCT01197794|11028686|FG000|Overall Study|Development of study withdrawal criteria|3
6976220|NCT01197794|11028687|FG001|Overall Study|Development of study withdrawal criteria|0
6976221|NCT01197794|11028688|FG002|Overall Study|Development of study withdrawal criteria|0
6976222|NCT01197794|11028689|FG003|Overall Study|Development of study withdrawal criteria|1
6976223|NCT01197794|11028690|FG004|Overall Study|Development of study withdrawal criteria|0
6976224|NCT01197794|11028691|FG005|Overall Study|Development of study withdrawal criteria|0
6976225|NCT01197794|11028692|FG006|Overall Study|Development of study withdrawal criteria|1
6976226|NCT01197794|11028686|FG000|Overall Study|Eligibility criteria not fulfilled|5
6976227|NCT01197794|11028687|FG001|Overall Study|Eligibility criteria not fulfilled|8
6976228|NCT01197794|11028688|FG002|Overall Study|Eligibility criteria not fulfilled|2
6976229|NCT01197794|11028689|FG003|Overall Study|Eligibility criteria not fulfilled|5
7070556|NCT02014116|11173146|FG008|Overall Study|Lost to Follow-up|1
7070557|NCT02014116|11173138|FG000|Overall Study|Death|0
7070558|NCT02014116|11173139|FG001|Overall Study|Death|0
7070559|NCT02014116|11173140|FG002|Overall Study|Death|0
7070560|NCT02014116|11173141|FG003|Overall Study|Death|0
6952435|NCT01021293|10993944|FG000|Overall Study|Serious Adverse Event|2
6952436|NCT01021293|10993945|FG001|Overall Study|Serious Adverse Event|1
6952437|NCT01021293|10993944|FG000|Overall Study|Adverse Event|2
6952438|NCT01021293|10993945|FG001|Overall Study|Adverse Event|1
6952439|NCT01021293|10993944|FG000|Overall Study|Withdrawal by Subject|1
6952440|NCT01021293|10993945|FG001|Overall Study|Withdrawal by Subject|3
6952441|NCT01021293|10993944|FG000|Overall Study|Migrated/moved from study area|6
6952442|NCT01021293|10993945|FG001|Overall Study|Migrated/moved from study area|18
6952443|NCT01021293|10993944|FG000|Overall Study|Lost to Follow-up|1
6952444|NCT01021293|10993945|FG001|Overall Study|Lost to Follow-up|1
6952445|NCT01021332|10993969|FG000|Overall Study|Not fulfilling incl./excl.criteria|5
6952446|NCT01021332|10993969|FG000|Overall Study|Adverse Event|43
6952447|NCT01021332|10993969|FG000|Overall Study|Lack of Efficacy|19
6952448|NCT01021332|10993969|FG000|Overall Study|Withdrawal of Consent|23
6952449|NCT01021332|10993969|FG000|Overall Study|Lost to Follow-up|4
6952450|NCT01021332|10993969|FG000|Overall Study|Protocol Violation|9
6952451|NCT01021332|10993969|FG000|Overall Study|Miscellaneous|3
6952452|NCT01021423|10993977|FG000|Overall Study|Study terminated|4
6952453|NCT01021423|10993978|FG001|Overall Study|Study terminated|5
6952454|NCT01021553|10993987|FG000|Overall Study|Adverse Event|1
6952455|NCT01021553|10993988|FG001|Overall Study|Adverse Event|0
6952456|NCT01021553|10993989|FG002|Overall Study|Adverse Event|0
6952457|NCT01021553|10993987|FG000|Overall Study|Lack of Efficacy|2
6952458|NCT01021553|10993988|FG001|Overall Study|Lack of Efficacy|2
6952459|NCT01021553|10993989|FG002|Overall Study|Lack of Efficacy|0
6952460|NCT01021553|10993987|FG000|Overall Study|Protocol Violation|0
6952461|NCT01021553|10993988|FG001|Overall Study|Protocol Violation|2
6952462|NCT01021553|10993989|FG002|Overall Study|Protocol Violation|2
6952463|NCT01021553|10993987|FG000|Overall Study|Lost to Follow-up|0
6952464|NCT01021553|10993988|FG001|Overall Study|Lost to Follow-up|0
6952465|NCT01021553|10993989|FG002|Overall Study|Lost to Follow-up|1
6952466|NCT01021553|10993987|FG000|Overall Study|Withdrawal by Subject|1
6952467|NCT01021553|10993988|FG001|Overall Study|Withdrawal by Subject|1
6952468|NCT01021553|10993989|FG002|Overall Study|Withdrawal by Subject|0
6952469|NCT01021683|10994011|FG000|Overall Study|Lack of Efficacy|12
6952470|NCT01021683|10994011|FG000|Overall Study|Recovery of neutrophil count|51
6952471|NCT01021683|10994011|FG000|Overall Study|Other|8
6952472|NCT01021748|10994024|FG000|Overall Study|Adverse Event|2
6952473|NCT01021748|10994025|FG001|Overall Study|Adverse Event|1
6952474|NCT01021748|10994026|FG002|Overall Study|Adverse Event|2
6952475|NCT01021748|10994027|FG003|Overall Study|Adverse Event|0
6952476|NCT01021748|10994028|FG004|Overall Study|Adverse Event|2
6952477|NCT01021748|10994029|FG005|Overall Study|Adverse Event|0
6952478|NCT01021748|10994030|FG006|Overall Study|Adverse Event|1
6952479|NCT01021748|10994031|FG007|Overall Study|Adverse Event|0
6952480|NCT01021748|10994032|FG008|Overall Study|Adverse Event|7
6952481|NCT01021748|10994024|FG000|Overall Study|Physician Decision|1
6952482|NCT01021748|10994025|FG001|Overall Study|Physician Decision|0
6952483|NCT01021748|10994026|FG002|Overall Study|Physician Decision|1
6952484|NCT01021748|10994027|FG003|Overall Study|Physician Decision|1
6952485|NCT01021748|10994028|FG004|Overall Study|Physician Decision|0
6952486|NCT01021748|10994029|FG005|Overall Study|Physician Decision|0
6952487|NCT01021748|10994030|FG006|Overall Study|Physician Decision|1
6952488|NCT01021748|10994031|FG007|Overall Study|Physician Decision|1
6952489|NCT01021748|10994032|FG008|Overall Study|Physician Decision|2
6952490|NCT01021748|10994024|FG000|Overall Study|Progressive Disease|3
6952491|NCT01021748|10994025|FG001|Overall Study|Progressive Disease|3
6952492|NCT01021748|10994026|FG002|Overall Study|Progressive Disease|4
6952493|NCT01021748|10994027|FG003|Overall Study|Progressive Disease|6
6952494|NCT01021748|10994028|FG004|Overall Study|Progressive Disease|7
6952495|NCT01021748|10994029|FG005|Overall Study|Progressive Disease|3
6952496|NCT01021748|10994030|FG006|Overall Study|Progressive Disease|0
6952497|NCT01021748|10994031|FG007|Overall Study|Progressive Disease|5
6952498|NCT01021748|10994032|FG008|Overall Study|Progressive Disease|6
6952499|NCT01021748|10994024|FG000|Overall Study|Withdrawal by Subject|0
6952500|NCT01021748|10994025|FG001|Overall Study|Withdrawal by Subject|0
6952501|NCT01021748|10994026|FG002|Overall Study|Withdrawal by Subject|0
6952502|NCT01021748|10994027|FG003|Overall Study|Withdrawal by Subject|0
6952503|NCT01021748|10994028|FG004|Overall Study|Withdrawal by Subject|0
6952504|NCT01021748|10994029|FG005|Overall Study|Withdrawal by Subject|0
6952505|NCT01021748|10994030|FG006|Overall Study|Withdrawal by Subject|1
6952506|NCT01021748|10994031|FG007|Overall Study|Withdrawal by Subject|0
6952507|NCT01021748|10994032|FG008|Overall Study|Withdrawal by Subject|1
6952508|NCT01021748|10994024|FG000|Overall Study|Not Treated|0
6952509|NCT01021748|10994025|FG001|Overall Study|Not Treated|1
6952510|NCT01021748|10994026|FG002|Overall Study|Not Treated|0
6952511|NCT01021748|10994027|FG003|Overall Study|Not Treated|0
6952512|NCT01021748|10994028|FG004|Overall Study|Not Treated|0
6952513|NCT01021748|10994029|FG005|Overall Study|Not Treated|0
6952514|NCT01021748|10994030|FG006|Overall Study|Not Treated|0
6952515|NCT01021748|10994031|FG007|Overall Study|Not Treated|0
6952516|NCT01021748|10994032|FG008|Overall Study|Not Treated|0
6952517|NCT01021813|10994067|FG000|DB Treatment Phase|Adverse Event|60
6952518|NCT01021813|10994068|FG001|DB Treatment Phase|Adverse Event|22
6952519|NCT01021813|10994069|FG002|DB Treatment Phase|Adverse Event|0
6952520|NCT01021813|10994070|FG003|DB Treatment Phase|Adverse Event|0
6952521|NCT01021813|10994071|FG004|DB Treatment Phase|Adverse Event|0
6952522|NCT01021813|10994067|FG000|DB Treatment Phase|Lack of Efficacy|44
6952523|NCT01021813|10994068|FG001|DB Treatment Phase|Lack of Efficacy|28
6952524|NCT01021813|10994069|FG002|DB Treatment Phase|Lack of Efficacy|0
6952525|NCT01021813|10994070|FG003|DB Treatment Phase|Lack of Efficacy|0
6952526|NCT01021813|10994071|FG004|DB Treatment Phase|Lack of Efficacy|0
6952527|NCT01021813|10994067|FG000|DB Treatment Phase|Lost to Follow-up|14
6952528|NCT01021813|10994068|FG001|DB Treatment Phase|Lost to Follow-up|12
6952529|NCT01021813|10994069|FG002|DB Treatment Phase|Lost to Follow-up|0
6952530|NCT01021813|10994070|FG003|DB Treatment Phase|Lost to Follow-up|0
6952531|NCT01021813|10994071|FG004|DB Treatment Phase|Lost to Follow-up|0
6952532|NCT01021813|10994067|FG000|DB Treatment Phase|Physician Decision|17
6952533|NCT01021813|10994068|FG001|DB Treatment Phase|Physician Decision|8
6952534|NCT01021813|10994069|FG002|DB Treatment Phase|Physician Decision|0
7070561|NCT02014116|11173142|FG004|Overall Study|Death|0
7070562|NCT02014116|11173143|FG005|Overall Study|Death|0
7070563|NCT02014116|11173144|FG006|Overall Study|Death|0
7070564|NCT02014116|11173145|FG007|Overall Study|Death|1
7070565|NCT02014116|11173146|FG008|Overall Study|Death|1
7070566|NCT02014116|11173138|FG000|Overall Study|Withdrawal by Subject|0
7070567|NCT02014116|11173139|FG001|Overall Study|Withdrawal by Subject|0
7070568|NCT02014116|11173140|FG002|Overall Study|Withdrawal by Subject|1
6952535|NCT01021813|10994070|FG003|DB Treatment Phase|Physician Decision|0
6952536|NCT01021813|10994071|FG004|DB Treatment Phase|Physician Decision|0
6952537|NCT01021813|10994067|FG000|DB Treatment Phase|Pregnancy|1
6952538|NCT01021813|10994068|FG001|DB Treatment Phase|Pregnancy|0
6952539|NCT01021813|10994069|FG002|DB Treatment Phase|Pregnancy|0
6952540|NCT01021813|10994070|FG003|DB Treatment Phase|Pregnancy|0
6952541|NCT01021813|10994071|FG004|DB Treatment Phase|Pregnancy|0
6952542|NCT01021813|10994067|FG000|DB Treatment Phase|Protocol Violation|4
6952543|NCT01021813|10994068|FG001|DB Treatment Phase|Protocol Violation|3
6952544|NCT01021813|10994069|FG002|DB Treatment Phase|Protocol Violation|0
6952545|NCT01021813|10994070|FG003|DB Treatment Phase|Protocol Violation|0
6952546|NCT01021813|10994071|FG004|DB Treatment Phase|Protocol Violation|0
6952547|NCT01021813|10994067|FG000|DB Treatment Phase|Withdrawal by Subject|60
6952548|NCT01021813|10994068|FG001|DB Treatment Phase|Withdrawal by Subject|24
6952549|NCT01021813|10994069|FG002|DB Treatment Phase|Withdrawal by Subject|0
6952550|NCT01021813|10994070|FG003|DB Treatment Phase|Withdrawal by Subject|0
6952551|NCT01021813|10994071|FG004|DB Treatment Phase|Withdrawal by Subject|0
6952552|NCT01021813|10994067|FG000|DB Randomized Discontinuation Phase|Adverse Event|0
6952553|NCT01021813|10994068|FG001|DB Randomized Discontinuation Phase|Adverse Event|0
6952554|NCT01021813|10994069|FG002|DB Randomized Discontinuation Phase|Adverse Event|0
6952555|NCT01021813|10994070|FG003|DB Randomized Discontinuation Phase|Adverse Event|3
6952556|NCT01021813|10994071|FG004|DB Randomized Discontinuation Phase|Adverse Event|1
6952557|NCT01021813|10994067|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0
6952558|NCT01021813|10994068|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0
6952559|NCT01021813|10994069|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0
6952560|NCT01021813|10994070|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1
6952561|NCT01021813|10994071|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0
6952562|NCT01021813|10994067|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0
6952563|NCT01021813|10994068|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0
6952564|NCT01021813|10994069|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0
6952565|NCT01021813|10994070|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0
6952566|NCT01021813|10994071|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1
6952567|NCT01021813|10994067|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0
6952568|NCT01021813|10994068|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0
6952569|NCT01021813|10994069|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1
6952570|NCT01021813|10994070|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0
6952571|NCT01021813|10994071|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0
6952572|NCT01021813|10994067|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
6952573|NCT01021813|10994068|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
6952574|NCT01021813|10994069|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
6952575|NCT01021813|10994070|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1
6952576|NCT01021813|10994071|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
6952577|NCT01021852|10994096|FG000|Treatment Period 1|Adverse Event|3
6952578|NCT01021852|10994097|FG001|Treatment Period 1|Adverse Event|1
6952579|NCT01021852|10994098|FG002|Treatment Period 1|Adverse Event|1
6952580|NCT01021852|10994099|FG003|Treatment Period 1|Adverse Event|0
6952581|NCT01021852|10994100|FG004|Treatment Period 1|Adverse Event|2
6952582|NCT01021852|10994101|FG005|Treatment Period 1|Adverse Event|2
6952583|NCT01021852|10994102|FG006|Treatment Period 1|Adverse Event|0
6952584|NCT01021852|10994103|FG007|Treatment Period 1|Adverse Event|0
6952585|NCT01021852|10994096|FG000|Treatment Period 1|Pregnancy|0
6952586|NCT01021852|10994097|FG001|Treatment Period 1|Pregnancy|0
6952587|NCT01021852|10994098|FG002|Treatment Period 1|Pregnancy|1
6952588|NCT01021852|10994099|FG003|Treatment Period 1|Pregnancy|0
6952589|NCT01021852|10994100|FG004|Treatment Period 1|Pregnancy|0
6952590|NCT01021852|10994101|FG005|Treatment Period 1|Pregnancy|0
6952591|NCT01021852|10994102|FG006|Treatment Period 1|Pregnancy|0
7070569|NCT02014116|11173141|FG003|Overall Study|Withdrawal by Subject|1
7070570|NCT02014116|11173142|FG004|Overall Study|Withdrawal by Subject|0
6952592|NCT01021852|10994103|FG007|Treatment Period 1|Pregnancy|0
6952593|NCT01021852|10994096|FG000|Treatment Period 1|Withdrawal by Subject|0
6952594|NCT01021852|10994097|FG001|Treatment Period 1|Withdrawal by Subject|0
6952595|NCT01021852|10994098|FG002|Treatment Period 1|Withdrawal by Subject|0
6952596|NCT01021852|10994099|FG003|Treatment Period 1|Withdrawal by Subject|0
6952597|NCT01021852|10994100|FG004|Treatment Period 1|Withdrawal by Subject|1
6952598|NCT01021852|10994101|FG005|Treatment Period 1|Withdrawal by Subject|0
6952599|NCT01021852|10994102|FG006|Treatment Period 1|Withdrawal by Subject|0
6952600|NCT01021852|10994103|FG007|Treatment Period 1|Withdrawal by Subject|1
6952601|NCT01021852|10994096|FG000|Treatment Period 1|Not Treated|0
6952602|NCT01021852|10994097|FG001|Treatment Period 1|Not Treated|0
6952603|NCT01021852|10994098|FG002|Treatment Period 1|Not Treated|0
6952604|NCT01021852|10994099|FG003|Treatment Period 1|Not Treated|2
6952605|NCT01021852|10994100|FG004|Treatment Period 1|Not Treated|0
6952606|NCT01021852|10994101|FG005|Treatment Period 1|Not Treated|0
6952607|NCT01021852|10994102|FG006|Treatment Period 1|Not Treated|0
6952608|NCT01021852|10994103|FG007|Treatment Period 1|Not Treated|0
6952609|NCT01021852|10994096|FG000|Washout Period-Placebo|Adverse Event|0
6952610|NCT01021852|10994097|FG001|Washout Period-Placebo|Adverse Event|0
6952611|NCT01021852|10994098|FG002|Washout Period-Placebo|Adverse Event|0
6952612|NCT01021852|10994099|FG003|Washout Period-Placebo|Adverse Event|1
6952613|NCT01021852|10994100|FG004|Washout Period-Placebo|Adverse Event|0
6952614|NCT01021852|10994101|FG005|Washout Period-Placebo|Adverse Event|1
6952615|NCT01021852|10994102|FG006|Washout Period-Placebo|Adverse Event|0
6952616|NCT01021852|10994103|FG007|Washout Period-Placebo|Adverse Event|0
6952617|NCT01021852|10994096|FG000|Washout Period-Placebo|Lost to Follow-up|0
6952618|NCT01021852|10994097|FG001|Washout Period-Placebo|Lost to Follow-up|0
6952619|NCT01021852|10994098|FG002|Washout Period-Placebo|Lost to Follow-up|0
6952620|NCT01021852|10994099|FG003|Washout Period-Placebo|Lost to Follow-up|0
6952621|NCT01021852|10994100|FG004|Washout Period-Placebo|Lost to Follow-up|1
6952622|NCT01021852|10994101|FG005|Washout Period-Placebo|Lost to Follow-up|0
6952623|NCT01021852|10994102|FG006|Washout Period-Placebo|Lost to Follow-up|0
6952624|NCT01021852|10994103|FG007|Washout Period-Placebo|Lost to Follow-up|0
6952625|NCT01021852|10994096|FG000|Washout Period-Placebo|Protocol Violation|0
6952626|NCT01021852|10994097|FG001|Washout Period-Placebo|Protocol Violation|0
6952627|NCT01021852|10994098|FG002|Washout Period-Placebo|Protocol Violation|0
6952628|NCT01021852|10994099|FG003|Washout Period-Placebo|Protocol Violation|0
6952629|NCT01021852|10994100|FG004|Washout Period-Placebo|Protocol Violation|0
6952630|NCT01021852|10994101|FG005|Washout Period-Placebo|Protocol Violation|0
6952631|NCT01021852|10994102|FG006|Washout Period-Placebo|Protocol Violation|1
6952632|NCT01021852|10994103|FG007|Washout Period-Placebo|Protocol Violation|0
6952633|NCT01021852|10994096|FG000|Washout Period-No Drug|Adverse Event|1
6952634|NCT01021852|10994097|FG001|Washout Period-No Drug|Adverse Event|0
6952635|NCT01021852|10994098|FG002|Washout Period-No Drug|Adverse Event|0
6952636|NCT01021852|10994099|FG003|Washout Period-No Drug|Adverse Event|0
6952637|NCT01021852|10994100|FG004|Washout Period-No Drug|Adverse Event|0
6952638|NCT01021852|10994101|FG005|Washout Period-No Drug|Adverse Event|1
6952639|NCT01021852|10994102|FG006|Washout Period-No Drug|Adverse Event|0
6952640|NCT01021852|10994103|FG007|Washout Period-No Drug|Adverse Event|0
6952641|NCT01021852|10994096|FG000|Treatment Period 2|Adverse Event|0
6952642|NCT01021852|10994097|FG001|Treatment Period 2|Adverse Event|1
6952643|NCT01021852|10994098|FG002|Treatment Period 2|Adverse Event|0
6952644|NCT01021852|10994099|FG003|Treatment Period 2|Adverse Event|0
6952645|NCT01021852|10994100|FG004|Treatment Period 2|Adverse Event|1
6952646|NCT01021852|10994101|FG005|Treatment Period 2|Adverse Event|0
6952647|NCT01021852|10994102|FG006|Treatment Period 2|Adverse Event|1
6952648|NCT01021852|10994103|FG007|Treatment Period 2|Adverse Event|0
6952649|NCT01021852|10994096|FG000|Treatment Period 2|Lack of Efficacy|0
6952650|NCT01021852|10994097|FG001|Treatment Period 2|Lack of Efficacy|0
6952651|NCT01021852|10994098|FG002|Treatment Period 2|Lack of Efficacy|0
6952652|NCT01021852|10994099|FG003|Treatment Period 2|Lack of Efficacy|0
6952653|NCT01021852|10994100|FG004|Treatment Period 2|Lack of Efficacy|0
6952654|NCT01021852|10994101|FG005|Treatment Period 2|Lack of Efficacy|1
6952655|NCT01021852|10994102|FG006|Treatment Period 2|Lack of Efficacy|0
6952656|NCT01021852|10994103|FG007|Treatment Period 2|Lack of Efficacy|0
6952657|NCT01021852|10994096|FG000|Treatment Period 2|Physician Decision|0
6952658|NCT01021852|10994097|FG001|Treatment Period 2|Physician Decision|0
6952659|NCT01021852|10994098|FG002|Treatment Period 2|Physician Decision|1
6952660|NCT01021852|10994099|FG003|Treatment Period 2|Physician Decision|0
6952661|NCT01021852|10994100|FG004|Treatment Period 2|Physician Decision|0
6952662|NCT01021852|10994101|FG005|Treatment Period 2|Physician Decision|0
6952663|NCT01021852|10994102|FG006|Treatment Period 2|Physician Decision|0
6952664|NCT01021852|10994103|FG007|Treatment Period 2|Physician Decision|0
6952665|NCT01021852|10994096|FG000|Treatment Period 2|Protocol Violation|0
6952666|NCT01021852|10994097|FG001|Treatment Period 2|Protocol Violation|0
6952667|NCT01021852|10994098|FG002|Treatment Period 2|Protocol Violation|0
6952668|NCT01021852|10994099|FG003|Treatment Period 2|Protocol Violation|0
6952669|NCT01021852|10994100|FG004|Treatment Period 2|Protocol Violation|1
6952670|NCT01021852|10994101|FG005|Treatment Period 2|Protocol Violation|0
6952671|NCT01021852|10994102|FG006|Treatment Period 2|Protocol Violation|1
6952672|NCT01021852|10994103|FG007|Treatment Period 2|Protocol Violation|0
6952673|NCT01021852|10994096|FG000|Treatment Period 2|Withdrawal by Subject|0
6952674|NCT01021852|10994097|FG001|Treatment Period 2|Withdrawal by Subject|0
6952675|NCT01021852|10994098|FG002|Treatment Period 2|Withdrawal by Subject|0
6952676|NCT01021852|10994099|FG003|Treatment Period 2|Withdrawal by Subject|0
6952677|NCT01021852|10994100|FG004|Treatment Period 2|Withdrawal by Subject|0
6952678|NCT01021852|10994101|FG005|Treatment Period 2|Withdrawal by Subject|0
6952679|NCT01021852|10994102|FG006|Treatment Period 2|Withdrawal by Subject|1
6952680|NCT01021852|10994103|FG007|Treatment Period 2|Withdrawal by Subject|2
6952681|NCT01021878|10994119|FG000|Overall Study|Lost to Follow-up|4
6952682|NCT01021878|10994120|FG001|Overall Study|Lost to Follow-up|3
6952683|NCT01021878|10994119|FG000|Overall Study|Death|0
6952684|NCT01021878|10994120|FG001|Overall Study|Death|1
6952685|NCT01021878|10994119|FG000|Overall Study|Adverse Event|6
6952686|NCT01021878|10994120|FG001|Overall Study|Adverse Event|5
6952687|NCT01021878|10994119|FG000|Overall Study|Transplantation|6
6952688|NCT01021878|10994120|FG001|Overall Study|Transplantation|1
6952689|NCT01022112|10994161|FG000|Overall Study|Adverse Event|1
6952690|NCT01022112|10994162|FG001|Overall Study|Adverse Event|2
6952691|NCT01022112|10994163|FG002|Overall Study|Adverse Event|0
6952692|NCT01022112|10994164|FG003|Overall Study|Adverse Event|1
6952693|NCT01022112|10994165|FG004|Overall Study|Adverse Event|0
6952694|NCT01022112|10994161|FG000|Overall Study|Lack of Efficacy|1
6952695|NCT01022112|10994162|FG001|Overall Study|Lack of Efficacy|0
6952696|NCT01022112|10994163|FG002|Overall Study|Lack of Efficacy|0
6952697|NCT01022112|10994164|FG003|Overall Study|Lack of Efficacy|0
6952698|NCT01022112|10994165|FG004|Overall Study|Lack of Efficacy|1
6952699|NCT01022112|10994161|FG000|Overall Study|Physician Decision|0
6952700|NCT01022112|10994162|FG001|Overall Study|Physician Decision|0
6952701|NCT01022112|10994163|FG002|Overall Study|Physician Decision|1
6952702|NCT01022112|10994164|FG003|Overall Study|Physician Decision|0
6952703|NCT01022112|10994165|FG004|Overall Study|Physician Decision|1
6952704|NCT01022112|10994161|FG000|Overall Study|Withdrawal by Subject|0
6952705|NCT01022112|10994162|FG001|Overall Study|Withdrawal by Subject|1
6952706|NCT01022112|10994163|FG002|Overall Study|Withdrawal by Subject|2
6952707|NCT01022112|10994164|FG003|Overall Study|Withdrawal by Subject|2
6952708|NCT01022112|10994165|FG004|Overall Study|Withdrawal by Subject|1
6952709|NCT01022112|10994161|FG000|Overall Study|Fasting plasma glucose level increased|1
6952710|NCT01022112|10994162|FG001|Overall Study|Fasting plasma glucose level increased|0
6952711|NCT01022112|10994163|FG002|Overall Study|Fasting plasma glucose level increased|0
6952712|NCT01022112|10994164|FG003|Overall Study|Fasting plasma glucose level increased|0
6952713|NCT01022112|10994165|FG004|Overall Study|Fasting plasma glucose level increased|7
6952714|NCT01022203|10994183|FG000|Post Treatment Assessment|Withdrawal by Subject|12
6952715|NCT01022203|10994184|FG001|Post Treatment Assessment|Withdrawal by Subject|12
6952716|NCT01022203|10994183|FG000|Post Treatment Assessment|Physician Decision|2
6952717|NCT01022203|10994184|FG001|Post Treatment Assessment|Physician Decision|0
6952718|NCT01022203|10994183|FG000|Post Treatment Assessment|Adverse Event|0
6952719|NCT01022203|10994184|FG001|Post Treatment Assessment|Adverse Event|2
6952720|NCT01022203|10994183|FG000|Follow-Up Assessment|Lost to Follow-up|2
6952721|NCT01022203|10994184|FG001|Follow-Up Assessment|Lost to Follow-up|2
6952722|NCT01022424|10994220|FG000|Overall Study|Adverse Event|1
6952723|NCT01022424|10994220|FG000|Overall Study|Physician Decision|1
6952724|NCT01022424|10994220|FG000|Overall Study|eGFR under the withdrawal criteria|2
6952725|NCT01022502|10994228|FG000|Overall Study|Adverse Event|1
6952726|NCT01022502|10994228|FG000|Overall Study|employment related reasons|1
6952727|NCT01022502|10994228|FG000|Overall Study|Withdrawal by Subject|1
6952728|NCT01022580|10994245|FG000|Overall Study|Death|18
6952729|NCT01022580|10994246|FG001|Overall Study|Death|22
6952730|NCT01022762|10994260|FG000|Overall Study|Adverse Event|3
6952731|NCT01022762|10994261|FG001|Overall Study|Adverse Event|1
6952732|NCT01022762|10994260|FG000|Overall Study|Lack of Efficacy|0
6952733|NCT01022762|10994261|FG001|Overall Study|Lack of Efficacy|1
6952734|NCT01022762|10994260|FG000|Overall Study|Protocol Violation|7
6952735|NCT01022762|10994261|FG001|Overall Study|Protocol Violation|6
6952736|NCT01022762|10994260|FG000|Overall Study|Unclassified|12
6952737|NCT01022762|10994261|FG001|Overall Study|Unclassified|20
6952738|NCT01022853|10994272|FG000|Overall Study|Progressive disease|2
6952739|NCT01022853|10994273|FG001|Overall Study|Progressive disease|3
6952740|NCT01022853|10994274|FG002|Overall Study|Progressive disease|11
6952741|NCT01022853|10994275|FG003|Overall Study|Progressive disease|7
6952742|NCT01022853|10994276|FG004|Overall Study|Progressive disease|1
6952743|NCT01022853|10994272|FG000|Overall Study|Dose-limiting toxicity|0
6952744|NCT01022853|10994273|FG001|Overall Study|Dose-limiting toxicity|0
6952745|NCT01022853|10994274|FG002|Overall Study|Dose-limiting toxicity|0
6952746|NCT01022853|10994275|FG003|Overall Study|Dose-limiting toxicity|0
6952747|NCT01022853|10994276|FG004|Overall Study|Dose-limiting toxicity|1
6952748|NCT01022853|10994272|FG000|Overall Study|Withdrawal by Subject|0
6952749|NCT01022853|10994273|FG001|Overall Study|Withdrawal by Subject|1
6952750|NCT01022853|10994274|FG002|Overall Study|Withdrawal by Subject|1
6952751|NCT01022853|10994275|FG003|Overall Study|Withdrawal by Subject|1
6952752|NCT01022853|10994276|FG004|Overall Study|Withdrawal by Subject|0
6952753|NCT01022853|10994272|FG000|Overall Study|Other not stated above|1
6952754|NCT01022853|10994273|FG001|Overall Study|Other not stated above|0
6952755|NCT01022853|10994274|FG002|Overall Study|Other not stated above|1
6952756|NCT01022853|10994275|FG003|Overall Study|Other not stated above|0
6952757|NCT01022853|10994276|FG004|Overall Study|Other not stated above|0
6952758|NCT01022996|10994291|FG000|Overall Study|Adverse Event|14
6952759|NCT01022996|10994291|FG000|Overall Study|Withdrawal by Subject|3
6952760|NCT01022996|10994291|FG000|Overall Study|Lost to Follow-up|1
6952761|NCT01022996|10994291|FG000|Overall Study|Administrative problems|6
6952762|NCT01022996|10994291|FG000|Overall Study|Disease Progression|32
6952763|NCT01022996|10994291|FG000|Overall Study|Protocol Violation|1
6952764|NCT01023022|10994295|FG000|Overall Study|Death|5
6952765|NCT01023022|10994295|FG000|Overall Study|Lost to Follow-up|7
6952766|NCT01023022|10994295|FG000|Overall Study|due to technical issues|2
6952767|NCT01023035|10994302|FG000|Treatment Period|Adverse Event|27
6952768|NCT01023035|10994303|FG001|Treatment Period|Adverse Event|32
6952769|NCT01023035|10994304|FG002|Treatment Period|Adverse Event|50
6952770|NCT01023035|10994302|FG000|Treatment Period|Non-Medical Reasons|19
6952771|NCT01023035|10994303|FG001|Treatment Period|Non-Medical Reasons|22
6952772|NCT01023035|10994304|FG002|Treatment Period|Non-Medical Reasons|44
6952773|NCT01023035|10994302|FG000|Treatment Period|Treatment Failure|26
6952774|NCT01023035|10994303|FG001|Treatment Period|Treatment Failure|31
6952775|NCT01023035|10994304|FG002|Treatment Period|Treatment Failure|24
6952776|NCT01023035|10994302|FG000|Follow-up Period (up to Week 72)|Adverse Event|2
6952777|NCT01023035|10994303|FG001|Follow-up Period (up to Week 72)|Adverse Event|0
6952778|NCT01023035|10994304|FG002|Follow-up Period (up to Week 72)|Adverse Event|1
6952779|NCT01023035|10994302|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26
6952780|NCT01023035|10994303|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28
6952781|NCT01023035|10994304|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38
6952782|NCT01023061|10994314|FG000|Overall Study|Withdrawal prior to treatment|2
6952783|NCT01023217|10994350|FG000|Overall Study|Withdrawal by Subject|1
6952784|NCT01023217|10994351|FG001|Overall Study|Withdrawal by Subject|0
6952785|NCT01023256|10994361|FG000|Overall Study|Protocol Violation|2
6952786|NCT01023256|10994362|FG001|Overall Study|Protocol Violation|3
6952787|NCT01023256|10994363|FG002|Overall Study|Protocol Violation|0
6952788|NCT01023256|10994364|FG003|Overall Study|Protocol Violation|0
6952789|NCT01023256|10994361|FG000|Overall Study|Randomized but not treated|1
6952790|NCT01023256|10994362|FG001|Overall Study|Randomized but not treated|0
6952791|NCT01023256|10994363|FG002|Overall Study|Randomized but not treated|1
6952792|NCT01023256|10994364|FG003|Overall Study|Randomized but not treated|0
6952793|NCT01023256|10994361|FG000|Overall Study|Other|1
6952794|NCT01023256|10994362|FG001|Overall Study|Other|0
6952795|NCT01023256|10994363|FG002|Overall Study|Other|0
6952796|NCT01023256|10994364|FG003|Overall Study|Other|2
6952797|NCT01023256|10994361|FG000|Overall Study|Adverse Event|0
6952798|NCT01023256|10994362|FG001|Overall Study|Adverse Event|0
6952799|NCT01023256|10994363|FG002|Overall Study|Adverse Event|0
6952800|NCT01023256|10994364|FG003|Overall Study|Adverse Event|1
6952801|NCT01023256|10994361|FG000|Overall Study|Withdrawal by Subject|0
6952802|NCT01023256|10994362|FG001|Overall Study|Withdrawal by Subject|0
6952803|NCT01023256|10994363|FG002|Overall Study|Withdrawal by Subject|0
6952804|NCT01023256|10994364|FG003|Overall Study|Withdrawal by Subject|2
6952805|NCT01023269|10994377|FG000|Overall Study|early termination of the study|2
6952806|NCT01023269|10994378|FG001|Overall Study|early termination of the study|0
6952807|NCT01023308|10994384|FG000|Overall Study|Abnormal test proceedure results|3
6952808|NCT01023308|10994385|FG001|Overall Study|Abnormal test proceedure results|8
6952809|NCT01023308|10994384|FG000|Overall Study|Administrative problems|2
6952810|NCT01023308|10994385|FG001|Overall Study|Administrative problems|1
6952811|NCT01023308|10994384|FG000|Overall Study|Adverse Event|130
6952812|NCT01023308|10994385|FG001|Overall Study|Adverse Event|66
6952813|NCT01023308|10994384|FG000|Overall Study|Death|21
6952814|NCT01023308|10994385|FG001|Overall Study|Death|17
6952815|NCT01023308|10994384|FG000|Overall Study|Disease progression|82
6952816|NCT01023308|10994385|FG001|Overall Study|Disease progression|153
6952817|NCT01023308|10994384|FG000|Overall Study|New Cancer therapy|4
6952818|NCT01023308|10994385|FG001|Overall Study|New Cancer therapy|7
6952819|NCT01023308|10994384|FG000|Overall Study|Protocol Violation|3
6952820|NCT01023308|10994385|FG001|Overall Study|Protocol Violation|4
6952821|NCT01023308|10994384|FG000|Overall Study|Untreated|5
6952822|NCT01023308|10994385|FG001|Overall Study|Untreated|5
6952823|NCT01023308|10994384|FG000|Overall Study|Lost to Follow-up|1
6952824|NCT01023308|10994385|FG001|Overall Study|Lost to Follow-up|0
6952825|NCT01023308|10994384|FG000|Overall Study|Withdrawal by Subject|34
6952826|NCT01023308|10994385|FG001|Overall Study|Withdrawal by Subject|18
6952827|NCT01023516|10994402|FG000|Overall Study|Voluntary discontinuation|7
6952828|NCT01023516|10994403|FG001|Overall Study|Voluntary discontinuation|5
6952829|NCT01023516|10994402|FG000|Overall Study|Adverse Event|9
6952830|NCT01023516|10994403|FG001|Overall Study|Adverse Event|6
6952831|NCT01023516|10994402|FG000|Overall Study|Safety reason|0
6952832|NCT01023516|10994403|FG001|Overall Study|Safety reason|3
6952833|NCT01023516|10994402|FG000|Overall Study|Study-specific criteria|4
6952834|NCT01023516|10994403|FG001|Overall Study|Study-specific criteria|2
6952835|NCT01023516|10994402|FG000|Overall Study|Incorrect enrolment|4
6952836|NCT01023516|10994403|FG001|Overall Study|Incorrect enrolment|2
6952837|NCT01023581|10994429|FG000|Overall Study|Adverse Event|4
6952838|NCT01023581|10994430|FG001|Overall Study|Adverse Event|4
6952839|NCT01023581|10994431|FG002|Overall Study|Adverse Event|7
6952840|NCT01023581|10994432|FG003|Overall Study|Adverse Event|3
6952841|NCT01023581|10994433|FG004|Overall Study|Adverse Event|2
6952842|NCT01023581|10994434|FG005|Overall Study|Adverse Event|5
6952843|NCT01023581|10994435|FG006|Overall Study|Adverse Event|11
6952844|NCT01023581|10994429|FG000|Overall Study|Major protocol deviation|2
6952845|NCT01023581|10994430|FG001|Overall Study|Major protocol deviation|0
6952846|NCT01023581|10994431|FG002|Overall Study|Major protocol deviation|3
6952847|NCT01023581|10994432|FG003|Overall Study|Major protocol deviation|0
6952848|NCT01023581|10994433|FG004|Overall Study|Major protocol deviation|0
6952849|NCT01023581|10994434|FG005|Overall Study|Major protocol deviation|0
6952850|NCT01023581|10994435|FG006|Overall Study|Major protocol deviation|0
6952851|NCT01023581|10994429|FG000|Overall Study|Lost to Follow-up|4
6952852|NCT01023581|10994430|FG001|Overall Study|Lost to Follow-up|8
6952853|NCT01023581|10994431|FG002|Overall Study|Lost to Follow-up|7
6952854|NCT01023581|10994432|FG003|Overall Study|Lost to Follow-up|2
6952855|NCT01023581|10994433|FG004|Overall Study|Lost to Follow-up|5
6952856|NCT01023581|10994434|FG005|Overall Study|Lost to Follow-up|2
6952857|NCT01023581|10994435|FG006|Overall Study|Lost to Follow-up|2
6952858|NCT01023581|10994429|FG000|Overall Study|Withdrawal by Subject|13
6952859|NCT01023581|10994430|FG001|Overall Study|Withdrawal by Subject|8
6952860|NCT01023581|10994431|FG002|Overall Study|Withdrawal by Subject|16
6952861|NCT01023581|10994432|FG003|Overall Study|Withdrawal by Subject|10
6952862|NCT01023581|10994433|FG004|Overall Study|Withdrawal by Subject|6
6952863|NCT01023581|10994434|FG005|Overall Study|Withdrawal by Subject|8
6952864|NCT01023581|10994435|FG006|Overall Study|Withdrawal by Subject|5
6952865|NCT01023581|10994429|FG000|Overall Study|Pregnancy|0
6952866|NCT01023581|10994430|FG001|Overall Study|Pregnancy|0
6952867|NCT01023581|10994431|FG002|Overall Study|Pregnancy|0
6952868|NCT01023581|10994432|FG003|Overall Study|Pregnancy|2
6952869|NCT01023581|10994433|FG004|Overall Study|Pregnancy|0
6952870|NCT01023581|10994434|FG005|Overall Study|Pregnancy|1
6952871|NCT01023581|10994435|FG006|Overall Study|Pregnancy|0
6952872|NCT01023581|10994429|FG000|Overall Study|Lack of Efficacy|9
6952873|NCT01023581|10994430|FG001|Overall Study|Lack of Efficacy|3
6952874|NCT01023581|10994431|FG002|Overall Study|Lack of Efficacy|6
6952875|NCT01023581|10994432|FG003|Overall Study|Lack of Efficacy|2
6952876|NCT01023581|10994433|FG004|Overall Study|Lack of Efficacy|1
6952877|NCT01023581|10994434|FG005|Overall Study|Lack of Efficacy|2
6952878|NCT01023581|10994435|FG006|Overall Study|Lack of Efficacy|1
6952879|NCT01023581|10994429|FG000|Overall Study|Physician Decision|2
6952880|NCT01023581|10994430|FG001|Overall Study|Physician Decision|0
6952881|NCT01023581|10994431|FG002|Overall Study|Physician Decision|2
6952882|NCT01023581|10994432|FG003|Overall Study|Physician Decision|1
6952883|NCT01023581|10994433|FG004|Overall Study|Physician Decision|1
6952884|NCT01023581|10994434|FG005|Overall Study|Physician Decision|1
6952885|NCT01023581|10994435|FG006|Overall Study|Physician Decision|1
6952886|NCT01023581|10994429|FG000|Overall Study|Other|1
6952887|NCT01023581|10994430|FG001|Overall Study|Other|0
6952888|NCT01023581|10994431|FG002|Overall Study|Other|1
6952889|NCT01023581|10994432|FG003|Overall Study|Other|0
6952890|NCT01023581|10994433|FG004|Overall Study|Other|1
6952891|NCT01023581|10994434|FG005|Overall Study|Other|0
6952892|NCT01023581|10994435|FG006|Overall Study|Other|0
6952893|NCT01023659|10994454|FG000|Overall Study|Lost to Follow-up|73
6952894|NCT01023659|10994455|FG001|Overall Study|Lost to Follow-up|228
6952895|NCT01023659|10994456|FG002|Overall Study|Lost to Follow-up|99
6952896|NCT01023672|10994465|FG000|Overall Study|Worsening disease|2
6952897|NCT01023672|10994465|FG000|Overall Study|Death|1
6952898|NCT01023789|10994487|FG000|3 - Year Visit|Death|29
6952899|NCT01023789|10994487|FG000|3 - Year Visit|Withdrawal of consent|1
6952900|NCT01023789|10994487|FG000|3 - Year Visit|Lost to Follow-up|13
6952901|NCT01023815|10994495|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144
6952902|NCT01023815|10994496|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
7070571|NCT02014116|11173143|FG005|Overall Study|Withdrawal by Subject|1
7070572|NCT02014116|11173144|FG006|Overall Study|Withdrawal by Subject|0
6952903|NCT01023815|10994497|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
6952904|NCT01023815|10994498|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
6952905|NCT01023815|10994495|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
6952906|NCT01023815|10994496|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
6952907|NCT01023815|10994497|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
6952908|NCT01023815|10994498|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
6952909|NCT01023815|10994495|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
6952910|NCT01023815|10994496|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
6952911|NCT01023815|10994497|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
6952912|NCT01023815|10994498|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
6952913|NCT01023815|10994495|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0
6952914|NCT01023815|10994496|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1
6952915|NCT01023815|10994497|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6
6952916|NCT01023815|10994498|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2
6952917|NCT01023815|10994495|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0
6952918|NCT01023815|10994496|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1
7040811|NCT01720524|11124006|FG000|Part B|No longer willing to participate in study|1
7070573|NCT02014116|11173145|FG007|Overall Study|Withdrawal by Subject|0
6952919|NCT01023815|10994497|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0
6952920|NCT01023815|10994498|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0
6952921|NCT01023958|10994518|FG000|Overall Study|Progressive disease|48
6952922|NCT01023958|10994518|FG000|Overall Study|Other adverse event|1
6952923|NCT01023958|10994518|FG000|Overall Study|Refused to continue medication|1
6952924|NCT01024036|10994533|FG000|Blinded Treatment|Adverse Event|1
6952925|NCT01024036|10994534|FG001|Blinded Treatment|Adverse Event|1
6952926|NCT01024036|10994533|FG000|Blinded Treatment|Lack of Efficacy|16
6952927|NCT01024036|10994534|FG001|Blinded Treatment|Lack of Efficacy|14
6952928|NCT01024036|10994533|FG000|Blinded Treatment|Physician Decision|1
6952929|NCT01024036|10994534|FG001|Blinded Treatment|Physician Decision|0
6952930|NCT01024036|10994533|FG000|Blinded Treatment|Death|0
6952931|NCT01024036|10994534|FG001|Blinded Treatment|Death|2
6952932|NCT01024036|10994533|FG000|Blinded Treatment|Withdrawal by Subject|4
6952933|NCT01024036|10994534|FG001|Blinded Treatment|Withdrawal by Subject|3
6952934|NCT01024036|10994533|FG000|Unblinded Treatment|Adverse Event|0
6952935|NCT01024036|10994534|FG001|Unblinded Treatment|Adverse Event|1
6952936|NCT01024036|10994533|FG000|Unblinded Treatment|Lack of Efficacy|0
6952937|NCT01024036|10994534|FG001|Unblinded Treatment|Lack of Efficacy|2
6952938|NCT01024036|10994533|FG000|Follow-Up Period|Lost to Follow-up|1
6952939|NCT01024036|10994534|FG001|Follow-Up Period|Lost to Follow-up|1
6952940|NCT01024036|10994533|FG000|Follow-Up Period|Withdrawal by Subject|0
6952941|NCT01024036|10994534|FG001|Follow-Up Period|Withdrawal by Subject|1
6952942|NCT01024036|10994533|FG000|Follow-Up Period|Adverse Event|4
6952943|NCT01024036|10994534|FG001|Follow-Up Period|Adverse Event|1
6952944|NCT01024231|10994550|FG000|Overall Study|Other Reasons|1
6952945|NCT01024231|10994551|FG001|Overall Study|Other Reasons|2
6952946|NCT01024231|10994552|FG002|Overall Study|Other Reasons|0
6952947|NCT01024231|10994553|FG003|Overall Study|Other Reasons|0
6952948|NCT01024231|10994554|FG004|Overall Study|Other Reasons|2
6952949|NCT01024231|10994555|FG005|Overall Study|Other Reasons|0
6952950|NCT01024231|10994556|FG006|Overall Study|Other Reasons|1
6952951|NCT01024231|10994550|FG000|Overall Study|Maximum Clinical Benefit|1
6952952|NCT01024231|10994551|FG001|Overall Study|Maximum Clinical Benefit|2
6952953|NCT01024231|10994552|FG002|Overall Study|Maximum Clinical Benefit|0
6952954|NCT01024231|10994553|FG003|Overall Study|Maximum Clinical Benefit|1
6952955|NCT01024231|10994554|FG004|Overall Study|Maximum Clinical Benefit|1
6952956|NCT01024231|10994555|FG005|Overall Study|Maximum Clinical Benefit|0
6952957|NCT01024231|10994556|FG006|Overall Study|Maximum Clinical Benefit|0
6952958|NCT01024231|10994550|FG000|Overall Study|Disease Progression|3
6952959|NCT01024231|10994551|FG001|Overall Study|Disease Progression|1
6952960|NCT01024231|10994552|FG002|Overall Study|Disease Progression|3
6952961|NCT01024231|10994553|FG003|Overall Study|Disease Progression|0
6952962|NCT01024231|10994554|FG004|Overall Study|Disease Progression|4
6952963|NCT01024231|10994555|FG005|Overall Study|Disease Progression|11
6952964|NCT01024231|10994556|FG006|Overall Study|Disease Progression|6
6952965|NCT01024231|10994550|FG000|Overall Study|AE unrelated to Study Drug|0
6952966|NCT01024231|10994551|FG001|Overall Study|AE unrelated to Study Drug|1
6952967|NCT01024231|10994552|FG002|Overall Study|AE unrelated to Study Drug|0
6952968|NCT01024231|10994553|FG003|Overall Study|AE unrelated to Study Drug|0
6952969|NCT01024231|10994554|FG004|Overall Study|AE unrelated to Study Drug|0
6952970|NCT01024231|10994555|FG005|Overall Study|AE unrelated to Study Drug|0
6952971|NCT01024231|10994556|FG006|Overall Study|AE unrelated to Study Drug|0
6952972|NCT01024231|10994550|FG000|Overall Study|No longer meets criteria|0
6952973|NCT01024231|10994551|FG001|Overall Study|No longer meets criteria|0
6952974|NCT01024231|10994552|FG002|Overall Study|No longer meets criteria|0
6952975|NCT01024231|10994553|FG003|Overall Study|No longer meets criteria|0
6952976|NCT01024231|10994554|FG004|Overall Study|No longer meets criteria|1
6952977|NCT01024231|10994555|FG005|Overall Study|No longer meets criteria|0
6952978|NCT01024231|10994556|FG006|Overall Study|No longer meets criteria|1
6952979|NCT01024231|10994550|FG000|Overall Study|Study Drug Toxicity|1
6952980|NCT01024231|10994551|FG001|Overall Study|Study Drug Toxicity|6
6952981|NCT01024231|10994552|FG002|Overall Study|Study Drug Toxicity|6
6952982|NCT01024231|10994553|FG003|Overall Study|Study Drug Toxicity|4
6952983|NCT01024231|10994554|FG004|Overall Study|Study Drug Toxicity|2
6952984|NCT01024231|10994555|FG005|Overall Study|Study Drug Toxicity|0
6952985|NCT01024231|10994556|FG006|Overall Study|Study Drug Toxicity|7
6952986|NCT01024231|10994550|FG000|Overall Study|Death|6
6952987|NCT01024231|10994551|FG001|Overall Study|Death|2
6952988|NCT01024231|10994552|FG002|Overall Study|Death|1
6952989|NCT01024231|10994553|FG003|Overall Study|Death|0
6952990|NCT01024231|10994554|FG004|Overall Study|Death|4
6952991|NCT01024231|10994555|FG005|Overall Study|Death|3
6952992|NCT01024231|10994556|FG006|Overall Study|Death|5
6952993|NCT01024231|10994550|FG000|Overall Study|Lost to Follow-up|0
6952994|NCT01024231|10994551|FG001|Overall Study|Lost to Follow-up|0
6952995|NCT01024231|10994552|FG002|Overall Study|Lost to Follow-up|0
6952996|NCT01024231|10994553|FG003|Overall Study|Lost to Follow-up|0
6952997|NCT01024231|10994554|FG004|Overall Study|Lost to Follow-up|0
6952998|NCT01024231|10994555|FG005|Overall Study|Lost to Follow-up|0
6952999|NCT01024231|10994556|FG006|Overall Study|Lost to Follow-up|1
6953000|NCT01024231|10994550|FG000|Overall Study|Withdrew Consent|0
6953001|NCT01024231|10994551|FG001|Overall Study|Withdrew Consent|1
6953002|NCT01024231|10994552|FG002|Overall Study|Withdrew Consent|0
6953003|NCT01024231|10994553|FG003|Overall Study|Withdrew Consent|0
6953004|NCT01024231|10994554|FG004|Overall Study|Withdrew Consent|0
6953005|NCT01024231|10994555|FG005|Overall Study|Withdrew Consent|0
6953006|NCT01024231|10994556|FG006|Overall Study|Withdrew Consent|0
6953007|NCT01024231|10994550|FG000|Overall Study|Continuing on Treatment|0
6953008|NCT01024231|10994551|FG001|Overall Study|Continuing on Treatment|0
6953009|NCT01024231|10994552|FG002|Overall Study|Continuing on Treatment|0
6953010|NCT01024231|10994553|FG003|Overall Study|Continuing on Treatment|0
6953011|NCT01024231|10994554|FG004|Overall Study|Continuing on Treatment|3
6953012|NCT01024231|10994555|FG005|Overall Study|Continuing on Treatment|2
6953013|NCT01024231|10994556|FG006|Overall Study|Continuing on Treatment|0
6953014|NCT01024244|10994582|FG000|Overall Study|Adverse Event|1
6953015|NCT01024244|10994583|FG001|Overall Study|Adverse Event|2
6953016|NCT01024244|10994584|FG002|Overall Study|Adverse Event|0
6953017|NCT01024244|10994585|FG003|Overall Study|Adverse Event|1
6953018|NCT01024244|10994586|FG004|Overall Study|Adverse Event|2
6953019|NCT01024244|10994582|FG000|Overall Study|Entry Criteria Not Met|0
6953020|NCT01024244|10994583|FG001|Overall Study|Entry Criteria Not Met|1
6953021|NCT01024244|10994584|FG002|Overall Study|Entry Criteria Not Met|0
6953022|NCT01024244|10994585|FG003|Overall Study|Entry Criteria Not Met|0
6953023|NCT01024244|10994586|FG004|Overall Study|Entry Criteria Not Met|0
6953024|NCT01024244|10994582|FG000|Overall Study|Lack of Efficacy|1
6953025|NCT01024244|10994583|FG001|Overall Study|Lack of Efficacy|0
6953026|NCT01024244|10994584|FG002|Overall Study|Lack of Efficacy|0
6953027|NCT01024244|10994585|FG003|Overall Study|Lack of Efficacy|0
6953028|NCT01024244|10994586|FG004|Overall Study|Lack of Efficacy|0
6953029|NCT01024244|10994582|FG000|Overall Study|Protocol Violation|1
6953030|NCT01024244|10994583|FG001|Overall Study|Protocol Violation|0
6953031|NCT01024244|10994584|FG002|Overall Study|Protocol Violation|0
6953032|NCT01024244|10994585|FG003|Overall Study|Protocol Violation|0
6953033|NCT01024244|10994586|FG004|Overall Study|Protocol Violation|2
6953034|NCT01024244|10994582|FG000|Overall Study|Sponsor Decision|14
6953035|NCT01024244|10994583|FG001|Overall Study|Sponsor Decision|7
6953036|NCT01024244|10994584|FG002|Overall Study|Sponsor Decision|14
6953037|NCT01024244|10994585|FG003|Overall Study|Sponsor Decision|12
6953038|NCT01024244|10994586|FG004|Overall Study|Sponsor Decision|10
6953039|NCT01024244|10994582|FG000|Overall Study|Withdrawal by Subject|0
6953040|NCT01024244|10994583|FG001|Overall Study|Withdrawal by Subject|1
6953041|NCT01024244|10994584|FG002|Overall Study|Withdrawal by Subject|0
6953042|NCT01024244|10994585|FG003|Overall Study|Withdrawal by Subject|0
6953043|NCT01024244|10994586|FG004|Overall Study|Withdrawal by Subject|0
6953044|NCT01024309|10994604|FG000|Overall Study|Physician Decision|4
6953045|NCT01024309|10994605|FG001|Overall Study|Physician Decision|0
6953046|NCT01024309|10994604|FG000|Overall Study|Withdrawal by Subject|4
6953047|NCT01024309|10994605|FG001|Overall Study|Withdrawal by Subject|4
6953048|NCT01024387|10994620|FG000|Overall Study|Radiographic Progression|29
6953049|NCT01024387|10994620|FG000|Overall Study|Symptomatic Progression|10
6953050|NCT01024387|10994620|FG000|Overall Study|Physician Decision|5
6953051|NCT01024387|10994620|FG000|Overall Study|Withdrawal by Subject|5
6953052|NCT01024387|10994620|FG000|Overall Study|Death|2
6953053|NCT01024387|10994620|FG000|Overall Study|Prolonged Treatment Delay|1
6953054|NCT01024387|10994620|FG000|Overall Study|Adverse Event|3
6953055|NCT01024387|10994620|FG000|Overall Study|Other|5
6953056|NCT01024465|10994624|FG000|Overall Study|Adverse Event|2
6953057|NCT01024465|10994624|FG000|Overall Study|Physician Decision|1
6953058|NCT01024751|10994667|FG000|Enrolled Participants|Ineligible at baseline|3
6953059|NCT01024751|10994668|FG001|Enrolled Participants|Ineligible at baseline|4
6953060|NCT01024751|10994667|FG000|Eligible Participants|Withdrawal by Subject|0
6953061|NCT01024751|10994668|FG001|Eligible Participants|Withdrawal by Subject|1
6953062|NCT01024751|10994667|FG000|Eligible Participants|Lost to Follow-up|0
6953063|NCT01024751|10994668|FG001|Eligible Participants|Lost to Follow-up|1
6953064|NCT01024751|10994667|FG000|Eligible Participants|Ineligible|0
6953065|NCT01024751|10994668|FG001|Eligible Participants|Ineligible|1
6953066|NCT01024855|10994674|FG000|Overall Study|Inclusion/exclusion criteria|1
6953067|NCT01024920|10994681|FG000|Overall Study|Progressive disease|47
6953068|NCT01024920|10994682|FG001|Overall Study|Progressive disease|25
6953069|NCT01024920|10994681|FG000|Overall Study|Adverse Event|8
6953070|NCT01024920|10994682|FG001|Overall Study|Adverse Event|4
6953071|NCT01024920|10994681|FG000|Overall Study|Lost to Follow-up|0
6953072|NCT01024920|10994682|FG001|Overall Study|Lost to Follow-up|1
6953073|NCT01024920|10994681|FG000|Overall Study|Patient refusal to continue|4
6953074|NCT01024920|10994682|FG001|Overall Study|Patient refusal to continue|0
6953075|NCT01024920|10994681|FG000|Overall Study|Other than listed|5
6953076|NCT01024920|10994682|FG001|Overall Study|Other than listed|1
6953077|NCT01024920|10994681|FG000|Overall Study|Not treated|3
6953078|NCT01024920|10994682|FG001|Overall Study|Not treated|0
6953079|NCT01024920|10994681|FG000|Overall Study|Protocol Violation|0
6953080|NCT01024920|10994682|FG001|Overall Study|Protocol Violation|1
6953081|NCT01024946|10994688|FG000|Overall Study|Screen Failure|3
6953082|NCT01024946|10994688|FG000|Overall Study|Withdrawal by Subject|1
6953083|NCT01024946|10994688|FG000|Overall Study|Adverse Event|1
6953084|NCT01024959|10994692|FG000|Overall Study|ineligible|12
6953085|NCT01024959|10994692|FG000|Overall Study|results not evaluable|12
6953086|NCT01024959|10994692|FG000|Overall Study|missing results required for analysis|17
6953087|NCT01025037|10994711|FG000|Overall Study|Adverse Event|3
6953088|NCT01025037|10994711|FG000|Overall Study|Lost to Follow-up|7
6953089|NCT01025037|10994711|FG000|Overall Study|Withdrawal by Subject|1
6953090|NCT01025154|10994719|FG000|Overall Study|Lost to Follow-up|1
6953091|NCT01025154|10994719|FG000|Overall Study|Withdrawal by Subject|1
6953092|NCT01025193|10994723|FG000|Overall Study|Protocol Violation|1
6953093|NCT01025193|10994723|FG000|Overall Study|Adverse Event|3
6953094|NCT01025232|10994733|FG000|Overall Study|Study drug no longer available|3
6953095|NCT01025232|10994734|FG001|Overall Study|Study drug no longer available|6
6953096|NCT01025284|10994743|FG000|Overall Study|Investigator Decision|0
6953097|NCT01025284|10994744|FG001|Overall Study|Investigator Decision|1
6953098|NCT01025284|10994745|FG002|Overall Study|Investigator Decision|0
6953099|NCT01025284|10994743|FG000|Overall Study|Withdrawal by Subject|0
6953100|NCT01025284|10994744|FG001|Overall Study|Withdrawal by Subject|1
6953101|NCT01025284|10994745|FG002|Overall Study|Withdrawal by Subject|0
6953102|NCT01025336|10994760|FG000|Overall Study|Protocol Violation|0
6953103|NCT01025336|10994761|FG001|Overall Study|Protocol Violation|0
6953104|NCT01025336|10994762|FG002|Overall Study|Protocol Violation|0
6953105|NCT01025336|10994763|FG003|Overall Study|Protocol Violation|2
6953106|NCT01025336|10994764|FG004|Overall Study|Protocol Violation|0
6953107|NCT01025635|10994798|FG000|Overall Study|Withdrawal by Subject|6
6953108|NCT01025635|10994799|FG001|Overall Study|Withdrawal by Subject|7
6953109|NCT01025635|10994798|FG000|Overall Study|Protocol Violation|4
6953110|NCT01025635|10994799|FG001|Overall Study|Protocol Violation|2
6953111|NCT01025635|10994798|FG000|Overall Study|Lack of Efficacy|0
6953112|NCT01025635|10994799|FG001|Overall Study|Lack of Efficacy|1
6953113|NCT01025635|10994798|FG000|Overall Study|Lost to Follow-up|9
6953114|NCT01025635|10994799|FG001|Overall Study|Lost to Follow-up|13
6953115|NCT01025635|10994798|FG000|Overall Study|Reason not known|4
6953116|NCT01025635|10994799|FG001|Overall Study|Reason not known|2
6953117|NCT01025752|10994807|FG000|Overall Study|Lost to Follow-up|7
6953118|NCT01025752|10994808|FG001|Overall Study|Lost to Follow-up|10
6953119|NCT01025752|10994807|FG000|Overall Study|Physician Decision|1
6953120|NCT01025752|10994808|FG001|Overall Study|Physician Decision|3
6953121|NCT01025817|10994883|FG000|Completed Study Medication|Adverse Event|66
6953122|NCT01025817|10994884|FG001|Completed Study Medication|Adverse Event|39
6953123|NCT01025817|10994883|FG000|Completed Study Medication|Protocol Deviation|9
6953124|NCT01025817|10994884|FG001|Completed Study Medication|Protocol Deviation|8
6953125|NCT01025817|10994883|FG000|Completed Study Medication|Withdrawal by Subject|8
6953126|NCT01025817|10994884|FG001|Completed Study Medication|Withdrawal by Subject|9
6953127|NCT01025817|10994883|FG000|Completed Study Medication|Administrative problems|7
6953128|NCT01025817|10994884|FG001|Completed Study Medication|Administrative problems|5
6953129|NCT01025817|10994883|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7
6953130|NCT01025817|10994884|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0
6953131|NCT01025817|10994883|FG000|Completed Study Medication|Abnormal test procedure|4
6953132|NCT01025817|10994884|FG001|Completed Study Medication|Abnormal test procedure|0
6953133|NCT01025817|10994883|FG000|Completed Study Medication|Graft loss|2
6953134|NCT01025817|10994884|FG001|Completed Study Medication|Graft loss|5
6953135|NCT01025817|10994883|FG000|Completed Study Medication|Death|2
6953136|NCT01025817|10994884|FG001|Completed Study Medication|Death|2
6953137|NCT01025817|10994883|FG000|Completed Study Medication|Abnormal lab values|0
6953138|NCT01025817|10994884|FG001|Completed Study Medication|Abnormal lab values|2
6953139|NCT01025817|10994883|FG000|Completed Study Medication|Subject no longer required study drug|0
6953140|NCT01025817|10994884|FG001|Completed Study Medication|Subject no longer required study drug|1
6953141|NCT01025817|10994883|FG000|Completed Study Medication|Lost to Follow-up|0
6953142|NCT01025817|10994884|FG001|Completed Study Medication|Lost to Follow-up|1
6953143|NCT01025817|10994883|FG000|Completed Study|Withdrawal by Subject|8
6953144|NCT01025817|10994884|FG001|Completed Study|Withdrawal by Subject|16
6953145|NCT01025817|10994883|FG000|Completed Study|Death|6
6953146|NCT01025817|10994884|FG001|Completed Study|Death|5
6953147|NCT01025817|10994883|FG000|Completed Study|Missing|2
6953148|NCT01025817|10994884|FG001|Completed Study|Missing|0
6953149|NCT01025817|10994883|FG000|Completed Study|Lost to Follow-up|0
6953150|NCT01025817|10994884|FG001|Completed Study|Lost to Follow-up|1
6953151|NCT01025843|10994912|FG000|Washout 4|Withdrawal by Subject|0
6953152|NCT01025843|10994913|FG001|Washout 4|Withdrawal by Subject|0
6953153|NCT01025843|10994914|FG002|Washout 4|Withdrawal by Subject|1
6953154|NCT01025843|10994915|FG003|Washout 4|Withdrawal by Subject|1
6953155|NCT01025843|10994916|FG004|Washout 4|Withdrawal by Subject|0
6953156|NCT01025843|10994917|FG005|Washout 4|Withdrawal by Subject|0
6953157|NCT01025843|10994918|FG006|Washout 4|Withdrawal by Subject|0
6953158|NCT01025843|10994919|FG007|Washout 4|Withdrawal by Subject|0
6953159|NCT01025843|10994920|FG008|Washout 4|Withdrawal by Subject|0
6953160|NCT01025843|10994921|FG009|Washout 4|Withdrawal by Subject|0
6953161|NCT01026038|10994956|FG000|Overall Study|Lost to Follow-up|1
6953162|NCT01026038|10994957|FG001|Overall Study|Lost to Follow-up|1
6953163|NCT01026038|10994958|FG002|Overall Study|Lost to Follow-up|0
6953164|NCT01026103|10994966|FG000|Overall Study|Physician Decision|1
6953165|NCT01026103|10994966|FG000|Overall Study|did not receive study device bc of error|1
6953166|NCT01026142|10994972|FG000|Overall Study|Death|136
6953167|NCT01026142|10994973|FG001|Overall Study|Death|134
6953168|NCT01026142|10994972|FG000|Overall Study|Withdrew consent or lost to follow-up|36
6953169|NCT01026142|10994973|FG001|Overall Study|Withdrew consent or lost to follow-up|29
6953170|NCT01026194|10994994|FG000|Period 1：Double Blind Period|Adverse Event|2
6953171|NCT01026194|10994995|FG001|Period 1：Double Blind Period|Adverse Event|1
6953172|NCT01026194|10994994|FG000|Period 1：Double Blind Period|Lack of Efficacy|1
6953173|NCT01026194|10994995|FG001|Period 1：Double Blind Period|Lack of Efficacy|0
6953174|NCT01026194|10994994|FG000|Period 1：Double Blind Period|Physician Decision|0
6953175|NCT01026194|10994995|FG001|Period 1：Double Blind Period|Physician Decision|4
6953176|NCT01026194|10994994|FG000|Period 2：Open-label Period|Adverse Event|4
6953177|NCT01026194|10994995|FG001|Period 2：Open-label Period|Adverse Event|5
6953178|NCT01026194|10994994|FG000|Period 2：Open-label Period|Physician Decision|3
6953179|NCT01026194|10994995|FG001|Period 2：Open-label Period|Physician Decision|1
6953180|NCT01026194|10994994|FG000|Period 2：Open-label Period|Withdrawal by Subject|0
6953181|NCT01026194|10994995|FG001|Period 2：Open-label Period|Withdrawal by Subject|4
6953182|NCT01026324|10995006|FG000|Follow up/Survival|Withdrawal by Subject|1
6953183|NCT01026324|10995007|FG001|Follow up/Survival|Withdrawal by Subject|0
6953184|NCT01026324|10995008|FG002|Follow up/Survival|Withdrawal by Subject|0
6953185|NCT01026389|10995019|FG000|Overall Study|Withdrawal by Subject|1
6953186|NCT01026389|10995020|FG001|Overall Study|Withdrawal by Subject|3
6953187|NCT01026389|10995019|FG000|Overall Study|change of treatment, patient moved|4
6953188|NCT01026389|10995020|FG001|Overall Study|change of treatment, patient moved|2
6953189|NCT01026454|10995100|FG000|Second Intervention|Pregnancy|1
6953190|NCT01026454|10995101|FG001|Second Intervention|Pregnancy|1
6953191|NCT01026493|10995115|FG000|Overall Study|Protocol Violation|0
6953192|NCT01026493|10995116|FG001|Overall Study|Protocol Violation|1
6953193|NCT01026493|10995117|FG002|Overall Study|Protocol Violation|0
6953194|NCT01026493|10995118|FG003|Overall Study|Protocol Violation|0
6953195|NCT01026493|10995119|FG004|Overall Study|Protocol Violation|2
6953196|NCT01026493|10995120|FG005|Overall Study|Protocol Violation|3
6953197|NCT01026493|10995121|FG006|Overall Study|Protocol Violation|4
6953198|NCT01026493|10995122|FG007|Overall Study|Protocol Violation|1
6953199|NCT01026792|10995154|FG000|Overall Study|Protocol Violation|1
6953200|NCT01026818|10995165|FG000|Screening Period|Entry Criteria Not Met|105
6953201|NCT01026818|10995166|FG001|Screening Period|Entry Criteria Not Met|0
6953202|NCT01026818|10995167|FG002|Screening Period|Entry Criteria Not Met|0
6953203|NCT01026818|10995168|FG003|Screening Period|Entry Criteria Not Met|0
6953204|NCT01026818|10995165|FG000|Screening Period|Withdrawal by Subject|49
6953205|NCT01026818|10995166|FG001|Screening Period|Withdrawal by Subject|0
6953206|NCT01026818|10995167|FG002|Screening Period|Withdrawal by Subject|0
6953207|NCT01026818|10995168|FG003|Screening Period|Withdrawal by Subject|0
6953208|NCT01026818|10995165|FG000|Screening Period|Protocol Deviation|3
6953209|NCT01026818|10995166|FG001|Screening Period|Protocol Deviation|0
6953210|NCT01026818|10995167|FG002|Screening Period|Protocol Deviation|0
6953211|NCT01026818|10995168|FG003|Screening Period|Protocol Deviation|0
6953212|NCT01026818|10995165|FG000|Screening Period|Adverse Event|2
6953213|NCT01026818|10995166|FG001|Screening Period|Adverse Event|0
6953214|NCT01026818|10995167|FG002|Screening Period|Adverse Event|0
6953215|NCT01026818|10995168|FG003|Screening Period|Adverse Event|0
6953216|NCT01026818|10995165|FG000|Screening Period|Physician Decision|1
6953217|NCT01026818|10995166|FG001|Screening Period|Physician Decision|0
6953218|NCT01026818|10995167|FG002|Screening Period|Physician Decision|0
6953219|NCT01026818|10995168|FG003|Screening Period|Physician Decision|0
6953220|NCT01026818|10995165|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0
6953221|NCT01026818|10995166|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10
6953222|NCT01026818|10995167|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6
6953223|NCT01026818|10995168|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4
6953224|NCT01026818|10995165|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0
6953225|NCT01026818|10995166|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7
6953226|NCT01026818|10995167|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
6953227|NCT01026818|10995168|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
6953228|NCT01026818|10995165|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0
6953229|NCT01026818|10995166|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3
6953230|NCT01026818|10995167|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2
6953231|NCT01026818|10995168|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6
6953232|NCT01026818|10995165|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
6953233|NCT01026818|10995166|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3
6953234|NCT01026818|10995167|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
6953235|NCT01026818|10995168|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4
6953236|NCT01026818|10995165|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0
6953237|NCT01026818|10995166|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2
6953238|NCT01026818|10995167|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9
6953239|NCT01026818|10995168|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7
6953240|NCT01026818|10995165|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
6953241|NCT01026818|10995166|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
6953242|NCT01026818|10995167|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1
6953243|NCT01026818|10995168|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2
6953244|NCT01026818|10995165|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0
6953245|NCT01026818|10995166|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
6953246|NCT01026818|10995167|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1
6953247|NCT01026818|10995168|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
6953248|NCT01026818|10995165|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0
6953249|NCT01026818|10995166|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
6953250|NCT01026818|10995167|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1
6953251|NCT01026818|10995168|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
6953252|NCT01026818|10995165|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
6953253|NCT01026818|10995166|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1
6953254|NCT01026818|10995167|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
6953255|NCT01026818|10995168|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
6953256|NCT01026818|10995165|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
6953257|NCT01026818|10995166|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1
6953258|NCT01026818|10995167|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
6953259|NCT01026818|10995168|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2
6953260|NCT01026818|10995165|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
6953261|NCT01026818|10995166|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
6953262|NCT01026818|10995167|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
6953263|NCT01026818|10995168|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
6953264|NCT01026818|10995165|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
6953265|NCT01026818|10995166|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1
6953266|NCT01026818|10995167|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
6953267|NCT01026818|10995168|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
6953268|NCT01026818|10995165|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
6953269|NCT01026818|10995166|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1
6953270|NCT01026818|10995167|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2
6953271|NCT01026818|10995168|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
6953272|NCT01026818|10995165|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0
6953273|NCT01026818|10995166|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0
6953274|NCT01026818|10995167|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0
6953275|NCT01026818|10995168|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1
6953276|NCT01026818|10995165|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
6953277|NCT01026818|10995166|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2
6953278|NCT01026818|10995167|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
6953279|NCT01026818|10995168|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
6953280|NCT01026818|10995165|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
6953281|NCT01026818|10995166|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1
6953282|NCT01026818|10995167|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
6953283|NCT01026818|10995168|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
6953284|NCT01026818|10995165|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0
6953285|NCT01026818|10995166|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
6953286|NCT01026818|10995167|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2
6953287|NCT01026818|10995168|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
6953288|NCT01026818|10995165|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0
6953289|NCT01026818|10995166|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
6953290|NCT01026818|10995167|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3
6953291|NCT01026818|10995168|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
6953292|NCT01026818|10995165|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
6953293|NCT01026818|10995166|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2
6953294|NCT01026818|10995167|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
6953295|NCT01026818|10995168|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1
6953296|NCT01026831|10995182|FG000|Overall Study|Adverse Event|4
6953297|NCT01026831|10995183|FG001|Overall Study|Adverse Event|3
6953298|NCT01026831|10995182|FG000|Overall Study|Lost to Follow-up|2
6953299|NCT01026831|10995183|FG001|Overall Study|Lost to Follow-up|0
6953300|NCT01026831|10995182|FG000|Overall Study|Physician Decision|1
6953301|NCT01026831|10995183|FG001|Overall Study|Physician Decision|1
6953302|NCT01026831|10995182|FG000|Overall Study|Protocol Violation|0
6953303|NCT01026831|10995183|FG001|Overall Study|Protocol Violation|2
6953304|NCT01026831|10995182|FG000|Overall Study|Withdrawal by Subject|7
6953305|NCT01026831|10995183|FG001|Overall Study|Withdrawal by Subject|5
6953306|NCT01026948|10995207|FG000|Overall Study|Physician Decision|8
6953307|NCT01026974|10995216|FG000|Overall Study|Withdrawal by Subject|0
6953308|NCT01026974|10995217|FG001|Overall Study|Withdrawal by Subject|1
6953309|NCT01026974|10995218|FG002|Overall Study|Withdrawal by Subject|7
6953310|NCT01026974|10995219|FG003|Overall Study|Withdrawal by Subject|2
6953311|NCT01026974|10995216|FG000|Overall Study|Lost to Follow-up|1
6953312|NCT01026974|10995217|FG001|Overall Study|Lost to Follow-up|1
6953313|NCT01026974|10995218|FG002|Overall Study|Lost to Follow-up|4
6953314|NCT01026974|10995219|FG003|Overall Study|Lost to Follow-up|0
6953315|NCT01026974|10995216|FG000|Overall Study|Adverse Event|0
6953316|NCT01026974|10995217|FG001|Overall Study|Adverse Event|0
6953317|NCT01026974|10995218|FG002|Overall Study|Adverse Event|0
6953318|NCT01026974|10995219|FG003|Overall Study|Adverse Event|1
6953319|NCT01026974|10995216|FG000|Overall Study|Inappropriate enrollment|0
6953320|NCT01026974|10995217|FG001|Overall Study|Inappropriate enrollment|0
6953321|NCT01026974|10995218|FG002|Overall Study|Inappropriate enrollment|1
6953322|NCT01026974|10995219|FG003|Overall Study|Inappropriate enrollment|0
6953323|NCT01027273|10995249|FG000|Overall Study|Lost to Follow-up|57
6953324|NCT01027273|10995250|FG001|Overall Study|Lost to Follow-up|31
6953325|NCT01027273|10995249|FG000|Overall Study|Death|2
6953326|NCT01027273|10995250|FG001|Overall Study|Death|2
6953327|NCT01027286|10995258|FG000|Overall Study|Unable to Obtain Required Blood Volume|1
6953328|NCT01027286|10995259|FG001|Overall Study|Unable to Obtain Required Blood Volume|0
6953329|NCT01027286|10995258|FG000|Overall Study|Lost to Follow-up|0
6953330|NCT01027286|10995259|FG001|Overall Study|Lost to Follow-up|1
6953331|NCT01027351|10995271|FG000|Overall Study|Withdrawal by Subject|1
6953332|NCT01027351|10995272|FG001|Overall Study|Withdrawal by Subject|0
6953333|NCT01027351|10995273|FG002|Overall Study|Withdrawal by Subject|1
6953334|NCT01027351|10995274|FG003|Overall Study|Withdrawal by Subject|0
6953335|NCT01027351|10995275|FG004|Overall Study|Withdrawal by Subject|3
6953336|NCT01027351|10995276|FG005|Overall Study|Withdrawal by Subject|5
6953337|NCT01027351|10995271|FG000|Overall Study|Lost to Follow-up|1
6953338|NCT01027351|10995272|FG001|Overall Study|Lost to Follow-up|1
6953339|NCT01027351|10995273|FG002|Overall Study|Lost to Follow-up|0
6953340|NCT01027351|10995274|FG003|Overall Study|Lost to Follow-up|1
6953341|NCT01027351|10995275|FG004|Overall Study|Lost to Follow-up|6
6953342|NCT01027351|10995276|FG005|Overall Study|Lost to Follow-up|0
6953343|NCT01027351|10995271|FG000|Overall Study|Inappropriate enrollment|0
6953344|NCT01027351|10995272|FG001|Overall Study|Inappropriate enrollment|0
6953345|NCT01027351|10995273|FG002|Overall Study|Inappropriate enrollment|0
6953346|NCT01027351|10995274|FG003|Overall Study|Inappropriate enrollment|0
6953347|NCT01027351|10995275|FG004|Overall Study|Inappropriate enrollment|1
6953348|NCT01027351|10995276|FG005|Overall Study|Inappropriate enrollment|0
6953349|NCT01027351|10995271|FG000|Overall Study|Protocol Violation|1
6953350|NCT01027351|10995272|FG001|Overall Study|Protocol Violation|0
6953351|NCT01027351|10995273|FG002|Overall Study|Protocol Violation|0
6953352|NCT01027351|10995274|FG003|Overall Study|Protocol Violation|1
6953353|NCT01027351|10995275|FG004|Overall Study|Protocol Violation|1
6953354|NCT01027351|10995276|FG005|Overall Study|Protocol Violation|0
6953355|NCT01027364|10995301|FG000|Overall Study|Adverse Event|1
6953356|NCT01027364|10995302|FG001|Overall Study|Adverse Event|0
6953357|NCT01027364|10995303|FG002|Overall Study|Adverse Event|1
6953358|NCT01027364|10995304|FG003|Overall Study|Adverse Event|0
6953359|NCT01027364|10995301|FG000|Overall Study|Lost to Follow-up|1
6953360|NCT01027364|10995302|FG001|Overall Study|Lost to Follow-up|0
6953361|NCT01027364|10995303|FG002|Overall Study|Lost to Follow-up|0
6953362|NCT01027364|10995304|FG003|Overall Study|Lost to Follow-up|0
6953363|NCT01027364|10995301|FG000|Overall Study|Protocol Violation|1
6953364|NCT01027364|10995302|FG001|Overall Study|Protocol Violation|0
6953365|NCT01027364|10995303|FG002|Overall Study|Protocol Violation|0
6953366|NCT01027364|10995304|FG003|Overall Study|Protocol Violation|1
6953367|NCT01027364|10995301|FG000|Overall Study|Withdrawal by Subject|1
6953368|NCT01027364|10995302|FG001|Overall Study|Withdrawal by Subject|2
6953369|NCT01027364|10995303|FG002|Overall Study|Withdrawal by Subject|0
6953370|NCT01027364|10995304|FG003|Overall Study|Withdrawal by Subject|0
6953371|NCT01027416|10995332|FG000|Overall Study|Withdrawal by Subject|0
6953372|NCT01027416|10995333|FG001|Overall Study|Withdrawal by Subject|1
6953373|NCT01027416|10995332|FG000|Overall Study|Physician Decision|1
6953374|NCT01027416|10995333|FG001|Overall Study|Physician Decision|4
6953375|NCT01027650|10995374|FG000|Overall Study|Personal Reasons|0
6953376|NCT01027650|10995375|FG001|Overall Study|Personal Reasons|0
6953377|NCT01027650|10995376|FG002|Overall Study|Personal Reasons|0
6953378|NCT01027650|10995377|FG003|Overall Study|Personal Reasons|0
6953379|NCT01027650|10995378|FG004|Overall Study|Personal Reasons|2
6953380|NCT01027650|10995379|FG005|Overall Study|Personal Reasons|1
6953381|NCT01027650|10995380|FG006|Overall Study|Personal Reasons|0
6953382|NCT01027650|10995381|FG007|Overall Study|Personal Reasons|0
6953383|NCT01027650|10995374|FG000|Overall Study|Lost to Follow-up|0
6953384|NCT01027650|10995375|FG001|Overall Study|Lost to Follow-up|0
6953385|NCT01027650|10995376|FG002|Overall Study|Lost to Follow-up|0
6953386|NCT01027650|10995377|FG003|Overall Study|Lost to Follow-up|0
6953387|NCT01027650|10995378|FG004|Overall Study|Lost to Follow-up|0
6953388|NCT01027650|10995379|FG005|Overall Study|Lost to Follow-up|0
6953389|NCT01027650|10995380|FG006|Overall Study|Lost to Follow-up|1
6953390|NCT01027650|10995381|FG007|Overall Study|Lost to Follow-up|0
6953391|NCT01027650|10995374|FG000|Overall Study|Lack of Efficacy|0
6953392|NCT01027650|10995375|FG001|Overall Study|Lack of Efficacy|0
6953393|NCT01027650|10995376|FG002|Overall Study|Lack of Efficacy|0
6953394|NCT01027650|10995377|FG003|Overall Study|Lack of Efficacy|0
6953395|NCT01027650|10995378|FG004|Overall Study|Lack of Efficacy|0
6953396|NCT01027650|10995379|FG005|Overall Study|Lack of Efficacy|1
6953397|NCT01027650|10995380|FG006|Overall Study|Lack of Efficacy|0
6953398|NCT01027650|10995381|FG007|Overall Study|Lack of Efficacy|0
6953399|NCT01027754|10995401|FG000|Overall Study|withdrew/lost to follow-up after interve|2
6953400|NCT01027754|10995402|FG001|Overall Study|withdrew/lost to follow-up after interve|3
6953401|NCT01027754|10995401|FG000|Overall Study|Withdrawal by Subject|0
6953402|NCT01027754|10995402|FG001|Overall Study|Withdrawal by Subject|5
6953403|NCT01027845|10995447|FG000|Primary Vaccination Phase|Serious Adverse Event|2
6953404|NCT01027845|10995448|FG001|Primary Vaccination Phase|Serious Adverse Event|0
6953405|NCT01027845|10995449|FG002|Primary Vaccination Phase|Serious Adverse Event|0
6953406|NCT01027845|10995450|FG003|Primary Vaccination Phase|Serious Adverse Event|0
6953407|NCT01027845|10995447|FG000|Primary Vaccination Phase|Adverse Event|1
6953408|NCT01027845|10995448|FG001|Primary Vaccination Phase|Adverse Event|0
6953409|NCT01027845|10995449|FG002|Primary Vaccination Phase|Adverse Event|0
6953410|NCT01027845|10995450|FG003|Primary Vaccination Phase|Adverse Event|0
6953411|NCT01027845|10995447|FG000|Primary Vaccination Phase|Protocol Violation|1
6953412|NCT01027845|10995448|FG001|Primary Vaccination Phase|Protocol Violation|0
6953413|NCT01027845|10995449|FG002|Primary Vaccination Phase|Protocol Violation|0
6953414|NCT01027845|10995450|FG003|Primary Vaccination Phase|Protocol Violation|0
6953415|NCT01027845|10995447|FG000|Primary Vaccination Phase|Migrated/moved from study area|0
6953416|NCT01027845|10995448|FG001|Primary Vaccination Phase|Migrated/moved from study area|1
6953417|NCT01027845|10995449|FG002|Primary Vaccination Phase|Migrated/moved from study area|0
6953418|NCT01027845|10995450|FG003|Primary Vaccination Phase|Migrated/moved from study area|0
6953419|NCT01027845|10995447|FG000|Booster Vaccination Phase|Withdrawal by Subject|1
6953420|NCT01027845|10995448|FG001|Booster Vaccination Phase|Withdrawal by Subject|0
6953421|NCT01027845|10995449|FG002|Booster Vaccination Phase|Withdrawal by Subject|0
6953422|NCT01027845|10995450|FG003|Booster Vaccination Phase|Withdrawal by Subject|0
6953423|NCT01027845|10995447|FG000|Booster Vaccination Phase|Migrated/moved from study area|1
6953424|NCT01027845|10995448|FG001|Booster Vaccination Phase|Migrated/moved from study area|0
6953425|NCT01027845|10995449|FG002|Booster Vaccination Phase|Migrated/moved from study area|0
6953426|NCT01027845|10995450|FG003|Booster Vaccination Phase|Migrated/moved from study area|0
6953427|NCT01027871|10995462|FG000|Overall Study|Physician Decision|1
6953428|NCT01027871|10995463|FG001|Overall Study|Physician Decision|5
6953429|NCT01027871|10995464|FG002|Overall Study|Physician Decision|0
6953430|NCT01027871|10995462|FG000|Overall Study|Protocol Violation|0
7070574|NCT02014116|11173146|FG008|Overall Study|Withdrawal by Subject|0
7070575|NCT02014116|11173138|FG000|Overall Study|Withdrawal Caregiver Decision|0
7070576|NCT02014116|11173139|FG001|Overall Study|Withdrawal Caregiver Decision|0
7040812|NCT01720524|11124007|FG001|Part B|No longer willing to participate in study|4
7070577|NCT02014116|11173140|FG002|Overall Study|Withdrawal Caregiver Decision|0
7070578|NCT02014116|11173141|FG003|Overall Study|Withdrawal Caregiver Decision|0
7070579|NCT02014116|11173142|FG004|Overall Study|Withdrawal Caregiver Decision|0
6953431|NCT01027871|10995463|FG001|Overall Study|Protocol Violation|2
6953432|NCT01027871|10995464|FG002|Overall Study|Protocol Violation|2
6953433|NCT01027871|10995462|FG000|Overall Study|Withdrawal by Subject|1
6953434|NCT01027871|10995463|FG001|Overall Study|Withdrawal by Subject|2
6953435|NCT01027871|10995464|FG002|Overall Study|Withdrawal by Subject|2
6953436|NCT01027871|10995462|FG000|Overall Study|Adverse Event|0
6953437|NCT01027871|10995463|FG001|Overall Study|Adverse Event|2
6953438|NCT01027871|10995464|FG002|Overall Study|Adverse Event|2
6953439|NCT01027871|10995462|FG000|Overall Study|Sponsor Decision|0
6953440|NCT01027871|10995463|FG001|Overall Study|Sponsor Decision|2
6953441|NCT01027871|10995464|FG002|Overall Study|Sponsor Decision|0
6953442|NCT01027871|10995462|FG000|Overall Study|Discontinued Prior to Treatment|0
6953443|NCT01027871|10995463|FG001|Overall Study|Discontinued Prior to Treatment|0
6953444|NCT01027871|10995464|FG002|Overall Study|Discontinued Prior to Treatment|1
6953445|NCT01027884|10995479|FG000|Overall Study|Adverse Event|2
6953446|NCT01027884|10995480|FG001|Overall Study|Adverse Event|1
6953447|NCT01027884|10995479|FG000|Overall Study|Protocol Violation|1
6953448|NCT01027884|10995480|FG001|Overall Study|Protocol Violation|0
6953449|NCT01027884|10995479|FG000|Overall Study|Non-compliance|1
6953450|NCT01027884|10995480|FG001|Overall Study|Non-compliance|1
6953451|NCT01027884|10995479|FG000|Overall Study|Withdrawal by Subject|0
6953452|NCT01027884|10995480|FG001|Overall Study|Withdrawal by Subject|1
6953453|NCT01027884|10995479|FG000|Overall Study|Lost to Follow-up|0
6953454|NCT01027884|10995480|FG001|Overall Study|Lost to Follow-up|1
6953455|NCT01027884|10995479|FG000|Overall Study|Spinal fixation surgery|0
6953456|NCT01027884|10995480|FG001|Overall Study|Spinal fixation surgery|3
6953457|NCT01027897|10995488|FG000|Overall Study|Protocol Violation|1
6953458|NCT01027897|10995488|FG000|Overall Study|Withdrawal by Subject|1
6953459|NCT01027949|10995503|FG000|Overall Study|Death|174
6953460|NCT01027949|10995503|FG000|Overall Study|Progressive Disease|163
6953461|NCT01027949|10995503|FG000|Overall Study|Adverse Event|172
6953462|NCT01027949|10995503|FG000|Overall Study|Withdrawal by Subject|113
6953463|NCT01027949|10995503|FG000|Overall Study|Lost to Follow-up|17
6953464|NCT01027949|10995503|FG000|Overall Study|Protocol Violation|13
6953465|NCT01027949|10995503|FG000|Overall Study|PI Decision|8
6953466|NCT01027949|10995503|FG000|Overall Study|Limited Study Drug Effectiveness|7
6953467|NCT01027949|10995503|FG000|Overall Study|Non-compliance with Study Procedures|7
6953468|NCT01027949|10995503|FG000|Overall Study|Lung Transplant|5
6953469|NCT01027949|10995503|FG000|Overall Study|Unable to Tolerate Study Drug|2
6953470|NCT01027949|10995503|FG000|Overall Study|Use of Excluded Medication|2
6953471|NCT01027949|10995503|FG000|Overall Study|Patient Self-discontinuation|1
6953472|NCT01027949|10995503|FG000|Overall Study|Pregnancy|1
6953473|NCT01027949|10995503|FG000|Overall Study|Surgery|1
6953474|NCT01028014|10995513|FG000|Overall Study|Lost to Follow-up|1
7040813|NCT01720524|11124006|FG000|Part B|Other|2
7040814|NCT01720524|11124007|FG001|Part B|Other|0
7040815|NCT01720524|11124006|FG000|Part B|Lost to Follow-up|2
7040816|NCT01720524|11124007|FG001|Part B|Lost to Follow-up|3
7040817|NCT01720524|11124006|FG000|Part B|Death|0
7040818|NCT01720524|11124007|FG001|Part B|Death|2
7040819|NCT01720602|11124015|FG000|Overall Study|Adverse Event|3
7040820|NCT01720602|11124015|FG000|Overall Study|Progressive disease on therapy|2
6953475|NCT01028014|10995514|FG001|Overall Study|Lost to Follow-up|2
6953476|NCT01028014|10995515|FG002|Overall Study|Lost to Follow-up|0
6953477|NCT01028014|10995516|FG003|Overall Study|Lost to Follow-up|1
6953478|NCT01028014|10995517|FG004|Overall Study|Lost to Follow-up|1
6953479|NCT01028014|10995518|FG005|Overall Study|Lost to Follow-up|2
6953480|NCT01028027|10995534|FG000|Overall Study|Lost to Follow-up|4
6953481|NCT01028027|10995535|FG001|Overall Study|Lost to Follow-up|1
6953482|NCT01028027|10995534|FG000|Overall Study|Withdrawal by Subject|5
6953483|NCT01028027|10995535|FG001|Overall Study|Withdrawal by Subject|3
6953484|NCT01028027|10995534|FG000|Overall Study|Adverse Event|4
6953485|NCT01028027|10995535|FG001|Overall Study|Adverse Event|7
6953486|NCT01028027|10995534|FG000|Overall Study|Protocol Violation|3
6953487|NCT01028027|10995535|FG001|Overall Study|Protocol Violation|1
6953488|NCT01028027|10995534|FG000|Overall Study|Lack of Efficacy|0
6953489|NCT01028027|10995535|FG001|Overall Study|Lack of Efficacy|1
6953490|NCT01028053|10995541|FG000|Overall Study|Screen Failure|113
6953491|NCT01028053|10995541|FG000|Overall Study|Patient Request|11
6953492|NCT01028053|10995541|FG000|Overall Study|Protocol Violation|1
6953493|NCT01028053|10995541|FG000|Overall Study|Physician Decision|2
6953494|NCT01028053|10995541|FG000|Overall Study|Technical Problem|1
6953495|NCT01028053|10995541|FG000|Overall Study|Terminated by Sponsor|1
6953496|NCT01028053|10995541|FG000|Overall Study|Various reasons|4
6953497|NCT01028222|10995566|FG000|Overall Study|Protocol deviation|1
6953498|NCT01028222|10995567|FG001|Overall Study|Protocol deviation|0
6953499|NCT01028222|10995566|FG000|Overall Study|Disease progression|33
6953500|NCT01028222|10995567|FG001|Overall Study|Disease progression|9
6953501|NCT01028222|10995566|FG000|Overall Study|Administrative problems|1
6953502|NCT01028222|10995567|FG001|Overall Study|Administrative problems|1
6953503|NCT01028222|10995566|FG000|Overall Study|Lost to Follow-up|0
6953504|NCT01028222|10995567|FG001|Overall Study|Lost to Follow-up|1
6953505|NCT01028222|10995566|FG000|Overall Study|Withdrawal by Subject|1
6953506|NCT01028222|10995567|FG001|Overall Study|Withdrawal by Subject|0
6953507|NCT01028222|10995566|FG000|Overall Study|Crossover to nilotinib w/out progression|0
6953508|NCT01028222|10995567|FG001|Overall Study|Crossover to nilotinib w/out progression|2
6953509|NCT01028222|10995566|FG000|Overall Study|Adverse Event|2
6953510|NCT01028222|10995567|FG001|Overall Study|Adverse Event|0
6953511|NCT01028352|10995574|FG000|Overall Study|Ineligible due to baseline average pain|5
6953512|NCT01028352|10995574|FG000|Overall Study|Withdrawal by Subject|1
6953513|NCT01028378|10995578|FG000|Overall Study|Lost to Follow-up|12
6953514|NCT01028378|10995578|FG000|Overall Study|Withdrawal by Subject|1
6953515|NCT01028378|10995578|FG000|Overall Study|Adminstrative Reasons|4
6953516|NCT01028391|10995584|FG000|Overall Study|Adverse Event|4
6953517|NCT01028391|10995585|FG001|Overall Study|Adverse Event|0
6953518|NCT01028391|10995584|FG000|Overall Study|Lack of Efficacy|0
6953519|NCT01028391|10995585|FG001|Overall Study|Lack of Efficacy|2
6953520|NCT01028391|10995584|FG000|Overall Study|Lost to Follow-up|3
6953521|NCT01028391|10995585|FG001|Overall Study|Lost to Follow-up|4
6953522|NCT01028391|10995584|FG000|Overall Study|Physician Decision|0
6953523|NCT01028391|10995585|FG001|Overall Study|Physician Decision|1
6953524|NCT01028391|10995584|FG000|Overall Study|Withdrawal by Subject|6
6953525|NCT01028391|10995585|FG001|Overall Study|Withdrawal by Subject|3
6953526|NCT01028391|10995584|FG000|Overall Study|Needed excluded medication|1
6953527|NCT01028391|10995585|FG001|Overall Study|Needed excluded medication|1
6953528|NCT01028560|10995593|FG000|Overall Study|Lack of Efficacy|3
6953529|NCT01028560|10995594|FG001|Overall Study|Lack of Efficacy|6
6953530|NCT01028560|10995593|FG000|Overall Study|Withdrawal by Subject|7
6953531|NCT01028560|10995594|FG001|Overall Study|Withdrawal by Subject|12
6953532|NCT01028651|10995601|FG000|Overall Study|Death|2
6953533|NCT01028651|10995601|FG000|Overall Study|Adverse Event|1
6953534|NCT01029262|10995642|FG000|Overall Study|Adverse Event|9
6953535|NCT01029262|10995643|FG001|Overall Study|Adverse Event|52
6953536|NCT01029262|10995642|FG000|Overall Study|Lack of therapeutic effect|57
6953537|NCT01029262|10995643|FG001|Overall Study|Lack of therapeutic effect|76
6953538|NCT01029262|10995642|FG000|Overall Study|Withdrawal by Subject|10
6953539|NCT01029262|10995643|FG001|Overall Study|Withdrawal by Subject|17
6953540|NCT01029262|10995642|FG000|Overall Study|Protocol Violation|2
6953541|NCT01029262|10995643|FG001|Overall Study|Protocol Violation|3
6953542|NCT01029262|10995642|FG000|Overall Study|Miscellaneous|1
6953543|NCT01029262|10995643|FG001|Overall Study|Miscellaneous|9
6953544|NCT01029262|10995642|FG000|Overall Study|Death|0
6953545|NCT01029262|10995643|FG001|Overall Study|Death|3
6953546|NCT01029340|10995659|FG000|Part B Treatment Period|Withdrawal by Subject|0
6953547|NCT01029340|10995660|FG001|Part B Treatment Period|Withdrawal by Subject|0
6953548|NCT01029340|10995661|FG002|Part B Treatment Period|Withdrawal by Subject|1
6953549|NCT01029340|10995662|FG003|Part B Treatment Period|Withdrawal by Subject|0
6953550|NCT01029340|10995663|FG004|Part B Treatment Period|Withdrawal by Subject|0
6953551|NCT01029340|10995664|FG005|Part B Treatment Period|Withdrawal by Subject|0
6953552|NCT01029340|10995659|FG000|Part B Treatment Period|Protocol Violation|0
6953553|NCT01029340|10995660|FG001|Part B Treatment Period|Protocol Violation|0
6953554|NCT01029340|10995661|FG002|Part B Treatment Period|Protocol Violation|1
6953555|NCT01029340|10995662|FG003|Part B Treatment Period|Protocol Violation|0
6953556|NCT01029340|10995663|FG004|Part B Treatment Period|Protocol Violation|0
6953557|NCT01029340|10995664|FG005|Part B Treatment Period|Protocol Violation|0
6953558|NCT01029340|10995659|FG000|Extension Period|Adverse Event|0
6953559|NCT01029340|10995660|FG001|Extension Period|Adverse Event|0
6953560|NCT01029340|10995661|FG002|Extension Period|Adverse Event|0
6953561|NCT01029340|10995662|FG003|Extension Period|Adverse Event|0
6953562|NCT01029340|10995663|FG004|Extension Period|Adverse Event|0
6953563|NCT01029340|10995664|FG005|Extension Period|Adverse Event|1
6953564|NCT01029340|10995659|FG000|Extension Period|starting another study|0
6953565|NCT01029340|10995660|FG001|Extension Period|starting another study|0
6953566|NCT01029340|10995661|FG002|Extension Period|starting another study|0
6953567|NCT01029340|10995662|FG003|Extension Period|starting another study|0
6953568|NCT01029340|10995663|FG004|Extension Period|starting another study|0
6953569|NCT01029340|10995664|FG005|Extension Period|starting another study|8
6953570|NCT01029340|10995659|FG000|Extension Period|non-compliance|0
6953571|NCT01029340|10995660|FG001|Extension Period|non-compliance|0
6953572|NCT01029340|10995661|FG002|Extension Period|non-compliance|0
6953573|NCT01029340|10995662|FG003|Extension Period|non-compliance|0
6953574|NCT01029340|10995663|FG004|Extension Period|non-compliance|0
6953575|NCT01029340|10995664|FG005|Extension Period|non-compliance|1
6953576|NCT01029340|10995659|FG000|Extension Period|Withdrawal by Subject|0
6953577|NCT01029340|10995660|FG001|Extension Period|Withdrawal by Subject|0
6953578|NCT01029340|10995661|FG002|Extension Period|Withdrawal by Subject|0
6953579|NCT01029340|10995662|FG003|Extension Period|Withdrawal by Subject|0
6953580|NCT01029340|10995663|FG004|Extension Period|Withdrawal by Subject|0
6953581|NCT01029340|10995664|FG005|Extension Period|Withdrawal by Subject|1
6953582|NCT01029340|10995659|FG000|Extension Period|Physician Decision|0
6953583|NCT01029340|10995660|FG001|Extension Period|Physician Decision|0
6953584|NCT01029340|10995661|FG002|Extension Period|Physician Decision|0
6953585|NCT01029340|10995662|FG003|Extension Period|Physician Decision|0
6953586|NCT01029340|10995663|FG004|Extension Period|Physician Decision|0
6953587|NCT01029340|10995664|FG005|Extension Period|Physician Decision|1
6953588|NCT01029353|10995681|FG000|Overall Study|Lost to Follow-up|4
6953589|NCT01029353|10995682|FG001|Overall Study|Lost to Follow-up|5
6953590|NCT01029353|10995683|FG002|Overall Study|Lost to Follow-up|5
6953591|NCT01029353|10995684|FG003|Overall Study|Lost to Follow-up|4
6953592|NCT01029353|10995681|FG000|Overall Study|Consent Withdrawn|2
6953593|NCT01029353|10995682|FG001|Overall Study|Consent Withdrawn|0
6953594|NCT01029353|10995683|FG002|Overall Study|Consent Withdrawn|0
6953595|NCT01029353|10995684|FG003|Overall Study|Consent Withdrawn|0
6953596|NCT01029353|10995681|FG000|Overall Study|Primary Outcome Indeterminate|1
6953597|NCT01029353|10995682|FG001|Overall Study|Primary Outcome Indeterminate|3
6953598|NCT01029353|10995683|FG002|Overall Study|Primary Outcome Indeterminate|2
6953599|NCT01029353|10995684|FG003|Overall Study|Primary Outcome Indeterminate|0
6953600|NCT01029366|10995696|FG000|Overall Study|Withdrawal by Subject|1
6953601|NCT01029366|10995697|FG001|Overall Study|Withdrawal by Subject|0
6953602|NCT01029366|10995696|FG000|Overall Study|Death|1
6953603|NCT01029366|10995697|FG001|Overall Study|Death|1
6953604|NCT01029366|10995696|FG000|Overall Study|disease progression|2
6953605|NCT01029366|10995697|FG001|Overall Study|disease progression|0
6953606|NCT01029366|10995696|FG000|Overall Study|manufacturing failure|0
6953607|NCT01029366|10995697|FG001|Overall Study|manufacturing failure|1
6953608|NCT01029392|10995706|FG000|Overall Study|Withdrawal by Subject|18
6953609|NCT01029392|10995707|FG001|Overall Study|Withdrawal by Subject|11
6953610|NCT01029392|10995706|FG000|Overall Study|Physician Decision|2
6953611|NCT01029392|10995707|FG001|Overall Study|Physician Decision|0
6953612|NCT01029405|10995719|FG000|Overall Study|Withdrawal by Subject|0
6953613|NCT01029405|10995720|FG001|Overall Study|Withdrawal by Subject|1
6953614|NCT01029405|10995721|FG002|Overall Study|Withdrawal by Subject|2
6953615|NCT01029405|10995722|FG003|Overall Study|Withdrawal by Subject|0
6953616|NCT01029405|10995719|FG000|Overall Study|Protocol Violation|0
6953617|NCT01029405|10995720|FG001|Overall Study|Protocol Violation|0
6953618|NCT01029405|10995721|FG002|Overall Study|Protocol Violation|0
6953619|NCT01029405|10995722|FG003|Overall Study|Protocol Violation|1
6953620|NCT01029405|10995719|FG000|Overall Study|Adverse Event|0
6953621|NCT01029405|10995720|FG001|Overall Study|Adverse Event|0
6953622|NCT01029405|10995721|FG002|Overall Study|Adverse Event|1
6953623|NCT01029405|10995722|FG003|Overall Study|Adverse Event|1
6953624|NCT01029405|10995719|FG000|Overall Study|Lost to Follow-up|2
6953625|NCT01029405|10995720|FG001|Overall Study|Lost to Follow-up|1
6953626|NCT01029405|10995721|FG002|Overall Study|Lost to Follow-up|1
6953627|NCT01029405|10995722|FG003|Overall Study|Lost to Follow-up|2
6953628|NCT01029405|10995719|FG000|Overall Study|Other|0
6953629|NCT01029405|10995720|FG001|Overall Study|Other|1
6953630|NCT01029405|10995721|FG002|Overall Study|Other|0
6953631|NCT01029405|10995722|FG003|Overall Study|Other|1
6953632|NCT01029535|10995732|FG000|Overall Study|Lost to Follow-up|24
6953633|NCT01029535|10995732|FG000|Overall Study|Protocol Violation|2
6953634|NCT01029535|10995732|FG000|Overall Study|Participant Withdrew Consent|2
6953635|NCT01029535|10995732|FG000|Overall Study|Adverse Event|1
6953636|NCT01029535|10995732|FG000|Overall Study|Use of Another Treatment|1
6953637|NCT01029535|10995732|FG000|Overall Study|Death|1
6953638|NCT01029652|10995743|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0
6953639|NCT01029652|10995744|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4
6953640|NCT01029652|10995743|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1
6953641|NCT01029652|10995744|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3
6953642|NCT01029652|10995743|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3
6953643|NCT01029652|10995744|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1
6953644|NCT01029652|10995743|FG000|Core Study (0-12 Weeks)|Administrative problems|2
6953645|NCT01029652|10995744|FG001|Core Study (0-12 Weeks)|Administrative problems|1
6953646|NCT01029652|10995743|FG000|Core Study (0-12 Weeks)|Death|0
6953647|NCT01029652|10995744|FG001|Core Study (0-12 Weeks)|Death|1
6953648|NCT01029652|10995743|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0
6953649|NCT01029652|10995744|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1
6953650|NCT01029652|10995743|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2
6953651|NCT01029652|10995744|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3
7070580|NCT02014116|11173143|FG005|Overall Study|Withdrawal Caregiver Decision|1
6953652|NCT01029652|10995743|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1
6953653|NCT01029652|10995744|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0
6953654|NCT01029652|10995743|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0
6953655|NCT01029652|10995744|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1
6953656|NCT01029652|10995743|FG000|Extension Study 2 (25-72 Weeks)|Death|1
6953657|NCT01029652|10995744|FG001|Extension Study 2 (25-72 Weeks)|Death|1
6953658|NCT01029652|10995743|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0
6953659|NCT01029652|10995744|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1
6953660|NCT01029652|10995743|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0
6953661|NCT01029652|10995744|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1
6953662|NCT01029691|10995771|FG000|Continued APAP to Delivery|Death|0
6953663|NCT01029691|10995772|FG001|Continued APAP to Delivery|Death|0
6953664|NCT01029691|10995773|FG002|Continued APAP to Delivery|Death|1
6953665|NCT01029704|10995791|FG000|Overall Study|Adverse Event|0
6953666|NCT01029704|10995792|FG001|Overall Study|Adverse Event|0
6953667|NCT01029704|10995793|FG002|Overall Study|Adverse Event|0
6953668|NCT01029704|10995794|FG003|Overall Study|Adverse Event|0
6953669|NCT01029704|10995795|FG004|Overall Study|Adverse Event|0
6953670|NCT01029704|10995796|FG005|Overall Study|Adverse Event|0
6953671|NCT01029704|10995797|FG006|Overall Study|Adverse Event|1
6953672|NCT01029704|10995798|FG007|Overall Study|Adverse Event|1
6953673|NCT01029704|10995799|FG008|Overall Study|Adverse Event|0
6953674|NCT01029704|10995791|FG000|Overall Study|Withdrawal by Subject|0
6953675|NCT01029704|10995792|FG001|Overall Study|Withdrawal by Subject|0
6953676|NCT01029704|10995793|FG002|Overall Study|Withdrawal by Subject|0
6953677|NCT01029704|10995794|FG003|Overall Study|Withdrawal by Subject|0
6953678|NCT01029704|10995795|FG004|Overall Study|Withdrawal by Subject|2
6953679|NCT01029704|10995796|FG005|Overall Study|Withdrawal by Subject|1
6953680|NCT01029704|10995797|FG006|Overall Study|Withdrawal by Subject|1
6953681|NCT01029704|10995798|FG007|Overall Study|Withdrawal by Subject|1
6953682|NCT01029704|10995799|FG008|Overall Study|Withdrawal by Subject|0
6953683|NCT01029704|10995791|FG000|Overall Study|Lost to Follow-up|0
6953684|NCT01029704|10995792|FG001|Overall Study|Lost to Follow-up|0
6953685|NCT01029704|10995793|FG002|Overall Study|Lost to Follow-up|0
6953686|NCT01029704|10995794|FG003|Overall Study|Lost to Follow-up|0
6953687|NCT01029704|10995795|FG004|Overall Study|Lost to Follow-up|0
6953688|NCT01029704|10995796|FG005|Overall Study|Lost to Follow-up|0
6953689|NCT01029704|10995797|FG006|Overall Study|Lost to Follow-up|1
7070581|NCT02014116|11173144|FG006|Overall Study|Withdrawal Caregiver Decision|0
7070582|NCT02014116|11173145|FG007|Overall Study|Withdrawal Caregiver Decision|0
7070583|NCT02014116|11173146|FG008|Overall Study|Withdrawal Caregiver Decision|0
6953690|NCT01029704|10995798|FG007|Overall Study|Lost to Follow-up|1
6953691|NCT01029704|10995799|FG008|Overall Study|Lost to Follow-up|1
6953692|NCT01029704|10995791|FG000|Overall Study|Lack of Efficacy|0
6953693|NCT01029704|10995792|FG001|Overall Study|Lack of Efficacy|0
6953694|NCT01029704|10995793|FG002|Overall Study|Lack of Efficacy|0
6953695|NCT01029704|10995794|FG003|Overall Study|Lack of Efficacy|0
6953696|NCT01029704|10995795|FG004|Overall Study|Lack of Efficacy|2
6953697|NCT01029704|10995796|FG005|Overall Study|Lack of Efficacy|3
6953698|NCT01029704|10995797|FG006|Overall Study|Lack of Efficacy|1
6953699|NCT01029704|10995798|FG007|Overall Study|Lack of Efficacy|2
6953700|NCT01029704|10995799|FG008|Overall Study|Lack of Efficacy|0
6953701|NCT01029704|10995791|FG000|Overall Study|Withdrawn due to major protocol violation|0
6953702|NCT01029704|10995792|FG001|Overall Study|Withdrawn due to major protocol violation|0
6953703|NCT01029704|10995793|FG002|Overall Study|Withdrawn due to major protocol violation|0
6953704|NCT01029704|10995794|FG003|Overall Study|Withdrawn due to major protocol violation|0
6953705|NCT01029704|10995795|FG004|Overall Study|Withdrawn due to major protocol violation|1
6953706|NCT01029704|10995796|FG005|Overall Study|Withdrawn due to major protocol violation|0
6953707|NCT01029704|10995797|FG006|Overall Study|Withdrawn due to major protocol violation|0
6953708|NCT01029704|10995798|FG007|Overall Study|Withdrawn due to major protocol violation|1
6953709|NCT01029704|10995799|FG008|Overall Study|Withdrawn due to major protocol violation|0
6953710|NCT01029782|10995825|FG000|Overall Study|Lost to Follow-up|2
6953711|NCT01029782|10995826|FG001|Overall Study|Lost to Follow-up|2
6953712|NCT01029782|10995825|FG000|Overall Study|Diagnosis changed|1
6953713|NCT01029782|10995826|FG001|Overall Study|Diagnosis changed|1
6953714|NCT01029782|10995825|FG000|Overall Study|Adverse Event|0
6953715|NCT01029782|10995826|FG001|Overall Study|Adverse Event|1
6953716|NCT01029782|10995825|FG000|Overall Study|Physician Decision|0
6953717|NCT01029782|10995826|FG001|Overall Study|Physician Decision|1
7070584|NCT02014116|11173138|FG000|Overall Study|Physician Decision|0
6953718|NCT01029782|10995825|FG000|Overall Study|Protocol Violation|0
6953719|NCT01029782|10995826|FG001|Overall Study|Protocol Violation|2
6953720|NCT01029782|10995825|FG000|Overall Study|Withdrawal by Subject|0
6953721|NCT01029782|10995826|FG001|Overall Study|Withdrawal by Subject|1
6953722|NCT01029795|10995834|FG000|Overall Study|Entry Criteria Not Met|2
6953723|NCT01029795|10995835|FG001|Overall Study|Entry Criteria Not Met|1
6953724|NCT01029795|10995834|FG000|Overall Study|Physician Decision|2
6953725|NCT01029795|10995835|FG001|Overall Study|Physician Decision|1
6953726|NCT01029795|10995834|FG000|Overall Study|Sponsor Decision|11
6953727|NCT01029795|10995835|FG001|Overall Study|Sponsor Decision|17
6953728|NCT01029795|10995834|FG000|Overall Study|Withdrawal by Subject|1
6953729|NCT01029795|10995835|FG001|Overall Study|Withdrawal by Subject|3
6953730|NCT01029886|10995843|FG000|Overall Study|Adverse Event|12
6953731|NCT01029886|10995844|FG001|Overall Study|Adverse Event|25
6953732|NCT01029886|10995843|FG000|Overall Study|Lost to Follow-up|1
6953733|NCT01029886|10995844|FG001|Overall Study|Lost to Follow-up|0
6953734|NCT01029886|10995843|FG000|Overall Study|Physician Decision|2
6953735|NCT01029886|10995844|FG001|Overall Study|Physician Decision|6
6953736|NCT01029886|10995843|FG000|Overall Study|Protocol Violation|17
6953737|NCT01029886|10995844|FG001|Overall Study|Protocol Violation|5
6953738|NCT01029886|10995843|FG000|Overall Study|Withdrawal by Subject|8
6953739|NCT01029886|10995844|FG001|Overall Study|Withdrawal by Subject|18
6953740|NCT01029886|10995843|FG000|Overall Study|Entry Criteria Not Met|13
6953741|NCT01029886|10995844|FG001|Overall Study|Entry Criteria Not Met|5
6953742|NCT01029886|10995843|FG000|Overall Study|Sponsor Decision|1
6953743|NCT01029886|10995844|FG001|Overall Study|Sponsor Decision|0
6953744|NCT01029886|10995843|FG000|Overall Study|Loss Glucose Control|7
6953745|NCT01029886|10995844|FG001|Overall Study|Loss Glucose Control|1
6953746|NCT01029925|10995863|FG000|Completion of Cycle 1 (28 Days)|Death|2
6953747|NCT01029925|10995863|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2
6953748|NCT01029925|10995863|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1
6953749|NCT01030133|10995869|FG000|Overall Study|failed to experience pain at level 7/10|2
6953750|NCT01030133|10995870|FG001|Overall Study|failed to experience pain at level 7/10|2
6953751|NCT01030458|10995911|FG000|Overall Study|Lost to Follow-up|9
6953752|NCT01030458|10995912|FG001|Overall Study|Lost to Follow-up|10
6953753|NCT01030458|10995911|FG000|Overall Study|Withdrawal by Subject|2
6953754|NCT01030458|10995912|FG001|Overall Study|Withdrawal by Subject|3
6953755|NCT01030458|10995911|FG000|Overall Study|Logistical reasons|9
6953756|NCT01030458|10995912|FG001|Overall Study|Logistical reasons|5
6953757|NCT01030458|10995911|FG000|Overall Study|Moved or changed job|6
6953758|NCT01030458|10995912|FG001|Overall Study|Moved or changed job|13
6953759|NCT01030458|10995911|FG000|Overall Study|Side effect of medication|1
6953760|NCT01030458|10995912|FG001|Overall Study|Side effect of medication|1
6953761|NCT01030523|10995920|FG000|Overall Study|Death|1
6953762|NCT01030523|10995921|FG001|Overall Study|Death|0
6953763|NCT01030523|10995920|FG000|Overall Study|Lost to Follow-up|4
6953764|NCT01030523|10995921|FG001|Overall Study|Lost to Follow-up|4
6953765|NCT01030523|10995920|FG000|Overall Study|Implant failure|1
6953766|NCT01030523|10995921|FG001|Overall Study|Implant failure|0
6953767|NCT01030523|10995920|FG000|Overall Study|Withdrawal by Subject|0
6953768|NCT01030523|10995921|FG001|Overall Study|Withdrawal by Subject|1
6953769|NCT01030536|10995932|FG000|Overall Study|Withdrawal by Subject|0
6953770|NCT01030536|10995933|FG001|Overall Study|Withdrawal by Subject|0
6953771|NCT01030536|10995934|FG002|Overall Study|Withdrawal by Subject|1
6953772|NCT01030536|10995935|FG003|Overall Study|Withdrawal by Subject|0
6953773|NCT01030536|10995936|FG004|Overall Study|Withdrawal by Subject|0
6953774|NCT01030536|10995932|FG000|Overall Study|undefined|1
6953775|NCT01030536|10995933|FG001|Overall Study|undefined|0
6953776|NCT01030536|10995934|FG002|Overall Study|undefined|1
6953777|NCT01030536|10995935|FG003|Overall Study|undefined|1
6953778|NCT01030536|10995936|FG004|Overall Study|undefined|0
6953779|NCT01030536|10995932|FG000|Overall Study|Adverse Event|0
6953780|NCT01030536|10995933|FG001|Overall Study|Adverse Event|3
6953781|NCT01030536|10995934|FG002|Overall Study|Adverse Event|1
6953782|NCT01030536|10995935|FG003|Overall Study|Adverse Event|0
6953783|NCT01030536|10995936|FG004|Overall Study|Adverse Event|1
6953784|NCT01030536|10995932|FG000|Overall Study|Progressive disease|6
6953785|NCT01030536|10995933|FG001|Overall Study|Progressive disease|2
6953786|NCT01030536|10995934|FG002|Overall Study|Progressive disease|3
6953787|NCT01030536|10995935|FG003|Overall Study|Progressive disease|2
6953788|NCT01030536|10995936|FG004|Overall Study|Progressive disease|0
6953789|NCT01030536|10995932|FG000|Overall Study|Death|0
6953790|NCT01030536|10995933|FG001|Overall Study|Death|1
6953791|NCT01030536|10995934|FG002|Overall Study|Death|0
6953792|NCT01030536|10995935|FG003|Overall Study|Death|0
6953793|NCT01030536|10995936|FG004|Overall Study|Death|0
6953794|NCT01030666|10995964|FG000|Overall Study|Lost to Follow-up|3
6953795|NCT01030666|10995965|FG001|Overall Study|Lost to Follow-up|2
6953796|NCT01030718|10995975|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1
6953797|NCT01030718|10995976|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1
6953798|NCT01030718|10995977|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11
6953799|NCT01030718|10995975|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3
6953800|NCT01030718|10995976|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5
6953801|NCT01030718|10995977|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1
6953802|NCT01030718|10995975|FG000|Studies CA180-031 and -036 Combined|Death|0
6953803|NCT01030718|10995976|FG001|Studies CA180-031 and -036 Combined|Death|1
6953804|NCT01030718|10995977|FG002|Studies CA180-031 and -036 Combined|Death|0
6953805|NCT01030718|10995975|FG000|Studies CA180-031 and -036 Combined|other reasons|0
6953806|NCT01030718|10995976|FG001|Studies CA180-031 and -036 Combined|other reasons|2
6953807|NCT01030718|10995977|FG002|Studies CA180-031 and -036 Combined|other reasons|0
6953808|NCT01030718|10995975|FG000|Study CA180-036 Only|insufficient effect|1
6953809|NCT01030718|10995976|FG001|Study CA180-036 Only|insufficient effect|1
6953810|NCT01030718|10995977|FG002|Study CA180-036 Only|insufficient effect|5
6953811|NCT01030718|10995975|FG000|Study CA180-036 Only|Adverse Event|2
6953812|NCT01030718|10995976|FG001|Study CA180-036 Only|Adverse Event|3
6953813|NCT01030718|10995977|FG002|Study CA180-036 Only|Adverse Event|0
6953814|NCT01030718|10995975|FG000|Study CA180-036 Only|Death|0
6953815|NCT01030718|10995976|FG001|Study CA180-036 Only|Death|1
6953816|NCT01030718|10995977|FG002|Study CA180-036 Only|Death|0
6953817|NCT01030718|10995975|FG000|Study CA180-036 Only|Other Reasons|0
6953818|NCT01030718|10995976|FG001|Study CA180-036 Only|Other Reasons|2
6953819|NCT01030718|10995977|FG002|Study CA180-036 Only|Other Reasons|0
6953820|NCT01030822|10996007|FG000|Overall Study|Moved/migrated from study area|6
6953821|NCT01030822|10996008|FG001|Overall Study|Moved/migrated from study area|7
6953822|NCT01030822|10996009|FG002|Overall Study|Moved/migrated from study area|3
6953823|NCT01030822|10996007|FG000|Overall Study|Withdrawal by Subject|16
6953824|NCT01030822|10996008|FG001|Overall Study|Withdrawal by Subject|13
6953825|NCT01030822|10996009|FG002|Overall Study|Withdrawal by Subject|16
6953826|NCT01030822|10996007|FG000|Overall Study|Lost to Follow-up|9
6953827|NCT01030822|10996008|FG001|Overall Study|Lost to Follow-up|4
6953828|NCT01030822|10996009|FG002|Overall Study|Lost to Follow-up|7
6976230|NCT01197794|11028690|FG004|Overall Study|Eligibility criteria not fulfilled|5
6976231|NCT01197794|11028691|FG005|Overall Study|Eligibility criteria not fulfilled|9
6976232|NCT01197794|11028692|FG006|Overall Study|Eligibility criteria not fulfilled|6
6976233|NCT01197794|11028686|FG000|Overall Study|Withdrawal by Subject|3
6976234|NCT01197794|11028687|FG001|Overall Study|Withdrawal by Subject|3
6976235|NCT01197794|11028688|FG002|Overall Study|Withdrawal by Subject|4
6976236|NCT01197794|11028689|FG003|Overall Study|Withdrawal by Subject|1
6976237|NCT01197794|11028690|FG004|Overall Study|Withdrawal by Subject|1
6976238|NCT01197794|11028691|FG005|Overall Study|Withdrawal by Subject|5
6976239|NCT01197794|11028692|FG006|Overall Study|Withdrawal by Subject|6
6976240|NCT01197794|11028686|FG000|Overall Study|Lost to Follow-up|1
6976241|NCT01197794|11028687|FG001|Overall Study|Lost to Follow-up|1
6976242|NCT01197794|11028688|FG002|Overall Study|Lost to Follow-up|0
6976243|NCT01197794|11028689|FG003|Overall Study|Lost to Follow-up|1
6976244|NCT01197794|11028690|FG004|Overall Study|Lost to Follow-up|0
6976245|NCT01197794|11028691|FG005|Overall Study|Lost to Follow-up|1
6976246|NCT01197794|11028692|FG006|Overall Study|Lost to Follow-up|0
6976247|NCT01197794|11028686|FG000|Overall Study|Other|1
6976248|NCT01197794|11028687|FG001|Overall Study|Other|1
6976249|NCT01197794|11028688|FG002|Overall Study|Other|3
6976250|NCT01197794|11028689|FG003|Overall Study|Other|0
6976251|NCT01197794|11028690|FG004|Overall Study|Other|2
6976252|NCT01197794|11028691|FG005|Overall Study|Other|2
6976253|NCT01197794|11028692|FG006|Overall Study|Other|4
6976254|NCT01197911|11028734|FG000|Overall Study|Adverse Event|0
6976255|NCT01197911|11028735|FG001|Overall Study|Adverse Event|0
6976256|NCT01197911|11028736|FG002|Overall Study|Adverse Event|1
6977269|NCT01207219|11030494|FG002|Overall Study|Lost to Follow-up|6
6977270|NCT01207388|11030502|FG000|Overall Study|Death|67
6977271|NCT01207388|11030502|FG000|Overall Study|Withdrawal by Subject|1
6977272|NCT01207414|11030525|FG000|Overall Study|Adverse Event|25
6977273|NCT01207414|11030526|FG001|Overall Study|Adverse Event|39
6977274|NCT01207414|11030525|FG000|Overall Study|Abnormal test procedure results|0
6977275|NCT01207414|11030526|FG001|Overall Study|Abnormal test procedure results|1
6977276|NCT01207414|11030525|FG000|Overall Study|Unsatisfactory therapeutic effect|5
6977277|NCT01207414|11030526|FG001|Overall Study|Unsatisfactory therapeutic effect|4
6977278|NCT01207414|11030525|FG000|Overall Study|Patient withdrew consent|14
6977279|NCT01207414|11030526|FG001|Overall Study|Patient withdrew consent|11
6977280|NCT01207414|11030525|FG000|Overall Study|Lost to Follow-up|15
6977281|NCT01207414|11030526|FG001|Overall Study|Lost to Follow-up|17
6977282|NCT01207414|11030525|FG000|Overall Study|Administrative problems|1
6977283|NCT01207414|11030526|FG001|Overall Study|Administrative problems|1
6977284|NCT01207414|11030525|FG000|Overall Study|Protocol deviation|12
6977285|NCT01207414|11030526|FG001|Overall Study|Protocol deviation|9
6977286|NCT01207414|11030525|FG000|Overall Study|Randomized in error|1
6977287|NCT01207414|11030526|FG001|Overall Study|Randomized in error|0
6977288|NCT01207427|11030535|FG000|Double-blind Treatment Period|Adverse Event|0
6977289|NCT01207427|11030536|FG001|Double-blind Treatment Period|Adverse Event|1
6977290|NCT01207427|11030537|FG002|Double-blind Treatment Period|Adverse Event|0
6977291|NCT01207427|11030535|FG000|Double-blind Treatment Period|Lost to Follow-up|0
6977292|NCT01207427|11030536|FG001|Double-blind Treatment Period|Lost to Follow-up|0
6977293|NCT01207427|11030537|FG002|Double-blind Treatment Period|Lost to Follow-up|1
6977294|NCT01207427|11030535|FG000|Double-blind Treatment Period|Protocol Violation|2
6977295|NCT01207427|11030536|FG001|Double-blind Treatment Period|Protocol Violation|1
6977296|NCT01207427|11030537|FG002|Double-blind Treatment Period|Protocol Violation|1
6953829|NCT01030874|10996029|FG000|Overall Study|Withdrawal by Subject|1
6953830|NCT01030874|10996030|FG001|Overall Study|Withdrawal by Subject|0
6953831|NCT01030874|10996029|FG000|Overall Study|Discharged in first 2 weeks|17
6953832|NCT01030874|10996030|FG001|Overall Study|Discharged in first 2 weeks|16
6953833|NCT01030952|10996038|FG000|Overall Study|Protocol Violation|0
6953834|NCT01030952|10996039|FG001|Overall Study|Protocol Violation|1
6953835|NCT01030952|10996038|FG000|Overall Study|Informed consent withdrawal|1
6953836|NCT01030952|10996039|FG001|Overall Study|Informed consent withdrawal|0
6953837|NCT01030952|10996038|FG000|Overall Study|Lost to Follow-up|0
6953838|NCT01030952|10996039|FG001|Overall Study|Lost to Follow-up|1
6953839|NCT01030952|10996038|FG000|Overall Study|Unexplained|1
6953840|NCT01030952|10996039|FG001|Overall Study|Unexplained|1
6953841|NCT01030965|10996051|FG000|Overall Study|Lack of Efficacy|3
6953842|NCT01030965|10996052|FG001|Overall Study|Lack of Efficacy|2
6953843|NCT01030965|10996053|FG002|Overall Study|Lack of Efficacy|0
6953844|NCT01030965|10996054|FG003|Overall Study|Lack of Efficacy|3
6953845|NCT01030965|10996051|FG000|Overall Study|Protocol Violation|1
6953846|NCT01030965|10996052|FG001|Overall Study|Protocol Violation|1
6953847|NCT01030965|10996053|FG002|Overall Study|Protocol Violation|1
6953848|NCT01030965|10996054|FG003|Overall Study|Protocol Violation|1
6953849|NCT01030965|10996051|FG000|Overall Study|Adverse Event|0
6953850|NCT01030965|10996052|FG001|Overall Study|Adverse Event|1
6953851|NCT01030965|10996053|FG002|Overall Study|Adverse Event|2
6953852|NCT01030965|10996054|FG003|Overall Study|Adverse Event|1
6953853|NCT01030965|10996051|FG000|Overall Study|Protocol-defined Stopping Criteria|0
6953854|NCT01030965|10996052|FG001|Overall Study|Protocol-defined Stopping Criteria|1
6953855|NCT01030965|10996053|FG002|Overall Study|Protocol-defined Stopping Criteria|1
6953856|NCT01030965|10996054|FG003|Overall Study|Protocol-defined Stopping Criteria|0
6953857|NCT01030965|10996051|FG000|Overall Study|Withdrawal by Subject|0
6953858|NCT01030965|10996052|FG001|Overall Study|Withdrawal by Subject|1
6953859|NCT01030965|10996053|FG002|Overall Study|Withdrawal by Subject|0
6953860|NCT01030965|10996054|FG003|Overall Study|Withdrawal by Subject|2
6953861|NCT01031004|10996066|FG000|Overall Study|Protocol Violation|0
6953862|NCT01031004|10996067|FG001|Overall Study|Protocol Violation|1
6953863|NCT01031004|10996066|FG000|Overall Study|Lost to Follow-up|1
6953864|NCT01031004|10996067|FG001|Overall Study|Lost to Follow-up|0
6953865|NCT01031069|10996081|FG000|Overall Study|Serious Adverse Event|0
6953866|NCT01031069|10996082|FG001|Overall Study|Serious Adverse Event|1
6953867|NCT01031069|10996083|FG002|Overall Study|Serious Adverse Event|0
6953868|NCT01031069|10996084|FG003|Overall Study|Serious Adverse Event|0
6953869|NCT01031069|10996081|FG000|Overall Study|Withdrawal by Subject|2
6953870|NCT01031069|10996082|FG001|Overall Study|Withdrawal by Subject|3
6953871|NCT01031069|10996083|FG002|Overall Study|Withdrawal by Subject|18
6953872|NCT01031069|10996084|FG003|Overall Study|Withdrawal by Subject|18
6953873|NCT01031069|10996081|FG000|Overall Study|Migrated/moved from study area|1
6953874|NCT01031069|10996082|FG001|Overall Study|Migrated/moved from study area|2
6953875|NCT01031069|10996083|FG002|Overall Study|Migrated/moved from study area|1
6953876|NCT01031069|10996084|FG003|Overall Study|Migrated/moved from study area|1
6953877|NCT01031069|10996081|FG000|Overall Study|Lost to Follow-up|9
6953878|NCT01031069|10996082|FG001|Overall Study|Lost to Follow-up|5
6953879|NCT01031069|10996083|FG002|Overall Study|Lost to Follow-up|21
6953880|NCT01031069|10996084|FG003|Overall Study|Lost to Follow-up|15
6953881|NCT01031069|10996081|FG000|Overall Study|Other|0
6953882|NCT01031069|10996082|FG001|Overall Study|Other|0
6953883|NCT01031069|10996083|FG002|Overall Study|Other|1
6953884|NCT01031069|10996084|FG003|Overall Study|Other|0
6953885|NCT01031381|10996114|FG000|Overall Study|Physician Decision|3
6953886|NCT01031381|10996114|FG000|Overall Study|Withdrawal by Subject|6
7070585|NCT02014116|11173139|FG001|Overall Study|Physician Decision|0
7070586|NCT02014116|11173140|FG002|Overall Study|Physician Decision|0
7070587|NCT02014116|11173141|FG003|Overall Study|Physician Decision|0
7070588|NCT02014116|11173142|FG004|Overall Study|Physician Decision|0
7070589|NCT02014116|11173143|FG005|Overall Study|Physician Decision|0
7070590|NCT02014116|11173144|FG006|Overall Study|Physician Decision|0
7070591|NCT02014116|11173145|FG007|Overall Study|Physician Decision|0
7070592|NCT02014116|11173146|FG008|Overall Study|Physician Decision|1
7070593|NCT02014272|11173182|FG000|Intervention Period 1|Withdrawal by Subject|1
7070594|NCT02014272|11173183|FG001|Intervention Period 1|Withdrawal by Subject|0
7070595|NCT02014272|11173182|FG000|Intervention Period 1|Adverse Event|0
7070596|NCT02014272|11173183|FG001|Intervention Period 1|Adverse Event|1
7070597|NCT02014376|11173205|FG000|Overall Study|Adverse Event|1
7070598|NCT02014376|11173206|FG001|Overall Study|Adverse Event|1
7070599|NCT02014376|11173207|FG002|Overall Study|Adverse Event|0
6953887|NCT01031446|10996123|FG000|Overall Study|Disease Progression|38
6953888|NCT01031446|10996123|FG000|Overall Study|Adverse Event|9
6953889|NCT01031446|10996123|FG000|Overall Study|Physician Decision|4
6953890|NCT01031446|10996123|FG000|Overall Study|Withdrawal by Subject|3
6953891|NCT01031446|10996123|FG000|Overall Study|Still on treatment|1
6953892|NCT01031537|10996142|FG000|Overall Study|medical reasons not related to study|3
6953893|NCT01031537|10996142|FG000|Overall Study|Lack of Efficacy|1
6953894|NCT01031537|10996142|FG000|Overall Study|retired from NIH, met exclusion criteria|1
7070600|NCT02014376|11173205|FG000|Overall Study|Lost to Follow-up|2
7070601|NCT02014376|11173206|FG001|Overall Study|Lost to Follow-up|0
7070602|NCT02014376|11173207|FG002|Overall Study|Lost to Follow-up|0
6953895|NCT01031537|10996142|FG000|Overall Study|moved, met exclusion criteria|10
6953896|NCT01031537|10996142|FG000|Overall Study|Withdrawal by Subject|5
6953897|NCT01031537|10996142|FG000|Overall Study|PI removal, no longer met eligibility|12
6953898|NCT01031680|10996148|FG000|Overall Study|Adverse Event|8
6953899|NCT01031680|10996149|FG001|Overall Study|Adverse Event|3
6953900|NCT01031680|10996148|FG000|Overall Study|Lost to Follow-up|2
6953901|NCT01031680|10996149|FG001|Overall Study|Lost to Follow-up|10
6953902|NCT01031680|10996148|FG000|Overall Study|Withdrawal by Subject|12
6953903|NCT01031680|10996149|FG001|Overall Study|Withdrawal by Subject|16
6953904|NCT01031680|10996148|FG000|Overall Study|Death|2
6953905|NCT01031680|10996149|FG001|Overall Study|Death|1
6953906|NCT01031680|10996148|FG000|Overall Study|Subject No Longer Meets Study Criteria|26
6953907|NCT01031680|10996149|FG001|Overall Study|Subject No Longer Meets Study Criteria|17
6953908|NCT01031680|10996148|FG000|Overall Study|Poor/Non-compliance|5
6953909|NCT01031680|10996149|FG001|Overall Study|Poor/Non-compliance|6
6953910|NCT01031680|10996148|FG000|Overall Study|Safety|1
6953911|NCT01031680|10996149|FG001|Overall Study|Safety|0
6953912|NCT01031680|10996148|FG000|Overall Study|Incorrect Enrolment|1
6953913|NCT01031680|10996149|FG001|Overall Study|Incorrect Enrolment|2
6953914|NCT01031680|10996148|FG000|Overall Study|Administrative Reason by Sponsor|0
6953915|NCT01031680|10996149|FG001|Overall Study|Administrative Reason by Sponsor|1
6953916|NCT01031680|10996148|FG000|Overall Study|Various|0
6953917|NCT01031680|10996149|FG001|Overall Study|Various|2
6953918|NCT01031706|10996157|FG000|Overall Study|Adverse Event|1
6953919|NCT01031706|10996158|FG001|Overall Study|Adverse Event|0
6953920|NCT01031706|10996157|FG000|Overall Study|Withdrawal by Subject|1
6953921|NCT01031706|10996158|FG001|Overall Study|Withdrawal by Subject|1
6953922|NCT01031836|10996176|FG000|Stage I|Adverse Event|1
6953923|NCT01031836|10996177|FG001|Stage I|Adverse Event|1
6953924|NCT01031836|10996178|FG002|Stage I|Adverse Event|0
6953925|NCT01031836|10996179|FG003|Stage I|Adverse Event|0
6953926|NCT01031836|10996180|FG004|Stage I|Adverse Event|0
6953927|NCT01031836|10996181|FG005|Stage I|Adverse Event|0
6953928|NCT01031836|10996176|FG000|Stage I|Other|0
6953929|NCT01031836|10996177|FG001|Stage I|Other|1
6953930|NCT01031836|10996178|FG002|Stage I|Other|0
6953931|NCT01031836|10996179|FG003|Stage I|Other|0
6953932|NCT01031836|10996180|FG004|Stage I|Other|0
6953933|NCT01031836|10996181|FG005|Stage I|Other|1
6953934|NCT01031836|10996176|FG000|Stage II|Adverse Event|0
6953935|NCT01031836|10996177|FG001|Stage II|Adverse Event|0
6953936|NCT01031836|10996178|FG002|Stage II|Adverse Event|2
6953937|NCT01031836|10996179|FG003|Stage II|Adverse Event|2
6953938|NCT01031836|10996180|FG004|Stage II|Adverse Event|1
6953939|NCT01031836|10996181|FG005|Stage II|Adverse Event|1
6953940|NCT01031836|10996176|FG000|Stage II|Other|2
6953941|NCT01031836|10996177|FG001|Stage II|Other|0
6953942|NCT01031836|10996178|FG002|Stage II|Other|0
6953943|NCT01031836|10996179|FG003|Stage II|Other|1
6953944|NCT01031836|10996180|FG004|Stage II|Other|1
6953945|NCT01031836|10996181|FG005|Stage II|Other|0
6953946|NCT01031979|10996211|FG000|Overall Study|Lost to Follow-up|5
6953947|NCT01031979|10996212|FG001|Overall Study|Lost to Follow-up|4
6953948|NCT01032018|10996220|FG000|Overall Study|Lost to Follow-up|6
6953949|NCT01032018|10996221|FG001|Overall Study|Lost to Follow-up|5
6953950|NCT01032018|10996220|FG000|Overall Study|Death|0
6953951|NCT01032018|10996221|FG001|Overall Study|Death|1
6953952|NCT01032044|10996229|FG000|Overall Study|Protocol Violation|14
6953953|NCT01032044|10996230|FG001|Overall Study|Protocol Violation|8
6953954|NCT01032044|10996229|FG000|Overall Study|Adverse Event|0
6953955|NCT01032044|10996230|FG001|Overall Study|Adverse Event|1
6953956|NCT01032044|10996229|FG000|Overall Study|Lost to Follow-up|11
6953957|NCT01032044|10996230|FG001|Overall Study|Lost to Follow-up|11
6953958|NCT01032070|10996238|FG000|Overall Study|Disease progression|13
6953959|NCT01032070|10996239|FG001|Overall Study|Disease progression|8
6953960|NCT01032070|10996238|FG000|Overall Study|Medical or ethical reasons|0
6953961|NCT01032070|10996239|FG001|Overall Study|Medical or ethical reasons|2
6953962|NCT01032070|10996238|FG000|Overall Study|Withdrawal by Subject|0
6953963|NCT01032070|10996239|FG001|Overall Study|Withdrawal by Subject|2
6953964|NCT01032174|10996272|FG000|Overall Study|Adverse Event|0
6953965|NCT01032174|10996273|FG001|Overall Study|Adverse Event|1
6953966|NCT01032200|10996281|FG000|Overall Study|Death|1
6953967|NCT01032200|10996282|FG001|Overall Study|Death|1
6953968|NCT01032200|10996281|FG000|Overall Study|Withdrawal by Subject|1
6953969|NCT01032200|10996282|FG001|Overall Study|Withdrawal by Subject|3
6953970|NCT01032200|10996281|FG000|Overall Study|Toxicity|0
6953971|NCT01032200|10996282|FG001|Overall Study|Toxicity|2
6953972|NCT01032200|10996281|FG000|Overall Study|Progression|1
6953973|NCT01032200|10996282|FG001|Overall Study|Progression|0
6953974|NCT01032200|10996281|FG000|Overall Study|Multiple|1
6953975|NCT01032200|10996282|FG001|Overall Study|Multiple|1
6953976|NCT01032239|10996290|FG000|Overall Study|Lost to Follow-up|3
6953977|NCT01032239|10996291|FG001|Overall Study|Lost to Follow-up|2
6953978|NCT01032239|10996290|FG000|Overall Study|Withdrawal by Subject|2
6953979|NCT01032239|10996291|FG001|Overall Study|Withdrawal by Subject|3
6953980|NCT01032239|10996290|FG000|Overall Study|Death|1
6953981|NCT01032239|10996291|FG001|Overall Study|Death|0
6953982|NCT01032239|10996290|FG000|Overall Study|Protocol Violation|1
6953983|NCT01032239|10996291|FG001|Overall Study|Protocol Violation|0
6953984|NCT01032291|10996300|FG000|Safety Lead-in|Adverse Event|1
6953985|NCT01032291|10996301|FG001|Safety Lead-in|Adverse Event|0
6953986|NCT01032291|10996302|FG002|Safety Lead-in|Adverse Event|0
6953987|NCT01032291|10996300|FG000|Safety Lead-in|Death|1
6953988|NCT01032291|10996301|FG001|Safety Lead-in|Death|0
6953989|NCT01032291|10996302|FG002|Safety Lead-in|Death|0
6953990|NCT01032291|10996300|FG000|Proof of Concept|Adverse Event|0
6953991|NCT01032291|10996301|FG001|Proof of Concept|Adverse Event|5
6953992|NCT01032291|10996302|FG002|Proof of Concept|Adverse Event|1
6953993|NCT01032291|10996300|FG000|Proof of Concept|Death|0
6953994|NCT01032291|10996301|FG001|Proof of Concept|Death|1
6953995|NCT01032291|10996302|FG002|Proof of Concept|Death|2
6953996|NCT01032291|10996300|FG000|Proof of Concept|Lack of Efficacy|0
6953997|NCT01032291|10996301|FG001|Proof of Concept|Lack of Efficacy|1
6953998|NCT01032291|10996302|FG002|Proof of Concept|Lack of Efficacy|0
6953999|NCT01032291|10996300|FG000|Proof of Concept|Never Received Study Drug|0
6954000|NCT01032291|10996301|FG001|Proof of Concept|Never Received Study Drug|1
6954001|NCT01032291|10996302|FG002|Proof of Concept|Never Received Study Drug|0
6954002|NCT01032382|10996340|FG000|Overall Study|Disease dissemination|1
6954003|NCT01032382|10996341|FG001|Overall Study|Disease dissemination|1
6954004|NCT01032382|10996340|FG000|Overall Study|Treatment failure|3
6954005|NCT01032382|10996341|FG001|Overall Study|Treatment failure|1
6954006|NCT01032382|10996340|FG000|Overall Study|Index lesion relapse|1
6954007|NCT01032382|10996341|FG001|Overall Study|Index lesion relapse|3
6954008|NCT01032629|10996356|FG000|Overall Study|Closed Site|21
6954009|NCT01032629|10996357|FG001|Overall Study|Closed Site|18
6954010|NCT01032629|10996358|FG002|Overall Study|Closed Site|16
6954011|NCT01032629|10996356|FG000|Overall Study|Withdrawal by Subject|50
6954012|NCT01032629|10996357|FG001|Overall Study|Withdrawal by Subject|36
6954013|NCT01032629|10996358|FG002|Overall Study|Withdrawal by Subject|35
6954014|NCT01032629|10996356|FG000|Overall Study|Lost to Follow-up|74
6954015|NCT01032629|10996357|FG001|Overall Study|Lost to Follow-up|47
6954016|NCT01032629|10996358|FG002|Overall Study|Lost to Follow-up|37
6954017|NCT01032837|10996399|FG000|Overall Study|Adverse event/internal illness|0
6954018|NCT01032837|10996400|FG001|Overall Study|Adverse event/internal illness|1
6954019|NCT01032837|10996401|FG002|Overall Study|Adverse event/internal illness|0
6954020|NCT01032837|10996402|FG003|Overall Study|Adverse event/internal illness|1
6954021|NCT01032837|10996399|FG000|Overall Study|Withdrew consent|0
6954022|NCT01032837|10996400|FG001|Overall Study|Withdrew consent|2
6954023|NCT01032837|10996401|FG002|Overall Study|Withdrew consent|0
6954024|NCT01032837|10996402|FG003|Overall Study|Withdrew consent|1
6954025|NCT01032837|10996399|FG000|Overall Study|Failed to return|0
6954026|NCT01032837|10996400|FG001|Overall Study|Failed to return|0
6954027|NCT01032837|10996401|FG002|Overall Study|Failed to return|1
6954028|NCT01032837|10996402|FG003|Overall Study|Failed to return|0
6954029|NCT01032837|10996399|FG000|Overall Study|Refused treatment|0
6954030|NCT01032837|10996400|FG001|Overall Study|Refused treatment|0
6954031|NCT01032837|10996401|FG002|Overall Study|Refused treatment|0
6954032|NCT01032837|10996402|FG003|Overall Study|Refused treatment|1
6954033|NCT01032889|10996419|FG000|Overall Study|Adverse Event|2
6954034|NCT01032889|10996420|FG001|Overall Study|Adverse Event|2
6954035|NCT01032889|10996421|FG002|Overall Study|Adverse Event|0
6954036|NCT01032889|10996419|FG000|Overall Study|Withdrawal of Consent|1
7070603|NCT02014402|11173219|FG000|Overall Study|Adverse Event|1
7070604|NCT02014402|11173220|FG001|Overall Study|Adverse Event|0
7070605|NCT02014402|11173221|FG002|Overall Study|Adverse Event|0
7070606|NCT02014402|11173222|FG003|Overall Study|Adverse Event|0
7070607|NCT02014402|11173219|FG000|Overall Study|Withdrawal by Subject|1
7070608|NCT02014402|11173220|FG001|Overall Study|Withdrawal by Subject|2
7070609|NCT02014402|11173221|FG002|Overall Study|Withdrawal by Subject|2
7070610|NCT02014402|11173222|FG003|Overall Study|Withdrawal by Subject|1
7070611|NCT02014402|11173219|FG000|Overall Study|Subject did not have transportation|0
7070612|NCT02014402|11173220|FG001|Overall Study|Subject did not have transportation|1
7070613|NCT02014402|11173221|FG002|Overall Study|Subject did not have transportation|0
7070614|NCT02014402|11173222|FG003|Overall Study|Subject did not have transportation|0
7070615|NCT02014402|11173219|FG000|Overall Study|Lost to Follow-up|0
7070616|NCT02014402|11173220|FG001|Overall Study|Lost to Follow-up|0
7070617|NCT02014402|11173221|FG002|Overall Study|Lost to Follow-up|1
7070618|NCT02014402|11173222|FG003|Overall Study|Lost to Follow-up|2
7070619|NCT02014441|11173239|FG000|Overall Study|Withdrawal by Subject|12
7070620|NCT02014467|11173247|FG000|Overall Study|Adverse Event|4
7070621|NCT02014467|11173248|FG001|Overall Study|Adverse Event|0
6954037|NCT01032889|10996420|FG001|Overall Study|Withdrawal of Consent|2
6954038|NCT01032889|10996421|FG002|Overall Study|Withdrawal of Consent|1
6954039|NCT01032889|10996419|FG000|Overall Study|Patient Request|0
6954040|NCT01032889|10996420|FG001|Overall Study|Patient Request|1
6954041|NCT01032889|10996421|FG002|Overall Study|Patient Request|0
6954042|NCT01032889|10996419|FG000|Overall Study|Lost to Follow-up|1
6954043|NCT01032889|10996420|FG001|Overall Study|Lost to Follow-up|1
6954044|NCT01032889|10996421|FG002|Overall Study|Lost to Follow-up|0
6954045|NCT01032889|10996419|FG000|Overall Study|Lack of Submental Fat|2
7070622|NCT02014467|11173247|FG000|Overall Study|Protocol Violation|3
7070623|NCT02014467|11173248|FG001|Overall Study|Protocol Violation|0
7070624|NCT02014467|11173247|FG000|Overall Study|Physician Decision|2
7070625|NCT02014467|11173248|FG001|Overall Study|Physician Decision|3
7070626|NCT02014467|11173247|FG000|Overall Study|Withdrawal by Subject|16
7070627|NCT02014467|11173248|FG001|Overall Study|Withdrawal by Subject|4
7070628|NCT02014480|11173254|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0
7070629|NCT02014480|11173255|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0
7070630|NCT02014480|11173256|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1
7070631|NCT02014480|11173257|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0
7070632|NCT02014480|11173258|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0
7070633|NCT02014480|11173259|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0
7070634|NCT02014480|11173254|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7070635|NCT02014480|11173255|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
7070636|NCT02014480|11173256|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7070637|NCT02014480|11173257|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2
7070638|NCT02014480|11173258|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
7070639|NCT02014480|11173259|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7070640|NCT02014480|11173254|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
7070641|NCT02014480|11173255|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
7070642|NCT02014480|11173256|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
7070643|NCT02014480|11173257|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
7070644|NCT02014480|11173258|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
7070645|NCT02014480|11173259|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
7070646|NCT02014480|11173254|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1
7070647|NCT02014480|11173255|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1
7070648|NCT02014480|11173256|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2
7070649|NCT02014480|11173257|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1
7070650|NCT02014480|11173258|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0
7070651|NCT02014480|11173259|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0
7070652|NCT02014480|11173254|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
7070653|NCT02014480|11173255|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
7070654|NCT02014480|11173256|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
7070655|NCT02014480|11173257|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
7070656|NCT02014480|11173258|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
7070657|NCT02014480|11173259|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
6838470|NCT00259610|10844214|FG001|Overall Study|Death|1
6838471|NCT00259610|10844215|FG002|Overall Study|Death|2
6838472|NCT00259610|10844216|FG003|Overall Study|Death|0
6954046|NCT01032889|10996420|FG001|Overall Study|Lack of Submental Fat|8
6954047|NCT01032889|10996421|FG002|Overall Study|Lack of Submental Fat|1
6954048|NCT01032889|10996419|FG000|Overall Study|Miscellaneous Reasons|2
6954049|NCT01032889|10996420|FG001|Overall Study|Miscellaneous Reasons|1
6954050|NCT01032889|10996421|FG002|Overall Study|Miscellaneous Reasons|1
6954051|NCT01032915|10996433|FG000|Overall Study|Adverse Event|2
6954052|NCT01032915|10996434|FG001|Overall Study|Adverse Event|2
6954053|NCT01032915|10996435|FG002|Overall Study|Adverse Event|1
6954054|NCT01032915|10996436|FG003|Overall Study|Adverse Event|1
6954055|NCT01032915|10996433|FG000|Overall Study|Abnormal test procedure result|0
6954056|NCT01032915|10996434|FG001|Overall Study|Abnormal test procedure result|0
6954057|NCT01032915|10996435|FG002|Overall Study|Abnormal test procedure result|1
6954058|NCT01032915|10996436|FG003|Overall Study|Abnormal test procedure result|0
6954059|NCT01032915|10996433|FG000|Overall Study|Withdrawal by Subject|0
6954060|NCT01032915|10996434|FG001|Overall Study|Withdrawal by Subject|3
6954061|NCT01032915|10996435|FG002|Overall Study|Withdrawal by Subject|1
6954062|NCT01032915|10996436|FG003|Overall Study|Withdrawal by Subject|1
6954063|NCT01032915|10996433|FG000|Overall Study|Administrative reasons|5
6954064|NCT01032915|10996434|FG001|Overall Study|Administrative reasons|6
6954065|NCT01032915|10996435|FG002|Overall Study|Administrative reasons|4
6954066|NCT01032915|10996436|FG003|Overall Study|Administrative reasons|4
6954067|NCT01032915|10996433|FG000|Overall Study|Protocol Violation|1
6954068|NCT01032915|10996434|FG001|Overall Study|Protocol Violation|0
6954069|NCT01032915|10996435|FG002|Overall Study|Protocol Violation|0
6954070|NCT01032915|10996436|FG003|Overall Study|Protocol Violation|1
6954071|NCT01033019|10996478|FG000|Overall Study|Withdrawal by Subject|1
6954072|NCT01033019|10996479|FG001|Overall Study|Withdrawal by Subject|0
6954073|NCT01033071|10996489|FG000|Overall Study|Adverse Event|28
6954074|NCT01033071|10996490|FG001|Overall Study|Adverse Event|51
6954075|NCT01033071|10996491|FG002|Overall Study|Adverse Event|26
6954076|NCT01033071|10996489|FG000|Overall Study|Protocol Violation|0
6954077|NCT01033071|10996490|FG001|Overall Study|Protocol Violation|2
6954078|NCT01033071|10996491|FG002|Overall Study|Protocol Violation|1
6954079|NCT01033071|10996489|FG000|Overall Study|Lost to Follow-up|4
6954080|NCT01033071|10996490|FG001|Overall Study|Lost to Follow-up|5
6954081|NCT01033071|10996491|FG002|Overall Study|Lost to Follow-up|5
6954082|NCT01033071|10996489|FG000|Overall Study|Withdrawal by Subject|17
6954083|NCT01033071|10996490|FG001|Overall Study|Withdrawal by Subject|14
6954084|NCT01033071|10996491|FG002|Overall Study|Withdrawal by Subject|11
6954085|NCT01033071|10996489|FG000|Overall Study|Lack of Efficacy|0
6954086|NCT01033071|10996490|FG001|Overall Study|Lack of Efficacy|1
6954087|NCT01033071|10996491|FG002|Overall Study|Lack of Efficacy|1
7070658|NCT02014480|11173254|FG000|Treatment Period 3 (14 Days)|Adverse Event|0
7070659|NCT02014480|11173255|FG001|Treatment Period 3 (14 Days)|Adverse Event|0
7070660|NCT02014480|11173256|FG002|Treatment Period 3 (14 Days)|Adverse Event|1
7070661|NCT02014480|11173257|FG003|Treatment Period 3 (14 Days)|Adverse Event|0
6954088|NCT01033071|10996489|FG000|Overall Study|Other|6
6954089|NCT01033071|10996490|FG001|Overall Study|Other|4
6954090|NCT01033071|10996491|FG002|Overall Study|Other|3
6954091|NCT01033136|10996501|FG000|Follow-Up (3 Month)|Lost to Follow-up|2
6954092|NCT01033136|10996502|FG001|Follow-Up (3 Month)|Lost to Follow-up|2
6954093|NCT01033240|10996524|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10
6954094|NCT01033240|10996525|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8
6954095|NCT01033240|10996526|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6
6954096|NCT01033240|10996524|FG000|Overall Study|Death|2
6954097|NCT01033240|10996525|FG001|Overall Study|Death|0
6954098|NCT01033240|10996526|FG002|Overall Study|Death|0
6954099|NCT01033240|10996524|FG000|Overall Study|Withdrew Consent|2
6954100|NCT01033240|10996525|FG001|Overall Study|Withdrew Consent|9
6954101|NCT01033240|10996526|FG002|Overall Study|Withdrew Consent|2
6954102|NCT01033240|10996524|FG000|Overall Study|Disease Progression|35
6954103|NCT01033240|10996525|FG001|Overall Study|Disease Progression|32
6954104|NCT01033240|10996526|FG002|Overall Study|Disease Progression|41
6954105|NCT01033240|10996524|FG000|Overall Study|Investigator Discretion|0
6954106|NCT01033240|10996525|FG001|Overall Study|Investigator Discretion|0
6954107|NCT01033240|10996526|FG002|Overall Study|Investigator Discretion|2
6954108|NCT01033240|10996524|FG000|Overall Study|Other|0
6954109|NCT01033240|10996525|FG001|Overall Study|Other|1
6954110|NCT01033240|10996526|FG002|Overall Study|Other|2
6954111|NCT01033448|10996564|FG000|Overall Study|Withdrawal by Subject|4
6954112|NCT01033448|10996564|FG000|Overall Study|Positive HCV-RNA at week 48|1
6954113|NCT01033448|10996564|FG000|Overall Study|Lost to Follow-up|3
6954114|NCT01033448|10996564|FG000|Overall Study|Withdrew due to other reasons|3
6954115|NCT01033448|10996564|FG000|Overall Study|Unknown disposition|1
6954116|NCT01033487|10996570|FG000|Fourth Intervention Period|Adverse Event|0
6954117|NCT01033487|10996571|FG001|Fourth Intervention Period|Adverse Event|0
6954118|NCT01033487|10996572|FG002|Fourth Intervention Period|Adverse Event|0
6954119|NCT01033487|10996573|FG003|Fourth Intervention Period|Adverse Event|0
6954120|NCT01033487|10996574|FG004|Fourth Intervention Period|Adverse Event|0
6954121|NCT01033487|10996575|FG005|Fourth Intervention Period|Adverse Event|0
6954122|NCT01033487|10996576|FG006|Fourth Intervention Period|Adverse Event|0
6954123|NCT01033487|10996577|FG007|Fourth Intervention Period|Adverse Event|0
6954124|NCT01033487|10996578|FG008|Fourth Intervention Period|Adverse Event|1
6954125|NCT01033487|10996579|FG009|Fourth Intervention Period|Adverse Event|0
6954126|NCT01033643|10996602|FG000|Overall Study|Withdrew Consent|0
6954127|NCT01033643|10996603|FG001|Overall Study|Withdrew Consent|3
6954128|NCT01033643|10996604|FG002|Overall Study|Withdrew Consent|0
6954129|NCT01033643|10996605|FG003|Overall Study|Withdrew Consent|0
6954130|NCT01033643|10996606|FG004|Overall Study|Withdrew Consent|0
6954131|NCT01033643|10996607|FG005|Overall Study|Withdrew Consent|1
6954132|NCT01033734|10996621|FG000|Overall Study|Withdrawal by Subject|1
6954133|NCT01033747|10996636|FG000|Overall Study|Adverse Event|9
6954134|NCT01033747|10996637|FG001|Overall Study|Adverse Event|4
6954135|NCT01033747|10996636|FG000|Overall Study|Abnormal Laboratory Value|1
6954136|NCT01033747|10996637|FG001|Overall Study|Abnormal Laboratory Value|0
6954137|NCT01033747|10996636|FG000|Overall Study|Abnormal test procedure|0
6954138|NCT01033747|10996637|FG001|Overall Study|Abnormal test procedure|1
6954139|NCT01033747|10996636|FG000|Overall Study|Unsatisfactory therapeutic effect|14
6954140|NCT01033747|10996637|FG001|Overall Study|Unsatisfactory therapeutic effect|4
6838473|NCT00259610|10844213|FG000|Overall Study|non medical reason|6
6954141|NCT01033747|10996636|FG000|Overall Study|Protocol Violation|1
6954142|NCT01033747|10996637|FG001|Overall Study|Protocol Violation|0
6954143|NCT01033747|10996636|FG000|Overall Study|Withdrawal by Subject|9
6954144|NCT01033747|10996637|FG001|Overall Study|Withdrawal by Subject|6
6954145|NCT01033747|10996636|FG000|Overall Study|Stopped at end of prolongation visit 1|1
6954146|NCT01033747|10996637|FG001|Overall Study|Stopped at end of prolongation visit 1|0
6954147|NCT01033747|10996636|FG000|Overall Study|Stopped at end of Extension 1|2
6954148|NCT01033747|10996637|FG001|Overall Study|Stopped at end of Extension 1|0
6954149|NCT01033825|10996654|FG000|Overall Study|Withdrawal by Subject|2
6954150|NCT01033825|10996655|FG001|Overall Study|Withdrawal by Subject|3
6954151|NCT01033825|10996656|FG002|Overall Study|Withdrawal by Subject|2
6954152|NCT01033825|10996657|FG003|Overall Study|Withdrawal by Subject|1
6954153|NCT01033825|10996658|FG004|Overall Study|Withdrawal by Subject|1
6954154|NCT01033825|10996659|FG005|Overall Study|Withdrawal by Subject|0
6954155|NCT01033825|10996660|FG006|Overall Study|Withdrawal by Subject|0
6954156|NCT01033825|10996654|FG000|Overall Study|Adverse Event|0
6954157|NCT01033825|10996655|FG001|Overall Study|Adverse Event|0
6954158|NCT01033825|10996656|FG002|Overall Study|Adverse Event|0
6954159|NCT01033825|10996657|FG003|Overall Study|Adverse Event|1
6954160|NCT01033825|10996658|FG004|Overall Study|Adverse Event|0
6954161|NCT01033825|10996659|FG005|Overall Study|Adverse Event|0
6954162|NCT01033825|10996660|FG006|Overall Study|Adverse Event|0
6954163|NCT01033825|10996654|FG000|Overall Study|Protocol Violation|1
6954164|NCT01033825|10996655|FG001|Overall Study|Protocol Violation|0
6954165|NCT01033825|10996656|FG002|Overall Study|Protocol Violation|0
6954166|NCT01033825|10996657|FG003|Overall Study|Protocol Violation|0
6838474|NCT00259610|10844214|FG001|Overall Study|non medical reason|2
6954167|NCT01033825|10996658|FG004|Overall Study|Protocol Violation|0
6954168|NCT01033825|10996659|FG005|Overall Study|Protocol Violation|0
6954169|NCT01033825|10996660|FG006|Overall Study|Protocol Violation|0
6954170|NCT01033825|10996654|FG000|Overall Study|Other|0
6954171|NCT01033825|10996655|FG001|Overall Study|Other|0
6954172|NCT01033825|10996656|FG002|Overall Study|Other|0
6954173|NCT01033825|10996657|FG003|Overall Study|Other|0
6954174|NCT01033825|10996658|FG004|Overall Study|Other|1
6954175|NCT01033825|10996659|FG005|Overall Study|Other|0
6954176|NCT01033825|10996660|FG006|Overall Study|Other|0
6954177|NCT01033851|10996680|FG000|Overall Study|Withdrawal by Subject|3
6954178|NCT01033851|10996681|FG001|Overall Study|Withdrawal by Subject|7
6954179|NCT01033942|10996699|FG000|Overall Study|Withdrawal by Subject|1
6954180|NCT01033942|10996700|FG001|Overall Study|Withdrawal by Subject|1
6954181|NCT01033942|10996701|FG002|Overall Study|Withdrawal by Subject|1
6954182|NCT01033942|10996699|FG000|Overall Study|Lost to Follow-up|1
6954183|NCT01033942|10996700|FG001|Overall Study|Lost to Follow-up|0
6954184|NCT01033942|10996701|FG002|Overall Study|Lost to Follow-up|0
6954185|NCT01033942|10996699|FG000|Overall Study|Enrolled in Extension Study|0
6954186|NCT01033942|10996700|FG001|Overall Study|Enrolled in Extension Study|3
6954187|NCT01033942|10996701|FG002|Overall Study|Enrolled in Extension Study|0
6954188|NCT01034137|10996718|FG000|Overall Study|Adverse Event|9
6954189|NCT01034137|10996719|FG001|Overall Study|Adverse Event|10
6954190|NCT01034137|10996720|FG002|Overall Study|Adverse Event|8
6954191|NCT01034137|10996718|FG000|Overall Study|Withdrawal by Subject|4
6954192|NCT01034137|10996719|FG001|Overall Study|Withdrawal by Subject|3
6954193|NCT01034137|10996720|FG002|Overall Study|Withdrawal by Subject|3
6954194|NCT01034137|10996718|FG000|Overall Study|Lack of Efficacy|9
6954195|NCT01034137|10996719|FG001|Overall Study|Lack of Efficacy|4
6954196|NCT01034137|10996720|FG002|Overall Study|Lack of Efficacy|13
6954197|NCT01034137|10996718|FG000|Overall Study|Protocol Violation|2
6954198|NCT01034137|10996719|FG001|Overall Study|Protocol Violation|2
6954199|NCT01034137|10996720|FG002|Overall Study|Protocol Violation|1
6954200|NCT01034137|10996718|FG000|Overall Study|Refused treatment or did not cooperate|2
6954201|NCT01034137|10996719|FG001|Overall Study|Refused treatment or did not cooperate|0
6954202|NCT01034137|10996720|FG002|Overall Study|Refused treatment or did not cooperate|1
6954203|NCT01034137|10996718|FG000|Overall Study|Administrative or other|2
6954204|NCT01034137|10996719|FG001|Overall Study|Administrative or other|3
6954205|NCT01034137|10996720|FG002|Overall Study|Administrative or other|4
6954206|NCT01034163|10996731|FG000|Overall Study|Treatment completed as per protocol|8
6954207|NCT01034163|10996732|FG001|Overall Study|Treatment completed as per protocol|7
6954208|NCT01034163|10996731|FG000|Overall Study|Withdrawal by Subject|8
6954209|NCT01034163|10996732|FG001|Overall Study|Withdrawal by Subject|2
6954210|NCT01034163|10996731|FG000|Overall Study|Protocol deviation|1
6954211|NCT01034163|10996732|FG001|Overall Study|Protocol deviation|0
6954212|NCT01034163|10996731|FG000|Overall Study|Disease progression|3
6954213|NCT01034163|10996732|FG001|Overall Study|Disease progression|4
6954214|NCT01034163|10996731|FG000|Overall Study|Adverse Event|6
6954215|NCT01034163|10996732|FG001|Overall Study|Adverse Event|0
6954216|NCT01034163|10996731|FG000|Overall Study|Administrative problems|0
6954217|NCT01034163|10996732|FG001|Overall Study|Administrative problems|1
6954218|NCT01034163|10996731|FG000|Overall Study|Abnormal laboratory value|1
6954219|NCT01034163|10996732|FG001|Overall Study|Abnormal laboratory value|0
6954220|NCT01034176|10996740|FG000|Overall Study|Physician Decision|2
6954221|NCT01034176|10996741|FG001|Overall Study|Physician Decision|0
6954222|NCT01034176|10996740|FG000|Overall Study|Withdrawal by Subject|0
6954223|NCT01034176|10996741|FG001|Overall Study|Withdrawal by Subject|1
6954224|NCT01034176|10996740|FG000|Overall Study|Lost to Follow-up|0
6954225|NCT01034176|10996741|FG001|Overall Study|Lost to Follow-up|1
6954226|NCT01034358|10996747|FG000|Overall Study|Withdrawal by Subject|1
6954227|NCT01034358|10996747|FG000|Overall Study|Protocol Violation|1
6954228|NCT01034397|10996753|FG000|Overall Study|Lack of compliance|0
6954229|NCT01034397|10996754|FG001|Overall Study|Lack of compliance|1
6954230|NCT01034397|10996753|FG000|Overall Study|Lack of Efficacy|3
6954231|NCT01034397|10996754|FG001|Overall Study|Lack of Efficacy|0
6954232|NCT01034397|10996753|FG000|Overall Study|Adverse Event|4
6954233|NCT01034397|10996754|FG001|Overall Study|Adverse Event|0
6954234|NCT01034397|10996753|FG000|Overall Study|Other|0
6954235|NCT01034397|10996754|FG001|Overall Study|Other|1
6954236|NCT01034462|10996771|FG000|Overall Study|Adverse Event|7
6954237|NCT01034462|10996772|FG001|Overall Study|Adverse Event|17
6954238|NCT01034462|10996771|FG000|Overall Study|Lack of Efficacy|4
6954239|NCT01034462|10996772|FG001|Overall Study|Lack of Efficacy|4
6954240|NCT01034462|10996771|FG000|Overall Study|Protocol Violation|10
6954241|NCT01034462|10996772|FG001|Overall Study|Protocol Violation|7
6954242|NCT01034462|10996771|FG000|Overall Study|Withdrawal by Subject|9
6954243|NCT01034462|10996772|FG001|Overall Study|Withdrawal by Subject|8
6954244|NCT01034462|10996771|FG000|Overall Study|Lost to Follow-up|14
6954245|NCT01034462|10996772|FG001|Overall Study|Lost to Follow-up|16
6954246|NCT01034462|10996771|FG000|Overall Study|Other reasons|1
6954247|NCT01034462|10996772|FG001|Overall Study|Other reasons|2
6954248|NCT01034540|10996791|FG000|Overall Study|Adverse Event|0
6954249|NCT01034540|10996792|FG001|Overall Study|Adverse Event|1
6954250|NCT01034631|10996836|FG000|Phase I|Symptomatic Deterioration before Treatme|3
6954251|NCT01034631|10996837|FG001|Phase I|Symptomatic Deterioration before Treatme|0
6954252|NCT01034631|10996838|FG002|Phase I|Symptomatic Deterioration before Treatme|0
6954253|NCT01034631|10996836|FG000|Phase II|Not Evaluable per protocol|0
6954254|NCT01034631|10996837|FG001|Phase II|Not Evaluable per protocol|0
6954255|NCT01034631|10996838|FG002|Phase II|Not Evaluable per protocol|2
6954256|NCT01034631|10996836|FG000|Phase II|Determined Ineligible per protocol|0
6954257|NCT01034631|10996837|FG001|Phase II|Determined Ineligible per protocol|1
6954258|NCT01034631|10996838|FG002|Phase II|Determined Ineligible per protocol|0
6954259|NCT01034657|10996848|FG000|Core Phase|Withdrawal by Subject|1
6954260|NCT01034657|10996849|FG001|Core Phase|Withdrawal by Subject|0
6954261|NCT01034657|10996850|FG002|Core Phase|Withdrawal by Subject|0
6954262|NCT01034657|10996848|FG000|Core Phase|Lack of Efficacy|2
6954263|NCT01034657|10996849|FG001|Core Phase|Lack of Efficacy|0
6954264|NCT01034657|10996850|FG002|Core Phase|Lack of Efficacy|0
6954265|NCT01034657|10996848|FG000|Core Phase|Abnormal laboratory value|1
6954266|NCT01034657|10996849|FG001|Core Phase|Abnormal laboratory value|0
6954267|NCT01034657|10996850|FG002|Core Phase|Abnormal laboratory value|0
6954268|NCT01034657|10996848|FG000|Core Phase|Adverse Event|8
6954269|NCT01034657|10996849|FG001|Core Phase|Adverse Event|0
6954270|NCT01034657|10996850|FG002|Core Phase|Adverse Event|0
6954271|NCT01034657|10996848|FG000|Core Phase|Protocol Violation|2
6954272|NCT01034657|10996849|FG001|Core Phase|Protocol Violation|0
6954273|NCT01034657|10996850|FG002|Core Phase|Protocol Violation|0
6954274|NCT01034657|10996848|FG000|Randomized Phase|Withdrawal by Subject|0
6954275|NCT01034657|10996849|FG001|Randomized Phase|Withdrawal by Subject|2
6954276|NCT01034657|10996850|FG002|Randomized Phase|Withdrawal by Subject|0
6954277|NCT01034657|10996848|FG000|Randomized Phase|Lack of Efficacy|5
6954278|NCT01034657|10996849|FG001|Randomized Phase|Lack of Efficacy|1
6954279|NCT01034657|10996850|FG002|Randomized Phase|Lack of Efficacy|0
6954280|NCT01034657|10996848|FG000|Randomized Phase|Abnormal laboratory value|0
6954281|NCT01034657|10996849|FG001|Randomized Phase|Abnormal laboratory value|1
6954282|NCT01034657|10996850|FG002|Randomized Phase|Abnormal laboratory value|0
6954283|NCT01034657|10996848|FG000|Randomized Phase|Adverse Event|0
6954284|NCT01034657|10996849|FG001|Randomized Phase|Adverse Event|2
6954285|NCT01034657|10996850|FG002|Randomized Phase|Adverse Event|1
6954286|NCT01034709|10996862|FG000|Overall Study|Protocol Violation|9
6954287|NCT01034709|10996863|FG001|Overall Study|Protocol Violation|16
6954288|NCT01035060|10996880|FG000|Overall Study|Lost to Follow-up|0
6954289|NCT01035060|10996881|FG001|Overall Study|Lost to Follow-up|7
6954290|NCT01035060|10996880|FG000|Overall Study|Did not quality after 2nd screening|14
6954291|NCT01035060|10996881|FG001|Overall Study|Did not quality after 2nd screening|1
6954292|NCT01035060|10996880|FG000|Overall Study|Withdrawal by Subject|8
6954293|NCT01035060|10996881|FG001|Overall Study|Withdrawal by Subject|6
6954294|NCT01035060|10996880|FG000|Overall Study|Physician Decision|2
6954295|NCT01035060|10996881|FG001|Overall Study|Physician Decision|0
6954296|NCT01035138|10996900|FG000|Overall Study|Adverse Event|4
6954297|NCT01035138|10996901|FG001|Overall Study|Adverse Event|0
6954298|NCT01035138|10996902|FG002|Overall Study|Adverse Event|2
6954299|NCT01035138|10996900|FG000|Overall Study|Caregiver Decision|2
6954300|NCT01035138|10996901|FG001|Overall Study|Caregiver Decision|0
6954301|NCT01035138|10996902|FG002|Overall Study|Caregiver Decision|1
6954302|NCT01035138|10996900|FG000|Overall Study|Withdrawal by Subject|1
6954303|NCT01035138|10996901|FG001|Overall Study|Withdrawal by Subject|0
6954304|NCT01035138|10996902|FG002|Overall Study|Withdrawal by Subject|0
6954305|NCT01035138|10996900|FG000|Overall Study|Physician Decision|0
6954306|NCT01035138|10996901|FG001|Overall Study|Physician Decision|0
6954307|NCT01035138|10996902|FG002|Overall Study|Physician Decision|1
6954308|NCT01035138|10996900|FG000|Overall Study|Sponsor Decision|66
6954309|NCT01035138|10996901|FG001|Overall Study|Sponsor Decision|60
6954310|NCT01035138|10996902|FG002|Overall Study|Sponsor Decision|42
6954311|NCT01035138|10996900|FG000|Overall Study|Lost to Follow-up|0
6954312|NCT01035138|10996901|FG001|Overall Study|Lost to Follow-up|0
6954313|NCT01035138|10996902|FG002|Overall Study|Lost to Follow-up|1
6954314|NCT01035229|10996923|FG000|Overall Study|Adverse Event|61
6954315|NCT01035229|10996924|FG001|Overall Study|Adverse Event|14
6954316|NCT01035229|10996923|FG000|Overall Study|Withdrawal by Subject|20
6954317|NCT01035229|10996924|FG001|Overall Study|Withdrawal by Subject|7
6954318|NCT01035229|10996923|FG000|Overall Study|Lost to Follow-up|1
6954319|NCT01035229|10996924|FG001|Overall Study|Lost to Follow-up|0
6954320|NCT01035229|10996923|FG000|Overall Study|Administrative problems|1
6954321|NCT01035229|10996924|FG001|Overall Study|Administrative problems|1
6954322|NCT01035229|10996923|FG000|Overall Study|Death|13
6954323|NCT01035229|10996924|FG001|Overall Study|Death|5
6954324|NCT01035229|10996923|FG000|Overall Study|New cancer therapy|2
6954325|NCT01035229|10996924|FG001|Overall Study|New cancer therapy|0
6954326|NCT01035229|10996923|FG000|Overall Study|Protocol Violation|0
6954327|NCT01035229|10996924|FG001|Overall Study|Protocol Violation|2
6954328|NCT01035229|10996923|FG000|Overall Study|Sponsor's decision to end study|3
6954329|NCT01035229|10996924|FG001|Overall Study|Sponsor's decision to end study|3
6954330|NCT01035229|10996923|FG000|Overall Study|Disease Progression|261
7040821|NCT01720667|11124021|FG000|Overall Study|Adverse Event|1
6954331|NCT01035229|10996924|FG001|Overall Study|Disease Progression|152
6954332|NCT01035255|10996934|FG000|Overall Study|Death|724
7040822|NCT01720667|11124022|FG001|Overall Study|Adverse Event|1
6954333|NCT01035255|10996935|FG001|Overall Study|Death|844
6954334|NCT01035255|10996934|FG000|Overall Study|Lost to Follow-up|2
6954335|NCT01035255|10996935|FG001|Overall Study|Lost to Follow-up|5
6954336|NCT01035255|10996934|FG000|Overall Study|patient's request|15
6954337|NCT01035255|10996935|FG001|Overall Study|patient's request|13
6954338|NCT01035463|10996956|FG000|Overall Study|Adverse Event|0
6954339|NCT01035463|10996957|FG001|Overall Study|Adverse Event|0
6954340|NCT01035463|10996958|FG002|Overall Study|Adverse Event|4
6954341|NCT01035463|10996959|FG003|Overall Study|Adverse Event|1
6954342|NCT01035463|10996960|FG004|Overall Study|Adverse Event|5
6954343|NCT01035463|10996961|FG005|Overall Study|Adverse Event|7
6954344|NCT01035463|10996956|FG000|Overall Study|Withdrawal by Subject|0
6954345|NCT01035463|10996957|FG001|Overall Study|Withdrawal by Subject|2
6954346|NCT01035463|10996958|FG002|Overall Study|Withdrawal by Subject|1
6954347|NCT01035463|10996959|FG003|Overall Study|Withdrawal by Subject|0
6954348|NCT01035463|10996960|FG004|Overall Study|Withdrawal by Subject|1
6954349|NCT01035463|10996961|FG005|Overall Study|Withdrawal by Subject|4
6954350|NCT01035463|10996956|FG000|Overall Study|Disease progression|0
6954351|NCT01035463|10996957|FG001|Overall Study|Disease progression|0
6954352|NCT01035463|10996958|FG002|Overall Study|Disease progression|0
6954353|NCT01035463|10996959|FG003|Overall Study|Disease progression|0
6954354|NCT01035463|10996960|FG004|Overall Study|Disease progression|0
6954355|NCT01035463|10996961|FG005|Overall Study|Disease progression|3
6954356|NCT01035463|10996956|FG000|Overall Study|Other Malignancy|0
6954357|NCT01035463|10996957|FG001|Overall Study|Other Malignancy|0
6954358|NCT01035463|10996958|FG002|Overall Study|Other Malignancy|0
6954359|NCT01035463|10996959|FG003|Overall Study|Other Malignancy|0
6954360|NCT01035463|10996960|FG004|Overall Study|Other Malignancy|0
6954361|NCT01035463|10996961|FG005|Overall Study|Other Malignancy|2
6954362|NCT01035463|10996956|FG000|Overall Study|Other|0
6954363|NCT01035463|10996957|FG001|Overall Study|Other|0
6954364|NCT01035463|10996958|FG002|Overall Study|Other|0
6954365|NCT01035463|10996959|FG003|Overall Study|Other|1
6954366|NCT01035463|10996960|FG004|Overall Study|Other|0
6954367|NCT01035463|10996961|FG005|Overall Study|Other|2
6954368|NCT01035606|10996971|FG000|Overall Study|change in health, job demands,family|3
6954369|NCT01035606|10996972|FG001|Overall Study|change in health, job demands,family|3
6954370|NCT01035606|10996973|FG002|Overall Study|change in health, job demands,family|4
6954371|NCT01035905|10997029|FG000|Overall Study|Lack of Efficacy|1
7070662|NCT02014480|11173258|FG004|Treatment Period 3 (14 Days)|Adverse Event|0
7070663|NCT02014480|11173259|FG005|Treatment Period 3 (14 Days)|Adverse Event|1
7070664|NCT02014480|11173254|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0
7070665|NCT02014480|11173255|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0
7070666|NCT02014480|11173256|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0
6954372|NCT01035905|10997030|FG001|Overall Study|Lack of Efficacy|1
6954373|NCT01036022|10997052|FG000|Overall Study|Adverse Event|1
6954374|NCT01036022|10997053|FG001|Overall Study|Adverse Event|3
6954375|NCT01036022|10997054|FG002|Overall Study|Adverse Event|2
6954376|NCT01036022|10997055|FG003|Overall Study|Adverse Event|1
6954377|NCT01036022|10997056|FG004|Overall Study|Adverse Event|0
6954378|NCT01036022|10997057|FG005|Overall Study|Adverse Event|2
6954379|NCT01036022|10997052|FG000|Overall Study|Lack of Efficacy|1
6954380|NCT01036022|10997053|FG001|Overall Study|Lack of Efficacy|1
6954381|NCT01036022|10997054|FG002|Overall Study|Lack of Efficacy|1
6954382|NCT01036022|10997055|FG003|Overall Study|Lack of Efficacy|0
6954383|NCT01036022|10997056|FG004|Overall Study|Lack of Efficacy|1
6954384|NCT01036022|10997057|FG005|Overall Study|Lack of Efficacy|1
6954385|NCT01036022|10997052|FG000|Overall Study|Physician Decision|0
6954386|NCT01036022|10997053|FG001|Overall Study|Physician Decision|0
6954387|NCT01036022|10997054|FG002|Overall Study|Physician Decision|1
6954388|NCT01036022|10997055|FG003|Overall Study|Physician Decision|0
6954389|NCT01036022|10997056|FG004|Overall Study|Physician Decision|0
6954390|NCT01036022|10997057|FG005|Overall Study|Physician Decision|0
6954391|NCT01036022|10997052|FG000|Overall Study|Withdrawal by Subject|0
6954392|NCT01036022|10997053|FG001|Overall Study|Withdrawal by Subject|0
6954393|NCT01036022|10997054|FG002|Overall Study|Withdrawal by Subject|0
6954394|NCT01036022|10997055|FG003|Overall Study|Withdrawal by Subject|1
6954395|NCT01036022|10997056|FG004|Overall Study|Withdrawal by Subject|2
6954396|NCT01036022|10997057|FG005|Overall Study|Withdrawal by Subject|0
6954397|NCT01036165|10997079|FG000|Overall Study|Adverse Event|6
6954398|NCT01036165|10997079|FG000|Overall Study|Lost to Follow-up|2
6954399|NCT01036165|10997079|FG000|Overall Study|Withdrawal by Subject|3
6954400|NCT01036165|10997079|FG000|Overall Study|Device Related Issues|3
6954401|NCT01036165|10997079|FG000|Overall Study|Problems finding proper area to inject|1
6954402|NCT01036321|10997085|FG000|Overall Study|Ineligible after randomization|0
6954403|NCT01036321|10997086|FG001|Overall Study|Ineligible after randomization|1
6954404|NCT01036321|10997085|FG000|Overall Study|Withdrawal by Subject|3
6954405|NCT01036321|10997086|FG001|Overall Study|Withdrawal by Subject|2
6954406|NCT01036321|10997085|FG000|Overall Study|Adverse Event|2
6954407|NCT01036321|10997086|FG001|Overall Study|Adverse Event|1
6954408|NCT01036438|10997094|FG000|Overall Study|Adverse Event|7
7147792|NCT03136068|11308651|FG000|Overall Study|Lost to Follow-up|1
6954409|NCT01036438|10997095|FG001|Overall Study|Adverse Event|8
6954410|NCT01036438|10997094|FG000|Overall Study|Death|0
6954411|NCT01036438|10997095|FG001|Overall Study|Death|1
6954412|NCT01036438|10997094|FG000|Overall Study|No effect of study treatment|3
6954413|NCT01036438|10997095|FG001|Overall Study|No effect of study treatment|1
6954414|NCT01036529|10997112|FG000|Overall Study|Adverse Event|0
6954415|NCT01036529|10997113|FG001|Overall Study|Adverse Event|1
7070667|NCT02014480|11173257|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0
6954416|NCT01036529|10997112|FG000|Overall Study|Lost to Follow-up|0
6954417|NCT01036529|10997113|FG001|Overall Study|Lost to Follow-up|1
6954418|NCT01036529|10997112|FG000|Overall Study|Physician Decision|1
6954419|NCT01036529|10997113|FG001|Overall Study|Physician Decision|0
6954420|NCT01036529|10997112|FG000|Overall Study|Withdrawal by Subject|1
6954421|NCT01036529|10997113|FG001|Overall Study|Withdrawal by Subject|1
6954422|NCT01036529|10997112|FG000|Overall Study|Sponsor study termination|11
6954423|NCT01036529|10997113|FG001|Overall Study|Sponsor study termination|12
6954424|NCT01036594|10997119|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1
6954425|NCT01036594|10997120|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0
6954426|NCT01036594|10997119|FG000|First Treatment Regimen|Withdrawal by Subject|1
6954427|NCT01036594|10997120|FG001|First Treatment Regimen|Withdrawal by Subject|0
6954428|NCT01036594|10997119|FG000|Week 12 Evaluation|Adverse Event|5
6954429|NCT01036594|10997120|FG001|Week 12 Evaluation|Adverse Event|0
6954430|NCT01036594|10997119|FG000|Week 12 Evaluation|Physician Decision|1
6954431|NCT01036594|10997120|FG001|Week 12 Evaluation|Physician Decision|0
6954432|NCT01036594|10997119|FG000|Treatment Regiments Post Week 12|Physician Decision|1
6954433|NCT01036594|10997120|FG001|Treatment Regiments Post Week 12|Physician Decision|1
6954434|NCT01036594|10997119|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1
6954435|NCT01036594|10997120|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0
6954436|NCT01036594|10997119|FG000|Treatment Regiments Post Week 12|Adverse Event|0
6954437|NCT01036594|10997120|FG001|Treatment Regiments Post Week 12|Adverse Event|1
6954438|NCT01036594|10997119|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0
6954439|NCT01036594|10997120|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1
6954440|NCT01036594|10997119|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0
6954441|NCT01036594|10997120|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1
6954442|NCT01036724|10997128|FG000|Overall Study|Adverse Event|1
6954443|NCT01036724|10997129|FG001|Overall Study|Adverse Event|2
6954444|NCT01036724|10997128|FG000|Overall Study|Lack of Efficacy|1
6954445|NCT01036724|10997129|FG001|Overall Study|Lack of Efficacy|1
6954446|NCT01036724|10997128|FG000|Overall Study|Protocol Violation|4
6954447|NCT01036724|10997129|FG001|Overall Study|Protocol Violation|5
6954448|NCT01036763|10997135|FG000|Overall Study|Adverse Event|25
6954449|NCT01036763|10997135|FG000|Overall Study|Lost to Follow-up|28
6954450|NCT01036763|10997135|FG000|Overall Study|Other reason (not specified)|40
6976257|NCT01198002|11028748|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18
6976258|NCT01198002|11028749|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
6976259|NCT01198002|11028750|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
6976260|NCT01198002|11028748|FG000|Treatment Period 1 (Weeks 0-52)|Death|2
6976261|NCT01198002|11028749|FG001|Treatment Period 1 (Weeks 0-52)|Death|0
6976262|NCT01198002|11028750|FG002|Treatment Period 1 (Weeks 0-52)|Death|1
6976263|NCT01198002|11028748|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10
7070668|NCT02014480|11173258|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0
7070669|NCT02014480|11173259|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1
7070670|NCT02014584|11173281|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0
7070671|NCT02014584|11173282|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1
7070672|NCT02014584|11173283|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0
7070673|NCT02014584|11173284|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0
7070674|NCT02014584|11173285|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0
7070675|NCT02014584|11173286|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0
7070676|NCT02014584|11173281|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2
7070677|NCT02014584|11173282|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5
7070678|NCT02014584|11173283|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
7070679|NCT02014584|11173284|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
7070680|NCT02014584|11173285|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
7070681|NCT02014584|11173286|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
7070682|NCT02014584|11173281|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0
7070683|NCT02014584|11173282|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0
7070684|NCT02014584|11173283|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2
7070685|NCT02014584|11173284|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0
7070686|NCT02014584|11173285|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0
7070687|NCT02014584|11173286|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0
7070688|NCT02014584|11173281|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
7070689|NCT02014584|11173282|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
7070690|NCT02014584|11173283|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3
7070691|NCT02014584|11173284|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1
7070692|NCT02014584|11173285|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
7070693|NCT02014584|11173286|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
7070694|NCT02014584|11173281|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
7070695|NCT02014584|11173282|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
7070696|NCT02014584|11173283|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
7070697|NCT02014584|11173284|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
7070698|NCT02014584|11173285|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1
7070699|NCT02014584|11173286|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
6976264|NCT01198002|11028749|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9
6954451|NCT01037088|10997149|FG000|Overall Study|Withdrawal by Subject|3
6954452|NCT01037114|10997158|FG000|Year 20|Others|1
6954453|NCT01037127|10997164|FG000|Overall Study|Lost to Follow-up|2
6954454|NCT01037127|10997165|FG001|Overall Study|Lost to Follow-up|4
6954455|NCT01037127|10997164|FG000|Overall Study|Physician Decision|1
6954456|NCT01037127|10997165|FG001|Overall Study|Physician Decision|0
6954457|NCT01037127|10997164|FG000|Overall Study|Study Closed Terminated|2
6954458|NCT01037127|10997165|FG001|Overall Study|Study Closed Terminated|17
6954459|NCT01037218|10997196|FG000|Overall Study|Adverse Event|4
6954460|NCT01037218|10997197|FG001|Overall Study|Adverse Event|2
6954461|NCT01037218|10997198|FG002|Overall Study|Adverse Event|2
6954462|NCT01037218|10997199|FG003|Overall Study|Adverse Event|1
6954463|NCT01037218|10997196|FG000|Overall Study|Lack of Efficacy|0
6954464|NCT01037218|10997197|FG001|Overall Study|Lack of Efficacy|2
6954465|NCT01037218|10997198|FG002|Overall Study|Lack of Efficacy|1
6954466|NCT01037218|10997199|FG003|Overall Study|Lack of Efficacy|5
6954467|NCT01037218|10997196|FG000|Overall Study|Lost to Follow-up|3
6954468|NCT01037218|10997197|FG001|Overall Study|Lost to Follow-up|5
6954469|NCT01037218|10997198|FG002|Overall Study|Lost to Follow-up|4
6954470|NCT01037218|10997199|FG003|Overall Study|Lost to Follow-up|2
6954471|NCT01037218|10997196|FG000|Overall Study|Withdrawal by Subject|6
6954472|NCT01037218|10997197|FG001|Overall Study|Withdrawal by Subject|7
6954473|NCT01037218|10997198|FG002|Overall Study|Withdrawal by Subject|7
6954474|NCT01037218|10997199|FG003|Overall Study|Withdrawal by Subject|4
6954475|NCT01037218|10997196|FG000|Overall Study|Partner Withdrew Consent|0
6954476|NCT01037218|10997197|FG001|Overall Study|Partner Withdrew Consent|3
6954477|NCT01037218|10997198|FG002|Overall Study|Partner Withdrew Consent|2
6954478|NCT01037218|10997199|FG003|Overall Study|Partner Withdrew Consent|1
6954479|NCT01037218|10997196|FG000|Overall Study|Protocol Violation|0
6954480|NCT01037218|10997197|FG001|Overall Study|Protocol Violation|0
6954481|NCT01037218|10997198|FG002|Overall Study|Protocol Violation|2
6954482|NCT01037218|10997199|FG003|Overall Study|Protocol Violation|2
6954483|NCT01037218|10997196|FG000|Overall Study|Various|3
6954484|NCT01037218|10997197|FG001|Overall Study|Various|2
6954485|NCT01037218|10997198|FG002|Overall Study|Various|3
6954486|NCT01037218|10997199|FG003|Overall Study|Various|1
6954487|NCT01037244|10997213|FG000|Overall Study|Adverse Event|3
6954488|NCT01037244|10997214|FG001|Overall Study|Adverse Event|2
6954489|NCT01037244|10997215|FG002|Overall Study|Adverse Event|6
6954490|NCT01037244|10997216|FG003|Overall Study|Adverse Event|3
6954491|NCT01037244|10997213|FG000|Overall Study|Lack of Efficacy|1
6954492|NCT01037244|10997214|FG001|Overall Study|Lack of Efficacy|1
6954493|NCT01037244|10997215|FG002|Overall Study|Lack of Efficacy|0
6954494|NCT01037244|10997216|FG003|Overall Study|Lack of Efficacy|1
6954495|NCT01037244|10997213|FG000|Overall Study|Lost to Follow-up|3
6954496|NCT01037244|10997214|FG001|Overall Study|Lost to Follow-up|3
6954497|NCT01037244|10997215|FG002|Overall Study|Lost to Follow-up|4
6954498|NCT01037244|10997216|FG003|Overall Study|Lost to Follow-up|4
6954499|NCT01037244|10997213|FG000|Overall Study|Withdrawal by Subject|1
6954500|NCT01037244|10997214|FG001|Overall Study|Withdrawal by Subject|5
6954501|NCT01037244|10997215|FG002|Overall Study|Withdrawal by Subject|3
6954502|NCT01037244|10997216|FG003|Overall Study|Withdrawal by Subject|5
6954503|NCT01037244|10997213|FG000|Overall Study|Partner Withdrew Consent|2
6954504|NCT01037244|10997214|FG001|Overall Study|Partner Withdrew Consent|1
6954505|NCT01037244|10997215|FG002|Overall Study|Partner Withdrew Consent|0
6954506|NCT01037244|10997216|FG003|Overall Study|Partner Withdrew Consent|0
6954507|NCT01037244|10997213|FG000|Overall Study|Various|3
6954508|NCT01037244|10997214|FG001|Overall Study|Various|2
6954509|NCT01037244|10997215|FG002|Overall Study|Various|1
6954510|NCT01037244|10997216|FG003|Overall Study|Various|1
6954511|NCT01037413|10997263|FG000|Part A: Skin Testing|Adverse Event|1
6954512|NCT01037413|10997264|FG001|Part A: Skin Testing|Adverse Event|0
6954513|NCT01037413|10997263|FG000|Part A: Skin Testing|Protocol Violation|1
6954514|NCT01037413|10997264|FG001|Part A: Skin Testing|Protocol Violation|0
6954515|NCT01037413|10997263|FG000|Part B: Scar Revision|Withdrawal by Subject|0
6954516|NCT01037413|10997264|FG001|Part B: Scar Revision|Withdrawal by Subject|1
6954517|NCT01037413|10997263|FG000|Part B: Scar Revision|Assigned But Not Treated|0
6954518|NCT01037413|10997264|FG001|Part B: Scar Revision|Assigned But Not Treated|1
6954519|NCT01037985|10997353|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3
6954520|NCT01037985|10997354|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0
6954521|NCT01037985|10997353|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1
6954522|NCT01037985|10997354|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0
7070700|NCT02014597|11173300|FG000|Overall Study|Unable to record log contrast sensitivity|2
7070701|NCT02014597|11173301|FG001|Overall Study|Unable to record log contrast sensitivity|1
7070702|NCT02014740|11173309|FG000|Overall Study|Lost to Follow-up|4
6954523|NCT01037985|10997353|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0
6954524|NCT01037985|10997354|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1
6954525|NCT01037985|10997353|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0
6954526|NCT01037985|10997354|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4
6954527|NCT01038128|10997364|FG000|Overall Study|Lack of Efficacy|1
6954528|NCT01038128|10997364|FG000|Overall Study|Lost to Follow-up|1
6954529|NCT01038128|10997364|FG000|Overall Study|Withdrawal by Subject|2
6954530|NCT01038297|10997373|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1
6954531|NCT01038297|10997374|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0
6954532|NCT01038297|10997375|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0
6954533|NCT01038323|10997395|FG000|Overall Study|Withdrawal by Subject|3
6954534|NCT01038323|10997396|FG001|Overall Study|Withdrawal by Subject|2
6954535|NCT01038323|10997397|FG002|Overall Study|Withdrawal by Subject|4
6954536|NCT01038427|10997426|FG000|Overall Study|Lost to follow up|1
6954537|NCT01038427|10997427|FG001|Overall Study|Lost to follow up|1
6954538|NCT01038427|10997428|FG002|Overall Study|Lost to follow up|0
6954539|NCT01038427|10997426|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0
6954540|NCT01038427|10997427|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0
6954541|NCT01038427|10997428|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1
6954542|NCT01038427|10997426|FG000|Overall Study|Withdrew consent|0
6954543|NCT01038427|10997427|FG001|Overall Study|Withdrew consent|0
6954544|NCT01038427|10997428|FG002|Overall Study|Withdrew consent|1
6954545|NCT01038427|10997426|FG000|Overall Study|Adverse Event|2
6954546|NCT01038427|10997427|FG001|Overall Study|Adverse Event|2
6954547|NCT01038427|10997428|FG002|Overall Study|Adverse Event|1
6954548|NCT01038427|10997426|FG000|Overall Study|Enrolled in error|0
6954549|NCT01038427|10997427|FG001|Overall Study|Enrolled in error|1
6954550|NCT01038427|10997428|FG002|Overall Study|Enrolled in error|1
6954551|NCT01038427|10997426|FG000|Overall Study|Other|0
6954552|NCT01038427|10997427|FG001|Overall Study|Other|2
6954553|NCT01038427|10997428|FG002|Overall Study|Other|0
6954554|NCT01038609|10997454|FG000|Overall Study|Adverse Event|0
6954555|NCT01038609|10997455|FG001|Overall Study|Adverse Event|0
6954556|NCT01038609|10997456|FG002|Overall Study|Adverse Event|1
6954557|NCT01038609|10997457|FG003|Overall Study|Adverse Event|0
6954558|NCT01038609|10997458|FG004|Overall Study|Adverse Event|0
6954559|NCT01038609|10997454|FG000|Overall Study|Dosing Error|0
6954560|NCT01038609|10997455|FG001|Overall Study|Dosing Error|0
6954561|NCT01038609|10997456|FG002|Overall Study|Dosing Error|0
6954562|NCT01038609|10997457|FG003|Overall Study|Dosing Error|1
6954563|NCT01038609|10997458|FG004|Overall Study|Dosing Error|1
6954564|NCT01038609|10997454|FG000|Overall Study|Death in the Family|1
6954565|NCT01038609|10997455|FG001|Overall Study|Death in the Family|0
6954566|NCT01038609|10997456|FG002|Overall Study|Death in the Family|0
6954567|NCT01038609|10997457|FG003|Overall Study|Death in the Family|0
6954568|NCT01038609|10997458|FG004|Overall Study|Death in the Family|0
6954569|NCT01038609|10997454|FG000|Overall Study|Refusal of Blood Draws|0
6954570|NCT01038609|10997455|FG001|Overall Study|Refusal of Blood Draws|1
6954571|NCT01038609|10997456|FG002|Overall Study|Refusal of Blood Draws|0
6954572|NCT01038609|10997457|FG003|Overall Study|Refusal of Blood Draws|0
6954573|NCT01038609|10997458|FG004|Overall Study|Refusal of Blood Draws|0
6954574|NCT01038635|10997479|FG000|Overall Study|Disease Progression|2
6954575|NCT01038635|10997480|FG001|Overall Study|Disease Progression|0
6954576|NCT01038635|10997481|FG002|Overall Study|Disease Progression|0
6954577|NCT01038635|10997482|FG003|Overall Study|Disease Progression|0
6954578|NCT01038635|10997483|FG004|Overall Study|Disease Progression|0
6954579|NCT01038635|10997484|FG005|Overall Study|Disease Progression|0
6954580|NCT01038635|10997485|FG006|Overall Study|Disease Progression|1
6954581|NCT01038635|10997486|FG007|Overall Study|Disease Progression|4
6954582|NCT01038635|10997487|FG008|Overall Study|Disease Progression|0
6954583|NCT01038635|10997479|FG000|Overall Study|Death|0
6954584|NCT01038635|10997480|FG001|Overall Study|Death|0
6954585|NCT01038635|10997481|FG002|Overall Study|Death|0
6954586|NCT01038635|10997482|FG003|Overall Study|Death|0
6954587|NCT01038635|10997483|FG004|Overall Study|Death|1
6954588|NCT01038635|10997484|FG005|Overall Study|Death|0
6954589|NCT01038635|10997485|FG006|Overall Study|Death|1
6954590|NCT01038635|10997486|FG007|Overall Study|Death|1
6954591|NCT01038635|10997487|FG008|Overall Study|Death|2
7040823|NCT01720667|11124021|FG000|Overall Study|Withdrawal by Subject|3
7040824|NCT01720667|11124022|FG001|Overall Study|Withdrawal by Subject|0
7040825|NCT01720797|11124032|FG000|Overall Study|Withdrawal by Subject|3
7040826|NCT01720797|11124033|FG001|Overall Study|Withdrawal by Subject|0
7040827|NCT01721044|11124042|FG000|Treatment Period|Adverse Event|7
7040828|NCT01721044|11124043|FG001|Treatment Period|Adverse Event|7
7040829|NCT01721044|11124044|FG002|Treatment Period|Adverse Event|10
7040830|NCT01721044|11124042|FG000|Treatment Period|Death|0
7040831|NCT01721044|11124043|FG001|Treatment Period|Death|0
7040832|NCT01721044|11124044|FG002|Treatment Period|Death|1
7040833|NCT01721044|11124042|FG000|Treatment Period|Lack of Efficacy|16
7040834|NCT01721044|11124043|FG001|Treatment Period|Lack of Efficacy|4
6954592|NCT01038687|10997511|FG000|Overall Study|Adverse Event|0
6954593|NCT01038687|10997512|FG001|Overall Study|Adverse Event|2
6954594|NCT01038687|10997513|FG002|Overall Study|Adverse Event|1
6954595|NCT01038713|10997524|FG000|Overall Study|Patient to hospice|1
6954596|NCT01038713|10997525|FG001|Overall Study|Patient to hospice|1
6954597|NCT01038713|10997526|FG002|Overall Study|Patient to hospice|1
6954598|NCT01038713|10997524|FG000|Overall Study|Lost to Follow-up|3
6954599|NCT01038713|10997525|FG001|Overall Study|Lost to Follow-up|0
6954600|NCT01038713|10997526|FG002|Overall Study|Lost to Follow-up|0
6954601|NCT01038713|10997524|FG000|Overall Study|Neuroendocrine Tumor|0
6954602|NCT01038713|10997525|FG001|Overall Study|Neuroendocrine Tumor|1
6954603|NCT01038713|10997526|FG002|Overall Study|Neuroendocrine Tumor|0
6954604|NCT01038713|10997524|FG000|Overall Study|died from PEP|0
6954605|NCT01038713|10997525|FG001|Overall Study|died from PEP|1
6954606|NCT01038713|10997526|FG002|Overall Study|died from PEP|0
6954607|NCT01038713|10997524|FG000|Overall Study|Autoimmune Pancreatitis|1
6954608|NCT01038713|10997525|FG001|Overall Study|Autoimmune Pancreatitis|0
6954609|NCT01038713|10997526|FG002|Overall Study|Autoimmune Pancreatitis|0
6954610|NCT01038856|10997534|FG000|Overall Study|Adverse Event|2
6954611|NCT01038869|10997540|FG000|Overall Study|Withdrawal by Subject|1
6954612|NCT01038869|10997540|FG000|Overall Study|Lost to Follow-up|6
6954613|NCT01038921|10997550|FG000|Overall Study|Withdrawal by Subject|1
6954614|NCT01038921|10997551|FG001|Overall Study|Withdrawal by Subject|0
6954615|NCT01038921|10997550|FG000|Overall Study|Physician Decision|1
6954616|NCT01038921|10997551|FG001|Overall Study|Physician Decision|0
6954617|NCT01039376|10997563|FG000|Overall Study|Lost to Follow-up|5
6954618|NCT01039376|10997564|FG001|Overall Study|Lost to Follow-up|12
6954619|NCT01039376|10997563|FG000|Overall Study|Physician Decision|15
6954620|NCT01039376|10997564|FG001|Overall Study|Physician Decision|10
6954621|NCT01039376|10997563|FG000|Overall Study|Withdrawal by Subject|20
6954622|NCT01039376|10997564|FG001|Overall Study|Withdrawal by Subject|32
6954623|NCT01039376|10997563|FG000|Overall Study|Study terminated by Sponsor|90
6954624|NCT01039376|10997564|FG001|Overall Study|Study terminated by Sponsor|72
6954625|NCT01039428|10997573|FG000|Overall Study|Protocol Violation|1
6954626|NCT01039428|10997574|FG001|Overall Study|Protocol Violation|0
6954627|NCT01039428|10997573|FG000|Overall Study|Withdrawal by Subject|1
6954628|NCT01039428|10997574|FG001|Overall Study|Withdrawal by Subject|0
6954629|NCT01039519|10997591|FG000|Treatment|Progressive disease|20
6954630|NCT01039519|10997591|FG000|Treatment|Treatment failure|2
6954631|NCT01039519|10997591|FG000|Treatment|Adverse Event|3
6954632|NCT01039519|10997591|FG000|Treatment|Physician Decision|2
6954633|NCT01039519|10997591|FG000|Survival Follow-up|Death|23
6954634|NCT01039519|10997591|FG000|Survival Follow-up|Sponsor decision|4
6954635|NCT01039584|10997598|FG000|Overall Study|Withdrawal by Subject|4
6954636|NCT01039584|10997599|FG001|Overall Study|Withdrawal by Subject|2
6954637|NCT01039584|10997600|FG002|Overall Study|Withdrawal by Subject|1
6954638|NCT01039584|10997598|FG000|Overall Study|Protocol Violation|10
6954639|NCT01039584|10997599|FG001|Overall Study|Protocol Violation|4
6954640|NCT01039584|10997600|FG002|Overall Study|Protocol Violation|6
6954641|NCT01039584|10997598|FG000|Overall Study|Lost to Follow-up|5
6954642|NCT01039584|10997599|FG001|Overall Study|Lost to Follow-up|3
6954643|NCT01039584|10997600|FG002|Overall Study|Lost to Follow-up|4
6954644|NCT01039584|10997598|FG000|Overall Study|Negative Baseline culture for Candida|59
6954645|NCT01039584|10997599|FG001|Overall Study|Negative Baseline culture for Candida|59
6954646|NCT01039584|10997600|FG002|Overall Study|Negative Baseline culture for Candida|24
6954647|NCT01039584|10997598|FG000|Overall Study|Lack of Efficacy|7
6954648|NCT01039584|10997599|FG001|Overall Study|Lack of Efficacy|6
6954649|NCT01039584|10997600|FG002|Overall Study|Lack of Efficacy|10
6954650|NCT01039584|10997598|FG000|Overall Study|other|1
6954651|NCT01039584|10997599|FG001|Overall Study|other|3
6954652|NCT01039584|10997600|FG002|Overall Study|other|1
6954653|NCT01039584|10997598|FG000|Overall Study|Pap smear with significant pathology|10
6954654|NCT01039584|10997599|FG001|Overall Study|Pap smear with significant pathology|10
6954655|NCT01039584|10997600|FG002|Overall Study|Pap smear with significant pathology|3
6954656|NCT01039584|10997598|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7
6954657|NCT01039584|10997599|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10
6954658|NCT01039584|10997600|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8
6954659|NCT01039675|10997610|FG000|Overall Study|Adverse Event|0
6954660|NCT01039675|10997611|FG001|Overall Study|Adverse Event|2
6954661|NCT01039675|10997610|FG000|Overall Study|Lack of Efficacy|0
6954662|NCT01039675|10997611|FG001|Overall Study|Lack of Efficacy|2
6954663|NCT01039675|10997610|FG000|Overall Study|Withdrawal by Subject|0
6954664|NCT01039675|10997611|FG001|Overall Study|Withdrawal by Subject|1
6954665|NCT01039675|10997610|FG000|Overall Study|Lost to Follow-up|0
6954666|NCT01039675|10997611|FG001|Overall Study|Lost to Follow-up|1
6954667|NCT01039675|10997610|FG000|Overall Study|Physician Decision|0
6954668|NCT01039675|10997611|FG001|Overall Study|Physician Decision|1
6954669|NCT01039688|10997620|FG000|Overall Study|Adverse Event|38
6954670|NCT01039688|10997621|FG001|Overall Study|Adverse Event|39
6954671|NCT01039688|10997622|FG002|Overall Study|Adverse Event|24
6954672|NCT01039688|10997620|FG000|Overall Study|Lack of Efficacy|20
6954673|NCT01039688|10997621|FG001|Overall Study|Lack of Efficacy|11
6954674|NCT01039688|10997622|FG002|Overall Study|Lack of Efficacy|26
6954675|NCT01039688|10997620|FG000|Overall Study|Lost to Follow-up|11
6954676|NCT01039688|10997621|FG001|Overall Study|Lost to Follow-up|9
6954677|NCT01039688|10997622|FG002|Overall Study|Lost to Follow-up|5
6954678|NCT01039688|10997620|FG000|Overall Study|Other|13
6954679|NCT01039688|10997621|FG001|Overall Study|Other|25
6954680|NCT01039688|10997622|FG002|Overall Study|Other|12
6954681|NCT01039688|10997620|FG000|Overall Study|Withdrawal by Subject|23
6954682|NCT01039688|10997621|FG001|Overall Study|Withdrawal by Subject|27
6954683|NCT01039688|10997622|FG002|Overall Study|Withdrawal by Subject|13
6954684|NCT01039688|10997620|FG000|Overall Study|Death|2
6954685|NCT01039688|10997621|FG001|Overall Study|Death|0
6954686|NCT01039688|10997622|FG002|Overall Study|Death|0
6954687|NCT01040130|10997646|FG000|Overall Study|Adverse Event|1
6954688|NCT01040130|10997647|FG001|Overall Study|Adverse Event|1
6954689|NCT01040130|10997648|FG002|Overall Study|Adverse Event|0
6954690|NCT01040130|10997649|FG003|Overall Study|Adverse Event|5
6954691|NCT01040130|10997650|FG004|Overall Study|Adverse Event|0
6954692|NCT01040130|10997651|FG005|Overall Study|Adverse Event|3
6954693|NCT01040130|10997646|FG000|Overall Study|Protocol Violation|0
6954694|NCT01040130|10997647|FG001|Overall Study|Protocol Violation|0
6954695|NCT01040130|10997648|FG002|Overall Study|Protocol Violation|2
6954696|NCT01040130|10997649|FG003|Overall Study|Protocol Violation|0
6838475|NCT00259610|10844215|FG002|Overall Study|non medical reason|10
6838476|NCT00259610|10844216|FG003|Overall Study|non medical reason|3
6838477|NCT00259610|10844213|FG000|Overall Study|Adverse Event|3
7070703|NCT02014740|11173310|FG001|Overall Study|Lost to Follow-up|4
6954697|NCT01040130|10997650|FG004|Overall Study|Protocol Violation|0
6954698|NCT01040130|10997651|FG005|Overall Study|Protocol Violation|0
6954699|NCT01040130|10997646|FG000|Overall Study|Withdrawal by Subject|0
6954700|NCT01040130|10997647|FG001|Overall Study|Withdrawal by Subject|2
6954701|NCT01040130|10997648|FG002|Overall Study|Withdrawal by Subject|0
6954702|NCT01040130|10997649|FG003|Overall Study|Withdrawal by Subject|0
6954703|NCT01040130|10997650|FG004|Overall Study|Withdrawal by Subject|0
6954704|NCT01040130|10997651|FG005|Overall Study|Withdrawal by Subject|1
6954705|NCT01040130|10997646|FG000|Overall Study|Other reasons not listed above|2
6954706|NCT01040130|10997647|FG001|Overall Study|Other reasons not listed above|0
6954707|NCT01040130|10997648|FG002|Overall Study|Other reasons not listed above|0
6954708|NCT01040130|10997649|FG003|Overall Study|Other reasons not listed above|0
6954709|NCT01040130|10997650|FG004|Overall Study|Other reasons not listed above|0
6954710|NCT01040130|10997651|FG005|Overall Study|Other reasons not listed above|0
6954711|NCT01040169|10997663|FG000|Overall Study|Lost to Follow-up|3
6954712|NCT01040169|10997664|FG001|Overall Study|Lost to Follow-up|8
6954713|NCT01040260|10997690|FG000|Overall Study|Withdrawal by Subject|12
6954714|NCT01040260|10997691|FG001|Overall Study|Withdrawal by Subject|6
6954715|NCT01040260|10997690|FG000|Overall Study|Lost to Follow-up|3
6954716|NCT01040260|10997691|FG001|Overall Study|Lost to Follow-up|5
6954717|NCT01040351|10997699|FG000|Overall Study|poor ovarian response|1
6954718|NCT01040351|10997700|FG001|Overall Study|poor ovarian response|2
6954719|NCT01040403|10997706|FG000|Overall Study|Adverse Event|10
6954720|NCT01040403|10997706|FG000|Overall Study|Protocol Violation|2
6954721|NCT01040403|10997706|FG000|Overall Study|Lost to Follow-up|1
6954722|NCT01040403|10997706|FG000|Overall Study|Not treated|1
6954723|NCT01040403|10997706|FG000|Overall Study|Other reason not defined above|6
6954724|NCT01040689|10997725|FG000|Overall Study|Adverse Event|0
6954725|NCT01040689|10997726|FG001|Overall Study|Adverse Event|0
6954726|NCT01040689|10997727|FG002|Overall Study|Adverse Event|2
6954727|NCT01040689|10997728|FG003|Overall Study|Adverse Event|4
6954728|NCT01040689|10997725|FG000|Overall Study|Lack of Efficacy|0
6954729|NCT01040689|10997726|FG001|Overall Study|Lack of Efficacy|0
6954730|NCT01040689|10997727|FG002|Overall Study|Lack of Efficacy|1
6954731|NCT01040689|10997728|FG003|Overall Study|Lack of Efficacy|0
6954732|NCT01040689|10997725|FG000|Overall Study|Lost to Follow-up|1
6954733|NCT01040689|10997726|FG001|Overall Study|Lost to Follow-up|0
6954734|NCT01040689|10997727|FG002|Overall Study|Lost to Follow-up|0
6954735|NCT01040689|10997728|FG003|Overall Study|Lost to Follow-up|0
6954736|NCT01040689|10997725|FG000|Overall Study|Withdrawal by Subject|2
6954737|NCT01040689|10997726|FG001|Overall Study|Withdrawal by Subject|1
6954738|NCT01040689|10997727|FG002|Overall Study|Withdrawal by Subject|1
6954739|NCT01040689|10997728|FG003|Overall Study|Withdrawal by Subject|0
6954740|NCT01040689|10997725|FG000|Overall Study|Other reasons not listed above|0
6954741|NCT01040689|10997726|FG001|Overall Study|Other reasons not listed above|1
6954742|NCT01040689|10997727|FG002|Overall Study|Other reasons not listed above|0
6954743|NCT01040689|10997728|FG003|Overall Study|Other reasons not listed above|0
6954744|NCT01040728|10997743|FG000|Overall Study|Adverse Event|4
6954745|NCT01040728|10997744|FG001|Overall Study|Adverse Event|8
6954746|NCT01040728|10997745|FG002|Overall Study|Adverse Event|0
6954747|NCT01040728|10997746|FG003|Overall Study|Adverse Event|4
6954748|NCT01040728|10997743|FG000|Overall Study|Withdrawal by Subject|0
6954749|NCT01040728|10997744|FG001|Overall Study|Withdrawal by Subject|1
6954750|NCT01040728|10997745|FG002|Overall Study|Withdrawal by Subject|1
7070704|NCT02014740|11173309|FG000|Overall Study|Withdrawal by Subject|2
7070705|NCT02014740|11173310|FG001|Overall Study|Withdrawal by Subject|1
7070706|NCT02015039|11173318|FG000|Overall Study|Not eligible|0
7070707|NCT02015039|11173319|FG001|Overall Study|Not eligible|1
7070708|NCT02015065|11173328|FG000|Overall Study|Death on study|1
7070709|NCT02015065|11173329|FG001|Overall Study|Death on study|2
7070710|NCT02015065|11173330|FG002|Overall Study|Death on study|1
6838478|NCT00259610|10844214|FG001|Overall Study|Adverse Event|4
6838479|NCT00259610|10844215|FG002|Overall Study|Adverse Event|5
6954751|NCT01040728|10997746|FG003|Overall Study|Withdrawal by Subject|0
6954752|NCT01040728|10997743|FG000|Overall Study|Protocol Violation|0
6954753|NCT01040728|10997744|FG001|Overall Study|Protocol Violation|0
6954754|NCT01040728|10997745|FG002|Overall Study|Protocol Violation|0
6954755|NCT01040728|10997746|FG003|Overall Study|Protocol Violation|1
6954756|NCT01040728|10997743|FG000|Overall Study|Lack of Efficacy|0
6954757|NCT01040728|10997744|FG001|Overall Study|Lack of Efficacy|1
6954758|NCT01040728|10997745|FG002|Overall Study|Lack of Efficacy|0
7070711|NCT02015104|11173340|FG000|Overall Study|Withdrew consent after first dose drug|1
6954759|NCT01040728|10997746|FG003|Overall Study|Lack of Efficacy|1
6954760|NCT01040728|10997743|FG000|Overall Study|Other reasons not listed above|0
6954761|NCT01040728|10997744|FG001|Overall Study|Other reasons not listed above|1
6954762|NCT01040728|10997745|FG002|Overall Study|Other reasons not listed above|0
6954763|NCT01040728|10997746|FG003|Overall Study|Other reasons not listed above|0
6954764|NCT01040780|10997764|FG000|Overall Study|Protocol Violation|1
6954765|NCT01040780|10997765|FG001|Overall Study|Protocol Violation|3
6954766|NCT01040793|10997774|FG000|Overall Study|Adverse Event|5
6954767|NCT01040793|10997775|FG001|Overall Study|Adverse Event|3
6954768|NCT01040793|10997776|FG002|Overall Study|Adverse Event|0
6954769|NCT01040793|10997777|FG003|Overall Study|Adverse Event|2
6954770|NCT01040793|10997778|FG004|Overall Study|Adverse Event|2
6954771|NCT01040793|10997779|FG005|Overall Study|Adverse Event|1
6954772|NCT01040793|10997774|FG000|Overall Study|Protocol Violation|1
6954773|NCT01040793|10997775|FG001|Overall Study|Protocol Violation|1
6954774|NCT01040793|10997776|FG002|Overall Study|Protocol Violation|1
6954775|NCT01040793|10997777|FG003|Overall Study|Protocol Violation|0
6954776|NCT01040793|10997778|FG004|Overall Study|Protocol Violation|1
6954777|NCT01040793|10997779|FG005|Overall Study|Protocol Violation|0
6954778|NCT01040793|10997774|FG000|Overall Study|Lost to Follow-up|0
6954779|NCT01040793|10997775|FG001|Overall Study|Lost to Follow-up|1
6954780|NCT01040793|10997776|FG002|Overall Study|Lost to Follow-up|1
6954781|NCT01040793|10997777|FG003|Overall Study|Lost to Follow-up|0
6954782|NCT01040793|10997778|FG004|Overall Study|Lost to Follow-up|0
6954783|NCT01040793|10997779|FG005|Overall Study|Lost to Follow-up|0
6954784|NCT01040793|10997774|FG000|Overall Study|Withdrawal by Subject|0
6954785|NCT01040793|10997775|FG001|Overall Study|Withdrawal by Subject|0
6954786|NCT01040793|10997776|FG002|Overall Study|Withdrawal by Subject|0
6954787|NCT01040793|10997777|FG003|Overall Study|Withdrawal by Subject|2
6954788|NCT01040793|10997778|FG004|Overall Study|Withdrawal by Subject|0
6954789|NCT01040793|10997779|FG005|Overall Study|Withdrawal by Subject|0
6954790|NCT01040793|10997774|FG000|Overall Study|Other reasons not listed above|0
6954791|NCT01040793|10997775|FG001|Overall Study|Other reasons not listed above|0
6954792|NCT01040793|10997776|FG002|Overall Study|Other reasons not listed above|1
6954793|NCT01040793|10997777|FG003|Overall Study|Other reasons not listed above|0
6954794|NCT01040793|10997778|FG004|Overall Study|Other reasons not listed above|1
6954795|NCT01040793|10997779|FG005|Overall Study|Other reasons not listed above|0
7070712|NCT02015104|11173341|FG001|Overall Study|Withdrew consent after first dose drug|0
6954796|NCT01040832|10997800|FG000|Overall Study|Adverse Event|4
6954797|NCT01040832|10997801|FG001|Overall Study|Adverse Event|5
6954798|NCT01040832|10997800|FG000|Overall Study|Death|4
6954799|NCT01040832|10997801|FG001|Overall Study|Death|6
6954800|NCT01040832|10997800|FG000|Overall Study|Withdrawal by Subject|2
6954801|NCT01040832|10997801|FG001|Overall Study|Withdrawal by Subject|3
6954802|NCT01040832|10997800|FG000|Overall Study|Progressive disease|32
6954803|NCT01040832|10997801|FG001|Overall Study|Progressive disease|17
6954804|NCT01040832|10997800|FG000|Overall Study|Symptomatic deterioration|2
6954805|NCT01040832|10997801|FG001|Overall Study|Symptomatic deterioration|5
6954806|NCT01040832|10997800|FG000|Overall Study|Other|2
6954807|NCT01040832|10997801|FG001|Overall Study|Other|1
6954808|NCT01040845|10997809|FG000|Overall Study|Withdrawal by Subject|1
6954809|NCT01040845|10997810|FG001|Overall Study|Withdrawal by Subject|1
6954810|NCT01040845|10997809|FG000|Overall Study|Physician Decision|1
6954811|NCT01040845|10997810|FG001|Overall Study|Physician Decision|0
6954812|NCT01040871|10997832|FG000|Overall Study|Adverse Event|6
6954813|NCT01040871|10997833|FG001|Overall Study|Adverse Event|2
6954814|NCT01040871|10997832|FG000|Overall Study|Withdrawal by Subject|2
6954815|NCT01040871|10997833|FG001|Overall Study|Withdrawal by Subject|0
6954816|NCT01040871|10997832|FG000|Overall Study|Death|1
6954817|NCT01040871|10997833|FG001|Overall Study|Death|3
6954818|NCT01040871|10997832|FG000|Overall Study|Lack of Efficacy|1
6954819|NCT01040871|10997833|FG001|Overall Study|Lack of Efficacy|1
6954820|NCT01040871|10997832|FG000|Overall Study|drug supply issue|1
6954821|NCT01040871|10997833|FG001|Overall Study|drug supply issue|0
6954822|NCT01040871|10997832|FG000|Overall Study|Randomized and Not Treated|2
6954823|NCT01040871|10997833|FG001|Overall Study|Randomized and Not Treated|1
6954824|NCT01041287|10997865|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3
6954825|NCT01041287|10997866|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3
6954826|NCT01041287|10997865|FG000|Treatment Period 2 (3 Months)|Adverse Event|0
6954827|NCT01041287|10997866|FG001|Treatment Period 2 (3 Months)|Adverse Event|2
6954828|NCT01041404|10997874|FG000|Overall Study|Adverse Event|45
6954829|NCT01041404|10997875|FG001|Overall Study|Adverse Event|35
6954830|NCT01041404|10997874|FG000|Overall Study|Lack of Efficacy|200
6954831|NCT01041404|10997875|FG001|Overall Study|Lack of Efficacy|210
6954832|NCT01041404|10997874|FG000|Overall Study|Violation of Selection Criteria|0
6954833|NCT01041404|10997875|FG001|Overall Study|Violation of Selection Criteria|1
6954834|NCT01041404|10997874|FG000|Overall Study|Protocol Violation|4
6954835|NCT01041404|10997875|FG001|Overall Study|Protocol Violation|0
6954836|NCT01041404|10997874|FG000|Overall Study|Withdrawal by Subject|29
6954837|NCT01041404|10997875|FG001|Overall Study|Withdrawal by Subject|23
6954838|NCT01041404|10997874|FG000|Overall Study|Failure to Return|1
6954839|NCT01041404|10997875|FG001|Overall Study|Failure to Return|2
6954840|NCT01041404|10997874|FG000|Overall Study|Other|11
6954841|NCT01041404|10997875|FG001|Overall Study|Other|23
6954842|NCT01041417|10997886|FG000|Overall Study|Adverse Event|5
6954843|NCT01041417|10997887|FG001|Overall Study|Adverse Event|2
6954844|NCT01041417|10997886|FG000|Overall Study|Lost to Follow-up|1
6954845|NCT01041417|10997887|FG001|Overall Study|Lost to Follow-up|1
6954846|NCT01041417|10997886|FG000|Overall Study|Death|1
6954847|NCT01041417|10997887|FG001|Overall Study|Death|0
6954848|NCT01041495|10997897|FG000|Overall Study|Withdrawal by Subject|2
6954849|NCT01041495|10997898|FG001|Overall Study|Withdrawal by Subject|5
6954850|NCT01041495|10997897|FG000|Overall Study|Adverse Event|2
6954851|NCT01041495|10997898|FG001|Overall Study|Adverse Event|1
6954852|NCT01041495|10997897|FG000|Overall Study|Lost to Follow-up|0
6954853|NCT01041495|10997898|FG001|Overall Study|Lost to Follow-up|1
6954854|NCT01041573|10997917|FG000|Overall Study|Withdrawal by Subject|2
6954855|NCT01041573|10997918|FG001|Overall Study|Withdrawal by Subject|5
6954856|NCT01041573|10997919|FG002|Overall Study|Withdrawal by Subject|2
6954857|NCT01041573|10997920|FG003|Overall Study|Withdrawal by Subject|0
6954858|NCT01041573|10997917|FG000|Overall Study|Death|1
6954859|NCT01041573|10997918|FG001|Overall Study|Death|0
6954860|NCT01041573|10997919|FG002|Overall Study|Death|0
6954861|NCT01041573|10997920|FG003|Overall Study|Death|0
6954862|NCT01041573|10997917|FG000|Overall Study|Lost to Follow-up|0
6954863|NCT01041573|10997918|FG001|Overall Study|Lost to Follow-up|1
6954864|NCT01041573|10997919|FG002|Overall Study|Lost to Follow-up|2
6954865|NCT01041573|10997920|FG003|Overall Study|Lost to Follow-up|1
6954866|NCT01041573|10997917|FG000|Overall Study|Adverse Event|0
6954867|NCT01041573|10997918|FG001|Overall Study|Adverse Event|2
6954868|NCT01041573|10997919|FG002|Overall Study|Adverse Event|0
6954869|NCT01041573|10997920|FG003|Overall Study|Adverse Event|0
6954870|NCT01041573|10997917|FG000|Overall Study|relocation|1
6954871|NCT01041573|10997918|FG001|Overall Study|relocation|4
6954872|NCT01041573|10997919|FG002|Overall Study|relocation|3
6954873|NCT01041573|10997920|FG003|Overall Study|relocation|1
6954874|NCT01041573|10997917|FG000|Overall Study|further blood extraction|0
6954875|NCT01041573|10997918|FG001|Overall Study|further blood extraction|1
6954876|NCT01041573|10997919|FG002|Overall Study|further blood extraction|0
6954877|NCT01041573|10997920|FG003|Overall Study|further blood extraction|0
6954878|NCT01041573|10997917|FG000|Overall Study|positive to anti-HCV|1
6954879|NCT01041573|10997918|FG001|Overall Study|positive to anti-HCV|0
6954880|NCT01041573|10997919|FG002|Overall Study|positive to anti-HCV|0
6954881|NCT01041573|10997920|FG003|Overall Study|positive to anti-HCV|0
6954882|NCT01041638|10997939|FG000|Overall Study|Adverse Event|4
6954883|NCT01041638|10997939|FG000|Overall Study|Death|1
6954884|NCT01041638|10997939|FG000|Overall Study|Lack of Efficacy|7
6954885|NCT01041638|10997939|FG000|Overall Study|Physician Decision|4
6954886|NCT01041638|10997939|FG000|Overall Study|Withdrawal by Subject|11
6954887|NCT01041859|10997962|FG000|Open-Label Titration|Adverse Event|69
6954888|NCT01041859|10997963|FG001|Open-Label Titration|Adverse Event|0
6954889|NCT01041859|10997964|FG002|Open-Label Titration|Adverse Event|0
6954890|NCT01041859|10997962|FG000|Open-Label Titration|Lack of Efficacy|3
6954891|NCT01041859|10997963|FG001|Open-Label Titration|Lack of Efficacy|0
6954892|NCT01041859|10997964|FG002|Open-Label Titration|Lack of Efficacy|0
6954893|NCT01041859|10997962|FG000|Open-Label Titration|Lost to Follow-up|1
6954894|NCT01041859|10997963|FG001|Open-Label Titration|Lost to Follow-up|0
6954895|NCT01041859|10997964|FG002|Open-Label Titration|Lost to Follow-up|0
6954896|NCT01041859|10997962|FG000|Open-Label Titration|Physician Decision|1
6954897|NCT01041859|10997963|FG001|Open-Label Titration|Physician Decision|0
6954898|NCT01041859|10997964|FG002|Open-Label Titration|Physician Decision|0
6954899|NCT01041859|10997962|FG000|Open-Label Titration|Protocol Violation|1
6954900|NCT01041859|10997963|FG001|Open-Label Titration|Protocol Violation|0
6954901|NCT01041859|10997964|FG002|Open-Label Titration|Protocol Violation|0
6954902|NCT01041859|10997962|FG000|Open-Label Titration|Other|7
6954903|NCT01041859|10997963|FG001|Open-Label Titration|Other|0
6954904|NCT01041859|10997964|FG002|Open-Label Titration|Other|0
6954905|NCT01041859|10997962|FG000|Open-Label Titration|Noncompliance With Study Drug|8
6954906|NCT01041859|10997963|FG001|Open-Label Titration|Noncompliance With Study Drug|0
6954907|NCT01041859|10997964|FG002|Open-Label Titration|Noncompliance With Study Drug|0
6954908|NCT01041859|10997962|FG000|Open-Label Titration|Withdrawal by Subject|11
6954909|NCT01041859|10997963|FG001|Open-Label Titration|Withdrawal by Subject|0
6954910|NCT01041859|10997964|FG002|Open-Label Titration|Withdrawal by Subject|0
6954911|NCT01041859|10997962|FG000|Double-Blind Maintenance|Adverse Event|0
6954912|NCT01041859|10997963|FG001|Double-Blind Maintenance|Adverse Event|23
6954913|NCT01041859|10997964|FG002|Double-Blind Maintenance|Adverse Event|13
6954914|NCT01041859|10997962|FG000|Double-Blind Maintenance|Lack of Efficacy|0
6954915|NCT01041859|10997963|FG001|Double-Blind Maintenance|Lack of Efficacy|3
6954916|NCT01041859|10997964|FG002|Double-Blind Maintenance|Lack of Efficacy|11
6954917|NCT01041859|10997962|FG000|Double-Blind Maintenance|Lost to Follow-up|0
6954918|NCT01041859|10997963|FG001|Double-Blind Maintenance|Lost to Follow-up|1
6954919|NCT01041859|10997964|FG002|Double-Blind Maintenance|Lost to Follow-up|0
6954920|NCT01041859|10997962|FG000|Double-Blind Maintenance|Physician Decision|0
6954921|NCT01041859|10997963|FG001|Double-Blind Maintenance|Physician Decision|2
6954922|NCT01041859|10997964|FG002|Double-Blind Maintenance|Physician Decision|1
6954923|NCT01041859|10997962|FG000|Double-Blind Maintenance|Protocol Violation|0
6954924|NCT01041859|10997963|FG001|Double-Blind Maintenance|Protocol Violation|1
6954925|NCT01041859|10997964|FG002|Double-Blind Maintenance|Protocol Violation|3
6954926|NCT01041859|10997962|FG000|Double-Blind Maintenance|Other|0
6954927|NCT01041859|10997963|FG001|Double-Blind Maintenance|Other|6
6954928|NCT01041859|10997964|FG002|Double-Blind Maintenance|Other|2
6954929|NCT01041859|10997962|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0
6954930|NCT01041859|10997963|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2
6954931|NCT01041859|10997964|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6
6954932|NCT01041859|10997962|FG000|Double-Blind Maintenance|Withdrawal by Subject|0
6954933|NCT01041859|10997963|FG001|Double-Blind Maintenance|Withdrawal by Subject|8
6954934|NCT01041859|10997964|FG002|Double-Blind Maintenance|Withdrawal by Subject|9
6954935|NCT01041976|10997973|FG000|Overall Study|Withdrawal by Subject|3
6954936|NCT01041976|10997974|FG001|Overall Study|Withdrawal by Subject|0
6954937|NCT01041976|10997973|FG000|Overall Study|Incarceration|2
6954938|NCT01041976|10997974|FG001|Overall Study|Incarceration|0
6954939|NCT01041976|10997973|FG000|Overall Study|Death|0
6954940|NCT01041976|10997974|FG001|Overall Study|Death|4
6954941|NCT01042093|10997984|FG000|Overall Study|Protocol Violation|2
6954942|NCT01042093|10997985|FG001|Overall Study|Protocol Violation|2
6954943|NCT01042093|10997986|FG002|Overall Study|Protocol Violation|2
6954944|NCT01042093|10997987|FG003|Overall Study|Protocol Violation|3
6954945|NCT01042093|10997984|FG000|Overall Study|Withdrawal by Subject|0
6954946|NCT01042093|10997985|FG001|Overall Study|Withdrawal by Subject|0
6954947|NCT01042093|10997986|FG002|Overall Study|Withdrawal by Subject|0
6954948|NCT01042093|10997987|FG003|Overall Study|Withdrawal by Subject|1
6954949|NCT01042158|10998009|FG000|Overall Study|Physician Decision|1
6954950|NCT01042236|10998013|FG000|Treatment Period 1|Adverse Event|0
6954951|NCT01042236|10998014|FG001|Treatment Period 1|Adverse Event|1
6954952|NCT01042236|10998015|FG002|Treatment Period 1|Adverse Event|0
6954953|NCT01042236|10998016|FG003|Treatment Period 1|Adverse Event|0
6954954|NCT01042236|10998017|FG004|Treatment Period 1|Adverse Event|1
6954955|NCT01042236|10998018|FG005|Treatment Period 1|Adverse Event|0
6954956|NCT01042236|10998013|FG000|Treatment Period 3|Adverse Event|0
6954957|NCT01042236|10998014|FG001|Treatment Period 3|Adverse Event|0
6954958|NCT01042236|10998015|FG002|Treatment Period 3|Adverse Event|0
6954959|NCT01042236|10998016|FG003|Treatment Period 3|Adverse Event|1
6954960|NCT01042236|10998017|FG004|Treatment Period 3|Adverse Event|0
6954961|NCT01042236|10998018|FG005|Treatment Period 3|Adverse Event|0
6954962|NCT01042236|10998013|FG000|Treatment Period 3|Protocol Violation|0
6954963|NCT01042236|10998014|FG001|Treatment Period 3|Protocol Violation|0
6954964|NCT01042236|10998015|FG002|Treatment Period 3|Protocol Violation|0
6954965|NCT01042236|10998016|FG003|Treatment Period 3|Protocol Violation|1
6954966|NCT01042236|10998017|FG004|Treatment Period 3|Protocol Violation|0
6954967|NCT01042236|10998018|FG005|Treatment Period 3|Protocol Violation|0
6954968|NCT01042392|10998043|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6
6954969|NCT01042392|10998044|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
6954970|NCT01042392|10998045|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5
6954971|NCT01042392|10998046|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
6954972|NCT01042392|10998043|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1
6954973|NCT01042392|10998044|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
6954974|NCT01042392|10998045|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
6954975|NCT01042392|10998046|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
6954976|NCT01042392|10998043|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1
6954977|NCT01042392|10998044|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
6954978|NCT01042392|10998045|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2
6954979|NCT01042392|10998046|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
6954980|NCT01042392|10998043|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
7070713|NCT02015104|11173340|FG000|Overall Study|Withdrew consent prior to treatment|0
7070714|NCT02015104|11173341|FG001|Overall Study|Withdrew consent prior to treatment|1
7070715|NCT02015195|11173357|FG000|Overall Study|Adverse Event|0
7070716|NCT02015195|11173358|FG001|Overall Study|Adverse Event|0
7070717|NCT02015195|11173359|FG002|Overall Study|Adverse Event|0
7070718|NCT02015195|11173360|FG003|Overall Study|Adverse Event|1
7070719|NCT02015195|11173361|FG004|Overall Study|Adverse Event|0
7070720|NCT02015195|11173362|FG005|Overall Study|Adverse Event|0
7070721|NCT02015195|11173363|FG006|Overall Study|Adverse Event|0
7070722|NCT02015221|11173380|FG000|Overall Study|Withdrawal by Subject|8
7070723|NCT02015221|11173381|FG001|Overall Study|Withdrawal by Subject|6
7070724|NCT02015221|11173380|FG000|Overall Study|Lost to Follow-up|1
7070725|NCT02015221|11173381|FG001|Overall Study|Lost to Follow-up|0
7070726|NCT02015390|11173400|FG000|Overall Study|Lost to Follow-up|1
7070727|NCT02015390|11173401|FG001|Overall Study|Lost to Follow-up|0
7070728|NCT02015390|11173400|FG000|Overall Study|Adverse Event|0
7070729|NCT02015390|11173401|FG001|Overall Study|Adverse Event|3
7070730|NCT02015390|11173400|FG000|Overall Study|Physician Decision|0
7070731|NCT02015390|11173401|FG001|Overall Study|Physician Decision|1
7070732|NCT02015481|11173415|FG000|Overall Study|Death|1
6954981|NCT01042392|10998044|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
7070733|NCT02015520|11173424|FG000|Overall Study|Lack of Efficacy|1
7070734|NCT02015520|11173425|FG001|Overall Study|Lack of Efficacy|0
7070735|NCT02015520|11173426|FG002|Overall Study|Lack of Efficacy|3
6954982|NCT01042392|10998045|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1
6954983|NCT01042392|10998046|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
6954984|NCT01042392|10998043|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2
6954985|NCT01042392|10998044|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
6954986|NCT01042392|10998045|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
6954987|NCT01042392|10998046|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
6954988|NCT01042392|10998043|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
6954989|NCT01042392|10998044|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
6954990|NCT01042392|10998045|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1
6954991|NCT01042392|10998046|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
6954992|NCT01042392|10998043|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2
6954993|NCT01042392|10998044|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
6954994|NCT01042392|10998045|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
6954995|NCT01042392|10998046|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
6954996|NCT01042392|10998043|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
6954997|NCT01042392|10998044|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
6954998|NCT01042392|10998045|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2
6954999|NCT01042392|10998046|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
6955000|NCT01042392|10998043|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0
6955001|NCT01042392|10998044|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
6955002|NCT01042392|10998045|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
6955003|NCT01042392|10998046|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
6955004|NCT01042535|10998075|FG000|Overall Study|disease progression prior to treatment|3
7070736|NCT02015520|11173427|FG003|Overall Study|Lack of Efficacy|2
7070737|NCT02015520|11173424|FG000|Overall Study|Adverse Event|0
7070738|NCT02015520|11173425|FG001|Overall Study|Adverse Event|0
7070739|NCT02015520|11173426|FG002|Overall Study|Adverse Event|0
7070740|NCT02015520|11173427|FG003|Overall Study|Adverse Event|1
7070741|NCT02015520|11173424|FG000|Overall Study|Withdrawal by Subject|2
7070742|NCT02015520|11173425|FG001|Overall Study|Withdrawal by Subject|2
7070743|NCT02015520|11173426|FG002|Overall Study|Withdrawal by Subject|1
7070744|NCT02015520|11173427|FG003|Overall Study|Withdrawal by Subject|0
7070745|NCT02015520|11173424|FG000|Overall Study|Death|1
7070746|NCT02015520|11173425|FG001|Overall Study|Death|0
7070747|NCT02015520|11173426|FG002|Overall Study|Death|0
7070748|NCT02015520|11173427|FG003|Overall Study|Death|0
7070749|NCT02015520|11173424|FG000|Overall Study|Lost to Follow-up|0
7070750|NCT02015520|11173425|FG001|Overall Study|Lost to Follow-up|0
7070751|NCT02015520|11173426|FG002|Overall Study|Lost to Follow-up|1
7070752|NCT02015520|11173427|FG003|Overall Study|Lost to Follow-up|0
7070753|NCT02015520|11173424|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1
7070754|NCT02015520|11173425|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1
7070755|NCT02015520|11173426|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2
7070756|NCT02015520|11173427|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1
7070757|NCT02015520|11173424|FG000|Overall Study|Subject no Longer Meets Study Criteria|0
7070758|NCT02015520|11173425|FG001|Overall Study|Subject no Longer Meets Study Criteria|1
7070759|NCT02015520|11173426|FG002|Overall Study|Subject no Longer Meets Study Criteria|0
7070760|NCT02015520|11173427|FG003|Overall Study|Subject no Longer Meets Study Criteria|0
7070761|NCT02015546|11173440|FG000|Overall Study|Withdrawal by Subject|1
7070762|NCT02015546|11173441|FG001|Overall Study|Withdrawal by Subject|1
7070763|NCT02015546|11173442|FG002|Overall Study|Withdrawal by Subject|1
7070764|NCT02015546|11173440|FG000|Overall Study|Screem Failure|2
7070765|NCT02015546|11173441|FG001|Overall Study|Screem Failure|1
7070766|NCT02015546|11173442|FG002|Overall Study|Screem Failure|3
7070767|NCT02015637|11173452|FG000|Overall Study|Lost to Follow-up|3
7070768|NCT02015637|11173453|FG001|Overall Study|Lost to Follow-up|5
7070769|NCT02015637|11173452|FG000|Overall Study|Adverse Event|3
7070770|NCT02015637|11173453|FG001|Overall Study|Adverse Event|0
7070771|NCT02015637|11173452|FG000|Overall Study|Did not take study drug|2
7070772|NCT02015637|11173453|FG001|Overall Study|Did not take study drug|0
7070773|NCT02015676|11173462|FG000|Overall Study|Adverse Event|2
7070774|NCT02015676|11173463|FG001|Overall Study|Adverse Event|18
7070775|NCT02015676|11173464|FG002|Overall Study|Adverse Event|0
7070776|NCT02015676|11173462|FG000|Overall Study|Lack of Efficacy|2
7070777|NCT02015676|11173463|FG001|Overall Study|Lack of Efficacy|4
7070778|NCT02015676|11173464|FG002|Overall Study|Lack of Efficacy|0
7070779|NCT02015676|11173462|FG000|Overall Study|Protocol Violation|1
7070780|NCT02015676|11173463|FG001|Overall Study|Protocol Violation|0
7070781|NCT02015676|11173464|FG002|Overall Study|Protocol Violation|0
7070782|NCT02015676|11173462|FG000|Overall Study|Withdrawal by Subject|1
7070783|NCT02015676|11173463|FG001|Overall Study|Withdrawal by Subject|7
7070784|NCT02015676|11173464|FG002|Overall Study|Withdrawal by Subject|1
7070785|NCT02015676|11173462|FG000|Overall Study|Administrative reasons|0
7070786|NCT02015676|11173463|FG001|Overall Study|Administrative reasons|3
7070787|NCT02015676|11173464|FG002|Overall Study|Administrative reasons|1
7070788|NCT02015676|11173462|FG000|Overall Study|Death|0
7070789|NCT02015676|11173463|FG001|Overall Study|Death|1
6955005|NCT01042535|10998075|FG000|Overall Study|disease progression during treatment|3
6955006|NCT01042535|10998075|FG000|Overall Study|complications from other disease|2
6955007|NCT01042600|10998081|FG000|Overall Study|Ineligible|1
6955008|NCT01042600|10998082|FG001|Overall Study|Ineligible|0
6955009|NCT01042678|10998101|FG000|Overall Study|Physician Decision|1
6955010|NCT01042678|10998102|FG001|Overall Study|Physician Decision|0
6955011|NCT01042678|10998103|FG002|Overall Study|Physician Decision|0
6955012|NCT01042678|10998104|FG003|Overall Study|Physician Decision|0
6955013|NCT01042678|10998105|FG004|Overall Study|Physician Decision|0
6955014|NCT01042678|10998106|FG005|Overall Study|Physician Decision|0
6955015|NCT01042938|10998120|FG000|Overall Study|Withdrawal by Subject|1
6955016|NCT01042938|10998121|FG001|Overall Study|Withdrawal by Subject|1
6955017|NCT01042938|10998120|FG000|Overall Study|Protocol Violation|1
6955018|NCT01042938|10998121|FG001|Overall Study|Protocol Violation|1
6838480|NCT00259610|10844216|FG003|Overall Study|Adverse Event|2
6838481|NCT00259610|10844213|FG000|Overall Study|Serious Adverse Event|8
6955019|NCT01042938|10998120|FG000|Overall Study|Ineligible: RTOG study conflict|1
6955020|NCT01042938|10998121|FG001|Overall Study|Ineligible: RTOG study conflict|0
6955021|NCT01042977|10998131|FG000|Overall Study|Adverse Event|4
6955022|NCT01042977|10998132|FG001|Overall Study|Adverse Event|12
6955023|NCT01042977|10998131|FG000|Overall Study|Death|2
6955024|NCT01042977|10998132|FG001|Overall Study|Death|1
6955025|NCT01042977|10998131|FG000|Overall Study|Withdrawal by Subject|8
6955026|NCT01042977|10998132|FG001|Overall Study|Withdrawal by Subject|16
6955027|NCT01042977|10998131|FG000|Overall Study|Lost to Follow-up|0
6955028|NCT01042977|10998132|FG001|Overall Study|Lost to Follow-up|2
6955029|NCT01042977|10998131|FG000|Overall Study|Poor/non-compliance|3
6955030|NCT01042977|10998132|FG001|Overall Study|Poor/non-compliance|4
6955031|NCT01042977|10998131|FG000|Overall Study|Subject no longer meets study criteria|15
6955032|NCT01042977|10998132|FG001|Overall Study|Subject no longer meets study criteria|13
6955033|NCT01042977|10998131|FG000|Overall Study|Incorrect enrollment|6
6955034|NCT01042977|10998132|FG001|Overall Study|Incorrect enrollment|4
6955035|NCT01042977|10998131|FG000|Overall Study|Safety|0
6955036|NCT01042977|10998132|FG001|Overall Study|Safety|2
6838482|NCT00259610|10844214|FG001|Overall Study|Serious Adverse Event|2
7070790|NCT02015676|11173464|FG002|Overall Study|Death|0
7070791|NCT02015676|11173462|FG000|Overall Study|Disease progression|3
7070792|NCT02015676|11173463|FG001|Overall Study|Disease progression|1
7070793|NCT02015676|11173464|FG002|Overall Study|Disease progression|1
7070794|NCT02015754|11173468|FG000|Overall Study|Disease progression|5
7070795|NCT02015754|11173468|FG000|Overall Study|Change in treatment modality|5
7070796|NCT02015754|11173468|FG000|Overall Study|Lost to Follow-up|1
7070797|NCT02015793|11173474|FG000|Overall Study|Adverse Event|3
6955037|NCT01042977|10998131|FG000|Overall Study|Administrative reason by sponsor|0
6955038|NCT01042977|10998132|FG001|Overall Study|Administrative reason by sponsor|1
6955039|NCT01042977|10998131|FG000|Overall Study|Various|3
6955040|NCT01042977|10998132|FG001|Overall Study|Various|0
6955041|NCT01043185|10998181|FG000|Period 6 - Third Washout Period|Protocol Violation|0
6955042|NCT01043185|10998182|FG001|Period 6 - Third Washout Period|Protocol Violation|0
6955043|NCT01043185|10998183|FG002|Period 6 - Third Washout Period|Protocol Violation|0
6955044|NCT01043185|10998184|FG003|Period 6 - Third Washout Period|Protocol Violation|0
7070798|NCT02015793|11173475|FG001|Overall Study|Adverse Event|3
7070799|NCT02015793|11173474|FG000|Overall Study|Withdrawal by Subject|1
7070800|NCT02015793|11173475|FG001|Overall Study|Withdrawal by Subject|1
7147793|NCT03136068|11308652|FG001|Overall Study|Lost to Follow-up|1
7147794|NCT03136068|11308651|FG000|Overall Study|Protocol Violation|1
7147795|NCT03136068|11308652|FG001|Overall Study|Protocol Violation|0
7147796|NCT03136107|11308658|FG000|Overall Study|Other (Not specified)|1
7147797|NCT03136159|11308668|FG000|Overall Study|chorioamnionitis|2
7147798|NCT03136159|11308669|FG001|Overall Study|chorioamnionitis|0
7147799|NCT03136159|11308668|FG000|Overall Study|vertical skin incision|1
7147800|NCT03136159|11308669|FG001|Overall Study|vertical skin incision|0
6955045|NCT01043185|10998185|FG004|Period 6 - Third Washout Period|Protocol Violation|0
6955046|NCT01043185|10998186|FG005|Period 6 - Third Washout Period|Protocol Violation|0
6955047|NCT01043185|10998187|FG006|Period 6 - Third Washout Period|Protocol Violation|0
6955048|NCT01043185|10998188|FG007|Period 6 - Third Washout Period|Protocol Violation|0
6955049|NCT01043185|10998189|FG008|Period 6 - Third Washout Period|Protocol Violation|1
6955050|NCT01043185|10998190|FG009|Period 6 - Third Washout Period|Protocol Violation|0
7070801|NCT02015819|11173491|FG000|Overall Study|Rickham catheter was misaligned|0
7070802|NCT02015819|11173492|FG001|Overall Study|Rickham catheter was misaligned|0
7070803|NCT02015819|11173493|FG002|Overall Study|Rickham catheter was misaligned|0
7070804|NCT02015819|11173494|FG003|Overall Study|Rickham catheter was misaligned|1
7070805|NCT02016105|11173510|FG000|TREATMENT PERIOD 1|Protocol Violation|2
7070806|NCT02016105|11173511|FG001|TREATMENT PERIOD 1|Protocol Violation|8
7070807|NCT02016105|11173512|FG002|TREATMENT PERIOD 1|Protocol Violation|0
7070808|NCT02016105|11173513|FG003|TREATMENT PERIOD 1|Protocol Violation|0
7070809|NCT02016105|11173514|FG004|TREATMENT PERIOD 1|Protocol Violation|0
7147801|NCT03136159|11308668|FG000|Overall Study|additional dressing|1
7147802|NCT03136159|11308669|FG001|Overall Study|additional dressing|0
7147803|NCT03136159|11308668|FG000|Overall Study|never got dressing placed|1
7070810|NCT02016105|11173515|FG005|TREATMENT PERIOD 1|Protocol Violation|0
7070811|NCT02016105|11173510|FG000|TREATMENT PERIOD 1|Physician Decision|0
6955051|NCT01043705|10998251|FG000|Overall Study|Death|28
6955052|NCT01043705|10998252|FG001|Overall Study|Death|60
6955053|NCT01043705|10998253|FG002|Overall Study|Death|26
6955054|NCT01043705|10998251|FG000|Overall Study|Lost to Follow-up|27
6955055|NCT01043705|10998252|FG001|Overall Study|Lost to Follow-up|12
6955056|NCT01043705|10998253|FG002|Overall Study|Lost to Follow-up|0
6955057|NCT01043705|10998251|FG000|Overall Study|Multiple Reasons|4
6955058|NCT01043705|10998252|FG001|Overall Study|Multiple Reasons|7
6955059|NCT01043705|10998253|FG002|Overall Study|Multiple Reasons|0
6955060|NCT01043705|10998251|FG000|Overall Study|Protocol Violation|2
6955061|NCT01043705|10998252|FG001|Overall Study|Protocol Violation|1
6955062|NCT01043705|10998253|FG002|Overall Study|Protocol Violation|0
6955063|NCT01043705|10998251|FG000|Overall Study|Withdrawal by Subject|8
6955064|NCT01043705|10998252|FG001|Overall Study|Withdrawal by Subject|6
6955065|NCT01043705|10998253|FG002|Overall Study|Withdrawal by Subject|0
6955066|NCT01043705|10998251|FG000|Overall Study|Site Closure|8
6955067|NCT01043705|10998252|FG001|Overall Study|Site Closure|0
6955068|NCT01043705|10998253|FG002|Overall Study|Site Closure|0
6955069|NCT01043705|10998251|FG000|Overall Study|Subsequent Procedure|9
6955070|NCT01043705|10998252|FG001|Overall Study|Subsequent Procedure|24
6955071|NCT01043705|10998253|FG002|Overall Study|Subsequent Procedure|29
6955072|NCT01043705|10998251|FG000|Overall Study|Adverse Event|0
6955073|NCT01043705|10998252|FG001|Overall Study|Adverse Event|2
6955074|NCT01043705|10998253|FG002|Overall Study|Adverse Event|0
6955075|NCT01043705|10998251|FG000|Overall Study|Screen Fail|21
6955076|NCT01043705|10998252|FG001|Overall Study|Screen Fail|0
6955077|NCT01043705|10998253|FG002|Overall Study|Screen Fail|0
6955078|NCT01043705|10998251|FG000|Overall Study|Other|0
6955079|NCT01043705|10998252|FG001|Overall Study|Other|19
6955080|NCT01043705|10998253|FG002|Overall Study|Other|25
6955081|NCT01043874|10998261|FG000|Overall Study|Adverse Event|3
6955082|NCT01043874|10998261|FG000|Overall Study|Withdrawal by Subject|1
6955083|NCT01043874|10998261|FG000|Overall Study|Lack of Efficacy|1
6955084|NCT01043874|10998261|FG000|Overall Study|Administrative Problems|1
6955085|NCT01044290|10998320|FG000|Follow-up 1|Death|3
6955086|NCT01044290|10998321|FG001|Follow-up 1|Death|3
6955087|NCT01044290|10998322|FG002|Follow-up 1|Death|1
6955088|NCT01044290|10998320|FG000|Follow-up 1|Withdrawal by Subject|2
6955089|NCT01044290|10998321|FG001|Follow-up 1|Withdrawal by Subject|2
6955090|NCT01044290|10998322|FG002|Follow-up 1|Withdrawal by Subject|0
6955091|NCT01044290|10998320|FG000|Follow-Up 2|Death|0
6955092|NCT01044290|10998321|FG001|Follow-Up 2|Death|1
6955093|NCT01044290|10998322|FG002|Follow-Up 2|Death|1
6955094|NCT01044290|10998320|FG000|Follow-Up 2|Withdrawal by Subject|0
6955095|NCT01044290|10998321|FG001|Follow-Up 2|Withdrawal by Subject|1
6955096|NCT01044290|10998322|FG002|Follow-Up 2|Withdrawal by Subject|1
6955097|NCT01044303|10998340|FG000|Overall Study|Lost to Follow-up|2
6955098|NCT01044433|10998347|FG000|Overall Study|Lost to Follow-up|3
6955099|NCT01044433|10998347|FG000|Overall Study|Withdrawal by Subject|3
6976265|NCT01198002|11028750|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6
6976266|NCT01198002|11028748|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1
6976267|NCT01198002|11028749|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
6976268|NCT01198002|11028750|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
6976269|NCT01198002|11028748|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
6976270|NCT01198002|11028749|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2
6976271|NCT01198002|11028750|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
6976272|NCT01198002|11028748|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16
6976273|NCT01198002|11028749|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21
6976274|NCT01198002|11028750|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12
6976275|NCT01198002|11028748|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1
6976276|NCT01198002|11028749|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
6976277|NCT01198002|11028750|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
6976278|NCT01198002|11028748|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14
6976279|NCT01198002|11028749|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
6976280|NCT01198002|11028750|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
6976281|NCT01198002|11028748|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213
6976282|NCT01198002|11028749|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216
6976283|NCT01198002|11028750|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224
6976284|NCT01198002|11028748|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2
6976285|NCT01198002|11028749|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0
6976286|NCT01198002|11028750|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1
6976287|NCT01198002|11028748|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3
6976288|NCT01198002|11028749|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
6976289|NCT01198002|11028750|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
6976290|NCT01198002|11028748|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1
6976291|NCT01198002|11028749|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
6976292|NCT01198002|11028750|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
6976293|NCT01198002|11028748|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
6976294|NCT01198002|11028749|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2
6976295|NCT01198002|11028750|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
6976296|NCT01198002|11028748|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
7040835|NCT01721044|11124044|FG002|Treatment Period|Lack of Efficacy|4
6955100|NCT01044459|10998354|FG000|Overall Study|Withdrawal by Subject|21
6955101|NCT01044459|10998355|FG001|Overall Study|Withdrawal by Subject|28
6955102|NCT01044459|10998354|FG000|Overall Study|Terminated by Sponsor|22
6955103|NCT01044459|10998355|FG001|Overall Study|Terminated by Sponsor|21
6955104|NCT01044459|10998354|FG000|Overall Study|Adverse Event|22
6955105|NCT01044459|10998355|FG001|Overall Study|Adverse Event|20
6955106|NCT01044459|10998354|FG000|Overall Study|Lack of Efficacy|23
6955107|NCT01044459|10998355|FG001|Overall Study|Lack of Efficacy|12
7070812|NCT02016105|11173511|FG001|TREATMENT PERIOD 1|Physician Decision|2
6955108|NCT01044459|10998354|FG000|Overall Study|Protocol Violation|11
6955109|NCT01044459|10998355|FG001|Overall Study|Protocol Violation|16
6955110|NCT01044459|10998354|FG000|Overall Study|Other Reason|7
6955111|NCT01044459|10998355|FG001|Overall Study|Other Reason|14
6955112|NCT01044459|10998354|FG000|Overall Study|COPD exacerbation|9
6955113|NCT01044459|10998355|FG001|Overall Study|COPD exacerbation|8
6955114|NCT01044459|10998354|FG000|Overall Study|Lost to Follow-up|18
6955115|NCT01044459|10998355|FG001|Overall Study|Lost to Follow-up|12
6955116|NCT01044498|10998363|FG000|Overall Study|Withdrew consent|1
6955117|NCT01044498|10998364|FG001|Overall Study|Withdrew consent|1
6955118|NCT01044498|10998363|FG000|Overall Study|Adverse Event|1
6955119|NCT01044498|10998364|FG001|Overall Study|Adverse Event|1
6955120|NCT01044498|10998363|FG000|Overall Study|Other|1
6955121|NCT01044498|10998364|FG001|Overall Study|Other|0
6955122|NCT01044732|10998448|FG000|Overall Study|Lost to Follow-up|2
6955123|NCT01044732|10998449|FG001|Overall Study|Lost to Follow-up|1
6955124|NCT01044732|10998448|FG000|Overall Study|Physician Decision|5
6955125|NCT01044732|10998449|FG001|Overall Study|Physician Decision|3
6955126|NCT01044732|10998448|FG000|Overall Study|Protocol Violation|11
6955127|NCT01044732|10998449|FG001|Overall Study|Protocol Violation|12
6955128|NCT01044732|10998448|FG000|Overall Study|Withdrawal by Subject|0
6955129|NCT01044732|10998449|FG001|Overall Study|Withdrawal by Subject|1
6955130|NCT01044732|10998448|FG000|Overall Study|Inadequate bowel preparation|11
6955131|NCT01044732|10998449|FG001|Overall Study|Inadequate bowel preparation|17
6955132|NCT01044732|10998448|FG000|Overall Study|Inability to reach cecum|5
6955133|NCT01044732|10998449|FG001|Overall Study|Inability to reach cecum|2
6955134|NCT01044732|10998448|FG000|Overall Study|Technical error or malfunction|15
6955135|NCT01044732|10998449|FG001|Overall Study|Technical error or malfunction|14
6955136|NCT01044745|10998457|FG000|Overall Study|Ineiligible|2
6955137|NCT01045096|10998539|FG000|Overall Study|Withdrawal by Subject|2
6955138|NCT01045096|10998540|FG001|Overall Study|Withdrawal by Subject|0
6955139|NCT01045096|10998541|FG002|Overall Study|Withdrawal by Subject|0
6955140|NCT01045096|10998539|FG000|Overall Study|Other|1
6955141|NCT01045096|10998540|FG001|Overall Study|Other|0
6955142|NCT01045096|10998541|FG002|Overall Study|Other|0
6955143|NCT01045161|10998565|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8
6955144|NCT01045161|10998566|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12
6955145|NCT01045161|10998567|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6
6955146|NCT01045161|10998565|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4
6955147|NCT01045161|10998566|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3
6955148|NCT01045161|10998567|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8
6955149|NCT01045161|10998565|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6
6955150|NCT01045161|10998566|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3
6955151|NCT01045161|10998567|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2
6955152|NCT01045161|10998565|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4
6955153|NCT01045161|10998566|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1
6955154|NCT01045161|10998567|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6
6955155|NCT01045161|10998565|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
6955156|NCT01045161|10998566|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
6955157|NCT01045161|10998567|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
6955158|NCT01045161|10998565|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
6955159|NCT01045161|10998566|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4
7070813|NCT02016105|11173512|FG002|TREATMENT PERIOD 1|Physician Decision|0
7070814|NCT02016105|11173513|FG003|TREATMENT PERIOD 1|Physician Decision|0
7070815|NCT02016105|11173514|FG004|TREATMENT PERIOD 1|Physician Decision|0
7070816|NCT02016105|11173515|FG005|TREATMENT PERIOD 1|Physician Decision|0
7070817|NCT02016105|11173510|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4
7070818|NCT02016105|11173511|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2
7070819|NCT02016105|11173512|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0
6955160|NCT01045161|10998567|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
6955161|NCT01045161|10998565|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
6955162|NCT01045161|10998566|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
6955163|NCT01045161|10998567|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2
6955164|NCT01045161|10998565|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10
6955165|NCT01045161|10998566|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7
7070820|NCT02016105|11173513|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0
7070821|NCT02016105|11173514|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0
6955166|NCT01045161|10998567|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9
6955167|NCT01045161|10998565|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10
6955168|NCT01045161|10998566|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10
6955169|NCT01045161|10998567|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7
6955170|NCT01045161|10998565|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3
6955171|NCT01045161|10998566|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
6955172|NCT01045161|10998567|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
6955173|NCT01045161|10998565|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
6955174|NCT01045161|10998566|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5
6955175|NCT01045161|10998567|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
6955176|NCT01045161|10998565|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4
6955177|NCT01045161|10998566|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2
6955178|NCT01045161|10998567|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1
6955179|NCT01045161|10998565|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
6955180|NCT01045161|10998566|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6
6955181|NCT01045161|10998567|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
6955182|NCT01045161|10998565|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5
6955183|NCT01045161|10998566|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1
6955184|NCT01045161|10998567|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6
6955185|NCT01045421|10998607|FG000|Phase 1|Progressive Disease|0
6955186|NCT01045421|10998608|FG001|Phase 1|Progressive Disease|0
6955187|NCT01045421|10998609|FG002|Phase 1|Progressive Disease|0
6955188|NCT01045421|10998610|FG003|Phase 1|Progressive Disease|0
6955189|NCT01045421|10998611|FG004|Phase 1|Progressive Disease|1
6955190|NCT01045421|10998612|FG005|Phase 1|Progressive Disease|0
6955191|NCT01045421|10998613|FG006|Phase 1|Progressive Disease|0
6955192|NCT01045421|10998614|FG007|Phase 1|Progressive Disease|0
6955193|NCT01045421|10998615|FG008|Phase 1|Progressive Disease|0
6955194|NCT01045421|10998616|FG009|Phase 1|Progressive Disease|0
6955195|NCT01045421|10998617|FG010|Phase 1|Progressive Disease|0
6955196|NCT01045421|10998607|FG000|Phase 1|Withdrawal by Subject|0
6955197|NCT01045421|10998608|FG001|Phase 1|Withdrawal by Subject|0
6955198|NCT01045421|10998609|FG002|Phase 1|Withdrawal by Subject|0
6955199|NCT01045421|10998610|FG003|Phase 1|Withdrawal by Subject|1
6955200|NCT01045421|10998611|FG004|Phase 1|Withdrawal by Subject|0
6955201|NCT01045421|10998612|FG005|Phase 1|Withdrawal by Subject|0
6955202|NCT01045421|10998613|FG006|Phase 1|Withdrawal by Subject|0
6955203|NCT01045421|10998614|FG007|Phase 1|Withdrawal by Subject|0
6955204|NCT01045421|10998615|FG008|Phase 1|Withdrawal by Subject|0
6955205|NCT01045421|10998616|FG009|Phase 1|Withdrawal by Subject|0
6955206|NCT01045421|10998617|FG010|Phase 1|Withdrawal by Subject|0
6955207|NCT01045421|10998607|FG000|Phase 2|Progressive Disease|0
6955208|NCT01045421|10998608|FG001|Phase 2|Progressive Disease|0
6955209|NCT01045421|10998609|FG002|Phase 2|Progressive Disease|0
7070822|NCT02016105|11173515|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0
7070823|NCT02016105|11173510|FG000|TREATMENT PERIOD 1|Pregnancy|0
7070824|NCT02016105|11173511|FG001|TREATMENT PERIOD 1|Pregnancy|1
7070825|NCT02016105|11173512|FG002|TREATMENT PERIOD 1|Pregnancy|0
7070826|NCT02016105|11173513|FG003|TREATMENT PERIOD 1|Pregnancy|0
7070827|NCT02016105|11173514|FG004|TREATMENT PERIOD 1|Pregnancy|0
7070828|NCT02016105|11173515|FG005|TREATMENT PERIOD 1|Pregnancy|0
7070829|NCT02016105|11173510|FG000|TREATMENT PERIOD 1|Adverse Event|3
7070830|NCT02016105|11173511|FG001|TREATMENT PERIOD 1|Adverse Event|5
7070831|NCT02016105|11173512|FG002|TREATMENT PERIOD 1|Adverse Event|0
7070832|NCT02016105|11173513|FG003|TREATMENT PERIOD 1|Adverse Event|0
7070833|NCT02016105|11173514|FG004|TREATMENT PERIOD 1|Adverse Event|0
7070834|NCT02016105|11173515|FG005|TREATMENT PERIOD 1|Adverse Event|0
7070835|NCT02016105|11173510|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15
7070836|NCT02016105|11173511|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11
7070837|NCT02016105|11173512|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0
7070838|NCT02016105|11173513|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0
7070839|NCT02016105|11173514|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0
7070840|NCT02016105|11173515|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0
7070841|NCT02016105|11173510|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6
7070842|NCT02016105|11173511|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4
7070843|NCT02016105|11173512|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0
7070844|NCT02016105|11173513|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0
7070845|NCT02016105|11173514|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0
7070846|NCT02016105|11173515|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0
7070847|NCT02016105|11173510|FG000|TREATMENT PERIOD 2|Non compliance study medication|0
7070848|NCT02016105|11173511|FG001|TREATMENT PERIOD 2|Non compliance study medication|0
7070849|NCT02016105|11173512|FG002|TREATMENT PERIOD 2|Non compliance study medication|0
7070850|NCT02016105|11173513|FG003|TREATMENT PERIOD 2|Non compliance study medication|0
7070851|NCT02016105|11173514|FG004|TREATMENT PERIOD 2|Non compliance study medication|0
7070852|NCT02016105|11173515|FG005|TREATMENT PERIOD 2|Non compliance study medication|1
7070853|NCT02016105|11173510|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0
7070854|NCT02016105|11173511|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0
7070855|NCT02016105|11173512|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2
7070856|NCT02016105|11173513|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6
7070857|NCT02016105|11173514|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3
6955210|NCT01045421|10998610|FG003|Phase 2|Progressive Disease|0
7070858|NCT02016105|11173515|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2
6955211|NCT01045421|10998611|FG004|Phase 2|Progressive Disease|0
6955212|NCT01045421|10998612|FG005|Phase 2|Progressive Disease|0
6955213|NCT01045421|10998613|FG006|Phase 2|Progressive Disease|0
6955214|NCT01045421|10998614|FG007|Phase 2|Progressive Disease|1
6955215|NCT01045421|10998615|FG008|Phase 2|Progressive Disease|1
6955216|NCT01045421|10998616|FG009|Phase 2|Progressive Disease|1
6955217|NCT01045421|10998617|FG010|Phase 2|Progressive Disease|1
6955218|NCT01045421|10998607|FG000|Phase 2|Death|0
6955219|NCT01045421|10998608|FG001|Phase 2|Death|0
6955220|NCT01045421|10998609|FG002|Phase 2|Death|0
6955221|NCT01045421|10998610|FG003|Phase 2|Death|0
6955222|NCT01045421|10998611|FG004|Phase 2|Death|0
6955223|NCT01045421|10998612|FG005|Phase 2|Death|0
6955224|NCT01045421|10998613|FG006|Phase 2|Death|0
6955225|NCT01045421|10998614|FG007|Phase 2|Death|1
6955226|NCT01045421|10998615|FG008|Phase 2|Death|1
6955227|NCT01045421|10998616|FG009|Phase 2|Death|2
6955228|NCT01045421|10998617|FG010|Phase 2|Death|0
6955229|NCT01045421|10998607|FG000|Phase 2|Other|0
6955230|NCT01045421|10998608|FG001|Phase 2|Other|0
6955231|NCT01045421|10998609|FG002|Phase 2|Other|0
6955232|NCT01045421|10998610|FG003|Phase 2|Other|0
6955233|NCT01045421|10998611|FG004|Phase 2|Other|0
6955234|NCT01045421|10998612|FG005|Phase 2|Other|0
6955235|NCT01045421|10998613|FG006|Phase 2|Other|0
6955236|NCT01045421|10998614|FG007|Phase 2|Other|3
6955237|NCT01045421|10998615|FG008|Phase 2|Other|0
6955238|NCT01045421|10998616|FG009|Phase 2|Other|0
6955239|NCT01045421|10998617|FG010|Phase 2|Other|1
6955240|NCT01045447|10998640|FG000|Overall Study|Adverse Event|0
6955241|NCT01045447|10998641|FG001|Overall Study|Adverse Event|1
6955242|NCT01045447|10998640|FG000|Overall Study|Lack of Efficacy|3
6955243|NCT01045447|10998641|FG001|Overall Study|Lack of Efficacy|1
6955244|NCT01045447|10998640|FG000|Overall Study|Protocol Violation|6
6955245|NCT01045447|10998641|FG001|Overall Study|Protocol Violation|3
6955246|NCT01045447|10998640|FG000|Overall Study|Withdrawal Criteria|10
6955247|NCT01045447|10998641|FG001|Overall Study|Withdrawal Criteria|10
6955248|NCT01045447|10998640|FG000|Overall Study|Unclassified|17
6955249|NCT01045447|10998641|FG001|Overall Study|Unclassified|13
6955250|NCT01045460|10998649|FG000|Overall Study|Physician Decision|3
6955251|NCT01045460|10998650|FG001|Overall Study|Physician Decision|2
6955252|NCT01045460|10998649|FG000|Overall Study|Lost to Follow-up|0
6955253|NCT01045460|10998650|FG001|Overall Study|Lost to Follow-up|1
6955254|NCT01045460|10998649|FG000|Overall Study|Lack of Efficacy|3
6955255|NCT01045460|10998650|FG001|Overall Study|Lack of Efficacy|0
6955256|NCT01045707|10998669|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5
6955257|NCT01045707|10998670|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3
6955258|NCT01045707|10998669|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4
6955259|NCT01045707|10998670|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2
6955260|NCT01045707|10998669|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6
6955261|NCT01045707|10998670|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5
6955262|NCT01045707|10998669|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22
6955263|NCT01045707|10998670|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11
6955264|NCT01045707|10998669|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10
6955265|NCT01045707|10998670|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11
6955266|NCT01045707|10998669|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
6955267|NCT01045707|10998670|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
6955268|NCT01045707|10998669|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2
6955269|NCT01045707|10998670|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3
6955270|NCT01045707|10998669|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2
6955271|NCT01045707|10998670|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1
6955272|NCT01045707|10998669|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6
6955273|NCT01045707|10998670|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5
6955274|NCT01045798|10998678|FG000|Overall Study|Changed to Open-Label Caspofungin|1
6955275|NCT01045798|10998679|FG001|Overall Study|Changed to Open-Label Caspofungin|0
6955276|NCT01045798|10998678|FG000|Overall Study|Invasive Fungal Infection at Baseline|0
6955277|NCT01045798|10998679|FG001|Overall Study|Invasive Fungal Infection at Baseline|1
7040836|NCT01721044|11124042|FG000|Treatment Period|Lost to Follow-up|0
6955278|NCT01045798|10998678|FG000|Overall Study|Changed to Other Antifungal Therapy|1
6955279|NCT01045798|10998679|FG001|Overall Study|Changed to Other Antifungal Therapy|2
6955280|NCT01045798|10998678|FG000|Overall Study|Received Systemic Antifungal Prestudy|0
6955281|NCT01045798|10998679|FG001|Overall Study|Received Systemic Antifungal Prestudy|1
6955282|NCT01045967|10998687|FG000|Second Intervention|Protocol Violation|0
7040837|NCT01721044|11124043|FG001|Treatment Period|Lost to Follow-up|0
6955283|NCT01045967|10998688|FG001|Second Intervention|Protocol Violation|1
6955284|NCT01045993|10998698|FG000|Overall Study|Treated-later found eligibility not met|0
6955285|NCT01045993|10998699|FG001|Overall Study|Treated-later found eligibility not met|1
6955286|NCT01045993|10998700|FG002|Overall Study|Treated-later found eligibility not met|0
6955287|NCT01045993|10998701|FG003|Overall Study|Treated-later found eligibility not met|0
6955288|NCT01046084|10998713|FG000|Third Washout of 7 Days|Withdrawal by Subject|2
6955289|NCT01046084|10998714|FG001|Third Washout of 7 Days|Withdrawal by Subject|0
6955290|NCT01046110|10998722|FG000|Overall Study|Adverse Event|9
6955291|NCT01046110|10998723|FG001|Overall Study|Adverse Event|2
6955292|NCT01046110|10998722|FG000|Overall Study|Lack of Efficacy|0
6955293|NCT01046110|10998723|FG001|Overall Study|Lack of Efficacy|1
6955294|NCT01046110|10998722|FG000|Overall Study|Protocol Violation|7
6955295|NCT01046110|10998723|FG001|Overall Study|Protocol Violation|12
6955296|NCT01046110|10998722|FG000|Overall Study|Withdrawal Criteria|3
6955297|NCT01046110|10998723|FG001|Overall Study|Withdrawal Criteria|5
6955298|NCT01046110|10998722|FG000|Overall Study|Unclassified|36
6955299|NCT01046110|10998723|FG001|Overall Study|Unclassified|35
6955300|NCT01046136|10998731|FG000|Overall Study|Withdrawal by Subject|0
6955301|NCT01046136|10998732|FG001|Overall Study|Withdrawal by Subject|4
6955302|NCT01046136|10998731|FG000|Overall Study|Physician Decision|1
6955303|NCT01046136|10998732|FG001|Overall Study|Physician Decision|1
6955304|NCT01046136|10998731|FG000|Overall Study|Lost to Follow-up|3
6955305|NCT01046136|10998732|FG001|Overall Study|Lost to Follow-up|3
7070859|NCT02016105|11173510|FG000|TREATMENT PERIOD 2|Pregnancy|0
7070860|NCT02016105|11173511|FG001|TREATMENT PERIOD 2|Pregnancy|0
7070861|NCT02016105|11173512|FG002|TREATMENT PERIOD 2|Pregnancy|0
7070862|NCT02016105|11173513|FG003|TREATMENT PERIOD 2|Pregnancy|0
7070863|NCT02016105|11173514|FG004|TREATMENT PERIOD 2|Pregnancy|0
7070864|NCT02016105|11173515|FG005|TREATMENT PERIOD 2|Pregnancy|1
7070865|NCT02016105|11173510|FG000|TREATMENT PERIOD 2|Death|0
7070866|NCT02016105|11173511|FG001|TREATMENT PERIOD 2|Death|0
7070867|NCT02016105|11173512|FG002|TREATMENT PERIOD 2|Death|0
7070868|NCT02016105|11173513|FG003|TREATMENT PERIOD 2|Death|0
7070869|NCT02016105|11173514|FG004|TREATMENT PERIOD 2|Death|0
7070870|NCT02016105|11173515|FG005|TREATMENT PERIOD 2|Death|1
7070871|NCT02016105|11173510|FG000|TREATMENT PERIOD 2|Adverse Event|0
7070872|NCT02016105|11173511|FG001|TREATMENT PERIOD 2|Adverse Event|0
7070873|NCT02016105|11173512|FG002|TREATMENT PERIOD 2|Adverse Event|0
7070874|NCT02016105|11173513|FG003|TREATMENT PERIOD 2|Adverse Event|4
7070875|NCT02016105|11173514|FG004|TREATMENT PERIOD 2|Adverse Event|0
7070876|NCT02016105|11173515|FG005|TREATMENT PERIOD 2|Adverse Event|1
7070877|NCT02016105|11173510|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0
7070878|NCT02016105|11173511|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0
7070879|NCT02016105|11173512|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3
7070880|NCT02016105|11173513|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1
7070881|NCT02016105|11173514|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1
7070882|NCT02016105|11173515|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7
7070883|NCT02016105|11173510|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0
7070884|NCT02016105|11173511|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0
7070885|NCT02016105|11173512|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1
7070886|NCT02016105|11173513|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0
7070887|NCT02016105|11173514|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0
7070888|NCT02016105|11173515|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1
7070889|NCT02016105|11173510|FG000|EXTENSION PERIOD|New therapy for study indication|0
7070890|NCT02016105|11173511|FG001|EXTENSION PERIOD|New therapy for study indication|0
7070891|NCT02016105|11173512|FG002|EXTENSION PERIOD|New therapy for study indication|0
7070892|NCT02016105|11173513|FG003|EXTENSION PERIOD|New therapy for study indication|0
7070893|NCT02016105|11173514|FG004|EXTENSION PERIOD|New therapy for study indication|1
7070894|NCT02016105|11173515|FG005|EXTENSION PERIOD|New therapy for study indication|1
7070895|NCT02016105|11173510|FG000|EXTENSION PERIOD|Lack of Efficacy|0
7070896|NCT02016105|11173511|FG001|EXTENSION PERIOD|Lack of Efficacy|0
7070897|NCT02016105|11173512|FG002|EXTENSION PERIOD|Lack of Efficacy|1
7070898|NCT02016105|11173513|FG003|EXTENSION PERIOD|Lack of Efficacy|3
7070899|NCT02016105|11173514|FG004|EXTENSION PERIOD|Lack of Efficacy|1
7070900|NCT02016105|11173515|FG005|EXTENSION PERIOD|Lack of Efficacy|1
7070901|NCT02016105|11173510|FG000|EXTENSION PERIOD|Adverse Event|0
7070902|NCT02016105|11173511|FG001|EXTENSION PERIOD|Adverse Event|0
7070903|NCT02016105|11173512|FG002|EXTENSION PERIOD|Adverse Event|2
7070904|NCT02016105|11173513|FG003|EXTENSION PERIOD|Adverse Event|0
7070905|NCT02016105|11173514|FG004|EXTENSION PERIOD|Adverse Event|1
7070906|NCT02016105|11173515|FG005|EXTENSION PERIOD|Adverse Event|0
7070907|NCT02016105|11173510|FG000|EXTENSION PERIOD|Withdrawal by Subject|0
7070908|NCT02016105|11173511|FG001|EXTENSION PERIOD|Withdrawal by Subject|0
7070909|NCT02016105|11173512|FG002|EXTENSION PERIOD|Withdrawal by Subject|2
7070910|NCT02016105|11173513|FG003|EXTENSION PERIOD|Withdrawal by Subject|2
7070911|NCT02016105|11173514|FG004|EXTENSION PERIOD|Withdrawal by Subject|2
7070912|NCT02016105|11173515|FG005|EXTENSION PERIOD|Withdrawal by Subject|2
7070913|NCT02016105|11173510|FG000|EXTENSION PERIOD|Non-compliance with study indication|0
7070914|NCT02016105|11173511|FG001|EXTENSION PERIOD|Non-compliance with study indication|0
7070915|NCT02016105|11173512|FG002|EXTENSION PERIOD|Non-compliance with study indication|0
7070916|NCT02016105|11173513|FG003|EXTENSION PERIOD|Non-compliance with study indication|0
7070917|NCT02016105|11173514|FG004|EXTENSION PERIOD|Non-compliance with study indication|1
7070918|NCT02016105|11173515|FG005|EXTENSION PERIOD|Non-compliance with study indication|0
7070919|NCT02016105|11173510|FG000|EXTENSION PERIOD|Lost to Follow-up|0
6955306|NCT01046253|10998742|FG000|Second Intervention|Adverse Event|0
7070920|NCT02016105|11173511|FG001|EXTENSION PERIOD|Lost to Follow-up|0
7070921|NCT02016105|11173512|FG002|EXTENSION PERIOD|Lost to Follow-up|0
7070922|NCT02016105|11173513|FG003|EXTENSION PERIOD|Lost to Follow-up|0
6955307|NCT01046253|10998743|FG001|Second Intervention|Adverse Event|1
6955308|NCT01046253|10998742|FG000|Second Intervention|Protocol Violation|0
6955309|NCT01046253|10998743|FG001|Second Intervention|Protocol Violation|1
7070923|NCT02016105|11173514|FG004|EXTENSION PERIOD|Lost to Follow-up|0
7070924|NCT02016105|11173515|FG005|EXTENSION PERIOD|Lost to Follow-up|2
7070925|NCT02016170|11173532|FG000|Overall Study|Adverse Event|1
6955310|NCT01046396|10998749|FG000|Overall Study|Withdrawal by Subject|5
6955311|NCT01046565|10998756|FG000|Overall Study|Adverse Event|2
6955312|NCT01046565|10998756|FG000|Overall Study|Withdrawal by Subject|7
6955313|NCT01046643|10998767|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0
6955314|NCT01046643|10998768|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1
6955315|NCT01046643|10998769|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0
6955316|NCT01046643|10998770|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0
6955317|NCT01046682|10998791|FG000|Overall Study|Adverse Event|2
6955318|NCT01046682|10998792|FG001|Overall Study|Adverse Event|0
6955319|NCT01046695|10998800|FG000|Overall Study|Subject had a pacemaker|0
6955320|NCT01046695|10998801|FG001|Overall Study|Subject had a pacemaker|1
6955321|NCT01046695|10998800|FG000|Overall Study|TENS interfered with the cardiac monitor|0
6955322|NCT01046695|10998801|FG001|Overall Study|TENS interfered with the cardiac monitor|1
6955323|NCT01046877|10998807|FG000|Overall Study|Exited voluntarily before tube extrusion|7
6955324|NCT01046877|10998807|FG000|Overall Study|Exited voluntarily after tube extrusion|11
6955325|NCT01046903|10998811|FG000|Overall Study|Lost to Follow-up|16
6955326|NCT01046903|10998811|FG000|Overall Study|Adverse Event|4
6955327|NCT01046903|10998811|FG000|Overall Study|Withdrawal by Subject|3
6955328|NCT01046903|10998811|FG000|Overall Study|Other|5
6955329|NCT01047007|10998819|FG000|Overall Study|Adverse Event|0
6955330|NCT01047007|10998820|FG001|Overall Study|Adverse Event|2
6955331|NCT01047007|10998821|FG002|Overall Study|Adverse Event|1
6955332|NCT01047007|10998822|FG003|Overall Study|Adverse Event|0
6955333|NCT01047007|10998819|FG000|Overall Study|Progressive Disease|2
6955334|NCT01047007|10998820|FG001|Overall Study|Progressive Disease|4
6955335|NCT01047007|10998821|FG002|Overall Study|Progressive Disease|1
6955336|NCT01047007|10998822|FG003|Overall Study|Progressive Disease|0
6955337|NCT01047293|10998848|FG000|Overall Study|DLT criteria not fulfilled|1
6955338|NCT01047293|10998849|FG001|Overall Study|DLT criteria not fulfilled|1
6955339|NCT01047293|10998850|FG002|Overall Study|DLT criteria not fulfilled|0
6955340|NCT01047293|10998851|FG003|Overall Study|DLT criteria not fulfilled|0
6955341|NCT01047306|10998860|FG000|Overall Study|Withdrawal by Subject|2
6955342|NCT01047306|10998861|FG001|Overall Study|Withdrawal by Subject|0
6955343|NCT01047306|10998860|FG000|Overall Study|Lost to Follow-up|1
6955344|NCT01047306|10998861|FG001|Overall Study|Lost to Follow-up|0
6955345|NCT01047332|10998871|FG000|Overall Study|SEMS Obstruction|11
6955346|NCT01047332|10998872|FG001|Overall Study|SEMS Obstruction|20
7070926|NCT02016170|11173533|FG001|Overall Study|Adverse Event|1
7070927|NCT02016170|11173534|FG002|Overall Study|Adverse Event|0
7070928|NCT02016170|11173532|FG000|Overall Study|Protocol Violation|1
7070929|NCT02016170|11173533|FG001|Overall Study|Protocol Violation|0
7070930|NCT02016170|11173534|FG002|Overall Study|Protocol Violation|0
7070931|NCT02016183|11173541|FG000|Overall Study|Case Report Forms Uncollected|13
7070932|NCT02016183|11173541|FG000|Overall Study|Protocol Violation|52
7070933|NCT02016300|11173560|FG000|Overall Study|Lost to Follow-up|0
7070934|NCT02016300|11173561|FG001|Overall Study|Lost to Follow-up|3
7070935|NCT02016482|11173569|FG000|Period A|Adverse Event|3
7070936|NCT02016482|11173570|FG001|Period A|Adverse Event|5
7070937|NCT02016482|11173569|FG000|Period A|Withdrawal by Subject|3
7070938|NCT02016482|11173570|FG001|Period A|Withdrawal by Subject|4
7070939|NCT02016482|11173569|FG000|Period A|Lost to Follow-up|3
7070940|NCT02016482|11173570|FG001|Period A|Lost to Follow-up|3
7070941|NCT02016482|11173569|FG000|Period A|Lack of Efficacy|2
7070942|NCT02016482|11173570|FG001|Period A|Lack of Efficacy|1
7070943|NCT02016482|11173569|FG000|Period A|Other|3
7070944|NCT02016482|11173570|FG001|Period A|Other|0
7070945|NCT02016482|11173569|FG000|Period A|Protocol Violation|0
7070946|NCT02016482|11173570|FG001|Period A|Protocol Violation|1
7070947|NCT02016482|11173569|FG000|Period A|Required Alternative/Prohibited Therapy|0
7070948|NCT02016482|11173570|FG001|Period A|Required Alternative/Prohibited Therapy|1
7070949|NCT02016482|11173569|FG000|Period B|Withdrawal by Subject|1
7070950|NCT02016482|11173570|FG001|Period B|Withdrawal by Subject|1
7070951|NCT02016482|11173569|FG000|Period B|Lost to Follow-up|2
7070952|NCT02016482|11173570|FG001|Period B|Lost to Follow-up|0
7070953|NCT02016482|11173569|FG000|Period B|Lack of Efficacy|6
7070954|NCT02016482|11173570|FG001|Period B|Lack of Efficacy|4
7070955|NCT02016482|11173569|FG000|Period B|Other|4
7070956|NCT02016482|11173570|FG001|Period B|Other|0
7070957|NCT02016482|11173569|FG000|Period B|Required Alternative/Prohibited Therapy|0
7070958|NCT02016482|11173570|FG001|Period B|Required Alternative/Prohibited Therapy|2
6955347|NCT01047332|10998871|FG000|Overall Study|Died Unobstructed|38
6955348|NCT01047332|10998872|FG001|Overall Study|Died Unobstructed|41
6955349|NCT01047332|10998871|FG000|Overall Study|Lost to Follow-up|8
7070959|NCT02016625|11173630|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0
7070960|NCT02016625|11173631|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1
7070961|NCT02016625|11173630|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1
7070962|NCT02016625|11173631|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0
6955350|NCT01047332|10998872|FG001|Overall Study|Lost to Follow-up|3
6955351|NCT01047345|10998880|FG000|Base Study|Adverse Event|3
6955352|NCT01047345|10998881|FG001|Base Study|Adverse Event|0
6955353|NCT01047345|10998882|FG002|Base Study|Adverse Event|0
6955354|NCT01047345|10998880|FG000|Base Study|Lost to Follow-up|4
6955355|NCT01047345|10998881|FG001|Base Study|Lost to Follow-up|1
7070963|NCT02016625|11173630|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2
7147804|NCT03136159|11308669|FG001|Overall Study|never got dressing placed|0
6955356|NCT01047345|10998882|FG002|Base Study|Lost to Follow-up|0
6955357|NCT01047345|10998880|FG000|Base Study|Protocol Violation|3
6955358|NCT01047345|10998881|FG001|Base Study|Protocol Violation|1
6955359|NCT01047345|10998882|FG002|Base Study|Protocol Violation|0
6955360|NCT01047345|10998880|FG000|Base Study|Withdrawal by Subject|12
6955361|NCT01047345|10998881|FG001|Base Study|Withdrawal by Subject|4
6955362|NCT01047345|10998882|FG002|Base Study|Withdrawal by Subject|0
6955363|NCT01047345|10998880|FG000|Extension|Withdrawal by Subject|0
6955364|NCT01047345|10998881|FG001|Extension|Withdrawal by Subject|0
6955365|NCT01047345|10998882|FG002|Extension|Withdrawal by Subject|1
6955366|NCT01047345|10998880|FG000|Extension|Lost to Follow-up|0
6955367|NCT01047345|10998881|FG001|Extension|Lost to Follow-up|0
6955368|NCT01047345|10998882|FG002|Extension|Lost to Follow-up|5
6955369|NCT01047436|10998897|FG000|Overall Study|Protocol Violation|1
6955370|NCT01047436|10998898|FG001|Overall Study|Protocol Violation|0
6955371|NCT01047553|10998929|FG000|Overall Study|Adverse Event|10
6955372|NCT01047553|10998930|FG001|Overall Study|Adverse Event|5
6955373|NCT01047553|10998929|FG000|Overall Study|Withdrawal by Subject|4
6955374|NCT01047553|10998930|FG001|Overall Study|Withdrawal by Subject|2
6955375|NCT01047553|10998929|FG000|Overall Study|Development of Study-Specific Withdrawal|1
6955376|NCT01047553|10998930|FG001|Overall Study|Development of Study-Specific Withdrawal|1
6955377|NCT01047553|10998929|FG000|Overall Study|Lost to Follow-up|1
6955378|NCT01047553|10998930|FG001|Overall Study|Lost to Follow-up|0
6955379|NCT01047553|10998929|FG000|Overall Study|Sever Non-Compliance to Protocol|1
6955380|NCT01047553|10998930|FG001|Overall Study|Sever Non-Compliance to Protocol|0
6955381|NCT01047553|10998929|FG000|Overall Study|PI's decision|0
6955382|NCT01047553|10998930|FG001|Overall Study|PI's decision|1
6955383|NCT01048099|10998963|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57
6955384|NCT01048099|10998963|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202
6955385|NCT01048242|10998971|FG000|Overall Study|See study flow chart|4
6955386|NCT01048242|10998972|FG001|Overall Study|See study flow chart|2
6955387|NCT01048333|10998978|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
6955388|NCT01048333|10998979|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1
6955389|NCT01048333|10998980|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
6955390|NCT01048333|10998981|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
6955391|NCT01048333|10998982|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
6955392|NCT01048333|10998983|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
6955393|NCT01048502|10999005|FG000|Overall Study|Lost to Follow-up|2
6955394|NCT01048502|10999006|FG001|Overall Study|Lost to Follow-up|0
6955395|NCT01048502|10999007|FG002|Overall Study|Lost to Follow-up|0
6955396|NCT01048502|10999008|FG003|Overall Study|Lost to Follow-up|0
6955397|NCT01048502|10999005|FG000|Overall Study|Adverse Event|1
6955398|NCT01048502|10999006|FG001|Overall Study|Adverse Event|0
6955399|NCT01048502|10999007|FG002|Overall Study|Adverse Event|0
6955400|NCT01048502|10999008|FG003|Overall Study|Adverse Event|0
6955401|NCT01048502|10999005|FG000|Overall Study|Withdrawal by Subject|1
6955402|NCT01048502|10999006|FG001|Overall Study|Withdrawal by Subject|4
6955403|NCT01048502|10999007|FG002|Overall Study|Withdrawal by Subject|5
6955404|NCT01048502|10999008|FG003|Overall Study|Withdrawal by Subject|3
6955405|NCT01048502|10999005|FG000|Overall Study|Physician Decision|0
6955406|NCT01048502|10999006|FG001|Overall Study|Physician Decision|3
6955407|NCT01048502|10999007|FG002|Overall Study|Physician Decision|0
6955408|NCT01048502|10999008|FG003|Overall Study|Physician Decision|1
6955409|NCT01048541|10999019|FG000|Overall Study|Withdrawal by Subject|1
6955410|NCT01048541|10999020|FG001|Overall Study|Withdrawal by Subject|0
6955411|NCT01048671|10999068|FG000|Overall Study|Protocol Violation|0
6955412|NCT01048671|10999069|FG001|Overall Study|Protocol Violation|1
6955413|NCT01048671|10999070|FG002|Overall Study|Protocol Violation|1
6955414|NCT01048788|10999085|FG000|Overall Study|Adverse Event|5
6955415|NCT01048788|10999086|FG001|Overall Study|Adverse Event|1
6955416|NCT01048788|10999087|FG002|Overall Study|Adverse Event|1
6955417|NCT01048788|10999085|FG000|Overall Study|Lack of Efficacy|0
6955418|NCT01048788|10999086|FG001|Overall Study|Lack of Efficacy|0
6955419|NCT01048788|10999087|FG002|Overall Study|Lack of Efficacy|1
6955420|NCT01048788|10999085|FG000|Overall Study|Withdrawal by Subject|0
6955421|NCT01048788|10999086|FG001|Overall Study|Withdrawal by Subject|1
6955422|NCT01048788|10999087|FG002|Overall Study|Withdrawal by Subject|0
6955423|NCT01048866|10999097|FG000|Overall Study|Adverse Event|1
6955424|NCT01048866|10999098|FG001|Overall Study|Adverse Event|0
6955425|NCT01048866|10999097|FG000|Overall Study|Protocol Violation|1
6955426|NCT01048866|10999098|FG001|Overall Study|Protocol Violation|0
6955427|NCT01048866|10999097|FG000|Overall Study|Physician Decision|1
6955428|NCT01048866|10999098|FG001|Overall Study|Physician Decision|0
6955429|NCT01048866|10999097|FG000|Overall Study|Withdrawal by Subject|0
6955430|NCT01048866|10999098|FG001|Overall Study|Withdrawal by Subject|2
6955431|NCT01048866|10999097|FG000|Overall Study|Lost to Follow-up|0
6955432|NCT01048866|10999098|FG001|Overall Study|Lost to Follow-up|2
6955433|NCT01048866|10999097|FG000|Overall Study|Other|1
6955434|NCT01048866|10999098|FG001|Overall Study|Other|1
6955435|NCT01048944|10999125|FG000|Overall Study|Protocol Violation|8
7040838|NCT01721044|11124044|FG002|Treatment Period|Lost to Follow-up|1
7040839|NCT01721044|11124042|FG000|Treatment Period|Physician Decision|1
6955436|NCT01048944|10999126|FG001|Overall Study|Protocol Violation|10
6955437|NCT01048944|10999127|FG002|Overall Study|Protocol Violation|10
6955438|NCT01048944|10999128|FG003|Overall Study|Protocol Violation|2
6955439|NCT01049009|10999140|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2
7070964|NCT02016625|11173631|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0
7070965|NCT02016690|11173647|FG000|Overall Study|Excluded from SAS: Enrollment violation|2
7070966|NCT02016690|11173647|FG000|Overall Study|Excluded from SAS: Duplication|2
7070967|NCT02016690|11173647|FG000|Overall Study|Excluded from SAS: Early treatment|2
6955440|NCT01049009|10999141|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2
6955441|NCT01049009|10999140|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
6955442|NCT01049009|10999141|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
6955443|NCT01049009|10999140|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
6955444|NCT01049009|10999141|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3
6955445|NCT01049009|10999140|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8
6955446|NCT01049009|10999141|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7
6955447|NCT01049217|10999149|FG000|Overall Study|Adverse Event|2
6955448|NCT01049217|10999150|FG001|Overall Study|Adverse Event|1
6955449|NCT01049217|10999149|FG000|Overall Study|Lack of Efficacy|1
6955450|NCT01049217|10999150|FG001|Overall Study|Lack of Efficacy|1
6955451|NCT01049217|10999149|FG000|Overall Study|Lost to Follow-up|3
6955452|NCT01049217|10999150|FG001|Overall Study|Lost to Follow-up|8
6955453|NCT01049217|10999149|FG000|Overall Study|Withdrawal by Subject|4
6955454|NCT01049217|10999150|FG001|Overall Study|Withdrawal by Subject|3
6955455|NCT01049217|10999149|FG000|Overall Study|Protocol Violation|1
6955456|NCT01049217|10999150|FG001|Overall Study|Protocol Violation|3
6955457|NCT01049217|10999149|FG000|Overall Study|Pregnancy|1
6955458|NCT01049217|10999150|FG001|Overall Study|Pregnancy|0
6955459|NCT01049217|10999149|FG000|Overall Study|Study Terminated by Sponsor|43
6955460|NCT01049217|10999150|FG001|Overall Study|Study Terminated by Sponsor|43
6955461|NCT01049217|10999149|FG000|Overall Study|Other|1
6955462|NCT01049217|10999150|FG001|Overall Study|Other|2
6955463|NCT01049217|10999149|FG000|Overall Study|Randomized but not Treated|0
6955464|NCT01049217|10999150|FG001|Overall Study|Randomized but not Treated|2
6955465|NCT01049308|10999161|FG000|Pill Counts|Withdrawal by Subject|83
6955466|NCT01049334|10999170|FG000|Overall Study|Withdrawal by Subject|5
6955467|NCT01049334|10999171|FG001|Overall Study|Withdrawal by Subject|3
6955468|NCT01049334|10999170|FG000|Overall Study|Adverse Event|2
6955469|NCT01049334|10999171|FG001|Overall Study|Adverse Event|3
7070968|NCT02016690|11173647|FG000|Overall Study|Excluded from SAS: Ineligible for study|2
7070969|NCT02016690|11173647|FG000|Overall Study|Did not meet inclusion criteria|13
7070970|NCT02016690|11173647|FG000|Overall Study|Hospitalized for RSV at study start|3
7070971|NCT02016716|11173654|FG000|Overall Study|Withdrawal by Subject|5
7070972|NCT02016716|11173655|FG001|Overall Study|Withdrawal by Subject|5
7070973|NCT02016716|11173656|FG002|Overall Study|Withdrawal by Subject|5
7070974|NCT02016716|11173654|FG000|Overall Study|Protocol-specified Criteria|0
7070975|NCT02016716|11173655|FG001|Overall Study|Protocol-specified Criteria|1
7070976|NCT02016716|11173656|FG002|Overall Study|Protocol-specified Criteria|0
7070977|NCT02016716|11173654|FG000|Overall Study|Lost to Follow-up|1
7070978|NCT02016716|11173655|FG001|Overall Study|Lost to Follow-up|2
7070979|NCT02016716|11173656|FG002|Overall Study|Lost to Follow-up|1
7070980|NCT02016755|11173665|FG000|Overall Study|Major amputation of index limb|2
7070981|NCT02016755|11173665|FG000|Overall Study|Adverse Event|2
7070982|NCT02016755|11173665|FG000|Overall Study|Physician Decision|1
7070983|NCT02016755|11173665|FG000|Overall Study|Death|2
7082650|NCT02143713|11193211|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2
7082651|NCT02143713|11193212|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4
7082652|NCT02143713|11193213|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4
7082653|NCT02143713|11193214|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1
7082654|NCT02143713|11193211|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0
7082655|NCT02143713|11193212|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1
7082656|NCT02143713|11193213|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0
7082657|NCT02143713|11193214|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1
7082658|NCT02143713|11193211|FG000|Post-treatment Follow-up (12 Months)|Other|3
7082659|NCT02143713|11193212|FG001|Post-treatment Follow-up (12 Months)|Other|4
7082660|NCT02143713|11193213|FG002|Post-treatment Follow-up (12 Months)|Other|7
7082661|NCT02143713|11193214|FG003|Post-treatment Follow-up (12 Months)|Other|7
7082662|NCT02143778|11193225|FG000|Overall Study|Withdrawal by Subject|2
7082663|NCT02143778|11193225|FG000|Overall Study|Device malfunction|1
7082664|NCT02143843|11193230|FG000|Overall Study|Adverse Event|8
7082665|NCT02143843|11193230|FG000|Overall Study|Lack of Efficacy|2
7082666|NCT02143843|11193230|FG000|Overall Study|Withdrawal by Subject|2
7082667|NCT02143947|11193236|FG000|Overall Study|Lost to Follow-up|4
7082668|NCT02143947|11193237|FG001|Overall Study|Lost to Follow-up|2
7082669|NCT02144012|11193251|FG000|Overall Study|Adverse Event|1
7082670|NCT02144012|11193252|FG001|Overall Study|Adverse Event|0
6955470|NCT01049334|10999170|FG000|Overall Study|Physician Decision|2
6955471|NCT01049334|10999171|FG001|Overall Study|Physician Decision|0
6955472|NCT01049334|10999170|FG000|Overall Study|Protocol Violation|0
6955473|NCT01049334|10999171|FG001|Overall Study|Protocol Violation|1
6955474|NCT01049360|10999177|FG000|Period 1|Adverse Event|0
6955475|NCT01049360|10999178|FG001|Period 1|Adverse Event|1
6955476|NCT01049360|10999179|FG002|Period 1|Adverse Event|0
6955477|NCT01049360|10999180|FG003|Period 1|Adverse Event|1
6955478|NCT01049360|10999181|FG004|Period 1|Adverse Event|0
6955479|NCT01049360|10999182|FG005|Period 1|Adverse Event|0
6955480|NCT01049360|10999183|FG006|Period 1|Adverse Event|0
6955481|NCT01049360|10999184|FG007|Period 1|Adverse Event|1
6955482|NCT01049360|10999185|FG008|Period 1|Adverse Event|0
6955483|NCT01049360|10999186|FG009|Period 1|Adverse Event|0
6955484|NCT01049360|10999187|FG010|Period 1|Adverse Event|0
6955485|NCT01049360|10999188|FG011|Period 1|Adverse Event|0
6955486|NCT01049360|10999189|FG012|Period 1|Adverse Event|1
6955487|NCT01049360|10999190|FG013|Period 1|Adverse Event|1
6955488|NCT01049360|10999191|FG014|Period 1|Adverse Event|0
6955489|NCT01049360|10999192|FG015|Period 1|Adverse Event|0
6955490|NCT01049360|10999193|FG016|Period 1|Adverse Event|1
6955491|NCT01049360|10999194|FG017|Period 1|Adverse Event|0
6955492|NCT01049360|10999195|FG018|Period 1|Adverse Event|1
6955493|NCT01049360|10999196|FG019|Period 1|Adverse Event|0
6955494|NCT01049360|10999177|FG000|Period 1|Did not meet inc/exc criteria|0
6955495|NCT01049360|10999178|FG001|Period 1|Did not meet inc/exc criteria|0
6955496|NCT01049360|10999179|FG002|Period 1|Did not meet inc/exc criteria|0
6955497|NCT01049360|10999180|FG003|Period 1|Did not meet inc/exc criteria|0
6955498|NCT01049360|10999181|FG004|Period 1|Did not meet inc/exc criteria|0
6955499|NCT01049360|10999182|FG005|Period 1|Did not meet inc/exc criteria|0
6955500|NCT01049360|10999183|FG006|Period 1|Did not meet inc/exc criteria|0
6955501|NCT01049360|10999184|FG007|Period 1|Did not meet inc/exc criteria|1
6955502|NCT01049360|10999185|FG008|Period 1|Did not meet inc/exc criteria|1
6955503|NCT01049360|10999186|FG009|Period 1|Did not meet inc/exc criteria|0
6955504|NCT01049360|10999187|FG010|Period 1|Did not meet inc/exc criteria|0
7070984|NCT02016898|11173692|FG000|Overall Study|Death|1
7070985|NCT02016898|11173693|FG001|Overall Study|Death|1
7070986|NCT02016898|11173692|FG000|Overall Study|Lost to Follow-up|4
7070987|NCT02016898|11173693|FG001|Overall Study|Lost to Follow-up|4
7070988|NCT02017015|11173704|FG000|Overall Study|Adverse Event|9
7070989|NCT02017015|11173704|FG000|Overall Study|Withdrawal by Subject|21
7070990|NCT02017015|11173704|FG000|Overall Study|Death|4
7070991|NCT02017015|11173704|FG000|Overall Study|Progressive Disease|31
7070992|NCT02017015|11173704|FG000|Overall Study|Non-compliance with study drug|2
7070993|NCT02017015|11173704|FG000|Overall Study|Physician Decision|2
7070994|NCT02017171|11173722|FG000|Overall Study|Death|10
7070995|NCT02017171|11173723|FG001|Overall Study|Death|4
7070996|NCT02017171|11173722|FG000|Overall Study|Withdrawal by Subject|23
7070997|NCT02017171|11173723|FG001|Overall Study|Withdrawal by Subject|17
7070998|NCT02017171|11173722|FG000|Overall Study|Lost to Follow-up|21
7070999|NCT02017171|11173723|FG001|Overall Study|Lost to Follow-up|20
7071000|NCT02017171|11173722|FG000|Overall Study|ESKD|6
7071001|NCT02017171|11173723|FG001|Overall Study|ESKD|2
7071002|NCT02017171|11173722|FG000|Overall Study|Miscellaneous|2
7071003|NCT02017171|11173723|FG001|Overall Study|Miscellaneous|3
7071004|NCT02017223|11173746|FG000|Overall Study|Algorithm problems|2
7071005|NCT02017444|11173765|FG000|Overall Study|Physician Decision|1
7071006|NCT02017444|11173766|FG001|Overall Study|Physician Decision|0
7071007|NCT02017444|11173765|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1
6955505|NCT01049360|10999188|FG011|Period 1|Did not meet inc/exc criteria|0
6955506|NCT01049360|10999189|FG012|Period 1|Did not meet inc/exc criteria|0
6955507|NCT01049360|10999190|FG013|Period 1|Did not meet inc/exc criteria|0
7071008|NCT02017444|11173766|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0
7071009|NCT02017535|11173776|FG000|Overall Study|Withdrawal by Subject|1
7071010|NCT02017535|11173777|FG001|Overall Study|Withdrawal by Subject|0
7071011|NCT02017535|11173778|FG002|Overall Study|Withdrawal by Subject|0
7071012|NCT02017535|11173779|FG003|Overall Study|Withdrawal by Subject|0
7071013|NCT02017860|11173798|FG000|Overall Study|Adverse Event|1
7071014|NCT02017860|11173798|FG000|Overall Study|Withdrawal by Subject|1
7071015|NCT02017899|11173808|FG000|Overall Study|Withdrawal by Subject|0
7071016|NCT02017899|11173809|FG001|Overall Study|Withdrawal by Subject|0
7071017|NCT02017899|11173810|FG002|Overall Study|Withdrawal by Subject|0
7071018|NCT02017899|11173811|FG003|Overall Study|Withdrawal by Subject|1
7071019|NCT02017899|11173812|FG004|Overall Study|Withdrawal by Subject|1
7071020|NCT02017899|11173813|FG005|Overall Study|Withdrawal by Subject|0
7071021|NCT02018042|11173827|FG000|Overall Study|Withdrawal by Subject|1
7071022|NCT02018458|11173846|FG000|Overall Study|Death|4
7071023|NCT02018562|11173852|FG000|Overall Study|Withdrawal by Subject|2
7071024|NCT02018562|11173853|FG001|Overall Study|Withdrawal by Subject|0
7071025|NCT02018562|11173852|FG000|Overall Study|Discharged prior to study completion|1
7071026|NCT02018562|11173853|FG001|Overall Study|Discharged prior to study completion|0
7071027|NCT02018822|11173896|FG000|Overall Study|filling replaced by crown|0
7071028|NCT02018822|11173897|FG001|Overall Study|filling replaced by crown|1
7071029|NCT02018822|11173898|FG002|Overall Study|filling replaced by crown|0
6955508|NCT01049360|10999191|FG014|Period 1|Did not meet inc/exc criteria|0
6955509|NCT01049360|10999192|FG015|Period 1|Did not meet inc/exc criteria|0
6955510|NCT01049360|10999193|FG016|Period 1|Did not meet inc/exc criteria|0
6955511|NCT01049360|10999194|FG017|Period 1|Did not meet inc/exc criteria|0
6955512|NCT01049360|10999195|FG018|Period 1|Did not meet inc/exc criteria|0
6955513|NCT01049360|10999196|FG019|Period 1|Did not meet inc/exc criteria|0
6955514|NCT01049360|10999177|FG000|Period 1|Withdrawal by Subject|0
6955515|NCT01049360|10999178|FG001|Period 1|Withdrawal by Subject|0
6955516|NCT01049360|10999179|FG002|Period 1|Withdrawal by Subject|0
6955517|NCT01049360|10999180|FG003|Period 1|Withdrawal by Subject|0
6955518|NCT01049360|10999181|FG004|Period 1|Withdrawal by Subject|0
6955519|NCT01049360|10999182|FG005|Period 1|Withdrawal by Subject|0
6955520|NCT01049360|10999183|FG006|Period 1|Withdrawal by Subject|0
6955521|NCT01049360|10999184|FG007|Period 1|Withdrawal by Subject|0
6955522|NCT01049360|10999185|FG008|Period 1|Withdrawal by Subject|1
6955523|NCT01049360|10999186|FG009|Period 1|Withdrawal by Subject|0
6955524|NCT01049360|10999187|FG010|Period 1|Withdrawal by Subject|1
6955525|NCT01049360|10999188|FG011|Period 1|Withdrawal by Subject|0
6955526|NCT01049360|10999189|FG012|Period 1|Withdrawal by Subject|1
6955527|NCT01049360|10999190|FG013|Period 1|Withdrawal by Subject|0
6955528|NCT01049360|10999191|FG014|Period 1|Withdrawal by Subject|0
6955529|NCT01049360|10999192|FG015|Period 1|Withdrawal by Subject|0
6955530|NCT01049360|10999193|FG016|Period 1|Withdrawal by Subject|0
6955531|NCT01049360|10999194|FG017|Period 1|Withdrawal by Subject|0
6955532|NCT01049360|10999195|FG018|Period 1|Withdrawal by Subject|0
6955533|NCT01049360|10999196|FG019|Period 1|Withdrawal by Subject|0
6955534|NCT01049360|10999177|FG000|Period 2|Protocol Violation|0
6955535|NCT01049360|10999178|FG001|Period 2|Protocol Violation|0
6955536|NCT01049360|10999179|FG002|Period 2|Protocol Violation|0
6955537|NCT01049360|10999180|FG003|Period 2|Protocol Violation|1
6955538|NCT01049360|10999181|FG004|Period 2|Protocol Violation|0
6955539|NCT01049360|10999182|FG005|Period 2|Protocol Violation|0
6955540|NCT01049360|10999183|FG006|Period 2|Protocol Violation|0
6955541|NCT01049360|10999184|FG007|Period 2|Protocol Violation|0
6955542|NCT01049360|10999185|FG008|Period 2|Protocol Violation|0
6955543|NCT01049360|10999186|FG009|Period 2|Protocol Violation|0
6955544|NCT01049360|10999187|FG010|Period 2|Protocol Violation|0
6955545|NCT01049360|10999188|FG011|Period 2|Protocol Violation|0
6955546|NCT01049360|10999189|FG012|Period 2|Protocol Violation|0
6955547|NCT01049360|10999190|FG013|Period 2|Protocol Violation|0
6955548|NCT01049360|10999191|FG014|Period 2|Protocol Violation|1
6955549|NCT01049360|10999192|FG015|Period 2|Protocol Violation|1
6955550|NCT01049360|10999193|FG016|Period 2|Protocol Violation|0
6955551|NCT01049360|10999194|FG017|Period 2|Protocol Violation|0
6955552|NCT01049360|10999195|FG018|Period 2|Protocol Violation|0
6955553|NCT01049360|10999196|FG019|Period 2|Protocol Violation|0
6955554|NCT01049360|10999177|FG000|Period 2|Adverse Event|0
6955555|NCT01049360|10999178|FG001|Period 2|Adverse Event|1
6955556|NCT01049360|10999179|FG002|Period 2|Adverse Event|0
6955557|NCT01049360|10999180|FG003|Period 2|Adverse Event|0
6955558|NCT01049360|10999181|FG004|Period 2|Adverse Event|0
6955559|NCT01049360|10999182|FG005|Period 2|Adverse Event|0
6955560|NCT01049360|10999183|FG006|Period 2|Adverse Event|0
6955561|NCT01049360|10999184|FG007|Period 2|Adverse Event|0
6955562|NCT01049360|10999185|FG008|Period 2|Adverse Event|1
6955563|NCT01049360|10999186|FG009|Period 2|Adverse Event|0
6955564|NCT01049360|10999187|FG010|Period 2|Adverse Event|0
6955565|NCT01049360|10999188|FG011|Period 2|Adverse Event|0
6955566|NCT01049360|10999189|FG012|Period 2|Adverse Event|0
6955567|NCT01049360|10999190|FG013|Period 2|Adverse Event|0
6955568|NCT01049360|10999191|FG014|Period 2|Adverse Event|0
6955569|NCT01049360|10999192|FG015|Period 2|Adverse Event|0
7071030|NCT02018822|11173896|FG000|Overall Study|Physician Decision|0
7071031|NCT02018822|11173897|FG001|Overall Study|Physician Decision|1
7071032|NCT02018822|11173898|FG002|Overall Study|Physician Decision|1
7071033|NCT02018822|11173896|FG000|Overall Study|Lost to Follow-up|6
7071034|NCT02018822|11173897|FG001|Overall Study|Lost to Follow-up|6
7071035|NCT02018822|11173898|FG002|Overall Study|Lost to Follow-up|5
7071036|NCT02018887|11173917|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1
7071037|NCT02018887|11173918|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0
7071038|NCT02018887|11173919|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0
7071039|NCT02018887|11173920|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0
7071040|NCT02018887|11173921|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0
7071041|NCT02018887|11173922|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0
7071042|NCT02018887|11173923|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0
7071043|NCT02018887|11173924|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0
6955570|NCT01049360|10999193|FG016|Period 2|Adverse Event|0
6955571|NCT01049360|10999194|FG017|Period 2|Adverse Event|0
6955572|NCT01049360|10999195|FG018|Period 2|Adverse Event|0
6955573|NCT01049360|10999196|FG019|Period 2|Adverse Event|1
6955574|NCT01049360|10999177|FG000|Period 2|Withdrawal by Subject|0
6955575|NCT01049360|10999178|FG001|Period 2|Withdrawal by Subject|0
6955576|NCT01049360|10999179|FG002|Period 2|Withdrawal by Subject|0
6955577|NCT01049360|10999180|FG003|Period 2|Withdrawal by Subject|1
6955578|NCT01049360|10999181|FG004|Period 2|Withdrawal by Subject|0
6955579|NCT01049360|10999182|FG005|Period 2|Withdrawal by Subject|0
6955580|NCT01049360|10999183|FG006|Period 2|Withdrawal by Subject|0
6955581|NCT01049360|10999184|FG007|Period 2|Withdrawal by Subject|0
6955582|NCT01049360|10999185|FG008|Period 2|Withdrawal by Subject|0
6955583|NCT01049360|10999186|FG009|Period 2|Withdrawal by Subject|0
6955584|NCT01049360|10999187|FG010|Period 2|Withdrawal by Subject|0
6955585|NCT01049360|10999188|FG011|Period 2|Withdrawal by Subject|0
6955586|NCT01049360|10999189|FG012|Period 2|Withdrawal by Subject|0
7071044|NCT02018887|11173925|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0
7071045|NCT02018887|11173926|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0
6955587|NCT01049360|10999190|FG013|Period 2|Withdrawal by Subject|0
6955588|NCT01049360|10999191|FG014|Period 2|Withdrawal by Subject|1
6955589|NCT01049360|10999192|FG015|Period 2|Withdrawal by Subject|0
6955590|NCT01049360|10999193|FG016|Period 2|Withdrawal by Subject|0
6955591|NCT01049360|10999194|FG017|Period 2|Withdrawal by Subject|0
6955592|NCT01049360|10999195|FG018|Period 2|Withdrawal by Subject|0
6955593|NCT01049360|10999196|FG019|Period 2|Withdrawal by Subject|1
6955594|NCT01049360|10999177|FG000|Period 2|Lack of Efficacy|0
6955595|NCT01049360|10999178|FG001|Period 2|Lack of Efficacy|0
6955596|NCT01049360|10999179|FG002|Period 2|Lack of Efficacy|0
6955597|NCT01049360|10999180|FG003|Period 2|Lack of Efficacy|0
6955598|NCT01049360|10999181|FG004|Period 2|Lack of Efficacy|0
6955599|NCT01049360|10999182|FG005|Period 2|Lack of Efficacy|1
6955600|NCT01049360|10999183|FG006|Period 2|Lack of Efficacy|0
6955601|NCT01049360|10999184|FG007|Period 2|Lack of Efficacy|0
6955602|NCT01049360|10999185|FG008|Period 2|Lack of Efficacy|0
6955603|NCT01049360|10999186|FG009|Period 2|Lack of Efficacy|0
6955604|NCT01049360|10999187|FG010|Period 2|Lack of Efficacy|0
6955605|NCT01049360|10999188|FG011|Period 2|Lack of Efficacy|0
6955606|NCT01049360|10999189|FG012|Period 2|Lack of Efficacy|0
6955607|NCT01049360|10999190|FG013|Period 2|Lack of Efficacy|0
6955608|NCT01049360|10999191|FG014|Period 2|Lack of Efficacy|0
6955609|NCT01049360|10999192|FG015|Period 2|Lack of Efficacy|0
6955610|NCT01049360|10999193|FG016|Period 2|Lack of Efficacy|0
6955611|NCT01049360|10999194|FG017|Period 2|Lack of Efficacy|0
6955612|NCT01049360|10999195|FG018|Period 2|Lack of Efficacy|0
6955613|NCT01049360|10999196|FG019|Period 2|Lack of Efficacy|0
6955614|NCT01049360|10999177|FG000|Period 4|Protocol Violation|0
6955615|NCT01049360|10999178|FG001|Period 4|Protocol Violation|0
6955616|NCT01049360|10999179|FG002|Period 4|Protocol Violation|0
6955617|NCT01049360|10999180|FG003|Period 4|Protocol Violation|0
6955618|NCT01049360|10999181|FG004|Period 4|Protocol Violation|0
6955619|NCT01049360|10999182|FG005|Period 4|Protocol Violation|0
6955620|NCT01049360|10999183|FG006|Period 4|Protocol Violation|0
6955621|NCT01049360|10999184|FG007|Period 4|Protocol Violation|0
6955622|NCT01049360|10999185|FG008|Period 4|Protocol Violation|0
6955623|NCT01049360|10999186|FG009|Period 4|Protocol Violation|0
6955624|NCT01049360|10999187|FG010|Period 4|Protocol Violation|0
6955625|NCT01049360|10999188|FG011|Period 4|Protocol Violation|0
6955626|NCT01049360|10999189|FG012|Period 4|Protocol Violation|0
6955627|NCT01049360|10999190|FG013|Period 4|Protocol Violation|0
6955628|NCT01049360|10999191|FG014|Period 4|Protocol Violation|0
6955629|NCT01049360|10999192|FG015|Period 4|Protocol Violation|0
6955630|NCT01049360|10999193|FG016|Period 4|Protocol Violation|0
6955631|NCT01049360|10999194|FG017|Period 4|Protocol Violation|1
6955632|NCT01049360|10999195|FG018|Period 4|Protocol Violation|0
6955633|NCT01049360|10999196|FG019|Period 4|Protocol Violation|0
6955634|NCT01049360|10999177|FG000|Period 4|Withdrawal by Subject|0
6955635|NCT01049360|10999178|FG001|Period 4|Withdrawal by Subject|0
6955636|NCT01049360|10999179|FG002|Period 4|Withdrawal by Subject|0
6955637|NCT01049360|10999180|FG003|Period 4|Withdrawal by Subject|1
6955638|NCT01049360|10999181|FG004|Period 4|Withdrawal by Subject|0
6955639|NCT01049360|10999182|FG005|Period 4|Withdrawal by Subject|0
6955640|NCT01049360|10999183|FG006|Period 4|Withdrawal by Subject|0
6955641|NCT01049360|10999184|FG007|Period 4|Withdrawal by Subject|0
6955642|NCT01049360|10999185|FG008|Period 4|Withdrawal by Subject|0
6955643|NCT01049360|10999186|FG009|Period 4|Withdrawal by Subject|0
6955644|NCT01049360|10999187|FG010|Period 4|Withdrawal by Subject|0
6955645|NCT01049360|10999188|FG011|Period 4|Withdrawal by Subject|0
6955646|NCT01049360|10999189|FG012|Period 4|Withdrawal by Subject|0
6955647|NCT01049360|10999190|FG013|Period 4|Withdrawal by Subject|0
6955648|NCT01049360|10999191|FG014|Period 4|Withdrawal by Subject|0
6955649|NCT01049360|10999192|FG015|Period 4|Withdrawal by Subject|0
6955650|NCT01049360|10999193|FG016|Period 4|Withdrawal by Subject|0
6955651|NCT01049360|10999194|FG017|Period 4|Withdrawal by Subject|0
6955652|NCT01049360|10999195|FG018|Period 4|Withdrawal by Subject|0
6955653|NCT01049360|10999196|FG019|Period 4|Withdrawal by Subject|0
6955654|NCT01049373|10999210|FG000|Overall Study|Protocol Violation|9
6955655|NCT01049373|10999211|FG001|Overall Study|Protocol Violation|9
6955656|NCT01049373|10999210|FG000|Overall Study|Withdrawal by Subject|8
6955657|NCT01049373|10999211|FG001|Overall Study|Withdrawal by Subject|5
6955658|NCT01049373|10999210|FG000|Overall Study|Adverse Event|3
6955659|NCT01049373|10999211|FG001|Overall Study|Adverse Event|3
6955660|NCT01049373|10999210|FG000|Overall Study|Lost to Follow-up|9
6955661|NCT01049373|10999211|FG001|Overall Study|Lost to Follow-up|4
6955662|NCT01049373|10999210|FG000|Overall Study|no evaluable study values|9
6955663|NCT01049373|10999211|FG001|Overall Study|no evaluable study values|21
6955664|NCT01049373|10999210|FG000|Overall Study|Other|1
6955665|NCT01049373|10999211|FG001|Overall Study|Other|1
6955666|NCT01049373|10999210|FG000|Overall Study|Non-cooperation|0
6955667|NCT01049373|10999211|FG001|Overall Study|Non-cooperation|1
6955668|NCT01049412|10999221|FG000|Period I|Withdrawal by Subject|4
6955669|NCT01049412|10999222|FG001|Period I|Withdrawal by Subject|6
6955670|NCT01049412|10999221|FG000|Period I|Lost to Follow-up|2
6955671|NCT01049412|10999222|FG001|Period I|Lost to Follow-up|2
6955672|NCT01049412|10999221|FG000|Period I|Physician Decision|0
6955673|NCT01049412|10999222|FG001|Period I|Physician Decision|3
6955674|NCT01049412|10999221|FG000|Period I|Protocol Violation|1
6955675|NCT01049412|10999222|FG001|Period I|Protocol Violation|2
6955676|NCT01049412|10999221|FG000|Period I|Adverse Event|1
6955677|NCT01049412|10999222|FG001|Period I|Adverse Event|0
6955678|NCT01049412|10999221|FG000|Period II|Withdrawal by Subject|2
6955679|NCT01049412|10999222|FG001|Period II|Withdrawal by Subject|3
6955680|NCT01049412|10999221|FG000|Period II|Adverse Event|1
6955681|NCT01049412|10999222|FG001|Period II|Adverse Event|0
6955682|NCT01049412|10999221|FG000|Period II|Lost to Follow-up|1
6955683|NCT01049412|10999222|FG001|Period II|Lost to Follow-up|0
6955684|NCT01049503|10999236|FG000|Overall Study|Lost to Follow-up|11
6955685|NCT01049503|10999237|FG001|Overall Study|Lost to Follow-up|12
6955686|NCT01049503|10999238|FG002|Overall Study|Lost to Follow-up|24
6955687|NCT01049503|10999239|FG003|Overall Study|Lost to Follow-up|26
6955688|NCT01049503|10999240|FG004|Overall Study|Lost to Follow-up|27
6955689|NCT01049503|10999241|FG005|Overall Study|Lost to Follow-up|8
6955690|NCT01049581|10999266|FG000|Overall Study|Lost to Follow-up|2
6955691|NCT01049581|10999267|FG001|Overall Study|Lost to Follow-up|1
6955692|NCT01049919|10999291|FG000|Overall Study|Met study endpoint (major amputation, death)|36
6955693|NCT01049919|10999292|FG001|Overall Study|Met study endpoint (major amputation, death)|16
6955694|NCT01049919|10999291|FG000|Overall Study|Withdrawal by Subject|5
6955695|NCT01049919|10999292|FG001|Overall Study|Withdrawal by Subject|0
6955696|NCT01049919|10999291|FG000|Overall Study|Lost to Follow-up|6
6955697|NCT01049919|10999292|FG001|Overall Study|Lost to Follow-up|1
6955698|NCT01049919|10999291|FG000|Overall Study|Physician Decision|2
6955699|NCT01049919|10999292|FG001|Overall Study|Physician Decision|0
6955700|NCT01049919|10999291|FG000|Overall Study|Received 2nd treatment via compassionate use|1
6955701|NCT01049919|10999292|FG001|Overall Study|Received 2nd treatment via compassionate use|0
6955702|NCT01049919|10999291|FG000|Overall Study|Early study termination by sponsor.|2
6955703|NCT01049919|10999292|FG001|Overall Study|Early study termination by sponsor.|0
6955704|NCT01049984|10999321|FG000|Overall Study|Withdrawal by Subject|1
6955705|NCT01049984|10999322|FG001|Overall Study|Withdrawal by Subject|5
6955706|NCT01049984|10999321|FG000|Overall Study|Protocol Violation|3
6955707|NCT01049984|10999322|FG001|Overall Study|Protocol Violation|4
6955708|NCT01049984|10999321|FG000|Overall Study|Lost to Follow-up|2
6955709|NCT01049984|10999322|FG001|Overall Study|Lost to Follow-up|1
6955710|NCT01049984|10999321|FG000|Overall Study|Adverse Event|13
6955711|NCT01049984|10999322|FG001|Overall Study|Adverse Event|7
6955712|NCT01049984|10999321|FG000|Overall Study|Treatment failure|0
6955713|NCT01049984|10999322|FG001|Overall Study|Treatment failure|2
6955714|NCT01050062|10999330|FG000|Overall Study|Adverse Event|75
6955715|NCT01050062|10999331|FG001|Overall Study|Adverse Event|22
6955716|NCT01050062|10999330|FG000|Overall Study|Lost to Follow-up|83
6955717|NCT01050062|10999331|FG001|Overall Study|Lost to Follow-up|35
6955718|NCT01050062|10999330|FG000|Overall Study|Lack of Efficacy|22
6955719|NCT01050062|10999331|FG001|Overall Study|Lack of Efficacy|35
6955720|NCT01050062|10999330|FG000|Overall Study|Physician Decision|74
6955721|NCT01050062|10999331|FG001|Overall Study|Physician Decision|9
6955722|NCT01050062|10999330|FG000|Overall Study|Others|17
6955723|NCT01050062|10999331|FG001|Overall Study|Others|11
6955724|NCT01050205|10999350|FG000|Overall Study|Lost to Follow-up|7
6955725|NCT01050205|10999351|FG001|Overall Study|Lost to Follow-up|1
6955726|NCT01050205|10999350|FG000|Overall Study|Withdrawal by Subject|1
6955727|NCT01050205|10999351|FG001|Overall Study|Withdrawal by Subject|1
6955728|NCT01050205|10999350|FG000|Overall Study|Relocated from area|1
6955729|NCT01050205|10999351|FG001|Overall Study|Relocated from area|2
6955730|NCT01050205|10999350|FG000|Overall Study|Discontinued Intervention|2
6955731|NCT01050205|10999351|FG001|Overall Study|Discontinued Intervention|0
6955732|NCT01050257|10999369|FG000|Overall Study|Adverse Event|4
6955733|NCT01050257|10999370|FG001|Overall Study|Adverse Event|4
6955734|NCT01050257|10999371|FG002|Overall Study|Adverse Event|2
6955735|NCT01050257|10999369|FG000|Overall Study|Admin/Other (did not switch to oral)|6
6955736|NCT01050257|10999370|FG001|Overall Study|Admin/Other (did not switch to oral)|2
7071046|NCT02018887|11173927|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0
7071047|NCT02018887|11173917|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0
7071048|NCT02018887|11173918|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0
7071049|NCT02018887|11173919|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0
7071050|NCT02018887|11173920|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0
7071051|NCT02018887|11173921|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1
7071052|NCT02018887|11173922|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0
7071053|NCT02018887|11173923|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1
7071054|NCT02018887|11173924|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4
7071055|NCT02018887|11173925|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0
6955737|NCT01050257|10999371|FG002|Overall Study|Admin/Other (did not switch to oral)|2
6955738|NCT01050257|10999369|FG000|Overall Study|Withdrawal by Subject|0
7071056|NCT02018887|11173926|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0
7071057|NCT02018887|11173927|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0
6955739|NCT01050257|10999370|FG001|Overall Study|Withdrawal by Subject|3
6955740|NCT01050257|10999371|FG002|Overall Study|Withdrawal by Subject|0
6955741|NCT01050257|10999369|FG000|Overall Study|No reason specified|0
6955742|NCT01050257|10999370|FG001|Overall Study|No reason specified|0
6955743|NCT01050257|10999371|FG002|Overall Study|No reason specified|2
6955744|NCT01050257|10999369|FG000|Overall Study|Refused treatment/ Did not Cooperate|1
6955745|NCT01050257|10999370|FG001|Overall Study|Refused treatment/ Did not Cooperate|1
6955746|NCT01050257|10999371|FG002|Overall Study|Refused treatment/ Did not Cooperate|0
7071058|NCT02018887|11173917|FG000|Part C: Cohort 8 Overall|Adverse Event|0
6955747|NCT01050257|10999369|FG000|Overall Study|Violation criteria|0
6955748|NCT01050257|10999370|FG001|Overall Study|Violation criteria|1
6955749|NCT01050257|10999371|FG002|Overall Study|Violation criteria|0
6955750|NCT01050257|10999369|FG000|Overall Study|Failure to return|0
6955751|NCT01050257|10999370|FG001|Overall Study|Failure to return|2
6955752|NCT01050257|10999371|FG002|Overall Study|Failure to return|0
6955753|NCT01050257|10999369|FG000|Overall Study|Death|0
6955754|NCT01050257|10999370|FG001|Overall Study|Death|0
6955755|NCT01050257|10999371|FG002|Overall Study|Death|1
6955756|NCT01050530|10999381|FG000|Overall Study|Adverse Event|6
6955757|NCT01050530|10999382|FG001|Overall Study|Adverse Event|3
6955758|NCT01050530|10999381|FG000|Overall Study|Lack of Efficacy|1
6955759|NCT01050530|10999382|FG001|Overall Study|Lack of Efficacy|4
6955760|NCT01050530|10999381|FG000|Overall Study|Withdrawal by Subject|0
6955761|NCT01050530|10999382|FG001|Overall Study|Withdrawal by Subject|3
6955762|NCT01050530|10999381|FG000|Overall Study|Protocol Violation|1
6955763|NCT01050530|10999382|FG001|Overall Study|Protocol Violation|0
7071059|NCT02018887|11173918|FG001|Part C: Cohort 8 Overall|Adverse Event|0
7071060|NCT02018887|11173919|FG002|Part C: Cohort 8 Overall|Adverse Event|0
7071061|NCT02018887|11173920|FG003|Part C: Cohort 8 Overall|Adverse Event|0
6955764|NCT01050543|10999390|FG000|Overall Study|Withdrawal by Subject|0
7071062|NCT02018887|11173921|FG004|Part C: Cohort 8 Overall|Adverse Event|0
7071063|NCT02018887|11173922|FG005|Part C: Cohort 8 Overall|Adverse Event|0
7071064|NCT02018887|11173923|FG006|Part C: Cohort 8 Overall|Adverse Event|0
7071065|NCT02018887|11173924|FG007|Part C: Cohort 8 Overall|Adverse Event|0
7071066|NCT02018887|11173925|FG008|Part C: Cohort 8 Overall|Adverse Event|1
7071067|NCT02018887|11173926|FG009|Part C: Cohort 8 Overall|Adverse Event|3
7071068|NCT02018887|11173927|FG010|Part C: Cohort 8 Overall|Adverse Event|0
7071069|NCT02018887|11173917|FG000|Part C: Cohort 8 Overall|Physician Decision|0
7071070|NCT02018887|11173918|FG001|Part C: Cohort 8 Overall|Physician Decision|0
7071071|NCT02018887|11173919|FG002|Part C: Cohort 8 Overall|Physician Decision|0
7071072|NCT02018887|11173920|FG003|Part C: Cohort 8 Overall|Physician Decision|0
7071073|NCT02018887|11173921|FG004|Part C: Cohort 8 Overall|Physician Decision|0
7071074|NCT02018887|11173922|FG005|Part C: Cohort 8 Overall|Physician Decision|0
7071075|NCT02018887|11173923|FG006|Part C: Cohort 8 Overall|Physician Decision|0
7071076|NCT02018887|11173924|FG007|Part C: Cohort 8 Overall|Physician Decision|0
7071077|NCT02018887|11173925|FG008|Part C: Cohort 8 Overall|Physician Decision|2
7071078|NCT02018887|11173926|FG009|Part C: Cohort 8 Overall|Physician Decision|0
7071079|NCT02018887|11173927|FG010|Part C: Cohort 8 Overall|Physician Decision|1
7071080|NCT02019108|11173999|FG000|Overall Study|Lost to Follow-up|5
7071081|NCT02019108|11174000|FG001|Overall Study|Lost to Follow-up|7
7071082|NCT02019264|11174008|FG000|Overall Study|Not treated|6
7071083|NCT02019264|11174009|FG001|Overall Study|Not treated|4
7071084|NCT02019264|11174008|FG000|Overall Study|Lost to Follow-up|50
7071085|NCT02019264|11174009|FG001|Overall Study|Lost to Follow-up|47
7071086|NCT02019264|11174008|FG000|Overall Study|Withdrawal by Subject|142
7071087|NCT02019264|11174009|FG001|Overall Study|Withdrawal by Subject|117
7071088|NCT02019264|11174008|FG000|Overall Study|Administrative reason|36
7071089|NCT02019264|11174009|FG001|Overall Study|Administrative reason|28
7071090|NCT02019264|11174008|FG000|Overall Study|Missing|14
7071091|NCT02019264|11174009|FG001|Overall Study|Missing|11
7071092|NCT02019277|11174015|FG000|Overall Study|Withdrawal by Subject|3
7071093|NCT02019277|11174015|FG000|Overall Study|Death|7
7071094|NCT02019277|11174015|FG000|Overall Study|Did no Cooperate|1
7071095|NCT02019277|11174015|FG000|Overall Study|Adverse Event|1
7071096|NCT02019420|11174021|FG000|Overall Study|Did not receive study drug|2
7071097|NCT02019420|11174022|FG001|Overall Study|Did not receive study drug|2
7071098|NCT02019420|11174021|FG000|Overall Study|Withdrawal by Subject|1
7071099|NCT02019420|11174022|FG001|Overall Study|Withdrawal by Subject|3
7071100|NCT02019420|11174021|FG000|Overall Study|At request of sponsor or investigator|0
7071101|NCT02019420|11174022|FG001|Overall Study|At request of sponsor or investigator|1
7071102|NCT02019420|11174021|FG000|Overall Study|Death|104
7071103|NCT02019420|11174022|FG001|Overall Study|Death|99
7071104|NCT02019420|11174021|FG000|Overall Study|Transferred to other care facility|1
7071105|NCT02019420|11174022|FG001|Overall Study|Transferred to other care facility|1
7071106|NCT02019472|11174031|FG000|Overall Study|Adverse Event|14
7071107|NCT02019472|11174032|FG001|Overall Study|Adverse Event|23
7071108|NCT02019472|11174033|FG002|Overall Study|Adverse Event|17
7071109|NCT02019472|11174031|FG000|Overall Study|Death|0
7071110|NCT02019472|11174032|FG001|Overall Study|Death|1
7071111|NCT02019472|11174033|FG002|Overall Study|Death|1
7071112|NCT02019472|11174031|FG000|Overall Study|Lack of Efficacy|7
7071113|NCT02019472|11174032|FG001|Overall Study|Lack of Efficacy|4
7071114|NCT02019472|11174033|FG002|Overall Study|Lack of Efficacy|4
6955765|NCT01050543|10999391|FG001|Overall Study|Withdrawal by Subject|2
7071115|NCT02019472|11174031|FG000|Overall Study|Lost to Follow-up|0
7071116|NCT02019472|11174032|FG001|Overall Study|Lost to Follow-up|2
7071117|NCT02019472|11174033|FG002|Overall Study|Lost to Follow-up|1
6955766|NCT01050543|10999390|FG000|Overall Study|Protocol Violation|0
6955767|NCT01050543|10999391|FG001|Overall Study|Protocol Violation|1
6955768|NCT01050543|10999390|FG000|Overall Study|Administrative|4
7071118|NCT02019472|11174031|FG000|Overall Study|Physician Decision|1
7071119|NCT02019472|11174032|FG001|Overall Study|Physician Decision|2
7071120|NCT02019472|11174033|FG002|Overall Study|Physician Decision|0
7071121|NCT02019472|11174031|FG000|Overall Study|Pregnancy|1
7071122|NCT02019472|11174032|FG001|Overall Study|Pregnancy|2
7071123|NCT02019472|11174033|FG002|Overall Study|Pregnancy|2
7071124|NCT02019472|11174031|FG000|Overall Study|Withdrawal by Subject|11
7071125|NCT02019472|11174032|FG001|Overall Study|Withdrawal by Subject|10
7071126|NCT02019472|11174033|FG002|Overall Study|Withdrawal by Subject|11
7071127|NCT02019472|11174031|FG000|Overall Study|Other|3
6955769|NCT01050543|10999391|FG001|Overall Study|Administrative|1
6955770|NCT01050569|10999400|FG000|Overall Study|Lost to Follow-up|20
6955771|NCT01050569|10999401|FG001|Overall Study|Lost to Follow-up|14
6955772|NCT01050569|10999402|FG002|Overall Study|Lost to Follow-up|16
6955773|NCT01050569|10999400|FG000|Overall Study|Withdrawal by Subject|9
6955774|NCT01050569|10999401|FG001|Overall Study|Withdrawal by Subject|3
6955775|NCT01050569|10999402|FG002|Overall Study|Withdrawal by Subject|11
6955776|NCT01050569|10999400|FG000|Overall Study|Lack of Efficacy|5
6955777|NCT01050569|10999401|FG001|Overall Study|Lack of Efficacy|4
6955778|NCT01050569|10999402|FG002|Overall Study|Lack of Efficacy|3
6955779|NCT01050569|10999400|FG000|Overall Study|Adverse Event|1
6955780|NCT01050569|10999401|FG001|Overall Study|Adverse Event|0
6955781|NCT01050569|10999402|FG002|Overall Study|Adverse Event|0
6955782|NCT01050569|10999400|FG000|Overall Study|Physician Decision|3
6955783|NCT01050569|10999401|FG001|Overall Study|Physician Decision|3
6955784|NCT01050569|10999402|FG002|Overall Study|Physician Decision|3
6955785|NCT01050634|10999423|FG000|Overall Study|Enrolled, but Not Treated|56
6955786|NCT01050634|10999423|FG000|Overall Study|Death|2
6955787|NCT01050634|10999423|FG000|Overall Study|Adverse Event|42
6955788|NCT01050634|10999423|FG000|Overall Study|Lost to Follow-up|2
6955789|NCT01050634|10999423|FG000|Overall Study|Other|21
6955790|NCT01050634|10999423|FG000|Overall Study|Ongoing at Date of Cut-Off|5
6976297|NCT01198002|11028749|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0
6976298|NCT01198002|11028750|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
6976299|NCT01198002|11028748|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62
6976300|NCT01198002|11028749|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70
6976301|NCT01198002|11028750|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75
6976302|NCT01198028|11028780|FG000|Overall Study|Adverse Event|5
6976303|NCT01198028|11028780|FG000|Overall Study|Death|3
6976304|NCT01198028|11028780|FG000|Overall Study|Physician Decision|2
6976305|NCT01198132|11028786|FG000|Overall Study|Withdrawal by Subject|4
6976306|NCT01198132|11028787|FG001|Overall Study|Withdrawal by Subject|5
6976307|NCT01198132|11028786|FG000|Overall Study|Physician Decision|5
6976308|NCT01198132|11028787|FG001|Overall Study|Physician Decision|4
6976309|NCT01198132|11028786|FG000|Overall Study|Other Unspecified|3
6976310|NCT01198132|11028787|FG001|Overall Study|Other Unspecified|6
6976311|NCT01198132|11028786|FG000|Overall Study|Lack of Efficacy|2
7071128|NCT02019472|11174032|FG001|Overall Study|Other|8
7071129|NCT02019472|11174033|FG002|Overall Study|Other|6
7071130|NCT02019550|11174047|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0
7071131|NCT02019550|11174048|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1
7071132|NCT02019602|11174069|FG000|Screening Period|Ineligibility|4
7071133|NCT02019602|11174070|FG001|Screening Period|Ineligibility|0
7071134|NCT02019602|11174069|FG000|Screening Period|Adverse Event|1
7071135|NCT02019602|11174070|FG001|Screening Period|Adverse Event|0
7071136|NCT02019667|11174077|FG000|First Intervention (6 Months)|Adverse Event|0
7071137|NCT02019667|11174078|FG001|First Intervention (6 Months)|Adverse Event|1
7071138|NCT02019667|11174077|FG000|2nd Intervention (6 Months)|Adverse Event|0
7071139|NCT02019667|11174078|FG001|2nd Intervention (6 Months)|Adverse Event|1
7071140|NCT02019667|11174077|FG000|2nd Intervention (6 Months)|Physician Decision|0
7071141|NCT02019667|11174078|FG001|2nd Intervention (6 Months)|Physician Decision|1
7071142|NCT02019719|11174091|FG000|Overall Study|Adverse Event|1
7071143|NCT02019719|11174092|FG001|Overall Study|Adverse Event|0
7071144|NCT02019719|11174093|FG002|Overall Study|Adverse Event|0
7071145|NCT02019719|11174094|FG003|Overall Study|Adverse Event|1
7071146|NCT02019719|11174095|FG004|Overall Study|Adverse Event|1
7071147|NCT02019719|11174091|FG000|Overall Study|Protocol Violation|1
7071148|NCT02019719|11174092|FG001|Overall Study|Protocol Violation|1
7071149|NCT02019719|11174093|FG002|Overall Study|Protocol Violation|0
7071150|NCT02019719|11174094|FG003|Overall Study|Protocol Violation|0
7071151|NCT02019719|11174095|FG004|Overall Study|Protocol Violation|0
7071152|NCT02019719|11174091|FG000|Overall Study|Protocol defined stopping criteria|2
7071153|NCT02019719|11174092|FG001|Overall Study|Protocol defined stopping criteria|0
7071154|NCT02019719|11174093|FG002|Overall Study|Protocol defined stopping criteria|0
7071155|NCT02019719|11174094|FG003|Overall Study|Protocol defined stopping criteria|1
7071156|NCT02019719|11174095|FG004|Overall Study|Protocol defined stopping criteria|1
7071157|NCT02019719|11174091|FG000|Overall Study|Physician Decision|2
7071158|NCT02019719|11174092|FG001|Overall Study|Physician Decision|0
7071159|NCT02019719|11174093|FG002|Overall Study|Physician Decision|0
6976312|NCT01198132|11028787|FG001|Overall Study|Lack of Efficacy|3
6976313|NCT01198132|11028786|FG000|Overall Study|Sign/symptoms of underlying disease|2
6976314|NCT01198132|11028787|FG001|Overall Study|Sign/symptoms of underlying disease|1
6976315|NCT01198132|11028786|FG000|Overall Study|Abnormal/clinically significant biologic|1
6976316|NCT01198132|11028787|FG001|Overall Study|Abnormal/clinically significant biologic|1
6976317|NCT01198132|11028786|FG000|Overall Study|Adverse Event|0
7071160|NCT02019719|11174094|FG003|Overall Study|Physician Decision|0
7071161|NCT02019719|11174095|FG004|Overall Study|Physician Decision|0
7071162|NCT02019927|11174142|FG000|Overall Study|Lost to Follow-up|2
6955791|NCT01050673|10999447|FG000|Overall Study|Physician Decision|4
6955792|NCT01050673|10999448|FG001|Overall Study|Physician Decision|5
6955793|NCT01050764|10999454|FG000|Overall Study|Death, before HSCT|1
6955794|NCT01050764|10999454|FG000|Overall Study|Donor mobilization failure, death|1
6955795|NCT01050764|10999454|FG000|Overall Study|Death after HSCT, before T-cell infusion|1
6955796|NCT01050790|10999458|FG000|Overall Study|Adverse Event|1
6955797|NCT01050816|10999463|FG000|Overall Study|Lost to Follow-up|2
6955798|NCT01050816|10999463|FG000|Overall Study|patient's refusal|2
6955799|NCT01050998|10999481|FG000|Overall Study|Adverse Event|1
6955800|NCT01050998|10999482|FG001|Overall Study|Adverse Event|0
6955801|NCT01050998|10999483|FG002|Overall Study|Adverse Event|1
6955802|NCT01050998|10999484|FG003|Overall Study|Adverse Event|0
6955803|NCT01050998|10999485|FG004|Overall Study|Adverse Event|2
6955804|NCT01050998|10999481|FG000|Overall Study|Withdrawal by Subject|0
6955805|NCT01050998|10999482|FG001|Overall Study|Withdrawal by Subject|0
6955806|NCT01050998|10999483|FG002|Overall Study|Withdrawal by Subject|0
6955807|NCT01050998|10999484|FG003|Overall Study|Withdrawal by Subject|1
6955808|NCT01050998|10999485|FG004|Overall Study|Withdrawal by Subject|3
6955809|NCT01050998|10999481|FG000|Overall Study|Other|3
6955810|NCT01050998|10999482|FG001|Overall Study|Other|2
6955811|NCT01050998|10999483|FG002|Overall Study|Other|1
6955812|NCT01050998|10999484|FG003|Overall Study|Other|1
6955813|NCT01050998|10999485|FG004|Overall Study|Other|5
6955814|NCT01050998|10999481|FG000|Overall Study|Data integrity issues|0
6955815|NCT01050998|10999482|FG001|Overall Study|Data integrity issues|0
6955816|NCT01050998|10999483|FG002|Overall Study|Data integrity issues|1
6955817|NCT01050998|10999484|FG003|Overall Study|Data integrity issues|1
6955818|NCT01050998|10999485|FG004|Overall Study|Data integrity issues|4
6955819|NCT01051063|10999503|FG000|Overall Study|Death|2
6955820|NCT01051063|10999504|FG001|Overall Study|Death|2
6955821|NCT01051063|10999503|FG000|Overall Study|Withdrawal by Subject|1
6955822|NCT01051063|10999504|FG001|Overall Study|Withdrawal by Subject|1
6955823|NCT01051063|10999503|FG000|Overall Study|Termination of the study|5
6955824|NCT01051063|10999504|FG001|Overall Study|Termination of the study|0
6955825|NCT01051063|10999503|FG000|Overall Study|Moved from the study site area|1
6955826|NCT01051063|10999504|FG001|Overall Study|Moved from the study site area|0
6955827|NCT01051063|10999503|FG000|Overall Study|Other|1
6955828|NCT01051063|10999504|FG001|Overall Study|Other|0
6955829|NCT01051063|10999503|FG000|Overall Study|Lost to Follow-up|0
6955830|NCT01051063|10999504|FG001|Overall Study|Lost to Follow-up|1
6955831|NCT01051323|10999517|FG000|Overall Study|Discontinuation of treatment|103
6955832|NCT01051323|10999517|FG000|Overall Study|Transplantation|28
6955833|NCT01051323|10999517|FG000|Overall Study|Dialysis dependency|22
6955834|NCT01051323|10999517|FG000|Overall Study|Withdrawal by Subject|13
6955835|NCT01051323|10999517|FG000|Overall Study|Lost to Follow-up|31
6955836|NCT01051323|10999517|FG000|Overall Study|Death|129
6955837|NCT01051323|10999517|FG000|Overall Study|Hospitalization|28
6955838|NCT01051323|10999517|FG000|Overall Study|Other|148
6955839|NCT01051323|10999517|FG000|Overall Study|Missing|37
6955840|NCT01051349|10999525|FG000|Overall Study|Adverse Event|88
6955841|NCT01051349|10999525|FG000|Overall Study|Consent Withdrawn|54
6955842|NCT01051349|10999525|FG000|Overall Study|Investigator Decision|6
6955843|NCT01051349|10999525|FG000|Overall Study|Lost to Follow-up|6
6955844|NCT01051349|10999525|FG000|Overall Study|Subject non-compliance|7
6955845|NCT01051349|10999525|FG000|Overall Study|Reason not Specified|12
6955846|NCT01051466|10999543|FG000|Overall Study|Adverse Event|1
6955847|NCT01051466|10999544|FG001|Overall Study|Adverse Event|0
6955848|NCT01051466|10999543|FG000|Overall Study|Lost to Follow-up|1
6955849|NCT01051466|10999544|FG001|Overall Study|Lost to Follow-up|1
6955850|NCT01051466|10999543|FG000|Overall Study|Withdrawal by Subject|5
6955851|NCT01051466|10999544|FG001|Overall Study|Withdrawal by Subject|1
6955852|NCT01051466|10999543|FG000|Overall Study|Entry Criteria Not Met|0
6955853|NCT01051466|10999544|FG001|Overall Study|Entry Criteria Not Met|3
6955854|NCT01051466|10999543|FG000|Overall Study|Physician Decision|1
6955855|NCT01051466|10999544|FG001|Overall Study|Physician Decision|0
6955856|NCT01051557|10999570|FG000|Overall Study|Physician Decision|1
6955857|NCT01051557|10999571|FG001|Overall Study|Physician Decision|0
6955858|NCT01051557|10999572|FG002|Overall Study|Physician Decision|0
6955859|NCT01051557|10999573|FG003|Overall Study|Physician Decision|0
6955860|NCT01051557|10999574|FG004|Overall Study|Physician Decision|0
6955861|NCT01051557|10999575|FG005|Overall Study|Physician Decision|0
6955862|NCT01051557|10999576|FG006|Overall Study|Physician Decision|0
6955863|NCT01051557|10999570|FG000|Overall Study|disease progression|3
6955864|NCT01051557|10999571|FG001|Overall Study|disease progression|3
6955865|NCT01051557|10999572|FG002|Overall Study|disease progression|5
6955866|NCT01051557|10999573|FG003|Overall Study|disease progression|2
6955867|NCT01051557|10999574|FG004|Overall Study|disease progression|4
6955868|NCT01051557|10999575|FG005|Overall Study|disease progression|3
6955869|NCT01051557|10999576|FG006|Overall Study|disease progression|1
6955870|NCT01051557|10999570|FG000|Overall Study|Withdrawal by Subject|0
6955871|NCT01051557|10999571|FG001|Overall Study|Withdrawal by Subject|0
6955872|NCT01051557|10999572|FG002|Overall Study|Withdrawal by Subject|1
6955873|NCT01051557|10999573|FG003|Overall Study|Withdrawal by Subject|0
6955874|NCT01051557|10999574|FG004|Overall Study|Withdrawal by Subject|2
6955875|NCT01051557|10999575|FG005|Overall Study|Withdrawal by Subject|0
6955876|NCT01051557|10999576|FG006|Overall Study|Withdrawal by Subject|1
6955877|NCT01051557|10999570|FG000|Overall Study|Adverse Event|0
6955878|NCT01051557|10999571|FG001|Overall Study|Adverse Event|0
6955879|NCT01051557|10999572|FG002|Overall Study|Adverse Event|0
6955880|NCT01051557|10999573|FG003|Overall Study|Adverse Event|1
6955881|NCT01051557|10999574|FG004|Overall Study|Adverse Event|1
6955882|NCT01051557|10999575|FG005|Overall Study|Adverse Event|3
6955883|NCT01051557|10999576|FG006|Overall Study|Adverse Event|4
6955884|NCT01051661|10999607|FG000|Overall Study|Adverse Event|1
6955885|NCT01051661|10999608|FG001|Overall Study|Adverse Event|1
6955886|NCT01051661|10999609|FG002|Overall Study|Adverse Event|1
6955887|NCT01051661|10999610|FG003|Overall Study|Adverse Event|1
6955888|NCT01051661|10999611|FG004|Overall Study|Adverse Event|0
6955889|NCT01051661|10999612|FG005|Overall Study|Adverse Event|0
6955890|NCT01051661|10999607|FG000|Overall Study|Lost to Follow-up|13
6955891|NCT01051661|10999608|FG001|Overall Study|Lost to Follow-up|22
6955892|NCT01051661|10999609|FG002|Overall Study|Lost to Follow-up|15
6955893|NCT01051661|10999610|FG003|Overall Study|Lost to Follow-up|17
6955894|NCT01051661|10999611|FG004|Overall Study|Lost to Follow-up|10
6955895|NCT01051661|10999612|FG005|Overall Study|Lost to Follow-up|24
6955896|NCT01051661|10999607|FG000|Overall Study|Migrated/moved from study area|1
6955897|NCT01051661|10999608|FG001|Overall Study|Migrated/moved from study area|6
6955898|NCT01051661|10999609|FG002|Overall Study|Migrated/moved from study area|6
6955899|NCT01051661|10999610|FG003|Overall Study|Migrated/moved from study area|8
6955900|NCT01051661|10999611|FG004|Overall Study|Migrated/moved from study area|7
6955901|NCT01051661|10999612|FG005|Overall Study|Migrated/moved from study area|3
6955902|NCT01051661|10999607|FG000|Overall Study|Refused blood sampling|0
6955903|NCT01051661|10999608|FG001|Overall Study|Refused blood sampling|0
6955904|NCT01051661|10999609|FG002|Overall Study|Refused blood sampling|0
6955905|NCT01051661|10999610|FG003|Overall Study|Refused blood sampling|0
6955906|NCT01051661|10999611|FG004|Overall Study|Refused blood sampling|0
6955907|NCT01051661|10999612|FG005|Overall Study|Refused blood sampling|1
6955908|NCT01051661|10999607|FG000|Overall Study|Data not reliable|1
6955909|NCT01051661|10999608|FG001|Overall Study|Data not reliable|0
6955910|NCT01051661|10999609|FG002|Overall Study|Data not reliable|0
6955911|NCT01051661|10999610|FG003|Overall Study|Data not reliable|0
6955912|NCT01051661|10999611|FG004|Overall Study|Data not reliable|0
6955913|NCT01051661|10999612|FG005|Overall Study|Data not reliable|1
6955914|NCT01051661|10999607|FG000|Overall Study|Unable to attend visit(s)|2
6955915|NCT01051661|10999608|FG001|Overall Study|Unable to attend visit(s)|4
6955916|NCT01051661|10999609|FG002|Overall Study|Unable to attend visit(s)|2
6955917|NCT01051661|10999610|FG003|Overall Study|Unable to attend visit(s)|1
6955918|NCT01051661|10999611|FG004|Overall Study|Unable to attend visit(s)|3
6955919|NCT01051661|10999612|FG005|Overall Study|Unable to attend visit(s)|2
6955920|NCT01051661|10999607|FG000|Overall Study|Consent not received from both parents|0
6955921|NCT01051661|10999608|FG001|Overall Study|Consent not received from both parents|0
6955922|NCT01051661|10999609|FG002|Overall Study|Consent not received from both parents|0
6955923|NCT01051661|10999610|FG003|Overall Study|Consent not received from both parents|0
6955924|NCT01051661|10999611|FG004|Overall Study|Consent not received from both parents|0
6955925|NCT01051661|10999612|FG005|Overall Study|Consent not received from both parents|1
6955926|NCT01051661|10999607|FG000|Overall Study|Failure to comply with protocol|0
6955927|NCT01051661|10999608|FG001|Overall Study|Failure to comply with protocol|0
6955928|NCT01051661|10999609|FG002|Overall Study|Failure to comply with protocol|2
6955929|NCT01051661|10999610|FG003|Overall Study|Failure to comply with protocol|0
6955930|NCT01051661|10999611|FG004|Overall Study|Failure to comply with protocol|0
6955931|NCT01051661|10999612|FG005|Overall Study|Failure to comply with protocol|0
6955932|NCT01051661|10999607|FG000|Overall Study|Subject lost legal representation|0
6955933|NCT01051661|10999608|FG001|Overall Study|Subject lost legal representation|0
6955934|NCT01051661|10999609|FG002|Overall Study|Subject lost legal representation|0
6955935|NCT01051661|10999610|FG003|Overall Study|Subject lost legal representation|0
6955936|NCT01051661|10999611|FG004|Overall Study|Subject lost legal representation|1
6955937|NCT01051661|10999612|FG005|Overall Study|Subject lost legal representation|0
6955938|NCT01051661|10999607|FG000|Overall Study|Protocol Violation|0
6955939|NCT01051661|10999608|FG001|Overall Study|Protocol Violation|0
6955940|NCT01051661|10999609|FG002|Overall Study|Protocol Violation|0
6955941|NCT01051661|10999610|FG003|Overall Study|Protocol Violation|1
6955942|NCT01051661|10999611|FG004|Overall Study|Protocol Violation|2
6955943|NCT01051661|10999612|FG005|Overall Study|Protocol Violation|1
6955944|NCT01051661|10999607|FG000|Overall Study|Withdrawal by Subject|16
6955945|NCT01051661|10999608|FG001|Overall Study|Withdrawal by Subject|30
6955946|NCT01051661|10999609|FG002|Overall Study|Withdrawal by Subject|13
6955947|NCT01051661|10999610|FG003|Overall Study|Withdrawal by Subject|28
6955948|NCT01051661|10999611|FG004|Overall Study|Withdrawal by Subject|12
6955949|NCT01051661|10999612|FG005|Overall Study|Withdrawal by Subject|34
6955950|NCT01051739|10999649|FG000|Overall Study|Death|3
6955951|NCT01051739|10999650|FG001|Overall Study|Death|3
6955952|NCT01051739|10999649|FG000|Overall Study|Withdrawal by Subject|25
6955953|NCT01051739|10999650|FG001|Overall Study|Withdrawal by Subject|10
6955954|NCT01051791|10999665|FG000|Overall Study|Failed screening|3
6955955|NCT01051791|10999665|FG000|Overall Study|Withdrawal by Subject|1
6955956|NCT01051817|10999672|FG000|Overall Study|Adverse Event|0
6955957|NCT01051817|10999673|FG001|Overall Study|Adverse Event|2
6955958|NCT01051817|10999672|FG000|Overall Study|Abnormal Test Proceedure reults|0
6955959|NCT01051817|10999673|FG001|Overall Study|Abnormal Test Proceedure reults|1
6955960|NCT01051817|10999672|FG000|Overall Study|Withdrawal by Subject|3
6955961|NCT01051817|10999673|FG001|Overall Study|Withdrawal by Subject|5
6955962|NCT01051817|10999672|FG000|Overall Study|Protocol Violation|0
6955963|NCT01051817|10999673|FG001|Overall Study|Protocol Violation|1
6955964|NCT01051856|10999681|FG000|Overall Study|Withdrawal by Subject|1
6955965|NCT01051856|10999682|FG001|Overall Study|Withdrawal by Subject|0
6955966|NCT01051960|10999688|FG000|Overall Study|Adverse Event|1
6955967|NCT01051986|10999694|FG000|Overall Study|Death|1
6955968|NCT01051986|10999695|FG001|Overall Study|Death|0
6955969|NCT01051986|10999694|FG000|Overall Study|Withdrawal by Subject|2
6955970|NCT01051986|10999695|FG001|Overall Study|Withdrawal by Subject|1
6955971|NCT01051986|10999694|FG000|Overall Study|Protocol Violation|2
6955972|NCT01051986|10999695|FG001|Overall Study|Protocol Violation|3
6955973|NCT01052012|10999707|FG000|Overall Study|Not treated|2
6955974|NCT01052012|10999708|FG001|Overall Study|Not treated|5
6955975|NCT01052012|10999709|FG002|Overall Study|Not treated|0
6955976|NCT01052012|10999710|FG003|Overall Study|Not treated|0
6955977|NCT01052012|10999711|FG004|Overall Study|Not treated|11
6955978|NCT01052012|10999712|FG005|Overall Study|Not treated|8
6955979|NCT01052012|10999707|FG000|Overall Study|Adverse Event|1
6955980|NCT01052012|10999708|FG001|Overall Study|Adverse Event|0
6955981|NCT01052012|10999709|FG002|Overall Study|Adverse Event|0
6955982|NCT01052012|10999710|FG003|Overall Study|Adverse Event|1
7071163|NCT02019927|11174143|FG001|Overall Study|Lost to Follow-up|4
7071164|NCT02019927|11174144|FG002|Overall Study|Lost to Follow-up|1
7071165|NCT02019927|11174145|FG003|Overall Study|Lost to Follow-up|2
7071166|NCT02019927|11174146|FG004|Overall Study|Lost to Follow-up|3
7071167|NCT02019927|11174147|FG005|Overall Study|Lost to Follow-up|1
7071168|NCT02019979|11174169|FG000|Overall Study|study terminated|14
7071169|NCT02020031|11174184|FG000|Overall Study|Physician Decision|1
7071170|NCT02020031|11174185|FG001|Overall Study|Physician Decision|1
7071171|NCT02020512|11174240|FG000|Overall Study|Adverse Event|1
7071172|NCT02020512|11174240|FG000|Overall Study|Lost to Follow-up|3
7071173|NCT02020512|11174240|FG000|Overall Study|Protocol Violation|4
7071174|NCT02020577|11174246|FG000|Overall Study|Progressive disease|3
7071175|NCT02020577|11174247|FG001|Overall Study|Progressive disease|38
7071176|NCT02020577|11174246|FG000|Overall Study|Other AE or clinical progression|0
7071177|NCT02020577|11174247|FG001|Overall Study|Other AE or clinical progression|15
7071178|NCT02020577|11174246|FG000|Overall Study|Withdrawal by Subject|0
7071179|NCT02020577|11174247|FG001|Overall Study|Withdrawal by Subject|1
7071180|NCT02020577|11174246|FG000|Overall Study|Other than stated above|0
7071181|NCT02020577|11174247|FG001|Overall Study|Other than stated above|1
7071182|NCT02020616|11174266|FG000|Overall Study|Adverse Event|0
7071183|NCT02020616|11174267|FG001|Overall Study|Adverse Event|0
7071184|NCT02020616|11174268|FG002|Overall Study|Adverse Event|0
7071185|NCT02020616|11174269|FG003|Overall Study|Adverse Event|0
7071186|NCT02020616|11174270|FG004|Overall Study|Adverse Event|0
7071187|NCT02020616|11174271|FG005|Overall Study|Adverse Event|1
7071188|NCT02020616|11174272|FG006|Overall Study|Adverse Event|1
7071189|NCT02020616|11174266|FG000|Overall Study|Physician Decision|0
7071190|NCT02020616|11174267|FG001|Overall Study|Physician Decision|0
7071191|NCT02020616|11174268|FG002|Overall Study|Physician Decision|0
7071192|NCT02020616|11174269|FG003|Overall Study|Physician Decision|0
7071193|NCT02020616|11174270|FG004|Overall Study|Physician Decision|0
7071194|NCT02020616|11174271|FG005|Overall Study|Physician Decision|1
7071195|NCT02020616|11174272|FG006|Overall Study|Physician Decision|2
7071196|NCT02020616|11174266|FG000|Overall Study|Withdrawal by Subject|0
7071197|NCT02020616|11174267|FG001|Overall Study|Withdrawal by Subject|0
7071198|NCT02020616|11174268|FG002|Overall Study|Withdrawal by Subject|1
7071199|NCT02020616|11174269|FG003|Overall Study|Withdrawal by Subject|0
7071200|NCT02020616|11174270|FG004|Overall Study|Withdrawal by Subject|0
7071201|NCT02020616|11174271|FG005|Overall Study|Withdrawal by Subject|1
7071202|NCT02020616|11174272|FG006|Overall Study|Withdrawal by Subject|1
7071203|NCT02020616|11174266|FG000|Overall Study|Lost to Follow-up|0
7071204|NCT02020616|11174267|FG001|Overall Study|Lost to Follow-up|1
7071205|NCT02020616|11174268|FG002|Overall Study|Lost to Follow-up|0
7071206|NCT02020616|11174269|FG003|Overall Study|Lost to Follow-up|1
7071207|NCT02020616|11174270|FG004|Overall Study|Lost to Follow-up|1
7071208|NCT02020616|11174271|FG005|Overall Study|Lost to Follow-up|1
7071209|NCT02020616|11174272|FG006|Overall Study|Lost to Follow-up|0
7071210|NCT02020616|11174266|FG000|Overall Study|Early Termination Criteria Met|0
7071211|NCT02020616|11174267|FG001|Overall Study|Early Termination Criteria Met|0
6955983|NCT01052012|10999711|FG004|Overall Study|Adverse Event|0
6955984|NCT01052012|10999712|FG005|Overall Study|Adverse Event|0
6955985|NCT01052012|10999707|FG000|Overall Study|Lost to Follow-up|0
7071212|NCT02020616|11174268|FG002|Overall Study|Early Termination Criteria Met|1
7071213|NCT02020616|11174269|FG003|Overall Study|Early Termination Criteria Met|0
7071214|NCT02020616|11174270|FG004|Overall Study|Early Termination Criteria Met|0
7071215|NCT02020616|11174271|FG005|Overall Study|Early Termination Criteria Met|1
7147805|NCT03136198|11308677|FG000|Overall Study|Withdrawal by Subject|0
6955986|NCT01052012|10999708|FG001|Overall Study|Lost to Follow-up|0
6955987|NCT01052012|10999709|FG002|Overall Study|Lost to Follow-up|0
7071216|NCT02020616|11174272|FG006|Overall Study|Early Termination Criteria Met|0
7071217|NCT02020616|11174266|FG000|Overall Study|Randomized in Error|0
7071218|NCT02020616|11174267|FG001|Overall Study|Randomized in Error|0
6955988|NCT01052012|10999710|FG003|Overall Study|Lost to Follow-up|0
6955989|NCT01052012|10999711|FG004|Overall Study|Lost to Follow-up|1
6955990|NCT01052012|10999712|FG005|Overall Study|Lost to Follow-up|0
7071219|NCT02020616|11174268|FG002|Overall Study|Randomized in Error|0
7071220|NCT02020616|11174269|FG003|Overall Study|Randomized in Error|1
7071221|NCT02020616|11174270|FG004|Overall Study|Randomized in Error|0
7071222|NCT02020616|11174271|FG005|Overall Study|Randomized in Error|0
7071223|NCT02020616|11174272|FG006|Overall Study|Randomized in Error|0
7071224|NCT02020616|11174266|FG000|Overall Study|Lack of Efficacy|0
7071225|NCT02020616|11174267|FG001|Overall Study|Lack of Efficacy|0
7071226|NCT02020616|11174268|FG002|Overall Study|Lack of Efficacy|0
7071227|NCT02020616|11174269|FG003|Overall Study|Lack of Efficacy|0
7071228|NCT02020616|11174270|FG004|Overall Study|Lack of Efficacy|1
7071229|NCT02020616|11174271|FG005|Overall Study|Lack of Efficacy|0
7071230|NCT02020616|11174272|FG006|Overall Study|Lack of Efficacy|0
7071231|NCT02020863|11174311|FG000|Overall Study|Discovery of Metastatic disease|4
7071232|NCT02020863|11174311|FG000|Overall Study|Team chose not to place an a line|1
7071233|NCT02020889|11174317|FG000|Overall Study|Adverse Event|0
7071234|NCT02020889|11174318|FG001|Overall Study|Adverse Event|1
7071235|NCT02020889|11174317|FG000|Overall Study|Lack of Efficacy|1
7071236|NCT02020889|11174318|FG001|Overall Study|Lack of Efficacy|0
7071237|NCT02020889|11174317|FG000|Overall Study|Lost to Follow-up|1
7071238|NCT02020889|11174318|FG001|Overall Study|Lost to Follow-up|0
7071239|NCT02020889|11174317|FG000|Overall Study|Physician Decision|2
7071240|NCT02020889|11174318|FG001|Overall Study|Physician Decision|0
7071241|NCT02020889|11174317|FG000|Overall Study|Withdrawal by Subject|3
7071242|NCT02020889|11174318|FG001|Overall Study|Withdrawal by Subject|2
7071243|NCT02020941|11174324|FG000|Overall Study|Adverse Event|1
7071244|NCT02020941|11174324|FG000|Overall Study|Physician Decision|2
7071245|NCT02020941|11174324|FG000|Overall Study|Withdrawal by Subject|1
7071246|NCT02020941|11174324|FG000|Overall Study|Disease Progression|4
7071247|NCT02020967|11174330|FG000|Overall Study|Withdrawal by Subject|51
7071248|NCT02021292|11174338|FG000|Overall Study|Physician Decision|0
7071249|NCT02021292|11174339|FG001|Overall Study|Physician Decision|1
7071250|NCT02021292|11174338|FG000|Overall Study|Lost to Follow-up|0
7071251|NCT02021292|11174339|FG001|Overall Study|Lost to Follow-up|1
7071252|NCT02021292|11174338|FG000|Overall Study|Death|0
7071253|NCT02021292|11174339|FG001|Overall Study|Death|1
7071254|NCT02021318|11174349|FG000|Overall Study|Adverse Event|2
7071255|NCT02021318|11174350|FG001|Overall Study|Adverse Event|1
7071256|NCT02021318|11174349|FG000|Overall Study|Death|33
7071257|NCT02021318|11174350|FG001|Overall Study|Death|34
7071258|NCT02021318|11174349|FG000|Overall Study|Lost to Follow-up|3
7071259|NCT02021318|11174350|FG001|Overall Study|Lost to Follow-up|3
7071260|NCT02021318|11174349|FG000|Overall Study|Progressive Disease|0
7071261|NCT02021318|11174350|FG001|Overall Study|Progressive Disease|1
7071262|NCT02021318|11174349|FG000|Overall Study|Withdrawal by Subject|30
7071263|NCT02021318|11174350|FG001|Overall Study|Withdrawal by Subject|18
7071264|NCT02021318|11174349|FG000|Overall Study|Physician Decision|3
7071265|NCT02021318|11174350|FG001|Overall Study|Physician Decision|3
7071266|NCT02021318|11174349|FG000|Overall Study|Miscellaneous|2
7071267|NCT02021318|11174350|FG001|Overall Study|Miscellaneous|3
7071268|NCT02021331|11174359|FG000|Overall Study|Adverse Event|0
7071269|NCT02021331|11174360|FG001|Overall Study|Adverse Event|2
7071270|NCT02021565|11174374|FG000|Baseline Through Intervention|Death|0
7071271|NCT02021565|11174375|FG001|Baseline Through Intervention|Death|1
7071272|NCT02021565|11174374|FG000|Baseline Through Intervention|Withdrawal by Subject|8
7071273|NCT02021565|11174375|FG001|Baseline Through Intervention|Withdrawal by Subject|8
7071274|NCT02021565|11174374|FG000|Baseline Through Intervention|Protocol Violation|0
7071275|NCT02021565|11174375|FG001|Baseline Through Intervention|Protocol Violation|7
7071276|NCT02021565|11174374|FG000|Baseline Through Intervention|Lost to Follow-up|4
7071277|NCT02021565|11174375|FG001|Baseline Through Intervention|Lost to Follow-up|2
7071278|NCT02021565|11174374|FG000|3-month Follow-up|Death|3
7071279|NCT02021565|11174375|FG001|3-month Follow-up|Death|0
7071280|NCT02021565|11174374|FG000|3-month Follow-up|Withdrawal by Subject|4
7071281|NCT02021565|11174375|FG001|3-month Follow-up|Withdrawal by Subject|0
7071282|NCT02021565|11174374|FG000|3-month Follow-up|Protocol Violation|3
7071283|NCT02021565|11174375|FG001|3-month Follow-up|Protocol Violation|2
7071284|NCT02021643|11174389|FG000|Overall Study|Enrolled but Never Treated|1
6955991|NCT01052012|10999707|FG000|Overall Study|Withdrawal by Subject|1
7071285|NCT02021643|11174390|FG001|Overall Study|Enrolled but Never Treated|0
7071286|NCT02021643|11174391|FG002|Overall Study|Enrolled but Never Treated|0
7071287|NCT02021643|11174392|FG003|Overall Study|Enrolled but Never Treated|0
7071288|NCT02021643|11174389|FG000|Overall Study|Adverse Event|0
7071289|NCT02021643|11174390|FG001|Overall Study|Adverse Event|1
7071290|NCT02021643|11174391|FG002|Overall Study|Adverse Event|0
7071291|NCT02021643|11174392|FG003|Overall Study|Adverse Event|0
7071292|NCT02021643|11174389|FG000|Overall Study|Death|0
7071293|NCT02021643|11174390|FG001|Overall Study|Death|1
7071294|NCT02021643|11174391|FG002|Overall Study|Death|0
7071295|NCT02021643|11174392|FG003|Overall Study|Death|0
7071296|NCT02021643|11174389|FG000|Overall Study|Investigator's Discretion|1
7071297|NCT02021643|11174390|FG001|Overall Study|Investigator's Discretion|0
7071298|NCT02021643|11174391|FG002|Overall Study|Investigator's Discretion|0
7071299|NCT02021643|11174392|FG003|Overall Study|Investigator's Discretion|0
7071300|NCT02021643|11174389|FG000|Overall Study|Lack of Efficacy|7
6955992|NCT01052012|10999708|FG001|Overall Study|Withdrawal by Subject|1
6955993|NCT01052012|10999709|FG002|Overall Study|Withdrawal by Subject|0
6955994|NCT01052012|10999710|FG003|Overall Study|Withdrawal by Subject|0
6955995|NCT01052012|10999711|FG004|Overall Study|Withdrawal by Subject|3
6955996|NCT01052012|10999712|FG005|Overall Study|Withdrawal by Subject|1
6955997|NCT01052012|10999707|FG000|Overall Study|Physician Decision|0
6955998|NCT01052012|10999708|FG001|Overall Study|Physician Decision|0
7071301|NCT02021643|11174390|FG001|Overall Study|Lack of Efficacy|6
6955999|NCT01052012|10999709|FG002|Overall Study|Physician Decision|0
6956000|NCT01052012|10999710|FG003|Overall Study|Physician Decision|0
6956001|NCT01052012|10999711|FG004|Overall Study|Physician Decision|0
6956002|NCT01052012|10999712|FG005|Overall Study|Physician Decision|1
6956003|NCT01052012|10999707|FG000|Overall Study|Other|0
6956004|NCT01052012|10999708|FG001|Overall Study|Other|0
6956005|NCT01052012|10999709|FG002|Overall Study|Other|0
6956006|NCT01052012|10999710|FG003|Overall Study|Other|0
6956007|NCT01052012|10999711|FG004|Overall Study|Other|1
6956008|NCT01052012|10999712|FG005|Overall Study|Other|0
6956009|NCT01052038|10999729|FG000|Overall Study|Lost to Follow-up|2
6956010|NCT01052038|10999730|FG001|Overall Study|Lost to Follow-up|3
6956011|NCT01052038|10999731|FG002|Overall Study|Lost to Follow-up|1
6956012|NCT01052038|10999729|FG000|Overall Study|Protocol Violation|2
6956013|NCT01052038|10999730|FG001|Overall Study|Protocol Violation|3
6956014|NCT01052038|10999731|FG002|Overall Study|Protocol Violation|3
6956015|NCT01052077|10999741|FG000|Phase A|Lost to Follow-up|22
6956016|NCT01052077|10999742|FG001|Phase A|Lost to Follow-up|0
6956017|NCT01052077|10999743|FG002|Phase A|Lost to Follow-up|0
6956018|NCT01052077|10999744|FG003|Phase A|Lost to Follow-up|0
6956019|NCT01052077|10999741|FG000|Phase A|Adverse Event|32
6956020|NCT01052077|10999742|FG001|Phase A|Adverse Event|0
6956021|NCT01052077|10999743|FG002|Phase A|Adverse Event|0
6956022|NCT01052077|10999744|FG003|Phase A|Adverse Event|0
6956023|NCT01052077|10999741|FG000|Phase A|Met Withdrawal Criteria|26
6956024|NCT01052077|10999742|FG001|Phase A|Met Withdrawal Criteria|0
6956025|NCT01052077|10999743|FG002|Phase A|Met Withdrawal Criteria|0
6956026|NCT01052077|10999744|FG003|Phase A|Met Withdrawal Criteria|0
6956027|NCT01052077|10999741|FG000|Phase A|Physician Decision|10
6956028|NCT01052077|10999742|FG001|Phase A|Physician Decision|0
6956029|NCT01052077|10999743|FG002|Phase A|Physician Decision|0
6956030|NCT01052077|10999744|FG003|Phase A|Physician Decision|0
6956031|NCT01052077|10999741|FG000|Phase A|Withdrawal by Subject|29
6956032|NCT01052077|10999742|FG001|Phase A|Withdrawal by Subject|0
6956033|NCT01052077|10999743|FG002|Phase A|Withdrawal by Subject|0
6956034|NCT01052077|10999744|FG003|Phase A|Withdrawal by Subject|0
6956035|NCT01052077|10999741|FG000|Phase A|Protocol Deviation|27
6956036|NCT01052077|10999742|FG001|Phase A|Protocol Deviation|0
6956037|NCT01052077|10999743|FG002|Phase A|Protocol Deviation|0
6956038|NCT01052077|10999744|FG003|Phase A|Protocol Deviation|0
6956039|NCT01052077|10999741|FG000|Phase B|Lost to Follow-up|0
6956040|NCT01052077|10999742|FG001|Phase B|Lost to Follow-up|2
6956041|NCT01052077|10999743|FG002|Phase B|Lost to Follow-up|3
6956042|NCT01052077|10999744|FG003|Phase B|Lost to Follow-up|0
6956043|NCT01052077|10999741|FG000|Phase B|Adverse Event|0
6956044|NCT01052077|10999742|FG001|Phase B|Adverse Event|9
6956045|NCT01052077|10999743|FG002|Phase B|Adverse Event|2
6956046|NCT01052077|10999744|FG003|Phase B|Adverse Event|0
6956047|NCT01052077|10999741|FG000|Phase B|Met Withdrawal Criteria|0
6956048|NCT01052077|10999742|FG001|Phase B|Met Withdrawal Criteria|2
6956049|NCT01052077|10999743|FG002|Phase B|Met Withdrawal Criteria|1
6956050|NCT01052077|10999744|FG003|Phase B|Met Withdrawal Criteria|0
6956051|NCT01052077|10999741|FG000|Phase B|Physician Decision|0
6956052|NCT01052077|10999742|FG001|Phase B|Physician Decision|1
6956053|NCT01052077|10999743|FG002|Phase B|Physician Decision|1
6956054|NCT01052077|10999744|FG003|Phase B|Physician Decision|0
6956055|NCT01052077|10999741|FG000|Phase B|Withdrawal by Subject|0
6956056|NCT01052077|10999742|FG001|Phase B|Withdrawal by Subject|0
6956057|NCT01052077|10999743|FG002|Phase B|Withdrawal by Subject|5
6956058|NCT01052077|10999744|FG003|Phase B|Withdrawal by Subject|0
6956059|NCT01052077|10999741|FG000|Phase B|Protocol Deviation|0
6956060|NCT01052077|10999742|FG001|Phase B|Protocol Deviation|3
6956061|NCT01052077|10999743|FG002|Phase B|Protocol Deviation|4
6956062|NCT01052077|10999744|FG003|Phase B|Protocol Deviation|0
6956063|NCT01052077|10999741|FG000|Phase B|Lack of Efficacy|0
6956064|NCT01052077|10999742|FG001|Phase B|Lack of Efficacy|1
6956065|NCT01052077|10999743|FG002|Phase B|Lack of Efficacy|0
6956066|NCT01052077|10999744|FG003|Phase B|Lack of Efficacy|0
6956067|NCT01052077|10999741|FG000|Phase A+|Lost to Follow-up|0
6956068|NCT01052077|10999742|FG001|Phase A+|Lost to Follow-up|0
6956069|NCT01052077|10999743|FG002|Phase A+|Lost to Follow-up|0
7071302|NCT02021643|11174391|FG002|Overall Study|Lack of Efficacy|0
6956070|NCT01052077|10999744|FG003|Phase A+|Lost to Follow-up|8
6956071|NCT01052077|10999741|FG000|Phase A+|Adverse Event|0
6956072|NCT01052077|10999742|FG001|Phase A+|Adverse Event|0
6956073|NCT01052077|10999743|FG002|Phase A+|Adverse Event|0
6956074|NCT01052077|10999744|FG003|Phase A+|Adverse Event|4
6956075|NCT01052077|10999741|FG000|Phase A+|Met Withdrawal Criteria|0
6956076|NCT01052077|10999742|FG001|Phase A+|Met Withdrawal Criteria|0
6956077|NCT01052077|10999743|FG002|Phase A+|Met Withdrawal Criteria|0
6956078|NCT01052077|10999744|FG003|Phase A+|Met Withdrawal Criteria|2
6956079|NCT01052077|10999741|FG000|Phase A+|Withdrawal by Subject|0
6956080|NCT01052077|10999742|FG001|Phase A+|Withdrawal by Subject|0
6956081|NCT01052077|10999743|FG002|Phase A+|Withdrawal by Subject|0
6956082|NCT01052077|10999744|FG003|Phase A+|Withdrawal by Subject|7
6956083|NCT01052103|10999752|FG000|Overall Study|Adverse Event|10
6956084|NCT01052103|10999753|FG001|Overall Study|Adverse Event|6
6956085|NCT01052103|10999752|FG000|Overall Study|Entry Criteria Not Met|3
6956086|NCT01052103|10999753|FG001|Overall Study|Entry Criteria Not Met|1
6956087|NCT01052103|10999752|FG000|Overall Study|Lost to Follow-up|3
6956088|NCT01052103|10999753|FG001|Overall Study|Lost to Follow-up|5
6956089|NCT01052103|10999752|FG000|Overall Study|Protocol Violation|10
6956090|NCT01052103|10999753|FG001|Overall Study|Protocol Violation|4
6956091|NCT01052103|10999752|FG000|Overall Study|Scheduling conflict|2
6956092|NCT01052103|10999753|FG001|Overall Study|Scheduling conflict|1
6956093|NCT01052103|10999752|FG000|Overall Study|Sponsor Decision|2
6956094|NCT01052103|10999753|FG001|Overall Study|Sponsor Decision|0
6956095|NCT01052103|10999752|FG000|Overall Study|Withdrawal by Subject|3
6956096|NCT01052103|10999753|FG001|Overall Study|Withdrawal by Subject|6
6956097|NCT01052103|10999752|FG000|Overall Study|Perceived Lack of Efficacy|1
6956098|NCT01052103|10999753|FG001|Overall Study|Perceived Lack of Efficacy|0
6956099|NCT01052116|10999762|FG000|Overall Study|Lost to Follow-up|11
6956100|NCT01052116|10999763|FG001|Overall Study|Lost to Follow-up|17
6956101|NCT01052116|10999762|FG000|Overall Study|Withdrawal by Subject|3
6956102|NCT01052116|10999763|FG001|Overall Study|Withdrawal by Subject|6
6956103|NCT01052116|10999762|FG000|Overall Study|Spirometry not performed|0
6956104|NCT01052116|10999763|FG001|Overall Study|Spirometry not performed|4
6956105|NCT01052272|10999782|FG000|Overall Study|Death|0
6956106|NCT01052272|10999783|FG001|Overall Study|Death|0
6956107|NCT01052272|10999784|FG002|Overall Study|Death|1
6956108|NCT01052272|10999785|FG003|Overall Study|Death|1
6956109|NCT01052272|10999782|FG000|Overall Study|Physician Decision|0
6956110|NCT01052272|10999783|FG001|Overall Study|Physician Decision|1
6956111|NCT01052272|10999784|FG002|Overall Study|Physician Decision|0
7071303|NCT02021643|11174392|FG003|Overall Study|Lack of Efficacy|12
7071304|NCT02021643|11174389|FG000|Overall Study|Lost to Follow-up|0
7071305|NCT02021643|11174390|FG001|Overall Study|Lost to Follow-up|1
7071306|NCT02021643|11174391|FG002|Overall Study|Lost to Follow-up|0
7071307|NCT02021643|11174392|FG003|Overall Study|Lost to Follow-up|0
7071308|NCT02021643|11174389|FG000|Overall Study|Withdrew Consent|0
7071309|NCT02021643|11174390|FG001|Overall Study|Withdrew Consent|1
7071310|NCT02021643|11174391|FG002|Overall Study|Withdrew Consent|0
7071311|NCT02021643|11174392|FG003|Overall Study|Withdrew Consent|0
7071312|NCT02021656|11174408|FG000|Overall Study|Adverse Event|1
7071313|NCT02021656|11174408|FG000|Overall Study|Lack of Efficacy|2
7071314|NCT02021656|11174408|FG000|Overall Study|Lost to Follow-up|1
7071315|NCT02021656|11174408|FG000|Overall Study|Withdrew Consent|2
7071321|NCT02022007|11174455|FG000|Overall Study|Withdrawal by Subject|1
7071322|NCT02022007|11174456|FG001|Overall Study|Withdrawal by Subject|1
7071323|NCT02022007|11174457|FG002|Overall Study|Withdrawal by Subject|1
7071324|NCT02022007|11174455|FG000|Overall Study|Noncompliant|0
7071325|NCT02022007|11174456|FG001|Overall Study|Noncompliant|0
7071326|NCT02022007|11174457|FG002|Overall Study|Noncompliant|1
7071327|NCT02022657|11174484|FG000|Overall Study|Withdrawal by Subject|2
7071328|NCT02022657|11174485|FG001|Overall Study|Withdrawal by Subject|0
7071329|NCT02022657|11174486|FG002|Overall Study|Withdrawal by Subject|1
7071330|NCT02022657|11174487|FG003|Overall Study|Withdrawal by Subject|0
7071331|NCT02022657|11174488|FG004|Overall Study|Withdrawal by Subject|0
7071332|NCT02022657|11174489|FG005|Overall Study|Withdrawal by Subject|0
7071333|NCT02022657|11174484|FG000|Overall Study|Physician Decision|0
7071334|NCT02022657|11174485|FG001|Overall Study|Physician Decision|0
7071335|NCT02022657|11174486|FG002|Overall Study|Physician Decision|0
7071336|NCT02022657|11174487|FG003|Overall Study|Physician Decision|0
6956112|NCT01052272|10999785|FG003|Overall Study|Physician Decision|0
6956113|NCT01052272|10999782|FG000|Overall Study|patient refuses follow-up|5
6956114|NCT01052272|10999783|FG001|Overall Study|patient refuses follow-up|4
6956115|NCT01052272|10999784|FG002|Overall Study|patient refuses follow-up|2
7071337|NCT02022657|11174488|FG004|Overall Study|Physician Decision|0
7071338|NCT02022657|11174489|FG005|Overall Study|Physician Decision|1
7071339|NCT02022670|11174498|FG000|Overall Study|Adverse Event|1
7071340|NCT02022670|11174499|FG001|Overall Study|Adverse Event|0
7071341|NCT02022670|11174500|FG002|Overall Study|Adverse Event|1
7071342|NCT02022748|11174521|FG000|Overall Study|Adverse Event|1
7071343|NCT02022748|11174522|FG001|Overall Study|Adverse Event|1
7071344|NCT02022748|11174523|FG002|Overall Study|Adverse Event|0
7071345|NCT02022748|11174521|FG000|Overall Study|Withdrawal by Subject|0
6956116|NCT01052272|10999785|FG003|Overall Study|patient refuses follow-up|4
6956117|NCT01052272|10999782|FG000|Overall Study|Withdrawal by Subject|0
6956118|NCT01052272|10999783|FG001|Overall Study|Withdrawal by Subject|2
6956119|NCT01052272|10999784|FG002|Overall Study|Withdrawal by Subject|3
6956120|NCT01052272|10999785|FG003|Overall Study|Withdrawal by Subject|2
6956121|NCT01052272|10999782|FG000|Overall Study|placed in long-term care|0
6956122|NCT01052272|10999783|FG001|Overall Study|placed in long-term care|0
6956123|NCT01052272|10999784|FG002|Overall Study|placed in long-term care|1
7071346|NCT02022748|11174522|FG001|Overall Study|Withdrawal by Subject|1
7071347|NCT02022748|11174523|FG002|Overall Study|Withdrawal by Subject|0
7071348|NCT02023099|11174538|FG000|Overall Study|Non-fatal Adverse Event (AE)|0
7071349|NCT02023099|11174539|FG001|Overall Study|Non-fatal Adverse Event (AE)|0
7071350|NCT02023099|11174540|FG002|Overall Study|Non-fatal Adverse Event (AE)|1
7071351|NCT02023099|11174538|FG000|Overall Study|Withdrawn Consent|3
7071352|NCT02023099|11174539|FG001|Overall Study|Withdrawn Consent|0
7071353|NCT02023099|11174540|FG002|Overall Study|Withdrawn Consent|1
7071354|NCT02023099|11174538|FG000|Overall Study|Non-treatment-emergent Fatal AE|0
7071355|NCT02023099|11174539|FG001|Overall Study|Non-treatment-emergent Fatal AE|0
7071356|NCT02023099|11174540|FG002|Overall Study|Non-treatment-emergent Fatal AE|1
7071357|NCT02023112|11174550|FG000|Overall Study|Withdrawal by Subject|2
7071358|NCT02023112|11174551|FG001|Overall Study|Withdrawal by Subject|1
7071359|NCT02023151|11174575|FG000|Overall Study|Lost to Follow-up|4
7071360|NCT02023242|11174581|FG000|Overall Study|Lost to Follow-up|3
7071361|NCT02023242|11174582|FG001|Overall Study|Lost to Follow-up|1
7071362|NCT02023242|11174581|FG000|Overall Study|Death|0
7071363|NCT02023242|11174582|FG001|Overall Study|Death|1
7071364|NCT02023268|11174590|FG000|Overall Study|Lack of Efficacy|0
7071365|NCT02023268|11174591|FG001|Overall Study|Lack of Efficacy|1
7071366|NCT02023268|11174590|FG000|Overall Study|Adverse Event|0
7071367|NCT02023268|11174591|FG001|Overall Study|Adverse Event|2
7071368|NCT02023268|11174590|FG000|Overall Study|Withdrawal by Subject|0
7071369|NCT02023268|11174591|FG001|Overall Study|Withdrawal by Subject|1
7071370|NCT02023697|11174619|FG000|Treatment Period|Radiological progression|13
7071371|NCT02023697|11174620|FG001|Treatment Period|Radiological progression|17
7071372|NCT02023697|11174621|FG002|Treatment Period|Radiological progression|26
7071373|NCT02023697|11174619|FG000|Treatment Period|Never Treated|5
7071374|NCT02023697|11174620|FG001|Treatment Period|Never Treated|6
7071375|NCT02023697|11174621|FG002|Treatment Period|Never Treated|10
7071376|NCT02023697|11174619|FG000|Treatment Period|Adverse Event|13
7071377|NCT02023697|11174620|FG001|Treatment Period|Adverse Event|25
7071378|NCT02023697|11174621|FG002|Treatment Period|Adverse Event|23
7071379|NCT02023697|11174619|FG000|Treatment Period|Logistical difficulties|1
7071380|NCT02023697|11174620|FG001|Treatment Period|Logistical difficulties|1
7071381|NCT02023697|11174621|FG002|Treatment Period|Logistical difficulties|1
7071382|NCT02023697|11174619|FG000|Treatment Period|Clinical progression|10
7071383|NCT02023697|11174620|FG001|Treatment Period|Clinical progression|8
7071384|NCT02023697|11174621|FG002|Treatment Period|Clinical progression|28
7071385|NCT02023697|11174619|FG000|Treatment Period|Withdrawal by Subject|4
7071386|NCT02023697|11174620|FG001|Treatment Period|Withdrawal by Subject|5
7071387|NCT02023697|11174621|FG002|Treatment Period|Withdrawal by Subject|13
7071388|NCT02023697|11174619|FG000|Treatment Period|Safety outcome reached|0
7071389|NCT02023697|11174620|FG001|Treatment Period|Safety outcome reached|1
7071390|NCT02023697|11174621|FG002|Treatment Period|Safety outcome reached|0
7071391|NCT02023697|11174619|FG000|Treatment Period|Physician Decision|0
7071392|NCT02023697|11174620|FG001|Treatment Period|Physician Decision|0
7071393|NCT02023697|11174621|FG002|Treatment Period|Physician Decision|1
7071394|NCT02023697|11174619|FG000|Active Follow-up Period|Withdrawal by Subject|5
7071395|NCT02023697|11174620|FG001|Active Follow-up Period|Withdrawal by Subject|13
7071396|NCT02023697|11174621|FG002|Active Follow-up Period|Withdrawal by Subject|7
7071397|NCT02023697|11174619|FG000|Active Follow-up Period|Lost to Follow-up|1
7071398|NCT02023697|11174620|FG001|Active Follow-up Period|Lost to Follow-up|1
7071399|NCT02023697|11174621|FG002|Active Follow-up Period|Lost to Follow-up|1
7071400|NCT02023697|11174619|FG000|Active Follow-up Period|Deterioration of general condition|1
7071401|NCT02023697|11174620|FG001|Active Follow-up Period|Deterioration of general condition|1
7071402|NCT02023697|11174621|FG002|Active Follow-up Period|Deterioration of general condition|1
7071403|NCT02023697|11174619|FG000|Active Follow-up Period|Other unspecified|2
7071404|NCT02023697|11174620|FG001|Active Follow-up Period|Other unspecified|0
7071405|NCT02023697|11174621|FG002|Active Follow-up Period|Other unspecified|1
7071406|NCT02023697|11174619|FG000|Active Follow-up Period|Clinical progression|0
7071407|NCT02023697|11174620|FG001|Active Follow-up Period|Clinical progression|2
7071408|NCT02023697|11174621|FG002|Active Follow-up Period|Clinical progression|1
7071409|NCT02023697|11174619|FG000|Active Follow-up Period|Radiological progression|0
7071410|NCT02023697|11174620|FG001|Active Follow-up Period|Radiological progression|0
7071411|NCT02023697|11174621|FG002|Active Follow-up Period|Radiological progression|1
7071412|NCT02023697|11174619|FG000|Active Follow-up Period|Death|83
7071413|NCT02023697|11174620|FG001|Active Follow-up Period|Death|82
7071414|NCT02023697|11174621|FG002|Active Follow-up Period|Death|87
7071415|NCT02023697|11174619|FG000|Long-term Follow-up Period|Death|9
7071416|NCT02023697|11174620|FG001|Long-term Follow-up Period|Death|6
7071417|NCT02023697|11174621|FG002|Long-term Follow-up Period|Death|4
7071418|NCT02023697|11174619|FG000|Long-term Follow-up Period|Withdrawal by Subject|6
7071419|NCT02023697|11174620|FG001|Long-term Follow-up Period|Withdrawal by Subject|3
7071420|NCT02023697|11174621|FG002|Long-term Follow-up Period|Withdrawal by Subject|0
7071421|NCT02023697|11174619|FG000|Long-term Follow-up Period|Lost to Follow-up|1
7071422|NCT02023697|11174620|FG001|Long-term Follow-up Period|Lost to Follow-up|0
7071423|NCT02023697|11174621|FG002|Long-term Follow-up Period|Lost to Follow-up|1
7082671|NCT02144012|11193251|FG000|Overall Study|Death|1
6956124|NCT01052272|10999785|FG003|Overall Study|placed in long-term care|0
6956125|NCT01052272|10999782|FG000|Overall Study|decline in health|0
6956126|NCT01052272|10999783|FG001|Overall Study|decline in health|0
6956127|NCT01052272|10999784|FG002|Overall Study|decline in health|1
6956128|NCT01052272|10999785|FG003|Overall Study|decline in health|0
6956129|NCT01052428|10999797|FG000|Overall Study|Death|1
6956130|NCT01052428|10999798|FG001|Overall Study|Death|0
6956131|NCT01052428|10999797|FG000|Overall Study|Withdrawal by Subject|0
6956132|NCT01052428|10999798|FG001|Overall Study|Withdrawal by Subject|1
6956133|NCT01052480|10999806|FG000|Overall Study|Lost to Follow-up|3
6956134|NCT01052480|10999807|FG001|Overall Study|Lost to Follow-up|3
6956135|NCT01052480|10999806|FG000|Overall Study|Protocol Violation|1
6956136|NCT01052480|10999807|FG001|Overall Study|Protocol Violation|0
6956137|NCT01052480|10999806|FG000|Overall Study|Withdrawal by Subject|3
6956138|NCT01052480|10999807|FG001|Overall Study|Withdrawal by Subject|7
6956139|NCT01052480|10999806|FG000|Overall Study|Physician Decision|0
6956140|NCT01052480|10999807|FG001|Overall Study|Physician Decision|2
6956141|NCT01052480|10999806|FG000|Overall Study|Death|1
6956142|NCT01052480|10999807|FG001|Overall Study|Death|5
6956143|NCT01052493|10999813|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1
6956144|NCT01052493|10999814|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0
6956145|NCT01052493|10999815|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0
7071424|NCT02023697|11174619|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6
7071425|NCT02023697|11174620|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9
7071426|NCT02023697|11174621|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6
7071427|NCT02023697|11174619|FG000|Long-term Follow-up Period|Technical problems|0
7071428|NCT02023697|11174620|FG001|Long-term Follow-up Period|Technical problems|0
7071429|NCT02023697|11174621|FG002|Long-term Follow-up Period|Technical problems|1
7071430|NCT02023697|11174619|FG000|Long-term Follow-up Period|Other unspecified|6
7071431|NCT02023697|11174620|FG001|Long-term Follow-up Period|Other unspecified|3
7071432|NCT02023697|11174621|FG002|Long-term Follow-up Period|Other unspecified|5
7071433|NCT02023866|11174640|FG000|Overall Study|Non-compliance|2
7071434|NCT02023866|11174640|FG000|Overall Study|Adverse Event|3
7071435|NCT02023866|11174640|FG000|Overall Study|Withdrawal by Subject|1
7071436|NCT02023879|11174647|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2
7071437|NCT02023879|11174648|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2
7071438|NCT02023879|11174649|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5
7071439|NCT02023879|11174647|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0
7071440|NCT02023879|11174648|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2
7071441|NCT02023879|11174649|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1
7071442|NCT02023879|11174647|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0
7071443|NCT02023879|11174648|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1
7071444|NCT02023879|11174649|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0
7071445|NCT02023879|11174647|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1
7071446|NCT02023879|11174648|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0
7071447|NCT02023879|11174649|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1
7071448|NCT02023879|11174647|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0
7071449|NCT02023879|11174648|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1
7071450|NCT02023879|11174649|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1
7071451|NCT02023879|11174647|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1
7071452|NCT02023879|11174648|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3
7071453|NCT02023879|11174649|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1
7071454|NCT02023879|11174647|FG000|Extension Open Label Treatment|Adverse Event|1
7071455|NCT02023879|11174648|FG001|Extension Open Label Treatment|Adverse Event|7
7071456|NCT02023879|11174649|FG002|Extension Open Label Treatment|Adverse Event|3
7071457|NCT02023879|11174647|FG000|Extension Open Label Treatment|Poor compliance to protocol|1
7071458|NCT02023879|11174648|FG001|Extension Open Label Treatment|Poor compliance to protocol|1
7071459|NCT02023879|11174649|FG002|Extension Open Label Treatment|Poor compliance to protocol|0
7071460|NCT02023879|11174647|FG000|Extension Open Label Treatment|Participant moved|1
7071461|NCT02023879|11174648|FG001|Extension Open Label Treatment|Participant moved|2
7071462|NCT02023879|11174649|FG002|Extension Open Label Treatment|Participant moved|0
7071463|NCT02023879|11174647|FG000|Extension Open Label Treatment|Other than specified above|2
7071464|NCT02023879|11174648|FG001|Extension Open Label Treatment|Other than specified above|7
7071465|NCT02023879|11174649|FG002|Extension Open Label Treatment|Other than specified above|2
7071466|NCT02024698|11174747|FG000|First Intervention (7 Days)|Withdrawal by Subject|0
7071467|NCT02024698|11174748|FG001|First Intervention (7 Days)|Withdrawal by Subject|1
7082672|NCT02144012|11193252|FG001|Overall Study|Death|0
7082673|NCT02144012|11193251|FG000|Overall Study|Withdrawal by Subject|11
7082674|NCT02144012|11193252|FG001|Overall Study|Withdrawal by Subject|3
6956146|NCT01052662|10999852|FG000|Overall Study|Lost to Follow-up|15
6956147|NCT01052662|10999853|FG001|Overall Study|Lost to Follow-up|13
6956148|NCT01052662|10999854|FG002|Overall Study|Lost to Follow-up|18
6956149|NCT01052662|10999852|FG000|Overall Study|Withdrawal by Subject|3
6956150|NCT01052662|10999853|FG001|Overall Study|Withdrawal by Subject|2
6956151|NCT01052662|10999854|FG002|Overall Study|Withdrawal by Subject|1
6956152|NCT01052662|10999852|FG000|Overall Study|Pharmacy issue|1
6956153|NCT01052662|10999853|FG001|Overall Study|Pharmacy issue|3
6956154|NCT01052662|10999854|FG002|Overall Study|Pharmacy issue|3
6956155|NCT01052662|10999852|FG000|Overall Study|Adverse Event|1
6956156|NCT01052662|10999853|FG001|Overall Study|Adverse Event|1
6956157|NCT01052662|10999854|FG002|Overall Study|Adverse Event|0
6956158|NCT01052662|10999852|FG000|Overall Study|Legal Problem|2
6956159|NCT01052662|10999853|FG001|Overall Study|Legal Problem|0
6956160|NCT01052662|10999854|FG002|Overall Study|Legal Problem|0
6956161|NCT01052662|10999852|FG000|Overall Study|Administrative|0
6956162|NCT01052662|10999853|FG001|Overall Study|Administrative|3
6956163|NCT01052662|10999854|FG002|Overall Study|Administrative|0
6956164|NCT01052714|10999873|FG000|Overall Study|Adverse Event|6
6956165|NCT01052714|10999874|FG001|Overall Study|Adverse Event|3
6956166|NCT01052714|10999875|FG002|Overall Study|Adverse Event|0
6956167|NCT01052714|10999873|FG000|Overall Study|Death|1
6956168|NCT01052714|10999874|FG001|Overall Study|Death|2
7071468|NCT02024750|11174774|FG000|Overall Study|Withdrawal by Subject|2
7071469|NCT02024750|11174775|FG001|Overall Study|Withdrawal by Subject|1
7071470|NCT02024867|11174783|FG000|Overall Study|Protocol Violation|3
7071471|NCT02024867|11174784|FG001|Overall Study|Protocol Violation|3
7071472|NCT02024867|11174783|FG000|Overall Study|Lost to Follow-up|6
7071473|NCT02024867|11174784|FG001|Overall Study|Lost to Follow-up|4
7071474|NCT02024932|11174796|FG000|Overall Study|Adverse Event|2
7071475|NCT02024932|11174797|FG001|Overall Study|Adverse Event|3
7071476|NCT02024932|11174798|FG002|Overall Study|Adverse Event|0
7071477|NCT02024932|11174799|FG003|Overall Study|Adverse Event|0
7071478|NCT02024932|11174800|FG004|Overall Study|Adverse Event|2
7071479|NCT02024932|11174801|FG005|Overall Study|Adverse Event|0
7071480|NCT02024932|11174796|FG000|Overall Study|Abnormal laboratory value|0
7071481|NCT02024932|11174797|FG001|Overall Study|Abnormal laboratory value|0
7071482|NCT02024932|11174798|FG002|Overall Study|Abnormal laboratory value|0
7071483|NCT02024932|11174799|FG003|Overall Study|Abnormal laboratory value|2
7071484|NCT02024932|11174800|FG004|Overall Study|Abnormal laboratory value|0
7071485|NCT02024932|11174801|FG005|Overall Study|Abnormal laboratory value|0
7071486|NCT02024971|11174821|FG000|Overall Study|Data Not Available|30
7071487|NCT02024971|11174821|FG000|Overall Study|Lost to Follow-up|6
7071488|NCT02025179|11174843|FG000|Overall Study|Lost to Follow-up|0
7071489|NCT02025179|11174844|FG001|Overall Study|Lost to Follow-up|0
7071490|NCT02025179|11174845|FG002|Overall Study|Lost to Follow-up|1
7071491|NCT02025205|11174855|FG000|Overall Study|Withdrawal by Subject|1
7071492|NCT02025205|11174856|FG001|Overall Study|Withdrawal by Subject|1
7071493|NCT02025205|11174855|FG000|Overall Study|Protocol Violation|2
7071494|NCT02025205|11174856|FG001|Overall Study|Protocol Violation|1
7071495|NCT02025205|11174855|FG000|Overall Study|Death|0
7071496|NCT02025205|11174856|FG001|Overall Study|Death|1
7071497|NCT02025530|11174884|FG000|Overall Study|No longer met elligibility criteria|5
7071498|NCT02025530|11174885|FG001|Overall Study|No longer met elligibility criteria|1
7071499|NCT02025621|11174893|FG000|Overall Study|Withdrawal by Subject|1
7071500|NCT02025621|11174894|FG001|Overall Study|Withdrawal by Subject|0
7071501|NCT02025621|11174893|FG000|Overall Study|Death|0
7071502|NCT02025621|11174894|FG001|Overall Study|Death|1
7071503|NCT02025621|11174893|FG000|Overall Study|No longer eligible|10
7071504|NCT02025621|11174894|FG001|Overall Study|No longer eligible|15
7071505|NCT02025621|11174893|FG000|Overall Study|Surgery initiated before infusion|3
7071506|NCT02025621|11174894|FG001|Overall Study|Surgery initiated before infusion|3
7071507|NCT02025725|11174915|FG000|Overall Study|Adverse Event|5
7071508|NCT02025725|11174916|FG001|Overall Study|Adverse Event|0
7071509|NCT02025725|11174915|FG000|Overall Study|Lost to Follow-up|2
7071510|NCT02025725|11174916|FG001|Overall Study|Lost to Follow-up|0
7071511|NCT02025725|11174915|FG000|Overall Study|Protocol Violation|1
7071512|NCT02025725|11174916|FG001|Overall Study|Protocol Violation|1
7071513|NCT02025725|11174915|FG000|Overall Study|Withdrawal by Subject|3
7071514|NCT02025725|11174916|FG001|Overall Study|Withdrawal by Subject|2
7071515|NCT02025725|11174915|FG000|Overall Study|Post-dose QTcB > 270 msec|0
7071516|NCT02025725|11174916|FG001|Overall Study|Post-dose QTcB > 270 msec|1
7071517|NCT02025751|11174926|FG000|Overall Study|Lost to Follow-up|1
7071518|NCT02025751|11174927|FG001|Overall Study|Lost to Follow-up|0
7071519|NCT02025751|11174926|FG000|Overall Study|Adverse Event|0
7071520|NCT02025751|11174927|FG001|Overall Study|Adverse Event|1
7071521|NCT02025751|11174926|FG000|Overall Study|Physician Decision|0
7071522|NCT02025751|11174927|FG001|Overall Study|Physician Decision|1
7071523|NCT02025751|11174926|FG000|Overall Study|Withdrawal by Subject|0
7071524|NCT02025751|11174927|FG001|Overall Study|Withdrawal by Subject|1
7071525|NCT02025907|11174945|FG000|Overall Study|Lack of Efficacy|1
7071526|NCT02025907|11174946|FG001|Overall Study|Lack of Efficacy|0
7071527|NCT02025907|11174945|FG000|Overall Study|Withdrawal by Subject|15
7071528|NCT02025907|11174946|FG001|Overall Study|Withdrawal by Subject|8
7071529|NCT02025907|11174945|FG000|Overall Study|Protocol Violation|2
7071530|NCT02025907|11174946|FG001|Overall Study|Protocol Violation|0
6956169|NCT01052714|10999875|FG002|Overall Study|Death|0
6956170|NCT01052714|10999873|FG000|Overall Study|Lost to Follow-up|2
6956171|NCT01052714|10999874|FG001|Overall Study|Lost to Follow-up|3
6956172|NCT01052714|10999875|FG002|Overall Study|Lost to Follow-up|0
7071531|NCT02025907|11174945|FG000|Overall Study|Physician Decision|2
6956173|NCT01052714|10999873|FG000|Overall Study|Physician Decision|9
6956174|NCT01052714|10999874|FG001|Overall Study|Physician Decision|9
6956175|NCT01052714|10999875|FG002|Overall Study|Physician Decision|1
6956176|NCT01052714|10999873|FG000|Overall Study|Withdrawal by Subject|7
6956177|NCT01052714|10999874|FG001|Overall Study|Withdrawal by Subject|12
6956178|NCT01052714|10999875|FG002|Overall Study|Withdrawal by Subject|1
7071532|NCT02025907|11174946|FG001|Overall Study|Physician Decision|0
7071533|NCT02025907|11174945|FG000|Overall Study|Lost to Follow-up|2
7071534|NCT02025907|11174946|FG001|Overall Study|Lost to Follow-up|2
7071535|NCT02025907|11174945|FG000|Overall Study|Adverse Event|3
7071536|NCT02025907|11174946|FG001|Overall Study|Adverse Event|1
7071537|NCT02025907|11174945|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2
7071538|NCT02025907|11174946|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1
7071539|NCT02025985|11174957|FG000|Overall Study|Consent withdrawn|0
7071540|NCT02025985|11174958|FG001|Overall Study|Consent withdrawn|0
7071541|NCT02025985|11174959|FG002|Overall Study|Consent withdrawn|1
7071542|NCT02025985|11174960|FG003|Overall Study|Consent withdrawn|0
7071543|NCT02025985|11174961|FG004|Overall Study|Consent withdrawn|0
7071544|NCT02025985|11174957|FG000|Overall Study|Termination of study by Sponsor|4
7071545|NCT02025985|11174958|FG001|Overall Study|Termination of study by Sponsor|3
7071546|NCT02025985|11174959|FG002|Overall Study|Termination of study by Sponsor|1
7071547|NCT02025985|11174960|FG003|Overall Study|Termination of study by Sponsor|1
7071548|NCT02025985|11174961|FG004|Overall Study|Termination of study by Sponsor|3
7071549|NCT02025985|11174957|FG000|Overall Study|Death|21
7071550|NCT02025985|11174958|FG001|Overall Study|Death|20
7071551|NCT02025985|11174959|FG002|Overall Study|Death|23
7071552|NCT02025985|11174960|FG003|Overall Study|Death|20
7071553|NCT02025985|11174961|FG004|Overall Study|Death|17
7071554|NCT02026011|11174977|FG000|Allocation 1 (First Set of Medication)|Side Effects|6
7071555|NCT02026011|11174978|FG001|Allocation 1 (First Set of Medication)|Side Effects|0
7071556|NCT02026011|11174977|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1
7071557|NCT02026011|11174978|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2
7071558|NCT02026011|11174977|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1
7071559|NCT02026011|11174978|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0
7071560|NCT02026011|11174977|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1
7071561|NCT02026011|11174978|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2
7071562|NCT02026063|11174989|FG000|Overall Study|Physician Decision|0
7071563|NCT02026063|11174990|FG001|Overall Study|Physician Decision|10
7071564|NCT02026063|11174989|FG000|Overall Study|Noncompliance with Study Drug|1
7071565|NCT02026063|11174990|FG001|Overall Study|Noncompliance with Study Drug|1
7071566|NCT02026063|11174989|FG000|Overall Study|Withdrawal of Consent|1
7071567|NCT02026063|11174990|FG001|Overall Study|Withdrawal of Consent|6
7071568|NCT02026063|11174989|FG000|Overall Study|Adverse Event|5
7071569|NCT02026063|11174990|FG001|Overall Study|Adverse Event|20
7071570|NCT02026063|11174989|FG000|Overall Study|Lack of Efficacy|0
7071571|NCT02026063|11174990|FG001|Overall Study|Lack of Efficacy|4
7071572|NCT02026063|11174989|FG000|Overall Study|Lost to Follow-up|0
7071573|NCT02026063|11174990|FG001|Overall Study|Lost to Follow-up|1
7071574|NCT02026063|11174989|FG000|Overall Study|Reason not Specified|2
7071575|NCT02026063|11174990|FG001|Overall Study|Reason not Specified|7
7071576|NCT02026141|11174999|FG000|Overall Study|Protocol Violation|0
7071577|NCT02026141|11175000|FG001|Overall Study|Protocol Violation|1
7071578|NCT02026258|11175026|FG000|Randomized|Did not start treatment|2
7071579|NCT02026258|11175027|FG001|Randomized|Did not start treatment|1
7071580|NCT02026258|11175026|FG000|Randomized|Change in treatment plan|1
7071581|NCT02026258|11175027|FG001|Randomized|Change in treatment plan|0
7071582|NCT02026258|11175026|FG000|Randomized|Presence of periodontal disease|1
7071583|NCT02026258|11175027|FG001|Randomized|Presence of periodontal disease|1
7071584|NCT02026258|11175026|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1
7071585|NCT02026258|11175027|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1
7071586|NCT02026258|11175026|FG000|Recieved Allocated Intervention|Lost to Follow-up|0
7071587|NCT02026258|11175027|FG001|Recieved Allocated Intervention|Lost to Follow-up|1
7071588|NCT02027025|11175068|FG000|Overall Study|Adverse Event|0
7071589|NCT02027025|11175069|FG001|Overall Study|Adverse Event|1
7071590|NCT02027025|11175070|FG002|Overall Study|Adverse Event|1
7071591|NCT02027025|11175068|FG000|Overall Study|Protocol Violation|1
7071592|NCT02027025|11175069|FG001|Overall Study|Protocol Violation|0
7071593|NCT02027025|11175070|FG002|Overall Study|Protocol Violation|0
7071594|NCT02027025|11175068|FG000|Overall Study|Lost to Follow-up|0
7071595|NCT02027025|11175069|FG001|Overall Study|Lost to Follow-up|2
7071596|NCT02027025|11175070|FG002|Overall Study|Lost to Follow-up|0
7071597|NCT02027025|11175068|FG000|Overall Study|Withdrawal by Subject|0
7071598|NCT02027025|11175069|FG001|Overall Study|Withdrawal by Subject|1
7071599|NCT02027025|11175070|FG002|Overall Study|Withdrawal by Subject|0
7071600|NCT02027025|11175068|FG000|Overall Study|Sponsor's decision|0
7071601|NCT02027025|11175069|FG001|Overall Study|Sponsor's decision|1
6956179|NCT01052779|10999883|FG000|Overall Study|Adverse Event|1
6956180|NCT01052779|10999884|FG001|Overall Study|Adverse Event|4
7071602|NCT02027025|11175070|FG002|Overall Study|Sponsor's decision|0
6956181|NCT01052779|10999883|FG000|Overall Study|Withdrawal by Subject|1
6956182|NCT01052779|10999884|FG001|Overall Study|Withdrawal by Subject|2
6956183|NCT01052779|10999883|FG000|Overall Study|Other-Protocol Violation|1
6956184|NCT01052779|10999884|FG001|Overall Study|Other-Protocol Violation|1
6956185|NCT01052779|10999883|FG000|Overall Study|Other-Surgery|0
6956186|NCT01052779|10999884|FG001|Overall Study|Other-Surgery|2
6956187|NCT01052779|10999883|FG000|Overall Study|Other-Missed Week 5 Visit|2
6956188|NCT01052779|10999884|FG001|Overall Study|Other-Missed Week 5 Visit|0
6956189|NCT01052844|10999901|FG000|Overall Study|Adverse Event|0
6956190|NCT01052844|10999902|FG001|Overall Study|Adverse Event|1
6956191|NCT01053247|11000063|FG000|Overall Study|Withdrawal by Subject|9
6956192|NCT01053247|11000064|FG001|Overall Study|Withdrawal by Subject|4
6956193|NCT01053247|11000065|FG002|Overall Study|Withdrawal by Subject|15
6956194|NCT01053247|11000063|FG000|Overall Study|Lack of Efficacy|1
6956195|NCT01053247|11000064|FG001|Overall Study|Lack of Efficacy|0
6956196|NCT01053247|11000065|FG002|Overall Study|Lack of Efficacy|1
6956197|NCT01053247|11000063|FG000|Overall Study|Protocol Violation|2
6956198|NCT01053247|11000064|FG001|Overall Study|Protocol Violation|1
6956199|NCT01053247|11000065|FG002|Overall Study|Protocol Violation|2
6956200|NCT01053247|11000063|FG000|Overall Study|Lost to Follow-up|8
6956201|NCT01053247|11000064|FG001|Overall Study|Lost to Follow-up|5
6956202|NCT01053247|11000065|FG002|Overall Study|Lost to Follow-up|7
6956203|NCT01053247|11000063|FG000|Overall Study|Adverse Event|0
6956204|NCT01053247|11000064|FG001|Overall Study|Adverse Event|9
6956205|NCT01053247|11000065|FG002|Overall Study|Adverse Event|3
6956206|NCT01053429|11000091|FG000|Overall Study|Adverse Event|64
6956207|NCT01053429|11000091|FG000|Overall Study|Other|309
6956208|NCT01053663|11000107|FG000|Overall Study|Death|2
6956209|NCT01053663|11000107|FG000|Overall Study|Lost to Follow-up|1
6956210|NCT01053663|11000107|FG000|Overall Study|Poor IV Access|1
6956211|NCT01053663|11000107|FG000|Overall Study|Transferred to Another Hospital|1
6956212|NCT01053663|11000107|FG000|Overall Study|Negative Influenza Diagnosis|1
6956213|NCT01053741|11000119|FG000|2nd Study Intervention|Physician Decision|0
6956214|NCT01053741|11000120|FG001|2nd Study Intervention|Physician Decision|1
6956215|NCT01053962|11000146|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0
6956216|NCT01053962|11000147|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0
6956217|NCT01053962|11000148|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0
6956218|NCT01053962|11000149|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1
6956219|NCT01053962|11000150|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2
6956220|NCT01053962|11000146|FG000|Pretreatment Period|Venipuncture Failure|0
6956221|NCT01053962|11000147|FG001|Pretreatment Period|Venipuncture Failure|0
6956222|NCT01053962|11000148|FG002|Pretreatment Period|Venipuncture Failure|1
6956223|NCT01053962|11000149|FG003|Pretreatment Period|Venipuncture Failure|0
6956224|NCT01053962|11000150|FG004|Pretreatment Period|Venipuncture Failure|0
6956225|NCT01053962|11000146|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0
6956226|NCT01053962|11000147|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1
6956227|NCT01053962|11000148|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0
6956228|NCT01053962|11000149|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0
6956229|NCT01053962|11000150|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0
6956230|NCT01053962|11000146|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0
6956231|NCT01053962|11000147|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0
6956232|NCT01053962|11000148|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0
6956233|NCT01053962|11000149|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1
6956234|NCT01053962|11000150|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0
6956235|NCT01053962|11000146|FG000|Treatment Period|Lack of Efficacy|0
6956236|NCT01053962|11000147|FG001|Treatment Period|Lack of Efficacy|0
6956237|NCT01053962|11000148|FG002|Treatment Period|Lack of Efficacy|0
6956238|NCT01053962|11000149|FG003|Treatment Period|Lack of Efficacy|0
6956239|NCT01053962|11000150|FG004|Treatment Period|Lack of Efficacy|1
7071603|NCT02027311|11175091|FG000|Overall Study|Protocol Violation|3
7071604|NCT02027311|11175092|FG001|Overall Study|Protocol Violation|2
7071605|NCT02027376|11175100|FG000|Overall Study|Death|1
7071606|NCT02027376|11175101|FG001|Overall Study|Death|0
7071607|NCT02027376|11175102|FG002|Overall Study|Death|0
7071608|NCT02027402|11175114|FG000|Overall Study|Withdrawal by Subject|4
7071609|NCT02027402|11175115|FG001|Overall Study|Withdrawal by Subject|1
7071610|NCT02027428|11175125|FG000|Induction|Never treated|7
7071611|NCT02027428|11175126|FG001|Induction|Never treated|0
7071612|NCT02027428|11175127|FG002|Induction|Never treated|0
7071613|NCT02027428|11175125|FG000|Induction|Progressive disease|77
7071614|NCT02027428|11175126|FG001|Induction|Progressive disease|0
7071615|NCT02027428|11175127|FG002|Induction|Progressive disease|0
7071616|NCT02027428|11175125|FG000|Induction|Adverse Event|51
6956240|NCT01053962|11000146|FG000|Treatment Period|Adverse Event|0
6956241|NCT01053962|11000147|FG001|Treatment Period|Adverse Event|0
6956242|NCT01053962|11000148|FG002|Treatment Period|Adverse Event|0
6956243|NCT01053962|11000149|FG003|Treatment Period|Adverse Event|0
6956244|NCT01053962|11000150|FG004|Treatment Period|Adverse Event|1
6956245|NCT01053962|11000146|FG000|Treatment Period|Withdrawal by Subject|0
7071617|NCT02027428|11175126|FG001|Induction|Adverse Event|0
7071618|NCT02027428|11175127|FG002|Induction|Adverse Event|0
7071619|NCT02027428|11175125|FG000|Induction|Withdrawal by Subject|22
7071620|NCT02027428|11175126|FG001|Induction|Withdrawal by Subject|0
7071621|NCT02027428|11175127|FG002|Induction|Withdrawal by Subject|0
6956246|NCT01053962|11000147|FG001|Treatment Period|Withdrawal by Subject|0
6956247|NCT01053962|11000148|FG002|Treatment Period|Withdrawal by Subject|0
6956248|NCT01053962|11000149|FG003|Treatment Period|Withdrawal by Subject|0
6956249|NCT01053962|11000150|FG004|Treatment Period|Withdrawal by Subject|1
6956250|NCT01053962|11000146|FG000|Treatment Period|Noncompliance with protocol|1
6956251|NCT01053962|11000147|FG001|Treatment Period|Noncompliance with protocol|0
6956252|NCT01053962|11000148|FG002|Treatment Period|Noncompliance with protocol|0
6956253|NCT01053962|11000149|FG003|Treatment Period|Noncompliance with protocol|0
6956254|NCT01053962|11000150|FG004|Treatment Period|Noncompliance with protocol|0
6956255|NCT01053988|11000172|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220
6956256|NCT01053988|11000173|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
6956257|NCT01053988|11000174|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
6956258|NCT01053988|11000175|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
6956259|NCT01053988|11000176|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
6956260|NCT01053988|11000177|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
6956261|NCT01053988|11000172|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98
6956262|NCT01053988|11000173|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
6956263|NCT01053988|11000174|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
6956264|NCT01053988|11000175|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
6956265|NCT01053988|11000176|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
6956266|NCT01053988|11000177|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
6956267|NCT01053988|11000172|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30
6956268|NCT01053988|11000173|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
6956269|NCT01053988|11000174|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
6956270|NCT01053988|11000175|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
6956271|NCT01053988|11000176|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
6956272|NCT01053988|11000177|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
6956273|NCT01053988|11000172|FG000|2-week, Single-blind Run-In Period|Adverse Event|6
6956274|NCT01053988|11000173|FG001|2-week, Single-blind Run-In Period|Adverse Event|0
6956275|NCT01053988|11000174|FG002|2-week, Single-blind Run-In Period|Adverse Event|0
6956276|NCT01053988|11000175|FG003|2-week, Single-blind Run-In Period|Adverse Event|0
6956277|NCT01053988|11000176|FG004|2-week, Single-blind Run-In Period|Adverse Event|0
6956278|NCT01053988|11000177|FG005|2-week, Single-blind Run-In Period|Adverse Event|0
6956279|NCT01053988|11000172|FG000|2-week, Single-blind Run-In Period|Physician Decision|5
6956280|NCT01053988|11000173|FG001|2-week, Single-blind Run-In Period|Physician Decision|0
6956281|NCT01053988|11000174|FG002|2-week, Single-blind Run-In Period|Physician Decision|0
6956282|NCT01053988|11000175|FG003|2-week, Single-blind Run-In Period|Physician Decision|0
6956283|NCT01053988|11000176|FG004|2-week, Single-blind Run-In Period|Physician Decision|0
6956284|NCT01053988|11000177|FG005|2-week, Single-blind Run-In Period|Physician Decision|0
6956285|NCT01053988|11000172|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1
6956286|NCT01053988|11000173|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0
6956287|NCT01053988|11000174|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0
6956288|NCT01053988|11000175|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0
6956289|NCT01053988|11000176|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0
6956290|NCT01053988|11000177|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0
6956291|NCT01053988|11000172|FG000|24-week, Double-blind Treatment Period|Adverse Event|0
6956292|NCT01053988|11000173|FG001|24-week, Double-blind Treatment Period|Adverse Event|15
6956293|NCT01053988|11000174|FG002|24-week, Double-blind Treatment Period|Adverse Event|23
6956294|NCT01053988|11000175|FG003|24-week, Double-blind Treatment Period|Adverse Event|24
7071622|NCT02027428|11175125|FG000|Induction|Death|21
7071623|NCT02027428|11175126|FG001|Induction|Death|0
7071624|NCT02027428|11175127|FG002|Induction|Death|0
7071625|NCT02027428|11175125|FG000|Induction|Symptomatic deterioration|16
7071626|NCT02027428|11175126|FG001|Induction|Symptomatic deterioration|0
7071627|NCT02027428|11175127|FG002|Induction|Symptomatic deterioration|0
7071628|NCT02027428|11175125|FG000|Induction|Study terminated by sponsor|12
7071629|NCT02027428|11175126|FG001|Induction|Study terminated by sponsor|0
7071630|NCT02027428|11175127|FG002|Induction|Study terminated by sponsor|0
7071631|NCT02027428|11175125|FG000|Induction|Protocol Violation|1
7071632|NCT02027428|11175126|FG001|Induction|Protocol Violation|0
7071633|NCT02027428|11175127|FG002|Induction|Protocol Violation|0
7071634|NCT02027428|11175125|FG000|Induction|Miscellaneous|14
7071635|NCT02027428|11175126|FG001|Induction|Miscellaneous|0
7071636|NCT02027428|11175127|FG002|Induction|Miscellaneous|0
7071637|NCT02027428|11175125|FG000|Induction|Induction Treatment Ongoing|4
7071638|NCT02027428|11175126|FG001|Induction|Induction Treatment Ongoing|0
7071639|NCT02027428|11175127|FG002|Induction|Induction Treatment Ongoing|0
7071640|NCT02027428|11175125|FG000|Maintenance|Death|0
7071641|NCT02027428|11175126|FG001|Maintenance|Death|3
7040840|NCT01721044|11124043|FG001|Treatment Period|Physician Decision|0
7071642|NCT02027428|11175127|FG002|Maintenance|Death|2
7071643|NCT02027428|11175125|FG000|Maintenance|Adverse Event|0
7071644|NCT02027428|11175126|FG001|Maintenance|Adverse Event|21
7071645|NCT02027428|11175127|FG002|Maintenance|Adverse Event|1
7071646|NCT02027428|11175125|FG000|Maintenance|Progressive disease|0
7071647|NCT02027428|11175126|FG001|Maintenance|Progressive disease|84
6956295|NCT01053988|11000176|FG004|24-week, Double-blind Treatment Period|Adverse Event|17
6956296|NCT01053988|11000177|FG005|24-week, Double-blind Treatment Period|Adverse Event|14
6956297|NCT01053988|11000172|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
6956298|NCT01053988|11000173|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
6956299|NCT01053988|11000174|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
6956300|NCT01053988|11000175|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
6956301|NCT01053988|11000176|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
6956302|NCT01053988|11000177|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
6956303|NCT01053988|11000172|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
6956304|NCT01053988|11000173|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17
6956305|NCT01053988|11000174|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16
6956306|NCT01053988|11000175|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
6956307|NCT01053988|11000176|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9
6956308|NCT01053988|11000177|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
6956309|NCT01053988|11000172|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0
6956310|NCT01053988|11000173|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3
6956311|NCT01053988|11000174|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4
6956312|NCT01053988|11000175|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2
6956313|NCT01053988|11000176|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1
6956314|NCT01053988|11000177|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4
6956315|NCT01053988|11000172|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
6956316|NCT01053988|11000173|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
6956317|NCT01053988|11000174|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5
6956318|NCT01053988|11000175|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8
6956319|NCT01053988|11000176|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
6956320|NCT01053988|11000177|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
6956321|NCT01053988|11000172|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0
6956322|NCT01053988|11000173|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4
6956323|NCT01053988|11000174|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0
6956324|NCT01053988|11000175|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2
7071648|NCT02027428|11175127|FG002|Maintenance|Progressive disease|47
7071649|NCT02027428|11175125|FG000|Maintenance|Symptomatic deterioration|0
7071650|NCT02027428|11175126|FG001|Maintenance|Symptomatic deterioration|4
7071651|NCT02027428|11175127|FG002|Maintenance|Symptomatic deterioration|1
7071652|NCT02027428|11175125|FG000|Maintenance|Withdrawal by Subject|0
7071653|NCT02027428|11175126|FG001|Maintenance|Withdrawal by Subject|6
7071654|NCT02027428|11175127|FG002|Maintenance|Withdrawal by Subject|5
7071655|NCT02027428|11175125|FG000|Maintenance|Protocol Violation|0
7071656|NCT02027428|11175126|FG001|Maintenance|Protocol Violation|0
7071657|NCT02027428|11175127|FG002|Maintenance|Protocol Violation|1
7071658|NCT02027428|11175125|FG000|Maintenance|Other|0
7071659|NCT02027428|11175126|FG001|Maintenance|Other|6
7071660|NCT02027428|11175127|FG002|Maintenance|Other|3
7071661|NCT02027428|11175125|FG000|Survival Follow-up|Death|0
7071662|NCT02027428|11175126|FG001|Survival Follow-up|Death|78
7071663|NCT02027428|11175127|FG002|Survival Follow-up|Death|45
7071664|NCT02027428|11175125|FG000|Survival Follow-up|Lost to Follow-up|0
7071665|NCT02027428|11175126|FG001|Survival Follow-up|Lost to Follow-up|1
7071666|NCT02027428|11175127|FG002|Survival Follow-up|Lost to Follow-up|1
7071667|NCT02027545|11175152|FG000|Overall Study|Failed to sign HIPAA|0
7071668|NCT02027545|11175153|FG001|Overall Study|Failed to sign HIPAA|2
7071669|NCT02027545|11175152|FG000|Overall Study|Failed to attend study visit|2
7071670|NCT02027545|11175153|FG001|Overall Study|Failed to attend study visit|0
7071671|NCT02027558|11175161|FG000|Overall Study|Death|0
7071672|NCT02027558|11175162|FG001|Overall Study|Death|1
7071673|NCT02027558|11175161|FG000|Overall Study|Withdrawal by Subject|2
7071674|NCT02027558|11175162|FG001|Overall Study|Withdrawal by Subject|0
7071675|NCT02027558|11175161|FG000|Overall Study|Lost to Follow-up|4
7071676|NCT02027558|11175162|FG001|Overall Study|Lost to Follow-up|1
7071677|NCT02027558|11175161|FG000|Overall Study|Refused assessment|3
7071678|NCT02027558|11175162|FG001|Overall Study|Refused assessment|0
7071679|NCT02027623|11175172|FG000|Overall Study|Lost to Follow-up|3
7071680|NCT02027623|11175173|FG001|Overall Study|Lost to Follow-up|3
7071681|NCT02027623|11175172|FG000|Overall Study|Withdrawal by Subject|6
7071682|NCT02027623|11175173|FG001|Overall Study|Withdrawal by Subject|9
7071683|NCT02027701|11175180|FG000|Overall Study|Adverse Event|3
7071684|NCT02027701|11175180|FG000|Overall Study|Lack of Efficacy|8
7071685|NCT02027701|11175180|FG000|Overall Study|Physician Decision|2
7071686|NCT02027701|11175180|FG000|Overall Study|Withdrawal by Subject|3
7071687|NCT02027844|11175189|FG000|Overall Study|Withdrawal by Subject|3
7071688|NCT02027844|11175190|FG001|Overall Study|Withdrawal by Subject|2
7071689|NCT02027844|11175191|FG002|Overall Study|Withdrawal by Subject|1
7071690|NCT02027844|11175189|FG000|Overall Study|Lost to Follow-up|0
7071691|NCT02027844|11175190|FG001|Overall Study|Lost to Follow-up|2
7071692|NCT02027844|11175191|FG002|Overall Study|Lost to Follow-up|1
6956325|NCT01053988|11000176|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1
6956326|NCT01053988|11000177|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3
6956327|NCT01053988|11000172|FG000|24-week, Double-blind Treatment Period|Physician Decision|0
6956328|NCT01053988|11000173|FG001|24-week, Double-blind Treatment Period|Physician Decision|5
6956329|NCT01053988|11000174|FG002|24-week, Double-blind Treatment Period|Physician Decision|2
6956330|NCT01053988|11000175|FG003|24-week, Double-blind Treatment Period|Physician Decision|5
6956331|NCT01053988|11000176|FG004|24-week, Double-blind Treatment Period|Physician Decision|5
6956332|NCT01053988|11000177|FG005|24-week, Double-blind Treatment Period|Physician Decision|4
6956333|NCT01053988|11000172|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
6956334|NCT01053988|11000173|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11
6956335|NCT01053988|11000174|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
6956336|NCT01053988|11000175|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
6956337|NCT01053988|11000176|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10
6956338|NCT01053988|11000177|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
6956339|NCT01054144|11000193|FG000|Overall Study|Death|2
6956340|NCT01054170|11000202|FG000|Overall Study|Protocol Violation|1
6956341|NCT01054170|11000203|FG001|Overall Study|Protocol Violation|0
6956342|NCT01054170|11000202|FG000|Overall Study|Withdrawal by Subject|3
6956343|NCT01054170|11000203|FG001|Overall Study|Withdrawal by Subject|2
6956344|NCT01054170|11000202|FG000|Overall Study|Adverse Event|0
6956345|NCT01054170|11000203|FG001|Overall Study|Adverse Event|4
6956346|NCT01054222|11000227|FG000|Overall Study|Lack of Efficacy|1
6956347|NCT01054222|11000227|FG000|Overall Study|Lost to Follow-up|4
6956348|NCT01054222|11000227|FG000|Overall Study|Withdrawal by Subject|6
6956349|NCT01054300|11000233|FG000|Period 1|Adverse Event|1
6956350|NCT01054300|11000234|FG001|Period 1|Adverse Event|0
6956351|NCT01054300|11000235|FG002|Period 1|Adverse Event|0
6956352|NCT01054300|11000236|FG003|Period 1|Adverse Event|0
6956353|NCT01054300|11000233|FG000|Period 2|Withdrawal by Subject|0
6956354|NCT01054300|11000234|FG001|Period 2|Withdrawal by Subject|0
6956355|NCT01054300|11000235|FG002|Period 2|Withdrawal by Subject|1
6956356|NCT01054300|11000236|FG003|Period 2|Withdrawal by Subject|0
6956357|NCT01054443|11000274|FG000|Overall Study|Withdrawal by Subject|0
6956358|NCT01054443|11000275|FG001|Overall Study|Withdrawal by Subject|0
6956359|NCT01054443|11000276|FG002|Overall Study|Withdrawal by Subject|0
6956360|NCT01054443|11000277|FG003|Overall Study|Withdrawal by Subject|1
6956361|NCT01054456|11000290|FG000|Overall Study|Other|1
6956362|NCT01054560|11000296|FG000|Overall Study|Death|10
6956363|NCT01054560|11000297|FG001|Overall Study|Death|21
6956364|NCT01054560|11000296|FG000|Overall Study|Lost to Follow-up|2
6956365|NCT01054560|11000297|FG001|Overall Study|Lost to Follow-up|5
6956366|NCT01054560|11000296|FG000|Overall Study|Withdrawal by Subject|0
6956367|NCT01054560|11000297|FG001|Overall Study|Withdrawal by Subject|2
6956368|NCT01054560|11000296|FG000|Overall Study|Physician Decision|1
6956369|NCT01054560|11000297|FG001|Overall Study|Physician Decision|0
6956370|NCT01054573|11000309|FG000|Overall Study|Adverse Event|1
6956371|NCT01054573|11000310|FG001|Overall Study|Adverse Event|0
6956372|NCT01054573|11000311|FG002|Overall Study|Adverse Event|1
6956373|NCT01054573|11000312|FG003|Overall Study|Adverse Event|1
7071693|NCT02027844|11175189|FG000|Overall Study|Protocol Violation|0
7071694|NCT02027844|11175190|FG001|Overall Study|Protocol Violation|2
7071695|NCT02027844|11175191|FG002|Overall Study|Protocol Violation|0
7071696|NCT02027844|11175189|FG000|Overall Study|Incomlete data|2
6956374|NCT01054573|11000309|FG000|Overall Study|Lost to Follow-up|0
6956375|NCT01054573|11000310|FG001|Overall Study|Lost to Follow-up|2
7071697|NCT02027844|11175190|FG001|Overall Study|Incomlete data|0
7071698|NCT02027844|11175191|FG002|Overall Study|Incomlete data|0
7071699|NCT02028065|11175215|FG000|Randomization Through Start Treatment|Not treated|1
7071700|NCT02028065|11175216|FG001|Randomization Through Start Treatment|Not treated|3
7071701|NCT02028065|11175217|FG002|Randomization Through Start Treatment|Not treated|3
7071702|NCT02028065|11175215|FG000|Treatment Through Study Completion|Lost to Follow-up|2
7071703|NCT02028065|11175216|FG001|Treatment Through Study Completion|Lost to Follow-up|4
7071704|NCT02028065|11175217|FG002|Treatment Through Study Completion|Lost to Follow-up|6
7071705|NCT02028065|11175215|FG000|Treatment Through Study Completion|Physician Decision|1
7071706|NCT02028065|11175216|FG001|Treatment Through Study Completion|Physician Decision|0
7071707|NCT02028065|11175217|FG002|Treatment Through Study Completion|Physician Decision|0
7071708|NCT02028065|11175215|FG000|Treatment Through Study Completion|Protocol Violation|1
7071709|NCT02028065|11175216|FG001|Treatment Through Study Completion|Protocol Violation|4
7071710|NCT02028065|11175217|FG002|Treatment Through Study Completion|Protocol Violation|0
6956376|NCT01054573|11000311|FG002|Overall Study|Lost to Follow-up|0
6956377|NCT01054573|11000312|FG003|Overall Study|Lost to Follow-up|0
6956378|NCT01054573|11000309|FG000|Overall Study|Withdrawal by Subject|0
6956379|NCT01054573|11000310|FG001|Overall Study|Withdrawal by Subject|2
6956380|NCT01054573|11000311|FG002|Overall Study|Withdrawal by Subject|2
6956381|NCT01054573|11000312|FG003|Overall Study|Withdrawal by Subject|1
6956382|NCT01054599|11000360|FG000|Overall Study|Dizziness due to phenytoin toxicity|1
7071711|NCT02028065|11175215|FG000|Treatment Through Study Completion|Withdrawal by Subject|5
7071712|NCT02028065|11175216|FG001|Treatment Through Study Completion|Withdrawal by Subject|4
6956383|NCT01054599|11000361|FG001|Overall Study|Dizziness due to phenytoin toxicity|0
6956384|NCT01054599|11000360|FG000|Overall Study|Protocol Violation|1
6956385|NCT01054599|11000361|FG001|Overall Study|Protocol Violation|0
6956386|NCT01054599|11000360|FG000|Overall Study|Spells/seizure-like episodes|1
6956387|NCT01054599|11000361|FG001|Overall Study|Spells/seizure-like episodes|1
6956388|NCT01054599|11000360|FG000|Overall Study|Timing/scheduling difficulties|1
6956389|NCT01054599|11000361|FG001|Overall Study|Timing/scheduling difficulties|1
6956390|NCT01054599|11000360|FG000|Overall Study|Visual impairment, WTAR <80|0
7071713|NCT02028065|11175217|FG002|Treatment Through Study Completion|Withdrawal by Subject|3
7071714|NCT02028065|11175215|FG000|Treatment Through Study Completion|Adverse Event|3
7071715|NCT02028065|11175216|FG001|Treatment Through Study Completion|Adverse Event|3
7071716|NCT02028065|11175217|FG002|Treatment Through Study Completion|Adverse Event|5
7071717|NCT02028169|11175225|FG000|Overall Study|Lost to Follow-up|21
7071718|NCT02028169|11175225|FG000|Overall Study|Lack of Efficacy|2
7071719|NCT02028169|11175225|FG000|Overall Study|Withdrawal by Subject|2
7071720|NCT02028169|11175225|FG000|Overall Study|Adverse Event|1
7071721|NCT02028169|11175225|FG000|Overall Study|Cessation of Drug|1
7071722|NCT02028169|11175225|FG000|Overall Study|Concomitant Medication Usage|1
7071723|NCT02028182|11175229|FG000|Overall Study|Protocol Violation|2
7071724|NCT02028715|11175316|FG000|Overall Study|Adverse Event|2
7071725|NCT02028715|11175317|FG001|Overall Study|Adverse Event|2
7071726|NCT02028715|11175316|FG000|Overall Study|Physician Decision|1
7071727|NCT02028715|11175317|FG001|Overall Study|Physician Decision|0
7071728|NCT02028715|11175316|FG000|Overall Study|Did not complete satisfaction surveys|2
7071729|NCT02028715|11175317|FG001|Overall Study|Did not complete satisfaction surveys|2
7071730|NCT02028767|11175332|FG000|Treatment Period 2|Non compliant with protocol|1
7071731|NCT02028767|11175333|FG001|Treatment Period 2|Non compliant with protocol|0
7071732|NCT02028767|11175332|FG000|Treatment Period 2|Reason other than those specified above|1
7071733|NCT02028767|11175333|FG001|Treatment Period 2|Reason other than those specified above|0
7071734|NCT02028871|11175408|FG000|Overall Study|Positive urine drug screen|1
7071735|NCT02028871|11175409|FG001|Overall Study|Positive urine drug screen|1
7071736|NCT02028871|11175408|FG000|Overall Study|Withdrawal by Subject|1
7071737|NCT02028871|11175409|FG001|Overall Study|Withdrawal by Subject|2
7071738|NCT02028871|11175408|FG000|Overall Study|IV placement difficulty|1
7071739|NCT02028871|11175409|FG001|Overall Study|IV placement difficulty|0
7071740|NCT02028871|11175408|FG000|Overall Study|Current Illness|1
7071741|NCT02028871|11175409|FG001|Overall Study|Current Illness|0
7071742|NCT02029235|11175438|FG000|Overall Study|Non-compliance with study meds or diary|4
7071743|NCT02029235|11175439|FG001|Overall Study|Non-compliance with study meds or diary|1
7071744|NCT02029274|11175449|FG000|Overall Study|Adverse Event|1
7071745|NCT02029274|11175450|FG001|Overall Study|Adverse Event|0
7071746|NCT02029274|11175451|FG002|Overall Study|Adverse Event|2
7071747|NCT02029274|11175452|FG003|Overall Study|Adverse Event|2
7071748|NCT02029417|11175466|FG000|Overall Study|Death|1
7071749|NCT02029417|11175466|FG000|Overall Study|Adverse Event|1
7071750|NCT02029521|11175485|FG000|Overall Study|Protocol Violation|1
7071751|NCT02029521|11175486|FG001|Overall Study|Protocol Violation|0
7071752|NCT02029521|11175485|FG000|Overall Study|Withdrawal by Subject|1
7071753|NCT02029521|11175486|FG001|Overall Study|Withdrawal by Subject|1
7071754|NCT02029638|11175498|FG000|Overall Study|Death|0
7071755|NCT02029638|11175499|FG001|Overall Study|Death|0
7071756|NCT02029638|11175500|FG002|Overall Study|Death|1
7071757|NCT02029638|11175498|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2
7071758|NCT02029638|11175499|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0
7071759|NCT02029638|11175500|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0
7071760|NCT02029976|11175545|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12
7071761|NCT02029976|11175546|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8
7071762|NCT02029976|11175545|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8
7071763|NCT02029976|11175546|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4
7071764|NCT02029976|11175545|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2
7071765|NCT02029976|11175546|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2
7071766|NCT02029976|11175545|FG000|YR-2 Follow Up vs Baseline|Moved from area|0
7071767|NCT02029976|11175546|FG001|YR-2 Follow Up vs Baseline|Moved from area|2
7071768|NCT02029989|11175554|FG000|Overall Study|Withdrawal by Subject|1
7071769|NCT02029989|11175555|FG001|Overall Study|Withdrawal by Subject|0
7071770|NCT02029989|11175554|FG000|Overall Study|Withdrawal: Fear of needles|1
7071771|NCT02029989|11175555|FG001|Overall Study|Withdrawal: Fear of needles|0
7071772|NCT02029989|11175554|FG000|Overall Study|Change of location|2
7071773|NCT02029989|11175555|FG001|Overall Study|Change of location|3
6956391|NCT01054599|11000361|FG001|Overall Study|Visual impairment, WTAR <80|1
6956392|NCT01054599|11000360|FG000|Overall Study|Lost to Follow-up|0
6956393|NCT01054599|11000361|FG001|Overall Study|Lost to Follow-up|2
7071774|NCT02029989|11175554|FG000|Overall Study|Physician Decision|2
7071775|NCT02029989|11175555|FG001|Overall Study|Physician Decision|0
7071776|NCT02029989|11175554|FG000|Overall Study|Lost to Follow-up|9
7071777|NCT02029989|11175555|FG001|Overall Study|Lost to Follow-up|7
7071778|NCT02029989|11175554|FG000|Overall Study|Death|0
7071779|NCT02029989|11175555|FG001|Overall Study|Death|1
7071780|NCT02029989|11175554|FG000|Overall Study|Protocol Violation|1
7071781|NCT02029989|11175555|FG001|Overall Study|Protocol Violation|0
7071782|NCT02030002|11175561|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1
6956394|NCT01054599|11000360|FG000|Overall Study|Adverse Event|0
6956395|NCT01054599|11000361|FG001|Overall Study|Adverse Event|1
6956396|NCT01054599|11000360|FG000|Overall Study|Withdrawal by Subject|0
6956397|NCT01054599|11000361|FG001|Overall Study|Withdrawal by Subject|1
6956398|NCT01054729|11000388|FG000|Overall Study|Randomized but Not Treated|0
6956399|NCT01054729|11000389|FG001|Overall Study|Randomized but Not Treated|1
6956400|NCT01054729|11000390|FG002|Overall Study|Randomized but Not Treated|0
6956401|NCT01054729|11000391|FG003|Overall Study|Randomized but Not Treated|0
6956402|NCT01054729|11000388|FG000|Overall Study|Adverse Event|1
6956403|NCT01054729|11000389|FG001|Overall Study|Adverse Event|1
6956404|NCT01054729|11000390|FG002|Overall Study|Adverse Event|2
6956405|NCT01054729|11000391|FG003|Overall Study|Adverse Event|1
6956406|NCT01054729|11000388|FG000|Overall Study|Withdrawal by Subject|1
6956407|NCT01054729|11000389|FG001|Overall Study|Withdrawal by Subject|0
6956408|NCT01054729|11000390|FG002|Overall Study|Withdrawal by Subject|1
6956409|NCT01054729|11000391|FG003|Overall Study|Withdrawal by Subject|0
6956410|NCT01054729|11000388|FG000|Overall Study|Lost to Follow-up|0
6956411|NCT01054729|11000389|FG001|Overall Study|Lost to Follow-up|1
6956412|NCT01054729|11000390|FG002|Overall Study|Lost to Follow-up|0
6956413|NCT01054729|11000391|FG003|Overall Study|Lost to Follow-up|0
6956414|NCT01054729|11000388|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0
6956415|NCT01054729|11000389|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1
6956416|NCT01054729|11000390|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0
6956417|NCT01054729|11000391|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0
6956418|NCT01054729|11000388|FG000|Overall Study|Non-responder|1
6956419|NCT01054729|11000389|FG001|Overall Study|Non-responder|0
6956420|NCT01054729|11000390|FG002|Overall Study|Non-responder|1
6956421|NCT01054729|11000391|FG003|Overall Study|Non-responder|1
6956422|NCT01054729|11000388|FG000|Overall Study|PEG/RBV Non-responder|1
6956423|NCT01054729|11000389|FG001|Overall Study|PEG/RBV Non-responder|0
6956424|NCT01054729|11000390|FG002|Overall Study|PEG/RBV Non-responder|1
6956425|NCT01054729|11000391|FG003|Overall Study|PEG/RBV Non-responder|0
6956426|NCT01054729|11000388|FG000|Overall Study|Personal/Obligations|0
6956427|NCT01054729|11000389|FG001|Overall Study|Personal/Obligations|1
6956428|NCT01054729|11000390|FG002|Overall Study|Personal/Obligations|0
6956429|NCT01054729|11000391|FG003|Overall Study|Personal/Obligations|0
6956430|NCT01054729|11000388|FG000|Overall Study|Subject moved|0
6956431|NCT01054729|11000389|FG001|Overall Study|Subject moved|0
6956432|NCT01054729|11000390|FG002|Overall Study|Subject moved|1
6956433|NCT01054729|11000391|FG003|Overall Study|Subject moved|0
6956434|NCT01054729|11000388|FG000|Overall Study|Lack of Efficacy|0
6956435|NCT01054729|11000389|FG001|Overall Study|Lack of Efficacy|0
6956436|NCT01054729|11000390|FG002|Overall Study|Lack of Efficacy|0
6956437|NCT01054729|11000391|FG003|Overall Study|Lack of Efficacy|1
6956438|NCT01054820|11000414|FG000|Overall Study|Withdrawal by Subject|2
6956439|NCT01054846|11000420|FG000|Overall Study|Lost to Follow-up|76
6956440|NCT01054846|11000421|FG001|Overall Study|Lost to Follow-up|17
6956441|NCT01054885|11000432|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246
6956442|NCT01054885|11000433|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
6956443|NCT01054885|11000434|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
6956444|NCT01054885|11000435|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
6956445|NCT01054885|11000436|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
6956446|NCT01054885|11000437|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
6956447|NCT01054885|11000438|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
6956448|NCT01054885|11000432|FG000|2-week, Single-blind Run-In Period|Physician Decision|6
6956449|NCT01054885|11000433|FG001|2-week, Single-blind Run-In Period|Physician Decision|0
6956450|NCT01054885|11000434|FG002|2-week, Single-blind Run-In Period|Physician Decision|0
6956451|NCT01054885|11000435|FG003|2-week, Single-blind Run-In Period|Physician Decision|0
6956452|NCT01054885|11000436|FG004|2-week, Single-blind Run-In Period|Physician Decision|0
6956453|NCT01054885|11000437|FG005|2-week, Single-blind Run-In Period|Physician Decision|0
6956454|NCT01054885|11000438|FG006|2-week, Single-blind Run-In Period|Physician Decision|0
6956455|NCT01054885|11000432|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23
6956456|NCT01054885|11000433|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
6956457|NCT01054885|11000434|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
6956458|NCT01054885|11000435|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
6956459|NCT01054885|11000436|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
6956460|NCT01054885|11000437|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
6956461|NCT01054885|11000438|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
6956462|NCT01054885|11000432|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1
6956463|NCT01054885|11000433|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0
6956464|NCT01054885|11000434|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0
6956465|NCT01054885|11000435|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0
6956466|NCT01054885|11000436|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0
6956467|NCT01054885|11000437|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0
6956468|NCT01054885|11000438|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0
6956469|NCT01054885|11000432|FG000|2-week, Single-blind Run-In Period|Adverse Event|7
6956470|NCT01054885|11000433|FG001|2-week, Single-blind Run-In Period|Adverse Event|0
6956471|NCT01054885|11000434|FG002|2-week, Single-blind Run-In Period|Adverse Event|0
6956472|NCT01054885|11000435|FG003|2-week, Single-blind Run-In Period|Adverse Event|0
6956473|NCT01054885|11000436|FG004|2-week, Single-blind Run-In Period|Adverse Event|0
6956474|NCT01054885|11000437|FG005|2-week, Single-blind Run-In Period|Adverse Event|0
6956475|NCT01054885|11000438|FG006|2-week, Single-blind Run-In Period|Adverse Event|0
6956476|NCT01054885|11000432|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68
6956477|NCT01054885|11000433|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
6956478|NCT01054885|11000434|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
6956479|NCT01054885|11000435|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
6956480|NCT01054885|11000436|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
6956481|NCT01054885|11000437|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
6956482|NCT01054885|11000438|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
6956483|NCT01054885|11000432|FG000|24-week, Double-blind Treatment Period|Adverse Event|0
6956484|NCT01054885|11000433|FG001|24-week, Double-blind Treatment Period|Adverse Event|18
6956485|NCT01054885|11000434|FG002|24-week, Double-blind Treatment Period|Adverse Event|12
6956486|NCT01054885|11000435|FG003|24-week, Double-blind Treatment Period|Adverse Event|15
7071783|NCT02030002|11175561|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4
7071784|NCT02030002|11175561|FG000|Follow-up|Lost to Follow-up|2
7071785|NCT02030041|11175570|FG000|Overall Study|Withdrawal by Subject|2
7071786|NCT02030041|11175571|FG001|Overall Study|Withdrawal by Subject|2
7071787|NCT02030041|11175572|FG002|Overall Study|Withdrawal by Subject|1
7147806|NCT03136198|11308678|FG001|Overall Study|Withdrawal by Subject|1
7147807|NCT03136367|11308692|FG000|T1 Consultation|discontinued mistakenly included|2
7147808|NCT03136367|11308693|FG001|T1 Consultation|discontinued mistakenly included|6
7147809|NCT03136367|11308694|FG002|T1 Consultation|discontinued mistakenly included|1
7147810|NCT03136367|11308692|FG000|T1 Consultation|Discontinued other|0
7147811|NCT03136367|11308693|FG001|T1 Consultation|Discontinued other|1
7147812|NCT03136367|11308694|FG002|T1 Consultation|Discontinued other|0
7147813|NCT03136367|11308692|FG000|T2 Post-consultation|Withdrawal by Subject|1
7147814|NCT03136367|11308693|FG001|T2 Post-consultation|Withdrawal by Subject|1
7147815|NCT03136367|11308694|FG002|T2 Post-consultation|Withdrawal by Subject|5
7147816|NCT03136367|11308692|FG000|T2 Post-consultation|discontinued mistakenly included|2
7147817|NCT03136367|11308693|FG001|T2 Post-consultation|discontinued mistakenly included|2
7147818|NCT03136367|11308694|FG002|T2 Post-consultation|discontinued mistakenly included|17
7147819|NCT03136367|11308692|FG000|T2 Post-consultation|Discontinued other|0
7147820|NCT03136367|11308693|FG001|T2 Post-consultation|Discontinued other|2
7147821|NCT03136367|11308694|FG002|T2 Post-consultation|Discontinued other|6
7147822|NCT03136367|11308692|FG000|T2 Post-consultation|Discontinued transferred care|0
7147823|NCT03136367|11308693|FG001|T2 Post-consultation|Discontinued transferred care|0
7147824|NCT03136367|11308694|FG002|T2 Post-consultation|Discontinued transferred care|3
7147825|NCT03136367|11308692|FG000|T2 Post-consultation|Discontinued lost contact|0
7147826|NCT03136367|11308693|FG001|T2 Post-consultation|Discontinued lost contact|1
7147827|NCT03136367|11308694|FG002|T2 Post-consultation|Discontinued lost contact|0
7147828|NCT03136367|11308692|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5
7147829|NCT03136367|11308693|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9
7147830|NCT03136367|11308694|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8
7147831|NCT03136367|11308692|FG000|T3 1 Week After Surgery|Discontinued transferred care|2
7147832|NCT03136367|11308693|FG001|T3 1 Week After Surgery|Discontinued transferred care|11
7147833|NCT03136367|11308694|FG002|T3 1 Week After Surgery|Discontinued transferred care|14
7147834|NCT03136367|11308692|FG000|T3 1 Week After Surgery|other discontinued|2
7147835|NCT03136367|11308693|FG001|T3 1 Week After Surgery|other discontinued|4
7147836|NCT03136367|11308694|FG002|T3 1 Week After Surgery|other discontinued|3
7147837|NCT03136367|11308692|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0
7147838|NCT03136367|11308693|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6
7147839|NCT03136367|11308694|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2
7147840|NCT03136367|11308692|FG000|T3 1 Week After Surgery|Discontinued lost contact|1
7147841|NCT03136367|11308693|FG001|T3 1 Week After Surgery|Discontinued lost contact|2
7147842|NCT03136367|11308694|FG002|T3 1 Week After Surgery|Discontinued lost contact|4
7147843|NCT03136367|11308692|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1
7147844|NCT03136367|11308693|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3
7147845|NCT03136367|11308694|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0
7147846|NCT03136367|11308692|FG000|T4 12 Weeks After Surgery|Death|0
7147847|NCT03136367|11308693|FG001|T4 12 Weeks After Surgery|Death|1
7147848|NCT03136367|11308694|FG002|T4 12 Weeks After Surgery|Death|3
7147849|NCT03136367|11308692|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1
7147850|NCT03136367|11308693|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0
7147851|NCT03136367|11308694|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0
7147852|NCT03136367|11308692|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0
7147853|NCT03136367|11308693|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1
7147854|NCT03136367|11308694|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5
7183771|NCT01150045|11383849|FG002|Overall Study|Protocol Violation|0
6956487|NCT01054885|11000436|FG004|24-week, Double-blind Treatment Period|Adverse Event|15
6956488|NCT01054885|11000437|FG005|24-week, Double-blind Treatment Period|Adverse Event|17
6956489|NCT01054885|11000438|FG006|24-week, Double-blind Treatment Period|Adverse Event|19
6956490|NCT01054885|11000432|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
7071788|NCT02030119|11175601|FG000|Overall Study|Withdrawal by Subject|3
7071789|NCT02030119|11175602|FG001|Overall Study|Withdrawal by Subject|1
7071790|NCT02030119|11175603|FG002|Overall Study|Withdrawal by Subject|5
7071791|NCT02030119|11175604|FG003|Overall Study|Withdrawal by Subject|3
7071792|NCT02030119|11175601|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0
7071793|NCT02030119|11175602|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1
7071794|NCT02030119|11175603|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1
7071795|NCT02030119|11175604|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0
7071796|NCT02030405|11175627|FG000|Overall Study|Withdrawal by Subject|1
7071797|NCT02030405|11175627|FG000|Overall Study|Lost to Follow-up|1
7071798|NCT02030535|11175632|FG000|Washout Period 1 (21 Days)|Adverse Event|1
7071799|NCT02030600|11175652|FG000|Treatment Period 1|Adverse Event|5
7071800|NCT02030600|11175653|FG001|Treatment Period 1|Adverse Event|7
7071801|NCT02030600|11175652|FG000|Treatment Period 1|Lack of Efficacy|0
7071802|NCT02030600|11175653|FG001|Treatment Period 1|Lack of Efficacy|1
7071803|NCT02030600|11175652|FG000|Treatment Period 1|Lost to Follow-up|11
7071804|NCT02030600|11175653|FG001|Treatment Period 1|Lost to Follow-up|3
7071805|NCT02030600|11175652|FG000|Treatment Period 1|Protocol Violation|22
7071806|NCT02030600|11175653|FG001|Treatment Period 1|Protocol Violation|17
7071807|NCT02030600|11175652|FG000|Treatment Period 1|Withdrawal by Subject|13
7071808|NCT02030600|11175653|FG001|Treatment Period 1|Withdrawal by Subject|17
7071809|NCT02030600|11175652|FG000|Treatment Period 1|Casebook Unsigned|1
7071810|NCT02030600|11175653|FG001|Treatment Period 1|Casebook Unsigned|0
7071811|NCT02030600|11175652|FG000|Treatment Period 1|Unclassified|1
7071812|NCT02030600|11175653|FG001|Treatment Period 1|Unclassified|0
7071813|NCT02030600|11175652|FG000|Treatment Period 2|Adverse Event|4
7071814|NCT02030600|11175653|FG001|Treatment Period 2|Adverse Event|4
7071815|NCT02030600|11175652|FG000|Treatment Period 2|Lack of Efficacy|2
7071816|NCT02030600|11175653|FG001|Treatment Period 2|Lack of Efficacy|1
7071817|NCT02030600|11175652|FG000|Treatment Period 2|Lost to Follow-up|4
7071818|NCT02030600|11175653|FG001|Treatment Period 2|Lost to Follow-up|2
7071819|NCT02030600|11175652|FG000|Treatment Period 2|Protocol Violation|1
7071820|NCT02030600|11175653|FG001|Treatment Period 2|Protocol Violation|2
7071821|NCT02030600|11175652|FG000|Treatment Period 2|Withdrawal by Subject|13
7071822|NCT02030600|11175653|FG001|Treatment Period 2|Withdrawal by Subject|9
7071823|NCT02030600|11175652|FG000|Treatment Period 2|Unclassified|1
7071824|NCT02030600|11175653|FG001|Treatment Period 2|Unclassified|0
7071825|NCT02030821|11175665|FG000|Overall Study|Physician Decision|2
7071826|NCT02030821|11175666|FG001|Overall Study|Physician Decision|2
7071827|NCT02030821|11175667|FG002|Overall Study|Physician Decision|5
7071828|NCT02030821|11175668|FG003|Overall Study|Physician Decision|2
7071829|NCT02030834|11175681|FG000|Overall Study|Death|4
7071830|NCT02030834|11175682|FG001|Overall Study|Death|0
7071831|NCT02030834|11175683|FG002|Overall Study|Death|0
7071832|NCT02030834|11175681|FG000|Overall Study|Manufacturing failure|2
7071833|NCT02030834|11175682|FG001|Overall Study|Manufacturing failure|0
7071834|NCT02030834|11175683|FG002|Overall Study|Manufacturing failure|1
7071835|NCT02030834|11175681|FG000|Overall Study|Disease progression|2
7071836|NCT02030834|11175682|FG001|Overall Study|Disease progression|0
7071837|NCT02030834|11175683|FG002|Overall Study|Disease progression|2
7071838|NCT02030834|11175681|FG000|Overall Study|Lost to Follow-up|1
7071839|NCT02030834|11175682|FG001|Overall Study|Lost to Follow-up|0
7071840|NCT02030834|11175683|FG002|Overall Study|Lost to Follow-up|0
7071841|NCT02030834|11175681|FG000|Overall Study|Withdrawal by Subject|1
7071842|NCT02030834|11175682|FG001|Overall Study|Withdrawal by Subject|0
7071843|NCT02030834|11175683|FG002|Overall Study|Withdrawal by Subject|0
7071844|NCT02030834|11175681|FG000|Overall Study|Lack of funding|1
7071845|NCT02030834|11175682|FG001|Overall Study|Lack of funding|0
7071846|NCT02030834|11175683|FG002|Overall Study|Lack of funding|0
7071847|NCT02030847|11175691|FG000|Overall Study|Death|10
7071848|NCT02030847|11175691|FG000|Overall Study|Disease Progression|15
7071849|NCT02030847|11175691|FG000|Overall Study|New Cancer Therapy|8
7071850|NCT02030847|11175691|FG000|Overall Study|Physician Decision|3
7071851|NCT02030847|11175691|FG000|Overall Study|Withdrawal by Subject|1
7071852|NCT02031146|11175709|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0
7071853|NCT02031146|11175710|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0
6976318|NCT01198132|11028787|FG001|Overall Study|Adverse Event|1
7071854|NCT02031146|11175711|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0
7071855|NCT02031146|11175712|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100
7071856|NCT02031146|11175713|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26
7071857|NCT02031146|11175714|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4
7071858|NCT02031146|11175715|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5
7071859|NCT02031237|11175727|FG000|Overall Study|Death|1
7071860|NCT02031237|11175728|FG001|Overall Study|Death|5
7071861|NCT02031237|11175729|FG002|Overall Study|Death|0
7071862|NCT02031237|11175727|FG000|Overall Study|Physician Decision|0
7071863|NCT02031237|11175728|FG001|Overall Study|Physician Decision|1
7071864|NCT02031237|11175729|FG002|Overall Study|Physician Decision|0
6956491|NCT01054885|11000433|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
7071865|NCT02031237|11175727|FG000|Overall Study|Withdrawal by Subject|2
7071866|NCT02031237|11175728|FG001|Overall Study|Withdrawal by Subject|2
7071867|NCT02031237|11175729|FG002|Overall Study|Withdrawal by Subject|0
7071868|NCT02031237|11175727|FG000|Overall Study|Protocol Violation|2
7071869|NCT02031237|11175728|FG001|Overall Study|Protocol Violation|6
7071870|NCT02031237|11175729|FG002|Overall Study|Protocol Violation|0
7071871|NCT02031237|11175727|FG000|Overall Study|Alternate Treatment Given|0
7071872|NCT02031237|11175728|FG001|Overall Study|Alternate Treatment Given|0
7071873|NCT02031237|11175729|FG002|Overall Study|Alternate Treatment Given|3
7071874|NCT02031276|11175739|FG000|Period 1 Double-blind IV|Adverse Event|6
7071875|NCT02031276|11175740|FG001|Period 1 Double-blind IV|Adverse Event|5
7071876|NCT02031276|11175741|FG002|Period 1 Double-blind IV|Adverse Event|1
7071877|NCT02031276|11175739|FG000|Period 1 Double-blind IV|Other|0
7071878|NCT02031276|11175740|FG001|Period 1 Double-blind IV|Other|1
7071879|NCT02031276|11175741|FG002|Period 1 Double-blind IV|Other|0
7071880|NCT02031276|11175739|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1
7071881|NCT02031276|11175740|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0
7071882|NCT02031276|11175741|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0
7071883|NCT02031276|11175739|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3
7071884|NCT02031276|11175740|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0
7071885|NCT02031276|11175741|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0
7071886|NCT02031276|11175739|FG000|Period 2 Open-label Risankizumab IV|Other|0
7071887|NCT02031276|11175740|FG001|Period 2 Open-label Risankizumab IV|Other|2
7071888|NCT02031276|11175741|FG002|Period 2 Open-label Risankizumab IV|Other|1
7071889|NCT02031276|11175739|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0
7071890|NCT02031276|11175740|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2
7071891|NCT02031276|11175741|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0
7071892|NCT02031276|11175739|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2
7071893|NCT02031276|11175740|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0
7071894|NCT02031276|11175741|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0
7071895|NCT02031276|11175739|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
7071896|NCT02031276|11175740|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
7071897|NCT02031276|11175741|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
7071898|NCT02031276|11175739|FG000|Period 3 Open-label Risankizumab SC|Other|0
7071899|NCT02031276|11175740|FG001|Period 3 Open-label Risankizumab SC|Other|0
7071900|NCT02031276|11175741|FG002|Period 3 Open-label Risankizumab SC|Other|1
7071901|NCT02031302|11175755|FG000|Overall Study|Death|115
7071902|NCT02031302|11175756|FG001|Overall Study|Death|0
7071903|NCT02031302|11175755|FG000|Overall Study|Not treated with study valve system|18
7071904|NCT02031302|11175756|FG001|Overall Study|Not treated with study valve system|0
7071905|NCT02031302|11175755|FG000|Overall Study|Missed Follow Up|27
7071906|NCT02031302|11175756|FG001|Overall Study|Missed Follow Up|0
7071907|NCT02031302|11175755|FG000|Overall Study|Lost to Follow-up|4
7071908|NCT02031302|11175756|FG001|Overall Study|Lost to Follow-up|0
7071909|NCT02031432|11175763|FG000|Overall Study|Protocol Violation|1
7071910|NCT02031432|11175763|FG000|Overall Study|Lack of Efficacy|5
7071911|NCT02031432|11175763|FG000|Overall Study|Cancer Progression|2
7071912|NCT02031432|11175763|FG000|Overall Study|Withdrawn as forbidden meds required|1
7071913|NCT02031432|11175763|FG000|Overall Study|Adverse Event|8
7071914|NCT02031432|11175763|FG000|Overall Study|Withdrawal by Subject|5
7071915|NCT02031432|11175763|FG000|Overall Study|Lost to Follow-up|1
7071916|NCT02031432|11175763|FG000|Overall Study|Inclusion/Exclusion criteria not met|5
7071917|NCT02031432|11175763|FG000|Overall Study|Death|10
7071918|NCT02031458|11175770|FG000|May 8, 2015 to January 11, 2019|Death|89
7071919|NCT02031458|11175771|FG001|May 8, 2015 to January 11, 2019|Death|193
7071920|NCT02031458|11175772|FG002|May 8, 2015 to January 11, 2019|Death|198
7071921|NCT02031458|11175770|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2
7071922|NCT02031458|11175771|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5
7071923|NCT02031458|11175772|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8
7071924|NCT02031458|11175770|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1
7071925|NCT02031458|11175771|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6
7071926|NCT02031458|11175772|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6
7071927|NCT02031458|11175770|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2
7071928|NCT02031458|11175771|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3
7071929|NCT02031458|11175772|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3
7071930|NCT02031458|11175770|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7
7071931|NCT02031458|11175771|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4
7071932|NCT02031458|11175772|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0
7071933|NCT02031458|11175770|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24
7071934|NCT02031458|11175771|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42
7071935|NCT02031458|11175772|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23
7071936|NCT02031458|11175770|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13
7071937|NCT02031458|11175771|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16
7071938|NCT02031458|11175772|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14
7071939|NCT02031458|11175770|FG000|Baseline to May 8, 2015|Death|36
7071940|NCT02031458|11175771|FG001|Baseline to May 8, 2015|Death|87
6956492|NCT01054885|11000434|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
6956493|NCT01054885|11000435|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
6956494|NCT01054885|11000436|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
6956495|NCT01054885|11000437|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
6956496|NCT01054885|11000438|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
6956497|NCT01054885|11000432|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
6956498|NCT01054885|11000433|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
6956499|NCT01054885|11000434|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2
6956500|NCT01054885|11000435|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5
6956501|NCT01054885|11000436|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11
7071941|NCT02031458|11175772|FG002|Baseline to May 8, 2015|Death|100
7071942|NCT02031458|11175770|FG000|Baseline to May 8, 2015|Protocol Violation|7
7071943|NCT02031458|11175771|FG001|Baseline to May 8, 2015|Protocol Violation|4
7071944|NCT02031458|11175772|FG002|Baseline to May 8, 2015|Protocol Violation|0
7071945|NCT02031458|11175770|FG000|Baseline to May 8, 2015|Physician Decision|0
7071946|NCT02031458|11175771|FG001|Baseline to May 8, 2015|Physician Decision|1
7071947|NCT02031458|11175772|FG002|Baseline to May 8, 2015|Physician Decision|0
7071948|NCT02031458|11175770|FG000|Baseline to May 8, 2015|Unknown Reason|0
7071949|NCT02031458|11175771|FG001|Baseline to May 8, 2015|Unknown Reason|1
7071950|NCT02031458|11175772|FG002|Baseline to May 8, 2015|Unknown Reason|2
6956502|NCT01054885|11000437|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
6956503|NCT01054885|11000438|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
6956504|NCT01054885|11000432|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0
6956505|NCT01054885|11000433|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7
6956506|NCT01054885|11000434|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7
6956507|NCT01054885|11000435|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2
6956508|NCT01054885|11000436|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3
6956509|NCT01054885|11000437|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8
6956510|NCT01054885|11000438|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4
6956511|NCT01054885|11000432|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0
6956512|NCT01054885|11000433|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
6956513|NCT01054885|11000434|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
6956514|NCT01054885|11000435|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
6956515|NCT01054885|11000436|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
6956516|NCT01054885|11000437|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15
6956517|NCT01054885|11000438|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
6956518|NCT01054885|11000432|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
6956519|NCT01054885|11000433|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
6956520|NCT01054885|11000434|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
6956521|NCT01054885|11000435|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
6956522|NCT01054885|11000436|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
6956523|NCT01054885|11000437|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
6956524|NCT01054885|11000438|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
6956525|NCT01054885|11000432|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0
6956526|NCT01054885|11000433|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3
6956527|NCT01054885|11000434|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2
6956528|NCT01054885|11000435|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0
6956529|NCT01054885|11000436|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0
6956530|NCT01054885|11000437|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2
6956531|NCT01054885|11000438|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1
6956532|NCT01054885|11000432|FG000|24-week, Double-blind Treatment Period|Physician Decision|0
6956533|NCT01054885|11000433|FG001|24-week, Double-blind Treatment Period|Physician Decision|4
6956534|NCT01054885|11000434|FG002|24-week, Double-blind Treatment Period|Physician Decision|1
6956535|NCT01054885|11000435|FG003|24-week, Double-blind Treatment Period|Physician Decision|6
6956536|NCT01054885|11000436|FG004|24-week, Double-blind Treatment Period|Physician Decision|3
6956537|NCT01054885|11000437|FG005|24-week, Double-blind Treatment Period|Physician Decision|1
6956538|NCT01054885|11000438|FG006|24-week, Double-blind Treatment Period|Physician Decision|1
6956539|NCT01054885|11000432|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
6956540|NCT01054885|11000433|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8
6956541|NCT01054885|11000434|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
6956542|NCT01054885|11000435|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
6956543|NCT01054885|11000436|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
6956544|NCT01054885|11000437|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
6956545|NCT01054885|11000438|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2
6956546|NCT01054976|11000459|FG000|Overall Study|Adverse Event|16
7040841|NCT01721044|11124044|FG002|Treatment Period|Physician Decision|2
7082675|NCT02144012|11193251|FG000|Overall Study|Study Terminated by Sponsor|18
6956547|NCT01054976|11000459|FG000|Overall Study|Uncooperative participations to study|7
6956548|NCT01054976|11000459|FG000|Overall Study|Withdrawal by Subject|4
6956549|NCT01054976|11000459|FG000|Overall Study|Other|8
6956550|NCT01055028|11000465|FG000|Screening|Screen Failure|1
6956551|NCT01055028|11000466|FG001|Screening|Screen Failure|1
6956552|NCT01055028|11000465|FG000|Treatment Cycles 1 to 3|Adverse Event|0
6956553|NCT01055028|11000466|FG001|Treatment Cycles 1 to 3|Adverse Event|1
6956554|NCT01055028|11000465|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
6956555|NCT01055028|11000466|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
6956556|NCT01055028|11000465|FG000|Inter-treatment Period|Did not start Cycle 4|0
6956557|NCT01055028|11000466|FG001|Inter-treatment Period|Did not start Cycle 4|3
6956558|NCT01055132|11000482|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1
6956559|NCT01055132|11000483|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0
6956560|NCT01055132|11000482|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0
6956561|NCT01055132|11000483|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1
6956562|NCT01055197|11000508|FG000|Overall Study|Protocol Violation|7
6956563|NCT01055197|11000509|FG001|Overall Study|Protocol Violation|2
6956564|NCT01055197|11000508|FG000|Overall Study|Withdrawal by Subject|2
6956565|NCT01055197|11000509|FG001|Overall Study|Withdrawal by Subject|0
6956566|NCT01055262|11000528|FG000|Overall Study|Adverse Event|5
6956567|NCT01055262|11000528|FG000|Overall Study|Protocol Violation|3
6956568|NCT01055262|11000528|FG000|Overall Study|Uncooperativeness|1
6956569|NCT01055314|11000534|FG000|Overall Study|Adverse Event|7
6956570|NCT01055314|11000535|FG001|Overall Study|Adverse Event|4
6956571|NCT01055314|11000534|FG000|Overall Study|Death|2
6956572|NCT01055314|11000535|FG001|Overall Study|Death|1
6956573|NCT01055314|11000534|FG000|Overall Study|Lack of Efficacy|11
6956574|NCT01055314|11000535|FG001|Overall Study|Lack of Efficacy|19
6956575|NCT01055314|11000534|FG000|Overall Study|Physician Decision|10
6956576|NCT01055314|11000535|FG001|Overall Study|Physician Decision|5
6956577|NCT01055314|11000534|FG000|Overall Study|Withdrawal by Subject|1
6956578|NCT01055314|11000535|FG001|Overall Study|Withdrawal by Subject|0
6956579|NCT01055314|11000534|FG000|Overall Study|Ineligible|3
6956580|NCT01055314|11000535|FG001|Overall Study|Ineligible|5
6956581|NCT01055314|11000534|FG000|Overall Study|Refusal of further protocol therapy|10
6956582|NCT01055314|11000535|FG001|Overall Study|Refusal of further protocol therapy|4
6956583|NCT01055314|11000534|FG000|Overall Study|No treatment|1
6956584|NCT01055314|11000535|FG001|Overall Study|No treatment|0
6956585|NCT01055457|11000552|FG000|Overall Study|Lost to Follow-up|0
6956586|NCT01055457|11000553|FG001|Overall Study|Lost to Follow-up|1
6956587|NCT01055457|11000554|FG002|Overall Study|Lost to Follow-up|0
6956588|NCT01055457|11000555|FG003|Overall Study|Lost to Follow-up|0
6956589|NCT01055457|11000556|FG004|Overall Study|Lost to Follow-up|0
6956590|NCT01055457|11000557|FG005|Overall Study|Lost to Follow-up|1
6956591|NCT01055457|11000558|FG006|Overall Study|Lost to Follow-up|0
6956592|NCT01055457|11000559|FG007|Overall Study|Lost to Follow-up|0
6956593|NCT01055457|11000560|FG008|Overall Study|Lost to Follow-up|0
6956594|NCT01055457|11000561|FG009|Overall Study|Lost to Follow-up|0
6956595|NCT01055457|11000552|FG000|Overall Study|Protocol Violation|0
6956596|NCT01055457|11000553|FG001|Overall Study|Protocol Violation|0
6956597|NCT01055457|11000554|FG002|Overall Study|Protocol Violation|1
6956598|NCT01055457|11000555|FG003|Overall Study|Protocol Violation|1
6956599|NCT01055457|11000556|FG004|Overall Study|Protocol Violation|1
6956600|NCT01055457|11000557|FG005|Overall Study|Protocol Violation|2
6956601|NCT01055457|11000558|FG006|Overall Study|Protocol Violation|1
6956602|NCT01055457|11000559|FG007|Overall Study|Protocol Violation|0
6956603|NCT01055457|11000560|FG008|Overall Study|Protocol Violation|0
6956604|NCT01055457|11000561|FG009|Overall Study|Protocol Violation|1
6956605|NCT01055457|11000552|FG000|Overall Study|Subject Disinterest|0
6956606|NCT01055457|11000553|FG001|Overall Study|Subject Disinterest|0
6956607|NCT01055457|11000554|FG002|Overall Study|Subject Disinterest|0
7071951|NCT02031458|11175770|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6
7071952|NCT02031458|11175771|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9
7071953|NCT02031458|11175772|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3
7071954|NCT02031458|11175770|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46
7071955|NCT02031458|11175771|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83
7071956|NCT02031458|11175772|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73
7071957|NCT02031458|11175770|FG000|Baseline to May 8, 2015|On Treatment|43
7071958|NCT02031458|11175771|FG001|Baseline to May 8, 2015|On Treatment|81
6956608|NCT01055457|11000555|FG003|Overall Study|Subject Disinterest|0
6956609|NCT01055457|11000556|FG004|Overall Study|Subject Disinterest|0
6956610|NCT01055457|11000557|FG005|Overall Study|Subject Disinterest|0
6956611|NCT01055457|11000558|FG006|Overall Study|Subject Disinterest|0
7071959|NCT02031458|11175772|FG002|Baseline to May 8, 2015|On Treatment|73
6956612|NCT01055457|11000559|FG007|Overall Study|Subject Disinterest|1
6956613|NCT01055457|11000560|FG008|Overall Study|Subject Disinterest|0
6956614|NCT01055457|11000561|FG009|Overall Study|Subject Disinterest|0
6956615|NCT01055457|11000552|FG000|Overall Study|Subject Ineligible|1
6956616|NCT01055457|11000553|FG001|Overall Study|Subject Ineligible|0
6956617|NCT01055457|11000554|FG002|Overall Study|Subject Ineligible|1
6956618|NCT01055457|11000555|FG003|Overall Study|Subject Ineligible|0
6956619|NCT01055457|11000556|FG004|Overall Study|Subject Ineligible|1
6956620|NCT01055457|11000557|FG005|Overall Study|Subject Ineligible|0
6956621|NCT01055457|11000558|FG006|Overall Study|Subject Ineligible|0
6956622|NCT01055457|11000559|FG007|Overall Study|Subject Ineligible|0
6956623|NCT01055457|11000560|FG008|Overall Study|Subject Ineligible|0
6956624|NCT01055457|11000561|FG009|Overall Study|Subject Ineligible|0
6956625|NCT01055457|11000552|FG000|Overall Study|Discomfort|0
6956626|NCT01055457|11000553|FG001|Overall Study|Discomfort|0
6956627|NCT01055457|11000554|FG002|Overall Study|Discomfort|0
6956628|NCT01055457|11000555|FG003|Overall Study|Discomfort|0
6956629|NCT01055457|11000556|FG004|Overall Study|Discomfort|1
6956630|NCT01055457|11000557|FG005|Overall Study|Discomfort|0
6956631|NCT01055457|11000558|FG006|Overall Study|Discomfort|0
6956632|NCT01055457|11000559|FG007|Overall Study|Discomfort|0
6956633|NCT01055457|11000560|FG008|Overall Study|Discomfort|0
6956634|NCT01055457|11000561|FG009|Overall Study|Discomfort|0
6956635|NCT01055457|11000552|FG000|Overall Study|Pregnancy|0
6956636|NCT01055457|11000553|FG001|Overall Study|Pregnancy|0
6956637|NCT01055457|11000554|FG002|Overall Study|Pregnancy|0
6956638|NCT01055457|11000555|FG003|Overall Study|Pregnancy|1
6956639|NCT01055457|11000556|FG004|Overall Study|Pregnancy|0
6956640|NCT01055457|11000557|FG005|Overall Study|Pregnancy|0
6956641|NCT01055457|11000558|FG006|Overall Study|Pregnancy|0
6956642|NCT01055457|11000559|FG007|Overall Study|Pregnancy|0
6956643|NCT01055457|11000560|FG008|Overall Study|Pregnancy|0
6956644|NCT01055457|11000561|FG009|Overall Study|Pregnancy|0
6956645|NCT01055457|11000552|FG000|Overall Study|Adverse Event|0
6956646|NCT01055457|11000553|FG001|Overall Study|Adverse Event|0
6956647|NCT01055457|11000554|FG002|Overall Study|Adverse Event|0
6956648|NCT01055457|11000555|FG003|Overall Study|Adverse Event|1
6956649|NCT01055457|11000556|FG004|Overall Study|Adverse Event|0
6956650|NCT01055457|11000557|FG005|Overall Study|Adverse Event|0
6956651|NCT01055457|11000558|FG006|Overall Study|Adverse Event|0
6956652|NCT01055457|11000559|FG007|Overall Study|Adverse Event|0
6956653|NCT01055457|11000560|FG008|Overall Study|Adverse Event|0
6956654|NCT01055457|11000561|FG009|Overall Study|Adverse Event|0
6956655|NCT01055496|11000585|FG000|Overall Study|Withdrawal by Subject|2
6956656|NCT01055496|11000586|FG001|Overall Study|Withdrawal by Subject|4
6956657|NCT01055496|11000585|FG000|Overall Study|Death|13
6956658|NCT01055496|11000586|FG001|Overall Study|Death|23
6956659|NCT01055496|11000585|FG000|Overall Study|Lost to Follow-up|0
6956660|NCT01055496|11000586|FG001|Overall Study|Lost to Follow-up|2
6956661|NCT01055496|11000585|FG000|Overall Study|Other - Unspecified|0
6956662|NCT01055496|11000586|FG001|Overall Study|Other - Unspecified|1
6956663|NCT01055613|11000615|FG000|Overall Study|No Longer Meets Eligibility Criteria|3
6956664|NCT01055613|11000616|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
6956665|NCT01055613|11000615|FG000|Overall Study|Unacceptable lens fit|1
6956666|NCT01055613|11000616|FG001|Overall Study|Unacceptable lens fit|0
6956667|NCT01055613|11000615|FG000|Overall Study|Discomfort|2
6956668|NCT01055613|11000616|FG001|Overall Study|Discomfort|1
6956669|NCT01055613|11000615|FG000|Overall Study|Lost to Follow-up|1
6956670|NCT01055613|11000616|FG001|Overall Study|Lost to Follow-up|1
6956671|NCT01055613|11000615|FG000|Overall Study|Protocol Violation|1
6956672|NCT01055613|11000616|FG001|Overall Study|Protocol Violation|1
6956673|NCT01055613|11000615|FG000|Overall Study|Subject Disinterest|1
6956674|NCT01055613|11000616|FG001|Overall Study|Subject Disinterest|1
6956675|NCT01055639|11000624|FG000|Overall Study|Adverse Event|0
6956676|NCT01055639|11000625|FG001|Overall Study|Adverse Event|1
6956677|NCT01055639|11000624|FG000|Overall Study|Lack of Efficacy|0
6956678|NCT01055639|11000625|FG001|Overall Study|Lack of Efficacy|1
6956679|NCT01055639|11000624|FG000|Overall Study|Lost to Follow-up|8
6956680|NCT01055639|11000625|FG001|Overall Study|Lost to Follow-up|11
6956681|NCT01055639|11000624|FG000|Overall Study|Protocol Violation|5
6956682|NCT01055639|11000625|FG001|Overall Study|Protocol Violation|5
6956683|NCT01055639|11000624|FG000|Overall Study|Withdrawal by Subject|8
6956684|NCT01055639|11000625|FG001|Overall Study|Withdrawal by Subject|11
6956685|NCT01055834|11000669|FG000|Treatment Period I|Adverse Event|1
6956686|NCT01055834|11000670|FG001|Treatment Period I|Adverse Event|0
6956687|NCT01055886|11000681|FG000|Overall Study|Withdrawal by Subject|4
6956688|NCT01055886|11000682|FG001|Overall Study|Withdrawal by Subject|9
6956689|NCT01055886|11000681|FG000|Overall Study|Lost to Follow-up|1
6956690|NCT01055886|11000682|FG001|Overall Study|Lost to Follow-up|1
6956691|NCT01055886|11000681|FG000|Overall Study|Withdrawal by PI|0
6956692|NCT01055886|11000682|FG001|Overall Study|Withdrawal by PI|1
6976319|NCT01198132|11028786|FG000|Overall Study|Protocol Violation|1
6976320|NCT01198132|11028787|FG001|Overall Study|Protocol Violation|0
6976321|NCT01198145|11028797|FG000|Overall Study|Withdrawal by Subject|1
6976322|NCT01198145|11028798|FG001|Overall Study|Withdrawal by Subject|1
6976323|NCT01198275|11028816|FG000|Overall Study|Adverse Event|2
6976324|NCT01198275|11028817|FG001|Overall Study|Adverse Event|3
6976325|NCT01198275|11028816|FG000|Overall Study|spontaneous return to sinus rhythm|4
6976326|NCT01198275|11028817|FG001|Overall Study|spontaneous return to sinus rhythm|2
6976327|NCT01198470|11028855|FG000|Overall Study|Adverse Event|2
6976328|NCT01198509|11028865|FG000|Overall Study|Withdrawal by Subject|1
6976329|NCT01198509|11028866|FG001|Overall Study|Withdrawal by Subject|0
6976330|NCT01198509|11028867|FG002|Overall Study|Withdrawal by Subject|0
6976331|NCT01198509|11028868|FG003|Overall Study|Withdrawal by Subject|0
6976332|NCT01198509|11028869|FG004|Overall Study|Withdrawal by Subject|0
6976333|NCT01198509|11028870|FG005|Overall Study|Withdrawal by Subject|0
6976334|NCT01198574|11028886|FG000|Overall Study|Resigned from schools|4
6976335|NCT01198574|11028887|FG001|Overall Study|Resigned from schools|1
6956693|NCT01056107|11000701|FG000|Overall Study|Withdrawal by Subject|0
6956694|NCT01056107|11000702|FG001|Overall Study|Withdrawal by Subject|1
6956695|NCT01056107|11000703|FG002|Overall Study|Withdrawal by Subject|3
6956696|NCT01056107|11000704|FG003|Overall Study|Withdrawal by Subject|0
6956697|NCT01056263|11000725|FG000|Overall Study|Adverse Event|12
6956698|NCT01056263|11000725|FG000|Overall Study|Death|1
6956699|NCT01056263|11000725|FG000|Overall Study|Withdrawal by Subject|1
6956700|NCT01056263|11000725|FG000|Overall Study|Lack of Efficacy|29
6956701|NCT01056263|11000725|FG000|Overall Study|Progressive disease|2
6956702|NCT01056263|11000725|FG000|Overall Study|Neoplasm progression|1
6956703|NCT01056263|11000725|FG000|Overall Study|Objective progression or relapse|1
6956704|NCT01056263|11000725|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5
6956705|NCT01056276|11000731|FG000|Treatment Period-Cycles 1-8|Toxicity|2
6956706|NCT01056276|11000732|FG001|Treatment Period-Cycles 1-8|Toxicity|1
6956707|NCT01056276|11000731|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1
6956708|NCT01056276|11000732|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2
6956709|NCT01056276|11000731|FG000|Treatment Period-Cycles 1-8|Disease Progression|2
6956710|NCT01056276|11000732|FG001|Treatment Period-Cycles 1-8|Disease Progression|2
6956711|NCT01056276|11000731|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1
6956712|NCT01056276|11000732|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2
6956713|NCT01056276|11000731|FG000|Treatment Period-Cycles 1-8|Physician Decision|3
6956714|NCT01056276|11000732|FG001|Treatment Period-Cycles 1-8|Physician Decision|0
6956715|NCT01056276|11000731|FG000|Treatment Period-Cycles 1-8|Death|3
6956716|NCT01056276|11000732|FG001|Treatment Period-Cycles 1-8|Death|1
6956717|NCT01056276|11000731|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1
6956718|NCT01056276|11000732|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0
6956719|NCT01056276|11000731|FG000|Maintenance Therapy|Toxicity|0
6956720|NCT01056276|11000732|FG001|Maintenance Therapy|Toxicity|2
6956721|NCT01056276|11000731|FG000|Maintenance Therapy|Progressive Disease|0
6956722|NCT01056276|11000732|FG001|Maintenance Therapy|Progressive Disease|9
6956723|NCT01056276|11000731|FG000|Maintenance Therapy|Physician Decision|0
6956724|NCT01056276|11000732|FG001|Maintenance Therapy|Physician Decision|1
6956725|NCT01056276|11000731|FG000|Maintenance Therapy|Withdrawal by Subject|0
6956726|NCT01056276|11000732|FG001|Maintenance Therapy|Withdrawal by Subject|1
6956727|NCT01056276|11000731|FG000|Maintenance Therapy|Intercurrent Illness|0
6956728|NCT01056276|11000732|FG001|Maintenance Therapy|Intercurrent Illness|1
6956729|NCT01056276|11000731|FG000|Maintenance Therapy|Continuing maintenance therapy|0
6956730|NCT01056276|11000732|FG001|Maintenance Therapy|Continuing maintenance therapy|14
6956731|NCT01056289|11000743|FG000|Open-label Phase|Adverse Event|29
6956732|NCT01056289|11000744|FG001|Open-label Phase|Adverse Event|0
6956733|NCT01056289|11000745|FG002|Open-label Phase|Adverse Event|0
6956734|NCT01056289|11000746|FG003|Open-label Phase|Adverse Event|0
6956735|NCT01056289|11000743|FG000|Open-label Phase|Lost to Follow-up|30
6956736|NCT01056289|11000744|FG001|Open-label Phase|Lost to Follow-up|0
6956737|NCT01056289|11000745|FG002|Open-label Phase|Lost to Follow-up|0
6956738|NCT01056289|11000746|FG003|Open-label Phase|Lost to Follow-up|0
6956739|NCT01056289|11000743|FG000|Open-label Phase|Other|9
6956740|NCT01056289|11000744|FG001|Open-label Phase|Other|0
6956741|NCT01056289|11000745|FG002|Open-label Phase|Other|0
6956742|NCT01056289|11000746|FG003|Open-label Phase|Other|0
6956743|NCT01056289|11000743|FG000|Open-label Phase|Protocol Violation|6
6956744|NCT01056289|11000744|FG001|Open-label Phase|Protocol Violation|0
6956745|NCT01056289|11000745|FG002|Open-label Phase|Protocol Violation|0
6956746|NCT01056289|11000746|FG003|Open-label Phase|Protocol Violation|0
6956747|NCT01056289|11000743|FG000|Open-label Phase|Withdrawal by Subject|26
6956748|NCT01056289|11000744|FG001|Open-label Phase|Withdrawal by Subject|0
6956749|NCT01056289|11000745|FG002|Open-label Phase|Withdrawal by Subject|0
6956750|NCT01056289|11000746|FG003|Open-label Phase|Withdrawal by Subject|0
6956751|NCT01056289|11000743|FG000|Open-label Phase|Lack of Efficacy|18
6956752|NCT01056289|11000744|FG001|Open-label Phase|Lack of Efficacy|0
6956753|NCT01056289|11000745|FG002|Open-label Phase|Lack of Efficacy|0
6956754|NCT01056289|11000746|FG003|Open-label Phase|Lack of Efficacy|0
6956755|NCT01056289|11000743|FG000|Open-label Phase|Not randomized to Double-blind phase|1
6956756|NCT01056289|11000744|FG001|Open-label Phase|Not randomized to Double-blind phase|0
6956757|NCT01056289|11000745|FG002|Open-label Phase|Not randomized to Double-blind phase|0
6956758|NCT01056289|11000746|FG003|Open-label Phase|Not randomized to Double-blind phase|0
6956759|NCT01056289|11000743|FG000|Double-blind Phase|Adverse Event|0
6956760|NCT01056289|11000744|FG001|Double-blind Phase|Adverse Event|1
6956761|NCT01056289|11000745|FG002|Double-blind Phase|Adverse Event|2
6956762|NCT01056289|11000746|FG003|Double-blind Phase|Adverse Event|1
6956763|NCT01056289|11000743|FG000|Double-blind Phase|Lost to Follow-up|0
6956764|NCT01056289|11000744|FG001|Double-blind Phase|Lost to Follow-up|2
6956765|NCT01056289|11000745|FG002|Double-blind Phase|Lost to Follow-up|2
6956766|NCT01056289|11000746|FG003|Double-blind Phase|Lost to Follow-up|2
6956767|NCT01056289|11000743|FG000|Double-blind Phase|Other|0
6956768|NCT01056289|11000744|FG001|Double-blind Phase|Other|0
6956769|NCT01056289|11000745|FG002|Double-blind Phase|Other|1
6956770|NCT01056289|11000746|FG003|Double-blind Phase|Other|2
6956771|NCT01056289|11000743|FG000|Double-blind Phase|Protocol Violation|0
6956772|NCT01056289|11000744|FG001|Double-blind Phase|Protocol Violation|0
6956773|NCT01056289|11000745|FG002|Double-blind Phase|Protocol Violation|1
6956774|NCT01056289|11000746|FG003|Double-blind Phase|Protocol Violation|1
6956775|NCT01056289|11000743|FG000|Double-blind Phase|Withdrawal by Subject|0
6956776|NCT01056289|11000744|FG001|Double-blind Phase|Withdrawal by Subject|0
7071960|NCT02031458|11175770|FG000|Baseline to May 8, 2015|Lost to Follow-up|1
7071961|NCT02031458|11175771|FG001|Baseline to May 8, 2015|Lost to Follow-up|1
6956777|NCT01056289|11000745|FG002|Double-blind Phase|Withdrawal by Subject|4
6956778|NCT01056289|11000746|FG003|Double-blind Phase|Withdrawal by Subject|2
6956779|NCT01056289|11000743|FG000|Double-blind Phase|Discontinuation symptom|0
6956780|NCT01056289|11000744|FG001|Double-blind Phase|Discontinuation symptom|1
6956781|NCT01056289|11000745|FG002|Double-blind Phase|Discontinuation symptom|2
6838483|NCT00259610|10844215|FG002|Overall Study|Serious Adverse Event|2
6838484|NCT00259610|10844216|FG003|Overall Study|Serious Adverse Event|2
6838485|NCT00259649|10844226|FG000|Overall Study|Lost to Follow-up|7
6838486|NCT00259649|10844226|FG000|Overall Study|irregular menses|3
6838487|NCT00259740|10844232|FG000|Overall Study|Physician Decision|1
6838488|NCT00259740|10844233|FG001|Overall Study|Physician Decision|1
6838489|NCT00259740|10844232|FG000|Overall Study|Adverse Event|0
6838490|NCT00259740|10844233|FG001|Overall Study|Adverse Event|2
6838491|NCT00259740|10844232|FG000|Overall Study|Withdrawal by Subject|2
6838492|NCT00259740|10844233|FG001|Overall Study|Withdrawal by Subject|6
6838493|NCT00259740|10844232|FG000|Overall Study|Death|1
6838494|NCT00259740|10844233|FG001|Overall Study|Death|1
6838495|NCT00259740|10844232|FG000|Overall Study|Disease progression|19
6838496|NCT00259740|10844233|FG001|Overall Study|Disease progression|36
6838497|NCT00259740|10844232|FG000|Overall Study|Ongoing|17
6956782|NCT01056289|11000746|FG003|Double-blind Phase|Discontinuation symptom|2
6956783|NCT01056289|11000743|FG000|Double-blind Phase|Physician Decision|0
6956784|NCT01056289|11000744|FG001|Double-blind Phase|Physician Decision|0
6956785|NCT01056289|11000745|FG002|Double-blind Phase|Physician Decision|1
6956786|NCT01056289|11000746|FG003|Double-blind Phase|Physician Decision|0
6956787|NCT01056341|11000778|FG000|Overall Study|Treatment Intolerance|0
6956788|NCT01056341|11000779|FG001|Overall Study|Treatment Intolerance|2
6956789|NCT01056341|11000780|FG002|Overall Study|Treatment Intolerance|0
6956790|NCT01056341|11000781|FG003|Overall Study|Treatment Intolerance|2
6956791|NCT01056341|11000782|FG004|Overall Study|Treatment Intolerance|0
6956792|NCT01056341|11000778|FG000|Overall Study|Lack of Efficacy|32
6956793|NCT01056341|11000779|FG001|Overall Study|Lack of Efficacy|30
6956794|NCT01056341|11000780|FG002|Overall Study|Lack of Efficacy|7
6956795|NCT01056341|11000781|FG003|Overall Study|Lack of Efficacy|25
6956796|NCT01056341|11000782|FG004|Overall Study|Lack of Efficacy|9
6956797|NCT01056341|11000778|FG000|Overall Study|Other reasons|4
6956798|NCT01056341|11000779|FG001|Overall Study|Other reasons|4
6956799|NCT01056341|11000780|FG002|Overall Study|Other reasons|8
6956800|NCT01056341|11000781|FG003|Overall Study|Other reasons|9
6956801|NCT01056341|11000782|FG004|Overall Study|Other reasons|5
7071962|NCT02031458|11175772|FG002|Baseline to May 8, 2015|Lost to Follow-up|2
7071963|NCT02031471|11175782|FG000|24 Week Treatment Period|Adverse Event|6
7071964|NCT02031471|11175782|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2
7071965|NCT02031471|11175782|FG000|24 Week Treatment Period|Protocol Violation|1
7071966|NCT02031471|11175782|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1
7071967|NCT02031471|11175782|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1
7071968|NCT02031471|11175782|FG000|Long Term Extension (LTE) Period|Adverse Event|1
7071969|NCT02031471|11175782|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1
7071970|NCT02031536|11175788|FG000|Overall Study|ineligible|1
7071971|NCT02031536|11175789|FG001|Overall Study|ineligible|0
7071972|NCT02031640|11175813|FG000|Screening Period|Adverse Event|1
7071973|NCT02031640|11175814|FG001|Screening Period|Adverse Event|0
7071974|NCT02031640|11175815|FG002|Screening Period|Adverse Event|0
7071975|NCT02031640|11175816|FG003|Screening Period|Adverse Event|0
7071976|NCT02031640|11175817|FG004|Screening Period|Adverse Event|0
7071977|NCT02031640|11175818|FG005|Screening Period|Adverse Event|0
7071978|NCT02031640|11175813|FG000|Screening Period|Withdrawal by Subject|29
7071979|NCT02031640|11175814|FG001|Screening Period|Withdrawal by Subject|0
7071980|NCT02031640|11175815|FG002|Screening Period|Withdrawal by Subject|0
7071981|NCT02031640|11175816|FG003|Screening Period|Withdrawal by Subject|0
7071982|NCT02031640|11175817|FG004|Screening Period|Withdrawal by Subject|0
7071983|NCT02031640|11175818|FG005|Screening Period|Withdrawal by Subject|0
7071984|NCT02031640|11175813|FG000|Screening Period|Inclusion criteria not met|312
7071985|NCT02031640|11175814|FG001|Screening Period|Inclusion criteria not met|0
7071986|NCT02031640|11175815|FG002|Screening Period|Inclusion criteria not met|0
7071987|NCT02031640|11175816|FG003|Screening Period|Inclusion criteria not met|0
7071988|NCT02031640|11175817|FG004|Screening Period|Inclusion criteria not met|0
7071989|NCT02031640|11175818|FG005|Screening Period|Inclusion criteria not met|0
6956802|NCT01056380|11000802|FG000|Overall Study|Lost to Follow-up|2
6956803|NCT01056380|11000803|FG001|Overall Study|Lost to Follow-up|3
6956804|NCT01056484|11000813|FG000|Randomized Controlled Trial|Withdrawal by Subject|6
6956805|NCT01056484|11000814|FG001|Randomized Controlled Trial|Withdrawal by Subject|1
7071990|NCT02031640|11175813|FG000|Screening Period|Exclusion criteria met|30
6838498|NCT00259740|10844233|FG001|Overall Study|Ongoing|3
6838499|NCT00259740|10844232|FG000|Overall Study|Other|3
6956806|NCT01056484|11000813|FG000|Randomized Controlled Trial|Physician Decision|1
6976336|NCT01198574|11028888|FG002|Overall Study|Resigned from schools|1
6956807|NCT01056484|11000814|FG001|Randomized Controlled Trial|Physician Decision|0
6956808|NCT01056484|11000813|FG000|Follow up - Non-randomized|Withdrawal by Subject|0
6956809|NCT01056484|11000814|FG001|Follow up - Non-randomized|Withdrawal by Subject|2
6956810|NCT01056510|11000823|FG000|Overall Study|Dropout Before Start of Treatment|1
6956811|NCT01056510|11000824|FG001|Overall Study|Dropout Before Start of Treatment|1
6956812|NCT01056510|11000823|FG000|Overall Study|Withdrawal by Subject|4
6956813|NCT01056510|11000824|FG001|Overall Study|Withdrawal by Subject|2
6956814|NCT01056510|11000823|FG000|Overall Study|Death|29
6956815|NCT01056510|11000824|FG001|Overall Study|Death|34
6956816|NCT01056510|11000823|FG000|Overall Study|Noncompliance|1
6956817|NCT01056510|11000824|FG001|Overall Study|Noncompliance|3
6956818|NCT01056510|11000823|FG000|Overall Study|Physician Decision|4
6956819|NCT01056510|11000824|FG001|Overall Study|Physician Decision|5
6956820|NCT01056510|11000823|FG000|Overall Study|Lost to Follow-up|5
6956821|NCT01056510|11000824|FG001|Overall Study|Lost to Follow-up|6
6956822|NCT01056510|11000823|FG000|Overall Study|Other|10
6956823|NCT01056510|11000824|FG001|Overall Study|Other|12
6956824|NCT01056510|11000823|FG000|Overall Study|Missing|0
6956825|NCT01056510|11000824|FG001|Overall Study|Missing|1
6956826|NCT01056523|11000830|FG000|Overall Study|Death|1
6956827|NCT01056523|11000831|FG001|Overall Study|Death|0
6956828|NCT01056523|11000832|FG002|Overall Study|Death|2
6956829|NCT01056523|11000833|FG003|Overall Study|Death|3
6956830|NCT01056523|11000834|FG004|Overall Study|Death|0
6956831|NCT01056523|11000835|FG005|Overall Study|Death|0
6956832|NCT01056523|11000836|FG006|Overall Study|Death|1
6956833|NCT01056536|11000844|FG000|Overall Study|Lost to Follow-up|202
6956834|NCT01056536|11000845|FG001|Overall Study|Lost to Follow-up|116
6956835|NCT01056536|11000846|FG002|Overall Study|Lost to Follow-up|248
6956836|NCT01056640|11000860|FG000|Overall Study|Withdrawal by Subject|11
6956837|NCT01056640|11000861|FG001|Overall Study|Withdrawal by Subject|8
6956838|NCT01056640|11000860|FG000|Overall Study|Death|15
6956839|NCT01056640|11000861|FG001|Overall Study|Death|4
6956840|NCT01056653|11000870|FG000|Overall Study|Lost to Follow-up|0
6956841|NCT01056653|11000871|FG001|Overall Study|Lost to Follow-up|0
6956842|NCT01056653|11000872|FG002|Overall Study|Lost to Follow-up|2
6956843|NCT01056718|11000881|FG000|Overall Study|Withdrawal by Subject|2
6956844|NCT01056718|11000881|FG000|Overall Study|Ischemia on baseline stress test|1
6956845|NCT01056822|11000888|FG000|Overall Study|Adverse Event|0
6956846|NCT01056822|11000889|FG001|Overall Study|Adverse Event|1
6956847|NCT01056822|11000888|FG000|Overall Study|Protocol Violation|6
6956848|NCT01056822|11000889|FG001|Overall Study|Protocol Violation|5
6956849|NCT01056822|11000888|FG000|Overall Study|Withdrawal by Subject|1
6956850|NCT01056822|11000889|FG001|Overall Study|Withdrawal by Subject|1
6956851|NCT01056822|11000888|FG000|Overall Study|Lost to Follow-up|1
6956852|NCT01056822|11000889|FG001|Overall Study|Lost to Follow-up|0
6956853|NCT01057251|11000924|FG000|Overall Study|Did not meet InclusionExclusion criteria|4
6956854|NCT01057251|11000925|FG001|Overall Study|Did not meet InclusionExclusion criteria|2
6956855|NCT01057251|11000924|FG000|Overall Study|Adverse Event|4
6956856|NCT01057251|11000925|FG001|Overall Study|Adverse Event|2
6956857|NCT01057251|11000924|FG000|Overall Study|Lack of Efficacy|2
6956858|NCT01057251|11000925|FG001|Overall Study|Lack of Efficacy|11
6956859|NCT01057251|11000924|FG000|Overall Study|Protocol Violation|6
6956860|NCT01057251|11000925|FG001|Overall Study|Protocol Violation|2
6956861|NCT01057251|11000924|FG000|Overall Study|Withdrawal by Subject|4
6956862|NCT01057251|11000925|FG001|Overall Study|Withdrawal by Subject|5
6956863|NCT01057251|11000924|FG000|Overall Study|Lost to Follow-up|7
6956864|NCT01057251|11000925|FG001|Overall Study|Lost to Follow-up|6
6956865|NCT01057251|11000924|FG000|Overall Study|Other Reason|1
6956866|NCT01057251|11000925|FG001|Overall Study|Other Reason|1
6956867|NCT01057394|11000952|FG000|Overall Study|Not eligible|0
6956868|NCT01057394|11000953|FG001|Overall Study|Not eligible|2
6956869|NCT01057433|11000957|FG000|Overall Study|Adverse Event|1
6956870|NCT01057589|11000961|FG000|Overall Study|Disease Progression|35
6956871|NCT01057589|11000961|FG000|Overall Study|Adverse Event|10
6956872|NCT01057589|11000961|FG000|Overall Study|Physician Decision|8
6956873|NCT01057589|11000961|FG000|Overall Study|Withdrawal by Subject|3
6956874|NCT01057589|11000961|FG000|Overall Study|Sponsor Decision|1
6956875|NCT01057589|11000961|FG000|Overall Study|Death|8
6956876|NCT01057589|11000961|FG000|Overall Study|Lost to Follow-up|1
6956877|NCT01057693|11000965|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45
6956878|NCT01057693|11000966|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0
6956879|NCT01057693|11000967|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0
7040842|NCT01721044|11124042|FG000|Treatment Period|Protocol Violation|1
7040843|NCT01721044|11124043|FG001|Treatment Period|Protocol Violation|0
6956880|NCT01057693|11000965|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7
6956881|NCT01057693|11000966|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
6956882|NCT01057693|11000967|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
6956883|NCT01057693|11000965|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14
6956884|NCT01057693|11000966|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
6956885|NCT01057693|11000967|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
6956886|NCT01057693|11000965|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9
6956887|NCT01057693|11000966|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
6956888|NCT01057693|11000967|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
6956889|NCT01057693|11000965|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22
6956890|NCT01057693|11000966|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
6956891|NCT01057693|11000967|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
6956892|NCT01057693|11000965|FG000|Single-Blind Phase (Up to Week 6)|Other|2
6956893|NCT01057693|11000966|FG001|Single-Blind Phase (Up to Week 6)|Other|0
6956894|NCT01057693|11000967|FG002|Single-Blind Phase (Up to Week 6)|Other|0
6956895|NCT01057693|11000965|FG000|Between Single-Blind and Double-Blind|Adverse Event|5
6956896|NCT01057693|11000966|FG001|Between Single-Blind and Double-Blind|Adverse Event|0
6956897|NCT01057693|11000967|FG002|Between Single-Blind and Double-Blind|Adverse Event|0
6956898|NCT01057693|11000965|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247
6956899|NCT01057693|11000966|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0
6956900|NCT01057693|11000967|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0
6956901|NCT01057693|11000965|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1
6956902|NCT01057693|11000966|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0
6956903|NCT01057693|11000967|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0
6956904|NCT01057693|11000965|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7
6956905|NCT01057693|11000966|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0
6956906|NCT01057693|11000967|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0
6956907|NCT01057693|11000965|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4
6956908|NCT01057693|11000966|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
6956909|NCT01057693|11000967|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
6956910|NCT01057693|11000965|FG000|Between Single-Blind and Double-Blind|Other|6
6956911|NCT01057693|11000966|FG001|Between Single-Blind and Double-Blind|Other|0
6956912|NCT01057693|11000967|FG002|Between Single-Blind and Double-Blind|Other|0
6956913|NCT01057693|11000965|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0
6956914|NCT01057693|11000966|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8
6956915|NCT01057693|11000967|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11
6956916|NCT01057693|11000965|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0
6956917|NCT01057693|11000966|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3
6956918|NCT01057693|11000967|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8
6956919|NCT01057693|11000965|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0
6956920|NCT01057693|11000966|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2
6956921|NCT01057693|11000967|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5
6956922|NCT01057693|11000965|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
6956923|NCT01057693|11000966|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
6956924|NCT01057693|11000967|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4
6956925|NCT01057693|11000965|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0
6956926|NCT01057693|11000966|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8
6956927|NCT01057693|11000967|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6
6956928|NCT01057693|11000965|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0
6956929|NCT01057693|11000966|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1
6956930|NCT01057693|11000967|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0
6956931|NCT01057693|11000965|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
6956932|NCT01057693|11000966|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
6956933|NCT01057693|11000967|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2
6956934|NCT01057810|11000977|FG000|Overall Study|Disease progression|156
6956935|NCT01057810|11000978|FG001|Overall Study|Disease progression|197
6956936|NCT01057810|11000977|FG000|Overall Study|Study drug toxicity|5
6956937|NCT01057810|11000978|FG001|Overall Study|Study drug toxicity|114
6956938|NCT01057810|11000977|FG000|Overall Study|Adverse event unrelated to study drug|13
6956939|NCT01057810|11000978|FG001|Overall Study|Adverse event unrelated to study drug|29
6956940|NCT01057810|11000977|FG000|Overall Study|Withdrawal by Subject|10
6956941|NCT01057810|11000978|FG001|Overall Study|Withdrawal by Subject|25
6956942|NCT01057810|11000977|FG000|Overall Study|Death|2
6956943|NCT01057810|11000978|FG001|Overall Study|Death|12
7071991|NCT02031640|11175814|FG001|Screening Period|Exclusion criteria met|0
7071992|NCT02031640|11175815|FG002|Screening Period|Exclusion criteria met|0
7071993|NCT02031640|11175816|FG003|Screening Period|Exclusion criteria met|0
7071994|NCT02031640|11175817|FG004|Screening Period|Exclusion criteria met|0
7071995|NCT02031640|11175818|FG005|Screening Period|Exclusion criteria met|0
7071996|NCT02031640|11175813|FG000|Screening Period|Lost to Follow-up|14
7071997|NCT02031640|11175814|FG001|Screening Period|Lost to Follow-up|0
7071998|NCT02031640|11175815|FG002|Screening Period|Lost to Follow-up|0
7071999|NCT02031640|11175816|FG003|Screening Period|Lost to Follow-up|0
7072000|NCT02031640|11175817|FG004|Screening Period|Lost to Follow-up|0
7072001|NCT02031640|11175818|FG005|Screening Period|Lost to Follow-up|0
7072002|NCT02031640|11175813|FG000|Screening Period|Enrollment closed|26
7072003|NCT02031640|11175814|FG001|Screening Period|Enrollment closed|0
7072004|NCT02031640|11175815|FG002|Screening Period|Enrollment closed|0
7072005|NCT02031640|11175816|FG003|Screening Period|Enrollment closed|0
7072006|NCT02031640|11175817|FG004|Screening Period|Enrollment closed|0
7072007|NCT02031640|11175818|FG005|Screening Period|Enrollment closed|0
7072008|NCT02031640|11175813|FG000|Run-In Period|Adverse Event|4
7072009|NCT02031640|11175814|FG001|Run-In Period|Adverse Event|0
6956944|NCT01057810|11000977|FG000|Overall Study|Maximum clinical benefit|5
6956945|NCT01057810|11000978|FG001|Overall Study|Maximum clinical benefit|5
6956946|NCT01057810|11000977|FG000|Overall Study|Poor/non-compliance|0
6956947|NCT01057810|11000978|FG001|Overall Study|Poor/non-compliance|1
6956948|NCT01057810|11000977|FG000|Overall Study|No longer met study criteria|0
6956949|NCT01057810|11000978|FG001|Overall Study|No longer met study criteria|1
6956950|NCT01057810|11000977|FG000|Overall Study|Other|7
6956951|NCT01057810|11000978|FG001|Overall Study|Other|14
6956952|NCT01057862|11000986|FG000|Overall Study|Withdrawal by Subject|1
6956953|NCT01057862|11000987|FG001|Overall Study|Withdrawal by Subject|2
6956954|NCT01058005|11001016|FG000|Overall Study|Adverse Event|0
6956955|NCT01058005|11001017|FG001|Overall Study|Adverse Event|2
6956956|NCT01058005|11001018|FG002|Overall Study|Adverse Event|1
6956957|NCT01058005|11001016|FG000|Overall Study|Physician Decision|2
6956958|NCT01058005|11001017|FG001|Overall Study|Physician Decision|2
6956959|NCT01058005|11001018|FG002|Overall Study|Physician Decision|0
6956960|NCT01058005|11001016|FG000|Overall Study|Withdrawal by Subject|4
6956961|NCT01058005|11001017|FG001|Overall Study|Withdrawal by Subject|5
6956962|NCT01058005|11001018|FG002|Overall Study|Withdrawal by Subject|11
6956963|NCT01058005|11001016|FG000|Overall Study|Withdrawn Due to Study Termination|27
6956964|NCT01058005|11001017|FG001|Overall Study|Withdrawn Due to Study Termination|13
6956965|NCT01058005|11001018|FG002|Overall Study|Withdrawn Due to Study Termination|7
6956966|NCT01058005|11001016|FG000|Overall Study|Reason Missing|5
6956967|NCT01058005|11001017|FG001|Overall Study|Reason Missing|3
6956968|NCT01058005|11001018|FG002|Overall Study|Reason Missing|1
6956969|NCT01058096|11001033|FG000|Double-blind Treatment Phase|Adverse Event|11
6956970|NCT01058096|11001034|FG001|Double-blind Treatment Phase|Adverse Event|15
6956971|NCT01058096|11001033|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16
6956972|NCT01058096|11001034|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7
6956973|NCT01058096|11001033|FG000|Double-blind Treatment Phase|Protocol Violation|2
6956974|NCT01058096|11001034|FG001|Double-blind Treatment Phase|Protocol Violation|1
6956975|NCT01058096|11001033|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17
6956976|NCT01058096|11001034|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26
6956977|NCT01058096|11001033|FG000|Double-blind Treatment Phase|Lost to Follow-up|0
6956978|NCT01058096|11001034|FG001|Double-blind Treatment Phase|Lost to Follow-up|1
6956979|NCT01058096|11001033|FG000|Double-blind Treatment Phase|Other Unspecified|2
6956980|NCT01058096|11001034|FG001|Double-blind Treatment Phase|Other Unspecified|0
6956981|NCT01058265|11001046|FG000|Overall Study|Lost to Follow-up|11
6956982|NCT01058265|11001047|FG001|Overall Study|Lost to Follow-up|12
6956983|NCT01058304|11001055|FG000|Overall Study|Withdrawal by Subject|8
6956984|NCT01058304|11001056|FG001|Overall Study|Withdrawal by Subject|5
6956985|NCT01058304|11001055|FG000|Overall Study|Lost to Follow-up|13
6956986|NCT01058304|11001056|FG001|Overall Study|Lost to Follow-up|16
6956987|NCT01058304|11001055|FG000|Overall Study|Developed exclusion criterion|6
6956988|NCT01058304|11001056|FG001|Overall Study|Developed exclusion criterion|12
6956989|NCT01058356|11001062|FG000|Overall Study|Adverse Event|5
6956990|NCT01058356|11001062|FG000|Overall Study|Administration of contraindicated drugs|12
6956991|NCT01058356|11001062|FG000|Overall Study|Withdrawal by Subject|21
7072010|NCT02031640|11175815|FG002|Run-In Period|Adverse Event|0
7072011|NCT02031640|11175816|FG003|Run-In Period|Adverse Event|0
6956992|NCT01058356|11001062|FG000|Overall Study|Lost to Follow-up|4
6956993|NCT01058395|11001068|FG000|Overall Study|Death|2
6956994|NCT01058395|11001069|FG001|Overall Study|Death|1
6956995|NCT01058395|11001068|FG000|Overall Study|Lost to Follow-up|1
6956996|NCT01058395|11001069|FG001|Overall Study|Lost to Follow-up|0
6956997|NCT01058421|11001077|FG000|1 Month Outcomes|Death|10
6956998|NCT01058421|11001078|FG001|1 Month Outcomes|Death|6
6956999|NCT01058421|11001077|FG000|1 Month Outcomes|Lost to Follow-up|8
6957000|NCT01058421|11001078|FG001|1 Month Outcomes|Lost to Follow-up|7
6957001|NCT01058421|11001077|FG000|1 Month Outcomes|Remained in Hospital|5
6957002|NCT01058421|11001078|FG001|1 Month Outcomes|Remained in Hospital|12
6957003|NCT01058421|11001077|FG000|1 Month Outcomes|Remained in Other Facility|16
6957004|NCT01058421|11001078|FG001|1 Month Outcomes|Remained in Other Facility|17
6957005|NCT01058421|11001077|FG000|3 Month Outcomes|Death|3
6957006|NCT01058421|11001078|FG001|3 Month Outcomes|Death|5
6957007|NCT01058421|11001077|FG000|3 Month Outcomes|Lost to Follow-up|12
6957008|NCT01058421|11001078|FG001|3 Month Outcomes|Lost to Follow-up|11
6957009|NCT01058421|11001077|FG000|3 Month Outcomes|Remained in Hospital|0
6957010|NCT01058421|11001078|FG001|3 Month Outcomes|Remained in Hospital|2
6957011|NCT01058421|11001077|FG000|3 Month Outcomes|Remained in Other Facility|5
6957012|NCT01058421|11001078|FG001|3 Month Outcomes|Remained in Other Facility|8
6957013|NCT01058421|11001077|FG000|6 Month Outcomes|Death|2
6957014|NCT01058421|11001078|FG001|6 Month Outcomes|Death|2
6957015|NCT01058421|11001077|FG000|6 Month Outcomes|Lost to Follow-up|16
6957016|NCT01058421|11001078|FG001|6 Month Outcomes|Lost to Follow-up|21
6957017|NCT01058421|11001077|FG000|6 Month Outcomes|Remained in Other Facility|1
6957018|NCT01058421|11001078|FG001|6 Month Outcomes|Remained in Other Facility|3
6957019|NCT01058655|11001088|FG000|Overall Study|Withdrawal by Subject|1
6957020|NCT01058655|11001089|FG001|Overall Study|Withdrawal by Subject|0
6957021|NCT01058655|11001090|FG002|Overall Study|Withdrawal by Subject|3
6957022|NCT01058655|11001091|FG003|Overall Study|Withdrawal by Subject|4
7072012|NCT02031640|11175817|FG004|Run-In Period|Adverse Event|0
6957023|NCT01058655|11001088|FG000|Overall Study|Prolonged Treatment Delay|0
6957024|NCT01058655|11001089|FG001|Overall Study|Prolonged Treatment Delay|0
6957025|NCT01058655|11001090|FG002|Overall Study|Prolonged Treatment Delay|0
6957026|NCT01058655|11001091|FG003|Overall Study|Prolonged Treatment Delay|2
6957027|NCT01058655|11001088|FG000|Overall Study|Symptomatic Deterioration|0
6957028|NCT01058655|11001089|FG001|Overall Study|Symptomatic Deterioration|0
6957029|NCT01058655|11001090|FG002|Overall Study|Symptomatic Deterioration|0
6957030|NCT01058655|11001091|FG003|Overall Study|Symptomatic Deterioration|1
6957031|NCT01058655|11001088|FG000|Overall Study|Clinical Progression (non-RECIST)|1
6957032|NCT01058655|11001089|FG001|Overall Study|Clinical Progression (non-RECIST)|0
6957033|NCT01058655|11001090|FG002|Overall Study|Clinical Progression (non-RECIST)|0
6957034|NCT01058655|11001091|FG003|Overall Study|Clinical Progression (non-RECIST)|7
6957035|NCT01058655|11001088|FG000|Overall Study|Death|0
6957036|NCT01058655|11001089|FG001|Overall Study|Death|1
6957037|NCT01058655|11001090|FG002|Overall Study|Death|1
6957038|NCT01058655|11001091|FG003|Overall Study|Death|0
6957039|NCT01058655|11001088|FG000|Overall Study|Disease Progression|1
6957040|NCT01058655|11001089|FG001|Overall Study|Disease Progression|2
6957041|NCT01058655|11001090|FG002|Overall Study|Disease Progression|4
6957042|NCT01058655|11001091|FG003|Overall Study|Disease Progression|24
6957043|NCT01058655|11001088|FG000|Overall Study|Other|0
6957044|NCT01058655|11001089|FG001|Overall Study|Other|0
6957045|NCT01058655|11001090|FG002|Overall Study|Other|0
6957046|NCT01058655|11001091|FG003|Overall Study|Other|4
6957047|NCT01058668|11001105|FG000|Double-blind Treatment Phase|Adverse Event|8
6957048|NCT01058668|11001106|FG001|Double-blind Treatment Phase|Adverse Event|15
6957049|NCT01058668|11001107|FG002|Double-blind Treatment Phase|Adverse Event|25
6957050|NCT01058668|11001105|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15
6957051|NCT01058668|11001106|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2
6957052|NCT01058668|11001107|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5
6957053|NCT01058668|11001105|FG000|Double-blind Treatment Phase|Protocol Violation|1
6957054|NCT01058668|11001106|FG001|Double-blind Treatment Phase|Protocol Violation|1
6957055|NCT01058668|11001107|FG002|Double-blind Treatment Phase|Protocol Violation|2
6957056|NCT01058668|11001105|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14
6957057|NCT01058668|11001106|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18
6957058|NCT01058668|11001107|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17
6957059|NCT01058668|11001105|FG000|Double-blind Treatment Phase|Lost to Follow-up|0
6957060|NCT01058668|11001106|FG001|Double-blind Treatment Phase|Lost to Follow-up|1
6957061|NCT01058668|11001107|FG002|Double-blind Treatment Phase|Lost to Follow-up|1
6957062|NCT01058668|11001105|FG000|Double-blind Treatment Phase|Other Unspecified|1
6957063|NCT01058668|11001106|FG001|Double-blind Treatment Phase|Other Unspecified|1
6957064|NCT01058668|11001107|FG002|Double-blind Treatment Phase|Other Unspecified|0
6957065|NCT01058707|11001122|FG000|Overall Study|Disease Progression|15
6957066|NCT01058707|11001123|FG001|Overall Study|Disease Progression|20
6957067|NCT01058707|11001124|FG002|Overall Study|Disease Progression|20
6957068|NCT01058707|11001125|FG003|Overall Study|Disease Progression|15
6957069|NCT01058707|11001126|FG004|Overall Study|Disease Progression|23
6957070|NCT01058707|11001127|FG005|Overall Study|Disease Progression|10
6957071|NCT01058707|11001128|FG006|Overall Study|Disease Progression|12
6957072|NCT01058707|11001122|FG000|Overall Study|Adverse Event|11
6957073|NCT01058707|11001123|FG001|Overall Study|Adverse Event|4
6957074|NCT01058707|11001124|FG002|Overall Study|Adverse Event|7
6957075|NCT01058707|11001125|FG003|Overall Study|Adverse Event|6
6957076|NCT01058707|11001126|FG004|Overall Study|Adverse Event|7
6957077|NCT01058707|11001127|FG005|Overall Study|Adverse Event|3
6957078|NCT01058707|11001128|FG006|Overall Study|Adverse Event|1
6957079|NCT01058707|11001122|FG000|Overall Study|Subject Decision|5
6957080|NCT01058707|11001123|FG001|Overall Study|Subject Decision|3
6957081|NCT01058707|11001124|FG002|Overall Study|Subject Decision|3
6957082|NCT01058707|11001125|FG003|Overall Study|Subject Decision|1
6957083|NCT01058707|11001126|FG004|Overall Study|Subject Decision|2
6957084|NCT01058707|11001127|FG005|Overall Study|Subject Decision|3
6957085|NCT01058707|11001128|FG006|Overall Study|Subject Decision|6
6957086|NCT01058707|11001122|FG000|Overall Study|Lost to Follow-up|0
6957087|NCT01058707|11001123|FG001|Overall Study|Lost to Follow-up|0
6957088|NCT01058707|11001124|FG002|Overall Study|Lost to Follow-up|1
6957089|NCT01058707|11001125|FG003|Overall Study|Lost to Follow-up|0
6957090|NCT01058707|11001126|FG004|Overall Study|Lost to Follow-up|0
6957091|NCT01058707|11001127|FG005|Overall Study|Lost to Follow-up|0
6957092|NCT01058707|11001128|FG006|Overall Study|Lost to Follow-up|0
6957093|NCT01058707|11001122|FG000|Overall Study|Reason Not Specified|0
6957094|NCT01058707|11001123|FG001|Overall Study|Reason Not Specified|3
6957095|NCT01058707|11001124|FG002|Overall Study|Reason Not Specified|2
6957096|NCT01058707|11001125|FG003|Overall Study|Reason Not Specified|0
6957097|NCT01058707|11001126|FG004|Overall Study|Reason Not Specified|7
6957098|NCT01058707|11001127|FG005|Overall Study|Reason Not Specified|1
6957099|NCT01058707|11001128|FG006|Overall Study|Reason Not Specified|7
6957100|NCT01058863|11001166|FG000|Overall Study|Lost to Follow-up|1
6957101|NCT01058863|11001166|FG000|Overall Study|Withdrawal by Subject|1
6957102|NCT01058863|11001166|FG000|Overall Study|Sponsor requested withdrawal|1
6957103|NCT01058863|11001166|FG000|Overall Study|Randomized in error|1
6957104|NCT01059175|11001194|FG000|Overall Study|Death|17
6957105|NCT01059175|11001195|FG001|Overall Study|Death|17
6957106|NCT01059175|11001194|FG000|Overall Study|Adverse Event|4
6957107|NCT01059175|11001195|FG001|Overall Study|Adverse Event|2
6957108|NCT01059175|11001194|FG000|Overall Study|Lost to Follow-up|0
6957109|NCT01059175|11001195|FG001|Overall Study|Lost to Follow-up|1
6957110|NCT01059318|11001205|FG000|Core Study (26 Week)|Adverse Event|3
6957111|NCT01059318|11001205|FG000|Core Study (26 Week)|Withdrawal by Subject|1
6957112|NCT01059318|11001205|FG000|Extension (36 Week)|Adverse Event|3
6957113|NCT01059344|11001214|FG000|Overall Study|Adverse Event|12
6957114|NCT01059344|11001215|FG001|Overall Study|Adverse Event|30
6957115|NCT01059344|11001214|FG000|Overall Study|Withdrawal by Subject|6
6957116|NCT01059344|11001215|FG001|Overall Study|Withdrawal by Subject|9
6957117|NCT01059344|11001214|FG000|Overall Study|Lost to Follow-up|1
6957118|NCT01059344|11001215|FG001|Overall Study|Lost to Follow-up|1
6957119|NCT01059344|11001214|FG000|Overall Study|Other|3
6957120|NCT01059344|11001215|FG001|Overall Study|Other|6
6957121|NCT01059526|11001280|FG000|Overall Study|Patient enrolled but not treated|20
6957122|NCT01059526|11001281|FG001|Overall Study|Patient enrolled but not treated|17
6957123|NCT01059526|11001280|FG000|Overall Study|Adverse Event|2
6957124|NCT01059526|11001281|FG001|Overall Study|Adverse Event|2
6957125|NCT01059526|11001280|FG000|Overall Study|Protocol Violation|0
6957126|NCT01059526|11001281|FG001|Overall Study|Protocol Violation|1
6957127|NCT01059526|11001280|FG000|Overall Study|Withdrawal by Subject|3
6957128|NCT01059526|11001281|FG001|Overall Study|Withdrawal by Subject|1
6957129|NCT01059526|11001280|FG000|Overall Study|Lost to Follow-up|4
6957130|NCT01059526|11001281|FG001|Overall Study|Lost to Follow-up|1
6957131|NCT01059526|11001280|FG000|Overall Study|Patient found to be dermatographic|1
6957132|NCT01059526|11001281|FG001|Overall Study|Patient found to be dermatographic|0
6957133|NCT01059539|11001287|FG000|Overall Study|Adverse Event|66
6957134|NCT01059539|11001287|FG000|Overall Study|Insufficient Therapeutic Response|26
6957135|NCT01059539|11001287|FG000|Overall Study|Protocol Violation|55
6957136|NCT01059539|11001287|FG000|Overall Study|Withdrawal of Consent|80
6957137|NCT01059539|11001287|FG000|Overall Study|Lost to Follow-up|42
6957138|NCT01059539|11001287|FG000|Overall Study|Reason Not Specified|2
6957139|NCT01059565|11001293|FG000|24-Week Randomized Phase|Randomized but not treated|1
6957140|NCT01059565|11001294|FG001|24-Week Randomized Phase|Randomized but not treated|0
6957141|NCT01059565|11001293|FG000|24-Week Randomized Phase|Adverse Event|5
6957142|NCT01059565|11001294|FG001|24-Week Randomized Phase|Adverse Event|0
6957143|NCT01059565|11001293|FG000|24-Week Randomized Phase|Withdrawal by Subject|3
6957144|NCT01059565|11001294|FG001|24-Week Randomized Phase|Withdrawal by Subject|1
6957145|NCT01059565|11001293|FG000|24-Week Randomized Phase|Lost to Follow-up|0
6957146|NCT01059565|11001294|FG001|24-Week Randomized Phase|Lost to Follow-up|1
6957147|NCT01059565|11001293|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1
6957148|NCT01059565|11001294|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5
6957149|NCT01059565|11001293|FG000|24-Week Open-Label Phase|Adverse Event|2
6957150|NCT01059565|11001294|FG001|24-Week Open-Label Phase|Adverse Event|0
6957151|NCT01059565|11001293|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1
6957152|NCT01059565|11001294|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1
6957153|NCT01059565|11001293|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1
6957154|NCT01059565|11001294|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0
6957155|NCT01059565|11001293|FG000|24-Week Open-Label Phase|Subject noncompliance|1
6957156|NCT01059565|11001294|FG001|24-Week Open-Label Phase|Subject noncompliance|0
6957157|NCT01059565|11001293|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0
6957158|NCT01059565|11001294|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1
6957159|NCT01059565|11001293|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0
6957160|NCT01059565|11001294|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1
6957161|NCT01059617|11001306|FG000|Overall Study|Other|7
6957162|NCT01059617|11001307|FG001|Overall Study|Other|1
6957163|NCT01059617|11001308|FG002|Overall Study|Other|8
6957164|NCT01059617|11001309|FG003|Overall Study|Other|6
6957165|NCT01059630|11001329|FG000|Overall Study|Death|100
6957166|NCT01059630|11001330|FG001|Overall Study|Death|84
6957167|NCT01059630|11001329|FG000|Overall Study|Lost to Follow-up|4
6957168|NCT01059630|11001330|FG001|Overall Study|Lost to Follow-up|1
6957169|NCT01059630|11001329|FG000|Overall Study|Physician Decision|2
6957170|NCT01059630|11001330|FG001|Overall Study|Physician Decision|4
6957171|NCT01059630|11001329|FG000|Overall Study|Withdrawal by Subject|21
6957172|NCT01059630|11001330|FG001|Overall Study|Withdrawal by Subject|14
6957173|NCT01059643|11001336|FG000|Overall Study|Adverse Event|3
6957174|NCT01059643|11001336|FG000|Overall Study|Withdrawal by Subject|2
6957175|NCT01059643|11001336|FG000|Overall Study|Physician Decision|1
6957176|NCT01059773|11001364|FG000|Overall Study|Adverse Event|2
6957177|NCT01059773|11001365|FG001|Overall Study|Adverse Event|2
6957178|NCT01059773|11001364|FG000|Overall Study|Withdrawal by Subject|1
6957179|NCT01059773|11001365|FG001|Overall Study|Withdrawal by Subject|5
6957180|NCT01059773|11001364|FG000|Overall Study|Lost to Follow-up|1
6957181|NCT01059773|11001365|FG001|Overall Study|Lost to Follow-up|1
6957182|NCT01059773|11001364|FG000|Overall Study|Pregnancy|1
6957183|NCT01059773|11001365|FG001|Overall Study|Pregnancy|1
6957184|NCT01059773|11001364|FG000|Overall Study|Protocol Violation|6
6957185|NCT01059773|11001365|FG001|Overall Study|Protocol Violation|2
6957186|NCT01059773|11001364|FG000|Overall Study|Physician Decision|5
6957187|NCT01059773|11001365|FG001|Overall Study|Physician Decision|4
6957188|NCT01059773|11001364|FG000|Overall Study|Lack of Efficacy|3
6957189|NCT01059773|11001365|FG001|Overall Study|Lack of Efficacy|3
6957190|NCT01059773|11001364|FG000|Overall Study|Death|0
6957191|NCT01059773|11001365|FG001|Overall Study|Death|1
6957192|NCT01059773|11001364|FG000|Overall Study|Malignancy including squamous cell skin|0
6957193|NCT01059773|11001365|FG001|Overall Study|Malignancy including squamous cell skin|1
6957194|NCT01059773|11001364|FG000|Overall Study|Ineligible follow TB screening criteria|0
6957195|NCT01059773|11001365|FG001|Overall Study|Ineligible follow TB screening criteria|1
6957196|NCT01059773|11001364|FG000|Overall Study|Other|1
6957197|NCT01059773|11001365|FG001|Overall Study|Other|3
6957198|NCT01059799|11001378|FG000|Overall Study|Adverse Event|2
6957199|NCT01059799|11001379|FG001|Overall Study|Adverse Event|3
6957200|NCT01059799|11001378|FG000|Overall Study|Lack of Efficacy|1
6957201|NCT01059799|11001379|FG001|Overall Study|Lack of Efficacy|0
6957202|NCT01059799|11001378|FG000|Overall Study|Protocol Violation|3
6957203|NCT01059799|11001379|FG001|Overall Study|Protocol Violation|2
6957204|NCT01059799|11001378|FG000|Overall Study|Withdrawal criteria|13
6957205|NCT01059799|11001379|FG001|Overall Study|Withdrawal criteria|2
6957206|NCT01059799|11001378|FG000|Overall Study|Other|12
6957207|NCT01059799|11001379|FG001|Overall Study|Other|3
6957208|NCT01059812|11001387|FG000|Overall Study|Adverse Event|9
6957209|NCT01059812|11001388|FG001|Overall Study|Adverse Event|5
6957210|NCT01059812|11001387|FG000|Overall Study|Lack of Efficacy|2
6957211|NCT01059812|11001388|FG001|Overall Study|Lack of Efficacy|2
6957212|NCT01059812|11001387|FG000|Overall Study|Protocol Violation|3
6957213|NCT01059812|11001388|FG001|Overall Study|Protocol Violation|1
6957214|NCT01059812|11001387|FG000|Overall Study|Withdrawal Criteria|9
6957215|NCT01059812|11001388|FG001|Overall Study|Withdrawal Criteria|4
6957216|NCT01059812|11001387|FG000|Overall Study|Unclassified|14
6957217|NCT01059812|11001388|FG001|Overall Study|Unclassified|4
6957218|NCT01059825|11001400|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0
6957219|NCT01059825|11001401|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0
6957220|NCT01059825|11001402|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0
6957221|NCT01059825|11001403|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0
6957222|NCT01059825|11001404|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0
6957223|NCT01059825|11001405|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0
6957224|NCT01059825|11001406|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3
6957225|NCT01059825|11001400|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0
6957226|NCT01059825|11001401|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0
6957227|NCT01059825|11001402|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0
6957228|NCT01059825|11001403|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0
6957229|NCT01059825|11001404|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0
6957230|NCT01059825|11001405|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0
6957231|NCT01059825|11001406|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14
6957232|NCT01059825|11001400|FG000|Enrolled, Run-in Period|Lost to Follow-up|0
6957233|NCT01059825|11001401|FG001|Enrolled, Run-in Period|Lost to Follow-up|0
6957234|NCT01059825|11001402|FG002|Enrolled, Run-in Period|Lost to Follow-up|0
6957235|NCT01059825|11001403|FG003|Enrolled, Run-in Period|Lost to Follow-up|0
6957236|NCT01059825|11001404|FG004|Enrolled, Run-in Period|Lost to Follow-up|0
6957237|NCT01059825|11001405|FG005|Enrolled, Run-in Period|Lost to Follow-up|0
6957238|NCT01059825|11001406|FG006|Enrolled, Run-in Period|Lost to Follow-up|5
6957239|NCT01059825|11001400|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0
6957240|NCT01059825|11001401|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0
6957241|NCT01059825|11001402|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0
6957242|NCT01059825|11001403|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0
6957243|NCT01059825|11001404|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0
6957244|NCT01059825|11001405|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0
6957245|NCT01059825|11001406|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13
6957246|NCT01059825|11001400|FG000|Enrolled, Run-in Period|Other reason not specified|0
6957247|NCT01059825|11001401|FG001|Enrolled, Run-in Period|Other reason not specified|0
6957248|NCT01059825|11001402|FG002|Enrolled, Run-in Period|Other reason not specified|0
6957249|NCT01059825|11001403|FG003|Enrolled, Run-in Period|Other reason not specified|0
6957250|NCT01059825|11001404|FG004|Enrolled, Run-in Period|Other reason not specified|0
6957251|NCT01059825|11001405|FG005|Enrolled, Run-in Period|Other reason not specified|0
6957252|NCT01059825|11001406|FG006|Enrolled, Run-in Period|Other reason not specified|7
6957253|NCT01059825|11001400|FG000|Enrolled, Run-in Period|Protocol Violation|0
6957254|NCT01059825|11001401|FG001|Enrolled, Run-in Period|Protocol Violation|0
6957255|NCT01059825|11001402|FG002|Enrolled, Run-in Period|Protocol Violation|0
6957256|NCT01059825|11001403|FG003|Enrolled, Run-in Period|Protocol Violation|0
6957257|NCT01059825|11001404|FG004|Enrolled, Run-in Period|Protocol Violation|0
6957258|NCT01059825|11001405|FG005|Enrolled, Run-in Period|Protocol Violation|0
6957259|NCT01059825|11001406|FG006|Enrolled, Run-in Period|Protocol Violation|5
6957260|NCT01059825|11001400|FG000|Treatment Period|Lost to Follow-up|2
6957261|NCT01059825|11001401|FG001|Treatment Period|Lost to Follow-up|1
6957262|NCT01059825|11001402|FG002|Treatment Period|Lost to Follow-up|0
6957263|NCT01059825|11001403|FG003|Treatment Period|Lost to Follow-up|1
6957264|NCT01059825|11001404|FG004|Treatment Period|Lost to Follow-up|2
6957265|NCT01059825|11001405|FG005|Treatment Period|Lost to Follow-up|0
6957266|NCT01059825|11001406|FG006|Treatment Period|Lost to Follow-up|0
6957267|NCT01059825|11001400|FG000|Treatment Period|Withdrawal by Subject|3
6957268|NCT01059825|11001401|FG001|Treatment Period|Withdrawal by Subject|0
6957269|NCT01059825|11001402|FG002|Treatment Period|Withdrawal by Subject|1
6957270|NCT01059825|11001403|FG003|Treatment Period|Withdrawal by Subject|5
6957271|NCT01059825|11001404|FG004|Treatment Period|Withdrawal by Subject|4
6957272|NCT01059825|11001405|FG005|Treatment Period|Withdrawal by Subject|1
6957273|NCT01059825|11001406|FG006|Treatment Period|Withdrawal by Subject|0
6957274|NCT01059825|11001400|FG000|Treatment Period|Other reason not specified|1
6957275|NCT01059825|11001401|FG001|Treatment Period|Other reason not specified|2
6957276|NCT01059825|11001402|FG002|Treatment Period|Other reason not specified|1
6957277|NCT01059825|11001403|FG003|Treatment Period|Other reason not specified|2
6957278|NCT01059825|11001404|FG004|Treatment Period|Other reason not specified|0
6957279|NCT01059825|11001405|FG005|Treatment Period|Other reason not specified|0
6957280|NCT01059825|11001406|FG006|Treatment Period|Other reason not specified|0
6957281|NCT01059825|11001400|FG000|Treatment Period|Protocol Violation|0
6957282|NCT01059825|11001401|FG001|Treatment Period|Protocol Violation|0
6957283|NCT01059825|11001402|FG002|Treatment Period|Protocol Violation|1
6957284|NCT01059825|11001403|FG003|Treatment Period|Protocol Violation|1
6957285|NCT01059825|11001404|FG004|Treatment Period|Protocol Violation|1
6957286|NCT01059825|11001405|FG005|Treatment Period|Protocol Violation|1
6957287|NCT01059825|11001406|FG006|Treatment Period|Protocol Violation|0
6957288|NCT01059825|11001400|FG000|Treatment Period|Adverse event related to study drug|1
6957289|NCT01059825|11001401|FG001|Treatment Period|Adverse event related to study drug|0
6957290|NCT01059825|11001402|FG002|Treatment Period|Adverse event related to study drug|1
6957291|NCT01059825|11001403|FG003|Treatment Period|Adverse event related to study drug|1
6957292|NCT01059825|11001404|FG004|Treatment Period|Adverse event related to study drug|0
6957293|NCT01059825|11001405|FG005|Treatment Period|Adverse event related to study drug|0
6957294|NCT01059825|11001406|FG006|Treatment Period|Adverse event related to study drug|0
6957295|NCT01059825|11001400|FG000|Treatment Period|Insufficient clinical response|3
6957296|NCT01059825|11001401|FG001|Treatment Period|Insufficient clinical response|0
6957297|NCT01059825|11001402|FG002|Treatment Period|Insufficient clinical response|0
6957298|NCT01059825|11001403|FG003|Treatment Period|Insufficient clinical response|0
6957299|NCT01059825|11001404|FG004|Treatment Period|Insufficient clinical response|0
6957300|NCT01059825|11001405|FG005|Treatment Period|Insufficient clinical response|0
6957301|NCT01059825|11001406|FG006|Treatment Period|Insufficient clinical response|0
6957302|NCT01059825|11001400|FG000|Treatment Period|Adverse event not related to study drug|0
6957303|NCT01059825|11001401|FG001|Treatment Period|Adverse event not related to study drug|1
6957304|NCT01059825|11001402|FG002|Treatment Period|Adverse event not related to study drug|2
6957305|NCT01059825|11001403|FG003|Treatment Period|Adverse event not related to study drug|1
6957306|NCT01059825|11001404|FG004|Treatment Period|Adverse event not related to study drug|1
6957307|NCT01059825|11001405|FG005|Treatment Period|Adverse event not related to study drug|1
6957308|NCT01059825|11001406|FG006|Treatment Period|Adverse event not related to study drug|0
6957309|NCT01059864|11001439|FG000|Open-Label Run-In Phase|Adverse Event|7
6957310|NCT01059864|11001440|FG001|Open-Label Run-In Phase|Adverse Event|0
6957311|NCT01059864|11001441|FG002|Open-Label Run-In Phase|Adverse Event|0
6957312|NCT01059864|11001439|FG000|Open-Label Run-In Phase|Lack of Efficacy|1
6957313|NCT01059864|11001440|FG001|Open-Label Run-In Phase|Lack of Efficacy|0
6957314|NCT01059864|11001441|FG002|Open-Label Run-In Phase|Lack of Efficacy|0
6957315|NCT01059864|11001439|FG000|Open-Label Run-In Phase|Lost to Follow-up|2
6957316|NCT01059864|11001440|FG001|Open-Label Run-In Phase|Lost to Follow-up|0
6957317|NCT01059864|11001441|FG002|Open-Label Run-In Phase|Lost to Follow-up|0
6957318|NCT01059864|11001439|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1
6957319|NCT01059864|11001440|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0
6957320|NCT01059864|11001441|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0
6957321|NCT01059864|11001439|FG000|Open-Label Run-In Phase|Protocol Violation|2
6957322|NCT01059864|11001440|FG001|Open-Label Run-In Phase|Protocol Violation|0
6957323|NCT01059864|11001441|FG002|Open-Label Run-In Phase|Protocol Violation|0
6957324|NCT01059864|11001439|FG000|Double-Blind Treatment Phase|Adverse Event|0
6957325|NCT01059864|11001440|FG001|Double-Blind Treatment Phase|Adverse Event|3
6957326|NCT01059864|11001441|FG002|Double-Blind Treatment Phase|Adverse Event|3
6957327|NCT01059903|11001459|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1
6957328|NCT01059903|11001460|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1
6957329|NCT01060007|11001492|FG000|Overall Study|Withdrawal by Subject|1
6957330|NCT01060007|11001492|FG000|Overall Study|Inevaluable for response at surgery|3
6957331|NCT01060059|11001506|FG000|Overall Study|Adverse Event|1
6957332|NCT01060059|11001507|FG001|Overall Study|Adverse Event|1
6957333|NCT01060059|11001506|FG000|Overall Study|Death|2
6957334|NCT01060059|11001507|FG001|Overall Study|Death|3
6957335|NCT01060059|11001506|FG000|Overall Study|Lost to Follow-up|18
6957336|NCT01060059|11001507|FG001|Overall Study|Lost to Follow-up|34
6957337|NCT01060059|11001506|FG000|Overall Study|entry criteria not met|4
6957338|NCT01060059|11001507|FG001|Overall Study|entry criteria not met|3
6957339|NCT01060059|11001506|FG000|Overall Study|Withdrawal by Subject|35
6957340|NCT01060059|11001507|FG001|Overall Study|Withdrawal by Subject|23
6957341|NCT01060059|11001506|FG000|Overall Study|lack of glycemic control|2
6957342|NCT01060059|11001507|FG001|Overall Study|lack of glycemic control|1
6957343|NCT01060059|11001506|FG000|Overall Study|lack of compliance|5
6957344|NCT01060059|11001507|FG001|Overall Study|lack of compliance|2
6957345|NCT01060072|11001517|FG000|Overall Study|Adverse Event|1
7072013|NCT02031640|11175818|FG005|Run-In Period|Adverse Event|0
7072014|NCT02031640|11175813|FG000|Run-In Period|Withdrawal by Subject|17
7072015|NCT02031640|11175814|FG001|Run-In Period|Withdrawal by Subject|0
7072016|NCT02031640|11175815|FG002|Run-In Period|Withdrawal by Subject|0
6838500|NCT00259740|10844233|FG001|Overall Study|Other|0
6957346|NCT01060072|11001518|FG001|Overall Study|Adverse Event|1
6957347|NCT01060072|11001517|FG000|Overall Study|Physician Decision|0
6957348|NCT01060072|11001518|FG001|Overall Study|Physician Decision|2
6957349|NCT01060072|11001517|FG000|Overall Study|Protocol Violation|0
6957350|NCT01060072|11001518|FG001|Overall Study|Protocol Violation|1
6957351|NCT01060072|11001517|FG000|Overall Study|Acute cholecystitis|1
6957352|NCT01060072|11001518|FG001|Overall Study|Acute cholecystitis|0
6957353|NCT01060072|11001517|FG000|Overall Study|Excluded Medications|0
6957354|NCT01060072|11001518|FG001|Overall Study|Excluded Medications|1
6957355|NCT01060111|11001540|FG000|Overall Study|Adverse Event|9
6957356|NCT01060111|11001541|FG001|Overall Study|Adverse Event|5
6957357|NCT01060111|11001542|FG002|Overall Study|Adverse Event|18
6957358|NCT01060111|11001540|FG000|Overall Study|Lack of Efficacy|2
6957359|NCT01060111|11001541|FG001|Overall Study|Lack of Efficacy|1
6957360|NCT01060111|11001542|FG002|Overall Study|Lack of Efficacy|0
6957361|NCT01060111|11001540|FG000|Overall Study|Inappropriate participant|5
6957362|NCT01060111|11001541|FG001|Overall Study|Inappropriate participant|4
6957363|NCT01060111|11001542|FG002|Overall Study|Inappropriate participant|5
6957364|NCT01060111|11001540|FG000|Overall Study|Participants' evasion for hospital visit|0
6957365|NCT01060111|11001541|FG001|Overall Study|Participants' evasion for hospital visit|3
6957366|NCT01060111|11001542|FG002|Overall Study|Participants' evasion for hospital visit|2
6957367|NCT01060111|11001540|FG000|Overall Study|Participants' non-cooperation|8
6957368|NCT01060111|11001541|FG001|Overall Study|Participants' non-cooperation|6
6957369|NCT01060111|11001542|FG002|Overall Study|Participants' non-cooperation|6
6957370|NCT01060111|11001540|FG000|Overall Study|Adverse event and insufficient effect|0
6957371|NCT01060111|11001541|FG001|Overall Study|Adverse event and insufficient effect|1
6957372|NCT01060111|11001542|FG002|Overall Study|Adverse event and insufficient effect|0
6957373|NCT01060111|11001540|FG000|Overall Study|Participants' non-cooperation|1
6957374|NCT01060111|11001541|FG001|Overall Study|Participants' non-cooperation|0
6957375|NCT01060111|11001542|FG002|Overall Study|Participants' non-cooperation|0
6957376|NCT01060111|11001540|FG000|Overall Study|Other|2
6957377|NCT01060111|11001541|FG001|Overall Study|Other|3
6957378|NCT01060111|11001542|FG002|Overall Study|Other|4
6957379|NCT01060124|11001553|FG000|Overall Study|Other|16
6957380|NCT01060124|11001553|FG000|Overall Study|Adverse Event|14
6957381|NCT01060124|11001553|FG000|Overall Study|Withdrawal by Subject|7
6957382|NCT01060150|11001557|FG000|Overall Study|Adverse Event|6
6957383|NCT01060150|11001557|FG000|Overall Study|Lost to Follow-up|1
6957384|NCT01060150|11001557|FG000|Overall Study|Protocol Violation|6
6957385|NCT01060150|11001557|FG000|Overall Study|Withdrawal by Subject|8
6957386|NCT01060150|11001557|FG000|Overall Study|Enrolled, but not treated|2
6957387|NCT01060384|11001565|FG000|Overall Study|Withdrawal by Subject|0
6957388|NCT01060384|11001566|FG001|Overall Study|Withdrawal by Subject|1
6957389|NCT01060384|11001567|FG002|Overall Study|Withdrawal by Subject|0
6957390|NCT01060384|11001568|FG003|Overall Study|Withdrawal by Subject|0
6957391|NCT01060384|11001569|FG004|Overall Study|Withdrawal by Subject|0
6957392|NCT01060384|11001565|FG000|Overall Study|Death|0
6957393|NCT01060384|11001566|FG001|Overall Study|Death|0
6957394|NCT01060384|11001567|FG002|Overall Study|Death|0
6957395|NCT01060384|11001568|FG003|Overall Study|Death|0
6957396|NCT01060384|11001569|FG004|Overall Study|Death|1
6957397|NCT01060384|11001565|FG000|Overall Study|Intercurrent illness|0
6957398|NCT01060384|11001566|FG001|Overall Study|Intercurrent illness|0
6957399|NCT01060384|11001567|FG002|Overall Study|Intercurrent illness|0
6957400|NCT01060384|11001568|FG003|Overall Study|Intercurrent illness|0
6957401|NCT01060384|11001569|FG004|Overall Study|Intercurrent illness|1
6957402|NCT01060540|11001580|FG000|Overall Study|Withdrawal by Subject|10
6957403|NCT01060540|11001581|FG001|Overall Study|Withdrawal by Subject|20
6957404|NCT01060540|11001580|FG000|Overall Study|Lost to Follow-up|52
6957405|NCT01060540|11001581|FG001|Overall Study|Lost to Follow-up|43
6957406|NCT01060540|11001580|FG000|Overall Study|Death|2
7072017|NCT02031640|11175816|FG003|Run-In Period|Withdrawal by Subject|0
6838501|NCT00259740|10844232|FG000|Overall Study|Requirement for alternative therapy|0
6838502|NCT00259740|10844233|FG001|Overall Study|Requirement for alternative therapy|4
6838503|NCT00259857|10844241|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1
6838504|NCT00259857|10844242|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2
6838505|NCT00259857|10844241|FG000|24 Months Treatment|Lost to Follow-up|0
6838506|NCT00259857|10844242|FG001|24 Months Treatment|Lost to Follow-up|3
6838507|NCT00260065|10844248|FG000|Overall Study|Progressive Disease|22
6838508|NCT00260065|10844248|FG000|Overall Study|Adverse Event|17
6838509|NCT00260065|10844248|FG000|Overall Study|Death|13
6838510|NCT00260065|10844248|FG000|Overall Study|Withdrawal by Subject|13
6838511|NCT00260065|10844248|FG000|Overall Study|Physician Decision|19
6838512|NCT00260065|10844248|FG000|Overall Study|Not otherwise specified|8
6957407|NCT01060540|11001581|FG001|Overall Study|Death|1
6957408|NCT01060540|11001580|FG000|Overall Study|Physician Decision|0
6957409|NCT01060540|11001581|FG001|Overall Study|Physician Decision|1
6957410|NCT01060553|11001589|FG000|Overall Study|Lost to Follow-up|3
6957411|NCT01060553|11001590|FG001|Overall Study|Lost to Follow-up|5
6957412|NCT01060553|11001589|FG000|Overall Study|Withdrawal by Subject|5
6957413|NCT01060553|11001590|FG001|Overall Study|Withdrawal by Subject|5
6957414|NCT01060553|11001589|FG000|Overall Study|Lack of Efficacy|1
6957415|NCT01060553|11001590|FG001|Overall Study|Lack of Efficacy|0
6957416|NCT01060670|11001606|FG000|Run In|screen failure|0
6957417|NCT01060670|11001607|FG001|Run In|screen failure|238
6957418|NCT01061008|11001617|FG000|Overall Study|Badiocephalic fistula failed|3
6957419|NCT01061008|11001618|FG001|Overall Study|Badiocephalic fistula failed|2
6957420|NCT01061008|11001617|FG000|Overall Study|Death|1
6957421|NCT01061008|11001618|FG001|Overall Study|Death|0
6957422|NCT01061008|11001617|FG000|Overall Study|Withdrawal by Subject|1
6957423|NCT01061008|11001618|FG001|Overall Study|Withdrawal by Subject|3
6957424|NCT01061008|11001617|FG000|Overall Study|Unable to exercise following surgery|1
6957425|NCT01061008|11001618|FG001|Overall Study|Unable to exercise following surgery|0
6957426|NCT01061008|11001617|FG000|Overall Study|Adverse Event|0
6957427|NCT01061008|11001618|FG001|Overall Study|Adverse Event|1
6957428|NCT01061177|11001628|FG000|Overall Study|Adverse Event|117
6957429|NCT01061177|11001628|FG000|Overall Study|Withdrawal by Subject|27
6957430|NCT01061177|11001628|FG000|Overall Study|Disease progression|17
6957431|NCT01061177|11001628|FG000|Overall Study|Protocol Violation|11
6957432|NCT01061177|11001628|FG000|Overall Study|Lost to Follow-up|9
6957433|NCT01061177|11001628|FG000|Overall Study|New cancer therapy|9
6957434|NCT01061177|11001628|FG000|Overall Study|Abnormal laboratory values|6
6957435|NCT01061177|11001628|FG000|Overall Study|Abnormal test procedure results|4
6957436|NCT01061177|11001628|FG000|Overall Study|Administratie problems|4
6957437|NCT01061177|11001628|FG000|Overall Study|Death|4
6957438|NCT01061333|11001632|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0
6957439|NCT01061333|11001633|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1
6957440|NCT01061359|11001644|FG000|Overall Study|Death|32
6957441|NCT01061359|11001644|FG000|Overall Study|Lost to Follow-up|1072
6957442|NCT01061359|11001644|FG000|Overall Study|Relapse|187
6957443|NCT01061359|11001644|FG000|Overall Study|Secondary neoplasm|11
6957444|NCT01061385|11001650|FG000|Overall Study|Lost to Follow-up|1
6957445|NCT01061385|11001651|FG001|Overall Study|Lost to Follow-up|0
6957446|NCT01061385|11001650|FG000|Overall Study|subject decision not related to AE|0
6957447|NCT01061385|11001651|FG001|Overall Study|subject decision not related to AE|1
6957448|NCT01061567|11001671|FG000|Overall Study|Adverse Event|32
6957449|NCT01061567|11001671|FG000|Overall Study|Death|2
6957450|NCT01061567|11001671|FG000|Overall Study|Lack of Efficacy|3
6957451|NCT01061567|11001671|FG000|Overall Study|Lost to Follow-up|24
6957452|NCT01061567|11001671|FG000|Overall Study|Protocol Violation|1
6957453|NCT01061567|11001671|FG000|Overall Study|Withdrawal by Subject|11
6957454|NCT01061567|11001671|FG000|Overall Study|Other reason than stated above|3
6957455|NCT01061606|11001675|FG000|Overall Study|Adverse Event|1
6957456|NCT01061606|11001675|FG000|Overall Study|Death|1
6957457|NCT01061606|11001675|FG000|Overall Study|Disease Progression|4
6957458|NCT01061606|11001675|FG000|Overall Study|alternative therapy|2
6957459|NCT01061671|11001681|FG000|Overall Study|Withdrawal by Subject|16
6957460|NCT01061671|11001682|FG001|Overall Study|Withdrawal by Subject|20
6957461|NCT01061671|11001681|FG000|Overall Study|Lost to Follow-up|3
6957462|NCT01061671|11001682|FG001|Overall Study|Lost to Follow-up|5
6957463|NCT01061671|11001681|FG000|Overall Study|Death|28
6957464|NCT01061671|11001682|FG001|Overall Study|Death|30
6957465|NCT01061710|11001688|FG000|Overall Study|Protocol Violation|14
6957466|NCT01061723|11001698|FG000|Overall Study|Adverse Event|0
6957467|NCT01061723|11001699|FG001|Overall Study|Adverse Event|2
6957468|NCT01061723|11001700|FG002|Overall Study|Adverse Event|5
6957469|NCT01061723|11001701|FG003|Overall Study|Adverse Event|5
6957470|NCT01061723|11001702|FG004|Overall Study|Adverse Event|2
6957471|NCT01061723|11001703|FG005|Overall Study|Adverse Event|6
6957472|NCT01061723|11001698|FG000|Overall Study|Lack of Efficacy|2
6957473|NCT01061723|11001699|FG001|Overall Study|Lack of Efficacy|3
6957474|NCT01061723|11001700|FG002|Overall Study|Lack of Efficacy|4
6957475|NCT01061723|11001701|FG003|Overall Study|Lack of Efficacy|2
6957476|NCT01061723|11001702|FG004|Overall Study|Lack of Efficacy|1
6957477|NCT01061723|11001703|FG005|Overall Study|Lack of Efficacy|1
6957478|NCT01061723|11001698|FG000|Overall Study|Randomized but not treated|0
6957479|NCT01061723|11001699|FG001|Overall Study|Randomized but not treated|0
6957480|NCT01061723|11001700|FG002|Overall Study|Randomized but not treated|0
6957481|NCT01061723|11001701|FG003|Overall Study|Randomized but not treated|0
6957482|NCT01061723|11001702|FG004|Overall Study|Randomized but not treated|0
6957483|NCT01061723|11001703|FG005|Overall Study|Randomized but not treated|1
6957484|NCT01061723|11001698|FG000|Overall Study|Other than specified above|2
6957485|NCT01061723|11001699|FG001|Overall Study|Other than specified above|1
6957486|NCT01061723|11001700|FG002|Overall Study|Other than specified above|1
6957487|NCT01061723|11001701|FG003|Overall Study|Other than specified above|1
6957488|NCT01061723|11001702|FG004|Overall Study|Other than specified above|0
6957489|NCT01061723|11001703|FG005|Overall Study|Other than specified above|1
6957490|NCT01061736|11001732|FG000|Overall Study|Dose regimen not selected|0
6957491|NCT01061736|11001733|FG001|Overall Study|Dose regimen not selected|0
6957492|NCT01061736|11001734|FG002|Overall Study|Dose regimen not selected|0
6957493|NCT01061736|11001735|FG003|Overall Study|Dose regimen not selected|0
6957494|NCT01061736|11001736|FG004|Overall Study|Dose regimen not selected|0
6957495|NCT01061736|11001737|FG005|Overall Study|Dose regimen not selected|0
6957496|NCT01061736|11001738|FG006|Overall Study|Dose regimen not selected|79
6957497|NCT01061736|11001739|FG007|Overall Study|Dose regimen not selected|0
6957498|NCT01061736|11001740|FG008|Overall Study|Dose regimen not selected|0
6957499|NCT01061736|11001741|FG009|Overall Study|Dose regimen not selected|0
6957500|NCT01061736|11001732|FG000|Overall Study|Adverse Event|13
6957501|NCT01061736|11001733|FG001|Overall Study|Adverse Event|1
6957502|NCT01061736|11001734|FG002|Overall Study|Adverse Event|3
6957503|NCT01061736|11001735|FG003|Overall Study|Adverse Event|2
6957504|NCT01061736|11001736|FG004|Overall Study|Adverse Event|4
6957505|NCT01061736|11001737|FG005|Overall Study|Adverse Event|1
6957506|NCT01061736|11001738|FG006|Overall Study|Adverse Event|4
6957507|NCT01061736|11001739|FG007|Overall Study|Adverse Event|63
6957508|NCT01061736|11001740|FG008|Overall Study|Adverse Event|67
7072018|NCT02031640|11175817|FG004|Run-In Period|Withdrawal by Subject|0
7072019|NCT02031640|11175818|FG005|Run-In Period|Withdrawal by Subject|0
7072020|NCT02031640|11175813|FG000|Run-In Period|Inclusion criteria not met|38
7072021|NCT02031640|11175814|FG001|Run-In Period|Inclusion criteria not met|0
7072022|NCT02031640|11175815|FG002|Run-In Period|Inclusion criteria not met|0
7072023|NCT02031640|11175816|FG003|Run-In Period|Inclusion criteria not met|0
7072024|NCT02031640|11175817|FG004|Run-In Period|Inclusion criteria not met|0
7072025|NCT02031640|11175818|FG005|Run-In Period|Inclusion criteria not met|0
7072026|NCT02031640|11175813|FG000|Run-In Period|Exclusion criteria met|8
7072027|NCT02031640|11175814|FG001|Run-In Period|Exclusion criteria met|0
7072028|NCT02031640|11175815|FG002|Run-In Period|Exclusion criteria met|0
7072029|NCT02031640|11175816|FG003|Run-In Period|Exclusion criteria met|0
7072030|NCT02031640|11175817|FG004|Run-In Period|Exclusion criteria met|0
7072031|NCT02031640|11175818|FG005|Run-In Period|Exclusion criteria met|0
7072032|NCT02031640|11175813|FG000|Run-In Period|Randomization criteria not met|85
7072033|NCT02031640|11175814|FG001|Run-In Period|Randomization criteria not met|0
7072034|NCT02031640|11175815|FG002|Run-In Period|Randomization criteria not met|0
7072035|NCT02031640|11175816|FG003|Run-In Period|Randomization criteria not met|0
7072036|NCT02031640|11175817|FG004|Run-In Period|Randomization criteria not met|0
7072037|NCT02031640|11175818|FG005|Run-In Period|Randomization criteria not met|0
7072038|NCT02031640|11175813|FG000|Run-In Period|Various administrative reasons|17
7072039|NCT02031640|11175814|FG001|Run-In Period|Various administrative reasons|0
7072040|NCT02031640|11175815|FG002|Run-In Period|Various administrative reasons|0
7072041|NCT02031640|11175816|FG003|Run-In Period|Various administrative reasons|0
7072042|NCT02031640|11175817|FG004|Run-In Period|Various administrative reasons|0
7072043|NCT02031640|11175818|FG005|Run-In Period|Various administrative reasons|0
7072044|NCT02031640|11175813|FG000|Double-blind Treatment Period|Protocol deviation|0
7072045|NCT02031640|11175814|FG001|Double-blind Treatment Period|Protocol deviation|2
7072046|NCT02031640|11175815|FG002|Double-blind Treatment Period|Protocol deviation|0
7072047|NCT02031640|11175816|FG003|Double-blind Treatment Period|Protocol deviation|1
7072048|NCT02031640|11175817|FG004|Double-blind Treatment Period|Protocol deviation|3
7072049|NCT02031640|11175818|FG005|Double-blind Treatment Period|Protocol deviation|1
7072050|NCT02031640|11175813|FG000|Double-blind Treatment Period|Lack of Efficacy|0
7072051|NCT02031640|11175814|FG001|Double-blind Treatment Period|Lack of Efficacy|14
7072052|NCT02031640|11175815|FG002|Double-blind Treatment Period|Lack of Efficacy|3
7072053|NCT02031640|11175816|FG003|Double-blind Treatment Period|Lack of Efficacy|2
7072054|NCT02031640|11175817|FG004|Double-blind Treatment Period|Lack of Efficacy|5
7072055|NCT02031640|11175818|FG005|Double-blind Treatment Period|Lack of Efficacy|1
7072056|NCT02031640|11175813|FG000|Double-blind Treatment Period|Non-compliance|0
7072057|NCT02031640|11175814|FG001|Double-blind Treatment Period|Non-compliance|1
7072058|NCT02031640|11175815|FG002|Double-blind Treatment Period|Non-compliance|0
7072059|NCT02031640|11175816|FG003|Double-blind Treatment Period|Non-compliance|1
7072060|NCT02031640|11175817|FG004|Double-blind Treatment Period|Non-compliance|1
7072061|NCT02031640|11175818|FG005|Double-blind Treatment Period|Non-compliance|0
7072062|NCT02031640|11175813|FG000|Double-blind Treatment Period|Adverse Event|0
7072063|NCT02031640|11175814|FG001|Double-blind Treatment Period|Adverse Event|0
7072064|NCT02031640|11175815|FG002|Double-blind Treatment Period|Adverse Event|0
7072065|NCT02031640|11175816|FG003|Double-blind Treatment Period|Adverse Event|2
7072066|NCT02031640|11175817|FG004|Double-blind Treatment Period|Adverse Event|0
7072067|NCT02031640|11175818|FG005|Double-blind Treatment Period|Adverse Event|0
6957509|NCT01061736|11001741|FG009|Overall Study|Adverse Event|34
6957510|NCT01061736|11001732|FG000|Overall Study|Lack of Efficacy|0
7072068|NCT02031640|11175813|FG000|Double-blind Treatment Period|Withdrawal by Subject|0
7072069|NCT02031640|11175814|FG001|Double-blind Treatment Period|Withdrawal by Subject|2
7072070|NCT02031640|11175815|FG002|Double-blind Treatment Period|Withdrawal by Subject|3
7072071|NCT02031640|11175816|FG003|Double-blind Treatment Period|Withdrawal by Subject|1
7072072|NCT02031640|11175817|FG004|Double-blind Treatment Period|Withdrawal by Subject|1
7072073|NCT02031640|11175818|FG005|Double-blind Treatment Period|Withdrawal by Subject|1
7072074|NCT02031640|11175813|FG000|Double-blind Treatment Period|Lost to Follow-up|0
7072075|NCT02031640|11175814|FG001|Double-blind Treatment Period|Lost to Follow-up|3
6957511|NCT01061736|11001733|FG001|Overall Study|Lack of Efficacy|2
6957512|NCT01061736|11001734|FG002|Overall Study|Lack of Efficacy|1
7072076|NCT02031640|11175815|FG002|Double-blind Treatment Period|Lost to Follow-up|0
7072077|NCT02031640|11175816|FG003|Double-blind Treatment Period|Lost to Follow-up|0
7072078|NCT02031640|11175817|FG004|Double-blind Treatment Period|Lost to Follow-up|1
7072079|NCT02031640|11175818|FG005|Double-blind Treatment Period|Lost to Follow-up|0
7072080|NCT02031679|11175839|FG000|Overall Study|Protocol Violation|0
7072081|NCT02031679|11175840|FG001|Overall Study|Protocol Violation|1
7072082|NCT02031679|11175839|FG000|Overall Study|Lack of Efficacy|0
7072083|NCT02031679|11175840|FG001|Overall Study|Lack of Efficacy|1
7072084|NCT02032173|11175853|FG000|Overall Study|Discontinuation due to sponsor decision|31
7072085|NCT02032238|11175876|FG000|Overall Study|Lost to Follow-up|2
7072086|NCT02032238|11175877|FG001|Overall Study|Lost to Follow-up|0
7072087|NCT02032407|11175883|FG000|Overall Study|Lost to Follow-up|2
7072088|NCT02032407|11175883|FG000|Overall Study|Pregnancy|1
7072089|NCT02032407|11175883|FG000|Overall Study|Other Miscellaneous Reasons|2
7082676|NCT02144012|11193252|FG001|Overall Study|Study Terminated by Sponsor|12
7082677|NCT02144012|11193251|FG000|Overall Study|Other|3
7082678|NCT02144012|11193252|FG001|Overall Study|Other|0
7082679|NCT02144077|11193260|FG000|Overall Study|Withdrawal by Subject|3
7082680|NCT02144077|11193261|FG001|Overall Study|Withdrawal by Subject|3
7082681|NCT02144077|11193260|FG000|Overall Study|Adverse Event|2
7082682|NCT02144077|11193261|FG001|Overall Study|Adverse Event|3
7082683|NCT02144077|11193260|FG000|Overall Study|Lost to Follow-up|2
7082684|NCT02144077|11193261|FG001|Overall Study|Lost to Follow-up|2
7082685|NCT02144077|11193260|FG000|Overall Study|Protocol Violation|1
7082686|NCT02144077|11193261|FG001|Overall Study|Protocol Violation|2
7082687|NCT02144077|11193260|FG000|Overall Study|Death|0
7082688|NCT02144077|11193261|FG001|Overall Study|Death|1
7082689|NCT02144077|11193260|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2
7082690|NCT02144077|11193261|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0
7082691|NCT02144220|11193267|FG000|Overall Study|technology incompatibility|9
7082692|NCT02144220|11193267|FG000|Overall Study|Lack of Efficacy|4
7082693|NCT02144220|11193267|FG000|Overall Study|Physician Decision|3
7082694|NCT02144220|11193267|FG000|Overall Study|Withdrawal by Subject|2
6838513|NCT00260065|10844248|FG000|Overall Study|Medication Noncompliance|1
6838514|NCT00260208|10844264|FG000|Overall Study|Subject withdrew consent|11
6838515|NCT00260208|10844265|FG001|Overall Study|Subject withdrew consent|7
6838516|NCT00260208|10844264|FG000|Overall Study|Lost to Follow-up|6
6838517|NCT00260208|10844265|FG001|Overall Study|Lost to Follow-up|1
6838518|NCT00260208|10844264|FG000|Overall Study|Death|12
6838519|NCT00260208|10844265|FG001|Overall Study|Death|10
6838520|NCT00260208|10844264|FG000|Overall Study|Missing|18
6838521|NCT00260208|10844265|FG001|Overall Study|Missing|16
6838522|NCT00260429|10844273|FG000|Overall Study|failure to follow appointments|1
6957513|NCT01061736|11001735|FG003|Overall Study|Lack of Efficacy|1
6957514|NCT01061736|11001736|FG004|Overall Study|Lack of Efficacy|1
6957515|NCT01061736|11001737|FG005|Overall Study|Lack of Efficacy|2
6957516|NCT01061736|11001738|FG006|Overall Study|Lack of Efficacy|1
6957517|NCT01061736|11001739|FG007|Overall Study|Lack of Efficacy|9
6957518|NCT01061736|11001740|FG008|Overall Study|Lack of Efficacy|9
6957519|NCT01061736|11001741|FG009|Overall Study|Lack of Efficacy|10
6957520|NCT01061736|11001732|FG000|Overall Study|Poor compliance to protocol|0
6957521|NCT01061736|11001733|FG001|Overall Study|Poor compliance to protocol|0
6957522|NCT01061736|11001734|FG002|Overall Study|Poor compliance to protocol|0
6957523|NCT01061736|11001735|FG003|Overall Study|Poor compliance to protocol|0
6957524|NCT01061736|11001736|FG004|Overall Study|Poor compliance to protocol|0
6957525|NCT01061736|11001737|FG005|Overall Study|Poor compliance to protocol|0
6957526|NCT01061736|11001738|FG006|Overall Study|Poor compliance to protocol|0
6957527|NCT01061736|11001739|FG007|Overall Study|Poor compliance to protocol|2
6957528|NCT01061736|11001740|FG008|Overall Study|Poor compliance to protocol|5
6957529|NCT01061736|11001741|FG009|Overall Study|Poor compliance to protocol|9
6957530|NCT01061736|11001732|FG000|Overall Study|Not treated|0
6957531|NCT01061736|11001733|FG001|Overall Study|Not treated|0
6957532|NCT01061736|11001734|FG002|Overall Study|Not treated|0
6957533|NCT01061736|11001735|FG003|Overall Study|Not treated|0
6957534|NCT01061736|11001736|FG004|Overall Study|Not treated|1
6957535|NCT01061736|11001737|FG005|Overall Study|Not treated|0
6957536|NCT01061736|11001738|FG006|Overall Study|Not treated|0
6957537|NCT01061736|11001739|FG007|Overall Study|Not treated|2
6957538|NCT01061736|11001740|FG008|Overall Study|Not treated|1
6957539|NCT01061736|11001741|FG009|Overall Study|Not treated|0
6957540|NCT01061736|11001732|FG000|Overall Study|Other than specified above|0
6957541|NCT01061736|11001733|FG001|Overall Study|Other than specified above|1
6957542|NCT01061736|11001734|FG002|Overall Study|Other than specified above|2
7082695|NCT02144220|11193267|FG000|Overall Study|Protocol Violation|1
7082696|NCT02144285|11193303|FG000|Overall Study|Withdrawal by Subject|0
7082697|NCT02144285|11193304|FG001|Overall Study|Withdrawal by Subject|0
7082698|NCT02144285|11193305|FG002|Overall Study|Withdrawal by Subject|0
7082699|NCT02144285|11193306|FG003|Overall Study|Withdrawal by Subject|0
6838523|NCT00260429|10844274|FG001|Overall Study|failure to follow appointments|0
6838524|NCT00260429|10844273|FG000|Overall Study|scheduled hand surgery|1
6957543|NCT01061736|11001735|FG003|Overall Study|Other than specified above|0
6838525|NCT00260429|10844274|FG001|Overall Study|scheduled hand surgery|0
6957544|NCT01061736|11001736|FG004|Overall Study|Other than specified above|1
6957545|NCT01061736|11001737|FG005|Overall Study|Other than specified above|0
6957546|NCT01061736|11001738|FG006|Overall Study|Other than specified above|0
6957547|NCT01061736|11001739|FG007|Overall Study|Other than specified above|18
6957548|NCT01061736|11001740|FG008|Overall Study|Other than specified above|15
6957549|NCT01061736|11001741|FG009|Overall Study|Other than specified above|21
6976337|NCT01198574|11028889|FG003|Overall Study|Resigned from schools|4
6976338|NCT01198587|11028903|FG000|Overall Study|Lost to Follow-up|8
6976339|NCT01198587|11028904|FG001|Overall Study|Lost to Follow-up|0
6976340|NCT01198587|11028905|FG002|Overall Study|Lost to Follow-up|9
6976341|NCT01198587|11028906|FG003|Overall Study|Lost to Follow-up|0
6976342|NCT01198600|11028921|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1
6976343|NCT01198600|11028922|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
6976344|NCT01198600|11028923|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
6976345|NCT01198600|11028924|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
6976346|NCT01198600|11028921|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1
6976347|NCT01198600|11028922|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
6976348|NCT01198600|11028923|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
6976349|NCT01198600|11028924|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
6976350|NCT01198600|11028921|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
6976351|NCT01198600|11028922|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1
6976352|NCT01198600|11028923|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
6976353|NCT01198600|11028924|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
6976354|NCT01198600|11028921|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
6976355|NCT01198600|11028922|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1
6976356|NCT01198600|11028923|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
6976357|NCT01198600|11028924|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
6976358|NCT01198600|11028921|FG000|Phase 2: 56 Days of Wear|Inconvenience|0
6976359|NCT01198600|11028922|FG001|Phase 2: 56 Days of Wear|Inconvenience|0
6976360|NCT01198600|11028923|FG002|Phase 2: 56 Days of Wear|Inconvenience|2
6976361|NCT01198600|11028924|FG003|Phase 2: 56 Days of Wear|Inconvenience|0
6976362|NCT01198600|11028921|FG000|Phase 2: 56 Days of Wear|Relocation|0
6976363|NCT01198600|11028922|FG001|Phase 2: 56 Days of Wear|Relocation|0
6976364|NCT01198600|11028923|FG002|Phase 2: 56 Days of Wear|Relocation|2
6976365|NCT01198600|11028924|FG003|Phase 2: 56 Days of Wear|Relocation|0
6976366|NCT01198600|11028921|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
6976367|NCT01198600|11028922|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
6976368|NCT01198600|11028923|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1
6976369|NCT01198600|11028924|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
6976370|NCT01198756|11028945|FG000|Overall Study|Adverse Event|0
6976371|NCT01198756|11028946|FG001|Overall Study|Adverse Event|0
6976372|NCT01198756|11028947|FG002|Overall Study|Adverse Event|0
6976373|NCT01198756|11028948|FG003|Overall Study|Adverse Event|1
6976374|NCT01198756|11028945|FG000|Overall Study|Protocol Violation|0
6976375|NCT01198756|11028946|FG001|Overall Study|Protocol Violation|0
6976376|NCT01198756|11028947|FG002|Overall Study|Protocol Violation|0
6976377|NCT01198756|11028948|FG003|Overall Study|Protocol Violation|2
6976378|NCT01198756|11028945|FG000|Overall Study|Withdrawal by Subject|9
6976379|NCT01198756|11028946|FG001|Overall Study|Withdrawal by Subject|4
6976380|NCT01198756|11028947|FG002|Overall Study|Withdrawal by Subject|7
6976381|NCT01198756|11028948|FG003|Overall Study|Withdrawal by Subject|5
6976382|NCT01198756|11028945|FG000|Overall Study|Lost to Follow-up|29
6976383|NCT01198756|11028946|FG001|Overall Study|Lost to Follow-up|36
6976384|NCT01198756|11028947|FG002|Overall Study|Lost to Follow-up|23
6976385|NCT01198756|11028948|FG003|Overall Study|Lost to Follow-up|18
6976386|NCT01198795|11028969|FG000|Overall Study|Did not meet InclusionExclusion criteria|30
6976387|NCT01198795|11028969|FG000|Overall Study|Withdrawal by Subject|17
6976388|NCT01198795|11028969|FG000|Overall Study|Lost to Follow-up|15
6976389|NCT01198795|11028969|FG000|Overall Study|Adverse Event|9
6976390|NCT01198795|11028969|FG000|Overall Study|Lack of Efficacy|5
6976391|NCT01198795|11028969|FG000|Overall Study|Protocol Violation|2
6976392|NCT01198795|11028969|FG000|Overall Study|Other Reason|4
6976393|NCT01198873|11028975|FG000|Overall Study|Adverse Event|4
6976394|NCT01198873|11028976|FG001|Overall Study|Adverse Event|7
6976395|NCT01198873|11028975|FG000|Overall Study|Study closure|29
6976396|NCT01198873|11028976|FG001|Overall Study|Study closure|23
6976397|NCT01198873|11028975|FG000|Overall Study|Other than above|4
6976398|NCT01198873|11028976|FG001|Overall Study|Other than above|2
6976399|NCT01198977|11028984|FG000|Overall Study|Lost to Follow-up|1
6976400|NCT01198977|11028985|FG001|Overall Study|Lost to Follow-up|0
6976401|NCT01199016|11028993|FG000|Overall Study|No longer meets eligibility criteria|4
6976402|NCT01199016|11028993|FG000|Overall Study|Entrance criteria|5
6976403|NCT01199016|11028993|FG000|Overall Study|Protocol Violation|9
6976404|NCT01199016|11028993|FG000|Overall Study|Other|13
6976405|NCT01199016|11028993|FG000|Overall Study|Withdrawal by Subject|21
6976406|NCT01199016|11028993|FG000|Overall Study|Lost to Follow-up|25
6976407|NCT01199042|11028997|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2
6976408|NCT01199042|11028997|FG000|At Home (3 Months)|Lost to Follow-up|1
6976409|NCT01199055|11029009|FG000|Overall Study|Death|0
6976410|NCT01199055|11029010|FG001|Overall Study|Death|1
6976411|NCT01199055|11029011|FG002|Overall Study|Death|0
6976412|NCT01199055|11029009|FG000|Overall Study|Physician Decision|0
6957550|NCT01061775|11001766|FG000|Overall Study|Physician Decision|2
6957551|NCT01061775|11001766|FG000|Overall Study|Lost to Follow-up|1
6957552|NCT01061866|11001771|FG000|Overall Study|Adverse Event|2
6957553|NCT01062061|11001792|FG000|Overall Study|Enrolled more than once|2
6957554|NCT01062061|11001792|FG000|Overall Study|Investigated before study start|13
6957555|NCT01062061|11001792|FG000|Overall Study|Outside chief indications|10
6957556|NCT01062061|11001792|FG000|Overall Study|Failed to meet inclusion criteria|2
6957557|NCT01062113|11001807|FG000|Overall Study|Adverse Event|1
6957558|NCT01062113|11001808|FG001|Overall Study|Adverse Event|0
6957559|NCT01062113|11001809|FG002|Overall Study|Adverse Event|0
6957560|NCT01062113|11001807|FG000|Overall Study|Lack of Efficacy|38
6957561|NCT01062113|11001808|FG001|Overall Study|Lack of Efficacy|22
6957562|NCT01062113|11001809|FG002|Overall Study|Lack of Efficacy|31
6957563|NCT01062113|11001807|FG000|Overall Study|Withdrawal by Subject|1
6957564|NCT01062113|11001808|FG001|Overall Study|Withdrawal by Subject|0
6957565|NCT01062113|11001809|FG002|Overall Study|Withdrawal by Subject|0
6957566|NCT01062126|11001817|FG000|Overall Study|Death|209
6957567|NCT01062126|11001817|FG000|Overall Study|All Withdrawals|324
6957568|NCT01062256|11001832|FG000|Overall Study|Adverse Event|1
6957569|NCT01062256|11001833|FG001|Overall Study|Adverse Event|0
6957570|NCT01062256|11001834|FG002|Overall Study|Adverse Event|0
6957571|NCT01062256|11001832|FG000|Overall Study|Withdrawal by Subject|1
6957572|NCT01062256|11001833|FG001|Overall Study|Withdrawal by Subject|1
6957573|NCT01062256|11001834|FG002|Overall Study|Withdrawal by Subject|1
6957574|NCT01062256|11001832|FG000|Overall Study|Ineligible|1
6957575|NCT01062256|11001833|FG001|Overall Study|Ineligible|4
6957576|NCT01062256|11001834|FG002|Overall Study|Ineligible|3
6957577|NCT01062256|11001832|FG000|Overall Study|Administrative|0
6957578|NCT01062256|11001833|FG001|Overall Study|Administrative|2
6957579|NCT01062256|11001834|FG002|Overall Study|Administrative|0
6957580|NCT01062555|11001861|FG000|Phase 1|Death|10
6957581|NCT01062555|11001862|FG001|Phase 1|Death|17
6957582|NCT01062555|11001863|FG002|Phase 1|Death|0
6957583|NCT01062555|11001864|FG003|Phase 1|Death|0
6957584|NCT01062555|11001861|FG000|Phase 1|Graft Failure|12
6957585|NCT01062555|11001862|FG001|Phase 1|Graft Failure|8
6957586|NCT01062555|11001863|FG002|Phase 1|Graft Failure|0
6957587|NCT01062555|11001864|FG003|Phase 1|Graft Failure|0
6957588|NCT01062555|11001861|FG000|Phase 1|Withdrawal by Subject|1
6957589|NCT01062555|11001862|FG001|Phase 1|Withdrawal by Subject|1
6957590|NCT01062555|11001863|FG002|Phase 1|Withdrawal by Subject|0
6957591|NCT01062555|11001864|FG003|Phase 1|Withdrawal by Subject|0
6957592|NCT01062555|11001861|FG000|Phase 2|Death|0
6957593|NCT01062555|11001862|FG001|Phase 2|Death|0
6957594|NCT01062555|11001863|FG002|Phase 2|Death|8
6957595|NCT01062555|11001864|FG003|Phase 2|Death|3
6957596|NCT01062555|11001861|FG000|Phase 2|Graft failure|0
6957597|NCT01062555|11001862|FG001|Phase 2|Graft failure|0
6957598|NCT01062555|11001863|FG002|Phase 2|Graft failure|7
6957599|NCT01062555|11001864|FG003|Phase 2|Graft failure|4
6957600|NCT01062555|11001861|FG000|Phase 2|Withdrawal by Subject|0
6957601|NCT01062555|11001862|FG001|Phase 2|Withdrawal by Subject|0
6957602|NCT01062555|11001863|FG002|Phase 2|Withdrawal by Subject|0
6957603|NCT01062555|11001864|FG003|Phase 2|Withdrawal by Subject|7
6957604|NCT01062555|11001861|FG000|Phase 2|Protocol Violation|0
6957605|NCT01062555|11001862|FG001|Phase 2|Protocol Violation|0
6957606|NCT01062555|11001863|FG002|Phase 2|Protocol Violation|0
6957607|NCT01062555|11001864|FG003|Phase 2|Protocol Violation|3
6957608|NCT01062555|11001861|FG000|Phase 2|Physician Decision|0
6957609|NCT01062555|11001862|FG001|Phase 2|Physician Decision|0
6957610|NCT01062555|11001863|FG002|Phase 2|Physician Decision|0
6957611|NCT01062555|11001864|FG003|Phase 2|Physician Decision|17
6957612|NCT01062763|11001890|FG000|Overall Study|Adverse Event|3
6957613|NCT01062763|11001891|FG001|Overall Study|Adverse Event|4
6957614|NCT01062841|11001899|FG000|Overall Study|Indwelling Device Removed|41
6957615|NCT01062841|11001900|FG001|Overall Study|Indwelling Device Removed|48
6957616|NCT01062841|11001899|FG000|Overall Study|Death|3
6957617|NCT01062841|11001900|FG001|Overall Study|Death|5
6957618|NCT01062841|11001899|FG000|Overall Study|Withdrawal by Subject|2
6957619|NCT01062841|11001900|FG001|Overall Study|Withdrawal by Subject|0
6957620|NCT01062841|11001899|FG000|Overall Study|Withdrawal by Study|3
6957621|NCT01062841|11001900|FG001|Overall Study|Withdrawal by Study|0
6957622|NCT01062971|11001917|FG000|Overall Study|Protocol Violation|1
6957623|NCT01062971|11001918|FG001|Overall Study|Protocol Violation|3
6957624|NCT01062971|11001917|FG000|Overall Study|Lost to Follow-up|3
6957625|NCT01062971|11001918|FG001|Overall Study|Lost to Follow-up|4
6957626|NCT01063036|11001924|FG000|Participants Treated With Study Drug|Adverse Event|1
6957627|NCT01063036|11001924|FG000|Participants Treated With Study Drug|Protocol Violation|1
6957628|NCT01063036|11001924|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2
6957629|NCT01063036|11001924|FG000|Participants Treated With Study Drug|Lost to Follow-up|1
6957630|NCT01063036|11001924|FG000|Participants Treated With Study Drug|Pregnancy|1
6957631|NCT01063036|11001924|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1
6957632|NCT01063036|11001924|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6
6957633|NCT01063036|11001924|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32
6957634|NCT01063062|11001943|FG000|Overall Study|Patient withdrew consent|0
6957635|NCT01063062|11001944|FG001|Overall Study|Patient withdrew consent|1
6957636|NCT01063062|11001943|FG000|Overall Study|Adverse Event|2
6957637|NCT01063062|11001944|FG001|Overall Study|Adverse Event|4
6957638|NCT01063062|11001943|FG000|Overall Study|Protocol Violation|5
6957639|NCT01063062|11001944|FG001|Overall Study|Protocol Violation|4
6957640|NCT01063062|11001943|FG000|Overall Study|Investigator's request|1
6957641|NCT01063062|11001944|FG001|Overall Study|Investigator's request|0
6957642|NCT01063062|11001943|FG000|Overall Study|Lost to Follow-up|0
6957643|NCT01063062|11001944|FG001|Overall Study|Lost to Follow-up|2
6957644|NCT01063062|11001943|FG000|Overall Study|Miscellaneous reason|0
6957645|NCT01063062|11001944|FG001|Overall Study|Miscellaneous reason|1
6957646|NCT01063153|11001966|FG000|Overall Study|Found Ineligible During Screening|2
6957647|NCT01063153|11001967|FG001|Overall Study|Found Ineligible During Screening|0
6957648|NCT01063153|11001966|FG000|Overall Study|Lost to Follow-up|0
6957649|NCT01063153|11001967|FG001|Overall Study|Lost to Follow-up|7
6957650|NCT01063153|11001966|FG000|Overall Study|Withdrawal by Subject|0
6957651|NCT01063153|11001967|FG001|Overall Study|Withdrawal by Subject|1
6957652|NCT01063153|11001966|FG000|Overall Study|Physician Decision|0
6957653|NCT01063153|11001967|FG001|Overall Study|Physician Decision|4
6957654|NCT01063283|11001979|FG000|Cycle 1|Adverse Event|2
6957655|NCT01063283|11001980|FG001|Cycle 1|Adverse Event|0
6957656|NCT01063283|11001981|FG002|Cycle 1|Adverse Event|0
6957657|NCT01063283|11001979|FG000|Cycle 1|Technical failure in data collection|1
6957658|NCT01063283|11001980|FG001|Cycle 1|Technical failure in data collection|0
6957659|NCT01063283|11001981|FG002|Cycle 1|Technical failure in data collection|0
6957660|NCT01063348|11001989|FG000|Overall Study|Lost to Follow-up|3
6957661|NCT01063348|11001990|FG001|Overall Study|Lost to Follow-up|10
6957662|NCT01063595|11001996|FG000|Enrolled in Study and Randomized|Reason not Specified|1
6957663|NCT01063595|11001997|FG001|Enrolled in Study and Randomized|Reason not Specified|0
6957664|NCT01063595|11001996|FG000|Enrolled in Study and Randomized|Adverse Event|0
6957665|NCT01063595|11001997|FG001|Enrolled in Study and Randomized|Adverse Event|1
6957666|NCT01063595|11001996|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0
6957667|NCT01063595|11001997|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1
6957668|NCT01063595|11001996|FG000|First Intervention|Adverse Event|1
6957669|NCT01063595|11001997|FG001|First Intervention|Adverse Event|4
6957670|NCT01063595|11001996|FG000|First Intervention|Withdrawal by Subject|1
6957671|NCT01063595|11001997|FG001|First Intervention|Withdrawal by Subject|0
6957672|NCT01063595|11001996|FG000|First Intervention|Reason not Specified|0
6957673|NCT01063595|11001997|FG001|First Intervention|Reason not Specified|1
6957674|NCT01063764|11002008|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4
6957675|NCT01063764|11002008|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6
6957676|NCT01063764|11002008|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1
6957677|NCT01063764|11002008|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3
6957678|NCT01063764|11002008|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9
6957679|NCT01063764|11002008|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7
6957680|NCT01063764|11002008|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1
6957681|NCT01063855|11002031|FG000|Overall Study|Adverse Event|4
6957682|NCT01063855|11002032|FG001|Overall Study|Adverse Event|4
6957683|NCT01063855|11002031|FG000|Overall Study|Death|0
6957684|NCT01063855|11002032|FG001|Overall Study|Death|1
6957685|NCT01063855|11002031|FG000|Overall Study|Lost to Follow-up|8
6957686|NCT01063855|11002032|FG001|Overall Study|Lost to Follow-up|4
6957687|NCT01063855|11002031|FG000|Overall Study|Pregnancy|1
6957688|NCT01063855|11002032|FG001|Overall Study|Pregnancy|0
6957689|NCT01063855|11002031|FG000|Overall Study|Lack of Efficacy|0
6957690|NCT01063855|11002032|FG001|Overall Study|Lack of Efficacy|1
6957691|NCT01063855|11002031|FG000|Overall Study|Withdrawal by Subject|11
6957692|NCT01063855|11002032|FG001|Overall Study|Withdrawal by Subject|8
6957693|NCT01063855|11002031|FG000|Overall Study|Reason not specified|13
6957694|NCT01063855|11002032|FG001|Overall Study|Reason not specified|11
6957695|NCT01063868|11002044|FG000|Overall Study|Adverse Event|9
6957696|NCT01063868|11002045|FG001|Overall Study|Adverse Event|7
6957697|NCT01063868|11002044|FG000|Overall Study|Withdrawal by Subject|3
6957698|NCT01063868|11002045|FG001|Overall Study|Withdrawal by Subject|1
6957699|NCT01063868|11002044|FG000|Overall Study|Study Terminated By Sponsor|23
6957700|NCT01063868|11002045|FG001|Overall Study|Study Terminated By Sponsor|4
6957701|NCT01063881|11002054|FG000|Overall Study|Adverse Event|12
6957702|NCT01063881|11002055|FG001|Overall Study|Adverse Event|2
6957703|NCT01063881|11002056|FG002|Overall Study|Adverse Event|0
6957704|NCT01063881|11002054|FG000|Overall Study|Lost to Follow-up|13
6957705|NCT01063881|11002055|FG001|Overall Study|Lost to Follow-up|7
6957706|NCT01063881|11002056|FG002|Overall Study|Lost to Follow-up|1
6957707|NCT01063881|11002054|FG000|Overall Study|Withdrawal by Subject|25
6957708|NCT01063881|11002055|FG001|Overall Study|Withdrawal by Subject|1
6957709|NCT01063881|11002056|FG002|Overall Study|Withdrawal by Subject|0
6957710|NCT01063881|11002054|FG000|Overall Study|Reason for not completed not specified|5
6957711|NCT01063881|11002055|FG001|Overall Study|Reason for not completed not specified|1
6957712|NCT01063881|11002056|FG002|Overall Study|Reason for not completed not specified|0
6957713|NCT01063972|11002096|FG000|Overall Study|Death|12
6957714|NCT01063972|11002097|FG001|Overall Study|Death|11
6957715|NCT01063972|11002096|FG000|Overall Study|Incarcerated|2
6957716|NCT01063972|11002097|FG001|Overall Study|Incarcerated|1
6957717|NCT01064167|11002110|FG000|Overall Study|Protocol Violation|14
6957718|NCT01064167|11002111|FG001|Overall Study|Protocol Violation|15
6957719|NCT01064297|11002130|FG000|Overall Study|Lost to Follow-up|791
6957720|NCT01064297|11002131|FG001|Overall Study|Lost to Follow-up|48
6957721|NCT01064297|11002132|FG002|Overall Study|Lost to Follow-up|133
6957722|NCT01064310|11002149|FG000|Period 1|Adverse Event|7
6957723|NCT01064310|11002150|FG001|Period 1|Adverse Event|10
6957724|NCT01064310|11002151|FG002|Period 1|Adverse Event|0
6957725|NCT01064310|11002149|FG000|Period 1|Physician Decision|1
6957726|NCT01064310|11002150|FG001|Period 1|Physician Decision|0
6957727|NCT01064310|11002151|FG002|Period 1|Physician Decision|0
6957728|NCT01064310|11002149|FG000|Period 1|Withdrawal by Subject|2
6957729|NCT01064310|11002150|FG001|Period 1|Withdrawal by Subject|2
6957730|NCT01064310|11002151|FG002|Period 1|Withdrawal by Subject|0
6957731|NCT01064310|11002149|FG000|Period 1|Lack of Efficacy|3
6957732|NCT01064310|11002150|FG001|Period 1|Lack of Efficacy|5
6957733|NCT01064310|11002151|FG002|Period 1|Lack of Efficacy|0
6957734|NCT01064310|11002149|FG000|Period 1|Entered Open-label Period|1
6957735|NCT01064310|11002150|FG001|Period 1|Entered Open-label Period|1
6957736|NCT01064310|11002151|FG002|Period 1|Entered Open-label Period|0
6957737|NCT01064310|11002149|FG000|Period 2|Adverse Event|2
6957738|NCT01064310|11002150|FG001|Period 2|Adverse Event|1
6957739|NCT01064310|11002151|FG002|Period 2|Adverse Event|0
6957740|NCT01064310|11002149|FG000|Period 2|Physician Decision|0
6957741|NCT01064310|11002150|FG001|Period 2|Physician Decision|1
6957742|NCT01064310|11002151|FG002|Period 2|Physician Decision|0
6957743|NCT01064310|11002149|FG000|Period 2|Entered Open-label Period|1
6957744|NCT01064310|11002150|FG001|Period 2|Entered Open-label Period|0
6957745|NCT01064310|11002151|FG002|Period 2|Entered Open-label Period|0
6957746|NCT01064310|11002149|FG000|Period 2|Lack of Efficacy|1
6957747|NCT01064310|11002150|FG001|Period 2|Lack of Efficacy|4
6957748|NCT01064310|11002151|FG002|Period 2|Lack of Efficacy|0
6957749|NCT01064310|11002149|FG000|Open Label Pazopinib|Withdrawal by Subject|0
6957750|NCT01064310|11002150|FG001|Open Label Pazopinib|Withdrawal by Subject|0
6957751|NCT01064310|11002151|FG002|Open Label Pazopinib|Withdrawal by Subject|1
6957752|NCT01064310|11002149|FG000|Open Label Pazopinib|Adverse Event|0
6957753|NCT01064310|11002150|FG001|Open Label Pazopinib|Adverse Event|0
6957754|NCT01064310|11002151|FG002|Open Label Pazopinib|Adverse Event|12
6957755|NCT01064310|11002149|FG000|Open Label Pazopinib|Lack of Efficacy|0
6957756|NCT01064310|11002150|FG001|Open Label Pazopinib|Lack of Efficacy|0
6957757|NCT01064310|11002151|FG002|Open Label Pazopinib|Lack of Efficacy|51
6957758|NCT01064310|11002149|FG000|Open Label Pazopinib|Physician Decision|0
6957759|NCT01064310|11002150|FG001|Open Label Pazopinib|Physician Decision|0
6957760|NCT01064310|11002151|FG002|Open Label Pazopinib|Physician Decision|20
6957761|NCT01064401|11002175|FG000|Overall Study|Adverse Event|47
6957762|NCT01064401|11002176|FG001|Overall Study|Adverse Event|56
6957763|NCT01064401|11002175|FG000|Overall Study|Lack of Efficacy|46
6957764|NCT01064401|11002176|FG001|Overall Study|Lack of Efficacy|23
6957765|NCT01064401|11002175|FG000|Overall Study|Lost to Follow-up|12
6957766|NCT01064401|11002176|FG001|Overall Study|Lost to Follow-up|9
6957767|NCT01064401|11002175|FG000|Overall Study|Consent Withdrawn|98
6957768|NCT01064401|11002176|FG001|Overall Study|Consent Withdrawn|80
6957769|NCT01064401|11002175|FG000|Overall Study|Investigator Decision|4
6957770|NCT01064401|11002176|FG001|Overall Study|Investigator Decision|6
6957771|NCT01064401|11002175|FG000|Overall Study|Death|4
6957772|NCT01064401|11002176|FG001|Overall Study|Death|0
6957773|NCT01064401|11002175|FG000|Overall Study|Pregnancy|4
6957774|NCT01064401|11002176|FG001|Overall Study|Pregnancy|7
6957775|NCT01064401|11002175|FG000|Overall Study|Noncompliance|7
6957776|NCT01064401|11002176|FG001|Overall Study|Noncompliance|8
6957777|NCT01064401|11002175|FG000|Overall Study|Site Closure|4
6957778|NCT01064401|11002176|FG001|Overall Study|Site Closure|5
6957779|NCT01064401|11002175|FG000|Overall Study|Other|2
6957780|NCT01064401|11002176|FG001|Overall Study|Other|1
6957781|NCT01064414|11002186|FG000|Core Period: Baseline to Week 26|Adverse Event|4
6957782|NCT01064414|11002187|FG001|Core Period: Baseline to Week 26|Adverse Event|4
6957783|NCT01064414|11002188|FG002|Core Period: Baseline to Week 26|Adverse Event|2
6957784|NCT01064414|11002186|FG000|Core Period: Baseline to Week 26|Death|0
6957785|NCT01064414|11002187|FG001|Core Period: Baseline to Week 26|Death|1
6957786|NCT01064414|11002188|FG002|Core Period: Baseline to Week 26|Death|0
6957787|NCT01064414|11002186|FG000|Core Period: Baseline to Week 26|Protocol Violation|1
6957788|NCT01064414|11002187|FG001|Core Period: Baseline to Week 26|Protocol Violation|0
6957789|NCT01064414|11002188|FG002|Core Period: Baseline to Week 26|Protocol Violation|1
6957790|NCT01064414|11002186|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4
6957791|NCT01064414|11002187|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2
6957792|NCT01064414|11002188|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2
6957793|NCT01064414|11002186|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0
6957794|NCT01064414|11002187|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1
6957795|NCT01064414|11002188|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0
6957796|NCT01064414|11002186|FG000|Core Period: Baseline to Week 26|Other|4
6957797|NCT01064414|11002187|FG001|Core Period: Baseline to Week 26|Other|7
6957798|NCT01064414|11002188|FG002|Core Period: Baseline to Week 26|Other|2
6957799|NCT01064414|11002186|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2
6957800|NCT01064414|11002187|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1
6957801|NCT01064414|11002188|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2
6957802|NCT01064414|11002186|FG000|Extension Period: Week 26 to Week 52|Death|0
6957803|NCT01064414|11002187|FG001|Extension Period: Week 26 to Week 52|Death|1
6957804|NCT01064414|11002188|FG002|Extension Period: Week 26 to Week 52|Death|0
6957805|NCT01064414|11002186|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
6957806|NCT01064414|11002187|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
6957807|NCT01064414|11002188|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
6957808|NCT01064414|11002186|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1
6957809|NCT01064414|11002187|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0
6957810|NCT01064414|11002188|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0
6957811|NCT01064414|11002186|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
6957812|NCT01064414|11002187|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
7072090|NCT02032706|11175929|FG000|Overall Study|Did not qualify|5
7072091|NCT02032706|11175929|FG000|Overall Study|Protocol Violation|1
7072092|NCT02032875|11175944|FG000|Treatment Period|Adverse Event|1
6957813|NCT01064414|11002188|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
6957814|NCT01064414|11002186|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
6957815|NCT01064414|11002187|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
6957816|NCT01064414|11002188|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
6957817|NCT01064414|11002186|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1
6957818|NCT01064414|11002187|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1
6957819|NCT01064414|11002188|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1
6957820|NCT01064414|11002186|FG000|Extension Period: Week 26 to Week 52|Other|5
6957821|NCT01064414|11002187|FG001|Extension Period: Week 26 to Week 52|Other|2
6957822|NCT01064414|11002188|FG002|Extension Period: Week 26 to Week 52|Other|1
6957823|NCT01064531|11002201|FG000|Overall Study|Lost to Follow-up|0
6957824|NCT01064531|11002202|FG001|Overall Study|Lost to Follow-up|2
6957825|NCT01064531|11002201|FG000|Overall Study|Physician Decision|0
6957826|NCT01064531|11002202|FG001|Overall Study|Physician Decision|1
6957827|NCT01064531|11002201|FG000|Overall Study|Withdrawal by Subject|2
6957828|NCT01064531|11002202|FG001|Overall Study|Withdrawal by Subject|2
6957829|NCT01064531|11002201|FG000|Overall Study|Revision due to femoral stem loosening|1
6957830|NCT01064531|11002202|FG001|Overall Study|Revision due to femoral stem loosening|0
6957831|NCT01064531|11002201|FG000|Overall Study|Revision due to dislocation|0
6957832|NCT01064531|11002202|FG001|Overall Study|Revision due to dislocation|1
6957833|NCT01064531|11002201|FG000|Overall Study|Death|0
6957834|NCT01064531|11002202|FG001|Overall Study|Death|1
6957835|NCT01064622|11002211|FG000|Randomized Phase II|Withdrawal by Subject|2
6957836|NCT01064622|11002212|FG001|Randomized Phase II|Withdrawal by Subject|2
6957837|NCT01064622|11002211|FG000|Randomized Phase II|Protocol Violation|0
6957838|NCT01064622|11002212|FG001|Randomized Phase II|Protocol Violation|1
6957839|NCT01064687|11002225|FG000|Overall Study|Adverse Event|9
6957840|NCT01064687|11002226|FG001|Overall Study|Adverse Event|4
6957841|NCT01064687|11002227|FG002|Overall Study|Adverse Event|10
6957842|NCT01064687|11002228|FG003|Overall Study|Adverse Event|3
6957843|NCT01064687|11002225|FG000|Overall Study|Death|1
6957844|NCT01064687|11002226|FG001|Overall Study|Death|1
6957845|NCT01064687|11002227|FG002|Overall Study|Death|0
6957846|NCT01064687|11002228|FG003|Overall Study|Death|0
6957847|NCT01064687|11002225|FG000|Overall Study|Entry Criteria Not Met|3
6957848|NCT01064687|11002226|FG001|Overall Study|Entry Criteria Not Met|0
6957849|NCT01064687|11002227|FG002|Overall Study|Entry Criteria Not Met|0
6957850|NCT01064687|11002228|FG003|Overall Study|Entry Criteria Not Met|0
6957851|NCT01064687|11002225|FG000|Overall Study|Lack of Efficacy|1
6957852|NCT01064687|11002226|FG001|Overall Study|Lack of Efficacy|0
6957853|NCT01064687|11002227|FG002|Overall Study|Lack of Efficacy|2
6957854|NCT01064687|11002228|FG003|Overall Study|Lack of Efficacy|3
6957855|NCT01064687|11002225|FG000|Overall Study|Lost to Follow-up|7
6957856|NCT01064687|11002226|FG001|Overall Study|Lost to Follow-up|10
6957857|NCT01064687|11002227|FG002|Overall Study|Lost to Follow-up|13
6957858|NCT01064687|11002228|FG003|Overall Study|Lost to Follow-up|5
6957859|NCT01064687|11002225|FG000|Overall Study|Physician Decision|2
6957860|NCT01064687|11002226|FG001|Overall Study|Physician Decision|2
6957861|NCT01064687|11002227|FG002|Overall Study|Physician Decision|0
6957862|NCT01064687|11002228|FG003|Overall Study|Physician Decision|0
6957863|NCT01064687|11002225|FG000|Overall Study|Protocol Violation|1
6957864|NCT01064687|11002226|FG001|Overall Study|Protocol Violation|1
6957865|NCT01064687|11002227|FG002|Overall Study|Protocol Violation|0
6957866|NCT01064687|11002228|FG003|Overall Study|Protocol Violation|1
6957867|NCT01064687|11002225|FG000|Overall Study|Sponsor Decision|0
6957868|NCT01064687|11002226|FG001|Overall Study|Sponsor Decision|0
6957869|NCT01064687|11002227|FG002|Overall Study|Sponsor Decision|3
6957870|NCT01064687|11002228|FG003|Overall Study|Sponsor Decision|0
6957871|NCT01064687|11002225|FG000|Overall Study|Withdrawal by Subject|9
6957872|NCT01064687|11002226|FG001|Overall Study|Withdrawal by Subject|7
6957873|NCT01064687|11002227|FG002|Overall Study|Withdrawal by Subject|12
6957874|NCT01064687|11002228|FG003|Overall Study|Withdrawal by Subject|5
6957875|NCT01064687|11002225|FG000|Overall Study|Treatment Noncompliance|1
6957876|NCT01064687|11002226|FG001|Overall Study|Treatment Noncompliance|1
7072093|NCT02032875|11175945|FG001|Treatment Period|Adverse Event|0
7072094|NCT02032875|11175944|FG000|Treatment Period|Liver transplant, No extension needed|0
6957877|NCT01064687|11002227|FG002|Overall Study|Treatment Noncompliance|1
6957878|NCT01064687|11002228|FG003|Overall Study|Treatment Noncompliance|0
6957879|NCT01064739|11002258|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1
6957880|NCT01064856|11002281|FG000|Double-blind (DB) Period|Adverse Event|1
6957881|NCT01064856|11002282|FG001|Double-blind (DB) Period|Adverse Event|0
6957882|NCT01064856|11002283|FG002|Double-blind (DB) Period|Adverse Event|0
6957883|NCT01064856|11002284|FG003|Double-blind (DB) Period|Adverse Event|0
6957884|NCT01064856|11002281|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1
6957885|NCT01064856|11002282|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0
6957886|NCT01064856|11002283|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0
6957887|NCT01064856|11002284|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0
7072095|NCT02032875|11175945|FG001|Treatment Period|Liver transplant, No extension needed|1
7072096|NCT02032875|11175944|FG000|Treatment Period|Liver transplant, Treatment extension|0
7072097|NCT02032875|11175945|FG001|Treatment Period|Liver transplant, Treatment extension|3
7072098|NCT02032875|11175944|FG000|Follow-up Period|Death|0
7072099|NCT02032875|11175945|FG001|Follow-up Period|Death|1
7072100|NCT02032875|11175944|FG000|Follow-up Period|Virologic Relapse|3
7072101|NCT02032875|11175945|FG001|Follow-up Period|Virologic Relapse|10
7072102|NCT02032888|11175955|FG000|Treatment Period|Poor compliance/noncompliance|1
7072103|NCT02032888|11175956|FG001|Treatment Period|Poor compliance/noncompliance|1
7072104|NCT02032888|11175957|FG002|Treatment Period|Poor compliance/noncompliance|0
7072105|NCT02032888|11175955|FG000|Treatment Period|Other|1
7072106|NCT02032888|11175956|FG001|Treatment Period|Other|1
7072107|NCT02032888|11175957|FG002|Treatment Period|Other|0
7072108|NCT02032888|11175955|FG000|Follow-up Period|Lost to Follow-up|1
7072109|NCT02032888|11175956|FG001|Follow-up Period|Lost to Follow-up|1
7072110|NCT02032888|11175957|FG002|Follow-up Period|Lost to Follow-up|0
7072111|NCT02032888|11175955|FG000|Follow-up Period|Death|1
7072112|NCT02032888|11175956|FG001|Follow-up Period|Death|1
7072113|NCT02032888|11175957|FG002|Follow-up Period|Death|0
7072114|NCT02032888|11175955|FG000|Follow-up Period|Other|1
7072115|NCT02032888|11175956|FG001|Follow-up Period|Other|0
7072116|NCT02032888|11175957|FG002|Follow-up Period|Other|0
6957888|NCT01064856|11002281|FG000|Open-label (OL) Period|Adverse Event|0
6957889|NCT01064856|11002282|FG001|Open-label (OL) Period|Adverse Event|0
6957890|NCT01064856|11002283|FG002|Open-label (OL) Period|Adverse Event|12
6957891|NCT01064856|11002284|FG003|Open-label (OL) Period|Adverse Event|6
6957892|NCT01064856|11002281|FG000|Open-label (OL) Period|Consent withdrawn by participant|0
6957893|NCT01064856|11002282|FG001|Open-label (OL) Period|Consent withdrawn by participant|0
6957894|NCT01064856|11002283|FG002|Open-label (OL) Period|Consent withdrawn by participant|5
6957895|NCT01064856|11002284|FG003|Open-label (OL) Period|Consent withdrawn by participant|6
6957896|NCT01064856|11002281|FG000|Open-label (OL) Period|Lost to Follow-up|0
6957897|NCT01064856|11002282|FG001|Open-label (OL) Period|Lost to Follow-up|0
6957898|NCT01064856|11002283|FG002|Open-label (OL) Period|Lost to Follow-up|2
6957899|NCT01064856|11002284|FG003|Open-label (OL) Period|Lost to Follow-up|1
6957900|NCT01064856|11002281|FG000|Open-label (OL) Period|Other|0
6957901|NCT01064856|11002282|FG001|Open-label (OL) Period|Other|0
6957902|NCT01064856|11002283|FG002|Open-label (OL) Period|Other|7
6957903|NCT01064856|11002284|FG003|Open-label (OL) Period|Other|7
6957904|NCT01064947|11002304|FG000|Overall Study|negative culture|41
6957905|NCT01065350|11002314|FG000|Overall Study|Received incorrect drug allocation|0
6957906|NCT01065350|11002315|FG001|Overall Study|Received incorrect drug allocation|1
6957907|NCT01065597|11002363|FG000|Overall Study|Adverse Event|1
6957908|NCT01065766|11002374|FG000|Overall Study|Assessed before the contracted date|1
6957909|NCT01065766|11002374|FG000|Overall Study|Contraindication to administration|6
6957910|NCT01065766|11002374|FG000|Overall Study|Violated dosage/administration|25
6957911|NCT01065844|11002378|FG000|Overall Study|Adverse Event|5
6957912|NCT01066000|11002382|FG000|Overall Study|Protocol Violation|4
6957913|NCT01066000|11002382|FG000|Overall Study|Death|3
6957914|NCT01066000|11002382|FG000|Overall Study|Withdrawal by Subject|1
6957915|NCT01066000|11002382|FG000|Overall Study|Adverse Event|1
6957916|NCT01066039|11002392|FG000|Overall Study|Adverse Event|6
6957917|NCT01066039|11002392|FG000|Overall Study|Withdrawal by Subject|17
6957918|NCT01066039|11002392|FG000|Overall Study|Protocol Violation|2
6957919|NCT01066039|11002392|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9
6957920|NCT01066039|11002392|FG000|Overall Study|Investigator's Request|1
6957921|NCT01066039|11002392|FG000|Overall Study|Dropout due to Insulin Administration|1
6957922|NCT01066039|11002392|FG000|Overall Study|Additional Antihypertensive Required|4
6957923|NCT01066039|11002392|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2
6957924|NCT01066039|11002392|FG000|Overall Study|Failure to Control Blood Pressure|1
6957925|NCT01066039|11002392|FG000|Overall Study|Drug/Dose Adjustment Required|1
6957926|NCT01066052|11002398|FG000|Overall Study|Enrolled But Not Treated|3
7072117|NCT02032901|11175976|FG000|Treatment Period (12 Weeks)|Pregnancy|1
7072118|NCT02032901|11175977|FG001|Treatment Period (12 Weeks)|Pregnancy|0
7072119|NCT02032901|11175976|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0
7072120|NCT02032901|11175977|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1
7072121|NCT02033369|11176041|FG000|Overall Study|Physician Decision|1
7072122|NCT02033369|11176042|FG001|Overall Study|Physician Decision|2
7072123|NCT02033369|11176041|FG000|Overall Study|Not a good demographic match|0
7072124|NCT02033369|11176042|FG001|Overall Study|Not a good demographic match|2
6957927|NCT01066052|11002399|FG001|Overall Study|Enrolled But Not Treated|0
6957928|NCT01066104|11002406|FG000|Overall Study|Adverse Event|1
6957929|NCT01066104|11002407|FG001|Overall Study|Adverse Event|1
6957930|NCT01066104|11002406|FG000|Overall Study|Protocol Violation|1
6957931|NCT01066104|11002407|FG001|Overall Study|Protocol Violation|0
6957932|NCT01066143|11002413|FG000|Overall Study|ineligible for the study|8
6957933|NCT01066156|11002417|FG000|Overall Study|ineligible|2
6957934|NCT01066156|11002417|FG000|Overall Study|Lost to Follow-up|7
6957935|NCT01066156|11002417|FG000|Overall Study|Withdrawal by Subject|1
6957936|NCT01066546|11002443|FG000|Overall Study|Study terminated by sponsor|5
6957937|NCT01066585|11002449|FG000|Overall Study|Protocol Violation|1
6957938|NCT01066585|11002450|FG001|Overall Study|Protocol Violation|0
6957939|NCT01066585|11002449|FG000|Overall Study|Withdrawal by Subject|0
6957940|NCT01066585|11002450|FG001|Overall Study|Withdrawal by Subject|3
6957941|NCT01066780|11002469|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1
6957942|NCT01066780|11002470|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1
6957943|NCT01066793|11002480|FG000|Overall Study|Death|4
6957944|NCT01066793|11002481|FG001|Overall Study|Death|1
6957945|NCT01066793|11002482|FG002|Overall Study|Death|1
6957946|NCT01066793|11002483|FG003|Overall Study|Death|0
6957947|NCT01066793|11002484|FG004|Overall Study|Death|0
6957948|NCT01066793|11002485|FG005|Overall Study|Death|0
6957949|NCT01066793|11002480|FG000|Overall Study|Lack of Efficacy|2
6957950|NCT01066793|11002481|FG001|Overall Study|Lack of Efficacy|1
6957951|NCT01066793|11002482|FG002|Overall Study|Lack of Efficacy|0
6957952|NCT01066793|11002483|FG003|Overall Study|Lack of Efficacy|0
6957953|NCT01066793|11002484|FG004|Overall Study|Lack of Efficacy|0
6957954|NCT01066793|11002485|FG005|Overall Study|Lack of Efficacy|0
6957955|NCT01066793|11002480|FG000|Overall Study|Lost to Follow-up|180
6957956|NCT01066793|11002481|FG001|Overall Study|Lost to Follow-up|39
6957957|NCT01066793|11002482|FG002|Overall Study|Lost to Follow-up|82
6957958|NCT01066793|11002483|FG003|Overall Study|Lost to Follow-up|16
6957959|NCT01066793|11002484|FG004|Overall Study|Lost to Follow-up|0
6957960|NCT01066793|11002485|FG005|Overall Study|Lost to Follow-up|1
6957961|NCT01066793|11002480|FG000|Overall Study|Physician Decision|3
6957962|NCT01066793|11002481|FG001|Overall Study|Physician Decision|0
6957963|NCT01066793|11002482|FG002|Overall Study|Physician Decision|0
6957964|NCT01066793|11002483|FG003|Overall Study|Physician Decision|0
6957965|NCT01066793|11002484|FG004|Overall Study|Physician Decision|0
6957966|NCT01066793|11002485|FG005|Overall Study|Physician Decision|0
6957967|NCT01066793|11002480|FG000|Overall Study|Protocol Violation|3
6957968|NCT01066793|11002481|FG001|Overall Study|Protocol Violation|2
6957969|NCT01066793|11002482|FG002|Overall Study|Protocol Violation|2
6957970|NCT01066793|11002483|FG003|Overall Study|Protocol Violation|0
6957971|NCT01066793|11002484|FG004|Overall Study|Protocol Violation|0
6957972|NCT01066793|11002485|FG005|Overall Study|Protocol Violation|0
6957973|NCT01066793|11002480|FG000|Overall Study|Withdrawal by Subject|7
6957974|NCT01066793|11002481|FG001|Overall Study|Withdrawal by Subject|4
6957975|NCT01066793|11002482|FG002|Overall Study|Withdrawal by Subject|1
6957976|NCT01066793|11002483|FG003|Overall Study|Withdrawal by Subject|0
6957977|NCT01066793|11002484|FG004|Overall Study|Withdrawal by Subject|0
6957978|NCT01066793|11002485|FG005|Overall Study|Withdrawal by Subject|0
6957979|NCT01066793|11002480|FG000|Overall Study|Early Termination|3
6957980|NCT01066793|11002481|FG001|Overall Study|Early Termination|0
6957981|NCT01066793|11002482|FG002|Overall Study|Early Termination|0
6957982|NCT01066793|11002483|FG003|Overall Study|Early Termination|0
6957983|NCT01066793|11002484|FG004|Overall Study|Early Termination|0
6957984|NCT01066793|11002485|FG005|Overall Study|Early Termination|0
6957985|NCT01066793|11002480|FG000|Overall Study|Lab test not done|7
6957986|NCT01066793|11002481|FG001|Overall Study|Lab test not done|0
6957987|NCT01066793|11002482|FG002|Overall Study|Lab test not done|0
6957988|NCT01066793|11002483|FG003|Overall Study|Lab test not done|1
6957989|NCT01066793|11002484|FG004|Overall Study|Lab test not done|0
6957990|NCT01066793|11002485|FG005|Overall Study|Lab test not done|0
6957991|NCT01066793|11002480|FG000|Overall Study|Miscellaneous|4
6957992|NCT01066793|11002481|FG001|Overall Study|Miscellaneous|5
6957993|NCT01066793|11002482|FG002|Overall Study|Miscellaneous|6
6957994|NCT01066793|11002483|FG003|Overall Study|Miscellaneous|0
6957995|NCT01066793|11002484|FG004|Overall Study|Miscellaneous|0
6957996|NCT01066793|11002485|FG005|Overall Study|Miscellaneous|0
6957997|NCT01066793|11002480|FG000|Overall Study|Non-responders|104
6957998|NCT01066793|11002481|FG001|Overall Study|Non-responders|5
6957999|NCT01066793|11002482|FG002|Overall Study|Non-responders|11
6958000|NCT01066793|11002483|FG003|Overall Study|Non-responders|25
6958001|NCT01066793|11002484|FG004|Overall Study|Non-responders|0
6958002|NCT01066793|11002485|FG005|Overall Study|Non-responders|0
6958003|NCT01066793|11002480|FG000|Overall Study|Other|15
6958004|NCT01066793|11002481|FG001|Overall Study|Other|5
6958005|NCT01066793|11002482|FG002|Overall Study|Other|6
6958006|NCT01066793|11002483|FG003|Overall Study|Other|2
6958007|NCT01066793|11002484|FG004|Overall Study|Other|0
6958008|NCT01066793|11002485|FG005|Overall Study|Other|0
6958009|NCT01066793|11002480|FG000|Overall Study|Relapse|20
6958010|NCT01066793|11002481|FG001|Overall Study|Relapse|8
6958011|NCT01066793|11002482|FG002|Overall Study|Relapse|2
6958012|NCT01066793|11002483|FG003|Overall Study|Relapse|3
6958013|NCT01066793|11002484|FG004|Overall Study|Relapse|0
6958014|NCT01066793|11002485|FG005|Overall Study|Relapse|0
6958015|NCT01066793|11002480|FG000|Overall Study|Result Not Available|1
6958016|NCT01066793|11002481|FG001|Overall Study|Result Not Available|0
6958017|NCT01066793|11002482|FG002|Overall Study|Result Not Available|0
6958018|NCT01066793|11002483|FG003|Overall Study|Result Not Available|0
6958019|NCT01066793|11002484|FG004|Overall Study|Result Not Available|0
6958020|NCT01066793|11002485|FG005|Overall Study|Result Not Available|0
6958021|NCT01066793|11002480|FG000|Overall Study|Treatment Interrupted|1
6958022|NCT01066793|11002481|FG001|Overall Study|Treatment Interrupted|1
6958023|NCT01066793|11002482|FG002|Overall Study|Treatment Interrupted|0
6958024|NCT01066793|11002483|FG003|Overall Study|Treatment Interrupted|0
6958025|NCT01066793|11002484|FG004|Overall Study|Treatment Interrupted|0
6958026|NCT01066793|11002485|FG005|Overall Study|Treatment Interrupted|0
6958027|NCT01066793|11002480|FG000|Overall Study|Treatment Never Started|18
6958028|NCT01066793|11002481|FG001|Overall Study|Treatment Never Started|5
6958029|NCT01066793|11002482|FG002|Overall Study|Treatment Never Started|4
6958030|NCT01066793|11002483|FG003|Overall Study|Treatment Never Started|1
6958031|NCT01066793|11002484|FG004|Overall Study|Treatment Never Started|0
6958032|NCT01066793|11002485|FG005|Overall Study|Treatment Never Started|0
6958033|NCT01066793|11002480|FG000|Overall Study|Treatment Stopped|2
6958034|NCT01066793|11002481|FG001|Overall Study|Treatment Stopped|1
6958035|NCT01066793|11002482|FG002|Overall Study|Treatment Stopped|0
6958036|NCT01066793|11002483|FG003|Overall Study|Treatment Stopped|1
6958037|NCT01066793|11002484|FG004|Overall Study|Treatment Stopped|0
6958038|NCT01066793|11002485|FG005|Overall Study|Treatment Stopped|0
6958039|NCT01066819|11002506|FG000|Overall Study|Adverse Event|18
6958040|NCT01066819|11002507|FG001|Overall Study|Adverse Event|1
6958041|NCT01066819|11002508|FG002|Overall Study|Adverse Event|6
6958042|NCT01066819|11002509|FG003|Overall Study|Adverse Event|0
6958043|NCT01066819|11002510|FG004|Overall Study|Adverse Event|0
6958044|NCT01066819|11002511|FG005|Overall Study|Adverse Event|0
6958045|NCT01066819|11002506|FG000|Overall Study|Death|5
6958046|NCT01066819|11002507|FG001|Overall Study|Death|0
6958047|NCT01066819|11002508|FG002|Overall Study|Death|1
6958048|NCT01066819|11002509|FG003|Overall Study|Death|0
6958049|NCT01066819|11002510|FG004|Overall Study|Death|0
6958050|NCT01066819|11002511|FG005|Overall Study|Death|0
6958051|NCT01066819|11002506|FG000|Overall Study|Lack of Efficacy|22
6958052|NCT01066819|11002507|FG001|Overall Study|Lack of Efficacy|1
6958053|NCT01066819|11002508|FG002|Overall Study|Lack of Efficacy|2
6958054|NCT01066819|11002509|FG003|Overall Study|Lack of Efficacy|1
6958055|NCT01066819|11002510|FG004|Overall Study|Lack of Efficacy|0
6958056|NCT01066819|11002511|FG005|Overall Study|Lack of Efficacy|0
6958057|NCT01066819|11002506|FG000|Overall Study|Physician Decision|6
6958058|NCT01066819|11002507|FG001|Overall Study|Physician Decision|2
6958059|NCT01066819|11002508|FG002|Overall Study|Physician Decision|3
6958060|NCT01066819|11002509|FG003|Overall Study|Physician Decision|0
6958061|NCT01066819|11002510|FG004|Overall Study|Physician Decision|0
6958062|NCT01066819|11002511|FG005|Overall Study|Physician Decision|0
6958063|NCT01066819|11002506|FG000|Overall Study|Protocol Violation|12
6958064|NCT01066819|11002507|FG001|Overall Study|Protocol Violation|6
6958065|NCT01066819|11002508|FG002|Overall Study|Protocol Violation|0
6958066|NCT01066819|11002509|FG003|Overall Study|Protocol Violation|0
6958067|NCT01066819|11002510|FG004|Overall Study|Protocol Violation|0
6958068|NCT01066819|11002511|FG005|Overall Study|Protocol Violation|0
6958069|NCT01066819|11002506|FG000|Overall Study|Withdrawal by Subject|29
6958070|NCT01066819|11002507|FG001|Overall Study|Withdrawal by Subject|11
6958071|NCT01066819|11002508|FG002|Overall Study|Withdrawal by Subject|6
6958072|NCT01066819|11002509|FG003|Overall Study|Withdrawal by Subject|0
6958073|NCT01066819|11002510|FG004|Overall Study|Withdrawal by Subject|0
6958074|NCT01066819|11002511|FG005|Overall Study|Withdrawal by Subject|0
6958075|NCT01066819|11002506|FG000|Overall Study|Administrative|6
6958076|NCT01066819|11002507|FG001|Overall Study|Administrative|4
6958077|NCT01066819|11002508|FG002|Overall Study|Administrative|2
6958078|NCT01066819|11002509|FG003|Overall Study|Administrative|0
6958079|NCT01066819|11002510|FG004|Overall Study|Administrative|0
6958080|NCT01066819|11002511|FG005|Overall Study|Administrative|0
6958081|NCT01066819|11002506|FG000|Overall Study|Not met inclusion/exclusion criteria|1
6958082|NCT01066819|11002507|FG001|Overall Study|Not met inclusion/exclusion criteria|0
6958083|NCT01066819|11002508|FG002|Overall Study|Not met inclusion/exclusion criteria|0
6958084|NCT01066819|11002509|FG003|Overall Study|Not met inclusion/exclusion criteria|0
6958085|NCT01066819|11002510|FG004|Overall Study|Not met inclusion/exclusion criteria|0
6958086|NCT01066819|11002511|FG005|Overall Study|Not met inclusion/exclusion criteria|0
6958087|NCT01066819|11002506|FG000|Overall Study|Early termination|2
6958088|NCT01066819|11002507|FG001|Overall Study|Early termination|0
6958089|NCT01066819|11002508|FG002|Overall Study|Early termination|0
6958090|NCT01066819|11002509|FG003|Overall Study|Early termination|0
6958091|NCT01066819|11002510|FG004|Overall Study|Early termination|0
6958092|NCT01066819|11002511|FG005|Overall Study|Early termination|0
6958093|NCT01066819|11002506|FG000|Overall Study|Failed to return|298
6958094|NCT01066819|11002507|FG001|Overall Study|Failed to return|107
6958095|NCT01066819|11002508|FG002|Overall Study|Failed to return|68
6958096|NCT01066819|11002509|FG003|Overall Study|Failed to return|7
6958097|NCT01066819|11002510|FG004|Overall Study|Failed to return|2
6958098|NCT01066819|11002511|FG005|Overall Study|Failed to return|3
6958099|NCT01066819|11002506|FG000|Overall Study|Lab test not done|9
6958100|NCT01066819|11002507|FG001|Overall Study|Lab test not done|0
6958101|NCT01066819|11002508|FG002|Overall Study|Lab test not done|2
6958102|NCT01066819|11002509|FG003|Overall Study|Lab test not done|1
6958103|NCT01066819|11002510|FG004|Overall Study|Lab test not done|0
6958104|NCT01066819|11002511|FG005|Overall Study|Lab test not done|0
6958105|NCT01066819|11002506|FG000|Overall Study|Miscellaneous|28
6958106|NCT01066819|11002507|FG001|Overall Study|Miscellaneous|10
6958107|NCT01066819|11002508|FG002|Overall Study|Miscellaneous|18
6958108|NCT01066819|11002509|FG003|Overall Study|Miscellaneous|1
6958109|NCT01066819|11002510|FG004|Overall Study|Miscellaneous|0
6958110|NCT01066819|11002511|FG005|Overall Study|Miscellaneous|0
6958111|NCT01066819|11002506|FG000|Overall Study|Non responders|123
6958112|NCT01066819|11002507|FG001|Overall Study|Non responders|2
6958113|NCT01066819|11002508|FG002|Overall Study|Non responders|7
6958114|NCT01066819|11002509|FG003|Overall Study|Non responders|2
6958115|NCT01066819|11002510|FG004|Overall Study|Non responders|0
6958116|NCT01066819|11002511|FG005|Overall Study|Non responders|1
6958117|NCT01066819|11002506|FG000|Overall Study|Not categorised|9
6958118|NCT01066819|11002507|FG001|Overall Study|Not categorised|2
6958119|NCT01066819|11002508|FG002|Overall Study|Not categorised|6
6958120|NCT01066819|11002509|FG003|Overall Study|Not categorised|1
6958121|NCT01066819|11002510|FG004|Overall Study|Not categorised|0
6958122|NCT01066819|11002511|FG005|Overall Study|Not categorised|0
6958123|NCT01066819|11002506|FG000|Overall Study|Relapse|16
6958124|NCT01066819|11002507|FG001|Overall Study|Relapse|4
6958125|NCT01066819|11002508|FG002|Overall Study|Relapse|3
6958126|NCT01066819|11002509|FG003|Overall Study|Relapse|0
6958127|NCT01066819|11002510|FG004|Overall Study|Relapse|0
6958128|NCT01066819|11002511|FG005|Overall Study|Relapse|0
6958129|NCT01066819|11002506|FG000|Overall Study|Results not available|1
6958130|NCT01066819|11002507|FG001|Overall Study|Results not available|0
6958131|NCT01066819|11002508|FG002|Overall Study|Results not available|0
6958132|NCT01066819|11002509|FG003|Overall Study|Results not available|0
6958133|NCT01066819|11002510|FG004|Overall Study|Results not available|0
6958134|NCT01066819|11002511|FG005|Overall Study|Results not available|0
6958135|NCT01066819|11002506|FG000|Overall Study|Screen failure|1
6958136|NCT01066819|11002507|FG001|Overall Study|Screen failure|0
6958137|NCT01066819|11002508|FG002|Overall Study|Screen failure|0
6958138|NCT01066819|11002509|FG003|Overall Study|Screen failure|0
6958139|NCT01066819|11002510|FG004|Overall Study|Screen failure|0
6958140|NCT01066819|11002511|FG005|Overall Study|Screen failure|0
6958141|NCT01066819|11002506|FG000|Overall Study|Spontaneous cure|1
6958142|NCT01066819|11002507|FG001|Overall Study|Spontaneous cure|0
6958143|NCT01066819|11002508|FG002|Overall Study|Spontaneous cure|0
6958144|NCT01066819|11002509|FG003|Overall Study|Spontaneous cure|0
6958145|NCT01066819|11002510|FG004|Overall Study|Spontaneous cure|0
6958146|NCT01066819|11002511|FG005|Overall Study|Spontaneous cure|0
6958147|NCT01066819|11002506|FG000|Overall Study|Treatment never started|85
6958148|NCT01066819|11002507|FG001|Overall Study|Treatment never started|19
6958149|NCT01066819|11002508|FG002|Overall Study|Treatment never started|19
6958150|NCT01066819|11002509|FG003|Overall Study|Treatment never started|3
6958151|NCT01066819|11002510|FG004|Overall Study|Treatment never started|2
6958152|NCT01066819|11002511|FG005|Overall Study|Treatment never started|2
6958153|NCT01066819|11002506|FG000|Overall Study|Treatment stopped|12
6958154|NCT01066819|11002507|FG001|Overall Study|Treatment stopped|1
6958155|NCT01066819|11002508|FG002|Overall Study|Treatment stopped|2
6958156|NCT01066819|11002509|FG003|Overall Study|Treatment stopped|1
6958157|NCT01066819|11002510|FG004|Overall Study|Treatment stopped|0
6958158|NCT01066819|11002511|FG005|Overall Study|Treatment stopped|0
6958159|NCT01066819|11002506|FG000|Overall Study|Other|5
6958160|NCT01066819|11002507|FG001|Overall Study|Other|1
6958161|NCT01066819|11002508|FG002|Overall Study|Other|1
6958162|NCT01066819|11002509|FG003|Overall Study|Other|0
6958163|NCT01066819|11002510|FG004|Overall Study|Other|0
6958164|NCT01066819|11002511|FG005|Overall Study|Other|0
6958165|NCT01066871|11002527|FG000|Overall Study|Lost to Follow-up|0
6958166|NCT01066871|11002528|FG001|Overall Study|Lost to Follow-up|2
6958167|NCT01066871|11002529|FG002|Overall Study|Lost to Follow-up|2
6958168|NCT01066871|11002530|FG003|Overall Study|Lost to Follow-up|0
6958169|NCT01066871|11002527|FG000|Overall Study|Protocol Violation|1
6958170|NCT01066871|11002528|FG001|Overall Study|Protocol Violation|0
6958171|NCT01066871|11002529|FG002|Overall Study|Protocol Violation|3
6958172|NCT01066871|11002530|FG003|Overall Study|Protocol Violation|2
6958173|NCT01066871|11002527|FG000|Overall Study|Lack of Efficacy|0
6958174|NCT01066871|11002528|FG001|Overall Study|Lack of Efficacy|0
6958175|NCT01066871|11002529|FG002|Overall Study|Lack of Efficacy|0
6958176|NCT01066871|11002530|FG003|Overall Study|Lack of Efficacy|1
6958177|NCT01066871|11002527|FG000|Overall Study|Withdrawal by Subject|3
6958178|NCT01066871|11002528|FG001|Overall Study|Withdrawal by Subject|1
6958179|NCT01066871|11002529|FG002|Overall Study|Withdrawal by Subject|0
6958180|NCT01066871|11002530|FG003|Overall Study|Withdrawal by Subject|0
6958181|NCT01066871|11002527|FG000|Overall Study|Other|0
6958182|NCT01066871|11002528|FG001|Overall Study|Other|2
6958183|NCT01066871|11002529|FG002|Overall Study|Other|1
6958184|NCT01066871|11002530|FG003|Overall Study|Other|2
6958185|NCT01066897|11002547|FG000|Overall Study|Withdrawal by Subject|1
6958186|NCT01066897|11002548|FG001|Overall Study|Withdrawal by Subject|0
6958187|NCT01066897|11002547|FG000|Overall Study|stopped study after developing the flu.|1
6958188|NCT01066897|11002548|FG001|Overall Study|stopped study after developing the flu.|0
6958189|NCT01066923|11002559|FG000|Overall Study|Withdrawal by Subject|3
6958190|NCT01066923|11002560|FG001|Overall Study|Withdrawal by Subject|3
6958191|NCT01066923|11002561|FG002|Overall Study|Withdrawal by Subject|8
6958192|NCT01066923|11002562|FG003|Overall Study|Withdrawal by Subject|8
6958193|NCT01066936|11002572|FG000|Overall Study|Death|2
6958194|NCT01066936|11002572|FG000|Overall Study|Device revised/removed|1
6958195|NCT01066936|11002572|FG000|Overall Study|Lost to Follow-up|3
6958196|NCT01066936|11002572|FG000|Overall Study|Withdrawal by Subject|4
6958197|NCT01067105|11002578|FG000|Overall Study|Adverse Event|14
6958198|NCT01067105|11002578|FG000|Overall Study|Protocol Violation|48
6958199|NCT01067105|11002578|FG000|Overall Study|Withdrawal by Subject|36
6958200|NCT01067105|11002578|FG000|Overall Study|Lost to Follow-up|6
6958201|NCT01067105|11002578|FG000|Overall Study|Physician Decision|6
6958202|NCT01067105|11002578|FG000|Overall Study|Other|31
6958203|NCT01067326|11002584|FG000|Overall Study|Adverse Event|0
6958204|NCT01067326|11002585|FG001|Overall Study|Adverse Event|2
6958205|NCT01067326|11002584|FG000|Overall Study|Withdrawal by Subject|1
6958206|NCT01067326|11002585|FG001|Overall Study|Withdrawal by Subject|0
6958207|NCT01067326|11002584|FG000|Overall Study|Early Study Termination|1
6958208|NCT01067326|11002585|FG001|Overall Study|Early Study Termination|1
6958209|NCT01067339|11002593|FG000|Overall Study|Withdrawal by Subject|6
6958210|NCT01067339|11002594|FG001|Overall Study|Withdrawal by Subject|5
6958211|NCT01067352|11002603|FG000|Overall Study|Withdrawal by Subject|1
6958212|NCT01067352|11002604|FG001|Overall Study|Withdrawal by Subject|2
6958213|NCT01067352|11002605|FG002|Overall Study|Withdrawal by Subject|1
6958214|NCT01067352|11002603|FG000|Overall Study|Physician Decision|0
6958215|NCT01067352|11002604|FG001|Overall Study|Physician Decision|1
6958216|NCT01067352|11002605|FG002|Overall Study|Physician Decision|0
6958217|NCT01067469|11002626|FG000|Overall Study|Withdrawal by Subject|0
6958218|NCT01067469|11002627|FG001|Overall Study|Withdrawal by Subject|1
6958219|NCT01067469|11002626|FG000|Overall Study|Disease Progression|0
6958220|NCT01067469|11002627|FG001|Overall Study|Disease Progression|1
6958221|NCT01067508|11002635|FG000|Overall Study|Physician Decision|0
6958222|NCT01067508|11002636|FG001|Overall Study|Physician Decision|1
6958223|NCT01067508|11002635|FG000|Overall Study|Withdrawal by Subject|0
6958224|NCT01067508|11002636|FG001|Overall Study|Withdrawal by Subject|1
6958225|NCT01067846|11002685|FG000|Overall Study|Lost to Follow-up|17
6958226|NCT01067846|11002686|FG001|Overall Study|Lost to Follow-up|19
6958227|NCT01067846|11002685|FG000|Overall Study|Withdrawal by Subject|1
6958228|NCT01067846|11002686|FG001|Overall Study|Withdrawal by Subject|0
6958229|NCT01067846|11002685|FG000|Overall Study|participation in other tx study|1
6958230|NCT01067846|11002686|FG001|Overall Study|participation in other tx study|0
6958231|NCT01067976|11002692|FG000|Overall Study|Study drug never administered|20
6958232|NCT01067976|11002692|FG000|Overall Study|Study prematurely discontinued|2
6958233|NCT01068158|11002712|FG000|Overall Study|Withdrawal by Subject|1
6958234|NCT01068158|11002713|FG001|Overall Study|Withdrawal by Subject|2
6958235|NCT01068158|11002712|FG000|Overall Study|Lost to Follow-up|7
6958236|NCT01068158|11002713|FG001|Overall Study|Lost to Follow-up|0
6958237|NCT01068158|11002712|FG000|Overall Study|Protocol Violation|0
6958238|NCT01068158|11002713|FG001|Overall Study|Protocol Violation|2
6958239|NCT01068262|11002723|FG000|Overall Study|Adverse Event|2
6958240|NCT01068262|11002724|FG001|Overall Study|Adverse Event|0
6958241|NCT01068262|11002725|FG002|Overall Study|Adverse Event|1
6958242|NCT01068262|11002726|FG003|Overall Study|Adverse Event|0
6958243|NCT01068262|11002723|FG000|Overall Study|Protocol Violation|1
6958244|NCT01068262|11002724|FG001|Overall Study|Protocol Violation|0
6958245|NCT01068262|11002725|FG002|Overall Study|Protocol Violation|0
6958246|NCT01068262|11002726|FG003|Overall Study|Protocol Violation|0
6958247|NCT01068262|11002723|FG000|Overall Study|Withdrawal by Subject|0
6958248|NCT01068262|11002724|FG001|Overall Study|Withdrawal by Subject|1
6958249|NCT01068262|11002725|FG002|Overall Study|Withdrawal by Subject|0
6958250|NCT01068262|11002726|FG003|Overall Study|Withdrawal by Subject|0
6958251|NCT01068418|11002739|FG000|Overall Study|Physician Decision|12
6958252|NCT01068509|11002746|FG000|Overall Study|Death|0
6958253|NCT01068509|11002747|FG001|Overall Study|Death|0
6958254|NCT01068509|11002748|FG002|Overall Study|Death|1
6958255|NCT01068509|11002746|FG000|Overall Study|Disease Progression|5
6958256|NCT01068509|11002747|FG001|Overall Study|Disease Progression|20
6958257|NCT01068509|11002748|FG002|Overall Study|Disease Progression|18
6958258|NCT01068509|11002746|FG000|Overall Study|Lost to Follow-up|1
6958259|NCT01068509|11002747|FG001|Overall Study|Lost to Follow-up|0
6958260|NCT01068509|11002748|FG002|Overall Study|Lost to Follow-up|0
6958261|NCT01068509|11002746|FG000|Overall Study|Withdrew Consent|0
6958262|NCT01068509|11002747|FG001|Overall Study|Withdrew Consent|1
6958263|NCT01068509|11002748|FG002|Overall Study|Withdrew Consent|2
6958264|NCT01068509|11002746|FG000|Overall Study|Reason Not Specified|0
6958265|NCT01068509|11002747|FG001|Overall Study|Reason Not Specified|1
6958266|NCT01068509|11002748|FG002|Overall Study|Reason Not Specified|0
6958267|NCT01068600|11002767|FG000|Overall Study|Withdrawal by Subject|5
6958268|NCT01068600|11002768|FG001|Overall Study|Withdrawal by Subject|6
6958269|NCT01068600|11002767|FG000|Overall Study|Adverse Event|3
6958270|NCT01068600|11002768|FG001|Overall Study|Adverse Event|3
6958271|NCT01068600|11002767|FG000|Overall Study|Abnormal laboratory value(s)|1
6958272|NCT01068600|11002768|FG001|Overall Study|Abnormal laboratory value(s)|0
6958273|NCT01068600|11002767|FG000|Overall Study|Lost to Follow-up|1
6958274|NCT01068600|11002768|FG001|Overall Study|Lost to Follow-up|2
6958275|NCT01068600|11002767|FG000|Overall Study|Protocol deviation|1
6958276|NCT01068600|11002768|FG001|Overall Study|Protocol deviation|1
6958277|NCT01068600|11002767|FG000|Overall Study|Unsatisfactory therapeutic effect|0
6958278|NCT01068600|11002768|FG001|Overall Study|Unsatisfactory therapeutic effect|4
6958279|NCT01068600|11002767|FG000|Overall Study|Administrative problems|0
6958280|NCT01068600|11002768|FG001|Overall Study|Administrative problems|1
6958281|NCT01068626|11002776|FG000|Overall Study|Adverse Event|3
6958282|NCT01068626|11002777|FG001|Overall Study|Adverse Event|0
6958283|NCT01068626|11002776|FG000|Overall Study|Withdrawal by Subject|0
6958284|NCT01068626|11002777|FG001|Overall Study|Withdrawal by Subject|2
6976413|NCT01199055|11029010|FG001|Overall Study|Physician Decision|1
6976414|NCT01199055|11029011|FG002|Overall Study|Physician Decision|1
6976415|NCT01199055|11029009|FG000|Overall Study|Progressive disease|2
6976416|NCT01199055|11029010|FG001|Overall Study|Progressive disease|1
6976417|NCT01199055|11029011|FG002|Overall Study|Progressive disease|2
6976418|NCT01199055|11029009|FG000|Overall Study|Withdrawal by Subject|0
6976419|NCT01199055|11029010|FG001|Overall Study|Withdrawal by Subject|0
6976420|NCT01199055|11029011|FG002|Overall Study|Withdrawal by Subject|1
6976421|NCT01199068|11029024|FG000|Overall Study|Unacceptable toxicity|0
6976422|NCT01199068|11029025|FG001|Overall Study|Unacceptable toxicity|0
6976423|NCT01199068|11029026|FG002|Overall Study|Unacceptable toxicity|2
6976424|NCT01199068|11029024|FG000|Overall Study|Progressive disease|3
6976425|NCT01199068|11029025|FG001|Overall Study|Progressive disease|3
6976426|NCT01199068|11029026|FG002|Overall Study|Progressive disease|6
6976427|NCT01199068|11029024|FG000|Overall Study|Withdrawal by Subject|0
6976428|NCT01199068|11029025|FG001|Overall Study|Withdrawal by Subject|0
6976429|NCT01199068|11029026|FG002|Overall Study|Withdrawal by Subject|1
6976430|NCT01199198|11029047|FG000|Overall Study|Adverse Event|3
6976431|NCT01199198|11029048|FG001|Overall Study|Adverse Event|0
6976432|NCT01199198|11029047|FG000|Overall Study|Lost to Follow-up|1
6976433|NCT01199198|11029048|FG001|Overall Study|Lost to Follow-up|5
6976434|NCT01199198|11029047|FG000|Overall Study|Withdrawal by Subject|1
6976435|NCT01199198|11029048|FG001|Overall Study|Withdrawal by Subject|2
6976436|NCT01199198|11029047|FG000|Overall Study|ICU Transfer|1
6976437|NCT01199198|11029048|FG001|Overall Study|ICU Transfer|2
6976438|NCT01199198|11029047|FG000|Overall Study|Hospice-care transfer|1
6976439|NCT01199198|11029048|FG001|Overall Study|Hospice-care transfer|2
6976440|NCT01199263|11029067|FG000|Overall Study|Ineligible|0
6976441|NCT01199263|11029068|FG001|Overall Study|Ineligible|2
6976442|NCT01199263|11029067|FG000|Overall Study|Never Treated|6
6976443|NCT01199263|11029068|FG001|Overall Study|Never Treated|0
6976444|NCT01199289|11029080|FG000|Overall Study|Ineligibility determined|2
6976445|NCT01199289|11029081|FG001|Overall Study|Ineligibility determined|1
6976446|NCT01199289|11029082|FG002|Overall Study|Ineligibility determined|0
6976447|NCT01199289|11029083|FG003|Overall Study|Ineligibility determined|0
6976448|NCT01199289|11029080|FG000|Overall Study|Protocol Violation|1
6976449|NCT01199289|11029081|FG001|Overall Study|Protocol Violation|0
6976450|NCT01199289|11029082|FG002|Overall Study|Protocol Violation|0
6976451|NCT01199289|11029083|FG003|Overall Study|Protocol Violation|1
6976452|NCT01199289|11029080|FG000|Overall Study|Noncompliance|1
6976453|NCT01199289|11029081|FG001|Overall Study|Noncompliance|0
6976454|NCT01199289|11029082|FG002|Overall Study|Noncompliance|2
6976455|NCT01199289|11029083|FG003|Overall Study|Noncompliance|0
6976456|NCT01199289|11029080|FG000|Overall Study|Adverse Event|0
6976457|NCT01199289|11029081|FG001|Overall Study|Adverse Event|3
6976458|NCT01199289|11029082|FG002|Overall Study|Adverse Event|1
6976459|NCT01199289|11029083|FG003|Overall Study|Adverse Event|4
6976460|NCT01199289|11029080|FG000|Overall Study|Full consent withdrawn|2
6976461|NCT01199289|11029081|FG001|Overall Study|Full consent withdrawn|2
6976462|NCT01199289|11029082|FG002|Overall Study|Full consent withdrawn|2
6976463|NCT01199289|11029083|FG003|Overall Study|Full consent withdrawn|3
6976464|NCT01199289|11029080|FG000|Overall Study|Administrative decision|0
6976465|NCT01199289|11029081|FG001|Overall Study|Administrative decision|0
6976466|NCT01199289|11029082|FG002|Overall Study|Administrative decision|0
6976467|NCT01199289|11029083|FG003|Overall Study|Administrative decision|1
6976468|NCT01199289|11029080|FG000|Overall Study|Lost to Follow-up|0
6976469|NCT01199289|11029081|FG001|Overall Study|Lost to Follow-up|0
6976470|NCT01199289|11029082|FG002|Overall Study|Lost to Follow-up|0
6976471|NCT01199289|11029083|FG003|Overall Study|Lost to Follow-up|1
6976472|NCT01199289|11029080|FG000|Overall Study|Protocol-specified criteria|3
6976473|NCT01199289|11029081|FG001|Overall Study|Protocol-specified criteria|0
6976474|NCT01199289|11029082|FG002|Overall Study|Protocol-specified criteria|0
6976475|NCT01199289|11029083|FG003|Overall Study|Protocol-specified criteria|1
6976476|NCT01199289|11029080|FG000|Overall Study|Pregnancy|0
6976477|NCT01199289|11029081|FG001|Overall Study|Pregnancy|1
6976478|NCT01199289|11029082|FG002|Overall Study|Pregnancy|0
6976479|NCT01199289|11029083|FG003|Overall Study|Pregnancy|1
6976480|NCT01199471|11029096|FG000|Overall Study|Protocol Violation|4
6976481|NCT01199471|11029096|FG000|Overall Study|Withdrawal by Subject|1
6976482|NCT01199471|11029096|FG000|Overall Study|Physician Decision|1
6976483|NCT01199575|11029101|FG000|Overall Study|Withdrawal by Subject|5
6976484|NCT01199601|11029108|FG000|Overall Study|Lost to Follow-up|47
6958285|NCT01068652|11002785|FG000|Overall Study|Adverse Event|4
6958286|NCT01068652|11002786|FG001|Overall Study|Adverse Event|0
6958287|NCT01068652|11002785|FG000|Overall Study|Lack of Efficacy|0
6958288|NCT01068652|11002786|FG001|Overall Study|Lack of Efficacy|2
6958289|NCT01068652|11002785|FG000|Overall Study|Lost to Follow-up|2
6958290|NCT01068652|11002786|FG001|Overall Study|Lost to Follow-up|1
6958291|NCT01068652|11002785|FG000|Overall Study|Protocol Violation|3
6958292|NCT01068652|11002786|FG001|Overall Study|Protocol Violation|6
6958293|NCT01068652|11002785|FG000|Overall Study|Withdrawal criteria|1
6958294|NCT01068652|11002786|FG001|Overall Study|Withdrawal criteria|2
6958295|NCT01068652|11002785|FG000|Overall Study|Patient was not eligible|1
6958296|NCT01068652|11002786|FG001|Overall Study|Patient was not eligible|0
6958297|NCT01068652|11002785|FG000|Overall Study|Unclassified|7
6958298|NCT01068652|11002786|FG001|Overall Study|Unclassified|4
6958299|NCT01068665|11002794|FG000|Overall Study|Adverse Event|5
6958300|NCT01068665|11002795|FG001|Overall Study|Adverse Event|4
6958301|NCT01068665|11002794|FG000|Overall Study|Lack of Efficacy|0
6958302|NCT01068665|11002795|FG001|Overall Study|Lack of Efficacy|2
6958303|NCT01068665|11002794|FG000|Overall Study|Protocol Violation|5
6958304|NCT01068665|11002795|FG001|Overall Study|Protocol Violation|2
6958305|NCT01068665|11002794|FG000|Overall Study|Withdrawal Criteria|3
6958306|NCT01068665|11002795|FG001|Overall Study|Withdrawal Criteria|9
6958307|NCT01068665|11002794|FG000|Overall Study|Other|17
6958308|NCT01068665|11002795|FG001|Overall Study|Other|12
6958309|NCT01068678|11002803|FG000|Overall Study|Lack of Efficacy|3
6958310|NCT01068678|11002804|FG001|Overall Study|Lack of Efficacy|2
6958311|NCT01068678|11002803|FG000|Overall Study|Protocol Violation|5
6958312|NCT01068678|11002804|FG001|Overall Study|Protocol Violation|1
6958313|NCT01068678|11002803|FG000|Overall Study|Withdrawal criteria|12
6958314|NCT01068678|11002804|FG001|Overall Study|Withdrawal criteria|6
6958315|NCT01068678|11002803|FG000|Overall Study|Unclassified|18
6958316|NCT01068678|11002804|FG001|Overall Study|Unclassified|15
6958317|NCT01068717|11002810|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1
6958318|NCT01068717|11002811|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
6958319|NCT01068717|11002812|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
6958320|NCT01068717|11002813|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
6958321|NCT01068730|11002827|FG000|Period 3|Personal reason|1
6958322|NCT01068730|11002828|FG001|Period 3|Personal reason|0
6958323|NCT01068730|11002829|FG002|Period 3|Personal reason|0
6958324|NCT01068730|11002830|FG003|Period 3|Personal reason|0
6958325|NCT01068730|11002827|FG000|Period 4|Family emergency|0
6958326|NCT01068730|11002828|FG001|Period 4|Family emergency|1
6958327|NCT01068730|11002829|FG002|Period 4|Family emergency|0
6958328|NCT01068730|11002830|FG003|Period 4|Family emergency|0
6958329|NCT01068743|11002847|FG000|Period 3|Adverse Event|0
6958330|NCT01068743|11002848|FG001|Period 3|Adverse Event|1
6958331|NCT01068743|11002849|FG002|Period 3|Adverse Event|0
6958332|NCT01068743|11002850|FG003|Period 3|Adverse Event|0
6958333|NCT01068769|11002863|FG000|Overall Study|Ineligible|1
6958334|NCT01068860|11002886|FG000|Overall Study|Withdrawal by Subject|0
6958335|NCT01068860|11002887|FG001|Overall Study|Withdrawal by Subject|0
6958336|NCT01068860|11002888|FG002|Overall Study|Withdrawal by Subject|0
6958337|NCT01068860|11002889|FG003|Overall Study|Withdrawal by Subject|0
6958338|NCT01068860|11002890|FG004|Overall Study|Withdrawal by Subject|0
7072125|NCT02033369|11176041|FG000|Overall Study|Withdrawal by Subject|1
7072126|NCT02033369|11176042|FG001|Overall Study|Withdrawal by Subject|1
7072127|NCT02033369|11176041|FG000|Overall Study|Lost to Follow-up|1
7072128|NCT02033369|11176042|FG001|Overall Study|Lost to Follow-up|0
7072129|NCT02033369|11176041|FG000|Overall Study|Protocol Violation|2
7072130|NCT02033369|11176042|FG001|Overall Study|Protocol Violation|0
7072131|NCT02033759|11176080|FG000|Overall Study|Withdrawal by Subject|2
7072132|NCT02033759|11176081|FG001|Overall Study|Withdrawal by Subject|1
7072133|NCT02033759|11176080|FG000|Overall Study|Protocol Violation|1
7072134|NCT02033759|11176081|FG001|Overall Study|Protocol Violation|1
7072135|NCT02033850|11176089|FG000|Overall Study|Death|1
7072136|NCT02033850|11176090|FG001|Overall Study|Death|0
7072137|NCT02033850|11176089|FG000|Overall Study|unrelated medical reason|1
6958339|NCT01068860|11002891|FG005|Overall Study|Withdrawal by Subject|2
6958340|NCT01068860|11002892|FG006|Overall Study|Withdrawal by Subject|0
6958341|NCT01068860|11002893|FG007|Overall Study|Withdrawal by Subject|0
6958342|NCT01068860|11002894|FG008|Overall Study|Withdrawal by Subject|0
6958343|NCT01068860|11002895|FG009|Overall Study|Withdrawal by Subject|3
6958344|NCT01068860|11002886|FG000|Overall Study|Administrative problems; misrandomized|0
6958345|NCT01068860|11002887|FG001|Overall Study|Administrative problems; misrandomized|0
6958346|NCT01068860|11002888|FG002|Overall Study|Administrative problems; misrandomized|0
6958347|NCT01068860|11002889|FG003|Overall Study|Administrative problems; misrandomized|1
6958348|NCT01068860|11002890|FG004|Overall Study|Administrative problems; misrandomized|0
6958349|NCT01068860|11002891|FG005|Overall Study|Administrative problems; misrandomized|0
6958350|NCT01068860|11002892|FG006|Overall Study|Administrative problems; misrandomized|0
7072138|NCT02033850|11176090|FG001|Overall Study|unrelated medical reason|1
7072139|NCT02033889|11176108|FG000|Overall Study|Adverse Event|3
6958351|NCT01068860|11002893|FG007|Overall Study|Administrative problems; misrandomized|0
6958352|NCT01068860|11002894|FG008|Overall Study|Administrative problems; misrandomized|0
6958353|NCT01068860|11002895|FG009|Overall Study|Administrative problems; misrandomized|1
6958354|NCT01068860|11002886|FG000|Overall Study|Lost to Follow-up|0
6958355|NCT01068860|11002887|FG001|Overall Study|Lost to Follow-up|1
6958356|NCT01068860|11002888|FG002|Overall Study|Lost to Follow-up|0
6958357|NCT01068860|11002889|FG003|Overall Study|Lost to Follow-up|0
6958358|NCT01068860|11002890|FG004|Overall Study|Lost to Follow-up|0
6958359|NCT01068860|11002891|FG005|Overall Study|Lost to Follow-up|0
6958360|NCT01068860|11002892|FG006|Overall Study|Lost to Follow-up|0
6958361|NCT01068860|11002893|FG007|Overall Study|Lost to Follow-up|0
6958362|NCT01068860|11002894|FG008|Overall Study|Lost to Follow-up|0
6958363|NCT01068860|11002895|FG009|Overall Study|Lost to Follow-up|0
6958364|NCT01068912|11002924|FG000|Overall Study|Adverse Event|2
6958365|NCT01068912|11002925|FG001|Overall Study|Adverse Event|3
6958366|NCT01068912|11002926|FG002|Overall Study|Adverse Event|2
6958367|NCT01068912|11002924|FG000|Overall Study|Withdrawal by Subject|5
6958368|NCT01068912|11002925|FG001|Overall Study|Withdrawal by Subject|6
6958369|NCT01068912|11002926|FG002|Overall Study|Withdrawal by Subject|6
6958370|NCT01068912|11002924|FG000|Overall Study|Lost to Follow-up|3
6958371|NCT01068912|11002925|FG001|Overall Study|Lost to Follow-up|7
6958372|NCT01068912|11002926|FG002|Overall Study|Lost to Follow-up|3
6958373|NCT01068912|11002924|FG000|Overall Study|Protocol Violation|0
6958374|NCT01068912|11002925|FG001|Overall Study|Protocol Violation|2
6958375|NCT01068912|11002926|FG002|Overall Study|Protocol Violation|0
6958376|NCT01068912|11002924|FG000|Overall Study|aggravation influenza|1
6958377|NCT01068912|11002925|FG001|Overall Study|aggravation influenza|1
6958378|NCT01068912|11002926|FG002|Overall Study|aggravation influenza|1
6958379|NCT01068912|11002924|FG000|Overall Study|other underlying illness|0
6958380|NCT01068912|11002925|FG001|Overall Study|other underlying illness|3
6958381|NCT01068912|11002926|FG002|Overall Study|other underlying illness|3
6958382|NCT01069172|11002958|FG000|Overall Study|Withdrawal by Subject|1
6958383|NCT01069172|11002959|FG001|Overall Study|Withdrawal by Subject|0
6958384|NCT01069289|11002977|FG000|Overall Study|Withdrawal by Subject|15
6958385|NCT01069289|11002978|FG001|Overall Study|Withdrawal by Subject|26
6958386|NCT01069289|11002977|FG000|Overall Study|Adverse Event|21
6958387|NCT01069289|11002978|FG001|Overall Study|Adverse Event|28
6958388|NCT01069289|11002977|FG000|Overall Study|Eligibility criteria not fulfilled|2
6958389|NCT01069289|11002978|FG001|Overall Study|Eligibility criteria not fulfilled|0
6958390|NCT01069289|11002977|FG000|Overall Study|Severe non-compliance to protocol|3
6958391|NCT01069289|11002978|FG001|Overall Study|Severe non-compliance to protocol|2
6958392|NCT01069289|11002977|FG000|Overall Study|Due to deteriorating health condition|1
6958393|NCT01069289|11002978|FG001|Overall Study|Due to deteriorating health condition|0
6958394|NCT01069341|11003005|FG000|Overall Study|Lost to Follow-up|1
6958395|NCT01069419|11003017|FG000|Overall Study|Adverse Event|233
6958396|NCT01069419|11003017|FG000|Overall Study|Lack of Efficacy|332
6958397|NCT01069419|11003017|FG000|Overall Study|Lost to Follow-up|49
6958398|NCT01069419|11003017|FG000|Overall Study|Remission of disease|11
6958399|NCT01069419|11003017|FG000|Overall Study|Withdrawal by Subject|34
6958400|NCT01069419|11003017|FG000|Overall Study|Other Reason|43
6958401|NCT01069419|11003017|FG000|Overall Study|Missing termination information|13
6958402|NCT01069484|11003023|FG000|Overall Study|Death-in-near-family|1
6958403|NCT01069484|11003024|FG001|Overall Study|Death-in-near-family|0
6958404|NCT01069484|11003023|FG000|Overall Study|No specific reason|8
6958405|NCT01069484|11003024|FG001|Overall Study|No specific reason|2
6958406|NCT01069484|11003023|FG000|Overall Study|Illness mother or child|3
6958407|NCT01069484|11003024|FG001|Overall Study|Illness mother or child|1
6958408|NCT01069523|11003042|FG000|Overall Study|Withdrawal by Subject|4
6958409|NCT01069523|11003043|FG001|Overall Study|Withdrawal by Subject|7
6958410|NCT01069627|11003060|FG000|Overall Study|Disease progression|7
6958411|NCT01069627|11003060|FG000|Overall Study|Adverse Event|12
6958412|NCT01069627|11003060|FG000|Overall Study|Protocol Violation|1
6958413|NCT01069705|11003064|FG000|Overall Study|Adverse Event|1
6958414|NCT01069705|11003064|FG000|Overall Study|Withdrawal by Subject|2
6958415|NCT01069900|11003070|FG000|Overall Study|Technical problems|0
6958416|NCT01069900|11003071|FG001|Overall Study|Technical problems|1
6958417|NCT01069900|11003070|FG000|Overall Study|Lost to Follow-up|7
6958418|NCT01069900|11003071|FG001|Overall Study|Lost to Follow-up|1
6958419|NCT01069900|11003070|FG000|Overall Study|Withdrawal by Subject|6
6958420|NCT01069900|11003071|FG001|Overall Study|Withdrawal by Subject|1
6958421|NCT01069900|11003070|FG000|Overall Study|Protocol Violation|4
6958422|NCT01069900|11003071|FG001|Overall Study|Protocol Violation|1
6958423|NCT01069900|11003070|FG000|Overall Study|Insufficient Therapeutic effect|1
6958424|NCT01069900|11003071|FG001|Overall Study|Insufficient Therapeutic effect|0
6958425|NCT01069939|11003079|FG000|Randomised and Included in the Analyses|Adverse Event|17
6958426|NCT01069939|11003080|FG001|Randomised and Included in the Analyses|Adverse Event|22
6958427|NCT01069939|11003079|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15
6958428|NCT01069939|11003080|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12
6958429|NCT01069939|11003079|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1
6958430|NCT01069939|11003080|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1
6958431|NCT01069939|11003079|FG000|Randomised and Included in the Analyses|Protocol Violation|0
6958432|NCT01069939|11003080|FG001|Randomised and Included in the Analyses|Protocol Violation|1
6958433|NCT01069939|11003079|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0
6958434|NCT01069939|11003080|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1
6958435|NCT01069939|11003079|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7
6958436|NCT01069939|11003080|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33
6958437|NCT01069939|11003079|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4
6958438|NCT01069939|11003080|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3
6958439|NCT01069939|11003079|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4
6958440|NCT01069939|11003080|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2
6958441|NCT01069939|11003079|FG000|Randomised and Included in the Analyses|Physician Decision|0
6958442|NCT01069939|11003080|FG001|Randomised and Included in the Analyses|Physician Decision|2
6958443|NCT01069939|11003079|FG000|Randomised and Included in the Analyses|Removal|1
6958444|NCT01069939|11003080|FG001|Randomised and Included in the Analyses|Removal|0
6958445|NCT01070043|11003088|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18
6958446|NCT01070043|11003089|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0
6958447|NCT01070043|11003090|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0
6958448|NCT01070043|11003088|FG000|Double-Blind Treatment|Adverse Event|0
6958449|NCT01070043|11003089|FG001|Double-Blind Treatment|Adverse Event|0
6958450|NCT01070043|11003090|FG002|Double-Blind Treatment|Adverse Event|2
6958451|NCT01070303|11003119|FG000|Overall Study|Adverse Event|39
6958452|NCT01070303|11003119|FG000|Overall Study|Withdrawal by Subject|20
6958453|NCT01070303|11003119|FG000|Overall Study|Lost to Follow-up|9
6958454|NCT01070303|11003119|FG000|Overall Study|Protocol Violation|0
6958455|NCT01070303|11003119|FG000|Overall Study|Lack of Efficacy|2
6958456|NCT01070303|11003119|FG000|Overall Study|Administrative Reason|1
6958457|NCT01070303|11003119|FG000|Overall Study|Other|18
6958458|NCT01070316|11003129|FG000|Extension Phase|Lack of Efficacy|3
6958459|NCT01070316|11003129|FG000|Extension Phase|Withdrawal by Subject|1
6958460|NCT01070329|11003135|FG000|Overall Study|Adverse Event|13
6958461|NCT01070329|11003136|FG001|Overall Study|Adverse Event|10
6958462|NCT01070329|11003135|FG000|Overall Study|Lost to Follow-up|22
6958463|NCT01070329|11003136|FG001|Overall Study|Lost to Follow-up|12
6958464|NCT01070329|11003135|FG000|Overall Study|Withdrawal by Subject|9
6958465|NCT01070329|11003136|FG001|Overall Study|Withdrawal by Subject|11
6958466|NCT01070329|11003135|FG000|Overall Study|Protocol Violation|3
6958467|NCT01070329|11003136|FG001|Overall Study|Protocol Violation|8
6958468|NCT01070329|11003135|FG000|Overall Study|Lack of Efficacy|2
6958469|NCT01070329|11003136|FG001|Overall Study|Lack of Efficacy|6
6958470|NCT01070329|11003135|FG000|Overall Study|Physician Decision|2
6958471|NCT01070329|11003136|FG001|Overall Study|Physician Decision|1
6958472|NCT01070329|11003135|FG000|Overall Study|Entry Criteria Not Met|1
6958473|NCT01070329|11003136|FG001|Overall Study|Entry Criteria Not Met|0
6958474|NCT01070329|11003135|FG000|Overall Study|Sponsor Decision|0
6958475|NCT01070329|11003136|FG001|Overall Study|Sponsor Decision|1
6958476|NCT01070381|11003142|FG000|Period 2, 1 Week of Wear|Handling|0
6958477|NCT01070381|11003143|FG001|Period 2, 1 Week of Wear|Handling|1
6958478|NCT01070381|11003142|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1
6958479|NCT01070381|11003143|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0
6958480|NCT01070394|11003149|FG000|Overall Study|Adverse Event|6
6958481|NCT01070394|11003149|FG000|Overall Study|Withdrawal by Subject|1
6958482|NCT01070550|11003161|FG000|Overall Study|Adverse Event|43
6958483|NCT01070550|11003162|FG001|Overall Study|Adverse Event|1
6958484|NCT01070550|11003163|FG002|Overall Study|Adverse Event|3
6958485|NCT01070550|11003164|FG003|Overall Study|Adverse Event|0
6958486|NCT01070550|11003165|FG004|Overall Study|Adverse Event|0
6958487|NCT01070550|11003166|FG005|Overall Study|Adverse Event|0
6958488|NCT01070550|11003161|FG000|Overall Study|Death|20
6958489|NCT01070550|11003162|FG001|Overall Study|Death|4
6958490|NCT01070550|11003163|FG002|Overall Study|Death|3
6958491|NCT01070550|11003164|FG003|Overall Study|Death|0
6958492|NCT01070550|11003165|FG004|Overall Study|Death|0
6958493|NCT01070550|11003166|FG005|Overall Study|Death|0
6958494|NCT01070550|11003161|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2
6958495|NCT01070550|11003162|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1
6958496|NCT01070550|11003163|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1
6958497|NCT01070550|11003164|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0
6958498|NCT01070550|11003165|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0
6958499|NCT01070550|11003166|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0
6958500|NCT01070550|11003161|FG000|Overall Study|Early termination|3
6958501|NCT01070550|11003162|FG001|Overall Study|Early termination|0
6958502|NCT01070550|11003163|FG002|Overall Study|Early termination|0
6958503|NCT01070550|11003164|FG003|Overall Study|Early termination|0
7040844|NCT01721044|11124044|FG002|Treatment Period|Protocol Violation|0
7040845|NCT01721044|11124042|FG000|Treatment Period|Withdrawal by Subject|7
6958504|NCT01070550|11003165|FG004|Overall Study|Early termination|0
6958505|NCT01070550|11003166|FG005|Overall Study|Early termination|0
6958506|NCT01070550|11003161|FG000|Overall Study|Failed to return|450
6958507|NCT01070550|11003162|FG001|Overall Study|Failed to return|33
6958508|NCT01070550|11003163|FG002|Overall Study|Failed to return|144
7040846|NCT01721044|11124043|FG001|Treatment Period|Withdrawal by Subject|6
6958509|NCT01070550|11003164|FG003|Overall Study|Failed to return|40
6958510|NCT01070550|11003165|FG004|Overall Study|Failed to return|1
6958511|NCT01070550|11003166|FG005|Overall Study|Failed to return|2
6958512|NCT01070550|11003161|FG000|Overall Study|Incomplete treatment|2
6958513|NCT01070550|11003162|FG001|Overall Study|Incomplete treatment|0
6958514|NCT01070550|11003163|FG002|Overall Study|Incomplete treatment|0
6958515|NCT01070550|11003164|FG003|Overall Study|Incomplete treatment|0
6958516|NCT01070550|11003165|FG004|Overall Study|Incomplete treatment|0
6958517|NCT01070550|11003166|FG005|Overall Study|Incomplete treatment|0
6958518|NCT01070550|11003161|FG000|Overall Study|Lab test not done|22
6958519|NCT01070550|11003162|FG001|Overall Study|Lab test not done|3
6958520|NCT01070550|11003163|FG002|Overall Study|Lab test not done|4
6958521|NCT01070550|11003164|FG003|Overall Study|Lab test not done|1
6958522|NCT01070550|11003165|FG004|Overall Study|Lab test not done|0
6958523|NCT01070550|11003166|FG005|Overall Study|Lab test not done|1
6958524|NCT01070550|11003161|FG000|Overall Study|Lack of Efficacy|65
6958525|NCT01070550|11003162|FG001|Overall Study|Lack of Efficacy|1
6958526|NCT01070550|11003163|FG002|Overall Study|Lack of Efficacy|5
6958527|NCT01070550|11003164|FG003|Overall Study|Lack of Efficacy|5
6958528|NCT01070550|11003165|FG004|Overall Study|Lack of Efficacy|0
6958529|NCT01070550|11003166|FG005|Overall Study|Lack of Efficacy|1
6958530|NCT01070550|11003161|FG000|Overall Study|Miscellaneous|12
6958531|NCT01070550|11003162|FG001|Overall Study|Miscellaneous|2
6958532|NCT01070550|11003163|FG002|Overall Study|Miscellaneous|3
6958533|NCT01070550|11003164|FG003|Overall Study|Miscellaneous|1
6958534|NCT01070550|11003165|FG004|Overall Study|Miscellaneous|0
6958535|NCT01070550|11003166|FG005|Overall Study|Miscellaneous|0
6958536|NCT01070550|11003161|FG000|Overall Study|New treatment started|3
7072140|NCT02033889|11176109|FG001|Overall Study|Adverse Event|1
7072141|NCT02033889|11176110|FG002|Overall Study|Adverse Event|3
7072142|NCT02033889|11176108|FG000|Overall Study|Death|3
7072143|NCT02033889|11176109|FG001|Overall Study|Death|1
7072144|NCT02033889|11176110|FG002|Overall Study|Death|2
7072145|NCT02033889|11176108|FG000|Overall Study|Excluded Medication|1
6958537|NCT01070550|11003162|FG001|Overall Study|New treatment started|1
6958538|NCT01070550|11003163|FG002|Overall Study|New treatment started|0
6958539|NCT01070550|11003164|FG003|Overall Study|New treatment started|2
6958540|NCT01070550|11003165|FG004|Overall Study|New treatment started|0
6958541|NCT01070550|11003166|FG005|Overall Study|New treatment started|0
6958542|NCT01070550|11003161|FG000|Overall Study|Non-responders|493
6958543|NCT01070550|11003162|FG001|Overall Study|Non-responders|4
6958544|NCT01070550|11003163|FG002|Overall Study|Non-responders|21
6958545|NCT01070550|11003164|FG003|Overall Study|Non-responders|20
6958546|NCT01070550|11003165|FG004|Overall Study|Non-responders|0
6958547|NCT01070550|11003166|FG005|Overall Study|Non-responders|2
6958548|NCT01070550|11003161|FG000|Overall Study|Not categorized|33
6958549|NCT01070550|11003162|FG001|Overall Study|Not categorized|2
6958550|NCT01070550|11003163|FG002|Overall Study|Not categorized|6
6958551|NCT01070550|11003164|FG003|Overall Study|Not categorized|1
6958552|NCT01070550|11003165|FG004|Overall Study|Not categorized|0
6958553|NCT01070550|11003166|FG005|Overall Study|Not categorized|1
6958554|NCT01070550|11003161|FG000|Overall Study|Protocol Violation|15
6958555|NCT01070550|11003162|FG001|Overall Study|Protocol Violation|1
6958556|NCT01070550|11003163|FG002|Overall Study|Protocol Violation|1
6958557|NCT01070550|11003164|FG003|Overall Study|Protocol Violation|1
6958558|NCT01070550|11003165|FG004|Overall Study|Protocol Violation|0
6958559|NCT01070550|11003166|FG005|Overall Study|Protocol Violation|0
6958560|NCT01070550|11003161|FG000|Overall Study|Relapse|44
6958561|NCT01070550|11003162|FG001|Overall Study|Relapse|5
6958562|NCT01070550|11003163|FG002|Overall Study|Relapse|14
6958563|NCT01070550|11003164|FG003|Overall Study|Relapse|4
6958564|NCT01070550|11003165|FG004|Overall Study|Relapse|0
6958565|NCT01070550|11003166|FG005|Overall Study|Relapse|0
6958566|NCT01070550|11003161|FG000|Overall Study|Result not available|3
6958567|NCT01070550|11003162|FG001|Overall Study|Result not available|1
6958568|NCT01070550|11003163|FG002|Overall Study|Result not available|3
6958569|NCT01070550|11003164|FG003|Overall Study|Result not available|0
6958570|NCT01070550|11003165|FG004|Overall Study|Result not available|0
6958571|NCT01070550|11003166|FG005|Overall Study|Result not available|0
6958572|NCT01070550|11003161|FG000|Overall Study|Screen failure|1
6958573|NCT01070550|11003162|FG001|Overall Study|Screen failure|0
6958574|NCT01070550|11003163|FG002|Overall Study|Screen failure|0
6958575|NCT01070550|11003164|FG003|Overall Study|Screen failure|0
6958576|NCT01070550|11003165|FG004|Overall Study|Screen failure|0
7072146|NCT02033889|11176109|FG001|Overall Study|Excluded Medication|1
7072147|NCT02033889|11176110|FG002|Overall Study|Excluded Medication|0
7072148|NCT02033889|11176108|FG000|Overall Study|Lost to Follow-up|8
6958577|NCT01070550|11003166|FG005|Overall Study|Screen failure|0
6958578|NCT01070550|11003161|FG000|Overall Study|Sponsor decision|1
6958579|NCT01070550|11003162|FG001|Overall Study|Sponsor decision|0
6958580|NCT01070550|11003163|FG002|Overall Study|Sponsor decision|0
6958581|NCT01070550|11003164|FG003|Overall Study|Sponsor decision|0
6958582|NCT01070550|11003165|FG004|Overall Study|Sponsor decision|0
6958583|NCT01070550|11003166|FG005|Overall Study|Sponsor decision|0
6958584|NCT01070550|11003161|FG000|Overall Study|Treatment duration shortened|1
6958585|NCT01070550|11003162|FG001|Overall Study|Treatment duration shortened|0
6958586|NCT01070550|11003163|FG002|Overall Study|Treatment duration shortened|0
6958587|NCT01070550|11003164|FG003|Overall Study|Treatment duration shortened|0
6958588|NCT01070550|11003165|FG004|Overall Study|Treatment duration shortened|0
7072149|NCT02033889|11176109|FG001|Overall Study|Lost to Follow-up|5
6958589|NCT01070550|11003166|FG005|Overall Study|Treatment duration shortened|0
6958590|NCT01070550|11003161|FG000|Overall Study|Treatment interrupted|7
6958591|NCT01070550|11003162|FG001|Overall Study|Treatment interrupted|0
6958592|NCT01070550|11003163|FG002|Overall Study|Treatment interrupted|1
6958593|NCT01070550|11003164|FG003|Overall Study|Treatment interrupted|1
6958594|NCT01070550|11003165|FG004|Overall Study|Treatment interrupted|0
6958595|NCT01070550|11003166|FG005|Overall Study|Treatment interrupted|0
6958596|NCT01070550|11003161|FG000|Overall Study|Treatment not started|14
6958597|NCT01070550|11003162|FG001|Overall Study|Treatment not started|2
6958598|NCT01070550|11003163|FG002|Overall Study|Treatment not started|4
6958599|NCT01070550|11003164|FG003|Overall Study|Treatment not started|0
6958600|NCT01070550|11003165|FG004|Overall Study|Treatment not started|0
6958601|NCT01070550|11003166|FG005|Overall Study|Treatment not started|0
6958602|NCT01070550|11003161|FG000|Overall Study|Treatment restarted|0
6958603|NCT01070550|11003162|FG001|Overall Study|Treatment restarted|1
6958604|NCT01070550|11003163|FG002|Overall Study|Treatment restarted|0
6958605|NCT01070550|11003164|FG003|Overall Study|Treatment restarted|0
6958606|NCT01070550|11003165|FG004|Overall Study|Treatment restarted|0
6958607|NCT01070550|11003166|FG005|Overall Study|Treatment restarted|0
6958608|NCT01070550|11003161|FG000|Overall Study|Treatment stopped|3
6958609|NCT01070550|11003162|FG001|Overall Study|Treatment stopped|0
6958610|NCT01070550|11003163|FG002|Overall Study|Treatment stopped|0
6958611|NCT01070550|11003164|FG003|Overall Study|Treatment stopped|0
6958612|NCT01070550|11003165|FG004|Overall Study|Treatment stopped|0
6958613|NCT01070550|11003166|FG005|Overall Study|Treatment stopped|0
6958614|NCT01070550|11003161|FG000|Overall Study|Treatment unavailable|1
6958615|NCT01070550|11003162|FG001|Overall Study|Treatment unavailable|0
6958616|NCT01070550|11003163|FG002|Overall Study|Treatment unavailable|0
6958617|NCT01070550|11003164|FG003|Overall Study|Treatment unavailable|0
6958618|NCT01070550|11003165|FG004|Overall Study|Treatment unavailable|0
6958619|NCT01070550|11003166|FG005|Overall Study|Treatment unavailable|0
6958620|NCT01070550|11003161|FG000|Overall Study|Treatment was stopped early|7
6958621|NCT01070550|11003162|FG001|Overall Study|Treatment was stopped early|0
6958622|NCT01070550|11003163|FG002|Overall Study|Treatment was stopped early|0
6958623|NCT01070550|11003164|FG003|Overall Study|Treatment was stopped early|0
6958624|NCT01070550|11003165|FG004|Overall Study|Treatment was stopped early|0
6958625|NCT01070550|11003166|FG005|Overall Study|Treatment was stopped early|0
6958626|NCT01070550|11003161|FG000|Overall Study|Other|5
6958627|NCT01070550|11003162|FG001|Overall Study|Other|0
6958628|NCT01070550|11003163|FG002|Overall Study|Other|0
6958629|NCT01070550|11003164|FG003|Overall Study|Other|1
6958630|NCT01070550|11003165|FG004|Overall Study|Other|0
6958631|NCT01070550|11003166|FG005|Overall Study|Other|0
6958632|NCT01070550|11003161|FG000|Overall Study|Withdrawal by Subject|35
6958633|NCT01070550|11003162|FG001|Overall Study|Withdrawal by Subject|0
6958634|NCT01070550|11003163|FG002|Overall Study|Withdrawal by Subject|3
6958635|NCT01070550|11003164|FG003|Overall Study|Withdrawal by Subject|0
6958636|NCT01070550|11003165|FG004|Overall Study|Withdrawal by Subject|0
6958637|NCT01070550|11003166|FG005|Overall Study|Withdrawal by Subject|0
6958638|NCT01070771|11003190|FG000|Overall Study|Adverse Event|2
6958639|NCT01070771|11003190|FG000|Overall Study|Protocol Violation|1
6958640|NCT01070784|11003197|FG000|Overall Study|Withdrawal by Subject|6
6958641|NCT01070784|11003198|FG001|Overall Study|Withdrawal by Subject|9
6958642|NCT01070784|11003197|FG000|Overall Study|Adverse Event|14
6958643|NCT01070784|11003198|FG001|Overall Study|Adverse Event|9
6958644|NCT01070888|11003217|FG000|First Intervention (14 Days)|Adverse Event|0
6958645|NCT01070888|11003218|FG001|First Intervention (14 Days)|Adverse Event|1
6958646|NCT01070888|11003217|FG000|First Intervention (14 Days)|Lost to Follow-up|0
6958647|NCT01070888|11003218|FG001|First Intervention (14 Days)|Lost to Follow-up|1
6958648|NCT01070888|11003217|FG000|Washout (14 Days)|Physician Decision|1
6958649|NCT01070888|11003218|FG001|Washout (14 Days)|Physician Decision|0
6958650|NCT01070979|11003227|FG000|Overall Study|Adverse Event|2
6958651|NCT01070979|11003228|FG001|Overall Study|Adverse Event|3
6958652|NCT01070979|11003229|FG002|Overall Study|Adverse Event|3
6958653|NCT01070979|11003227|FG000|Overall Study|Lost to Follow-up|2
6958654|NCT01070979|11003228|FG001|Overall Study|Lost to Follow-up|1
6958655|NCT01070979|11003229|FG002|Overall Study|Lost to Follow-up|1
6958656|NCT01070979|11003227|FG000|Overall Study|Protocol Violation|0
6958657|NCT01070979|11003228|FG001|Overall Study|Protocol Violation|2
6958658|NCT01070979|11003229|FG002|Overall Study|Protocol Violation|6
6958659|NCT01070979|11003227|FG000|Overall Study|Surgery, moving, personal, abn. labs|4
6958660|NCT01070979|11003228|FG001|Overall Study|Surgery, moving, personal, abn. labs|4
6958661|NCT01070979|11003229|FG002|Overall Study|Surgery, moving, personal, abn. labs|2
6958662|NCT01070979|11003227|FG000|Overall Study|Withdrawal by Subject|3
6958663|NCT01070979|11003228|FG001|Overall Study|Withdrawal by Subject|1
6958664|NCT01070979|11003229|FG002|Overall Study|Withdrawal by Subject|1
6958665|NCT01070979|11003227|FG000|Overall Study|No study drug taken|0
6958666|NCT01070979|11003228|FG001|Overall Study|No study drug taken|1
6958667|NCT01070979|11003229|FG002|Overall Study|No study drug taken|0
6958668|NCT01071070|11003251|FG000|Overall Study|Adverse Event|0
6958669|NCT01071070|11003252|FG001|Overall Study|Adverse Event|3
6958670|NCT01071070|11003251|FG000|Overall Study|Withdrawal by Subject|1
6958671|NCT01071070|11003252|FG001|Overall Study|Withdrawal by Subject|0
6976485|NCT01199601|11029109|FG001|Overall Study|Lost to Follow-up|66
6958672|NCT01071070|11003251|FG000|Overall Study|Missed 3 consecutive doses of study drug|2
6958673|NCT01071070|11003252|FG001|Overall Study|Missed 3 consecutive doses of study drug|0
6958674|NCT01071070|11003251|FG000|Overall Study|Hypercalcemia|1
6958675|NCT01071070|11003252|FG001|Overall Study|Hypercalcemia|0
6958676|NCT01071083|11003263|FG000|Overall Study|Adverse Event|1
6958677|NCT01071083|11003264|FG001|Overall Study|Adverse Event|0
6958678|NCT01071083|11003265|FG002|Overall Study|Adverse Event|1
6958679|NCT01071083|11003266|FG003|Overall Study|Adverse Event|0
6958680|NCT01071083|11003267|FG004|Overall Study|Adverse Event|1
6958681|NCT01071083|11003263|FG000|Overall Study|Withdrawal by Subject|3
6958682|NCT01071083|11003264|FG001|Overall Study|Withdrawal by Subject|0
6958683|NCT01071083|11003265|FG002|Overall Study|Withdrawal by Subject|2
6958684|NCT01071083|11003266|FG003|Overall Study|Withdrawal by Subject|0
6958685|NCT01071083|11003267|FG004|Overall Study|Withdrawal by Subject|3
6958686|NCT01071083|11003263|FG000|Overall Study|Physician Decision|1
6958687|NCT01071083|11003264|FG001|Overall Study|Physician Decision|0
6958688|NCT01071083|11003265|FG002|Overall Study|Physician Decision|0
6958689|NCT01071083|11003266|FG003|Overall Study|Physician Decision|1
6958690|NCT01071083|11003267|FG004|Overall Study|Physician Decision|1
6958691|NCT01071083|11003263|FG000|Overall Study|Early Rescue|1
6958692|NCT01071083|11003264|FG001|Overall Study|Early Rescue|0
6958693|NCT01071083|11003265|FG002|Overall Study|Early Rescue|0
6958694|NCT01071083|11003266|FG003|Overall Study|Early Rescue|0
6958695|NCT01071083|11003267|FG004|Overall Study|Early Rescue|1
6958696|NCT01071083|11003263|FG000|Overall Study|Subject Moved|0
6958697|NCT01071083|11003264|FG001|Overall Study|Subject Moved|1
6958698|NCT01071083|11003265|FG002|Overall Study|Subject Moved|0
6958699|NCT01071083|11003266|FG003|Overall Study|Subject Moved|0
6958700|NCT01071083|11003267|FG004|Overall Study|Subject Moved|0
6958701|NCT01071083|11003263|FG000|Overall Study|Images Not Usable (Motion)|0
6958702|NCT01071083|11003264|FG001|Overall Study|Images Not Usable (Motion)|1
6958703|NCT01071083|11003265|FG002|Overall Study|Images Not Usable (Motion)|0
6958704|NCT01071083|11003266|FG003|Overall Study|Images Not Usable (Motion)|0
6958705|NCT01071083|11003267|FG004|Overall Study|Images Not Usable (Motion)|0
6958706|NCT01071083|11003263|FG000|Overall Study|Did Not Meet Eligibility Criteria|0
6958707|NCT01071083|11003264|FG001|Overall Study|Did Not Meet Eligibility Criteria|0
6958708|NCT01071083|11003265|FG002|Overall Study|Did Not Meet Eligibility Criteria|1
6958709|NCT01071083|11003266|FG003|Overall Study|Did Not Meet Eligibility Criteria|1
6958710|NCT01071083|11003267|FG004|Overall Study|Did Not Meet Eligibility Criteria|1
6958711|NCT01071083|11003263|FG000|Overall Study|Did Not Want Per Protocol Treatment|0
6958712|NCT01071083|11003264|FG001|Overall Study|Did Not Want Per Protocol Treatment|0
6958713|NCT01071083|11003265|FG002|Overall Study|Did Not Want Per Protocol Treatment|1
6958714|NCT01071083|11003266|FG003|Overall Study|Did Not Want Per Protocol Treatment|0
6958715|NCT01071083|11003267|FG004|Overall Study|Did Not Want Per Protocol Treatment|1
6958716|NCT01071083|11003263|FG000|Overall Study|Subject Refused to Continue|1
6958717|NCT01071083|11003264|FG001|Overall Study|Subject Refused to Continue|0
6958718|NCT01071083|11003265|FG002|Overall Study|Subject Refused to Continue|0
6958719|NCT01071083|11003266|FG003|Overall Study|Subject Refused to Continue|0
6958720|NCT01071083|11003267|FG004|Overall Study|Subject Refused to Continue|0
6958721|NCT01071096|11003279|FG000|First Intervention (90 Days)|Lost to Follow-up|1
6958722|NCT01071096|11003280|FG001|First Intervention (90 Days)|Lost to Follow-up|0
6958723|NCT01071200|11003299|FG000|Overall Study|Lack of ovarian response|1
6958724|NCT01071200|11003300|FG001|Overall Study|Lack of ovarian response|1
6958725|NCT01071200|11003299|FG000|Overall Study|No fertilization|4
6958726|NCT01071200|11003300|FG001|Overall Study|No fertilization|0
6958727|NCT01071200|11003299|FG000|Overall Study|No oocytes retrieved|1
6958728|NCT01071200|11003300|FG001|Overall Study|No oocytes retrieved|1
6958729|NCT01071200|11003299|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1
6958730|NCT01071200|11003300|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0
6958731|NCT01071200|11003299|FG000|Overall Study|No viable embryos|0
6958732|NCT01071200|11003300|FG001|Overall Study|No viable embryos|1
6958733|NCT01071252|11003311|FG000|Overall Study|unsatisfactory therapeutic effect|4
6958734|NCT01071252|11003312|FG001|Overall Study|unsatisfactory therapeutic effect|6
6958735|NCT01071252|11003313|FG002|Overall Study|unsatisfactory therapeutic effect|2
6958736|NCT01071252|11003314|FG003|Overall Study|unsatisfactory therapeutic effect|0
6958737|NCT01071252|11003315|FG004|Overall Study|unsatisfactory therapeutic effect|6
6958738|NCT01071252|11003311|FG000|Overall Study|Withdrawal by Subject|8
6958739|NCT01071252|11003312|FG001|Overall Study|Withdrawal by Subject|2
6958740|NCT01071252|11003313|FG002|Overall Study|Withdrawal by Subject|1
6958741|NCT01071252|11003314|FG003|Overall Study|Withdrawal by Subject|2
6958742|NCT01071252|11003315|FG004|Overall Study|Withdrawal by Subject|3
6958743|NCT01071252|11003311|FG000|Overall Study|administrative problems|1
6958744|NCT01071252|11003312|FG001|Overall Study|administrative problems|1
6958745|NCT01071252|11003313|FG002|Overall Study|administrative problems|0
6958746|NCT01071252|11003314|FG003|Overall Study|administrative problems|2
6958747|NCT01071252|11003315|FG004|Overall Study|administrative problems|1
6958748|NCT01071252|11003311|FG000|Overall Study|Lost to Follow-up|1
6958749|NCT01071252|11003312|FG001|Overall Study|Lost to Follow-up|0
6958750|NCT01071252|11003313|FG002|Overall Study|Lost to Follow-up|1
6958751|NCT01071252|11003314|FG003|Overall Study|Lost to Follow-up|2
6958752|NCT01071252|11003315|FG004|Overall Study|Lost to Follow-up|0
6958753|NCT01071252|11003311|FG000|Overall Study|Adverse Event|1
6958754|NCT01071252|11003312|FG001|Overall Study|Adverse Event|1
6958755|NCT01071252|11003313|FG002|Overall Study|Adverse Event|0
6958756|NCT01071252|11003314|FG003|Overall Study|Adverse Event|1
6958757|NCT01071252|11003315|FG004|Overall Study|Adverse Event|0
6958758|NCT01071252|11003311|FG000|Overall Study|Death|0
6958759|NCT01071252|11003312|FG001|Overall Study|Death|0
6958760|NCT01071252|11003313|FG002|Overall Study|Death|0
6958761|NCT01071252|11003314|FG003|Overall Study|Death|0
6958762|NCT01071252|11003315|FG004|Overall Study|Death|1
6958763|NCT01071278|11003327|FG000|Overall Study|Premature Discontinuation|254
6958764|NCT01071278|11003327|FG000|Overall Study|Completion Status Unknown|459
6958765|NCT01071317|11003335|FG000|Overall Study|Lost to Follow-up|2
6958766|NCT01071317|11003336|FG001|Overall Study|Lost to Follow-up|2
6958767|NCT01071395|11003353|FG000|Overall Study|Withdrawal by Subject|2
6958768|NCT01071395|11003354|FG001|Overall Study|Withdrawal by Subject|1
6958769|NCT01071395|11003353|FG000|Overall Study|Adverse Event|3
6958770|NCT01071395|11003354|FG001|Overall Study|Adverse Event|1
6958771|NCT01071512|11003360|FG000|Overall Study|Adverse Event|1
6958772|NCT01071512|11003360|FG000|Overall Study|Development of antibodies to drug|2
6958773|NCT01071512|11003360|FG000|Overall Study|positive anti-JC virus antibody test|2
6958774|NCT01071798|11003368|FG000|Participants Who Received One Cycle|Lack of Efficacy|18
6958775|NCT01071798|11003368|FG000|Participants Who Received One Cycle|Lack of tolerability|14
6958776|NCT01071798|11003368|FG000|Participants Who Received One Cycle|Patient requirement|20
6958777|NCT01071798|11003368|FG000|Participants Who Received One Cycle|Death|5
6958778|NCT01071798|11003368|FG000|Participants Who Received One Cycle|Change of therapy|6
6958779|NCT01071798|11003368|FG000|Participants Who Received One Cycle|Severe concomitant disease|2
6958780|NCT01071798|11003368|FG000|Subpopulation Who Received Two Cycles|Remission|1
6958781|NCT01071798|11003368|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3
6958782|NCT01071798|11003368|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4
7072150|NCT02033889|11176110|FG002|Overall Study|Lost to Follow-up|6
7072151|NCT02033889|11176108|FG000|Overall Study|Non-Compliance With Study Drug|1
7072152|NCT02033889|11176109|FG001|Overall Study|Non-Compliance With Study Drug|0
7072153|NCT02033889|11176110|FG002|Overall Study|Non-Compliance With Study Drug|0
7072154|NCT02033889|11176108|FG000|Overall Study|Physician Decision|0
7072155|NCT02033889|11176109|FG001|Overall Study|Physician Decision|1
7072156|NCT02033889|11176110|FG002|Overall Study|Physician Decision|1
6958783|NCT01071798|11003368|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7
6958784|NCT01071915|11003382|FG000|Overall Study|Adverse Event|3
6958785|NCT01071915|11003382|FG000|Overall Study|Physician Decision|2
6958786|NCT01071915|11003382|FG000|Overall Study|Withdrawal by Subject|2
6958787|NCT01071915|11003382|FG000|Overall Study|Miscellaneous Reasons|2
6958788|NCT01071954|11003386|FG000|Overall Study|Noncompliance|4
6958789|NCT01071954|11003386|FG000|Overall Study|Adverse Event|1
6958790|NCT01071954|11003386|FG000|Overall Study|Withdrawal by Subject|11
6958791|NCT01071954|11003386|FG000|Overall Study|Requirement for Alternative Therapy|5
6958792|NCT01071954|11003386|FG000|Overall Study|Administrative Decision|5
6958793|NCT01071954|11003386|FG000|Overall Study|Protocol Specified Criteria|1
6958794|NCT01072149|11003430|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
6958795|NCT01072149|11003431|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
6958796|NCT01072149|11003432|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
6958797|NCT01072149|11003433|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
6958798|NCT01072149|11003434|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
6958799|NCT01072149|11003435|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
6958800|NCT01072149|11003436|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
6958801|NCT01072149|11003437|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
6958802|NCT01072149|11003438|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
6958803|NCT01072149|11003439|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
6958804|NCT01072149|11003440|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
6958805|NCT01072149|11003441|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
6958806|NCT01072149|11003442|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
6958807|NCT01072149|11003443|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
6958808|NCT01072149|11003444|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
6958809|NCT01072149|11003445|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
6958810|NCT01072149|11003446|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
6958811|NCT01072149|11003447|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
6958812|NCT01072149|11003430|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0
6958813|NCT01072149|11003431|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0
6958814|NCT01072149|11003432|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0
6958815|NCT01072149|11003433|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0
6958816|NCT01072149|11003434|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0
6958817|NCT01072149|11003435|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0
6958818|NCT01072149|11003436|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0
6958819|NCT01072149|11003437|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0
6958820|NCT01072149|11003438|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0
7072157|NCT02033889|11176108|FG000|Overall Study|Participant moved|0
7072158|NCT02033889|11176109|FG001|Overall Study|Participant moved|1
7072159|NCT02033889|11176110|FG002|Overall Study|Participant moved|0
7072160|NCT02033889|11176108|FG000|Overall Study|Withdrawal by Subject|18
7072161|NCT02033889|11176109|FG001|Overall Study|Withdrawal by Subject|10
7072162|NCT02033889|11176110|FG002|Overall Study|Withdrawal by Subject|13
7072163|NCT02034006|11176129|FG000|Overall Study|Withdrawal by Subject|7
7072164|NCT02034006|11176129|FG000|Overall Study|Lost to Follow-up|5
7072165|NCT02034006|11176129|FG000|Overall Study|Death|1
7072166|NCT02034006|11176129|FG000|Overall Study|Pregnancy|1
7072167|NCT02034058|11176145|FG000|Overall Study|Death|3
7072168|NCT02034162|11176151|FG000|Double-blind|Lost to Follow-up|3
7072169|NCT02034162|11176152|FG001|Double-blind|Lost to Follow-up|0
7072170|NCT02034162|11176153|FG002|Double-blind|Lost to Follow-up|0
7072171|NCT02034162|11176151|FG000|Double-blind|Physician Decision|1
7072172|NCT02034162|11176152|FG001|Double-blind|Physician Decision|0
7072173|NCT02034162|11176153|FG002|Double-blind|Physician Decision|0
7072174|NCT02034162|11176151|FG000|Double-blind|Protocol Violation|0
7072175|NCT02034162|11176152|FG001|Double-blind|Protocol Violation|1
7072176|NCT02034162|11176153|FG002|Double-blind|Protocol Violation|0
7072177|NCT02034162|11176151|FG000|Double-blind|Withdrawal by Subject|5
7072178|NCT02034162|11176152|FG001|Double-blind|Withdrawal by Subject|7
7072179|NCT02034162|11176153|FG002|Double-blind|Withdrawal by Subject|0
7072180|NCT02034409|11176170|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4
7072181|NCT02034409|11176171|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0
7072182|NCT02034409|11176170|FG000|Sham-Controlled Treatment Period|Adverse Event|1
7072183|NCT02034409|11176171|FG001|Sham-Controlled Treatment Period|Adverse Event|1
7072184|NCT02034409|11176170|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0
7072185|NCT02034409|11176171|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1
7072186|NCT02034409|11176170|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8
7072187|NCT02034409|11176171|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8
7072188|NCT02034409|11176170|FG000|Sham-Controlled Treatment Period|Physician Decision|1
7072189|NCT02034409|11176171|FG001|Sham-Controlled Treatment Period|Physician Decision|3
7072190|NCT02034409|11176170|FG000|Sham-Controlled Treatment Period|misrandomized|2
6958821|NCT01072149|11003439|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0
6958822|NCT01072149|11003440|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0
6958823|NCT01072149|11003441|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0
6958824|NCT01072149|11003442|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0
6958825|NCT01072149|11003443|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0
6958826|NCT01072149|11003444|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0
6958827|NCT01072149|11003445|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0
6958828|NCT01072149|11003446|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0
6958829|NCT01072149|11003447|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1
6958830|NCT01072149|11003430|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0
6958831|NCT01072149|11003431|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0
6958832|NCT01072149|11003432|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0
6958833|NCT01072149|11003433|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0
6958834|NCT01072149|11003434|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0
6958835|NCT01072149|11003435|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0
6958836|NCT01072149|11003436|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0
6958837|NCT01072149|11003437|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0
6958838|NCT01072149|11003438|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0
6958839|NCT01072149|11003439|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0
6958840|NCT01072149|11003440|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1
6958841|NCT01072149|11003441|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0
6958842|NCT01072149|11003442|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0
6958843|NCT01072149|11003443|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0
6958844|NCT01072149|11003444|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7072191|NCT02034409|11176171|FG001|Sham-Controlled Treatment Period|misrandomized|2
7072192|NCT02034435|11176179|FG000|Overall Study|Withdrawal by Subject|1
7072193|NCT02034435|11176180|FG001|Overall Study|Withdrawal by Subject|0
7072194|NCT02034435|11176181|FG002|Overall Study|Withdrawal by Subject|0
7072195|NCT02034435|11176182|FG003|Overall Study|Withdrawal by Subject|0
7072196|NCT02034435|11176179|FG000|Overall Study|Illness|0
7072197|NCT02034435|11176180|FG001|Overall Study|Illness|2
7072198|NCT02034435|11176181|FG002|Overall Study|Illness|0
7072199|NCT02034435|11176182|FG003|Overall Study|Illness|0
7072200|NCT02034435|11176179|FG000|Overall Study|Inadequate IV access|1
6958845|NCT01072149|11003445|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0
6958846|NCT01072149|11003446|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0
6958847|NCT01072149|11003447|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0
6958848|NCT01072149|11003430|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0
6958849|NCT01072149|11003431|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1
6958850|NCT01072149|11003432|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0
6958851|NCT01072149|11003433|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0
6958852|NCT01072149|11003434|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0
6958853|NCT01072149|11003435|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0
6958854|NCT01072149|11003436|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0
6958855|NCT01072149|11003437|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7072201|NCT02034435|11176180|FG001|Overall Study|Inadequate IV access|0
7072202|NCT02034435|11176181|FG002|Overall Study|Inadequate IV access|0
7072203|NCT02034435|11176182|FG003|Overall Study|Inadequate IV access|1
6958856|NCT01072149|11003438|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0
6958857|NCT01072149|11003439|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0
6958858|NCT01072149|11003440|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0
6958859|NCT01072149|11003441|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0
6958860|NCT01072149|11003442|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0
6958861|NCT01072149|11003443|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0
6958862|NCT01072149|11003444|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0
6958863|NCT01072149|11003445|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0
6958864|NCT01072149|11003446|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0
6958865|NCT01072149|11003447|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0
6958866|NCT01072149|11003430|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
6958867|NCT01072149|11003431|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
6958868|NCT01072149|11003432|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1
6958869|NCT01072149|11003433|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
6958870|NCT01072149|11003434|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
6958871|NCT01072149|11003435|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
6958872|NCT01072149|11003436|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
6958873|NCT01072149|11003437|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
6958874|NCT01072149|11003438|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
6958875|NCT01072149|11003439|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
6958876|NCT01072149|11003440|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
6958877|NCT01072149|11003441|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
6958878|NCT01072149|11003442|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
6958879|NCT01072149|11003443|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
6958880|NCT01072149|11003444|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
6958881|NCT01072149|11003445|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
6958882|NCT01072149|11003446|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
6958883|NCT01072149|11003447|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
6958884|NCT01072149|11003430|FG000|Treatment Period 2 (28 Days)|Physician Decision|0
6958885|NCT01072149|11003431|FG001|Treatment Period 2 (28 Days)|Physician Decision|0
6958886|NCT01072149|11003432|FG002|Treatment Period 2 (28 Days)|Physician Decision|0
6958887|NCT01072149|11003433|FG003|Treatment Period 2 (28 Days)|Physician Decision|0
6958888|NCT01072149|11003434|FG004|Treatment Period 2 (28 Days)|Physician Decision|0
6958889|NCT01072149|11003435|FG005|Treatment Period 2 (28 Days)|Physician Decision|0
6958890|NCT01072149|11003436|FG006|Treatment Period 2 (28 Days)|Physician Decision|0
6958891|NCT01072149|11003437|FG007|Treatment Period 2 (28 Days)|Physician Decision|1
6958892|NCT01072149|11003438|FG008|Treatment Period 2 (28 Days)|Physician Decision|0
6958893|NCT01072149|11003439|FG009|Treatment Period 2 (28 Days)|Physician Decision|0
6958894|NCT01072149|11003440|FG010|Treatment Period 2 (28 Days)|Physician Decision|0
6958895|NCT01072149|11003441|FG011|Treatment Period 2 (28 Days)|Physician Decision|0
6958896|NCT01072149|11003442|FG012|Treatment Period 2 (28 Days)|Physician Decision|0
6958897|NCT01072149|11003443|FG013|Treatment Period 2 (28 Days)|Physician Decision|0
6958898|NCT01072149|11003444|FG014|Treatment Period 2 (28 Days)|Physician Decision|0
6958899|NCT01072149|11003445|FG015|Treatment Period 2 (28 Days)|Physician Decision|0
6958900|NCT01072149|11003446|FG016|Treatment Period 2 (28 Days)|Physician Decision|0
6958901|NCT01072149|11003447|FG017|Treatment Period 2 (28 Days)|Physician Decision|0
6958902|NCT01072149|11003430|FG000|Washout Period 2 (14 Days)|Physician Decision|1
6958903|NCT01072149|11003431|FG001|Washout Period 2 (14 Days)|Physician Decision|0
6958904|NCT01072149|11003432|FG002|Washout Period 2 (14 Days)|Physician Decision|0
6958905|NCT01072149|11003433|FG003|Washout Period 2 (14 Days)|Physician Decision|0
6958906|NCT01072149|11003434|FG004|Washout Period 2 (14 Days)|Physician Decision|0
6958907|NCT01072149|11003435|FG005|Washout Period 2 (14 Days)|Physician Decision|0
6958908|NCT01072149|11003436|FG006|Washout Period 2 (14 Days)|Physician Decision|0
6958909|NCT01072149|11003437|FG007|Washout Period 2 (14 Days)|Physician Decision|0
6958910|NCT01072149|11003438|FG008|Washout Period 2 (14 Days)|Physician Decision|0
6958911|NCT01072149|11003439|FG009|Washout Period 2 (14 Days)|Physician Decision|0
6958912|NCT01072149|11003440|FG010|Washout Period 2 (14 Days)|Physician Decision|0
6958913|NCT01072149|11003441|FG011|Washout Period 2 (14 Days)|Physician Decision|0
6958914|NCT01072149|11003442|FG012|Washout Period 2 (14 Days)|Physician Decision|0
6958915|NCT01072149|11003443|FG013|Washout Period 2 (14 Days)|Physician Decision|0
6958916|NCT01072149|11003444|FG014|Washout Period 2 (14 Days)|Physician Decision|0
6958917|NCT01072149|11003445|FG015|Washout Period 2 (14 Days)|Physician Decision|0
6958918|NCT01072149|11003446|FG016|Washout Period 2 (14 Days)|Physician Decision|0
6958919|NCT01072149|11003447|FG017|Washout Period 2 (14 Days)|Physician Decision|0
6958920|NCT01072149|11003430|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0
6958921|NCT01072149|11003431|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0
6958922|NCT01072149|11003432|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0
6958923|NCT01072149|11003433|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0
6958924|NCT01072149|11003434|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0
6958925|NCT01072149|11003435|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0
6958926|NCT01072149|11003436|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0
6958927|NCT01072149|11003437|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0
6958928|NCT01072149|11003438|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0
6958929|NCT01072149|11003439|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0
6958930|NCT01072149|11003440|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0
6958931|NCT01072149|11003441|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0
6958932|NCT01072149|11003442|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0
6958933|NCT01072149|11003443|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0
6958934|NCT01072149|11003444|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0
6958935|NCT01072149|11003445|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1
6958936|NCT01072149|11003446|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0
6958937|NCT01072149|11003447|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0
6958938|NCT01072149|11003430|FG000|Washout Period 2 (14 Days)|Adverse Event|0
6958939|NCT01072149|11003431|FG001|Washout Period 2 (14 Days)|Adverse Event|0
6958940|NCT01072149|11003432|FG002|Washout Period 2 (14 Days)|Adverse Event|0
6958941|NCT01072149|11003433|FG003|Washout Period 2 (14 Days)|Adverse Event|0
6958942|NCT01072149|11003434|FG004|Washout Period 2 (14 Days)|Adverse Event|0
6958943|NCT01072149|11003435|FG005|Washout Period 2 (14 Days)|Adverse Event|0
6958944|NCT01072149|11003436|FG006|Washout Period 2 (14 Days)|Adverse Event|0
6958945|NCT01072149|11003437|FG007|Washout Period 2 (14 Days)|Adverse Event|0
6958946|NCT01072149|11003438|FG008|Washout Period 2 (14 Days)|Adverse Event|0
6958947|NCT01072149|11003439|FG009|Washout Period 2 (14 Days)|Adverse Event|0
6958948|NCT01072149|11003440|FG010|Washout Period 2 (14 Days)|Adverse Event|0
6958949|NCT01072149|11003441|FG011|Washout Period 2 (14 Days)|Adverse Event|0
6958950|NCT01072149|11003442|FG012|Washout Period 2 (14 Days)|Adverse Event|0
6958951|NCT01072149|11003443|FG013|Washout Period 2 (14 Days)|Adverse Event|0
6958952|NCT01072149|11003444|FG014|Washout Period 2 (14 Days)|Adverse Event|0
6958953|NCT01072149|11003445|FG015|Washout Period 2 (14 Days)|Adverse Event|1
6958954|NCT01072149|11003446|FG016|Washout Period 2 (14 Days)|Adverse Event|0
6958955|NCT01072149|11003447|FG017|Washout Period 2 (14 Days)|Adverse Event|0
6958956|NCT01072149|11003430|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0
6958957|NCT01072149|11003431|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0
6958958|NCT01072149|11003432|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0
6958959|NCT01072149|11003433|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0
6958960|NCT01072149|11003434|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0
6958961|NCT01072149|11003435|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0
6958962|NCT01072149|11003436|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0
6958963|NCT01072149|11003437|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0
6958964|NCT01072149|11003438|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0
6958965|NCT01072149|11003439|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0
6958966|NCT01072149|11003440|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0
6958967|NCT01072149|11003441|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0
6958968|NCT01072149|11003442|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1
6958969|NCT01072149|11003443|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0
6958970|NCT01072149|11003444|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0
6958971|NCT01072149|11003445|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0
6958972|NCT01072149|11003446|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0
6958973|NCT01072149|11003447|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0
6958974|NCT01072149|11003430|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
6958975|NCT01072149|11003431|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
6958976|NCT01072149|11003432|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
6958977|NCT01072149|11003433|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
6958978|NCT01072149|11003434|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
6958979|NCT01072149|11003435|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
6958980|NCT01072149|11003436|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
6958981|NCT01072149|11003437|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
6958982|NCT01072149|11003438|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
6958983|NCT01072149|11003439|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
6958984|NCT01072149|11003440|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
6958985|NCT01072149|11003441|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
6958986|NCT01072149|11003442|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
6958987|NCT01072149|11003443|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
6958988|NCT01072149|11003444|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
6958989|NCT01072149|11003445|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
6958990|NCT01072149|11003446|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
6958991|NCT01072149|11003447|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
6958992|NCT01072201|11003468|FG000|Overall Study|Lost to Follow-up|0
6958993|NCT01072201|11003469|FG001|Overall Study|Lost to Follow-up|1
6958994|NCT01072344|11003490|FG000|Overall Study|Relasped-reached end point|7
6958995|NCT01072344|11003491|FG001|Overall Study|Relasped-reached end point|12
6958996|NCT01072344|11003490|FG000|Overall Study|Protocol Violation|1
6958997|NCT01072344|11003491|FG001|Overall Study|Protocol Violation|2
6958998|NCT01072344|11003490|FG000|Overall Study|Lost to Follow-up|3
6958999|NCT01072344|11003491|FG001|Overall Study|Lost to Follow-up|4
6959000|NCT01072357|11003499|FG000|Overall Study|Lost to Follow-up|0
6959001|NCT01072357|11003500|FG001|Overall Study|Lost to Follow-up|1
6959002|NCT01072396|11003508|FG000|Period One|Adverse Event|1
6959003|NCT01072396|11003509|FG001|Period One|Adverse Event|1
6959004|NCT01072396|11003508|FG000|Period One|Protocol Violation|2
6959005|NCT01072396|11003509|FG001|Period One|Protocol Violation|1
6959006|NCT01072396|11003508|FG000|Period One|Withdrawal by Subject|2
6959007|NCT01072396|11003509|FG001|Period One|Withdrawal by Subject|0
6959008|NCT01072396|11003508|FG000|Washout Period|Missing termination information|0
6959009|NCT01072396|11003509|FG001|Washout Period|Missing termination information|1
6959010|NCT01072396|11003508|FG000|Period Two|Adverse Event|0
6959011|NCT01072396|11003509|FG001|Period Two|Adverse Event|3
6959012|NCT01072396|11003508|FG000|Period Two|Lost to Follow-up|1
6959013|NCT01072396|11003509|FG001|Period Two|Lost to Follow-up|0
6959014|NCT01072448|11003521|FG000|Overall Study|Adverse Event|9
6959015|NCT01072448|11003522|FG001|Overall Study|Adverse Event|10
6959016|NCT01072448|11003521|FG000|Overall Study|Subject withdrew consent|4
6959017|NCT01072448|11003522|FG001|Overall Study|Subject withdrew consent|9
6959018|NCT01072448|11003521|FG000|Overall Study|Protocol deviation|3
6959019|NCT01072448|11003522|FG001|Overall Study|Protocol deviation|4
6959020|NCT01072448|11003521|FG000|Overall Study|Abnormal test procedure result(s)|1
6959021|NCT01072448|11003522|FG001|Overall Study|Abnormal test procedure result(s)|0
6959022|NCT01072448|11003521|FG000|Overall Study|Unsatisfactory therapeutic effect|1
6959023|NCT01072448|11003522|FG001|Overall Study|Unsatisfactory therapeutic effect|3
6959024|NCT01072448|11003521|FG000|Overall Study|Lost to Follow-up|1
6959025|NCT01072448|11003522|FG001|Overall Study|Lost to Follow-up|1
6959026|NCT01072448|11003521|FG000|Overall Study|Abnormal laboratory value(s)|0
6959027|NCT01072448|11003522|FG001|Overall Study|Abnormal laboratory value(s)|1
6959028|NCT01072448|11003521|FG000|Overall Study|Death|0
6959029|NCT01072448|11003522|FG001|Overall Study|Death|2
6959030|NCT01072500|11003530|FG000|Overall Study|Death|2
6959031|NCT01072500|11003531|FG001|Overall Study|Death|2
6959032|NCT01072500|11003530|FG000|Overall Study|Lost to Follow-up|5
6959033|NCT01072500|11003531|FG001|Overall Study|Lost to Follow-up|2
6959034|NCT01072500|11003530|FG000|Overall Study|Withdrawal by Subject|17
6959035|NCT01072500|11003531|FG001|Overall Study|Withdrawal by Subject|10
6959036|NCT01072539|11003539|FG000|Overall Study|Treated prior to the Site Initiation|1
6959037|NCT01072539|11003539|FG000|Overall Study|Protocol Violation|2
6959038|NCT01072630|11003551|FG000|Overall Study|Adverse Event|11
6959039|NCT01072630|11003552|FG001|Overall Study|Adverse Event|19
6959040|NCT01072630|11003553|FG002|Overall Study|Adverse Event|2
6959041|NCT01072630|11003551|FG000|Overall Study|Lack of Efficacy|10
6959042|NCT01072630|11003552|FG001|Overall Study|Lack of Efficacy|10
6959043|NCT01072630|11003553|FG002|Overall Study|Lack of Efficacy|1
6959044|NCT01072630|11003551|FG000|Overall Study|Withdrawal by Subject|8
6959045|NCT01072630|11003552|FG001|Overall Study|Withdrawal by Subject|7
6959046|NCT01072630|11003553|FG002|Overall Study|Withdrawal by Subject|2
6959047|NCT01072630|11003551|FG000|Overall Study|Protocol Violation|10
6959048|NCT01072630|11003552|FG001|Overall Study|Protocol Violation|8
6959049|NCT01072630|11003553|FG002|Overall Study|Protocol Violation|4
6959050|NCT01072630|11003551|FG000|Overall Study|Lost to Follow-up|11
6959051|NCT01072630|11003552|FG001|Overall Study|Lost to Follow-up|11
6959052|NCT01072630|11003553|FG002|Overall Study|Lost to Follow-up|1
6959053|NCT01072630|11003551|FG000|Overall Study|Noncompliance with study medication|1
6959054|NCT01072630|11003552|FG001|Overall Study|Noncompliance with study medication|1
6959055|NCT01072630|11003553|FG002|Overall Study|Noncompliance with study medication|1
6959056|NCT01072630|11003551|FG000|Overall Study|Noncompliance with study procedures|1
6959057|NCT01072630|11003552|FG001|Overall Study|Noncompliance with study procedures|2
6959058|NCT01072630|11003553|FG002|Overall Study|Noncompliance with study procedures|1
6959059|NCT01072630|11003551|FG000|Overall Study|Other|3
6959060|NCT01072630|11003552|FG001|Overall Study|Other|2
6959061|NCT01072630|11003553|FG002|Overall Study|Other|1
6959062|NCT01072877|11003613|FG000|Overall Study|Lost to Follow-up|1
6959063|NCT01072877|11003614|FG001|Overall Study|Lost to Follow-up|1
6959064|NCT01072877|11003615|FG002|Overall Study|Lost to Follow-up|0
6959065|NCT01072877|11003616|FG003|Overall Study|Lost to Follow-up|2
6959066|NCT01072877|11003617|FG004|Overall Study|Lost to Follow-up|0
6959067|NCT01072929|11003634|FG000|Overall Study|Adverse Event|8
6959068|NCT01072929|11003635|FG001|Overall Study|Adverse Event|11
6959069|NCT01072929|11003636|FG002|Overall Study|Adverse Event|2
6959070|NCT01072929|11003634|FG000|Overall Study|Lack of Efficacy|7
6959071|NCT01072929|11003635|FG001|Overall Study|Lack of Efficacy|4
6959072|NCT01072929|11003636|FG002|Overall Study|Lack of Efficacy|0
6959073|NCT01072929|11003634|FG000|Overall Study|Withdrawal by Subject|7
6959074|NCT01072929|11003635|FG001|Overall Study|Withdrawal by Subject|15
6959075|NCT01072929|11003636|FG002|Overall Study|Withdrawal by Subject|3
6959076|NCT01072929|11003634|FG000|Overall Study|Protocol Violation|13
6959077|NCT01072929|11003635|FG001|Overall Study|Protocol Violation|11
6959078|NCT01072929|11003636|FG002|Overall Study|Protocol Violation|2
6959079|NCT01072929|11003634|FG000|Overall Study|Lost to Follow-up|8
6959080|NCT01072929|11003635|FG001|Overall Study|Lost to Follow-up|4
6959081|NCT01072929|11003636|FG002|Overall Study|Lost to Follow-up|1
6959082|NCT01072929|11003634|FG000|Overall Study|Noncompliance with study medication|0
6959083|NCT01072929|11003635|FG001|Overall Study|Noncompliance with study medication|3
6959084|NCT01072929|11003636|FG002|Overall Study|Noncompliance with study medication|0
6959085|NCT01072929|11003634|FG000|Overall Study|Noncompliance with study procedures|1
6959086|NCT01072929|11003635|FG001|Overall Study|Noncompliance with study procedures|0
6959087|NCT01072929|11003636|FG002|Overall Study|Noncompliance with study procedures|1
6959088|NCT01072929|11003634|FG000|Overall Study|Other|0
6959089|NCT01072929|11003635|FG001|Overall Study|Other|3
6959090|NCT01072929|11003636|FG002|Overall Study|Other|0
6959091|NCT01073020|11003649|FG000|Overall Study|Withdrawal by Subject|6
6959092|NCT01073020|11003650|FG001|Overall Study|Withdrawal by Subject|4
6959093|NCT01073020|11003651|FG002|Overall Study|Withdrawal by Subject|1
6959094|NCT01073020|11003652|FG003|Overall Study|Withdrawal by Subject|2
6959095|NCT01073020|11003649|FG000|Overall Study|Physician Decision|1
6959096|NCT01073020|11003650|FG001|Overall Study|Physician Decision|0
6959097|NCT01073020|11003651|FG002|Overall Study|Physician Decision|2
6959098|NCT01073020|11003652|FG003|Overall Study|Physician Decision|0
6959099|NCT01073020|11003649|FG000|Overall Study|Death|0
6959100|NCT01073020|11003650|FG001|Overall Study|Death|1
6959101|NCT01073020|11003651|FG002|Overall Study|Death|0
6959102|NCT01073020|11003652|FG003|Overall Study|Death|0
6959103|NCT01073163|11003662|FG000|Overall Study|Adverse Event|1
6959104|NCT01073163|11003662|FG000|Overall Study|Disease Progression|1
6959105|NCT01073163|11003662|FG000|Overall Study|Early termination|1
6959106|NCT01073267|11003670|FG000|Overall Study|Disease Progression|3
6959107|NCT01073293|11003676|FG000|Overall Study|Lost to Follow-up|0
6959108|NCT01073293|11003677|FG001|Overall Study|Lost to Follow-up|1
6959109|NCT01073293|11003676|FG000|Overall Study|Withdrawal by Subject|5
6959110|NCT01073293|11003677|FG001|Overall Study|Withdrawal by Subject|10
6959111|NCT01073462|11003687|FG000|Overall Study|Death|14
6959112|NCT01073462|11003687|FG000|Overall Study|Kidney transplant|10
6959113|NCT01073462|11003687|FG000|Overall Study|Low parathyroid hormone levels|8
6959114|NCT01073462|11003687|FG000|Overall Study|Serious adverse event|2
6959115|NCT01073462|11003687|FG000|Overall Study|Lost to Follow-up|7
6959116|NCT01073566|11003693|FG000|Period 2 (6 Weeks)|Adverse Event|1
6959117|NCT01073566|11003694|FG001|Period 2 (6 Weeks)|Adverse Event|0
6959118|NCT01073605|11003703|FG000|Overall Study|Ongoing at Cutoff Date|1
6959119|NCT01073605|11003704|FG001|Overall Study|Ongoing at Cutoff Date|1
6959120|NCT01073605|11003705|FG002|Overall Study|Ongoing at Cutoff Date|0
6959121|NCT01073605|11003703|FG000|Overall Study|Adverse Event|2
6959122|NCT01073605|11003704|FG001|Overall Study|Adverse Event|1
6959123|NCT01073605|11003705|FG002|Overall Study|Adverse Event|0
6959124|NCT01073605|11003703|FG000|Overall Study|Lost to Follow-up|3
6959125|NCT01073605|11003704|FG001|Overall Study|Lost to Follow-up|4
6959126|NCT01073605|11003705|FG002|Overall Study|Lost to Follow-up|9
6959127|NCT01073605|11003703|FG000|Overall Study|Other|25
6959128|NCT01073605|11003704|FG001|Overall Study|Other|21
6959129|NCT01073605|11003705|FG002|Overall Study|Other|29
7072204|NCT02034474|11176194|FG000|Overall Study|Adverse Event|3
7072205|NCT02034474|11176195|FG001|Overall Study|Adverse Event|2
7072206|NCT02034474|11176194|FG000|Overall Study|Withdrawal by Subject|1
7072207|NCT02034474|11176195|FG001|Overall Study|Withdrawal by Subject|2
6959130|NCT01073605|11003703|FG000|Overall Study|Withdrawal by Subject|31
6959131|NCT01073605|11003704|FG001|Overall Study|Withdrawal by Subject|39
6959132|NCT01073605|11003705|FG002|Overall Study|Withdrawal by Subject|22
6959133|NCT01073605|11003703|FG000|Overall Study|Randomized But Not Treated|0
6959134|NCT01073605|11003704|FG001|Overall Study|Randomized But Not Treated|1
6959135|NCT01073605|11003705|FG002|Overall Study|Randomized But Not Treated|1
6959136|NCT01073618|11003713|FG000|Overall Study|Death|208
6959137|NCT01073618|11003713|FG000|Overall Study|Adverse Event|19
6959138|NCT01073618|11003713|FG000|Overall Study|Other|80
6959139|NCT01073631|11003717|FG000|Overall Study|Death|82
6959140|NCT01073631|11003717|FG000|Overall Study|Adverse Event|24
6959141|NCT01073631|11003717|FG000|Overall Study|Other|63
6959142|NCT01073865|11003732|FG000|Overall Study|Reasons other than below|19
6959143|NCT01073865|11003733|FG001|Overall Study|Reasons other than below|31
6959144|NCT01073865|11003732|FG000|Overall Study|Lost to Follow-up|1
6959145|NCT01073865|11003733|FG001|Overall Study|Lost to Follow-up|1
6959146|NCT01073865|11003732|FG000|Overall Study|Death|3
6959147|NCT01073865|11003733|FG001|Overall Study|Death|2
6959148|NCT01073865|11003732|FG000|Overall Study|Withdrawal by Subject|5
6959149|NCT01073865|11003733|FG001|Overall Study|Withdrawal by Subject|5
6959150|NCT01073930|11003741|FG000|Overall Study|Withdrawal by Subject|3
6959151|NCT01073930|11003742|FG001|Overall Study|Withdrawal by Subject|2
6959152|NCT01073930|11003741|FG000|Overall Study|Lost to Follow-up|0
6959153|NCT01073930|11003742|FG001|Overall Study|Lost to Follow-up|1
6959154|NCT01073930|11003741|FG000|Overall Study|Adverse Event|0
6959155|NCT01073930|11003742|FG001|Overall Study|Adverse Event|1
6959156|NCT01073930|11003741|FG000|Overall Study|Noncompliance with study drug|0
6959157|NCT01073930|11003742|FG001|Overall Study|Noncompliance with study drug|1
6959158|NCT01073930|11003741|FG000|Overall Study|Inadequate prep; unable to do procedure|0
6959159|NCT01073930|11003742|FG001|Overall Study|Inadequate prep; unable to do procedure|1
6959160|NCT01073943|11003750|FG000|Overall Study|Withdrawal by Subject|8
6959161|NCT01073943|11003751|FG001|Overall Study|Withdrawal by Subject|2
6959162|NCT01073943|11003750|FG000|Overall Study|Protocol Violation|2
6959163|NCT01073943|11003751|FG001|Overall Study|Protocol Violation|1
6959164|NCT01073943|11003750|FG000|Overall Study|Adverse Event|1
6959165|NCT01073943|11003751|FG001|Overall Study|Adverse Event|1
6959166|NCT01073943|11003750|FG000|Overall Study|Lost to Follow-up|0
6959167|NCT01073943|11003751|FG001|Overall Study|Lost to Follow-up|2
6959168|NCT01073943|11003750|FG000|Overall Study|Power outage; colonoscopy not done|1
6959169|NCT01073943|11003751|FG001|Overall Study|Power outage; colonoscopy not done|0
6959170|NCT01073943|11003750|FG000|Overall Study|Subject forgot|0
7072208|NCT02034513|11176205|FG000|Overall Study|Adverse Event|11
6959171|NCT01073943|11003751|FG001|Overall Study|Subject forgot|1
6959172|NCT01073943|11003750|FG000|Overall Study|Unable to return for follow-up|0
6959173|NCT01073943|11003751|FG001|Overall Study|Unable to return for follow-up|1
6959174|NCT01073943|11003750|FG000|Overall Study|Could not tolerate prep|1
6959175|NCT01073943|11003751|FG001|Overall Study|Could not tolerate prep|0
6959176|NCT01074008|11003766|FG000|Overall Study|Adverse Event|0
6959177|NCT01074008|11003767|FG001|Overall Study|Adverse Event|1
6959178|NCT01074008|11003768|FG002|Overall Study|Adverse Event|0
6959179|NCT01074008|11003769|FG003|Overall Study|Adverse Event|0
6959180|NCT01074008|11003770|FG004|Overall Study|Adverse Event|0
6959181|NCT01074008|11003771|FG005|Overall Study|Adverse Event|0
6959182|NCT01074008|11003772|FG006|Overall Study|Adverse Event|0
6959183|NCT01074008|11003773|FG007|Overall Study|Adverse Event|0
6959184|NCT01074008|11003774|FG008|Overall Study|Adverse Event|0
6959185|NCT01074008|11003766|FG000|Overall Study|Withdrawal by Subject|1
6959186|NCT01074008|11003767|FG001|Overall Study|Withdrawal by Subject|1
6959187|NCT01074008|11003768|FG002|Overall Study|Withdrawal by Subject|1
6959188|NCT01074008|11003769|FG003|Overall Study|Withdrawal by Subject|0
6959189|NCT01074008|11003770|FG004|Overall Study|Withdrawal by Subject|1
6959190|NCT01074008|11003771|FG005|Overall Study|Withdrawal by Subject|0
6959191|NCT01074008|11003772|FG006|Overall Study|Withdrawal by Subject|0
6959192|NCT01074008|11003773|FG007|Overall Study|Withdrawal by Subject|0
6959193|NCT01074008|11003774|FG008|Overall Study|Withdrawal by Subject|0
6959194|NCT01074008|11003766|FG000|Overall Study|Lost to Follow-up|0
6959195|NCT01074008|11003767|FG001|Overall Study|Lost to Follow-up|1
6959196|NCT01074008|11003768|FG002|Overall Study|Lost to Follow-up|1
6959197|NCT01074008|11003769|FG003|Overall Study|Lost to Follow-up|1
6959198|NCT01074008|11003770|FG004|Overall Study|Lost to Follow-up|1
6959199|NCT01074008|11003771|FG005|Overall Study|Lost to Follow-up|0
6959200|NCT01074008|11003772|FG006|Overall Study|Lost to Follow-up|1
6959201|NCT01074008|11003773|FG007|Overall Study|Lost to Follow-up|0
6959202|NCT01074008|11003774|FG008|Overall Study|Lost to Follow-up|4
6959203|NCT01074047|11003810|FG000|Treatment Phase|Adverse Event|89
6959204|NCT01074047|11003811|FG001|Treatment Phase|Adverse Event|66
6959205|NCT01074047|11003810|FG000|Treatment Phase|Disease Progression|16
6959206|NCT01074047|11003811|FG001|Treatment Phase|Disease Progression|21
6959207|NCT01074047|11003810|FG000|Treatment Phase|Withdrawal by Subject|27
6959208|NCT01074047|11003811|FG001|Treatment Phase|Withdrawal by Subject|48
6959209|NCT01074047|11003810|FG000|Treatment Phase|Death|53
6959210|NCT01074047|11003811|FG001|Treatment Phase|Death|58
6959211|NCT01074047|11003810|FG000|Treatment Phase|Lost to Follow-up|0
6959212|NCT01074047|11003811|FG001|Treatment Phase|Lost to Follow-up|1
6959213|NCT01074047|11003810|FG000|Treatment Phase|Protocol Violation|0
6959214|NCT01074047|11003811|FG001|Treatment Phase|Protocol Violation|1
6959215|NCT01074047|11003810|FG000|Treatment Phase|Miscellaneous|32
6959216|NCT01074047|11003811|FG001|Treatment Phase|Miscellaneous|39
6959217|NCT01074047|11003810|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5
6959218|NCT01074047|11003811|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8
6959219|NCT01074047|11003810|FG000|Survival Follow-Up Phase|Lost to Follow-up|2
6959220|NCT01074047|11003811|FG001|Survival Follow-Up Phase|Lost to Follow-up|1
6959221|NCT01074047|11003810|FG000|Survival Follow-Up Phase|Death|116
7072209|NCT02034513|11176206|FG001|Overall Study|Adverse Event|10
6959222|NCT01074047|11003811|FG001|Survival Follow-Up Phase|Death|124
6959223|NCT01074047|11003810|FG000|Survival Follow-Up Phase|Alive at study closure|1
6959224|NCT01074047|11003811|FG001|Survival Follow-Up Phase|Alive at study closure|3
6959225|NCT01074047|11003810|FG000|Extension Phase|Physician Decision|1
6959226|NCT01074047|11003811|FG001|Extension Phase|Physician Decision|0
6959227|NCT01074047|11003810|FG000|Extension Phase|Adverse Event|5
6959228|NCT01074047|11003811|FG001|Extension Phase|Adverse Event|0
6959229|NCT01074047|11003810|FG000|Extension Phase|Disease Progression|9
6959230|NCT01074047|11003811|FG001|Extension Phase|Disease Progression|0
6959231|NCT01074047|11003810|FG000|Extension Phase|Withdrawal by Subject|2
6959232|NCT01074047|11003811|FG001|Extension Phase|Withdrawal by Subject|0
6959233|NCT01074047|11003810|FG000|Extension Phase|Death|5
6959234|NCT01074047|11003811|FG001|Extension Phase|Death|0
6976486|NCT01199601|11029108|FG000|Overall Study|Withdrawal by Subject|15
6976487|NCT01199601|11029109|FG001|Overall Study|Withdrawal by Subject|3
6976488|NCT01199601|11029108|FG000|Overall Study|Insecurity prevented staff interviewing.|7
6976489|NCT01199601|11029109|FG001|Overall Study|Insecurity prevented staff interviewing.|9
6976490|NCT01199705|11029115|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1
6976491|NCT01199731|11029133|FG000|Overall Study|Adverse Event|0
6976492|NCT01199731|11029134|FG001|Overall Study|Adverse Event|1
7072210|NCT02034513|11176205|FG000|Overall Study|Lack of Efficacy|0
6976493|NCT01199731|11029135|FG002|Overall Study|Adverse Event|0
6976494|NCT01199731|11029133|FG000|Overall Study|Study closed/terminated|7
6976495|NCT01199731|11029134|FG001|Overall Study|Study closed/terminated|9
6976496|NCT01199731|11029135|FG002|Overall Study|Study closed/terminated|7
6976497|NCT01199731|11029133|FG000|Overall Study|Lost to Follow-up|0
6976498|NCT01199731|11029134|FG001|Overall Study|Lost to Follow-up|0
6976499|NCT01199731|11029135|FG002|Overall Study|Lost to Follow-up|2
6976500|NCT01199731|11029133|FG000|Overall Study|Physician Decision|0
6976501|NCT01199731|11029134|FG001|Overall Study|Physician Decision|1
6976502|NCT01199731|11029135|FG002|Overall Study|Physician Decision|1
7072211|NCT02034513|11176206|FG001|Overall Study|Lack of Efficacy|1
6959235|NCT01074216|11003862|FG000|Overall Study|Physician Decision|1
6959236|NCT01074216|11003862|FG000|Overall Study|Not Treated|12
6959237|NCT01074229|11003869|FG000|Overall Study|Lost to Follow-up|1
6959238|NCT01074229|11003870|FG001|Overall Study|Lost to Follow-up|0
6959239|NCT01074229|11003871|FG002|Overall Study|Lost to Follow-up|0
6959240|NCT01074229|11003869|FG000|Overall Study|Change to open surgical procedure|1
6959241|NCT01074229|11003870|FG001|Overall Study|Change to open surgical procedure|3
6959242|NCT01074229|11003871|FG002|Overall Study|Change to open surgical procedure|4
6959243|NCT01074242|11003881|FG000|Overall Study|Case report before date of contract|40
6959244|NCT01074242|11003881|FG000|Overall Study|Lost to Follow-up|1
6959245|NCT01074242|11003881|FG000|Overall Study|Case report unclear|6
6959246|NCT01074242|11003881|FG000|Overall Study|Violation of vaccine dose or dosage|351
6959247|NCT01074242|11003881|FG000|Overall Study|Duplicate Case Report Form|5
6959248|NCT01074255|11003885|FG000|Overall Study|Did not receive EMEND|2
6959249|NCT01074268|11003891|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3
6959250|NCT01074268|11003892|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1
6959251|NCT01074268|11003891|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0
6959252|NCT01074268|11003892|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2
6959253|NCT01074268|11003891|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3
6959254|NCT01074268|11003892|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4
6959255|NCT01074268|11003891|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6
6959256|NCT01074268|11003892|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3
6959257|NCT01074268|11003891|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8
6959258|NCT01074268|11003892|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5
6959259|NCT01074268|11003891|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
6959260|NCT01074268|11003892|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
6959261|NCT01074268|11003891|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0
6959262|NCT01074268|11003892|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2
6959263|NCT01074268|11003891|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
6959264|NCT01074268|11003892|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
6959265|NCT01074268|11003891|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3
6959266|NCT01074268|11003892|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2
6959267|NCT01074307|11003900|FG000|Overall Study|No primary endpoint evaluation|14
6959268|NCT01074307|11003901|FG001|Overall Study|No primary endpoint evaluation|6
6959269|NCT01074307|11003900|FG000|Overall Study|Exclusion criterion|0
6959270|NCT01074307|11003901|FG001|Overall Study|Exclusion criterion|1
6959271|NCT01074307|11003900|FG000|Overall Study|Protocol Violation|8
6959272|NCT01074307|11003901|FG001|Overall Study|Protocol Violation|5
6959273|NCT01074450|11003909|FG000|First Intervention|Emesis in Dosing Interval|0
6959274|NCT01074450|11003910|FG001|First Intervention|Emesis in Dosing Interval|2
6959275|NCT01074450|11003909|FG000|Second Intervention|Protocol Violation|1
6959276|NCT01074450|11003910|FG001|Second Intervention|Protocol Violation|0
6959277|NCT01074450|11003909|FG000|Second Intervention|Physician Decision|0
6959278|NCT01074450|11003910|FG001|Second Intervention|Physician Decision|1
6959279|NCT01074554|11003927|FG000|Overall Study|Adverse Event|3
6959280|NCT01074554|11003928|FG001|Overall Study|Adverse Event|3
6959281|NCT01074554|11003927|FG000|Overall Study|Lost to Follow-up|0
6959282|NCT01074554|11003928|FG001|Overall Study|Lost to Follow-up|1
6959283|NCT01074658|11003934|FG000|Overall Study|No implant attempted|19
6959284|NCT01074931|11003938|FG000|Overall Study|Economic reasons|1
6959285|NCT01074931|11003938|FG000|Overall Study|Death|5
6959286|NCT01074944|11003946|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2
6959287|NCT01074944|11003947|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0
6959288|NCT01074944|11003948|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0
6959289|NCT01074944|11003949|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0
6959290|NCT01074944|11003950|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0
6959291|NCT01074944|11003946|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1
6959292|NCT01074944|11003947|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
6959293|NCT01074944|11003948|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
6959294|NCT01074944|11003949|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
6959295|NCT01074944|11003950|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
7072212|NCT02034513|11176205|FG000|Overall Study|Lost to Follow-up|6
7072213|NCT02034513|11176206|FG001|Overall Study|Lost to Follow-up|7
7072214|NCT02034513|11176205|FG000|Overall Study|Pregnancy|0
7072215|NCT02034513|11176206|FG001|Overall Study|Pregnancy|3
7072216|NCT02034513|11176205|FG000|Overall Study|Protocol Violation|7
7072217|NCT02034513|11176206|FG001|Overall Study|Protocol Violation|10
7072218|NCT02034513|11176205|FG000|Overall Study|Withdrawal by Subject|25
7072219|NCT02034513|11176206|FG001|Overall Study|Withdrawal by Subject|25
6959296|NCT01074944|11003946|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4
6959297|NCT01074944|11003947|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0
6959298|NCT01074944|11003948|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0
6959299|NCT01074944|11003949|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0
6959300|NCT01074944|11003950|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0
6959301|NCT01074944|11003946|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6
7072220|NCT02034513|11176205|FG000|Overall Study|Unclassified|0
7072221|NCT02034513|11176206|FG001|Overall Study|Unclassified|1
7072222|NCT02034552|11176217|FG000|Overall Study|Never treated|3
6959302|NCT01074944|11003947|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
6959303|NCT01074944|11003948|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
6959304|NCT01074944|11003949|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
6959305|NCT01074944|11003950|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
6959306|NCT01074944|11003946|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
6959307|NCT01074944|11003947|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2
6959308|NCT01074944|11003948|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3
6959309|NCT01074944|11003949|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
6959310|NCT01074944|11003950|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
6959311|NCT01074944|11003946|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
6959312|NCT01074944|11003947|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6
6959313|NCT01074944|11003948|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1
6959314|NCT01074944|11003949|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
6959315|NCT01074944|11003950|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
6959316|NCT01074944|11003946|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
6959317|NCT01074944|11003947|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
6959318|NCT01074944|11003948|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
6959319|NCT01074944|11003949|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
6959320|NCT01074944|11003950|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
6959321|NCT01074944|11003946|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
6959322|NCT01074944|11003947|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1
6959323|NCT01074944|11003948|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
6959324|NCT01074944|11003949|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
6959325|NCT01074944|11003950|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
6959326|NCT01074944|11003946|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
6959327|NCT01074944|11003947|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
6959328|NCT01074944|11003948|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
6959329|NCT01074944|11003949|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
6959330|NCT01074944|11003950|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
6959331|NCT01074944|11003946|FG000|Long Term Treatment|Adverse Event|0
6959332|NCT01074944|11003947|FG001|Long Term Treatment|Adverse Event|0
6959333|NCT01074944|11003948|FG002|Long Term Treatment|Adverse Event|0
6959334|NCT01074944|11003949|FG003|Long Term Treatment|Adverse Event|3
6959335|NCT01074944|11003950|FG004|Long Term Treatment|Adverse Event|0
6959336|NCT01074944|11003946|FG000|Long Term Treatment|Lost to Follow-up|0
6959337|NCT01074944|11003947|FG001|Long Term Treatment|Lost to Follow-up|0
6959338|NCT01074944|11003948|FG002|Long Term Treatment|Lost to Follow-up|0
6959339|NCT01074944|11003949|FG003|Long Term Treatment|Lost to Follow-up|2
6959340|NCT01074944|11003950|FG004|Long Term Treatment|Lost to Follow-up|0
6959341|NCT01074944|11003946|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0
6959342|NCT01074944|11003947|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0
6959343|NCT01074944|11003948|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0
6959344|NCT01074944|11003949|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18
6959345|NCT01074944|11003950|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0
6959346|NCT01074944|11003946|FG000|Long Term Treatment|Entered in Period, But Not Treated|0
6959347|NCT01074944|11003947|FG001|Long Term Treatment|Entered in Period, But Not Treated|0
6959348|NCT01074944|11003948|FG002|Long Term Treatment|Entered in Period, But Not Treated|0
6959349|NCT01074944|11003949|FG003|Long Term Treatment|Entered in Period, But Not Treated|1
6959350|NCT01074944|11003950|FG004|Long Term Treatment|Entered in Period, But Not Treated|0
6959351|NCT01074944|11003946|FG000|Long Term Treatment|Withdrawal by Subject|0
6959352|NCT01074944|11003947|FG001|Long Term Treatment|Withdrawal by Subject|0
6959353|NCT01074944|11003948|FG002|Long Term Treatment|Withdrawal by Subject|0
6959354|NCT01074944|11003949|FG003|Long Term Treatment|Withdrawal by Subject|2
6959355|NCT01074944|11003950|FG004|Long Term Treatment|Withdrawal by Subject|0
6959356|NCT01074944|11003946|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0
6959357|NCT01074944|11003947|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0
6959358|NCT01074944|11003948|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0
6959359|NCT01074944|11003949|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0
6959360|NCT01074944|11003950|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2
6959361|NCT01074944|11003946|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
6959362|NCT01074944|11003947|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
6959363|NCT01074944|11003948|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
6959364|NCT01074944|11003949|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
6959365|NCT01074944|11003950|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3
6959366|NCT01075048|11003961|FG000|Overall Study|Death|4
6959367|NCT01075048|11003962|FG001|Overall Study|Death|17
6959368|NCT01075048|11003963|FG002|Overall Study|Death|12
6959369|NCT01075048|11003961|FG000|Overall Study|Start of other or new therapy|4
6959370|NCT01075048|11003962|FG001|Overall Study|Start of other or new therapy|36
6959371|NCT01075048|11003963|FG002|Overall Study|Start of other or new therapy|46
6959372|NCT01075048|11003961|FG000|Overall Study|Withdrawal by Subject|1
6959373|NCT01075048|11003962|FG001|Overall Study|Withdrawal by Subject|6
6959374|NCT01075048|11003963|FG002|Overall Study|Withdrawal by Subject|3
6959375|NCT01075048|11003961|FG000|Overall Study|Lost to Follow-up|0
6959376|NCT01075048|11003962|FG001|Overall Study|Lost to Follow-up|1
6959377|NCT01075048|11003963|FG002|Overall Study|Lost to Follow-up|1
6959378|NCT01075074|11003977|FG000|Overall Study|Surgeon changed to open incisional case|1
6959379|NCT01075074|11003978|FG001|Overall Study|Surgeon changed to open incisional case|2
6959380|NCT01075074|11003979|FG002|Overall Study|Surgeon changed to open incisional case|2
6959381|NCT01075100|11004002|FG000|Overall Study|Adverse Event|15
6959382|NCT01075100|11004003|FG001|Overall Study|Adverse Event|18
6959383|NCT01075100|11004002|FG000|Overall Study|Patient Request|4
6959384|NCT01075100|11004003|FG001|Overall Study|Patient Request|4
6959385|NCT01075100|11004002|FG000|Overall Study|Investigator Request|2
6959386|NCT01075100|11004003|FG001|Overall Study|Investigator Request|1
6959387|NCT01075100|11004002|FG000|Overall Study|Disease Progression|25
6959388|NCT01075100|11004003|FG001|Overall Study|Disease Progression|29
6959389|NCT01075100|11004002|FG000|Overall Study|Other|3
6959390|NCT01075100|11004003|FG001|Overall Study|Other|1
6959391|NCT01075152|11004013|FG000|Overall Study|Withdrawal by Subject|1
6959392|NCT01075152|11004014|FG001|Overall Study|Withdrawal by Subject|0
6959393|NCT01075178|11004024|FG000|Subject Matching|eligible but not matched|130
6959394|NCT01075178|11004025|FG001|Subject Matching|eligible but not matched|403
6959395|NCT01075178|11004024|FG000|Subject Chart Review|died before chart review period|0
6959396|NCT01075178|11004025|FG001|Subject Chart Review|died before chart review period|2
6959397|NCT01075178|11004024|FG000|Subject Chart Review|no data collected due to site closure|3
6959398|NCT01075178|11004025|FG001|Subject Chart Review|no data collected due to site closure|4
6959399|NCT01075178|11004024|FG000|Subject Chart Review|matched partner excluded (reasons above)|6
6959400|NCT01075178|11004025|FG001|Subject Chart Review|matched partner excluded (reasons above)|3
6959401|NCT01075191|11004031|FG000|Overall Study|Death|1
6959402|NCT01075191|11004031|FG000|Overall Study|Intensification|3
6959403|NCT01075191|11004031|FG000|Overall Study|Co-morbidities|1
6959404|NCT01075191|11004031|FG000|Overall Study|Adverse Event|4
6959405|NCT01075191|11004031|FG000|Overall Study|Noncompliance|3
6959406|NCT01075191|11004031|FG000|Overall Study|Therapy Break|3
6959407|NCT01075191|11004031|FG000|Overall Study|Patient's Wish|2
6959408|NCT01075191|11004031|FG000|Overall Study|Unknown Reasons|1
6959409|NCT01075217|11004041|FG000|Overall Study|Adverse Event|1
6959410|NCT01075217|11004042|FG001|Overall Study|Adverse Event|1
6959411|NCT01075217|11004041|FG000|Overall Study|Physician Decision|1
6959412|NCT01075217|11004042|FG001|Overall Study|Physician Decision|0
6959413|NCT01075243|11004059|FG000|Overall Study|Lost to Follow-up|5
6959414|NCT01075243|11004060|FG001|Overall Study|Lost to Follow-up|2
6959415|NCT01075243|11004061|FG002|Overall Study|Lost to Follow-up|0
6959416|NCT01075243|11004059|FG000|Overall Study|Withdrawal by Subject|1
6959417|NCT01075243|11004060|FG001|Overall Study|Withdrawal by Subject|1
6959418|NCT01075243|11004061|FG002|Overall Study|Withdrawal by Subject|0
6959419|NCT01075256|11004074|FG000|Overall Study|Withdrawal by Subject|1
6959420|NCT01075256|11004075|FG001|Overall Study|Withdrawal by Subject|0
6959421|NCT01075256|11004076|FG002|Overall Study|Withdrawal by Subject|0
6959422|NCT01075282|11004092|FG000|Overall Study|Withdrawal by Subject|11
6959423|NCT01075282|11004093|FG001|Overall Study|Withdrawal by Subject|7
6959424|NCT01075282|11004094|FG002|Overall Study|Withdrawal by Subject|11
6959425|NCT01075282|11004092|FG000|Overall Study|Adverse Event|9
6959426|NCT01075282|11004093|FG001|Overall Study|Adverse Event|8
6959427|NCT01075282|11004094|FG002|Overall Study|Adverse Event|5
6959428|NCT01075282|11004092|FG000|Overall Study|Entry Criteria Not Met|3
6959429|NCT01075282|11004093|FG001|Overall Study|Entry Criteria Not Met|2
6959430|NCT01075282|11004094|FG002|Overall Study|Entry Criteria Not Met|0
6959431|NCT01075282|11004092|FG000|Overall Study|Lost to Follow-up|3
6959432|NCT01075282|11004093|FG001|Overall Study|Lost to Follow-up|3
6959433|NCT01075282|11004094|FG002|Overall Study|Lost to Follow-up|3
6959434|NCT01075282|11004092|FG000|Overall Study|Physician Decision|3
6959435|NCT01075282|11004093|FG001|Overall Study|Physician Decision|3
6959436|NCT01075282|11004094|FG002|Overall Study|Physician Decision|3
6959437|NCT01075282|11004092|FG000|Overall Study|Lack of Efficacy|1
6959438|NCT01075282|11004093|FG001|Overall Study|Lack of Efficacy|1
6959439|NCT01075282|11004094|FG002|Overall Study|Lack of Efficacy|0
6959440|NCT01075282|11004092|FG000|Overall Study|Treatment Non-compliance|1
6959441|NCT01075282|11004093|FG001|Overall Study|Treatment Non-compliance|2
6959442|NCT01075282|11004094|FG002|Overall Study|Treatment Non-compliance|2
6959443|NCT01075282|11004092|FG000|Overall Study|Protocol Violation|0
6959444|NCT01075282|11004093|FG001|Overall Study|Protocol Violation|2
6959445|NCT01075282|11004094|FG002|Overall Study|Protocol Violation|1
6959446|NCT01075282|11004092|FG000|Overall Study|Death|0
6959447|NCT01075282|11004093|FG001|Overall Study|Death|1
6959448|NCT01075282|11004094|FG002|Overall Study|Death|2
6959449|NCT01075321|11004103|FG000|Overall Study|Withdrawal by Subject|0
6959450|NCT01075321|11004104|FG001|Overall Study|Withdrawal by Subject|0
6959451|NCT01075321|11004105|FG002|Overall Study|Withdrawal by Subject|1
6959452|NCT01075321|11004106|FG003|Overall Study|Withdrawal by Subject|1
6959453|NCT01075321|11004103|FG000|Overall Study|Protocol Violation|0
6959454|NCT01075321|11004104|FG001|Overall Study|Protocol Violation|0
6959455|NCT01075321|11004105|FG002|Overall Study|Protocol Violation|1
6959456|NCT01075321|11004106|FG003|Overall Study|Protocol Violation|0
6959457|NCT01075321|11004103|FG000|Overall Study|Treatment Incomplete due to progression|1
6959458|NCT01075321|11004104|FG001|Overall Study|Treatment Incomplete due to progression|0
6959459|NCT01075321|11004105|FG002|Overall Study|Treatment Incomplete due to progression|0
6959460|NCT01075321|11004106|FG003|Overall Study|Treatment Incomplete due to progression|0
6959461|NCT01075321|11004103|FG000|Overall Study|Ineligible (miscalculated lab value)|0
6959462|NCT01075321|11004104|FG001|Overall Study|Ineligible (miscalculated lab value)|0
6959463|NCT01075321|11004105|FG002|Overall Study|Ineligible (miscalculated lab value)|0
6959464|NCT01075321|11004106|FG003|Overall Study|Ineligible (miscalculated lab value)|1
6959465|NCT01075412|11004133|FG000|Overall Study|Withdrawal by Subject|0
6959466|NCT01075412|11004134|FG001|Overall Study|Withdrawal by Subject|1
6959467|NCT01075516|11004141|FG000|Overall Study|Death|5
6959468|NCT01075516|11004142|FG001|Overall Study|Death|9
6959469|NCT01075516|11004141|FG000|Overall Study|Lost to Follow-up|10
7072223|NCT02034552|11176218|FG001|Overall Study|Never treated|2
7072224|NCT02034552|11176219|FG002|Overall Study|Never treated|0
7072225|NCT02034552|11176217|FG000|Overall Study|Radiological progression|3
6959470|NCT01075516|11004142|FG001|Overall Study|Lost to Follow-up|2
6959471|NCT01075516|11004141|FG000|Overall Study|Withdrawal by Subject|3
6959472|NCT01075516|11004142|FG001|Overall Study|Withdrawal by Subject|5
6959473|NCT01075646|11004152|FG000|Overall Study|Lost to Follow-up|4
6959474|NCT01075646|11004153|FG001|Overall Study|Lost to Follow-up|3
6959475|NCT01075646|11004154|FG002|Overall Study|Lost to Follow-up|1
6959476|NCT01075646|11004155|FG003|Overall Study|Lost to Follow-up|2
6959477|NCT01075685|11004167|FG000|Overall Study|Protocol Violation|9
6959478|NCT01075685|11004168|FG001|Overall Study|Protocol Violation|1
6959479|NCT01075685|11004167|FG000|Overall Study|Withdrawal by Subject|20
6959480|NCT01075685|11004168|FG001|Overall Study|Withdrawal by Subject|5
6959481|NCT01075685|11004167|FG000|Overall Study|Lost to Follow-up|563
6959482|NCT01075685|11004168|FG001|Overall Study|Lost to Follow-up|220
6959483|NCT01075763|11004176|FG000|Overall Study|Lost to Follow-up|2
6959484|NCT01075763|11004177|FG001|Overall Study|Lost to Follow-up|1
6959485|NCT01075763|11004176|FG000|Overall Study|Lack of Efficacy|0
6959486|NCT01075763|11004177|FG001|Overall Study|Lack of Efficacy|1
6959487|NCT01075763|11004176|FG000|Overall Study|Withdrawal by Subject|2
6959488|NCT01075763|11004177|FG001|Overall Study|Withdrawal by Subject|2
6959489|NCT01075815|11004185|FG000|Overall Study|Withdrawal before r-hCG administration|6
6959490|NCT01075815|11004186|FG001|Overall Study|Withdrawal before r-hCG administration|1
6959491|NCT01075815|11004185|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
6959492|NCT01075815|11004186|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
6959493|NCT01075815|11004185|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3
6959494|NCT01075815|11004186|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2
6959495|NCT01075958|11004192|FG000|Overall Study|Blood sample could not be obtained|44
6959496|NCT01075984|11004205|FG000|Treatment Phase|Adverse Event|0
6959497|NCT01075984|11004206|FG001|Treatment Phase|Adverse Event|1
6959498|NCT01075984|11004207|FG002|Treatment Phase|Adverse Event|3
6959499|NCT01075984|11004208|FG003|Treatment Phase|Adverse Event|7
6959500|NCT01075984|11004209|FG004|Treatment Phase|Adverse Event|35
6959501|NCT01075984|11004205|FG000|Treatment Phase|Protocol Violation|0
6959502|NCT01075984|11004206|FG001|Treatment Phase|Protocol Violation|0
6959503|NCT01075984|11004207|FG002|Treatment Phase|Protocol Violation|1
6959504|NCT01075984|11004208|FG003|Treatment Phase|Protocol Violation|0
6959505|NCT01075984|11004209|FG004|Treatment Phase|Protocol Violation|3
6959506|NCT01075984|11004205|FG000|Treatment Phase|Withdrawal by Subject|0
6959507|NCT01075984|11004206|FG001|Treatment Phase|Withdrawal by Subject|0
6959508|NCT01075984|11004207|FG002|Treatment Phase|Withdrawal by Subject|2
6959509|NCT01075984|11004208|FG003|Treatment Phase|Withdrawal by Subject|0
6959510|NCT01075984|11004209|FG004|Treatment Phase|Withdrawal by Subject|15
6959511|NCT01075984|11004205|FG000|Treatment Phase|Treatment Failure|0
6959512|NCT01075984|11004206|FG001|Treatment Phase|Treatment Failure|0
6959513|NCT01075984|11004207|FG002|Treatment Phase|Treatment Failure|1
6959514|NCT01075984|11004208|FG003|Treatment Phase|Treatment Failure|0
6959515|NCT01075984|11004209|FG004|Treatment Phase|Treatment Failure|5
6959516|NCT01075984|11004205|FG000|Treatment Phase|Progression of disease|0
6959517|NCT01075984|11004206|FG001|Treatment Phase|Progression of disease|0
7072226|NCT02034552|11176218|FG001|Overall Study|Radiological progression|5
7072227|NCT02034552|11176219|FG002|Overall Study|Radiological progression|4
7072228|NCT02034552|11176217|FG000|Overall Study|AE not assoc. with disease progression|1
7072229|NCT02034552|11176218|FG001|Overall Study|AE not assoc. with disease progression|4
7072230|NCT02034552|11176219|FG002|Overall Study|AE not assoc. with disease progression|2
7072231|NCT02034552|11176217|FG000|Overall Study|AE associated with disease progression|0
7072232|NCT02034552|11176218|FG001|Overall Study|AE associated with disease progression|1
7072233|NCT02034552|11176219|FG002|Overall Study|AE associated with disease progression|0
7072234|NCT02034552|11176217|FG000|Overall Study|Withdrawal by Subject|2
7072235|NCT02034552|11176218|FG001|Overall Study|Withdrawal by Subject|1
6959518|NCT01075984|11004207|FG002|Treatment Phase|Progression of disease|0
6959519|NCT01075984|11004208|FG003|Treatment Phase|Progression of disease|0
6959520|NCT01075984|11004209|FG004|Treatment Phase|Progression of disease|2
6959521|NCT01075984|11004205|FG000|Follow-up Phase|Protocol Violation|0
6959522|NCT01075984|11004206|FG001|Follow-up Phase|Protocol Violation|0
7072236|NCT02034552|11176219|FG002|Overall Study|Withdrawal by Subject|1
6959523|NCT01075984|11004207|FG002|Follow-up Phase|Protocol Violation|1
6959524|NCT01075984|11004208|FG003|Follow-up Phase|Protocol Violation|0
6959525|NCT01075984|11004209|FG004|Follow-up Phase|Protocol Violation|3
6959526|NCT01075984|11004205|FG000|Follow-up Phase|Adverse Event|0
6959527|NCT01075984|11004206|FG001|Follow-up Phase|Adverse Event|0
6959528|NCT01075984|11004207|FG002|Follow-up Phase|Adverse Event|0
6959529|NCT01075984|11004208|FG003|Follow-up Phase|Adverse Event|2
7072237|NCT02034552|11176217|FG000|Overall Study|Non-compliance with study drug|0
7072238|NCT02034552|11176218|FG001|Overall Study|Non-compliance with study drug|0
7072239|NCT02034552|11176219|FG002|Overall Study|Non-compliance with study drug|1
7072240|NCT02034552|11176217|FG000|Overall Study|Clinical progression|5
7072241|NCT02034552|11176218|FG001|Overall Study|Clinical progression|7
7072242|NCT02034552|11176219|FG002|Overall Study|Clinical progression|9
7072243|NCT02034565|11176227|FG000|Overall Study|Adverse Event|1
7072244|NCT02034565|11176228|FG001|Overall Study|Adverse Event|0
7072245|NCT02034591|11176250|FG000|Overall Study|Withdrawal by Subject|0
7072246|NCT02034591|11176251|FG001|Overall Study|Withdrawal by Subject|0
6959530|NCT01075984|11004209|FG004|Follow-up Phase|Adverse Event|27
6959531|NCT01075984|11004205|FG000|Follow-up Phase|Administrative|0
6959532|NCT01075984|11004206|FG001|Follow-up Phase|Administrative|0
6959533|NCT01075984|11004207|FG002|Follow-up Phase|Administrative|0
6959534|NCT01075984|11004208|FG003|Follow-up Phase|Administrative|0
6959535|NCT01075984|11004209|FG004|Follow-up Phase|Administrative|1
6959536|NCT01075984|11004205|FG000|Follow-up Phase|Withdrawal by Subject|0
6959537|NCT01075984|11004206|FG001|Follow-up Phase|Withdrawal by Subject|0
6959538|NCT01075984|11004207|FG002|Follow-up Phase|Withdrawal by Subject|0
6959539|NCT01075984|11004208|FG003|Follow-up Phase|Withdrawal by Subject|0
6959540|NCT01075984|11004209|FG004|Follow-up Phase|Withdrawal by Subject|10
6959541|NCT01075984|11004205|FG000|Follow-up Phase|Progression of disease|0
6959542|NCT01075984|11004206|FG001|Follow-up Phase|Progression of disease|0
6959543|NCT01075984|11004207|FG002|Follow-up Phase|Progression of disease|0
6959544|NCT01075984|11004208|FG003|Follow-up Phase|Progression of disease|0
6959545|NCT01075984|11004209|FG004|Follow-up Phase|Progression of disease|2
6959546|NCT01075984|11004205|FG000|Follow-up Phase|Treatment failure|0
6959547|NCT01075984|11004206|FG001|Follow-up Phase|Treatment failure|0
6959548|NCT01075984|11004207|FG002|Follow-up Phase|Treatment failure|0
6959549|NCT01075984|11004208|FG003|Follow-up Phase|Treatment failure|0
6959550|NCT01075984|11004209|FG004|Follow-up Phase|Treatment failure|4
6959551|NCT01076010|11004224|FG000|Overall Study|Death|15
6959552|NCT01076010|11004225|FG001|Overall Study|Death|1
6959553|NCT01076010|11004226|FG002|Overall Study|Death|0
6959554|NCT01076010|11004224|FG000|Overall Study|Adverse Event|7
6959555|NCT01076010|11004225|FG001|Overall Study|Adverse Event|2
6959556|NCT01076010|11004226|FG002|Overall Study|Adverse Event|0
6959557|NCT01076010|11004224|FG000|Overall Study|Progressive disease|90
6959558|NCT01076010|11004225|FG001|Overall Study|Progressive disease|30
6959559|NCT01076010|11004226|FG002|Overall Study|Progressive disease|1
6959560|NCT01076010|11004224|FG000|Overall Study|Lack of Efficacy|4
6959561|NCT01076010|11004225|FG001|Overall Study|Lack of Efficacy|0
6959562|NCT01076010|11004226|FG002|Overall Study|Lack of Efficacy|0
6959563|NCT01076010|11004224|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0
6959564|NCT01076010|11004225|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1
6959565|NCT01076010|11004226|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0
6959566|NCT01076010|11004224|FG000|Overall Study|Significant Surgical Procedure|0
6959567|NCT01076010|11004225|FG001|Overall Study|Significant Surgical Procedure|1
6959568|NCT01076010|11004226|FG002|Overall Study|Significant Surgical Procedure|0
6959569|NCT01076010|11004224|FG000|Overall Study|Protocol Violation|0
6959570|NCT01076010|11004225|FG001|Overall Study|Protocol Violation|1
6959571|NCT01076010|11004226|FG002|Overall Study|Protocol Violation|0
6959572|NCT01076010|11004224|FG000|Overall Study|Noncompliance|1
6959573|NCT01076010|11004225|FG001|Overall Study|Noncompliance|1
6959574|NCT01076010|11004226|FG002|Overall Study|Noncompliance|0
6959575|NCT01076010|11004224|FG000|Overall Study|Withdrawal by Subject|3
6959576|NCT01076010|11004225|FG001|Overall Study|Withdrawal by Subject|0
6959577|NCT01076010|11004226|FG002|Overall Study|Withdrawal by Subject|1
6959578|NCT01076010|11004224|FG000|Overall Study|Other|5
6959579|NCT01076010|11004225|FG001|Overall Study|Other|2
6959580|NCT01076010|11004226|FG002|Overall Study|Other|0
6959581|NCT01076036|11004234|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2
6959582|NCT01076075|11004255|FG000|Overall Study|Adverse Event|3
6959583|NCT01076075|11004256|FG001|Overall Study|Adverse Event|9
6959584|NCT01076075|11004255|FG000|Overall Study|Lack of Efficacy|5
6959585|NCT01076075|11004256|FG001|Overall Study|Lack of Efficacy|4
6959586|NCT01076075|11004255|FG000|Overall Study|Lost to Follow-up|6
6959587|NCT01076075|11004256|FG001|Overall Study|Lost to Follow-up|5
6959588|NCT01076075|11004255|FG000|Overall Study|other|19
6959589|NCT01076075|11004256|FG001|Overall Study|other|9
6959590|NCT01076075|11004255|FG000|Overall Study|Protocol Violation|0
6959591|NCT01076075|11004256|FG001|Overall Study|Protocol Violation|1
6959592|NCT01076075|11004255|FG000|Overall Study|Withdrawal by Subject|8
6959593|NCT01076075|11004256|FG001|Overall Study|Withdrawal by Subject|19
7072247|NCT02034591|11176252|FG002|Overall Study|Withdrawal by Subject|0
7072248|NCT02034591|11176253|FG003|Overall Study|Withdrawal by Subject|0
7072249|NCT02034591|11176254|FG004|Overall Study|Withdrawal by Subject|1
6959594|NCT01076088|11004271|FG000|Overall Study|Adverse Event|1
6959595|NCT01076088|11004272|FG001|Overall Study|Adverse Event|6
6959596|NCT01076088|11004273|FG002|Overall Study|Adverse Event|3
6959597|NCT01076088|11004274|FG003|Overall Study|Adverse Event|2
6959598|NCT01076088|11004275|FG004|Overall Study|Adverse Event|3
6959599|NCT01076088|11004276|FG005|Overall Study|Adverse Event|3
6959600|NCT01076088|11004271|FG000|Overall Study|Lost to Follow-up|1
6959601|NCT01076088|11004272|FG001|Overall Study|Lost to Follow-up|1
6959602|NCT01076088|11004273|FG002|Overall Study|Lost to Follow-up|0
6959603|NCT01076088|11004274|FG003|Overall Study|Lost to Follow-up|1
6959604|NCT01076088|11004275|FG004|Overall Study|Lost to Follow-up|1
6959605|NCT01076088|11004276|FG005|Overall Study|Lost to Follow-up|2
6959606|NCT01076088|11004271|FG000|Overall Study|Non-compliance with study drug|0
6959607|NCT01076088|11004272|FG001|Overall Study|Non-compliance with study drug|0
6959608|NCT01076088|11004273|FG002|Overall Study|Non-compliance with study drug|0
6959609|NCT01076088|11004274|FG003|Overall Study|Non-compliance with study drug|1
6959610|NCT01076088|11004275|FG004|Overall Study|Non-compliance with study drug|0
6959611|NCT01076088|11004276|FG005|Overall Study|Non-compliance with study drug|0
6959612|NCT01076088|11004271|FG000|Overall Study|Physician Decision|1
6959613|NCT01076088|11004272|FG001|Overall Study|Physician Decision|3
6959614|NCT01076088|11004273|FG002|Overall Study|Physician Decision|0
6959615|NCT01076088|11004274|FG003|Overall Study|Physician Decision|1
6959616|NCT01076088|11004275|FG004|Overall Study|Physician Decision|1
6959617|NCT01076088|11004276|FG005|Overall Study|Physician Decision|0
6959618|NCT01076088|11004271|FG000|Overall Study|Withdrawal by Subject|8
6959619|NCT01076088|11004272|FG001|Overall Study|Withdrawal by Subject|8
6959620|NCT01076088|11004273|FG002|Overall Study|Withdrawal by Subject|14
6959621|NCT01076088|11004274|FG003|Overall Study|Withdrawal by Subject|10
6959622|NCT01076088|11004275|FG004|Overall Study|Withdrawal by Subject|11
6959623|NCT01076088|11004276|FG005|Overall Study|Withdrawal by Subject|17
6959624|NCT01076088|11004271|FG000|Overall Study|Other protocol specified criteria|0
6959625|NCT01076088|11004272|FG001|Overall Study|Other protocol specified criteria|0
6959626|NCT01076088|11004273|FG002|Overall Study|Other protocol specified criteria|0
6959627|NCT01076088|11004274|FG003|Overall Study|Other protocol specified criteria|0
6959628|NCT01076088|11004275|FG004|Overall Study|Other protocol specified criteria|0
6959629|NCT01076088|11004276|FG005|Overall Study|Other protocol specified criteria|1
6959630|NCT01076153|11004291|FG000|Overall Study|Symptoms improved/resolved|10
6959631|NCT01076153|11004291|FG000|Overall Study|Adverse Event|1
6959632|NCT01076166|11004299|FG000|Overall Study|Adverse Event|3
6959633|NCT01076166|11004299|FG000|Overall Study|Symptoms improved/resolved|6
6959634|NCT01076179|11004306|FG000|Overall Study|Withdrawal by Subject|1
6959635|NCT01076192|11004311|FG000|Overall Study|Other|197
6959636|NCT01076205|11004316|FG000|Overall Study|Adverse Drug Reaction|299
6959637|NCT01076205|11004316|FG000|Overall Study|Lack of Effectiveness|1423
6959638|NCT01076205|11004316|FG000|Overall Study|Other Reason|1075
6959639|NCT01076205|11004316|FG000|Overall Study|Unknown Reason|71
6959640|NCT01076205|11004316|FG000|Overall Study|Lost to Follow-up|3151
6959641|NCT01076335|11004382|FG000|Overall Study|Withdrawal by Subject|3
6959642|NCT01076335|11004382|FG000|Overall Study|Withdrawal without treatment|1
6959643|NCT01076361|11004390|FG000|Overall Study|22 leads were excluded from analysis|21
6959644|NCT01076400|11004394|FG000|Overall Study|Adverse Event|2
6959645|NCT01076400|11004395|FG001|Overall Study|Adverse Event|0
6959646|NCT01076400|11004396|FG002|Overall Study|Adverse Event|0
6959647|NCT01076400|11004394|FG000|Overall Study|Progressive Disease|5
6959648|NCT01076400|11004395|FG001|Overall Study|Progressive Disease|0
6959649|NCT01076400|11004396|FG002|Overall Study|Progressive Disease|0
6959650|NCT01076543|11004419|FG000|Overall Study|Withdrawal by Subject|2
6959651|NCT01076543|11004420|FG001|Overall Study|Withdrawal by Subject|0
6959652|NCT01076543|11004421|FG002|Overall Study|Withdrawal by Subject|0
6959653|NCT01076543|11004422|FG003|Overall Study|Withdrawal by Subject|0
6959654|NCT01076543|11004423|FG004|Overall Study|Withdrawal by Subject|0
6959655|NCT01076543|11004424|FG005|Overall Study|Withdrawal by Subject|0
6959656|NCT01076647|11004441|FG000|Overall Study|Adverse Event|4
6959657|NCT01076647|11004442|FG001|Overall Study|Adverse Event|1
6959658|NCT01076647|11004441|FG000|Overall Study|Lack of Efficacy|0
6959659|NCT01076647|11004442|FG001|Overall Study|Lack of Efficacy|1
6959660|NCT01076647|11004441|FG000|Overall Study|Protocol Violation|7
6959661|NCT01076647|11004442|FG001|Overall Study|Protocol Violation|9
6959662|NCT01076647|11004441|FG000|Overall Study|Withdrawal criteria|2
6959663|NCT01076647|11004442|FG001|Overall Study|Withdrawal criteria|2
6959664|NCT01076647|11004441|FG000|Overall Study|Unclassified|12
6959665|NCT01076647|11004442|FG001|Overall Study|Unclassified|12
6959666|NCT01076959|11004465|FG000|Overall Study|Adverse Event|767
6959667|NCT01076959|11004465|FG000|Overall Study|Lack of Efficacy|849
6959668|NCT01076959|11004465|FG000|Overall Study|Non-compliance|274
6959669|NCT01076959|11004465|FG000|Overall Study|Lost to Follow-up|241
6959670|NCT01076959|11004465|FG000|Overall Study|Other|119
6959671|NCT01077024|11004504|FG000|Overall Study|Lost to Follow-up|20
6959672|NCT01077024|11004505|FG001|Overall Study|Lost to Follow-up|14
6959673|NCT01077024|11004504|FG000|Overall Study|Withdrawal by Subject|0
6959674|NCT01077024|11004505|FG001|Overall Study|Withdrawal by Subject|2
6959675|NCT01077024|11004504|FG000|Overall Study|Incarcerated|7
6959676|NCT01077024|11004505|FG001|Overall Study|Incarcerated|8
6959677|NCT01077024|11004504|FG000|Overall Study|Other|4
6959678|NCT01077024|11004505|FG001|Overall Study|Other|4
6959679|NCT01077050|11004511|FG000|Overall Study|Subjects signed ICF could not be located|1
6959680|NCT01077050|11004511|FG000|Overall Study|Screen failure|8
6959681|NCT01077063|11004517|FG000|Overall Study|Adverse Event|3
6959682|NCT01077063|11004518|FG001|Overall Study|Adverse Event|0
6959683|NCT01077063|11004517|FG000|Overall Study|Death|1
6959684|NCT01077063|11004518|FG001|Overall Study|Death|1
6959685|NCT01077063|11004517|FG000|Overall Study|Withdrawal by Subject|0
6959686|NCT01077063|11004518|FG001|Overall Study|Withdrawal by Subject|2
6959687|NCT01077076|11004524|FG000|First Intervention|Withdrawal by Subject|1
6959688|NCT01077076|11004525|FG001|First Intervention|Withdrawal by Subject|0
6959689|NCT01077076|11004526|FG002|First Intervention|Withdrawal by Subject|0
6959690|NCT01077076|11004527|FG003|First Intervention|Withdrawal by Subject|0
6959691|NCT01077076|11004528|FG004|First Intervention|Withdrawal by Subject|0
6959692|NCT01077076|11004529|FG005|First Intervention|Withdrawal by Subject|0
6959693|NCT01077076|11004524|FG000|Third Intervention|Death in the participant's family|0
6959694|NCT01077076|11004525|FG001|Third Intervention|Death in the participant's family|0
6959695|NCT01077076|11004526|FG002|Third Intervention|Death in the participant's family|0
6959696|NCT01077076|11004527|FG003|Third Intervention|Death in the participant's family|0
6959697|NCT01077076|11004528|FG004|Third Intervention|Death in the participant's family|0
6959698|NCT01077076|11004529|FG005|Third Intervention|Death in the participant's family|1
6959699|NCT01077128|11004537|FG000|Overall Study|Adverse Event|8
6959700|NCT01077128|11004537|FG000|Overall Study|Lack of Efficacy|1
6959701|NCT01077128|11004537|FG000|Overall Study|Disease exacerbation|1
6959702|NCT01077128|11004537|FG000|Overall Study|Adverse event and consent withdrawal|1
6959703|NCT01077128|11004537|FG000|Overall Study|Adverse event and disease exacerbation|1
6959704|NCT01077128|11004537|FG000|Overall Study|Lack of efficacy/disease exacerbation|1
6959705|NCT01077128|11004537|FG000|Overall Study|Other|54
6976503|NCT01199731|11029133|FG000|Overall Study|Withdrawal by Subject|2
6976504|NCT01199731|11029134|FG001|Overall Study|Withdrawal by Subject|0
6976505|NCT01199731|11029135|FG002|Overall Study|Withdrawal by Subject|0
6976506|NCT01199822|11029150|FG000|Overall Study|Investigator discontinued therapy|0
6976507|NCT01199822|11029151|FG001|Overall Study|Investigator discontinued therapy|1
6976508|NCT01199822|11029152|FG002|Overall Study|Investigator discontinued therapy|0
6976509|NCT01199861|11029179|FG000|Overall Study|Administrative problems|1
6976510|NCT01199861|11029180|FG001|Overall Study|Administrative problems|0
6976511|NCT01199861|11029179|FG000|Overall Study|Adverse Event|1
6976512|NCT01199861|11029180|FG001|Overall Study|Adverse Event|0
6976513|NCT01199939|11029195|FG000|Overall Study|Adverse Event|4
6976514|NCT01199939|11029195|FG000|Overall Study|Protocol Violation|3
6976515|NCT01199939|11029195|FG000|Overall Study|Lost to Follow-up|2
6976516|NCT01199939|11029195|FG000|Overall Study|Reached a virologic endpoint|4
6976517|NCT01200069|11029241|FG000|Overall Study|Withdrawal by Subject|0
6976518|NCT01200069|11029242|FG001|Overall Study|Withdrawal by Subject|1
6976519|NCT01200238|11029297|FG000|Overall Study|Adverse Event|2
6976520|NCT01200238|11029298|FG001|Overall Study|Adverse Event|1
6976521|NCT01200238|11029297|FG000|Overall Study|Progressive Disease|5
6976522|NCT01200238|11029298|FG001|Overall Study|Progressive Disease|8
6976523|NCT01200238|11029297|FG000|Overall Study|Withdrawal by Subject|0
6976524|NCT01200238|11029298|FG001|Overall Study|Withdrawal by Subject|1
6976525|NCT01200290|11029304|FG000|Treatment Period|Adverse Event|1
6976526|NCT01200290|11029304|FG000|Post-Treatment Follow-Up Period|Death|2
6976527|NCT01200329|11029308|FG000|Overall Study|Lack of financial coverage|2
6976528|NCT01200329|11029308|FG000|Overall Study|Progressive disease|1
6976529|NCT01200342|11029312|FG000|Overall Study|Disease Progression|1
6976530|NCT01200355|11029318|FG000|Overall Study|Death|7
6976531|NCT01200355|11029319|FG001|Overall Study|Death|2
6976532|NCT01200368|11029328|FG000|Infant Series|Adverse Event|2
6976533|NCT01200368|11029329|FG001|Infant Series|Adverse Event|2
6976534|NCT01200368|11029330|FG002|Infant Series|Adverse Event|3
6976535|NCT01200368|11029328|FG000|Infant Series|Withdrawal by Subject|0
6976536|NCT01200368|11029329|FG001|Infant Series|Withdrawal by Subject|2
6976537|NCT01200368|11029330|FG002|Infant Series|Withdrawal by Subject|2
6976538|NCT01200368|11029328|FG000|Infant Series|Did not meet entrance criteria|0
6976539|NCT01200368|11029329|FG001|Infant Series|Did not meet entrance criteria|1
6976540|NCT01200368|11029330|FG002|Infant Series|Did not meet entrance criteria|0
6976541|NCT01200368|11029328|FG000|Infant Series|Randomized, not vaccinated|0
6976542|NCT01200368|11029329|FG001|Infant Series|Randomized, not vaccinated|1
6976543|NCT01200368|11029330|FG002|Infant Series|Randomized, not vaccinated|1
6976544|NCT01200368|11029328|FG000|Infant Series|Other|1
6976545|NCT01200368|11029329|FG001|Infant Series|Other|0
6976546|NCT01200368|11029330|FG002|Infant Series|Other|0
6976547|NCT01200368|11029328|FG000|After Infant Series|Adverse Event|6
6976548|NCT01200368|11029329|FG001|After Infant Series|Adverse Event|6
6976549|NCT01200368|11029330|FG002|After Infant Series|Adverse Event|3
6976550|NCT01200368|11029328|FG000|After Infant Series|Withdrawal by Subject|10
6976551|NCT01200368|11029329|FG001|After Infant Series|Withdrawal by Subject|8
6976552|NCT01200368|11029330|FG002|After Infant Series|Withdrawal by Subject|4
6976553|NCT01200368|11029328|FG000|After Infant Series|Lost to Follow-up|1
6976554|NCT01200368|11029329|FG001|After Infant Series|Lost to Follow-up|0
6976555|NCT01200368|11029330|FG002|After Infant Series|Lost to Follow-up|0
6976556|NCT01200368|11029328|FG000|After Infant Series|Other|1
6959706|NCT01077154|11004593|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524
6959707|NCT01077154|11004594|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514
6959708|NCT01077154|11004593|FG000|Overall Study|Withdrawal by Subject|369
6959709|NCT01077154|11004594|FG001|Overall Study|Withdrawal by Subject|385
6959710|NCT01077154|11004593|FG000|Overall Study|Death|215
6959711|NCT01077154|11004594|FG001|Overall Study|Death|214
6959712|NCT01077154|11004593|FG000|Overall Study|Lost to Follow-up|43
6959713|NCT01077154|11004594|FG001|Overall Study|Lost to Follow-up|35
6959714|NCT01077154|11004593|FG000|Overall Study|Noncompliance|22
6959715|NCT01077154|11004594|FG001|Overall Study|Noncompliance|20
6959716|NCT01077154|11004593|FG000|Overall Study|Disease Progression|18
6959717|NCT01077154|11004594|FG001|Overall Study|Disease Progression|20
6959718|NCT01077154|11004593|FG000|Overall Study|Ineligibility Determined|10
6959719|NCT01077154|11004594|FG001|Overall Study|Ineligibility Determined|14
6959720|NCT01077154|11004593|FG000|Overall Study|Other|14
6959721|NCT01077154|11004594|FG001|Overall Study|Other|11
6959722|NCT01077154|11004593|FG000|Overall Study|Adverse Event|9
6959723|NCT01077154|11004594|FG001|Overall Study|Adverse Event|9
6959724|NCT01077154|11004593|FG000|Overall Study|Administrative Decision|1
6959725|NCT01077154|11004594|FG001|Overall Study|Administrative Decision|6
6959726|NCT01077154|11004593|FG000|Overall Study|Protocol Deviation|1
6959727|NCT01077154|11004594|FG001|Overall Study|Protocol Deviation|0
6959728|NCT01077193|11004600|FG000|Overall Study|Lost to Follow-up|1
6959729|NCT01077193|11004600|FG000|Overall Study|Withdrawal by Subject|2
6959730|NCT01077193|11004600|FG000|Overall Study|Lack of Efficacy|1
6959731|NCT01077193|11004600|FG000|Overall Study|Study Terminated by Sponsor|40
6959732|NCT01077258|11004604|FG000|Overall Study|Lost to Follow-up|1390
6959733|NCT01077258|11004604|FG000|Overall Study|Adverse drug reaction|218
6959734|NCT01077258|11004604|FG000|Overall Study|Lack of Efficacy|663
6959735|NCT01077258|11004604|FG000|Overall Study|Clinical remission|37
6959736|NCT01077258|11004604|FG000|Overall Study|Other reasons|260
6959737|NCT01077271|11004621|FG000|Overall Study|Parental desire|8
6959738|NCT01077271|11004621|FG000|Overall Study|Screen failure, did not take palivizumab|4
6959739|NCT01077271|11004621|FG000|Overall Study|Noncompliance|2
6959740|NCT01077271|11004621|FG000|Overall Study|Quota used up (insurance reimb issue)|2
6959741|NCT01077271|11004621|FG000|Overall Study|Changed doctors|2
6959742|NCT01077271|11004621|FG000|Overall Study|Parents thought too many injections|2
7072250|NCT02034591|11176255|FG005|Overall Study|Withdrawal by Subject|0
7072251|NCT02034708|11176266|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2
7072252|NCT02034708|11176267|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5
7072253|NCT02034708|11176266|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1
7072254|NCT02034708|11176267|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0
6959743|NCT01077271|11004621|FG000|Overall Study|End of RSV season nearly reached|1
6959744|NCT01077271|11004621|FG000|Overall Study|Mother unconvinced of the necessity|1
6959745|NCT01077284|11004636|FG000|Overall Study|Adverse Event|2
6959746|NCT01077284|11004637|FG001|Overall Study|Adverse Event|0
6959747|NCT01077284|11004638|FG002|Overall Study|Adverse Event|1
6959748|NCT01077284|11004636|FG000|Overall Study|Lost to Follow-up|1
6959749|NCT01077284|11004637|FG001|Overall Study|Lost to Follow-up|2
6959750|NCT01077284|11004638|FG002|Overall Study|Lost to Follow-up|0
6959751|NCT01077284|11004636|FG000|Overall Study|Withdrawal by Subject|2
6959752|NCT01077284|11004637|FG001|Overall Study|Withdrawal by Subject|3
6959753|NCT01077284|11004638|FG002|Overall Study|Withdrawal by Subject|1
6959754|NCT01077284|11004636|FG000|Overall Study|Other|0
6959755|NCT01077284|11004637|FG001|Overall Study|Other|0
6959756|NCT01077284|11004638|FG002|Overall Study|Other|1
6959757|NCT01077323|11004663|FG000|Overall Study|<9 months enroll before drug dispensed|11226
6959758|NCT01077323|11004664|FG001|Overall Study|<9 months enroll before drug dispensed|263954
6959759|NCT01077323|11004665|FG002|Overall Study|<9 months enroll before drug dispensed|11655523
6959760|NCT01077323|11004663|FG000|Overall Study|Dispensing of drug in baseline period|0
6959761|NCT01077323|11004664|FG001|Overall Study|Dispensing of drug in baseline period|120229
6959762|NCT01077323|11004665|FG002|Overall Study|Dispensing of drug in baseline period|256446
6959763|NCT01077323|11004663|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152
6959764|NCT01077323|11004664|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080
6959765|NCT01077323|11004665|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120
6959766|NCT01077362|11004676|FG000|Overall Study|Lack of Efficacy|13
6959767|NCT01077362|11004677|FG001|Overall Study|Lack of Efficacy|8
6959768|NCT01077362|11004678|FG002|Overall Study|Lack of Efficacy|10
6959769|NCT01077362|11004676|FG000|Overall Study|Lost to Follow-up|1
6959770|NCT01077362|11004677|FG001|Overall Study|Lost to Follow-up|0
6959771|NCT01077362|11004678|FG002|Overall Study|Lost to Follow-up|3
6959772|NCT01077362|11004676|FG000|Overall Study|Adverse Event|12
6959773|NCT01077362|11004677|FG001|Overall Study|Adverse Event|7
6959774|NCT01077362|11004678|FG002|Overall Study|Adverse Event|4
6959775|NCT01077362|11004676|FG000|Overall Study|Withdrawal by Subject|5
6959776|NCT01077362|11004677|FG001|Overall Study|Withdrawal by Subject|3
6959777|NCT01077362|11004678|FG002|Overall Study|Withdrawal by Subject|5
6959778|NCT01077362|11004676|FG000|Overall Study|Other|0
6959779|NCT01077362|11004677|FG001|Overall Study|Other|1
6959780|NCT01077362|11004678|FG002|Overall Study|Other|2
6959781|NCT01077375|11004693|FG000|Overall Study|Adverse Event|2
6959782|NCT01077375|11004694|FG001|Overall Study|Adverse Event|15
6959783|NCT01077375|11004693|FG000|Overall Study|Lack of Efficacy|6
6959784|NCT01077375|11004694|FG001|Overall Study|Lack of Efficacy|8
6959785|NCT01077375|11004693|FG000|Overall Study|Withdrawal by Subject|0
6959786|NCT01077375|11004694|FG001|Overall Study|Withdrawal by Subject|6
6959787|NCT01077375|11004693|FG000|Overall Study|Lost to Follow-up|2
6959788|NCT01077375|11004694|FG001|Overall Study|Lost to Follow-up|5
6959789|NCT01077375|11004693|FG000|Overall Study|Other Reason|0
6959790|NCT01077375|11004694|FG001|Overall Study|Other Reason|1
6959791|NCT01077518|11004713|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8
6959792|NCT01077518|11004714|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4
6959793|NCT01077518|11004715|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0
6959794|NCT01077518|11004713|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10
6959795|NCT01077518|11004714|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11
6959796|NCT01077518|11004715|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0
6959797|NCT01077518|11004713|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28
6959798|NCT01077518|11004714|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22
6959799|NCT01077518|11004715|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0
6959800|NCT01077518|11004713|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32
6959801|NCT01077518|11004714|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28
6959802|NCT01077518|11004715|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0
6959803|NCT01077518|11004713|FG000|Optional Ofa Phase|Physician Decision|0
6959804|NCT01077518|11004714|FG001|Optional Ofa Phase|Physician Decision|0
6959805|NCT01077518|11004715|FG002|Optional Ofa Phase|Physician Decision|1
6959806|NCT01077518|11004713|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0
7072255|NCT02034708|11176266|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
7072256|NCT02034708|11176267|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
7072257|NCT02034708|11176266|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3
7072258|NCT02034708|11176267|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2
6959807|NCT01077518|11004714|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0
6959808|NCT01077518|11004715|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12
6959809|NCT01077518|11004713|FG000|Optional Ofa Phase|Withdrawal by Subject|0
6959810|NCT01077518|11004714|FG001|Optional Ofa Phase|Withdrawal by Subject|0
6959811|NCT01077518|11004715|FG002|Optional Ofa Phase|Withdrawal by Subject|3
6959812|NCT01077544|11004726|FG000|Overall Study|New Cancer Therapy|3
6959813|NCT01077544|11004727|FG001|Overall Study|New Cancer Therapy|3
6959814|NCT01077544|11004726|FG000|Overall Study|Adverse Event|0
6959815|NCT01077544|11004727|FG001|Overall Study|Adverse Event|1
6959816|NCT01077544|11004726|FG000|Overall Study|Disease Progression|0
6959817|NCT01077544|11004727|FG001|Overall Study|Disease Progression|1
6959818|NCT01077622|11004777|FG000|Overall Study|Physician Decision|2
6959819|NCT01077622|11004777|FG000|Overall Study|Withdrawal by Subject|1
6959820|NCT01077713|11004783|FG000|Overall Study|Withdrawal by Subject|1
6959821|NCT01077713|11004784|FG001|Overall Study|Withdrawal by Subject|2
6959822|NCT01077713|11004783|FG000|Overall Study|Progressive Disease (PD)|0
6959823|NCT01077713|11004784|FG001|Overall Study|Progressive Disease (PD)|1
6959824|NCT01077713|11004783|FG000|Overall Study|Death|28
6959825|NCT01077713|11004784|FG001|Overall Study|Death|29
6959826|NCT01077713|11004783|FG000|Overall Study|Lost to Follow-up|1
6959827|NCT01077713|11004784|FG001|Overall Study|Lost to Follow-up|1
6959828|NCT01077713|11004783|FG000|Overall Study|Adverse Event|2
6959829|NCT01077713|11004784|FG001|Overall Study|Adverse Event|1
6959830|NCT01077713|11004783|FG000|Overall Study|Other|4
6959831|NCT01077713|11004784|FG001|Overall Study|Other|2
6959832|NCT01077739|11004792|FG000|Overall Study|Premature withdrawal|1
6959833|NCT01077739|11004793|FG001|Overall Study|Premature withdrawal|3
6959834|NCT01077739|11004792|FG000|Overall Study|Withdrawal by Subject|1
6959835|NCT01077739|11004793|FG001|Overall Study|Withdrawal by Subject|0
6959836|NCT01077739|11004792|FG000|Overall Study|Death|0
6959837|NCT01077739|11004793|FG001|Overall Study|Death|3
6959838|NCT01077739|11004792|FG000|Overall Study|Unacceptable toxicity|1
6959839|NCT01077739|11004793|FG001|Overall Study|Unacceptable toxicity|2
6959840|NCT01077739|11004792|FG000|Overall Study|Other|2
6959841|NCT01077739|11004793|FG001|Overall Study|Other|2
6959842|NCT01077804|11004799|FG000|Overall Study|Unreachable|102
6959843|NCT01077804|11004799|FG000|Overall Study|Refused to continue|79
7072259|NCT02034799|11176280|FG000|Overall Study|Withdrawal by Subject|0
7072260|NCT02034799|11176281|FG001|Overall Study|Withdrawal by Subject|2
7072261|NCT02034799|11176280|FG000|Overall Study|Lost to Follow-up|0
7072262|NCT02034799|11176281|FG001|Overall Study|Lost to Follow-up|1
7072263|NCT02034799|11176280|FG000|Overall Study|Death|2
6959844|NCT01077804|11004799|FG000|Overall Study|Other|18
6959845|NCT01077960|11004858|FG000|Overall Study|Adverse Event|6
6959846|NCT01077960|11004858|FG000|Overall Study|Protocol Violation|3
6959847|NCT01077960|11004858|FG000|Overall Study|Lost to Follow-up|5
6959848|NCT01077960|11004858|FG000|Overall Study|Subject decision|1
6959849|NCT01077960|11004858|FG000|Overall Study|Reason unspecified|1
6959850|NCT01078090|11004877|FG000|Overall Study|Lost to Follow-up|2363
6959851|NCT01078090|11004877|FG000|Overall Study|Adverse drug reaction (ADR)|453
6959852|NCT01078090|11004877|FG000|Overall Study|Lack of Efficacy|1193
6959853|NCT01078090|11004877|FG000|Overall Study|ADR and lack of efficacy|61
6959854|NCT01078090|11004877|FG000|Overall Study|Other|523
7072264|NCT02034799|11176281|FG001|Overall Study|Death|1
6959855|NCT01078116|11004895|FG000|Overall Study|Lost to Follow-up|17
6959856|NCT01078116|11004895|FG000|Overall Study|Adverse Event|5
6959857|NCT01078116|11004895|FG000|Overall Study|Withdrawal by Subject|8
6959858|NCT01078116|11004895|FG000|Overall Study|Lack of effectiveness|15
6959859|NCT01078116|11004895|FG000|Overall Study|Case report form not completed|3
6959860|NCT01078155|11004899|FG000|Overall Study|Adverse Event|7
6959861|NCT01078155|11004899|FG000|Overall Study|Lack of Efficacy|16
6959862|NCT01078155|11004899|FG000|Overall Study|Participant's Decision|6
6959863|NCT01078155|11004899|FG000|Overall Study|Lost to Follow-up|15
6959864|NCT01078168|11004905|FG000|Overall Study|Physician Decision|0
6959865|NCT01078168|11004906|FG001|Overall Study|Physician Decision|1
6959866|NCT01078298|11004965|FG000|Overall Study|Lost to Follow-up|12
6959867|NCT01078298|11004966|FG001|Overall Study|Lost to Follow-up|13
6959868|NCT01078298|11004965|FG000|Overall Study|Withdrawal by Subject|31
6959869|NCT01078298|11004966|FG001|Overall Study|Withdrawal by Subject|33
6959870|NCT01078298|11004965|FG000|Overall Study|Protocol Violation|6
6959871|NCT01078298|11004966|FG001|Overall Study|Protocol Violation|6
6959872|NCT01078298|11004965|FG000|Overall Study|Adverse Event|6
6959873|NCT01078298|11004966|FG001|Overall Study|Adverse Event|5
6959874|NCT01078298|11004965|FG000|Overall Study|Death|2
6959875|NCT01078298|11004966|FG001|Overall Study|Death|0
6959876|NCT01078298|11004965|FG000|Overall Study|Did not meet entrance criteria|0
6959877|NCT01078298|11004966|FG001|Overall Study|Did not meet entrance criteria|1
6959878|NCT01078298|11004965|FG000|Overall Study|Other|24
6959879|NCT01078298|11004966|FG001|Overall Study|Other|32
6976557|NCT01200368|11029329|FG001|After Infant Series|Other|2
6976558|NCT01200368|11029330|FG002|After Infant Series|Other|2
6976559|NCT01200368|11029328|FG000|Toddler Dose|Adverse Event|0
6976560|NCT01200368|11029329|FG001|Toddler Dose|Adverse Event|3
6976561|NCT01200368|11029330|FG002|Toddler Dose|Adverse Event|1
6976562|NCT01200394|11029347|FG000|Overall Study|Adverse Event|0
6976563|NCT01200394|11029348|FG001|Overall Study|Adverse Event|14
6976564|NCT01200394|11029347|FG000|Overall Study|Death|1
6976565|NCT01200394|11029348|FG001|Overall Study|Death|0
6976566|NCT01200394|11029347|FG000|Overall Study|Lost to Follow-up|0
6976567|NCT01200394|11029348|FG001|Overall Study|Lost to Follow-up|1
7072265|NCT02034877|11176289|FG000|Overall Study|Lost to Follow-up|0
7072266|NCT02034877|11176290|FG001|Overall Study|Lost to Follow-up|3
7072267|NCT02034877|11176289|FG000|Overall Study|No Longer Willing to Participate|0
7072268|NCT02034877|11176290|FG001|Overall Study|No Longer Willing to Participate|3
7072269|NCT02034916|11176298|FG000|Overall Study|Death|39
7072270|NCT02034916|11176299|FG001|Overall Study|Death|28
7072271|NCT02034916|11176298|FG000|Overall Study|Withdrawal by Subject|2
7072272|NCT02034916|11176299|FG001|Overall Study|Withdrawal by Subject|1
7072273|NCT02034916|11176298|FG000|Overall Study|Lost to Follow-up|4
7072274|NCT02034916|11176299|FG001|Overall Study|Lost to Follow-up|1
7072275|NCT02034916|11176298|FG000|Overall Study|Study terminated by sponsor|4
7072276|NCT02034916|11176299|FG001|Overall Study|Study terminated by sponsor|5
7072277|NCT02035202|11176309|FG000|Overall Study|Lost to Follow-up|8
7072278|NCT02035202|11176310|FG001|Overall Study|Lost to Follow-up|16
7072279|NCT02035202|11176311|FG002|Overall Study|Lost to Follow-up|2
7072280|NCT02035267|11176323|FG000|Overall Study|Withdrawal consent-subject convenience|0
7072281|NCT02035267|11176324|FG001|Overall Study|Withdrawal consent-subject convenience|0
7072282|NCT02035267|11176325|FG002|Overall Study|Withdrawal consent-subject convenience|1
7072283|NCT02035267|11176326|FG003|Overall Study|Withdrawal consent-subject convenience|0
7072284|NCT02035267|11176323|FG000|Overall Study|Adverse Event|0
7072285|NCT02035267|11176324|FG001|Overall Study|Adverse Event|0
7072286|NCT02035267|11176325|FG002|Overall Study|Adverse Event|1
7072287|NCT02035267|11176326|FG003|Overall Study|Adverse Event|0
7072288|NCT02035267|11176323|FG000|Overall Study|Lost to Follow-up|0
7072289|NCT02035267|11176324|FG001|Overall Study|Lost to Follow-up|0
7072290|NCT02035267|11176325|FG002|Overall Study|Lost to Follow-up|0
7072291|NCT02035267|11176326|FG003|Overall Study|Lost to Follow-up|1
7072292|NCT02035267|11176323|FG000|Overall Study|Other unspecified|0
7072293|NCT02035267|11176324|FG001|Overall Study|Other unspecified|1
7072294|NCT02035267|11176325|FG002|Overall Study|Other unspecified|0
7072295|NCT02035267|11176326|FG003|Overall Study|Other unspecified|0
7072296|NCT02035332|11176338|FG000|Overall Study|Procedure Aborted due to Uterine Width|1
7072297|NCT02035475|11176347|FG000|Overall Study|Withdrawal by Subject|4
7072298|NCT02035475|11176347|FG000|Overall Study|Physician Decision|1
7072299|NCT02035475|11176347|FG000|Overall Study|Equipment Error|1
7072300|NCT02035553|11176355|FG000|Overall Study|Death (See All-Cause Mortality Table)|0
7072301|NCT02035553|11176356|FG001|Overall Study|Death (See All-Cause Mortality Table)|1
7072302|NCT02035553|11176355|FG000|Overall Study|Adverse Event|10
7072303|NCT02035553|11176356|FG001|Overall Study|Adverse Event|6
7072304|NCT02035553|11176355|FG000|Overall Study|Physician Decision|3
7072305|NCT02035553|11176356|FG001|Overall Study|Physician Decision|2
6976568|NCT01200394|11029347|FG000|Overall Study|Did Not Meet Entrance Criteria|1
6976569|NCT01200394|11029348|FG001|Overall Study|Did Not Meet Entrance Criteria|4
6976570|NCT01200394|11029347|FG000|Overall Study|Protocol Violation|0
6976571|NCT01200394|11029348|FG001|Overall Study|Protocol Violation|3
6976572|NCT01200394|11029347|FG000|Overall Study|Withdrawal by Subject|0
7072306|NCT02035553|11176355|FG000|Overall Study|Lack of Efficacy|1
7072307|NCT02035553|11176356|FG001|Overall Study|Lack of Efficacy|1
7072308|NCT02035553|11176355|FG000|Overall Study|Withdrawal by Subject|4
7072309|NCT02035553|11176356|FG001|Overall Study|Withdrawal by Subject|7
7072310|NCT02035553|11176355|FG000|Overall Study|Non-compliance with Study Drug|0
6959880|NCT01078389|11005005|FG000|Overall Study|Adverse Event|10
6959881|NCT01078389|11005006|FG001|Overall Study|Adverse Event|6
6959882|NCT01078389|11005005|FG000|Overall Study|Major Protocol Deviation|2
6959883|NCT01078389|11005006|FG001|Overall Study|Major Protocol Deviation|0
6959884|NCT01078389|11005005|FG000|Overall Study|Lost to Follow-up|23
6959885|NCT01078389|11005006|FG001|Overall Study|Lost to Follow-up|23
6959886|NCT01078389|11005005|FG000|Overall Study|Voluntary Withdrawal|20
6959887|NCT01078389|11005006|FG001|Overall Study|Voluntary Withdrawal|36
6959888|NCT01078389|11005005|FG000|Overall Study|Other|9
6959889|NCT01078389|11005006|FG001|Overall Study|Other|2
6959890|NCT01078441|11005029|FG000|Overall Study|Withdrawal by Subject|1
6959891|NCT01078545|11005033|FG000|Overall Study|Lost to Follow-up|13
6959892|NCT01078545|11005033|FG000|Overall Study|Physician Decision|6
6959893|NCT01078545|11005033|FG000|Overall Study|Withdrawal by Subject|3
6959894|NCT01078545|11005033|FG000|Overall Study|Death|3
6959895|NCT01078545|11005033|FG000|Overall Study|Participant moved to another physician|1
6959896|NCT01078571|11005050|FG000|Overall Study|Adverse Event|36
6959897|NCT01078571|11005050|FG000|Overall Study|Lack of effectiveness|36
6959898|NCT01078571|11005050|FG000|Overall Study|Reason not reported|21
6959899|NCT01078571|11005050|FG000|Overall Study|Withdrawal by Subject|12
6959900|NCT01078571|11005050|FG000|Overall Study|Lost to Follow-up|8
6959901|NCT01078571|11005050|FG000|Overall Study|Protocol Violation|2
6959902|NCT01078584|11005059|FG000|Overall Study|Final Status Unknown|1073
6959903|NCT01078584|11005059|FG000|Overall Study|Lost to Follow-up|670
6959904|NCT01078584|11005059|FG000|Overall Study|Non-serious Adverse Event|577
6959905|NCT01078584|11005059|FG000|Overall Study|Withdrawal of Consent|244
6959906|NCT01078584|11005059|FG000|Overall Study|Physician Withdrew from Study|90
6959907|NCT01078584|11005059|FG000|Overall Study|Non-compliance|67
6959908|NCT01078584|11005059|FG000|Overall Study|Blood Pressure Controlled|49
6959909|NCT01078584|11005059|FG000|Overall Study|Physician Switched Medication|26
6959910|NCT01078584|11005059|FG000|Overall Study|Physician Discontinued Patient|12
6959911|NCT01078584|11005059|FG000|Overall Study|Lack of Efficacy|98
6959912|NCT01078584|11005059|FG000|Overall Study|Protocol Violation|75
6959913|NCT01078584|11005059|FG000|Overall Study|Serious Adverse Event|27
6959914|NCT01078584|11005059|FG000|Overall Study|Multiple Reasons|2
6959915|NCT01078623|11005076|FG000|Treatment Period 1|Adverse Event|1
6959916|NCT01078623|11005077|FG001|Treatment Period 1|Adverse Event|1
6959917|NCT01078623|11005078|FG002|Treatment Period 1|Adverse Event|1
6959918|NCT01078623|11005079|FG003|Treatment Period 1|Adverse Event|0
6959919|NCT01078623|11005080|FG004|Treatment Period 1|Adverse Event|0
6959920|NCT01078623|11005081|FG005|Treatment Period 1|Adverse Event|0
6959921|NCT01078623|11005082|FG006|Treatment Period 1|Adverse Event|1
6959922|NCT01078623|11005083|FG007|Treatment Period 1|Adverse Event|0
6959923|NCT01078623|11005084|FG008|Treatment Period 1|Adverse Event|1
6959924|NCT01078623|11005085|FG009|Treatment Period 1|Adverse Event|1
6959925|NCT01078623|11005086|FG010|Treatment Period 1|Adverse Event|0
6959926|NCT01078623|11005087|FG011|Treatment Period 1|Adverse Event|0
6959927|NCT01078623|11005088|FG012|Treatment Period 1|Adverse Event|0
6959928|NCT01078623|11005089|FG013|Treatment Period 1|Adverse Event|0
6959929|NCT01078623|11005090|FG014|Treatment Period 1|Adverse Event|0
6959930|NCT01078623|11005091|FG015|Treatment Period 1|Adverse Event|0
6959931|NCT01078623|11005092|FG016|Treatment Period 1|Adverse Event|0
6959932|NCT01078623|11005093|FG017|Treatment Period 1|Adverse Event|0
6959933|NCT01078623|11005094|FG018|Treatment Period 1|Adverse Event|0
6959934|NCT01078623|11005095|FG019|Treatment Period 1|Adverse Event|0
6959935|NCT01078623|11005076|FG000|Treatment Period 1|Withdrawal by Subject|0
6959936|NCT01078623|11005077|FG001|Treatment Period 1|Withdrawal by Subject|0
6959937|NCT01078623|11005078|FG002|Treatment Period 1|Withdrawal by Subject|0
6959938|NCT01078623|11005079|FG003|Treatment Period 1|Withdrawal by Subject|0
6959939|NCT01078623|11005080|FG004|Treatment Period 1|Withdrawal by Subject|0
6959940|NCT01078623|11005081|FG005|Treatment Period 1|Withdrawal by Subject|0
6959941|NCT01078623|11005082|FG006|Treatment Period 1|Withdrawal by Subject|0
6959942|NCT01078623|11005083|FG007|Treatment Period 1|Withdrawal by Subject|1
6959943|NCT01078623|11005084|FG008|Treatment Period 1|Withdrawal by Subject|0
6959944|NCT01078623|11005085|FG009|Treatment Period 1|Withdrawal by Subject|0
6959945|NCT01078623|11005086|FG010|Treatment Period 1|Withdrawal by Subject|1
6959946|NCT01078623|11005087|FG011|Treatment Period 1|Withdrawal by Subject|0
6959947|NCT01078623|11005088|FG012|Treatment Period 1|Withdrawal by Subject|0
6959948|NCT01078623|11005089|FG013|Treatment Period 1|Withdrawal by Subject|0
7072311|NCT02035553|11176356|FG001|Overall Study|Non-compliance with Study Drug|1
7072312|NCT02035553|11176355|FG000|Overall Study|Lost to Follow-up|0
6959949|NCT01078623|11005090|FG014|Treatment Period 1|Withdrawal by Subject|0
6959950|NCT01078623|11005091|FG015|Treatment Period 1|Withdrawal by Subject|0
6959951|NCT01078623|11005092|FG016|Treatment Period 1|Withdrawal by Subject|0
6959952|NCT01078623|11005093|FG017|Treatment Period 1|Withdrawal by Subject|0
6959953|NCT01078623|11005094|FG018|Treatment Period 1|Withdrawal by Subject|0
6959954|NCT01078623|11005095|FG019|Treatment Period 1|Withdrawal by Subject|0
6959955|NCT01078623|11005076|FG000|Treatment Period 1|Protocol Violation|0
6959956|NCT01078623|11005077|FG001|Treatment Period 1|Protocol Violation|0
6959957|NCT01078623|11005078|FG002|Treatment Period 1|Protocol Violation|0
6959958|NCT01078623|11005079|FG003|Treatment Period 1|Protocol Violation|0
6959959|NCT01078623|11005080|FG004|Treatment Period 1|Protocol Violation|0
6959960|NCT01078623|11005081|FG005|Treatment Period 1|Protocol Violation|1
6959961|NCT01078623|11005082|FG006|Treatment Period 1|Protocol Violation|0
6959962|NCT01078623|11005083|FG007|Treatment Period 1|Protocol Violation|0
6959963|NCT01078623|11005084|FG008|Treatment Period 1|Protocol Violation|0
6959964|NCT01078623|11005085|FG009|Treatment Period 1|Protocol Violation|0
6959965|NCT01078623|11005086|FG010|Treatment Period 1|Protocol Violation|0
6959966|NCT01078623|11005087|FG011|Treatment Period 1|Protocol Violation|0
6959967|NCT01078623|11005088|FG012|Treatment Period 1|Protocol Violation|0
6959968|NCT01078623|11005089|FG013|Treatment Period 1|Protocol Violation|0
6959969|NCT01078623|11005090|FG014|Treatment Period 1|Protocol Violation|0
6959970|NCT01078623|11005091|FG015|Treatment Period 1|Protocol Violation|0
6959971|NCT01078623|11005092|FG016|Treatment Period 1|Protocol Violation|0
6959972|NCT01078623|11005093|FG017|Treatment Period 1|Protocol Violation|0
6959973|NCT01078623|11005094|FG018|Treatment Period 1|Protocol Violation|0
6959974|NCT01078623|11005095|FG019|Treatment Period 1|Protocol Violation|0
6959975|NCT01078623|11005076|FG000|Treatment Period 2|Adverse Event|0
6959976|NCT01078623|11005077|FG001|Treatment Period 2|Adverse Event|0
6959977|NCT01078623|11005078|FG002|Treatment Period 2|Adverse Event|0
6959978|NCT01078623|11005079|FG003|Treatment Period 2|Adverse Event|0
6959979|NCT01078623|11005080|FG004|Treatment Period 2|Adverse Event|0
6959980|NCT01078623|11005081|FG005|Treatment Period 2|Adverse Event|0
6959981|NCT01078623|11005082|FG006|Treatment Period 2|Adverse Event|1
6959982|NCT01078623|11005083|FG007|Treatment Period 2|Adverse Event|0
6959983|NCT01078623|11005084|FG008|Treatment Period 2|Adverse Event|0
7072313|NCT02035553|11176356|FG001|Overall Study|Lost to Follow-up|1
7072314|NCT02035553|11176355|FG000|Overall Study|Other Reason|0
7072315|NCT02035553|11176356|FG001|Overall Study|Other Reason|4
7072316|NCT02035696|11176366|FG000|Overall Study|Lost to Follow-up|0
7072317|NCT02035696|11176367|FG001|Overall Study|Lost to Follow-up|3
7072318|NCT02035696|11176368|FG002|Overall Study|Lost to Follow-up|1
7072319|NCT02035696|11176369|FG003|Overall Study|Lost to Follow-up|2
7072320|NCT02035696|11176366|FG000|Overall Study|Withdrawal by Subject|3
7072321|NCT02035696|11176367|FG001|Overall Study|Withdrawal by Subject|0
6959984|NCT01078623|11005085|FG009|Treatment Period 2|Adverse Event|0
6959985|NCT01078623|11005086|FG010|Treatment Period 2|Adverse Event|0
6959986|NCT01078623|11005087|FG011|Treatment Period 2|Adverse Event|0
6959987|NCT01078623|11005088|FG012|Treatment Period 2|Adverse Event|0
6959988|NCT01078623|11005089|FG013|Treatment Period 2|Adverse Event|0
6959989|NCT01078623|11005090|FG014|Treatment Period 2|Adverse Event|0
6959990|NCT01078623|11005091|FG015|Treatment Period 2|Adverse Event|0
6959991|NCT01078623|11005092|FG016|Treatment Period 2|Adverse Event|0
6959992|NCT01078623|11005093|FG017|Treatment Period 2|Adverse Event|0
6959993|NCT01078623|11005094|FG018|Treatment Period 2|Adverse Event|1
6959994|NCT01078623|11005095|FG019|Treatment Period 2|Adverse Event|0
6959995|NCT01078623|11005076|FG000|Treatment Period 2|Withdrawal by Subject|0
6959996|NCT01078623|11005077|FG001|Treatment Period 2|Withdrawal by Subject|0
6959997|NCT01078623|11005078|FG002|Treatment Period 2|Withdrawal by Subject|0
6959998|NCT01078623|11005079|FG003|Treatment Period 2|Withdrawal by Subject|0
6959999|NCT01078623|11005080|FG004|Treatment Period 2|Withdrawal by Subject|0
6960000|NCT01078623|11005081|FG005|Treatment Period 2|Withdrawal by Subject|1
6960001|NCT01078623|11005082|FG006|Treatment Period 2|Withdrawal by Subject|0
6960002|NCT01078623|11005083|FG007|Treatment Period 2|Withdrawal by Subject|0
6960003|NCT01078623|11005084|FG008|Treatment Period 2|Withdrawal by Subject|0
6960004|NCT01078623|11005085|FG009|Treatment Period 2|Withdrawal by Subject|0
6960005|NCT01078623|11005086|FG010|Treatment Period 2|Withdrawal by Subject|0
6960006|NCT01078623|11005087|FG011|Treatment Period 2|Withdrawal by Subject|0
6960007|NCT01078623|11005088|FG012|Treatment Period 2|Withdrawal by Subject|0
6960008|NCT01078623|11005089|FG013|Treatment Period 2|Withdrawal by Subject|0
6960009|NCT01078623|11005090|FG014|Treatment Period 2|Withdrawal by Subject|0
6960010|NCT01078623|11005091|FG015|Treatment Period 2|Withdrawal by Subject|0
6960011|NCT01078623|11005092|FG016|Treatment Period 2|Withdrawal by Subject|0
6960012|NCT01078623|11005093|FG017|Treatment Period 2|Withdrawal by Subject|0
6960013|NCT01078623|11005094|FG018|Treatment Period 2|Withdrawal by Subject|0
6960014|NCT01078623|11005095|FG019|Treatment Period 2|Withdrawal by Subject|0
6960015|NCT01078623|11005076|FG000|Treatment Period 3|Adverse Event|0
6960016|NCT01078623|11005077|FG001|Treatment Period 3|Adverse Event|0
6960017|NCT01078623|11005078|FG002|Treatment Period 3|Adverse Event|0
6960018|NCT01078623|11005079|FG003|Treatment Period 3|Adverse Event|0
6960019|NCT01078623|11005080|FG004|Treatment Period 3|Adverse Event|1
6960020|NCT01078623|11005081|FG005|Treatment Period 3|Adverse Event|0
6960021|NCT01078623|11005082|FG006|Treatment Period 3|Adverse Event|0
6960022|NCT01078623|11005083|FG007|Treatment Period 3|Adverse Event|0
6960023|NCT01078623|11005084|FG008|Treatment Period 3|Adverse Event|0
6960024|NCT01078623|11005085|FG009|Treatment Period 3|Adverse Event|0
6960025|NCT01078623|11005086|FG010|Treatment Period 3|Adverse Event|0
6960026|NCT01078623|11005087|FG011|Treatment Period 3|Adverse Event|0
6960027|NCT01078623|11005088|FG012|Treatment Period 3|Adverse Event|0
7072322|NCT02035696|11176368|FG002|Overall Study|Withdrawal by Subject|2
7072323|NCT02035696|11176369|FG003|Overall Study|Withdrawal by Subject|1
7072324|NCT02035748|11176383|FG000|Overall Study|Adverse Event|5
6960028|NCT01078623|11005089|FG013|Treatment Period 3|Adverse Event|1
6960029|NCT01078623|11005090|FG014|Treatment Period 3|Adverse Event|0
6960030|NCT01078623|11005091|FG015|Treatment Period 3|Adverse Event|0
6960031|NCT01078623|11005092|FG016|Treatment Period 3|Adverse Event|0
7072325|NCT02035748|11176383|FG000|Overall Study|Death|3
6960032|NCT01078623|11005093|FG017|Treatment Period 3|Adverse Event|0
6960033|NCT01078623|11005094|FG018|Treatment Period 3|Adverse Event|0
6960034|NCT01078623|11005095|FG019|Treatment Period 3|Adverse Event|0
6960035|NCT01078623|11005076|FG000|Treatment Period 4|Adverse Event|0
6960036|NCT01078623|11005077|FG001|Treatment Period 4|Adverse Event|0
6960037|NCT01078623|11005078|FG002|Treatment Period 4|Adverse Event|1
6960038|NCT01078623|11005079|FG003|Treatment Period 4|Adverse Event|0
6960039|NCT01078623|11005080|FG004|Treatment Period 4|Adverse Event|0
6960040|NCT01078623|11005081|FG005|Treatment Period 4|Adverse Event|0
6960041|NCT01078623|11005082|FG006|Treatment Period 4|Adverse Event|0
6960042|NCT01078623|11005083|FG007|Treatment Period 4|Adverse Event|0
6960043|NCT01078623|11005084|FG008|Treatment Period 4|Adverse Event|0
6960044|NCT01078623|11005085|FG009|Treatment Period 4|Adverse Event|0
6960045|NCT01078623|11005086|FG010|Treatment Period 4|Adverse Event|0
6960046|NCT01078623|11005087|FG011|Treatment Period 4|Adverse Event|0
6960047|NCT01078623|11005088|FG012|Treatment Period 4|Adverse Event|0
6960048|NCT01078623|11005089|FG013|Treatment Period 4|Adverse Event|0
6960049|NCT01078623|11005090|FG014|Treatment Period 4|Adverse Event|0
6960050|NCT01078623|11005091|FG015|Treatment Period 4|Adverse Event|0
6960051|NCT01078623|11005092|FG016|Treatment Period 4|Adverse Event|0
6960052|NCT01078623|11005093|FG017|Treatment Period 4|Adverse Event|0
6960053|NCT01078623|11005094|FG018|Treatment Period 4|Adverse Event|0
6960054|NCT01078623|11005095|FG019|Treatment Period 4|Adverse Event|0
6960055|NCT01078623|11005076|FG000|Treatment Period 4|Withdrawal by Subject|0
6960056|NCT01078623|11005077|FG001|Treatment Period 4|Withdrawal by Subject|0
6960057|NCT01078623|11005078|FG002|Treatment Period 4|Withdrawal by Subject|0
6960058|NCT01078623|11005079|FG003|Treatment Period 4|Withdrawal by Subject|0
6960059|NCT01078623|11005080|FG004|Treatment Period 4|Withdrawal by Subject|0
6960060|NCT01078623|11005081|FG005|Treatment Period 4|Withdrawal by Subject|0
6960061|NCT01078623|11005082|FG006|Treatment Period 4|Withdrawal by Subject|0
6960062|NCT01078623|11005083|FG007|Treatment Period 4|Withdrawal by Subject|0
6960063|NCT01078623|11005084|FG008|Treatment Period 4|Withdrawal by Subject|0
6960064|NCT01078623|11005085|FG009|Treatment Period 4|Withdrawal by Subject|0
6960065|NCT01078623|11005086|FG010|Treatment Period 4|Withdrawal by Subject|0
6960066|NCT01078623|11005087|FG011|Treatment Period 4|Withdrawal by Subject|0
6960067|NCT01078623|11005088|FG012|Treatment Period 4|Withdrawal by Subject|0
6960068|NCT01078623|11005089|FG013|Treatment Period 4|Withdrawal by Subject|0
6960069|NCT01078623|11005090|FG014|Treatment Period 4|Withdrawal by Subject|0
6960070|NCT01078623|11005091|FG015|Treatment Period 4|Withdrawal by Subject|1
6960071|NCT01078623|11005092|FG016|Treatment Period 4|Withdrawal by Subject|0
6960072|NCT01078623|11005093|FG017|Treatment Period 4|Withdrawal by Subject|0
6960073|NCT01078623|11005094|FG018|Treatment Period 4|Withdrawal by Subject|0
6960074|NCT01078623|11005095|FG019|Treatment Period 4|Withdrawal by Subject|0
6960075|NCT01078675|11005109|FG000|Overall Study|Withdrawal by Subject|7
6960076|NCT01078675|11005110|FG001|Overall Study|Withdrawal by Subject|3
6960077|NCT01078675|11005109|FG000|Overall Study|Protocol Violation|56
6960078|NCT01078675|11005110|FG001|Overall Study|Protocol Violation|0
6960079|NCT01078675|11005109|FG000|Overall Study|Provided in CRF for specific reasons|2
6960080|NCT01078675|11005110|FG001|Overall Study|Provided in CRF for specific reasons|3
6960081|NCT01078675|11005109|FG000|Overall Study|Adverse Event|3
6960082|NCT01078675|11005110|FG001|Overall Study|Adverse Event|0
6960083|NCT01078805|11005125|FG000|Overall Study|Clinically significant abnormal lab|5
6960084|NCT01078805|11005125|FG000|Overall Study|Death|134
6960085|NCT01078805|11005125|FG000|Overall Study|Lost to Follow-up|676
6960086|NCT01078805|11005125|FG000|Overall Study|Physician Decision|169
6960087|NCT01078805|11005125|FG000|Overall Study|Serious adverse event|26
6960088|NCT01078805|11005125|FG000|Overall Study|Sponsor decision|46
6960089|NCT01078805|11005125|FG000|Overall Study|Withdrawal by Subject|739
6960090|NCT01078805|11005125|FG000|Overall Study|Other|173
6960091|NCT01078805|11005125|FG000|Overall Study|Didn't take study drug|82
6960092|NCT01078922|11005150|FG000|Overall Study|Adverse Event|1
6960093|NCT01078974|11005155|FG000|Overall Study|Adverse Event|3
6960094|NCT01079130|11005165|FG000|Overall Study|Adverse Event|1
6960095|NCT01079130|11005166|FG001|Overall Study|Adverse Event|1
6960096|NCT01079130|11005167|FG002|Overall Study|Adverse Event|0
6960097|NCT01079130|11005168|FG003|Overall Study|Adverse Event|1
6960098|NCT01079130|11005169|FG004|Overall Study|Adverse Event|5
6960099|NCT01079130|11005170|FG005|Overall Study|Adverse Event|1
6960100|NCT01079130|11005165|FG000|Overall Study|Administrative problems|1
6960101|NCT01079130|11005166|FG001|Overall Study|Administrative problems|3
6960102|NCT01079130|11005167|FG002|Overall Study|Administrative problems|0
6960103|NCT01079130|11005168|FG003|Overall Study|Administrative problems|0
6960104|NCT01079130|11005169|FG004|Overall Study|Administrative problems|0
6960105|NCT01079130|11005170|FG005|Overall Study|Administrative problems|1
6960106|NCT01079130|11005165|FG000|Overall Study|Withdrawal by Subject|0
6960107|NCT01079130|11005166|FG001|Overall Study|Withdrawal by Subject|1
6960108|NCT01079130|11005167|FG002|Overall Study|Withdrawal by Subject|0
6960109|NCT01079130|11005168|FG003|Overall Study|Withdrawal by Subject|0
6960110|NCT01079130|11005169|FG004|Overall Study|Withdrawal by Subject|1
6960111|NCT01079130|11005170|FG005|Overall Study|Withdrawal by Subject|3
6960112|NCT01079130|11005165|FG000|Overall Study|Protocol deviation|0
6960113|NCT01079130|11005166|FG001|Overall Study|Protocol deviation|2
6960114|NCT01079130|11005167|FG002|Overall Study|Protocol deviation|1
6960115|NCT01079130|11005168|FG003|Overall Study|Protocol deviation|2
6960116|NCT01079130|11005169|FG004|Overall Study|Protocol deviation|0
6960117|NCT01079130|11005170|FG005|Overall Study|Protocol deviation|0
6960118|NCT01079130|11005165|FG000|Overall Study|Abnormal test procedure result(s)|0
6960119|NCT01079130|11005166|FG001|Overall Study|Abnormal test procedure result(s)|0
6960120|NCT01079130|11005167|FG002|Overall Study|Abnormal test procedure result(s)|0
6960121|NCT01079130|11005168|FG003|Overall Study|Abnormal test procedure result(s)|0
6960122|NCT01079130|11005169|FG004|Overall Study|Abnormal test procedure result(s)|1
6960123|NCT01079130|11005170|FG005|Overall Study|Abnormal test procedure result(s)|0
6960124|NCT01079130|11005165|FG000|Overall Study|Unsatisfactory therapeutic effect|0
6960125|NCT01079130|11005166|FG001|Overall Study|Unsatisfactory therapeutic effect|0
6960126|NCT01079130|11005167|FG002|Overall Study|Unsatisfactory therapeutic effect|0
6960127|NCT01079130|11005168|FG003|Overall Study|Unsatisfactory therapeutic effect|2
6960128|NCT01079130|11005169|FG004|Overall Study|Unsatisfactory therapeutic effect|0
6960129|NCT01079130|11005170|FG005|Overall Study|Unsatisfactory therapeutic effect|0
6960130|NCT01079130|11005165|FG000|Overall Study|Lost to Follow-up|0
6960131|NCT01079130|11005166|FG001|Overall Study|Lost to Follow-up|0
6960132|NCT01079130|11005167|FG002|Overall Study|Lost to Follow-up|0
6960133|NCT01079130|11005168|FG003|Overall Study|Lost to Follow-up|0
6960134|NCT01079130|11005169|FG004|Overall Study|Lost to Follow-up|1
6960135|NCT01079130|11005170|FG005|Overall Study|Lost to Follow-up|0
6960136|NCT01079182|11005205|FG000|Overall Study|Lost to Follow-up|1634
6960137|NCT01079182|11005205|FG000|Overall Study|Adverse Drug Reaction (ADR)|261
6960138|NCT01079182|11005205|FG000|Overall Study|Lack of Efficacy|514
7072326|NCT02035748|11176383|FG000|Overall Study|Lost to Follow-up|2
7072327|NCT02035748|11176383|FG000|Overall Study|Physician Decision|3
7072328|NCT02035748|11176383|FG000|Overall Study|Withdrawal by Subject|6
7072329|NCT02035748|11176383|FG000|Overall Study|Progressive Disease|1
7072330|NCT02036294|11176390|FG000|Overall Study|Death|7
7072331|NCT02036294|11176391|FG001|Overall Study|Death|8
7072332|NCT02036294|11176390|FG000|Overall Study|Withdrawal by Subject|2
7072333|NCT02036294|11176391|FG001|Overall Study|Withdrawal by Subject|3
7072334|NCT02036502|11176421|FG000|Part 1:Dose Determination/Escalation|Death|3
7072335|NCT02036502|11176422|FG001|Part 1:Dose Determination/Escalation|Death|2
7072336|NCT02036502|11176423|FG002|Part 1:Dose Determination/Escalation|Death|0
7072337|NCT02036502|11176424|FG003|Part 1:Dose Determination/Escalation|Death|0
7072338|NCT02036502|11176425|FG004|Part 1:Dose Determination/Escalation|Death|0
7072339|NCT02036502|11176426|FG005|Part 1:Dose Determination/Escalation|Death|0
7072340|NCT02036502|11176427|FG006|Part 1:Dose Determination/Escalation|Death|0
7072341|NCT02036502|11176428|FG007|Part 1:Dose Determination/Escalation|Death|0
7072342|NCT02036502|11176421|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3
7072343|NCT02036502|11176422|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
7072344|NCT02036502|11176423|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
7072345|NCT02036502|11176424|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
7072346|NCT02036502|11176425|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
7072347|NCT02036502|11176426|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
7072348|NCT02036502|11176427|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
7072349|NCT02036502|11176428|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
7072350|NCT02036502|11176421|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0
7072351|NCT02036502|11176422|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1
7072352|NCT02036502|11176423|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0
7072353|NCT02036502|11176424|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0
7072354|NCT02036502|11176425|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0
7072355|NCT02036502|11176426|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0
7072356|NCT02036502|11176427|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0
7072357|NCT02036502|11176428|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0
7072358|NCT02036502|11176421|FG000|Part 1:Dose Determination/Escalation|Not treated|0
7072359|NCT02036502|11176422|FG001|Part 1:Dose Determination/Escalation|Not treated|1
7072360|NCT02036502|11176423|FG002|Part 1:Dose Determination/Escalation|Not treated|0
7072361|NCT02036502|11176424|FG003|Part 1:Dose Determination/Escalation|Not treated|0
7072362|NCT02036502|11176425|FG004|Part 1:Dose Determination/Escalation|Not treated|0
7072363|NCT02036502|11176426|FG005|Part 1:Dose Determination/Escalation|Not treated|0
7072364|NCT02036502|11176427|FG006|Part 1:Dose Determination/Escalation|Not treated|0
7072365|NCT02036502|11176428|FG007|Part 1:Dose Determination/Escalation|Not treated|0
7072366|NCT02036502|11176421|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0
7072367|NCT02036502|11176422|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0
7072368|NCT02036502|11176423|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2
7072369|NCT02036502|11176424|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1
7072370|NCT02036502|11176425|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1
7072371|NCT02036502|11176426|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0
7072372|NCT02036502|11176427|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0
7072373|NCT02036502|11176428|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0
7072374|NCT02036502|11176421|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0
7072375|NCT02036502|11176422|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0
6960139|NCT01079182|11005205|FG000|Overall Study|ADR and Lack of Effectiveness|39
6960140|NCT01079182|11005205|FG000|Overall Study|Reasons not Evaluated|271
6960141|NCT01079195|11005209|FG000|Overall Study|No Documentation of Tarka Therapy|739
6960142|NCT01079195|11005209|FG000|Overall Study|No Documentation Available|437
6960143|NCT01079195|11005209|FG000|Overall Study|Adverse Event|157
6960144|NCT01079195|11005209|FG000|Overall Study|Reason Unknown|39
6960145|NCT01079195|11005209|FG000|Overall Study|Withdrawal by Subject|18
6960146|NCT01079195|11005209|FG000|Overall Study|Financial Reasons|15
6960147|NCT01079195|11005209|FG000|Overall Study|Lack of Effectiveness|12
6960148|NCT01079195|11005209|FG000|Overall Study|Physician Decision|4
6960149|NCT01079195|11005209|FG000|Overall Study|Improved Status of Participant|4
6960150|NCT01079195|11005209|FG000|Overall Study|No Follow-up Documentation Available|4
6960151|NCT01079195|11005209|FG000|Overall Study|Non-compliance|2
6960152|NCT01079234|11005216|FG000|Main: Week 0 to 26|Adverse Event|5
6960153|NCT01079234|11005217|FG001|Main: Week 0 to 26|Adverse Event|4
6960154|NCT01079234|11005218|FG002|Main: Week 0 to 26|Adverse Event|1
6960155|NCT01079234|11005219|FG003|Main: Week 0 to 26|Adverse Event|0
6960156|NCT01079234|11005216|FG000|Main: Week 0 to 26|Lack of Efficacy|2
6960157|NCT01079234|11005217|FG001|Main: Week 0 to 26|Lack of Efficacy|1
6960158|NCT01079234|11005218|FG002|Main: Week 0 to 26|Lack of Efficacy|1
6960159|NCT01079234|11005219|FG003|Main: Week 0 to 26|Lack of Efficacy|0
6960160|NCT01079234|11005216|FG000|Main: Week 0 to 26|Protocol Violation|6
6960161|NCT01079234|11005217|FG001|Main: Week 0 to 26|Protocol Violation|2
6960162|NCT01079234|11005218|FG002|Main: Week 0 to 26|Protocol Violation|4
6960163|NCT01079234|11005219|FG003|Main: Week 0 to 26|Protocol Violation|0
6960164|NCT01079234|11005216|FG000|Main: Week 0 to 26|Withdrawal criteria|6
6960165|NCT01079234|11005217|FG001|Main: Week 0 to 26|Withdrawal criteria|6
6960166|NCT01079234|11005218|FG002|Main: Week 0 to 26|Withdrawal criteria|2
6960167|NCT01079234|11005219|FG003|Main: Week 0 to 26|Withdrawal criteria|0
6960168|NCT01079234|11005216|FG000|Main: Week 0 to 26|Unclassified|7
6960169|NCT01079234|11005217|FG001|Main: Week 0 to 26|Unclassified|13
6960170|NCT01079234|11005218|FG002|Main: Week 0 to 26|Unclassified|4
6960171|NCT01079234|11005219|FG003|Main: Week 0 to 26|Unclassified|0
6960172|NCT01079234|11005216|FG000|Extension: Week 27 to 52|Adverse Event|0
6960173|NCT01079234|11005217|FG001|Extension: Week 27 to 52|Adverse Event|0
6960174|NCT01079234|11005218|FG002|Extension: Week 27 to 52|Adverse Event|1
6960175|NCT01079234|11005219|FG003|Extension: Week 27 to 52|Adverse Event|0
6960176|NCT01079234|11005216|FG000|Extension: Week 27 to 52|Lack of Efficacy|0
6960177|NCT01079234|11005217|FG001|Extension: Week 27 to 52|Lack of Efficacy|0
6960178|NCT01079234|11005218|FG002|Extension: Week 27 to 52|Lack of Efficacy|0
6960179|NCT01079234|11005219|FG003|Extension: Week 27 to 52|Lack of Efficacy|2
6960180|NCT01079234|11005216|FG000|Extension: Week 27 to 52|Protocol Violation|0
6960181|NCT01079234|11005217|FG001|Extension: Week 27 to 52|Protocol Violation|0
6960182|NCT01079234|11005218|FG002|Extension: Week 27 to 52|Protocol Violation|2
6960183|NCT01079234|11005219|FG003|Extension: Week 27 to 52|Protocol Violation|5
6960184|NCT01079234|11005216|FG000|Extension: Week 27 to 52|Withdrawal criteria|0
6960185|NCT01079234|11005217|FG001|Extension: Week 27 to 52|Withdrawal criteria|0
6960186|NCT01079234|11005218|FG002|Extension: Week 27 to 52|Withdrawal criteria|4
6960187|NCT01079234|11005219|FG003|Extension: Week 27 to 52|Withdrawal criteria|2
6960188|NCT01079234|11005216|FG000|Extension: Week 27 to 52|Unclassified|0
6960189|NCT01079234|11005217|FG001|Extension: Week 27 to 52|Unclassified|0
6960190|NCT01079234|11005218|FG002|Extension: Week 27 to 52|Unclassified|4
6960191|NCT01079234|11005219|FG003|Extension: Week 27 to 52|Unclassified|7
6960192|NCT01079663|11005254|FG000|Overall Study|Adverse Event|0
6960193|NCT01079663|11005255|FG001|Overall Study|Adverse Event|2
6960194|NCT01079663|11005254|FG000|Overall Study|Protocol Violation|0
6960195|NCT01079663|11005255|FG001|Overall Study|Protocol Violation|2
6960196|NCT01079741|11005266|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
6960197|NCT01079741|11005267|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1
6960198|NCT01079741|11005268|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
6960199|NCT01079741|11005269|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
6960200|NCT01079741|11005270|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
6960201|NCT01079741|11005266|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
6960202|NCT01079741|11005267|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
6960203|NCT01079741|11005268|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
6960204|NCT01079741|11005269|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
6960205|NCT01079741|11005270|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3
6960206|NCT01079806|11005284|FG000|Day 1 to Week 96|Adverse Event|0
6960207|NCT01079806|11005285|FG001|Day 1 to Week 96|Adverse Event|3
6960208|NCT01079806|11005284|FG000|Day 1 to Week 96|Withdrawal by Subject|3
6960209|NCT01079806|11005285|FG001|Day 1 to Week 96|Withdrawal by Subject|2
6960210|NCT01079806|11005284|FG000|Day 1 to Week 96|Pregnancy|0
6960211|NCT01079806|11005285|FG001|Day 1 to Week 96|Pregnancy|1
6960212|NCT01079806|11005284|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2
6960213|NCT01079806|11005285|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0
6960214|NCT01079806|11005284|FG000|Day 1 to Week 96|Lost to Follow-up|1
6960215|NCT01079806|11005285|FG001|Day 1 to Week 96|Lost to Follow-up|0
6960216|NCT01079806|11005284|FG000|Day 1 to Week 96|Subject request to stop study treatment|1
6960217|NCT01079806|11005285|FG001|Day 1 to Week 96|Subject request to stop study treatment|0
6960218|NCT01079806|11005284|FG000|Day 1 to Week 96|Removal by Medical Monitor|0
6960219|NCT01079806|11005285|FG001|Day 1 to Week 96|Removal by Medical Monitor|1
6976573|NCT01200394|11029348|FG001|Overall Study|Withdrawal by Subject|5
6960220|NCT01079806|11005284|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13
6960221|NCT01079806|11005285|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8
6960222|NCT01079806|11005284|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0
6960223|NCT01079806|11005285|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1
6960224|NCT01079806|11005284|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6
7072376|NCT02036502|11176423|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3
7072377|NCT02036502|11176424|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0
7072378|NCT02036502|11176425|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0
7072379|NCT02036502|11176426|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0
7072380|NCT02036502|11176427|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0
7072381|NCT02036502|11176428|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0
7072382|NCT02036502|11176421|FG000|Part 2:Dose Confirmation|Death|0
7072383|NCT02036502|11176422|FG001|Part 2:Dose Confirmation|Death|0
7072384|NCT02036502|11176423|FG002|Part 2:Dose Confirmation|Death|1
7072385|NCT02036502|11176424|FG003|Part 2:Dose Confirmation|Death|0
7072386|NCT02036502|11176425|FG004|Part 2:Dose Confirmation|Death|0
7072387|NCT02036502|11176426|FG005|Part 2:Dose Confirmation|Death|0
7072388|NCT02036502|11176427|FG006|Part 2:Dose Confirmation|Death|0
7072389|NCT02036502|11176428|FG007|Part 2:Dose Confirmation|Death|0
7072390|NCT02036502|11176421|FG000|Part 2:Dose Confirmation|Not treated|0
7072391|NCT02036502|11176422|FG001|Part 2:Dose Confirmation|Not treated|0
6960225|NCT01079806|11005285|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6
6960226|NCT01079832|11005293|FG000|Overall Study|Withdrawal by Subject|1
6960227|NCT01079936|11005301|FG000|Phase I: MTD|First Remission Status|2
6960228|NCT01079936|11005302|FG001|Phase I: MTD|First Remission Status|0
6960229|NCT01079936|11005303|FG002|Phase I: MTD|First Remission Status|0
6960230|NCT01079936|11005304|FG003|Phase I: MTD|First Remission Status|0
6960231|NCT01079936|11005305|FG004|Phase I: MTD|First Remission Status|0
6960232|NCT01079936|11005301|FG000|Phase I: MTD|No Stem Cell Transplantation|2
6960233|NCT01079936|11005302|FG001|Phase I: MTD|No Stem Cell Transplantation|0
6960234|NCT01079936|11005303|FG002|Phase I: MTD|No Stem Cell Transplantation|0
6960235|NCT01079936|11005304|FG003|Phase I: MTD|No Stem Cell Transplantation|0
6960236|NCT01079936|11005305|FG004|Phase I: MTD|No Stem Cell Transplantation|0
6960237|NCT01079936|11005301|FG000|Phase II|Adverse Event|0
6960238|NCT01079936|11005302|FG001|Phase II|Adverse Event|0
6960239|NCT01079936|11005303|FG002|Phase II|Adverse Event|1
6960240|NCT01079936|11005304|FG003|Phase II|Adverse Event|0
6960241|NCT01079936|11005305|FG004|Phase II|Adverse Event|0
6960242|NCT01079936|11005301|FG000|Phase II|Insurance Issue|0
6960243|NCT01079936|11005302|FG001|Phase II|Insurance Issue|0
6960244|NCT01079936|11005303|FG002|Phase II|Insurance Issue|0
6960245|NCT01079936|11005304|FG003|Phase II|Insurance Issue|0
6960246|NCT01079936|11005305|FG004|Phase II|Insurance Issue|1
6960247|NCT01079949|11005318|FG000|Overall Study|Withdrawal before r-hCG administration|2
6960248|NCT01079949|11005319|FG001|Overall Study|Withdrawal before r-hCG administration|3
6960249|NCT01079949|11005318|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4
6960250|NCT01079949|11005319|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8
6960251|NCT01079949|11005318|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8
6960252|NCT01079949|11005319|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2
6960253|NCT01079949|11005318|FG000|Overall Study|Randomized but not treated|1
6960254|NCT01079949|11005319|FG001|Overall Study|Randomized but not treated|0
6960255|NCT01079962|11005327|FG000|Overall Study|Adverse Event|2
6960256|NCT01079962|11005328|FG001|Overall Study|Adverse Event|2
6960257|NCT01079962|11005327|FG000|Overall Study|Withdrawal by Subject|5
6960258|NCT01079962|11005328|FG001|Overall Study|Withdrawal by Subject|7
6960259|NCT01079962|11005327|FG000|Overall Study|Protocol Violation|2
6960260|NCT01079962|11005328|FG001|Overall Study|Protocol Violation|2
6960261|NCT01079962|11005327|FG000|Overall Study|No blood pressure (BP) control|3
6960262|NCT01079962|11005328|FG001|Overall Study|No blood pressure (BP) control|0
6960263|NCT01079962|11005327|FG000|Overall Study|Inclusion/exclusion criteria|1
6960264|NCT01079962|11005328|FG001|Overall Study|Inclusion/exclusion criteria|3
6960265|NCT01079962|11005327|FG000|Overall Study|Participant not returning for next visit|1
6960266|NCT01079962|11005328|FG001|Overall Study|Participant not returning for next visit|0
6960267|NCT01079962|11005327|FG000|Overall Study|Due to arrhythmia/bradycardia|1
6960268|NCT01079962|11005328|FG001|Overall Study|Due to arrhythmia/bradycardia|1
6960269|NCT01079988|11005339|FG000|Overall Study|Lost to Follow-up|0
6960270|NCT01079988|11005340|FG001|Overall Study|Lost to Follow-up|0
6960271|NCT01079988|11005341|FG002|Overall Study|Lost to Follow-up|0
6960272|NCT01079988|11005342|FG003|Overall Study|Lost to Follow-up|1
6960273|NCT01079988|11005343|FG004|Overall Study|Lost to Follow-up|0
6960274|NCT01079988|11005339|FG000|Overall Study|Lack of Efficacy|1
6960275|NCT01079988|11005340|FG001|Overall Study|Lack of Efficacy|0
6960276|NCT01079988|11005341|FG002|Overall Study|Lack of Efficacy|0
7072392|NCT02036502|11176423|FG002|Part 2:Dose Confirmation|Not treated|0
6960277|NCT01079988|11005342|FG003|Overall Study|Lack of Efficacy|0
6960278|NCT01079988|11005343|FG004|Overall Study|Lack of Efficacy|0
6960279|NCT01079988|11005339|FG000|Overall Study|Other|0
6960280|NCT01079988|11005340|FG001|Overall Study|Other|0
6960281|NCT01079988|11005341|FG002|Overall Study|Other|0
6960282|NCT01079988|11005342|FG003|Overall Study|Other|2
6960283|NCT01079988|11005343|FG004|Overall Study|Other|1
6960284|NCT01080131|11005368|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
6960285|NCT01080131|11005369|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
6960286|NCT01080131|11005368|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6
6960287|NCT01080131|11005369|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4
6960288|NCT01080131|11005368|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5
6960289|NCT01080131|11005369|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3
6960290|NCT01080131|11005368|FG000|Core Study (0- 12 Weeks)|Administrative problems|0
6960291|NCT01080131|11005369|FG001|Core Study (0- 12 Weeks)|Administrative problems|1
6960292|NCT01080131|11005368|FG000|Core Study (0- 12 Weeks)|Death|1
6960293|NCT01080131|11005369|FG001|Core Study (0- 12 Weeks)|Death|0
6960294|NCT01080131|11005368|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0
6960295|NCT01080131|11005369|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2
6960296|NCT01080131|11005368|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1
6960297|NCT01080131|11005369|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0
6960298|NCT01080131|11005368|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0
6960299|NCT01080131|11005369|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1
6960300|NCT01080131|11005368|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4
6960301|NCT01080131|11005369|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3
6960302|NCT01080131|11005368|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1
6960303|NCT01080131|11005369|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0
6960304|NCT01080131|11005368|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1
6960305|NCT01080131|11005369|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2
6960306|NCT01080131|11005368|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3
6960307|NCT01080131|11005369|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4
6960308|NCT01080131|11005368|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4
6960309|NCT01080131|11005369|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5
6960310|NCT01080300|11005432|FG000|Overall Study|Adverse Event|49
6960311|NCT01080300|11005433|FG001|Overall Study|Adverse Event|35
6960312|NCT01080300|11005432|FG000|Overall Study|Lack of Efficacy|12
6960313|NCT01080300|11005433|FG001|Overall Study|Lack of Efficacy|15
6960314|NCT01080300|11005432|FG000|Overall Study|Protocol Violation|7
6960315|NCT01080300|11005433|FG001|Overall Study|Protocol Violation|13
6960316|NCT01080300|11005432|FG000|Overall Study|Lost to Follow-up|10
6960317|NCT01080300|11005433|FG001|Overall Study|Lost to Follow-up|6
6960318|NCT01080300|11005432|FG000|Overall Study|Death|0
6960319|NCT01080300|11005433|FG001|Overall Study|Death|1
6960320|NCT01080300|11005432|FG000|Overall Study|Withdrawal by Subject|12
6960321|NCT01080300|11005433|FG001|Overall Study|Withdrawal by Subject|28
6960322|NCT01080300|11005432|FG000|Overall Study|Reasons not specified|4
6960323|NCT01080300|11005433|FG001|Overall Study|Reasons not specified|6
6960324|NCT01080326|11005441|FG000|Overall Study|Patient deterioration prior to procedure|3
6960325|NCT01080326|11005441|FG000|Overall Study|Surgeon decision|1
6960326|NCT01080391|11005447|FG000|Overall Study|Randomized but not treated|7
6960327|NCT01080391|11005448|FG001|Overall Study|Randomized but not treated|4
6960328|NCT01080625|11005457|FG000|Overall Study|Physician Decision|0
6960329|NCT01080625|11005458|FG001|Overall Study|Physician Decision|2
6960330|NCT01080625|11005459|FG002|Overall Study|Physician Decision|1
6960331|NCT01080716|11005484|FG000|Part 1|Physician Decision|1
6960332|NCT01080716|11005485|FG001|Part 1|Physician Decision|0
6960333|NCT01080716|11005486|FG002|Part 1|Physician Decision|0
6960334|NCT01080716|11005487|FG003|Part 1|Physician Decision|0
6960335|NCT01080807|11005520|FG000|Overall Study|Adverse Event|9
6960336|NCT01080807|11005521|FG001|Overall Study|Adverse Event|1
6960337|NCT01080807|11005520|FG000|Overall Study|Lack of Efficacy|0
6960338|NCT01080807|11005521|FG001|Overall Study|Lack of Efficacy|1
6960339|NCT01080807|11005520|FG000|Overall Study|Withdrawal by Subject|7
6960340|NCT01080807|11005521|FG001|Overall Study|Withdrawal by Subject|2
6960341|NCT01080807|11005520|FG000|Overall Study|Protocol Violation|7
6960342|NCT01080807|11005521|FG001|Overall Study|Protocol Violation|6
6960343|NCT01080807|11005520|FG000|Overall Study|Lost to Follow-up|6
6960344|NCT01080807|11005521|FG001|Overall Study|Lost to Follow-up|4
6960345|NCT01080807|11005520|FG000|Overall Study|Noncompliance with drug administration|1
6960346|NCT01080807|11005521|FG001|Overall Study|Noncompliance with drug administration|1
6960347|NCT01080807|11005520|FG000|Overall Study|Noncompliance to study procedures|1
6960348|NCT01080807|11005521|FG001|Overall Study|Noncompliance to study procedures|1
6960349|NCT01080807|11005520|FG000|Overall Study|Began working day shift|0
6960350|NCT01080807|11005521|FG001|Overall Study|Began working day shift|2
6960351|NCT01080807|11005520|FG000|Overall Study|Laid off or terminated from job|1
6960352|NCT01080807|11005521|FG001|Overall Study|Laid off or terminated from job|2
6960353|NCT01080807|11005520|FG000|Overall Study|Stopped working consistent night shifts|0
6960354|NCT01080807|11005521|FG001|Overall Study|Stopped working consistent night shifts|1
6960355|NCT01080807|11005520|FG000|Overall Study|Work schedule changing|1
6960356|NCT01080807|11005521|FG001|Overall Study|Work schedule changing|1
6960357|NCT01080807|11005520|FG000|Overall Study|Work schedule and travel|0
7072393|NCT02036502|11176424|FG003|Part 2:Dose Confirmation|Not treated|1
7072394|NCT02036502|11176425|FG004|Part 2:Dose Confirmation|Not treated|0
6960358|NCT01080807|11005521|FG001|Overall Study|Work schedule and travel|1
6838526|NCT00260533|10844282|FG000|Overall Study|Other|3
6838527|NCT00260533|10844283|FG001|Overall Study|Other|3
6960359|NCT01080807|11005520|FG000|Overall Study|Switched to first shift|1
6960360|NCT01080807|11005521|FG001|Overall Study|Switched to first shift|0
6960361|NCT01080807|11005520|FG000|Overall Study|Moved away without notifying center|1
6960362|NCT01080807|11005521|FG001|Overall Study|Moved away without notifying center|0
6960363|NCT01081132|11005556|FG000|Overall Study|Lack of Efficacy|25
6960364|NCT01081132|11005557|FG001|Overall Study|Lack of Efficacy|9
6960365|NCT01081132|11005556|FG000|Overall Study|Withdrawal by Subject|13
6960366|NCT01081132|11005557|FG001|Overall Study|Withdrawal by Subject|16
6960367|NCT01081132|11005556|FG000|Overall Study|Lost to Follow-up|4
6960368|NCT01081132|11005557|FG001|Overall Study|Lost to Follow-up|11
6960369|NCT01081132|11005556|FG000|Overall Study|Adverse Event|3
6960370|NCT01081132|11005557|FG001|Overall Study|Adverse Event|9
6960371|NCT01081132|11005556|FG000|Overall Study|Non Compliance|4
6960372|NCT01081132|11005557|FG001|Overall Study|Non Compliance|2
6960373|NCT01081132|11005556|FG000|Overall Study|Lack Of Compliance|0
6960374|NCT01081132|11005557|FG001|Overall Study|Lack Of Compliance|1
6960375|NCT01081132|11005556|FG000|Overall Study|Missed Visits|1
6960376|NCT01081132|11005557|FG001|Overall Study|Missed Visits|1
6960377|NCT01081132|11005556|FG000|Overall Study|Stopped Taking Meds|2
6960378|NCT01081132|11005557|FG001|Overall Study|Stopped Taking Meds|0
6960379|NCT01081132|11005556|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0
6960380|NCT01081132|11005557|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1
6960381|NCT01081132|11005556|FG000|Overall Study|Declined Taper Phase|0
6960382|NCT01081132|11005557|FG001|Overall Study|Declined Taper Phase|1
6960383|NCT01081132|11005556|FG000|Overall Study|Protocol Violation|3
6960384|NCT01081132|11005557|FG001|Overall Study|Protocol Violation|1
6960385|NCT01081145|11005563|FG000|Open-Label Phase|Lack of Efficacy|56
6960386|NCT01081145|11005564|FG001|Open-Label Phase|Lack of Efficacy|0
6960387|NCT01081145|11005563|FG000|Open-Label Phase|Response criteria not met|46
6960388|NCT01081145|11005564|FG001|Open-Label Phase|Response criteria not met|0
6960389|NCT01081145|11005563|FG000|Open-Label Phase|Adverse Event|42
6960390|NCT01081145|11005564|FG001|Open-Label Phase|Adverse Event|0
6960391|NCT01081145|11005563|FG000|Open-Label Phase|Withdrawal by Subject|41
6960392|NCT01081145|11005564|FG001|Open-Label Phase|Withdrawal by Subject|0
6960393|NCT01081145|11005563|FG000|Open-Label Phase|Other|12
6960394|NCT01081145|11005564|FG001|Open-Label Phase|Other|0
6960395|NCT01081145|11005563|FG000|Open-Label Phase|Lost to Follow-up|11
6960396|NCT01081145|11005564|FG001|Open-Label Phase|Lost to Follow-up|0
6960397|NCT01081145|11005563|FG000|Open-Label Phase|Protocol Violation|4
6960398|NCT01081145|11005564|FG001|Open-Label Phase|Protocol Violation|0
6960399|NCT01081145|11005563|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3
6960400|NCT01081145|11005564|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2
6960401|NCT01081145|11005563|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1
6960402|NCT01081145|11005564|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0
6960403|NCT01081145|11005563|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10
6960404|NCT01081145|11005564|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8
6960405|NCT01081145|11005563|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3
6960406|NCT01081145|11005564|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2
6960407|NCT01081145|11005563|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13
6960408|NCT01081145|11005564|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20
6960409|NCT01081145|11005563|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47
6960410|NCT01081145|11005564|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71
6960411|NCT01081145|11005563|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4
6960412|NCT01081145|11005564|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3
6960413|NCT01081249|11005572|FG000|Overall Study|Diagnosed with Bipolar Disorder|0
6960414|NCT01081249|11005573|FG001|Overall Study|Diagnosed with Bipolar Disorder|1
6960415|NCT01081301|11005579|FG000|Overall Study|Bereaved|3
6960416|NCT01081301|11005579|FG000|Overall Study|Too busy|5
6960417|NCT01081301|11005579|FG000|Overall Study|Patient too ill|2
6960418|NCT01081301|11005579|FG000|Overall Study|Lost to Follow-up|4
6960419|NCT01081626|11005602|FG000|Overall Study|Dosing error|1
6960420|NCT01081626|11005603|FG001|Overall Study|Dosing error|1
6960421|NCT01081626|11005602|FG000|Overall Study|Missing Estradiol|25
6960422|NCT01081626|11005603|FG001|Overall Study|Missing Estradiol|28
6960423|NCT01081626|11005602|FG000|Overall Study|Low antral follicle count|1
6960424|NCT01081626|11005603|FG001|Overall Study|Low antral follicle count|0
6960425|NCT01081626|11005602|FG000|Overall Study|Overstimulation|0
6960426|NCT01081626|11005603|FG001|Overall Study|Overstimulation|1
6960427|NCT01081626|11005602|FG000|Overall Study|Lost to Follow-up|0
7040847|NCT01721044|11124044|FG002|Treatment Period|Withdrawal by Subject|1
6960428|NCT01081626|11005603|FG001|Overall Study|Lost to Follow-up|1
6960429|NCT01081626|11005602|FG000|Overall Study|Other|33
6960430|NCT01081626|11005603|FG001|Overall Study|Other|30
6960431|NCT01081665|11005609|FG000|Overall Study|Death|41
6960432|NCT01081665|11005609|FG000|Overall Study|Lost to Follow-up|18
6960433|NCT01081665|11005609|FG000|Overall Study|Withdrawal by Subject|17
6960434|NCT01081665|11005609|FG000|Overall Study|Change of dialysis unit|10
6960435|NCT01081665|11005609|FG000|Overall Study|Regulation of iPTH|5
6960436|NCT01081665|11005609|FG000|Overall Study|Change in renal replacement therapy|2
6960437|NCT01081665|11005609|FG000|Overall Study|Adverse Event|1
7040848|NCT01721057|11124066|FG000|Treatment Period|Withdrawal by Subject|11
6960438|NCT01081665|11005609|FG000|Overall Study|Lack of Efficacy|1
6960439|NCT01081678|11005617|FG000|Overall Study|Ineligibility Determined|0
6960440|NCT01081678|11005618|FG001|Overall Study|Ineligibility Determined|0
6960441|NCT01081678|11005619|FG002|Overall Study|Ineligibility Determined|1
6960442|NCT01081678|11005620|FG003|Overall Study|Ineligibility Determined|1
6960443|NCT01081678|11005617|FG000|Overall Study|Noncompliance|3
6960444|NCT01081678|11005618|FG001|Overall Study|Noncompliance|4
6960445|NCT01081678|11005619|FG002|Overall Study|Noncompliance|5
6960446|NCT01081678|11005620|FG003|Overall Study|Noncompliance|2
6960447|NCT01081678|11005617|FG000|Overall Study|Adverse Event|2
6960448|NCT01081678|11005618|FG001|Overall Study|Adverse Event|1
6960449|NCT01081678|11005619|FG002|Overall Study|Adverse Event|2
6960450|NCT01081678|11005620|FG003|Overall Study|Adverse Event|2
6960451|NCT01081678|11005617|FG000|Overall Study|Withdrawal by Subject|15
6960452|NCT01081678|11005618|FG001|Overall Study|Withdrawal by Subject|7
6960453|NCT01081678|11005619|FG002|Overall Study|Withdrawal by Subject|17
6960454|NCT01081678|11005620|FG003|Overall Study|Withdrawal by Subject|14
6960455|NCT01081678|11005617|FG000|Overall Study|Administrative Decision|1
6960456|NCT01081678|11005618|FG001|Overall Study|Administrative Decision|0
6960457|NCT01081678|11005619|FG002|Overall Study|Administrative Decision|0
6960458|NCT01081678|11005620|FG003|Overall Study|Administrative Decision|1
6960459|NCT01081678|11005617|FG000|Overall Study|Lost to Follow-up|4
6960460|NCT01081678|11005618|FG001|Overall Study|Lost to Follow-up|1
6960461|NCT01081678|11005619|FG002|Overall Study|Lost to Follow-up|4
6960462|NCT01081678|11005620|FG003|Overall Study|Lost to Follow-up|3
6960463|NCT01081678|11005617|FG000|Overall Study|Death|2
6960464|NCT01081678|11005618|FG001|Overall Study|Death|2
7072395|NCT02036502|11176426|FG005|Part 2:Dose Confirmation|Not treated|0
7072396|NCT02036502|11176427|FG006|Part 2:Dose Confirmation|Not treated|0
7072397|NCT02036502|11176428|FG007|Part 2:Dose Confirmation|Not treated|0
7072398|NCT02036502|11176421|FG000|Part 3:Dose Expansion|Adverse Event|0
7072399|NCT02036502|11176422|FG001|Part 3:Dose Expansion|Adverse Event|0
7072400|NCT02036502|11176423|FG002|Part 3:Dose Expansion|Adverse Event|0
6960465|NCT01081678|11005619|FG002|Overall Study|Death|2
6960466|NCT01081678|11005620|FG003|Overall Study|Death|6
6960467|NCT01081678|11005617|FG000|Overall Study|Other|0
6960468|NCT01081678|11005618|FG001|Overall Study|Other|1
6960469|NCT01081678|11005619|FG002|Overall Study|Other|0
6960470|NCT01081678|11005620|FG003|Overall Study|Other|0
6960471|NCT01081769|11005632|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10
6960472|NCT01081769|11005633|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12
6960473|NCT01081769|11005632|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
6960474|NCT01081769|11005633|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
6960475|NCT01081769|11005632|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6
6960476|NCT01081769|11005633|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7
6960477|NCT01081769|11005632|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2
6960478|NCT01081769|11005633|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0
6960479|NCT01081769|11005632|FG000|CORE Intent-To-Treat|Adverse Event|14
6960480|NCT01081769|11005633|FG001|CORE Intent-To-Treat|Adverse Event|11
6960481|NCT01081769|11005632|FG000|CORE Intent-To-Treat|Death|1
6960482|NCT01081769|11005633|FG001|CORE Intent-To-Treat|Death|1
6960483|NCT01081769|11005632|FG000|CORE Intent-To-Treat|Lack of Efficacy|2
6960484|NCT01081769|11005633|FG001|CORE Intent-To-Treat|Lack of Efficacy|6
6960485|NCT01081769|11005632|FG000|CORE Intent-To-Treat|Lost to Follow-up|4
6960486|NCT01081769|11005633|FG001|CORE Intent-To-Treat|Lost to Follow-up|5
6960487|NCT01081769|11005632|FG000|CORE Intent-To-Treat|Pregnancy|1
6960488|NCT01081769|11005633|FG001|CORE Intent-To-Treat|Pregnancy|0
6960489|NCT01081769|11005632|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52
6960490|NCT01081769|11005633|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60
6960491|NCT01081769|11005632|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0
6960492|NCT01081769|11005633|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5
6960493|NCT01081769|11005632|FG000|CORE Intent-To-Treat|Other|0
6960494|NCT01081769|11005633|FG001|CORE Intent-To-Treat|Other|1
6960495|NCT01081769|11005632|FG000|CORE Intent-To-Treat|Ineligibility|3
6960496|NCT01081769|11005633|FG001|CORE Intent-To-Treat|Ineligibility|4
6960497|NCT01081769|11005632|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1
6960498|NCT01081769|11005633|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2
6960499|NCT01081769|11005632|FG000|CORE Intent-To-Treat|Patient Moved|2
6960500|NCT01081769|11005633|FG001|CORE Intent-To-Treat|Patient Moved|2
7072401|NCT02036502|11176424|FG003|Part 3:Dose Expansion|Adverse Event|0
6960501|NCT01081795|11005642|FG000|Overall Study|Adverse Event|18
6960502|NCT01081795|11005643|FG001|Overall Study|Adverse Event|23
6960503|NCT01081795|11005644|FG002|Overall Study|Adverse Event|6
6960504|NCT01081795|11005642|FG000|Overall Study|Lack of Efficacy|7
6960505|NCT01081795|11005643|FG001|Overall Study|Lack of Efficacy|5
6960506|NCT01081795|11005644|FG002|Overall Study|Lack of Efficacy|19
6960507|NCT01081795|11005642|FG000|Overall Study|Subject's schedule|1
6960508|NCT01081795|11005643|FG001|Overall Study|Subject's schedule|1
6960509|NCT01081795|11005644|FG002|Overall Study|Subject's schedule|2
6960510|NCT01081795|11005642|FG000|Overall Study|Revocation of informed consent|2
6960511|NCT01081795|11005643|FG001|Overall Study|Revocation of informed consent|0
6960512|NCT01081795|11005644|FG002|Overall Study|Revocation of informed consent|0
6960513|NCT01081795|11005642|FG000|Overall Study|Ineligible for participation|1
6960514|NCT01081795|11005643|FG001|Overall Study|Ineligible for participation|0
6960515|NCT01081795|11005644|FG002|Overall Study|Ineligible for participation|0
6960516|NCT01081795|11005642|FG000|Overall Study|Use of a prohibited concomitant drug|1
6960517|NCT01081795|11005643|FG001|Overall Study|Use of a prohibited concomitant drug|1
6960518|NCT01081795|11005644|FG002|Overall Study|Use of a prohibited concomitant drug|1
6960519|NCT01081795|11005642|FG000|Overall Study|Using drug with restricted days of use|2
6960520|NCT01081795|11005643|FG001|Overall Study|Using drug with restricted days of use|3
6960521|NCT01081795|11005644|FG002|Overall Study|Using drug with restricted days of use|2
6960522|NCT01081795|11005642|FG000|Overall Study|Other|1
6960523|NCT01081795|11005643|FG001|Overall Study|Other|2
6960524|NCT01081795|11005644|FG002|Overall Study|Other|0
6960525|NCT01081834|11005657|FG000|Core Period: Baseline to Week 26|Pregnancy|1
6960526|NCT01081834|11005658|FG001|Core Period: Baseline to Week 26|Pregnancy|0
6960527|NCT01081834|11005659|FG002|Core Period: Baseline to Week 26|Pregnancy|0
6960528|NCT01081834|11005660|FG003|Core Period: Baseline to Week 26|Pregnancy|0
6960529|NCT01081834|11005661|FG004|Core Period: Baseline to Week 26|Pregnancy|0
6960530|NCT01081834|11005657|FG000|Core Period: Baseline to Week 26|Adverse Event|2
6960531|NCT01081834|11005658|FG001|Core Period: Baseline to Week 26|Adverse Event|5
6960532|NCT01081834|11005659|FG002|Core Period: Baseline to Week 26|Adverse Event|3
6960533|NCT01081834|11005660|FG003|Core Period: Baseline to Week 26|Adverse Event|1
6960534|NCT01081834|11005661|FG004|Core Period: Baseline to Week 26|Adverse Event|1
6960535|NCT01081834|11005657|FG000|Core Period: Baseline to Week 26|Death|1
6960536|NCT01081834|11005658|FG001|Core Period: Baseline to Week 26|Death|0
6960537|NCT01081834|11005659|FG002|Core Period: Baseline to Week 26|Death|0
6960538|NCT01081834|11005660|FG003|Core Period: Baseline to Week 26|Death|0
6960539|NCT01081834|11005661|FG004|Core Period: Baseline to Week 26|Death|0
6960540|NCT01081834|11005657|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2
6960541|NCT01081834|11005658|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2
6960542|NCT01081834|11005659|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5
6960543|NCT01081834|11005660|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0
6960544|NCT01081834|11005661|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0
6960545|NCT01081834|11005657|FG000|Core Period: Baseline to Week 26|Protocol Violation|0
6960546|NCT01081834|11005658|FG001|Core Period: Baseline to Week 26|Protocol Violation|4
6960547|NCT01081834|11005659|FG002|Core Period: Baseline to Week 26|Protocol Violation|0
6960548|NCT01081834|11005660|FG003|Core Period: Baseline to Week 26|Protocol Violation|0
6960549|NCT01081834|11005661|FG004|Core Period: Baseline to Week 26|Protocol Violation|2
6960550|NCT01081834|11005657|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15
6960551|NCT01081834|11005658|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3
6960552|NCT01081834|11005659|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9
6960553|NCT01081834|11005660|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3
6960554|NCT01081834|11005661|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1
6960555|NCT01081834|11005657|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3
6960556|NCT01081834|11005658|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4
6960557|NCT01081834|11005659|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2
6960558|NCT01081834|11005660|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2
6960559|NCT01081834|11005661|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0
6960560|NCT01081834|11005657|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
6960561|NCT01081834|11005658|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
6960562|NCT01081834|11005659|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
6960563|NCT01081834|11005660|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
6960564|NCT01081834|11005661|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
6960565|NCT01081834|11005657|FG000|Core Period: Baseline to Week 26|Other|4
6960566|NCT01081834|11005658|FG001|Core Period: Baseline to Week 26|Other|4
6960567|NCT01081834|11005659|FG002|Core Period: Baseline to Week 26|Other|3
6960568|NCT01081834|11005660|FG003|Core Period: Baseline to Week 26|Other|1
6960569|NCT01081834|11005661|FG004|Core Period: Baseline to Week 26|Other|0
6960570|NCT01081834|11005657|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3
6960571|NCT01081834|11005658|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
6960572|NCT01081834|11005659|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
6960573|NCT01081834|11005660|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
6960574|NCT01081834|11005661|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
6960575|NCT01081834|11005657|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1
6960576|NCT01081834|11005658|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0
6960577|NCT01081834|11005659|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0
6960578|NCT01081834|11005660|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0
6960579|NCT01081834|11005661|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0
6960580|NCT01081834|11005657|FG000|Extension Period: Week 26 to Week 52|Death|1
6960581|NCT01081834|11005658|FG001|Extension Period: Week 26 to Week 52|Death|0
6960582|NCT01081834|11005659|FG002|Extension Period: Week 26 to Week 52|Death|0
6960583|NCT01081834|11005660|FG003|Extension Period: Week 26 to Week 52|Death|0
6960584|NCT01081834|11005661|FG004|Extension Period: Week 26 to Week 52|Death|0
6960585|NCT01081834|11005657|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
6960586|NCT01081834|11005658|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
6960587|NCT01081834|11005659|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
6960588|NCT01081834|11005660|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
6960589|NCT01081834|11005661|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
6960590|NCT01081834|11005657|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0
6960591|NCT01081834|11005658|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1
6960592|NCT01081834|11005659|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0
6960593|NCT01081834|11005660|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0
6960594|NCT01081834|11005661|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0
6960595|NCT01081834|11005657|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
6960596|NCT01081834|11005658|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
6960597|NCT01081834|11005659|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
6960598|NCT01081834|11005660|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
6960599|NCT01081834|11005661|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
6960600|NCT01081834|11005657|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
6960601|NCT01081834|11005658|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
6960602|NCT01081834|11005659|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
6960603|NCT01081834|11005660|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
6960604|NCT01081834|11005661|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
6960605|NCT01081834|11005657|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
6960606|NCT01081834|11005658|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
6960607|NCT01081834|11005659|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
6960608|NCT01081834|11005660|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
6960609|NCT01081834|11005661|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
6960610|NCT01081834|11005657|FG000|Extension Period: Week 26 to Week 52|Other|4
6960611|NCT01081834|11005658|FG001|Extension Period: Week 26 to Week 52|Other|5
6960612|NCT01081834|11005659|FG002|Extension Period: Week 26 to Week 52|Other|4
6960613|NCT01081834|11005660|FG003|Extension Period: Week 26 to Week 52|Other|0
6960614|NCT01081834|11005661|FG004|Extension Period: Week 26 to Week 52|Other|0
6960615|NCT01081834|11005657|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7
6960616|NCT01081834|11005658|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1
6960617|NCT01081834|11005659|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
6960618|NCT01081834|11005660|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
6960619|NCT01081834|11005661|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
6960620|NCT01081834|11005657|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0
6960621|NCT01081834|11005658|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1
6960622|NCT01081834|11005659|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0
6960623|NCT01081834|11005660|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0
6960624|NCT01081834|11005661|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0
6960625|NCT01081873|11005680|FG000|Overall Study|Death|86
6960626|NCT01081873|11005680|FG000|Overall Study|Withdrawal by Subject|10
6960627|NCT01081873|11005680|FG000|Overall Study|Lost to Follow-up|142
6960628|NCT01081873|11005680|FG000|Overall Study|Progression of prostate cancer|13
6960629|NCT01081873|11005680|FG000|Overall Study|Other|47
6960630|NCT01081912|11005709|FG000|Conversion/Titration|Adverse Event|47
6960631|NCT01081912|11005710|FG001|Conversion/Titration|Adverse Event|0
6960632|NCT01081912|11005711|FG002|Conversion/Titration|Adverse Event|0
6960633|NCT01081912|11005709|FG000|Conversion/Titration|Lack of Efficacy|17
6960634|NCT01081912|11005710|FG001|Conversion/Titration|Lack of Efficacy|0
6960635|NCT01081912|11005711|FG002|Conversion/Titration|Lack of Efficacy|0
6960636|NCT01081912|11005709|FG000|Conversion/Titration|Lost to Follow-up|5
6960637|NCT01081912|11005710|FG001|Conversion/Titration|Lost to Follow-up|0
6960638|NCT01081912|11005711|FG002|Conversion/Titration|Lost to Follow-up|0
6960639|NCT01081912|11005709|FG000|Conversion/Titration|Physician Decision|2
6960640|NCT01081912|11005710|FG001|Conversion/Titration|Physician Decision|0
6960641|NCT01081912|11005711|FG002|Conversion/Titration|Physician Decision|0
6960642|NCT01081912|11005709|FG000|Conversion/Titration|Protocol Violation|67
6960643|NCT01081912|11005710|FG001|Conversion/Titration|Protocol Violation|0
6960644|NCT01081912|11005711|FG002|Conversion/Titration|Protocol Violation|0
6960645|NCT01081912|11005709|FG000|Conversion/Titration|Withdrawal by Subject|23
6960646|NCT01081912|11005710|FG001|Conversion/Titration|Withdrawal by Subject|0
6960647|NCT01081912|11005711|FG002|Conversion/Titration|Withdrawal by Subject|0
6960648|NCT01081912|11005709|FG000|Conversion/Titration|Non-Compliance|47
6960649|NCT01081912|11005710|FG001|Conversion/Titration|Non-Compliance|0
6960650|NCT01081912|11005711|FG002|Conversion/Titration|Non-Compliance|0
6960651|NCT01081912|11005709|FG000|Maintenance Treatment|Adverse Event|0
6960652|NCT01081912|11005710|FG001|Maintenance Treatment|Adverse Event|2
6960653|NCT01081912|11005711|FG002|Maintenance Treatment|Adverse Event|12
6960654|NCT01081912|11005709|FG000|Maintenance Treatment|Lack of Efficacy|0
6960655|NCT01081912|11005710|FG001|Maintenance Treatment|Lack of Efficacy|14
7072402|NCT02036502|11176425|FG004|Part 3:Dose Expansion|Adverse Event|0
7072403|NCT02036502|11176426|FG005|Part 3:Dose Expansion|Adverse Event|4
7072404|NCT02036502|11176427|FG006|Part 3:Dose Expansion|Adverse Event|0
7072405|NCT02036502|11176428|FG007|Part 3:Dose Expansion|Adverse Event|2
7072406|NCT02036502|11176421|FG000|Part 3:Dose Expansion|Death|0
7072407|NCT02036502|11176422|FG001|Part 3:Dose Expansion|Death|0
7072408|NCT02036502|11176423|FG002|Part 3:Dose Expansion|Death|0
7072409|NCT02036502|11176424|FG003|Part 3:Dose Expansion|Death|0
7072410|NCT02036502|11176425|FG004|Part 3:Dose Expansion|Death|0
7072411|NCT02036502|11176426|FG005|Part 3:Dose Expansion|Death|24
7072412|NCT02036502|11176427|FG006|Part 3:Dose Expansion|Death|0
7072413|NCT02036502|11176428|FG007|Part 3:Dose Expansion|Death|3
7072414|NCT02036502|11176421|FG000|Part 3:Dose Expansion|Lost to Follow-up|0
7072415|NCT02036502|11176422|FG001|Part 3:Dose Expansion|Lost to Follow-up|0
7072416|NCT02036502|11176423|FG002|Part 3:Dose Expansion|Lost to Follow-up|0
7072417|NCT02036502|11176424|FG003|Part 3:Dose Expansion|Lost to Follow-up|0
7072418|NCT02036502|11176425|FG004|Part 3:Dose Expansion|Lost to Follow-up|0
7072419|NCT02036502|11176426|FG005|Part 3:Dose Expansion|Lost to Follow-up|0
7072420|NCT02036502|11176427|FG006|Part 3:Dose Expansion|Lost to Follow-up|0
7072421|NCT02036502|11176428|FG007|Part 3:Dose Expansion|Lost to Follow-up|1
7072422|NCT02036502|11176421|FG000|Part 3:Dose Expansion|Physician Decision|0
7072423|NCT02036502|11176422|FG001|Part 3:Dose Expansion|Physician Decision|0
7072424|NCT02036502|11176423|FG002|Part 3:Dose Expansion|Physician Decision|0
7072425|NCT02036502|11176424|FG003|Part 3:Dose Expansion|Physician Decision|0
7072426|NCT02036502|11176425|FG004|Part 3:Dose Expansion|Physician Decision|0
7072427|NCT02036502|11176426|FG005|Part 3:Dose Expansion|Physician Decision|1
7072428|NCT02036502|11176427|FG006|Part 3:Dose Expansion|Physician Decision|0
6960656|NCT01081912|11005711|FG002|Maintenance Treatment|Lack of Efficacy|64
6960657|NCT01081912|11005709|FG000|Maintenance Treatment|Lost to Follow-up|0
6960658|NCT01081912|11005710|FG001|Maintenance Treatment|Lost to Follow-up|1
6960659|NCT01081912|11005711|FG002|Maintenance Treatment|Lost to Follow-up|0
6960660|NCT01081912|11005709|FG000|Maintenance Treatment|Physician Decision|0
6960661|NCT01081912|11005710|FG001|Maintenance Treatment|Physician Decision|0
6960662|NCT01081912|11005711|FG002|Maintenance Treatment|Physician Decision|1
6960663|NCT01081912|11005709|FG000|Maintenance Treatment|Protocol Violation|0
6960664|NCT01081912|11005710|FG001|Maintenance Treatment|Protocol Violation|1
7072429|NCT02036502|11176428|FG007|Part 3:Dose Expansion|Physician Decision|0
7072430|NCT02036502|11176421|FG000|Part 3:Dose Expansion|Progressive Disease|0
6960665|NCT01081912|11005711|FG002|Maintenance Treatment|Protocol Violation|2
6960666|NCT01081912|11005709|FG000|Maintenance Treatment|Withdrawal by Subject|0
6960667|NCT01081912|11005710|FG001|Maintenance Treatment|Withdrawal by Subject|5
6960668|NCT01081912|11005711|FG002|Maintenance Treatment|Withdrawal by Subject|5
6960669|NCT01081912|11005709|FG000|Maintenance Treatment|Non-Compliance|0
6960670|NCT01081912|11005710|FG001|Maintenance Treatment|Non-Compliance|4
6960671|NCT01081912|11005711|FG002|Maintenance Treatment|Non-Compliance|7
6960672|NCT01081912|11005709|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0
6960673|NCT01081912|11005710|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0
6960674|NCT01081912|11005711|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1
6960675|NCT01082081|11005721|FG000|Overall Study|Lost to Follow-up|0
6960676|NCT01082081|11005722|FG001|Overall Study|Lost to Follow-up|0
6960677|NCT01082081|11005723|FG002|Overall Study|Lost to Follow-up|1
6960678|NCT01082081|11005721|FG000|Overall Study|Withdrawal by Subject|0
6960679|NCT01082081|11005722|FG001|Overall Study|Withdrawal by Subject|0
6960680|NCT01082081|11005723|FG002|Overall Study|Withdrawal by Subject|1
6960681|NCT01082081|11005721|FG000|Overall Study|Other Reason|0
6960682|NCT01082081|11005722|FG001|Overall Study|Other Reason|1
7072431|NCT02036502|11176422|FG001|Part 3:Dose Expansion|Progressive Disease|0
6960683|NCT01082081|11005723|FG002|Overall Study|Other Reason|0
6960684|NCT01082328|11005736|FG000|Overall Study|Adverse Event|1
6960685|NCT01082367|11005742|FG000|Double-blind Period|Administrative problems|0
6960686|NCT01082367|11005743|FG001|Double-blind Period|Administrative problems|1
6960687|NCT01082367|11005742|FG000|Double-blind Period|Lack of Efficacy|5
6960688|NCT01082367|11005743|FG001|Double-blind Period|Lack of Efficacy|11
6960689|NCT01082367|11005742|FG000|Double-blind Period|Adverse Event|0
6960690|NCT01082367|11005743|FG001|Double-blind Period|Adverse Event|1
6960691|NCT01082367|11005742|FG000|Follow-up (F-U) Period|Administrative problems|1
6960692|NCT01082367|11005743|FG001|Follow-up (F-U) Period|Administrative problems|0
6960693|NCT01082367|11005742|FG000|Follow-up (F-U) Period|Abnormal lab values|1
7072432|NCT02036502|11176423|FG002|Part 3:Dose Expansion|Progressive Disease|0
7072433|NCT02036502|11176424|FG003|Part 3:Dose Expansion|Progressive Disease|0
7072434|NCT02036502|11176425|FG004|Part 3:Dose Expansion|Progressive Disease|0
7072435|NCT02036502|11176426|FG005|Part 3:Dose Expansion|Progressive Disease|1
7072436|NCT02036502|11176427|FG006|Part 3:Dose Expansion|Progressive Disease|0
7072437|NCT02036502|11176428|FG007|Part 3:Dose Expansion|Progressive Disease|0
7072438|NCT02036502|11176421|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0
7072439|NCT02036502|11176422|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0
7072440|NCT02036502|11176423|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0
7072441|NCT02036502|11176424|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0
7072442|NCT02036502|11176425|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0
7072443|NCT02036502|11176426|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11
6960694|NCT01082367|11005743|FG001|Follow-up (F-U) Period|Abnormal lab values|0
6960695|NCT01082367|11005742|FG000|Follow-up (F-U) Period|Adverse Event|0
6960696|NCT01082367|11005743|FG001|Follow-up (F-U) Period|Adverse Event|1
6960697|NCT01082614|11005772|FG000|Overall Study|Adverse Event|1
6960698|NCT01082614|11005773|FG001|Overall Study|Adverse Event|4
6960699|NCT01082614|11005772|FG000|Overall Study|Equipment Malfunction|0
6960700|NCT01082614|11005773|FG001|Overall Study|Equipment Malfunction|1
6960701|NCT01082614|11005772|FG000|Overall Study|Physician Decision|2
6960702|NCT01082614|11005773|FG001|Overall Study|Physician Decision|0
6960703|NCT01082640|11005782|FG000|Overall Study|Adverse Event|9
6960704|NCT01082640|11005783|FG001|Overall Study|Adverse Event|5
6960705|NCT01082640|11005784|FG002|Overall Study|Adverse Event|3
6960706|NCT01082640|11005782|FG000|Overall Study|Withdrawal by Subject|3
6960707|NCT01082640|11005783|FG001|Overall Study|Withdrawal by Subject|3
6960708|NCT01082640|11005784|FG002|Overall Study|Withdrawal by Subject|2
6960709|NCT01082640|11005782|FG000|Overall Study|Major protocol deviation|3
6960710|NCT01082640|11005783|FG001|Overall Study|Major protocol deviation|3
6960711|NCT01082640|11005784|FG002|Overall Study|Major protocol deviation|0
6960712|NCT01082640|11005782|FG000|Overall Study|Lost to Follow-up|0
6960713|NCT01082640|11005783|FG001|Overall Study|Lost to Follow-up|3
6960714|NCT01082640|11005784|FG002|Overall Study|Lost to Follow-up|0
6960715|NCT01082640|11005782|FG000|Overall Study|Other|2
6960716|NCT01082640|11005783|FG001|Overall Study|Other|1
6960717|NCT01082640|11005784|FG002|Overall Study|Other|3
6960718|NCT01082874|11005799|FG000|Overall Study|Lost to Follow-up|10
6960719|NCT01082874|11005800|FG001|Overall Study|Lost to Follow-up|10
6960720|NCT01082874|11005801|FG002|Overall Study|Lost to Follow-up|6
6960721|NCT01082874|11005802|FG003|Overall Study|Lost to Follow-up|10
6960722|NCT01082874|11005799|FG000|Overall Study|Withdrawal by Subject|1
6960723|NCT01082874|11005800|FG001|Overall Study|Withdrawal by Subject|2
6960724|NCT01082874|11005801|FG002|Overall Study|Withdrawal by Subject|5
6960725|NCT01082874|11005802|FG003|Overall Study|Withdrawal by Subject|3
6960726|NCT01082965|11005827|FG000|Overall Study|Protocol Violation|0
6960727|NCT01082965|11005828|FG001|Overall Study|Protocol Violation|1
6960728|NCT01082965|11005827|FG000|Overall Study|Other|1
6960729|NCT01082965|11005828|FG001|Overall Study|Other|1
6960730|NCT01083121|11005834|FG000|Overall Study|Use of Humira outside the approved label|81
6960731|NCT01083160|11005842|FG000|Overall Study|Adverse Event|1
6960732|NCT01083173|11005846|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
6960733|NCT01083173|11005847|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
6960734|NCT01083173|11005846|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1
6960735|NCT01083173|11005847|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0
6960736|NCT01083173|11005846|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201
6960737|NCT01083173|11005847|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0
6960738|NCT01083173|11005846|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168
6960739|NCT01083173|11005847|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0
6960740|NCT01083173|11005846|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13
6960741|NCT01083173|11005847|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0
6960742|NCT01083173|11005846|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
6960743|NCT01083173|11005847|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
6960744|NCT01083173|11005846|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0
6960745|NCT01083173|11005847|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1
6960746|NCT01083173|11005846|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0
6960747|NCT01083173|11005847|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101
6960748|NCT01083173|11005846|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0
6960749|NCT01083173|11005847|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195
6960750|NCT01083173|11005846|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0
6960751|NCT01083173|11005847|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136
6960752|NCT01083173|11005846|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0
6960753|NCT01083173|11005847|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46
6960754|NCT01083186|11005856|FG000|Overall Study|Lost to Follow-up|48
6960755|NCT01083186|11005856|FG000|Overall Study|Consent Withdrawal|7
6960756|NCT01083186|11005856|FG000|Overall Study|Death|3
6960757|NCT01083186|11005856|FG000|Overall Study|Adverse Event|3
6960758|NCT01083186|11005856|FG000|Overall Study|Lack of Efficacy|2
6960759|NCT01083186|11005856|FG000|Overall Study|Hemodialysis Initiation|28
6960760|NCT01083186|11005856|FG000|Overall Study|Administrative Reasons|2
6960761|NCT01083186|11005856|FG000|Overall Study|Non-compliance to Study Treatment|1
6960762|NCT01083316|11005885|FG000|Overall Study|Adverse Event|2
6960763|NCT01083316|11005885|FG000|Overall Study|Withdrawal by Subject|1
6960764|NCT01083485|11005905|FG000|Overall Study|Adverse Event|0
6960765|NCT01083485|11005906|FG001|Overall Study|Adverse Event|1
6960766|NCT01083485|11005905|FG000|Overall Study|Protocol Violation|1
6960767|NCT01083485|11005906|FG001|Overall Study|Protocol Violation|0
6960768|NCT01083485|11005905|FG000|Overall Study|Withdrawal by Subject|5
6960769|NCT01083485|11005906|FG001|Overall Study|Withdrawal by Subject|2
6960770|NCT01083485|11005905|FG000|Overall Study|Other|1
6960771|NCT01083485|11005906|FG001|Overall Study|Other|0
6960772|NCT01083576|11005916|FG000|Overall Study|Treatment Failure|6
6960773|NCT01083576|11005917|FG001|Overall Study|Treatment Failure|1
6960774|NCT01083602|11005924|FG000|Overall Study|Adverse Event|11
6960775|NCT01083602|11005924|FG000|Overall Study|New Cancer Therapy|2
6960776|NCT01083602|11005924|FG000|Overall Study|Death|1
6960777|NCT01083602|11005924|FG000|Overall Study|Withdrawal by Subject|5
6960778|NCT01083602|11005924|FG000|Overall Study|Lack of Efficacy|36
6960779|NCT01083641|11005937|FG000|Overall Study|Withdrawal by Subject|2
6960780|NCT01083680|11005954|FG000|Overall Study|Lost to Follow-up|2758
7072444|NCT02036502|11176427|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0
7072445|NCT02036502|11176428|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2
7072446|NCT02036502|11176421|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0
7072447|NCT02036502|11176422|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0
7072448|NCT02036502|11176423|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0
7072449|NCT02036502|11176424|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0
7072450|NCT02036502|11176425|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0
7072451|NCT02036502|11176426|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4
7072452|NCT02036502|11176427|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1
7072453|NCT02036502|11176428|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2
7072454|NCT02036502|11176421|FG000|Part 3:Dose Expansion|Not Treated|0
7072455|NCT02036502|11176422|FG001|Part 3:Dose Expansion|Not Treated|0
7072456|NCT02036502|11176423|FG002|Part 3:Dose Expansion|Not Treated|0
7072457|NCT02036502|11176424|FG003|Part 3:Dose Expansion|Not Treated|0
7072458|NCT02036502|11176425|FG004|Part 3:Dose Expansion|Not Treated|0
7072459|NCT02036502|11176426|FG005|Part 3:Dose Expansion|Not Treated|2
7072460|NCT02036502|11176427|FG006|Part 3:Dose Expansion|Not Treated|0
7072461|NCT02036502|11176428|FG007|Part 3:Dose Expansion|Not Treated|0
7072462|NCT02036515|11176451|FG000|Overall Study|Adverse Event|1
7072463|NCT02036515|11176452|FG001|Overall Study|Adverse Event|1
7072464|NCT02036515|11176453|FG002|Overall Study|Adverse Event|2
7072465|NCT02036515|11176451|FG000|Overall Study|Lost to Follow-up|0
7072466|NCT02036515|11176452|FG001|Overall Study|Lost to Follow-up|2
7072467|NCT02036515|11176453|FG002|Overall Study|Lost to Follow-up|0
7072468|NCT02036515|11176451|FG000|Overall Study|Non-compliance with study drug|0
7072469|NCT02036515|11176452|FG001|Overall Study|Non-compliance with study drug|0
7072470|NCT02036515|11176453|FG002|Overall Study|Non-compliance with study drug|2
7072471|NCT02036515|11176451|FG000|Overall Study|Screen failure|0
7072472|NCT02036515|11176452|FG001|Overall Study|Screen failure|2
7072473|NCT02036515|11176453|FG002|Overall Study|Screen failure|0
7072474|NCT02036515|11176451|FG000|Overall Study|Withdrawal by Subject|4
7072475|NCT02036515|11176452|FG001|Overall Study|Withdrawal by Subject|7
7072476|NCT02036515|11176453|FG002|Overall Study|Withdrawal by Subject|9
7072477|NCT02036515|11176451|FG000|Overall Study|Hyperglycemia|0
7072478|NCT02036515|11176452|FG001|Overall Study|Hyperglycemia|0
7072479|NCT02036515|11176453|FG002|Overall Study|Hyperglycemia|1
7072480|NCT02036580|11176468|FG000|Overall Study|Withdrawal by Subject|0
7072481|NCT02036580|11176469|FG001|Overall Study|Withdrawal by Subject|1
7072482|NCT02036580|11176470|FG002|Overall Study|Withdrawal by Subject|0
7072483|NCT02036580|11176468|FG000|Overall Study|Adverse Event|1
7072484|NCT02036580|11176469|FG001|Overall Study|Adverse Event|0
7072485|NCT02036580|11176470|FG002|Overall Study|Adverse Event|0
7072486|NCT02036645|11176490|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7072487|NCT02036645|11176491|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7072488|NCT02036645|11176492|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7072489|NCT02036645|11176493|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7072490|NCT02036645|11176494|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7072491|NCT02036645|11176495|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7072492|NCT02036645|11176496|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1
7072493|NCT02036645|11176497|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7072494|NCT02036645|11176498|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7072495|NCT02036645|11176499|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7072496|NCT02036645|11176500|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0
6960781|NCT01083680|11005954|FG000|Overall Study|Withdrawal by Subject|1086
6960782|NCT01083693|11005961|FG000|Overall Study|Adverse Event|1
6960783|NCT01083693|11005962|FG001|Overall Study|Adverse Event|1
6960784|NCT01083693|11005963|FG002|Overall Study|Adverse Event|0
6960785|NCT01083693|11005961|FG000|Overall Study|Lost to Follow-up|2
6960786|NCT01083693|11005962|FG001|Overall Study|Lost to Follow-up|0
6960787|NCT01083693|11005963|FG002|Overall Study|Lost to Follow-up|2
6960788|NCT01083693|11005961|FG000|Overall Study|Lack of effectiveness|13
6960789|NCT01083693|11005962|FG001|Overall Study|Lack of effectiveness|2
6960790|NCT01083693|11005963|FG002|Overall Study|Lack of effectiveness|2
6960791|NCT01083693|11005961|FG000|Overall Study|Patient Moved|0
6960792|NCT01083693|11005962|FG001|Overall Study|Patient Moved|1
6960793|NCT01083693|11005963|FG002|Overall Study|Patient Moved|0
6960794|NCT01083693|11005961|FG000|Overall Study|Complete remission|0
6960795|NCT01083693|11005962|FG001|Overall Study|Complete remission|1
6960796|NCT01083693|11005963|FG002|Overall Study|Complete remission|0
6960797|NCT01083693|11005961|FG000|Overall Study|Other medical condition/surgery|1
6960798|NCT01083693|11005962|FG001|Overall Study|Other medical condition/surgery|1
7072497|NCT02036645|11176501|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0
6960799|NCT01083693|11005963|FG002|Overall Study|Other medical condition/surgery|0
6960800|NCT01083693|11005961|FG000|Overall Study|Withdrawal by Subject|3
6960801|NCT01083693|11005962|FG001|Overall Study|Withdrawal by Subject|0
6960802|NCT01083693|11005963|FG002|Overall Study|Withdrawal by Subject|2
6960803|NCT01083693|11005961|FG000|Overall Study|Reason unknown|0
6960804|NCT01083693|11005962|FG001|Overall Study|Reason unknown|0
6960805|NCT01083693|11005963|FG002|Overall Study|Reason unknown|1
6960806|NCT01083810|11006002|FG000|Overall Study|Lost to Follow-up|23
6960807|NCT01083810|11006003|FG001|Overall Study|Lost to Follow-up|11
6960808|NCT01083810|11006004|FG002|Overall Study|Lost to Follow-up|4
6960809|NCT01083810|11006002|FG000|Overall Study|Adverse Event|15
6960810|NCT01083810|11006003|FG001|Overall Study|Adverse Event|11
6960811|NCT01083810|11006004|FG002|Overall Study|Adverse Event|4
6960812|NCT01083810|11006002|FG000|Overall Study|Withdrawal by Subject|7
6960813|NCT01083810|11006003|FG001|Overall Study|Withdrawal by Subject|2
6960814|NCT01083810|11006004|FG002|Overall Study|Withdrawal by Subject|4
6960815|NCT01083810|11006002|FG000|Overall Study|Reason not reported|6
6960816|NCT01083810|11006003|FG001|Overall Study|Reason not reported|1
6960817|NCT01083810|11006004|FG002|Overall Study|Reason not reported|1
6960818|NCT01083810|11006002|FG000|Overall Study|Non-compliance|4
6960819|NCT01083810|11006003|FG001|Overall Study|Non-compliance|7
6960820|NCT01083810|11006004|FG002|Overall Study|Non-compliance|2
6960821|NCT01083810|11006002|FG000|Overall Study|Simplification|4
6960822|NCT01083810|11006003|FG001|Overall Study|Simplification|1
6960823|NCT01083810|11006004|FG002|Overall Study|Simplification|0
6960824|NCT01083810|11006002|FG000|Overall Study|Death|2
6960825|NCT01083810|11006003|FG001|Overall Study|Death|2
6960826|NCT01083810|11006004|FG002|Overall Study|Death|3
6960827|NCT01083810|11006002|FG000|Overall Study|Co-morbidities|1
6960828|NCT01083810|11006003|FG001|Overall Study|Co-morbidities|0
6960829|NCT01083810|11006004|FG002|Overall Study|Co-morbidities|0
6960830|NCT01083810|11006002|FG000|Overall Study|Participation in study|1
6960831|NCT01083810|11006003|FG001|Overall Study|Participation in study|0
6960832|NCT01083810|11006004|FG002|Overall Study|Participation in study|0
6960833|NCT01083810|11006002|FG000|Overall Study|Therapy break|1
6960834|NCT01083810|11006003|FG001|Overall Study|Therapy break|2
6960835|NCT01083810|11006004|FG002|Overall Study|Therapy break|2
6960836|NCT01083810|11006002|FG000|Overall Study|Virologic failure|1
6960837|NCT01083810|11006003|FG001|Overall Study|Virologic failure|8
6960838|NCT01083810|11006004|FG002|Overall Study|Virologic failure|0
6960839|NCT01084005|11006041|FG000|Overall Study|Adverse Event|1
6960840|NCT01084005|11006042|FG001|Overall Study|Adverse Event|8
6960841|NCT01084005|11006041|FG000|Overall Study|Protocol Violation|3
6960842|NCT01084005|11006042|FG001|Overall Study|Protocol Violation|7
6960843|NCT01084005|11006041|FG000|Overall Study|Withdrawal by Subject|1
6960844|NCT01084005|11006042|FG001|Overall Study|Withdrawal by Subject|1
6960845|NCT01084083|11006048|FG000|Overall Study|Adverse Event|5
6960846|NCT01084083|11006048|FG000|Overall Study|Death|1
6960847|NCT01084083|11006048|FG000|Overall Study|Withdrawal by Subject|2
6960848|NCT01084083|11006048|FG000|Overall Study|Complicating disease|1
6960849|NCT01084083|11006048|FG000|Overall Study|Other|2
6960850|NCT01084083|11006048|FG000|Overall Study|Never started assigned therapy|1
6960851|NCT01084135|11006057|FG000|20 Week|Physician Decision|0
6960852|NCT01084135|11006058|FG001|20 Week|Physician Decision|1
7072498|NCT02036645|11176490|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7072499|NCT02036645|11176491|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7072500|NCT02036645|11176492|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
6960853|NCT01084174|11006079|FG000|Overall Study|gastrointestinal symptoms|1
6960854|NCT01084174|11006080|FG001|Overall Study|gastrointestinal symptoms|1
6960855|NCT01084174|11006079|FG000|Overall Study|Eosinophilic esophagitis|0
6960856|NCT01084174|11006080|FG001|Overall Study|Eosinophilic esophagitis|1
6960857|NCT01084174|11006079|FG000|Overall Study|Anaphylaxis|0
6960858|NCT01084174|11006080|FG001|Overall Study|Anaphylaxis|1
6960859|NCT01084174|11006079|FG000|Overall Study|Participant noncompliance|0
6960860|NCT01084174|11006080|FG001|Overall Study|Participant noncompliance|1
6960861|NCT01084239|11006088|FG000|28-Day Follow-up|Lost to Follow-up|4
6960862|NCT01084239|11006089|FG001|28-Day Follow-up|Lost to Follow-up|9
6976574|NCT01200394|11029347|FG000|Overall Study|Other|0
6976575|NCT01200394|11029348|FG001|Overall Study|Other|1
6976576|NCT01200407|11029355|FG000|Overall Study|Lost to Follow-up|56
6976577|NCT01200407|11029355|FG000|Overall Study|Adverse Event|3
6976578|NCT01200407|11029355|FG000|Overall Study|Withdrawal by Subject|4
6976579|NCT01200407|11029355|FG000|Overall Study|Other|19
6976580|NCT01200485|11029368|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1
6976581|NCT01200485|11029369|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0
6976582|NCT01200485|11029370|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0
6976583|NCT01200485|11029368|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2
6976584|NCT01200485|11029369|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0
6976585|NCT01200485|11029370|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0
6976586|NCT01200511|11029381|FG000|Overall Study|Lost to Follow-up|3
6976587|NCT01200511|11029381|FG000|Overall Study|Withdrawal by Subject|1
6976588|NCT01200511|11029381|FG000|Overall Study|Adverse Event|1
6976589|NCT01200524|11029390|FG000|Overall Study|Withdrawal by Subject|1
6976590|NCT01200524|11029391|FG001|Overall Study|Withdrawal by Subject|1
6976591|NCT01200524|11029392|FG002|Overall Study|Withdrawal by Subject|3
6960863|NCT01084538|11006133|FG000|Overall Study|Drug not available|30
6960864|NCT01084538|11006133|FG000|Overall Study|Adverse Event|9
6960865|NCT01084538|11006133|FG000|Overall Study|Kidney transplant|6
6960866|NCT01084538|11006133|FG000|Overall Study|Serious Adverse Event|3
6960867|NCT01084538|11006133|FG000|Overall Study|Lack of effectiveness|2
6960868|NCT01084538|11006133|FG000|Overall Study|Patient noncompliance|2
6960869|NCT01084538|11006133|FG000|Overall Study|Hyperphosphatemia|2
6960870|NCT01084538|11006133|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2
6960871|NCT01084538|11006133|FG000|Overall Study|Change of residence|2
6960872|NCT01084538|11006133|FG000|Overall Study|Over-suppression of parathyroid gland|2
6960873|NCT01084538|11006133|FG000|Overall Study|Reason unknown|8
6960874|NCT01084551|11006140|FG000|Overall Study|Adverse Event|2
6960875|NCT01084551|11006141|FG001|Overall Study|Adverse Event|9
6960876|NCT01084551|11006142|FG002|Overall Study|Adverse Event|4
6960877|NCT01084551|11006140|FG000|Overall Study|Lack of Efficacy|2
6960878|NCT01084551|11006141|FG001|Overall Study|Lack of Efficacy|0
6960879|NCT01084551|11006142|FG002|Overall Study|Lack of Efficacy|1
6960880|NCT01084551|11006140|FG000|Overall Study|Withdrawal by Subject|2
6960881|NCT01084551|11006141|FG001|Overall Study|Withdrawal by Subject|1
6960882|NCT01084551|11006142|FG002|Overall Study|Withdrawal by Subject|0
6960883|NCT01084551|11006140|FG000|Overall Study|Protocol Violation|2
6960884|NCT01084551|11006141|FG001|Overall Study|Protocol Violation|4
6960885|NCT01084551|11006142|FG002|Overall Study|Protocol Violation|0
6960886|NCT01084551|11006140|FG000|Overall Study|Lost to Follow-up|0
6960887|NCT01084551|11006141|FG001|Overall Study|Lost to Follow-up|0
6960888|NCT01084551|11006142|FG002|Overall Study|Lost to Follow-up|3
6960889|NCT01084551|11006140|FG000|Overall Study|Physician Decision|1
6960890|NCT01084551|11006141|FG001|Overall Study|Physician Decision|0
6960891|NCT01084551|11006142|FG002|Overall Study|Physician Decision|0
6960892|NCT01084603|11006150|FG000|Baseline|Withdrawal by Subject|2
6960893|NCT01084603|11006150|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1
6960894|NCT01084603|11006150|FG000|Nicorette® Gum|Withdrawal by Subject|1
6960895|NCT01084603|11006150|FG000|Oral Nicotine 1|Withdrawal by Subject|1
6960896|NCT01084603|11006150|FG000|Washout Period 4|Adverse Event|1
6960897|NCT01084655|11006166|FG000|Overall Study|Radiographic disease progression|3
6960898|NCT01084655|11006167|FG001|Overall Study|Radiographic disease progression|2
6960899|NCT01084655|11006168|FG002|Overall Study|Radiographic disease progression|8
6960900|NCT01084655|11006166|FG000|Overall Study|Withdrawal by Subject|1
6960901|NCT01084655|11006167|FG001|Overall Study|Withdrawal by Subject|0
6960902|NCT01084655|11006168|FG002|Overall Study|Withdrawal by Subject|4
6960903|NCT01084655|11006166|FG000|Overall Study|Adverse Event|2
6960904|NCT01084655|11006167|FG001|Overall Study|Adverse Event|1
6960905|NCT01084655|11006168|FG002|Overall Study|Adverse Event|2
6960906|NCT01084655|11006166|FG000|Overall Study|Other|0
6960907|NCT01084655|11006167|FG001|Overall Study|Other|3
6960908|NCT01084655|11006168|FG002|Overall Study|Other|2
6960909|NCT01084655|11006166|FG000|Overall Study|Symptomatic deterioration|0
6960910|NCT01084655|11006167|FG001|Overall Study|Symptomatic deterioration|0
6960911|NCT01084655|11006168|FG002|Overall Study|Symptomatic deterioration|2
6960912|NCT01084655|11006166|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0
6960913|NCT01084655|11006167|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0
6960914|NCT01084655|11006168|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1
6960915|NCT01084668|11006180|FG000|Overall Study|Lack of Efficacy|5
6960916|NCT01084668|11006180|FG000|Overall Study|Withdrawal by Subject|2
6960917|NCT01084668|11006180|FG000|Overall Study|Pregnancy|1
6960918|NCT01084668|11006180|FG000|Overall Study|Non-compliance|1
6960919|NCT01084694|11006188|FG000|Overall Study|Withdrawal by Subject|2
6960920|NCT01084694|11006189|FG001|Overall Study|Withdrawal by Subject|1
6960921|NCT01084694|11006188|FG000|Overall Study|Death|2
6960922|NCT01084694|11006189|FG001|Overall Study|Death|12
6960923|NCT01084694|11006188|FG000|Overall Study|eligibility not maintained|2
6960924|NCT01084694|11006189|FG001|Overall Study|eligibility not maintained|7
6960925|NCT01084707|11006203|FG000|Overall Study|Withdrawal by Subject|6
6960926|NCT01084772|11006221|FG000|Baseline|Withdrawal by Subject|7
6960927|NCT01084772|11006222|FG001|Baseline|Withdrawal by Subject|6
6960928|NCT01084772|11006221|FG000|3 Months|Death|1
6960929|NCT01084772|11006222|FG001|3 Months|Death|0
6960930|NCT01084772|11006221|FG000|3 Months|Study Termination|2
6960931|NCT01084772|11006222|FG001|3 Months|Study Termination|2
6960932|NCT01084772|11006221|FG000|1 Year|Withdrawal by Subject|0
6960933|NCT01084772|11006222|FG001|1 Year|Withdrawal by Subject|1
6960934|NCT01084772|11006221|FG000|1 Year|Lost to Follow-up|3
6960935|NCT01084772|11006222|FG001|1 Year|Lost to Follow-up|0
6960936|NCT01084772|11006221|FG000|1 Year|Study Termination|0
6960937|NCT01084772|11006222|FG001|1 Year|Study Termination|7
6960938|NCT01084772|11006221|FG000|2 Years|Withdrawal by Subject|1
6960939|NCT01084772|11006222|FG001|2 Years|Withdrawal by Subject|0
6960940|NCT01084772|11006221|FG000|2 Years|Lost to Follow-up|5
6960941|NCT01084772|11006222|FG001|2 Years|Lost to Follow-up|2
6960942|NCT01084772|11006221|FG000|2 Years|Study Termination|3
6960943|NCT01084772|11006222|FG001|2 Years|Study Termination|2
6960944|NCT01085045|11006237|FG000|Part A|Withdrawal by Subject|4
6960945|NCT01085045|11006237|FG000|Part A|Adverse Event|6
6960946|NCT01085045|11006237|FG000|Part A|Protocol Violation|1
6960947|NCT01085045|11006237|FG000|Part A|Protocol Specified Criteria|7
6960948|NCT01085045|11006237|FG000|Part B|Withdrawal by Subject|2
6960949|NCT01085045|11006237|FG000|Part B|Protocol Specified Criteria|6
6960950|NCT01085045|11006237|FG000|Part B|Lost to Follow-up|1
6960951|NCT01085045|11006237|FG000|Part B|Adverse Event|6
6960952|NCT01085136|11006257|FG000|Part A|Other Adverse event|223
6960953|NCT01085136|11006258|FG001|Part A|Other Adverse event|0
6960954|NCT01085136|11006259|FG002|Part A|Other Adverse event|0
6960955|NCT01085136|11006257|FG000|Part A|Protocol Violation|3
6960956|NCT01085136|11006258|FG001|Part A|Protocol Violation|0
6960957|NCT01085136|11006259|FG002|Part A|Protocol Violation|0
6960958|NCT01085136|11006257|FG000|Part A|Lost to Follow-up|3
6960959|NCT01085136|11006258|FG001|Part A|Lost to Follow-up|0
6960960|NCT01085136|11006259|FG002|Part A|Lost to Follow-up|0
6960961|NCT01085136|11006257|FG000|Part A|Refusal to continue trial medication|64
6960962|NCT01085136|11006258|FG001|Part A|Refusal to continue trial medication|0
6960963|NCT01085136|11006259|FG002|Part A|Refusal to continue trial medication|0
6960964|NCT01085136|11006257|FG000|Part A|Other reason not defined above|30
6960965|NCT01085136|11006258|FG001|Part A|Other reason not defined above|0
6960966|NCT01085136|11006259|FG002|Part A|Other reason not defined above|0
6960967|NCT01085136|11006257|FG000|Part B|Other AE|0
6960968|NCT01085136|11006258|FG001|Part B|Other AE|29
6960969|NCT01085136|11006259|FG002|Part B|Other AE|8
6960970|NCT01085136|11006257|FG000|Part B|Refusal to continue trial medication|0
6960971|NCT01085136|11006258|FG001|Part B|Refusal to continue trial medication|12
6960972|NCT01085136|11006259|FG002|Part B|Refusal to continue trial medication|7
6960973|NCT01085136|11006257|FG000|Part B|Not treated|0
6960974|NCT01085136|11006258|FG001|Part B|Not treated|4
6960975|NCT01085136|11006259|FG002|Part B|Not treated|8
6960976|NCT01085136|11006257|FG000|Part B|Other reason not defined above|0
6960977|NCT01085136|11006258|FG001|Part B|Other reason not defined above|6
6960978|NCT01085136|11006259|FG002|Part B|Other reason not defined above|3
6960979|NCT01085201|11006274|FG000|Overall Study|Scheduling conflict|1
6960980|NCT01085201|11006275|FG001|Overall Study|Scheduling conflict|0
6960981|NCT01085201|11006276|FG002|Overall Study|Scheduling conflict|1
6960982|NCT01085201|11006277|FG003|Overall Study|Scheduling conflict|0
6960983|NCT01085201|11006278|FG004|Overall Study|Scheduling conflict|0
6960984|NCT01085201|11006274|FG000|Overall Study|Unknown- no study drug|2
6960985|NCT01085201|11006275|FG001|Overall Study|Unknown- no study drug|0
6960986|NCT01085201|11006276|FG002|Overall Study|Unknown- no study drug|0
6960987|NCT01085201|11006277|FG003|Overall Study|Unknown- no study drug|0
6960988|NCT01085201|11006278|FG004|Overall Study|Unknown- no study drug|0
6960989|NCT01085201|11006274|FG000|Overall Study|Fond ineligible after consent|0
6960990|NCT01085201|11006275|FG001|Overall Study|Fond ineligible after consent|1
6960991|NCT01085201|11006276|FG002|Overall Study|Fond ineligible after consent|1
6960992|NCT01085201|11006277|FG003|Overall Study|Fond ineligible after consent|0
6960993|NCT01085201|11006278|FG004|Overall Study|Fond ineligible after consent|0
6960994|NCT01085214|11006295|FG000|Overall Study|Alternate treatment required|1
6960995|NCT01085357|11006327|FG000|Overall Study|Adverse Event|1
6960996|NCT01085357|11006328|FG001|Overall Study|Adverse Event|1
6960997|NCT01085357|11006327|FG000|Overall Study|Subject Decision|4
6960998|NCT01085357|11006328|FG001|Overall Study|Subject Decision|3
6960999|NCT01085357|11006327|FG000|Overall Study|Investigator Decision|1
6961000|NCT01085357|11006328|FG001|Overall Study|Investigator Decision|1
6961001|NCT01085357|11006327|FG000|Overall Study|Death|11
6961002|NCT01085357|11006328|FG001|Overall Study|Death|1
6961003|NCT01085357|11006327|FG000|Overall Study|Lost to Follow-up|2
6961004|NCT01085357|11006328|FG001|Overall Study|Lost to Follow-up|0
6961005|NCT01085591|11006359|FG000|Overall Study|Adverse Event|0
7072501|NCT02036645|11176493|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1
7072502|NCT02036645|11176494|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7072503|NCT02036645|11176495|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7072504|NCT02036645|11176496|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7072505|NCT02036645|11176497|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7072506|NCT02036645|11176498|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7072507|NCT02036645|11176499|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7072508|NCT02036645|11176500|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7072509|NCT02036645|11176501|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7072510|NCT02036775|11176539|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
7072511|NCT02036775|11176540|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
7072512|NCT02036775|11176541|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
7072513|NCT02036775|11176542|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
7072514|NCT02036775|11176543|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
7072515|NCT02036775|11176544|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1
6961006|NCT01085591|11006360|FG001|Overall Study|Adverse Event|1
6961007|NCT01085591|11006361|FG002|Overall Study|Adverse Event|3
6961008|NCT01085591|11006359|FG000|Overall Study|Physician Decision|1
6961009|NCT01085591|11006360|FG001|Overall Study|Physician Decision|0
7072516|NCT02036853|11176558|FG000|Overall Study|Adverse Event|0
6961010|NCT01085591|11006361|FG002|Overall Study|Physician Decision|1
6961011|NCT01085591|11006359|FG000|Overall Study|Withdrawal by Subject|0
6961012|NCT01085591|11006360|FG001|Overall Study|Withdrawal by Subject|2
6961013|NCT01085591|11006361|FG002|Overall Study|Withdrawal by Subject|1
6961014|NCT01085591|11006359|FG000|Overall Study|Lost to Follow-up|0
6961015|NCT01085591|11006360|FG001|Overall Study|Lost to Follow-up|1
6961016|NCT01085591|11006361|FG002|Overall Study|Lost to Follow-up|1
6961017|NCT01085591|11006359|FG000|Overall Study|Protocol Violation|1
6961018|NCT01085591|11006360|FG001|Overall Study|Protocol Violation|1
6961019|NCT01085591|11006361|FG002|Overall Study|Protocol Violation|1
6961020|NCT01085591|11006359|FG000|Overall Study|Other|0
6961021|NCT01085591|11006360|FG001|Overall Study|Other|1
6961022|NCT01085591|11006361|FG002|Overall Study|Other|0
6961023|NCT01085591|11006359|FG000|Overall Study|Not Properly Consented|1
6961024|NCT01085591|11006360|FG001|Overall Study|Not Properly Consented|0
6961025|NCT01085591|11006361|FG002|Overall Study|Not Properly Consented|0
6961026|NCT01085630|11006372|FG000|Overall Study|Insufficient data|1
6961027|NCT01085630|11006373|FG001|Overall Study|Insufficient data|0
6961028|NCT01085630|11006372|FG000|Overall Study|Ineligible|3
6961029|NCT01085630|11006373|FG001|Overall Study|Ineligible|0
6961030|NCT01085682|11006381|FG000|Overall Study|Withdrawal by Subject|25
6961031|NCT01085682|11006382|FG001|Overall Study|Withdrawal by Subject|25
6961032|NCT01085734|11006390|FG000|Overall Study|Adverse Event|0
6961033|NCT01085734|11006391|FG001|Overall Study|Adverse Event|2
6961034|NCT01085734|11006390|FG000|Overall Study|Death|1
6961035|NCT01085734|11006391|FG001|Overall Study|Death|0
6961036|NCT01085734|11006390|FG000|Overall Study|Lost to Follow-up|0
6961037|NCT01085734|11006391|FG001|Overall Study|Lost to Follow-up|1
6961038|NCT01085734|11006390|FG000|Overall Study|Withdrawal by Subject|0
7072517|NCT02036853|11176559|FG001|Overall Study|Adverse Event|2
7072518|NCT02036853|11176558|FG000|Overall Study|Lack of Efficacy|0
7072519|NCT02036853|11176559|FG001|Overall Study|Lack of Efficacy|2
6961039|NCT01085734|11006391|FG001|Overall Study|Withdrawal by Subject|1
6961040|NCT01085812|11006424|FG000|Open-Label Period|Adverse Event|0
6961041|NCT01085812|11006425|FG001|Open-Label Period|Adverse Event|80
6961042|NCT01085812|11006424|FG000|Open-Label Period|Lack of Efficacy|0
6961043|NCT01085812|11006425|FG001|Open-Label Period|Lack of Efficacy|26
6961044|NCT01085812|11006424|FG000|Open-Label Period|Protocol Violation|0
6961045|NCT01085812|11006425|FG001|Open-Label Period|Protocol Violation|39
6961046|NCT01085812|11006424|FG000|Open-Label Period|Withdrawal by Subject|0
6961047|NCT01085812|11006425|FG001|Open-Label Period|Withdrawal by Subject|53
6961048|NCT01085812|11006424|FG000|Open-Label Period|Lost to Follow-up|0
6961049|NCT01085812|11006425|FG001|Open-Label Period|Lost to Follow-up|42
6961050|NCT01085812|11006424|FG000|Double-Blind Period|Adverse Event|3
6961051|NCT01085812|11006425|FG001|Double-Blind Period|Adverse Event|8
6961052|NCT01085812|11006424|FG000|Double-Blind Period|Protocol Violation|2
6961053|NCT01085812|11006425|FG001|Double-Blind Period|Protocol Violation|7
6961054|NCT01085812|11006424|FG000|Double-Blind Period|Withdrawal by Subject|11
6961055|NCT01085812|11006425|FG001|Double-Blind Period|Withdrawal by Subject|24
6961056|NCT01085812|11006424|FG000|Double-Blind Period|Lost to Follow-up|5
6961057|NCT01085812|11006425|FG001|Double-Blind Period|Lost to Follow-up|17
6961058|NCT01085812|11006424|FG000|Double-Blind Period|Other Reasons|0
6961059|NCT01085812|11006425|FG001|Double-Blind Period|Other Reasons|2
6961060|NCT01085812|11006424|FG000|Double-blind Intent-to-treat Population|Adverse Event|3
6961061|NCT01085812|11006425|FG001|Double-blind Intent-to-treat Population|Adverse Event|8
6961062|NCT01085812|11006424|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2
6961063|NCT01085812|11006425|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7
6961064|NCT01085812|11006424|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11
6961065|NCT01085812|11006425|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22
6961066|NCT01085812|11006424|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4
6961067|NCT01085812|11006425|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17
6961068|NCT01085812|11006424|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0
6961069|NCT01085812|11006425|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2
6961070|NCT01086033|11006473|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86
6961071|NCT01086033|11006473|FG000|Overall Study|Lost to Follow-up|86
6961072|NCT01086033|11006473|FG000|Overall Study|Adverse Event|42
7072520|NCT02036853|11176558|FG000|Overall Study|Physician Decision|0
7072521|NCT02036853|11176559|FG001|Overall Study|Physician Decision|1
7072522|NCT02036853|11176558|FG000|Overall Study|Withdrawal by Subject|0
7072523|NCT02036853|11176559|FG001|Overall Study|Withdrawal by Subject|1
7072524|NCT02037165|11176581|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0
7072525|NCT02037165|11176582|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0
6961073|NCT01086033|11006473|FG000|Overall Study|Withdrawal by Subject|41
6961074|NCT01086033|11006473|FG000|Overall Study|Other|14
6961075|NCT01086033|11006473|FG000|Overall Study|Other|13
6961076|NCT01086033|11006473|FG000|Overall Study|AE and Withdrew Consent|5
6961077|NCT01086033|11006473|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5
6961078|NCT01086033|11006473|FG000|Overall Study|Withdrew consent and Other Reason|4
6961079|NCT01086033|11006473|FG000|Overall Study|AE and Lack of Efficacy|4
6961080|NCT01086033|11006473|FG000|Overall Study|Death|1
6961081|NCT01086033|11006473|FG000|Overall Study|AE and Lost to Follow-up|1
6961082|NCT01086033|11006473|FG000|Overall Study|AE and Other Reason|1
6961083|NCT01086033|11006473|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1
6961084|NCT01086150|11006483|FG000|Overall Study|Withdrawal by Subject|0
6961085|NCT01086150|11006484|FG001|Overall Study|Withdrawal by Subject|4
6961086|NCT01086150|11006485|FG002|Overall Study|Withdrawal by Subject|1
6961087|NCT01086150|11006483|FG000|Overall Study|Lost to Follow-up|0
6961088|NCT01086150|11006484|FG001|Overall Study|Lost to Follow-up|1
6961089|NCT01086150|11006485|FG002|Overall Study|Lost to Follow-up|0
6961090|NCT01086150|11006483|FG000|Overall Study|Screen Failure|0
6961091|NCT01086150|11006484|FG001|Overall Study|Screen Failure|1
6961092|NCT01086150|11006485|FG002|Overall Study|Screen Failure|0
6961093|NCT01086215|11006497|FG000|Overall Study|Death|14
6961094|NCT01086215|11006498|FG001|Overall Study|Death|8
6961095|NCT01086215|11006499|FG002|Overall Study|Death|8
6961096|NCT01086215|11006500|FG003|Overall Study|Death|1
6961097|NCT01086215|11006497|FG000|Overall Study|Lost to Follow-up|22
6961098|NCT01086215|11006498|FG001|Overall Study|Lost to Follow-up|39
6961099|NCT01086215|11006499|FG002|Overall Study|Lost to Follow-up|18
6961100|NCT01086215|11006500|FG003|Overall Study|Lost to Follow-up|2
6961101|NCT01086358|11006514|FG000|First Intervention|Lost to Follow-up|9
6961102|NCT01086358|11006515|FG001|First Intervention|Lost to Follow-up|4
6961103|NCT01086358|11006514|FG000|First Intervention|Withdrawal by Subject|0
6961104|NCT01086358|11006515|FG001|First Intervention|Withdrawal by Subject|1
6961105|NCT01086358|11006514|FG000|Second Intervention|Lost to Follow-up|4
6961106|NCT01086358|11006515|FG001|Second Intervention|Lost to Follow-up|4
6961107|NCT01086384|11006523|FG000|2-week Run-in Period|Adverse Event|1
6961108|NCT01086384|11006524|FG001|2-week Run-in Period|Adverse Event|0
6961109|NCT01086384|11006525|FG002|2-week Run-in Period|Adverse Event|0
6961110|NCT01086384|11006523|FG000|2-week Run-in Period|Protocol Violation|1
6961111|NCT01086384|11006524|FG001|2-week Run-in Period|Protocol Violation|0
6961112|NCT01086384|11006525|FG002|2-week Run-in Period|Protocol Violation|0
6961113|NCT01086384|11006523|FG000|2-week Run-in Period|Lost to Follow-up|1
6961114|NCT01086384|11006524|FG001|2-week Run-in Period|Lost to Follow-up|0
6961115|NCT01086384|11006525|FG002|2-week Run-in Period|Lost to Follow-up|0
6961116|NCT01086384|11006523|FG000|2-week Run-in Period|Physician Decision|6
6961117|NCT01086384|11006524|FG001|2-week Run-in Period|Physician Decision|0
6961118|NCT01086384|11006525|FG002|2-week Run-in Period|Physician Decision|0
6961119|NCT01086384|11006523|FG000|2-week Run-in Period|Withdrawal by Subject|19
6961120|NCT01086384|11006524|FG001|2-week Run-in Period|Withdrawal by Subject|0
6961121|NCT01086384|11006525|FG002|2-week Run-in Period|Withdrawal by Subject|0
6961122|NCT01086384|11006523|FG000|2-week Run-in Period|Study Closed/Terminated|42
6961123|NCT01086384|11006524|FG001|2-week Run-in Period|Study Closed/Terminated|0
6961124|NCT01086384|11006525|FG002|2-week Run-in Period|Study Closed/Terminated|0
6961125|NCT01086384|11006523|FG000|2-week Run-in Period|Continuation Criteria Not Met|92
6961126|NCT01086384|11006524|FG001|2-week Run-in Period|Continuation Criteria Not Met|0
6961127|NCT01086384|11006525|FG002|2-week Run-in Period|Continuation Criteria Not Met|0
6961128|NCT01086384|11006523|FG000|2-week Run-in Period|Randomized in Error|1
6961129|NCT01086384|11006524|FG001|2-week Run-in Period|Randomized in Error|0
6961130|NCT01086384|11006525|FG002|2-week Run-in Period|Randomized in Error|0
6961131|NCT01086384|11006523|FG000|Treatment Period|Withdrawal by Subject|0
6961132|NCT01086384|11006524|FG001|Treatment Period|Withdrawal by Subject|53
6961133|NCT01086384|11006525|FG002|Treatment Period|Withdrawal by Subject|55
6961134|NCT01086384|11006523|FG000|Treatment Period|Protocol Violation|0
6961135|NCT01086384|11006524|FG001|Treatment Period|Protocol Violation|26
6961136|NCT01086384|11006525|FG002|Treatment Period|Protocol Violation|17
6961137|NCT01086384|11006523|FG000|Treatment Period|Lack of Efficacy|0
6961138|NCT01086384|11006524|FG001|Treatment Period|Lack of Efficacy|22
6961139|NCT01086384|11006525|FG002|Treatment Period|Lack of Efficacy|13
6961140|NCT01086384|11006523|FG000|Treatment Period|Adverse Event|0
6961141|NCT01086384|11006524|FG001|Treatment Period|Adverse Event|19
6961142|NCT01086384|11006525|FG002|Treatment Period|Adverse Event|15
6961143|NCT01086384|11006523|FG000|Treatment Period|Lost to Follow-up|0
6961144|NCT01086384|11006524|FG001|Treatment Period|Lost to Follow-up|11
6961145|NCT01086384|11006525|FG002|Treatment Period|Lost to Follow-up|9
6961146|NCT01086384|11006523|FG000|Treatment Period|Physician Decision|0
6961147|NCT01086384|11006524|FG001|Treatment Period|Physician Decision|9
6961148|NCT01086384|11006525|FG002|Treatment Period|Physician Decision|6
6961149|NCT01086384|11006523|FG000|Treatment Period|Study Closed/Terminated|0
6961150|NCT01086384|11006524|FG001|Treatment Period|Study Closed/Terminated|7
6961151|NCT01086384|11006525|FG002|Treatment Period|Study Closed/Terminated|8
6961152|NCT01086384|11006523|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0
6961153|NCT01086384|11006524|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0
6961154|NCT01086384|11006525|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1
6961155|NCT01086384|11006523|FG000|Treatment Period|Received Treatment in Error|0
6961156|NCT01086384|11006524|FG001|Treatment Period|Received Treatment in Error|1
6961157|NCT01086384|11006525|FG002|Treatment Period|Received Treatment in Error|0
6961158|NCT01086410|11006535|FG000|Overall Study|Adverse Event|1
6961159|NCT01086410|11006536|FG001|Overall Study|Adverse Event|0
6961160|NCT01086410|11006537|FG002|Overall Study|Adverse Event|0
6961161|NCT01086410|11006538|FG003|Overall Study|Adverse Event|2
6961162|NCT01086410|11006535|FG000|Overall Study|Lack of Efficacy|1
6961163|NCT01086410|11006536|FG001|Overall Study|Lack of Efficacy|1
6961164|NCT01086410|11006537|FG002|Overall Study|Lack of Efficacy|0
6961165|NCT01086410|11006538|FG003|Overall Study|Lack of Efficacy|0
6961166|NCT01086410|11006535|FG000|Overall Study|Protocol Violation|1
6961167|NCT01086410|11006536|FG001|Overall Study|Protocol Violation|1
6961168|NCT01086410|11006537|FG002|Overall Study|Protocol Violation|0
6961169|NCT01086410|11006538|FG003|Overall Study|Protocol Violation|0
6961170|NCT01086410|11006535|FG000|Overall Study|Lost to Follow-up|0
6961171|NCT01086410|11006536|FG001|Overall Study|Lost to Follow-up|0
6961172|NCT01086410|11006537|FG002|Overall Study|Lost to Follow-up|1
7040849|NCT01721057|11124067|FG001|Treatment Period|Withdrawal by Subject|5
7040850|NCT01721057|11124068|FG002|Treatment Period|Withdrawal by Subject|8
7040851|NCT01721057|11124069|FG003|Treatment Period|Withdrawal by Subject|0
7040852|NCT01721057|11124070|FG004|Treatment Period|Withdrawal by Subject|0
7040853|NCT01721057|11124071|FG005|Treatment Period|Withdrawal by Subject|0
7040854|NCT01721057|11124072|FG006|Treatment Period|Withdrawal by Subject|0
7040855|NCT01721057|11124066|FG000|Treatment Period|Adverse Event|7
7040856|NCT01721057|11124067|FG001|Treatment Period|Adverse Event|10
7040857|NCT01721057|11124068|FG002|Treatment Period|Adverse Event|12
7040858|NCT01721057|11124069|FG003|Treatment Period|Adverse Event|0
7040859|NCT01721057|11124070|FG004|Treatment Period|Adverse Event|0
6961173|NCT01086410|11006538|FG003|Overall Study|Lost to Follow-up|0
6961174|NCT01086423|11006551|FG000|Overall Study|Protocol Violation|0
6961175|NCT01086423|11006552|FG001|Overall Study|Protocol Violation|0
6961176|NCT01086423|11006553|FG002|Overall Study|Protocol Violation|1
6961177|NCT01086423|11006551|FG000|Overall Study|Migrated/moved from study area|2
6961178|NCT01086423|11006552|FG001|Overall Study|Migrated/moved from study area|0
6961179|NCT01086423|11006553|FG002|Overall Study|Migrated/moved from study area|4
6961180|NCT01086423|11006551|FG000|Overall Study|Adverse event, fatal|1
6961181|NCT01086423|11006552|FG001|Overall Study|Adverse event, fatal|1
6961182|NCT01086423|11006553|FG002|Overall Study|Adverse event, fatal|0
6961183|NCT01086423|11006551|FG000|Overall Study|Adverse event, non-fatal|2
6961184|NCT01086423|11006552|FG001|Overall Study|Adverse event, non-fatal|1
6961185|NCT01086423|11006553|FG002|Overall Study|Adverse event, non-fatal|0
6961186|NCT01086423|11006551|FG000|Overall Study|Withdrawal by Subject|5
6961187|NCT01086423|11006552|FG001|Overall Study|Withdrawal by Subject|1
6961188|NCT01086423|11006553|FG002|Overall Study|Withdrawal by Subject|3
6961189|NCT01086423|11006551|FG000|Overall Study|Lost to Follow-up|0
6961190|NCT01086423|11006552|FG001|Overall Study|Lost to Follow-up|0
6961191|NCT01086423|11006553|FG002|Overall Study|Lost to Follow-up|1
6961192|NCT01086540|11006572|FG000|Overall Study|Death|3
6961193|NCT01086540|11006573|FG001|Overall Study|Death|1
6961194|NCT01086540|11006572|FG000|Overall Study|Physician Decision|2
6961195|NCT01086540|11006573|FG001|Overall Study|Physician Decision|1
6961196|NCT01086540|11006572|FG000|Overall Study|Addition of new therapy for PAH|1
6961197|NCT01086540|11006573|FG001|Overall Study|Addition of new therapy for PAH|0
6961198|NCT01086969|11006620|FG000|Overall Study|Withdrawal by Subject|1
6961199|NCT01086969|11006621|FG001|Overall Study|Withdrawal by Subject|2
6961200|NCT01086969|11006622|FG002|Overall Study|Withdrawal by Subject|0
6961201|NCT01087489|11006630|FG000|Overall Study|enrolled in another VA study|0
6961202|NCT01087489|11006631|FG001|Overall Study|enrolled in another VA study|1
6961203|NCT01087489|11006630|FG000|Overall Study|Death|0
6961204|NCT01087489|11006631|FG001|Overall Study|Death|1
6961205|NCT01087489|11006630|FG000|Overall Study|unable to survey by telephone|0
6961206|NCT01087489|11006631|FG001|Overall Study|unable to survey by telephone|1
6961207|NCT01087502|11006639|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5
6961208|NCT01087502|11006640|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4
6961209|NCT01087502|11006639|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1
6961210|NCT01087502|11006640|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1
6961211|NCT01087502|11006639|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
6961212|NCT01087502|11006640|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
6961213|NCT01087502|11006639|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1
6961214|NCT01087502|11006640|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0
6961215|NCT01087502|11006639|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1
6961216|NCT01087502|11006640|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2
6961217|NCT01087502|11006639|FG000|Up to Final Analysis (Week 52)|Adverse Event|17
6961218|NCT01087502|11006640|FG001|Up to Final Analysis (Week 52)|Adverse Event|10
6961219|NCT01087502|11006639|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1
6961220|NCT01087502|11006640|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2
6961221|NCT01087502|11006639|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4
6961222|NCT01087502|11006640|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0
6961223|NCT01087502|11006639|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2
6961224|NCT01087502|11006640|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0
6961225|NCT01087502|11006639|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3
6961226|NCT01087502|11006640|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2
6961227|NCT01087502|11006639|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1
6961228|NCT01087502|11006640|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5
6961229|NCT01087502|11006639|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5
6961230|NCT01087502|11006640|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4
6961231|NCT01087528|11006648|FG000|Overall Study|Withdrawal by Subject|1
6961232|NCT01087528|11006648|FG000|Overall Study|Incomplete CE procedure|6
6961233|NCT01087723|11006665|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0
6961234|NCT01087723|11006666|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1
6961235|NCT01087723|11006665|FG000|Overall Study|Withdrawal by Subject|10
6961236|NCT01087723|11006666|FG001|Overall Study|Withdrawal by Subject|13
6961237|NCT01087723|11006665|FG000|Overall Study|Physician Decision|2
7040860|NCT01721057|11124071|FG005|Treatment Period|Adverse Event|0
6961238|NCT01087723|11006666|FG001|Overall Study|Physician Decision|0
6961239|NCT01087723|11006665|FG000|Overall Study|Lost to Follow-up|1
6961240|NCT01087723|11006666|FG001|Overall Study|Lost to Follow-up|4
6961241|NCT01087723|11006665|FG000|Overall Study|Reason Not Specified|1
6961242|NCT01087723|11006666|FG001|Overall Study|Reason Not Specified|2
6961243|NCT01087736|11006674|FG000|Overall Study|Lost to Follow-up|1
6961244|NCT01087736|11006675|FG001|Overall Study|Lost to Follow-up|0
6961245|NCT01087736|11006674|FG000|Overall Study|Death|0
6961246|NCT01087736|11006675|FG001|Overall Study|Death|1
6961247|NCT01087736|11006674|FG000|Overall Study|Withdrawal by Subject|0
6961248|NCT01087736|11006675|FG001|Overall Study|Withdrawal by Subject|1
6961249|NCT01087762|11006684|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2
6961250|NCT01087762|11006685|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
6961251|NCT01087762|11006686|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3
6961252|NCT01087762|11006687|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
6961253|NCT01087762|11006688|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
6961254|NCT01087762|11006684|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6
6961255|NCT01087762|11006685|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0
6961256|NCT01087762|11006686|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1
6961257|NCT01087762|11006687|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0
6961258|NCT01087762|11006688|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0
6961259|NCT01087762|11006684|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
6961260|NCT01087762|11006685|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2
6961261|NCT01087762|11006686|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
6961262|NCT01087762|11006687|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
6961263|NCT01087762|11006688|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
6961264|NCT01087762|11006684|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
6961265|NCT01087762|11006685|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2
6961266|NCT01087762|11006686|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
6961267|NCT01087762|11006687|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
6961268|NCT01087762|11006688|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
6961269|NCT01087762|11006684|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
6961270|NCT01087762|11006685|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
6961271|NCT01087762|11006686|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3
6961272|NCT01087762|11006687|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
6961273|NCT01087762|11006688|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
6961274|NCT01087762|11006684|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
6961275|NCT01087762|11006685|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
6961276|NCT01087762|11006686|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
6961277|NCT01087762|11006687|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4
6961278|NCT01087762|11006688|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14
6961279|NCT01087762|11006684|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0
6961280|NCT01087762|11006685|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0
6961281|NCT01087762|11006686|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0
6961282|NCT01087762|11006687|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1
6961283|NCT01087762|11006688|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1
6961284|NCT01087762|11006684|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
6961285|NCT01087762|11006685|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
6961286|NCT01087762|11006686|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
6961287|NCT01087762|11006687|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5
6961288|NCT01087762|11006688|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2
6961289|NCT01087762|11006684|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
6961290|NCT01087762|11006685|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
6961291|NCT01087762|11006686|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
6961292|NCT01087762|11006687|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22
6961293|NCT01087762|11006688|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15
6961294|NCT01087762|11006684|FG000|Open-Label Period (Weeks 48-204)|Other|0
6961295|NCT01087762|11006685|FG001|Open-Label Period (Weeks 48-204)|Other|0
6961296|NCT01087762|11006686|FG002|Open-Label Period (Weeks 48-204)|Other|0
6961297|NCT01087762|11006687|FG003|Open-Label Period (Weeks 48-204)|Other|2
6961298|NCT01087762|11006688|FG004|Open-Label Period (Weeks 48-204)|Other|4
6961299|NCT01087762|11006684|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
6961300|NCT01087762|11006685|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
6961301|NCT01087762|11006686|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
6961302|NCT01087762|11006687|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7
6961303|NCT01087762|11006688|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4
6961304|NCT01087762|11006684|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
6961305|NCT01087762|11006685|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
6961306|NCT01087762|11006686|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
6961307|NCT01087762|11006687|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16
6961308|NCT01087762|11006688|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13
6961309|NCT01087762|11006684|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
6961310|NCT01087762|11006685|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
6961311|NCT01087762|11006686|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
6961312|NCT01087762|11006687|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2
6961313|NCT01087762|11006688|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4
6961314|NCT01087775|11006698|FG000|Overall Study|failed inclusion criteria|2
6961315|NCT01087788|11006706|FG000|24-weeks Double-blind Period|Lack of Efficacy|2
6961316|NCT01087788|11006707|FG001|24-weeks Double-blind Period|Lack of Efficacy|0
6961317|NCT01087788|11006708|FG002|24-weeks Double-blind Period|Lack of Efficacy|1
6961318|NCT01087788|11006706|FG000|24-weeks Double-blind Period|Protocol Violation|0
6961319|NCT01087788|11006707|FG001|24-weeks Double-blind Period|Protocol Violation|1
6961320|NCT01087788|11006708|FG002|24-weeks Double-blind Period|Protocol Violation|0
6961321|NCT01087788|11006706|FG000|24-weeks Double-blind Period|Lost to Follow-up|4
6961322|NCT01087788|11006707|FG001|24-weeks Double-blind Period|Lost to Follow-up|1
6961323|NCT01087788|11006708|FG002|24-weeks Double-blind Period|Lost to Follow-up|1
6961324|NCT01087788|11006706|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7
6961325|NCT01087788|11006707|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2
6961326|NCT01087788|11006708|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5
6961327|NCT01087788|11006706|FG000|24-weeks Double-blind Period|AE, serious fatal|0
6961328|NCT01087788|11006707|FG001|24-weeks Double-blind Period|AE, serious fatal|1
6961329|NCT01087788|11006708|FG002|24-weeks Double-blind Period|AE, serious fatal|1
6961330|NCT01087788|11006706|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0
6961331|NCT01087788|11006707|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2
6961332|NCT01087788|11006708|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3
6961333|NCT01087788|11006706|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2
6961334|NCT01087788|11006707|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1
6961335|NCT01087788|11006708|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2
6961336|NCT01087788|11006706|FG000|24-weeks Double-blind Period|AE, unknown type|0
6961337|NCT01087788|11006707|FG001|24-weeks Double-blind Period|AE, unknown type|0
6961338|NCT01087788|11006708|FG002|24-weeks Double-blind Period|AE, unknown type|1
6961339|NCT01087788|11006706|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1
6961340|NCT01087788|11006707|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0
6961341|NCT01087788|11006708|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0
6961342|NCT01087788|11006706|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
6961343|NCT01087788|11006707|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1
6961344|NCT01087788|11006708|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
6961345|NCT01087788|11006706|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0
6961346|NCT01087788|11006707|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1
6961347|NCT01087788|11006708|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0
6961348|NCT01087788|11006706|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
6961349|NCT01087788|11006707|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
6961350|NCT01087788|11006708|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1
6961351|NCT01087788|11006706|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0
6961352|NCT01087788|11006707|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2
6961353|NCT01087788|11006708|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1
6961354|NCT01087788|11006706|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1
6961355|NCT01087788|11006707|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0
6961356|NCT01087788|11006708|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1
6961357|NCT01087788|11006706|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1
6961358|NCT01087788|11006707|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0
6961359|NCT01087788|11006708|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0
6961360|NCT01087788|11006706|FG000|24-weeks Dose-blind Period|AE, serious fatal|0
6961361|NCT01087788|11006707|FG001|24-weeks Dose-blind Period|AE, serious fatal|1
6961362|NCT01087788|11006708|FG002|24-weeks Dose-blind Period|AE, serious fatal|0
6961363|NCT01087788|11006706|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2
6961364|NCT01087788|11006707|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1
6961365|NCT01087788|11006708|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2
6961366|NCT01087788|11006706|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2
6961367|NCT01087788|11006707|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
6961368|NCT01087788|11006708|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
6961369|NCT01087788|11006706|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1
6961370|NCT01087788|11006707|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
6961371|NCT01087788|11006708|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
6961372|NCT01087788|11006706|FG000|24-weeks Dose-blind Period|Patient moved|0
7040861|NCT01721057|11124072|FG006|Treatment Period|Adverse Event|0
7040862|NCT01721057|11124066|FG000|Treatment Period|Lack of Efficacy|7
7040863|NCT01721057|11124067|FG001|Treatment Period|Lack of Efficacy|3
7040864|NCT01721057|11124068|FG002|Treatment Period|Lack of Efficacy|0
7040865|NCT01721057|11124069|FG003|Treatment Period|Lack of Efficacy|0
7040866|NCT01721057|11124070|FG004|Treatment Period|Lack of Efficacy|0
7040867|NCT01721057|11124071|FG005|Treatment Period|Lack of Efficacy|0
7040868|NCT01721057|11124072|FG006|Treatment Period|Lack of Efficacy|0
7040869|NCT01721057|11124066|FG000|Treatment Period|Lost to Follow-up|1
6961373|NCT01087788|11006707|FG001|24-weeks Dose-blind Period|Patient moved|0
6961374|NCT01087788|11006708|FG002|24-weeks Dose-blind Period|Patient moved|1
6961375|NCT01087788|11006706|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4
6961376|NCT01087788|11006707|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2
6961377|NCT01087788|11006708|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3
6961378|NCT01087788|11006706|FG000|Open-Label Period (OL-P)|Protocol Violation|2
6961379|NCT01087788|11006707|FG001|Open-Label Period (OL-P)|Protocol Violation|1
6961380|NCT01087788|11006708|FG002|Open-Label Period (OL-P)|Protocol Violation|0
6961381|NCT01087788|11006706|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0
6961382|NCT01087788|11006707|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4
6961383|NCT01087788|11006708|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2
6961384|NCT01087788|11006706|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13
6961385|NCT01087788|11006707|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8
6961386|NCT01087788|11006708|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10
6961387|NCT01087788|11006706|FG000|Open-Label Period (OL-P)|AE, serious fatal|2
6961388|NCT01087788|11006707|FG001|Open-Label Period (OL-P)|AE, serious fatal|0
6961389|NCT01087788|11006708|FG002|Open-Label Period (OL-P)|AE, serious fatal|1
6961390|NCT01087788|11006706|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1
6961391|NCT01087788|11006707|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3
6961392|NCT01087788|11006708|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4
6961393|NCT01087788|11006706|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6
6961394|NCT01087788|11006707|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
6961395|NCT01087788|11006708|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
6961396|NCT01087788|11006706|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
6961397|NCT01087788|11006707|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1
6961398|NCT01087788|11006708|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
6961399|NCT01087788|11006706|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1
6961400|NCT01087788|11006707|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0
6961401|NCT01087788|11006708|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0
6961402|NCT01087788|11006706|FG000|Open-Label Period (OL-P)|Sponsor request|1
6961403|NCT01087788|11006707|FG001|Open-Label Period (OL-P)|Sponsor request|0
6961404|NCT01087788|11006708|FG002|Open-Label Period (OL-P)|Sponsor request|0
6961405|NCT01087788|11006706|FG000|Open-Label Period (OL-P)|Principal investigator decision|0
6961406|NCT01087788|11006707|FG001|Open-Label Period (OL-P)|Principal investigator decision|1
6961407|NCT01087788|11006708|FG002|Open-Label Period (OL-P)|Principal investigator decision|2
6961408|NCT01087788|11006706|FG000|Open-Label Period (OL-P)|No participation in study extension|0
6961409|NCT01087788|11006707|FG001|Open-Label Period (OL-P)|No participation in study extension|0
6961410|NCT01087788|11006708|FG002|Open-Label Period (OL-P)|No participation in study extension|1
6961411|NCT01087788|11006706|FG000|Open-Label Period (OL-P)|Personal reasons|0
6961412|NCT01087788|11006707|FG001|Open-Label Period (OL-P)|Personal reasons|0
6961413|NCT01087788|11006708|FG002|Open-Label Period (OL-P)|Personal reasons|1
6961414|NCT01087814|11006728|FG000|First Intervention (5 Days)|Withdrawal by Subject|3
6961415|NCT01087814|11006729|FG001|First Intervention (5 Days)|Withdrawal by Subject|1
6961416|NCT01087814|11006728|FG000|Second Intervention (5 Days)|Physician Decision|1
6961417|NCT01087814|11006729|FG001|Second Intervention (5 Days)|Physician Decision|0
6961418|NCT01087905|11006743|FG000|Overall Study|Lost to Follow-up|24
6961419|NCT01087905|11006744|FG001|Overall Study|Lost to Follow-up|28
6961420|NCT01087905|11006745|FG002|Overall Study|Lost to Follow-up|18
6961421|NCT01087905|11006746|FG003|Overall Study|Lost to Follow-up|31
6961422|NCT01087905|11006747|FG004|Overall Study|Lost to Follow-up|27
6961423|NCT01087905|11006748|FG005|Overall Study|Lost to Follow-up|25
6961424|NCT01087905|11006749|FG006|Overall Study|Lost to Follow-up|20
6961425|NCT01087905|11006750|FG007|Overall Study|Lost to Follow-up|24
6961426|NCT01087905|11006743|FG000|Overall Study|Withdrawal by Subject|5
6961427|NCT01087905|11006744|FG001|Overall Study|Withdrawal by Subject|4
6961428|NCT01087905|11006745|FG002|Overall Study|Withdrawal by Subject|4
6961429|NCT01087905|11006746|FG003|Overall Study|Withdrawal by Subject|5
6961430|NCT01087905|11006747|FG004|Overall Study|Withdrawal by Subject|4
6961431|NCT01087905|11006748|FG005|Overall Study|Withdrawal by Subject|3
6961432|NCT01087905|11006749|FG006|Overall Study|Withdrawal by Subject|3
6961433|NCT01087905|11006750|FG007|Overall Study|Withdrawal by Subject|5
6961434|NCT01087944|11006788|FG000|Period 1 (Week 1-3)|Adverse Event|1
6961435|NCT01087944|11006789|FG001|Period 1 (Week 1-3)|Adverse Event|0
6961436|NCT01087944|11006788|FG000|Period 2 (Week 4-6)|Adverse Event|0
6961437|NCT01087944|11006789|FG001|Period 2 (Week 4-6)|Adverse Event|2
6961438|NCT01087957|11006797|FG000|Overall Study|Death|2
6961439|NCT01087957|11006798|FG001|Overall Study|Death|2
6961440|NCT01087957|11006797|FG000|Overall Study|Lost to Follow-up|3
6961441|NCT01087957|11006798|FG001|Overall Study|Lost to Follow-up|4
6961442|NCT01087957|11006797|FG000|Overall Study|Protocol Violation|13
6961443|NCT01087957|11006798|FG001|Overall Study|Protocol Violation|25
6961444|NCT01087957|11006797|FG000|Overall Study|Withdrawal by Subject|18
6961445|NCT01087957|11006798|FG001|Overall Study|Withdrawal by Subject|15
6961446|NCT01087957|11006797|FG000|Overall Study|Physician Decision|5
6961447|NCT01087957|11006798|FG001|Overall Study|Physician Decision|9
6961448|NCT01087970|11006804|FG000|Overall Study|Protocol Violation|2
6961449|NCT01088048|11006828|FG000|Overall Study|Adverse Event|7
6961450|NCT01088048|11006829|FG001|Overall Study|Adverse Event|9
6961451|NCT01088048|11006830|FG002|Overall Study|Adverse Event|7
6961452|NCT01088048|11006831|FG003|Overall Study|Adverse Event|5
6961453|NCT01088048|11006832|FG004|Overall Study|Adverse Event|6
6961454|NCT01088048|11006833|FG005|Overall Study|Adverse Event|3
6961455|NCT01088048|11006834|FG006|Overall Study|Adverse Event|3
6961456|NCT01088048|11006835|FG007|Overall Study|Adverse Event|0
6961457|NCT01088048|11006836|FG008|Overall Study|Adverse Event|2
6961458|NCT01088048|11006837|FG009|Overall Study|Adverse Event|2
6961459|NCT01088048|11006828|FG000|Overall Study|Withdrew Consent|1
6961460|NCT01088048|11006829|FG001|Overall Study|Withdrew Consent|1
6961461|NCT01088048|11006830|FG002|Overall Study|Withdrew Consent|1
6961462|NCT01088048|11006831|FG003|Overall Study|Withdrew Consent|1
6961463|NCT01088048|11006832|FG004|Overall Study|Withdrew Consent|2
6961464|NCT01088048|11006833|FG005|Overall Study|Withdrew Consent|1
6961465|NCT01088048|11006834|FG006|Overall Study|Withdrew Consent|0
6961466|NCT01088048|11006835|FG007|Overall Study|Withdrew Consent|2
6961467|NCT01088048|11006836|FG008|Overall Study|Withdrew Consent|2
6961468|NCT01088048|11006837|FG009|Overall Study|Withdrew Consent|1
6961469|NCT01088048|11006828|FG000|Overall Study|Concomitant Medication Prohibited|1
6961470|NCT01088048|11006829|FG001|Overall Study|Concomitant Medication Prohibited|0
6961471|NCT01088048|11006830|FG002|Overall Study|Concomitant Medication Prohibited|0
6961472|NCT01088048|11006831|FG003|Overall Study|Concomitant Medication Prohibited|0
6961473|NCT01088048|11006832|FG004|Overall Study|Concomitant Medication Prohibited|0
6961474|NCT01088048|11006833|FG005|Overall Study|Concomitant Medication Prohibited|0
6961475|NCT01088048|11006834|FG006|Overall Study|Concomitant Medication Prohibited|0
6961476|NCT01088048|11006835|FG007|Overall Study|Concomitant Medication Prohibited|0
6961477|NCT01088048|11006836|FG008|Overall Study|Concomitant Medication Prohibited|0
6961478|NCT01088048|11006837|FG009|Overall Study|Concomitant Medication Prohibited|0
6961479|NCT01088048|11006828|FG000|Overall Study|Investigator Request|2
6961480|NCT01088048|11006829|FG001|Overall Study|Investigator Request|2
6961481|NCT01088048|11006830|FG002|Overall Study|Investigator Request|0
6961482|NCT01088048|11006831|FG003|Overall Study|Investigator Request|0
6961483|NCT01088048|11006832|FG004|Overall Study|Investigator Request|3
6961484|NCT01088048|11006833|FG005|Overall Study|Investigator Request|1
6961485|NCT01088048|11006834|FG006|Overall Study|Investigator Request|1
6961486|NCT01088048|11006835|FG007|Overall Study|Investigator Request|0
6961487|NCT01088048|11006836|FG008|Overall Study|Investigator Request|0
6961488|NCT01088048|11006837|FG009|Overall Study|Investigator Request|0
6961489|NCT01088048|11006828|FG000|Overall Study|Patient Non-compliance|0
6961490|NCT01088048|11006829|FG001|Overall Study|Patient Non-compliance|1
6961491|NCT01088048|11006830|FG002|Overall Study|Patient Non-compliance|0
6961492|NCT01088048|11006831|FG003|Overall Study|Patient Non-compliance|0
6961493|NCT01088048|11006832|FG004|Overall Study|Patient Non-compliance|0
6961494|NCT01088048|11006833|FG005|Overall Study|Patient Non-compliance|0
6961495|NCT01088048|11006834|FG006|Overall Study|Patient Non-compliance|0
6961496|NCT01088048|11006835|FG007|Overall Study|Patient Non-compliance|0
6961497|NCT01088048|11006836|FG008|Overall Study|Patient Non-compliance|0
6961498|NCT01088048|11006837|FG009|Overall Study|Patient Non-compliance|0
6961499|NCT01088048|11006828|FG000|Overall Study|Disease Progression|7
6961500|NCT01088048|11006829|FG001|Overall Study|Disease Progression|4
6961501|NCT01088048|11006830|FG002|Overall Study|Disease Progression|3
6961502|NCT01088048|11006831|FG003|Overall Study|Disease Progression|5
6961503|NCT01088048|11006832|FG004|Overall Study|Disease Progression|3
6961504|NCT01088048|11006833|FG005|Overall Study|Disease Progression|3
6961505|NCT01088048|11006834|FG006|Overall Study|Disease Progression|2
6961506|NCT01088048|11006835|FG007|Overall Study|Disease Progression|1
6961507|NCT01088048|11006836|FG008|Overall Study|Disease Progression|0
6961508|NCT01088048|11006837|FG009|Overall Study|Disease Progression|0
6961509|NCT01088048|11006828|FG000|Overall Study|Death|1
6961510|NCT01088048|11006829|FG001|Overall Study|Death|5
6961511|NCT01088048|11006830|FG002|Overall Study|Death|3
6961512|NCT01088048|11006831|FG003|Overall Study|Death|3
6961513|NCT01088048|11006832|FG004|Overall Study|Death|1
6961514|NCT01088048|11006833|FG005|Overall Study|Death|3
6961515|NCT01088048|11006834|FG006|Overall Study|Death|0
6961516|NCT01088048|11006835|FG007|Overall Study|Death|0
6961517|NCT01088048|11006836|FG008|Overall Study|Death|3
6961518|NCT01088048|11006837|FG009|Overall Study|Death|1
6961519|NCT01088048|11006828|FG000|Overall Study|Other|3
6961520|NCT01088048|11006829|FG001|Overall Study|Other|5
6961521|NCT01088048|11006830|FG002|Overall Study|Other|0
6961522|NCT01088048|11006831|FG003|Overall Study|Other|0
7040870|NCT01721057|11124067|FG001|Treatment Period|Lost to Follow-up|0
6961523|NCT01088048|11006832|FG004|Overall Study|Other|2
6961524|NCT01088048|11006833|FG005|Overall Study|Other|0
6961525|NCT01088048|11006834|FG006|Overall Study|Other|0
6961526|NCT01088048|11006835|FG007|Overall Study|Other|2
6961527|NCT01088048|11006836|FG008|Overall Study|Other|0
6961528|NCT01088048|11006837|FG009|Overall Study|Other|0
6961529|NCT01088243|11006872|FG000|Overall Study|Adverse Event|1
6961530|NCT01088243|11006873|FG001|Overall Study|Adverse Event|0
6961531|NCT01088399|11006886|FG000|Overall Study|Adverse Event|211
6961532|NCT01088399|11006887|FG001|Overall Study|Adverse Event|16
6961533|NCT01088399|11006888|FG002|Overall Study|Adverse Event|0
6961534|NCT01088399|11006886|FG000|Overall Study|Death|204
6961535|NCT01088399|11006887|FG001|Overall Study|Death|45
6961536|NCT01088399|11006888|FG002|Overall Study|Death|0
6961537|NCT01088399|11006886|FG000|Overall Study|Lack of Efficacy|298
6961538|NCT01088399|11006887|FG001|Overall Study|Lack of Efficacy|7
6961539|NCT01088399|11006888|FG002|Overall Study|Lack of Efficacy|5
6961540|NCT01088399|11006886|FG000|Overall Study|Lost to Follow-up|1070
6961541|NCT01088399|11006887|FG001|Overall Study|Lost to Follow-up|278
6961542|NCT01088399|11006888|FG002|Overall Study|Lost to Follow-up|58
6961543|NCT01088399|11006886|FG000|Overall Study|Physician Decision|531
6961544|NCT01088399|11006887|FG001|Overall Study|Physician Decision|88
6961545|NCT01088399|11006888|FG002|Overall Study|Physician Decision|16
6961546|NCT01088399|11006886|FG000|Overall Study|Withdrawal by Subject|544
6961547|NCT01088399|11006887|FG001|Overall Study|Withdrawal by Subject|195
6961548|NCT01088399|11006888|FG002|Overall Study|Withdrawal by Subject|33
6961549|NCT01088399|11006886|FG000|Overall Study|Change to or start of somatropin therapy|234
6961550|NCT01088399|11006887|FG001|Overall Study|Change to or start of somatropin therapy|17
6961551|NCT01088399|11006888|FG002|Overall Study|Change to or start of somatropin therapy|12
6961552|NCT01088399|11006886|FG000|Overall Study|Sponsor decision|1573
6961553|NCT01088399|11006887|FG001|Overall Study|Sponsor decision|298
6961554|NCT01088399|11006888|FG002|Overall Study|Sponsor decision|7
6961555|NCT01088399|11006886|FG000|Overall Study|Protocol Violation|10
6961556|NCT01088399|11006887|FG001|Overall Study|Protocol Violation|1
6961557|NCT01088399|11006888|FG002|Overall Study|Protocol Violation|0
6961558|NCT01088399|11006886|FG000|Overall Study|Enrollment criteria not met|48
6961559|NCT01088399|11006887|FG001|Overall Study|Enrollment criteria not met|119
6961560|NCT01088399|11006888|FG002|Overall Study|Enrollment criteria not met|70
6961561|NCT01088399|11006886|FG000|Overall Study|Study summary visit not completed|2398
6961562|NCT01088399|11006887|FG001|Overall Study|Study summary visit not completed|283
6961563|NCT01088399|11006888|FG002|Overall Study|Study summary visit not completed|80
6961564|NCT01088412|11006899|FG000|Overall Study|Adverse Event|38
6961565|NCT01088412|11006900|FG001|Overall Study|Adverse Event|0
6961566|NCT01088412|11006901|FG002|Overall Study|Adverse Event|0
6961567|NCT01088412|11006899|FG000|Overall Study|Death|42
6961568|NCT01088412|11006900|FG001|Overall Study|Death|6
6961569|NCT01088412|11006901|FG002|Overall Study|Death|0
6961570|NCT01088412|11006899|FG000|Overall Study|Other Reason per Case Report Form|2089
6961571|NCT01088412|11006900|FG001|Overall Study|Other Reason per Case Report Form|103
6961572|NCT01088412|11006901|FG002|Overall Study|Other Reason per Case Report Form|9
6961573|NCT01088412|11006899|FG000|Overall Study|Withdrawal by Subject|1761
6961574|NCT01088412|11006900|FG001|Overall Study|Withdrawal by Subject|25
6961575|NCT01088412|11006901|FG002|Overall Study|Withdrawal by Subject|1
6961576|NCT01088412|11006899|FG000|Overall Study|Received Another GH Product|79
6961577|NCT01088412|11006900|FG001|Overall Study|Received Another GH Product|0
6961578|NCT01088412|11006901|FG002|Overall Study|Received Another GH Product|0
6961579|NCT01088412|11006899|FG000|Overall Study|Participant Moved|601
6961580|NCT01088412|11006900|FG001|Overall Study|Participant Moved|21
6961581|NCT01088412|11006901|FG002|Overall Study|Participant Moved|2
6961582|NCT01088412|11006899|FG000|Overall Study|Physician Decision|1041
6961583|NCT01088412|11006900|FG001|Overall Study|Physician Decision|8
6961584|NCT01088412|11006901|FG002|Overall Study|Physician Decision|4
6961585|NCT01088412|11006899|FG000|Overall Study|Sponsor Decision|4467
6961586|NCT01088412|11006900|FG001|Overall Study|Sponsor Decision|79
6961587|NCT01088412|11006901|FG002|Overall Study|Sponsor Decision|23
6961588|NCT01088412|11006899|FG000|Overall Study|Third Party Required to Change Brand|487
6961589|NCT01088412|11006900|FG001|Overall Study|Third Party Required to Change Brand|0
6961590|NCT01088412|11006901|FG002|Overall Study|Third Party Required to Change Brand|0
6961591|NCT01088412|11006899|FG000|Overall Study|Lost to Follow-up|3052
6961592|NCT01088412|11006900|FG001|Overall Study|Lost to Follow-up|130
6961593|NCT01088412|11006901|FG002|Overall Study|Lost to Follow-up|11
6961594|NCT01088412|11006899|FG000|Overall Study|Study Summary Not Completed|4360
7040871|NCT01721057|11124068|FG002|Treatment Period|Lost to Follow-up|0
7040872|NCT01721057|11124069|FG003|Treatment Period|Lost to Follow-up|0
7040873|NCT01721057|11124070|FG004|Treatment Period|Lost to Follow-up|0
7040874|NCT01721057|11124071|FG005|Treatment Period|Lost to Follow-up|0
7040875|NCT01721057|11124072|FG006|Treatment Period|Lost to Follow-up|0
7040876|NCT01721057|11124066|FG000|Treatment Period|Physician Decision|0
7040877|NCT01721057|11124067|FG001|Treatment Period|Physician Decision|1
7040878|NCT01721057|11124068|FG002|Treatment Period|Physician Decision|3
7040879|NCT01721057|11124069|FG003|Treatment Period|Physician Decision|0
7040880|NCT01721057|11124070|FG004|Treatment Period|Physician Decision|0
7040881|NCT01721057|11124071|FG005|Treatment Period|Physician Decision|0
7040882|NCT01721057|11124072|FG006|Treatment Period|Physician Decision|0
7040883|NCT01721057|11124066|FG000|Treatment Period|Death|2
6961595|NCT01088412|11006900|FG001|Overall Study|Study Summary Not Completed|64
6961596|NCT01088412|11006901|FG002|Overall Study|Study Summary Not Completed|22
6961597|NCT01088438|11006914|FG000|Overall Study|Withdrawal by Subject|11
6961598|NCT01088438|11006915|FG001|Overall Study|Withdrawal by Subject|6
6961599|NCT01088438|11006914|FG000|Overall Study|Lost to Follow-up|18
6961600|NCT01088438|11006915|FG001|Overall Study|Lost to Follow-up|30
6961601|NCT01088503|11006937|FG000|Overall Study|Withdrawal by Subject|118
6961602|NCT01088503|11006938|FG001|Overall Study|Withdrawal by Subject|327
6961603|NCT01088503|11006939|FG002|Overall Study|Withdrawal by Subject|10
6961604|NCT01088503|11006937|FG000|Overall Study|Death|64
6961605|NCT01088503|11006938|FG001|Overall Study|Death|358
6961606|NCT01088503|11006939|FG002|Overall Study|Death|7
7040884|NCT01721057|11124067|FG001|Treatment Period|Death|0
6961607|NCT01088529|11006947|FG000|Overall Study|Did not receive study treatment|0
6961608|NCT01088529|11006948|FG001|Overall Study|Did not receive study treatment|1
6961609|NCT01088984|11006984|FG000|Phase 1|Death|2
6961610|NCT01088984|11006985|FG001|Phase 1|Death|1
6961611|NCT01088984|11006984|FG000|Phase 1|Disease Progression|2
6961612|NCT01088984|11006985|FG001|Phase 1|Disease Progression|4
6961613|NCT01088984|11006984|FG000|Phase 1|Other|1
6961614|NCT01088984|11006985|FG001|Phase 1|Other|1
6961615|NCT01088984|11006984|FG000|Phase 2|Death|0
6961616|NCT01088984|11006985|FG001|Phase 2|Death|5
6961617|NCT01088984|11006984|FG000|Phase 2|Withdrawal by Subject|0
6961618|NCT01088984|11006985|FG001|Phase 2|Withdrawal by Subject|1
6961619|NCT01088984|11006984|FG000|Phase 2|DIsease Progression|0
6961620|NCT01088984|11006985|FG001|Phase 2|DIsease Progression|25
6961621|NCT01088984|11006984|FG000|Phase 2|Other|0
6961622|NCT01088984|11006985|FG001|Phase 2|Other|1
6961623|NCT01088997|11006996|FG000|Overall Study|Physician Decision|1
6961624|NCT01088997|11006997|FG001|Overall Study|Physician Decision|1
7072526|NCT02037165|11176583|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0
7072527|NCT02037165|11176584|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0
6961625|NCT01088997|11006996|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1
6961626|NCT01088997|11006997|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1
6961627|NCT01088997|11006996|FG000|Overall Study|Excluded prior to receiving drug|1
6961628|NCT01088997|11006997|FG001|Overall Study|Excluded prior to receiving drug|1
6961629|NCT01089023|11007006|FG000|Overall Study|Lost to Follow-up|3
6961630|NCT01089023|11007006|FG000|Overall Study|Adverse Event|1
6961631|NCT01089023|11007006|FG000|Overall Study|Withdrawal by Subject|1
6961632|NCT01089023|11007006|FG000|Overall Study|Protocol Violation|1
6961633|NCT01089023|11007006|FG000|Overall Study|Lack of Efficacy|1
6961634|NCT01089127|11007036|FG000|Overall Study|Adverse Event|5
6961635|NCT01089127|11007037|FG001|Overall Study|Adverse Event|1
6961636|NCT01089127|11007038|FG002|Overall Study|Adverse Event|1
6961637|NCT01089127|11007039|FG003|Overall Study|Adverse Event|0
6961638|NCT01089127|11007040|FG004|Overall Study|Adverse Event|0
6961639|NCT01089127|11007041|FG005|Overall Study|Adverse Event|1
6961640|NCT01089127|11007036|FG000|Overall Study|Subject withdrew consent|0
6961641|NCT01089127|11007037|FG001|Overall Study|Subject withdrew consent|1
6961642|NCT01089127|11007038|FG002|Overall Study|Subject withdrew consent|1
6961643|NCT01089127|11007039|FG003|Overall Study|Subject withdrew consent|1
6961644|NCT01089127|11007040|FG004|Overall Study|Subject withdrew consent|0
6961645|NCT01089127|11007041|FG005|Overall Study|Subject withdrew consent|2
6961646|NCT01089127|11007036|FG000|Overall Study|Abnormal test procedure result(s)|2
7072528|NCT02037165|11176585|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1
6961647|NCT01089127|11007037|FG001|Overall Study|Abnormal test procedure result(s)|1
6961648|NCT01089127|11007038|FG002|Overall Study|Abnormal test procedure result(s)|0
6961649|NCT01089127|11007039|FG003|Overall Study|Abnormal test procedure result(s)|0
6961650|NCT01089127|11007040|FG004|Overall Study|Abnormal test procedure result(s)|0
6961651|NCT01089127|11007041|FG005|Overall Study|Abnormal test procedure result(s)|0
6961652|NCT01089127|11007036|FG000|Overall Study|Lost to Follow-up|1
6961653|NCT01089127|11007037|FG001|Overall Study|Lost to Follow-up|1
6961654|NCT01089127|11007038|FG002|Overall Study|Lost to Follow-up|0
6961655|NCT01089127|11007039|FG003|Overall Study|Lost to Follow-up|0
6961656|NCT01089127|11007040|FG004|Overall Study|Lost to Follow-up|1
6961657|NCT01089127|11007041|FG005|Overall Study|Lost to Follow-up|0
6961658|NCT01089127|11007036|FG000|Overall Study|Protocol deviation|0
6961659|NCT01089127|11007037|FG001|Overall Study|Protocol deviation|1
6961660|NCT01089127|11007038|FG002|Overall Study|Protocol deviation|0
6961661|NCT01089127|11007039|FG003|Overall Study|Protocol deviation|0
6961662|NCT01089127|11007040|FG004|Overall Study|Protocol deviation|1
6961663|NCT01089127|11007041|FG005|Overall Study|Protocol deviation|0
6961664|NCT01089361|11007074|FG000|Overall Study|Death|1
6961665|NCT01089361|11007075|FG001|Overall Study|Death|0
6961666|NCT01089413|11007086|FG000|Overall Study|Lost to Follow-up|1
6961667|NCT01089413|11007086|FG000|Overall Study|Progressive Disease|93
6961668|NCT01089413|11007086|FG000|Overall Study|Participant Withdrew Consent|1
6961669|NCT01089413|11007086|FG000|Overall Study|Unacceptable Toxicity|12
6961670|NCT01089413|11007086|FG000|Overall Study|Death|10
6961671|NCT01089413|11007086|FG000|Overall Study|Metastasectomy|13
6961672|NCT01089413|11007086|FG000|Overall Study|Other|71
7072529|NCT02037256|11176626|FG000|Overall Study|Protocol Violation|0
7072530|NCT02037256|11176627|FG001|Overall Study|Protocol Violation|1
7072531|NCT02037256|11176626|FG000|Overall Study|Withdrawn prior to Velcade|0
7072532|NCT02037256|11176627|FG001|Overall Study|Withdrawn prior to Velcade|2
7072533|NCT02037295|11176639|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1
7072534|NCT02037295|11176640|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0
7072535|NCT02037295|11176641|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0
7072536|NCT02037295|11176642|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1
7072537|NCT02037477|11176677|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0
7072538|NCT02037477|11176678|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0
7072539|NCT02037477|11176679|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1
7082700|NCT02144285|11193307|FG004|Overall Study|Withdrawal by Subject|1
6961673|NCT01089504|11007098|FG000|Overall Study|Lost to Follow-up|1
6961674|NCT01089504|11007099|FG001|Overall Study|Lost to Follow-up|1
6961675|NCT01089504|11007098|FG000|Overall Study|Withdrawal by Subject|2
6961676|NCT01089504|11007099|FG001|Overall Study|Withdrawal by Subject|0
6961677|NCT01089543|11007122|FG000|Overall Study|Withdrawal by Subject|2
6961678|NCT01089543|11007123|FG001|Overall Study|Withdrawal by Subject|3
6961679|NCT01089543|11007124|FG002|Overall Study|Withdrawal by Subject|3
6961680|NCT01089543|11007125|FG003|Overall Study|Withdrawal by Subject|1
6961681|NCT01089543|11007122|FG000|Overall Study|Physician Decision|1
6961682|NCT01089543|11007123|FG001|Overall Study|Physician Decision|0
6961683|NCT01089543|11007124|FG002|Overall Study|Physician Decision|0
6961684|NCT01089543|11007125|FG003|Overall Study|Physician Decision|1
6961685|NCT01089543|11007122|FG000|Overall Study|Adverse Event|0
6961686|NCT01089543|11007123|FG001|Overall Study|Adverse Event|1
6961687|NCT01089543|11007124|FG002|Overall Study|Adverse Event|0
6961688|NCT01089543|11007125|FG003|Overall Study|Adverse Event|0
6961689|NCT01089556|11007137|FG000|Study Period II (Weeks 1-8)|Adverse Event|35
6961690|NCT01089556|11007138|FG001|Study Period II (Weeks 1-8)|Adverse Event|39
6961691|NCT01089556|11007139|FG002|Study Period II (Weeks 1-8)|Adverse Event|0
6961692|NCT01089556|11007140|FG003|Study Period II (Weeks 1-8)|Adverse Event|0
6961693|NCT01089556|11007141|FG004|Study Period II (Weeks 1-8)|Adverse Event|0
6961694|NCT01089556|11007142|FG005|Study Period II (Weeks 1-8)|Adverse Event|0
6961695|NCT01089556|11007137|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12
6961696|NCT01089556|11007138|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8
6961697|NCT01089556|11007139|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
6961698|NCT01089556|11007140|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
6961699|NCT01089556|11007141|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
6961700|NCT01089556|11007142|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
6961701|NCT01089556|11007137|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1
6961702|NCT01089556|11007138|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2
6961703|NCT01089556|11007139|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0
6961704|NCT01089556|11007140|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0
6961705|NCT01089556|11007141|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0
6961706|NCT01089556|11007142|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0
6961707|NCT01089556|11007137|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0
6961708|NCT01089556|11007138|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3
6961709|NCT01089556|11007139|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0
6961710|NCT01089556|11007140|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0
6961711|NCT01089556|11007141|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0
6961712|NCT01089556|11007142|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0
6961713|NCT01089556|11007137|FG000|Study Period II (Weeks 1-8)|Physician Decision|4
6961714|NCT01089556|11007138|FG001|Study Period II (Weeks 1-8)|Physician Decision|0
6961715|NCT01089556|11007139|FG002|Study Period II (Weeks 1-8)|Physician Decision|0
6961716|NCT01089556|11007140|FG003|Study Period II (Weeks 1-8)|Physician Decision|0
6961717|NCT01089556|11007141|FG004|Study Period II (Weeks 1-8)|Physician Decision|0
6961718|NCT01089556|11007142|FG005|Study Period II (Weeks 1-8)|Physician Decision|0
6961719|NCT01089556|11007137|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4
6961720|NCT01089556|11007138|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4
6961721|NCT01089556|11007139|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0
6961722|NCT01089556|11007140|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0
6961723|NCT01089556|11007141|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0
6961724|NCT01089556|11007142|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0
6961725|NCT01089556|11007137|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12
6961726|NCT01089556|11007138|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14
7072540|NCT02037477|11176680|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0
7072541|NCT02037568|11176701|FG000|Overall Study|Withdrawal by Subject|17
7072542|NCT02037568|11176702|FG001|Overall Study|Withdrawal by Subject|24
6961727|NCT01089556|11007139|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
6961728|NCT01089556|11007140|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
6961729|NCT01089556|11007141|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
6961730|NCT01089556|11007142|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
6961731|NCT01089556|11007137|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3
6961732|NCT01089556|11007138|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4
6961733|NCT01089556|11007139|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0
6961734|NCT01089556|11007140|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0
6961735|NCT01089556|11007141|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0
6961736|NCT01089556|11007142|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0
6961737|NCT01089556|11007137|FG000|Study Period III (Weeks 9-16)|Adverse Event|0
6961738|NCT01089556|11007138|FG001|Study Period III (Weeks 9-16)|Adverse Event|0
6961739|NCT01089556|11007139|FG002|Study Period III (Weeks 9-16)|Adverse Event|4
6961740|NCT01089556|11007140|FG003|Study Period III (Weeks 9-16)|Adverse Event|2
6961741|NCT01089556|11007141|FG004|Study Period III (Weeks 9-16)|Adverse Event|4
6961742|NCT01089556|11007142|FG005|Study Period III (Weeks 9-16)|Adverse Event|3
6961743|NCT01089556|11007137|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
7072543|NCT02037568|11176701|FG000|Overall Study|Lost to Follow-up|16
7072544|NCT02037568|11176702|FG001|Overall Study|Lost to Follow-up|13
6961744|NCT01089556|11007138|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
6961745|NCT01089556|11007139|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
6961746|NCT01089556|11007140|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
6961747|NCT01089556|11007141|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
6961748|NCT01089556|11007142|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
6961749|NCT01089556|11007137|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0
6961750|NCT01089556|11007138|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0
6961751|NCT01089556|11007139|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0
6961752|NCT01089556|11007140|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2
6961753|NCT01089556|11007141|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1
6961754|NCT01089556|11007142|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0
6961755|NCT01089556|11007137|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0
6961756|NCT01089556|11007138|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0
6961757|NCT01089556|11007139|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1
7072545|NCT02037568|11176701|FG000|Overall Study|Screen Failure|3
7072546|NCT02037568|11176702|FG001|Overall Study|Screen Failure|1
7072547|NCT02037568|11176701|FG000|Overall Study|Patient did not receive transplant|0
7072548|NCT02037568|11176702|FG001|Overall Study|Patient did not receive transplant|1
7072549|NCT02037984|11176746|FG000|Overall Study|Lack of Efficacy|0
7072550|NCT02037984|11176747|FG001|Overall Study|Lack of Efficacy|0
6961758|NCT01089556|11007140|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0
6961759|NCT01089556|11007141|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0
6961760|NCT01089556|11007142|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0
6961761|NCT01089556|11007137|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0
6961762|NCT01089556|11007138|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0
6961763|NCT01089556|11007139|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1
6961764|NCT01089556|11007140|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1
6961765|NCT01089556|11007141|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1
6961766|NCT01089556|11007142|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0
6961767|NCT01089556|11007137|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0
6961768|NCT01089556|11007138|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0
6961769|NCT01089556|11007139|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4
6961770|NCT01089556|11007140|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3
6961771|NCT01089556|11007141|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4
6961772|NCT01089556|11007142|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1
6961773|NCT01089556|11007137|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
6961774|NCT01089556|11007138|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
6961775|NCT01089556|11007139|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3
6961776|NCT01089556|11007140|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
7072551|NCT02037984|11176748|FG002|Overall Study|Lack of Efficacy|3
7072552|NCT02037984|11176749|FG003|Overall Study|Lack of Efficacy|10
7072553|NCT02037984|11176750|FG004|Overall Study|Lack of Efficacy|2
7072554|NCT02037984|11176751|FG005|Overall Study|Lack of Efficacy|2
7072555|NCT02037984|11176752|FG006|Overall Study|Lack of Efficacy|4
7072556|NCT02037984|11176753|FG007|Overall Study|Lack of Efficacy|3
6961777|NCT01089556|11007141|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1
6961778|NCT01089556|11007142|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2
6961779|NCT01089582|11007167|FG000|Overall Study|Death|2
6961780|NCT01089582|11007167|FG000|Overall Study|Adverse Event|15
6961781|NCT01089582|11007167|FG000|Overall Study|Lost to Follow-up|8
6961782|NCT01089582|11007167|FG000|Overall Study|Other|4
6961783|NCT01089582|11007167|FG000|Overall Study|Withdrawal by Subject|1
6961784|NCT01089608|11007184|FG000|Overall Study|Adverse Event|0
6961785|NCT01089608|11007185|FG001|Overall Study|Adverse Event|4
6961786|NCT01089608|11007184|FG000|Overall Study|Lost to Follow-up|0
6961787|NCT01089608|11007185|FG001|Overall Study|Lost to Follow-up|2
6961788|NCT01089647|11007193|FG000|Overall Study|Lost to Follow-up|2
6961789|NCT01089647|11007194|FG001|Overall Study|Lost to Follow-up|2
6961790|NCT01089647|11007193|FG000|Overall Study|Withdrawal by Subject|2
6961791|NCT01089647|11007194|FG001|Overall Study|Withdrawal by Subject|1
6961792|NCT01089647|11007193|FG000|Overall Study|Adverse Event|0
6961793|NCT01089647|11007194|FG001|Overall Study|Adverse Event|1
6961794|NCT01089725|11007205|FG000|Overall Study|Adverse Event|1
6961795|NCT01089725|11007206|FG001|Overall Study|Adverse Event|1
6961796|NCT01089725|11007207|FG002|Overall Study|Adverse Event|0
6961797|NCT01089725|11007208|FG003|Overall Study|Adverse Event|0
6961798|NCT01089725|11007209|FG004|Overall Study|Adverse Event|2
6961799|NCT01089725|11007205|FG000|Overall Study|Lack of Efficacy|4
6961800|NCT01089725|11007206|FG001|Overall Study|Lack of Efficacy|3
6961801|NCT01089725|11007207|FG002|Overall Study|Lack of Efficacy|1
6961802|NCT01089725|11007208|FG003|Overall Study|Lack of Efficacy|0
6961803|NCT01089725|11007209|FG004|Overall Study|Lack of Efficacy|4
6961804|NCT01089725|11007205|FG000|Overall Study|Lost to Follow-up|2
6961805|NCT01089725|11007206|FG001|Overall Study|Lost to Follow-up|2
6961806|NCT01089725|11007207|FG002|Overall Study|Lost to Follow-up|0
6961807|NCT01089725|11007208|FG003|Overall Study|Lost to Follow-up|3
6961808|NCT01089725|11007209|FG004|Overall Study|Lost to Follow-up|0
6961809|NCT01089725|11007205|FG000|Overall Study|Protocol Violation|0
6961810|NCT01089725|11007206|FG001|Overall Study|Protocol Violation|0
7072557|NCT02037984|11176746|FG000|Overall Study|Lost to Follow-up|1
7072558|NCT02037984|11176747|FG001|Overall Study|Lost to Follow-up|0
6961811|NCT01089725|11007207|FG002|Overall Study|Protocol Violation|1
7072559|NCT02037984|11176748|FG002|Overall Study|Lost to Follow-up|3
7072560|NCT02037984|11176749|FG003|Overall Study|Lost to Follow-up|5
7072561|NCT02037984|11176750|FG004|Overall Study|Lost to Follow-up|2
7072562|NCT02037984|11176751|FG005|Overall Study|Lost to Follow-up|2
7072563|NCT02037984|11176752|FG006|Overall Study|Lost to Follow-up|2
7072564|NCT02037984|11176753|FG007|Overall Study|Lost to Follow-up|4
7072565|NCT02037984|11176746|FG000|Overall Study|Physician Decision|0
7072566|NCT02037984|11176747|FG001|Overall Study|Physician Decision|0
7072567|NCT02037984|11176748|FG002|Overall Study|Physician Decision|0
7072568|NCT02037984|11176749|FG003|Overall Study|Physician Decision|0
7072569|NCT02037984|11176750|FG004|Overall Study|Physician Decision|0
7072570|NCT02037984|11176751|FG005|Overall Study|Physician Decision|0
7072571|NCT02037984|11176752|FG006|Overall Study|Physician Decision|1
7072572|NCT02037984|11176753|FG007|Overall Study|Physician Decision|0
7072573|NCT02037984|11176746|FG000|Overall Study|Protocol Violation|0
7072574|NCT02037984|11176747|FG001|Overall Study|Protocol Violation|0
7072575|NCT02037984|11176748|FG002|Overall Study|Protocol Violation|0
7072576|NCT02037984|11176749|FG003|Overall Study|Protocol Violation|0
7072577|NCT02037984|11176750|FG004|Overall Study|Protocol Violation|0
7072578|NCT02037984|11176751|FG005|Overall Study|Protocol Violation|1
6961812|NCT01089725|11007208|FG003|Overall Study|Protocol Violation|1
6961813|NCT01089725|11007209|FG004|Overall Study|Protocol Violation|0
6961814|NCT01089725|11007205|FG000|Overall Study|Withdrawal by Subject|5
6961815|NCT01089725|11007206|FG001|Overall Study|Withdrawal by Subject|5
6961816|NCT01089725|11007207|FG002|Overall Study|Withdrawal by Subject|4
6961817|NCT01089725|11007208|FG003|Overall Study|Withdrawal by Subject|5
6961818|NCT01089725|11007209|FG004|Overall Study|Withdrawal by Subject|4
6961819|NCT01089725|11007205|FG000|Overall Study|Study Terminated by Sponsor|51
6961820|NCT01089725|11007206|FG001|Overall Study|Study Terminated by Sponsor|56
6961821|NCT01089725|11007207|FG002|Overall Study|Study Terminated by Sponsor|53
6961822|NCT01089725|11007208|FG003|Overall Study|Study Terminated by Sponsor|68
6961823|NCT01089725|11007209|FG004|Overall Study|Study Terminated by Sponsor|68
6961824|NCT01089725|11007205|FG000|Overall Study|Randomized, but not treated|0
6961825|NCT01089725|11007206|FG001|Overall Study|Randomized, but not treated|1
6961826|NCT01089725|11007207|FG002|Overall Study|Randomized, but not treated|2
6961827|NCT01089725|11007208|FG003|Overall Study|Randomized, but not treated|1
6961828|NCT01089725|11007209|FG004|Overall Study|Randomized, but not treated|2
6961829|NCT01089725|11007205|FG000|Overall Study|Other|3
6961830|NCT01089725|11007206|FG001|Overall Study|Other|0
6961831|NCT01089725|11007207|FG002|Overall Study|Other|0
6961832|NCT01089725|11007208|FG003|Overall Study|Other|1
6961833|NCT01089725|11007209|FG004|Overall Study|Other|0
6961834|NCT01090011|11007234|FG000|Overall Study|Progressive disease|128
6961835|NCT01090011|11007234|FG000|Overall Study|Adverse Event|32
6961836|NCT01090011|11007234|FG000|Overall Study|Protocol Violation|1
6961837|NCT01090011|11007234|FG000|Overall Study|Refusal to start/continue medication|5
6961838|NCT01090011|11007234|FG000|Overall Study|Other reason not defined above|5
6961839|NCT01090050|11007248|FG000|Overall Study|Lost to Follow-up|0
6961840|NCT01090050|11007249|FG001|Overall Study|Lost to Follow-up|1
6961841|NCT01090050|11007248|FG000|Overall Study|Lack of Efficacy|1
6961842|NCT01090050|11007249|FG001|Overall Study|Lack of Efficacy|5
6961843|NCT01090050|11007248|FG000|Overall Study|Physician Decision|0
6961844|NCT01090050|11007249|FG001|Overall Study|Physician Decision|1
6961845|NCT01090063|11007259|FG000|Screen|Screen Failed|4
6961846|NCT01090063|11007259|FG000|Treatment|Withdrawal by Subject|4
6961847|NCT01090076|11007275|FG000|Overall Study|Death|1
6961848|NCT01090076|11007276|FG001|Overall Study|Death|1
6961849|NCT01090076|11007275|FG000|Overall Study|Withdrawal by Subject|0
6961850|NCT01090076|11007276|FG001|Overall Study|Withdrawal by Subject|1
6976592|NCT01200524|11029390|FG000|Overall Study|Adverse Event|1
6976593|NCT01200524|11029391|FG001|Overall Study|Adverse Event|0
6976594|NCT01200524|11029392|FG002|Overall Study|Adverse Event|0
6976595|NCT01200524|11029390|FG000|Overall Study|Non availability of study nurse|0
6976596|NCT01200524|11029391|FG001|Overall Study|Non availability of study nurse|0
6976597|NCT01200524|11029392|FG002|Overall Study|Non availability of study nurse|1
6976598|NCT01200589|11029402|FG000|Overall Study|Withdrawal by Subject|13
6976599|NCT01200589|11029403|FG001|Overall Study|Withdrawal by Subject|11
6976600|NCT01200589|11029402|FG000|Overall Study|Physician Decision|2
6976601|NCT01200589|11029403|FG001|Overall Study|Physician Decision|2
6976602|NCT01200589|11029402|FG000|Overall Study|Lost to Follow-up|5
6976603|NCT01200589|11029403|FG001|Overall Study|Lost to Follow-up|4
6976604|NCT01200589|11029402|FG000|Overall Study|Study terminated|170
6976605|NCT01200589|11029403|FG001|Overall Study|Study terminated|172
6976606|NCT01200758|11029411|FG000|Stage I|Death|0
6976607|NCT01200758|11029412|FG001|Stage I|Death|1
7072579|NCT02037984|11176752|FG006|Overall Study|Protocol Violation|2
7072580|NCT02037984|11176753|FG007|Overall Study|Protocol Violation|0
7072581|NCT02037984|11176746|FG000|Overall Study|Technical Problems|0
6976608|NCT01200758|11029413|FG002|Stage I|Death|0
6976609|NCT01200758|11029414|FG003|Stage I|Death|0
6976610|NCT01200758|11029411|FG000|Stage I|Physician Decision|1
6976611|NCT01200758|11029412|FG001|Stage I|Physician Decision|1
6976612|NCT01200758|11029413|FG002|Stage I|Physician Decision|0
6976613|NCT01200758|11029414|FG003|Stage I|Physician Decision|0
6976614|NCT01200758|11029411|FG000|Stage I|Lack of Efficacy|2
6976615|NCT01200758|11029412|FG001|Stage I|Lack of Efficacy|1
6976616|NCT01200758|11029413|FG002|Stage I|Lack of Efficacy|0
7072582|NCT02037984|11176747|FG001|Overall Study|Technical Problems|0
7072583|NCT02037984|11176748|FG002|Overall Study|Technical Problems|3
7072584|NCT02037984|11176749|FG003|Overall Study|Technical Problems|3
7072585|NCT02037984|11176750|FG004|Overall Study|Technical Problems|2
7072586|NCT02037984|11176751|FG005|Overall Study|Technical Problems|3
7072587|NCT02037984|11176752|FG006|Overall Study|Technical Problems|4
7072588|NCT02037984|11176753|FG007|Overall Study|Technical Problems|2
7072589|NCT02037984|11176746|FG000|Overall Study|Withdrawal by Parent/Guardian|0
7072590|NCT02037984|11176747|FG001|Overall Study|Withdrawal by Parent/Guardian|0
7072591|NCT02037984|11176748|FG002|Overall Study|Withdrawal by Parent/Guardian|3
7072592|NCT02037984|11176749|FG003|Overall Study|Withdrawal by Parent/Guardian|2
7072593|NCT02037984|11176750|FG004|Overall Study|Withdrawal by Parent/Guardian|5
7072594|NCT02037984|11176751|FG005|Overall Study|Withdrawal by Parent/Guardian|1
7072595|NCT02037984|11176752|FG006|Overall Study|Withdrawal by Parent/Guardian|4
7072596|NCT02037984|11176753|FG007|Overall Study|Withdrawal by Parent/Guardian|2
7072597|NCT02037984|11176746|FG000|Overall Study|Withdrawal by Subject|0
7072598|NCT02037984|11176747|FG001|Overall Study|Withdrawal by Subject|0
6838528|NCT00260832|10844304|FG000|Overall Study|Adverse Event|26
6838529|NCT00260832|10844305|FG001|Overall Study|Adverse Event|19
6838530|NCT00260832|10844304|FG000|Overall Study|Progression|116
6838531|NCT00260832|10844305|FG001|Overall Study|Progression|96
6838532|NCT00260832|10844304|FG000|Overall Study|Withdrawal by Subject|15
6838533|NCT00260832|10844305|FG001|Overall Study|Withdrawal by Subject|17
6838534|NCT00260832|10844304|FG000|Overall Study|Physician Decision|15
6838535|NCT00260832|10844305|FG001|Overall Study|Physician Decision|9
6838536|NCT00260832|10844304|FG000|Overall Study|Death|43
6838537|NCT00260832|10844305|FG001|Overall Study|Death|62
6838538|NCT00260832|10844304|FG000|Overall Study|Other|10
6838539|NCT00260832|10844305|FG001|Overall Study|Other|7
6838540|NCT00260832|10844304|FG000|Overall Study|Protocol Violation|3
6838541|NCT00260832|10844305|FG001|Overall Study|Protocol Violation|1
6897637|NCT00642369|10916778|FG000|Overall Study|misdiagnosis|0
6897638|NCT00642369|10916779|FG001|Overall Study|misdiagnosis|1
6897639|NCT00642369|10916778|FG000|Overall Study|Lack of Efficacy|2
6897640|NCT00642369|10916779|FG001|Overall Study|Lack of Efficacy|2
6897641|NCT00642460|10916789|FG000|Part I: 12 Week Double-Blind|Adverse Event|0
6897642|NCT00642460|10916790|FG001|Part I: 12 Week Double-Blind|Adverse Event|1
6897643|NCT00642460|10916791|FG002|Part I: 12 Week Double-Blind|Adverse Event|1
6897644|NCT00642460|10916792|FG003|Part I: 12 Week Double-Blind|Adverse Event|0
6897645|NCT00642460|10916793|FG004|Part I: 12 Week Double-Blind|Adverse Event|0
6897646|NCT00642460|10916794|FG005|Part I: 12 Week Double-Blind|Adverse Event|0
6897647|NCT00642460|10916789|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1
6897648|NCT00642460|10916790|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0
6897649|NCT00642460|10916791|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0
6897650|NCT00642460|10916792|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0
6897651|NCT00642460|10916793|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0
6897652|NCT00642460|10916794|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0
6897653|NCT00642460|10916789|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4
6897654|NCT00642460|10916790|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2
6897655|NCT00642460|10916791|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0
6897656|NCT00642460|10916792|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0
6897657|NCT00642460|10916793|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0
6897658|NCT00642460|10916794|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0
6897659|NCT00642460|10916789|FG000|Part II: Open-Label Up to Week 92|Death|0
6897660|NCT00642460|10916790|FG001|Part II: Open-Label Up to Week 92|Death|1
6897661|NCT00642460|10916791|FG002|Part II: Open-Label Up to Week 92|Death|0
6897662|NCT00642460|10916792|FG003|Part II: Open-Label Up to Week 92|Death|2
6897663|NCT00642460|10916793|FG004|Part II: Open-Label Up to Week 92|Death|0
6897664|NCT00642460|10916794|FG005|Part II: Open-Label Up to Week 92|Death|0
6897665|NCT00642460|10916789|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2
6897666|NCT00642460|10916790|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3
6897667|NCT00642460|10916791|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
6897668|NCT00642460|10916792|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
6897669|NCT00642460|10916793|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
6897670|NCT00642460|10916794|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
6897671|NCT00642460|10916789|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3
6897672|NCT00642460|10916790|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1
6897673|NCT00642460|10916791|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0
6897674|NCT00642460|10916792|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0
6897675|NCT00642460|10916793|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0
6897676|NCT00642460|10916794|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0
6897677|NCT00642460|10916789|FG000|Part II: Open-Label Up to Week 92|Failure to return|0
6897678|NCT00642460|10916790|FG001|Part II: Open-Label Up to Week 92|Failure to return|1
6897679|NCT00642460|10916791|FG002|Part II: Open-Label Up to Week 92|Failure to return|0
6897680|NCT00642460|10916792|FG003|Part II: Open-Label Up to Week 92|Failure to return|0
6897681|NCT00642460|10916793|FG004|Part II: Open-Label Up to Week 92|Failure to return|0
6897682|NCT00642460|10916794|FG005|Part II: Open-Label Up to Week 92|Failure to return|0
6961851|NCT01090102|11007286|FG000|First 12 Weeks|Withdrawal by Subject|1
6961852|NCT01090102|11007287|FG001|First 12 Weeks|Withdrawal by Subject|1
6961853|NCT01090102|11007286|FG000|First 12 Weeks|Adverse Event|2
6961854|NCT01090102|11007287|FG001|First 12 Weeks|Adverse Event|0
6961855|NCT01090102|11007286|FG000|First 12 Weeks|Death|1
6961856|NCT01090102|11007287|FG001|First 12 Weeks|Death|1
6961857|NCT01090102|11007286|FG000|Second 12 Weeks|Withdrawal by Subject|0
6961858|NCT01090102|11007287|FG001|Second 12 Weeks|Withdrawal by Subject|1
6961859|NCT01090310|11007306|FG000|Core Study|Adverse Event|2
6961860|NCT01090310|11007307|FG001|Core Study|Adverse Event|2
6961861|NCT01090310|11007308|FG002|Core Study|Adverse Event|1
6961862|NCT01090310|11007309|FG003|Core Study|Adverse Event|1
6961863|NCT01090310|11007306|FG000|Core Study|Subject withdrew consent|0
6961864|NCT01090310|11007307|FG001|Core Study|Subject withdrew consent|3
6961865|NCT01090310|11007308|FG002|Core Study|Subject withdrew consent|1
6961866|NCT01090310|11007309|FG003|Core Study|Subject withdrew consent|1
6961867|NCT01090310|11007306|FG000|Core Study|Abnormal test procedure result|0
6961868|NCT01090310|11007307|FG001|Core Study|Abnormal test procedure result|0
7072599|NCT02037984|11176748|FG002|Overall Study|Withdrawal by Subject|0
7072600|NCT02037984|11176749|FG003|Overall Study|Withdrawal by Subject|1
7072601|NCT02037984|11176750|FG004|Overall Study|Withdrawal by Subject|1
6961869|NCT01090310|11007308|FG002|Core Study|Abnormal test procedure result|1
6961870|NCT01090310|11007309|FG003|Core Study|Abnormal test procedure result|0
6961871|NCT01090310|11007306|FG000|Core Study|Administrative reasons|5
6961872|NCT01090310|11007307|FG001|Core Study|Administrative reasons|6
6961873|NCT01090310|11007308|FG002|Core Study|Administrative reasons|4
6961874|NCT01090310|11007309|FG003|Core Study|Administrative reasons|4
6961875|NCT01090310|11007306|FG000|Core Study|Protocol deviation|1
6961876|NCT01090310|11007307|FG001|Core Study|Protocol deviation|0
6961877|NCT01090310|11007308|FG002|Core Study|Protocol deviation|0
6961878|NCT01090310|11007309|FG003|Core Study|Protocol deviation|1
6961879|NCT01090310|11007306|FG000|Extension Study|Aministrative problems|13
6961880|NCT01090310|11007307|FG001|Extension Study|Aministrative problems|15
6961881|NCT01090310|11007308|FG002|Extension Study|Aministrative problems|14
6961882|NCT01090310|11007309|FG003|Extension Study|Aministrative problems|18
6961883|NCT01090310|11007306|FG000|Extension Study|Adverse Event|0
6961884|NCT01090310|11007307|FG001|Extension Study|Adverse Event|0
6961885|NCT01090310|11007308|FG002|Extension Study|Adverse Event|0
6961886|NCT01090310|11007309|FG003|Extension Study|Adverse Event|1
6961887|NCT01090310|11007306|FG000|Extension Study|Unsatisfactory therapeutic effect|1
6961888|NCT01090310|11007307|FG001|Extension Study|Unsatisfactory therapeutic effect|0
6961889|NCT01090310|11007308|FG002|Extension Study|Unsatisfactory therapeutic effect|1
6961890|NCT01090310|11007309|FG003|Extension Study|Unsatisfactory therapeutic effect|1
6961891|NCT01090310|11007306|FG000|Extension Study|Subject withdrew consent|0
6961892|NCT01090310|11007307|FG001|Extension Study|Subject withdrew consent|1
6961893|NCT01090310|11007308|FG002|Extension Study|Subject withdrew consent|0
6961894|NCT01090310|11007309|FG003|Extension Study|Subject withdrew consent|0
6961895|NCT01090323|11007321|FG000|Overall Study|Adverse Event|12
6961896|NCT01090323|11007322|FG001|Overall Study|Adverse Event|2
6961897|NCT01090323|11007321|FG000|Overall Study|Abnormal Lab Values|3
6961898|NCT01090323|11007322|FG001|Overall Study|Abnormal Lab Values|1
6961899|NCT01090323|11007321|FG000|Overall Study|Abnormal Test Procedure Results|2
6961900|NCT01090323|11007322|FG001|Overall Study|Abnormal Test Procedure Results|0
6961901|NCT01090323|11007321|FG000|Overall Study|Unsatisfactory therapeutic effect|4
6961902|NCT01090323|11007322|FG001|Overall Study|Unsatisfactory therapeutic effect|2
6961903|NCT01090323|11007321|FG000|Overall Study|Condition no longer requires drug|5
6961904|NCT01090323|11007322|FG001|Overall Study|Condition no longer requires drug|4
6961905|NCT01090323|11007321|FG000|Overall Study|Protocol Violation|2
6961906|NCT01090323|11007322|FG001|Overall Study|Protocol Violation|1
6961907|NCT01090323|11007321|FG000|Overall Study|Withdrew consent|33
6961908|NCT01090323|11007322|FG001|Overall Study|Withdrew consent|11
6961909|NCT01090323|11007321|FG000|Overall Study|Lost to Follow-up|11
6961910|NCT01090323|11007322|FG001|Overall Study|Lost to Follow-up|6
6961911|NCT01090323|11007321|FG000|Overall Study|Administrative problems|6
6961912|NCT01090323|11007322|FG001|Overall Study|Administrative problems|4
6961913|NCT01090323|11007321|FG000|Overall Study|Death|1
6961914|NCT01090323|11007322|FG001|Overall Study|Death|2
6961915|NCT01090323|11007321|FG000|Overall Study|Stopped end of core|7
6961916|NCT01090323|11007322|FG001|Overall Study|Stopped end of core|0
6961917|NCT01090323|11007321|FG000|Overall Study|Stopped end of extension 1#|3
6961918|NCT01090323|11007322|FG001|Overall Study|Stopped end of extension 1#|1
6961919|NCT01090414|11007332|FG000|Study 101-99|Progressive Disease|28
6961920|NCT01090414|11007333|FG001|Study 101-99|Progressive Disease|48
6961921|NCT01090414|11007334|FG002|Study 101-99|Progressive Disease|10
6961922|NCT01090414|11007335|FG003|Study 101-99|Progressive Disease|4
6961923|NCT01090414|11007332|FG000|Study 101-99|Adverse Event|10
6961924|NCT01090414|11007333|FG001|Study 101-99|Adverse Event|28
6961925|NCT01090414|11007334|FG002|Study 101-99|Adverse Event|18
6961926|NCT01090414|11007335|FG003|Study 101-99|Adverse Event|0
6961927|NCT01090414|11007332|FG000|Study 101-99|Investigator Request|1
6961928|NCT01090414|11007333|FG001|Study 101-99|Investigator Request|11
6961929|NCT01090414|11007334|FG002|Study 101-99|Investigator Request|4
6961930|NCT01090414|11007335|FG003|Study 101-99|Investigator Request|0
6961931|NCT01090414|11007332|FG000|Study 101-99|Death|3
6961932|NCT01090414|11007333|FG001|Study 101-99|Death|8
6961933|NCT01090414|11007334|FG002|Study 101-99|Death|1
6961934|NCT01090414|11007335|FG003|Study 101-99|Death|0
6961935|NCT01090414|11007332|FG000|Study 101-99|Sponsor Discontinued Study|0
6961936|NCT01090414|11007333|FG001|Study 101-99|Sponsor Discontinued Study|7
6961937|NCT01090414|11007334|FG002|Study 101-99|Sponsor Discontinued Study|5
6961938|NCT01090414|11007335|FG003|Study 101-99|Sponsor Discontinued Study|0
6961939|NCT01090414|11007332|FG000|Study 101-99|Other (Unknown Reasons)|3
6961940|NCT01090414|11007333|FG001|Study 101-99|Other (Unknown Reasons)|3
6961941|NCT01090414|11007334|FG002|Study 101-99|Other (Unknown Reasons)|0
6961942|NCT01090414|11007335|FG003|Study 101-99|Other (Unknown Reasons)|0
6961943|NCT01090414|11007332|FG000|Study 101-99|Withdrew Consent|0
6961944|NCT01090414|11007333|FG001|Study 101-99|Withdrew Consent|2
6961945|NCT01090414|11007334|FG002|Study 101-99|Withdrew Consent|3
6961946|NCT01090414|11007335|FG003|Study 101-99|Withdrew Consent|1
6961947|NCT01090414|11007332|FG000|Study 101-99|Participant Request|3
6961948|NCT01090414|11007333|FG001|Study 101-99|Participant Request|1
7072602|NCT02037984|11176751|FG005|Overall Study|Withdrawal by Subject|3
7072603|NCT02037984|11176752|FG006|Overall Study|Withdrawal by Subject|0
7072604|NCT02037984|11176753|FG007|Overall Study|Withdrawal by Subject|1
7072605|NCT02038010|11176781|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0
7072606|NCT02038010|11176782|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1
7072607|NCT02038010|11176783|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0
7072608|NCT02038010|11176784|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0
7072609|NCT02038010|11176781|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1
7072610|NCT02038010|11176782|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0
7072611|NCT02038010|11176783|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0
7072612|NCT02038010|11176784|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0
7072613|NCT02038010|11176781|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0
7072614|NCT02038010|11176782|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1
7072615|NCT02038010|11176783|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0
7072616|NCT02038010|11176784|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0
7072617|NCT02038010|11176781|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1
6838542|NCT00261443|10844331|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33
6961949|NCT01090414|11007334|FG002|Study 101-99|Participant Request|0
6961950|NCT01090414|11007335|FG003|Study 101-99|Participant Request|0
6961951|NCT01090427|11007360|FG000|After Controlled Period|Death|0
6961952|NCT01090427|11007361|FG001|After Controlled Period|Death|0
6961953|NCT01090427|11007362|FG002|After Controlled Period|Death|0
6961954|NCT01090427|11007363|FG003|After Controlled Period|Death|0
6961955|NCT01090427|11007364|FG004|After Controlled Period|Death|0
6961956|NCT01090427|11007365|FG005|After Controlled Period|Death|1
6961957|NCT01090427|11007366|FG006|After Controlled Period|Death|0
6961958|NCT01090427|11007360|FG000|After Controlled Period|Lack of Efficacy|0
6961959|NCT01090427|11007361|FG001|After Controlled Period|Lack of Efficacy|0
6961960|NCT01090427|11007362|FG002|After Controlled Period|Lack of Efficacy|0
6961961|NCT01090427|11007363|FG003|After Controlled Period|Lack of Efficacy|0
6961962|NCT01090427|11007364|FG004|After Controlled Period|Lack of Efficacy|0
6961963|NCT01090427|11007365|FG005|After Controlled Period|Lack of Efficacy|3
6961964|NCT01090427|11007366|FG006|After Controlled Period|Lack of Efficacy|2
6961965|NCT01090427|11007360|FG000|After Controlled Period|Adverse Event|0
6961966|NCT01090427|11007361|FG001|After Controlled Period|Adverse Event|0
6961967|NCT01090427|11007362|FG002|After Controlled Period|Adverse Event|0
6961968|NCT01090427|11007363|FG003|After Controlled Period|Adverse Event|2
6961969|NCT01090427|11007364|FG004|After Controlled Period|Adverse Event|0
6961970|NCT01090427|11007365|FG005|After Controlled Period|Adverse Event|1
6961971|NCT01090427|11007366|FG006|After Controlled Period|Adverse Event|0
6961972|NCT01090453|11007380|FG000|Overall Study|Withdrawal by Subject|1
6961973|NCT01090453|11007381|FG001|Overall Study|Withdrawal by Subject|2
6961974|NCT01090453|11007380|FG000|Overall Study|Lost to Follow-up|7
7072618|NCT02038010|11176782|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1
7072619|NCT02038010|11176783|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0
6838543|NCT00261443|10844332|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0
6838544|NCT00261443|10844333|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0
6838545|NCT00261443|10844331|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93
6838546|NCT00261443|10844332|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
6838547|NCT00261443|10844333|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
6838548|NCT00261443|10844331|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111
6838549|NCT00261443|10844332|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
6961975|NCT01090453|11007381|FG001|Overall Study|Lost to Follow-up|7
6961976|NCT01090453|11007380|FG000|Overall Study|Non serious AEs|1
6961977|NCT01090453|11007381|FG001|Overall Study|Non serious AEs|0
6961978|NCT01090453|11007380|FG000|Overall Study|Protocol Violation|2
6961979|NCT01090453|11007381|FG001|Overall Study|Protocol Violation|0
6961980|NCT01090453|11007380|FG000|Overall Study|Other|2
6961981|NCT01090453|11007381|FG001|Overall Study|Other|4
6961982|NCT01090453|11007380|FG000|Overall Study|Eligibility Criteria|0
6961983|NCT01090453|11007381|FG001|Overall Study|Eligibility Criteria|1
6961984|NCT01090492|11007404|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1
6961985|NCT01090492|11007405|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1
6961986|NCT01090492|11007406|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1
6961987|NCT01090492|11007407|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2
6961988|NCT01090492|11007408|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0
6961989|NCT01090492|11007409|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0
6961990|NCT01090492|11007410|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1
6961991|NCT01090492|11007411|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0
6961992|NCT01090492|11007404|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
6961993|NCT01090492|11007405|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2
6961994|NCT01090492|11007406|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
6961995|NCT01090492|11007407|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
6961996|NCT01090492|11007408|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
6961997|NCT01090492|11007409|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
6961998|NCT01090492|11007410|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
6961999|NCT01090492|11007411|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1
6962000|NCT01090492|11007404|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0
6962001|NCT01090492|11007405|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0
6962002|NCT01090492|11007406|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1
6962003|NCT01090492|11007407|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0
6962004|NCT01090492|11007408|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0
6962005|NCT01090492|11007409|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0
6962006|NCT01090492|11007410|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0
6962007|NCT01090492|11007411|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0
6962008|NCT01090492|11007404|FG000|First Intervention Period (4 Weeks)|Other|0
6962009|NCT01090492|11007405|FG001|First Intervention Period (4 Weeks)|Other|0
6962010|NCT01090492|11007406|FG002|First Intervention Period (4 Weeks)|Other|1
6962011|NCT01090492|11007407|FG003|First Intervention Period (4 Weeks)|Other|1
6962012|NCT01090492|11007408|FG004|First Intervention Period (4 Weeks)|Other|2
6962013|NCT01090492|11007409|FG005|First Intervention Period (4 Weeks)|Other|0
6962014|NCT01090492|11007410|FG006|First Intervention Period (4 Weeks)|Other|0
6962015|NCT01090492|11007411|FG007|First Intervention Period (4 Weeks)|Other|0
6962016|NCT01090492|11007404|FG000|First Intervention Period (4 Weeks)|Pregnancy|0
6962017|NCT01090492|11007405|FG001|First Intervention Period (4 Weeks)|Pregnancy|0
6962018|NCT01090492|11007406|FG002|First Intervention Period (4 Weeks)|Pregnancy|0
6962019|NCT01090492|11007407|FG003|First Intervention Period (4 Weeks)|Pregnancy|0
6962020|NCT01090492|11007408|FG004|First Intervention Period (4 Weeks)|Pregnancy|1
6962021|NCT01090492|11007409|FG005|First Intervention Period (4 Weeks)|Pregnancy|0
6962022|NCT01090492|11007410|FG006|First Intervention Period (4 Weeks)|Pregnancy|0
6962023|NCT01090492|11007411|FG007|First Intervention Period (4 Weeks)|Pregnancy|0
6962024|NCT01090492|11007404|FG000|First Intervention Period (4 Weeks)|Adverse Event|0
6962025|NCT01090492|11007405|FG001|First Intervention Period (4 Weeks)|Adverse Event|2
6962026|NCT01090492|11007406|FG002|First Intervention Period (4 Weeks)|Adverse Event|0
6962027|NCT01090492|11007407|FG003|First Intervention Period (4 Weeks)|Adverse Event|3
6962028|NCT01090492|11007408|FG004|First Intervention Period (4 Weeks)|Adverse Event|1
6962029|NCT01090492|11007409|FG005|First Intervention Period (4 Weeks)|Adverse Event|2
6962030|NCT01090492|11007410|FG006|First Intervention Period (4 Weeks)|Adverse Event|0
6962031|NCT01090492|11007411|FG007|First Intervention Period (4 Weeks)|Adverse Event|5
6962032|NCT01090492|11007404|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1
6962033|NCT01090492|11007405|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0
6962034|NCT01090492|11007406|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0
6962035|NCT01090492|11007407|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0
6962036|NCT01090492|11007408|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1
6962037|NCT01090492|11007409|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0
6962038|NCT01090492|11007410|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1
6962039|NCT01090492|11007411|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1
6962040|NCT01090492|11007404|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0
6962041|NCT01090492|11007405|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1
6962042|NCT01090492|11007406|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0
6962043|NCT01090492|11007407|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0
6962044|NCT01090492|11007408|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0
6962045|NCT01090492|11007409|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0
6962046|NCT01090492|11007410|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0
6962047|NCT01090492|11007411|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0
6962048|NCT01090492|11007404|FG000|Second Intervention Period (4 Weeks)|Other|0
6962049|NCT01090492|11007405|FG001|Second Intervention Period (4 Weeks)|Other|1
6962050|NCT01090492|11007406|FG002|Second Intervention Period (4 Weeks)|Other|1
6962051|NCT01090492|11007407|FG003|Second Intervention Period (4 Weeks)|Other|0
6962052|NCT01090492|11007408|FG004|Second Intervention Period (4 Weeks)|Other|0
6962053|NCT01090492|11007409|FG005|Second Intervention Period (4 Weeks)|Other|0
6962054|NCT01090492|11007410|FG006|Second Intervention Period (4 Weeks)|Other|0
6962055|NCT01090492|11007411|FG007|Second Intervention Period (4 Weeks)|Other|0
6962056|NCT01090492|11007404|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0
6962057|NCT01090492|11007405|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0
6962058|NCT01090492|11007406|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1
6962059|NCT01090492|11007407|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0
6962060|NCT01090492|11007408|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1
6962061|NCT01090492|11007409|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1
6962062|NCT01090492|11007410|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7
6962063|NCT01090492|11007411|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1
6962064|NCT01090492|11007404|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
6962065|NCT01090492|11007405|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
6962066|NCT01090492|11007406|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
6962067|NCT01090492|11007407|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
6962068|NCT01090492|11007408|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
6962069|NCT01090492|11007409|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
6962070|NCT01090492|11007410|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1
6962071|NCT01090492|11007411|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
6962072|NCT01090739|11007430|FG000|Enrollment|Withdrawal by Subject|24
6962073|NCT01090739|11007430|FG000|Enrollment|Protocol Violation|14
6962074|NCT01090739|11007430|FG000|Enrollment|Lost to Follow-up|5
6962075|NCT01090739|11007430|FG000|Enrollment|Physician Decision|5
6962076|NCT01090739|11007430|FG000|Enrollment|Sponsor termination of site|4
6962077|NCT01090739|11007430|FG000|Enrollment|Study implant limit reached|2
6962078|NCT01090739|11007430|FG000|Enrollment|Adverse Event|1
6962079|NCT01090739|11007430|FG000|12 Month Follow-up|Withdrawal by Subject|2
6962080|NCT01090739|11007430|FG000|12 Month Follow-up|Lost to Follow-up|1
6962081|NCT01090739|11007430|FG000|12 Month Follow-up|Physician Decision|1
6962082|NCT01090739|11007430|FG000|12 Month Follow-up|Death|1
6962083|NCT01090739|11007430|FG000|24 Month Follow-up|Withdrawal by Subject|7
6962084|NCT01090739|11007430|FG000|24 Month Follow-up|Lost to Follow-up|1
6962085|NCT01090739|11007430|FG000|24 Month Follow-up|Death|1
6962086|NCT01090739|11007430|FG000|36 Month Follow-up|Withdrawal by Subject|6
6962087|NCT01090739|11007430|FG000|36 Month Follow-up|Visit still pending|17
6962088|NCT01090765|11007450|FG000|Overall Study|Patient withdrew consent|0
6962089|NCT01090765|11007451|FG001|Overall Study|Patient withdrew consent|0
6962090|NCT01090765|11007452|FG002|Overall Study|Patient withdrew consent|0
6962091|NCT01090765|11007453|FG003|Overall Study|Patient withdrew consent|0
6962092|NCT01090765|11007454|FG004|Overall Study|Patient withdrew consent|1
6962093|NCT01090765|11007455|FG005|Overall Study|Patient withdrew consent|1
6962094|NCT01090765|11007450|FG000|Overall Study|Developed a DVT, needed anticoagulation|0
6962095|NCT01090765|11007451|FG001|Overall Study|Developed a DVT, needed anticoagulation|0
6962096|NCT01090765|11007452|FG002|Overall Study|Developed a DVT, needed anticoagulation|0
6838550|NCT00261443|10844333|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
6838551|NCT00261443|10844331|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23
6838552|NCT00261443|10844332|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
6838553|NCT00261443|10844333|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
6838554|NCT00261443|10844331|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1
6838555|NCT00261443|10844332|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0
6838556|NCT00261443|10844333|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0
6838557|NCT00261443|10844331|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307
6838558|NCT00261443|10844332|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
6838559|NCT00261443|10844333|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
6838560|NCT00261443|10844331|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16
6838561|NCT00261443|10844332|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0
6838562|NCT00261443|10844333|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0
6838563|NCT00261443|10844331|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43
6838564|NCT00261443|10844332|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0
6838565|NCT00261443|10844333|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0
6838566|NCT00261443|10844331|FG000|2: Stability & Maintenance of Stability|Adverse Event|93
6838567|NCT00261443|10844332|FG001|2: Stability & Maintenance of Stability|Adverse Event|0
6838568|NCT00261443|10844333|FG002|2: Stability & Maintenance of Stability|Adverse Event|0
6838569|NCT00261443|10844331|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65
6838570|NCT00261443|10844332|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
6838571|NCT00261443|10844333|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
6838572|NCT00261443|10844331|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59
6838573|NCT00261443|10844332|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0
6838574|NCT00261443|10844333|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0
6838575|NCT00261443|10844331|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33
6838576|NCT00261443|10844332|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
6838577|NCT00261443|10844333|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
6962097|NCT01090765|11007453|FG003|Overall Study|Developed a DVT, needed anticoagulation|1
6962098|NCT01090765|11007454|FG004|Overall Study|Developed a DVT, needed anticoagulation|0
6976617|NCT01200758|11029414|FG003|Stage I|Lack of Efficacy|0
6838578|NCT00261443|10844331|FG000|2: Stability & Maintenance of Stability|Pregnancy|1
6838579|NCT00261443|10844332|FG001|2: Stability & Maintenance of Stability|Pregnancy|0
6962099|NCT01090765|11007455|FG005|Overall Study|Developed a DVT, needed anticoagulation|0
6962100|NCT01090765|11007450|FG000|Overall Study|Vasovagal reaction with first infusion|0
6962101|NCT01090765|11007451|FG001|Overall Study|Vasovagal reaction with first infusion|0
6962102|NCT01090765|11007452|FG002|Overall Study|Vasovagal reaction with first infusion|0
6962103|NCT01090765|11007453|FG003|Overall Study|Vasovagal reaction with first infusion|0
6962104|NCT01090765|11007454|FG004|Overall Study|Vasovagal reaction with first infusion|1
6962105|NCT01090765|11007455|FG005|Overall Study|Vasovagal reaction with first infusion|0
6962106|NCT01090973|11007474|FG000|Overall Study|Disease progression|1
6962107|NCT01091103|11007478|FG000|Overall Study|Adverse Event|1
6962108|NCT01091103|11007478|FG000|Overall Study|Progressive Disease|3
6962109|NCT01091168|11007511|FG000|Overall Study|Progressive disease|250
6962110|NCT01091168|11007512|FG001|Overall Study|Progressive disease|234
6962111|NCT01091168|11007511|FG000|Overall Study|Adverse Event|21
6962112|NCT01091168|11007512|FG001|Overall Study|Adverse Event|24
6962113|NCT01091168|11007511|FG000|Overall Study|Lost to Follow-up|0
6962114|NCT01091168|11007512|FG001|Overall Study|Lost to Follow-up|1
6962115|NCT01091168|11007511|FG000|Overall Study|Physician, patient's decision, other|27
6962116|NCT01091168|11007512|FG001|Overall Study|Physician, patient's decision, other|37
6962117|NCT01091246|11007521|FG000|Overall Study|Lost to Follow-up|23
6962118|NCT01091246|11007522|FG001|Overall Study|Lost to Follow-up|11
6962119|NCT01091246|11007523|FG002|Overall Study|Lost to Follow-up|7
6962120|NCT01091246|11007521|FG000|Overall Study|Adverse Event|1
6962121|NCT01091246|11007522|FG001|Overall Study|Adverse Event|0
6962122|NCT01091246|11007523|FG002|Overall Study|Adverse Event|1
6962123|NCT01091246|11007521|FG000|Overall Study|Withdrawal by Subject|9
6962124|NCT01091246|11007522|FG001|Overall Study|Withdrawal by Subject|5
6962125|NCT01091246|11007523|FG002|Overall Study|Withdrawal by Subject|4
6962126|NCT01091246|11007521|FG000|Overall Study|Subject not dosed|2
6962127|NCT01091246|11007522|FG001|Overall Study|Subject not dosed|0
6962128|NCT01091246|11007523|FG002|Overall Study|Subject not dosed|1
6962129|NCT01091259|11007533|FG000|Overall Study|Adverse Event|3
6962130|NCT01091259|11007533|FG000|Overall Study|Lack of Efficacy|2
6962131|NCT01091363|11007539|FG000|Overall Study|Withdrawal by Subject|11
6962132|NCT01091363|11007540|FG001|Overall Study|Withdrawal by Subject|15
6962133|NCT01091363|11007539|FG000|Overall Study|Lost to Follow-up|2
6962134|NCT01091363|11007540|FG001|Overall Study|Lost to Follow-up|2
6962135|NCT01091428|11007550|FG000|Phase 1|Progressive Disease|24
6962136|NCT01091428|11007551|FG001|Phase 1|Progressive Disease|8
6962137|NCT01091428|11007552|FG002|Phase 1|Progressive Disease|0
6962138|NCT01091428|11007553|FG003|Phase 1|Progressive Disease|0
6962139|NCT01091428|11007550|FG000|Phase 1|Symptomatic Deterioration|3
6962140|NCT01091428|11007551|FG001|Phase 1|Symptomatic Deterioration|2
6962141|NCT01091428|11007552|FG002|Phase 1|Symptomatic Deterioration|0
6962142|NCT01091428|11007553|FG003|Phase 1|Symptomatic Deterioration|0
6962143|NCT01091428|11007550|FG000|Phase 1|Adverse Event|2
6962144|NCT01091428|11007551|FG001|Phase 1|Adverse Event|0
6962145|NCT01091428|11007552|FG002|Phase 1|Adverse Event|0
6962146|NCT01091428|11007553|FG003|Phase 1|Adverse Event|0
6962147|NCT01091428|11007550|FG000|Phase 1|Withdrawal by Subject|7
6962148|NCT01091428|11007551|FG001|Phase 1|Withdrawal by Subject|0
6962149|NCT01091428|11007552|FG002|Phase 1|Withdrawal by Subject|0
6962150|NCT01091428|11007553|FG003|Phase 1|Withdrawal by Subject|0
6962151|NCT01091428|11007550|FG000|Phase 1|Reason not specified|0
6962152|NCT01091428|11007551|FG001|Phase 1|Reason not specified|1
6962153|NCT01091428|11007552|FG002|Phase 1|Reason not specified|0
6962154|NCT01091428|11007553|FG003|Phase 1|Reason not specified|0
6962155|NCT01091428|11007550|FG000|Phase 1|Single-Patient IND|2
6962156|NCT01091428|11007551|FG001|Phase 1|Single-Patient IND|0
6962157|NCT01091428|11007552|FG002|Phase 1|Single-Patient IND|0
6962158|NCT01091428|11007553|FG003|Phase 1|Single-Patient IND|0
6962159|NCT01091428|11007550|FG000|Phase 2|Progressive Disease|0
6962160|NCT01091428|11007551|FG001|Phase 2|Progressive Disease|0
6962161|NCT01091428|11007552|FG002|Phase 2|Progressive Disease|44
6962162|NCT01091428|11007553|FG003|Phase 2|Progressive Disease|46
6962163|NCT01091428|11007550|FG000|Phase 2|Symptomatic Deterioration|0
6962164|NCT01091428|11007551|FG001|Phase 2|Symptomatic Deterioration|0
6962165|NCT01091428|11007552|FG002|Phase 2|Symptomatic Deterioration|1
6962166|NCT01091428|11007553|FG003|Phase 2|Symptomatic Deterioration|6
6962167|NCT01091428|11007550|FG000|Phase 2|Adverse Event|0
6962168|NCT01091428|11007551|FG001|Phase 2|Adverse Event|0
6962169|NCT01091428|11007552|FG002|Phase 2|Adverse Event|12
6962170|NCT01091428|11007553|FG003|Phase 2|Adverse Event|5
6962171|NCT01091428|11007550|FG000|Phase 2|Withdrawal by Subject|0
6962172|NCT01091428|11007551|FG001|Phase 2|Withdrawal by Subject|0
6962173|NCT01091428|11007552|FG002|Phase 2|Withdrawal by Subject|9
6962174|NCT01091428|11007553|FG003|Phase 2|Withdrawal by Subject|8
6962175|NCT01091428|11007550|FG000|Phase 2|Unsatisfactory Therapeutic Response|0
6962176|NCT01091428|11007551|FG001|Phase 2|Unsatisfactory Therapeutic Response|0
6962177|NCT01091428|11007552|FG002|Phase 2|Unsatisfactory Therapeutic Response|1
6838580|NCT00261443|10844333|FG002|2: Stability & Maintenance of Stability|Pregnancy|0
6962178|NCT01091428|11007553|FG003|Phase 2|Unsatisfactory Therapeutic Response|1
6962179|NCT01091428|11007550|FG000|Phase 2|Reason not specified|0
6962180|NCT01091428|11007551|FG001|Phase 2|Reason not specified|0
6962181|NCT01091428|11007552|FG002|Phase 2|Reason not specified|4
6962182|NCT01091428|11007553|FG003|Phase 2|Reason not specified|3
6962183|NCT01091428|11007550|FG000|Phase 2|Physician Decision|0
6962184|NCT01091428|11007551|FG001|Phase 2|Physician Decision|0
6962185|NCT01091428|11007552|FG002|Phase 2|Physician Decision|2
6962186|NCT01091428|11007553|FG003|Phase 2|Physician Decision|0
6962187|NCT01091454|11007572|FG000|Overall Study|Ineligible|1
6962188|NCT01091519|11007578|FG000|Overall Study|Adverse Event|12
6962189|NCT01091519|11007579|FG001|Overall Study|Adverse Event|16
6962190|NCT01091519|11007578|FG000|Overall Study|Death|1
6962191|NCT01091519|11007579|FG001|Overall Study|Death|0
6962192|NCT01091519|11007578|FG000|Overall Study|Lack of Efficacy|16
6962193|NCT01091519|11007579|FG001|Overall Study|Lack of Efficacy|19
6962194|NCT01091519|11007578|FG000|Overall Study|Lost to Follow-up|14
6962195|NCT01091519|11007579|FG001|Overall Study|Lost to Follow-up|24
6962196|NCT01091519|11007578|FG000|Overall Study|Withdrawal by Subject|2
6962197|NCT01091519|11007579|FG001|Overall Study|Withdrawal by Subject|2
6962198|NCT01091519|11007578|FG000|Overall Study|Other|6
6962199|NCT01091519|11007579|FG001|Overall Study|Other|8
6962200|NCT01091519|11007578|FG000|Overall Study|Randomized not treated|4
6962201|NCT01091519|11007579|FG001|Overall Study|Randomized not treated|4
6962202|NCT01091662|11007587|FG000|Overall Study|Adverse Event|1
6962203|NCT01091662|11007588|FG001|Overall Study|Adverse Event|9
6962204|NCT01091662|11007587|FG000|Overall Study|Physician Decision|1
6962205|NCT01091662|11007588|FG001|Overall Study|Physician Decision|1
6962206|NCT01091662|11007587|FG000|Overall Study|Withdrawal by Subject|7
6962207|NCT01091662|11007588|FG001|Overall Study|Withdrawal by Subject|6
6962208|NCT01091662|11007587|FG000|Overall Study|met exit criteria|7
6962209|NCT01091662|11007588|FG001|Overall Study|met exit criteria|13
6962210|NCT01091662|11007587|FG000|Overall Study|met exclusion criteria|1
6962211|NCT01091662|11007588|FG001|Overall Study|met exclusion criteria|0
6962212|NCT01091662|11007587|FG000|Overall Study|Lost to Follow-up|0
6962213|NCT01091662|11007588|FG001|Overall Study|Lost to Follow-up|1
6962214|NCT01091662|11007587|FG000|Overall Study|Pregnancy|0
6962215|NCT01091662|11007588|FG001|Overall Study|Pregnancy|1
7072620|NCT02038010|11176784|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0
7072621|NCT02038010|11176781|FG000|Follow Up|Death|4
7072622|NCT02038010|11176782|FG001|Follow Up|Death|3
7072623|NCT02038010|11176783|FG002|Follow Up|Death|0
7072624|NCT02038010|11176784|FG003|Follow Up|Death|0
7072625|NCT02038010|11176781|FG000|Follow Up|Other|3
6962216|NCT01091662|11007587|FG000|Overall Study|Protocol Violation|0
6962217|NCT01091662|11007588|FG001|Overall Study|Protocol Violation|2
6962218|NCT01091662|11007587|FG000|Overall Study|unable to swallow capsule|0
6962219|NCT01091662|11007588|FG001|Overall Study|unable to swallow capsule|1
6962220|NCT01091675|11007599|FG000|Overall Study|Adverse Event|7
6962221|NCT01091675|11007599|FG000|Overall Study|Lack of Efficacy|27
6962222|NCT01091974|11007617|FG000|Overall Study|Did not start intervention|3
6962223|NCT01091974|11007618|FG001|Overall Study|Did not start intervention|1
6962224|NCT01091974|11007619|FG002|Overall Study|Did not start intervention|3
6962225|NCT01091974|11007620|FG003|Overall Study|Did not start intervention|1
6962226|NCT01091974|11007617|FG000|Overall Study|resumed sleep medication|0
6962227|NCT01091974|11007618|FG001|Overall Study|resumed sleep medication|0
6962228|NCT01091974|11007619|FG002|Overall Study|resumed sleep medication|1
6962229|NCT01091974|11007620|FG003|Overall Study|resumed sleep medication|2
6962230|NCT01091974|11007617|FG000|Overall Study|Withdrawal by Subject|1
6962231|NCT01091974|11007618|FG001|Overall Study|Withdrawal by Subject|3
6962232|NCT01091974|11007619|FG002|Overall Study|Withdrawal by Subject|2
6962233|NCT01091974|11007620|FG003|Overall Study|Withdrawal by Subject|2
6962234|NCT01091974|11007617|FG000|Overall Study|side-effects|1
6962235|NCT01091974|11007618|FG001|Overall Study|side-effects|1
6962236|NCT01091974|11007619|FG002|Overall Study|side-effects|0
6962237|NCT01091974|11007620|FG003|Overall Study|side-effects|2
6962238|NCT01092182|11007633|FG000|Overall Study|Death|0
6962239|NCT01092182|11007634|FG001|Overall Study|Death|5
6962240|NCT01092182|11007635|FG002|Overall Study|Death|3
6962241|NCT01092182|11007633|FG000|Overall Study|participant safety|1
6962242|NCT01092182|11007634|FG001|Overall Study|participant safety|2
6962243|NCT01092182|11007635|FG002|Overall Study|participant safety|0
6962244|NCT01092182|11007633|FG000|Overall Study|Physician Decision|0
6962245|NCT01092182|11007634|FG001|Overall Study|Physician Decision|6
6962246|NCT01092182|11007635|FG002|Overall Study|Physician Decision|0
6962247|NCT01092182|11007633|FG000|Overall Study|Did not meet criteria|0
6962248|NCT01092182|11007634|FG001|Overall Study|Did not meet criteria|0
6962249|NCT01092182|11007635|FG002|Overall Study|Did not meet criteria|25
6962250|NCT01092182|11007633|FG000|Overall Study|Non-compliance|0
6962251|NCT01092182|11007634|FG001|Overall Study|Non-compliance|3
7072626|NCT02038010|11176782|FG001|Follow Up|Other|0
6962252|NCT01092182|11007635|FG002|Overall Study|Non-compliance|0
6962253|NCT01092182|11007633|FG000|Overall Study|Participant refused follow-up|0
6962254|NCT01092182|11007634|FG001|Overall Study|Participant refused follow-up|2
6962255|NCT01092182|11007635|FG002|Overall Study|Participant refused follow-up|0
6962256|NCT01092416|11007678|FG000|Enrollment|Atherectomy device not inserted|3
6962257|NCT01092416|11007678|FG000|30-Day Follow-up|Death|2
6962258|NCT01092416|11007678|FG000|30-Day Follow-up|Missed 30-day follow-up|3
6962259|NCT01092416|11007678|FG000|30-Day Follow-up|Data collected after close of 30D window|5
7072627|NCT02038010|11176783|FG002|Follow Up|Other|0
6962260|NCT01092416|11007678|FG000|12-Month Follow-up|Death|16
6962261|NCT01092416|11007678|FG000|12-Month Follow-up|Lost to Follow-up|4
6962262|NCT01092416|11007678|FG000|12-Month Follow-up|Withdrawal by Subject|2
6962263|NCT01092416|11007678|FG000|12-Month Follow-up|Missed 1-year follow-up|1
6962264|NCT01092416|11007678|FG000|12-Month Follow-up|Data collected after close of 1Y window|2
6962265|NCT01092507|11007701|FG000|Overall Study|Withdrawal by Subject|2
6962266|NCT01092507|11007702|FG001|Overall Study|Withdrawal by Subject|0
6962267|NCT01092546|11007708|FG000|Overall Study|Subjects withdrawn prior to dosing|4
6962268|NCT01092637|11007718|FG000|Overall Study|Death|47
6962269|NCT01092637|11007719|FG001|Overall Study|Death|49
6962270|NCT01092663|11007728|FG000|Overall Study|Withdrawal by Subject|3
6962271|NCT01092663|11007729|FG001|Overall Study|Withdrawal by Subject|2
6962272|NCT01092663|11007728|FG000|Overall Study|Glucose >300mg/dL|1
6962273|NCT01092663|11007729|FG001|Overall Study|Glucose >300mg/dL|0
6962274|NCT01092663|11007728|FG000|Overall Study|High fasting triglyceride|2
6962275|NCT01092663|11007729|FG001|Overall Study|High fasting triglyceride|0
6962276|NCT01092663|11007728|FG000|Overall Study|Adverse Event|1
6962277|NCT01092663|11007729|FG001|Overall Study|Adverse Event|1
6962278|NCT01092663|11007728|FG000|Overall Study|Protocol Violation|0
6962279|NCT01092663|11007729|FG001|Overall Study|Protocol Violation|1
6962280|NCT01092702|11007749|FG000|Overall Study|Withdrawal by Subject|7
6962281|NCT01092702|11007749|FG000|Overall Study|Lost to Follow-up|2
6962282|NCT01092728|11007755|FG000|Overall Study|Withdrawal by Subject|2
6962283|NCT01092728|11007756|FG001|Overall Study|Withdrawal by Subject|0
6962284|NCT01092728|11007755|FG000|Overall Study|Adverse Event|0
6962285|NCT01092728|11007756|FG001|Overall Study|Adverse Event|1
6962286|NCT01092728|11007755|FG000|Overall Study|Disease Progression|1
6962287|NCT01092728|11007756|FG001|Overall Study|Disease Progression|13
6962288|NCT01092728|11007755|FG000|Overall Study|Prohibited Concomitant Medications|1
6962289|NCT01092728|11007756|FG001|Overall Study|Prohibited Concomitant Medications|0
6962290|NCT01092780|11007766|FG000|Washout Period 1|Adverse Event|0
6962291|NCT01092780|11007767|FG001|Washout Period 1|Adverse Event|1
6962292|NCT01092780|11007768|FG002|Washout Period 1|Adverse Event|0
6962293|NCT01092780|11007769|FG003|Washout Period 1|Adverse Event|0
6962294|NCT01092780|11007766|FG000|Washout Period 1|Noncompliance with nCPAP|1
6962295|NCT01092780|11007767|FG001|Washout Period 1|Noncompliance with nCPAP|0
6962296|NCT01092780|11007768|FG002|Washout Period 1|Noncompliance with nCPAP|0
6962297|NCT01092780|11007769|FG003|Washout Period 1|Noncompliance with nCPAP|0
6962298|NCT01092780|11007766|FG000|Washout Period 2|Adverse Event|0
6962299|NCT01092780|11007767|FG001|Washout Period 2|Adverse Event|1
6962300|NCT01092780|11007768|FG002|Washout Period 2|Adverse Event|1
6962301|NCT01092780|11007769|FG003|Washout Period 2|Adverse Event|0
6962302|NCT01092832|11007781|FG000|Overall Study|Other|1
6962303|NCT01092832|11007782|FG001|Overall Study|Other|0
6962304|NCT01093222|11007833|FG000|Overall Study|Ineligible|6
6962305|NCT01093222|11007833|FG000|Overall Study|Adverse Event|7
6962306|NCT01093222|11007833|FG000|Overall Study|Progression/relapse|24
6962307|NCT01093222|11007833|FG000|Overall Study|Death|2
6962308|NCT01093222|11007833|FG000|Overall Study|Not protocol specified|1
6962309|NCT01093534|11007872|FG000|Overall Study|Adverse Event|2
6962310|NCT01093534|11007873|FG001|Overall Study|Adverse Event|5
6962311|NCT01093534|11007874|FG002|Overall Study|Adverse Event|2
6962312|NCT01093534|11007872|FG000|Overall Study|Lack of Efficacy|2
6962313|NCT01093534|11007873|FG001|Overall Study|Lack of Efficacy|1
6962314|NCT01093534|11007874|FG002|Overall Study|Lack of Efficacy|1
6962315|NCT01093534|11007872|FG000|Overall Study|Withdrawal by Subject|5
6962316|NCT01093534|11007873|FG001|Overall Study|Withdrawal by Subject|7
6962317|NCT01093534|11007874|FG002|Overall Study|Withdrawal by Subject|2
6962318|NCT01093534|11007872|FG000|Overall Study|Other|1
6962319|NCT01093534|11007873|FG001|Overall Study|Other|3
6962320|NCT01093534|11007874|FG002|Overall Study|Other|4
6962327|NCT01093586|11007899|FG000|Overall Study|Failed to engraft|3
6962328|NCT01093599|11007905|FG000|Overall Study|Lost to Follow-up|32
6962329|NCT01093599|11007906|FG001|Overall Study|Lost to Follow-up|46
7040885|NCT01721057|11124068|FG002|Treatment Period|Death|0
6962330|NCT01093625|11007914|FG000|Baseline and Dispensed|Withdrawal by Subject|2
6962331|NCT01093625|11007915|FG001|Baseline and Dispensed|Withdrawal by Subject|0
6962332|NCT01093625|11007914|FG000|2-Week Visit|Withdrawal by Subject|1
6962333|NCT01093625|11007915|FG001|2-Week Visit|Withdrawal by Subject|0
6962334|NCT01093625|11007914|FG000|1-Month Visit|Lost to Follow-up|2
6962335|NCT01093625|11007915|FG001|1-Month Visit|Lost to Follow-up|0
6962336|NCT01093625|11007914|FG000|3-Month Visit|Lost to Follow-up|2
6962337|NCT01093625|11007915|FG001|3-Month Visit|Lost to Follow-up|0
6962338|NCT01093625|11007914|FG000|6-Month Visit|Withdrawal by Subject|6
6962339|NCT01093625|11007915|FG001|6-Month Visit|Withdrawal by Subject|7
6962340|NCT01093625|11007914|FG000|6-Month Visit|Lost to Follow-up|2
6962341|NCT01093625|11007915|FG001|6-Month Visit|Lost to Follow-up|2
6962342|NCT01093625|11007914|FG000|1-Year Visit|Lost to Follow-up|5
7040886|NCT01721057|11124069|FG003|Treatment Period|Death|0
6962343|NCT01093625|11007915|FG001|1-Year Visit|Lost to Follow-up|3
6962344|NCT01093755|11007941|FG000|Overall Study|Withdrawal by Subject|3
6962345|NCT01093755|11007942|FG001|Overall Study|Withdrawal by Subject|4
6962346|NCT01093885|11007961|FG000|Overall Study|Adverse Event|4
6962347|NCT01093885|11007961|FG000|Overall Study|Lost to Follow-up|1
6962348|NCT01094119|11007981|FG000|Overall Study|Lack of Efficacy|2
6962349|NCT01094119|11007982|FG001|Overall Study|Lack of Efficacy|4
6962350|NCT01094171|11007988|FG000|Overall Study|Lost to Follow-up|2
6962351|NCT01094171|11007988|FG000|Overall Study|Informed consent withdrawal|4
6962352|NCT01094171|11007988|FG000|Overall Study|Migration from the study area|3
6962353|NCT01094171|11007988|FG000|Overall Study|Other|1
6962354|NCT01094184|11007994|FG000|Overall Study|Death|35
6962355|NCT01094184|11007995|FG001|Overall Study|Death|11
6962356|NCT01094288|11008009|FG000|Overall Study|Adverse Event|0
6962357|NCT01094288|11008010|FG001|Overall Study|Adverse Event|3
6962358|NCT01094288|11008011|FG002|Overall Study|Adverse Event|1
6962359|NCT01094288|11008012|FG003|Overall Study|Adverse Event|1
6962360|NCT01094288|11008013|FG004|Overall Study|Adverse Event|0
6962361|NCT01094288|11008014|FG005|Overall Study|Adverse Event|0
6962362|NCT01094288|11008015|FG006|Overall Study|Adverse Event|0
6962363|NCT01094288|11008016|FG007|Overall Study|Adverse Event|0
6962364|NCT01094288|11008009|FG000|Overall Study|Withdrawal by Subject|0
6962365|NCT01094288|11008010|FG001|Overall Study|Withdrawal by Subject|1
6962366|NCT01094288|11008011|FG002|Overall Study|Withdrawal by Subject|2
6962367|NCT01094288|11008012|FG003|Overall Study|Withdrawal by Subject|0
6962368|NCT01094288|11008013|FG004|Overall Study|Withdrawal by Subject|0
6962369|NCT01094288|11008014|FG005|Overall Study|Withdrawal by Subject|0
6962370|NCT01094288|11008015|FG006|Overall Study|Withdrawal by Subject|0
6962371|NCT01094288|11008016|FG007|Overall Study|Withdrawal by Subject|2
6962372|NCT01094288|11008009|FG000|Overall Study|Initiation of Alternative Therapy|0
6962373|NCT01094288|11008010|FG001|Overall Study|Initiation of Alternative Therapy|0
6962374|NCT01094288|11008011|FG002|Overall Study|Initiation of Alternative Therapy|1
6962375|NCT01094288|11008012|FG003|Overall Study|Initiation of Alternative Therapy|0
6962376|NCT01094288|11008013|FG004|Overall Study|Initiation of Alternative Therapy|0
6962377|NCT01094288|11008014|FG005|Overall Study|Initiation of Alternative Therapy|0
6962378|NCT01094288|11008015|FG006|Overall Study|Initiation of Alternative Therapy|0
6962379|NCT01094288|11008016|FG007|Overall Study|Initiation of Alternative Therapy|0
6962380|NCT01094288|11008009|FG000|Overall Study|Reason not Specified|2
6962381|NCT01094288|11008010|FG001|Overall Study|Reason not Specified|3
6962382|NCT01094288|11008011|FG002|Overall Study|Reason not Specified|0
6962383|NCT01094288|11008012|FG003|Overall Study|Reason not Specified|1
6962384|NCT01094288|11008013|FG004|Overall Study|Reason not Specified|0
6962385|NCT01094288|11008014|FG005|Overall Study|Reason not Specified|0
6962386|NCT01094288|11008015|FG006|Overall Study|Reason not Specified|0
6962387|NCT01094288|11008016|FG007|Overall Study|Reason not Specified|0
6962388|NCT01094288|11008009|FG000|Overall Study|Ongoing Participants|0
6962389|NCT01094288|11008010|FG001|Overall Study|Ongoing Participants|3
6962390|NCT01094288|11008011|FG002|Overall Study|Ongoing Participants|0
6962391|NCT01094288|11008012|FG003|Overall Study|Ongoing Participants|0
6962392|NCT01094288|11008013|FG004|Overall Study|Ongoing Participants|0
6962393|NCT01094288|11008014|FG005|Overall Study|Ongoing Participants|0
6962394|NCT01094288|11008015|FG006|Overall Study|Ongoing Participants|0
6962395|NCT01094288|11008016|FG007|Overall Study|Ongoing Participants|0
6962396|NCT01094301|11008038|FG000|Trial Stage|Withdrawal by Subject|1
6962397|NCT01094301|11008038|FG000|Implant Stage|Adverse Event|1
6962398|NCT01094301|11008038|FG000|Implant Stage|Protocol Violation|1
6962399|NCT01094301|11008038|FG000|Implant Stage|Withdrawal by Subject|2
6962400|NCT01094301|11008038|FG000|Implant Stage|No return of pain|4
6962401|NCT01094730|11008115|FG000|Period 1 (14 Days)|Lost to Follow-up|0
6962402|NCT01094730|11008116|FG001|Period 1 (14 Days)|Lost to Follow-up|1
6962403|NCT01094730|11008115|FG000|Period 1 (14 Days)|Withdrawal by Subject|0
6962404|NCT01094730|11008116|FG001|Period 1 (14 Days)|Withdrawal by Subject|1
6962405|NCT01094730|11008115|FG000|Period 1 (14 Days)|No time for the follow-up visit|1
6962406|NCT01094730|11008116|FG001|Period 1 (14 Days)|No time for the follow-up visit|0
6962407|NCT01094730|11008115|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1
6962408|NCT01094730|11008116|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0
6962409|NCT01094730|11008115|FG000|Period 2 (14 Days)|Protocol Violation|2
6962410|NCT01094730|11008116|FG001|Period 2 (14 Days)|Protocol Violation|0
6962411|NCT01094730|11008115|FG000|Period 2 (14 Days)|No time for the follow-up visit|1
6962412|NCT01094730|11008116|FG001|Period 2 (14 Days)|No time for the follow-up visit|0
6962413|NCT01094730|11008115|FG000|Period 2 (14 Days)|Adverse Event|0
6962414|NCT01094730|11008116|FG001|Period 2 (14 Days)|Adverse Event|1
6962415|NCT01094730|11008115|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0
6962416|NCT01094730|11008116|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1
6962417|NCT01094743|11008123|FG000|Period 1|Unsatisfactory comfort at lens fitting|2
6962418|NCT01094808|11008131|FG000|Overall Study|Withdrawal by Subject|1
6962419|NCT01094808|11008132|FG001|Overall Study|Withdrawal by Subject|1
6962420|NCT01094808|11008133|FG002|Overall Study|Withdrawal by Subject|0
6962421|NCT01094886|11008141|FG000|Overall Study|Adverse Event|2
6962422|NCT01094886|11008141|FG000|Overall Study|Withdrawal by Subject|5
6962423|NCT01095094|11008145|FG000|Overall Study|Withdrawal by Subject|1
6962424|NCT01095094|11008145|FG000|Overall Study|Death|1
6962425|NCT01095094|11008145|FG000|Overall Study|Physician Decision|1
6962426|NCT01095653|11008180|FG000|Overall Study|Lack of Efficacy|3
6962427|NCT01095653|11008181|FG001|Overall Study|Lack of Efficacy|0
6962428|NCT01095653|11008182|FG002|Overall Study|Lack of Efficacy|0
6962429|NCT01095653|11008180|FG000|Overall Study|Adverse Event|1
6962430|NCT01095653|11008181|FG001|Overall Study|Adverse Event|4
6962431|NCT01095653|11008182|FG002|Overall Study|Adverse Event|4
6962432|NCT01095653|11008180|FG000|Overall Study|Lost to Follow-up|1
6962433|NCT01095653|11008181|FG001|Overall Study|Lost to Follow-up|0
6962434|NCT01095653|11008182|FG002|Overall Study|Lost to Follow-up|4
6962435|NCT01095653|11008180|FG000|Overall Study|Withdrawal by Subject|4
6962436|NCT01095653|11008181|FG001|Overall Study|Withdrawal by Subject|5
6962437|NCT01095653|11008182|FG002|Overall Study|Withdrawal by Subject|3
6962438|NCT01095653|11008180|FG000|Overall Study|non-compliance, not met criteria, etc.|10
6962439|NCT01095653|11008181|FG001|Overall Study|non-compliance, not met criteria, etc.|6
6962440|NCT01095653|11008182|FG002|Overall Study|non-compliance, not met criteria, etc.|5
6962441|NCT01095666|11008193|FG000|Overall Study|Lack of Efficacy|0
6962442|NCT01095666|11008194|FG001|Overall Study|Lack of Efficacy|0
6962443|NCT01095666|11008195|FG002|Overall Study|Lack of Efficacy|1
6962444|NCT01095666|11008193|FG000|Overall Study|Adverse Event|2
6962445|NCT01095666|11008194|FG001|Overall Study|Adverse Event|1
6962446|NCT01095666|11008195|FG002|Overall Study|Adverse Event|3
6962447|NCT01095666|11008193|FG000|Overall Study|Lost to Follow-up|2
6962448|NCT01095666|11008194|FG001|Overall Study|Lost to Follow-up|2
6962449|NCT01095666|11008195|FG002|Overall Study|Lost to Follow-up|0
6962450|NCT01095666|11008193|FG000|Overall Study|Withdrawal by Subject|6
6962451|NCT01095666|11008194|FG001|Overall Study|Withdrawal by Subject|6
6962452|NCT01095666|11008195|FG002|Overall Study|Withdrawal by Subject|1
6962453|NCT01095666|11008193|FG000|Overall Study|Non-compliance, not met criteria etc.|7
6962454|NCT01095666|11008194|FG001|Overall Study|Non-compliance, not met criteria etc.|2
6962455|NCT01095666|11008195|FG002|Overall Study|Non-compliance, not met criteria etc.|2
6962456|NCT01095796|11008210|FG000|Overall Study|Randomized but Not Treated|5
6962457|NCT01095796|11008211|FG001|Overall Study|Randomized but Not Treated|2
6962458|NCT01095796|11008210|FG000|Overall Study|Adverse Event|9
6962459|NCT01095796|11008211|FG001|Overall Study|Adverse Event|19
6962460|NCT01095796|11008210|FG000|Overall Study|Death|3
6962461|NCT01095796|11008211|FG001|Overall Study|Death|2
6962462|NCT01095796|11008210|FG000|Overall Study|Pregnancy|2
6962463|NCT01095796|11008211|FG001|Overall Study|Pregnancy|0
6962464|NCT01095796|11008210|FG000|Overall Study|Lack of Efficacy|5
6962465|NCT01095796|11008211|FG001|Overall Study|Lack of Efficacy|3
6962466|NCT01095796|11008210|FG000|Overall Study|Investigator's Discretion|7
6962467|NCT01095796|11008211|FG001|Overall Study|Investigator's Discretion|2
6962468|NCT01095796|11008210|FG000|Overall Study|Withdrew Consent|16
6962469|NCT01095796|11008211|FG001|Overall Study|Withdrew Consent|22
6962470|NCT01095796|11008210|FG000|Overall Study|Lost to Follow-up|27
6962471|NCT01095796|11008211|FG001|Overall Study|Lost to Follow-up|29
6962472|NCT01095796|11008210|FG000|Overall Study|Participant Noncompliance|5
6962473|NCT01095796|11008211|FG001|Overall Study|Participant Noncompliance|10
6962474|NCT01095796|11008210|FG000|Overall Study|Protocol Violation|1
6962475|NCT01095796|11008211|FG001|Overall Study|Protocol Violation|0
6962476|NCT01095796|11008210|FG000|Overall Study|Participant Transferred to Another Study|215
6962477|NCT01095796|11008211|FG001|Overall Study|Participant Transferred to Another Study|200
7072628|NCT02038010|11176784|FG003|Follow Up|Other|0
7072629|NCT02038036|11176800|FG000|Core Study|Adverse Event|7
6962478|NCT01095835|11008220|FG000|Overall Study|Adverse Event|8
6962479|NCT01095835|11008221|FG001|Overall Study|Adverse Event|6
6962480|NCT01095835|11008222|FG002|Overall Study|Adverse Event|6
6962481|NCT01095835|11008220|FG000|Overall Study|Lack of Efficacy|0
6962482|NCT01095835|11008221|FG001|Overall Study|Lack of Efficacy|1
6962483|NCT01095835|11008222|FG002|Overall Study|Lack of Efficacy|0
6962484|NCT01095835|11008220|FG000|Overall Study|Physician Decision|0
6962485|NCT01095835|11008221|FG001|Overall Study|Physician Decision|0
6962486|NCT01095835|11008222|FG002|Overall Study|Physician Decision|1
6962487|NCT01095835|11008220|FG000|Overall Study|Withdrawal by Subject|1
6962488|NCT01095835|11008221|FG001|Overall Study|Withdrawal by Subject|3
6962489|NCT01095835|11008222|FG002|Overall Study|Withdrawal by Subject|0
6962490|NCT01095835|11008220|FG000|Overall Study|Non study compliance|0
6962491|NCT01095835|11008221|FG001|Overall Study|Non study compliance|0
6962492|NCT01095835|11008222|FG002|Overall Study|Non study compliance|1
6962493|NCT01095835|11008220|FG000|Overall Study|Protocol Violation|1
6962494|NCT01095835|11008221|FG001|Overall Study|Protocol Violation|2
6962495|NCT01095835|11008222|FG002|Overall Study|Protocol Violation|0
6962496|NCT01095978|11008235|FG000|Overall Study|Did not take Klacid SR|2
6962497|NCT01095978|11008235|FG000|Overall Study|Adverse Event|1
6962498|NCT01096017|11008241|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1
6962499|NCT01096017|11008242|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1
6962500|NCT01096056|11008250|FG000|Overall Study|Lost to Follow-up|0
6962501|NCT01096056|11008251|FG001|Overall Study|Lost to Follow-up|1
6962502|NCT01096160|11008267|FG000|Overall Study|Adverse Event|0
6962503|NCT01096160|11008268|FG001|Overall Study|Adverse Event|0
6962504|NCT01096160|11008269|FG002|Overall Study|Adverse Event|1
6962505|NCT01096160|11008270|FG003|Overall Study|Adverse Event|0
6962506|NCT01096160|11008271|FG004|Overall Study|Adverse Event|0
6962507|NCT01096160|11008272|FG005|Overall Study|Adverse Event|0
7072630|NCT02038036|11176801|FG001|Core Study|Adverse Event|7
6962508|NCT01096160|11008273|FG006|Overall Study|Adverse Event|0
7072631|NCT02038036|11176800|FG000|Core Study|Death|1
7072632|NCT02038036|11176801|FG001|Core Study|Death|1
7072633|NCT02038036|11176800|FG000|Core Study|Disease progression|2
7072634|NCT02038036|11176801|FG001|Core Study|Disease progression|2
7072635|NCT02038036|11176800|FG000|Core Study|Lost to Follow-up|0
7072636|NCT02038036|11176801|FG001|Core Study|Lost to Follow-up|1
6962509|NCT01096160|11008274|FG007|Overall Study|Adverse Event|0
6962510|NCT01096160|11008275|FG008|Overall Study|Adverse Event|0
6962511|NCT01096160|11008276|FG009|Overall Study|Adverse Event|1
6962512|NCT01096160|11008267|FG000|Overall Study|Met stopping criteria per protocol|0
6962513|NCT01096160|11008268|FG001|Overall Study|Met stopping criteria per protocol|0
6962514|NCT01096160|11008269|FG002|Overall Study|Met stopping criteria per protocol|0
6962515|NCT01096160|11008270|FG003|Overall Study|Met stopping criteria per protocol|0
6962516|NCT01096160|11008271|FG004|Overall Study|Met stopping criteria per protocol|1
6962517|NCT01096160|11008272|FG005|Overall Study|Met stopping criteria per protocol|0
6962518|NCT01096160|11008273|FG006|Overall Study|Met stopping criteria per protocol|2
6962519|NCT01096160|11008274|FG007|Overall Study|Met stopping criteria per protocol|0
6962520|NCT01096160|11008275|FG008|Overall Study|Met stopping criteria per protocol|2
6962521|NCT01096160|11008276|FG009|Overall Study|Met stopping criteria per protocol|0
6962522|NCT01096186|11008311|FG000|Overall Study|Adverse Event|16
6962523|NCT01096186|11008311|FG000|Overall Study|Death|4
6962524|NCT01096186|11008311|FG000|Overall Study|Lack of Efficacy|4
6962525|NCT01096186|11008311|FG000|Overall Study|Lost to Follow-up|2
6962526|NCT01096186|11008311|FG000|Overall Study|Withdrawal by Subject|22
6962527|NCT01096186|11008311|FG000|Overall Study|Physician Decision|1
6962528|NCT01096186|11008311|FG000|Overall Study|Noncompliance with study drug|1
6962529|NCT01096316|11008326|FG000|Overall Study|Lost to Follow-up|15
6962530|NCT01096316|11008327|FG001|Overall Study|Lost to Follow-up|9
6962531|NCT01096342|11008333|FG000|Overall Study|Protocol Violation|1
6962532|NCT01096446|11008339|FG000|Overall Study|Death|1
6962533|NCT01096446|11008340|FG001|Overall Study|Death|0
6962534|NCT01096446|11008339|FG000|Overall Study|Protocol Violation|2
6962535|NCT01096446|11008340|FG001|Overall Study|Protocol Violation|0
6962536|NCT01096550|11008347|FG000|Overall Study|discontinued site|10
6962537|NCT01096550|11008348|FG001|Overall Study|discontinued site|11
6962538|NCT01096550|11008347|FG000|Overall Study|non-regular treatment track at clinic|1
6962539|NCT01096550|11008348|FG001|Overall Study|non-regular treatment track at clinic|1
6962540|NCT01096550|11008347|FG000|Overall Study|clinic readmission|1
6962541|NCT01096550|11008348|FG001|Overall Study|clinic readmission|1
6962542|NCT01096550|11008347|FG000|Overall Study|Withdrawal by Subject|0
7072637|NCT02038036|11176800|FG000|Core Study|Physician Decision|2
7072638|NCT02038036|11176801|FG001|Core Study|Physician Decision|1
7072639|NCT02038036|11176800|FG000|Core Study|Subject/guardian decision|0
7072640|NCT02038036|11176801|FG001|Core Study|Subject/guardian decision|1
7072641|NCT02038036|11176800|FG000|Core Study|Withdrawal by Subject|3
7072642|NCT02038036|11176801|FG001|Core Study|Withdrawal by Subject|1
7072643|NCT02038036|11176800|FG000|Crossover Period|Withdrawal by Subject|0
7072644|NCT02038036|11176801|FG001|Crossover Period|Withdrawal by Subject|3
7072645|NCT02038036|11176800|FG000|Crossover Period|Adverse Event|0
7072646|NCT02038036|11176801|FG001|Crossover Period|Adverse Event|9
7072647|NCT02038036|11176800|FG000|Crossover Period|Death|0
7072648|NCT02038036|11176801|FG001|Crossover Period|Death|2
7072649|NCT02038036|11176800|FG000|Crossover Period|Disease progression|0
7072650|NCT02038036|11176801|FG001|Crossover Period|Disease progression|3
7072651|NCT02038036|11176800|FG000|Crossover Period|Lost to Follow-up|0
7072652|NCT02038036|11176801|FG001|Crossover Period|Lost to Follow-up|1
7072653|NCT02038036|11176800|FG000|Crossover Period|Physician Decision|0
7072654|NCT02038036|11176801|FG001|Crossover Period|Physician Decision|2
7072655|NCT02038049|11176812|FG000|Overall Study|Lost to Follow-up|1
7072656|NCT02038049|11176813|FG001|Overall Study|Lost to Follow-up|0
7072657|NCT02038075|11176825|FG000|Overall Study|Withdrawal by Subject|3
7072658|NCT02038075|11176826|FG001|Overall Study|Withdrawal by Subject|0
7072659|NCT02038543|11176852|FG000|Overall Study|Screen Failure|0
7072660|NCT02038543|11176853|FG001|Overall Study|Screen Failure|0
7072661|NCT02038543|11176854|FG002|Overall Study|Screen Failure|0
7072662|NCT02038543|11176855|FG003|Overall Study|Screen Failure|1
7072663|NCT02038543|11176852|FG000|Overall Study|Withdrawal by Subject|0
7072664|NCT02038543|11176853|FG001|Overall Study|Withdrawal by Subject|0
7072665|NCT02038543|11176854|FG002|Overall Study|Withdrawal by Subject|0
7072666|NCT02038543|11176855|FG003|Overall Study|Withdrawal by Subject|1
7072667|NCT02038647|11176872|FG000|Overall Study|Progressive Disease|50
6962543|NCT01096550|11008348|FG001|Overall Study|Withdrawal by Subject|1
6962544|NCT01096550|11008347|FG000|Overall Study|non-African American participant|13
6962545|NCT01096550|11008348|FG001|Overall Study|non-African American participant|6
6962546|NCT01096550|11008347|FG000|Overall Study|Lost to Follow-up|12
6962547|NCT01096550|11008348|FG001|Overall Study|Lost to Follow-up|9
6976618|NCT01200758|11029411|FG000|Stage I|Adverse Event|5
6976619|NCT01200758|11029412|FG001|Stage I|Adverse Event|5
6976620|NCT01200758|11029413|FG002|Stage I|Adverse Event|0
6976621|NCT01200758|11029414|FG003|Stage I|Adverse Event|0
7072668|NCT02038647|11176873|FG001|Overall Study|Progressive Disease|59
6976622|NCT01200758|11029411|FG000|Stage I|Withdrawal by Subject|1
7072669|NCT02038647|11176872|FG000|Overall Study|Adverse Event|18
7072670|NCT02038647|11176873|FG001|Overall Study|Adverse Event|10
7072671|NCT02038647|11176872|FG000|Overall Study|Symptomatic Deterioration|7
7072672|NCT02038647|11176873|FG001|Overall Study|Symptomatic Deterioration|7
7072673|NCT02038647|11176872|FG000|Overall Study|Withdrawal by Subject|5
7072674|NCT02038647|11176873|FG001|Overall Study|Withdrawal by Subject|2
7072675|NCT02038647|11176872|FG000|Overall Study|Not Reported|0
7072676|NCT02038647|11176873|FG001|Overall Study|Not Reported|1
7072677|NCT02038647|11176872|FG000|Overall Study|Ongoing at Datacut|9
7072678|NCT02038647|11176873|FG001|Overall Study|Ongoing at Datacut|10
7072679|NCT02038764|11176884|FG000|Overall Study|Adverse Event|0
7072680|NCT02038764|11176885|FG001|Overall Study|Adverse Event|0
7072681|NCT02038764|11176886|FG002|Overall Study|Adverse Event|1
7072682|NCT02038764|11176887|FG003|Overall Study|Adverse Event|0
7072683|NCT02038764|11176888|FG004|Overall Study|Adverse Event|0
7072684|NCT02038764|11176884|FG000|Overall Study|Lost to Follow-up|0
7072685|NCT02038764|11176885|FG001|Overall Study|Lost to Follow-up|1
7072686|NCT02038764|11176886|FG002|Overall Study|Lost to Follow-up|0
7072687|NCT02038764|11176887|FG003|Overall Study|Lost to Follow-up|0
7072688|NCT02038764|11176888|FG004|Overall Study|Lost to Follow-up|0
7072689|NCT02038764|11176884|FG000|Overall Study|Withdrawal by Subject|0
6962548|NCT01096589|11008358|FG000|Overall Study|Adverse Event|2
6962549|NCT01096589|11008359|FG001|Overall Study|Adverse Event|1
6962550|NCT01096589|11008360|FG002|Overall Study|Adverse Event|2
6962551|NCT01096589|11008361|FG003|Overall Study|Adverse Event|1
6962552|NCT01096589|11008358|FG000|Overall Study|Withdrawal by Subject|2
6962553|NCT01096589|11008359|FG001|Overall Study|Withdrawal by Subject|1
6962554|NCT01096589|11008360|FG002|Overall Study|Withdrawal by Subject|1
6962555|NCT01096589|11008361|FG003|Overall Study|Withdrawal by Subject|1
6962556|NCT01096589|11008358|FG000|Overall Study|Compliance with protocol|0
6962557|NCT01096589|11008359|FG001|Overall Study|Compliance with protocol|0
6962558|NCT01096589|11008360|FG002|Overall Study|Compliance with protocol|1
6962559|NCT01096589|11008361|FG003|Overall Study|Compliance with protocol|0
6962560|NCT01096589|11008358|FG000|Overall Study|found treatment exhausting|0
6962561|NCT01096589|11008359|FG001|Overall Study|found treatment exhausting|0
6962562|NCT01096589|11008360|FG002|Overall Study|found treatment exhausting|0
6962563|NCT01096589|11008361|FG003|Overall Study|found treatment exhausting|1
6962564|NCT01096667|11008380|FG000|Overall Study|Lost to Follow-up|1
6962565|NCT01096667|11008381|FG001|Overall Study|Lost to Follow-up|1
6962566|NCT01096667|11008382|FG002|Overall Study|Lost to Follow-up|1
6962567|NCT01096667|11008383|FG003|Overall Study|Lost to Follow-up|0
6962568|NCT01096667|11008384|FG004|Overall Study|Lost to Follow-up|0
6962569|NCT01096667|11008380|FG000|Overall Study|Withdrawal by Subject|1
6962570|NCT01096667|11008381|FG001|Overall Study|Withdrawal by Subject|0
6962571|NCT01096667|11008382|FG002|Overall Study|Withdrawal by Subject|0
6962572|NCT01096667|11008383|FG003|Overall Study|Withdrawal by Subject|1
6962573|NCT01096667|11008384|FG004|Overall Study|Withdrawal by Subject|0
6962574|NCT01096667|11008380|FG000|Overall Study|Reason not available|0
6962575|NCT01096667|11008381|FG001|Overall Study|Reason not available|1
6962576|NCT01096667|11008382|FG002|Overall Study|Reason not available|1
6962577|NCT01096667|11008383|FG003|Overall Study|Reason not available|1
6962578|NCT01096667|11008384|FG004|Overall Study|Reason not available|0
6962579|NCT01096667|11008380|FG000|Overall Study|Protocol Violation|0
6962580|NCT01096667|11008381|FG001|Overall Study|Protocol Violation|0
6962581|NCT01096667|11008382|FG002|Overall Study|Protocol Violation|0
6962582|NCT01096667|11008383|FG003|Overall Study|Protocol Violation|1
6962583|NCT01096667|11008384|FG004|Overall Study|Protocol Violation|0
6962584|NCT01096667|11008380|FG000|Overall Study|Not treated|1
6962585|NCT01096667|11008381|FG001|Overall Study|Not treated|0
6962586|NCT01096667|11008382|FG002|Overall Study|Not treated|0
6962587|NCT01096667|11008383|FG003|Overall Study|Not treated|0
6962588|NCT01096667|11008384|FG004|Overall Study|Not treated|0
6962589|NCT01096784|11008429|FG000|Overall Study|Withdrawal by Subject|2
6962590|NCT01096784|11008430|FG001|Overall Study|Withdrawal by Subject|1
6962591|NCT01096784|11008429|FG000|Overall Study|Adverse Event|11
6962592|NCT01096784|11008430|FG001|Overall Study|Adverse Event|9
6962593|NCT01096784|11008429|FG000|Overall Study|Protocol Deviation|2
6962594|NCT01096784|11008430|FG001|Overall Study|Protocol Deviation|2
6962595|NCT01096784|11008429|FG000|Overall Study|Administrative Decision|0
6962596|NCT01096784|11008430|FG001|Overall Study|Administrative Decision|1
6962597|NCT01096784|11008429|FG000|Overall Study|Other Unspecified|0
6962598|NCT01096784|11008430|FG001|Overall Study|Other Unspecified|1
6962599|NCT01096849|11008454|FG000|Overall Study|Consent Withdrawn|1
6962600|NCT01096849|11008455|FG001|Overall Study|Consent Withdrawn|4
6962601|NCT01096849|11008456|FG002|Overall Study|Consent Withdrawn|2
6962602|NCT01096849|11008454|FG000|Overall Study|Lack of Efficacy|0
6962603|NCT01096849|11008455|FG001|Overall Study|Lack of Efficacy|2
6962604|NCT01096849|11008456|FG002|Overall Study|Lack of Efficacy|0
6962605|NCT01096849|11008454|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0
6962606|NCT01096849|11008455|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1
6962607|NCT01096849|11008456|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1
6976623|NCT01200758|11029412|FG001|Stage I|Withdrawal by Subject|2
7072690|NCT02038764|11176885|FG001|Overall Study|Withdrawal by Subject|0
7072691|NCT02038764|11176886|FG002|Overall Study|Withdrawal by Subject|0
7072692|NCT02038764|11176887|FG003|Overall Study|Withdrawal by Subject|0
7072693|NCT02038764|11176888|FG004|Overall Study|Withdrawal by Subject|1
7072694|NCT02038764|11176884|FG000|Overall Study|Other|1
6962608|NCT01096849|11008454|FG000|Overall Study|Investigator or Medical Monitor Decision|0
6962609|NCT01096849|11008455|FG001|Overall Study|Investigator or Medical Monitor Decision|1
6962610|NCT01096849|11008456|FG002|Overall Study|Investigator or Medical Monitor Decision|0
6962611|NCT01096849|11008454|FG000|Overall Study|Administrative Reasons|0
6962612|NCT01096849|11008455|FG001|Overall Study|Administrative Reasons|1
6962613|NCT01096849|11008456|FG002|Overall Study|Administrative Reasons|2
6962614|NCT01096849|11008454|FG000|Overall Study|Lost to Follow-up|1
6962615|NCT01096849|11008455|FG001|Overall Study|Lost to Follow-up|3
6962616|NCT01096849|11008456|FG002|Overall Study|Lost to Follow-up|1
6962617|NCT01097044|11008499|FG000|Overall Study|Withdrawal by Subject|4
6962618|NCT01097044|11008500|FG001|Overall Study|Withdrawal by Subject|4
6962619|NCT01097044|11008499|FG000|Overall Study|Lost to Follow-up|1
6962620|NCT01097044|11008500|FG001|Overall Study|Lost to Follow-up|0
6962621|NCT01097044|11008499|FG000|Overall Study|Withdrawal by Sponsor|0
6962622|NCT01097044|11008500|FG001|Overall Study|Withdrawal by Sponsor|1
6962623|NCT01097057|11008508|FG000|Overall Study|Physician Decision|3
6962624|NCT01097330|11008519|FG000|Overall Study|Study terminated early|7
6962625|NCT01097330|11008520|FG001|Overall Study|Study terminated early|5
6962626|NCT01097421|11008542|FG000|Overall Study|Adverse Event|8
6962627|NCT01097421|11008542|FG000|Overall Study|Protocol Violation|2
6962628|NCT01097421|11008542|FG000|Overall Study|Lost to Follow-up|1
6962629|NCT01097421|11008542|FG000|Overall Study|Withdrawal by Subject|3
6962630|NCT01097577|11008552|FG000|Overall Study|Adverse Event|0
6962631|NCT01097577|11008553|FG001|Overall Study|Adverse Event|1
6962632|NCT01097616|11008562|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6
6962633|NCT01097616|11008563|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15
6962634|NCT01097616|11008564|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21
6962635|NCT01097616|11008565|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
6962636|NCT01097616|11008566|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
6962637|NCT01097616|11008567|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
6962638|NCT01097616|11008568|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
6962639|NCT01097616|11008569|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
6962640|NCT01097616|11008562|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6
6962641|NCT01097616|11008563|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
7072695|NCT02038764|11176885|FG001|Overall Study|Other|0
7072696|NCT02038764|11176886|FG002|Overall Study|Other|1
7072697|NCT02038764|11176887|FG003|Overall Study|Other|0
7072698|NCT02038764|11176888|FG004|Overall Study|Other|0
7072699|NCT02038790|11176904|FG000|Day 0 - First Treatment|Withdrawal by Subject|1
7072700|NCT02038790|11176905|FG001|Day 0 - First Treatment|Withdrawal by Subject|1
7072701|NCT02038829|11176912|FG000|Washout Period 1|Death|0
7072702|NCT02038829|11176913|FG001|Washout Period 1|Death|0
6962642|NCT01097616|11008564|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12
6962643|NCT01097616|11008565|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
6962644|NCT01097616|11008566|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
6962645|NCT01097616|11008567|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
6962646|NCT01097616|11008568|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
6962647|NCT01097616|11008569|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
6962648|NCT01097616|11008562|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
6962649|NCT01097616|11008563|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3
6962650|NCT01097616|11008564|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1
6962651|NCT01097616|11008565|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
6962652|NCT01097616|11008566|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
6962653|NCT01097616|11008567|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
6962654|NCT01097616|11008568|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
6962655|NCT01097616|11008569|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
6962656|NCT01097616|11008562|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
6962657|NCT01097616|11008563|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
6962658|NCT01097616|11008564|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
6962659|NCT01097616|11008565|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
6962660|NCT01097616|11008566|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
6962661|NCT01097616|11008567|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
6962662|NCT01097616|11008568|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
6962663|NCT01097616|11008569|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
6962664|NCT01097616|11008562|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1
6962665|NCT01097616|11008563|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
6962666|NCT01097616|11008564|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9
6962667|NCT01097616|11008565|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
6962668|NCT01097616|11008566|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
6962669|NCT01097616|11008567|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
6962670|NCT01097616|11008568|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
6962671|NCT01097616|11008569|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
7072703|NCT02038829|11176914|FG002|Washout Period 1|Death|0
7072704|NCT02038829|11176915|FG003|Washout Period 1|Death|0
6962672|NCT01097616|11008562|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
6962673|NCT01097616|11008563|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
6962674|NCT01097616|11008564|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
6962675|NCT01097616|11008565|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
6962676|NCT01097616|11008566|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
6962677|NCT01097616|11008567|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
6962678|NCT01097616|11008568|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
6976624|NCT01200758|11029413|FG002|Stage I|Withdrawal by Subject|0
7072705|NCT02038829|11176916|FG004|Washout Period 1|Death|1
7072706|NCT02038829|11176917|FG005|Washout Period 1|Death|0
7072707|NCT02038829|11176918|FG006|Washout Period 1|Death|0
7072708|NCT02038829|11176919|FG007|Washout Period 1|Death|0
7072709|NCT02038829|11176920|FG008|Washout Period 1|Death|0
7072710|NCT02038829|11176921|FG009|Washout Period 1|Death|0
7072711|NCT02038829|11176922|FG010|Washout Period 1|Death|0
7072712|NCT02038829|11176923|FG011|Washout Period 1|Death|0
7072713|NCT02038829|11176912|FG000|Treatment Period 2|Adverse Event|0
7072714|NCT02038829|11176913|FG001|Treatment Period 2|Adverse Event|0
7072715|NCT02038829|11176914|FG002|Treatment Period 2|Adverse Event|0
7072716|NCT02038829|11176915|FG003|Treatment Period 2|Adverse Event|0
7072717|NCT02038829|11176916|FG004|Treatment Period 2|Adverse Event|0
7072718|NCT02038829|11176917|FG005|Treatment Period 2|Adverse Event|0
7072719|NCT02038829|11176918|FG006|Treatment Period 2|Adverse Event|0
7072720|NCT02038829|11176919|FG007|Treatment Period 2|Adverse Event|0
7072721|NCT02038829|11176920|FG008|Treatment Period 2|Adverse Event|0
7072722|NCT02038829|11176921|FG009|Treatment Period 2|Adverse Event|0
7072723|NCT02038829|11176922|FG010|Treatment Period 2|Adverse Event|1
7072724|NCT02038829|11176923|FG011|Treatment Period 2|Adverse Event|0
7072725|NCT02038829|11176912|FG000|Treatment Period 2|Withdrawal by Subject|1
7072726|NCT02038829|11176913|FG001|Treatment Period 2|Withdrawal by Subject|0
7072727|NCT02038829|11176914|FG002|Treatment Period 2|Withdrawal by Subject|0
7072728|NCT02038829|11176915|FG003|Treatment Period 2|Withdrawal by Subject|0
7072729|NCT02038829|11176916|FG004|Treatment Period 2|Withdrawal by Subject|0
7072730|NCT02038829|11176917|FG005|Treatment Period 2|Withdrawal by Subject|0
7072731|NCT02038829|11176918|FG006|Treatment Period 2|Withdrawal by Subject|0
7072732|NCT02038829|11176919|FG007|Treatment Period 2|Withdrawal by Subject|0
7072733|NCT02038829|11176920|FG008|Treatment Period 2|Withdrawal by Subject|0
7072734|NCT02038829|11176921|FG009|Treatment Period 2|Withdrawal by Subject|0
7072735|NCT02038829|11176922|FG010|Treatment Period 2|Withdrawal by Subject|0
7072736|NCT02038829|11176923|FG011|Treatment Period 2|Withdrawal by Subject|0
7072737|NCT02038829|11176912|FG000|Washout Period 2|Adverse Event|0
7072738|NCT02038829|11176913|FG001|Washout Period 2|Adverse Event|0
7072739|NCT02038829|11176914|FG002|Washout Period 2|Adverse Event|0
7072740|NCT02038829|11176915|FG003|Washout Period 2|Adverse Event|0
6838581|NCT00261443|10844331|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32
6838582|NCT00261443|10844332|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
6838583|NCT00261443|10844333|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
6838584|NCT00261443|10844331|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1
6838585|NCT00261443|10844332|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
6838586|NCT00261443|10844333|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
6838587|NCT00261443|10844331|FG000|2: Stability & Maintenance of Stability|Other Reasons|13
6838588|NCT00261443|10844332|FG001|2: Stability & Maintenance of Stability|Other Reasons|0
6838589|NCT00261443|10844333|FG002|2: Stability & Maintenance of Stability|Other Reasons|0
6838590|NCT00261443|10844331|FG000|3: Assessment of Relapse|Lack of Efficacy|0
6838591|NCT00261443|10844332|FG001|3: Assessment of Relapse|Lack of Efficacy|31
6838592|NCT00261443|10844333|FG002|3: Assessment of Relapse|Lack of Efficacy|14
6838593|NCT00261443|10844331|FG000|3: Assessment of Relapse|Adverse Event|0
6838594|NCT00261443|10844332|FG001|3: Assessment of Relapse|Adverse Event|15
6838595|NCT00261443|10844333|FG002|3: Assessment of Relapse|Adverse Event|19
6838596|NCT00261443|10844331|FG000|3: Assessment of Relapse|Withdrawal by Subject|0
6838597|NCT00261443|10844332|FG001|3: Assessment of Relapse|Withdrawal by Subject|14
6838598|NCT00261443|10844333|FG002|3: Assessment of Relapse|Withdrawal by Subject|15
6838599|NCT00261443|10844331|FG000|3: Assessment of Relapse|Death|0
6838600|NCT00261443|10844332|FG001|3: Assessment of Relapse|Death|0
6838601|NCT00261443|10844333|FG002|3: Assessment of Relapse|Death|1
6838602|NCT00261443|10844331|FG000|3: Assessment of Relapse|Lost to Follow-up|0
6838603|NCT00261443|10844332|FG001|3: Assessment of Relapse|Lost to Follow-up|7
6838604|NCT00261443|10844333|FG002|3: Assessment of Relapse|Lost to Follow-up|6
6838605|NCT00261443|10844331|FG000|3: Assessment of Relapse|Poor/Noncompliance|0
6838606|NCT00261443|10844332|FG001|3: Assessment of Relapse|Poor/Noncompliance|5
6838607|NCT00261443|10844333|FG002|3: Assessment of Relapse|Poor/Noncompliance|3
6838608|NCT00261443|10844331|FG000|3: Assessment of Relapse|Pregnancy|0
6838609|NCT00261443|10844332|FG001|3: Assessment of Relapse|Pregnancy|2
7072741|NCT02038829|11176916|FG004|Washout Period 2|Adverse Event|0
7072742|NCT02038829|11176917|FG005|Washout Period 2|Adverse Event|0
7072743|NCT02038829|11176918|FG006|Washout Period 2|Adverse Event|0
7072744|NCT02038829|11176919|FG007|Washout Period 2|Adverse Event|0
7072745|NCT02038829|11176920|FG008|Washout Period 2|Adverse Event|1
7072746|NCT02038829|11176921|FG009|Washout Period 2|Adverse Event|0
6962679|NCT01097616|11008569|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
6962680|NCT01097616|11008562|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4
6962681|NCT01097616|11008563|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3
6962682|NCT01097616|11008564|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
6962683|NCT01097616|11008565|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
6962684|NCT01097616|11008566|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
6962685|NCT01097616|11008567|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
6962686|NCT01097616|11008568|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
6962687|NCT01097616|11008569|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
6962688|NCT01097616|11008562|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
6962689|NCT01097616|11008563|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
6962690|NCT01097616|11008564|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
6962691|NCT01097616|11008565|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
6962692|NCT01097616|11008566|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
6962693|NCT01097616|11008567|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
6962694|NCT01097616|11008568|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
6962695|NCT01097616|11008569|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
6962696|NCT01097616|11008562|FG000|Optional DB EXT Phase|Adverse Event|0
6962697|NCT01097616|11008563|FG001|Optional DB EXT Phase|Adverse Event|7
6962698|NCT01097616|11008564|FG002|Optional DB EXT Phase|Adverse Event|2
6962699|NCT01097616|11008565|FG003|Optional DB EXT Phase|Adverse Event|0
6962700|NCT01097616|11008566|FG004|Optional DB EXT Phase|Adverse Event|0
6962701|NCT01097616|11008567|FG005|Optional DB EXT Phase|Adverse Event|0
6962702|NCT01097616|11008568|FG006|Optional DB EXT Phase|Adverse Event|0
6962703|NCT01097616|11008569|FG007|Optional DB EXT Phase|Adverse Event|0
6962704|NCT01097616|11008562|FG000|Optional DB EXT Phase|Withdrawal by Subject|12
6962705|NCT01097616|11008563|FG001|Optional DB EXT Phase|Withdrawal by Subject|6
6962706|NCT01097616|11008564|FG002|Optional DB EXT Phase|Withdrawal by Subject|3
6962707|NCT01097616|11008565|FG003|Optional DB EXT Phase|Withdrawal by Subject|0
6962708|NCT01097616|11008566|FG004|Optional DB EXT Phase|Withdrawal by Subject|0
6962709|NCT01097616|11008567|FG005|Optional DB EXT Phase|Withdrawal by Subject|0
6962710|NCT01097616|11008568|FG006|Optional DB EXT Phase|Withdrawal by Subject|0
6962711|NCT01097616|11008569|FG007|Optional DB EXT Phase|Withdrawal by Subject|0
6962712|NCT01097616|11008562|FG000|Optional DB EXT Phase|Protocol Violation|0
6962713|NCT01097616|11008563|FG001|Optional DB EXT Phase|Protocol Violation|2
6962714|NCT01097616|11008564|FG002|Optional DB EXT Phase|Protocol Violation|3
6962715|NCT01097616|11008565|FG003|Optional DB EXT Phase|Protocol Violation|0
6962716|NCT01097616|11008566|FG004|Optional DB EXT Phase|Protocol Violation|0
6962717|NCT01097616|11008567|FG005|Optional DB EXT Phase|Protocol Violation|0
6962718|NCT01097616|11008568|FG006|Optional DB EXT Phase|Protocol Violation|0
7072747|NCT02038829|11176922|FG010|Washout Period 2|Adverse Event|0
6962719|NCT01097616|11008569|FG007|Optional DB EXT Phase|Protocol Violation|0
6962720|NCT01097616|11008562|FG000|Optional DB EXT Phase|Lost to Follow-up|1
6962721|NCT01097616|11008563|FG001|Optional DB EXT Phase|Lost to Follow-up|5
6962722|NCT01097616|11008564|FG002|Optional DB EXT Phase|Lost to Follow-up|1
6962723|NCT01097616|11008565|FG003|Optional DB EXT Phase|Lost to Follow-up|0
6962724|NCT01097616|11008566|FG004|Optional DB EXT Phase|Lost to Follow-up|0
6962725|NCT01097616|11008567|FG005|Optional DB EXT Phase|Lost to Follow-up|0
6962726|NCT01097616|11008568|FG006|Optional DB EXT Phase|Lost to Follow-up|0
6962727|NCT01097616|11008569|FG007|Optional DB EXT Phase|Lost to Follow-up|0
6962728|NCT01097616|11008562|FG000|Optional DB EXT Phase|Lack of Efficacy|1
6962729|NCT01097616|11008563|FG001|Optional DB EXT Phase|Lack of Efficacy|1
6962730|NCT01097616|11008564|FG002|Optional DB EXT Phase|Lack of Efficacy|1
6962731|NCT01097616|11008565|FG003|Optional DB EXT Phase|Lack of Efficacy|0
6962732|NCT01097616|11008566|FG004|Optional DB EXT Phase|Lack of Efficacy|0
6962733|NCT01097616|11008567|FG005|Optional DB EXT Phase|Lack of Efficacy|0
6962734|NCT01097616|11008568|FG006|Optional DB EXT Phase|Lack of Efficacy|0
6962735|NCT01097616|11008569|FG007|Optional DB EXT Phase|Lack of Efficacy|0
6962736|NCT01097616|11008562|FG000|Optional DB EXT Phase|Physician Decision|1
6962737|NCT01097616|11008563|FG001|Optional DB EXT Phase|Physician Decision|0
6962738|NCT01097616|11008564|FG002|Optional DB EXT Phase|Physician Decision|0
6962739|NCT01097616|11008565|FG003|Optional DB EXT Phase|Physician Decision|0
6962740|NCT01097616|11008566|FG004|Optional DB EXT Phase|Physician Decision|0
7072748|NCT02038829|11176923|FG011|Washout Period 2|Adverse Event|0
6838610|NCT00261443|10844333|FG002|3: Assessment of Relapse|Pregnancy|1
6838611|NCT00261443|10844331|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0
6838612|NCT00261443|10844332|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2
6838613|NCT00261443|10844333|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1
6838614|NCT00261443|10844331|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0
6838615|NCT00261443|10844332|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0
7072749|NCT02038829|11176912|FG000|Washout Period 2|Withdrawal by Subject|0
6838616|NCT00261443|10844333|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2
6838617|NCT00261443|10844331|FG000|3: Assessment of Relapse|Other Reasons|0
6838618|NCT00261443|10844332|FG001|3: Assessment of Relapse|Other Reasons|4
6838619|NCT00261443|10844333|FG002|3: Assessment of Relapse|Other Reasons|3
6838620|NCT00261443|10844331|FG000|4: Extension Phase|Adverse Event|0
6962741|NCT01097616|11008567|FG005|Optional DB EXT Phase|Physician Decision|0
6962742|NCT01097616|11008568|FG006|Optional DB EXT Phase|Physician Decision|0
6962743|NCT01097616|11008569|FG007|Optional DB EXT Phase|Physician Decision|0
6962744|NCT01097616|11008562|FG000|DB RO Phase|Adverse Event|0
6962745|NCT01097616|11008563|FG001|DB RO Phase|Adverse Event|0
6962746|NCT01097616|11008564|FG002|DB RO Phase|Adverse Event|0
6962747|NCT01097616|11008565|FG003|DB RO Phase|Adverse Event|0
6962748|NCT01097616|11008566|FG004|DB RO Phase|Adverse Event|0
6962749|NCT01097616|11008567|FG005|DB RO Phase|Adverse Event|0
6962750|NCT01097616|11008568|FG006|DB RO Phase|Adverse Event|1
7072750|NCT02038829|11176913|FG001|Washout Period 2|Withdrawal by Subject|0
7072751|NCT02038829|11176914|FG002|Washout Period 2|Withdrawal by Subject|0
7072752|NCT02038829|11176915|FG003|Washout Period 2|Withdrawal by Subject|0
7072753|NCT02038829|11176916|FG004|Washout Period 2|Withdrawal by Subject|0
7072754|NCT02038829|11176917|FG005|Washout Period 2|Withdrawal by Subject|1
6962751|NCT01097616|11008569|FG007|DB RO Phase|Adverse Event|0
6962752|NCT01097616|11008562|FG000|DB RO Phase|Withdrawal by Subject|0
6962753|NCT01097616|11008563|FG001|DB RO Phase|Withdrawal by Subject|0
6962754|NCT01097616|11008564|FG002|DB RO Phase|Withdrawal by Subject|0
6962755|NCT01097616|11008565|FG003|DB RO Phase|Withdrawal by Subject|0
6962756|NCT01097616|11008566|FG004|DB RO Phase|Withdrawal by Subject|0
6962757|NCT01097616|11008567|FG005|DB RO Phase|Withdrawal by Subject|1
6962758|NCT01097616|11008568|FG006|DB RO Phase|Withdrawal by Subject|0
6962759|NCT01097616|11008569|FG007|DB RO Phase|Withdrawal by Subject|0
6962760|NCT01097616|11008562|FG000|DB RO Phase|Lost to Follow-up|0
6962761|NCT01097616|11008563|FG001|DB RO Phase|Lost to Follow-up|0
6962762|NCT01097616|11008564|FG002|DB RO Phase|Lost to Follow-up|0
6962763|NCT01097616|11008565|FG003|DB RO Phase|Lost to Follow-up|1
6962764|NCT01097616|11008566|FG004|DB RO Phase|Lost to Follow-up|1
6962765|NCT01097616|11008567|FG005|DB RO Phase|Lost to Follow-up|0
6962766|NCT01097616|11008568|FG006|DB RO Phase|Lost to Follow-up|0
6962767|NCT01097616|11008569|FG007|DB RO Phase|Lost to Follow-up|1
6962768|NCT01097616|11008562|FG000|DB RO Phase|Not Treated in RO|0
6962769|NCT01097616|11008563|FG001|DB RO Phase|Not Treated in RO|0
6962770|NCT01097616|11008564|FG002|DB RO Phase|Not Treated in RO|0
6962771|NCT01097616|11008565|FG003|DB RO Phase|Not Treated in RO|0
6962772|NCT01097616|11008566|FG004|DB RO Phase|Not Treated in RO|0
6962773|NCT01097616|11008567|FG005|DB RO Phase|Not Treated in RO|1
6962774|NCT01097616|11008568|FG006|DB RO Phase|Not Treated in RO|0
6962775|NCT01097616|11008569|FG007|DB RO Phase|Not Treated in RO|0
6962776|NCT01097629|11008598|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10
6962777|NCT01097629|11008599|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19
6962778|NCT01097629|11008600|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17
6962779|NCT01097629|11008601|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
6962780|NCT01097629|11008602|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
6962781|NCT01097629|11008603|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
6962782|NCT01097629|11008604|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
6962783|NCT01097629|11008605|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
6962784|NCT01097629|11008598|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
6962785|NCT01097629|11008599|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9
6962786|NCT01097629|11008600|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19
6962787|NCT01097629|11008601|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
6962788|NCT01097629|11008602|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
6962789|NCT01097629|11008603|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
6962790|NCT01097629|11008604|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
6962791|NCT01097629|11008605|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
6962792|NCT01097629|11008598|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
6962793|NCT01097629|11008599|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4
6962794|NCT01097629|11008600|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8
6962795|NCT01097629|11008601|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
6962796|NCT01097629|11008602|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
6962797|NCT01097629|11008603|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
6962798|NCT01097629|11008604|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
6962799|NCT01097629|11008605|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
6962800|NCT01097629|11008598|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2
6962801|NCT01097629|11008599|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4
6962802|NCT01097629|11008600|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
6962803|NCT01097629|11008601|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
6962804|NCT01097629|11008602|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
6962805|NCT01097629|11008603|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
6962806|NCT01097629|11008604|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
6962807|NCT01097629|11008605|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
6962808|NCT01097629|11008598|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
6962809|NCT01097629|11008599|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4
6962810|NCT01097629|11008600|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8
6962811|NCT01097629|11008601|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
6976625|NCT01200758|11029414|FG003|Stage I|Withdrawal by Subject|0
6962812|NCT01097629|11008602|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
6962813|NCT01097629|11008603|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
6962814|NCT01097629|11008604|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
6962815|NCT01097629|11008605|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
6962816|NCT01097629|11008598|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2
6962817|NCT01097629|11008599|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1
6962818|NCT01097629|11008600|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
6962819|NCT01097629|11008601|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
6962820|NCT01097629|11008602|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
6962821|NCT01097629|11008603|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
6962822|NCT01097629|11008604|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
6962823|NCT01097629|11008605|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
6962824|NCT01097629|11008598|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
6962825|NCT01097629|11008599|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5
6962826|NCT01097629|11008600|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4
6962827|NCT01097629|11008601|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
6962828|NCT01097629|11008602|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
6962829|NCT01097629|11008603|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
6962830|NCT01097629|11008604|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
6962831|NCT01097629|11008605|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
6962832|NCT01097629|11008598|FG000|DB RO Phase|Withdrawal by Subject|0
6962833|NCT01097629|11008599|FG001|DB RO Phase|Withdrawal by Subject|0
6962834|NCT01097629|11008600|FG002|DB RO Phase|Withdrawal by Subject|0
6962835|NCT01097629|11008601|FG003|DB RO Phase|Withdrawal by Subject|0
6962836|NCT01097629|11008602|FG004|DB RO Phase|Withdrawal by Subject|0
6962837|NCT01097629|11008603|FG005|DB RO Phase|Withdrawal by Subject|0
6962838|NCT01097629|11008604|FG006|DB RO Phase|Withdrawal by Subject|0
6962839|NCT01097629|11008605|FG007|DB RO Phase|Withdrawal by Subject|1
6962840|NCT01097629|11008598|FG000|DB RO Phase|Protocol Violation|0
6962841|NCT01097629|11008599|FG001|DB RO Phase|Protocol Violation|0
6962842|NCT01097629|11008600|FG002|DB RO Phase|Protocol Violation|0
6962843|NCT01097629|11008601|FG003|DB RO Phase|Protocol Violation|1
6962844|NCT01097629|11008602|FG004|DB RO Phase|Protocol Violation|0
6962845|NCT01097629|11008603|FG005|DB RO Phase|Protocol Violation|1
6962846|NCT01097629|11008604|FG006|DB RO Phase|Protocol Violation|1
6962847|NCT01097629|11008605|FG007|DB RO Phase|Protocol Violation|0
6962848|NCT01097629|11008598|FG000|DB RO Phase|Lost to Follow-up|0
6962849|NCT01097629|11008599|FG001|DB RO Phase|Lost to Follow-up|0
6962850|NCT01097629|11008600|FG002|DB RO Phase|Lost to Follow-up|0
6962851|NCT01097629|11008601|FG003|DB RO Phase|Lost to Follow-up|0
6962852|NCT01097629|11008602|FG004|DB RO Phase|Lost to Follow-up|0
6962853|NCT01097629|11008603|FG005|DB RO Phase|Lost to Follow-up|0
6962854|NCT01097629|11008604|FG006|DB RO Phase|Lost to Follow-up|2
6962855|NCT01097629|11008605|FG007|DB RO Phase|Lost to Follow-up|0
6962856|NCT01097655|11008637|FG000|Overall Study|Withdrawal by Subject|1
6962857|NCT01097655|11008637|FG000|Overall Study|Subject Documented Twice|1
6962858|NCT01097655|11008637|FG000|Overall Study|Did Not Meet Inclusion Criteria|8
6962859|NCT01097668|11008643|FG000|Overall Study|Withdrawal by Subject|1
6962860|NCT01097668|11008644|FG001|Overall Study|Withdrawal by Subject|2
6962861|NCT01097668|11008643|FG000|Overall Study|Lost to Follow-up|1
6962862|NCT01097668|11008644|FG001|Overall Study|Lost to Follow-up|0
6962863|NCT01097694|11008656|FG000|Overall Study|Adverse Event|5
6962864|NCT01097694|11008657|FG001|Overall Study|Adverse Event|0
6962865|NCT01097694|11008656|FG000|Overall Study|Lost to Follow-up|0
6962866|NCT01097694|11008657|FG001|Overall Study|Lost to Follow-up|3
6962867|NCT01097694|11008656|FG000|Overall Study|Withdrawal by Subject|3
6962868|NCT01097694|11008657|FG001|Overall Study|Withdrawal by Subject|1
6962869|NCT01097707|11008668|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0
6962870|NCT01097707|11008669|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0
6962871|NCT01097707|11008670|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1
6962872|NCT01097707|11008671|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1
6962873|NCT01097707|11008672|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1
6962874|NCT01097707|11008668|FG000|Overall Study|Adverse Event|4
6962875|NCT01097707|11008669|FG001|Overall Study|Adverse Event|2
6962876|NCT01097707|11008670|FG002|Overall Study|Adverse Event|3
6962877|NCT01097707|11008671|FG003|Overall Study|Adverse Event|1
6962878|NCT01097707|11008672|FG004|Overall Study|Adverse Event|3
6962879|NCT01097707|11008668|FG000|Overall Study|Entry Criteria Not Met|2
6962880|NCT01097707|11008669|FG001|Overall Study|Entry Criteria Not Met|1
6962881|NCT01097707|11008670|FG002|Overall Study|Entry Criteria Not Met|1
6962882|NCT01097707|11008671|FG003|Overall Study|Entry Criteria Not Met|0
6962883|NCT01097707|11008672|FG004|Overall Study|Entry Criteria Not Met|1
6962884|NCT01097707|11008668|FG000|Overall Study|Lack of Efficacy|1
6962885|NCT01097707|11008669|FG001|Overall Study|Lack of Efficacy|0
6962886|NCT01097707|11008670|FG002|Overall Study|Lack of Efficacy|0
6962887|NCT01097707|11008671|FG003|Overall Study|Lack of Efficacy|1
6962888|NCT01097707|11008672|FG004|Overall Study|Lack of Efficacy|0
6962889|NCT01097707|11008668|FG000|Overall Study|Lost to Follow-up|1
6962890|NCT01097707|11008669|FG001|Overall Study|Lost to Follow-up|1
6962891|NCT01097707|11008670|FG002|Overall Study|Lost to Follow-up|2
6962892|NCT01097707|11008671|FG003|Overall Study|Lost to Follow-up|0
6962893|NCT01097707|11008672|FG004|Overall Study|Lost to Follow-up|3
6962894|NCT01097707|11008668|FG000|Overall Study|Protocol Violation|2
6962895|NCT01097707|11008669|FG001|Overall Study|Protocol Violation|2
6962896|NCT01097707|11008670|FG002|Overall Study|Protocol Violation|3
6962897|NCT01097707|11008671|FG003|Overall Study|Protocol Violation|2
6962898|NCT01097707|11008672|FG004|Overall Study|Protocol Violation|2
6962899|NCT01097707|11008668|FG000|Overall Study|Sponsor Decision|31
6962900|NCT01097707|11008669|FG001|Overall Study|Sponsor Decision|31
6962901|NCT01097707|11008670|FG002|Overall Study|Sponsor Decision|34
6962902|NCT01097707|11008671|FG003|Overall Study|Sponsor Decision|35
6962903|NCT01097707|11008672|FG004|Overall Study|Sponsor Decision|36
6962904|NCT01097707|11008668|FG000|Overall Study|Withdrawal by Subject|3
6962905|NCT01097707|11008669|FG001|Overall Study|Withdrawal by Subject|6
6962906|NCT01097707|11008670|FG002|Overall Study|Withdrawal by Subject|1
6962907|NCT01097707|11008671|FG003|Overall Study|Withdrawal by Subject|4
6962908|NCT01097707|11008672|FG004|Overall Study|Withdrawal by Subject|3
6962909|NCT01097707|11008668|FG000|Overall Study|Reason unknown|0
6962910|NCT01097707|11008669|FG001|Overall Study|Reason unknown|0
6962911|NCT01097707|11008670|FG002|Overall Study|Reason unknown|0
6962912|NCT01097707|11008671|FG003|Overall Study|Reason unknown|0
6962913|NCT01097707|11008672|FG004|Overall Study|Reason unknown|1
6962914|NCT01097863|11008697|FG000|Overall Study|Discomfort|1
6962915|NCT01097863|11008698|FG001|Overall Study|Discomfort|0
6962916|NCT01097863|11008699|FG002|Overall Study|Discomfort|1
6962917|NCT01097863|11008697|FG000|Overall Study|Did not return for final visit|0
6962918|NCT01097863|11008698|FG001|Overall Study|Did not return for final visit|0
6962919|NCT01097863|11008699|FG002|Overall Study|Did not return for final visit|1
6962920|NCT01098097|11008744|FG000|Overall Study|Adverse Event|17
6962921|NCT01098097|11008744|FG000|Overall Study|Lost to Follow-up|18
6962922|NCT01098097|11008744|FG000|Overall Study|Status unknown|16
6962923|NCT01098097|11008744|FG000|Overall Study|No reason reported|31
6962924|NCT01098162|11008748|FG000|Overall Study|Adverse Event|37
6962925|NCT01098162|11008748|FG000|Overall Study|Lack of Efficacy|4
6962926|NCT01098162|11008748|FG000|Overall Study|Wish of Patient|7
6962927|NCT01098162|11008748|FG000|Overall Study|Lost to Follow-up|9
6962928|NCT01098162|11008748|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5
6962929|NCT01098162|11008748|FG000|Overall Study|Adverse Event & Lack of Efficacy|6
6962930|NCT01098162|11008748|FG000|Overall Study|Adverse Event & Wish of Patient|13
6962931|NCT01098162|11008748|FG000|Overall Study|Adverse Event & Lost to Follow-up|2
6962932|NCT01098162|11008748|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1
6962933|NCT01098162|11008748|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1
6962934|NCT01098162|11008748|FG000|Overall Study|Other Reason|1
6962935|NCT01098162|11008748|FG000|Overall Study|Reason Unknown|26
6962936|NCT01098240|11008752|FG000|Open-Label Phase|Study Terminated by Sponsor|27
6962937|NCT01098240|11008753|FG001|Open-Label Phase|Study Terminated by Sponsor|0
6962938|NCT01098240|11008754|FG002|Open-Label Phase|Study Terminated by Sponsor|0
6962939|NCT01098240|11008752|FG000|Open-Label Phase|Protocol Violation|4
6962940|NCT01098240|11008753|FG001|Open-Label Phase|Protocol Violation|0
6962941|NCT01098240|11008754|FG002|Open-Label Phase|Protocol Violation|0
6962942|NCT01098240|11008752|FG000|Open-Label Phase|Lost to Follow-up|13
6962943|NCT01098240|11008753|FG001|Open-Label Phase|Lost to Follow-up|0
6962944|NCT01098240|11008754|FG002|Open-Label Phase|Lost to Follow-up|0
6962945|NCT01098240|11008752|FG000|Open-Label Phase|Other|19
6962946|NCT01098240|11008753|FG001|Open-Label Phase|Other|0
6962947|NCT01098240|11008754|FG002|Open-Label Phase|Other|0
6962948|NCT01098240|11008752|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50
6962949|NCT01098240|11008753|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0
6962950|NCT01098240|11008754|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0
6962951|NCT01098240|11008752|FG000|Open-Label Phase|Pregnancy|1
6962952|NCT01098240|11008753|FG001|Open-Label Phase|Pregnancy|0
6962953|NCT01098240|11008754|FG002|Open-Label Phase|Pregnancy|0
6962954|NCT01098240|11008752|FG000|Open-Label Phase|Withdrawal by Subject|9
6962955|NCT01098240|11008753|FG001|Open-Label Phase|Withdrawal by Subject|0
6962956|NCT01098240|11008754|FG002|Open-Label Phase|Withdrawal by Subject|0
6962957|NCT01098240|11008752|FG000|Open-Label Phase|Adverse Event|12
6962958|NCT01098240|11008753|FG001|Open-Label Phase|Adverse Event|0
6962959|NCT01098240|11008754|FG002|Open-Label Phase|Adverse Event|0
6962960|NCT01098240|11008752|FG000|Double-Blind Phase|Study Terminated by Sponsor|0
6962961|NCT01098240|11008753|FG001|Double-Blind Phase|Study Terminated by Sponsor|5
6962962|NCT01098240|11008754|FG002|Double-Blind Phase|Study Terminated by Sponsor|8
6962963|NCT01098240|11008752|FG000|Double-Blind Phase|Protocol Violation|0
6962964|NCT01098240|11008753|FG001|Double-Blind Phase|Protocol Violation|2
6962965|NCT01098240|11008754|FG002|Double-Blind Phase|Protocol Violation|4
6962966|NCT01098240|11008752|FG000|Double-Blind Phase|Lost to Follow-up|0
6962967|NCT01098240|11008753|FG001|Double-Blind Phase|Lost to Follow-up|2
6962968|NCT01098240|11008754|FG002|Double-Blind Phase|Lost to Follow-up|0
6962969|NCT01098240|11008752|FG000|Double-Blind Phase|Other|0
6962970|NCT01098240|11008753|FG001|Double-Blind Phase|Other|2
6962971|NCT01098240|11008754|FG002|Double-Blind Phase|Other|2
6962972|NCT01098240|11008752|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0
6962973|NCT01098240|11008753|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1
6962974|NCT01098240|11008754|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0
6962975|NCT01098240|11008752|FG000|Double-Blind Phase|Insufficient Clinical Response|0
6962976|NCT01098240|11008753|FG001|Double-Blind Phase|Insufficient Clinical Response|1
6962977|NCT01098240|11008754|FG002|Double-Blind Phase|Insufficient Clinical Response|2
6962978|NCT01098240|11008752|FG000|Double-Blind Phase|Withdrawal by Subject|0
6962979|NCT01098240|11008753|FG001|Double-Blind Phase|Withdrawal by Subject|1
6962980|NCT01098240|11008754|FG002|Double-Blind Phase|Withdrawal by Subject|3
6962981|NCT01098240|11008752|FG000|Double-Blind Phase|Adverse Event|0
6962982|NCT01098240|11008753|FG001|Double-Blind Phase|Adverse Event|3
6962983|NCT01098240|11008754|FG002|Double-Blind Phase|Adverse Event|3
6962984|NCT01098266|11008772|FG000|Overall Study|Physician Decision|1
6962985|NCT01098266|11008773|FG001|Overall Study|Physician Decision|0
6962986|NCT01098266|11008772|FG000|Overall Study|Death|3
6962987|NCT01098266|11008773|FG001|Overall Study|Death|2
6962988|NCT01098266|11008772|FG000|Overall Study|Withdrawal by Subject|3
6962989|NCT01098266|11008773|FG001|Overall Study|Withdrawal by Subject|5
6962990|NCT01098305|11008781|FG000|Overall Study|Lost to Follow-up|31
6962991|NCT01098305|11008782|FG001|Overall Study|Lost to Follow-up|33
6962992|NCT01098461|11008809|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10
6962993|NCT01098461|11008810|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2
6962994|NCT01098461|11008811|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
6962995|NCT01098461|11008812|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
6962996|NCT01098461|11008809|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1
6962997|NCT01098461|11008810|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2
6962998|NCT01098461|11008811|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1
6962999|NCT01098461|11008812|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3
6963000|NCT01098461|11008809|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1
6963001|NCT01098461|11008810|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2
6963002|NCT01098461|11008811|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
6963003|NCT01098461|11008812|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
6963004|NCT01098461|11008809|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
6963005|NCT01098461|11008810|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1
6963006|NCT01098461|11008811|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
6963007|NCT01098461|11008812|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
6963008|NCT01098461|11008809|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
6963009|NCT01098461|11008810|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1
6963010|NCT01098461|11008811|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
6963011|NCT01098461|11008812|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
6963012|NCT01098461|11008809|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
6963013|NCT01098461|11008810|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1
6963014|NCT01098461|11008811|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
6963015|NCT01098461|11008812|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
6963016|NCT01098461|11008809|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
6963017|NCT01098461|11008810|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
6963018|NCT01098461|11008811|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
6963019|NCT01098461|11008812|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
6963020|NCT01098474|11008829|FG000|Active Phase|Other|0
6963021|NCT01098474|11008830|FG001|Active Phase|Other|0
6963022|NCT01098474|11008831|FG002|Active Phase|Other|3
6963023|NCT01098474|11008832|FG003|Active Phase|Other|0
6963024|NCT01098474|11008833|FG004|Active Phase|Other|0
6963025|NCT01098474|11008834|FG005|Active Phase|Other|0
6963026|NCT01098474|11008829|FG000|Active Phase|Withdrawal by Subject|1
6963027|NCT01098474|11008830|FG001|Active Phase|Withdrawal by Subject|1
6963028|NCT01098474|11008831|FG002|Active Phase|Withdrawal by Subject|2
6963029|NCT01098474|11008832|FG003|Active Phase|Withdrawal by Subject|0
6963030|NCT01098474|11008833|FG004|Active Phase|Withdrawal by Subject|0
6963031|NCT01098474|11008834|FG005|Active Phase|Withdrawal by Subject|0
6963032|NCT01098474|11008829|FG000|Active Phase|Lost to Follow-up|1
6963033|NCT01098474|11008830|FG001|Active Phase|Lost to Follow-up|0
6963034|NCT01098474|11008831|FG002|Active Phase|Lost to Follow-up|0
6963035|NCT01098474|11008832|FG003|Active Phase|Lost to Follow-up|0
6963036|NCT01098474|11008833|FG004|Active Phase|Lost to Follow-up|0
6963037|NCT01098474|11008834|FG005|Active Phase|Lost to Follow-up|0
6963038|NCT01098474|11008829|FG000|Follow Up Phase|Travelled out of study area|0
6963039|NCT01098474|11008830|FG001|Follow Up Phase|Travelled out of study area|0
6963040|NCT01098474|11008831|FG002|Follow Up Phase|Travelled out of study area|0
6963041|NCT01098474|11008832|FG003|Follow Up Phase|Travelled out of study area|0
6963042|NCT01098474|11008833|FG004|Follow Up Phase|Travelled out of study area|1
6963043|NCT01098474|11008834|FG005|Follow Up Phase|Travelled out of study area|0
6963044|NCT01098474|11008829|FG000|Follow Up Phase|Other|0
6963045|NCT01098474|11008830|FG001|Follow Up Phase|Other|0
6963046|NCT01098474|11008831|FG002|Follow Up Phase|Other|0
6963047|NCT01098474|11008832|FG003|Follow Up Phase|Other|0
6963048|NCT01098474|11008833|FG004|Follow Up Phase|Other|0
6963049|NCT01098474|11008834|FG005|Follow Up Phase|Other|4
6963050|NCT01098474|11008829|FG000|Follow Up Phase|Withdrawal by Subject|0
6963051|NCT01098474|11008830|FG001|Follow Up Phase|Withdrawal by Subject|0
6963052|NCT01098474|11008831|FG002|Follow Up Phase|Withdrawal by Subject|0
6963053|NCT01098474|11008832|FG003|Follow Up Phase|Withdrawal by Subject|2
6963054|NCT01098474|11008833|FG004|Follow Up Phase|Withdrawal by Subject|0
6963055|NCT01098474|11008834|FG005|Follow Up Phase|Withdrawal by Subject|1
6963056|NCT01098474|11008829|FG000|Follow Up Phase|Lost to Follow-up|0
6963057|NCT01098474|11008830|FG001|Follow Up Phase|Lost to Follow-up|0
6963058|NCT01098474|11008831|FG002|Follow Up Phase|Lost to Follow-up|0
6963059|NCT01098474|11008832|FG003|Follow Up Phase|Lost to Follow-up|0
6963060|NCT01098474|11008833|FG004|Follow Up Phase|Lost to Follow-up|1
6963061|NCT01098474|11008834|FG005|Follow Up Phase|Lost to Follow-up|0
6963062|NCT01098487|11008858|FG000|Overall Study|Adverse Event|22
6963063|NCT01098487|11008858|FG000|Overall Study|Lack of Efficacy|11
6963064|NCT01098487|11008858|FG000|Overall Study|Withdrawal by Subject|7
6963065|NCT01098487|11008858|FG000|Overall Study|Lost to Follow-up|3
6963066|NCT01098487|11008858|FG000|Overall Study|Physician Decision|1
6963067|NCT01098539|11008868|FG000|Overall Study|Adverse Event|26
6963068|NCT01098539|11008869|FG001|Overall Study|Adverse Event|26
6963069|NCT01098539|11008868|FG000|Overall Study|Protocol Violation|1
6963070|NCT01098539|11008869|FG001|Overall Study|Protocol Violation|4
6963071|NCT01098539|11008868|FG000|Overall Study|Noncompliance|3
6963072|NCT01098539|11008869|FG001|Overall Study|Noncompliance|5
6963073|NCT01098539|11008868|FG000|Overall Study|Lost to Follow-up|4
6963074|NCT01098539|11008869|FG001|Overall Study|Lost to Follow-up|4
6963075|NCT01098539|11008868|FG000|Overall Study|Withdrawal by Subject|12
6963076|NCT01098539|11008869|FG001|Overall Study|Withdrawal by Subject|26
6963077|NCT01098539|11008868|FG000|Overall Study|Physician Decision|5
6963078|NCT01098539|11008869|FG001|Overall Study|Physician Decision|3
6963079|NCT01098812|11008900|FG000|Overall Study|Death|2
6963080|NCT01098812|11008901|FG001|Overall Study|Death|0
6963081|NCT01098812|11008902|FG002|Overall Study|Death|1
6963082|NCT01098812|11008900|FG000|Overall Study|Lost to Follow-up|0
6963083|NCT01098812|11008901|FG001|Overall Study|Lost to Follow-up|1
6963084|NCT01098812|11008902|FG002|Overall Study|Lost to Follow-up|0
6963085|NCT01098851|11008911|FG000|Overall Study|Equipment failure|1
6963086|NCT01098851|11008912|FG001|Overall Study|Equipment failure|0
6963087|NCT01099215|11008951|FG000|Overall Study|Withdrawal by Subject|1
6963088|NCT01099215|11008952|FG001|Overall Study|Withdrawal by Subject|0
6963089|NCT01099215|11008951|FG000|Overall Study|Adverse Event|0
6963090|NCT01099215|11008952|FG001|Overall Study|Adverse Event|1
6963091|NCT01099267|11008958|FG000|MDS-003 Study|Adverse Event|37
6963092|NCT01099267|11008958|FG000|MDS-003 Study|Lack of Efficacy|52
6963093|NCT01099267|11008958|FG000|MDS-003 Study|Withdrawal by Subject|8
6963094|NCT01099267|11008958|FG000|MDS-003 Study|Lost to Follow-up|1
6963095|NCT01099267|11008958|FG000|MDS-003 Study|Death|11
6963096|NCT01099267|11008958|FG000|MDS-003 Study|Study Closed by Sponsor|2
6963097|NCT01099267|11008958|FG000|MDS-003 Study|Disease Progression|7
6963098|NCT01099267|11008958|FG000|MDS-003 Study|Investigator Decision|2
6963099|NCT01099267|11008958|FG000|MDS-003 Study|Non-Compliance|2
6963100|NCT01099267|11008958|FG000|MDS-003 Study|Loss of Response|1
6963101|NCT01099267|11008958|FG000|MDS-003 Study|Secondary Malign Disease|1
6963102|NCT01099397|11008976|FG000|Overall Study|Lost to Follow-up|4
6963103|NCT01099397|11008976|FG000|Overall Study|Protocol Violation|4
6963104|NCT01099397|11008976|FG000|Overall Study|Withdrawal by Subject|5
6963105|NCT01099579|11009019|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4
6963106|NCT01099579|11009020|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1
6963107|NCT01099579|11009021|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0
6963108|NCT01099579|11009019|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
6963109|NCT01099579|11009020|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
6963110|NCT01099579|11009021|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1
6963111|NCT01099579|11009019|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
6963112|NCT01099579|11009020|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2
6963113|NCT01099579|11009021|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
6963114|NCT01099579|11009019|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
6963115|NCT01099579|11009020|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2
6963116|NCT01099579|11009021|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
6963117|NCT01099579|11009019|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2
6963118|NCT01099579|11009020|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2
6963119|NCT01099579|11009021|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1
6963120|NCT01099579|11009019|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1
6963121|NCT01099579|11009020|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1
6963122|NCT01099579|11009021|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1
6963123|NCT01099579|11009019|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0
6963124|NCT01099579|11009020|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0
6963125|NCT01099579|11009021|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2
6963126|NCT01099579|11009019|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
6963127|NCT01099579|11009020|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
6963128|NCT01099579|11009021|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
6963129|NCT01099579|11009019|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2
6963130|NCT01099579|11009020|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0
6963131|NCT01099579|11009021|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1
6963132|NCT01099579|11009019|FG000|Stage 2 (ATV Capsule)|Adverse Event|0
6963133|NCT01099579|11009020|FG001|Stage 2 (ATV Capsule)|Adverse Event|1
6963134|NCT01099579|11009021|FG002|Stage 2 (ATV Capsule)|Adverse Event|0
6963135|NCT01099709|11009075|FG000|Period 1|Withdrawal by Subject|0
6963136|NCT01099709|11009076|FG001|Period 1|Withdrawal by Subject|1
6963137|NCT01099709|11009075|FG000|Period 1|Positive cotinine test|0
6963138|NCT01099709|11009076|FG001|Period 1|Positive cotinine test|1
6963139|NCT01099709|11009075|FG000|Period 1|Adverse Event|1
6963140|NCT01099709|11009076|FG001|Period 1|Adverse Event|0
6963141|NCT01099917|11009108|FG000|Overall Study|Adverse Event|3
6963142|NCT01099917|11009108|FG000|Overall Study|Not Treated|24
6963143|NCT01100034|11009129|FG000|Overall Study|Lost to Follow-up|11
6963144|NCT01100034|11009129|FG000|Overall Study|Withdrawal of parent/guardian consent|1
6963145|NCT01100034|11009129|FG000|Overall Study|Withdrawal by Subject|4
6963146|NCT01100034|11009129|FG000|Overall Study|Sponsor decision|21
6963147|NCT01100034|11009129|FG000|Overall Study|Participated in another clinical trial|1
6963148|NCT01100034|11009129|FG000|Overall Study|Participants moved to another hospital|4
6963149|NCT01100034|11009129|FG000|Overall Study|Site closed due to non-responsiveness|1
6963150|NCT01100073|11009133|FG000|Overall Study|Lack of Efficacy|4
6963151|NCT01100073|11009133|FG000|Overall Study|Insufficient Tolerability|21
6963152|NCT01100073|11009133|FG000|Overall Study|Withdrawal by Subject|13
6963153|NCT01100073|11009133|FG000|Overall Study|Lost to Follow-up|39
6963154|NCT01100073|11009133|FG000|Overall Study|Lack of effect + patient's wish|2
6963155|NCT01100073|11009133|FG000|Overall Study|Insufficient tolerability +patients wish|8
6963156|NCT01100073|11009133|FG000|Overall Study|Other|8
6963157|NCT01100073|11009133|FG000|Overall Study|Missing|5
6963158|NCT01100086|11009137|FG000|Period 1|Withdrawal by Subject|1
6963159|NCT01100086|11009138|FG001|Period 1|Withdrawal by Subject|0
6963160|NCT01100307|11009167|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
6963161|NCT01100307|11009168|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
6963162|NCT01100307|11009167|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0
6963163|NCT01100307|11009168|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1
6963164|NCT01100307|11009167|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5
6963165|NCT01100307|11009168|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2
6963166|NCT01100307|11009167|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1
6963167|NCT01100307|11009168|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2
6963168|NCT01100307|11009167|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2
6963169|NCT01100307|11009168|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3
6963170|NCT01100307|11009167|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3
6963171|NCT01100307|11009168|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8
6963172|NCT01100320|11009176|FG000|Period 1|Withdrawal by Subject|2
6963173|NCT01100320|11009177|FG001|Period 1|Withdrawal by Subject|4
6963174|NCT01100320|11009176|FG000|Period 1|Positive Drug Screen|1
6963175|NCT01100320|11009177|FG001|Period 1|Positive Drug Screen|1
6963176|NCT01100320|11009176|FG000|Period 1|Adverse Event|2
6963177|NCT01100320|11009177|FG001|Period 1|Adverse Event|2
6963178|NCT01100320|11009176|FG000|Period 2|Withdrawal by Subject|1
6963179|NCT01100320|11009177|FG001|Period 2|Withdrawal by Subject|1
6963180|NCT01100437|11009183|FG000|Titration/Stabilization|Adverse Event|0
6963181|NCT01100437|11009184|FG001|Titration/Stabilization|Adverse Event|0
6963182|NCT01100437|11009185|FG002|Titration/Stabilization|Adverse Event|4
6963183|NCT01100437|11009183|FG000|Titration/Stabilization|Non-compliance|0
6963184|NCT01100437|11009184|FG001|Titration/Stabilization|Non-compliance|0
6963185|NCT01100437|11009185|FG002|Titration/Stabilization|Non-compliance|1
6963186|NCT01100437|11009183|FG000|Titration/Stabilization|Sponsor canceled study|0
6963187|NCT01100437|11009184|FG001|Titration/Stabilization|Sponsor canceled study|0
6963188|NCT01100437|11009185|FG002|Titration/Stabilization|Sponsor canceled study|1
6963189|NCT01100437|11009183|FG000|Maintenance|Withdrawal by Subject|0
6963190|NCT01100437|11009184|FG001|Maintenance|Withdrawal by Subject|0
6963191|NCT01100437|11009185|FG002|Maintenance|Withdrawal by Subject|1
7040887|NCT01721057|11124070|FG004|Treatment Period|Death|0
7072755|NCT02038829|11176918|FG006|Washout Period 2|Withdrawal by Subject|0
7072756|NCT02038829|11176919|FG007|Washout Period 2|Withdrawal by Subject|0
7072757|NCT02038829|11176920|FG008|Washout Period 2|Withdrawal by Subject|0
7072758|NCT02038829|11176921|FG009|Washout Period 2|Withdrawal by Subject|0
7072759|NCT02038829|11176922|FG010|Washout Period 2|Withdrawal by Subject|0
7072760|NCT02038829|11176923|FG011|Washout Period 2|Withdrawal by Subject|0
7072761|NCT02038829|11176912|FG000|Treatment Period 4|Adverse Event|0
7072762|NCT02038829|11176913|FG001|Treatment Period 4|Adverse Event|1
6838621|NCT00261443|10844332|FG001|4: Extension Phase|Adverse Event|1
6963192|NCT01100437|11009183|FG000|Maintenance|Sponsor termination of study|0
6963193|NCT01100437|11009184|FG001|Maintenance|Sponsor termination of study|0
6963194|NCT01100437|11009185|FG002|Maintenance|Sponsor termination of study|1
6963195|NCT01100502|11009196|FG000|Overall Study|Withdrawal by Subject|18
6963196|NCT01100502|11009197|FG001|Overall Study|Withdrawal by Subject|25
6963197|NCT01100502|11009196|FG000|Overall Study|Lost to Follow-up|13
6963198|NCT01100502|11009197|FG001|Overall Study|Lost to Follow-up|28
6963199|NCT01100502|11009196|FG000|Overall Study|Site request to end participation in study|0
6963200|NCT01100502|11009197|FG001|Overall Study|Site request to end participation in study|1
6963201|NCT01100502|11009196|FG000|Overall Study|Death|45
6963202|NCT01100502|11009197|FG001|Overall Study|Death|40
6963203|NCT01100528|11009203|FG000|Overall Study|Death|1
6963204|NCT01100528|11009203|FG000|Overall Study|Withdrawal by Subject|2
6963205|NCT01100567|11009209|FG000|Overall Study|Withdrawal by Subject|5
6963206|NCT01100567|11009210|FG001|Overall Study|Withdrawal by Subject|8
6963207|NCT01100567|11009209|FG000|Overall Study|Early Hospital Discharge|6
6963208|NCT01100567|11009210|FG001|Overall Study|Early Hospital Discharge|4
6963209|NCT01100567|11009209|FG000|Overall Study|Lost to Follow-up|1
6963210|NCT01100567|11009210|FG001|Overall Study|Lost to Follow-up|2
6963211|NCT01100567|11009209|FG000|Overall Study|Physician Decision|0
6963212|NCT01100567|11009210|FG001|Overall Study|Physician Decision|1
6963213|NCT01100567|11009209|FG000|Overall Study|Deemed ineligible after consent|0
6963214|NCT01100567|11009210|FG001|Overall Study|Deemed ineligible after consent|1
6963215|NCT01100853|11009240|FG000|Overall Study|Lost to Follow-up|11
6963216|NCT01100853|11009241|FG001|Overall Study|Lost to Follow-up|6
6963217|NCT01100853|11009240|FG000|Overall Study|Received <4 study injections|10
6963218|NCT01100853|11009241|FG001|Overall Study|Received <4 study injections|13
6963219|NCT01100853|11009240|FG000|Overall Study|Withdrawal by Subject|6
6963220|NCT01100853|11009241|FG001|Overall Study|Withdrawal by Subject|4
6963221|NCT01100944|11009257|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2
6963222|NCT01100944|11009258|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
6963223|NCT01100944|11009259|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
6963224|NCT01100944|11009257|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1
6963225|NCT01100944|11009258|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
6963226|NCT01100944|11009259|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
6963227|NCT01100944|11009257|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1
6963228|NCT01100944|11009258|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
6963229|NCT01100944|11009259|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
6963230|NCT01100944|11009257|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
6963231|NCT01100944|11009258|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2
6963232|NCT01100944|11009259|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
6963233|NCT01101022|11009282|FG000|Overall Study|Adverse Event|6
6963234|NCT01101022|11009283|FG001|Overall Study|Adverse Event|2
6963235|NCT01101022|11009282|FG000|Overall Study|Protocol Violation|4
6963236|NCT01101022|11009283|FG001|Overall Study|Protocol Violation|3
6963237|NCT01101022|11009282|FG000|Overall Study|Withdrawal by Subject|3
6963238|NCT01101022|11009283|FG001|Overall Study|Withdrawal by Subject|8
6963239|NCT01101022|11009282|FG000|Overall Study|Lost to Follow-up|1
6963240|NCT01101022|11009283|FG001|Overall Study|Lost to Follow-up|4
6963241|NCT01101022|11009282|FG000|Overall Study|Lack of Efficacy|0
6963242|NCT01101022|11009283|FG001|Overall Study|Lack of Efficacy|7
6963243|NCT01101022|11009282|FG000|Overall Study|Sponsor decision|1
6963244|NCT01101022|11009283|FG001|Overall Study|Sponsor decision|1
6963245|NCT01101022|11009282|FG000|Overall Study|Non-compliance|1
6963246|NCT01101022|11009283|FG001|Overall Study|Non-compliance|0
6963247|NCT01101022|11009282|FG000|Overall Study|Work schedule|1
7072763|NCT02038829|11176914|FG002|Treatment Period 4|Adverse Event|0
7072764|NCT02038829|11176915|FG003|Treatment Period 4|Adverse Event|0
7072765|NCT02038829|11176916|FG004|Treatment Period 4|Adverse Event|0
7072766|NCT02038829|11176917|FG005|Treatment Period 4|Adverse Event|0
7072767|NCT02038829|11176918|FG006|Treatment Period 4|Adverse Event|0
7072768|NCT02038829|11176919|FG007|Treatment Period 4|Adverse Event|0
7072769|NCT02038829|11176920|FG008|Treatment Period 4|Adverse Event|0
6838622|NCT00261443|10844333|FG002|4: Extension Phase|Adverse Event|0
6838623|NCT00261443|10844331|FG000|4: Extension Phase|Withdrawal by Subject|0
6838624|NCT00261443|10844332|FG001|4: Extension Phase|Withdrawal by Subject|1
6838625|NCT00261443|10844333|FG002|4: Extension Phase|Withdrawal by Subject|2
6838626|NCT00261443|10844331|FG000|4: Extension Phase|Lost to Follow-up|0
6838627|NCT00261443|10844332|FG001|4: Extension Phase|Lost to Follow-up|1
6838628|NCT00261443|10844333|FG002|4: Extension Phase|Lost to Follow-up|0
6838629|NCT00261495|10844346|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28
6838630|NCT00261495|10844347|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36
6838631|NCT00261495|10844346|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6
6838632|NCT00261495|10844347|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11
6838633|NCT00261495|10844346|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
6838634|NCT00261495|10844347|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
6838635|NCT00261495|10844346|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3
6838636|NCT00261495|10844347|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1
6838637|NCT00261495|10844346|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2
6838638|NCT00261495|10844347|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5
6963248|NCT01101022|11009283|FG001|Overall Study|Work schedule|1
6963249|NCT01101022|11009282|FG000|Overall Study|Vacation|0
6963250|NCT01101022|11009283|FG001|Overall Study|Vacation|1
6963251|NCT01101035|11009291|FG000|Overall Study|Adverse Event|191
6963252|NCT01101035|11009292|FG001|Overall Study|Adverse Event|172
6963253|NCT01101035|11009291|FG000|Overall Study|Major Protocol Deviation|52
7072770|NCT02038829|11176921|FG009|Treatment Period 4|Adverse Event|0
7072771|NCT02038829|11176922|FG010|Treatment Period 4|Adverse Event|0
7072772|NCT02038829|11176923|FG011|Treatment Period 4|Adverse Event|0
6838639|NCT00261495|10844346|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1
6838640|NCT00261495|10844347|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4
6838641|NCT00261495|10844346|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29
6963254|NCT01101035|11009292|FG001|Overall Study|Major Protocol Deviation|46
6963255|NCT01101035|11009291|FG000|Overall Study|Lost to Follow-up|226
6963256|NCT01101035|11009292|FG001|Overall Study|Lost to Follow-up|223
6963257|NCT01101035|11009291|FG000|Overall Study|Voluntary Withdrawal|595
6963258|NCT01101035|11009292|FG001|Overall Study|Voluntary Withdrawal|587
6963259|NCT01101035|11009291|FG000|Overall Study|Reason not Specified|333
6963260|NCT01101035|11009292|FG001|Overall Study|Reason not Specified|363
6963261|NCT01101061|11009304|FG000|Overall Study|Adverse Event|0
6963262|NCT01101061|11009305|FG001|Overall Study|Adverse Event|0
6963263|NCT01101061|11009306|FG002|Overall Study|Adverse Event|1
6963264|NCT01101061|11009307|FG003|Overall Study|Adverse Event|0
6963265|NCT01101061|11009308|FG004|Overall Study|Adverse Event|0
6963266|NCT01101061|11009309|FG005|Overall Study|Adverse Event|0
6963267|NCT01101165|11009332|FG000|Period 1|Adverse Event|1
6963268|NCT01101165|11009333|FG001|Period 1|Adverse Event|2
6963269|NCT01101165|11009332|FG000|Period 1|Withdrawal by Subject|0
6963270|NCT01101165|11009333|FG001|Period 1|Withdrawal by Subject|2
6963271|NCT01101165|11009332|FG000|Period 1|Positive Drug Screen|0
6963272|NCT01101165|11009333|FG001|Period 1|Positive Drug Screen|1
6963273|NCT01101165|11009332|FG000|Period 1|Lost to Follow-up|1
6963274|NCT01101165|11009333|FG001|Period 1|Lost to Follow-up|0
6963275|NCT01101165|11009332|FG000|Period 2|Withdrawal by Subject|3
6963276|NCT01101165|11009333|FG001|Period 2|Withdrawal by Subject|1
6963277|NCT01101165|11009332|FG000|Period 2|Adverse Event|1
6963278|NCT01101165|11009333|FG001|Period 2|Adverse Event|0
6963279|NCT01101178|11009339|FG000|Period 1|Withdrawal by Subject|1
6963280|NCT01101178|11009340|FG001|Period 1|Withdrawal by Subject|2
6963281|NCT01101178|11009339|FG000|Period 1|Positive drug screen|1
6963282|NCT01101178|11009340|FG001|Period 1|Positive drug screen|1
6963283|NCT01101178|11009339|FG000|Period 1|Adverse Event|2
6963284|NCT01101178|11009340|FG001|Period 1|Adverse Event|1
6963285|NCT01101178|11009339|FG000|Period 2|Withdrawal by Subject|0
6963286|NCT01101178|11009340|FG001|Period 2|Withdrawal by Subject|1
6963287|NCT01101191|11009347|FG000|Period 1|Withdrawal by Subject|1
6963288|NCT01101191|11009348|FG001|Period 1|Withdrawal by Subject|0
6963289|NCT01101191|11009347|FG000|Period 1|Adverse Event|1
6963290|NCT01101191|11009348|FG001|Period 1|Adverse Event|2
6963291|NCT01101308|11009355|FG000|Period 1|Adverse Event|2
6963292|NCT01101308|11009356|FG001|Period 1|Adverse Event|1
7072773|NCT02038829|11176912|FG000|Washout Period 4|Adverse Event|0
7072774|NCT02038829|11176913|FG001|Washout Period 4|Adverse Event|0
6963293|NCT01101308|11009355|FG000|Period 1|Positive for cotinine|1
6963294|NCT01101308|11009356|FG001|Period 1|Positive for cotinine|0
6963295|NCT01101321|11009363|FG000|Period 1|Withdrawal by Subject|1
6963296|NCT01101321|11009364|FG001|Period 1|Withdrawal by Subject|1
6963297|NCT01101321|11009363|FG000|Period 1|Adverse Event|3
6963298|NCT01101321|11009364|FG001|Period 1|Adverse Event|3
6963299|NCT01101334|11009372|FG000|Overall Study|Adverse Event|9
6963300|NCT01101334|11009373|FG001|Overall Study|Adverse Event|4
6963301|NCT01101334|11009372|FG000|Overall Study|Death|7
6963302|NCT01101334|11009373|FG001|Overall Study|Death|1
6963303|NCT01101334|11009372|FG000|Overall Study|Withdrawal by Subject|4
6963304|NCT01101334|11009373|FG001|Overall Study|Withdrawal by Subject|3
6963305|NCT01101334|11009372|FG000|Overall Study|Withdrawal by Sponsor|1
6963306|NCT01101334|11009373|FG001|Overall Study|Withdrawal by Sponsor|1
6963307|NCT01101334|11009372|FG000|Overall Study|Progressive Disease|22
6963308|NCT01101334|11009373|FG001|Overall Study|Progressive Disease|35
6963309|NCT01101334|11009372|FG000|Overall Study|Other|2
7040888|NCT01721057|11124071|FG005|Treatment Period|Death|0
7040889|NCT01721057|11124072|FG006|Treatment Period|Death|0
7040890|NCT01721057|11124066|FG000|Rescue Period|Adverse Event|0
7072775|NCT02038829|11176914|FG002|Washout Period 4|Adverse Event|0
7072776|NCT02038829|11176915|FG003|Washout Period 4|Adverse Event|0
7072777|NCT02038829|11176916|FG004|Washout Period 4|Adverse Event|0
7072778|NCT02038829|11176917|FG005|Washout Period 4|Adverse Event|0
7072779|NCT02038829|11176918|FG006|Washout Period 4|Adverse Event|1
7072780|NCT02038829|11176919|FG007|Washout Period 4|Adverse Event|0
7072781|NCT02038829|11176920|FG008|Washout Period 4|Adverse Event|0
6963310|NCT01101334|11009373|FG001|Overall Study|Other|1
6963311|NCT01101477|11009382|FG000|Overall Study|Protocol Violation|5
6963312|NCT01101477|11009383|FG001|Overall Study|Protocol Violation|3
6963313|NCT01101477|11009384|FG002|Overall Study|Protocol Violation|1
6963314|NCT01101542|11009392|FG000|Year 3 Surveillance Period|Lost to Follow-up|7
6963315|NCT01101542|11009392|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4
6963316|NCT01101542|11009392|FG000|Year 4 Surveillance Period|Other|287
6963317|NCT01101542|11009392|FG000|Year 5 Surveillance Period|Lost to Follow-up|140
6963318|NCT01101542|11009392|FG000|Year 5 Surveillance Period|Pregnancy|1
6963319|NCT01101542|11009392|FG000|Year 6 Surveillance Period|Lost to Follow-up|986
6963320|NCT01101542|11009392|FG000|Year 6 Surveillance Period|Pregnancy|1
6963321|NCT01101542|11009392|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4
6963322|NCT01101841|11009402|FG000|Overall Study|Adverse Event|15
6963323|NCT01101841|11009403|FG001|Overall Study|Adverse Event|15
6963324|NCT01101841|11009402|FG000|Overall Study|Lost to Follow-up|9
6963325|NCT01101841|11009403|FG001|Overall Study|Lost to Follow-up|3
6963326|NCT01101841|11009402|FG000|Overall Study|Withdrawal by Subject|21
6963327|NCT01101841|11009403|FG001|Overall Study|Withdrawal by Subject|40
7040891|NCT01721057|11124067|FG001|Rescue Period|Adverse Event|0
7072782|NCT02038829|11176921|FG009|Washout Period 4|Adverse Event|0
6963328|NCT01101841|11009402|FG000|Overall Study|Protocol Violation|1
6963329|NCT01101841|11009403|FG001|Overall Study|Protocol Violation|1
6963330|NCT01101841|11009402|FG000|Overall Study|Physician Decision|0
6963331|NCT01101841|11009403|FG001|Overall Study|Physician Decision|2
6963332|NCT01101841|11009402|FG000|Overall Study|Lack of Efficacy|0
6963333|NCT01101841|11009403|FG001|Overall Study|Lack of Efficacy|2
6963334|NCT01101841|11009402|FG000|Overall Study|Other|0
6963335|NCT01101841|11009403|FG001|Overall Study|Other|1
6963336|NCT01101841|11009402|FG000|Overall Study|Suicidality Tracking Scale|3
6963337|NCT01101841|11009403|FG001|Overall Study|Suicidality Tracking Scale|1
6963338|NCT01101841|11009402|FG000|Overall Study|Eligibility Criteria|1
6963339|NCT01101841|11009403|FG001|Overall Study|Eligibility Criteria|2
6976626|NCT01200758|11029411|FG000|Stage I|Disease Progression|9
6976627|NCT01200758|11029412|FG001|Stage I|Disease Progression|7
6976628|NCT01200758|11029413|FG002|Stage I|Disease Progression|0
6976629|NCT01200758|11029414|FG003|Stage I|Disease Progression|0
6976630|NCT01200758|11029411|FG000|Stage 2|Disease Progression|0
6976631|NCT01200758|11029412|FG001|Stage 2|Disease Progression|0
6976632|NCT01200758|11029413|FG002|Stage 2|Disease Progression|16
6976633|NCT01200758|11029414|FG003|Stage 2|Disease Progression|21
6976634|NCT01200758|11029411|FG000|Stage 2|Lack of Efficacy|0
6976635|NCT01200758|11029412|FG001|Stage 2|Lack of Efficacy|0
6976636|NCT01200758|11029413|FG002|Stage 2|Lack of Efficacy|4
6976637|NCT01200758|11029414|FG003|Stage 2|Lack of Efficacy|2
6976638|NCT01200758|11029411|FG000|Stage 2|Physician Decision|0
6976639|NCT01200758|11029412|FG001|Stage 2|Physician Decision|0
6976640|NCT01200758|11029413|FG002|Stage 2|Physician Decision|5
6976641|NCT01200758|11029414|FG003|Stage 2|Physician Decision|7
6976642|NCT01200758|11029411|FG000|Stage 2|Adverse Event|0
6976643|NCT01200758|11029412|FG001|Stage 2|Adverse Event|0
6976644|NCT01200758|11029413|FG002|Stage 2|Adverse Event|5
6976645|NCT01200758|11029414|FG003|Stage 2|Adverse Event|9
6976646|NCT01200758|11029411|FG000|Stage 2|Withdrawal by Subject|0
6976647|NCT01200758|11029412|FG001|Stage 2|Withdrawal by Subject|0
6976648|NCT01200758|11029413|FG002|Stage 2|Withdrawal by Subject|4
6976649|NCT01200758|11029414|FG003|Stage 2|Withdrawal by Subject|1
6976650|NCT01200758|11029411|FG000|Stage 2|Lost to Follow-up|0
6976651|NCT01200758|11029412|FG001|Stage 2|Lost to Follow-up|0
6976652|NCT01200758|11029413|FG002|Stage 2|Lost to Follow-up|3
6976653|NCT01200758|11029414|FG003|Stage 2|Lost to Follow-up|1
6976654|NCT01200758|11029411|FG000|Stage 2|Protocol Violation|0
6976655|NCT01200758|11029412|FG001|Stage 2|Protocol Violation|0
6976656|NCT01200758|11029413|FG002|Stage 2|Protocol Violation|1
6976657|NCT01200758|11029414|FG003|Stage 2|Protocol Violation|4
6976658|NCT01200758|11029411|FG000|Stage 2|Death|0
6976659|NCT01200758|11029412|FG001|Stage 2|Death|0
6976660|NCT01200758|11029413|FG002|Stage 2|Death|3
6976661|NCT01200758|11029414|FG003|Stage 2|Death|5
6976662|NCT01200797|11029426|FG000|Overall Study|symptomatic deterioration|2
6976663|NCT01200797|11029426|FG000|Overall Study|Adverse Event|4
6976664|NCT01200797|11029426|FG000|Overall Study|Disease Progression|13
6976665|NCT01200810|11029433|FG000|Overall Study|Physician Decision|1
6976666|NCT01200810|11029434|FG001|Overall Study|Physician Decision|0
6976667|NCT01200810|11029433|FG000|Overall Study|Withdrawal by Subject|1
6976668|NCT01200810|11029434|FG001|Overall Study|Withdrawal by Subject|2
6976669|NCT01200810|11029433|FG000|Overall Study|Sponsor stopped making study drug|3
6976670|NCT01200810|11029434|FG001|Overall Study|Sponsor stopped making study drug|3
6976671|NCT01200992|11029446|FG000|Overall Study|Study terminated early|35
6976672|NCT01200992|11029447|FG001|Overall Study|Study terminated early|41
6976673|NCT01200992|11029446|FG000|Overall Study|Randomized but not treated|2
6976674|NCT01200992|11029447|FG001|Overall Study|Randomized but not treated|0
6976675|NCT01201265|11029472|FG000|Overall Study|Death|14
6976676|NCT01201265|11029472|FG000|Overall Study|Insufficient Therapeutic Response|3
6976677|NCT01201265|11029472|FG000|Overall Study|Lost to Follow-up|10
6976678|NCT01201265|11029472|FG000|Overall Study|Withdrawal by Subject|7
6976679|NCT01201265|11029472|FG000|Overall Study|Disease Progression|4
6976680|NCT01201317|11029479|FG000|Overall Study|Withdrawal by Subject|5
6976681|NCT01201317|11029480|FG001|Overall Study|Withdrawal by Subject|0
6976682|NCT01201317|11029481|FG002|Overall Study|Withdrawal by Subject|3
6976683|NCT01201317|11029479|FG000|Overall Study|Adverse Event|2
6976684|NCT01201317|11029480|FG001|Overall Study|Adverse Event|2
6976685|NCT01201317|11029481|FG002|Overall Study|Adverse Event|2
6976686|NCT01201317|11029479|FG000|Overall Study|Screen failure|1
6976687|NCT01201317|11029480|FG001|Overall Study|Screen failure|1
6976688|NCT01201317|11029481|FG002|Overall Study|Screen failure|0
6976689|NCT01201317|11029479|FG000|Overall Study|Protocol Violation|0
6976690|NCT01201317|11029480|FG001|Overall Study|Protocol Violation|1
6976691|NCT01201317|11029481|FG002|Overall Study|Protocol Violation|1
6976692|NCT01201317|11029479|FG000|Overall Study|Death|0
6976693|NCT01201317|11029480|FG001|Overall Study|Death|1
6976694|NCT01201317|11029481|FG002|Overall Study|Death|0
6976695|NCT01201317|11029479|FG000|Overall Study|Study-specific withdrawal criteria|0
6976696|NCT01201317|11029480|FG001|Overall Study|Study-specific withdrawal criteria|0
6976697|NCT01201317|11029481|FG002|Overall Study|Study-specific withdrawal criteria|1
6976698|NCT01201317|11029479|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0
6976699|NCT01201317|11029480|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1
6976700|NCT01201317|11029481|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0
6976701|NCT01201317|11029479|FG000|Overall Study|Decrease in renal function|0
6976702|NCT01201317|11029480|FG001|Overall Study|Decrease in renal function|1
6963340|NCT01101997|11009440|FG000|Overall Study|Withdrawal by Subject|2
6963341|NCT01102231|11009455|FG000|Overall Study|Protocol Violation|3
6963342|NCT01102231|11009455|FG000|Overall Study|Lack of Efficacy|2
6963343|NCT01102231|11009455|FG000|Overall Study|Death|2
6963344|NCT01102231|11009455|FG000|Overall Study|Adverse Event|3
6963345|NCT01102231|11009455|FG000|Overall Study|Withdrawal by Subject|1
6963346|NCT01102231|11009455|FG000|Overall Study|Did not received the treatment|4
6963347|NCT01102257|11009462|FG000|Overall Study|Adverse Event|1
6963348|NCT01102257|11009463|FG001|Overall Study|Adverse Event|0
6963349|NCT01102257|11009462|FG000|Overall Study|Adverse Event|1
6963350|NCT01102257|11009463|FG001|Overall Study|Adverse Event|0
6963351|NCT01102374|11009478|FG000|Overall Study|Death|9
6963352|NCT01102374|11009479|FG001|Overall Study|Death|13
6963353|NCT01102374|11009478|FG000|Overall Study|Lost to Follow-up|7
6963354|NCT01102374|11009479|FG001|Overall Study|Lost to Follow-up|6
6963355|NCT01102426|11009496|FG000|Overall Study|Randomized but not treated|4
6963356|NCT01102426|11009497|FG001|Overall Study|Randomized but not treated|1
6963357|NCT01102426|11009496|FG000|Overall Study|Adverse Events (treatment-related)|15
7072783|NCT02038829|11176922|FG010|Washout Period 4|Adverse Event|0
7072784|NCT02038829|11176923|FG011|Washout Period 4|Adverse Event|0
7072785|NCT02038829|11176912|FG000|Treatment Period 6|Adverse Event|0
7072786|NCT02038829|11176913|FG001|Treatment Period 6|Adverse Event|0
6963358|NCT01102426|11009497|FG001|Overall Study|Adverse Events (treatment-related)|8
6963359|NCT01102426|11009496|FG000|Overall Study|Physician Decision|9
6963360|NCT01102426|11009497|FG001|Overall Study|Physician Decision|6
6963361|NCT01102426|11009496|FG000|Overall Study|Progressive Disease|85
6963362|NCT01102426|11009497|FG001|Overall Study|Progressive Disease|44
6963363|NCT01102426|11009496|FG000|Overall Study|Adverse Events (unrelated to|9
6963364|NCT01102426|11009497|FG001|Overall Study|Adverse Events (unrelated to|1
6963365|NCT01102426|11009496|FG000|Overall Study|Patient Refusal|24
6963366|NCT01102426|11009497|FG001|Overall Study|Patient Refusal|12
6963367|NCT01102426|11009496|FG000|Overall Study|Death (due to adverse events|0
6963368|NCT01102426|11009497|FG001|Overall Study|Death (due to adverse events|1
6963369|NCT01102426|11009496|FG000|Overall Study|Death (non-related to the study|19
6963370|NCT01102426|11009497|FG001|Overall Study|Death (non-related to the study|8
6963371|NCT01102491|11009505|FG000|Overall Study|Protocol Violation|11
6963372|NCT01102491|11009506|FG001|Overall Study|Protocol Violation|12
6963373|NCT01102777|11009527|FG000|Overall Study|Death|2
6963374|NCT01102777|11009528|FG001|Overall Study|Death|6
6963375|NCT01102777|11009527|FG000|Overall Study|Lost to Follow-up|7
6963376|NCT01102777|11009528|FG001|Overall Study|Lost to Follow-up|10
6963377|NCT01102803|11009537|FG000|Baseline to Post-Treatment|Lost to Follow-up|3
6963378|NCT01102803|11009538|FG001|Baseline to Post-Treatment|Lost to Follow-up|0
6963379|NCT01102803|11009537|FG000|Post to Follow-Up|Lost to Follow-up|1
6963380|NCT01102803|11009538|FG001|Post to Follow-Up|Lost to Follow-up|3
6963381|NCT01102972|11009554|FG000|Overall Study|Adverse Event|8
6963382|NCT01102972|11009555|FG001|Overall Study|Adverse Event|2
6963383|NCT01102972|11009554|FG000|Overall Study|Lack of Efficacy|2
6963384|NCT01102972|11009555|FG001|Overall Study|Lack of Efficacy|1
6963385|NCT01102972|11009554|FG000|Overall Study|Protocol Violation|1
6963386|NCT01102972|11009555|FG001|Overall Study|Protocol Violation|0
6963387|NCT01102972|11009554|FG000|Overall Study|Lost to Follow-up|10
6963388|NCT01102972|11009555|FG001|Overall Study|Lost to Follow-up|5
7072787|NCT02038829|11176914|FG002|Treatment Period 6|Adverse Event|1
7072788|NCT02038829|11176915|FG003|Treatment Period 6|Adverse Event|0
7072789|NCT02038829|11176916|FG004|Treatment Period 6|Adverse Event|0
7072790|NCT02038829|11176917|FG005|Treatment Period 6|Adverse Event|0
7072791|NCT02038829|11176918|FG006|Treatment Period 6|Adverse Event|0
7072792|NCT02038829|11176919|FG007|Treatment Period 6|Adverse Event|0
7072793|NCT02038829|11176920|FG008|Treatment Period 6|Adverse Event|0
7072794|NCT02038829|11176921|FG009|Treatment Period 6|Adverse Event|0
7072795|NCT02038829|11176922|FG010|Treatment Period 6|Adverse Event|0
7072796|NCT02038829|11176923|FG011|Treatment Period 6|Adverse Event|0
7072797|NCT02038881|11176941|FG000|Overall Study|Withdrawal by Subject|0
7072798|NCT02038881|11176942|FG001|Overall Study|Withdrawal by Subject|0
7072799|NCT02038881|11176943|FG002|Overall Study|Withdrawal by Subject|1
7072800|NCT02038881|11176941|FG000|Overall Study|Lost to Follow-up|2
7072801|NCT02038881|11176942|FG001|Overall Study|Lost to Follow-up|0
6963389|NCT01102972|11009554|FG000|Overall Study|Investigator Discretion|2
6963390|NCT01102972|11009555|FG001|Overall Study|Investigator Discretion|0
6963391|NCT01102972|11009554|FG000|Overall Study|Withdrawal by Subject|6
6963392|NCT01102972|11009555|FG001|Overall Study|Withdrawal by Subject|6
6963393|NCT01103063|11009563|FG000|Overall Study|Adverse Event|3
6963394|NCT01103063|11009564|FG001|Overall Study|Adverse Event|1
6963395|NCT01103063|11009563|FG000|Overall Study|Lost to Follow-up|68
6963396|NCT01103063|11009564|FG001|Overall Study|Lost to Follow-up|51
6963397|NCT01103063|11009563|FG000|Overall Study|Withdrawal by Subject|60
6963398|NCT01103063|11009564|FG001|Overall Study|Withdrawal by Subject|15
6963399|NCT01103063|11009563|FG000|Overall Study|Other|16
6963400|NCT01103063|11009564|FG001|Overall Study|Other|11
6963401|NCT01103063|11009563|FG000|Overall Study|Protocol Violation|1
7072802|NCT02038881|11176943|FG002|Overall Study|Lost to Follow-up|0
7072803|NCT02038881|11176941|FG000|Overall Study|incarcerated|1
7072804|NCT02038881|11176942|FG001|Overall Study|incarcerated|0
7072805|NCT02038881|11176943|FG002|Overall Study|incarcerated|0
7072806|NCT02038907|11176984|FG000|Overall Study|Protocol Violation|0
7072807|NCT02038907|11176985|FG001|Overall Study|Protocol Violation|0
7072808|NCT02038907|11176986|FG002|Overall Study|Protocol Violation|0
7072809|NCT02038907|11176987|FG003|Overall Study|Protocol Violation|0
7072810|NCT02038907|11176988|FG004|Overall Study|Protocol Violation|0
7072811|NCT02038907|11176989|FG005|Overall Study|Protocol Violation|0
7072812|NCT02038907|11176990|FG006|Overall Study|Protocol Violation|0
6963402|NCT01103063|11009564|FG001|Overall Study|Protocol Violation|0
6963403|NCT01103063|11009563|FG000|Overall Study|Study terminated by Sponsor|326
6963404|NCT01103063|11009564|FG001|Overall Study|Study terminated by Sponsor|342
6963405|NCT01103063|11009563|FG000|Overall Study|Death|3
6963406|NCT01103063|11009564|FG001|Overall Study|Death|1
6963407|NCT01103141|11009574|FG000|Overall Study|Death|0
6963408|NCT01103141|11009575|FG001|Overall Study|Death|1
6963409|NCT01103141|11009574|FG000|Overall Study|Lost to Follow-up|2
6963410|NCT01103141|11009575|FG001|Overall Study|Lost to Follow-up|1
6963411|NCT01103232|11009583|FG000|Overall Study|Withdrawal by Subject|1
6963412|NCT01103232|11009584|FG001|Overall Study|Withdrawal by Subject|1
6963413|NCT01103232|11009583|FG000|Overall Study|Protocol Violation|0
6963414|NCT01103232|11009584|FG001|Overall Study|Protocol Violation|1
6963415|NCT01103245|11009594|FG000|Overall Study|Withdrawal by Subject|1
6963416|NCT01103245|11009595|FG001|Overall Study|Withdrawal by Subject|0
6963417|NCT01103245|11009596|FG002|Overall Study|Withdrawal by Subject|3
6963418|NCT01103245|11009597|FG003|Overall Study|Withdrawal by Subject|0
6963419|NCT01103245|11009594|FG000|Overall Study|Inadequate IV access|1
6963420|NCT01103245|11009595|FG001|Overall Study|Inadequate IV access|0
6963421|NCT01103245|11009596|FG002|Overall Study|Inadequate IV access|0
6963422|NCT01103245|11009597|FG003|Overall Study|Inadequate IV access|0
6963423|NCT01103245|11009594|FG000|Overall Study|Adverse Event|0
6963424|NCT01103245|11009595|FG001|Overall Study|Adverse Event|2
6963425|NCT01103245|11009596|FG002|Overall Study|Adverse Event|1
6963426|NCT01103245|11009597|FG003|Overall Study|Adverse Event|0
6963427|NCT01103245|11009594|FG000|Overall Study|Physician Decision|1
6963428|NCT01103245|11009595|FG001|Overall Study|Physician Decision|0
6963429|NCT01103245|11009596|FG002|Overall Study|Physician Decision|0
6963430|NCT01103245|11009597|FG003|Overall Study|Physician Decision|0
6963431|NCT01103284|11009619|FG000|Overall Study|Death|2
6963432|NCT01103284|11009620|FG001|Overall Study|Death|0
6963433|NCT01103284|11009619|FG000|Overall Study|Lost to Follow-up|9
6963434|NCT01103284|11009620|FG001|Overall Study|Lost to Follow-up|10
6963435|NCT01103284|11009619|FG000|Overall Study|Pregnancy|3
6963436|NCT01103284|11009620|FG001|Overall Study|Pregnancy|1
6963437|NCT01103284|11009619|FG000|Overall Study|Protocol Violation|12
6963438|NCT01103284|11009620|FG001|Overall Study|Protocol Violation|5
6963439|NCT01103284|11009619|FG000|Overall Study|Adverse Event|0
6963440|NCT01103284|11009620|FG001|Overall Study|Adverse Event|5
6963441|NCT01103284|11009619|FG000|Overall Study|Withdrawal by Subject|14
6963442|NCT01103284|11009620|FG001|Overall Study|Withdrawal by Subject|18
6963443|NCT01103284|11009619|FG000|Overall Study|Dermal Hypersensitivity|0
6963444|NCT01103284|11009620|FG001|Overall Study|Dermal Hypersensitivity|1
6963445|NCT01103284|11009619|FG000|Overall Study|Termination by the Sponsor|0
6963446|NCT01103284|11009620|FG001|Overall Study|Termination by the Sponsor|1
6963447|NCT01103284|11009619|FG000|Overall Study|Not described|2
6963448|NCT01103284|11009620|FG001|Overall Study|Not described|1
6963449|NCT01103284|11009619|FG000|Overall Study|Missing CRF entries for study completion|0
6963450|NCT01103284|11009620|FG001|Overall Study|Missing CRF entries for study completion|2
6963451|NCT01103323|11009628|FG000|Without/Before Drug Switch|Adverse Event|50
6963452|NCT01103323|11009629|FG001|Without/Before Drug Switch|Adverse Event|7
6963453|NCT01103323|11009628|FG000|Without/Before Drug Switch|Withdrawal by Subject|17
6963454|NCT01103323|11009629|FG001|Without/Before Drug Switch|Withdrawal by Subject|5
6963455|NCT01103323|11009628|FG000|Without/Before Drug Switch|Protocol Violation|2
6963456|NCT01103323|11009629|FG001|Without/Before Drug Switch|Protocol Violation|0
6963457|NCT01103323|11009628|FG000|Without/Before Drug Switch|Physician Decision|2
6963458|NCT01103323|11009629|FG001|Without/Before Drug Switch|Physician Decision|0
6963459|NCT01103323|11009628|FG000|Without/Before Drug Switch|did not receive study treatment|5
6963460|NCT01103323|11009629|FG001|Without/Before Drug Switch|did not receive study treatment|2
6963461|NCT01103323|11009628|FG000|Without/Before Drug Switch|Switch to Regorafenib|0
6963462|NCT01103323|11009629|FG001|Without/Before Drug Switch|Switch to Regorafenib|4
6963463|NCT01103323|11009628|FG000|Switched From Placebo to Regorafenib|Adverse Event|0
6963464|NCT01103323|11009629|FG001|Switched From Placebo to Regorafenib|Adverse Event|1
6963465|NCT01103362|11009636|FG000|Overall Study|study terminated|596
6963466|NCT01103466|11009670|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2
6963467|NCT01103466|11009671|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0
6963468|NCT01103466|11009672|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0
6963469|NCT01103466|11009670|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2
6963470|NCT01103466|11009671|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1
6963471|NCT01103466|11009672|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0
6963472|NCT01103466|11009670|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0
6963473|NCT01103466|11009671|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
6963474|NCT01103466|11009672|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
6976703|NCT01201317|11029481|FG002|Overall Study|Decrease in renal function|0
7072813|NCT02038907|11176991|FG007|Overall Study|Protocol Violation|0
6963475|NCT01103466|11009670|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1
6963476|NCT01103466|11009671|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0
6963477|NCT01103466|11009672|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0
6963478|NCT01103466|11009670|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1
6963479|NCT01103466|11009671|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
6963480|NCT01103466|11009672|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
6963481|NCT01103466|11009670|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0
6963482|NCT01103466|11009671|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0
6963483|NCT01103466|11009672|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1
6963484|NCT01103479|11009683|FG000|Overall Study|Up to date with CRC screening|1
6963485|NCT01103479|11009684|FG001|Overall Study|Up to date with CRC screening|9
6963486|NCT01103479|11009685|FG002|Overall Study|Up to date with CRC screening|12
6963487|NCT01103479|11009683|FG000|Overall Study|Family history of CRC|1
6963488|NCT01103479|11009684|FG001|Overall Study|Family history of CRC|0
6963489|NCT01103479|11009685|FG002|Overall Study|Family history of CRC|2
6963490|NCT01103479|11009683|FG000|Overall Study|Active cancer|1
6963491|NCT01103479|11009684|FG001|Overall Study|Active cancer|0
6963492|NCT01103479|11009685|FG002|Overall Study|Active cancer|0
6963493|NCT01103479|11009683|FG000|Overall Study|Saw non-study physician|2
6963494|NCT01103479|11009684|FG001|Overall Study|Saw non-study physician|0
6963495|NCT01103479|11009685|FG002|Overall Study|Saw non-study physician|0
6963496|NCT01103713|11009715|FG000|Overall Study|Lost to Follow-up|2
6963497|NCT01103713|11009715|FG000|Overall Study|Withdrawal by Subject|8
6963498|NCT01103713|11009715|FG000|Overall Study|Study terminated by sponsor|2
6963499|NCT01103713|11009715|FG000|Overall Study|Other|1
6963500|NCT01103778|11009722|FG000|Overall Study|Lost to Follow-up|1
6963501|NCT01103778|11009722|FG000|Overall Study|Proteinuria improved prior to enrollment|1
6963502|NCT01103778|11009722|FG000|Overall Study|Screen failure|1
6963503|NCT01103960|11009739|FG000|Overall Study|Adverse Event|2
6963504|NCT01103960|11009740|FG001|Overall Study|Adverse Event|1
6963505|NCT01103960|11009739|FG000|Overall Study|Withdrawal by Subject|2
6963506|NCT01103960|11009740|FG001|Overall Study|Withdrawal by Subject|1
6963507|NCT01103960|11009739|FG000|Overall Study|Other|1
6963508|NCT01103960|11009740|FG001|Overall Study|Other|0
6963509|NCT01104155|11009781|FG000|Overall Study|Adverse Event|15
6963510|NCT01104155|11009782|FG001|Overall Study|Adverse Event|8
7072814|NCT02038907|11176992|FG008|Overall Study|Protocol Violation|0
6963511|NCT01104155|11009781|FG000|Overall Study|Participant choice|6
6963512|NCT01104155|11009782|FG001|Overall Study|Participant choice|5
6963513|NCT01104155|11009781|FG000|Overall Study|Withdrawal of consent|1
6963514|NCT01104155|11009782|FG001|Overall Study|Withdrawal of consent|1
6963515|NCT01104155|11009781|FG000|Overall Study|Other|3
6963516|NCT01104155|11009782|FG001|Overall Study|Other|4
6963517|NCT01104246|11009797|FG000|Overall Study|Withdrawal by Subject|1
6963518|NCT01104246|11009797|FG000|Overall Study|did not meet inclusion criteria|4
6963519|NCT01104311|11009812|FG000|Overall Study|Withdrawal by Subject|6
6963520|NCT01104311|11009813|FG001|Overall Study|Withdrawal by Subject|6
6963521|NCT01104311|11009812|FG000|Overall Study|Protocol Violation|0
6963522|NCT01104311|11009813|FG001|Overall Study|Protocol Violation|1
6963523|NCT01104311|11009812|FG000|Overall Study|Physician Decision|2
6963524|NCT01104311|11009813|FG001|Overall Study|Physician Decision|2
6963525|NCT01104311|11009812|FG000|Overall Study|low compliance|1
6963526|NCT01104311|11009813|FG001|Overall Study|low compliance|1
6963527|NCT01104311|11009812|FG000|Overall Study|Adverse Event|1
6963528|NCT01104311|11009813|FG001|Overall Study|Adverse Event|2
6963529|NCT01104376|11009823|FG000|Overall Study|Withdrawal by Subject|15
6963530|NCT01104376|11009823|FG000|Overall Study|Consented but excluded after labs|13
7072815|NCT02038907|11176993|FG009|Overall Study|Protocol Violation|0
7072816|NCT02038907|11176994|FG010|Overall Study|Protocol Violation|1
7072817|NCT02038907|11176995|FG011|Overall Study|Protocol Violation|0
7072818|NCT02038907|11176996|FG012|Overall Study|Protocol Violation|0
7072819|NCT02038907|11176997|FG013|Overall Study|Protocol Violation|0
7072820|NCT02038907|11176984|FG000|Overall Study|Withdrawal by Subject|0
7072821|NCT02038907|11176985|FG001|Overall Study|Withdrawal by Subject|0
7072822|NCT02038907|11176986|FG002|Overall Study|Withdrawal by Subject|0
6963531|NCT01104415|11009836|FG000|Core Phase|Consent withdrawn by subjects|1
6963532|NCT01104415|11009837|FG001|Core Phase|Consent withdrawn by subjects|0
6963533|NCT01104415|11009836|FG000|Extension Period|Progressive disease|0
6963534|NCT01104415|11009837|FG001|Extension Period|Progressive disease|4
6963535|NCT01104415|11009836|FG000|Extension Period|Death|0
6963536|NCT01104415|11009837|FG001|Extension Period|Death|1
6963537|NCT01104415|11009836|FG000|Extension Period|Physician Decision|0
6963538|NCT01104415|11009837|FG001|Extension Period|Physician Decision|1
6963539|NCT01104415|11009836|FG000|Extension Period|Transition to Study LX1606.302|0
6963540|NCT01104415|11009837|FG001|Extension Period|Transition to Study LX1606.302|4
6963541|NCT01104415|11009836|FG000|Extension Period|Heart surgery/feeling miserable|0
6963542|NCT01104415|11009837|FG001|Extension Period|Heart surgery/feeling miserable|1
6963543|NCT01104493|11009846|FG000|Overall Study|Lost to Follow-up|0
6963544|NCT01104493|11009847|FG001|Overall Study|Lost to Follow-up|2
6963545|NCT01104545|11009856|FG000|Overall Study|Adverse Event|0
6963546|NCT01104545|11009857|FG001|Overall Study|Adverse Event|1
7072823|NCT02038907|11176987|FG003|Overall Study|Withdrawal by Subject|0
7072824|NCT02038907|11176988|FG004|Overall Study|Withdrawal by Subject|0
6963547|NCT01104545|11009858|FG002|Overall Study|Adverse Event|2
6963548|NCT01104558|11009903|FG000|Overall Study|Protocol Violation|6
6963549|NCT01104558|11009903|FG000|Overall Study|Missing of primary efficacy assessment|10
6963550|NCT01104558|11009903|FG000|Overall Study|Missing of genetic analysis results|1
6963551|NCT01104584|11009907|FG000|Overall Study|Study drug never administered|21
6963552|NCT01104584|11009907|FG000|Overall Study|Study prematurely discontinued|2
6963553|NCT01104636|11009929|FG000|Overall Study|Lack of Efficacy|43
6963554|NCT01104636|11009929|FG000|Overall Study|Lost to Follow-up|24
6963555|NCT01104636|11009929|FG000|Overall Study|Withdrawal by Subject|4
6963556|NCT01104636|11009929|FG000|Overall Study|Other|43
6963557|NCT01104636|11009929|FG000|Overall Study|Study terminated by sponsor|1
6963558|NCT01104636|11009929|FG000|Overall Study|Pregnancy|2
6963559|NCT01104636|11009929|FG000|Overall Study|Adverse Event|40
6963560|NCT01104636|11009929|FG000|Overall Study|Ongoing|21
6963561|NCT01104662|11009941|FG000|Overall Study|Adverse Event|2
6963562|NCT01104662|11009942|FG001|Overall Study|Adverse Event|2
6963563|NCT01104662|11009943|FG002|Overall Study|Adverse Event|0
6963564|NCT01104662|11009944|FG003|Overall Study|Adverse Event|1
6963565|NCT01104662|11009945|FG004|Overall Study|Adverse Event|1
6963566|NCT01104662|11009946|FG005|Overall Study|Adverse Event|1
6963567|NCT01104662|11009947|FG006|Overall Study|Adverse Event|0
6963568|NCT01104662|11009948|FG007|Overall Study|Adverse Event|0
6963569|NCT01104662|11009941|FG000|Overall Study|Clinical Failure|1
6963570|NCT01104662|11009942|FG001|Overall Study|Clinical Failure|0
6963571|NCT01104662|11009943|FG002|Overall Study|Clinical Failure|0
6963572|NCT01104662|11009944|FG003|Overall Study|Clinical Failure|0
6963573|NCT01104662|11009945|FG004|Overall Study|Clinical Failure|0
6963574|NCT01104662|11009946|FG005|Overall Study|Clinical Failure|1
6963575|NCT01104662|11009947|FG006|Overall Study|Clinical Failure|0
6963576|NCT01104662|11009948|FG007|Overall Study|Clinical Failure|0
6963577|NCT01104662|11009941|FG000|Overall Study|Participant left investigator's care|1
6963578|NCT01104662|11009942|FG001|Overall Study|Participant left investigator's care|1
6963579|NCT01104662|11009943|FG002|Overall Study|Participant left investigator's care|0
6963580|NCT01104662|11009944|FG003|Overall Study|Participant left investigator's care|0
6963581|NCT01104662|11009945|FG004|Overall Study|Participant left investigator's care|0
6963582|NCT01104662|11009946|FG005|Overall Study|Participant left investigator's care|0
6963583|NCT01104662|11009947|FG006|Overall Study|Participant left investigator's care|0
6963584|NCT01104662|11009948|FG007|Overall Study|Participant left investigator's care|0
6963585|NCT01104662|11009941|FG000|Overall Study|Reason not specified|3
6963586|NCT01104662|11009942|FG001|Overall Study|Reason not specified|3
6963587|NCT01104662|11009943|FG002|Overall Study|Reason not specified|0
6963588|NCT01104662|11009944|FG003|Overall Study|Reason not specified|0
6963589|NCT01104662|11009945|FG004|Overall Study|Reason not specified|0
6963590|NCT01104662|11009946|FG005|Overall Study|Reason not specified|1
6963591|NCT01104662|11009947|FG006|Overall Study|Reason not specified|0
6963592|NCT01104662|11009948|FG007|Overall Study|Reason not specified|0
6963593|NCT01104662|11009941|FG000|Overall Study|Randomized but not treated|3
6963594|NCT01104662|11009942|FG001|Overall Study|Randomized but not treated|4
6963595|NCT01104662|11009943|FG002|Overall Study|Randomized but not treated|1
6963596|NCT01104662|11009944|FG003|Overall Study|Randomized but not treated|0
6963597|NCT01104662|11009945|FG004|Overall Study|Randomized but not treated|0
6963598|NCT01104662|11009946|FG005|Overall Study|Randomized but not treated|1
6963599|NCT01104662|11009947|FG006|Overall Study|Randomized but not treated|0
6963600|NCT01104662|11009948|FG007|Overall Study|Randomized but not treated|0
6963601|NCT01104701|11009971|FG000|Overall Study|Withdrawal by Subject|0
6963602|NCT01104701|11009972|FG001|Overall Study|Withdrawal by Subject|1
6963603|NCT01104701|11009973|FG002|Overall Study|Withdrawal by Subject|2
6963604|NCT01104701|11009974|FG003|Overall Study|Withdrawal by Subject|1
6963605|NCT01104701|11009971|FG000|Overall Study|Adverse Event|0
6963606|NCT01104701|11009972|FG001|Overall Study|Adverse Event|0
6963607|NCT01104701|11009973|FG002|Overall Study|Adverse Event|0
6963608|NCT01104701|11009974|FG003|Overall Study|Adverse Event|1
6963609|NCT01104701|11009971|FG000|Overall Study|Physician Decision|0
6963610|NCT01104701|11009972|FG001|Overall Study|Physician Decision|2
6963611|NCT01104701|11009973|FG002|Overall Study|Physician Decision|0
6963612|NCT01104701|11009974|FG003|Overall Study|Physician Decision|0
6963613|NCT01104766|11009988|FG000|Overall Study|Did not meet inc/exc criteria|1
6963614|NCT01104766|11009989|FG001|Overall Study|Did not meet inc/exc criteria|0
6963615|NCT01104766|11009990|FG002|Overall Study|Did not meet inc/exc criteria|0
6963616|NCT01104766|11009991|FG003|Overall Study|Did not meet inc/exc criteria|0
6963617|NCT01104766|11009988|FG000|Overall Study|Adverse Event|17
6963618|NCT01104766|11009989|FG001|Overall Study|Adverse Event|15
6963619|NCT01104766|11009990|FG002|Overall Study|Adverse Event|20
6963620|NCT01104766|11009991|FG003|Overall Study|Adverse Event|14
6963621|NCT01104766|11009988|FG000|Overall Study|Lack of Efficacy|20
6963622|NCT01104766|11009989|FG001|Overall Study|Lack of Efficacy|15
6963623|NCT01104766|11009990|FG002|Overall Study|Lack of Efficacy|14
6963624|NCT01104766|11009991|FG003|Overall Study|Lack of Efficacy|8
6963625|NCT01104766|11009988|FG000|Overall Study|Protocol Violation|2
6963626|NCT01104766|11009989|FG001|Overall Study|Protocol Violation|0
6963627|NCT01104766|11009990|FG002|Overall Study|Protocol Violation|0
6963628|NCT01104766|11009991|FG003|Overall Study|Protocol Violation|0
6963629|NCT01104766|11009988|FG000|Overall Study|Withdrawal by Subject|17
6963630|NCT01104766|11009989|FG001|Overall Study|Withdrawal by Subject|19
6963631|NCT01104766|11009990|FG002|Overall Study|Withdrawal by Subject|25
6963632|NCT01104766|11009991|FG003|Overall Study|Withdrawal by Subject|15
6963633|NCT01104766|11009988|FG000|Overall Study|Lost to Follow-up|1
6963634|NCT01104766|11009989|FG001|Overall Study|Lost to Follow-up|2
6963635|NCT01104766|11009990|FG002|Overall Study|Lost to Follow-up|1
6963636|NCT01104766|11009991|FG003|Overall Study|Lost to Follow-up|1
6963637|NCT01104779|11010004|FG000|Overall Study|Protocol Violation|1
6963638|NCT01104779|11010005|FG001|Overall Study|Protocol Violation|2
6963639|NCT01104779|11010006|FG002|Overall Study|Protocol Violation|2
6963640|NCT01104779|11010004|FG000|Overall Study|Lack of Efficacy|26
6963641|NCT01104779|11010005|FG001|Overall Study|Lack of Efficacy|12
6963642|NCT01104779|11010006|FG002|Overall Study|Lack of Efficacy|13
6963643|NCT01104779|11010004|FG000|Overall Study|Adverse Event|13
6963644|NCT01104779|11010005|FG001|Overall Study|Adverse Event|14
6963645|NCT01104779|11010006|FG002|Overall Study|Adverse Event|13
6963646|NCT01104779|11010004|FG000|Overall Study|Did not meet inc/exc criteria|1
6963647|NCT01104779|11010005|FG001|Overall Study|Did not meet inc/exc criteria|1
6963648|NCT01104779|11010006|FG002|Overall Study|Did not meet inc/exc criteria|1
6963649|NCT01104779|11010004|FG000|Overall Study|Other reasons|0
6963650|NCT01104779|11010005|FG001|Overall Study|Other reasons|1
6963651|NCT01104779|11010006|FG002|Overall Study|Other reasons|0
6963652|NCT01104779|11010004|FG000|Overall Study|Lost to Follow-up|2
6963653|NCT01104779|11010005|FG001|Overall Study|Lost to Follow-up|0
6963654|NCT01104779|11010006|FG002|Overall Study|Lost to Follow-up|1
6963655|NCT01104779|11010004|FG000|Overall Study|Withdrawal by Subject|16
6963656|NCT01104779|11010005|FG001|Overall Study|Withdrawal by Subject|25
6963657|NCT01104779|11010006|FG002|Overall Study|Withdrawal by Subject|32
6963658|NCT01104792|11010014|FG000|Overall Study|Adverse Event|77
6963659|NCT01104792|11010014|FG000|Overall Study|Insufficient Therapeutic Response|22
6963660|NCT01104792|11010014|FG000|Overall Study|Protocol Violation|45
6963661|NCT01104792|11010014|FG000|Overall Study|Withdrawal of Consent|179
6963662|NCT01104792|11010014|FG000|Overall Study|Lost to Follow-up|43
6963663|NCT01104792|11010014|FG000|Overall Study|Reasons Not Specified|27
6963664|NCT01104792|11010014|FG000|Overall Study|Did Not Meet Eligibility Criteria|133
6963665|NCT01104870|11010021|FG000|Overall Study|Adverse Event|1
6963666|NCT01104870|11010022|FG001|Overall Study|Adverse Event|1
6963667|NCT01104870|11010023|FG002|Overall Study|Adverse Event|0
6963668|NCT01104870|11010021|FG000|Overall Study|Death|0
6963669|NCT01104870|11010022|FG001|Overall Study|Death|0
6963670|NCT01104870|11010023|FG002|Overall Study|Death|1
6963671|NCT01104870|11010021|FG000|Overall Study|Withdrawal by Subject|0
6963672|NCT01104870|11010022|FG001|Overall Study|Withdrawal by Subject|0
6963673|NCT01104870|11010023|FG002|Overall Study|Withdrawal by Subject|1
6963674|NCT01105065|11010031|FG000|Overall Study|Adverse Event|5
6963675|NCT01105065|11010031|FG000|Overall Study|Technical Problems|1
6963676|NCT01105091|11010039|FG000|Overall Study|Death|2
6963677|NCT01105091|11010040|FG001|Overall Study|Death|0
6963678|NCT01105130|11010060|FG000|Overall Study|Withdrawal by Subject|4
6963679|NCT01105130|11010061|FG001|Overall Study|Withdrawal by Subject|6
6963680|NCT01105130|11010062|FG002|Overall Study|Withdrawal by Subject|2
6963681|NCT01105130|11010060|FG000|Overall Study|Never Started|2
6963682|NCT01105130|11010061|FG001|Overall Study|Never Started|2
6963683|NCT01105130|11010062|FG002|Overall Study|Never Started|4
6963684|NCT01105130|11010060|FG000|Overall Study|Toxicity|1
6963685|NCT01105130|11010061|FG001|Overall Study|Toxicity|3
6963686|NCT01105130|11010062|FG002|Overall Study|Toxicity|2
6963687|NCT01105130|11010060|FG000|Overall Study|Multiple Reasons|3
6963688|NCT01105130|11010061|FG001|Overall Study|Multiple Reasons|0
6963689|NCT01105130|11010062|FG002|Overall Study|Multiple Reasons|2
6963690|NCT01105377|11010099|FG000|Overall Study|Withdrawal by Subject|0
6963691|NCT01105377|11010100|FG001|Overall Study|Withdrawal by Subject|1
6963692|NCT01105533|11010106|FG000|Overall Study|Death|0
6963693|NCT01105533|11010107|FG001|Overall Study|Death|0
6963694|NCT01105533|11010108|FG002|Overall Study|Death|0
6963695|NCT01105533|11010109|FG003|Overall Study|Death|0
6963696|NCT01105533|11010110|FG004|Overall Study|Death|1
6963697|NCT01105533|11010111|FG005|Overall Study|Death|0
6963698|NCT01105533|11010112|FG006|Overall Study|Death|0
6963699|NCT01105533|11010113|FG007|Overall Study|Death|0
6963700|NCT01105533|11010114|FG008|Overall Study|Death|0
6963701|NCT01105533|11010106|FG000|Overall Study|Lack of Efficacy|1
6963702|NCT01105533|11010107|FG001|Overall Study|Lack of Efficacy|1
6963703|NCT01105533|11010108|FG002|Overall Study|Lack of Efficacy|3
6963704|NCT01105533|11010109|FG003|Overall Study|Lack of Efficacy|3
6963705|NCT01105533|11010110|FG004|Overall Study|Lack of Efficacy|4
6963706|NCT01105533|11010111|FG005|Overall Study|Lack of Efficacy|5
6963707|NCT01105533|11010112|FG006|Overall Study|Lack of Efficacy|3
6963708|NCT01105533|11010113|FG007|Overall Study|Lack of Efficacy|2
6963709|NCT01105533|11010114|FG008|Overall Study|Lack of Efficacy|9
6963710|NCT01105533|11010106|FG000|Overall Study|Adverse Event|0
6963711|NCT01105533|11010107|FG001|Overall Study|Adverse Event|0
6963712|NCT01105533|11010108|FG002|Overall Study|Adverse Event|0
6963713|NCT01105533|11010109|FG003|Overall Study|Adverse Event|0
6963714|NCT01105533|11010110|FG004|Overall Study|Adverse Event|1
6963715|NCT01105533|11010111|FG005|Overall Study|Adverse Event|2
6963716|NCT01105533|11010112|FG006|Overall Study|Adverse Event|2
6963717|NCT01105533|11010113|FG007|Overall Study|Adverse Event|0
6963718|NCT01105533|11010114|FG008|Overall Study|Adverse Event|1
6963719|NCT01105533|11010106|FG000|Overall Study|Other|0
6963720|NCT01105533|11010107|FG001|Overall Study|Other|0
6963721|NCT01105533|11010108|FG002|Overall Study|Other|0
6963722|NCT01105533|11010109|FG003|Overall Study|Other|0
6963723|NCT01105533|11010110|FG004|Overall Study|Other|1
6963724|NCT01105533|11010111|FG005|Overall Study|Other|0
6963725|NCT01105533|11010112|FG006|Overall Study|Other|3
6963726|NCT01105533|11010113|FG007|Overall Study|Other|1
6963727|NCT01105533|11010114|FG008|Overall Study|Other|2
6963728|NCT01105533|11010106|FG000|Overall Study|Physician Decision|0
6963729|NCT01105533|11010107|FG001|Overall Study|Physician Decision|0
6963730|NCT01105533|11010108|FG002|Overall Study|Physician Decision|0
6963731|NCT01105533|11010109|FG003|Overall Study|Physician Decision|0
6963732|NCT01105533|11010110|FG004|Overall Study|Physician Decision|0
6963733|NCT01105533|11010111|FG005|Overall Study|Physician Decision|0
6963734|NCT01105533|11010112|FG006|Overall Study|Physician Decision|0
6963735|NCT01105533|11010113|FG007|Overall Study|Physician Decision|1
6963736|NCT01105533|11010114|FG008|Overall Study|Physician Decision|0
6963737|NCT01105767|11010159|FG000|Overall Study|Lost to Follow-up|1160
6963738|NCT01105767|11010160|FG001|Overall Study|Lost to Follow-up|1614
6963739|NCT01105767|11010161|FG002|Overall Study|Lost to Follow-up|1184
6963740|NCT01105936|11010169|FG000|Period 1|Adverse Event|0
6963741|NCT01105936|11010170|FG001|Period 1|Adverse Event|0
6963742|NCT01105936|11010171|FG002|Period 1|Adverse Event|0
6963743|NCT01105936|11010172|FG003|Period 1|Adverse Event|1
6963744|NCT01105936|11010169|FG000|Period 2|Adverse Event|1
6963745|NCT01105936|11010170|FG001|Period 2|Adverse Event|0
6963746|NCT01105936|11010171|FG002|Period 2|Adverse Event|0
6963747|NCT01105936|11010172|FG003|Period 2|Adverse Event|0
6963748|NCT01105936|11010169|FG000|Period 3|Protocol Violation|0
6963749|NCT01105936|11010170|FG001|Period 3|Protocol Violation|2
6963750|NCT01105936|11010171|FG002|Period 3|Protocol Violation|0
6963751|NCT01105936|11010172|FG003|Period 3|Protocol Violation|0
6963752|NCT01105975|11010191|FG000|Overall Study|Adverse Event|2
6963753|NCT01105975|11010192|FG001|Overall Study|Adverse Event|1
6963754|NCT01105975|11010193|FG002|Overall Study|Adverse Event|5
6963755|NCT01105975|11010194|FG003|Overall Study|Adverse Event|1
6963756|NCT01105975|11010195|FG004|Overall Study|Adverse Event|0
6963757|NCT01105975|11010196|FG005|Overall Study|Adverse Event|1
6963758|NCT01105975|11010197|FG006|Overall Study|Adverse Event|2
6963759|NCT01105975|11010198|FG007|Overall Study|Adverse Event|4
6963760|NCT01105975|11010199|FG008|Overall Study|Adverse Event|1
6963761|NCT01105975|11010200|FG009|Overall Study|Adverse Event|4
6963762|NCT01105975|11010191|FG000|Overall Study|Withdrawal by Subject|2
6963763|NCT01105975|11010192|FG001|Overall Study|Withdrawal by Subject|2
6963764|NCT01105975|11010193|FG002|Overall Study|Withdrawal by Subject|2
6963765|NCT01105975|11010194|FG003|Overall Study|Withdrawal by Subject|0
6963766|NCT01105975|11010195|FG004|Overall Study|Withdrawal by Subject|4
6963767|NCT01105975|11010196|FG005|Overall Study|Withdrawal by Subject|1
6963768|NCT01105975|11010197|FG006|Overall Study|Withdrawal by Subject|2
6963769|NCT01105975|11010198|FG007|Overall Study|Withdrawal by Subject|1
6963770|NCT01105975|11010199|FG008|Overall Study|Withdrawal by Subject|0
6963771|NCT01105975|11010200|FG009|Overall Study|Withdrawal by Subject|3
6963772|NCT01105975|11010191|FG000|Overall Study|Lost to Follow-up|1
6963773|NCT01105975|11010192|FG001|Overall Study|Lost to Follow-up|0
6963774|NCT01105975|11010193|FG002|Overall Study|Lost to Follow-up|0
6963775|NCT01105975|11010194|FG003|Overall Study|Lost to Follow-up|1
6963776|NCT01105975|11010195|FG004|Overall Study|Lost to Follow-up|1
6963777|NCT01105975|11010196|FG005|Overall Study|Lost to Follow-up|0
6963778|NCT01105975|11010197|FG006|Overall Study|Lost to Follow-up|0
6963779|NCT01105975|11010198|FG007|Overall Study|Lost to Follow-up|0
6963780|NCT01105975|11010199|FG008|Overall Study|Lost to Follow-up|1
6963781|NCT01105975|11010200|FG009|Overall Study|Lost to Follow-up|0
6963782|NCT01105975|11010191|FG000|Overall Study|Physician Decision|0
6963783|NCT01105975|11010192|FG001|Overall Study|Physician Decision|0
6963784|NCT01105975|11010193|FG002|Overall Study|Physician Decision|0
6963785|NCT01105975|11010194|FG003|Overall Study|Physician Decision|0
6963786|NCT01105975|11010195|FG004|Overall Study|Physician Decision|0
6963787|NCT01105975|11010196|FG005|Overall Study|Physician Decision|0
6963788|NCT01105975|11010197|FG006|Overall Study|Physician Decision|2
6963789|NCT01105975|11010198|FG007|Overall Study|Physician Decision|0
6963790|NCT01105975|11010199|FG008|Overall Study|Physician Decision|0
6963791|NCT01105975|11010200|FG009|Overall Study|Physician Decision|0
6963792|NCT01105975|11010191|FG000|Overall Study|Protocol Violation|0
6963793|NCT01105975|11010192|FG001|Overall Study|Protocol Violation|2
6963794|NCT01105975|11010193|FG002|Overall Study|Protocol Violation|2
6963795|NCT01105975|11010194|FG003|Overall Study|Protocol Violation|0
6963796|NCT01105975|11010195|FG004|Overall Study|Protocol Violation|1
6963797|NCT01105975|11010196|FG005|Overall Study|Protocol Violation|1
6963798|NCT01105975|11010197|FG006|Overall Study|Protocol Violation|1
6963799|NCT01105975|11010198|FG007|Overall Study|Protocol Violation|1
6963800|NCT01105975|11010199|FG008|Overall Study|Protocol Violation|2
6963801|NCT01105975|11010200|FG009|Overall Study|Protocol Violation|2
6963802|NCT01105975|11010191|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0
6963803|NCT01105975|11010192|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0
6963804|NCT01105975|11010193|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1
6963805|NCT01105975|11010194|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0
6963806|NCT01105975|11010195|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0
6963807|NCT01105975|11010196|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2
6963808|NCT01105975|11010197|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1
6963809|NCT01105975|11010198|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1
6963810|NCT01105975|11010199|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2
6963811|NCT01105975|11010200|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0
6963812|NCT01106014|11010243|FG000|Overall Study|Morbidity or Mortality primary endpoint|155
6963813|NCT01106014|11010244|FG001|Overall Study|Morbidity or Mortality primary endpoint|242
6963814|NCT01106014|11010243|FG000|Overall Study|Adverse Event|78
6963815|NCT01106014|11010244|FG001|Overall Study|Adverse Event|42
6963816|NCT01106014|11010243|FG000|Overall Study|Withdrawal by Subject|43
6963817|NCT01106014|11010244|FG001|Overall Study|Withdrawal by Subject|37
6963818|NCT01106014|11010243|FG000|Overall Study|Administrative reason|7
6963819|NCT01106014|11010244|FG001|Overall Study|Administrative reason|6
6963820|NCT01106014|11010243|FG000|Overall Study|Lost to Follow-up|2
6963821|NCT01106014|11010244|FG001|Overall Study|Lost to Follow-up|3
6963822|NCT01106027|11010250|FG000|Overall Study|Lost graft early, discontinued|1
6963823|NCT01106092|11010263|FG000|Overall Study|Withdrawal by Subject|0
6963824|NCT01106092|11010264|FG001|Overall Study|Withdrawal by Subject|0
6963825|NCT01106092|11010265|FG002|Overall Study|Withdrawal by Subject|0
6963826|NCT01106092|11010266|FG003|Overall Study|Withdrawal by Subject|1
6963827|NCT01106157|11010278|FG000|Overall Study|Withdrawal by Subject|1
6963828|NCT01106157|11010279|FG001|Overall Study|Withdrawal by Subject|0
6963829|NCT01106248|11010285|FG000|Overall Study|Adverse Event|1
6963830|NCT01106248|11010285|FG000|Overall Study|Administrative|2
6963831|NCT01106287|11010293|FG000|Overall Study|Adverse Event|1
6963832|NCT01106287|11010294|FG001|Overall Study|Adverse Event|0
6963833|NCT01106287|11010295|FG002|Overall Study|Adverse Event|0
6963834|NCT01106287|11010296|FG003|Overall Study|Adverse Event|0
6963835|NCT01106352|11010321|FG000|Overall Study|Subjects untreated|0
6963836|NCT01106352|11010322|FG001|Overall Study|Subjects untreated|0
6963837|NCT01106352|11010323|FG002|Overall Study|Subjects untreated|0
6963838|NCT01106352|11010324|FG003|Overall Study|Subjects untreated|3
6963839|NCT01106352|11010325|FG004|Overall Study|Subjects untreated|4
6963840|NCT01106352|11010321|FG000|Overall Study|Sponsor Decision|1
6963841|NCT01106352|11010322|FG001|Overall Study|Sponsor Decision|0
6963842|NCT01106352|11010323|FG002|Overall Study|Sponsor Decision|0
6963843|NCT01106352|11010324|FG003|Overall Study|Sponsor Decision|0
6963844|NCT01106352|11010325|FG004|Overall Study|Sponsor Decision|0
6963845|NCT01106352|11010321|FG000|Overall Study|Too ill to come in for the visit|0
6963846|NCT01106352|11010322|FG001|Overall Study|Too ill to come in for the visit|0
6963847|NCT01106352|11010323|FG002|Overall Study|Too ill to come in for the visit|1
6963848|NCT01106352|11010324|FG003|Overall Study|Too ill to come in for the visit|0
6963849|NCT01106352|11010325|FG004|Overall Study|Too ill to come in for the visit|0
6963850|NCT01106352|11010321|FG000|Overall Study|Lost to Follow-up|0
6963851|NCT01106352|11010322|FG001|Overall Study|Lost to Follow-up|0
6963852|NCT01106352|11010323|FG002|Overall Study|Lost to Follow-up|0
6963853|NCT01106352|11010324|FG003|Overall Study|Lost to Follow-up|0
6963854|NCT01106352|11010325|FG004|Overall Study|Lost to Follow-up|1
6963855|NCT01106352|11010321|FG000|Overall Study|Death|0
6963856|NCT01106352|11010322|FG001|Overall Study|Death|0
6963857|NCT01106352|11010323|FG002|Overall Study|Death|1
6963858|NCT01106352|11010324|FG003|Overall Study|Death|3
6963859|NCT01106352|11010325|FG004|Overall Study|Death|1
6963860|NCT01106352|11010321|FG000|Overall Study|Disease progression|0
6963861|NCT01106352|11010322|FG001|Overall Study|Disease progression|0
6963862|NCT01106352|11010323|FG002|Overall Study|Disease progression|0
6963863|NCT01106352|11010324|FG003|Overall Study|Disease progression|1
6963864|NCT01106352|11010325|FG004|Overall Study|Disease progression|0
6963865|NCT01106352|11010321|FG000|Overall Study|Withdrawal by Subject|0
6963866|NCT01106352|11010322|FG001|Overall Study|Withdrawal by Subject|0
6963867|NCT01106352|11010323|FG002|Overall Study|Withdrawal by Subject|0
6963868|NCT01106352|11010324|FG003|Overall Study|Withdrawal by Subject|3
6963869|NCT01106352|11010325|FG004|Overall Study|Withdrawal by Subject|2
6963870|NCT01106352|11010321|FG000|Overall Study|Went on hospice|0
6963871|NCT01106352|11010322|FG001|Overall Study|Went on hospice|0
6963872|NCT01106352|11010323|FG002|Overall Study|Went on hospice|0
6963873|NCT01106352|11010324|FG003|Overall Study|Went on hospice|1
6963874|NCT01106352|11010325|FG004|Overall Study|Went on hospice|0
6963875|NCT01106352|11010321|FG000|Overall Study|Subject entered hospice|0
6963876|NCT01106352|11010322|FG001|Overall Study|Subject entered hospice|0
6963877|NCT01106352|11010323|FG002|Overall Study|Subject entered hospice|0
6963878|NCT01106352|11010324|FG003|Overall Study|Subject entered hospice|1
6963879|NCT01106352|11010325|FG004|Overall Study|Subject entered hospice|0
6963880|NCT01106352|11010321|FG000|Overall Study|Home hospice since July 2013|0
6963881|NCT01106352|11010322|FG001|Overall Study|Home hospice since July 2013|0
6963882|NCT01106352|11010323|FG002|Overall Study|Home hospice since July 2013|0
6963883|NCT01106352|11010324|FG003|Overall Study|Home hospice since July 2013|1
6963884|NCT01106352|11010325|FG004|Overall Study|Home hospice since July 2013|0
6963885|NCT01106404|11010347|FG000|Period I (First 6 Weeks)|Adverse Event|2
6963886|NCT01106404|11010348|FG001|Period I (First 6 Weeks)|Adverse Event|0
6963887|NCT01106404|11010347|FG000|Period I (First 6 Weeks)|Physician Decision|1
6963888|NCT01106404|11010348|FG001|Period I (First 6 Weeks)|Physician Decision|0
6963889|NCT01106404|11010347|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0
6963890|NCT01106404|11010348|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1
6963891|NCT01106404|11010347|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0
6963892|NCT01106404|11010348|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1
6963893|NCT01106430|11010362|FG000|Overall Study|Adverse Event|8
6963894|NCT01106430|11010363|FG001|Overall Study|Adverse Event|10
6963895|NCT01106430|11010362|FG000|Overall Study|Lack of Efficacy|2
6963896|NCT01106430|11010363|FG001|Overall Study|Lack of Efficacy|13
6963897|NCT01106430|11010362|FG000|Overall Study|Lost to Follow-up|5
6963898|NCT01106430|11010363|FG001|Overall Study|Lost to Follow-up|1
6963899|NCT01106430|11010362|FG000|Overall Study|Early Termination Requested By Sponsor|1
6963900|NCT01106430|11010363|FG001|Overall Study|Early Termination Requested By Sponsor|0
6963901|NCT01106430|11010362|FG000|Overall Study|Moved Out Of State|0
6963902|NCT01106430|11010363|FG001|Overall Study|Moved Out Of State|1
6963903|NCT01106430|11010362|FG000|Overall Study|Refused To Take Medication|0
6963904|NCT01106430|11010363|FG001|Overall Study|Refused To Take Medication|1
6963905|NCT01106430|11010362|FG000|Overall Study|Noncompliance|0
6963906|NCT01106430|11010363|FG001|Overall Study|Noncompliance|1
6963907|NCT01106430|11010362|FG000|Overall Study|Hard Time Swallowing The Pills|1
6963908|NCT01106430|11010363|FG001|Overall Study|Hard Time Swallowing The Pills|0
6963909|NCT01106430|11010362|FG000|Overall Study|Previous Use Of Marijuana|1
6963910|NCT01106430|11010363|FG001|Overall Study|Previous Use Of Marijuana|0
6963911|NCT01106430|11010362|FG000|Overall Study|Protocol Violation|7
6963912|NCT01106430|11010363|FG001|Overall Study|Protocol Violation|2
6963913|NCT01106430|11010362|FG000|Overall Study|Withdrawal by Subject|8
6963914|NCT01106430|11010363|FG001|Overall Study|Withdrawal by Subject|4
6963915|NCT01106586|11010380|FG000|Overall Study|Adverse Event|9
6963916|NCT01106586|11010381|FG001|Overall Study|Adverse Event|15
6963917|NCT01106586|11010380|FG000|Overall Study|Death|1
6963918|NCT01106586|11010381|FG001|Overall Study|Death|3
6963919|NCT01106586|11010380|FG000|Overall Study|Pregnancy|2
6963920|NCT01106586|11010381|FG001|Overall Study|Pregnancy|2
6963921|NCT01106586|11010380|FG000|Overall Study|Lack of Efficacy|1
6963922|NCT01106586|11010381|FG001|Overall Study|Lack of Efficacy|0
6963923|NCT01106586|11010380|FG000|Overall Study|Investigator's Discretion|5
6963924|NCT01106586|11010381|FG001|Overall Study|Investigator's Discretion|8
6963925|NCT01106586|11010380|FG000|Overall Study|Withdrew Consent|18
6963926|NCT01106586|11010381|FG001|Overall Study|Withdrew Consent|30
6963927|NCT01106586|11010380|FG000|Overall Study|Lost to Follow-up|24
6963928|NCT01106586|11010381|FG001|Overall Study|Lost to Follow-up|20
6963929|NCT01106586|11010380|FG000|Overall Study|Participant Noncompliance|12
6963930|NCT01106586|11010381|FG001|Overall Study|Participant Noncompliance|10
6963931|NCT01106586|11010380|FG000|Overall Study|Protocol Violation|1
6963932|NCT01106586|11010381|FG001|Overall Study|Protocol Violation|0
6963933|NCT01106586|11010380|FG000|Overall Study|Participant Transferred to Another Study|212
6963934|NCT01106586|11010381|FG001|Overall Study|Participant Transferred to Another Study|197
6963935|NCT01106625|11010390|FG000|Core Period: Baseline to Week 26|Adverse Event|6
6963936|NCT01106625|11010391|FG001|Core Period: Baseline to Week 26|Adverse Event|8
6963937|NCT01106625|11010392|FG002|Core Period: Baseline to Week 26|Adverse Event|8
6963938|NCT01106625|11010390|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5
6963939|NCT01106625|11010391|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0
6963940|NCT01106625|11010392|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4
6963941|NCT01106625|11010390|FG000|Core Period: Baseline to Week 26|Physician Decision|1
6963942|NCT01106625|11010391|FG001|Core Period: Baseline to Week 26|Physician Decision|0
6963943|NCT01106625|11010392|FG002|Core Period: Baseline to Week 26|Physician Decision|0
6963944|NCT01106625|11010390|FG000|Core Period: Baseline to Week 26|Protocol Violation|2
6963945|NCT01106625|11010391|FG001|Core Period: Baseline to Week 26|Protocol Violation|1
6963946|NCT01106625|11010392|FG002|Core Period: Baseline to Week 26|Protocol Violation|3
6963947|NCT01106625|11010390|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6
6963948|NCT01106625|11010391|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9
6963949|NCT01106625|11010392|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7
6963950|NCT01106625|11010390|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4
6963951|NCT01106625|11010391|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
6963952|NCT01106625|11010392|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
6963953|NCT01106625|11010390|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0
6963954|NCT01106625|11010391|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
6963955|NCT01106625|11010392|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
6963956|NCT01106625|11010390|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1
6963957|NCT01106625|11010391|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1
6963958|NCT01106625|11010392|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0
6963959|NCT01106625|11010390|FG000|Core Period: Baseline to Week 26|Other|8
6963960|NCT01106625|11010391|FG001|Core Period: Baseline to Week 26|Other|7
6963961|NCT01106625|11010392|FG002|Core Period: Baseline to Week 26|Other|4
6963962|NCT01106625|11010390|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2
6963963|NCT01106625|11010391|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2
6963964|NCT01106625|11010392|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3
6963965|NCT01106625|11010390|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
6963966|NCT01106625|11010391|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3
6963967|NCT01106625|11010392|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
6963968|NCT01106625|11010390|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2
6963969|NCT01106625|11010391|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0
6963970|NCT01106625|11010392|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1
6963971|NCT01106625|11010390|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0
6963972|NCT01106625|11010391|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1
6963973|NCT01106625|11010392|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0
6963974|NCT01106625|11010390|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4
6963975|NCT01106625|11010391|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
6963976|NCT01106625|11010392|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
6963977|NCT01106625|11010390|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14
6963978|NCT01106625|11010391|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5
6963979|NCT01106625|11010392|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4
6963980|NCT01106625|11010390|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
6963981|NCT01106625|11010391|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
6963982|NCT01106625|11010392|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
6963983|NCT01106625|11010390|FG000|Extension Period: Week 26 to Week 52|Other|5
6963984|NCT01106625|11010391|FG001|Extension Period: Week 26 to Week 52|Other|5
6963985|NCT01106625|11010392|FG002|Extension Period: Week 26 to Week 52|Other|4
6963986|NCT01106651|11010406|FG000|Overall Study|Adverse Event|17
6963987|NCT01106651|11010407|FG001|Overall Study|Adverse Event|9
6963988|NCT01106651|11010408|FG002|Overall Study|Adverse Event|23
6963989|NCT01106651|11010406|FG000|Overall Study|Lost to Follow-up|8
6963990|NCT01106651|11010407|FG001|Overall Study|Lost to Follow-up|2
6963991|NCT01106651|11010408|FG002|Overall Study|Lost to Follow-up|6
6963992|NCT01106651|11010406|FG000|Overall Study|Physician Decision|4
6963993|NCT01106651|11010407|FG001|Overall Study|Physician Decision|3
6963994|NCT01106651|11010408|FG002|Overall Study|Physician Decision|1
6963995|NCT01106651|11010406|FG000|Overall Study|Protocol Violation|1
6963996|NCT01106651|11010407|FG001|Overall Study|Protocol Violation|2
6963997|NCT01106651|11010408|FG002|Overall Study|Protocol Violation|1
6963998|NCT01106651|11010406|FG000|Overall Study|Withdrawal by Subject|14
6963999|NCT01106651|11010407|FG001|Overall Study|Withdrawal by Subject|7
6964000|NCT01106651|11010408|FG002|Overall Study|Withdrawal by Subject|4
6964001|NCT01106651|11010406|FG000|Overall Study|Noncompliance with study drug|1
6964002|NCT01106651|11010407|FG001|Overall Study|Noncompliance with study drug|0
6964003|NCT01106651|11010408|FG002|Overall Study|Noncompliance with study drug|2
6964004|NCT01106651|11010406|FG000|Overall Study|Other|34
6964005|NCT01106651|11010407|FG001|Overall Study|Other|31
6964006|NCT01106651|11010408|FG002|Overall Study|Other|21
6964007|NCT01106651|11010406|FG000|Overall Study|Death|0
6964008|NCT01106651|11010407|FG001|Overall Study|Death|3
6964009|NCT01106651|11010408|FG002|Overall Study|Death|0
6964010|NCT01106677|11010423|FG000|Core Period: Baseline to Week 26|Adverse Event|7
6964011|NCT01106677|11010424|FG001|Core Period: Baseline to Week 26|Adverse Event|18
6964012|NCT01106677|11010425|FG002|Core Period: Baseline to Week 26|Adverse Event|6
6964013|NCT01106677|11010426|FG003|Core Period: Baseline to Week 26|Adverse Event|8
6964014|NCT01106677|11010423|FG000|Core Period: Baseline to Week 26|Death|0
6964015|NCT01106677|11010424|FG001|Core Period: Baseline to Week 26|Death|0
6964016|NCT01106677|11010425|FG002|Core Period: Baseline to Week 26|Death|1
6964017|NCT01106677|11010426|FG003|Core Period: Baseline to Week 26|Death|0
6964018|NCT01106677|11010423|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1
6964019|NCT01106677|11010424|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0
6964020|NCT01106677|11010425|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0
6964021|NCT01106677|11010426|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0
6964022|NCT01106677|11010423|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3
6964023|NCT01106677|11010424|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1
6964024|NCT01106677|11010425|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6
6964025|NCT01106677|11010426|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3
6964026|NCT01106677|11010423|FG000|Core Period: Baseline to Week 26|Physician Decision|2
6964027|NCT01106677|11010424|FG001|Core Period: Baseline to Week 26|Physician Decision|1
6964028|NCT01106677|11010425|FG002|Core Period: Baseline to Week 26|Physician Decision|3
6964029|NCT01106677|11010426|FG003|Core Period: Baseline to Week 26|Physician Decision|1
6964030|NCT01106677|11010423|FG000|Core Period: Baseline to Week 26|Protocol Violation|0
6964031|NCT01106677|11010424|FG001|Core Period: Baseline to Week 26|Protocol Violation|1
6964032|NCT01106677|11010425|FG002|Core Period: Baseline to Week 26|Protocol Violation|0
6964033|NCT01106677|11010426|FG003|Core Period: Baseline to Week 26|Protocol Violation|3
7040892|NCT01721057|11124068|FG002|Rescue Period|Adverse Event|0
6964034|NCT01106677|11010423|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5
6964035|NCT01106677|11010424|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3
6964036|NCT01106677|11010425|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15
6964037|NCT01106677|11010426|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6
6976704|NCT01201317|11029479|FG000|Overall Study|Lack of Efficacy|1
6964038|NCT01106677|11010423|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
6964039|NCT01106677|11010424|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
6964040|NCT01106677|11010425|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
6964041|NCT01106677|11010426|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
6964042|NCT01106677|11010423|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1
6964043|NCT01106677|11010424|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3
6964044|NCT01106677|11010425|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0
6964045|NCT01106677|11010426|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0
6964046|NCT01106677|11010423|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0
6964047|NCT01106677|11010424|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1
6964048|NCT01106677|11010425|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2
6964049|NCT01106677|11010426|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0
6964050|NCT01106677|11010423|FG000|Core Period: Baseline to Week 26|Product quality complaint|0
6964051|NCT01106677|11010424|FG001|Core Period: Baseline to Week 26|Product quality complaint|1
6964052|NCT01106677|11010425|FG002|Core Period: Baseline to Week 26|Product quality complaint|1
6964053|NCT01106677|11010426|FG003|Core Period: Baseline to Week 26|Product quality complaint|0
6964054|NCT01106677|11010423|FG000|Core Period: Baseline to Week 26|Other|8
6964055|NCT01106677|11010424|FG001|Core Period: Baseline to Week 26|Other|14
6964056|NCT01106677|11010425|FG002|Core Period: Baseline to Week 26|Other|8
6964057|NCT01106677|11010426|FG003|Core Period: Baseline to Week 26|Other|23
6964058|NCT01106677|11010423|FG000|Core Period: Baseline to Week 26|Pregnancy|0
6964059|NCT01106677|11010424|FG001|Core Period: Baseline to Week 26|Pregnancy|1
6964060|NCT01106677|11010425|FG002|Core Period: Baseline to Week 26|Pregnancy|0
6964061|NCT01106677|11010426|FG003|Core Period: Baseline to Week 26|Pregnancy|0
6964062|NCT01106677|11010423|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1
6964063|NCT01106677|11010424|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1
6964064|NCT01106677|11010425|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5
6964065|NCT01106677|11010426|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9
6964066|NCT01106677|11010423|FG000|Extension Period: Week 26 to Week 52|Death|0
6964067|NCT01106677|11010424|FG001|Extension Period: Week 26 to Week 52|Death|0
6964068|NCT01106677|11010425|FG002|Extension Period: Week 26 to Week 52|Death|0
6964069|NCT01106677|11010426|FG003|Extension Period: Week 26 to Week 52|Death|1
6964070|NCT01106677|11010423|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2
6964071|NCT01106677|11010424|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
6964072|NCT01106677|11010425|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
6964073|NCT01106677|11010426|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4
6964074|NCT01106677|11010423|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
6964075|NCT01106677|11010424|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
6964076|NCT01106677|11010425|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
6964077|NCT01106677|11010426|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
6964078|NCT01106677|11010423|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2
6964079|NCT01106677|11010424|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3
6964080|NCT01106677|11010425|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2
6964081|NCT01106677|11010426|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3
6964082|NCT01106677|11010423|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1
6964083|NCT01106677|11010424|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0
6964084|NCT01106677|11010425|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0
6964085|NCT01106677|11010426|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0
6964086|NCT01106677|11010423|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
6964087|NCT01106677|11010424|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3
6964088|NCT01106677|11010425|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
6964089|NCT01106677|11010426|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
6964090|NCT01106677|11010423|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
6964091|NCT01106677|11010424|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
6964092|NCT01106677|11010425|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3
6964093|NCT01106677|11010426|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
6964094|NCT01106677|11010423|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
6964095|NCT01106677|11010424|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
6964096|NCT01106677|11010425|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
6964097|NCT01106677|11010426|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
6964098|NCT01106677|11010423|FG000|Extension Period: Week 26 to Week 52|Other|6
6964099|NCT01106677|11010424|FG001|Extension Period: Week 26 to Week 52|Other|5
6964100|NCT01106677|11010425|FG002|Extension Period: Week 26 to Week 52|Other|8
6964101|NCT01106677|11010426|FG003|Extension Period: Week 26 to Week 52|Other|5
6964102|NCT01106690|11010446|FG000|Core Period: Baseline to Week 26|Adverse Event|6
6964103|NCT01106690|11010447|FG001|Core Period: Baseline to Week 26|Adverse Event|1
6964104|NCT01106690|11010448|FG002|Core Period: Baseline to Week 26|Adverse Event|4
7040893|NCT01721057|11124069|FG003|Rescue Period|Adverse Event|1
6964105|NCT01106690|11010446|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1
6964106|NCT01106690|11010447|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1
6964107|NCT01106690|11010448|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2
6964108|NCT01106690|11010446|FG000|Core Period: Baseline to Week 26|Protocol Violation|1
6964109|NCT01106690|11010447|FG001|Core Period: Baseline to Week 26|Protocol Violation|0
6964110|NCT01106690|11010448|FG002|Core Period: Baseline to Week 26|Protocol Violation|0
6964111|NCT01106690|11010446|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4
6964112|NCT01106690|11010447|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1
6964113|NCT01106690|11010448|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0
6964114|NCT01106690|11010446|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0
6964115|NCT01106690|11010447|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
6964116|NCT01106690|11010448|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
6964117|NCT01106690|11010446|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0
6964118|NCT01106690|11010447|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1
6964119|NCT01106690|11010448|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0
6964120|NCT01106690|11010446|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
6964121|NCT01106690|11010447|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
6964122|NCT01106690|11010448|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
6964123|NCT01106690|11010446|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
6964124|NCT01106690|11010447|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
6964125|NCT01106690|11010448|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
6964126|NCT01106690|11010446|FG000|Core Period: Baseline to Week 26|Other|10
6964127|NCT01106690|11010447|FG001|Core Period: Baseline to Week 26|Other|2
6964128|NCT01106690|11010448|FG002|Core Period: Baseline to Week 26|Other|6
6964129|NCT01106690|11010446|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1
6964130|NCT01106690|11010447|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1
6964131|NCT01106690|11010448|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0
6964132|NCT01106690|11010446|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
6964133|NCT01106690|11010447|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
6964134|NCT01106690|11010448|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
6964135|NCT01106690|11010446|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0
6964136|NCT01106690|11010447|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2
6964137|NCT01106690|11010448|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2
6964138|NCT01106690|11010446|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
6964139|NCT01106690|11010447|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
6964140|NCT01106690|11010448|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
6964141|NCT01106690|11010446|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
6964142|NCT01106690|11010447|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
6964143|NCT01106690|11010448|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
6964144|NCT01106690|11010446|FG000|Extension Period: Week 26 to Week 52|Other|8
6964145|NCT01106690|11010447|FG001|Extension Period: Week 26 to Week 52|Other|3
6964146|NCT01106690|11010448|FG002|Extension Period: Week 26 to Week 52|Other|4
6964147|NCT01106690|11010446|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
6964148|NCT01106690|11010447|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
6964149|NCT01106690|11010448|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
6964150|NCT01106846|11010470|FG000|Overall Study|Change in surgical procedure|0
6964151|NCT01106846|11010471|FG001|Overall Study|Change in surgical procedure|1
6964152|NCT01106898|11010488|FG000|Overall Study|Adverse Event|6
6964153|NCT01106911|11010492|FG000|Overall Study|Physician Decision|2
6964154|NCT01106911|11010492|FG000|Overall Study|deemed ineligible after screening|3
6964155|NCT01106976|11010502|FG000|Overall Study|Lost to Follow-up|8
6964156|NCT01107197|11010525|FG000|Overall Study|Death|12
6964157|NCT01107197|11010526|FG001|Overall Study|Death|10
6964158|NCT01107197|11010525|FG000|Overall Study|Lost to Follow-up|5
6964159|NCT01107197|11010526|FG001|Overall Study|Lost to Follow-up|8
6964160|NCT01107197|11010525|FG000|Overall Study|Withdrawal by Subject|3
6964161|NCT01107197|11010526|FG001|Overall Study|Withdrawal by Subject|5
6964162|NCT01107353|11010534|FG000|Overall Study|Positive Drug Screen|1
6964163|NCT01107353|11010535|FG001|Overall Study|Positive Drug Screen|0
6964164|NCT01107379|11010541|FG000|Overall Study|Withdrawal by Subject|18
6964165|NCT01107379|11010541|FG000|Overall Study|Lost to Follow-up|3
6964166|NCT01107392|11010547|FG000|Overall Study|Adverse Event|2
6964167|NCT01107392|11010548|FG001|Overall Study|Adverse Event|0
6964168|NCT01107392|11010547|FG000|Overall Study|Personal Reasons|2
6964169|NCT01107392|11010548|FG001|Overall Study|Personal Reasons|3
6964170|NCT01107392|11010547|FG000|Overall Study|Administrative decision|1
6964171|NCT01107392|11010548|FG001|Overall Study|Administrative decision|0
6976705|NCT01201317|11029480|FG001|Overall Study|Lack of Efficacy|0
6976706|NCT01201317|11029481|FG002|Overall Study|Lack of Efficacy|0
6976707|NCT01201317|11029479|FG000|Overall Study|Safety, possible history of tuberculosis|0
6976708|NCT01201317|11029480|FG001|Overall Study|Safety, possible history of tuberculosis|0
6976709|NCT01201317|11029481|FG002|Overall Study|Safety, possible history of tuberculosis|1
6964172|NCT01107405|11010559|FG000|Overall Study|Adverse Event|1
6964173|NCT01107405|11010560|FG001|Overall Study|Adverse Event|1
6964174|NCT01107405|11010561|FG002|Overall Study|Adverse Event|0
6964175|NCT01107405|11010562|FG003|Overall Study|Adverse Event|0
6964176|NCT01107405|11010563|FG004|Overall Study|Adverse Event|2
6964177|NCT01107405|11010559|FG000|Overall Study|Withdrawal by Subject|1
6964178|NCT01107405|11010560|FG001|Overall Study|Withdrawal by Subject|0
6964179|NCT01107405|11010561|FG002|Overall Study|Withdrawal by Subject|1
6964180|NCT01107405|11010562|FG003|Overall Study|Withdrawal by Subject|2
6964181|NCT01107405|11010563|FG004|Overall Study|Withdrawal by Subject|1
6964182|NCT01107405|11010559|FG000|Overall Study|Protocol Violation|0
6964183|NCT01107405|11010560|FG001|Overall Study|Protocol Violation|0
6964184|NCT01107405|11010561|FG002|Overall Study|Protocol Violation|1
6964185|NCT01107405|11010562|FG003|Overall Study|Protocol Violation|1
6964186|NCT01107405|11010563|FG004|Overall Study|Protocol Violation|0
6964187|NCT01107418|11010579|FG000|Overall Study|Disease Progression|45
6964188|NCT01107418|11010579|FG000|Overall Study|Adverse Event|3
6964189|NCT01107418|11010579|FG000|Overall Study|Withdrawal by Subject|1
6964190|NCT01107418|11010579|FG000|Overall Study|Study Closing|1
6964191|NCT01107418|11010579|FG000|Overall Study|Started Other Therapy|1
6964192|NCT01107418|11010579|FG000|Overall Study|Entered Extension Study|1
6964193|NCT01107444|11010596|FG000|Overall Study|Withdrawal by Subject|8
6964194|NCT01107444|11010597|FG001|Overall Study|Withdrawal by Subject|12
6964195|NCT01107444|11010596|FG000|Overall Study|Protocol Entry Criteria Not Met|0
6964196|NCT01107444|11010597|FG001|Overall Study|Protocol Entry Criteria Not Met|1
6964197|NCT01107457|11010611|FG000|Part A|Adverse Event|1
6964198|NCT01107457|11010612|FG001|Part A|Adverse Event|2
6964199|NCT01107457|11010613|FG002|Part A|Adverse Event|1
6964200|NCT01107457|11010614|FG003|Part A|Adverse Event|0
6964201|NCT01107457|11010615|FG004|Part A|Adverse Event|0
6964202|NCT01107457|11010616|FG005|Part A|Adverse Event|0
6964203|NCT01107457|11010611|FG000|Part A|Withdrawal by Subject|3
6964204|NCT01107457|11010612|FG001|Part A|Withdrawal by Subject|3
6964205|NCT01107457|11010613|FG002|Part A|Withdrawal by Subject|0
6964206|NCT01107457|11010614|FG003|Part A|Withdrawal by Subject|3
6964207|NCT01107457|11010615|FG004|Part A|Withdrawal by Subject|1
6964208|NCT01107457|11010616|FG005|Part A|Withdrawal by Subject|0
6964209|NCT01107457|11010611|FG000|Part A|Lost to Follow-up|0
6964210|NCT01107457|11010612|FG001|Part A|Lost to Follow-up|1
6964211|NCT01107457|11010613|FG002|Part A|Lost to Follow-up|0
6964212|NCT01107457|11010614|FG003|Part A|Lost to Follow-up|0
6964213|NCT01107457|11010615|FG004|Part A|Lost to Follow-up|0
6964214|NCT01107457|11010616|FG005|Part A|Lost to Follow-up|0
6964215|NCT01107457|11010611|FG000|Part A|Lack of Efficacy|1
6964216|NCT01107457|11010612|FG001|Part A|Lack of Efficacy|0
6964217|NCT01107457|11010613|FG002|Part A|Lack of Efficacy|0
6964218|NCT01107457|11010614|FG003|Part A|Lack of Efficacy|0
6964219|NCT01107457|11010615|FG004|Part A|Lack of Efficacy|0
6964220|NCT01107457|11010616|FG005|Part A|Lack of Efficacy|0
6964221|NCT01107457|11010611|FG000|Part A|Protocol Violation|0
6964222|NCT01107457|11010612|FG001|Part A|Protocol Violation|1
6964223|NCT01107457|11010613|FG002|Part A|Protocol Violation|0
6964224|NCT01107457|11010614|FG003|Part A|Protocol Violation|0
6964225|NCT01107457|11010615|FG004|Part A|Protocol Violation|0
6964226|NCT01107457|11010616|FG005|Part A|Protocol Violation|0
6964227|NCT01107457|11010611|FG000|Part B and C|Adverse Event|0
6964228|NCT01107457|11010612|FG001|Part B and C|Adverse Event|0
6964229|NCT01107457|11010613|FG002|Part B and C|Adverse Event|0
6964230|NCT01107457|11010614|FG003|Part B and C|Adverse Event|0
6964231|NCT01107457|11010615|FG004|Part B and C|Adverse Event|0
6964232|NCT01107457|11010616|FG005|Part B and C|Adverse Event|12
6964233|NCT01107457|11010611|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0
6964234|NCT01107457|11010612|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0
6964235|NCT01107457|11010613|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0
6964236|NCT01107457|11010614|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0
6964237|NCT01107457|11010615|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0
6964238|NCT01107457|11010616|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1
6964239|NCT01107457|11010611|FG000|Part B and C|Physician Decision|0
6964240|NCT01107457|11010612|FG001|Part B and C|Physician Decision|0
6964241|NCT01107457|11010613|FG002|Part B and C|Physician Decision|0
6964242|NCT01107457|11010614|FG003|Part B and C|Physician Decision|0
6964243|NCT01107457|11010615|FG004|Part B and C|Physician Decision|0
6964244|NCT01107457|11010616|FG005|Part B and C|Physician Decision|3
6964245|NCT01107457|11010611|FG000|Part B and C|Lack of Efficacy|0
6964246|NCT01107457|11010612|FG001|Part B and C|Lack of Efficacy|0
6964247|NCT01107457|11010613|FG002|Part B and C|Lack of Efficacy|0
6964248|NCT01107457|11010614|FG003|Part B and C|Lack of Efficacy|0
6964249|NCT01107457|11010615|FG004|Part B and C|Lack of Efficacy|0
6964250|NCT01107457|11010616|FG005|Part B and C|Lack of Efficacy|7
6964251|NCT01107457|11010611|FG000|Part B and C|Lost to Follow-up|0
6964252|NCT01107457|11010612|FG001|Part B and C|Lost to Follow-up|0
6964253|NCT01107457|11010613|FG002|Part B and C|Lost to Follow-up|0
6964254|NCT01107457|11010614|FG003|Part B and C|Lost to Follow-up|0
6964255|NCT01107457|11010615|FG004|Part B and C|Lost to Follow-up|0
6964256|NCT01107457|11010616|FG005|Part B and C|Lost to Follow-up|10
6964257|NCT01107457|11010611|FG000|Part B and C|Protocol Violation|0
6964258|NCT01107457|11010612|FG001|Part B and C|Protocol Violation|0
6964259|NCT01107457|11010613|FG002|Part B and C|Protocol Violation|0
6964260|NCT01107457|11010614|FG003|Part B and C|Protocol Violation|0
6964261|NCT01107457|11010615|FG004|Part B and C|Protocol Violation|0
6964262|NCT01107457|11010616|FG005|Part B and C|Protocol Violation|1
6964263|NCT01107457|11010611|FG000|Part B and C|Sponsor Decision|0
6964264|NCT01107457|11010612|FG001|Part B and C|Sponsor Decision|0
6964265|NCT01107457|11010613|FG002|Part B and C|Sponsor Decision|0
6964266|NCT01107457|11010614|FG003|Part B and C|Sponsor Decision|0
6964267|NCT01107457|11010615|FG004|Part B and C|Sponsor Decision|0
6964268|NCT01107457|11010616|FG005|Part B and C|Sponsor Decision|66
6964269|NCT01107457|11010611|FG000|Part B and C|Withdrawal by Subject|0
6964270|NCT01107457|11010612|FG001|Part B and C|Withdrawal by Subject|0
6964271|NCT01107457|11010613|FG002|Part B and C|Withdrawal by Subject|0
6964272|NCT01107457|11010614|FG003|Part B and C|Withdrawal by Subject|0
6964273|NCT01107457|11010615|FG004|Part B and C|Withdrawal by Subject|0
6964274|NCT01107457|11010616|FG005|Part B and C|Withdrawal by Subject|16
6964275|NCT01107457|11010611|FG000|Part B and C|Clinical Relapse|0
6964276|NCT01107457|11010612|FG001|Part B and C|Clinical Relapse|0
6964277|NCT01107457|11010613|FG002|Part B and C|Clinical Relapse|0
6964278|NCT01107457|11010614|FG003|Part B and C|Clinical Relapse|0
7072825|NCT02038907|11176989|FG005|Overall Study|Withdrawal by Subject|0
7072826|NCT02038907|11176990|FG006|Overall Study|Withdrawal by Subject|0
7072827|NCT02038907|11176991|FG007|Overall Study|Withdrawal by Subject|0
7072828|NCT02038907|11176992|FG008|Overall Study|Withdrawal by Subject|0
7072829|NCT02038907|11176993|FG009|Overall Study|Withdrawal by Subject|0
7072830|NCT02038907|11176994|FG010|Overall Study|Withdrawal by Subject|1
7072831|NCT02038907|11176995|FG011|Overall Study|Withdrawal by Subject|0
7072832|NCT02038907|11176996|FG012|Overall Study|Withdrawal by Subject|0
7072833|NCT02038907|11176997|FG013|Overall Study|Withdrawal by Subject|0
7072834|NCT02038920|11177031|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3
7072835|NCT02038920|11177032|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11
7072836|NCT02038920|11177033|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
7072837|NCT02038920|11177034|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
7072838|NCT02038920|11177035|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
7072839|NCT02038920|11177036|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
7072840|NCT02038920|11177031|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2
7072841|NCT02038920|11177032|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
7072842|NCT02038920|11177033|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
7072843|NCT02038920|11177034|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
7072844|NCT02038920|11177035|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
7072845|NCT02038920|11177036|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
7072846|NCT02038920|11177031|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1
6964279|NCT01107457|11010615|FG004|Part B and C|Clinical Relapse|0
6964280|NCT01107457|11010616|FG005|Part B and C|Clinical Relapse|4
6964281|NCT01107535|11010634|FG000|Overall Study|Death|5
6964282|NCT01107626|11010642|FG000|Step 1: Induction Therapy|Lack of Efficacy|167
6964283|NCT01107626|11010643|FG001|Step 1: Induction Therapy|Lack of Efficacy|0
6964284|NCT01107626|11010644|FG002|Step 1: Induction Therapy|Lack of Efficacy|0
6964285|NCT01107626|11010645|FG003|Step 1: Induction Therapy|Lack of Efficacy|0
6964286|NCT01107626|11010642|FG000|Step 1: Induction Therapy|Adverse Event|198
6964287|NCT01107626|11010643|FG001|Step 1: Induction Therapy|Adverse Event|0
6964288|NCT01107626|11010644|FG002|Step 1: Induction Therapy|Adverse Event|0
6964289|NCT01107626|11010645|FG003|Step 1: Induction Therapy|Adverse Event|0
6964290|NCT01107626|11010642|FG000|Step 1: Induction Therapy|Death|62
6964291|NCT01107626|11010643|FG001|Step 1: Induction Therapy|Death|0
7072847|NCT02038920|11177032|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1
7072848|NCT02038920|11177033|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
7072849|NCT02038920|11177034|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
7072850|NCT02038920|11177035|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
7072851|NCT02038920|11177036|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
7072852|NCT02038920|11177031|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
7072853|NCT02038920|11177032|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
6964292|NCT01107626|11010644|FG002|Step 1: Induction Therapy|Death|0
6964293|NCT01107626|11010645|FG003|Step 1: Induction Therapy|Death|0
6964294|NCT01107626|11010642|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54
6964295|NCT01107626|11010643|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0
6964296|NCT01107626|11010644|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0
6964297|NCT01107626|11010645|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0
6964298|NCT01107626|11010642|FG000|Step 1: Induction Therapy|Complicating disease|13
6964299|NCT01107626|11010643|FG001|Step 1: Induction Therapy|Complicating disease|0
6964300|NCT01107626|11010644|FG002|Step 1: Induction Therapy|Complicating disease|0
6964301|NCT01107626|11010645|FG003|Step 1: Induction Therapy|Complicating disease|0
6964302|NCT01107626|11010642|FG000|Step 1: Induction Therapy|Alternative therapy|12
6964303|NCT01107626|11010643|FG001|Step 1: Induction Therapy|Alternative therapy|0
6964304|NCT01107626|11010644|FG002|Step 1: Induction Therapy|Alternative therapy|0
6964305|NCT01107626|11010645|FG003|Step 1: Induction Therapy|Alternative therapy|0
6964306|NCT01107626|11010642|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10
6964307|NCT01107626|11010643|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0
6964308|NCT01107626|11010644|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0
6964309|NCT01107626|11010645|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0
6964310|NCT01107626|11010642|FG000|Step 1: Induction Therapy|Non-compliance|4
6964311|NCT01107626|11010643|FG001|Step 1: Induction Therapy|Non-compliance|0
6964312|NCT01107626|11010644|FG002|Step 1: Induction Therapy|Non-compliance|0
6964313|NCT01107626|11010645|FG003|Step 1: Induction Therapy|Non-compliance|0
6964314|NCT01107626|11010642|FG000|Step 1: Induction Therapy|Pain|4
6964315|NCT01107626|11010643|FG001|Step 1: Induction Therapy|Pain|0
6964316|NCT01107626|11010644|FG002|Step 1: Induction Therapy|Pain|0
6964317|NCT01107626|11010645|FG003|Step 1: Induction Therapy|Pain|0
6964318|NCT01107626|11010642|FG000|Step 1: Induction Therapy|Protocol Violation|1
6964319|NCT01107626|11010643|FG001|Step 1: Induction Therapy|Protocol Violation|0
6964320|NCT01107626|11010644|FG002|Step 1: Induction Therapy|Protocol Violation|0
6964321|NCT01107626|11010645|FG003|Step 1: Induction Therapy|Protocol Violation|0
6964322|NCT01107626|11010642|FG000|Step 1: Induction Therapy|Hospice care|1
6964323|NCT01107626|11010643|FG001|Step 1: Induction Therapy|Hospice care|0
6964324|NCT01107626|11010644|FG002|Step 1: Induction Therapy|Hospice care|0
6964325|NCT01107626|11010645|FG003|Step 1: Induction Therapy|Hospice care|0
6964326|NCT01107626|11010642|FG000|Step 1: Induction Therapy|Physician Decision|1
6964327|NCT01107626|11010643|FG001|Step 1: Induction Therapy|Physician Decision|0
6964328|NCT01107626|11010644|FG002|Step 1: Induction Therapy|Physician Decision|0
6964329|NCT01107626|11010645|FG003|Step 1: Induction Therapy|Physician Decision|0
6964330|NCT01107626|11010642|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50
6964331|NCT01107626|11010643|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0
6964332|NCT01107626|11010644|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0
6964333|NCT01107626|11010645|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0
6964334|NCT01107626|11010642|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0
6964335|NCT01107626|11010643|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217
6964336|NCT01107626|11010644|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217
6964337|NCT01107626|11010645|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170
6964338|NCT01107626|11010642|FG000|Step 2: Maintenance Therapy|Adverse Event|0
6964339|NCT01107626|11010643|FG001|Step 2: Maintenance Therapy|Adverse Event|32
6964340|NCT01107626|11010644|FG002|Step 2: Maintenance Therapy|Adverse Event|29
6964341|NCT01107626|11010645|FG003|Step 2: Maintenance Therapy|Adverse Event|46
7072854|NCT02038920|11177033|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2
7072855|NCT02038920|11177034|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4
7072856|NCT02038920|11177035|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2
7072857|NCT02038920|11177036|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
7072858|NCT02038920|11177031|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
7072859|NCT02038920|11177032|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
7072860|NCT02038920|11177033|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1
7072861|NCT02038920|11177034|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
7072862|NCT02038920|11177035|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
7072863|NCT02038920|11177036|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
7072864|NCT02038920|11177031|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
7072865|NCT02038920|11177032|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
7072866|NCT02038920|11177033|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2
7072867|NCT02038920|11177034|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4
7072868|NCT02038920|11177035|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10
7072869|NCT02038920|11177036|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
7072870|NCT02038920|11177031|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
7072871|NCT02038920|11177032|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
7072872|NCT02038920|11177033|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
7072873|NCT02038920|11177034|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
7072874|NCT02038920|11177035|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
7072875|NCT02038920|11177036|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43
7072876|NCT02038920|11177031|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
7072877|NCT02038920|11177032|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
7072878|NCT02038920|11177033|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
7072879|NCT02038920|11177034|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
7072880|NCT02038920|11177035|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
7072881|NCT02038920|11177036|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1
7072882|NCT02038920|11177031|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
7072883|NCT02038920|11177032|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
7072884|NCT02038920|11177033|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
7072885|NCT02038920|11177034|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
7072886|NCT02038920|11177035|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
7072887|NCT02038920|11177036|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7
7072888|NCT02038920|11177031|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0
7072889|NCT02038920|11177032|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0
7147855|NCT03136367|11308692|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0
6964342|NCT01107626|11010642|FG000|Step 2: Maintenance Therapy|Death|0
6964343|NCT01107626|11010643|FG001|Step 2: Maintenance Therapy|Death|8
6964344|NCT01107626|11010644|FG002|Step 2: Maintenance Therapy|Death|2
6964345|NCT01107626|11010645|FG003|Step 2: Maintenance Therapy|Death|13
6964346|NCT01107626|11010642|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0
6964347|NCT01107626|11010643|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11
6964348|NCT01107626|11010644|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21
6964349|NCT01107626|11010645|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27
6964350|NCT01107626|11010642|FG000|Step 2: Maintenance Therapy|Alternative therapy|0
6964351|NCT01107626|11010643|FG001|Step 2: Maintenance Therapy|Alternative therapy|2
6964352|NCT01107626|11010644|FG002|Step 2: Maintenance Therapy|Alternative therapy|4
6964353|NCT01107626|11010645|FG003|Step 2: Maintenance Therapy|Alternative therapy|5
6964354|NCT01107626|11010642|FG000|Step 2: Maintenance Therapy|Other complicating disease|0
6964355|NCT01107626|11010643|FG001|Step 2: Maintenance Therapy|Other complicating disease|2
6964356|NCT01107626|11010644|FG002|Step 2: Maintenance Therapy|Other complicating disease|5
6964357|NCT01107626|11010645|FG003|Step 2: Maintenance Therapy|Other complicating disease|9
6964358|NCT01107626|11010642|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0
6964359|NCT01107626|11010643|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2
6964360|NCT01107626|11010644|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4
6964361|NCT01107626|11010645|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3
6964362|NCT01107626|11010642|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0
6964363|NCT01107626|11010643|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2
6964364|NCT01107626|11010644|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2
6964365|NCT01107626|11010645|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3
6964366|NCT01107626|11010642|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0
6964367|NCT01107626|11010643|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1
6964368|NCT01107626|11010644|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1
6964369|NCT01107626|11010645|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0
6964370|NCT01107626|11010642|FG000|Step 2: Maintenance Therapy|Financial reason|0
6964371|NCT01107626|11010643|FG001|Step 2: Maintenance Therapy|Financial reason|2
6964372|NCT01107626|11010644|FG002|Step 2: Maintenance Therapy|Financial reason|0
6964373|NCT01107626|11010645|FG003|Step 2: Maintenance Therapy|Financial reason|0
6964374|NCT01107626|11010642|FG000|Step 2: Maintenance Therapy|Physician Decision|0
6964375|NCT01107626|11010643|FG001|Step 2: Maintenance Therapy|Physician Decision|2
6964376|NCT01107626|11010644|FG002|Step 2: Maintenance Therapy|Physician Decision|3
6964377|NCT01107626|11010645|FG003|Step 2: Maintenance Therapy|Physician Decision|3
6964378|NCT01107626|11010642|FG000|Step 2: Maintenance Therapy|Hospice care|0
6964379|NCT01107626|11010643|FG001|Step 2: Maintenance Therapy|Hospice care|1
6964380|NCT01107626|11010644|FG002|Step 2: Maintenance Therapy|Hospice care|2
6964381|NCT01107626|11010645|FG003|Step 2: Maintenance Therapy|Hospice care|0
6964382|NCT01107626|11010642|FG000|Step 2: Maintenance Therapy|Non-compliance|0
6964383|NCT01107626|11010643|FG001|Step 2: Maintenance Therapy|Non-compliance|0
6964384|NCT01107626|11010644|FG002|Step 2: Maintenance Therapy|Non-compliance|0
6964385|NCT01107626|11010645|FG003|Step 2: Maintenance Therapy|Non-compliance|2
6964386|NCT01107626|11010642|FG000|Step 2: Maintenance Therapy|Pain|0
6964387|NCT01107626|11010643|FG001|Step 2: Maintenance Therapy|Pain|0
6964388|NCT01107626|11010644|FG002|Step 2: Maintenance Therapy|Pain|0
6964389|NCT01107626|11010645|FG003|Step 2: Maintenance Therapy|Pain|1
6964390|NCT01107626|11010642|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0
6964391|NCT01107626|11010643|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4
6964392|NCT01107626|11010644|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4
6964393|NCT01107626|11010645|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10
6964394|NCT01107743|11010673|FG000|Overall Study|Protocol Violation|46
6964395|NCT01107886|11010733|FG000|Overall Study|Lost to Follow-up|15
6964396|NCT01107886|11010734|FG001|Overall Study|Lost to Follow-up|13
6964397|NCT01107886|11010733|FG000|Overall Study|Withdrawal by Subject|180
6964398|NCT01107886|11010734|FG001|Overall Study|Withdrawal by Subject|196
6964399|NCT01107886|11010733|FG000|Overall Study|Administrative withdrawal of consent|7
6964400|NCT01107886|11010734|FG001|Overall Study|Administrative withdrawal of consent|5
6964401|NCT01107899|11010743|FG000|Overall Study|Physician Decision|5
6964402|NCT01107899|11010744|FG001|Overall Study|Physician Decision|0
6964403|NCT01107899|11010745|FG002|Overall Study|Physician Decision|3
6964404|NCT01107899|11010743|FG000|Overall Study|Withdrawal by Subject|0
6964405|NCT01107899|11010744|FG001|Overall Study|Withdrawal by Subject|0
6964406|NCT01107899|11010745|FG002|Overall Study|Withdrawal by Subject|1
6964407|NCT01107912|11010760|FG000|Period 1|Adverse Event|0
6964408|NCT01107912|11010761|FG001|Period 1|Adverse Event|0
6964409|NCT01107912|11010762|FG002|Period 1|Adverse Event|0
6964410|NCT01107912|11010763|FG003|Period 1|Adverse Event|0
6964411|NCT01107912|11010764|FG004|Period 1|Adverse Event|2
6964412|NCT01107912|11010765|FG005|Period 1|Adverse Event|0
6964413|NCT01107912|11010760|FG000|Period 1|Physician Decision|0
6964414|NCT01107912|11010761|FG001|Period 1|Physician Decision|0
6964415|NCT01107912|11010762|FG002|Period 1|Physician Decision|0
6964416|NCT01107912|11010763|FG003|Period 1|Physician Decision|0
6964417|NCT01107912|11010764|FG004|Period 1|Physician Decision|1
6964418|NCT01107912|11010765|FG005|Period 1|Physician Decision|0
6964419|NCT01107912|11010760|FG000|Period 1|Withdrawal by Subject|1
6964420|NCT01107912|11010761|FG001|Period 1|Withdrawal by Subject|0
7072890|NCT02038920|11177033|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0
7072891|NCT02038920|11177034|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0
7072892|NCT02038920|11177035|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0
7072893|NCT02038920|11177036|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1
7072894|NCT02038920|11177031|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
7072895|NCT02038920|11177032|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
6964421|NCT01107912|11010762|FG002|Period 1|Withdrawal by Subject|0
6964422|NCT01107912|11010763|FG003|Period 1|Withdrawal by Subject|0
6964423|NCT01107912|11010764|FG004|Period 1|Withdrawal by Subject|0
6964424|NCT01107912|11010765|FG005|Period 1|Withdrawal by Subject|0
6964425|NCT01107912|11010760|FG000|Period 2|Physician Decision|0
6964426|NCT01107912|11010761|FG001|Period 2|Physician Decision|0
6964427|NCT01107912|11010762|FG002|Period 2|Physician Decision|1
6964428|NCT01107912|11010763|FG003|Period 2|Physician Decision|0
6964429|NCT01107912|11010764|FG004|Period 2|Physician Decision|0
6964430|NCT01107912|11010765|FG005|Period 2|Physician Decision|0
6964431|NCT01107912|11010760|FG000|Period 3|Adverse Event|0
6964432|NCT01107912|11010761|FG001|Period 3|Adverse Event|1
6964433|NCT01107912|11010762|FG002|Period 3|Adverse Event|1
6964434|NCT01107912|11010763|FG003|Period 3|Adverse Event|0
6964435|NCT01107912|11010764|FG004|Period 3|Adverse Event|0
6964436|NCT01107912|11010765|FG005|Period 3|Adverse Event|0
6964437|NCT01107912|11010760|FG000|Period 3|Withdrawal by Subject|0
6964438|NCT01107912|11010761|FG001|Period 3|Withdrawal by Subject|0
6964439|NCT01107912|11010762|FG002|Period 3|Withdrawal by Subject|0
6964440|NCT01107912|11010763|FG003|Period 3|Withdrawal by Subject|1
6964441|NCT01107912|11010764|FG004|Period 3|Withdrawal by Subject|0
6964442|NCT01107912|11010765|FG005|Period 3|Withdrawal by Subject|0
6964443|NCT01107925|11010784|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
6964444|NCT01107925|11010785|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
6964445|NCT01107925|11010786|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
6964446|NCT01107925|11010787|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
6964447|NCT01107925|11010788|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
6964448|NCT01107925|11010789|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
6964449|NCT01107925|11010784|FG000|Period 2|Withdrawal by Subject|0
6964450|NCT01107925|11010785|FG001|Period 2|Withdrawal by Subject|1
6964451|NCT01107925|11010786|FG002|Period 2|Withdrawal by Subject|0
6964452|NCT01107925|11010787|FG003|Period 2|Withdrawal by Subject|0
6964453|NCT01107925|11010788|FG004|Period 2|Withdrawal by Subject|0
6964454|NCT01107925|11010789|FG005|Period 2|Withdrawal by Subject|1
6964455|NCT01108068|11010837|FG000|Overall Study|5 not started, 1 stop due to side effect|6
6964456|NCT01108068|11010838|FG001|Overall Study|5 not started, 1 stop due to side effect|0
6964457|NCT01108094|11010866|FG000|Overall Study|Adverse Event|2
6964458|NCT01108094|11010867|FG001|Overall Study|Adverse Event|0
6964459|NCT01108094|11010868|FG002|Overall Study|Adverse Event|0
6964460|NCT01108094|11010869|FG003|Overall Study|Adverse Event|0
6964461|NCT01108094|11010866|FG000|Overall Study|Withdrawal by Subject|1
6964462|NCT01108094|11010867|FG001|Overall Study|Withdrawal by Subject|0
6964463|NCT01108094|11010868|FG002|Overall Study|Withdrawal by Subject|0
6964464|NCT01108094|11010869|FG003|Overall Study|Withdrawal by Subject|0
6964465|NCT01108185|11010882|FG000|Overall Study|Non-compliance|15
7072896|NCT02038920|11177033|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
7072897|NCT02038920|11177034|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
7072898|NCT02038920|11177035|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
7072899|NCT02038920|11177036|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23
7072900|NCT02038920|11177031|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
7072901|NCT02038920|11177032|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
6838642|NCT00261495|10844347|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20
6838643|NCT00261495|10844346|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14
6838644|NCT00261495|10844347|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10
6838645|NCT00261495|10844346|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6
6838646|NCT00261495|10844347|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5
6838647|NCT00261495|10844346|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1
6838648|NCT00261495|10844347|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5
6838649|NCT00261495|10844346|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5
6838650|NCT00261495|10844347|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2
6838651|NCT00261495|10844346|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6
6838652|NCT00261495|10844347|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5
6838653|NCT00261495|10844346|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
6838654|NCT00261495|10844347|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
6964466|NCT01108185|11010882|FG000|Overall Study|Lost to Follow-up|12
6964467|NCT01108237|11010888|FG000|Overall Study|No alignment data|2
6964468|NCT01108237|11010889|FG001|Overall Study|No alignment data|17
6964469|NCT01108237|11010888|FG000|Overall Study|Did not meet criteria for analysis|7
6964470|NCT01108237|11010889|FG001|Overall Study|Did not meet criteria for analysis|0
6964471|NCT01108263|11010897|FG000|Overall Study|Adverse Event|0
6964472|NCT01108263|11010898|FG001|Overall Study|Adverse Event|1
6964473|NCT01108341|11010904|FG000|Overall Study|Death|2
6964474|NCT01108341|11010904|FG000|Overall Study|Withdrawal by Subject|1
6964475|NCT01108341|11010904|FG000|Overall Study|Lost to Follow-up|1
6964476|NCT01108341|11010904|FG000|Overall Study|Other|1
6964477|NCT01108458|11010923|FG000|Overall Study|Withdrawal by Subject|1
7072902|NCT02038920|11177033|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
6964478|NCT01108510|11010929|FG000|Overall Study|Randomized but Not Treated|5
6964479|NCT01108510|11010930|FG001|Overall Study|Randomized but Not Treated|1
6964480|NCT01108510|11010929|FG000|Overall Study|Joined Another Gilead-sponsored Study|186
6964481|NCT01108510|11010930|FG001|Overall Study|Joined Another Gilead-sponsored Study|195
6964482|NCT01108510|11010929|FG000|Overall Study|Adverse Event|26
6964483|NCT01108510|11010930|FG001|Overall Study|Adverse Event|19
6964484|NCT01108510|11010929|FG000|Overall Study|Lost to Follow-up|20
6964485|NCT01108510|11010930|FG001|Overall Study|Lost to Follow-up|17
6964486|NCT01108510|11010929|FG000|Overall Study|Withdrew Consent|21
6964487|NCT01108510|11010930|FG001|Overall Study|Withdrew Consent|15
6964488|NCT01108510|11010929|FG000|Overall Study|Investigator's Discretion|12
6964489|NCT01108510|11010930|FG001|Overall Study|Investigator's Discretion|10
6964490|NCT01108510|11010929|FG000|Overall Study|Participant Noncompliance|5
6964491|NCT01108510|11010930|FG001|Overall Study|Participant Noncompliance|7
6964492|NCT01108510|11010929|FG000|Overall Study|Lack of Efficacy|3
6964493|NCT01108510|11010930|FG001|Overall Study|Lack of Efficacy|0
6964494|NCT01108510|11010929|FG000|Overall Study|Pregnancy|0
6964495|NCT01108510|11010930|FG001|Overall Study|Pregnancy|3
6964496|NCT01108510|11010929|FG000|Overall Study|Death|1
6964497|NCT01108510|11010930|FG001|Overall Study|Death|1
6964498|NCT01108718|11010938|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1
6964499|NCT01108718|11010939|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0
6964500|NCT01108731|11010946|FG000|Overall Study|Withdrawal by Subject|1
6964501|NCT01108731|11010947|FG001|Overall Study|Withdrawal by Subject|1
6964502|NCT01108731|11010946|FG000|Overall Study|Adverse Event|3
6964503|NCT01108731|11010947|FG001|Overall Study|Adverse Event|3
6964504|NCT01108796|11010966|FG000|Overall Study|Adverse Event|0
6964505|NCT01108796|11010967|FG001|Overall Study|Adverse Event|1
6964506|NCT01108796|11010966|FG000|Overall Study|Lost to Follow-up|7
6964507|NCT01108796|11010967|FG001|Overall Study|Lost to Follow-up|6
6964508|NCT01108809|11010975|FG000|Overall Study|Adverse Event|3
6964509|NCT01108809|11010975|FG000|Overall Study|Lost to Follow-up|1
6964510|NCT01109173|11011030|FG000|Overall Study|Adverse Event|15
6964511|NCT01109173|11011031|FG001|Overall Study|Adverse Event|17
6964512|NCT01109173|11011032|FG002|Overall Study|Adverse Event|9
6964513|NCT01109173|11011033|FG003|Overall Study|Adverse Event|6
6964514|NCT01109173|11011030|FG000|Overall Study|Lost to Follow-up|0
6964515|NCT01109173|11011031|FG001|Overall Study|Lost to Follow-up|1
6964516|NCT01109173|11011032|FG002|Overall Study|Lost to Follow-up|0
6964517|NCT01109173|11011033|FG003|Overall Study|Lost to Follow-up|0
6964518|NCT01109173|11011030|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5
6964519|NCT01109173|11011031|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
6964520|NCT01109173|11011032|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2
6964521|NCT01109173|11011033|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
6964522|NCT01109173|11011030|FG000|Overall Study|Noncompliance|0
6964523|NCT01109173|11011031|FG001|Overall Study|Noncompliance|1
6964524|NCT01109173|11011032|FG002|Overall Study|Noncompliance|0
6964525|NCT01109173|11011033|FG003|Overall Study|Noncompliance|0
6964526|NCT01109173|11011030|FG000|Overall Study|Treatment Failure|25
6964527|NCT01109173|11011031|FG001|Overall Study|Treatment Failure|32
6964528|NCT01109173|11011032|FG002|Overall Study|Treatment Failure|69
6964529|NCT01109173|11011033|FG003|Overall Study|Treatment Failure|64
6964530|NCT01109173|11011030|FG000|Overall Study|Protocol Violation|4
6964531|NCT01109173|11011031|FG001|Overall Study|Protocol Violation|5
6964532|NCT01109173|11011032|FG002|Overall Study|Protocol Violation|1
6964533|NCT01109173|11011033|FG003|Overall Study|Protocol Violation|2
6964534|NCT01109173|11011030|FG000|Overall Study|Patient Did Not Use Study Medication|34
6964535|NCT01109173|11011031|FG001|Overall Study|Patient Did Not Use Study Medication|26
6964536|NCT01109173|11011032|FG002|Overall Study|Patient Did Not Use Study Medication|11
6964537|NCT01109173|11011033|FG003|Overall Study|Patient Did Not Use Study Medication|7
6964538|NCT01109173|11011030|FG000|Overall Study|Not Specifiied|5
6964539|NCT01109173|11011031|FG001|Overall Study|Not Specifiied|4
6964540|NCT01109173|11011032|FG002|Overall Study|Not Specifiied|9
6964541|NCT01109173|11011033|FG003|Overall Study|Not Specifiied|14
6964542|NCT01109316|11011049|FG000|Study Period 1|Adverse Event|0
6964543|NCT01109316|11011050|FG001|Study Period 1|Adverse Event|0
6964544|NCT01109316|11011051|FG002|Study Period 1|Adverse Event|1
6964545|NCT01109316|11011052|FG003|Study Period 1|Adverse Event|0
7072903|NCT02038920|11177034|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
6964546|NCT01109316|11011053|FG004|Study Period 1|Adverse Event|0
6964547|NCT01109316|11011054|FG005|Study Period 1|Adverse Event|0
6964548|NCT01109316|11011049|FG000|Study Period 1|Lost to Follow-up|0
6964549|NCT01109316|11011050|FG001|Study Period 1|Lost to Follow-up|0
6964550|NCT01109316|11011051|FG002|Study Period 1|Lost to Follow-up|1
6964551|NCT01109316|11011052|FG003|Study Period 1|Lost to Follow-up|1
6964552|NCT01109316|11011053|FG004|Study Period 1|Lost to Follow-up|0
6964553|NCT01109316|11011054|FG005|Study Period 1|Lost to Follow-up|0
6964554|NCT01109316|11011049|FG000|Study Period 1|Withdrawal by Subject|0
6964555|NCT01109316|11011050|FG001|Study Period 1|Withdrawal by Subject|0
6964556|NCT01109316|11011051|FG002|Study Period 1|Withdrawal by Subject|1
6964557|NCT01109316|11011052|FG003|Study Period 1|Withdrawal by Subject|0
6964558|NCT01109316|11011053|FG004|Study Period 1|Withdrawal by Subject|2
6964559|NCT01109316|11011054|FG005|Study Period 1|Withdrawal by Subject|0
6964560|NCT01109316|11011049|FG000|Study Period 1|Sponsor Decision|0
6964561|NCT01109316|11011050|FG001|Study Period 1|Sponsor Decision|0
6964562|NCT01109316|11011051|FG002|Study Period 1|Sponsor Decision|0
6964563|NCT01109316|11011052|FG003|Study Period 1|Sponsor Decision|0
6964564|NCT01109316|11011053|FG004|Study Period 1|Sponsor Decision|0
6964565|NCT01109316|11011054|FG005|Study Period 1|Sponsor Decision|2
6964566|NCT01109316|11011049|FG000|Study Period 2|Entry Criteria Not Met|0
6964567|NCT01109316|11011050|FG001|Study Period 2|Entry Criteria Not Met|1
6964568|NCT01109316|11011051|FG002|Study Period 2|Entry Criteria Not Met|0
6964569|NCT01109316|11011052|FG003|Study Period 2|Entry Criteria Not Met|0
6964570|NCT01109316|11011053|FG004|Study Period 2|Entry Criteria Not Met|0
6964571|NCT01109316|11011054|FG005|Study Period 2|Entry Criteria Not Met|0
6964572|NCT01109316|11011049|FG000|Study Period 2|Physician Decision|0
6964573|NCT01109316|11011050|FG001|Study Period 2|Physician Decision|0
6964574|NCT01109316|11011051|FG002|Study Period 2|Physician Decision|0
6964575|NCT01109316|11011052|FG003|Study Period 2|Physician Decision|1
6964576|NCT01109316|11011053|FG004|Study Period 2|Physician Decision|0
6964577|NCT01109316|11011054|FG005|Study Period 2|Physician Decision|0
6964578|NCT01109316|11011049|FG000|Study Period 2|Protocol Violation|1
6964579|NCT01109316|11011050|FG001|Study Period 2|Protocol Violation|0
6964580|NCT01109316|11011051|FG002|Study Period 2|Protocol Violation|0
6964581|NCT01109316|11011052|FG003|Study Period 2|Protocol Violation|0
6964582|NCT01109316|11011053|FG004|Study Period 2|Protocol Violation|0
6964583|NCT01109316|11011054|FG005|Study Period 2|Protocol Violation|0
6964584|NCT01109316|11011049|FG000|Study Period 2|Withdrawal by Subject|0
6964585|NCT01109316|11011050|FG001|Study Period 2|Withdrawal by Subject|0
6964586|NCT01109316|11011051|FG002|Study Period 2|Withdrawal by Subject|1
6964587|NCT01109316|11011052|FG003|Study Period 2|Withdrawal by Subject|0
6964588|NCT01109316|11011053|FG004|Study Period 2|Withdrawal by Subject|0
6964589|NCT01109316|11011054|FG005|Study Period 2|Withdrawal by Subject|1
6964590|NCT01109316|11011049|FG000|Study Period 3|Lost to Follow-up|0
6964591|NCT01109316|11011050|FG001|Study Period 3|Lost to Follow-up|0
6964592|NCT01109316|11011051|FG002|Study Period 3|Lost to Follow-up|0
6964593|NCT01109316|11011052|FG003|Study Period 3|Lost to Follow-up|0
7072904|NCT02038920|11177035|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
7072905|NCT02038920|11177036|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2
7072906|NCT02038933|11177055|FG000|Overall Study|Disease progression|104
6964594|NCT01109316|11011053|FG004|Study Period 3|Lost to Follow-up|1
6964595|NCT01109316|11011054|FG005|Study Period 3|Lost to Follow-up|0
6964596|NCT01109316|11011049|FG000|Study Period 3|Withdrawal by Subject|1
6964597|NCT01109316|11011050|FG001|Study Period 3|Withdrawal by Subject|0
6964598|NCT01109316|11011051|FG002|Study Period 3|Withdrawal by Subject|0
6964599|NCT01109316|11011052|FG003|Study Period 3|Withdrawal by Subject|0
6964600|NCT01109316|11011053|FG004|Study Period 3|Withdrawal by Subject|1
6964601|NCT01109316|11011054|FG005|Study Period 3|Withdrawal by Subject|0
6964602|NCT01109524|11011068|FG000|Overall Study|Disease Progression|29
6964603|NCT01109524|11011068|FG000|Overall Study|Study Drug toxicity|6
6964604|NCT01109524|11011068|FG000|Overall Study|Adverse Event|4
6964605|NCT01109524|11011068|FG000|Overall Study|Withdrawal by Subject|2
6964606|NCT01109524|11011068|FG000|Overall Study|Maximum clinical benefit|3
6964607|NCT01109524|11011068|FG000|Overall Study|Death|2
6964608|NCT01109524|11011068|FG000|Overall Study|No longer meets criteria|2
6964609|NCT01109524|11011068|FG000|Overall Study|Participant requested to end treatment|4
6964610|NCT01109524|11011068|FG000|Overall Study|Other|5
6964611|NCT01109849|11011090|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9
6964612|NCT01109849|11011091|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35
6964613|NCT01109849|11011092|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
6964614|NCT01109849|11011093|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
6964615|NCT01109849|11011094|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
6964616|NCT01109849|11011090|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1
7072907|NCT02038933|11177055|FG000|Overall Study|Study drug toxicity|6
7072908|NCT02038933|11177055|FG000|Overall Study|Adverse event unrelated to study drug|6
6964617|NCT01109849|11011091|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0
6964618|NCT01109849|11011092|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0
6964619|NCT01109849|11011093|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0
6964620|NCT01109849|11011094|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0
6964621|NCT01109849|11011090|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6
6964622|NCT01109849|11011091|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7
6964623|NCT01109849|11011092|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
6964624|NCT01109849|11011093|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
6964625|NCT01109849|11011094|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
7082701|NCT02144285|11193308|FG005|Overall Study|Withdrawal by Subject|0
6964626|NCT01109849|11011090|FG000|Initial Randomization: ADHD Treatment|move away|2
6964627|NCT01109849|11011091|FG001|Initial Randomization: ADHD Treatment|move away|7
6964628|NCT01109849|11011092|FG002|Initial Randomization: ADHD Treatment|move away|0
6964629|NCT01109849|11011093|FG003|Initial Randomization: ADHD Treatment|move away|0
6964630|NCT01109849|11011094|FG004|Initial Randomization: ADHD Treatment|move away|0
6964631|NCT01109849|11011090|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
6964632|NCT01109849|11011091|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
6964633|NCT01109849|11011092|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
6964634|NCT01109849|11011093|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
6964635|NCT01109849|11011094|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
6964636|NCT01109849|11011090|FG000|Adaptive Randomization: Weight Recovery|moved away|0
6964637|NCT01109849|11011091|FG001|Adaptive Randomization: Weight Recovery|moved away|0
6964638|NCT01109849|11011092|FG002|Adaptive Randomization: Weight Recovery|moved away|0
6964639|NCT01109849|11011093|FG003|Adaptive Randomization: Weight Recovery|moved away|2
6964640|NCT01109849|11011094|FG004|Adaptive Randomization: Weight Recovery|moved away|0
6964641|NCT01109940|11011118|FG000|Overall Study|Administrative problems|2
6964642|NCT01109940|11011119|FG001|Overall Study|Administrative problems|0
6964643|NCT01109940|11011120|FG002|Overall Study|Administrative problems|0
6964644|NCT01109940|11011121|FG003|Overall Study|Administrative problems|0
6964645|NCT01109940|11011118|FG000|Overall Study|Serious Adverse Event|2
6964646|NCT01109940|11011119|FG001|Overall Study|Serious Adverse Event|1
6964647|NCT01109940|11011120|FG002|Overall Study|Serious Adverse Event|0
6964648|NCT01109940|11011121|FG003|Overall Study|Serious Adverse Event|0
6964649|NCT01109940|11011118|FG000|Overall Study|Lost to Follow-up|1
6964650|NCT01109940|11011119|FG001|Overall Study|Lost to Follow-up|0
6964651|NCT01109940|11011120|FG002|Overall Study|Lost to Follow-up|0
6964652|NCT01109940|11011121|FG003|Overall Study|Lost to Follow-up|0
6964653|NCT01109940|11011118|FG000|Overall Study|Patient withdrew consent|1
6964654|NCT01109940|11011119|FG001|Overall Study|Patient withdrew consent|1
6964655|NCT01109940|11011120|FG002|Overall Study|Patient withdrew consent|0
6964656|NCT01109940|11011121|FG003|Overall Study|Patient withdrew consent|0
6964657|NCT01109940|11011118|FG000|Overall Study|Unsatisfactory therapeutic effect|2
6964658|NCT01109940|11011119|FG001|Overall Study|Unsatisfactory therapeutic effect|0
6964659|NCT01109940|11011120|FG002|Overall Study|Unsatisfactory therapeutic effect|1
6964660|NCT01109940|11011121|FG003|Overall Study|Unsatisfactory therapeutic effect|0
6964661|NCT01109979|11011133|FG000|Overall Study|Physician Decision|2
6964662|NCT01109979|11011134|FG001|Overall Study|Physician Decision|0
6964663|NCT01109979|11011133|FG000|Overall Study|Withdrawal by Subject|0
6964664|NCT01109979|11011134|FG001|Overall Study|Withdrawal by Subject|1
6964665|NCT01109992|11011142|FG000|Overall Study|Withdrawal by Subject|0
6964666|NCT01109992|11011143|FG001|Overall Study|Withdrawal by Subject|1
6964667|NCT01109992|11011142|FG000|Overall Study|Movement during rest scan.|0
6964668|NCT01109992|11011143|FG001|Overall Study|Movement during rest scan.|1
6964669|NCT01110005|11011154|FG000|Overall Study|ineligible|1
6964670|NCT01110005|11011155|FG001|Overall Study|ineligible|2
6964671|NCT01110005|11011154|FG000|Overall Study|missing consent|3
6964672|NCT01110005|11011155|FG001|Overall Study|missing consent|2
6964673|NCT01110005|11011154|FG000|Overall Study|Withdrawal by Subject|0
6964674|NCT01110005|11011155|FG001|Overall Study|Withdrawal by Subject|1
6964675|NCT01110200|11011178|FG000|Overall Study|Adverse Event|28
6964676|NCT01110200|11011179|FG001|Overall Study|Adverse Event|28
6964677|NCT01110200|11011178|FG000|Overall Study|Withdrawal by Subject|25
6964678|NCT01110200|11011179|FG001|Overall Study|Withdrawal by Subject|32
6964679|NCT01110200|11011178|FG000|Overall Study|Lack of Efficacy|16
6964680|NCT01110200|11011179|FG001|Overall Study|Lack of Efficacy|25
6964681|NCT01110200|11011178|FG000|Overall Study|Protocol Violation|14
6964682|NCT01110200|11011179|FG001|Overall Study|Protocol Violation|12
6964683|NCT01110200|11011178|FG000|Overall Study|Physician Decision|13
6964684|NCT01110200|11011179|FG001|Overall Study|Physician Decision|17
6964685|NCT01110200|11011178|FG000|Overall Study|Lost to Follow-up|10
6964686|NCT01110200|11011179|FG001|Overall Study|Lost to Follow-up|7
6964687|NCT01110239|11011189|FG000|Sham Preconditioning|Withdrawal by Subject|0
6964688|NCT01110239|11011190|FG001|Sham Preconditioning|Withdrawal by Subject|0
6964689|NCT01110239|11011191|FG002|Sham Preconditioning|Withdrawal by Subject|1
6964690|NCT01110239|11011192|FG003|Sham Preconditioning|Withdrawal by Subject|0
6964691|NCT01110239|11011189|FG000|7.5 Min Ischemia|Withdrawal by Subject|0
6964692|NCT01110239|11011190|FG001|7.5 Min Ischemia|Withdrawal by Subject|0
6964693|NCT01110239|11011191|FG002|7.5 Min Ischemia|Withdrawal by Subject|1
6964694|NCT01110239|11011192|FG003|7.5 Min Ischemia|Withdrawal by Subject|0
6964695|NCT01110330|11011211|FG000|Overall Study|Adverse Event|0
7072909|NCT02038933|11177055|FG000|Overall Study|Participant request to discontinue treatment|2
7072910|NCT02038933|11177055|FG000|Overall Study|Lost to Follow-up|1
7072911|NCT02038933|11177055|FG000|Overall Study|Other reasons|2
7072912|NCT02038959|11177062|FG000|Overall Study|Withdrawal by Subject|6
7072913|NCT02038959|11177063|FG001|Overall Study|Withdrawal by Subject|8
7072914|NCT02039219|11177080|FG000|Treatment|Withdrawal by Subject|1
6964696|NCT01110330|11011212|FG001|Overall Study|Adverse Event|4
6964697|NCT01110330|11011213|FG002|Overall Study|Adverse Event|3
6964698|NCT01110330|11011211|FG000|Overall Study|Lack of Efficacy|3
6964699|NCT01110330|11011212|FG001|Overall Study|Lack of Efficacy|1
6964700|NCT01110330|11011213|FG002|Overall Study|Lack of Efficacy|1
6964701|NCT01110330|11011211|FG000|Overall Study|Lost to Follow-up|9
6964702|NCT01110330|11011212|FG001|Overall Study|Lost to Follow-up|10
6964703|NCT01110330|11011213|FG002|Overall Study|Lost to Follow-up|15
6964704|NCT01110330|11011211|FG000|Overall Study|Physician Decision|0
6964705|NCT01110330|11011212|FG001|Overall Study|Physician Decision|1
6964706|NCT01110330|11011213|FG002|Overall Study|Physician Decision|0
6964707|NCT01110330|11011211|FG000|Overall Study|Protocol Violation|2
6964708|NCT01110330|11011212|FG001|Overall Study|Protocol Violation|0
6964709|NCT01110330|11011213|FG002|Overall Study|Protocol Violation|4
6964710|NCT01110330|11011211|FG000|Overall Study|Withdrawal by Subject|0
6964711|NCT01110330|11011212|FG001|Overall Study|Withdrawal by Subject|6
6964712|NCT01110330|11011213|FG002|Overall Study|Withdrawal by Subject|2
6964713|NCT01110330|11011211|FG000|Overall Study|Other|1
6964714|NCT01110330|11011212|FG001|Overall Study|Other|1
6964715|NCT01110330|11011213|FG002|Overall Study|Other|1
6964716|NCT01110382|11011223|FG000|Overall Study|Withdrawal by Subject|0
6964717|NCT01110382|11011224|FG001|Overall Study|Withdrawal by Subject|1
6964718|NCT01110382|11011223|FG000|Overall Study|Protocol Violation|0
6964719|NCT01110382|11011224|FG001|Overall Study|Protocol Violation|1
6964720|NCT01110408|11011236|FG000|Overall Study|Protocol Violation|1
6964721|NCT01110408|11011237|FG001|Overall Study|Protocol Violation|0
6964722|NCT01110707|11011302|FG000|Overall Study|Protocol Violation|0
6964723|NCT01110707|11011303|FG001|Overall Study|Protocol Violation|3
6964724|NCT01110915|11011322|FG000|Overall Study|Death|2
6964725|NCT01110915|11011323|FG001|Overall Study|Death|1
6964726|NCT01110915|11011322|FG000|Overall Study|Lost to Follow-up|1
6964727|NCT01110915|11011323|FG001|Overall Study|Lost to Follow-up|0
6964728|NCT01110915|11011322|FG000|Overall Study|Withdrawal by Subject|7
6964729|NCT01110915|11011323|FG001|Overall Study|Withdrawal by Subject|1
6964730|NCT01111123|11011345|FG000|Open- Label Phase|Failed to be clear or almost cleared|14
6964731|NCT01111123|11011346|FG001|Open- Label Phase|Failed to be clear or almost cleared|0
6964732|NCT01111123|11011345|FG000|Maintenance Phase|Lost to Follow-up|0
6964733|NCT01111123|11011346|FG001|Maintenance Phase|Lost to Follow-up|2
6964734|NCT01111149|11011357|FG000|Overall Study|Protocol Violation|1
6964735|NCT01111149|11011358|FG001|Overall Study|Protocol Violation|1
6964736|NCT01111149|11011359|FG002|Overall Study|Protocol Violation|2
6964737|NCT01111149|11011357|FG000|Overall Study|Withdrawal by Subject|1
6964738|NCT01111149|11011358|FG001|Overall Study|Withdrawal by Subject|0
6964739|NCT01111149|11011359|FG002|Overall Study|Withdrawal by Subject|2
6964740|NCT01111240|11011372|FG000|Overall Study|Adverse Event|190
6964741|NCT01111240|11011372|FG000|Overall Study|Lack of Efficacy|545
6964742|NCT01111240|11011372|FG000|Overall Study|Lack of Efficacy and Adverse Event|19
6964743|NCT01111240|11011372|FG000|Overall Study|Other|312
6964744|NCT01111292|11011378|FG000|Treatment|Physician Decision|1
6964745|NCT01111292|11011379|FG001|Treatment|Physician Decision|1
6964746|NCT01111461|11011417|FG000|Overall Study|Adverse Event|32
6964747|NCT01111461|11011417|FG000|Overall Study|Participant choice|11
6964748|NCT01111461|11011417|FG000|Overall Study|Lost to Follow-up|1
6964749|NCT01111461|11011417|FG000|Overall Study|Withdrawal by Subject|1
6964750|NCT01111461|11011417|FG000|Overall Study|Other|6
6964751|NCT01111474|11011421|FG000|Overall Study|Lost to Follow-up|12
6964752|NCT01111526|11011427|FG000|Overall Study|GVHD Disease Progression|0
6964753|NCT01111526|11011428|FG001|Overall Study|GVHD Disease Progression|1
6964754|NCT01111526|11011429|FG002|Overall Study|GVHD Disease Progression|2
6964755|NCT01111539|11011433|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6
6964756|NCT01111539|11011434|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
6964757|NCT01111539|11011435|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
6964758|NCT01111539|11011436|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
6964759|NCT01111539|11011437|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
6964760|NCT01111539|11011433|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5
6964761|NCT01111539|11011434|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0
6964762|NCT01111539|11011435|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0
6964763|NCT01111539|11011436|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0
6964764|NCT01111539|11011437|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0
6964765|NCT01111539|11011433|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60
6964766|NCT01111539|11011434|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
6964767|NCT01111539|11011435|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
6964768|NCT01111539|11011436|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
6964769|NCT01111539|11011437|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
6964770|NCT01111539|11011433|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1
6964771|NCT01111539|11011434|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0
6964772|NCT01111539|11011435|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0
6964773|NCT01111539|11011436|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0
6964774|NCT01111539|11011437|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0
6964775|NCT01111539|11011433|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7
6964776|NCT01111539|11011434|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0
6964777|NCT01111539|11011435|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0
6964778|NCT01111539|11011436|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0
6964779|NCT01111539|11011437|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0
6964780|NCT01111539|11011433|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2
6964781|NCT01111539|11011434|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0
6964782|NCT01111539|11011435|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0
6964783|NCT01111539|11011436|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0
6964784|NCT01111539|11011437|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0
6964785|NCT01111539|11011433|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1
6964786|NCT01111539|11011434|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0
6964787|NCT01111539|11011435|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0
6964788|NCT01111539|11011436|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0
6964789|NCT01111539|11011437|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0
6964790|NCT01111539|11011433|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
6964791|NCT01111539|11011434|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
6964792|NCT01111539|11011435|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1
6964793|NCT01111539|11011436|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
6964794|NCT01111539|11011437|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1
6964795|NCT01111539|11011433|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
6964796|NCT01111539|11011434|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
6964797|NCT01111539|11011435|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1
6964798|NCT01111539|11011436|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
6964799|NCT01111539|11011437|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2
6964800|NCT01111539|11011433|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0
6964801|NCT01111539|11011434|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7
6964802|NCT01111539|11011435|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4
6964803|NCT01111539|11011436|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5
6964804|NCT01111539|11011437|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5
6964805|NCT01111539|11011433|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0
6964806|NCT01111539|11011434|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0
6964807|NCT01111539|11011435|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0
6964808|NCT01111539|11011436|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0
6964809|NCT01111539|11011437|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1
6964810|NCT01111539|11011433|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0
6964811|NCT01111539|11011434|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0
6964812|NCT01111539|11011435|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0
6964813|NCT01111539|11011436|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1
6964814|NCT01111539|11011437|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0
6964815|NCT01111539|11011433|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0
6964816|NCT01111539|11011434|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0
6964817|NCT01111539|11011435|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0
6964818|NCT01111539|11011436|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2
6964819|NCT01111539|11011437|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0
6964820|NCT01111539|11011433|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
6964821|NCT01111539|11011434|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
6964822|NCT01111539|11011435|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
6964823|NCT01111539|11011436|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
6964824|NCT01111539|11011437|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1
6964825|NCT01111552|11011447|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9
6964826|NCT01111552|11011448|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
6964827|NCT01111552|11011449|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
6964828|NCT01111552|11011450|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
6964829|NCT01111552|11011451|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
6964830|NCT01111552|11011447|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4
6964831|NCT01111552|11011448|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0
6964832|NCT01111552|11011449|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0
6964833|NCT01111552|11011450|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0
6964834|NCT01111552|11011451|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0
6964835|NCT01111552|11011447|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89
6964836|NCT01111552|11011448|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
6964837|NCT01111552|11011449|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
6964838|NCT01111552|11011450|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
6964839|NCT01111552|11011451|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
6964840|NCT01111552|11011447|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3
6964841|NCT01111552|11011448|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0
6964842|NCT01111552|11011449|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0
6964843|NCT01111552|11011450|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0
6964844|NCT01111552|11011451|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0
6964845|NCT01111552|11011447|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3
6964846|NCT01111552|11011448|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0
6964847|NCT01111552|11011449|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0
6964848|NCT01111552|11011450|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0
6964849|NCT01111552|11011451|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0
6964850|NCT01111552|11011447|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7
7040894|NCT01721057|11124070|FG004|Rescue Period|Adverse Event|0
6964851|NCT01111552|11011448|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0
6964852|NCT01111552|11011449|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0
6964853|NCT01111552|11011450|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0
6964854|NCT01111552|11011451|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0
7072915|NCT02039219|11177081|FG001|Treatment|Withdrawal by Subject|0
7072916|NCT02039219|11177080|FG000|Treatment|Adverse Event|0
7072917|NCT02039219|11177081|FG001|Treatment|Adverse Event|1
7072918|NCT02039219|11177080|FG000|Treatment|Physician Decision|1
7072919|NCT02039219|11177081|FG001|Treatment|Physician Decision|0
7072920|NCT02039219|11177080|FG000|Treatment|Lost to Follow-up|0
7072921|NCT02039219|11177081|FG001|Treatment|Lost to Follow-up|1
7072922|NCT02039219|11177080|FG000|Treatment|Protocol Violation|1
7072923|NCT02039219|11177081|FG001|Treatment|Protocol Violation|0
7072924|NCT02039219|11177080|FG000|Treatment|Death|1
7072925|NCT02039219|11177081|FG001|Treatment|Death|0
7072926|NCT02039219|11177080|FG000|Follow up|Adverse Event|0
7072927|NCT02039219|11177081|FG001|Follow up|Adverse Event|1
7072928|NCT02039375|11177087|FG000|Overall Study|Lost to Follow-up|2
7072929|NCT02039414|11177093|FG000|Overall Study|Delivered|1
7072930|NCT02039414|11177094|FG001|Overall Study|Delivered|1
7072931|NCT02039414|11177093|FG000|Overall Study|Lost to Follow-up|2
7072932|NCT02039414|11177094|FG001|Overall Study|Lost to Follow-up|0
7072933|NCT02039414|11177093|FG000|Overall Study|Protocol Violation|3
7072934|NCT02039414|11177094|FG001|Overall Study|Protocol Violation|1
7072935|NCT02039427|11177104|FG000|Overall Study|Duration of surgery > 3h|1
7072936|NCT02039427|11177105|FG001|Overall Study|Duration of surgery > 3h|1
7072937|NCT02039427|11177106|FG002|Overall Study|Duration of surgery > 3h|0
7072938|NCT02039427|11177107|FG003|Overall Study|Duration of surgery > 3h|0
7072939|NCT02039427|11177104|FG000|Overall Study|Withdrawal on concent|0
7072940|NCT02039427|11177105|FG001|Overall Study|Withdrawal on concent|0
7072941|NCT02039427|11177106|FG002|Overall Study|Withdrawal on concent|0
7072942|NCT02039427|11177107|FG003|Overall Study|Withdrawal on concent|1
7072943|NCT02039427|11177104|FG000|Overall Study|Cancellation of surgery|0
7072944|NCT02039427|11177105|FG001|Overall Study|Cancellation of surgery|0
7072945|NCT02039427|11177106|FG002|Overall Study|Cancellation of surgery|1
7072946|NCT02039427|11177107|FG003|Overall Study|Cancellation of surgery|0
7072947|NCT02039427|11177104|FG000|Overall Study|Loss of follow - up|1
7072948|NCT02039427|11177105|FG001|Overall Study|Loss of follow - up|0
7072949|NCT02039427|11177106|FG002|Overall Study|Loss of follow - up|2
7072950|NCT02039427|11177107|FG003|Overall Study|Loss of follow - up|4
7072951|NCT02039427|11177104|FG000|Overall Study|Steroid Use|1
7072952|NCT02039427|11177105|FG001|Overall Study|Steroid Use|0
7072953|NCT02039427|11177106|FG002|Overall Study|Steroid Use|0
7072954|NCT02039427|11177107|FG003|Overall Study|Steroid Use|0
7072955|NCT02039505|11177124|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2
6838655|NCT00261495|10844346|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2
6838656|NCT00261495|10844347|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0
6838657|NCT00261495|10844346|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2
6838658|NCT00261495|10844347|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0
6838659|NCT00261495|10844346|FG000|Extension Phase (Weeks 24 to 52)|Other|4
6838660|NCT00261495|10844347|FG001|Extension Phase (Weeks 24 to 52)|Other|2
6838661|NCT00261495|10844346|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4
6838662|NCT00261495|10844347|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1
6838663|NCT00261495|10844346|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
6838664|NCT00261495|10844347|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1
6838665|NCT00261495|10844346|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
6838666|NCT00261495|10844347|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
6838667|NCT00261495|10844346|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1
6838668|NCT00261495|10844347|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0
6838669|NCT00261495|10844346|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1
6838670|NCT00261495|10844347|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
6838671|NCT00261716|10844355|FG000|Overall Study|Withdrawal by Subject|6
6838672|NCT00261716|10844356|FG001|Overall Study|Withdrawal by Subject|8
6838673|NCT00261716|10844355|FG000|Overall Study|Lost to Follow-up|0
6838674|NCT00261716|10844356|FG001|Overall Study|Lost to Follow-up|2
6838675|NCT00261833|10844368|FG000|Overall Study|Death|1
6838676|NCT00261833|10844369|FG001|Overall Study|Death|3
6838677|NCT00261833|10844368|FG000|Overall Study|Adverse Event|1
6838678|NCT00261833|10844369|FG001|Overall Study|Adverse Event|4
6838679|NCT00261833|10844368|FG000|Overall Study|Withdrawal by Subject|5
6838680|NCT00261833|10844369|FG001|Overall Study|Withdrawal by Subject|7
6838681|NCT00261833|10844368|FG000|Overall Study|Protocol Violation|0
6838682|NCT00261833|10844369|FG001|Overall Study|Protocol Violation|1
6838683|NCT00261833|10844368|FG000|Overall Study|Suspicion of pulmonary cancer|0
6838684|NCT00261833|10844369|FG001|Overall Study|Suspicion of pulmonary cancer|1
7072956|NCT02039505|11177125|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8
7072957|NCT02039505|11177126|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7
7072958|NCT02039505|11177127|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
7072959|NCT02039505|11177128|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
6964855|NCT01111552|11011447|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1
6964856|NCT01111552|11011448|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0
6964857|NCT01111552|11011449|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0
6964858|NCT01111552|11011450|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0
6964859|NCT01111552|11011451|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0
6964860|NCT01111552|11011447|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1
6964861|NCT01111552|11011448|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0
6964862|NCT01111552|11011449|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0
6964863|NCT01111552|11011450|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0
6964864|NCT01111552|11011451|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0
6964865|NCT01111552|11011447|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
6964866|NCT01111552|11011448|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
6964867|NCT01111552|11011449|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
6964868|NCT01111552|11011450|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1
6964869|NCT01111552|11011451|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
6964870|NCT01111552|11011447|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0
6964871|NCT01111552|11011448|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5
6964872|NCT01111552|11011449|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4
6964873|NCT01111552|11011450|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3
6964874|NCT01111552|11011451|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5
6964875|NCT01111552|11011447|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0
6964876|NCT01111552|11011448|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2
6964877|NCT01111552|11011449|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0
6964878|NCT01111552|11011450|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0
6964879|NCT01111552|11011451|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0
6964880|NCT01111552|11011447|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0
6964881|NCT01111552|11011448|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1
6964882|NCT01111552|11011449|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0
6964883|NCT01111552|11011450|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0
6964884|NCT01111552|11011451|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0
6964885|NCT01111552|11011447|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0
6964886|NCT01111552|11011448|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1
6964887|NCT01111552|11011449|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0
6964888|NCT01111552|11011450|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0
6964889|NCT01111552|11011451|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0
6964890|NCT01111552|11011447|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
6964891|NCT01111552|11011448|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
6964892|NCT01111552|11011449|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1
6964893|NCT01111552|11011450|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
6964894|NCT01111552|11011451|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
6964895|NCT01111604|11011464|FG000|Overall Study|Lost to Follow-up|0
6964896|NCT01111604|11011465|FG001|Overall Study|Lost to Follow-up|0
6964897|NCT01111604|11011466|FG002|Overall Study|Lost to Follow-up|1
6964898|NCT01111604|11011464|FG000|Overall Study|Withdrew Consent|3
6964899|NCT01111604|11011465|FG001|Overall Study|Withdrew Consent|0
6964900|NCT01111604|11011466|FG002|Overall Study|Withdrew Consent|2
6964901|NCT01111604|11011464|FG000|Overall Study|Withdrawal by Subject|2
6964902|NCT01111604|11011465|FG001|Overall Study|Withdrawal by Subject|0
6964903|NCT01111604|11011466|FG002|Overall Study|Withdrawal by Subject|0
6964904|NCT01111604|11011464|FG000|Overall Study|Death|1
6964905|NCT01111604|11011465|FG001|Overall Study|Death|0
6964906|NCT01111604|11011466|FG002|Overall Study|Death|0
6964907|NCT01111604|11011464|FG000|Overall Study|Met Exclusion Criteria|2
6964908|NCT01111604|11011465|FG001|Overall Study|Met Exclusion Criteria|0
6964909|NCT01111604|11011466|FG002|Overall Study|Met Exclusion Criteria|0
6964910|NCT01111825|11011496|FG000|Overall Study|Withdrawal by Subject|0
6964911|NCT01111825|11011497|FG001|Overall Study|Withdrawal by Subject|0
6964912|NCT01111825|11011498|FG002|Overall Study|Withdrawal by Subject|1
6964913|NCT01111825|11011499|FG003|Overall Study|Withdrawal by Subject|0
6964914|NCT01111825|11011496|FG000|Overall Study|Lost to Follow-up|0
6964915|NCT01111825|11011497|FG001|Overall Study|Lost to Follow-up|0
6964916|NCT01111825|11011498|FG002|Overall Study|Lost to Follow-up|3
6964917|NCT01111825|11011499|FG003|Overall Study|Lost to Follow-up|1
6964918|NCT01111825|11011496|FG000|Overall Study|Adverse Event|2
6964919|NCT01111825|11011497|FG001|Overall Study|Adverse Event|1
6964920|NCT01111825|11011498|FG002|Overall Study|Adverse Event|4
6964921|NCT01111825|11011499|FG003|Overall Study|Adverse Event|0
6964922|NCT01111825|11011496|FG000|Overall Study|Disease Progression|1
6964923|NCT01111825|11011497|FG001|Overall Study|Disease Progression|0
6964924|NCT01111825|11011498|FG002|Overall Study|Disease Progression|0
6964925|NCT01111825|11011499|FG003|Overall Study|Disease Progression|0
6964926|NCT01111825|11011496|FG000|Overall Study|Discontinuation by Sponsor|0
6964927|NCT01111825|11011497|FG001|Overall Study|Discontinuation by Sponsor|0
6964928|NCT01111825|11011498|FG002|Overall Study|Discontinuation by Sponsor|0
6964929|NCT01111825|11011499|FG003|Overall Study|Discontinuation by Sponsor|20
6964930|NCT01111838|11011509|FG000|Overall Study|Patient Ineligible|2
6964931|NCT01111838|11011509|FG000|Overall Study|Not Treated|3
6964932|NCT01111838|11011509|FG000|Overall Study|Clinical deterioration|1
6964933|NCT01111838|11011509|FG000|Overall Study|Other Complicating Disease|1
6964934|NCT01111851|11011515|FG000|Overall Study|All planned PET scans were not obtained.|2
6964935|NCT01111851|11011516|FG001|Overall Study|All planned PET scans were not obtained.|0
6964936|NCT01112059|11011524|FG000|Overall Study|Withdrawal by Subject|1
6964937|NCT01112059|11011525|FG001|Overall Study|Withdrawal by Subject|0
6964938|NCT01112267|11011546|FG000|Overall Study|Adverse Event|24
6964939|NCT01112267|11011547|FG001|Overall Study|Adverse Event|6
6964940|NCT01112267|11011546|FG000|Overall Study|Withdrawal by Subject|3
6964941|NCT01112267|11011547|FG001|Overall Study|Withdrawal by Subject|5
6964942|NCT01112267|11011546|FG000|Overall Study|Protocol Violation|5
6964943|NCT01112267|11011547|FG001|Overall Study|Protocol Violation|3
6964944|NCT01112267|11011546|FG000|Overall Study|Participants not compliant|1
6964945|NCT01112267|11011547|FG001|Overall Study|Participants not compliant|2
6964946|NCT01112267|11011546|FG000|Overall Study|Participants not receive any study drug|1
6964947|NCT01112267|11011547|FG001|Overall Study|Participants not receive any study drug|2
6964948|NCT01112514|11011566|FG000|Overall Study|Lost to Follow-up|1
6964949|NCT01112579|11011572|FG000|Overall Study|Missed Visit|1
6964950|NCT01112579|11011573|FG001|Overall Study|Missed Visit|1
6964951|NCT01112579|11011572|FG000|Overall Study|Death|0
6964952|NCT01112579|11011573|FG001|Overall Study|Death|2
6964953|NCT01112917|11011621|FG000|Overall Study|Death|2
6964954|NCT01112917|11011622|FG001|Overall Study|Death|11
6964955|NCT01112917|11011621|FG000|Overall Study|Lost to Follow-up|1
6964956|NCT01112917|11011622|FG001|Overall Study|Lost to Follow-up|1
6964957|NCT01112917|11011621|FG000|Overall Study|Withdrawal by Subject|1
6964958|NCT01112917|11011622|FG001|Overall Study|Withdrawal by Subject|3
6964959|NCT01112917|11011621|FG000|Overall Study|Unable to Convert Filter|3
6964960|NCT01112917|11011622|FG001|Overall Study|Unable to Convert Filter|0
6964961|NCT01112982|11011626|FG000|Overall Study|Withdrawal by Subject|1
6964962|NCT01112982|11011626|FG000|Overall Study|exceeded weight limit to complete MRI|1
6976710|NCT01201343|11029489|FG000|Overall Study|Adverse Event|6
6976711|NCT01201343|11029489|FG000|Overall Study|Withdrawal by Subject|5
6976712|NCT01201343|11029489|FG000|Overall Study|Lost to Follow-up|2
6976713|NCT01201343|11029489|FG000|Overall Study|Lack of Efficacy|2
6976714|NCT01201343|11029489|FG000|Overall Study|Participant wrongly included in trial|1
6976715|NCT01201343|11029489|FG000|Overall Study|Randomized, not treated|3
6976716|NCT01201356|11029493|FG000|Overall Study|Adverse Event|170
6976717|NCT01201356|11029493|FG000|Overall Study|Abnormal laboratory value(s)|51
6976718|NCT01201356|11029493|FG000|Overall Study|Abnormal test procedure result(s)|3
6976719|NCT01201356|11029493|FG000|Overall Study|Unsatisfactory therapeutic effect|112
6976720|NCT01201356|11029493|FG000|Overall Study|Condition no longer requires study drug|12
6976721|NCT01201356|11029493|FG000|Overall Study|Withdrawal by Subject|144
6976722|NCT01201356|11029493|FG000|Overall Study|Lost to Follow-up|50
6976723|NCT01201356|11029493|FG000|Overall Study|administrative problems|74
6976724|NCT01201356|11029493|FG000|Overall Study|Death|16
6976725|NCT01201356|11029493|FG000|Overall Study|Protocol Violation|12
6976726|NCT01201759|11029512|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2
6976727|NCT01201759|11029513|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1
6976728|NCT01201759|11029512|FG000|Visit 3 - Washout|Adverse Event|0
6976729|NCT01201759|11029513|FG001|Visit 3 - Washout|Adverse Event|3
6976730|NCT01201759|11029512|FG000|Visit 3 - Washout|Lost to Follow-up|1
6976731|NCT01201759|11029513|FG001|Visit 3 - Washout|Lost to Follow-up|0
6976732|NCT01201759|11029512|FG000|Visit 4 Crossover|Lost to Follow-up|0
6976733|NCT01201759|11029513|FG001|Visit 4 Crossover|Lost to Follow-up|1
6976734|NCT01201785|11029532|FG000|Overall Study|Lost to Follow-up|16
6976735|NCT01201798|11029538|FG000|Overall Study|Adverse Event|2
6976736|NCT01201798|11029539|FG001|Overall Study|Adverse Event|0
6976737|NCT01201798|11029538|FG000|Overall Study|Lost to Follow-up|3
6976738|NCT01201798|11029539|FG001|Overall Study|Lost to Follow-up|5
6976739|NCT01201798|11029538|FG000|Overall Study|Decision Unrelated to an Adverse Event|1
6976740|NCT01201798|11029539|FG001|Overall Study|Decision Unrelated to an Adverse Event|1
6976741|NCT01201798|11029538|FG000|Overall Study|Noncompliance|1
6976742|NCT01201798|11029539|FG001|Overall Study|Noncompliance|0
6976743|NCT01201798|11029538|FG000|Overall Study|Protocol Violation|1
6976744|NCT01201798|11029539|FG001|Overall Study|Protocol Violation|1
6976745|NCT01201798|11029538|FG000|Overall Study|Treatment Failure|1
6976746|NCT01201798|11029539|FG001|Overall Study|Treatment Failure|8
6976747|NCT01201811|11029545|FG000|Overall Study|Adverse Event|6
6976748|NCT01201811|11029545|FG000|Overall Study|Disease progression|3
6976749|NCT01201811|11029545|FG000|Overall Study|Withdrawal by Subject|3
6976750|NCT01201811|11029545|FG000|Overall Study|Death|4
6976751|NCT01201811|11029545|FG000|Overall Study|Treatment Failure|2
6976752|NCT01201811|11029545|FG000|Overall Study|Physician Decision|1
6976753|NCT01201850|11029549|FG000|Overall Study|Tumor progression|4
6976754|NCT01201915|11029569|FG000|Overall Study|Adverse Event|2
6976755|NCT01201915|11029570|FG001|Overall Study|Adverse Event|1
6976756|NCT01201915|11029571|FG002|Overall Study|Adverse Event|1
6976757|NCT01201915|11029569|FG000|Overall Study|Lost to Follow-up|0
6964963|NCT01113463|11011650|FG000|Overall Study|Physician Decision|5
6964964|NCT01113502|11011659|FG000|Overall Study|Withdrawal by Subject|1
6964965|NCT01113502|11011660|FG001|Overall Study|Withdrawal by Subject|0
6964966|NCT01113502|11011661|FG002|Overall Study|Withdrawal by Subject|1
6964967|NCT01113502|11011662|FG003|Overall Study|Withdrawal by Subject|1
6964968|NCT01113502|11011663|FG004|Overall Study|Withdrawal by Subject|0
6964969|NCT01113502|11011659|FG000|Overall Study|Adverse Event|0
6964970|NCT01113502|11011660|FG001|Overall Study|Adverse Event|0
6964971|NCT01113502|11011661|FG002|Overall Study|Adverse Event|3
6964972|NCT01113502|11011662|FG003|Overall Study|Adverse Event|2
6964973|NCT01113502|11011663|FG004|Overall Study|Adverse Event|0
6964974|NCT01113541|11011676|FG000|Overall Study|Withdrawal by Subject|1
6964975|NCT01113541|11011676|FG000|Overall Study|Protocol Violation|1
6964976|NCT01113541|11011676|FG000|Overall Study|Study Terminated by Sponsor|7
6964977|NCT01113541|11011676|FG000|Overall Study|Adverse Event|4
6964978|NCT01113580|11011682|FG000|Overall Study|Protocol Violation|1
6964979|NCT01113580|11011683|FG001|Overall Study|Protocol Violation|0
6964980|NCT01113710|11011698|FG000|Overall Study|Adverse Event|64
6964981|NCT01113710|11011698|FG000|Overall Study|Lack of Efficacy|41
6964982|NCT01113710|11011698|FG000|Overall Study|No Information Available|40
6964983|NCT01113710|11011698|FG000|Overall Study|Withdrawal by Subject|28
6964984|NCT01113710|11011698|FG000|Overall Study|Lost to Follow-up|20
6964985|NCT01113710|11011698|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13
6964986|NCT01113710|11011698|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11
6964987|NCT01113710|11011698|FG000|Overall Study|Lack of Patient's Compliance|8
6964988|NCT01113710|11011698|FG000|Overall Study|Other|7
6964989|NCT01113710|11011698|FG000|Overall Study|Adverse Event/Other|5
6964990|NCT01113710|11011698|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5
6964991|NCT01113710|11011698|FG000|Overall Study|Lack of Efficacy/Other|4
6964992|NCT01113710|11011698|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4
6964993|NCT01113710|11011698|FG000|Overall Study|Lack of Efficacy/Adverse Event|3
6964994|NCT01113710|11011698|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2
6964995|NCT01113710|11011698|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2
6964996|NCT01113710|11011698|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2
6964997|NCT01113710|11011698|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1
6964998|NCT01113710|11011698|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1
6964999|NCT01113710|11011698|FG000|Overall Study|Compliance/Efficacy/AE/Other|1
6965000|NCT01113710|11011698|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1
6965001|NCT01113710|11011698|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1
6965002|NCT01113710|11011698|FG000|Overall Study|Lack of Patient's Compliance/Other|1
6965003|NCT01113710|11011698|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1
6965004|NCT01113710|11011698|FG000|Overall Study|Subject Did Not Receive Neupro|3
7072960|NCT02039505|11177129|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
7072961|NCT02039505|11177130|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
7072962|NCT02039505|11177124|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1
7072963|NCT02039505|11177125|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1
7072964|NCT02039505|11177126|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3
7072965|NCT02039505|11177127|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
7072966|NCT02039505|11177128|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
7072967|NCT02039505|11177129|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
7072968|NCT02039505|11177130|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
7072969|NCT02039505|11177124|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1
7072970|NCT02039505|11177125|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
7072971|NCT02039505|11177126|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
7072972|NCT02039505|11177127|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
7072973|NCT02039505|11177128|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
7072974|NCT02039505|11177129|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
7072975|NCT02039505|11177130|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
7072976|NCT02039505|11177124|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
6965005|NCT01113749|11011715|FG000|Overall Study|Lost to Follow-up|1
6965006|NCT01113749|11011716|FG001|Overall Study|Lost to Follow-up|2
6965007|NCT01113801|11011726|FG000|Overall Study|Adverse Event|4
6965008|NCT01113801|11011727|FG001|Overall Study|Adverse Event|0
6965009|NCT01113801|11011728|FG002|Overall Study|Adverse Event|2
6965010|NCT01113801|11011729|FG003|Overall Study|Adverse Event|6
6965011|NCT01113801|11011726|FG000|Overall Study|Death|4
6965012|NCT01113801|11011727|FG001|Overall Study|Death|5
6965013|NCT01113801|11011728|FG002|Overall Study|Death|3
6965014|NCT01113801|11011729|FG003|Overall Study|Death|4
7072977|NCT02039505|11177125|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
7072978|NCT02039505|11177126|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
7072979|NCT02039505|11177127|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13
7072980|NCT02039505|11177128|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8
7072981|NCT02039505|11177129|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12
7072982|NCT02039505|11177130|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
6965015|NCT01113801|11011726|FG000|Overall Study|Protocol Violation|0
6965016|NCT01113801|11011727|FG001|Overall Study|Protocol Violation|1
6965017|NCT01113801|11011728|FG002|Overall Study|Protocol Violation|0
6965018|NCT01113801|11011729|FG003|Overall Study|Protocol Violation|0
6965019|NCT01113801|11011726|FG000|Overall Study|Withdrawal by Subject|9
6965020|NCT01113801|11011727|FG001|Overall Study|Withdrawal by Subject|7
6965021|NCT01113801|11011728|FG002|Overall Study|Withdrawal by Subject|7
6965022|NCT01113801|11011729|FG003|Overall Study|Withdrawal by Subject|8
6965023|NCT01113801|11011726|FG000|Overall Study|Physician Decision|2
6965024|NCT01113801|11011727|FG001|Overall Study|Physician Decision|2
6965025|NCT01113801|11011728|FG002|Overall Study|Physician Decision|3
6965026|NCT01113801|11011729|FG003|Overall Study|Physician Decision|3
6965027|NCT01113801|11011726|FG000|Overall Study|Sponsor Decision|15
6965028|NCT01113801|11011727|FG001|Overall Study|Sponsor Decision|21
6965029|NCT01113801|11011728|FG002|Overall Study|Sponsor Decision|20
6965030|NCT01113801|11011729|FG003|Overall Study|Sponsor Decision|15
6965031|NCT01113801|11011726|FG000|Overall Study|Clinical Endpoint (ESRD)|7
6965032|NCT01113801|11011727|FG001|Overall Study|Clinical Endpoint (ESRD)|4
6965033|NCT01113801|11011728|FG002|Overall Study|Clinical Endpoint (ESRD)|2
6965034|NCT01113801|11011729|FG003|Overall Study|Clinical Endpoint (ESRD)|5
6965035|NCT01113879|11011741|FG000|Period 1: Block 1|Withdrawal by Subject|2
6965036|NCT01113879|11011742|FG001|Period 1: Block 1|Withdrawal by Subject|0
6965037|NCT01113892|11011752|FG000|Overall Study|Lost to Follow-up|2
6965038|NCT01113892|11011753|FG001|Overall Study|Lost to Follow-up|2
6965039|NCT01113892|11011752|FG000|Overall Study|Withdrawal by Subject|1
6965040|NCT01113892|11011753|FG001|Overall Study|Withdrawal by Subject|1
6965041|NCT01113892|11011752|FG000|Overall Study|Death|2
6965042|NCT01113892|11011753|FG001|Overall Study|Death|4
6965043|NCT01113892|11011752|FG000|Overall Study|Graft no longer evaluable|9
6965044|NCT01113892|11011753|FG001|Overall Study|Graft no longer evaluable|9
6965045|NCT01113931|11011761|FG000|Overall Study|Adverse Event|2
6965046|NCT01113931|11011762|FG001|Overall Study|Adverse Event|2
6965047|NCT01113931|11011761|FG000|Overall Study|Physician Decision|0
6965048|NCT01113931|11011762|FG001|Overall Study|Physician Decision|2
6965049|NCT01113931|11011761|FG000|Overall Study|Lost to Follow-up|12
6965050|NCT01113931|11011762|FG001|Overall Study|Lost to Follow-up|9
6965051|NCT01113931|11011761|FG000|Overall Study|Various|2
6965052|NCT01113931|11011762|FG001|Overall Study|Various|4
6965053|NCT01113931|11011761|FG000|Overall Study|Withdrawal by Subject|3
6965054|NCT01113931|11011762|FG001|Overall Study|Withdrawal by Subject|0
6965055|NCT01114360|11011787|FG000|Intervention 1 (4 Weeks)|Physician Decision|0
6965056|NCT01114360|11011788|FG001|Intervention 1 (4 Weeks)|Physician Decision|1
6965057|NCT01114373|11011808|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1
6965058|NCT01114373|11011809|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0
6965059|NCT01114373|11011808|FG000|Intervention 1 (4 Weeks)|Incarceration|1
6965060|NCT01114373|11011809|FG001|Intervention 1 (4 Weeks)|Incarceration|0
6965061|NCT01114373|11011808|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1
6965062|NCT01114373|11011809|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0
6965063|NCT01114373|11011808|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0
6965064|NCT01114373|11011809|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1
6965065|NCT01114438|11011819|FG000|Overall Study|Adverse Event|10
6965066|NCT01114438|11011819|FG000|Overall Study|concomitant medication|1
6965067|NCT01114438|11011819|FG000|Overall Study|Physician Decision|1
6965068|NCT01114438|11011819|FG000|Overall Study|Withdrawal by Subject|2
6965069|NCT01114516|11011834|FG000|Overall Study|Lost to Follow-up|2
6965070|NCT01114516|11011835|FG001|Overall Study|Lost to Follow-up|1
6965071|NCT01114529|11011844|FG000|Completed Study Medication at Month 24|Adverse Event|87
6965072|NCT01114529|11011845|FG001|Completed Study Medication at Month 24|Adverse Event|18
6965073|NCT01114529|11011846|FG002|Completed Study Medication at Month 24|Adverse Event|17
6965074|NCT01114529|11011844|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6
6965075|NCT01114529|11011845|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0
6965076|NCT01114529|11011846|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1
6965077|NCT01114529|11011844|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3
6965078|NCT01114529|11011845|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0
6965079|NCT01114529|11011846|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1
6965080|NCT01114529|11011844|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2
6965081|NCT01114529|11011845|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1
6965082|NCT01114529|11011846|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2
6965083|NCT01114529|11011844|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1
6965084|NCT01114529|11011845|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1
6965085|NCT01114529|11011846|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1
6965086|NCT01114529|11011844|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18
6965087|NCT01114529|11011845|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8
6965088|NCT01114529|11011846|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2
6965089|NCT01114529|11011844|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1
6965090|NCT01114529|11011845|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4
6965091|NCT01114529|11011846|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2
6965092|NCT01114529|11011844|FG000|Completed Study Medication at Month 24|Administrative problems|2
6965093|NCT01114529|11011845|FG001|Completed Study Medication at Month 24|Administrative problems|1
6965094|NCT01114529|11011846|FG002|Completed Study Medication at Month 24|Administrative problems|2
6965095|NCT01114529|11011844|FG000|Completed Study Medication at Month 24|Death|2
6965096|NCT01114529|11011845|FG001|Completed Study Medication at Month 24|Death|1
6965097|NCT01114529|11011846|FG002|Completed Study Medication at Month 24|Death|2
6965098|NCT01114529|11011844|FG000|Completed Study Medication at Month 24|Graft loss|0
6965099|NCT01114529|11011845|FG001|Completed Study Medication at Month 24|Graft loss|2
6965100|NCT01114529|11011846|FG002|Completed Study Medication at Month 24|Graft loss|0
6965101|NCT01114529|11011844|FG000|Completed Study Medication at Month 24|Protocol Violation|0
6965102|NCT01114529|11011845|FG001|Completed Study Medication at Month 24|Protocol Violation|5
6965103|NCT01114529|11011846|FG002|Completed Study Medication at Month 24|Protocol Violation|2
6965104|NCT01114529|11011844|FG000|Completed Study Medication at Month 24|Missing|2
6965105|NCT01114529|11011845|FG001|Completed Study Medication at Month 24|Missing|0
6965106|NCT01114529|11011846|FG002|Completed Study Medication at Month 24|Missing|0
6965107|NCT01114529|11011844|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18
6965108|NCT01114529|11011845|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6
6965109|NCT01114529|11011846|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3
6965110|NCT01114529|11011844|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10
6965111|NCT01114529|11011845|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5
6965112|NCT01114529|11011846|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7
6965113|NCT01114529|11011844|FG000|Completed Study Phase at Month 24|Death|8
6965114|NCT01114529|11011845|FG001|Completed Study Phase at Month 24|Death|5
6965115|NCT01114529|11011846|FG002|Completed Study Phase at Month 24|Death|4
6965116|NCT01114529|11011844|FG000|Completed Study Phase at Month 24|Other|2
6965117|NCT01114529|11011845|FG001|Completed Study Phase at Month 24|Other|0
6965118|NCT01114529|11011846|FG002|Completed Study Phase at Month 24|Other|0
6965119|NCT01114529|11011844|FG000|Completed Study Phase at Month 24|Missing|2
6965120|NCT01114529|11011845|FG001|Completed Study Phase at Month 24|Missing|0
6965121|NCT01114529|11011846|FG002|Completed Study Phase at Month 24|Missing|0
6965122|NCT01114646|11011875|FG000|Overall Study|Withdrawal by Subject|3
6965123|NCT01114646|11011876|FG001|Overall Study|Withdrawal by Subject|2
6965124|NCT01114672|11011884|FG000|Overall Study|Death|0
6965125|NCT01114672|11011885|FG001|Overall Study|Death|1
6965126|NCT01114672|11011884|FG000|Overall Study|Withdrawal by Subject|2
6965127|NCT01114672|11011885|FG001|Overall Study|Withdrawal by Subject|1
6965128|NCT01114672|11011884|FG000|Overall Study|Lost to Follow-up|1
6965129|NCT01114672|11011885|FG001|Overall Study|Lost to Follow-up|0
6965130|NCT01114672|11011884|FG000|Overall Study|transplanted|1
6965131|NCT01114672|11011885|FG001|Overall Study|transplanted|0
6965132|NCT01114724|11011891|FG000|Overall Study|Death|8
6965133|NCT01114724|11011891|FG000|Overall Study|Lost to Follow-up|1
6965134|NCT01114724|11011891|FG000|Overall Study|Withdrawal by Subject|1
6965135|NCT01114737|11011898|FG000|Randomized Treatment Period|Withdrawal by Subject|1
6965136|NCT01114737|11011899|FG001|Randomized Treatment Period|Withdrawal by Subject|0
6965137|NCT01114737|11011898|FG000|Randomized Treatment Period|Lost to Follow-up|1
6965138|NCT01114737|11011899|FG001|Randomized Treatment Period|Lost to Follow-up|1
6965139|NCT01114737|11011898|FG000|Randomized Treatment Period|Pregnancy|1
6965140|NCT01114737|11011899|FG001|Randomized Treatment Period|Pregnancy|0
6965141|NCT01114737|11011898|FG000|Open-Label Treatment Period|Withdrawal by Subject|1
6965142|NCT01114737|11011899|FG001|Open-Label Treatment Period|Withdrawal by Subject|1
6965143|NCT01114737|11011898|FG000|Open-Label Treatment Period|Lost to Follow-up|3
6965144|NCT01114737|11011899|FG001|Open-Label Treatment Period|Lost to Follow-up|1
6965145|NCT01114737|11011898|FG000|Open-Label Treatment Period|Difficult Personal Events|1
6965146|NCT01114737|11011899|FG001|Open-Label Treatment Period|Difficult Personal Events|0
6965147|NCT01114828|11011918|FG000|Overall Study|Adverse Event|1
6965148|NCT01114828|11011919|FG001|Overall Study|Adverse Event|1
6965149|NCT01114828|11011918|FG000|Overall Study|Lack of Efficacy|0
6965150|NCT01114828|11011919|FG001|Overall Study|Lack of Efficacy|2
6965151|NCT01114828|11011918|FG000|Overall Study|Protocol Violation|2
6965152|NCT01114828|11011919|FG001|Overall Study|Protocol Violation|0
6965153|NCT01114828|11011918|FG000|Overall Study|Withdrawal by Subject|0
6965154|NCT01114828|11011919|FG001|Overall Study|Withdrawal by Subject|1
6965155|NCT01114880|11011927|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4
6965156|NCT01114880|11011928|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0
6965157|NCT01114880|11011927|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1
6965158|NCT01114880|11011928|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0
6965159|NCT01114880|11011927|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0
6965160|NCT01114880|11011928|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1
6965161|NCT01114880|11011927|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0
6965162|NCT01114880|11011928|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1
6965163|NCT01114880|11011927|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3
6965164|NCT01114880|11011928|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0
6965165|NCT01114880|11011927|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0
6965166|NCT01114880|11011928|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2
6965167|NCT01115309|11012025|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2
6965168|NCT01115309|11012025|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1
6965169|NCT01115309|11012025|FG000|Long-term Follow-up|Lost to Follow-up|6
6965170|NCT01115491|11012038|FG000|Overall Study|Death|22
6965171|NCT01115491|11012038|FG000|Overall Study|Adverse Event|3
6965172|NCT01115491|11012038|FG000|Overall Study|Lost to Follow-up|3
6965173|NCT01115491|11012038|FG000|Overall Study|Withdrawal by Subject|1
6965174|NCT01115491|11012038|FG000|Overall Study|Physician Decision|1
6965175|NCT01115569|11012062|FG000|Conversion/Titration Phase|Adverse Event|59
6965176|NCT01115569|11012063|FG001|Conversion/Titration Phase|Adverse Event|0
6965177|NCT01115569|11012062|FG000|Conversion/Titration Phase|Lost to Follow-up|3
6965178|NCT01115569|11012063|FG001|Conversion/Titration Phase|Lost to Follow-up|0
6965179|NCT01115569|11012062|FG000|Conversion/Titration Phase|Physician Decision|5
6965180|NCT01115569|11012063|FG001|Conversion/Titration Phase|Physician Decision|0
6965181|NCT01115569|11012062|FG000|Conversion/Titration Phase|Protocol Violation|68
6965182|NCT01115569|11012063|FG001|Conversion/Titration Phase|Protocol Violation|0
6965183|NCT01115569|11012062|FG000|Conversion/Titration Phase|Withdrawal by Subject|26
6965184|NCT01115569|11012063|FG001|Conversion/Titration Phase|Withdrawal by Subject|0
6965185|NCT01115569|11012062|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53
6965186|NCT01115569|11012063|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0
6965187|NCT01115569|11012062|FG000|Maintenance Phase|Adverse Event|0
6965188|NCT01115569|11012063|FG001|Maintenance Phase|Adverse Event|43
6965189|NCT01115569|11012062|FG000|Maintenance Phase|Lost to Follow-up|0
6965190|NCT01115569|11012063|FG001|Maintenance Phase|Lost to Follow-up|8
6965191|NCT01115569|11012062|FG000|Maintenance Phase|Physician Decision|0
6965192|NCT01115569|11012063|FG001|Maintenance Phase|Physician Decision|3
6965193|NCT01115569|11012062|FG000|Maintenance Phase|Protocol Violation|0
6965194|NCT01115569|11012063|FG001|Maintenance Phase|Protocol Violation|9
6965195|NCT01115569|11012062|FG000|Maintenance Phase|Withdrawal by Subject|0
6965196|NCT01115569|11012063|FG001|Maintenance Phase|Withdrawal by Subject|27
6965197|NCT01115569|11012062|FG000|Maintenance Phase|Non-Compliance with Study Drug|0
6965198|NCT01115569|11012063|FG001|Maintenance Phase|Non-Compliance with Study Drug|48
6965199|NCT01115569|11012062|FG000|Maintenance Phase|Administrative|0
6965200|NCT01115569|11012063|FG001|Maintenance Phase|Administrative|1
6965201|NCT01115738|11012097|FG000|Overall Study|Death|1
6965202|NCT01115738|11012098|FG001|Overall Study|Death|0
6965203|NCT01115738|11012099|FG002|Overall Study|Death|0
6965204|NCT01115738|11012097|FG000|Overall Study|Lost to Follow-up|0
6965205|NCT01115738|11012098|FG001|Overall Study|Lost to Follow-up|0
6965206|NCT01115738|11012099|FG002|Overall Study|Lost to Follow-up|1
6965207|NCT01115738|11012097|FG000|Overall Study|Physician Decision|18
6965208|NCT01115738|11012098|FG001|Overall Study|Physician Decision|15
6965209|NCT01115738|11012099|FG002|Overall Study|Physician Decision|17
6965210|NCT01115738|11012097|FG000|Overall Study|Withdrawal by Subject|6
6965211|NCT01115738|11012098|FG001|Overall Study|Withdrawal by Subject|6
6965212|NCT01115738|11012099|FG002|Overall Study|Withdrawal by Subject|9
6965213|NCT01115803|11012122|FG000|Overall Study|Withdrawal by Subject|0
6965214|NCT01115803|11012123|FG001|Overall Study|Withdrawal by Subject|0
6965215|NCT01115803|11012124|FG002|Overall Study|Withdrawal by Subject|0
6965216|NCT01115803|11012125|FG003|Overall Study|Withdrawal by Subject|0
6965217|NCT01115803|11012126|FG004|Overall Study|Withdrawal by Subject|0
6965218|NCT01115803|11012127|FG005|Overall Study|Withdrawal by Subject|0
6965219|NCT01115803|11012128|FG006|Overall Study|Withdrawal by Subject|1
6965220|NCT01115803|11012122|FG000|Overall Study|Lost to Follow-up|0
6965221|NCT01115803|11012123|FG001|Overall Study|Lost to Follow-up|0
6965222|NCT01115803|11012124|FG002|Overall Study|Lost to Follow-up|1
6965223|NCT01115803|11012125|FG003|Overall Study|Lost to Follow-up|0
6965224|NCT01115803|11012126|FG004|Overall Study|Lost to Follow-up|0
6965225|NCT01115803|11012127|FG005|Overall Study|Lost to Follow-up|0
6965226|NCT01115803|11012128|FG006|Overall Study|Lost to Follow-up|0
6965227|NCT01115803|11012122|FG000|Overall Study|Progressive Disease during Cycle1|0
6965228|NCT01115803|11012123|FG001|Overall Study|Progressive Disease during Cycle1|0
6965229|NCT01115803|11012124|FG002|Overall Study|Progressive Disease during Cycle1|0
6965230|NCT01115803|11012125|FG003|Overall Study|Progressive Disease during Cycle1|0
6965231|NCT01115803|11012126|FG004|Overall Study|Progressive Disease during Cycle1|0
6965232|NCT01115803|11012127|FG005|Overall Study|Progressive Disease during Cycle1|0
6965233|NCT01115803|11012128|FG006|Overall Study|Progressive Disease during Cycle1|1
6965234|NCT01115855|11012151|FG000|Overall Study|Adverse Event|16
6965235|NCT01115855|11012152|FG001|Overall Study|Adverse Event|18
6965236|NCT01115855|11012151|FG000|Overall Study|Death|6
6965237|NCT01115855|11012152|FG001|Overall Study|Death|5
6965238|NCT01115855|11012151|FG000|Overall Study|Lab Abnormality|1
6965239|NCT01115855|11012152|FG001|Overall Study|Lab Abnormality|1
6965240|NCT01115855|11012151|FG000|Overall Study|Protocol Violation|0
6965241|NCT01115855|11012152|FG001|Overall Study|Protocol Violation|1
6965242|NCT01115855|11012151|FG000|Overall Study|Withdrawal by Subject|5
6965243|NCT01115855|11012152|FG001|Overall Study|Withdrawal by Subject|5
6965244|NCT01115855|11012151|FG000|Overall Study|Other|8
6965245|NCT01115855|11012152|FG001|Overall Study|Other|6
6965246|NCT01115933|11012158|FG000|Overall Study|Did not receive XIENCE PRIME SV|1
6965247|NCT01115998|11012217|FG000|Overall Study|Lost to Follow-up|6
6965248|NCT01115998|11012218|FG001|Overall Study|Lost to Follow-up|6
6965249|NCT01116427|11012293|FG000|Core Phase|Adverse Event|0
6965250|NCT01116427|11012294|FG001|Core Phase|Adverse Event|1
6965251|NCT01116427|11012293|FG000|Core Phase|Lost to Follow-up|1
6965252|NCT01116427|11012294|FG001|Core Phase|Lost to Follow-up|0
6965253|NCT01116427|11012293|FG000|Core Phase|Withdrawal by Subject|3
6965254|NCT01116427|11012294|FG001|Core Phase|Withdrawal by Subject|0
6965255|NCT01116427|11012293|FG000|Core Phase|Worsening Multiple Sclerosis|1
6965256|NCT01116427|11012294|FG001|Core Phase|Worsening Multiple Sclerosis|0
6965257|NCT01116427|11012293|FG000|Extension Phase|Adverse Event|1
6965258|NCT01116427|11012294|FG001|Extension Phase|Adverse Event|1
6965259|NCT01116427|11012293|FG000|Extension Phase|Lost to Follow-up|2
6965260|NCT01116427|11012294|FG001|Extension Phase|Lost to Follow-up|0
6965261|NCT01116427|11012293|FG000|Extension Phase|Withdrawal by Subject|5
6965262|NCT01116427|11012294|FG001|Extension Phase|Withdrawal by Subject|1
6965263|NCT01116427|11012293|FG000|Extension Phase|Not using appropriate birth control|1
6965264|NCT01116427|11012294|FG001|Extension Phase|Not using appropriate birth control|0
6965265|NCT01116440|11012306|FG000|Treatment|Withdrawal by Subject|2
6965266|NCT01116440|11012307|FG001|Treatment|Withdrawal by Subject|2
6965267|NCT01116440|11012306|FG000|Treatment|Lost to Follow-up|1
6965268|NCT01116440|11012307|FG001|Treatment|Lost to Follow-up|1
6965269|NCT01116440|11012306|FG000|Treatment|Protocol Violation|0
6965270|NCT01116440|11012307|FG001|Treatment|Protocol Violation|2
6965271|NCT01116440|11012306|FG000|Treatment|Lack of Efficacy|0
6965272|NCT01116440|11012307|FG001|Treatment|Lack of Efficacy|1
6965273|NCT01116440|11012306|FG000|Treatment|Adverse Event|0
6965274|NCT01116440|11012307|FG001|Treatment|Adverse Event|1
6965275|NCT01116440|11012306|FG000|Withdrawal|Withdrawal by Subject|0
6965276|NCT01116440|11012307|FG001|Withdrawal|Withdrawal by Subject|1
6965277|NCT01116440|11012306|FG000|Withdrawal|Lost to Follow-up|0
6965278|NCT01116440|11012307|FG001|Withdrawal|Lost to Follow-up|1
6965279|NCT01116440|11012306|FG000|Follow-up|Lost to Follow-up|0
6965280|NCT01116440|11012307|FG001|Follow-up|Lost to Follow-up|1
6965281|NCT01116440|11012306|FG000|Follow-up|Withdrawal by Subject|0
6965282|NCT01116440|11012307|FG001|Follow-up|Withdrawal by Subject|1
6965283|NCT01116544|11012322|FG000|Overall Study|Protocol Violation|1
6965284|NCT01116544|11012323|FG001|Overall Study|Protocol Violation|0
6965285|NCT01116544|11012322|FG000|Overall Study|Withdrawal by Subject|1
6965286|NCT01116544|11012323|FG001|Overall Study|Withdrawal by Subject|1
6965287|NCT01116687|11012333|FG000|Overall Study|Withdrawal by Subject|4
6965288|NCT01116739|11012339|FG000|Overall Study|Child had 2 years of HS|110
6965289|NCT01116739|11012340|FG001|Overall Study|Child had 2 years of HS|128
6965290|NCT01116739|11012339|FG000|Overall Study|Withdrawal by Subject|6
6965291|NCT01116739|11012340|FG001|Overall Study|Withdrawal by Subject|0
6965292|NCT01116739|11012339|FG000|Overall Study|child too young|2
7072983|NCT02039505|11177124|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
7072984|NCT02039505|11177125|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
7072985|NCT02039505|11177126|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
7072986|NCT02039505|11177127|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6
7072987|NCT02039505|11177128|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1
7072988|NCT02039505|11177129|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1
7072989|NCT02039505|11177130|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
7072990|NCT02039505|11177124|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
7072991|NCT02039505|11177125|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
7072992|NCT02039505|11177126|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
7072993|NCT02039505|11177127|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3
7072994|NCT02039505|11177128|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2
7072995|NCT02039505|11177129|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1
7072996|NCT02039505|11177130|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
7072997|NCT02039505|11177124|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
7072998|NCT02039505|11177125|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
7072999|NCT02039505|11177126|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
7073000|NCT02039505|11177127|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2
7073001|NCT02039505|11177128|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
7073002|NCT02039505|11177129|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
7073003|NCT02039505|11177130|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
7073004|NCT02039505|11177124|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
7073005|NCT02039505|11177125|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
7073006|NCT02039505|11177126|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
7073007|NCT02039505|11177127|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
7073008|NCT02039505|11177128|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
6965293|NCT01116739|11012340|FG001|Overall Study|child too young|6
6965294|NCT01116739|11012339|FG000|Overall Study|child not enrolled in head start|10
6965295|NCT01116739|11012340|FG001|Overall Study|child not enrolled in head start|2
6965296|NCT01116739|11012339|FG000|Overall Study|enrolled caregiver not legal guardian|2
6965297|NCT01116739|11012340|FG001|Overall Study|enrolled caregiver not legal guardian|0
6965298|NCT01116882|11012348|FG000|30-day|Lost to Follow-up|50
6965299|NCT01116882|11012349|FG001|30-day|Lost to Follow-up|21
6965300|NCT01116882|11012348|FG000|30-day|Withdrawal by Subject|2
6965301|NCT01116882|11012349|FG001|30-day|Withdrawal by Subject|4
6965302|NCT01116882|11012348|FG000|30-day|Other Reasons|16
6965303|NCT01116882|11012349|FG001|30-day|Other Reasons|6
6965304|NCT01116882|11012348|FG000|12-month|Lost to Follow-up|111
7073009|NCT02039505|11177129|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
7073010|NCT02039505|11177130|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44
7073011|NCT02039505|11177124|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
7073012|NCT02039505|11177125|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
7073013|NCT02039505|11177126|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
7073014|NCT02039505|11177127|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
6965305|NCT01116882|11012349|FG001|12-month|Lost to Follow-up|42
6965306|NCT01116882|11012348|FG000|12-month|Other Reasons|151
6965307|NCT01116882|11012349|FG001|12-month|Other Reasons|49
6965308|NCT01116882|11012348|FG000|12-month|Withdrawal by Subject|5
6965309|NCT01116882|11012349|FG001|12-month|Withdrawal by Subject|8
6965310|NCT01117012|11012478|FG000|Overall Study|Adverse Event|0
6965311|NCT01117012|11012479|FG001|Overall Study|Adverse Event|1
6965312|NCT01117012|11012478|FG000|Overall Study|Death|1
6965313|NCT01117012|11012479|FG001|Overall Study|Death|1
6965314|NCT01117012|11012478|FG000|Overall Study|Withdrawal by Subject|3
6965315|NCT01117012|11012479|FG001|Overall Study|Withdrawal by Subject|0
6965316|NCT01117012|11012478|FG000|Overall Study|Undefined|4
6965317|NCT01117012|11012479|FG001|Overall Study|Undefined|3
6965318|NCT01117051|11012487|FG000|Overall Study|Withdrawal by Subject|5
6965319|NCT01117051|11012488|FG001|Overall Study|Withdrawal by Subject|3
6965320|NCT01117051|11012487|FG000|Overall Study|Adverse Event|4
6965321|NCT01117051|11012488|FG001|Overall Study|Adverse Event|3
6965322|NCT01117051|11012487|FG000|Overall Study|Lost to Follow-up|0
6965323|NCT01117051|11012488|FG001|Overall Study|Lost to Follow-up|1
6965324|NCT01117051|11012487|FG000|Overall Study|Did not meet in-/exclusion criteria|0
6965325|NCT01117051|11012488|FG001|Overall Study|Did not meet in-/exclusion criteria|1
6965326|NCT01117051|11012487|FG000|Overall Study|Sponsor's decision|3
6965327|NCT01117051|11012488|FG001|Overall Study|Sponsor's decision|1
6965328|NCT01117051|11012487|FG000|Overall Study|Surgical procedure|0
6965329|NCT01117051|11012488|FG001|Overall Study|Surgical procedure|1
6965330|NCT01117051|11012487|FG000|Overall Study|Randomized by mistake|0
6965331|NCT01117051|11012488|FG001|Overall Study|Randomized by mistake|1
6965332|NCT01117051|11012487|FG000|Overall Study|Convenience issue|1
6965333|NCT01117051|11012488|FG001|Overall Study|Convenience issue|0
6965334|NCT01117181|11012508|FG000|Overall Study|Lost to Follow-up|1
6965335|NCT01117181|11012509|FG001|Overall Study|Lost to Follow-up|0
6965336|NCT01117181|11012508|FG000|Overall Study|Withdrawal by Subject|0
6965337|NCT01117181|11012509|FG001|Overall Study|Withdrawal by Subject|2
6965338|NCT01117337|11012526|FG000|Overall Study|Lost to Follow-up|4
6965339|NCT01117337|11012527|FG001|Overall Study|Lost to Follow-up|0
6965340|NCT01117350|11012535|FG000|Comparative Period|Not Treated|5
6965341|NCT01117350|11012536|FG001|Comparative Period|Not Treated|8
6965342|NCT01117350|11012535|FG000|Comparative Period|Adverse Event|6
6965343|NCT01117350|11012536|FG001|Comparative Period|Adverse Event|33
6965344|NCT01117350|11012535|FG000|Comparative Period|Lost to Follow-up|11
6965345|NCT01117350|11012536|FG001|Comparative Period|Lost to Follow-up|7
6965346|NCT01117350|11012535|FG000|Comparative Period|Withdrawal by Subject|9
6965347|NCT01117350|11012536|FG001|Comparative Period|Withdrawal by Subject|13
6965348|NCT01117350|11012535|FG000|Comparative Period|Protocol Violation|8
6965349|NCT01117350|11012536|FG001|Comparative Period|Protocol Violation|12
6965350|NCT01117350|11012535|FG000|Comparative Period|Lack of Efficacy|1
6965351|NCT01117350|11012536|FG001|Comparative Period|Lack of Efficacy|0
6965352|NCT01117350|11012535|FG000|Comparative Period|Physician Decision|0
6965353|NCT01117350|11012536|FG001|Comparative Period|Physician Decision|1
6965354|NCT01117350|11012535|FG000|Comparative Period|Move to another city/country|2
6965355|NCT01117350|11012536|FG001|Comparative Period|Move to another city/country|1
6965356|NCT01117350|11012535|FG000|Extension Period|Not included in extension, not treated|0
6965357|NCT01117350|11012536|FG001|Extension Period|Not included in extension, not treated|50
6965358|NCT01117350|11012535|FG000|Extension Period|Adverse Event|0
6965359|NCT01117350|11012536|FG001|Extension Period|Adverse Event|2
6965360|NCT01117350|11012535|FG000|Extension Period|Protocol Violation|0
6965361|NCT01117350|11012536|FG001|Extension Period|Protocol Violation|2
6965362|NCT01117350|11012535|FG000|Extension Period|Lost to Follow-up|0
6965363|NCT01117350|11012536|FG001|Extension Period|Lost to Follow-up|2
6965364|NCT01117350|11012535|FG000|Extension Period|Withdrawal by Subject|0
6965365|NCT01117350|11012536|FG001|Extension Period|Withdrawal by Subject|3
6965366|NCT01117350|11012535|FG000|Extension Period|Lack of Efficacy|0
6965367|NCT01117350|11012536|FG001|Extension Period|Lack of Efficacy|2
7082702|NCT02144285|11193309|FG006|Overall Study|Withdrawal by Subject|0
6965368|NCT01117350|11012535|FG000|Extension Period|Inclusion criteria not respected|0
6965369|NCT01117350|11012536|FG001|Extension Period|Inclusion criteria not respected|1
6965370|NCT01117350|11012535|FG000|Extension Period|Prohibited medication|0
6965371|NCT01117350|11012536|FG001|Extension Period|Prohibited medication|1
6965372|NCT01117428|11012551|FG000|Overall Study|Lack of Efficacy|1
6965373|NCT01117428|11012552|FG001|Overall Study|Lack of Efficacy|0
6965374|NCT01117428|11012553|FG002|Overall Study|Lack of Efficacy|0
6965375|NCT01117428|11012554|FG003|Overall Study|Lack of Efficacy|0
6965376|NCT01117428|11012555|FG004|Overall Study|Lack of Efficacy|0
6965377|NCT01117428|11012556|FG005|Overall Study|Lack of Efficacy|0
6965378|NCT01117428|11012551|FG000|Overall Study|Adverse Event|4
6965379|NCT01117428|11012552|FG001|Overall Study|Adverse Event|0
6965380|NCT01117428|11012553|FG002|Overall Study|Adverse Event|0
6965381|NCT01117428|11012554|FG003|Overall Study|Adverse Event|0
6965382|NCT01117428|11012555|FG004|Overall Study|Adverse Event|1
6965383|NCT01117428|11012556|FG005|Overall Study|Adverse Event|2
6965384|NCT01117428|11012551|FG000|Overall Study|Death|0
7073015|NCT02039505|11177128|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
7073016|NCT02039505|11177129|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
7073017|NCT02039505|11177130|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19
7073018|NCT02039505|11177124|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
7073019|NCT02039505|11177125|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
7073020|NCT02039505|11177126|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
7073021|NCT02039505|11177127|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
7073022|NCT02039505|11177128|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
7073023|NCT02039505|11177129|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
6965385|NCT01117428|11012552|FG001|Overall Study|Death|1
6965386|NCT01117428|11012553|FG002|Overall Study|Death|2
6965387|NCT01117428|11012554|FG003|Overall Study|Death|0
6965388|NCT01117428|11012555|FG004|Overall Study|Death|0
6965389|NCT01117428|11012556|FG005|Overall Study|Death|1
6965390|NCT01117428|11012551|FG000|Overall Study|Physician Decision|0
6965391|NCT01117428|11012552|FG001|Overall Study|Physician Decision|1
6965392|NCT01117428|11012553|FG002|Overall Study|Physician Decision|0
6965393|NCT01117428|11012554|FG003|Overall Study|Physician Decision|0
6965394|NCT01117428|11012555|FG004|Overall Study|Physician Decision|0
6965395|NCT01117428|11012556|FG005|Overall Study|Physician Decision|0
6965396|NCT01117428|11012551|FG000|Overall Study|Withdrawal by Subject|0
6965397|NCT01117428|11012552|FG001|Overall Study|Withdrawal by Subject|0
6965398|NCT01117428|11012553|FG002|Overall Study|Withdrawal by Subject|1
6965399|NCT01117428|11012554|FG003|Overall Study|Withdrawal by Subject|0
6965400|NCT01117428|11012555|FG004|Overall Study|Withdrawal by Subject|0
6965401|NCT01117428|11012556|FG005|Overall Study|Withdrawal by Subject|0
6965402|NCT01117428|11012551|FG000|Overall Study|Progressive disease|15
6965403|NCT01117428|11012552|FG001|Overall Study|Progressive disease|27
6965404|NCT01117428|11012553|FG002|Overall Study|Progressive disease|10
6965405|NCT01117428|11012554|FG003|Overall Study|Progressive disease|12
6965406|NCT01117428|11012555|FG004|Overall Study|Progressive disease|16
6965407|NCT01117428|11012556|FG005|Overall Study|Progressive disease|17
6965408|NCT01117454|11012574|FG000|Overall Study|Pregnancy|0
6965409|NCT01117454|11012575|FG001|Overall Study|Pregnancy|1
6965410|NCT01117480|11012581|FG000|Overall Study|Protocol Violation|8
6965411|NCT01117480|11012581|FG000|Overall Study|Did Not Start Adalimumab Therapy|20
6965412|NCT01117623|11012593|FG000|Overall Study|Adverse Event|0
6965413|NCT01117623|11012594|FG001|Overall Study|Adverse Event|2
6965414|NCT01117623|11012595|FG002|Overall Study|Adverse Event|4
6965415|NCT01117623|11012596|FG003|Overall Study|Adverse Event|0
6965416|NCT01117623|11012597|FG004|Overall Study|Adverse Event|2
6965417|NCT01117623|11012598|FG005|Overall Study|Adverse Event|0
6965418|NCT01117623|11012599|FG006|Overall Study|Adverse Event|0
6965419|NCT01117623|11012600|FG007|Overall Study|Adverse Event|2
6965420|NCT01117623|11012593|FG000|Overall Study|Disease progression, recurrence, relapse|3
6965421|NCT01117623|11012594|FG001|Overall Study|Disease progression, recurrence, relapse|6
6965422|NCT01117623|11012595|FG002|Overall Study|Disease progression, recurrence, relapse|5
6965423|NCT01117623|11012596|FG003|Overall Study|Disease progression, recurrence, relapse|6
6965424|NCT01117623|11012597|FG004|Overall Study|Disease progression, recurrence, relapse|8
6965425|NCT01117623|11012598|FG005|Overall Study|Disease progression, recurrence, relapse|14
6965426|NCT01117623|11012599|FG006|Overall Study|Disease progression, recurrence, relapse|5
6965427|NCT01117623|11012600|FG007|Overall Study|Disease progression, recurrence, relapse|22
6965428|NCT01117623|11012593|FG000|Overall Study|Withdrawal by Subject|0
6965429|NCT01117623|11012594|FG001|Overall Study|Withdrawal by Subject|0
6965430|NCT01117623|11012595|FG002|Overall Study|Withdrawal by Subject|2
6965431|NCT01117623|11012596|FG003|Overall Study|Withdrawal by Subject|0
6965432|NCT01117623|11012597|FG004|Overall Study|Withdrawal by Subject|0
6965433|NCT01117623|11012598|FG005|Overall Study|Withdrawal by Subject|1
6965434|NCT01117623|11012599|FG006|Overall Study|Withdrawal by Subject|1
6965435|NCT01117623|11012600|FG007|Overall Study|Withdrawal by Subject|1
6965436|NCT01117623|11012593|FG000|Overall Study|Non-compliance with study medication|0
6965437|NCT01117623|11012594|FG001|Overall Study|Non-compliance with study medication|0
6965438|NCT01117623|11012595|FG002|Overall Study|Non-compliance with study medication|0
6965439|NCT01117623|11012596|FG003|Overall Study|Non-compliance with study medication|0
6965440|NCT01117623|11012597|FG004|Overall Study|Non-compliance with study medication|0
6965441|NCT01117623|11012598|FG005|Overall Study|Non-compliance with study medication|0
6965442|NCT01117623|11012599|FG006|Overall Study|Non-compliance with study medication|0
6965443|NCT01117623|11012600|FG007|Overall Study|Non-compliance with study medication|1
6965444|NCT01117623|11012593|FG000|Overall Study|Invest. text: completed all planned txs|0
6965445|NCT01117623|11012594|FG001|Overall Study|Invest. text: completed all planned txs|0
6965446|NCT01117623|11012595|FG002|Overall Study|Invest. text: completed all planned txs|0
6965447|NCT01117623|11012596|FG003|Overall Study|Invest. text: completed all planned txs|0
6965448|NCT01117623|11012597|FG004|Overall Study|Invest. text: completed all planned txs|0
6965449|NCT01117623|11012598|FG005|Overall Study|Invest. text: completed all planned txs|1
6965450|NCT01117623|11012599|FG006|Overall Study|Invest. text: completed all planned txs|0
6965451|NCT01117623|11012600|FG007|Overall Study|Invest. text: completed all planned txs|0
6965452|NCT01117766|11012625|FG000|First Intervention|Adverse Event|0
6965453|NCT01117766|11012626|FG001|First Intervention|Adverse Event|1
6965454|NCT01117766|11012625|FG000|First Intervention|Protocol Violation|1
6965455|NCT01117766|11012626|FG001|First Intervention|Protocol Violation|0
6965456|NCT01117766|11012625|FG000|Washout Period|Protocol Violation|0
6965457|NCT01117766|11012626|FG001|Washout Period|Protocol Violation|2
6965458|NCT01117766|11012625|FG000|Second Intervention|Lost to Follow-up|1
6965459|NCT01117766|11012626|FG001|Second Intervention|Lost to Follow-up|0
6965460|NCT01117766|11012625|FG000|Second Intervention|Other|1
6965461|NCT01117766|11012626|FG001|Second Intervention|Other|2
6965462|NCT01117766|11012625|FG000|Second Intervention|Adverse Event|0
6965463|NCT01117766|11012626|FG001|Second Intervention|Adverse Event|2
6965464|NCT01117766|11012625|FG000|Second Intervention|Withdrawal by Subject|0
6965465|NCT01117766|11012626|FG001|Second Intervention|Withdrawal by Subject|1
6965466|NCT01117792|11012632|FG000|Overall Study|Death|1
6965467|NCT01117792|11012632|FG000|Overall Study|Adverse Event|3
6965468|NCT01117857|11012636|FG000|Overall Study|Lost to Follow-up|4
6965469|NCT01117857|11012636|FG000|Overall Study|Withdrawal by Subject|4
6965470|NCT01117857|11012636|FG000|Overall Study|Physician Decision|1
6965471|NCT01117870|11012642|FG000|Overall Study|Inability to place needle|1
6965472|NCT01117870|11012643|FG001|Overall Study|Inability to place needle|0
6965473|NCT01117987|11012664|FG000|Overall Study|Protocol deviation|0
6965474|NCT01117987|11012665|FG001|Overall Study|Protocol deviation|1
6965475|NCT01117987|11012664|FG000|Overall Study|Subject no longer requires study drug|1
6965476|NCT01117987|11012665|FG001|Overall Study|Subject no longer requires study drug|0
6965477|NCT01117987|11012664|FG000|Overall Study|Lost to Follow-up|1
6965478|NCT01117987|11012665|FG001|Overall Study|Lost to Follow-up|1
6965479|NCT01117987|11012664|FG000|Overall Study|Abnormal test procedure result|2
6965480|NCT01117987|11012665|FG001|Overall Study|Abnormal test procedure result|0
6965481|NCT01117987|11012664|FG000|Overall Study|Lack of Efficacy|3
6965482|NCT01117987|11012665|FG001|Overall Study|Lack of Efficacy|4
6965483|NCT01117987|11012664|FG000|Overall Study|Death|5
7073024|NCT02039505|11177130|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7
7073025|NCT02039505|11177124|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
7073026|NCT02039505|11177125|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
7073027|NCT02039505|11177126|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
6965484|NCT01117987|11012665|FG001|Overall Study|Death|10
6965485|NCT01117987|11012664|FG000|Overall Study|Withdrawal by Subject|5
6965486|NCT01117987|11012665|FG001|Overall Study|Withdrawal by Subject|10
6965487|NCT01117987|11012664|FG000|Overall Study|Adverse Event|19
6965488|NCT01117987|11012665|FG001|Overall Study|Adverse Event|26
6965489|NCT01117987|11012664|FG000|Overall Study|Administrative problems|25
6965490|NCT01117987|11012665|FG001|Overall Study|Administrative problems|22
6965491|NCT01118052|11012671|FG000|Overall Study|Never treated|2
6965492|NCT01118117|11012692|FG000|Overall Study|Death|8
6965493|NCT01118117|11012693|FG001|Overall Study|Death|0
6965494|NCT01118117|11012692|FG000|Overall Study|Lost to Follow-up|6
6965495|NCT01118117|11012693|FG001|Overall Study|Lost to Follow-up|0
7073028|NCT02039505|11177127|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
7073029|NCT02039505|11177128|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
7073030|NCT02039505|11177129|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
7073031|NCT02039505|11177130|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1
7073032|NCT02039674|11177164|FG000|Overall Study|Adverse Event|0
7073033|NCT02039674|11177165|FG001|Overall Study|Adverse Event|0
7073034|NCT02039674|11177166|FG002|Overall Study|Adverse Event|1
7073035|NCT02039674|11177167|FG003|Overall Study|Adverse Event|1
7073036|NCT02039674|11177168|FG004|Overall Study|Adverse Event|0
7073037|NCT02039674|11177169|FG005|Overall Study|Adverse Event|0
7073038|NCT02039674|11177170|FG006|Overall Study|Adverse Event|0
7073039|NCT02039674|11177171|FG007|Overall Study|Adverse Event|0
7073040|NCT02039674|11177172|FG008|Overall Study|Adverse Event|2
6965496|NCT01118117|11012692|FG000|Overall Study|Missed 12 Month Visit|7
6965497|NCT01118117|11012693|FG001|Overall Study|Missed 12 Month Visit|0
6965498|NCT01118143|11012701|FG000|Overall Study|Withdrawal by Subject|2
6965499|NCT01118143|11012702|FG001|Overall Study|Withdrawal by Subject|5
6965500|NCT01118299|11012750|FG000|Overall Study|Death|7
6965501|NCT01118299|11012751|FG001|Overall Study|Death|5
6965502|NCT01118299|11012750|FG000|Overall Study|Withdrawal by Subject|8
6965503|NCT01118299|11012751|FG001|Overall Study|Withdrawal by Subject|8
6965504|NCT01118299|11012750|FG000|Overall Study|Lost to Follow-up|2
6965505|NCT01118299|11012751|FG001|Overall Study|Lost to Follow-up|1
6965506|NCT01118299|11012750|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6
6965507|NCT01118299|11012751|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15
6965508|NCT01118312|11012758|FG000|Overall Study|Lost to Follow-up|33
6965509|NCT01118312|11012759|FG001|Overall Study|Lost to Follow-up|32
6965510|NCT01118312|11012758|FG000|Overall Study|Withdrawal by Subject|1
6965511|NCT01118312|11012759|FG001|Overall Study|Withdrawal by Subject|3
6965512|NCT01118325|11012768|FG000|Overall Study|Adverse Event|1
6965513|NCT01118325|11012769|FG001|Overall Study|Adverse Event|0
6965514|NCT01118325|11012770|FG002|Overall Study|Adverse Event|1
6965515|NCT01118351|11012800|FG000|Overall Study|Adverse Event|3
6965516|NCT01118351|11012800|FG000|Overall Study|Withdrawal by Subject|1
6965517|NCT01118377|11012804|FG000|Overall Study|Did Not Receive Study Medication|1
6965518|NCT01118377|11012804|FG000|Overall Study|Death|38
6965519|NCT01118377|11012804|FG000|Overall Study|Failure to Return|3
6965520|NCT01118455|11012810|FG000|Baseline [Visits 1 & 2]|Adverse Event|1
6965521|NCT01118455|11012811|FG001|Baseline [Visits 1 & 2]|Adverse Event|0
6965522|NCT01118520|11012828|FG000|Overall Study|AAA repair|9
6965523|NCT01118520|11012829|FG001|Overall Study|AAA repair|7
6965524|NCT01118520|11012830|FG002|Overall Study|AAA repair|9
6965525|NCT01118520|11012828|FG000|Overall Study|Adverse Event|3
6965526|NCT01118520|11012829|FG001|Overall Study|Adverse Event|3
6965527|NCT01118520|11012830|FG002|Overall Study|Adverse Event|3
6965528|NCT01118520|11012828|FG000|Overall Study|Withdrawal by Subject|8
6965529|NCT01118520|11012829|FG001|Overall Study|Withdrawal by Subject|13
6965530|NCT01118520|11012830|FG002|Overall Study|Withdrawal by Subject|8
6976758|NCT01201915|11029570|FG001|Overall Study|Lost to Follow-up|4
6976759|NCT01201915|11029571|FG002|Overall Study|Lost to Follow-up|0
6976760|NCT01201915|11029569|FG000|Overall Study|Physician Decision|3
6976761|NCT01201915|11029570|FG001|Overall Study|Physician Decision|0
6976762|NCT01201915|11029571|FG002|Overall Study|Physician Decision|0
6976763|NCT01201915|11029569|FG000|Overall Study|Subject Decision|3
6976764|NCT01201915|11029570|FG001|Overall Study|Subject Decision|3
6976765|NCT01201915|11029571|FG002|Overall Study|Subject Decision|5
6976766|NCT01201915|11029569|FG000|Overall Study|Target Lesion Progression|0
6976767|NCT01201915|11029570|FG001|Overall Study|Target Lesion Progression|3
6976768|NCT01201915|11029571|FG002|Overall Study|Target Lesion Progression|0
6976769|NCT01201967|11029581|FG000|Overall Study|Lost to Follow-up|6
6976770|NCT01201967|11029582|FG001|Overall Study|Lost to Follow-up|5
6976771|NCT01202175|11029613|FG000|Overall Study|Lost to Follow-up|2
6976772|NCT01202175|11029613|FG000|Overall Study|Withdrawal by Subject|1
6976773|NCT01202175|11029613|FG000|Overall Study|Adverse Event|2
6976774|NCT01202188|11029623|FG000|Overall Study|Protocol deviation|14
6976775|NCT01202188|11029624|FG001|Overall Study|Protocol deviation|8
6976776|NCT01202188|11029625|FG002|Overall Study|Protocol deviation|12
6976777|NCT01202188|11029626|FG003|Overall Study|Protocol deviation|10
6976778|NCT01202188|11029627|FG004|Overall Study|Protocol deviation|11
6976779|NCT01202188|11029623|FG000|Overall Study|Subject withdrew consent|12
6976780|NCT01202188|11029624|FG001|Overall Study|Subject withdrew consent|13
6976781|NCT01202188|11029625|FG002|Overall Study|Subject withdrew consent|22
6976782|NCT01202188|11029626|FG003|Overall Study|Subject withdrew consent|11
6976783|NCT01202188|11029627|FG004|Overall Study|Subject withdrew consent|13
7073041|NCT02039674|11177173|FG009|Overall Study|Adverse Event|0
7073042|NCT02039674|11177174|FG010|Overall Study|Adverse Event|0
7073043|NCT02039674|11177175|FG011|Overall Study|Adverse Event|2
7073044|NCT02039674|11177176|FG012|Overall Study|Adverse Event|2
7073045|NCT02039674|11177177|FG013|Overall Study|Adverse Event|1
7073046|NCT02039674|11177164|FG000|Overall Study|Death|0
7073047|NCT02039674|11177165|FG001|Overall Study|Death|0
7073048|NCT02039674|11177166|FG002|Overall Study|Death|1
7073049|NCT02039674|11177167|FG003|Overall Study|Death|2
7073050|NCT02039674|11177168|FG004|Overall Study|Death|0
7073051|NCT02039674|11177169|FG005|Overall Study|Death|0
7073052|NCT02039674|11177170|FG006|Overall Study|Death|0
7073053|NCT02039674|11177171|FG007|Overall Study|Death|0
7073054|NCT02039674|11177172|FG008|Overall Study|Death|0
7073055|NCT02039674|11177173|FG009|Overall Study|Death|0
7073056|NCT02039674|11177174|FG010|Overall Study|Death|1
7073057|NCT02039674|11177175|FG011|Overall Study|Death|1
7073058|NCT02039674|11177176|FG012|Overall Study|Death|0
7073059|NCT02039674|11177177|FG013|Overall Study|Death|8
7073060|NCT02039674|11177164|FG000|Overall Study|Excluded Medication|1
7073061|NCT02039674|11177165|FG001|Overall Study|Excluded Medication|1
7073062|NCT02039674|11177166|FG002|Overall Study|Excluded Medication|0
7073063|NCT02039674|11177167|FG003|Overall Study|Excluded Medication|1
6976784|NCT01202188|11029623|FG000|Overall Study|Adverse Event|5
6976785|NCT01202188|11029624|FG001|Overall Study|Adverse Event|23
6976786|NCT01202188|11029625|FG002|Overall Study|Adverse Event|13
6976787|NCT01202188|11029626|FG003|Overall Study|Adverse Event|10
6976788|NCT01202188|11029627|FG004|Overall Study|Adverse Event|10
6976789|NCT01202188|11029623|FG000|Overall Study|Administrative problems|3
6976790|NCT01202188|11029624|FG001|Overall Study|Administrative problems|2
6976791|NCT01202188|11029625|FG002|Overall Study|Administrative problems|1
6976792|NCT01202188|11029626|FG003|Overall Study|Administrative problems|1
6976793|NCT01202188|11029627|FG004|Overall Study|Administrative problems|2
6976794|NCT01202188|11029623|FG000|Overall Study|Unsatisfactory therapeutic effect|2
6976795|NCT01202188|11029624|FG001|Overall Study|Unsatisfactory therapeutic effect|8
6976796|NCT01202188|11029625|FG002|Overall Study|Unsatisfactory therapeutic effect|2
6976797|NCT01202188|11029626|FG003|Overall Study|Unsatisfactory therapeutic effect|5
6976798|NCT01202188|11029627|FG004|Overall Study|Unsatisfactory therapeutic effect|8
6976799|NCT01202188|11029623|FG000|Overall Study|Lost to Follow-up|1
7073064|NCT02039674|11177168|FG004|Overall Study|Excluded Medication|0
7073065|NCT02039674|11177169|FG005|Overall Study|Excluded Medication|1
7073066|NCT02039674|11177170|FG006|Overall Study|Excluded Medication|0
7073067|NCT02039674|11177171|FG007|Overall Study|Excluded Medication|0
7073068|NCT02039674|11177172|FG008|Overall Study|Excluded Medication|2
7073069|NCT02039674|11177173|FG009|Overall Study|Excluded Medication|2
6965531|NCT01118663|11012844|FG000|Overall Study|Adverse Event|2
6965532|NCT01118663|11012845|FG001|Overall Study|Adverse Event|1
6965533|NCT01118663|11012844|FG000|Overall Study|Withdrawal by Subject|0
6965534|NCT01118663|11012845|FG001|Overall Study|Withdrawal by Subject|1
6965535|NCT01118728|11012881|FG000|Overall Study|Adverse Event|17
6965536|NCT01118728|11012881|FG000|Overall Study|Lack of Efficacy|27
6965537|NCT01118728|11012881|FG000|Overall Study|Sponsor's decision to discontinue study|172
6965538|NCT01118728|11012881|FG000|Overall Study|Withdrawal by Subject|3
6965539|NCT01118728|11012881|FG000|Overall Study|Lost to Follow-up|4
6965540|NCT01118780|11012898|FG000|Overall Study|Adverse Event|15
6965541|NCT01118780|11012899|FG001|Overall Study|Adverse Event|15
6965542|NCT01118780|11012898|FG000|Overall Study|Death|1
6965543|NCT01118780|11012899|FG001|Overall Study|Death|0
6965544|NCT01118780|11012898|FG000|Overall Study|Lack of Efficacy|2
6965545|NCT01118780|11012899|FG001|Overall Study|Lack of Efficacy|6
6965546|NCT01118780|11012898|FG000|Overall Study|Physician Decision|2
6965547|NCT01118780|11012899|FG001|Overall Study|Physician Decision|0
6965548|NCT01118780|11012898|FG000|Overall Study|Protocol Violation|3
6965549|NCT01118780|11012899|FG001|Overall Study|Protocol Violation|6
6965550|NCT01118780|11012898|FG000|Overall Study|Withdrawal by Subject|13
6965551|NCT01118780|11012899|FG001|Overall Study|Withdrawal by Subject|8
6965552|NCT01118949|11012912|FG000|Overall Study|Adverse Event|5
6965553|NCT01118949|11012912|FG000|Overall Study|Withdrawal by Subject|4
6965554|NCT01118962|11012916|FG000|Overall Study|Adverse Event|2
6965555|NCT01118962|11012916|FG000|Overall Study|Lack of Efficacy|1
6965556|NCT01118962|11012916|FG000|Overall Study|Protocol Violation|1
6965557|NCT01118962|11012916|FG000|Overall Study|Withdrawal by Subject|4
7073070|NCT02039674|11177174|FG010|Overall Study|Excluded Medication|4
7073071|NCT02039674|11177175|FG011|Overall Study|Excluded Medication|2
7073072|NCT02039674|11177176|FG012|Overall Study|Excluded Medication|4
7073073|NCT02039674|11177177|FG013|Overall Study|Excluded Medication|3
7073074|NCT02039674|11177164|FG000|Overall Study|Lost to Follow-up|0
7073075|NCT02039674|11177165|FG001|Overall Study|Lost to Follow-up|0
7073076|NCT02039674|11177166|FG002|Overall Study|Lost to Follow-up|0
7073077|NCT02039674|11177167|FG003|Overall Study|Lost to Follow-up|0
7073078|NCT02039674|11177168|FG004|Overall Study|Lost to Follow-up|0
7073079|NCT02039674|11177169|FG005|Overall Study|Lost to Follow-up|0
7073080|NCT02039674|11177170|FG006|Overall Study|Lost to Follow-up|0
7073081|NCT02039674|11177171|FG007|Overall Study|Lost to Follow-up|0
7073082|NCT02039674|11177172|FG008|Overall Study|Lost to Follow-up|0
7073083|NCT02039674|11177173|FG009|Overall Study|Lost to Follow-up|0
7073084|NCT02039674|11177174|FG010|Overall Study|Lost to Follow-up|0
7073085|NCT02039674|11177175|FG011|Overall Study|Lost to Follow-up|0
7073086|NCT02039674|11177176|FG012|Overall Study|Lost to Follow-up|1
7073087|NCT02039674|11177177|FG013|Overall Study|Lost to Follow-up|0
7073088|NCT02039674|11177164|FG000|Overall Study|Physician Decision|0
7073089|NCT02039674|11177165|FG001|Overall Study|Physician Decision|0
7073090|NCT02039674|11177166|FG002|Overall Study|Physician Decision|0
7073091|NCT02039674|11177167|FG003|Overall Study|Physician Decision|0
7073092|NCT02039674|11177168|FG004|Overall Study|Physician Decision|0
7073093|NCT02039674|11177169|FG005|Overall Study|Physician Decision|0
7073094|NCT02039674|11177170|FG006|Overall Study|Physician Decision|0
7073095|NCT02039674|11177171|FG007|Overall Study|Physician Decision|0
7073096|NCT02039674|11177172|FG008|Overall Study|Physician Decision|0
7073097|NCT02039674|11177173|FG009|Overall Study|Physician Decision|0
7073098|NCT02039674|11177174|FG010|Overall Study|Physician Decision|0
7073099|NCT02039674|11177175|FG011|Overall Study|Physician Decision|1
7073100|NCT02039674|11177176|FG012|Overall Study|Physician Decision|0
7073101|NCT02039674|11177177|FG013|Overall Study|Physician Decision|0
7073102|NCT02039674|11177164|FG000|Overall Study|Progressive Disease|6
7073103|NCT02039674|11177165|FG001|Overall Study|Progressive Disease|7
7073104|NCT02039674|11177166|FG002|Overall Study|Progressive Disease|6
7073105|NCT02039674|11177167|FG003|Overall Study|Progressive Disease|7
7073106|NCT02039674|11177168|FG004|Overall Study|Progressive Disease|8
7073107|NCT02039674|11177169|FG005|Overall Study|Progressive Disease|10
6965558|NCT01118962|11012916|FG000|Overall Study|Pregnancy|1
6965559|NCT01118962|11012916|FG000|Overall Study|Non-compliance with Medicinal Product|1
6965560|NCT01118975|11012922|FG000|Overall Study|Adverse Event|0
6965561|NCT01118975|11012923|FG001|Overall Study|Adverse Event|1
6965562|NCT01119001|11012941|FG000|Overall Study|Withdrawal by Subject|2
6965563|NCT01119105|11012954|FG000|Overall Study|Withdrawal by Subject|1
6965564|NCT01119105|11012955|FG001|Overall Study|Withdrawal by Subject|1
6965565|NCT01119105|11012956|FG002|Overall Study|Withdrawal by Subject|1
6965566|NCT01119105|11012954|FG000|Overall Study|Lost to Follow-up|0
6965567|NCT01119105|11012955|FG001|Overall Study|Lost to Follow-up|2
6965568|NCT01119105|11012956|FG002|Overall Study|Lost to Follow-up|5
6965569|NCT01119105|11012954|FG000|Overall Study|Adverse Event|1
6965570|NCT01119105|11012955|FG001|Overall Study|Adverse Event|0
7073108|NCT02039674|11177170|FG006|Overall Study|Progressive Disease|1
7073109|NCT02039674|11177171|FG007|Overall Study|Progressive Disease|3
6965571|NCT01119105|11012956|FG002|Overall Study|Adverse Event|1
7073110|NCT02039674|11177172|FG008|Overall Study|Progressive Disease|7
7073111|NCT02039674|11177173|FG009|Overall Study|Progressive Disease|2
7073112|NCT02039674|11177174|FG010|Overall Study|Progressive Disease|0
7073113|NCT02039674|11177175|FG011|Overall Study|Progressive Disease|17
7073114|NCT02039674|11177176|FG012|Overall Study|Progressive Disease|18
6965572|NCT01119105|11012954|FG000|Overall Study|study drug missed on 2 consecutive days|1
6965573|NCT01119105|11012955|FG001|Overall Study|study drug missed on 2 consecutive days|2
6965574|NCT01119105|11012956|FG002|Overall Study|study drug missed on 2 consecutive days|1
6965575|NCT01119105|11012954|FG000|Overall Study|Other|1
6965576|NCT01119105|11012955|FG001|Overall Study|Other|1
6965577|NCT01119105|11012956|FG002|Overall Study|Other|0
6965578|NCT01119118|11012964|FG000|Overall Study|Adverse Event|1
6965579|NCT01119131|11012971|FG000|Overall Study|Adverse Event|1
6965580|NCT01119131|11012972|FG001|Overall Study|Adverse Event|1
6965581|NCT01119131|11012973|FG002|Overall Study|Adverse Event|1
6965582|NCT01119131|11012971|FG000|Overall Study|Non-Compliance|1
6965583|NCT01119131|11012972|FG001|Overall Study|Non-Compliance|0
6965584|NCT01119131|11012973|FG002|Overall Study|Non-Compliance|4
6965585|NCT01119131|11012971|FG000|Overall Study|Physician Decision|0
6965586|NCT01119131|11012972|FG001|Overall Study|Physician Decision|0
6965587|NCT01119131|11012973|FG002|Overall Study|Physician Decision|1
6965588|NCT01119248|11012997|FG000|Overall Study|Physician Decision|5
6965589|NCT01119287|11013008|FG000|Overall Study|Patient Decision, not related to AE|0
6965590|NCT01119287|11013009|FG001|Overall Study|Patient Decision, not related to AE|0
6965591|NCT01119287|11013010|FG002|Overall Study|Patient Decision, not related to AE|2
6965592|NCT01119287|11013011|FG003|Overall Study|Patient Decision, not related to AE|2
6965593|NCT01119287|11013012|FG004|Overall Study|Patient Decision, not related to AE|1
6965594|NCT01119287|11013013|FG005|Overall Study|Patient Decision, not related to AE|0
6965595|NCT01119443|11013027|FG000|Crossover Period 1 (5 Days)|Adverse Event|0
6965596|NCT01119443|11013028|FG001|Crossover Period 1 (5 Days)|Adverse Event|1
6965597|NCT01119508|11013077|FG000|Overall Study|Adverse Event|56
6965598|NCT01119508|11013077|FG000|Overall Study|Withdrawal by Subject|2
6965599|NCT01119508|11013077|FG000|Overall Study|Died before tumor response evaluation|1
6965600|NCT01119625|11013083|FG000|Overall Study|Lost to Follow-up|1
6965601|NCT01119625|11013084|FG001|Overall Study|Lost to Follow-up|2
6965602|NCT01119625|11013083|FG000|Overall Study|Withdrawal by Subject|2
6965603|NCT01119625|11013084|FG001|Overall Study|Withdrawal by Subject|1
6965604|NCT01119625|11013083|FG000|Overall Study|Other|0
6965605|NCT01119625|11013084|FG001|Overall Study|Other|1
6965606|NCT01119703|11013092|FG000|Overall Study|Adverse Event|0
7073115|NCT02039674|11177177|FG013|Overall Study|Progressive Disease|16
7073116|NCT02039674|11177164|FG000|Overall Study|Withdrawal by Subject|0
7073117|NCT02039674|11177165|FG001|Overall Study|Withdrawal by Subject|2
7073118|NCT02039674|11177166|FG002|Overall Study|Withdrawal by Subject|1
7073119|NCT02039674|11177167|FG003|Overall Study|Withdrawal by Subject|0
7073120|NCT02039674|11177168|FG004|Overall Study|Withdrawal by Subject|1
7073121|NCT02039674|11177169|FG005|Overall Study|Withdrawal by Subject|0
7073122|NCT02039674|11177170|FG006|Overall Study|Withdrawal by Subject|0
7073123|NCT02039674|11177171|FG007|Overall Study|Withdrawal by Subject|0
7073124|NCT02039674|11177172|FG008|Overall Study|Withdrawal by Subject|0
7073125|NCT02039674|11177173|FG009|Overall Study|Withdrawal by Subject|2
7073126|NCT02039674|11177174|FG010|Overall Study|Withdrawal by Subject|1
7073127|NCT02039674|11177175|FG011|Overall Study|Withdrawal by Subject|3
7073128|NCT02039674|11177176|FG012|Overall Study|Withdrawal by Subject|5
7073129|NCT02039674|11177177|FG013|Overall Study|Withdrawal by Subject|2
7073130|NCT02039674|11177164|FG000|Overall Study|Ongoing in Study|5
7073131|NCT02039674|11177165|FG001|Overall Study|Ongoing in Study|2
7073132|NCT02039674|11177166|FG002|Overall Study|Ongoing in Study|3
7073133|NCT02039674|11177167|FG003|Overall Study|Ongoing in Study|2
7073134|NCT02039674|11177168|FG004|Overall Study|Ongoing in Study|3
7073135|NCT02039674|11177169|FG005|Overall Study|Ongoing in Study|1
7073136|NCT02039674|11177170|FG006|Overall Study|Ongoing in Study|2
7073137|NCT02039674|11177171|FG007|Overall Study|Ongoing in Study|0
7073138|NCT02039674|11177172|FG008|Overall Study|Ongoing in Study|1
7073139|NCT02039674|11177173|FG009|Overall Study|Ongoing in Study|6
7073140|NCT02039674|11177174|FG010|Overall Study|Ongoing in Study|1
7073141|NCT02039674|11177175|FG011|Overall Study|Ongoing in Study|34
7073142|NCT02039674|11177176|FG012|Overall Study|Ongoing in Study|33
7073143|NCT02039674|11177177|FG013|Overall Study|Ongoing in Study|3
7073144|NCT02039687|11177214|FG000|Overall Study|Adverse Event|0
7073145|NCT02039687|11177215|FG001|Overall Study|Adverse Event|0
7073146|NCT02039687|11177216|FG002|Overall Study|Adverse Event|1
7073147|NCT02039687|11177217|FG003|Overall Study|Adverse Event|0
6965607|NCT01119703|11013093|FG001|Overall Study|Adverse Event|1
6965608|NCT01119768|11013112|FG000|Treatment Period|Lack of Efficacy|18
6965609|NCT01119768|11013113|FG001|Treatment Period|Lack of Efficacy|25
6965610|NCT01119846|11013126|FG000|Overall Study|Adverse Event|1
6965611|NCT01119846|11013127|FG001|Overall Study|Adverse Event|0
6965612|NCT01119846|11013128|FG002|Overall Study|Adverse Event|6
6965613|NCT01119846|11013126|FG000|Overall Study|Physician Decision|1
6965614|NCT01119846|11013127|FG001|Overall Study|Physician Decision|0
6965615|NCT01119846|11013128|FG002|Overall Study|Physician Decision|0
6965616|NCT01119846|11013126|FG000|Overall Study|Protocol Violation|0
6965617|NCT01119846|11013127|FG001|Overall Study|Protocol Violation|0
6965618|NCT01119846|11013128|FG002|Overall Study|Protocol Violation|1
7073148|NCT02039687|11177214|FG000|Overall Study|Withdrawal by Subject|0
7073149|NCT02039687|11177215|FG001|Overall Study|Withdrawal by Subject|1
7073150|NCT02039687|11177216|FG002|Overall Study|Withdrawal by Subject|0
7073151|NCT02039687|11177217|FG003|Overall Study|Withdrawal by Subject|0
6965619|NCT01119846|11013126|FG000|Overall Study|Withdrawal by Subject|0
6965620|NCT01119846|11013127|FG001|Overall Study|Withdrawal by Subject|0
6965621|NCT01119846|11013128|FG002|Overall Study|Withdrawal by Subject|4
7073152|NCT02039687|11177214|FG000|Overall Study|treatment assignment could not be confir|0
7073153|NCT02039687|11177215|FG001|Overall Study|treatment assignment could not be confir|0
7073154|NCT02039687|11177216|FG002|Overall Study|treatment assignment could not be confir|2
7073155|NCT02039687|11177217|FG003|Overall Study|treatment assignment could not be confir|0
7082703|NCT02144285|11193310|FG007|Overall Study|Withdrawal by Subject|0
7082704|NCT02144285|11193311|FG008|Overall Study|Withdrawal by Subject|0
7147856|NCT03136367|11308693|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0
7147857|NCT03136367|11308694|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1
7147858|NCT03136367|11308692|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1
7147859|NCT03136367|11308693|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1
7147860|NCT03136367|11308694|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1
7147861|NCT03136367|11308692|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1
7147862|NCT03136367|11308693|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0
7147863|NCT03136367|11308694|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0
7147864|NCT03136367|11308692|FG000|T5 1 Year After Surgery|Death|0
7147865|NCT03136367|11308693|FG001|T5 1 Year After Surgery|Death|0
7147866|NCT03136367|11308694|FG002|T5 1 Year After Surgery|Death|1
7147867|NCT03136367|11308692|FG000|T5 1 Year After Surgery|Discontinued lost contact|1
7147868|NCT03136367|11308693|FG001|T5 1 Year After Surgery|Discontinued lost contact|6
7147869|NCT03136367|11308694|FG002|T5 1 Year After Surgery|Discontinued lost contact|0
7147870|NCT03136367|11308692|FG000|T5 1 Year After Surgery|Lost to Follow-up|2
7147871|NCT03136367|11308693|FG001|T5 1 Year After Surgery|Lost to Follow-up|22
7147872|NCT03136367|11308694|FG002|T5 1 Year After Surgery|Lost to Follow-up|15
7147873|NCT03136367|11308692|FG000|T5 1 Year After Surgery|study ended before due|31
7147874|NCT03136367|11308693|FG001|T5 1 Year After Surgery|study ended before due|103
6838685|NCT00261833|10844368|FG000|Overall Study|Lung transplantation|1
6838686|NCT00261833|10844369|FG001|Overall Study|Lung transplantation|1
6838687|NCT00261833|10844368|FG000|Overall Study|Missing reason|1
6838688|NCT00261833|10844369|FG001|Overall Study|Missing reason|0
6838689|NCT00261833|10844368|FG000|Overall Study|Not interested in being participant|0
6838690|NCT00261833|10844369|FG001|Overall Study|Not interested in being participant|1
6838691|NCT00261846|10844385|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
6838692|NCT00261846|10844386|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
6838693|NCT00261846|10844387|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12
6838694|NCT00261846|10844388|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
6838695|NCT00261846|10844389|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
7147875|NCT03136367|11308694|FG002|T5 1 Year After Surgery|study ended before due|110
7147876|NCT03136367|11308692|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0
7147877|NCT03136367|11308693|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4
7147878|NCT03136367|11308694|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2
7147879|NCT03136380|11308707|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
7147880|NCT03136380|11308708|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1
7147881|NCT03136380|11308709|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
7147882|NCT03136380|11308710|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
7147883|NCT03136380|11308711|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
7147884|NCT03136484|11308731|FG000|Overall Study|Withdrawal by Subject|19
7147885|NCT03136484|11308732|FG001|Overall Study|Withdrawal by Subject|14
7147886|NCT03136484|11308731|FG000|Overall Study|Lost to Follow-up|7
7147887|NCT03136484|11308732|FG001|Overall Study|Lost to Follow-up|8
7147888|NCT03136484|11308731|FG000|Overall Study|Death|1
7147889|NCT03136484|11308732|FG001|Overall Study|Death|0
7147890|NCT03136861|11308745|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3
7147891|NCT03136861|11308746|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2
7147892|NCT03136861|11308747|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
7147893|NCT03136861|11308748|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
7147894|NCT03136861|11308749|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
7147895|NCT03136861|11308750|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
7147896|NCT03136861|11308751|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
7147897|NCT03136861|11308745|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1
7147898|NCT03136861|11308746|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1
7147899|NCT03136861|11308747|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
7147900|NCT03136861|11308748|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
7147901|NCT03136861|11308749|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
7147902|NCT03136861|11308750|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
6838696|NCT00261846|10844390|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
6838697|NCT00261846|10844391|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
6838698|NCT00261846|10844392|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
6838699|NCT00261846|10844393|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
6838700|NCT00261846|10844394|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
6965622|NCT01119859|11013165|FG000|Overall Study|Adverse Event|9
6965623|NCT01119859|11013166|FG001|Overall Study|Adverse Event|10
6965624|NCT01119859|11013165|FG000|Overall Study|Death|2
6965625|NCT01119859|11013166|FG001|Overall Study|Death|0
6965626|NCT01119859|11013165|FG000|Overall Study|Insufficient therapeutic response|7
6965627|NCT01119859|11013166|FG001|Overall Study|Insufficient therapeutic response|14
6965628|NCT01119859|11013165|FG000|Overall Study|Refused treatment|3
6965629|NCT01119859|11013166|FG001|Overall Study|Refused treatment|6
6965630|NCT01119859|11013165|FG000|Overall Study|Failure to return|3
6965631|NCT01119859|11013166|FG001|Overall Study|Failure to return|0
6965632|NCT01119898|11013174|FG000|Overall Study|Adverse Event|4
6965633|NCT01119898|11013175|FG001|Overall Study|Adverse Event|5
6965634|NCT01119898|11013174|FG000|Overall Study|Withdrawal by Subject|1
6965635|NCT01119898|11013175|FG001|Overall Study|Withdrawal by Subject|4
6965636|NCT01119898|11013174|FG000|Overall Study|Lack of Efficacy|0
6965637|NCT01119898|11013175|FG001|Overall Study|Lack of Efficacy|2
6965638|NCT01119898|11013174|FG000|Overall Study|Protocol Violation|1
6965639|NCT01119898|11013175|FG001|Overall Study|Protocol Violation|1
6965640|NCT01119898|11013174|FG000|Overall Study|Medical procedure|1
6965641|NCT01119898|11013175|FG001|Overall Study|Medical procedure|0
6965642|NCT01119898|11013174|FG000|Overall Study|Randomized in error did not participate|1
6965643|NCT01119898|11013175|FG001|Overall Study|Randomized in error did not participate|0
7073156|NCT02039778|11177236|FG000|Overall Study|Death|2
7073157|NCT02039778|11177236|FG000|Overall Study|Withdrawal by Subject|1
7073158|NCT02039778|11177236|FG000|Overall Study|Never started the protocol treatment|1
7073159|NCT02039856|11177250|FG000|Overall Study|Death|5
7073160|NCT02039856|11177251|FG001|Overall Study|Death|3
7073161|NCT02039856|11177250|FG000|Overall Study|Partial survey completion|61
7073162|NCT02039856|11177251|FG001|Overall Study|Partial survey completion|26
7073163|NCT02039856|11177250|FG000|Overall Study|Lost to Follow-up|388
7073164|NCT02039856|11177251|FG001|Overall Study|Lost to Follow-up|206
7073165|NCT02039856|11177250|FG000|Overall Study|Withdrawal by Subject|1573
7073166|NCT02039856|11177251|FG001|Overall Study|Withdrawal by Subject|618
7073167|NCT02039908|11177259|FG000|Phase 1-Summer|Withdrawal by Subject|7
7073168|NCT02039908|11177260|FG001|Phase 1-Summer|Withdrawal by Subject|6
7073169|NCT02039908|11177261|FG002|Phase 1-Summer|Withdrawal by Subject|0
7073170|NCT02039908|11177262|FG003|Phase 1-Summer|Withdrawal by Subject|0
7073171|NCT02039908|11177259|FG000|Phase 1-Summer|Protocol Violation|6
7073172|NCT02039908|11177260|FG001|Phase 1-Summer|Protocol Violation|0
7073173|NCT02039908|11177261|FG002|Phase 1-Summer|Protocol Violation|0
7073174|NCT02039908|11177262|FG003|Phase 1-Summer|Protocol Violation|0
7073175|NCT02039908|11177259|FG000|Phase 2-School Year|Lost to Follow-up|0
7073176|NCT02039908|11177260|FG001|Phase 2-School Year|Lost to Follow-up|0
7073177|NCT02039908|11177261|FG002|Phase 2-School Year|Lost to Follow-up|1
7073178|NCT02039908|11177262|FG003|Phase 2-School Year|Lost to Follow-up|3
7073179|NCT02039908|11177259|FG000|Phase 2-School Year|Protocol Violation|0
7073180|NCT02039908|11177260|FG001|Phase 2-School Year|Protocol Violation|0
7073181|NCT02039908|11177261|FG002|Phase 2-School Year|Protocol Violation|3
6838701|NCT00261846|10844395|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
6838702|NCT00261846|10844396|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
6838703|NCT00261846|10844385|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
6838704|NCT00261846|10844386|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
6838705|NCT00261846|10844387|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
6838706|NCT00261846|10844388|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
6838707|NCT00261846|10844389|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
6838708|NCT00261846|10844390|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
6838709|NCT00261846|10844391|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
6838710|NCT00261846|10844392|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
6838711|NCT00261846|10844393|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
6838712|NCT00261846|10844394|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
6838713|NCT00261846|10844395|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
6838714|NCT00261846|10844396|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
6838715|NCT00261846|10844385|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
6838716|NCT00261846|10844386|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
6838717|NCT00261846|10844387|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
6838718|NCT00261846|10844388|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9
6838719|NCT00261846|10844389|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8
6838720|NCT00261846|10844390|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1
6838721|NCT00261846|10844391|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
6838722|NCT00261846|10844392|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
6838723|NCT00261846|10844393|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
6838724|NCT00261846|10844394|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2
6838725|NCT00261846|10844395|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
6838726|NCT00261846|10844396|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
6965644|NCT01119937|11013183|FG000|Overall Study|Adverse Event|11
6965645|NCT01119937|11013184|FG001|Overall Study|Adverse Event|5
6965646|NCT01119937|11013183|FG000|Overall Study|Protocol deviation|3
6965647|NCT01119937|11013184|FG001|Overall Study|Protocol deviation|1
6965648|NCT01119937|11013183|FG000|Overall Study|Unsatisfactory therapeutic effect|3
6965649|NCT01119937|11013184|FG001|Overall Study|Unsatisfactory therapeutic effect|0
6965650|NCT01119937|11013183|FG000|Overall Study|Withdrawal by Subject|2
6965651|NCT01119937|11013184|FG001|Overall Study|Withdrawal by Subject|1
6965652|NCT01119950|11013190|FG000|Overall Study|Adverse Event|25
6965653|NCT01119950|11013190|FG000|Overall Study|Withdrawal by Subject|9
6965654|NCT01119950|11013190|FG000|Overall Study|Protocol Violation|5
7073182|NCT02039908|11177262|FG003|Phase 2-School Year|Protocol Violation|0
7073183|NCT02039908|11177259|FG000|Phase 2-School Year|Withdrawal by Subject|0
7073184|NCT02039908|11177260|FG001|Phase 2-School Year|Withdrawal by Subject|0
7073185|NCT02039908|11177261|FG002|Phase 2-School Year|Withdrawal by Subject|8
7073186|NCT02039908|11177262|FG003|Phase 2-School Year|Withdrawal by Subject|5
7073187|NCT02040090|11177307|FG000|Overall Study|Adverse Event|2
6965655|NCT01119950|11013190|FG000|Overall Study|Lost to Follow-up|4
6965656|NCT01119950|11013190|FG000|Overall Study|Administrative|2
6965657|NCT01119950|11013190|FG000|Overall Study|Abnormal lab value|1
6965658|NCT01119950|11013190|FG000|Overall Study|Death|1
6965659|NCT01119963|11013218|FG000|Overall Study|Lost to Follow-up|1
6965660|NCT01119963|11013219|FG001|Overall Study|Lost to Follow-up|1
6965661|NCT01120028|11013231|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
6965662|NCT01120028|11013232|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5
6965663|NCT01120028|11013233|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
6965664|NCT01120028|11013234|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
6965665|NCT01120028|11013231|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14
6965666|NCT01120028|11013232|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18
6965667|NCT01120028|11013233|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0
6965668|NCT01120028|11013234|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0
6965669|NCT01120067|11013247|FG000|Overall Study|Lost to Follow-up|3
6965670|NCT01120067|11013248|FG001|Overall Study|Lost to Follow-up|1
6965671|NCT01120067|11013247|FG000|Overall Study|fail to engage >3 sessions|2
6965672|NCT01120067|11013248|FG001|Overall Study|fail to engage >3 sessions|0
6965673|NCT01120093|11013254|FG000|Treatment Period 1|Adverse Event|0
6965674|NCT01120093|11013255|FG001|Treatment Period 1|Adverse Event|0
6965675|NCT01120093|11013256|FG002|Treatment Period 1|Adverse Event|1
6965676|NCT01120093|11013257|FG003|Treatment Period 1|Adverse Event|0
6965677|NCT01120093|11013258|FG004|Treatment Period 1|Adverse Event|1
6965678|NCT01120093|11013254|FG000|Treatment Period 1|Withdrawal by Subject|0
6965679|NCT01120093|11013255|FG001|Treatment Period 1|Withdrawal by Subject|1
6965680|NCT01120093|11013256|FG002|Treatment Period 1|Withdrawal by Subject|0
6965681|NCT01120093|11013257|FG003|Treatment Period 1|Withdrawal by Subject|0
6965682|NCT01120093|11013258|FG004|Treatment Period 1|Withdrawal by Subject|0
6965683|NCT01120093|11013254|FG000|Treatment Period 2|Adverse Event|0
6965684|NCT01120093|11013255|FG001|Treatment Period 2|Adverse Event|0
6965685|NCT01120093|11013256|FG002|Treatment Period 2|Adverse Event|0
6965686|NCT01120093|11013257|FG003|Treatment Period 2|Adverse Event|1
6965687|NCT01120093|11013258|FG004|Treatment Period 2|Adverse Event|0
6965688|NCT01120093|11013254|FG000|Treatment Period 2|Withdrawal by Subject|0
6965689|NCT01120093|11013255|FG001|Treatment Period 2|Withdrawal by Subject|0
6965690|NCT01120093|11013256|FG002|Treatment Period 2|Withdrawal by Subject|0
6965691|NCT01120093|11013257|FG003|Treatment Period 2|Withdrawal by Subject|0
6965692|NCT01120093|11013258|FG004|Treatment Period 2|Withdrawal by Subject|1
6965693|NCT01120093|11013254|FG000|Treatment Period 3|Lack of Efficacy|0
6965694|NCT01120093|11013255|FG001|Treatment Period 3|Lack of Efficacy|0
6965695|NCT01120093|11013256|FG002|Treatment Period 3|Lack of Efficacy|0
6965696|NCT01120093|11013257|FG003|Treatment Period 3|Lack of Efficacy|1
6965697|NCT01120093|11013258|FG004|Treatment Period 3|Lack of Efficacy|0
6965698|NCT01120093|11013254|FG000|Treatment Period 3|Adverse Event|0
6965699|NCT01120093|11013255|FG001|Treatment Period 3|Adverse Event|0
6965700|NCT01120093|11013256|FG002|Treatment Period 3|Adverse Event|0
6965701|NCT01120093|11013257|FG003|Treatment Period 3|Adverse Event|0
6965702|NCT01120093|11013258|FG004|Treatment Period 3|Adverse Event|1
6965703|NCT01120093|11013254|FG000|Treatment Period 3|Withdrawal by Subject|0
6965704|NCT01120093|11013255|FG001|Treatment Period 3|Withdrawal by Subject|0
6965705|NCT01120093|11013256|FG002|Treatment Period 3|Withdrawal by Subject|1
6965706|NCT01120093|11013257|FG003|Treatment Period 3|Withdrawal by Subject|0
7073188|NCT02040090|11177308|FG001|Overall Study|Adverse Event|0
7073189|NCT02040090|11177307|FG000|Overall Study|Physician Decision|1
7073190|NCT02040090|11177308|FG001|Overall Study|Physician Decision|0
7073191|NCT02040090|11177307|FG000|Overall Study|Withdrawal by Subject|0
7073192|NCT02040090|11177308|FG001|Overall Study|Withdrawal by Subject|1
7073193|NCT02040090|11177307|FG000|Overall Study|Lost to Follow-up|0
7073194|NCT02040090|11177308|FG001|Overall Study|Lost to Follow-up|1
7073195|NCT02040259|11177322|FG000|Overall Study|Death|280
6965707|NCT01120093|11013258|FG004|Treatment Period 3|Withdrawal by Subject|0
6965708|NCT01120093|11013254|FG000|Treatment Period 4|Adverse Event|1
6965709|NCT01120093|11013255|FG001|Treatment Period 4|Adverse Event|0
7073196|NCT02040259|11177322|FG000|Overall Study|Lost to Follow-up|76
7073197|NCT02040259|11177322|FG000|Overall Study|Assessment not completed|3
6965710|NCT01120093|11013256|FG002|Treatment Period 4|Adverse Event|0
6965711|NCT01120093|11013257|FG003|Treatment Period 4|Adverse Event|0
6965712|NCT01120093|11013258|FG004|Treatment Period 4|Adverse Event|0
6965713|NCT01120093|11013254|FG000|Treatment Period 5|Adverse Event|0
6965714|NCT01120093|11013255|FG001|Treatment Period 5|Adverse Event|1
6965715|NCT01120093|11013256|FG002|Treatment Period 5|Adverse Event|0
7073198|NCT02040259|11177322|FG000|Overall Study|Withdrawal by Subject|4
6965716|NCT01120093|11013257|FG003|Treatment Period 5|Adverse Event|1
6965717|NCT01120093|11013258|FG004|Treatment Period 5|Adverse Event|0
6965718|NCT01120184|11013273|FG000|Overall Study|Adverse Event|0
6965719|NCT01120184|11013274|FG001|Overall Study|Adverse Event|1
6965720|NCT01120184|11013275|FG002|Overall Study|Adverse Event|0
6965721|NCT01120184|11013273|FG000|Overall Study|Lost to Follow-up|13
6965722|NCT01120184|11013274|FG001|Overall Study|Lost to Follow-up|13
6965723|NCT01120184|11013275|FG002|Overall Study|Lost to Follow-up|11
6965724|NCT01120184|11013273|FG000|Overall Study|Physician Decision|9
6965725|NCT01120184|11013274|FG001|Overall Study|Physician Decision|1
6965726|NCT01120184|11013275|FG002|Overall Study|Physician Decision|3
6965727|NCT01120184|11013273|FG000|Overall Study|Reason not Specified|8
6965728|NCT01120184|11013274|FG001|Overall Study|Reason not Specified|3
6965729|NCT01120184|11013275|FG002|Overall Study|Reason not Specified|12
6965730|NCT01120184|11013273|FG000|Overall Study|Sponsor Decision to Terminate Study|133
6965731|NCT01120184|11013274|FG001|Overall Study|Sponsor Decision to Terminate Study|144
6965732|NCT01120184|11013275|FG002|Overall Study|Sponsor Decision to Terminate Study|143
6965733|NCT01120184|11013273|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32
6965734|NCT01120184|11013274|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29
6965735|NCT01120184|11013275|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25
6965736|NCT01120184|11013273|FG000|Overall Study|Death|170
6965737|NCT01120184|11013274|FG001|Overall Study|Death|176
6965738|NCT01120184|11013275|FG002|Overall Study|Death|169
6965739|NCT01120210|11013295|FG000|MAIN INFUSION|Adverse Event|1
6965740|NCT01120210|11013296|FG001|MAIN INFUSION|Adverse Event|0
6965741|NCT01120210|11013295|FG000|MAIN INFUSION|Withdrawal by Subject|0
6965742|NCT01120210|11013296|FG001|MAIN INFUSION|Withdrawal by Subject|1
6965743|NCT01120275|11013323|FG000|Overall Study|Adverse Event|3
6965744|NCT01120275|11013323|FG000|Overall Study|Progression|27
6965745|NCT01120275|11013323|FG000|Overall Study|Ineligible|3
6965746|NCT01120275|11013323|FG000|Overall Study|Withdrawal by Subject|1
6965747|NCT01120275|11013323|FG000|Overall Study|Refusal|1
6965748|NCT01120275|11013323|FG000|Overall Study|Not specific|1
6965749|NCT01120379|11013328|FG000|One Year Timepoint|Withdrawal by Subject|41
6965750|NCT01120379|11013328|FG000|One Year Timepoint|Lost to Follow-up|115
6965751|NCT01120379|11013328|FG000|One Year Timepoint|Death|108
6965752|NCT01120379|11013328|FG000|One Year Timepoint|Physician Decision|9
6965753|NCT01120379|11013328|FG000|One Year Timepoint|Any other reason for early termination|5
6965754|NCT01120379|11013328|FG000|Two Year Timepoint|Withdrawal by Subject|11
6965755|NCT01120379|11013328|FG000|Two Year Timepoint|Lost to Follow-up|87
6965756|NCT01120379|11013328|FG000|Two Year Timepoint|Death|123
6965757|NCT01120379|11013328|FG000|Two Year Timepoint|Physician Decision|12
6965758|NCT01120379|11013328|FG000|Two Year Timepoint|Any other reason for early termination|4
6965759|NCT01120379|11013328|FG000|Three Year Timepoint|Withdrawal by Subject|25
6965760|NCT01120379|11013328|FG000|Three Year Timepoint|Lost to Follow-up|43
6965761|NCT01120379|11013328|FG000|Three Year Timepoint|Death|120
6965762|NCT01120379|11013328|FG000|Three Year Timepoint|Physician Decision|9
6965763|NCT01120379|11013328|FG000|Three Year Timepoint|Any other reason for early termination|17
6965764|NCT01120379|11013328|FG000|Four Year Timepoint|Withdrawal by Subject|5
6965765|NCT01120379|11013328|FG000|Four Year Timepoint|Lost to Follow-up|10
6965766|NCT01120379|11013328|FG000|Four Year Timepoint|Death|131
6965767|NCT01120379|11013328|FG000|Four Year Timepoint|Physician Decision|5
6965768|NCT01120379|11013328|FG000|Four Year Timepoint|Any other reason for early termination|217
6965769|NCT01120600|11013345|FG000|Overall Study|Adverse Event|7
6965770|NCT01120600|11013346|FG001|Overall Study|Adverse Event|7
6965771|NCT01120600|11013345|FG000|Overall Study|Excessive Bone Loss|0
6965772|NCT01120600|11013346|FG001|Overall Study|Excessive Bone Loss|4
6965773|NCT01120600|11013345|FG000|Overall Study|Lost to Follow-up|1
6965774|NCT01120600|11013346|FG001|Overall Study|Lost to Follow-up|3
6965775|NCT01120600|11013345|FG000|Overall Study|Physician Decision|1
6965776|NCT01120600|11013346|FG001|Overall Study|Physician Decision|3
6965777|NCT01120600|11013345|FG000|Overall Study|Protocol Violation|0
6965778|NCT01120600|11013346|FG001|Overall Study|Protocol Violation|4
6965779|NCT01120600|11013345|FG000|Overall Study|Withdrawal by Subject|10
6965780|NCT01120600|11013346|FG001|Overall Study|Withdrawal by Subject|11
6965781|NCT01120626|11013354|FG000|Overall Study|Withdrawal by Subject|1
6965782|NCT01120626|11013355|FG001|Overall Study|Withdrawal by Subject|0
6965783|NCT01120691|11013381|FG000|Overall Study|Adverse Event|59
6965784|NCT01120691|11013382|FG001|Overall Study|Adverse Event|67
6965785|NCT01120691|11013383|FG002|Overall Study|Adverse Event|47
6965786|NCT01120691|11013381|FG000|Overall Study|Subject withdrew consent|33
6965787|NCT01120691|11013382|FG001|Overall Study|Subject withdrew consent|50
6965788|NCT01120691|11013383|FG002|Overall Study|Subject withdrew consent|44
6965789|NCT01120691|11013381|FG000|Overall Study|Death|21
6965790|NCT01120691|11013382|FG001|Overall Study|Death|22
6965791|NCT01120691|11013383|FG002|Overall Study|Death|24
6965792|NCT01120691|11013381|FG000|Overall Study|Unsatisfactory therapeutic effect|18
6965793|NCT01120691|11013382|FG001|Overall Study|Unsatisfactory therapeutic effect|32
6965794|NCT01120691|11013383|FG002|Overall Study|Unsatisfactory therapeutic effect|38
6965795|NCT01120691|11013381|FG000|Overall Study|Administrative problems|15
6965796|NCT01120691|11013382|FG001|Overall Study|Administrative problems|8
6965797|NCT01120691|11013383|FG002|Overall Study|Administrative problems|9
6965798|NCT01120691|11013381|FG000|Overall Study|Protocol deviation|13
6965799|NCT01120691|11013382|FG001|Overall Study|Protocol deviation|12
6965800|NCT01120691|11013383|FG002|Overall Study|Protocol deviation|12
6965801|NCT01120691|11013381|FG000|Overall Study|Lost to Follow-up|5
6965802|NCT01120691|11013382|FG001|Overall Study|Lost to Follow-up|6
6965803|NCT01120691|11013383|FG002|Overall Study|Lost to Follow-up|4
6965804|NCT01120691|11013381|FG000|Overall Study|Abnormal test procedure result(s)|3
6965805|NCT01120691|11013382|FG001|Overall Study|Abnormal test procedure result(s)|2
6965806|NCT01120691|11013383|FG002|Overall Study|Abnormal test procedure result(s)|1
6965807|NCT01120691|11013381|FG000|Overall Study|Patient's inability to use the device|3
6965808|NCT01120691|11013382|FG001|Overall Study|Patient's inability to use the device|1
6965809|NCT01120691|11013383|FG002|Overall Study|Patient's inability to use the device|0
6965810|NCT01120691|11013381|FG000|Overall Study|Abnormal laboratory value(s)|1
6965811|NCT01120691|11013382|FG001|Overall Study|Abnormal laboratory value(s)|3
6965812|NCT01120691|11013383|FG002|Overall Study|Abnormal laboratory value(s)|4
6965813|NCT01120717|11013474|FG000|Overall Study|Withdrawal by Subject|11
6965814|NCT01120717|11013475|FG001|Overall Study|Withdrawal by Subject|6
6965815|NCT01120717|11013474|FG000|Overall Study|Adverse Event|10
6965816|NCT01120717|11013475|FG001|Overall Study|Adverse Event|6
6965817|NCT01120717|11013474|FG000|Overall Study|Protocol Deviation|2
6965818|NCT01120717|11013475|FG001|Overall Study|Protocol Deviation|5
6965819|NCT01120717|11013474|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3
6965820|NCT01120717|11013475|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3
7073199|NCT02040428|11177345|FG000|Overall Study|Death|4
7073200|NCT02040428|11177346|FG001|Overall Study|Death|3
7073201|NCT02040428|11177345|FG000|Overall Study|Withdrawal by Subject|1
7073202|NCT02040428|11177346|FG001|Overall Study|Withdrawal by Subject|1
7073203|NCT02040532|11177352|FG000|Overall Study|Lost to Follow-up|1
7073204|NCT02040532|11177352|FG000|Overall Study|Physician Decision|4
7073205|NCT02040532|11177352|FG000|Overall Study|Adverse Event|4
7073206|NCT02040532|11177352|FG000|Overall Study|Withdrawal by Subject|3
7073207|NCT02040766|11177374|FG000|Overall Study|Adverse Event|1
7073208|NCT02040766|11177375|FG001|Overall Study|Adverse Event|1
7073209|NCT02040766|11177376|FG002|Overall Study|Adverse Event|1
7073210|NCT02040766|11177377|FG003|Overall Study|Adverse Event|0
7073211|NCT02040766|11177378|FG004|Overall Study|Adverse Event|2
7073212|NCT02040766|11177374|FG000|Overall Study|Withdrawal by Subject|4
7073213|NCT02040766|11177375|FG001|Overall Study|Withdrawal by Subject|3
7073214|NCT02040766|11177376|FG002|Overall Study|Withdrawal by Subject|2
7073215|NCT02040766|11177377|FG003|Overall Study|Withdrawal by Subject|3
7073216|NCT02040766|11177378|FG004|Overall Study|Withdrawal by Subject|2
7073217|NCT02040766|11177374|FG000|Overall Study|Non-compliance|0
7073218|NCT02040766|11177375|FG001|Overall Study|Non-compliance|1
7073219|NCT02040766|11177376|FG002|Overall Study|Non-compliance|0
7073220|NCT02040766|11177377|FG003|Overall Study|Non-compliance|0
7073221|NCT02040766|11177378|FG004|Overall Study|Non-compliance|0
7073222|NCT02040766|11177374|FG000|Overall Study|Protocol Violation|2
7073223|NCT02040766|11177375|FG001|Overall Study|Protocol Violation|1
7073224|NCT02040766|11177376|FG002|Overall Study|Protocol Violation|2
7073225|NCT02040766|11177377|FG003|Overall Study|Protocol Violation|3
6838727|NCT00261846|10844385|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
6838728|NCT00261846|10844386|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
6838729|NCT00261846|10844387|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
6838730|NCT00261846|10844388|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12
6838731|NCT00261846|10844389|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
6838732|NCT00261846|10844390|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
6838733|NCT00261846|10844391|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
6838734|NCT00261846|10844392|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
6838735|NCT00261846|10844393|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1
6838736|NCT00261846|10844394|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
6838737|NCT00261846|10844395|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
6838738|NCT00261846|10844396|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
6838739|NCT00261846|10844385|FG000|Period 2: Part 2 (Efficacy)|Other|0
6838740|NCT00261846|10844386|FG001|Period 2: Part 2 (Efficacy)|Other|0
6838741|NCT00261846|10844387|FG002|Period 2: Part 2 (Efficacy)|Other|0
6838742|NCT00261846|10844388|FG003|Period 2: Part 2 (Efficacy)|Other|15
6838743|NCT00261846|10844389|FG004|Period 2: Part 2 (Efficacy)|Other|4
6838744|NCT00261846|10844390|FG005|Period 2: Part 2 (Efficacy)|Other|0
6838745|NCT00261846|10844391|FG006|Period 2: Part 2 (Efficacy)|Other|1
6838746|NCT00261846|10844392|FG007|Period 2: Part 2 (Efficacy)|Other|5
6838747|NCT00261846|10844393|FG008|Period 2: Part 2 (Efficacy)|Other|4
6838748|NCT00261846|10844394|FG009|Period 2: Part 2 (Efficacy)|Other|4
6838749|NCT00261846|10844395|FG010|Period 2: Part 2 (Efficacy)|Other|0
6838750|NCT00261846|10844396|FG011|Period 2: Part 2 (Efficacy)|Other|0
6838751|NCT00261846|10844385|FG000|Period 2: Part 2 (Efficacy)|Death|0
6838752|NCT00261846|10844386|FG001|Period 2: Part 2 (Efficacy)|Death|0
6838753|NCT00261846|10844387|FG002|Period 2: Part 2 (Efficacy)|Death|0
6965821|NCT01120717|11013474|FG000|Overall Study|Lost to Follow-up|2
6965822|NCT01120717|11013475|FG001|Overall Study|Lost to Follow-up|3
6965823|NCT01120717|11013474|FG000|Overall Study|Death|3
6965824|NCT01120717|11013475|FG001|Overall Study|Death|1
6965825|NCT01120717|11013474|FG000|Overall Study|Abnormal Test Procedure Result(s)|1
7073226|NCT02040766|11177378|FG004|Overall Study|Protocol Violation|0
7073227|NCT02040766|11177374|FG000|Overall Study|Lost to Follow-up|4
6965826|NCT01120717|11013475|FG001|Overall Study|Abnormal Test Procedure Result(s)|0
6965827|NCT01120756|11013483|FG000|Overall Study|Withdrawal by Subject|1
6965828|NCT01120756|11013484|FG001|Overall Study|Withdrawal by Subject|1
6965829|NCT01120782|11013490|FG000|Overall Study|Test article shipping error|11
6965830|NCT01120899|11013502|FG000|Overall Study|Withdrawal by Subject|3
6965831|NCT01121146|11013512|FG000|Overall Study|Death|17
6965832|NCT01121146|11013513|FG001|Overall Study|Death|15
6965833|NCT01121146|11013512|FG000|Overall Study|Adverse Event|2
6965834|NCT01121146|11013513|FG001|Overall Study|Adverse Event|11
6965835|NCT01121146|11013512|FG000|Overall Study|Lost to Follow-up|7
6965836|NCT01121146|11013513|FG001|Overall Study|Lost to Follow-up|16
6965837|NCT01121185|11013532|FG000|Overall Study|Not infused|0
6965838|NCT01121185|11013533|FG001|Overall Study|Not infused|1
6965839|NCT01121185|11013532|FG000|Overall Study|Not transplanted|1
6965840|NCT01121185|11013533|FG001|Overall Study|Not transplanted|0
6965841|NCT01121263|11013574|FG000|Overall Study|Death|3
6965842|NCT01121263|11013575|FG001|Overall Study|Death|2
6965843|NCT01121263|11013574|FG000|Overall Study|Lost to Follow-up|22
6965844|NCT01121263|11013575|FG001|Overall Study|Lost to Follow-up|12
6965845|NCT01121263|11013574|FG000|Overall Study|Withdrawal by Subject|0
6965846|NCT01121263|11013575|FG001|Overall Study|Withdrawal by Subject|1
6965847|NCT01121393|11013585|FG000|Overall Study|Progressive disease|201
6965848|NCT01121393|11013586|FG001|Overall Study|Progressive disease|20
6965849|NCT01121393|11013585|FG000|Overall Study|Other Adverse events|24
6965850|NCT01121393|11013586|FG001|Overall Study|Other Adverse events|45
6965851|NCT01121393|11013585|FG000|Overall Study|Non-compliant with protocol|0
6965852|NCT01121393|11013586|FG001|Overall Study|Non-compliant with protocol|3
6965853|NCT01121393|11013585|FG000|Overall Study|Lost to Follow-up|1
6965854|NCT01121393|11013586|FG001|Overall Study|Lost to Follow-up|0
6965855|NCT01121393|11013585|FG000|Overall Study|Refused cont. medication|7
6965856|NCT01121393|11013586|FG001|Overall Study|Refused cont. medication|7
6965857|NCT01121393|11013585|FG000|Overall Study|Not treated|3
6965858|NCT01121393|11013586|FG001|Overall Study|Not treated|9
6965859|NCT01121393|11013585|FG000|Overall Study|Other than listed|6
6965860|NCT01121393|11013586|FG001|Overall Study|Other than listed|0
6965861|NCT01121406|11013600|FG000|Overall Study|Progressive disease RECIST|44
6965862|NCT01121406|11013601|FG001|Overall Study|Progressive disease RECIST|28
6965863|NCT01121406|11013600|FG000|Overall Study|Wors. or AE of underlying cancer disease|4
6965864|NCT01121406|11013601|FG001|Overall Study|Wors. or AE of underlying cancer disease|6
6965865|NCT01121406|11013600|FG000|Overall Study|Other AE|3
6965866|NCT01121406|11013601|FG001|Overall Study|Other AE|10
6965867|NCT01121406|11013600|FG000|Overall Study|Non-compliant with protocol|0
6965868|NCT01121406|11013601|FG001|Overall Study|Non-compliant with protocol|2
6965869|NCT01121406|11013600|FG000|Overall Study|Lost to Follow-up|0
6965870|NCT01121406|11013601|FG001|Overall Study|Lost to Follow-up|1
6965871|NCT01121406|11013600|FG000|Overall Study|Refused continuation of study med.|1
6965872|NCT01121406|11013601|FG001|Overall Study|Refused continuation of study med.|2
6965873|NCT01121406|11013600|FG000|Overall Study|Reason other than specified above|2
6965874|NCT01121406|11013601|FG001|Overall Study|Reason other than specified above|6
6965875|NCT01121406|11013600|FG000|Overall Study|Not treated|1
6965876|NCT01121406|11013601|FG001|Overall Study|Not treated|0
6965877|NCT01121484|11013612|FG000|Overall Study|Adverse Event|12
6965878|NCT01121484|11013613|FG001|Overall Study|Adverse Event|5
6965879|NCT01121484|11013612|FG000|Overall Study|Lack of Efficacy|3
6965880|NCT01121484|11013613|FG001|Overall Study|Lack of Efficacy|11
6965881|NCT01121484|11013612|FG000|Overall Study|Lost to Follow-up|5
6965882|NCT01121484|11013613|FG001|Overall Study|Lost to Follow-up|9
6965883|NCT01121484|11013612|FG000|Overall Study|Physician Decision|0
6965884|NCT01121484|11013613|FG001|Overall Study|Physician Decision|3
6965885|NCT01121484|11013612|FG000|Overall Study|Protocol Violation|1
6965886|NCT01121484|11013613|FG001|Overall Study|Protocol Violation|0
6965887|NCT01121484|11013612|FG000|Overall Study|Withdrawal by Subject|8
6965888|NCT01121484|11013613|FG001|Overall Study|Withdrawal by Subject|7
6965889|NCT01121484|11013612|FG000|Overall Study|Discontinuation of study by sponsor|0
6965890|NCT01121484|11013613|FG001|Overall Study|Discontinuation of study by sponsor|1
6965891|NCT01121484|11013612|FG000|Overall Study|Other|3
6965892|NCT01121484|11013613|FG001|Overall Study|Other|3
6965893|NCT01121484|11013612|FG000|Overall Study|Randomized, not treated|1
6965894|NCT01121484|11013613|FG001|Overall Study|Randomized, not treated|4
6965895|NCT01121536|11013619|FG000|Overall Study|Adverse Event|63
6965896|NCT01121536|11013619|FG000|Overall Study|Lack of Efficacy|35
6965897|NCT01121536|11013619|FG000|Overall Study|Withdrawal by Subject|65
6965898|NCT01121536|11013619|FG000|Overall Study|Protocol Violation|20
6965899|NCT01121536|11013619|FG000|Overall Study|Noncompliance with study medication|12
6965900|NCT01121536|11013619|FG000|Overall Study|Noncompliance with study procedures|9
6965901|NCT01121536|11013619|FG000|Overall Study|Lost to Follow-up|39
6965902|NCT01121536|11013619|FG000|Overall Study|Other|118
6965903|NCT01121549|11013623|FG000|Overall Study|Adverse Event|10
6965904|NCT01121549|11013623|FG000|Overall Study|Lack of Efficacy|11
6965905|NCT01121549|11013623|FG000|Overall Study|Lost to Follow-up|12
6965906|NCT01121549|11013623|FG000|Overall Study|Did not meet entrance criteria|9
6965907|NCT01121549|11013623|FG000|Overall Study|Study terminated by sponsor|197
6965908|NCT01121549|11013623|FG000|Overall Study|Pregnancy|1
6965909|NCT01121549|11013623|FG000|Overall Study|Protocol Violation|33
6965910|NCT01121549|11013623|FG000|Overall Study|Withdrawal by Subject|16
6965911|NCT01121549|11013623|FG000|Overall Study|Other|58
6965912|NCT01121562|11013627|FG000|Overall Study|Objective progression or relapse|8
6965913|NCT01121562|11013627|FG000|Overall Study|Withdrawal by Subject|1
6965914|NCT01121562|11013627|FG000|Overall Study|Adverse Event|1
6965915|NCT01121562|11013627|FG000|Overall Study|Sponsor Decision|1
6965916|NCT01121562|11013627|FG000|Overall Study|Met study discontinuation criteria|1
6965917|NCT01121575|11013637|FG000|Overall Study|Participant Refused Further Follow-Up|0
6965918|NCT01121575|11013638|FG001|Overall Study|Participant Refused Further Follow-Up|0
6965919|NCT01121575|11013639|FG002|Overall Study|Participant Refused Further Follow-Up|0
6965920|NCT01121575|11013640|FG003|Overall Study|Participant Refused Further Follow-Up|0
6965921|NCT01121575|11013641|FG004|Overall Study|Participant Refused Further Follow-Up|5
6965922|NCT01121575|11013642|FG005|Overall Study|Participant Refused Further Follow-Up|1
6965923|NCT01121575|11013637|FG000|Overall Study|Unspecified Reasons|8
6965924|NCT01121575|11013638|FG001|Overall Study|Unspecified Reasons|6
6965925|NCT01121575|11013639|FG002|Overall Study|Unspecified Reasons|7
6965926|NCT01121575|11013640|FG003|Overall Study|Unspecified Reasons|5
6965927|NCT01121575|11013641|FG004|Overall Study|Unspecified Reasons|13
6965928|NCT01121575|11013642|FG005|Overall Study|Unspecified Reasons|10
6965929|NCT01121575|11013637|FG000|Overall Study|Death|6
6965930|NCT01121575|11013638|FG001|Overall Study|Death|0
6965931|NCT01121575|11013639|FG002|Overall Study|Death|0
6965932|NCT01121575|11013640|FG003|Overall Study|Death|1
6965933|NCT01121575|11013641|FG004|Overall Study|Death|7
6965934|NCT01121575|11013642|FG005|Overall Study|Death|1
6965935|NCT01121666|11013663|FG000|Overall Study|Protocol Violation|29
6965936|NCT01121666|11013664|FG001|Overall Study|Protocol Violation|10
6965937|NCT01121757|11013672|FG000|First Drug|Death|1
6965938|NCT01121757|11013673|FG001|First Drug|Death|0
6965939|NCT01121757|11013672|FG000|First Drug|Disease Progression|0
6965940|NCT01121757|11013673|FG001|First Drug|Disease Progression|2
6965941|NCT01121757|11013672|FG000|Combination|Physician Decision|0
6965942|NCT01121757|11013673|FG001|Combination|Physician Decision|1
6965943|NCT01121757|11013672|FG000|Combination|Disease Progression|2
6965944|NCT01121757|11013673|FG001|Combination|Disease Progression|0
6965945|NCT01121900|11013681|FG000|First Intervention Period|Adverse Event|1
6965946|NCT01121900|11013682|FG001|First Intervention Period|Adverse Event|1
6965947|NCT01121900|11013681|FG000|Washout Period of 7 Days|Withdrawal by Subject|0
6965948|NCT01121900|11013682|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
6965949|NCT01121913|11013688|FG000|First Intervention Period|Adverse Event|0
6965950|NCT01121913|11013689|FG001|First Intervention Period|Adverse Event|0
6965951|NCT01121913|11013690|FG002|First Intervention Period|Adverse Event|1
6965952|NCT01121913|11013691|FG003|First Intervention Period|Adverse Event|0
6965953|NCT01121913|11013688|FG000|First Washout Period|Withdrawal by Subject|1
6965954|NCT01121913|11013689|FG001|First Washout Period|Withdrawal by Subject|0
6965955|NCT01121913|11013690|FG002|First Washout Period|Withdrawal by Subject|0
6965956|NCT01121913|11013691|FG003|First Washout Period|Withdrawal by Subject|0
6965957|NCT01121913|11013688|FG000|Second Intervention Period|Adverse Event|0
6965958|NCT01121913|11013689|FG001|Second Intervention Period|Adverse Event|0
6965959|NCT01121913|11013690|FG002|Second Intervention Period|Adverse Event|1
6965960|NCT01121913|11013691|FG003|Second Intervention Period|Adverse Event|0
6965961|NCT01121913|11013688|FG000|Second Washout Period|Withdrawal by Subject|0
6965962|NCT01121913|11013689|FG001|Second Washout Period|Withdrawal by Subject|0
6965963|NCT01121913|11013690|FG002|Second Washout Period|Withdrawal by Subject|1
6965964|NCT01121913|11013691|FG003|Second Washout Period|Withdrawal by Subject|0
6965965|NCT01121913|11013688|FG000|Third Washout Period|Adverse Event|1
6965966|NCT01121913|11013689|FG001|Third Washout Period|Adverse Event|0
6965967|NCT01121913|11013690|FG002|Third Washout Period|Adverse Event|0
6965968|NCT01121913|11013691|FG003|Third Washout Period|Adverse Event|0
6965969|NCT01121926|11013701|FG000|First Intervention Period|Adverse Event|1
6965970|NCT01121926|11013702|FG001|First Intervention Period|Adverse Event|0
6965971|NCT01121926|11013701|FG000|Washout Period|Adverse Event|0
6965972|NCT01121926|11013702|FG001|Washout Period|Adverse Event|1
6965973|NCT01121926|11013701|FG000|Washout Period|Positive pregnancy test|0
6965974|NCT01121926|11013702|FG001|Washout Period|Positive pregnancy test|1
6965975|NCT01121991|11013715|FG000|Overall Study|Lack of Ovarian Response|2
6965976|NCT01121991|11013715|FG000|Overall Study|No Oocytes Retrieved|3
6965977|NCT01121991|11013715|FG000|Overall Study|No Fertilization|1
6965978|NCT01122173|11013770|FG000|Overall Study|Lost to Follow-up|3
6965979|NCT01122173|11013770|FG000|Overall Study|Withdrawal by Subject|3
6965980|NCT01122173|11013770|FG000|Overall Study|Left study for other reasons|3
6965981|NCT01122264|11013823|FG000|Overall Study|Adverse Event|6
6965982|NCT01122264|11013824|FG001|Overall Study|Adverse Event|5
6965983|NCT01122264|11013825|FG002|Overall Study|Adverse Event|7
6965984|NCT01122264|11013823|FG000|Overall Study|Death|1
6965985|NCT01122264|11013824|FG001|Overall Study|Death|0
6965986|NCT01122264|11013825|FG002|Overall Study|Death|0
6965987|NCT01122264|11013823|FG000|Overall Study|Lost to Follow-up|5
6965988|NCT01122264|11013824|FG001|Overall Study|Lost to Follow-up|9
6965989|NCT01122264|11013825|FG002|Overall Study|Lost to Follow-up|13
6965990|NCT01122264|11013823|FG000|Overall Study|Entry Criteria Not Met|1
6965991|NCT01122264|11013824|FG001|Overall Study|Entry Criteria Not Met|0
6965992|NCT01122264|11013825|FG002|Overall Study|Entry Criteria Not Met|0
6965993|NCT01122264|11013823|FG000|Overall Study|Protocol Violation|7
6965994|NCT01122264|11013824|FG001|Overall Study|Protocol Violation|7
6965995|NCT01122264|11013825|FG002|Overall Study|Protocol Violation|9
6965996|NCT01122264|11013823|FG000|Overall Study|Withdrawal by Subject|6
6965997|NCT01122264|11013824|FG001|Overall Study|Withdrawal by Subject|6
6965998|NCT01122264|11013825|FG002|Overall Study|Withdrawal by Subject|16
6965999|NCT01122264|11013823|FG000|Overall Study|Physician Decision|3
6966000|NCT01122264|11013824|FG001|Overall Study|Physician Decision|1
6966001|NCT01122264|11013825|FG002|Overall Study|Physician Decision|1
6966002|NCT01122264|11013823|FG000|Overall Study|Lack of Efficacy|3
6966003|NCT01122264|11013824|FG001|Overall Study|Lack of Efficacy|1
6966004|NCT01122264|11013825|FG002|Overall Study|Lack of Efficacy|1
6966005|NCT01122394|11013843|FG000|Overall Study|Withdrawal by Subject|1
6966006|NCT01122394|11013844|FG001|Overall Study|Withdrawal by Subject|1
6966007|NCT01122394|11013843|FG000|Overall Study|Lost to Follow-up|2
6966008|NCT01122394|11013844|FG001|Overall Study|Lost to Follow-up|2
6966009|NCT01122394|11013843|FG000|Overall Study|Adverse Event|0
6966010|NCT01122394|11013844|FG001|Overall Study|Adverse Event|1
6966011|NCT01122576|11013864|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0
6966012|NCT01122576|11013865|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1
6966013|NCT01122576|11013866|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2
6966014|NCT01122576|11013864|FG000|Post-Cataract Surgery|Central Macular Edema|0
6966015|NCT01122576|11013865|FG001|Post-Cataract Surgery|Central Macular Edema|0
6966016|NCT01122576|11013866|FG002|Post-Cataract Surgery|Central Macular Edema|1
6966017|NCT01122576|11013864|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0
6966018|NCT01122576|11013865|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0
6966019|NCT01122576|11013866|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1
6966020|NCT01122680|11013877|FG000|Period 1 (4 Weeks)|Adverse Event|1
6966021|NCT01122680|11013878|FG001|Period 1 (4 Weeks)|Adverse Event|0
6966022|NCT01122680|11013879|FG002|Period 1 (4 Weeks)|Adverse Event|0
6966023|NCT01122680|11013880|FG003|Period 1 (4 Weeks)|Adverse Event|0
6966024|NCT01122680|11013877|FG000|Period 1 (4 Weeks)|Protocol Violation|1
6966025|NCT01122680|11013878|FG001|Period 1 (4 Weeks)|Protocol Violation|0
6966026|NCT01122680|11013879|FG002|Period 1 (4 Weeks)|Protocol Violation|0
6966027|NCT01122680|11013880|FG003|Period 1 (4 Weeks)|Protocol Violation|0
6966028|NCT01122680|11013877|FG000|Period 1 (4 Weeks)|Other|1
6966029|NCT01122680|11013878|FG001|Period 1 (4 Weeks)|Other|1
6966030|NCT01122680|11013879|FG002|Period 1 (4 Weeks)|Other|0
6966031|NCT01122680|11013880|FG003|Period 1 (4 Weeks)|Other|0
6966032|NCT01122680|11013877|FG000|Period 2 (4 Weeks)|Protocol Violation|0
6966033|NCT01122680|11013878|FG001|Period 2 (4 Weeks)|Protocol Violation|0
6966034|NCT01122680|11013879|FG002|Period 2 (4 Weeks)|Protocol Violation|0
6966035|NCT01122680|11013880|FG003|Period 2 (4 Weeks)|Protocol Violation|1
6966036|NCT01122680|11013877|FG000|Period 2 (4 Weeks)|Other|1
6966037|NCT01122680|11013878|FG001|Period 2 (4 Weeks)|Other|0
6966038|NCT01122680|11013879|FG002|Period 2 (4 Weeks)|Other|0
6966039|NCT01122680|11013880|FG003|Period 2 (4 Weeks)|Other|0
6966040|NCT01122680|11013877|FG000|Period 3 (4 Weeks)|Adverse Event|1
6966041|NCT01122680|11013878|FG001|Period 3 (4 Weeks)|Adverse Event|0
6966042|NCT01122680|11013879|FG002|Period 3 (4 Weeks)|Adverse Event|0
6966043|NCT01122680|11013880|FG003|Period 3 (4 Weeks)|Adverse Event|0
6966044|NCT01122680|11013877|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0
7073228|NCT02040766|11177375|FG001|Overall Study|Lost to Follow-up|1
7073229|NCT02040766|11177376|FG002|Overall Study|Lost to Follow-up|3
7073230|NCT02040766|11177377|FG003|Overall Study|Lost to Follow-up|1
7073231|NCT02040766|11177378|FG004|Overall Study|Lost to Follow-up|4
7073232|NCT02040766|11177374|FG000|Overall Study|Not reported|1
6838754|NCT00261846|10844388|FG003|Period 2: Part 2 (Efficacy)|Death|37
6838755|NCT00261846|10844389|FG004|Period 2: Part 2 (Efficacy)|Death|7
6838756|NCT00261846|10844390|FG005|Period 2: Part 2 (Efficacy)|Death|1
6838757|NCT00261846|10844391|FG006|Period 2: Part 2 (Efficacy)|Death|10
6838758|NCT00261846|10844392|FG007|Period 2: Part 2 (Efficacy)|Death|12
6838759|NCT00261846|10844393|FG008|Period 2: Part 2 (Efficacy)|Death|3
6838760|NCT00261846|10844394|FG009|Period 2: Part 2 (Efficacy)|Death|30
6838761|NCT00261846|10844395|FG010|Period 2: Part 2 (Efficacy)|Death|44
6966045|NCT01122680|11013878|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1
6966046|NCT01122680|11013879|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0
7073233|NCT02040766|11177375|FG001|Overall Study|Not reported|0
7073234|NCT02040766|11177376|FG002|Overall Study|Not reported|0
7073235|NCT02040766|11177377|FG003|Overall Study|Not reported|0
7073236|NCT02040766|11177378|FG004|Overall Study|Not reported|0
6966047|NCT01122680|11013880|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0
6966048|NCT01122862|11013913|FG000|Period 1|Protocol Violation|0
7073237|NCT02040766|11177374|FG000|Overall Study|Lack of Efficacy|6
7073238|NCT02040766|11177375|FG001|Overall Study|Lack of Efficacy|3
6966049|NCT01122862|11013914|FG001|Period 1|Protocol Violation|1
6966050|NCT01122862|11013915|FG002|Period 1|Protocol Violation|0
7073239|NCT02040766|11177376|FG002|Overall Study|Lack of Efficacy|4
7073240|NCT02040766|11177377|FG003|Overall Study|Lack of Efficacy|6
7073241|NCT02040766|11177378|FG004|Overall Study|Lack of Efficacy|5
7073242|NCT02040779|11177394|FG000|Overall Study|Adverse Event|1
6838762|NCT00261846|10844396|FG011|Period 2: Part 2 (Efficacy)|Death|22
6966051|NCT01122862|11013913|FG000|Period 2|Adverse Event|0
6966052|NCT01122862|11013914|FG001|Period 2|Adverse Event|0
6966053|NCT01122862|11013915|FG002|Period 2|Adverse Event|1
6838763|NCT00261846|10844385|FG000|Period 2: Part 2 (Efficacy)|Extension study|0
7073243|NCT02040779|11177395|FG001|Overall Study|Adverse Event|0
6966054|NCT01122927|11013938|FG000|Period 1 - Conversion Phase|Adverse Event|3
6966055|NCT01122927|11013939|FG001|Period 1 - Conversion Phase|Adverse Event|0
6966056|NCT01122927|11013938|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
6966057|NCT01122927|11013939|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
6966058|NCT01122927|11013938|FG000|Period 1 - Conversion Phase|Physician Decision|2
6966059|NCT01122927|11013939|FG001|Period 1 - Conversion Phase|Physician Decision|0
6966060|NCT01122927|11013938|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7
6966061|NCT01122927|11013939|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0
6966062|NCT01122927|11013938|FG000|Period 1 - Conversion Phase|Protocol Deviation|1
6966063|NCT01122927|11013939|FG001|Period 1 - Conversion Phase|Protocol Deviation|0
7073244|NCT02040779|11177396|FG002|Overall Study|Adverse Event|0
7073245|NCT02040779|11177394|FG000|Overall Study|Withdrawal by Subject|4
7073246|NCT02040779|11177395|FG001|Overall Study|Withdrawal by Subject|1
7073247|NCT02040779|11177396|FG002|Overall Study|Withdrawal by Subject|3
7073248|NCT02040779|11177394|FG000|Overall Study|Non-compliance|0
7073249|NCT02040779|11177395|FG001|Overall Study|Non-compliance|1
7073250|NCT02040779|11177396|FG002|Overall Study|Non-compliance|0
7073251|NCT02040779|11177394|FG000|Overall Study|Protocol Violation|2
7073252|NCT02040779|11177395|FG001|Overall Study|Protocol Violation|1
7073253|NCT02040779|11177396|FG002|Overall Study|Protocol Violation|0
7073254|NCT02040779|11177394|FG000|Overall Study|Lost to Follow-up|1
7073255|NCT02040779|11177395|FG001|Overall Study|Lost to Follow-up|2
7073256|NCT02040779|11177396|FG002|Overall Study|Lost to Follow-up|1
7073257|NCT02040779|11177394|FG000|Overall Study|Lack of Efficacy|4
7073258|NCT02040779|11177395|FG001|Overall Study|Lack of Efficacy|2
7073259|NCT02040779|11177396|FG002|Overall Study|Lack of Efficacy|0
7073260|NCT02040805|11177406|FG000|Overall Study|Lost to Follow-up|14
7073261|NCT02040805|11177407|FG001|Overall Study|Lost to Follow-up|9
7073262|NCT02040805|11177406|FG000|Overall Study|Withdrawal by Subject|28
7073263|NCT02040805|11177407|FG001|Overall Study|Withdrawal by Subject|41
7073264|NCT02040844|11177416|FG000|Overall Study|Adverse Event|0
7073265|NCT02040844|11177417|FG001|Overall Study|Adverse Event|0
7073266|NCT02040844|11177418|FG002|Overall Study|Adverse Event|1
7073267|NCT02040844|11177416|FG000|Overall Study|Withdrawal by Subject|16
7073268|NCT02040844|11177417|FG001|Overall Study|Withdrawal by Subject|22
7073269|NCT02040844|11177418|FG002|Overall Study|Withdrawal by Subject|25
7073270|NCT02040844|11177416|FG000|Overall Study|Lost to Follow-up|12
7073271|NCT02040844|11177417|FG001|Overall Study|Lost to Follow-up|9
7073272|NCT02040844|11177418|FG002|Overall Study|Lost to Follow-up|13
7073273|NCT02040844|11177416|FG000|Overall Study|Missing|13
7073274|NCT02040844|11177417|FG001|Overall Study|Missing|3
7073275|NCT02040844|11177418|FG002|Overall Study|Missing|2
7073276|NCT02040844|11177416|FG000|Overall Study|Non-specified|8
7073277|NCT02040844|11177417|FG001|Overall Study|Non-specified|2
7073278|NCT02040844|11177418|FG002|Overall Study|Non-specified|5
7073279|NCT02040844|11177416|FG000|Overall Study|Concomitant medication|1
7073280|NCT02040844|11177417|FG001|Overall Study|Concomitant medication|3
7073281|NCT02040844|11177418|FG002|Overall Study|Concomitant medication|1
7073282|NCT02040870|11177426|FG000|Overall Study|Completed treatment phase|6
7073283|NCT02040870|11177426|FG000|Overall Study|Adverse Event|7
7073284|NCT02040870|11177426|FG000|Overall Study|Progressive disease|58
7073285|NCT02040870|11177426|FG000|Overall Study|Physician Decision|6
7073286|NCT02040870|11177426|FG000|Overall Study|Subject/guardian decision|10
7073287|NCT02040870|11177426|FG000|Overall Study|Lost to Follow-up|3
7073288|NCT02040870|11177426|FG000|Overall Study|Death|13
7073289|NCT02041091|11177432|FG000|Treatment|Adverse Event|3
7073290|NCT02041091|11177433|FG001|Treatment|Adverse Event|3
7073291|NCT02041091|11177432|FG000|Treatment|Withdrawal by Subject|2
7073292|NCT02041091|11177433|FG001|Treatment|Withdrawal by Subject|4
7073293|NCT02041091|11177432|FG000|Treatment|Physician Decision|1
7073294|NCT02041091|11177433|FG001|Treatment|Physician Decision|0
7073295|NCT02041091|11177432|FG000|Treatment|Sponsor Decision|15
7073296|NCT02041091|11177433|FG001|Treatment|Sponsor Decision|16
7073297|NCT02041091|11177432|FG000|Treatment|Lost to Follow-up|1
7073298|NCT02041091|11177433|FG001|Treatment|Lost to Follow-up|0
7073299|NCT02041091|11177432|FG000|Optional Safety Extension Period|Adverse Event|4
7073300|NCT02041091|11177433|FG001|Optional Safety Extension Period|Adverse Event|2
7073301|NCT02041091|11177432|FG000|Optional Safety Extension Period|Withdrawal by Subject|5
7073302|NCT02041091|11177433|FG001|Optional Safety Extension Period|Withdrawal by Subject|2
7073303|NCT02041091|11177432|FG000|Optional Safety Extension Period|Protocol Violation|2
7073304|NCT02041091|11177433|FG001|Optional Safety Extension Period|Protocol Violation|0
7073305|NCT02041091|11177432|FG000|Optional Safety Extension Period|Physician Decision|2
7073306|NCT02041091|11177433|FG001|Optional Safety Extension Period|Physician Decision|1
7073307|NCT02041091|11177432|FG000|Optional Safety Extension Period|Sponsor Decision|70
7073308|NCT02041091|11177433|FG001|Optional Safety Extension Period|Sponsor Decision|74
7073309|NCT02041091|11177432|FG000|Optional Safety Extension Period|Lost to Follow-up|2
7073310|NCT02041091|11177433|FG001|Optional Safety Extension Period|Lost to Follow-up|3
7073311|NCT02041104|11177447|FG000|Overall Study|Lost to Follow-up|1
7073312|NCT02041104|11177448|FG001|Overall Study|Lost to Follow-up|4
7073313|NCT02041104|11177447|FG000|Overall Study|discomfort during OGTT|0
7073314|NCT02041104|11177448|FG001|Overall Study|discomfort during OGTT|3
7073315|NCT02041286|11177481|FG000|Overall Study|Adverse Event|1
7073316|NCT02041299|11177489|FG000|Overall Study|Adverse Event|9
6966064|NCT01122927|11013938|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0
6966065|NCT01122927|11013939|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21
6966066|NCT01122927|11013938|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0
6966067|NCT01122927|11013939|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33
6966068|NCT01122927|11013938|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0
6966069|NCT01122927|11013939|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165
6966070|NCT01122927|11013938|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0
6966071|NCT01122927|11013939|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9
6966072|NCT01122927|11013938|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0
6966073|NCT01122927|11013939|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12
6966074|NCT01122927|11013938|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0
6966075|NCT01122927|11013939|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65
6966076|NCT01122927|11013938|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0
6966077|NCT01122927|11013939|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7
6966078|NCT01123070|11013953|FG000|Part B Double Blind Period|Protocol Violation|0
7073317|NCT02041299|11177490|FG001|Overall Study|Adverse Event|3
7073318|NCT02041299|11177489|FG000|Overall Study|Lost to Follow-up|4
7073319|NCT02041299|11177490|FG001|Overall Study|Lost to Follow-up|1
7073320|NCT02041299|11177489|FG000|Overall Study|Physician Decision|1
7073321|NCT02041299|11177490|FG001|Overall Study|Physician Decision|1
6966079|NCT01123070|11013954|FG001|Part B Double Blind Period|Protocol Violation|0
6966080|NCT01123070|11013955|FG002|Part B Double Blind Period|Protocol Violation|0
6966081|NCT01123070|11013956|FG003|Part B Double Blind Period|Protocol Violation|1
6966082|NCT01123070|11013953|FG000|Part B Double Blind Period|Adverse Event|0
6966083|NCT01123070|11013954|FG001|Part B Double Blind Period|Adverse Event|0
6966084|NCT01123070|11013955|FG002|Part B Double Blind Period|Adverse Event|2
6966085|NCT01123070|11013956|FG003|Part B Double Blind Period|Adverse Event|0
6966086|NCT01123070|11013953|FG000|Part B Double Blind Period|Sponsor's Decision|0
6966087|NCT01123070|11013954|FG001|Part B Double Blind Period|Sponsor's Decision|0
6966088|NCT01123070|11013955|FG002|Part B Double Blind Period|Sponsor's Decision|2
6966089|NCT01123070|11013956|FG003|Part B Double Blind Period|Sponsor's Decision|2
6966090|NCT01123083|11013969|FG000|Overall Study|Investigator recommendation|1
6966091|NCT01123083|11013970|FG001|Overall Study|Investigator recommendation|1
6966092|NCT01123083|11013969|FG000|Overall Study|Administrative reasons|0
6966093|NCT01123083|11013970|FG001|Overall Study|Administrative reasons|4
6966094|NCT01123083|11013969|FG000|Overall Study|Lost to Follow-up|2
6966095|NCT01123083|11013970|FG001|Overall Study|Lost to Follow-up|6
6966096|NCT01123083|11013969|FG000|Overall Study|Adverse Event|1
6966097|NCT01123083|11013970|FG001|Overall Study|Adverse Event|0
6966098|NCT01123083|11013969|FG000|Overall Study|Withdrew for another reason not covered|0
6966099|NCT01123083|11013970|FG001|Overall Study|Withdrew for another reason not covered|1
6966100|NCT01123083|11013969|FG000|Overall Study|Participant/legal representative request|7
6966101|NCT01123083|11013970|FG001|Overall Study|Participant/legal representative request|3
6966102|NCT01123148|11013976|FG000|Overall Study|Coughing caused unacceptable EEG quality|1
6966103|NCT01123148|11013976|FG000|Overall Study|Didn't meet milestone criteria|1
6966104|NCT01123161|11013982|FG000|Overall Study|Lost to Follow-up|1
6966105|NCT01123161|11013983|FG001|Overall Study|Lost to Follow-up|0
6966106|NCT01123161|11013982|FG000|Overall Study|Withdrawal by Subject|1
6966107|NCT01123161|11013983|FG001|Overall Study|Withdrawal by Subject|0
6966108|NCT01123200|11013992|FG000|Overall Study|Withdrawal by Subject|1
6966109|NCT01123356|11013996|FG000|Overall Study|Adverse Event|2
6966110|NCT01123356|11013996|FG000|Overall Study|Lack of Efficacy|4
6966111|NCT01123356|11013996|FG000|Overall Study|Withdrawal by Subject|1
6966112|NCT01123382|11014003|FG000|Overall Study|Withdrawal by Subject|1
6966113|NCT01123382|11014004|FG001|Overall Study|Withdrawal by Subject|4
6966114|NCT01123382|11014003|FG000|Overall Study|Lost to Follow-up|1
6966115|NCT01123382|11014004|FG001|Overall Study|Lost to Follow-up|2
6966116|NCT01123395|11014010|FG000|Washout Period of 14 Days|Withdrawal by Subject|0
6966117|NCT01123395|11014011|FG001|Washout Period of 14 Days|Withdrawal by Subject|1
6976800|NCT01202188|11029624|FG001|Overall Study|Lost to Follow-up|1
6976801|NCT01202188|11029625|FG002|Overall Study|Lost to Follow-up|0
6976802|NCT01202188|11029626|FG003|Overall Study|Lost to Follow-up|4
6976803|NCT01202188|11029627|FG004|Overall Study|Lost to Follow-up|1
6976804|NCT01202188|11029623|FG000|Overall Study|Death|1
6976805|NCT01202188|11029624|FG001|Overall Study|Death|1
6976806|NCT01202188|11029625|FG002|Overall Study|Death|1
6976807|NCT01202188|11029626|FG003|Overall Study|Death|1
6976808|NCT01202188|11029627|FG004|Overall Study|Death|0
6976809|NCT01202188|11029623|FG000|Overall Study|Abnormal test procedure result (s)|0
6976810|NCT01202188|11029624|FG001|Overall Study|Abnormal test procedure result (s)|0
6976811|NCT01202188|11029625|FG002|Overall Study|Abnormal test procedure result (s)|2
6976812|NCT01202188|11029626|FG003|Overall Study|Abnormal test procedure result (s)|0
6976813|NCT01202188|11029627|FG004|Overall Study|Abnormal test procedure result (s)|0
6976814|NCT01202227|11029645|FG000|Overall Study|Adverse Event|16
6976815|NCT01202227|11029645|FG000|Overall Study|Withdrawal by Subject|2
6976816|NCT01202227|11029645|FG000|Overall Study|Lack of Efficacy|1
6976817|NCT01202279|11029655|FG000|Overall Study|Adverse Event|8
7073322|NCT02041299|11177489|FG000|Overall Study|Withdrawal by Subject|13
6966118|NCT01123642|11014026|FG000|Overall Study|Lost to Follow-up|23
6966119|NCT01123642|11014026|FG000|Overall Study|Withdrawal by Subject|9
6966120|NCT01123642|11014026|FG000|Overall Study|ineligible at baseline assessment|36
6966121|NCT01123655|11014033|FG000|Overall Study|Medication for RA had to be changed|1
6966122|NCT01123655|11014034|FG001|Overall Study|Medication for RA had to be changed|0
6966123|NCT01123655|11014035|FG002|Overall Study|Medication for RA had to be changed|0
7073323|NCT02041299|11177490|FG001|Overall Study|Withdrawal by Subject|7
7073324|NCT02041299|11177489|FG000|Overall Study|Protocol Violation|11
7073325|NCT02041299|11177490|FG001|Overall Study|Protocol Violation|4
7073326|NCT02041299|11177489|FG000|Overall Study|Termination of the study|7
7073327|NCT02041299|11177490|FG001|Overall Study|Termination of the study|3
7073328|NCT02041299|11177489|FG000|Overall Study|Required bone marrow transplant|0
7073329|NCT02041299|11177490|FG001|Overall Study|Required bone marrow transplant|1
7073330|NCT02041299|11177489|FG000|Overall Study|Patient stopped dosing on unknown date|1
7073331|NCT02041299|11177490|FG001|Overall Study|Patient stopped dosing on unknown date|0
7073332|NCT02041429|11177521|FG000|Overall Study|Progressive Disease|2
7073333|NCT02041429|11177522|FG001|Overall Study|Progressive Disease|2
7073334|NCT02041429|11177523|FG002|Overall Study|Progressive Disease|3
7073335|NCT02041429|11177524|FG003|Overall Study|Progressive Disease|2
7073336|NCT02041429|11177521|FG000|Overall Study|Toxicity|0
7073337|NCT02041429|11177522|FG001|Overall Study|Toxicity|1
7073338|NCT02041429|11177523|FG002|Overall Study|Toxicity|4
7073339|NCT02041429|11177524|FG003|Overall Study|Toxicity|2
7073340|NCT02041429|11177521|FG000|Overall Study|Withdrawal by Subject|0
7073341|NCT02041429|11177522|FG001|Overall Study|Withdrawal by Subject|1
7073342|NCT02041429|11177523|FG002|Overall Study|Withdrawal by Subject|0
7073343|NCT02041429|11177524|FG003|Overall Study|Withdrawal by Subject|0
7073344|NCT02041429|11177521|FG000|Overall Study|On Maintenance Therapy|1
7073345|NCT02041429|11177522|FG001|Overall Study|On Maintenance Therapy|0
6838764|NCT00261846|10844386|FG001|Period 2: Part 2 (Efficacy)|Extension study|0
6838765|NCT00261846|10844387|FG002|Period 2: Part 2 (Efficacy)|Extension study|0
6838766|NCT00261846|10844388|FG003|Period 2: Part 2 (Efficacy)|Extension study|61
6838767|NCT00261846|10844389|FG004|Period 2: Part 2 (Efficacy)|Extension study|27
6838768|NCT00261846|10844390|FG005|Period 2: Part 2 (Efficacy)|Extension study|0
6838769|NCT00261846|10844391|FG006|Period 2: Part 2 (Efficacy)|Extension study|4
6838770|NCT00261846|10844392|FG007|Period 2: Part 2 (Efficacy)|Extension study|9
6838771|NCT00261846|10844393|FG008|Period 2: Part 2 (Efficacy)|Extension study|5
6838772|NCT00261846|10844394|FG009|Period 2: Part 2 (Efficacy)|Extension study|9
6838773|NCT00261846|10844395|FG010|Period 2: Part 2 (Efficacy)|Extension study|1
6838774|NCT00261846|10844396|FG011|Period 2: Part 2 (Efficacy)|Extension study|1
6838775|NCT00261950|10844435|FG000|Overall Study|Lost to Follow-up|2
6838776|NCT00261950|10844435|FG000|Overall Study|Death|6
6838777|NCT00261950|10844435|FG000|Overall Study|Withdrawal by Subject|5
6838778|NCT00261950|10844435|FG000|Overall Study|Other|1
6838779|NCT00261950|10844435|FG000|Overall Study|Physician Decision|1
6838780|NCT00261950|10844435|FG000|Overall Study|Protocol specified Criteria|11
6838781|NCT00262002|10844446|FG000|Overall Study|Adverse Event|2
6838782|NCT00262002|10844447|FG001|Overall Study|Adverse Event|1
6838783|NCT00262002|10844448|FG002|Overall Study|Adverse Event|0
6838784|NCT00262002|10844449|FG003|Overall Study|Adverse Event|0
6838785|NCT00262002|10844450|FG004|Overall Study|Adverse Event|0
6838786|NCT00262002|10844451|FG005|Overall Study|Adverse Event|1
6838787|NCT00262002|10844452|FG006|Overall Study|Adverse Event|0
6838788|NCT00262002|10844446|FG000|Overall Study|Withdrawal by Subject|4
6838789|NCT00262002|10844447|FG001|Overall Study|Withdrawal by Subject|2
6838790|NCT00262002|10844448|FG002|Overall Study|Withdrawal by Subject|0
6838791|NCT00262002|10844449|FG003|Overall Study|Withdrawal by Subject|1
6838792|NCT00262002|10844450|FG004|Overall Study|Withdrawal by Subject|2
6838793|NCT00262002|10844451|FG005|Overall Study|Withdrawal by Subject|2
6838794|NCT00262002|10844452|FG006|Overall Study|Withdrawal by Subject|2
6838795|NCT00262002|10844446|FG000|Overall Study|Lost to Follow-up|2
6838796|NCT00262002|10844447|FG001|Overall Study|Lost to Follow-up|0
6838797|NCT00262002|10844448|FG002|Overall Study|Lost to Follow-up|0
6838798|NCT00262002|10844449|FG003|Overall Study|Lost to Follow-up|2
6838799|NCT00262002|10844450|FG004|Overall Study|Lost to Follow-up|0
6838800|NCT00262002|10844451|FG005|Overall Study|Lost to Follow-up|1
6838801|NCT00262002|10844452|FG006|Overall Study|Lost to Follow-up|0
6838802|NCT00262002|10844446|FG000|Overall Study|Inapropriate enrollment|0
6966124|NCT01123655|11014033|FG000|Overall Study|new illness|0
7073346|NCT02041429|11177523|FG002|Overall Study|On Maintenance Therapy|0
7073347|NCT02041429|11177524|FG003|Overall Study|On Maintenance Therapy|2
7073348|NCT02041494|11177541|FG000|Overall Study|Death|1
7073349|NCT02041494|11177542|FG001|Overall Study|Death|3
7073350|NCT02041494|11177541|FG000|Overall Study|Lost to Follow-up|2
7073351|NCT02041494|11177542|FG001|Overall Study|Lost to Follow-up|6
6838803|NCT00262002|10844447|FG001|Overall Study|Inapropriate enrollment|1
6838804|NCT00262002|10844448|FG002|Overall Study|Inapropriate enrollment|0
6838805|NCT00262002|10844449|FG003|Overall Study|Inapropriate enrollment|0
6838806|NCT00262002|10844450|FG004|Overall Study|Inapropriate enrollment|0
6838807|NCT00262002|10844451|FG005|Overall Study|Inapropriate enrollment|0
6838808|NCT00262002|10844452|FG006|Overall Study|Inapropriate enrollment|0
6838809|NCT00262002|10844446|FG000|Overall Study|Protocol Violation|3
6838810|NCT00262002|10844447|FG001|Overall Study|Protocol Violation|2
6966125|NCT01123655|11014034|FG001|Overall Study|new illness|1
6966126|NCT01123655|11014035|FG002|Overall Study|new illness|0
6966127|NCT01123655|11014033|FG000|Overall Study|began prohibitive drug|0
6966128|NCT01123655|11014034|FG001|Overall Study|began prohibitive drug|0
6966129|NCT01123655|11014035|FG002|Overall Study|began prohibitive drug|1
6966130|NCT01123889|11014043|FG000|Overall Study|Lost to Follow-up|3
6966131|NCT01123889|11014044|FG001|Overall Study|Lost to Follow-up|1
6966132|NCT01123941|11014061|FG000|Overall Study|Lost to Follow-up|2
6966133|NCT01123941|11014062|FG001|Overall Study|Lost to Follow-up|1
6966134|NCT01123980|11014070|FG000|Overall Study|Adverse Event|1
6966135|NCT01123980|11014071|FG001|Overall Study|Adverse Event|1
6966136|NCT01123980|11014070|FG000|Overall Study|Lack of Efficacy|1
6966137|NCT01123980|11014071|FG001|Overall Study|Lack of Efficacy|0
6966138|NCT01123980|11014070|FG000|Overall Study|Physician Decision|0
6966139|NCT01123980|11014071|FG001|Overall Study|Physician Decision|1
6966140|NCT01123980|11014070|FG000|Overall Study|Lost to Follow-up|0
6966141|NCT01123980|11014071|FG001|Overall Study|Lost to Follow-up|6
6966142|NCT01123980|11014070|FG000|Overall Study|Protocol Violation|6
7073352|NCT02041494|11177541|FG000|Overall Study|study terminated|16
7073353|NCT02041494|11177542|FG001|Overall Study|study terminated|11
7073354|NCT02041520|11177551|FG000|Overall Study|Adverse Event|2
7073355|NCT02041520|11177552|FG001|Overall Study|Adverse Event|1
7073356|NCT02041520|11177551|FG000|Overall Study|Withdrawal by Subject|3
7073357|NCT02041520|11177552|FG001|Overall Study|Withdrawal by Subject|4
7073358|NCT02041520|11177551|FG000|Overall Study|Protocol Violation|1
7073359|NCT02041520|11177552|FG001|Overall Study|Protocol Violation|0
7073360|NCT02041520|11177551|FG000|Overall Study|Lost to Follow-up|0
7073361|NCT02041520|11177552|FG001|Overall Study|Lost to Follow-up|1
7073362|NCT02041520|11177551|FG000|Overall Study|Hypothiroidism identified during follow-|0
7073363|NCT02041520|11177552|FG001|Overall Study|Hypothiroidism identified during follow-|1
7073364|NCT02041702|11177562|FG000|Overall Study|Lost to Follow-up|1
7073365|NCT02041702|11177563|FG001|Overall Study|Lost to Follow-up|6
7073366|NCT02041702|11177562|FG000|Overall Study|Death|4
7073367|NCT02041702|11177563|FG001|Overall Study|Death|0
7073368|NCT02041702|11177562|FG000|Overall Study|Withdrawal by Subject|4
7073369|NCT02041702|11177563|FG001|Overall Study|Withdrawal by Subject|3
7073370|NCT02041702|11177562|FG000|Overall Study|Patient not confirmed as MRI compatible|1
7073371|NCT02041702|11177563|FG001|Overall Study|Patient not confirmed as MRI compatible|0
7073372|NCT02041702|11177562|FG000|Overall Study|Cardiac Resynchronization Therapy|1
7073373|NCT02041702|11177563|FG001|Overall Study|Cardiac Resynchronization Therapy|0
7073374|NCT02041923|11177571|FG000|Overall Study|Lost to Follow-up|26
7073375|NCT02041923|11177572|FG001|Overall Study|Lost to Follow-up|30
7073376|NCT02041962|11177582|FG000|Overall Study|Lost Aetna Coverage|43
7073377|NCT02041962|11177583|FG001|Overall Study|Lost Aetna Coverage|40
7073378|NCT02041962|11177582|FG000|Overall Study|Death|1
7073379|NCT02041962|11177583|FG001|Overall Study|Death|1
7073380|NCT02041962|11177582|FG000|Overall Study|Lost to Follow-up|37
7073381|NCT02041962|11177583|FG001|Overall Study|Lost to Follow-up|32
7073382|NCT02041962|11177582|FG000|Overall Study|Withdrawal by Subject|0
7073383|NCT02041962|11177583|FG001|Overall Study|Withdrawal by Subject|11
7073384|NCT02042014|11177589|FG000|Overall Study|Adverse Event|1
7073385|NCT02042014|11177589|FG000|Overall Study|Physician Decision|7
7073386|NCT02042183|11177610|FG000|Overall Study|Physician Decision|7
7073387|NCT02042183|11177611|FG001|Overall Study|Physician Decision|2
7073388|NCT02042183|11177610|FG000|Overall Study|Lack of Efficacy|4
6838811|NCT00262002|10844448|FG002|Overall Study|Protocol Violation|0
6838812|NCT00262002|10844449|FG003|Overall Study|Protocol Violation|2
6966143|NCT01123980|11014071|FG001|Overall Study|Protocol Violation|6
6966144|NCT01123980|11014070|FG000|Overall Study|Withdrawal by Subject|5
7073389|NCT02042183|11177611|FG001|Overall Study|Lack of Efficacy|3
7073390|NCT02042183|11177610|FG000|Overall Study|Non-compliance with Study Drug|2
7073391|NCT02042183|11177611|FG001|Overall Study|Non-compliance with Study Drug|3
7073392|NCT02042183|11177610|FG000|Overall Study|Adverse Event|17
7073393|NCT02042183|11177611|FG001|Overall Study|Adverse Event|6
6966145|NCT01123980|11014071|FG001|Overall Study|Withdrawal by Subject|3
7073394|NCT02042183|11177610|FG000|Overall Study|Other|3
7073395|NCT02042183|11177611|FG001|Overall Study|Other|3
7073396|NCT02042183|11177610|FG000|Overall Study|Withdrawal by Subject|21
7073397|NCT02042183|11177611|FG001|Overall Study|Withdrawal by Subject|16
7073398|NCT02042183|11177610|FG000|Overall Study|Site Terminated by Sponsor|2
7073399|NCT02042183|11177611|FG001|Overall Study|Site Terminated by Sponsor|1
7073400|NCT02042183|11177610|FG000|Overall Study|Lost to Follow-up|9
7073401|NCT02042183|11177611|FG001|Overall Study|Lost to Follow-up|2
7073402|NCT02042404|11177623|FG000|Overall Study|Death|1
7073403|NCT02042404|11177624|FG001|Overall Study|Death|0
7073404|NCT02042404|11177623|FG000|Overall Study|Unrelated Adverse Event|3
7073405|NCT02042404|11177624|FG001|Overall Study|Unrelated Adverse Event|0
7073406|NCT02042404|11177623|FG000|Overall Study|Inability to meet time requirements|1
7073407|NCT02042404|11177624|FG001|Overall Study|Inability to meet time requirements|0
7073408|NCT02042443|11177633|FG000|Overall Study|Adverse Event|2
7073409|NCT02042443|11177634|FG001|Overall Study|Adverse Event|1
7073410|NCT02042443|11177633|FG000|Overall Study|Withdrawal by Subject|0
7073411|NCT02042443|11177634|FG001|Overall Study|Withdrawal by Subject|1
6966146|NCT01123980|11014070|FG000|Overall Study|Unclassified|6
6966147|NCT01123980|11014071|FG001|Overall Study|Unclassified|7
6966148|NCT01124006|11014080|FG000|Overall Study|Withdrawal by Subject|2
6966149|NCT01124006|11014081|FG001|Overall Study|Withdrawal by Subject|2
6966150|NCT01124006|11014082|FG002|Overall Study|Withdrawal by Subject|0
7073412|NCT02042443|11177633|FG000|Overall Study|Progression|21
7073413|NCT02042443|11177634|FG001|Overall Study|Progression|17
7073414|NCT02042443|11177633|FG000|Overall Study|not protocol specified|1
6838813|NCT00262002|10844450|FG004|Overall Study|Protocol Violation|5
6838814|NCT00262002|10844451|FG005|Overall Study|Protocol Violation|3
6838815|NCT00262002|10844452|FG006|Overall Study|Protocol Violation|2
6838816|NCT00262002|10844446|FG000|Overall Study|Unable to classify|0
6838817|NCT00262002|10844447|FG001|Overall Study|Unable to classify|0
6838818|NCT00262002|10844448|FG002|Overall Study|Unable to classify|0
6838819|NCT00262002|10844449|FG003|Overall Study|Unable to classify|0
6838820|NCT00262002|10844450|FG004|Overall Study|Unable to classify|0
6838821|NCT00262002|10844451|FG005|Overall Study|Unable to classify|0
6838822|NCT00262002|10844452|FG006|Overall Study|Unable to classify|2
6838823|NCT00262028|10844526|FG000|Overall Study|Withdrawal by Subject|6
6838824|NCT00262028|10844527|FG001|Overall Study|Withdrawal by Subject|3
6838825|NCT00262028|10844528|FG002|Overall Study|Withdrawal by Subject|6
6838826|NCT00262028|10844529|FG003|Overall Study|Withdrawal by Subject|5
6838827|NCT00262028|10844530|FG004|Overall Study|Withdrawal by Subject|2
6838828|NCT00262028|10844531|FG005|Overall Study|Withdrawal by Subject|3
6838829|NCT00262028|10844532|FG006|Overall Study|Withdrawal by Subject|5
6838830|NCT00262028|10844533|FG007|Overall Study|Withdrawal by Subject|7
6838831|NCT00262028|10844534|FG008|Overall Study|Withdrawal by Subject|2
6838832|NCT00262028|10844526|FG000|Overall Study|Lost to Follow-up|7
7073415|NCT02042443|11177634|FG001|Overall Study|not protocol specified|1
7073416|NCT02042443|11177633|FG000|Overall Study|Not eligible/not analyzable|3
7073417|NCT02042443|11177634|FG001|Overall Study|Not eligible/not analyzable|6
6838833|NCT00262028|10844527|FG001|Overall Study|Lost to Follow-up|7
6838834|NCT00262028|10844528|FG002|Overall Study|Lost to Follow-up|5
6838835|NCT00262028|10844529|FG003|Overall Study|Lost to Follow-up|5
6838836|NCT00262028|10844530|FG004|Overall Study|Lost to Follow-up|4
6838837|NCT00262028|10844531|FG005|Overall Study|Lost to Follow-up|3
6838838|NCT00262028|10844532|FG006|Overall Study|Lost to Follow-up|3
6838839|NCT00262028|10844533|FG007|Overall Study|Lost to Follow-up|5
6838840|NCT00262028|10844534|FG008|Overall Study|Lost to Follow-up|6
6838841|NCT00262028|10844526|FG000|Overall Study|Administrative Reason|11
6838842|NCT00262028|10844527|FG001|Overall Study|Administrative Reason|14
6838843|NCT00262028|10844528|FG002|Overall Study|Administrative Reason|9
6838844|NCT00262028|10844529|FG003|Overall Study|Administrative Reason|12
6838845|NCT00262028|10844530|FG004|Overall Study|Administrative Reason|6
6838846|NCT00262028|10844531|FG005|Overall Study|Administrative Reason|7
6838847|NCT00262028|10844532|FG006|Overall Study|Administrative Reason|4
6838848|NCT00262028|10844533|FG007|Overall Study|Administrative Reason|6
6838849|NCT00262028|10844534|FG008|Overall Study|Administrative Reason|10
6838850|NCT00262028|10844526|FG000|Overall Study|Protocol Violation|0
6838851|NCT00262028|10844527|FG001|Overall Study|Protocol Violation|0
6838852|NCT00262028|10844528|FG002|Overall Study|Protocol Violation|0
6838853|NCT00262028|10844529|FG003|Overall Study|Protocol Violation|1
6838854|NCT00262028|10844530|FG004|Overall Study|Protocol Violation|0
6838855|NCT00262028|10844531|FG005|Overall Study|Protocol Violation|0
6838856|NCT00262028|10844532|FG006|Overall Study|Protocol Violation|0
6838857|NCT00262028|10844533|FG007|Overall Study|Protocol Violation|0
6838858|NCT00262028|10844534|FG008|Overall Study|Protocol Violation|0
6838859|NCT00262028|10844526|FG000|Overall Study|Unable to classify|0
6838860|NCT00262028|10844527|FG001|Overall Study|Unable to classify|3
6838861|NCT00262028|10844528|FG002|Overall Study|Unable to classify|0
6838862|NCT00262028|10844529|FG003|Overall Study|Unable to classify|0
6838863|NCT00262028|10844530|FG004|Overall Study|Unable to classify|0
6838864|NCT00262028|10844531|FG005|Overall Study|Unable to classify|0
6838865|NCT00262028|10844532|FG006|Overall Study|Unable to classify|0
6838866|NCT00262028|10844533|FG007|Overall Study|Unable to classify|0
6838867|NCT00262028|10844534|FG008|Overall Study|Unable to classify|1
6838868|NCT00262041|10844580|FG000|Overall Study|Withdrawal by Subject|0
6838869|NCT00262041|10844581|FG001|Overall Study|Withdrawal by Subject|3
6838870|NCT00262041|10844582|FG002|Overall Study|Withdrawal by Subject|1
6838871|NCT00262041|10844580|FG000|Overall Study|Lost to Follow-up|1
6838872|NCT00262041|10844581|FG001|Overall Study|Lost to Follow-up|1
7073418|NCT02043015|11177663|FG000|Overall Study|Lost to Follow-up|4
7073419|NCT02043015|11177663|FG000|Overall Study|Withdrawal by Subject|4
7073420|NCT02043015|11177663|FG000|Overall Study|Removed once target enrollment reached|15
6838873|NCT00262041|10844582|FG002|Overall Study|Lost to Follow-up|5
6838874|NCT00262041|10844580|FG000|Overall Study|Unable to classify|1
6838875|NCT00262041|10844581|FG001|Overall Study|Unable to classify|0
6838876|NCT00262041|10844582|FG002|Overall Study|Unable to classify|0
7073421|NCT02043015|11177663|FG000|Overall Study|Participant moved away from study city|4
7073422|NCT02043015|11177663|FG000|Overall Study|Incarceration|1
6838877|NCT00262067|10844600|FG000|Overall Study|Death|190
6838878|NCT00262067|10844601|FG001|Overall Study|Death|89
7073423|NCT02043132|11177671|FG000|Overall Study|Lost to Follow-up|1
6838879|NCT00262067|10844602|FG002|Overall Study|Death|186
6838880|NCT00262067|10844603|FG003|Overall Study|Death|99
6838881|NCT00262067|10844600|FG000|Overall Study|Lost to Follow-up|5
7073424|NCT02043132|11177672|FG001|Overall Study|Lost to Follow-up|1
7073425|NCT02043132|11177671|FG000|Overall Study|screen failures|4
6966151|NCT01124006|11014080|FG000|Overall Study|Lost to Follow-up|1
6966152|NCT01124006|11014081|FG001|Overall Study|Lost to Follow-up|0
6966153|NCT01124006|11014082|FG002|Overall Study|Lost to Follow-up|1
6966154|NCT01124006|11014080|FG000|Overall Study|Other|0
6966155|NCT01124006|11014081|FG001|Overall Study|Other|0
7073426|NCT02043132|11177672|FG001|Overall Study|screen failures|8
7073427|NCT02043301|11177700|FG000|Overall Study|Discontinued|0
7073428|NCT02043301|11177701|FG001|Overall Study|Discontinued|1
7073429|NCT02043301|11177702|FG002|Overall Study|Discontinued|0
7073430|NCT02043366|11177716|FG000|Overall Study|Lost to Follow-up|2
7073431|NCT02043366|11177717|FG001|Overall Study|Lost to Follow-up|2
7073432|NCT02043366|11177718|FG002|Overall Study|Lost to Follow-up|2
7073433|NCT02043366|11177719|FG003|Overall Study|Lost to Follow-up|2
7073434|NCT02043366|11177720|FG004|Overall Study|Lost to Follow-up|2
7073435|NCT02043366|11177721|FG005|Overall Study|Lost to Follow-up|2
7073436|NCT02043509|11177748|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61
7073437|NCT02043509|11177749|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47
7073438|NCT02043509|11177748|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4
7073439|NCT02043509|11177749|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0
7073440|NCT02043509|11177748|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67
7073441|NCT02043509|11177749|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67
7073442|NCT02043509|11177748|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7
7073443|NCT02043509|11177749|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5
7073444|NCT02043548|11177757|FG000|Overall Study|Lack of Efficacy|1
7073445|NCT02043548|11177758|FG001|Overall Study|Lack of Efficacy|0
7073446|NCT02043548|11177757|FG000|Overall Study|Adverse Event|0
7073447|NCT02043548|11177758|FG001|Overall Study|Adverse Event|1
7073448|NCT02043782|11177787|FG000|Period 1|Adverse Event|0
7073449|NCT02043782|11177788|FG001|Period 1|Adverse Event|0
7073450|NCT02043782|11177789|FG002|Period 1|Adverse Event|1
7073451|NCT02043782|11177790|FG003|Period 1|Adverse Event|0
7073452|NCT02043782|11177791|FG004|Period 1|Adverse Event|0
7073453|NCT02043782|11177792|FG005|Period 1|Adverse Event|0
7073454|NCT02043899|11177809|FG000|Overall Study|Adverse Event|3
7073455|NCT02043899|11177809|FG000|Overall Study|Physician Decision|1
7073456|NCT02043899|11177809|FG000|Overall Study|Withdrawal by Subject|2
7073457|NCT02043899|11177809|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5
7073458|NCT02043899|11177809|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12
7073459|NCT02043899|11177809|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2
7073460|NCT02043899|11177809|FG000|Overall Study|Clinical progression necessitating urgent treatment|1
7073461|NCT02043899|11177809|FG000|Overall Study|Treatment delayed|1
7073462|NCT02043938|11177813|FG000|Overall Study|Withdrawal by Subject|7
6838882|NCT00262067|10844601|FG001|Overall Study|Lost to Follow-up|4
6838883|NCT00262067|10844602|FG002|Overall Study|Lost to Follow-up|7
6838884|NCT00262067|10844603|FG003|Overall Study|Lost to Follow-up|5
6838885|NCT00262067|10844600|FG000|Overall Study|Sponsor's Decision to Terminate Study|1
6838886|NCT00262067|10844601|FG001|Overall Study|Sponsor's Decision to Terminate Study|0
6838887|NCT00262067|10844602|FG002|Overall Study|Sponsor's Decision to Terminate Study|0
6838888|NCT00262067|10844603|FG003|Overall Study|Sponsor's Decision to Terminate Study|0
6838889|NCT00262067|10844600|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23
6838890|NCT00262067|10844601|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7
6838891|NCT00262067|10844602|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23
7073463|NCT02043938|11177813|FG000|Overall Study|Unable to place EEG sensors on patient|1
6838892|NCT00262067|10844603|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9
6838893|NCT00262080|10844616|FG000|Double Blind Treatment Period|Lost to Follow-up|1
6838894|NCT00262080|10844617|FG001|Double Blind Treatment Period|Lost to Follow-up|0
7073464|NCT02043938|11177813|FG000|Overall Study|No show by subject|1
7073465|NCT02043938|11177813|FG000|Overall Study|Investigator decision|1
7073466|NCT02044094|11177820|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3
7073467|NCT02044094|11177820|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3
7073468|NCT02044094|11177820|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3
7073469|NCT02044094|11177820|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4
7073470|NCT02044094|11177820|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5
7073471|NCT02044094|11177820|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2
7073472|NCT02044094|11177820|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1
7073473|NCT02044094|11177820|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1
7073474|NCT02044159|11177837|FG000|Overall Study|Consent declined (deferred consent)|2
7073475|NCT02044159|11177838|FG001|Overall Study|Consent declined (deferred consent)|4
7073476|NCT02044159|11177837|FG000|Overall Study|No longer eligible, drug not given|1
7073477|NCT02044159|11177838|FG001|Overall Study|No longer eligible, drug not given|0
7073478|NCT02044159|11177837|FG000|Overall Study|Nurse declined to give study drug|1
7073479|NCT02044159|11177838|FG001|Overall Study|Nurse declined to give study drug|0
7073480|NCT02044458|11177896|FG000|Overall Study|Protocol Violation|3
6838895|NCT00262080|10844618|FG002|Double Blind Treatment Period|Lost to Follow-up|0
6966156|NCT01124006|11014082|FG002|Overall Study|Other|1
7073481|NCT02044458|11177897|FG001|Overall Study|Protocol Violation|8
7073482|NCT02044510|11177905|FG000|Overall Study|Adverse Event|1
7073483|NCT02044510|11177906|FG001|Overall Study|Adverse Event|2
6966157|NCT01124045|11014092|FG000|Overall Study|Lost to Follow-up|0
6966158|NCT01124045|11014093|FG001|Overall Study|Lost to Follow-up|1
6966159|NCT01124045|11014092|FG000|Overall Study|Physician Decision|0
6966160|NCT01124045|11014093|FG001|Overall Study|Physician Decision|2
6966161|NCT01124097|11014103|FG000|Overall Study|Withdrawal by Subject|4
6966162|NCT01124097|11014104|FG001|Overall Study|Withdrawal by Subject|3
6966163|NCT01124097|11014105|FG002|Overall Study|Withdrawal by Subject|2
6966164|NCT01124097|11014106|FG003|Overall Study|Withdrawal by Subject|3
6966165|NCT01124097|11014103|FG000|Overall Study|Lack of Efficacy|2
6966166|NCT01124097|11014104|FG001|Overall Study|Lack of Efficacy|3
6966167|NCT01124097|11014105|FG002|Overall Study|Lack of Efficacy|1
6966168|NCT01124097|11014106|FG003|Overall Study|Lack of Efficacy|3
6966169|NCT01124097|11014103|FG000|Overall Study|Adverse Event|24
6966170|NCT01124097|11014104|FG001|Overall Study|Adverse Event|15
6966171|NCT01124097|11014105|FG002|Overall Study|Adverse Event|15
6966172|NCT01124097|11014106|FG003|Overall Study|Adverse Event|7
6966173|NCT01124097|11014103|FG000|Overall Study|Protocol Violation|2
6966174|NCT01124097|11014104|FG001|Overall Study|Protocol Violation|0
6966175|NCT01124097|11014105|FG002|Overall Study|Protocol Violation|2
7073484|NCT02044874|11177944|FG000|Overall Study|Adverse Event|5
7073485|NCT02044874|11177945|FG001|Overall Study|Adverse Event|6
7073486|NCT02044874|11177946|FG002|Overall Study|Adverse Event|6
7073487|NCT02044874|11177944|FG000|Overall Study|Withdrawal by Subject|8
7073488|NCT02044874|11177945|FG001|Overall Study|Withdrawal by Subject|16
7073489|NCT02044874|11177946|FG002|Overall Study|Withdrawal by Subject|23
7073490|NCT02044874|11177944|FG000|Overall Study|Physician Decision|0
7073491|NCT02044874|11177945|FG001|Overall Study|Physician Decision|2
7073492|NCT02044874|11177946|FG002|Overall Study|Physician Decision|1
7073493|NCT02044874|11177944|FG000|Overall Study|Lost to Follow-up|10
7073494|NCT02044874|11177945|FG001|Overall Study|Lost to Follow-up|27
7073495|NCT02044874|11177946|FG002|Overall Study|Lost to Follow-up|21
7073496|NCT02044874|11177944|FG000|Overall Study|Sponsor Decision|0
7073497|NCT02044874|11177945|FG001|Overall Study|Sponsor Decision|1
7073498|NCT02044874|11177946|FG002|Overall Study|Sponsor Decision|1
7073499|NCT02044874|11177944|FG000|Overall Study|Other|7
7073500|NCT02044874|11177945|FG001|Overall Study|Other|3
7073501|NCT02044874|11177946|FG002|Overall Study|Other|8
7073502|NCT02045095|11177965|FG000|Overall Study|Other|0
7073503|NCT02045095|11177966|FG001|Overall Study|Other|0
7073504|NCT02045095|11177967|FG002|Overall Study|Other|1
7073505|NCT02045095|11177968|FG003|Overall Study|Other|0
7073506|NCT02045095|11177969|FG004|Overall Study|Other|0
6838896|NCT00262080|10844616|FG000|Repeat Dose Treatment Period|Adverse Event|1
6838897|NCT00262080|10844617|FG001|Repeat Dose Treatment Period|Adverse Event|0
6838898|NCT00262080|10844618|FG002|Repeat Dose Treatment Period|Adverse Event|0
6838899|NCT00262080|10844616|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0
6838900|NCT00262080|10844617|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1
6838901|NCT00262080|10844618|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1
6838902|NCT00262080|10844616|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2
6838903|NCT00262080|10844617|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0
6838904|NCT00262080|10844618|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2
6838905|NCT00262080|10844616|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0
6838906|NCT00262080|10844617|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0
6838907|NCT00262080|10844618|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2
6838908|NCT00262080|10844616|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1
6838909|NCT00262080|10844617|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0
6838910|NCT00262080|10844618|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0
6838911|NCT00262119|10844629|FG000|Overall Study|Lost to Follow-up|38
6838912|NCT00262119|10844630|FG001|Overall Study|Lost to Follow-up|51
6838913|NCT00262119|10844631|FG002|Overall Study|Lost to Follow-up|42
6838914|NCT00262119|10844629|FG000|Overall Study|Death|20
6838915|NCT00262119|10844630|FG001|Overall Study|Death|19
6838916|NCT00262119|10844631|FG002|Overall Study|Death|16
6838917|NCT00262223|10844641|FG000|Treatment Phase|Withdrawal by Subject|3
6838918|NCT00262223|10844642|FG001|Treatment Phase|Withdrawal by Subject|6
6838919|NCT00262223|10844641|FG000|Treatment Phase|Adverse Event|1
6838920|NCT00262223|10844642|FG001|Treatment Phase|Adverse Event|2
6838921|NCT00262223|10844641|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4
6838922|NCT00262223|10844642|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4
6838923|NCT00262223|10844641|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6
6838924|NCT00262223|10844642|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1
6966176|NCT01124097|11014106|FG003|Overall Study|Protocol Violation|1
7073507|NCT02045095|11177970|FG005|Overall Study|Other|2
6966177|NCT01124097|11014103|FG000|Overall Study|Physician Decision|2
6838925|NCT00262223|10844641|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7
6838926|NCT00262223|10844642|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7
6838927|NCT00262301|10844652|FG000|Double-blind Phase|Lost to Follow-up|1
6838928|NCT00262301|10844653|FG001|Double-blind Phase|Lost to Follow-up|0
6966178|NCT01124097|11014104|FG001|Overall Study|Physician Decision|1
7073508|NCT02045095|11177971|FG006|Overall Study|Other|0
6966179|NCT01124097|11014105|FG002|Overall Study|Physician Decision|0
7073509|NCT02045095|11177965|FG000|Overall Study|Progressive Disease|3
7073510|NCT02045095|11177966|FG001|Overall Study|Progressive Disease|3
7073511|NCT02045095|11177967|FG002|Overall Study|Progressive Disease|2
6966180|NCT01124097|11014106|FG003|Overall Study|Physician Decision|0
6966181|NCT01124149|11014116|FG000|Acute Phase|Withdrawal by Subject|22
6966182|NCT01124149|11014116|FG000|Acute Phase|Adverse Event|21
6966183|NCT01124149|11014116|FG000|Acute Phase|Lack of Efficacy|17
6966184|NCT01124149|11014116|FG000|Acute Phase|Protocol Violation|14
6966185|NCT01124149|11014116|FG000|Acute Phase|Lost to Follow-up|2
6966186|NCT01124149|11014116|FG000|Acute Phase|Prolonged antibiotic therapy|1
6966187|NCT01124149|11014116|FG000|Acute Phase|Sponsor request|1
6966188|NCT01124149|11014116|FG000|Acute Phase|UC symptoms not ameliorated|1
6966189|NCT01124149|11014116|FG000|Acute Phase|Non-compliance|1
6966190|NCT01124149|11014116|FG000|Acute Phase|Low hemoglobin|1
6966191|NCT01124149|11014116|FG000|Acute Phase|Travelling to another country|1
6966192|NCT01124149|11014116|FG000|Acute Phase|Sponsor decision|1
6966193|NCT01124149|11014116|FG000|Maintenance Phase|Lack of Efficacy|40
6966194|NCT01124149|11014116|FG000|Maintenance Phase|Adverse Event|24
6966195|NCT01124149|11014116|FG000|Maintenance Phase|Lost to Follow-up|15
6966196|NCT01124149|11014116|FG000|Maintenance Phase|Withdrawal by Subject|10
6966197|NCT01124149|11014116|FG000|Maintenance Phase|Protocol Violation|5
6966198|NCT01124149|11014116|FG000|Maintenance Phase|Coordinator error|1
6966199|NCT01124149|11014116|FG000|Maintenance Phase|Non-compliance|1
6966200|NCT01124162|11014125|FG000|First Intervention|Adverse Event|2
6966201|NCT01124162|11014126|FG001|First Intervention|Adverse Event|0
6966202|NCT01124162|11014125|FG000|Washout of 7 Days|Withdrawal by Subject|1
6966203|NCT01124162|11014126|FG001|Washout of 7 Days|Withdrawal by Subject|0
6966204|NCT01124175|11014134|FG000|Washout of 7 Days|Withdrawal by Subject|0
6966205|NCT01124175|11014135|FG001|Washout of 7 Days|Withdrawal by Subject|2
6966206|NCT01124292|11014153|FG000|Overall Study|Lost to Follow-up|2
6966207|NCT01124292|11014154|FG001|Overall Study|Lost to Follow-up|4
6966208|NCT01124292|11014155|FG002|Overall Study|Lost to Follow-up|3
6966209|NCT01124292|11014153|FG000|Overall Study|Physician Decision|0
6966210|NCT01124292|11014154|FG001|Overall Study|Physician Decision|3
6966211|NCT01124292|11014155|FG002|Overall Study|Physician Decision|2
6966212|NCT01124292|11014153|FG000|Overall Study|Withdrawal by Subject|0
6966213|NCT01124292|11014154|FG001|Overall Study|Withdrawal by Subject|6
6966214|NCT01124292|11014155|FG002|Overall Study|Withdrawal by Subject|2
6966215|NCT01124292|11014153|FG000|Overall Study|medical issue unrelated to the study|0
6966216|NCT01124292|11014154|FG001|Overall Study|medical issue unrelated to the study|0
6966217|NCT01124292|11014155|FG002|Overall Study|medical issue unrelated to the study|2
6966218|NCT01124292|11014153|FG000|Overall Study|piercing track closed|0
6966219|NCT01124292|11014154|FG001|Overall Study|piercing track closed|2
6966220|NCT01124292|11014155|FG002|Overall Study|piercing track closed|1
6966221|NCT01124422|11014181|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5
6966222|NCT01124422|11014182|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
6966223|NCT01124422|11014183|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
6966224|NCT01124422|11014181|FG000|4-Week Open-label Run-in Phase|Adverse Event|7
6966225|NCT01124422|11014182|FG001|4-Week Open-label Run-in Phase|Adverse Event|0
6966226|NCT01124422|11014183|FG002|4-Week Open-label Run-in Phase|Adverse Event|0
6966227|NCT01124422|11014181|FG000|4-Week Open-label Run-in Phase|Physician Decision|4
6966228|NCT01124422|11014182|FG001|4-Week Open-label Run-in Phase|Physician Decision|0
6966229|NCT01124422|11014183|FG002|4-Week Open-label Run-in Phase|Physician Decision|0
6966230|NCT01124422|11014181|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1
6966231|NCT01124422|11014182|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0
6966232|NCT01124422|11014183|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0
6966233|NCT01124422|11014181|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61
6966234|NCT01124422|11014182|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
6966235|NCT01124422|11014183|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
6966236|NCT01124422|11014181|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5
6966237|NCT01124422|11014182|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0
6966238|NCT01124422|11014183|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0
6966239|NCT01124422|11014181|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
6966240|NCT01124422|11014182|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
6966241|NCT01124422|11014183|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3
6966242|NCT01124422|11014181|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0
6966243|NCT01124422|11014182|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6
6966244|NCT01124422|11014183|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3
6966245|NCT01124422|11014181|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0
6966246|NCT01124422|11014182|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5
6966247|NCT01124422|11014183|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2
6966248|NCT01124422|11014181|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
6966249|NCT01124422|11014182|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
6966250|NCT01124422|11014183|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1
6966251|NCT01124448|11014192|FG000|Overall Study|Lost to Follow-up|0
6966252|NCT01124448|11014193|FG001|Overall Study|Lost to Follow-up|3
6966253|NCT01124448|11014192|FG000|Overall Study|Protocol Violation|2
6966254|NCT01124448|11014193|FG001|Overall Study|Protocol Violation|0
6966255|NCT01124604|11014201|FG000|Overall Study|Adverse Event|10
6966256|NCT01124604|11014202|FG001|Overall Study|Adverse Event|1
6966257|NCT01124604|11014201|FG000|Overall Study|Lack of Efficacy|1
6966258|NCT01124604|11014202|FG001|Overall Study|Lack of Efficacy|0
6966259|NCT01124604|11014201|FG000|Overall Study|Withdrawal by Subject|4
6966260|NCT01124604|11014202|FG001|Overall Study|Withdrawal by Subject|0
6966261|NCT01124604|11014201|FG000|Overall Study|Disease Progression|0
6966262|NCT01124604|11014202|FG001|Overall Study|Disease Progression|1
6966263|NCT01124617|11014210|FG000|Overall Study|Adverse Event|5
6966264|NCT01124617|11014211|FG001|Overall Study|Adverse Event|2
6966265|NCT01124617|11014210|FG000|Overall Study|Lack of Efficacy|2
6966266|NCT01124617|11014211|FG001|Overall Study|Lack of Efficacy|1
6966267|NCT01124617|11014210|FG000|Overall Study|Protocol Violation|1
6966268|NCT01124617|11014211|FG001|Overall Study|Protocol Violation|1
6966269|NCT01124617|11014210|FG000|Overall Study|Withdrawal by Subject|9
6966270|NCT01124617|11014211|FG001|Overall Study|Withdrawal by Subject|1
6966271|NCT01124617|11014210|FG000|Overall Study|Other|2
6966272|NCT01124617|11014211|FG001|Overall Study|Other|1
6966273|NCT01124643|11014217|FG000|Overall Study|Death|1
6966274|NCT01124734|11014221|FG000|Overall Study|Disease progression|13
6966275|NCT01124734|11014221|FG000|Overall Study|Adverse Event|1
6966276|NCT01124734|11014221|FG000|Overall Study|Withdrawal by Subject|1
6966277|NCT01124734|11014221|FG000|Overall Study|Elected for alternative treatment|2
6966278|NCT01124838|11014241|FG000|Overall Study|Miscellaneous|4
6966279|NCT01124838|11014242|FG001|Overall Study|Miscellaneous|2
6966280|NCT01124838|11014241|FG000|Overall Study|Adverse Event|7
6966281|NCT01124838|11014242|FG001|Overall Study|Adverse Event|11
6966282|NCT01124838|11014241|FG000|Overall Study|Lack of Efficacy|2
6966283|NCT01124838|11014242|FG001|Overall Study|Lack of Efficacy|0
6966284|NCT01124838|11014241|FG000|Overall Study|Withdrawal by Subject|3
6966285|NCT01124838|11014242|FG001|Overall Study|Withdrawal by Subject|2
6966286|NCT01124838|11014241|FG000|Overall Study|Lost to Follow-up|2
6966287|NCT01124838|11014242|FG001|Overall Study|Lost to Follow-up|0
6966288|NCT01124864|11014256|FG000|Overall Study|Follow up phase competed as per protocol|18
6966289|NCT01124864|11014257|FG001|Overall Study|Follow up phase competed as per protocol|22
6966290|NCT01124864|11014258|FG002|Overall Study|Follow up phase competed as per protocol|24
6966291|NCT01124864|11014259|FG003|Overall Study|Follow up phase competed as per protocol|18
6966292|NCT01124864|11014260|FG004|Overall Study|Follow up phase competed as per protocol|26
6966293|NCT01124864|11014261|FG005|Overall Study|Follow up phase competed as per protocol|2
6966294|NCT01124864|11014256|FG000|Overall Study|Death|6
6966295|NCT01124864|11014257|FG001|Overall Study|Death|9
6966296|NCT01124864|11014258|FG002|Overall Study|Death|6
6966297|NCT01124864|11014259|FG003|Overall Study|Death|2
6966298|NCT01124864|11014260|FG004|Overall Study|Death|1
6966299|NCT01124864|11014261|FG005|Overall Study|Death|0
6966300|NCT01124864|11014256|FG000|Overall Study|Withdrawal by Subject|2
6966301|NCT01124864|11014257|FG001|Overall Study|Withdrawal by Subject|3
6966302|NCT01124864|11014258|FG002|Overall Study|Withdrawal by Subject|4
6966303|NCT01124864|11014259|FG003|Overall Study|Withdrawal by Subject|0
6966304|NCT01124864|11014260|FG004|Overall Study|Withdrawal by Subject|2
6966305|NCT01124864|11014261|FG005|Overall Study|Withdrawal by Subject|1
6966306|NCT01124864|11014256|FG000|Overall Study|Lost to Follow-up|1
6966307|NCT01124864|11014257|FG001|Overall Study|Lost to Follow-up|1
6966308|NCT01124864|11014258|FG002|Overall Study|Lost to Follow-up|0
6966309|NCT01124864|11014259|FG003|Overall Study|Lost to Follow-up|1
6966310|NCT01124864|11014260|FG004|Overall Study|Lost to Follow-up|0
6966311|NCT01124864|11014261|FG005|Overall Study|Lost to Follow-up|0
6966312|NCT01124864|11014256|FG000|Overall Study|Protocol Violation|1
6966313|NCT01124864|11014257|FG001|Overall Study|Protocol Violation|0
6966314|NCT01124864|11014258|FG002|Overall Study|Protocol Violation|0
7073512|NCT02045095|11177968|FG003|Overall Study|Progressive Disease|4
7073513|NCT02045095|11177969|FG004|Overall Study|Progressive Disease|2
7073514|NCT02045095|11177970|FG005|Overall Study|Progressive Disease|4
7073515|NCT02045095|11177971|FG006|Overall Study|Progressive Disease|1
7073516|NCT02045095|11177965|FG000|Overall Study|Withdrawal by Subject|0
7073517|NCT02045095|11177966|FG001|Overall Study|Withdrawal by Subject|0
7073518|NCT02045095|11177967|FG002|Overall Study|Withdrawal by Subject|0
7073519|NCT02045095|11177968|FG003|Overall Study|Withdrawal by Subject|0
7073520|NCT02045095|11177969|FG004|Overall Study|Withdrawal by Subject|3
7073521|NCT02045095|11177970|FG005|Overall Study|Withdrawal by Subject|0
7073522|NCT02045095|11177971|FG006|Overall Study|Withdrawal by Subject|0
7073523|NCT02045095|11177965|FG000|Overall Study|Adverse Event|0
7073524|NCT02045095|11177966|FG001|Overall Study|Adverse Event|1
7073525|NCT02045095|11177967|FG002|Overall Study|Adverse Event|1
7073526|NCT02045095|11177968|FG003|Overall Study|Adverse Event|0
7073527|NCT02045095|11177969|FG004|Overall Study|Adverse Event|0
7073528|NCT02045095|11177970|FG005|Overall Study|Adverse Event|2
7073529|NCT02045095|11177971|FG006|Overall Study|Adverse Event|0
7073530|NCT02045212|11178006|FG000|Overall Study|Adverse Event|0
6966315|NCT01124864|11014259|FG003|Overall Study|Protocol Violation|0
6966316|NCT01124864|11014260|FG004|Overall Study|Protocol Violation|1
6966317|NCT01124864|11014261|FG005|Overall Study|Protocol Violation|0
6966318|NCT01124916|11014279|FG000|Overall Study|Lost to Follow-up|3
6966319|NCT01124916|11014280|FG001|Overall Study|Lost to Follow-up|2
6966320|NCT01125046|11014295|FG000|First 6 Months of Treatment|Death|1
6966321|NCT01125046|11014295|FG000|First 6 Months of Treatment|Withdrawal by Subject|2
6966322|NCT01125046|11014295|FG000|First 6 Months of Treatment|Non-compliance|1
6966323|NCT01125046|11014295|FG000|First 6 Months of Treatment|Surgery|1
6966324|NCT01125046|11014295|FG000|First 6 Months of Treatment|Progressive Disease|7
6966325|NCT01125046|11014295|FG000|First 6 Months of Treatment|Adverse Event|2
6966326|NCT01125046|11014295|FG000|Continued Treatment After 6 Months|Progressive Disease|2
7073531|NCT02045212|11178007|FG001|Overall Study|Adverse Event|1
7073532|NCT02045212|11178006|FG000|Overall Study|Withdrawal by Subject|1
7073533|NCT02045212|11178007|FG001|Overall Study|Withdrawal by Subject|0
7073534|NCT02045212|11178006|FG000|Overall Study|Finished 13 weeks, chose not to extend|1
7073535|NCT02045212|11178007|FG001|Overall Study|Finished 13 weeks, chose not to extend|0
7073536|NCT02045433|11178047|FG000|Overall Study|Withdrawal by Subject|1
7073537|NCT02045732|11178062|FG000|Overall Study|At the discretion of the investigator|1
7073538|NCT02045732|11178063|FG001|Overall Study|At the discretion of the investigator|1
7073539|NCT02045836|11178071|FG000|Overall Study|Adverse Event|4
7073540|NCT02045836|11178072|FG001|Overall Study|Adverse Event|4
7073541|NCT02045836|11178071|FG000|Overall Study|Withdrawal by Subject|1
7073542|NCT02045836|11178072|FG001|Overall Study|Withdrawal by Subject|1
7073543|NCT02045836|11178071|FG000|Overall Study|Lost to Follow-up|4
7073544|NCT02045836|11178072|FG001|Overall Study|Lost to Follow-up|7
7073545|NCT02045836|11178071|FG000|Overall Study|Migrated from study area|0
7073546|NCT02045836|11178072|FG001|Overall Study|Migrated from study area|2
7073547|NCT02045862|11178082|FG000|Overall Study|Death|0
7073548|NCT02045862|11178083|FG001|Overall Study|Death|0
7073549|NCT02045862|11178084|FG002|Overall Study|Death|1
7073550|NCT02045862|11178082|FG000|Overall Study|Miscellaneous|5
7073551|NCT02045862|11178083|FG001|Overall Study|Miscellaneous|0
7073552|NCT02045862|11178084|FG002|Overall Study|Miscellaneous|8
7073553|NCT02045862|11178082|FG000|Overall Study|Withdrawal by Patient|18
7073554|NCT02045862|11178083|FG001|Overall Study|Withdrawal by Patient|27
7073555|NCT02045862|11178084|FG002|Overall Study|Withdrawal by Patient|57
7073556|NCT02045862|11178082|FG000|Overall Study|Protocol Violation|0
7073557|NCT02045862|11178083|FG001|Overall Study|Protocol Violation|0
7073558|NCT02045862|11178084|FG002|Overall Study|Protocol Violation|6
7073559|NCT02045862|11178082|FG000|Overall Study|Lack of Efficacy|8
7073560|NCT02045862|11178083|FG001|Overall Study|Lack of Efficacy|4
6838929|NCT00262301|10844654|FG002|Double-blind Phase|Lost to Follow-up|0
6838930|NCT00262301|10844652|FG000|Double-blind Phase|"worsening of HAE symptoms"|0
7073561|NCT02045862|11178084|FG002|Overall Study|Lack of Efficacy|13
7073562|NCT02045862|11178082|FG000|Overall Study|Randomized but not Received Study Drug|0
7073563|NCT02045862|11178083|FG001|Overall Study|Randomized but not Received Study Drug|2
7073564|NCT02045862|11178084|FG002|Overall Study|Randomized but not Received Study Drug|8
7073565|NCT02045862|11178082|FG000|Overall Study|Adverse Event|7
7073566|NCT02045862|11178083|FG001|Overall Study|Adverse Event|5
7073567|NCT02045862|11178084|FG002|Overall Study|Adverse Event|27
7073568|NCT02045862|11178082|FG000|Overall Study|Lost to Follow-up|1
7073569|NCT02045862|11178083|FG001|Overall Study|Lost to Follow-up|2
6838931|NCT00262301|10844653|FG001|Double-blind Phase|"worsening of HAE symptoms"|1
6838932|NCT00262301|10844654|FG002|Double-blind Phase|"worsening of HAE symptoms"|0
6838933|NCT00262314|10844662|FG000|Overall Study|Changing physicians|38
6838934|NCT00262314|10844662|FG000|Overall Study|Death|12
6838935|NCT00262314|10844662|FG000|Overall Study|Patient's decision|92
6838936|NCT00262314|10844662|FG000|Overall Study|Other|95
6838937|NCT00262314|10844662|FG000|Overall Study|Lost to Follow-up|70
6838938|NCT00262314|10844662|FG000|Overall Study|Administrative withdrawal|30
6838939|NCT00262522|10844679|FG000|Study Start Through 8 Weeks|Adverse Event|1
6838940|NCT00262522|10844680|FG001|Study Start Through 8 Weeks|Adverse Event|2
6838941|NCT00262522|10844681|FG002|Study Start Through 8 Weeks|Adverse Event|3
6838942|NCT00262522|10844682|FG003|Study Start Through 8 Weeks|Adverse Event|1
6838943|NCT00262522|10844679|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1
6838944|NCT00262522|10844680|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1
6838945|NCT00262522|10844681|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3
7073570|NCT02045862|11178084|FG002|Overall Study|Lost to Follow-up|6
7073571|NCT02045875|11178094|FG000|Overall Study|Lost to Follow-up|3
6838946|NCT00262522|10844682|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0
6966327|NCT01125046|11014295|FG000|Continued Treatment After 6 Months|Adverse Event|1
7073572|NCT02045875|11178095|FG001|Overall Study|Lost to Follow-up|0
7073573|NCT02045875|11178094|FG000|Overall Study|Withdrawal by Subject|4
7073574|NCT02045875|11178095|FG001|Overall Study|Withdrawal by Subject|3
7073575|NCT02045979|11178104|FG000|Overall Study|Informed Consent Withdrawn|2
7073576|NCT02045979|11178105|FG001|Overall Study|Informed Consent Withdrawn|0
7073577|NCT02045979|11178106|FG002|Overall Study|Informed Consent Withdrawn|1
7073578|NCT02045979|11178104|FG000|Overall Study|not specified above|0
7073579|NCT02045979|11178105|FG001|Overall Study|not specified above|1
7073580|NCT02045979|11178106|FG002|Overall Study|not specified above|0
7073581|NCT02046070|11178130|FG000|Overall Study|Progressive Disease|18
7073582|NCT02046070|11178131|FG001|Overall Study|Progressive Disease|11
7073583|NCT02046070|11178132|FG002|Overall Study|Progressive Disease|40
7073584|NCT02046070|11178130|FG000|Overall Study|Adverse Event|8
7073585|NCT02046070|11178131|FG001|Overall Study|Adverse Event|10
7073586|NCT02046070|11178132|FG002|Overall Study|Adverse Event|17
7073587|NCT02046070|11178130|FG000|Overall Study|Withdrawal by Subject|1
7073588|NCT02046070|11178131|FG001|Overall Study|Withdrawal by Subject|2
6838947|NCT00262522|10844679|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1
6838948|NCT00262522|10844680|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2
7073589|NCT02046070|11178132|FG002|Overall Study|Withdrawal by Subject|6
6966328|NCT01125046|11014295|FG000|Follow-up/Data Cut Off Point|Death|29
6966329|NCT01125046|11014295|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4
6966330|NCT01125189|11014321|FG000|Treatment Period|Lack of Efficacy|15
6966331|NCT01125189|11014322|FG001|Treatment Period|Lack of Efficacy|18
6966332|NCT01125189|11014323|FG002|Treatment Period|Lack of Efficacy|25
6966333|NCT01125189|11014321|FG000|Treatment Period|Adverse Event|7
6966334|NCT01125189|11014322|FG001|Treatment Period|Adverse Event|8
6966335|NCT01125189|11014323|FG002|Treatment Period|Adverse Event|8
6966336|NCT01125189|11014321|FG000|Treatment Period|Withdrawal by Subject|3
6966337|NCT01125189|11014322|FG001|Treatment Period|Withdrawal by Subject|1
6966338|NCT01125189|11014323|FG002|Treatment Period|Withdrawal by Subject|1
7073590|NCT02046070|11178130|FG000|Overall Study|Study Terminated by Sponsor|1
7073591|NCT02046070|11178131|FG001|Overall Study|Study Terminated by Sponsor|1
7073592|NCT02046070|11178132|FG002|Overall Study|Study Terminated by Sponsor|1
7073593|NCT02046070|11178130|FG000|Overall Study|Reason not Specified|4
7073594|NCT02046070|11178131|FG001|Overall Study|Reason not Specified|4
7073595|NCT02046070|11178132|FG002|Overall Study|Reason not Specified|6
7073596|NCT02046122|11178140|FG000|Overall Study|Physician Decision|8
7073597|NCT02046122|11178140|FG000|Overall Study|Withdrawal by Subject|1
7073598|NCT02046148|11178155|FG000|Overall Study|Lost to Follow-up|1
7073599|NCT02046148|11178156|FG001|Overall Study|Lost to Follow-up|1
7073600|NCT02046148|11178155|FG000|Overall Study|Withdrawal by Subject|0
7073601|NCT02046148|11178156|FG001|Overall Study|Withdrawal by Subject|2
7073602|NCT02046174|11178162|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1
6838949|NCT00262522|10844681|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3
6838950|NCT00262522|10844682|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2
6838951|NCT00262522|10844679|FG000|Study Start Through 8 Weeks|Noncompliance|0
6838952|NCT00262522|10844680|FG001|Study Start Through 8 Weeks|Noncompliance|0
6838953|NCT00262522|10844681|FG002|Study Start Through 8 Weeks|Noncompliance|2
6838954|NCT00262522|10844682|FG003|Study Start Through 8 Weeks|Noncompliance|2
6838955|NCT00262522|10844679|FG000|Study Start Through 8 Weeks|Death|1
6838956|NCT00262522|10844680|FG001|Study Start Through 8 Weeks|Death|0
6838957|NCT00262522|10844681|FG002|Study Start Through 8 Weeks|Death|0
6838958|NCT00262522|10844682|FG003|Study Start Through 8 Weeks|Death|0
6838959|NCT00262522|10844679|FG000|Study Start Through 48 Weeks|Adverse Event|16
6838960|NCT00262522|10844680|FG001|Study Start Through 48 Weeks|Adverse Event|0
6838961|NCT00262522|10844681|FG002|Study Start Through 48 Weeks|Adverse Event|10
6838962|NCT00262522|10844682|FG003|Study Start Through 48 Weeks|Adverse Event|0
6838963|NCT00262522|10844679|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10
6838964|NCT00262522|10844680|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0
6838965|NCT00262522|10844681|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11
6838966|NCT00262522|10844682|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0
6838967|NCT00262522|10844679|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8
6838968|NCT00262522|10844680|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0
6838969|NCT00262522|10844681|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14
6838970|NCT00262522|10844682|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0
6838971|NCT00262522|10844679|FG000|Study Start Through 48 Weeks|Noncompliance|3
6838972|NCT00262522|10844680|FG001|Study Start Through 48 Weeks|Noncompliance|0
6838973|NCT00262522|10844681|FG002|Study Start Through 48 Weeks|Noncompliance|8
6838974|NCT00262522|10844682|FG003|Study Start Through 48 Weeks|Noncompliance|0
6838975|NCT00262522|10844679|FG000|Study Start Through 48 Weeks|Death|2
6838976|NCT00262522|10844680|FG001|Study Start Through 48 Weeks|Death|0
6838977|NCT00262522|10844681|FG002|Study Start Through 48 Weeks|Death|1
6838978|NCT00262522|10844682|FG003|Study Start Through 48 Weeks|Death|0
6838979|NCT00262522|10844679|FG000|Study Start Through 48 Weeks|Virologic failure|2
6838980|NCT00262522|10844680|FG001|Study Start Through 48 Weeks|Virologic failure|0
6838981|NCT00262522|10844681|FG002|Study Start Through 48 Weeks|Virologic failure|4
6838982|NCT00262522|10844682|FG003|Study Start Through 48 Weeks|Virologic failure|0
6838983|NCT00262522|10844679|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8
6838984|NCT00262522|10844680|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
6838985|NCT00262522|10844681|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7
6838986|NCT00262522|10844682|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
6838987|NCT00262522|10844679|FG000|Study Start Through 96 Weeks|Adverse Event|20
6838988|NCT00262522|10844680|FG001|Study Start Through 96 Weeks|Adverse Event|0
6838989|NCT00262522|10844681|FG002|Study Start Through 96 Weeks|Adverse Event|16
6838990|NCT00262522|10844682|FG003|Study Start Through 96 Weeks|Adverse Event|0
6838991|NCT00262522|10844679|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15
6838992|NCT00262522|10844680|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0
6838993|NCT00262522|10844681|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13
6838994|NCT00262522|10844682|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0
6838995|NCT00262522|10844679|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19
6838996|NCT00262522|10844680|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0
6966339|NCT01125189|11014321|FG000|Treatment Period|Death|1
6966340|NCT01125189|11014322|FG001|Treatment Period|Death|0
6966341|NCT01125189|11014323|FG002|Treatment Period|Death|0
7073603|NCT02046174|11178163|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0
7073604|NCT02046369|11178291|FG000|Overall Study|Adverse Event|3
6966342|NCT01125189|11014321|FG000|Treatment Period|Lost to Follow-up|1
6966343|NCT01125189|11014322|FG001|Treatment Period|Lost to Follow-up|2
6966344|NCT01125189|11014323|FG002|Treatment Period|Lost to Follow-up|1
6966345|NCT01125189|11014321|FG000|Treatment Period|Poor compliance/noncompliance|0
6966346|NCT01125189|11014322|FG001|Treatment Period|Poor compliance/noncompliance|1
7073605|NCT02046369|11178292|FG001|Overall Study|Adverse Event|3
7073606|NCT02046369|11178291|FG000|Overall Study|Lack of Efficacy|3
7073607|NCT02046369|11178292|FG001|Overall Study|Lack of Efficacy|3
7073608|NCT02046369|11178291|FG000|Overall Study|Lost to Follow-up|3
7073609|NCT02046369|11178292|FG001|Overall Study|Lost to Follow-up|3
7073610|NCT02046369|11178291|FG000|Overall Study|Protocol Violation|1
7073611|NCT02046369|11178292|FG001|Overall Study|Protocol Violation|2
7073612|NCT02046369|11178291|FG000|Overall Study|Withdrawal by Subject|3
7073613|NCT02046369|11178292|FG001|Overall Study|Withdrawal by Subject|6
7073614|NCT02046369|11178291|FG000|Overall Study|never received study drug|0
7073615|NCT02046369|11178292|FG001|Overall Study|never received study drug|1
7073616|NCT02046369|11178291|FG000|Overall Study|non compliance|1
7073617|NCT02046369|11178292|FG001|Overall Study|non compliance|0
7073618|NCT02046564|11178318|FG000|Overall Study|Adverse Event|6
7073619|NCT02046564|11178319|FG001|Overall Study|Adverse Event|3
7073620|NCT02046564|11178318|FG000|Overall Study|Physician Decision|0
7073621|NCT02046564|11178319|FG001|Overall Study|Physician Decision|1
7073622|NCT02046564|11178318|FG000|Overall Study|Protocol Violation|3
7073623|NCT02046564|11178319|FG001|Overall Study|Protocol Violation|1
7073624|NCT02046564|11178318|FG000|Overall Study|Withdrawal by Subject|4
7073625|NCT02046564|11178319|FG001|Overall Study|Withdrawal by Subject|10
7073626|NCT02046564|11178318|FG000|Overall Study|Subject met withdrawal criteria|2
7073627|NCT02046564|11178319|FG001|Overall Study|Subject met withdrawal criteria|5
7073628|NCT02046603|11178327|FG000|Overall Study|Other|11
7073629|NCT02046603|11178328|FG001|Overall Study|Other|66
7073630|NCT02046603|11178327|FG000|Overall Study|Protocol Violation|0
7073631|NCT02046603|11178328|FG001|Overall Study|Protocol Violation|1
7073632|NCT02046603|11178327|FG000|Overall Study|Participant/legal guardian decision|1
7073633|NCT02046603|11178328|FG001|Overall Study|Participant/legal guardian decision|3
7073634|NCT02046603|11178327|FG000|Overall Study|Physician Decision|2
7073635|NCT02046603|11178328|FG001|Overall Study|Physician Decision|1
7073636|NCT02046603|11178327|FG000|Overall Study|Lost to Follow-up|1
7073637|NCT02046603|11178328|FG001|Overall Study|Lost to Follow-up|2
7073638|NCT02046603|11178327|FG000|Overall Study|Death|0
7073639|NCT02046603|11178328|FG001|Overall Study|Death|1
7073640|NCT02046603|11178327|FG000|Overall Study|Adverse Event|0
7073641|NCT02046603|11178328|FG001|Overall Study|Adverse Event|1
7073642|NCT02046616|11178335|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1
7073643|NCT02046616|11178335|FG000|24-Week Treatment Period|Any Other Adverse Event|13
7073644|NCT02046616|11178335|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1
7073645|NCT02046616|11178335|FG000|24-Week Treatment Period|Physician Decision|3
7073646|NCT02046616|11178335|FG000|24-Week Treatment Period|Other|1
7073647|NCT02046616|11178335|FG000|8-Week FU Period|Lost to Follow-up|1
7082705|NCT02144285|11193312|FG009|Overall Study|Withdrawal by Subject|0
7082706|NCT02144337|11193350|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
7082707|NCT02144337|11193351|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
7082708|NCT02144337|11193350|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2
7082709|NCT02144337|11193351|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0
7082710|NCT02144337|11193350|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1
7082711|NCT02144337|11193351|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0
7082712|NCT02144337|11193350|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2
7082713|NCT02144337|11193351|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0
7082714|NCT02144337|11193350|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1
7082715|NCT02144337|11193351|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0
7082716|NCT02144610|11193391|FG000|Overall Study|Physician Decision|1
7082717|NCT02144610|11193392|FG001|Overall Study|Physician Decision|0
7082718|NCT02144610|11193391|FG000|Overall Study|Withdrawal by Subject|1
7082719|NCT02144610|11193392|FG001|Overall Study|Withdrawal by Subject|5
7082720|NCT02144610|11193391|FG000|Overall Study|Death|2
7082721|NCT02144610|11193392|FG001|Overall Study|Death|2
7082722|NCT02144610|11193391|FG000|Overall Study|Study Discontinuation by Sponsor|19
7082723|NCT02144610|11193392|FG001|Overall Study|Study Discontinuation by Sponsor|14
7082724|NCT02144610|11193391|FG000|Overall Study|Other|0
7082725|NCT02144610|11193392|FG001|Overall Study|Other|1
7082726|NCT02144701|11193409|FG000|Overall Study|development of relapse, GVHD or death|9
7082727|NCT02144701|11193410|FG001|Overall Study|development of relapse, GVHD or death|3
7082728|NCT02145026|11193429|FG000|Overall Study|Adverse Event|2
7082729|NCT02145026|11193429|FG000|Overall Study|Death|4
7082730|NCT02145026|11193429|FG000|Overall Study|Withdrawal by Subject|2
7082731|NCT02145026|11193429|FG000|Overall Study|Physician Decision|4
6966347|NCT01125189|11014323|FG002|Treatment Period|Poor compliance/noncompliance|0
7082993|NCT02147288|11193731|FG008|Overall Study|complications from concurrent hernia rep|0
7082994|NCT02147288|11193732|FG009|Overall Study|complications from concurrent hernia rep|0
7082995|NCT02147353|11193744|FG000|Overall Study|Lost to Follow-up|2
7082996|NCT02147353|11193745|FG001|Overall Study|Lost to Follow-up|0
6966348|NCT01125189|11014321|FG000|Treatment Period|Participants requested to discontinue|1
7073648|NCT02046993|11178384|FG000|Overall Study|Withdrawal by Subject|2
7073649|NCT02046993|11178385|FG001|Overall Study|Withdrawal by Subject|10
7073650|NCT02046993|11178384|FG000|Overall Study|Lost to Follow-up|1
7073651|NCT02046993|11178385|FG001|Overall Study|Lost to Follow-up|1
7073652|NCT02047045|11178406|FG000|Baseline|Withdrawal by Subject|3
7073653|NCT02047045|11178407|FG001|Baseline|Withdrawal by Subject|2
7073654|NCT02047045|11178406|FG000|Treatment Period (8 Weeks )|Adverse Event|3
7073655|NCT02047045|11178407|FG001|Treatment Period (8 Weeks )|Adverse Event|1
7073656|NCT02047045|11178406|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1
7073657|NCT02047045|11178407|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3
7073658|NCT02047045|11178406|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3
7073659|NCT02047045|11178407|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5
7073660|NCT02047045|11178406|FG000|Treatment Period (8 Weeks )|moved far away out of work|3
7073661|NCT02047045|11178407|FG001|Treatment Period (8 Weeks )|moved far away out of work|0
7073662|NCT02047045|11178406|FG000|Treatment Period (8 Weeks )|no reason was given|1
7073663|NCT02047045|11178407|FG001|Treatment Period (8 Weeks )|no reason was given|0
7073664|NCT02047045|11178406|FG000|Treatment Period (8 Weeks )|refused to take drugs|0
7073665|NCT02047045|11178407|FG001|Treatment Period (8 Weeks )|refused to take drugs|5
7073666|NCT02047045|11178406|FG000|Treatment Period (8 Weeks )|for safety considerations|0
7073667|NCT02047045|11178407|FG001|Treatment Period (8 Weeks )|for safety considerations|1
7073668|NCT02047045|11178406|FG000|Follow-up Period (24 Weeks)|Adverse Event|1
7073669|NCT02047045|11178407|FG001|Follow-up Period (24 Weeks)|Adverse Event|1
7073670|NCT02047110|11178417|FG000|DB Treatment Period up to Week 24|Adverse Event|1
7073671|NCT02047110|11178418|FG001|DB Treatment Period up to Week 24|Adverse Event|0
7073672|NCT02047110|11178419|FG002|DB Treatment Period up to Week 24|Adverse Event|0
7073673|NCT02047110|11178420|FG003|DB Treatment Period up to Week 24|Adverse Event|0
7073674|NCT02047110|11178417|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1
7073675|NCT02047110|11178418|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0
7073676|NCT02047110|11178419|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0
7073677|NCT02047110|11178420|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0
7073678|NCT02047110|11178417|FG000|DB Treatment Period up to Week 24|Protocol Violation|1
7073679|NCT02047110|11178418|FG001|DB Treatment Period up to Week 24|Protocol Violation|0
7073680|NCT02047110|11178419|FG002|DB Treatment Period up to Week 24|Protocol Violation|0
7073681|NCT02047110|11178420|FG003|DB Treatment Period up to Week 24|Protocol Violation|0
7073682|NCT02047110|11178417|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1
7073683|NCT02047110|11178418|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0
7073684|NCT02047110|11178419|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0
7073685|NCT02047110|11178420|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1
7073686|NCT02047110|11178417|FG000|DB Treatment Period up to Week 24|Other than specified|1
7073687|NCT02047110|11178418|FG001|DB Treatment Period up to Week 24|Other than specified|2
7073688|NCT02047110|11178419|FG002|DB Treatment Period up to Week 24|Other than specified|3
7073689|NCT02047110|11178420|FG003|DB Treatment Period up to Week 24|Other than specified|1
7073690|NCT02047110|11178417|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
7073691|NCT02047110|11178418|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1
7073692|NCT02047110|11178419|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
7073693|NCT02047110|11178420|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
7073694|NCT02047110|11178417|FG000|DB (Week 12 up to Week 24)|Other than specified|0
7073695|NCT02047110|11178418|FG001|DB (Week 12 up to Week 24)|Other than specified|1
7073696|NCT02047110|11178419|FG002|DB (Week 12 up to Week 24)|Other than specified|1
7073697|NCT02047110|11178420|FG003|DB (Week 12 up to Week 24)|Other than specified|0
7073698|NCT02047110|11178417|FG000|Escape Treatment Period|Withdrawal by Subject|1
7073699|NCT02047110|11178418|FG001|Escape Treatment Period|Withdrawal by Subject|2
7073700|NCT02047110|11178419|FG002|Escape Treatment Period|Withdrawal by Subject|1
7073701|NCT02047110|11178420|FG003|Escape Treatment Period|Withdrawal by Subject|1
7073702|NCT02047110|11178417|FG000|Escape Treatment Period|Adverse Event|1
7073703|NCT02047110|11178418|FG001|Escape Treatment Period|Adverse Event|2
7073704|NCT02047110|11178419|FG002|Escape Treatment Period|Adverse Event|2
7073705|NCT02047110|11178420|FG003|Escape Treatment Period|Adverse Event|0
7073706|NCT02047110|11178417|FG000|Escape Treatment Period|Other than specified|1
7073707|NCT02047110|11178418|FG001|Escape Treatment Period|Other than specified|2
7073708|NCT02047110|11178419|FG002|Escape Treatment Period|Other than specified|0
7073709|NCT02047110|11178420|FG003|Escape Treatment Period|Other than specified|1
7073710|NCT02047110|11178417|FG000|OLE Treatment Period|Other than specified|0
7073711|NCT02047110|11178418|FG001|OLE Treatment Period|Other than specified|0
7073712|NCT02047110|11178419|FG002|OLE Treatment Period|Other than specified|1
7073713|NCT02047110|11178420|FG003|OLE Treatment Period|Other than specified|0
7073714|NCT02047227|11178439|FG000|Overall Study|Adverse Event|2
7073715|NCT02047227|11178440|FG001|Overall Study|Adverse Event|4
7073716|NCT02047227|11178439|FG000|Overall Study|Lost to Follow-up|0
7073717|NCT02047227|11178440|FG001|Overall Study|Lost to Follow-up|3
7073718|NCT02047227|11178439|FG000|Overall Study|Protocol Violation|1
7073719|NCT02047227|11178440|FG001|Overall Study|Protocol Violation|0
7073720|NCT02047227|11178439|FG000|Overall Study|Spontaneous pregnancy|1
7073721|NCT02047227|11178440|FG001|Overall Study|Spontaneous pregnancy|0
7073722|NCT02047227|11178439|FG000|Overall Study|Lack of ovarian response to stimulation|35
7073723|NCT02047227|11178440|FG001|Overall Study|Lack of ovarian response to stimulation|32
7073724|NCT02047227|11178439|FG000|Overall Study|No oocytes retrieved|21
7073725|NCT02047227|11178440|FG001|Overall Study|No oocytes retrieved|20
7073726|NCT02047227|11178439|FG000|Overall Study|No fertilization|61
7073727|NCT02047227|11178440|FG001|Overall Study|No fertilization|51
7073728|NCT02047227|11178439|FG000|Overall Study|Intention to freeze all embryos|1
7073729|NCT02047227|11178440|FG001|Overall Study|Intention to freeze all embryos|0
7073730|NCT02047227|11178439|FG000|Overall Study|All embryos discarded|12
7073731|NCT02047227|11178440|FG001|Overall Study|All embryos discarded|11
7073732|NCT02047227|11178439|FG000|Overall Study|Other|10
7073733|NCT02047227|11178440|FG001|Overall Study|Other|9
7073734|NCT02047253|11178446|FG000|Overall Study|Lost to Follow-up|8
7073735|NCT02047318|11178454|FG000|Core Study Period|Did not consent to 52-week follow- up|8
7073736|NCT02047318|11178454|FG000|Core Study Period|Adverse Event|1
7073737|NCT02047318|11178454|FG000|Core Study Period|Withdrawal by caregiver|3
7073738|NCT02047318|11178454|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1
7073739|NCT02047604|11178494|FG000|Overall Study|Withdrawal by Subject|0
7073740|NCT02047604|11178495|FG001|Overall Study|Withdrawal by Subject|0
7073741|NCT02047604|11178496|FG002|Overall Study|Withdrawal by Subject|0
7073742|NCT02047604|11178497|FG003|Overall Study|Withdrawal by Subject|0
7073743|NCT02047604|11178498|FG004|Overall Study|Withdrawal by Subject|1
7073744|NCT02047604|11178499|FG005|Overall Study|Withdrawal by Subject|1
7073745|NCT02047734|11178523|FG000|Overall Study|Adverse Event|18
7073746|NCT02047734|11178524|FG001|Overall Study|Adverse Event|13
7073747|NCT02047734|11178525|FG002|Overall Study|Adverse Event|13
7073748|NCT02047734|11178523|FG000|Overall Study|Lack of Efficacy|4
7073749|NCT02047734|11178524|FG001|Overall Study|Lack of Efficacy|5
7073750|NCT02047734|11178525|FG002|Overall Study|Lack of Efficacy|1
7073751|NCT02047734|11178523|FG000|Overall Study|Protocol Violation|3
7073752|NCT02047734|11178524|FG001|Overall Study|Protocol Violation|1
7073753|NCT02047734|11178525|FG002|Overall Study|Protocol Violation|1
7073754|NCT02047734|11178523|FG000|Overall Study|Lost to Follow-up|1
7073755|NCT02047734|11178524|FG001|Overall Study|Lost to Follow-up|4
7073756|NCT02047734|11178525|FG002|Overall Study|Lost to Follow-up|0
7073757|NCT02047734|11178523|FG000|Overall Study|Death|0
7073758|NCT02047734|11178524|FG001|Overall Study|Death|1
7073759|NCT02047734|11178525|FG002|Overall Study|Death|0
7073760|NCT02047734|11178523|FG000|Overall Study|Withdrawal by Subject|30
7073761|NCT02047734|11178524|FG001|Overall Study|Withdrawal by Subject|31
7073762|NCT02047734|11178525|FG002|Overall Study|Withdrawal by Subject|19
7073763|NCT02047734|11178523|FG000|Overall Study|Physician Decision|7
7073764|NCT02047734|11178524|FG001|Overall Study|Physician Decision|6
7073765|NCT02047734|11178525|FG002|Overall Study|Physician Decision|5
7073766|NCT02047734|11178523|FG000|Overall Study|Miscellaneous|2
7073767|NCT02047734|11178524|FG001|Overall Study|Miscellaneous|4
7073768|NCT02047734|11178525|FG002|Overall Study|Miscellaneous|6
7073769|NCT02047734|11178523|FG000|Overall Study|Did Not Receive Study Drug|2
7073770|NCT02047734|11178524|FG001|Overall Study|Did Not Receive Study Drug|4
7073771|NCT02047734|11178525|FG002|Overall Study|Did Not Receive Study Drug|1
7073772|NCT02047903|11178533|FG000|Overall Study|Adverse Event|14
7073773|NCT02047903|11178533|FG000|Overall Study|Serious adverse event|10
7073774|NCT02047903|11178533|FG000|Overall Study|Withdrawal by Subject|16
7073775|NCT02047903|11178533|FG000|Overall Study|Lost to Follow-up|4
7073776|NCT02047903|11178533|FG000|Overall Study|Reason not listed|6
7073777|NCT02047903|11178533|FG000|Overall Study|Not Treated|9
7073778|NCT02048072|11178546|FG000|Overall Study|Adverse Event|3
7073779|NCT02048072|11178546|FG000|Overall Study|Lost to Follow-up|1
7073780|NCT02048241|11178552|FG000|Overall Study|Withdrawal by Subject|0
7073781|NCT02048241|11178553|FG001|Overall Study|Withdrawal by Subject|1
7073782|NCT02048826|11178570|FG000|Overall Study|Withdrawal by Subject|1
7073783|NCT02048826|11178571|FG001|Overall Study|Withdrawal by Subject|0
7073784|NCT02049437|11178624|FG000|Period 1|Adverse Event|1
7073785|NCT02049437|11178625|FG001|Period 1|Adverse Event|1
7073786|NCT02049437|11178624|FG000|Period 1|Adverse Event|1
7073787|NCT02049437|11178625|FG001|Period 1|Adverse Event|0
7073788|NCT02049450|11178631|FG000|Overall Study|Adverse Event|2
7073789|NCT02049450|11178631|FG000|Overall Study|Withdrawal by Subject|1
7073790|NCT02049450|11178631|FG000|Overall Study|Patients/guardian decision|1
7073791|NCT02049814|11178662|FG000|Overall Study|Reason not Specified|4
7073792|NCT02049814|11178663|FG001|Overall Study|Reason not Specified|3
7073793|NCT02049814|11178662|FG000|Overall Study|Pregnancy|1
7073794|NCT02049814|11178663|FG001|Overall Study|Pregnancy|0
7073795|NCT02049814|11178662|FG000|Overall Study|Lost to Follow-up|2
7073796|NCT02049814|11178663|FG001|Overall Study|Lost to Follow-up|3
7073797|NCT02049814|11178662|FG000|Overall Study|Serious Protocol Violation|5
7073798|NCT02049814|11178663|FG001|Overall Study|Serious Protocol Violation|7
7073799|NCT02049814|11178662|FG000|Overall Study|Study Termination|0
7073800|NCT02049814|11178663|FG001|Overall Study|Study Termination|1
7073801|NCT02049814|11178662|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8
7073802|NCT02049814|11178663|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5
7073803|NCT02049814|11178662|FG000|Overall Study|Voluntary withdrawal|9
7073804|NCT02049814|11178663|FG001|Overall Study|Voluntary withdrawal|8
7073805|NCT02049866|11178669|FG000|Overall Study|Withdrawal by Subject|1
7073806|NCT02049944|11178686|FG000|Overall Study|Protocol Violation|2
7073807|NCT02049957|11178699|FG000|Overall Study|Progressive Disease|5
7073808|NCT02049957|11178700|FG001|Overall Study|Progressive Disease|4
7073809|NCT02049957|11178701|FG002|Overall Study|Progressive Disease|2
7073810|NCT02049957|11178702|FG003|Overall Study|Progressive Disease|2
7073811|NCT02049957|11178703|FG004|Overall Study|Progressive Disease|6
7073812|NCT02049957|11178704|FG005|Overall Study|Progressive Disease|35
7073813|NCT02049957|11178705|FG006|Overall Study|Progressive Disease|7
7073814|NCT02049957|11178706|FG007|Overall Study|Progressive Disease|26
7073815|NCT02049957|11178707|FG008|Overall Study|Progressive Disease|6
7073816|NCT02049957|11178699|FG000|Overall Study|Adverse Event|1
7073817|NCT02049957|11178700|FG001|Overall Study|Adverse Event|1
7073818|NCT02049957|11178701|FG002|Overall Study|Adverse Event|1
7073819|NCT02049957|11178702|FG003|Overall Study|Adverse Event|0
7073820|NCT02049957|11178703|FG004|Overall Study|Adverse Event|0
7073821|NCT02049957|11178704|FG005|Overall Study|Adverse Event|5
7073822|NCT02049957|11178705|FG006|Overall Study|Adverse Event|0
7073823|NCT02049957|11178706|FG007|Overall Study|Adverse Event|6
7073824|NCT02049957|11178707|FG008|Overall Study|Adverse Event|1
7073825|NCT02049957|11178699|FG000|Overall Study|Study Terminated by Sponsor|0
7073826|NCT02049957|11178700|FG001|Overall Study|Study Terminated by Sponsor|1
7073827|NCT02049957|11178701|FG002|Overall Study|Study Terminated by Sponsor|0
7073828|NCT02049957|11178702|FG003|Overall Study|Study Terminated by Sponsor|0
7073829|NCT02049957|11178703|FG004|Overall Study|Study Terminated by Sponsor|0
7073830|NCT02049957|11178704|FG005|Overall Study|Study Terminated by Sponsor|0
7073831|NCT02049957|11178705|FG006|Overall Study|Study Terminated by Sponsor|1
7073832|NCT02049957|11178706|FG007|Overall Study|Study Terminated by Sponsor|0
7147903|NCT03136861|11308751|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
7147904|NCT03136861|11308745|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2
7147905|NCT03136861|11308746|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1
6838997|NCT00262522|10844681|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18
6838998|NCT00262522|10844682|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0
6838999|NCT00262522|10844679|FG000|Study Start Through 96 Weeks|Noncompliance|6
6839000|NCT00262522|10844680|FG001|Study Start Through 96 Weeks|Noncompliance|0
7147906|NCT03136861|11308747|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
7147907|NCT03136861|11308748|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
7147908|NCT03136861|11308749|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
7147909|NCT03136861|11308750|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
7147910|NCT03136861|11308751|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
7147911|NCT03136861|11308745|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
7147912|NCT03136861|11308746|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1
7147913|NCT03136861|11308747|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
7147914|NCT03136861|11308748|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
7147915|NCT03136861|11308749|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
7147916|NCT03136861|11308750|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
7147917|NCT03136861|11308751|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
7147918|NCT03136861|11308745|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1
7147919|NCT03136861|11308746|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1
7147920|NCT03136861|11308747|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
7147921|NCT03136861|11308748|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
7147922|NCT03136861|11308749|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
7147923|NCT03136861|11308750|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
7183772|NCT01150045|11383850|FG003|Overall Study|Protocol Violation|1
6839001|NCT00262522|10844681|FG002|Study Start Through 96 Weeks|Noncompliance|11
6839002|NCT00262522|10844682|FG003|Study Start Through 96 Weeks|Noncompliance|0
6839003|NCT00262522|10844679|FG000|Study Start Through 96 Weeks|Death|2
6839004|NCT00262522|10844680|FG001|Study Start Through 96 Weeks|Death|0
6839005|NCT00262522|10844681|FG002|Study Start Through 96 Weeks|Death|2
6839006|NCT00262522|10844682|FG003|Study Start Through 96 Weeks|Death|0
6839007|NCT00262522|10844679|FG000|Study Start Through 96 Weeks|Virologic failure|5
6839008|NCT00262522|10844680|FG001|Study Start Through 96 Weeks|Virologic failure|0
6839009|NCT00262522|10844681|FG002|Study Start Through 96 Weeks|Virologic failure|8
6839010|NCT00262522|10844682|FG003|Study Start Through 96 Weeks|Virologic failure|0
6839011|NCT00262522|10844679|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10
6839012|NCT00262522|10844680|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
6839013|NCT00262522|10844681|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9
6839014|NCT00262522|10844682|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
6839015|NCT00262600|10844693|FG000|Overall Study|Lost to Follow-up|17
6839016|NCT00262600|10844694|FG001|Overall Study|Lost to Follow-up|31
6839017|NCT00262600|10844695|FG002|Overall Study|Lost to Follow-up|41
6839018|NCT00262600|10844693|FG000|Overall Study|Withdrawal by Subject|128
6839019|NCT00262600|10844694|FG001|Overall Study|Withdrawal by Subject|145
6839020|NCT00262600|10844695|FG002|Overall Study|Withdrawal by Subject|139
6839021|NCT00262600|10844693|FG000|Overall Study|Not Treated|32
6839022|NCT00262600|10844694|FG001|Overall Study|Not Treated|17
7073833|NCT02049957|11178707|FG008|Overall Study|Study Terminated by Sponsor|0
7073834|NCT02049957|11178699|FG000|Overall Study|Withdrawal by Subject|0
7073835|NCT02049957|11178700|FG001|Overall Study|Withdrawal by Subject|0
7073836|NCT02049957|11178701|FG002|Overall Study|Withdrawal by Subject|0
7073837|NCT02049957|11178702|FG003|Overall Study|Withdrawal by Subject|1
7073838|NCT02049957|11178703|FG004|Overall Study|Withdrawal by Subject|0
7073839|NCT02049957|11178704|FG005|Overall Study|Withdrawal by Subject|2
7073840|NCT02049957|11178705|FG006|Overall Study|Withdrawal by Subject|0
7073841|NCT02049957|11178706|FG007|Overall Study|Withdrawal by Subject|3
7073842|NCT02049957|11178707|FG008|Overall Study|Withdrawal by Subject|1
7073843|NCT02049957|11178699|FG000|Overall Study|Physician Decision|0
7073844|NCT02049957|11178700|FG001|Overall Study|Physician Decision|0
7073845|NCT02049957|11178701|FG002|Overall Study|Physician Decision|0
7073846|NCT02049957|11178702|FG003|Overall Study|Physician Decision|0
7073847|NCT02049957|11178703|FG004|Overall Study|Physician Decision|0
7073848|NCT02049957|11178704|FG005|Overall Study|Physician Decision|1
7073849|NCT02049957|11178705|FG006|Overall Study|Physician Decision|0
7073850|NCT02049957|11178706|FG007|Overall Study|Physician Decision|0
7073851|NCT02049957|11178707|FG008|Overall Study|Physician Decision|0
7073852|NCT02050048|11178729|FG000|Overall Study|Lost to Follow-up|0
7073853|NCT02050048|11178730|FG001|Overall Study|Lost to Follow-up|1
7073854|NCT02050048|11178729|FG000|Overall Study|Death|1
7073855|NCT02050048|11178730|FG001|Overall Study|Death|0
7073856|NCT02050048|11178729|FG000|Overall Study|Ineligible after ERCP|4
7073857|NCT02050048|11178730|FG001|Overall Study|Ineligible after ERCP|1
7073858|NCT02050321|11178736|FG000|Overall Study|Withdrawal by Subject|1
7073859|NCT02050321|11178736|FG000|Overall Study|Adverse Event|1
6839023|NCT00262600|10844695|FG002|Overall Study|Not Treated|24
6839024|NCT00262600|10844693|FG000|Overall Study|Other|58
6839025|NCT00262600|10844694|FG001|Overall Study|Other|59
6839026|NCT00262600|10844695|FG002|Overall Study|Other|62
6839027|NCT00262743|10844726|FG000|Overall Study|Adverse Event|0
6839028|NCT00262743|10844727|FG001|Overall Study|Adverse Event|9
6839029|NCT00262743|10844726|FG000|Overall Study|Disease progression|0
6839030|NCT00262743|10844727|FG001|Overall Study|Disease progression|3
6839031|NCT00262821|10844733|FG000|Overall Study|Ineligible - wrong stage|0
6839032|NCT00262821|10844734|FG001|Overall Study|Ineligible - wrong stage|3
6839033|NCT00262821|10844733|FG000|Overall Study|Ineligible - wrong cell type|2
6839034|NCT00262821|10844734|FG001|Overall Study|Ineligible - wrong cell type|2
6839035|NCT00262821|10844733|FG000|Overall Study|Ineligible - wrong primary|0
6839036|NCT00262821|10844734|FG001|Overall Study|Ineligible - wrong primary|1
6839037|NCT00262821|10844733|FG000|Overall Study|Ineligible - inadequate pathology|1
6839038|NCT00262821|10844734|FG001|Overall Study|Ineligible - inadequate pathology|3
6839039|NCT00262821|10844733|FG000|Overall Study|Ineligible - elevated creatinine|0
6839040|NCT00262821|10844734|FG001|Overall Study|Ineligible - elevated creatinine|2
6839041|NCT00262821|10844733|FG000|Overall Study|Ineligible - required test not done|1
6839042|NCT00262821|10844734|FG001|Overall Study|Ineligible - required test not done|4
6839043|NCT00262821|10844733|FG000|Overall Study|Inevaluable - inadequate data|0
6839044|NCT00262821|10844734|FG001|Overall Study|Inevaluable - inadequate data|4
6839045|NCT00262834|10844742|FG000|Overall Study|Surgery delayed/tissue not collected|1
6839046|NCT00262834|10844743|FG001|Overall Study|Surgery delayed/tissue not collected|4
6839047|NCT00262847|10844752|FG000|Overall Study|Disease Progression|309
6839048|NCT00262847|10844753|FG001|Overall Study|Disease Progression|274
6839049|NCT00262847|10844754|FG002|Overall Study|Disease Progression|195
6839050|NCT00262847|10844752|FG000|Overall Study|Patient Refusal|41
6839051|NCT00262847|10844753|FG001|Overall Study|Patient Refusal|52
6839052|NCT00262847|10844754|FG002|Overall Study|Patient Refusal|47
6839053|NCT00262847|10844752|FG000|Overall Study|Adverse Event|74
6839054|NCT00262847|10844753|FG001|Overall Study|Adverse Event|88
6839055|NCT00262847|10844754|FG002|Overall Study|Adverse Event|108
6839056|NCT00262847|10844752|FG000|Overall Study|Death|8
6839057|NCT00262847|10844753|FG001|Overall Study|Death|8
6839058|NCT00262847|10844754|FG002|Overall Study|Death|11
6839059|NCT00262847|10844752|FG000|Overall Study|Concomitant disease|3
6839060|NCT00262847|10844753|FG001|Overall Study|Concomitant disease|2
6839061|NCT00262847|10844754|FG002|Overall Study|Concomitant disease|4
6839062|NCT00262847|10844752|FG000|Overall Study|Other Reasons|79
6839063|NCT00262847|10844753|FG001|Overall Study|Other Reasons|88
6839064|NCT00262847|10844754|FG002|Overall Study|Other Reasons|27
6839065|NCT00262847|10844752|FG000|Overall Study|Did not receive study treatment|4
6839066|NCT00262847|10844753|FG001|Overall Study|Did not receive study treatment|1
6839067|NCT00262847|10844754|FG002|Overall Study|Did not receive study treatment|4
6839068|NCT00262860|10844765|FG000|Overall Study|Adverse Event|2
7073860|NCT02050373|11178752|FG000|Overall Study|Adverse Event|4
7073861|NCT02050373|11178753|FG001|Overall Study|Adverse Event|7
7073862|NCT02050373|11178752|FG000|Overall Study|Death|3
7073863|NCT02050373|11178753|FG001|Overall Study|Death|3
6839069|NCT00262873|10844769|FG000|Overall Study|Adverse Event|3
6839070|NCT00262873|10844769|FG000|Overall Study|Withdrawal by Subject|5
6839071|NCT00262925|10844773|FG000|Overall Study|Lack of Efficacy|3
6839072|NCT00262925|10844773|FG000|Overall Study|Adverse Event|4
6839073|NCT00262925|10844773|FG000|Overall Study|Death|2
6839074|NCT00262925|10844773|FG000|Overall Study|alternative therapy|1
6839075|NCT00262925|10844773|FG000|Overall Study|Other|1
6839076|NCT00262951|10844779|FG000|Overall Study|Progressive disease/relapse|3
6839077|NCT00262951|10844779|FG000|Overall Study|Adverse Event|7
7073864|NCT02051296|11178772|FG000|Overall Study|Lost to Follow-up|1
7073865|NCT02051296|11178773|FG001|Overall Study|Lost to Follow-up|2
7073866|NCT02051296|11178772|FG000|Overall Study|withdraw prior to treatment|7
7073867|NCT02051296|11178773|FG001|Overall Study|withdraw prior to treatment|7
7073868|NCT02051764|11178829|FG000|Overall Study|Study terminated by sponsor|0
7073869|NCT02051764|11178830|FG001|Overall Study|Study terminated by sponsor|7
7073870|NCT02052011|11178863|FG000|Overall Study|Lost to Follow-up|3
7073871|NCT02052011|11178864|FG001|Overall Study|Lost to Follow-up|0
7073872|NCT02052011|11178863|FG000|Overall Study|Withdrawal by Subject|1
7073873|NCT02052011|11178864|FG001|Overall Study|Withdrawal by Subject|2
7073874|NCT02052310|11178881|FG000|Overall Study|Death|64
7073875|NCT02052310|11178882|FG001|Overall Study|Death|54
7073876|NCT02052310|11178881|FG000|Overall Study|Withdrawal by Subject|37
7073877|NCT02052310|11178882|FG001|Overall Study|Withdrawal by Subject|49
7073878|NCT02052310|11178881|FG000|Overall Study|Other than specified|32
7073879|NCT02052310|11178882|FG001|Overall Study|Other than specified|29
7073880|NCT02052310|11178881|FG000|Overall Study|Adverse Event|29
7073881|NCT02052310|11178882|FG001|Overall Study|Adverse Event|22
7073882|NCT02052310|11178881|FG000|Overall Study|Kidney Transplant|23
7073883|NCT02052310|11178882|FG001|Overall Study|Kidney Transplant|29
7073884|NCT02052310|11178881|FG000|Overall Study|Physician Decision|14
7073885|NCT02052310|11178882|FG001|Overall Study|Physician Decision|7
7073886|NCT02052310|11178881|FG000|Overall Study|Lack of Efficacy|6
7073887|NCT02052310|11178882|FG001|Overall Study|Lack of Efficacy|1
7073888|NCT02052310|11178881|FG000|Overall Study|Site Terminated by Sponsor|5
7073889|NCT02052310|11178882|FG001|Overall Study|Site Terminated by Sponsor|13
7073890|NCT02052310|11178881|FG000|Overall Study|Lost to Follow-up|4
7073891|NCT02052310|11178882|FG001|Overall Study|Lost to Follow-up|2
7073892|NCT02052310|11178881|FG000|Overall Study|Protocol Violation|1
7073893|NCT02052310|11178882|FG001|Overall Study|Protocol Violation|6
7073894|NCT02052414|11178888|FG000|Overall Study|Adverse Event|12
7073895|NCT02052414|11178888|FG000|Overall Study|Lack of Efficacy|2
7073896|NCT02052414|11178888|FG000|Overall Study|Withdrawal by Subject|3
7073897|NCT02052440|11178895|FG000|Overall Study|Withdrawal by Subject|0
7073898|NCT02052440|11178896|FG001|Overall Study|Withdrawal by Subject|1
7073899|NCT02052466|11178902|FG000|Overall Study|Withdrawal by Subject|1
6839078|NCT00262951|10844779|FG000|Overall Study|Death|1
6839079|NCT00262951|10844779|FG000|Overall Study|Withdrawal by Subject|1
6839080|NCT00262951|10844779|FG000|Overall Study|Alternative treatment|3
6839081|NCT00262951|10844779|FG000|Overall Study|Off treatment for other disease|1
6839082|NCT00263211|10844812|FG000|Overall Study|Death|1
6839083|NCT00263211|10844813|FG001|Overall Study|Death|0
6839084|NCT00263211|10844812|FG000|Overall Study|Withdrawal by Subject|3
6839085|NCT00263211|10844813|FG001|Overall Study|Withdrawal by Subject|0
6839086|NCT00263211|10844812|FG000|Overall Study|Protocol Violation|1
6839087|NCT00263211|10844813|FG001|Overall Study|Protocol Violation|0
6839088|NCT00263211|10844812|FG000|Overall Study|Disease Progression|0
6839089|NCT00263211|10844813|FG001|Overall Study|Disease Progression|1
6839090|NCT00263328|10844825|FG000|Overall Study|Death|0
6839091|NCT00263328|10844826|FG001|Overall Study|Death|0
6839092|NCT00263328|10844827|FG002|Overall Study|Death|1
6839093|NCT00263328|10844825|FG000|Overall Study|Lost to Follow-up|1
6839094|NCT00263328|10844826|FG001|Overall Study|Lost to Follow-up|1
6839095|NCT00263328|10844827|FG002|Overall Study|Lost to Follow-up|0
6839096|NCT00263328|10844825|FG000|Overall Study|Withdrawal by Subject|3
6839097|NCT00263328|10844826|FG001|Overall Study|Withdrawal by Subject|0
6839098|NCT00263328|10844827|FG002|Overall Study|Withdrawal by Subject|1
6839099|NCT00263328|10844825|FG000|Overall Study|Other|3
6839100|NCT00263328|10844826|FG001|Overall Study|Other|0
6839101|NCT00263328|10844827|FG002|Overall Study|Other|1
6839102|NCT00263328|10844825|FG000|Overall Study|Adverse Event|1
6839103|NCT00263328|10844826|FG001|Overall Study|Adverse Event|1
6839104|NCT00263328|10844827|FG002|Overall Study|Adverse Event|4
6839105|NCT00263562|10844839|FG000|Overall Study|Protocol Violation|3
6839106|NCT00263562|10844840|FG001|Overall Study|Protocol Violation|0
6839107|NCT00263575|10844848|FG000|Titration Period|Adverse Event|14
6839108|NCT00263575|10844848|FG000|Titration Period|Withdrawal by Subject|10
6839109|NCT00263575|10844848|FG000|Titration Period|Protocol Violation|9
7073900|NCT02052466|11178902|FG000|Overall Study|Acromial fracture|1
7073901|NCT02052596|11178924|FG000|Active Phase|Adverse Event|3
7073902|NCT02052596|11178925|FG001|Active Phase|Adverse Event|2
7073903|NCT02052596|11178924|FG000|Active Phase|Lost to Follow-up|8
7073904|NCT02052596|11178925|FG001|Active Phase|Lost to Follow-up|11
6839110|NCT00263575|10844848|FG000|Titration Period|Sponsor Decision|2
6839111|NCT00263575|10844848|FG000|Titration Period|Other|2
7073905|NCT02052596|11178924|FG000|Active Phase|Protocol Violation|1
7073906|NCT02052596|11178925|FG001|Active Phase|Protocol Violation|2
7073907|NCT02052596|11178924|FG000|Active Phase|Withdrawal by Subject|3
7073908|NCT02052596|11178925|FG001|Active Phase|Withdrawal by Subject|4
7073909|NCT02052596|11178924|FG000|Active Phase|Enrolled in error|1
7073910|NCT02052596|11178925|FG001|Active Phase|Enrolled in error|0
7073911|NCT02052596|11178924|FG000|Active Phase|Lost due to Crohn's disease|0
6839112|NCT00263575|10844848|FG000|Titration Period|Lack of Efficacy|6
6839113|NCT00263575|10844848|FG000|Maintence Period|Adverse Event|23
6839114|NCT00263575|10844848|FG000|Maintence Period|Withdrawal by Subject|8
7073912|NCT02052596|11178925|FG001|Active Phase|Lost due to Crohn's disease|1
7073913|NCT02052596|11178924|FG000|Safety Phase|Adverse Event|6
7073914|NCT02052596|11178925|FG001|Safety Phase|Adverse Event|3
7073915|NCT02052596|11178924|FG000|Safety Phase|Lost to Follow-up|11
7073916|NCT02052596|11178925|FG001|Safety Phase|Lost to Follow-up|18
7073917|NCT02052596|11178924|FG000|Safety Phase|Protocol Violation|1
7073918|NCT02052596|11178925|FG001|Safety Phase|Protocol Violation|2
7073919|NCT02052596|11178924|FG000|Safety Phase|Withdrawal by Subject|8
7073920|NCT02052596|11178925|FG001|Safety Phase|Withdrawal by Subject|11
7073921|NCT02052596|11178924|FG000|Safety Phase|Enrolled in error|1
7073922|NCT02052596|11178925|FG001|Safety Phase|Enrolled in error|0
7073923|NCT02052596|11178924|FG000|Safety Phase|Lost due to Crohn's disease|0
7073924|NCT02052596|11178925|FG001|Safety Phase|Lost due to Crohn's disease|1
7073925|NCT02052960|11178972|FG000|Overall Study|Adverse Event|19
7073926|NCT02052960|11178973|FG001|Overall Study|Adverse Event|17
7073927|NCT02052960|11178972|FG000|Overall Study|Protocol Violation|4
7073928|NCT02052960|11178973|FG001|Overall Study|Protocol Violation|3
7073929|NCT02052960|11178972|FG000|Overall Study|Withdrawal by Subject|6
7073930|NCT02052960|11178973|FG001|Overall Study|Withdrawal by Subject|11
7073931|NCT02052960|11178972|FG000|Overall Study|Other|25
7073932|NCT02052960|11178973|FG001|Overall Study|Other|15
7073933|NCT02053168|11178986|FG000|Overall Study|Withdrawal by Subject|1
7073934|NCT02053168|11178986|FG000|Overall Study|Physician Decision|1
7073935|NCT02053168|11178986|FG000|Overall Study|Lost to Follow-up|1
7073936|NCT02053493|11179013|FG000|Overall Study|Withdrawal by Subject|1
7073937|NCT02053493|11179014|FG001|Overall Study|Withdrawal by Subject|1
7073938|NCT02053610|11179022|FG000|Overall Study|Adverse Event/Intercurrent Illness|25
7073939|NCT02053610|11179023|FG001|Overall Study|Adverse Event/Intercurrent Illness|43
7073940|NCT02053610|11179022|FG000|Overall Study|Withdrew Consent|2
7073941|NCT02053610|11179023|FG001|Overall Study|Withdrew Consent|9
7073942|NCT02053610|11179022|FG000|Overall Study|Death|5
7073943|NCT02053610|11179023|FG001|Overall Study|Death|5
7073944|NCT02053610|11179022|FG000|Overall Study|Administrative/Other|1
7073945|NCT02053610|11179023|FG001|Overall Study|Administrative/Other|1
7073946|NCT02053610|11179022|FG000|Overall Study|Disease Progression|2
7073947|NCT02053610|11179023|FG001|Overall Study|Disease Progression|3
7073948|NCT02053610|11179022|FG000|Overall Study|Refused treatment/Did not cooperate|1
7073949|NCT02053610|11179023|FG001|Overall Study|Refused treatment/Did not cooperate|3
7073950|NCT02053610|11179022|FG000|Overall Study|Did not Receive Treatment|4
7073951|NCT02053610|11179023|FG001|Overall Study|Did not Receive Treatment|2
7073952|NCT02053610|11179022|FG000|Overall Study|Insufficient Therapeutic Response|1
7073953|NCT02053610|11179023|FG001|Overall Study|Insufficient Therapeutic Response|1
7073954|NCT02053610|11179022|FG000|Overall Study|Violation of Selection Criteria|1
7073955|NCT02053610|11179023|FG001|Overall Study|Violation of Selection Criteria|0
7073956|NCT02053753|11179031|FG000|Overall Study|Withdrawal by Subject|2
7073957|NCT02053753|11179032|FG001|Overall Study|Withdrawal by Subject|4
7073958|NCT02053753|11179031|FG000|Overall Study|Decision by Sponsor|1
7073959|NCT02053753|11179032|FG001|Overall Study|Decision by Sponsor|1
7073960|NCT02053753|11179031|FG000|Overall Study|Lost to Follow-up|4
7073961|NCT02053753|11179032|FG001|Overall Study|Lost to Follow-up|3
7073962|NCT02054130|11179042|FG000|Overall Study|Withdrawal by Subject|4
7073963|NCT02054130|11179043|FG001|Overall Study|Withdrawal by Subject|4
7073964|NCT02054130|11179044|FG002|Overall Study|Withdrawal by Subject|7
7073965|NCT02054130|11179045|FG003|Overall Study|Withdrawal by Subject|10
7073966|NCT02054130|11179042|FG000|Overall Study|Death|0
7073967|NCT02054130|11179043|FG001|Overall Study|Death|1
7073968|NCT02054130|11179044|FG002|Overall Study|Death|0
7073969|NCT02054130|11179045|FG003|Overall Study|Death|0
7073970|NCT02054130|11179042|FG000|Overall Study|Lost to Follow-up|0
7073971|NCT02054130|11179043|FG001|Overall Study|Lost to Follow-up|0
7073972|NCT02054130|11179044|FG002|Overall Study|Lost to Follow-up|1
7073973|NCT02054130|11179045|FG003|Overall Study|Lost to Follow-up|2
7073974|NCT02054130|11179042|FG000|Overall Study|Missed dose|4
7073975|NCT02054130|11179043|FG001|Overall Study|Missed dose|6
7073976|NCT02054130|11179044|FG002|Overall Study|Missed dose|7
7073977|NCT02054130|11179045|FG003|Overall Study|Missed dose|10
7073978|NCT02054325|11179069|FG000|Overall Study|Lost to Follow-up|8
7073979|NCT02054325|11179070|FG001|Overall Study|Lost to Follow-up|5
7073980|NCT02054481|11179089|FG000|Overall Study|Adverse Event|1
7073981|NCT02054481|11179090|FG001|Overall Study|Adverse Event|1
7073982|NCT02054481|11179091|FG002|Overall Study|Adverse Event|0
7073983|NCT02054481|11179092|FG003|Overall Study|Adverse Event|1
7073984|NCT02054481|11179089|FG000|Overall Study|Lost to Follow-up|1
7073985|NCT02054481|11179090|FG001|Overall Study|Lost to Follow-up|0
7073986|NCT02054481|11179091|FG002|Overall Study|Lost to Follow-up|0
7073987|NCT02054481|11179092|FG003|Overall Study|Lost to Follow-up|0
7073988|NCT02054481|11179089|FG000|Overall Study|Other reason|2
7073989|NCT02054481|11179090|FG001|Overall Study|Other reason|1
7073990|NCT02054481|11179091|FG002|Overall Study|Other reason|2
7073991|NCT02054481|11179092|FG003|Overall Study|Other reason|0
7073992|NCT02054520|11179109|FG000|Overall Study|Adverse Event|1
7073993|NCT02054520|11179110|FG001|Overall Study|Adverse Event|4
7073994|NCT02054520|11179111|FG002|Overall Study|Adverse Event|2
7073995|NCT02054520|11179112|FG003|Overall Study|Adverse Event|1
7073996|NCT02054520|11179113|FG004|Overall Study|Adverse Event|1
7073997|NCT02054520|11179114|FG005|Overall Study|Adverse Event|0
7073998|NCT02054520|11179109|FG000|Overall Study|Lack of Efficacy|7
7073999|NCT02054520|11179110|FG001|Overall Study|Lack of Efficacy|0
7074000|NCT02054520|11179111|FG002|Overall Study|Lack of Efficacy|2
7074001|NCT02054520|11179112|FG003|Overall Study|Lack of Efficacy|1
7074002|NCT02054520|11179113|FG004|Overall Study|Lack of Efficacy|3
7074003|NCT02054520|11179114|FG005|Overall Study|Lack of Efficacy|2
7074004|NCT02054520|11179109|FG000|Overall Study|Withdrawal by Subject|1
7074005|NCT02054520|11179110|FG001|Overall Study|Withdrawal by Subject|0
7074006|NCT02054520|11179111|FG002|Overall Study|Withdrawal by Subject|0
7074007|NCT02054520|11179112|FG003|Overall Study|Withdrawal by Subject|2
7074008|NCT02054520|11179113|FG004|Overall Study|Withdrawal by Subject|1
7074009|NCT02054520|11179114|FG005|Overall Study|Withdrawal by Subject|0
7074010|NCT02054520|11179109|FG000|Overall Study|Physician Decision|0
7074011|NCT02054520|11179110|FG001|Overall Study|Physician Decision|1
7074012|NCT02054520|11179111|FG002|Overall Study|Physician Decision|0
7074013|NCT02054520|11179112|FG003|Overall Study|Physician Decision|1
7074014|NCT02054520|11179113|FG004|Overall Study|Physician Decision|0
7074015|NCT02054520|11179114|FG005|Overall Study|Physician Decision|1
7074016|NCT02054520|11179109|FG000|Overall Study|Study terminated by Sponsor|0
7074017|NCT02054520|11179110|FG001|Overall Study|Study terminated by Sponsor|0
7074018|NCT02054520|11179111|FG002|Overall Study|Study terminated by Sponsor|2
7074019|NCT02054520|11179112|FG003|Overall Study|Study terminated by Sponsor|1
7074020|NCT02054520|11179113|FG004|Overall Study|Study terminated by Sponsor|0
6839115|NCT00263575|10844848|FG000|Maintence Period|Protocol Violation|4
6839116|NCT00263575|10844848|FG000|Maintence Period|Lack of Efficacy|4
6839117|NCT00263575|10844848|FG000|Maintence Period|Physician Decision|6
6839118|NCT00263575|10844848|FG000|Maintence Period|Lost to Follow-up|1
6839119|NCT00263575|10844848|FG000|Maintence Period|Sponsor Decision|24
6839120|NCT00263575|10844848|FG000|Maintence Period|Other|7
6839121|NCT00263588|10844856|FG000|Overall Study|Death|54
6839122|NCT00263588|10844857|FG001|Overall Study|Death|90
6839123|NCT00263588|10844856|FG000|Overall Study|disease progression, coma, 1 unknown|10
6839124|NCT00263588|10844857|FG001|Overall Study|disease progression, coma, 1 unknown|11
6839125|NCT00263588|10844856|FG000|Overall Study|Lost to Follow-up|7
6839126|NCT00263588|10844857|FG001|Overall Study|Lost to Follow-up|10
6839127|NCT00263588|10844856|FG000|Overall Study|Withdrawal by Subject|3
6839128|NCT00263588|10844857|FG001|Overall Study|Withdrawal by Subject|4
6839129|NCT00263588|10844856|FG000|Overall Study|Protocol Violation|0
6839130|NCT00263588|10844857|FG001|Overall Study|Protocol Violation|1
6839131|NCT00263588|10844856|FG000|Overall Study|Investigator decision|7
7074021|NCT02054520|11179114|FG005|Overall Study|Study terminated by Sponsor|0
7074022|NCT02054702|11179134|FG000|Overall Study|Lost to Follow-up|3
7074023|NCT02054702|11179135|FG001|Overall Study|Lost to Follow-up|5
7074024|NCT02054702|11179134|FG000|Overall Study|Adverse Event|3
6839132|NCT00263588|10844857|FG001|Overall Study|Investigator decision|15
6839133|NCT00263588|10844856|FG000|Overall Study|Sponsor terminated study|0
6839134|NCT00263588|10844857|FG001|Overall Study|Sponsor terminated study|1
6839135|NCT00263666|10844866|FG000|Overall Study|Adverse Event|6
6839136|NCT00263666|10844867|FG001|Overall Study|Adverse Event|8
6839137|NCT00263666|10844866|FG000|Overall Study|Lost to Follow-up|1
6839138|NCT00263666|10844867|FG001|Overall Study|Lost to Follow-up|2
6839139|NCT00263666|10844866|FG000|Overall Study|Withdrawal by Subject|0
6839140|NCT00263666|10844867|FG001|Overall Study|Withdrawal by Subject|1
6839141|NCT00263757|10844875|FG000|Overall Study|Withdrawal by Subject|5
6839142|NCT00263757|10844876|FG001|Overall Study|Withdrawal by Subject|4
6839143|NCT00263757|10844875|FG000|Overall Study|Screen failure|0
6839144|NCT00263757|10844876|FG001|Overall Study|Screen failure|1
6839145|NCT00263757|10844875|FG000|Overall Study|Adverse Event|3
6839146|NCT00263757|10844876|FG001|Overall Study|Adverse Event|3
6839147|NCT00263887|10844884|FG000|Overall Study|Withdrawal by Subject|1
6839148|NCT00263887|10844885|FG001|Overall Study|Withdrawal by Subject|1
6839149|NCT00263887|10844884|FG000|Overall Study|Lung transplantation|1
6839150|NCT00263887|10844885|FG001|Overall Study|Lung transplantation|2
6839151|NCT00263887|10844884|FG000|Overall Study|Too ill to attend visit|1
6839152|NCT00263887|10844885|FG001|Overall Study|Too ill to attend visit|0
6839153|NCT00263887|10844884|FG000|Overall Study|Adverse Event|0
6839154|NCT00263887|10844885|FG001|Overall Study|Adverse Event|2
6839155|NCT00263887|10844884|FG000|Overall Study|Disease progression|0
6839156|NCT00263887|10844885|FG001|Overall Study|Disease progression|1
6839157|NCT00263887|10844884|FG000|Overall Study|Lack of Efficacy|0
6839158|NCT00263887|10844885|FG001|Overall Study|Lack of Efficacy|1
6839159|NCT00264004|10844895|FG000|Overall Study|Adverse Event|2
6839160|NCT00264004|10844896|FG001|Overall Study|Adverse Event|3
6839161|NCT00264004|10844897|FG002|Overall Study|Adverse Event|6
6839162|NCT00264004|10844898|FG003|Overall Study|Adverse Event|4
6839163|NCT00264004|10844895|FG000|Overall Study|Withdrawal by Subject|0
7074025|NCT02054702|11179135|FG001|Overall Study|Adverse Event|1
7074026|NCT02054702|11179134|FG000|Overall Study|Met Withdrawal Criteria|4
7074027|NCT02054702|11179135|FG001|Overall Study|Met Withdrawal Criteria|1
7074028|NCT02054702|11179134|FG000|Overall Study|Physician Decision|0
7074029|NCT02054702|11179135|FG001|Overall Study|Physician Decision|1
7074030|NCT02054702|11179134|FG000|Overall Study|Withdrawal by Subject|14
6839164|NCT00264004|10844896|FG001|Overall Study|Withdrawal by Subject|1
6839165|NCT00264004|10844897|FG002|Overall Study|Withdrawal by Subject|2
6839166|NCT00264004|10844898|FG003|Overall Study|Withdrawal by Subject|2
6839167|NCT00264004|10844895|FG000|Overall Study|Other|2
7074031|NCT02054702|11179135|FG001|Overall Study|Withdrawal by Subject|4
7074032|NCT02054715|11179143|FG000|Baseline/Follow-up 1|Refused|1
7074033|NCT02054715|11179144|FG001|Baseline/Follow-up 1|Refused|3
7074034|NCT02054715|11179143|FG000|Baseline/Follow-up 1|Medical|0
7074035|NCT02054715|11179144|FG001|Baseline/Follow-up 1|Medical|1
7074036|NCT02054715|11179143|FG000|Baseline/Follow-up 1|Changed MD/Facility|0
7074037|NCT02054715|11179144|FG001|Baseline/Follow-up 1|Changed MD/Facility|1
7074038|NCT02054715|11179143|FG000|Baseline/Follow-up 1|Disliked Procedure|0
7074039|NCT02054715|11179144|FG001|Baseline/Follow-up 1|Disliked Procedure|1
7074040|NCT02054715|11179143|FG000|Baseline/Follow-up 1|No Reason|0
7074041|NCT02054715|11179144|FG001|Baseline/Follow-up 1|No Reason|1
7074042|NCT02054715|11179143|FG000|Baseline/Follow-up 1|Overwhelmed|2
7074043|NCT02054715|11179144|FG001|Baseline/Follow-up 1|Overwhelmed|0
7074044|NCT02054715|11179143|FG000|Baseline/Follow-up 1|Ineligible|3
7074045|NCT02054715|11179144|FG001|Baseline/Follow-up 1|Ineligible|0
7074046|NCT02054715|11179143|FG000|Baseline/Follow-up 1|Hospitalization|1
7074047|NCT02054715|11179144|FG001|Baseline/Follow-up 1|Hospitalization|0
7074048|NCT02054715|11179143|FG000|Baseline/Follow-up 1|Changed Mind|1
7074049|NCT02054715|11179144|FG001|Baseline/Follow-up 1|Changed Mind|0
7074050|NCT02054715|11179143|FG000|Follow-up 2|Lost to Followup|3
7074051|NCT02054715|11179144|FG001|Follow-up 2|Lost to Followup|1
7074052|NCT02054715|11179143|FG000|Follow-up 2|Refused|3
6839168|NCT00264004|10844896|FG001|Overall Study|Other|2
6839169|NCT00264004|10844897|FG002|Overall Study|Other|0
6839170|NCT00264004|10844898|FG003|Overall Study|Other|3
6839171|NCT00264004|10844895|FG000|Overall Study|Development study specific disc. crit.|1
6839172|NCT00264004|10844896|FG001|Overall Study|Development study specific disc. crit.|0
6839173|NCT00264004|10844897|FG002|Overall Study|Development study specific disc. crit.|1
6839174|NCT00264004|10844898|FG003|Overall Study|Development study specific disc. crit.|0
6839175|NCT00264004|10844895|FG000|Overall Study|Cond. under inv. worsened|9
6839176|NCT00264004|10844896|FG001|Overall Study|Cond. under inv. worsened|5
6839177|NCT00264004|10844897|FG002|Overall Study|Cond. under inv. worsened|3
6839178|NCT00264004|10844898|FG003|Overall Study|Cond. under inv. worsened|4
6839179|NCT00264004|10844895|FG000|Overall Study|Not treated|3
6839180|NCT00264004|10844896|FG001|Overall Study|Not treated|0
6839181|NCT00264004|10844897|FG002|Overall Study|Not treated|2
6839182|NCT00264004|10844898|FG003|Overall Study|Not treated|2
6839183|NCT00264238|10844908|FG000|Overall Study|Protocol Violation|1
6839184|NCT00264290|10844916|FG000|Intervention (8 Weeks)|Adverse Event|1
6839185|NCT00264290|10844917|FG001|Intervention (8 Weeks)|Adverse Event|0
6839186|NCT00264303|10844929|FG000|Overall Study|Adverse Event|4
6839187|NCT00264303|10844930|FG001|Overall Study|Adverse Event|3
6839188|NCT00264303|10844929|FG000|Overall Study|Lack of Efficacy|10
6839189|NCT00264303|10844930|FG001|Overall Study|Lack of Efficacy|13
6839190|NCT00264303|10844929|FG000|Overall Study|Lost to Follow-up|3
6839191|NCT00264303|10844930|FG001|Overall Study|Lost to Follow-up|3
6839192|NCT00264303|10844929|FG000|Overall Study|Withdrawal by Subject|2
6839193|NCT00264303|10844930|FG001|Overall Study|Withdrawal by Subject|3
6839194|NCT00264303|10844929|FG000|Overall Study|Various reasons listed in study report|6
6839195|NCT00264303|10844930|FG001|Overall Study|Various reasons listed in study report|7
6839196|NCT00264498|10844947|FG000|Randomized Treatment|Death|0
6839197|NCT00264498|10844948|FG001|Randomized Treatment|Death|3
6839198|NCT00264498|10844947|FG000|Randomized Treatment|Withdrawal by Subject|0
6839199|NCT00264498|10844948|FG001|Randomized Treatment|Withdrawal by Subject|1
7074053|NCT02054715|11179144|FG001|Follow-up 2|Refused|2
7074054|NCT02054715|11179143|FG000|Follow-up 2|Followup Not Completed|3
7074055|NCT02054715|11179144|FG001|Follow-up 2|Followup Not Completed|4
7074056|NCT02054715|11179143|FG000|Follow-up 2|Ineligible|4
7074057|NCT02054715|11179144|FG001|Follow-up 2|Ineligible|5
7074058|NCT02054715|11179143|FG000|Follow-up 2|Death|3
7074059|NCT02054715|11179144|FG001|Follow-up 2|Death|3
7074060|NCT02054715|11179143|FG000|Follow-up 2|Hospitalization|0
7074061|NCT02054715|11179144|FG001|Follow-up 2|Hospitalization|2
7074062|NCT02054715|11179143|FG000|Follow-up 2|Changed MD/Facility|0
7074063|NCT02054715|11179144|FG001|Follow-up 2|Changed MD/Facility|1
7074064|NCT02054715|11179143|FG000|Follow-up 2|Changed Mind|0
7074065|NCT02054715|11179144|FG001|Follow-up 2|Changed Mind|1
7074066|NCT02054715|11179143|FG000|Follow-up 2|No Reason|2
7074067|NCT02054715|11179144|FG001|Follow-up 2|No Reason|0
7074068|NCT02054715|11179143|FG000|Follow-up 2|Treatment Change or Delay|1
6839200|NCT00264498|10844947|FG000|Randomized Treatment|Objective disease Progression|13
6839201|NCT00264498|10844948|FG001|Randomized Treatment|Objective disease Progression|14
6839202|NCT00264498|10844947|FG000|Randomized Treatment|Physician Decision|1
6839203|NCT00264498|10844948|FG001|Randomized Treatment|Physician Decision|0
6839204|NCT00264498|10844947|FG000|Randomized Treatment|Incorrectly randomized|1
6839205|NCT00264498|10844948|FG001|Randomized Treatment|Incorrectly randomized|0
6839206|NCT00264498|10844947|FG000|Randomized Treatment|Study Closure|1
6839207|NCT00264498|10844948|FG001|Randomized Treatment|Study Closure|0
6839208|NCT00264498|10844947|FG000|Randomized Treatment|Protocol Violation|1
7074069|NCT02054715|11179144|FG001|Follow-up 2|Treatment Change or Delay|0
7074070|NCT02054897|11179175|FG000|Overall Study|Withdrawal by Subject|2
7074071|NCT02054897|11179176|FG001|Overall Study|Withdrawal by Subject|0
7074072|NCT02054897|11179177|FG002|Overall Study|Withdrawal by Subject|2
7074073|NCT02054897|11179175|FG000|Overall Study|Missing follow-up information|3
7074074|NCT02054897|11179176|FG001|Overall Study|Missing follow-up information|5
7074075|NCT02054897|11179177|FG002|Overall Study|Missing follow-up information|3
7074076|NCT02054897|11179175|FG000|Overall Study|Lost to Follow-up|4
7074077|NCT02054897|11179176|FG001|Overall Study|Lost to Follow-up|2
7074078|NCT02054897|11179177|FG002|Overall Study|Lost to Follow-up|7
7074079|NCT02054897|11179175|FG000|Overall Study|Randomized but not exposed|1
7074080|NCT02054897|11179176|FG001|Overall Study|Randomized but not exposed|0
7074081|NCT02054897|11179177|FG002|Overall Study|Randomized but not exposed|0
7074082|NCT02055118|11179188|FG000|Overall Study|Withdrawal by Subject|0
7074083|NCT02055118|11179189|FG001|Overall Study|Withdrawal by Subject|2
7074084|NCT02055118|11179190|FG002|Overall Study|Withdrawal by Subject|0
7074085|NCT02055157|11179203|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0
7074086|NCT02055157|11179204|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1
7074087|NCT02055157|11179205|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0
7074088|NCT02055157|11179206|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0
7074089|NCT02055157|11179203|FG000|Initial 6 Months|Adverse Event|0
7074090|NCT02055157|11179204|FG001|Initial 6 Months|Adverse Event|0
7074091|NCT02055157|11179205|FG002|Initial 6 Months|Adverse Event|0
7074092|NCT02055157|11179206|FG003|Initial 6 Months|Adverse Event|1
7074093|NCT02055157|11179203|FG000|Initial 6 Months|Consent withdrawn by subject|1
7074094|NCT02055157|11179204|FG001|Initial 6 Months|Consent withdrawn by subject|0
7074095|NCT02055157|11179205|FG002|Initial 6 Months|Consent withdrawn by subject|0
7074096|NCT02055157|11179206|FG003|Initial 6 Months|Consent withdrawn by subject|0
7074097|NCT02055157|11179203|FG000|18-month Extension|Investigator decision|0
7074098|NCT02055157|11179204|FG001|18-month Extension|Investigator decision|1
7074099|NCT02055157|11179205|FG002|18-month Extension|Investigator decision|0
7074100|NCT02055157|11179206|FG003|18-month Extension|Investigator decision|0
7074101|NCT02055157|11179203|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1
7074102|NCT02055157|11179204|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0
7074103|NCT02055157|11179205|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0
7074104|NCT02055157|11179206|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0
7074105|NCT02055352|11179229|FG000|Overall Study|Adverse Event|0
7074106|NCT02055352|11179230|FG001|Overall Study|Adverse Event|1
7074107|NCT02055352|11179229|FG000|Overall Study|Non-eligible|0
7074108|NCT02055352|11179230|FG001|Overall Study|Non-eligible|1
7074109|NCT02055352|11179229|FG000|Overall Study|Poor compliance|1
7074110|NCT02055352|11179230|FG001|Overall Study|Poor compliance|1
7074111|NCT02055352|11179229|FG000|Overall Study|Death|1
7074112|NCT02055352|11179230|FG001|Overall Study|Death|2
7074113|NCT02055352|11179229|FG000|Overall Study|Patient decision|1
7074114|NCT02055352|11179230|FG001|Overall Study|Patient decision|1
7074115|NCT02055352|11179229|FG000|Overall Study|Use of prohibited treatment|0
7074116|NCT02055352|11179230|FG001|Overall Study|Use of prohibited treatment|3
7074117|NCT02055352|11179229|FG000|Overall Study|AE, study drug would be detrimental|1
7074118|NCT02055352|11179230|FG001|Overall Study|AE, study drug would be detrimental|3
7074119|NCT02055352|11179229|FG000|Overall Study|Withdrawal of informed consent|1
7074120|NCT02055352|11179230|FG001|Overall Study|Withdrawal of informed consent|0
7074121|NCT02055352|11179229|FG000|Overall Study|Reason unknown|1
7074122|NCT02055352|11179230|FG001|Overall Study|Reason unknown|5
7074123|NCT02055365|11179236|FG000|Overall Study|Prematurely Withdrawn|1
7074124|NCT02055820|11179301|FG000|Phase I: Dose-Finding|Death|1
7074125|NCT02055820|11179302|FG001|Phase I: Dose-Finding|Death|0
7074126|NCT02055820|11179303|FG002|Phase I: Dose-Finding|Death|1
7074127|NCT02055820|11179304|FG003|Phase I: Dose-Finding|Death|2
7074128|NCT02055820|11179305|FG004|Phase I: Dose-Finding|Death|0
7074129|NCT02055820|11179306|FG005|Phase I: Dose-Finding|Death|1
7074130|NCT02055820|11179307|FG006|Phase I: Dose-Finding|Death|1
7074131|NCT02055820|11179308|FG007|Phase I: Dose-Finding|Death|0
7074132|NCT02055820|11179309|FG008|Phase I: Dose-Finding|Death|0
7074133|NCT02055820|11179310|FG009|Phase I: Dose-Finding|Death|0
7074134|NCT02055820|11179301|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0
7074135|NCT02055820|11179302|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0
7074136|NCT02055820|11179303|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0
7074137|NCT02055820|11179304|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0
7074138|NCT02055820|11179305|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0
7074139|NCT02055820|11179306|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1
7074140|NCT02055820|11179307|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0
7074141|NCT02055820|11179308|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0
7074142|NCT02055820|11179309|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0
7074143|NCT02055820|11179310|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0
7074144|NCT02055820|11179301|FG000|Phase I: Dose-Finding|Lost to Follow-up|0
7074145|NCT02055820|11179302|FG001|Phase I: Dose-Finding|Lost to Follow-up|0
7074146|NCT02055820|11179303|FG002|Phase I: Dose-Finding|Lost to Follow-up|0
7074147|NCT02055820|11179304|FG003|Phase I: Dose-Finding|Lost to Follow-up|1
7074148|NCT02055820|11179305|FG004|Phase I: Dose-Finding|Lost to Follow-up|0
7074149|NCT02055820|11179306|FG005|Phase I: Dose-Finding|Lost to Follow-up|0
7074150|NCT02055820|11179307|FG006|Phase I: Dose-Finding|Lost to Follow-up|1
7074151|NCT02055820|11179308|FG007|Phase I: Dose-Finding|Lost to Follow-up|0
7074152|NCT02055820|11179309|FG008|Phase I: Dose-Finding|Lost to Follow-up|0
7074153|NCT02055820|11179310|FG009|Phase I: Dose-Finding|Lost to Follow-up|0
7074154|NCT02055820|11179301|FG000|Phase II: Expansion|Death|0
7074155|NCT02055820|11179302|FG001|Phase II: Expansion|Death|0
7074156|NCT02055820|11179303|FG002|Phase II: Expansion|Death|0
7074157|NCT02055820|11179304|FG003|Phase II: Expansion|Death|0
7074158|NCT02055820|11179305|FG004|Phase II: Expansion|Death|33
7074159|NCT02055820|11179306|FG005|Phase II: Expansion|Death|0
7074160|NCT02055820|11179307|FG006|Phase II: Expansion|Death|0
7074161|NCT02055820|11179308|FG007|Phase II: Expansion|Death|0
7074162|NCT02055820|11179309|FG008|Phase II: Expansion|Death|0
7074163|NCT02055820|11179310|FG009|Phase II: Expansion|Death|0
7074164|NCT02055820|11179301|FG000|Phase II: Expansion|Lost to Follow-up|0
7074165|NCT02055820|11179302|FG001|Phase II: Expansion|Lost to Follow-up|0
7074166|NCT02055820|11179303|FG002|Phase II: Expansion|Lost to Follow-up|0
7074167|NCT02055820|11179304|FG003|Phase II: Expansion|Lost to Follow-up|0
7074168|NCT02055820|11179305|FG004|Phase II: Expansion|Lost to Follow-up|4
7074169|NCT02055820|11179306|FG005|Phase II: Expansion|Lost to Follow-up|0
7074170|NCT02055820|11179307|FG006|Phase II: Expansion|Lost to Follow-up|0
7074171|NCT02055820|11179308|FG007|Phase II: Expansion|Lost to Follow-up|0
7074172|NCT02055820|11179309|FG008|Phase II: Expansion|Lost to Follow-up|0
7074173|NCT02055820|11179310|FG009|Phase II: Expansion|Lost to Follow-up|0
7074174|NCT02055820|11179301|FG000|Phase II: Expansion|Withdrawal by Subject|0
7074175|NCT02055820|11179302|FG001|Phase II: Expansion|Withdrawal by Subject|0
7074176|NCT02055820|11179303|FG002|Phase II: Expansion|Withdrawal by Subject|0
7074177|NCT02055820|11179304|FG003|Phase II: Expansion|Withdrawal by Subject|0
7074178|NCT02055820|11179305|FG004|Phase II: Expansion|Withdrawal by Subject|12
7074179|NCT02055820|11179306|FG005|Phase II: Expansion|Withdrawal by Subject|0
7074180|NCT02055820|11179307|FG006|Phase II: Expansion|Withdrawal by Subject|0
7074181|NCT02055820|11179308|FG007|Phase II: Expansion|Withdrawal by Subject|0
7074182|NCT02055820|11179309|FG008|Phase II: Expansion|Withdrawal by Subject|0
7074183|NCT02055820|11179310|FG009|Phase II: Expansion|Withdrawal by Subject|0
7074184|NCT02055898|11179354|FG000|First Intervention (5 Days)|Physician Decision|2
7074185|NCT02055898|11179355|FG001|First Intervention (5 Days)|Physician Decision|0
7074186|NCT02055898|11179354|FG000|First Intervention (5 Days)|Withdrawal by Subject|0
7074187|NCT02055898|11179355|FG001|First Intervention (5 Days)|Withdrawal by Subject|1
7074188|NCT02055976|11179370|FG000|Overall Study|Other|0
7074189|NCT02055976|11179371|FG001|Overall Study|Other|0
7074190|NCT02055976|11179372|FG002|Overall Study|Other|1
7074191|NCT02055976|11179373|FG003|Overall Study|Other|0
7074192|NCT02055976|11179374|FG004|Overall Study|Other|0
7074193|NCT02055976|11179375|FG005|Overall Study|Other|0
7074194|NCT02055976|11179376|FG006|Overall Study|Other|0
7074195|NCT02055976|11179377|FG007|Overall Study|Other|0
7074196|NCT02055976|11179378|FG008|Overall Study|Other|0
7074197|NCT02055976|11179370|FG000|Overall Study|Adverse Event|0
7074198|NCT02055976|11179371|FG001|Overall Study|Adverse Event|0
7074199|NCT02055976|11179372|FG002|Overall Study|Adverse Event|0
7074200|NCT02055976|11179373|FG003|Overall Study|Adverse Event|0
7074201|NCT02055976|11179374|FG004|Overall Study|Adverse Event|0
7074202|NCT02055976|11179375|FG005|Overall Study|Adverse Event|1
7074203|NCT02055976|11179376|FG006|Overall Study|Adverse Event|1
7074204|NCT02055976|11179377|FG007|Overall Study|Adverse Event|0
7074205|NCT02055976|11179378|FG008|Overall Study|Adverse Event|0
7074206|NCT02055976|11179370|FG000|Overall Study|Does not meet entrance criteria|0
7074207|NCT02055976|11179371|FG001|Overall Study|Does not meet entrance criteria|0
7074208|NCT02055976|11179372|FG002|Overall Study|Does not meet entrance criteria|0
7074209|NCT02055976|11179373|FG003|Overall Study|Does not meet entrance criteria|0
7074210|NCT02055976|11179374|FG004|Overall Study|Does not meet entrance criteria|0
7074211|NCT02055976|11179375|FG005|Overall Study|Does not meet entrance criteria|0
7074212|NCT02055976|11179376|FG006|Overall Study|Does not meet entrance criteria|1
7074213|NCT02055976|11179377|FG007|Overall Study|Does not meet entrance criteria|0
7074214|NCT02055976|11179378|FG008|Overall Study|Does not meet entrance criteria|0
7074215|NCT02055976|11179370|FG000|Overall Study|Lost to Follow-up|0
7074216|NCT02055976|11179371|FG001|Overall Study|Lost to Follow-up|0
7074217|NCT02055976|11179372|FG002|Overall Study|Lost to Follow-up|0
7074218|NCT02055976|11179373|FG003|Overall Study|Lost to Follow-up|1
7074219|NCT02055976|11179374|FG004|Overall Study|Lost to Follow-up|0
7074220|NCT02055976|11179375|FG005|Overall Study|Lost to Follow-up|0
7074221|NCT02055976|11179376|FG006|Overall Study|Lost to Follow-up|0
7074222|NCT02055976|11179377|FG007|Overall Study|Lost to Follow-up|0
7074223|NCT02055976|11179378|FG008|Overall Study|Lost to Follow-up|0
7074224|NCT02056288|11179416|FG000|In-Hospital Data|Surgery cancelled|1
7074225|NCT02056288|11179417|FG001|In-Hospital Data|Surgery cancelled|0
7074226|NCT02056288|11179416|FG000|In-Hospital Data|Protocol Violation|3
7074227|NCT02056288|11179417|FG001|In-Hospital Data|Protocol Violation|0
7074228|NCT02056288|11179416|FG000|In-Hospital Data|Physician Decision|1
7074229|NCT02056288|11179417|FG001|In-Hospital Data|Physician Decision|0
7074230|NCT02056288|11179416|FG000|48-Hour Post-Discharge Data|Did not return diary|14
7074231|NCT02056288|11179417|FG001|48-Hour Post-Discharge Data|Did not return diary|20
7074232|NCT02056301|11179425|FG000|Overall Study|Protocol Violation|1
7074233|NCT02056301|11179426|FG001|Overall Study|Protocol Violation|2
7074234|NCT02056301|11179425|FG000|Overall Study|Surgical complications req. 2nd surgery|1
7074235|NCT02056301|11179426|FG001|Overall Study|Surgical complications req. 2nd surgery|0
7074236|NCT02056301|11179425|FG000|Overall Study|Withdrawal by Subject|0
7074237|NCT02056301|11179426|FG001|Overall Study|Withdrawal by Subject|1
7074238|NCT02056301|11179425|FG000|Overall Study|Issues with epidural|0
7074239|NCT02056301|11179426|FG001|Overall Study|Issues with epidural|3
7074240|NCT02056340|11179434|FG000|Overall Study|Lost to Follow-up|5
7074241|NCT02056340|11179435|FG001|Overall Study|Lost to Follow-up|5
7074242|NCT02056340|11179434|FG000|Overall Study|Withdrawal by Subject|2
7074243|NCT02056340|11179435|FG001|Overall Study|Withdrawal by Subject|6
7074244|NCT02056392|11179447|FG000|Overall Study|Lost to Follow-up|0
7074245|NCT02056392|11179448|FG001|Overall Study|Lost to Follow-up|1
7074246|NCT02056392|11179449|FG002|Overall Study|Lost to Follow-up|2
7074247|NCT02056392|11179450|FG003|Overall Study|Lost to Follow-up|0
7074248|NCT02056392|11179451|FG004|Overall Study|Lost to Follow-up|0
7074249|NCT02056392|11179452|FG005|Overall Study|Lost to Follow-up|0
7074250|NCT02056392|11179447|FG000|Overall Study|Protocol Violation|1
7074251|NCT02056392|11179448|FG001|Overall Study|Protocol Violation|0
7074252|NCT02056392|11179449|FG002|Overall Study|Protocol Violation|1
7074253|NCT02056392|11179450|FG003|Overall Study|Protocol Violation|0
7074254|NCT02056392|11179451|FG004|Overall Study|Protocol Violation|0
7074255|NCT02056392|11179452|FG005|Overall Study|Protocol Violation|0
7074256|NCT02056392|11179447|FG000|Overall Study|Withdrawal by Subject|1
7074257|NCT02056392|11179448|FG001|Overall Study|Withdrawal by Subject|0
7074258|NCT02056392|11179449|FG002|Overall Study|Withdrawal by Subject|0
7074259|NCT02056392|11179450|FG003|Overall Study|Withdrawal by Subject|0
7074260|NCT02056392|11179451|FG004|Overall Study|Withdrawal by Subject|1
7074261|NCT02056392|11179452|FG005|Overall Study|Withdrawal by Subject|0
7074262|NCT02056626|11179475|FG000|Overall Study|patient did not follow directions|3
7074263|NCT02056626|11179476|FG001|Overall Study|patient did not follow directions|1
7074264|NCT02056626|11179477|FG002|Overall Study|patient did not follow directions|0
7074265|NCT02056626|11179478|FG003|Overall Study|patient did not follow directions|0
7082732|NCT02145078|11193437|FG000|Overall Study|Death|1
7082733|NCT02145078|11193437|FG000|Overall Study|Reason not given|3
6839209|NCT00264498|10844948|FG001|Randomized Treatment|Protocol Violation|0
6839210|NCT00264498|10844947|FG000|Crossover Treatment|Death|1
6839211|NCT00264498|10844948|FG001|Crossover Treatment|Death|3
6839212|NCT00264498|10844947|FG000|Crossover Treatment|Objective disease progression|4
7082734|NCT02145156|11193444|FG000|Overall Study|No match to vaccination records|60
7082735|NCT02145156|11193445|FG001|Overall Study|No match to vaccination records|52
7082736|NCT02145156|11193446|FG002|Overall Study|No match to vaccination records|41
7082737|NCT02145182|11193456|FG000|Overall Study|Adverse Event|4
7082738|NCT02145182|11193457|FG001|Overall Study|Adverse Event|1
7082739|NCT02145182|11193456|FG000|Overall Study|Death|7
7082740|NCT02145182|11193457|FG001|Overall Study|Death|7
7082741|NCT02145182|11193456|FG000|Overall Study|Lost to Follow-up|2
7082742|NCT02145182|11193457|FG001|Overall Study|Lost to Follow-up|2
7082743|NCT02145182|11193456|FG000|Overall Study|Pre-transplant Withdrawal|0
7082744|NCT02145182|11193457|FG001|Overall Study|Pre-transplant Withdrawal|2
7082745|NCT02145182|11193456|FG000|Overall Study|Withdrawal by Subject|5
6839213|NCT00264498|10844948|FG001|Crossover Treatment|Objective disease progression|5
6839214|NCT00264498|10844947|FG000|Crossover Treatment|Study closure|0
6839215|NCT00264498|10844948|FG001|Crossover Treatment|Study closure|1
6839216|NCT00264498|10844947|FG000|Crossover Treatment|Withdrawal by Subject|1
6839217|NCT00264498|10844948|FG001|Crossover Treatment|Withdrawal by Subject|0
6839218|NCT00264537|10844958|FG000|Overall Study|Death|0
6839219|NCT00264537|10844959|FG001|Overall Study|Death|3
6966349|NCT01125189|11014322|FG001|Treatment Period|Participants requested to discontinue|3
6966350|NCT01125189|11014323|FG002|Treatment Period|Participants requested to discontinue|4
6966351|NCT01125189|11014321|FG000|Treatment Period|Other reasons|1
6966352|NCT01125189|11014322|FG001|Treatment Period|Other reasons|1
6966353|NCT01125189|11014323|FG002|Treatment Period|Other reasons|0
6966354|NCT01125189|11014321|FG000|Treatment Period|Completed 24 week treatment period only|2
6966355|NCT01125189|11014322|FG001|Treatment Period|Completed 24 week treatment period only|1
6966356|NCT01125189|11014323|FG002|Treatment Period|Completed 24 week treatment period only|2
6966357|NCT01125189|11014321|FG000|Follow up Period|Withdrawal by Subject|3
6966358|NCT01125189|11014322|FG001|Follow up Period|Withdrawal by Subject|2
6966359|NCT01125189|11014323|FG002|Follow up Period|Withdrawal by Subject|5
7082746|NCT02145182|11193457|FG001|Overall Study|Withdrawal by Subject|4
7082747|NCT02145429|11193483|FG000|Overall Study|Death|4
7082748|NCT02145429|11193484|FG001|Overall Study|Death|5
7082749|NCT02145429|11193483|FG000|Overall Study|Lost to Follow-up|4
7082750|NCT02145429|11193484|FG001|Overall Study|Lost to Follow-up|3
7082751|NCT02145429|11193483|FG000|Overall Study|Withdrawal by Subject|8
7082752|NCT02145429|11193484|FG001|Overall Study|Withdrawal by Subject|3
7082753|NCT02145468|11193492|FG000|Overall Study|Withdrawal by Subject|5
7082754|NCT02145468|11193493|FG001|Overall Study|Withdrawal by Subject|8
7082755|NCT02146105|11193525|FG000|Overall Study|Adverse Event|1
7082756|NCT02146105|11193525|FG000|Overall Study|Withdrawal by Subject|5
7082757|NCT02146131|11193531|FG000|Overall Study|Physician Decision|61
7082758|NCT02146131|11193532|FG001|Overall Study|Physician Decision|56
7082759|NCT02146248|11193538|FG000|Overall Study|Withdrawal by Subject|2
6966360|NCT01125189|11014321|FG000|Follow up Period|Death|1
6966361|NCT01125189|11014322|FG001|Follow up Period|Death|0
6966362|NCT01125189|11014323|FG002|Follow up Period|Death|0
6966363|NCT01125189|11014321|FG000|Follow up Period|Lost to Follow-up|12
7082760|NCT02146274|11193546|FG000|Overall Study|Protocol Violation|73
7082761|NCT02146326|11193557|FG000|Overall Study|Lost to Follow-up|3
7074266|NCT02056652|11179501|FG000|Overall Study|Withdrawal by Subject|1
7074267|NCT02056652|11179502|FG001|Overall Study|Withdrawal by Subject|0
7074268|NCT02056652|11179501|FG000|Overall Study|Lost to Follow-up|0
7074269|NCT02056652|11179502|FG001|Overall Study|Lost to Follow-up|3
7074270|NCT02056834|11179508|FG000|Overall Study|Lost to Follow-up|7
7074271|NCT02057068|11179524|FG000|Overall Study|Withdrawal by Subject|2
7074272|NCT02057068|11179525|FG001|Overall Study|Withdrawal by Subject|2
7074273|NCT02057068|11179524|FG000|Overall Study|Caregiver (CG) Health|0
7074274|NCT02057068|11179525|FG001|Overall Study|Caregiver (CG) Health|2
7074275|NCT02057068|11179524|FG000|Overall Study|Carepartner (CP) Health|4
7074276|NCT02057068|11179525|FG001|Overall Study|Carepartner (CP) Health|2
7074277|NCT02057068|11179524|FG000|Overall Study|Lost to Follow-up|2
7074278|NCT02057068|11179525|FG001|Overall Study|Lost to Follow-up|2
7074279|NCT02057198|11179545|FG000|Overall Study|Death|0
7074280|NCT02057198|11179546|FG001|Overall Study|Death|0
7074281|NCT02057198|11179547|FG002|Overall Study|Death|1
7074282|NCT02057198|11179545|FG000|Overall Study|Discharged early; lost to followup|0
7074283|NCT02057198|11179546|FG001|Overall Study|Discharged early; lost to followup|1
7074284|NCT02057198|11179547|FG002|Overall Study|Discharged early; lost to followup|0
7074285|NCT02057250|11179559|FG000|AID Assessment Phase|Adverse Event|3
7074286|NCT02057250|11179560|FG001|AID Assessment Phase|Adverse Event|2
7074287|NCT02057250|11179561|FG002|AID Assessment Phase|Adverse Event|6
7074288|NCT02057250|11179562|FG003|AID Assessment Phase|Adverse Event|1
7074289|NCT02057250|11179563|FG004|AID Assessment Phase|Adverse Event|0
7074290|NCT02057250|11179559|FG000|AID Assessment Phase|Other than specified above|1
7074291|NCT02057250|11179560|FG001|AID Assessment Phase|Other than specified above|1
7074292|NCT02057250|11179561|FG002|AID Assessment Phase|Other than specified above|1
7074293|NCT02057250|11179562|FG003|AID Assessment Phase|Other than specified above|1
7074294|NCT02057250|11179563|FG004|AID Assessment Phase|Other than specified above|0
7074295|NCT02057250|11179559|FG000|Extension Phase|Adverse Event|0
7074296|NCT02057250|11179560|FG001|Extension Phase|Adverse Event|0
7074297|NCT02057250|11179561|FG002|Extension Phase|Adverse Event|0
7074298|NCT02057250|11179562|FG003|Extension Phase|Adverse Event|0
6839220|NCT00264537|10844960|FG002|Overall Study|Death|3
6839221|NCT00264537|10844961|FG003|Overall Study|Death|2
6839222|NCT00264537|10844958|FG000|Overall Study|Lost to Follow-up|3
6839223|NCT00264537|10844959|FG001|Overall Study|Lost to Follow-up|4
6839224|NCT00264537|10844960|FG002|Overall Study|Lost to Follow-up|7
6839225|NCT00264537|10844961|FG003|Overall Study|Lost to Follow-up|6
6839226|NCT00264537|10844958|FG000|Overall Study|Adverse Event|21
6839227|NCT00264537|10844959|FG001|Overall Study|Adverse Event|32
6839228|NCT00264537|10844960|FG002|Overall Study|Adverse Event|24
6839229|NCT00264537|10844961|FG003|Overall Study|Adverse Event|34
6839230|NCT00264537|10844958|FG000|Overall Study|Unsatisfactory therapeutic effect|5
6839231|NCT00264537|10844959|FG001|Overall Study|Unsatisfactory therapeutic effect|6
6839232|NCT00264537|10844960|FG002|Overall Study|Unsatisfactory therapeutic effect|5
6839233|NCT00264537|10844961|FG003|Overall Study|Unsatisfactory therapeutic effect|7
6839234|NCT00264537|10844958|FG000|Overall Study|Other|21
6839235|NCT00264537|10844959|FG001|Overall Study|Other|11
6839236|NCT00264537|10844960|FG002|Overall Study|Other|10
6839237|NCT00264537|10844961|FG003|Overall Study|Other|11
6839238|NCT00264537|10844958|FG000|Overall Study|Not treated|0
6839239|NCT00264537|10844959|FG001|Overall Study|Not treated|2
7074299|NCT02057250|11179563|FG004|Extension Phase|Adverse Event|15
7074300|NCT02057250|11179559|FG000|Extension Phase|Lack of Efficacy|0
7074301|NCT02057250|11179560|FG001|Extension Phase|Lack of Efficacy|0
7074302|NCT02057250|11179561|FG002|Extension Phase|Lack of Efficacy|0
7074303|NCT02057250|11179562|FG003|Extension Phase|Lack of Efficacy|0
7074304|NCT02057250|11179563|FG004|Extension Phase|Lack of Efficacy|10
7074305|NCT02057250|11179559|FG000|Extension Phase|Entered in this period but not treated|0
7147924|NCT03136861|11308751|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
7147925|NCT03136861|11308745|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
7147926|NCT03136861|11308746|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
7147927|NCT03136861|11308747|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
7147928|NCT03136861|11308748|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1
7147929|NCT03136861|11308749|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2
7147930|NCT03136861|11308750|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
7147931|NCT03136861|11308751|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1
7147932|NCT03136861|11308745|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
7147933|NCT03136861|11308746|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
7147934|NCT03136861|11308747|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1
7147935|NCT03136861|11308748|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
7147936|NCT03136861|11308749|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
6839240|NCT00264537|10844960|FG002|Overall Study|Not treated|1
6966364|NCT01125189|11014322|FG001|Follow up Period|Lost to Follow-up|9
7147937|NCT03136861|11308750|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
6839241|NCT00264537|10844961|FG003|Overall Study|Not treated|0
6839242|NCT00264550|10844977|FG000|Overall Study|Death|0
6839243|NCT00264550|10844978|FG001|Overall Study|Death|3
7074306|NCT02057250|11179560|FG001|Extension Phase|Entered in this period but not treated|0
7074307|NCT02057250|11179561|FG002|Extension Phase|Entered in this period but not treated|0
7074308|NCT02057250|11179562|FG003|Extension Phase|Entered in this period but not treated|0
7074309|NCT02057250|11179563|FG004|Extension Phase|Entered in this period but not treated|4
7074310|NCT02057250|11179559|FG000|Extension Phase|Other than specified above|0
7074311|NCT02057250|11179560|FG001|Extension Phase|Other than specified above|0
7074312|NCT02057250|11179561|FG002|Extension Phase|Other than specified above|0
7074313|NCT02057250|11179562|FG003|Extension Phase|Other than specified above|0
7074314|NCT02057250|11179563|FG004|Extension Phase|Other than specified above|7
7074315|NCT02057393|11179575|FG000|Overall Study|Withdrawal by Subject|1
7074316|NCT02057393|11179575|FG000|Overall Study|Patient did not meet criteria|1
7074317|NCT02057406|11179582|FG000|Overall Study|Physician Decision|0
7074318|NCT02057406|11179583|FG001|Overall Study|Physician Decision|0
7074319|NCT02057406|11179584|FG002|Overall Study|Physician Decision|2
7074320|NCT02057406|11179582|FG000|Overall Study|Withdrawal by Subject|0
7074321|NCT02057406|11179583|FG001|Overall Study|Withdrawal by Subject|2
7074322|NCT02057406|11179584|FG002|Overall Study|Withdrawal by Subject|0
7074323|NCT02057406|11179582|FG000|Overall Study|Lost to Follow-up|0
7074324|NCT02057406|11179583|FG001|Overall Study|Lost to Follow-up|0
7074325|NCT02057406|11179584|FG002|Overall Study|Lost to Follow-up|1
6839244|NCT00264550|10844979|FG002|Overall Study|Death|0
6839245|NCT00264550|10844980|FG003|Overall Study|Death|0
6839246|NCT00264550|10844977|FG000|Overall Study|Lost to Follow-up|3
6839247|NCT00264550|10844978|FG001|Overall Study|Lost to Follow-up|1
6839248|NCT00264550|10844979|FG002|Overall Study|Lost to Follow-up|1
6839249|NCT00264550|10844980|FG003|Overall Study|Lost to Follow-up|1
6839250|NCT00264550|10844977|FG000|Overall Study|Adverse Event|23
6839251|NCT00264550|10844978|FG001|Overall Study|Adverse Event|18
6839252|NCT00264550|10844979|FG002|Overall Study|Adverse Event|9
6839253|NCT00264550|10844980|FG003|Overall Study|Adverse Event|14
6839254|NCT00264550|10844977|FG000|Overall Study|Unsatisfactory therapeutic effect|4
6839255|NCT00264550|10844978|FG001|Overall Study|Unsatisfactory therapeutic effect|11
6839256|NCT00264550|10844979|FG002|Overall Study|Unsatisfactory therapeutic effect|4
6839257|NCT00264550|10844980|FG003|Overall Study|Unsatisfactory therapeutic effect|6
6839258|NCT00264550|10844977|FG000|Overall Study|Discontinued oral study agent|0
6839259|NCT00264550|10844978|FG001|Overall Study|Discontinued oral study agent|1
6839260|NCT00264550|10844979|FG002|Overall Study|Discontinued oral study agent|0
6839261|NCT00264550|10844980|FG003|Overall Study|Discontinued oral study agent|0
6839262|NCT00264550|10844977|FG000|Overall Study|Other|13
6839263|NCT00264550|10844978|FG001|Overall Study|Other|7
6839264|NCT00264550|10844979|FG002|Overall Study|Other|3
6839265|NCT00264550|10844980|FG003|Overall Study|Other|9
6839266|NCT00264576|10844992|FG000|Overall Study|Lost to Follow-up|1
6839267|NCT00264576|10844993|FG001|Overall Study|Lost to Follow-up|1
6839268|NCT00264797|10845010|FG000|Overall Study|Withdrawal by Subject|11
6839269|NCT00264797|10845011|FG001|Overall Study|Withdrawal by Subject|11
6839270|NCT00264797|10845010|FG000|Overall Study|Lost to Follow-up|9
6839271|NCT00264797|10845011|FG001|Overall Study|Lost to Follow-up|17
6839272|NCT00264797|10845010|FG000|Overall Study|Moved from area|3
6839273|NCT00264797|10845011|FG001|Overall Study|Moved from area|1
6839274|NCT00264797|10845010|FG000|Overall Study|Practical Problems|2
6839275|NCT00264797|10845011|FG001|Overall Study|Practical Problems|3
6839276|NCT00264797|10845010|FG000|Overall Study|Incarceration|4
6839277|NCT00264797|10845011|FG001|Overall Study|Incarceration|5
6839278|NCT00264797|10845010|FG000|Overall Study|Pressure/advice from Outsiders|1
6839279|NCT00264797|10845011|FG001|Overall Study|Pressure/advice from Outsiders|1
6839280|NCT00264797|10845010|FG000|Overall Study|Feels treatment not necessary, not worki|0
6839281|NCT00264797|10845011|FG001|Overall Study|Feels treatment not necessary, not worki|1
6839282|NCT00264797|10845010|FG000|Overall Study|Other|3
6839283|NCT00264797|10845011|FG001|Overall Study|Other|4
6839284|NCT00264810|10845019|FG000|Baseline|Withdrawal by Subject|10
6839285|NCT00264810|10845020|FG001|Baseline|Withdrawal by Subject|10
6839286|NCT00264810|10845019|FG000|Baseline|Physician Decision|7
6839287|NCT00264810|10845020|FG001|Baseline|Physician Decision|8
6839288|NCT00264810|10845019|FG000|Baseline|Subject Compliance Failure|3
6839289|NCT00264810|10845020|FG001|Baseline|Subject Compliance Failure|3
6839290|NCT00264810|10845019|FG000|Baseline|Insufficient Seizure Frequency|2
6839291|NCT00264810|10845020|FG001|Baseline|Insufficient Seizure Frequency|2
6839292|NCT00264810|10845019|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1
6839293|NCT00264810|10845020|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2
6839294|NCT00264810|10845019|FG000|Baseline|Other|0
6839295|NCT00264810|10845020|FG001|Baseline|Other|1
6839296|NCT00264810|10845019|FG000|Stimulation Optimization Period|Withdrawal by Subject|1
6839297|NCT00264810|10845020|FG001|Stimulation Optimization Period|Withdrawal by Subject|0
6839298|NCT00264810|10845019|FG000|Stimulation Optimization Period|Death|0
6839299|NCT00264810|10845020|FG001|Stimulation Optimization Period|Death|1
6839300|NCT00264810|10845019|FG000|Blinded Evaluation Period|Explant due to infection|1
7074326|NCT02057406|11179582|FG000|Overall Study|Death|1
7074327|NCT02057406|11179583|FG001|Overall Study|Death|0
7074328|NCT02057406|11179584|FG002|Overall Study|Death|0
6839301|NCT00264810|10845020|FG001|Blinded Evaluation Period|Explant due to infection|1
6839302|NCT00264810|10845019|FG000|Open Label Evaluation Period|Explant due to infection|1
6839303|NCT00264810|10845020|FG001|Open Label Evaluation Period|Explant due to infection|1
6839304|NCT00264810|10845019|FG000|Open Label Evaluation Period|Death|3
7074329|NCT02057406|11179582|FG000|Overall Study|Protocol Violation|0
7074330|NCT02057406|11179583|FG001|Overall Study|Protocol Violation|1
7074331|NCT02057406|11179584|FG002|Overall Study|Protocol Violation|0
7074332|NCT02057406|11179582|FG000|Overall Study|Patient transportation issues|0
7074333|NCT02057406|11179583|FG001|Overall Study|Patient transportation issues|0
7074334|NCT02057406|11179584|FG002|Overall Study|Patient transportation issues|1
7074335|NCT02057458|11179592|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0
7074336|NCT02057458|11179593|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1
7074337|NCT02057458|11179594|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0
7074338|NCT02057458|11179592|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2
7074339|NCT02057458|11179593|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0
7074340|NCT02057458|11179594|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0
7074341|NCT02057458|11179592|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1
7074342|NCT02057458|11179593|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0
7074343|NCT02057458|11179594|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0
7074344|NCT02057523|11179624|FG000|Overall Study|Withdrawal by Subject|1
7074345|NCT02057523|11179624|FG000|Overall Study|Lack of Efficacy|1
7074346|NCT02057549|11179630|FG000|Overall Study|Lost to Follow-up|1
7074347|NCT02057549|11179631|FG001|Overall Study|Lost to Follow-up|0
7074348|NCT02057549|11179630|FG000|Overall Study|Physician Decision|1
7074349|NCT02057549|11179631|FG001|Overall Study|Physician Decision|0
7074350|NCT02057549|11179630|FG000|Overall Study|Withdrawal by Subject|1
7074351|NCT02057549|11179631|FG001|Overall Study|Withdrawal by Subject|0
7074352|NCT02057575|11179641|FG000|Overall Study|Adverse Event|0
7074353|NCT02057575|11179642|FG001|Overall Study|Adverse Event|2
7074354|NCT02057575|11179643|FG002|Overall Study|Adverse Event|0
7074355|NCT02057575|11179644|FG003|Overall Study|Adverse Event|1
7074356|NCT02057575|11179641|FG000|Overall Study|Withdrawal by Subject|1
7074357|NCT02057575|11179642|FG001|Overall Study|Withdrawal by Subject|0
6839305|NCT00264810|10845020|FG001|Open Label Evaluation Period|Death|2
6839306|NCT00264810|10845019|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2
6839307|NCT00264810|10845020|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3
6839308|NCT00264849|10845030|FG000|Overall Study|Adverse Event|7
6839309|NCT00264849|10845031|FG001|Overall Study|Adverse Event|2
6839310|NCT00264849|10845030|FG000|Overall Study|Withdrawal by Subject|7
6839311|NCT00264849|10845031|FG001|Overall Study|Withdrawal by Subject|11
6839312|NCT00264849|10845030|FG000|Overall Study|Protocol Violation|5
6839313|NCT00264849|10845031|FG001|Overall Study|Protocol Violation|3
6839314|NCT00264849|10845030|FG000|Overall Study|Lack of Efficacy|1
6839315|NCT00264849|10845031|FG001|Overall Study|Lack of Efficacy|6
6839316|NCT00264849|10845030|FG000|Overall Study|Lost to Follow-up|0
6839317|NCT00264849|10845031|FG001|Overall Study|Lost to Follow-up|2
6839318|NCT00264849|10845030|FG000|Overall Study|Death|0
6839319|NCT00264849|10845031|FG001|Overall Study|Death|1
6839320|NCT00264849|10845030|FG000|Overall Study|Administrative Problems|2
6839321|NCT00264849|10845031|FG001|Overall Study|Administrative Problems|0
6839322|NCT00264875|10845037|FG000|Overall Study|Adverse Event|6
6839323|NCT00264875|10845037|FG000|Overall Study|Lost to Follow-up|6
6839324|NCT00264875|10845037|FG000|Overall Study|Protocol Violation|11
6839325|NCT00264875|10845037|FG000|Overall Study|Withdrawal by Subject|7
6839326|NCT00265083|10845044|FG000|Overall Study|Adverse Event|5
6839327|NCT00265083|10845045|FG001|Overall Study|Adverse Event|13
6839328|NCT00265083|10845046|FG002|Overall Study|Adverse Event|15
6839329|NCT00265083|10845044|FG000|Overall Study|Lost to Follow-up|3
6839330|NCT00265083|10845045|FG001|Overall Study|Lost to Follow-up|4
6839331|NCT00265083|10845046|FG002|Overall Study|Lost to Follow-up|4
6839332|NCT00265083|10845044|FG000|Overall Study|Unsatisfactory therapeutic effect|8
6839333|NCT00265083|10845045|FG001|Overall Study|Unsatisfactory therapeutic effect|13
6839334|NCT00265083|10845046|FG002|Overall Study|Unsatisfactory therapeutic effect|14
6839335|NCT00265083|10845044|FG000|Overall Study|Other|1
6839336|NCT00265083|10845045|FG001|Overall Study|Other|12
6839337|NCT00265083|10845046|FG002|Overall Study|Other|9
6839338|NCT00265096|10845058|FG000|Overall Study|Adverse Event|14
6839339|NCT00265096|10845059|FG001|Overall Study|Adverse Event|18
6839340|NCT00265096|10845060|FG002|Overall Study|Adverse Event|18
6839341|NCT00265096|10845058|FG000|Overall Study|Lost to Follow-up|2
6839342|NCT00265096|10845059|FG001|Overall Study|Lost to Follow-up|5
6839343|NCT00265096|10845060|FG002|Overall Study|Lost to Follow-up|3
6839344|NCT00265096|10845058|FG000|Overall Study|Death|0
7074358|NCT02057575|11179643|FG002|Overall Study|Withdrawal by Subject|0
7074359|NCT02057575|11179644|FG003|Overall Study|Withdrawal by Subject|0
7074360|NCT02057575|11179641|FG000|Overall Study|Dissallowed Concurrent Medication|0
7074361|NCT02057575|11179642|FG001|Overall Study|Dissallowed Concurrent Medication|1
6839345|NCT00265096|10845059|FG001|Overall Study|Death|1
6839346|NCT00265096|10845060|FG002|Overall Study|Death|2
6839347|NCT00265096|10845058|FG000|Overall Study|Unsatisfactory therapeutic effect|9
6839348|NCT00265096|10845059|FG001|Overall Study|Unsatisfactory therapeutic effect|8
6839349|NCT00265096|10845060|FG002|Overall Study|Unsatisfactory therapeutic effect|6
6839350|NCT00265096|10845058|FG000|Overall Study|Other|11
6839351|NCT00265096|10845059|FG001|Overall Study|Other|19
7074362|NCT02057575|11179643|FG002|Overall Study|Dissallowed Concurrent Medication|0
7074363|NCT02057575|11179644|FG003|Overall Study|Dissallowed Concurrent Medication|0
7074364|NCT02057575|11179641|FG000|Overall Study|Protocol Violation|0
7074365|NCT02057575|11179642|FG001|Overall Study|Protocol Violation|1
7074366|NCT02057575|11179643|FG002|Overall Study|Protocol Violation|0
7074367|NCT02057575|11179644|FG003|Overall Study|Protocol Violation|0
7074368|NCT02057666|11179666|FG000|Double Blind Treatment Period|Withdrawal by Subject|8
7074369|NCT02057666|11179667|FG001|Double Blind Treatment Period|Withdrawal by Subject|5
7074370|NCT02057666|11179666|FG000|Double Blind Treatment Period|Poor tolerability|7
7074371|NCT02057666|11179667|FG001|Double Blind Treatment Period|Poor tolerability|2
7074372|NCT02057666|11179666|FG000|Double Blind Treatment Period|Symptomatic disease progression|8
7074373|NCT02057666|11179667|FG001|Double Blind Treatment Period|Symptomatic disease progression|3
7074374|NCT02057666|11179666|FG000|Double Blind Treatment Period|Physician Decision|1
7074375|NCT02057666|11179667|FG001|Double Blind Treatment Period|Physician Decision|0
7074376|NCT02057666|11179666|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1
7074377|NCT02057666|11179667|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0
7074378|NCT02057666|11179666|FG000|Double Blind Treatment Period|Subject planning to withdraw|1
7074379|NCT02057666|11179667|FG001|Double Blind Treatment Period|Subject planning to withdraw|0
7074380|NCT02057666|11179666|FG000|Double Blind Treatment Period|Sponsor's request|70
7074381|NCT02057666|11179667|FG001|Double Blind Treatment Period|Sponsor's request|34
7074382|NCT02057666|11179666|FG000|Open-Label Treatment Period|Poor tolerability|0
7074383|NCT02057666|11179667|FG001|Open-Label Treatment Period|Poor tolerability|1
6839352|NCT00265096|10845060|FG002|Overall Study|Other|10
6839353|NCT00265109|10845070|FG000|Overall Study|Withdrawal by Subject|5
6839354|NCT00265109|10845070|FG000|Overall Study|Adverse Event|1
6839355|NCT00265122|10845081|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
6839356|NCT00265122|10845082|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
6839357|NCT00265122|10845083|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3
6839358|NCT00265122|10845084|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
6839359|NCT00265122|10845085|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
6839360|NCT00265122|10845086|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
6839361|NCT00265122|10845081|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
6839362|NCT00265122|10845082|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
6839363|NCT00265122|10845083|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
6839364|NCT00265122|10845084|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
6839365|NCT00265122|10845085|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
6839366|NCT00265122|10845086|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
6839367|NCT00265122|10845081|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0
6839368|NCT00265122|10845082|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1
6839369|NCT00265122|10845083|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2
6839370|NCT00265122|10845084|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1
6839371|NCT00265122|10845085|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0
7074384|NCT02057666|11179666|FG000|Open-Label Treatment Period|Symptomatic disease progression|0
7074385|NCT02057666|11179667|FG001|Open-Label Treatment Period|Symptomatic disease progression|1
7074386|NCT02057666|11179666|FG000|Open-Label Treatment Period|Sponsor's request|0
7074387|NCT02057666|11179667|FG001|Open-Label Treatment Period|Sponsor's request|4
7074388|NCT02057692|11179677|FG000|Overall Study|Adverse Event|1
7074389|NCT02057692|11179678|FG001|Overall Study|Adverse Event|0
7074390|NCT02057692|11179679|FG002|Overall Study|Adverse Event|0
7074391|NCT02057692|11179680|FG003|Overall Study|Adverse Event|0
7074392|NCT02057692|11179677|FG000|Overall Study|Lost to Follow-up|0
7074393|NCT02057692|11179678|FG001|Overall Study|Lost to Follow-up|0
7074394|NCT02057692|11179679|FG002|Overall Study|Lost to Follow-up|0
7074395|NCT02057692|11179680|FG003|Overall Study|Lost to Follow-up|1
7074396|NCT02057718|11179698|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0
7074397|NCT02057718|11179699|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2
7074398|NCT02057718|11179698|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1
7074399|NCT02057718|11179699|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0
7074400|NCT02057718|11179698|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0
7074401|NCT02057718|11179699|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1
7074402|NCT02057718|11179698|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0
7074403|NCT02057718|11179699|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3
7074404|NCT02057718|11179698|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1
7074405|NCT02057718|11179699|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1
7074406|NCT02057718|11179698|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0
7074407|NCT02057718|11179699|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1
7074408|NCT02057718|11179698|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0
7074409|NCT02057718|11179699|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1
7074410|NCT02057718|11179698|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1
7074411|NCT02057718|11179699|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3
7074412|NCT02057718|11179698|FG000|Optional Follow-up Treatment Period|Progressive disease|0
7074413|NCT02057718|11179699|FG001|Optional Follow-up Treatment Period|Progressive disease|1
7074414|NCT02057718|11179698|FG000|Optional Follow-up Treatment Period|Adverse Event|1
7074415|NCT02057718|11179699|FG001|Optional Follow-up Treatment Period|Adverse Event|2
7074416|NCT02057718|11179698|FG000|Optional Follow-up Treatment Period|Liver Transplant|0
7074417|NCT02057718|11179699|FG001|Optional Follow-up Treatment Period|Liver Transplant|2
7074418|NCT02057757|11179707|FG000|Overall Study|Withdrawal by Subject|3
7074419|NCT02057757|11179708|FG001|Overall Study|Withdrawal by Subject|5
7074420|NCT02057757|11179707|FG000|Overall Study|Death|2
7074421|NCT02057757|11179708|FG001|Overall Study|Death|0
7074422|NCT02057757|11179707|FG000|Overall Study|Lost to Follow-up|8
7074423|NCT02057757|11179708|FG001|Overall Study|Lost to Follow-up|3
7074424|NCT02057757|11179707|FG000|Overall Study|Non-compliance|1
7074425|NCT02057757|11179708|FG001|Overall Study|Non-compliance|0
7074426|NCT02057835|11179728|FG000|Overall Study|Withdrawal by Subject|0
7074427|NCT02057835|11179729|FG001|Overall Study|Withdrawal by Subject|2
7074428|NCT02057835|11179730|FG002|Overall Study|Withdrawal by Subject|0
7074429|NCT02057835|11179731|FG003|Overall Study|Withdrawal by Subject|0
7074430|NCT02057835|11179732|FG004|Overall Study|Withdrawal by Subject|0
7074431|NCT02057835|11179733|FG005|Overall Study|Withdrawal by Subject|0
7074432|NCT02057835|11179734|FG006|Overall Study|Withdrawal by Subject|0
7074433|NCT02057835|11179735|FG007|Overall Study|Withdrawal by Subject|0
7074434|NCT02057835|11179736|FG008|Overall Study|Withdrawal by Subject|0
7074435|NCT02057835|11179737|FG009|Overall Study|Withdrawal by Subject|0
7074436|NCT02058069|11179783|FG000|Overall Study|Exclusion due to implant size|5
7074437|NCT02058069|11179783|FG000|Overall Study|Withdrawal by Subject|6
7074438|NCT02058095|11179789|FG000|Overall Study|Adverse Event|1
7074439|NCT02058095|11179790|FG001|Overall Study|Adverse Event|0
7074440|NCT02058108|11179798|FG000|Overall Study|Abnormal Laboratory Values|0
7074441|NCT02058108|11179799|FG001|Overall Study|Abnormal Laboratory Values|1
7074442|NCT02058108|11179798|FG000|Overall Study|Unsatisfactory therapeutic effect|37
7074443|NCT02058108|11179799|FG001|Overall Study|Unsatisfactory therapeutic effect|4
7074444|NCT02058108|11179798|FG000|Overall Study|No longer requires study drug|0
7074445|NCT02058108|11179799|FG001|Overall Study|No longer requires study drug|1
7074446|NCT02058108|11179798|FG000|Overall Study|Withdrawal by Subject|1
7074447|NCT02058108|11179799|FG001|Overall Study|Withdrawal by Subject|0
7074448|NCT02058108|11179798|FG000|Overall Study|Administrative problems|3
7074449|NCT02058108|11179799|FG001|Overall Study|Administrative problems|3
7074450|NCT02058108|11179798|FG000|Overall Study|Protocol Violation|0
7074451|NCT02058108|11179799|FG001|Overall Study|Protocol Violation|1
7074452|NCT02058147|11179810|FG000|Overall Study|Randomized but not treated|0
7074453|NCT02058147|11179811|FG001|Overall Study|Randomized but not treated|0
7074454|NCT02058147|11179812|FG002|Overall Study|Randomized but not treated|1
7074455|NCT02058147|11179810|FG000|Overall Study|Adverse Event|12
6839372|NCT00265122|10845086|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0
6839373|NCT00265122|10845081|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2
6839374|NCT00265122|10845082|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
6839375|NCT00265122|10845083|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
6839376|NCT00265122|10845084|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
6839377|NCT00265122|10845085|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
6839378|NCT00265122|10845086|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0
6839379|NCT00265122|10845081|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
6839380|NCT00265122|10845082|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
6839381|NCT00265122|10845083|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
7074456|NCT02058147|11179811|FG001|Overall Study|Adverse Event|9
7074457|NCT02058147|11179812|FG002|Overall Study|Adverse Event|21
7074458|NCT02058147|11179810|FG000|Overall Study|Lack of Efficacy|1
7074459|NCT02058147|11179811|FG001|Overall Study|Lack of Efficacy|0
7074460|NCT02058147|11179812|FG002|Overall Study|Lack of Efficacy|3
7074461|NCT02058147|11179810|FG000|Overall Study|Poor compliance to protocol|8
7074462|NCT02058147|11179811|FG001|Overall Study|Poor compliance to protocol|9
7074463|NCT02058147|11179812|FG002|Overall Study|Poor compliance to protocol|4
6839382|NCT00265122|10845084|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
6839383|NCT00265122|10845085|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
6839384|NCT00265122|10845086|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
6839385|NCT00265122|10845081|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4
6839386|NCT00265122|10845082|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0
6839387|NCT00265122|10845083|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1
6839388|NCT00265122|10845084|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1
7074464|NCT02058147|11179810|FG000|Overall Study|Other than specified|8
7074465|NCT02058147|11179811|FG001|Overall Study|Other than specified|9
7074466|NCT02058147|11179812|FG002|Overall Study|Other than specified|0
7074467|NCT02058160|11179822|FG000|Overall Study|Randomized but not treated|2
7074468|NCT02058160|11179823|FG001|Overall Study|Randomized but not treated|4
7074469|NCT02058160|11179822|FG000|Overall Study|Poor compliance to protocol|4
7074470|NCT02058160|11179823|FG001|Overall Study|Poor compliance to protocol|1
7074471|NCT02058160|11179822|FG000|Overall Study|Adverse Event|12
7074472|NCT02058160|11179823|FG001|Overall Study|Adverse Event|3
7074473|NCT02058160|11179822|FG000|Overall Study|Lost to Follow-up|1
7074474|NCT02058160|11179823|FG001|Overall Study|Lost to Follow-up|0
7074475|NCT02058160|11179822|FG000|Overall Study|Other than specified above|12
7074476|NCT02058160|11179823|FG001|Overall Study|Other than specified above|6
7074477|NCT02058290|11179840|FG000|Overall Study|Protocol Violation|2
7074478|NCT02058290|11179841|FG001|Overall Study|Protocol Violation|1
7074479|NCT02058290|11179840|FG000|Overall Study|Physician Decision|1
7074480|NCT02058290|11179841|FG001|Overall Study|Physician Decision|0
7074481|NCT02058290|11179840|FG000|Overall Study|Didn't meet intraoperative criteria|8
7074482|NCT02058290|11179841|FG001|Overall Study|Didn't meet intraoperative criteria|7
7074483|NCT02058290|11179840|FG000|Overall Study|Withdrawal by Subject|0
7074484|NCT02058290|11179841|FG001|Overall Study|Withdrawal by Subject|1
7074485|NCT02058368|11179849|FG000|Overall Study|Adverse Event|15
7074486|NCT02058368|11179850|FG001|Overall Study|Adverse Event|20
7074487|NCT02058368|11179849|FG000|Overall Study|Lack of Efficacy|0
7074488|NCT02058368|11179850|FG001|Overall Study|Lack of Efficacy|1
7074489|NCT02058368|11179849|FG000|Overall Study|Protocol Violation|0
6839389|NCT00265122|10845085|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0
6839390|NCT00265122|10845086|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0
6839391|NCT00265148|10845107|FG000|Overall Study|Adverse Event|2
6839392|NCT00265148|10845108|FG001|Overall Study|Adverse Event|2
6839393|NCT00265148|10845107|FG000|Overall Study|Lack of Efficacy|0
6839394|NCT00265148|10845108|FG001|Overall Study|Lack of Efficacy|2
6839395|NCT00265148|10845107|FG000|Overall Study|Protocol Violation|3
6839396|NCT00265148|10845108|FG001|Overall Study|Protocol Violation|2
6839397|NCT00265148|10845107|FG000|Overall Study|Lost to Follow-up|0
6839398|NCT00265148|10845108|FG001|Overall Study|Lost to Follow-up|1
6839399|NCT00265148|10845107|FG000|Overall Study|Withdrawal by Subject|2
6839400|NCT00265148|10845108|FG001|Overall Study|Withdrawal by Subject|1
6839401|NCT00265148|10845107|FG000|Overall Study|Physician Decision|1
6839402|NCT00265148|10845108|FG001|Overall Study|Physician Decision|0
6839403|NCT00265148|10845107|FG000|Overall Study|Increasing frailty|0
6839404|NCT00265148|10845108|FG001|Overall Study|Increasing frailty|1
6839405|NCT00265148|10845107|FG000|Overall Study|Subject chose to change of the dose|1
6839406|NCT00265148|10845108|FG001|Overall Study|Subject chose to change of the dose|0
6839407|NCT00265239|10845121|FG000|Overall Study|Adverse Event|2
6839408|NCT00265239|10845122|FG001|Overall Study|Adverse Event|1
6839409|NCT00265317|10845132|FG000|Lead-In|Objective progression or relapse|6
6839410|NCT00265317|10845133|FG001|Lead-In|Objective progression or relapse|11
6839411|NCT00265317|10845134|FG002|Lead-In|Objective progression or relapse|0
6839412|NCT00265317|10845135|FG003|Lead-In|Objective progression or relapse|0
6839413|NCT00265317|10845132|FG000|Lead-In|Adverse Event|2
6839414|NCT00265317|10845133|FG001|Lead-In|Adverse Event|1
6839415|NCT00265317|10845134|FG002|Lead-In|Adverse Event|0
6839416|NCT00265317|10845135|FG003|Lead-In|Adverse Event|0
6839417|NCT00265317|10845132|FG000|Lead-In|Death|3
6839418|NCT00265317|10845133|FG001|Lead-In|Death|5
6839419|NCT00265317|10845134|FG002|Lead-In|Death|0
6839420|NCT00265317|10845135|FG003|Lead-In|Death|0
6839421|NCT00265317|10845132|FG000|Lead-In|Withdrawal/other than adverse event|1
6839422|NCT00265317|10845133|FG001|Lead-In|Withdrawal/other than adverse event|0
6839423|NCT00265317|10845134|FG002|Lead-In|Withdrawal/other than adverse event|0
6839424|NCT00265317|10845135|FG003|Lead-In|Withdrawal/other than adverse event|0
6839425|NCT00265317|10845132|FG000|Phase 2|Objective progression or relapse|0
6839426|NCT00265317|10845133|FG001|Phase 2|Objective progression or relapse|0
6839427|NCT00265317|10845134|FG002|Phase 2|Objective progression or relapse|37
6839428|NCT00265317|10845135|FG003|Phase 2|Objective progression or relapse|38
6839429|NCT00265317|10845132|FG000|Phase 2|Global deterioration of health status|0
6839430|NCT00265317|10845133|FG001|Phase 2|Global deterioration of health status|0
6839431|NCT00265317|10845134|FG002|Phase 2|Global deterioration of health status|3
6839432|NCT00265317|10845135|FG003|Phase 2|Global deterioration of health status|0
6839433|NCT00265317|10845132|FG000|Phase 2|Adverse Event|0
6839434|NCT00265317|10845133|FG001|Phase 2|Adverse Event|0
6839435|NCT00265317|10845134|FG002|Phase 2|Adverse Event|7
6839436|NCT00265317|10845135|FG003|Phase 2|Adverse Event|5
6839437|NCT00265317|10845132|FG000|Phase 2|Death|0
6839438|NCT00265317|10845133|FG001|Phase 2|Death|0
6839439|NCT00265317|10845134|FG002|Phase 2|Death|12
6839440|NCT00265317|10845135|FG003|Phase 2|Death|15
6839441|NCT00265317|10845132|FG000|Phase 2|Protocol Violation|0
6839442|NCT00265317|10845133|FG001|Phase 2|Protocol Violation|0
6839443|NCT00265317|10845134|FG002|Phase 2|Protocol Violation|1
6839444|NCT00265317|10845135|FG003|Phase 2|Protocol Violation|4
6839445|NCT00265317|10845132|FG000|Phase 2|Lost to Follow-up|0
7074490|NCT02058368|11179850|FG001|Overall Study|Protocol Violation|4
7074491|NCT02058368|11179849|FG000|Overall Study|Lost to Follow-up|2
7074492|NCT02058368|11179850|FG001|Overall Study|Lost to Follow-up|0
7074493|NCT02058368|11179849|FG000|Overall Study|Physician Decision|2
6839446|NCT00265317|10845133|FG001|Phase 2|Lost to Follow-up|0
6839447|NCT00265317|10845134|FG002|Phase 2|Lost to Follow-up|0
6839448|NCT00265317|10845135|FG003|Phase 2|Lost to Follow-up|1
6839449|NCT00265317|10845132|FG000|Phase 2|Withdrawal/other than adverse event|0
6839450|NCT00265317|10845133|FG001|Phase 2|Withdrawal/other than adverse event|0
6839451|NCT00265317|10845134|FG002|Phase 2|Withdrawal/other than adverse event|2
6839452|NCT00265317|10845135|FG003|Phase 2|Withdrawal/other than adverse event|1
6839453|NCT00265317|10845132|FG000|Phase 2|Study terminated by sponsor|0
7074494|NCT02058368|11179850|FG001|Overall Study|Physician Decision|3
6839454|NCT00265317|10845133|FG001|Phase 2|Study terminated by sponsor|0
6839455|NCT00265317|10845134|FG002|Phase 2|Study terminated by sponsor|1
7074495|NCT02058368|11179849|FG000|Overall Study|Withdrawal by Subject|22
7074496|NCT02058368|11179850|FG001|Overall Study|Withdrawal by Subject|26
7074497|NCT02058498|11179856|FG000|Overall Study|Withdrawal by Subject|4
7074498|NCT02058563|11179866|FG000|Overall Study|Lost to Follow-up|26
7074499|NCT02058563|11179867|FG001|Overall Study|Lost to Follow-up|22
7074500|NCT02058563|11179866|FG000|Overall Study|Other (vaccinated later as new subject)|1
7074501|NCT02058563|11179867|FG001|Overall Study|Other (vaccinated later as new subject)|0
7074502|NCT02058563|11179866|FG000|Overall Study|Consent Withdrawal|1
7074503|NCT02058563|11179867|FG001|Overall Study|Consent Withdrawal|1
7074504|NCT02058563|11179866|FG000|Overall Study|Other (patient incarcerated)|0
7074505|NCT02058563|11179867|FG001|Overall Study|Other (patient incarcerated)|1
7074506|NCT02058589|11179875|FG000|Overall Study|Serious Adverse Event|1
7074507|NCT02058589|11179876|FG001|Overall Study|Serious Adverse Event|1
7074508|NCT02058589|11179875|FG000|Overall Study|Non-Serious Adverse Event|1
7074509|NCT02058589|11179876|FG001|Overall Study|Non-Serious Adverse Event|0
7074510|NCT02058589|11179875|FG000|Overall Study|Withdrawal by Subject|0
7074511|NCT02058589|11179876|FG001|Overall Study|Withdrawal by Subject|1
7074512|NCT02058628|11179886|FG000|Overall Study|Adverse Event|1
7074513|NCT02058628|11179887|FG001|Overall Study|Adverse Event|0
7074514|NCT02058628|11179886|FG000|Overall Study|Withdrawal by Subject|2
7074515|NCT02058628|11179887|FG001|Overall Study|Withdrawal by Subject|2
7074516|NCT02058628|11179886|FG000|Overall Study|Lost to Follow-up|2
7074517|NCT02058628|11179887|FG001|Overall Study|Lost to Follow-up|4
7074518|NCT02058628|11179886|FG000|Overall Study|Not in time schedule|0
7074519|NCT02058628|11179887|FG001|Overall Study|Not in time schedule|1
7074520|NCT02058628|11179886|FG000|Overall Study|The visit date was not in timeline|0
7074521|NCT02058628|11179887|FG001|Overall Study|The visit date was not in timeline|1
7074522|NCT02058628|11179886|FG000|Overall Study|A lot of time for study for participant|1
7074523|NCT02058628|11179887|FG001|Overall Study|A lot of time for study for participant|0
7074524|NCT02058628|11179886|FG000|Overall Study|Non compliance|1
7074525|NCT02058628|11179887|FG001|Overall Study|Non compliance|0
7074526|NCT02058836|11179898|FG000|Overall Study|Withdrawal by Subject|1
7074527|NCT02058836|11179899|FG001|Overall Study|Withdrawal by Subject|1
7074528|NCT02058849|11179907|FG000|Overall Study|Hospitalization|1
7074529|NCT02058849|11179908|FG001|Overall Study|Hospitalization|1
7074530|NCT02058849|11179907|FG000|Overall Study|Death|1
7074531|NCT02058849|11179908|FG001|Overall Study|Death|0
7074532|NCT02058849|11179907|FG000|Overall Study|Lost to Follow-up|1
7074533|NCT02058849|11179908|FG001|Overall Study|Lost to Follow-up|0
7074534|NCT02058849|11179907|FG000|Overall Study|Withdrawal by Subject|4
7074535|NCT02058849|11179908|FG001|Overall Study|Withdrawal by Subject|0
7074536|NCT02058940|11179914|FG000|Overall Study|Discharged from Critical Care Unit|1
7074537|NCT02058966|11179918|FG000|Open-Label Methamphetamine|Adverse Event|1
7074538|NCT02058966|11179918|FG000|First Intervention|Withdrawal by Subject|1
7074539|NCT02058992|11179930|FG000|Overall Study|Lost to Follow-up|4
7074540|NCT02058992|11179930|FG000|Overall Study|Protocol Violation|92
7074541|NCT02058992|11179930|FG000|Overall Study|CRF Uncollected|20
7074542|NCT02059005|11179936|FG000|Overall Study|Death|1
7074543|NCT02059005|11179937|FG001|Overall Study|Death|3
7074544|NCT02059005|11179936|FG000|Overall Study|Lost to Follow-up|19
7074545|NCT02059005|11179937|FG001|Overall Study|Lost to Follow-up|19
7074546|NCT02059005|11179936|FG000|Overall Study|Incarceration|0
7074547|NCT02059005|11179937|FG001|Overall Study|Incarceration|1
7074548|NCT02059005|11179936|FG000|Overall Study|Inpatient|0
7074549|NCT02059005|11179937|FG001|Overall Study|Inpatient|1
7074550|NCT02059135|11179961|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3
7074551|NCT02059135|11179962|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2
7074552|NCT02059135|11179961|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0
7074553|NCT02059135|11179962|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3
7074554|NCT02059135|11179961|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0
7074555|NCT02059135|11179962|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1
7074556|NCT02059135|11179961|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0
7074557|NCT02059135|11179962|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1
7074558|NCT02059135|11179961|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1
7074559|NCT02059135|11179962|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0
7147938|NCT03136861|11308751|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
7147939|NCT03136861|11308745|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
7147940|NCT03136861|11308746|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
7147941|NCT03136861|11308747|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1
7147942|NCT03136861|11308748|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
7147943|NCT03136861|11308749|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
7147944|NCT03136861|11308750|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
7147945|NCT03136861|11308751|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
7147946|NCT03137069|11308775|FG000|Overall Study|Withdrawal by Subject|1
7147947|NCT03137069|11308776|FG001|Overall Study|Withdrawal by Subject|2
7147948|NCT03137069|11308777|FG002|Overall Study|Withdrawal by Subject|2
7147949|NCT03137069|11308778|FG003|Overall Study|Withdrawal by Subject|2
7074560|NCT02059135|11179961|FG000|Neonatal Follow-up (Safety Population)|Death|3
7074561|NCT02059135|11179962|FG001|Neonatal Follow-up (Safety Population)|Death|2
7074562|NCT02059135|11179961|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0
7074563|NCT02059135|11179962|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1
7074564|NCT02059135|11179961|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0
7074565|NCT02059135|11179962|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1
7074566|NCT02059148|11179970|FG000|Treatment 1|Protocol Violation|0
7074567|NCT02059148|11179971|FG001|Treatment 1|Protocol Violation|0
7074568|NCT02059148|11179972|FG002|Treatment 1|Protocol Violation|0
7074569|NCT02059148|11179973|FG003|Treatment 1|Protocol Violation|0
7074570|NCT02059148|11179974|FG004|Treatment 1|Protocol Violation|0
7074571|NCT02059148|11179975|FG005|Treatment 1|Protocol Violation|1
7074572|NCT02059161|11179988|FG000|Overall Study|Pregnancy|0
7074573|NCT02059161|11179989|FG001|Overall Study|Pregnancy|2
7074574|NCT02059161|11179988|FG000|Overall Study|Adverse Event|2
7074575|NCT02059161|11179989|FG001|Overall Study|Adverse Event|6
7074576|NCT02059161|11179988|FG000|Overall Study|Lost to Follow-up|20
7074577|NCT02059161|11179989|FG001|Overall Study|Lost to Follow-up|12
7074578|NCT02059161|11179988|FG000|Overall Study|Physician Decision|4
7074579|NCT02059161|11179989|FG001|Overall Study|Physician Decision|4
7074580|NCT02059161|11179988|FG000|Overall Study|Protocol Violation|1
7074581|NCT02059161|11179989|FG001|Overall Study|Protocol Violation|1
7074582|NCT02059161|11179988|FG000|Overall Study|Withdrawal by Subject|16
7074583|NCT02059161|11179989|FG001|Overall Study|Withdrawal by Subject|13
6839456|NCT00265317|10845135|FG003|Phase 2|Study terminated by sponsor|0
6839457|NCT00265317|10845132|FG000|Phase 2|Other|0
6839458|NCT00265317|10845133|FG001|Phase 2|Other|0
6839459|NCT00265317|10845134|FG002|Phase 2|Other|1
6839460|NCT00265317|10845135|FG003|Phase 2|Other|1
6839461|NCT00265330|10845154|FG000|Overall Study|Adverse Event|41
6839462|NCT00265330|10845154|FG000|Overall Study|Lost to Follow-up|8
6839463|NCT00265330|10845154|FG000|Overall Study|Withdrawal by Subject|34
6839464|NCT00265330|10845154|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1
6839465|NCT00265330|10845154|FG000|Overall Study|Lack of Efficacy|4
6839466|NCT00265330|10845154|FG000|Overall Study|Family Scheduling Conflicts|1
6839467|NCT00265330|10845154|FG000|Overall Study|Began Taking Formulary Geodon|1
6839468|NCT00265330|10845154|FG000|Overall Study|Discharged from Unit for Long Term Care|1
6839469|NCT00265330|10845154|FG000|Overall Study|Site Closed by Sponsor|1
6839470|NCT00265330|10845154|FG000|Overall Study|Principal Investigators Request|1
6839471|NCT00265330|10845154|FG000|Overall Study|Withdrew Consent|1
6839472|NCT00265330|10845154|FG000|Overall Study|Protocol Violation|1
6839473|NCT00265382|10845158|FG000|Overall Study|Adverse Event|21
6839474|NCT00265382|10845158|FG000|Overall Study|Laboratory Abnormality|1
6839475|NCT00265382|10845158|FG000|Overall Study|Lost to Follow-up|3
6839476|NCT00265382|10845158|FG000|Overall Study|Lack of Efficacy|6
6839477|NCT00265382|10845158|FG000|Overall Study|Miscellaneous|6
6839478|NCT00265382|10845158|FG000|Overall Study|Withdrawal by Subject|13
6839479|NCT00265382|10845158|FG000|Overall Study|Study terminated by sponsor|94
6839480|NCT00265382|10845158|FG000|Overall Study|Death|1
6839481|NCT00265395|10845164|FG000|Overall Study|Adverse Event|3
6839482|NCT00265395|10845165|FG001|Overall Study|Adverse Event|6
6839483|NCT00265395|10845164|FG000|Overall Study|Lost to Follow-up|2
6839484|NCT00265395|10845165|FG001|Overall Study|Lost to Follow-up|1
6839485|NCT00265395|10845164|FG000|Overall Study|Withdrawal by Subject|1
6839486|NCT00265395|10845165|FG001|Overall Study|Withdrawal by Subject|6
6839487|NCT00265395|10845164|FG000|Overall Study|Protocol Violation|2
6839488|NCT00265395|10845165|FG001|Overall Study|Protocol Violation|2
6839489|NCT00265395|10845164|FG000|Overall Study|Lack of Efficacy|0
6839490|NCT00265395|10845165|FG001|Overall Study|Lack of Efficacy|1
6839491|NCT00265395|10845164|FG000|Overall Study|Administrative|0
6839492|NCT00265395|10845165|FG001|Overall Study|Administrative|1
6839493|NCT00265564|10845203|FG000|Overall Study|Lost to Follow-up|5
6839494|NCT00265564|10845204|FG001|Overall Study|Lost to Follow-up|7
6839495|NCT00265564|10845203|FG000|Overall Study|met exclusion criteria|5
6839496|NCT00265564|10845204|FG001|Overall Study|met exclusion criteria|2
6839497|NCT00265759|10845225|FG000|Overall Study|Withdrawal by Subject|0
6839498|NCT00265759|10845226|FG001|Overall Study|Withdrawal by Subject|1
6839499|NCT00265759|10845227|FG002|Overall Study|Withdrawal by Subject|2
6966365|NCT01125189|11014323|FG002|Follow up Period|Lost to Follow-up|6
6839500|NCT00265759|10845228|FG003|Overall Study|Withdrawal by Subject|2
6839501|NCT00265759|10845225|FG000|Overall Study|Cancel|0
6839502|NCT00265759|10845226|FG001|Overall Study|Cancel|0
6839503|NCT00265759|10845227|FG002|Overall Study|Cancel|0
7074584|NCT02059161|11179988|FG000|Overall Study|Randomized in error, no study drug|0
7074585|NCT02059161|11179989|FG001|Overall Study|Randomized in error, no study drug|1
7074586|NCT02059161|11179988|FG000|Overall Study|Non-compliance with study drug|6
6839504|NCT00265759|10845228|FG003|Overall Study|Cancel|3
6839505|NCT00265759|10845225|FG000|Overall Study|Ineligible|0
6839506|NCT00265759|10845226|FG001|Overall Study|Ineligible|0
6839507|NCT00265759|10845227|FG002|Overall Study|Ineligible|0
6839508|NCT00265759|10845228|FG003|Overall Study|Ineligible|1
6839509|NCT00265759|10845225|FG000|Overall Study|Bilateral disease|0
6839510|NCT00265759|10845226|FG001|Overall Study|Bilateral disease|0
6839511|NCT00265759|10845227|FG002|Overall Study|Bilateral disease|0
6839512|NCT00265759|10845228|FG003|Overall Study|Bilateral disease|2
6839513|NCT00265759|10845225|FG000|Overall Study|Discontinued due to intolerability|0
7074587|NCT02059161|11179989|FG001|Overall Study|Non-compliance with study drug|2
7074588|NCT02059174|11179995|FG000|Period 1|Withdrawal by Subject|0
7074589|NCT02059174|11179996|FG001|Period 1|Withdrawal by Subject|2
7074590|NCT02059174|11179995|FG000|Period 2|Withdrawal by Subject|0
7074591|NCT02059174|11179996|FG001|Period 2|Withdrawal by Subject|2
7074592|NCT02059174|11179995|FG000|Period 2|Protocol Violation|1
7074593|NCT02059174|11179996|FG001|Period 2|Protocol Violation|0
7074594|NCT02059174|11179995|FG000|Period 3|Physician Decision|1
7074595|NCT02059174|11179996|FG001|Period 3|Physician Decision|0
7074596|NCT02059187|11180004|FG000|Overall Study|Adverse Event|0
7074597|NCT02059187|11180005|FG001|Overall Study|Adverse Event|3
7074598|NCT02059187|11180004|FG000|Overall Study|Death|1
7074599|NCT02059187|11180005|FG001|Overall Study|Death|1
7074600|NCT02059187|11180004|FG000|Overall Study|Lost to Follow-up|9
7074601|NCT02059187|11180005|FG001|Overall Study|Lost to Follow-up|8
7074602|NCT02059187|11180004|FG000|Overall Study|Non-compliance with study drug|1
7074603|NCT02059187|11180005|FG001|Overall Study|Non-compliance with study drug|0
7074604|NCT02059187|11180004|FG000|Overall Study|Physician Decision|1
7074605|NCT02059187|11180005|FG001|Overall Study|Physician Decision|2
7074606|NCT02059187|11180004|FG000|Overall Study|Protocol Violation|1
7074607|NCT02059187|11180005|FG001|Overall Study|Protocol Violation|0
7074608|NCT02059187|11180004|FG000|Overall Study|Withdrawal by Subject|12
7074609|NCT02059187|11180005|FG001|Overall Study|Withdrawal by Subject|8
7074610|NCT02059239|11180025|FG000|Overall Study|Progressive Disease after Bendamustine|1
7074611|NCT02059239|11180026|FG001|Overall Study|Progressive Disease after Bendamustine|3
7074612|NCT02059239|11180025|FG000|Overall Study|Physician Decision|1
7074613|NCT02059239|11180026|FG001|Overall Study|Physician Decision|0
7074614|NCT02059278|11180035|FG000|Overall Study|Adverse Event|1
7074615|NCT02059278|11180036|FG001|Overall Study|Adverse Event|1
7074616|NCT02059278|11180035|FG000|Overall Study|Lost to Follow-up|1
7074617|NCT02059278|11180036|FG001|Overall Study|Lost to Follow-up|0
7074618|NCT02059278|11180035|FG000|Overall Study|Withdrawal by Subject|0
7074619|NCT02059278|11180036|FG001|Overall Study|Withdrawal by Subject|3
7074620|NCT02059278|11180035|FG000|Overall Study|Ran out of IP and decided to discontinue|1
7074621|NCT02059278|11180036|FG001|Overall Study|Ran out of IP and decided to discontinue|0
7074622|NCT02059291|11180051|FG000|Epoch 2|Lack of Efficacy|0
7074623|NCT02059291|11180052|FG001|Epoch 2|Lack of Efficacy|0
7074624|NCT02059291|11180053|FG002|Epoch 2|Lack of Efficacy|0
7074625|NCT02059291|11180054|FG003|Epoch 2|Lack of Efficacy|1
7074626|NCT02059291|11180055|FG004|Epoch 2|Lack of Efficacy|0
7074627|NCT02059291|11180056|FG005|Epoch 2|Lack of Efficacy|1
7074628|NCT02059291|11180057|FG006|Epoch 2|Lack of Efficacy|0
7074629|NCT02059291|11180058|FG007|Epoch 2|Lack of Efficacy|0
7074630|NCT02059291|11180059|FG008|Epoch 2|Lack of Efficacy|0
7074631|NCT02059291|11180060|FG009|Epoch 2|Lack of Efficacy|0
7074632|NCT02059291|11180061|FG010|Epoch 2|Lack of Efficacy|0
7074633|NCT02059291|11180062|FG011|Epoch 2|Lack of Efficacy|0
7074634|NCT02059291|11180063|FG012|Epoch 2|Lack of Efficacy|0
7074635|NCT02059291|11180064|FG013|Epoch 2|Lack of Efficacy|0
7074636|NCT02059291|11180065|FG014|Epoch 2|Lack of Efficacy|0
7074637|NCT02059291|11180066|FG015|Epoch 2|Lack of Efficacy|0
7074638|NCT02059291|11180067|FG016|Epoch 2|Lack of Efficacy|0
7074639|NCT02059291|11180068|FG017|Epoch 2|Lack of Efficacy|0
7074640|NCT02059291|11180069|FG018|Epoch 2|Lack of Efficacy|0
7074641|NCT02059291|11180070|FG019|Epoch 2|Lack of Efficacy|0
7074642|NCT02059291|11180071|FG020|Epoch 2|Lack of Efficacy|0
7074643|NCT02059291|11180072|FG021|Epoch 2|Lack of Efficacy|0
7074644|NCT02059291|11180073|FG022|Epoch 2|Lack of Efficacy|0
7074645|NCT02059291|11180074|FG023|Epoch 2|Lack of Efficacy|0
7074646|NCT02059291|11180075|FG024|Epoch 2|Lack of Efficacy|0
7074647|NCT02059291|11180051|FG000|Epoch 2|Adverse Event|0
7074648|NCT02059291|11180052|FG001|Epoch 2|Adverse Event|0
7074649|NCT02059291|11180053|FG002|Epoch 2|Adverse Event|1
7074650|NCT02059291|11180054|FG003|Epoch 2|Adverse Event|1
7074651|NCT02059291|11180055|FG004|Epoch 2|Adverse Event|0
7074652|NCT02059291|11180056|FG005|Epoch 2|Adverse Event|0
7074653|NCT02059291|11180057|FG006|Epoch 2|Adverse Event|0
7074654|NCT02059291|11180058|FG007|Epoch 2|Adverse Event|1
7074655|NCT02059291|11180059|FG008|Epoch 2|Adverse Event|1
7074656|NCT02059291|11180060|FG009|Epoch 2|Adverse Event|0
7074657|NCT02059291|11180061|FG010|Epoch 2|Adverse Event|0
7074658|NCT02059291|11180062|FG011|Epoch 2|Adverse Event|0
7074659|NCT02059291|11180063|FG012|Epoch 2|Adverse Event|0
7074660|NCT02059291|11180064|FG013|Epoch 2|Adverse Event|0
7074661|NCT02059291|11180065|FG014|Epoch 2|Adverse Event|0
7074662|NCT02059291|11180066|FG015|Epoch 2|Adverse Event|0
7074663|NCT02059291|11180067|FG016|Epoch 2|Adverse Event|0
7074664|NCT02059291|11180068|FG017|Epoch 2|Adverse Event|0
7074665|NCT02059291|11180069|FG018|Epoch 2|Adverse Event|0
7074666|NCT02059291|11180070|FG019|Epoch 2|Adverse Event|0
7074667|NCT02059291|11180071|FG020|Epoch 2|Adverse Event|0
7074668|NCT02059291|11180072|FG021|Epoch 2|Adverse Event|0
7074669|NCT02059291|11180073|FG022|Epoch 2|Adverse Event|0
7074670|NCT02059291|11180074|FG023|Epoch 2|Adverse Event|0
7074671|NCT02059291|11180075|FG024|Epoch 2|Adverse Event|0
7074672|NCT02059291|11180051|FG000|Epoch 2|Withdrawal by Subject|0
7074673|NCT02059291|11180052|FG001|Epoch 2|Withdrawal by Subject|1
7074674|NCT02059291|11180053|FG002|Epoch 2|Withdrawal by Subject|0
7074675|NCT02059291|11180054|FG003|Epoch 2|Withdrawal by Subject|0
7074676|NCT02059291|11180055|FG004|Epoch 2|Withdrawal by Subject|0
7074677|NCT02059291|11180056|FG005|Epoch 2|Withdrawal by Subject|1
7074678|NCT02059291|11180057|FG006|Epoch 2|Withdrawal by Subject|0
7074679|NCT02059291|11180058|FG007|Epoch 2|Withdrawal by Subject|0
7074680|NCT02059291|11180059|FG008|Epoch 2|Withdrawal by Subject|1
7074681|NCT02059291|11180060|FG009|Epoch 2|Withdrawal by Subject|0
7074682|NCT02059291|11180061|FG010|Epoch 2|Withdrawal by Subject|0
7074683|NCT02059291|11180062|FG011|Epoch 2|Withdrawal by Subject|0
7074684|NCT02059291|11180063|FG012|Epoch 2|Withdrawal by Subject|0
7074685|NCT02059291|11180064|FG013|Epoch 2|Withdrawal by Subject|0
7074686|NCT02059291|11180065|FG014|Epoch 2|Withdrawal by Subject|0
7074687|NCT02059291|11180066|FG015|Epoch 2|Withdrawal by Subject|0
7074688|NCT02059291|11180067|FG016|Epoch 2|Withdrawal by Subject|0
7074689|NCT02059291|11180068|FG017|Epoch 2|Withdrawal by Subject|0
7074690|NCT02059291|11180069|FG018|Epoch 2|Withdrawal by Subject|0
7074691|NCT02059291|11180070|FG019|Epoch 2|Withdrawal by Subject|0
7074692|NCT02059291|11180071|FG020|Epoch 2|Withdrawal by Subject|0
7074693|NCT02059291|11180072|FG021|Epoch 2|Withdrawal by Subject|0
7074694|NCT02059291|11180073|FG022|Epoch 2|Withdrawal by Subject|0
7074695|NCT02059291|11180074|FG023|Epoch 2|Withdrawal by Subject|0
7074696|NCT02059291|11180075|FG024|Epoch 2|Withdrawal by Subject|0
7074697|NCT02059291|11180051|FG000|Epoch 3|Physician Decision|0
7074698|NCT02059291|11180052|FG001|Epoch 3|Physician Decision|0
7074699|NCT02059291|11180053|FG002|Epoch 3|Physician Decision|0
7074700|NCT02059291|11180054|FG003|Epoch 3|Physician Decision|0
7074701|NCT02059291|11180055|FG004|Epoch 3|Physician Decision|0
7074702|NCT02059291|11180056|FG005|Epoch 3|Physician Decision|0
7074703|NCT02059291|11180057|FG006|Epoch 3|Physician Decision|0
7074704|NCT02059291|11180058|FG007|Epoch 3|Physician Decision|0
7074705|NCT02059291|11180059|FG008|Epoch 3|Physician Decision|0
7074706|NCT02059291|11180060|FG009|Epoch 3|Physician Decision|0
7074707|NCT02059291|11180061|FG010|Epoch 3|Physician Decision|0
7074708|NCT02059291|11180062|FG011|Epoch 3|Physician Decision|0
7074709|NCT02059291|11180063|FG012|Epoch 3|Physician Decision|0
7074710|NCT02059291|11180064|FG013|Epoch 3|Physician Decision|1
7074711|NCT02059291|11180065|FG014|Epoch 3|Physician Decision|0
7074712|NCT02059291|11180066|FG015|Epoch 3|Physician Decision|1
7074713|NCT02059291|11180067|FG016|Epoch 3|Physician Decision|0
7074714|NCT02059291|11180068|FG017|Epoch 3|Physician Decision|0
7074715|NCT02059291|11180069|FG018|Epoch 3|Physician Decision|0
7074716|NCT02059291|11180070|FG019|Epoch 3|Physician Decision|0
7074717|NCT02059291|11180071|FG020|Epoch 3|Physician Decision|0
7074718|NCT02059291|11180072|FG021|Epoch 3|Physician Decision|0
7074719|NCT02059291|11180073|FG022|Epoch 3|Physician Decision|0
7074720|NCT02059291|11180074|FG023|Epoch 3|Physician Decision|0
7074721|NCT02059291|11180075|FG024|Epoch 3|Physician Decision|0
7074722|NCT02059291|11180051|FG000|Epoch 3|Adverse Event|0
7074723|NCT02059291|11180052|FG001|Epoch 3|Adverse Event|0
7074724|NCT02059291|11180053|FG002|Epoch 3|Adverse Event|0
7074725|NCT02059291|11180054|FG003|Epoch 3|Adverse Event|0
7074726|NCT02059291|11180055|FG004|Epoch 3|Adverse Event|0
7074727|NCT02059291|11180056|FG005|Epoch 3|Adverse Event|0
7074728|NCT02059291|11180057|FG006|Epoch 3|Adverse Event|0
7074729|NCT02059291|11180058|FG007|Epoch 3|Adverse Event|0
7074730|NCT02059291|11180059|FG008|Epoch 3|Adverse Event|0
7074731|NCT02059291|11180060|FG009|Epoch 3|Adverse Event|0
7074732|NCT02059291|11180061|FG010|Epoch 3|Adverse Event|0
7074733|NCT02059291|11180062|FG011|Epoch 3|Adverse Event|0
7074734|NCT02059291|11180063|FG012|Epoch 3|Adverse Event|0
7074735|NCT02059291|11180064|FG013|Epoch 3|Adverse Event|0
7074736|NCT02059291|11180065|FG014|Epoch 3|Adverse Event|0
7074737|NCT02059291|11180066|FG015|Epoch 3|Adverse Event|1
7074738|NCT02059291|11180067|FG016|Epoch 3|Adverse Event|0
7074739|NCT02059291|11180068|FG017|Epoch 3|Adverse Event|0
7074740|NCT02059291|11180069|FG018|Epoch 3|Adverse Event|0
7074741|NCT02059291|11180070|FG019|Epoch 3|Adverse Event|0
7074742|NCT02059291|11180071|FG020|Epoch 3|Adverse Event|0
7074743|NCT02059291|11180072|FG021|Epoch 3|Adverse Event|0
7074744|NCT02059291|11180073|FG022|Epoch 3|Adverse Event|0
7074745|NCT02059291|11180074|FG023|Epoch 3|Adverse Event|0
7074746|NCT02059291|11180075|FG024|Epoch 3|Adverse Event|0
7074747|NCT02059291|11180051|FG000|Epoch 3|Lack of Efficacy|0
7074748|NCT02059291|11180052|FG001|Epoch 3|Lack of Efficacy|0
7074749|NCT02059291|11180053|FG002|Epoch 3|Lack of Efficacy|0
7074750|NCT02059291|11180054|FG003|Epoch 3|Lack of Efficacy|0
7074751|NCT02059291|11180055|FG004|Epoch 3|Lack of Efficacy|0
7074752|NCT02059291|11180056|FG005|Epoch 3|Lack of Efficacy|0
7074753|NCT02059291|11180057|FG006|Epoch 3|Lack of Efficacy|0
7074754|NCT02059291|11180058|FG007|Epoch 3|Lack of Efficacy|0
7074755|NCT02059291|11180059|FG008|Epoch 3|Lack of Efficacy|0
7074756|NCT02059291|11180060|FG009|Epoch 3|Lack of Efficacy|0
7074757|NCT02059291|11180061|FG010|Epoch 3|Lack of Efficacy|0
7074758|NCT02059291|11180062|FG011|Epoch 3|Lack of Efficacy|0
7074759|NCT02059291|11180063|FG012|Epoch 3|Lack of Efficacy|0
7074760|NCT02059291|11180064|FG013|Epoch 3|Lack of Efficacy|0
7074761|NCT02059291|11180065|FG014|Epoch 3|Lack of Efficacy|0
7074762|NCT02059291|11180066|FG015|Epoch 3|Lack of Efficacy|3
7074763|NCT02059291|11180067|FG016|Epoch 3|Lack of Efficacy|0
7074764|NCT02059291|11180068|FG017|Epoch 3|Lack of Efficacy|0
7074765|NCT02059291|11180069|FG018|Epoch 3|Lack of Efficacy|0
7074766|NCT02059291|11180070|FG019|Epoch 3|Lack of Efficacy|0
7074767|NCT02059291|11180071|FG020|Epoch 3|Lack of Efficacy|0
7074768|NCT02059291|11180072|FG021|Epoch 3|Lack of Efficacy|0
7074769|NCT02059291|11180073|FG022|Epoch 3|Lack of Efficacy|0
7074770|NCT02059291|11180074|FG023|Epoch 3|Lack of Efficacy|0
7074771|NCT02059291|11180075|FG024|Epoch 3|Lack of Efficacy|0
7074772|NCT02059291|11180051|FG000|Epoch 3|Withdrawal by Subject|0
7074773|NCT02059291|11180052|FG001|Epoch 3|Withdrawal by Subject|0
7074774|NCT02059291|11180053|FG002|Epoch 3|Withdrawal by Subject|0
7074775|NCT02059291|11180054|FG003|Epoch 3|Withdrawal by Subject|0
7074776|NCT02059291|11180055|FG004|Epoch 3|Withdrawal by Subject|0
7074777|NCT02059291|11180056|FG005|Epoch 3|Withdrawal by Subject|0
7074778|NCT02059291|11180057|FG006|Epoch 3|Withdrawal by Subject|0
7074779|NCT02059291|11180058|FG007|Epoch 3|Withdrawal by Subject|0
7074780|NCT02059291|11180059|FG008|Epoch 3|Withdrawal by Subject|0
7074781|NCT02059291|11180060|FG009|Epoch 3|Withdrawal by Subject|0
7074782|NCT02059291|11180061|FG010|Epoch 3|Withdrawal by Subject|0
7074783|NCT02059291|11180062|FG011|Epoch 3|Withdrawal by Subject|0
7074784|NCT02059291|11180063|FG012|Epoch 3|Withdrawal by Subject|0
7074785|NCT02059291|11180064|FG013|Epoch 3|Withdrawal by Subject|0
7074786|NCT02059291|11180065|FG014|Epoch 3|Withdrawal by Subject|0
7074787|NCT02059291|11180066|FG015|Epoch 3|Withdrawal by Subject|1
7074788|NCT02059291|11180067|FG016|Epoch 3|Withdrawal by Subject|0
7074789|NCT02059291|11180068|FG017|Epoch 3|Withdrawal by Subject|0
7074790|NCT02059291|11180069|FG018|Epoch 3|Withdrawal by Subject|0
7074791|NCT02059291|11180070|FG019|Epoch 3|Withdrawal by Subject|0
7074792|NCT02059291|11180071|FG020|Epoch 3|Withdrawal by Subject|0
7074793|NCT02059291|11180072|FG021|Epoch 3|Withdrawal by Subject|0
7074794|NCT02059291|11180073|FG022|Epoch 3|Withdrawal by Subject|0
6839514|NCT00265759|10845226|FG001|Overall Study|Discontinued due to intolerability|0
6966366|NCT01125189|11014321|FG000|Follow up Period|Other reasons|4
6966367|NCT01125189|11014322|FG001|Follow up Period|Other reasons|4
6966368|NCT01125189|11014323|FG002|Follow up Period|Other reasons|5
6966369|NCT01125293|11014349|FG000|Overall Study|Disease Progression|1
6966370|NCT01125293|11014350|FG001|Overall Study|Disease Progression|3
6966371|NCT01125293|11014351|FG002|Overall Study|Disease Progression|4
6966372|NCT01125293|11014352|FG003|Overall Study|Disease Progression|3
6966373|NCT01125293|11014353|FG004|Overall Study|Disease Progression|5
6966374|NCT01125293|11014354|FG005|Overall Study|Disease Progression|12
6966375|NCT01125293|11014349|FG000|Overall Study|Adverse Event|1
6966376|NCT01125293|11014350|FG001|Overall Study|Adverse Event|0
6966377|NCT01125293|11014351|FG002|Overall Study|Adverse Event|0
7074795|NCT02059291|11180074|FG023|Epoch 3|Withdrawal by Subject|0
7074796|NCT02059291|11180075|FG024|Epoch 3|Withdrawal by Subject|0
7074797|NCT02059291|11180051|FG000|Epoch 4|Adverse Event|0
7074798|NCT02059291|11180052|FG001|Epoch 4|Adverse Event|0
7074799|NCT02059291|11180053|FG002|Epoch 4|Adverse Event|0
7074800|NCT02059291|11180054|FG003|Epoch 4|Adverse Event|0
7074801|NCT02059291|11180055|FG004|Epoch 4|Adverse Event|0
7074802|NCT02059291|11180056|FG005|Epoch 4|Adverse Event|0
7074803|NCT02059291|11180057|FG006|Epoch 4|Adverse Event|0
7074804|NCT02059291|11180058|FG007|Epoch 4|Adverse Event|0
7074805|NCT02059291|11180059|FG008|Epoch 4|Adverse Event|0
7074806|NCT02059291|11180060|FG009|Epoch 4|Adverse Event|0
7074807|NCT02059291|11180061|FG010|Epoch 4|Adverse Event|0
7074808|NCT02059291|11180062|FG011|Epoch 4|Adverse Event|0
7074809|NCT02059291|11180063|FG012|Epoch 4|Adverse Event|0
7074810|NCT02059291|11180064|FG013|Epoch 4|Adverse Event|0
7074811|NCT02059291|11180065|FG014|Epoch 4|Adverse Event|0
7074812|NCT02059291|11180066|FG015|Epoch 4|Adverse Event|0
7074813|NCT02059291|11180067|FG016|Epoch 4|Adverse Event|1
7074814|NCT02059291|11180068|FG017|Epoch 4|Adverse Event|0
7074815|NCT02059291|11180069|FG018|Epoch 4|Adverse Event|0
7074816|NCT02059291|11180070|FG019|Epoch 4|Adverse Event|0
7074817|NCT02059291|11180071|FG020|Epoch 4|Adverse Event|0
7074818|NCT02059291|11180072|FG021|Epoch 4|Adverse Event|0
7074819|NCT02059291|11180073|FG022|Epoch 4|Adverse Event|1
7074820|NCT02059291|11180074|FG023|Epoch 4|Adverse Event|0
7074821|NCT02059291|11180075|FG024|Epoch 4|Adverse Event|0
7074822|NCT02059291|11180051|FG000|Epoch 4|Pregnancy|0
7074823|NCT02059291|11180052|FG001|Epoch 4|Pregnancy|0
7074824|NCT02059291|11180053|FG002|Epoch 4|Pregnancy|0
7074825|NCT02059291|11180054|FG003|Epoch 4|Pregnancy|0
7074826|NCT02059291|11180055|FG004|Epoch 4|Pregnancy|0
7074827|NCT02059291|11180056|FG005|Epoch 4|Pregnancy|0
7074828|NCT02059291|11180057|FG006|Epoch 4|Pregnancy|0
7074829|NCT02059291|11180058|FG007|Epoch 4|Pregnancy|0
7074830|NCT02059291|11180059|FG008|Epoch 4|Pregnancy|0
7074831|NCT02059291|11180060|FG009|Epoch 4|Pregnancy|0
7074832|NCT02059291|11180061|FG010|Epoch 4|Pregnancy|0
7074833|NCT02059291|11180062|FG011|Epoch 4|Pregnancy|0
7074834|NCT02059291|11180063|FG012|Epoch 4|Pregnancy|0
7074835|NCT02059291|11180064|FG013|Epoch 4|Pregnancy|0
7074836|NCT02059291|11180065|FG014|Epoch 4|Pregnancy|0
7074837|NCT02059291|11180066|FG015|Epoch 4|Pregnancy|0
6966378|NCT01125293|11014352|FG003|Overall Study|Adverse Event|0
7074838|NCT02059291|11180067|FG016|Epoch 4|Pregnancy|1
7074839|NCT02059291|11180068|FG017|Epoch 4|Pregnancy|0
6966379|NCT01125293|11014353|FG004|Overall Study|Adverse Event|2
6966380|NCT01125293|11014354|FG005|Overall Study|Adverse Event|8
7074840|NCT02059291|11180069|FG018|Epoch 4|Pregnancy|0
7074841|NCT02059291|11180070|FG019|Epoch 4|Pregnancy|0
7074842|NCT02059291|11180071|FG020|Epoch 4|Pregnancy|0
7074843|NCT02059291|11180072|FG021|Epoch 4|Pregnancy|0
7074844|NCT02059291|11180073|FG022|Epoch 4|Pregnancy|0
7074845|NCT02059291|11180074|FG023|Epoch 4|Pregnancy|0
7074846|NCT02059291|11180075|FG024|Epoch 4|Pregnancy|0
7074847|NCT02059291|11180051|FG000|Epoch 4|Withdrawal by Subject|0
7074848|NCT02059291|11180052|FG001|Epoch 4|Withdrawal by Subject|0
7074849|NCT02059291|11180053|FG002|Epoch 4|Withdrawal by Subject|0
7074850|NCT02059291|11180054|FG003|Epoch 4|Withdrawal by Subject|0
7074851|NCT02059291|11180055|FG004|Epoch 4|Withdrawal by Subject|0
7074852|NCT02059291|11180056|FG005|Epoch 4|Withdrawal by Subject|0
7074853|NCT02059291|11180057|FG006|Epoch 4|Withdrawal by Subject|0
7074854|NCT02059291|11180058|FG007|Epoch 4|Withdrawal by Subject|0
7074855|NCT02059291|11180059|FG008|Epoch 4|Withdrawal by Subject|0
7074856|NCT02059291|11180060|FG009|Epoch 4|Withdrawal by Subject|0
7074857|NCT02059291|11180061|FG010|Epoch 4|Withdrawal by Subject|0
7074858|NCT02059291|11180062|FG011|Epoch 4|Withdrawal by Subject|0
7074859|NCT02059291|11180063|FG012|Epoch 4|Withdrawal by Subject|0
7074860|NCT02059291|11180064|FG013|Epoch 4|Withdrawal by Subject|0
7074861|NCT02059291|11180065|FG014|Epoch 4|Withdrawal by Subject|0
7074862|NCT02059291|11180066|FG015|Epoch 4|Withdrawal by Subject|0
7074863|NCT02059291|11180067|FG016|Epoch 4|Withdrawal by Subject|0
7074864|NCT02059291|11180068|FG017|Epoch 4|Withdrawal by Subject|0
7074865|NCT02059291|11180069|FG018|Epoch 4|Withdrawal by Subject|0
7074866|NCT02059291|11180070|FG019|Epoch 4|Withdrawal by Subject|0
7074867|NCT02059291|11180071|FG020|Epoch 4|Withdrawal by Subject|1
7074868|NCT02059291|11180072|FG021|Epoch 4|Withdrawal by Subject|0
7074869|NCT02059291|11180073|FG022|Epoch 4|Withdrawal by Subject|0
7074870|NCT02059291|11180074|FG023|Epoch 4|Withdrawal by Subject|0
7074871|NCT02059291|11180075|FG024|Epoch 4|Withdrawal by Subject|0
7074872|NCT02059291|11180051|FG000|Epoch 4|Lack of Efficacy|0
7074873|NCT02059291|11180052|FG001|Epoch 4|Lack of Efficacy|0
7074874|NCT02059291|11180053|FG002|Epoch 4|Lack of Efficacy|0
7074875|NCT02059291|11180054|FG003|Epoch 4|Lack of Efficacy|0
7074876|NCT02059291|11180055|FG004|Epoch 4|Lack of Efficacy|0
7074877|NCT02059291|11180056|FG005|Epoch 4|Lack of Efficacy|0
7074878|NCT02059291|11180057|FG006|Epoch 4|Lack of Efficacy|0
7074879|NCT02059291|11180058|FG007|Epoch 4|Lack of Efficacy|0
7074880|NCT02059291|11180059|FG008|Epoch 4|Lack of Efficacy|0
7074881|NCT02059291|11180060|FG009|Epoch 4|Lack of Efficacy|0
7074882|NCT02059291|11180061|FG010|Epoch 4|Lack of Efficacy|0
7074883|NCT02059291|11180062|FG011|Epoch 4|Lack of Efficacy|0
7074884|NCT02059291|11180063|FG012|Epoch 4|Lack of Efficacy|0
7074885|NCT02059291|11180064|FG013|Epoch 4|Lack of Efficacy|0
7074886|NCT02059291|11180065|FG014|Epoch 4|Lack of Efficacy|0
7074887|NCT02059291|11180066|FG015|Epoch 4|Lack of Efficacy|0
7074888|NCT02059291|11180067|FG016|Epoch 4|Lack of Efficacy|0
7074889|NCT02059291|11180068|FG017|Epoch 4|Lack of Efficacy|0
7074890|NCT02059291|11180069|FG018|Epoch 4|Lack of Efficacy|0
7074891|NCT02059291|11180070|FG019|Epoch 4|Lack of Efficacy|0
7074892|NCT02059291|11180071|FG020|Epoch 4|Lack of Efficacy|0
7074893|NCT02059291|11180072|FG021|Epoch 4|Lack of Efficacy|0
7074894|NCT02059291|11180073|FG022|Epoch 4|Lack of Efficacy|0
7074895|NCT02059291|11180074|FG023|Epoch 4|Lack of Efficacy|1
7074896|NCT02059291|11180075|FG024|Epoch 4|Lack of Efficacy|0
7074897|NCT02059395|11180105|FG000|Overall Study|Lost to Follow-up|2
7074898|NCT02059395|11180106|FG001|Overall Study|Lost to Follow-up|4
7074899|NCT02059408|11180115|FG000|Overall Study|Did not get tested|0
7074900|NCT02059408|11180116|FG001|Overall Study|Did not get tested|330
7074901|NCT02059408|11180117|FG002|Overall Study|Did not get tested|358
7074902|NCT02059434|11180136|FG000|Washout Between Periods 1 and 2|Physician Decision|0
7074903|NCT02059434|11180137|FG001|Washout Between Periods 1 and 2|Physician Decision|0
7074904|NCT02059434|11180138|FG002|Washout Between Periods 1 and 2|Physician Decision|0
7074905|NCT02059434|11180139|FG003|Washout Between Periods 1 and 2|Physician Decision|0
7074906|NCT02059434|11180140|FG004|Washout Between Periods 1 and 2|Physician Decision|0
7074907|NCT02059434|11180141|FG005|Washout Between Periods 1 and 2|Physician Decision|0
7074908|NCT02059434|11180142|FG006|Washout Between Periods 1 and 2|Physician Decision|0
7074909|NCT02059434|11180143|FG007|Washout Between Periods 1 and 2|Physician Decision|1
7074910|NCT02059434|11180144|FG008|Washout Between Periods 1 and 2|Physician Decision|0
7074911|NCT02059434|11180136|FG000|Washout Between Periods 4 and 5|Adverse Event|0
7074912|NCT02059434|11180137|FG001|Washout Between Periods 4 and 5|Adverse Event|0
7074913|NCT02059434|11180138|FG002|Washout Between Periods 4 and 5|Adverse Event|0
7074914|NCT02059434|11180139|FG003|Washout Between Periods 4 and 5|Adverse Event|0
7074915|NCT02059434|11180140|FG004|Washout Between Periods 4 and 5|Adverse Event|0
7074916|NCT02059434|11180141|FG005|Washout Between Periods 4 and 5|Adverse Event|0
7074917|NCT02059434|11180142|FG006|Washout Between Periods 4 and 5|Adverse Event|0
7074918|NCT02059434|11180143|FG007|Washout Between Periods 4 and 5|Adverse Event|0
7074919|NCT02059434|11180144|FG008|Washout Between Periods 4 and 5|Adverse Event|1
7074920|NCT02059434|11180136|FG000|Washout Between Periods 6 and 7|Physician Decision|0
7074921|NCT02059434|11180137|FG001|Washout Between Periods 6 and 7|Physician Decision|0
7074922|NCT02059434|11180138|FG002|Washout Between Periods 6 and 7|Physician Decision|0
7074923|NCT02059434|11180139|FG003|Washout Between Periods 6 and 7|Physician Decision|0
7074924|NCT02059434|11180140|FG004|Washout Between Periods 6 and 7|Physician Decision|0
7074925|NCT02059434|11180141|FG005|Washout Between Periods 6 and 7|Physician Decision|0
7074926|NCT02059434|11180142|FG006|Washout Between Periods 6 and 7|Physician Decision|0
7074927|NCT02059434|11180143|FG007|Washout Between Periods 6 and 7|Physician Decision|0
7074928|NCT02059434|11180144|FG008|Washout Between Periods 6 and 7|Physician Decision|1
7074929|NCT02059434|11180136|FG000|Washout Between Periods 7 and 8|Adverse Event|0
7074930|NCT02059434|11180137|FG001|Washout Between Periods 7 and 8|Adverse Event|0
7074931|NCT02059434|11180138|FG002|Washout Between Periods 7 and 8|Adverse Event|0
7074932|NCT02059434|11180139|FG003|Washout Between Periods 7 and 8|Adverse Event|0
7074933|NCT02059434|11180140|FG004|Washout Between Periods 7 and 8|Adverse Event|0
7074934|NCT02059434|11180141|FG005|Washout Between Periods 7 and 8|Adverse Event|0
7074935|NCT02059434|11180142|FG006|Washout Between Periods 7 and 8|Adverse Event|0
7074936|NCT02059434|11180143|FG007|Washout Between Periods 7 and 8|Adverse Event|0
7074937|NCT02059434|11180144|FG008|Washout Between Periods 7 and 8|Adverse Event|1
7074938|NCT02059434|11180136|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0
7074939|NCT02059434|11180137|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0
7074940|NCT02059434|11180138|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0
7074941|NCT02059434|11180139|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0
7074942|NCT02059434|11180140|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0
7074943|NCT02059434|11180141|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0
7074944|NCT02059434|11180142|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0
7074945|NCT02059434|11180143|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0
7074946|NCT02059434|11180144|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1
7074947|NCT02059980|11180225|FG000|Overall Study|Lost to Follow-up|2
7074948|NCT02059980|11180226|FG001|Overall Study|Lost to Follow-up|1
7074949|NCT02060370|11180255|FG000|Overall Study|Physician Decision|1
7074950|NCT02060383|11180264|FG000|Core Phase|Unsatisfactory therapeutic effect|1
7074951|NCT02060383|11180265|FG001|Core Phase|Unsatisfactory therapeutic effect|5
7074952|NCT02060383|11180266|FG002|Core Phase|Unsatisfactory therapeutic effect|0
7074953|NCT02060383|11180267|FG003|Core Phase|Unsatisfactory therapeutic effect|0
7074954|NCT02060383|11180268|FG004|Core Phase|Unsatisfactory therapeutic effect|0
7074955|NCT02060383|11180264|FG000|Core Phase|Adverse Event|2
7074956|NCT02060383|11180265|FG001|Core Phase|Adverse Event|0
7074957|NCT02060383|11180266|FG002|Core Phase|Adverse Event|0
7074958|NCT02060383|11180267|FG003|Core Phase|Adverse Event|2
7074959|NCT02060383|11180268|FG004|Core Phase|Adverse Event|6
7074960|NCT02060383|11180264|FG000|Core Phase|Administrative problems|0
7074961|NCT02060383|11180265|FG001|Core Phase|Administrative problems|1
7074962|NCT02060383|11180266|FG002|Core Phase|Administrative problems|0
7074963|NCT02060383|11180267|FG003|Core Phase|Administrative problems|0
7074964|NCT02060383|11180268|FG004|Core Phase|Administrative problems|0
7074965|NCT02060383|11180264|FG000|Core Phase|Protocol Violation|0
7074966|NCT02060383|11180265|FG001|Core Phase|Protocol Violation|0
7074967|NCT02060383|11180266|FG002|Core Phase|Protocol Violation|0
7074968|NCT02060383|11180267|FG003|Core Phase|Protocol Violation|1
7074969|NCT02060383|11180268|FG004|Core Phase|Protocol Violation|0
7074970|NCT02060383|11180264|FG000|Core Phase|Withdrawal by Subject|0
7074971|NCT02060383|11180265|FG001|Core Phase|Withdrawal by Subject|0
7074972|NCT02060383|11180266|FG002|Core Phase|Withdrawal by Subject|0
7074973|NCT02060383|11180267|FG003|Core Phase|Withdrawal by Subject|4
7074974|NCT02060383|11180268|FG004|Core Phase|Withdrawal by Subject|2
7074975|NCT02060383|11180264|FG000|Extension Phase|Unsatisfactory therapeutic effect|1
7074976|NCT02060383|11180265|FG001|Extension Phase|Unsatisfactory therapeutic effect|1
7074977|NCT02060383|11180266|FG002|Extension Phase|Unsatisfactory therapeutic effect|0
7074978|NCT02060383|11180267|FG003|Extension Phase|Unsatisfactory therapeutic effect|2
7074979|NCT02060383|11180268|FG004|Extension Phase|Unsatisfactory therapeutic effect|2
7074980|NCT02060383|11180264|FG000|Extension Phase|Adverse Event|1
6839515|NCT00265759|10845227|FG002|Overall Study|Discontinued due to intolerability|0
6839516|NCT00265759|10845228|FG003|Overall Study|Discontinued due to intolerability|1
6839517|NCT00265785|10845239|FG000|Overall Study|Adverse Event|4
6839518|NCT00265785|10845239|FG000|Overall Study|Withdrawal by Subject|3
6839519|NCT00265785|10845239|FG000|Overall Study|Progression/Relapse|15
7074981|NCT02060383|11180265|FG001|Extension Phase|Adverse Event|1
7074982|NCT02060383|11180266|FG002|Extension Phase|Adverse Event|2
7074983|NCT02060383|11180267|FG003|Extension Phase|Adverse Event|0
7074984|NCT02060383|11180268|FG004|Extension Phase|Adverse Event|1
7074985|NCT02060383|11180264|FG000|Extension Phase|Withdrawal by Subject|0
7074986|NCT02060383|11180265|FG001|Extension Phase|Withdrawal by Subject|1
7074987|NCT02060383|11180266|FG002|Extension Phase|Withdrawal by Subject|0
7074988|NCT02060383|11180267|FG003|Extension Phase|Withdrawal by Subject|0
7074989|NCT02060383|11180268|FG004|Extension Phase|Withdrawal by Subject|2
7074990|NCT02060383|11180264|FG000|Extension Phase|Administrative problems|1
7074991|NCT02060383|11180265|FG001|Extension Phase|Administrative problems|0
7074992|NCT02060383|11180266|FG002|Extension Phase|Administrative problems|0
7074993|NCT02060383|11180267|FG003|Extension Phase|Administrative problems|0
7074994|NCT02060383|11180268|FG004|Extension Phase|Administrative problems|0
7074995|NCT02060383|11180264|FG000|Extension Phase|Death|0
7074996|NCT02060383|11180265|FG001|Extension Phase|Death|0
7074997|NCT02060383|11180266|FG002|Extension Phase|Death|1
7074998|NCT02060383|11180267|FG003|Extension Phase|Death|0
7074999|NCT02060383|11180268|FG004|Extension Phase|Death|1
7075000|NCT02060383|11180264|FG000|Extension Phase|Protocol Violation|0
7075001|NCT02060383|11180265|FG001|Extension Phase|Protocol Violation|0
6839520|NCT00265785|10845239|FG000|Overall Study|Not protocol specified|2
7075002|NCT02060383|11180266|FG002|Extension Phase|Protocol Violation|0
7075003|NCT02060383|11180267|FG003|Extension Phase|Protocol Violation|0
7075004|NCT02060383|11180268|FG004|Extension Phase|Protocol Violation|1
7075005|NCT02060903|11180321|FG000|Overall Study|Lost to Follow-up|4
6839521|NCT00265785|10845239|FG000|Overall Study|Ineligible|1
7075006|NCT02060903|11180322|FG001|Overall Study|Lost to Follow-up|0
6839522|NCT00265785|10845239|FG000|Overall Study|Did not receive protocol treatment|2
7075007|NCT02060903|11180321|FG000|Overall Study|Withdrawal by Subject|0
7075008|NCT02060903|11180322|FG001|Overall Study|Withdrawal by Subject|7
7075009|NCT02061202|11180330|FG000|Overall Study|Lost to Follow-up|1
7075010|NCT02061202|11180331|FG001|Overall Study|Lost to Follow-up|1
7075011|NCT02061280|11180339|FG000|Overall Study|Protocol Violation|12
7075012|NCT02061280|11180340|FG001|Overall Study|Protocol Violation|8
7075013|NCT02061280|11180339|FG000|Overall Study|moved out of state|0
7075014|NCT02061280|11180340|FG001|Overall Study|moved out of state|1
7075015|NCT02061280|11180339|FG000|Overall Study|Withdrawal by Subject|1
7075016|NCT02061280|11180340|FG001|Overall Study|Withdrawal by Subject|2
7075017|NCT02061280|11180339|FG000|Overall Study|Lost to Follow-up|5
7075018|NCT02061280|11180340|FG001|Overall Study|Lost to Follow-up|1
7075019|NCT02061540|11180399|FG000|Overall Study|Adverse Event|2
7075020|NCT02061540|11180399|FG000|Overall Study|Withdrawal by Subject|2
6839523|NCT00265889|10845255|FG000|Overall Study|Physician Decision|1
6966381|NCT01125293|11014349|FG000|Overall Study|Symptomatic Deterioration|1
6966382|NCT01125293|11014350|FG001|Overall Study|Symptomatic Deterioration|0
6966383|NCT01125293|11014351|FG002|Overall Study|Symptomatic Deterioration|0
6966384|NCT01125293|11014352|FG003|Overall Study|Symptomatic Deterioration|0
6966385|NCT01125293|11014353|FG004|Overall Study|Symptomatic Deterioration|0
6966386|NCT01125293|11014354|FG005|Overall Study|Symptomatic Deterioration|0
6966387|NCT01125293|11014349|FG000|Overall Study|Death|0
6966388|NCT01125293|11014350|FG001|Overall Study|Death|0
6966389|NCT01125293|11014351|FG002|Overall Study|Death|0
6966390|NCT01125293|11014352|FG003|Overall Study|Death|0
6966391|NCT01125293|11014353|FG004|Overall Study|Death|1
6966392|NCT01125293|11014354|FG005|Overall Study|Death|0
6966393|NCT01125293|11014349|FG000|Overall Study|Withdrawal by Subject|0
6966394|NCT01125293|11014350|FG001|Overall Study|Withdrawal by Subject|0
6966395|NCT01125293|11014351|FG002|Overall Study|Withdrawal by Subject|0
6966396|NCT01125293|11014352|FG003|Overall Study|Withdrawal by Subject|0
6966397|NCT01125293|11014353|FG004|Overall Study|Withdrawal by Subject|2
6966398|NCT01125293|11014354|FG005|Overall Study|Withdrawal by Subject|1
6966399|NCT01125293|11014349|FG000|Overall Study|Physician Decision|0
6966400|NCT01125293|11014350|FG001|Overall Study|Physician Decision|0
6966401|NCT01125293|11014351|FG002|Overall Study|Physician Decision|0
6966402|NCT01125293|11014352|FG003|Overall Study|Physician Decision|0
6966403|NCT01125293|11014353|FG004|Overall Study|Physician Decision|0
6966404|NCT01125293|11014354|FG005|Overall Study|Physician Decision|2
6966405|NCT01125358|11014375|FG000|Overall Study|Adverse Event|3
6966406|NCT01125358|11014376|FG001|Overall Study|Adverse Event|0
6966407|NCT01125358|11014377|FG002|Overall Study|Adverse Event|0
6966408|NCT01125358|11014378|FG003|Overall Study|Adverse Event|2
6966409|NCT01125358|11014375|FG000|Overall Study|Perceived Lack of Efficacy|6
6966410|NCT01125358|11014376|FG001|Overall Study|Perceived Lack of Efficacy|3
6966411|NCT01125358|11014377|FG002|Overall Study|Perceived Lack of Efficacy|7
7075021|NCT02061592|11180410|FG000|Period 1|Withdrawal by Subject|1
7075022|NCT02061592|11180411|FG001|Period 1|Withdrawal by Subject|0
7075023|NCT02061592|11180410|FG000|Period 1|Protocol Violation|1
6839524|NCT00265889|10845255|FG000|Overall Study|Protocol Violation|1
6839525|NCT00265889|10845255|FG000|Overall Study|Insurance denied the request|3
6839526|NCT00266032|10845266|FG000|Treatment|Adverse Event|42
6839527|NCT00266032|10845267|FG001|Treatment|Adverse Event|26
6839528|NCT00266032|10845268|FG002|Treatment|Adverse Event|10
6839529|NCT00266032|10845266|FG000|Treatment|Lost to Follow-up|19
6839530|NCT00266032|10845267|FG001|Treatment|Lost to Follow-up|4
6839531|NCT00266032|10845268|FG002|Treatment|Lost to Follow-up|2
6839532|NCT00266032|10845266|FG000|Treatment|Pregnancy|3
6839533|NCT00266032|10845267|FG001|Treatment|Pregnancy|2
6839534|NCT00266032|10845268|FG002|Treatment|Pregnancy|2
6839535|NCT00266032|10845266|FG000|Treatment|Protocol Violation|6
6839536|NCT00266032|10845267|FG001|Treatment|Protocol Violation|14
6839537|NCT00266032|10845268|FG002|Treatment|Protocol Violation|13
6839538|NCT00266032|10845266|FG000|Treatment|Withdrawal by Subject|28
6839539|NCT00266032|10845267|FG001|Treatment|Withdrawal by Subject|13
6839540|NCT00266032|10845268|FG002|Treatment|Withdrawal by Subject|12
6839541|NCT00266032|10845266|FG000|Treatment|patient moved/wish for pregnancy/no need|13
6839542|NCT00266032|10845267|FG001|Treatment|patient moved/wish for pregnancy/no need|5
6839543|NCT00266032|10845268|FG002|Treatment|patient moved/wish for pregnancy/no need|8
6839544|NCT00266032|10845266|FG000|Open-label Safety Extension|Adverse Event|5
6839545|NCT00266032|10845267|FG001|Open-label Safety Extension|Adverse Event|0
6839546|NCT00266032|10845268|FG002|Open-label Safety Extension|Adverse Event|4
6839547|NCT00266032|10845266|FG000|Open-label Safety Extension|Lost to Follow-up|2
6839548|NCT00266032|10845267|FG001|Open-label Safety Extension|Lost to Follow-up|5
6839549|NCT00266032|10845268|FG002|Open-label Safety Extension|Lost to Follow-up|4
6966412|NCT01125358|11014378|FG003|Overall Study|Perceived Lack of Efficacy|4
6966413|NCT01125358|11014375|FG000|Overall Study|Protocol Violation|1
6966414|NCT01125358|11014376|FG001|Overall Study|Protocol Violation|0
6966415|NCT01125358|11014377|FG002|Overall Study|Protocol Violation|0
6966416|NCT01125358|11014378|FG003|Overall Study|Protocol Violation|0
6966417|NCT01125358|11014375|FG000|Overall Study|Sponsor Decision|0
6966418|NCT01125358|11014376|FG001|Overall Study|Sponsor Decision|0
6966419|NCT01125358|11014377|FG002|Overall Study|Sponsor Decision|1
6966420|NCT01125358|11014378|FG003|Overall Study|Sponsor Decision|1
6966421|NCT01125358|11014375|FG000|Overall Study|Withdrawal by Subject|2
6839550|NCT00266032|10845266|FG000|Open-label Safety Extension|Pregnancy|4
7075024|NCT02061592|11180411|FG001|Period 1|Protocol Violation|0
7075025|NCT02061592|11180410|FG000|Period 2|Lost to Follow-up|0
7075026|NCT02061592|11180411|FG001|Period 2|Lost to Follow-up|1
7075027|NCT02061813|11180450|FG000|Overall Study|Withdrawal by Subject|1
7075028|NCT02061813|11180450|FG000|Overall Study|Protocol Violation|2
7075029|NCT02062151|11180470|FG000|Overall Study|screen failure|1
7075030|NCT02062385|11180495|FG000|Overall Study|Adverse Event|19
7075031|NCT02062385|11180496|FG001|Overall Study|Adverse Event|13
7075032|NCT02062385|11180497|FG002|Overall Study|Adverse Event|1
7075033|NCT02062385|11180498|FG003|Overall Study|Adverse Event|0
7075034|NCT02062385|11180495|FG000|Overall Study|Protocol Violation|1
7075035|NCT02062385|11180496|FG001|Overall Study|Protocol Violation|0
7075036|NCT02062385|11180497|FG002|Overall Study|Protocol Violation|0
7075037|NCT02062385|11180498|FG003|Overall Study|Protocol Violation|0
7147950|NCT03137069|11308779|FG004|Overall Study|Withdrawal by Subject|0
7147951|NCT03137069|11308780|FG005|Overall Study|Withdrawal by Subject|0
7147952|NCT03137069|11308775|FG000|Overall Study|Adverse Event|0
7147953|NCT03137069|11308776|FG001|Overall Study|Adverse Event|3
7147954|NCT03137069|11308777|FG002|Overall Study|Adverse Event|1
7147955|NCT03137069|11308778|FG003|Overall Study|Adverse Event|1
7147956|NCT03137069|11308779|FG004|Overall Study|Adverse Event|0
7147957|NCT03137069|11308780|FG005|Overall Study|Adverse Event|1
7147958|NCT03137069|11308775|FG000|Overall Study|Protocol Violation|0
7147959|NCT03137069|11308776|FG001|Overall Study|Protocol Violation|1
7147960|NCT03137069|11308777|FG002|Overall Study|Protocol Violation|0
7147961|NCT03137069|11308778|FG003|Overall Study|Protocol Violation|1
7147962|NCT03137069|11308779|FG004|Overall Study|Protocol Violation|1
7147963|NCT03137069|11308780|FG005|Overall Study|Protocol Violation|1
7147964|NCT03137069|11308775|FG000|Overall Study|Physician Decision|0
7147965|NCT03137069|11308776|FG001|Overall Study|Physician Decision|0
7147966|NCT03137069|11308777|FG002|Overall Study|Physician Decision|0
7147967|NCT03137069|11308778|FG003|Overall Study|Physician Decision|1
7147968|NCT03137069|11308779|FG004|Overall Study|Physician Decision|0
7147969|NCT03137069|11308780|FG005|Overall Study|Physician Decision|0
7147970|NCT03137069|11308775|FG000|Overall Study|Study Terminated by Sponsor|0
7147971|NCT03137069|11308776|FG001|Overall Study|Study Terminated by Sponsor|0
7147972|NCT03137069|11308777|FG002|Overall Study|Study Terminated by Sponsor|0
7147973|NCT03137069|11308778|FG003|Overall Study|Study Terminated by Sponsor|0
7147974|NCT03137069|11308779|FG004|Overall Study|Study Terminated by Sponsor|1
7147975|NCT03137069|11308780|FG005|Overall Study|Study Terminated by Sponsor|0
7147976|NCT03137069|11308775|FG000|Overall Study|Data Entry Error|0
7147977|NCT03137069|11308776|FG001|Overall Study|Data Entry Error|0
7147978|NCT03137069|11308777|FG002|Overall Study|Data Entry Error|0
7147979|NCT03137069|11308778|FG003|Overall Study|Data Entry Error|1
7147980|NCT03137069|11308779|FG004|Overall Study|Data Entry Error|0
7147981|NCT03137069|11308780|FG005|Overall Study|Data Entry Error|0
7147982|NCT03137121|11308800|FG000|Overall Study|Withdrawal by Subject|0
7147983|NCT03137121|11308801|FG001|Overall Study|Withdrawal by Subject|1
7147984|NCT03137303|11308809|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1
7147985|NCT03137303|11308810|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4
7147986|NCT03137303|11308809|FG000|T1: 3-month Follow-up|Lost to Follow-up|5
7147987|NCT03137303|11308810|FG001|T1: 3-month Follow-up|Lost to Follow-up|6
7147988|NCT03137303|11308809|FG000|T2: 6-month Follow-up|Lost to Follow-up|5
7147989|NCT03137303|11308810|FG001|T2: 6-month Follow-up|Lost to Follow-up|5
7147990|NCT03137303|11308809|FG000|T3: 9-month Follow-up|Death|1
7147991|NCT03137303|11308810|FG001|T3: 9-month Follow-up|Death|0
7075038|NCT02062385|11180495|FG000|Overall Study|Incomplete EPI by database lock|2
7075039|NCT02062385|11180496|FG001|Overall Study|Incomplete EPI by database lock|0
7075040|NCT02062385|11180497|FG002|Overall Study|Incomplete EPI by database lock|0
7075041|NCT02062385|11180498|FG003|Overall Study|Incomplete EPI by database lock|0
7075042|NCT02062385|11180495|FG000|Overall Study|Moved|10
7075043|NCT02062385|11180496|FG001|Overall Study|Moved|11
7075044|NCT02062385|11180497|FG002|Overall Study|Moved|1
7075045|NCT02062385|11180498|FG003|Overall Study|Moved|0
7075046|NCT02062385|11180495|FG000|Overall Study|Withdrawn by parent/guardian|46
7075047|NCT02062385|11180496|FG001|Overall Study|Withdrawn by parent/guardian|41
7075048|NCT02062385|11180497|FG002|Overall Study|Withdrawn by parent/guardian|9
7075049|NCT02062385|11180498|FG003|Overall Study|Withdrawn by parent/guardian|8
7075050|NCT02062385|11180495|FG000|Overall Study|Death|0
7075051|NCT02062385|11180496|FG001|Overall Study|Death|0
7075052|NCT02062385|11180497|FG002|Overall Study|Death|0
7075053|NCT02062385|11180498|FG003|Overall Study|Death|1
7075054|NCT02062385|11180495|FG000|Overall Study|Lost to Follow-up|0
7075055|NCT02062385|11180496|FG001|Overall Study|Lost to Follow-up|0
7075056|NCT02062385|11180497|FG002|Overall Study|Lost to Follow-up|1
7147992|NCT03137303|11308809|FG000|T3: 9-month Follow-up|Lost to Follow-up|4
7147993|NCT03137303|11308810|FG001|T3: 9-month Follow-up|Lost to Follow-up|4
7147994|NCT03137303|11308809|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0
7147995|NCT03137303|11308810|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1
7147996|NCT03137303|11308809|FG000|T4: 12-month Follow-up|Lost to Follow-up|7
7147997|NCT03137303|11308810|FG001|T4: 12-month Follow-up|Lost to Follow-up|4
7075057|NCT02062385|11180498|FG003|Overall Study|Lost to Follow-up|0
7075058|NCT02062398|11180506|FG000|Overall Study|Implant removal|1
7075059|NCT02062437|11180510|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31
7075060|NCT02062437|11180510|FG000|Overall Study|Patient not available for the 2y visit|18
7075061|NCT02062437|11180510|FG000|Overall Study|Death|2
7075062|NCT02062437|11180510|FG000|Overall Study|Pt. couldn't come due to med. condition|1
7075063|NCT02062450|11180516|FG000|Overall Study|No follow-up visit|124
7075064|NCT02062632|11180584|FG000|Overall Study|No treatment data|1
7075065|NCT02062645|11180588|FG000|Overall Study|Adverse Event|2
7075066|NCT02062645|11180588|FG000|Overall Study|Protocol Violation|8
7075067|NCT02062645|11180588|FG000|Overall Study|Lost to Follow-up|5
7075068|NCT02062658|11180592|FG000|Overall Study|Withdrawal by Subject|1
7075069|NCT02062658|11180592|FG000|Overall Study|Lack of Efficacy|1
7082762|NCT02146326|11193558|FG001|Overall Study|Lost to Follow-up|3
7082763|NCT02146326|11193559|FG002|Overall Study|Lost to Follow-up|11
7082764|NCT02146326|11193560|FG003|Overall Study|Lost to Follow-up|19
7082765|NCT02146326|11193557|FG000|Overall Study|Withdrawal by Subject|2
7082766|NCT02146326|11193558|FG001|Overall Study|Withdrawal by Subject|1
7082767|NCT02146326|11193559|FG002|Overall Study|Withdrawal by Subject|15
7082768|NCT02146326|11193560|FG003|Overall Study|Withdrawal by Subject|11
7082769|NCT02146326|11193557|FG000|Overall Study|Separated from mental health center|23
7082770|NCT02146326|11193558|FG001|Overall Study|Separated from mental health center|33
7082771|NCT02146326|11193559|FG002|Overall Study|Separated from mental health center|0
7082772|NCT02146326|11193560|FG003|Overall Study|Separated from mental health center|0
7082773|NCT02146326|11193557|FG000|Overall Study|Incarcerated|0
7082774|NCT02146326|11193558|FG001|Overall Study|Incarcerated|0
7082775|NCT02146326|11193559|FG002|Overall Study|Incarcerated|3
7082776|NCT02146326|11193560|FG003|Overall Study|Incarcerated|8
7082777|NCT02146326|11193557|FG000|Overall Study|Death|0
7082778|NCT02146326|11193558|FG001|Overall Study|Death|0
7082779|NCT02146326|11193559|FG002|Overall Study|Death|4
7082780|NCT02146326|11193560|FG003|Overall Study|Death|4
7082781|NCT02146326|11193557|FG000|Overall Study|Unable to complete interview|0
7082782|NCT02146326|11193558|FG001|Overall Study|Unable to complete interview|0
7082783|NCT02146326|11193559|FG002|Overall Study|Unable to complete interview|10
7082784|NCT02146326|11193560|FG003|Overall Study|Unable to complete interview|6
7082785|NCT02146352|11193576|FG000|Overall Study|Death|1
7082786|NCT02146352|11193576|FG000|Overall Study|Patient entered hospice care|1
7082787|NCT02146365|11193586|FG000|Overall Study|Lost to Follow-up|2
7082788|NCT02146365|11193587|FG001|Overall Study|Lost to Follow-up|1
7082789|NCT02146365|11193588|FG002|Overall Study|Lost to Follow-up|3
7082790|NCT02146365|11193589|FG003|Overall Study|Lost to Follow-up|3
7082791|NCT02146365|11193590|FG004|Overall Study|Lost to Follow-up|1
7082792|NCT02146365|11193591|FG005|Overall Study|Lost to Follow-up|1
7082793|NCT02146365|11193592|FG006|Overall Study|Lost to Follow-up|0
7082794|NCT02146365|11193593|FG007|Overall Study|Lost to Follow-up|1
7082795|NCT02146365|11193586|FG000|Overall Study|Withdrawal by Subject|1
7082796|NCT02146365|11193587|FG001|Overall Study|Withdrawal by Subject|2
7082797|NCT02146365|11193588|FG002|Overall Study|Withdrawal by Subject|1
7082798|NCT02146365|11193589|FG003|Overall Study|Withdrawal by Subject|5
7082799|NCT02146365|11193590|FG004|Overall Study|Withdrawal by Subject|1
7082800|NCT02146365|11193591|FG005|Overall Study|Withdrawal by Subject|0
7082801|NCT02146365|11193592|FG006|Overall Study|Withdrawal by Subject|0
7082802|NCT02146365|11193593|FG007|Overall Study|Withdrawal by Subject|0
7082803|NCT02146365|11193586|FG000|Overall Study|Unable to Comply with Protocol|0
7082804|NCT02146365|11193587|FG001|Overall Study|Unable to Comply with Protocol|1
7082805|NCT02146365|11193588|FG002|Overall Study|Unable to Comply with Protocol|1
7082806|NCT02146365|11193589|FG003|Overall Study|Unable to Comply with Protocol|0
7082807|NCT02146365|11193590|FG004|Overall Study|Unable to Comply with Protocol|0
7082808|NCT02146365|11193591|FG005|Overall Study|Unable to Comply with Protocol|0
7082809|NCT02146365|11193592|FG006|Overall Study|Unable to Comply with Protocol|0
7082810|NCT02146365|11193593|FG007|Overall Study|Unable to Comply with Protocol|0
7082811|NCT02146365|11193586|FG000|Overall Study|Other|1
7082812|NCT02146365|11193587|FG001|Overall Study|Other|0
7082813|NCT02146365|11193588|FG002|Overall Study|Other|2
7082814|NCT02146365|11193589|FG003|Overall Study|Other|1
7082815|NCT02146365|11193590|FG004|Overall Study|Other|0
7082816|NCT02146365|11193591|FG005|Overall Study|Other|0
7082817|NCT02146365|11193592|FG006|Overall Study|Other|0
7082818|NCT02146365|11193593|FG007|Overall Study|Other|0
7082819|NCT02146430|11193615|FG000|Overall Study|Protocol Violation|5
7082820|NCT02146430|11193616|FG001|Overall Study|Protocol Violation|4
7082821|NCT02146430|11193617|FG002|Overall Study|Protocol Violation|8
7082822|NCT02146430|11193618|FG003|Overall Study|Protocol Violation|6
7082823|NCT02146430|11193615|FG000|Overall Study|Lack of Efficacy|13
7082824|NCT02146430|11193616|FG001|Overall Study|Lack of Efficacy|11
7082825|NCT02146430|11193617|FG002|Overall Study|Lack of Efficacy|8
7082826|NCT02146430|11193618|FG003|Overall Study|Lack of Efficacy|5
7082827|NCT02146430|11193615|FG000|Overall Study|Adverse Event|20
7082828|NCT02146430|11193616|FG001|Overall Study|Adverse Event|40
7082829|NCT02146430|11193617|FG002|Overall Study|Adverse Event|32
7082830|NCT02146430|11193618|FG003|Overall Study|Adverse Event|49
7082831|NCT02146430|11193615|FG000|Overall Study|Reason missing or not reported|2
7082832|NCT02146430|11193616|FG001|Overall Study|Reason missing or not reported|3
7082833|NCT02146430|11193617|FG002|Overall Study|Reason missing or not reported|4
7147998|NCT03137459|11308818|FG000|2-month Assessment|Withdrawal by Subject|13
7075070|NCT02062879|11180620|FG000|Overall Study|Withdrawal by Subject|4
7075071|NCT02062879|11180621|FG001|Overall Study|Withdrawal by Subject|1
7075072|NCT02063217|11180670|FG000|Overall Study|Withdrawal by Subject|1
7075073|NCT02063217|11180671|FG001|Overall Study|Withdrawal by Subject|0
7075074|NCT02063217|11180672|FG002|Overall Study|Withdrawal by Subject|0
7075075|NCT02063659|11180709|FG000|Double-Blind Treatment Period|Adverse Event|1
7075076|NCT02063659|11180710|FG001|Double-Blind Treatment Period|Adverse Event|2
7075077|NCT02063659|11180711|FG002|Double-Blind Treatment Period|Adverse Event|0
7075078|NCT02063659|11180712|FG003|Double-Blind Treatment Period|Adverse Event|0
7075079|NCT02063659|11180709|FG000|Double-Blind Treatment Period|Physician Decision|1
7075080|NCT02063659|11180710|FG001|Double-Blind Treatment Period|Physician Decision|0
7075081|NCT02063659|11180711|FG002|Double-Blind Treatment Period|Physician Decision|0
7075082|NCT02063659|11180712|FG003|Double-Blind Treatment Period|Physician Decision|0
7075083|NCT02063659|11180709|FG000|Double-Blind Treatment Period|Withdrawal of consent|0
7075084|NCT02063659|11180710|FG001|Double-Blind Treatment Period|Withdrawal of consent|1
7075085|NCT02063659|11180711|FG002|Double-Blind Treatment Period|Withdrawal of consent|3
7075086|NCT02063659|11180712|FG003|Double-Blind Treatment Period|Withdrawal of consent|0
7075087|NCT02063659|11180709|FG000|Open-Label Extension Period (OLE)|Physician Decision|0
7075088|NCT02063659|11180710|FG001|Open-Label Extension Period (OLE)|Physician Decision|0
7075089|NCT02063659|11180711|FG002|Open-Label Extension Period (OLE)|Physician Decision|0
7075090|NCT02063659|11180712|FG003|Open-Label Extension Period (OLE)|Physician Decision|1
7075091|NCT02063659|11180709|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
7075092|NCT02063659|11180710|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
7075093|NCT02063659|11180711|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
7075094|NCT02063659|11180712|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
7075095|NCT02063659|11180709|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0
7075096|NCT02063659|11180710|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0
7075097|NCT02063659|11180711|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0
7075098|NCT02063659|11180712|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1
7075099|NCT02063659|11180709|FG000|Open-Label Extension Period (OLE)|Adverse Event|0
7075100|NCT02063659|11180710|FG001|Open-Label Extension Period (OLE)|Adverse Event|0
7075101|NCT02063659|11180711|FG002|Open-Label Extension Period (OLE)|Adverse Event|0
7075102|NCT02063659|11180712|FG003|Open-Label Extension Period (OLE)|Adverse Event|7
7075103|NCT02063659|11180709|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0
7075104|NCT02063659|11180710|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0
7075105|NCT02063659|11180711|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0
7075106|NCT02063659|11180712|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2
7075107|NCT02063672|11180728|FG000|Overall Study|Ongoing Follow-up|27
7075108|NCT02063672|11180729|FG001|Overall Study|Ongoing Follow-up|14
7075109|NCT02063672|11180728|FG000|Overall Study|Death|5
7075110|NCT02063672|11180729|FG001|Overall Study|Death|3
7075111|NCT02063672|11180728|FG000|Overall Study|Lost to Follow-up|1
7075112|NCT02063672|11180729|FG001|Overall Study|Lost to Follow-up|3
7075113|NCT02063672|11180728|FG000|Overall Study|Withdrawal by Subject|2
7075114|NCT02063672|11180729|FG001|Overall Study|Withdrawal by Subject|2
7075115|NCT02063698|11180737|FG000|Overall Study|did not complete booklet for days 2-8|1
7075116|NCT02063698|11180738|FG001|Overall Study|did not complete booklet for days 2-8|2
7075117|NCT02063737|11180746|FG000|Overall Study|Lost to Follow-up|11
7075118|NCT02063737|11180747|FG001|Overall Study|Lost to Follow-up|4
7075119|NCT02063828|11180756|FG000|Overall Study|Withdrawal by Subject|4
7075120|NCT02063828|11180757|FG001|Overall Study|Withdrawal by Subject|6
7075121|NCT02063828|11180758|FG002|Overall Study|Withdrawal by Subject|3
7075122|NCT02063828|11180756|FG000|Overall Study|Death|0
7075123|NCT02063828|11180757|FG001|Overall Study|Death|0
7075124|NCT02063828|11180758|FG002|Overall Study|Death|1
7075125|NCT02063854|11180773|FG000|Overall Study|Pretreatment Event/Adverse Event|13
7075126|NCT02063854|11180774|FG001|Overall Study|Pretreatment Event/Adverse Event|10
7075127|NCT02063854|11180775|FG002|Overall Study|Pretreatment Event/Adverse Event|13
7075128|NCT02063854|11180776|FG003|Overall Study|Pretreatment Event/Adverse Event|8
7075129|NCT02063854|11180777|FG004|Overall Study|Pretreatment Event/Adverse Event|7
7075130|NCT02063854|11180778|FG005|Overall Study|Pretreatment Event/Adverse Event|18
7075131|NCT02063854|11180779|FG006|Overall Study|Pretreatment Event/Adverse Event|4
7075132|NCT02063854|11180773|FG000|Overall Study|Major Protocol Deviation|0
7075133|NCT02063854|11180774|FG001|Overall Study|Major Protocol Deviation|0
7075134|NCT02063854|11180775|FG002|Overall Study|Major Protocol Deviation|3
7075135|NCT02063854|11180776|FG003|Overall Study|Major Protocol Deviation|0
7075136|NCT02063854|11180777|FG004|Overall Study|Major Protocol Deviation|0
7075137|NCT02063854|11180778|FG005|Overall Study|Major Protocol Deviation|0
7075138|NCT02063854|11180779|FG006|Overall Study|Major Protocol Deviation|0
7075139|NCT02063854|11180773|FG000|Overall Study|Voluntary Withdrawal|2
7075140|NCT02063854|11180774|FG001|Overall Study|Voluntary Withdrawal|0
7075141|NCT02063854|11180775|FG002|Overall Study|Voluntary Withdrawal|8
7075142|NCT02063854|11180776|FG003|Overall Study|Voluntary Withdrawal|1
7075143|NCT02063854|11180777|FG004|Overall Study|Voluntary Withdrawal|3
7075144|NCT02063854|11180778|FG005|Overall Study|Voluntary Withdrawal|6
7075145|NCT02063854|11180779|FG006|Overall Study|Voluntary Withdrawal|1
7075146|NCT02063854|11180773|FG000|Overall Study|Surgical Dental Work Performed/Planned|5
7075147|NCT02063854|11180774|FG001|Overall Study|Surgical Dental Work Performed/Planned|2
7075148|NCT02063854|11180775|FG002|Overall Study|Surgical Dental Work Performed/Planned|6
7075149|NCT02063854|11180776|FG003|Overall Study|Surgical Dental Work Performed/Planned|1
7075150|NCT02063854|11180777|FG004|Overall Study|Surgical Dental Work Performed/Planned|1
7075151|NCT02063854|11180778|FG005|Overall Study|Surgical Dental Work Performed/Planned|6
7075152|NCT02063854|11180779|FG006|Overall Study|Surgical Dental Work Performed/Planned|1
7075153|NCT02063854|11180773|FG000|Overall Study|Reason Not Specified|1
7075154|NCT02063854|11180774|FG001|Overall Study|Reason Not Specified|0
7075155|NCT02063854|11180775|FG002|Overall Study|Reason Not Specified|0
7075156|NCT02063854|11180776|FG003|Overall Study|Reason Not Specified|0
7075157|NCT02063854|11180777|FG004|Overall Study|Reason Not Specified|0
7075158|NCT02063854|11180778|FG005|Overall Study|Reason Not Specified|0
7075159|NCT02063854|11180779|FG006|Overall Study|Reason Not Specified|0
7075160|NCT02063854|11180773|FG000|Overall Study|Did Not Receive Study Drug|0
7075161|NCT02063854|11180774|FG001|Overall Study|Did Not Receive Study Drug|0
7075162|NCT02063854|11180775|FG002|Overall Study|Did Not Receive Study Drug|0
7075163|NCT02063854|11180776|FG003|Overall Study|Did Not Receive Study Drug|0
7075164|NCT02063854|11180777|FG004|Overall Study|Did Not Receive Study Drug|0
6839551|NCT00266032|10845267|FG001|Open-label Safety Extension|Pregnancy|1
6839552|NCT00266032|10845268|FG002|Open-label Safety Extension|Pregnancy|2
6839553|NCT00266032|10845266|FG000|Open-label Safety Extension|Protocol Violation|1
6839554|NCT00266032|10845267|FG001|Open-label Safety Extension|Protocol Violation|3
6839555|NCT00266032|10845268|FG002|Open-label Safety Extension|Protocol Violation|2
6839556|NCT00266032|10845266|FG000|Open-label Safety Extension|Withdrawal by Subject|19
6839557|NCT00266032|10845267|FG001|Open-label Safety Extension|Withdrawal by Subject|3
6839558|NCT00266032|10845268|FG002|Open-label Safety Extension|Withdrawal by Subject|12
6839559|NCT00266032|10845266|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10
6839560|NCT00266032|10845267|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2
6839561|NCT00266032|10845268|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1
6839562|NCT00266227|10845283|FG000|Initial Treatment|Adverse Event|0
6839563|NCT00266227|10845284|FG001|Initial Treatment|Adverse Event|0
6839564|NCT00266227|10845285|FG002|Initial Treatment|Adverse Event|13
6839565|NCT00266227|10845283|FG000|Initial Treatment|Lost to Follow-up|0
6839566|NCT00266227|10845284|FG001|Initial Treatment|Lost to Follow-up|0
6839567|NCT00266227|10845285|FG002|Initial Treatment|Lost to Follow-up|6
6839568|NCT00266227|10845283|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0
6839569|NCT00266227|10845284|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0
6839570|NCT00266227|10845285|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45
6839571|NCT00266227|10845283|FG000|Initial Treatment|Physician decision to withdraw|0
6839572|NCT00266227|10845284|FG001|Initial Treatment|Physician decision to withdraw|0
6839573|NCT00266227|10845285|FG002|Initial Treatment|Physician decision to withdraw|12
6839574|NCT00266227|10845283|FG000|Initial Treatment|Pregnancy|0
6839575|NCT00266227|10845284|FG001|Initial Treatment|Pregnancy|0
6839576|NCT00266227|10845285|FG002|Initial Treatment|Pregnancy|1
6839577|NCT00266227|10845283|FG000|Retreatment: Up to Week 48|Death|1
6839578|NCT00266227|10845284|FG001|Retreatment: Up to Week 48|Death|0
6839579|NCT00266227|10845285|FG002|Retreatment: Up to Week 48|Death|0
6839580|NCT00266227|10845283|FG000|Retreatment: Up to Week 48|Adverse Event|7
6839581|NCT00266227|10845284|FG001|Retreatment: Up to Week 48|Adverse Event|7
6839582|NCT00266227|10845285|FG002|Retreatment: Up to Week 48|Adverse Event|0
6839583|NCT00266227|10845283|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3
7075165|NCT02063854|11180778|FG005|Overall Study|Did Not Receive Study Drug|1
7075166|NCT02063854|11180779|FG006|Overall Study|Did Not Receive Study Drug|0
7075167|NCT02063880|11180808|FG000|Overall Study|Death|21
7075168|NCT02063880|11180809|FG001|Overall Study|Death|18
7075169|NCT02063880|11180808|FG000|Overall Study|Lost to Follow-up|7
7075170|NCT02063880|11180809|FG001|Overall Study|Lost to Follow-up|7
7075171|NCT02063880|11180808|FG000|Overall Study|Ineligible|0
7075172|NCT02063880|11180809|FG001|Overall Study|Ineligible|2
7075173|NCT02063984|11180817|FG000|Overall Study|Lost to Follow-up|6
7075174|NCT02063984|11180818|FG001|Overall Study|Lost to Follow-up|5
7075175|NCT02064166|11180830|FG000|Overall Study|Adverse Event|1
7075176|NCT02064166|11180831|FG001|Overall Study|Adverse Event|0
7075177|NCT02064205|11180859|FG000|Overall Study|Withdrawal by Subject|1
7075178|NCT02064231|11180875|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5
7075179|NCT02064231|11180876|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3
7075180|NCT02064231|11180877|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0
7075181|NCT02064231|11180878|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0
7075182|NCT02064231|11180875|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1
7075183|NCT02064231|11180876|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1
7075184|NCT02064231|11180877|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0
6839584|NCT00266227|10845284|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0
6839585|NCT00266227|10845285|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0
7075185|NCT02064231|11180878|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0
7075186|NCT02064231|11180875|FG000|First Test Period (Test A or Test C)|Adverse Event|1
7075187|NCT02064231|11180876|FG001|First Test Period (Test A or Test C)|Adverse Event|0
7075188|NCT02064231|11180877|FG002|First Test Period (Test A or Test C)|Adverse Event|1
7075189|NCT02064231|11180878|FG003|First Test Period (Test A or Test C)|Adverse Event|0
7075190|NCT02064231|11180875|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1
7075191|NCT02064231|11180876|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1
7075192|NCT02064231|11180877|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0
7075193|NCT02064231|11180878|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0
7075194|NCT02064439|11180902|FG000|Overall Study|Adverse Event|51
7075195|NCT02064439|11180903|FG001|Overall Study|Adverse Event|47
7075196|NCT02064439|11180904|FG002|Overall Study|Adverse Event|46
7075197|NCT02064439|11180902|FG000|Overall Study|Death|0
7075198|NCT02064439|11180903|FG001|Overall Study|Death|2
7075199|NCT02064439|11180904|FG002|Overall Study|Death|3
7075200|NCT02064439|11180902|FG000|Overall Study|Withdrawal by Subject|29
7075201|NCT02064439|11180903|FG001|Overall Study|Withdrawal by Subject|18
7075202|NCT02064439|11180904|FG002|Overall Study|Withdrawal by Subject|26
7075203|NCT02064439|11180902|FG000|Overall Study|Protocol Violation|3
7075204|NCT02064439|11180903|FG001|Overall Study|Protocol Violation|5
7075205|NCT02064439|11180904|FG002|Overall Study|Protocol Violation|3
7075206|NCT02064439|11180902|FG000|Overall Study|Lost to Follow-up|1
7075207|NCT02064439|11180903|FG001|Overall Study|Lost to Follow-up|3
7075208|NCT02064439|11180904|FG002|Overall Study|Lost to Follow-up|4
7075209|NCT02064439|11180902|FG000|Overall Study|Non-compliance with study medication|21
7075210|NCT02064439|11180903|FG001|Overall Study|Non-compliance with study medication|19
7075211|NCT02064439|11180904|FG002|Overall Study|Non-compliance with study medication|23
7075212|NCT02064439|11180902|FG000|Overall Study|Physician Decision|0
7075213|NCT02064439|11180903|FG001|Overall Study|Physician Decision|1
7075214|NCT02064439|11180904|FG002|Overall Study|Physician Decision|1
7075215|NCT02064439|11180902|FG000|Overall Study|Logistical difficulties|6
7075216|NCT02064439|11180903|FG001|Overall Study|Logistical difficulties|5
7075217|NCT02064439|11180904|FG002|Overall Study|Logistical difficulties|2
7075218|NCT02064439|11180902|FG000|Overall Study|Efficacy outcome reached|18
7075219|NCT02064439|11180903|FG001|Overall Study|Efficacy outcome reached|16
7075220|NCT02064439|11180904|FG002|Overall Study|Efficacy outcome reached|57
7075221|NCT02064439|11180902|FG000|Overall Study|Safety outcome reached|12
7075222|NCT02064439|11180903|FG001|Overall Study|Safety outcome reached|20
7075223|NCT02064439|11180904|FG002|Overall Study|Safety outcome reached|10
7075224|NCT02064439|11180902|FG000|Overall Study|Other|2
7075225|NCT02064439|11180903|FG001|Overall Study|Other|2
7075226|NCT02064439|11180904|FG002|Overall Study|Other|7
7075227|NCT02064816|11180918|FG000|Overall Study|Adverse Event|3
7075228|NCT02064816|11180919|FG001|Overall Study|Adverse Event|2
7075229|NCT02064816|11180918|FG000|Overall Study|Withdrawal by Subject|2
7075230|NCT02064816|11180919|FG001|Overall Study|Withdrawal by Subject|1
7075231|NCT02064816|11180918|FG000|Overall Study|Lost to Follow-up|2
7075232|NCT02064816|11180919|FG001|Overall Study|Lost to Follow-up|1
7075233|NCT02064816|11180918|FG000|Overall Study|Therapeutic failure|0
7075234|NCT02064816|11180919|FG001|Overall Study|Therapeutic failure|1
7075235|NCT02064816|11180918|FG000|Overall Study|Other|1
7075236|NCT02064816|11180919|FG001|Overall Study|Other|3
7075237|NCT02064868|11180974|FG000|Overall Study|Lost to Follow-up|14
7075238|NCT02064868|11180975|FG001|Overall Study|Lost to Follow-up|8
7075239|NCT02064868|11180974|FG000|Overall Study|Physician Decision|1
7075240|NCT02064868|11180975|FG001|Overall Study|Physician Decision|0
7075241|NCT02064868|11180974|FG000|Overall Study|Withdrawal by Subject|14
7075242|NCT02064868|11180975|FG001|Overall Study|Withdrawal by Subject|3
7075243|NCT02064868|11180974|FG000|Overall Study|Technical Problems or Missing|5
7075244|NCT02064868|11180975|FG001|Overall Study|Technical Problems or Missing|2
7075245|NCT02064894|11180984|FG000|Overall Study|Withdrawal by Subject|43
7075246|NCT02064894|11180985|FG001|Overall Study|Withdrawal by Subject|102
7075247|NCT02064894|11180986|FG002|Overall Study|Withdrawal by Subject|115
7075248|NCT02064920|11181005|FG000|Overall Study|Adverse Event|0
7075249|NCT02064920|11181006|FG001|Overall Study|Adverse Event|4
7075250|NCT02064920|11181005|FG000|Overall Study|Physician Decision|0
7075251|NCT02064920|11181006|FG001|Overall Study|Physician Decision|1
7075252|NCT02064920|11181005|FG000|Overall Study|Technical Problems|0
7075253|NCT02064920|11181006|FG001|Overall Study|Technical Problems|1
7075254|NCT02064920|11181005|FG000|Overall Study|Withdrawal by Subject|1
7075255|NCT02064920|11181006|FG001|Overall Study|Withdrawal by Subject|3
7075256|NCT02065245|11181041|FG000|Infusion 1|Lost to Follow-up|0
7075257|NCT02065245|11181042|FG001|Infusion 1|Lost to Follow-up|0
7075258|NCT02065245|11181043|FG002|Infusion 1|Lost to Follow-up|0
7075259|NCT02065245|11181044|FG003|Infusion 1|Lost to Follow-up|0
7075260|NCT02065245|11181045|FG004|Infusion 1|Lost to Follow-up|0
7075261|NCT02065245|11181046|FG005|Infusion 1|Lost to Follow-up|0
7075262|NCT02065245|11181047|FG006|Infusion 1|Lost to Follow-up|1
7075263|NCT02065245|11181041|FG000|Infusion 1|Death|0
7075264|NCT02065245|11181042|FG001|Infusion 1|Death|0
7075265|NCT02065245|11181043|FG002|Infusion 1|Death|1
7075266|NCT02065245|11181044|FG003|Infusion 1|Death|0
7075267|NCT02065245|11181045|FG004|Infusion 1|Death|1
7075268|NCT02065245|11181046|FG005|Infusion 1|Death|0
7075269|NCT02065245|11181047|FG006|Infusion 1|Death|0
7075270|NCT02065245|11181041|FG000|Infusion 2|Death|0
7075271|NCT02065245|11181042|FG001|Infusion 2|Death|0
7075272|NCT02065245|11181043|FG002|Infusion 2|Death|0
7075273|NCT02065245|11181044|FG003|Infusion 2|Death|0
7075274|NCT02065245|11181045|FG004|Infusion 2|Death|0
7075275|NCT02065245|11181046|FG005|Infusion 2|Death|0
7075276|NCT02065245|11181047|FG006|Infusion 2|Death|1
7075277|NCT02065245|11181041|FG000|Infusion 3|Lost to Follow-up|1
6966422|NCT01125358|11014376|FG001|Overall Study|Withdrawal by Subject|1
7075278|NCT02065245|11181042|FG001|Infusion 3|Lost to Follow-up|1
7075279|NCT02065245|11181043|FG002|Infusion 3|Lost to Follow-up|0
7075280|NCT02065245|11181044|FG003|Infusion 3|Lost to Follow-up|0
7075281|NCT02065245|11181045|FG004|Infusion 3|Lost to Follow-up|0
7075282|NCT02065245|11181046|FG005|Infusion 3|Lost to Follow-up|0
7075283|NCT02065245|11181047|FG006|Infusion 3|Lost to Follow-up|0
7075284|NCT02065336|11181071|FG000|Extension Phase|Study Terminated by Sponsor|0
7075285|NCT02065336|11181072|FG001|Extension Phase|Study Terminated by Sponsor|0
7075286|NCT02065336|11181073|FG002|Extension Phase|Study Terminated by Sponsor|0
7075287|NCT02065336|11181074|FG003|Extension Phase|Study Terminated by Sponsor|0
7075288|NCT02065336|11181075|FG004|Extension Phase|Study Terminated by Sponsor|0
7075289|NCT02065336|11181076|FG005|Extension Phase|Study Terminated by Sponsor|0
7075290|NCT02065336|11181077|FG006|Extension Phase|Study Terminated by Sponsor|0
7075291|NCT02065336|11181078|FG007|Extension Phase|Study Terminated by Sponsor|0
7075292|NCT02065336|11181079|FG008|Extension Phase|Study Terminated by Sponsor|2
7075293|NCT02065336|11181080|FG009|Extension Phase|Study Terminated by Sponsor|8
7075294|NCT02065518|11181132|FG000|Overall Study|Lost to Follow-up|3
7075295|NCT02065518|11181133|FG001|Overall Study|Lost to Follow-up|4
7075296|NCT02065518|11181134|FG002|Overall Study|Lost to Follow-up|0
7075297|NCT02065518|11181135|FG003|Overall Study|Lost to Follow-up|3
7075298|NCT02065518|11181132|FG000|Overall Study|Withdrawal by Subject|3
7075299|NCT02065518|11181133|FG001|Overall Study|Withdrawal by Subject|4
7075300|NCT02065518|11181134|FG002|Overall Study|Withdrawal by Subject|9
7075301|NCT02065518|11181135|FG003|Overall Study|Withdrawal by Subject|2
7075302|NCT02065557|11181148|FG000|Induction Period|Withdrawal by Subject|2
7075303|NCT02065557|11181149|FG001|Induction Period|Withdrawal by Subject|1
7075304|NCT02065557|11181150|FG002|Induction Period|Withdrawal by Subject|0
7075305|NCT02065557|11181151|FG003|Induction Period|Withdrawal by Subject|0
7075306|NCT02065557|11181152|FG004|Induction Period|Withdrawal by Subject|0
7075307|NCT02065557|11181153|FG005|Induction Period|Withdrawal by Subject|0
7075308|NCT02065557|11181148|FG000|Induction Period|Lack of Efficacy|2
7075309|NCT02065557|11181149|FG001|Induction Period|Lack of Efficacy|1
7075310|NCT02065557|11181150|FG002|Induction Period|Lack of Efficacy|1
7075311|NCT02065557|11181151|FG003|Induction Period|Lack of Efficacy|0
7075312|NCT02065557|11181152|FG004|Induction Period|Lack of Efficacy|0
7075313|NCT02065557|11181153|FG005|Induction Period|Lack of Efficacy|0
7075314|NCT02065557|11181148|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1
7075315|NCT02065557|11181149|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1
7075316|NCT02065557|11181150|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1
7075317|NCT02065557|11181151|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0
7075318|NCT02065557|11181152|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0
7075319|NCT02065557|11181153|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0
7075320|NCT02065557|11181148|FG000|Induction Period|Non-Responder at Week 8|4
7075321|NCT02065557|11181149|FG001|Induction Period|Non-Responder at Week 8|4
7075322|NCT02065557|11181150|FG002|Induction Period|Non-Responder at Week 8|0
7075323|NCT02065557|11181151|FG003|Induction Period|Non-Responder at Week 8|0
7075324|NCT02065557|11181152|FG004|Induction Period|Non-Responder at Week 8|0
7075325|NCT02065557|11181153|FG005|Induction Period|Non-Responder at Week 8|0
7075326|NCT02065557|11181148|FG000|Induction Period|Adverse Event|1
7075327|NCT02065557|11181149|FG001|Induction Period|Adverse Event|1
7075328|NCT02065557|11181150|FG002|Induction Period|Adverse Event|0
7075329|NCT02065557|11181151|FG003|Induction Period|Adverse Event|0
7075330|NCT02065557|11181152|FG004|Induction Period|Adverse Event|0
7075331|NCT02065557|11181153|FG005|Induction Period|Adverse Event|0
7075332|NCT02065557|11181148|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0
7075333|NCT02065557|11181149|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0
7075334|NCT02065557|11181150|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0
7075335|NCT02065557|11181151|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1
7075336|NCT02065557|11181152|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1
7075337|NCT02065557|11181153|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0
7075338|NCT02065557|11181148|FG000|Maintenance Period|Withdrawal by Subject|0
7075339|NCT02065557|11181149|FG001|Maintenance Period|Withdrawal by Subject|0
7075340|NCT02065557|11181150|FG002|Maintenance Period|Withdrawal by Subject|0
7075341|NCT02065557|11181151|FG003|Maintenance Period|Withdrawal by Subject|0
7075342|NCT02065557|11181152|FG004|Maintenance Period|Withdrawal by Subject|2
7075343|NCT02065557|11181153|FG005|Maintenance Period|Withdrawal by Subject|1
7075344|NCT02065557|11181148|FG000|Maintenance Period|Lack of Efficacy|0
7075345|NCT02065557|11181149|FG001|Maintenance Period|Lack of Efficacy|0
7075346|NCT02065557|11181150|FG002|Maintenance Period|Lack of Efficacy|0
7075347|NCT02065557|11181151|FG003|Maintenance Period|Lack of Efficacy|0
7075348|NCT02065557|11181152|FG004|Maintenance Period|Lack of Efficacy|5
7075349|NCT02065557|11181153|FG005|Maintenance Period|Lack of Efficacy|2
7075350|NCT02065557|11181148|FG000|Maintenance Period|Subject Non-Compliance|0
7075351|NCT02065557|11181149|FG001|Maintenance Period|Subject Non-Compliance|0
7075352|NCT02065557|11181150|FG002|Maintenance Period|Subject Non-Compliance|0
7075353|NCT02065557|11181151|FG003|Maintenance Period|Subject Non-Compliance|0
7075354|NCT02065557|11181152|FG004|Maintenance Period|Subject Non-Compliance|0
7075355|NCT02065557|11181153|FG005|Maintenance Period|Subject Non-Compliance|1
7075356|NCT02065570|11181180|FG000|Induction Study|Adverse Event|5
7075357|NCT02065570|11181181|FG001|Induction Study|Adverse Event|12
7075358|NCT02065570|11181182|FG002|Induction Study|Adverse Event|0
7075359|NCT02065570|11181183|FG003|Induction Study|Adverse Event|0
7075360|NCT02065570|11181180|FG000|Induction Study|Withdrawal by Subject|2
7075361|NCT02065570|11181181|FG001|Induction Study|Withdrawal by Subject|3
7075362|NCT02065570|11181182|FG002|Induction Study|Withdrawal by Subject|0
7075363|NCT02065570|11181183|FG003|Induction Study|Withdrawal by Subject|0
7075364|NCT02065570|11181180|FG000|Induction Study|Lost to Follow-up|1
7075365|NCT02065570|11181181|FG001|Induction Study|Lost to Follow-up|1
7075366|NCT02065570|11181182|FG002|Induction Study|Lost to Follow-up|0
7075367|NCT02065570|11181183|FG003|Induction Study|Lost to Follow-up|0
7075368|NCT02065570|11181180|FG000|Induction Study|Other, Not Specified|6
7075369|NCT02065570|11181181|FG001|Induction Study|Other, Not Specified|5
7075370|NCT02065570|11181182|FG002|Induction Study|Other, Not Specified|0
7075371|NCT02065570|11181183|FG003|Induction Study|Other, Not Specified|0
7075372|NCT02065570|11181180|FG000|Maintenance Study|Adverse Event|0
7075373|NCT02065570|11181181|FG001|Maintenance Study|Adverse Event|0
7075374|NCT02065570|11181182|FG002|Maintenance Study|Adverse Event|8
7075375|NCT02065570|11181183|FG003|Maintenance Study|Adverse Event|8
7075376|NCT02065570|11181180|FG000|Maintenance Study|Withdrawal by Subject|0
7075377|NCT02065570|11181181|FG001|Maintenance Study|Withdrawal by Subject|0
7075378|NCT02065570|11181182|FG002|Maintenance Study|Withdrawal by Subject|1
7075379|NCT02065570|11181183|FG003|Maintenance Study|Withdrawal by Subject|4
7075380|NCT02065570|11181180|FG000|Maintenance Study|Lost to Follow-up|0
7075381|NCT02065570|11181181|FG001|Maintenance Study|Lost to Follow-up|0
7075382|NCT02065570|11181182|FG002|Maintenance Study|Lost to Follow-up|2
7075383|NCT02065570|11181183|FG003|Maintenance Study|Lost to Follow-up|2
7075384|NCT02065570|11181180|FG000|Maintenance Study|Other, Not Specified|0
7075385|NCT02065570|11181181|FG001|Maintenance Study|Other, Not Specified|0
7075386|NCT02065570|11181182|FG002|Maintenance Study|Other, Not Specified|11
7075387|NCT02065570|11181183|FG003|Maintenance Study|Other, Not Specified|5
7075388|NCT02065622|11181196|FG000|Induction Study|Adverse Event|13
7075389|NCT02065622|11181197|FG001|Induction Study|Adverse Event|19
7075390|NCT02065622|11181198|FG002|Induction Study|Adverse Event|0
7075391|NCT02065622|11181199|FG003|Induction Study|Adverse Event|0
7075392|NCT02065622|11181200|FG004|Induction Study|Adverse Event|0
7075393|NCT02065622|11181196|FG000|Induction Study|Withdrawal by Subject|3
7075394|NCT02065622|11181197|FG001|Induction Study|Withdrawal by Subject|5
7075395|NCT02065622|11181198|FG002|Induction Study|Withdrawal by Subject|0
7075396|NCT02065622|11181199|FG003|Induction Study|Withdrawal by Subject|0
7075397|NCT02065622|11181200|FG004|Induction Study|Withdrawal by Subject|0
7075398|NCT02065622|11181196|FG000|Induction Study|Lost to Follow-up|1
7075399|NCT02065622|11181197|FG001|Induction Study|Lost to Follow-up|0
7075400|NCT02065622|11181198|FG002|Induction Study|Lost to Follow-up|0
7075401|NCT02065622|11181199|FG003|Induction Study|Lost to Follow-up|0
7075402|NCT02065622|11181200|FG004|Induction Study|Lost to Follow-up|0
7075403|NCT02065622|11181196|FG000|Induction Study|Lack of Efficacy|22
7075404|NCT02065622|11181197|FG001|Induction Study|Lack of Efficacy|27
7075405|NCT02065622|11181198|FG002|Induction Study|Lack of Efficacy|0
7075406|NCT02065622|11181199|FG003|Induction Study|Lack of Efficacy|0
7075407|NCT02065622|11181200|FG004|Induction Study|Lack of Efficacy|0
7075408|NCT02065622|11181196|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4
7075409|NCT02065622|11181197|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5
7075410|NCT02065622|11181198|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0
7075411|NCT02065622|11181199|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0
7075412|NCT02065622|11181200|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0
7075413|NCT02065622|11181196|FG000|Induction Study|Subject Noncompliance|1
7075414|NCT02065622|11181197|FG001|Induction Study|Subject Noncompliance|1
7075415|NCT02065622|11181198|FG002|Induction Study|Subject Noncompliance|0
7075416|NCT02065622|11181199|FG003|Induction Study|Subject Noncompliance|0
7075417|NCT02065622|11181200|FG004|Induction Study|Subject Noncompliance|0
7075418|NCT02065622|11181196|FG000|Induction Study|Other, Not Specified|3
7075419|NCT02065622|11181197|FG001|Induction Study|Other, Not Specified|2
7075420|NCT02065622|11181198|FG002|Induction Study|Other, Not Specified|0
7075421|NCT02065622|11181199|FG003|Induction Study|Other, Not Specified|0
7075422|NCT02065622|11181200|FG004|Induction Study|Other, Not Specified|0
7075423|NCT02065622|11181196|FG000|Maintenance Study|Adverse Event|0
7075424|NCT02065622|11181197|FG001|Maintenance Study|Adverse Event|0
7075425|NCT02065622|11181198|FG002|Maintenance Study|Adverse Event|25
7075426|NCT02065622|11181199|FG003|Maintenance Study|Adverse Event|22
7075427|NCT02065622|11181200|FG004|Maintenance Study|Adverse Event|11
7075428|NCT02065622|11181196|FG000|Maintenance Study|Withdrawal by Subject|0
7075429|NCT02065622|11181197|FG001|Maintenance Study|Withdrawal by Subject|0
7075430|NCT02065622|11181198|FG002|Maintenance Study|Withdrawal by Subject|11
7075431|NCT02065622|11181199|FG003|Maintenance Study|Withdrawal by Subject|5
7075432|NCT02065622|11181200|FG004|Maintenance Study|Withdrawal by Subject|7
7075433|NCT02065622|11181196|FG000|Maintenance Study|Lost to Follow-up|0
7075434|NCT02065622|11181197|FG001|Maintenance Study|Lost to Follow-up|0
7075435|NCT02065622|11181198|FG002|Maintenance Study|Lost to Follow-up|4
7075436|NCT02065622|11181199|FG003|Maintenance Study|Lost to Follow-up|1
7075437|NCT02065622|11181200|FG004|Maintenance Study|Lost to Follow-up|1
7075438|NCT02065622|11181196|FG000|Maintenance Study|Lack of Efficacy|0
7075439|NCT02065622|11181197|FG001|Maintenance Study|Lack of Efficacy|0
7075440|NCT02065622|11181198|FG002|Maintenance Study|Lack of Efficacy|70
7075441|NCT02065622|11181199|FG003|Maintenance Study|Lack of Efficacy|55
7075442|NCT02065622|11181200|FG004|Maintenance Study|Lack of Efficacy|19
7075443|NCT02065622|11181196|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0
7075444|NCT02065622|11181197|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0
7075445|NCT02065622|11181198|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7
7075446|NCT02065622|11181199|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3
7075447|NCT02065622|11181200|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4
7075448|NCT02065622|11181196|FG000|Maintenance Study|Subject Non-Compliance|0
7075449|NCT02065622|11181197|FG001|Maintenance Study|Subject Non-Compliance|0
7075450|NCT02065622|11181198|FG002|Maintenance Study|Subject Non-Compliance|1
7075451|NCT02065622|11181199|FG003|Maintenance Study|Subject Non-Compliance|3
7075452|NCT02065622|11181200|FG004|Maintenance Study|Subject Non-Compliance|2
7075453|NCT02065622|11181196|FG000|Maintenance Study|Other, Not Specified|0
7075454|NCT02065622|11181197|FG001|Maintenance Study|Other, Not Specified|0
7075455|NCT02065622|11181198|FG002|Maintenance Study|Other, Not Specified|6
7075456|NCT02065622|11181199|FG003|Maintenance Study|Other, Not Specified|14
7075457|NCT02065622|11181200|FG004|Maintenance Study|Other, Not Specified|2
7075458|NCT02065622|11181196|FG000|Maintenance Study|Unknown Reason|0
7075459|NCT02065622|11181197|FG001|Maintenance Study|Unknown Reason|0
7075460|NCT02065622|11181198|FG002|Maintenance Study|Unknown Reason|0
7075461|NCT02065622|11181199|FG003|Maintenance Study|Unknown Reason|1
7075462|NCT02065622|11181200|FG004|Maintenance Study|Unknown Reason|0
7075463|NCT02065713|11181226|FG000|Overall Study|Adverse Event|0
7075464|NCT02065713|11181227|FG001|Overall Study|Adverse Event|1
7075465|NCT02065713|11181226|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7075466|NCT02065713|11181227|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7075467|NCT02065791|11181235|FG000|Overall Study|Closed Site|1
7075468|NCT02065791|11181236|FG001|Overall Study|Closed Site|1
7075469|NCT02065791|11181235|FG000|Overall Study|Withdrawal by Subject|11
7075470|NCT02065791|11181236|FG001|Overall Study|Withdrawal by Subject|5
7075471|NCT02065791|11181235|FG000|Overall Study|Lost to Follow-up|13
7075472|NCT02065791|11181236|FG001|Overall Study|Lost to Follow-up|9
7075473|NCT02065895|11181242|FG000|Overall Study|Protocol Violation|1
7075474|NCT02065895|11181243|FG001|Overall Study|Protocol Violation|0
7075475|NCT02065895|11181244|FG002|Overall Study|Protocol Violation|0
7075476|NCT02065895|11181245|FG003|Overall Study|Protocol Violation|1
7075477|NCT02065895|11181246|FG004|Overall Study|Protocol Violation|0
7075478|NCT02065895|11181247|FG005|Overall Study|Protocol Violation|0
7075479|NCT02065895|11181242|FG000|Overall Study|Scheduling conflicts|0
7075480|NCT02065895|11181243|FG001|Overall Study|Scheduling conflicts|1
7075481|NCT02065895|11181244|FG002|Overall Study|Scheduling conflicts|0
7075482|NCT02065895|11181245|FG003|Overall Study|Scheduling conflicts|0
7075483|NCT02065895|11181246|FG004|Overall Study|Scheduling conflicts|0
7075484|NCT02065895|11181247|FG005|Overall Study|Scheduling conflicts|0
7075485|NCT02066051|11181264|FG000|Overall Study|Subject developed active GVHD|1
7075486|NCT02066129|11181270|FG000|Overall Study|Lost to Follow-up|13
7075487|NCT02066129|11181271|FG001|Overall Study|Lost to Follow-up|12
7075488|NCT02066129|11181270|FG000|Overall Study|Withdrawal by Subject|7
7075489|NCT02066129|11181271|FG001|Overall Study|Withdrawal by Subject|10
7075490|NCT02066129|11181270|FG000|Overall Study|Lack of Efficacy|8
7075491|NCT02066129|11181271|FG001|Overall Study|Lack of Efficacy|10
7075492|NCT02066129|11181270|FG000|Overall Study|Physician Decision|1
7075493|NCT02066129|11181271|FG001|Overall Study|Physician Decision|1
7075494|NCT02066233|11181279|FG000|EG Scan II (Day 1)|difficulty intubating subject|6
7075495|NCT02066233|11181280|FG001|EG Scan II (Day 1)|difficulty intubating subject|6
7075496|NCT02066298|11181292|FG000|Overall Study|Lost to Follow-up|3
7075497|NCT02066298|11181293|FG001|Overall Study|Lost to Follow-up|2
7075498|NCT02066298|11181294|FG002|Overall Study|Lost to Follow-up|3
7075499|NCT02066298|11181295|FG003|Overall Study|Lost to Follow-up|2
7075500|NCT02066298|11181296|FG004|Overall Study|Lost to Follow-up|3
7075501|NCT02066298|11181297|FG005|Overall Study|Lost to Follow-up|4
7075502|NCT02066298|11181292|FG000|Overall Study|Withdrawal by Subject|6
7075503|NCT02066298|11181293|FG001|Overall Study|Withdrawal by Subject|6
7075504|NCT02066298|11181294|FG002|Overall Study|Withdrawal by Subject|6
7075505|NCT02066298|11181295|FG003|Overall Study|Withdrawal by Subject|4
7075506|NCT02066298|11181296|FG004|Overall Study|Withdrawal by Subject|5
7075507|NCT02066298|11181297|FG005|Overall Study|Withdrawal by Subject|8
7075508|NCT02066298|11181292|FG000|Overall Study|Physician Decision|0
7075509|NCT02066298|11181293|FG001|Overall Study|Physician Decision|0
7075510|NCT02066298|11181294|FG002|Overall Study|Physician Decision|1
7075511|NCT02066298|11181295|FG003|Overall Study|Physician Decision|0
7075512|NCT02066298|11181296|FG004|Overall Study|Physician Decision|1
7075513|NCT02066298|11181297|FG005|Overall Study|Physician Decision|0
7075514|NCT02066311|11181309|FG000|Overall Study|Adverse Event|4
7075515|NCT02066311|11181309|FG000|Overall Study|Withdrawal by Subject|1
7075516|NCT02066389|11181319|FG000|Overall Study|Adverse Event|1
7075517|NCT02066389|11181320|FG001|Overall Study|Adverse Event|1
7075518|NCT02066389|11181321|FG002|Overall Study|Adverse Event|1
7075519|NCT02066389|11181322|FG003|Overall Study|Adverse Event|1
7075520|NCT02066389|11181323|FG004|Overall Study|Adverse Event|5
7075521|NCT02066389|11181324|FG005|Overall Study|Adverse Event|1
7075522|NCT02066389|11181319|FG000|Overall Study|Withdrawal by Subject|4
7075523|NCT02066389|11181320|FG001|Overall Study|Withdrawal by Subject|0
7075524|NCT02066389|11181321|FG002|Overall Study|Withdrawal by Subject|5
7075525|NCT02066389|11181322|FG003|Overall Study|Withdrawal by Subject|1
7075526|NCT02066389|11181323|FG004|Overall Study|Withdrawal by Subject|1
7075527|NCT02066389|11181324|FG005|Overall Study|Withdrawal by Subject|2
7075528|NCT02066389|11181319|FG000|Overall Study|Lost to Follow-up|0
7075529|NCT02066389|11181320|FG001|Overall Study|Lost to Follow-up|0
7075530|NCT02066389|11181321|FG002|Overall Study|Lost to Follow-up|0
7075531|NCT02066389|11181322|FG003|Overall Study|Lost to Follow-up|1
7075532|NCT02066389|11181323|FG004|Overall Study|Lost to Follow-up|1
7075533|NCT02066389|11181324|FG005|Overall Study|Lost to Follow-up|1
7075534|NCT02066389|11181319|FG000|Overall Study|Randomized in Error|0
7075535|NCT02066389|11181320|FG001|Overall Study|Randomized in Error|0
7075536|NCT02066389|11181321|FG002|Overall Study|Randomized in Error|0
7075537|NCT02066389|11181322|FG003|Overall Study|Randomized in Error|0
7075538|NCT02066389|11181323|FG004|Overall Study|Randomized in Error|0
7075539|NCT02066389|11181324|FG005|Overall Study|Randomized in Error|1
7075540|NCT02066402|11181340|FG000|Overall Study|Adverse Event|1
7075541|NCT02066402|11181341|FG001|Overall Study|Adverse Event|2
7075542|NCT02066402|11181340|FG000|Overall Study|Lost to Follow-up|11
7075543|NCT02066402|11181341|FG001|Overall Study|Lost to Follow-up|8
7075544|NCT02066402|11181340|FG000|Overall Study|Withdrawal by Subject|14
7075545|NCT02066402|11181341|FG001|Overall Study|Withdrawal by Subject|11
7075546|NCT02066402|11181340|FG000|Overall Study|Progressive disease-clinical progression|0
7075547|NCT02066402|11181341|FG001|Overall Study|Progressive disease-clinical progression|1
7075548|NCT02066402|11181340|FG000|Overall Study|Protocol driven decision point|0
7075549|NCT02066402|11181341|FG001|Overall Study|Protocol driven decision point|1
7075550|NCT02066467|11181347|FG000|Overall Study|Did not undergo implant procedure|24
7075551|NCT02066467|11181347|FG000|Overall Study|Attempted to implant withoput success|43
7075552|NCT02066467|11181347|FG000|Overall Study|Consent ineligible|1
7075553|NCT02066467|11181347|FG000|Overall Study|Death|54
7075554|NCT02066467|11181347|FG000|Overall Study|Lost to Follow-up|51
7075555|NCT02066467|11181347|FG000|Overall Study|Adverse Event|20
7075556|NCT02066467|11181347|FG000|Overall Study|Withdrawal by Subject|16
7075557|NCT02066467|11181347|FG000|Overall Study|Physician Decision|2
7075558|NCT02066467|11181347|FG000|Overall Study|Not defined|4
7075559|NCT02066922|11181400|FG000|Overall Study|Adverse Event|1
7075560|NCT02067533|11181446|FG000|Overall Study|Lost to Follow-up|4
7075561|NCT02067533|11181447|FG001|Overall Study|Lost to Follow-up|2
7075562|NCT02067663|11181468|FG000|Overall Study|Lost to Follow-up|13
7075563|NCT02067663|11181469|FG001|Overall Study|Lost to Follow-up|14
7075564|NCT02067676|11181481|FG000|Overall Study|Withdrawal by Subject|1
7075565|NCT02067676|11181482|FG001|Overall Study|Withdrawal by Subject|0
7075566|NCT02067676|11181483|FG002|Overall Study|Withdrawal by Subject|0
7075567|NCT02067676|11181484|FG003|Overall Study|Withdrawal by Subject|0
7075568|NCT02067676|11181485|FG004|Overall Study|Withdrawal by Subject|0
7075569|NCT02067676|11181486|FG005|Overall Study|Withdrawal by Subject|0
7075570|NCT02067728|11181507|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7
7075571|NCT02067728|11181508|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28
7075572|NCT02067728|11181507|FG000|6 Month Follow up Survey|Lost to Follow-up|48
7075573|NCT02067728|11181508|FG001|6 Month Follow up Survey|Lost to Follow-up|60
7075574|NCT02067728|11181507|FG000|6 Month Measurements|Unable to attend|114
7075575|NCT02067728|11181508|FG001|6 Month Measurements|Unable to attend|97
7075576|NCT02068118|11181534|FG000|18-month Comparative Study Period|Death|90
7075577|NCT02068118|11181535|FG001|18-month Comparative Study Period|Death|97
7075578|NCT02068118|11181534|FG000|18-month Comparative Study Period|Withdrawal by Subject|23
7075579|NCT02068118|11181535|FG001|18-month Comparative Study Period|Withdrawal by Subject|52
7075580|NCT02068118|11181534|FG000|18-month Comparative Study Period|Lost to Follow-up|6
7075581|NCT02068118|11181535|FG001|18-month Comparative Study Period|Lost to Follow-up|7
7075582|NCT02068118|11181534|FG000|18-month Comparative Study Period|Heart transplant|9
7075583|NCT02068118|11181535|FG001|18-month Comparative Study Period|Heart transplant|15
7075584|NCT02068118|11181534|FG000|18-month Comparative Study Period|Inclusion in another protocol|0
7075585|NCT02068118|11181535|FG001|18-month Comparative Study Period|Inclusion in another protocol|2
7075586|NCT02068118|11181534|FG000|18-month Comparative Study Period|Hemiplegia|0
7075587|NCT02068118|11181535|FG001|18-month Comparative Study Period|Hemiplegia|1
7075588|NCT02068118|11181534|FG000|18-month Comparative Study Period|Alzheimer's disease|0
7075589|NCT02068118|11181535|FG001|18-month Comparative Study Period|Alzheimer's disease|1
7075590|NCT02068118|11181534|FG000|18-month Comparative Study Period|Move|0
7075591|NCT02068118|11181535|FG001|18-month Comparative Study Period|Move|1
7075592|NCT02068118|11181534|FG000|18-month Comparative Study Period|Hearing loss|0
7075593|NCT02068118|11181535|FG001|18-month Comparative Study Period|Hearing loss|1
7075594|NCT02068118|11181534|FG000|Extension Period|Death|0
7075595|NCT02068118|11181535|FG001|Extension Period|Death|2
7075596|NCT02068118|11181534|FG000|Extension Period|Withdrawal by Subject|1
7075597|NCT02068118|11181535|FG001|Extension Period|Withdrawal by Subject|0
7075598|NCT02068118|11181534|FG000|Extension Period|Heart transplant|1
7075599|NCT02068118|11181535|FG001|Extension Period|Heart transplant|0
7075600|NCT02068118|11181534|FG000|Extension Period|Wrong device use|0
7075601|NCT02068118|11181535|FG001|Extension Period|Wrong device use|1
7075602|NCT02068222|11181547|FG000|Overall Study|Lost to Follow-up|1
7075603|NCT02068352|11181554|FG000|Overall Study|Lost to Follow-up|0
7075604|NCT02068352|11181555|FG001|Overall Study|Lost to Follow-up|2
7075605|NCT02068352|11181556|FG002|Overall Study|Lost to Follow-up|0
7075606|NCT02068352|11181554|FG000|Overall Study|Adverse Event|4
7075607|NCT02068352|11181555|FG001|Overall Study|Adverse Event|2
7075608|NCT02068352|11181556|FG002|Overall Study|Adverse Event|7
7075609|NCT02068352|11181554|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0
7075610|NCT02068352|11181555|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1
7075611|NCT02068352|11181556|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0
7075612|NCT02068352|11181554|FG000|Overall Study|Participant Withdrew Consent to Participate|6
7075613|NCT02068352|11181555|FG001|Overall Study|Participant Withdrew Consent to Participate|3
7075614|NCT02068352|11181556|FG002|Overall Study|Participant Withdrew Consent to Participate|1
7075615|NCT02068352|11181554|FG000|Overall Study|Protocol Deviation|0
7075616|NCT02068352|11181555|FG001|Overall Study|Protocol Deviation|0
7075617|NCT02068352|11181556|FG002|Overall Study|Protocol Deviation|1
7075618|NCT02068443|11181567|FG000|Overall Study|Pretreatment Event/Adverse Event|0
7075619|NCT02068443|11181568|FG001|Overall Study|Pretreatment Event/Adverse Event|5
7075620|NCT02068443|11181569|FG002|Overall Study|Pretreatment Event/Adverse Event|2
7075621|NCT02068443|11181567|FG000|Overall Study|Voluntary Withdrawal|4
7075622|NCT02068443|11181568|FG001|Overall Study|Voluntary Withdrawal|0
7075623|NCT02068443|11181569|FG002|Overall Study|Voluntary Withdrawal|1
7075624|NCT02068443|11181567|FG000|Overall Study|Lack of Efficacy|2
7075625|NCT02068443|11181568|FG001|Overall Study|Lack of Efficacy|1
7075626|NCT02068443|11181569|FG002|Overall Study|Lack of Efficacy|0
7075627|NCT02068443|11181567|FG000|Overall Study|Other Reason Not Specified|1
7075628|NCT02068443|11181568|FG001|Overall Study|Other Reason Not Specified|0
7075629|NCT02068443|11181569|FG002|Overall Study|Other Reason Not Specified|0
7075630|NCT02068495|11181577|FG000|Overall Study|Case Report Forms Uncollected|60
7075631|NCT02068495|11181577|FG000|Overall Study|Protocol Deviation|49
7075632|NCT02068508|11181581|FG000|Overall Study|Case report forms uncollected|27
7075633|NCT02068508|11181581|FG000|Overall Study|Patient did not visit the study site|1
7075634|NCT02068508|11181581|FG000|Overall Study|Protocol Violation|4
7075635|NCT02068599|11181588|FG000|Overall Study|Adverse Event|4
7075636|NCT02068599|11181589|FG001|Overall Study|Adverse Event|1
7075637|NCT02068599|11181590|FG002|Overall Study|Adverse Event|1
7075638|NCT02068599|11181588|FG000|Overall Study|Withdrawal by Subject|2
7075639|NCT02068599|11181589|FG001|Overall Study|Withdrawal by Subject|7
7075640|NCT02068599|11181590|FG002|Overall Study|Withdrawal by Subject|5
7075641|NCT02068599|11181588|FG000|Overall Study|Protocol Violation|4
7075642|NCT02068599|11181589|FG001|Overall Study|Protocol Violation|2
7075643|NCT02068599|11181590|FG002|Overall Study|Protocol Violation|3
7075644|NCT02068599|11181588|FG000|Overall Study|Lost to Follow-up|1
7075645|NCT02068599|11181589|FG001|Overall Study|Lost to Follow-up|0
7075646|NCT02068599|11181590|FG002|Overall Study|Lost to Follow-up|0
7075647|NCT02068599|11181588|FG000|Overall Study|Lack of Efficacy|0
7075648|NCT02068599|11181589|FG001|Overall Study|Lack of Efficacy|0
7075649|NCT02068599|11181590|FG002|Overall Study|Lack of Efficacy|3
7075650|NCT02068599|11181588|FG000|Overall Study|Noncompliance|0
7075651|NCT02068599|11181589|FG001|Overall Study|Noncompliance|0
7075652|NCT02068599|11181590|FG002|Overall Study|Noncompliance|1
7075653|NCT02068768|11181657|FG000|Overall Study|Lost to Follow-up|5
7075654|NCT02068768|11181657|FG000|Overall Study|Early Termination by Sponsor|2
7075655|NCT02068885|11181687|FG000|Overall Study|Withdrew|3
7075656|NCT02068885|11181688|FG001|Overall Study|Withdrew|5
7075657|NCT02068885|11181689|FG002|Overall Study|Withdrew|8
7075658|NCT02069015|11181700|FG000|Overall Study|Lost to Follow-up|39
7075659|NCT02069015|11181701|FG001|Overall Study|Lost to Follow-up|32
7075660|NCT02069015|11181700|FG000|Overall Study|Withdrawal by Subject|1
7075661|NCT02069015|11181701|FG001|Overall Study|Withdrawal by Subject|1
7075662|NCT02069093|11181712|FG000|Overall Study|Disease progression|14
7075663|NCT02069093|11181712|FG000|Overall Study|New cancer therapy|1
7075664|NCT02069093|11181712|FG000|Overall Study|Death|1
7075665|NCT02069093|11181712|FG000|Overall Study|Administrative problems|1
7075666|NCT02069093|11181712|FG000|Overall Study|Withdrawal by Subject|2
7075667|NCT02069093|11181712|FG000|Overall Study|Abnormal laboratory values|1
7075668|NCT02069093|11181712|FG000|Overall Study|Adverse Event|10
7075669|NCT02069379|11181750|FG000|Baseline Measurements|Lost to Follow-up|1
7075670|NCT02069379|11181751|FG001|Baseline Measurements|Lost to Follow-up|0
7075671|NCT02069379|11181752|FG002|Baseline Measurements|Lost to Follow-up|0
7075672|NCT02069379|11181753|FG003|Baseline Measurements|Lost to Follow-up|0
7075673|NCT02069379|11181750|FG000|Baseline Measurements|Ineligible based on initial assessments|2
7075674|NCT02069379|11181751|FG001|Baseline Measurements|Ineligible based on initial assessments|0
7075675|NCT02069379|11181752|FG002|Baseline Measurements|Ineligible based on initial assessments|0
7075676|NCT02069379|11181753|FG003|Baseline Measurements|Ineligible based on initial assessments|2
7075677|NCT02069379|11181750|FG000|First Treatment Arm|Lost to Follow-up|0
7075678|NCT02069379|11181751|FG001|First Treatment Arm|Lost to Follow-up|1
7075679|NCT02069379|11181752|FG002|First Treatment Arm|Lost to Follow-up|1
7075680|NCT02069379|11181753|FG003|First Treatment Arm|Lost to Follow-up|0
7075681|NCT02069379|11181750|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0
7075682|NCT02069379|11181751|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1
7075683|NCT02069379|11181752|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0
7075684|NCT02069379|11181753|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0
7075685|NCT02069379|11181750|FG000|Washout Period (4 Weeks)|Unrelated event|0
7075686|NCT02069379|11181751|FG001|Washout Period (4 Weeks)|Unrelated event|1
7075687|NCT02069379|11181752|FG002|Washout Period (4 Weeks)|Unrelated event|0
7075688|NCT02069379|11181753|FG003|Washout Period (4 Weeks)|Unrelated event|0
7075689|NCT02069379|11181750|FG000|Second Treatment Arm|Lost to Follow-up|0
7075690|NCT02069379|11181751|FG001|Second Treatment Arm|Lost to Follow-up|0
7075691|NCT02069379|11181752|FG002|Second Treatment Arm|Lost to Follow-up|1
7075692|NCT02069379|11181753|FG003|Second Treatment Arm|Lost to Follow-up|0
7075693|NCT02069392|11181765|FG000|Overall Study|Withdrawal by Subject|4
7075694|NCT02069392|11181766|FG001|Overall Study|Withdrawal by Subject|2
7075695|NCT02070380|11181833|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0
7075696|NCT02070380|11181834|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5
7075697|NCT02070380|11181835|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2
7075698|NCT02070380|11181836|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3
7075699|NCT02070380|11181833|FG000|Second Injection|Image sets missing or technically inadeq|0
7075700|NCT02070380|11181834|FG001|Second Injection|Image sets missing or technically inadeq|1
7075701|NCT02070380|11181835|FG002|Second Injection|Image sets missing or technically inadeq|0
7075702|NCT02070380|11181836|FG003|Second Injection|Image sets missing or technically inadeq|0
7075703|NCT02070380|11181833|FG000|Second Injection|Protocol Violation|0
7075704|NCT02070380|11181834|FG001|Second Injection|Protocol Violation|1
7075705|NCT02070380|11181835|FG002|Second Injection|Protocol Violation|1
7075706|NCT02070380|11181836|FG003|Second Injection|Protocol Violation|5
7075707|NCT02070484|11181850|FG000|Overall Study|Withdrawal by Subject|1
7075708|NCT02070484|11181851|FG001|Overall Study|Withdrawal by Subject|0
7075709|NCT02070588|11181860|FG000|Overall Study|Withdrawal by Subject|29
7075710|NCT02070588|11181861|FG001|Overall Study|Withdrawal by Subject|1
7075711|NCT02070588|11181862|FG002|Overall Study|Withdrawal by Subject|0
7075712|NCT02070588|11181860|FG000|Overall Study|Writhdrawal due to early termination|9
7075713|NCT02070588|11181861|FG001|Overall Study|Writhdrawal due to early termination|0
7075714|NCT02070588|11181862|FG002|Overall Study|Writhdrawal due to early termination|0
7075715|NCT02070588|11181860|FG000|Overall Study|Adverse Event|1
7075716|NCT02070588|11181861|FG001|Overall Study|Adverse Event|0
7075717|NCT02070588|11181862|FG002|Overall Study|Adverse Event|0
7082834|NCT02146430|11193618|FG003|Overall Study|Reason missing or not reported|5
7082835|NCT02146430|11193615|FG000|Overall Study|Withdrawal by Subject|27
7082836|NCT02146430|11193616|FG001|Overall Study|Withdrawal by Subject|29
7082837|NCT02146430|11193617|FG002|Overall Study|Withdrawal by Subject|30
7082838|NCT02146430|11193618|FG003|Overall Study|Withdrawal by Subject|34
7082839|NCT02146599|11193641|FG000|Overall Study|Failed to meet inclusion criteria|5
7082840|NCT02146833|11193645|FG000|Overall Study|Death|10
7082841|NCT02146833|11193645|FG000|Overall Study|No longer consented to study treatment|1
7082842|NCT02147067|11193651|FG000|Overall Study|Withdrawal by Subject|2
7082843|NCT02147067|11193652|FG001|Overall Study|Withdrawal by Subject|2
7082844|NCT02147093|11193660|FG000|Period 1|Lost to Follow-up|0
7082845|NCT02147093|11193661|FG001|Period 1|Lost to Follow-up|1
7082846|NCT02147093|11193660|FG000|Period 2|Protocol Violation|2
7082847|NCT02147093|11193661|FG001|Period 2|Protocol Violation|0
7082848|NCT02147132|11193667|FG000|Overall Study|Lost to Follow-up|1
7082849|NCT02147132|11193668|FG001|Overall Study|Lost to Follow-up|0
7082850|NCT02147132|11193669|FG002|Overall Study|Lost to Follow-up|0
7082851|NCT02147132|11193670|FG003|Overall Study|Lost to Follow-up|0
7082852|NCT02147158|11193686|FG000|Treatment Course 1|Adverse Event|1
7082853|NCT02147158|11193687|FG001|Treatment Course 1|Adverse Event|4
7082854|NCT02147158|11193688|FG002|Treatment Course 1|Adverse Event|3
7082855|NCT02147158|11193689|FG003|Treatment Course 1|Adverse Event|4
7082856|NCT02147158|11193690|FG004|Treatment Course 1|Adverse Event|1
7082857|NCT02147158|11193691|FG005|Treatment Course 1|Adverse Event|2
7082858|NCT02147158|11193686|FG000|Treatment Course 1|Lost to Follow-up|2
7082859|NCT02147158|11193687|FG001|Treatment Course 1|Lost to Follow-up|4
7082860|NCT02147158|11193688|FG002|Treatment Course 1|Lost to Follow-up|3
7082861|NCT02147158|11193689|FG003|Treatment Course 1|Lost to Follow-up|3
7082862|NCT02147158|11193690|FG004|Treatment Course 1|Lost to Follow-up|2
7082863|NCT02147158|11193691|FG005|Treatment Course 1|Lost to Follow-up|4
7082864|NCT02147158|11193686|FG000|Treatment Course 1|Protocol Violation|0
7082865|NCT02147158|11193687|FG001|Treatment Course 1|Protocol Violation|0
7082866|NCT02147158|11193688|FG002|Treatment Course 1|Protocol Violation|1
7082867|NCT02147158|11193689|FG003|Treatment Course 1|Protocol Violation|1
7082868|NCT02147158|11193690|FG004|Treatment Course 1|Protocol Violation|0
7082869|NCT02147158|11193691|FG005|Treatment Course 1|Protocol Violation|0
7082870|NCT02147158|11193686|FG000|Treatment Course 1|Withdrawal of Consent|1
7082871|NCT02147158|11193687|FG001|Treatment Course 1|Withdrawal of Consent|1
7082872|NCT02147158|11193688|FG002|Treatment Course 1|Withdrawal of Consent|1
7082873|NCT02147158|11193689|FG003|Treatment Course 1|Withdrawal of Consent|5
7082874|NCT02147158|11193690|FG004|Treatment Course 1|Withdrawal of Consent|3
7082875|NCT02147158|11193691|FG005|Treatment Course 1|Withdrawal of Consent|2
7082876|NCT02147158|11193686|FG000|Off-Treatment Interval 1|Adverse Event|1
7082877|NCT02147158|11193687|FG001|Off-Treatment Interval 1|Adverse Event|0
7082878|NCT02147158|11193688|FG002|Off-Treatment Interval 1|Adverse Event|0
7075718|NCT02070744|11181893|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0
7075719|NCT02070744|11181894|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0
7075720|NCT02070744|11181895|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0
7075721|NCT02070744|11181896|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1
7075722|NCT02070744|11181897|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0
7075723|NCT02070744|11181893|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0
7075724|NCT02070744|11181894|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0
7075725|NCT02070744|11181895|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0
7075726|NCT02070744|11181896|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0
7075727|NCT02070744|11181897|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2
7075728|NCT02070744|11181893|FG000|OLE Phase (48 Weeks)|Other|0
7075729|NCT02070744|11181894|FG001|OLE Phase (48 Weeks)|Other|0
7075730|NCT02070744|11181895|FG002|OLE Phase (48 Weeks)|Other|0
7075731|NCT02070744|11181896|FG003|OLE Phase (48 Weeks)|Other|0
7075732|NCT02070744|11181897|FG004|OLE Phase (48 Weeks)|Other|1
7075733|NCT02070757|11181914|FG000|Overall Study|Adverse Event|107
7075734|NCT02070757|11181915|FG001|Overall Study|Adverse Event|99
7075735|NCT02070757|11181914|FG000|Overall Study|Lost to Follow-up|7
7075736|NCT02070757|11181915|FG001|Overall Study|Lost to Follow-up|4
7075737|NCT02070757|11181914|FG000|Overall Study|Protocol Violation|0
7075738|NCT02070757|11181915|FG001|Overall Study|Protocol Violation|4
7075739|NCT02070757|11181914|FG000|Overall Study|Withdrawal by Subject|1
7075740|NCT02070757|11181915|FG001|Overall Study|Withdrawal by Subject|3
7075741|NCT02070757|11181914|FG000|Overall Study|Investigator Decision|0
7075742|NCT02070757|11181915|FG001|Overall Study|Investigator Decision|2
7075743|NCT02070757|11181914|FG000|Overall Study|Discharged from Study Hospital|2
7075744|NCT02070757|11181915|FG001|Overall Study|Discharged from Study Hospital|2
7075745|NCT02070965|11181924|FG000|Overall Study|Lost to Follow-up|0
7075746|NCT02070965|11181925|FG001|Overall Study|Lost to Follow-up|1
7075747|NCT02070965|11181926|FG002|Overall Study|Lost to Follow-up|0
7075748|NCT02070965|11181924|FG000|Overall Study|Withdrawal by Subject|1
7075749|NCT02070965|11181925|FG001|Overall Study|Withdrawal by Subject|1
7075750|NCT02070965|11181926|FG002|Overall Study|Withdrawal by Subject|1
7075751|NCT02070965|11181924|FG000|Overall Study|Subject moved|1
7075752|NCT02070965|11181925|FG001|Overall Study|Subject moved|0
7075753|NCT02070965|11181926|FG002|Overall Study|Subject moved|0
7075754|NCT02070978|11181937|FG000|Overall Study|Adverse Event|6
7075755|NCT02070978|11181938|FG001|Overall Study|Adverse Event|2
7075756|NCT02070978|11181939|FG002|Overall Study|Adverse Event|0
7075757|NCT02070978|11181937|FG000|Overall Study|Lost to Follow-up|1
7075758|NCT02070978|11181938|FG001|Overall Study|Lost to Follow-up|3
6839586|NCT00266227|10845283|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11
6839587|NCT00266227|10845284|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14
6839588|NCT00266227|10845285|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0
6839589|NCT00266227|10845283|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4
6839590|NCT00266227|10845284|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2
6839591|NCT00266227|10845285|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0
6839592|NCT00266227|10845283|FG000|Retreatment: Up to Week 48|Pregnancy|1
6839593|NCT00266227|10845284|FG001|Retreatment: Up to Week 48|Pregnancy|0
6839594|NCT00266227|10845285|FG002|Retreatment: Up to Week 48|Pregnancy|0
6839595|NCT00266227|10845283|FG000|Retreatment: Week 48 to Week 72|Death|1
6839596|NCT00266227|10845284|FG001|Retreatment: Week 48 to Week 72|Death|1
6839597|NCT00266227|10845285|FG002|Retreatment: Week 48 to Week 72|Death|0
6839598|NCT00266227|10845283|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6
6839599|NCT00266227|10845284|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2
6839600|NCT00266227|10845285|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0
6839601|NCT00266227|10845283|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1
6839602|NCT00266227|10845284|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
6839603|NCT00266227|10845285|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
6839604|NCT00266227|10845283|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41
6839605|NCT00266227|10845284|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29
6839606|NCT00266227|10845285|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0
6839607|NCT00266227|10845283|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15
6839608|NCT00266227|10845284|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10
6839609|NCT00266227|10845285|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0
6839610|NCT00266409|10845303|FG000|Overall Study|Lack of Efficacy|2
6839611|NCT00266409|10845304|FG001|Overall Study|Lack of Efficacy|6
6839612|NCT00266409|10845305|FG002|Overall Study|Lack of Efficacy|1
6839613|NCT00266409|10845306|FG003|Overall Study|Lack of Efficacy|2
6839614|NCT00266409|10845303|FG000|Overall Study|Adverse Event|7
6839615|NCT00266409|10845304|FG001|Overall Study|Adverse Event|2
6839616|NCT00266409|10845305|FG002|Overall Study|Adverse Event|1
6839617|NCT00266409|10845306|FG003|Overall Study|Adverse Event|1
7075759|NCT02070978|11181939|FG002|Overall Study|Lost to Follow-up|4
7075760|NCT02070978|11181937|FG000|Overall Study|Withdrawal by Subject|3
7075761|NCT02070978|11181938|FG001|Overall Study|Withdrawal by Subject|5
7075762|NCT02070978|11181939|FG002|Overall Study|Withdrawal by Subject|3
7075763|NCT02070978|11181937|FG000|Overall Study|Protocol Violation|1
7075764|NCT02070978|11181938|FG001|Overall Study|Protocol Violation|0
7075765|NCT02070978|11181939|FG002|Overall Study|Protocol Violation|3
7075766|NCT02070978|11181937|FG000|Overall Study|Lack of Efficacy|0
7075767|NCT02070978|11181938|FG001|Overall Study|Lack of Efficacy|1
7075768|NCT02070978|11181939|FG002|Overall Study|Lack of Efficacy|0
7075769|NCT02070978|11181937|FG000|Overall Study|Death|0
7075770|NCT02070978|11181938|FG001|Overall Study|Death|0
7075771|NCT02070978|11181939|FG002|Overall Study|Death|2
7075772|NCT02070978|11181937|FG000|Overall Study|Un-specified|3
7075773|NCT02070978|11181938|FG001|Overall Study|Un-specified|2
7075774|NCT02070978|11181939|FG002|Overall Study|Un-specified|2
6839618|NCT00266409|10845303|FG000|Overall Study|Lost to Follow-up|18
6839619|NCT00266409|10845304|FG001|Overall Study|Lost to Follow-up|21
6839620|NCT00266409|10845305|FG002|Overall Study|Lost to Follow-up|6
6839621|NCT00266409|10845306|FG003|Overall Study|Lost to Follow-up|8
7075775|NCT02070978|11181937|FG000|Overall Study|Terminated by Sponsor|33
7075776|NCT02070978|11181938|FG001|Overall Study|Terminated by Sponsor|40
7075777|NCT02070978|11181939|FG002|Overall Study|Terminated by Sponsor|39
7075778|NCT02070991|11181949|FG000|Overall Study|Death|2
7075779|NCT02070991|11181950|FG001|Overall Study|Death|0
7075780|NCT02070991|11181949|FG000|Overall Study|Withdrawal by Subject|1
7075781|NCT02070991|11181950|FG001|Overall Study|Withdrawal by Subject|0
7075782|NCT02071082|11181958|FG000|Overall Study|Enrolled and Never Treated|1
7075783|NCT02071082|11181959|FG001|Overall Study|Enrolled and Never Treated|1
7075784|NCT02071082|11181958|FG000|Overall Study|Adverse Event|0
7075785|NCT02071082|11181959|FG001|Overall Study|Adverse Event|1
7075786|NCT02071082|11181958|FG000|Overall Study|Withdrew Consent|0
7075787|NCT02071082|11181959|FG001|Overall Study|Withdrew Consent|4
7075788|NCT02071082|11181958|FG000|Overall Study|Lost to Follow-up|1
7075789|NCT02071082|11181959|FG001|Overall Study|Lost to Follow-up|1
7075790|NCT02071225|11181983|FG000|Overall Study|Withdrawal of Consent|2
7075791|NCT02071225|11181983|FG000|Overall Study|Protocol Deviation|1
7075792|NCT02071225|11181983|FG000|Overall Study|Lost to Follow-up|2
7075793|NCT02071225|11181983|FG000|Overall Study|Death|25
7075794|NCT02071290|11181989|FG000|Overall Study|Death|1
7075795|NCT02071290|11181990|FG001|Overall Study|Death|0
7075796|NCT02071290|11181989|FG000|Overall Study|Withdrawal by Subject|0
7075797|NCT02071290|11181990|FG001|Overall Study|Withdrawal by Subject|1
7075798|NCT02071290|11181989|FG000|Overall Study|Protocol Violation|3
7075799|NCT02071290|11181990|FG001|Overall Study|Protocol Violation|5
7075800|NCT02071290|11181989|FG000|Overall Study|Physician Decision|0
7075801|NCT02071290|11181990|FG001|Overall Study|Physician Decision|1
7075802|NCT02071706|11182005|FG000|Overall Study|Adverse Event|1
7075803|NCT02071706|11182005|FG000|Overall Study|Withdrawal by Subject|2
7075804|NCT02071771|11182009|FG000|Period 1: First 10 Days|Unacceptable lens fit|1
7075805|NCT02071771|11182010|FG001|Period 1: First 10 Days|Unacceptable lens fit|0
7075806|NCT02071771|11182009|FG000|Period 1: First 10 Days|Unavailable lens power|1
7075807|NCT02071771|11182010|FG001|Period 1: First 10 Days|Unavailable lens power|0
7075808|NCT02071849|11182048|FG000|6-month Primary Endpoint|Did not receive device|4
7075809|NCT02071849|11182048|FG000|6-month Primary Endpoint|Adverse Event|1
7075810|NCT02071849|11182048|FG000|2-year Extended Follow-up|Adverse Event|1
7075811|NCT02072096|11182067|FG000|Overall Study|Lack of Efficacy|18
7075812|NCT02072096|11182068|FG001|Overall Study|Lack of Efficacy|29
7075813|NCT02072096|11182067|FG000|Overall Study|Protocol Violation|7
7075814|NCT02072096|11182068|FG001|Overall Study|Protocol Violation|7
7075815|NCT02072096|11182067|FG000|Overall Study|Withdrawal by Subject|5
7075816|NCT02072096|11182068|FG001|Overall Study|Withdrawal by Subject|7
7075817|NCT02072096|11182067|FG000|Overall Study|Adverse Event|5
7075818|NCT02072096|11182068|FG001|Overall Study|Adverse Event|2
7075819|NCT02072096|11182067|FG000|Overall Study|No Reason Provided|4
7075820|NCT02072096|11182068|FG001|Overall Study|No Reason Provided|2
7075821|NCT02072096|11182067|FG000|Overall Study|Death|2
7075822|NCT02072096|11182068|FG001|Overall Study|Death|0
7075823|NCT02072096|11182067|FG000|Overall Study|Physician Decision|0
7075824|NCT02072096|11182068|FG001|Overall Study|Physician Decision|1
7075825|NCT02072096|11182067|FG000|Overall Study|Study Terminated by Sponsor|43
7075826|NCT02072096|11182068|FG001|Overall Study|Study Terminated by Sponsor|30
7075827|NCT02072096|11182067|FG000|Overall Study|Lost to Follow-up|1
7075828|NCT02072096|11182068|FG001|Overall Study|Lost to Follow-up|0
7075829|NCT02072174|11182077|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14
7075830|NCT02072174|11182078|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15
7075831|NCT02072174|11182077|FG000|Overall Study|Protocol Violation|16
7075832|NCT02072174|11182078|FG001|Overall Study|Protocol Violation|23
7075833|NCT02072174|11182077|FG000|Overall Study|Physician Decision|0
7075834|NCT02072174|11182078|FG001|Overall Study|Physician Decision|1
7075835|NCT02072174|11182077|FG000|Overall Study|Non-compliance with protocol requirement|2
6839622|NCT00266409|10845303|FG000|Overall Study|Withdrawal by Subject|6
6839623|NCT00266409|10845304|FG001|Overall Study|Withdrawal by Subject|10
6839624|NCT00266409|10845305|FG002|Overall Study|Withdrawal by Subject|3
7075836|NCT02072174|11182078|FG001|Overall Study|Non-compliance with protocol requirement|0
7075837|NCT02072226|11182092|FG000|Overall Study|Lost to Follow-up|11
7075838|NCT02072226|11182093|FG001|Overall Study|Lost to Follow-up|7
7075839|NCT02072226|11182092|FG000|Overall Study|Patient Non-compliance|2
7075840|NCT02072226|11182093|FG001|Overall Study|Patient Non-compliance|3
7075841|NCT02072226|11182092|FG000|Overall Study|Death|1
7075842|NCT02072226|11182093|FG001|Overall Study|Death|0
7075843|NCT02072226|11182092|FG000|Overall Study|Patient Withdrawal of Consent|1
7075844|NCT02072226|11182093|FG001|Overall Study|Patient Withdrawal of Consent|0
7075845|NCT02072434|11182106|FG000|Overall Study|Protocol Violation|10
7075846|NCT02072434|11182107|FG001|Overall Study|Protocol Violation|9
7075847|NCT02072434|11182106|FG000|Overall Study|Physician Decision|5
7075848|NCT02072434|11182107|FG001|Overall Study|Physician Decision|10
7075849|NCT02072434|11182106|FG000|Overall Study|Adverse event, serious fatal|1
7075850|NCT02072434|11182107|FG001|Overall Study|Adverse event, serious fatal|6
7075851|NCT02072434|11182106|FG000|Overall Study|Adverse Event|7
7075852|NCT02072434|11182107|FG001|Overall Study|Adverse Event|6
7075853|NCT02072434|11182106|FG000|Overall Study|Withdrawal by Subject|17
7075854|NCT02072434|11182107|FG001|Overall Study|Withdrawal by Subject|29
7075855|NCT02072434|11182106|FG000|Overall Study|Other|14
7075856|NCT02072434|11182107|FG001|Overall Study|Other|29
7075857|NCT02072434|11182106|FG000|Overall Study|Lost to Follow-up|0
7075858|NCT02072434|11182107|FG001|Overall Study|Lost to Follow-up|1
7075859|NCT02072668|11182113|FG000|Second Intervention|Lost to Follow-up|1
7075860|NCT02072668|11182114|FG001|Second Intervention|Lost to Follow-up|0
7075861|NCT02072824|11182125|FG000|Overall Study|Insufficient clinical response|1
7075862|NCT02072824|11182126|FG001|Overall Study|Insufficient clinical response|0
7075863|NCT02072824|11182127|FG002|Overall Study|Insufficient clinical response|1
7075864|NCT02072824|11182125|FG000|Overall Study|No longer willing to participate|1
7075865|NCT02072824|11182126|FG001|Overall Study|No longer willing to participate|0
7075866|NCT02072824|11182127|FG002|Overall Study|No longer willing to participate|1
7075867|NCT02072824|11182125|FG000|Overall Study|Medication error|0
7075868|NCT02072824|11182126|FG001|Overall Study|Medication error|1
7075869|NCT02072824|11182127|FG002|Overall Study|Medication error|0
7075870|NCT02072824|11182125|FG000|Overall Study|Adverse Event|0
7075871|NCT02072824|11182126|FG001|Overall Study|Adverse Event|0
7075872|NCT02072824|11182127|FG002|Overall Study|Adverse Event|1
7075873|NCT02072941|11182141|FG000|Overall Study|Withdrawal by Subject|29
7075874|NCT02072941|11182142|FG001|Overall Study|Withdrawal by Subject|21
7075875|NCT02072941|11182141|FG000|Overall Study|Lost to Follow-up|4
7075876|NCT02072941|11182142|FG001|Overall Study|Lost to Follow-up|4
7075877|NCT02072941|11182141|FG000|Overall Study|Death|3
7075878|NCT02072941|11182142|FG001|Overall Study|Death|2
7075879|NCT02072941|11182141|FG000|Overall Study|Removed by Study Staff|2
7075880|NCT02072941|11182142|FG001|Overall Study|Removed by Study Staff|2
7075881|NCT02072980|11182148|FG000|Period 2, Second Wear|Adverse Event|0
7075882|NCT02072980|11182149|FG001|Period 2, Second Wear|Adverse Event|1
7075883|NCT02073643|11182215|FG000|Overall Study|Lost to Follow-up|24
7075884|NCT02073656|11182219|FG000|Primary Study|Lost to Follow-up|6
7075885|NCT02073656|11182219|FG000|Primary Study|Death|1
7075886|NCT02073656|11182219|FG000|Primary Study|Withdrew Consent|1
7075887|NCT02073682|11182227|FG000|Overall Study|Low Creatinine Clearance|1
7075888|NCT02073682|11182228|FG001|Overall Study|Low Creatinine Clearance|2
7075889|NCT02073682|11182227|FG000|Overall Study|Death|86
7147999|NCT03137459|11308819|FG001|2-month Assessment|Withdrawal by Subject|3
7148000|NCT03137459|11308818|FG000|2-month Assessment|Unable to reach|42
7148001|NCT03137459|11308819|FG001|2-month Assessment|Unable to reach|32
7148002|NCT03137459|11308818|FG000|2-month Assessment|Refused assessment|7
7148003|NCT03137459|11308819|FG001|2-month Assessment|Refused assessment|5
7148004|NCT03137459|11308818|FG000|2-month Assessment|Acutely ill|6
7148005|NCT03137459|11308819|FG001|2-month Assessment|Acutely ill|2
6839625|NCT00266409|10845306|FG003|Overall Study|Withdrawal by Subject|9
6839626|NCT00266409|10845303|FG000|Overall Study|Protocol Violation|5
6839627|NCT00266409|10845304|FG001|Overall Study|Protocol Violation|3
6839628|NCT00266409|10845305|FG002|Overall Study|Protocol Violation|4
6839629|NCT00266409|10845306|FG003|Overall Study|Protocol Violation|2
6839630|NCT00266409|10845303|FG000|Overall Study|Other|7
6839631|NCT00266409|10845304|FG001|Overall Study|Other|4
6839632|NCT00266409|10845305|FG002|Overall Study|Other|2
6839633|NCT00266409|10845306|FG003|Overall Study|Other|0
7075890|NCT02073682|11182228|FG001|Overall Study|Death|100
6839634|NCT00266630|10845318|FG000|Overall Study|Adverse Event|8
6839635|NCT00266630|10845319|FG001|Overall Study|Adverse Event|6
6839636|NCT00266630|10845318|FG000|Overall Study|Lack of Efficacy|1
6839637|NCT00266630|10845319|FG001|Overall Study|Lack of Efficacy|4
6839638|NCT00266630|10845318|FG000|Overall Study|Entry Criteria not met|1
6839639|NCT00266630|10845319|FG001|Overall Study|Entry Criteria not met|0
6839640|NCT00266630|10845318|FG000|Overall Study|Protocol Violation|1
6839641|NCT00266630|10845319|FG001|Overall Study|Protocol Violation|3
6839642|NCT00266630|10845318|FG000|Overall Study|Physician Decision|1
6839643|NCT00266630|10845319|FG001|Overall Study|Physician Decision|2
7075891|NCT02073682|11182227|FG000|Overall Study|Cancer Cured|10
7075892|NCT02073682|11182228|FG001|Overall Study|Cancer Cured|15
6839644|NCT00266630|10845318|FG000|Overall Study|Withdrawal by Subject|10
6839645|NCT00266630|10845319|FG001|Overall Study|Withdrawal by Subject|2
7075893|NCT02073682|11182227|FG000|Overall Study|ID: Patient Noncompliance|1
7075894|NCT02073682|11182228|FG001|Overall Study|ID: Patient Noncompliance|2
7075895|NCT02073682|11182227|FG000|Overall Study|ID: Palliative Treatment Only|10
7075896|NCT02073682|11182228|FG001|Overall Study|ID: Palliative Treatment Only|7
7075897|NCT02073682|11182227|FG000|Overall Study|Prohibited Concomitant Medication Use|0
7075898|NCT02073682|11182228|FG001|Overall Study|Prohibited Concomitant Medication Use|1
7075899|NCT02073682|11182227|FG000|Overall Study|Platelet Count <50,000/mL|1
7075900|NCT02073682|11182228|FG001|Overall Study|Platelet Count <50,000/mL|2
7075901|NCT02073682|11182227|FG000|Overall Study|Surgery/Medical Procedure|3
7075902|NCT02073682|11182228|FG001|Overall Study|Surgery/Medical Procedure|1
7075903|NCT02073682|11182227|FG000|Overall Study|Withdrawal by Subject|6
7075904|NCT02073682|11182228|FG001|Overall Study|Withdrawal by Subject|8
7075905|NCT02073682|11182227|FG000|Overall Study|Start of New Chemotherapy Regimen|6
7075906|NCT02073682|11182228|FG001|Overall Study|Start of New Chemotherapy Regimen|3
7075907|NCT02073682|11182227|FG000|Overall Study|Cancer Progression|53
7075908|NCT02073682|11182228|FG001|Overall Study|Cancer Progression|33
7075909|NCT02073682|11182227|FG000|Overall Study|Protocol Violation|1
7075910|NCT02073682|11182228|FG001|Overall Study|Protocol Violation|0
7075911|NCT02073682|11182227|FG000|Overall Study|Adverse Event|79
7075912|NCT02073682|11182228|FG001|Overall Study|Adverse Event|62
7075913|NCT02073682|11182227|FG000|Overall Study|No reason provided|11
7075914|NCT02073682|11182228|FG001|Overall Study|No reason provided|9
7075915|NCT02073682|11182227|FG000|Overall Study|PD: Inconvenience of Dosing|21
7075916|NCT02073682|11182228|FG001|Overall Study|PD: Inconvenience of Dosing|78
7075917|NCT02073682|11182227|FG000|Overall Study|Lost to Follow-up|1
7075918|NCT02073682|11182228|FG001|Overall Study|Lost to Follow-up|1
7075919|NCT02073682|11182227|FG000|Overall Study|ID: Benefit/Risk Judgment|32
7075920|NCT02073682|11182228|FG001|Overall Study|ID: Benefit/Risk Judgment|46
7075921|NCT02073929|11182245|FG000|Overall Study|Lost to Follow-up|2
7075922|NCT02073929|11182246|FG001|Overall Study|Lost to Follow-up|1
7075923|NCT02073929|11182245|FG000|Overall Study|Adverse Event|2
7075924|NCT02073929|11182246|FG001|Overall Study|Adverse Event|1
7075925|NCT02073929|11182245|FG000|Overall Study|Withdrawal by Subject|0
7075926|NCT02073929|11182246|FG001|Overall Study|Withdrawal by Subject|1
7075927|NCT02074059|11182258|FG000|Overall Study|Death|0
7075928|NCT02074059|11182259|FG001|Overall Study|Death|0
7075929|NCT02074059|11182260|FG002|Overall Study|Death|0
7075930|NCT02074059|11182261|FG003|Overall Study|Death|0
7075931|NCT02074059|11182262|FG004|Overall Study|Death|1
7075932|NCT02074059|11182263|FG005|Overall Study|Death|1
6839646|NCT00266630|10845318|FG000|Overall Study|Lost to Follow-up|1
6839647|NCT00266630|10845319|FG001|Overall Study|Lost to Follow-up|0
6839648|NCT00266630|10845318|FG000|Overall Study|Other|19
6839649|NCT00266630|10845319|FG001|Overall Study|Other|11
6839650|NCT00266656|10845329|FG000|Overall Study|Death|1
6839651|NCT00266656|10845330|FG001|Overall Study|Death|0
6839652|NCT00266656|10845329|FG000|Overall Study|Lost to Follow-up|4
6839653|NCT00266656|10845330|FG001|Overall Study|Lost to Follow-up|1
6839654|NCT00266656|10845329|FG000|Overall Study|Withdrawal by Subject|4
6839655|NCT00266656|10845330|FG001|Overall Study|Withdrawal by Subject|2
7075933|NCT02074514|11182312|FG000|Overall Study|Lack of Efficacy|3
6839656|NCT00266656|10845329|FG000|Overall Study|Did Not Reach Final Height|4
6839657|NCT00266656|10845330|FG001|Overall Study|Did Not Reach Final Height|8
6839658|NCT00266656|10845329|FG000|Overall Study|Parent/Caregiver Decision|1
6839659|NCT00266656|10845330|FG001|Overall Study|Parent/Caregiver Decision|2
6839660|NCT00266695|10845336|FG000|Overall Study|Adverse Event|1
6839661|NCT00266695|10845336|FG000|Overall Study|Death|9
7075934|NCT02074514|11182313|FG001|Overall Study|Lack of Efficacy|2
7075935|NCT02074514|11182312|FG000|Overall Study|Lost to Follow-up|0
7075936|NCT02074514|11182313|FG001|Overall Study|Lost to Follow-up|1
7075937|NCT02074514|11182312|FG000|Overall Study|Withdrew Consent|0
7075938|NCT02074514|11182313|FG001|Overall Study|Withdrew Consent|1
7075939|NCT02074553|11182325|FG000|Intervention Period 1|Family Emergency|0
7075940|NCT02074553|11182326|FG001|Intervention Period 1|Family Emergency|0
7075941|NCT02074553|11182327|FG002|Intervention Period 1|Family Emergency|0
7075942|NCT02074553|11182328|FG003|Intervention Period 1|Family Emergency|1
7075943|NCT02074553|11182329|FG004|Intervention Period 1|Family Emergency|0
7075944|NCT02074553|11182330|FG005|Intervention Period 1|Family Emergency|0
7075945|NCT02074553|11182331|FG006|Intervention Period 1|Family Emergency|0
7075946|NCT02074553|11182332|FG007|Intervention Period 1|Family Emergency|0
7075947|NCT02074553|11182325|FG000|Washout Period 1|Adverse Event|1
7075948|NCT02074553|11182326|FG001|Washout Period 1|Adverse Event|0
7075949|NCT02074553|11182327|FG002|Washout Period 1|Adverse Event|0
7075950|NCT02074553|11182328|FG003|Washout Period 1|Adverse Event|0
7075951|NCT02074553|11182329|FG004|Washout Period 1|Adverse Event|0
7075952|NCT02074553|11182330|FG005|Washout Period 1|Adverse Event|0
7075953|NCT02074553|11182331|FG006|Washout Period 1|Adverse Event|0
7075954|NCT02074553|11182332|FG007|Washout Period 1|Adverse Event|0
7075955|NCT02074553|11182325|FG000|Washout Period 1|Physician Decision|0
7075956|NCT02074553|11182326|FG001|Washout Period 1|Physician Decision|0
7075957|NCT02074553|11182327|FG002|Washout Period 1|Physician Decision|0
7075958|NCT02074553|11182328|FG003|Washout Period 1|Physician Decision|1
7075959|NCT02074553|11182329|FG004|Washout Period 1|Physician Decision|0
7075960|NCT02074553|11182330|FG005|Washout Period 1|Physician Decision|0
7075961|NCT02074553|11182331|FG006|Washout Period 1|Physician Decision|0
7075962|NCT02074553|11182332|FG007|Washout Period 1|Physician Decision|0
7075963|NCT02074553|11182325|FG000|Washout Period 1|Other|0
7075964|NCT02074553|11182326|FG001|Washout Period 1|Other|0
7075965|NCT02074553|11182327|FG002|Washout Period 1|Other|0
7075966|NCT02074553|11182328|FG003|Washout Period 1|Other|0
6839662|NCT00266695|10845336|FG000|Overall Study|Physician Decision|1
7075967|NCT02074553|11182329|FG004|Washout Period 1|Other|0
7075968|NCT02074553|11182330|FG005|Washout Period 1|Other|1
7075969|NCT02074553|11182331|FG006|Washout Period 1|Other|0
7075970|NCT02074553|11182332|FG007|Washout Period 1|Other|0
7075971|NCT02074553|11182325|FG000|Washout Period 2|Adverse Event|0
7075972|NCT02074553|11182326|FG001|Washout Period 2|Adverse Event|0
7075973|NCT02074553|11182327|FG002|Washout Period 2|Adverse Event|0
7075974|NCT02074553|11182328|FG003|Washout Period 2|Adverse Event|0
7075975|NCT02074553|11182329|FG004|Washout Period 2|Adverse Event|0
7075976|NCT02074553|11182330|FG005|Washout Period 2|Adverse Event|0
7075977|NCT02074553|11182331|FG006|Washout Period 2|Adverse Event|1
7075978|NCT02074553|11182332|FG007|Washout Period 2|Adverse Event|0
7075979|NCT02074553|11182325|FG000|Washout Period 2|Physician Decision|0
7075980|NCT02074553|11182326|FG001|Washout Period 2|Physician Decision|0
7075981|NCT02074553|11182327|FG002|Washout Period 2|Physician Decision|0
7075982|NCT02074553|11182328|FG003|Washout Period 2|Physician Decision|0
7075983|NCT02074553|11182329|FG004|Washout Period 2|Physician Decision|0
7075984|NCT02074553|11182330|FG005|Washout Period 2|Physician Decision|1
7075985|NCT02074553|11182331|FG006|Washout Period 2|Physician Decision|0
7075986|NCT02074553|11182332|FG007|Washout Period 2|Physician Decision|0
7075987|NCT02074553|11182325|FG000|Washout Period 2|Lost to Follow-up|0
7075988|NCT02074553|11182326|FG001|Washout Period 2|Lost to Follow-up|0
7075989|NCT02074553|11182327|FG002|Washout Period 2|Lost to Follow-up|1
7075990|NCT02074553|11182328|FG003|Washout Period 2|Lost to Follow-up|0
7075991|NCT02074553|11182329|FG004|Washout Period 2|Lost to Follow-up|0
7075992|NCT02074553|11182330|FG005|Washout Period 2|Lost to Follow-up|0
7075993|NCT02074553|11182331|FG006|Washout Period 2|Lost to Follow-up|0
7075994|NCT02074553|11182332|FG007|Washout Period 2|Lost to Follow-up|0
7075995|NCT02074553|11182325|FG000|Washout Period 3|Physician Decision|0
7075996|NCT02074553|11182326|FG001|Washout Period 3|Physician Decision|0
7075997|NCT02074553|11182327|FG002|Washout Period 3|Physician Decision|0
7075998|NCT02074553|11182328|FG003|Washout Period 3|Physician Decision|0
7075999|NCT02074553|11182329|FG004|Washout Period 3|Physician Decision|0
7076000|NCT02074553|11182330|FG005|Washout Period 3|Physician Decision|0
7076001|NCT02074553|11182331|FG006|Washout Period 3|Physician Decision|0
7076002|NCT02074553|11182332|FG007|Washout Period 3|Physician Decision|1
7076003|NCT02074982|11182370|FG000|Overall Study|Adverse Event|15
7076004|NCT02074982|11182371|FG001|Overall Study|Adverse Event|7
7076005|NCT02074982|11182370|FG000|Overall Study|Lack of Efficacy|6
7076006|NCT02074982|11182371|FG001|Overall Study|Lack of Efficacy|1
7076007|NCT02074982|11182370|FG000|Overall Study|Lost to Follow-up|9
7076008|NCT02074982|11182371|FG001|Overall Study|Lost to Follow-up|10
7076009|NCT02074982|11182370|FG000|Overall Study|Non-compliance with study treatment|0
7076010|NCT02074982|11182371|FG001|Overall Study|Non-compliance with study treatment|2
7076011|NCT02074982|11182370|FG000|Overall Study|Physician Decision|1
7076012|NCT02074982|11182371|FG001|Overall Study|Physician Decision|1
7076013|NCT02074982|11182370|FG000|Overall Study|Pregnancy|1
7076014|NCT02074982|11182371|FG001|Overall Study|Pregnancy|2
7076015|NCT02074982|11182370|FG000|Overall Study|Protocol deviation|4
7076016|NCT02074982|11182371|FG001|Overall Study|Protocol deviation|3
7076017|NCT02074982|11182370|FG000|Overall Study|Technical problems|0
7076018|NCT02074982|11182371|FG001|Overall Study|Technical problems|2
7076019|NCT02074982|11182370|FG000|Overall Study|Subject/guardian decision|15
7076020|NCT02074982|11182371|FG001|Overall Study|Subject/guardian decision|24
6839663|NCT00266695|10845336|FG000|Overall Study|Lost to Follow-up|3
6839664|NCT00266695|10845336|FG000|Overall Study|Withdrawal by Subject|15
6839665|NCT00266708|10845342|FG000|Overall Study|No renal function|1
6839666|NCT00266708|10845343|FG001|Overall Study|No renal function|1
6839667|NCT00266708|10845342|FG000|Overall Study|Refused biopsy|3
6839668|NCT00266708|10845343|FG001|Overall Study|Refused biopsy|6
6839669|NCT00266708|10845342|FG000|Overall Study|Asthma|0
6839670|NCT00266708|10845343|FG001|Overall Study|Asthma|2
6839671|NCT00266812|10845360|FG000|Overall Study|Disease Progression|9
6839672|NCT00266812|10845361|FG001|Overall Study|Disease Progression|3
6839673|NCT00266812|10845360|FG000|Overall Study|Death|5
6839674|NCT00266812|10845361|FG001|Overall Study|Death|4
6839675|NCT00266812|10845360|FG000|Overall Study|Adverse Event|3
6839676|NCT00266812|10845361|FG001|Overall Study|Adverse Event|1
6839677|NCT00266812|10845360|FG000|Overall Study|Protocol Violation|0
6839678|NCT00266812|10845361|FG001|Overall Study|Protocol Violation|1
6839679|NCT00266812|10845360|FG000|Overall Study|Withdrawal by Subject|0
6839680|NCT00266812|10845361|FG001|Overall Study|Withdrawal by Subject|2
6839681|NCT00266812|10845360|FG000|Overall Study|Discontinued before starting study drug|4
6839682|NCT00266812|10845361|FG001|Overall Study|Discontinued before starting study drug|0
7076021|NCT02074982|11182370|FG000|Overall Study|Death|0
7076022|NCT02074982|11182371|FG001|Overall Study|Death|2
7076023|NCT02075008|11182383|FG000|Overall Study|Technical problems|1
7076024|NCT02075008|11182383|FG000|Overall Study|Pregnancy|1
7076025|NCT02075008|11182383|FG000|Overall Study|Physician Decision|1
6839683|NCT00266825|10845369|FG000|Completed Follow-Up|Lost to Follow-up|14
6839684|NCT00266825|10845370|FG001|Completed Follow-Up|Lost to Follow-up|19
6839685|NCT00266825|10845369|FG000|Completed Follow-Up|Withdrawal by Subject|11
6839686|NCT00266825|10845370|FG001|Completed Follow-Up|Withdrawal by Subject|5
7076026|NCT02075008|11182383|FG000|Overall Study|Lost to Follow-up|1
7076027|NCT02075008|11182383|FG000|Overall Study|Lack of Efficacy|1
7076028|NCT02075008|11182383|FG000|Overall Study|Death|1
7076029|NCT02075008|11182383|FG000|Overall Study|Adverse Event|5
7076030|NCT02075008|11182383|FG000|Overall Study|Withdrawal by Subject|6
7076031|NCT02075008|11182383|FG000|Overall Study|Study terminated by Sponsor|159
7076032|NCT02075047|11182389|FG000|Treatment Phase (4 Weeks)|Adverse Event|14
7076033|NCT02075047|11182390|FG001|Treatment Phase (4 Weeks)|Adverse Event|4
7076034|NCT02075047|11182389|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2
7076035|NCT02075047|11182390|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2
7076036|NCT02075047|11182389|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0
7076037|NCT02075047|11182390|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1
7076038|NCT02075047|11182389|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1
7076039|NCT02075047|11182390|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0
7076040|NCT02075047|11182389|FG000|Treatment Phase (4 Weeks)|Screen Failure|1
7076041|NCT02075047|11182390|FG001|Treatment Phase (4 Weeks)|Screen Failure|0
7076042|NCT02075047|11182389|FG000|Treatment Phase (4 Weeks)|Other|1
7076043|NCT02075047|11182390|FG001|Treatment Phase (4 Weeks)|Other|1
7076044|NCT02075047|11182389|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4
7076045|NCT02075047|11182390|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2
7076046|NCT02075047|11182389|FG000|Follow up Phase (5 Weeks)|Adverse Event|14
7076047|NCT02075047|11182390|FG001|Follow up Phase (5 Weeks)|Adverse Event|4
7076048|NCT02075047|11182389|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2
7076049|NCT02075047|11182390|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2
7076050|NCT02075047|11182389|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0
7076051|NCT02075047|11182390|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1
7076052|NCT02075047|11182389|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1
7076053|NCT02075047|11182390|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0
7076054|NCT02075047|11182389|FG000|Follow up Phase (5 Weeks)|Screen Failure|1
7076055|NCT02075047|11182390|FG001|Follow up Phase (5 Weeks)|Screen Failure|0
7076056|NCT02075047|11182389|FG000|Follow up Phase (5 Weeks)|Other|1
7076057|NCT02075047|11182390|FG001|Follow up Phase (5 Weeks)|Other|2
7076058|NCT02075047|11182389|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7
7076059|NCT02075047|11182390|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4
7076060|NCT02075073|11182399|FG000|Overall Study|Withdrawal by Subject|0
7076061|NCT02075073|11182400|FG001|Overall Study|Withdrawal by Subject|1
7076062|NCT02075073|11182401|FG002|Overall Study|Withdrawal by Subject|0
7076063|NCT02075203|11182421|FG000|Overall Study|Withdrawal by Subject|1
7076064|NCT02075203|11182422|FG001|Overall Study|Withdrawal by Subject|0
7076065|NCT02075203|11182423|FG002|Overall Study|Withdrawal by Subject|1
7076066|NCT02075203|11182421|FG000|Overall Study|Adverse Event|1
7076067|NCT02075203|11182422|FG001|Overall Study|Adverse Event|0
7076068|NCT02075203|11182423|FG002|Overall Study|Adverse Event|0
7076069|NCT02075203|11182421|FG000|Overall Study|participant refused to use contraception|1
7076070|NCT02075203|11182422|FG001|Overall Study|participant refused to use contraception|0
7076071|NCT02075203|11182423|FG002|Overall Study|participant refused to use contraception|0
7076072|NCT02075255|11182434|FG000|Overall Study|Study specific withdrawal criteria|0
7076073|NCT02075255|11182435|FG001|Overall Study|Study specific withdrawal criteria|1
7076074|NCT02075255|11182436|FG002|Overall Study|Study specific withdrawal criteria|1
7076075|NCT02075255|11182434|FG000|Overall Study|Withdrawal by Subject|4
7076076|NCT02075255|11182435|FG001|Overall Study|Withdrawal by Subject|1
7076077|NCT02075255|11182436|FG002|Overall Study|Withdrawal by Subject|0
6839687|NCT00266864|10845397|FG000|Overall Study|Lost to Follow-up|4
6839688|NCT00266864|10845398|FG001|Overall Study|Lost to Follow-up|1
6839689|NCT00266864|10845397|FG000|Overall Study|Withdrawal by Subject|1
6839690|NCT00266864|10845398|FG001|Overall Study|Withdrawal by Subject|1
6839691|NCT00266877|10845407|FG000|Overall Study|Death|1
6839692|NCT00266877|10845408|FG001|Overall Study|Death|1
6839693|NCT00266877|10845409|FG002|Overall Study|Death|1
6839694|NCT00266877|10845407|FG000|Overall Study|Adverse Event|6
6839695|NCT00266877|10845408|FG001|Overall Study|Adverse Event|4
6839696|NCT00266877|10845409|FG002|Overall Study|Adverse Event|1
6839697|NCT00266877|10845407|FG000|Overall Study|Physician Decision|2
6839698|NCT00266877|10845408|FG001|Overall Study|Physician Decision|1
6839699|NCT00266877|10845409|FG002|Overall Study|Physician Decision|1
6839700|NCT00266877|10845407|FG000|Overall Study|Withdrawal by Subject|3
6839701|NCT00266877|10845408|FG001|Overall Study|Withdrawal by Subject|1
6839702|NCT00266877|10845409|FG002|Overall Study|Withdrawal by Subject|1
6839703|NCT00266877|10845407|FG000|Overall Study|Disease Progression|72
6839704|NCT00266877|10845408|FG001|Overall Study|Disease Progression|37
6839705|NCT00266877|10845409|FG002|Overall Study|Disease Progression|23
6839706|NCT00266877|10845407|FG000|Overall Study|Symptomatic Deterioration|6
6839707|NCT00266877|10845408|FG001|Overall Study|Symptomatic Deterioration|3
6839708|NCT00266877|10845409|FG002|Overall Study|Symptomatic Deterioration|1
7076078|NCT02075255|11182434|FG000|Overall Study|Lost to Follow-up|0
7076079|NCT02075255|11182435|FG001|Overall Study|Lost to Follow-up|0
7076080|NCT02075255|11182436|FG002|Overall Study|Lost to Follow-up|1
7076081|NCT02075255|11182434|FG000|Overall Study|Adverse Event|0
7076082|NCT02075255|11182435|FG001|Overall Study|Adverse Event|0
7076083|NCT02075255|11182436|FG002|Overall Study|Adverse Event|1
7076084|NCT02075255|11182434|FG000|Overall Study|Death|0
6839709|NCT00266877|10845407|FG000|Overall Study|Hospitalization|1
6839710|NCT00266877|10845408|FG001|Overall Study|Hospitalization|0
7076085|NCT02075255|11182435|FG001|Overall Study|Death|2
7076086|NCT02075255|11182436|FG002|Overall Study|Death|0
7076087|NCT02075463|11182444|FG000|Overall Study|Adverse Event|3
7076088|NCT02075463|11182444|FG000|Overall Study|Par. reached stopping criteria|4
7076089|NCT02075463|11182444|FG000|Overall Study|Withdrawal by Subject|1
7076090|NCT02075476|11182451|FG000|Overall Study|Death|2
7076091|NCT02075476|11182452|FG001|Overall Study|Death|2
7076092|NCT02075476|11182451|FG000|Overall Study|Lost to Follow-up|1
7076093|NCT02075476|11182452|FG001|Overall Study|Lost to Follow-up|3
7076094|NCT02075515|11182461|FG000|Overall Study|Serious Adverse Event|1
7076095|NCT02075515|11182462|FG001|Overall Study|Serious Adverse Event|1
7076096|NCT02075515|11182463|FG002|Overall Study|Serious Adverse Event|1
7076097|NCT02075515|11182461|FG000|Overall Study|Non-Serious Adverse Event|0
7076098|NCT02075515|11182462|FG001|Overall Study|Non-Serious Adverse Event|1
7076099|NCT02075515|11182463|FG002|Overall Study|Non-Serious Adverse Event|0
7076100|NCT02075515|11182461|FG000|Overall Study|Withdrawal by Subject|2
7076101|NCT02075515|11182462|FG001|Overall Study|Withdrawal by Subject|0
7076102|NCT02075515|11182463|FG002|Overall Study|Withdrawal by Subject|1
7076103|NCT02075515|11182461|FG000|Overall Study|Lost to Follow-up|1
7076104|NCT02075515|11182462|FG001|Overall Study|Lost to Follow-up|3
7076105|NCT02075515|11182463|FG002|Overall Study|Lost to Follow-up|6
7076106|NCT02075541|11182474|FG000|Overall Study|Serious Adverse Event|1
7076107|NCT02075541|11182475|FG001|Overall Study|Serious Adverse Event|4
7076108|NCT02075541|11182474|FG000|Overall Study|Protocol Violation|1
7076109|NCT02075541|11182475|FG001|Overall Study|Protocol Violation|0
7076110|NCT02075541|11182474|FG000|Overall Study|Withdrawal by Subject|1
7076111|NCT02075541|11182475|FG001|Overall Study|Withdrawal by Subject|3
7076112|NCT02075541|11182474|FG000|Overall Study|Sponsor study termination|0
7076113|NCT02075541|11182475|FG001|Overall Study|Sponsor study termination|1
7076114|NCT02075541|11182474|FG000|Overall Study|Other- unable to perform study procedure|1
7076115|NCT02075541|11182475|FG001|Overall Study|Other- unable to perform study procedure|0
7076116|NCT02075554|11182481|FG000|Overall Study|Lost to Follow-up|7
7076117|NCT02075554|11182481|FG000|Overall Study|Withdrawal by Subject|5
7076118|NCT02075554|11182481|FG000|Overall Study|Physician Decision|3
7076119|NCT02075606|11182485|FG000|Overall Study|Adverse Event|5
7076120|NCT02075606|11182485|FG000|Overall Study|Withdrawal by Subject|1
7076121|NCT02075606|11182485|FG000|Overall Study|Death|1
7076122|NCT02075606|11182485|FG000|Overall Study|Investigator's decision|1
7076123|NCT02075606|11182485|FG000|Overall Study|Symptom management|1
7076124|NCT02075606|11182485|FG000|Overall Study|Increasing Symptoms|1
7076125|NCT02075632|11182496|FG000|Overall Study|Adverse Event|1
7076126|NCT02075632|11182497|FG001|Overall Study|Adverse Event|1
7076127|NCT02075632|11182496|FG000|Overall Study|Lost to Follow-up|0
7076128|NCT02075632|11182497|FG001|Overall Study|Lost to Follow-up|3
7076129|NCT02075632|11182496|FG000|Overall Study|Withdrawal by Subject|0
7076130|NCT02075632|11182497|FG001|Overall Study|Withdrawal by Subject|1
7076131|NCT02075658|11182505|FG000|Overall Study|Physician Decision|2
7076132|NCT02075658|11182506|FG001|Overall Study|Physician Decision|2
7076133|NCT02076022|11182514|FG000|Overall Study|Withdrawal by Subject|2
7076134|NCT02076022|11182515|FG001|Overall Study|Withdrawal by Subject|0
7076135|NCT02076113|11182556|FG000|Overall Study|Lost to Follow-up|4
7076136|NCT02076113|11182557|FG001|Overall Study|Lost to Follow-up|1
7076137|NCT02076113|11182556|FG000|Overall Study|Withdrawal by Subject|2
7076138|NCT02076113|11182557|FG001|Overall Study|Withdrawal by Subject|3
7076139|NCT02076113|11182556|FG000|Overall Study|Death|1
7076140|NCT02076113|11182557|FG001|Overall Study|Death|3
7076141|NCT02076165|11182576|FG000|Overall Study|Lost to Follow-up|7
7076142|NCT02076165|11182577|FG001|Overall Study|Lost to Follow-up|5
7076143|NCT02076165|11182576|FG000|Overall Study|Refused follow-up assessment|1
7076144|NCT02076165|11182577|FG001|Overall Study|Refused follow-up assessment|1
7076145|NCT02076334|11182600|FG000|Overall Study|Protocol Violation|1
7076146|NCT02076334|11182601|FG001|Overall Study|Protocol Violation|0
7076147|NCT02076334|11182602|FG002|Overall Study|Protocol Violation|0
6839711|NCT00266877|10845409|FG002|Overall Study|Hospitalization|0
6839712|NCT00266877|10845407|FG000|Overall Study|Concomitant Radiotherapy|0
6839713|NCT00266877|10845408|FG001|Overall Study|Concomitant Radiotherapy|1
6839714|NCT00266877|10845409|FG002|Overall Study|Concomitant Radiotherapy|0
6839715|NCT00267007|10845419|FG000|Overall Study|Withdrawal by Subject|6
6966423|NCT01125358|11014377|FG002|Overall Study|Withdrawal by Subject|1
6839716|NCT00267007|10845420|FG001|Overall Study|Withdrawal by Subject|0
6839717|NCT00267007|10845419|FG000|Overall Study|Lost to Follow-up|1
6839718|NCT00267007|10845420|FG001|Overall Study|Lost to Follow-up|0
6839719|NCT00267007|10845419|FG000|Overall Study|Non-compliance|0
6839720|NCT00267007|10845420|FG001|Overall Study|Non-compliance|1
6839721|NCT00267007|10845419|FG000|Overall Study|Adverse Event|1
6966424|NCT01125358|11014378|FG003|Overall Study|Withdrawal by Subject|1
6839722|NCT00267007|10845420|FG001|Overall Study|Adverse Event|0
6839723|NCT00267020|10845428|FG000|Overall Study|Adverse Event|22
6839724|NCT00267020|10845429|FG001|Overall Study|Adverse Event|5
7076148|NCT02076334|11182603|FG003|Overall Study|Protocol Violation|0
7076149|NCT02076334|11182600|FG000|Overall Study|Lost to Follow-up|0
7076150|NCT02076334|11182601|FG001|Overall Study|Lost to Follow-up|1
7076151|NCT02076334|11182602|FG002|Overall Study|Lost to Follow-up|1
6976818|NCT01202279|11029656|FG001|Overall Study|Adverse Event|6
7076152|NCT02076334|11182603|FG003|Overall Study|Lost to Follow-up|0
7076153|NCT02076334|11182600|FG000|Overall Study|muscle soreness|0
7076154|NCT02076334|11182601|FG001|Overall Study|muscle soreness|0
7076155|NCT02076334|11182602|FG002|Overall Study|muscle soreness|0
7076156|NCT02076334|11182603|FG003|Overall Study|muscle soreness|1
7076157|NCT02077140|11182704|FG000|Overall Study|Lost to Follow-up|4
7076158|NCT02077140|11182705|FG001|Overall Study|Lost to Follow-up|1
7076159|NCT02077140|11182706|FG002|Overall Study|Lost to Follow-up|2
7076160|NCT02077140|11182707|FG003|Overall Study|Lost to Follow-up|2
7076161|NCT02077140|11182708|FG004|Overall Study|Lost to Follow-up|3
7076162|NCT02077140|11182704|FG000|Overall Study|Withdrawal by Subject|0
7076163|NCT02077140|11182705|FG001|Overall Study|Withdrawal by Subject|1
7076164|NCT02077140|11182706|FG002|Overall Study|Withdrawal by Subject|0
7076165|NCT02077140|11182707|FG003|Overall Study|Withdrawal by Subject|2
7076166|NCT02077140|11182708|FG004|Overall Study|Withdrawal by Subject|2
7076167|NCT02077374|11182725|FG000|Overall Study|Withdrawal by Subject|0
7076168|NCT02077374|11182726|FG001|Overall Study|Withdrawal by Subject|1
7076169|NCT02077374|11182725|FG000|Overall Study|Protocol Violation|0
7076170|NCT02077374|11182726|FG001|Overall Study|Protocol Violation|1
7076171|NCT02077465|11182737|FG000|Overall Study|Withdrew Consent|0
7076172|NCT02077465|11182738|FG001|Overall Study|Withdrew Consent|1
7076173|NCT02077465|11182737|FG000|Overall Study|Lost to Follow-up|1
7076174|NCT02077465|11182738|FG001|Overall Study|Lost to Follow-up|0
7076175|NCT02078102|11182746|FG000|Overall Study|Adverse Event|1
7076176|NCT02078102|11182747|FG001|Overall Study|Adverse Event|0
7076177|NCT02078102|11182746|FG000|Overall Study|Withdrawal by Subject|1
7076178|NCT02078102|11182747|FG001|Overall Study|Withdrawal by Subject|0
7076179|NCT02078102|11182746|FG000|Overall Study|Physician Decision|0
7076180|NCT02078102|11182747|FG001|Overall Study|Physician Decision|1
7076181|NCT02078219|11182773|FG000|Overall Study|Other|2
7076182|NCT02078219|11182774|FG001|Overall Study|Other|2
7076183|NCT02078219|11182775|FG002|Overall Study|Other|3
7076184|NCT02078219|11182776|FG003|Overall Study|Other|0
7076185|NCT02078219|11182777|FG004|Overall Study|Other|1
7076186|NCT02078219|11182773|FG000|Overall Study|Withdrawal by Subject|0
7076187|NCT02078219|11182774|FG001|Overall Study|Withdrawal by Subject|1
7076188|NCT02078219|11182775|FG002|Overall Study|Withdrawal by Subject|0
7076189|NCT02078219|11182776|FG003|Overall Study|Withdrawal by Subject|1
7076190|NCT02078219|11182777|FG004|Overall Study|Withdrawal by Subject|1
7076191|NCT02078219|11182773|FG000|Overall Study|Protocol Violation|0
7076192|NCT02078219|11182774|FG001|Overall Study|Protocol Violation|0
7076193|NCT02078219|11182775|FG002|Overall Study|Protocol Violation|0
7076194|NCT02078219|11182776|FG003|Overall Study|Protocol Violation|1
7076195|NCT02078219|11182777|FG004|Overall Study|Protocol Violation|0
7076196|NCT02078219|11182773|FG000|Overall Study|Death|0
7076197|NCT02078219|11182774|FG001|Overall Study|Death|0
7076198|NCT02078219|11182775|FG002|Overall Study|Death|0
7076199|NCT02078219|11182776|FG003|Overall Study|Death|1
7076200|NCT02078219|11182777|FG004|Overall Study|Death|0
7076201|NCT02078219|11182773|FG000|Overall Study|Adverse Event|1
7076202|NCT02078219|11182774|FG001|Overall Study|Adverse Event|1
7076203|NCT02078219|11182775|FG002|Overall Study|Adverse Event|3
7076204|NCT02078219|11182776|FG003|Overall Study|Adverse Event|1
7076205|NCT02078219|11182777|FG004|Overall Study|Adverse Event|0
7076206|NCT02078713|11182831|FG000|Overall Study|Lost to Follow-up|49
7076207|NCT02078713|11182832|FG001|Overall Study|Lost to Follow-up|55
7076208|NCT02078713|11182833|FG002|Overall Study|Lost to Follow-up|0
7076209|NCT02078713|11182834|FG003|Overall Study|Lost to Follow-up|0
7076210|NCT02078713|11182831|FG000|Overall Study|Pregnant at baseline|3
7076211|NCT02078713|11182832|FG001|Overall Study|Pregnant at baseline|5
7076212|NCT02078713|11182833|FG002|Overall Study|Pregnant at baseline|0
7076213|NCT02078713|11182834|FG003|Overall Study|Pregnant at baseline|0
7076214|NCT02078713|11182831|FG000|Overall Study|Enrolled twice|0
7076215|NCT02078713|11182832|FG001|Overall Study|Enrolled twice|1
7076216|NCT02078713|11182833|FG002|Overall Study|Enrolled twice|0
7076217|NCT02078713|11182834|FG003|Overall Study|Enrolled twice|0
7076218|NCT02078752|11182865|FG000|Overall Study|Death|0
7076219|NCT02078752|11182866|FG001|Overall Study|Death|3
7076220|NCT02078752|11182867|FG002|Overall Study|Death|0
7076221|NCT02078752|11182868|FG003|Overall Study|Death|0
7076222|NCT02078752|11182869|FG004|Overall Study|Death|0
7076223|NCT02078752|11182870|FG005|Overall Study|Death|1
7076224|NCT02078752|11182871|FG006|Overall Study|Death|0
7076225|NCT02078752|11182872|FG007|Overall Study|Death|1
7076226|NCT02078752|11182873|FG008|Overall Study|Death|0
7076227|NCT02078752|11182874|FG009|Overall Study|Death|4
7076228|NCT02078752|11182865|FG000|Overall Study|Lost to Follow-up|1
7076229|NCT02078752|11182866|FG001|Overall Study|Lost to Follow-up|0
7076230|NCT02078752|11182867|FG002|Overall Study|Lost to Follow-up|0
7076231|NCT02078752|11182868|FG003|Overall Study|Lost to Follow-up|1
7076232|NCT02078752|11182869|FG004|Overall Study|Lost to Follow-up|0
7076233|NCT02078752|11182870|FG005|Overall Study|Lost to Follow-up|0
7076234|NCT02078752|11182871|FG006|Overall Study|Lost to Follow-up|0
7076235|NCT02078752|11182872|FG007|Overall Study|Lost to Follow-up|0
7076236|NCT02078752|11182873|FG008|Overall Study|Lost to Follow-up|0
7076237|NCT02078752|11182874|FG009|Overall Study|Lost to Follow-up|0
7076238|NCT02078752|11182865|FG000|Overall Study|Withdrawal by Subject|1
7076239|NCT02078752|11182866|FG001|Overall Study|Withdrawal by Subject|1
7076240|NCT02078752|11182867|FG002|Overall Study|Withdrawal by Subject|1
6839725|NCT00267020|10845428|FG000|Overall Study|Death|2
6839726|NCT00267020|10845429|FG001|Overall Study|Death|1
6839727|NCT00267020|10845428|FG000|Overall Study|Withdrawal by Subject|17
6839728|NCT00267020|10845429|FG001|Overall Study|Withdrawal by Subject|7
6839729|NCT00267020|10845428|FG000|Overall Study|Physician Decision|3
6839730|NCT00267020|10845429|FG001|Overall Study|Physician Decision|2
6839731|NCT00267020|10845428|FG000|Overall Study|Disease Progression|39
6839732|NCT00267020|10845429|FG001|Overall Study|Disease Progression|25
6839733|NCT00267020|10845428|FG000|Overall Study|Unrelated Complication|1
6839734|NCT00267020|10845429|FG001|Overall Study|Unrelated Complication|1
6839735|NCT00267020|10845428|FG000|Overall Study|Sponsor Request|1
6839736|NCT00267020|10845429|FG001|Overall Study|Sponsor Request|0
6839737|NCT00267020|10845428|FG000|Overall Study|Other|1
6839738|NCT00267020|10845429|FG001|Overall Study|Other|2
6839739|NCT00267046|10845437|FG000|Overall Study|Disease progression|4
6839740|NCT00267046|10845438|FG001|Overall Study|Disease progression|2
6839741|NCT00267046|10845437|FG000|Overall Study|Chemotoxicity|2
6839742|NCT00267046|10845438|FG001|Overall Study|Chemotoxicity|0
6839743|NCT00267046|10845437|FG000|Overall Study|Open-label palifermin|2
6839744|NCT00267046|10845438|FG001|Overall Study|Open-label palifermin|7
6839745|NCT00267046|10845437|FG000|Overall Study|Surgery|3
6839746|NCT00267046|10845438|FG001|Overall Study|Surgery|1
6839747|NCT00267046|10845437|FG000|Overall Study|Withdrawal by Subject|1
6839748|NCT00267046|10845438|FG001|Overall Study|Withdrawal by Subject|0
6839749|NCT00267046|10845437|FG000|Overall Study|Radiation|0
6839750|NCT00267046|10845438|FG001|Overall Study|Radiation|1
6839751|NCT00267098|10845460|FG000|Overall Study|Death|0
6839752|NCT00267098|10845461|FG001|Overall Study|Death|0
6839753|NCT00267098|10845462|FG002|Overall Study|Death|57
6839754|NCT00267098|10845463|FG003|Overall Study|Death|66
6839755|NCT00267098|10845464|FG004|Overall Study|Death|14
6839756|NCT00267098|10845465|FG005|Overall Study|Death|23
6839757|NCT00267098|10845466|FG006|Overall Study|Death|28
7076241|NCT02078752|11182868|FG003|Overall Study|Withdrawal by Subject|1
7076242|NCT02078752|11182869|FG004|Overall Study|Withdrawal by Subject|0
7076243|NCT02078752|11182870|FG005|Overall Study|Withdrawal by Subject|3
7076244|NCT02078752|11182871|FG006|Overall Study|Withdrawal by Subject|2
6839758|NCT00267098|10845467|FG007|Overall Study|Death|9
6839759|NCT00267098|10845460|FG000|Overall Study|Lost to Follow-up|0
6839760|NCT00267098|10845461|FG001|Overall Study|Lost to Follow-up|0
6839761|NCT00267098|10845462|FG002|Overall Study|Lost to Follow-up|6
6839762|NCT00267098|10845463|FG003|Overall Study|Lost to Follow-up|5
6839763|NCT00267098|10845464|FG004|Overall Study|Lost to Follow-up|2
6839764|NCT00267098|10845465|FG005|Overall Study|Lost to Follow-up|3
6839765|NCT00267098|10845466|FG006|Overall Study|Lost to Follow-up|1
6839766|NCT00267098|10845467|FG007|Overall Study|Lost to Follow-up|1
6839767|NCT00267098|10845460|FG000|Overall Study|Withdrawal by Subject|8
6966425|NCT04516746|11014411|FG000|Overall Study|Ongoing in the study at clinical DCO for the primary analysis.|21090
6966426|NCT04516746|11014412|FG001|Overall Study|Ongoing in the study at clinical DCO for the primary analysis.|10305
7076245|NCT02078752|11182872|FG007|Overall Study|Withdrawal by Subject|1
7076246|NCT02078752|11182873|FG008|Overall Study|Withdrawal by Subject|0
7076247|NCT02078752|11182874|FG009|Overall Study|Withdrawal by Subject|1
7076248|NCT02078752|11182865|FG000|Overall Study|Other|0
7076249|NCT02078752|11182866|FG001|Overall Study|Other|3
7076250|NCT02078752|11182867|FG002|Overall Study|Other|0
6966427|NCT04516746|11014411|FG000|Overall Study|Withdrawal by Subject|362
7076251|NCT02078752|11182868|FG003|Overall Study|Other|0
7076252|NCT02078752|11182869|FG004|Overall Study|Other|1
7076253|NCT02078752|11182870|FG005|Overall Study|Other|0
7076254|NCT02078752|11182871|FG006|Overall Study|Other|0
7076255|NCT02078752|11182872|FG007|Overall Study|Other|1
7076256|NCT02078752|11182873|FG008|Overall Study|Other|0
7076257|NCT02078752|11182874|FG009|Overall Study|Other|0
7076258|NCT02078752|11182865|FG000|Overall Study|Study terminated by sponsor|0
7076259|NCT02078752|11182866|FG001|Overall Study|Study terminated by sponsor|0
7076260|NCT02078752|11182867|FG002|Overall Study|Study terminated by sponsor|0
7076261|NCT02078752|11182868|FG003|Overall Study|Study terminated by sponsor|0
7076262|NCT02078752|11182869|FG004|Overall Study|Study terminated by sponsor|0
7076263|NCT02078752|11182870|FG005|Overall Study|Study terminated by sponsor|0
7076264|NCT02078752|11182871|FG006|Overall Study|Study terminated by sponsor|0
7076265|NCT02078752|11182872|FG007|Overall Study|Study terminated by sponsor|0
7076266|NCT02078752|11182873|FG008|Overall Study|Study terminated by sponsor|0
7076267|NCT02078752|11182874|FG009|Overall Study|Study terminated by sponsor|5
7076268|NCT02078817|11182905|FG000|Overall Study|Withdrawal by Subject|1
7076269|NCT02078960|11182916|FG000|Treatment Period|Other|0
7076270|NCT02078960|11182917|FG001|Treatment Period|Other|0
7076271|NCT02078960|11182918|FG002|Treatment Period|Other|1
7076272|NCT02078960|11182916|FG000|Treatment Period|Lack of Efficacy|0
7076273|NCT02078960|11182917|FG001|Treatment Period|Lack of Efficacy|1
6839768|NCT00267098|10845461|FG001|Overall Study|Withdrawal by Subject|0
6839769|NCT00267098|10845462|FG002|Overall Study|Withdrawal by Subject|24
6839770|NCT00267098|10845463|FG003|Overall Study|Withdrawal by Subject|21
6839771|NCT00267098|10845464|FG004|Overall Study|Withdrawal by Subject|12
6839772|NCT00267098|10845465|FG005|Overall Study|Withdrawal by Subject|9
6839773|NCT00267098|10845466|FG006|Overall Study|Withdrawal by Subject|12
7076274|NCT02078960|11182918|FG002|Treatment Period|Lack of Efficacy|0
6839774|NCT00267098|10845467|FG007|Overall Study|Withdrawal by Subject|5
6839775|NCT00267098|10845460|FG000|Overall Study|Physician Decision|5
6839776|NCT00267098|10845461|FG001|Overall Study|Physician Decision|0
6839777|NCT00267098|10845462|FG002|Overall Study|Physician Decision|7
6839778|NCT00267098|10845463|FG003|Overall Study|Physician Decision|11
6839779|NCT00267098|10845464|FG004|Overall Study|Physician Decision|5
6839780|NCT00267098|10845465|FG005|Overall Study|Physician Decision|4
6839781|NCT00267098|10845466|FG006|Overall Study|Physician Decision|3
6839782|NCT00267098|10845467|FG007|Overall Study|Physician Decision|0
6839783|NCT00267098|10845460|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96
6839784|NCT00267098|10845461|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0
6839785|NCT00267098|10845462|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0
6839786|NCT00267098|10845463|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0
6839787|NCT00267098|10845464|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2
6839788|NCT00267098|10845465|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0
6839789|NCT00267098|10845466|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0
6839790|NCT00267098|10845467|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0
6839791|NCT00267098|10845460|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0
6839792|NCT00267098|10845461|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51
6839793|NCT00267098|10845462|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0
6839794|NCT00267098|10845463|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0
6839795|NCT00267098|10845464|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0
6839796|NCT00267098|10845465|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0
6839797|NCT00267098|10845466|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0
6839798|NCT00267098|10845467|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0
6839799|NCT00267098|10845460|FG000|Overall Study|Site closure|0
6839800|NCT00267098|10845461|FG001|Overall Study|Site closure|0
6839801|NCT00267098|10845462|FG002|Overall Study|Site closure|0
6839802|NCT00267098|10845463|FG003|Overall Study|Site closure|1
6839803|NCT00267098|10845464|FG004|Overall Study|Site closure|0
6839804|NCT00267098|10845465|FG005|Overall Study|Site closure|1
6839805|NCT00267098|10845466|FG006|Overall Study|Site closure|1
6839806|NCT00267098|10845467|FG007|Overall Study|Site closure|0
6839807|NCT00267098|10845460|FG000|Overall Study|Explanted Medtronic device|0
6839808|NCT00267098|10845461|FG001|Overall Study|Explanted Medtronic device|0
6839809|NCT00267098|10845462|FG002|Overall Study|Explanted Medtronic device|0
6839810|NCT00267098|10845463|FG003|Overall Study|Explanted Medtronic device|1
6839811|NCT00267098|10845464|FG004|Overall Study|Explanted Medtronic device|0
6839812|NCT00267098|10845465|FG005|Overall Study|Explanted Medtronic device|0
6839813|NCT00267098|10845466|FG006|Overall Study|Explanted Medtronic device|0
6839814|NCT00267098|10845467|FG007|Overall Study|Explanted Medtronic device|0
6839815|NCT00267098|10845460|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0
6839816|NCT00267098|10845461|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0
6839817|NCT00267098|10845462|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0
6839818|NCT00267098|10845463|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0
6839819|NCT00267098|10845464|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2
6839820|NCT00267098|10845465|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0
6839821|NCT00267098|10845466|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0
6839822|NCT00267098|10845467|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0
7076275|NCT02078960|11182916|FG000|Treatment Period|Disease progression - accelerated phase|0
7076276|NCT02078960|11182917|FG001|Treatment Period|Disease progression - accelerated phase|1
7076277|NCT02078960|11182918|FG002|Treatment Period|Disease progression - accelerated phase|0
7076278|NCT02078960|11182916|FG000|Treatment Period|Disease progression - blast phase|1
7076279|NCT02078960|11182917|FG001|Treatment Period|Disease progression - blast phase|0
7076280|NCT02078960|11182918|FG002|Treatment Period|Disease progression - blast phase|0
7076281|NCT02078960|11182916|FG000|Treatment Period|Withdrawal by Subject|0
7076282|NCT02078960|11182917|FG001|Treatment Period|Withdrawal by Subject|1
7076283|NCT02078960|11182918|FG002|Treatment Period|Withdrawal by Subject|1
7076284|NCT02078960|11182916|FG000|Treatment Period|Adverse Event|1
7076285|NCT02078960|11182917|FG001|Treatment Period|Adverse Event|0
7076286|NCT02078960|11182918|FG002|Treatment Period|Adverse Event|0
7076287|NCT02078960|11182916|FG000|Treatment Period|Death|0
7076288|NCT02078960|11182917|FG001|Treatment Period|Death|0
7076289|NCT02078960|11182918|FG002|Treatment Period|Death|1
7076290|NCT02078960|11182916|FG000|Follow-up Period|Death|2
7076291|NCT02078960|11182917|FG001|Follow-up Period|Death|0
7076292|NCT02078960|11182918|FG002|Follow-up Period|Death|0
7076293|NCT02078960|11182916|FG000|Follow-up Period|Lost to Follow-up|0
7076294|NCT02078960|11182917|FG001|Follow-up Period|Lost to Follow-up|1
7076295|NCT02078960|11182918|FG002|Follow-up Period|Lost to Follow-up|0
7076296|NCT02079038|11182940|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6
6839823|NCT00267098|10845460|FG000|Overall Study|Subject listed for heart transplant|0
6839824|NCT00267098|10845461|FG001|Overall Study|Subject listed for heart transplant|0
6839825|NCT00267098|10845462|FG002|Overall Study|Subject listed for heart transplant|0
6839826|NCT00267098|10845463|FG003|Overall Study|Subject listed for heart transplant|0
7076297|NCT02079038|11182941|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5
7076298|NCT02079038|11182940|FG000|Modified Intent to Treat Population|Death|1
7076299|NCT02079038|11182941|FG001|Modified Intent to Treat Population|Death|0
7076300|NCT02079038|11182940|FG000|Completed 6 Months|Lost to Follow-up|2
7076301|NCT02079038|11182941|FG001|Completed 6 Months|Lost to Follow-up|1
7076302|NCT02079077|11182949|FG000|Overall Study|Lost to Follow-up|5
7076303|NCT02079077|11182950|FG001|Overall Study|Lost to Follow-up|7
7076304|NCT02079077|11182949|FG000|Overall Study|Became STIs Positive|1
7076305|NCT02079077|11182950|FG001|Overall Study|Became STIs Positive|2
7076306|NCT02079246|11182956|FG000|OLEX|Withdrawal before treatment|1
7076307|NCT02079246|11182957|FG001|OLEX|Withdrawal before treatment|0
7076308|NCT02079246|11182956|FG000|OLEX|Death|11
7076309|NCT02079246|11182957|FG001|OLEX|Death|0
7076310|NCT02079246|11182956|FG000|OLEX|Adverse Event|66
7076311|NCT02079246|11182957|FG001|OLEX|Adverse Event|0
7076312|NCT02079246|11182956|FG000|OLEX|Withdrawal by Subject|60
7076313|NCT02079246|11182957|FG001|OLEX|Withdrawal by Subject|0
7076314|NCT02079246|11182956|FG000|OLEX|Lost to Follow-up|6
7076315|NCT02079246|11182957|FG001|OLEX|Lost to Follow-up|0
7076316|NCT02079246|11182956|FG000|OLEX|Protocol Violation|6
7076317|NCT02079246|11182957|FG001|OLEX|Protocol Violation|0
7076318|NCT02079246|11182956|FG000|OLEX|Lack of Efficacy|3
7076319|NCT02079246|11182957|FG001|OLEX|Lack of Efficacy|0
7076320|NCT02079246|11182956|FG000|OLEX|Results of the lead-in studies|58
7076321|NCT02079246|11182957|FG001|OLEX|Results of the lead-in studies|0
7076322|NCT02079246|11182956|FG000|OLEX|Other: Disallowed medication|8
7076323|NCT02079246|11182957|FG001|OLEX|Other: Disallowed medication|0
7076324|NCT02079246|11182956|FG000|OLEX|Other: Insufficient compliance|2
7076325|NCT02079246|11182957|FG001|OLEX|Other: Insufficient compliance|0
7076326|NCT02079246|11182956|FG000|OLEX|Other: Caregiver unavailable|3
7076327|NCT02079246|11182957|FG001|OLEX|Other: Caregiver unavailable|0
7076328|NCT02079246|11182956|FG000|OLEX|Other: Coordinator decision|1
7076329|NCT02079246|11182957|FG001|OLEX|Other: Coordinator decision|0
7076330|NCT02079246|11182956|FG000|OLEX|Other: Worsening of condition|1
7076331|NCT02079246|11182957|FG001|OLEX|Other: Worsening of condition|0
7076332|NCT02079246|11182956|FG000|OLEX|Other: Moved to nursing home|1
7076333|NCT02079246|11182957|FG001|OLEX|Other: Moved to nursing home|0
7076334|NCT02079246|11182956|FG000|OLEX|Other: Withdrawal of caregiver consent|1
7076335|NCT02079246|11182957|FG001|OLEX|Other: Withdrawal of caregiver consent|0
7076336|NCT02079246|11182956|FG000|OLEX-MEM|Adverse Event|0
7076337|NCT02079246|11182957|FG001|OLEX-MEM|Adverse Event|6
7076338|NCT02079246|11182956|FG000|OLEX-MEM|Withdrawal by Subject|0
7076339|NCT02079246|11182957|FG001|OLEX-MEM|Withdrawal by Subject|7
7076340|NCT02079246|11182956|FG000|OLEX-MEM|Protocol Violation|0
7076341|NCT02079246|11182957|FG001|OLEX-MEM|Protocol Violation|2
7076342|NCT02079246|11182956|FG000|OLEX-MEM|Lost to Follow-up|0
7076343|NCT02079246|11182957|FG001|OLEX-MEM|Lost to Follow-up|1
7076344|NCT02079246|11182956|FG000|OLEX-MEM|Other: Moved to nursing home|0
7076345|NCT02079246|11182957|FG001|OLEX-MEM|Other: Moved to nursing home|3
7076346|NCT02079519|11182975|FG000|Overall Study|Disease Progression|9
7076347|NCT02079519|11182975|FG000|Overall Study|Adverse Event|1
7082879|NCT02147158|11193689|FG003|Off-Treatment Interval 1|Adverse Event|1
7082880|NCT02147158|11193690|FG004|Off-Treatment Interval 1|Adverse Event|0
7082881|NCT02147158|11193691|FG005|Off-Treatment Interval 1|Adverse Event|0
7082882|NCT02147158|11193686|FG000|Off-Treatment Interval 1|Lost to Follow-up|2
7082883|NCT02147158|11193687|FG001|Off-Treatment Interval 1|Lost to Follow-up|1
7082884|NCT02147158|11193688|FG002|Off-Treatment Interval 1|Lost to Follow-up|3
7082885|NCT02147158|11193689|FG003|Off-Treatment Interval 1|Lost to Follow-up|2
6839827|NCT00267098|10845464|FG004|Overall Study|Subject listed for heart transplant|0
6839828|NCT00267098|10845465|FG005|Overall Study|Subject listed for heart transplant|0
6839829|NCT00267098|10845466|FG006|Overall Study|Subject listed for heart transplant|1
6839830|NCT00267098|10845467|FG007|Overall Study|Subject listed for heart transplant|0
6839831|NCT00267098|10845460|FG000|Overall Study|Sponsor withdrew subject|0
6839832|NCT00267098|10845461|FG001|Overall Study|Sponsor withdrew subject|0
6839833|NCT00267098|10845462|FG002|Overall Study|Sponsor withdrew subject|0
6839834|NCT00267098|10845463|FG003|Overall Study|Sponsor withdrew subject|1
6839835|NCT00267098|10845464|FG004|Overall Study|Sponsor withdrew subject|0
6839836|NCT00267098|10845465|FG005|Overall Study|Sponsor withdrew subject|0
6839837|NCT00267098|10845466|FG006|Overall Study|Sponsor withdrew subject|0
6839838|NCT00267098|10845467|FG007|Overall Study|Sponsor withdrew subject|0
6839839|NCT00267150|10845500|FG000|Overall Study|Adverse Event|1
6839840|NCT00267189|10845506|FG000|Overall Study|Patient withdrew consent|1
7082886|NCT02147158|11193690|FG004|Off-Treatment Interval 1|Lost to Follow-up|4
7082887|NCT02147158|11193691|FG005|Off-Treatment Interval 1|Lost to Follow-up|2
7082888|NCT02147158|11193686|FG000|Off-Treatment Interval 1|Protocol Violation|1
7082889|NCT02147158|11193687|FG001|Off-Treatment Interval 1|Protocol Violation|0
7082890|NCT02147158|11193688|FG002|Off-Treatment Interval 1|Protocol Violation|2
7082891|NCT02147158|11193689|FG003|Off-Treatment Interval 1|Protocol Violation|0
6839841|NCT00267189|10845507|FG001|Overall Study|Patient withdrew consent|1
6839842|NCT00267189|10845506|FG000|Overall Study|Death|1
6839843|NCT00267189|10845507|FG001|Overall Study|Death|0
7082892|NCT02147158|11193690|FG004|Off-Treatment Interval 1|Protocol Violation|1
7082893|NCT02147158|11193691|FG005|Off-Treatment Interval 1|Protocol Violation|0
7082894|NCT02147158|11193686|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4
7082895|NCT02147158|11193687|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3
7082896|NCT02147158|11193688|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5
7082897|NCT02147158|11193689|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10
7076348|NCT02079532|11182979|FG000|Overall Study|Adverse Event|7
7076349|NCT02079532|11182979|FG000|Overall Study|Additional or changed therapy|2
7076350|NCT02079532|11182979|FG000|Overall Study|Lack of Efficacy|9
7076351|NCT02079532|11182979|FG000|Overall Study|Protocol Violation|3
7076352|NCT02079532|11182979|FG000|Overall Study|Withdrawal by Subject|1
7076353|NCT02079532|11182979|FG000|Overall Study|Administrative problems|1
7076354|NCT02079532|11182979|FG000|Overall Study|Inclusion into ReFIRST|3
7076355|NCT02079532|11182979|FG000|Overall Study|Other|3
7076356|NCT02079610|11182985|FG000|Overall Study|Withdrawal by Subject|1
7076357|NCT02079610|11182986|FG001|Overall Study|Withdrawal by Subject|1
7076358|NCT02079636|11183007|FG000|Overall Study|Death|2
7076359|NCT02079636|11183008|FG001|Overall Study|Death|1
7076360|NCT02079636|11183009|FG002|Overall Study|Death|0
7076361|NCT02079636|11183010|FG003|Overall Study|Death|5
7076362|NCT02079636|11183011|FG004|Overall Study|Death|1
7076363|NCT02079636|11183012|FG005|Overall Study|Death|2
7076364|NCT02079636|11183013|FG006|Overall Study|Death|1
7076365|NCT02079636|11183014|FG007|Overall Study|Death|0
7076366|NCT02079636|11183015|FG008|Overall Study|Death|0
7076367|NCT02079636|11183016|FG009|Overall Study|Death|0
7076368|NCT02079636|11183017|FG010|Overall Study|Death|0
6839844|NCT00267189|10845506|FG000|Overall Study|Missing|3
6839845|NCT00267189|10845507|FG001|Overall Study|Missing|0
6839846|NCT00267202|10845515|FG000|Overall Study|Unsatisfactory therapeutic effect|21
6839847|NCT00267202|10845516|FG001|Overall Study|Unsatisfactory therapeutic effect|8
6839848|NCT00267202|10845515|FG000|Overall Study|Withdrawal by Subject|12
6839849|NCT00267202|10845516|FG001|Overall Study|Withdrawal by Subject|15
6839850|NCT00267202|10845515|FG000|Overall Study|Adverse Event|13
6839851|NCT00267202|10845516|FG001|Overall Study|Adverse Event|7
6839852|NCT00267202|10845515|FG000|Overall Study|Protocol Violation|2
6839853|NCT00267202|10845516|FG001|Overall Study|Protocol Violation|3
6839854|NCT00267202|10845515|FG000|Overall Study|Administrative problems|2
6839855|NCT00267202|10845516|FG001|Overall Study|Administrative problems|1
6839856|NCT00267202|10845515|FG000|Overall Study|Lost to Follow-up|3
6839857|NCT00267202|10845516|FG001|Overall Study|Lost to Follow-up|0
6839858|NCT00267488|10845536|FG000|Overall Study|Sponsor Terminated Study|9
6839859|NCT00267488|10845536|FG000|Overall Study|Protocol Violation|1
6839860|NCT00267488|10845536|FG000|Overall Study|Other (Disease Progression)|1
6897683|NCT00642460|10916789|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0
6897684|NCT00642460|10916790|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0
6897685|NCT00642460|10916791|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0
6897686|NCT00642460|10916792|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1
6897687|NCT00642460|10916793|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0
6897688|NCT00642460|10916794|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0
6897689|NCT00642460|10916789|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0
6897690|NCT00642460|10916790|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0
6897691|NCT00642460|10916791|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0
6897692|NCT00642460|10916792|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0
6897693|NCT00642460|10916793|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7
6897694|NCT00642460|10916794|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6
6897695|NCT00642460|10916789|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
6897696|NCT00642460|10916790|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
6897697|NCT00642460|10916791|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
6897698|NCT00642460|10916792|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
6897699|NCT00642460|10916793|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3
6897700|NCT00642460|10916794|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4
6897701|NCT00642460|10916789|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
6897702|NCT00642460|10916790|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
6897703|NCT00642460|10916791|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
6897704|NCT00642460|10916792|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
6897705|NCT00642460|10916793|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4
6897706|NCT00642460|10916794|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1
6897707|NCT00642460|10916789|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
6897708|NCT00642460|10916790|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
6897709|NCT00642460|10916791|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
6897710|NCT00642460|10916792|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
6897711|NCT00642460|10916793|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
6897712|NCT00642460|10916794|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
6897713|NCT00642460|10916789|FG000|Part III: Open-Label Up to Week 260|Other|0
6897714|NCT00642460|10916790|FG001|Part III: Open-Label Up to Week 260|Other|0
6897715|NCT00642460|10916791|FG002|Part III: Open-Label Up to Week 260|Other|0
6897716|NCT00642460|10916792|FG003|Part III: Open-Label Up to Week 260|Other|0
7076369|NCT02079636|11183018|FG011|Overall Study|Death|1
7076370|NCT02079636|11183019|FG012|Overall Study|Death|1
7076371|NCT02079636|11183020|FG013|Overall Study|Death|0
7076372|NCT02079636|11183021|FG014|Overall Study|Death|2
7076373|NCT02079636|11183007|FG000|Overall Study|Adverse Event|1
7076374|NCT02079636|11183008|FG001|Overall Study|Adverse Event|1
7076375|NCT02079636|11183009|FG002|Overall Study|Adverse Event|0
7076376|NCT02079636|11183010|FG003|Overall Study|Adverse Event|1
7076377|NCT02079636|11183011|FG004|Overall Study|Adverse Event|1
7076378|NCT02079636|11183012|FG005|Overall Study|Adverse Event|2
7076379|NCT02079636|11183013|FG006|Overall Study|Adverse Event|0
7076380|NCT02079636|11183014|FG007|Overall Study|Adverse Event|0
7076381|NCT02079636|11183015|FG008|Overall Study|Adverse Event|0
7076382|NCT02079636|11183016|FG009|Overall Study|Adverse Event|0
7076383|NCT02079636|11183017|FG010|Overall Study|Adverse Event|0
7076384|NCT02079636|11183018|FG011|Overall Study|Adverse Event|0
7076385|NCT02079636|11183019|FG012|Overall Study|Adverse Event|0
7076386|NCT02079636|11183020|FG013|Overall Study|Adverse Event|0
7076387|NCT02079636|11183021|FG014|Overall Study|Adverse Event|0
7076388|NCT02079636|11183007|FG000|Overall Study|Progressive disease|0
7076389|NCT02079636|11183008|FG001|Overall Study|Progressive disease|0
7076390|NCT02079636|11183009|FG002|Overall Study|Progressive disease|0
7076391|NCT02079636|11183010|FG003|Overall Study|Progressive disease|2
7076392|NCT02079636|11183011|FG004|Overall Study|Progressive disease|0
7076393|NCT02079636|11183012|FG005|Overall Study|Progressive disease|0
7076394|NCT02079636|11183013|FG006|Overall Study|Progressive disease|0
7076395|NCT02079636|11183014|FG007|Overall Study|Progressive disease|0
7076396|NCT02079636|11183015|FG008|Overall Study|Progressive disease|0
7076397|NCT02079636|11183016|FG009|Overall Study|Progressive disease|0
7076398|NCT02079636|11183017|FG010|Overall Study|Progressive disease|0
7076399|NCT02079636|11183018|FG011|Overall Study|Progressive disease|0
7076400|NCT02079636|11183019|FG012|Overall Study|Progressive disease|1
7076401|NCT02079636|11183020|FG013|Overall Study|Progressive disease|0
7076402|NCT02079636|11183021|FG014|Overall Study|Progressive disease|0
7076403|NCT02079636|11183007|FG000|Overall Study|Withdrawal by Subject|0
7076404|NCT02079636|11183008|FG001|Overall Study|Withdrawal by Subject|0
7076405|NCT02079636|11183009|FG002|Overall Study|Withdrawal by Subject|0
7076406|NCT02079636|11183010|FG003|Overall Study|Withdrawal by Subject|4
7076407|NCT02079636|11183011|FG004|Overall Study|Withdrawal by Subject|0
7076408|NCT02079636|11183012|FG005|Overall Study|Withdrawal by Subject|1
7076409|NCT02079636|11183013|FG006|Overall Study|Withdrawal by Subject|0
7076410|NCT02079636|11183014|FG007|Overall Study|Withdrawal by Subject|0
7076411|NCT02079636|11183015|FG008|Overall Study|Withdrawal by Subject|0
7076412|NCT02079636|11183016|FG009|Overall Study|Withdrawal by Subject|2
7076413|NCT02079636|11183017|FG010|Overall Study|Withdrawal by Subject|1
7076414|NCT02079636|11183018|FG011|Overall Study|Withdrawal by Subject|1
7076415|NCT02079636|11183019|FG012|Overall Study|Withdrawal by Subject|1
6839861|NCT00267748|10845577|FG000|Non-randomized Period|Progressive disease|10
6839862|NCT00267748|10845578|FG001|Non-randomized Period|Progressive disease|0
6839863|NCT00267748|10845579|FG002|Non-randomized Period|Progressive disease|0
6839864|NCT00267748|10845577|FG000|Non-randomized Period|Adverse Event|8
6839865|NCT00267748|10845578|FG001|Non-randomized Period|Adverse Event|0
6839866|NCT00267748|10845579|FG002|Non-randomized Period|Adverse Event|0
6839867|NCT00267748|10845577|FG000|Non-randomized Period|Death|1
6839868|NCT00267748|10845578|FG001|Non-randomized Period|Death|0
6839869|NCT00267748|10845579|FG002|Non-randomized Period|Death|0
6839870|NCT00267748|10845577|FG000|Non-randomized Period|Participant not willing to participate|1
6839871|NCT00267748|10845578|FG001|Non-randomized Period|Participant not willing to participate|0
6839872|NCT00267748|10845579|FG002|Non-randomized Period|Participant not willing to participate|0
6839873|NCT00267748|10845577|FG000|Non-randomized Period|Other|3
6839874|NCT00267748|10845578|FG001|Non-randomized Period|Other|0
6839875|NCT00267748|10845579|FG002|Non-randomized Period|Other|0
6839876|NCT00267748|10845577|FG000|Randomized Period|Death|0
6839877|NCT00267748|10845578|FG001|Randomized Period|Death|2
6839878|NCT00267748|10845579|FG002|Randomized Period|Death|3
6839879|NCT00267748|10845577|FG000|Randomized Period|Adverse Event|0
6839880|NCT00267748|10845578|FG001|Randomized Period|Adverse Event|23
6839881|NCT00267748|10845579|FG002|Randomized Period|Adverse Event|25
6839882|NCT00267748|10845577|FG000|Randomized Period|Global deterioration of health status|0
6839883|NCT00267748|10845578|FG001|Randomized Period|Global deterioration of health status|6
6839884|NCT00267748|10845579|FG002|Randomized Period|Global deterioration of health status|7
6839885|NCT00267748|10845577|FG000|Randomized Period|Lost to Follow-up|0
6839886|NCT00267748|10845578|FG001|Randomized Period|Lost to Follow-up|1
6839887|NCT00267748|10845579|FG002|Randomized Period|Lost to Follow-up|0
6839888|NCT00267748|10845577|FG000|Randomized Period|Objective progression or relapse|0
6839889|NCT00267748|10845578|FG001|Randomized Period|Objective progression or relapse|77
6839890|NCT00267748|10845579|FG002|Randomized Period|Objective progression or relapse|86
6839891|NCT00267748|10845577|FG000|Randomized Period|Withdrawal by Subject|0
6839892|NCT00267748|10845578|FG001|Randomized Period|Withdrawal by Subject|9
6839893|NCT00267748|10845579|FG002|Randomized Period|Withdrawal by Subject|2
6839894|NCT00267748|10845577|FG000|Randomized Period|Other|0
6839895|NCT00267748|10845578|FG001|Randomized Period|Other|9
6839896|NCT00267748|10845579|FG002|Randomized Period|Other|6
6839897|NCT00267748|10845577|FG000|Randomized Period|randomized but not treated|0
6839898|NCT00267748|10845578|FG001|Randomized Period|randomized but not treated|0
6839899|NCT00267748|10845579|FG002|Randomized Period|randomized but not treated|3
6839900|NCT00267865|10845595|FG000|Induction Treatment|Died before completing.|2
7076416|NCT02079636|11183020|FG013|Overall Study|Withdrawal by Subject|0
7076417|NCT02079636|11183021|FG014|Overall Study|Withdrawal by Subject|2
7076418|NCT02079636|11183007|FG000|Overall Study|Physician Decision|0
7076419|NCT02079636|11183008|FG001|Overall Study|Physician Decision|0
7076420|NCT02079636|11183009|FG002|Overall Study|Physician Decision|0
7076421|NCT02079636|11183010|FG003|Overall Study|Physician Decision|0
7076422|NCT02079636|11183011|FG004|Overall Study|Physician Decision|0
6839901|NCT00267865|10845595|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1
6839902|NCT00267956|10845601|FG000|Controlled Period|Adverse Event|4
6839903|NCT00267956|10845602|FG001|Controlled Period|Adverse Event|1
6839904|NCT00267956|10845603|FG002|Controlled Period|Adverse Event|0
7076423|NCT02079636|11183012|FG005|Overall Study|Physician Decision|1
7076424|NCT02079636|11183013|FG006|Overall Study|Physician Decision|0
6839905|NCT00267956|10845604|FG003|Controlled Period|Adverse Event|0
6839906|NCT00267956|10845601|FG000|Controlled Period|Lack of Efficacy|4
6839907|NCT00267956|10845602|FG001|Controlled Period|Lack of Efficacy|2
6839908|NCT00267956|10845603|FG002|Controlled Period|Lack of Efficacy|0
6839909|NCT00267956|10845604|FG003|Controlled Period|Lack of Efficacy|0
6839910|NCT00267956|10845601|FG000|Controlled Period|Lost to Follow-up|2
6839911|NCT00267956|10845602|FG001|Controlled Period|Lost to Follow-up|0
6839912|NCT00267956|10845603|FG002|Controlled Period|Lost to Follow-up|0
6839913|NCT00267956|10845604|FG003|Controlled Period|Lost to Follow-up|0
6839914|NCT00267956|10845601|FG000|Controlled Period|Withdrew consent|3
6839915|NCT00267956|10845602|FG001|Controlled Period|Withdrew consent|1
6839916|NCT00267956|10845603|FG002|Controlled Period|Withdrew consent|0
6839917|NCT00267956|10845604|FG003|Controlled Period|Withdrew consent|0
6839918|NCT00267956|10845601|FG000|After Controlled Period|Adverse Event|0
6839919|NCT00267956|10845602|FG001|After Controlled Period|Adverse Event|0
6839920|NCT00267956|10845603|FG002|After Controlled Period|Adverse Event|2
6839921|NCT00267956|10845604|FG003|After Controlled Period|Adverse Event|1
6839922|NCT00267956|10845601|FG000|After Controlled Period|Lack of Efficacy|0
6839923|NCT00267956|10845602|FG001|After Controlled Period|Lack of Efficacy|0
6839924|NCT00267956|10845603|FG002|After Controlled Period|Lack of Efficacy|1
6839925|NCT00267956|10845604|FG003|After Controlled Period|Lack of Efficacy|1
6839926|NCT00267956|10845601|FG000|After Controlled Period|Lost to Follow-up|0
6839927|NCT00267956|10845602|FG001|After Controlled Period|Lost to Follow-up|0
6839928|NCT00267956|10845603|FG002|After Controlled Period|Lost to Follow-up|1
6839929|NCT00267956|10845604|FG003|After Controlled Period|Lost to Follow-up|0
6839930|NCT00267956|10845601|FG000|After Controlled Period|Withdrew consent|0
6839931|NCT00267956|10845602|FG001|After Controlled Period|Withdrew consent|0
6839932|NCT00267956|10845603|FG002|After Controlled Period|Withdrew consent|1
6839933|NCT00267956|10845604|FG003|After Controlled Period|Withdrew consent|0
6839934|NCT00267969|10845615|FG000|Controlled Period|Adverse Event|6
6839935|NCT00267969|10845616|FG001|Controlled Period|Adverse Event|0
6839936|NCT00267969|10845617|FG002|Controlled Period|Adverse Event|2
6839937|NCT00267969|10845618|FG003|Controlled Period|Adverse Event|0
6839938|NCT00267969|10845619|FG004|Controlled Period|Adverse Event|0
6839939|NCT00267969|10845620|FG005|Controlled Period|Adverse Event|0
6839940|NCT00267969|10845621|FG006|Controlled Period|Adverse Event|0
6839941|NCT00267969|10845615|FG000|Controlled Period|Lack of Efficacy|3
6839942|NCT00267969|10845616|FG001|Controlled Period|Lack of Efficacy|0
6839943|NCT00267969|10845617|FG002|Controlled Period|Lack of Efficacy|1
6839944|NCT00267969|10845618|FG003|Controlled Period|Lack of Efficacy|0
6839945|NCT00267969|10845619|FG004|Controlled Period|Lack of Efficacy|0
6839946|NCT00267969|10845620|FG005|Controlled Period|Lack of Efficacy|0
6839947|NCT00267969|10845621|FG006|Controlled Period|Lack of Efficacy|0
6839948|NCT00267969|10845615|FG000|Controlled Period|Lost to Follow-up|1
6839949|NCT00267969|10845616|FG001|Controlled Period|Lost to Follow-up|0
6839950|NCT00267969|10845617|FG002|Controlled Period|Lost to Follow-up|1
6839951|NCT00267969|10845618|FG003|Controlled Period|Lost to Follow-up|0
6839952|NCT00267969|10845619|FG004|Controlled Period|Lost to Follow-up|0
6839953|NCT00267969|10845620|FG005|Controlled Period|Lost to Follow-up|0
6839954|NCT00267969|10845621|FG006|Controlled Period|Lost to Follow-up|0
6839955|NCT00267969|10845615|FG000|Controlled Period|Randomized but not treated|0
6839956|NCT00267969|10845616|FG001|Controlled Period|Randomized but not treated|0
6839957|NCT00267969|10845617|FG002|Controlled Period|Randomized but not treated|1
6839958|NCT00267969|10845618|FG003|Controlled Period|Randomized but not treated|0
6839959|NCT00267969|10845619|FG004|Controlled Period|Randomized but not treated|0
6839960|NCT00267969|10845620|FG005|Controlled Period|Randomized but not treated|0
7076425|NCT02079636|11183014|FG007|Overall Study|Physician Decision|0
6897717|NCT00642460|10916793|FG004|Part III: Open-Label Up to Week 260|Other|2
7076426|NCT02079636|11183015|FG008|Overall Study|Physician Decision|0
7076427|NCT02079636|11183016|FG009|Overall Study|Physician Decision|1
7076428|NCT02079636|11183017|FG010|Overall Study|Physician Decision|1
7076429|NCT02079636|11183018|FG011|Overall Study|Physician Decision|0
7076430|NCT02079636|11183019|FG012|Overall Study|Physician Decision|0
7076431|NCT02079636|11183020|FG013|Overall Study|Physician Decision|0
7076432|NCT02079636|11183021|FG014|Overall Study|Physician Decision|1
7076433|NCT02079636|11183007|FG000|Overall Study|Lost to Follow-up|0
7076434|NCT02079636|11183008|FG001|Overall Study|Lost to Follow-up|0
7076435|NCT02079636|11183009|FG002|Overall Study|Lost to Follow-up|0
7076436|NCT02079636|11183010|FG003|Overall Study|Lost to Follow-up|0
7076437|NCT02079636|11183011|FG004|Overall Study|Lost to Follow-up|0
7076438|NCT02079636|11183012|FG005|Overall Study|Lost to Follow-up|0
7076439|NCT02079636|11183013|FG006|Overall Study|Lost to Follow-up|0
6897718|NCT00642460|10916794|FG005|Part III: Open-Label Up to Week 260|Other|2
7076440|NCT02079636|11183014|FG007|Overall Study|Lost to Follow-up|1
7076441|NCT02079636|11183015|FG008|Overall Study|Lost to Follow-up|0
7076442|NCT02079636|11183016|FG009|Overall Study|Lost to Follow-up|0
7076443|NCT02079636|11183017|FG010|Overall Study|Lost to Follow-up|0
7076444|NCT02079636|11183018|FG011|Overall Study|Lost to Follow-up|0
7076445|NCT02079636|11183019|FG012|Overall Study|Lost to Follow-up|0
7076446|NCT02079636|11183020|FG013|Overall Study|Lost to Follow-up|0
7076447|NCT02079636|11183021|FG014|Overall Study|Lost to Follow-up|0
7076448|NCT02079649|11183089|FG000|Overall Study|Lost to Follow-up|0
7076449|NCT02079649|11183090|FG001|Overall Study|Lost to Follow-up|0
7076450|NCT02079649|11183091|FG002|Overall Study|Lost to Follow-up|0
7076451|NCT02079649|11183092|FG003|Overall Study|Lost to Follow-up|1
7076452|NCT02079649|11183089|FG000|Overall Study|Withdrawal by Subject|0
7076453|NCT02079649|11183090|FG001|Overall Study|Withdrawal by Subject|0
7076454|NCT02079649|11183091|FG002|Overall Study|Withdrawal by Subject|0
7076455|NCT02079649|11183092|FG003|Overall Study|Withdrawal by Subject|1
7076456|NCT02079649|11183089|FG000|Overall Study|Randomization error (prior to treatment)|1
7076457|NCT02079649|11183090|FG001|Overall Study|Randomization error (prior to treatment)|0
7076458|NCT02079649|11183091|FG002|Overall Study|Randomization error (prior to treatment)|1
7076459|NCT02079649|11183092|FG003|Overall Study|Randomization error (prior to treatment)|0
7076460|NCT02079805|11183105|FG000|Overall Study|Pretreatment Event/Adverse Event|0
7076461|NCT02079805|11183106|FG001|Overall Study|Pretreatment Event/Adverse Event|1
7076462|NCT02079805|11183105|FG000|Overall Study|Voluntary Withdrawal|0
7076463|NCT02079805|11183106|FG001|Overall Study|Voluntary Withdrawal|1
7076464|NCT02079844|11183115|FG000|Treatment Period 1|Voluntary Withdrawal|0
7076465|NCT02079844|11183116|FG001|Treatment Period 1|Voluntary Withdrawal|0
7076466|NCT02079844|11183117|FG002|Treatment Period 1|Voluntary Withdrawal|2
7076467|NCT02079844|11183115|FG000|Treatment Period 2|Voluntary Withdrawal|0
7076468|NCT02079844|11183116|FG001|Treatment Period 2|Voluntary Withdrawal|1
7076469|NCT02079844|11183117|FG002|Treatment Period 2|Voluntary Withdrawal|0
7076470|NCT02079909|11183131|FG000|Overall Study|Adverse Event|23
7076471|NCT02079909|11183132|FG001|Overall Study|Adverse Event|23
7076472|NCT02079909|11183133|FG002|Overall Study|Adverse Event|7
7076473|NCT02079909|11183131|FG000|Overall Study|Withdrawal by Subject|9
6839961|NCT00267969|10845621|FG006|Controlled Period|Randomized but not treated|0
6839962|NCT00267969|10845615|FG000|Controlled Period|Other|2
6839963|NCT00267969|10845616|FG001|Controlled Period|Other|1
6839964|NCT00267969|10845617|FG002|Controlled Period|Other|6
6839965|NCT00267969|10845618|FG003|Controlled Period|Other|0
6839966|NCT00267969|10845619|FG004|Controlled Period|Other|0
6839967|NCT00267969|10845620|FG005|Controlled Period|Other|0
6839968|NCT00267969|10845621|FG006|Controlled Period|Other|0
6839969|NCT00267969|10845615|FG000|After Controlled Period|Adverse Event|0
6839970|NCT00267969|10845616|FG001|After Controlled Period|Adverse Event|0
6839971|NCT00267969|10845617|FG002|After Controlled Period|Adverse Event|0
6839972|NCT00267969|10845618|FG003|After Controlled Period|Adverse Event|7
6839973|NCT00267969|10845619|FG004|After Controlled Period|Adverse Event|8
6839974|NCT00267969|10845620|FG005|After Controlled Period|Adverse Event|23
6839975|NCT00267969|10845621|FG006|After Controlled Period|Adverse Event|21
6839976|NCT00267969|10845615|FG000|After Controlled Period|Death|0
6839977|NCT00267969|10845616|FG001|After Controlled Period|Death|0
6839978|NCT00267969|10845617|FG002|After Controlled Period|Death|0
6839979|NCT00267969|10845618|FG003|After Controlled Period|Death|1
6839980|NCT00267969|10845619|FG004|After Controlled Period|Death|2
6839981|NCT00267969|10845620|FG005|After Controlled Period|Death|0
6839982|NCT00267969|10845621|FG006|After Controlled Period|Death|1
6839983|NCT00267969|10845615|FG000|After Controlled Period|Lack of Efficacy|0
6839984|NCT00267969|10845616|FG001|After Controlled Period|Lack of Efficacy|0
6839985|NCT00267969|10845617|FG002|After Controlled Period|Lack of Efficacy|0
6839986|NCT00267969|10845618|FG003|After Controlled Period|Lack of Efficacy|10
6839987|NCT00267969|10845619|FG004|After Controlled Period|Lack of Efficacy|6
6839988|NCT00267969|10845620|FG005|After Controlled Period|Lack of Efficacy|28
6839989|NCT00267969|10845621|FG006|After Controlled Period|Lack of Efficacy|15
6839990|NCT00267969|10845615|FG000|After Controlled Period|Lost to Follow-up|0
6839991|NCT00267969|10845616|FG001|After Controlled Period|Lost to Follow-up|0
6839992|NCT00267969|10845617|FG002|After Controlled Period|Lost to Follow-up|0
6839993|NCT00267969|10845618|FG003|After Controlled Period|Lost to Follow-up|5
6839994|NCT00267969|10845619|FG004|After Controlled Period|Lost to Follow-up|8
6839995|NCT00267969|10845620|FG005|After Controlled Period|Lost to Follow-up|9
6839996|NCT00267969|10845621|FG006|After Controlled Period|Lost to Follow-up|10
6839997|NCT00267969|10845615|FG000|After Controlled Period|Other|0
6839998|NCT00267969|10845616|FG001|After Controlled Period|Other|0
7076474|NCT02079909|11183132|FG001|Overall Study|Withdrawal by Subject|17
7076475|NCT02079909|11183133|FG002|Overall Study|Withdrawal by Subject|4
7076476|NCT02079909|11183131|FG000|Overall Study|Lost to Follow-up|2
7076477|NCT02079909|11183132|FG001|Overall Study|Lost to Follow-up|3
7076478|NCT02079909|11183133|FG002|Overall Study|Lost to Follow-up|1
7076479|NCT02079909|11183131|FG000|Overall Study|Death|2
7076480|NCT02079909|11183132|FG001|Overall Study|Death|2
6839999|NCT00267969|10845617|FG002|After Controlled Period|Other|0
6840000|NCT00267969|10845618|FG003|After Controlled Period|Other|13
6840001|NCT00267969|10845619|FG004|After Controlled Period|Other|11
6840002|NCT00267969|10845620|FG005|After Controlled Period|Other|22
6840003|NCT00267969|10845621|FG006|After Controlled Period|Other|25
7076481|NCT02079909|11183133|FG002|Overall Study|Death|0
7076482|NCT02079909|11183131|FG000|Overall Study|Lack of Efficacy|0
7076483|NCT02079909|11183132|FG001|Overall Study|Lack of Efficacy|0
7076484|NCT02079909|11183133|FG002|Overall Study|Lack of Efficacy|1
7076485|NCT02079909|11183131|FG000|Overall Study|Protocol Violation|0
7076486|NCT02079909|11183132|FG001|Overall Study|Protocol Violation|1
7076487|NCT02079909|11183133|FG002|Overall Study|Protocol Violation|1
7076488|NCT02079909|11183131|FG000|Overall Study|Physician Decision|0
7076489|NCT02079909|11183132|FG001|Overall Study|Physician Decision|1
7076490|NCT02079909|11183133|FG002|Overall Study|Physician Decision|1
7076491|NCT02079909|11183131|FG000|Overall Study|Relocation etc.|2
7076492|NCT02079909|11183132|FG001|Overall Study|Relocation etc.|2
7076493|NCT02079909|11183133|FG002|Overall Study|Relocation etc.|3
7076494|NCT02080091|11183151|FG000|Overall Study|Study Terminated|22
7076495|NCT02080091|11183151|FG000|Overall Study|Death|1
7076496|NCT02080091|11183151|FG000|Overall Study|Withdrawal by Subject|1
7076497|NCT02080091|11183151|FG000|Overall Study|Other|1
7076498|NCT02080221|11183159|FG000|Overall Study|Withdrawal by Subject|1
7076499|NCT02080221|11183159|FG000|Overall Study|Clinical Progression of Disease|1
7076500|NCT02080364|11183185|FG000|Baseline Period|Protocol Violation|2
7076501|NCT02080364|11183186|FG001|Baseline Period|Protocol Violation|1
7076502|NCT02080364|11183187|FG002|Baseline Period|Protocol Violation|0
7076503|NCT02080364|11183188|FG003|Baseline Period|Protocol Violation|0
7076504|NCT02080364|11183185|FG000|Baseline Period|Other|0
7076505|NCT02080364|11183186|FG001|Baseline Period|Other|1
7076506|NCT02080364|11183187|FG002|Baseline Period|Other|1
7076507|NCT02080364|11183188|FG003|Baseline Period|Other|0
7076508|NCT02080364|11183185|FG000|Treatment Period|Adverse Event|10
7076509|NCT02080364|11183186|FG001|Treatment Period|Adverse Event|15
7076510|NCT02080364|11183187|FG002|Treatment Period|Adverse Event|11
7076511|NCT02080364|11183188|FG003|Treatment Period|Adverse Event|14
7076512|NCT02080364|11183185|FG000|Treatment Period|Lost to Follow-up|2
7076513|NCT02080364|11183186|FG001|Treatment Period|Lost to Follow-up|3
7076514|NCT02080364|11183187|FG002|Treatment Period|Lost to Follow-up|5
7076515|NCT02080364|11183188|FG003|Treatment Period|Lost to Follow-up|0
7076516|NCT02080364|11183185|FG000|Treatment Period|Protocol Violation|5
7076517|NCT02080364|11183186|FG001|Treatment Period|Protocol Violation|3
7076518|NCT02080364|11183187|FG002|Treatment Period|Protocol Violation|5
7076519|NCT02080364|11183188|FG003|Treatment Period|Protocol Violation|1
7076520|NCT02080364|11183185|FG000|Treatment Period|Withdrawal by Subject|16
7076521|NCT02080364|11183186|FG001|Treatment Period|Withdrawal by Subject|16
7076522|NCT02080364|11183187|FG002|Treatment Period|Withdrawal by Subject|15
7076523|NCT02080364|11183188|FG003|Treatment Period|Withdrawal by Subject|10
7076524|NCT02080364|11183185|FG000|Treatment Period|Study Terminated by Sponsor|0
7076525|NCT02080364|11183186|FG001|Treatment Period|Study Terminated by Sponsor|0
7076526|NCT02080364|11183187|FG002|Treatment Period|Study Terminated by Sponsor|180
7076527|NCT02080364|11183188|FG003|Treatment Period|Study Terminated by Sponsor|183
7076528|NCT02080364|11183185|FG000|Treatment Period|Other|14
7076529|NCT02080364|11183186|FG001|Treatment Period|Other|12
7076530|NCT02080364|11183187|FG002|Treatment Period|Other|21
7076531|NCT02080364|11183188|FG003|Treatment Period|Other|16
6840004|NCT00268203|10845639|FG000|Overall Study|Lost to Follow-up|92
6840005|NCT00268203|10845639|FG000|Overall Study|Withdrawal by Subject|9
6840006|NCT00268203|10845639|FG000|Overall Study|Received Other NHL Therapy|7
6840007|NCT00268203|10845639|FG000|Overall Study|Progressive Disease|359
6840008|NCT00268203|10845639|FG000|Overall Study|Death|84
6840009|NCT00268203|10845639|FG000|Overall Study|Reason Not Specified|34
6840010|NCT00268203|10845639|FG000|Overall Study|Completed 2 Years of Follow-up|62
6840011|NCT00268242|10845643|FG000|Overall Study|Death|1
6840012|NCT00268346|10845649|FG000|Overall Study|Adverse Event|0
6840013|NCT00268346|10845650|FG001|Overall Study|Adverse Event|1
6840014|NCT00268346|10845649|FG000|Overall Study|Death|0
6840015|NCT00268346|10845650|FG001|Overall Study|Death|1
6840016|NCT00268346|10845649|FG000|Overall Study|Withdrawal by Subject|0
6840017|NCT00268346|10845650|FG001|Overall Study|Withdrawal by Subject|1
6840018|NCT00268437|10845656|FG000|Overall Study|Ineligible|1
7076532|NCT02080403|11183200|FG000|Overall Study|Adverse Event|5
7076533|NCT02080403|11183201|FG001|Overall Study|Adverse Event|1
7076534|NCT02080403|11183200|FG000|Overall Study|Death|0
7076535|NCT02080403|11183201|FG001|Overall Study|Death|2
7076536|NCT02080403|11183200|FG000|Overall Study|Lost to Follow-up|2
7076537|NCT02080403|11183201|FG001|Overall Study|Lost to Follow-up|0
6840019|NCT00268892|10845668|FG000|Overall Study|Adverse Event|14
6840020|NCT00268892|10845669|FG001|Overall Study|Adverse Event|17
7076538|NCT02080403|11183200|FG000|Overall Study|Pregnancy|0
6840021|NCT00268892|10845670|FG002|Overall Study|Adverse Event|20
6840022|NCT00268892|10845668|FG000|Overall Study|Lack of Efficacy|1
6840023|NCT00268892|10845669|FG001|Overall Study|Lack of Efficacy|3
7076539|NCT02080403|11183201|FG001|Overall Study|Pregnancy|1
7076540|NCT02080403|11183200|FG000|Overall Study|Protocol Violation|3
7076541|NCT02080403|11183201|FG001|Overall Study|Protocol Violation|7
7076542|NCT02080403|11183200|FG000|Overall Study|Withdrawal by Subject|5
7076543|NCT02080403|11183201|FG001|Overall Study|Withdrawal by Subject|1
7076544|NCT02080481|11183242|FG000|Overall Study|Never received a block.|1
7076545|NCT02080481|11183243|FG001|Overall Study|Never received a block.|0
7076546|NCT02080832|11183299|FG000|Overall Study|Excluded from analysis by MRI|9
7076547|NCT02080832|11183300|FG001|Overall Study|Excluded from analysis by MRI|10
7076548|NCT02080832|11183301|FG002|Overall Study|Excluded from analysis by MRI|14
7076549|NCT02080832|11183299|FG000|Overall Study|Lost to Follow-up|0
7076550|NCT02080832|11183300|FG001|Overall Study|Lost to Follow-up|2
7076551|NCT02080832|11183301|FG002|Overall Study|Lost to Follow-up|2
7076552|NCT02080871|11183311|FG000|Overall Study|Death|1
7076553|NCT02080871|11183311|FG000|Overall Study|Lost to Follow-up|1
7076554|NCT02081001|11183317|FG000|Overall Study|Adverse Event|0
7076555|NCT02081001|11183318|FG001|Overall Study|Adverse Event|0
7076556|NCT02081001|11183319|FG002|Overall Study|Adverse Event|0
7076557|NCT02081001|11183320|FG003|Overall Study|Adverse Event|0
7076558|NCT02081001|11183321|FG004|Overall Study|Adverse Event|1
7076559|NCT02081001|11183322|FG005|Overall Study|Adverse Event|0
7076560|NCT02081001|11183323|FG006|Overall Study|Adverse Event|0
7076561|NCT02081001|11183324|FG007|Overall Study|Adverse Event|0
7076562|NCT02081001|11183325|FG008|Overall Study|Adverse Event|0
7076563|NCT02081001|11183326|FG009|Overall Study|Adverse Event|0
7076564|NCT02081001|11183327|FG010|Overall Study|Adverse Event|0
7076565|NCT02081001|11183328|FG011|Overall Study|Adverse Event|0
7076566|NCT02081079|11183365|FG000|Overall Study|Lack of Efficacy|3
7076567|NCT02081079|11183366|FG001|Overall Study|Lack of Efficacy|2
7076568|NCT02081079|11183365|FG000|Overall Study|Lost to Follow-up|1
7076569|NCT02081079|11183366|FG001|Overall Study|Lost to Follow-up|0
7076570|NCT02081196|11183376|FG000|Overall Study|Lost to Follow-up|1
7076571|NCT02081417|11183402|FG000|Overall Study|Lost to Follow-up|26
7076572|NCT02081417|11183403|FG001|Overall Study|Lost to Follow-up|23
6840024|NCT00268892|10845670|FG002|Overall Study|Lack of Efficacy|0
6840025|NCT00268892|10845668|FG000|Overall Study|Withdrawal by Subject|14
6840026|NCT00268892|10845669|FG001|Overall Study|Withdrawal by Subject|15
6840027|NCT00268892|10845670|FG002|Overall Study|Withdrawal by Subject|13
6840028|NCT00268892|10845668|FG000|Overall Study|Physician Decision|0
6840029|NCT00268892|10845669|FG001|Overall Study|Physician Decision|1
6840030|NCT00268892|10845670|FG002|Overall Study|Physician Decision|0
6840031|NCT00268892|10845668|FG000|Overall Study|Lost to Follow-up|5
6840032|NCT00268892|10845669|FG001|Overall Study|Lost to Follow-up|2
6840033|NCT00268892|10845670|FG002|Overall Study|Lost to Follow-up|4
6840034|NCT00268892|10845668|FG000|Overall Study|Protocol Violation|0
6840035|NCT00268892|10845669|FG001|Overall Study|Protocol Violation|1
6840036|NCT00268892|10845670|FG002|Overall Study|Protocol Violation|0
6840037|NCT00268892|10845668|FG000|Overall Study|Disease Progression|1
6840038|NCT00268892|10845669|FG001|Overall Study|Disease Progression|1
6840039|NCT00268892|10845670|FG002|Overall Study|Disease Progression|0
6840040|NCT00268892|10845668|FG000|Overall Study|Trial Site Closed|4
6840041|NCT00268892|10845669|FG001|Overall Study|Trial Site Closed|2
6840042|NCT00268892|10845670|FG002|Overall Study|Trial Site Closed|2
6840043|NCT00268905|10845681|FG000|Overall Study|Adverse Event|3
6840044|NCT00268905|10845682|FG001|Overall Study|Adverse Event|0
6840045|NCT00268905|10845683|FG002|Overall Study|Adverse Event|4
6840046|NCT00268905|10845681|FG000|Overall Study|Lost to Follow-up|0
6840047|NCT00268905|10845682|FG001|Overall Study|Lost to Follow-up|1
6840048|NCT00268905|10845683|FG002|Overall Study|Lost to Follow-up|0
6840049|NCT00268905|10845681|FG000|Overall Study|Withdrawal by Subject|0
6840050|NCT00268905|10845682|FG001|Overall Study|Withdrawal by Subject|0
6840051|NCT00268905|10845683|FG002|Overall Study|Withdrawal by Subject|3
6840052|NCT00268905|10845681|FG000|Overall Study|Progressive Disease|28
6840053|NCT00268905|10845682|FG001|Overall Study|Progressive Disease|4
6840054|NCT00268905|10845683|FG002|Overall Study|Progressive Disease|3
6840055|NCT00268905|10845681|FG000|Overall Study|Physician Decision|3
6840056|NCT00268905|10845682|FG001|Overall Study|Physician Decision|0
6840057|NCT00268905|10845683|FG002|Overall Study|Physician Decision|1
6840058|NCT00268905|10845681|FG000|Overall Study|Clinical Progression|9
6840059|NCT00268905|10845682|FG001|Overall Study|Clinical Progression|4
6966428|NCT04516746|11014412|FG001|Overall Study|Withdrawal by Subject|408
7076573|NCT02081417|11183402|FG000|Overall Study|Moved Away|1
7076574|NCT02081417|11183403|FG001|Overall Study|Moved Away|2
7076575|NCT02081417|11183402|FG000|Overall Study|Incarcerated|2
6840060|NCT00268905|10845683|FG002|Overall Study|Clinical Progression|1
6840061|NCT00268983|10845693|FG000|Overall Study|Death|3
6840062|NCT00268983|10845694|FG001|Overall Study|Death|0
6840063|NCT00268996|10845702|FG000|Overall Study|Adverse Event|11
7076576|NCT02081417|11183403|FG001|Overall Study|Incarcerated|2
7076577|NCT02081417|11183402|FG000|Overall Study|Death|4
7076578|NCT02081417|11183403|FG001|Overall Study|Death|3
7148006|NCT03137459|11308818|FG000|4-month Assessment|Death|4
6840064|NCT00268996|10845703|FG001|Overall Study|Adverse Event|7
6840065|NCT00268996|10845702|FG000|Overall Study|Lost to Follow-up|3
6840066|NCT00268996|10845703|FG001|Overall Study|Lost to Follow-up|1
6840067|NCT00268996|10845702|FG000|Overall Study|Withdrawal by Subject|5
6840068|NCT00268996|10845703|FG001|Overall Study|Withdrawal by Subject|11
6840069|NCT00268996|10845702|FG000|Overall Study|Non-compliance|1
6840070|NCT00268996|10845703|FG001|Overall Study|Non-compliance|0
7076579|NCT02081417|11183402|FG000|Overall Study|Withdrawal by Subject|4
7076580|NCT02081417|11183403|FG001|Overall Study|Withdrawal by Subject|0
7076581|NCT02081417|11183402|FG000|Overall Study|Admitted to Residential Treatment|2
7076582|NCT02081417|11183403|FG001|Overall Study|Admitted to Residential Treatment|0
7076583|NCT02081417|11183402|FG000|Overall Study|Did not start treatment|17
7076584|NCT02081417|11183403|FG001|Overall Study|Did not start treatment|21
7076585|NCT02081534|11183434|FG000|Overall Study|Adverse Event|5
7076586|NCT02081534|11183435|FG001|Overall Study|Adverse Event|4
7076587|NCT02081534|11183436|FG002|Overall Study|Adverse Event|3
7076588|NCT02081534|11183437|FG003|Overall Study|Adverse Event|10
7076589|NCT02081534|11183438|FG004|Overall Study|Adverse Event|2
7076590|NCT02081534|11183439|FG005|Overall Study|Adverse Event|8
7076591|NCT02081534|11183440|FG006|Overall Study|Adverse Event|2
7076592|NCT02081534|11183434|FG000|Overall Study|Withdrawal by Subject|0
7076593|NCT02081534|11183435|FG001|Overall Study|Withdrawal by Subject|1
7076594|NCT02081534|11183436|FG002|Overall Study|Withdrawal by Subject|1
7076595|NCT02081534|11183437|FG003|Overall Study|Withdrawal by Subject|1
7076596|NCT02081534|11183438|FG004|Overall Study|Withdrawal by Subject|1
7076597|NCT02081534|11183439|FG005|Overall Study|Withdrawal by Subject|0
7076598|NCT02081534|11183440|FG006|Overall Study|Withdrawal by Subject|1
7076599|NCT02081534|11183434|FG000|Overall Study|Protocol Violation|0
7076600|NCT02081534|11183435|FG001|Overall Study|Protocol Violation|3
7076601|NCT02081534|11183436|FG002|Overall Study|Protocol Violation|0
7076602|NCT02081534|11183437|FG003|Overall Study|Protocol Violation|0
7076603|NCT02081534|11183438|FG004|Overall Study|Protocol Violation|0
7076604|NCT02081534|11183439|FG005|Overall Study|Protocol Violation|0
7076605|NCT02081534|11183440|FG006|Overall Study|Protocol Violation|1
7076606|NCT02081534|11183434|FG000|Overall Study|Lost to Follow-up|0
7076607|NCT02081534|11183435|FG001|Overall Study|Lost to Follow-up|0
7076608|NCT02081534|11183436|FG002|Overall Study|Lost to Follow-up|0
7076609|NCT02081534|11183437|FG003|Overall Study|Lost to Follow-up|2
7076610|NCT02081534|11183438|FG004|Overall Study|Lost to Follow-up|1
7076611|NCT02081534|11183439|FG005|Overall Study|Lost to Follow-up|1
7076612|NCT02081534|11183440|FG006|Overall Study|Lost to Follow-up|0
7076613|NCT02081586|11183464|FG000|Overall Study|Lost to Follow-up|0
7076614|NCT02081586|11183465|FG001|Overall Study|Lost to Follow-up|1
7076615|NCT02081586|11183466|FG002|Overall Study|Lost to Follow-up|0
7076616|NCT02081586|11183467|FG003|Overall Study|Lost to Follow-up|1
7076617|NCT02081586|11183464|FG000|Overall Study|Head injury not related to study|0
7076618|NCT02081586|11183465|FG001|Overall Study|Head injury not related to study|0
7076619|NCT02081586|11183466|FG002|Overall Study|Head injury not related to study|1
7076620|NCT02081586|11183467|FG003|Overall Study|Head injury not related to study|0
7076621|NCT02081599|11183481|FG000|Period 1：Double-blind Period|Adverse Event|3
7076622|NCT02081599|11183482|FG001|Period 1：Double-blind Period|Adverse Event|0
7076623|NCT02081599|11183481|FG000|Period 1：Double-blind Period|Lack of Efficacy|2
7076624|NCT02081599|11183482|FG001|Period 1：Double-blind Period|Lack of Efficacy|1
7076625|NCT02081599|11183481|FG000|Period 1：Double-blind Period|Physician Decision|1
7076626|NCT02081599|11183482|FG001|Period 1：Double-blind Period|Physician Decision|0
7076627|NCT02081599|11183481|FG000|Period 1：Double-blind Period|Protocol Violation|0
7076628|NCT02081599|11183482|FG001|Period 1：Double-blind Period|Protocol Violation|1
7076629|NCT02081599|11183481|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1
7076630|NCT02081599|11183482|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0
7076631|NCT02081599|11183481|FG000|Period 1：Double-blind Period|stopping criteria|1
7076632|NCT02081599|11183482|FG001|Period 1：Double-blind Period|stopping criteria|0
7076633|NCT02081599|11183481|FG000|Period 2：Open-label Period|Adverse Event|1
7076634|NCT02081599|11183482|FG001|Period 2：Open-label Period|Adverse Event|0
7076635|NCT02081599|11183481|FG000|Period 2：Open-label Period|Lack of Efficacy|2
7076636|NCT02081599|11183482|FG001|Period 2：Open-label Period|Lack of Efficacy|4
7076637|NCT02081599|11183481|FG000|Period 2：Open-label Period|Physician Decision|1
7076638|NCT02081599|11183482|FG001|Period 2：Open-label Period|Physician Decision|0
7076639|NCT02081599|11183481|FG000|Period 2：Open-label Period|Withdrawal by Subject|2
7076640|NCT02081599|11183482|FG001|Period 2：Open-label Period|Withdrawal by Subject|0
7076641|NCT02081677|11183507|FG000|Overall Study|Adverse Event|0
7076642|NCT02081677|11183508|FG001|Overall Study|Adverse Event|0
7076643|NCT02081677|11183509|FG002|Overall Study|Adverse Event|1
7076644|NCT02081677|11183510|FG003|Overall Study|Adverse Event|0
7076645|NCT02081677|11183507|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
7076646|NCT02081677|11183508|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
7076647|NCT02081677|11183509|FG002|Overall Study|No Longer Meets Eligibility Criteria|1
7076648|NCT02081677|11183510|FG003|Overall Study|No Longer Meets Eligibility Criteria|0
7076649|NCT02081677|11183507|FG000|Overall Study|Not comfortable with lens care system|1
7076650|NCT02081677|11183508|FG001|Overall Study|Not comfortable with lens care system|0
7076651|NCT02081677|11183509|FG002|Overall Study|Not comfortable with lens care system|0
7076652|NCT02081677|11183510|FG003|Overall Study|Not comfortable with lens care system|0
7076653|NCT02081677|11183507|FG000|Overall Study|Unsatisfactory Lens Fitting|0
7076654|NCT02081677|11183508|FG001|Overall Study|Unsatisfactory Lens Fitting|1
7076655|NCT02081677|11183509|FG002|Overall Study|Unsatisfactory Lens Fitting|0
7076656|NCT02081677|11183510|FG003|Overall Study|Unsatisfactory Lens Fitting|0
7076657|NCT02081690|11183520|FG000|Overall Study|Death|3
7076658|NCT02081690|11183520|FG000|Overall Study|Physician Decision|3
7076659|NCT02081690|11183520|FG000|Overall Study|Withdrawal by Subject|1
7076660|NCT02081846|11183569|FG000|Overall Study|Withdrawal by Subject|1
7076661|NCT02081846|11183570|FG001|Overall Study|Withdrawal by Subject|0
7076662|NCT02081846|11183569|FG000|Overall Study|invalid consent|1
7076663|NCT02081846|11183570|FG001|Overall Study|invalid consent|0
7076664|NCT02081859|11183578|FG000|Overall Study|No fertilization|2
7076665|NCT02081859|11183579|FG001|Overall Study|No fertilization|2
7076666|NCT02081859|11183578|FG000|Overall Study|No sperm|1
7076667|NCT02081859|11183579|FG001|Overall Study|No sperm|0
7076668|NCT02081859|11183578|FG000|Overall Study|Unanticipated freeze all cycle|2
7076669|NCT02081859|11183579|FG001|Overall Study|Unanticipated freeze all cycle|6
7076670|NCT02081859|11183578|FG000|Overall Study|< 4 embryos|27
7076671|NCT02081859|11183579|FG001|Overall Study|< 4 embryos|23
7076672|NCT02081859|11183578|FG000|Overall Study|Other reasons|2
7076673|NCT02081859|11183579|FG001|Overall Study|Other reasons|0
7076674|NCT02082158|11183621|FG000|Overall Study|Withdrawal by Subject|0
7076675|NCT02082158|11183622|FG001|Overall Study|Withdrawal by Subject|0
7076676|NCT02082158|11183623|FG002|Overall Study|Withdrawal by Subject|0
7076677|NCT02082158|11183624|FG003|Overall Study|Withdrawal by Subject|0
7076678|NCT02082158|11183625|FG004|Overall Study|Withdrawal by Subject|1
7148007|NCT03137459|11308819|FG001|4-month Assessment|Death|2
7148008|NCT03137459|11308818|FG000|4-month Assessment|Withdrawal by Subject|4
7148009|NCT03137459|11308819|FG001|4-month Assessment|Withdrawal by Subject|2
7148010|NCT03137459|11308818|FG000|4-month Assessment|Unable to reach|44
7148011|NCT03137459|11308819|FG001|4-month Assessment|Unable to reach|29
6840071|NCT00268996|10845702|FG000|Overall Study|Other|1
6840072|NCT00268996|10845703|FG001|Overall Study|Other|1
6840073|NCT00269087|10845711|FG000|Overall Study|Adverse Event|20
6840074|NCT00269087|10845711|FG000|Overall Study|Withdrawal by Subject|1
6840075|NCT00269087|10845711|FG000|Overall Study|Exacerbation of COPD|13
6840076|NCT00269113|10845717|FG000|Overall Study|Adverse Event|14
6840077|NCT00269113|10845718|FG001|Overall Study|Adverse Event|7
6840078|NCT00269113|10845717|FG000|Overall Study|Lack of Efficacy|35
6840079|NCT00269113|10845718|FG001|Overall Study|Lack of Efficacy|18
6840080|NCT00269113|10845717|FG000|Overall Study|Early Improvement|2
6840081|NCT00269113|10845718|FG001|Overall Study|Early Improvement|0
6840082|NCT00269113|10845717|FG000|Overall Study|Withdrawal by Subject|0
6840083|NCT00269113|10845718|FG001|Overall Study|Withdrawal by Subject|2
6840084|NCT00269113|10845717|FG000|Overall Study|Death|6
6840085|NCT00269113|10845718|FG001|Overall Study|Death|2
6840086|NCT00269113|10845717|FG000|Overall Study|Lost to Follow-up|2
6840087|NCT00269113|10845718|FG001|Overall Study|Lost to Follow-up|1
6840088|NCT00269113|10845717|FG000|Overall Study|Protocol Violation|15
6840089|NCT00269113|10845718|FG001|Overall Study|Protocol Violation|5
6840090|NCT00269113|10845717|FG000|Overall Study|Other|0
6840091|NCT00269113|10845718|FG001|Overall Study|Other|2
6840092|NCT00269152|10845726|FG000|Overall Study|Adverse Event|9
6840093|NCT00269152|10845727|FG001|Overall Study|Adverse Event|3
6840094|NCT00269152|10845726|FG000|Overall Study|Withdrawal by Subject|7
6840095|NCT00269152|10845727|FG001|Overall Study|Withdrawal by Subject|3
6840096|NCT00269152|10845726|FG000|Overall Study|Physician Decision|2
6840097|NCT00269152|10845727|FG001|Overall Study|Physician Decision|3
6840098|NCT00269152|10845726|FG000|Overall Study|Protocol Violation|0
6840099|NCT00269152|10845727|FG001|Overall Study|Protocol Violation|1
6840100|NCT00269399|10845735|FG000|Overall Study|Lack of Efficacy|27
6840101|NCT00269399|10845736|FG001|Overall Study|Lack of Efficacy|10
6840102|NCT00269399|10845735|FG000|Overall Study|Adverse Event|10
6840103|NCT00269399|10845736|FG001|Overall Study|Adverse Event|4
6840104|NCT00269399|10845735|FG000|Overall Study|Withdrawal by Subject|2
6840105|NCT00269399|10845736|FG001|Overall Study|Withdrawal by Subject|5
6840106|NCT00269399|10845735|FG000|Overall Study|Negative Lab Result for C. difficile|2
6840107|NCT00269399|10845736|FG001|Overall Study|Negative Lab Result for C. difficile|3
6840108|NCT00269399|10845735|FG000|Overall Study|Other|0
6840109|NCT00269399|10845736|FG001|Overall Study|Other|4
6840110|NCT00269399|10845735|FG000|Overall Study|Development of exclusion criteria|0
6840111|NCT00269399|10845736|FG001|Overall Study|Development of exclusion criteria|1
6840112|NCT00269477|10845746|FG000|Overall Study|Protocol Violation|5
6840113|NCT00269477|10845747|FG001|Overall Study|Protocol Violation|5
6840114|NCT00269477|10845748|FG002|Overall Study|Protocol Violation|1
6840115|NCT00269477|10845749|FG003|Overall Study|Protocol Violation|0
6840116|NCT00269477|10845746|FG000|Overall Study|Missed post-vaccination blood draw|0
6840117|NCT00269477|10845747|FG001|Overall Study|Missed post-vaccination blood draw|1
6840118|NCT00269477|10845748|FG002|Overall Study|Missed post-vaccination blood draw|0
6840119|NCT00269477|10845749|FG003|Overall Study|Missed post-vaccination blood draw|0
6840120|NCT00269633|10845761|FG000|Overall Study|Withdrawal by Subject|1
6840121|NCT00269633|10845762|FG001|Overall Study|Withdrawal by Subject|0
6840122|NCT00269919|10845768|FG000|Overall Study|Other|26
7148012|NCT03137459|11308818|FG000|4-month Assessment|Refused assessment|24
7148013|NCT03137459|11308819|FG001|4-month Assessment|Refused assessment|10
7148014|NCT03137459|11308818|FG000|4-month Assessment|Acutely ill|2
7148015|NCT03137459|11308819|FG001|4-month Assessment|Acutely ill|3
7148016|NCT03137459|11308818|FG000|6-months|Lost to Follow-up|14
6840123|NCT00269919|10845768|FG000|Overall Study|Started but not treated|1
6840124|NCT00270205|10845777|FG000|Overall Study|Lost to Follow-up|1
7148017|NCT03137459|11308819|FG001|6-months|Lost to Follow-up|11
7148018|NCT03137459|11308818|FG000|6-months|Death|0
6840125|NCT00270205|10845778|FG001|Overall Study|Lost to Follow-up|0
6840126|NCT00270205|10845779|FG002|Overall Study|Lost to Follow-up|0
6840127|NCT00270205|10845780|FG003|Overall Study|Lost to Follow-up|1
6840128|NCT00270231|10845790|FG000|First Intervention|Lost to Follow-up|1
6840129|NCT00270231|10845791|FG001|First Intervention|Lost to Follow-up|1
7076679|NCT02082158|11183626|FG005|Overall Study|Withdrawal by Subject|0
7076680|NCT02082158|11183621|FG000|Overall Study|Failed Fit-testing|8
7076681|NCT02082158|11183622|FG001|Overall Study|Failed Fit-testing|8
7076682|NCT02082158|11183623|FG002|Overall Study|Failed Fit-testing|14
7076683|NCT02082158|11183624|FG003|Overall Study|Failed Fit-testing|4
7076684|NCT02082158|11183625|FG004|Overall Study|Failed Fit-testing|3
7076685|NCT02082158|11183626|FG005|Overall Study|Failed Fit-testing|7
7076686|NCT02082184|11183648|FG000|Overall Study|Adverse Event|1
7076687|NCT02082184|11183649|FG001|Overall Study|Adverse Event|0
7076688|NCT02082184|11183648|FG000|Overall Study|Medical diagnosis|1
7076689|NCT02082184|11183649|FG001|Overall Study|Medical diagnosis|2
7076690|NCT02082184|11183648|FG000|Overall Study|Device associated symptoms|5
7076691|NCT02082184|11183649|FG001|Overall Study|Device associated symptoms|0
7076692|NCT02082184|11183648|FG000|Overall Study|Withdrawal by Subject|3
7076693|NCT02082184|11183649|FG001|Overall Study|Withdrawal by Subject|2
7076694|NCT02082184|11183648|FG000|Overall Study|Protocol Violation|0
7076695|NCT02082184|11183649|FG001|Overall Study|Protocol Violation|6
7076696|NCT02082184|11183648|FG000|Overall Study|Lost to Follow-up|0
7076697|NCT02082184|11183649|FG001|Overall Study|Lost to Follow-up|2
7076698|NCT02082184|11183648|FG000|Overall Study|Subject non-compliance|0
7076699|NCT02082184|11183649|FG001|Overall Study|Subject non-compliance|1
7076700|NCT02082210|11183661|FG000|Overall Study|Death|0
7076701|NCT02082210|11183662|FG001|Overall Study|Death|0
7076702|NCT02082210|11183663|FG002|Overall Study|Death|1
7076703|NCT02082210|11183664|FG003|Overall Study|Death|1
7076704|NCT02082210|11183665|FG004|Overall Study|Death|1
7076705|NCT02082210|11183666|FG005|Overall Study|Death|0
7076706|NCT02082210|11183661|FG000|Overall Study|Withdrawal by Subject|0
7076707|NCT02082210|11183662|FG001|Overall Study|Withdrawal by Subject|0
7076708|NCT02082210|11183663|FG002|Overall Study|Withdrawal by Subject|0
7076709|NCT02082210|11183664|FG003|Overall Study|Withdrawal by Subject|1
7076710|NCT02082210|11183665|FG004|Overall Study|Withdrawal by Subject|2
7076711|NCT02082210|11183666|FG005|Overall Study|Withdrawal by Subject|2
7076712|NCT02082210|11183661|FG000|Overall Study|Clinical Progression|0
6840130|NCT00270231|10845790|FG000|Washout Period|Lost to Follow-up|1
6840131|NCT00270231|10845791|FG001|Washout Period|Lost to Follow-up|0
6840132|NCT00270231|10845790|FG000|Second Intervention|Lost to Follow-up|0
6840133|NCT00270231|10845791|FG001|Second Intervention|Lost to Follow-up|1
6840134|NCT00270257|10845799|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412
6840135|NCT00270257|10845800|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424
6840136|NCT00270855|10845861|FG000|Overall Study|Withdrawal by Subject|8
6840137|NCT00270855|10845862|FG001|Overall Study|Withdrawal by Subject|8
6840138|NCT00270894|10845870|FG000|Overall Study|Adverse Event|1
7076713|NCT02082210|11183662|FG001|Overall Study|Clinical Progression|0
7076714|NCT02082210|11183663|FG002|Overall Study|Clinical Progression|0
7076715|NCT02082210|11183664|FG003|Overall Study|Clinical Progression|1
7076716|NCT02082210|11183665|FG004|Overall Study|Clinical Progression|0
7076717|NCT02082210|11183666|FG005|Overall Study|Clinical Progression|0
7076718|NCT02082210|11183661|FG000|Overall Study|No Post-Baseline Tumor Assesment|0
7076719|NCT02082210|11183662|FG001|Overall Study|No Post-Baseline Tumor Assesment|0
7076720|NCT02082210|11183663|FG002|Overall Study|No Post-Baseline Tumor Assesment|1
7076721|NCT02082210|11183664|FG003|Overall Study|No Post-Baseline Tumor Assesment|2
7076722|NCT02082210|11183665|FG004|Overall Study|No Post-Baseline Tumor Assesment|0
7076723|NCT02082210|11183666|FG005|Overall Study|No Post-Baseline Tumor Assesment|0
7076724|NCT02082210|11183661|FG000|Overall Study|Physician Decision|0
7076725|NCT02082210|11183662|FG001|Overall Study|Physician Decision|0
7076726|NCT02082210|11183663|FG002|Overall Study|Physician Decision|1
7076727|NCT02082210|11183664|FG003|Overall Study|Physician Decision|1
7076728|NCT02082210|11183665|FG004|Overall Study|Physician Decision|0
7076729|NCT02082210|11183666|FG005|Overall Study|Physician Decision|0
7076730|NCT02082262|11183692|FG000|Overall Study|Withdrawal by Subject|3
7076731|NCT02082262|11183692|FG000|Overall Study|Adverse Event|48
7076732|NCT02082340|11183702|FG000|Overall Study|Lost to Follow-up|1
7076733|NCT02082340|11183703|FG001|Overall Study|Lost to Follow-up|1
7076734|NCT02082483|11183720|FG000|Overall Study|Lost to Follow-up|1
7076735|NCT02082483|11183721|FG001|Overall Study|Lost to Follow-up|1
7076736|NCT02082483|11183720|FG000|Overall Study|Withdrawal by Subject|2
7076737|NCT02082483|11183721|FG001|Overall Study|Withdrawal by Subject|1
7076738|NCT02082483|11183720|FG000|Overall Study|Physician Decision|1
7076739|NCT02082483|11183721|FG001|Overall Study|Physician Decision|1
7076740|NCT02082483|11183720|FG000|Overall Study|Death|2
7076741|NCT02082483|11183721|FG001|Overall Study|Death|3
7076742|NCT02082522|11183730|FG000|Overall Study|Sponsor termination|5
7076743|NCT02082522|11183731|FG001|Overall Study|Sponsor termination|3
7076744|NCT02082522|11183730|FG000|Overall Study|Withdrawal by Subject|2
7076745|NCT02082522|11183731|FG001|Overall Study|Withdrawal by Subject|4
7076746|NCT02082522|11183730|FG000|Overall Study|Death|1
7076747|NCT02082522|11183731|FG001|Overall Study|Death|0
7076748|NCT02082522|11183730|FG000|Overall Study|Lost to Follow-up|1
7076749|NCT02082522|11183731|FG001|Overall Study|Lost to Follow-up|0
7076750|NCT02082522|11183730|FG000|Overall Study|Physician Decision|3
7076751|NCT02082522|11183731|FG001|Overall Study|Physician Decision|1
7076752|NCT02082522|11183730|FG000|Overall Study|Disease progression|2
7076753|NCT02082522|11183731|FG001|Overall Study|Disease progression|2
7076754|NCT02082522|11183730|FG000|Overall Study|Chemotherapy change|1
7076755|NCT02082522|11183731|FG001|Overall Study|Chemotherapy change|3
7076756|NCT02082912|11183774|FG000|Overall Study|Physician Decision|0
7076757|NCT02082912|11183775|FG001|Overall Study|Physician Decision|1
7076758|NCT02082977|11183791|FG000|Part 1 (Up to 3.2 Years)|Death|1
7076759|NCT02082977|11183792|FG001|Part 1 (Up to 3.2 Years)|Death|0
7076760|NCT02082977|11183793|FG002|Part 1 (Up to 3.2 Years)|Death|0
7076761|NCT02082977|11183794|FG003|Part 1 (Up to 3.2 Years)|Death|0
7076762|NCT02082977|11183795|FG004|Part 1 (Up to 3.2 Years)|Death|0
7076763|NCT02082977|11183796|FG005|Part 1 (Up to 3.2 Years)|Death|1
7076764|NCT02082977|11183797|FG006|Part 1 (Up to 3.2 Years)|Death|2
6840139|NCT00270894|10845870|FG000|Overall Study|Withdrawal by Subject|1
6840140|NCT00270998|10845877|FG000|3 Month Follow-up|Adverse Event|1
6840141|NCT00270998|10845878|FG001|3 Month Follow-up|Adverse Event|0
6840142|NCT00270998|10845879|FG002|3 Month Follow-up|Adverse Event|0
6840143|NCT00270998|10845877|FG000|3 Month Follow-up|Lack of Efficacy|1
6840144|NCT00270998|10845878|FG001|3 Month Follow-up|Lack of Efficacy|2
6840145|NCT00270998|10845879|FG002|3 Month Follow-up|Lack of Efficacy|1
6840146|NCT00270998|10845877|FG000|3 Month Follow-up|Withdrawal by Subject|11
6840147|NCT00270998|10845878|FG001|3 Month Follow-up|Withdrawal by Subject|14
6840148|NCT00270998|10845879|FG002|3 Month Follow-up|Withdrawal by Subject|15
6840149|NCT00270998|10845877|FG000|3 Month Follow-up|Pessary did not fit|12
6840150|NCT00270998|10845878|FG001|3 Month Follow-up|Pessary did not fit|0
6840151|NCT00270998|10845879|FG002|3 Month Follow-up|Pessary did not fit|0
6840152|NCT00270998|10845877|FG000|3 Month Follow-up|Personal/family health|1
6840153|NCT00270998|10845878|FG001|3 Month Follow-up|Personal/family health|1
6840154|NCT00270998|10845879|FG002|3 Month Follow-up|Personal/family health|0
6840155|NCT00270998|10845877|FG000|3 Month Follow-up|Received/desired alternate treatment|13
6840156|NCT00270998|10845878|FG001|3 Month Follow-up|Received/desired alternate treatment|5
6840157|NCT00270998|10845879|FG002|3 Month Follow-up|Received/desired alternate treatment|2
6840158|NCT00270998|10845877|FG000|12 Month Follow-up|Lack of Efficacy|5
6840159|NCT00270998|10845878|FG001|12 Month Follow-up|Lack of Efficacy|4
6840160|NCT00270998|10845879|FG002|12 Month Follow-up|Lack of Efficacy|3
6840161|NCT00270998|10845877|FG000|12 Month Follow-up|Withdrawal by Subject|7
6840162|NCT00270998|10845878|FG001|12 Month Follow-up|Withdrawal by Subject|12
6840163|NCT00270998|10845879|FG002|12 Month Follow-up|Withdrawal by Subject|16
6840164|NCT00270998|10845877|FG000|12 Month Follow-up|Pessary did not fit|1
7076765|NCT02082977|11183798|FG007|Part 1 (Up to 3.2 Years)|Death|0
7076766|NCT02082977|11183799|FG008|Part 1 (Up to 3.2 Years)|Death|1
7076767|NCT02082977|11183800|FG009|Part 1 (Up to 3.2 Years)|Death|0
7076768|NCT02082977|11183791|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
7076769|NCT02082977|11183792|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
7076770|NCT02082977|11183793|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
7076771|NCT02082977|11183794|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
7076772|NCT02082977|11183795|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
7076773|NCT02082977|11183796|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
7076774|NCT02082977|11183797|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
7076775|NCT02082977|11183798|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2
6840165|NCT00270998|10845878|FG001|12 Month Follow-up|Pessary did not fit|0
7076776|NCT02082977|11183799|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
7076777|NCT02082977|11183800|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
7076778|NCT02082977|11183791|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
7076779|NCT02082977|11183792|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
7076780|NCT02082977|11183793|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
7076781|NCT02082977|11183794|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
7076782|NCT02082977|11183795|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
7076783|NCT02082977|11183796|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1
7076784|NCT02082977|11183797|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
7076785|NCT02082977|11183798|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
7076786|NCT02082977|11183799|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
7076787|NCT02082977|11183800|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
7076788|NCT02082977|11183791|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0
7076789|NCT02082977|11183792|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0
7076790|NCT02082977|11183793|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0
7076791|NCT02082977|11183794|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0
7076792|NCT02082977|11183795|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1
7076793|NCT02082977|11183796|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1
7076794|NCT02082977|11183797|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4
7076795|NCT02082977|11183798|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1
7076796|NCT02082977|11183799|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2
7076797|NCT02082977|11183800|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0
7076798|NCT02082977|11183791|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
7076799|NCT02082977|11183792|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
7076800|NCT02082977|11183793|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
7076801|NCT02082977|11183794|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
7076802|NCT02082977|11183795|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
7076803|NCT02082977|11183796|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
6840166|NCT00270998|10845879|FG002|12 Month Follow-up|Pessary did not fit|0
6840167|NCT00270998|10845877|FG000|12 Month Follow-up|Personal/family health|0
7076804|NCT02082977|11183797|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
7076805|NCT02082977|11183798|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2
7076806|NCT02082977|11183799|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
7076807|NCT02082977|11183800|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
7076808|NCT02083185|11183848|FG000|Overall Study|Lost to Follow-up|0
7076809|NCT02083185|11183849|FG001|Overall Study|Lost to Follow-up|3
7076810|NCT02083185|11183850|FG002|Overall Study|Lost to Follow-up|0
7076811|NCT02083185|11183848|FG000|Overall Study|Withdrawal by Subject|9
7076812|NCT02083185|11183849|FG001|Overall Study|Withdrawal by Subject|15
7076813|NCT02083185|11183850|FG002|Overall Study|Withdrawal by Subject|1
7076814|NCT02083185|11183848|FG000|Overall Study|Death|2
7076815|NCT02083185|11183849|FG001|Overall Study|Death|2
7076816|NCT02083185|11183850|FG002|Overall Study|Death|1
7076817|NCT02083185|11183848|FG000|Overall Study|Reason not Specified|9
7076818|NCT02083185|11183849|FG001|Overall Study|Reason not Specified|6
7076819|NCT02083185|11183850|FG002|Overall Study|Reason not Specified|5
7076820|NCT02083185|11183848|FG000|Overall Study|Study Terminated by Sponsor|0
7076821|NCT02083185|11183849|FG001|Overall Study|Study Terminated by Sponsor|1
7076822|NCT02083185|11183850|FG002|Overall Study|Study Terminated by Sponsor|0
7076823|NCT02083185|11183848|FG000|Overall Study|Did not Receive Study Drug|0
7076824|NCT02083185|11183849|FG001|Overall Study|Did not Receive Study Drug|2
7076825|NCT02083185|11183850|FG002|Overall Study|Did not Receive Study Drug|0
7076826|NCT02083380|11183870|FG000|Overall Study|Lack of Efficacy|68
7076827|NCT02083380|11183871|FG001|Overall Study|Lack of Efficacy|79
7076828|NCT02083380|11183872|FG002|Overall Study|Lack of Efficacy|64
7076829|NCT02083380|11183870|FG000|Overall Study|Withdrawal by Subject|9
7076830|NCT02083380|11183871|FG001|Overall Study|Withdrawal by Subject|3
7076831|NCT02083380|11183872|FG002|Overall Study|Withdrawal by Subject|7
7076832|NCT02083380|11183870|FG000|Overall Study|Physician Decision|1
7076833|NCT02083380|11183871|FG001|Overall Study|Physician Decision|6
7076834|NCT02083380|11183872|FG002|Overall Study|Physician Decision|3
7076835|NCT02083380|11183870|FG000|Overall Study|Adverse Event|0
7076836|NCT02083380|11183871|FG001|Overall Study|Adverse Event|0
7076837|NCT02083380|11183872|FG002|Overall Study|Adverse Event|1
7076838|NCT02083380|11183870|FG000|Overall Study|Lost to Follow-up|5
7076839|NCT02083380|11183871|FG001|Overall Study|Lost to Follow-up|3
7076840|NCT02083380|11183872|FG002|Overall Study|Lost to Follow-up|3
7076841|NCT02083380|11183870|FG000|Overall Study|Other|8
7076842|NCT02083380|11183871|FG001|Overall Study|Other|4
7076843|NCT02083380|11183872|FG002|Overall Study|Other|6
7076844|NCT02083653|11183901|FG000|Overall Study|Randomized but not Treated|0
7076845|NCT02083653|11183902|FG001|Overall Study|Randomized but not Treated|2
7076846|NCT02083653|11183903|FG002|Overall Study|Randomized but not Treated|7
7076847|NCT02083653|11183901|FG000|Overall Study|Adverse Event|12
7076848|NCT02083653|11183902|FG001|Overall Study|Adverse Event|5
7076849|NCT02083653|11183903|FG002|Overall Study|Adverse Event|4
7076850|NCT02083653|11183901|FG000|Overall Study|Lost to Follow-up|1
7076851|NCT02083653|11183902|FG001|Overall Study|Lost to Follow-up|0
7076852|NCT02083653|11183903|FG002|Overall Study|Lost to Follow-up|0
7076853|NCT02083653|11183901|FG000|Overall Study|Death|2
7076854|NCT02083653|11183902|FG001|Overall Study|Death|2
7076855|NCT02083653|11183903|FG002|Overall Study|Death|2
7076856|NCT02083653|11183901|FG000|Overall Study|Progressive Disease|65
7076857|NCT02083653|11183902|FG001|Overall Study|Progressive Disease|73
7076858|NCT02083653|11183903|FG002|Overall Study|Progressive Disease|63
7076859|NCT02083653|11183901|FG000|Overall Study|Withdrawal by Subject|2
7076860|NCT02083653|11183902|FG001|Overall Study|Withdrawal by Subject|1
7076861|NCT02083653|11183903|FG002|Overall Study|Withdrawal by Subject|2
7076862|NCT02083653|11183901|FG000|Overall Study|Other Events|0
7076863|NCT02083653|11183902|FG001|Overall Study|Other Events|2
7076864|NCT02083653|11183903|FG002|Overall Study|Other Events|2
7076865|NCT02083653|11183901|FG000|Overall Study|Reason Missing|0
7076866|NCT02083653|11183902|FG001|Overall Study|Reason Missing|0
7076867|NCT02083653|11183903|FG002|Overall Study|Reason Missing|4
7076868|NCT02083783|11183930|FG000|Overall Study|Withdrawal by Subject|1
7076869|NCT02083783|11183931|FG001|Overall Study|Withdrawal by Subject|0
7076870|NCT02083926|11183961|FG000|Overall Study|Withdrawal by Subject|1
7076871|NCT02083926|11183962|FG001|Overall Study|Withdrawal by Subject|0
7076872|NCT02083965|11183971|FG000|Treatment Period|Other|1
7076873|NCT02083965|11183972|FG001|Treatment Period|Other|0
7076874|NCT02084056|11183982|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
7076875|NCT02084056|11183983|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
7076876|NCT02084056|11183984|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
7076877|NCT02084056|11183985|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
7076878|NCT02084056|11183982|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1
7076879|NCT02084056|11183983|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0
7076880|NCT02084056|11183984|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0
7076881|NCT02084056|11183985|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0
7076882|NCT02084082|11184006|FG000|Washout Period 1 (35 Days)|Adverse Event|0
7076883|NCT02084082|11184007|FG001|Washout Period 1 (35 Days)|Adverse Event|0
7076884|NCT02084082|11184008|FG002|Washout Period 1 (35 Days)|Adverse Event|1
7076885|NCT02084082|11184009|FG003|Washout Period 1 (35 Days)|Adverse Event|1
7076886|NCT02084082|11184006|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0
7076887|NCT02084082|11184007|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0
7076888|NCT02084082|11184008|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0
7076889|NCT02084082|11184009|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1
7076890|NCT02084134|11184021|FG000|Overall Study|Protocol Violation|4
7076891|NCT02084134|11184022|FG001|Overall Study|Protocol Violation|2
7076892|NCT02084134|11184021|FG000|Overall Study|Death|0
7076893|NCT02084134|11184022|FG001|Overall Study|Death|1
7076894|NCT02084238|11184032|FG000|Overall Study|Lost to Follow-up|2
7076895|NCT02085135|11184088|FG000|Overall Study|Adverse Event|4
7076896|NCT02085135|11184089|FG001|Overall Study|Adverse Event|7
7076897|NCT02085135|11184088|FG000|Overall Study|Lost to Follow-up|2
7076898|NCT02085135|11184089|FG001|Overall Study|Lost to Follow-up|2
7076899|NCT02085135|11184088|FG000|Overall Study|Withdrawal by Subject|3
7076900|NCT02085135|11184089|FG001|Overall Study|Withdrawal by Subject|0
7076901|NCT02085135|11184088|FG000|Overall Study|Lack of Efficacy|2
7076902|NCT02085135|11184089|FG001|Overall Study|Lack of Efficacy|0
7076903|NCT02085161|11184099|FG000|Overall Study|Not Treated|1
7076904|NCT02085161|11184100|FG001|Overall Study|Not Treated|0
7076905|NCT02085161|11184101|FG002|Overall Study|Not Treated|0
7076906|NCT02085161|11184102|FG003|Overall Study|Not Treated|0
7076907|NCT02085161|11184099|FG000|Overall Study|Adverse Event|8
7076908|NCT02085161|11184100|FG001|Overall Study|Adverse Event|5
7076909|NCT02085161|11184101|FG002|Overall Study|Adverse Event|4
7076910|NCT02085161|11184102|FG003|Overall Study|Adverse Event|5
7076911|NCT02085161|11184099|FG000|Overall Study|Protocol Violation|0
7076912|NCT02085161|11184100|FG001|Overall Study|Protocol Violation|1
7076913|NCT02085161|11184101|FG002|Overall Study|Protocol Violation|0
7076914|NCT02085161|11184102|FG003|Overall Study|Protocol Violation|1
7076915|NCT02085161|11184099|FG000|Overall Study|Withdrawal by Subject|2
7076916|NCT02085161|11184100|FG001|Overall Study|Withdrawal by Subject|4
7076917|NCT02085161|11184101|FG002|Overall Study|Withdrawal by Subject|0
7076918|NCT02085161|11184102|FG003|Overall Study|Withdrawal by Subject|3
7076919|NCT02085161|11184099|FG000|Overall Study|Other Reason|1
7076920|NCT02085161|11184100|FG001|Overall Study|Other Reason|0
7076921|NCT02085161|11184101|FG002|Overall Study|Other Reason|1
7076922|NCT02085161|11184102|FG003|Overall Study|Other Reason|1
7076923|NCT02085252|11184115|FG000|Overall Study|Withdrawal of Consent|1
7076924|NCT02085252|11184116|FG001|Overall Study|Withdrawal of Consent|0
7148019|NCT03137459|11308819|FG001|6-months|Death|2
7148020|NCT03137459|11308818|FG000|6-months|Refused assessment|6
7148021|NCT03137459|11308819|FG001|6-months|Refused assessment|3
7148022|NCT03137459|11308818|FG000|6-months|Acutely ill|1
7148023|NCT03137459|11308819|FG001|6-months|Acutely ill|1
7148024|NCT03137784|11308826|FG000|Overall Study|Adverse Event|1
7148025|NCT03137784|11308827|FG001|Overall Study|Adverse Event|1
7148026|NCT03137784|11308828|FG002|Overall Study|Adverse Event|0
7148027|NCT03137784|11308829|FG003|Overall Study|Adverse Event|0
7148028|NCT03137784|11308830|FG004|Overall Study|Adverse Event|0
7148029|NCT03137784|11308831|FG005|Overall Study|Adverse Event|0
7148030|NCT03137784|11308826|FG000|Overall Study|Subject/guardian decision|1
7148031|NCT03137784|11308827|FG001|Overall Study|Subject/guardian decision|0
7148032|NCT03137784|11308828|FG002|Overall Study|Subject/guardian decision|0
7148033|NCT03137784|11308829|FG003|Overall Study|Subject/guardian decision|0
7148034|NCT03137784|11308830|FG004|Overall Study|Subject/guardian decision|0
7148035|NCT03137784|11308831|FG005|Overall Study|Subject/guardian decision|0
7148036|NCT03137784|11308826|FG000|Overall Study|Non-compliance with study treatment|0
7148037|NCT03137784|11308827|FG001|Overall Study|Non-compliance with study treatment|0
7148038|NCT03137784|11308828|FG002|Overall Study|Non-compliance with study treatment|0
7148039|NCT03137784|11308829|FG003|Overall Study|Non-compliance with study treatment|0
7148040|NCT03137784|11308830|FG004|Overall Study|Non-compliance with study treatment|1
7148041|NCT03137784|11308831|FG005|Overall Study|Non-compliance with study treatment|0
7148042|NCT03137992|11308839|FG000|Washout Period 1|Adverse Event|1
7148043|NCT03137992|11308840|FG001|Washout Period 1|Adverse Event|1
7148044|NCT03137992|11308841|FG002|Washout Period 1|Adverse Event|0
7148045|NCT03137992|11308842|FG003|Washout Period 1|Adverse Event|0
7148046|NCT03137992|11308843|FG004|Washout Period 1|Adverse Event|0
7148047|NCT03137992|11308844|FG005|Washout Period 1|Adverse Event|1
7148048|NCT03137992|11308839|FG000|Washout Period 1|Withdrawal by Subject|0
7148049|NCT03137992|11308840|FG001|Washout Period 1|Withdrawal by Subject|1
7148050|NCT03137992|11308841|FG002|Washout Period 1|Withdrawal by Subject|1
7148051|NCT03137992|11308842|FG003|Washout Period 1|Withdrawal by Subject|0
7148052|NCT03137992|11308843|FG004|Washout Period 1|Withdrawal by Subject|0
7148053|NCT03137992|11308844|FG005|Washout Period 1|Withdrawal by Subject|0
7148054|NCT03137992|11308839|FG000|Washout Period 1|Principal Investigator Discretion|0
7148055|NCT03137992|11308840|FG001|Washout Period 1|Principal Investigator Discretion|1
7148056|NCT03137992|11308841|FG002|Washout Period 1|Principal Investigator Discretion|0
7148057|NCT03137992|11308842|FG003|Washout Period 1|Principal Investigator Discretion|0
7148058|NCT03137992|11308843|FG004|Washout Period 1|Principal Investigator Discretion|0
7076925|NCT02085252|11184115|FG000|Overall Study|Adverse Event|0
7076926|NCT02085252|11184116|FG001|Overall Study|Adverse Event|1
7076927|NCT02085252|11184115|FG000|Overall Study|Discontinuation Due to Patient Decision|0
7076928|NCT02085252|11184116|FG001|Overall Study|Discontinuation Due to Patient Decision|1
6840168|NCT00270998|10845878|FG001|12 Month Follow-up|Personal/family health|5
6840169|NCT00270998|10845879|FG002|12 Month Follow-up|Personal/family health|1
6840170|NCT00270998|10845877|FG000|12 Month Follow-up|Received/desired alternate treatment|1
6840171|NCT00270998|10845878|FG001|12 Month Follow-up|Received/desired alternate treatment|4
6840172|NCT00270998|10845879|FG002|12 Month Follow-up|Received/desired alternate treatment|1
6840173|NCT00271024|10845893|FG000|Overall Study|Lost Interest|3
6840174|NCT00271024|10845894|FG001|Overall Study|Lost Interest|4
6840175|NCT00271024|10845895|FG002|Overall Study|Lost Interest|2
6840176|NCT00271024|10845896|FG003|Overall Study|Lost Interest|3
6840177|NCT00271024|10845893|FG000|Overall Study|Unknown/Unspecified|11
6840178|NCT00271024|10845894|FG001|Overall Study|Unknown/Unspecified|11
6840179|NCT00271024|10845895|FG002|Overall Study|Unknown/Unspecified|8
6840180|NCT00271024|10845896|FG003|Overall Study|Unknown/Unspecified|4
6840181|NCT00271024|10845893|FG000|Overall Study|Protocol Violation|1
6840182|NCT00271024|10845894|FG001|Overall Study|Protocol Violation|6
6840183|NCT00271024|10845895|FG002|Overall Study|Protocol Violation|5
6840184|NCT00271024|10845896|FG003|Overall Study|Protocol Violation|11
6840185|NCT00271024|10845893|FG000|Overall Study|Unpleasant Reaction To Tablet|1
6840186|NCT00271024|10845894|FG001|Overall Study|Unpleasant Reaction To Tablet|3
6840187|NCT00271024|10845895|FG002|Overall Study|Unpleasant Reaction To Tablet|4
6840188|NCT00271024|10845896|FG003|Overall Study|Unpleasant Reaction To Tablet|2
6840189|NCT00271024|10845893|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6
6840190|NCT00271024|10845894|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2
6840191|NCT00271024|10845895|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4
6840192|NCT00271024|10845896|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4
6840193|NCT00271505|10845943|FG000|Overall Study|Screen Failure|3
6840194|NCT00271505|10845943|FG000|Overall Study|Adverse Event|1
6840195|NCT00271505|10845943|FG000|Overall Study|Death|1
6840196|NCT00271596|10845959|FG000|Overall Study|Protocol Violation|1
6840197|NCT00271596|10845960|FG001|Overall Study|Protocol Violation|0
6840198|NCT00271596|10845959|FG000|Overall Study|Withdrawal by Subject|0
6840199|NCT00271596|10845960|FG001|Overall Study|Withdrawal by Subject|1
6840200|NCT00271609|10845968|FG000|Overall Study|Adverse Event|11
6840201|NCT00271609|10845969|FG001|Overall Study|Adverse Event|3
6840202|NCT00271609|10845968|FG000|Overall Study|Withdrawal by Subject|2
6840203|NCT00271609|10845969|FG001|Overall Study|Withdrawal by Subject|0
6840204|NCT00271856|10845986|FG000|Overall Study|Withdrawal by Subject|1
6840205|NCT00271856|10845987|FG001|Overall Study|Withdrawal by Subject|7
6840206|NCT00271856|10845986|FG000|Overall Study|Lost to Follow-up|10
6840207|NCT00271856|10845987|FG001|Overall Study|Lost to Follow-up|11
6840208|NCT00272038|10845993|FG000|Overall Study|withdrew before they received 2 cycles|7
6840209|NCT00272779|10846051|FG000|Baseline Through Week 48|Adverse event before Week 48|10
6840210|NCT00272779|10846052|FG001|Baseline Through Week 48|Adverse event before Week 48|14
6840211|NCT00272779|10846051|FG000|Baseline Through Week 48|Death before Week 48|4
6840212|NCT00272779|10846052|FG001|Baseline Through Week 48|Death before Week 48|4
6840213|NCT00272779|10846051|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5
6840214|NCT00272779|10846052|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8
7148059|NCT03137992|11308844|FG005|Washout Period 1|Principal Investigator Discretion|0
7148060|NCT03137992|11308839|FG000|Washout Period 1|COPD Exacerbation|1
7148061|NCT03137992|11308840|FG001|Washout Period 1|COPD Exacerbation|1
7148062|NCT03137992|11308841|FG002|Washout Period 1|COPD Exacerbation|1
7148063|NCT03137992|11308842|FG003|Washout Period 1|COPD Exacerbation|0
7148064|NCT03137992|11308843|FG004|Washout Period 1|COPD Exacerbation|1
7148065|NCT03137992|11308844|FG005|Washout Period 1|COPD Exacerbation|1
7148066|NCT03137992|11308839|FG000|Washout Period 1|Subject Noncompliance|1
7148067|NCT03137992|11308840|FG001|Washout Period 1|Subject Noncompliance|0
7148068|NCT03137992|11308841|FG002|Washout Period 1|Subject Noncompliance|0
7148069|NCT03137992|11308842|FG003|Washout Period 1|Subject Noncompliance|0
7148070|NCT03137992|11308843|FG004|Washout Period 1|Subject Noncompliance|1
7148071|NCT03137992|11308844|FG005|Washout Period 1|Subject Noncompliance|0
7148072|NCT03137992|11308839|FG000|Period 2 (Visit 3)|COPD Exacerbation|1
7148073|NCT03137992|11308840|FG001|Period 2 (Visit 3)|COPD Exacerbation|1
7148074|NCT03137992|11308841|FG002|Period 2 (Visit 3)|COPD Exacerbation|0
7148075|NCT03137992|11308842|FG003|Period 2 (Visit 3)|COPD Exacerbation|0
7148076|NCT03137992|11308843|FG004|Period 2 (Visit 3)|COPD Exacerbation|0
7148077|NCT03137992|11308844|FG005|Period 2 (Visit 3)|COPD Exacerbation|1
7148078|NCT03137992|11308839|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2
7148079|NCT03137992|11308840|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3
7148080|NCT03137992|11308841|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3
6840215|NCT00272779|10846051|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6
6840216|NCT00272779|10846052|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6
6840217|NCT00272779|10846051|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1
6840218|NCT00272779|10846052|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0
7148081|NCT03137992|11308842|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4
6840219|NCT00272779|10846051|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6
6840220|NCT00272779|10846052|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9
6840221|NCT00272779|10846051|FG000|Baseline Through Week 48|Pregnancy before Week 48|2
7148082|NCT03137992|11308843|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3
7148083|NCT03137992|11308844|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7
7148084|NCT03137992|11308839|FG000|Period 2 (Visit 3)|Adverse Event|0
7148085|NCT03137992|11308840|FG001|Period 2 (Visit 3)|Adverse Event|1
7148086|NCT03137992|11308841|FG002|Period 2 (Visit 3)|Adverse Event|0
7148087|NCT03137992|11308842|FG003|Period 2 (Visit 3)|Adverse Event|0
7148088|NCT03137992|11308843|FG004|Period 2 (Visit 3)|Adverse Event|0
7148089|NCT03137992|11308844|FG005|Period 2 (Visit 3)|Adverse Event|0
7148090|NCT03137992|11308839|FG000|Period 2 (Visit 3)|Lost to Follow-up|0
7148091|NCT03137992|11308840|FG001|Period 2 (Visit 3)|Lost to Follow-up|0
7148092|NCT03137992|11308841|FG002|Period 2 (Visit 3)|Lost to Follow-up|0
7076929|NCT02085252|11184115|FG000|Overall Study|Reason Not Specified|0
7076930|NCT02085252|11184116|FG001|Overall Study|Reason Not Specified|1
7076931|NCT02085252|11184115|FG000|Overall Study|Reason Unknown|0
7076932|NCT02085252|11184116|FG001|Overall Study|Reason Unknown|1
7076933|NCT02085460|11184147|FG000|Overall Study|Adverse Event|2
7076934|NCT02085460|11184148|FG001|Overall Study|Adverse Event|2
7076935|NCT02085460|11184149|FG002|Overall Study|Adverse Event|1
7076936|NCT02085460|11184147|FG000|Overall Study|Physician Decision|1
7076937|NCT02085460|11184148|FG001|Overall Study|Physician Decision|1
7076938|NCT02085460|11184149|FG002|Overall Study|Physician Decision|2
7076939|NCT02085460|11184147|FG000|Overall Study|Withdrawal by Subject|11
7076940|NCT02085460|11184148|FG001|Overall Study|Withdrawal by Subject|5
7076941|NCT02085460|11184149|FG002|Overall Study|Withdrawal by Subject|7
7076942|NCT02085785|11184188|FG000|Overall Study|Withdrawal by Subject|2
7076943|NCT02085785|11184189|FG001|Overall Study|Withdrawal by Subject|1
7076944|NCT02085785|11184188|FG000|Overall Study|Lost to Follow-up|0
7076945|NCT02085785|11184189|FG001|Overall Study|Lost to Follow-up|1
7076946|NCT02086110|11184203|FG000|Overall Study|Withdrawal by Subject|1
7076947|NCT02086110|11184204|FG001|Overall Study|Withdrawal by Subject|1
7076948|NCT02086162|11184213|FG000|Overall Study|Withdrawal by Subject|4
7076949|NCT02086162|11184214|FG001|Overall Study|Withdrawal by Subject|4
7076950|NCT02086162|11184213|FG000|Overall Study|moved|1
7148093|NCT03137992|11308842|FG003|Period 2 (Visit 3)|Lost to Follow-up|1
7148094|NCT03137992|11308843|FG004|Period 2 (Visit 3)|Lost to Follow-up|0
7148095|NCT03137992|11308844|FG005|Period 2 (Visit 3)|Lost to Follow-up|0
7148096|NCT03137992|11308839|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0
7148097|NCT03137992|11308840|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2
7148098|NCT03137992|11308841|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0
7148099|NCT03137992|11308842|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0
7148100|NCT03137992|11308843|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1
7148101|NCT03137992|11308844|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0
7148102|NCT03137992|11308839|FG000|Washout Period 2|COPD Exacerbation|1
7148103|NCT03137992|11308840|FG001|Washout Period 2|COPD Exacerbation|1
7148104|NCT03137992|11308841|FG002|Washout Period 2|COPD Exacerbation|0
7148105|NCT03137992|11308842|FG003|Washout Period 2|COPD Exacerbation|0
7148106|NCT03137992|11308843|FG004|Washout Period 2|COPD Exacerbation|1
7148107|NCT03137992|11308844|FG005|Washout Period 2|COPD Exacerbation|0
7148108|NCT03137992|11308839|FG000|Washout Period 2|Subject Non-compliance|0
7148109|NCT03137992|11308840|FG001|Washout Period 2|Subject Non-compliance|1
7148110|NCT03137992|11308841|FG002|Washout Period 2|Subject Non-compliance|0
7148111|NCT03137992|11308842|FG003|Washout Period 2|Subject Non-compliance|0
7148112|NCT03137992|11308843|FG004|Washout Period 2|Subject Non-compliance|0
7148113|NCT03137992|11308844|FG005|Washout Period 2|Subject Non-compliance|0
7148114|NCT03137992|11308839|FG000|Washout Period 2|Adverse Event|0
7148115|NCT03137992|11308840|FG001|Washout Period 2|Adverse Event|0
7148116|NCT03137992|11308841|FG002|Washout Period 2|Adverse Event|0
7148117|NCT03137992|11308842|FG003|Washout Period 2|Adverse Event|1
7148118|NCT03137992|11308843|FG004|Washout Period 2|Adverse Event|1
7148119|NCT03137992|11308844|FG005|Washout Period 2|Adverse Event|0
7148120|NCT03137992|11308839|FG000|Washout Period 2|Withdrawal by Subject|1
6840222|NCT00272779|10846052|FG001|Baseline Through Week 48|Pregnancy before Week 48|2
6840223|NCT00272779|10846051|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1
6840224|NCT00272779|10846052|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0
6840225|NCT00272779|10846051|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4
6840226|NCT00272779|10846052|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13
6840227|NCT00272779|10846051|FG000|Baseline Through Week 48|Participant's decision before wk 48|0
7076951|NCT02086162|11184214|FG001|Overall Study|moved|1
7076952|NCT02086162|11184213|FG000|Overall Study|Lost to Follow-up|4
7076953|NCT02086162|11184214|FG001|Overall Study|Lost to Follow-up|2
7148121|NCT03137992|11308840|FG001|Washout Period 2|Withdrawal by Subject|0
7148122|NCT03137992|11308841|FG002|Washout Period 2|Withdrawal by Subject|0
7148123|NCT03137992|11308842|FG003|Washout Period 2|Withdrawal by Subject|0
7148124|NCT03137992|11308843|FG004|Washout Period 2|Withdrawal by Subject|1
7148125|NCT03137992|11308844|FG005|Washout Period 2|Withdrawal by Subject|0
7148126|NCT03137992|11308839|FG000|Washout Period 2|Sponsor Decision|0
7148127|NCT03137992|11308840|FG001|Washout Period 2|Sponsor Decision|0
7076954|NCT02086162|11184213|FG000|Overall Study|Death|1
7148128|NCT03137992|11308841|FG002|Washout Period 2|Sponsor Decision|0
7076955|NCT02086162|11184214|FG001|Overall Study|Death|0
7082898|NCT02147158|11193690|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2
7082899|NCT02147158|11193691|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3
7148129|NCT03137992|11308842|FG003|Washout Period 2|Sponsor Decision|0
7148130|NCT03137992|11308843|FG004|Washout Period 2|Sponsor Decision|0
7148131|NCT03137992|11308844|FG005|Washout Period 2|Sponsor Decision|1
7148132|NCT03137992|11308839|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6
7148133|NCT03137992|11308840|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0
7148134|NCT03137992|11308841|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2
7148135|NCT03137992|11308842|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0
7148136|NCT03137992|11308843|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2
7148137|NCT03137992|11308844|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3
7148138|NCT03137992|11308839|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0
7148139|NCT03137992|11308840|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2
7148140|NCT03137992|11308841|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1
7148141|NCT03137992|11308842|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0
7148142|NCT03137992|11308843|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1
7148143|NCT03137992|11308844|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0
7148144|NCT03137992|11308839|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1
7148145|NCT03137992|11308840|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0
7148146|NCT03137992|11308841|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1
7148147|NCT03137992|11308842|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0
7148148|NCT03137992|11308843|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0
7148149|NCT03137992|11308844|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0
7148150|NCT03137992|11308839|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0
7148151|NCT03137992|11308840|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0
7148152|NCT03137992|11308841|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0
7148153|NCT03137992|11308842|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1
7148154|NCT03137992|11308843|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0
7148155|NCT03137992|11308844|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0
7148156|NCT03137992|11308839|FG000|Part 2 (Open-label Extension)|Per study team|1
7148157|NCT03137992|11308840|FG001|Part 2 (Open-label Extension)|Per study team|0
7148158|NCT03137992|11308841|FG002|Part 2 (Open-label Extension)|Per study team|0
7148159|NCT03137992|11308842|FG003|Part 2 (Open-label Extension)|Per study team|0
7148160|NCT03137992|11308843|FG004|Part 2 (Open-label Extension)|Per study team|0
7148161|NCT03137992|11308844|FG005|Part 2 (Open-label Extension)|Per study team|0
7148162|NCT03137992|11308839|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0
7148163|NCT03137992|11308840|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0
7148164|NCT03137992|11308841|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0
7148165|NCT03137992|11308842|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0
7148166|NCT03137992|11308843|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0
7148167|NCT03137992|11308844|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1
7148168|NCT03138655|11308904|FG000|Overall Study|Adverse Event|2
7148169|NCT03138655|11308905|FG001|Overall Study|Adverse Event|1
7148170|NCT03138655|11308906|FG002|Overall Study|Adverse Event|2
7148171|NCT03138655|11308907|FG003|Overall Study|Adverse Event|1
7148172|NCT03138655|11308908|FG004|Overall Study|Adverse Event|1
7148173|NCT03138655|11308909|FG005|Overall Study|Adverse Event|4
7148174|NCT03138655|11308910|FG006|Overall Study|Adverse Event|2
7148175|NCT03138655|11308911|FG007|Overall Study|Adverse Event|2
7148176|NCT03138655|11308904|FG000|Overall Study|Withdrawal by Subject|0
7148177|NCT03138655|11308905|FG001|Overall Study|Withdrawal by Subject|1
7148178|NCT03138655|11308906|FG002|Overall Study|Withdrawal by Subject|0
7148179|NCT03138655|11308907|FG003|Overall Study|Withdrawal by Subject|0
7148180|NCT03138655|11308908|FG004|Overall Study|Withdrawal by Subject|0
7148181|NCT03138655|11308909|FG005|Overall Study|Withdrawal by Subject|0
7148182|NCT03138655|11308910|FG006|Overall Study|Withdrawal by Subject|1
7148183|NCT03138655|11308911|FG007|Overall Study|Withdrawal by Subject|0
7148184|NCT03138655|11308904|FG000|Overall Study|Reason not Specified|1
7148185|NCT03138655|11308905|FG001|Overall Study|Reason not Specified|0
7148186|NCT03138655|11308906|FG002|Overall Study|Reason not Specified|0
7148187|NCT03138655|11308907|FG003|Overall Study|Reason not Specified|2
7148188|NCT03138655|11308908|FG004|Overall Study|Reason not Specified|1
7148189|NCT03138655|11308909|FG005|Overall Study|Reason not Specified|1
7148190|NCT03138655|11308910|FG006|Overall Study|Reason not Specified|0
7148191|NCT03138655|11308911|FG007|Overall Study|Reason not Specified|0
7148192|NCT03138967|11308949|FG000|Overall Study|Death|0
7148193|NCT03138967|11308950|FG001|Overall Study|Death|1
7148194|NCT03138967|11308949|FG000|Overall Study|Physician Decision|1
7148195|NCT03138967|11308950|FG001|Overall Study|Physician Decision|3
7148196|NCT03139240|11308965|FG000|Overall Study|Lost to Follow-up|0
7148197|NCT03139240|11308966|FG001|Overall Study|Lost to Follow-up|1
7148198|NCT03139240|11308967|FG002|Overall Study|Lost to Follow-up|1
7148199|NCT03139240|11308968|FG003|Overall Study|Lost to Follow-up|0
7148200|NCT03139279|11308978|FG000|Overall Study|Physician Decision|2
7148201|NCT03139279|11308979|FG001|Overall Study|Physician Decision|0
7148202|NCT03139279|11308978|FG000|Overall Study|Protocol Violation|5
7148203|NCT03139279|11308979|FG001|Overall Study|Protocol Violation|4
7148204|NCT03139279|11308978|FG000|Overall Study|Withdrawal by Subject|0
7148205|NCT03139279|11308979|FG001|Overall Study|Withdrawal by Subject|2
7148206|NCT03139448|11308987|FG000|Overall Study|Lack of Efficacy|6
7148207|NCT03139448|11308988|FG001|Overall Study|Lack of Efficacy|7
7148208|NCT03139448|11308987|FG000|Overall Study|Location of procedure changed|2
7148209|NCT03139448|11308988|FG001|Overall Study|Location of procedure changed|8
7148210|NCT03139448|11308987|FG000|Overall Study|Withdrawal by Subject|3
7148211|NCT03139448|11308988|FG001|Overall Study|Withdrawal by Subject|6
7148212|NCT03139448|11308987|FG000|Overall Study|Screen fail|1
7148213|NCT03139448|11308988|FG001|Overall Study|Screen fail|3
7148214|NCT03139448|11308987|FG000|Overall Study|Physician Decision|0
7148215|NCT03139448|11308988|FG001|Overall Study|Physician Decision|2
7148216|NCT03139552|11308994|FG000|Overall Study|unable to attend tasting due to schedule|3
7148217|NCT03139604|11309020|FG000|Overall Study|Other|7
7148218|NCT03139604|11309021|FG001|Overall Study|Other|3
7148219|NCT03139604|11309020|FG000|Overall Study|Withdrawal by Subject|16
7148220|NCT03139604|11309021|FG001|Overall Study|Withdrawal by Subject|17
7148221|NCT03139604|11309020|FG000|Overall Study|Physician Decision|1
7148222|NCT03139604|11309021|FG001|Overall Study|Physician Decision|2
7148223|NCT03139604|11309020|FG000|Overall Study|Lost to Follow-up|3
7148224|NCT03139604|11309021|FG001|Overall Study|Lost to Follow-up|1
7148225|NCT03139604|11309020|FG000|Overall Study|Death|65
7148226|NCT03139604|11309021|FG001|Overall Study|Death|67
7148227|NCT03139604|11309020|FG000|Overall Study|Study Terminated by Sponsor|122
7148228|NCT03139604|11309021|FG001|Overall Study|Study Terminated by Sponsor|127
7148229|NCT03139604|11309020|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5
7148230|NCT03139604|11309021|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3
7148231|NCT03141086|11309055|FG000|Overall Study|Study Terminated By Sponsor|1
7148232|NCT03141086|11309056|FG001|Overall Study|Study Terminated By Sponsor|1
7148233|NCT03141086|11309055|FG000|Overall Study|Withdrawal by Subject|0
7148234|NCT03141086|11309056|FG001|Overall Study|Withdrawal by Subject|1
7148235|NCT03141086|11309055|FG000|Overall Study|Protocol Violation|0
7148236|NCT03141086|11309056|FG001|Overall Study|Protocol Violation|1
7148237|NCT03141086|11309055|FG000|Overall Study|Adverse Event|0
7148238|NCT03141086|11309056|FG001|Overall Study|Adverse Event|2
7148239|NCT03141151|11309064|FG000|Overall Study|Lost to Follow-up|3
7148240|NCT03141151|11309065|FG001|Overall Study|Lost to Follow-up|2
7148241|NCT03141151|11309064|FG000|Overall Study|Withdrawal by Subject|3
7148242|NCT03141151|11309065|FG001|Overall Study|Withdrawal by Subject|2
7148243|NCT03141307|11309100|FG000|In-Hospital|Withdrawal by Subject|0
7148244|NCT03141307|11309101|FG001|In-Hospital|Withdrawal by Subject|2
7148245|NCT03141307|11309100|FG000|In-Hospital|Protocol Violation|4
6840228|NCT00272779|10846052|FG001|Baseline Through Week 48|Participant's decision before wk 48|1
6840229|NCT00272779|10846051|FG000|Baseline Through Week 48|Chose different site before wk 48|0
6840230|NCT00272779|10846052|FG001|Baseline Through Week 48|Chose different site before wk 48|1
6840231|NCT00272779|10846051|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1
6840232|NCT00272779|10846052|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1
6840233|NCT00272779|10846051|FG000|Baseline Through Week 48|Death on/after Week 48|1
6840234|NCT00272779|10846052|FG001|Baseline Through Week 48|Death on/after Week 48|1
6840235|NCT00272779|10846051|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7
6840236|NCT00272779|10846052|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1
6840237|NCT00272779|10846051|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2
6840238|NCT00272779|10846052|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2
6840239|NCT00272779|10846051|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
6840240|NCT00272779|10846052|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
7148246|NCT03141307|11309101|FG001|In-Hospital|Protocol Violation|0
7148247|NCT03141307|11309100|FG000|Follow-Up|Lost to Follow-up|97
7148248|NCT03141307|11309101|FG001|Follow-Up|Lost to Follow-up|54
7148249|NCT03141788|11309127|FG000|Overall Study|Lost to Follow-up|1
7148250|NCT03141788|11309127|FG000|Overall Study|Protocol Violation|3
7148251|NCT03141788|11309127|FG000|Overall Study|Withdrawal by Subject|4
7148252|NCT03141905|11309136|FG000|Overall Study|Death|3
7148253|NCT03141905|11309137|FG001|Overall Study|Death|2
7148254|NCT03141905|11309136|FG000|Overall Study|Withdrawal by Subject|1
7148255|NCT03141905|11309137|FG001|Overall Study|Withdrawal by Subject|0
7148256|NCT03141905|11309136|FG000|Overall Study|Lost to Follow-up|3
7148257|NCT03141905|11309137|FG001|Overall Study|Lost to Follow-up|7
7148258|NCT03141905|11309136|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17
7148259|NCT03141905|11309137|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10
7148260|NCT03142451|11309159|FG000|Overall Study|Adverse Event|5
7148261|NCT03142451|11309160|FG001|Overall Study|Adverse Event|2
7148262|NCT03142451|11309159|FG000|Overall Study|Lost to Follow-up|25
7148263|NCT03142451|11309160|FG001|Overall Study|Lost to Follow-up|8
7148264|NCT03142451|11309159|FG000|Overall Study|Participant request|24
7148265|NCT03142451|11309160|FG001|Overall Study|Participant request|12
7148266|NCT03142451|11309159|FG000|Overall Study|Protocol Violation|3
7148267|NCT03142451|11309160|FG001|Overall Study|Protocol Violation|1
7148268|NCT03142451|11309159|FG000|Overall Study|Other|1
7148269|NCT03142451|11309160|FG001|Overall Study|Other|1
7148270|NCT03142750|11309168|FG000|Overall Study|Lost to Follow-up|4
7148271|NCT03142750|11309169|FG001|Overall Study|Lost to Follow-up|1
7148272|NCT03142932|11309181|FG000|Overall Study|Lost to Follow-up|2
7148273|NCT03142932|11309182|FG001|Overall Study|Lost to Follow-up|11
6840241|NCT00272779|10846051|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1
6840242|NCT00272779|10846052|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2
6840243|NCT00272779|10846051|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0
6840244|NCT00272779|10846052|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2
6840245|NCT00272779|10846051|FG000|Baseline Through Week 48|Continuing treatment|385
6840246|NCT00272779|10846052|FG001|Baseline Through Week 48|Continuing treatment|368
6840247|NCT00272779|10846051|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0
6840248|NCT00272779|10846052|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3
6840249|NCT00272779|10846051|FG000|Baseline Through Week 48|Never treated|2
6840250|NCT00272779|10846052|FG001|Baseline Through Week 48|Never treated|3
6840251|NCT00272779|10846051|FG000|Baseline Through Week 96|Adverse event before Week 96|13
6840252|NCT00272779|10846052|FG001|Baseline Through Week 96|Adverse event before Week 96|22
6840253|NCT00272779|10846051|FG000|Baseline Through Week 96|Death before Week 96|6
6840254|NCT00272779|10846052|FG001|Baseline Through Week 96|Death before Week 96|5
6840255|NCT00272779|10846051|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16
6840256|NCT00272779|10846052|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10
6840257|NCT00272779|10846051|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10
6840258|NCT00272779|10846052|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13
6840259|NCT00272779|10846051|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1
6840260|NCT00272779|10846052|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0
6840261|NCT00272779|10846051|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12
6840262|NCT00272779|10846052|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16
6840263|NCT00272779|10846051|FG000|Baseline Through Week 96|Pregnancy before Week 96|5
6840264|NCT00272779|10846052|FG001|Baseline Through Week 96|Pregnancy before Week 96|7
6840265|NCT00272779|10846051|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4
6840266|NCT00272779|10846052|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3
6840267|NCT00272779|10846051|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5
6840268|NCT00272779|10846052|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18
6840269|NCT00272779|10846051|FG000|Baseline Through Week 96|Changed address before Week 96|0
6840270|NCT00272779|10846052|FG001|Baseline Through Week 96|Changed address before Week 96|1
6840271|NCT00272779|10846051|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1
6840272|NCT00272779|10846052|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0
6840273|NCT00272779|10846051|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2
6840274|NCT00272779|10846052|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0
6840275|NCT00272779|10846051|FG000|Baseline Through Week 96|Pregnancy at Week 96|1
6840276|NCT00272779|10846052|FG001|Baseline Through Week 96|Pregnancy at Week 96|0
6840277|NCT00272779|10846051|FG000|Baseline Through Week 96|Never treated|2
6840278|NCT00272779|10846052|FG001|Baseline Through Week 96|Never treated|3
6840279|NCT00272779|10846051|FG000|Baseline Through Week 96|Continuing on treatment|61
6840280|NCT00272779|10846052|FG001|Baseline Through Week 96|Continuing on treatment|38
6840281|NCT00272792|10846061|FG000|Part 1: Responsiveness|Lost to Follow-up|1
6840282|NCT00272792|10846062|FG001|Part 1: Responsiveness|Lost to Follow-up|0
6840283|NCT00272792|10846061|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0
6840284|NCT00272792|10846062|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2
6840285|NCT00272792|10846061|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1
6840286|NCT00272792|10846062|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0
6840287|NCT00272792|10846061|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0
6840288|NCT00272792|10846062|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1
7148274|NCT03143101|11309191|FG000|Overall Study|Withdrawal by Subject|0
7148275|NCT03143101|11309192|FG001|Overall Study|Withdrawal by Subject|1
7148276|NCT03143101|11309193|FG002|Overall Study|Withdrawal by Subject|0
7148277|NCT03143101|11309191|FG000|Overall Study|Lost to Follow-up|2
7148278|NCT03143101|11309192|FG001|Overall Study|Lost to Follow-up|2
7148279|NCT03143101|11309193|FG002|Overall Study|Lost to Follow-up|0
7148280|NCT03143166|11309201|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1
7148281|NCT03143855|11309220|FG000|Overall Study|Withdrawal by Subject|4
7148282|NCT03143855|11309221|FG001|Overall Study|Withdrawal by Subject|3
7148283|NCT03143855|11309220|FG000|Overall Study|Protocol Violation|1
7148284|NCT03143855|11309221|FG001|Overall Study|Protocol Violation|0
7148285|NCT03143855|11309220|FG000|Overall Study|Participant experienced withdrawal|0
7148286|NCT03143855|11309221|FG001|Overall Study|Participant experienced withdrawal|1
7148287|NCT03144180|11309251|FG000|Overall Study|STAT Delivery|1
7148288|NCT03144180|11309252|FG001|Overall Study|STAT Delivery|1
7148289|NCT03144180|11309251|FG000|Overall Study|Provider forgot to fill out forms|1
7148290|NCT03144180|11309252|FG001|Overall Study|Provider forgot to fill out forms|3
7148291|NCT03144180|11309251|FG000|Overall Study|Provider forgot to use the Q-cup|0
7148292|NCT03144180|11309252|FG001|Overall Study|Provider forgot to use the Q-cup|1
7148293|NCT03144180|11309251|FG000|Overall Study|Scrub tech removed tube cap|0
6840289|NCT00272844|10846068|FG000|Overall Study|Withdrawal by Subject|5
6840290|NCT00272961|10846077|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1
7148294|NCT03144180|11309252|FG001|Overall Study|Scrub tech removed tube cap|1
7148295|NCT03144804|11309276|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4
7148296|NCT03145064|11309280|FG000|Overall Study|Death|24
7148297|NCT03145064|11309280|FG000|Overall Study|Lost to Follow-up|3
7148298|NCT03145064|11309280|FG000|Overall Study|Withdrawal by Subject|6
7148299|NCT03145064|11309280|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4
7148300|NCT03145064|11309280|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4
7148301|NCT03145207|11309285|FG000|Overall Study|volunteer started taking allergy shots|1
7148302|NCT03145207|11309285|FG000|Overall Study|baseline blood pressure high|1
7148303|NCT03146403|11309324|FG000|Overall Study|Withdrawal by Subject|0
7148304|NCT03146403|11309325|FG001|Overall Study|Withdrawal by Subject|3
7148305|NCT03146403|11309324|FG000|Overall Study|Lost to Follow-up|2
7148306|NCT03146403|11309325|FG001|Overall Study|Lost to Follow-up|0
7148307|NCT03146663|11309346|FG000|Overall Study|Did not receive study treatment|1
7148308|NCT03146663|11309347|FG001|Overall Study|Did not receive study treatment|1
7148309|NCT03146741|11309354|FG000|Overall Study|Txp with non-HCV+ heart|4
7148310|NCT03146741|11309354|FG000|Overall Study|Listeted for MOT|2
7148311|NCT03146741|11309354|FG000|Overall Study|Physician Decision|2
7148312|NCT03146741|11309354|FG000|Overall Study|Awaiting txp|2
7148313|NCT03147248|11309380|FG000|Overall Study|Adverse Event|0
7148314|NCT03147248|11309381|FG001|Overall Study|Adverse Event|2
7148315|NCT03147248|11309382|FG002|Overall Study|Adverse Event|2
7148316|NCT03147248|11309383|FG003|Overall Study|Adverse Event|2
7148317|NCT03147248|11309384|FG004|Overall Study|Adverse Event|6
7148318|NCT03147248|11309385|FG005|Overall Study|Adverse Event|11
7148319|NCT03147248|11309380|FG000|Overall Study|Disease progression|1
7148320|NCT03147248|11309381|FG001|Overall Study|Disease progression|0
7148321|NCT03147248|11309382|FG002|Overall Study|Disease progression|0
7148322|NCT03147248|11309383|FG003|Overall Study|Disease progression|0
7148323|NCT03147248|11309384|FG004|Overall Study|Disease progression|0
7148324|NCT03147248|11309385|FG005|Overall Study|Disease progression|2
7148325|NCT03147248|11309380|FG000|Overall Study|Withdrawal by Subject|0
7148326|NCT03147248|11309381|FG001|Overall Study|Withdrawal by Subject|0
6840291|NCT00272961|10846078|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
6840292|NCT00272961|10846079|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
6840293|NCT00272961|10846080|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
6840294|NCT00272961|10846081|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
6840295|NCT00272961|10846077|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1
6840296|NCT00272961|10846078|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
6840297|NCT00272961|10846079|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
6840298|NCT00272961|10846080|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
6840299|NCT00272961|10846081|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
6840300|NCT00272961|10846077|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5
6840301|NCT00272961|10846078|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
6840302|NCT00272961|10846079|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
6840303|NCT00272961|10846080|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
6840304|NCT00272961|10846081|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
6840305|NCT00272961|10846077|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2
6840306|NCT00272961|10846078|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
6840307|NCT00272961|10846079|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
6840308|NCT00272961|10846080|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
6840309|NCT00272961|10846081|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
6840310|NCT00272961|10846077|FG000|Placebo Run-in Phase: Up to Week 2|Other|2
6840311|NCT00272961|10846078|FG001|Placebo Run-in Phase: Up to Week 2|Other|0
6840312|NCT00272961|10846079|FG002|Placebo Run-in Phase: Up to Week 2|Other|0
6840313|NCT00272961|10846080|FG003|Placebo Run-in Phase: Up to Week 2|Other|0
6840314|NCT00272961|10846081|FG004|Placebo Run-in Phase: Up to Week 2|Other|0
6840315|NCT00272961|10846077|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
6840316|NCT00272961|10846078|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
7148327|NCT03147248|11309382|FG002|Overall Study|Withdrawal by Subject|0
7148328|NCT03147248|11309383|FG003|Overall Study|Withdrawal by Subject|0
7148329|NCT03147248|11309384|FG004|Overall Study|Withdrawal by Subject|12
7148330|NCT03147248|11309385|FG005|Overall Study|Withdrawal by Subject|9
7148331|NCT03147248|11309380|FG000|Overall Study|Protocol Violation|0
7148332|NCT03147248|11309381|FG001|Overall Study|Protocol Violation|0
7148333|NCT03147248|11309382|FG002|Overall Study|Protocol Violation|0
7148334|NCT03147248|11309383|FG003|Overall Study|Protocol Violation|0
7148335|NCT03147248|11309384|FG004|Overall Study|Protocol Violation|2
7148336|NCT03147248|11309385|FG005|Overall Study|Protocol Violation|0
7148337|NCT03147248|11309380|FG000|Overall Study|Lost to Follow-up|0
7148338|NCT03147248|11309381|FG001|Overall Study|Lost to Follow-up|0
7148339|NCT03147248|11309382|FG002|Overall Study|Lost to Follow-up|0
7148340|NCT03147248|11309383|FG003|Overall Study|Lost to Follow-up|0
7148341|NCT03147248|11309384|FG004|Overall Study|Lost to Follow-up|2
7148342|NCT03147248|11309385|FG005|Overall Study|Lost to Follow-up|0
7148343|NCT03147248|11309380|FG000|Overall Study|Pregnancy|0
7148344|NCT03147248|11309381|FG001|Overall Study|Pregnancy|0
7148345|NCT03147248|11309382|FG002|Overall Study|Pregnancy|0
7148346|NCT03147248|11309383|FG003|Overall Study|Pregnancy|0
7148347|NCT03147248|11309384|FG004|Overall Study|Pregnancy|1
7148348|NCT03147248|11309385|FG005|Overall Study|Pregnancy|0
7148349|NCT03147248|11309380|FG000|Overall Study|Death|0
7148350|NCT03147248|11309381|FG001|Overall Study|Death|0
7148351|NCT03147248|11309382|FG002|Overall Study|Death|0
7148352|NCT03147248|11309383|FG003|Overall Study|Death|0
7148353|NCT03147248|11309384|FG004|Overall Study|Death|0
7148354|NCT03147248|11309385|FG005|Overall Study|Death|4
7148355|NCT03147248|11309380|FG000|Overall Study|Physician Decision|0
7148356|NCT03147248|11309381|FG001|Overall Study|Physician Decision|0
7148357|NCT03147248|11309382|FG002|Overall Study|Physician Decision|0
7148358|NCT03147248|11309383|FG003|Overall Study|Physician Decision|0
7148359|NCT03147248|11309384|FG004|Overall Study|Physician Decision|2
7148360|NCT03147248|11309385|FG005|Overall Study|Physician Decision|4
7148361|NCT03147248|11309380|FG000|Overall Study|Prolonged Dosing Interval|0
7148362|NCT03147248|11309381|FG001|Overall Study|Prolonged Dosing Interval|0
7148363|NCT03147248|11309382|FG002|Overall Study|Prolonged Dosing Interval|0
7148364|NCT03147248|11309383|FG003|Overall Study|Prolonged Dosing Interval|0
7148365|NCT03147248|11309384|FG004|Overall Study|Prolonged Dosing Interval|1
7148366|NCT03147248|11309385|FG005|Overall Study|Prolonged Dosing Interval|1
7148367|NCT03147495|11309401|FG000|Overall Study|Physician Decision|0
7148368|NCT03147495|11309402|FG001|Overall Study|Physician Decision|6
7148369|NCT03148067|11309425|FG000|Overall Study|Lost to Follow-up|3
7148370|NCT03148067|11309425|FG000|Overall Study|Death|1
7148371|NCT03148691|11309468|FG000|Overall Study|Protocol Violation|1
7148372|NCT03148691|11309469|FG001|Overall Study|Protocol Violation|2
7148373|NCT03148691|11309470|FG002|Overall Study|Protocol Violation|7
7148374|NCT03148691|11309468|FG000|Overall Study|Lost to Follow-up|0
6840317|NCT00272961|10846079|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
6840318|NCT00272961|10846080|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
6840319|NCT00272961|10846081|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2
6840320|NCT00272961|10846077|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
6840321|NCT00272961|10846078|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
6840322|NCT00272961|10846079|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
6840323|NCT00272961|10846080|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
6840324|NCT00272961|10846081|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
6840325|NCT00272961|10846077|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1
6840326|NCT00272961|10846078|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3
6840327|NCT00272961|10846079|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3
6840328|NCT00272961|10846080|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2
6840329|NCT00272961|10846081|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2
6840330|NCT00272987|10846096|FG000|Overall Study|Adverse Event|1
6840331|NCT00272987|10846097|FG001|Overall Study|Adverse Event|0
6840332|NCT00272987|10846098|FG002|Overall Study|Adverse Event|0
6840333|NCT00272987|10846096|FG000|Overall Study|Lost to Follow-up|3
6840334|NCT00272987|10846097|FG001|Overall Study|Lost to Follow-up|1
6840335|NCT00272987|10846098|FG002|Overall Study|Lost to Follow-up|1
6840336|NCT00272987|10846096|FG000|Overall Study|Withdrawal by Subject|1
6840337|NCT00272987|10846097|FG001|Overall Study|Withdrawal by Subject|0
6840338|NCT00272987|10846098|FG002|Overall Study|Withdrawal by Subject|3
6840339|NCT00272987|10846096|FG000|Overall Study|Sponsor Terminated study|0
6840340|NCT00272987|10846097|FG001|Overall Study|Sponsor Terminated study|1
6840341|NCT00272987|10846098|FG002|Overall Study|Sponsor Terminated study|1
6840342|NCT00272987|10846096|FG000|Overall Study|Disease progression|1
6840343|NCT00272987|10846097|FG001|Overall Study|Disease progression|1
6840344|NCT00272987|10846098|FG002|Overall Study|Disease progression|2
6840345|NCT00272987|10846096|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2
6840346|NCT00272987|10846097|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1
7148375|NCT03148691|11309469|FG001|Overall Study|Lost to Follow-up|0
7148376|NCT03148691|11309470|FG002|Overall Study|Lost to Follow-up|1
7148377|NCT03148691|11309468|FG000|Overall Study|Other|1
7148378|NCT03148691|11309469|FG001|Overall Study|Other|0
7148379|NCT03148691|11309470|FG002|Overall Study|Other|0
7148380|NCT03148691|11309468|FG000|Overall Study|Withdrawal by Subject|1
7148381|NCT03148691|11309469|FG001|Overall Study|Withdrawal by Subject|0
7148382|NCT03148691|11309470|FG002|Overall Study|Withdrawal by Subject|0
7148383|NCT03149042|11309478|FG000|Overall Study|Invasive FFR not performed|21
7148384|NCT03149042|11309478|FG000|Overall Study|Poor CT Image Quality|1
7148385|NCT03149042|11309478|FG000|Overall Study|Invasive FFR Measurement cancelled|1
7148386|NCT03149055|11309483|FG000|Overall Study|Not treated|4
7148387|NCT03149328|11309502|FG000|Overall Study|Withdrawal by Subject|30
7148388|NCT03149328|11309503|FG001|Overall Study|Withdrawal by Subject|26
6840347|NCT00272987|10846098|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4
7148389|NCT03149328|11309502|FG000|Overall Study|Changed Dialysis Modality|18
7148390|NCT03149328|11309503|FG001|Overall Study|Changed Dialysis Modality|1
7148391|NCT03149328|11309502|FG000|Overall Study|Transplant|9
7148392|NCT03149328|11309503|FG001|Overall Study|Transplant|1
7148393|NCT03149328|11309502|FG000|Overall Study|Lost to Follow-up|25
6840348|NCT00272987|10846096|FG000|Overall Study|Death|1
6840349|NCT00272987|10846097|FG001|Overall Study|Death|0
6840350|NCT00272987|10846098|FG002|Overall Study|Death|0
6840351|NCT00273052|10846108|FG000|Overall Study|Withdrawal by Subject|16
7148394|NCT03149328|11309503|FG001|Overall Study|Lost to Follow-up|16
7148395|NCT03149328|11309502|FG000|Overall Study|Left Study Site|1
7148396|NCT03149328|11309503|FG001|Overall Study|Left Study Site|2
7148397|NCT03149328|11309502|FG000|Overall Study|Language Barrier|1
7148398|NCT03149328|11309503|FG001|Overall Study|Language Barrier|0
7148399|NCT03149848|11309509|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1
7148400|NCT03149848|11309509|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2
7183773|NCT01098032|11383860|FG000|Overall Study|Withdrawal by Subject|1
7183774|NCT01098032|11383861|FG001|Overall Study|Withdrawal by Subject|1
7183775|NCT01034306|11383869|FG000|Overall Study|Adverse Event|1
7183776|NCT01034306|11383870|FG001|Overall Study|Adverse Event|0
7183777|NCT01034306|11383869|FG000|Overall Study|Lost to Follow-up|0
7183778|NCT01034306|11383870|FG001|Overall Study|Lost to Follow-up|1
7183779|NCT01034306|11383869|FG000|Overall Study|Withdrawal by Subject|2
7183780|NCT01034306|11383870|FG001|Overall Study|Withdrawal by Subject|2
7183781|NCT01034306|11383869|FG000|Overall Study|hospitalized and decided to stop|1
7183782|NCT01034306|11383870|FG001|Overall Study|hospitalized and decided to stop|0
7183783|NCT01034306|11383869|FG000|Overall Study|Noncomplience|1
7183784|NCT01034306|11383870|FG001|Overall Study|Noncomplience|0
7183785|NCT01005745|11383876|FG000|Overall Study|No TIL growth|1
7183786|NCT01005745|11383876|FG000|Overall Study|Disease progressed during TIL growth|3
7183787|NCT01005745|11383876|FG000|Overall Study|Death prior to treatment|1
7183788|NCT01005745|11383876|FG000|Overall Study|Inappropriate antidiuretic hormone|1
7183789|NCT00993447|11383882|FG000|Overall Study|Withdrawal by Subject|23
7183790|NCT00993447|11383883|FG001|Overall Study|Withdrawal by Subject|8
7183791|NCT00993447|11383882|FG000|Overall Study|Protocol Violation|12
7183792|NCT00993447|11383883|FG001|Overall Study|Protocol Violation|8
7183793|NCT00993447|11383882|FG000|Overall Study|Lost to Follow-up|1
7183794|NCT00993447|11383883|FG001|Overall Study|Lost to Follow-up|3
7183795|NCT00993447|11383882|FG000|Overall Study|Adverse Event|1
7183796|NCT00993447|11383883|FG001|Overall Study|Adverse Event|0
7183797|NCT00945009|11383892|FG000|Overall Study|Lack of Efficacy|10
7183798|NCT00945009|11383893|FG001|Overall Study|Lack of Efficacy|0
7183799|NCT00945009|11383894|FG002|Overall Study|Lack of Efficacy|0
7183800|NCT00945009|11383892|FG000|Overall Study|Physician Decision|21
7183801|NCT00945009|11383893|FG001|Overall Study|Physician Decision|4
7183802|NCT00945009|11383894|FG002|Overall Study|Physician Decision|3
7183803|NCT00945009|11383892|FG000|Overall Study|Protocol Violation|6
7183804|NCT00945009|11383893|FG001|Overall Study|Protocol Violation|1
7183805|NCT00945009|11383894|FG002|Overall Study|Protocol Violation|0
7183806|NCT00945009|11383892|FG000|Overall Study|Withdrawal by Subject|1
7183807|NCT00945009|11383893|FG001|Overall Study|Withdrawal by Subject|0
7183808|NCT00945009|11383894|FG002|Overall Study|Withdrawal by Subject|0
7183809|NCT00945009|11383892|FG000|Overall Study|Ineligible|6
7183810|NCT00945009|11383893|FG001|Overall Study|Ineligible|1
7183811|NCT00945009|11383894|FG002|Overall Study|Ineligible|0
7183812|NCT00945009|11383892|FG000|Overall Study|Inevaluable|0
7183813|NCT00945009|11383893|FG001|Overall Study|Inevaluable|1
7183814|NCT00945009|11383894|FG002|Overall Study|Inevaluable|0
7183815|NCT00945009|11383892|FG000|Overall Study|Refusal of further protocol|1
7183816|NCT00945009|11383893|FG001|Overall Study|Refusal of further protocol|0
7183817|NCT00945009|11383894|FG002|Overall Study|Refusal of further protocol|0
7183818|NCT00942877|11383904|FG000|Overall Study|Refused further treatment|1
7183819|NCT00942877|11383905|FG001|Overall Study|Refused further treatment|1
7183820|NCT00942877|11383904|FG000|Overall Study|Patient was not treated|1
7183821|NCT00942877|11383905|FG001|Overall Study|Patient was not treated|0
7183822|NCT00942877|11383904|FG000|Overall Study|Adverse Event|1
7183823|NCT00942877|11383905|FG001|Overall Study|Adverse Event|0
7183824|NCT00942877|11383904|FG000|Overall Study|Progressive disease|42
7183825|NCT00942877|11383905|FG001|Overall Study|Progressive disease|3
7183826|NCT00880893|11383920|FG000|Overall Study|Protocol Violation|13
7183827|NCT00880893|11383921|FG001|Overall Study|Protocol Violation|1
7183828|NCT00880893|11383920|FG000|Overall Study|Withdrawal by Subject|15
7183829|NCT00880893|11383921|FG001|Overall Study|Withdrawal by Subject|11
7183830|NCT00880893|11383920|FG000|Overall Study|Lost to Follow-up|76
7183831|NCT00880893|11383921|FG001|Overall Study|Lost to Follow-up|33
7183832|NCT00880893|11383920|FG000|Overall Study|Serious adverse event|3
7183833|NCT00880893|11383921|FG001|Overall Study|Serious adverse event|0
7183834|NCT00866918|11383929|FG000|Overall Study|Death|1
7183835|NCT00866918|11383930|FG001|Overall Study|Death|5
7183836|NCT00866918|11383929|FG000|Overall Study|Lack of Efficacy|1
7183837|NCT00866918|11383930|FG001|Overall Study|Lack of Efficacy|1
7183838|NCT00866918|11383929|FG000|Overall Study|Physician Decision|10
7183839|NCT00866918|11383930|FG001|Overall Study|Physician Decision|2
7183840|NCT00866918|11383929|FG000|Overall Study|Ineligible|2
7183841|NCT00866918|11383930|FG001|Overall Study|Ineligible|4
7183842|NCT00866918|11383929|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1
7183843|NCT00866918|11383930|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0
7183844|NCT00866918|11383929|FG000|Overall Study|Secondary malignancy|1
7183845|NCT00866918|11383930|FG001|Overall Study|Secondary malignancy|0
7148401|NCT03150056|11309545|FG000|Overall Study|Withdrawal by Subject|0
7148402|NCT03150056|11309546|FG001|Overall Study|Withdrawal by Subject|0
7148403|NCT03150056|11309547|FG002|Overall Study|Withdrawal by Subject|0
7148404|NCT03150056|11309548|FG003|Overall Study|Withdrawal by Subject|0
7148405|NCT03150056|11309549|FG004|Overall Study|Withdrawal by Subject|0
7148406|NCT03150056|11309550|FG005|Overall Study|Withdrawal by Subject|2
7148407|NCT03150056|11309545|FG000|Overall Study|Study terminated by Sponsor|1
7148408|NCT03150056|11309546|FG001|Overall Study|Study terminated by Sponsor|3
7148409|NCT03150056|11309547|FG002|Overall Study|Study terminated by Sponsor|1
7148410|NCT03150056|11309548|FG003|Overall Study|Study terminated by Sponsor|1
7148411|NCT03150056|11309549|FG004|Overall Study|Study terminated by Sponsor|5
7148412|NCT03150056|11309550|FG005|Overall Study|Study terminated by Sponsor|6
7148413|NCT03150056|11309545|FG000|Overall Study|Death|9
7148414|NCT03150056|11309546|FG001|Overall Study|Death|2
7148415|NCT03150056|11309547|FG002|Overall Study|Death|2
7148416|NCT03150056|11309548|FG003|Overall Study|Death|7
7148417|NCT03150056|11309549|FG004|Overall Study|Death|8
7148418|NCT03150056|11309550|FG005|Overall Study|Death|10
7148419|NCT03150056|11309545|FG000|Overall Study|Ongoing in the study|0
7148420|NCT03150056|11309546|FG001|Overall Study|Ongoing in the study|0
7148421|NCT03150056|11309547|FG002|Overall Study|Ongoing in the study|1
7148422|NCT03150056|11309548|FG003|Overall Study|Ongoing in the study|1
7148423|NCT03150056|11309549|FG004|Overall Study|Ongoing in the study|3
7148424|NCT03150056|11309550|FG005|Overall Study|Ongoing in the study|0
7148425|NCT03150082|11309567|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1
7148426|NCT03150082|11309568|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0
7148427|NCT03150485|11309604|FG000|Overall Study|Unsatisfactory Lens Fitting|0
7148428|NCT03150485|11309605|FG001|Overall Study|Unsatisfactory Lens Fitting|1
7148429|NCT03150485|11309606|FG002|Overall Study|Unsatisfactory Lens Fitting|0
7148430|NCT03150485|11309607|FG003|Overall Study|Unsatisfactory Lens Fitting|0
7148431|NCT03150485|11309608|FG004|Overall Study|Unsatisfactory Lens Fitting|0
7148432|NCT03150485|11309609|FG005|Overall Study|Unsatisfactory Lens Fitting|0
7148433|NCT03150589|11309616|FG000|Overall Study|Withdrawal by Subject|16
7148434|NCT03150589|11309617|FG001|Overall Study|Withdrawal by Subject|9
7148435|NCT03150589|11309616|FG000|Overall Study|Adverse Event|7
7148436|NCT03150589|11309617|FG001|Overall Study|Adverse Event|6
7148437|NCT03150589|11309616|FG000|Overall Study|Protocol Violation|4
7148438|NCT03150589|11309617|FG001|Overall Study|Protocol Violation|3
7148439|NCT03150589|11309616|FG000|Overall Study|Lost to Follow-up|3
7148440|NCT03150589|11309617|FG001|Overall Study|Lost to Follow-up|3
7148441|NCT03150589|11309616|FG000|Overall Study|Death|2
7148442|NCT03150589|11309617|FG001|Overall Study|Death|3
7148443|NCT03150589|11309616|FG000|Overall Study|IP non-compliance and other reasons|12
7148444|NCT03150589|11309617|FG001|Overall Study|IP non-compliance and other reasons|3
7148445|NCT03150719|11309625|FG000|Overall Study|Adverse Event|0
7148446|NCT03150719|11309626|FG001|Overall Study|Adverse Event|1
7148447|NCT03150719|11309625|FG000|Overall Study|Death|0
7148448|NCT03150719|11309626|FG001|Overall Study|Death|1
7148449|NCT03150719|11309625|FG000|Overall Study|Other|1
7148450|NCT03150719|11309626|FG001|Overall Study|Other|0
7148451|NCT03151148|11309647|FG000|Overall Study|Lost to Follow-up|1
7148452|NCT03151148|11309648|FG001|Overall Study|Lost to Follow-up|0
7148453|NCT03151148|11309647|FG000|Overall Study|Withdrawal by Subject|1
7148454|NCT03151148|11309648|FG001|Overall Study|Withdrawal by Subject|0
7148455|NCT03151395|11309664|FG000|Overall Study|Adverse Event|2
7148456|NCT03151395|11309664|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6
7148457|NCT03151395|11309664|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3
7148458|NCT03151395|11309664|FG000|Overall Study|Unspecified reason|4
7148459|NCT03151551|11309686|FG000|Open-Label Treatment Period|Adverse Event|0
7148460|NCT03151551|11309687|FG001|Open-Label Treatment Period|Adverse Event|2
7148461|NCT03151551|11309686|FG000|Open-Label Treatment Period|Lost to Follow-up|1
7148462|NCT03151551|11309687|FG001|Open-Label Treatment Period|Lost to Follow-up|1
7148463|NCT03151551|11309686|FG000|Open-Label Treatment Period|Withdrawal by Subject|12
7148464|NCT03151551|11309687|FG001|Open-Label Treatment Period|Withdrawal by Subject|18
7148465|NCT03151551|11309686|FG000|Open-Label Treatment Period|Lack of Efficacy|1
7148466|NCT03151551|11309687|FG001|Open-Label Treatment Period|Lack of Efficacy|1
7148467|NCT03151551|11309686|FG000|Open-Label Treatment Period|Physician Decision|3
7148468|NCT03151551|11309687|FG001|Open-Label Treatment Period|Physician Decision|0
7148469|NCT03151551|11309686|FG000|Open-Label Treatment Period|Protocol Deviation|1
7148470|NCT03151551|11309687|FG001|Open-Label Treatment Period|Protocol Deviation|2
7148471|NCT03151551|11309686|FG000|Post-Treatment Follow-Up Period|Adverse Event|1
7148472|NCT03151551|11309687|FG001|Post-Treatment Follow-Up Period|Adverse Event|3
7148473|NCT03151551|11309686|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4
7148474|NCT03151551|11309687|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2
7148475|NCT03151551|11309686|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20
7148476|NCT03151551|11309687|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22
7148477|NCT03151551|11309686|FG000|Post-Treatment Follow-Up Period|Physician Decision|0
7148478|NCT03151551|11309687|FG001|Post-Treatment Follow-Up Period|Physician Decision|1
7148479|NCT03152019|11309697|FG000|Overall Study|Adverse Event|0
7148480|NCT03152019|11309698|FG001|Overall Study|Adverse Event|1
7148481|NCT03152110|11309713|FG000|Overall Study|Withdrawal by Subject|3
7148482|NCT03152552|11309735|FG000|Treatment Period 1 (12 Weeks)|Death|0
7148483|NCT03152552|11309736|FG001|Treatment Period 1 (12 Weeks)|Death|1
7148484|NCT03152552|11309737|FG002|Treatment Period 1 (12 Weeks)|Death|0
7148485|NCT03152552|11309738|FG003|Treatment Period 1 (12 Weeks)|Death|0
7148486|NCT03152552|11309739|FG004|Treatment Period 1 (12 Weeks)|Death|1
7148487|NCT03152552|11309735|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0
7148488|NCT03152552|11309736|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1
7148489|NCT03152552|11309737|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0
7148490|NCT03152552|11309738|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0
7148491|NCT03152552|11309739|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0
7148492|NCT03152552|11309735|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8
7148493|NCT03152552|11309736|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9
7148494|NCT03152552|11309737|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19
7148495|NCT03152552|11309738|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19
7148496|NCT03152552|11309739|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20
7148497|NCT03152552|11309735|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7148498|NCT03152552|11309736|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7148499|NCT03152552|11309737|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
7148500|NCT03152552|11309738|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7148501|NCT03152552|11309739|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7148502|NCT03152552|11309735|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0
7076956|NCT02086565|11184248|FG000|Overall Study|Lost to Follow-up|9
7076957|NCT02086565|11184249|FG001|Overall Study|Lost to Follow-up|7
7076958|NCT02086565|11184248|FG000|Overall Study|Withdrawal by Subject|2
7076959|NCT02086565|11184249|FG001|Overall Study|Withdrawal by Subject|1
7076960|NCT02086565|11184248|FG000|Overall Study|Death|3
7076961|NCT02086565|11184249|FG001|Overall Study|Death|2
7076962|NCT02086565|11184248|FG000|Overall Study|withdrawn by research team|2
7076963|NCT02086565|11184249|FG001|Overall Study|withdrawn by research team|2
7076964|NCT02086591|11184255|FG000|Overall Study|Adverse Event|1
7076965|NCT02086591|11184255|FG000|Overall Study|Withdrawal by Subject|1
7076966|NCT02086591|11184255|FG000|Overall Study|protocol terminated|3
7076967|NCT02086968|11184293|FG000|Overall Study|Adverse Event|1
7076968|NCT02086968|11184294|FG001|Overall Study|Adverse Event|5
7076969|NCT02086968|11184293|FG000|Overall Study|Lost to Follow-up|2
7076970|NCT02086968|11184294|FG001|Overall Study|Lost to Follow-up|3
7076971|NCT02086968|11184293|FG000|Overall Study|Study drug received outside protocol|0
7076972|NCT02086968|11184294|FG001|Overall Study|Study drug received outside protocol|1
7076973|NCT02086968|11184293|FG000|Overall Study|Physician Decision|4
7076974|NCT02086968|11184294|FG001|Overall Study|Physician Decision|0
7076975|NCT02086968|11184293|FG000|Overall Study|Withdrawal by Subject|1
7148503|NCT03152552|11309736|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0
7148504|NCT03152552|11309737|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1
7148505|NCT03152552|11309738|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0
7148506|NCT03152552|11309739|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0
7148507|NCT03152552|11309735|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
7148508|NCT03152552|11309736|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
7148509|NCT03152552|11309737|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
7148510|NCT03152552|11309738|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1
7148511|NCT03152552|11309739|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
7148512|NCT03152552|11309735|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6
7148513|NCT03152552|11309736|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5
7148514|NCT03152552|11309737|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9
7148515|NCT03152552|11309738|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9
7148516|NCT03152552|11309739|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11
7148517|NCT03154047|11309770|FG000|Overall Study|Death|1
7148518|NCT03154047|11309770|FG000|Overall Study|Study terminated by sponsor|76
7148519|NCT03154047|11309770|FG000|Overall Study|Withdrawal by Subject|3
7148520|NCT03154086|11309789|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7148521|NCT03154086|11309790|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7148522|NCT03154086|11309791|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7148523|NCT03154086|11309792|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1
7148524|NCT03154086|11309793|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7148525|NCT03154086|11309794|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7148526|NCT03154086|11309795|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7148527|NCT03154086|11309796|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7148528|NCT03154086|11309797|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7148529|NCT03154086|11309798|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7076976|NCT02086968|11184294|FG001|Overall Study|Withdrawal by Subject|4
7076977|NCT02087046|11184300|FG000|Overall Study|Adverse Event|4
7076978|NCT02087046|11184300|FG000|Overall Study|Death|1
7076979|NCT02087046|11184300|FG000|Overall Study|Lost to Follow-up|3
7076980|NCT02087046|11184300|FG000|Overall Study|Withdrawal by Subject|2
7076981|NCT02087046|11184300|FG000|Overall Study|Physician Decision|1
7076982|NCT02087059|11184305|FG000|Overall Study|Disease Progression|1
7148530|NCT03154086|11309799|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7148531|NCT03154086|11309800|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7148532|NCT03154086|11309801|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7148533|NCT03154086|11309802|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7148534|NCT03154086|11309803|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7148535|NCT03154086|11309789|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7148536|NCT03154086|11309790|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1
7148537|NCT03154086|11309791|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7148538|NCT03154086|11309792|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7148539|NCT03154086|11309793|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7148540|NCT03154086|11309794|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7148541|NCT03154086|11309795|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7148542|NCT03154086|11309796|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7148543|NCT03154086|11309797|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7148544|NCT03154086|11309798|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7148545|NCT03154086|11309799|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7148546|NCT03154086|11309800|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7148547|NCT03154086|11309801|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7148548|NCT03154086|11309802|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7148549|NCT03154086|11309803|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7148550|NCT03154086|11309789|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7148551|NCT03154086|11309790|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7148552|NCT03154086|11309791|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1
7076983|NCT02087059|11184305|FG000|Overall Study|Adverse Event|5
7148553|NCT03154086|11309792|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7148554|NCT03154086|11309793|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7148555|NCT03154086|11309794|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7148556|NCT03154086|11309795|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7148557|NCT03154086|11309796|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7148558|NCT03154086|11309797|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7148559|NCT03154086|11309798|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7148560|NCT03154086|11309799|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7148561|NCT03154086|11309800|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7148562|NCT03154086|11309801|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7148563|NCT03154086|11309802|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7148564|NCT03154086|11309803|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7148565|NCT03154086|11309789|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1
7148566|NCT03154086|11309790|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7148567|NCT03154086|11309791|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7148568|NCT03154086|11309792|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7148569|NCT03154086|11309793|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7148570|NCT03154086|11309794|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7148571|NCT03154086|11309795|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7148572|NCT03154086|11309796|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7148573|NCT03154086|11309797|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7148574|NCT03154086|11309798|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7148575|NCT03154086|11309799|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7148576|NCT03154086|11309800|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7148577|NCT03154086|11309801|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7148578|NCT03154086|11309802|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7148579|NCT03154086|11309803|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7148580|NCT03154086|11309789|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7148581|NCT03154086|11309790|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7148582|NCT03154086|11309791|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7148583|NCT03154086|11309792|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7148584|NCT03154086|11309793|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7148585|NCT03154086|11309794|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7076984|NCT02087059|11184305|FG000|Overall Study|Lost to Follow-up|1
7076985|NCT02087085|11184311|FG000|Overall Study|Adverse Event|10
7076986|NCT02087085|11184312|FG001|Overall Study|Adverse Event|14
7076987|NCT02087085|11184311|FG000|Overall Study|Lack of Efficacy|4
7076988|NCT02087085|11184312|FG001|Overall Study|Lack of Efficacy|3
7076989|NCT02087085|11184311|FG000|Overall Study|Lost to Follow-up|6
7076990|NCT02087085|11184312|FG001|Overall Study|Lost to Follow-up|4
7076991|NCT02087085|11184311|FG000|Overall Study|Withdrawal by Subject|9
7076992|NCT02087085|11184312|FG001|Overall Study|Withdrawal by Subject|11
7076993|NCT02087085|11184311|FG000|Overall Study|Protocol Violation|1
7076994|NCT02087085|11184312|FG001|Overall Study|Protocol Violation|0
7076995|NCT02087085|11184311|FG000|Overall Study|Study Terminated by Sponsor|87
7076996|NCT02087085|11184312|FG001|Overall Study|Study Terminated by Sponsor|80
7148586|NCT03154086|11309795|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7148587|NCT03154086|11309796|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7148588|NCT03154086|11309797|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1
7148589|NCT03154086|11309798|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7148590|NCT03154086|11309799|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7148591|NCT03154086|11309800|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7148592|NCT03154086|11309801|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7148593|NCT03154086|11309802|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7148594|NCT03154086|11309803|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7148595|NCT03154086|11309789|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7148596|NCT03154086|11309790|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7148597|NCT03154086|11309791|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7148598|NCT03154086|11309792|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7148599|NCT03154086|11309793|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7148600|NCT03154086|11309794|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7148601|NCT03154086|11309795|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7148602|NCT03154086|11309796|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1
7148603|NCT03154086|11309797|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7148604|NCT03154086|11309798|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7148605|NCT03154086|11309799|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7148606|NCT03154086|11309800|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7148607|NCT03154086|11309801|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7148608|NCT03154086|11309802|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7148609|NCT03154086|11309803|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7148610|NCT03154086|11309789|FG000|Part B (Up to 25 Days)|Adverse Event|0
7148611|NCT03154086|11309790|FG001|Part B (Up to 25 Days)|Adverse Event|0
7148612|NCT03154086|11309791|FG002|Part B (Up to 25 Days)|Adverse Event|0
7148613|NCT03154086|11309792|FG003|Part B (Up to 25 Days)|Adverse Event|0
7148614|NCT03154086|11309793|FG004|Part B (Up to 25 Days)|Adverse Event|0
7148615|NCT03154086|11309794|FG005|Part B (Up to 25 Days)|Adverse Event|0
7148616|NCT03154086|11309795|FG006|Part B (Up to 25 Days)|Adverse Event|0
7148617|NCT03154086|11309796|FG007|Part B (Up to 25 Days)|Adverse Event|0
7148618|NCT03154086|11309797|FG008|Part B (Up to 25 Days)|Adverse Event|0
6840352|NCT00273052|10846109|FG001|Overall Study|Withdrawal by Subject|19
6840353|NCT00273052|10846108|FG000|Overall Study|Adverse Event|21
6840354|NCT00273052|10846109|FG001|Overall Study|Adverse Event|19
6840355|NCT00273052|10846108|FG000|Overall Study|Protocol Violation|14
6840356|NCT00273052|10846109|FG001|Overall Study|Protocol Violation|18
6840357|NCT00273052|10846108|FG000|Overall Study|Lost to Follow-up|7
6840358|NCT00273052|10846109|FG001|Overall Study|Lost to Follow-up|25
6840359|NCT00273052|10846108|FG000|Overall Study|Lack of Efficacy|6
6840360|NCT00273052|10846109|FG001|Overall Study|Lack of Efficacy|4
6840361|NCT00273052|10846108|FG000|Overall Study|Non-Compliance|3
6840362|NCT00273052|10846109|FG001|Overall Study|Non-Compliance|1
6840363|NCT00273052|10846108|FG000|Overall Study|Other|2
6840364|NCT00273052|10846109|FG001|Overall Study|Other|0
6840365|NCT00273052|10846108|FG000|Overall Study|Worsening serum lipid levels|0
6840366|NCT00273052|10846109|FG001|Overall Study|Worsening serum lipid levels|2
6840367|NCT00273182|10846115|FG000|Overall Study|Death|450
6840368|NCT00273182|10846115|FG000|Overall Study|Lost to Follow-up|88
6840369|NCT00273182|10846115|FG000|Overall Study|Withdrawal by Subject|257
6840370|NCT00273182|10846115|FG000|Overall Study|Device/System Explant|154
6840371|NCT00273182|10846115|FG000|Overall Study|Site exit, system change, 36 m FU missed|36
6840372|NCT00273858|10846163|FG000|Overall Study|Not completed 24 month observation time|334
6840373|NCT00273858|10846163|FG000|Overall Study|Lost to Follow-up|101
6840374|NCT00273858|10846163|FG000|Overall Study|Withdrawal by Subject|21
6840375|NCT00273858|10846163|FG000|Overall Study|Adverse Event|81
6840376|NCT00274261|10846194|FG000|Overall Study|Adverse Event|19
6840377|NCT00274261|10846195|FG001|Overall Study|Adverse Event|11
6840378|NCT00274261|10846194|FG000|Overall Study|Pregnancy|114
6840379|NCT00274261|10846195|FG001|Overall Study|Pregnancy|83
6840380|NCT00274261|10846194|FG000|Overall Study|Withdrawal by Subject|179
6840381|NCT00274261|10846195|FG001|Overall Study|Withdrawal by Subject|126
6840382|NCT00274261|10846194|FG000|Overall Study|Protocol Violation|71
6840383|NCT00274261|10846195|FG001|Overall Study|Protocol Violation|42
6840384|NCT00274261|10846194|FG000|Overall Study|Lost to Follow-up|106
6840385|NCT00274261|10846195|FG001|Overall Study|Lost to Follow-up|75
6840386|NCT00274287|10846203|FG000|Overall Study|Withdrawal by Subject|1
6840387|NCT00274287|10846203|FG000|Overall Study|subject non-compliance|1
6840388|NCT00274456|10846212|FG000|Overall Study|Still on treatment|2
6840389|NCT00274456|10846213|FG001|Overall Study|Still on treatment|3
6840390|NCT00274456|10846214|FG002|Overall Study|Still on treatment|5
6840391|NCT00274456|10846215|FG003|Overall Study|Still on treatment|1
6840392|NCT00274456|10846212|FG000|Overall Study|Unacceptable toxicity|10
6840393|NCT00274456|10846213|FG001|Overall Study|Unacceptable toxicity|5
6840394|NCT00274456|10846214|FG002|Overall Study|Unacceptable toxicity|12
6840395|NCT00274456|10846215|FG003|Overall Study|Unacceptable toxicity|16
6840396|NCT00274456|10846212|FG000|Overall Study|Adverse Event|0
6840397|NCT00274456|10846213|FG001|Overall Study|Adverse Event|1
6840398|NCT00274456|10846214|FG002|Overall Study|Adverse Event|2
6840399|NCT00274456|10846215|FG003|Overall Study|Adverse Event|2
6840400|NCT00274456|10846212|FG000|Overall Study|Physician Decision|7
6840401|NCT00274456|10846213|FG001|Overall Study|Physician Decision|5
6840402|NCT00274456|10846214|FG002|Overall Study|Physician Decision|6
6840403|NCT00274456|10846215|FG003|Overall Study|Physician Decision|13
7148619|NCT03154086|11309798|FG009|Part B (Up to 25 Days)|Adverse Event|0
7148620|NCT03154086|11309799|FG010|Part B (Up to 25 Days)|Adverse Event|1
7148621|NCT03154086|11309800|FG011|Part B (Up to 25 Days)|Adverse Event|0
7148622|NCT03154086|11309801|FG012|Part B (Up to 25 Days)|Adverse Event|0
7148623|NCT03154086|11309802|FG013|Part B (Up to 25 Days)|Adverse Event|0
7148624|NCT03154086|11309803|FG014|Part B (Up to 25 Days)|Adverse Event|0
7148625|NCT03154476|11309871|FG000|Overall Study|Lost to Follow-up|4
7148626|NCT03154476|11309872|FG001|Overall Study|Lost to Follow-up|4
7148627|NCT03155178|11309900|FG000|Overall Study|Did not meet treatment day baseline|7
7148628|NCT03155178|11309901|FG001|Overall Study|Did not meet treatment day baseline|7
7148629|NCT03155178|11309902|FG002|Overall Study|Did not meet treatment day baseline|7
7148630|NCT03155178|11309903|FG003|Overall Study|Did not meet treatment day baseline|7
7148631|NCT03155269|11309919|FG000|Overall Study|Withdrawal by Subject|4
7148632|NCT03155269|11309920|FG001|Overall Study|Withdrawal by Subject|5
7148633|NCT03155269|11309919|FG000|Overall Study|Lost to Follow-up|1
7148634|NCT03155269|11309920|FG001|Overall Study|Lost to Follow-up|2
7148635|NCT03155724|11309926|FG000|Overall Study|Death|3
7148636|NCT03155724|11309926|FG000|Overall Study|Physician Decision|1
7148637|NCT03155724|11309926|FG000|Overall Study|Study closure|7
7148638|NCT03155945|11309932|FG000|Overall Study|Lost to Follow-up|0
7148639|NCT03155945|11309933|FG001|Overall Study|Lost to Follow-up|1
7148640|NCT03155945|11309932|FG000|Overall Study|Withdrawal by Subject|0
7148641|NCT03155945|11309933|FG001|Overall Study|Withdrawal by Subject|1
7148642|NCT03155945|11309932|FG000|Overall Study|Other Reason|0
7148643|NCT03155945|11309933|FG001|Overall Study|Other Reason|1
7148644|NCT03156270|11309939|FG000|Overall Study|Failed pre-treatment screening|1
7148645|NCT03156270|11309939|FG000|Overall Study|Lost to Follow-up|1
7148646|NCT03156543|11309947|FG000|Overall Study|Withdrawal by Subject|1
7148647|NCT03156543|11309948|FG001|Overall Study|Withdrawal by Subject|0
7148648|NCT03156621|11309956|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0
7148649|NCT03156621|11309957|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2
7148650|NCT03156621|11309956|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0
7148651|NCT03156621|11309957|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1
7148652|NCT03157089|11309968|FG000|Overall Study|Treated only with pembrolizumab|1
7148653|NCT03157089|11309969|FG001|Overall Study|Treated only with pembrolizumab|0
7148654|NCT03157089|11309968|FG000|Overall Study|Adverse Event|5
7148655|NCT03157089|11309969|FG001|Overall Study|Adverse Event|4
7148656|NCT03157089|11309968|FG000|Overall Study|Progressive disease|6
7148657|NCT03157089|11309969|FG001|Overall Study|Progressive disease|8
7148658|NCT03157531|11309980|FG000|Overall Study|Death|2
7148659|NCT03157531|11309980|FG000|Overall Study|Lost to Follow-up|4
7148660|NCT03157583|11309984|FG000|Overall Study|Other (did not meet study criteria)|1
7148661|NCT03158012|11310004|FG000|Overall Study|Withdrawal by Subject|0
7148662|NCT03158012|11310005|FG001|Overall Study|Withdrawal by Subject|1
7148663|NCT03158220|11310026|FG000|Overall Study|Screen Failure|0
7148664|NCT03158220|11310027|FG001|Overall Study|Screen Failure|1
7148665|NCT03158220|11310026|FG000|Overall Study|Withdrawal by Subject|8
7148666|NCT03158220|11310027|FG001|Overall Study|Withdrawal by Subject|9
7148667|NCT03158220|11310026|FG000|Overall Study|Status unknown|0
7148668|NCT03158220|11310027|FG001|Overall Study|Status unknown|1
7148669|NCT03158220|11310026|FG000|Overall Study|Lost to Follow-up|8
7148670|NCT03158220|11310027|FG001|Overall Study|Lost to Follow-up|5
7148671|NCT03158220|11310026|FG000|Overall Study|Physician Decision|1
7148672|NCT03158220|11310027|FG001|Overall Study|Physician Decision|0
7148673|NCT03158272|11310037|FG000|Overall Study|Disease progression|3
7148674|NCT03158272|11310038|FG001|Overall Study|Disease progression|3
7148675|NCT03158272|11310039|FG002|Overall Study|Disease progression|4
7148676|NCT03158272|11310040|FG003|Overall Study|Disease progression|6
7148677|NCT03158272|11310037|FG000|Overall Study|Death|0
7148678|NCT03158272|11310038|FG001|Overall Study|Death|0
7148679|NCT03158272|11310039|FG002|Overall Study|Death|1
7148680|NCT03158272|11310040|FG003|Overall Study|Death|0
7148681|NCT03158272|11310037|FG000|Overall Study|Other reasons|0
6840404|NCT00274456|10846212|FG000|Overall Study|Lost to Follow-up|0
7148682|NCT03158272|11310038|FG001|Overall Study|Other reasons|0
7148683|NCT03158272|11310039|FG002|Overall Study|Other reasons|1
7148684|NCT03158272|11310040|FG003|Overall Study|Other reasons|0
7148685|NCT03158272|11310037|FG000|Overall Study|Adverse event unrelated to the drug|0
7148686|NCT03158272|11310038|FG001|Overall Study|Adverse event unrelated to the drug|1
7148687|NCT03158272|11310039|FG002|Overall Study|Adverse event unrelated to the drug|0
7148688|NCT03158272|11310040|FG003|Overall Study|Adverse event unrelated to the drug|0
7148689|NCT03158311|11310055|FG000|Overall Study|Subject/Guardian Decision|10
7148690|NCT03158311|11310056|FG001|Overall Study|Subject/Guardian Decision|6
7148691|NCT03158311|11310057|FG002|Overall Study|Subject/Guardian Decision|11
7148692|NCT03158311|11310055|FG000|Overall Study|Adverse Event|5
6840405|NCT00274456|10846213|FG001|Overall Study|Lost to Follow-up|0
6840406|NCT00274456|10846214|FG002|Overall Study|Lost to Follow-up|1
6840407|NCT00274456|10846215|FG003|Overall Study|Lost to Follow-up|0
6840408|NCT00274456|10846212|FG000|Overall Study|Withdrawal by Subject|18
6840409|NCT00274456|10846213|FG001|Overall Study|Withdrawal by Subject|13
6840410|NCT00274456|10846214|FG002|Overall Study|Withdrawal by Subject|9
6840411|NCT00274456|10846215|FG003|Overall Study|Withdrawal by Subject|13
6840412|NCT00274469|10846227|FG000|Overall Study|Death|63
6840413|NCT00274469|10846228|FG001|Overall Study|Death|74
6840414|NCT00274469|10846227|FG000|Overall Study|Did not consent to OS follow-up|16
6840415|NCT00274469|10846228|FG001|Overall Study|Did not consent to OS follow-up|19
6840416|NCT00274625|10846236|FG000|Overall Study|Lost to Follow-up|46
6840417|NCT00274625|10846237|FG001|Overall Study|Lost to Follow-up|54
6840418|NCT00274625|10846236|FG000|Overall Study|Excluded from analysis|14
6840419|NCT00274625|10846237|FG001|Overall Study|Excluded from analysis|8
6840420|NCT00274651|10846245|FG000|Overall Study|Adverse Event|6
6840421|NCT00274651|10846246|FG001|Overall Study|Adverse Event|3
6840422|NCT00274651|10846245|FG000|Overall Study|Lack of Efficacy|13
6840423|NCT00274651|10846246|FG001|Overall Study|Lack of Efficacy|6
6840424|NCT00274651|10846245|FG000|Overall Study|Death|1
6840425|NCT00274651|10846246|FG001|Overall Study|Death|3
6840426|NCT00274651|10846245|FG000|Overall Study|Withdrawal by Subject|0
6840427|NCT00274651|10846246|FG001|Overall Study|Withdrawal by Subject|1
6840428|NCT00274651|10846245|FG000|Overall Study|Physician Decision|8
6840429|NCT00274651|10846246|FG001|Overall Study|Physician Decision|7
6840430|NCT00274716|10846259|FG000|Phase A|Other non-reported reason|4
7148693|NCT03158311|11310056|FG001|Overall Study|Adverse Event|3
7148694|NCT03158311|11310057|FG002|Overall Study|Adverse Event|3
6840431|NCT00274716|10846260|FG001|Phase A|Other non-reported reason|2
6840432|NCT00274716|10846261|FG002|Phase A|Other non-reported reason|1
6840433|NCT00274716|10846262|FG003|Phase A|Other non-reported reason|2
6840434|NCT00274716|10846263|FG004|Phase A|Other non-reported reason|0
6840435|NCT00274716|10846264|FG005|Phase A|Other non-reported reason|1
6840436|NCT00274716|10846259|FG000|Phase A|Participant moved|0
6840437|NCT00274716|10846260|FG001|Phase A|Participant moved|0
6840438|NCT00274716|10846261|FG002|Phase A|Participant moved|1
6840439|NCT00274716|10846262|FG003|Phase A|Participant moved|0
6840440|NCT00274716|10846263|FG004|Phase A|Participant moved|0
6840441|NCT00274716|10846264|FG005|Phase A|Participant moved|1
6840442|NCT00274716|10846259|FG000|Phase A|Site Terminated|0
6840443|NCT00274716|10846260|FG001|Phase A|Site Terminated|0
6840444|NCT00274716|10846261|FG002|Phase A|Site Terminated|0
6840445|NCT00274716|10846262|FG003|Phase A|Site Terminated|1
6840446|NCT00274716|10846263|FG004|Phase A|Site Terminated|0
6840447|NCT00274716|10846264|FG005|Phase A|Site Terminated|0
6840448|NCT00274716|10846259|FG000|Phase A|Protocol Violation|1
6840449|NCT00274716|10846260|FG001|Phase A|Protocol Violation|0
6840450|NCT00274716|10846261|FG002|Phase A|Protocol Violation|0
6840451|NCT00274716|10846262|FG003|Phase A|Protocol Violation|1
6840452|NCT00274716|10846263|FG004|Phase A|Protocol Violation|0
6840453|NCT00274716|10846264|FG005|Phase A|Protocol Violation|0
6840454|NCT00274716|10846259|FG000|Phase A|Met criteria for discontinuation|1
6840455|NCT00274716|10846260|FG001|Phase A|Met criteria for discontinuation|1
7148695|NCT03158311|11310055|FG000|Overall Study|Techinical Problems|3
7148696|NCT03158311|11310056|FG001|Overall Study|Techinical Problems|1
7148697|NCT03158311|11310057|FG002|Overall Study|Techinical Problems|5
7148698|NCT03158311|11310055|FG000|Overall Study|Physician Decision|2
7148699|NCT03158311|11310056|FG001|Overall Study|Physician Decision|3
7148700|NCT03158311|11310057|FG002|Overall Study|Physician Decision|7
7148701|NCT03158311|11310055|FG000|Overall Study|Lost to Follow-up|1
7148702|NCT03158311|11310056|FG001|Overall Study|Lost to Follow-up|1
7148703|NCT03158311|11310057|FG002|Overall Study|Lost to Follow-up|1
7148704|NCT03158311|11310055|FG000|Overall Study|Sponsor decision|1
7148705|NCT03158311|11310056|FG001|Overall Study|Sponsor decision|0
7148706|NCT03158311|11310057|FG002|Overall Study|Sponsor decision|0
7148707|NCT03158311|11310055|FG000|Overall Study|Pregnancy|0
7148708|NCT03158311|11310056|FG001|Overall Study|Pregnancy|2
6840456|NCT00274716|10846261|FG002|Phase A|Met criteria for discontinuation|0
7148709|NCT03158311|11310057|FG002|Overall Study|Pregnancy|0
7148710|NCT03158311|11310055|FG000|Overall Study|Randomized in error|0
6840457|NCT00274716|10846262|FG003|Phase A|Met criteria for discontinuation|0
6840458|NCT00274716|10846263|FG004|Phase A|Met criteria for discontinuation|0
6840459|NCT00274716|10846264|FG005|Phase A|Met criteria for discontinuation|0
6840460|NCT00274716|10846259|FG000|Phase A|Withdrawal by Subject|2
6840461|NCT00274716|10846260|FG001|Phase A|Withdrawal by Subject|2
6840462|NCT00274716|10846261|FG002|Phase A|Withdrawal by Subject|1
6840463|NCT00274716|10846262|FG003|Phase A|Withdrawal by Subject|3
6840464|NCT00274716|10846263|FG004|Phase A|Withdrawal by Subject|0
6840465|NCT00274716|10846264|FG005|Phase A|Withdrawal by Subject|1
6840466|NCT00274716|10846259|FG000|Phase A|Adverse Event|2
6840467|NCT00274716|10846260|FG001|Phase A|Adverse Event|3
6840468|NCT00274716|10846261|FG002|Phase A|Adverse Event|3
6840469|NCT00274716|10846262|FG003|Phase A|Adverse Event|0
6840470|NCT00274716|10846263|FG004|Phase A|Adverse Event|2
6840471|NCT00274716|10846264|FG005|Phase A|Adverse Event|0
7148711|NCT03158311|11310056|FG001|Overall Study|Randomized in error|0
7148712|NCT03158311|11310057|FG002|Overall Study|Randomized in error|1
6840472|NCT00274716|10846259|FG000|Phase A|Completed but did not enter Phase B|1
6840473|NCT00274716|10846260|FG001|Phase A|Completed but did not enter Phase B|2
6840474|NCT00274716|10846261|FG002|Phase A|Completed but did not enter Phase B|2
6840475|NCT00274716|10846262|FG003|Phase A|Completed but did not enter Phase B|2
6840476|NCT00274716|10846263|FG004|Phase A|Completed but did not enter Phase B|1
6840477|NCT00274716|10846264|FG005|Phase A|Completed but did not enter Phase B|1
6840478|NCT00274716|10846259|FG000|Phase B|Adverse Event|0
6840479|NCT00274716|10846260|FG001|Phase B|Adverse Event|0
6840480|NCT00274716|10846261|FG002|Phase B|Adverse Event|2
6840481|NCT00274716|10846262|FG003|Phase B|Adverse Event|0
6840482|NCT00274716|10846263|FG004|Phase B|Adverse Event|0
6840483|NCT00274716|10846264|FG005|Phase B|Adverse Event|1
6840484|NCT00274716|10846259|FG000|Phase B|Protocol Violation|0
6840485|NCT00274716|10846260|FG001|Phase B|Protocol Violation|2
7076997|NCT02087085|11184311|FG000|Overall Study|Other Miscellaneous Reasons|3
7076998|NCT02087085|11184312|FG001|Overall Study|Other Miscellaneous Reasons|4
7076999|NCT02087150|11184321|FG000|Overall Study|Death|0
6840486|NCT00274716|10846261|FG002|Phase B|Protocol Violation|0
6840487|NCT00274716|10846262|FG003|Phase B|Protocol Violation|0
6840488|NCT00274716|10846263|FG004|Phase B|Protocol Violation|0
6840489|NCT00274716|10846264|FG005|Phase B|Protocol Violation|0
6840490|NCT00274716|10846259|FG000|Phase B|Withdrawal by Subject|0
6840491|NCT00274716|10846260|FG001|Phase B|Withdrawal by Subject|1
6840492|NCT00274716|10846261|FG002|Phase B|Withdrawal by Subject|0
6840493|NCT00274716|10846262|FG003|Phase B|Withdrawal by Subject|0
6840494|NCT00274716|10846263|FG004|Phase B|Withdrawal by Subject|0
6840495|NCT00274716|10846264|FG005|Phase B|Withdrawal by Subject|0
6840496|NCT00274716|10846259|FG000|Phase B|Participant moved|1
7077000|NCT02087150|11184322|FG001|Overall Study|Death|1
7077001|NCT02087150|11184323|FG002|Overall Study|Death|0
7077002|NCT02087150|11184321|FG000|Overall Study|Lost to Follow-up|6
7148713|NCT03159091|11310080|FG000|Overall Study|Incorrect inclusion ineligible patient|5
7148714|NCT03159091|11310081|FG001|Overall Study|Incorrect inclusion ineligible patient|3
7148715|NCT03159091|11310080|FG000|Overall Study|Patient has taken no dose of study drug|0
7148716|NCT03159091|11310081|FG001|Overall Study|Patient has taken no dose of study drug|1
7148717|NCT03159455|11310115|FG000|Overall Study|Adverse Event|0
7148718|NCT03159455|11310116|FG001|Overall Study|Adverse Event|0
7148719|NCT03159455|11310117|FG002|Overall Study|Adverse Event|0
7148720|NCT03159455|11310118|FG003|Overall Study|Adverse Event|0
7148721|NCT03159455|11310119|FG004|Overall Study|Adverse Event|0
7148722|NCT03159455|11310120|FG005|Overall Study|Adverse Event|1
7148723|NCT03159468|11310144|FG000|Overall Study|Withdrawal by Subject|0
7148724|NCT03159468|11310145|FG001|Overall Study|Withdrawal by Subject|0
7148725|NCT03159468|11310146|FG002|Overall Study|Withdrawal by Subject|3
7148726|NCT03159468|11310147|FG003|Overall Study|Withdrawal by Subject|0
7148727|NCT03159468|11310148|FG004|Overall Study|Withdrawal by Subject|0
7148728|NCT03159468|11310149|FG005|Overall Study|Withdrawal by Subject|0
7148729|NCT03159611|11310165|FG000|Overall Study|Did Not Meet Inclusion Criteria|9
7148730|NCT03159611|11310166|FG001|Overall Study|Did Not Meet Inclusion Criteria|5
7148731|NCT03159611|11310165|FG000|Overall Study|Did Not Meet Exclusion Criteria|1
7148732|NCT03159611|11310166|FG001|Overall Study|Did Not Meet Exclusion Criteria|3
7148733|NCT03159611|11310165|FG000|Overall Study|Protocol Violation|7
7148734|NCT03159611|11310166|FG001|Overall Study|Protocol Violation|4
7148735|NCT03159611|11310165|FG000|Overall Study|Adverse Event|1
7148736|NCT03159611|11310166|FG001|Overall Study|Adverse Event|0
7148737|NCT03159611|11310165|FG000|Overall Study|Withdrawal by Subject|1
7148738|NCT03159611|11310166|FG001|Overall Study|Withdrawal by Subject|1
7148739|NCT03159611|11310165|FG000|Overall Study|Non-compliance with protocol requirement|3
7148740|NCT03159611|11310166|FG001|Overall Study|Non-compliance with protocol requirement|2
7148741|NCT03159611|11310165|FG000|Overall Study|Inability to perform procedures|1
7148742|NCT03159611|11310166|FG001|Overall Study|Inability to perform procedures|0
7148743|NCT03160560|11310216|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2
7148744|NCT03160560|11310217|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1
6840497|NCT00274716|10846260|FG001|Phase B|Participant moved|0
6840498|NCT00274716|10846261|FG002|Phase B|Participant moved|0
6840499|NCT00274716|10846262|FG003|Phase B|Participant moved|0
6840500|NCT00274716|10846263|FG004|Phase B|Participant moved|0
7077003|NCT02087150|11184322|FG001|Overall Study|Lost to Follow-up|13
7077004|NCT02087150|11184323|FG002|Overall Study|Lost to Follow-up|7
7077005|NCT02087150|11184321|FG000|Overall Study|Withdrawal by Subject|2
7077006|NCT02087150|11184322|FG001|Overall Study|Withdrawal by Subject|5
7077007|NCT02087150|11184323|FG002|Overall Study|Withdrawal by Subject|3
7077008|NCT02087150|11184321|FG000|Overall Study|Physician Decision|0
7077009|NCT02087150|11184322|FG001|Overall Study|Physician Decision|1
7077010|NCT02087150|11184323|FG002|Overall Study|Physician Decision|0
6840501|NCT00274716|10846264|FG005|Phase B|Participant moved|0
6840502|NCT00274716|10846259|FG000|Phase B|Other non-reported reason|0
6840503|NCT00274716|10846260|FG001|Phase B|Other non-reported reason|0
6840504|NCT00274716|10846261|FG002|Phase B|Other non-reported reason|1
6840505|NCT00274716|10846262|FG003|Phase B|Other non-reported reason|1
6840506|NCT00274716|10846263|FG004|Phase B|Other non-reported reason|0
7077011|NCT02087150|11184321|FG000|Overall Study|Procedure not done|1
7148745|NCT03160560|11310218|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1
7148746|NCT03160560|11310219|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0
7148747|NCT03160560|11310216|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1
7148748|NCT03160560|11310217|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0
7148749|NCT03160560|11310218|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0
7148750|NCT03160560|11310219|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0
7148751|NCT03160573|11310233|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1
7148752|NCT03160573|11310234|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3
7148753|NCT03160573|11310235|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2
7148754|NCT03160573|11310236|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2
7148755|NCT03160703|11310250|FG000|Overall Study|Withdrawal by Subject|0
7148756|NCT03160703|11310251|FG001|Overall Study|Withdrawal by Subject|0
7148757|NCT03160703|11310252|FG002|Overall Study|Withdrawal by Subject|0
7148758|NCT03160703|11310253|FG003|Overall Study|Withdrawal by Subject|1
7148759|NCT03160716|11310263|FG000|Overall Study|Lost to Follow-up|1
7148760|NCT03160885|11310269|FG000|Initial Treatment Period|Not dosed|2
7148761|NCT03160885|11310270|FG001|Initial Treatment Period|Not dosed|0
7148762|NCT03160885|11310271|FG002|Initial Treatment Period|Not dosed|0
7148763|NCT03160885|11310272|FG003|Initial Treatment Period|Not dosed|0
7148764|NCT03160885|11310273|FG004|Initial Treatment Period|Not dosed|0
7148765|NCT03160885|11310274|FG005|Initial Treatment Period|Not dosed|0
7148766|NCT03160885|11310275|FG006|Initial Treatment Period|Not dosed|0
7148767|NCT03160885|11310269|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33
7148768|NCT03160885|11310270|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22
7148769|NCT03160885|11310271|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0
7148770|NCT03160885|11310272|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0
7148771|NCT03160885|11310273|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0
7148772|NCT03160885|11310274|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0
7148773|NCT03160885|11310275|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0
7148774|NCT03160885|11310269|FG000|Open-label Treatment|Not dosed|0
7148775|NCT03160885|11310270|FG001|Open-label Treatment|Not dosed|0
7148776|NCT03160885|11310271|FG002|Open-label Treatment|Not dosed|0
7148777|NCT03160885|11310272|FG003|Open-label Treatment|Not dosed|0
7148778|NCT03160885|11310273|FG004|Open-label Treatment|Not dosed|0
7148779|NCT03160885|11310274|FG005|Open-label Treatment|Not dosed|0
7148780|NCT03160885|11310275|FG006|Open-label Treatment|Not dosed|2
7148781|NCT03160885|11310269|FG000|Open-label Treatment|Discontinued IMP|0
7148782|NCT03160885|11310270|FG001|Open-label Treatment|Discontinued IMP|0
7148783|NCT03160885|11310271|FG002|Open-label Treatment|Discontinued IMP|0
7148784|NCT03160885|11310272|FG003|Open-label Treatment|Discontinued IMP|0
7148785|NCT03160885|11310273|FG004|Open-label Treatment|Discontinued IMP|0
7148786|NCT03160885|11310274|FG005|Open-label Treatment|Discontinued IMP|0
7148787|NCT03160885|11310275|FG006|Open-label Treatment|Discontinued IMP|131
7148788|NCT03160885|11310269|FG000|Open-label Treatment|Completed Week 50|0
7148789|NCT03160885|11310270|FG001|Open-label Treatment|Completed Week 50|0
7148790|NCT03160885|11310271|FG002|Open-label Treatment|Completed Week 50|0
7148791|NCT03160885|11310272|FG003|Open-label Treatment|Completed Week 50|0
7148792|NCT03160885|11310273|FG004|Open-label Treatment|Completed Week 50|0
7148793|NCT03160885|11310274|FG005|Open-label Treatment|Completed Week 50|0
7148794|NCT03160885|11310275|FG006|Open-label Treatment|Completed Week 50|4
7148795|NCT03160885|11310269|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0
7148796|NCT03160885|11310270|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0
7148797|NCT03160885|11310271|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0
7148798|NCT03160885|11310272|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1
7148799|NCT03160885|11310273|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0
7148800|NCT03160885|11310274|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0
7148801|NCT03160885|11310275|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0
7148802|NCT03160885|11310269|FG000|Maintenance Treatment Period|Discontinued IMP|0
7148803|NCT03160885|11310270|FG001|Maintenance Treatment Period|Discontinued IMP|0
7148804|NCT03160885|11310271|FG002|Maintenance Treatment Period|Discontinued IMP|9
7148805|NCT03160885|11310272|FG003|Maintenance Treatment Period|Discontinued IMP|13
7148806|NCT03160885|11310273|FG004|Maintenance Treatment Period|Discontinued IMP|5
7148807|NCT03160885|11310274|FG005|Maintenance Treatment Period|Discontinued IMP|7
7148808|NCT03160885|11310275|FG006|Maintenance Treatment Period|Discontinued IMP|0
7148809|NCT03160885|11310269|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0
7148810|NCT03160885|11310270|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0
7148811|NCT03160885|11310271|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29
7148812|NCT03160885|11310272|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26
7148813|NCT03160885|11310273|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26
7148814|NCT03160885|11310274|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8
7148815|NCT03160885|11310275|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0
7148816|NCT03160885|11310269|FG000|Maintenance Treatment Period|Completed Week 50|0
7148817|NCT03160885|11310270|FG001|Maintenance Treatment Period|Completed Week 50|0
7148818|NCT03160885|11310271|FG002|Maintenance Treatment Period|Completed Week 50|1
7148819|NCT03160885|11310272|FG003|Maintenance Treatment Period|Completed Week 50|0
7148820|NCT03160885|11310273|FG004|Maintenance Treatment Period|Completed Week 50|0
7148821|NCT03160885|11310274|FG005|Maintenance Treatment Period|Completed Week 50|0
7148822|NCT03160885|11310275|FG006|Maintenance Treatment Period|Completed Week 50|0
7148823|NCT03160898|11310296|FG000|Overall Study|Adverse Event|4
7148824|NCT03160898|11310297|FG001|Overall Study|Adverse Event|8
7148825|NCT03160898|11310298|FG002|Overall Study|Adverse Event|7
7148826|NCT03160898|11310299|FG003|Overall Study|Adverse Event|10
7148827|NCT03160898|11310296|FG000|Overall Study|Death|1
7148828|NCT03160898|11310297|FG001|Overall Study|Death|0
7148829|NCT03160898|11310298|FG002|Overall Study|Death|0
7148830|NCT03160898|11310299|FG003|Overall Study|Death|1
7148831|NCT03160898|11310296|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3
7148832|NCT03160898|11310297|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0
7148833|NCT03160898|11310298|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0
7148834|NCT03160898|11310299|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1
7148835|NCT03160898|11310296|FG000|Overall Study|Lost to Follow-up|1
7148836|NCT03160898|11310297|FG001|Overall Study|Lost to Follow-up|1
7148837|NCT03160898|11310298|FG002|Overall Study|Lost to Follow-up|1
7148838|NCT03160898|11310299|FG003|Overall Study|Lost to Follow-up|2
7148839|NCT03160898|11310296|FG000|Overall Study|Physician Decision|1
7148840|NCT03160898|11310297|FG001|Overall Study|Physician Decision|0
7148841|NCT03160898|11310298|FG002|Overall Study|Physician Decision|0
7148842|NCT03160898|11310299|FG003|Overall Study|Physician Decision|1
7148843|NCT03160898|11310296|FG000|Overall Study|Progressive Disease|4
7148844|NCT03160898|11310297|FG001|Overall Study|Progressive Disease|1
7148845|NCT03160898|11310298|FG002|Overall Study|Progressive Disease|2
7148846|NCT03160898|11310299|FG003|Overall Study|Progressive Disease|1
7148847|NCT03160898|11310296|FG000|Overall Study|Protocol Violation|1
7148848|NCT03160898|11310297|FG001|Overall Study|Protocol Violation|0
7148849|NCT03160898|11310298|FG002|Overall Study|Protocol Violation|2
7148850|NCT03160898|11310299|FG003|Overall Study|Protocol Violation|0
7148851|NCT03160898|11310296|FG000|Overall Study|Sponsor Discretion|2
7148852|NCT03160898|11310297|FG001|Overall Study|Sponsor Discretion|0
7148853|NCT03160898|11310298|FG002|Overall Study|Sponsor Discretion|0
7148854|NCT03160898|11310299|FG003|Overall Study|Sponsor Discretion|0
7148855|NCT03160898|11310296|FG000|Overall Study|Withdrawal by Subject|1
6840507|NCT00274716|10846264|FG005|Phase B|Other non-reported reason|0
6840508|NCT00274716|10846259|FG000|Phase B|Lost to Follow-up|0
6840509|NCT00274716|10846260|FG001|Phase B|Lost to Follow-up|1
6840510|NCT00274716|10846261|FG002|Phase B|Lost to Follow-up|0
6840511|NCT00274716|10846262|FG003|Phase B|Lost to Follow-up|0
6840512|NCT00274716|10846263|FG004|Phase B|Lost to Follow-up|0
6840513|NCT00274716|10846264|FG005|Phase B|Lost to Follow-up|0
6840514|NCT00274742|10846288|FG000|Overall Study|Adverse Event|0
6840515|NCT00274742|10846289|FG001|Overall Study|Adverse Event|4
6840516|NCT00274742|10846290|FG002|Overall Study|Adverse Event|1
6840517|NCT00274742|10846291|FG003|Overall Study|Adverse Event|4
6840518|NCT00274742|10846292|FG004|Overall Study|Adverse Event|12
6840519|NCT00274742|10846293|FG005|Overall Study|Adverse Event|3
6840520|NCT00274742|10846288|FG000|Overall Study|Lost to Follow-up|0
6840521|NCT00274742|10846289|FG001|Overall Study|Lost to Follow-up|0
6840522|NCT00274742|10846290|FG002|Overall Study|Lost to Follow-up|0
6840523|NCT00274742|10846291|FG003|Overall Study|Lost to Follow-up|0
6840524|NCT00274742|10846292|FG004|Overall Study|Lost to Follow-up|1
6840525|NCT00274742|10846293|FG005|Overall Study|Lost to Follow-up|0
6840526|NCT00274742|10846288|FG000|Overall Study|End of Study|0
6840527|NCT00274742|10846289|FG001|Overall Study|End of Study|0
6840528|NCT00274742|10846290|FG002|Overall Study|End of Study|0
6840529|NCT00274742|10846291|FG003|Overall Study|End of Study|1
6840530|NCT00274742|10846292|FG004|Overall Study|End of Study|0
6840531|NCT00274742|10846293|FG005|Overall Study|End of Study|0
6840532|NCT00274742|10846288|FG000|Overall Study|Disease Progression|0
6840533|NCT00274742|10846289|FG001|Overall Study|Disease Progression|1
7148856|NCT03160898|11310297|FG001|Overall Study|Withdrawal by Subject|3
7148857|NCT03160898|11310298|FG002|Overall Study|Withdrawal by Subject|2
7148858|NCT03160898|11310299|FG003|Overall Study|Withdrawal by Subject|1
7148859|NCT03160898|11310296|FG000|Overall Study|Other|2
7148860|NCT03160898|11310297|FG001|Overall Study|Other|0
7148861|NCT03160898|11310298|FG002|Overall Study|Other|2
7148862|NCT03160898|11310299|FG003|Overall Study|Other|2
7148863|NCT03161405|11310324|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1
7148864|NCT03161483|11310335|FG000|Overall Study|Death|1
7148865|NCT03161483|11310336|FG001|Overall Study|Death|0
6840534|NCT00274742|10846290|FG002|Overall Study|Disease Progression|1
7148866|NCT03161483|11310337|FG002|Overall Study|Death|0
7148867|NCT03161483|11310338|FG003|Overall Study|Death|0
7148868|NCT03161483|11310335|FG000|Overall Study|Adverse Event|5
6840535|NCT00274742|10846291|FG003|Overall Study|Disease Progression|0
6840536|NCT00274742|10846292|FG004|Overall Study|Disease Progression|1
6840537|NCT00274742|10846293|FG005|Overall Study|Disease Progression|0
6840538|NCT00274742|10846288|FG000|Overall Study|Other|0
6840539|NCT00274742|10846289|FG001|Overall Study|Other|3
6840540|NCT00274742|10846290|FG002|Overall Study|Other|0
6840541|NCT00274742|10846291|FG003|Overall Study|Other|0
6840542|NCT00274742|10846292|FG004|Overall Study|Other|2
6840543|NCT00274742|10846293|FG005|Overall Study|Other|0
7148869|NCT03161483|11310336|FG001|Overall Study|Adverse Event|1
7148870|NCT03161483|11310337|FG002|Overall Study|Adverse Event|11
7148871|NCT03161483|11310338|FG003|Overall Study|Adverse Event|2
7148872|NCT03161483|11310335|FG000|Overall Study|Pregnancy|1
7148873|NCT03161483|11310336|FG001|Overall Study|Pregnancy|0
7148874|NCT03161483|11310337|FG002|Overall Study|Pregnancy|0
7148875|NCT03161483|11310338|FG003|Overall Study|Pregnancy|0
7148876|NCT03161483|11310335|FG000|Overall Study|Lack of Efficacy|0
7148877|NCT03161483|11310336|FG001|Overall Study|Lack of Efficacy|0
7148878|NCT03161483|11310337|FG002|Overall Study|Lack of Efficacy|1
7148879|NCT03161483|11310338|FG003|Overall Study|Lack of Efficacy|0
7148880|NCT03161483|11310335|FG000|Overall Study|Withdrawal by Subject|2
7148881|NCT03161483|11310336|FG001|Overall Study|Withdrawal by Subject|2
7148882|NCT03161483|11310337|FG002|Overall Study|Withdrawal by Subject|6
7148883|NCT03161483|11310338|FG003|Overall Study|Withdrawal by Subject|5
7148884|NCT03161483|11310335|FG000|Overall Study|Lost to Follow-up|0
7148885|NCT03161483|11310336|FG001|Overall Study|Lost to Follow-up|0
7148886|NCT03161483|11310337|FG002|Overall Study|Lost to Follow-up|1
7148887|NCT03161483|11310338|FG003|Overall Study|Lost to Follow-up|0
7148888|NCT03161483|11310335|FG000|Overall Study|Protocol Violation|0
7148889|NCT03161483|11310336|FG001|Overall Study|Protocol Violation|0
7148890|NCT03161483|11310337|FG002|Overall Study|Protocol Violation|1
6840544|NCT00274846|10846322|FG000|Overall Study|Did not receive adequate NK cells|1
6840545|NCT00274924|10846330|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4
6840546|NCT00274924|10846331|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14
6840547|NCT00274924|10846332|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1
6840548|NCT00274924|10846330|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
6840549|NCT00274924|10846331|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
6840550|NCT00274924|10846332|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1
6840551|NCT00274924|10846330|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
6840552|NCT00274924|10846331|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
6840553|NCT00274924|10846332|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1
6840554|NCT00274924|10846330|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
6840555|NCT00274924|10846331|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
6840556|NCT00274924|10846332|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1
6840557|NCT00274924|10846330|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
6840558|NCT00274924|10846331|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
6840559|NCT00274924|10846332|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1
6840560|NCT00274924|10846330|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
6840561|NCT00274924|10846331|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
6840562|NCT00274924|10846332|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1
6840563|NCT00274924|10846330|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4
6840564|NCT00274924|10846331|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15
6840565|NCT00274924|10846332|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0
6840566|NCT00274924|10846330|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1
6840567|NCT00274924|10846331|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
6840568|NCT00274924|10846332|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
6840569|NCT00274924|10846330|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1
6840570|NCT00274924|10846331|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
6840571|NCT00274924|10846332|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
6840572|NCT00274924|10846330|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1
6840573|NCT00274924|10846331|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
6840574|NCT00274924|10846332|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
6840575|NCT00274924|10846330|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0
6840576|NCT00274924|10846331|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1
6840577|NCT00274924|10846332|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0
6840578|NCT00274924|10846330|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
6840579|NCT00274924|10846331|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1
7148891|NCT03161483|11310338|FG003|Overall Study|Protocol Violation|0
7148892|NCT03161483|11310335|FG000|Overall Study|Other reasons|1
7148893|NCT03161483|11310336|FG001|Overall Study|Other reasons|0
7148894|NCT03161483|11310337|FG002|Overall Study|Other reasons|0
7148895|NCT03161483|11310338|FG003|Overall Study|Other reasons|1
7148896|NCT03162055|11310359|FG000|Overall Study|Adverse Event|6
7148897|NCT03162055|11310360|FG001|Overall Study|Adverse Event|5
7148898|NCT03162055|11310359|FG000|Overall Study|Death|3
7148899|NCT03162055|11310360|FG001|Overall Study|Death|3
7148900|NCT03162055|11310359|FG000|Overall Study|Lost to Follow-up|0
7148901|NCT03162055|11310360|FG001|Overall Study|Lost to Follow-up|1
7148902|NCT03162055|11310359|FG000|Overall Study|Study-specific withdrawal criteria|22
7148903|NCT03162055|11310360|FG001|Overall Study|Study-specific withdrawal criteria|14
7148904|NCT03162055|11310359|FG000|Overall Study|Withdrawal by Subject|17
6840580|NCT00274924|10846332|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
6840581|NCT00274924|10846330|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
6840582|NCT00274924|10846331|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1
7148905|NCT03162055|11310360|FG001|Overall Study|Withdrawal by Subject|2
7148906|NCT03162055|11310359|FG000|Overall Study|Did not receive treatment|2
7148907|NCT03162055|11310360|FG001|Overall Study|Did not receive treatment|0
7148908|NCT03162055|11310359|FG000|Overall Study|Incorrect randomization|4
7148909|NCT03162055|11310360|FG001|Overall Study|Incorrect randomization|3
7148910|NCT03162055|11310359|FG000|Overall Study|Other|8
7148911|NCT03162055|11310360|FG001|Overall Study|Other|15
7148912|NCT03162328|11310366|FG000|Screening Period|Did not meet inclusion/exclusion|21
7148913|NCT03162328|11310367|FG001|Screening Period|Did not meet inclusion/exclusion|0
7148914|NCT03162328|11310368|FG002|Screening Period|Did not meet inclusion/exclusion|0
7148915|NCT03162328|11310366|FG000|Screening Period|Withdrawal by Subject|1
7148916|NCT03162328|11310367|FG001|Screening Period|Withdrawal by Subject|0
7148917|NCT03162328|11310368|FG002|Screening Period|Withdrawal by Subject|0
7148918|NCT03162328|11310366|FG000|Study Period|Withdrawal by Subject|0
7148919|NCT03162328|11310367|FG001|Study Period|Withdrawal by Subject|0
7148920|NCT03162328|11310368|FG002|Study Period|Withdrawal by Subject|1
7148921|NCT03162614|11310408|FG000|Overall Study|Lost to Follow-up|2
7148922|NCT03162614|11310409|FG001|Overall Study|Lost to Follow-up|1
7148923|NCT03162614|11310410|FG002|Overall Study|Lost to Follow-up|1
7148924|NCT03162614|11310411|FG003|Overall Study|Lost to Follow-up|1
7148925|NCT03162614|11310412|FG004|Overall Study|Lost to Follow-up|2
7148926|NCT03162614|11310413|FG005|Overall Study|Lost to Follow-up|0
7148927|NCT03162614|11310408|FG000|Overall Study|Protocol Violation|0
7148928|NCT03162614|11310409|FG001|Overall Study|Protocol Violation|1
7148929|NCT03162614|11310410|FG002|Overall Study|Protocol Violation|0
7148930|NCT03162614|11310411|FG003|Overall Study|Protocol Violation|1
7148931|NCT03162614|11310412|FG004|Overall Study|Protocol Violation|0
7148932|NCT03162614|11310413|FG005|Overall Study|Protocol Violation|0
7148933|NCT03162614|11310408|FG000|Overall Study|Withdrawal by Subject|2
7148934|NCT03162614|11310409|FG001|Overall Study|Withdrawal by Subject|1
7148935|NCT03162614|11310410|FG002|Overall Study|Withdrawal by Subject|1
7148936|NCT03162614|11310411|FG003|Overall Study|Withdrawal by Subject|1
7148937|NCT03162614|11310412|FG004|Overall Study|Withdrawal by Subject|0
7148938|NCT03162614|11310413|FG005|Overall Study|Withdrawal by Subject|0
7148939|NCT03162614|11310408|FG000|Overall Study|Missed vaccination, exclusion criteria|2
7148940|NCT03162614|11310409|FG001|Overall Study|Missed vaccination, exclusion criteria|2
7148941|NCT03162614|11310410|FG002|Overall Study|Missed vaccination, exclusion criteria|2
7148942|NCT03162614|11310411|FG003|Overall Study|Missed vaccination, exclusion criteria|4
7148943|NCT03162614|11310412|FG004|Overall Study|Missed vaccination, exclusion criteria|3
7148944|NCT03162614|11310413|FG005|Overall Study|Missed vaccination, exclusion criteria|0
7148945|NCT03162796|11310430|FG000|Placebo Controlled Period: Week 0 - 24|Other|0
7148946|NCT03162796|11310431|FG001|Placebo Controlled Period: Week 0 - 24|Other|1
7148947|NCT03162796|11310432|FG002|Placebo Controlled Period: Week 0 - 24|Other|1
7148948|NCT03162796|11310430|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1
7148949|NCT03162796|11310431|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0
7148950|NCT03162796|11310432|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0
7148951|NCT03162796|11310430|FG000|Placebo Controlled Period: Week 0 - 24|Death|1
7148952|NCT03162796|11310431|FG001|Placebo Controlled Period: Week 0 - 24|Death|0
7148953|NCT03162796|11310432|FG002|Placebo Controlled Period: Week 0 - 24|Death|0
7148954|NCT03162796|11310430|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1
7148955|NCT03162796|11310431|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0
6840583|NCT00274924|10846332|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
6840584|NCT00274937|10846339|FG000|Overall Study|Physician Decision|10
6840585|NCT00274937|10846339|FG000|Overall Study|Withdrawal by Subject|6
6840586|NCT00274937|10846339|FG000|Overall Study|Progressive Disease|4
6840587|NCT00275002|10846345|FG000|Overall Study|Death|1
6840588|NCT00275002|10846346|FG001|Overall Study|Death|0
6840589|NCT00275002|10846345|FG000|Overall Study|Disease progression|21
6840590|NCT00275002|10846346|FG001|Overall Study|Disease progression|15
6840591|NCT00275002|10846345|FG000|Overall Study|Adverse Event|0
6840592|NCT00275002|10846346|FG001|Overall Study|Adverse Event|1
6840593|NCT00275028|10846352|FG000|Overall Study|Withdrew consent before treatment began|1
6840594|NCT00275028|10846352|FG000|Overall Study|Withdrawal by Subject|5
6840595|NCT00275028|10846352|FG000|Overall Study|Adverse Event|9
6840596|NCT00275028|10846352|FG000|Overall Study|Progressive Disease|30
6840597|NCT00275028|10846352|FG000|Overall Study|Physician Decision|2
6840598|NCT00275262|10846358|FG000|Overall Study|Adverse Event|2
6840599|NCT00275262|10846359|FG001|Overall Study|Adverse Event|0
6840600|NCT00275262|10846358|FG000|Overall Study|Disease progression|2
6840601|NCT00275262|10846359|FG001|Overall Study|Disease progression|5
6840602|NCT00275262|10846358|FG000|Overall Study|Lost to Follow-up|0
6840603|NCT00275262|10846359|FG001|Overall Study|Lost to Follow-up|2
6840604|NCT00275262|10846358|FG000|Overall Study|Protocol Violation|0
6840605|NCT00275262|10846359|FG001|Overall Study|Protocol Violation|2
6840606|NCT00275262|10846358|FG000|Overall Study|Death|1
6840607|NCT00275262|10846359|FG001|Overall Study|Death|0
6840608|NCT00275262|10846358|FG000|Overall Study|Started Chemotherapy|1
7148956|NCT03162796|11310432|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0
7148957|NCT03162796|11310430|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3
7148958|NCT03162796|11310431|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0
6840609|NCT00275262|10846359|FG001|Overall Study|Started Chemotherapy|0
6840610|NCT00275301|10846378|FG000|Overall Study|Adverse Event|5
6840611|NCT00275509|10846393|FG000|Overall Study|graft thrombosis, post-operative day #8|0
6840612|NCT00275509|10846394|FG001|Overall Study|graft thrombosis, post-operative day #8|1
6840613|NCT00275561|10846402|FG000|Overall Study|Withdrawal by Subject|0
7148959|NCT03162796|11310432|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1
7148960|NCT03162796|11310430|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4
7148961|NCT03162796|11310431|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0
7148962|NCT03162796|11310432|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0
7148963|NCT03162796|11310430|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2
7148964|NCT03162796|11310431|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3
7148965|NCT03162796|11310432|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1
7148966|NCT03162796|11310430|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0
7148967|NCT03162796|11310431|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2
7148968|NCT03162796|11310432|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0
7148969|NCT03162796|11310430|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4
7148970|NCT03162796|11310431|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3
7148971|NCT03162796|11310432|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1
7148972|NCT03162796|11310430|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3
7148973|NCT03162796|11310431|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2
7148974|NCT03162796|11310432|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0
7148975|NCT03162796|11310430|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1
7148976|NCT03162796|11310431|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2
7148977|NCT03162796|11310432|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1
7148978|NCT03163446|11310473|FG000|Overall Study|Unable to return for Day 180 visit|2
7148979|NCT03163446|11310474|FG001|Overall Study|Unable to return for Day 180 visit|0
7148980|NCT03163446|11310473|FG000|Overall Study|Withdrawal by Subject|2
7148981|NCT03163446|11310474|FG001|Overall Study|Withdrawal by Subject|6
7148982|NCT03163446|11310473|FG000|Overall Study|Death|16
7148983|NCT03163446|11310474|FG001|Overall Study|Death|5
7148984|NCT03163446|11310473|FG000|Overall Study|Lost to Follow-up|6
7148985|NCT03163446|11310474|FG001|Overall Study|Lost to Follow-up|5
7148986|NCT03163446|11310473|FG000|Overall Study|Physician Decision|1
7148987|NCT03163446|11310474|FG001|Overall Study|Physician Decision|1
7148988|NCT03163446|11310473|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1
7148989|NCT03163446|11310474|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0
7148990|NCT03164551|11310517|FG000|Overall Study|Imaging discontinued prior completion|8
7148991|NCT03164551|11310518|FG001|Overall Study|Imaging discontinued prior completion|0
7148992|NCT03164551|11310517|FG000|Overall Study|Participant was non-compliant|1
7148993|NCT03164551|11310518|FG001|Overall Study|Participant was non-compliant|0
7148994|NCT03164551|11310517|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12
7148995|NCT03164551|11310518|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14
7148996|NCT03164551|11310517|FG000|Overall Study|Other|8
7148997|NCT03164551|11310518|FG001|Overall Study|Other|2
7148998|NCT03165045|11310533|FG000|Visit 1|No registration after visit 1|9
7148999|NCT03165045|11310533|FG000|Visit 1|No treatment documented|10
7149000|NCT03165045|11310533|FG000|Visit 1|No visit 1|10
7149001|NCT03165045|11310533|FG000|Visit 2|Available CCQ score at visit 1 only|109
7149002|NCT03165045|11310533|FG000|Visit 2|No available total CCQ score at all|29
7149003|NCT03165045|11310533|FG000|Visit 2|Available total CCQ score at vist 2 only|44
7149004|NCT03165110|11310548|FG000|Overall Study|Anroid phone software incompatibility|1
7149005|NCT03166124|11310599|FG000|Treatment Period 1|Adverse Event|0
7149006|NCT03166124|11310600|FG001|Treatment Period 1|Adverse Event|0
7149007|NCT03166124|11310601|FG002|Treatment Period 1|Adverse Event|1
7149008|NCT03166124|11310602|FG003|Treatment Period 1|Adverse Event|0
7149009|NCT03166124|11310599|FG000|Wash-out Period|Withdrawal by Subject|0
7149010|NCT03166124|11310600|FG001|Wash-out Period|Withdrawal by Subject|1
7149011|NCT03166124|11310601|FG002|Wash-out Period|Withdrawal by Subject|0
7149012|NCT03166124|11310602|FG003|Wash-out Period|Withdrawal by Subject|1
7149013|NCT03166124|11310599|FG000|Wash-out Period|Adverse Event|0
7149014|NCT03166124|11310600|FG001|Wash-out Period|Adverse Event|1
7149015|NCT03166124|11310601|FG002|Wash-out Period|Adverse Event|1
7149016|NCT03166124|11310602|FG003|Wash-out Period|Adverse Event|0
7149017|NCT03166215|11310615|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0
7149018|NCT03166215|11310616|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2
7149019|NCT03166215|11310617|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0
7149020|NCT03166215|11310615|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0
7149021|NCT03166215|11310616|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0
7149022|NCT03166215|11310617|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2
7149023|NCT03166735|11310633|FG000|Overall Study|Not Treated|1
7149024|NCT03166735|11310634|FG001|Overall Study|Not Treated|0
7149025|NCT03166735|11310635|FG002|Overall Study|Not Treated|0
7149026|NCT03166735|11310636|FG003|Overall Study|Not Treated|0
7149027|NCT03166735|11310637|FG004|Overall Study|Not Treated|0
7149028|NCT03166735|11310633|FG000|Overall Study|follow-up not completed as planned|0
7149029|NCT03166735|11310634|FG001|Overall Study|follow-up not completed as planned|1
7149030|NCT03166735|11310635|FG002|Overall Study|follow-up not completed as planned|1
7149031|NCT03166735|11310636|FG003|Overall Study|follow-up not completed as planned|0
7077012|NCT02087150|11184322|FG001|Overall Study|Procedure not done|13
7077013|NCT02087150|11184323|FG002|Overall Study|Procedure not done|0
7077014|NCT02087150|11184321|FG000|Overall Study|F/U not completed w/in study window|0
7077015|NCT02087150|11184322|FG001|Overall Study|F/U not completed w/in study window|0
7077016|NCT02087150|11184323|FG002|Overall Study|F/U not completed w/in study window|1
7149032|NCT03166735|11310637|FG004|Overall Study|follow-up not completed as planned|1
7149033|NCT03166735|11310633|FG000|Overall Study|Withdrawal by Subject|0
7149034|NCT03166735|11310634|FG001|Overall Study|Withdrawal by Subject|0
7149035|NCT03166735|11310635|FG002|Overall Study|Withdrawal by Subject|1
7149036|NCT03166735|11310636|FG003|Overall Study|Withdrawal by Subject|1
7149037|NCT03166735|11310637|FG004|Overall Study|Withdrawal by Subject|2
7149038|NCT03166735|11310633|FG000|Overall Study|Lost to Follow-up|0
7149039|NCT03166735|11310634|FG001|Overall Study|Lost to Follow-up|2
7149040|NCT03166735|11310635|FG002|Overall Study|Lost to Follow-up|1
7149041|NCT03166735|11310636|FG003|Overall Study|Lost to Follow-up|0
7149042|NCT03166735|11310637|FG004|Overall Study|Lost to Follow-up|1
7149043|NCT03167073|11310652|FG000|Overall Study|Stillbirth|1
7149044|NCT03167073|11310653|FG001|Overall Study|Stillbirth|0
7149045|NCT03167151|11310662|FG000|Overall Study|Withdrawal by Subject|1
7149046|NCT03167151|11310663|FG001|Overall Study|Withdrawal by Subject|0
7149047|NCT03167151|11310664|FG002|Overall Study|Withdrawal by Subject|0
7149048|NCT03167151|11310662|FG000|Overall Study|No evidence of tumour at surgery|0
7149049|NCT03167151|11310663|FG001|Overall Study|No evidence of tumour at surgery|1
7149050|NCT03167151|11310664|FG002|Overall Study|No evidence of tumour at surgery|1
7149051|NCT03167359|11310672|FG000|Overall Study|Physician Decision|1
7149052|NCT03167359|11310672|FG000|Overall Study|Lost to Follow-up|1
7149053|NCT03167411|11310678|FG000|Overall Study|Adverse Event|0
7149054|NCT03167411|11310679|FG001|Overall Study|Adverse Event|1
7183854|NCT00587301|11383945|FG000|Overall Study|Screen Failure|9
7183855|NCT00587301|11383945|FG000|Overall Study|Lost to Follow-up|22
7183856|NCT00587301|11383945|FG000|Overall Study|Withdrawal by Subject|7
7183857|NCT00587301|11383945|FG000|Overall Study|Protocol Violation|7
7183858|NCT00579527|11383949|FG000|Overall Study|Death|4
7183859|NCT00576836|11383954|FG000|Overall Study|Death|0
7183860|NCT00576836|11383955|FG001|Overall Study|Death|1
7183861|NCT00576836|11383954|FG000|Overall Study|Physician Decision|0
7183862|NCT00576836|11383955|FG001|Overall Study|Physician Decision|1
7183863|NCT00576407|11383959|FG000|Overall Study|Death|7
7183864|NCT00576407|11383959|FG000|Overall Study|Physician Decision|1
7183865|NCT00557193|11383964|FG000|Induction|Adverse Event|2
7183866|NCT00557193|11383965|FG001|Induction|Adverse Event|0
7183867|NCT00557193|11383966|FG002|Induction|Adverse Event|0
7183868|NCT00557193|11383967|FG003|Induction|Adverse Event|0
7183869|NCT00557193|11383968|FG004|Induction|Adverse Event|0
7183870|NCT00557193|11383969|FG005|Induction|Adverse Event|0
7183871|NCT00557193|11383964|FG000|Induction|Death|6
7183872|NCT00557193|11383965|FG001|Induction|Death|0
7183873|NCT00557193|11383966|FG002|Induction|Death|0
7183874|NCT00557193|11383967|FG003|Induction|Death|0
7183875|NCT00557193|11383968|FG004|Induction|Death|0
7183876|NCT00557193|11383969|FG005|Induction|Death|0
7183877|NCT00557193|11383964|FG000|Induction|Physician Decision|3
6840614|NCT00275561|10846403|FG001|Overall Study|Withdrawal by Subject|1
6840615|NCT00275561|10846402|FG000|Overall Study|Travel|1
6840616|NCT00275561|10846403|FG001|Overall Study|Travel|1
7183878|NCT00557193|11383965|FG001|Induction|Physician Decision|0
7183879|NCT00557193|11383966|FG002|Induction|Physician Decision|0
7183880|NCT00557193|11383967|FG003|Induction|Physician Decision|0
7183881|NCT00557193|11383968|FG004|Induction|Physician Decision|0
7183882|NCT00557193|11383969|FG005|Induction|Physician Decision|0
7183883|NCT00557193|11383964|FG000|Induction|Withdrawal by Subject|1
7183884|NCT00557193|11383965|FG001|Induction|Withdrawal by Subject|0
7183885|NCT00557193|11383966|FG002|Induction|Withdrawal by Subject|0
7183886|NCT00557193|11383967|FG003|Induction|Withdrawal by Subject|0
7183887|NCT00557193|11383968|FG004|Induction|Withdrawal by Subject|0
7183888|NCT00557193|11383969|FG005|Induction|Withdrawal by Subject|0
7183889|NCT00557193|11383964|FG000|Induction|Refusal of Further Protocol Therapy|2
7183890|NCT00557193|11383965|FG001|Induction|Refusal of Further Protocol Therapy|0
7183891|NCT00557193|11383966|FG002|Induction|Refusal of Further Protocol Therapy|0
7183892|NCT00557193|11383967|FG003|Induction|Refusal of Further Protocol Therapy|0
6840617|NCT00275561|10846402|FG000|Overall Study|Scheduling|1
7077017|NCT02087150|11184321|FG000|Overall Study|Other|1
7077018|NCT02087150|11184322|FG001|Overall Study|Other|0
7077019|NCT02087150|11184323|FG002|Overall Study|Other|0
7077020|NCT02087150|11184321|FG000|Overall Study|Pt moved out of town|0
7077021|NCT02087150|11184322|FG001|Overall Study|Pt moved out of town|1
7077022|NCT02087150|11184323|FG002|Overall Study|Pt moved out of town|0
7077023|NCT02087176|11184336|FG000|Overall Study|Withdrawal by Subject|1
7077024|NCT02087176|11184336|FG000|Overall Study|Death|10
7077025|NCT02087176|11184336|FG000|Overall Study|Censored|19
7077026|NCT02087176|11184336|FG000|Overall Study|Study Terminated by Sponsor|2
7077027|NCT02087241|11184344|FG000|Overall Study|Death|2
7077028|NCT02087241|11184345|FG001|Overall Study|Death|1
7077029|NCT02087241|11184346|FG002|Overall Study|Death|1
7077030|NCT02087241|11184347|FG003|Overall Study|Death|1
7077031|NCT02087241|11184344|FG000|Overall Study|Withdrawal by Subject|1
7077032|NCT02087241|11184345|FG001|Overall Study|Withdrawal by Subject|0
7077033|NCT02087241|11184346|FG002|Overall Study|Withdrawal by Subject|0
7077034|NCT02087241|11184347|FG003|Overall Study|Withdrawal by Subject|1
7077035|NCT02087241|11184344|FG000|Overall Study|Progressive Disease|0
7077036|NCT02087241|11184345|FG001|Overall Study|Progressive Disease|0
7077037|NCT02087241|11184346|FG002|Overall Study|Progressive Disease|0
7077038|NCT02087241|11184347|FG003|Overall Study|Progressive Disease|1
7077039|NCT02087241|11184344|FG000|Overall Study|Study Terminated by Sponsor|0
7077040|NCT02087241|11184345|FG001|Overall Study|Study Terminated by Sponsor|2
7077041|NCT02087241|11184346|FG002|Overall Study|Study Terminated by Sponsor|0
7077042|NCT02087241|11184347|FG003|Overall Study|Study Terminated by Sponsor|4
7077043|NCT02087670|11184400|FG000|Overall Study|Withdrawal by Subject|3
7077044|NCT02087670|11184401|FG001|Overall Study|Withdrawal by Subject|2
7077045|NCT02087774|11184417|FG000|Overall Study|Were absent day of data collection|8
7077046|NCT02087774|11184418|FG001|Overall Study|Were absent day of data collection|20
7077047|NCT02087904|11184428|FG000|Overall Study|Did Not Receive Study Drug|0
7077048|NCT02087904|11184429|FG001|Overall Study|Did Not Receive Study Drug|0
7077049|NCT02087904|11184430|FG002|Overall Study|Did Not Receive Study Drug|2
7077050|NCT02087904|11184431|FG003|Overall Study|Did Not Receive Study Drug|1
7077051|NCT02087904|11184428|FG000|Overall Study|Adverse Event|8
7077052|NCT02087904|11184429|FG001|Overall Study|Adverse Event|4
7077053|NCT02087904|11184430|FG002|Overall Study|Adverse Event|4
7077054|NCT02087904|11184431|FG003|Overall Study|Adverse Event|12
7149055|NCT03168425|11310749|FG000|Overall Study|Lost to Follow-up|5
7149056|NCT03168425|11310750|FG001|Overall Study|Lost to Follow-up|8
7149057|NCT03168425|11310749|FG000|Overall Study|unable to confirm post op opioids|2
7149058|NCT03168425|11310750|FG001|Overall Study|unable to confirm post op opioids|3
7149059|NCT03168711|11310766|FG000|Overall Study|Adverse Event|2
7149060|NCT03168711|11310767|FG001|Overall Study|Adverse Event|0
7149061|NCT03168711|11310766|FG000|Overall Study|Withdrawal by Subject|0
7149062|NCT03168711|11310767|FG001|Overall Study|Withdrawal by Subject|1
7149063|NCT03168711|11310766|FG000|Overall Study|Death|0
7149064|NCT03168711|11310767|FG001|Overall Study|Death|1
7149065|NCT03168919|11310777|FG000|Overall Study|Withdrawal by Subject|2
7149066|NCT03169153|11310789|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1
7149067|NCT03169153|11310790|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1
7149068|NCT03169153|11310789|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2
7149069|NCT03169153|11310790|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3
7149070|NCT03169153|11310789|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1
7149071|NCT03169153|11310790|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2
7149072|NCT03169153|11310789|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1
7149073|NCT03169153|11310790|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0
7149074|NCT03169244|11310798|FG000|Overall Study|Lost to Follow-up|1
7149075|NCT03169244|11310799|FG001|Overall Study|Lost to Follow-up|2
7149076|NCT03169244|11310798|FG000|Overall Study|Adverse Event|1
7149077|NCT03169244|11310799|FG001|Overall Study|Adverse Event|0
7149078|NCT03169244|11310798|FG000|Overall Study|Withdrawal by Subject|2
7149079|NCT03169244|11310799|FG001|Overall Study|Withdrawal by Subject|2
7149080|NCT03169244|11310798|FG000|Overall Study|Physician Decision|1
7149081|NCT03169244|11310799|FG001|Overall Study|Physician Decision|0
7149082|NCT03170154|11310814|FG000|Overall Study|Lost to Follow-up|4
7149083|NCT03170154|11310814|FG000|Overall Study|Death|2
7149084|NCT03170154|11310814|FG000|Overall Study|Withdrawal by Subject|2
7149085|NCT03170193|11310830|FG000|Overall Study|Withdrawal by Subject|0
7149086|NCT03170193|11310831|FG001|Overall Study|Withdrawal by Subject|0
7149087|NCT03170193|11310832|FG002|Overall Study|Withdrawal by Subject|0
7149088|NCT03170193|11310833|FG003|Overall Study|Withdrawal by Subject|1
7149089|NCT03170193|11310834|FG004|Overall Study|Withdrawal by Subject|0
7149090|NCT03170193|11310835|FG005|Overall Study|Withdrawal by Subject|0
7149091|NCT03170193|11310836|FG006|Overall Study|Withdrawal by Subject|0
7149092|NCT03170193|11310830|FG000|Overall Study|Lost to Follow-up|1
7149093|NCT03170193|11310831|FG001|Overall Study|Lost to Follow-up|1
7149094|NCT03170193|11310832|FG002|Overall Study|Lost to Follow-up|0
7149095|NCT03170193|11310833|FG003|Overall Study|Lost to Follow-up|0
7149096|NCT03170193|11310834|FG004|Overall Study|Lost to Follow-up|0
7149097|NCT03170193|11310835|FG005|Overall Study|Lost to Follow-up|0
7149098|NCT03170193|11310836|FG006|Overall Study|Lost to Follow-up|0
7077055|NCT02087904|11184428|FG000|Overall Study|Lack of Efficacy|3
7077056|NCT02087904|11184429|FG001|Overall Study|Lack of Efficacy|6
7077057|NCT02087904|11184430|FG002|Overall Study|Lack of Efficacy|3
7149099|NCT03170232|11310869|FG000|Overall Study|Adverse Event|0
7149100|NCT03170232|11310870|FG001|Overall Study|Adverse Event|1
7149101|NCT03170232|11310869|FG000|Overall Study|Protocol Violation|0
7149102|NCT03170232|11310870|FG001|Overall Study|Protocol Violation|1
7149103|NCT03170232|11310869|FG000|Overall Study|Lack of Efficacy|0
7149104|NCT03170232|11310870|FG001|Overall Study|Lack of Efficacy|1
7077058|NCT02087904|11184431|FG003|Overall Study|Lack of Efficacy|2
7077059|NCT02087904|11184428|FG000|Overall Study|Other|6
7077060|NCT02087904|11184429|FG001|Overall Study|Other|2
7149105|NCT03170232|11310869|FG000|Overall Study|Study closed/terminated|26
6840618|NCT00275561|10846403|FG001|Overall Study|Scheduling|2
6840619|NCT00275561|10846402|FG000|Overall Study|Family Issues|0
6840620|NCT00275561|10846403|FG001|Overall Study|Family Issues|2
6840621|NCT00275821|10846412|FG000|Overall Study|Adverse Event|4
6840622|NCT00275821|10846413|FG001|Overall Study|Adverse Event|12
6840623|NCT00275821|10846414|FG002|Overall Study|Adverse Event|5
6840624|NCT00275821|10846412|FG000|Overall Study|Administrative problems|3
6840625|NCT00275821|10846413|FG001|Overall Study|Administrative problems|4
6840626|NCT00275821|10846414|FG002|Overall Study|Administrative problems|4
6840627|NCT00275821|10846412|FG000|Overall Study|Withdrawal by Subject|0
6840628|NCT00275821|10846413|FG001|Overall Study|Withdrawal by Subject|2
6840629|NCT00275821|10846414|FG002|Overall Study|Withdrawal by Subject|1
6840630|NCT00275821|10846412|FG000|Overall Study|Lost to Follow-up|0
6840631|NCT00275821|10846413|FG001|Overall Study|Lost to Follow-up|1
6840632|NCT00275821|10846414|FG002|Overall Study|Lost to Follow-up|1
6840633|NCT00275821|10846412|FG000|Overall Study|Death|0
6840634|NCT00275821|10846413|FG001|Overall Study|Death|2
6840635|NCT00275821|10846414|FG002|Overall Study|Death|1
6840636|NCT00275821|10846412|FG000|Overall Study|Lack of Efficacy|2
6840637|NCT00275821|10846413|FG001|Overall Study|Lack of Efficacy|1
6840638|NCT00275821|10846414|FG002|Overall Study|Lack of Efficacy|0
6840639|NCT00275821|10846412|FG000|Overall Study|Protocol Violation|5
6840640|NCT00275821|10846413|FG001|Overall Study|Protocol Violation|1
6840641|NCT00275821|10846414|FG002|Overall Study|Protocol Violation|0
6840642|NCT00276094|10846440|FG000|Overall Study|Adverse Event|15
6840643|NCT00276094|10846441|FG001|Overall Study|Adverse Event|13
6840644|NCT00276094|10846442|FG002|Overall Study|Adverse Event|11
6840645|NCT00276094|10846440|FG000|Overall Study|Withdrawal by Subject|14
6840646|NCT00276094|10846441|FG001|Overall Study|Withdrawal by Subject|14
6840647|NCT00276094|10846442|FG002|Overall Study|Withdrawal by Subject|12
6840648|NCT00276094|10846440|FG000|Overall Study|Protocol Violation|16
6840649|NCT00276094|10846441|FG001|Overall Study|Protocol Violation|7
6840650|NCT00276094|10846442|FG002|Overall Study|Protocol Violation|10
6840651|NCT00276094|10846440|FG000|Overall Study|Lost to Follow-up|8
6840652|NCT00276094|10846441|FG001|Overall Study|Lost to Follow-up|6
6840653|NCT00276094|10846442|FG002|Overall Study|Lost to Follow-up|4
6840654|NCT00276094|10846440|FG000|Overall Study|Other-Subject moved out of country|1
6840655|NCT00276094|10846441|FG001|Overall Study|Other-Subject moved out of country|0
6840656|NCT00276094|10846442|FG002|Overall Study|Other-Subject moved out of country|0
6840657|NCT00276094|10846440|FG000|Overall Study|Other-Scheduled gastroplasty|1
6840658|NCT00276094|10846441|FG001|Overall Study|Other-Scheduled gastroplasty|0
6840659|NCT00276094|10846442|FG002|Overall Study|Other-Scheduled gastroplasty|0
6840660|NCT00276094|10846440|FG000|Overall Study|Other-Lack of efficacy|1
6840661|NCT00276094|10846441|FG001|Overall Study|Other-Lack of efficacy|0
6840662|NCT00276094|10846442|FG002|Overall Study|Other-Lack of efficacy|0
6840663|NCT00276094|10846440|FG000|Overall Study|Other-Refused follow-up visit|1
6840664|NCT00276094|10846441|FG001|Overall Study|Other-Refused follow-up visit|0
6840665|NCT00276094|10846442|FG002|Overall Study|Other-Refused follow-up visit|0
6840666|NCT00276094|10846440|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0
6840667|NCT00276094|10846441|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1
6840668|NCT00276094|10846442|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0
6840669|NCT00276094|10846440|FG000|Overall Study|Other-Relocation|0
6840670|NCT00276094|10846441|FG001|Overall Study|Other-Relocation|1
6840671|NCT00276094|10846442|FG002|Overall Study|Other-Relocation|0
7077061|NCT02087904|11184430|FG002|Overall Study|Other|4
7077062|NCT02087904|11184431|FG003|Overall Study|Other|4
7077063|NCT02087904|11184428|FG000|Overall Study|Withdrawal by Subject|8
7077064|NCT02087904|11184429|FG001|Overall Study|Withdrawal by Subject|3
7077065|NCT02087904|11184430|FG002|Overall Study|Withdrawal by Subject|7
7077066|NCT02087904|11184431|FG003|Overall Study|Withdrawal by Subject|4
7077067|NCT02087904|11184428|FG000|Overall Study|Lost to Follow-up|0
7077068|NCT02087904|11184429|FG001|Overall Study|Lost to Follow-up|4
7077069|NCT02087904|11184430|FG002|Overall Study|Lost to Follow-up|2
7077070|NCT02087904|11184431|FG003|Overall Study|Lost to Follow-up|2
7149106|NCT03170232|11310870|FG001|Overall Study|Study closed/terminated|23
7149107|NCT03170232|11310869|FG000|Overall Study|Lost to Follow-up|1
6840672|NCT00276094|10846440|FG000|Overall Study|Other-Study medication lost|0
6840673|NCT00276094|10846441|FG001|Overall Study|Other-Study medication lost|0
6840674|NCT00276094|10846442|FG002|Overall Study|Other-Study medication lost|1
6840675|NCT00276159|10846450|FG000|Overall Study|Did not receive all 24 doses of 852A|6
6840676|NCT00276380|10846469|FG000|Overall Study|Adverse Event|5
6840677|NCT00276380|10846470|FG001|Overall Study|Adverse Event|3
7077071|NCT02087943|11184444|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1
7077072|NCT02087943|11184445|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2
6840678|NCT00276380|10846469|FG000|Overall Study|Lost to Follow-up|1
6840679|NCT00276380|10846470|FG001|Overall Study|Lost to Follow-up|1
6840680|NCT00276380|10846469|FG000|Overall Study|Withdrawal by Subject|3
6840681|NCT00276380|10846470|FG001|Overall Study|Withdrawal by Subject|6
6840682|NCT00276380|10846469|FG000|Overall Study|Death|5
6840683|NCT00276380|10846470|FG001|Overall Study|Death|3
6840684|NCT00276380|10846469|FG000|Overall Study|Abnormal aPPT Levels|0
6840685|NCT00276380|10846470|FG001|Overall Study|Abnormal aPPT Levels|1
6840686|NCT00276614|10846490|FG000|Overall Study|Progression of disease under study|3
7149108|NCT03170232|11310870|FG001|Overall Study|Lost to Follow-up|0
7077073|NCT02087943|11184446|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6
7077074|NCT02087943|11184447|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0
7077075|NCT02087943|11184448|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0
7077076|NCT02087943|11184444|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8
7077077|NCT02087943|11184445|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7
7077078|NCT02087943|11184446|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4
7077079|NCT02087943|11184447|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
7077080|NCT02087943|11184448|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
7077081|NCT02087943|11184444|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4
7077082|NCT02087943|11184445|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
7077083|NCT02087943|11184446|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
7077084|NCT02087943|11184447|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
7077085|NCT02087943|11184448|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
7077086|NCT02087943|11184444|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
7077087|NCT02087943|11184445|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
7077088|NCT02087943|11184446|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
7077089|NCT02087943|11184447|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
7077090|NCT02087943|11184448|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
7077091|NCT02087943|11184444|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
7149109|NCT03170232|11310869|FG000|Overall Study|Withdrawal by Subject|0
7149110|NCT03170232|11310870|FG001|Overall Study|Withdrawal by Subject|1
7149111|NCT03170271|11310878|FG000|Overall Study|Adverse Event|7
7149112|NCT03170271|11310879|FG001|Overall Study|Adverse Event|2
7149113|NCT03170271|11310878|FG000|Overall Study|Lost to Follow-up|0
7149114|NCT03170271|11310879|FG001|Overall Study|Lost to Follow-up|1
7149115|NCT03170271|11310878|FG000|Overall Study|Physician Decision|1
7149116|NCT03170271|11310879|FG001|Overall Study|Physician Decision|0
7149117|NCT03170271|11310878|FG000|Overall Study|Protocol-specified withdrawal criterion|2
7149118|NCT03170271|11310879|FG001|Overall Study|Protocol-specified withdrawal criterion|1
7149119|NCT03170271|11310878|FG000|Overall Study|Withdrawal by Subject|17
7149120|NCT03170271|11310879|FG001|Overall Study|Withdrawal by Subject|5
7149121|NCT03170271|11310878|FG000|Overall Study|Other|2
7149122|NCT03170271|11310879|FG001|Overall Study|Other|2
7149123|NCT03170271|11310878|FG000|Overall Study|Randomized in error|4
7149124|NCT03170271|11310879|FG001|Overall Study|Randomized in error|0
7149125|NCT03170544|11310918|FG000|Part 1|Lost to Follow-up|1
7149126|NCT03170544|11310919|FG001|Part 1|Lost to Follow-up|0
7149127|NCT03170544|11310920|FG002|Part 1|Lost to Follow-up|0
7149128|NCT03170544|11310921|FG003|Part 1|Lost to Follow-up|0
7149129|NCT03170544|11310922|FG004|Part 1|Lost to Follow-up|0
7149130|NCT03170544|11310923|FG005|Part 1|Lost to Follow-up|0
7149131|NCT03170544|11310924|FG006|Part 1|Lost to Follow-up|0
7149132|NCT03170544|11310925|FG007|Part 1|Lost to Follow-up|0
7149133|NCT03170544|11310926|FG008|Part 1|Lost to Follow-up|0
7149134|NCT03170544|11310927|FG009|Part 1|Lost to Follow-up|0
7149135|NCT03170544|11310928|FG010|Part 1|Lost to Follow-up|0
7149136|NCT03170544|11310929|FG011|Part 1|Lost to Follow-up|0
7149137|NCT03170544|11310918|FG000|Part 1|Not treated|0
7149138|NCT03170544|11310919|FG001|Part 1|Not treated|0
7149139|NCT03170544|11310920|FG002|Part 1|Not treated|0
7149140|NCT03170544|11310921|FG003|Part 1|Not treated|1
7149141|NCT03170544|11310922|FG004|Part 1|Not treated|0
7149142|NCT03170544|11310923|FG005|Part 1|Not treated|0
7149143|NCT03170544|11310924|FG006|Part 1|Not treated|0
7149144|NCT03170544|11310925|FG007|Part 1|Not treated|0
7149145|NCT03170544|11310926|FG008|Part 1|Not treated|0
7149146|NCT03170544|11310927|FG009|Part 1|Not treated|0
7149147|NCT03170544|11310928|FG010|Part 1|Not treated|0
7149148|NCT03170544|11310929|FG011|Part 1|Not treated|0
7149149|NCT03170609|11311019|FG000|Overall Study|Death|0
7149150|NCT03170609|11311020|FG001|Overall Study|Death|0
7149151|NCT03170609|11311021|FG002|Overall Study|Death|1
7149152|NCT03170609|11311022|FG003|Overall Study|Death|0
7149153|NCT03170609|11311023|FG004|Overall Study|Death|0
7149154|NCT03170609|11311024|FG005|Overall Study|Death|0
7149155|NCT03170609|11311025|FG006|Overall Study|Death|0
7149156|NCT03170609|11311019|FG000|Overall Study|Withdrawal by Subject|1
7149157|NCT03170609|11311020|FG001|Overall Study|Withdrawal by Subject|2
7149158|NCT03170609|11311021|FG002|Overall Study|Withdrawal by Subject|0
7149159|NCT03170609|11311022|FG003|Overall Study|Withdrawal by Subject|0
7149160|NCT03170609|11311023|FG004|Overall Study|Withdrawal by Subject|0
7149161|NCT03170609|11311024|FG005|Overall Study|Withdrawal by Subject|0
7149162|NCT03170609|11311025|FG006|Overall Study|Withdrawal by Subject|1
7149163|NCT03170609|11311019|FG000|Overall Study|Lost to Follow-up|1
7149164|NCT03170609|11311020|FG001|Overall Study|Lost to Follow-up|0
7149165|NCT03170609|11311021|FG002|Overall Study|Lost to Follow-up|5
7149166|NCT03170609|11311022|FG003|Overall Study|Lost to Follow-up|2
7149167|NCT03170609|11311023|FG004|Overall Study|Lost to Follow-up|1
7149168|NCT03170609|11311024|FG005|Overall Study|Lost to Follow-up|1
7149169|NCT03170609|11311025|FG006|Overall Study|Lost to Follow-up|0
7149170|NCT03170609|11311019|FG000|Overall Study|Other|1
7149171|NCT03170609|11311020|FG001|Overall Study|Other|0
7149172|NCT03170609|11311021|FG002|Overall Study|Other|0
6840687|NCT00276744|10846494|FG000|PART A|Reason unknown|98
6840688|NCT00277095|10846503|FG000|Overall Study|Death|2
6840689|NCT00277095|10846503|FG000|Overall Study|Explanted|7
6840690|NCT00277095|10846503|FG000|Overall Study|Lost to Follow-up|2
6840691|NCT00277095|10846503|FG000|Overall Study|Missed Follow-up|9
6840692|NCT00277095|10846503|FG000|Overall Study|Physician Decision|1
6840693|NCT00277212|10846507|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61
6840694|NCT00277212|10846508|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
6840695|NCT00277212|10846509|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
6840696|NCT00277212|10846507|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93
6840697|NCT00277212|10846508|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0
6840698|NCT00277212|10846509|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0
6840699|NCT00277212|10846507|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96
6840700|NCT00277212|10846508|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
6840701|NCT00277212|10846509|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
6840702|NCT00277212|10846507|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87
6840703|NCT00277212|10846508|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
6840704|NCT00277212|10846509|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
6840705|NCT00277212|10846507|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35
6840706|NCT00277212|10846508|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
6840707|NCT00277212|10846509|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
6840708|NCT00277212|10846507|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6
6840709|NCT00277212|10846508|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0
6840710|NCT00277212|10846509|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0
6840711|NCT00277212|10846507|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44
6840712|NCT00277212|10846508|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
6840713|NCT00277212|10846509|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
6840714|NCT00277212|10846507|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1
6840715|NCT00277212|10846508|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
6840716|NCT00277212|10846509|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
6840717|NCT00277212|10846507|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12
6840718|NCT00277212|10846508|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0
6840719|NCT00277212|10846509|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0
6840720|NCT00277212|10846507|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0
6840721|NCT00277212|10846508|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54
6840722|NCT00277212|10846509|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39
6840723|NCT00277212|10846507|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0
6840724|NCT00277212|10846508|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10
6840725|NCT00277212|10846509|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16
7149173|NCT03170609|11311022|FG003|Overall Study|Other|0
7149174|NCT03170609|11311023|FG004|Overall Study|Other|0
7149175|NCT03170609|11311024|FG005|Overall Study|Other|1
7149176|NCT03170609|11311025|FG006|Overall Study|Other|0
7149177|NCT03171415|11311062|FG000|Overall Study|Lost to Follow-up|0
7149178|NCT03171415|11311063|FG001|Overall Study|Lost to Follow-up|0
7149179|NCT03171415|11311064|FG002|Overall Study|Lost to Follow-up|0
7149180|NCT03171415|11311065|FG003|Overall Study|Lost to Follow-up|0
7149181|NCT03171415|11311066|FG004|Overall Study|Lost to Follow-up|2
7149182|NCT03172130|11311091|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3
7149183|NCT03172130|11311092|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1
7149184|NCT03172325|11311100|FG000|Overall Study|Adverse Event|2
7149185|NCT03172325|11311101|FG001|Overall Study|Adverse Event|3
7149186|NCT03172325|11311100|FG000|Overall Study|Positive PPD|1
7149187|NCT03172325|11311101|FG001|Overall Study|Positive PPD|0
7149188|NCT03172325|11311100|FG000|Overall Study|Poor Compliance|1
7149189|NCT03172325|11311101|FG001|Overall Study|Poor Compliance|1
7149190|NCT03172364|11311109|FG000|Overall Study|Adverse Event|1
7149191|NCT03172364|11311110|FG001|Overall Study|Adverse Event|1
7149192|NCT03172364|11311109|FG000|Overall Study|Protocol Violation|1
7149193|NCT03172364|11311110|FG001|Overall Study|Protocol Violation|0
7149194|NCT03172481|11311118|FG000|Double-blind|Withdrawal by Subject|1
7149195|NCT03172481|11311119|FG001|Double-blind|Withdrawal by Subject|0
7149196|NCT03172494|11311128|FG000|Overall Study|Adverse Event|5
7149197|NCT03172494|11311129|FG001|Overall Study|Adverse Event|1
7149198|NCT03172494|11311130|FG002|Overall Study|Adverse Event|15
7149199|NCT03172494|11311128|FG000|Overall Study|Protocol Violation|3
7149200|NCT03172494|11311129|FG001|Overall Study|Protocol Violation|2
7149201|NCT03172494|11311130|FG002|Overall Study|Protocol Violation|1
7149202|NCT03172494|11311128|FG000|Overall Study|Lack of Efficacy|0
7149203|NCT03172494|11311129|FG001|Overall Study|Lack of Efficacy|0
7149204|NCT03172494|11311130|FG002|Overall Study|Lack of Efficacy|4
7149205|NCT03172494|11311128|FG000|Overall Study|Pregnancy|0
7149206|NCT03172494|11311129|FG001|Overall Study|Pregnancy|1
7149207|NCT03172494|11311130|FG002|Overall Study|Pregnancy|0
7149208|NCT03172494|11311128|FG000|Overall Study|Withdrawal by Subject|10
7149209|NCT03172494|11311129|FG001|Overall Study|Withdrawal by Subject|8
7149210|NCT03172494|11311130|FG002|Overall Study|Withdrawal by Subject|8
7149211|NCT03172494|11311128|FG000|Overall Study|Severe hypoglycaemic episode|0
7149212|NCT03172494|11311129|FG001|Overall Study|Severe hypoglycaemic episode|0
7149213|NCT03172494|11311130|FG002|Overall Study|Severe hypoglycaemic episode|1
7149214|NCT03172494|11311128|FG000|Overall Study|Non-compliance towards treatment|2
7149215|NCT03172494|11311129|FG001|Overall Study|Non-compliance towards treatment|0
7149216|NCT03172494|11311130|FG002|Overall Study|Non-compliance towards treatment|0
7149217|NCT03172702|11311139|FG000|Overall Study|Adverse Event|9
7149218|NCT03172702|11311139|FG000|Overall Study|Death|2
7149219|NCT03172702|11311139|FG000|Overall Study|Study-specific Withdrawal Criteria|10
7149220|NCT03172702|11311139|FG000|Overall Study|Withdrawal by Subject|5
7149221|NCT03172702|11311139|FG000|Overall Study|Other|2
7149222|NCT03173313|11311171|FG000|Overall Study|Lost to Follow-up|2
7149223|NCT03173313|11311172|FG001|Overall Study|Lost to Follow-up|3
7149224|NCT03173313|11311171|FG000|Overall Study|Withdrawal by Subject|0
7149225|NCT03173313|11311172|FG001|Overall Study|Withdrawal by Subject|1
7149226|NCT03173313|11311171|FG000|Overall Study|Death|5
7149227|NCT03173313|11311172|FG001|Overall Study|Death|0
7149228|NCT03173313|11311171|FG000|Overall Study|Physician Decision|1
7149229|NCT03173313|11311172|FG001|Overall Study|Physician Decision|0
7149230|NCT03173313|11311171|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0
7149231|NCT03173313|11311172|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1
7149232|NCT03173313|11311171|FG000|Overall Study|Bone Fracture|1
7149233|NCT03173313|11311172|FG001|Overall Study|Bone Fracture|0
7149234|NCT03173547|11311180|FG000|Overall Study|Adverse Event|2
7149235|NCT03173547|11311181|FG001|Overall Study|Adverse Event|0
7149236|NCT03173547|11311180|FG000|Overall Study|Withdrawal by Subject|2
7149237|NCT03173547|11311181|FG001|Overall Study|Withdrawal by Subject|2
7149238|NCT03173560|11311189|FG000|Overall Study|Ongoing on Treatment|38
7149239|NCT03173560|11311190|FG001|Overall Study|Ongoing on Treatment|50
7149240|NCT03173560|11311189|FG000|Overall Study|Ongoing Survival Follow-up|56
7149241|NCT03173560|11311190|FG001|Overall Study|Ongoing Survival Follow-up|57
7149242|NCT03173560|11311189|FG000|Overall Study|Lost to Follow-up|1
7149243|NCT03173560|11311190|FG001|Overall Study|Lost to Follow-up|4
7149244|NCT03173560|11311189|FG000|Overall Study|Withdrawal by Subject|10
7149245|NCT03173560|11311190|FG001|Overall Study|Withdrawal by Subject|5
7149246|NCT03173560|11311189|FG000|Overall Study|Other|0
7149247|NCT03173560|11311190|FG001|Overall Study|Other|1
7149248|NCT03174925|11311229|FG000|Overall Study|Elastographic images not retrievable|2
7149249|NCT03174925|11311229|FG000|Overall Study|Elastography image not interpretable|1
7149250|NCT03175120|11311235|FG000|Overall Study|Adverse Event|2
7149251|NCT03175120|11311236|FG001|Overall Study|Adverse Event|2
7149252|NCT03175120|11311235|FG000|Overall Study|Protocol Violation|5
7149253|NCT03175120|11311236|FG001|Overall Study|Protocol Violation|2
7149254|NCT03175120|11311235|FG000|Overall Study|Lost to Follow-up|1
7149255|NCT03175120|11311236|FG001|Overall Study|Lost to Follow-up|0
7149256|NCT03175120|11311235|FG000|Overall Study|Withdrawal by Subject|2
7149257|NCT03175120|11311236|FG001|Overall Study|Withdrawal by Subject|5
7149258|NCT03175120|11311235|FG000|Overall Study|Other|2
7149259|NCT03175120|11311236|FG001|Overall Study|Other|3
7149260|NCT03175172|11311242|FG000|Overall Study|Death|3
7149261|NCT03175172|11311242|FG000|Overall Study|Withdrawal by Subject|3
6840726|NCT00277212|10846507|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0
6966429|NCT04516746|11014411|FG000|Overall Study|Lost to Follow-up|157
6966430|NCT04516746|11014412|FG001|Overall Study|Lost to Follow-up|86
7149262|NCT03175172|11311242|FG000|Overall Study|Lost to Follow-up|1
7149263|NCT03175172|11311242|FG000|Overall Study|Study Terminated by Sponsor|3
7149264|NCT03175562|11311246|FG000|Overall Study|Adverse Event|1
7149265|NCT03175562|11311246|FG000|Overall Study|Lost to Follow-up|3
7149266|NCT03175562|11311246|FG000|Overall Study|Withdrawal by Subject|7
7149267|NCT03175562|11311246|FG000|Overall Study|Other (Not Specified)|5
7149268|NCT03176238|11311264|FG000|Overall Study|Unacceptable AEs|15
7149269|NCT03176238|11311265|FG001|Overall Study|Unacceptable AEs|8
7149270|NCT03176238|11311264|FG000|Overall Study|Abnormal lab value(s)|2
7149271|NCT03176238|11311265|FG001|Overall Study|Abnormal lab value(s)|0
7149272|NCT03176238|11311264|FG000|Overall Study|Inter-current illness|0
7149273|NCT03176238|11311265|FG001|Overall Study|Inter-current illness|1
7149274|NCT03176238|11311264|FG000|Overall Study|Consent withdrawal|14
7149275|NCT03176238|11311265|FG001|Overall Study|Consent withdrawal|2
7149276|NCT03176238|11311264|FG000|Overall Study|Lost to Follow-up|3
7149277|NCT03176238|11311265|FG001|Overall Study|Lost to Follow-up|0
6966431|NCT04516746|11014411|FG000|Overall Study|Protocol deviation|18
7149278|NCT03176238|11311264|FG000|Overall Study|Administrative problems|1
7149279|NCT03176238|11311265|FG001|Overall Study|Administrative problems|0
7149280|NCT03176238|11311264|FG000|Overall Study|Death|3
7149281|NCT03176238|11311265|FG001|Overall Study|Death|0
7149282|NCT03176238|11311264|FG000|Overall Study|Disease Progression|133
7149283|NCT03176238|11311265|FG001|Overall Study|Disease Progression|22
7149284|NCT03176238|11311264|FG000|Overall Study|Tx duration completed per EAP|0
7149285|NCT03176238|11311265|FG001|Overall Study|Tx duration completed per EAP|1
7149286|NCT03176238|11311264|FG000|Overall Study|Patient is switched to commercial drug|16
7149287|NCT03176238|11311265|FG001|Overall Study|Patient is switched to commercial drug|1
7149288|NCT03176238|11311264|FG000|Overall Study|Protocol Violation|1
7149289|NCT03176238|11311265|FG001|Overall Study|Protocol Violation|0
6966432|NCT04516746|11014412|FG001|Overall Study|Protocol deviation|7
7149290|NCT03176238|11311264|FG000|Overall Study|Changes in the patient's condition|2
7149291|NCT03176238|11311265|FG001|Overall Study|Changes in the patient's condition|1
7149292|NCT03176238|11311264|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9
7149293|NCT03176238|11311265|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0
7149294|NCT03176407|11311275|FG000|Overall Study|Protocol Violation|1
7149295|NCT03176407|11311275|FG000|Overall Study|human failure|1
7149296|NCT03176407|11311275|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1
7149297|NCT03176459|11311283|FG000|Overall Study|Lost to Follow-up|5
7149298|NCT03176459|11311284|FG001|Overall Study|Lost to Follow-up|7
7149299|NCT03176784|11311303|FG000|Overall Study|Lost to Follow-up|77
7149300|NCT03176784|11311304|FG001|Overall Study|Lost to Follow-up|79
7149301|NCT03176784|11311305|FG002|Overall Study|Lost to Follow-up|79
7149302|NCT03176784|11311306|FG003|Overall Study|Lost to Follow-up|49
7149303|NCT03176784|11311303|FG000|Overall Study|Withdrawal by Subject|28
7149304|NCT03176784|11311304|FG001|Overall Study|Withdrawal by Subject|34
7149305|NCT03176784|11311305|FG002|Overall Study|Withdrawal by Subject|34
7149306|NCT03176784|11311306|FG003|Overall Study|Withdrawal by Subject|21
7149307|NCT03178266|11311374|FG000|Overall Study|Death|0
7149308|NCT03178266|11311375|FG001|Overall Study|Death|1
7149309|NCT03178266|11311374|FG000|Overall Study|Disont. Early|0
7149310|NCT03178266|11311375|FG001|Overall Study|Disont. Early|1
7149311|NCT03178266|11311374|FG000|Overall Study|Withdrawal by Subject|0
7149312|NCT03178266|11311375|FG001|Overall Study|Withdrawal by Subject|2
7149313|NCT03178669|11311393|FG000|Overall Study|Adverse Event|4
7149314|NCT03178669|11311394|FG001|Overall Study|Adverse Event|1
7149315|NCT03178669|11311395|FG002|Overall Study|Adverse Event|4
7149316|NCT03178669|11311396|FG003|Overall Study|Adverse Event|2
7149317|NCT03178669|11311397|FG004|Overall Study|Adverse Event|2
7149318|NCT03178669|11311393|FG000|Overall Study|Lack of Efficacy|0
7149319|NCT03178669|11311394|FG001|Overall Study|Lack of Efficacy|0
7149320|NCT03178669|11311395|FG002|Overall Study|Lack of Efficacy|2
7149321|NCT03178669|11311396|FG003|Overall Study|Lack of Efficacy|0
7149322|NCT03178669|11311397|FG004|Overall Study|Lack of Efficacy|1
7149323|NCT03178669|11311393|FG000|Overall Study|Physician Decision|0
7149324|NCT03178669|11311394|FG001|Overall Study|Physician Decision|0
7149325|NCT03178669|11311395|FG002|Overall Study|Physician Decision|0
7149326|NCT03178669|11311396|FG003|Overall Study|Physician Decision|0
7149327|NCT03178669|11311397|FG004|Overall Study|Physician Decision|1
7149328|NCT03178669|11311393|FG000|Overall Study|Withdrawal by Subject|1
7149329|NCT03178669|11311394|FG001|Overall Study|Withdrawal by Subject|0
7149330|NCT03178669|11311395|FG002|Overall Study|Withdrawal by Subject|1
7149331|NCT03178669|11311396|FG003|Overall Study|Withdrawal by Subject|1
7149332|NCT03178669|11311397|FG004|Overall Study|Withdrawal by Subject|0
7149333|NCT03178669|11311393|FG000|Overall Study|Lost to Follow-up|0
7149334|NCT03178669|11311394|FG001|Overall Study|Lost to Follow-up|0
7149335|NCT03178669|11311395|FG002|Overall Study|Lost to Follow-up|0
7149336|NCT03178669|11311396|FG003|Overall Study|Lost to Follow-up|1
7149337|NCT03178669|11311397|FG004|Overall Study|Lost to Follow-up|0
7149338|NCT03178773|11311411|FG000|Overall Study|Death|0
7149339|NCT03178773|11311412|FG001|Overall Study|Death|1
7149340|NCT03178773|11311411|FG000|Overall Study|Lost to Follow-up|29
7149341|NCT03178773|11311412|FG001|Overall Study|Lost to Follow-up|25
7149342|NCT03178773|11311411|FG000|Overall Study|Withdrawal by Subject|10
7149343|NCT03178773|11311412|FG001|Overall Study|Withdrawal by Subject|14
7149344|NCT03178851|11311422|FG000|Overall Study|Death|48
7149345|NCT03178851|11311423|FG001|Overall Study|Death|2
7149346|NCT03178851|11311424|FG002|Overall Study|Death|25
7149347|NCT03178851|11311422|FG000|Overall Study|Withdrawal by Subject|8
7149348|NCT03178851|11311423|FG001|Overall Study|Withdrawal by Subject|0
7149349|NCT03178851|11311424|FG002|Overall Study|Withdrawal by Subject|0
7149350|NCT03178851|11311422|FG000|Overall Study|Lost to Follow-up|5
7149351|NCT03178851|11311423|FG001|Overall Study|Lost to Follow-up|2
7149352|NCT03178851|11311424|FG002|Overall Study|Lost to Follow-up|0
7149353|NCT03178851|11311422|FG000|Overall Study|Adverse Event|0
7149354|NCT03178851|11311423|FG001|Overall Study|Adverse Event|0
7149355|NCT03178851|11311424|FG002|Overall Study|Adverse Event|1
7149356|NCT03178851|11311422|FG000|Overall Study|Study Termination by Sponsor|31
7149357|NCT03178851|11311423|FG001|Overall Study|Study Termination by Sponsor|7
6897719|NCT00642460|10916789|FG000|Part III: Open-Label Up to Week 260|Death|0
7149358|NCT03178851|11311424|FG002|Overall Study|Study Termination by Sponsor|26
7149359|NCT03178942|11311435|FG000|Overall Study|Withdrawal by Subject|2
7149360|NCT03178942|11311436|FG001|Overall Study|Withdrawal by Subject|0
7149361|NCT03178942|11311435|FG000|Overall Study|Lost to Follow-up|1
7149362|NCT03178942|11311436|FG001|Overall Study|Lost to Follow-up|2
7149363|NCT03179319|11311444|FG000|Overall Study|Lost to Follow-up|6
7149364|NCT03179319|11311445|FG001|Overall Study|Lost to Follow-up|0
7149365|NCT03179787|11311478|FG000|Overall Study|Lost to Follow-up|15
7149366|NCT03179787|11311478|FG000|Overall Study|Case report failures|2
7149367|NCT03179787|11311478|FG000|Overall Study|Treatment not administered|1
7149368|NCT03179891|11311482|FG000|First Intervention|Withdrawal by Subject|1
7149369|NCT03179891|11311483|FG001|First Intervention|Withdrawal by Subject|1
7149370|NCT03179891|11311482|FG000|First Intervention|Unspecified reason|1
7149371|NCT03179891|11311483|FG001|First Intervention|Unspecified reason|0
7149372|NCT03179891|11311482|FG000|First Intervention|Protocol Violation|0
7149373|NCT03179891|11311483|FG001|First Intervention|Protocol Violation|1
7149374|NCT03180138|11311495|FG000|Overall Study|Mobile-phone could not be verified|2
7149375|NCT03180138|11311496|FG001|Overall Study|Mobile-phone could not be verified|13
7149376|NCT03180138|11311497|FG002|Overall Study|Mobile-phone could not be verified|15
7149377|NCT03180138|11311495|FG000|Overall Study|No prior immunization records|17
7149378|NCT03180138|11311496|FG001|Overall Study|No prior immunization records|0
7149379|NCT03180138|11311497|FG002|Overall Study|No prior immunization records|6
7149380|NCT03180138|11311495|FG000|Overall Study|Found to be >24 mon after randomization|3
7149381|NCT03180138|11311496|FG001|Overall Study|Found to be >24 mon after randomization|0
7149382|NCT03180138|11311497|FG002|Overall Study|Found to be >24 mon after randomization|3
7149383|NCT03180528|11311539|FG000|Overall Study|Adverse Event|1
7149384|NCT03180528|11311539|FG000|Overall Study|Withdrawal by Subject|1
7149385|NCT03180528|11311539|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1
7149386|NCT03180619|11311546|FG000|Overall Study|Withdrew Consent|5
6840727|NCT00277212|10846508|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17
6840728|NCT00277212|10846509|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16
6840729|NCT00277212|10846507|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0
6840730|NCT00277212|10846508|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
7149387|NCT03180619|11311547|FG001|Overall Study|Withdrew Consent|0
7149388|NCT03180619|11311548|FG002|Overall Study|Withdrew Consent|2
7149389|NCT03180619|11311546|FG000|Overall Study|Death|2
7149390|NCT03180619|11311547|FG001|Overall Study|Death|1
7149391|NCT03180619|11311548|FG002|Overall Study|Death|2
7149392|NCT03180619|11311546|FG000|Overall Study|Adverse Event|2
7149393|NCT03180619|11311547|FG001|Overall Study|Adverse Event|0
7149394|NCT03180619|11311548|FG002|Overall Study|Adverse Event|1
7149395|NCT03180619|11311546|FG000|Overall Study|Investigator's discretion|2
7149396|NCT03180619|11311547|FG001|Overall Study|Investigator's discretion|0
7149397|NCT03180619|11311548|FG002|Overall Study|Investigator's discretion|1
7183893|NCT00557193|11383968|FG004|Induction|Refusal of Further Protocol Therapy|0
7183894|NCT00557193|11383969|FG005|Induction|Refusal of Further Protocol Therapy|0
7183895|NCT00557193|11383964|FG000|Induction|Ineligible|8
7183896|NCT00557193|11383965|FG001|Induction|Ineligible|0
7183897|NCT00557193|11383966|FG002|Induction|Ineligible|0
7183898|NCT00557193|11383967|FG003|Induction|Ineligible|0
7183899|NCT00557193|11383968|FG004|Induction|Ineligible|0
7183900|NCT00557193|11383969|FG005|Induction|Ineligible|0
7183901|NCT00557193|11383964|FG000|Induction|Inevaluable for post Induction|2
7183902|NCT00557193|11383965|FG001|Induction|Inevaluable for post Induction|0
7183903|NCT00557193|11383966|FG002|Induction|Inevaluable for post Induction|0
7183904|NCT00557193|11383967|FG003|Induction|Inevaluable for post Induction|0
7183905|NCT00557193|11383968|FG004|Induction|Inevaluable for post Induction|0
7183906|NCT00557193|11383969|FG005|Induction|Inevaluable for post Induction|0
7183907|NCT00557193|11383964|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2
7183908|NCT00557193|11383965|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0
7183909|NCT00557193|11383966|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0
7183910|NCT00557193|11383967|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0
7183911|NCT00557193|11383968|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0
7183912|NCT00557193|11383969|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0
7183913|NCT00557193|11383964|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0
7183914|NCT00557193|11383965|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1
7183915|NCT00557193|11383966|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2
7183916|NCT00557193|11383967|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1
7183917|NCT00557193|11383968|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0
7183918|NCT00557193|11383969|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3
7183919|NCT00557193|11383964|FG000|Post Induction Therapy by Tx Assignment|Death|0
7183920|NCT00557193|11383965|FG001|Post Induction Therapy by Tx Assignment|Death|0
7183921|NCT00557193|11383966|FG002|Post Induction Therapy by Tx Assignment|Death|2
7183922|NCT00557193|11383967|FG003|Post Induction Therapy by Tx Assignment|Death|0
7183923|NCT00557193|11383968|FG004|Post Induction Therapy by Tx Assignment|Death|2
7183924|NCT00557193|11383969|FG005|Post Induction Therapy by Tx Assignment|Death|2
7183925|NCT00557193|11383964|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0
7183926|NCT00557193|11383965|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3
7183927|NCT00557193|11383966|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5
7183928|NCT00557193|11383967|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1
7183929|NCT00557193|11383968|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2
7183930|NCT00557193|11383969|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2
7183931|NCT00557193|11383964|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0
7183932|NCT00557193|11383965|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1
7183933|NCT00557193|11383966|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0
7183934|NCT00557193|11383967|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2
7183935|NCT00557193|11383968|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2
7183936|NCT00557193|11383969|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5
7183937|NCT00557193|11383964|FG000|Post Induction Therapy by Tx Assignment|Relapse|0
7149400|NCT04448756|11311594|FG000|Overall Study|Adverse Event|0
7149401|NCT04448756|11311595|FG001|Overall Study|Adverse Event|1
7149402|NCT04448756|11311596|FG002|Overall Study|Adverse Event|0
7149403|NCT04448756|11311594|FG000|Overall Study|Participant unable to attend Day 60 visit|1
7149404|NCT04448756|11311595|FG001|Overall Study|Participant unable to attend Day 60 visit|0
7149405|NCT04448756|11311596|FG002|Overall Study|Participant unable to attend Day 60 visit|0
7149406|NCT04448756|11311594|FG000|Overall Study|Withdrawal by Subject|0
7149407|NCT04448756|11311595|FG001|Overall Study|Withdrawal by Subject|3
7149408|NCT04448756|11311596|FG002|Overall Study|Withdrawal by Subject|1
7149409|NCT04448756|11311594|FG000|Overall Study|Death|2
7149410|NCT04448756|11311595|FG001|Overall Study|Death|1
7149411|NCT04448756|11311596|FG002|Overall Study|Death|0
7149412|NCT04397718|11311606|FG000|Overall Study|Death|7
7149413|NCT04397718|11311607|FG001|Overall Study|Death|11
7149414|NCT04397718|11311606|FG000|Overall Study|Lost to Follow-up|0
7149415|NCT04397718|11311607|FG001|Overall Study|Lost to Follow-up|4
7149416|NCT04352127|11311616|FG000|Overall Study|Unable to obtain readings|4
7149417|NCT04352127|11311617|FG001|Overall Study|Unable to obtain readings|1
7149418|NCT04352127|11311618|FG002|Overall Study|Unable to obtain readings|0
7149419|NCT04157751|11311634|FG000|Overall Study|Withdrawal by Subject|12
7149420|NCT04157751|11311635|FG001|Overall Study|Withdrawal by Subject|17
7149421|NCT04157751|11311634|FG000|Overall Study|Lost to Follow-up|6
7149422|NCT04157751|11311635|FG001|Overall Study|Lost to Follow-up|2
7149423|NCT04157751|11311634|FG000|Overall Study|Adverse Event|34
7149424|NCT04157751|11311635|FG001|Overall Study|Adverse Event|23
7149425|NCT04157751|11311634|FG000|Overall Study|Not treated|1
7149426|NCT04157751|11311635|FG001|Overall Study|Not treated|5
7149427|NCT04157751|11311634|FG000|Overall Study|Other reason not stated above|10
7149428|NCT04157751|11311635|FG001|Overall Study|Other reason not stated above|10
7149429|NCT03975920|11311644|FG000|Overall Study|Lost to Follow-up|1
7149430|NCT03975920|11311645|FG001|Overall Study|Lost to Follow-up|2
7149431|NCT03975920|11311644|FG000|Overall Study|Protocol Violation|1
7149432|NCT03975920|11311645|FG001|Overall Study|Protocol Violation|1
7149433|NCT03975920|11311644|FG000|Overall Study|Did not complete survey|2
7149434|NCT03975920|11311645|FG001|Overall Study|Did not complete survey|1
7149435|NCT03917472|11311653|FG000|Overall Study|Physician Decision|4
7149436|NCT03917472|11311654|FG001|Overall Study|Physician Decision|0
7149437|NCT03917472|11311653|FG000|Overall Study|Adverse Event|3
7149438|NCT03917472|11311654|FG001|Overall Study|Adverse Event|1
7149439|NCT03917472|11311653|FG000|Overall Study|Death|7
7149440|NCT03917472|11311654|FG001|Overall Study|Death|5
7149441|NCT03917472|11311653|FG000|Overall Study|Withdrawal by Subject|11
7149442|NCT03917472|11311654|FG001|Overall Study|Withdrawal by Subject|4
7149443|NCT03917472|11311653|FG000|Overall Study|Lost to Follow-up|10
7149444|NCT03917472|11311654|FG001|Overall Study|Lost to Follow-up|5
7149447|NCT03746483|11311672|FG000|Overall Study|Adverse Event|0
7149448|NCT03746483|11311673|FG001|Overall Study|Adverse Event|1
7149449|NCT03746483|11311672|FG000|Overall Study|Lack of Efficacy|3
7149450|NCT03746483|11311673|FG001|Overall Study|Lack of Efficacy|2
7149451|NCT03746483|11311672|FG000|Overall Study|Lost to Follow-up|1
7149452|NCT03746483|11311673|FG001|Overall Study|Lost to Follow-up|0
7149453|NCT03746483|11311672|FG000|Overall Study|Protocol Violation|2
7149454|NCT03746483|11311673|FG001|Overall Study|Protocol Violation|0
7149455|NCT03694327|11311687|FG000|Overall Study|Lost to Follow-up|13
6840731|NCT00277212|10846509|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
6840732|NCT00277212|10846507|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0
7149456|NCT03694327|11311688|FG001|Overall Study|Lost to Follow-up|23
7149457|NCT03624036|11311698|FG000|Overall Study|Still on Study|5
7149458|NCT03624036|11311699|FG001|Overall Study|Still on Study|1
7149459|NCT03624036|11311700|FG002|Overall Study|Still on Study|3
7149460|NCT03624036|11311701|FG003|Overall Study|Still on Study|3
7149461|NCT03624036|11311698|FG000|Overall Study|Death|1
7149462|NCT03624036|11311699|FG001|Overall Study|Death|2
7149463|NCT03624036|11311700|FG002|Overall Study|Death|0
7149464|NCT03624036|11311701|FG003|Overall Study|Death|0
7149465|NCT03624036|11311698|FG000|Overall Study|Enrolled but Never Treated|1
7149466|NCT03624036|11311699|FG001|Overall Study|Enrolled but Never Treated|0
7149467|NCT03624036|11311700|FG002|Overall Study|Enrolled but Never Treated|0
7149468|NCT03624036|11311701|FG003|Overall Study|Enrolled but Never Treated|0
7149471|NCT03057951|11311726|FG000|Overall Study|Adverse Event|553
7149472|NCT03057951|11311727|FG001|Overall Study|Adverse Event|575
7149473|NCT03057951|11311726|FG000|Overall Study|Protocol Violation|30
7149474|NCT03057951|11311727|FG001|Overall Study|Protocol Violation|24
7149475|NCT03057951|11311726|FG000|Overall Study|Lost to Follow-up|6
7149476|NCT03057951|11311727|FG001|Overall Study|Lost to Follow-up|16
7149477|NCT03057951|11311726|FG000|Overall Study|Patient refusal to continue, not due to AE|304
7149478|NCT03057951|11311727|FG001|Overall Study|Patient refusal to continue, not due to AE|284
7149479|NCT03057951|11311726|FG000|Overall Study|Study drug stopped, reason missing|6
7149480|NCT03057951|11311727|FG001|Overall Study|Study drug stopped, reason missing|1
7149481|NCT03057951|11311726|FG000|Overall Study|Medical advice|6
7149482|NCT03057951|11311727|FG001|Overall Study|Medical advice|2
7149483|NCT03057951|11311726|FG000|Overall Study|Due to Covid-19 Pandemic|2
7149484|NCT03057951|11311727|FG001|Overall Study|Due to Covid-19 Pandemic|8
7149485|NCT03057951|11311726|FG000|Overall Study|Investigator decision|2
7149486|NCT03057951|11311727|FG001|Overall Study|Investigator decision|0
7149487|NCT03057951|11311726|FG000|Overall Study|Patient decision|5
7149488|NCT03057951|11311727|FG001|Overall Study|Patient decision|2
7149489|NCT03057951|11311726|FG000|Overall Study|Not attending study visits|3
7149490|NCT03057951|11311727|FG001|Overall Study|Not attending study visits|0
7149491|NCT03057951|11311726|FG000|Overall Study|Patient moved away|3
7149492|NCT03057951|11311727|FG001|Overall Study|Patient moved away|4
7149493|NCT03057951|11311726|FG000|Overall Study|Other reason than stated above|23
7149494|NCT03057951|11311727|FG001|Overall Study|Other reason than stated above|29
7149495|NCT03057951|11311726|FG000|Overall Study|Not treated|2
7149496|NCT03057951|11311727|FG001|Overall Study|Not treated|1
7149497|NCT03007888|11311733|FG000|First Intervention (14 Days)|Adverse Event|1
6840733|NCT00277212|10846508|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7
6840734|NCT00277212|10846509|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8
6840735|NCT00277212|10846507|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0
6840736|NCT00277212|10846508|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2
6840737|NCT00277212|10846509|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2
6840738|NCT00277212|10846507|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0
6840739|NCT00277212|10846508|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4
6840740|NCT00277212|10846509|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6
6840741|NCT00277212|10846507|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0
6840742|NCT00277212|10846508|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1
6840743|NCT00277212|10846509|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3
6840744|NCT00277212|10846507|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0
6840745|NCT00277212|10846508|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7
6840746|NCT00277212|10846509|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5
6840747|NCT00277355|10846519|FG000|Overall Study|Withdrawal by Subject|3
6840748|NCT00277355|10846520|FG001|Overall Study|Withdrawal by Subject|3
6840749|NCT00277355|10846519|FG000|Overall Study|Lost to Follow-up|2
6840750|NCT00277355|10846520|FG001|Overall Study|Lost to Follow-up|2
6840751|NCT00277355|10846519|FG000|Overall Study|Adverse Event|5
6840752|NCT00277355|10846520|FG001|Overall Study|Adverse Event|0
6840753|NCT00277355|10846519|FG000|Overall Study|Death|3
6840754|NCT00277355|10846520|FG001|Overall Study|Death|0
6840755|NCT00277355|10846519|FG000|Overall Study|Physician Decision|1
6840756|NCT00277355|10846520|FG001|Overall Study|Physician Decision|0
6840757|NCT00278109|10846561|FG000|Overall Study|Adverse Event|3
6840758|NCT00278109|10846561|FG000|Overall Study|social circumstances|1
6897720|NCT00642460|10916790|FG001|Part III: Open-Label Up to Week 260|Death|0
6897721|NCT00642460|10916791|FG002|Part III: Open-Label Up to Week 260|Death|0
6897722|NCT00642460|10916792|FG003|Part III: Open-Label Up to Week 260|Death|0
6897723|NCT00642460|10916793|FG004|Part III: Open-Label Up to Week 260|Death|0
6897724|NCT00642460|10916794|FG005|Part III: Open-Label Up to Week 260|Death|3
6897725|NCT00642460|10916789|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0
6897726|NCT00642460|10916790|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0
6897727|NCT00642460|10916791|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0
6897728|NCT00642460|10916792|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0
6897729|NCT00642460|10916793|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0
6897730|NCT00642460|10916794|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1
6897731|NCT00642460|10916789|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0
6897732|NCT00642460|10916790|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0
6897733|NCT00642460|10916791|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0
6897734|NCT00642460|10916792|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0
6897735|NCT00642460|10916793|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8
6897736|NCT00642460|10916794|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3
6897737|NCT00642473|10916806|FG000|Overall Study|Withdrawal by Subject|0
6897738|NCT00642473|10916807|FG001|Overall Study|Withdrawal by Subject|5
6897739|NCT00642473|10916806|FG000|Overall Study|Progression or death|2
6897740|NCT00642473|10916807|FG001|Overall Study|Progression or death|4
6897741|NCT00642473|10916806|FG000|Overall Study|Other|2
6897742|NCT00642473|10916807|FG001|Overall Study|Other|2
6897743|NCT00642616|10916820|FG000|Overall Study|Adverse Event|2
6897744|NCT00642616|10916821|FG001|Overall Study|Adverse Event|0
6897745|NCT00642616|10916822|FG002|Overall Study|Adverse Event|1
6897746|NCT00642616|10916823|FG003|Overall Study|Adverse Event|0
6897747|NCT00642616|10916820|FG000|Overall Study|Study Terminated by Sponsor|7
6897748|NCT00642616|10916821|FG001|Overall Study|Study Terminated by Sponsor|6
6897749|NCT00642616|10916822|FG002|Overall Study|Study Terminated by Sponsor|4
6897750|NCT00642616|10916823|FG003|Overall Study|Study Terminated by Sponsor|5
6897751|NCT00642616|10916820|FG000|Overall Study|Withdrawal by Subject|0
7149498|NCT03007888|11311734|FG001|First Intervention (14 Days)|Adverse Event|0
7149499|NCT02961374|11311756|FG000|Overall Study|Adverse Event|4
7149500|NCT02949934|11311766|FG000|Natural Drinking Period|Adverse Event|1
7149501|NCT02949934|11311767|FG001|Natural Drinking Period|Adverse Event|0
7149502|NCT02949934|11311768|FG002|Natural Drinking Period|Adverse Event|0
7149503|NCT02949934|11311769|FG003|Natural Drinking Period|Adverse Event|1
7149504|NCT02949934|11311770|FG004|Natural Drinking Period|Adverse Event|0
7149505|NCT02949934|11311771|FG005|Natural Drinking Period|Adverse Event|0
7149506|NCT02949934|11311766|FG000|Natural Drinking Period|Lost to Follow-up|0
7149507|NCT02949934|11311767|FG001|Natural Drinking Period|Lost to Follow-up|0
7149508|NCT02949934|11311768|FG002|Natural Drinking Period|Lost to Follow-up|0
7149509|NCT02949934|11311769|FG003|Natural Drinking Period|Lost to Follow-up|0
7149510|NCT02949934|11311770|FG004|Natural Drinking Period|Lost to Follow-up|1
7149511|NCT02949934|11311771|FG005|Natural Drinking Period|Lost to Follow-up|0
7149512|NCT02949934|11311766|FG000|Neuroimaging|Protocol Violation|2
7149513|NCT02949934|11311767|FG001|Neuroimaging|Protocol Violation|0
7149514|NCT02949934|11311768|FG002|Neuroimaging|Protocol Violation|0
7149515|NCT02949934|11311769|FG003|Neuroimaging|Protocol Violation|0
7149516|NCT02949934|11311770|FG004|Neuroimaging|Protocol Violation|1
7149517|NCT02949934|11311771|FG005|Neuroimaging|Protocol Violation|0
7149518|NCT02949934|11311766|FG000|Neuroimaging|Motion artifacts in imaging data|1
7149519|NCT02949934|11311767|FG001|Neuroimaging|Motion artifacts in imaging data|0
7149520|NCT02949934|11311768|FG002|Neuroimaging|Motion artifacts in imaging data|1
7149521|NCT02949934|11311769|FG003|Neuroimaging|Motion artifacts in imaging data|0
6840759|NCT00278148|10846565|FG000|Phase II - Expansion Phase|Disease progression|0
6840760|NCT00278148|10846566|FG001|Phase II - Expansion Phase|Disease progression|0
6840761|NCT00278148|10846567|FG002|Phase II - Expansion Phase|Disease progression|4
6840762|NCT00278148|10846565|FG000|Phase II - Expansion Phase|Adverse Event|0
6840763|NCT00278148|10846566|FG001|Phase II - Expansion Phase|Adverse Event|0
6840764|NCT00278148|10846567|FG002|Phase II - Expansion Phase|Adverse Event|2
6840765|NCT00278161|10846574|FG000|Overall Study|Death|11
6840766|NCT00278200|10846580|FG000|Overall Study|Death|1
6840767|NCT00278200|10846581|FG001|Overall Study|Death|3
6840768|NCT00278200|10846580|FG000|Overall Study|Physician Decision|0
6840769|NCT00278200|10846581|FG001|Overall Study|Physician Decision|1
6840770|NCT00278395|10846587|FG000|Overall Study|Adverse Event|2
6840771|NCT00278395|10846587|FG000|Overall Study|Nonevaluable|1
6840772|NCT00278473|10846596|FG000|Overall Study|drop out|4
6840773|NCT00278473|10846597|FG001|Overall Study|drop out|3
6840774|NCT00278512|10846605|FG000|Overall Study|Death|1
6840775|NCT00278512|10846606|FG001|Overall Study|Death|0
7149522|NCT02949934|11311770|FG004|Neuroimaging|Motion artifacts in imaging data|1
7149523|NCT02949934|11311771|FG005|Neuroimaging|Motion artifacts in imaging data|0
7149524|NCT02949934|11311766|FG000|Neuroimaging|Not scanned|0
7149525|NCT02949934|11311767|FG001|Neuroimaging|Not scanned|0
7149526|NCT02949934|11311768|FG002|Neuroimaging|Not scanned|1
7149527|NCT02949934|11311769|FG003|Neuroimaging|Not scanned|0
7149528|NCT02949934|11311770|FG004|Neuroimaging|Not scanned|0
7149529|NCT02949934|11311771|FG005|Neuroimaging|Not scanned|2
7149530|NCT02949934|11311766|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0
7149531|NCT02949934|11311767|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5
7149532|NCT02949934|11311768|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5
7149533|NCT02949934|11311769|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3
7149534|NCT02949934|11311770|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5
7149535|NCT02949934|11311771|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1
7149536|NCT02949934|11311766|FG000|Bar Laboratory|Adverse Event|1
7149537|NCT02949934|11311767|FG001|Bar Laboratory|Adverse Event|0
7149538|NCT02949934|11311768|FG002|Bar Laboratory|Adverse Event|2
7149539|NCT02949934|11311769|FG003|Bar Laboratory|Adverse Event|0
7149540|NCT02949934|11311770|FG004|Bar Laboratory|Adverse Event|1
7149541|NCT02949934|11311771|FG005|Bar Laboratory|Adverse Event|0
7149542|NCT02949934|11311766|FG000|Bar Laboratory|Protocol Violation|0
7149543|NCT02949934|11311767|FG001|Bar Laboratory|Protocol Violation|0
7149544|NCT02949934|11311768|FG002|Bar Laboratory|Protocol Violation|0
7149545|NCT02949934|11311769|FG003|Bar Laboratory|Protocol Violation|1
7149546|NCT02949934|11311770|FG004|Bar Laboratory|Protocol Violation|0
7149547|NCT02949934|11311771|FG005|Bar Laboratory|Protocol Violation|0
7149548|NCT02658656|11311809|FG000|Screening|Failed eligibility criteria|0
7149549|NCT02658656|11311810|FG001|Screening|Failed eligibility criteria|0
7149550|NCT02658656|11311811|FG002|Screening|Failed eligibility criteria|263
7149551|NCT02658656|11311809|FG000|Randomization|Withdrawal by Subject|8
7149552|NCT02658656|11311810|FG001|Randomization|Withdrawal by Subject|7
7149553|NCT02658656|11311811|FG002|Randomization|Withdrawal by Subject|0
7149554|NCT02658656|11311809|FG000|Randomization|Lost to Follow-up|1
7149555|NCT02658656|11311810|FG001|Randomization|Lost to Follow-up|3
7149556|NCT02658656|11311811|FG002|Randomization|Lost to Follow-up|0
7149557|NCT02658656|11311809|FG000|Randomization|Adverse Event|4
6840776|NCT00278564|10846625|FG000|Overall Study|Lack of Efficacy|4
7149558|NCT02658656|11311810|FG001|Randomization|Adverse Event|0
7149559|NCT02658656|11311811|FG002|Randomization|Adverse Event|0
7149560|NCT02658656|11311809|FG000|Randomization|Administrative Termination|3
7149561|NCT02658656|11311810|FG001|Randomization|Administrative Termination|1
6840777|NCT00278629|10846629|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14
6840778|NCT00278889|10846655|FG000|Overall Study|Withdrawal by Subject|0
7149562|NCT02658656|11311811|FG002|Randomization|Administrative Termination|0
7149563|NCT02658656|11311809|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13
7149564|NCT02658656|11311810|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15
7149565|NCT02658656|11311811|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0
7149566|NCT02658656|11311809|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2
7149567|NCT02658656|11311810|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0
7149568|NCT02658656|11311811|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0
7149569|NCT02658656|11311809|FG000|Randomization|Not eligible for Randomization|1
7149570|NCT02658656|11311810|FG001|Randomization|Not eligible for Randomization|0
7149571|NCT02658656|11311811|FG002|Randomization|Not eligible for Randomization|0
7149572|NCT02658656|11311809|FG000|Randomization|Protocol Violation|1
7149573|NCT02658656|11311810|FG001|Randomization|Protocol Violation|0
7149574|NCT02658656|11311811|FG002|Randomization|Protocol Violation|0
7149575|NCT02094261|11311831|FG000|Overall Study|Death|24
7149576|NCT02094261|11311831|FG000|Overall Study|Lost to Follow-up|1
7149577|NCT02094261|11311831|FG000|Overall Study|Withdrawal by Subject|4
7149578|NCT02094261|11311831|FG000|Overall Study|Ongoing Study at Data Cut-off|181
7149579|NCT01920932|11311835|FG000|Overall Study|Death|1
7149580|NCT01920932|11311835|FG000|Overall Study|Withdrawal of consent|1
7149581|NCT01667081|11311867|FG000|Overall Study|Death|43
7149582|NCT01667081|11311868|FG001|Overall Study|Death|3
7149583|NCT01667081|11311867|FG000|Overall Study|Lost to Follow-up|99
7149584|NCT01667081|11311868|FG001|Overall Study|Lost to Follow-up|48
7149585|NCT01667081|11311867|FG000|Overall Study|Physician Decision|16
7149586|NCT01667081|11311868|FG001|Overall Study|Physician Decision|2
7149587|NCT01667081|11311867|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529
7149588|NCT01667081|11311868|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269
7149589|NCT01667081|11311867|FG000|Overall Study|Withdrawal by Subject|90
7149590|NCT01667081|11311868|FG001|Overall Study|Withdrawal by Subject|35
7149591|NCT01197950|11311888|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16
7149592|NCT01197950|11311889|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16
7149593|NCT01197950|11311890|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18
7183938|NCT00557193|11383965|FG001|Post Induction Therapy by Tx Assignment|Relapse|5
7183939|NCT00557193|11383966|FG002|Post Induction Therapy by Tx Assignment|Relapse|16
7183940|NCT00557193|11383967|FG003|Post Induction Therapy by Tx Assignment|Relapse|3
7183941|NCT00557193|11383968|FG004|Post Induction Therapy by Tx Assignment|Relapse|1
7183942|NCT00557193|11383969|FG005|Post Induction Therapy by Tx Assignment|Relapse|20
7183943|NCT00557193|11383964|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
7187210|NCT01373151|11387717|FG001|Period 1|Withdrawal by Subject|0
6840779|NCT00278889|10846656|FG001|Overall Study|Withdrawal by Subject|5
6840780|NCT00278889|10846657|FG002|Overall Study|Withdrawal by Subject|3
6840781|NCT00278889|10846655|FG000|Overall Study|Lost to Follow-up|1
6840782|NCT00278889|10846656|FG001|Overall Study|Lost to Follow-up|1
6840783|NCT00278889|10846657|FG002|Overall Study|Lost to Follow-up|0
6840784|NCT00278889|10846655|FG000|Overall Study|Death|24
6840785|NCT00278889|10846656|FG001|Overall Study|Death|21
6840786|NCT00278889|10846657|FG002|Overall Study|Death|17
6840787|NCT00278954|10846665|FG000|Overall Study|Adverse Event|3
6840788|NCT00278954|10846665|FG000|Overall Study|Lost to Follow-up|1
6840789|NCT00278954|10846665|FG000|Overall Study|Withdrawal by Subject|1
6966433|NCT04516746|11014411|FG000|Overall Study|Death|8
6966434|NCT04516746|11014412|FG001|Overall Study|Death|7
6966435|NCT04516746|11014411|FG000|Overall Study|Physician Decision|0
6966436|NCT04516746|11014412|FG001|Overall Study|Physician Decision|2
6966437|NCT04516746|11014411|FG000|Overall Study|Other|0
6966438|NCT04516746|11014412|FG001|Overall Study|Other|1
6966439|NCT04364737|11014424|FG000|Overall Study|Withdrawal by Subject|4
6966440|NCT04364737|11014425|FG001|Overall Study|Withdrawal by Subject|9
6966441|NCT04364737|11014424|FG000|Overall Study|Lost to Follow-up|1
6966442|NCT04364737|11014425|FG001|Overall Study|Lost to Follow-up|1
6966443|NCT04354155|11014431|FG000|Overall Study|Withdrawal by Subject|1
6966444|NCT04354155|11014431|FG000|Overall Study|Did not meet criteria for study intervention|1
6976819|NCT01202279|11029655|FG000|Overall Study|Withdrawal by Subject|13
6976820|NCT01202279|11029656|FG001|Overall Study|Withdrawal by Subject|10
6976821|NCT01202279|11029655|FG000|Overall Study|Physician Decision|0
6976822|NCT01202279|11029656|FG001|Overall Study|Physician Decision|1
6976823|NCT01202279|11029655|FG000|Overall Study|Lost to Follow-up|10
6976824|NCT01202279|11029656|FG001|Overall Study|Lost to Follow-up|7
6976825|NCT01202279|11029655|FG000|Overall Study|Protocol Violation|1
6976826|NCT01202279|11029656|FG001|Overall Study|Protocol Violation|1
6840790|NCT00278993|10846669|FG000|Overall Study|Adverse Event|24
6840791|NCT00278993|10846669|FG000|Overall Study|Withdrawal by Subject|5
6840792|NCT00278993|10846669|FG000|Overall Study|Progressive Disease|65
6976827|NCT01202279|11029655|FG000|Overall Study|study compliance|5
6976828|NCT01202279|11029656|FG001|Overall Study|study compliance|2
6976829|NCT01202409|11029662|FG000|Overall Study|Adverse Event|1
6976830|NCT01202409|11029662|FG000|Overall Study|Ineligible - KRAS mutants|7
6976831|NCT01202591|11029680|FG000|Overall Study|Adverse Event|2
6976832|NCT01202591|11029681|FG001|Overall Study|Adverse Event|1
7149594|NCT00846742|11311898|FG000|Overall Study|Withdrawal by Subject|1
7149595|NCT00634504|11311905|FG000|Overall Study|Protocol Violation|1
7149596|NCT00634504|11311906|FG001|Overall Study|Protocol Violation|0
6840793|NCT00278993|10846669|FG000|Overall Study|Physician Decision|9
6840794|NCT00278993|10846669|FG000|Overall Study|Not Otherwise Specified|4
6840795|NCT00279201|10846675|FG000|Initiation|Death|1
6840796|NCT00279201|10846676|FG001|Initiation|Death|5
6840797|NCT00279201|10846677|FG002|Initiation|Death|0
7077092|NCT02087943|11184445|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1
6840798|NCT00279201|10846678|FG003|Initiation|Death|0
6840799|NCT00279201|10846679|FG004|Initiation|Death|0
6840800|NCT00279201|10846680|FG005|Initiation|Death|0
6840801|NCT00279201|10846675|FG000|Initiation|Adverse Event|6
6840802|NCT00279201|10846676|FG001|Initiation|Adverse Event|15
6840803|NCT00279201|10846677|FG002|Initiation|Adverse Event|0
6840804|NCT00279201|10846678|FG003|Initiation|Adverse Event|0
6840805|NCT00279201|10846679|FG004|Initiation|Adverse Event|0
6840806|NCT00279201|10846680|FG005|Initiation|Adverse Event|0
6840807|NCT00279201|10846675|FG000|Initiation|Lost to Follow-up|42
6840808|NCT00279201|10846676|FG001|Initiation|Lost to Follow-up|41
6840809|NCT00279201|10846677|FG002|Initiation|Lost to Follow-up|0
6840810|NCT00279201|10846678|FG003|Initiation|Lost to Follow-up|0
6840811|NCT00279201|10846679|FG004|Initiation|Lost to Follow-up|0
6840812|NCT00279201|10846680|FG005|Initiation|Lost to Follow-up|0
6840813|NCT00279201|10846675|FG000|Initiation|Entry Criteria Exclusion|7
6840814|NCT00279201|10846676|FG001|Initiation|Entry Criteria Exclusion|9
6840815|NCT00279201|10846677|FG002|Initiation|Entry Criteria Exclusion|0
6840816|NCT00279201|10846678|FG003|Initiation|Entry Criteria Exclusion|0
6840817|NCT00279201|10846679|FG004|Initiation|Entry Criteria Exclusion|0
6840818|NCT00279201|10846680|FG005|Initiation|Entry Criteria Exclusion|0
6840819|NCT00279201|10846675|FG000|Initiation|Protocol Violation|9
6840820|NCT00279201|10846676|FG001|Initiation|Protocol Violation|10
6840821|NCT00279201|10846677|FG002|Initiation|Protocol Violation|0
6840822|NCT00279201|10846678|FG003|Initiation|Protocol Violation|0
6840823|NCT00279201|10846679|FG004|Initiation|Protocol Violation|0
6840824|NCT00279201|10846680|FG005|Initiation|Protocol Violation|0
6840825|NCT00279201|10846675|FG000|Initiation|Withdrawal by Subject|35
6840826|NCT00279201|10846676|FG001|Initiation|Withdrawal by Subject|41
6840827|NCT00279201|10846677|FG002|Initiation|Withdrawal by Subject|0
6840828|NCT00279201|10846678|FG003|Initiation|Withdrawal by Subject|0
6840829|NCT00279201|10846679|FG004|Initiation|Withdrawal by Subject|0
7077093|NCT02087943|11184446|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
7077094|NCT02087943|11184447|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
7149619|NCT00352027|11311932|FG000|Overall Study|Progressive disease|3
7149620|NCT00104676|11311960|FG000|Overall Study|Death|3
7149621|NCT00104676|11311961|FG001|Overall Study|Death|2
6840830|NCT00279201|10846680|FG005|Initiation|Withdrawal by Subject|0
6840831|NCT00279201|10846675|FG000|Initiation|Physician Decision|15
6840832|NCT00279201|10846676|FG001|Initiation|Physician Decision|18
6840833|NCT00279201|10846677|FG002|Initiation|Physician Decision|0
6840834|NCT00279201|10846678|FG003|Initiation|Physician Decision|0
6840835|NCT00279201|10846679|FG004|Initiation|Physician Decision|0
6840836|NCT00279201|10846680|FG005|Initiation|Physician Decision|0
6840837|NCT00279201|10846675|FG000|Initiation|Sponsor Decision|13
6840838|NCT00279201|10846676|FG001|Initiation|Sponsor Decision|5
6840839|NCT00279201|10846677|FG002|Initiation|Sponsor Decision|0
6840840|NCT00279201|10846678|FG003|Initiation|Sponsor Decision|0
7077095|NCT02087943|11184448|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
7077096|NCT02087943|11184444|FG000|Active Treatment Phase Week 12-24|Adverse Event|0
7077097|NCT02087943|11184445|FG001|Active Treatment Phase Week 12-24|Adverse Event|1
7077098|NCT02087943|11184446|FG002|Active Treatment Phase Week 12-24|Adverse Event|2
7077099|NCT02087943|11184447|FG003|Active Treatment Phase Week 12-24|Adverse Event|0
7077100|NCT02087943|11184448|FG004|Active Treatment Phase Week 12-24|Adverse Event|1
7082900|NCT02147158|11193686|FG000|Off-Treatment Interval 1|Lack of Efficacy|0
7149622|NCT00104676|11311960|FG000|Overall Study|Withdrawal by Subject|0
7149623|NCT00104676|11311961|FG001|Overall Study|Withdrawal by Subject|2
7149624|NCT00104676|11311960|FG000|Overall Study|treatment interruption|4
7149625|NCT00104676|11311961|FG001|Overall Study|treatment interruption|10
7183944|NCT00557193|11383965|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
7183945|NCT00557193|11383966|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1
7183946|NCT00557193|11383967|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
7183947|NCT00557193|11383968|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
7183948|NCT00557193|11383969|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
7183949|NCT00557193|11383964|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
7183950|NCT00557193|11383965|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
7183951|NCT00557193|11383966|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2
7183952|NCT00557193|11383967|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
7183953|NCT00557193|11383968|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
7183954|NCT00557193|11383969|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
7183955|NCT00557193|11383964|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0
7183956|NCT00557193|11383965|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0
7183957|NCT00557193|11383966|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4
7183958|NCT00557193|11383967|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0
7183959|NCT00557193|11383968|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0
7183960|NCT00557193|11383969|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5
7183961|NCT00547339|11383998|FG000|Overall Study|Physician Decision|0
7183962|NCT00547339|11383999|FG001|Overall Study|Physician Decision|0
7183963|NCT00547339|11384000|FG002|Overall Study|Physician Decision|1
7183964|NCT00547339|11384001|FG003|Overall Study|Physician Decision|0
7183965|NCT00531232|11384023|FG000|Overall Study|Investigator decision|0
7183966|NCT00531232|11384024|FG001|Overall Study|Investigator decision|0
7183967|NCT00531232|11384025|FG002|Overall Study|Investigator decision|4
7183968|NCT00531232|11384023|FG000|Overall Study|Participants refused further treatment|0
7183969|NCT00531232|11384024|FG001|Overall Study|Participants refused further treatment|1
7183970|NCT00531232|11384025|FG002|Overall Study|Participants refused further treatment|2
7183971|NCT00531232|11384023|FG000|Overall Study|Adverse events (AEs)|1
7183972|NCT00531232|11384024|FG001|Overall Study|Adverse events (AEs)|2
7183973|NCT00531232|11384025|FG002|Overall Study|Adverse events (AEs)|2
7183974|NCT00531232|11384023|FG000|Overall Study|Treatment failure|1
7183975|NCT00531232|11384024|FG001|Overall Study|Treatment failure|3
7183976|NCT00531232|11384025|FG002|Overall Study|Treatment failure|7
7183977|NCT00531232|11384023|FG000|Overall Study|Disease recurrence|0
7183978|NCT00531232|11384024|FG001|Overall Study|Disease recurrence|0
7183979|NCT00531232|11384025|FG002|Overall Study|Disease recurrence|1
7183980|NCT00531232|11384023|FG000|Overall Study|Deceased|2
7183981|NCT00531232|11384024|FG001|Overall Study|Deceased|2
7183982|NCT00531232|11384025|FG002|Overall Study|Deceased|2
7183983|NCT00531232|11384023|FG000|Overall Study|Withdrawal by Subject|0
7183984|NCT00531232|11384024|FG001|Overall Study|Withdrawal by Subject|1
7183985|NCT00531232|11384025|FG002|Overall Study|Withdrawal by Subject|2
7183986|NCT00531232|11384023|FG000|Overall Study|Other|0
7183987|NCT00531232|11384024|FG001|Overall Study|Other|0
7183988|NCT00531232|11384025|FG002|Overall Study|Other|5
7183989|NCT00379340|11384041|FG000|Overall Study|Death|0
7183990|NCT00379340|11384042|FG001|Overall Study|Death|0
7183991|NCT00379340|11384043|FG002|Overall Study|Death|0
7183992|NCT00379340|11384044|FG003|Overall Study|Death|2
7183993|NCT00379340|11384045|FG004|Overall Study|Death|0
7183994|NCT00379340|11384041|FG000|Overall Study|Lack of Efficacy|6
7183995|NCT00379340|11384042|FG001|Overall Study|Lack of Efficacy|1
7183996|NCT00379340|11384043|FG002|Overall Study|Lack of Efficacy|0
7183997|NCT00379340|11384044|FG003|Overall Study|Lack of Efficacy|4
7183998|NCT00379340|11384045|FG004|Overall Study|Lack of Efficacy|3
7183999|NCT00379340|11384041|FG000|Overall Study|Physician Decision|6
7184000|NCT00379340|11384042|FG001|Overall Study|Physician Decision|2
7184001|NCT00379340|11384043|FG002|Overall Study|Physician Decision|1
7184002|NCT00379340|11384044|FG003|Overall Study|Physician Decision|2
7184003|NCT00379340|11384045|FG004|Overall Study|Physician Decision|3
7184004|NCT00379340|11384041|FG000|Overall Study|Withdrawal by Subject|0
7184005|NCT00379340|11384042|FG001|Overall Study|Withdrawal by Subject|0
7184006|NCT00379340|11384043|FG002|Overall Study|Withdrawal by Subject|0
7184007|NCT00379340|11384044|FG003|Overall Study|Withdrawal by Subject|1
7184008|NCT00379340|11384045|FG004|Overall Study|Withdrawal by Subject|0
7184009|NCT00379340|11384041|FG000|Overall Study|Refusal of further protocol therapy|1
7184010|NCT00379340|11384042|FG001|Overall Study|Refusal of further protocol therapy|0
7184011|NCT00379340|11384043|FG002|Overall Study|Refusal of further protocol therapy|1
7184012|NCT00379340|11384044|FG003|Overall Study|Refusal of further protocol therapy|1
7184013|NCT00379340|11384045|FG004|Overall Study|Refusal of further protocol therapy|7
7184014|NCT00379340|11384041|FG000|Overall Study|On more than 1 tumor therapeutic study|0
7184015|NCT00379340|11384042|FG001|Overall Study|On more than 1 tumor therapeutic study|0
7184016|NCT00379340|11384043|FG002|Overall Study|On more than 1 tumor therapeutic study|0
6840841|NCT00279201|10846679|FG004|Initiation|Sponsor Decision|0
6840842|NCT00279201|10846680|FG005|Initiation|Sponsor Decision|0
6840843|NCT00279201|10846675|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0
6840844|NCT00279201|10846676|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1
6840845|NCT00279201|10846677|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0
6840846|NCT00279201|10846678|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0
6840847|NCT00279201|10846679|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0
6840848|NCT00279201|10846680|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0
6840849|NCT00279201|10846675|FG000|Maintenance|Lack of Efficacy|32
6840850|NCT00279201|10846676|FG001|Maintenance|Lack of Efficacy|30
6840851|NCT00279201|10846677|FG002|Maintenance|Lack of Efficacy|0
6840852|NCT00279201|10846678|FG003|Maintenance|Lack of Efficacy|0
6840853|NCT00279201|10846679|FG004|Maintenance|Lack of Efficacy|0
6840854|NCT00279201|10846680|FG005|Maintenance|Lack of Efficacy|0
6840855|NCT00279201|10846675|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3
6840856|NCT00279201|10846676|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2
6840857|NCT00279201|10846677|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0
6840858|NCT00279201|10846678|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0
6840859|NCT00279201|10846679|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0
6840860|NCT00279201|10846680|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0
6840861|NCT00279201|10846675|FG000|Maintenance|Adverse Event|4
6840862|NCT00279201|10846676|FG001|Maintenance|Adverse Event|4
6840863|NCT00279201|10846677|FG002|Maintenance|Adverse Event|0
6840864|NCT00279201|10846678|FG003|Maintenance|Adverse Event|0
6840865|NCT00279201|10846679|FG004|Maintenance|Adverse Event|0
6840866|NCT00279201|10846680|FG005|Maintenance|Adverse Event|0
6840867|NCT00279201|10846675|FG000|Maintenance|Death|4
6840868|NCT00279201|10846676|FG001|Maintenance|Death|4
6840869|NCT00279201|10846677|FG002|Maintenance|Death|0
6840870|NCT00279201|10846678|FG003|Maintenance|Death|0
7077101|NCT02087943|11184444|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0
7077102|NCT02087943|11184445|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3
7077103|NCT02087943|11184446|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1
7077104|NCT02087943|11184447|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1
7077105|NCT02087943|11184448|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0
7149626|NCT04042103|11311980|FG000|Overall Study|Lost to Follow-up|1
6840871|NCT00279201|10846679|FG004|Maintenance|Death|0
6840872|NCT00279201|10846680|FG005|Maintenance|Death|0
6840873|NCT00279201|10846675|FG000|Maintenance|Lost to Follow-up|17
6840874|NCT00279201|10846676|FG001|Maintenance|Lost to Follow-up|13
6840875|NCT00279201|10846677|FG002|Maintenance|Lost to Follow-up|0
6840876|NCT00279201|10846678|FG003|Maintenance|Lost to Follow-up|0
6840877|NCT00279201|10846679|FG004|Maintenance|Lost to Follow-up|0
6840878|NCT00279201|10846680|FG005|Maintenance|Lost to Follow-up|0
6840879|NCT00279201|10846675|FG000|Maintenance|Entry Criteria Exclusion|1
6840880|NCT00279201|10846676|FG001|Maintenance|Entry Criteria Exclusion|4
6840881|NCT00279201|10846677|FG002|Maintenance|Entry Criteria Exclusion|0
6840882|NCT00279201|10846678|FG003|Maintenance|Entry Criteria Exclusion|0
6840883|NCT00279201|10846679|FG004|Maintenance|Entry Criteria Exclusion|0
6840884|NCT00279201|10846680|FG005|Maintenance|Entry Criteria Exclusion|0
6840885|NCT00279201|10846675|FG000|Maintenance|Protocol Violation|16
6840886|NCT00279201|10846676|FG001|Maintenance|Protocol Violation|24
6840887|NCT00279201|10846677|FG002|Maintenance|Protocol Violation|0
6840888|NCT00279201|10846678|FG003|Maintenance|Protocol Violation|0
6840889|NCT00279201|10846679|FG004|Maintenance|Protocol Violation|0
6840890|NCT00279201|10846680|FG005|Maintenance|Protocol Violation|0
6840891|NCT00279201|10846675|FG000|Maintenance|Withdrawal by Subject|18
6840892|NCT00279201|10846676|FG001|Maintenance|Withdrawal by Subject|18
6840893|NCT00279201|10846677|FG002|Maintenance|Withdrawal by Subject|0
6840894|NCT00279201|10846678|FG003|Maintenance|Withdrawal by Subject|0
6840895|NCT00279201|10846679|FG004|Maintenance|Withdrawal by Subject|0
6840896|NCT00279201|10846680|FG005|Maintenance|Withdrawal by Subject|0
6840897|NCT00279201|10846675|FG000|Maintenance|Physician Decision|9
6840898|NCT00279201|10846676|FG001|Maintenance|Physician Decision|9
6840899|NCT00279201|10846677|FG002|Maintenance|Physician Decision|0
6840900|NCT00279201|10846678|FG003|Maintenance|Physician Decision|0
6840901|NCT00279201|10846679|FG004|Maintenance|Physician Decision|0
6840902|NCT00279201|10846680|FG005|Maintenance|Physician Decision|0
6840903|NCT00279201|10846675|FG000|Maintenance|Sponsor Decision|4
6840904|NCT00279201|10846676|FG001|Maintenance|Sponsor Decision|0
6840905|NCT00279201|10846677|FG002|Maintenance|Sponsor Decision|0
6840906|NCT00279201|10846678|FG003|Maintenance|Sponsor Decision|0
6840907|NCT00279201|10846679|FG004|Maintenance|Sponsor Decision|0
6840908|NCT00279201|10846680|FG005|Maintenance|Sponsor Decision|0
7077106|NCT02087943|11184444|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
6840909|NCT00279201|10846675|FG000|Maintenance|HbA1c>7.5%|123
6840910|NCT00279201|10846676|FG001|Maintenance|HbA1c>7.5%|126
6840911|NCT00279201|10846677|FG002|Maintenance|HbA1c>7.5%|0
6840912|NCT00279201|10846678|FG003|Maintenance|HbA1c>7.5%|0
6840913|NCT00279201|10846679|FG004|Maintenance|HbA1c>7.5%|0
6840914|NCT00279201|10846680|FG005|Maintenance|HbA1c>7.5%|0
6840915|NCT00279201|10846675|FG000|Intensification Addendum|Withdrawal by Subject|0
6840916|NCT00279201|10846676|FG001|Intensification Addendum|Withdrawal by Subject|0
6840917|NCT00279201|10846677|FG002|Intensification Addendum|Withdrawal by Subject|12
7149627|NCT04042103|11311980|FG000|Overall Study|Withdrawal by Subject|1
7149628|NCT04004208|11311986|FG000|Overall Study|Withdrawal by parent/guardian|1
7149629|NCT04004208|11311987|FG001|Overall Study|Withdrawal by parent/guardian|1
7149630|NCT04004208|11311986|FG000|Overall Study|Death|3
7149631|NCT04004208|11311987|FG001|Overall Study|Death|0
7149632|NCT04004208|11311986|FG000|Overall Study|COVID-19 pandemic|1
7149633|NCT04004208|11311987|FG001|Overall Study|COVID-19 pandemic|0
7149634|NCT04004208|11311986|FG000|Overall Study|Physician Decision|1
7149635|NCT04004208|11311987|FG001|Overall Study|Physician Decision|0
7149636|NCT04004208|11311986|FG000|Overall Study|Adverse Event|1
7149637|NCT04004208|11311987|FG001|Overall Study|Adverse Event|1
7184017|NCT00379340|11384044|FG003|Overall Study|On more than 1 tumor therapeutic study|2
7184018|NCT00379340|11384045|FG004|Overall Study|On more than 1 tumor therapeutic study|0
7184019|NCT00379340|11384041|FG000|Overall Study|Delayed nephrectomy and anaplasia|0
7184020|NCT00379340|11384042|FG001|Overall Study|Delayed nephrectomy and anaplasia|0
7184021|NCT00379340|11384043|FG002|Overall Study|Delayed nephrectomy and anaplasia|0
7184022|NCT00379340|11384044|FG003|Overall Study|Delayed nephrectomy and anaplasia|1
7184023|NCT00379340|11384045|FG004|Overall Study|Delayed nephrectomy and anaplasia|1
7184024|NCT00304070|11384061|FG000|Overall Study|Death|0
7184025|NCT00304070|11384062|FG001|Overall Study|Death|0
7184026|NCT00304070|11384063|FG002|Overall Study|Death|3
7184027|NCT00304070|11384061|FG000|Overall Study|Lost to Follow-up|0
7184028|NCT00304070|11384062|FG001|Overall Study|Lost to Follow-up|0
7184029|NCT00304070|11384063|FG002|Overall Study|Lost to Follow-up|1
7184030|NCT00304070|11384061|FG000|Overall Study|Physician Decision|0
7184031|NCT00304070|11384062|FG001|Overall Study|Physician Decision|0
7184032|NCT00304070|11384063|FG002|Overall Study|Physician Decision|3
7184033|NCT00304070|11384061|FG000|Overall Study|Withdrawal by Subject|0
7184034|NCT00304070|11384062|FG001|Overall Study|Withdrawal by Subject|0
7184035|NCT00304070|11384063|FG002|Overall Study|Withdrawal by Subject|1
7184036|NCT00304070|11384061|FG000|Overall Study|Progressive Disease|3
7184037|NCT00304070|11384062|FG001|Overall Study|Progressive Disease|7
7184038|NCT00304070|11384063|FG002|Overall Study|Progressive Disease|4
7187211|NCT01373151|11387718|FG002|Period 1|Withdrawal by Subject|3
7187212|NCT01373151|11387719|FG003|Period 1|Withdrawal by Subject|1
7187213|NCT01373151|11387720|FG004|Period 1|Withdrawal by Subject|0
7187214|NCT01373151|11387721|FG005|Period 1|Withdrawal by Subject|1
7187215|NCT01373151|11387722|FG006|Period 1|Withdrawal by Subject|0
7187216|NCT01373151|11387716|FG000|Period 2|Lack of Efficacy|9
7187217|NCT01373151|11387717|FG001|Period 2|Lack of Efficacy|0
7187218|NCT01373151|11387718|FG002|Period 2|Lack of Efficacy|0
7187219|NCT01373151|11387719|FG003|Period 2|Lack of Efficacy|1
7187220|NCT01373151|11387720|FG004|Period 2|Lack of Efficacy|2
7187221|NCT01373151|11387721|FG005|Period 2|Lack of Efficacy|0
7187222|NCT01373151|11387722|FG006|Period 2|Lack of Efficacy|3
7187223|NCT01373151|11387716|FG000|Period 2|Adverse Event|0
7187224|NCT01373151|11387717|FG001|Period 2|Adverse Event|0
7187225|NCT01373151|11387718|FG002|Period 2|Adverse Event|3
7187226|NCT01373151|11387719|FG003|Period 2|Adverse Event|3
7187227|NCT01373151|11387720|FG004|Period 2|Adverse Event|0
7187228|NCT01373151|11387721|FG005|Period 2|Adverse Event|0
7187229|NCT01373151|11387722|FG006|Period 2|Adverse Event|1
7187230|NCT01373151|11387716|FG000|Period 2|subject request to discontinue|0
7187231|NCT01373151|11387717|FG001|Period 2|subject request to discontinue|1
7187232|NCT01373151|11387718|FG002|Period 2|subject request to discontinue|0
7187233|NCT01373151|11387719|FG003|Period 2|subject request to discontinue|0
7187234|NCT01373151|11387720|FG004|Period 2|subject request to discontinue|0
7187235|NCT01373151|11387721|FG005|Period 2|subject request to discontinue|0
7187236|NCT01373151|11387722|FG006|Period 2|subject request to discontinue|0
7187237|NCT01373151|11387716|FG000|Period 2|Withdrawal by Subject|0
7187238|NCT01373151|11387717|FG001|Period 2|Withdrawal by Subject|0
7187239|NCT01373151|11387718|FG002|Period 2|Withdrawal by Subject|0
7187240|NCT01373151|11387719|FG003|Period 2|Withdrawal by Subject|1
7187241|NCT01373151|11387720|FG004|Period 2|Withdrawal by Subject|0
7187242|NCT01373151|11387721|FG005|Period 2|Withdrawal by Subject|0
7187243|NCT01373151|11387722|FG006|Period 2|Withdrawal by Subject|0
7187244|NCT01373151|11387716|FG000|Period 2|Other|0
7187245|NCT01373151|11387717|FG001|Period 2|Other|0
7187246|NCT01373151|11387718|FG002|Period 2|Other|1
7187247|NCT01373151|11387719|FG003|Period 2|Other|0
7187248|NCT01373151|11387720|FG004|Period 2|Other|0
7187249|NCT01373151|11387721|FG005|Period 2|Other|0
7187250|NCT01373151|11387722|FG006|Period 2|Other|1
7187251|NCT01281644|11387751|FG000|Overall Study|Lost to Follow-up|3
7187252|NCT01281644|11387751|FG000|Overall Study|Withdrawal by Subject|2
7187253|NCT00960297|11387763|FG000|Overall Study|Physician Decision|1
7187254|NCT00960297|11387763|FG000|Overall Study|Venous port infection|1
7187255|NCT00960297|11387763|FG000|Overall Study|Disease progression|1
7187256|NCT00910650|11387767|FG000|Overall Study|Death|2
7187257|NCT00703326|11387777|FG000|Overall Study|Lost to Follow-up|47
7187258|NCT00703326|11387778|FG001|Overall Study|Lost to Follow-up|18
7187259|NCT00703326|11387777|FG000|Overall Study|Withdrawal by Subject|54
7187260|NCT00703326|11387778|FG001|Overall Study|Withdrawal by Subject|20
7187261|NCT00703326|11387777|FG000|Overall Study|Adverse Event|1
7187262|NCT00703326|11387778|FG001|Overall Study|Adverse Event|0
7187263|NCT00602667|11387788|FG000|Overall Study|Still on Therapy|0
7149638|NCT03817190|11311995|FG000|Overall Study|Early Termination|13
7149639|NCT03817190|11311996|FG001|Overall Study|Early Termination|20
7149640|NCT03817190|11311995|FG000|Overall Study|Adverse Event|10
7149641|NCT03817190|11311996|FG001|Overall Study|Adverse Event|17
7149642|NCT03817190|11311995|FG000|Overall Study|Withdrawal by Subject|12
7149643|NCT03817190|11311996|FG001|Overall Study|Withdrawal by Subject|8
7149644|NCT03817190|11311995|FG000|Overall Study|Lost to Follow-up|11
7149645|NCT03817190|11311996|FG001|Overall Study|Lost to Follow-up|7
7149646|NCT03817190|11311995|FG000|Overall Study|Lack of Efficacy|7
7149647|NCT03817190|11311996|FG001|Overall Study|Lack of Efficacy|5
7149648|NCT03817190|11311995|FG000|Overall Study|Investigator Decision|5
7149649|NCT03817190|11311996|FG001|Overall Study|Investigator Decision|1
7149650|NCT03817190|11311995|FG000|Overall Study|Missing Effect|2
7149651|NCT03817190|11311996|FG001|Overall Study|Missing Effect|1
7184039|NCT01701583|11384087|FG000|Overall Study|Withdrawal by Subject|2
7184040|NCT01701583|11384088|FG001|Overall Study|Withdrawal by Subject|0
7184041|NCT01714817|11384097|FG000|Year 1 Period|Lack of Efficacy|11
7184042|NCT01714817|11384098|FG001|Year 1 Period|Lack of Efficacy|9
7184043|NCT01714817|11384097|FG000|Year 1 Period|Adverse Event|20
7184044|NCT01714817|11384098|FG001|Year 1 Period|Adverse Event|17
7184045|NCT01714817|11384097|FG000|Year 1 Period|Withdrawal by Subject|6
7184046|NCT01714817|11384098|FG001|Year 1 Period|Withdrawal by Subject|7
7184047|NCT01714817|11384097|FG000|Year 1 Period|Death|1
7184048|NCT01714817|11384098|FG001|Year 1 Period|Death|1
6840918|NCT00279201|10846678|FG003|Intensification Addendum|Withdrawal by Subject|14
6840919|NCT00279201|10846679|FG004|Intensification Addendum|Withdrawal by Subject|9
6840920|NCT00279201|10846680|FG005|Intensification Addendum|Withdrawal by Subject|18
6840921|NCT00279201|10846675|FG000|Intensification Addendum|Lost to Follow-up|0
6840922|NCT00279201|10846676|FG001|Intensification Addendum|Lost to Follow-up|0
6840923|NCT00279201|10846677|FG002|Intensification Addendum|Lost to Follow-up|4
6840924|NCT00279201|10846678|FG003|Intensification Addendum|Lost to Follow-up|6
6840925|NCT00279201|10846679|FG004|Intensification Addendum|Lost to Follow-up|7
6840926|NCT00279201|10846680|FG005|Intensification Addendum|Lost to Follow-up|7
6840927|NCT00279201|10846675|FG000|Intensification Addendum|Protocol Violation|0
6840928|NCT00279201|10846676|FG001|Intensification Addendum|Protocol Violation|0
6840929|NCT00279201|10846677|FG002|Intensification Addendum|Protocol Violation|2
6840930|NCT00279201|10846678|FG003|Intensification Addendum|Protocol Violation|2
6840931|NCT00279201|10846679|FG004|Intensification Addendum|Protocol Violation|6
6840932|NCT00279201|10846680|FG005|Intensification Addendum|Protocol Violation|6
6840933|NCT00279201|10846675|FG000|Intensification Addendum|Adverse Event|0
6840934|NCT00279201|10846676|FG001|Intensification Addendum|Adverse Event|0
6840935|NCT00279201|10846677|FG002|Intensification Addendum|Adverse Event|0
6840936|NCT00279201|10846678|FG003|Intensification Addendum|Adverse Event|4
6840937|NCT00279201|10846679|FG004|Intensification Addendum|Adverse Event|1
6840938|NCT00279201|10846680|FG005|Intensification Addendum|Adverse Event|3
6840939|NCT00279201|10846675|FG000|Intensification Addendum|Physician Decision|0
6840940|NCT00279201|10846676|FG001|Intensification Addendum|Physician Decision|0
6840941|NCT00279201|10846677|FG002|Intensification Addendum|Physician Decision|4
6840942|NCT00279201|10846678|FG003|Intensification Addendum|Physician Decision|1
6840943|NCT00279201|10846679|FG004|Intensification Addendum|Physician Decision|3
6840944|NCT00279201|10846680|FG005|Intensification Addendum|Physician Decision|2
6840945|NCT00279201|10846675|FG000|Intensification Addendum|Sponsor Decision|0
6840946|NCT00279201|10846676|FG001|Intensification Addendum|Sponsor Decision|0
6840947|NCT00279201|10846677|FG002|Intensification Addendum|Sponsor Decision|0
6840948|NCT00279201|10846678|FG003|Intensification Addendum|Sponsor Decision|0
6840949|NCT00279201|10846679|FG004|Intensification Addendum|Sponsor Decision|1
6840950|NCT00279201|10846680|FG005|Intensification Addendum|Sponsor Decision|1
6840951|NCT00279201|10846675|FG000|Intensification Addendum|Entry Criteria Exclusion|0
6840952|NCT00279201|10846676|FG001|Intensification Addendum|Entry Criteria Exclusion|0
6840953|NCT00279201|10846677|FG002|Intensification Addendum|Entry Criteria Exclusion|1
6840954|NCT00279201|10846678|FG003|Intensification Addendum|Entry Criteria Exclusion|0
6840955|NCT00279201|10846679|FG004|Intensification Addendum|Entry Criteria Exclusion|0
6840956|NCT00279201|10846680|FG005|Intensification Addendum|Entry Criteria Exclusion|0
6840957|NCT00279201|10846675|FG000|Intensification Addendum|Lack of Efficacy|0
6840958|NCT00279201|10846676|FG001|Intensification Addendum|Lack of Efficacy|0
6840959|NCT00279201|10846677|FG002|Intensification Addendum|Lack of Efficacy|0
6840960|NCT00279201|10846678|FG003|Intensification Addendum|Lack of Efficacy|1
6840961|NCT00279201|10846679|FG004|Intensification Addendum|Lack of Efficacy|1
6840962|NCT00279201|10846680|FG005|Intensification Addendum|Lack of Efficacy|0
6840963|NCT00279201|10846675|FG000|Intensification Addendum|Death|0
6840964|NCT00279201|10846676|FG001|Intensification Addendum|Death|0
6840965|NCT00279201|10846677|FG002|Intensification Addendum|Death|0
6840966|NCT00279201|10846678|FG003|Intensification Addendum|Death|0
6840967|NCT00279201|10846679|FG004|Intensification Addendum|Death|1
6840968|NCT00279201|10846680|FG005|Intensification Addendum|Death|0
7184049|NCT01714817|11384097|FG000|Year 1 Period|Lost to Follow-up|0
7184050|NCT01714817|11384098|FG001|Year 1 Period|Lost to Follow-up|2
7184051|NCT01714817|11384097|FG000|Year 1 Period|Poor / non-compliance|0
7184052|NCT01714817|11384098|FG001|Year 1 Period|Poor / non-compliance|1
7184053|NCT01714817|11384097|FG000|Year 1 Period|Pregnancy|2
7184054|NCT01714817|11384098|FG001|Year 1 Period|Pregnancy|0
7149652|NCT03041311|11312008|FG000|Overall Study|Death|39
7149653|NCT03041311|11312009|FG001|Overall Study|Death|42
7149654|NCT03041311|11312008|FG000|Overall Study|Lost to Follow-up|0
7149655|NCT03041311|11312009|FG001|Overall Study|Lost to Follow-up|1
7149656|NCT03041311|11312008|FG000|Overall Study|Withdrawal by Subject|8
7149657|NCT03041311|11312009|FG001|Overall Study|Withdrawal by Subject|5
7149658|NCT03041311|11312008|FG000|Overall Study|Sponsor Terminated Study|2
7149659|NCT03041311|11312009|FG001|Overall Study|Sponsor Terminated Study|4
7149660|NCT03041311|11312008|FG000|Overall Study|Disease Progression|3
7149661|NCT03041311|11312009|FG001|Overall Study|Disease Progression|1
7149662|NCT03041311|11312008|FG000|Overall Study|Randomized in error, did not receive drug|2
7149663|NCT03041311|11312009|FG001|Overall Study|Randomized in error, did not receive drug|0
7149664|NCT03020914|11312025|FG000|Overall Study|Surgery Cancelled|1
7149665|NCT03020914|11312026|FG001|Overall Study|Surgery Cancelled|0
7149666|NCT02698891|11312041|FG000|Overall Study|Withdrawal by Subject|2
7149667|NCT02698891|11312041|FG000|Overall Study|deemed ineligible|1
7149668|NCT02698891|11312041|FG000|Overall Study|Adverse Event|9
7149669|NCT02537678|11312047|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4
7149670|NCT02537678|11312048|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3
7149671|NCT02537678|11312047|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4
7149672|NCT02537678|11312048|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4
7149673|NCT02537678|11312047|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6
7149674|NCT02537678|11312048|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5
7149675|NCT02537678|11312047|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2
7149676|NCT02537678|11312048|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3
7149677|NCT02537678|11312047|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14
7149678|NCT02537678|11312048|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6
7149679|NCT02537678|11312047|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8
6840969|NCT00279214|10846715|FG000|Overall Study|Physician Decision|3
6840970|NCT00279214|10846716|FG001|Overall Study|Physician Decision|2
6840971|NCT00279305|10846724|FG000|Overall Study|Pregnancy|1
6840972|NCT00279305|10846725|FG001|Overall Study|Pregnancy|0
6840973|NCT00279305|10846724|FG000|Overall Study|Withdrawal by Subject|2
6840974|NCT00279305|10846725|FG001|Overall Study|Withdrawal by Subject|0
6840975|NCT00279305|10846724|FG000|Overall Study|Dificulting establishing IV|1
6840976|NCT00279305|10846725|FG001|Overall Study|Dificulting establishing IV|0
6840977|NCT00279305|10846724|FG000|Overall Study|FDA Safety Alert|4
6840978|NCT00279305|10846725|FG001|Overall Study|FDA Safety Alert|1
6840979|NCT00279708|10846748|FG000|Overall Study|Withdrawal by Subject|2
6840980|NCT00279708|10846749|FG001|Overall Study|Withdrawal by Subject|3
6840981|NCT00279708|10846748|FG000|Overall Study|Adverse Event|1
6840982|NCT00279708|10846749|FG001|Overall Study|Adverse Event|1
6840983|NCT00279812|10846761|FG000|Overall Study|Protocol Violation|1
6840984|NCT00279812|10846762|FG001|Overall Study|Protocol Violation|1
6840985|NCT00279812|10846763|FG002|Overall Study|Protocol Violation|0
6840986|NCT00279812|10846764|FG003|Overall Study|Protocol Violation|0
6840987|NCT00279812|10846765|FG004|Overall Study|Protocol Violation|1
6840988|NCT00279812|10846766|FG005|Overall Study|Protocol Violation|0
6840989|NCT00279812|10846761|FG000|Overall Study|Withdrawal by Subject|0
6840990|NCT00279812|10846762|FG001|Overall Study|Withdrawal by Subject|4
6840991|NCT00279812|10846763|FG002|Overall Study|Withdrawal by Subject|2
6840992|NCT00279812|10846764|FG003|Overall Study|Withdrawal by Subject|0
6840993|NCT00279812|10846765|FG004|Overall Study|Withdrawal by Subject|0
6840994|NCT00279812|10846766|FG005|Overall Study|Withdrawal by Subject|0
6840995|NCT00279812|10846761|FG000|Overall Study|Adverse Event|0
6840996|NCT00279812|10846762|FG001|Overall Study|Adverse Event|1
6840997|NCT00279812|10846763|FG002|Overall Study|Adverse Event|1
6840998|NCT00279812|10846764|FG003|Overall Study|Adverse Event|0
6840999|NCT00279812|10846765|FG004|Overall Study|Adverse Event|2
6841000|NCT00279812|10846766|FG005|Overall Study|Adverse Event|1
6841001|NCT00279916|10846782|FG000|Overall Study|Withdrawal by Subject|4
6841002|NCT00279916|10846783|FG001|Overall Study|Withdrawal by Subject|3
6841003|NCT00279916|10846782|FG000|Overall Study|Lost to Follow-up|3
6966445|NCT04085367|11014437|FG000|Overall Study|Adverse Event|1
7149680|NCT02537678|11312048|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7
7149681|NCT02537678|11312047|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0
7149682|NCT02537678|11312048|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1
7149683|NCT02400476|11312064|FG000|Overall Study|Adverse Event|57
7149684|NCT02400476|11312065|FG001|Overall Study|Adverse Event|10
7149685|NCT02400476|11312066|FG002|Overall Study|Adverse Event|22
7149686|NCT02400476|11312067|FG003|Overall Study|Adverse Event|19
7149687|NCT02400476|11312068|FG004|Overall Study|Adverse Event|5
6841004|NCT00279916|10846783|FG001|Overall Study|Lost to Follow-up|2
6841005|NCT00280059|10846803|FG000|Efficacy Assessment Phase|Death|2
6841006|NCT00280059|10846804|FG001|Efficacy Assessment Phase|Death|0
6841007|NCT00280059|10846803|FG000|Efficacy Assessment Phase|Adverse Event|33
6841008|NCT00280059|10846804|FG001|Efficacy Assessment Phase|Adverse Event|31
6841009|NCT00280059|10846803|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1
6841010|NCT00280059|10846804|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0
6841011|NCT00280059|10846803|FG000|Efficacy Assessment Phase|Lack of Efficacy|19
7149688|NCT02400476|11312069|FG005|Overall Study|Adverse Event|8
7149689|NCT02400476|11312064|FG000|Overall Study|Withdrawal by Subject|4
7149690|NCT02400476|11312065|FG001|Overall Study|Withdrawal by Subject|1
7149691|NCT02400476|11312066|FG002|Overall Study|Withdrawal by Subject|12
7149692|NCT02400476|11312067|FG003|Overall Study|Withdrawal by Subject|7
7149693|NCT02400476|11312068|FG004|Overall Study|Withdrawal by Subject|5
7149694|NCT02400476|11312069|FG005|Overall Study|Withdrawal by Subject|5
7149695|NCT02400476|11312064|FG000|Overall Study|Lost to Follow-up|0
7149696|NCT02400476|11312065|FG001|Overall Study|Lost to Follow-up|0
7149697|NCT02400476|11312066|FG002|Overall Study|Lost to Follow-up|0
7149698|NCT02400476|11312067|FG003|Overall Study|Lost to Follow-up|1
7149699|NCT02400476|11312068|FG004|Overall Study|Lost to Follow-up|3
7149700|NCT02400476|11312069|FG005|Overall Study|Lost to Follow-up|1
7149701|NCT02400476|11312064|FG000|Overall Study|Physician Decision|0
7149702|NCT02400476|11312065|FG001|Overall Study|Physician Decision|0
7149703|NCT02400476|11312066|FG002|Overall Study|Physician Decision|1
7149704|NCT02400476|11312067|FG003|Overall Study|Physician Decision|1
7149705|NCT02400476|11312068|FG004|Overall Study|Physician Decision|0
7149706|NCT02400476|11312069|FG005|Overall Study|Physician Decision|1
7149707|NCT02400476|11312064|FG000|Overall Study|Other, Disease Progression|0
7149708|NCT02400476|11312065|FG001|Overall Study|Other, Disease Progression|1
7149709|NCT02400476|11312066|FG002|Overall Study|Other, Disease Progression|2
7149710|NCT02400476|11312067|FG003|Overall Study|Other, Disease Progression|1
7149711|NCT02400476|11312068|FG004|Overall Study|Other, Disease Progression|2
7149712|NCT02400476|11312069|FG005|Overall Study|Other, Disease Progression|1
7149713|NCT02400476|11312064|FG000|Overall Study|Other, Decreased Quality of Life|0
7149714|NCT02400476|11312065|FG001|Overall Study|Other, Decreased Quality of Life|0
7149715|NCT02400476|11312066|FG002|Overall Study|Other, Decreased Quality of Life|2
7149716|NCT02400476|11312067|FG003|Overall Study|Other, Decreased Quality of Life|0
7149717|NCT02400476|11312068|FG004|Overall Study|Other, Decreased Quality of Life|0
7149718|NCT02400476|11312069|FG005|Overall Study|Other, Decreased Quality of Life|0
7149719|NCT02400476|11312064|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0
7149720|NCT02400476|11312065|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0
7149721|NCT02400476|11312066|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2
6841012|NCT00280059|10846804|FG001|Efficacy Assessment Phase|Lack of Efficacy|3
6841013|NCT00280059|10846803|FG000|Efficacy Assessment Phase|Lost to Follow-up|6
6841014|NCT00280059|10846804|FG001|Efficacy Assessment Phase|Lost to Follow-up|13
6841015|NCT00280059|10846803|FG000|Efficacy Assessment Phase|Other|7
6841016|NCT00280059|10846804|FG001|Efficacy Assessment Phase|Other|8
6841017|NCT00280059|10846803|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26
6841018|NCT00280059|10846804|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25
6841019|NCT00280150|10846822|FG000|Overall Study|Adverse Event|0
6841020|NCT00280150|10846823|FG001|Overall Study|Adverse Event|1
6841021|NCT00280150|10846824|FG002|Overall Study|Adverse Event|2
6841022|NCT00280150|10846825|FG003|Overall Study|Adverse Event|3
6841023|NCT00280150|10846822|FG000|Overall Study|Lack of Efficacy|0
6841024|NCT00280150|10846823|FG001|Overall Study|Lack of Efficacy|0
6841025|NCT00280150|10846824|FG002|Overall Study|Lack of Efficacy|0
6841026|NCT00280150|10846825|FG003|Overall Study|Lack of Efficacy|3
6841027|NCT00280150|10846822|FG000|Overall Study|Physician Decision|0
6841028|NCT00280150|10846823|FG001|Overall Study|Physician Decision|0
6841029|NCT00280150|10846824|FG002|Overall Study|Physician Decision|0
6841030|NCT00280150|10846825|FG003|Overall Study|Physician Decision|1
6841031|NCT00280150|10846822|FG000|Overall Study|Protocol Violation|0
6841032|NCT00280150|10846823|FG001|Overall Study|Protocol Violation|0
6841033|NCT00280150|10846824|FG002|Overall Study|Protocol Violation|0
6841034|NCT00280150|10846825|FG003|Overall Study|Protocol Violation|1
6841035|NCT00280150|10846822|FG000|Overall Study|Withdrawal by Subject|0
6841036|NCT00280150|10846823|FG001|Overall Study|Withdrawal by Subject|0
6841037|NCT00280150|10846824|FG002|Overall Study|Withdrawal by Subject|0
6841038|NCT00280150|10846825|FG003|Overall Study|Withdrawal by Subject|1
6841039|NCT00280150|10846822|FG000|Overall Study|Did not get consolidation therapy|3
6841040|NCT00280150|10846823|FG001|Overall Study|Did not get consolidation therapy|0
6841041|NCT00280150|10846824|FG002|Overall Study|Did not get consolidation therapy|3
6841042|NCT00280150|10846825|FG003|Overall Study|Did not get consolidation therapy|0
6841043|NCT00280150|10846822|FG000|Overall Study|Declining Performance Status|0
6841044|NCT00280150|10846823|FG001|Overall Study|Declining Performance Status|0
6841045|NCT00280150|10846824|FG002|Overall Study|Declining Performance Status|0
6841046|NCT00280150|10846825|FG003|Overall Study|Declining Performance Status|1
6841047|NCT00280293|10846842|FG000|Overall Study|Protocol Violation|3
7149722|NCT02400476|11312067|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1
7149723|NCT02400476|11312068|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0
7149724|NCT02400476|11312069|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0
7149725|NCT02362035|11312083|FG000|Overall Study|Death|67
6841048|NCT00280293|10846843|FG001|Overall Study|Protocol Violation|0
6841049|NCT00280293|10846842|FG000|Overall Study|Physician Decision|5
6841050|NCT00280293|10846843|FG001|Overall Study|Physician Decision|4
6841051|NCT00280293|10846842|FG000|Overall Study|Lost to Follow-up|14
6841052|NCT00280293|10846843|FG001|Overall Study|Lost to Follow-up|12
6841053|NCT00280293|10846842|FG000|Overall Study|Withdrawal by Subject|3
6841054|NCT00280293|10846843|FG001|Overall Study|Withdrawal by Subject|5
7149726|NCT02362035|11312083|FG000|Overall Study|Lost to Follow-up|3
7149727|NCT02362035|11312083|FG000|Overall Study|Adverse Event|1
7149728|NCT02362035|11312083|FG000|Overall Study|Physician Decision|1
7149729|NCT02362035|11312083|FG000|Overall Study|Subject started another cancer therapy|10
7149730|NCT02362035|11312083|FG000|Overall Study|Study terminated by sponsor|45
7149731|NCT02362035|11312083|FG000|Overall Study|Decision by subject not related to AE/SAE|2
7149732|NCT02362035|11312083|FG000|Overall Study|Decision by PI not related to AE/SAE|1
7149733|NCT02362035|11312083|FG000|Overall Study|Disease progression|11
7149734|NCT02362035|11312083|FG000|Overall Study|Withdrawal by Subject|20
7149759|NCT01507545|11312102|FG000|Overall Study|Withdrawal by Subject|6
7149760|NCT01507545|11312103|FG001|Overall Study|Withdrawal by Subject|2
7149761|NCT01507545|11312102|FG000|Overall Study|Lost to Follow-up|1
7149762|NCT01507545|11312103|FG001|Overall Study|Lost to Follow-up|0
7149763|NCT01507545|11312102|FG000|Overall Study|Discontinuation of the study by sponsor|11
7149764|NCT01507545|11312103|FG001|Overall Study|Discontinuation of the study by sponsor|9
7149765|NCT01507545|11312102|FG000|Overall Study|Progressive disease|60
7149766|NCT01507545|11312103|FG001|Overall Study|Progressive disease|27
7149767|NCT01507545|11312102|FG000|Overall Study|Other|6
6841055|NCT00280293|10846842|FG000|Overall Study|Incarceration/Legal Reasons|1
6841056|NCT00280293|10846843|FG001|Overall Study|Incarceration/Legal Reasons|1
6841057|NCT00280293|10846842|FG000|Overall Study|Adverse Event|0
6841058|NCT00280293|10846843|FG001|Overall Study|Adverse Event|1
6841059|NCT00280397|10846882|FG000|Overall Study|Adverse Event|1
6841060|NCT00280566|10846890|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31
6841061|NCT00280566|10846891|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
6841062|NCT00280566|10846892|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
6841063|NCT00280566|10846890|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3
6841064|NCT00280566|10846891|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
6841065|NCT00280566|10846892|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
6841066|NCT00280566|10846890|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148
6841067|NCT00280566|10846891|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0
6841068|NCT00280566|10846892|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0
6841069|NCT00280566|10846890|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35
6841070|NCT00280566|10846891|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
6841071|NCT00280566|10846892|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
6841072|NCT00280566|10846890|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76
6841073|NCT00280566|10846891|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
6841074|NCT00280566|10846892|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
6841075|NCT00280566|10846890|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50
6841076|NCT00280566|10846891|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0
6841077|NCT00280566|10846892|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0
6841078|NCT00280566|10846890|FG000|Period 2 Double Blind|Lack of Efficacy|0
6841079|NCT00280566|10846891|FG001|Period 2 Double Blind|Lack of Efficacy|9
6841080|NCT00280566|10846892|FG002|Period 2 Double Blind|Lack of Efficacy|22
6841081|NCT00280566|10846890|FG000|Period 2 Double Blind|Laboratory Abnormality|0
6841082|NCT00280566|10846891|FG001|Period 2 Double Blind|Laboratory Abnormality|1
6841083|NCT00280566|10846892|FG002|Period 2 Double Blind|Laboratory Abnormality|0
6841084|NCT00280566|10846890|FG000|Period 2 Double Blind|Adverse Event|0
6841085|NCT00280566|10846891|FG001|Period 2 Double Blind|Adverse Event|11
6841086|NCT00280566|10846892|FG002|Period 2 Double Blind|Adverse Event|15
7149768|NCT01507545|11312103|FG001|Overall Study|Other|4
7149769|NCT00920816|11312117|FG000|Overall Study|Death|116
7149770|NCT00920816|11312118|FG001|Overall Study|Death|63
6841087|NCT00280566|10846890|FG000|Period 2 Double Blind|Lost to Follow-up|0
6841088|NCT00280566|10846891|FG001|Period 2 Double Blind|Lost to Follow-up|3
6841089|NCT00280566|10846892|FG002|Period 2 Double Blind|Lost to Follow-up|6
7149771|NCT00920816|11312119|FG002|Overall Study|Death|8
7149772|NCT00920816|11312120|FG003|Overall Study|Death|3
7149773|NCT00920816|11312117|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11
7149774|NCT00920816|11312118|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5
7149775|NCT00920816|11312119|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1
7149776|NCT00920816|11312120|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0
7149777|NCT00920816|11312117|FG000|Overall Study|Global deterioration of health status|2
7149778|NCT00920816|11312118|FG001|Overall Study|Global deterioration of health status|0
7149779|NCT00920816|11312119|FG002|Overall Study|Global deterioration of health status|0
7149780|NCT00920816|11312120|FG003|Overall Study|Global deterioration of health status|0
7149781|NCT00920816|11312117|FG000|Overall Study|Objective progression or relapse|6
7149782|NCT00920816|11312118|FG001|Overall Study|Objective progression or relapse|2
7149783|NCT00920816|11312119|FG002|Overall Study|Objective progression or relapse|0
7149784|NCT00920816|11312120|FG003|Overall Study|Objective progression or relapse|0
7149785|NCT00920816|11312117|FG000|Overall Study|Other|26
7149786|NCT00920816|11312118|FG001|Overall Study|Other|15
7149787|NCT00920816|11312119|FG002|Overall Study|Other|1
7149788|NCT00920816|11312120|FG003|Overall Study|Other|2
7149789|NCT00920816|11312117|FG000|Overall Study|Lost to Follow-up|11
7149790|NCT00920816|11312118|FG001|Overall Study|Lost to Follow-up|2
7149791|NCT00920816|11312119|FG002|Overall Study|Lost to Follow-up|0
6841090|NCT00280566|10846890|FG000|Period 2 Double Blind|Withdrawal by Subject|0
6841091|NCT00280566|10846891|FG001|Period 2 Double Blind|Withdrawal by Subject|9
6841092|NCT00280566|10846892|FG002|Period 2 Double Blind|Withdrawal by Subject|9
6841093|NCT00280566|10846890|FG000|Period 2 Double Blind|miscellaneous|0
6841094|NCT00280566|10846891|FG001|Period 2 Double Blind|miscellaneous|10
6841095|NCT00280566|10846892|FG002|Period 2 Double Blind|miscellaneous|5
6841096|NCT00280683|10846901|FG000|Overall Study|Withdrawal by Subject|1
6841097|NCT00280683|10846902|FG001|Overall Study|Withdrawal by Subject|2
6841098|NCT00280683|10846901|FG000|Overall Study|Adverse Event|1
6841099|NCT00280683|10846902|FG001|Overall Study|Adverse Event|1
6841100|NCT00280735|10846910|FG000|Overall Study|Adverse Event|5
6841101|NCT00280735|10846910|FG000|Overall Study|Lack of Efficacy|3
6841102|NCT00280735|10846910|FG000|Overall Study|Withdrawal by Subject|8
6841103|NCT00280735|10846910|FG000|Overall Study|Intercurrent Illness|2
6841104|NCT00280748|10846918|FG000|Overall Study|Decline in performance|3
6841105|NCT00280748|10846918|FG000|Overall Study|Extra-cranial disease progression|1
6841106|NCT00280917|10846935|FG000|Overall Study|Adverse Event|1
6841107|NCT00280917|10846936|FG001|Overall Study|Adverse Event|1
6841108|NCT00280917|10846937|FG002|Overall Study|Adverse Event|4
6841109|NCT00280917|10846938|FG003|Overall Study|Adverse Event|1
6841110|NCT00280917|10846935|FG000|Overall Study|Change Therapy|1
6841111|NCT00280917|10846936|FG001|Overall Study|Change Therapy|2
6841112|NCT00280917|10846937|FG002|Overall Study|Change Therapy|0
6841113|NCT00280917|10846938|FG003|Overall Study|Change Therapy|0
6841114|NCT00280917|10846935|FG000|Overall Study|Withdrawal by Subject|0
6841115|NCT00280917|10846936|FG001|Overall Study|Withdrawal by Subject|2
6841116|NCT00280917|10846937|FG002|Overall Study|Withdrawal by Subject|0
6841117|NCT00280917|10846938|FG003|Overall Study|Withdrawal by Subject|1
6841118|NCT00280917|10846935|FG000|Overall Study|Noncompliance|0
6841119|NCT00280917|10846936|FG001|Overall Study|Noncompliance|1
6841120|NCT00280917|10846937|FG002|Overall Study|Noncompliance|2
6841121|NCT00280917|10846938|FG003|Overall Study|Noncompliance|0
6841122|NCT00281099|10846954|FG000|Overall Study|Death|46
6841123|NCT00281099|10846955|FG001|Overall Study|Death|57
6841124|NCT00281099|10846954|FG000|Overall Study|Lost to Follow-up|10
6841125|NCT00281099|10846955|FG001|Overall Study|Lost to Follow-up|19
6841126|NCT00281099|10846954|FG000|Overall Study|Withdrawal by Subject|65
6841127|NCT00281099|10846955|FG001|Overall Study|Withdrawal by Subject|70
6841128|NCT00281099|10846954|FG000|Overall Study|Physician Decision|79
6841129|NCT00281099|10846955|FG001|Overall Study|Physician Decision|72
6841130|NCT00281099|10846954|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5
6841131|NCT00281099|10846955|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4
6841132|NCT00281528|10846969|FG000|Overall Study|Progressive Disease|28
6841133|NCT00281528|10846970|FG001|Overall Study|Progressive Disease|18
6841134|NCT00281528|10846971|FG002|Overall Study|Progressive Disease|27
6841135|NCT00281528|10846969|FG000|Overall Study|Unacceptable Toxicity-related to trt|21
6841136|NCT00281528|10846970|FG001|Overall Study|Unacceptable Toxicity-related to trt|24
6841137|NCT00281528|10846971|FG002|Overall Study|Unacceptable Toxicity-related to trt|32
6841138|NCT00281528|10846969|FG000|Overall Study|Adverse Event-unrelated to treatment|3
6841139|NCT00281528|10846970|FG001|Overall Study|Adverse Event-unrelated to treatment|0
6841140|NCT00281528|10846971|FG002|Overall Study|Adverse Event-unrelated to treatment|2
6841141|NCT00281528|10846969|FG000|Overall Study|Physician Decision|11
6841142|NCT00281528|10846970|FG001|Overall Study|Physician Decision|4
6841143|NCT00281528|10846971|FG002|Overall Study|Physician Decision|5
6841144|NCT00281528|10846969|FG000|Overall Study|Protocol Violation|1
6841145|NCT00281528|10846970|FG001|Overall Study|Protocol Violation|0
6841146|NCT00281528|10846971|FG002|Overall Study|Protocol Violation|1
6841147|NCT00281528|10846969|FG000|Overall Study|Withdrawal by Subject|5
6841148|NCT00281528|10846970|FG001|Overall Study|Withdrawal by Subject|5
7149792|NCT00920816|11312120|FG003|Overall Study|Lost to Follow-up|0
7149793|NCT00920816|11312117|FG000|Overall Study|Adverse Event|1
7149794|NCT00920816|11312118|FG001|Overall Study|Adverse Event|1
7149795|NCT00920816|11312119|FG002|Overall Study|Adverse Event|1
7149796|NCT00920816|11312120|FG003|Overall Study|Adverse Event|0
7149797|NCT00920816|11312117|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16
7149798|NCT00920816|11312118|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8
7149799|NCT00920816|11312119|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124
7149800|NCT00920816|11312120|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64
7149801|NCT00920816|11312117|FG000|Overall Study|Randomized but not treated|3
7149802|NCT00920816|11312118|FG001|Overall Study|Randomized but not treated|0
7149803|NCT00920816|11312119|FG002|Overall Study|Randomized but not treated|0
7149804|NCT00920816|11312120|FG003|Overall Study|Randomized but not treated|0
7149805|NCT00565851|11312138|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9
7149806|NCT00565851|11312139|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9
7149807|NCT00565851|11312140|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3
7149808|NCT00565851|11312141|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18
7149809|NCT00565851|11312142|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0
7149810|NCT00565851|11312143|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2
7149811|NCT00565851|11312144|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0
7149812|NCT00565851|11312145|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2
7149813|NCT00565851|11312138|FG000|Chemotherapy Assignment|Still On Chemotherapy|0
7149814|NCT00565851|11312139|FG001|Chemotherapy Assignment|Still On Chemotherapy|14
7149815|NCT00565851|11312140|FG002|Chemotherapy Assignment|Still On Chemotherapy|0
7149816|NCT00565851|11312141|FG003|Chemotherapy Assignment|Still On Chemotherapy|18
7149817|NCT00565851|11312142|FG004|Chemotherapy Assignment|Still On Chemotherapy|0
7149818|NCT00565851|11312143|FG005|Chemotherapy Assignment|Still On Chemotherapy|1
7149819|NCT00565851|11312144|FG006|Chemotherapy Assignment|Still On Chemotherapy|0
7149820|NCT00565851|11312145|FG007|Chemotherapy Assignment|Still On Chemotherapy|1
7149821|NCT03180645|11312170|FG000|Overall Study|Adverse Event|0
7149822|NCT03180645|11312171|FG001|Overall Study|Adverse Event|1
7149823|NCT03180645|11312172|FG002|Overall Study|Adverse Event|2
7149824|NCT03180801|11312187|FG000|Overall Study|Physician Decision|3
7149825|NCT03180801|11312188|FG001|Overall Study|Physician Decision|3
7149826|NCT03180801|11312189|FG002|Overall Study|Physician Decision|1
7149827|NCT03180801|11312187|FG000|Overall Study|Non-compliance|1
7149828|NCT03180801|11312188|FG001|Overall Study|Non-compliance|4
7149829|NCT03180801|11312189|FG002|Overall Study|Non-compliance|0
7149830|NCT03180801|11312187|FG000|Overall Study|Inoculation Target Reached|1
7149831|NCT03180801|11312188|FG001|Overall Study|Inoculation Target Reached|1
7149832|NCT03180801|11312189|FG002|Overall Study|Inoculation Target Reached|3
7149833|NCT03180801|11312187|FG000|Overall Study|Adverse Event|1
7149834|NCT03180801|11312188|FG001|Overall Study|Adverse Event|0
7149835|NCT03180801|11312189|FG002|Overall Study|Adverse Event|2
7149836|NCT03180801|11312187|FG000|Overall Study|Withdrawal by Subject|2
7149837|NCT03180801|11312188|FG001|Overall Study|Withdrawal by Subject|2
7149838|NCT03180801|11312189|FG002|Overall Study|Withdrawal by Subject|1
7149839|NCT03180801|11312187|FG000|Overall Study|Lost to Follow-up|0
7149840|NCT03180801|11312188|FG001|Overall Study|Lost to Follow-up|2
7149841|NCT03180801|11312189|FG002|Overall Study|Lost to Follow-up|3
7149842|NCT03181451|11312221|FG000|Overall Study|Adverse Event|0
7149843|NCT03181451|11312222|FG001|Overall Study|Adverse Event|1
7149844|NCT03181451|11312223|FG002|Overall Study|Adverse Event|0
7149845|NCT03181451|11312221|FG000|Overall Study|Withdrawal by Subject|0
7149846|NCT03181451|11312222|FG001|Overall Study|Withdrawal by Subject|1
7149847|NCT03181451|11312223|FG002|Overall Study|Withdrawal by Subject|0
7149848|NCT03181503|11312235|FG000|Overall Study|Adverse Event|2
7149849|NCT03181503|11312236|FG001|Overall Study|Adverse Event|2
7149850|NCT03181503|11312235|FG000|Overall Study|Protocol Violation|1
7149851|NCT03181503|11312236|FG001|Overall Study|Protocol Violation|0
7149852|NCT03181503|11312235|FG000|Overall Study|Withdrawal by Subject|3
7149853|NCT03181503|11312236|FG001|Overall Study|Withdrawal by Subject|0
7149854|NCT03181503|11312235|FG000|Overall Study|Lost to Follow-up|1
7149855|NCT03181503|11312236|FG001|Overall Study|Lost to Follow-up|1
7149856|NCT03181594|11312245|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4
7149857|NCT03181594|11312245|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3
7149858|NCT03181594|11312245|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1
7149859|NCT03181594|11312245|FG000|Initial Study Protocol (12-month FU)|Death|1
7149860|NCT03181594|11312245|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3
7149861|NCT03181594|11312245|FG000|Long-term Extension (15-24 Month FU)|Death|2
6841149|NCT00281528|10846971|FG002|Overall Study|Withdrawal by Subject|7
7149862|NCT03181932|11312260|FG000|Period 1 (Double-blind Period)|Adverse Event|5
7149863|NCT03181932|11312261|FG001|Period 1 (Double-blind Period)|Adverse Event|1
7149864|NCT03181932|11312260|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0
7149865|NCT03181932|11312261|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1
7149866|NCT03181932|11312260|FG000|Period 1 (Double-blind Period)|Protocol Violation|1
6841150|NCT00281528|10846969|FG000|Overall Study|Other|6
6841151|NCT00281528|10846970|FG001|Overall Study|Other|3
7149867|NCT03181932|11312261|FG001|Period 1 (Double-blind Period)|Protocol Violation|2
7149868|NCT03181932|11312260|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5
7149869|NCT03181932|11312261|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9
7149870|NCT03181932|11312260|FG000|Period 2 (Open-label Period)|Adverse Event|1
7149871|NCT03181932|11312261|FG001|Period 2 (Open-label Period)|Adverse Event|6
7149872|NCT03181932|11312260|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0
7149873|NCT03181932|11312261|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1
7149874|NCT03181932|11312260|FG000|Period 2 (Open-label Period)|Protocol Violation|3
7149875|NCT03181932|11312261|FG001|Period 2 (Open-label Period)|Protocol Violation|1
7149876|NCT03181932|11312260|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2
7149877|NCT03181932|11312261|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5
7149878|NCT03181932|11312260|FG000|Period 2 (Open-label Period)|Reason missing|2
7149879|NCT03181932|11312261|FG001|Period 2 (Open-label Period)|Reason missing|0
7149880|NCT03181958|11312271|FG000|Overall Study|Lost to Follow-up|17
7149881|NCT03181958|11312272|FG001|Overall Study|Lost to Follow-up|21
7149882|NCT03181958|11312273|FG002|Overall Study|Lost to Follow-up|15
7149883|NCT03182738|11312304|FG000|Overall Study|Lost to Follow-up|9
7149884|NCT03182738|11312305|FG001|Overall Study|Lost to Follow-up|3
7149885|NCT03182738|11312304|FG000|Overall Study|Pregnancy|0
7149886|NCT03182738|11312305|FG001|Overall Study|Pregnancy|1
7149887|NCT03182738|11312304|FG000|Overall Study|Withdrawal by Subject|0
7149888|NCT03182738|11312305|FG001|Overall Study|Withdrawal by Subject|1
7149889|NCT03183063|11312334|FG000|Overall Study|Withdrawal by Subject|2
7149890|NCT03183063|11312335|FG001|Overall Study|Withdrawal by Subject|0
7149891|NCT03183063|11312336|FG002|Overall Study|Withdrawal by Subject|0
7149892|NCT03183063|11312334|FG000|Overall Study|Physician Decision|3
7149893|NCT03183063|11312335|FG001|Overall Study|Physician Decision|4
7149894|NCT03183063|11312336|FG002|Overall Study|Physician Decision|4
7149895|NCT03183518|11312350|FG000|Overall Study|Other (Not specified)|2
7149896|NCT03183518|11312350|FG000|Overall Study|Other (Withdrawal of consent)|1
7149897|NCT03183908|11312366|FG000|Overall Study|Missing Symptom Diary Data|0
7149898|NCT03183908|11312367|FG001|Overall Study|Missing Symptom Diary Data|2
7149899|NCT03184077|11312379|FG000|Overall Study|Lost to Follow-up|21
7149900|NCT03184077|11312380|FG001|Overall Study|Lost to Follow-up|21
7184055|NCT01714817|11384097|FG000|Year 1 Period|Participant no longer meets criteria|6
7184056|NCT01714817|11384098|FG001|Year 1 Period|Participant no longer meets criteria|2
7184057|NCT01714817|11384097|FG000|Year 1 Period|Not treated- received ACE inhibition|1
6841152|NCT00281528|10846971|FG002|Overall Study|Other|5
6841153|NCT00281580|10846995|FG000|Overall Study|Adverse Event|2
6841154|NCT00281580|10846996|FG001|Overall Study|Adverse Event|0
6841155|NCT00281580|10846997|FG002|Overall Study|Adverse Event|2
7077107|NCT02087943|11184445|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
7077108|NCT02087943|11184446|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1
7077109|NCT02087943|11184447|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
6841156|NCT00281580|10846998|FG003|Overall Study|Adverse Event|4
6841157|NCT00281580|10846999|FG004|Overall Study|Adverse Event|1
6841158|NCT00281580|10847000|FG005|Overall Study|Adverse Event|0
6841159|NCT00281580|10847001|FG006|Overall Study|Adverse Event|1
6841160|NCT00281580|10847002|FG007|Overall Study|Adverse Event|0
6841161|NCT00281580|10847003|FG008|Overall Study|Adverse Event|1
6841162|NCT00281580|10847004|FG009|Overall Study|Adverse Event|6
6841163|NCT00281580|10847005|FG010|Overall Study|Adverse Event|0
6841164|NCT00281580|10847006|FG011|Overall Study|Adverse Event|5
6841165|NCT00281580|10847007|FG012|Overall Study|Adverse Event|8
6841166|NCT00281580|10847008|FG013|Overall Study|Adverse Event|2
6841167|NCT00281580|10847009|FG014|Overall Study|Adverse Event|3
6841168|NCT00281580|10847010|FG015|Overall Study|Adverse Event|3
6841169|NCT00281580|10846995|FG000|Overall Study|Protocol Violation|0
6841170|NCT00281580|10846996|FG001|Overall Study|Protocol Violation|0
6841171|NCT00281580|10846997|FG002|Overall Study|Protocol Violation|1
6841172|NCT00281580|10846998|FG003|Overall Study|Protocol Violation|1
6841173|NCT00281580|10846999|FG004|Overall Study|Protocol Violation|0
6841174|NCT00281580|10847000|FG005|Overall Study|Protocol Violation|0
6841175|NCT00281580|10847001|FG006|Overall Study|Protocol Violation|1
6841176|NCT00281580|10847002|FG007|Overall Study|Protocol Violation|0
6841177|NCT00281580|10847003|FG008|Overall Study|Protocol Violation|2
6841178|NCT00281580|10847004|FG009|Overall Study|Protocol Violation|0
6841179|NCT00281580|10847005|FG010|Overall Study|Protocol Violation|1
7077110|NCT02087943|11184448|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
7077111|NCT02087943|11184444|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0
7077112|NCT02087943|11184445|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0
7077113|NCT02087943|11184446|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0
7077114|NCT02087943|11184447|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0
7077115|NCT02087943|11184448|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1
7077116|NCT02087943|11184444|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0
7077117|NCT02087943|11184445|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0
7077118|NCT02087943|11184446|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1
7077119|NCT02087943|11184447|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1
7184058|NCT01714817|11384098|FG001|Year 1 Period|Not treated- received ACE inhibition|0
7184059|NCT01714817|11384097|FG000|Year 1 Period|Change in Concomitant Medication|0
7149901|NCT03184441|11312402|FG000|Overall Study|Withdrawal by Subject|1
7149902|NCT03184519|11312409|FG000|Overall Study|Lost to Follow-up|6
7149903|NCT03184519|11312409|FG000|Overall Study|Physician Decision|21
7149904|NCT03184558|11312413|FG000|Overall Study|Withdrawal by Subject|2
7149905|NCT03184558|11312413|FG000|Overall Study|Death|16
7149906|NCT03184558|11312413|FG000|Overall Study|Lost to Follow-up|2
7149907|NCT03184558|11312413|FG000|Overall Study|Other|9
7149908|NCT03184701|11312417|FG000|Overall Study|Death|3
7149909|NCT03184701|11312417|FG000|Overall Study|Physician Decision|3
7149910|NCT03184701|11312417|FG000|Overall Study|Withdrawal by Subject|6
7149911|NCT03184701|11312417|FG000|Overall Study|Lost to Follow-up|5
7149912|NCT03184987|11312424|FG000|Overall Study|Withdrawal by Subject|0
7149913|NCT03184987|11312425|FG001|Overall Study|Withdrawal by Subject|1
7149914|NCT03184987|11312426|FG002|Overall Study|Withdrawal by Subject|2
7149915|NCT03184987|11312424|FG000|Overall Study|Physician Decision|0
7149916|NCT03184987|11312425|FG001|Overall Study|Physician Decision|0
7149917|NCT03184987|11312426|FG002|Overall Study|Physician Decision|1
7149918|NCT03184987|11312424|FG000|Overall Study|Adverse Event|1
7149919|NCT03184987|11312425|FG001|Overall Study|Adverse Event|0
7149920|NCT03184987|11312426|FG002|Overall Study|Adverse Event|1
7149921|NCT03185481|11312466|FG000|Overall Study|Adverse Event|1
7149922|NCT03185481|11312466|FG000|Overall Study|Study Terminated by Sponsor|4
7149923|NCT03186378|11312515|FG000|Overall Study|Lost to Follow-up|1
7149924|NCT03186378|11312516|FG001|Overall Study|Lost to Follow-up|0
7149925|NCT03186781|11312549|FG000|Overall Study|Lost to Follow-up|0
7149926|NCT03186781|11312550|FG001|Overall Study|Lost to Follow-up|0
7149927|NCT03186781|11312551|FG002|Overall Study|Lost to Follow-up|1
7149928|NCT03186781|11312552|FG003|Overall Study|Lost to Follow-up|0
7149929|NCT03186781|11312553|FG004|Overall Study|Lost to Follow-up|1
7149930|NCT03186781|11312554|FG005|Overall Study|Lost to Follow-up|0
7149931|NCT03186781|11312549|FG000|Overall Study|Moved from Area|0
7149932|NCT03186781|11312550|FG001|Overall Study|Moved from Area|0
7149933|NCT03186781|11312551|FG002|Overall Study|Moved from Area|0
7149934|NCT03186781|11312552|FG003|Overall Study|Moved from Area|0
7149935|NCT03186781|11312553|FG004|Overall Study|Moved from Area|1
7149936|NCT03186781|11312554|FG005|Overall Study|Moved from Area|0
7149937|NCT03186781|11312549|FG000|Overall Study|Withdrawal by Subject|0
7149938|NCT03186781|11312550|FG001|Overall Study|Withdrawal by Subject|0
7149939|NCT03186781|11312551|FG002|Overall Study|Withdrawal by Subject|0
7149940|NCT03186781|11312552|FG003|Overall Study|Withdrawal by Subject|0
7149941|NCT03186781|11312553|FG004|Overall Study|Withdrawal by Subject|1
7149942|NCT03186781|11312554|FG005|Overall Study|Withdrawal by Subject|0
7149943|NCT03187132|11312592|FG000|Inpatient Trauma Only|Lost to Follow-up|3
7149944|NCT03187132|11312593|FG001|Inpatient Trauma Only|Lost to Follow-up|12
7149945|NCT03187132|11312592|FG000|Inpatient Trauma Only|socioeconomic burden|1
7149946|NCT03187132|11312593|FG001|Inpatient Trauma Only|socioeconomic burden|0
7149947|NCT03187132|11312592|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0
7149948|NCT03187132|11312593|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5
7149949|NCT03187132|11312592|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1
7149950|NCT03187132|11312593|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0
7149951|NCT03187132|11312592|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2
7149952|NCT03187132|11312593|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5
7149953|NCT03187132|11312592|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1
7149954|NCT03187132|11312593|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0
7149955|NCT03187132|11312592|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0
7149956|NCT03187132|11312593|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2
7149957|NCT03187132|11312592|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27
7149958|NCT03187132|11312593|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47
7149959|NCT03187132|11312592|FG000|Pain Clinic Only, Fully Remote|Disease burden|6
7149960|NCT03187132|11312593|FG001|Pain Clinic Only, Fully Remote|Disease burden|5
7149961|NCT03187132|11312592|FG000|Pain Clinic Only, Fully Remote|Language barrier|0
7149962|NCT03187132|11312593|FG001|Pain Clinic Only, Fully Remote|Language barrier|1
7149963|NCT03187132|11312592|FG000|Pain Clinic Only, Fully Remote|EMR|0
7149964|NCT03187132|11312593|FG001|Pain Clinic Only, Fully Remote|EMR|1
7149965|NCT03187197|11312602|FG000|Overall Study|Stopped Pradaxa®/VKA|11
7149966|NCT03187197|11312603|FG001|Overall Study|Stopped Pradaxa®/VKA|65
7149967|NCT03187197|11312604|FG002|Overall Study|Stopped Pradaxa®/VKA|4
7149968|NCT03187197|11312602|FG000|Overall Study|Withdrawal by Subject|8
7149969|NCT03187197|11312603|FG001|Overall Study|Withdrawal by Subject|63
7149970|NCT03187197|11312604|FG002|Overall Study|Withdrawal by Subject|4
7149971|NCT03187197|11312602|FG000|Overall Study|Lost to Follow-up|1
7149972|NCT03187197|11312603|FG001|Overall Study|Lost to Follow-up|60
7149973|NCT03187197|11312604|FG002|Overall Study|Lost to Follow-up|7
7149974|NCT03187197|11312602|FG000|Overall Study|Adverse Event|6
7149975|NCT03187197|11312603|FG001|Overall Study|Adverse Event|29
7149976|NCT03187197|11312604|FG002|Overall Study|Adverse Event|0
7149977|NCT03187197|11312602|FG000|Overall Study|Death|0
7149978|NCT03187197|11312603|FG001|Overall Study|Death|11
7149979|NCT03187197|11312604|FG002|Overall Study|Death|0
7149980|NCT03187197|11312602|FG000|Overall Study|Administrative problem|1
7149981|NCT03187197|11312603|FG001|Overall Study|Administrative problem|1
7149982|NCT03187197|11312604|FG002|Overall Study|Administrative problem|0
7149983|NCT03187197|11312602|FG000|Overall Study|Reason not listed|2
7149984|NCT03187197|11312603|FG001|Overall Study|Reason not listed|54
7149985|NCT03187197|11312604|FG002|Overall Study|Reason not listed|1
7149986|NCT03187197|11312602|FG000|Overall Study|Missing|1
7149987|NCT03187197|11312603|FG001|Overall Study|Missing|32
7149988|NCT03187197|11312604|FG002|Overall Study|Missing|3
7149989|NCT03187197|11312602|FG000|Overall Study|Status missing|2
7149990|NCT03187197|11312603|FG001|Overall Study|Status missing|33
7149991|NCT03187197|11312604|FG002|Overall Study|Status missing|3
7149992|NCT03187197|11312602|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14
7149993|NCT03187197|11312603|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45
7149994|NCT03187197|11312604|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1
7149995|NCT03187301|11312612|FG000|Titration Period|Adverse Event|0
6841180|NCT00281580|10847006|FG011|Overall Study|Protocol Violation|2
6841181|NCT00281580|10847007|FG012|Overall Study|Protocol Violation|0
6841182|NCT00281580|10847008|FG013|Overall Study|Protocol Violation|1
6841183|NCT00281580|10847009|FG014|Overall Study|Protocol Violation|1
6841184|NCT00281580|10847010|FG015|Overall Study|Protocol Violation|3
6841185|NCT00281580|10846995|FG000|Overall Study|Withdrawal by Subject|3
6841186|NCT00281580|10846996|FG001|Overall Study|Withdrawal by Subject|0
6841187|NCT00281580|10846997|FG002|Overall Study|Withdrawal by Subject|1
6841188|NCT00281580|10846998|FG003|Overall Study|Withdrawal by Subject|1
6841189|NCT00281580|10846999|FG004|Overall Study|Withdrawal by Subject|1
6841190|NCT00281580|10847000|FG005|Overall Study|Withdrawal by Subject|2
6841191|NCT00281580|10847001|FG006|Overall Study|Withdrawal by Subject|2
6841192|NCT00281580|10847002|FG007|Overall Study|Withdrawal by Subject|0
6841193|NCT00281580|10847003|FG008|Overall Study|Withdrawal by Subject|1
6841194|NCT00281580|10847004|FG009|Overall Study|Withdrawal by Subject|4
6841195|NCT00281580|10847005|FG010|Overall Study|Withdrawal by Subject|1
6841196|NCT00281580|10847006|FG011|Overall Study|Withdrawal by Subject|1
6841197|NCT00281580|10847007|FG012|Overall Study|Withdrawal by Subject|2
6841198|NCT00281580|10847008|FG013|Overall Study|Withdrawal by Subject|2
6841199|NCT00281580|10847009|FG014|Overall Study|Withdrawal by Subject|1
6841200|NCT00281580|10847010|FG015|Overall Study|Withdrawal by Subject|5
6841201|NCT00281580|10846995|FG000|Overall Study|Lack of Efficacy|2
6841202|NCT00281580|10846996|FG001|Overall Study|Lack of Efficacy|1
6841203|NCT00281580|10846997|FG002|Overall Study|Lack of Efficacy|1
6841204|NCT00281580|10846998|FG003|Overall Study|Lack of Efficacy|6
6841205|NCT00281580|10846999|FG004|Overall Study|Lack of Efficacy|2
6841206|NCT00281580|10847000|FG005|Overall Study|Lack of Efficacy|0
6841207|NCT00281580|10847001|FG006|Overall Study|Lack of Efficacy|0
6841208|NCT00281580|10847002|FG007|Overall Study|Lack of Efficacy|0
6841209|NCT00281580|10847003|FG008|Overall Study|Lack of Efficacy|0
6841210|NCT00281580|10847004|FG009|Overall Study|Lack of Efficacy|0
6841211|NCT00281580|10847005|FG010|Overall Study|Lack of Efficacy|0
6841212|NCT00281580|10847006|FG011|Overall Study|Lack of Efficacy|1
6841213|NCT00281580|10847007|FG012|Overall Study|Lack of Efficacy|0
6841214|NCT00281580|10847008|FG013|Overall Study|Lack of Efficacy|2
6841215|NCT00281580|10847009|FG014|Overall Study|Lack of Efficacy|1
6841216|NCT00281580|10847010|FG015|Overall Study|Lack of Efficacy|0
6841217|NCT00281580|10846995|FG000|Overall Study|Lost to Follow-up|0
6841218|NCT00281580|10846996|FG001|Overall Study|Lost to Follow-up|0
6841219|NCT00281580|10846997|FG002|Overall Study|Lost to Follow-up|0
6841220|NCT00281580|10846998|FG003|Overall Study|Lost to Follow-up|3
6841221|NCT00281580|10846999|FG004|Overall Study|Lost to Follow-up|0
6841222|NCT00281580|10847000|FG005|Overall Study|Lost to Follow-up|1
6841223|NCT00281580|10847001|FG006|Overall Study|Lost to Follow-up|0
6841224|NCT00281580|10847002|FG007|Overall Study|Lost to Follow-up|1
6841225|NCT00281580|10847003|FG008|Overall Study|Lost to Follow-up|2
6841226|NCT00281580|10847004|FG009|Overall Study|Lost to Follow-up|1
6841227|NCT00281580|10847005|FG010|Overall Study|Lost to Follow-up|1
6841228|NCT00281580|10847006|FG011|Overall Study|Lost to Follow-up|0
6841229|NCT00281580|10847007|FG012|Overall Study|Lost to Follow-up|1
6841230|NCT00281580|10847008|FG013|Overall Study|Lost to Follow-up|0
6841231|NCT00281580|10847009|FG014|Overall Study|Lost to Follow-up|0
6841232|NCT00281580|10847010|FG015|Overall Study|Lost to Follow-up|0
6841233|NCT00281580|10846995|FG000|Overall Study|Randomised in error; pregnancy; moving|0
6841234|NCT00281580|10846996|FG001|Overall Study|Randomised in error; pregnancy; moving|0
6841235|NCT00281580|10846997|FG002|Overall Study|Randomised in error; pregnancy; moving|0
6841236|NCT00281580|10846998|FG003|Overall Study|Randomised in error; pregnancy; moving|2
7149996|NCT03187301|11312613|FG001|Titration Period|Adverse Event|0
7149997|NCT03187301|11312614|FG002|Titration Period|Adverse Event|0
7149998|NCT03187301|11312615|FG003|Titration Period|Adverse Event|0
7149999|NCT03187301|11312616|FG004|Titration Period|Adverse Event|0
7150000|NCT03187301|11312617|FG005|Titration Period|Adverse Event|0
7150001|NCT03187301|11312618|FG006|Titration Period|Adverse Event|5
7150002|NCT03187301|11312612|FG000|Titration Period|Withdrawal by Subject|0
6841237|NCT00281580|10846999|FG004|Overall Study|Randomised in error; pregnancy; moving|0
6841238|NCT00281580|10847000|FG005|Overall Study|Randomised in error; pregnancy; moving|0
6841239|NCT00281580|10847001|FG006|Overall Study|Randomised in error; pregnancy; moving|1
7150003|NCT03187301|11312613|FG001|Titration Period|Withdrawal by Subject|0
7150004|NCT03187301|11312614|FG002|Titration Period|Withdrawal by Subject|0
7150005|NCT03187301|11312615|FG003|Titration Period|Withdrawal by Subject|0
7150006|NCT03187301|11312616|FG004|Titration Period|Withdrawal by Subject|0
7150007|NCT03187301|11312617|FG005|Titration Period|Withdrawal by Subject|0
7150008|NCT03187301|11312618|FG006|Titration Period|Withdrawal by Subject|1
7150009|NCT03187301|11312612|FG000|Titration Period|Exclusion Criteria Met|0
7150010|NCT03187301|11312613|FG001|Titration Period|Exclusion Criteria Met|0
7150011|NCT03187301|11312614|FG002|Titration Period|Exclusion Criteria Met|0
7150012|NCT03187301|11312615|FG003|Titration Period|Exclusion Criteria Met|0
7150013|NCT03187301|11312616|FG004|Titration Period|Exclusion Criteria Met|0
7150014|NCT03187301|11312617|FG005|Titration Period|Exclusion Criteria Met|0
7150015|NCT03187301|11312618|FG006|Titration Period|Exclusion Criteria Met|1
7150016|NCT03187301|11312612|FG000|Pre-Intervention|Withdrawal by Subject|1
7150017|NCT03187301|11312613|FG001|Pre-Intervention|Withdrawal by Subject|0
7150018|NCT03187301|11312614|FG002|Pre-Intervention|Withdrawal by Subject|0
7150019|NCT03187301|11312615|FG003|Pre-Intervention|Withdrawal by Subject|0
7150020|NCT03187301|11312616|FG004|Pre-Intervention|Withdrawal by Subject|0
7150021|NCT03187301|11312617|FG005|Pre-Intervention|Withdrawal by Subject|0
7150022|NCT03187301|11312618|FG006|Pre-Intervention|Withdrawal by Subject|0
7150023|NCT03187756|11312656|FG000|Overall Study|Termination of study|4
7150024|NCT03188055|11312662|FG000|Overall Study|Unavailable for training|0
7150025|NCT03188055|11312663|FG001|Overall Study|Unavailable for training|0
7150026|NCT03188055|11312664|FG002|Overall Study|Unavailable for training|19
7150027|NCT03188055|11312665|FG003|Overall Study|Unavailable for training|0
7150028|NCT03188055|11312666|FG004|Overall Study|Unavailable for training|0
7150029|NCT03188055|11312667|FG005|Overall Study|Unavailable for training|
7150030|NCT03188055|11312662|FG000|Overall Study|Lost to Follow-up|0
7150031|NCT03188055|11312663|FG001|Overall Study|Lost to Follow-up|18
7150032|NCT03188055|11312664|FG002|Overall Study|Lost to Follow-up|0
7150033|NCT03188055|11312665|FG003|Overall Study|Lost to Follow-up|11
7150034|NCT03188055|11312666|FG004|Overall Study|Lost to Follow-up|0
7150035|NCT03188055|11312667|FG005|Overall Study|Lost to Follow-up|
7150036|NCT03188055|11312662|FG000|Overall Study|Withdrawal by Subject|0
7150037|NCT03188055|11312663|FG001|Overall Study|Withdrawal by Subject|1
7150038|NCT03188055|11312664|FG002|Overall Study|Withdrawal by Subject|0
7150039|NCT03188055|11312665|FG003|Overall Study|Withdrawal by Subject|1
7150040|NCT03188055|11312666|FG004|Overall Study|Withdrawal by Subject|0
7150041|NCT03188055|11312667|FG005|Overall Study|Withdrawal by Subject|
7150042|NCT03188120|11312678|FG000|Overall Study|Adverse Event|4
7150043|NCT03188120|11312678|FG000|Overall Study|Insufficient Effectiveness|8
7150044|NCT03188120|11312678|FG000|Overall Study|Improved|12
7150045|NCT03188120|11312678|FG000|Overall Study|Lost to Follow-up|7
7150046|NCT03188120|11312678|FG000|Overall Study|Other than specified|3
7150047|NCT03188120|11312678|FG000|Overall Study|No visit after the first visit|13
7150048|NCT03188185|11312684|FG000|Stage 1|Adverse Event|4
7150049|NCT03188185|11312685|FG001|Stage 1|Adverse Event|12
7150050|NCT03188185|11312686|FG002|Stage 1|Adverse Event|0
7150051|NCT03188185|11312687|FG003|Stage 1|Adverse Event|0
7150052|NCT03188185|11312684|FG000|Stage 1|Lack of Efficacy|0
7150053|NCT03188185|11312685|FG001|Stage 1|Lack of Efficacy|2
7150054|NCT03188185|11312686|FG002|Stage 1|Lack of Efficacy|0
7150055|NCT03188185|11312687|FG003|Stage 1|Lack of Efficacy|0
7150056|NCT03188185|11312684|FG000|Stage 1|Lost to Follow-up|6
7150057|NCT03188185|11312685|FG001|Stage 1|Lost to Follow-up|1
7150058|NCT03188185|11312686|FG002|Stage 1|Lost to Follow-up|0
7150059|NCT03188185|11312687|FG003|Stage 1|Lost to Follow-up|0
7150060|NCT03188185|11312684|FG000|Stage 1|Withdrawal by Subject|9
7150061|NCT03188185|11312685|FG001|Stage 1|Withdrawal by Subject|0
7150062|NCT03188185|11312686|FG002|Stage 1|Withdrawal by Subject|0
7150063|NCT03188185|11312687|FG003|Stage 1|Withdrawal by Subject|0
7150064|NCT03188185|11312684|FG000|Stage 1|Identified as a professional patient|0
7150065|NCT03188185|11312685|FG001|Stage 1|Identified as a professional patient|1
7150066|NCT03188185|11312686|FG002|Stage 1|Identified as a professional patient|0
7150067|NCT03188185|11312687|FG003|Stage 1|Identified as a professional patient|0
7150068|NCT03188185|11312684|FG000|Stage 2|Adverse Event|0
7150069|NCT03188185|11312685|FG001|Stage 2|Adverse Event|0
7150070|NCT03188185|11312686|FG002|Stage 2|Adverse Event|2
7150071|NCT03188185|11312687|FG003|Stage 2|Adverse Event|4
7150072|NCT03188185|11312684|FG000|Stage 2|Lack of Efficacy|0
7150073|NCT03188185|11312685|FG001|Stage 2|Lack of Efficacy|0
7150074|NCT03188185|11312686|FG002|Stage 2|Lack of Efficacy|3
7150075|NCT03188185|11312687|FG003|Stage 2|Lack of Efficacy|0
7150076|NCT03188185|11312684|FG000|Stage 2|Lost to Follow-up|0
7150077|NCT03188185|11312685|FG001|Stage 2|Lost to Follow-up|0
7150078|NCT03188185|11312686|FG002|Stage 2|Lost to Follow-up|1
7150079|NCT03188185|11312687|FG003|Stage 2|Lost to Follow-up|0
7150080|NCT03188185|11312684|FG000|Stage 2|Physician Decision|0
7150081|NCT03188185|11312685|FG001|Stage 2|Physician Decision|0
7150082|NCT03188185|11312686|FG002|Stage 2|Physician Decision|0
7150083|NCT03188185|11312687|FG003|Stage 2|Physician Decision|1
7150084|NCT03188185|11312684|FG000|Stage 2|Withdrawal by Subject|0
7150085|NCT03188185|11312685|FG001|Stage 2|Withdrawal by Subject|0
7150086|NCT03188185|11312686|FG002|Stage 2|Withdrawal by Subject|3
7150087|NCT03188185|11312687|FG003|Stage 2|Withdrawal by Subject|1
7150088|NCT03188263|11312699|FG000|Overall Study|Withdrawal by Subject|3
7150089|NCT03188263|11312700|FG001|Overall Study|Withdrawal by Subject|0
7150090|NCT03188263|11312699|FG000|Overall Study|Physician Decision|1
7150091|NCT03188263|11312700|FG001|Overall Study|Physician Decision|0
7150092|NCT03188536|11312717|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5
7150093|NCT03188536|11312717|FG000|Overall Study|Not participated/met inclusion criteria|1
7150094|NCT03188718|11312721|FG000|Overall Study|Participant noncompliance|4
7150095|NCT03188718|11312721|FG000|Overall Study|Withdrawal by Subject|1
7150096|NCT03188718|11312721|FG000|Overall Study|Device failure|3
7150097|NCT03188991|11312729|FG000|Overall Study|Withdrawal by Subject|0
7150098|NCT03188991|11312730|FG001|Overall Study|Withdrawal by Subject|0
7150099|NCT03188991|11312731|FG002|Overall Study|Withdrawal by Subject|0
7150100|NCT03188991|11312732|FG003|Overall Study|Withdrawal by Subject|1
7150101|NCT03189446|11312746|FG000|Overall Study|Adverse Event|2
7150102|NCT03189446|11312746|FG000|Overall Study|Withdrawal by Subject|2
7150103|NCT03189446|11312746|FG000|Overall Study|Physician Decision|1
7150104|NCT03189524|11312753|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7
7150105|NCT03189524|11312754|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5
6841240|NCT00281580|10847002|FG007|Overall Study|Randomised in error; pregnancy; moving|0
6841241|NCT00281580|10847003|FG008|Overall Study|Randomised in error; pregnancy; moving|2
6841242|NCT00281580|10847004|FG009|Overall Study|Randomised in error; pregnancy; moving|1
6841243|NCT00281580|10847005|FG010|Overall Study|Randomised in error; pregnancy; moving|1
6841244|NCT00281580|10847006|FG011|Overall Study|Randomised in error; pregnancy; moving|1
6841245|NCT00281580|10847007|FG012|Overall Study|Randomised in error; pregnancy; moving|2
6841246|NCT00281580|10847008|FG013|Overall Study|Randomised in error; pregnancy; moving|0
6841247|NCT00281580|10847009|FG014|Overall Study|Randomised in error; pregnancy; moving|1
6841248|NCT00281580|10847010|FG015|Overall Study|Randomised in error; pregnancy; moving|2
6841249|NCT00281632|10847079|FG000|Overall Study|Adverse Event|7
6841250|NCT00281632|10847079|FG000|Overall Study|Withdrawal by Subject|2
6841251|NCT00281632|10847079|FG000|Overall Study|Disease Progression|22
6841252|NCT00281632|10847079|FG000|Overall Study|Death|1
6841253|NCT00281632|10847079|FG000|Overall Study|Physician Decision|1
6841254|NCT00281632|10847079|FG000|Overall Study|Ongoing|3
6841255|NCT00281684|10847105|FG000|Overall Study|Lost to Follow-up|0
6841256|NCT00281684|10847106|FG001|Overall Study|Lost to Follow-up|0
6841257|NCT00281684|10847107|FG002|Overall Study|Lost to Follow-up|1
6841258|NCT00281684|10847108|FG003|Overall Study|Lost to Follow-up|0
6841259|NCT00281684|10847105|FG000|Overall Study|Withdrawal by Subject|1
6841260|NCT00281684|10847106|FG001|Overall Study|Withdrawal by Subject|0
6841261|NCT00281684|10847107|FG002|Overall Study|Withdrawal by Subject|0
6841262|NCT00281684|10847108|FG003|Overall Study|Withdrawal by Subject|0
6841263|NCT00281697|10847122|FG000|Overall Study|> 60 days since last dose of study drug|4
6841264|NCT00281697|10847123|FG001|Overall Study|> 60 days since last dose of study drug|4
6841265|NCT00281697|10847122|FG000|Overall Study|Adverse Event|54
6841266|NCT00281697|10847123|FG001|Overall Study|Adverse Event|15
6841267|NCT00281697|10847122|FG000|Overall Study|Death|8
6841268|NCT00281697|10847123|FG001|Overall Study|Death|3
6841269|NCT00281697|10847122|FG000|Overall Study|Disease progression|279
6841270|NCT00281697|10847123|FG001|Overall Study|Disease progression|149
6841271|NCT00281697|10847122|FG000|Overall Study|Other|5
6841272|NCT00281697|10847123|FG001|Overall Study|Other|6
6841273|NCT00281697|10847122|FG000|Overall Study|Physician's decision to withdraw|15
6841274|NCT00281697|10847123|FG001|Overall Study|Physician's decision to withdraw|12
6841275|NCT00281697|10847122|FG000|Overall Study|Subject/guardian's decision to withdraw|33
6841276|NCT00281697|10847123|FG001|Overall Study|Subject/guardian's decision to withdraw|6
6841277|NCT00281697|10847122|FG000|Overall Study|Did not receive study drug|3
6841278|NCT00281697|10847123|FG001|Overall Study|Did not receive study drug|2
6841279|NCT00281840|10847135|FG000|Overall Study|Adverse Event|12
6841280|NCT00281840|10847135|FG000|Overall Study|Physician Decision|6
6841281|NCT00281840|10847135|FG000|Overall Study|Withdrawal by Subject|3
6841282|NCT00281840|10847135|FG000|Overall Study|Disease Progression|2
6841283|NCT00281840|10847135|FG000|Overall Study|exceed maximum delay in treatment|1
6841284|NCT00281840|10847135|FG000|Overall Study|Complicating Disease|1
6841285|NCT00281957|10847151|FG000|Overall Study|Adverse Event|7
6841286|NCT00281957|10847152|FG001|Overall Study|Adverse Event|2
6841287|NCT00281957|10847151|FG000|Overall Study|Death|1
6841288|NCT00281957|10847152|FG001|Overall Study|Death|0
6841289|NCT00281957|10847151|FG000|Overall Study|Progression/relapse|47
6841290|NCT00281957|10847152|FG001|Overall Study|Progression/relapse|35
6841291|NCT00281957|10847151|FG000|Overall Study|Not protocol specified|8
6841292|NCT00281957|10847152|FG001|Overall Study|Not protocol specified|1
6841293|NCT00281957|10847151|FG000|Overall Study|Not eligible|1
6841294|NCT00281957|10847152|FG001|Overall Study|Not eligible|2
6841295|NCT00281957|10847151|FG000|Overall Study|Did not start treatment|3
6841296|NCT00281957|10847152|FG001|Overall Study|Did not start treatment|1
6841297|NCT00281957|10847151|FG000|Overall Study|Refusal unrelated to adverse events|0
6841298|NCT00281957|10847152|FG001|Overall Study|Refusal unrelated to adverse events|1
6841299|NCT00282048|10847160|FG000|Overall Study|Lack of Efficacy|30
6841300|NCT00282048|10847160|FG000|Overall Study|Adverse Event|22
6841301|NCT00282048|10847160|FG000|Overall Study|Withdrawal by Subject|1
6966446|NCT04085367|11014438|FG001|Overall Study|Adverse Event|1
6966447|NCT04085367|11014437|FG000|Overall Study|Withdrawal by Subject|13
7150106|NCT03189524|11312755|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11
7150107|NCT03189524|11312753|FG000|Overall Study|Death|2
6841302|NCT00282048|10847160|FG000|Overall Study|Other|8
7150108|NCT03189524|11312754|FG001|Overall Study|Death|2
7150109|NCT03189524|11312755|FG002|Overall Study|Death|1
7150110|NCT03189524|11312753|FG000|Overall Study|Lost to Follow-up|1
7150111|NCT03189524|11312754|FG001|Overall Study|Lost to Follow-up|0
7150112|NCT03189524|11312755|FG002|Overall Study|Lost to Follow-up|8
7150113|NCT03189524|11312753|FG000|Overall Study|Withdrawal by Subject|1
7150114|NCT03189524|11312754|FG001|Overall Study|Withdrawal by Subject|1
7150115|NCT03189524|11312755|FG002|Overall Study|Withdrawal by Subject|3
7150116|NCT03189524|11312753|FG000|Overall Study|Progressive Disease|0
7150117|NCT03189524|11312754|FG001|Overall Study|Progressive Disease|2
7150118|NCT03189524|11312755|FG002|Overall Study|Progressive Disease|0
7150119|NCT03189745|11312778|FG000|Overall Study|Conflict in work schedule of participant|1
7150120|NCT03189745|11312779|FG001|Overall Study|Conflict in work schedule of participant|1
7150121|NCT03191396|11312833|FG000|Overall Study|Lost to Follow-up|0
7150122|NCT03191396|11312834|FG001|Overall Study|Lost to Follow-up|3
7150123|NCT03191396|11312833|FG000|Overall Study|Withdrawal by Subject|3
7150124|NCT03191396|11312834|FG001|Overall Study|Withdrawal by Subject|2
7150125|NCT03191552|11312843|FG000|Overall Study|Lost to Follow-up|1
7150126|NCT03191552|11312844|FG001|Overall Study|Lost to Follow-up|0
7150127|NCT03191552|11312845|FG002|Overall Study|Lost to Follow-up|0
7150128|NCT03191552|11312843|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0
7150129|NCT03191552|11312844|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1
7150130|NCT03191552|11312845|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0
7150131|NCT03191630|11312859|FG000|Overall Study|Lost to Follow-up|7
7150132|NCT03191630|11312860|FG001|Overall Study|Lost to Follow-up|7
7150133|NCT03191799|11312868|FG000|Overall Study|Withdrawal by Subject|4
7150134|NCT03191799|11312868|FG000|Overall Study|Physician Decision|2
7150135|NCT03191799|11312868|FG000|Overall Study|Lost to Follow-up|1
7150136|NCT03191799|11312868|FG000|Overall Study|Death|2
7150137|NCT03192137|11312874|FG000|Overall Study|Adverse Event|10
7150138|NCT03192137|11312875|FG001|Overall Study|Adverse Event|11
7150139|NCT03192137|11312874|FG000|Overall Study|Physician Decision|1
7150140|NCT03192137|11312875|FG001|Overall Study|Physician Decision|0
7150141|NCT03192137|11312874|FG000|Overall Study|Lack of Efficacy|20
7150142|NCT03192137|11312875|FG001|Overall Study|Lack of Efficacy|37
7150143|NCT03192137|11312874|FG000|Overall Study|Withdrawal by Subject|3
7150144|NCT03192137|11312875|FG001|Overall Study|Withdrawal by Subject|3
7150145|NCT03192137|11312874|FG000|Overall Study|Protocol Violation|4
7150146|NCT03192137|11312875|FG001|Overall Study|Protocol Violation|3
7150147|NCT03192137|11312874|FG000|Overall Study|Surgery Cancelled|4
7150148|NCT03192137|11312875|FG001|Overall Study|Surgery Cancelled|1
7150149|NCT03192137|11312874|FG000|Overall Study|Other - Various Administrative Reasons|8
7150150|NCT03192137|11312875|FG001|Overall Study|Other - Various Administrative Reasons|3
7150151|NCT03192150|11312883|FG000|Overall Study|Adverse Event|14
7150152|NCT03192150|11312884|FG001|Overall Study|Adverse Event|12
7150153|NCT03192150|11312883|FG000|Overall Study|Lack of Efficacy|23
7150154|NCT03192150|11312884|FG001|Overall Study|Lack of Efficacy|30
7150155|NCT03192150|11312883|FG000|Overall Study|Lost to Follow-up|1
7150156|NCT03192150|11312884|FG001|Overall Study|Lost to Follow-up|1
7150157|NCT03192150|11312883|FG000|Overall Study|Withdrawal by Subject|4
7150158|NCT03192150|11312884|FG001|Overall Study|Withdrawal by Subject|2
7150159|NCT03192150|11312883|FG000|Overall Study|Protocol Violation|5
7150160|NCT03192150|11312884|FG001|Overall Study|Protocol Violation|2
7150161|NCT03192150|11312883|FG000|Overall Study|Surgery Canceled|6
7150162|NCT03192150|11312884|FG001|Overall Study|Surgery Canceled|2
7150163|NCT03192150|11312883|FG000|Overall Study|Other-Various Administrative Reasons|2
7150164|NCT03192150|11312884|FG001|Overall Study|Other-Various Administrative Reasons|5
7150165|NCT03192176|11312898|FG000|Overall Study|Adverse Event|1
7150166|NCT03192176|11312899|FG001|Overall Study|Adverse Event|0
7150167|NCT03192176|11312900|FG002|Overall Study|Adverse Event|4
7150168|NCT03192176|11312901|FG003|Overall Study|Adverse Event|5
7150169|NCT03192176|11312902|FG004|Overall Study|Adverse Event|3
7150170|NCT03192176|11312903|FG005|Overall Study|Adverse Event|2
7150171|NCT03192176|11312904|FG006|Overall Study|Adverse Event|3
7150172|NCT03192176|11312905|FG007|Overall Study|Adverse Event|3
7150173|NCT03192176|11312898|FG000|Overall Study|Lost to Follow-up|0
7150174|NCT03192176|11312899|FG001|Overall Study|Lost to Follow-up|0
7150175|NCT03192176|11312900|FG002|Overall Study|Lost to Follow-up|1
7150176|NCT03192176|11312901|FG003|Overall Study|Lost to Follow-up|2
7150177|NCT03192176|11312902|FG004|Overall Study|Lost to Follow-up|3
7150178|NCT03192176|11312903|FG005|Overall Study|Lost to Follow-up|1
7150179|NCT03192176|11312904|FG006|Overall Study|Lost to Follow-up|1
7150180|NCT03192176|11312905|FG007|Overall Study|Lost to Follow-up|1
7150181|NCT03192176|11312898|FG000|Overall Study|Physician Decision|1
7150182|NCT03192176|11312899|FG001|Overall Study|Physician Decision|0
7150183|NCT03192176|11312900|FG002|Overall Study|Physician Decision|0
7150184|NCT03192176|11312901|FG003|Overall Study|Physician Decision|0
7150185|NCT03192176|11312902|FG004|Overall Study|Physician Decision|0
7150186|NCT03192176|11312903|FG005|Overall Study|Physician Decision|2
7150187|NCT03192176|11312904|FG006|Overall Study|Physician Decision|1
7150188|NCT03192176|11312905|FG007|Overall Study|Physician Decision|0
7150189|NCT03192176|11312898|FG000|Overall Study|Protocol Deviation|1
7150190|NCT03192176|11312899|FG001|Overall Study|Protocol Deviation|1
7150191|NCT03192176|11312900|FG002|Overall Study|Protocol Deviation|0
7150192|NCT03192176|11312901|FG003|Overall Study|Protocol Deviation|0
7150193|NCT03192176|11312902|FG004|Overall Study|Protocol Deviation|2
7150194|NCT03192176|11312903|FG005|Overall Study|Protocol Deviation|0
7150195|NCT03192176|11312904|FG006|Overall Study|Protocol Deviation|0
7150196|NCT03192176|11312905|FG007|Overall Study|Protocol Deviation|0
7150197|NCT03192176|11312898|FG000|Overall Study|Withdrawal by Subject|3
7150198|NCT03192176|11312899|FG001|Overall Study|Withdrawal by Subject|4
7150199|NCT03192176|11312900|FG002|Overall Study|Withdrawal by Subject|0
7150200|NCT03192176|11312901|FG003|Overall Study|Withdrawal by Subject|4
7150201|NCT03192176|11312902|FG004|Overall Study|Withdrawal by Subject|3
7150202|NCT03192176|11312903|FG005|Overall Study|Withdrawal by Subject|4
7150203|NCT03192176|11312904|FG006|Overall Study|Withdrawal by Subject|4
7150204|NCT03192176|11312905|FG007|Overall Study|Withdrawal by Subject|2
7150205|NCT03192176|11312898|FG000|Overall Study|Miscellaneous|1
7150206|NCT03192176|11312899|FG001|Overall Study|Miscellaneous|0
7150207|NCT03192176|11312900|FG002|Overall Study|Miscellaneous|1
7150208|NCT03192176|11312901|FG003|Overall Study|Miscellaneous|1
7150209|NCT03192176|11312902|FG004|Overall Study|Miscellaneous|1
7150210|NCT03192176|11312903|FG005|Overall Study|Miscellaneous|2
7150211|NCT03192176|11312904|FG006|Overall Study|Miscellaneous|0
7150212|NCT03192176|11312905|FG007|Overall Study|Miscellaneous|1
7150213|NCT03192306|11312926|FG000|Overall Study|Did not treat cold sore during study|149
7150214|NCT03192306|11312927|FG001|Overall Study|Did not treat cold sore during study|143
6841303|NCT00282048|10847160|FG000|Overall Study|Ongoing|1
6841304|NCT00282087|10847164|FG000|Overall Study|Death|1
6841305|NCT00282113|10847172|FG000|Overall Study|Removed at parents request|1
6841306|NCT00282113|10847173|FG001|Overall Study|Removed at parents request|0
6841307|NCT00282113|10847174|FG002|Overall Study|Removed at parents request|0
6841308|NCT00282152|10847184|FG000|Overall Study|Withdrawal by Subject|1
6841309|NCT00282152|10847185|FG001|Overall Study|Withdrawal by Subject|0
6841310|NCT00282243|10847192|FG000|Pharmacokinetic Treatment Period|Adverse Event|3
6841311|NCT00282243|10847192|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2
6841312|NCT00282243|10847192|FG000|Extension Treatment Period|Adverse Event|15
6841313|NCT00282243|10847192|FG000|Extension Treatment Period|Withdrawal by Subject|4
6841314|NCT00282243|10847192|FG000|Extension Treatment Period|Non-compliance|2
6841315|NCT00282243|10847192|FG000|Extension Treatment Period|Physician Decision|1
6841316|NCT00282256|10847196|FG000|Pharmacokinetic Treatment Period|Poor venous access|1
6841317|NCT00282256|10847196|FG000|Extension Treatment Period|Adverse Event|2
6841318|NCT00282295|10847208|FG000|Overall Study|Adverse Event|0
6841319|NCT00282295|10847209|FG001|Overall Study|Adverse Event|1
6841320|NCT00282295|10847210|FG002|Overall Study|Adverse Event|0
6841321|NCT00282295|10847208|FG000|Overall Study|Serious Adverse Events|0
6841322|NCT00282295|10847209|FG001|Overall Study|Serious Adverse Events|0
6841323|NCT00282295|10847210|FG002|Overall Study|Serious Adverse Events|1
6841324|NCT00282295|10847208|FG000|Overall Study|Protocol Violation|0
6841325|NCT00282295|10847209|FG001|Overall Study|Protocol Violation|2
6841326|NCT00282295|10847210|FG002|Overall Study|Protocol Violation|1
6841327|NCT00282295|10847208|FG000|Overall Study|Withdrawal by Subject|2
6841328|NCT00282295|10847209|FG001|Overall Study|Withdrawal by Subject|6
6841329|NCT00282295|10847210|FG002|Overall Study|Withdrawal by Subject|4
6841330|NCT00282295|10847208|FG000|Overall Study|Lost to Follow-up|1
6841331|NCT00282295|10847209|FG001|Overall Study|Lost to Follow-up|7
6841332|NCT00282295|10847210|FG002|Overall Study|Lost to Follow-up|2
6841333|NCT00282295|10847208|FG000|Overall Study|Other|0
6841334|NCT00282295|10847209|FG001|Overall Study|Other|1
6841335|NCT00282295|10847210|FG002|Overall Study|Other|0
6841336|NCT00282308|10847225|FG000|Treatment Period|Lost to Follow-up|1
6841337|NCT00282308|10847226|FG001|Treatment Period|Lost to Follow-up|0
6841338|NCT00282308|10847227|FG002|Treatment Period|Lost to Follow-up|0
6841339|NCT00282308|10847225|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2
6841340|NCT00282308|10847226|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4
6841341|NCT00282308|10847227|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0
6841342|NCT00282308|10847225|FG000|Treatment Period|Adverse Event|0
6841343|NCT00282308|10847226|FG001|Treatment Period|Adverse Event|2
6841344|NCT00282308|10847227|FG002|Treatment Period|Adverse Event|0
6841345|NCT00282308|10847225|FG000|Treatment Period|Not Treated with Study Drug|1
6841346|NCT00282308|10847226|FG001|Treatment Period|Not Treated with Study Drug|0
6841347|NCT00282308|10847227|FG002|Treatment Period|Not Treated with Study Drug|0
6841348|NCT00282308|10847225|FG000|Optional Extension Re-treatment Period|Adverse Event|0
6841349|NCT00282308|10847226|FG001|Optional Extension Re-treatment Period|Adverse Event|0
6841350|NCT00282308|10847227|FG002|Optional Extension Re-treatment Period|Adverse Event|4
6841351|NCT00282308|10847225|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
6841352|NCT00282308|10847226|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
6841353|NCT00282308|10847227|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1
6841354|NCT00282308|10847225|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
6841355|NCT00282308|10847226|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
7150215|NCT03192306|11312926|FG000|Overall Study|Withdrawal by Subject|1
7150216|NCT03192306|11312927|FG001|Overall Study|Withdrawal by Subject|1
7150217|NCT03192306|11312926|FG000|Overall Study|Lost to Follow-up|1
7150218|NCT03192306|11312927|FG001|Overall Study|Lost to Follow-up|0
7150219|NCT03192306|11312926|FG000|Overall Study|Protocol Violation|1
7150220|NCT03192306|11312927|FG001|Overall Study|Protocol Violation|1
7150221|NCT03192475|11312935|FG000|Overall Study|Death|0
7150222|NCT03192475|11312936|FG001|Overall Study|Death|1
7150223|NCT03192475|11312935|FG000|Overall Study|Lost to Follow-up|13
7150224|NCT03192475|11312936|FG001|Overall Study|Lost to Follow-up|8
7150225|NCT03192488|11312943|FG000|First Washout (>6d)|Withdrawal by Subject|0
7150226|NCT03192488|11312944|FG001|First Washout (>6d)|Withdrawal by Subject|0
7150227|NCT03192488|11312945|FG002|First Washout (>6d)|Withdrawal by Subject|1
7150228|NCT03192488|11312946|FG003|First Washout (>6d)|Withdrawal by Subject|0
7150229|NCT03192488|11312947|FG004|First Washout (>6d)|Withdrawal by Subject|0
7150230|NCT03192488|11312948|FG005|First Washout (>6d)|Withdrawal by Subject|1
7150231|NCT03192488|11312943|FG000|Third Intervention (d1)|Adverse Event|0
7150232|NCT03192488|11312944|FG001|Third Intervention (d1)|Adverse Event|0
7150233|NCT03192488|11312945|FG002|Third Intervention (d1)|Adverse Event|0
7150234|NCT03192488|11312946|FG003|Third Intervention (d1)|Adverse Event|0
7150235|NCT03192488|11312947|FG004|Third Intervention (d1)|Adverse Event|1
7150236|NCT03192488|11312948|FG005|Third Intervention (d1)|Adverse Event|0
7150237|NCT03192904|11312977|FG000|Overall Study|Physician Decision|3
7150238|NCT03192904|11312978|FG001|Overall Study|Physician Decision|1
7150239|NCT03192904|11312977|FG000|Overall Study|Lost to Follow-up|0
7150240|NCT03192904|11312978|FG001|Overall Study|Lost to Follow-up|1
7150241|NCT03193021|11312986|FG000|Overall Study|Lost to Follow-up|1
7150242|NCT03193021|11312987|FG001|Overall Study|Lost to Follow-up|1
7150243|NCT03193047|11312995|FG000|Overall Study|Physician Decision|1
7150244|NCT03193047|11312996|FG001|Overall Study|Physician Decision|0
7150245|NCT03193047|11312995|FG000|Overall Study|Participant Left State|1
7150246|NCT03193047|11312996|FG001|Overall Study|Participant Left State|0
7150247|NCT03193736|11313042|FG000|Overall Study|Death|2
7150248|NCT03193736|11313042|FG000|Overall Study|Withdrawal by Subject|1
7150249|NCT03193736|11313042|FG000|Overall Study|Lost to Follow-up|1
7150250|NCT03193736|11313042|FG000|Overall Study|implant not received|1
7150251|NCT03194217|11313050|FG000|Overall Study|Adverse Event|0
7150252|NCT03194217|11313051|FG001|Overall Study|Adverse Event|2
7150253|NCT03194217|11313052|FG002|Overall Study|Adverse Event|3
7150254|NCT03194217|11313053|FG003|Overall Study|Adverse Event|3
7150255|NCT03194217|11313050|FG000|Overall Study|Failure to meet randomisation criteria|0
7150256|NCT03194217|11313051|FG001|Overall Study|Failure to meet randomisation criteria|0
7150257|NCT03194217|11313052|FG002|Overall Study|Failure to meet randomisation criteria|0
7150258|NCT03194217|11313053|FG003|Overall Study|Failure to meet randomisation criteria|1
7150259|NCT03194217|11313050|FG000|Overall Study|Other|0
7150260|NCT03194217|11313051|FG001|Overall Study|Other|1
7150261|NCT03194217|11313052|FG002|Overall Study|Other|1
7150262|NCT03194217|11313053|FG003|Overall Study|Other|0
7150263|NCT03194464|11313081|FG000|Overall Study|data not usable|2
7150264|NCT03194490|11313089|FG000|Overall Study|Lost to Follow-up|1
7150265|NCT03194490|11313090|FG001|Overall Study|Lost to Follow-up|3
7150266|NCT03194490|11313089|FG000|Overall Study|participant developed specific neck pain|1
7150267|NCT03194490|11313090|FG001|Overall Study|participant developed specific neck pain|0
7150268|NCT03196193|11313170|FG000|Overall Study|Adverse Event|1
7150269|NCT03196193|11313171|FG001|Overall Study|Adverse Event|0
7150270|NCT03196193|11313170|FG000|Overall Study|Computed Tomography (CT) data missing|2
7150271|NCT03196193|11313171|FG001|Overall Study|Computed Tomography (CT) data missing|0
7150272|NCT03196284|11313183|FG000|Main Part|Withdrawal by Subject|0
7150273|NCT03196284|11313184|FG001|Main Part|Withdrawal by Subject|1
7150274|NCT03196284|11313185|FG002|Main Part|Withdrawal by Subject|0
7150275|NCT03196284|11313183|FG000|Extension Part|Lack of Efficacy|0
7150276|NCT03196284|11313184|FG001|Extension Part|Lack of Efficacy|0
7150277|NCT03196284|11313185|FG002|Extension Part|Lack of Efficacy|1
7150278|NCT03196284|11313183|FG000|Extension Part|Withdrawal by Subject|0
7150279|NCT03196284|11313184|FG001|Extension Part|Withdrawal by Subject|0
7150280|NCT03196284|11313185|FG002|Extension Part|Withdrawal by Subject|1
7150281|NCT03196284|11313183|FG000|Extension Part|Physician Decision|0
7150282|NCT03196284|11313184|FG001|Extension Part|Physician Decision|0
7150283|NCT03196284|11313185|FG002|Extension Part|Physician Decision|1
7150284|NCT03196297|11313205|FG000|Main Period|Withdrawal by Subject|4
7150285|NCT03196297|11313205|FG000|Extension Period|Withdrawal by Subject|1
7150286|NCT03196297|11313205|FG000|Extension Period|Lack of Efficacy|2
7150287|NCT03196349|11313224|FG000|Overall Study|Did not receive study drug|0
7150288|NCT03196349|11313225|FG001|Overall Study|Did not receive study drug|1
7150289|NCT03196349|11313226|FG002|Overall Study|Did not receive study drug|2
7150290|NCT03196349|11313224|FG000|Overall Study|No data entered|2
7150291|NCT03196349|11313225|FG001|Overall Study|No data entered|4
7150292|NCT03196349|11313226|FG002|Overall Study|No data entered|0
7150293|NCT03196349|11313224|FG000|Overall Study|Study Terminated early|15
7150294|NCT03196349|11313225|FG001|Overall Study|Study Terminated early|9
7150295|NCT03196349|11313226|FG002|Overall Study|Study Terminated early|11
7150296|NCT03196505|11313236|FG000|Overall Study|Physician Decision|26
7150297|NCT03196505|11313237|FG001|Overall Study|Physician Decision|26
7150298|NCT03196635|11313243|FG000|Overall Study|Withdrawal by Subject|1
7150299|NCT03196791|11313263|FG000|Overall Study|Protocol Violation|7
7150300|NCT03196791|11313264|FG001|Overall Study|Protocol Violation|3
7150301|NCT03196791|11313263|FG000|Overall Study|Withdrawal by Subject|3
7150302|NCT03196791|11313264|FG001|Overall Study|Withdrawal by Subject|2
7150303|NCT03196973|11313273|FG000|Overall Study|Adverse Event|1
7150304|NCT03196973|11313274|FG001|Overall Study|Adverse Event|1
7150305|NCT03196973|11313275|FG002|Overall Study|Adverse Event|2
7150306|NCT03196973|11313273|FG000|Overall Study|Lack of Efficacy|2
7150307|NCT03196973|11313274|FG001|Overall Study|Lack of Efficacy|6
7150308|NCT03196973|11313275|FG002|Overall Study|Lack of Efficacy|1
7150309|NCT03196973|11313273|FG000|Overall Study|Lost to Follow-up|4
7150310|NCT03196973|11313274|FG001|Overall Study|Lost to Follow-up|3
7150311|NCT03196973|11313275|FG002|Overall Study|Lost to Follow-up|2
7150312|NCT03196973|11313273|FG000|Overall Study|Consent withdrawn|2
7150313|NCT03196973|11313274|FG001|Overall Study|Consent withdrawn|1
7150314|NCT03196973|11313275|FG002|Overall Study|Consent withdrawn|0
7150315|NCT03196973|11313273|FG000|Overall Study|Administration of a wrong kit of study medication|0
7150316|NCT03196973|11313274|FG001|Overall Study|Administration of a wrong kit of study medication|1
7150317|NCT03196973|11313275|FG002|Overall Study|Administration of a wrong kit of study medication|0
7150318|NCT03197129|11313298|FG000|Overall Study|did not answer the VPT: shyness|4
7150319|NCT03197129|11313299|FG001|Overall Study|did not answer the VPT: shyness|5
7150320|NCT03197324|11313307|FG000|Overall Study|Adverse Event|0
7150321|NCT03197324|11313308|FG001|Overall Study|Adverse Event|1
7150322|NCT03197376|11313318|FG000|Primary and Booster Phase|Adverse Event|0
7150323|NCT03197376|11313319|FG001|Primary and Booster Phase|Adverse Event|0
7150324|NCT03197376|11313320|FG002|Primary and Booster Phase|Adverse Event|0
7150325|NCT03197376|11313321|FG003|Primary and Booster Phase|Adverse Event|1
7150326|NCT03197376|11313318|FG000|Primary and Booster Phase|Death|1
7150327|NCT03197376|11313319|FG001|Primary and Booster Phase|Death|0
7150328|NCT03197376|11313320|FG002|Primary and Booster Phase|Death|0
7150329|NCT03197376|11313321|FG003|Primary and Booster Phase|Death|2
7150330|NCT03197376|11313318|FG000|Primary and Booster Phase|Lost to Follow-up|0
7150331|NCT03197376|11313319|FG001|Primary and Booster Phase|Lost to Follow-up|0
7150332|NCT03197376|11313320|FG002|Primary and Booster Phase|Lost to Follow-up|1
7150333|NCT03197376|11313321|FG003|Primary and Booster Phase|Lost to Follow-up|0
7150334|NCT03197376|11313318|FG000|Primary and Booster Phase|Physician Decision|1
7150335|NCT03197376|11313319|FG001|Primary and Booster Phase|Physician Decision|0
7150336|NCT03197376|11313320|FG002|Primary and Booster Phase|Physician Decision|1
7150337|NCT03197376|11313321|FG003|Primary and Booster Phase|Physician Decision|3
7150338|NCT03197376|11313318|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11
7150339|NCT03197376|11313319|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10
7150340|NCT03197376|11313320|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14
7150341|NCT03197376|11313321|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11
7150342|NCT03197376|11313318|FG000|Primary and Booster Phase|Ineligibility criteria|1
7150343|NCT03197376|11313319|FG001|Primary and Booster Phase|Ineligibility criteria|1
7150344|NCT03197376|11313320|FG002|Primary and Booster Phase|Ineligibility criteria|4
7150345|NCT03197376|11313321|FG003|Primary and Booster Phase|Ineligibility criteria|2
7150346|NCT03197376|11313318|FG000|Primary and Booster Phase|Not vaccine related|1
7150347|NCT03197376|11313319|FG001|Primary and Booster Phase|Not vaccine related|2
7150348|NCT03197376|11313320|FG002|Primary and Booster Phase|Not vaccine related|0
7150349|NCT03197376|11313321|FG003|Primary and Booster Phase|Not vaccine related|6
7150350|NCT03197376|11313318|FG000|Immune Persistence Phase|Lost to Follow-up|0
7150351|NCT03197376|11313319|FG001|Immune Persistence Phase|Lost to Follow-up|0
7150352|NCT03197376|11313320|FG002|Immune Persistence Phase|Lost to Follow-up|2
7150353|NCT03197376|11313321|FG003|Immune Persistence Phase|Lost to Follow-up|1
7150354|NCT03197376|11313318|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4
7150355|NCT03197376|11313319|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4
7150356|NCT03197376|11313320|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2
7150357|NCT03197376|11313321|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3
7150358|NCT03197376|11313318|FG000|Immune Persistence Phase|Not vaccine related|1
7150359|NCT03197376|11313319|FG001|Immune Persistence Phase|Not vaccine related|0
7150360|NCT03197376|11313320|FG002|Immune Persistence Phase|Not vaccine related|1
7150361|NCT03197376|11313321|FG003|Immune Persistence Phase|Not vaccine related|1
7150362|NCT03197558|11313379|FG000|Overall Study|Tubes not placed|1
7150363|NCT03197883|11313385|FG000|Overall Study|Adverse Event|1
7150364|NCT03197883|11313386|FG001|Overall Study|Adverse Event|1
7150365|NCT03197883|11313385|FG000|Overall Study|Lost to Follow-up|1
7150366|NCT03197883|11313386|FG001|Overall Study|Lost to Follow-up|0
7150367|NCT03197883|11313385|FG000|Overall Study|Protocol Violation|1
7150368|NCT03197883|11313386|FG001|Overall Study|Protocol Violation|0
7150369|NCT03197883|11313385|FG000|Overall Study|Other (Not Specified)|0
7150370|NCT03197883|11313386|FG001|Overall Study|Other (Not Specified)|5
7150371|NCT03198507|11313424|FG000|Overall Study|Withdrawal by Subject|1
7150372|NCT03198507|11313425|FG001|Overall Study|Withdrawal by Subject|0
7150373|NCT03198520|11313431|FG000|Overall Study|Physician Decision|2
7150374|NCT03198520|11313431|FG000|Overall Study|Protocol Violation|2
7150375|NCT03198520|11313431|FG000|Overall Study|Withdrawal by Subject|1
7150376|NCT03198520|11313431|FG000|Overall Study|Study Ended|1
7150377|NCT03198715|11313448|FG000|Overall Study|Death|0
7150378|NCT03198715|11313449|FG001|Overall Study|Death|0
7150379|NCT03198715|11313450|FG002|Overall Study|Death|1
7150380|NCT03198715|11313451|FG003|Overall Study|Death|0
7150381|NCT03198715|11313452|FG004|Overall Study|Death|2
7150382|NCT03198715|11313448|FG000|Overall Study|Other|0
7150383|NCT03198715|11313449|FG001|Overall Study|Other|1
7150384|NCT03198715|11313450|FG002|Overall Study|Other|1
7150385|NCT03198715|11313451|FG003|Overall Study|Other|0
7150386|NCT03198715|11313452|FG004|Overall Study|Other|0
7150387|NCT03198754|11313466|FG000|Overall Study|Withdrawal by Subject|5
7150388|NCT03198754|11313467|FG001|Overall Study|Withdrawal by Subject|4
7150389|NCT03198754|11313466|FG000|Overall Study|Lost to Follow-up|4
7150390|NCT03198754|11313467|FG001|Overall Study|Lost to Follow-up|3
7150391|NCT03198754|11313466|FG000|Overall Study|Ineligible|2
7150392|NCT03198754|11313467|FG001|Overall Study|Ineligible|1
7150393|NCT03198767|11313480|FG000|Overall Study|Protocol Violation|0
7150394|NCT03198767|11313481|FG001|Overall Study|Protocol Violation|0
7150395|NCT03198767|11313482|FG002|Overall Study|Protocol Violation|0
7150396|NCT03198767|11313483|FG003|Overall Study|Protocol Violation|6
7150397|NCT03198767|11313484|FG004|Overall Study|Protocol Violation|0
7150398|NCT03198767|11313485|FG005|Overall Study|Protocol Violation|0
7150399|NCT03198767|11313486|FG006|Overall Study|Protocol Violation|0
7150400|NCT03199911|11313553|FG000|Overall Study|Lost to Follow-up|5
7150401|NCT03199911|11313554|FG001|Overall Study|Lost to Follow-up|5
7150402|NCT03199911|11313553|FG000|Overall Study|Did not proceed with surgery|2
7150403|NCT03199911|11313554|FG001|Overall Study|Did not proceed with surgery|1
7184060|NCT01714817|11384098|FG001|Year 1 Period|Change in Concomitant Medication|1
7184061|NCT01714817|11384097|FG000|Year 1 Period|Need of use of Prohibited Medications|1
7184062|NCT01714817|11384098|FG001|Year 1 Period|Need of use of Prohibited Medications|0
7184063|NCT01714817|11384097|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0
7184064|NCT01714817|11384098|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1
7184065|NCT01714817|11384097|FG000|Year 1 Period|Hypersensitivity to the medication|0
7184066|NCT01714817|11384098|FG001|Year 1 Period|Hypersensitivity to the medication|1
7184067|NCT01714817|11384097|FG000|Year 2 Period|Lack of Efficacy|4
7184068|NCT01714817|11384098|FG001|Year 2 Period|Lack of Efficacy|12
7184069|NCT01714817|11384097|FG000|Year 2 Period|Adverse Event|7
7184070|NCT01714817|11384098|FG001|Year 2 Period|Adverse Event|6
7184071|NCT01714817|11384097|FG000|Year 2 Period|Participant request to stop treatment|4
7184072|NCT01714817|11384098|FG001|Year 2 Period|Participant request to stop treatment|4
7184073|NCT01714817|11384097|FG000|Year 2 Period|Administrative reason by Sponsor|4
7184074|NCT01714817|11384098|FG001|Year 2 Period|Administrative reason by Sponsor|3
7184075|NCT01714817|11384097|FG000|Year 2 Period|Participant withdrew consent|1
7184076|NCT01714817|11384098|FG001|Year 2 Period|Participant withdrew consent|5
7184077|NCT01714817|11384097|FG000|Year 2 Period|Participant no longer meets criteria|1
7184078|NCT01714817|11384098|FG001|Year 2 Period|Participant no longer meets criteria|4
7184079|NCT01714817|11384097|FG000|Year 2 Period|Lost to Follow-up|2
7184080|NCT01714817|11384098|FG001|Year 2 Period|Lost to Follow-up|0
7184081|NCT01714817|11384097|FG000|Year 2 Period|Participant went to US stopped treatment|0
7184082|NCT01714817|11384098|FG001|Year 2 Period|Participant went to US stopped treatment|1
7184083|NCT01714817|11384097|FG000|Year 2 Period|Pregnancy|1
7184084|NCT01714817|11384098|FG001|Year 2 Period|Pregnancy|1
7184085|NCT01714817|11384097|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2
7184086|NCT01714817|11384098|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1
7184087|NCT01714817|11384097|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0
7184088|NCT01714817|11384098|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1
7184089|NCT01714817|11384097|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27
7184090|NCT01714817|11384098|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21
6841356|NCT00282308|10847227|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1
6841357|NCT00282308|10847225|FG000|Safety Follow-up Period|Adverse Event|0
6841358|NCT00282308|10847226|FG001|Safety Follow-up Period|Adverse Event|0
6841359|NCT00282308|10847227|FG002|Safety Follow-up Period|Adverse Event|1
6841360|NCT00282308|10847225|FG000|Safety Follow-up Period|Lost to Follow-up|0
6841361|NCT00282308|10847226|FG001|Safety Follow-up Period|Lost to Follow-up|0
6841362|NCT00282308|10847227|FG002|Safety Follow-up Period|Lost to Follow-up|5
7184091|NCT01714817|11384097|FG000|Long-Term Extension (LTE) Period|Disease progression|1
7184092|NCT01714817|11384098|FG001|Long-Term Extension (LTE) Period|Disease progression|4
7184093|NCT01714817|11384097|FG000|Long-Term Extension (LTE) Period|Not effective|0
7184094|NCT01714817|11384098|FG001|Long-Term Extension (LTE) Period|Not effective|1
7184095|NCT01714817|11384097|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1
7184096|NCT01714817|11384098|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1
7184097|NCT01714817|11384097|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1
7184098|NCT01714817|11384098|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1
7184099|NCT01714817|11384097|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1
7184100|NCT01714817|11384098|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0
7184101|NCT01714817|11384097|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0
7184102|NCT01714817|11384098|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1
7184103|NCT01714817|11384097|FG000|Long-Term Extension (LTE) Period|Pregnancy|1
7184104|NCT01714817|11384098|FG001|Long-Term Extension (LTE) Period|Pregnancy|0
7184105|NCT01714817|11384097|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1
7184106|NCT01714817|11384098|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0
7184107|NCT01714817|11384097|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1
6841363|NCT00282308|10847225|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0
7150404|NCT03199963|11313562|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5
7150405|NCT03199963|11313563|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5
7150406|NCT03199963|11313562|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9
7150407|NCT03199963|11313563|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2
7150408|NCT03199963|11313562|FG000|Blinded Phase - Overall Study|Adverse Event|10
7150409|NCT03199963|11313563|FG001|Blinded Phase - Overall Study|Adverse Event|5
7150410|NCT03199963|11313562|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109
7150411|NCT03199963|11313563|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54
7150412|NCT03199963|11313562|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7
7150413|NCT03199963|11313563|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5
7150414|NCT03199963|11313562|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0
7150415|NCT03199963|11313563|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1
7150416|NCT03200366|11313574|FG000|Patient Navigation Intervention Given|Death|0
7150417|NCT03200366|11313575|FG001|Patient Navigation Intervention Given|Death|2
7150418|NCT03200366|11313576|FG002|Patient Navigation Intervention Given|Death|0
7150419|NCT03200366|11313574|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0
7150420|NCT03200366|11313575|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25
7150421|NCT03200366|11313576|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0
7150422|NCT03200366|11313574|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0
7150423|NCT03200366|11313575|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1
7150424|NCT03200366|11313576|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0
7150425|NCT03200366|11313574|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0
7150426|NCT03200366|11313575|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2
7150427|NCT03200366|11313576|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0
7150428|NCT03200366|11313574|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0
7150429|NCT03200366|11313575|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1
7150430|NCT03200366|11313576|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0
7150431|NCT03200366|11313574|FG000|6 Month Post-Baseline Interview|Death|1
7150432|NCT03200366|11313575|FG001|6 Month Post-Baseline Interview|Death|1
7150433|NCT03200366|11313576|FG002|6 Month Post-Baseline Interview|Death|1
7150434|NCT03200366|11313574|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27
7150435|NCT03200366|11313575|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21
7150436|NCT03200366|11313576|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17
7150437|NCT03200366|11313574|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1
7150438|NCT03200366|11313575|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1
7150439|NCT03200366|11313576|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0
7150440|NCT03200366|11313574|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1
7150441|NCT03200366|11313575|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0
7150442|NCT03200366|11313576|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0
7150443|NCT03200366|11313574|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0
7150444|NCT03200366|11313575|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0
7150445|NCT03200366|11313576|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1
7150446|NCT03200366|11313574|FG000|9 Month Post-Baseline Interview|Death|1
7150447|NCT03200366|11313575|FG001|9 Month Post-Baseline Interview|Death|1
7150448|NCT03200366|11313576|FG002|9 Month Post-Baseline Interview|Death|1
7150449|NCT03200366|11313574|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23
7150450|NCT03200366|11313575|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18
7150451|NCT03200366|11313576|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9
7150452|NCT03200366|11313574|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0
7150453|NCT03200366|11313575|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0
7150454|NCT03200366|11313576|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1
7150455|NCT03200366|11313574|FG000|9 Month Post-Baseline Interview|Refused interview|0
7150456|NCT03200366|11313575|FG001|9 Month Post-Baseline Interview|Refused interview|2
7150457|NCT03200366|11313576|FG002|9 Month Post-Baseline Interview|Refused interview|0
7150458|NCT03200860|11313605|FG000|Overall Study|Withdrawal by Subject|1
7150459|NCT03200860|11313606|FG001|Overall Study|Withdrawal by Subject|0
7150460|NCT03200912|11313615|FG000|Overall Study|Adverse Event|3
7150461|NCT03200912|11313616|FG001|Overall Study|Adverse Event|0
7150462|NCT03200912|11313617|FG002|Overall Study|Adverse Event|0
7150463|NCT03200912|11313615|FG000|Overall Study|Withdrawal by Subject|1
7150464|NCT03200912|11313616|FG001|Overall Study|Withdrawal by Subject|2
6966448|NCT04085367|11014438|FG001|Overall Study|Withdrawal by Subject|4
7150465|NCT03200912|11313617|FG002|Overall Study|Withdrawal by Subject|4
7150466|NCT03200912|11313615|FG000|Overall Study|Non-compliance with study drug|0
7150467|NCT03200912|11313616|FG001|Overall Study|Non-compliance with study drug|1
7150468|NCT03200912|11313617|FG002|Overall Study|Non-compliance with study drug|0
7150469|NCT03201003|11313636|FG000|Overall Study|Adverse Event|14
7150470|NCT03201003|11313637|FG001|Overall Study|Adverse Event|1
7150471|NCT03201003|11313636|FG000|Overall Study|Other reasons|5
7150472|NCT03201003|11313637|FG001|Overall Study|Other reasons|1
7150473|NCT03201003|11313636|FG000|Overall Study|Withdrawal by Subject|4
7150474|NCT03201003|11313637|FG001|Overall Study|Withdrawal by Subject|1
7150475|NCT03201003|11313636|FG000|Overall Study|Lost to Follow-up|2
7150476|NCT03201003|11313637|FG001|Overall Study|Lost to Follow-up|0
7150477|NCT03201003|11313636|FG000|Overall Study|Protocol Violation|1
7150478|NCT03201003|11313637|FG001|Overall Study|Protocol Violation|0
7150479|NCT03201211|11313646|FG000|Overall Study|Adverse Event|1
7150480|NCT03201211|11313647|FG001|Overall Study|Adverse Event|0
7150481|NCT03201211|11313648|FG002|Overall Study|Adverse Event|0
7150482|NCT03201211|11313646|FG000|Overall Study|Protocol Violation|1
7150483|NCT03201211|11313647|FG001|Overall Study|Protocol Violation|0
7150484|NCT03201211|11313648|FG002|Overall Study|Protocol Violation|0
7150485|NCT03201211|11313646|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
7150486|NCT03201211|11313647|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
7150487|NCT03201211|11313648|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1
7150488|NCT03201211|11313646|FG000|Overall Study|OTHER unknown reasons|0
7150489|NCT03201211|11313647|FG001|Overall Study|OTHER unknown reasons|1
7150490|NCT03201211|11313648|FG002|Overall Study|OTHER unknown reasons|0
7150491|NCT03201562|11313659|FG000|Overall Study|Physician Decision|0
7150492|NCT03201562|11313660|FG001|Overall Study|Physician Decision|0
7150493|NCT03201562|11313661|FG002|Overall Study|Physician Decision|1
7150494|NCT03201562|11313659|FG000|Overall Study|Adverse Event|0
7150495|NCT03201562|11313660|FG001|Overall Study|Adverse Event|0
7150496|NCT03201562|11313661|FG002|Overall Study|Adverse Event|1
7150497|NCT03201562|11313659|FG000|Overall Study|Lost to Follow-up|0
7150498|NCT03201562|11313660|FG001|Overall Study|Lost to Follow-up|1
7150499|NCT03201562|11313661|FG002|Overall Study|Lost to Follow-up|2
7150500|NCT03201809|11313671|FG000|Overall Study|Lost to Follow-up|2
7150501|NCT03201809|11313672|FG001|Overall Study|Lost to Follow-up|0
7150502|NCT03201900|11313678|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9
7150503|NCT03201900|11313678|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1
7150504|NCT03201900|11313678|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6
7150505|NCT03201900|11313678|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2
7150506|NCT03201900|11313678|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6
7150507|NCT03201900|11313678|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11
6841364|NCT00282308|10847226|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0
6841365|NCT00282308|10847227|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1
6841366|NCT00282308|10847225|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
6841367|NCT00282308|10847226|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
6841368|NCT00282308|10847227|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12
6841369|NCT00282334|10847239|FG000|Overall Study|Withdrawal by Subject|8
6841370|NCT00282334|10847240|FG001|Overall Study|Withdrawal by Subject|5
6841371|NCT00282347|10847248|FG000|Treatment Period|Death|2
6841372|NCT00282347|10847249|FG001|Treatment Period|Death|0
6841373|NCT00282347|10847248|FG000|Treatment Period|Lost to Follow-up|2
6841374|NCT00282347|10847249|FG001|Treatment Period|Lost to Follow-up|5
6841375|NCT00282347|10847248|FG000|Treatment Period|Withdrawal by Subject|1
6841376|NCT00282347|10847249|FG001|Treatment Period|Withdrawal by Subject|3
6841377|NCT00282347|10847248|FG000|Treatment Period|Physician Decision|0
6841378|NCT00282347|10847249|FG001|Treatment Period|Physician Decision|1
6841379|NCT00282347|10847248|FG000|Safety Follow-up Period|Lost to Follow-up|0
6841380|NCT00282347|10847249|FG001|Safety Follow-up Period|Lost to Follow-up|2
6841381|NCT00282347|10847248|FG000|Safety Follow-up Period|Withdrawal by Subject|2
6841382|NCT00282347|10847249|FG001|Safety Follow-up Period|Withdrawal by Subject|1
6841383|NCT00282347|10847248|FG000|Safety Follow-up Period|Physician Decision|1
6841384|NCT00282347|10847249|FG001|Safety Follow-up Period|Physician Decision|1
6841385|NCT00282347|10847248|FG000|Safety Follow-up Period|Protocol Deviation|0
6841386|NCT00282347|10847249|FG001|Safety Follow-up Period|Protocol Deviation|2
6841387|NCT00282347|10847248|FG000|B Cell Follow-up Period|Withdrawal by Subject|2
6841388|NCT00282347|10847249|FG001|B Cell Follow-up Period|Withdrawal by Subject|0
6841389|NCT00282347|10847248|FG000|B Cell Follow-up Period|Physician Decision|1
6841390|NCT00282347|10847249|FG001|B Cell Follow-up Period|Physician Decision|0
7150508|NCT03201900|11313678|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2
7150509|NCT03201900|11313678|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1
7150510|NCT03201900|11313678|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1
7150511|NCT03201900|11313678|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1
7150512|NCT03201900|11313678|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1
7150513|NCT03201900|11313678|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3
7150514|NCT03201900|11313678|FG000|Extension Phase (From Week 63 to 156)|Other|1
7150515|NCT03202511|11313701|FG000|Overall Study|Withdrawal by Subject|1
7150516|NCT03202511|11313702|FG001|Overall Study|Withdrawal by Subject|0
7150517|NCT03203291|11313717|FG000|Overall Study|Withdrawal by Subject|1
7150518|NCT03203447|11313723|FG000|Overall Study|Withdrawal by Subject|2
7150519|NCT03203447|11313724|FG001|Overall Study|Withdrawal by Subject|1
7150520|NCT03203447|11313723|FG000|Overall Study|Lost to Follow-up|1
7150521|NCT03203447|11313724|FG001|Overall Study|Lost to Follow-up|10
7150522|NCT03203447|11313723|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159
7150523|NCT03203447|11313724|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152
7150524|NCT03204279|11313753|FG000|Overall Study|Withdrawal by Subject|0
7150525|NCT03204279|11313754|FG001|Overall Study|Withdrawal by Subject|1
7150526|NCT03204981|11313783|FG000|Overall Study|Physician Decision|2
7150527|NCT03204981|11313783|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4
7150528|NCT03205046|11313791|FG000|Overall Study|Death|10
7150529|NCT03205046|11313792|FG001|Overall Study|Death|6
7150530|NCT03205046|11313791|FG000|Overall Study|Withdrawal by Subject|1
7150531|NCT03205046|11313792|FG001|Overall Study|Withdrawal by Subject|2
7150532|NCT03205046|11313791|FG000|Overall Study|Lost to Follow-up|0
7150533|NCT03205046|11313792|FG001|Overall Study|Lost to Follow-up|1
7150534|NCT03205046|11313791|FG000|Overall Study|Study terminated by sponsor|2
7150535|NCT03205046|11313792|FG001|Overall Study|Study terminated by sponsor|1
7150536|NCT03205150|11313801|FG000|Overall Study|Protocol deviation|1
7150537|NCT03205150|11313802|FG001|Overall Study|Protocol deviation|3
7150538|NCT03205150|11313803|FG002|Overall Study|Protocol deviation|0
7150539|NCT03205150|11313801|FG000|Overall Study|Patient/guardian decision|0
7150540|NCT03205150|11313802|FG001|Overall Study|Patient/guardian decision|3
7150541|NCT03205150|11313803|FG002|Overall Study|Patient/guardian decision|0
7150542|NCT03205150|11313801|FG000|Overall Study|Adverse Event|1
7150543|NCT03205150|11313802|FG001|Overall Study|Adverse Event|1
7150544|NCT03205150|11313803|FG002|Overall Study|Adverse Event|1
7150545|NCT03205150|11313801|FG000|Overall Study|Lost to Follow-up|0
7150546|NCT03205150|11313802|FG001|Overall Study|Lost to Follow-up|0
7150547|NCT03205150|11313803|FG002|Overall Study|Lost to Follow-up|1
7150548|NCT03205488|11313815|FG000|Overall Study|Adverse Event|1
7150549|NCT03205488|11313816|FG001|Overall Study|Adverse Event|2
7150550|NCT03205488|11313817|FG002|Overall Study|Adverse Event|4
7150551|NCT03205488|11313815|FG000|Overall Study|Protocol Violation|0
7150552|NCT03205488|11313816|FG001|Overall Study|Protocol Violation|0
7150553|NCT03205488|11313817|FG002|Overall Study|Protocol Violation|1
7150554|NCT03205566|11313831|FG000|Phase 1|Protocol Violation|1
7150555|NCT03205566|11313832|FG001|Phase 1|Protocol Violation|1
7150556|NCT03206749|11313845|FG000|Overall Study|Withdrawal of consent|5
7077120|NCT02087943|11184448|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0
7077121|NCT02088034|11184478|FG000|Overall Study|Lost to Follow-up|1
7077122|NCT02088034|11184479|FG001|Overall Study|Lost to Follow-up|1
7077123|NCT02088034|11184480|FG002|Overall Study|Lost to Follow-up|0
7150557|NCT03206749|11313846|FG001|Overall Study|Withdrawal of consent|3
7150558|NCT03206749|11313847|FG002|Overall Study|Withdrawal of consent|6
7150559|NCT03206749|11313845|FG000|Overall Study|Lost to Follow-up|0
7150560|NCT03206749|11313846|FG001|Overall Study|Lost to Follow-up|0
7150561|NCT03206749|11313847|FG002|Overall Study|Lost to Follow-up|1
7150562|NCT03206788|11313858|FG000|Overall Study|Withdrawal by Subject|0
7150563|NCT03206788|11313859|FG001|Overall Study|Withdrawal by Subject|1
7150564|NCT03206788|11313858|FG000|Overall Study|Adverse Event|0
7150565|NCT03206788|11313859|FG001|Overall Study|Adverse Event|1
7150566|NCT03206788|11313858|FG000|Overall Study|Physician Decision|0
7150567|NCT03206788|11313859|FG001|Overall Study|Physician Decision|1
7150568|NCT03206918|11313865|FG000|Overall Study|Death|11
7150569|NCT03206918|11313865|FG000|Overall Study|Withdrawal by Subject|5
7150570|NCT03206918|11313865|FG000|Overall Study|Study terminated by sponsor|12
7150571|NCT03206918|11313865|FG000|Overall Study|Lost to Follow-up|3
7150572|NCT03206918|11313865|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60
7150573|NCT03206970|11313870|FG000|Overall Study|Death|21
7150574|NCT03206970|11313870|FG000|Overall Study|Withdrawal by Subject|13
7150575|NCT03206970|11313870|FG000|Overall Study|Lost to Follow-up|3
7150576|NCT03206970|11313870|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49
7150577|NCT03207243|11313898|FG000|Overall Study|Adverse Event|2
7150578|NCT03207243|11313899|FG001|Overall Study|Adverse Event|2
7150579|NCT03207243|11313898|FG000|Overall Study|Loss of Asthma Control|47
7150580|NCT03207243|11313899|FG001|Overall Study|Loss of Asthma Control|31
7150581|NCT03207243|11313898|FG000|Overall Study|Withdrawal by Subject|2
7150582|NCT03207243|11313899|FG001|Overall Study|Withdrawal by Subject|4
7150583|NCT03207243|11313898|FG000|Overall Study|Physician Decision|1
7150584|NCT03207243|11313899|FG001|Overall Study|Physician Decision|1
7150585|NCT03207243|11313898|FG000|Overall Study|Lost to Follow-up|0
7077124|NCT02088034|11184478|FG000|Overall Study|Pregnancy|2
7077125|NCT02088034|11184479|FG001|Overall Study|Pregnancy|1
7077126|NCT02088034|11184480|FG002|Overall Study|Pregnancy|2
7077127|NCT02088047|11184490|FG000|Overall Study|Withdrawal by Subject|1
7077128|NCT02088047|11184491|FG001|Overall Study|Withdrawal by Subject|0
7077129|NCT02088073|11184502|FG000|Acute Phase|Withdrawal by Subject|5
7077130|NCT02088073|11184503|FG001|Acute Phase|Withdrawal by Subject|0
7077131|NCT02088073|11184504|FG002|Acute Phase|Withdrawal by Subject|0
7150586|NCT03207243|11313899|FG001|Overall Study|Lost to Follow-up|1
7150587|NCT03207243|11313898|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7
7150588|NCT03207243|11313899|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2
7150589|NCT03207243|11313898|FG000|Overall Study|Protocol Violation|0
7150590|NCT03207243|11313899|FG001|Overall Study|Protocol Violation|3
7150591|NCT03207750|11313939|FG000|Overall Study|Adverse Event|3
7150592|NCT03207750|11313940|FG001|Overall Study|Adverse Event|2
7150593|NCT03207750|11313939|FG000|Overall Study|Lost to Follow-up|21
7150594|NCT03207750|11313940|FG001|Overall Study|Lost to Follow-up|29
7150595|NCT03207750|11313939|FG000|Overall Study|Protocol Violation|0
7150596|NCT03207750|11313940|FG001|Overall Study|Protocol Violation|1
7150597|NCT03207750|11313939|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11
7150598|NCT03207750|11313940|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13
7150599|NCT03207750|11313939|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7
7150600|NCT03207750|11313940|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10
7150601|NCT03207750|11313939|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10
6841391|NCT00282347|10847248|FG000|B Cell Follow-up Period|Reason Not Specified|2
6841392|NCT00282347|10847249|FG001|B Cell Follow-up Period|Reason Not Specified|0
6841393|NCT00282412|10847257|FG000|Overall Study|Death|2
6841394|NCT00282438|10847263|FG000|Overall Study|Lack of Efficacy|1
6841395|NCT00282438|10847264|FG001|Overall Study|Lack of Efficacy|0
6841396|NCT00282438|10847263|FG000|Overall Study|Death|0
6841397|NCT00282438|10847264|FG001|Overall Study|Death|1
6841398|NCT00282464|10847272|FG000|Overall Study|Adverse Event|26
6841399|NCT00282464|10847273|FG001|Overall Study|Adverse Event|20
6841400|NCT00282464|10847272|FG000|Overall Study|Lack of Efficacy|8
6841401|NCT00282464|10847273|FG001|Overall Study|Lack of Efficacy|8
6841402|NCT00282464|10847272|FG000|Overall Study|Lost to Follow-up|10
6841403|NCT00282464|10847273|FG001|Overall Study|Lost to Follow-up|10
6841404|NCT00282464|10847272|FG000|Overall Study|Withdrawal by Subject|24
6841405|NCT00282464|10847273|FG001|Overall Study|Withdrawal by Subject|10
6841406|NCT00282464|10847272|FG000|Overall Study|laboratory abnormality|1
6841407|NCT00282464|10847273|FG001|Overall Study|laboratory abnormality|2
6841408|NCT00282464|10847272|FG000|Overall Study|Protocol Violation|0
6841409|NCT00282464|10847273|FG001|Overall Study|Protocol Violation|7
6841410|NCT00282464|10847272|FG000|Overall Study|Patient moved|1
6841411|NCT00282464|10847273|FG001|Overall Study|Patient moved|0
6841412|NCT00282464|10847272|FG000|Overall Study|patient non-compliant|3
6841413|NCT00282464|10847273|FG001|Overall Study|patient non-compliant|0
6841414|NCT00282464|10847272|FG000|Overall Study|patient no show|0
6841415|NCT00282464|10847273|FG001|Overall Study|patient no show|1
6841416|NCT00282464|10847272|FG000|Overall Study|patient incarcerated|0
6841417|NCT00282464|10847273|FG001|Overall Study|patient incarcerated|1
6841418|NCT00282464|10847272|FG000|Overall Study|family crisis|0
6841419|NCT00282464|10847273|FG001|Overall Study|family crisis|1
6841420|NCT00282464|10847272|FG000|Overall Study|dispensed wrong kit|0
6841421|NCT00282464|10847273|FG001|Overall Study|dispensed wrong kit|1
6841422|NCT00282464|10847272|FG000|Overall Study|dropped due to missed visits|0
6841423|NCT00282464|10847273|FG001|Overall Study|dropped due to missed visits|1
6841424|NCT00282568|10847279|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2
6841425|NCT00282568|10847279|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1
6841426|NCT00282568|10847279|FG000|Extended Treatment Period|Adverse Event|17
6841427|NCT00282568|10847279|FG000|Extended Treatment Period|Non-compliance|4
6841428|NCT00282568|10847279|FG000|Extended Treatment Period|Physician Decision|1
6841429|NCT00282568|10847279|FG000|Extended Treatment Period|Lost to Follow-up|2
6841430|NCT00282919|10847354|FG000|Overall Study|Lack of Efficacy|4
6841431|NCT00282919|10847354|FG000|Overall Study|Withdrawal by Subject|1
6841432|NCT00282919|10847354|FG000|Overall Study|Asymptomatic Parasitemia|2
6841433|NCT00282984|10847369|FG000|Overall Study|Death|2
6841434|NCT00282984|10847370|FG001|Overall Study|Death|5
7150602|NCT03207750|11313940|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5
7150603|NCT03207750|11313939|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1
7150604|NCT03207750|11313940|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2
7150605|NCT03207750|11313939|FG000|Overall Study|OTHER, NOT SPECIFIED|5
7150606|NCT03207750|11313940|FG001|Overall Study|OTHER, NOT SPECIFIED|4
7150607|NCT03207763|11313948|FG000|Overall Study|Lost to Follow-up|1
7150608|NCT03207763|11313949|FG001|Overall Study|Lost to Follow-up|0
7150609|NCT03208088|11313964|FG000|Period 2|Withdrawal by Subject|0
7150610|NCT03208088|11313965|FG001|Period 2|Withdrawal by Subject|0
7150611|NCT03208088|11313966|FG002|Period 2|Withdrawal by Subject|0
7150612|NCT03208088|11313967|FG003|Period 2|Withdrawal by Subject|0
7150613|NCT03208088|11313968|FG004|Period 2|Withdrawal by Subject|0
7150614|NCT03208088|11313969|FG005|Period 2|Withdrawal by Subject|0
7150615|NCT03208088|11313970|FG006|Period 2|Withdrawal by Subject|0
7150616|NCT03208088|11313971|FG007|Period 2|Withdrawal by Subject|0
7150617|NCT03208088|11313972|FG008|Period 2|Withdrawal by Subject|1
7150618|NCT03208088|11313973|FG009|Period 2|Withdrawal by Subject|0
7150619|NCT03208088|11313964|FG000|Period 3|Unsatisfactory Test Article|0
7150620|NCT03208088|11313965|FG001|Period 3|Unsatisfactory Test Article|0
7150621|NCT03208088|11313966|FG002|Period 3|Unsatisfactory Test Article|0
7150622|NCT03208088|11313967|FG003|Period 3|Unsatisfactory Test Article|1
7150623|NCT03208088|11313968|FG004|Period 3|Unsatisfactory Test Article|0
7150624|NCT03208088|11313969|FG005|Period 3|Unsatisfactory Test Article|0
7150625|NCT03208088|11313970|FG006|Period 3|Unsatisfactory Test Article|0
6841435|NCT00282984|10847369|FG000|Overall Study|Adverse Event|8
6841436|NCT00282984|10847370|FG001|Overall Study|Adverse Event|5
6841437|NCT00282984|10847369|FG000|Overall Study|Lack of Efficacy|0
6841438|NCT00282984|10847370|FG001|Overall Study|Lack of Efficacy|2
6841439|NCT00282984|10847369|FG000|Overall Study|Lost to Follow-up|14
6841440|NCT00282984|10847370|FG001|Overall Study|Lost to Follow-up|10
6841441|NCT00282984|10847369|FG000|Overall Study|Withdrawal by Participant|22
7150626|NCT03208088|11313971|FG007|Period 3|Unsatisfactory Test Article|0
7150627|NCT03208088|11313972|FG008|Period 3|Unsatisfactory Test Article|0
7150628|NCT03208088|11313973|FG009|Period 3|Unsatisfactory Test Article|0
7150629|NCT03208088|11313964|FG000|Period 4|Unsatisfactory Test Article|0
7150630|NCT03208088|11313965|FG001|Period 4|Unsatisfactory Test Article|0
7150631|NCT03208088|11313966|FG002|Period 4|Unsatisfactory Test Article|0
7150632|NCT03208088|11313967|FG003|Period 4|Unsatisfactory Test Article|1
7150633|NCT03208088|11313968|FG004|Period 4|Unsatisfactory Test Article|0
7150634|NCT03208088|11313969|FG005|Period 4|Unsatisfactory Test Article|0
7150635|NCT03208088|11313970|FG006|Period 4|Unsatisfactory Test Article|0
7150636|NCT03208088|11313971|FG007|Period 4|Unsatisfactory Test Article|0
7150637|NCT03208088|11313972|FG008|Period 4|Unsatisfactory Test Article|0
7150638|NCT03208088|11313973|FG009|Period 4|Unsatisfactory Test Article|0
7150639|NCT03208933|11314009|FG000|Overall Study|Death|3
7150640|NCT03208933|11314009|FG000|Overall Study|Withdrawal by Subject|3
7150641|NCT03208933|11314009|FG000|Overall Study|Adverse Event|1
7150642|NCT03208933|11314009|FG000|Overall Study|Lost to Follow-up|2
7150643|NCT03208933|11314009|FG000|Overall Study|Physician Decision|3
7150644|NCT03208933|11314009|FG000|Overall Study|Protocol Violation|1
7150645|NCT03209362|11314020|FG000|Overall Study|Adverse Event|0
7150646|NCT03209362|11314021|FG001|Overall Study|Adverse Event|1
7150647|NCT03209362|11314020|FG000|Overall Study|Lost to Follow-up|0
7150648|NCT03209362|11314021|FG001|Overall Study|Lost to Follow-up|1
7150649|NCT03209362|11314020|FG000|Overall Study|Withdrawal by Subject|2
7150650|NCT03209362|11314021|FG001|Overall Study|Withdrawal by Subject|0
7150651|NCT03209362|11314020|FG000|Overall Study|Other|0
7150652|NCT03209362|11314021|FG001|Overall Study|Other|1
7150653|NCT03209492|11314027|FG000|Overall Study|Case Report Forms Uncollected|5
7150654|NCT03209518|11314038|FG000|Overall Study|Case Report Forms Uncollected|1
7150655|NCT03209518|11314038|FG000|Overall Study|Protocol Deviation|1
7150656|NCT03209570|11314044|FG000|Overall Study|Death|1
7150657|NCT03209570|11314045|FG001|Overall Study|Death|0
7150658|NCT03209570|11314044|FG000|Overall Study|Incomplete Data|8
7150659|NCT03209570|11314045|FG001|Overall Study|Incomplete Data|10
7150660|NCT03209570|11314044|FG000|Overall Study|Protocol Violation|1
7150661|NCT03209570|11314045|FG001|Overall Study|Protocol Violation|0
7150662|NCT03209570|11314044|FG000|Overall Study|Withdrawal by Subject|0
7150663|NCT03209570|11314045|FG001|Overall Study|Withdrawal by Subject|3
7150664|NCT03209973|11314062|FG000|Overall Study|Withdrawal by Subject|7
7150665|NCT03209973|11314062|FG000|Overall Study|Lost to Follow-up|2
7150666|NCT03209973|11314062|FG000|Overall Study|Death|8
7150667|NCT03209973|11314062|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32
7150668|NCT03209973|11314062|FG000|Overall Study|Sponsor Decision|18
7150669|NCT03209973|11314062|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1
7150670|NCT03209973|11314062|FG000|Overall Study|Participant Refused to Return to Treatment|2
7150671|NCT03210220|11314079|FG000|Overall Study|Physician Decision|1
7150672|NCT03210220|11314080|FG001|Overall Study|Physician Decision|0
7150673|NCT03210259|11314088|FG000|12-Week Run-in Period|Adverse Event|1
7150674|NCT03210259|11314089|FG001|12-Week Run-in Period|Adverse Event|0
7077132|NCT02088073|11184505|FG003|Acute Phase|Withdrawal by Subject|0
7077133|NCT02088073|11184506|FG004|Acute Phase|Withdrawal by Subject|0
7077134|NCT02088073|11184502|FG000|Acute Phase|Hyperkalemia|2
7077135|NCT02088073|11184503|FG001|Acute Phase|Hyperkalemia|0
7077136|NCT02088073|11184504|FG002|Acute Phase|Hyperkalemia|0
7077137|NCT02088073|11184505|FG003|Acute Phase|Hyperkalemia|0
7077138|NCT02088073|11184506|FG004|Acute Phase|Hyperkalemia|0
7077139|NCT02088073|11184502|FG000|Maintanance Phase|Withdrawal by Subject|0
7077140|NCT02088073|11184503|FG001|Maintanance Phase|Withdrawal by Subject|2
7077141|NCT02088073|11184504|FG002|Maintanance Phase|Withdrawal by Subject|0
7077142|NCT02088073|11184505|FG003|Maintanance Phase|Withdrawal by Subject|0
7077143|NCT02088073|11184506|FG004|Maintanance Phase|Withdrawal by Subject|0
7077144|NCT02088073|11184502|FG000|Maintanance Phase|Adverse Event|0
7077145|NCT02088073|11184503|FG001|Maintanance Phase|Adverse Event|0
7077146|NCT02088073|11184504|FG002|Maintanance Phase|Adverse Event|3
7077147|NCT02088073|11184505|FG003|Maintanance Phase|Adverse Event|0
7077148|NCT02088073|11184506|FG004|Maintanance Phase|Adverse Event|1
7077149|NCT02088073|11184502|FG000|Maintanance Phase|Physician Decision|0
7077150|NCT02088073|11184503|FG001|Maintanance Phase|Physician Decision|0
7077151|NCT02088073|11184504|FG002|Maintanance Phase|Physician Decision|0
7077152|NCT02088073|11184505|FG003|Maintanance Phase|Physician Decision|0
7077153|NCT02088073|11184506|FG004|Maintanance Phase|Physician Decision|1
7077154|NCT02088073|11184502|FG000|Maintanance Phase|Sponsor's decision|0
7077155|NCT02088073|11184503|FG001|Maintanance Phase|Sponsor's decision|2
7077156|NCT02088073|11184504|FG002|Maintanance Phase|Sponsor's decision|0
7077157|NCT02088073|11184505|FG003|Maintanance Phase|Sponsor's decision|2
7077158|NCT02088073|11184506|FG004|Maintanance Phase|Sponsor's decision|1
7077159|NCT02088073|11184502|FG000|Maintanance Phase|Hypo- or hyperkalemia|0
7077160|NCT02088073|11184503|FG001|Maintanance Phase|Hypo- or hyperkalemia|3
7077161|NCT02088073|11184504|FG002|Maintanance Phase|Hypo- or hyperkalemia|0
7150675|NCT03210259|11314090|FG002|12-Week Run-in Period|Adverse Event|0
7150676|NCT03210259|11314088|FG000|12-Week Run-in Period|Death|1
7150677|NCT03210259|11314089|FG001|12-Week Run-in Period|Death|0
7150678|NCT03210259|11314090|FG002|12-Week Run-in Period|Death|0
7150679|NCT03210259|11314088|FG000|12-Week Run-in Period|Withdrawal by Subject|9
7150680|NCT03210259|11314089|FG001|12-Week Run-in Period|Withdrawal by Subject|0
7150681|NCT03210259|11314090|FG002|12-Week Run-in Period|Withdrawal by Subject|0
7150682|NCT03210259|11314088|FG000|12-Week Run-in Period|Lost to Follow-up|4
7150683|NCT03210259|11314089|FG001|12-Week Run-in Period|Lost to Follow-up|0
7150684|NCT03210259|11314090|FG002|12-Week Run-in Period|Lost to Follow-up|0
7150685|NCT03210259|11314088|FG000|12-Week Run-in Period|Lack of Efficacy|6
7150686|NCT03210259|11314089|FG001|12-Week Run-in Period|Lack of Efficacy|0
7150687|NCT03210259|11314090|FG002|12-Week Run-in Period|Lack of Efficacy|0
7150688|NCT03210259|11314088|FG000|48-Week Randomized Responder Period|Missed study visit|0
7150689|NCT03210259|11314089|FG001|48-Week Randomized Responder Period|Missed study visit|1
7150690|NCT03210259|11314090|FG002|48-Week Randomized Responder Period|Missed study visit|2
7150691|NCT03210259|11314088|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0
7150692|NCT03210259|11314089|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3
7150693|NCT03210259|11314090|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8
7150694|NCT03210259|11314088|FG000|48-Week Randomized Responder Period|Pregnancy|0
7150695|NCT03210259|11314089|FG001|48-Week Randomized Responder Period|Pregnancy|1
7150696|NCT03210259|11314090|FG002|48-Week Randomized Responder Period|Pregnancy|0
7150697|NCT03210259|11314088|FG000|48-Week Randomized Responder Period|Physician Decision|0
7150698|NCT03210259|11314089|FG001|48-Week Randomized Responder Period|Physician Decision|0
7150699|NCT03210259|11314090|FG002|48-Week Randomized Responder Period|Physician Decision|1
7150700|NCT03210259|11314088|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0
7150701|NCT03210259|11314089|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5
7150702|NCT03210259|11314090|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17
7150703|NCT03210259|11314088|FG000|48-Week Randomized Responder Period|Adverse Event|0
7150704|NCT03210259|11314089|FG001|48-Week Randomized Responder Period|Adverse Event|1
7150705|NCT03210259|11314090|FG002|48-Week Randomized Responder Period|Adverse Event|1
7150706|NCT03210519|11314117|FG000|Overall Study|Adverse Event|2
7150707|NCT03210519|11314118|FG001|Overall Study|Adverse Event|0
7150708|NCT03210961|11314143|FG000|Overall Study|Adverse Event|0
7150709|NCT03210961|11314144|FG001|Overall Study|Adverse Event|0
7150710|NCT03210961|11314145|FG002|Overall Study|Adverse Event|0
7150711|NCT03210961|11314146|FG003|Overall Study|Adverse Event|0
7150712|NCT03210961|11314147|FG004|Overall Study|Adverse Event|0
7150713|NCT03210961|11314148|FG005|Overall Study|Adverse Event|0
7150714|NCT03210961|11314149|FG006|Overall Study|Adverse Event|0
7150715|NCT03210961|11314150|FG007|Overall Study|Adverse Event|0
7150716|NCT03210961|11314151|FG008|Overall Study|Adverse Event|0
7150717|NCT03210961|11314152|FG009|Overall Study|Adverse Event|0
7150718|NCT03210961|11314153|FG010|Overall Study|Adverse Event|0
7150719|NCT03210961|11314154|FG011|Overall Study|Adverse Event|0
7150720|NCT03210961|11314155|FG012|Overall Study|Adverse Event|0
7150721|NCT03210961|11314156|FG013|Overall Study|Adverse Event|1
7150722|NCT03210961|11314157|FG014|Overall Study|Adverse Event|0
7150723|NCT03210961|11314143|FG000|Overall Study|Lost to Follow-up|0
7150724|NCT03210961|11314144|FG001|Overall Study|Lost to Follow-up|0
7150725|NCT03210961|11314145|FG002|Overall Study|Lost to Follow-up|0
7150726|NCT03210961|11314146|FG003|Overall Study|Lost to Follow-up|0
7150727|NCT03210961|11314147|FG004|Overall Study|Lost to Follow-up|0
7150728|NCT03210961|11314148|FG005|Overall Study|Lost to Follow-up|0
7150729|NCT03210961|11314149|FG006|Overall Study|Lost to Follow-up|0
7150730|NCT03210961|11314150|FG007|Overall Study|Lost to Follow-up|0
7150731|NCT03210961|11314151|FG008|Overall Study|Lost to Follow-up|0
7150732|NCT03210961|11314152|FG009|Overall Study|Lost to Follow-up|0
7150733|NCT03210961|11314153|FG010|Overall Study|Lost to Follow-up|0
7150734|NCT03210961|11314154|FG011|Overall Study|Lost to Follow-up|0
7150735|NCT03210961|11314155|FG012|Overall Study|Lost to Follow-up|0
7150736|NCT03210961|11314156|FG013|Overall Study|Lost to Follow-up|0
7150737|NCT03210961|11314157|FG014|Overall Study|Lost to Follow-up|1
7150738|NCT03210961|11314143|FG000|Overall Study|Withdrawal by Subject|0
7150739|NCT03210961|11314144|FG001|Overall Study|Withdrawal by Subject|0
7150740|NCT03210961|11314145|FG002|Overall Study|Withdrawal by Subject|0
7150741|NCT03210961|11314146|FG003|Overall Study|Withdrawal by Subject|0
7150742|NCT03210961|11314147|FG004|Overall Study|Withdrawal by Subject|0
7150743|NCT03210961|11314148|FG005|Overall Study|Withdrawal by Subject|0
7150744|NCT03210961|11314149|FG006|Overall Study|Withdrawal by Subject|0
7150745|NCT03210961|11314150|FG007|Overall Study|Withdrawal by Subject|0
7150746|NCT03210961|11314151|FG008|Overall Study|Withdrawal by Subject|0
7150747|NCT03210961|11314152|FG009|Overall Study|Withdrawal by Subject|0
7150748|NCT03210961|11314153|FG010|Overall Study|Withdrawal by Subject|0
7150749|NCT03210961|11314154|FG011|Overall Study|Withdrawal by Subject|0
7150750|NCT03210961|11314155|FG012|Overall Study|Withdrawal by Subject|0
7150751|NCT03210961|11314156|FG013|Overall Study|Withdrawal by Subject|0
7150752|NCT03210961|11314157|FG014|Overall Study|Withdrawal by Subject|1
7150753|NCT03210961|11314143|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
7150754|NCT03210961|11314144|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
7150755|NCT03210961|11314145|FG002|Overall Study|No Longer Meets Eligibility Criteria|0
7150756|NCT03210961|11314146|FG003|Overall Study|No Longer Meets Eligibility Criteria|0
7150757|NCT03210961|11314147|FG004|Overall Study|No Longer Meets Eligibility Criteria|0
7150758|NCT03210961|11314148|FG005|Overall Study|No Longer Meets Eligibility Criteria|0
7150759|NCT03210961|11314149|FG006|Overall Study|No Longer Meets Eligibility Criteria|0
7150760|NCT03210961|11314150|FG007|Overall Study|No Longer Meets Eligibility Criteria|0
7150761|NCT03210961|11314151|FG008|Overall Study|No Longer Meets Eligibility Criteria|0
7150762|NCT03210961|11314152|FG009|Overall Study|No Longer Meets Eligibility Criteria|0
7150763|NCT03210961|11314153|FG010|Overall Study|No Longer Meets Eligibility Criteria|0
7150764|NCT03210961|11314154|FG011|Overall Study|No Longer Meets Eligibility Criteria|0
7150765|NCT03210961|11314155|FG012|Overall Study|No Longer Meets Eligibility Criteria|0
7150766|NCT03210961|11314156|FG013|Overall Study|No Longer Meets Eligibility Criteria|1
7150767|NCT03210961|11314157|FG014|Overall Study|No Longer Meets Eligibility Criteria|0
7150768|NCT03210961|11314143|FG000|Overall Study|Other|0
7150769|NCT03210961|11314144|FG001|Overall Study|Other|0
7150770|NCT03210961|11314145|FG002|Overall Study|Other|0
7150771|NCT03210961|11314146|FG003|Overall Study|Other|1
7150772|NCT03210961|11314147|FG004|Overall Study|Other|0
7150773|NCT03210961|11314148|FG005|Overall Study|Other|0
7150774|NCT03210961|11314149|FG006|Overall Study|Other|1
6841442|NCT00282984|10847370|FG001|Overall Study|Withdrawal by Participant|34
6841443|NCT00282984|10847369|FG000|Overall Study|Participant stopped study medication|2
6841444|NCT00282984|10847370|FG001|Overall Study|Participant stopped study medication|2
6841445|NCT00282984|10847369|FG000|Overall Study|Participant only allowed phone follow-up|0
6841446|NCT00282984|10847370|FG001|Overall Study|Participant only allowed phone follow-up|1
6841447|NCT00282984|10847369|FG000|Overall Study|Participant used antipsychosis meds|0
6841448|NCT00282984|10847370|FG001|Overall Study|Participant used antipsychosis meds|1
6841449|NCT00282984|10847369|FG000|Overall Study|lack of motivation|1
6841450|NCT00282984|10847370|FG001|Overall Study|lack of motivation|0
6841451|NCT00282984|10847369|FG000|Overall Study|in prison|0
6841452|NCT00282984|10847370|FG001|Overall Study|in prison|1
6841453|NCT00282984|10847369|FG000|Overall Study|Protocol Violation|2
6841454|NCT00282984|10847370|FG001|Overall Study|Protocol Violation|0
6841455|NCT00283049|10847379|FG000|Overall Study|Adverse Event|6
6841456|NCT00283049|10847380|FG001|Overall Study|Adverse Event|1
6841457|NCT00283049|10847381|FG002|Overall Study|Adverse Event|4
6841458|NCT00283049|10847379|FG000|Overall Study|Protocol Violation|3
6841459|NCT00283049|10847380|FG001|Overall Study|Protocol Violation|0
6841460|NCT00283049|10847381|FG002|Overall Study|Protocol Violation|3
6841461|NCT00283049|10847379|FG000|Overall Study|Death|1
6841462|NCT00283049|10847380|FG001|Overall Study|Death|1
6841463|NCT00283049|10847381|FG002|Overall Study|Death|1
6841464|NCT00283049|10847379|FG000|Overall Study|Lack of Efficacy|0
6841465|NCT00283049|10847380|FG001|Overall Study|Lack of Efficacy|1
6841466|NCT00283049|10847381|FG002|Overall Study|Lack of Efficacy|1
6841467|NCT00283049|10847379|FG000|Overall Study|Lost to Follow-up|4
6841468|NCT00283049|10847380|FG001|Overall Study|Lost to Follow-up|2
6841469|NCT00283049|10847381|FG002|Overall Study|Lost to Follow-up|5
6841470|NCT00283049|10847379|FG000|Overall Study|Withdrawal by Subject|26
6841471|NCT00283049|10847380|FG001|Overall Study|Withdrawal by Subject|24
6841472|NCT00283049|10847381|FG002|Overall Study|Withdrawal by Subject|19
6841473|NCT00283049|10847379|FG000|Overall Study|Discontinuation of Study|18
6841474|NCT00283049|10847380|FG001|Overall Study|Discontinuation of Study|16
6841475|NCT00283049|10847381|FG002|Overall Study|Discontinuation of Study|20
6841476|NCT00283049|10847379|FG000|Overall Study|No longer requires study treatment|0
6841477|NCT00283049|10847380|FG001|Overall Study|No longer requires study treatment|0
7150775|NCT03210961|11314150|FG007|Overall Study|Other|0
7150776|NCT03210961|11314151|FG008|Overall Study|Other|0
7150777|NCT03210961|11314152|FG009|Overall Study|Other|0
7150778|NCT03210961|11314153|FG010|Overall Study|Other|1
7150779|NCT03210961|11314154|FG011|Overall Study|Other|0
7150780|NCT03210961|11314155|FG012|Overall Study|Other|2
7150781|NCT03210961|11314156|FG013|Overall Study|Other|2
7150782|NCT03210961|11314157|FG014|Overall Study|Other|0
7150783|NCT03211156|11314217|FG000|Overall Study|Withdrawal by Subject|0
7150784|NCT03211156|11314218|FG001|Overall Study|Withdrawal by Subject|2
7150785|NCT03211156|11314217|FG000|Overall Study|Lost to Follow-up|1
7150786|NCT03211156|11314218|FG001|Overall Study|Lost to Follow-up|1
7150787|NCT03211156|11314217|FG000|Overall Study|Adverse Event|1
7150788|NCT03211156|11314218|FG001|Overall Study|Adverse Event|0
7150789|NCT03212261|11314237|FG000|Overall Study|Became ineligible d/t tech|2
7150790|NCT03212261|11314237|FG000|Overall Study|Tech Trouble- No first study visit|1
7150791|NCT03212261|11314237|FG000|Overall Study|Lost to Follow-up|7
7150792|NCT03212261|11314237|FG000|Overall Study|Family Emergency|1
7150793|NCT03212261|11314237|FG000|Overall Study|Too busy/ No time|5
7150794|NCT03212326|11314242|FG000|Overall Study|Physician Decision|4
7150795|NCT03212365|11314248|FG000|Overall Study|Discharged prior to Xa level|12
7150796|NCT03212365|11314249|FG001|Overall Study|Discharged prior to Xa level|8
7150797|NCT03212365|11314248|FG000|Overall Study|Bled requiring enoxaparin cessation|4
7150798|NCT03212365|11314249|FG001|Overall Study|Bled requiring enoxaparin cessation|2
6841478|NCT00283049|10847381|FG002|Overall Study|No longer requires study treatment|1
7150799|NCT03212365|11314248|FG000|Overall Study|Refused study medication|3
6841479|NCT00283062|10847393|FG000|Overall Study|Did not receive any study medication|5
7150800|NCT03212365|11314249|FG001|Overall Study|Refused study medication|0
7150801|NCT03212365|11314248|FG000|Overall Study|Initiated heparin infusion on floor|1
7150802|NCT03212365|11314249|FG001|Overall Study|Initiated heparin infusion on floor|1
7150803|NCT03212365|11314248|FG000|Overall Study|Unexpected return to OR|1
7150804|NCT03212365|11314249|FG001|Overall Study|Unexpected return to OR|1
7150805|NCT03212365|11314248|FG000|Overall Study|Medication distribution error|1
7150806|NCT03212365|11314249|FG001|Overall Study|Medication distribution error|0
7150807|NCT03212365|11314248|FG000|Overall Study|Required epidural placement|1
7150808|NCT03212365|11314249|FG001|Overall Study|Required epidural placement|0
7150809|NCT03212365|11314248|FG000|Overall Study|Withdrawal by Subject|0
7150810|NCT03212365|11314249|FG001|Overall Study|Withdrawal by Subject|1
7150811|NCT03212365|11314248|FG000|Overall Study|developed acute renal failure|0
7150812|NCT03212365|11314249|FG001|Overall Study|developed acute renal failure|1
7150813|NCT03212521|11314255|FG000|Overall Study|Adverse Event|1
7150814|NCT03212521|11314255|FG000|Overall Study|Lost to Follow-up|4
7150815|NCT03212521|11314255|FG000|Overall Study|Withdrawal by Subject|1
7150816|NCT03212521|11314255|FG000|Overall Study|Other|1
7150817|NCT03212690|11314277|FG000|Overall Study|Protocol Violation|1
7150818|NCT03213210|11314281|FG000|Overall Study|Lost to Follow-up|2
7150819|NCT03213210|11314281|FG000|Overall Study|Study termination|3
7150820|NCT03213366|11314287|FG000|Overall Study|Lost to Follow-up|9
7150821|NCT03213366|11314288|FG001|Overall Study|Lost to Follow-up|4
7150822|NCT03213509|11314313|FG000|Overall Study|Did not consent for verbal autopsy|4
7150823|NCT03213509|11314314|FG001|Overall Study|Did not consent for verbal autopsy|5
7150824|NCT03213626|11314321|FG000|Overall Study|Adverse Event|1
7150825|NCT03213626|11314321|FG000|Overall Study|Progressive Disease|6
7150826|NCT03213938|11314327|FG000|Overall Study|Lost to Follow-up|4
7150827|NCT03213938|11314328|FG001|Overall Study|Lost to Follow-up|3
7150828|NCT03213938|11314327|FG000|Overall Study|Lack of Efficacy|1
7150829|NCT03213938|11314328|FG001|Overall Study|Lack of Efficacy|0
7150830|NCT03213938|11314327|FG000|Overall Study|Decline to participate|5
7150831|NCT03213938|11314328|FG001|Overall Study|Decline to participate|4
7150832|NCT03213938|11314327|FG000|Overall Study|Without reason|4
7150833|NCT03213938|11314328|FG001|Overall Study|Without reason|5
7150834|NCT03214081|11314334|FG000|Overall Study|Case Report Forms Uncollected|9
7150835|NCT03214081|11314334|FG000|Overall Study|Protocol Deviation|54
7150836|NCT03214094|11314338|FG000|Overall Study|Case Report Forms Uncollected|14
7150837|NCT03214094|11314338|FG000|Overall Study|Protocol Deviation|46
7150838|NCT03214198|11314342|FG000|Overall Study|Case Report Forms Uncollected|18
7150839|NCT03214198|11314342|FG000|Overall Study|Protocol Deviation|18
7150840|NCT03214224|11314346|FG000|Overall Study|Protocol Violation|1
7150841|NCT03214224|11314346|FG000|Overall Study|Withdrawal by Subject|2
7150842|NCT03214224|11314346|FG000|Overall Study|Practice controls or therapists|6
7150843|NCT03214367|11314356|FG000|Lead-in Period|Withdrawal by Subject|50
7150844|NCT03214367|11314357|FG001|Lead-in Period|Withdrawal by Subject|0
7150845|NCT03214367|11314358|FG002|Lead-in Period|Withdrawal by Subject|0
7150846|NCT03214367|11314359|FG003|Lead-in Period|Withdrawal by Subject|0
7150847|NCT03214367|11314360|FG004|Lead-in Period|Withdrawal by Subject|2
7150848|NCT03214367|11314361|FG005|Lead-in Period|Withdrawal by Subject|0
7150849|NCT03214367|11314362|FG006|Lead-in Period|Withdrawal by Subject|0
7150850|NCT03214367|11314363|FG007|Lead-in Period|Withdrawal by Subject|0
7150851|NCT03214367|11314356|FG000|Lead-in Period|Adverse Event|3
7150852|NCT03214367|11314357|FG001|Lead-in Period|Adverse Event|0
7150853|NCT03214367|11314358|FG002|Lead-in Period|Adverse Event|0
7077162|NCT02088073|11184505|FG003|Maintanance Phase|Hypo- or hyperkalemia|3
7077163|NCT02088073|11184506|FG004|Maintanance Phase|Hypo- or hyperkalemia|1
7077164|NCT02088073|11184502|FG000|Maintanance Phase|Miscellaneous|0
7077165|NCT02088073|11184503|FG001|Maintanance Phase|Miscellaneous|2
7077166|NCT02088073|11184504|FG002|Maintanance Phase|Miscellaneous|1
7077167|NCT02088073|11184505|FG003|Maintanance Phase|Miscellaneous|2
7077168|NCT02088073|11184506|FG004|Maintanance Phase|Miscellaneous|1
7077169|NCT02088073|11184502|FG000|Maintanance Phase|Met ECG withdrawal criteria|0
7077170|NCT02088073|11184503|FG001|Maintanance Phase|Met ECG withdrawal criteria|0
7077171|NCT02088073|11184504|FG002|Maintanance Phase|Met ECG withdrawal criteria|1
7077172|NCT02088073|11184505|FG003|Maintanance Phase|Met ECG withdrawal criteria|0
7077173|NCT02088073|11184506|FG004|Maintanance Phase|Met ECG withdrawal criteria|2
7077174|NCT02088073|11184502|FG000|Maintanance Phase|Subject compliance|0
7077175|NCT02088073|11184503|FG001|Maintanance Phase|Subject compliance|1
7077176|NCT02088073|11184504|FG002|Maintanance Phase|Subject compliance|0
7077177|NCT02088073|11184505|FG003|Maintanance Phase|Subject compliance|0
7077178|NCT02088073|11184506|FG004|Maintanance Phase|Subject compliance|0
7077179|NCT02088177|11184519|FG000|Overall Study|Lost to Follow-up|3
7077180|NCT02088541|11184546|FG000|Overall Study|Adverse Event|3
7077181|NCT02088541|11184547|FG001|Overall Study|Adverse Event|0
7077182|NCT02088541|11184548|FG002|Overall Study|Adverse Event|3
7077183|NCT02088541|11184549|FG003|Overall Study|Adverse Event|3
7077184|NCT02088541|11184550|FG004|Overall Study|Adverse Event|0
7077185|NCT02088541|11184546|FG000|Overall Study|Death|51
7077186|NCT02088541|11184547|FG001|Overall Study|Death|21
7077187|NCT02088541|11184548|FG002|Overall Study|Death|85
7077188|NCT02088541|11184549|FG003|Overall Study|Death|28
7077189|NCT02088541|11184550|FG004|Overall Study|Death|38
7077190|NCT02088541|11184546|FG000|Overall Study|Lost to Follow-up|2
7077191|NCT02088541|11184547|FG001|Overall Study|Lost to Follow-up|0
7077192|NCT02088541|11184548|FG002|Overall Study|Lost to Follow-up|1
7077193|NCT02088541|11184549|FG003|Overall Study|Lost to Follow-up|0
7150854|NCT03214367|11314359|FG003|Lead-in Period|Adverse Event|0
7150855|NCT03214367|11314360|FG004|Lead-in Period|Adverse Event|0
7150856|NCT03214367|11314361|FG005|Lead-in Period|Adverse Event|0
7150857|NCT03214367|11314362|FG006|Lead-in Period|Adverse Event|0
7150858|NCT03214367|11314363|FG007|Lead-in Period|Adverse Event|0
7150859|NCT03214367|11314356|FG000|Lead-in Period|Lost to Follow-up|12
7150860|NCT03214367|11314357|FG001|Lead-in Period|Lost to Follow-up|0
7150861|NCT03214367|11314358|FG002|Lead-in Period|Lost to Follow-up|0
7150862|NCT03214367|11314359|FG003|Lead-in Period|Lost to Follow-up|0
7150863|NCT03214367|11314360|FG004|Lead-in Period|Lost to Follow-up|0
7150864|NCT03214367|11314361|FG005|Lead-in Period|Lost to Follow-up|0
7150865|NCT03214367|11314362|FG006|Lead-in Period|Lost to Follow-up|0
7150866|NCT03214367|11314363|FG007|Lead-in Period|Lost to Follow-up|0
7150867|NCT03214367|11314356|FG000|Lead-in Period|Sponsor Decision|11
7150868|NCT03214367|11314357|FG001|Lead-in Period|Sponsor Decision|0
7150869|NCT03214367|11314358|FG002|Lead-in Period|Sponsor Decision|0
7150870|NCT03214367|11314359|FG003|Lead-in Period|Sponsor Decision|0
7150871|NCT03214367|11314360|FG004|Lead-in Period|Sponsor Decision|0
7150872|NCT03214367|11314361|FG005|Lead-in Period|Sponsor Decision|0
7150873|NCT03214367|11314362|FG006|Lead-in Period|Sponsor Decision|0
7150874|NCT03214367|11314363|FG007|Lead-in Period|Sponsor Decision|0
7150875|NCT03214367|11314356|FG000|Lead-in Period|Physician Decision|12
7150876|NCT03214367|11314357|FG001|Lead-in Period|Physician Decision|0
7150877|NCT03214367|11314358|FG002|Lead-in Period|Physician Decision|0
7150878|NCT03214367|11314359|FG003|Lead-in Period|Physician Decision|0
7150879|NCT03214367|11314360|FG004|Lead-in Period|Physician Decision|0
7150880|NCT03214367|11314361|FG005|Lead-in Period|Physician Decision|0
7150881|NCT03214367|11314362|FG006|Lead-in Period|Physician Decision|0
7150882|NCT03214367|11314363|FG007|Lead-in Period|Physician Decision|0
7150883|NCT03214367|11314356|FG000|Lead-in Period|Protocol Violation|5
7150884|NCT03214367|11314357|FG001|Lead-in Period|Protocol Violation|0
7150885|NCT03214367|11314358|FG002|Lead-in Period|Protocol Violation|0
7150886|NCT03214367|11314359|FG003|Lead-in Period|Protocol Violation|0
6966449|NCT04085367|11014437|FG000|Overall Study|Lost to Follow-up|3
7150887|NCT03214367|11314360|FG004|Lead-in Period|Protocol Violation|0
7150888|NCT03214367|11314361|FG005|Lead-in Period|Protocol Violation|0
7150889|NCT03214367|11314362|FG006|Lead-in Period|Protocol Violation|0
7150890|NCT03214367|11314363|FG007|Lead-in Period|Protocol Violation|0
7150891|NCT03214367|11314356|FG000|Lead-in Period|Treatment Interruption|1
7150892|NCT03214367|11314357|FG001|Lead-in Period|Treatment Interruption|0
7150893|NCT03214367|11314358|FG002|Lead-in Period|Treatment Interruption|0
7150894|NCT03214367|11314359|FG003|Lead-in Period|Treatment Interruption|0
7150895|NCT03214367|11314360|FG004|Lead-in Period|Treatment Interruption|0
7150896|NCT03214367|11314361|FG005|Lead-in Period|Treatment Interruption|0
7150897|NCT03214367|11314362|FG006|Lead-in Period|Treatment Interruption|0
7150898|NCT03214367|11314363|FG007|Lead-in Period|Treatment Interruption|0
7150899|NCT03214367|11314356|FG000|Treatment Period|Adverse Event|0
7150900|NCT03214367|11314357|FG001|Treatment Period|Adverse Event|1
7150901|NCT03214367|11314358|FG002|Treatment Period|Adverse Event|4
7150902|NCT03214367|11314359|FG003|Treatment Period|Adverse Event|2
7150903|NCT03214367|11314360|FG004|Treatment Period|Adverse Event|0
7150904|NCT03214367|11314361|FG005|Treatment Period|Adverse Event|0
7150905|NCT03214367|11314362|FG006|Treatment Period|Adverse Event|0
7150906|NCT03214367|11314363|FG007|Treatment Period|Adverse Event|0
7150907|NCT03214367|11314356|FG000|Treatment Period|Death|0
7150908|NCT03214367|11314357|FG001|Treatment Period|Death|1
7150909|NCT03214367|11314358|FG002|Treatment Period|Death|1
7150910|NCT03214367|11314359|FG003|Treatment Period|Death|1
7150911|NCT03214367|11314360|FG004|Treatment Period|Death|0
7150912|NCT03214367|11314361|FG005|Treatment Period|Death|0
7150913|NCT03214367|11314362|FG006|Treatment Period|Death|0
7150914|NCT03214367|11314363|FG007|Treatment Period|Death|0
7150915|NCT03214367|11314356|FG000|Treatment Period|Lost to Follow-up|0
7150916|NCT03214367|11314357|FG001|Treatment Period|Lost to Follow-up|5
7150917|NCT03214367|11314358|FG002|Treatment Period|Lost to Follow-up|3
7150918|NCT03214367|11314359|FG003|Treatment Period|Lost to Follow-up|2
7150919|NCT03214367|11314360|FG004|Treatment Period|Lost to Follow-up|0
7150920|NCT03214367|11314361|FG005|Treatment Period|Lost to Follow-up|2
6841480|NCT00283062|10847394|FG001|Overall Study|Did not receive any study medication|4
6841481|NCT00283062|10847395|FG002|Overall Study|Did not receive any study medication|36
6841482|NCT00283062|10847396|FG003|Overall Study|Did not receive any study medication|45
6841483|NCT00283062|10847393|FG000|Overall Study|Adverse Event|2
6841484|NCT00283062|10847394|FG001|Overall Study|Adverse Event|0
6841485|NCT00283062|10847395|FG002|Overall Study|Adverse Event|1
6841486|NCT00283062|10847396|FG003|Overall Study|Adverse Event|0
6841487|NCT00283062|10847393|FG000|Overall Study|Lost to Follow-up|1
6841488|NCT00283062|10847394|FG001|Overall Study|Lost to Follow-up|0
7150921|NCT03214367|11314362|FG006|Treatment Period|Lost to Follow-up|1
7150922|NCT03214367|11314363|FG007|Treatment Period|Lost to Follow-up|0
7150923|NCT03214367|11314356|FG000|Treatment Period|Sponsor Decision|0
7150924|NCT03214367|11314357|FG001|Treatment Period|Sponsor Decision|3
7150925|NCT03214367|11314358|FG002|Treatment Period|Sponsor Decision|0
7150926|NCT03214367|11314359|FG003|Treatment Period|Sponsor Decision|0
7150927|NCT03214367|11314360|FG004|Treatment Period|Sponsor Decision|0
7150928|NCT03214367|11314361|FG005|Treatment Period|Sponsor Decision|0
7150929|NCT03214367|11314362|FG006|Treatment Period|Sponsor Decision|0
7150930|NCT03214367|11314363|FG007|Treatment Period|Sponsor Decision|0
7150931|NCT03214367|11314356|FG000|Treatment Period|Physician Decision|0
7150932|NCT03214367|11314357|FG001|Treatment Period|Physician Decision|1
7150933|NCT03214367|11314358|FG002|Treatment Period|Physician Decision|2
7150934|NCT03214367|11314359|FG003|Treatment Period|Physician Decision|0
7150935|NCT03214367|11314360|FG004|Treatment Period|Physician Decision|0
7150936|NCT03214367|11314361|FG005|Treatment Period|Physician Decision|0
7150937|NCT03214367|11314362|FG006|Treatment Period|Physician Decision|0
7150938|NCT03214367|11314363|FG007|Treatment Period|Physician Decision|0
7150939|NCT03214367|11314356|FG000|Treatment Period|Protocol Violation|0
7150940|NCT03214367|11314357|FG001|Treatment Period|Protocol Violation|3
7150941|NCT03214367|11314358|FG002|Treatment Period|Protocol Violation|0
7150942|NCT03214367|11314359|FG003|Treatment Period|Protocol Violation|0
7150943|NCT03214367|11314360|FG004|Treatment Period|Protocol Violation|0
7150944|NCT03214367|11314361|FG005|Treatment Period|Protocol Violation|0
7150945|NCT03214367|11314362|FG006|Treatment Period|Protocol Violation|0
7150946|NCT03214367|11314363|FG007|Treatment Period|Protocol Violation|0
7150947|NCT03214367|11314356|FG000|Treatment Period|Withdrawal by Subject|0
7150948|NCT03214367|11314357|FG001|Treatment Period|Withdrawal by Subject|20
7150949|NCT03214367|11314358|FG002|Treatment Period|Withdrawal by Subject|23
7150950|NCT03214367|11314359|FG003|Treatment Period|Withdrawal by Subject|14
7150951|NCT03214367|11314360|FG004|Treatment Period|Withdrawal by Subject|0
7150952|NCT03214367|11314361|FG005|Treatment Period|Withdrawal by Subject|1
7150953|NCT03214367|11314362|FG006|Treatment Period|Withdrawal by Subject|1
7150954|NCT03214367|11314363|FG007|Treatment Period|Withdrawal by Subject|1
7150955|NCT03214380|11314381|FG000|Lead-in|Adverse Event|3
7150956|NCT03214380|11314382|FG001|Lead-in|Adverse Event|0
7150957|NCT03214380|11314383|FG002|Lead-in|Adverse Event|0
7150958|NCT03214380|11314384|FG003|Lead-in|Adverse Event|1
7150959|NCT03214380|11314385|FG004|Lead-in|Adverse Event|0
7150960|NCT03214380|11314386|FG005|Lead-in|Adverse Event|0
7150961|NCT03214380|11314381|FG000|Lead-in|Lost to Follow-up|4
7150962|NCT03214380|11314382|FG001|Lead-in|Lost to Follow-up|0
7150963|NCT03214380|11314383|FG002|Lead-in|Lost to Follow-up|0
7150964|NCT03214380|11314384|FG003|Lead-in|Lost to Follow-up|1
7150965|NCT03214380|11314385|FG004|Lead-in|Lost to Follow-up|0
7150966|NCT03214380|11314386|FG005|Lead-in|Lost to Follow-up|0
7150967|NCT03214380|11314381|FG000|Lead-in|Eligibility Criteria|3
7150968|NCT03214380|11314382|FG001|Lead-in|Eligibility Criteria|0
7150969|NCT03214380|11314383|FG002|Lead-in|Eligibility Criteria|0
7150970|NCT03214380|11314384|FG003|Lead-in|Eligibility Criteria|0
7150971|NCT03214380|11314385|FG004|Lead-in|Eligibility Criteria|0
7150972|NCT03214380|11314386|FG005|Lead-in|Eligibility Criteria|0
7150973|NCT03214380|11314381|FG000|Lead-in|Physician Decision|6
7150974|NCT03214380|11314382|FG001|Lead-in|Physician Decision|0
7150975|NCT03214380|11314383|FG002|Lead-in|Physician Decision|0
7150976|NCT03214380|11314384|FG003|Lead-in|Physician Decision|0
7150977|NCT03214380|11314385|FG004|Lead-in|Physician Decision|0
7150978|NCT03214380|11314386|FG005|Lead-in|Physician Decision|0
7150979|NCT03214380|11314381|FG000|Lead-in|Protocol Deviation|7
7150980|NCT03214380|11314382|FG001|Lead-in|Protocol Deviation|0
7150981|NCT03214380|11314383|FG002|Lead-in|Protocol Deviation|0
7150982|NCT03214380|11314384|FG003|Lead-in|Protocol Deviation|3
7150983|NCT03214380|11314385|FG004|Lead-in|Protocol Deviation|0
7150984|NCT03214380|11314386|FG005|Lead-in|Protocol Deviation|0
7150985|NCT03214380|11314381|FG000|Lead-in|Withdrawal by Subject|41
7150986|NCT03214380|11314382|FG001|Lead-in|Withdrawal by Subject|0
7150987|NCT03214380|11314383|FG002|Lead-in|Withdrawal by Subject|0
7150988|NCT03214380|11314384|FG003|Lead-in|Withdrawal by Subject|14
7150989|NCT03214380|11314385|FG004|Lead-in|Withdrawal by Subject|0
7150990|NCT03214380|11314386|FG005|Lead-in|Withdrawal by Subject|0
7150991|NCT03214380|11314381|FG000|Lead-in|Family Emergency|1
7150992|NCT03214380|11314382|FG001|Lead-in|Family Emergency|0
7150993|NCT03214380|11314383|FG002|Lead-in|Family Emergency|0
7150994|NCT03214380|11314384|FG003|Lead-in|Family Emergency|0
7150995|NCT03214380|11314385|FG004|Lead-in|Family Emergency|0
7150996|NCT03214380|11314386|FG005|Lead-in|Family Emergency|0
7150997|NCT03214380|11314381|FG000|Lead-in|Natural Disaster|9
7150998|NCT03214380|11314382|FG001|Lead-in|Natural Disaster|0
7150999|NCT03214380|11314383|FG002|Lead-in|Natural Disaster|0
7151000|NCT03214380|11314384|FG003|Lead-in|Natural Disaster|0
7151001|NCT03214380|11314385|FG004|Lead-in|Natural Disaster|0
7151002|NCT03214380|11314386|FG005|Lead-in|Natural Disaster|0
7151003|NCT03214380|11314381|FG000|Lead-in|Non Compliance|1
7151004|NCT03214380|11314382|FG001|Lead-in|Non Compliance|0
7151005|NCT03214380|11314383|FG002|Lead-in|Non Compliance|0
7151006|NCT03214380|11314384|FG003|Lead-in|Non Compliance|0
7151007|NCT03214380|11314385|FG004|Lead-in|Non Compliance|0
7151008|NCT03214380|11314386|FG005|Lead-in|Non Compliance|0
7151009|NCT03214380|11314381|FG000|Lead-in|Participant Schedule|2
7151010|NCT03214380|11314382|FG001|Lead-in|Participant Schedule|0
7151011|NCT03214380|11314383|FG002|Lead-in|Participant Schedule|0
7151012|NCT03214380|11314384|FG003|Lead-in|Participant Schedule|0
7151013|NCT03214380|11314385|FG004|Lead-in|Participant Schedule|0
7151014|NCT03214380|11314386|FG005|Lead-in|Participant Schedule|0
7151015|NCT03214380|11314381|FG000|Treatment Period|Adverse Event|0
7151016|NCT03214380|11314382|FG001|Treatment Period|Adverse Event|1
7151017|NCT03214380|11314383|FG002|Treatment Period|Adverse Event|1
7151018|NCT03214380|11314384|FG003|Treatment Period|Adverse Event|0
7151019|NCT03214380|11314385|FG004|Treatment Period|Adverse Event|1
7151020|NCT03214380|11314386|FG005|Treatment Period|Adverse Event|0
7151021|NCT03214380|11314381|FG000|Treatment Period|Non-Compliance with Study Drug|0
7151022|NCT03214380|11314382|FG001|Treatment Period|Non-Compliance with Study Drug|0
7151023|NCT03214380|11314383|FG002|Treatment Period|Non-Compliance with Study Drug|0
7151024|NCT03214380|11314384|FG003|Treatment Period|Non-Compliance with Study Drug|0
7151025|NCT03214380|11314385|FG004|Treatment Period|Non-Compliance with Study Drug|1
7151026|NCT03214380|11314386|FG005|Treatment Period|Non-Compliance with Study Drug|0
7151027|NCT03214380|11314381|FG000|Treatment Period|Withdrawal by Subject|0
7151028|NCT03214380|11314382|FG001|Treatment Period|Withdrawal by Subject|10
7151029|NCT03214380|11314383|FG002|Treatment Period|Withdrawal by Subject|8
7151030|NCT03214380|11314384|FG003|Treatment Period|Withdrawal by Subject|0
7151031|NCT03214380|11314385|FG004|Treatment Period|Withdrawal by Subject|7
7151032|NCT03214380|11314386|FG005|Treatment Period|Withdrawal by Subject|11
7151033|NCT03214380|11314381|FG000|Treatment Period|Death|0
7151034|NCT03214380|11314382|FG001|Treatment Period|Death|1
7151035|NCT03214380|11314383|FG002|Treatment Period|Death|2
7151036|NCT03214380|11314384|FG003|Treatment Period|Death|0
7151037|NCT03214380|11314385|FG004|Treatment Period|Death|0
7151038|NCT03214380|11314386|FG005|Treatment Period|Death|0
7151039|NCT03214380|11314381|FG000|Treatment Period|Lost to Follow-up|0
7151040|NCT03214380|11314382|FG001|Treatment Period|Lost to Follow-up|6
7151041|NCT03214380|11314383|FG002|Treatment Period|Lost to Follow-up|3
7151042|NCT03214380|11314384|FG003|Treatment Period|Lost to Follow-up|0
7151043|NCT03214380|11314385|FG004|Treatment Period|Lost to Follow-up|0
7151044|NCT03214380|11314386|FG005|Treatment Period|Lost to Follow-up|0
7151045|NCT03214380|11314381|FG000|Treatment Period|Participant schedule|0
7151046|NCT03214380|11314382|FG001|Treatment Period|Participant schedule|0
7151047|NCT03214380|11314383|FG002|Treatment Period|Participant schedule|1
7151048|NCT03214380|11314384|FG003|Treatment Period|Participant schedule|0
7151049|NCT03214380|11314385|FG004|Treatment Period|Participant schedule|0
7151050|NCT03214380|11314386|FG005|Treatment Period|Participant schedule|0
7151051|NCT03214380|11314381|FG000|Treatment Period|Treatment Interruption|0
7151052|NCT03214380|11314382|FG001|Treatment Period|Treatment Interruption|0
7151053|NCT03214380|11314383|FG002|Treatment Period|Treatment Interruption|1
7151054|NCT03214380|11314384|FG003|Treatment Period|Treatment Interruption|0
7151055|NCT03214380|11314385|FG004|Treatment Period|Treatment Interruption|0
7151056|NCT03214380|11314386|FG005|Treatment Period|Treatment Interruption|0
7151057|NCT03214406|11314400|FG000|Overall Study|did not meet enrollment criteria|9
7151058|NCT03214406|11314401|FG001|Overall Study|did not meet enrollment criteria|13
7151059|NCT03214406|11314400|FG000|Overall Study|Withdrawal by Subject|1
7151060|NCT03214406|11314401|FG001|Overall Study|Withdrawal by Subject|0
7151061|NCT03214406|11314400|FG000|Overall Study|Lost to Follow-up|0
6841489|NCT00283062|10847395|FG002|Overall Study|Lost to Follow-up|1
6841490|NCT00283062|10847396|FG003|Overall Study|Lost to Follow-up|0
6841491|NCT00283062|10847393|FG000|Overall Study|Progressive disease|0
6841492|NCT00283062|10847394|FG001|Overall Study|Progressive disease|0
6841493|NCT00283062|10847395|FG002|Overall Study|Progressive disease|1
6841494|NCT00283062|10847396|FG003|Overall Study|Progressive disease|0
7077194|NCT02088541|11184550|FG004|Overall Study|Lost to Follow-up|0
7077195|NCT02088541|11184546|FG000|Overall Study|Physician Decision|2
7077196|NCT02088541|11184547|FG001|Overall Study|Physician Decision|1
7077197|NCT02088541|11184548|FG002|Overall Study|Physician Decision|2
7077198|NCT02088541|11184549|FG003|Overall Study|Physician Decision|0
7077199|NCT02088541|11184550|FG004|Overall Study|Physician Decision|2
7077200|NCT02088541|11184546|FG000|Overall Study|Disease progression|7
7077201|NCT02088541|11184547|FG001|Overall Study|Disease progression|1
7077202|NCT02088541|11184548|FG002|Overall Study|Disease progression|2
7077203|NCT02088541|11184549|FG003|Overall Study|Disease progression|3
7077204|NCT02088541|11184550|FG004|Overall Study|Disease progression|1
7077205|NCT02088541|11184546|FG000|Overall Study|Study terminated by sponsor|1
7077206|NCT02088541|11184547|FG001|Overall Study|Study terminated by sponsor|1
7077207|NCT02088541|11184548|FG002|Overall Study|Study terminated by sponsor|12
7151062|NCT03214406|11314401|FG001|Overall Study|Lost to Follow-up|2
7151063|NCT03214588|11314410|FG000|Overall Study|Adverse Event|1
7151064|NCT03214588|11314411|FG001|Overall Study|Adverse Event|0
7151065|NCT03214588|11314412|FG002|Overall Study|Adverse Event|2
7151066|NCT03214588|11314410|FG000|Overall Study|Reason Not Specified|0
7151067|NCT03214588|11314411|FG001|Overall Study|Reason Not Specified|1
7151068|NCT03214588|11314412|FG002|Overall Study|Reason Not Specified|0
7151069|NCT03214640|11314424|FG000|Overall Study|Protocol Violation|1
7151070|NCT03214640|11314425|FG001|Overall Study|Protocol Violation|2
7151071|NCT03214640|11314426|FG002|Overall Study|Protocol Violation|1
7151072|NCT03214640|11314427|FG003|Overall Study|Protocol Violation|4
7151073|NCT03214952|11314437|FG000|Overall Study|Protocol Deviation|45
7151074|NCT03214952|11314437|FG000|Overall Study|Case Report Forms Uncollected|13
7151075|NCT03215667|11314441|FG000|Overall Study|Physician Decision|4
7151076|NCT03215758|11314447|FG000|Overall Study|Technical Problems|1
7151077|NCT03215758|11314448|FG001|Overall Study|Technical Problems|0
7151078|NCT03215758|11314447|FG000|Overall Study|Protocol deviation|0
7077208|NCT02088541|11184549|FG003|Overall Study|Study terminated by sponsor|2
7077209|NCT02088541|11184550|FG004|Overall Study|Study terminated by sponsor|6
7077210|NCT02088541|11184546|FG000|Overall Study|Withdrawal by Subject|3
7077211|NCT02088541|11184547|FG001|Overall Study|Withdrawal by Subject|2
7077212|NCT02088541|11184548|FG002|Overall Study|Withdrawal by Subject|9
7077213|NCT02088541|11184549|FG003|Overall Study|Withdrawal by Subject|7
7077214|NCT02088541|11184550|FG004|Overall Study|Withdrawal by Subject|10
7077215|NCT02088541|11184546|FG000|Overall Study|Other|2
7077216|NCT02088541|11184547|FG001|Overall Study|Other|1
7077217|NCT02088541|11184548|FG002|Overall Study|Other|3
7077218|NCT02088541|11184549|FG003|Overall Study|Other|1
7151079|NCT03215758|11314448|FG001|Overall Study|Protocol deviation|1
7151080|NCT03215758|11314447|FG000|Overall Study|Physician Decision|0
7151081|NCT03215758|11314448|FG001|Overall Study|Physician Decision|1
7151082|NCT03215758|11314447|FG000|Overall Study|Death|0
7151083|NCT03215758|11314448|FG001|Overall Study|Death|1
7151084|NCT03215758|11314447|FG000|Overall Study|Adverse Event|1
7151085|NCT03215758|11314448|FG001|Overall Study|Adverse Event|2
7151086|NCT03215758|11314447|FG000|Overall Study|Subject/Guardian Decision|3
7151087|NCT03215758|11314448|FG001|Overall Study|Subject/Guardian Decision|3
7151088|NCT03215771|11314454|FG000|Overall Study|Withdrawal by Subject|2
7151089|NCT03215771|11314454|FG000|Overall Study|Physician Decision|1
7151090|NCT03216226|11314478|FG000|Overall Study|Adverse Event|3
7151091|NCT03216226|11314479|FG001|Overall Study|Adverse Event|0
7151092|NCT03216226|11314478|FG000|Overall Study|Protocol Violation|1
7151093|NCT03216226|11314479|FG001|Overall Study|Protocol Violation|3
7151094|NCT03216226|11314478|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1
7151095|NCT03216226|11314479|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0
7151096|NCT03216226|11314478|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0
7151097|NCT03216226|11314479|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1
7151098|NCT03216226|11314478|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0
7151099|NCT03216226|11314479|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1
7151100|NCT03216265|11314488|FG000|Overall Study|Adverse Event|2
7151101|NCT03216265|11314489|FG001|Overall Study|Adverse Event|0
7151102|NCT03216265|11314490|FG002|Overall Study|Adverse Event|2
7151103|NCT03216265|11314488|FG000|Overall Study|Lost to Follow-up|0
7151104|NCT03216265|11314489|FG001|Overall Study|Lost to Follow-up|1
7151105|NCT03216265|11314490|FG002|Overall Study|Lost to Follow-up|0
7151106|NCT03216265|11314488|FG000|Overall Study|Withdrawal by Subject|0
7151107|NCT03216265|11314489|FG001|Overall Study|Withdrawal by Subject|0
7151108|NCT03216265|11314490|FG002|Overall Study|Withdrawal by Subject|1
7151109|NCT03216746|11314529|FG000|Overall Study|Lost to Follow-up|6
7151110|NCT03216746|11314530|FG001|Overall Study|Lost to Follow-up|8
7151111|NCT03216746|11314531|FG002|Overall Study|Lost to Follow-up|5
7151112|NCT03216746|11314532|FG003|Overall Study|Lost to Follow-up|6
7151113|NCT03216850|11314542|FG000|Overall Study|Pre-analytical error|6
7151114|NCT03216954|11314579|FG000|Overall Study|Adverse Event|0
7151115|NCT03216954|11314580|FG001|Overall Study|Adverse Event|0
7151116|NCT03216954|11314581|FG002|Overall Study|Adverse Event|1
7151117|NCT03216954|11314582|FG003|Overall Study|Adverse Event|0
7151118|NCT03216954|11314583|FG004|Overall Study|Adverse Event|1
7151119|NCT03216954|11314579|FG000|Overall Study|Withdrawal by Subject|2
7151120|NCT03216954|11314580|FG001|Overall Study|Withdrawal by Subject|0
7151121|NCT03216954|11314581|FG002|Overall Study|Withdrawal by Subject|0
7151122|NCT03216954|11314582|FG003|Overall Study|Withdrawal by Subject|0
7151123|NCT03216954|11314583|FG004|Overall Study|Withdrawal by Subject|0
7151124|NCT03216954|11314579|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0
7151125|NCT03216954|11314580|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1
7151126|NCT03216954|11314581|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0
7151127|NCT03216954|11314582|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0
7151128|NCT03216954|11314583|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0
7184108|NCT01714817|11384098|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0
7184109|NCT01714817|11384097|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33
7184110|NCT01714817|11384098|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38
7184111|NCT01714817|11384097|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0
7184112|NCT01714817|11384098|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1
7184113|NCT01714817|11384097|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0
7184114|NCT01714817|11384098|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1
7184115|NCT01714817|11384097|FG000|Long-Term Extension (LTE) Period|Study was terminated|0
7184116|NCT01714817|11384098|FG001|Long-Term Extension (LTE) Period|Study was terminated|1
7187264|NCT00602667|11387789|FG001|Overall Study|Still on Therapy|2
7187265|NCT00602667|11387790|FG002|Overall Study|Still on Therapy|2
7187266|NCT00602667|11387788|FG000|Overall Study|Death|0
7077219|NCT02088541|11184550|FG004|Overall Study|Other|1
7187267|NCT00602667|11387789|FG001|Overall Study|Death|1
7187268|NCT00602667|11387790|FG002|Overall Study|Death|1
7077220|NCT02088697|11184562|FG000|Period I|Physician Decision|1
7151129|NCT03217968|11314591|FG000|Overall Study|Withdrawal by Subject|4
7151130|NCT03217968|11314591|FG000|Overall Study|Lost to Follow-up|1
7151131|NCT03217968|11314591|FG000|Overall Study|Protocol Violation|6
7151132|NCT03218397|11314597|FG000|Overall Study|Prior positive blood culture|8
7151133|NCT03218397|11314598|FG001|Overall Study|Prior positive blood culture|13
7151134|NCT03218397|11314597|FG000|Overall Study|Comfort care|8
7151135|NCT03218397|11314598|FG001|Overall Study|Comfort care|5
7151136|NCT03218397|11314597|FG000|Overall Study|Comfort care and positive blood culture|1
7151137|NCT03218397|11314598|FG001|Overall Study|Comfort care and positive blood culture|0
7151138|NCT03218397|11314597|FG000|Overall Study|Comfort care and mixed culture|0
7151139|NCT03218397|11314598|FG001|Overall Study|Comfort care and mixed culture|1
7151140|NCT03218397|11314597|FG000|Overall Study|Mixed culture|2
7151141|NCT03218397|11314598|FG001|Overall Study|Mixed culture|2
7151142|NCT03218397|11314597|FG000|Overall Study|Inaccessible hospital records|2
7151143|NCT03218397|11314598|FG001|Overall Study|Inaccessible hospital records|5
7151144|NCT03218397|11314597|FG000|Overall Study|No gram-negative bacilli (GNB)|0
7151145|NCT03218397|11314598|FG001|Overall Study|No gram-negative bacilli (GNB)|2
7151146|NCT03218397|11314597|FG000|Overall Study|Randomized during laboratory off hours|2
7151147|NCT03218397|11314598|FG001|Overall Study|Randomized during laboratory off hours|1
7151148|NCT03218787|11314626|FG000|Overall Study|Lost to Follow-up|12
7151149|NCT03218787|11314626|FG000|Overall Study|Withdrawal by Subject|72
7151150|NCT03218787|11314626|FG000|Overall Study|Physician Decision|11
7151151|NCT03218787|11314626|FG000|Overall Study|Death|111
7151152|NCT03219216|11314632|FG000|Overall Study|Lost to Follow-up|0
7151153|NCT03219216|11314633|FG001|Overall Study|Lost to Follow-up|1
7151154|NCT03219723|11314664|FG000|Overall Study|Case Report Forms Uncollected|6
7151155|NCT03219723|11314664|FG000|Overall Study|Protocol Deviation|4
7151156|NCT03220217|11314730|FG000|Overall Study|Withdrawal by Subject|0
7151157|NCT03220217|11314731|FG001|Overall Study|Withdrawal by Subject|1
7151158|NCT03220217|11314732|FG002|Overall Study|Withdrawal by Subject|0
7151159|NCT03220217|11314730|FG000|Overall Study|Subject Missed Procedure|0
7151160|NCT03220217|11314731|FG001|Overall Study|Subject Missed Procedure|0
7151161|NCT03220217|11314732|FG002|Overall Study|Subject Missed Procedure|1
7151162|NCT03220737|11314783|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4
7151163|NCT03220737|11314784|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1
7151164|NCT03220737|11314785|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4
7151165|NCT03220737|11314786|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1
7151166|NCT03220737|11314787|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4
7151167|NCT03220737|11314788|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0
7151168|NCT03220737|11314789|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0
7151169|NCT03220737|11314783|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2
7151170|NCT03220737|11314784|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1
7151171|NCT03220737|11314785|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6
7151172|NCT03220737|11314786|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1
7151173|NCT03220737|11314787|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13
7151174|NCT03220737|11314788|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1
7151175|NCT03220737|11314789|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0
7151176|NCT03220737|11314783|FG000|Main Study (Day 1 - 181)|Protocol Violation|0
7151177|NCT03220737|11314784|FG001|Main Study (Day 1 - 181)|Protocol Violation|0
7151178|NCT03220737|11314785|FG002|Main Study (Day 1 - 181)|Protocol Violation|1
7151179|NCT03220737|11314786|FG003|Main Study (Day 1 - 181)|Protocol Violation|1
7151180|NCT03220737|11314787|FG004|Main Study (Day 1 - 181)|Protocol Violation|3
7151181|NCT03220737|11314788|FG005|Main Study (Day 1 - 181)|Protocol Violation|0
7151182|NCT03220737|11314789|FG006|Main Study (Day 1 - 181)|Protocol Violation|1
7151183|NCT03220737|11314783|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
7151184|NCT03220737|11314784|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
7151185|NCT03220737|11314785|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1
7151186|NCT03220737|11314786|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
7151187|NCT03220737|11314787|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
7151188|NCT03220737|11314788|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
7151189|NCT03220737|11314789|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
7151190|NCT03220737|11314783|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
7151191|NCT03220737|11314784|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
7151192|NCT03220737|11314785|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
7151193|NCT03220737|11314786|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
7151194|NCT03220737|11314787|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2
7151195|NCT03220737|11314788|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
7151196|NCT03220737|11314789|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
7151197|NCT03220737|11314783|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1
7151198|NCT03220737|11314784|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
7151199|NCT03220737|11314785|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
7151200|NCT03220737|11314786|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
7151201|NCT03220737|11314787|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
7151202|NCT03220737|11314788|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
7151203|NCT03220737|11314789|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
7151204|NCT03220737|11314783|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9
6841495|NCT00283062|10847393|FG000|Overall Study|Participant did not wish to continue|3
6841496|NCT00283062|10847394|FG001|Overall Study|Participant did not wish to continue|2
6841497|NCT00283062|10847395|FG002|Overall Study|Participant did not wish to continue|1
6841498|NCT00283062|10847396|FG003|Overall Study|Participant did not wish to continue|0
6841499|NCT00283062|10847393|FG000|Overall Study|Undefined|0
6841500|NCT00283062|10847394|FG001|Overall Study|Undefined|1
6841501|NCT00283062|10847395|FG002|Overall Study|Undefined|1
6841502|NCT00283062|10847396|FG003|Overall Study|Undefined|4
6841503|NCT00283062|10847393|FG000|Overall Study|chemotherapy not completed (cycle 6)|1
6841504|NCT00283062|10847394|FG001|Overall Study|chemotherapy not completed (cycle 6)|0
6841505|NCT00283062|10847395|FG002|Overall Study|chemotherapy not completed (cycle 6)|0
6841506|NCT00283062|10847396|FG003|Overall Study|chemotherapy not completed (cycle 6)|0
6841507|NCT00283244|10847421|FG000|Overall Study|Adverse Event|0
6841508|NCT00283244|10847422|FG001|Overall Study|Adverse Event|8
6841509|NCT00283244|10847423|FG002|Overall Study|Adverse Event|11
6841510|NCT00283244|10847421|FG000|Overall Study|Death|4
6841511|NCT00283244|10847422|FG001|Overall Study|Death|3
6841512|NCT00283244|10847423|FG002|Overall Study|Death|2
6841513|NCT00283244|10847421|FG000|Overall Study|Lack of Efficacy|8
6841514|NCT00283244|10847422|FG001|Overall Study|Lack of Efficacy|32
6841515|NCT00283244|10847423|FG002|Overall Study|Lack of Efficacy|26
6841516|NCT00283244|10847421|FG000|Overall Study|Withdrawal by Subject|1
6841517|NCT00283244|10847422|FG001|Overall Study|Withdrawal by Subject|2
6841518|NCT00283244|10847423|FG002|Overall Study|Withdrawal by Subject|2
6841519|NCT00283244|10847421|FG000|Overall Study|Physician Decision|0
6841520|NCT00283244|10847422|FG001|Overall Study|Physician Decision|0
6841521|NCT00283244|10847423|FG002|Overall Study|Physician Decision|1
6841522|NCT00283244|10847421|FG000|Overall Study|Medical illness (other complicating dz)|4
6841523|NCT00283244|10847422|FG001|Overall Study|Medical illness (other complicating dz)|3
6841524|NCT00283244|10847423|FG002|Overall Study|Medical illness (other complicating dz)|6
6841525|NCT00283244|10847421|FG000|Overall Study|Clinical deterioration|1
6841526|NCT00283244|10847422|FG001|Overall Study|Clinical deterioration|3
6841527|NCT00283244|10847423|FG002|Overall Study|Clinical deterioration|3
6841528|NCT00283296|10847454|FG000|Overall Study|in-home trial not completed|5
6841529|NCT00283387|10847459|FG000|First Intervention|Subject non-compliant|1
6841530|NCT00283387|10847460|FG001|First Intervention|Subject non-compliant|1
6841531|NCT00283387|10847459|FG000|First Intervention|Withdrawal by Subject|0
6841532|NCT00283387|10847460|FG001|First Intervention|Withdrawal by Subject|1
6841533|NCT00283400|10847470|FG000|Overall Study|Withdrawal by Subject|1
6841534|NCT00283400|10847471|FG001|Overall Study|Withdrawal by Subject|1
6841535|NCT00283400|10847472|FG002|Overall Study|Withdrawal by Subject|0
6841536|NCT00283400|10847473|FG003|Overall Study|Withdrawal by Subject|0
6841537|NCT00283400|10847470|FG000|Overall Study|Death|1
6841538|NCT00283400|10847471|FG001|Overall Study|Death|0
6841539|NCT00283400|10847472|FG002|Overall Study|Death|1
6841540|NCT00283400|10847473|FG003|Overall Study|Death|0
6841541|NCT00283439|10847487|FG000|Overall Study|Adverse Event|0
6841542|NCT00283439|10847488|FG001|Overall Study|Adverse Event|0
6841543|NCT00283439|10847489|FG002|Overall Study|Adverse Event|0
6841544|NCT00283439|10847490|FG003|Overall Study|Adverse Event|1
6841545|NCT00283439|10847487|FG000|Overall Study|Death|0
6841546|NCT00283439|10847488|FG001|Overall Study|Death|0
6841547|NCT00283439|10847489|FG002|Overall Study|Death|1
6841548|NCT00283439|10847490|FG003|Overall Study|Death|0
6841549|NCT00283439|10847487|FG000|Overall Study|Disease progression|0
6841550|NCT00283439|10847488|FG001|Overall Study|Disease progression|1
6841551|NCT00283439|10847489|FG002|Overall Study|Disease progression|0
6841552|NCT00283439|10847490|FG003|Overall Study|Disease progression|0
6841553|NCT00283439|10847487|FG000|Overall Study|Requirement for alternative therapy|1
6841554|NCT00283439|10847488|FG001|Overall Study|Requirement for alternative therapy|2
6841555|NCT00283439|10847489|FG002|Overall Study|Requirement for alternative therapy|5
6841556|NCT00283439|10847490|FG003|Overall Study|Requirement for alternative therapy|2
7151205|NCT03220737|11314784|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
7151206|NCT03220737|11314785|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
7151207|NCT03220737|11314786|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
7151208|NCT03220737|11314787|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
7151209|NCT03220737|11314788|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
7151210|NCT03220737|11314789|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
7151211|NCT03220737|11314783|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1
7151212|NCT03220737|11314784|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
7151213|NCT03220737|11314785|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
7151214|NCT03220737|11314786|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
6841557|NCT00283439|10847487|FG000|Overall Study|Stem cell transplant|6
6841558|NCT00283439|10847488|FG001|Overall Study|Stem cell transplant|6
6841559|NCT00283439|10847489|FG002|Overall Study|Stem cell transplant|4
6841560|NCT00283439|10847490|FG003|Overall Study|Stem cell transplant|3
6841561|NCT00283439|10847487|FG000|Overall Study|Treatment discontinued|0
6841562|NCT00283439|10847488|FG001|Overall Study|Treatment discontinued|2
6841563|NCT00283439|10847489|FG002|Overall Study|Treatment discontinued|1
7151215|NCT03220737|11314787|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
7151216|NCT03220737|11314788|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
7151217|NCT03220737|11314789|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
7151218|NCT03221387|11314824|FG000|Overall Study|Lost to Follow-up|1
7151219|NCT03221387|11314824|FG000|Overall Study|Lung transplant|1
7151220|NCT03222141|11314852|FG000|Overall Study|Death|15
7151221|NCT03222141|11314852|FG000|Overall Study|Lost to Follow-up|3
7151222|NCT03222349|11314857|FG000|Overall Study|Treatment B not done|5
7151223|NCT03222349|11314858|FG001|Overall Study|Treatment B not done|0
7151224|NCT03222349|11314857|FG000|Overall Study|Lost to Follow-up|1
7151225|NCT03222349|11314858|FG001|Overall Study|Lost to Follow-up|2
7151226|NCT03222349|11314857|FG000|Overall Study|Withdrawal by Subject|1
7151227|NCT03222349|11314858|FG001|Overall Study|Withdrawal by Subject|0
7151228|NCT03222349|11314857|FG000|Overall Study|Treatment A not done|0
7151229|NCT03222349|11314858|FG001|Overall Study|Treatment A not done|5
7151230|NCT03222349|11314857|FG000|Overall Study|Study terminated by sponsor|1
7151231|NCT03222349|11314858|FG001|Overall Study|Study terminated by sponsor|0
7151232|NCT03222583|11314897|FG000|Overall Study|Withdrawal by Subject|3
7151233|NCT03222583|11314898|FG001|Overall Study|Withdrawal by Subject|3
7151234|NCT03222583|11314897|FG000|Overall Study|Lost to Follow-up|1
7151235|NCT03222583|11314898|FG001|Overall Study|Lost to Follow-up|0
7151236|NCT03222583|11314897|FG000|Overall Study|Other|1
7151237|NCT03222583|11314898|FG001|Overall Study|Other|3
7151238|NCT03223909|11314946|FG000|Overall Study|Protocol Violation|48
7151239|NCT03223909|11314947|FG001|Overall Study|Protocol Violation|45
7151240|NCT03223909|11314948|FG002|Overall Study|Protocol Violation|16
7151241|NCT03224130|11314958|FG000|Overall Study|consent issue|0
7151242|NCT03224130|11314959|FG001|Overall Study|consent issue|1
7151243|NCT03224182|11314967|FG000|Overall Study|Study Drug Not Instilled|6
7151244|NCT03224182|11314968|FG001|Overall Study|Study Drug Not Instilled|1
7151245|NCT03224182|11314967|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22
7151246|NCT03224182|11314968|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11
7151247|NCT03224182|11314967|FG000|Overall Study|Withdrew of Consent|4
7151248|NCT03224182|11314968|FG001|Overall Study|Withdrew of Consent|2
7151249|NCT03224182|11314967|FG000|Overall Study|Investigator Decision|3
7151250|NCT03224182|11314968|FG001|Overall Study|Investigator Decision|1
7151251|NCT03224182|11314967|FG000|Overall Study|Sponsor Decision|26
7151252|NCT03224182|11314968|FG001|Overall Study|Sponsor Decision|12
7151253|NCT03224182|11314967|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4
7151254|NCT03224182|11314968|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0
7151255|NCT03224182|11314967|FG000|Overall Study|Lost to Follow-up|1
7151256|NCT03224182|11314968|FG001|Overall Study|Lost to Follow-up|0
7151257|NCT03224182|11314967|FG000|Overall Study|Participant Had Recurrence|11
7151258|NCT03224182|11314968|FG001|Overall Study|Participant Had Recurrence|5
7151259|NCT03224182|11314967|FG000|Overall Study|Death|0
7151260|NCT03224182|11314968|FG001|Overall Study|Death|1
7151261|NCT03224182|11314967|FG000|Overall Study|Reason not Specified|3
7151262|NCT03224182|11314968|FG001|Overall Study|Reason not Specified|3
7151263|NCT03224182|11314967|FG000|Overall Study|Other|1
7151264|NCT03224182|11314968|FG001|Overall Study|Other|0
6841564|NCT00283439|10847490|FG003|Overall Study|Treatment discontinued|3
6841565|NCT00283439|10847487|FG000|Overall Study|Other|1
6841566|NCT00283439|10847488|FG001|Overall Study|Other|0
6841567|NCT00283439|10847489|FG002|Overall Study|Other|0
6841568|NCT00283439|10847490|FG003|Overall Study|Other|0
6841569|NCT00283595|10847513|FG000|Overall Study|Withdrawal by Subject|1
6841570|NCT00283595|10847514|FG001|Overall Study|Withdrawal by Subject|2
6841571|NCT00283686|10847524|FG000|Overall Study|Death|1
6841572|NCT00283686|10847525|FG001|Overall Study|Death|1
6841573|NCT00283686|10847526|FG002|Overall Study|Death|1
6841574|NCT00283686|10847527|FG003|Overall Study|Death|0
6841575|NCT00283686|10847524|FG000|Overall Study|Lost to Follow-up|21
7151265|NCT03224234|11314978|FG000|Main Study|Lost to Follow-up|5
7151266|NCT03224234|11314979|FG001|Main Study|Lost to Follow-up|5
7151267|NCT03224325|11315013|FG000|Overall Study|Adverse Event|1
7151268|NCT03224325|11315014|FG001|Overall Study|Adverse Event|0
7151269|NCT03224325|11315015|FG002|Overall Study|Adverse Event|0
7151270|NCT03224325|11315016|FG003|Overall Study|Adverse Event|0
7151271|NCT03224325|11315017|FG004|Overall Study|Adverse Event|0
7151272|NCT03224325|11315018|FG005|Overall Study|Adverse Event|0
7151273|NCT03224325|11315019|FG006|Overall Study|Adverse Event|1
7151274|NCT03224325|11315013|FG000|Overall Study|Withdrawal by Subject|0
7151275|NCT03224325|11315014|FG001|Overall Study|Withdrawal by Subject|0
7151276|NCT03224325|11315015|FG002|Overall Study|Withdrawal by Subject|0
7151277|NCT03224325|11315016|FG003|Overall Study|Withdrawal by Subject|1
7151278|NCT03224325|11315017|FG004|Overall Study|Withdrawal by Subject|0
7151279|NCT03224325|11315018|FG005|Overall Study|Withdrawal by Subject|0
7151280|NCT03224325|11315019|FG006|Overall Study|Withdrawal by Subject|0
7151281|NCT03224598|11315138|FG000|Overall Study|Lost to Follow-up|0
7151282|NCT03224598|11315139|FG001|Overall Study|Lost to Follow-up|2
7151283|NCT03224598|11315140|FG002|Overall Study|Lost to Follow-up|0
6841576|NCT00283686|10847525|FG001|Overall Study|Lost to Follow-up|31
6841577|NCT00283686|10847526|FG002|Overall Study|Lost to Follow-up|26
6841578|NCT00283686|10847527|FG003|Overall Study|Lost to Follow-up|20
6841579|NCT00283686|10847524|FG000|Overall Study|Less than full participation|7
6841580|NCT00283686|10847525|FG001|Overall Study|Less than full participation|9
6841581|NCT00283686|10847526|FG002|Overall Study|Less than full participation|6
6841582|NCT00283686|10847527|FG003|Overall Study|Less than full participation|12
6841583|NCT00283712|10847539|FG000|Overall Study|Death|0
6841584|NCT00283712|10847540|FG001|Overall Study|Death|1
6841585|NCT00283803|10847546|FG000|Overall Study|Physician Decision|9
6841586|NCT00283803|10847546|FG000|Overall Study|Withdrawal by Subject|4
6841587|NCT00283842|10847566|FG000|Overall Study|Adverse Event|8
6841588|NCT00283842|10847567|FG001|Overall Study|Adverse Event|7
6841589|NCT00283842|10847568|FG002|Overall Study|Adverse Event|21
6841590|NCT00283842|10847569|FG003|Overall Study|Adverse Event|21
6841591|NCT00283842|10847570|FG004|Overall Study|Adverse Event|5
6841592|NCT00283842|10847566|FG000|Overall Study|Protocol Violation|1
6841593|NCT00283842|10847567|FG001|Overall Study|Protocol Violation|5
6841594|NCT00283842|10847568|FG002|Overall Study|Protocol Violation|4
6841595|NCT00283842|10847569|FG003|Overall Study|Protocol Violation|0
6841596|NCT00283842|10847570|FG004|Overall Study|Protocol Violation|0
6841597|NCT00283842|10847566|FG000|Overall Study|Protocol deviation|0
6841598|NCT00283842|10847567|FG001|Overall Study|Protocol deviation|0
6841599|NCT00283842|10847568|FG002|Overall Study|Protocol deviation|0
6841600|NCT00283842|10847569|FG003|Overall Study|Protocol deviation|0
6841601|NCT00283842|10847570|FG004|Overall Study|Protocol deviation|2
6841602|NCT00283842|10847566|FG000|Overall Study|Withdrawal by Subject|2
6841603|NCT00283842|10847567|FG001|Overall Study|Withdrawal by Subject|1
6841604|NCT00283842|10847568|FG002|Overall Study|Withdrawal by Subject|1
6841605|NCT00283842|10847569|FG003|Overall Study|Withdrawal by Subject|5
6841606|NCT00283842|10847570|FG004|Overall Study|Withdrawal by Subject|4
6841607|NCT00283842|10847566|FG000|Overall Study|Lack of Efficacy|1
6841608|NCT00283842|10847567|FG001|Overall Study|Lack of Efficacy|3
6841609|NCT00283842|10847568|FG002|Overall Study|Lack of Efficacy|1
6841610|NCT00283842|10847569|FG003|Overall Study|Lack of Efficacy|0
6841611|NCT00283842|10847570|FG004|Overall Study|Lack of Efficacy|3
6841612|NCT00283842|10847566|FG000|Overall Study|Lost to Follow-up|0
6841613|NCT00283842|10847567|FG001|Overall Study|Lost to Follow-up|2
6841614|NCT00283842|10847568|FG002|Overall Study|Lost to Follow-up|4
6841615|NCT00283842|10847569|FG003|Overall Study|Lost to Follow-up|1
6841616|NCT00283842|10847570|FG004|Overall Study|Lost to Follow-up|1
6841617|NCT00284050|10847589|FG000|Overall Study|Adverse Event|1
6841618|NCT00284050|10847590|FG001|Overall Study|Adverse Event|1
6841619|NCT00284050|10847591|FG002|Overall Study|Adverse Event|1
6841620|NCT00284050|10847589|FG000|Overall Study|Lack of Efficacy|0
6841621|NCT00284050|10847590|FG001|Overall Study|Lack of Efficacy|1
6841622|NCT00284050|10847591|FG002|Overall Study|Lack of Efficacy|3
6841623|NCT00284050|10847589|FG000|Overall Study|Protocol Violation|0
6841624|NCT00284050|10847590|FG001|Overall Study|Protocol Violation|1
6841625|NCT00284050|10847591|FG002|Overall Study|Protocol Violation|2
6841626|NCT00284050|10847589|FG000|Overall Study|Withdrawal by Subject|2
6841627|NCT00284050|10847590|FG001|Overall Study|Withdrawal by Subject|2
6841628|NCT00284050|10847591|FG002|Overall Study|Withdrawal by Subject|2
6841629|NCT00284050|10847589|FG000|Overall Study|Lost to Follow-up|1
6841630|NCT00284050|10847590|FG001|Overall Study|Lost to Follow-up|0
6841631|NCT00284050|10847591|FG002|Overall Study|Lost to Follow-up|1
6841632|NCT00284050|10847589|FG000|Overall Study|Death|1
6841633|NCT00284050|10847590|FG001|Overall Study|Death|0
6841634|NCT00284050|10847591|FG002|Overall Study|Death|0
6841635|NCT00284089|10847603|FG000|Multiple Dose Phase|Adverse Event|1
6841636|NCT00284089|10847604|FG001|Multiple Dose Phase|Adverse Event|0
6841637|NCT00284089|10847605|FG002|Multiple Dose Phase|Adverse Event|1
6841638|NCT00284089|10847606|FG003|Multiple Dose Phase|Adverse Event|1
6841639|NCT00284089|10847603|FG000|Multiple Dose Phase|Protocol Violation|0
6841640|NCT00284089|10847604|FG001|Multiple Dose Phase|Protocol Violation|0
6841641|NCT00284089|10847605|FG002|Multiple Dose Phase|Protocol Violation|1
6841642|NCT00284089|10847606|FG003|Multiple Dose Phase|Protocol Violation|0
6841643|NCT00284089|10847603|FG000|Multiple Dose Phase|Withdrawal by Subject|0
6841644|NCT00284089|10847604|FG001|Multiple Dose Phase|Withdrawal by Subject|0
6841645|NCT00284089|10847605|FG002|Multiple Dose Phase|Withdrawal by Subject|1
6841646|NCT00284089|10847606|FG003|Multiple Dose Phase|Withdrawal by Subject|2
6841647|NCT00284089|10847603|FG000|Multiple Dose Phase|Death|0
6841648|NCT00284089|10847604|FG001|Multiple Dose Phase|Death|0
6841649|NCT00284089|10847605|FG002|Multiple Dose Phase|Death|1
6841650|NCT00284089|10847606|FG003|Multiple Dose Phase|Death|1
6841651|NCT00284089|10847603|FG000|Extension Phase|Adverse Event|0
6841652|NCT00284089|10847604|FG001|Extension Phase|Adverse Event|0
6841653|NCT00284089|10847605|FG002|Extension Phase|Adverse Event|2
6841654|NCT00284089|10847606|FG003|Extension Phase|Adverse Event|2
6841655|NCT00284089|10847603|FG000|Extension Phase|condition no longer requires study drug|2
6841656|NCT00284089|10847604|FG001|Extension Phase|condition no longer requires study drug|0
6841657|NCT00284089|10847605|FG002|Extension Phase|condition no longer requires study drug|2
6841658|NCT00284089|10847606|FG003|Extension Phase|condition no longer requires study drug|7
6841659|NCT00284089|10847603|FG000|Extension Phase|Protocol Violation|0
6841660|NCT00284089|10847604|FG001|Extension Phase|Protocol Violation|0
6841661|NCT00284089|10847605|FG002|Extension Phase|Protocol Violation|1
6841662|NCT00284089|10847606|FG003|Extension Phase|Protocol Violation|0
6841663|NCT00284089|10847603|FG000|Extension Phase|Withdrawal by Subject|0
6841664|NCT00284089|10847604|FG001|Extension Phase|Withdrawal by Subject|0
6841665|NCT00284089|10847605|FG002|Extension Phase|Withdrawal by Subject|1
6841666|NCT00284089|10847606|FG003|Extension Phase|Withdrawal by Subject|3
6841667|NCT00284141|10847616|FG000|Overall Study|Disease Progression / Lack of efficacy|51
6841668|NCT00284141|10847616|FG000|Overall Study|Adverse Event|19
6841669|NCT00284141|10847616|FG000|Overall Study|Participant's request|9
6841670|NCT00284141|10847616|FG000|Overall Study|Symptomatic / Clinical Progression|11
6841671|NCT00284141|10847616|FG000|Overall Study|Clinical deterioration / death|2
6841672|NCT00284141|10847616|FG000|Overall Study|General decline|1
6841673|NCT00284141|10847616|FG000|Overall Study|Pneumonia|1
6841674|NCT00284141|10847616|FG000|Overall Study|Did not take study medication|2
6841675|NCT00284141|10847616|FG000|Overall Study|Ongoing treatment|2
6841676|NCT00284934|10847672|FG000|Overall Study|Adverse Event|1
6841677|NCT00284934|10847673|FG001|Overall Study|Adverse Event|2
6841678|NCT00284934|10847672|FG000|Overall Study|Other reasons|3
6841679|NCT00284934|10847673|FG001|Overall Study|Other reasons|1
6841680|NCT00285012|10847681|FG000|Assigned to Study Treatment (Tx)|Other|2
6841681|NCT00285012|10847682|FG001|Assigned to Study Treatment (Tx)|Other|3
6841682|NCT00285012|10847681|FG000|Received Study Tx|Death|2
6841683|NCT00285012|10847682|FG001|Received Study Tx|Death|1
6841684|NCT00285012|10847681|FG000|Received Study Tx|Adverse Event|5
6841685|NCT00285012|10847682|FG001|Received Study Tx|Adverse Event|11
6841686|NCT00285012|10847681|FG000|Received Study Tx|Lack of Efficacy|0
6841687|NCT00285012|10847682|FG001|Received Study Tx|Lack of Efficacy|3
6841688|NCT00285012|10847681|FG000|Received Study Tx|Lost to Follow-up|29
6841689|NCT00285012|10847682|FG001|Received Study Tx|Lost to Follow-up|31
6841690|NCT00285012|10847681|FG000|Received Study Tx|Withdrawal by Subject|31
6841691|NCT00285012|10847682|FG001|Received Study Tx|Withdrawal by Subject|43
6841692|NCT00285012|10847681|FG000|Received Study Tx|Other|5
6841693|NCT00285012|10847682|FG001|Received Study Tx|Other|5
6897752|NCT00642616|10916821|FG001|Overall Study|Withdrawal by Subject|1
6897753|NCT00642616|10916822|FG002|Overall Study|Withdrawal by Subject|1
6897754|NCT00642616|10916823|FG003|Overall Study|Withdrawal by Subject|1
6897755|NCT00642616|10916820|FG000|Overall Study|Protocol Violation|0
6897756|NCT00642616|10916821|FG001|Overall Study|Protocol Violation|0
6897757|NCT00642616|10916822|FG002|Overall Study|Protocol Violation|2
6897758|NCT00642616|10916823|FG003|Overall Study|Protocol Violation|0
6897759|NCT00642616|10916820|FG000|Overall Study|Physician Decision|0
6897760|NCT00642616|10916821|FG001|Overall Study|Physician Decision|0
6897761|NCT00642616|10916822|FG002|Overall Study|Physician Decision|1
6897762|NCT00642616|10916823|FG003|Overall Study|Physician Decision|1
6897763|NCT00642642|10916835|FG000|Treatment & Follow Up|Adverse Event|2
6897764|NCT00642642|10916835|FG000|Treatment & Follow Up|Withdrawal by Subject|5
6897765|NCT00642642|10916835|FG000|Treatment & Follow Up|Lost to Follow-up|10
6897766|NCT00642668|10916845|FG000|Overall Study|Lost to Follow-up|1
6897767|NCT00642668|10916845|FG000|Overall Study|Adverse Event|2
6897768|NCT00642668|10916845|FG000|Overall Study|Death|2
6897769|NCT00642668|10916845|FG000|Overall Study|Insufficient Therapeutic Response|1
6897770|NCT00642668|10916845|FG000|Overall Study|Failure to Return|1
6897771|NCT00642668|10916845|FG000|Overall Study|Dialysis Initiation|5
6897772|NCT00642668|10916845|FG000|Overall Study|Blood Transfusion|2
6897773|NCT00642707|10916862|FG000|Overall Study|Adverse Event|0
6897774|NCT00642707|10916863|FG001|Overall Study|Adverse Event|0
6897775|NCT00642707|10916864|FG002|Overall Study|Adverse Event|0
6897776|NCT00642707|10916865|FG003|Overall Study|Adverse Event|2
6897777|NCT00642707|10916862|FG000|Overall Study|Withdrawal by Subject|1
6897778|NCT00642707|10916863|FG001|Overall Study|Withdrawal by Subject|0
6897779|NCT00642707|10916864|FG002|Overall Study|Withdrawal by Subject|0
6897780|NCT00642707|10916865|FG003|Overall Study|Withdrawal by Subject|0
6966450|NCT04085367|11014438|FG001|Overall Study|Lost to Follow-up|1
6966451|NCT04085367|11014437|FG000|Overall Study|Other unspecified|2
6966452|NCT04085367|11014438|FG001|Overall Study|Other unspecified|1
6966453|NCT04085367|11014437|FG000|Overall Study|Status Unknown|1
6966454|NCT04085367|11014438|FG001|Overall Study|Status Unknown|1
6976833|NCT01202591|11029682|FG002|Overall Study|Adverse Event|4
6976834|NCT01202591|11029683|FG003|Overall Study|Adverse Event|4
6976835|NCT01202591|11029684|FG004|Overall Study|Adverse Event|0
6976836|NCT01202591|11029685|FG005|Overall Study|Adverse Event|0
6976837|NCT01202591|11029680|FG000|Overall Study|Other reason as per investigator|3
6976838|NCT01202591|11029681|FG001|Overall Study|Other reason as per investigator|4
6976839|NCT01202591|11029682|FG002|Overall Study|Other reason as per investigator|7
6976840|NCT01202591|11029683|FG003|Overall Study|Other reason as per investigator|3
6976841|NCT01202591|11029684|FG004|Overall Study|Other reason as per investigator|1
6976842|NCT01202591|11029685|FG005|Overall Study|Other reason as per investigator|3
6976843|NCT01202591|11029680|FG000|Overall Study|Withdrawal by Subject|0
6976844|NCT01202591|11029681|FG001|Overall Study|Withdrawal by Subject|0
6976845|NCT01202591|11029682|FG002|Overall Study|Withdrawal by Subject|0
6976846|NCT01202591|11029683|FG003|Overall Study|Withdrawal by Subject|0
6976847|NCT01202591|11029684|FG004|Overall Study|Withdrawal by Subject|2
6976848|NCT01202591|11029685|FG005|Overall Study|Withdrawal by Subject|1
6976849|NCT01202591|11029680|FG000|Overall Study|Objective Disease Progression|0
6976850|NCT01202591|11029681|FG001|Overall Study|Objective Disease Progression|0
6976851|NCT01202591|11029682|FG002|Overall Study|Objective Disease Progression|0
6841694|NCT00285207|10847690|FG000|Overall Study|Lost to Follow-up|3
6841695|NCT00285207|10847691|FG001|Overall Study|Lost to Follow-up|2
6841696|NCT00285207|10847690|FG000|Overall Study|Withdrawal by Subject|5
6841697|NCT00285207|10847691|FG001|Overall Study|Withdrawal by Subject|2
6841698|NCT00285207|10847690|FG000|Overall Study|Pregnancy|1
6841699|NCT00285207|10847691|FG001|Overall Study|Pregnancy|1
6841700|NCT00285207|10847690|FG000|Overall Study|non-compliance|0
6841701|NCT00285207|10847691|FG001|Overall Study|non-compliance|1
6841702|NCT00285584|10847712|FG000|Month 3|Lost to Follow-up|3
6841703|NCT00285584|10847713|FG001|Month 3|Lost to Follow-up|3
6841704|NCT00285584|10847712|FG000|Month 3|Withdrawal by Subject|1
6841705|NCT00285584|10847713|FG001|Month 3|Withdrawal by Subject|0
6841706|NCT00285584|10847712|FG000|Month 6|Lost to Follow-up|0
6841707|NCT00285584|10847713|FG001|Month 6|Lost to Follow-up|1
6841708|NCT00285649|10847726|FG000|Overall Study|Lost to Follow-up|6
6841709|NCT00285649|10847727|FG001|Overall Study|Lost to Follow-up|4
6841710|NCT00285649|10847728|FG002|Overall Study|Lost to Follow-up|4
6841711|NCT00285649|10847726|FG000|Overall Study|Withdrawal by Subject|3
6841712|NCT00285649|10847727|FG001|Overall Study|Withdrawal by Subject|2
6841713|NCT00285649|10847728|FG002|Overall Study|Withdrawal by Subject|2
6841714|NCT00285818|10847747|FG000|Overall Study|Withdrawal by Subject|3
6841715|NCT00285818|10847748|FG001|Overall Study|Withdrawal by Subject|2
6841716|NCT00285818|10847747|FG000|Overall Study|Lost to Follow-up|1
6841717|NCT00285818|10847748|FG001|Overall Study|Lost to Follow-up|0
6841718|NCT00285857|10847754|FG000|Overall Study|Withdrawal by Subject|2
6841719|NCT00285857|10847754|FG000|Overall Study|Inadequate initial breast cytology|1
6841720|NCT00285857|10847754|FG000|Overall Study|Adverse Event|1
6841721|NCT00286091|10847774|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103
6841722|NCT00286091|10847775|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113
6841723|NCT00286091|10847774|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307
6841724|NCT00286091|10847775|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269
6841725|NCT00286091|10847774|FG000|Double-blind Treatment Phase|Death|58
6841726|NCT00286091|10847775|FG001|Double-blind Treatment Phase|Death|65
6841727|NCT00286091|10847774|FG000|Double-blind Treatment Phase|Adverse Event|28
6841728|NCT00286091|10847775|FG001|Double-blind Treatment Phase|Adverse Event|40
6841729|NCT00286091|10847774|FG000|Double-blind Treatment Phase|Disease Progression|22
6841730|NCT00286091|10847775|FG001|Double-blind Treatment Phase|Disease Progression|35
6841731|NCT00286091|10847774|FG000|Double-blind Treatment Phase|Other|25
6841732|NCT00286091|10847775|FG001|Double-blind Treatment Phase|Other|33
6841733|NCT00286091|10847774|FG000|Double-blind Treatment Phase|Administrative Decision|20
6841734|NCT00286091|10847775|FG001|Double-blind Treatment Phase|Administrative Decision|21
6841735|NCT00286091|10847774|FG000|Double-blind Treatment Phase|Noncompliance|8
6841736|NCT00286091|10847775|FG001|Double-blind Treatment Phase|Noncompliance|8
6841737|NCT00286091|10847774|FG000|Double-blind Treatment Phase|Lost to Follow-up|11
6841738|NCT00286091|10847775|FG001|Double-blind Treatment Phase|Lost to Follow-up|4
6841739|NCT00286091|10847774|FG000|Double-blind Treatment Phase|Protocol Deviation|1
6841740|NCT00286091|10847775|FG001|Double-blind Treatment Phase|Protocol Deviation|3
6841741|NCT00286091|10847774|FG000|Double-blind Treatment Phase|Ineligibility Determined|1
6841742|NCT00286091|10847775|FG001|Double-blind Treatment Phase|Ineligibility Determined|2
6841743|NCT00286091|10847774|FG000|Open-label Treatment Phase|Physician Decision|24
6841744|NCT00286091|10847775|FG001|Open-label Treatment Phase|Physician Decision|21
6841745|NCT00286091|10847774|FG000|Open-label Treatment Phase|Adverse Event|5
6841746|NCT00286091|10847775|FG001|Open-label Treatment Phase|Adverse Event|16
6841747|NCT00286091|10847774|FG000|Open-label Treatment Phase|Other|11
6841748|NCT00286091|10847775|FG001|Open-label Treatment Phase|Other|11
6841749|NCT00286091|10847774|FG000|Open-label Treatment Phase|Withdrawal by Subject|14
6841750|NCT00286091|10847775|FG001|Open-label Treatment Phase|Withdrawal by Subject|10
6841751|NCT00286091|10847774|FG000|Open-label Treatment Phase|Death|10
6841752|NCT00286091|10847775|FG001|Open-label Treatment Phase|Death|7
6841753|NCT00286091|10847774|FG000|Open-label Treatment Phase|Disease Progression|9
6841754|NCT00286091|10847775|FG001|Open-label Treatment Phase|Disease Progression|3
6841755|NCT00286091|10847774|FG000|Open-label Treatment Phase|Noncompliance|3
6841756|NCT00286091|10847775|FG001|Open-label Treatment Phase|Noncompliance|1
6841757|NCT00286091|10847774|FG000|Open-label Treatment Phase|Lost to Follow-up|0
6841758|NCT00286091|10847775|FG001|Open-label Treatment Phase|Lost to Follow-up|1
6841759|NCT00286091|10847774|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1
6841760|NCT00286091|10847775|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0
6841761|NCT00286091|10847774|FG000|Open-label Treatment Phase|Missing End of Study Information|0
6966455|NCT03621696|11014452|FG000|Overall Study|Not eligible|0
6841762|NCT00286091|10847775|FG001|Open-label Treatment Phase|Missing End of Study Information|1
6841763|NCT00286156|10847786|FG000|Overall Study|Missed 12 month visit|0
6841764|NCT00286156|10847787|FG001|Overall Study|Missed 12 month visit|0
6841765|NCT00286156|10847788|FG002|Overall Study|Missed 12 month visit|1
6841766|NCT00286156|10847786|FG000|Overall Study|AE: pulmonary embolus|0
6841767|NCT00286156|10847787|FG001|Overall Study|AE: pulmonary embolus|1
6841768|NCT00286156|10847788|FG002|Overall Study|AE: pulmonary embolus|0
6841769|NCT00286156|10847786|FG000|Overall Study|AE: nephrotic-range proteinuruia|1
6841770|NCT00286156|10847787|FG001|Overall Study|AE: nephrotic-range proteinuruia|0
6841771|NCT00286156|10847788|FG002|Overall Study|AE: nephrotic-range proteinuruia|0
6841772|NCT00286156|10847786|FG000|Overall Study|AE: pneumonia|1
6841773|NCT00286156|10847787|FG001|Overall Study|AE: pneumonia|0
6841774|NCT00286156|10847788|FG002|Overall Study|AE: pneumonia|0
6841775|NCT00286221|10847809|FG000|Overall Study|Protocol Violation|2
6841776|NCT00286221|10847810|FG001|Overall Study|Protocol Violation|1
6841777|NCT00286221|10847811|FG002|Overall Study|Protocol Violation|6
6841778|NCT00286221|10847812|FG003|Overall Study|Protocol Violation|4
6841779|NCT00286221|10847809|FG000|Overall Study|Unanticipated Neurosurgical Complication|6
6841780|NCT00286221|10847810|FG001|Overall Study|Unanticipated Neurosurgical Complication|3
6841781|NCT00286221|10847811|FG002|Overall Study|Unanticipated Neurosurgical Complication|3
6841782|NCT00286221|10847812|FG003|Overall Study|Unanticipated Neurosurgical Complication|2
6841783|NCT00286221|10847809|FG000|Overall Study|Inability to trigger PCA|2
6841784|NCT00286221|10847810|FG001|Overall Study|Inability to trigger PCA|0
6841785|NCT00286221|10847811|FG002|Overall Study|Inability to trigger PCA|0
6841786|NCT00286221|10847812|FG003|Overall Study|Inability to trigger PCA|0
6841787|NCT00286221|10847809|FG000|Overall Study|Unrecognized exclusion criteria met|0
6841788|NCT00286221|10847810|FG001|Overall Study|Unrecognized exclusion criteria met|1
6841789|NCT00286221|10847811|FG002|Overall Study|Unrecognized exclusion criteria met|0
6841790|NCT00286221|10847812|FG003|Overall Study|Unrecognized exclusion criteria met|0
6841791|NCT00286234|10847826|FG000|Overall Study|Protocol Violation|1
6841792|NCT00286234|10847827|FG001|Overall Study|Protocol Violation|2
6841793|NCT00286234|10847828|FG002|Overall Study|Protocol Violation|0
6841794|NCT00286234|10847829|FG003|Overall Study|Protocol Violation|1
6841795|NCT00286234|10847826|FG000|Overall Study|Physician Decision|1
6841796|NCT00286234|10847827|FG001|Overall Study|Physician Decision|0
6841797|NCT00286234|10847828|FG002|Overall Study|Physician Decision|0
6841798|NCT00286234|10847829|FG003|Overall Study|Physician Decision|1
6841799|NCT00286234|10847826|FG000|Overall Study|Adverse Event|0
6841800|NCT00286234|10847827|FG001|Overall Study|Adverse Event|0
6841801|NCT00286234|10847828|FG002|Overall Study|Adverse Event|0
6841802|NCT00286234|10847829|FG003|Overall Study|Adverse Event|1
6841803|NCT00286234|10847826|FG000|Overall Study|Adverse Event|0
6841804|NCT00286234|10847827|FG001|Overall Study|Adverse Event|0
6841805|NCT00286234|10847828|FG002|Overall Study|Adverse Event|0
6841806|NCT00286234|10847829|FG003|Overall Study|Adverse Event|1
6841807|NCT00286429|10847846|FG000|Overall Study|Adverse Event|4
6841808|NCT00286429|10847847|FG001|Overall Study|Adverse Event|1
6841809|NCT00286429|10847848|FG002|Overall Study|Adverse Event|6
6841810|NCT00286429|10847846|FG000|Overall Study|Lack of Efficacy|52
6841811|NCT00286429|10847847|FG001|Overall Study|Lack of Efficacy|27
6841812|NCT00286429|10847848|FG002|Overall Study|Lack of Efficacy|25
6841813|NCT00286429|10847846|FG000|Overall Study|Lost to Follow-up|2
6841814|NCT00286429|10847847|FG001|Overall Study|Lost to Follow-up|4
6841815|NCT00286429|10847848|FG002|Overall Study|Lost to Follow-up|3
6841816|NCT00286429|10847846|FG000|Overall Study|Physician Decision|10
6841817|NCT00286429|10847847|FG001|Overall Study|Physician Decision|7
6841818|NCT00286429|10847848|FG002|Overall Study|Physician Decision|7
6841819|NCT00286429|10847846|FG000|Overall Study|Protocol Violation|3
6841820|NCT00286429|10847847|FG001|Overall Study|Protocol Violation|5
6841821|NCT00286429|10847848|FG002|Overall Study|Protocol Violation|4
6841822|NCT00286429|10847846|FG000|Overall Study|Withdrawal by Subject|3
6841823|NCT00286429|10847847|FG001|Overall Study|Withdrawal by Subject|2
6841824|NCT00286429|10847848|FG002|Overall Study|Withdrawal by Subject|6
6841825|NCT00286429|10847846|FG000|Overall Study|Administrative Error|1
6841826|NCT00286429|10847847|FG001|Overall Study|Administrative Error|1
6841827|NCT00286429|10847848|FG002|Overall Study|Administrative Error|1
6841828|NCT00286429|10847846|FG000|Overall Study|Administrative Decision|0
6841829|NCT00286429|10847847|FG001|Overall Study|Administrative Decision|1
6841830|NCT00286429|10847848|FG002|Overall Study|Administrative Decision|0
6841831|NCT00286442|10847859|FG000|Overall Study|Hyperglycemic Rescue|19
6841832|NCT00286442|10847860|FG001|Overall Study|Hyperglycemic Rescue|17
6841833|NCT00286442|10847861|FG002|Overall Study|Hyperglycemic Rescue|25
6841834|NCT00286442|10847859|FG000|Overall Study|Adverse Event|7
6841835|NCT00286442|10847860|FG001|Overall Study|Adverse Event|6
6841836|NCT00286442|10847861|FG002|Overall Study|Adverse Event|1
6841837|NCT00286442|10847859|FG000|Overall Study|Protocol Violation|2
6841838|NCT00286442|10847860|FG001|Overall Study|Protocol Violation|4
6841839|NCT00286442|10847861|FG002|Overall Study|Protocol Violation|2
6841840|NCT00286442|10847859|FG000|Overall Study|Lost to Follow-up|5
6841841|NCT00286442|10847860|FG001|Overall Study|Lost to Follow-up|2
6841842|NCT00286442|10847861|FG002|Overall Study|Lost to Follow-up|1
6841843|NCT00286442|10847859|FG000|Overall Study|Physician Decision|1
6841844|NCT00286442|10847860|FG001|Overall Study|Physician Decision|1
6841845|NCT00286442|10847861|FG002|Overall Study|Physician Decision|1
6841846|NCT00286442|10847859|FG000|Overall Study|Administrative Error|1
6841847|NCT00286442|10847860|FG001|Overall Study|Administrative Error|1
6841848|NCT00286442|10847861|FG002|Overall Study|Administrative Error|0
6841849|NCT00286442|10847859|FG000|Overall Study|Withdrawal by Subject|2
6841850|NCT00286442|10847860|FG001|Overall Study|Withdrawal by Subject|14
6841851|NCT00286442|10847861|FG002|Overall Study|Withdrawal by Subject|2
6841852|NCT00286455|10847872|FG000|Overall Study|Hyperglycemia rescue|19
6841853|NCT00286455|10847873|FG001|Overall Study|Hyperglycemia rescue|13
6841854|NCT00286455|10847874|FG002|Overall Study|Hyperglycemia rescue|10
6841855|NCT00286455|10847872|FG000|Overall Study|Adverse Event|1
6841856|NCT00286455|10847873|FG001|Overall Study|Adverse Event|3
6841857|NCT00286455|10847874|FG002|Overall Study|Adverse Event|2
6841858|NCT00286455|10847872|FG000|Overall Study|Lost to Follow-up|0
6841859|NCT00286455|10847873|FG001|Overall Study|Lost to Follow-up|3
6841860|NCT00286455|10847874|FG002|Overall Study|Lost to Follow-up|3
6841861|NCT00286455|10847872|FG000|Overall Study|Physician Decision|3
6841862|NCT00286455|10847873|FG001|Overall Study|Physician Decision|0
6841863|NCT00286455|10847874|FG002|Overall Study|Physician Decision|2
6841864|NCT00286455|10847872|FG000|Overall Study|Protocol Violation|1
6841865|NCT00286455|10847873|FG001|Overall Study|Protocol Violation|1
6841866|NCT00286455|10847874|FG002|Overall Study|Protocol Violation|0
6841867|NCT00286455|10847872|FG000|Overall Study|Participant Non-compliance|1
6841868|NCT00286455|10847873|FG001|Overall Study|Participant Non-compliance|0
6841869|NCT00286455|10847874|FG002|Overall Study|Participant Non-compliance|0
6841870|NCT00286455|10847872|FG000|Overall Study|Withdrawal by Subject|0
6841871|NCT00286455|10847873|FG001|Overall Study|Withdrawal by Subject|8
6841872|NCT00286455|10847874|FG002|Overall Study|Withdrawal by Subject|7
6841873|NCT00286468|10847885|FG000|Overall Study|Hyperglycemic Rescue|28
6841874|NCT00286468|10847886|FG001|Overall Study|Hyperglycemic Rescue|30
6841875|NCT00286468|10847887|FG002|Overall Study|Hyperglycemic Rescue|31
6841876|NCT00286468|10847885|FG000|Overall Study|Adverse Event|2
6841877|NCT00286468|10847886|FG001|Overall Study|Adverse Event|6
6841878|NCT00286468|10847887|FG002|Overall Study|Adverse Event|4
6841879|NCT00286468|10847885|FG000|Overall Study|Protocol Violation|0
6841880|NCT00286468|10847886|FG001|Overall Study|Protocol Violation|3
6841881|NCT00286468|10847887|FG002|Overall Study|Protocol Violation|1
6841882|NCT00286468|10847885|FG000|Overall Study|Lost to Follow-up|1
6841883|NCT00286468|10847886|FG001|Overall Study|Lost to Follow-up|1
6841884|NCT00286468|10847887|FG002|Overall Study|Lost to Follow-up|2
6841885|NCT00286468|10847885|FG000|Overall Study|Withdrawal by Subject|3
6841886|NCT00286468|10847886|FG001|Overall Study|Withdrawal by Subject|8
6841887|NCT00286468|10847887|FG002|Overall Study|Withdrawal by Subject|11
6841888|NCT00286468|10847885|FG000|Overall Study|Physician Decision|3
6841889|NCT00286468|10847886|FG001|Overall Study|Physician Decision|2
6841890|NCT00286468|10847887|FG002|Overall Study|Physician Decision|1
6841891|NCT00286494|10847898|FG000|Overall Study|Hyperglycemic rescue|12
6841892|NCT00286494|10847899|FG001|Overall Study|Hyperglycemic rescue|19
6841893|NCT00286494|10847900|FG002|Overall Study|Hyperglycemic rescue|18
6841894|NCT00286494|10847898|FG000|Overall Study|Withdrawal by Subject|2
6841895|NCT00286494|10847899|FG001|Overall Study|Withdrawal by Subject|10
6841896|NCT00286494|10847900|FG002|Overall Study|Withdrawal by Subject|9
6841897|NCT00286494|10847898|FG000|Overall Study|Adverse Event|3
6841898|NCT00286494|10847899|FG001|Overall Study|Adverse Event|8
6841899|NCT00286494|10847900|FG002|Overall Study|Adverse Event|6
6841900|NCT00286494|10847898|FG000|Overall Study|Physician Decision|5
6841901|NCT00286494|10847899|FG001|Overall Study|Physician Decision|5
6841902|NCT00286494|10847900|FG002|Overall Study|Physician Decision|1
6841903|NCT00286494|10847898|FG000|Overall Study|Lost to Follow-up|3
6841904|NCT00286494|10847899|FG001|Overall Study|Lost to Follow-up|1
6841905|NCT00286494|10847900|FG002|Overall Study|Lost to Follow-up|3
6841906|NCT00286494|10847898|FG000|Overall Study|Protocol Violation|1
6841907|NCT00286494|10847899|FG001|Overall Study|Protocol Violation|1
6841908|NCT00286494|10847900|FG002|Overall Study|Protocol Violation|2
6841909|NCT00286754|10847932|FG000|Overall Study|Adverse Event|2
6841910|NCT00286754|10847933|FG001|Overall Study|Adverse Event|2
6841911|NCT00286754|10847934|FG002|Overall Study|Adverse Event|3
6841912|NCT00286754|10847932|FG000|Overall Study|Withdrawal by Subject|6
6841913|NCT00286754|10847933|FG001|Overall Study|Withdrawal by Subject|2
6841914|NCT00286754|10847934|FG002|Overall Study|Withdrawal by Subject|0
6841915|NCT00286754|10847932|FG000|Overall Study|Lost to Follow-up|12
6841916|NCT00286754|10847933|FG001|Overall Study|Lost to Follow-up|14
6841917|NCT00286754|10847934|FG002|Overall Study|Lost to Follow-up|6
6841918|NCT00286754|10847932|FG000|Overall Study|Moved out of state|0
6841919|NCT00286754|10847933|FG001|Overall Study|Moved out of state|0
6841920|NCT00286754|10847934|FG002|Overall Study|Moved out of state|1
6841921|NCT00287079|10847965|FG000|Overall Study|Qualifying relapse|12
6841922|NCT00287079|10847966|FG001|Overall Study|Qualifying relapse|1
6841923|NCT00287079|10847965|FG000|Overall Study|Non-qualifying relapse|1
6841924|NCT00287079|10847966|FG001|Overall Study|Non-qualifying relapse|0
6841925|NCT00287079|10847965|FG000|Overall Study|Adverse Event|5
6841926|NCT00287079|10847966|FG001|Overall Study|Adverse Event|0
6841927|NCT00287079|10847965|FG000|Overall Study|Protocol Violation|1
6841928|NCT00287079|10847966|FG001|Overall Study|Protocol Violation|0
6841929|NCT00287079|10847965|FG000|Overall Study|Other|3
6841930|NCT00287079|10847966|FG001|Overall Study|Other|0
6841931|NCT00287118|10847972|FG000|Overall Study|Adverse Event|30
6841932|NCT00287118|10847972|FG000|Overall Study|Death|1
6841933|NCT00287118|10847972|FG000|Overall Study|Lack of Efficacy|11
6841934|NCT00287118|10847972|FG000|Overall Study|Lost to Follow-up|1
6841935|NCT00287118|10847972|FG000|Overall Study|Protocol Violation|2
6841936|NCT00287118|10847972|FG000|Overall Study|Other|7
6841937|NCT00287365|10847993|FG000|Overall Study|sample not acquired|13
6841938|NCT00287469|10848000|FG000|Overall Study|serious adverse event|1
6841939|NCT00287469|10848001|FG001|Overall Study|serious adverse event|6
6841940|NCT00287469|10848000|FG000|Overall Study|Adverse Event|1
6841941|NCT00287469|10848001|FG001|Overall Study|Adverse Event|1
6841942|NCT00287469|10848000|FG000|Overall Study|moved from area|144
6841943|NCT00287469|10848001|FG001|Overall Study|moved from area|138
6841944|NCT00287469|10848000|FG000|Overall Study|Lost to Follow-up|74
6841945|NCT00287469|10848001|FG001|Overall Study|Lost to Follow-up|69
6841946|NCT00287586|10848011|FG000|Overall Study|Withdrew Consent|19
6841947|NCT00287586|10848012|FG001|Overall Study|Withdrew Consent|30
6841948|NCT00287586|10848011|FG000|Overall Study|Lost to Follow-up|5
6841949|NCT00287586|10848012|FG001|Overall Study|Lost to Follow-up|4
6841950|NCT00287586|10848011|FG000|Overall Study|Death|2
6841951|NCT00287586|10848012|FG001|Overall Study|Death|3
6841952|NCT00287586|10848011|FG000|Overall Study|Elevated Hematocrit|3
6841953|NCT00287586|10848012|FG001|Overall Study|Elevated Hematocrit|0
6841954|NCT00287586|10848011|FG000|Overall Study|Rash|3
6841955|NCT00287586|10848012|FG001|Overall Study|Rash|0
6841956|NCT00287586|10848011|FG000|Overall Study|Elevated Prostate Specific Antigen|2
6841957|NCT00287586|10848012|FG001|Overall Study|Elevated Prostate Specific Antigen|0
6841958|NCT00287586|10848011|FG000|Overall Study|Stroke|2
6841959|NCT00287586|10848012|FG001|Overall Study|Stroke|0
6841960|NCT00287586|10848011|FG000|Overall Study|Myocardial Infarction|1
6841961|NCT00287586|10848012|FG001|Overall Study|Myocardial Infarction|0
6841962|NCT00287586|10848011|FG000|Overall Study|Lower Urinary Tract Symptoms|1
6841963|NCT00287586|10848012|FG001|Overall Study|Lower Urinary Tract Symptoms|0
6841964|NCT00287586|10848011|FG000|Overall Study|Cognitive Impairment|1
6841965|NCT00287586|10848012|FG001|Overall Study|Cognitive Impairment|0
6841966|NCT00287586|10848011|FG000|Overall Study|Pancreatic Cancer|1
6841967|NCT00287586|10848012|FG001|Overall Study|Pancreatic Cancer|3
6841968|NCT00287586|10848011|FG000|Overall Study|Sleep Apnea|1
6841969|NCT00287586|10848012|FG001|Overall Study|Sleep Apnea|0
6841970|NCT00287586|10848011|FG000|Overall Study|Shoulder Pain|1
6841971|NCT00287586|10848012|FG001|Overall Study|Shoulder Pain|0
6841972|NCT00287586|10848011|FG000|Overall Study|Inappropriate Behaviour with Staff|1
6841973|NCT00287586|10848012|FG001|Overall Study|Inappropriate Behaviour with Staff|0
6841974|NCT00287586|10848011|FG000|Overall Study|Nonadherence|1
6841975|NCT00287586|10848012|FG001|Overall Study|Nonadherence|1
6841976|NCT00287586|10848011|FG000|Overall Study|Enrolled in Another Study|1
6841977|NCT00287586|10848012|FG001|Overall Study|Enrolled in Another Study|0
6841978|NCT00287586|10848011|FG000|Overall Study|Major Depression|0
6841979|NCT00287586|10848012|FG001|Overall Study|Major Depression|2
6841980|NCT00287586|10848011|FG000|Overall Study|Lung Cancer|0
6841981|NCT00287586|10848012|FG001|Overall Study|Lung Cancer|2
6841982|NCT00287586|10848011|FG000|Overall Study|Elevated IPSS Score|0
6841983|NCT00287586|10848012|FG001|Overall Study|Elevated IPSS Score|1
6841984|NCT00287586|10848011|FG000|Overall Study|Retroperitoneal Cancer|0
6841985|NCT00287586|10848012|FG001|Overall Study|Retroperitoneal Cancer|1
6841986|NCT00287586|10848011|FG000|Overall Study|Mastodynia and Gynecomastia|0
6841987|NCT00287586|10848012|FG001|Overall Study|Mastodynia and Gynecomastia|1
6841988|NCT00287586|10848011|FG000|Overall Study|Mood Swings and Irritability|0
6841989|NCT00287586|10848012|FG001|Overall Study|Mood Swings and Irritability|1
6841990|NCT00287586|10848011|FG000|Overall Study|Bradycardia|0
6841991|NCT00287586|10848012|FG001|Overall Study|Bradycardia|1
6841992|NCT00287586|10848011|FG000|Overall Study|Itchy Swollen Eyes|0
6841993|NCT00287586|10848012|FG001|Overall Study|Itchy Swollen Eyes|1
6841994|NCT00287586|10848011|FG000|Overall Study|Recurrent Melanoma|0
6841995|NCT00287586|10848012|FG001|Overall Study|Recurrent Melanoma|1
6841996|NCT00287690|10848020|FG000|Overall Study|Protocol Violation|20
6841997|NCT00287690|10848021|FG001|Overall Study|Protocol Violation|26
6841998|NCT00288015|10848067|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1
6841999|NCT00288015|10848067|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1
6842000|NCT00288015|10848067|FG000|First Response Assessment|Withdrawal by Subject|1
6842001|NCT00288015|10848067|FG000|First Response Assessment|Death|1
6842002|NCT00288015|10848067|FG000|First Response Assessment|Physician Decision|2
6842003|NCT00288015|10848067|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7
6842004|NCT00288015|10848067|FG000|Follow up for Survival x 2 Years|Death|13
6842005|NCT00288015|10848067|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4
6842006|NCT00288015|10848067|FG000|Follow up for Survival x 2 Years|Other|9
6842007|NCT00288054|10848071|FG000|Overall Study|Protocol Violation|2
6842008|NCT00288054|10848071|FG000|Overall Study|Lack of Efficacy|16
6842009|NCT00288054|10848071|FG000|Overall Study|Adverse Event|3
6842010|NCT00288054|10848071|FG000|Overall Study|Withdrawal by Subject|1
6842011|NCT00288054|10848071|FG000|Overall Study|Not protocol specified|2
6842012|NCT00288509|10848092|FG000|Treatment Cycle 1|Adverse Event|1
6842013|NCT00288509|10848092|FG000|Treatment Cycle 1|Lack of Efficacy|1
6842014|NCT00288509|10848092|FG000|Treatment Cycle 1|Withdrawal by Subject|1
6842015|NCT00288509|10848092|FG000|Treatment Cycle 1|Lost to Follow-up|2
6842016|NCT00288509|10848092|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1
6842017|NCT00288509|10848092|FG000|Treatment Cycle 2|Lack of Efficacy|1
6842018|NCT00288509|10848092|FG000|Treatment Cycle 2|Withdrawal by Subject|2
6842019|NCT00288509|10848092|FG000|Treatment Cycle 3|Lack of Efficacy|1
6842020|NCT00288509|10848092|FG000|Treatment Cycle 3|Withdrawal by Subject|1
6842021|NCT00288509|10848092|FG000|Treatment Cycle 3|Lost to Follow-up|2
6842022|NCT00288509|10848092|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1
6842023|NCT00288509|10848092|FG000|Treatment Cycle 4|Withdrawal by Subject|3
6842024|NCT00288509|10848092|FG000|Treatment Cycle 4|Physician Decision|4
6842025|NCT00288509|10848092|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1
6842026|NCT00288587|10848110|FG000|Overall Study|Death|4
6842027|NCT00288587|10848111|FG001|Overall Study|Death|4
6842028|NCT00288587|10848110|FG000|Overall Study|Transplant|0
6842029|NCT00288587|10848111|FG001|Overall Study|Transplant|3
6842030|NCT00288587|10848110|FG000|Overall Study|Adverse Event|0
6842031|NCT00288587|10848111|FG001|Overall Study|Adverse Event|1
6842032|NCT00288587|10848110|FG000|Overall Study|Physician Decision|0
6842033|NCT00288587|10848111|FG001|Overall Study|Physician Decision|2
6842034|NCT00288587|10848110|FG000|Overall Study|Severe Aortic Stenosis|1
6842035|NCT00288587|10848111|FG001|Overall Study|Severe Aortic Stenosis|0
6842036|NCT00288626|10848126|FG000|Overall Study|Death|3
6842037|NCT00288626|10848126|FG000|Overall Study|Withdrawal by Subject|4
6842038|NCT00288639|10848132|FG000|Overall Study|Adverse Event|5
6842039|NCT00288639|10848132|FG000|Overall Study|Lack of Efficacy|4
6842040|NCT00288639|10848132|FG000|Overall Study|Withdrawal by Subject|2
6842041|NCT00288639|10848132|FG000|Overall Study|Other|1
6842042|NCT00288704|10848139|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
6842043|NCT00288704|10848140|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1
6842044|NCT00288704|10848141|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
6842045|NCT00288704|10848139|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
6842046|NCT00288704|10848140|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1
7151284|NCT03224598|11315138|FG000|Overall Study|Other|0
7151285|NCT03224598|11315139|FG001|Overall Study|Other|1
6842047|NCT00288704|10848141|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
6842048|NCT00288704|10848139|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
6842049|NCT00288704|10848140|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
6842050|NCT00288704|10848141|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1
6842051|NCT00288704|10848139|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
6842052|NCT00288704|10848140|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
6842053|NCT00288704|10848141|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1
6842054|NCT00288704|10848139|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0
6842055|NCT00288704|10848140|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0
6842056|NCT00288704|10848141|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2
6842057|NCT00288704|10848139|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
6842058|NCT00288704|10848140|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
6842059|NCT00288704|10848141|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15
6842060|NCT00288704|10848139|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
6842061|NCT00288704|10848140|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
6842062|NCT00288704|10848141|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1
6842063|NCT00288860|10848150|FG000|Overall Study|Did not complete intake|4
6842064|NCT00288860|10848151|FG001|Overall Study|Did not complete intake|8
6842065|NCT00288860|10848150|FG000|Overall Study|Death|4
6842066|NCT00288860|10848151|FG001|Overall Study|Death|3
6842067|NCT00288860|10848150|FG000|Overall Study|Withdrawal by Subject|20
6842068|NCT00288860|10848151|FG001|Overall Study|Withdrawal by Subject|15
6842069|NCT00288860|10848150|FG000|Overall Study|Lost to Follow-up|74
6842070|NCT00288860|10848151|FG001|Overall Study|Lost to Follow-up|71
6842071|NCT00288912|10848172|FG000|Overall Study|Developed exclusion criterion|4
6842072|NCT00288912|10848173|FG001|Overall Study|Developed exclusion criterion|6
6842073|NCT00288912|10848174|FG002|Overall Study|Developed exclusion criterion|7
7151286|NCT03224598|11315140|FG002|Overall Study|Other|0
7151287|NCT03226249|11315188|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1
7151288|NCT03226249|11315188|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29
7151289|NCT03226249|11315188|FG000|Survival Follow-up|Patients still in follow-up.|30
7151290|NCT03226275|11315196|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
7151291|NCT03226275|11315197|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
7151292|NCT03226275|11315198|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1
6842074|NCT00288912|10848172|FG000|Overall Study|Lost to Follow-up|9
6842075|NCT00288912|10848173|FG001|Overall Study|Lost to Follow-up|6
6842076|NCT00288912|10848174|FG002|Overall Study|Lost to Follow-up|9
6842077|NCT00288912|10848172|FG000|Overall Study|Withdrawal by Subject|4
6842078|NCT00288912|10848173|FG001|Overall Study|Withdrawal by Subject|5
6842079|NCT00288912|10848174|FG002|Overall Study|Withdrawal by Subject|12
6842080|NCT00289016|10848182|FG000|Overall Study|Disease Progression|29
6842081|NCT00289016|10848182|FG000|Overall Study|Death|2
6842082|NCT00289016|10848182|FG000|Overall Study|Unrelated Medical Condition or Accident|2
6842083|NCT00289016|10848182|FG000|Overall Study|Withdrawal by Subject|2
6842084|NCT00289016|10848182|FG000|Overall Study|Adverse Event|1
6842085|NCT00289016|10848182|FG000|Overall Study|Other|1
6842086|NCT00289133|10848214|FG000|Overall Study|Non-study device implanted|12
6842087|NCT00289133|10848215|FG001|Overall Study|Non-study device implanted|0
6842088|NCT00289133|10848214|FG000|Overall Study|Protocol Violation|32
6842089|NCT00289133|10848215|FG001|Overall Study|Protocol Violation|38
6842090|NCT00289133|10848214|FG000|Overall Study|Withdrawal by Subject|9
6842091|NCT00289133|10848215|FG001|Overall Study|Withdrawal by Subject|10
6842092|NCT00289133|10848214|FG000|Overall Study|Death|5
6842093|NCT00289133|10848215|FG001|Overall Study|Death|10
6842094|NCT00289133|10848214|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73
6842095|NCT00289133|10848215|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74
6842096|NCT00289133|10848214|FG000|Overall Study|Physician Decision|41
6842097|NCT00289133|10848215|FG001|Overall Study|Physician Decision|45
6842098|NCT00289133|10848214|FG000|Overall Study|Revision|8
6842099|NCT00289133|10848215|FG001|Overall Study|Revision|6
6842100|NCT00289133|10848214|FG000|Overall Study|Lost to Follow-up|92
6842101|NCT00289133|10848215|FG001|Overall Study|Lost to Follow-up|115
6842102|NCT00289185|10848227|FG000|Overall Study|Withdrawal by Subject|4
6842103|NCT00289185|10848228|FG001|Overall Study|Withdrawal by Subject|8
6842104|NCT00289185|10848227|FG000|Overall Study|Lost to Follow-up|23
6842105|NCT00289185|10848228|FG001|Overall Study|Lost to Follow-up|17
6842106|NCT00289185|10848227|FG000|Overall Study|Death|1
6842107|NCT00289185|10848228|FG001|Overall Study|Death|1
6842108|NCT00289198|10848237|FG000|Overall Study|Adverse Event|0
6842109|NCT00289198|10848238|FG001|Overall Study|Adverse Event|2
6842110|NCT00289198|10848237|FG000|Overall Study|Protocol Violation|2
6966456|NCT03621696|11014453|FG001|Overall Study|Not eligible|0
6966457|NCT03621696|11014454|FG002|Overall Study|Not eligible|0
6966458|NCT03621696|11014455|FG003|Overall Study|Not eligible|5
6966459|NCT03621696|11014452|FG000|Overall Study|Withdrawal by Subject|1
6966460|NCT03621696|11014453|FG001|Overall Study|Withdrawal by Subject|1
6966461|NCT03621696|11014454|FG002|Overall Study|Withdrawal by Subject|1
6966462|NCT03621696|11014455|FG003|Overall Study|Withdrawal by Subject|0
6966463|NCT03621696|11014452|FG000|Overall Study|Physician Decision|0
6966464|NCT03621696|11014453|FG001|Overall Study|Physician Decision|0
6966465|NCT03621696|11014454|FG002|Overall Study|Physician Decision|1
6966466|NCT03621696|11014455|FG003|Overall Study|Physician Decision|0
6966467|NCT03544268|11014465|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2
6966468|NCT03544268|11014466|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0
6966469|NCT03038438|11014518|FG000|Overall Study|Death|2
6966470|NCT03038438|11014518|FG000|Overall Study|Lost to Follow-up|4
6966471|NCT03038438|11014518|FG000|Overall Study|Subject Incarceration|1
6966472|NCT03038438|11014518|FG000|Overall Study|Withdrawal by Subject|2
6966473|NCT03038438|11014518|FG000|Overall Study|No 24-Month Follow-Up|43
6966474|NCT02451943|11014533|FG000|Overall Study|On Treatment|4
6966475|NCT02451943|11014534|FG001|Overall Study|On Treatment|4
6966476|NCT02451943|11014533|FG000|Overall Study|Withdrawal by Subject|13
6966477|NCT02451943|11014534|FG001|Overall Study|Withdrawal by Subject|16
6966478|NCT02451943|11014533|FG000|Overall Study|Lost to Follow-up|3
6966479|NCT02451943|11014534|FG001|Overall Study|Lost to Follow-up|4
6976852|NCT01202591|11029683|FG003|Overall Study|Objective Disease Progression|0
6976853|NCT01202591|11029684|FG004|Overall Study|Objective Disease Progression|2
6976854|NCT01202591|11029685|FG005|Overall Study|Objective Disease Progression|0
6976855|NCT01202747|11029736|FG000|Overall Study|Withdrawal by Subject|1
6976856|NCT01202760|11029743|FG000|Overall Study|Entry Criteria Not Met|0
6976857|NCT01202760|11029744|FG001|Overall Study|Entry Criteria Not Met|3
6976858|NCT01202760|11029745|FG002|Overall Study|Entry Criteria Not Met|1
6976859|NCT01202760|11029743|FG000|Overall Study|Adverse Event|11
6976860|NCT01202760|11029744|FG001|Overall Study|Adverse Event|9
6976861|NCT01202760|11029745|FG002|Overall Study|Adverse Event|10
6976862|NCT01202760|11029743|FG000|Overall Study|Death|2
6976863|NCT01202760|11029744|FG001|Overall Study|Death|1
6976864|NCT01202760|11029745|FG002|Overall Study|Death|0
6976865|NCT01202760|11029743|FG000|Overall Study|Lack of Efficacy|6
6976866|NCT01202760|11029744|FG001|Overall Study|Lack of Efficacy|8
6976867|NCT01202760|11029745|FG002|Overall Study|Lack of Efficacy|7
6976868|NCT01202760|11029743|FG000|Overall Study|Lost to Follow-up|0
6976869|NCT01202760|11029744|FG001|Overall Study|Lost to Follow-up|2
6976870|NCT01202760|11029745|FG002|Overall Study|Lost to Follow-up|1
6976871|NCT01202760|11029743|FG000|Overall Study|Parent / Caregiver Decision|0
6976872|NCT01202760|11029744|FG001|Overall Study|Parent / Caregiver Decision|1
6976873|NCT01202760|11029745|FG002|Overall Study|Parent / Caregiver Decision|0
6976874|NCT01202760|11029743|FG000|Overall Study|Withdrawal by Subject|17
6976875|NCT01202760|11029744|FG001|Overall Study|Withdrawal by Subject|18
6976876|NCT01202760|11029745|FG002|Overall Study|Withdrawal by Subject|14
6976877|NCT01202760|11029743|FG000|Overall Study|Physician Decision|0
6976878|NCT01202760|11029744|FG001|Overall Study|Physician Decision|1
6976879|NCT01202760|11029745|FG002|Overall Study|Physician Decision|0
6976880|NCT01202760|11029743|FG000|Overall Study|Protocol Violation|7
6976881|NCT01202760|11029744|FG001|Overall Study|Protocol Violation|5
6976882|NCT01202760|11029745|FG002|Overall Study|Protocol Violation|2
6976883|NCT01202760|11029743|FG000|Overall Study|Sponsor Decision|4
6842111|NCT00289198|10848238|FG001|Overall Study|Protocol Violation|1
6842112|NCT00289198|10848237|FG000|Overall Study|Withdrawal by Subject|4
6842113|NCT00289198|10848238|FG001|Overall Study|Withdrawal by Subject|1
6976884|NCT01202760|11029744|FG001|Overall Study|Sponsor Decision|4
6976885|NCT01202760|11029745|FG002|Overall Study|Sponsor Decision|0
6976886|NCT01202773|11029768|FG000|Overall Study|Adverse Event|4
6976887|NCT01202773|11029769|FG001|Overall Study|Adverse Event|5
6976888|NCT01202773|11029770|FG002|Overall Study|Adverse Event|5
6976889|NCT01202773|11029768|FG000|Overall Study|Lack of Efficacy|5
6976890|NCT01202773|11029769|FG001|Overall Study|Lack of Efficacy|4
6976891|NCT01202773|11029770|FG002|Overall Study|Lack of Efficacy|9
6976892|NCT01202773|11029768|FG000|Overall Study|Entry Criteria Not Met|2
6976893|NCT01202773|11029769|FG001|Overall Study|Entry Criteria Not Met|0
6976894|NCT01202773|11029770|FG002|Overall Study|Entry Criteria Not Met|1
6842114|NCT00289198|10848237|FG000|Overall Study|Lack of Efficacy|2
6842115|NCT00289198|10848238|FG001|Overall Study|Lack of Efficacy|0
6842116|NCT00289198|10848237|FG000|Overall Study|Other: Low compliance|0
6842117|NCT00289198|10848238|FG001|Overall Study|Other: Low compliance|1
6842118|NCT00289198|10848237|FG000|Overall Study|Other: Physician's decision|0
6842119|NCT00289198|10848238|FG001|Overall Study|Other: Physician's decision|1
6842120|NCT00289198|10848237|FG000|Overall Study|Other: Unable to attend on schedule|2
6842121|NCT00289198|10848238|FG001|Overall Study|Other: Unable to attend on schedule|1
6842122|NCT00289198|10848237|FG000|Overall Study|Other: Miscalculation of the visit date|21
6842123|NCT00289198|10848238|FG001|Overall Study|Other: Miscalculation of the visit date|22
6842124|NCT00289198|10848237|FG000|Overall Study|Other: Impossible to come on visit|0
6842125|NCT00289198|10848238|FG001|Overall Study|Other: Impossible to come on visit|1
6842126|NCT00289276|10848258|FG000|Second Part of FAST Study (Expansion)|Death|0
6842127|NCT00289276|10848259|FG001|Second Part of FAST Study (Expansion)|Death|2
6842128|NCT00289276|10848258|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0
6842129|NCT00289276|10848259|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1
6842130|NCT00289289|10848268|FG000|Overall Study|Withdrawal by Subject|5
6842131|NCT00289289|10848269|FG001|Overall Study|Withdrawal by Subject|3
6842132|NCT00289289|10848270|FG002|Overall Study|Withdrawal by Subject|15
6842133|NCT00289289|10848268|FG000|Overall Study|Lost to Follow-up|1
6842134|NCT00289289|10848269|FG001|Overall Study|Lost to Follow-up|0
6842135|NCT00289289|10848270|FG002|Overall Study|Lost to Follow-up|1
6842136|NCT00289289|10848268|FG000|Overall Study|Death|4
6842137|NCT00289289|10848269|FG001|Overall Study|Death|2
6842138|NCT00289289|10848270|FG002|Overall Study|Death|5
6842139|NCT00289289|10848268|FG000|Overall Study|No implant attempted|0
6842140|NCT00289289|10848269|FG001|Overall Study|No implant attempted|0
6842141|NCT00289289|10848270|FG002|Overall Study|No implant attempted|1
6842142|NCT00289289|10848268|FG000|Overall Study|Physician Decision|1
6842143|NCT00289289|10848269|FG001|Overall Study|Physician Decision|0
6842144|NCT00289289|10848270|FG002|Overall Study|Physician Decision|6
6842145|NCT00289289|10848268|FG000|Overall Study|Non-study device implanted|2
6842146|NCT00289289|10848269|FG001|Overall Study|Non-study device implanted|1
6842147|NCT00289289|10848270|FG002|Overall Study|Non-study device implanted|3
6842148|NCT00289289|10848268|FG000|Overall Study|Did not meet inclusion/exclusion|0
6842149|NCT00289289|10848269|FG001|Overall Study|Did not meet inclusion/exclusion|0
6842150|NCT00289289|10848270|FG002|Overall Study|Did not meet inclusion/exclusion|6
6842151|NCT00289289|10848268|FG000|Overall Study|Other Exit Reason|6
6842152|NCT00289289|10848269|FG001|Overall Study|Other Exit Reason|4
6842153|NCT00289289|10848270|FG002|Overall Study|Other Exit Reason|12
6842154|NCT00289458|10848306|FG000|Overall Study|Death|1
6842155|NCT00289458|10848307|FG001|Overall Study|Death|0
6842156|NCT00289458|10848308|FG002|Overall Study|Death|0
6842157|NCT00289458|10848306|FG000|Overall Study|Physician Decision|3
6842158|NCT00289458|10848307|FG001|Overall Study|Physician Decision|4
6842159|NCT00289458|10848308|FG002|Overall Study|Physician Decision|2
6842160|NCT00289458|10848306|FG000|Overall Study|Withdrawal by Subject|2
6842161|NCT00289458|10848307|FG001|Overall Study|Withdrawal by Subject|2
6842162|NCT00289458|10848308|FG002|Overall Study|Withdrawal by Subject|4
6842163|NCT00289536|10848320|FG000|Period 3|Lost to Follow-up|0
6842164|NCT00289536|10848321|FG001|Period 3|Lost to Follow-up|0
6842165|NCT00289536|10848322|FG002|Period 3|Lost to Follow-up|1
6842166|NCT00289731|10848345|FG000|Overall Study|Adverse Event|1
6842167|NCT00289731|10848346|FG001|Overall Study|Adverse Event|2
6842168|NCT00289731|10848347|FG002|Overall Study|Adverse Event|2
6842169|NCT00289731|10848345|FG000|Overall Study|Other|1
6842170|NCT00289731|10848346|FG001|Overall Study|Other|0
6842171|NCT00289731|10848347|FG002|Overall Study|Other|0
6842172|NCT00289770|10848371|FG000|Year 15|Withdrawal by Subject|1
6842173|NCT00289783|10848377|FG000|Primary Phase|Adverse Event|10
6842174|NCT00289783|10848378|FG001|Primary Phase|Adverse Event|1
6842175|NCT00289783|10848377|FG000|Primary Phase|Protocol Violation|27
6842176|NCT00289783|10848378|FG001|Primary Phase|Protocol Violation|6
7151293|NCT03226275|11315199|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
7151294|NCT03226275|11315196|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0
7151295|NCT03226275|11315197|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0
7151296|NCT03226275|11315198|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0
7151297|NCT03226275|11315199|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1
7151298|NCT03226353|11315209|FG000|Overall Study|Withdrawal by Subject|1
7151299|NCT03226353|11315209|FG000|Overall Study|Screen Failure|5
6842177|NCT00289783|10848377|FG000|Primary Phase|Withdrawal by Subject|93
6842178|NCT00289783|10848378|FG001|Primary Phase|Withdrawal by Subject|40
6842179|NCT00289783|10848377|FG000|Primary Phase|Lost to Follow-up|60
6842180|NCT00289783|10848378|FG001|Primary Phase|Lost to Follow-up|14
6842181|NCT00289783|10848377|FG000|Primary Phase|Migration from the study area|26
6842182|NCT00289783|10848378|FG001|Primary Phase|Migration from the study area|10
6842183|NCT00289783|10848377|FG000|Primary Phase|Other|32
6842184|NCT00289783|10848378|FG001|Primary Phase|Other|12
6842185|NCT00289783|10848377|FG000|Fourth Dose Phase|Adverse Event|1
6842186|NCT00289783|10848378|FG001|Fourth Dose Phase|Adverse Event|0
6842187|NCT00289783|10848377|FG000|Fourth Dose Phase|Withdrawal by Subject|10
6842188|NCT00289783|10848378|FG001|Fourth Dose Phase|Withdrawal by Subject|1
6842189|NCT00289783|10848377|FG000|Fourth Dose Phase|Lost to Follow-up|53
6842190|NCT00289783|10848378|FG001|Fourth Dose Phase|Lost to Follow-up|12
6842191|NCT00289783|10848377|FG000|Fourth Dose Phase|Migration from the study area|1
6842192|NCT00289783|10848378|FG001|Fourth Dose Phase|Migration from the study area|1
6842193|NCT00289783|10848377|FG000|Fourth Dose Phase|Other|22
6842194|NCT00289783|10848378|FG001|Fourth Dose Phase|Other|10
6842195|NCT00289848|10848394|FG000|Overall Study|Adverse Event|6
6842196|NCT00289848|10848395|FG001|Overall Study|Adverse Event|4
6842197|NCT00289848|10848394|FG000|Overall Study|Death|1
6842198|NCT00289848|10848395|FG001|Overall Study|Death|0
6842199|NCT00289848|10848394|FG000|Overall Study|Lack of Efficacy|20
6842200|NCT00289848|10848395|FG001|Overall Study|Lack of Efficacy|24
6842201|NCT00289848|10848394|FG000|Overall Study|Lost to Follow-up|3
6842202|NCT00289848|10848395|FG001|Overall Study|Lost to Follow-up|1
6842203|NCT00289848|10848394|FG000|Overall Study|Protocol Violation|5
6842204|NCT00289848|10848395|FG001|Overall Study|Protocol Violation|2
6842205|NCT00289848|10848394|FG000|Overall Study|Withdrawal by Subject|5
6842206|NCT00289848|10848395|FG001|Overall Study|Withdrawal by Subject|11
6842207|NCT00289848|10848394|FG000|Overall Study|Patient Moved|6
6842208|NCT00289848|10848395|FG001|Overall Study|Patient Moved|2
6842209|NCT00289848|10848394|FG000|Overall Study|Open-Label AHA Treatment Requested|0
6842210|NCT00289848|10848395|FG001|Overall Study|Open-Label AHA Treatment Requested|1
6842211|NCT00289900|10848407|FG000|Overall Study|Adverse Event|28
6842212|NCT00289900|10848408|FG001|Overall Study|Adverse Event|40
6842213|NCT00289900|10848409|FG002|Overall Study|Adverse Event|13
6842214|NCT00289900|10848410|FG003|Overall Study|Adverse Event|19
6842215|NCT00289900|10848411|FG004|Overall Study|Adverse Event|20
6842216|NCT00289900|10848412|FG005|Overall Study|Adverse Event|33
6842217|NCT00289900|10848407|FG000|Overall Study|Lost to Follow-up|7
6842218|NCT00289900|10848408|FG001|Overall Study|Lost to Follow-up|7
6842219|NCT00289900|10848409|FG002|Overall Study|Lost to Follow-up|8
6842220|NCT00289900|10848410|FG003|Overall Study|Lost to Follow-up|8
6842221|NCT00289900|10848411|FG004|Overall Study|Lost to Follow-up|4
6842222|NCT00289900|10848412|FG005|Overall Study|Lost to Follow-up|8
6842223|NCT00289900|10848407|FG000|Overall Study|Participant had flushing|18
6842224|NCT00289900|10848408|FG001|Overall Study|Participant had flushing|42
6842225|NCT00289900|10848409|FG002|Overall Study|Participant had flushing|1
6842226|NCT00289900|10848410|FG003|Overall Study|Participant had flushing|2
6842227|NCT00289900|10848411|FG004|Overall Study|Participant had flushing|0
6842228|NCT00289900|10848412|FG005|Overall Study|Participant had flushing|4
6842229|NCT00289900|10848407|FG000|Overall Study|Other|0
6842230|NCT00289900|10848408|FG001|Overall Study|Other|0
6842231|NCT00289900|10848409|FG002|Overall Study|Other|0
6842232|NCT00289900|10848410|FG003|Overall Study|Other|5
6842233|NCT00289900|10848411|FG004|Overall Study|Other|1
6842234|NCT00289900|10848412|FG005|Overall Study|Other|0
6842235|NCT00289900|10848407|FG000|Overall Study|Participant moved|1
6842236|NCT00289900|10848408|FG001|Overall Study|Participant moved|0
6842237|NCT00289900|10848409|FG002|Overall Study|Participant moved|0
6842238|NCT00289900|10848410|FG003|Overall Study|Participant moved|1
6842239|NCT00289900|10848411|FG004|Overall Study|Participant moved|1
6842240|NCT00289900|10848412|FG005|Overall Study|Participant moved|1
6842241|NCT00289900|10848407|FG000|Overall Study|Withdrawal by Subject|10
6842242|NCT00289900|10848408|FG001|Overall Study|Withdrawal by Subject|21
6842243|NCT00289900|10848409|FG002|Overall Study|Withdrawal by Subject|8
6842244|NCT00289900|10848410|FG003|Overall Study|Withdrawal by Subject|18
6842245|NCT00289900|10848411|FG004|Overall Study|Withdrawal by Subject|12
6842246|NCT00289900|10848412|FG005|Overall Study|Withdrawal by Subject|11
6842247|NCT00289900|10848407|FG000|Overall Study|Protocol Violation|3
6842248|NCT00289900|10848408|FG001|Overall Study|Protocol Violation|9
6842249|NCT00289900|10848409|FG002|Overall Study|Protocol Violation|2
6842250|NCT00289900|10848410|FG003|Overall Study|Protocol Violation|6
6842251|NCT00289900|10848411|FG004|Overall Study|Protocol Violation|7
6842252|NCT00289900|10848412|FG005|Overall Study|Protocol Violation|4
6842253|NCT00289900|10848407|FG000|Overall Study|site terminated|1
6842254|NCT00289900|10848408|FG001|Overall Study|site terminated|0
6842255|NCT00289900|10848409|FG002|Overall Study|site terminated|1
6842256|NCT00289900|10848410|FG003|Overall Study|site terminated|0
6842257|NCT00289900|10848411|FG004|Overall Study|site terminated|0
6842258|NCT00289900|10848412|FG005|Overall Study|site terminated|0
6842259|NCT00289900|10848407|FG000|Overall Study|Not treated|0
6842260|NCT00289900|10848408|FG001|Overall Study|Not treated|1
6842261|NCT00289900|10848409|FG002|Overall Study|Not treated|0
6842262|NCT00289900|10848410|FG003|Overall Study|Not treated|0
6842263|NCT00289900|10848411|FG004|Overall Study|Not treated|0
6842264|NCT00289900|10848412|FG005|Overall Study|Not treated|0
6842265|NCT00289913|10848434|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
6842266|NCT00289913|10848435|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1
6842267|NCT00289913|10848436|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
6842268|NCT00289913|10848437|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
6842269|NCT00289913|10848438|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
6842270|NCT00289913|10848434|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3
6842271|NCT00289913|10848435|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
6842272|NCT00289913|10848436|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
6842273|NCT00289913|10848437|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
6842274|NCT00289913|10848438|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1
6842275|NCT00289913|10848434|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
6842276|NCT00289913|10848435|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
6842277|NCT00289913|10848436|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0
6842278|NCT00289913|10848437|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
6842279|NCT00289913|10848438|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
6842280|NCT00289913|10848434|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
6842281|NCT00289913|10848435|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
6842282|NCT00289913|10848436|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
6842283|NCT00289913|10848437|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
6842284|NCT00289913|10848438|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1
6842285|NCT00289913|10848434|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
6842286|NCT00289913|10848435|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
6842287|NCT00289913|10848436|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
6842288|NCT00289913|10848437|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1
6842289|NCT00289913|10848438|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
6842290|NCT00289913|10848434|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1
6842291|NCT00289913|10848435|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2
6842292|NCT00289913|10848436|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
6842293|NCT00289913|10848437|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
6842294|NCT00289913|10848438|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
6842295|NCT00289913|10848434|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2
6842296|NCT00289913|10848435|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1
6842297|NCT00289913|10848436|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
6842298|NCT00289913|10848437|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
6842299|NCT00289913|10848438|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5
6842300|NCT00289913|10848434|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
6842301|NCT00289913|10848435|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8
6842302|NCT00289913|10848436|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5
6842303|NCT00289913|10848437|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6
6842304|NCT00289913|10848438|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
6842305|NCT00289913|10848434|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1
6842306|NCT00289913|10848435|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
6842307|NCT00289913|10848436|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2
6842308|NCT00289913|10848437|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
6842309|NCT00289913|10848438|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
6842310|NCT00289913|10848434|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
6842311|NCT00289913|10848435|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
6842312|NCT00289913|10848436|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1
6842313|NCT00289913|10848437|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
6842314|NCT00289913|10848438|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
6842315|NCT00289913|10848434|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8
6842316|NCT00289913|10848435|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11
6842317|NCT00289913|10848436|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
6842318|NCT00289913|10848437|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
6842319|NCT00289913|10848438|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0
6842320|NCT00289913|10848434|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
6842321|NCT00289913|10848435|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1
6842322|NCT00289913|10848436|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
6842323|NCT00289913|10848437|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
6842324|NCT00289913|10848438|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
6842325|NCT00289913|10848434|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3
6842326|NCT00289913|10848435|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2
6842327|NCT00289913|10848436|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1
6842328|NCT00289913|10848437|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
6842329|NCT00289913|10848438|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
6842330|NCT00289913|10848434|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
6842331|NCT00289913|10848435|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
6842332|NCT00289913|10848436|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
6842333|NCT00289913|10848437|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
6842334|NCT00289913|10848438|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
6842335|NCT00289913|10848434|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
6842336|NCT00289913|10848435|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
6842337|NCT00289913|10848436|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3
6842338|NCT00289913|10848437|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
6842339|NCT00289913|10848438|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
6842340|NCT00289913|10848434|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2
6842341|NCT00289913|10848435|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5
6842342|NCT00289913|10848436|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
6842343|NCT00289913|10848437|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3
6842344|NCT00289913|10848438|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
6842345|NCT00289913|10848434|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
6842346|NCT00289913|10848435|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1
6842347|NCT00289913|10848436|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2
6842348|NCT00289913|10848437|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
6842349|NCT00289913|10848438|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
6842350|NCT00289913|10848434|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1
6842351|NCT00289913|10848435|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
6842352|NCT00289913|10848436|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
6842353|NCT00289913|10848437|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
6842354|NCT00289913|10848438|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
6842355|NCT00289913|10848434|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
6842356|NCT00289913|10848435|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
6842357|NCT00289913|10848436|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
6842358|NCT00289913|10848437|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
6842359|NCT00289913|10848438|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7
6842360|NCT00289913|10848434|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
6842361|NCT00289913|10848435|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
6842362|NCT00289913|10848436|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
6842363|NCT00289913|10848437|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
6842364|NCT00289913|10848438|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11
6842365|NCT00289913|10848434|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
6842366|NCT00289913|10848435|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
6842367|NCT00289913|10848436|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
6842368|NCT00289913|10848437|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
6842369|NCT00289913|10848438|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6
6842370|NCT00289913|10848434|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
6842371|NCT00289913|10848435|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
6842372|NCT00289913|10848436|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
6842373|NCT00289913|10848437|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
6842374|NCT00289913|10848438|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7
6842375|NCT00289913|10848434|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
6842376|NCT00289913|10848435|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
6842377|NCT00289913|10848436|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
6842378|NCT00289913|10848437|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
6842379|NCT00289913|10848438|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9
6842380|NCT00289913|10848434|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
6842381|NCT00289913|10848435|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1
6842382|NCT00289913|10848436|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
6842383|NCT00289913|10848437|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
6842384|NCT00289913|10848438|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
6842385|NCT00289913|10848434|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8
6842386|NCT00289913|10848435|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3
6842387|NCT00289913|10848436|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1
6842388|NCT00289913|10848437|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
6842389|NCT00289913|10848438|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
6842390|NCT00289913|10848434|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
6842391|NCT00289913|10848435|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
6842392|NCT00289913|10848436|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
6842393|NCT00289913|10848437|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1
6842394|NCT00289913|10848438|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
6842395|NCT00289913|10848434|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
6842396|NCT00289913|10848435|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
6842397|NCT00289913|10848436|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
6842398|NCT00289913|10848437|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
6842399|NCT00289913|10848438|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1
6842400|NCT00289913|10848434|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
6842401|NCT00289913|10848435|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2
6842402|NCT00289913|10848436|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0
6842403|NCT00289913|10848437|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
6842404|NCT00289913|10848438|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4
6842405|NCT00289913|10848434|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
6842406|NCT00289913|10848435|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
6842407|NCT00289913|10848436|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
6842408|NCT00289913|10848437|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
6842409|NCT00289913|10848438|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
6842410|NCT00289913|10848434|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
6842411|NCT00289913|10848435|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
6842412|NCT00289913|10848436|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
6842413|NCT00289913|10848437|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
6842414|NCT00289913|10848438|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1
6842415|NCT00289913|10848434|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
6842416|NCT00289913|10848435|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1
6842417|NCT00289913|10848436|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
6842418|NCT00289913|10848437|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
6842419|NCT00289913|10848438|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
6842420|NCT00289978|10848456|FG000|Overall Study|Withdrawal by Subject|31
6842421|NCT00289978|10848457|FG001|Overall Study|Withdrawal by Subject|17
6842422|NCT00289978|10848458|FG002|Overall Study|Withdrawal by Subject|28
6842423|NCT00289978|10848456|FG000|Overall Study|Adverse Event|22
6842424|NCT00289978|10848457|FG001|Overall Study|Adverse Event|13
6842425|NCT00289978|10848458|FG002|Overall Study|Adverse Event|18
6842426|NCT00289978|10848456|FG000|Overall Study|Lack of Efficacy|13
6842427|NCT00289978|10848457|FG001|Overall Study|Lack of Efficacy|6
6842428|NCT00289978|10848458|FG002|Overall Study|Lack of Efficacy|25
6842429|NCT00289978|10848456|FG000|Overall Study|Abnormal laboratory value(s)|20
6842430|NCT00289978|10848457|FG001|Overall Study|Abnormal laboratory value(s)|9
6842431|NCT00289978|10848458|FG002|Overall Study|Abnormal laboratory value(s)|1
6842432|NCT00289978|10848456|FG000|Overall Study|Lost to Follow-up|3
6842433|NCT00289978|10848457|FG001|Overall Study|Lost to Follow-up|5
6842434|NCT00289978|10848458|FG002|Overall Study|Lost to Follow-up|7
6842435|NCT00289978|10848456|FG000|Overall Study|Protocol Violation|5
6842436|NCT00289978|10848457|FG001|Overall Study|Protocol Violation|5
6842437|NCT00289978|10848458|FG002|Overall Study|Protocol Violation|4
6842438|NCT00289978|10848456|FG000|Overall Study|Abnormal test procedure result(s)|2
6842439|NCT00289978|10848457|FG001|Overall Study|Abnormal test procedure result(s)|1
6842440|NCT00289978|10848458|FG002|Overall Study|Abnormal test procedure result(s)|1
6842441|NCT00289978|10848456|FG000|Overall Study|Death|1
6842442|NCT00289978|10848457|FG001|Overall Study|Death|0
6842443|NCT00289978|10848458|FG002|Overall Study|Death|2
6842444|NCT00289991|10848468|FG000|Overall Study|Death|35
6842445|NCT00289991|10848469|FG001|Overall Study|Death|38
6842446|NCT00289991|10848468|FG000|Overall Study|Adverse Event|15
6842447|NCT00289991|10848469|FG001|Overall Study|Adverse Event|13
6842448|NCT00289991|10848468|FG000|Overall Study|Failure of prophylaxis|1
6842449|NCT00289991|10848469|FG001|Overall Study|Failure of prophylaxis|1
6842450|NCT00289991|10848468|FG000|Overall Study|Fungal breakthrough infection|0
6842451|NCT00289991|10848469|FG001|Overall Study|Fungal breakthrough infection|1
6842452|NCT00289991|10848468|FG000|Overall Study|Lost to Follow-up|0
6842453|NCT00289991|10848469|FG001|Overall Study|Lost to Follow-up|1
6842454|NCT00289991|10848468|FG000|Overall Study|Withdrawal by Subject|2
6842455|NCT00289991|10848469|FG001|Overall Study|Withdrawal by Subject|12
6842456|NCT00289991|10848468|FG000|Overall Study|Other|5
6842457|NCT00289991|10848469|FG001|Overall Study|Other|14
6842458|NCT00290186|10848486|FG000|Overall Study|Adverse Event|1
6842459|NCT00290186|10848487|FG001|Overall Study|Adverse Event|1
6842460|NCT00290186|10848486|FG000|Overall Study|Lost to Follow-up|3
6842461|NCT00290186|10848487|FG001|Overall Study|Lost to Follow-up|2
6842462|NCT00290186|10848486|FG000|Overall Study|Study was terminated prior to 3-month te|1
6842463|NCT00290186|10848487|FG001|Overall Study|Study was terminated prior to 3-month te|1
6842464|NCT00290186|10848486|FG000|Overall Study|Withdrawal by Subject|0
6842465|NCT00290186|10848487|FG001|Overall Study|Withdrawal by Subject|1
6842466|NCT00290238|10848508|FG000|Overall Study|Study terminated|27
6842467|NCT00290238|10848509|FG001|Overall Study|Study terminated|27
6842468|NCT00290238|10848508|FG000|Overall Study|Lost to Follow-up|0
6842469|NCT00290238|10848509|FG001|Overall Study|Lost to Follow-up|1
6842470|NCT00290238|10848508|FG000|Overall Study|Withdrawal by Subject|15
6842471|NCT00290238|10848509|FG001|Overall Study|Withdrawal by Subject|13
6842472|NCT00290290|10848517|FG000|Overall Study|Death|3
6842473|NCT00290290|10848518|FG001|Overall Study|Death|4
6842474|NCT00290290|10848517|FG000|Overall Study|Withdrawal by Subject|2
6842475|NCT00290290|10848518|FG001|Overall Study|Withdrawal by Subject|2
6842476|NCT00290290|10848517|FG000|Overall Study|Underwent clean surgical procedure|13
6842477|NCT00290290|10848518|FG001|Overall Study|Underwent clean surgical procedure|12
6842478|NCT00290342|10848541|FG000|Overall Study|Other|0
6842479|NCT00290342|10848542|FG001|Overall Study|Other|1
6842480|NCT00290342|10848541|FG000|Overall Study|Withdrawal by Subject|6
6842481|NCT00290342|10848542|FG001|Overall Study|Withdrawal by Subject|4
6842482|NCT00290342|10848541|FG000|Overall Study|Lost to Follow-up|1
6842483|NCT00290342|10848542|FG001|Overall Study|Lost to Follow-up|0
6842484|NCT00290355|10848550|FG000|Overall Study|Serious adverse event|7
6842485|NCT00290355|10848551|FG001|Overall Study|Serious adverse event|4
6842486|NCT00290355|10848550|FG000|Overall Study|Study product reactogenicity|1
6842487|NCT00290355|10848551|FG001|Overall Study|Study product reactogenicity|0
6842488|NCT00290355|10848550|FG000|Overall Study|Protocol Violation|1
6842489|NCT00290355|10848551|FG001|Overall Study|Protocol Violation|0
6842490|NCT00290355|10848550|FG000|Overall Study|Withdrawal by Subject|2
6842491|NCT00290355|10848551|FG001|Overall Study|Withdrawal by Subject|0
6842492|NCT00290355|10848550|FG000|Overall Study|Migrated / moved from the study area|1
6842493|NCT00290355|10848551|FG001|Overall Study|Migrated / moved from the study area|0
6842494|NCT00290355|10848550|FG000|Overall Study|Lost to Follow-up|3
6842495|NCT00290355|10848551|FG001|Overall Study|Lost to Follow-up|1
6842496|NCT00290355|10848550|FG000|Overall Study|Other|2
6842497|NCT00290355|10848551|FG001|Overall Study|Other|0
6842498|NCT00290433|10848557|FG000|Overall Study|Disease Progression|13
6842499|NCT00290433|10848557|FG000|Overall Study|Adverse Event|14
6842500|NCT00290433|10848557|FG000|Overall Study|Withdrawal by Subject|1
6842501|NCT00290433|10848557|FG000|Overall Study|Non-Compliance|1
6842502|NCT00290433|10848557|FG000|Overall Study|Congestive Heart Failure|1
6842503|NCT00290433|10848557|FG000|Overall Study|Transplant in CR|5
6842504|NCT00290433|10848557|FG000|Overall Study|Unrelated Infection/Death|1
6842505|NCT00290498|10848574|FG000|Overall Study|Death|2
6842506|NCT00290498|10848575|FG001|Overall Study|Death|0
6842507|NCT00290498|10848574|FG000|Overall Study|Physician Decision|1
6842508|NCT00290498|10848575|FG001|Overall Study|Physician Decision|0
6842509|NCT00290498|10848574|FG000|Overall Study|Withdrawal by Subject|1
6842510|NCT00290498|10848575|FG001|Overall Study|Withdrawal by Subject|0
6842511|NCT00290498|10848574|FG000|Overall Study|Ineligible|3
6842512|NCT00290498|10848575|FG001|Overall Study|Ineligible|0
6842513|NCT00290498|10848574|FG000|Overall Study|Non-Compliance|1
6842514|NCT00290498|10848575|FG001|Overall Study|Non-Compliance|0
6842515|NCT00290589|10848590|FG000|Overall Study|Lost to Follow-up|2
6842516|NCT00290589|10848591|FG001|Overall Study|Lost to Follow-up|2
6842517|NCT00290693|10848605|FG000|Overall Study|Withdrawal by Subject|2
6842518|NCT00290706|10848614|FG000|Overall Study|Withdrawal by Subject|2
6842519|NCT00290706|10848615|FG001|Overall Study|Withdrawal by Subject|0
6842520|NCT00290706|10848616|FG002|Overall Study|Withdrawal by Subject|0
6842521|NCT00290706|10848617|FG003|Overall Study|Withdrawal by Subject|0
6842522|NCT00290706|10848614|FG000|Overall Study|Progressive Disease|3
6842523|NCT00290706|10848615|FG001|Overall Study|Progressive Disease|5
6842524|NCT00290706|10848616|FG002|Overall Study|Progressive Disease|4
6842525|NCT00290706|10848617|FG003|Overall Study|Progressive Disease|10
6842526|NCT00290706|10848614|FG000|Overall Study|Adverse Event|0
6842527|NCT00290706|10848615|FG001|Overall Study|Adverse Event|1
6842528|NCT00290706|10848616|FG002|Overall Study|Adverse Event|2
6842529|NCT00290706|10848617|FG003|Overall Study|Adverse Event|0
6842530|NCT00290706|10848614|FG000|Overall Study|Receive auto transplant or radiation|0
6842531|NCT00290706|10848615|FG001|Overall Study|Receive auto transplant or radiation|0
6842532|NCT00290706|10848616|FG002|Overall Study|Receive auto transplant or radiation|0
6842533|NCT00290706|10848617|FG003|Overall Study|Receive auto transplant or radiation|1
6842534|NCT00290706|10848614|FG000|Overall Study|Physician Decision|0
6842535|NCT00290706|10848615|FG001|Overall Study|Physician Decision|0
6842536|NCT00290706|10848616|FG002|Overall Study|Physician Decision|0
6842537|NCT00290706|10848617|FG003|Overall Study|Physician Decision|1
6842538|NCT00290732|10848630|FG000|Overall Study|Inability to instill drug intraductally.|0
6842539|NCT00290732|10848631|FG001|Overall Study|Inability to instill drug intraductally.|1
6842540|NCT00290732|10848632|FG002|Overall Study|Inability to instill drug intraductally.|1
6842541|NCT00290732|10848633|FG003|Overall Study|Inability to instill drug intraductally.|0
6842542|NCT00290732|10848634|FG004|Overall Study|Inability to instill drug intraductally.|0
6842543|NCT00290745|10848647|FG000|Overall Study|Withdrawal by Subject|4
6842544|NCT00290745|10848647|FG000|Overall Study|Physician Decision|2
6842545|NCT00290745|10848647|FG000|Overall Study|Surgery after 3 months for progression|3
6842546|NCT00290745|10848647|FG000|Overall Study|Baseline MRI not available|3
6842547|NCT00290771|10848653|FG000|Overall Study|Disease progression|95
6842548|NCT00290771|10848654|FG001|Overall Study|Disease progression|73
6842549|NCT00290771|10848653|FG000|Overall Study|Death|11
6842550|NCT00290771|10848654|FG001|Overall Study|Death|10
6842551|NCT00290771|10848653|FG000|Overall Study|Adverse Event|12
6842552|NCT00290771|10848654|FG001|Overall Study|Adverse Event|6
6842553|NCT00290771|10848653|FG000|Overall Study|Withdrawal by Subject|5
6842554|NCT00290771|10848654|FG001|Overall Study|Withdrawal by Subject|6
6842555|NCT00290771|10848653|FG000|Overall Study|Administrative problems|2
6842556|NCT00290771|10848654|FG001|Overall Study|Administrative problems|1
6842557|NCT00290771|10848653|FG000|Overall Study|Protocol Violation|2
6842558|NCT00290771|10848654|FG001|Overall Study|Protocol Violation|0
6842559|NCT00290771|10848653|FG000|Overall Study|Lost to Follow-up|0
6842560|NCT00290771|10848654|FG001|Overall Study|Lost to Follow-up|1
6897781|NCT00642746|10916877|FG000|Overall Study|Patient unevaluable|1
6897782|NCT00642746|10916878|FG001|Overall Study|Patient unevaluable|0
6897783|NCT00642759|10916884|FG000|Overall Study|Protocol Violation|1
6897784|NCT00642772|10916889|FG000|Overall Study|Lost to Follow-up|3
6897785|NCT00642772|10916889|FG000|Overall Study|Withdrawal by Subject|7
6897786|NCT00642811|10916899|FG000|Overall Study|Adverse Event|2
6897787|NCT00642811|10916900|FG001|Overall Study|Adverse Event|3
6897788|NCT00642811|10916901|FG002|Overall Study|Adverse Event|0
6842561|NCT00290888|10848667|FG000|Overall Study|Physician Decision|3
6842562|NCT00290888|10848668|FG001|Overall Study|Physician Decision|1
6842563|NCT00291018|10848678|FG000|Overall Study|Not Consented or Declined PAS|12
6842564|NCT00291018|10848679|FG001|Overall Study|Not Consented or Declined PAS|15
6842565|NCT00291018|10848680|FG002|Overall Study|Not Consented or Declined PAS|15
6842566|NCT00291018|10848678|FG000|Overall Study|Death|3
6842567|NCT00291018|10848679|FG001|Overall Study|Death|3
6842568|NCT00291018|10848680|FG002|Overall Study|Death|4
6842569|NCT00291018|10848678|FG000|Overall Study|Withdrawal by Subject|2
6842570|NCT00291018|10848679|FG001|Overall Study|Withdrawal by Subject|8
6842571|NCT00291018|10848680|FG002|Overall Study|Withdrawal by Subject|1
6842572|NCT00291018|10848678|FG000|Overall Study|Failures|5
6842573|NCT00291018|10848679|FG001|Overall Study|Failures|12
6842574|NCT00291018|10848680|FG002|Overall Study|Failures|5
6842575|NCT00291018|10848678|FG000|Overall Study|Lost to Follow-up|3
6842576|NCT00291018|10848679|FG001|Overall Study|Lost to Follow-up|4
6842577|NCT00291018|10848680|FG002|Overall Study|Lost to Follow-up|18
6842578|NCT00291187|10848714|FG000|Overall Study|Protocol Violation- No Drug Administered|0
6842579|NCT00291187|10848715|FG001|Overall Study|Protocol Violation- No Drug Administered|0
6842580|NCT00291187|10848716|FG002|Overall Study|Protocol Violation- No Drug Administered|1
6842581|NCT00291187|10848717|FG003|Overall Study|Protocol Violation- No Drug Administered|0
6842582|NCT00291330|10848747|FG000|Overall Study|Adverse Event|47
6842583|NCT00291330|10848748|FG001|Overall Study|Adverse Event|40
6842584|NCT00291330|10848747|FG000|Overall Study|Protocol Violation|13
6842585|NCT00291330|10848748|FG001|Overall Study|Protocol Violation|20
6842586|NCT00291330|10848747|FG000|Overall Study|Lost to Follow-up|16
6842587|NCT00291330|10848748|FG001|Overall Study|Lost to Follow-up|11
6842588|NCT00291330|10848747|FG000|Overall Study|Withdrawal by Subject|22
6842589|NCT00291330|10848748|FG001|Overall Study|Withdrawal by Subject|25
6842590|NCT00291330|10848747|FG000|Overall Study|Other|3
6842591|NCT00291330|10848748|FG001|Overall Study|Other|1
6842592|NCT00291499|10848783|FG000|Overall Study|Adverse Event|3
6842593|NCT00291499|10848784|FG001|Overall Study|Adverse Event|8
6842594|NCT00291499|10848783|FG000|Overall Study|Change to other therapy|2
6842595|NCT00291499|10848784|FG001|Overall Study|Change to other therapy|1
6842596|NCT00291499|10848783|FG000|Overall Study|Intercurrent illness|1
6842597|NCT00291499|10848784|FG001|Overall Study|Intercurrent illness|0
6842598|NCT00291499|10848783|FG000|Overall Study|Protocol Violation|2
6842599|NCT00291499|10848784|FG001|Overall Study|Protocol Violation|2
6842600|NCT00291499|10848783|FG000|Overall Study|Other reasons|1
6842601|NCT00291499|10848784|FG001|Overall Study|Other reasons|4
6842602|NCT00291551|10848790|FG000|Overall Study|Death|7
6842603|NCT00291551|10848790|FG000|Overall Study|Withdrawal by Subject|6
6842604|NCT00291577|10848795|FG000|Overall Study|Adverse Event|1
6842605|NCT00291577|10848795|FG000|Overall Study|Other|4
6842606|NCT00291577|10848795|FG000|Overall Study|Withdrawal by Subject|2
6842607|NCT00291577|10848795|FG000|Overall Study|Lack of Efficacy|14
6842608|NCT00291642|10848804|FG000|Overall Study|Adverse Event|1
6842609|NCT00291642|10848805|FG001|Overall Study|Adverse Event|0
6842610|NCT00291642|10848806|FG002|Overall Study|Adverse Event|1
6842611|NCT00291642|10848807|FG003|Overall Study|Adverse Event|0
6842612|NCT00291642|10848808|FG004|Overall Study|Adverse Event|1
6842613|NCT00291642|10848804|FG000|Overall Study|Patient missed visit|0
6842614|NCT00291642|10848805|FG001|Overall Study|Patient missed visit|0
6842615|NCT00291642|10848806|FG002|Overall Study|Patient missed visit|1
6842616|NCT00291642|10848807|FG003|Overall Study|Patient missed visit|0
6842617|NCT00291642|10848808|FG004|Overall Study|Patient missed visit|0
6842618|NCT00291642|10848804|FG000|Overall Study|Intake of prohibited medication|1
6842619|NCT00291642|10848805|FG001|Overall Study|Intake of prohibited medication|0
6842620|NCT00291642|10848806|FG002|Overall Study|Intake of prohibited medication|0
6842621|NCT00291642|10848807|FG003|Overall Study|Intake of prohibited medication|0
6842622|NCT00291642|10848808|FG004|Overall Study|Intake of prohibited medication|0
6842623|NCT00291668|10848827|FG000|Overall Study|Lack of Efficacy|1
6842624|NCT00291668|10848828|FG001|Overall Study|Lack of Efficacy|0
6842625|NCT00291668|10848829|FG002|Overall Study|Lack of Efficacy|0
6842626|NCT00291668|10848827|FG000|Overall Study|SAE, non-fatal|1
6842627|NCT00291668|10848828|FG001|Overall Study|SAE, non-fatal|1
7077221|NCT02088697|11184563|FG001|Period I|Physician Decision|4
7077222|NCT02088697|11184562|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1
7077223|NCT02088697|11184563|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0
7077224|NCT02088905|11184580|FG000|Overall Study|Withdrawal by Subject|5
7077225|NCT02088905|11184581|FG001|Overall Study|Withdrawal by Subject|1
7077226|NCT02089230|11184606|FG000|Overall Study|Death|0
7077227|NCT02089230|11184607|FG001|Overall Study|Death|0
7077228|NCT02089230|11184608|FG002|Overall Study|Death|2
7077229|NCT02089230|11184606|FG000|Overall Study|Seeking Alternative Therapy|0
7077230|NCT02089230|11184607|FG001|Overall Study|Seeking Alternative Therapy|0
7077231|NCT02089230|11184608|FG002|Overall Study|Seeking Alternative Therapy|4
7077232|NCT02089334|11184620|FG000|Overall Study|Withdrawal by Subject|0
6842628|NCT00291668|10848829|FG002|Overall Study|SAE, non-fatal|1
6842629|NCT00291668|10848827|FG000|Overall Study|AE, non-serious non-fatal|1
6842630|NCT00291668|10848828|FG001|Overall Study|AE, non-serious non-fatal|0
7077233|NCT02089334|11184621|FG001|Overall Study|Withdrawal by Subject|0
7077234|NCT02089334|11184622|FG002|Overall Study|Withdrawal by Subject|0
7151300|NCT03226392|11315235|FG000|Overall Study|Protocol Deviation|1
7151301|NCT03226392|11315236|FG001|Overall Study|Protocol Deviation|0
7151302|NCT03226392|11315235|FG000|Overall Study|Physician Decision|1
6842631|NCT00291668|10848829|FG002|Overall Study|AE, non-serious non-fatal|0
6842632|NCT00291668|10848827|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
6842633|NCT00291668|10848828|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
6842634|NCT00291668|10848829|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
6842635|NCT00292045|10848852|FG000|Core Study (Through Week 13)|Adverse Event|1
6842636|NCT00292045|10848852|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1
6842637|NCT00292188|10848867|FG000|Single-Blind|Adverse Event|14
7077235|NCT02089334|11184623|FG003|Overall Study|Withdrawal by Subject|2
6842638|NCT00292188|10848868|FG001|Single-Blind|Adverse Event|0
6842639|NCT00292188|10848869|FG002|Single-Blind|Adverse Event|0
6842640|NCT00292188|10848867|FG000|Single-Blind|Lack of Efficacy|2
6842641|NCT00292188|10848868|FG001|Single-Blind|Lack of Efficacy|0
6842642|NCT00292188|10848869|FG002|Single-Blind|Lack of Efficacy|0
6842643|NCT00292188|10848867|FG000|Single-Blind|Laboratory Abnormality|5
6842644|NCT00292188|10848868|FG001|Single-Blind|Laboratory Abnormality|0
6842645|NCT00292188|10848869|FG002|Single-Blind|Laboratory Abnormality|0
6842646|NCT00292188|10848867|FG000|Single-Blind|Lost to Follow-up|3
6842647|NCT00292188|10848868|FG001|Single-Blind|Lost to Follow-up|0
6842648|NCT00292188|10848869|FG002|Single-Blind|Lost to Follow-up|0
6842649|NCT00292188|10848867|FG000|Single-Blind|Other|77
6842650|NCT00292188|10848868|FG001|Single-Blind|Other|0
6842651|NCT00292188|10848869|FG002|Single-Blind|Other|0
6842652|NCT00292188|10848867|FG000|Single-Blind|Withdrawal by Subject|12
6842653|NCT00292188|10848868|FG001|Single-Blind|Withdrawal by Subject|0
6842654|NCT00292188|10848869|FG002|Single-Blind|Withdrawal by Subject|0
6842655|NCT00292188|10848867|FG000|Single-Blind|Did not receive treatment|1
6842656|NCT00292188|10848868|FG001|Single-Blind|Did not receive treatment|0
6842657|NCT00292188|10848869|FG002|Single-Blind|Did not receive treatment|0
6842658|NCT00292188|10848867|FG000|Double-Blind|Adverse Event|0
6842659|NCT00292188|10848868|FG001|Double-Blind|Adverse Event|25
6842660|NCT00292188|10848869|FG002|Double-Blind|Adverse Event|9
6842661|NCT00292188|10848867|FG000|Double-Blind|Lack of Efficacy|0
6842662|NCT00292188|10848868|FG001|Double-Blind|Lack of Efficacy|2
6842663|NCT00292188|10848869|FG002|Double-Blind|Lack of Efficacy|12
6842664|NCT00292188|10848867|FG000|Double-Blind|Lost to Follow-up|0
6842665|NCT00292188|10848868|FG001|Double-Blind|Lost to Follow-up|1
6842666|NCT00292188|10848869|FG002|Double-Blind|Lost to Follow-up|0
6842667|NCT00292188|10848867|FG000|Double-Blind|Other|0
6842668|NCT00292188|10848868|FG001|Double-Blind|Other|3
6842669|NCT00292188|10848869|FG002|Double-Blind|Other|4
6842670|NCT00292188|10848867|FG000|Double-Blind|Withdrawal by Subject|0
6842671|NCT00292188|10848868|FG001|Double-Blind|Withdrawal by Subject|0
6842672|NCT00292188|10848869|FG002|Double-Blind|Withdrawal by Subject|3
6842673|NCT00292188|10848867|FG000|Double-Blind|Laboratory Abnormality|0
6842674|NCT00292188|10848868|FG001|Double-Blind|Laboratory Abnormality|0
6842675|NCT00292188|10848869|FG002|Double-Blind|Laboratory Abnormality|1
6842676|NCT00292227|10848878|FG000|Patch Period|Adverse Event|1
6842677|NCT00292227|10848879|FG001|Patch Period|Adverse Event|0
6842678|NCT00292227|10848880|FG002|Patch Period|Adverse Event|2
6842679|NCT00292227|10848878|FG000|Patch Period|Withdrawal by Subject|0
6842680|NCT00292227|10848879|FG001|Patch Period|Withdrawal by Subject|0
6842681|NCT00292227|10848880|FG002|Patch Period|Withdrawal by Subject|1
6842682|NCT00292318|10848890|FG000|Overall Study|Study terminated by officials|2
6842683|NCT00292318|10848891|FG001|Overall Study|Study terminated by officials|1
6842684|NCT00292370|10848900|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12
6842685|NCT00292370|10848901|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
6842686|NCT00292370|10848902|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
6842687|NCT00292370|10848900|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22
6842688|NCT00292370|10848901|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
6842689|NCT00292370|10848902|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
6842690|NCT00292370|10848900|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8
6842691|NCT00292370|10848901|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
6842692|NCT00292370|10848902|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
6842693|NCT00292370|10848900|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4
6842694|NCT00292370|10848901|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
6842695|NCT00292370|10848902|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
6842696|NCT00292370|10848900|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0
7077236|NCT02089334|11184620|FG000|Overall Study|Adverse Event|0
7077237|NCT02089334|11184621|FG001|Overall Study|Adverse Event|0
7077238|NCT02089334|11184622|FG002|Overall Study|Adverse Event|0
7077239|NCT02089334|11184623|FG003|Overall Study|Adverse Event|2
7077240|NCT02089334|11184620|FG000|Overall Study|Progressive disease|0
7077241|NCT02089334|11184621|FG001|Overall Study|Progressive disease|0
7077242|NCT02089334|11184622|FG002|Overall Study|Progressive disease|0
7151303|NCT03226392|11315236|FG001|Overall Study|Physician Decision|0
7077243|NCT02089334|11184623|FG003|Overall Study|Progressive disease|2
7077244|NCT02089334|11184620|FG000|Overall Study|Physician Decision|0
7077245|NCT02089334|11184621|FG001|Overall Study|Physician Decision|0
6842697|NCT00292370|10848901|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3
6842698|NCT00292370|10848902|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2
6842699|NCT00292370|10848900|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0
6842700|NCT00292370|10848901|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1
6842701|NCT00292370|10848902|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5
6842702|NCT00292461|10848911|FG000|Overall Study|Adverse Event|4
6842703|NCT00292461|10848912|FG001|Overall Study|Adverse Event|2
6842704|NCT00292461|10848911|FG000|Overall Study|Lack of Efficacy|1
6842705|NCT00292461|10848912|FG001|Overall Study|Lack of Efficacy|0
6842706|NCT00292461|10848911|FG000|Overall Study|Withdrawal by Subject|0
6842707|NCT00292461|10848912|FG001|Overall Study|Withdrawal by Subject|1
6842708|NCT00292461|10848911|FG000|Overall Study|Protocol Violation|4
6842709|NCT00292461|10848912|FG001|Overall Study|Protocol Violation|3
6842710|NCT00292461|10848911|FG000|Overall Study|Lost to Follow-up|1
6842711|NCT00292461|10848912|FG001|Overall Study|Lost to Follow-up|0
6842712|NCT00292942|10848935|FG000|Overall Study|Withdrawal by Subject|0
6842713|NCT00292942|10848936|FG001|Overall Study|Withdrawal by Subject|0
6842714|NCT00292942|10848937|FG002|Overall Study|Withdrawal by Subject|1
6842715|NCT00292942|10848938|FG003|Overall Study|Withdrawal by Subject|0
6842716|NCT00292942|10848935|FG000|Overall Study|Adverse Event|0
6842717|NCT00292942|10848936|FG001|Overall Study|Adverse Event|0
6842718|NCT00292942|10848937|FG002|Overall Study|Adverse Event|0
6842719|NCT00292942|10848938|FG003|Overall Study|Adverse Event|1
6842720|NCT00292981|10848951|FG000|Overall Study|Adverse Event|1
6842721|NCT00292981|10848951|FG000|Overall Study|Lost to Follow-up|13
6842722|NCT00292981|10848951|FG000|Overall Study|Withdrawal by Subject|22
6842723|NCT00292981|10848951|FG000|Overall Study|Other|3
6842724|NCT00293020|10848955|FG000|Overall Study|Withdrawal by Subject|34
6842725|NCT00293020|10848955|FG000|Overall Study|Adverse Event|30
6842726|NCT00293020|10848955|FG000|Overall Study|Death|32
6842727|NCT00293020|10848955|FG000|Overall Study|Lack of Efficacy|12
6842728|NCT00293020|10848955|FG000|Overall Study|Lost to Follow-up|4
6842729|NCT00293020|10848955|FG000|Overall Study|Protocol Violation|6
6842730|NCT00293020|10848955|FG000|Overall Study|Physician Decision|21
6842731|NCT00293020|10848955|FG000|Overall Study|Other Reason|22
6842732|NCT00293020|10848955|FG000|Overall Study|No dose taken|1
6842733|NCT00293033|10848959|FG000|Open-label Titration Period|Adverse Event|10
6842734|NCT00293033|10848959|FG000|Open-label Titration Period|Death|3
6842735|NCT00293033|10848959|FG000|Open-label Titration Period|Lack of Efficacy|5
6842736|NCT00293033|10848959|FG000|Open-label Titration Period|Protocol Violation|2
6842737|NCT00293033|10848959|FG000|Open-label Titration Period|Withdrawal by Subject|22
6842738|NCT00293033|10848959|FG000|Open-label Titration Period|Noncompliance and other|27
6842739|NCT00293033|10848959|FG000|Double-blind Treatment Period|Adverse Event|3
6842740|NCT00293033|10848959|FG000|Double-blind Treatment Period|Lack of Efficacy|1
6842741|NCT00293033|10848959|FG000|Double-blind Treatment Period|Withdrawal by Subject|4
6842742|NCT00293033|10848959|FG000|Double-blind Treatment Period|Noncompliance|4
6842743|NCT00293059|10848969|FG000|Overall Study|Adverse Event|12
6842744|NCT00293059|10848970|FG001|Overall Study|Adverse Event|4
6842745|NCT00293059|10848969|FG000|Overall Study|Lack of Efficacy|2
6842746|NCT00293059|10848970|FG001|Overall Study|Lack of Efficacy|0
6842747|NCT00293059|10848969|FG000|Overall Study|Lost to Follow-up|2
6842748|NCT00293059|10848970|FG001|Overall Study|Lost to Follow-up|3
6842749|NCT00293059|10848969|FG000|Overall Study|Pregnancy|1
6842750|NCT00293059|10848970|FG001|Overall Study|Pregnancy|1
6842751|NCT00293059|10848969|FG000|Overall Study|Protocol Violation|2
6842752|NCT00293059|10848970|FG001|Overall Study|Protocol Violation|0
6842753|NCT00293059|10848969|FG000|Overall Study|Withdrawal by Subject|11
6842754|NCT00293059|10848970|FG001|Overall Study|Withdrawal by Subject|5
6842755|NCT00293059|10848969|FG000|Overall Study|Participant moved out of state|1
6842756|NCT00293059|10848970|FG001|Overall Study|Participant moved out of state|0
6842757|NCT00293059|10848969|FG000|Overall Study|Participant stopped study drug|1
6842758|NCT00293059|10848970|FG001|Overall Study|Participant stopped study drug|0
6842759|NCT00293059|10848969|FG000|Overall Study|Noncompliant - sanitary pads collection|0
6842760|NCT00293059|10848970|FG001|Overall Study|Noncompliant - sanitary pads collection|1
6842761|NCT00293059|10848969|FG000|Overall Study|missing|3
6842762|NCT00293059|10848970|FG001|Overall Study|missing|5
6842763|NCT00293202|10848978|FG000|Overall Study|Withdrawal by Subject|1
6842764|NCT00293202|10848979|FG001|Overall Study|Withdrawal by Subject|2
6842765|NCT00293202|10848978|FG000|Overall Study|positive ANA (antinuclear antibody)|1
6842766|NCT00293202|10848979|FG001|Overall Study|positive ANA (antinuclear antibody)|0
6842767|NCT00293202|10848978|FG000|Overall Study|on-hold due to fistula maturation time|1
6842768|NCT00293202|10848979|FG001|Overall Study|on-hold due to fistula maturation time|0
6842769|NCT00293215|10848991|FG000|Overall Study|Progressive disease|3
6842770|NCT00293215|10848992|FG001|Overall Study|Progressive disease|1
6842771|NCT00293215|10848991|FG000|Overall Study|Adverse Event|2
6842772|NCT00293215|10848992|FG001|Overall Study|Adverse Event|2
6842773|NCT00293241|10849000|FG000|Overall Study|Lost to Follow-up|9
6842774|NCT00293241|10849001|FG001|Overall Study|Lost to Follow-up|16
6842775|NCT00293241|10849000|FG000|Overall Study|Physician Decision|23
6842776|NCT00293241|10849001|FG001|Overall Study|Physician Decision|17
6842777|NCT00293241|10849000|FG000|Overall Study|Withdrawal by Subject|4
6842778|NCT00293241|10849001|FG001|Overall Study|Withdrawal by Subject|8
6842779|NCT00293254|10849012|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2
6842780|NCT00293254|10849013|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0
6842781|NCT00293254|10849012|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2
6842782|NCT00293254|10849013|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1
6842783|NCT00293254|10849012|FG000|Primary Study - Double-Blind Week 0-48|Death|5
6842784|NCT00293254|10849013|FG001|Primary Study - Double-Blind Week 0-48|Death|2
6842785|NCT00293254|10849012|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
6842786|NCT00293254|10849013|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
6842787|NCT00293254|10849012|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3
6842788|NCT00293254|10849013|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
6842789|NCT00293254|10849012|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5
6842790|NCT00293254|10849013|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
6842791|NCT00293254|10849012|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1
6842792|NCT00293254|10849013|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0
6842793|NCT00293254|10849012|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35
6842794|NCT00293254|10849013|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57
6842795|NCT00293254|10849012|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4
6842796|NCT00293254|10849013|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1
6842797|NCT00293254|10849012|FG000|Extension - Double-Blind Week 49-156|Death|4
6842798|NCT00293254|10849013|FG001|Extension - Double-Blind Week 49-156|Death|1
6842799|NCT00293254|10849012|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3
6842800|NCT00293254|10849013|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4
6842801|NCT00293254|10849012|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
6842802|NCT00293254|10849013|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
6842803|NCT00293254|10849012|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12
6842804|NCT00293254|10849013|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8
6842805|NCT00293254|10849012|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6
6842806|NCT00293254|10849013|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3
6842807|NCT00293254|10849012|FG000|Extension - Double-Blind Week 49-156|Other Reason|10
6842808|NCT00293254|10849013|FG001|Extension - Double-Blind Week 49-156|Other Reason|2
6842809|NCT00293254|10849012|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
6842810|NCT00293254|10849013|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7
6842811|NCT00293254|10849012|FG000|Extension - Open-Label Week 157-240|Adverse Event|2
6842812|NCT00293254|10849013|FG001|Extension - Open-Label Week 157-240|Adverse Event|1
6842813|NCT00293254|10849012|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1
6842814|NCT00293254|10849013|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0
6842815|NCT00293254|10849012|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
6842816|NCT00293254|10849013|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0
6842817|NCT00293254|10849012|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2
6842818|NCT00293254|10849013|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0
6842819|NCT00293254|10849012|FG000|Extension - Open-Label Week 157-240|Other Reason|4
6842820|NCT00293254|10849013|FG001|Extension - Open-Label Week 157-240|Other Reason|0
6842821|NCT00293254|10849012|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4
6842822|NCT00293254|10849013|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7
6842823|NCT00293254|10849012|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16
6842824|NCT00293254|10849013|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14
6842825|NCT00293254|10849012|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6
6842826|NCT00293254|10849013|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3
6842827|NCT00293254|10849012|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3
6842828|NCT00293254|10849013|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0
6842829|NCT00293254|10849012|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
6842830|NCT00293254|10849013|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
6842831|NCT00293254|10849012|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1
6842832|NCT00293254|10849013|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2
6842833|NCT00293267|10849023|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2
6842834|NCT00293267|10849024|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0
6842835|NCT00293267|10849023|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1
6842836|NCT00293267|10849024|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1
6842837|NCT00293267|10849023|FG000|Primary Study - Double-Blind Week 0-48|Death|3
6842838|NCT00293267|10849024|FG001|Primary Study - Double-Blind Week 0-48|Death|3
6842839|NCT00293267|10849023|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0
6842840|NCT00293267|10849024|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
6842841|NCT00293267|10849023|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
6842842|NCT00293267|10849024|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
6842843|NCT00293267|10849023|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
6842844|NCT00293267|10849024|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
6842845|NCT00293267|10849023|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33
6842846|NCT00293267|10849024|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60
6842847|NCT00293267|10849023|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1
6842848|NCT00293267|10849024|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4
6842849|NCT00293267|10849023|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7
6842850|NCT00293267|10849024|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1
6842851|NCT00293267|10849023|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4
6842852|NCT00293267|10849024|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0
6842853|NCT00293267|10849023|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13
6842854|NCT00293267|10849024|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4
6842855|NCT00293267|10849023|FG000|Extension - Double-Blind Week 49-156|Death|3
6842856|NCT00293267|10849024|FG001|Extension - Double-Blind Week 49-156|Death|0
6842857|NCT00293267|10849023|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2
6842858|NCT00293267|10849024|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0
6842859|NCT00293267|10849023|FG000|Extension - Double-Blind Week 49-156|Other Reason|7
6842860|NCT00293267|10849024|FG001|Extension - Double-Blind Week 49-156|Other Reason|0
6842861|NCT00293267|10849023|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
6842862|NCT00293267|10849024|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6
6842863|NCT00293267|10849023|FG000|Extension - Open-Label Week 157-240|Adverse Event|5
6842864|NCT00293267|10849024|FG001|Extension - Open-Label Week 157-240|Adverse Event|0
6842865|NCT00293267|10849023|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7
6842866|NCT00293267|10849024|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0
6842867|NCT00293267|10849023|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1
6842868|NCT00293267|10849024|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0
6842869|NCT00293267|10849023|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2
6842870|NCT00293267|10849024|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
6842871|NCT00293267|10849023|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2
6842872|NCT00293267|10849024|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0
6842873|NCT00293267|10849023|FG000|Extension - Open-Label Week 157-240|Other Reason|3
6842874|NCT00293267|10849024|FG001|Extension - Open-Label Week 157-240|Other Reason|1
6842875|NCT00293267|10849023|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2
6842876|NCT00293267|10849024|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3
6842877|NCT00293267|10849023|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23
6842878|NCT00293267|10849024|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19
6842879|NCT00293267|10849023|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2
6842880|NCT00293267|10849024|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4
6842881|NCT00293267|10849023|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
6842882|NCT00293267|10849024|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
6842883|NCT00293267|10849023|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0
6842884|NCT00293267|10849024|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2
6842885|NCT00293267|10849023|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0
6842886|NCT00293267|10849024|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2
6842887|NCT00293267|10849023|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4
6842888|NCT00293267|10849024|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5
6842889|NCT00293293|10849034|FG000|Overall Study|Withdrawal by Subject|1
6842890|NCT00293293|10849035|FG001|Overall Study|Withdrawal by Subject|1
6842891|NCT00293293|10849034|FG000|Overall Study|"Patient too anxious to complete trial"|1
6842892|NCT00293293|10849035|FG001|Overall Study|"Patient too anxious to complete trial"|0
6842893|NCT00293293|10849034|FG000|Overall Study|Patient discontinued chemotherapy|0
6842894|NCT00293293|10849035|FG001|Overall Study|Patient discontinued chemotherapy|1
6842895|NCT00293384|10849042|FG000|Overall Study|Non-compliance|2
6842896|NCT00293384|10849042|FG000|Overall Study|Missed dosage/study drug|1
6842897|NCT00293384|10849042|FG000|Overall Study|Ineligible|2
6842898|NCT00293397|10849046|FG000|Overall Study|Death|2
6842899|NCT00293423|10849053|FG000|Surgical Resection|Less than a 90% extent of resection|0
6842900|NCT00293423|10849054|FG001|Surgical Resection|Less than a 90% extent of resection|1
6842901|NCT00293423|10849053|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0
6842902|NCT00293423|10849054|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4
6842903|NCT00293423|10849053|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9
6842904|NCT00293423|10849054|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13
6842905|NCT00293423|10849053|FG000|Surgical Resection|disease progression prior to initial vaccination|2
6842906|NCT00293423|10849054|FG001|Surgical Resection|disease progression prior to initial vaccination|9
6842907|NCT00293423|10849053|FG000|Surgical Resection|processing error during surgical resection|1
6842908|NCT00293423|10849054|FG001|Surgical Resection|processing error during surgical resection|0
6842909|NCT00293423|10849053|FG000|Surgical Resection|Withdrawal by Subject|4
7151304|NCT03226392|11315235|FG000|Overall Study|Lost to Follow-up|1
7151305|NCT03226392|11315236|FG001|Overall Study|Lost to Follow-up|0
7151306|NCT03226392|11315235|FG000|Overall Study|Adverse Event|1
6842910|NCT00293423|10849054|FG001|Surgical Resection|Withdrawal by Subject|0
6842911|NCT00293423|10849053|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0
6842912|NCT00293423|10849054|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3
6842913|NCT00293462|10849063|FG000|Overall Study|Withdrawal by Subject|4
6842914|NCT00293462|10849064|FG001|Overall Study|Withdrawal by Subject|3
6842915|NCT00293462|10849065|FG002|Overall Study|Withdrawal by Subject|8
6842916|NCT00293462|10849063|FG000|Overall Study|Death|1
6842917|NCT00293462|10849064|FG001|Overall Study|Death|0
6842918|NCT00293462|10849065|FG002|Overall Study|Death|0
6842919|NCT00293462|10849063|FG000|Overall Study|Lost to Follow-up|0
6842920|NCT00293462|10849064|FG001|Overall Study|Lost to Follow-up|1
6842921|NCT00293462|10849065|FG002|Overall Study|Lost to Follow-up|0
6842922|NCT00293462|10849063|FG000|Overall Study|Change Treatment Regimen (ineligible)|1
6842923|NCT00293462|10849064|FG001|Overall Study|Change Treatment Regimen (ineligible)|0
6842924|NCT00293462|10849065|FG002|Overall Study|Change Treatment Regimen (ineligible)|0
6842925|NCT00293462|10849063|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
6842926|NCT00293462|10849064|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1
6842927|NCT00293462|10849065|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
6842928|NCT00293462|10849063|FG000|Overall Study|Refuse Radiation Treatment|1
6842929|NCT00293462|10849064|FG001|Overall Study|Refuse Radiation Treatment|0
6842930|NCT00293462|10849065|FG002|Overall Study|Refuse Radiation Treatment|0
6842931|NCT00293462|10849063|FG000|Overall Study|No Show|0
6842932|NCT00293462|10849064|FG001|Overall Study|No Show|0
6842933|NCT00293462|10849065|FG002|Overall Study|No Show|1
6842934|NCT00293462|10849063|FG000|Overall Study|Went back to his home country|0
6842935|NCT00293462|10849064|FG001|Overall Study|Went back to his home country|0
6842936|NCT00293462|10849065|FG002|Overall Study|Went back to his home country|1
6842937|NCT00293462|10849063|FG000|Overall Study|Blood clot after chemotherapy|0
6842938|NCT00293462|10849064|FG001|Overall Study|Blood clot after chemotherapy|0
6842939|NCT00293462|10849065|FG002|Overall Study|Blood clot after chemotherapy|1
6842940|NCT00293462|10849063|FG000|Overall Study|Ischemic stroke after chemotherapy|0
6842941|NCT00293462|10849064|FG001|Overall Study|Ischemic stroke after chemotherapy|0
6842942|NCT00293462|10849065|FG002|Overall Study|Ischemic stroke after chemotherapy|1
6842943|NCT00293462|10849063|FG000|Overall Study|Possible Tracheostomy leakage|0
6842944|NCT00293462|10849064|FG001|Overall Study|Possible Tracheostomy leakage|1
6842945|NCT00293462|10849065|FG002|Overall Study|Possible Tracheostomy leakage|0
6842946|NCT00293462|10849063|FG000|Overall Study|Low radiation dose in oral cavity|0
6842947|NCT00293462|10849064|FG001|Overall Study|Low radiation dose in oral cavity|1
6842948|NCT00293462|10849065|FG002|Overall Study|Low radiation dose in oral cavity|0
6842949|NCT00293462|10849063|FG000|Overall Study|Physician Decision|0
6842950|NCT00293462|10849064|FG001|Overall Study|Physician Decision|1
6842951|NCT00293462|10849065|FG002|Overall Study|Physician Decision|0
6842952|NCT00293579|10849082|FG000|Overall Study|Withdrawal by Subject|1
6842953|NCT00293709|10849087|FG000|Overall Study|Other|47
6842954|NCT00293722|10849091|FG000|Overall Study|Other|427
6842955|NCT00293813|10849098|FG000|Overall Study|Physician Decision|0
6842956|NCT00293813|10849099|FG001|Overall Study|Physician Decision|1
6842957|NCT00293813|10849100|FG002|Overall Study|Physician Decision|0
6842958|NCT00293813|10849098|FG000|Overall Study|Adverse Event|3
6842959|NCT00293813|10849099|FG001|Overall Study|Adverse Event|1
6842960|NCT00293813|10849100|FG002|Overall Study|Adverse Event|1
6842961|NCT00293813|10849098|FG000|Overall Study|Withdrawal by Subject|7
6842962|NCT00293813|10849099|FG001|Overall Study|Withdrawal by Subject|4
6842963|NCT00293813|10849100|FG002|Overall Study|Withdrawal by Subject|4
6842964|NCT00293813|10849098|FG000|Overall Study|Lost to Follow-up|3
6842965|NCT00293813|10849099|FG001|Overall Study|Lost to Follow-up|2
6842966|NCT00293813|10849100|FG002|Overall Study|Lost to Follow-up|3
6842967|NCT00293813|10849098|FG000|Overall Study|Noncompliance|0
6842968|NCT00293813|10849099|FG001|Overall Study|Noncompliance|1
6842969|NCT00293813|10849100|FG002|Overall Study|Noncompliance|0
6842970|NCT00294047|10849110|FG000|Month 48|Adverse Event|28
6842971|NCT00294047|10849111|FG001|Month 48|Adverse Event|13
6842972|NCT00294047|10849110|FG000|Month 48|Protocol Violation|4
6842973|NCT00294047|10849111|FG001|Month 48|Protocol Violation|4
6842974|NCT00294047|10849110|FG000|Month 48|Withdrawal by Subject|111
6842975|NCT00294047|10849111|FG001|Month 48|Withdrawal by Subject|115
6842976|NCT00294047|10849110|FG000|Month 48|Lost to Follow-up|272
6842977|NCT00294047|10849111|FG001|Month 48|Lost to Follow-up|287
6842978|NCT00294047|10849110|FG000|Month 48|Other|10
6842979|NCT00294047|10849111|FG001|Month 48|Other|14
6842980|NCT00294047|10849110|FG000|Month 84|Adverse Event|4
6842981|NCT00294047|10849111|FG001|Month 84|Adverse Event|2
6842982|NCT00294047|10849110|FG000|Month 84|Protocol Violation|1
6842983|NCT00294047|10849111|FG001|Month 84|Protocol Violation|1
6842984|NCT00294047|10849110|FG000|Month 84|Withdrawal by Subject|33
6842985|NCT00294047|10849111|FG001|Month 84|Withdrawal by Subject|31
6842986|NCT00294047|10849110|FG000|Month 84|Lost to Follow-up|187
6842987|NCT00294047|10849111|FG001|Month 84|Lost to Follow-up|190
6842988|NCT00294047|10849110|FG000|Month 84|Absent Cervix|2
6842989|NCT00294047|10849111|FG001|Month 84|Absent Cervix|0
6842990|NCT00294047|10849110|FG000|Month 84|Work related reasons|4
6842991|NCT00294047|10849111|FG001|Month 84|Work related reasons|2
6842992|NCT00294047|10849110|FG000|Month 84|Center closed, subject did not transfer|1
6842993|NCT00294047|10849111|FG001|Month 84|Center closed, subject did not transfer|0
6842994|NCT00294047|10849110|FG000|Month 84|Family problems|2
6842995|NCT00294047|10849111|FG001|Month 84|Family problems|2
6842996|NCT00294047|10849110|FG000|Month 84|Lack of time|3
6842997|NCT00294047|10849111|FG001|Month 84|Lack of time|1
6842998|NCT00294047|10849110|FG000|Month 84|Personal reason|2
6842999|NCT00294047|10849111|FG001|Month 84|Personal reason|4
6843000|NCT00294047|10849110|FG000|Month 84|Subject does not want male physician|1
6843001|NCT00294047|10849111|FG001|Month 84|Subject does not want male physician|0
6843002|NCT00294047|10849110|FG000|Month 84|Transport reimbursement delayed|0
6843003|NCT00294047|10849111|FG001|Month 84|Transport reimbursement delayed|1
6843004|NCT00294047|10849110|FG000|Month 84|Unable to reach study site|1
6843005|NCT00294047|10849111|FG001|Month 84|Unable to reach study site|0
6843006|NCT00294047|10849110|FG000|Month 84|Under investigation locally|1
6843007|NCT00294047|10849111|FG001|Month 84|Under investigation locally|0
6843008|NCT00294047|10849110|FG000|Month 84|Visit missed|0
6843009|NCT00294047|10849111|FG001|Month 84|Visit missed|1
6843010|NCT00294047|10849110|FG000|Month 84|No consent for Month 84 Follow-up|731
6843011|NCT00294047|10849111|FG001|Month 84|No consent for Month 84 Follow-up|754
6843012|NCT00294060|10849118|FG000|Overall Study|Death|225
6843013|NCT00294060|10849118|FG000|Overall Study|Other|59
6843014|NCT00294060|10849118|FG000|Overall Study|Lost to Follow-up|55
6843015|NCT00294060|10849118|FG000|Overall Study|Withdrawal by Subject|11
6843016|NCT00294060|10849118|FG000|Overall Study|Physician Decision|797
6843017|NCT00294060|10849118|FG000|Overall Study|Medical condition|3
6843018|NCT00294060|10849118|FG000|Overall Study|Device explanted/not replaced|23
6843019|NCT00294398|10849124|FG000|Overall Study|Lost to Follow-up|21
6843020|NCT00294398|10849125|FG001|Overall Study|Lost to Follow-up|26
7077246|NCT02089334|11184622|FG002|Overall Study|Physician Decision|1
6843021|NCT00294554|10849142|FG000|Overall Study|Lack of Efficacy|0
6843022|NCT00294554|10849143|FG001|Overall Study|Lack of Efficacy|1
6843023|NCT00294554|10849142|FG000|Overall Study|Physician Decision|0
6843024|NCT00294554|10849143|FG001|Overall Study|Physician Decision|1
6843025|NCT00294645|10849161|FG000|Overall Study|Death|10
6843026|NCT00294645|10849162|FG001|Overall Study|Death|18
6843027|NCT00294645|10849161|FG000|Overall Study|Lost to Follow-up|1
6843028|NCT00294645|10849162|FG001|Overall Study|Lost to Follow-up|10
6843029|NCT00294645|10849161|FG000|Overall Study|Withdrawal by Subject|18
6843030|NCT00294645|10849162|FG001|Overall Study|Withdrawal by Subject|34
6843031|NCT00294645|10849161|FG000|Overall Study|Physician Decision|15
6843032|NCT00294645|10849162|FG001|Overall Study|Physician Decision|20
6843033|NCT00294645|10849161|FG000|Overall Study|Other|4
6843034|NCT00294645|10849162|FG001|Overall Study|Other|10
6843035|NCT00294658|10849170|FG000|Overall Study|Death|0
6843036|NCT00294658|10849171|FG001|Overall Study|Death|1
6843037|NCT00294658|10849170|FG000|Overall Study|Lost to Follow-up|4
6843038|NCT00294658|10849171|FG001|Overall Study|Lost to Follow-up|0
6843039|NCT00294658|10849170|FG000|Overall Study|Physician Decision|1
6843040|NCT00294658|10849171|FG001|Overall Study|Physician Decision|2
6843041|NCT00294658|10849170|FG000|Overall Study|Pregnancy|0
6843042|NCT00294658|10849171|FG001|Overall Study|Pregnancy|1
6843043|NCT00294658|10849170|FG000|Overall Study|Withdrawal by Subject|0
6843044|NCT00294658|10849171|FG001|Overall Study|Withdrawal by Subject|4
6843045|NCT00294658|10849170|FG000|Overall Study|Found to have invasive thymoma|1
6843046|NCT00294658|10849171|FG001|Overall Study|Found to have invasive thymoma|0
6843047|NCT00294658|10849170|FG000|Overall Study|Patient and family were not satisfied|0
6843048|NCT00294658|10849171|FG001|Overall Study|Patient and family were not satisfied|1
7077247|NCT02089334|11184623|FG003|Overall Study|Physician Decision|1
7077248|NCT02089347|11184638|FG000|Overall Study|Protocol Violation|1
7077249|NCT02089347|11184639|FG001|Overall Study|Protocol Violation|0
7077250|NCT02089737|11184664|FG000|Overall Study|Survey form not completed|5
7077251|NCT02089737|11184664|FG000|Overall Study|Not treated|1
7077252|NCT02089997|11184669|FG000|Overall Study|Case report forms uncollected|99
7077253|NCT02089997|11184669|FG000|Overall Study|Protocol Violation|147
7077254|NCT02090283|11184690|FG000|Overall Study|Withdrawal by Subject|6
7077255|NCT02090283|11184691|FG001|Overall Study|Withdrawal by Subject|6
7077256|NCT02090283|11184692|FG002|Overall Study|Withdrawal by Subject|6
7077257|NCT02090283|11184690|FG000|Overall Study|Sponsor Terminated Study|6
7077258|NCT02090283|11184691|FG001|Overall Study|Sponsor Terminated Study|6
7077259|NCT02090283|11184692|FG002|Overall Study|Sponsor Terminated Study|1
7077260|NCT02090283|11184690|FG000|Overall Study|Lost to Follow-up|2
7077261|NCT02090283|11184691|FG001|Overall Study|Lost to Follow-up|2
6843049|NCT00294671|10849179|FG000|Overall Study|Lack of Efficacy|11
6843050|NCT00294671|10849180|FG001|Overall Study|Lack of Efficacy|23
6843051|NCT00294671|10849179|FG000|Overall Study|Liver transplant|7
6843052|NCT00294671|10849180|FG001|Overall Study|Liver transplant|9
7077262|NCT02090283|11184692|FG002|Overall Study|Lost to Follow-up|3
7077263|NCT02090283|11184690|FG000|Overall Study|Adverse Event|1
7077264|NCT02090283|11184691|FG001|Overall Study|Adverse Event|1
6843053|NCT00294671|10849179|FG000|Overall Study|Drug related adverse event (AE)|4
6843054|NCT00294671|10849180|FG001|Overall Study|Drug related adverse event (AE)|2
6843055|NCT00294671|10849179|FG000|Overall Study|Non-drug related AE|3
6843056|NCT00294671|10849180|FG001|Overall Study|Non-drug related AE|2
6843057|NCT00294671|10849179|FG000|Overall Study|Lost to Follow-up|1
6843058|NCT00294671|10849180|FG001|Overall Study|Lost to Follow-up|3
6843059|NCT00294671|10849179|FG000|Overall Study|Non-compliance|1
7077265|NCT02090283|11184692|FG002|Overall Study|Adverse Event|0
7077266|NCT02090283|11184690|FG000|Overall Study|Protocol Violation|2
7077267|NCT02090283|11184691|FG001|Overall Study|Protocol Violation|0
7077268|NCT02090283|11184692|FG002|Overall Study|Protocol Violation|0
7077269|NCT02090413|11184736|FG000|Overall Study|Adverse Event|11
7077270|NCT02090413|11184737|FG001|Overall Study|Adverse Event|15
7077271|NCT02090413|11184738|FG002|Overall Study|Adverse Event|20
7077272|NCT02090413|11184736|FG000|Overall Study|Flushing event|2
7077273|NCT02090413|11184737|FG001|Overall Study|Flushing event|0
7077274|NCT02090413|11184738|FG002|Overall Study|Flushing event|1
7077275|NCT02090413|11184736|FG000|Overall Study|Withdrawal by Subject|2
7077276|NCT02090413|11184737|FG001|Overall Study|Withdrawal by Subject|2
7077277|NCT02090413|11184738|FG002|Overall Study|Withdrawal by Subject|2
7077278|NCT02090413|11184736|FG000|Overall Study|Investigator Decision|1
7077279|NCT02090413|11184737|FG001|Overall Study|Investigator Decision|1
6843060|NCT00294671|10849180|FG001|Overall Study|Non-compliance|0
6843061|NCT00294671|10849179|FG000|Overall Study|Death|0
6843062|NCT00294671|10849180|FG001|Overall Study|Death|1
6843063|NCT00294684|10849188|FG000|Overall Study|Lost to Follow-up|5
6843064|NCT00294684|10849189|FG001|Overall Study|Lost to Follow-up|8
6843065|NCT00294723|10849198|FG000|Double-Blind Period 52 Weeks|Adverse Event|18
6843066|NCT00294723|10849199|FG001|Double-Blind Period 52 Weeks|Adverse Event|25
6843067|NCT00294723|10849200|FG002|Double-Blind Period 52 Weeks|Adverse Event|15
6843068|NCT00294723|10849198|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9
6843069|NCT00294723|10849199|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15
6843070|NCT00294723|10849200|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25
6843071|NCT00294723|10849198|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11
6843072|NCT00294723|10849199|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11
6843073|NCT00294723|10849200|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5
6843074|NCT00294723|10849198|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36
6843075|NCT00294723|10849199|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38
6843076|NCT00294723|10849200|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51
6843077|NCT00294723|10849198|FG000|Open-Label Extension 52 Weeks|Adverse Event|5
6843078|NCT00294723|10849199|FG001|Open-Label Extension 52 Weeks|Adverse Event|5
6843079|NCT00294723|10849200|FG002|Open-Label Extension 52 Weeks|Adverse Event|2
6843080|NCT00294723|10849198|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12
6843081|NCT00294723|10849199|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15
6843082|NCT00294723|10849200|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21
6843083|NCT00294723|10849198|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4
6843084|NCT00294723|10849199|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3
6843085|NCT00294723|10849200|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3
6843086|NCT00294723|10849198|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19
6843087|NCT00294723|10849199|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16
6843088|NCT00294723|10849200|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14
6843089|NCT00294723|10849198|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1
6843090|NCT00294723|10849199|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1
6843091|NCT00294723|10849200|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0
6843092|NCT00294723|10849198|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24
6843093|NCT00294723|10849199|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14
6843094|NCT00294723|10849200|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16
6843095|NCT00294723|10849198|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
6843096|NCT00294723|10849199|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
6843097|NCT00294723|10849200|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
6843098|NCT00294723|10849198|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2
6843099|NCT00294723|10849199|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5
6843100|NCT00294723|10849200|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3
6843101|NCT00294762|10849213|FG000|Overall Study|Did not receive study treatment|3
6843102|NCT00294762|10849214|FG001|Overall Study|Did not receive study treatment|3
6843103|NCT00295022|10849248|FG000|Overall Study|Adverse Event|1
6843104|NCT00295022|10849249|FG001|Overall Study|Adverse Event|1
6843105|NCT00295022|10849250|FG002|Overall Study|Adverse Event|2
6843106|NCT00295022|10849248|FG000|Overall Study|Lost to Follow-up|0
6843107|NCT00295022|10849249|FG001|Overall Study|Lost to Follow-up|0
6843108|NCT00295022|10849250|FG002|Overall Study|Lost to Follow-up|1
6843109|NCT00295022|10849248|FG000|Overall Study|Withdrawal by Subject|0
6843110|NCT00295022|10849249|FG001|Overall Study|Withdrawal by Subject|0
6843111|NCT00295022|10849250|FG002|Overall Study|Withdrawal by Subject|2
6843112|NCT00295620|10849276|FG000|Overall Study|Lost to Follow-up|9
6843113|NCT00295620|10849277|FG001|Overall Study|Lost to Follow-up|5
6843114|NCT00295620|10849276|FG000|Overall Study|Withdrawal by Subject|37
6843115|NCT00295620|10849277|FG001|Overall Study|Withdrawal by Subject|50
6843116|NCT00295620|10849276|FG000|Overall Study|Death|206
7077280|NCT02090413|11184738|FG002|Overall Study|Investigator Decision|0
6843117|NCT00295620|10849277|FG001|Overall Study|Death|207
7077281|NCT02090413|11184736|FG000|Overall Study|Other|2
7077282|NCT02090413|11184737|FG001|Overall Study|Other|1
7077283|NCT02090413|11184738|FG002|Overall Study|Other|0
7077284|NCT02090413|11184736|FG000|Overall Study|Lost to Follow-up|1
6843118|NCT00295620|10849276|FG000|Overall Study|Other reasons|10
6843119|NCT00295620|10849277|FG001|Overall Study|Other reasons|9
6843120|NCT00295620|10849276|FG000|Overall Study|Discontinuation by sponsor|580
6843121|NCT00295620|10849277|FG001|Overall Study|Discontinuation by sponsor|593
6843122|NCT00295620|10849276|FG000|Overall Study|Protocol Violation|30
6843123|NCT00295620|10849277|FG001|Overall Study|Protocol Violation|32
6843124|NCT00295633|10849286|FG000|Overall Study|Lack of Efficacy|19
6843125|NCT00295633|10849287|FG001|Overall Study|Lack of Efficacy|7
6843126|NCT00295633|10849288|FG002|Overall Study|Lack of Efficacy|16
6843127|NCT00295633|10849286|FG000|Overall Study|Withdrawal of consent by subject|16
6843128|NCT00295633|10849287|FG001|Overall Study|Withdrawal of consent by subject|16
6843129|NCT00295633|10849288|FG002|Overall Study|Withdrawal of consent by subject|26
6843130|NCT00295633|10849286|FG000|Overall Study|Adverse Event|9
6843131|NCT00295633|10849287|FG001|Overall Study|Adverse Event|17
6843132|NCT00295633|10849288|FG002|Overall Study|Adverse Event|9
6843133|NCT00295633|10849286|FG000|Overall Study|Lost to Follow-up|6
6843134|NCT00295633|10849287|FG001|Overall Study|Lost to Follow-up|11
6843135|NCT00295633|10849288|FG002|Overall Study|Lost to Follow-up|7
6843136|NCT00295633|10849286|FG000|Overall Study|Physician Decision|9
6843137|NCT00295633|10849287|FG001|Overall Study|Physician Decision|10
6843138|NCT00295633|10849288|FG002|Overall Study|Physician Decision|8
6843139|NCT00295633|10849286|FG000|Overall Study|Poor/Noncompliance|2
6843140|NCT00295633|10849287|FG001|Overall Study|Poor/Noncompliance|2
6843141|NCT00295633|10849288|FG002|Overall Study|Poor/Noncompliance|6
6843142|NCT00295633|10849286|FG000|Overall Study|Subject No Longer Meets Study Criteria|0
6843143|NCT00295633|10849287|FG001|Overall Study|Subject No Longer Meets Study Criteria|3
6843144|NCT00295633|10849288|FG002|Overall Study|Subject No Longer Meets Study Criteria|3
6843145|NCT00295633|10849286|FG000|Overall Study|Death|1
6843146|NCT00295633|10849287|FG001|Overall Study|Death|1
6843147|NCT00295633|10849288|FG002|Overall Study|Death|0
6843148|NCT00295633|10849286|FG000|Overall Study|Administrative reason by sponsor|0
6843149|NCT00295633|10849287|FG001|Overall Study|Administrative reason by sponsor|0
6843150|NCT00295633|10849288|FG002|Overall Study|Administrative reason by sponsor|1
6843151|NCT00295750|10849299|FG000|Overall Study|Adverse Event|19
6843152|NCT00295750|10849300|FG001|Overall Study|Adverse Event|15
6843153|NCT00295750|10849301|FG002|Overall Study|Adverse Event|12
6843154|NCT00295750|10849299|FG000|Overall Study|Lack of Efficacy|1
6843155|NCT00295750|10849300|FG001|Overall Study|Lack of Efficacy|1
6843156|NCT00295750|10849301|FG002|Overall Study|Lack of Efficacy|0
6843157|NCT00295750|10849299|FG000|Overall Study|Lost to Follow-up|1
6843158|NCT00295750|10849300|FG001|Overall Study|Lost to Follow-up|4
6843159|NCT00295750|10849301|FG002|Overall Study|Lost to Follow-up|1
6843160|NCT00295750|10849299|FG000|Overall Study|Taking prohibited therapy|2
6843161|NCT00295750|10849300|FG001|Overall Study|Taking prohibited therapy|3
6843162|NCT00295750|10849301|FG002|Overall Study|Taking prohibited therapy|2
6843163|NCT00295750|10849299|FG000|Overall Study|Administrative errors|2
6843164|NCT00295750|10849300|FG001|Overall Study|Administrative errors|4
6843165|NCT00295750|10849301|FG002|Overall Study|Administrative errors|5
6843166|NCT00295750|10849299|FG000|Overall Study|Trial drug errors|1
6843167|NCT00295750|10849300|FG001|Overall Study|Trial drug errors|1
6843168|NCT00295750|10849301|FG002|Overall Study|Trial drug errors|0
6843169|NCT00295750|10849299|FG000|Overall Study|Disease progression|2
6843170|NCT00295750|10849300|FG001|Overall Study|Disease progression|1
6843171|NCT00295750|10849301|FG002|Overall Study|Disease progression|0
6843172|NCT00295750|10849299|FG000|Overall Study|Personal reasons|0
6843173|NCT00295750|10849300|FG001|Overall Study|Personal reasons|1
6843174|NCT00295750|10849301|FG002|Overall Study|Personal reasons|0
6843175|NCT00295750|10849299|FG000|Overall Study|Randomized but never received trial drug|4
6843176|NCT00295750|10849300|FG001|Overall Study|Randomized but never received trial drug|3
6843177|NCT00295750|10849301|FG002|Overall Study|Randomized but never received trial drug|3
6843178|NCT00295750|10849299|FG000|Overall Study|Withdrawal by Subject|9
6843179|NCT00295750|10849300|FG001|Overall Study|Withdrawal by Subject|4
6843180|NCT00295750|10849301|FG002|Overall Study|Withdrawal by Subject|7
6843181|NCT00295750|10849299|FG000|Overall Study|Protocol Violation|2
6843182|NCT00295750|10849300|FG001|Overall Study|Protocol Violation|4
6843183|NCT00295750|10849301|FG002|Overall Study|Protocol Violation|2
6843184|NCT00295854|10849312|FG000|Overall Study|Adverse Event|7
6843185|NCT00295854|10849313|FG001|Overall Study|Adverse Event|7
6843186|NCT00295854|10849314|FG002|Overall Study|Adverse Event|6
6843187|NCT00295854|10849312|FG000|Overall Study|Protocol Violation|1
6843188|NCT00295854|10849313|FG001|Overall Study|Protocol Violation|1
6843189|NCT00295854|10849314|FG002|Overall Study|Protocol Violation|1
6843190|NCT00295854|10849312|FG000|Overall Study|Lost to Follow-up|2
6843191|NCT00295854|10849313|FG001|Overall Study|Lost to Follow-up|0
6843192|NCT00295854|10849314|FG002|Overall Study|Lost to Follow-up|1
6843193|NCT00295854|10849312|FG000|Overall Study|Withdrawal by Subject|3
6843194|NCT00295854|10849313|FG001|Overall Study|Withdrawal by Subject|7
6843195|NCT00295854|10849314|FG002|Overall Study|Withdrawal by Subject|4
6843196|NCT00295854|10849312|FG000|Overall Study|did not continue to meet criteria|1
6843197|NCT00295854|10849313|FG001|Overall Study|did not continue to meet criteria|1
6843198|NCT00295854|10849314|FG002|Overall Study|did not continue to meet criteria|2
6843199|NCT00295854|10849312|FG000|Overall Study|required a prohibited medication|1
6843200|NCT00295854|10849313|FG001|Overall Study|required a prohibited medication|0
6843201|NCT00295854|10849314|FG002|Overall Study|required a prohibited medication|0
6843202|NCT00295854|10849312|FG000|Overall Study|Other|3
6843203|NCT00295854|10849313|FG001|Overall Study|Other|5
6843204|NCT00295854|10849314|FG002|Overall Study|Other|1
6843205|NCT00295880|10849326|FG000|Overall Study|IBMI unit could not be volume reduced|1
6843206|NCT00295880|10849326|FG000|Overall Study|Unit randomization did not occur|1
6843207|NCT00295932|10849341|FG000|Overall Study|Not Treated|0
6843208|NCT00295932|10849342|FG001|Overall Study|Not Treated|0
6843209|NCT00295932|10849343|FG002|Overall Study|Not Treated|0
6843210|NCT00295932|10849344|FG003|Overall Study|Not Treated|0
6843211|NCT00295932|10849345|FG004|Overall Study|Not Treated|0
6843212|NCT00295932|10849346|FG005|Overall Study|Not Treated|0
6843213|NCT00295932|10849347|FG006|Overall Study|Not Treated|0
6843214|NCT00295932|10849348|FG007|Overall Study|Not Treated|0
6843215|NCT00295932|10849349|FG008|Overall Study|Not Treated|0
6843216|NCT00295932|10849350|FG009|Overall Study|Not Treated|0
6843217|NCT00295932|10849351|FG010|Overall Study|Not Treated|1
6843218|NCT00296036|10849379|FG000|Overall Study|Withdrawal by Subject|1
6843219|NCT00296036|10849380|FG001|Overall Study|Withdrawal by Subject|0
6843220|NCT00296036|10849381|FG002|Overall Study|Withdrawal by Subject|2
6843221|NCT00296036|10849382|FG003|Overall Study|Withdrawal by Subject|1
6843222|NCT00296036|10849383|FG004|Overall Study|Withdrawal by Subject|2
6843223|NCT00296036|10849384|FG005|Overall Study|Withdrawal by Subject|1
6843224|NCT00296036|10849379|FG000|Overall Study|Protocol Violation|0
6843225|NCT00296036|10849380|FG001|Overall Study|Protocol Violation|0
6843226|NCT00296036|10849381|FG002|Overall Study|Protocol Violation|0
6843227|NCT00296036|10849382|FG003|Overall Study|Protocol Violation|0
6843228|NCT00296036|10849383|FG004|Overall Study|Protocol Violation|0
6843229|NCT00296036|10849384|FG005|Overall Study|Protocol Violation|3
6843230|NCT00296140|10849403|FG000|Overall Study|Lost to Follow-up|1
6843231|NCT00296140|10849404|FG001|Overall Study|Lost to Follow-up|0
6843232|NCT00296140|10849403|FG000|Overall Study|Withdrawal by Subject|1
6843233|NCT00296140|10849404|FG001|Overall Study|Withdrawal by Subject|0
6843234|NCT00296140|10849403|FG000|Overall Study|Discharge to Nursing Home|1
6843235|NCT00296140|10849404|FG001|Overall Study|Discharge to Nursing Home|0
6843236|NCT00296244|10849437|FG000|Overall Study|Underwent retransplant|0
6843237|NCT00296244|10849438|FG001|Overall Study|Underwent retransplant|1
6843238|NCT00296335|10849469|FG000|Overall Study|Recurrence|3
6843239|NCT00296335|10849470|FG001|Overall Study|Recurrence|51
6843240|NCT00296335|10849469|FG000|Overall Study|Adverse Event|17
6843241|NCT00296335|10849470|FG001|Overall Study|Adverse Event|27
6843242|NCT00296335|10849469|FG000|Overall Study|Lost to Follow-up|7
6843243|NCT00296335|10849470|FG001|Overall Study|Lost to Follow-up|33
6843244|NCT00296335|10849469|FG000|Overall Study|Physician Decision|3
6843245|NCT00296335|10849470|FG001|Overall Study|Physician Decision|11
6843246|NCT00296374|10849481|FG000|Overall Study|Adverse Event|14
6843247|NCT00296374|10849482|FG001|Overall Study|Adverse Event|10
6843248|NCT00296374|10849483|FG002|Overall Study|Adverse Event|7
6843249|NCT00296374|10849481|FG000|Overall Study|Withdrawal by Subject|3
6843250|NCT00296374|10849482|FG001|Overall Study|Withdrawal by Subject|5
6843251|NCT00296374|10849483|FG002|Overall Study|Withdrawal by Subject|11
6843252|NCT00296374|10849481|FG000|Overall Study|Incorrect enrollment|3
6843253|NCT00296374|10849482|FG001|Overall Study|Incorrect enrollment|3
6843254|NCT00296374|10849483|FG002|Overall Study|Incorrect enrollment|4
6843255|NCT00296374|10849481|FG000|Overall Study|Protocol Violation|1
6843256|NCT00296374|10849482|FG001|Overall Study|Protocol Violation|2
6843257|NCT00296374|10849483|FG002|Overall Study|Protocol Violation|3
6843258|NCT00296374|10849481|FG000|Overall Study|Lost to Follow-up|3
6843259|NCT00296374|10849482|FG001|Overall Study|Lost to Follow-up|1
6843260|NCT00296374|10849483|FG002|Overall Study|Lost to Follow-up|1
6843261|NCT00296374|10849481|FG000|Overall Study|Relocated to another state|1
6843262|NCT00296374|10849482|FG001|Overall Study|Relocated to another state|0
6843263|NCT00296374|10849483|FG002|Overall Study|Relocated to another state|0
6843264|NCT00296374|10849481|FG000|Overall Study|Stopped drug before end of study visit|0
6843265|NCT00296374|10849482|FG001|Overall Study|Stopped drug before end of study visit|1
6843266|NCT00296374|10849483|FG002|Overall Study|Stopped drug before end of study visit|0
6843267|NCT00296374|10849481|FG000|Overall Study|Nephrologist introduced ACE|0
6843268|NCT00296374|10849482|FG001|Overall Study|Nephrologist introduced ACE|1
6843269|NCT00296374|10849483|FG002|Overall Study|Nephrologist introduced ACE|0
6843270|NCT00296374|10849481|FG000|Overall Study|Pregnancy|0
6843271|NCT00296374|10849482|FG001|Overall Study|Pregnancy|0
6843272|NCT00296374|10849483|FG002|Overall Study|Pregnancy|2
6843273|NCT00296374|10849481|FG000|Overall Study|Other|0
6843274|NCT00296374|10849482|FG001|Overall Study|Other|0
6843275|NCT00296374|10849483|FG002|Overall Study|Other|1
6843276|NCT00296400|10849500|FG000|Overall Study|Adverse Event|7
6843277|NCT00296400|10849501|FG001|Overall Study|Adverse Event|7
6843278|NCT00296400|10849502|FG002|Overall Study|Adverse Event|7
6843279|NCT00296400|10849500|FG000|Overall Study|Withdrawal by Subject|5
6843280|NCT00296400|10849501|FG001|Overall Study|Withdrawal by Subject|6
6843281|NCT00296400|10849502|FG002|Overall Study|Withdrawal by Subject|2
6843282|NCT00296400|10849500|FG000|Overall Study|Incorrect enrollment|2
6843283|NCT00296400|10849501|FG001|Overall Study|Incorrect enrollment|0
6843284|NCT00296400|10849502|FG002|Overall Study|Incorrect enrollment|0
6843285|NCT00296400|10849500|FG000|Overall Study|Protocol Violation|1
6843286|NCT00296400|10849501|FG001|Overall Study|Protocol Violation|1
6843287|NCT00296400|10849502|FG002|Overall Study|Protocol Violation|1
7151307|NCT03226392|11315236|FG001|Overall Study|Adverse Event|0
6843288|NCT00296400|10849500|FG000|Overall Study|Lost to Follow-up|1
6843289|NCT00296400|10849501|FG001|Overall Study|Lost to Follow-up|1
6843290|NCT00296400|10849502|FG002|Overall Study|Lost to Follow-up|2
6843291|NCT00296400|10849500|FG000|Overall Study|Study specific discontinuation criteria|0
6843292|NCT00296400|10849501|FG001|Overall Study|Study specific discontinuation criteria|0
6843293|NCT00296400|10849502|FG002|Overall Study|Study specific discontinuation criteria|1
6843294|NCT00296400|10849500|FG000|Overall Study|Visit 10 was performed earlier|0
6843295|NCT00296400|10849501|FG001|Overall Study|Visit 10 was performed earlier|1
6843296|NCT00296400|10849502|FG002|Overall Study|Visit 10 was performed earlier|0
6843297|NCT00296400|10849500|FG000|Overall Study|Pregnancy|1
6843298|NCT00296400|10849501|FG001|Overall Study|Pregnancy|2
6843299|NCT00296400|10849502|FG002|Overall Study|Pregnancy|0
6843300|NCT00296491|10849517|FG000|Overall Study|Low Pollen Counts|18
6843301|NCT00296491|10849518|FG001|Overall Study|Low Pollen Counts|26
6843302|NCT00296491|10849519|FG002|Overall Study|Low Pollen Counts|25
6843303|NCT00296491|10849520|FG003|Overall Study|Low Pollen Counts|16
6843304|NCT00296491|10849517|FG000|Overall Study|Protocol Violation|4
6843305|NCT00296491|10849518|FG001|Overall Study|Protocol Violation|6
6843306|NCT00296491|10849519|FG002|Overall Study|Protocol Violation|2
6843307|NCT00296491|10849520|FG003|Overall Study|Protocol Violation|3
6843308|NCT00296491|10849517|FG000|Overall Study|Adverse Event|1
6843309|NCT00296491|10849518|FG001|Overall Study|Adverse Event|3
6843310|NCT00296491|10849519|FG002|Overall Study|Adverse Event|1
6843311|NCT00296491|10849520|FG003|Overall Study|Adverse Event|4
6843312|NCT00296491|10849517|FG000|Overall Study|Withdrawn due to Asthma|0
6843313|NCT00296491|10849518|FG001|Overall Study|Withdrawn due to Asthma|0
6843314|NCT00296491|10849519|FG002|Overall Study|Withdrawn due to Asthma|0
6843315|NCT00296491|10849520|FG003|Overall Study|Withdrawn due to Asthma|4
6843316|NCT00296491|10849517|FG000|Overall Study|Withdrawal by Subject|7
6843317|NCT00296491|10849518|FG001|Overall Study|Withdrawal by Subject|3
6843318|NCT00296491|10849519|FG002|Overall Study|Withdrawal by Subject|3
6843319|NCT00296491|10849520|FG003|Overall Study|Withdrawal by Subject|2
6843320|NCT00296491|10849517|FG000|Overall Study|Non-Compliance|12
6843321|NCT00296491|10849518|FG001|Overall Study|Non-Compliance|13
6843322|NCT00296491|10849519|FG002|Overall Study|Non-Compliance|10
6843323|NCT00296491|10849520|FG003|Overall Study|Non-Compliance|14
6843324|NCT00296491|10849517|FG000|Overall Study|Lost to Follow-up|0
6843325|NCT00296491|10849518|FG001|Overall Study|Lost to Follow-up|2
6843326|NCT00296491|10849519|FG002|Overall Study|Lost to Follow-up|2
6843327|NCT00296491|10849520|FG003|Overall Study|Lost to Follow-up|0
6843328|NCT00296504|10849545|FG000|Interim Analysis|Withdrawal by Subject|8
6843329|NCT00296504|10849546|FG001|Interim Analysis|Withdrawal by Subject|0
6843330|NCT00296504|10849547|FG002|Interim Analysis|Withdrawal by Subject|12
6843331|NCT00296504|10849548|FG003|Interim Analysis|Withdrawal by Subject|0
6843332|NCT00296504|10849549|FG004|Interim Analysis|Withdrawal by Subject|5
6843333|NCT00296504|10849550|FG005|Interim Analysis|Withdrawal by Subject|5
6843334|NCT00296504|10849551|FG006|Interim Analysis|Withdrawal by Subject|9
6843335|NCT00296504|10849552|FG007|Interim Analysis|Withdrawal by Subject|3
6843336|NCT00296504|10849553|FG008|Interim Analysis|Withdrawal by Subject|0
6843337|NCT00296504|10849545|FG000|Interim Analysis|Lost to Follow-up|13
6843338|NCT00296504|10849546|FG001|Interim Analysis|Lost to Follow-up|3
6843339|NCT00296504|10849547|FG002|Interim Analysis|Lost to Follow-up|26
6843340|NCT00296504|10849548|FG003|Interim Analysis|Lost to Follow-up|8
6843341|NCT00296504|10849549|FG004|Interim Analysis|Lost to Follow-up|14
6843342|NCT00296504|10849550|FG005|Interim Analysis|Lost to Follow-up|4
6843343|NCT00296504|10849551|FG006|Interim Analysis|Lost to Follow-up|11
6843344|NCT00296504|10849552|FG007|Interim Analysis|Lost to Follow-up|4
6843345|NCT00296504|10849553|FG008|Interim Analysis|Lost to Follow-up|0
6843346|NCT00296504|10849545|FG000|Interim Analysis|Clinical Progression|1
6843347|NCT00296504|10849546|FG001|Interim Analysis|Clinical Progression|0
6843348|NCT00296504|10849547|FG002|Interim Analysis|Clinical Progression|1
6843349|NCT00296504|10849548|FG003|Interim Analysis|Clinical Progression|1
6843350|NCT00296504|10849549|FG004|Interim Analysis|Clinical Progression|0
6843351|NCT00296504|10849550|FG005|Interim Analysis|Clinical Progression|2
6843352|NCT00296504|10849551|FG006|Interim Analysis|Clinical Progression|1
6843353|NCT00296504|10849552|FG007|Interim Analysis|Clinical Progression|2
6843354|NCT00296504|10849553|FG008|Interim Analysis|Clinical Progression|0
6843355|NCT00296504|10849545|FG000|Interim Analysis|Insufficient Viral Load Response|5
6843356|NCT00296504|10849546|FG001|Interim Analysis|Insufficient Viral Load Response|1
6843357|NCT00296504|10849547|FG002|Interim Analysis|Insufficient Viral Load Response|12
6843358|NCT00296504|10849548|FG003|Interim Analysis|Insufficient Viral Load Response|2
6843359|NCT00296504|10849549|FG004|Interim Analysis|Insufficient Viral Load Response|7
6843360|NCT00296504|10849550|FG005|Interim Analysis|Insufficient Viral Load Response|9
6843361|NCT00296504|10849551|FG006|Interim Analysis|Insufficient Viral Load Response|2
6843362|NCT00296504|10849552|FG007|Interim Analysis|Insufficient Viral Load Response|24
6843363|NCT00296504|10849553|FG008|Interim Analysis|Insufficient Viral Load Response|0
6843364|NCT00296504|10849545|FG000|Interim Analysis|Adverse Event|0
6843365|NCT00296504|10849546|FG001|Interim Analysis|Adverse Event|0
6843366|NCT00296504|10849547|FG002|Interim Analysis|Adverse Event|13
6843367|NCT00296504|10849548|FG003|Interim Analysis|Adverse Event|4
6843368|NCT00296504|10849549|FG004|Interim Analysis|Adverse Event|6
6843369|NCT00296504|10849550|FG005|Interim Analysis|Adverse Event|3
6843370|NCT00296504|10849551|FG006|Interim Analysis|Adverse Event|4
6843371|NCT00296504|10849552|FG007|Interim Analysis|Adverse Event|5
6843372|NCT00296504|10849553|FG008|Interim Analysis|Adverse Event|0
6843373|NCT00296504|10849545|FG000|Interim Analysis|Protocol Violation|0
6843374|NCT00296504|10849546|FG001|Interim Analysis|Protocol Violation|0
6843375|NCT00296504|10849547|FG002|Interim Analysis|Protocol Violation|2
6843376|NCT00296504|10849548|FG003|Interim Analysis|Protocol Violation|0
6843377|NCT00296504|10849549|FG004|Interim Analysis|Protocol Violation|1
6843378|NCT00296504|10849550|FG005|Interim Analysis|Protocol Violation|0
6843379|NCT00296504|10849551|FG006|Interim Analysis|Protocol Violation|0
6843380|NCT00296504|10849552|FG007|Interim Analysis|Protocol Violation|1
6843381|NCT00296504|10849553|FG008|Interim Analysis|Protocol Violation|0
6843382|NCT00296504|10849545|FG000|Interim Analysis|Insufficient CD4 Response|0
6843383|NCT00296504|10849546|FG001|Interim Analysis|Insufficient CD4 Response|0
6843384|NCT00296504|10849547|FG002|Interim Analysis|Insufficient CD4 Response|0
6843385|NCT00296504|10849548|FG003|Interim Analysis|Insufficient CD4 Response|0
6843386|NCT00296504|10849549|FG004|Interim Analysis|Insufficient CD4 Response|1
6843387|NCT00296504|10849550|FG005|Interim Analysis|Insufficient CD4 Response|1
6843388|NCT00296504|10849551|FG006|Interim Analysis|Insufficient CD4 Response|0
6843389|NCT00296504|10849552|FG007|Interim Analysis|Insufficient CD4 Response|0
6843390|NCT00296504|10849553|FG008|Interim Analysis|Insufficient CD4 Response|0
6843391|NCT00296504|10849545|FG000|Interim Analysis|Switched to Commercially Available Drug|2
6843392|NCT00296504|10849546|FG001|Interim Analysis|Switched to Commercially Available Drug|0
6843393|NCT00296504|10849547|FG002|Interim Analysis|Switched to Commercially Available Drug|4
6843394|NCT00296504|10849548|FG003|Interim Analysis|Switched to Commercially Available Drug|1
6843395|NCT00296504|10849549|FG004|Interim Analysis|Switched to Commercially Available Drug|0
6843396|NCT00296504|10849550|FG005|Interim Analysis|Switched to Commercially Available Drug|5
6843397|NCT00296504|10849551|FG006|Interim Analysis|Switched to Commercially Available Drug|3
6843398|NCT00296504|10849552|FG007|Interim Analysis|Switched to Commercially Available Drug|4
6843399|NCT00296504|10849553|FG008|Interim Analysis|Switched to Commercially Available Drug|0
6843400|NCT00296504|10849545|FG000|Interim Analysis|Pregnancy|4
6843401|NCT00296504|10849546|FG001|Interim Analysis|Pregnancy|1
6843402|NCT00296504|10849547|FG002|Interim Analysis|Pregnancy|4
6843403|NCT00296504|10849548|FG003|Interim Analysis|Pregnancy|2
6843404|NCT00296504|10849549|FG004|Interim Analysis|Pregnancy|0
6843405|NCT00296504|10849550|FG005|Interim Analysis|Pregnancy|1
6843406|NCT00296504|10849551|FG006|Interim Analysis|Pregnancy|1
6843407|NCT00296504|10849552|FG007|Interim Analysis|Pregnancy|1
6843408|NCT00296504|10849553|FG008|Interim Analysis|Pregnancy|0
6843409|NCT00296504|10849545|FG000|Interim Analysis|Death|1
6843410|NCT00296504|10849546|FG001|Interim Analysis|Death|0
6843411|NCT00296504|10849547|FG002|Interim Analysis|Death|3
6843412|NCT00296504|10849548|FG003|Interim Analysis|Death|0
6843413|NCT00296504|10849549|FG004|Interim Analysis|Death|0
6843414|NCT00296504|10849550|FG005|Interim Analysis|Death|0
6843415|NCT00296504|10849551|FG006|Interim Analysis|Death|0
6843416|NCT00296504|10849552|FG007|Interim Analysis|Death|0
6843417|NCT00296504|10849553|FG008|Interim Analysis|Death|0
6843418|NCT00296504|10849545|FG000|Interim Analysis|Participant Non-compliant|0
6843419|NCT00296504|10849546|FG001|Interim Analysis|Participant Non-compliant|1
6843420|NCT00296504|10849547|FG002|Interim Analysis|Participant Non-compliant|2
6843421|NCT00296504|10849548|FG003|Interim Analysis|Participant Non-compliant|1
6843422|NCT00296504|10849549|FG004|Interim Analysis|Participant Non-compliant|1
6843423|NCT00296504|10849550|FG005|Interim Analysis|Participant Non-compliant|3
6843424|NCT00296504|10849551|FG006|Interim Analysis|Participant Non-compliant|6
6843425|NCT00296504|10849552|FG007|Interim Analysis|Participant Non-compliant|2
6843426|NCT00296504|10849553|FG008|Interim Analysis|Participant Non-compliant|0
6843427|NCT00296504|10849545|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0
6843428|NCT00296504|10849546|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0
6843429|NCT00296504|10849547|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2
6843430|NCT00296504|10849548|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0
6843431|NCT00296504|10849549|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0
6843432|NCT00296504|10849550|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1
6843433|NCT00296504|10849551|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0
6843434|NCT00296504|10849552|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0
6843435|NCT00296504|10849553|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0
6843436|NCT00296504|10849545|FG000|Interim Analysis|To Simplify Treatment|0
6843437|NCT00296504|10849546|FG001|Interim Analysis|To Simplify Treatment|0
6843438|NCT00296504|10849547|FG002|Interim Analysis|To Simplify Treatment|1
6843439|NCT00296504|10849548|FG003|Interim Analysis|To Simplify Treatment|0
6843440|NCT00296504|10849549|FG004|Interim Analysis|To Simplify Treatment|0
6843441|NCT00296504|10849550|FG005|Interim Analysis|To Simplify Treatment|0
6843442|NCT00296504|10849551|FG006|Interim Analysis|To Simplify Treatment|2
6843443|NCT00296504|10849552|FG007|Interim Analysis|To Simplify Treatment|0
6843444|NCT00296504|10849553|FG008|Interim Analysis|To Simplify Treatment|0
6843445|NCT00296504|10849545|FG000|Interim Analysis|Participant Had Problems with Alcohol|0
6843446|NCT00296504|10849546|FG001|Interim Analysis|Participant Had Problems with Alcohol|0
6843447|NCT00296504|10849547|FG002|Interim Analysis|Participant Had Problems with Alcohol|1
6843448|NCT00296504|10849548|FG003|Interim Analysis|Participant Had Problems with Alcohol|0
6843449|NCT00296504|10849549|FG004|Interim Analysis|Participant Had Problems with Alcohol|0
6843450|NCT00296504|10849550|FG005|Interim Analysis|Participant Had Problems with Alcohol|0
6843451|NCT00296504|10849551|FG006|Interim Analysis|Participant Had Problems with Alcohol|0
6843452|NCT00296504|10849552|FG007|Interim Analysis|Participant Had Problems with Alcohol|0
6843453|NCT00296504|10849553|FG008|Interim Analysis|Participant Had Problems with Alcohol|0
6843454|NCT00296504|10849545|FG000|Interim Analysis|Participant Moved|1
6843455|NCT00296504|10849546|FG001|Interim Analysis|Participant Moved|0
6843456|NCT00296504|10849547|FG002|Interim Analysis|Participant Moved|1
6843457|NCT00296504|10849548|FG003|Interim Analysis|Participant Moved|0
6843458|NCT00296504|10849549|FG004|Interim Analysis|Participant Moved|0
6843459|NCT00296504|10849550|FG005|Interim Analysis|Participant Moved|1
6843460|NCT00296504|10849551|FG006|Interim Analysis|Participant Moved|1
6843461|NCT00296504|10849552|FG007|Interim Analysis|Participant Moved|0
6843462|NCT00296504|10849553|FG008|Interim Analysis|Participant Moved|0
6843463|NCT00296504|10849545|FG000|Interim Analysis|Participant Was Incarcerated|2
6843464|NCT00296504|10849546|FG001|Interim Analysis|Participant Was Incarcerated|0
6843465|NCT00296504|10849547|FG002|Interim Analysis|Participant Was Incarcerated|1
6843466|NCT00296504|10849548|FG003|Interim Analysis|Participant Was Incarcerated|0
6843467|NCT00296504|10849549|FG004|Interim Analysis|Participant Was Incarcerated|0
6843468|NCT00296504|10849550|FG005|Interim Analysis|Participant Was Incarcerated|0
6843469|NCT00296504|10849551|FG006|Interim Analysis|Participant Was Incarcerated|0
6843470|NCT00296504|10849552|FG007|Interim Analysis|Participant Was Incarcerated|0
6843471|NCT00296504|10849553|FG008|Interim Analysis|Participant Was Incarcerated|0
6843472|NCT00296504|10849545|FG000|Interim Analysis|Resistance to FPV|0
6843473|NCT00296504|10849546|FG001|Interim Analysis|Resistance to FPV|0
6843474|NCT00296504|10849547|FG002|Interim Analysis|Resistance to FPV|1
6843475|NCT00296504|10849548|FG003|Interim Analysis|Resistance to FPV|0
6843476|NCT00296504|10849549|FG004|Interim Analysis|Resistance to FPV|0
6843477|NCT00296504|10849550|FG005|Interim Analysis|Resistance to FPV|0
6843478|NCT00296504|10849551|FG006|Interim Analysis|Resistance to FPV|0
6843479|NCT00296504|10849552|FG007|Interim Analysis|Resistance to FPV|0
6843480|NCT00296504|10849553|FG008|Interim Analysis|Resistance to FPV|0
6843481|NCT00296504|10849545|FG000|Interim Analysis|Physician Decision|0
6843482|NCT00296504|10849546|FG001|Interim Analysis|Physician Decision|0
6843483|NCT00296504|10849547|FG002|Interim Analysis|Physician Decision|1
6843484|NCT00296504|10849548|FG003|Interim Analysis|Physician Decision|0
6843485|NCT00296504|10849549|FG004|Interim Analysis|Physician Decision|0
6843486|NCT00296504|10849550|FG005|Interim Analysis|Physician Decision|0
6843487|NCT00296504|10849551|FG006|Interim Analysis|Physician Decision|0
6843488|NCT00296504|10849552|FG007|Interim Analysis|Physician Decision|0
6843489|NCT00296504|10849553|FG008|Interim Analysis|Physician Decision|0
6843490|NCT00296504|10849545|FG000|Interim Analysis|Principle Investigator Discretion|2
6843491|NCT00296504|10849546|FG001|Interim Analysis|Principle Investigator Discretion|0
6843492|NCT00296504|10849547|FG002|Interim Analysis|Principle Investigator Discretion|1
6843493|NCT00296504|10849548|FG003|Interim Analysis|Principle Investigator Discretion|1
6843494|NCT00296504|10849549|FG004|Interim Analysis|Principle Investigator Discretion|0
7077285|NCT02090413|11184737|FG001|Overall Study|Lost to Follow-up|1
7077286|NCT02090413|11184738|FG002|Overall Study|Lost to Follow-up|0
7077287|NCT02090426|11184749|FG000|Overall Study|Lost to Follow-up|12
7077288|NCT02090426|11184750|FG001|Overall Study|Lost to Follow-up|6
7077289|NCT02090634|11184758|FG000|Overall Study|Lost to Follow-up|0
7077290|NCT02090634|11184759|FG001|Overall Study|Lost to Follow-up|1
7077291|NCT02090634|11184758|FG000|Overall Study|Death|0
7077292|NCT02090634|11184759|FG001|Overall Study|Death|1
7077293|NCT02090634|11184758|FG000|Overall Study|Protocol Violation|3
7077294|NCT02090634|11184759|FG001|Overall Study|Protocol Violation|1
7077295|NCT02090634|11184758|FG000|Overall Study|Adverse Event|2
7077296|NCT02090634|11184759|FG001|Overall Study|Adverse Event|0
7077297|NCT02090725|11184765|FG000|Overall Study|Withdrawal by Subject|1
7077298|NCT02090725|11184765|FG000|Overall Study|participants moved from area|3
7077299|NCT02090764|11184771|FG000|Overall Study|Adverse Event|1
7077300|NCT02090764|11184772|FG001|Overall Study|Adverse Event|3
7077301|NCT02090764|11184771|FG000|Overall Study|Lack of Efficacy|0
7077302|NCT02090764|11184772|FG001|Overall Study|Lack of Efficacy|13
7077303|NCT02090764|11184771|FG000|Overall Study|Withdrawal by Subject|2
7077304|NCT02090764|11184772|FG001|Overall Study|Withdrawal by Subject|1
6843495|NCT00296504|10849550|FG005|Interim Analysis|Principle Investigator Discretion|0
6843496|NCT00296504|10849551|FG006|Interim Analysis|Principle Investigator Discretion|0
6843497|NCT00296504|10849552|FG007|Interim Analysis|Principle Investigator Discretion|0
6843498|NCT00296504|10849553|FG008|Interim Analysis|Principle Investigator Discretion|0
6843499|NCT00296504|10849545|FG000|Interim Analysis|Principle Investigator Terminated Study|0
6843500|NCT00296504|10849546|FG001|Interim Analysis|Principle Investigator Terminated Study|0
6843501|NCT00296504|10849547|FG002|Interim Analysis|Principle Investigator Terminated Study|1
6843502|NCT00296504|10849548|FG003|Interim Analysis|Principle Investigator Terminated Study|0
7077305|NCT02090764|11184771|FG000|Overall Study|Intercurrent illness and other|1
7077306|NCT02090764|11184772|FG001|Overall Study|Intercurrent illness and other|1
7077307|NCT02090764|11184771|FG000|Overall Study|Lost to Follow-up|2
6843503|NCT00296504|10849549|FG004|Interim Analysis|Principle Investigator Terminated Study|0
6843504|NCT00296504|10849550|FG005|Interim Analysis|Principle Investigator Terminated Study|0
6843505|NCT00296504|10849551|FG006|Interim Analysis|Principle Investigator Terminated Study|0
6843506|NCT00296504|10849552|FG007|Interim Analysis|Principle Investigator Terminated Study|0
6843507|NCT00296504|10849553|FG008|Interim Analysis|Principle Investigator Terminated Study|0
6843508|NCT00296504|10849545|FG000|Interim Analysis|Non-adherence|2
6843509|NCT00296504|10849546|FG001|Interim Analysis|Non-adherence|0
6843510|NCT00296504|10849547|FG002|Interim Analysis|Non-adherence|0
6843511|NCT00296504|10849548|FG003|Interim Analysis|Non-adherence|0
6843512|NCT00296504|10849549|FG004|Interim Analysis|Non-adherence|1
6843513|NCT00296504|10849550|FG005|Interim Analysis|Non-adherence|0
6843514|NCT00296504|10849551|FG006|Interim Analysis|Non-adherence|0
6843515|NCT00296504|10849552|FG007|Interim Analysis|Non-adherence|1
6843516|NCT00296504|10849553|FG008|Interim Analysis|Non-adherence|0
6843517|NCT00296504|10849545|FG000|Interim Analysis|Site Closing|1
6843518|NCT00296504|10849546|FG001|Interim Analysis|Site Closing|0
6843519|NCT00296504|10849547|FG002|Interim Analysis|Site Closing|0
6843520|NCT00296504|10849548|FG003|Interim Analysis|Site Closing|0
6843521|NCT00296504|10849549|FG004|Interim Analysis|Site Closing|0
6843522|NCT00296504|10849550|FG005|Interim Analysis|Site Closing|1
6843523|NCT00296504|10849551|FG006|Interim Analysis|Site Closing|2
6843524|NCT00296504|10849552|FG007|Interim Analysis|Site Closing|0
6843525|NCT00296504|10849553|FG008|Interim Analysis|Site Closing|0
6843526|NCT00296504|10849545|FG000|Interim Analysis|Lack of Personnel at Site|1
6843527|NCT00296504|10849546|FG001|Interim Analysis|Lack of Personnel at Site|0
6843528|NCT00296504|10849547|FG002|Interim Analysis|Lack of Personnel at Site|0
6843529|NCT00296504|10849548|FG003|Interim Analysis|Lack of Personnel at Site|0
6843530|NCT00296504|10849549|FG004|Interim Analysis|Lack of Personnel at Site|0
6843531|NCT00296504|10849550|FG005|Interim Analysis|Lack of Personnel at Site|0
6843532|NCT00296504|10849551|FG006|Interim Analysis|Lack of Personnel at Site|0
6843533|NCT00296504|10849552|FG007|Interim Analysis|Lack of Personnel at Site|0
6843534|NCT00296504|10849553|FG008|Interim Analysis|Lack of Personnel at Site|0
6843535|NCT00296504|10849545|FG000|Interim Analysis|Missed Schedule Date|1
6843536|NCT00296504|10849546|FG001|Interim Analysis|Missed Schedule Date|0
6843537|NCT00296504|10849547|FG002|Interim Analysis|Missed Schedule Date|0
6843538|NCT00296504|10849548|FG003|Interim Analysis|Missed Schedule Date|0
6843539|NCT00296504|10849549|FG004|Interim Analysis|Missed Schedule Date|0
6843540|NCT00296504|10849550|FG005|Interim Analysis|Missed Schedule Date|0
6843541|NCT00296504|10849551|FG006|Interim Analysis|Missed Schedule Date|0
6843542|NCT00296504|10849552|FG007|Interim Analysis|Missed Schedule Date|0
6843543|NCT00296504|10849553|FG008|Interim Analysis|Missed Schedule Date|0
6843544|NCT00296504|10849545|FG000|Interim Analysis|Inclusion in Other Protocol|0
6843545|NCT00296504|10849546|FG001|Interim Analysis|Inclusion in Other Protocol|0
6843546|NCT00296504|10849547|FG002|Interim Analysis|Inclusion in Other Protocol|0
6843547|NCT00296504|10849548|FG003|Interim Analysis|Inclusion in Other Protocol|1
6843548|NCT00296504|10849549|FG004|Interim Analysis|Inclusion in Other Protocol|0
6843549|NCT00296504|10849550|FG005|Interim Analysis|Inclusion in Other Protocol|0
6843550|NCT00296504|10849551|FG006|Interim Analysis|Inclusion in Other Protocol|0
6843551|NCT00296504|10849552|FG007|Interim Analysis|Inclusion in Other Protocol|0
6843552|NCT00296504|10849553|FG008|Interim Analysis|Inclusion in Other Protocol|0
6843553|NCT00296504|10849545|FG000|Interim Analysis|Participant Stopped|0
6843554|NCT00296504|10849546|FG001|Interim Analysis|Participant Stopped|0
6843555|NCT00296504|10849547|FG002|Interim Analysis|Participant Stopped|0
6843556|NCT00296504|10849548|FG003|Interim Analysis|Participant Stopped|0
6843557|NCT00296504|10849549|FG004|Interim Analysis|Participant Stopped|1
6843558|NCT00296504|10849550|FG005|Interim Analysis|Participant Stopped|0
6843559|NCT00296504|10849551|FG006|Interim Analysis|Participant Stopped|0
6843560|NCT00296504|10849552|FG007|Interim Analysis|Participant Stopped|0
6843561|NCT00296504|10849553|FG008|Interim Analysis|Participant Stopped|0
6843562|NCT00296504|10849545|FG000|Interim Analysis|Physician and Participant Decision|0
6843563|NCT00296504|10849546|FG001|Interim Analysis|Physician and Participant Decision|0
6843564|NCT00296504|10849547|FG002|Interim Analysis|Physician and Participant Decision|0
6843565|NCT00296504|10849548|FG003|Interim Analysis|Physician and Participant Decision|0
6843566|NCT00296504|10849549|FG004|Interim Analysis|Physician and Participant Decision|0
6843567|NCT00296504|10849550|FG005|Interim Analysis|Physician and Participant Decision|1
6843568|NCT00296504|10849551|FG006|Interim Analysis|Physician and Participant Decision|0
6843569|NCT00296504|10849552|FG007|Interim Analysis|Physician and Participant Decision|0
6843570|NCT00296504|10849553|FG008|Interim Analysis|Physician and Participant Decision|0
6843571|NCT00296504|10849545|FG000|Interim Analysis|Participant Stopped HIV Medications|0
6843572|NCT00296504|10849546|FG001|Interim Analysis|Participant Stopped HIV Medications|0
6843573|NCT00296504|10849547|FG002|Interim Analysis|Participant Stopped HIV Medications|0
6843574|NCT00296504|10849548|FG003|Interim Analysis|Participant Stopped HIV Medications|0
6843575|NCT00296504|10849549|FG004|Interim Analysis|Participant Stopped HIV Medications|0
6843576|NCT00296504|10849550|FG005|Interim Analysis|Participant Stopped HIV Medications|0
6843577|NCT00296504|10849551|FG006|Interim Analysis|Participant Stopped HIV Medications|1
6843578|NCT00296504|10849552|FG007|Interim Analysis|Participant Stopped HIV Medications|0
6843579|NCT00296504|10849553|FG008|Interim Analysis|Participant Stopped HIV Medications|0
6843580|NCT00296504|10849545|FG000|Interim Analysis|Study Ended|0
6843581|NCT00296504|10849546|FG001|Interim Analysis|Study Ended|0
6843582|NCT00296504|10849547|FG002|Interim Analysis|Study Ended|0
6843583|NCT00296504|10849548|FG003|Interim Analysis|Study Ended|0
6843584|NCT00296504|10849549|FG004|Interim Analysis|Study Ended|0
6843585|NCT00296504|10849550|FG005|Interim Analysis|Study Ended|0
6843586|NCT00296504|10849551|FG006|Interim Analysis|Study Ended|1
6843587|NCT00296504|10849552|FG007|Interim Analysis|Study Ended|0
6843588|NCT00296504|10849553|FG008|Interim Analysis|Study Ended|0
6843589|NCT00296504|10849545|FG000|Interim Analysis|Participant Needed Interferon|0
7077308|NCT02090764|11184772|FG001|Overall Study|Lost to Follow-up|2
6843590|NCT00296504|10849546|FG001|Interim Analysis|Participant Needed Interferon|0
6843591|NCT00296504|10849547|FG002|Interim Analysis|Participant Needed Interferon|0
6843592|NCT00296504|10849548|FG003|Interim Analysis|Participant Needed Interferon|0
6843593|NCT00296504|10849549|FG004|Interim Analysis|Participant Needed Interferon|0
6843594|NCT00296504|10849550|FG005|Interim Analysis|Participant Needed Interferon|0
6843595|NCT00296504|10849551|FG006|Interim Analysis|Participant Needed Interferon|0
6843596|NCT00296504|10849552|FG007|Interim Analysis|Participant Needed Interferon|1
6843597|NCT00296504|10849553|FG008|Interim Analysis|Participant Needed Interferon|0
6843598|NCT00296504|10849545|FG000|Interim Analysis|Ongoing|32
6843599|NCT00296504|10849546|FG001|Interim Analysis|Ongoing|12
6843600|NCT00296504|10849547|FG002|Interim Analysis|Ongoing|16
6843601|NCT00296504|10849548|FG003|Interim Analysis|Ongoing|22
6843602|NCT00296504|10849549|FG004|Interim Analysis|Ongoing|0
6843603|NCT00296504|10849550|FG005|Interim Analysis|Ongoing|0
6843604|NCT00296504|10849551|FG006|Interim Analysis|Ongoing|30
6843605|NCT00296504|10849552|FG007|Interim Analysis|Ongoing|1
6843606|NCT00296504|10849553|FG008|Interim Analysis|Ongoing|0
6843607|NCT00296504|10849545|FG000|Final Analysis|Withdrawal by Subject|0
6843608|NCT00296504|10849546|FG001|Final Analysis|Withdrawal by Subject|0
6843609|NCT00296504|10849547|FG002|Final Analysis|Withdrawal by Subject|0
6843610|NCT00296504|10849548|FG003|Final Analysis|Withdrawal by Subject|0
6843611|NCT00296504|10849549|FG004|Final Analysis|Withdrawal by Subject|0
6843612|NCT00296504|10849550|FG005|Final Analysis|Withdrawal by Subject|0
6843613|NCT00296504|10849551|FG006|Final Analysis|Withdrawal by Subject|0
6843614|NCT00296504|10849552|FG007|Final Analysis|Withdrawal by Subject|0
6843615|NCT00296504|10849553|FG008|Final Analysis|Withdrawal by Subject|1
6843616|NCT00296504|10849545|FG000|Final Analysis|Lost to Follow-up|0
6843617|NCT00296504|10849546|FG001|Final Analysis|Lost to Follow-up|0
6843618|NCT00296504|10849547|FG002|Final Analysis|Lost to Follow-up|0
6843619|NCT00296504|10849548|FG003|Final Analysis|Lost to Follow-up|0
6843620|NCT00296504|10849549|FG004|Final Analysis|Lost to Follow-up|0
6843621|NCT00296504|10849550|FG005|Final Analysis|Lost to Follow-up|0
6843622|NCT00296504|10849551|FG006|Final Analysis|Lost to Follow-up|0
6843623|NCT00296504|10849552|FG007|Final Analysis|Lost to Follow-up|0
6843624|NCT00296504|10849553|FG008|Final Analysis|Lost to Follow-up|5
6843625|NCT00296504|10849545|FG000|Final Analysis|Insufficient Viral Load Response|0
6843626|NCT00296504|10849546|FG001|Final Analysis|Insufficient Viral Load Response|0
6843627|NCT00296504|10849547|FG002|Final Analysis|Insufficient Viral Load Response|0
6843628|NCT00296504|10849548|FG003|Final Analysis|Insufficient Viral Load Response|0
6843629|NCT00296504|10849549|FG004|Final Analysis|Insufficient Viral Load Response|0
6843630|NCT00296504|10849550|FG005|Final Analysis|Insufficient Viral Load Response|0
6843631|NCT00296504|10849551|FG006|Final Analysis|Insufficient Viral Load Response|0
6843632|NCT00296504|10849552|FG007|Final Analysis|Insufficient Viral Load Response|0
6843633|NCT00296504|10849553|FG008|Final Analysis|Insufficient Viral Load Response|6
6843634|NCT00296504|10849545|FG000|Final Analysis|Adverse Event|0
6843635|NCT00296504|10849546|FG001|Final Analysis|Adverse Event|0
6843636|NCT00296504|10849547|FG002|Final Analysis|Adverse Event|0
6843637|NCT00296504|10849548|FG003|Final Analysis|Adverse Event|0
6843638|NCT00296504|10849549|FG004|Final Analysis|Adverse Event|0
6843639|NCT00296504|10849550|FG005|Final Analysis|Adverse Event|0
6843640|NCT00296504|10849551|FG006|Final Analysis|Adverse Event|0
6843641|NCT00296504|10849552|FG007|Final Analysis|Adverse Event|0
6843642|NCT00296504|10849553|FG008|Final Analysis|Adverse Event|2
6843643|NCT00296504|10849545|FG000|Final Analysis|Pregnancy|0
6843644|NCT00296504|10849546|FG001|Final Analysis|Pregnancy|0
6843645|NCT00296504|10849547|FG002|Final Analysis|Pregnancy|0
6843646|NCT00296504|10849548|FG003|Final Analysis|Pregnancy|0
6843647|NCT00296504|10849549|FG004|Final Analysis|Pregnancy|0
6843648|NCT00296504|10849550|FG005|Final Analysis|Pregnancy|0
6843649|NCT00296504|10849551|FG006|Final Analysis|Pregnancy|0
6843650|NCT00296504|10849552|FG007|Final Analysis|Pregnancy|0
6843651|NCT00296504|10849553|FG008|Final Analysis|Pregnancy|4
6843652|NCT00296504|10849545|FG000|Final Analysis|Tuberculosis|0
6843653|NCT00296504|10849546|FG001|Final Analysis|Tuberculosis|0
6843654|NCT00296504|10849547|FG002|Final Analysis|Tuberculosis|0
6843655|NCT00296504|10849548|FG003|Final Analysis|Tuberculosis|0
6843656|NCT00296504|10849549|FG004|Final Analysis|Tuberculosis|0
6843657|NCT00296504|10849550|FG005|Final Analysis|Tuberculosis|0
6843658|NCT00296504|10849551|FG006|Final Analysis|Tuberculosis|0
6843659|NCT00296504|10849552|FG007|Final Analysis|Tuberculosis|0
6843660|NCT00296504|10849553|FG008|Final Analysis|Tuberculosis|1
6843661|NCT00296504|10849545|FG000|Final Analysis|Participant Moved to Another Country|0
6843662|NCT00296504|10849546|FG001|Final Analysis|Participant Moved to Another Country|0
6843663|NCT00296504|10849547|FG002|Final Analysis|Participant Moved to Another Country|0
6843664|NCT00296504|10849548|FG003|Final Analysis|Participant Moved to Another Country|0
6843665|NCT00296504|10849549|FG004|Final Analysis|Participant Moved to Another Country|0
6843666|NCT00296504|10849550|FG005|Final Analysis|Participant Moved to Another Country|0
6843667|NCT00296504|10849551|FG006|Final Analysis|Participant Moved to Another Country|0
6843668|NCT00296504|10849552|FG007|Final Analysis|Participant Moved to Another Country|0
6843669|NCT00296504|10849553|FG008|Final Analysis|Participant Moved to Another Country|1
6843670|NCT00296504|10849545|FG000|Final Analysis|Poor Adherence|0
6843671|NCT00296504|10849546|FG001|Final Analysis|Poor Adherence|0
6843672|NCT00296504|10849547|FG002|Final Analysis|Poor Adherence|0
6843673|NCT00296504|10849548|FG003|Final Analysis|Poor Adherence|0
6843674|NCT00296504|10849549|FG004|Final Analysis|Poor Adherence|0
6843675|NCT00296504|10849550|FG005|Final Analysis|Poor Adherence|0
6843676|NCT00296504|10849551|FG006|Final Analysis|Poor Adherence|0
6843677|NCT00296504|10849552|FG007|Final Analysis|Poor Adherence|0
6843678|NCT00296504|10849553|FG008|Final Analysis|Poor Adherence|1
6843679|NCT00296517|10849580|FG000|Dose Level 2 - Week 2|Adverse Event|1
6843680|NCT00296517|10849581|FG001|Dose Level 2 - Week 2|Adverse Event|5
6843681|NCT00296517|10849580|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1
6843682|NCT00296517|10849581|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0
6843683|NCT00296517|10849580|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30
6843684|NCT00296517|10849581|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34
6843685|NCT00296517|10849580|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3
6843686|NCT00296517|10849581|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6
6843687|NCT00296517|10849580|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3
6843688|NCT00296517|10849581|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2
6843689|NCT00296517|10849580|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1
6843690|NCT00296517|10849581|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0
6843691|NCT00296517|10849580|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7
6843692|NCT00296517|10849581|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18
6843693|NCT00296517|10849580|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1
6843694|NCT00296517|10849581|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0
6843695|NCT00296517|10849580|FG000|Dose Level 3 - Weeks 3-12|Other|0
6843696|NCT00296517|10849581|FG001|Dose Level 3 - Weeks 3-12|Other|2
6843697|NCT00296647|10849592|FG000|Overall Study|Death|4
6843698|NCT00296647|10849593|FG001|Overall Study|Death|1
6843699|NCT00296647|10849594|FG002|Overall Study|Death|2
6843700|NCT00296647|10849595|FG003|Overall Study|Death|1
6843701|NCT00296647|10849596|FG004|Overall Study|Death|1
6843702|NCT00296647|10849592|FG000|Overall Study|Withdrawal by Subject|28
6843703|NCT00296647|10849593|FG001|Overall Study|Withdrawal by Subject|27
6843704|NCT00296647|10849594|FG002|Overall Study|Withdrawal by Subject|32
6843705|NCT00296647|10849595|FG003|Overall Study|Withdrawal by Subject|16
6843706|NCT00296647|10849596|FG004|Overall Study|Withdrawal by Subject|19
6843707|NCT00296725|10849608|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1
6843708|NCT00296725|10849608|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4
6843709|NCT00296725|10849608|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1
6843710|NCT00296816|10849616|FG000|Overall Study|Disease Progression|37
6843711|NCT00296816|10849616|FG000|Overall Study|Adverse Event|18
6843712|NCT00296816|10849616|FG000|Overall Study|Investigator/Participant request|5
6843713|NCT00296816|10849616|FG000|Overall Study|Non-compliance|1
6843714|NCT00296816|10849616|FG000|Overall Study|Missing for end of treatment|4
6843715|NCT00296816|10849616|FG000|Overall Study|Progression based on CA-125 (biomarker)|2
6843716|NCT00296816|10849616|FG000|Overall Study|Poor performance status|1
6843717|NCT00296816|10849616|FG000|Overall Study|Relocation to Florida|1
6843718|NCT00296816|10849616|FG000|Overall Study|Noncompliance/decision to discontinue|1
6843719|NCT00296816|10849616|FG000|Overall Study|Urine protein/creatinine ratio delay|1
6843720|NCT00296816|10849616|FG000|Overall Study|Neuropathy/patient preference|1
6843721|NCT00296816|10849616|FG000|Overall Study|Proteinuria|1
6843722|NCT00296816|10849616|FG000|Overall Study|ineligibility due to radiation treatment|1
6843723|NCT00297037|10849622|FG000|Overall Study|Withdrawal by Subject|2
6843724|NCT00297037|10849623|FG001|Overall Study|Withdrawal by Subject|0
6843725|NCT00297167|10849649|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
6843726|NCT00297167|10849650|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
6843727|NCT00297167|10849651|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1
6843728|NCT00297167|10849649|FG000|Second Double-blind Intervention Period|Protocol Violation|1
6843729|NCT00297167|10849650|FG001|Second Double-blind Intervention Period|Protocol Violation|0
6843730|NCT00297167|10849651|FG002|Second Double-blind Intervention Period|Protocol Violation|0
6843731|NCT00297232|10849658|FG000|Overall Study|Lack of Efficacy|7
6843732|NCT00297232|10849658|FG000|Overall Study|Lost to Follow-up|10
6843733|NCT00297232|10849658|FG000|Overall Study|Adverse Event|63
6843734|NCT00297232|10849658|FG000|Overall Study|Voluntary Withdrawal|120
6843735|NCT00297232|10849658|FG000|Overall Study|Subject was Noncompliant|9
6843736|NCT00297232|10849658|FG000|Overall Study|Death|9
6843737|NCT00297232|10849658|FG000|Overall Study|Anti-natalizumab Positive|8
6843738|NCT00297232|10849658|FG000|Overall Study|Switched to Commercial Tysabri|22
6843739|NCT00297232|10849658|FG000|Overall Study|Disease Progression|8
6843740|NCT00297232|10849658|FG000|Overall Study|Fear of PML|10
6843741|NCT00297232|10849658|FG000|Overall Study|Anti-JCV Antibody Positive|13
6843742|NCT00297232|10849658|FG000|Overall Study|Miscellaneous|5
6843743|NCT00297232|10849658|FG000|Overall Study|Sponsor Decision|34
6843744|NCT00297232|10849658|FG000|Overall Study|Subject Relocated|7
6843745|NCT00297232|10849658|FG000|Overall Study|Subject Withdrew Consent|37
6843746|NCT00297232|10849658|FG000|Overall Study|Persistently Positive Antibodies|11
6843747|NCT00297232|10849658|FG000|Overall Study|Investigator Withdrew From Program|19
6843748|NCT00297232|10849658|FG000|Overall Study|Did Not Enroll to Week 264|34
6843749|NCT00297232|10849658|FG000|Overall Study|Did Not Enroll to Week 480|17
6843750|NCT00297232|10849658|FG000|Overall Study|No data available after Week 264|161
6843751|NCT00297232|10849658|FG000|Overall Study|Other|1
6843752|NCT00297258|10849662|FG000|Overall Study|Disease Progression, Relapse, Death|120
6843753|NCT00297258|10849662|FG000|Overall Study|Toxicity (or Toxic Death)|10
6843754|NCT00297258|10849662|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2
6843755|NCT00297258|10849662|FG000|Overall Study|Intercurrent Illness|3
6843756|NCT00297258|10849662|FG000|Overall Study|Intercurrent Death|2
6843757|NCT00297258|10849662|FG000|Overall Study|Deteriorization of General Condition|1
6843758|NCT00297258|10849662|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1
6843759|NCT00297258|10849662|FG000|Overall Study|Surgery Performed on Target Lesion|1
6843760|NCT00297258|10849662|FG000|Overall Study|Switch to Commercial Treatment|1
6843761|NCT00297258|10849662|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1
6843762|NCT00297427|10849671|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8
6843763|NCT00297427|10849672|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5
6843764|NCT00297427|10849671|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0
6843765|NCT00297427|10849672|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3
6843766|NCT00297427|10849671|FG000|Phase 1: Initial Intervention|Death|0
6843767|NCT00297427|10849672|FG001|Phase 1: Initial Intervention|Death|1
6843768|NCT00297427|10849671|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15
6843769|NCT00297427|10849672|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0
6843770|NCT00297427|10849671|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1
6843771|NCT00297427|10849672|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0
6843772|NCT00297427|10849671|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29
6843773|NCT00297427|10849672|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0
6843774|NCT00297427|10849671|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3
6843775|NCT00297427|10849672|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0
6843776|NCT00297427|10849671|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2
6843777|NCT00297427|10849672|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0
6843778|NCT00297479|10849689|FG000|Overall Study|Lost to Follow-up|37
6843779|NCT00297479|10849690|FG001|Overall Study|Lost to Follow-up|54
6843780|NCT00297479|10849691|FG002|Overall Study|Lost to Follow-up|51
6843781|NCT00297492|10849702|FG000|Set Quit Date|Lost to Follow-up|7
6843782|NCT00297492|10849703|FG001|Set Quit Date|Lost to Follow-up|13
6843783|NCT00297492|10849704|FG002|Set Quit Date|Lost to Follow-up|5
6843784|NCT00297492|10849702|FG000|6 Month Follow-up|Lost to Follow-up|63
6843785|NCT00297492|10849703|FG001|6 Month Follow-up|Lost to Follow-up|49
6843786|NCT00297492|10849704|FG002|6 Month Follow-up|Lost to Follow-up|27
6843787|NCT00297648|10849716|FG000|Overall Study|Adverse Event|13
6843788|NCT00297648|10849716|FG000|Overall Study|Lack of Efficacy|18
6843789|NCT00297648|10849716|FG000|Overall Study|Lost to Follow-up|1
6843790|NCT00297648|10849716|FG000|Overall Study|Withdrawal by Subject|3
6843791|NCT00297648|10849716|FG000|Overall Study|Other: Incompliance|1
6843792|NCT00297778|10849722|FG000|Overall Study|Adverse Event|16
6843793|NCT00297778|10849723|FG001|Overall Study|Adverse Event|10
6843794|NCT00297778|10849722|FG000|Overall Study|Withdrawal by Subject|1
6843795|NCT00297778|10849723|FG001|Overall Study|Withdrawal by Subject|5
6843796|NCT00297778|10849722|FG000|Overall Study|Lack of Efficacy|2
6843797|NCT00297778|10849723|FG001|Overall Study|Lack of Efficacy|1
6843798|NCT00297778|10849722|FG000|Overall Study|Non-compliant with trial protocol|0
6843799|NCT00297778|10849723|FG001|Overall Study|Non-compliant with trial protocol|3
6843800|NCT00297778|10849722|FG000|Overall Study|Other|0
6843801|NCT00297778|10849723|FG001|Overall Study|Other|1
6843802|NCT00297830|10849732|FG000|6 Month Visit|Death|1
6843803|NCT00297830|10849733|FG001|6 Month Visit|Death|0
6843804|NCT00297830|10849734|FG002|6 Month Visit|Death|2
6843805|NCT00297830|10849732|FG000|6 Month Visit|Withdrawal by Subject|2
6843806|NCT00297830|10849733|FG001|6 Month Visit|Withdrawal by Subject|1
6843807|NCT00297830|10849734|FG002|6 Month Visit|Withdrawal by Subject|1
6843808|NCT00297830|10849732|FG000|6 Month Visit|Adverse Event|0
6843809|NCT00297830|10849733|FG001|6 Month Visit|Adverse Event|1
6843810|NCT00297830|10849734|FG002|6 Month Visit|Adverse Event|0
6843811|NCT00297830|10849732|FG000|12 Month Visit|Lost to Follow-up|1
6843812|NCT00297830|10849733|FG001|12 Month Visit|Lost to Follow-up|0
6843813|NCT00297830|10849734|FG002|12 Month Visit|Lost to Follow-up|0
6843814|NCT00297830|10849732|FG000|12 Month Visit|Adverse Event|0
6843815|NCT00297830|10849733|FG001|12 Month Visit|Adverse Event|3
6843816|NCT00297830|10849734|FG002|12 Month Visit|Adverse Event|0
6843817|NCT00297830|10849732|FG000|12 Month Visit|Withdrawal by Subject|0
6843818|NCT00297830|10849733|FG001|12 Month Visit|Withdrawal by Subject|3
6843819|NCT00297830|10849734|FG002|12 Month Visit|Withdrawal by Subject|0
6843820|NCT00297882|10849744|FG000|Day 14|Lack of Efficacy|12
6843821|NCT00297882|10849745|FG001|Day 14|Lack of Efficacy|49
6843822|NCT00297882|10849744|FG000|Day 28|Lost to Follow-up|13
6843823|NCT00297882|10849745|FG001|Day 28|Lost to Follow-up|23
6843824|NCT00297882|10849744|FG000|Day 28|Lack of Efficacy|3
6843825|NCT00297882|10849745|FG001|Day 28|Lack of Efficacy|0
6843826|NCT00298038|10849755|FG000|Overall Study|Lost to Follow-up|0
6843827|NCT00298038|10849756|FG001|Overall Study|Lost to Follow-up|1
6843828|NCT00298038|10849755|FG000|Overall Study|Liver Transplant|0
6843829|NCT00298038|10849756|FG001|Overall Study|Liver Transplant|1
6843830|NCT00298038|10849755|FG000|Overall Study|Protocol Violation|1
6843831|NCT00298038|10849756|FG001|Overall Study|Protocol Violation|3
6843832|NCT00298038|10849755|FG000|Overall Study|Death|6
6843833|NCT00298038|10849756|FG001|Overall Study|Death|3
6843834|NCT00298038|10849755|FG000|Overall Study|Withdrawal by Subject|6
6843835|NCT00298038|10849756|FG001|Overall Study|Withdrawal by Subject|9
6843836|NCT00298038|10849755|FG000|Overall Study|Adverse Event|8
6843837|NCT00298038|10849756|FG001|Overall Study|Adverse Event|7
6843838|NCT00298038|10849755|FG000|Overall Study|Breakthrough overt HE episode|28
6843839|NCT00298038|10849756|FG001|Overall Study|Breakthrough overt HE episode|69
6843840|NCT00298038|10849755|FG000|Overall Study|Noncompliance|1
6843841|NCT00298038|10849756|FG001|Overall Study|Noncompliance|0
6843842|NCT00298038|10849755|FG000|Overall Study|Cocaine Abuse|1
6843843|NCT00298038|10849756|FG001|Overall Study|Cocaine Abuse|0
6843844|NCT00298038|10849755|FG000|Overall Study|Severe Gastrointestinal Bleed|1
6843845|NCT00298038|10849756|FG001|Overall Study|Severe Gastrointestinal Bleed|0
6897789|NCT00642811|10916902|FG003|Overall Study|Adverse Event|0
6897790|NCT00642811|10916903|FG004|Overall Study|Adverse Event|0
6897791|NCT00642811|10916904|FG005|Overall Study|Adverse Event|1
6897792|NCT00642811|10916899|FG000|Overall Study|Developement of discontinuation criteria|0
6897793|NCT00642811|10916900|FG001|Overall Study|Developement of discontinuation criteria|0
6897794|NCT00642811|10916901|FG002|Overall Study|Developement of discontinuation criteria|0
6897795|NCT00642811|10916902|FG003|Overall Study|Developement of discontinuation criteria|0
6897796|NCT00642811|10916903|FG004|Overall Study|Developement of discontinuation criteria|1
6897797|NCT00642811|10916904|FG005|Overall Study|Developement of discontinuation criteria|0
6897798|NCT00642811|10916899|FG000|Overall Study|Severe Non-compliance to protocol|1
6897799|NCT00642811|10916900|FG001|Overall Study|Severe Non-compliance to protocol|0
6897800|NCT00642811|10916901|FG002|Overall Study|Severe Non-compliance to protocol|0
6897801|NCT00642811|10916902|FG003|Overall Study|Severe Non-compliance to protocol|0
6897802|NCT00642811|10916903|FG004|Overall Study|Severe Non-compliance to protocol|0
6897803|NCT00642811|10916904|FG005|Overall Study|Severe Non-compliance to protocol|0
6897804|NCT00642811|10916899|FG000|Overall Study|Other|0
6897805|NCT00642811|10916900|FG001|Overall Study|Other|1
6897806|NCT00642811|10916901|FG002|Overall Study|Other|0
6897807|NCT00642811|10916902|FG003|Overall Study|Other|1
6897808|NCT00642811|10916903|FG004|Overall Study|Other|0
6897809|NCT00642811|10916904|FG005|Overall Study|Other|0
6897810|NCT00642850|10916918|FG000|Overall Study|Death|7
6897811|NCT00642850|10916918|FG000|Overall Study|Adverse Event|2
6897812|NCT00642850|10916918|FG000|Overall Study|Lack of Efficacy|1
6897813|NCT00642850|10916918|FG000|Overall Study|Protocol Violation|2
6897814|NCT00642850|10916918|FG000|Overall Study|Kidney transplantation|8
6897815|NCT00642850|10916918|FG000|Overall Study|Blood transfusion|6
6897816|NCT00642850|10916918|FG000|Overall Study|Other reasons|7
6897817|NCT00642902|10916926|FG000|Overall Study|Adverse Event|0
6897818|NCT00642902|10916927|FG001|Overall Study|Adverse Event|1
6897819|NCT00642902|10916928|FG002|Overall Study|Adverse Event|3
6897820|NCT00642902|10916929|FG003|Overall Study|Adverse Event|1
6897821|NCT00642902|10916926|FG000|Overall Study|Lost to Follow-up|1
6897822|NCT00642902|10916927|FG001|Overall Study|Lost to Follow-up|1
7077309|NCT02090855|11184782|FG000|Overall Study|no evaluable Standard of Truth results|2
6897823|NCT00642902|10916928|FG002|Overall Study|Lost to Follow-up|0
6897824|NCT00642902|10916929|FG003|Overall Study|Lost to Follow-up|0
6897825|NCT00642902|10916926|FG000|Overall Study|Lack of Efficacy|0
6897826|NCT00642902|10916927|FG001|Overall Study|Lack of Efficacy|3
6897827|NCT00642902|10916928|FG002|Overall Study|Lack of Efficacy|3
6897828|NCT00642902|10916929|FG003|Overall Study|Lack of Efficacy|0
6897829|NCT00642902|10916926|FG000|Overall Study|Death|1
6897830|NCT00642902|10916927|FG001|Overall Study|Death|0
6897831|NCT00642902|10916928|FG002|Overall Study|Death|0
6897832|NCT00642902|10916929|FG003|Overall Study|Death|0
6897833|NCT00642902|10916926|FG000|Overall Study|Premature termination of clinical trial|37
6897834|NCT00642902|10916927|FG001|Overall Study|Premature termination of clinical trial|32
6897835|NCT00642902|10916928|FG002|Overall Study|Premature termination of clinical trial|35
6897836|NCT00642902|10916929|FG003|Overall Study|Premature termination of clinical trial|35
6897837|NCT00642902|10916926|FG000|Overall Study|Randomized, but not treated|0
6897838|NCT00642902|10916927|FG001|Overall Study|Randomized, but not treated|0
6897839|NCT00642902|10916928|FG002|Overall Study|Randomized, but not treated|1
6897840|NCT00642902|10916929|FG003|Overall Study|Randomized, but not treated|0
6897841|NCT00642902|10916926|FG000|Overall Study|Other|1
6897842|NCT00642902|10916927|FG001|Overall Study|Other|5
6897843|NCT00642902|10916928|FG002|Overall Study|Other|1
6897844|NCT00642902|10916929|FG003|Overall Study|Other|4
6897845|NCT00642941|10916951|FG000|Overall Study|Physician Decision|3
6897846|NCT00642941|10916952|FG001|Overall Study|Physician Decision|1
6897847|NCT00642941|10916953|FG002|Overall Study|Physician Decision|0
6897848|NCT00642941|10916954|FG003|Overall Study|Physician Decision|0
6843846|NCT00298272|10849792|FG000|Double-blind Phase|Adverse Event|2
6843847|NCT00298272|10849793|FG001|Double-blind Phase|Adverse Event|0
6843848|NCT00298272|10849792|FG000|Double-blind Phase|Failure to Return|2
6843849|NCT00298272|10849793|FG001|Double-blind Phase|Failure to Return|0
6843850|NCT00298272|10849792|FG000|Double-blind Phase|Protocol Violation|2
6843851|NCT00298272|10849793|FG001|Double-blind Phase|Protocol Violation|0
6843852|NCT00298272|10849792|FG000|Double-blind Phase|Withdrawal by Subject|2
6843853|NCT00298272|10849793|FG001|Double-blind Phase|Withdrawal by Subject|0
6843854|NCT00298272|10849792|FG000|Open Label Retreatment Phase|Adverse Event|1
6843855|NCT00298272|10849793|FG001|Open Label Retreatment Phase|Adverse Event|2
6843856|NCT00298272|10849792|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2
6843857|NCT00298272|10849793|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1
6843858|NCT00298272|10849792|FG000|Open Label Retreatment Phase|Failure to Return|1
6843859|NCT00298272|10849793|FG001|Open Label Retreatment Phase|Failure to Return|0
6843860|NCT00298272|10849792|FG000|Open Label Retreatment Phase|Protocol Violation|2
6843861|NCT00298272|10849793|FG001|Open Label Retreatment Phase|Protocol Violation|1
6843862|NCT00298272|10849792|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1
6843863|NCT00298272|10849793|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0
6843864|NCT00298272|10849792|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2
6843865|NCT00298272|10849793|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0
6843866|NCT00298272|10849792|FG000|Safety Follow-up Phase|Failure to Return|1
6843867|NCT00298272|10849793|FG001|Safety Follow-up Phase|Failure to Return|1
6843868|NCT00298272|10849792|FG000|Safety Follow-up Phase|Withdrawal by Subject|2
6843869|NCT00298272|10849793|FG001|Safety Follow-up Phase|Withdrawal by Subject|2
6843870|NCT00298272|10849792|FG000|Safety Follow-up Phase|Administrative/Other Reason|1
6843871|NCT00298272|10849793|FG001|Safety Follow-up Phase|Administrative/Other Reason|1
6843872|NCT00298363|10849805|FG000|Overall Study|Lost to Follow-up|0
6843873|NCT00298363|10849806|FG001|Overall Study|Lost to Follow-up|0
6843874|NCT00298363|10849807|FG002|Overall Study|Lost to Follow-up|1
6843875|NCT00298363|10849805|FG000|Overall Study|Physician Decision|4
6843876|NCT00298363|10849806|FG001|Overall Study|Physician Decision|1
6843877|NCT00298363|10849807|FG002|Overall Study|Physician Decision|0
6843878|NCT00298363|10849805|FG000|Overall Study|Protocol Violation|1
6843879|NCT00298363|10849806|FG001|Overall Study|Protocol Violation|1
6843880|NCT00298363|10849807|FG002|Overall Study|Protocol Violation|0
6843881|NCT00298363|10849805|FG000|Overall Study|Withdrawal by Subject|5
6843882|NCT00298363|10849806|FG001|Overall Study|Withdrawal by Subject|1
6843883|NCT00298363|10849807|FG002|Overall Study|Withdrawal by Subject|3
6843884|NCT00298363|10849805|FG000|Overall Study|Adverse Event|5
6843885|NCT00298363|10849806|FG001|Overall Study|Adverse Event|2
6843886|NCT00298363|10849807|FG002|Overall Study|Adverse Event|2
6843887|NCT00298363|10849805|FG000|Overall Study|Lack of Efficacy|2
6843888|NCT00298363|10849806|FG001|Overall Study|Lack of Efficacy|3
6843889|NCT00298363|10849807|FG002|Overall Study|Lack of Efficacy|0
6843890|NCT00298766|10849855|FG000|Overall Study|Adverse Event|18
6843891|NCT00298766|10849855|FG000|Overall Study|Death|2
6843892|NCT00298766|10849855|FG000|Overall Study|Withdrawal by Subject|9
6843893|NCT00298766|10849855|FG000|Overall Study|Treatment ongoing|4
6843894|NCT00298766|10849855|FG000|Overall Study|Progression of amyloid markers|4
6843895|NCT00298766|10849855|FG000|Overall Study|Deterioration in KPS and organ function|1
6843896|NCT00298766|10849855|FG000|Overall Study|Subjects overall condition deterioration|4
6843897|NCT00298766|10849855|FG000|Overall Study|Other|4
6843898|NCT00298831|10849859|FG000|Overall Study|Adverse Event|1
6843899|NCT00298831|10849859|FG000|Overall Study|Lost to Follow-up|3
6843900|NCT00298831|10849859|FG000|Overall Study|Withdrawal by Subject|1
6843901|NCT00298831|10849859|FG000|Overall Study|Participants did not receive treatment|27
6843902|NCT00298896|10849863|FG000|Overall Study|Death|3
6843903|NCT00298896|10849863|FG000|Overall Study|Physician Decision|2
6843904|NCT00298896|10849863|FG000|Overall Study|Intercurrent Illness|1
6843905|NCT00298896|10849863|FG000|Overall Study|Disease Progression|41
6843906|NCT00298896|10849863|FG000|Overall Study|Withdrawal by Subject|2
6843907|NCT00298896|10849863|FG000|Overall Study|Assigned to treatment in error|1
6843908|NCT00299104|10849879|FG000|Treatment Period|Adverse Event|14
6843909|NCT00299104|10849880|FG001|Treatment Period|Adverse Event|9
6843910|NCT00299104|10849881|FG002|Treatment Period|Adverse Event|7
6843911|NCT00299104|10849879|FG000|Treatment Period|Death|1
6843912|NCT00299104|10849880|FG001|Treatment Period|Death|1
6843913|NCT00299104|10849881|FG002|Treatment Period|Death|1
6843914|NCT00299104|10849879|FG000|Treatment Period|Insufficient therapeutic response|34
6843915|NCT00299104|10849880|FG001|Treatment Period|Insufficient therapeutic response|13
6843916|NCT00299104|10849881|FG002|Treatment Period|Insufficient therapeutic response|8
6843917|NCT00299104|10849879|FG000|Treatment Period|Failure to return|9
6843918|NCT00299104|10849880|FG001|Treatment Period|Failure to return|8
6843919|NCT00299104|10849881|FG002|Treatment Period|Failure to return|8
6843920|NCT00299104|10849879|FG000|Treatment Period|Violation of selection criteria|1
6843921|NCT00299104|10849880|FG001|Treatment Period|Violation of selection criteria|2
6843922|NCT00299104|10849881|FG002|Treatment Period|Violation of selection criteria|0
6843923|NCT00299104|10849879|FG000|Treatment Period|Protocol Violation|1
6843924|NCT00299104|10849880|FG001|Treatment Period|Protocol Violation|1
6843925|NCT00299104|10849881|FG002|Treatment Period|Protocol Violation|0
6843926|NCT00299104|10849879|FG000|Treatment Period|Refused treatment|9
6843927|NCT00299104|10849880|FG001|Treatment Period|Refused treatment|2
6843928|NCT00299104|10849881|FG002|Treatment Period|Refused treatment|2
6843929|NCT00299104|10849879|FG000|Treatment Period|Withdrew consent|14
7077310|NCT02090959|11184793|FG000|Overall Study|Withdrawal by Subject|10
7077311|NCT02090959|11184793|FG000|Overall Study|Adverse Event|1
7077312|NCT02090959|11184793|FG000|Overall Study|Investigator decision|2
7077313|NCT02090959|11184793|FG000|Overall Study|Study termination|6
7077314|NCT02090959|11184793|FG000|Overall Study|Enrolled but not treated|1
7077315|NCT02090959|11184793|FG000|Overall Study|Transfer for compassionate use medicine|4
7077316|NCT02090959|11184793|FG000|Overall Study|Move to medical need program|3
7077317|NCT02090959|11184793|FG000|Overall Study|Entered in to other study|34
7077318|NCT02090959|11184793|FG000|Overall Study|Switched to commercial supply|88
7077319|NCT02090959|11184793|FG000|Overall Study|Other than specified|2
7077320|NCT02091089|11184797|FG000|Overall Study|Lost to Follow-up|2
7077321|NCT02091167|11184807|FG000|Overall Study|Lost to Follow-up|0
7077322|NCT02091167|11184808|FG001|Overall Study|Lost to Follow-up|2
7077323|NCT02091206|11184818|FG000|Treatment Period|Adverse Event|0
7077324|NCT02091206|11184819|FG001|Treatment Period|Adverse Event|1
7077325|NCT02091206|11184820|FG002|Treatment Period|Adverse Event|0
7077326|NCT02091206|11184821|FG003|Treatment Period|Adverse Event|0
7077327|NCT02091206|11184818|FG000|Treatment Period|Met withdrawal criteria|0
7077328|NCT02091206|11184819|FG001|Treatment Period|Met withdrawal criteria|0
6843930|NCT00299104|10849880|FG001|Treatment Period|Withdrew consent|19
6843931|NCT00299104|10849881|FG002|Treatment Period|Withdrew consent|9
6843932|NCT00299104|10849879|FG000|Treatment Period|Administrative reasons|106
6843933|NCT00299104|10849880|FG001|Treatment Period|Administrative reasons|120
6843934|NCT00299104|10849881|FG002|Treatment Period|Administrative reasons|137
6843935|NCT00299104|10849879|FG000|Safety Follow-Up (SFU) Period|Death|3
6843936|NCT00299104|10849880|FG001|Safety Follow-Up (SFU) Period|Death|2
6843937|NCT00299104|10849881|FG002|Safety Follow-Up (SFU) Period|Death|1
6843938|NCT00299104|10849879|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9
6843939|NCT00299104|10849880|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11
6843940|NCT00299104|10849881|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20
6843941|NCT00299104|10849879|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16
6843942|NCT00299104|10849880|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21
6843943|NCT00299104|10849881|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11
6843944|NCT00299104|10849879|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27
6843945|NCT00299104|10849880|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7
6843946|NCT00299104|10849881|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5
6843947|NCT00299104|10849879|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0
6843948|NCT00299104|10849880|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1
6843949|NCT00299104|10849881|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0
6843950|NCT00299104|10849879|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
6843951|NCT00299104|10849880|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
6843952|NCT00299104|10849881|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
6843953|NCT00299104|10849879|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2
6843954|NCT00299104|10849880|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4
6843955|NCT00299104|10849881|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8
6843956|NCT00299104|10849879|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1
6843957|NCT00299104|10849880|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
6843958|NCT00299104|10849881|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
6843959|NCT00299130|10849892|FG000|Treatment Period (up to 5 Years)|Adverse Event|13
6843960|NCT00299130|10849893|FG001|Treatment Period (up to 5 Years)|Adverse Event|8
6843961|NCT00299130|10849894|FG002|Treatment Period (up to 5 Years)|Adverse Event|13
6843962|NCT00299130|10849892|FG000|Treatment Period (up to 5 Years)|Death|1
6843963|NCT00299130|10849893|FG001|Treatment Period (up to 5 Years)|Death|3
6843964|NCT00299130|10849894|FG002|Treatment Period (up to 5 Years)|Death|1
6843965|NCT00299130|10849892|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19
6843966|NCT00299130|10849893|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
6843967|NCT00299130|10849894|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
6843968|NCT00299130|10849892|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0
6843969|NCT00299130|10849893|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1
6843970|NCT00299130|10849894|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0
6843971|NCT00299130|10849892|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12
6843972|NCT00299130|10849893|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12
6843973|NCT00299130|10849894|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19
6843974|NCT00299130|10849892|FG000|Treatment Period (up to 5 Years)|Failure to Return|4
6843975|NCT00299130|10849893|FG001|Treatment Period (up to 5 Years)|Failure to Return|6
6843976|NCT00299130|10849894|FG002|Treatment Period (up to 5 Years)|Failure to Return|6
7077329|NCT02091206|11184820|FG002|Treatment Period|Met withdrawal criteria|1
6843977|NCT00299130|10849892|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4
6843978|NCT00299130|10849893|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6
6843979|NCT00299130|10849894|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4
7077330|NCT02091206|11184821|FG003|Treatment Period|Met withdrawal criteria|0
6843980|NCT00299130|10849892|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0
6843981|NCT00299130|10849893|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
6843982|NCT00299130|10849894|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
6843983|NCT00299130|10849892|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
6843984|NCT00299130|10849893|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9
6843985|NCT00299130|10849894|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
6843986|NCT00299130|10849892|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4
6843987|NCT00299130|10849893|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5
6843988|NCT00299130|10849894|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3
6843989|NCT00299130|10849892|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
6843990|NCT00299130|10849893|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
6843991|NCT00299130|10849894|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2
6843992|NCT00299130|10849892|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14
6843993|NCT00299130|10849893|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7
6843994|NCT00299130|10849894|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15
6843995|NCT00299130|10849892|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
6843996|NCT00299130|10849893|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1
6843997|NCT00299130|10849894|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
6843998|NCT00299130|10849892|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
6843999|NCT00299130|10849893|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
6844000|NCT00299130|10849894|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21
6844001|NCT00299130|10849892|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
6844002|NCT00299130|10849893|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3
6844003|NCT00299130|10849894|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
6844004|NCT00299130|10849892|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0
6844005|NCT00299130|10849893|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
6844006|NCT00299130|10849894|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
6844007|NCT00299130|10849892|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0
6844008|NCT00299130|10849893|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3
6844009|NCT00299130|10849894|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4
6844010|NCT00299156|10849912|FG000|Period 2 (Randomized)|Screen Failure|0
6844011|NCT00299156|10849913|FG001|Period 2 (Randomized)|Screen Failure|1
6844012|NCT00299156|10849914|FG002|Period 2 (Randomized)|Screen Failure|0
6844013|NCT00299182|10849929|FG000|Overall Study|Withdrawal by Subject|0
6844014|NCT00299182|10849930|FG001|Overall Study|Withdrawal by Subject|0
6844015|NCT00299182|10849931|FG002|Overall Study|Withdrawal by Subject|1
6844016|NCT00299182|10849932|FG003|Overall Study|Withdrawal by Subject|0
6844017|NCT00299182|10849933|FG004|Overall Study|Withdrawal by Subject|1
6844018|NCT00299182|10849934|FG005|Overall Study|Withdrawal by Subject|2
6844019|NCT00299182|10849935|FG006|Overall Study|Withdrawal by Subject|0
6844020|NCT00299182|10849929|FG000|Overall Study|Chemotherapy Changed|0
6844021|NCT00299182|10849930|FG001|Overall Study|Chemotherapy Changed|0
6844022|NCT00299182|10849931|FG002|Overall Study|Chemotherapy Changed|1
6844023|NCT00299182|10849932|FG003|Overall Study|Chemotherapy Changed|0
6844024|NCT00299182|10849933|FG004|Overall Study|Chemotherapy Changed|1
6844025|NCT00299182|10849934|FG005|Overall Study|Chemotherapy Changed|0
6844026|NCT00299182|10849935|FG006|Overall Study|Chemotherapy Changed|1
6844027|NCT00299182|10849929|FG000|Overall Study|Adverse Event|0
6844028|NCT00299182|10849930|FG001|Overall Study|Adverse Event|0
6844029|NCT00299182|10849931|FG002|Overall Study|Adverse Event|0
6844030|NCT00299182|10849932|FG003|Overall Study|Adverse Event|0
6844031|NCT00299182|10849933|FG004|Overall Study|Adverse Event|0
6844032|NCT00299182|10849934|FG005|Overall Study|Adverse Event|1
6844033|NCT00299182|10849935|FG006|Overall Study|Adverse Event|0
6844034|NCT00299182|10849929|FG000|Overall Study|Not Eligible|0
6844035|NCT00299182|10849930|FG001|Overall Study|Not Eligible|0
6844036|NCT00299182|10849931|FG002|Overall Study|Not Eligible|0
6844037|NCT00299182|10849932|FG003|Overall Study|Not Eligible|0
6844038|NCT00299182|10849933|FG004|Overall Study|Not Eligible|1
6844039|NCT00299182|10849934|FG005|Overall Study|Not Eligible|0
6844040|NCT00299182|10849935|FG006|Overall Study|Not Eligible|0
6844041|NCT00299494|10849972|FG000|Overall Study|Withdrawal by Subject|0
6844042|NCT00299494|10849973|FG001|Overall Study|Withdrawal by Subject|0
6844043|NCT00299494|10849974|FG002|Overall Study|Withdrawal by Subject|0
6844044|NCT00299494|10849975|FG003|Overall Study|Withdrawal by Subject|3
6844045|NCT00299494|10849976|FG004|Overall Study|Withdrawal by Subject|1
6844046|NCT00299494|10849977|FG005|Overall Study|Withdrawal by Subject|4
6844047|NCT00299494|10849972|FG000|Overall Study|Physician Decision|0
6844048|NCT00299494|10849973|FG001|Overall Study|Physician Decision|0
6844049|NCT00299494|10849974|FG002|Overall Study|Physician Decision|0
6844050|NCT00299494|10849975|FG003|Overall Study|Physician Decision|0
6844051|NCT00299494|10849976|FG004|Overall Study|Physician Decision|1
6844052|NCT00299494|10849977|FG005|Overall Study|Physician Decision|0
6844053|NCT00299494|10849972|FG000|Overall Study|Death|3
6844054|NCT00299494|10849973|FG001|Overall Study|Death|1
6844055|NCT00299494|10849974|FG002|Overall Study|Death|4
6844056|NCT00299494|10849975|FG003|Overall Study|Death|6
6844057|NCT00299494|10849976|FG004|Overall Study|Death|18
6844058|NCT00299494|10849977|FG005|Overall Study|Death|19
6844059|NCT00299494|10849972|FG000|Overall Study|Lost to Follow-up|0
6844060|NCT00299494|10849973|FG001|Overall Study|Lost to Follow-up|0
6844061|NCT00299494|10849974|FG002|Overall Study|Lost to Follow-up|0
6844062|NCT00299494|10849975|FG003|Overall Study|Lost to Follow-up|0
6844063|NCT00299494|10849976|FG004|Overall Study|Lost to Follow-up|3
6844064|NCT00299494|10849977|FG005|Overall Study|Lost to Follow-up|1
6844065|NCT00299494|10849972|FG000|Overall Study|Other - Unspecified|0
6844066|NCT00299494|10849973|FG001|Overall Study|Other - Unspecified|0
6844067|NCT00299494|10849974|FG002|Overall Study|Other - Unspecified|0
6844068|NCT00299494|10849975|FG003|Overall Study|Other - Unspecified|0
6844069|NCT00299494|10849976|FG004|Overall Study|Other - Unspecified|3
6844070|NCT00299494|10849977|FG005|Overall Study|Other - Unspecified|1
6844071|NCT00299494|10849972|FG000|Overall Study|Other - site closure|0
6844072|NCT00299494|10849973|FG001|Overall Study|Other - site closure|0
6844073|NCT00299494|10849974|FG002|Overall Study|Other - site closure|0
6844074|NCT00299494|10849975|FG003|Overall Study|Other - site closure|1
6844075|NCT00299494|10849976|FG004|Overall Study|Other - site closure|1
6844076|NCT00299494|10849977|FG005|Overall Study|Other - site closure|1
6844077|NCT00299546|10850005|FG000|Overall Study|Death|3
6844078|NCT00299546|10850006|FG001|Overall Study|Death|2
6844079|NCT00299546|10850007|FG002|Overall Study|Death|0
6844080|NCT00299546|10850005|FG000|Overall Study|Lost to Follow-up|2
6844081|NCT00299546|10850006|FG001|Overall Study|Lost to Follow-up|2
6844082|NCT00299546|10850007|FG002|Overall Study|Lost to Follow-up|5
6844083|NCT00299546|10850005|FG000|Overall Study|Adverse Event|37
6844084|NCT00299546|10850006|FG001|Overall Study|Adverse Event|22
6844085|NCT00299546|10850007|FG002|Overall Study|Adverse Event|27
6844086|NCT00299546|10850005|FG000|Overall Study|Unsatisfactory therapeutic effect|34
6844087|NCT00299546|10850006|FG001|Overall Study|Unsatisfactory therapeutic effect|39
6844088|NCT00299546|10850007|FG002|Overall Study|Unsatisfactory therapeutic effect|34
6844089|NCT00299546|10850005|FG000|Overall Study|Other|24
6844090|NCT00299546|10850006|FG001|Overall Study|Other|26
6844091|NCT00299546|10850007|FG002|Overall Study|Other|19
6844092|NCT00299546|10850005|FG000|Overall Study|Not treated|0
6844093|NCT00299546|10850006|FG001|Overall Study|Not treated|1
6844094|NCT00299546|10850007|FG002|Overall Study|Not treated|1
6844095|NCT00299702|10850022|FG000|Overall Study|Death|1
6844096|NCT00299702|10850023|FG001|Overall Study|Death|0
6844097|NCT00299702|10850022|FG000|Overall Study|Adverse Event|0
6844098|NCT00299702|10850023|FG001|Overall Study|Adverse Event|4
6844099|NCT00299702|10850022|FG000|Overall Study|Lost to Follow-up|18
6844100|NCT00299702|10850023|FG001|Overall Study|Lost to Follow-up|10
6844101|NCT00299702|10850022|FG000|Overall Study|Withdrawal by Subject|25
6844102|NCT00299702|10850023|FG001|Overall Study|Withdrawal by Subject|23
6844103|NCT00299702|10850022|FG000|Overall Study|Pregnancy|0
6844104|NCT00299702|10850023|FG001|Overall Study|Pregnancy|1
6844105|NCT00299702|10850022|FG000|Overall Study|Insufficient Response|4
6844106|NCT00299702|10850023|FG001|Overall Study|Insufficient Response|3
6844107|NCT00299702|10850022|FG000|Overall Study|Admin issues, sponsor decision, etc.|5
6844108|NCT00299702|10850023|FG001|Overall Study|Admin issues, sponsor decision, etc.|9
6844109|NCT00299975|10850036|FG000|Overall Study|Adverse Event|1
6844110|NCT00299975|10850037|FG001|Overall Study|Adverse Event|0
6844111|NCT00299975|10850038|FG002|Overall Study|Adverse Event|2
6844112|NCT00299975|10850036|FG000|Overall Study|Pregnancy|0
6844113|NCT00299975|10850037|FG001|Overall Study|Pregnancy|0
6844114|NCT00299975|10850038|FG002|Overall Study|Pregnancy|1
6844115|NCT00299975|10850036|FG000|Overall Study|Lack of Efficacy|1
6844116|NCT00299975|10850037|FG001|Overall Study|Lack of Efficacy|0
6844117|NCT00299975|10850038|FG002|Overall Study|Lack of Efficacy|1
6844118|NCT00299975|10850036|FG000|Overall Study|Lost to Follow-up|1
6844119|NCT00299975|10850037|FG001|Overall Study|Lost to Follow-up|0
6844120|NCT00299975|10850038|FG002|Overall Study|Lost to Follow-up|0
6844121|NCT00299975|10850036|FG000|Overall Study|Withdrawal by Subject|0
6844122|NCT00299975|10850037|FG001|Overall Study|Withdrawal by Subject|1
6844123|NCT00299975|10850038|FG002|Overall Study|Withdrawal by Subject|3
6844124|NCT00299975|10850036|FG000|Overall Study|Physician Decision|0
6844125|NCT00299975|10850037|FG001|Overall Study|Physician Decision|0
6844126|NCT00299975|10850038|FG002|Overall Study|Physician Decision|1
6844127|NCT00300053|10850059|FG000|Overall Study|Patient/Caregiver Preference|2
6844128|NCT00300053|10850060|FG001|Overall Study|Patient/Caregiver Preference|2
6844129|NCT00300053|10850061|FG002|Overall Study|Patient/Caregiver Preference|3
6844130|NCT00300053|10850059|FG000|Overall Study|Death|0
6844131|NCT00300053|10850060|FG001|Overall Study|Death|0
6844132|NCT00300053|10850061|FG002|Overall Study|Death|3
6844133|NCT00300053|10850059|FG000|Overall Study|Lost to Follow-up|0
6844134|NCT00300053|10850060|FG001|Overall Study|Lost to Follow-up|1
6844135|NCT00300053|10850061|FG002|Overall Study|Lost to Follow-up|0
6844136|NCT00300274|10850094|FG000|Overall Study|Withdrawal by Subject|12
6844137|NCT00300274|10850095|FG001|Overall Study|Withdrawal by Subject|3
6844138|NCT00300274|10850096|FG002|Overall Study|Withdrawal by Subject|14
6844139|NCT00300274|10850094|FG000|Overall Study|Lost to Follow-up|3
6844140|NCT00300274|10850095|FG001|Overall Study|Lost to Follow-up|4
6844141|NCT00300274|10850096|FG002|Overall Study|Lost to Follow-up|5
6844142|NCT00300274|10850094|FG000|Overall Study|Death|31
6844143|NCT00300274|10850095|FG001|Overall Study|Death|20
6844144|NCT00300274|10850096|FG002|Overall Study|Death|25
6844145|NCT00300274|10850094|FG000|Overall Study|Re-transplant|0
6844146|NCT00300274|10850095|FG001|Overall Study|Re-transplant|0
6844147|NCT00300274|10850096|FG002|Overall Study|Re-transplant|1
6844148|NCT00300365|10850106|FG000|Overall Study|Lost to Follow-up|1
6844149|NCT00300365|10850107|FG001|Overall Study|Lost to Follow-up|0
6844150|NCT00300365|10850106|FG000|Overall Study|Physician Decision|2
6844151|NCT00300365|10850107|FG001|Overall Study|Physician Decision|0
6844152|NCT00300365|10850106|FG000|Overall Study|Withdrawal by Subject|1
6844153|NCT00300365|10850107|FG001|Overall Study|Withdrawal by Subject|0
6844154|NCT00300365|10850106|FG000|Overall Study|Adverse Event|0
6844155|NCT00300365|10850107|FG001|Overall Study|Adverse Event|2
6844156|NCT00300495|10850213|FG000|Overall Study|Protocol Violation|4
6844157|NCT00300495|10850214|FG001|Overall Study|Protocol Violation|1
6844158|NCT00300755|10850232|FG000|Overall Study|Adverse Event|1
6844159|NCT00300755|10850233|FG001|Overall Study|Adverse Event|2
6844160|NCT00300755|10850234|FG002|Overall Study|Adverse Event|1
6844161|NCT00300755|10850232|FG000|Overall Study|Withdrawal by Subject|0
6844162|NCT00300755|10850233|FG001|Overall Study|Withdrawal by Subject|2
6844163|NCT00300755|10850234|FG002|Overall Study|Withdrawal by Subject|0
6844164|NCT00300755|10850232|FG000|Overall Study|Protocol Violation|0
6844165|NCT00300755|10850233|FG001|Overall Study|Protocol Violation|0
6844166|NCT00300755|10850234|FG002|Overall Study|Protocol Violation|1
6844167|NCT00300781|10850244|FG000|Overall Study|Disease Progression|55
6844168|NCT00300781|10850245|FG001|Overall Study|Disease Progression|52
6844169|NCT00300781|10850244|FG000|Overall Study|Adverse Event|5
6844170|NCT00300781|10850245|FG001|Overall Study|Adverse Event|6
6844171|NCT00300781|10850244|FG000|Overall Study|Withdrawal by Subject|1
6844172|NCT00300781|10850245|FG001|Overall Study|Withdrawal by Subject|2
6844173|NCT00300781|10850244|FG000|Overall Study|Physician Decision|1
6844174|NCT00300781|10850245|FG001|Overall Study|Physician Decision|0
6844175|NCT00300781|10850244|FG000|Overall Study|Not Recorded|0
6844176|NCT00300781|10850245|FG001|Overall Study|Not Recorded|1
6844177|NCT00300781|10850244|FG000|Overall Study|Symptomatic Deterioration|1
6844178|NCT00300781|10850245|FG001|Overall Study|Symptomatic Deterioration|0
6844179|NCT00300781|10850244|FG000|Overall Study|Lost to Follow-up|0
6844180|NCT00300781|10850245|FG001|Overall Study|Lost to Follow-up|1
6844181|NCT00300885|10850253|FG000|Treatment|Adverse Event|134
6844182|NCT00300885|10850254|FG001|Treatment|Adverse Event|82
6844183|NCT00300885|10850253|FG000|Treatment|Death|20
6844184|NCT00300885|10850254|FG001|Treatment|Death|7
6844185|NCT00300885|10850253|FG000|Treatment|Lack of Efficacy|1
6844186|NCT00300885|10850254|FG001|Treatment|Lack of Efficacy|1
6844187|NCT00300885|10850253|FG000|Treatment|Lost to Follow-up|3
6844188|NCT00300885|10850254|FG001|Treatment|Lost to Follow-up|2
6844189|NCT00300885|10850253|FG000|Treatment|Physician Decision|4
6844190|NCT00300885|10850254|FG001|Treatment|Physician Decision|5
6844191|NCT00300885|10850253|FG000|Treatment|Protocol Violation|11
6844192|NCT00300885|10850254|FG001|Treatment|Protocol Violation|11
6844193|NCT00300885|10850253|FG000|Treatment|Withdrawal by Subject|26
6844194|NCT00300885|10850254|FG001|Treatment|Withdrawal by Subject|23
6844195|NCT00300885|10850253|FG000|Treatment|Disease progression|171
7151308|NCT03226392|11315235|FG000|Overall Study|Technical Problems|0
7151309|NCT03226392|11315236|FG001|Overall Study|Technical Problems|2
7151310|NCT03226392|11315235|FG000|Overall Study|Subject/Guardian Decision|7
7151311|NCT03226392|11315236|FG001|Overall Study|Subject/Guardian Decision|6
6844196|NCT00300885|10850254|FG001|Treatment|Disease progression|238
6844197|NCT00300885|10850253|FG000|Treatment|Random code broken (subject died)|0
6844198|NCT00300885|10850254|FG001|Treatment|Random code broken (subject died)|1
6844199|NCT00300885|10850253|FG000|Treatment|Non-compliant with study medication|3
6844200|NCT00300885|10850254|FG001|Treatment|Non-compliant with study medication|4
6844201|NCT00300885|10850253|FG000|Follow-up|Death|141
6844202|NCT00300885|10850254|FG001|Follow-up|Death|163
6844203|NCT00300885|10850253|FG000|Follow-up|Lost to Follow-up|11
6844204|NCT00300885|10850254|FG001|Follow-up|Lost to Follow-up|7
6844205|NCT00300885|10850253|FG000|Follow-up|Withdrawal by Subject|26
6844206|NCT00300885|10850254|FG001|Follow-up|Withdrawal by Subject|25
6844207|NCT00301067|10850264|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1
6844208|NCT00301067|10850265|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0
6844209|NCT00301067|10850266|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0
6844210|NCT00301067|10850267|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1
6844211|NCT00301067|10850264|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2
6844212|NCT00301067|10850265|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1
6844213|NCT00301067|10850266|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1
6844214|NCT00301067|10850267|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2
6844215|NCT00301067|10850264|FG000|Completed 4 Cycles of Treatment|Progressive disease|1
6844216|NCT00301067|10850265|FG001|Completed 4 Cycles of Treatment|Progressive disease|1
6844217|NCT00301067|10850266|FG002|Completed 4 Cycles of Treatment|Progressive disease|2
6844218|NCT00301067|10850267|FG003|Completed 4 Cycles of Treatment|Progressive disease|5
6844219|NCT00301067|10850264|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0
6844220|NCT00301067|10850265|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1
6844221|NCT00301067|10850266|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0
6844222|NCT00301067|10850267|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1
6844223|NCT00301067|10850264|FG000|Completed 12 Cycles of Treatment|Adverse Event|0
7151312|NCT03226769|11315259|FG000|Overall Study|Withdrawal by Subject|0
6844224|NCT00301067|10850265|FG001|Completed 12 Cycles of Treatment|Adverse Event|0
6844225|NCT00301067|10850266|FG002|Completed 12 Cycles of Treatment|Adverse Event|0
6844226|NCT00301067|10850267|FG003|Completed 12 Cycles of Treatment|Adverse Event|1
6844227|NCT00301067|10850264|FG000|Follow up Until Death|Alive at last data cut point|1
6844228|NCT00301067|10850265|FG001|Follow up Until Death|Alive at last data cut point|0
6844229|NCT00301067|10850266|FG002|Follow up Until Death|Alive at last data cut point|0
6844230|NCT00301067|10850267|FG003|Follow up Until Death|Alive at last data cut point|1
6844231|NCT00301366|10850278|FG000|Overall Study|Adverse Event|1
6844232|NCT00301808|10850292|FG000|Overall Study|Adverse Event|5
6844233|NCT00301808|10850292|FG000|Overall Study|Death|3
6844234|NCT00301808|10850292|FG000|Overall Study|Lack of Efficacy|4
6844235|NCT00301821|10850296|FG000|Overall Study|Ineligible|25
6844236|NCT00301821|10850296|FG000|Overall Study|Cancel|1
6844237|NCT00301834|10850300|FG000|Overall Study|Death|1
6844238|NCT00301964|10850311|FG000|Overall Study|Second primary|2
6844239|NCT00301964|10850311|FG000|Overall Study|Wrong primary|1
6844240|NCT00301964|10850311|FG000|Overall Study|Inadequate pathology|1
6844241|NCT00302003|10850321|FG000|Overall Study|Lack of Efficacy|62
6844242|NCT00302003|10850321|FG000|Overall Study|Lost to Follow-up|1
6844243|NCT00302003|10850321|FG000|Overall Study|Physician Decision|2
6844244|NCT00302003|10850321|FG000|Overall Study|Withdrawal by Subject|5
6844245|NCT00302003|10850321|FG000|Overall Study|Ineligible|9
6844246|NCT00302003|10850321|FG000|Overall Study|Protocol Violation|1
6844247|NCT00302081|10850360|FG000|Overall Study|Adverse Event|6
6844248|NCT00302081|10850361|FG001|Overall Study|Adverse Event|5
6844249|NCT00302081|10850362|FG002|Overall Study|Adverse Event|4
6844250|NCT00302081|10850360|FG000|Overall Study|Lost to Follow-up|21
6844251|NCT00302081|10850361|FG001|Overall Study|Lost to Follow-up|18
6844252|NCT00302081|10850362|FG002|Overall Study|Lost to Follow-up|28
6844253|NCT00302081|10850360|FG000|Overall Study|Withdrawal by Subject|8
6844254|NCT00302081|10850361|FG001|Overall Study|Withdrawal by Subject|12
6844255|NCT00302081|10850362|FG002|Overall Study|Withdrawal by Subject|8
6844256|NCT00302081|10850360|FG000|Overall Study|Protocol Violation|5
6844257|NCT00302081|10850361|FG001|Overall Study|Protocol Violation|1
6844258|NCT00302081|10850362|FG002|Overall Study|Protocol Violation|2
6844259|NCT00302081|10850360|FG000|Overall Study|Lack of Efficacy|1
6844260|NCT00302081|10850361|FG001|Overall Study|Lack of Efficacy|0
6844261|NCT00302081|10850362|FG002|Overall Study|Lack of Efficacy|5
6844262|NCT00302081|10850360|FG000|Overall Study|Death|2
6844263|NCT00302081|10850361|FG001|Overall Study|Death|1
6844264|NCT00302081|10850362|FG002|Overall Study|Death|0
6844265|NCT00302081|10850360|FG000|Overall Study|Other|13
6844266|NCT00302081|10850361|FG001|Overall Study|Other|6
6844267|NCT00302081|10850362|FG002|Overall Study|Other|5
6844268|NCT00302107|10850372|FG000|Overall Study|Lost to Follow-up|6
6844269|NCT00302107|10850373|FG001|Overall Study|Lost to Follow-up|5
6844270|NCT00302107|10850372|FG000|Overall Study|Protocol Violation|1
6844271|NCT00302107|10850373|FG001|Overall Study|Protocol Violation|0
6844272|NCT00302107|10850372|FG000|Overall Study|Relocation|0
6844273|NCT00302107|10850373|FG001|Overall Study|Relocation|1
6844274|NCT00302107|10850372|FG000|Overall Study|Withdrawal by Subject|0
6844275|NCT00302107|10850373|FG001|Overall Study|Withdrawal by Subject|3
6844276|NCT00302107|10850372|FG000|Overall Study|Adverse Event|1
6844277|NCT00302107|10850373|FG001|Overall Study|Adverse Event|0
6844278|NCT00302159|10850388|FG000|Overall Study|pt declined before treatment started|1
6844279|NCT00302159|10850388|FG000|Overall Study|pt started Avastin|1
6844280|NCT00302211|10850396|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2
6844281|NCT00302211|10850397|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1
6844282|NCT00302211|10850398|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0
6844283|NCT00302211|10850399|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0
6844284|NCT00302211|10850400|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0
6844285|NCT00302211|10850396|FG000|Double Blind Period (New Patients)|Adverse Event|0
6844286|NCT00302211|10850397|FG001|Double Blind Period (New Patients)|Adverse Event|0
6844287|NCT00302211|10850398|FG002|Double Blind Period (New Patients)|Adverse Event|3
6844288|NCT00302211|10850399|FG003|Double Blind Period (New Patients)|Adverse Event|0
6844289|NCT00302211|10850400|FG004|Double Blind Period (New Patients)|Adverse Event|0
6844290|NCT00302211|10850396|FG000|Double Blind Period (New Patients)|Investigator's judgement|1
6844291|NCT00302211|10850397|FG001|Double Blind Period (New Patients)|Investigator's judgement|0
6844292|NCT00302211|10850398|FG002|Double Blind Period (New Patients)|Investigator's judgement|0
6844293|NCT00302211|10850399|FG003|Double Blind Period (New Patients)|Investigator's judgement|0
6844294|NCT00302211|10850400|FG004|Double Blind Period (New Patients)|Investigator's judgement|0
6844295|NCT00302211|10850396|FG000|Double Blind Period (New Patients)|Disease progression|0
6844296|NCT00302211|10850397|FG001|Double Blind Period (New Patients)|Disease progression|1
6844297|NCT00302211|10850398|FG002|Double Blind Period (New Patients)|Disease progression|1
6844298|NCT00302211|10850399|FG003|Double Blind Period (New Patients)|Disease progression|0
6844299|NCT00302211|10850400|FG004|Double Blind Period (New Patients)|Disease progression|0
6844300|NCT00302211|10850396|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
6844301|NCT00302211|10850397|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
6844302|NCT00302211|10850398|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
6844303|NCT00302211|10850399|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
6844304|NCT00302211|10850400|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
6844305|NCT00302211|10850396|FG000|Open Label-Patients From Double-Blind|Adverse Event|0
6844306|NCT00302211|10850397|FG001|Open Label-Patients From Double-Blind|Adverse Event|0
6844307|NCT00302211|10850398|FG002|Open Label-Patients From Double-Blind|Adverse Event|0
6844308|NCT00302211|10850399|FG003|Open Label-Patients From Double-Blind|Adverse Event|1
6844309|NCT00302211|10850400|FG004|Open Label-Patients From Double-Blind|Adverse Event|0
6844310|NCT00302211|10850396|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0
6844311|NCT00302211|10850397|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0
6844312|NCT00302211|10850398|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0
6844313|NCT00302211|10850399|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1
6844314|NCT00302211|10850400|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0
6844315|NCT00302211|10850396|FG000|Open Label-Patients From Double-Blind|Disease progression|0
6844316|NCT00302211|10850397|FG001|Open Label-Patients From Double-Blind|Disease progression|0
6844317|NCT00302211|10850398|FG002|Open Label-Patients From Double-Blind|Disease progression|0
6844318|NCT00302211|10850399|FG003|Open Label-Patients From Double-Blind|Disease progression|1
6844319|NCT00302211|10850400|FG004|Open Label-Patients From Double-Blind|Disease progression|2
6844320|NCT00302211|10850396|FG000|Open Label-Patients From Double-Blind|Death|0
6844321|NCT00302211|10850397|FG001|Open Label-Patients From Double-Blind|Death|0
6844322|NCT00302211|10850398|FG002|Open Label-Patients From Double-Blind|Death|0
6844323|NCT00302211|10850399|FG003|Open Label-Patients From Double-Blind|Death|1
6844324|NCT00302211|10850400|FG004|Open Label-Patients From Double-Blind|Death|1
6844325|NCT00302211|10850396|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0
6844326|NCT00302211|10850397|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0
6844327|NCT00302211|10850398|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0
6844328|NCT00302211|10850399|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0
6844329|NCT00302211|10850400|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1
6844330|NCT00302211|10850396|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
6844331|NCT00302211|10850397|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
6844332|NCT00302211|10850398|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
6844333|NCT00302211|10850399|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
6844334|NCT00302211|10850400|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1
6844335|NCT00302211|10850396|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
6844336|NCT00302211|10850397|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
6844337|NCT00302211|10850398|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
6844338|NCT00302211|10850399|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1
6844339|NCT00302211|10850400|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
6844340|NCT00302328|10850415|FG000|Overall Study|Physician Decision|0
6844341|NCT00302328|10850416|FG001|Overall Study|Physician Decision|1
6844342|NCT00302328|10850417|FG002|Overall Study|Physician Decision|0
6844343|NCT00302458|10850428|FG000|Overall Study|Lost to Follow-up|1
6844344|NCT00302458|10850428|FG000|Overall Study|Ineligible after screening|1
6844345|NCT00302458|10850428|FG000|Overall Study|Withdrawal by Subject|1
6844346|NCT00302718|10850440|FG000|Overall Study|Participant left the hospital|1
6844347|NCT00302718|10850441|FG001|Overall Study|Participant left the hospital|0
6844348|NCT00302718|10850442|FG002|Overall Study|Participant left the hospital|0
6844349|NCT00302718|10850443|FG003|Overall Study|Participant left the hospital|1
6844350|NCT00302718|10850440|FG000|Overall Study|Withdrawal by Subject|0
6844351|NCT00302718|10850441|FG001|Overall Study|Withdrawal by Subject|1
6844352|NCT00302718|10850442|FG002|Overall Study|Withdrawal by Subject|0
6844353|NCT00302718|10850443|FG003|Overall Study|Withdrawal by Subject|0
6844354|NCT00302718|10850440|FG000|Overall Study|Participant left primary care setting|0
6844355|NCT00302718|10850441|FG001|Overall Study|Participant left primary care setting|0
6844356|NCT00302718|10850442|FG002|Overall Study|Participant left primary care setting|2
6844357|NCT00302718|10850443|FG003|Overall Study|Participant left primary care setting|1
6844358|NCT00302731|10850462|FG000|Overall Study|Lost to Follow-up|1
6844359|NCT00302731|10850463|FG001|Overall Study|Lost to Follow-up|2
6844360|NCT00302731|10850464|FG002|Overall Study|Lost to Follow-up|0
6844361|NCT00302731|10850465|FG003|Overall Study|Lost to Follow-up|0
6844362|NCT00302731|10850462|FG000|Overall Study|Adverse Event|0
6844363|NCT00302731|10850463|FG001|Overall Study|Adverse Event|2
6844364|NCT00302731|10850464|FG002|Overall Study|Adverse Event|2
6844365|NCT00302731|10850465|FG003|Overall Study|Adverse Event|0
6844366|NCT00302731|10850462|FG000|Overall Study|Withdrawal by Subject|1
6844367|NCT00302731|10850463|FG001|Overall Study|Withdrawal by Subject|1
6844368|NCT00302731|10850464|FG002|Overall Study|Withdrawal by Subject|0
6844369|NCT00302731|10850465|FG003|Overall Study|Withdrawal by Subject|0
6844370|NCT00302731|10850462|FG000|Overall Study|Protocol Violation|1
6844371|NCT00302731|10850463|FG001|Overall Study|Protocol Violation|0
6844372|NCT00302731|10850464|FG002|Overall Study|Protocol Violation|0
6844373|NCT00302731|10850465|FG003|Overall Study|Protocol Violation|0
6844374|NCT00302731|10850462|FG000|Overall Study|cancer unrelated to study discovered|1
6844375|NCT00302731|10850463|FG001|Overall Study|cancer unrelated to study discovered|0
6844376|NCT00302731|10850464|FG002|Overall Study|cancer unrelated to study discovered|1
6844377|NCT00302731|10850465|FG003|Overall Study|cancer unrelated to study discovered|0
6844378|NCT00302952|10850489|FG000|Overall Study|Physician Decision|1
6844379|NCT00302952|10850490|FG001|Overall Study|Physician Decision|1
6844380|NCT00302952|10850489|FG000|Overall Study|Withdrawal by Subject|2
6844381|NCT00302952|10850490|FG001|Overall Study|Withdrawal by Subject|3
6844382|NCT00302952|10850489|FG000|Overall Study|Elevated SGOT (AST) lab value|0
6844383|NCT00302952|10850490|FG001|Overall Study|Elevated SGOT (AST) lab value|1
6844384|NCT00303069|10850500|FG000|Overall Study|Lost to Follow-up|1
6844385|NCT00303069|10850501|FG001|Overall Study|Lost to Follow-up|0
6844386|NCT00303069|10850502|FG002|Overall Study|Lost to Follow-up|0
6844387|NCT00303069|10850503|FG003|Overall Study|Lost to Follow-up|2
6844388|NCT00303069|10850500|FG000|Overall Study|subject moved|1
6844389|NCT00303069|10850501|FG001|Overall Study|subject moved|0
6844390|NCT00303069|10850502|FG002|Overall Study|subject moved|0
6844391|NCT00303069|10850503|FG003|Overall Study|subject moved|0
6844392|NCT00303069|10850500|FG000|Overall Study|Recruitment into Army Reserves|0
6844393|NCT00303069|10850501|FG001|Overall Study|Recruitment into Army Reserves|0
6844394|NCT00303069|10850502|FG002|Overall Study|Recruitment into Army Reserves|1
6844395|NCT00303069|10850503|FG003|Overall Study|Recruitment into Army Reserves|0
6844396|NCT00303108|10850516|FG000|Overall Study|Adverse Event|5
6844397|NCT00303108|10850517|FG001|Overall Study|Adverse Event|6
6844398|NCT00303108|10850518|FG002|Overall Study|Adverse Event|7
6844399|NCT00303108|10850516|FG000|Overall Study|Patient Request|4
6844400|NCT00303108|10850517|FG001|Overall Study|Patient Request|2
6844401|NCT00303108|10850518|FG002|Overall Study|Patient Request|8
6844402|NCT00303108|10850516|FG000|Overall Study|Failed Entry|1
6844403|NCT00303108|10850517|FG001|Overall Study|Failed Entry|0
6844404|NCT00303108|10850518|FG002|Overall Study|Failed Entry|1
6844405|NCT00303108|10850516|FG000|Overall Study|ineligible|2
6844406|NCT00303108|10850517|FG001|Overall Study|ineligible|1
6844407|NCT00303108|10850518|FG002|Overall Study|ineligible|0
6844408|NCT00303186|10850525|FG000|Overall Study|Other|52
6844409|NCT00303316|10850531|FG000|Overall Study|Protocol Violation|1
6844410|NCT00303316|10850532|FG001|Overall Study|Protocol Violation|0
6844411|NCT00303316|10850531|FG000|Overall Study|Lost to Follow-up|0
6844412|NCT00303316|10850532|FG001|Overall Study|Lost to Follow-up|1
6844413|NCT00303316|10850531|FG000|Overall Study|Withdrawal by Subject|1
6844414|NCT00303316|10850532|FG001|Overall Study|Withdrawal by Subject|2
6844415|NCT00303329|10850540|FG000|Overall Study|Adverse Event|7
6844416|NCT00303329|10850541|FG001|Overall Study|Adverse Event|14
6844417|NCT00303329|10850540|FG000|Overall Study|Abnormal Laboratory Values|0
6844418|NCT00303329|10850541|FG001|Overall Study|Abnormal Laboratory Values|1
6844419|NCT00303329|10850540|FG000|Overall Study|Unsatisfactory therapeutic effect|9
6844420|NCT00303329|10850541|FG001|Overall Study|Unsatisfactory therapeutic effect|2
6844421|NCT00303329|10850540|FG000|Overall Study|Condition no longer requires study drug|0
6844422|NCT00303329|10850541|FG001|Overall Study|Condition no longer requires study drug|8
6844423|NCT00303329|10850540|FG000|Overall Study|Protocol Violation|3
6844424|NCT00303329|10850541|FG001|Overall Study|Protocol Violation|0
6844425|NCT00303329|10850540|FG000|Overall Study|Withdrawal by Subject|9
6844426|NCT00303329|10850541|FG001|Overall Study|Withdrawal by Subject|15
6844427|NCT00303329|10850540|FG000|Overall Study|Lost to Follow-up|0
6844428|NCT00303329|10850541|FG001|Overall Study|Lost to Follow-up|1
6844429|NCT00303329|10850540|FG000|Overall Study|Administrative problems|1
6844430|NCT00303329|10850541|FG001|Overall Study|Administrative problems|0
6844431|NCT00303329|10850540|FG000|Overall Study|Death|2
6844432|NCT00303329|10850541|FG001|Overall Study|Death|12
6844433|NCT00303329|10850540|FG000|Overall Study|Stopped at end of core|3
6844434|NCT00303329|10850541|FG001|Overall Study|Stopped at end of core|9
6844435|NCT00303329|10850540|FG000|Overall Study|Stopped at end of extension 1|1
6844436|NCT00303329|10850541|FG001|Overall Study|Stopped at end of extension 1|0
6844437|NCT00303446|10850549|FG000|Overall Study|Withdrawal by Subject|2
6844438|NCT00303446|10850550|FG001|Overall Study|Withdrawal by Subject|2
6844439|NCT00303446|10850549|FG000|Overall Study|Death|0
6844440|NCT00303446|10850550|FG001|Overall Study|Death|1
6844441|NCT00303446|10850549|FG000|Overall Study|Physician Decision|0
6844442|NCT00303446|10850550|FG001|Overall Study|Physician Decision|1
6844443|NCT00303459|10850558|FG000|Overall Study|Death|33
6844444|NCT00303459|10850559|FG001|Overall Study|Death|44
6844445|NCT00303459|10850558|FG000|Overall Study|Withdrawal of consent|32
6844446|NCT00303459|10850559|FG001|Overall Study|Withdrawal of consent|26
6844447|NCT00303459|10850558|FG000|Overall Study|Lost to Follow-up|5
6844448|NCT00303459|10850559|FG001|Overall Study|Lost to Follow-up|4
6844449|NCT00303459|10850558|FG000|Overall Study|Administrative reason|7
6844450|NCT00303459|10850559|FG001|Overall Study|Administrative reason|7
6844451|NCT00303459|10850558|FG000|Overall Study|Decision by the investigator|5
6844452|NCT00303459|10850559|FG001|Overall Study|Decision by the investigator|7
6844453|NCT00303459|10850558|FG000|Overall Study|Lung transplantation|1
6844454|NCT00303459|10850559|FG001|Overall Study|Lung transplantation|1
6844455|NCT00303472|10850573|FG000|Treatment Period|Adverse Event|0
6844456|NCT00303472|10850574|FG001|Treatment Period|Adverse Event|0
6844457|NCT00303472|10850575|FG002|Treatment Period|Adverse Event|0
6844458|NCT00303472|10850576|FG003|Treatment Period|Adverse Event|0
6844459|NCT00303472|10850577|FG004|Treatment Period|Adverse Event|1
6844460|NCT00303472|10850578|FG005|Treatment Period|Adverse Event|0
6844461|NCT00303472|10850579|FG006|Treatment Period|Adverse Event|0
6844462|NCT00303472|10850573|FG000|Treatment Period|Death|0
6844463|NCT00303472|10850574|FG001|Treatment Period|Death|0
6844464|NCT00303472|10850575|FG002|Treatment Period|Death|0
6844465|NCT00303472|10850576|FG003|Treatment Period|Death|1
6844466|NCT00303472|10850577|FG004|Treatment Period|Death|0
6844467|NCT00303472|10850578|FG005|Treatment Period|Death|0
6844468|NCT00303472|10850579|FG006|Treatment Period|Death|1
6844469|NCT00303472|10850573|FG000|Treatment Period|Withdrawal by Subject|0
6844470|NCT00303472|10850574|FG001|Treatment Period|Withdrawal by Subject|0
6844471|NCT00303472|10850575|FG002|Treatment Period|Withdrawal by Subject|0
6844472|NCT00303472|10850576|FG003|Treatment Period|Withdrawal by Subject|1
6844473|NCT00303472|10850577|FG004|Treatment Period|Withdrawal by Subject|0
6844474|NCT00303472|10850578|FG005|Treatment Period|Withdrawal by Subject|1
6844475|NCT00303472|10850579|FG006|Treatment Period|Withdrawal by Subject|0
6844476|NCT00303472|10850573|FG000|Treatment Period|Other|0
7077331|NCT02091206|11184818|FG000|Taper Period|Participant refused study drug|1
7077332|NCT02091206|11184819|FG001|Taper Period|Participant refused study drug|0
7077333|NCT02091206|11184820|FG002|Taper Period|Participant refused study drug|0
7077334|NCT02091206|11184821|FG003|Taper Period|Participant refused study drug|1
7077335|NCT02091206|11184818|FG000|Taper Period|Lost to Follow-up|0
7077336|NCT02091206|11184819|FG001|Taper Period|Lost to Follow-up|0
7077337|NCT02091206|11184820|FG002|Taper Period|Lost to Follow-up|0
7077338|NCT02091206|11184821|FG003|Taper Period|Lost to Follow-up|1
7077339|NCT02091284|11184833|FG000|Overall Study|Withdrawal by Subject|2
7077340|NCT02091284|11184834|FG001|Overall Study|Withdrawal by Subject|1
7077341|NCT02091284|11184833|FG000|Overall Study|unreliable data|1
7077342|NCT02091284|11184834|FG001|Overall Study|unreliable data|0
7077343|NCT02091362|11184844|FG000|Period 1|Protocol Violation|1
7077344|NCT02091362|11184845|FG001|Period 1|Protocol Violation|0
7077345|NCT02091362|11184844|FG000|Period 1|Withdrawal by Subject|2
7077346|NCT02091362|11184845|FG001|Period 1|Withdrawal by Subject|3
7077347|NCT02091362|11184844|FG000|Period 1|Lost to Follow-up|0
7077348|NCT02091362|11184845|FG001|Period 1|Lost to Follow-up|1
7077349|NCT02091362|11184844|FG000|Period 1|Adverse Event|2
7077350|NCT02091362|11184845|FG001|Period 1|Adverse Event|0
7077351|NCT02091362|11184844|FG000|Wash-out|Lost to Follow-up|1
7077352|NCT02091362|11184845|FG001|Wash-out|Lost to Follow-up|1
7077353|NCT02091362|11184844|FG000|Wash-out|Withdrawal by Subject|0
7077354|NCT02091362|11184845|FG001|Wash-out|Withdrawal by Subject|2
7077355|NCT02091362|11184844|FG000|Period 2|Adverse Event|1
7077356|NCT02091362|11184845|FG001|Period 2|Adverse Event|0
7077357|NCT02091362|11184844|FG000|Period 2|Lost to Follow-up|0
7077358|NCT02091362|11184845|FG001|Period 2|Lost to Follow-up|1
7077359|NCT02091362|11184844|FG000|Period 2|Withdrawal by Subject|1
7077360|NCT02091362|11184845|FG001|Period 2|Withdrawal by Subject|1
7077361|NCT02091375|11184857|FG000|Overall Study|Adverse Event|8
7077362|NCT02091375|11184858|FG001|Overall Study|Adverse Event|1
7077363|NCT02091375|11184857|FG000|Overall Study|Lost to Follow-up|0
7077364|NCT02091375|11184858|FG001|Overall Study|Lost to Follow-up|1
6844477|NCT00303472|10850574|FG001|Treatment Period|Other|0
6844478|NCT00303472|10850575|FG002|Treatment Period|Other|0
6844479|NCT00303472|10850576|FG003|Treatment Period|Other|0
6844480|NCT00303472|10850577|FG004|Treatment Period|Other|1
6844481|NCT00303472|10850578|FG005|Treatment Period|Other|0
6844482|NCT00303472|10850579|FG006|Treatment Period|Other|1
6844483|NCT00303472|10850573|FG000|Treatment Period|Disease Progression (to AML)|0
6844484|NCT00303472|10850574|FG001|Treatment Period|Disease Progression (to AML)|0
6844485|NCT00303472|10850575|FG002|Treatment Period|Disease Progression (to AML)|0
6844486|NCT00303472|10850576|FG003|Treatment Period|Disease Progression (to AML)|0
6844487|NCT00303472|10850577|FG004|Treatment Period|Disease Progression (to AML)|1
6844488|NCT00303472|10850578|FG005|Treatment Period|Disease Progression (to AML)|0
6844489|NCT00303472|10850579|FG006|Treatment Period|Disease Progression (to AML)|0
6844490|NCT00303472|10850573|FG000|Treatment Extension (Optional)|Adverse Event|1
6844491|NCT00303472|10850574|FG001|Treatment Extension (Optional)|Adverse Event|0
6844492|NCT00303472|10850575|FG002|Treatment Extension (Optional)|Adverse Event|1
6844493|NCT00303472|10850576|FG003|Treatment Extension (Optional)|Adverse Event|0
6844494|NCT00303472|10850577|FG004|Treatment Extension (Optional)|Adverse Event|0
6844495|NCT00303472|10850578|FG005|Treatment Extension (Optional)|Adverse Event|0
6844496|NCT00303472|10850579|FG006|Treatment Extension (Optional)|Adverse Event|0
6844497|NCT00303472|10850573|FG000|Treatment Extension (Optional)|Death|2
6844498|NCT00303472|10850574|FG001|Treatment Extension (Optional)|Death|0
6844499|NCT00303472|10850575|FG002|Treatment Extension (Optional)|Death|1
6844500|NCT00303472|10850576|FG003|Treatment Extension (Optional)|Death|0
6844501|NCT00303472|10850577|FG004|Treatment Extension (Optional)|Death|0
6844502|NCT00303472|10850578|FG005|Treatment Extension (Optional)|Death|0
6844503|NCT00303472|10850579|FG006|Treatment Extension (Optional)|Death|0
6844504|NCT00303472|10850573|FG000|Treatment Extension (Optional)|Lost to Follow-up|0
6844505|NCT00303472|10850574|FG001|Treatment Extension (Optional)|Lost to Follow-up|0
6844506|NCT00303472|10850575|FG002|Treatment Extension (Optional)|Lost to Follow-up|0
7077365|NCT02091375|11184857|FG000|Overall Study|Withdrawal by Subject|0
7077366|NCT02091375|11184858|FG001|Overall Study|Withdrawal by Subject|1
7077367|NCT02091375|11184857|FG000|Overall Study|Withdrawn by the investigator|1
7077368|NCT02091375|11184858|FG001|Overall Study|Withdrawn by the investigator|0
6844507|NCT00303472|10850576|FG003|Treatment Extension (Optional)|Lost to Follow-up|1
6844508|NCT00303472|10850577|FG004|Treatment Extension (Optional)|Lost to Follow-up|0
6844509|NCT00303472|10850578|FG005|Treatment Extension (Optional)|Lost to Follow-up|0
6844510|NCT00303472|10850579|FG006|Treatment Extension (Optional)|Lost to Follow-up|0
6844511|NCT00303472|10850573|FG000|Treatment Extension (Optional)|Physician Decision|0
6844512|NCT00303472|10850574|FG001|Treatment Extension (Optional)|Physician Decision|4
6844513|NCT00303472|10850575|FG002|Treatment Extension (Optional)|Physician Decision|2
6844514|NCT00303472|10850576|FG003|Treatment Extension (Optional)|Physician Decision|3
6844515|NCT00303472|10850577|FG004|Treatment Extension (Optional)|Physician Decision|2
6844516|NCT00303472|10850578|FG005|Treatment Extension (Optional)|Physician Decision|0
6844517|NCT00303472|10850579|FG006|Treatment Extension (Optional)|Physician Decision|0
6844518|NCT00303472|10850573|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1
6844519|NCT00303472|10850574|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0
6844520|NCT00303472|10850575|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1
6844521|NCT00303472|10850576|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2
6844522|NCT00303472|10850577|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1
6844523|NCT00303472|10850578|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0
6844524|NCT00303472|10850579|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0
6844525|NCT00303472|10850573|FG000|Treatment Extension (Optional)|Other|0
6844526|NCT00303472|10850574|FG001|Treatment Extension (Optional)|Other|2
6844527|NCT00303472|10850575|FG002|Treatment Extension (Optional)|Other|4
6844528|NCT00303472|10850576|FG003|Treatment Extension (Optional)|Other|2
6844529|NCT00303472|10850577|FG004|Treatment Extension (Optional)|Other|1
6844530|NCT00303472|10850578|FG005|Treatment Extension (Optional)|Other|0
6844531|NCT00303472|10850579|FG006|Treatment Extension (Optional)|Other|0
6844532|NCT00303472|10850573|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1
6844533|NCT00303472|10850574|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0
6844534|NCT00303472|10850575|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0
6844535|NCT00303472|10850576|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0
6844536|NCT00303472|10850577|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0
6844537|NCT00303472|10850578|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1
6844538|NCT00303472|10850579|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0
6844539|NCT00303485|10850597|FG000|Overall Study|Adverse Event/Intercurrent Illness|0
6844540|NCT00303485|10850598|FG001|Overall Study|Adverse Event/Intercurrent Illness|1
6844541|NCT00303485|10850597|FG000|Overall Study|Failure to return|0
6844542|NCT00303485|10850598|FG001|Overall Study|Failure to return|1
6844543|NCT00303485|10850597|FG000|Overall Study|Withdrawal by Subject|1
6844544|NCT00303485|10850598|FG001|Overall Study|Withdrawal by Subject|0
6844545|NCT00303602|10850610|FG000|Overall Study|Adverse Event|2
6844546|NCT00303602|10850611|FG001|Overall Study|Adverse Event|2
6844547|NCT00303602|10850610|FG000|Overall Study|Withdrawal by Subject|5
6844548|NCT00303602|10850611|FG001|Overall Study|Withdrawal by Subject|6
6844549|NCT00303602|10850610|FG000|Overall Study|Lost to Follow-up|5
6844550|NCT00303602|10850611|FG001|Overall Study|Lost to Follow-up|2
6844551|NCT00303602|10850610|FG000|Overall Study|Protocol entry criteria not met|2
6844552|NCT00303602|10850611|FG001|Overall Study|Protocol entry criteria not met|2
6844553|NCT00303602|10850610|FG000|Overall Study|Physician Decision|2
6844554|NCT00303602|10850611|FG001|Overall Study|Physician Decision|1
6844555|NCT00303602|10850610|FG000|Overall Study|Noncompliance|2
6844556|NCT00303602|10850611|FG001|Overall Study|Noncompliance|2
6844557|NCT00303602|10850610|FG000|Overall Study|Protocol Violation|1
6844558|NCT00303602|10850611|FG001|Overall Study|Protocol Violation|0
6844559|NCT00303628|10850619|FG000|Overall Study|Disease progression|0
6844560|NCT00303628|10850620|FG001|Overall Study|Disease progression|1
6844561|NCT00303628|10850619|FG000|Overall Study|Adverse Event|26
6844562|NCT00303628|10850620|FG001|Overall Study|Adverse Event|36
6844563|NCT00303628|10850619|FG000|Overall Study|Death|0
6844564|NCT00303628|10850620|FG001|Overall Study|Death|1
6844565|NCT00303628|10850619|FG000|Overall Study|Withdrawal by Subject|11
6844566|NCT00303628|10850620|FG001|Overall Study|Withdrawal by Subject|20
6844567|NCT00303628|10850619|FG000|Overall Study|Alternative therapy|2
6844568|NCT00303628|10850620|FG001|Overall Study|Alternative therapy|0
6844569|NCT00303628|10850619|FG000|Overall Study|Other complicating disease|0
6844570|NCT00303628|10850620|FG001|Overall Study|Other complicating disease|1
6844571|NCT00303628|10850619|FG000|Overall Study|Not start protocol therapy|3
6844572|NCT00303628|10850620|FG001|Overall Study|Not start protocol therapy|5
6844573|NCT00303628|10850619|FG000|Overall Study|Other|8
6844574|NCT00303628|10850620|FG001|Overall Study|Other|9
6844575|NCT00303667|10850628|FG000|Overall Study|Death|0
6844576|NCT00303667|10850629|FG001|Overall Study|Death|4
6844577|NCT00303719|10850637|FG000|Overall Study|Not evaluable, prior therapies|0
6844578|NCT00303719|10850638|FG001|Overall Study|Not evaluable, prior therapies|30
6844579|NCT00303719|10850637|FG000|Overall Study|Lost to Follow-up|0
6844580|NCT00303719|10850638|FG001|Overall Study|Lost to Follow-up|7
6844581|NCT00303953|10850662|FG000|Overall Study|Ineligible|1
6844582|NCT00303953|10850662|FG000|Overall Study|Death|1
6844583|NCT00303953|10850662|FG000|Overall Study|Adverse Event|4
6844584|NCT00303953|10850662|FG000|Overall Study|Lack of Efficacy|12
6844585|NCT00303953|10850662|FG000|Overall Study|Physician Decision|1
6897849|NCT00642941|10916955|FG004|Overall Study|Physician Decision|0
6844586|NCT00304031|10850695|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144
6844587|NCT00304031|10850696|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0
6844588|NCT00304031|10850697|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0
6844589|NCT00304031|10850695|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48
6844590|NCT00304031|10850696|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0
6844591|NCT00304031|10850697|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0
6844592|NCT00304031|10850695|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19
6844593|NCT00304031|10850696|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0
6844594|NCT00304031|10850697|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0
6844595|NCT00304031|10850695|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18
6844596|NCT00304031|10850696|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0
6844597|NCT00304031|10850697|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0
6844598|NCT00304031|10850695|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15
6844599|NCT00304031|10850696|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0
6844600|NCT00304031|10850697|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0
6844601|NCT00304031|10850695|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10
6844602|NCT00304031|10850696|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0
6844603|NCT00304031|10850697|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0
6844604|NCT00304031|10850695|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1
6844605|NCT00304031|10850696|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0
6844606|NCT00304031|10850697|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0
6844607|NCT00304031|10850695|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37
6844608|NCT00304031|10850696|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0
6844609|NCT00304031|10850697|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0
6844610|NCT00304031|10850695|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
6844611|NCT00304031|10850696|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
6844612|NCT00304031|10850697|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2
6844613|NCT00304083|10850714|FG000|Overall Study|Withdrawal by Subject|4
6844614|NCT00304083|10850715|FG001|Overall Study|Withdrawal by Subject|2
6844615|NCT00304083|10850714|FG000|Overall Study|Physician Decision|8
6844616|NCT00304083|10850715|FG001|Overall Study|Physician Decision|3
6844617|NCT00304083|10850714|FG000|Overall Study|Disease Progression|5
6844618|NCT00304083|10850715|FG001|Overall Study|Disease Progression|1
6844619|NCT00304083|10850714|FG000|Overall Study|Other|5
6844620|NCT00304083|10850715|FG001|Overall Study|Other|2
6844621|NCT00304278|10850759|FG000|Overall Study|lack of insurance coverage for chemoRT|1
6844622|NCT00304278|10850759|FG000|Overall Study|PT had medical condition preventing TX|1
6844623|NCT00304356|10850763|FG000|Nitazoxanide|Physician Decision|5
6844624|NCT00304356|10850763|FG000|Nitazoxanide|Physician Decision|1
6844625|NCT00304356|10850763|FG000|Nitazoxanide|number is 0|1
6844626|NCT00304356|10850763|FG000|Nitazoxanide|Physician Decision|1
6844627|NCT00304356|10850763|FG000|Nitazoxanide|Physician Decision|1
6844628|NCT00304356|10850763|FG000|Nitazoxanide|Physician Decision|1
6897850|NCT00642941|10916956|FG005|Overall Study|Physician Decision|0
6897851|NCT00642941|10916957|FG006|Overall Study|Physician Decision|1
6897852|NCT00642941|10916958|FG007|Overall Study|Physician Decision|0
6897853|NCT00642941|10916959|FG008|Overall Study|Physician Decision|0
6897854|NCT00642941|10916960|FG009|Overall Study|Physician Decision|1
6897855|NCT00642941|10916961|FG010|Overall Study|Physician Decision|0
6897856|NCT00642941|10916962|FG011|Overall Study|Physician Decision|1
6897857|NCT00642941|10916951|FG000|Overall Study|Death|4
6897858|NCT00642941|10916952|FG001|Overall Study|Death|0
6897859|NCT00642941|10916953|FG002|Overall Study|Death|1
6897860|NCT00642941|10916954|FG003|Overall Study|Death|1
6897861|NCT00642941|10916955|FG004|Overall Study|Death|2
6897862|NCT00642941|10916956|FG005|Overall Study|Death|1
6897863|NCT00642941|10916957|FG006|Overall Study|Death|0
6897864|NCT00642941|10916958|FG007|Overall Study|Death|0
6897865|NCT00642941|10916959|FG008|Overall Study|Death|0
6897866|NCT00642941|10916960|FG009|Overall Study|Death|0
6897867|NCT00642941|10916961|FG010|Overall Study|Death|0
6897868|NCT00642941|10916962|FG011|Overall Study|Death|1
6897869|NCT00642941|10916951|FG000|Overall Study|Study closed by Sponsor|0
6897870|NCT00642941|10916952|FG001|Overall Study|Study closed by Sponsor|1
6897871|NCT00642941|10916953|FG002|Overall Study|Study closed by Sponsor|0
6897872|NCT00642941|10916954|FG003|Overall Study|Study closed by Sponsor|0
6897873|NCT00642941|10916955|FG004|Overall Study|Study closed by Sponsor|0
6897874|NCT00642941|10916956|FG005|Overall Study|Study closed by Sponsor|0
6897875|NCT00642941|10916957|FG006|Overall Study|Study closed by Sponsor|0
6897876|NCT00642941|10916958|FG007|Overall Study|Study closed by Sponsor|0
6897877|NCT00642941|10916959|FG008|Overall Study|Study closed by Sponsor|0
6897878|NCT00642941|10916960|FG009|Overall Study|Study closed by Sponsor|0
6897879|NCT00642941|10916961|FG010|Overall Study|Study closed by Sponsor|0
6897880|NCT00642941|10916962|FG011|Overall Study|Study closed by Sponsor|0
6897881|NCT00642941|10916951|FG000|Overall Study|Withdrawal by Subject|1
6897882|NCT00642941|10916952|FG001|Overall Study|Withdrawal by Subject|0
6897883|NCT00642941|10916953|FG002|Overall Study|Withdrawal by Subject|0
6897884|NCT00642941|10916954|FG003|Overall Study|Withdrawal by Subject|2
6844629|NCT04493931|10850838|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1
6844630|NCT04493931|10850839|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0
6844631|NCT04493931|10850840|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0
6844632|NCT04493931|10850841|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0
6844633|NCT04493931|10850842|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0
6844634|NCT04493931|10850843|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0
6844635|NCT04493931|10850844|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0
6844636|NCT04493931|10850838|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0
6844637|NCT04493931|10850839|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2
6844638|NCT04493931|10850840|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0
6844639|NCT04493931|10850841|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0
6844640|NCT04493931|10850842|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0
6844641|NCT04493931|10850843|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0
6844642|NCT04493931|10850844|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0
6844643|NCT04493931|10850838|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0
6844644|NCT04493931|10850839|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1
6844645|NCT04493931|10850840|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0
6844646|NCT04493931|10850841|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0
6844647|NCT04493931|10850842|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0
6844648|NCT04493931|10850843|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0
6844649|NCT04493931|10850844|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0
6844650|NCT04493931|10850838|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0
6844651|NCT04493931|10850839|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0
6844652|NCT04493931|10850840|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1
6844653|NCT04493931|10850841|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0
6844654|NCT04493931|10850842|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0
6844655|NCT04493931|10850843|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0
6844656|NCT04493931|10850844|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0
6844657|NCT04428034|10850874|FG000|Enrollment to Intervention Completion|Protocol Violation|9
6844658|NCT04428034|10850874|FG000|Enrollment to Intervention Completion|Suspected Fraudulent Case|1
6844659|NCT03999554|10850903|FG000|Overall Study|Lost to Follow-up|4
6844660|NCT03999554|10850904|FG001|Overall Study|Lost to Follow-up|5
6844661|NCT03999554|10850905|FG002|Overall Study|Lost to Follow-up|4
6844662|NCT03999554|10850906|FG003|Overall Study|Lost to Follow-up|5
6844663|NCT03999554|10850907|FG004|Overall Study|Lost to Follow-up|8
6844664|NCT03999554|10850903|FG000|Overall Study|Protocol Violation|0
6844665|NCT03999554|10850904|FG001|Overall Study|Protocol Violation|0
6844666|NCT03999554|10850905|FG002|Overall Study|Protocol Violation|5
6844667|NCT03999554|10850906|FG003|Overall Study|Protocol Violation|0
6844668|NCT03999554|10850907|FG004|Overall Study|Protocol Violation|0
6844669|NCT03999554|10850903|FG000|Overall Study|Pregnancy|0
6844670|NCT03999554|10850904|FG001|Overall Study|Pregnancy|0
6844671|NCT03999554|10850905|FG002|Overall Study|Pregnancy|1
6844672|NCT03999554|10850906|FG003|Overall Study|Pregnancy|0
6844673|NCT03999554|10850907|FG004|Overall Study|Pregnancy|0
6844674|NCT03999554|10850903|FG000|Overall Study|Withdrawal by Subject|2
6844675|NCT03999554|10850904|FG001|Overall Study|Withdrawal by Subject|2
6844676|NCT03999554|10850905|FG002|Overall Study|Withdrawal by Subject|2
6844677|NCT03999554|10850906|FG003|Overall Study|Withdrawal by Subject|1
6844678|NCT03999554|10850907|FG004|Overall Study|Withdrawal by Subject|1
6844679|NCT03999554|10850903|FG000|Overall Study|failure to comply with protocol requirements|0
6844680|NCT03999554|10850904|FG001|Overall Study|failure to comply with protocol requirements|0
6844681|NCT03999554|10850905|FG002|Overall Study|failure to comply with protocol requirements|0
6844682|NCT03999554|10850906|FG003|Overall Study|failure to comply with protocol requirements|1
6844683|NCT03999554|10850907|FG004|Overall Study|failure to comply with protocol requirements|0
6844684|NCT03651622|10850923|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0
6844685|NCT03651622|10850924|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6
6844686|NCT03651622|10850925|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2
6844687|NCT03651622|10850923|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4
6844688|NCT03651622|10850924|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1
6844689|NCT03651622|10850925|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7
6844690|NCT03651622|10850923|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0
6844691|NCT03651622|10850924|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2
6844692|NCT03651622|10850925|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3
6844693|NCT03651622|10850923|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2
6844694|NCT03651622|10850924|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0
6844695|NCT03651622|10850925|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0
6844696|NCT03651622|10850923|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0
6844697|NCT03651622|10850924|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0
6844698|NCT03651622|10850925|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1
6844699|NCT03410992|10850935|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0
6844700|NCT03410992|10850936|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5
6844701|NCT03410992|10850937|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0
6844702|NCT03410992|10850938|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0
6844703|NCT03410992|10850939|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0
7151313|NCT03226769|11315260|FG001|Overall Study|Withdrawal by Subject|1
7151314|NCT03227445|11315275|FG000|Period 1 (28 Days)|Adverse Event|1
6844704|NCT03410992|10850940|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0
6844705|NCT03410992|10850941|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0
6844706|NCT03410992|10850942|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0
6844707|NCT03410992|10850943|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0
6844708|NCT03410992|10850944|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0
6844709|NCT03410992|10850945|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0
6844710|NCT03410992|10850935|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2
6844711|NCT03410992|10850936|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1
6844712|NCT03410992|10850937|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0
6844713|NCT03410992|10850938|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0
6844714|NCT03410992|10850939|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0
6844715|NCT03410992|10850940|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0
6844716|NCT03410992|10850941|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0
6844717|NCT03410992|10850942|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0
6844718|NCT03410992|10850943|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0
6844719|NCT03410992|10850944|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0
6844720|NCT03410992|10850945|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0
6844721|NCT03410992|10850935|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1
6844722|NCT03410992|10850936|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3
6844723|NCT03410992|10850937|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0
6844724|NCT03410992|10850938|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0
6844725|NCT03410992|10850939|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0
6844726|NCT03410992|10850940|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0
6844727|NCT03410992|10850941|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0
6844728|NCT03410992|10850942|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0
6844729|NCT03410992|10850943|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0
6844730|NCT03410992|10850944|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0
6844731|NCT03410992|10850945|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0
6844732|NCT03410992|10850935|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1
6844733|NCT03410992|10850936|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
6844734|NCT03410992|10850937|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
6844735|NCT03410992|10850938|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
6844736|NCT03410992|10850939|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
6844737|NCT03410992|10850940|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
6844738|NCT03410992|10850941|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
6844739|NCT03410992|10850942|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
6844740|NCT03410992|10850943|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
6844741|NCT03410992|10850944|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
6844742|NCT03410992|10850945|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
6844743|NCT03410992|10850935|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81
6844744|NCT03410992|10850936|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23
6844745|NCT03410992|10850937|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0
6844746|NCT03410992|10850938|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0
6844747|NCT03410992|10850939|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0
6844748|NCT03410992|10850940|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0
6844749|NCT03410992|10850941|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0
6844750|NCT03410992|10850942|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0
6844751|NCT03410992|10850943|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0
6844752|NCT03410992|10850944|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0
6844753|NCT03410992|10850945|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0
6844754|NCT03410992|10850935|FG000|Week 16 Assessment|Incorrect escapers|0
6844755|NCT03410992|10850936|FG001|Week 16 Assessment|Incorrect escapers|6
6844756|NCT03410992|10850937|FG002|Week 16 Assessment|Incorrect escapers|0
6844757|NCT03410992|10850938|FG003|Week 16 Assessment|Incorrect escapers|0
6844758|NCT03410992|10850939|FG004|Week 16 Assessment|Incorrect escapers|0
6844759|NCT03410992|10850940|FG005|Week 16 Assessment|Incorrect escapers|0
6844760|NCT03410992|10850941|FG006|Week 16 Assessment|Incorrect escapers|0
6844761|NCT03410992|10850942|FG007|Week 16 Assessment|Incorrect escapers|0
6844762|NCT03410992|10850943|FG008|Week 16 Assessment|Incorrect escapers|0
6844763|NCT03410992|10850944|FG009|Week 16 Assessment|Incorrect escapers|0
6844764|NCT03410992|10850945|FG010|Week 16 Assessment|Incorrect escapers|0
6844765|NCT03410992|10850935|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0
6844766|NCT03410992|10850936|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0
6844767|NCT03410992|10850937|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0
6844768|NCT03410992|10850938|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3
6844769|NCT03410992|10850939|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2
6844770|NCT03410992|10850940|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0
6844771|NCT03410992|10850941|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0
6844772|NCT03410992|10850942|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0
6844773|NCT03410992|10850943|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0
6844774|NCT03410992|10850944|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0
6844775|NCT03410992|10850945|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0
6844776|NCT03410992|10850935|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0
6844777|NCT03410992|10850936|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0
6844778|NCT03410992|10850937|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0
6844779|NCT03410992|10850938|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2
6844780|NCT03410992|10850939|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1
6844781|NCT03410992|10850940|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2
6844782|NCT03410992|10850941|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0
6844783|NCT03410992|10850942|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0
6844784|NCT03410992|10850943|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0
6844785|NCT03410992|10850944|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0
6844786|NCT03410992|10850945|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0
6844787|NCT03410992|10850935|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
6844788|NCT03410992|10850936|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
6844789|NCT03410992|10850937|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
6844790|NCT03410992|10850938|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
6844791|NCT03410992|10850939|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
6844792|NCT03410992|10850940|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3
6844793|NCT03410992|10850941|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
6844794|NCT03410992|10850942|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
6844795|NCT03410992|10850943|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
6844796|NCT03410992|10850944|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
6844797|NCT03410992|10850945|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
6844798|NCT03410992|10850935|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0
6844799|NCT03410992|10850936|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0
6844800|NCT03410992|10850937|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0
6844801|NCT03410992|10850938|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67
6844802|NCT03410992|10850939|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4
6844803|NCT03410992|10850940|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7
6844804|NCT03410992|10850941|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0
6844805|NCT03410992|10850942|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0
6844806|NCT03410992|10850943|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0
6844807|NCT03410992|10850944|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0
6844808|NCT03410992|10850945|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0
6844809|NCT03410992|10850935|FG000|Escape Treatment: 12 Weeks|Adverse Event|0
6844810|NCT03410992|10850936|FG001|Escape Treatment: 12 Weeks|Adverse Event|0
6844811|NCT03410992|10850937|FG002|Escape Treatment: 12 Weeks|Adverse Event|0
6844812|NCT03410992|10850938|FG003|Escape Treatment: 12 Weeks|Adverse Event|0
6844813|NCT03410992|10850939|FG004|Escape Treatment: 12 Weeks|Adverse Event|0
6844814|NCT03410992|10850940|FG005|Escape Treatment: 12 Weeks|Adverse Event|0
6844815|NCT03410992|10850941|FG006|Escape Treatment: 12 Weeks|Adverse Event|0
6844816|NCT03410992|10850942|FG007|Escape Treatment: 12 Weeks|Adverse Event|1
6844817|NCT03410992|10850943|FG008|Escape Treatment: 12 Weeks|Adverse Event|0
6844818|NCT03410992|10850944|FG009|Escape Treatment: 12 Weeks|Adverse Event|0
6844819|NCT03410992|10850945|FG010|Escape Treatment: 12 Weeks|Adverse Event|0
6844820|NCT03410992|10850935|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
6844821|NCT03410992|10850936|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
6844822|NCT03410992|10850937|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
6844823|NCT03410992|10850938|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
6844824|NCT03410992|10850939|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
6844825|NCT03410992|10850940|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
6844826|NCT03410992|10850941|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
6844827|NCT03410992|10850942|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
6844828|NCT03410992|10850943|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1
6844829|NCT03410992|10850944|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
6844830|NCT03410992|10850945|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
6844831|NCT02678351|10851007|FG000|Overall Study|Withdrawal by Subject|1
6844832|NCT02272790|10851021|FG000|Overall Study|Physician Decision|0
6844833|NCT02272790|10851022|FG001|Overall Study|Physician Decision|1
6844834|NCT02272790|10851023|FG002|Overall Study|Physician Decision|0
6844835|NCT02272790|10851024|FG003|Overall Study|Physician Decision|0
6844836|NCT02272790|10851025|FG004|Overall Study|Physician Decision|0
6844837|NCT02272790|10851026|FG005|Overall Study|Physician Decision|0
6844838|NCT01693692|10851062|FG000|Overall Study|Withdrawal by Subject|12
6844839|NCT01693692|10851063|FG001|Overall Study|Withdrawal by Subject|10
6844840|NCT01693692|10851064|FG002|Overall Study|Withdrawal by Subject|11
6844841|NCT01693692|10851062|FG000|Overall Study|Adverse Event|7
6844842|NCT01693692|10851063|FG001|Overall Study|Adverse Event|14
6844843|NCT01693692|10851064|FG002|Overall Study|Adverse Event|9
6844844|NCT01693692|10851062|FG000|Overall Study|Physician Decision|0
6844845|NCT01693692|10851063|FG001|Overall Study|Physician Decision|0
6844846|NCT01693692|10851064|FG002|Overall Study|Physician Decision|1
6844847|NCT01693692|10851062|FG000|Overall Study|Protocol Violation|5
6844848|NCT01693692|10851063|FG001|Overall Study|Protocol Violation|4
6844849|NCT01693692|10851064|FG002|Overall Study|Protocol Violation|6
6844850|NCT01693692|10851062|FG000|Overall Study|Lost to Follow-up|2
6844851|NCT01693692|10851063|FG001|Overall Study|Lost to Follow-up|2
6844852|NCT01693692|10851064|FG002|Overall Study|Lost to Follow-up|3
6844853|NCT01693692|10851062|FG000|Overall Study|Other|4
6844854|NCT01693692|10851063|FG001|Overall Study|Other|4
6844855|NCT01693692|10851064|FG002|Overall Study|Other|6
6844856|NCT01685606|10851072|FG000|Overall Study|Withdrawal by Subject|1
6844857|NCT01650285|10851082|FG000|Overall Study|Adverse Event|1
6844858|NCT01083771|10851086|FG000|Overall Study|non-compliant|2
6844859|NCT01083771|10851086|FG000|Overall Study|Withdrawal by Subject|3
6844860|NCT00743197|10851092|FG000|Overall Study|Study terminated due to departure of PI.|1
6844861|NCT00743197|10851093|FG001|Overall Study|Study terminated due to departure of PI.|2
6844862|NCT00304915|10851101|FG000|Overall Study|Lost to Follow-up|11
6844863|NCT00304915|10851102|FG001|Overall Study|Lost to Follow-up|11
6844864|NCT00304915|10851101|FG000|Overall Study|Death|4
6844865|NCT00304915|10851102|FG001|Overall Study|Death|5
6844866|NCT00304915|10851101|FG000|Overall Study|Withdrawal by Subject|3
6844867|NCT00304915|10851102|FG001|Overall Study|Withdrawal by Subject|0
6844868|NCT00304954|10851112|FG000|Overall Study|Withdrawal by Subject|0
6844869|NCT00304954|10851113|FG001|Overall Study|Withdrawal by Subject|0
6844870|NCT00304954|10851114|FG002|Overall Study|Withdrawal by Subject|1
6844871|NCT00304954|10851115|FG003|Overall Study|Withdrawal by Subject|0
6844872|NCT00304954|10851112|FG000|Overall Study|Adverse Event|1
6844873|NCT00304954|10851113|FG001|Overall Study|Adverse Event|0
6844874|NCT00304954|10851114|FG002|Overall Study|Adverse Event|0
6844875|NCT00304954|10851115|FG003|Overall Study|Adverse Event|0
6844876|NCT00305006|10851135|FG000|Overall Study|Withdrawal by Subject|1
6844877|NCT00305006|10851136|FG001|Overall Study|Withdrawal by Subject|0
6844878|NCT00305006|10851135|FG000|Overall Study|Failure to complete pretest|0
6844879|NCT00305006|10851136|FG001|Overall Study|Failure to complete pretest|1
6844880|NCT00305058|10851144|FG000|Overall Study|Participant too young|1
6844881|NCT00305058|10851145|FG001|Overall Study|Participant too young|0
6844882|NCT00305058|10851144|FG000|Overall Study|Missing data collection instrument|3
6844883|NCT00305058|10851145|FG001|Overall Study|Missing data collection instrument|2
6844884|NCT00305058|10851144|FG000|Overall Study|Missing outcome data|3
6844885|NCT00305058|10851145|FG001|Overall Study|Missing outcome data|2
6844886|NCT00305110|10851200|FG000|Overall Study|Missing data|29
6897885|NCT00642941|10916955|FG004|Overall Study|Withdrawal by Subject|0
6897886|NCT00642941|10916956|FG005|Overall Study|Withdrawal by Subject|0
6897887|NCT00642941|10916957|FG006|Overall Study|Withdrawal by Subject|2
6897888|NCT00642941|10916958|FG007|Overall Study|Withdrawal by Subject|0
6897889|NCT00642941|10916959|FG008|Overall Study|Withdrawal by Subject|1
6897890|NCT00642941|10916960|FG009|Overall Study|Withdrawal by Subject|0
6897891|NCT00642941|10916961|FG010|Overall Study|Withdrawal by Subject|0
6897892|NCT00642941|10916962|FG011|Overall Study|Withdrawal by Subject|1
6897893|NCT00642941|10916951|FG000|Overall Study|Protocol Violation|0
6897894|NCT00642941|10916952|FG001|Overall Study|Protocol Violation|0
6897895|NCT00642941|10916953|FG002|Overall Study|Protocol Violation|0
6897896|NCT00642941|10916954|FG003|Overall Study|Protocol Violation|0
6897897|NCT00642941|10916955|FG004|Overall Study|Protocol Violation|0
6897898|NCT00642941|10916956|FG005|Overall Study|Protocol Violation|0
6897899|NCT00642941|10916957|FG006|Overall Study|Protocol Violation|1
6897900|NCT00642941|10916958|FG007|Overall Study|Protocol Violation|0
6897901|NCT00642941|10916959|FG008|Overall Study|Protocol Violation|0
6897902|NCT00642941|10916960|FG009|Overall Study|Protocol Violation|0
6897903|NCT00642941|10916961|FG010|Overall Study|Protocol Violation|0
6897904|NCT00642941|10916962|FG011|Overall Study|Protocol Violation|0
6897905|NCT00642941|10916951|FG000|Overall Study|Adverse Event|1
6897906|NCT00642941|10916952|FG001|Overall Study|Adverse Event|1
6897907|NCT00642941|10916953|FG002|Overall Study|Adverse Event|0
6897908|NCT00642941|10916954|FG003|Overall Study|Adverse Event|0
6897909|NCT00642941|10916955|FG004|Overall Study|Adverse Event|0
6897910|NCT00642941|10916956|FG005|Overall Study|Adverse Event|0
6897911|NCT00642941|10916957|FG006|Overall Study|Adverse Event|1
6897912|NCT00642941|10916958|FG007|Overall Study|Adverse Event|1
6897913|NCT00642941|10916959|FG008|Overall Study|Adverse Event|0
6897914|NCT00642941|10916960|FG009|Overall Study|Adverse Event|1
6897915|NCT00642941|10916961|FG010|Overall Study|Adverse Event|0
6897916|NCT00642941|10916962|FG011|Overall Study|Adverse Event|0
6897917|NCT00642941|10916951|FG000|Overall Study|Other|1
6897918|NCT00642941|10916952|FG001|Overall Study|Other|1
6897919|NCT00642941|10916953|FG002|Overall Study|Other|1
6897920|NCT00642941|10916954|FG003|Overall Study|Other|1
6897921|NCT00642941|10916955|FG004|Overall Study|Other|0
6897922|NCT00642941|10916956|FG005|Overall Study|Other|1
6897923|NCT00642941|10916957|FG006|Overall Study|Other|0
6844887|NCT00305227|10851216|FG000|Overall Study|Lost to Follow-up|7
6844888|NCT00305227|10851217|FG001|Overall Study|Lost to Follow-up|6
6844889|NCT00305253|10851225|FG000|Overall Study|Withdrawal by Subject|0
6844890|NCT00305253|10851226|FG001|Overall Study|Withdrawal by Subject|1
6844891|NCT00305448|10851235|FG000|Overall Study|Protocol Violation|0
6844892|NCT00305448|10851236|FG001|Overall Study|Protocol Violation|1
6844893|NCT00305448|10851237|FG002|Overall Study|Protocol Violation|0
6844894|NCT00305448|10851235|FG000|Overall Study|Withdrawal by Subject|2
6844895|NCT00305448|10851236|FG001|Overall Study|Withdrawal by Subject|0
6844896|NCT00305448|10851237|FG002|Overall Study|Withdrawal by Subject|1
6844897|NCT00305448|10851235|FG000|Overall Study|Adverse Event|1
6844898|NCT00305448|10851236|FG001|Overall Study|Adverse Event|0
6844899|NCT00305448|10851237|FG002|Overall Study|Adverse Event|1
6844900|NCT00305448|10851235|FG000|Overall Study|Disease Progression|27
6844901|NCT00305448|10851236|FG001|Overall Study|Disease Progression|31
6844902|NCT00305448|10851237|FG002|Overall Study|Disease Progression|28
6844903|NCT00305448|10851235|FG000|Overall Study|Subjective Disease Progression|1
6844904|NCT00305448|10851236|FG001|Overall Study|Subjective Disease Progression|2
6844905|NCT00305448|10851237|FG002|Overall Study|Subjective Disease Progression|2
6844906|NCT00305448|10851235|FG000|Overall Study|Tumor Marker Elevation|0
6844907|NCT00305448|10851236|FG001|Overall Study|Tumor Marker Elevation|0
6844908|NCT00305448|10851237|FG002|Overall Study|Tumor Marker Elevation|1
6844909|NCT00305604|10851271|FG000|Overall Study|Adverse Event|6
6844910|NCT00305604|10851272|FG001|Overall Study|Adverse Event|3
6844911|NCT00305604|10851271|FG000|Overall Study|Lack of Efficacy|11
6844912|NCT00305604|10851272|FG001|Overall Study|Lack of Efficacy|18
6844913|NCT00305604|10851271|FG000|Overall Study|Lost to Follow-up|0
6844914|NCT00305604|10851272|FG001|Overall Study|Lost to Follow-up|4
6844915|NCT00305604|10851271|FG000|Overall Study|Protocol Violation|2
6844916|NCT00305604|10851272|FG001|Overall Study|Protocol Violation|1
6844917|NCT00305604|10851271|FG000|Overall Study|Withdrawal by Subject|12
6844918|NCT00305604|10851272|FG001|Overall Study|Withdrawal by Subject|21
6844919|NCT00305604|10851271|FG000|Overall Study|Patient moved|1
6844920|NCT00305604|10851272|FG001|Overall Study|Patient moved|0
6844921|NCT00305695|10851305|FG000|Overall Study|Withdrawal by subject prior to 18 month|40
6844922|NCT00305695|10851306|FG001|Overall Study|Withdrawal by subject prior to 18 month|26
6844923|NCT00305695|10851305|FG000|Overall Study|Did not have baseline scan|1
6844924|NCT00305695|10851306|FG001|Overall Study|Did not have baseline scan|1
6844925|NCT00305773|10851318|FG000|Overall Study|Death|3
6844926|NCT00305773|10851319|FG001|Overall Study|Death|2
6844927|NCT00305773|10851318|FG000|Overall Study|Adverse Event|1
6844928|NCT00305773|10851319|FG001|Overall Study|Adverse Event|2
6844929|NCT00305773|10851318|FG000|Overall Study|Alternative Treatment|4
6844930|NCT00305773|10851319|FG001|Overall Study|Alternative Treatment|4
6844931|NCT00305773|10851318|FG000|Overall Study|Physician Decision|1
6844932|NCT00305773|10851319|FG001|Overall Study|Physician Decision|1
6844933|NCT00305773|10851318|FG000|Overall Study|Withdrawal by Subject|1
7077369|NCT02091414|11184864|FG000|Overall Study|Withdrawal by Subject|2
7077370|NCT02091414|11184864|FG000|Overall Study|Death|2
6844934|NCT00305773|10851319|FG001|Overall Study|Withdrawal by Subject|4
6844935|NCT00305773|10851318|FG000|Overall Study|Disease Progression|1
6844936|NCT00305773|10851319|FG001|Overall Study|Disease Progression|3
6844937|NCT00305773|10851318|FG000|Overall Study|All other reasons|3
6844938|NCT00305773|10851319|FG001|Overall Study|All other reasons|2
6844939|NCT00305864|10851329|FG000|Overall Study|Ineligible / No protocol treatment|0
6844940|NCT00305864|10851330|FG001|Overall Study|Ineligible / No protocol treatment|1
6844941|NCT00305864|10851331|FG002|Overall Study|Ineligible / No protocol treatment|1
6844942|NCT00305864|10851332|FG003|Overall Study|Ineligible / No protocol treatment|13
6844943|NCT00305877|10851344|FG000|Overall Study|Lack of Efficacy|6
6844944|NCT00305877|10851345|FG001|Overall Study|Lack of Efficacy|9
6844945|NCT00305877|10851344|FG000|Overall Study|Adverse Event|9
6844946|NCT00305877|10851345|FG001|Overall Study|Adverse Event|14
6844947|NCT00305877|10851344|FG000|Overall Study|Death|0
6844948|NCT00305877|10851345|FG001|Overall Study|Death|1
6844949|NCT00305877|10851344|FG000|Overall Study|Withdrawal by Subject|4
6844950|NCT00305877|10851345|FG001|Overall Study|Withdrawal by Subject|2
6844951|NCT00305877|10851344|FG000|Overall Study|Physician Decision|1
6844952|NCT00305877|10851345|FG001|Overall Study|Physician Decision|1
6844953|NCT00305877|10851344|FG000|Overall Study|Never start treatment|2
6844954|NCT00305877|10851345|FG001|Overall Study|Never start treatment|5
6844955|NCT00305877|10851344|FG000|Overall Study|Ineligible|2
6844956|NCT00305877|10851345|FG001|Overall Study|Ineligible|1
6844957|NCT00305877|10851344|FG000|Overall Study|Transportation issue with daily RT|0
6844958|NCT00305877|10851345|FG001|Overall Study|Transportation issue with daily RT|1
6844959|NCT00306189|10851368|FG000|Overall Study|Physician Decision|0
6844960|NCT00306189|10851369|FG001|Overall Study|Physician Decision|0
6844961|NCT00306189|10851370|FG002|Overall Study|Physician Decision|0
6844962|NCT00306189|10851371|FG003|Overall Study|Physician Decision|1
6844963|NCT00306189|10851368|FG000|Overall Study|Adverse Event|3
6844964|NCT00306189|10851369|FG001|Overall Study|Adverse Event|3
6844965|NCT00306189|10851370|FG002|Overall Study|Adverse Event|2
6844966|NCT00306189|10851371|FG003|Overall Study|Adverse Event|2
6844967|NCT00306189|10851368|FG000|Overall Study|Withdrawal by Subject|4
7077371|NCT02091440|11184868|FG000|Overall Study|Death|2
7077372|NCT02091726|11184885|FG000|Overall Study|Lost to Follow-up|6
6844968|NCT00306189|10851369|FG001|Overall Study|Withdrawal by Subject|2
6844969|NCT00306189|10851370|FG002|Overall Study|Withdrawal by Subject|8
6844970|NCT00306189|10851371|FG003|Overall Study|Withdrawal by Subject|1
6844971|NCT00306189|10851368|FG000|Overall Study|Ineligibility determined|1
6844972|NCT00306189|10851369|FG001|Overall Study|Ineligibility determined|1
6844973|NCT00306189|10851370|FG002|Overall Study|Ineligibility determined|1
6844974|NCT00306189|10851371|FG003|Overall Study|Ineligibility determined|1
6844975|NCT00306189|10851368|FG000|Overall Study|Other|1
6844976|NCT00306189|10851369|FG001|Overall Study|Other|0
6844977|NCT00306189|10851370|FG002|Overall Study|Other|0
6844978|NCT00306189|10851371|FG003|Overall Study|Other|0
6844979|NCT00306293|10851432|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1
6844980|NCT00306293|10851433|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0
6844981|NCT00306293|10851432|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3
6844982|NCT00306293|10851433|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4
6844983|NCT00306293|10851432|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
6844984|NCT00306293|10851433|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
6844985|NCT00306293|10851432|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
6844986|NCT00306293|10851433|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
6844987|NCT00306293|10851432|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1
6844988|NCT00306293|10851433|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0
6844989|NCT00306293|10851432|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1
6844990|NCT00306293|10851433|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0
6844991|NCT00306293|10851432|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0
6844992|NCT00306293|10851433|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1
6844993|NCT00306293|10851432|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1
6844994|NCT00306293|10851433|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0
6844995|NCT00306384|10851444|FG000|Overall Study|Adverse Event|103
6844996|NCT00306384|10851445|FG001|Overall Study|Adverse Event|87
6844997|NCT00306384|10851446|FG002|Overall Study|Adverse Event|40
6844998|NCT00306384|10851444|FG000|Overall Study|Major protocol deviation|43
6844999|NCT00306384|10851445|FG001|Overall Study|Major protocol deviation|51
6845000|NCT00306384|10851446|FG002|Overall Study|Major protocol deviation|18
6845001|NCT00306384|10851444|FG000|Overall Study|Lost to Follow-up|57
6845002|NCT00306384|10851445|FG001|Overall Study|Lost to Follow-up|41
6845003|NCT00306384|10851446|FG002|Overall Study|Lost to Follow-up|35
6845004|NCT00306384|10851444|FG000|Overall Study|Voluntary withdrawal|199
6845005|NCT00306384|10851445|FG001|Overall Study|Voluntary withdrawal|187
6845006|NCT00306384|10851446|FG002|Overall Study|Voluntary withdrawal|91
6845007|NCT00306384|10851444|FG000|Overall Study|Study termination|1
6845008|NCT00306384|10851445|FG001|Overall Study|Study termination|0
6845009|NCT00306384|10851446|FG002|Overall Study|Study termination|1
6845010|NCT00306384|10851444|FG000|Overall Study|Pregnancy|3
6845011|NCT00306384|10851445|FG001|Overall Study|Pregnancy|1
6845012|NCT00306384|10851446|FG002|Overall Study|Pregnancy|1
6845013|NCT00306384|10851444|FG000|Overall Study|Lack of Efficacy|26
6845014|NCT00306384|10851445|FG001|Overall Study|Lack of Efficacy|40
6845015|NCT00306384|10851446|FG002|Overall Study|Lack of Efficacy|38
6845016|NCT00306384|10851444|FG000|Overall Study|Investigator discretion|28
6845017|NCT00306384|10851445|FG001|Overall Study|Investigator discretion|31
6845018|NCT00306384|10851446|FG002|Overall Study|Investigator discretion|21
6845019|NCT00306384|10851444|FG000|Overall Study|Other|80
6845020|NCT00306384|10851445|FG001|Overall Study|Other|70
6845021|NCT00306384|10851446|FG002|Overall Study|Other|32
6845022|NCT00306384|10851444|FG000|Overall Study|Site closure|2
6845023|NCT00306384|10851445|FG001|Overall Study|Site closure|0
6845024|NCT00306384|10851446|FG002|Overall Study|Site closure|0
6845025|NCT00306527|10851463|FG000|Overall Study|Lost to Follow-up|3
6845026|NCT00306527|10851464|FG001|Overall Study|Lost to Follow-up|4
6845027|NCT00306527|10851465|FG002|Overall Study|Lost to Follow-up|3
6845028|NCT00306527|10851466|FG003|Overall Study|Lost to Follow-up|0
6845029|NCT00306527|10851463|FG000|Overall Study|Withdrawal by Subject|2
6845030|NCT00306527|10851464|FG001|Overall Study|Withdrawal by Subject|3
6845031|NCT00306527|10851465|FG002|Overall Study|Withdrawal by Subject|0
6845032|NCT00306527|10851466|FG003|Overall Study|Withdrawal by Subject|3
6845033|NCT00306527|10851463|FG000|Overall Study|Adverse Event|0
6845034|NCT00306527|10851464|FG001|Overall Study|Adverse Event|0
6845035|NCT00306527|10851465|FG002|Overall Study|Adverse Event|1
6845036|NCT00306527|10851466|FG003|Overall Study|Adverse Event|1
6845037|NCT00306527|10851463|FG000|Overall Study|Death|1
6845038|NCT00306527|10851464|FG001|Overall Study|Death|0
6845039|NCT00306527|10851465|FG002|Overall Study|Death|1
6845040|NCT00306527|10851466|FG003|Overall Study|Death|2
6845041|NCT00306592|10851480|FG000|Overall Study|Adverse Event|8
6845042|NCT00306592|10851481|FG001|Overall Study|Adverse Event|15
6845043|NCT00306592|10851480|FG000|Overall Study|Lost to Follow-up|1
6845044|NCT00306592|10851481|FG001|Overall Study|Lost to Follow-up|0
6845045|NCT00306592|10851480|FG000|Overall Study|Noncompliance|0
6845046|NCT00306592|10851481|FG001|Overall Study|Noncompliance|2
6845047|NCT00306592|10851480|FG000|Overall Study|Persistent Antibodies|6
6845048|NCT00306592|10851481|FG001|Overall Study|Persistent Antibodies|3
6845049|NCT00306592|10851480|FG000|Overall Study|Voluntary|10
6845050|NCT00306592|10851481|FG001|Overall Study|Voluntary|6
6845051|NCT00306592|10851480|FG000|Overall Study|Other|5
6845052|NCT00306592|10851481|FG001|Overall Study|Other|10
6845053|NCT00306592|10851480|FG000|Overall Study|Other|1
6845054|NCT00306592|10851481|FG001|Overall Study|Other|2
6845055|NCT00306592|10851480|FG000|Overall Study|48-week Treatment Period Ongoing|0
6845056|NCT00306592|10851481|FG001|Overall Study|48-week Treatment Period Ongoing|20
6845057|NCT00306670|10851487|FG000|Overall Study|patients recruited; Genentech, the st|0
6845058|NCT00306670|10851488|FG001|Overall Study|patients recruited; Genentech, the st|2
6845059|NCT00306787|10851496|FG000|Overall Study|Discontinued without taking study drug|208
7151315|NCT03227445|11315276|FG001|Period 1 (28 Days)|Adverse Event|2
7151316|NCT03227445|11315277|FG002|Period 1 (28 Days)|Adverse Event|0
7151317|NCT03227445|11315278|FG003|Period 1 (28 Days)|Adverse Event|1
7151318|NCT03227445|11315275|FG000|Period 1 (28 Days)|Protocol Violation|1
7151319|NCT03227445|11315276|FG001|Period 1 (28 Days)|Protocol Violation|0
7151320|NCT03227445|11315277|FG002|Period 1 (28 Days)|Protocol Violation|0
7151321|NCT03227445|11315278|FG003|Period 1 (28 Days)|Protocol Violation|0
7151322|NCT03227445|11315275|FG000|Period 1 (28 Days)|Withdrawal by Subject|0
7151323|NCT03227445|11315276|FG001|Period 1 (28 Days)|Withdrawal by Subject|0
6845060|NCT00306787|10851497|FG001|Overall Study|Discontinued without taking study drug|215
6845061|NCT00306787|10851496|FG000|Overall Study|Adverse Event|1
6845062|NCT00306787|10851497|FG001|Overall Study|Adverse Event|1
6845063|NCT00306787|10851496|FG000|Overall Study|Lack of Efficacy|1
6845064|NCT00306787|10851497|FG001|Overall Study|Lack of Efficacy|0
6845065|NCT00306787|10851496|FG000|Overall Study|Protocol Violation|8
6845066|NCT00306787|10851497|FG001|Overall Study|Protocol Violation|10
6845067|NCT00306787|10851496|FG000|Overall Study|Withdrawal by Subject|2
6845068|NCT00306787|10851497|FG001|Overall Study|Withdrawal by Subject|9
6845069|NCT00306787|10851496|FG000|Overall Study|Lost to Follow-up|9
6845070|NCT00306787|10851497|FG001|Overall Study|Lost to Follow-up|6
6845071|NCT00306787|10851496|FG000|Overall Study|Administrative problems|4
6845072|NCT00306787|10851497|FG001|Overall Study|Administrative problems|0
6845073|NCT00306787|10851496|FG000|Overall Study|Abnormal laboratory value(s)|1
6845074|NCT00306787|10851497|FG001|Overall Study|Abnormal laboratory value(s)|0
6845075|NCT00306852|10851505|FG000|Overall Study|Death|14
6845076|NCT00306852|10851506|FG001|Overall Study|Death|14
6845077|NCT00306852|10851505|FG000|Overall Study|Lost to Follow-up|15
6845078|NCT00306852|10851506|FG001|Overall Study|Lost to Follow-up|24
6845079|NCT00306891|10851516|FG000|Part A|Withdrawal by Subject|1
6845080|NCT00306891|10851517|FG001|Part A|Withdrawal by Subject|1
6845081|NCT00306891|10851518|FG002|Part A|Withdrawal by Subject|0
6845082|NCT00306891|10851519|FG003|Part A|Withdrawal by Subject|0
6845083|NCT00306891|10851516|FG000|Part A|Condition under investigation worsened|2
6845084|NCT00306891|10851517|FG001|Part A|Condition under investigation worsened|2
6845085|NCT00306891|10851518|FG002|Part A|Condition under investigation worsened|0
6845086|NCT00306891|10851519|FG003|Part A|Condition under investigation worsened|0
6845087|NCT00306891|10851516|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0
6845088|NCT00306891|10851517|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1
6845089|NCT00306891|10851518|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0
6845090|NCT00306891|10851519|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0
6845091|NCT00306891|10851516|FG000|Part A|Partial bowel obstruction|1
6845092|NCT00306891|10851517|FG001|Part A|Partial bowel obstruction|0
6845093|NCT00306891|10851518|FG002|Part A|Partial bowel obstruction|0
6845094|NCT00306891|10851519|FG003|Part A|Partial bowel obstruction|0
6845095|NCT00306891|10851516|FG000|Part A|Reaccumul. of ascites following drainage|0
6845096|NCT00306891|10851517|FG001|Part A|Reaccumul. of ascites following drainage|1
6845097|NCT00306891|10851518|FG002|Part A|Reaccumul. of ascites following drainage|0
6845098|NCT00306891|10851519|FG003|Part A|Reaccumul. of ascites following drainage|0
6845099|NCT00306891|10851516|FG000|Part A|Suspicion of second malignancy|0
6845100|NCT00306891|10851517|FG001|Part A|Suspicion of second malignancy|1
6845101|NCT00306891|10851518|FG002|Part A|Suspicion of second malignancy|0
6845102|NCT00306891|10851519|FG003|Part A|Suspicion of second malignancy|0
6845103|NCT00306891|10851516|FG000|Part A|QTC interval outwith elig. criteria|1
6845104|NCT00306891|10851517|FG001|Part A|QTC interval outwith elig. criteria|0
6845105|NCT00306891|10851518|FG002|Part A|QTC interval outwith elig. criteria|0
6845106|NCT00306891|10851519|FG003|Part A|QTC interval outwith elig. criteria|0
6845107|NCT00306891|10851516|FG000|Part B|Death|0
6845108|NCT00306891|10851517|FG001|Part B|Death|0
6845109|NCT00306891|10851518|FG002|Part B|Death|1
6845110|NCT00306891|10851519|FG003|Part B|Death|2
6845111|NCT00306891|10851516|FG000|Part B|Adverse Event|0
6845112|NCT00306891|10851517|FG001|Part B|Adverse Event|0
6845113|NCT00306891|10851518|FG002|Part B|Adverse Event|5
6845114|NCT00306891|10851519|FG003|Part B|Adverse Event|5
6845115|NCT00306891|10851516|FG000|Part B|Withdrawal by Subject|0
6845116|NCT00306891|10851517|FG001|Part B|Withdrawal by Subject|0
6845117|NCT00306891|10851518|FG002|Part B|Withdrawal by Subject|3
6845118|NCT00306891|10851519|FG003|Part B|Withdrawal by Subject|1
6845119|NCT00306891|10851516|FG000|Part B|Condition under investigation worsened|0
6845120|NCT00306891|10851517|FG001|Part B|Condition under investigation worsened|0
6845121|NCT00306891|10851518|FG002|Part B|Condition under investigation worsened|2
6845122|NCT00306891|10851519|FG003|Part B|Condition under investigation worsened|8
7151324|NCT03227445|11315277|FG002|Period 1 (28 Days)|Withdrawal by Subject|1
7151325|NCT03227445|11315278|FG003|Period 1 (28 Days)|Withdrawal by Subject|1
6845123|NCT00306891|10851516|FG000|Part B|Development of study specific disc crit.|0
6897924|NCT00642941|10916958|FG007|Overall Study|Other|1
6845124|NCT00306891|10851517|FG001|Part B|Development of study specific disc crit.|0
6845125|NCT00306891|10851518|FG002|Part B|Development of study specific disc crit.|0
6845126|NCT00306891|10851519|FG003|Part B|Development of study specific disc crit.|1
6845127|NCT00306995|10851546|FG000|Study Part I|Withdrawal by Subject|0
6845128|NCT00306995|10851547|FG001|Study Part I|Withdrawal by Subject|0
6845129|NCT00306995|10851548|FG002|Study Part I|Withdrawal by Subject|0
6845130|NCT00306995|10851549|FG003|Study Part I|Withdrawal by Subject|0
6845131|NCT00306995|10851550|FG004|Study Part I|Withdrawal by Subject|0
6845132|NCT00306995|10851551|FG005|Study Part I|Withdrawal by Subject|0
6845133|NCT00306995|10851552|FG006|Study Part I|Withdrawal by Subject|1
6845134|NCT00306995|10851546|FG000|Study Part II for Subset 2|Serious Adverse Event|0
6845135|NCT00306995|10851547|FG001|Study Part II for Subset 2|Serious Adverse Event|1
6845136|NCT00306995|10851548|FG002|Study Part II for Subset 2|Serious Adverse Event|0
6845137|NCT00306995|10851549|FG003|Study Part II for Subset 2|Serious Adverse Event|0
6845138|NCT00306995|10851550|FG004|Study Part II for Subset 2|Serious Adverse Event|0
6845139|NCT00306995|10851551|FG005|Study Part II for Subset 2|Serious Adverse Event|0
6845140|NCT00306995|10851552|FG006|Study Part II for Subset 2|Serious Adverse Event|0
6845141|NCT00307034|10851599|FG000|Overall Study|Adverse Event|1
6845142|NCT00307034|10851600|FG001|Overall Study|Adverse Event|2
6845143|NCT00307034|10851599|FG000|Overall Study|Withdrawal by Subject|1
6845144|NCT00307034|10851600|FG001|Overall Study|Withdrawal by Subject|2
6845145|NCT00307034|10851599|FG000|Overall Study|Lost to Follow-up|0
6845146|NCT00307034|10851600|FG001|Overall Study|Lost to Follow-up|3
6845147|NCT00307047|10851608|FG000|Overall Study|Lost to Follow-up|35
6845148|NCT00307047|10851609|FG001|Overall Study|Lost to Follow-up|24
6845149|NCT00307047|10851608|FG000|Overall Study|Withdrawal by Subject|6
6845150|NCT00307047|10851609|FG001|Overall Study|Withdrawal by Subject|6
6845151|NCT00307047|10851608|FG000|Overall Study|Physician Decision|1
6845152|NCT00307047|10851609|FG001|Overall Study|Physician Decision|2
6845153|NCT00307047|10851608|FG000|Overall Study|Lost to follow-up for other reasons|0
6845154|NCT00307047|10851609|FG001|Overall Study|Lost to follow-up for other reasons|1
6845155|NCT00307047|10851608|FG000|Overall Study|All death, all MI, all Revascularization|27
6845156|NCT00307047|10851609|FG001|Overall Study|All death, all MI, all Revascularization|16
6845157|NCT00307086|10851615|FG000|Overall Study|ineligible|5
6845158|NCT00307125|10851621|FG000|Screening Phase|Adverse Event|1
6845159|NCT00307125|10851622|FG001|Screening Phase|Adverse Event|0
6845160|NCT00307125|10851623|FG002|Screening Phase|Adverse Event|0
6845161|NCT00307125|10851621|FG000|Screening Phase|Protocol Violation|27
6845162|NCT00307125|10851622|FG001|Screening Phase|Protocol Violation|0
6845163|NCT00307125|10851623|FG002|Screening Phase|Protocol Violation|0
6845164|NCT00307125|10851621|FG000|Screening Phase|Lost to Follow-up|87
6845165|NCT00307125|10851622|FG001|Screening Phase|Lost to Follow-up|0
6845166|NCT00307125|10851623|FG002|Screening Phase|Lost to Follow-up|0
6845167|NCT00307125|10851621|FG000|Screening Phase|Death|10
6845168|NCT00307125|10851622|FG001|Screening Phase|Death|0
6845169|NCT00307125|10851623|FG002|Screening Phase|Death|0
6845170|NCT00307125|10851621|FG000|Screening Phase|Withdrawal by Subject|77
6845171|NCT00307125|10851622|FG001|Screening Phase|Withdrawal by Subject|0
6845172|NCT00307125|10851623|FG002|Screening Phase|Withdrawal by Subject|0
6845173|NCT00307125|10851621|FG000|Screening Phase|Physician Decision|26
6845174|NCT00307125|10851622|FG001|Screening Phase|Physician Decision|0
6845175|NCT00307125|10851623|FG002|Screening Phase|Physician Decision|0
6845176|NCT00307125|10851621|FG000|Screening Phase|Sponsor Decision|4
6845177|NCT00307125|10851622|FG001|Screening Phase|Sponsor Decision|0
6845178|NCT00307125|10851623|FG002|Screening Phase|Sponsor Decision|0
6845179|NCT00307125|10851621|FG000|Screening Phase|Study Terminated|17
6845180|NCT00307125|10851622|FG001|Screening Phase|Study Terminated|0
6845181|NCT00307125|10851623|FG002|Screening Phase|Study Terminated|0
6845182|NCT00307125|10851621|FG000|Screening Phase|Graft Loss|3
6845183|NCT00307125|10851622|FG001|Screening Phase|Graft Loss|0
6845184|NCT00307125|10851623|FG002|Screening Phase|Graft Loss|0
6845185|NCT00307125|10851621|FG000|Screening Phase|Graft Failure|8
6845186|NCT00307125|10851622|FG001|Screening Phase|Graft Failure|0
6845187|NCT00307125|10851623|FG002|Screening Phase|Graft Failure|0
6845188|NCT00307125|10851621|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83
6845189|NCT00307125|10851622|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0
6845190|NCT00307125|10851623|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0
6845191|NCT00307125|10851621|FG000|Screening Phase|Scheduling issues/Non-compliance|55
6845192|NCT00307125|10851622|FG001|Screening Phase|Scheduling issues/Non-compliance|0
6845193|NCT00307125|10851623|FG002|Screening Phase|Scheduling issues/Non-compliance|0
6845194|NCT00307125|10851621|FG000|Screening Phase|Moved or transferred facilities|34
6845195|NCT00307125|10851622|FG001|Screening Phase|Moved or transferred facilities|0
6845196|NCT00307125|10851623|FG002|Screening Phase|Moved or transferred facilities|0
6845197|NCT00307125|10851621|FG000|Screening Phase|Received Pancreas Transplant|8
6845198|NCT00307125|10851622|FG001|Screening Phase|Received Pancreas Transplant|0
6845199|NCT00307125|10851623|FG002|Screening Phase|Received Pancreas Transplant|0
6845200|NCT00307125|10851621|FG000|Screening Phase|Ineligible for pilot|4
6845201|NCT00307125|10851622|FG001|Screening Phase|Ineligible for pilot|0
6845202|NCT00307125|10851623|FG002|Screening Phase|Ineligible for pilot|0
6845203|NCT00307125|10851621|FG000|Screening Phase|Try to get pregnant|1
6845204|NCT00307125|10851622|FG001|Screening Phase|Try to get pregnant|0
6845205|NCT00307125|10851623|FG002|Screening Phase|Try to get pregnant|0
6845206|NCT00307125|10851621|FG000|Screening Phase|Developed acute leukemia|1
6845207|NCT00307125|10851622|FG001|Screening Phase|Developed acute leukemia|0
6845208|NCT00307125|10851623|FG002|Screening Phase|Developed acute leukemia|0
6845209|NCT00307125|10851621|FG000|Screening Phase|Metastatic colon cancer|1
6845210|NCT00307125|10851622|FG001|Screening Phase|Metastatic colon cancer|0
6845211|NCT00307125|10851623|FG002|Screening Phase|Metastatic colon cancer|0
6845212|NCT00307125|10851621|FG000|Screening Phase|Malignancy|1
6845213|NCT00307125|10851622|FG001|Screening Phase|Malignancy|0
6845214|NCT00307125|10851623|FG002|Screening Phase|Malignancy|0
6845215|NCT00307125|10851621|FG000|Screening Phase|PAK|1
6845216|NCT00307125|10851622|FG001|Screening Phase|PAK|0
6845217|NCT00307125|10851623|FG002|Screening Phase|PAK|0
6845218|NCT00307125|10851621|FG000|Screening Phase|Ineligible|1
6845219|NCT00307125|10851622|FG001|Screening Phase|Ineligible|0
6845220|NCT00307125|10851623|FG002|Screening Phase|Ineligible|0
6845221|NCT00307125|10851621|FG000|Screening Phase|Screen Error|1
6845222|NCT00307125|10851622|FG001|Screening Phase|Screen Error|0
6845223|NCT00307125|10851623|FG002|Screening Phase|Screen Error|0
6845224|NCT00307125|10851621|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1
6845225|NCT00307125|10851622|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
6845226|NCT00307125|10851623|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
6845227|NCT00307125|10851621|FG000|Screening Phase|AMR and treated with rituximab|1
6845228|NCT00307125|10851622|FG001|Screening Phase|AMR and treated with rituximab|0
6845229|NCT00307125|10851623|FG002|Screening Phase|AMR and treated with rituximab|0
6845230|NCT00307125|10851621|FG000|Screening Phase|Coronary artery bypass|1
6845231|NCT00307125|10851622|FG001|Screening Phase|Coronary artery bypass|0
6845232|NCT00307125|10851623|FG002|Screening Phase|Coronary artery bypass|0
6845233|NCT00307125|10851621|FG000|Pilot Phase|Lost to Follow-up|0
6845234|NCT00307125|10851622|FG001|Pilot Phase|Lost to Follow-up|1
6845235|NCT00307125|10851623|FG002|Pilot Phase|Lost to Follow-up|0
6845236|NCT00307125|10851621|FG000|Pilot Phase|Withdrawal by Subject|0
6845237|NCT00307125|10851622|FG001|Pilot Phase|Withdrawal by Subject|1
6845238|NCT00307125|10851623|FG002|Pilot Phase|Withdrawal by Subject|1
6845239|NCT00307151|10851637|FG000|Overall Study|Death|4
6845240|NCT00307151|10851638|FG001|Overall Study|Death|3
6845241|NCT00307151|10851639|FG002|Overall Study|Death|10
6845242|NCT00307151|10851640|FG003|Overall Study|Death|3
6845243|NCT00307151|10851637|FG000|Overall Study|Severe debilitation, unable to continue|1
6845244|NCT00307151|10851638|FG001|Overall Study|Severe debilitation, unable to continue|0
6845245|NCT00307151|10851639|FG002|Overall Study|Severe debilitation, unable to continue|0
6845246|NCT00307151|10851640|FG003|Overall Study|Severe debilitation, unable to continue|0
6845247|NCT00307151|10851637|FG000|Overall Study|Subject unable to get to clinic|1
6845248|NCT00307151|10851638|FG001|Overall Study|Subject unable to get to clinic|0
6845249|NCT00307151|10851639|FG002|Overall Study|Subject unable to get to clinic|6
6845250|NCT00307151|10851640|FG003|Overall Study|Subject unable to get to clinic|2
6845251|NCT00307151|10851637|FG000|Overall Study|Withdrew consent|0
6845252|NCT00307151|10851638|FG001|Overall Study|Withdrew consent|1
6845253|NCT00307151|10851639|FG002|Overall Study|Withdrew consent|1
6845254|NCT00307151|10851640|FG003|Overall Study|Withdrew consent|3
6845255|NCT00307151|10851637|FG000|Overall Study|Not willing to adhere to study reqs|2
6845256|NCT00307151|10851638|FG001|Overall Study|Not willing to adhere to study reqs|0
6845257|NCT00307151|10851639|FG002|Overall Study|Not willing to adhere to study reqs|2
6845258|NCT00307151|10851640|FG003|Overall Study|Not willing to adhere to study reqs|2
6845259|NCT00307151|10851637|FG000|Overall Study|Clinic unable to contact subject|3
6845260|NCT00307151|10851638|FG001|Overall Study|Clinic unable to contact subject|3
6845261|NCT00307151|10851639|FG002|Overall Study|Clinic unable to contact subject|1
6845262|NCT00307151|10851640|FG003|Overall Study|Clinic unable to contact subject|1
6845263|NCT00307164|10851652|FG000|Overall Study|Death|1
6845264|NCT00307164|10851653|FG001|Overall Study|Death|0
6845265|NCT00307164|10851652|FG000|Overall Study|Severe debilitation, unable to continue|1
6845266|NCT00307164|10851653|FG001|Overall Study|Severe debilitation, unable to continue|0
6845267|NCT00307164|10851652|FG000|Overall Study|Subject/parent not able to get to clinic|2
6845268|NCT00307164|10851653|FG001|Overall Study|Subject/parent not able to get to clinic|1
6845269|NCT00307164|10851652|FG000|Overall Study|Withdrawal by Subject|1
6845270|NCT00307164|10851653|FG001|Overall Study|Withdrawal by Subject|8
6845271|NCT00307164|10851652|FG000|Overall Study|Not compliant with requirements|4
6845272|NCT00307164|10851653|FG001|Overall Study|Not compliant with requirements|4
6845273|NCT00307164|10851652|FG000|Overall Study|Lost to Follow-up|6
7077373|NCT02091739|11184892|FG000|MP: 16 Weeks|Adverse Event|1
6845274|NCT00307164|10851653|FG001|Overall Study|Lost to Follow-up|1
6845275|NCT00307294|10851659|FG000|Overall Study|Withdrawal by Subject|1
6845276|NCT00307333|10851666|FG000|Overall Study|Lost to Follow-up|11
6845277|NCT00307333|10851667|FG001|Overall Study|Lost to Follow-up|3
6845278|NCT00307437|10851676|FG000|Controlled Period|Adverse Event|7
6845279|NCT00307437|10851677|FG001|Controlled Period|Adverse Event|2
6845280|NCT00307437|10851678|FG002|Controlled Period|Adverse Event|5
6845281|NCT00307437|10851679|FG003|Controlled Period|Adverse Event|0
6845282|NCT00307437|10851680|FG004|Controlled Period|Adverse Event|0
6845283|NCT00307437|10851681|FG005|Controlled Period|Adverse Event|0
7077374|NCT02091739|11184893|FG001|MP: 16 Weeks|Adverse Event|1
6845284|NCT00307437|10851682|FG006|Controlled Period|Adverse Event|0
6845285|NCT00307437|10851676|FG000|Controlled Period|Death|0
6845286|NCT00307437|10851677|FG001|Controlled Period|Death|0
6845287|NCT00307437|10851678|FG002|Controlled Period|Death|1
6845288|NCT00307437|10851679|FG003|Controlled Period|Death|0
6845289|NCT00307437|10851680|FG004|Controlled Period|Death|0
6845290|NCT00307437|10851681|FG005|Controlled Period|Death|0
6845291|NCT00307437|10851682|FG006|Controlled Period|Death|0
6845292|NCT00307437|10851676|FG000|Controlled Period|Lack of Efficacy|2
6845293|NCT00307437|10851677|FG001|Controlled Period|Lack of Efficacy|0
6845294|NCT00307437|10851678|FG002|Controlled Period|Lack of Efficacy|0
6845295|NCT00307437|10851679|FG003|Controlled Period|Lack of Efficacy|0
6845296|NCT00307437|10851680|FG004|Controlled Period|Lack of Efficacy|0
6845297|NCT00307437|10851681|FG005|Controlled Period|Lack of Efficacy|0
6845298|NCT00307437|10851682|FG006|Controlled Period|Lack of Efficacy|0
6845299|NCT00307437|10851676|FG000|Controlled Period|Lost to Follow-up|2
6845300|NCT00307437|10851677|FG001|Controlled Period|Lost to Follow-up|3
6845301|NCT00307437|10851678|FG002|Controlled Period|Lost to Follow-up|0
6845302|NCT00307437|10851679|FG003|Controlled Period|Lost to Follow-up|0
6845303|NCT00307437|10851680|FG004|Controlled Period|Lost to Follow-up|0
6845304|NCT00307437|10851681|FG005|Controlled Period|Lost to Follow-up|0
6845305|NCT00307437|10851682|FG006|Controlled Period|Lost to Follow-up|0
6845306|NCT00307437|10851676|FG000|Controlled Period|Other|5
6845307|NCT00307437|10851677|FG001|Controlled Period|Other|1
6845308|NCT00307437|10851678|FG002|Controlled Period|Other|3
6845309|NCT00307437|10851679|FG003|Controlled Period|Other|0
6845310|NCT00307437|10851680|FG004|Controlled Period|Other|0
6845311|NCT00307437|10851681|FG005|Controlled Period|Other|0
6845312|NCT00307437|10851682|FG006|Controlled Period|Other|0
6845313|NCT00307437|10851676|FG000|After Controlled Period|Adverse Event|0
6845314|NCT00307437|10851677|FG001|After Controlled Period|Adverse Event|0
6845315|NCT00307437|10851678|FG002|After Controlled Period|Adverse Event|0
6845316|NCT00307437|10851679|FG003|After Controlled Period|Adverse Event|18
6845317|NCT00307437|10851680|FG004|After Controlled Period|Adverse Event|16
6845318|NCT00307437|10851681|FG005|After Controlled Period|Adverse Event|31
6845319|NCT00307437|10851682|FG006|After Controlled Period|Adverse Event|40
6845320|NCT00307437|10851676|FG000|After Controlled Period|Death|0
6845321|NCT00307437|10851677|FG001|After Controlled Period|Death|0
6845322|NCT00307437|10851678|FG002|After Controlled Period|Death|0
6845323|NCT00307437|10851679|FG003|After Controlled Period|Death|3
6845324|NCT00307437|10851680|FG004|After Controlled Period|Death|1
6845325|NCT00307437|10851681|FG005|After Controlled Period|Death|1
6845326|NCT00307437|10851682|FG006|After Controlled Period|Death|3
6845327|NCT00307437|10851676|FG000|After Controlled Period|Lack of Efficacy|0
6845328|NCT00307437|10851677|FG001|After Controlled Period|Lack of Efficacy|0
6845329|NCT00307437|10851678|FG002|After Controlled Period|Lack of Efficacy|0
6845330|NCT00307437|10851679|FG003|After Controlled Period|Lack of Efficacy|15
6845331|NCT00307437|10851680|FG004|After Controlled Period|Lack of Efficacy|17
6845332|NCT00307437|10851681|FG005|After Controlled Period|Lack of Efficacy|37
6845333|NCT00307437|10851682|FG006|After Controlled Period|Lack of Efficacy|24
6845334|NCT00307437|10851676|FG000|After Controlled Period|Lost to Follow-up|0
6845335|NCT00307437|10851677|FG001|After Controlled Period|Lost to Follow-up|0
6845336|NCT00307437|10851678|FG002|After Controlled Period|Lost to Follow-up|0
6845337|NCT00307437|10851679|FG003|After Controlled Period|Lost to Follow-up|7
6845338|NCT00307437|10851680|FG004|After Controlled Period|Lost to Follow-up|12
6845339|NCT00307437|10851681|FG005|After Controlled Period|Lost to Follow-up|13
6845340|NCT00307437|10851682|FG006|After Controlled Period|Lost to Follow-up|18
6845341|NCT00307437|10851676|FG000|After Controlled Period|Other|0
6845342|NCT00307437|10851677|FG001|After Controlled Period|Other|0
6845343|NCT00307437|10851678|FG002|After Controlled Period|Other|0
6845344|NCT00307437|10851679|FG003|After Controlled Period|Other|15
6845345|NCT00307437|10851680|FG004|After Controlled Period|Other|9
6845346|NCT00307437|10851681|FG005|After Controlled Period|Other|40
6845347|NCT00307437|10851682|FG006|After Controlled Period|Other|28
6845348|NCT00307489|10851706|FG000|Baseline Through Week 48|Lost to Follow-up|0
6845349|NCT00307489|10851707|FG001|Baseline Through Week 48|Lost to Follow-up|1
6845350|NCT00307489|10851706|FG000|Baseline Through Week 48|Physician Decision|1
6845351|NCT00307489|10851707|FG001|Baseline Through Week 48|Physician Decision|0
6845352|NCT00307489|10851706|FG000|Baseline Through Week 48|Withdrawal by Subject|0
6845353|NCT00307489|10851707|FG001|Baseline Through Week 48|Withdrawal by Subject|1
6845354|NCT00307489|10851706|FG000|Week 48 Through Week 168|Adverse Event|1
6845355|NCT00307489|10851707|FG001|Week 48 Through Week 168|Adverse Event|0
6845356|NCT00307489|10851706|FG000|Week 48 Through Week 168|Physician Decision|1
6845357|NCT00307489|10851707|FG001|Week 48 Through Week 168|Physician Decision|0
6845358|NCT00307489|10851706|FG000|Week 48 Through Week 168|Withdrawal by Subject|1
6845359|NCT00307489|10851707|FG001|Week 48 Through Week 168|Withdrawal by Subject|2
6845360|NCT00307489|10851706|FG000|Week 48 Through Week 168|Lack of Efficacy|2
6845361|NCT00307489|10851707|FG001|Week 48 Through Week 168|Lack of Efficacy|2
6845362|NCT00307489|10851706|FG000|Week 48 Through Week 168|Death|0
6845363|NCT00307489|10851707|FG001|Week 48 Through Week 168|Death|1
6845364|NCT00307489|10851706|FG000|Week 48 Through Week 168|Lost to Follow-up|0
6845365|NCT00307489|10851707|FG001|Week 48 Through Week 168|Lost to Follow-up|1
6845366|NCT00307489|10851706|FG000|Week 48 Through Week 168|Seroconversion|1
6845367|NCT00307489|10851707|FG001|Week 48 Through Week 168|Seroconversion|0
6845368|NCT00307684|10851713|FG000|Open Label Phase|Lack of Efficacy|0
6845369|NCT00307684|10851714|FG001|Open Label Phase|Lack of Efficacy|0
6845370|NCT00307684|10851715|FG002|Open Label Phase|Lack of Efficacy|3
6845371|NCT00307684|10851713|FG000|Open Label Phase|Adverse Event|0
6845372|NCT00307684|10851714|FG001|Open Label Phase|Adverse Event|0
6845373|NCT00307684|10851715|FG002|Open Label Phase|Adverse Event|16
6845374|NCT00307684|10851713|FG000|Open Label Phase|Withdrawal by Subject|0
6845375|NCT00307684|10851714|FG001|Open Label Phase|Withdrawal by Subject|0
6845376|NCT00307684|10851715|FG002|Open Label Phase|Withdrawal by Subject|15
6845377|NCT00307684|10851713|FG000|Open Label Phase|Lost to Follow-up|0
6845378|NCT00307684|10851714|FG001|Open Label Phase|Lost to Follow-up|0
6845379|NCT00307684|10851715|FG002|Open Label Phase|Lost to Follow-up|11
6845380|NCT00307684|10851713|FG000|Open Label Phase|non compliance|0
6845381|NCT00307684|10851714|FG001|Open Label Phase|non compliance|0
6845382|NCT00307684|10851715|FG002|Open Label Phase|non compliance|5
6845383|NCT00307684|10851713|FG000|Open Label Phase|other|0
6845384|NCT00307684|10851714|FG001|Open Label Phase|other|0
6845385|NCT00307684|10851715|FG002|Open Label Phase|other|6
6845386|NCT00307684|10851713|FG000|Double Blind Phase|Lack of Efficacy|2
6845387|NCT00307684|10851714|FG001|Double Blind Phase|Lack of Efficacy|5
6845388|NCT00307684|10851715|FG002|Double Blind Phase|Lack of Efficacy|0
6845389|NCT00307736|10851723|FG000|Overall Study|Adverse Event|0
6845390|NCT00307736|10851724|FG001|Overall Study|Adverse Event|0
6845391|NCT00307736|10851725|FG002|Overall Study|Adverse Event|1
6845392|NCT00307736|10851726|FG003|Overall Study|Adverse Event|3
6845393|NCT00307736|10851723|FG000|Overall Study|Withdrawal by Subject|0
6845394|NCT00307736|10851724|FG001|Overall Study|Withdrawal by Subject|0
6845395|NCT00307736|10851725|FG002|Overall Study|Withdrawal by Subject|2
6845396|NCT00307736|10851726|FG003|Overall Study|Withdrawal by Subject|0
6845397|NCT00307801|10851739|FG000|Overall Study|Adverse Event|12
6845398|NCT00307801|10851740|FG001|Overall Study|Adverse Event|4
6845399|NCT00307801|10851739|FG000|Overall Study|Withdrawal by Subject|9
6845400|NCT00307801|10851740|FG001|Overall Study|Withdrawal by Subject|4
6845401|NCT00307801|10851739|FG000|Overall Study|Non-compliance, not taken all tablets|1
6845402|NCT00307801|10851740|FG001|Overall Study|Non-compliance, not taken all tablets|2
6845403|NCT00307801|10851739|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2
6845404|NCT00307801|10851740|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0
6845405|NCT00307801|10851739|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0
6845406|NCT00307801|10851740|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1
6845407|NCT00307801|10851739|FG000|Overall Study|Wrong Randomization|1
6845408|NCT00307801|10851740|FG001|Overall Study|Wrong Randomization|0
6845409|NCT00307801|10851739|FG000|Overall Study|Lack of Efficacy|0
6845410|NCT00307801|10851740|FG001|Overall Study|Lack of Efficacy|2
6845411|NCT00307801|10851739|FG000|Overall Study|Lost to Follow-up, moved abroad|1
6845412|NCT00307801|10851740|FG001|Overall Study|Lost to Follow-up, moved abroad|1
6845413|NCT00307801|10851739|FG000|Overall Study|Frustration with e-diary|1
6845414|NCT00307801|10851740|FG001|Overall Study|Frustration with e-diary|0
6845415|NCT00307801|10851739|FG000|Overall Study|Protocol Violation|3
6845416|NCT00307801|10851740|FG001|Overall Study|Protocol Violation|2
6845417|NCT00307801|10851739|FG000|Overall Study|No reason specified|2
6845418|NCT00307801|10851740|FG001|Overall Study|No reason specified|0
6845419|NCT00307801|10851739|FG000|Overall Study|Pregnancy|0
6845420|NCT00307801|10851740|FG001|Overall Study|Pregnancy|1
6845421|NCT00307931|10851747|FG000|Overall Study|Adverse Event|1
6845422|NCT00308074|10851761|FG000|Overall Study|Withdrawal by Subject|1
6845423|NCT00308087|10851767|FG000|Overall Study|Progressive Disease|19
6845424|NCT00308087|10851768|FG001|Overall Study|Progressive Disease|21
6845425|NCT00308087|10851767|FG000|Overall Study|Study Closure|11
6845426|NCT00308087|10851768|FG001|Overall Study|Study Closure|12
6845427|NCT00308087|10851767|FG000|Overall Study|Withdrawal by Subject|2
6845428|NCT00308087|10851768|FG001|Overall Study|Withdrawal by Subject|1
6845429|NCT00308087|10851767|FG000|Overall Study|Other|4
6845430|NCT00308087|10851768|FG001|Overall Study|Other|3
6845431|NCT00308139|10851776|FG000|Overall Study|Adverse Event|20
6845432|NCT00308139|10851777|FG001|Overall Study|Adverse Event|14
6845433|NCT00308139|10851776|FG000|Overall Study|Lost to Follow-up|13
6845434|NCT00308139|10851777|FG001|Overall Study|Lost to Follow-up|8
6845435|NCT00308139|10851776|FG000|Overall Study|Protocol Violation|3
6845436|NCT00308139|10851777|FG001|Overall Study|Protocol Violation|2
6845437|NCT00308139|10851776|FG000|Overall Study|Withdrawal of Consent|40
6845438|NCT00308139|10851777|FG001|Overall Study|Withdrawal of Consent|42
6845439|NCT00308139|10851776|FG000|Overall Study|Investigator Decision|11
6845440|NCT00308139|10851777|FG001|Overall Study|Investigator Decision|10
6845441|NCT00308139|10851776|FG000|Overall Study|Loss of Glucose Control|5
6845442|NCT00308139|10851777|FG001|Overall Study|Loss of Glucose Control|7
6845443|NCT00308139|10851776|FG000|Overall Study|Administrative|1
6845444|NCT00308139|10851777|FG001|Overall Study|Administrative|4
6845445|NCT00308139|10851776|FG000|Overall Study|Other|1
6845446|NCT00308139|10851777|FG001|Overall Study|Other|0
6845447|NCT00308308|10851838|FG000|Overall Study|Adverse Event|17
6845448|NCT00308308|10851839|FG001|Overall Study|Adverse Event|2
6845449|NCT00308308|10851838|FG000|Overall Study|Lost to Follow-up|5
6845450|NCT00308308|10851839|FG001|Overall Study|Lost to Follow-up|5
6845451|NCT00308308|10851838|FG000|Overall Study|Physician Decision|15
6845452|NCT00308308|10851839|FG001|Overall Study|Physician Decision|7
6845453|NCT00308308|10851838|FG000|Overall Study|Protocol Violation|3
6845454|NCT00308308|10851839|FG001|Overall Study|Protocol Violation|14
6845455|NCT00308308|10851838|FG000|Overall Study|Withdrawal by Subject|47
6845456|NCT00308308|10851839|FG001|Overall Study|Withdrawal by Subject|19
6845457|NCT00308308|10851838|FG000|Overall Study|Various|7
6845458|NCT00308308|10851839|FG001|Overall Study|Various|5
6845459|NCT00308308|10851838|FG000|Overall Study|Randomized but not dosed|8
6845460|NCT00308308|10851839|FG001|Overall Study|Randomized but not dosed|16
6845461|NCT00308308|10851838|FG000|Overall Study|Other|1
6845462|NCT00308308|10851839|FG001|Overall Study|Other|0
6845463|NCT00308555|10851847|FG000|Overall Study|Withdrawal by Subject|1
6845464|NCT00308555|10851848|FG001|Overall Study|Withdrawal by Subject|0
6845465|NCT00308555|10851847|FG000|Overall Study|Physician Decision|2
6845466|NCT00308555|10851848|FG001|Overall Study|Physician Decision|0
6845467|NCT00308581|10851854|FG000|Induction Phase|Adverse Event|0
6845468|NCT00308581|10851855|FG001|Induction Phase|Adverse Event|0
6845469|NCT00308581|10851856|FG002|Induction Phase|Adverse Event|37
6845470|NCT00308581|10851854|FG000|Induction Phase|Lack of Efficacy|0
6845471|NCT00308581|10851855|FG001|Induction Phase|Lack of Efficacy|0
6845472|NCT00308581|10851856|FG002|Induction Phase|Lack of Efficacy|121
6845473|NCT00308581|10851854|FG000|Induction Phase|Withdrawal by Subject|0
6845474|NCT00308581|10851855|FG001|Induction Phase|Withdrawal by Subject|0
6845475|NCT00308581|10851856|FG002|Induction Phase|Withdrawal by Subject|5
6845476|NCT00308581|10851854|FG000|Induction Phase|Unknown reason|0
6845477|NCT00308581|10851855|FG001|Induction Phase|Unknown reason|0
6845478|NCT00308581|10851856|FG002|Induction Phase|Unknown reason|3
6845479|NCT00308581|10851854|FG000|Randomized Maintenance Phase|Adverse Event|10
6845480|NCT00308581|10851855|FG001|Randomized Maintenance Phase|Adverse Event|17
6845481|NCT00308581|10851856|FG002|Randomized Maintenance Phase|Adverse Event|0
6845482|NCT00308581|10851854|FG000|Randomized Maintenance Phase|Lack of Efficacy|9
6845483|NCT00308581|10851855|FG001|Randomized Maintenance Phase|Lack of Efficacy|21
6845484|NCT00308581|10851856|FG002|Randomized Maintenance Phase|Lack of Efficacy|0
6845485|NCT00308581|10851854|FG000|Randomized Maintenance Phase|Lost to Follow-up|0
6845486|NCT00308581|10851855|FG001|Randomized Maintenance Phase|Lost to Follow-up|2
6845487|NCT00308581|10851856|FG002|Randomized Maintenance Phase|Lost to Follow-up|0
6845488|NCT00308581|10851854|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1
6845489|NCT00308581|10851855|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4
6845490|NCT00308581|10851856|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0
6845491|NCT00308581|10851854|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82
6845492|NCT00308581|10851855|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59
6845493|NCT00308581|10851856|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0
6845494|NCT00308581|10851854|FG000|Randomized Maintenance Phase|Unknown reason|3
6845495|NCT00308581|10851855|FG001|Randomized Maintenance Phase|Unknown reason|0
6845496|NCT00308581|10851856|FG002|Randomized Maintenance Phase|Unknown reason|0
6845497|NCT00308620|10851867|FG000|Overall Study|Death|1
6845498|NCT00308620|10851868|FG001|Overall Study|Death|1
6845499|NCT00308620|10851869|FG002|Overall Study|Death|0
6845500|NCT00308620|10851867|FG000|Overall Study|Lost to Follow-up|0
6845501|NCT00308620|10851868|FG001|Overall Study|Lost to Follow-up|0
6845502|NCT00308620|10851869|FG002|Overall Study|Lost to Follow-up|1
6845503|NCT00308711|10851880|FG000|Overall Study|Withdrawal by Subject|1
6845504|NCT00308711|10851881|FG001|Overall Study|Withdrawal by Subject|0
6845505|NCT00308711|10851882|FG002|Overall Study|Withdrawal by Subject|1
6845506|NCT00308711|10851880|FG000|Overall Study|Protocol Violation|0
6845507|NCT00308711|10851881|FG001|Overall Study|Protocol Violation|1
6845508|NCT00308711|10851882|FG002|Overall Study|Protocol Violation|1
6845509|NCT00308711|10851880|FG000|Overall Study|Lost to Follow-up|0
6845510|NCT00308711|10851881|FG001|Overall Study|Lost to Follow-up|1
6845511|NCT00308711|10851882|FG002|Overall Study|Lost to Follow-up|0
6845512|NCT00308711|10851880|FG000|Overall Study|Baby not born within 7 days of treatment|1
6845513|NCT00308711|10851881|FG001|Overall Study|Baby not born within 7 days of treatment|2
6845514|NCT00308711|10851882|FG002|Overall Study|Baby not born within 7 days of treatment|2
6845515|NCT00308711|10851880|FG000|Overall Study|Subject incarcerated, data not allowed|0
6845516|NCT00308711|10851881|FG001|Overall Study|Subject incarcerated, data not allowed|0
6845517|NCT00308711|10851882|FG002|Overall Study|Subject incarcerated, data not allowed|1
6845518|NCT00308737|10851893|FG000|Overall Study|Adverse Event|104
6845519|NCT00308737|10851894|FG001|Overall Study|Adverse Event|9
6845520|NCT00308737|10851895|FG002|Overall Study|Adverse Event|0
6845521|NCT00308737|10851893|FG000|Overall Study|Death|4
6845522|NCT00308737|10851894|FG001|Overall Study|Death|3
6845523|NCT00308737|10851895|FG002|Overall Study|Death|0
6845524|NCT00308737|10851893|FG000|Overall Study|Lost to Follow-up|56
6845525|NCT00308737|10851894|FG001|Overall Study|Lost to Follow-up|80
6845526|NCT00308737|10851895|FG002|Overall Study|Lost to Follow-up|5
6845527|NCT00308737|10851893|FG000|Overall Study|Physician Decision|15
6845528|NCT00308737|10851894|FG001|Overall Study|Physician Decision|2
6845529|NCT00308737|10851895|FG002|Overall Study|Physician Decision|1
6845530|NCT00308737|10851893|FG000|Overall Study|Protocol Violation|34
6845531|NCT00308737|10851894|FG001|Overall Study|Protocol Violation|9
6845532|NCT00308737|10851895|FG002|Overall Study|Protocol Violation|5
6845533|NCT00308737|10851893|FG000|Overall Study|Withdrawal by Subject|218
6845534|NCT00308737|10851894|FG001|Overall Study|Withdrawal by Subject|166
6845535|NCT00308737|10851895|FG002|Overall Study|Withdrawal by Subject|18
6845536|NCT00308737|10851893|FG000|Overall Study|Various|32
6845537|NCT00308737|10851894|FG001|Overall Study|Various|20
6845538|NCT00308737|10851895|FG002|Overall Study|Various|8
6845539|NCT00308750|10851906|FG000|Overall Study|Adverse Event|9
6845540|NCT00308750|10851907|FG001|Overall Study|Adverse Event|9
6845541|NCT00308750|10851908|FG002|Overall Study|Adverse Event|13
6845542|NCT00308750|10851906|FG000|Overall Study|Withdrawal by Subject|6
6845543|NCT00308750|10851907|FG001|Overall Study|Withdrawal by Subject|2
6845544|NCT00308750|10851908|FG002|Overall Study|Withdrawal by Subject|3
6845545|NCT00308750|10851906|FG000|Overall Study|Physician Decision|3
6845546|NCT00308750|10851907|FG001|Overall Study|Physician Decision|4
6845547|NCT00308750|10851908|FG002|Overall Study|Physician Decision|3
6845548|NCT00308750|10851906|FG000|Overall Study|Sponsor Decision|1
6845549|NCT00308750|10851907|FG001|Overall Study|Sponsor Decision|0
6845550|NCT00308750|10851908|FG002|Overall Study|Sponsor Decision|0
6845551|NCT00308750|10851906|FG000|Overall Study|Disease Progression|47
6845552|NCT00308750|10851907|FG001|Overall Study|Disease Progression|24
6845553|NCT00308750|10851908|FG002|Overall Study|Disease Progression|28
6845554|NCT00308750|10851906|FG000|Overall Study|Unrelated Complication|3
6845555|NCT00308750|10851907|FG001|Overall Study|Unrelated Complication|0
6845556|NCT00308750|10851908|FG002|Overall Study|Unrelated Complication|1
6845557|NCT00308750|10851906|FG000|Overall Study|Death|1
6845558|NCT00308750|10851907|FG001|Overall Study|Death|0
6845559|NCT00308750|10851908|FG002|Overall Study|Death|1
6845560|NCT00308750|10851906|FG000|Overall Study|Protocol Violation|1
6845561|NCT00308750|10851907|FG001|Overall Study|Protocol Violation|0
6845562|NCT00308750|10851908|FG002|Overall Study|Protocol Violation|0
6845563|NCT00308750|10851906|FG000|Overall Study|New Primary Disease Identified|1
6845564|NCT00308750|10851907|FG001|Overall Study|New Primary Disease Identified|1
6845565|NCT00308750|10851908|FG002|Overall Study|New Primary Disease Identified|0
6845566|NCT00308997|10851919|FG000|Overall Study|Subject feigned clinical data|0
6845567|NCT00308997|10851920|FG001|Overall Study|Subject feigned clinical data|1
6845568|NCT00308997|10851919|FG000|Overall Study|Unable to tolerate intervention|1
6845569|NCT00308997|10851920|FG001|Overall Study|Unable to tolerate intervention|0
6845570|NCT00309166|10851932|FG000|Overall Study|Adverse event, non-fatal|1
6845571|NCT00309166|10851933|FG001|Overall Study|Adverse event, non-fatal|0
6845572|NCT00309166|10851932|FG000|Overall Study|Withdrawal by Subject|4
6845573|NCT00309166|10851933|FG001|Overall Study|Withdrawal by Subject|3
6845574|NCT00309244|10851941|FG000|Overall Study|Adverse Event|29
6845575|NCT00309244|10851942|FG001|Overall Study|Adverse Event|12
6845576|NCT00309244|10851941|FG000|Overall Study|Lost to Follow-up|6
6845577|NCT00309244|10851942|FG001|Overall Study|Lost to Follow-up|22
6845578|NCT00309244|10851941|FG000|Overall Study|Physician Decision|5
6845579|NCT00309244|10851942|FG001|Overall Study|Physician Decision|8
6845580|NCT00309244|10851941|FG000|Overall Study|Protocol Violation|6
6845581|NCT00309244|10851942|FG001|Overall Study|Protocol Violation|3
6845582|NCT00309244|10851941|FG000|Overall Study|Withdrawal by Subject|50
6845583|NCT00309244|10851942|FG001|Overall Study|Withdrawal by Subject|32
6845584|NCT00309244|10851941|FG000|Overall Study|Various|7
6845585|NCT00309244|10851942|FG001|Overall Study|Various|7
6845586|NCT00309244|10851941|FG000|Overall Study|Randomized but not dosed|11
6845587|NCT00309244|10851942|FG001|Overall Study|Randomized but not dosed|12
6845588|NCT00309244|10851941|FG000|Overall Study|Death|4
6845589|NCT00309244|10851942|FG001|Overall Study|Death|1
6845590|NCT00309387|10851950|FG000|Overall Study|Death|72
6845591|NCT00309387|10851951|FG001|Overall Study|Death|73
6845592|NCT00309387|10851950|FG000|Overall Study|Lost to Follow-up|70
6845593|NCT00309387|10851951|FG001|Overall Study|Lost to Follow-up|86
6845594|NCT00309452|10851960|FG000|Overall Study|Withdrawal by Subject|3
6845595|NCT00309452|10851961|FG001|Overall Study|Withdrawal by Subject|0
6845596|NCT00309608|10851997|FG000|Overall Study|Adverse Event|1
6845597|NCT00309608|10851998|FG001|Overall Study|Adverse Event|5
6845598|NCT00309608|10851999|FG002|Overall Study|Adverse Event|3
6845599|NCT00309608|10852000|FG003|Overall Study|Adverse Event|2
6845600|NCT00309608|10852001|FG004|Overall Study|Adverse Event|3
6845601|NCT00309608|10851997|FG000|Overall Study|Protocol Violation|2
6845602|NCT00309608|10851998|FG001|Overall Study|Protocol Violation|0
6845603|NCT00309608|10851999|FG002|Overall Study|Protocol Violation|0
6845604|NCT00309608|10852000|FG003|Overall Study|Protocol Violation|0
6845605|NCT00309608|10852001|FG004|Overall Study|Protocol Violation|0
6845606|NCT00309608|10851997|FG000|Overall Study|Lost to Follow-up|0
6845607|NCT00309608|10851998|FG001|Overall Study|Lost to Follow-up|0
6845608|NCT00309608|10851999|FG002|Overall Study|Lost to Follow-up|2
6845609|NCT00309608|10852000|FG003|Overall Study|Lost to Follow-up|0
6845610|NCT00309608|10852001|FG004|Overall Study|Lost to Follow-up|1
6845611|NCT00309608|10851997|FG000|Overall Study|Withdrawal by Subject|1
6845612|NCT00309608|10851998|FG001|Overall Study|Withdrawal by Subject|4
6845613|NCT00309608|10851999|FG002|Overall Study|Withdrawal by Subject|2
6845614|NCT00309608|10852000|FG003|Overall Study|Withdrawal by Subject|0
6845615|NCT00309608|10852001|FG004|Overall Study|Withdrawal by Subject|0
6845616|NCT00309608|10851997|FG000|Overall Study|Other incl. Lack of efficacy|10
6845617|NCT00309608|10851998|FG001|Overall Study|Other incl. Lack of efficacy|4
6845618|NCT00309608|10851999|FG002|Overall Study|Other incl. Lack of efficacy|3
6845619|NCT00309608|10852000|FG003|Overall Study|Other incl. Lack of efficacy|4
6845620|NCT00309608|10852001|FG004|Overall Study|Other incl. Lack of efficacy|0
6845621|NCT00309777|10852035|FG000|Overall Study|Adverse Event|13
6845622|NCT00309777|10852036|FG001|Overall Study|Adverse Event|2
6845623|NCT00309777|10852037|FG002|Overall Study|Adverse Event|8
6845624|NCT00309777|10852038|FG003|Overall Study|Adverse Event|1
6845625|NCT00309777|10852035|FG000|Overall Study|Protocol Violation|4
6845626|NCT00309777|10852036|FG001|Overall Study|Protocol Violation|1
6845627|NCT00309777|10852037|FG002|Overall Study|Protocol Violation|3
6845628|NCT00309777|10852038|FG003|Overall Study|Protocol Violation|1
6845629|NCT00309777|10852035|FG000|Overall Study|Withdrawal by Subject|6
6845630|NCT00309777|10852036|FG001|Overall Study|Withdrawal by Subject|5
6845631|NCT00309777|10852037|FG002|Overall Study|Withdrawal by Subject|7
6845632|NCT00309777|10852038|FG003|Overall Study|Withdrawal by Subject|2
6845633|NCT00309777|10852035|FG000|Overall Study|Lost to Follow-up|0
6845634|NCT00309777|10852036|FG001|Overall Study|Lost to Follow-up|0
6845635|NCT00309777|10852037|FG002|Overall Study|Lost to Follow-up|1
6845636|NCT00309777|10852038|FG003|Overall Study|Lost to Follow-up|0
6845637|NCT00309777|10852035|FG000|Overall Study|Death|0
6845638|NCT00309777|10852036|FG001|Overall Study|Death|1
6845639|NCT00309777|10852037|FG002|Overall Study|Death|0
6845640|NCT00309777|10852038|FG003|Overall Study|Death|0
6845641|NCT00309842|10852048|FG000|Overall Study|Lost to Follow-up|1
6845642|NCT00309907|10852052|FG000|Overall Study|Death|4
6845643|NCT00309907|10852052|FG000|Overall Study|Physician Decision|1
6845644|NCT00309907|10852052|FG000|Overall Study|Ineligible|11
6845645|NCT00309907|10852052|FG000|Overall Study|Major infectious event|4
6845646|NCT00309946|10852057|FG000|Overall Study|Withdrawal by Subject|1
6845647|NCT00309959|10852061|FG000|Overall Study|Ineligible - no prior chemotherapy|2
6845648|NCT00310037|10852072|FG000|Overall Study|Adverse Event|7
6845649|NCT00310037|10852073|FG001|Overall Study|Adverse Event|14
6845650|NCT00310037|10852072|FG000|Overall Study|Withdrawal by Subject|4
6845651|NCT00310037|10852073|FG001|Overall Study|Withdrawal by Subject|3
6845652|NCT00310037|10852072|FG000|Overall Study|Progression|6
6845653|NCT00310037|10852073|FG001|Overall Study|Progression|0
6845654|NCT00310037|10852072|FG000|Overall Study|Non-protocol treatment|1
6845655|NCT00310037|10852073|FG001|Overall Study|Non-protocol treatment|0
6845656|NCT00310375|10852117|FG000|Primary Reporting Phase|Adverse Event|28
6845657|NCT00310375|10852118|FG001|Primary Reporting Phase|Adverse Event|22
6845658|NCT00310375|10852119|FG002|Primary Reporting Phase|Adverse Event|0
6845659|NCT00310375|10852117|FG000|Primary Reporting Phase|Lack of Efficacy|24
6845660|NCT00310375|10852118|FG001|Primary Reporting Phase|Lack of Efficacy|19
6845661|NCT00310375|10852119|FG002|Primary Reporting Phase|Lack of Efficacy|0
6845662|NCT00310375|10852117|FG000|Primary Reporting Phase|Pregnancy|2
6845663|NCT00310375|10852118|FG001|Primary Reporting Phase|Pregnancy|2
6845664|NCT00310375|10852119|FG002|Primary Reporting Phase|Pregnancy|0
6845665|NCT00310375|10852117|FG000|Primary Reporting Phase|Withdrawal by Subject|10
6845666|NCT00310375|10852118|FG001|Primary Reporting Phase|Withdrawal by Subject|7
6845667|NCT00310375|10852119|FG002|Primary Reporting Phase|Withdrawal by Subject|0
6845668|NCT00310375|10852117|FG000|Primary Reporting Phase|Protocol Violation|8
6845669|NCT00310375|10852118|FG001|Primary Reporting Phase|Protocol Violation|5
6845670|NCT00310375|10852119|FG002|Primary Reporting Phase|Protocol Violation|0
6845671|NCT00310375|10852117|FG000|Primary Reporting Phase|Change in Par medical condition|2
6845672|NCT00310375|10852118|FG001|Primary Reporting Phase|Change in Par medical condition|0
6845673|NCT00310375|10852119|FG002|Primary Reporting Phase|Change in Par medical condition|0
6845674|NCT00310375|10852117|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2
6845675|NCT00310375|10852118|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1
6845676|NCT00310375|10852119|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0
6845677|NCT00310375|10852117|FG000|Primary Reporting Phase|Physician Decision|5
6845678|NCT00310375|10852118|FG001|Primary Reporting Phase|Physician Decision|3
6845679|NCT00310375|10852119|FG002|Primary Reporting Phase|Physician Decision|0
6845680|NCT00310375|10852117|FG000|Primary Reporting Phase|Request of the sponsor|2
6845681|NCT00310375|10852118|FG001|Primary Reporting Phase|Request of the sponsor|2
6845682|NCT00310375|10852119|FG002|Primary Reporting Phase|Request of the sponsor|0
6845683|NCT00310375|10852117|FG000|Primary Reporting Phase|Failed to return|1
6845684|NCT00310375|10852118|FG001|Primary Reporting Phase|Failed to return|3
6845685|NCT00310375|10852119|FG002|Primary Reporting Phase|Failed to return|0
6845686|NCT00310375|10852117|FG000|Primary Reporting Phase|Participant request unrelated to study|1
6845687|NCT00310375|10852118|FG001|Primary Reporting Phase|Participant request unrelated to study|2
6845688|NCT00310375|10852119|FG002|Primary Reporting Phase|Participant request unrelated to study|0
6845689|NCT00310375|10852117|FG000|Primary Reporting Phase|Going for temporal lobectomy|1
6845690|NCT00310375|10852118|FG001|Primary Reporting Phase|Going for temporal lobectomy|0
6845691|NCT00310375|10852119|FG002|Primary Reporting Phase|Going for temporal lobectomy|0
6845692|NCT00310375|10852117|FG000|Primary Reporting Phase|Missed study drug >5 days|1
6845693|NCT00310375|10852118|FG001|Primary Reporting Phase|Missed study drug >5 days|0
6845694|NCT00310375|10852119|FG002|Primary Reporting Phase|Missed study drug >5 days|0
6845695|NCT00310375|10852117|FG000|Primary Reporting Phase|Site closure|3
6845696|NCT00310375|10852118|FG001|Primary Reporting Phase|Site closure|0
6845697|NCT00310375|10852119|FG002|Primary Reporting Phase|Site closure|0
6845698|NCT00310375|10852117|FG000|Primary Reporting Phase|Missed study drug for 2 months|1
6845699|NCT00310375|10852118|FG001|Primary Reporting Phase|Missed study drug for 2 months|0
6897925|NCT00642941|10916959|FG008|Overall Study|Other|0
6845700|NCT00310375|10852119|FG002|Primary Reporting Phase|Missed study drug for 2 months|0
6845701|NCT00310375|10852117|FG000|Primary Reporting Phase|Par. switched to commercial product|0
6845702|NCT00310375|10852118|FG001|Primary Reporting Phase|Par. switched to commercial product|1
6845703|NCT00310375|10852119|FG002|Primary Reporting Phase|Par. switched to commercial product|0
6845704|NCT00310375|10852117|FG000|Primary Reporting Phase|Request of Ethics Committee|0
7151326|NCT03227445|11315275|FG000|Period 2 (28 Days)|Adverse Event|1
7151327|NCT03227445|11315276|FG001|Period 2 (28 Days)|Adverse Event|0
6966492|NCT02198794|11014555|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79
6966493|NCT02198794|11014556|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0
6966494|NCT02198794|11014557|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0
6966495|NCT02198794|11014558|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0
6966496|NCT02198794|11014555|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33
7151328|NCT03227445|11315277|FG002|Period 2 (28 Days)|Adverse Event|2
7151329|NCT03227445|11315278|FG003|Period 2 (28 Days)|Adverse Event|1
7151330|NCT03227445|11315275|FG000|Period 2 (28 Days)|Protocol Violation|0
7151331|NCT03227445|11315276|FG001|Period 2 (28 Days)|Protocol Violation|0
7151332|NCT03227445|11315277|FG002|Period 2 (28 Days)|Protocol Violation|0
7151333|NCT03227445|11315278|FG003|Period 2 (28 Days)|Protocol Violation|1
7151334|NCT03227445|11315275|FG000|Period 2 (28 Days)|Withdrawal by Subject|0
7151335|NCT03227445|11315276|FG001|Period 2 (28 Days)|Withdrawal by Subject|1
7151336|NCT03227445|11315277|FG002|Period 2 (28 Days)|Withdrawal by Subject|0
7151337|NCT03227445|11315278|FG003|Period 2 (28 Days)|Withdrawal by Subject|1
7151338|NCT03227692|11315289|FG000|Overall Study|Protocol Violation|1
7151339|NCT03227692|11315290|FG001|Overall Study|Protocol Violation|1
7151340|NCT03227692|11315289|FG000|Overall Study|Lost to Follow-up|4
7151341|NCT03227692|11315290|FG001|Overall Study|Lost to Follow-up|2
7151342|NCT03227692|11315289|FG000|Overall Study|Adverse Event|0
7151343|NCT03227692|11315290|FG001|Overall Study|Adverse Event|2
7151344|NCT03227861|11315296|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4
7151345|NCT03227861|11315296|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1
7151346|NCT03227861|11315296|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1
7151347|NCT03227861|11315296|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1
7151348|NCT03227861|11315296|FG000|Main Study Period (Week 0 to Week 48)|Other|5
7151349|NCT03227861|11315296|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55
7151350|NCT03227861|11315296|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16
7151351|NCT03227861|11315296|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6
7151352|NCT03227861|11315296|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1
7151353|NCT03227861|11315296|FG000|Extension Period (Week 48 to Week 96)|Other|2
7151354|NCT03228212|11315311|FG000|Period 1|Adverse Event|1
7151355|NCT03228212|11315312|FG001|Period 1|Adverse Event|0
7151356|NCT03228212|11315311|FG000|Period 1|no longer meets eligibility criteria|0
7151357|NCT03228212|11315312|FG001|Period 1|no longer meets eligibility criteria|1
7151358|NCT03228212|11315311|FG000|Period 2|Lost to Follow-up|1
7151359|NCT03228212|11315312|FG001|Period 2|Lost to Follow-up|0
7151360|NCT03228420|11315320|FG000|Overall Study|Lost to Follow-up|5
7151361|NCT03228420|11315321|FG001|Overall Study|Lost to Follow-up|3
7151362|NCT03228420|11315320|FG000|Overall Study|Withdrawal by Subject|10
7151363|NCT03228420|11315321|FG001|Overall Study|Withdrawal by Subject|0
7151364|NCT03228420|11315320|FG000|Overall Study|Adverse Event|5
7151365|NCT03228420|11315321|FG001|Overall Study|Adverse Event|2
7151366|NCT03228433|11315333|FG000|Overall Study|Lost to Follow-up|1
7151367|NCT03228433|11315334|FG001|Overall Study|Lost to Follow-up|0
7151368|NCT03228433|11315335|FG002|Overall Study|Lost to Follow-up|0
7151369|NCT03228433|11315336|FG003|Overall Study|Lost to Follow-up|0
7151370|NCT03228433|11315337|FG004|Overall Study|Lost to Follow-up|0
7151371|NCT03228433|11315338|FG005|Overall Study|Lost to Follow-up|0
7151372|NCT03228433|11315333|FG000|Overall Study|Positive alcohol test|0
7151373|NCT03228433|11315334|FG001|Overall Study|Positive alcohol test|0
7151374|NCT03228433|11315335|FG002|Overall Study|Positive alcohol test|0
7151375|NCT03228433|11315336|FG003|Overall Study|Positive alcohol test|1
7151376|NCT03228433|11315337|FG004|Overall Study|Positive alcohol test|0
7151377|NCT03228433|11315338|FG005|Overall Study|Positive alcohol test|0
7151378|NCT03228836|11315360|FG000|Overall Study|Adverse Event|3
7151379|NCT03228836|11315360|FG000|Overall Study|Withdrawal by Subject|1
7151380|NCT03228836|11315360|FG000|Overall Study|Death|1
7151381|NCT03228836|11315360|FG000|Overall Study|Physician Decision|1
7151382|NCT03228836|11315360|FG000|Overall Study|Disease Progression|7
7151383|NCT03228836|11315360|FG000|Overall Study|Other|4
7151384|NCT03229109|11315375|FG000|Overall Study|Withdrawal by Subject|0
7151385|NCT03229109|11315376|FG001|Overall Study|Withdrawal by Subject|0
7151386|NCT03229109|11315377|FG002|Overall Study|Withdrawal by Subject|0
7151387|NCT03229109|11315378|FG003|Overall Study|Withdrawal by Subject|1
7151388|NCT03229486|11315403|FG000|Overall Study|Protocol Violation|0
7151389|NCT03229486|11315404|FG001|Overall Study|Protocol Violation|1
7151390|NCT03229759|11315410|FG000|Overall Study|Screen Failure|30
7151391|NCT03230864|11315423|FG000|Prospective Confirmation (PC) Period|Adverse Event|3
7151392|NCT03230864|11315424|FG001|Prospective Confirmation (PC) Period|Adverse Event|0
7151393|NCT03230864|11315425|FG002|Prospective Confirmation (PC) Period|Adverse Event|0
7151394|NCT03230864|11315426|FG003|Prospective Confirmation (PC) Period|Adverse Event|0
7151395|NCT03230864|11315423|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0
7151396|NCT03230864|11315424|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2
7151397|NCT03230864|11315425|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0
7151398|NCT03230864|11315426|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0
7151399|NCT03230864|11315423|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1
7151400|NCT03230864|11315424|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2
7151401|NCT03230864|11315425|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0
7151402|NCT03230864|11315426|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0
7151403|NCT03230864|11315423|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4
7151404|NCT03230864|11315424|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1
7151405|NCT03230864|11315425|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
7151406|NCT03230864|11315426|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
7151407|NCT03230864|11315423|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14
7151408|NCT03230864|11315424|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5
7151409|NCT03230864|11315425|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0
7151410|NCT03230864|11315426|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0
7151411|NCT03230864|11315423|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9
7151412|NCT03230864|11315424|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9
7151413|NCT03230864|11315425|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0
7151414|NCT03230864|11315426|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0
7151415|NCT03230864|11315423|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1
7151416|NCT03230864|11315424|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0
7151417|NCT03230864|11315425|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0
7151418|NCT03230864|11315426|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0
7151419|NCT03230864|11315423|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0
7151420|NCT03230864|11315424|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0
7151421|NCT03230864|11315425|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5
7151422|NCT03230864|11315426|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1
7151423|NCT03230864|11315423|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0
7151424|NCT03230864|11315424|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0
7151425|NCT03230864|11315425|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1
6845705|NCT00310375|10852118|FG001|Primary Reporting Phase|Request of Ethics Committee|1
6845706|NCT00310375|10852119|FG002|Primary Reporting Phase|Request of Ethics Committee|0
6845707|NCT00310375|10852117|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0
6845708|NCT00310375|10852118|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0
6845709|NCT00310375|10852119|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1
6845710|NCT00310440|10852150|FG000|Overall Study|Lost to Follow-up|17
6845711|NCT00310440|10852151|FG001|Overall Study|Lost to Follow-up|8
6845712|NCT00310440|10852150|FG000|Overall Study|Withdrawal by Subject|2
6845713|NCT00310440|10852151|FG001|Overall Study|Withdrawal by Subject|1
6845714|NCT00310440|10852150|FG000|Overall Study|Missed 12 Month Visit|7
6845715|NCT00310440|10852151|FG001|Overall Study|Missed 12 Month Visit|4
6845716|NCT00310804|10852177|FG000|Overall Study|Lost to Follow-up|2
6845717|NCT00310804|10852178|FG001|Overall Study|Lost to Follow-up|0
6845718|NCT00310804|10852177|FG000|Overall Study|Withdrawal by Subject|3
6845719|NCT00310804|10852178|FG001|Overall Study|Withdrawal by Subject|0
6845720|NCT00310817|10852202|FG000|Overall Study|AE or Death|3
6845721|NCT00310817|10852203|FG001|Overall Study|AE or Death|1
6845722|NCT00310817|10852204|FG002|Overall Study|AE or Death|0
6845723|NCT00310817|10852205|FG003|Overall Study|AE or Death|0
6845724|NCT00310817|10852202|FG000|Overall Study|Withdrawal by Subject|1
6845725|NCT00310817|10852203|FG001|Overall Study|Withdrawal by Subject|4
6845726|NCT00310817|10852204|FG002|Overall Study|Withdrawal by Subject|6
6845727|NCT00310817|10852205|FG003|Overall Study|Withdrawal by Subject|7
6845728|NCT00310817|10852202|FG000|Overall Study|Lost to Follow-up|2
6845729|NCT00310817|10852203|FG001|Overall Study|Lost to Follow-up|1
6845730|NCT00310817|10852204|FG002|Overall Study|Lost to Follow-up|0
6845731|NCT00310817|10852205|FG003|Overall Study|Lost to Follow-up|0
6845732|NCT00310817|10852202|FG000|Overall Study|Inappropriate Enrollment|1
6845733|NCT00310817|10852203|FG001|Overall Study|Inappropriate Enrollment|0
6845734|NCT00310817|10852204|FG002|Overall Study|Inappropriate Enrollment|1
6845735|NCT00310817|10852205|FG003|Overall Study|Inappropriate Enrollment|0
6845736|NCT00310817|10852202|FG000|Overall Study|Protocol Violation|1
6845737|NCT00310817|10852203|FG001|Overall Study|Protocol Violation|1
6845738|NCT00310817|10852204|FG002|Overall Study|Protocol Violation|1
6845739|NCT00310817|10852205|FG003|Overall Study|Protocol Violation|1
6845740|NCT00310817|10852202|FG000|Overall Study|Unable to classify|3
6845741|NCT00310817|10852203|FG001|Overall Study|Unable to classify|1
6845742|NCT00310817|10852204|FG002|Overall Study|Unable to classify|0
6845743|NCT00310817|10852205|FG003|Overall Study|Unable to classify|0
6845744|NCT00310856|10852251|FG000|Overall Study|Withdrawal by Subject|2
6845745|NCT00310856|10852252|FG001|Overall Study|Withdrawal by Subject|2
6845746|NCT00310856|10852253|FG002|Overall Study|Withdrawal by Subject|2
6845747|NCT00310856|10852251|FG000|Overall Study|Lost to Follow-up|1
6845748|NCT00310856|10852252|FG001|Overall Study|Lost to Follow-up|2
6845749|NCT00310856|10852253|FG002|Overall Study|Lost to Follow-up|6
6845750|NCT00310856|10852251|FG000|Overall Study|Inappropriate enrollment|1
6845751|NCT00310856|10852252|FG001|Overall Study|Inappropriate enrollment|1
6845752|NCT00310856|10852253|FG002|Overall Study|Inappropriate enrollment|0
6845753|NCT00310856|10852251|FG000|Overall Study|Unable to classify|1
6845754|NCT00310856|10852252|FG001|Overall Study|Unable to classify|0
6845755|NCT00310856|10852253|FG002|Overall Study|Unable to classify|0
6845756|NCT00311155|10852262|FG000|Overall Study|Adverse Event|21
6845757|NCT00311155|10852262|FG000|Overall Study|Withdrawal by Subject|17
6845758|NCT00311155|10852262|FG000|Overall Study|Did not meet entry criteria|55
6845759|NCT00311168|10852268|FG000|First Intervention|Withdrawal by Subject|2
6845760|NCT00311168|10852269|FG001|First Intervention|Withdrawal by Subject|2
6845761|NCT00311168|10852268|FG000|First Intervention|Lost to Follow-up|1
6845762|NCT00311168|10852269|FG001|First Intervention|Lost to Follow-up|1
6845763|NCT00311168|10852268|FG000|First Intervention|Protocol Violation|1
6845764|NCT00311168|10852269|FG001|First Intervention|Protocol Violation|1
6845765|NCT00311168|10852268|FG000|First Intervention|Adverse Event|1
6845766|NCT00311168|10852269|FG001|First Intervention|Adverse Event|0
6845767|NCT00311168|10852268|FG000|First Intervention|Other|2
6845768|NCT00311168|10852269|FG001|First Intervention|Other|2
6845769|NCT00311168|10852268|FG000|Second Intervention|Lost to Follow-up|9
6845770|NCT00311168|10852269|FG001|Second Intervention|Lost to Follow-up|2
6845771|NCT00311168|10852268|FG000|Second Intervention|Withdrawal by Subject|0
6845772|NCT00311168|10852269|FG001|Second Intervention|Withdrawal by Subject|1
6845773|NCT00311168|10852268|FG000|Second Intervention|Other|1
6845774|NCT00311168|10852269|FG001|Second Intervention|Other|1
6845775|NCT00311181|10852277|FG000|Overall Study|Final DFTs were not obtained|96
6845776|NCT00311311|10852290|FG000|Overall Study|Adverse Event|3
6845777|NCT00311311|10852291|FG001|Overall Study|Adverse Event|2
6845778|NCT00311311|10852290|FG000|Overall Study|Withdrawal by Subject|1
6845779|NCT00311311|10852291|FG001|Overall Study|Withdrawal by Subject|1
6845780|NCT00311311|10852290|FG000|Overall Study|Noncompliance|0
6845781|NCT00311311|10852291|FG001|Overall Study|Noncompliance|1
6845782|NCT00311311|10852290|FG000|Overall Study|Study Termination by Sponsor|3
6845783|NCT00311311|10852291|FG001|Overall Study|Study Termination by Sponsor|4
6845784|NCT00311311|10852290|FG000|Overall Study|Death|1
6845785|NCT00311311|10852291|FG001|Overall Study|Death|0
6845786|NCT00311311|10852290|FG000|Overall Study|Lack of ancillary assistance|0
6845787|NCT00311311|10852291|FG001|Overall Study|Lack of ancillary assistance|1
6845788|NCT00311363|10852300|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42
6845789|NCT00311363|10852301|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0
6845790|NCT00311363|10852302|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0
6845791|NCT00311363|10852300|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13
6845792|NCT00311363|10852301|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
6845793|NCT00311363|10852302|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
6845794|NCT00311363|10852300|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27
6845795|NCT00311363|10852301|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
6845796|NCT00311363|10852302|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
6845797|NCT00311363|10852300|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12
6845798|NCT00311363|10852301|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
6845799|NCT00311363|10852302|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
6845800|NCT00311363|10852300|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8
6845801|NCT00311363|10852301|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0
6845802|NCT00311363|10852302|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0
6845803|NCT00311363|10852300|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1
6845804|NCT00311363|10852301|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0
6845805|NCT00311363|10852302|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0
6845806|NCT00311363|10852300|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1
6845807|NCT00311363|10852301|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
6845808|NCT00311363|10852302|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
6845809|NCT00311363|10852300|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1
6845810|NCT00311363|10852301|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0
6845811|NCT00311363|10852302|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0
6845812|NCT00311363|10852300|FG000|24-Week Single-Blind Treatment Period|Death|1
6845813|NCT00311363|10852301|FG001|24-Week Single-Blind Treatment Period|Death|0
6845814|NCT00311363|10852302|FG002|24-Week Single-Blind Treatment Period|Death|0
6845815|NCT00311363|10852300|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0
6845816|NCT00311363|10852301|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3
6845817|NCT00311363|10852302|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0
6845818|NCT00311363|10852300|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0
6845819|NCT00311363|10852301|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1
6845820|NCT00311363|10852302|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2
6845821|NCT00311363|10852300|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0
6845822|NCT00311363|10852301|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6
6845823|NCT00311363|10852302|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4
6845824|NCT00311363|10852300|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0
6845825|NCT00311363|10852301|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2
6845826|NCT00311363|10852302|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4
6845827|NCT00311363|10852300|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0
6845828|NCT00311363|10852301|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1
6845829|NCT00311363|10852302|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2
6845830|NCT00311363|10852300|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
6845831|NCT00311363|10852301|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1
6845832|NCT00311363|10852302|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
6845833|NCT00311402|10852327|FG000|Overall Study|Adverse Event|118
6845834|NCT00311402|10852328|FG001|Overall Study|Adverse Event|105
6845835|NCT00311402|10852327|FG000|Overall Study|Lost to Follow-up|0
6845836|NCT00311402|10852328|FG001|Overall Study|Lost to Follow-up|3
6845837|NCT00311402|10852327|FG000|Overall Study|Withdrawal by Subject|17
6845838|NCT00311402|10852328|FG001|Overall Study|Withdrawal by Subject|18
6845839|NCT00311402|10852327|FG000|Overall Study|Lack of Efficacy|58
6845840|NCT00311402|10852328|FG001|Overall Study|Lack of Efficacy|42
6845841|NCT00311402|10852327|FG000|Overall Study|Protocol Violation|7
6845842|NCT00311402|10852328|FG001|Overall Study|Protocol Violation|6
6845843|NCT00311402|10852327|FG000|Overall Study|IRB's rejection etc.|10
6845844|NCT00311402|10852328|FG001|Overall Study|IRB's rejection etc.|3
6845845|NCT00311584|10852336|FG000|Overall Study|Death|1
6845846|NCT00311584|10852337|FG001|Overall Study|Death|0
6845847|NCT00311584|10852336|FG000|Overall Study|Lack of Efficacy|12
6845848|NCT00311584|10852337|FG001|Overall Study|Lack of Efficacy|15
6845849|NCT00311584|10852336|FG000|Overall Study|Physician Decision|4
6845850|NCT00311584|10852337|FG001|Overall Study|Physician Decision|5
6845851|NCT00311584|10852336|FG000|Overall Study|Withdrawal by Subject|1
6845852|NCT00311584|10852337|FG001|Overall Study|Withdrawal by Subject|1
6845853|NCT00311584|10852336|FG000|Overall Study|ineligible|2
6845854|NCT00311584|10852337|FG001|Overall Study|ineligible|2
6845855|NCT00311623|10852346|FG000|Overall Study|Physician Decision|0
6845856|NCT00311623|10852347|FG001|Overall Study|Physician Decision|0
6845857|NCT00311623|10852348|FG002|Overall Study|Physician Decision|2
6845858|NCT00312195|10852368|FG000|Overall Study|Adverse Event|4
6845859|NCT00312195|10852369|FG001|Overall Study|Adverse Event|6
6845860|NCT00312195|10852368|FG000|Overall Study|Lost to Follow-up|1
6845861|NCT00312195|10852369|FG001|Overall Study|Lost to Follow-up|0
6845862|NCT00312195|10852368|FG000|Overall Study|Protocol Violation|1
6845863|NCT00312195|10852369|FG001|Overall Study|Protocol Violation|0
6845864|NCT00312208|10852379|FG000|Overall Study|Adverse Event|97
6845865|NCT00312208|10852380|FG001|Overall Study|Adverse Event|61
6845866|NCT00312208|10852379|FG000|Overall Study|Protocol Violation|5
6845867|NCT00312208|10852380|FG001|Overall Study|Protocol Violation|3
6845868|NCT00312208|10852379|FG000|Overall Study|Death|2
6845869|NCT00312208|10852380|FG001|Overall Study|Death|1
6845870|NCT00312208|10852379|FG000|Overall Study|Lack of Efficacy|7
6845871|NCT00312208|10852380|FG001|Overall Study|Lack of Efficacy|4
6845872|NCT00312208|10852379|FG000|Overall Study|Lost to Follow-up|3
6845873|NCT00312208|10852380|FG001|Overall Study|Lost to Follow-up|5
6845874|NCT00312208|10852379|FG000|Overall Study|Withdrawal by Subject|53
6845875|NCT00312208|10852380|FG001|Overall Study|Withdrawal by Subject|42
6845876|NCT00312208|10852379|FG000|Overall Study|Other|5
6845877|NCT00312208|10852380|FG001|Overall Study|Other|7
6845878|NCT00312221|10852389|FG000|Open-label Run-in Period|Withdrawal by Subject|6
6845879|NCT00312221|10852390|FG001|Open-label Run-in Period|Withdrawal by Subject|0
6845880|NCT00312221|10852391|FG002|Open-label Run-in Period|Withdrawal by Subject|0
6845881|NCT00312221|10852392|FG003|Open-label Run-in Period|Withdrawal by Subject|0
6845882|NCT00312221|10852389|FG000|Open-label Run-in Period|Adverse Event|74
6845883|NCT00312221|10852390|FG001|Open-label Run-in Period|Adverse Event|0
6845884|NCT00312221|10852391|FG002|Open-label Run-in Period|Adverse Event|0
6845885|NCT00312221|10852392|FG003|Open-label Run-in Period|Adverse Event|0
6845886|NCT00312221|10852389|FG000|Open-label Run-in Period|Lost to Follow-up|5
6845887|NCT00312221|10852390|FG001|Open-label Run-in Period|Lost to Follow-up|0
6845888|NCT00312221|10852391|FG002|Open-label Run-in Period|Lost to Follow-up|0
6845889|NCT00312221|10852392|FG003|Open-label Run-in Period|Lost to Follow-up|0
6845890|NCT00312221|10852389|FG000|Open-label Run-in Period|Administrative|42
6845891|NCT00312221|10852390|FG001|Open-label Run-in Period|Administrative|0
6845892|NCT00312221|10852391|FG002|Open-label Run-in Period|Administrative|0
6845893|NCT00312221|10852392|FG003|Open-label Run-in Period|Administrative|0
6845894|NCT00312221|10852389|FG000|Open-label Run-in Period|Lack of Efficacy|102
6845895|NCT00312221|10852390|FG001|Open-label Run-in Period|Lack of Efficacy|0
6845896|NCT00312221|10852391|FG002|Open-label Run-in Period|Lack of Efficacy|0
6845897|NCT00312221|10852392|FG003|Open-label Run-in Period|Lack of Efficacy|0
6845898|NCT00312221|10852389|FG000|Open-label Run-in Period|Did not qualify|5
6845899|NCT00312221|10852390|FG001|Open-label Run-in Period|Did not qualify|0
6845900|NCT00312221|10852391|FG002|Open-label Run-in Period|Did not qualify|0
6845901|NCT00312221|10852392|FG003|Open-label Run-in Period|Did not qualify|0
6845902|NCT00312221|10852389|FG000|Double-blind Phase|Withdrawal by Subject|0
6845903|NCT00312221|10852390|FG001|Double-blind Phase|Withdrawal by Subject|6
6845904|NCT00312221|10852391|FG002|Double-blind Phase|Withdrawal by Subject|8
6845905|NCT00312221|10852392|FG003|Double-blind Phase|Withdrawal by Subject|7
6845906|NCT00312221|10852389|FG000|Double-blind Phase|Adverse Event|0
6845907|NCT00312221|10852390|FG001|Double-blind Phase|Adverse Event|10
6845908|NCT00312221|10852391|FG002|Double-blind Phase|Adverse Event|19
6845909|NCT00312221|10852392|FG003|Double-blind Phase|Adverse Event|18
6845910|NCT00312221|10852389|FG000|Double-blind Phase|Lost to Follow-up|0
6845911|NCT00312221|10852390|FG001|Double-blind Phase|Lost to Follow-up|0
6845912|NCT00312221|10852391|FG002|Double-blind Phase|Lost to Follow-up|2
6845913|NCT00312221|10852392|FG003|Double-blind Phase|Lost to Follow-up|2
6845914|NCT00312221|10852389|FG000|Double-blind Phase|Administrative|0
6845915|NCT00312221|10852390|FG001|Double-blind Phase|Administrative|26
6845916|NCT00312221|10852391|FG002|Double-blind Phase|Administrative|37
6845917|NCT00312221|10852392|FG003|Double-blind Phase|Administrative|33
6845918|NCT00312221|10852389|FG000|Double-blind Phase|Lack of Efficacy|0
6845919|NCT00312221|10852390|FG001|Double-blind Phase|Lack of Efficacy|17
6845920|NCT00312221|10852391|FG002|Double-blind Phase|Lack of Efficacy|6
6845921|NCT00312221|10852392|FG003|Double-blind Phase|Lack of Efficacy|10
6845922|NCT00312338|10852403|FG000|Overall Study|Adverse Event|7
6845923|NCT00312338|10852404|FG001|Overall Study|Adverse Event|2
6845924|NCT00312338|10852403|FG000|Overall Study|Lost to Follow-up|9
6845925|NCT00312338|10852404|FG001|Overall Study|Lost to Follow-up|1
6845926|NCT00312338|10852403|FG000|Overall Study|Withdrawal by Subject|4
6845927|NCT00312338|10852404|FG001|Overall Study|Withdrawal by Subject|0
6845928|NCT00312338|10852403|FG000|Overall Study|Subsequent infection|2
6845929|NCT00312338|10852404|FG001|Overall Study|Subsequent infection|0
6845930|NCT00312377|10852412|FG000|Overall Study|Death|403
6845931|NCT00312377|10852413|FG001|Overall Study|Death|418
6845932|NCT00312377|10852412|FG000|Overall Study|Withdrawal by Subject|23
6845933|NCT00312377|10852413|FG001|Overall Study|Withdrawal by Subject|30
6845934|NCT00312377|10852412|FG000|Overall Study|Lost to Follow-up|9
6845935|NCT00312377|10852413|FG001|Overall Study|Lost to Follow-up|12
6845936|NCT00312377|10852412|FG000|Overall Study|Non-compliance|0
6845937|NCT00312377|10852413|FG001|Overall Study|Non-compliance|2
6845938|NCT00312377|10852412|FG000|Overall Study|Randomised but never received treatment|6
7077375|NCT02091739|11184894|FG002|MP: 16 Weeks|Adverse Event|1
7077376|NCT02091739|11184895|FG003|MP: 16 Weeks|Adverse Event|0
7151426|NCT03230864|11315426|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1
6845939|NCT00312377|10852413|FG001|Overall Study|Randomised but never received treatment|6
6845940|NCT00312377|10852412|FG000|Overall Study|Discontinue treatment survival follow up|202
6845941|NCT00312377|10852413|FG001|Overall Study|Discontinue treatment survival follow up|200
6845942|NCT00312377|10852412|FG000|Overall Study|Site ended participation in study|1
6845943|NCT00312377|10852413|FG001|Overall Study|Site ended participation in study|0
6845944|NCT00312494|10852422|FG000|Overall Study|Randomized; not treated with study drug|9
6845945|NCT00312494|10852423|FG001|Overall Study|Randomized; not treated with study drug|10
6845946|NCT00312494|10852424|FG002|Overall Study|Randomized; not treated with study drug|5
6845947|NCT00312494|10852422|FG000|Overall Study|Adverse Event|33
6845948|NCT00312494|10852423|FG001|Overall Study|Adverse Event|15
6845949|NCT00312494|10852424|FG002|Overall Study|Adverse Event|11
6845950|NCT00312494|10852422|FG000|Overall Study|Lack of Efficacy|4
6845951|NCT00312494|10852423|FG001|Overall Study|Lack of Efficacy|6
6845952|NCT00312494|10852424|FG002|Overall Study|Lack of Efficacy|8
6845953|NCT00312494|10852422|FG000|Overall Study|Laboratory abnormality|1
6845954|NCT00312494|10852423|FG001|Overall Study|Laboratory abnormality|0
6845955|NCT00312494|10852424|FG002|Overall Study|Laboratory abnormality|0
6845956|NCT00312494|10852422|FG000|Overall Study|Lost to Follow-up|8
6845957|NCT00312494|10852423|FG001|Overall Study|Lost to Follow-up|8
6845958|NCT00312494|10852424|FG002|Overall Study|Lost to Follow-up|8
6845959|NCT00312494|10852422|FG000|Overall Study|Withdrawal by Subject|6
6845960|NCT00312494|10852423|FG001|Overall Study|Withdrawal by Subject|9
6845961|NCT00312494|10852424|FG002|Overall Study|Withdrawal by Subject|10
6845962|NCT00312494|10852422|FG000|Overall Study|Other|10
6845963|NCT00312494|10852423|FG001|Overall Study|Other|10
6845964|NCT00312494|10852424|FG002|Overall Study|Other|1
6897926|NCT00642941|10916960|FG009|Overall Study|Other|0
6897927|NCT00642941|10916961|FG010|Overall Study|Other|0
6897928|NCT00642941|10916962|FG011|Overall Study|Other|1
6897929|NCT00642941|10916951|FG000|Overall Study|Disease progression|60
6897930|NCT00642941|10916952|FG001|Overall Study|Disease progression|50
6897931|NCT00642941|10916953|FG002|Overall Study|Disease progression|5
6897932|NCT00642941|10916954|FG003|Overall Study|Disease progression|36
6897933|NCT00642941|10916955|FG004|Overall Study|Disease progression|23
7077377|NCT02091739|11184896|FG004|MP: 16 Weeks|Adverse Event|0
7077378|NCT02091739|11184892|FG000|MP: 16 Weeks|Withdrawal by Subject|3
7077379|NCT02091739|11184893|FG001|MP: 16 Weeks|Withdrawal by Subject|4
7077380|NCT02091739|11184894|FG002|MP: 16 Weeks|Withdrawal by Subject|0
7077381|NCT02091739|11184895|FG003|MP: 16 Weeks|Withdrawal by Subject|0
7077382|NCT02091739|11184896|FG004|MP: 16 Weeks|Withdrawal by Subject|0
7077383|NCT02091739|11184892|FG000|MP: 16 Weeks|Lost to Follow-up|0
7077384|NCT02091739|11184893|FG001|MP: 16 Weeks|Lost to Follow-up|0
7077385|NCT02091739|11184894|FG002|MP: 16 Weeks|Lost to Follow-up|1
7077386|NCT02091739|11184895|FG003|MP: 16 Weeks|Lost to Follow-up|0
7077387|NCT02091739|11184896|FG004|MP: 16 Weeks|Lost to Follow-up|0
7077388|NCT02091739|11184892|FG000|EP: 48 Weeks|Other|0
6845965|NCT00312572|10852434|FG000|Overall Study|Adverse Event|10
6845966|NCT00312572|10852435|FG001|Overall Study|Adverse Event|16
6845967|NCT00312572|10852434|FG000|Overall Study|Lost to Follow-up|1
6845968|NCT00312572|10852435|FG001|Overall Study|Lost to Follow-up|1
6845969|NCT00312572|10852434|FG000|Overall Study|Administrative|4
6845970|NCT00312572|10852435|FG001|Overall Study|Administrative|2
6845971|NCT00312572|10852434|FG000|Overall Study|Lack of Efficacy|1
6845972|NCT00312572|10852435|FG001|Overall Study|Lack of Efficacy|2
7077389|NCT02091739|11184893|FG001|EP: 48 Weeks|Other|0
7077390|NCT02091739|11184894|FG002|EP: 48 Weeks|Other|0
7077391|NCT02091739|11184895|FG003|EP: 48 Weeks|Other|1
7077392|NCT02091739|11184896|FG004|EP: 48 Weeks|Other|0
7151427|NCT03230864|11315423|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0
6845973|NCT00312663|10852446|FG000|Immunization Phase|Adverse Event|0
6845974|NCT00312663|10852447|FG001|Immunization Phase|Adverse Event|1
6845975|NCT00312663|10852448|FG002|Immunization Phase|Adverse Event|0
6845976|NCT00312702|10852460|FG000|Immunization Phase|Lost to Follow-up|0
6845977|NCT00312702|10852461|FG001|Immunization Phase|Lost to Follow-up|1
6845978|NCT00312702|10852462|FG002|Immunization Phase|Lost to Follow-up|0
6845979|NCT00312728|10852470|FG000|Overall Study|Progressive disease|53
6845980|NCT00312728|10852470|FG000|Overall Study|Adverse Event|32
6845981|NCT00312728|10852470|FG000|Overall Study|Withdrawal by Subject|10
6845982|NCT00312728|10852470|FG000|Overall Study|Required non-protocol cancer treatment|2
6845983|NCT00312728|10852470|FG000|Overall Study|Protocol Violation|2
6845984|NCT00312728|10852470|FG000|Overall Study|Other|10
6845985|NCT00312728|10852470|FG000|Overall Study|Other|1
6845986|NCT00312845|10852476|FG000|Overall Study|Adverse Event|19
6845987|NCT00312845|10852477|FG001|Overall Study|Adverse Event|5
6845988|NCT00312845|10852476|FG000|Overall Study|Death|2
6845989|NCT00312845|10852477|FG001|Overall Study|Death|2
6845990|NCT00312845|10852476|FG000|Overall Study|Withdrawal by Subject|14
6845991|NCT00312845|10852477|FG001|Overall Study|Withdrawal by Subject|6
6845992|NCT00312845|10852476|FG000|Overall Study|Disease Progression|56
6845993|NCT00312845|10852477|FG001|Overall Study|Disease Progression|77
6845994|NCT00312845|10852476|FG000|Overall Study|Lost to Follow-up|2
6845995|NCT00312845|10852477|FG001|Overall Study|Lost to Follow-up|0
6845996|NCT00312845|10852476|FG000|Overall Study|Other|6
6845997|NCT00312845|10852477|FG001|Overall Study|Other|5
6845998|NCT00312858|10852485|FG000|Overall Study|Adverse Event|0
6845999|NCT00312858|10852486|FG001|Overall Study|Adverse Event|1
6846000|NCT00312858|10852485|FG000|Overall Study|Lost to Follow-up|25
6846001|NCT00312858|10852486|FG001|Overall Study|Lost to Follow-up|42
6846002|NCT00312858|10852485|FG000|Overall Study|Protocol Violation|3
6846003|NCT00312858|10852486|FG001|Overall Study|Protocol Violation|8
6846004|NCT00312858|10852485|FG000|Overall Study|Withdraw by Participant|20
6846005|NCT00312858|10852486|FG001|Overall Study|Withdraw by Participant|20
6846006|NCT00312858|10852485|FG000|Overall Study|Participant Moved|11
6846007|NCT00312858|10852486|FG001|Overall Study|Participant Moved|10
6846008|NCT00312858|10852485|FG000|Overall Study|Other|9
6846009|NCT00312858|10852486|FG001|Overall Study|Other|12
6846010|NCT00312897|10852503|FG000|Overall Study|Adverse Event|1
6846011|NCT00312897|10852504|FG001|Overall Study|Adverse Event|0
6846012|NCT00312897|10852503|FG000|Overall Study|Lost to Follow-up|2
6846013|NCT00312897|10852504|FG001|Overall Study|Lost to Follow-up|0
6846014|NCT00312897|10852503|FG000|Overall Study|Physician Decision|1
6846015|NCT00312897|10852504|FG001|Overall Study|Physician Decision|0
6846016|NCT00312897|10852503|FG000|Overall Study|Withdrawal by Subject|1
6846017|NCT00312897|10852504|FG001|Overall Study|Withdrawal by Subject|3
6846018|NCT00312897|10852503|FG000|Overall Study|Pregnancy|1
6846019|NCT00312897|10852504|FG001|Overall Study|Pregnancy|0
6846020|NCT00312897|10852503|FG000|Overall Study|discontinued prior to getting treatment|0
6846021|NCT00312897|10852504|FG001|Overall Study|discontinued prior to getting treatment|3
6846022|NCT00313014|10852522|FG000|Overall Study|Withdrawal by Subject|11
6846023|NCT00313014|10852523|FG001|Overall Study|Withdrawal by Subject|7
6846024|NCT00313014|10852524|FG002|Overall Study|Withdrawal by Subject|5
6846025|NCT00313014|10852522|FG000|Overall Study|Adverse Event|14
6846026|NCT00313014|10852523|FG001|Overall Study|Adverse Event|29
6846027|NCT00313014|10852524|FG002|Overall Study|Adverse Event|16
6846028|NCT00313014|10852522|FG000|Overall Study|Lost to Follow-up|7
7077393|NCT02091739|11184892|FG000|EP: 48 Weeks|Death|0
7151428|NCT03230864|11315424|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0
6846029|NCT00313014|10852523|FG001|Overall Study|Lost to Follow-up|6
6846030|NCT00313014|10852524|FG002|Overall Study|Lost to Follow-up|10
7077394|NCT02091739|11184893|FG001|EP: 48 Weeks|Death|0
7151429|NCT03230864|11315425|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2
7151430|NCT03230864|11315426|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0
7151431|NCT03231228|11315438|FG000|Overall Study|Lost to Follow-up|2
7151432|NCT03231228|11315439|FG001|Overall Study|Lost to Follow-up|0
7151433|NCT03231228|11315438|FG000|Overall Study|Physician Decision|1
6846031|NCT00313014|10852522|FG000|Overall Study|Administrative|9
6846032|NCT00313014|10852523|FG001|Overall Study|Administrative|6
6846033|NCT00313014|10852524|FG002|Overall Study|Administrative|14
6846034|NCT00313014|10852522|FG000|Overall Study|Lack of Efficacy|52
6846035|NCT00313014|10852523|FG001|Overall Study|Lack of Efficacy|25
6846036|NCT00313014|10852524|FG002|Overall Study|Lack of Efficacy|16
6846037|NCT00313144|10852533|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12
7151434|NCT03231228|11315439|FG001|Overall Study|Physician Decision|0
7151435|NCT03231371|11315449|FG000|Overall Study|Withdrawal by Subject|1
6846038|NCT00313144|10852533|FG000|Overall Study|Death|7
6966497|NCT02198794|11014556|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0
6966498|NCT02198794|11014557|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0
6966499|NCT02198794|11014558|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0
6966500|NCT02198794|11014555|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24
6966501|NCT02198794|11014556|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0
6966502|NCT02198794|11014557|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0
7077395|NCT02091739|11184894|FG002|EP: 48 Weeks|Death|0
7077396|NCT02091739|11184895|FG003|EP: 48 Weeks|Death|3
7077397|NCT02091739|11184896|FG004|EP: 48 Weeks|Death|2
7077398|NCT02091739|11184892|FG000|EP: 48 Weeks|Adverse Event|0
7077399|NCT02091739|11184893|FG001|EP: 48 Weeks|Adverse Event|0
7151436|NCT03231371|11315449|FG000|Overall Study|chose or were ineligible to have MRI|12
6966503|NCT02198794|11014558|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0
6966504|NCT02198794|11014555|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9
6966505|NCT02198794|11014556|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0
6966506|NCT02198794|11014557|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0
6966507|NCT02198794|11014558|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0
6966508|NCT02198794|11014555|FG000|Part A: Open-Label (158 Weeks)|Death|8
6966509|NCT02198794|11014556|FG001|Part A: Open-Label (158 Weeks)|Death|0
6966510|NCT02198794|11014557|FG002|Part A: Open-Label (158 Weeks)|Death|0
6966511|NCT02198794|11014558|FG003|Part A: Open-Label (158 Weeks)|Death|0
6966512|NCT02198794|11014555|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3
6966513|NCT02198794|11014556|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0
6966514|NCT02198794|11014557|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0
6966515|NCT02198794|11014558|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0
6966516|NCT02198794|11014555|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5
6966517|NCT02198794|11014556|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0
6966518|NCT02198794|11014557|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0
6966519|NCT02198794|11014558|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0
6966520|NCT02198794|11014555|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1
6966521|NCT02198794|11014556|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0
6966522|NCT02198794|11014557|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0
6966523|NCT02198794|11014558|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0
6966524|NCT02198794|11014555|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1
6966525|NCT02198794|11014556|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0
6966526|NCT02198794|11014557|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0
6966527|NCT02198794|11014558|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0
6966528|NCT02198794|11014555|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142
6966529|NCT02198794|11014556|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0
6966530|NCT02198794|11014557|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0
6966531|NCT02198794|11014558|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0
6966532|NCT02198794|11014555|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0
6966533|NCT02198794|11014556|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3
6966534|NCT02198794|11014557|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1
6966535|NCT02198794|11014558|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0
6966536|NCT02198794|11014555|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0
6966537|NCT02198794|11014556|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2
6966538|NCT02198794|11014557|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2
6966539|NCT02198794|11014558|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0
6966540|NCT02198794|11014555|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0
6966541|NCT02198794|11014556|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0
6966542|NCT02198794|11014557|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0
6966543|NCT02198794|11014558|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3
6966544|NCT02198794|11014555|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0
6966545|NCT02198794|11014556|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0
6966546|NCT02198794|11014557|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0
6966547|NCT02198794|11014558|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2
6966548|NCT02198794|11014555|FG000|Part C: Safety Assessment (52 Weeks)|Death|0
6966549|NCT02198794|11014556|FG001|Part C: Safety Assessment (52 Weeks)|Death|0
6966550|NCT02198794|11014557|FG002|Part C: Safety Assessment (52 Weeks)|Death|0
6966551|NCT02198794|11014558|FG003|Part C: Safety Assessment (52 Weeks)|Death|2
6966552|NCT01877655|11014569|FG000|Overall Study|Death|57
6966553|NCT01877655|11014570|FG001|Overall Study|Death|52
6966554|NCT01877655|11014569|FG000|Overall Study|Withdrawal by Subject|18
6966555|NCT01877655|11014570|FG001|Overall Study|Withdrawal by Subject|26
6966556|NCT01877655|11014569|FG000|Overall Study|Physician Decision|11
6966557|NCT01877655|11014570|FG001|Overall Study|Physician Decision|10
6966558|NCT01877655|11014569|FG000|Overall Study|Miscellaneous|4
6966559|NCT01877655|11014570|FG001|Overall Study|Miscellaneous|4
6966560|NCT01877655|11014569|FG000|Overall Study|Randomized but Never Received Drug|8
6966561|NCT01877655|11014570|FG001|Overall Study|Randomized but Never Received Drug|5
7077400|NCT02091739|11184894|FG002|EP: 48 Weeks|Adverse Event|0
6846039|NCT00313144|10852533|FG000|Overall Study|Lost to Follow-up|5
6846040|NCT00313144|10852533|FG000|Overall Study|Withdrawal by Subject|4
6846041|NCT00313144|10852533|FG000|Overall Study|Terminated by sponsor/ homecare provider|4
6846042|NCT00313144|10852533|FG000|Overall Study|Physician Decision|4
6846043|NCT00313144|10852533|FG000|Overall Study|Adverse event - transient|5
6846044|NCT00313144|10852533|FG000|Overall Study|Liver transplant|1
6846045|NCT00313144|10852533|FG000|Overall Study|Insurance (homecare provider) change|1
6846046|NCT00313144|10852533|FG000|Overall Study|Change to different product|1
6846047|NCT00313144|10852533|FG000|Overall Study|Due to termination of the study|66
6846048|NCT00313170|10852549|FG000|Overall Study|Death|2
6846049|NCT00313170|10852550|FG001|Overall Study|Death|4
6846050|NCT00313170|10852551|FG002|Overall Study|Death|2
6846051|NCT00313170|10852549|FG000|Overall Study|Adverse Event|1
6846052|NCT00313170|10852550|FG001|Overall Study|Adverse Event|2
6846053|NCT00313170|10852551|FG002|Overall Study|Adverse Event|0
6846054|NCT00313170|10852549|FG000|Overall Study|Disease progression|31
6846055|NCT00313170|10852550|FG001|Overall Study|Disease progression|26
6846056|NCT00313170|10852551|FG002|Overall Study|Disease progression|27
6846057|NCT00313170|10852549|FG000|Overall Study|Withdrawal by Subject|1
6846058|NCT00313170|10852550|FG001|Overall Study|Withdrawal by Subject|0
6846059|NCT00313170|10852551|FG002|Overall Study|Withdrawal by Subject|1
6846060|NCT00313170|10852549|FG000|Overall Study|Incorrect enrollment|0
6846061|NCT00313170|10852550|FG001|Overall Study|Incorrect enrollment|2
6846062|NCT00313170|10852551|FG002|Overall Study|Incorrect enrollment|1
6846063|NCT00313170|10852549|FG000|Overall Study|Lost to Follow-up|0
6846064|NCT00313170|10852550|FG001|Overall Study|Lost to Follow-up|0
6846065|NCT00313170|10852551|FG002|Overall Study|Lost to Follow-up|1
6846066|NCT00313170|10852549|FG000|Overall Study|Progression (investigators opinion)|1
6846067|NCT00313170|10852550|FG001|Overall Study|Progression (investigators opinion)|0
6846068|NCT00313170|10852551|FG002|Overall Study|Progression (investigators opinion)|0
6846069|NCT00313300|10852574|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19
6846070|NCT00313300|10852575|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14
6846071|NCT00313300|10852576|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17
6846072|NCT00313300|10852577|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0
6846073|NCT00313300|10852578|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0
6846074|NCT00313300|10852574|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20
6846075|NCT00313300|10852575|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12
6846076|NCT00313300|10852576|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13
6846077|NCT00313300|10852577|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
6846078|NCT00313300|10852578|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
6846079|NCT00313300|10852574|FG000|Randomized in Phase A (26 Weeks)|Death|3
6846080|NCT00313300|10852575|FG001|Randomized in Phase A (26 Weeks)|Death|4
6846081|NCT00313300|10852576|FG002|Randomized in Phase A (26 Weeks)|Death|0
6846082|NCT00313300|10852577|FG003|Randomized in Phase A (26 Weeks)|Death|0
6846083|NCT00313300|10852578|FG004|Randomized in Phase A (26 Weeks)|Death|0
6846084|NCT00313300|10852574|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
6846085|NCT00313300|10852575|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
6846086|NCT00313300|10852576|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2
6846087|NCT00313300|10852577|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
6846088|NCT00313300|10852578|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
6846089|NCT00313300|10852574|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3
6846090|NCT00313300|10852575|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2
6846091|NCT00313300|10852576|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1
6846092|NCT00313300|10852577|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
6846093|NCT00313300|10852578|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
6846094|NCT00313300|10852574|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4
6846095|NCT00313300|10852575|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3
6846096|NCT00313300|10852576|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2
6846097|NCT00313300|10852577|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
6846098|NCT00313300|10852578|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
6846099|NCT00313300|10852574|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1
6846100|NCT00313300|10852575|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
6846101|NCT00313300|10852576|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
6846102|NCT00313300|10852577|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
6846103|NCT00313300|10852578|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
6846104|NCT00313300|10852574|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34
6846105|NCT00313300|10852575|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9
6846106|NCT00313300|10852576|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12
6846107|NCT00313300|10852577|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23
6846108|NCT00313300|10852578|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19
6846109|NCT00313300|10852574|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35
6846110|NCT00313300|10852575|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14
6846111|NCT00313300|10852576|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
6846112|NCT00313300|10852577|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15
6966562|NCT00308685|11014578|FG000|Overall Study|Lost to Follow-up|1
6846113|NCT00313300|10852578|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
6846114|NCT00313300|10852574|FG000|Randomized in Phase B (26 Weeks)|Death|5
6846115|NCT00313300|10852575|FG001|Randomized in Phase B (26 Weeks)|Death|3
6846116|NCT00313300|10852576|FG002|Randomized in Phase B (26 Weeks)|Death|1
6846117|NCT00313300|10852577|FG003|Randomized in Phase B (26 Weeks)|Death|0
6846118|NCT00313300|10852578|FG004|Randomized in Phase B (26 Weeks)|Death|1
6846119|NCT00313300|10852574|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5
6846120|NCT00313300|10852575|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
6846121|NCT00313300|10852576|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
6846122|NCT00313300|10852577|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
6846123|NCT00313300|10852578|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
6846124|NCT00313300|10852574|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
6846125|NCT00313300|10852575|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1
6846126|NCT00313300|10852576|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
6846127|NCT00313300|10852577|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
6846128|NCT00313300|10852578|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
6846129|NCT00313300|10852574|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9
6846130|NCT00313300|10852575|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3
6846131|NCT00313300|10852576|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
6846132|NCT00313300|10852577|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0
6846133|NCT00313300|10852578|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
6846134|NCT00313300|10852574|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2
6846135|NCT00313300|10852575|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1
6846136|NCT00313300|10852576|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0
6846137|NCT00313300|10852577|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193
6846138|NCT00313300|10852578|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164
6846139|NCT00313300|10852574|FG000|Randomized in Phase B (26 Weeks)|non-specified|1
6846140|NCT00313300|10852575|FG001|Randomized in Phase B (26 Weeks)|non-specified|0
6846141|NCT00313300|10852576|FG002|Randomized in Phase B (26 Weeks)|non-specified|0
6846142|NCT00313300|10852577|FG003|Randomized in Phase B (26 Weeks)|non-specified|0
6846143|NCT00313300|10852578|FG004|Randomized in Phase B (26 Weeks)|non-specified|0
6846144|NCT00313300|10852574|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
6846145|NCT00313300|10852575|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
6846146|NCT00313300|10852576|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2
6846147|NCT00313300|10852577|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
6846148|NCT00313300|10852578|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
6846149|NCT00313300|10852574|FG000|Follow-Up(30days)-Randomized Phase A|Death|0
6846150|NCT00313300|10852575|FG001|Follow-Up(30days)-Randomized Phase A|Death|1
6846151|NCT00313300|10852576|FG002|Follow-Up(30days)-Randomized Phase A|Death|0
6846152|NCT00313300|10852577|FG003|Follow-Up(30days)-Randomized Phase A|Death|0
6846153|NCT00313300|10852578|FG004|Follow-Up(30days)-Randomized Phase A|Death|0
6846154|NCT00313300|10852574|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
6846155|NCT00313300|10852575|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0
6846156|NCT00313300|10852576|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2
6846157|NCT00313300|10852577|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
6846158|NCT00313300|10852578|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
6846159|NCT00313300|10852574|FG000|Follow-Up(30days)-Randomized Phase B|Death|1
6846160|NCT00313300|10852575|FG001|Follow-Up(30days)-Randomized Phase B|Death|0
6846161|NCT00313300|10852576|FG002|Follow-Up(30days)-Randomized Phase B|Death|0
6846162|NCT00313300|10852577|FG003|Follow-Up(30days)-Randomized Phase B|Death|0
6846163|NCT00313300|10852578|FG004|Follow-Up(30days)-Randomized Phase B|Death|0
6846164|NCT00313300|10852574|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
6846165|NCT00313300|10852575|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
6846166|NCT00313300|10852576|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
6846167|NCT00313300|10852577|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2
6846168|NCT00313300|10852578|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1
6846169|NCT00313300|10852574|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1
6846170|NCT00313300|10852575|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
6846171|NCT00313300|10852576|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
6846172|NCT00313300|10852577|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2
6846173|NCT00313300|10852578|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
6846174|NCT00313313|10852599|FG000|Overall Study|Lack of Efficacy|14
6846175|NCT00313313|10852600|FG001|Overall Study|Lack of Efficacy|9
6846176|NCT00313313|10852601|FG002|Overall Study|Lack of Efficacy|20
6846177|NCT00313313|10852599|FG000|Overall Study|Withdrawal of consent by subject|18
6846178|NCT00313313|10852600|FG001|Overall Study|Withdrawal of consent by subject|17
6846179|NCT00313313|10852601|FG002|Overall Study|Withdrawal of consent by subject|31
6846180|NCT00313313|10852599|FG000|Overall Study|Lost to Follow-up|10
6846181|NCT00313313|10852600|FG001|Overall Study|Lost to Follow-up|7
6846182|NCT00313313|10852601|FG002|Overall Study|Lost to Follow-up|9
6846183|NCT00313313|10852599|FG000|Overall Study|Adverse Event|15
6846184|NCT00313313|10852600|FG001|Overall Study|Adverse Event|16
6846185|NCT00313313|10852601|FG002|Overall Study|Adverse Event|12
6846186|NCT00313313|10852599|FG000|Overall Study|Physician Decision|2
6846187|NCT00313313|10852600|FG001|Overall Study|Physician Decision|6
6846188|NCT00313313|10852601|FG002|Overall Study|Physician Decision|4
6846189|NCT00313313|10852599|FG000|Overall Study|Poor/Noncompliance|3
6846190|NCT00313313|10852600|FG001|Overall Study|Poor/Noncompliance|6
6846191|NCT00313313|10852601|FG002|Overall Study|Poor/Noncompliance|2
6846192|NCT00313313|10852599|FG000|Overall Study|Pregnancy|1
6846193|NCT00313313|10852600|FG001|Overall Study|Pregnancy|2
6846194|NCT00313313|10852601|FG002|Overall Study|Pregnancy|0
6846195|NCT00313313|10852599|FG000|Overall Study|Death|0
6846196|NCT00313313|10852600|FG001|Overall Study|Death|0
6846197|NCT00313313|10852601|FG002|Overall Study|Death|2
6846198|NCT00313313|10852599|FG000|Overall Study|Subject No Longer Meets Study Criteria|0
6846199|NCT00313313|10852600|FG001|Overall Study|Subject No Longer Meets Study Criteria|3
6846200|NCT00313313|10852601|FG002|Overall Study|Subject No Longer Meets Study Criteria|2
6846201|NCT00313586|10852625|FG000|Overall Study|Disease progression|14
6846202|NCT00313586|10852626|FG001|Overall Study|Disease progression|19
6846203|NCT00313586|10852627|FG002|Overall Study|Disease progression|10
6846204|NCT00313586|10852628|FG003|Overall Study|Disease progression|3
6846205|NCT00313586|10852625|FG000|Overall Study|Adverse Event|12
6846206|NCT00313586|10852626|FG001|Overall Study|Adverse Event|18
6846207|NCT00313586|10852627|FG002|Overall Study|Adverse Event|3
6846208|NCT00313586|10852628|FG003|Overall Study|Adverse Event|10
6846209|NCT00313586|10852625|FG000|Overall Study|Death|11
6846210|NCT00313586|10852626|FG001|Overall Study|Death|8
6846211|NCT00313586|10852627|FG002|Overall Study|Death|1
6846212|NCT00313586|10852628|FG003|Overall Study|Death|7
6846213|NCT00313586|10852625|FG000|Overall Study|Withdrawal by Subject|13
6846214|NCT00313586|10852626|FG001|Overall Study|Withdrawal by Subject|6
6846215|NCT00313586|10852627|FG002|Overall Study|Withdrawal by Subject|6
6846216|NCT00313586|10852628|FG003|Overall Study|Withdrawal by Subject|2
6846217|NCT00313586|10852625|FG000|Overall Study|Alternative therapy|3
6846218|NCT00313586|10852626|FG001|Overall Study|Alternative therapy|6
6846219|NCT00313586|10852627|FG002|Overall Study|Alternative therapy|2
6846220|NCT00313586|10852628|FG003|Overall Study|Alternative therapy|0
6846221|NCT00313586|10852625|FG000|Overall Study|Other complicating disease|2
6846222|NCT00313586|10852626|FG001|Overall Study|Other complicating disease|2
6846223|NCT00313586|10852627|FG002|Overall Study|Other complicating disease|0
6846224|NCT00313586|10852628|FG003|Overall Study|Other complicating disease|0
6846225|NCT00313586|10852625|FG000|Overall Study|Did not achieve HI-major/better response|10
6846226|NCT00313586|10852626|FG001|Overall Study|Did not achieve HI-major/better response|7
6846227|NCT00313586|10852627|FG002|Overall Study|Did not achieve HI-major/better response|2
6846228|NCT00313586|10852628|FG003|Overall Study|Did not achieve HI-major/better response|1
6846229|NCT00313586|10852625|FG000|Overall Study|Physician Decision|2
6846230|NCT00313586|10852626|FG001|Overall Study|Physician Decision|1
6846231|NCT00313586|10852627|FG002|Overall Study|Physician Decision|0
6846232|NCT00313586|10852628|FG003|Overall Study|Physician Decision|0
6846233|NCT00313586|10852625|FG000|Overall Study|Absolute neutrophil count not recovered|2
6846234|NCT00313586|10852626|FG001|Overall Study|Absolute neutrophil count not recovered|1
6846235|NCT00313586|10852627|FG002|Overall Study|Absolute neutrophil count not recovered|0
6846236|NCT00313586|10852628|FG003|Overall Study|Absolute neutrophil count not recovered|0
6846237|NCT00313586|10852625|FG000|Overall Study|Lost insurance|0
6846238|NCT00313586|10852626|FG001|Overall Study|Lost insurance|1
6846239|NCT00313586|10852627|FG002|Overall Study|Lost insurance|0
6846240|NCT00313586|10852628|FG003|Overall Study|Lost insurance|0
6846241|NCT00313586|10852625|FG000|Overall Study|Moved|0
6846242|NCT00313586|10852626|FG001|Overall Study|Moved|1
6846243|NCT00313586|10852627|FG002|Overall Study|Moved|0
6846244|NCT00313586|10852628|FG003|Overall Study|Moved|0
6846245|NCT00313586|10852625|FG000|Overall Study|Death before starting treatment|1
6846246|NCT00313586|10852626|FG001|Overall Study|Death before starting treatment|0
6846247|NCT00313586|10852627|FG002|Overall Study|Death before starting treatment|0
6846248|NCT00313586|10852628|FG003|Overall Study|Death before starting treatment|0
6846249|NCT00313612|10852638|FG000|Overall Study|Patient never received treatment|0
6846250|NCT00313612|10852639|FG001|Overall Study|Patient never received treatment|1
6846251|NCT00313703|10852649|FG000|Overall Study|Lost to Follow-up|11
6846252|NCT00313703|10852650|FG001|Overall Study|Lost to Follow-up|2
6846253|NCT00313703|10852651|FG002|Overall Study|Lost to Follow-up|5
6846254|NCT00313703|10852652|FG003|Overall Study|Lost to Follow-up|12
6846255|NCT00313716|10852668|FG000|Overall Study|Death|3
6846256|NCT00313716|10852669|FG001|Overall Study|Death|2
6846257|NCT00313716|10852670|FG002|Overall Study|Death|9
6846258|NCT00313716|10852671|FG003|Overall Study|Death|3
6846259|NCT00313716|10852672|FG004|Overall Study|Death|5
6846260|NCT00313716|10852673|FG005|Overall Study|Death|9
6846261|NCT00313716|10852668|FG000|Overall Study|Lost to Follow-up|2
6846262|NCT00313716|10852669|FG001|Overall Study|Lost to Follow-up|5
6846263|NCT00313716|10852670|FG002|Overall Study|Lost to Follow-up|2
6846264|NCT00313716|10852671|FG003|Overall Study|Lost to Follow-up|1
6846265|NCT00313716|10852672|FG004|Overall Study|Lost to Follow-up|0
6846266|NCT00313716|10852673|FG005|Overall Study|Lost to Follow-up|4
6846267|NCT00313716|10852668|FG000|Overall Study|Withdrawal by Subject|0
6846268|NCT00313716|10852669|FG001|Overall Study|Withdrawal by Subject|1
6846269|NCT00313716|10852670|FG002|Overall Study|Withdrawal by Subject|1
6846270|NCT00313716|10852671|FG003|Overall Study|Withdrawal by Subject|0
6846271|NCT00313716|10852672|FG004|Overall Study|Withdrawal by Subject|1
6846272|NCT00313716|10852673|FG005|Overall Study|Withdrawal by Subject|0
6846273|NCT00313781|10852697|FG000|Before Crossover|Death|22
6846274|NCT00313781|10852698|FG001|Before Crossover|Death|8
6846275|NCT00313781|10852699|FG002|Before Crossover|Death|0
6846276|NCT00313781|10852697|FG000|Before Crossover|Lost to Follow-up|0
6846277|NCT00313781|10852698|FG001|Before Crossover|Lost to Follow-up|3
6846278|NCT00313781|10852699|FG002|Before Crossover|Lost to Follow-up|0
6846279|NCT00313781|10852697|FG000|Before Crossover|Withdrawal by Subject|3
6846280|NCT00313781|10852698|FG001|Before Crossover|Withdrawal by Subject|1
6846281|NCT00313781|10852699|FG002|Before Crossover|Withdrawal by Subject|0
6846282|NCT00313781|10852697|FG000|Before Crossover|Other|45
6846283|NCT00313781|10852698|FG001|Before Crossover|Other|30
6846284|NCT00313781|10852699|FG002|Before Crossover|Other|0
6846285|NCT00313781|10852697|FG000|Before Crossover|Crossover|0
6846286|NCT00313781|10852698|FG001|Before Crossover|Crossover|37
6846287|NCT00313781|10852699|FG002|Before Crossover|Crossover|0
6846288|NCT00313781|10852697|FG000|Before Crossover|Randomized, not treated|5
6846289|NCT00313781|10852698|FG001|Before Crossover|Randomized, not treated|0
6846290|NCT00313781|10852699|FG002|Before Crossover|Randomized, not treated|0
6846291|NCT00313781|10852697|FG000|After Crossover|Death|0
6846292|NCT00313781|10852698|FG001|After Crossover|Death|0
6846293|NCT00313781|10852699|FG002|After Crossover|Death|6
6846294|NCT00313781|10852697|FG000|After Crossover|Withdrawal by Subject|0
6846295|NCT00313781|10852698|FG001|After Crossover|Withdrawal by Subject|0
6846296|NCT00313781|10852699|FG002|After Crossover|Withdrawal by Subject|3
6846297|NCT00313781|10852697|FG000|After Crossover|Other|0
6846298|NCT00313781|10852698|FG001|After Crossover|Other|0
6846299|NCT00313781|10852699|FG002|After Crossover|Other|18
6846300|NCT00313820|10852710|FG000|Assigned to Treatment|Other|1
6846301|NCT00313820|10852711|FG001|Assigned to Treatment|Other|0
6846302|NCT00313820|10852710|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9
6846303|NCT00313820|10852711|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4
6846304|NCT00313820|10852710|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0
6846305|NCT00313820|10852711|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1
6846306|NCT00313820|10852710|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0
6846307|NCT00313820|10852711|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7
6846308|NCT00313820|10852710|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6
6846309|NCT00313820|10852711|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4
6846310|NCT00313820|10852710|FG000|Pregabalin or Placebo Treatment Period|Other|2
6846311|NCT00313820|10852711|FG001|Pregabalin or Placebo Treatment Period|Other|3
6846312|NCT00313846|10852719|FG000|Overall Study|Withdrawal by Subject|2
6846313|NCT00313846|10852720|FG001|Overall Study|Withdrawal by Subject|0
6846314|NCT00313846|10852719|FG000|Overall Study|Adverse Event|1
6846315|NCT00313846|10852720|FG001|Overall Study|Adverse Event|8
6846316|NCT00313846|10852719|FG000|Overall Study|Administrative|2
6846317|NCT00313846|10852720|FG001|Overall Study|Administrative|3
6846318|NCT00313911|10852729|FG000|Overall Study|Serious adverse event|6
6846319|NCT00313911|10852730|FG001|Overall Study|Serious adverse event|1
6846320|NCT00313911|10852729|FG000|Overall Study|Adverse Event|2
6846321|NCT00313911|10852730|FG001|Overall Study|Adverse Event|3
6846322|NCT00313911|10852729|FG000|Overall Study|Protocol Violation|19
6846323|NCT00313911|10852730|FG001|Overall Study|Protocol Violation|10
6846324|NCT00313911|10852729|FG000|Overall Study|Lost to Follow-up|27
6846325|NCT00313911|10852730|FG001|Overall Study|Lost to Follow-up|14
6846326|NCT00313911|10852729|FG000|Overall Study|Withdrawal by Subject|39
6846327|NCT00313911|10852730|FG001|Overall Study|Withdrawal by Subject|12
6846328|NCT00313911|10852729|FG000|Overall Study|Did not meet age criteria|1
6846329|NCT00313911|10852730|FG001|Overall Study|Did not meet age criteria|1
6846330|NCT00314132|10852747|FG000|Overall Study|Lost to Follow-up|3
6846331|NCT00314132|10852748|FG001|Overall Study|Lost to Follow-up|13
6846332|NCT00314132|10852747|FG000|Overall Study|Withdrawal by Subject|3
6846333|NCT00314132|10852748|FG001|Overall Study|Withdrawal by Subject|5
6846334|NCT00314132|10852747|FG000|Overall Study|Adverse Event|1
6846335|NCT00314132|10852748|FG001|Overall Study|Adverse Event|0
6846336|NCT00314132|10852747|FG000|Overall Study|Physician Decision|1
6846337|NCT00314132|10852748|FG001|Overall Study|Physician Decision|0
6846338|NCT00314145|10852758|FG000|Overall Study|Withdrawal by Subject|8
6846339|NCT00314145|10852759|FG001|Overall Study|Withdrawal by Subject|10
6846340|NCT00314145|10852758|FG000|Overall Study|Lost to Follow-up|5
6846341|NCT00314145|10852759|FG001|Overall Study|Lost to Follow-up|12
6846342|NCT00314145|10852758|FG000|Overall Study|Physician Decision|3
6846343|NCT00314145|10852759|FG001|Overall Study|Physician Decision|4
6846344|NCT00314145|10852758|FG000|Overall Study|Adverse Event|0
6846345|NCT00314145|10852759|FG001|Overall Study|Adverse Event|3
6846346|NCT00314145|10852758|FG000|Overall Study|Protocol Violation|3
6846347|NCT00314145|10852759|FG001|Overall Study|Protocol Violation|0
6846348|NCT00314145|10852758|FG000|Overall Study|Sponsor Decision|2
6846349|NCT00314145|10852759|FG001|Overall Study|Sponsor Decision|0
6846350|NCT00314249|10852777|FG000|Overall Study|Adverse Event|73
6846351|NCT00314249|10852778|FG001|Overall Study|Adverse Event|94
6846352|NCT00314249|10852777|FG000|Overall Study|Lack of Efficacy|33
6846353|NCT00314249|10852778|FG001|Overall Study|Lack of Efficacy|24
6846354|NCT00314249|10852777|FG000|Overall Study|Withdrawal by Subject|21
6846355|NCT00314249|10852778|FG001|Overall Study|Withdrawal by Subject|28
6846356|NCT00314249|10852777|FG000|Overall Study|Lost to Follow-up|15
6846357|NCT00314249|10852778|FG001|Overall Study|Lost to Follow-up|9
6846358|NCT00314249|10852777|FG000|Overall Study|Physician Decision|1
6846359|NCT00314249|10852778|FG001|Overall Study|Physician Decision|1
6846360|NCT00314249|10852777|FG000|Overall Study|Withdrawn for other reasons|4
6846361|NCT00314249|10852778|FG001|Overall Study|Withdrawn for other reasons|1
6846362|NCT00314249|10852777|FG000|Overall Study|Non-Compliant|5
6846363|NCT00314249|10852778|FG001|Overall Study|Non-Compliant|6
6846364|NCT00314262|10852784|FG000|Overall Study|Adverse Event|2
6846365|NCT00314262|10852784|FG000|Overall Study|Withdrawal by Subject|2
6846366|NCT00314262|10852784|FG000|Overall Study|Physician Decision|1
6846367|NCT00314340|10852788|FG000|Overall Study|lost interest|1
6846368|NCT00314574|10852796|FG000|Overall Study|Death|3
6846369|NCT00314574|10852797|FG001|Overall Study|Death|0
6846370|NCT00314574|10852796|FG000|Overall Study|Adverse Event|11
6846371|NCT00314574|10852797|FG001|Overall Study|Adverse Event|16
6846372|NCT00314574|10852796|FG000|Overall Study|Lost to Follow-up|19
6846373|NCT00314574|10852797|FG001|Overall Study|Lost to Follow-up|25
6846374|NCT00314574|10852796|FG000|Overall Study|Withdrawal by Subject|33
6846375|NCT00314574|10852797|FG001|Overall Study|Withdrawal by Subject|22
6846376|NCT00314574|10852796|FG000|Overall Study|Physician Decision|22
6846377|NCT00314574|10852797|FG001|Overall Study|Physician Decision|15
6846378|NCT00314574|10852796|FG000|Overall Study|Pregnancy|6
6846379|NCT00314574|10852797|FG001|Overall Study|Pregnancy|4
6846380|NCT00314574|10852796|FG000|Overall Study|Data unknown at database lock|0
6846381|NCT00314574|10852797|FG001|Overall Study|Data unknown at database lock|1
6846382|NCT00314795|10852803|FG000|Overall Study|Adverse Event|8
6846383|NCT00314795|10852803|FG000|Overall Study|Death|4
6846384|NCT00314795|10852803|FG000|Overall Study|Reason not Specified|3
6846385|NCT00314795|10852803|FG000|Overall Study|Renal Transplant|3
6846386|NCT00314795|10852803|FG000|Overall Study|Participants Withdrew Consent|2
6846387|NCT00314808|10852807|FG000|Overall Study|Disease Progression without AE|4
6846388|NCT00314808|10852807|FG000|Overall Study|Withdrawal by Subject/PI without AE|4
6846389|NCT00314951|10852813|FG000|Treatment|Didn't meet criteria for mITT population|16
6846390|NCT00314951|10852814|FG001|Treatment|Didn't meet criteria for mITT population|11
6846391|NCT00314951|10852813|FG000|Follow-up|mITT failure|44
6846392|NCT00314951|10852814|FG001|Follow-up|mITT failure|34
6846393|NCT00315055|10852822|FG000|Overall Study|Protocol Violation|2
6846394|NCT00315055|10852823|FG001|Overall Study|Protocol Violation|4
6846395|NCT00315055|10852822|FG000|Overall Study|Lost to Follow-up|1
6846396|NCT00315055|10852823|FG001|Overall Study|Lost to Follow-up|1
6846397|NCT00315445|10852918|FG000|Overall Study|Adverse Event|7
6846398|NCT00315445|10852919|FG001|Overall Study|Adverse Event|12
6846399|NCT00315445|10852920|FG002|Overall Study|Adverse Event|15
6846400|NCT00315445|10852918|FG000|Overall Study|Lack of Efficacy|16
6846401|NCT00315445|10852919|FG001|Overall Study|Lack of Efficacy|1
6846402|NCT00315445|10852920|FG002|Overall Study|Lack of Efficacy|7
6846403|NCT00315445|10852918|FG000|Overall Study|Lost to Follow-up|1
6846404|NCT00315445|10852919|FG001|Overall Study|Lost to Follow-up|0
6846405|NCT00315445|10852920|FG002|Overall Study|Lost to Follow-up|1
6846406|NCT00315445|10852918|FG000|Overall Study|Protocol Violation|2
6846407|NCT00315445|10852919|FG001|Overall Study|Protocol Violation|0
6846408|NCT00315445|10852920|FG002|Overall Study|Protocol Violation|1
6846409|NCT00315445|10852918|FG000|Overall Study|Other|1
6846410|NCT00315445|10852919|FG001|Overall Study|Other|3
6846411|NCT00315445|10852920|FG002|Overall Study|Other|0
6846412|NCT00315458|10852930|FG000|Overall Study|Administrative|0
6846413|NCT00315458|10852931|FG001|Overall Study|Administrative|3
6846414|NCT00315458|10852932|FG002|Overall Study|Administrative|8
6846415|NCT00315458|10852933|FG003|Overall Study|Administrative|21
6846416|NCT00315458|10852930|FG000|Overall Study|Adverse Event|2
6846417|NCT00315458|10852931|FG001|Overall Study|Adverse Event|4
6846418|NCT00315458|10852932|FG002|Overall Study|Adverse Event|23
6846419|NCT00315458|10852933|FG003|Overall Study|Adverse Event|3
6846420|NCT00315458|10852930|FG000|Overall Study|Lost to Follow-up|1
6846421|NCT00315458|10852931|FG001|Overall Study|Lost to Follow-up|2
6846422|NCT00315458|10852932|FG002|Overall Study|Lost to Follow-up|0
6846423|NCT00315458|10852933|FG003|Overall Study|Lost to Follow-up|2
6846424|NCT00315458|10852930|FG000|Overall Study|Withdrawal by Subject|0
6846425|NCT00315458|10852931|FG001|Overall Study|Withdrawal by Subject|3
6846426|NCT00315458|10852932|FG002|Overall Study|Withdrawal by Subject|0
6846427|NCT00315458|10852933|FG003|Overall Study|Withdrawal by Subject|2
6846428|NCT00315458|10852930|FG000|Overall Study|Lack of Efficacy|0
6846429|NCT00315458|10852931|FG001|Overall Study|Lack of Efficacy|0
6846430|NCT00315458|10852932|FG002|Overall Study|Lack of Efficacy|20
6846431|NCT00315458|10852933|FG003|Overall Study|Lack of Efficacy|1
6846432|NCT00315458|10852930|FG000|Overall Study|Did not qualify|0
6846433|NCT00315458|10852931|FG001|Overall Study|Did not qualify|0
6846434|NCT00315458|10852932|FG002|Overall Study|Did not qualify|1
6846435|NCT00315458|10852933|FG003|Overall Study|Did not qualify|0
6846436|NCT00315705|10852962|FG000|Phase 1|Refused further treatment|1
6846437|NCT00315705|10852962|FG000|Phase 1|Failure to achieve response|8
6846438|NCT00315705|10852962|FG000|Phase 1|Disease relapse|4
6846439|NCT00315705|10852962|FG000|Phase 1|Scheduled for transplant|9
6846440|NCT00315705|10852962|FG000|Phase 1|Death|3
6846441|NCT00315705|10852962|FG000|Phase 2|Physician Decision|4
6846442|NCT00315705|10852962|FG000|Phase 2|Adverse Event|1
6846443|NCT00315705|10852962|FG000|Phase 2|Failure to achieve response|3
6846444|NCT00315705|10852962|FG000|Phase 2|Disease relapse|1
6846445|NCT00315705|10852962|FG000|Phase 2|Scheduled for transplant|8
6846446|NCT00315705|10852962|FG000|Phase 2|Other|1
6846447|NCT00315705|10852962|FG000|Phase 2|Death|7
6846448|NCT00315731|10852979|FG000|Overall Study|Lost to Follow-up|1
6846449|NCT00315731|10852979|FG000|Overall Study|Death|5
6846450|NCT00316004|10853005|FG000|Overall Study|Subject was not given study fluid.|14
6846451|NCT00316004|10853006|FG001|Overall Study|Subject was not given study fluid.|14
6846452|NCT00316004|10853007|FG002|Overall Study|Subject was not given study fluid.|21
6846453|NCT00316017|10853018|FG000|Overall Study|Protocol Violation|11
6846454|NCT00316017|10853019|FG001|Overall Study|Protocol Violation|13
6846455|NCT00316017|10853020|FG002|Overall Study|Protocol Violation|19
6846456|NCT00316082|10853033|FG000|Overall Study|Lack of Efficacy|2
6846457|NCT00316082|10853034|FG001|Overall Study|Lack of Efficacy|3
6846458|NCT00316082|10853035|FG002|Overall Study|Lack of Efficacy|3
6846459|NCT00316082|10853036|FG003|Overall Study|Lack of Efficacy|4
6846460|NCT00316082|10853037|FG004|Overall Study|Lack of Efficacy|6
6846461|NCT00316082|10853033|FG000|Overall Study|Withdrawal of Consent by Subject|10
6846462|NCT00316082|10853034|FG001|Overall Study|Withdrawal of Consent by Subject|8
6846463|NCT00316082|10853035|FG002|Overall Study|Withdrawal of Consent by Subject|2
6846464|NCT00316082|10853036|FG003|Overall Study|Withdrawal of Consent by Subject|9
6846465|NCT00316082|10853037|FG004|Overall Study|Withdrawal of Consent by Subject|5
6846466|NCT00316082|10853033|FG000|Overall Study|Lost to Follow-up|7
6846467|NCT00316082|10853034|FG001|Overall Study|Lost to Follow-up|6
6846468|NCT00316082|10853035|FG002|Overall Study|Lost to Follow-up|7
6846469|NCT00316082|10853036|FG003|Overall Study|Lost to Follow-up|8
6846470|NCT00316082|10853037|FG004|Overall Study|Lost to Follow-up|6
6846471|NCT00316082|10853033|FG000|Overall Study|Poor/noncompliance|6
6846472|NCT00316082|10853034|FG001|Overall Study|Poor/noncompliance|1
6846473|NCT00316082|10853035|FG002|Overall Study|Poor/noncompliance|4
6846474|NCT00316082|10853036|FG003|Overall Study|Poor/noncompliance|1
6846475|NCT00316082|10853037|FG004|Overall Study|Poor/noncompliance|4
6846476|NCT00316082|10853033|FG000|Overall Study|Adverse Event|4
6846477|NCT00316082|10853034|FG001|Overall Study|Adverse Event|2
7151437|NCT03231709|11315455|FG000|Treatment Period 1|Reason not Specified|0
7151438|NCT03231709|11315456|FG001|Treatment Period 1|Reason not Specified|1
7151439|NCT03231709|11315455|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0
7151440|NCT03231709|11315456|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1
7151441|NCT03231800|11315468|FG000|Overall Study|Lost to Follow-up|0
7151442|NCT03231800|11315469|FG001|Overall Study|Lost to Follow-up|2
6846478|NCT00316082|10853035|FG002|Overall Study|Adverse Event|5
6846479|NCT00316082|10853036|FG003|Overall Study|Adverse Event|1
6846480|NCT00316082|10853037|FG004|Overall Study|Adverse Event|3
6846481|NCT00316082|10853033|FG000|Overall Study|Subject no longer meets study criteria|3
6846482|NCT00316082|10853034|FG001|Overall Study|Subject no longer meets study criteria|1
6846483|NCT00316082|10853035|FG002|Overall Study|Subject no longer meets study criteria|2
6846484|NCT00316082|10853036|FG003|Overall Study|Subject no longer meets study criteria|2
6846485|NCT00316082|10853037|FG004|Overall Study|Subject no longer meets study criteria|1
6846486|NCT00316082|10853033|FG000|Overall Study|Physician Decision|1
6846487|NCT00316082|10853034|FG001|Overall Study|Physician Decision|1
6846488|NCT00316082|10853035|FG002|Overall Study|Physician Decision|2
6846489|NCT00316082|10853036|FG003|Overall Study|Physician Decision|1
6846490|NCT00316082|10853037|FG004|Overall Study|Physician Decision|1
6846491|NCT00316082|10853033|FG000|Overall Study|Death|0
6846492|NCT00316082|10853034|FG001|Overall Study|Death|0
6846493|NCT00316082|10853035|FG002|Overall Study|Death|1
6846494|NCT00316082|10853036|FG003|Overall Study|Death|0
6846495|NCT00316082|10853037|FG004|Overall Study|Death|0
6846496|NCT00316082|10853033|FG000|Overall Study|Administrative reason by sponsor|0
6846497|NCT00316082|10853034|FG001|Overall Study|Administrative reason by sponsor|0
6846498|NCT00316082|10853035|FG002|Overall Study|Administrative reason by sponsor|1
6846499|NCT00316082|10853036|FG003|Overall Study|Administrative reason by sponsor|0
6846500|NCT00316082|10853037|FG004|Overall Study|Administrative reason by sponsor|0
6846501|NCT00316121|10853055|FG000|Overall Study|Death|1
6846502|NCT00316121|10853056|FG001|Overall Study|Death|0
6846503|NCT00316121|10853055|FG000|Overall Study|Lost to Follow-up|14
6846504|NCT00316121|10853056|FG001|Overall Study|Lost to Follow-up|8
6846505|NCT00316121|10853055|FG000|Overall Study|Withdrawal by Subject|2
6846506|NCT00316121|10853056|FG001|Overall Study|Withdrawal by Subject|0
6846507|NCT00316121|10853055|FG000|Overall Study|Reason is missing|1
7151443|NCT03231800|11315468|FG000|Overall Study|Protocol Violation|1
6846508|NCT00316121|10853056|FG001|Overall Study|Reason is missing|0
6846509|NCT00316121|10853055|FG000|Overall Study|Subject relocated|1
6846510|NCT00316121|10853056|FG001|Overall Study|Subject relocated|1
6846511|NCT00316121|10853055|FG000|Overall Study|Subject refused to return|1
6846512|NCT00316121|10853056|FG001|Overall Study|Subject refused to return|0
6846513|NCT00316121|10853055|FG000|Overall Study|Subject no show for visit x 3|1
6846514|NCT00316121|10853056|FG001|Overall Study|Subject no show for visit x 3|0
6846515|NCT00316121|10853055|FG000|Overall Study|Subject did not have 24 month visit|1
6846516|NCT00316121|10853056|FG001|Overall Study|Subject did not have 24 month visit|0
7151444|NCT03231800|11315469|FG001|Overall Study|Protocol Violation|1
6846517|NCT00316173|10853064|FG000|Run-in Phase|Adverse Event|1
6846518|NCT00316173|10853065|FG001|Run-in Phase|Adverse Event|0
6846519|NCT00316173|10853064|FG000|Run-in Phase|Protocol Violation|1
6846520|NCT00316173|10853065|FG001|Run-in Phase|Protocol Violation|0
6846521|NCT00316173|10853064|FG000|Run-in Phase|Study Follow-up Stopped|5
6846522|NCT00316173|10853065|FG001|Run-in Phase|Study Follow-up Stopped|0
6846523|NCT00316173|10853064|FG000|Treatment Phase|Adverse Event|0
6846524|NCT00316173|10853065|FG001|Treatment Phase|Adverse Event|1
6846525|NCT00316173|10853064|FG000|Treatment Phase|Lack of Efficacy|0
6846526|NCT00316173|10853065|FG001|Treatment Phase|Lack of Efficacy|3
6846527|NCT00316173|10853064|FG000|Treatment Phase|Lost to Follow-up|0
6846528|NCT00316173|10853065|FG001|Treatment Phase|Lost to Follow-up|3
6846529|NCT00316173|10853064|FG000|Treatment Phase|Withdrawal by Subject|0
6846530|NCT00316173|10853065|FG001|Treatment Phase|Withdrawal by Subject|1
6846531|NCT00316173|10853064|FG000|Treatment Phase|Study Follow-up Stopped|0
6846532|NCT00316173|10853065|FG001|Treatment Phase|Study Follow-up Stopped|34
6846533|NCT00316186|10853070|FG000|Overall Study|Adverse Event|6
6846534|NCT00316186|10853070|FG000|Overall Study|Disease Progression|4
6846535|NCT00316186|10853070|FG000|Overall Study|Lost to Follow-up|1
6846536|NCT00316186|10853070|FG000|Overall Study|Other|1
6846537|NCT00316199|10853074|FG000|Overall Study|Adverse Event|2
6846538|NCT00316199|10853074|FG000|Overall Study|Death|8
6846539|NCT00316199|10853074|FG000|Overall Study|Lost to Follow-up|2
6846540|NCT00316225|10853078|FG000|Overall Study|Adverse Event|2
6846541|NCT00316225|10853078|FG000|Overall Study|Physician Decision|3
6846542|NCT00316225|10853078|FG000|Overall Study|Progressive Disease|15
6846543|NCT00316225|10853078|FG000|Overall Study|Withdrawal by Subject|3
6846544|NCT00316225|10853078|FG000|Overall Study|Death|2
6846545|NCT00316264|10853085|FG000|Overall Study|Lost to Follow-up|0
6846546|NCT00316264|10853086|FG001|Overall Study|Lost to Follow-up|1
6846547|NCT00316264|10853087|FG002|Overall Study|Lost to Follow-up|0
6846548|NCT00316264|10853085|FG000|Overall Study|Withdrawal of Consent|3
6846549|NCT00316264|10853086|FG001|Overall Study|Withdrawal of Consent|5
6846550|NCT00316264|10853087|FG002|Overall Study|Withdrawal of Consent|6
6846551|NCT00316264|10853085|FG000|Overall Study|Death|2
6846552|NCT00316264|10853086|FG001|Overall Study|Death|0
6846553|NCT00316264|10853087|FG002|Overall Study|Death|0
6846554|NCT00316264|10853085|FG000|Overall Study|Other|1
6846555|NCT00316264|10853086|FG001|Overall Study|Other|1
6846556|NCT00316264|10853087|FG002|Overall Study|Other|0
6846557|NCT00316277|10853097|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88
6846558|NCT00316277|10853098|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75
6846559|NCT00316277|10853097|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2
6846560|NCT00316277|10853098|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0
6846561|NCT00316277|10853097|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220
6846562|NCT00316277|10853098|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225
6846563|NCT00316277|10853097|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19
6846564|NCT00316277|10853098|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18
6846565|NCT00316277|10853097|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0
6846566|NCT00316277|10853098|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1
6846567|NCT00316303|10853114|FG000|Overall Study|Lost to Follow-up|11
6846568|NCT00316303|10853115|FG001|Overall Study|Lost to Follow-up|16
6846569|NCT00316589|10853158|FG000|Overall Study|Withdrawal by Subject|0
6846570|NCT00316589|10853159|FG001|Overall Study|Withdrawal by Subject|5
6846571|NCT00316589|10853160|FG002|Overall Study|Withdrawal by Subject|0
6846572|NCT00316589|10853161|FG003|Overall Study|Withdrawal by Subject|1
6846573|NCT00316589|10853158|FG000|Overall Study|Subject unwilling/unable to comply|0
6846574|NCT00316589|10853159|FG001|Overall Study|Subject unwilling/unable to comply|6
6846575|NCT00316589|10853160|FG002|Overall Study|Subject unwilling/unable to comply|0
6846576|NCT00316589|10853161|FG003|Overall Study|Subject unwilling/unable to comply|2
6846577|NCT00316589|10853158|FG000|Overall Study|Adverse Event|1
6846578|NCT00316589|10853159|FG001|Overall Study|Adverse Event|0
6846579|NCT00316589|10853160|FG002|Overall Study|Adverse Event|0
6846580|NCT00316589|10853161|FG003|Overall Study|Adverse Event|1
6846581|NCT00316589|10853158|FG000|Overall Study|Physician Decision|0
6846582|NCT00316589|10853159|FG001|Overall Study|Physician Decision|1
6846583|NCT00316589|10853160|FG002|Overall Study|Physician Decision|0
6846584|NCT00316589|10853161|FG003|Overall Study|Physician Decision|0
6846585|NCT00316589|10853158|FG000|Overall Study|Other reason|0
6846586|NCT00316589|10853159|FG001|Overall Study|Other reason|12
6846587|NCT00316589|10853160|FG002|Overall Study|Other reason|1
6846588|NCT00316589|10853161|FG003|Overall Study|Other reason|1
6846589|NCT00316602|10853175|FG000|Overall Study|Withdrawal by Subject|3
6846590|NCT00316602|10853176|FG001|Overall Study|Withdrawal by Subject|2
6846591|NCT00316602|10853175|FG000|Overall Study|Subject unwilling/unable to comply with|3
6846592|NCT00316602|10853176|FG001|Overall Study|Subject unwilling/unable to comply with|17
6846593|NCT00316602|10853175|FG000|Overall Study|Adverse Event|1
6846594|NCT00316602|10853176|FG001|Overall Study|Adverse Event|0
6846595|NCT00316602|10853175|FG000|Overall Study|Other|3
6846596|NCT00316602|10853176|FG001|Overall Study|Other|6
6846597|NCT00316693|10853184|FG000|Overall Study|Adverse Event|6
6846598|NCT00316693|10853185|FG001|Overall Study|Adverse Event|1
6846599|NCT00316693|10853184|FG000|Overall Study|Protocol Violation|1
6846600|NCT00316693|10853185|FG001|Overall Study|Protocol Violation|0
6846601|NCT00316693|10853184|FG000|Overall Study|Withdrawal by Subject|6
6846602|NCT00316693|10853185|FG001|Overall Study|Withdrawal by Subject|6
6846603|NCT00316693|10853184|FG000|Overall Study|Lost to Follow-up|26
6846604|NCT00316693|10853185|FG001|Overall Study|Lost to Follow-up|34
6846605|NCT00316693|10853184|FG000|Overall Study|Other|38
6846606|NCT00316693|10853185|FG001|Overall Study|Other|44
6846607|NCT00316706|10853193|FG000|Overall Study|Lost to Follow-up|38
6846608|NCT00316706|10853194|FG001|Overall Study|Lost to Follow-up|48
6846609|NCT00316719|10853202|FG000|Overall Study|Adverse Event|0
6846610|NCT00316719|10853203|FG001|Overall Study|Adverse Event|6
6846611|NCT00316719|10853202|FG000|Overall Study|Consent withdrawn|2
6846612|NCT00316719|10853203|FG001|Overall Study|Consent withdrawn|0
6846619|NCT00316914|10853224|FG000|Overall Study|Withdrawal by Subject|5
6846620|NCT00316914|10853225|FG001|Overall Study|Withdrawal by Subject|3
6846621|NCT00316914|10853224|FG000|Overall Study|Adverse Event|8
6846622|NCT00316914|10853225|FG001|Overall Study|Adverse Event|7
6846623|NCT00316914|10853224|FG000|Overall Study|Other Problems|6
6846624|NCT00316914|10853225|FG001|Overall Study|Other Problems|11
6846625|NCT00316914|10853224|FG000|Overall Study|Missing end of treatment documentation|14
6846626|NCT00316914|10853225|FG001|Overall Study|Missing end of treatment documentation|15
6846627|NCT00317044|10853234|FG000|Overall Study|Protocol Violation|28
6846628|NCT00317044|10853235|FG001|Overall Study|Protocol Violation|22
6846629|NCT00317044|10853236|FG002|Overall Study|Protocol Violation|20
6846630|NCT00317044|10853234|FG000|Overall Study|Adverse Event|4
6846631|NCT00317044|10853235|FG001|Overall Study|Adverse Event|7
6846632|NCT00317044|10853236|FG002|Overall Study|Adverse Event|4
6846633|NCT00317044|10853234|FG000|Overall Study|Withdrawal by Subject|10
6846634|NCT00317044|10853235|FG001|Overall Study|Withdrawal by Subject|7
6846635|NCT00317044|10853236|FG002|Overall Study|Withdrawal by Subject|12
6846636|NCT00317044|10853234|FG000|Overall Study|Lost to Follow-up|0
6846637|NCT00317044|10853235|FG001|Overall Study|Lost to Follow-up|2
6846638|NCT00317044|10853236|FG002|Overall Study|Lost to Follow-up|3
6846639|NCT00317044|10853234|FG000|Overall Study|Multiple Reasons|6
6846640|NCT00317044|10853235|FG001|Overall Study|Multiple Reasons|2
6846641|NCT00317044|10853236|FG002|Overall Study|Multiple Reasons|6
6846642|NCT00317109|10853246|FG000|Overall Study|Withdrawal by Subject|2
6846643|NCT00317109|10853247|FG001|Overall Study|Withdrawal by Subject|0
6846644|NCT00317109|10853246|FG000|Overall Study|Migated/moved from study area|1
6846645|NCT00317109|10853247|FG001|Overall Study|Migated/moved from study area|0
6846646|NCT00317356|10853270|FG000|Overall Study|Adverse Event|0
6846647|NCT00317356|10853271|FG001|Overall Study|Adverse Event|0
6846648|NCT00317356|10853272|FG002|Overall Study|Adverse Event|1
6846649|NCT00317356|10853273|FG003|Overall Study|Adverse Event|0
6846650|NCT00317356|10853270|FG000|Overall Study|Lack of Efficacy|1
6846651|NCT00317356|10853271|FG001|Overall Study|Lack of Efficacy|1
6846652|NCT00317356|10853272|FG002|Overall Study|Lack of Efficacy|0
6846653|NCT00317356|10853273|FG003|Overall Study|Lack of Efficacy|3
6846654|NCT00317356|10853270|FG000|Overall Study|Physician Decision|0
6846655|NCT00317356|10853271|FG001|Overall Study|Physician Decision|1
6846656|NCT00317356|10853272|FG002|Overall Study|Physician Decision|0
6846657|NCT00317356|10853273|FG003|Overall Study|Physician Decision|0
6846658|NCT00317369|10853286|FG000|Overall Study|Adverse Event|2
6846659|NCT00317369|10853287|FG001|Overall Study|Adverse Event|1
6846660|NCT00317369|10853288|FG002|Overall Study|Adverse Event|0
6846661|NCT00317369|10853286|FG000|Overall Study|Lack of Efficacy|0
6846662|NCT00317369|10853287|FG001|Overall Study|Lack of Efficacy|1
6846663|NCT00317369|10853288|FG002|Overall Study|Lack of Efficacy|1
6846664|NCT00317369|10853286|FG000|Overall Study|Withdrawal by Subject|0
6846665|NCT00317369|10853287|FG001|Overall Study|Withdrawal by Subject|0
6846666|NCT00317369|10853288|FG002|Overall Study|Withdrawal by Subject|1
6846667|NCT00317473|10853302|FG000|Overall Study|Withdrawal by Subject|2
6846668|NCT00317473|10853303|FG001|Overall Study|Withdrawal by Subject|1
6846669|NCT00317473|10853304|FG002|Overall Study|Withdrawal by Subject|2
6846670|NCT00317473|10853305|FG003|Overall Study|Withdrawal by Subject|1
6846671|NCT00317473|10853306|FG004|Overall Study|Withdrawal by Subject|3
6846672|NCT00317473|10853307|FG005|Overall Study|Withdrawal by Subject|1
6846673|NCT00317473|10853302|FG000|Overall Study|Relocation|1
6846674|NCT00317473|10853303|FG001|Overall Study|Relocation|0
6846675|NCT00317473|10853304|FG002|Overall Study|Relocation|1
6846676|NCT00317473|10853305|FG003|Overall Study|Relocation|1
6846677|NCT00317473|10853306|FG004|Overall Study|Relocation|5
6846678|NCT00317473|10853307|FG005|Overall Study|Relocation|2
6846679|NCT00317473|10853302|FG000|Overall Study|Death|1
6846680|NCT00317473|10853303|FG001|Overall Study|Death|0
6846681|NCT00317473|10853304|FG002|Overall Study|Death|0
6846682|NCT00317473|10853305|FG003|Overall Study|Death|0
6846683|NCT00317473|10853306|FG004|Overall Study|Death|0
6846684|NCT00317473|10853307|FG005|Overall Study|Death|0
6846685|NCT00317473|10853302|FG000|Overall Study|Other|0
6846686|NCT00317473|10853303|FG001|Overall Study|Other|2
6846687|NCT00317473|10853304|FG002|Overall Study|Other|0
6846688|NCT00317473|10853305|FG003|Overall Study|Other|0
6846689|NCT00317473|10853306|FG004|Overall Study|Other|0
6846690|NCT00317473|10853307|FG005|Overall Study|Other|0
6846691|NCT00317603|10853331|FG000|Overall Study|Progressive Disease|3
6846692|NCT00317642|10853337|FG000|Overall Study|Not Received Either Study Drug|1
7151445|NCT03231800|11315468|FG000|Overall Study|reason not provided|2
7151446|NCT03231800|11315469|FG001|Overall Study|reason not provided|0
7151447|NCT03231943|11315491|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7151448|NCT03231943|11315492|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1
7151449|NCT03231943|11315493|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1
7151450|NCT03231943|11315494|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7151451|NCT03231943|11315495|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7151452|NCT03231943|11315496|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7151453|NCT03231943|11315497|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7151454|NCT03231943|11315498|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7151455|NCT03231943|11315499|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7151456|NCT03231943|11315500|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7151457|NCT03231943|11315501|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7151458|NCT03231943|11315502|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7151459|NCT03231943|11315503|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7151460|NCT03231943|11315491|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7151461|NCT03231943|11315492|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1
7151462|NCT03231943|11315493|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7151463|NCT03231943|11315494|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7151464|NCT03231943|11315495|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7151465|NCT03231943|11315496|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7151466|NCT03231943|11315497|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
6846693|NCT00317642|10853338|FG001|Overall Study|Not Received Either Study Drug|3
6846694|NCT00317642|10853337|FG000|Overall Study|Physician Decision|15
6846695|NCT00317642|10853338|FG001|Overall Study|Physician Decision|7
6846696|NCT00317642|10853337|FG000|Overall Study|Participant declined treatment|14
6846697|NCT00317642|10853338|FG001|Overall Study|Participant declined treatment|3
6846698|NCT00317642|10853337|FG000|Overall Study|Adverse Event|17
6846699|NCT00317642|10853338|FG001|Overall Study|Adverse Event|5
6846700|NCT00317642|10853337|FG000|Overall Study|Treatment Failure|56
6846701|NCT00317642|10853338|FG001|Overall Study|Treatment Failure|102
6846702|NCT00317642|10853337|FG000|Overall Study|Disease Recurrence|1
6846703|NCT00317642|10853338|FG001|Overall Study|Disease Recurrence|2
6846704|NCT00317642|10853337|FG000|Overall Study|Death|14
6846705|NCT00317642|10853338|FG001|Overall Study|Death|7
6846706|NCT00317642|10853337|FG000|Overall Study|Not Continue to Consolidation|2
6846707|NCT00317642|10853338|FG001|Overall Study|Not Continue to Consolidation|0
6846708|NCT00317642|10853337|FG000|Overall Study|Withdrawal by Subject|0
6846709|NCT00317642|10853338|FG001|Overall Study|Withdrawal by Subject|1
6846710|NCT00317642|10853337|FG000|Overall Study|Referred For Transplantation|1
6846711|NCT00317642|10853338|FG001|Overall Study|Referred For Transplantation|0
6846712|NCT00317642|10853337|FG000|Overall Study|AML Not Centrally Confirmed|1
6846713|NCT00317642|10853338|FG001|Overall Study|AML Not Centrally Confirmed|5
6846714|NCT00318149|10853379|FG000|Overall Study|Adverse Event|0
6846715|NCT00318149|10853380|FG001|Overall Study|Adverse Event|0
6846716|NCT00318149|10853381|FG002|Overall Study|Adverse Event|0
6846717|NCT00318149|10853382|FG003|Overall Study|Adverse Event|0
6846718|NCT00318149|10853383|FG004|Overall Study|Adverse Event|0
6846719|NCT00318149|10853384|FG005|Overall Study|Adverse Event|2
6846720|NCT00318370|10853418|FG000|Period 1|Lack of Efficacy|5
6846721|NCT00318370|10853419|FG001|Period 1|Lack of Efficacy|0
6846722|NCT00318370|10853420|FG002|Period 1|Lack of Efficacy|0
6846723|NCT00318370|10853418|FG000|Period 1|Physician Decision|1
6846724|NCT00318370|10853419|FG001|Period 1|Physician Decision|0
6846725|NCT00318370|10853420|FG002|Period 1|Physician Decision|0
6846726|NCT00318370|10853418|FG000|Period 1|Withdrawal by Subject|1
6846727|NCT00318370|10853419|FG001|Period 1|Withdrawal by Subject|0
6846728|NCT00318370|10853420|FG002|Period 1|Withdrawal by Subject|0
6846729|NCT00318370|10853418|FG000|Period 2|Adverse Event|0
6846730|NCT00318370|10853419|FG001|Period 2|Adverse Event|3
6846731|NCT00318370|10853420|FG002|Period 2|Adverse Event|0
6846732|NCT00318370|10853418|FG000|Period 2|Lack of Efficacy|0
7151467|NCT03231943|11315498|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7151468|NCT03231943|11315499|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7184117|NCT01755689|11384111|FG000|Overall Study|Withdrawal by Subject|1
6846733|NCT00318370|10853419|FG001|Period 2|Lack of Efficacy|5
6846734|NCT00318370|10853420|FG002|Period 2|Lack of Efficacy|0
6846735|NCT00318370|10853418|FG000|Period 2|Physician Decision|0
6846736|NCT00318370|10853419|FG001|Period 2|Physician Decision|1
6846737|NCT00318370|10853420|FG002|Period 2|Physician Decision|0
6846738|NCT00318370|10853418|FG000|Period 2|Withdrawal by Subject|0
6846739|NCT00318370|10853419|FG001|Period 2|Withdrawal by Subject|1
6846740|NCT00318370|10853420|FG002|Period 2|Withdrawal by Subject|0
6846741|NCT00318370|10853418|FG000|Period 2|Other|0
6846742|NCT00318370|10853419|FG001|Period 2|Other|1
6846743|NCT00318370|10853420|FG002|Period 2|Other|0
6846744|NCT00318370|10853418|FG000|Period 3|Adverse Event|0
6846745|NCT00318370|10853419|FG001|Period 3|Adverse Event|0
6846746|NCT00318370|10853420|FG002|Period 3|Adverse Event|1
6846747|NCT00318370|10853418|FG000|Period 3|Lack of Efficacy|0
6846748|NCT00318370|10853419|FG001|Period 3|Lack of Efficacy|0
6846749|NCT00318370|10853420|FG002|Period 3|Lack of Efficacy|24
6846750|NCT00318370|10853418|FG000|Period 3|Death|0
6846751|NCT00318370|10853419|FG001|Period 3|Death|0
6846752|NCT00318370|10853420|FG002|Period 3|Death|1
6846753|NCT00318370|10853418|FG000|Period 3|Physician Decision|0
6846754|NCT00318370|10853419|FG001|Period 3|Physician Decision|0
6846755|NCT00318370|10853420|FG002|Period 3|Physician Decision|1
6846756|NCT00318370|10853418|FG000|Period 3|Withdrawal by Subject|0
6846757|NCT00318370|10853419|FG001|Period 3|Withdrawal by Subject|0
6846758|NCT00318370|10853420|FG002|Period 3|Withdrawal by Subject|3
6846759|NCT00318370|10853418|FG000|Period 3|Other|0
6846760|NCT00318370|10853419|FG001|Period 3|Other|0
6846761|NCT00318370|10853420|FG002|Period 3|Other|3
6846762|NCT00318461|10853441|FG000|Double-Blind, 6 Months|Adverse Event|11
6846763|NCT00318461|10853442|FG001|Double-Blind, 6 Months|Adverse Event|23
6846764|NCT00318461|10853443|FG002|Double-Blind, 6 Months|Adverse Event|29
6846765|NCT00318461|10853444|FG003|Double-Blind, 6 Months|Adverse Event|2
6846766|NCT00318461|10853445|FG004|Double-Blind, 6 Months|Adverse Event|8
6846767|NCT00318461|10853441|FG000|Double-Blind, 6 Months|Lack of Efficacy|19
6846768|NCT00318461|10853442|FG001|Double-Blind, 6 Months|Lack of Efficacy|8
6846769|NCT00318461|10853443|FG002|Double-Blind, 6 Months|Lack of Efficacy|13
6846770|NCT00318461|10853444|FG003|Double-Blind, 6 Months|Lack of Efficacy|29
6846771|NCT00318461|10853445|FG004|Double-Blind, 6 Months|Lack of Efficacy|9
6846772|NCT00318461|10853441|FG000|Double-Blind, 6 Months|Protocol Violation|2
6846773|NCT00318461|10853442|FG001|Double-Blind, 6 Months|Protocol Violation|4
6846774|NCT00318461|10853443|FG002|Double-Blind, 6 Months|Protocol Violation|4
6846775|NCT00318461|10853444|FG003|Double-Blind, 6 Months|Protocol Violation|4
6846776|NCT00318461|10853445|FG004|Double-Blind, 6 Months|Protocol Violation|5
6846777|NCT00318461|10853441|FG000|Double-Blind, 6 Months|Lost to follow up|0
6846778|NCT00318461|10853442|FG001|Double-Blind, 6 Months|Lost to follow up|1
6846779|NCT00318461|10853443|FG002|Double-Blind, 6 Months|Lost to follow up|0
6846780|NCT00318461|10853444|FG003|Double-Blind, 6 Months|Lost to follow up|0
6846781|NCT00318461|10853445|FG004|Double-Blind, 6 Months|Lost to follow up|0
6846782|NCT00318461|10853441|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
6846783|NCT00318461|10853442|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1
6846784|NCT00318461|10853443|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
6846785|NCT00318461|10853444|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
6846786|NCT00318461|10853445|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
6846787|NCT00318461|10853441|FG000|Double-Blind, 6 Months|Consent withdrawn|0
6846788|NCT00318461|10853442|FG001|Double-Blind, 6 Months|Consent withdrawn|3
6846789|NCT00318461|10853443|FG002|Double-Blind, 6 Months|Consent withdrawn|4
6846790|NCT00318461|10853444|FG003|Double-Blind, 6 Months|Consent withdrawn|10
6846791|NCT00318461|10853445|FG004|Double-Blind, 6 Months|Consent withdrawn|4
6846792|NCT00318461|10853441|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0
6846793|NCT00318461|10853442|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2
6846794|NCT00318461|10853443|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1
6846795|NCT00318461|10853444|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0
6846796|NCT00318461|10853445|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2
6846797|NCT00318461|10853441|FG000|Double-Blind, 6 Months|Move|0
6846798|NCT00318461|10853442|FG001|Double-Blind, 6 Months|Move|1
6846799|NCT00318461|10853443|FG002|Double-Blind, 6 Months|Move|0
6846800|NCT00318461|10853444|FG003|Double-Blind, 6 Months|Move|0
6846801|NCT00318461|10853445|FG004|Double-Blind, 6 Months|Move|0
6846802|NCT00318461|10853441|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
6846803|NCT00318461|10853442|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
6846804|NCT00318461|10853443|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
6846805|NCT00318461|10853444|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
6846806|NCT00318461|10853445|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1
6846807|NCT00318461|10853441|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1
6846808|NCT00318461|10853442|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0
6846809|NCT00318461|10853443|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0
6846810|NCT00318461|10853444|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2
6846811|NCT00318461|10853445|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0
7151469|NCT03231943|11315500|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7151470|NCT03231943|11315501|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7151471|NCT03231943|11315502|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7151472|NCT03231943|11315503|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7151473|NCT03231943|11315491|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1
7151474|NCT03231943|11315492|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0
6846812|NCT00318461|10853441|FG000|Double-Blind, 6 Months|Work commitment|0
6846813|NCT00318461|10853442|FG001|Double-Blind, 6 Months|Work commitment|0
6846814|NCT00318461|10853443|FG002|Double-Blind, 6 Months|Work commitment|0
6846815|NCT00318461|10853444|FG003|Double-Blind, 6 Months|Work commitment|0
6846816|NCT00318461|10853445|FG004|Double-Blind, 6 Months|Work commitment|1
6846817|NCT00318461|10853441|FG000|Double-Blind, 6 Months|Investigator decision|0
6846818|NCT00318461|10853442|FG001|Double-Blind, 6 Months|Investigator decision|0
6846819|NCT00318461|10853443|FG002|Double-Blind, 6 Months|Investigator decision|0
6846820|NCT00318461|10853444|FG003|Double-Blind, 6 Months|Investigator decision|0
6846821|NCT00318461|10853445|FG004|Double-Blind, 6 Months|Investigator decision|1
6846822|NCT00318461|10853441|FG000|Double-Blind, 6 Months|Lack of time|1
6846823|NCT00318461|10853442|FG001|Double-Blind, 6 Months|Lack of time|0
6846824|NCT00318461|10853443|FG002|Double-Blind, 6 Months|Lack of time|0
6846825|NCT00318461|10853444|FG003|Double-Blind, 6 Months|Lack of time|0
6846826|NCT00318461|10853445|FG004|Double-Blind, 6 Months|Lack of time|0
6846827|NCT00318461|10853441|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
6846828|NCT00318461|10853442|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
6846829|NCT00318461|10853443|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
6846830|NCT00318461|10853444|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
6846831|NCT00318461|10853445|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2
6846832|NCT00318461|10853441|FG000|Double-Blind, 6 Months|Hyperglicaemia|0
6846833|NCT00318461|10853442|FG001|Double-Blind, 6 Months|Hyperglicaemia|0
6846834|NCT00318461|10853443|FG002|Double-Blind, 6 Months|Hyperglicaemia|0
6846835|NCT00318461|10853444|FG003|Double-Blind, 6 Months|Hyperglicaemia|1
6846836|NCT00318461|10853445|FG004|Double-Blind, 6 Months|Hyperglicaemia|0
6846837|NCT00318461|10853441|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
6846838|NCT00318461|10853442|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
6846839|NCT00318461|10853443|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
6846840|NCT00318461|10853444|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
6846841|NCT00318461|10853445|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1
6846842|NCT00318461|10853441|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0
6846843|NCT00318461|10853442|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1
6846844|NCT00318461|10853443|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0
6846845|NCT00318461|10853444|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0
6846846|NCT00318461|10853445|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0
6846847|NCT00318461|10853441|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19
6846848|NCT00318461|10853442|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14
6846849|NCT00318461|10853443|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27
6846850|NCT00318461|10853444|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11
6846851|NCT00318461|10853445|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22
6846852|NCT00318461|10853441|FG000|Open-Label Extension, 18 Months|Adverse Event|11
6846853|NCT00318461|10853442|FG001|Open-Label Extension, 18 Months|Adverse Event|8
6846854|NCT00318461|10853443|FG002|Open-Label Extension, 18 Months|Adverse Event|6
6846855|NCT00318461|10853444|FG003|Open-Label Extension, 18 Months|Adverse Event|1
6846856|NCT00318461|10853445|FG004|Open-Label Extension, 18 Months|Adverse Event|6
6846857|NCT00318461|10853441|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41
6846858|NCT00318461|10853442|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33
6846859|NCT00318461|10853443|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37
6846860|NCT00318461|10853444|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27
6846861|NCT00318461|10853445|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63
6846862|NCT00318461|10853441|FG000|Open-Label Extension, 18 Months|Protocol Violation|7
6846863|NCT00318461|10853442|FG001|Open-Label Extension, 18 Months|Protocol Violation|5
6846864|NCT00318461|10853443|FG002|Open-Label Extension, 18 Months|Protocol Violation|3
6846865|NCT00318461|10853444|FG003|Open-Label Extension, 18 Months|Protocol Violation|4
6846866|NCT00318461|10853445|FG004|Open-Label Extension, 18 Months|Protocol Violation|6
6846867|NCT00318474|10853459|FG000|Overall Study|Adverse Event|1
6846868|NCT00318474|10853460|FG001|Overall Study|Adverse Event|1
6846869|NCT00318474|10853459|FG000|Overall Study|Lost to Follow-up|0
6846870|NCT00318474|10853460|FG001|Overall Study|Lost to Follow-up|1
6846871|NCT00318474|10853459|FG000|Overall Study|Pregnancy|0
6846872|NCT00318474|10853460|FG001|Overall Study|Pregnancy|2
6846873|NCT00318474|10853459|FG000|Overall Study|Protocol Violation|1
6846874|NCT00318474|10853460|FG001|Overall Study|Protocol Violation|0
6846875|NCT00318474|10853459|FG000|Overall Study|Withdrawal by Subject|3
6846876|NCT00318474|10853460|FG001|Overall Study|Withdrawal by Subject|2
6846877|NCT00318474|10853459|FG000|Overall Study|Fall in GFR|3
6846878|NCT00318474|10853460|FG001|Overall Study|Fall in GFR|3
6846879|NCT00318474|10853459|FG000|Overall Study|Post-therapy hyperflycemia|0
6846880|NCT00318474|10853460|FG001|Overall Study|Post-therapy hyperflycemia|1
6846881|NCT00318474|10853459|FG000|Overall Study|Trial terminated|10
6846882|NCT00318474|10853460|FG001|Overall Study|Trial terminated|7
6846883|NCT00318565|10853466|FG000|Overall Study|Excluded per protocol|24
6846884|NCT00318643|10853486|FG000|Overall Study|Adverse Event|0
6846885|NCT00318643|10853487|FG001|Overall Study|Adverse Event|0
6846886|NCT00318643|10853488|FG002|Overall Study|Adverse Event|0
6846887|NCT00318643|10853489|FG003|Overall Study|Adverse Event|0
6846888|NCT00318643|10853490|FG004|Overall Study|Adverse Event|1
6846889|NCT00318643|10853486|FG000|Overall Study|Participant's Decision|0
6846890|NCT00318643|10853487|FG001|Overall Study|Participant's Decision|0
6846891|NCT00318643|10853488|FG002|Overall Study|Participant's Decision|0
6846892|NCT00318643|10853489|FG003|Overall Study|Participant's Decision|0
6846893|NCT00318643|10853490|FG004|Overall Study|Participant's Decision|1
6846894|NCT00318643|10853486|FG000|Overall Study|Investigator's Decision|0
6846895|NCT00318643|10853487|FG001|Overall Study|Investigator's Decision|0
6846896|NCT00318643|10853488|FG002|Overall Study|Investigator's Decision|0
6846897|NCT00318643|10853489|FG003|Overall Study|Investigator's Decision|0
6846898|NCT00318643|10853490|FG004|Overall Study|Investigator's Decision|1
6846899|NCT00319020|10853531|FG000|Overall Study|Death|2
6846900|NCT00319020|10853532|FG001|Overall Study|Death|2
6846901|NCT00319020|10853531|FG000|Overall Study|Withdrawal by Subject|4
6846902|NCT00319020|10853532|FG001|Overall Study|Withdrawal by Subject|1
6846903|NCT00319020|10853531|FG000|Overall Study|F-1 completed but not enrolled in F-2|1
6846904|NCT00319020|10853532|FG001|Overall Study|F-1 completed but not enrolled in F-2|0
6846905|NCT00319020|10853531|FG000|Overall Study|Administrative reason|0
6846906|NCT00319020|10853532|FG001|Overall Study|Administrative reason|5
6846907|NCT00319020|10853531|FG000|Overall Study|Disease progression|0
6846908|NCT00319020|10853532|FG001|Overall Study|Disease progression|2
6846909|NCT00319020|10853531|FG000|Overall Study|Transplant|0
6846910|NCT00319020|10853532|FG001|Overall Study|Transplant|1
6846911|NCT00319020|10853531|FG000|Overall Study|Treatment failure|0
6846912|NCT00319020|10853532|FG001|Overall Study|Treatment failure|1
6846913|NCT00319020|10853531|FG000|Overall Study|Adverse Event|0
6846914|NCT00319020|10853532|FG001|Overall Study|Adverse Event|1
6846915|NCT00319046|10853540|FG000|Overall Study|withdrawal of subject's consent|7
6846916|NCT00319046|10853540|FG000|Overall Study|administrative reason|1
6897934|NCT00642941|10916956|FG005|Overall Study|Disease progression|39
6897935|NCT00642941|10916957|FG006|Overall Study|Disease progression|18
6897936|NCT00642941|10916958|FG007|Overall Study|Disease progression|12
6897937|NCT00642941|10916959|FG008|Overall Study|Disease progression|10
6897938|NCT00642941|10916960|FG009|Overall Study|Disease progression|7
6897939|NCT00642941|10916961|FG010|Overall Study|Disease progression|12
6897940|NCT00642941|10916962|FG011|Overall Study|Disease progression|7
6897941|NCT00642954|10917014|FG000|Overall Study|Progressive Disease|3
6897942|NCT00642954|10917015|FG001|Overall Study|Progressive Disease|3
6897943|NCT00642954|10917016|FG002|Overall Study|Progressive Disease|3
6897944|NCT00642954|10917017|FG003|Overall Study|Progressive Disease|3
6897945|NCT00642954|10917018|FG004|Overall Study|Progressive Disease|9
6897946|NCT00642954|10917014|FG000|Overall Study|Withdrawal by Subject|0
6897947|NCT00642954|10917015|FG001|Overall Study|Withdrawal by Subject|0
6897948|NCT00642954|10917016|FG002|Overall Study|Withdrawal by Subject|0
6897949|NCT00642954|10917017|FG003|Overall Study|Withdrawal by Subject|0
6897950|NCT00642954|10917018|FG004|Overall Study|Withdrawal by Subject|1
6897951|NCT00642954|10917014|FG000|Overall Study|Adverse Event|1
6897952|NCT00642954|10917015|FG001|Overall Study|Adverse Event|1
6897953|NCT00642954|10917016|FG002|Overall Study|Adverse Event|0
6897954|NCT00642954|10917017|FG003|Overall Study|Adverse Event|0
6897955|NCT00642954|10917018|FG004|Overall Study|Adverse Event|6
6897956|NCT00642993|10917032|FG000|Overall Study|Adverse Event|85
6897957|NCT00642993|10917033|FG001|Overall Study|Adverse Event|4
6897958|NCT00642993|10917032|FG000|Overall Study|Lost to Follow-up|8
6897959|NCT00642993|10917033|FG001|Overall Study|Lost to Follow-up|4
6897960|NCT00642993|10917032|FG000|Overall Study|Withdrew - reason unrelated to treatment|11
6897961|NCT00642993|10917033|FG001|Overall Study|Withdrew - reason unrelated to treatment|3
6897962|NCT00642993|10917032|FG000|Overall Study|Protocol Violation|1
6897963|NCT00642993|10917033|FG001|Overall Study|Protocol Violation|4
6897964|NCT00642993|10917032|FG000|Overall Study|Did not meet protocol eligibility|0
6897965|NCT00642993|10917033|FG001|Overall Study|Did not meet protocol eligibility|1
6897966|NCT00642993|10917032|FG000|Overall Study|Administrative|1
6897967|NCT00642993|10917033|FG001|Overall Study|Administrative|0
6897968|NCT00643006|10917041|FG000|Overall Study|Lost to Follow-up|5
6897969|NCT00643006|10917042|FG001|Overall Study|Lost to Follow-up|4
6897970|NCT00643123|10917065|FG000|Overall Study|Lost to Follow-up|4
6897971|NCT00643123|10917066|FG001|Overall Study|Lost to Follow-up|0
6897972|NCT00643123|10917065|FG000|Overall Study|Withdrawal by Subject|1
6897973|NCT00643123|10917066|FG001|Overall Study|Withdrawal by Subject|1
6897974|NCT00643162|10917074|FG000|Overall Study|Withdrawal by Subject|1
6897975|NCT00643162|10917075|FG001|Overall Study|Withdrawal by Subject|1
6897976|NCT00643201|10917083|FG000|Randomized, Completed 6 Months of Study|Death|20
6897977|NCT00643201|10917084|FG001|Randomized, Completed 6 Months of Study|Death|26
6897978|NCT00643201|10917083|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150
6897979|NCT00643201|10917084|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182
6897980|NCT00643201|10917083|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
6897981|NCT00643201|10917084|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
6897982|NCT00643201|10917083|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
6897983|NCT00643201|10917084|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
6897984|NCT00643201|10917083|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20
6897985|NCT00643201|10917084|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23
6897986|NCT00643201|10917083|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3
6897987|NCT00643201|10917084|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2
6897988|NCT00643201|10917083|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13
6897989|NCT00643201|10917084|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9
6897990|NCT00643201|10917083|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1
6897991|NCT00643201|10917084|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1
6897992|NCT00643201|10917083|FG000|Randomized, Completed 6 Months of Study|Other|107
6897993|NCT00643201|10917084|FG001|Randomized, Completed 6 Months of Study|Other|107
6846917|NCT00319098|10853548|FG000|Overall Study|Serious adverse event|3
6846918|NCT00319098|10853549|FG001|Overall Study|Serious adverse event|0
6846919|NCT00319098|10853548|FG000|Overall Study|Adverse Event|20
6846920|NCT00319098|10853549|FG001|Overall Study|Adverse Event|1
6846921|NCT00319098|10853548|FG000|Overall Study|Withdrawal by Subject|37
6846922|NCT00319098|10853549|FG001|Overall Study|Withdrawal by Subject|8
6846923|NCT00319098|10853548|FG000|Overall Study|Migrated/moved from study area|2
6846924|NCT00319098|10853549|FG001|Overall Study|Migrated/moved from study area|1
6846925|NCT00319098|10853548|FG000|Overall Study|Lost to Follow-up|37
6846926|NCT00319098|10853549|FG001|Overall Study|Lost to Follow-up|13
6846927|NCT00319098|10853548|FG000|Overall Study|Others|33
6846928|NCT00319098|10853549|FG001|Overall Study|Others|8
6846929|NCT00319098|10853548|FG000|Overall Study|Protocol Violation|3
6846930|NCT00319098|10853549|FG001|Overall Study|Protocol Violation|1
6846931|NCT00319111|10853559|FG000|Overall Study|Adverse Event|20
6846932|NCT00319111|10853559|FG000|Overall Study|Withdrawal of consent|11
6846933|NCT00319111|10853559|FG000|Overall Study|Death|9
6846934|NCT00319111|10853559|FG000|Overall Study|Lack of clinical improvement|4
6846935|NCT00319111|10853559|FG000|Overall Study|Administrative|2
6846936|NCT00319111|10853559|FG000|Overall Study|Treatment failure|1
6846937|NCT00319254|10853563|FG000|Overall Study|Withdrawal by Subject|4
6846938|NCT00319254|10853563|FG000|Overall Study|Death|46
6846939|NCT00319254|10853563|FG000|Overall Study|Lost to Follow-up|2
6846940|NCT00319254|10853563|FG000|Overall Study|Enrolled, Not Treated|2
6846941|NCT00319436|10853569|FG000|Overall Study|Withdrawal by Subject|6
6846942|NCT00319436|10853570|FG001|Overall Study|Withdrawal by Subject|7
6846943|NCT00319501|10853578|FG000|Double-blind Period|Withdrawal by Subject|0
6846944|NCT00319501|10853579|FG001|Double-blind Period|Withdrawal by Subject|3
6846945|NCT00319501|10853578|FG000|Double-blind Period|Sponsor Request|1
6846946|NCT00319501|10853579|FG001|Double-blind Period|Sponsor Request|0
6846947|NCT00319501|10853578|FG000|Double-blind Period|Did not receive treatment|42
6846948|NCT00319501|10853579|FG001|Double-blind Period|Did not receive treatment|29
6846949|NCT00319501|10853578|FG000|Open-label Period|Adverse Event|5
6846950|NCT00319501|10853579|FG001|Open-label Period|Adverse Event|0
6846951|NCT00319501|10853578|FG000|Open-label Period|Protocol Violation|6
6846952|NCT00319501|10853579|FG001|Open-label Period|Protocol Violation|0
6846953|NCT00319501|10853578|FG000|Open-label Period|Withdrawal by Subject|38
6846954|NCT00319501|10853579|FG001|Open-label Period|Withdrawal by Subject|0
6846955|NCT00319501|10853578|FG000|Open-label Period|Principal Investigator decision|6
6846956|NCT00319501|10853579|FG001|Open-label Period|Principal Investigator decision|0
6846957|NCT00319501|10853578|FG000|Open-label Period|Sponsor request|12
6846958|NCT00319501|10853579|FG001|Open-label Period|Sponsor request|0
6846959|NCT00319501|10853578|FG000|Open-label Period|Lost to Follow-up|5
6846960|NCT00319501|10853579|FG001|Open-label Period|Lost to Follow-up|0
6846961|NCT00319501|10853578|FG000|Open-label Period|Did not receive treatment|33
6846962|NCT00319501|10853579|FG001|Open-label Period|Did not receive treatment|0
6846963|NCT00319501|10853578|FG000|Open-label Period|Other|11
6846964|NCT00319501|10853579|FG001|Open-label Period|Other|0
6846965|NCT00319501|10853578|FG000|Open-label Extension Period|Adverse Event|2
6846966|NCT00319501|10853579|FG001|Open-label Extension Period|Adverse Event|0
6846967|NCT00319501|10853578|FG000|Open-label Extension Period|Did not receive treatment|18
6846968|NCT00319501|10853579|FG001|Open-label Extension Period|Did not receive treatment|0
6846969|NCT00319501|10853578|FG000|Open-label Extension Period|Other|1
6846970|NCT00319501|10853579|FG001|Open-label Extension Period|Other|0
6846971|NCT00319501|10853578|FG000|Open-label Extension Period|Principal investigator decision|2
6846972|NCT00319501|10853579|FG001|Open-label Extension Period|Principal investigator decision|0
6846973|NCT00319501|10853578|FG000|Open-label Extension Period|Sponsor request|26
6846974|NCT00319501|10853579|FG001|Open-label Extension Period|Sponsor request|0
6846975|NCT00319501|10853578|FG000|Open-label Extension Period|Withdrawal by Subject|2
6846976|NCT00319501|10853579|FG001|Open-label Extension Period|Withdrawal by Subject|0
6846977|NCT00319553|10853592|FG000|Overall Study|Protocol Violation|1
6846978|NCT00319553|10853593|FG001|Overall Study|Protocol Violation|2
6846979|NCT00319553|10853592|FG000|Overall Study|Lost to Follow-up|2
6846980|NCT00319553|10853593|FG001|Overall Study|Lost to Follow-up|1
6846981|NCT00319553|10853592|FG000|Overall Study|Withdrawal by Subject|1
6846982|NCT00319553|10853593|FG001|Overall Study|Withdrawal by Subject|1
6846983|NCT00319592|10853601|FG000|Overall Study|Protocol Violation|1
6846984|NCT00319592|10853602|FG001|Overall Study|Protocol Violation|0
6846985|NCT00319592|10853601|FG000|Overall Study|Physician Decision|0
6846986|NCT00319592|10853602|FG001|Overall Study|Physician Decision|1
6846987|NCT00319696|10853617|FG000|Overall Study|Adverse Event|36
6846988|NCT00319696|10853617|FG000|Overall Study|withdrawal of consent|14
6846989|NCT00319696|10853617|FG000|Overall Study|administrative|7
6846990|NCT00319696|10853617|FG000|Overall Study|Lost to Follow-up|3
6846991|NCT00319735|10853627|FG000|Overall Study|Death|2
6846992|NCT00319956|10853644|FG000|Overall Study|Death|20
6846993|NCT00319956|10853645|FG001|Overall Study|Death|24
6846994|NCT00319982|10853653|FG000|Overall Study|Withdrawal by Subject|1
6846995|NCT00319982|10853654|FG001|Overall Study|Withdrawal by Subject|0
6846996|NCT00320112|10853662|FG000|Overall Study|Lost to Follow-up|3
6846997|NCT00320112|10853663|FG001|Overall Study|Lost to Follow-up|4
6846998|NCT00320112|10853662|FG000|Overall Study|Withdrawal by Subject|3
6846999|NCT00320112|10853663|FG001|Overall Study|Withdrawal by Subject|0
6847000|NCT00320112|10853662|FG000|Overall Study|Death|2
6847001|NCT00320112|10853663|FG001|Overall Study|Death|1
6847002|NCT00320190|10853677|FG000|First 12 Months|Completed but did not enter extension|5
6847003|NCT00320190|10853678|FG001|First 12 Months|Completed but did not enter extension|3
6847004|NCT00320190|10853677|FG000|First 12 Months|Sponsor terminated study|2
6847005|NCT00320190|10853678|FG001|First 12 Months|Sponsor terminated study|2
6847006|NCT00320190|10853677|FG000|First 12 Months|Lost to Follow-up|0
6847007|NCT00320190|10853678|FG001|First 12 Months|Lost to Follow-up|1
6847008|NCT00320190|10853677|FG000|First 12 Months|Enrollment failure|0
6847009|NCT00320190|10853678|FG001|First 12 Months|Enrollment failure|1
6847010|NCT00320190|10853677|FG000|First 12 Months|Adverse event unrelated to study drug|1
6847011|NCT00320190|10853678|FG001|First 12 Months|Adverse event unrelated to study drug|0
6847012|NCT00320190|10853677|FG000|First 12 Months|Investigator request|0
6847013|NCT00320190|10853678|FG001|First 12 Months|Investigator request|1
6847014|NCT00320190|10853677|FG000|First 12 Months|Study drug toxicity|0
6847015|NCT00320190|10853678|FG001|First 12 Months|Study drug toxicity|1
6847016|NCT00320190|10853677|FG000|First 12 Months|Withdrawal by Subject|0
6847017|NCT00320190|10853678|FG001|First 12 Months|Withdrawal by Subject|1
6847018|NCT00320190|10853677|FG000|Long-term (12-month) Extension|Sponsor terminated study|7
6847019|NCT00320190|10853678|FG001|Long-term (12-month) Extension|Sponsor terminated study|0
6847020|NCT00320190|10853677|FG000|Long-term (12-month) Extension|Lack of major molecular response|1
6847021|NCT00320190|10853678|FG001|Long-term (12-month) Extension|Lack of major molecular response|2
6847022|NCT00320190|10853677|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1
6847023|NCT00320190|10853678|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0
6847024|NCT00320216|10853689|FG000|Overall Study|Adverse Event|0
6847025|NCT00320216|10853690|FG001|Overall Study|Adverse Event|6
6847026|NCT00320216|10853691|FG002|Overall Study|Adverse Event|0
6847027|NCT00320216|10853692|FG003|Overall Study|Adverse Event|2
6847028|NCT00320216|10853693|FG004|Overall Study|Adverse Event|2
6847029|NCT00320216|10853689|FG000|Overall Study|Lack of Efficacy|6
6847030|NCT00320216|10853690|FG001|Overall Study|Lack of Efficacy|2
6847031|NCT00320216|10853691|FG002|Overall Study|Lack of Efficacy|1
6847032|NCT00320216|10853692|FG003|Overall Study|Lack of Efficacy|0
6847033|NCT00320216|10853693|FG004|Overall Study|Lack of Efficacy|1
6847034|NCT00320216|10853689|FG000|Overall Study|Lost to Follow-up|3
6847035|NCT00320216|10853690|FG001|Overall Study|Lost to Follow-up|0
6847036|NCT00320216|10853691|FG002|Overall Study|Lost to Follow-up|0
6847037|NCT00320216|10853692|FG003|Overall Study|Lost to Follow-up|0
6847038|NCT00320216|10853693|FG004|Overall Study|Lost to Follow-up|0
6847039|NCT00320216|10853689|FG000|Overall Study|Other|7
6847040|NCT00320216|10853690|FG001|Overall Study|Other|2
6847041|NCT00320216|10853691|FG002|Overall Study|Other|5
6847042|NCT00320216|10853692|FG003|Overall Study|Other|1
6847043|NCT00320216|10853693|FG004|Overall Study|Other|3
6847044|NCT00320255|10853724|FG000|Overall Study|Lack of Efficacy|1
6847045|NCT00320255|10853725|FG001|Overall Study|Lack of Efficacy|0
6847046|NCT00320255|10853726|FG002|Overall Study|Lack of Efficacy|0
6847047|NCT00320255|10853727|FG003|Overall Study|Lack of Efficacy|0
6847048|NCT00320255|10853728|FG004|Overall Study|Lack of Efficacy|0
6847049|NCT00320255|10853729|FG005|Overall Study|Lack of Efficacy|0
6847050|NCT00320255|10853724|FG000|Overall Study|Adverse Event|5
6847051|NCT00320255|10853725|FG001|Overall Study|Adverse Event|2
6847052|NCT00320255|10853726|FG002|Overall Study|Adverse Event|3
6847053|NCT00320255|10853727|FG003|Overall Study|Adverse Event|2
6847054|NCT00320255|10853728|FG004|Overall Study|Adverse Event|0
6847055|NCT00320255|10853729|FG005|Overall Study|Adverse Event|0
6847056|NCT00320255|10853724|FG000|Overall Study|Withdrawal by Subject|1
6847057|NCT00320255|10853725|FG001|Overall Study|Withdrawal by Subject|2
6847058|NCT00320255|10853726|FG002|Overall Study|Withdrawal by Subject|2
6847059|NCT00320255|10853727|FG003|Overall Study|Withdrawal by Subject|4
6847060|NCT00320255|10853728|FG004|Overall Study|Withdrawal by Subject|0
6847061|NCT00320255|10853729|FG005|Overall Study|Withdrawal by Subject|0
6847062|NCT00320255|10853724|FG000|Overall Study|Poor compliance/noncompliance|1
6847063|NCT00320255|10853725|FG001|Overall Study|Poor compliance/noncompliance|1
6847064|NCT00320255|10853726|FG002|Overall Study|Poor compliance/noncompliance|0
6847065|NCT00320255|10853727|FG003|Overall Study|Poor compliance/noncompliance|1
6847066|NCT00320255|10853728|FG004|Overall Study|Poor compliance/noncompliance|0
6847067|NCT00320255|10853729|FG005|Overall Study|Poor compliance/noncompliance|0
6847068|NCT00320255|10853724|FG000|Overall Study|No longer meets study criteria|0
6847069|NCT00320255|10853725|FG001|Overall Study|No longer meets study criteria|0
6847070|NCT00320255|10853726|FG002|Overall Study|No longer meets study criteria|0
6847071|NCT00320255|10853727|FG003|Overall Study|No longer meets study criteria|1
6847072|NCT00320255|10853728|FG004|Overall Study|No longer meets study criteria|0
6847073|NCT00320255|10853729|FG005|Overall Study|No longer meets study criteria|0
6847074|NCT00320255|10853724|FG000|Overall Study|Other|3
6847075|NCT00320255|10853725|FG001|Overall Study|Other|2
6847076|NCT00320255|10853726|FG002|Overall Study|Other|1
6847077|NCT00320255|10853727|FG003|Overall Study|Other|0
6847078|NCT00320255|10853728|FG004|Overall Study|Other|0
6847079|NCT00320255|10853729|FG005|Overall Study|Other|0
6847080|NCT00320372|10853758|FG000|Overall Study|Physician Decision|4
6847081|NCT00320372|10853759|FG001|Overall Study|Physician Decision|7
6847082|NCT00320372|10853758|FG000|Overall Study|Death|7
6847083|NCT00320372|10853759|FG001|Overall Study|Death|8
6847084|NCT00320372|10853758|FG000|Overall Study|Withdrawal by Subject|55
6847085|NCT00320372|10853759|FG001|Overall Study|Withdrawal by Subject|37
6847086|NCT00320372|10853758|FG000|Overall Study|Non-Compliance|40
6847087|NCT00320372|10853759|FG001|Overall Study|Non-Compliance|39
6847088|NCT00320372|10853758|FG000|Overall Study|Did not Meet (I/E)|3
6847089|NCT00320372|10853759|FG001|Overall Study|Did not Meet (I/E)|1
6847090|NCT00320372|10853758|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86
6847091|NCT00320372|10853759|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71
6847092|NCT00320385|10853775|FG000|Overall Study|Lost to Follow-up|7
6847093|NCT00320385|10853776|FG001|Overall Study|Lost to Follow-up|10
6847094|NCT00320385|10853775|FG000|Overall Study|Withdrawal by Subject|6
6847095|NCT00320385|10853776|FG001|Overall Study|Withdrawal by Subject|7
6847096|NCT00320385|10853775|FG000|Overall Study|Sponsor Terminated Study|2
6847097|NCT00320385|10853776|FG001|Overall Study|Sponsor Terminated Study|1
6847098|NCT00320385|10853775|FG000|Overall Study|Investigator Decision|0
6847099|NCT00320385|10853776|FG001|Overall Study|Investigator Decision|1
7077401|NCT02091739|11184895|FG003|EP: 48 Weeks|Adverse Event|2
7077402|NCT02091739|11184896|FG004|EP: 48 Weeks|Adverse Event|6
6847100|NCT00320385|10853775|FG000|Overall Study|Death|1
6847101|NCT00320385|10853776|FG001|Overall Study|Death|2
6847102|NCT00320385|10853775|FG000|Overall Study|Serious Adverse Event|1
6847103|NCT00320385|10853776|FG001|Overall Study|Serious Adverse Event|0
6847104|NCT00320385|10853775|FG000|Overall Study|Withdrew Consent|1
6847105|NCT00320385|10853776|FG001|Overall Study|Withdrew Consent|0
6847106|NCT00320385|10853775|FG000|Overall Study|Adverse Event|0
6847107|NCT00320385|10853776|FG001|Overall Study|Adverse Event|1
6847108|NCT00320398|10853784|FG000|Overall Study|Adverse Event|1
6847109|NCT00320398|10853785|FG001|Overall Study|Adverse Event|4
6847110|NCT00320398|10853784|FG000|Overall Study|Other|1
6847111|NCT00320398|10853785|FG001|Overall Study|Other|0
6847112|NCT00320411|10853792|FG000|Overall Study|No investigational product admin.|4
6847113|NCT00320424|10853796|FG000|Overall Study|Adverse Event|3
6847114|NCT00320424|10853796|FG000|Overall Study|Other|3
6847115|NCT00320489|10853802|FG000|Overall Study|Adverse Event|26
6847116|NCT00320489|10853803|FG001|Overall Study|Adverse Event|25
6847117|NCT00320489|10853802|FG000|Overall Study|Clinical Relapse|26
6847118|NCT00320489|10853803|FG001|Overall Study|Clinical Relapse|20
6847119|NCT00320489|10853802|FG000|Overall Study|Death|0
6847120|NCT00320489|10853803|FG001|Overall Study|Death|2
6847121|NCT00320489|10853802|FG000|Overall Study|Entry Criteria Exclusion|2
6847122|NCT00320489|10853803|FG001|Overall Study|Entry Criteria Exclusion|4
6847123|NCT00320489|10853802|FG000|Overall Study|Lack of Efficacy|16
6847124|NCT00320489|10853803|FG001|Overall Study|Lack of Efficacy|7
6847125|NCT00320489|10853802|FG000|Overall Study|Lost to Follow-up|21
6847126|NCT00320489|10853803|FG001|Overall Study|Lost to Follow-up|22
6847127|NCT00320489|10853802|FG000|Overall Study|Physician Decision|8
6847128|NCT00320489|10853803|FG001|Overall Study|Physician Decision|8
6847129|NCT00320489|10853802|FG000|Overall Study|Protocol Violation|4
6847130|NCT00320489|10853803|FG001|Overall Study|Protocol Violation|4
6847131|NCT00320489|10853802|FG000|Overall Study|Sponsor Decision|3
6847132|NCT00320489|10853803|FG001|Overall Study|Sponsor Decision|3
7077403|NCT02091739|11184892|FG000|EP: 48 Weeks|Withdrawal by Subject|0
7151475|NCT03231943|11315493|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7151476|NCT03231943|11315494|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0
6847133|NCT00320489|10853802|FG000|Overall Study|Withdrawal by Subject|39
6847134|NCT00320489|10853803|FG001|Overall Study|Withdrawal by Subject|41
6847135|NCT00320515|10853809|FG000|Overall Study|Death|33
6847136|NCT00320515|10853809|FG000|Overall Study|Lost to Follow-up|6
6847137|NCT00320515|10853809|FG000|Overall Study|Physician Decision|2
6847138|NCT00320515|10853809|FG000|Overall Study|Withdrawal by Subject|8
6847139|NCT00320528|10853816|FG000|Study Period II|Adverse Event|3
6847140|NCT00320528|10853817|FG001|Study Period II|Adverse Event|4
6847141|NCT00320528|10853818|FG002|Study Period II|Adverse Event|8
6847142|NCT00320528|10853816|FG000|Study Period II|Parent/Caregiver Decision|8
6847143|NCT00320528|10853817|FG001|Study Period II|Parent/Caregiver Decision|3
7077404|NCT02091739|11184893|FG001|EP: 48 Weeks|Withdrawal by Subject|0
7077405|NCT02091739|11184894|FG002|EP: 48 Weeks|Withdrawal by Subject|0
7077406|NCT02091739|11184895|FG003|EP: 48 Weeks|Withdrawal by Subject|2
7077407|NCT02091739|11184896|FG004|EP: 48 Weeks|Withdrawal by Subject|6
7077408|NCT02091869|11184925|FG000|Overall Study|Withdrawal by Subject|0
7077409|NCT02091869|11184926|FG001|Overall Study|Withdrawal by Subject|3
7077410|NCT02091921|11184936|FG000|Overall Study|Adverse Event|3
7077411|NCT02091986|11184946|FG000|Overall Study|7 rand in error 1 patient decision|2
7077412|NCT02091986|11184947|FG001|Overall Study|7 rand in error 1 patient decision|3
7077413|NCT02091986|11184948|FG002|Overall Study|7 rand in error 1 patient decision|3
7077414|NCT02091986|11184946|FG000|Overall Study|Lost to Follow-up|1
7077415|NCT02091986|11184947|FG001|Overall Study|Lost to Follow-up|0
7077416|NCT02091986|11184948|FG002|Overall Study|Lost to Follow-up|0
7077417|NCT02091986|11184946|FG000|Overall Study|Withdrawal by Subject|4
7077418|NCT02091986|11184947|FG001|Overall Study|Withdrawal by Subject|8
7077419|NCT02091986|11184948|FG002|Overall Study|Withdrawal by Subject|3
7077420|NCT02091986|11184946|FG000|Overall Study|Adverse Event|0
7077421|NCT02091986|11184947|FG001|Overall Study|Adverse Event|0
6847144|NCT00320528|10853818|FG002|Study Period II|Parent/Caregiver Decision|11
6847145|NCT00320528|10853816|FG000|Study Period II|Withdrawal by Subject|0
6847146|NCT00320528|10853817|FG001|Study Period II|Withdrawal by Subject|1
6847147|NCT00320528|10853818|FG002|Study Period II|Withdrawal by Subject|1
6847148|NCT00320528|10853816|FG000|Study Period II|Entry Criteria Exclusion|0
6847149|NCT00320528|10853817|FG001|Study Period II|Entry Criteria Exclusion|2
6847150|NCT00320528|10853818|FG002|Study Period II|Entry Criteria Exclusion|2
6847151|NCT00320528|10853816|FG000|Study Period III|Adverse Event|1
6847152|NCT00320528|10853817|FG001|Study Period III|Adverse Event|0
6847153|NCT00320528|10853818|FG002|Study Period III|Adverse Event|0
6847154|NCT00320528|10853816|FG000|Study Period III|Lost to Follow-up|1
6847155|NCT00320528|10853817|FG001|Study Period III|Lost to Follow-up|0
6847156|NCT00320528|10853818|FG002|Study Period III|Lost to Follow-up|0
6847157|NCT00320528|10853816|FG000|Study Period III|Withdrawal by Subject|1
6847158|NCT00320528|10853817|FG001|Study Period III|Withdrawal by Subject|1
6847159|NCT00320528|10853818|FG002|Study Period III|Withdrawal by Subject|2
6847160|NCT00320528|10853816|FG000|Study Period III|Lack of Efficacy|2
6847161|NCT00320528|10853817|FG001|Study Period III|Lack of Efficacy|0
6847162|NCT00320528|10853818|FG002|Study Period III|Lack of Efficacy|0
6847163|NCT00320528|10853816|FG000|Study Period III|Parent/Caregiver Decision|14
6847164|NCT00320528|10853817|FG001|Study Period III|Parent/Caregiver Decision|3
6847165|NCT00320528|10853818|FG002|Study Period III|Parent/Caregiver Decision|11
6847166|NCT00320528|10853816|FG000|Study Period III|Protocol Violation|0
6847167|NCT00320528|10853817|FG001|Study Period III|Protocol Violation|1
6847168|NCT00320528|10853818|FG002|Study Period III|Protocol Violation|0
6847169|NCT00320528|10853816|FG000|Study Period III|Physician Decision|0
6847170|NCT00320528|10853817|FG001|Study Period III|Physician Decision|1
6847171|NCT00320528|10853818|FG002|Study Period III|Physician Decision|2
6847172|NCT00320528|10853816|FG000|Study Period III|Sponsor Decision|0
6847173|NCT00320528|10853817|FG001|Study Period III|Sponsor Decision|0
6847174|NCT00320528|10853818|FG002|Study Period III|Sponsor Decision|1
6847175|NCT00320528|10853816|FG000|Study Period III|Atomoxetine Commercially Available|68
6847176|NCT00320528|10853817|FG001|Study Period III|Atomoxetine Commercially Available|25
6847177|NCT00320528|10853818|FG002|Study Period III|Atomoxetine Commercially Available|90
6847178|NCT00320541|10853828|FG000|Overall Study|Adverse Event|21
6847179|NCT00320541|10853829|FG001|Overall Study|Adverse Event|19
6847180|NCT00320541|10853828|FG000|Overall Study|Protocol Violation|0
6847181|NCT00320541|10853829|FG001|Overall Study|Protocol Violation|1
6847182|NCT00320541|10853828|FG000|Overall Study|Withdrawal by Subject|12
6847183|NCT00320541|10853829|FG001|Overall Study|Withdrawal by Subject|16
6847184|NCT00320541|10853828|FG000|Overall Study|Physician Decision|9
6847185|NCT00320541|10853829|FG001|Overall Study|Physician Decision|13
6847186|NCT00320541|10853828|FG000|Overall Study|Other|3
6847187|NCT00320541|10853829|FG001|Overall Study|Other|4
6847188|NCT00320541|10853828|FG000|Overall Study|Sponsor Decision|2
6847189|NCT00320541|10853829|FG001|Overall Study|Sponsor Decision|1
6847190|NCT00320541|10853828|FG000|Overall Study|Death due to Study Disease|1
6847191|NCT00320541|10853829|FG001|Overall Study|Death due to Study Disease|3
6847192|NCT00320541|10853828|FG000|Overall Study|Death due to Adverse Event(s)|1
6847193|NCT00320541|10853829|FG001|Overall Study|Death due to Adverse Event(s)|0
6847194|NCT00320541|10853828|FG000|Overall Study|Protocol Entry Criterion Not Met|1
6847195|NCT00320541|10853829|FG001|Overall Study|Protocol Entry Criterion Not Met|0
6847196|NCT00320593|10853837|FG000|Overall Study|Lost to Follow-up|3
6847197|NCT00320593|10853838|FG001|Overall Study|Lost to Follow-up|0
6847198|NCT00320593|10853837|FG000|Overall Study|Moved to another state|1
6847199|NCT00320593|10853838|FG001|Overall Study|Moved to another state|0
6847200|NCT00320593|10853837|FG000|Overall Study|Withdrawal by Subject|2
6847201|NCT00320593|10853838|FG001|Overall Study|Withdrawal by Subject|1
6847202|NCT00320593|10853837|FG000|Overall Study|Withdrawal by clinical center|1
6847203|NCT00320593|10853838|FG001|Overall Study|Withdrawal by clinical center|0
6847204|NCT00320606|10853844|FG000|Overall Study|Adverse Event|1
6847205|NCT00320606|10853844|FG000|Overall Study|Protocol Violation|1
6847206|NCT00320606|10853844|FG000|Overall Study|Withdrawal by Subject|1
6847207|NCT00320710|10853861|FG000|Overall Study|Disease progression|24
6847208|NCT00320710|10853862|FG001|Overall Study|Disease progression|19
6847209|NCT00320710|10853863|FG002|Overall Study|Disease progression|2
6847210|NCT00320710|10853861|FG000|Overall Study|Death|10
6847211|NCT00320710|10853862|FG001|Overall Study|Death|7
6847212|NCT00320710|10853863|FG002|Overall Study|Death|1
6847213|NCT00320710|10853861|FG000|Overall Study|Administrative problems|1
6847214|NCT00320710|10853862|FG001|Overall Study|Administrative problems|2
6847215|NCT00320710|10853863|FG002|Overall Study|Administrative problems|0
6847216|NCT00320710|10853861|FG000|Overall Study|Withdrawal by Subject|20
6847217|NCT00320710|10853862|FG001|Overall Study|Withdrawal by Subject|26
6847218|NCT00320710|10853863|FG002|Overall Study|Withdrawal by Subject|1
6847219|NCT00320710|10853861|FG000|Overall Study|Protocol Violation|6
6847220|NCT00320710|10853862|FG001|Overall Study|Protocol Violation|5
6847221|NCT00320710|10853863|FG002|Overall Study|Protocol Violation|0
6847222|NCT00320710|10853861|FG000|Overall Study|Abnormal test procedure result(s)|2
6847223|NCT00320710|10853862|FG001|Overall Study|Abnormal test procedure result(s)|0
6847224|NCT00320710|10853863|FG002|Overall Study|Abnormal test procedure result(s)|0
6847225|NCT00320710|10853861|FG000|Overall Study|Abnormal laboratory value(s)|12
6847226|NCT00320710|10853862|FG001|Overall Study|Abnormal laboratory value(s)|3
6847227|NCT00320710|10853863|FG002|Overall Study|Abnormal laboratory value(s)|0
6847228|NCT00320710|10853861|FG000|Overall Study|Adverse Event|18
6847229|NCT00320710|10853862|FG001|Overall Study|Adverse Event|14
6847230|NCT00320710|10853863|FG002|Overall Study|Adverse Event|1
6847231|NCT00320710|10853861|FG000|Overall Study|Lost to Follow-up|1
6847232|NCT00320710|10853862|FG001|Overall Study|Lost to Follow-up|0
6847233|NCT00320710|10853863|FG002|Overall Study|Lost to Follow-up|0
6847234|NCT00320788|10853882|FG000|Overall Study|Adverse Event|0
6847235|NCT00320788|10853883|FG001|Overall Study|Adverse Event|0
6847236|NCT00320788|10853884|FG002|Overall Study|Adverse Event|0
6847237|NCT00320788|10853885|FG003|Overall Study|Adverse Event|1
6847238|NCT00320788|10853886|FG004|Overall Study|Adverse Event|0
6847239|NCT00320788|10853882|FG000|Overall Study|Death|0
6847240|NCT00320788|10853883|FG001|Overall Study|Death|0
6847241|NCT00320788|10853884|FG002|Overall Study|Death|1
6847242|NCT00320788|10853885|FG003|Overall Study|Death|0
6847243|NCT00320788|10853886|FG004|Overall Study|Death|1
6847244|NCT00320788|10853882|FG000|Overall Study|Lost to Follow-up|0
6847245|NCT00320788|10853883|FG001|Overall Study|Lost to Follow-up|2
6847246|NCT00320788|10853884|FG002|Overall Study|Lost to Follow-up|1
6847247|NCT00320788|10853885|FG003|Overall Study|Lost to Follow-up|0
6847248|NCT00320788|10853886|FG004|Overall Study|Lost to Follow-up|0
6847249|NCT00320788|10853882|FG000|Overall Study|Decision by the Sponsor|1
6847250|NCT00320788|10853883|FG001|Overall Study|Decision by the Sponsor|1
6847251|NCT00320788|10853884|FG002|Overall Study|Decision by the Sponsor|0
6847252|NCT00320788|10853885|FG003|Overall Study|Decision by the Sponsor|0
6847253|NCT00320788|10853886|FG004|Overall Study|Decision by the Sponsor|1
6847254|NCT00320788|10853882|FG000|Overall Study|Other|1
6847255|NCT00320788|10853883|FG001|Overall Study|Other|2
6847256|NCT00320788|10853884|FG002|Overall Study|Other|1
6847257|NCT00320788|10853885|FG003|Overall Study|Other|1
6847258|NCT00320788|10853886|FG004|Overall Study|Other|1
6847259|NCT00320788|10853882|FG000|Overall Study|Physician Decision|1
6847260|NCT00320788|10853883|FG001|Overall Study|Physician Decision|1
6847261|NCT00320788|10853884|FG002|Overall Study|Physician Decision|0
7077422|NCT02091986|11184948|FG002|Overall Study|Adverse Event|2
7077423|NCT02092025|11184956|FG000|Overall Study|Case Report Forms Uncollected|44
7151477|NCT03231943|11315495|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7151478|NCT03231943|11315496|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0
6847262|NCT00320788|10853885|FG003|Overall Study|Physician Decision|0
6847263|NCT00320788|10853886|FG004|Overall Study|Physician Decision|0
6847264|NCT00320788|10853882|FG000|Overall Study|Protocol Violation|0
6847265|NCT00320788|10853883|FG001|Overall Study|Protocol Violation|0
6847266|NCT00320788|10853884|FG002|Overall Study|Protocol Violation|0
6847267|NCT00320788|10853885|FG003|Overall Study|Protocol Violation|0
6847268|NCT00320788|10853886|FG004|Overall Study|Protocol Violation|1
6847269|NCT00320788|10853882|FG000|Overall Study|Withdrawal by Subject|3
6847270|NCT00320788|10853883|FG001|Overall Study|Withdrawal by Subject|0
6847271|NCT00320788|10853884|FG002|Overall Study|Withdrawal by Subject|0
7151479|NCT03231943|11315497|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7151480|NCT03231943|11315498|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7151481|NCT03231943|11315499|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7151482|NCT03231943|11315500|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7151483|NCT03231943|11315501|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7151484|NCT03231943|11315502|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7151485|NCT03231943|11315503|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7151486|NCT03231943|11315491|FG000|Part 2|Adverse Event|0
6847272|NCT00320788|10853885|FG003|Overall Study|Withdrawal by Subject|3
6847273|NCT00320788|10853886|FG004|Overall Study|Withdrawal by Subject|1
6847274|NCT00320801|10853906|FG000|Open-label Run-in Period|Withdrawal by Subject|2
6847275|NCT00320801|10853907|FG001|Open-label Run-in Period|Withdrawal by Subject|0
6847276|NCT00320801|10853908|FG002|Open-label Run-in Period|Withdrawal by Subject|0
6847277|NCT00320801|10853909|FG003|Open-label Run-in Period|Withdrawal by Subject|0
6847278|NCT00320801|10853906|FG000|Open-label Run-in Period|Adverse Event|33
6847279|NCT00320801|10853907|FG001|Open-label Run-in Period|Adverse Event|0
6847280|NCT00320801|10853908|FG002|Open-label Run-in Period|Adverse Event|0
6847281|NCT00320801|10853909|FG003|Open-label Run-in Period|Adverse Event|0
7077424|NCT02092025|11184956|FG000|Overall Study|Protocol Deviation|24
7077425|NCT02092116|11184962|FG000|Overall Study|Withdrawal by Subject|0
7077426|NCT02092116|11184963|FG001|Overall Study|Withdrawal by Subject|3
7077427|NCT02092116|11184962|FG000|Overall Study|Adverse Event|0
7077428|NCT02092116|11184963|FG001|Overall Study|Adverse Event|1
7077429|NCT02092220|11184987|FG000|Period 1|Unrelated Illness|0
7077430|NCT02092220|11184988|FG001|Period 1|Unrelated Illness|2
7077431|NCT02092220|11184987|FG000|Period 2|Severe Hypoglycaemia|1
7077432|NCT02092220|11184988|FG001|Period 2|Severe Hypoglycaemia|0
7077433|NCT02092220|11184987|FG000|Period 2|Nausea, Anxiety, Inconvenience|0
7077434|NCT02092220|11184988|FG001|Period 2|Nausea, Anxiety, Inconvenience|1
7077435|NCT02092285|11184996|FG000|Induction Phase|Adverse Event|7
7077436|NCT02092285|11184996|FG000|Induction Phase|Physician Decision|4
7077437|NCT02092285|11184996|FG000|Induction Phase|Pregnancy|1
6847282|NCT00320801|10853906|FG000|Open-label Run-in Period|Administrative|10
6847283|NCT00320801|10853907|FG001|Open-label Run-in Period|Administrative|0
6847284|NCT00320801|10853908|FG002|Open-label Run-in Period|Administrative|0
6847285|NCT00320801|10853909|FG003|Open-label Run-in Period|Administrative|0
6847286|NCT00320801|10853906|FG000|Open-label Run-in Period|Lack of Efficacy|44
6847287|NCT00320801|10853907|FG001|Open-label Run-in Period|Lack of Efficacy|0
6847288|NCT00320801|10853908|FG002|Open-label Run-in Period|Lack of Efficacy|0
6847289|NCT00320801|10853909|FG003|Open-label Run-in Period|Lack of Efficacy|0
6847290|NCT00320801|10853906|FG000|Open-label Run-in Period|Lost to Follow-up|2
6847291|NCT00320801|10853907|FG001|Open-label Run-in Period|Lost to Follow-up|0
6847292|NCT00320801|10853908|FG002|Open-label Run-in Period|Lost to Follow-up|0
6847293|NCT00320801|10853909|FG003|Open-label Run-in Period|Lost to Follow-up|0
6847294|NCT00320801|10853906|FG000|Open-label Run-in Period|Did not qualify|1
6847295|NCT00320801|10853907|FG001|Open-label Run-in Period|Did not qualify|0
6847296|NCT00320801|10853908|FG002|Open-label Run-in Period|Did not qualify|0
6847297|NCT00320801|10853909|FG003|Open-label Run-in Period|Did not qualify|0
6847298|NCT00320801|10853906|FG000|Double-blind Phase|Withdrawal by Subject|0
6847299|NCT00320801|10853907|FG001|Double-blind Phase|Withdrawal by Subject|0
6847300|NCT00320801|10853908|FG002|Double-blind Phase|Withdrawal by Subject|1
6847301|NCT00320801|10853909|FG003|Double-blind Phase|Withdrawal by Subject|0
6847302|NCT00320801|10853906|FG000|Double-blind Phase|Adverse Event|0
6847303|NCT00320801|10853907|FG001|Double-blind Phase|Adverse Event|2
6847304|NCT00320801|10853908|FG002|Double-blind Phase|Adverse Event|8
6847305|NCT00320801|10853909|FG003|Double-blind Phase|Adverse Event|0
6847306|NCT00320801|10853906|FG000|Double-blind Phase|Administrative|0
6847307|NCT00320801|10853907|FG001|Double-blind Phase|Administrative|0
6847308|NCT00320801|10853908|FG002|Double-blind Phase|Administrative|4
6847309|NCT00320801|10853909|FG003|Double-blind Phase|Administrative|0
6847310|NCT00320801|10853906|FG000|Double-blind Phase|Lack of Efficacy|0
6847311|NCT00320801|10853907|FG001|Double-blind Phase|Lack of Efficacy|9
6847312|NCT00320801|10853908|FG002|Double-blind Phase|Lack of Efficacy|1
6847313|NCT00320801|10853909|FG003|Double-blind Phase|Lack of Efficacy|0
6847314|NCT00320801|10853906|FG000|Extension Phase|Withdrawal by Subject|0
6847315|NCT00320801|10853907|FG001|Extension Phase|Withdrawal by Subject|0
6847316|NCT00320801|10853908|FG002|Extension Phase|Withdrawal by Subject|0
6847317|NCT00320801|10853909|FG003|Extension Phase|Withdrawal by Subject|6
6847318|NCT00320801|10853906|FG000|Extension Phase|Adverse Event|0
6847319|NCT00320801|10853907|FG001|Extension Phase|Adverse Event|0
6847320|NCT00320801|10853908|FG002|Extension Phase|Adverse Event|0
6847321|NCT00320801|10853909|FG003|Extension Phase|Adverse Event|8
6847322|NCT00320801|10853906|FG000|Extension Phase|Administrative|0
6847323|NCT00320801|10853907|FG001|Extension Phase|Administrative|0
6847324|NCT00320801|10853908|FG002|Extension Phase|Administrative|0
6847325|NCT00320801|10853909|FG003|Extension Phase|Administrative|29
6847326|NCT00320801|10853906|FG000|Extension Phase|Lack of Efficacy|0
7151487|NCT03231943|11315492|FG001|Part 2|Adverse Event|0
7151488|NCT03231943|11315493|FG002|Part 2|Adverse Event|0
7151489|NCT03231943|11315494|FG003|Part 2|Adverse Event|0
7151490|NCT03231943|11315495|FG004|Part 2|Adverse Event|0
7151491|NCT03231943|11315496|FG005|Part 2|Adverse Event|0
7151492|NCT03231943|11315497|FG006|Part 2|Adverse Event|0
7151493|NCT03231943|11315498|FG007|Part 2|Adverse Event|0
7151494|NCT03231943|11315499|FG008|Part 2|Adverse Event|0
7151495|NCT03231943|11315500|FG009|Part 2|Adverse Event|0
7151496|NCT03231943|11315501|FG010|Part 2|Adverse Event|1
7151497|NCT03231943|11315502|FG011|Part 2|Adverse Event|0
7151498|NCT03231943|11315503|FG012|Part 2|Adverse Event|0
7151499|NCT03231943|11315491|FG000|Part 2|Withdrawal by Subject|0
7151500|NCT03231943|11315492|FG001|Part 2|Withdrawal by Subject|0
7151501|NCT03231943|11315493|FG002|Part 2|Withdrawal by Subject|0
7151502|NCT03231943|11315494|FG003|Part 2|Withdrawal by Subject|0
7151503|NCT03231943|11315495|FG004|Part 2|Withdrawal by Subject|0
7151504|NCT03231943|11315496|FG005|Part 2|Withdrawal by Subject|0
7151505|NCT03231943|11315497|FG006|Part 2|Withdrawal by Subject|0
7151506|NCT03231943|11315498|FG007|Part 2|Withdrawal by Subject|0
7151507|NCT03231943|11315499|FG008|Part 2|Withdrawal by Subject|0
7151508|NCT03231943|11315500|FG009|Part 2|Withdrawal by Subject|0
7151509|NCT03231943|11315501|FG010|Part 2|Withdrawal by Subject|0
7151510|NCT03231943|11315502|FG011|Part 2|Withdrawal by Subject|1
7151511|NCT03231943|11315503|FG012|Part 2|Withdrawal by Subject|0
7151512|NCT03232281|11315552|FG000|Overall Study|Adverse Event|1
6847327|NCT00320801|10853907|FG001|Extension Phase|Lack of Efficacy|0
6847328|NCT00320801|10853908|FG002|Extension Phase|Lack of Efficacy|0
6847329|NCT00320801|10853909|FG003|Extension Phase|Lack of Efficacy|2
6847330|NCT00320801|10853906|FG000|Extension Phase|Lost to Follow-up|0
6847331|NCT00320801|10853907|FG001|Extension Phase|Lost to Follow-up|0
6847332|NCT00320801|10853908|FG002|Extension Phase|Lost to Follow-up|0
6847333|NCT00320801|10853909|FG003|Extension Phase|Lost to Follow-up|3
6847334|NCT00321048|10853921|FG000|Overall Study|Withdrawal by Subject|6
7151513|NCT03232281|11315553|FG001|Overall Study|Adverse Event|1
7151514|NCT03232281|11315552|FG000|Overall Study|Withdrawal by Subject|5
7151515|NCT03232281|11315553|FG001|Overall Study|Withdrawal by Subject|4
7151516|NCT03232281|11315552|FG000|Overall Study|Protocol Deviation|1
6847335|NCT00321048|10853922|FG001|Overall Study|Withdrawal by Subject|8
7151517|NCT03232281|11315553|FG001|Overall Study|Protocol Deviation|1
7151518|NCT03232333|11315559|FG000|Overall Study|Infection or Osteomyelitis|9
7151519|NCT03232333|11315559|FG000|Overall Study|Lost to Follow-up|4
7151520|NCT03232333|11315559|FG000|Overall Study|Withdrawal by Subject|2
6847336|NCT00321373|10853946|FG000|Overall Study|Adverse Event|0
6847337|NCT00321373|10853947|FG001|Overall Study|Adverse Event|0
6847338|NCT00321373|10853948|FG002|Overall Study|Adverse Event|1
6847339|NCT00321373|10853946|FG000|Overall Study|Lost to Follow-up|1
6847340|NCT00321373|10853947|FG001|Overall Study|Lost to Follow-up|0
6847341|NCT00321373|10853948|FG002|Overall Study|Lost to Follow-up|1
6847342|NCT00321373|10853946|FG000|Overall Study|Withdrawal by Subject|1
6847343|NCT00321373|10853947|FG001|Overall Study|Withdrawal by Subject|0
6847344|NCT00321373|10853948|FG002|Overall Study|Withdrawal by Subject|0
6847345|NCT00321373|10853946|FG000|Overall Study|Other|0
6847346|NCT00321373|10853947|FG001|Overall Study|Other|0
6847347|NCT00321373|10853948|FG002|Overall Study|Other|1
6847348|NCT00321464|10853958|FG000|Overall Study|Death|169
6847349|NCT00321464|10853959|FG001|Overall Study|Death|174
6847350|NCT00321464|10853958|FG000|Overall Study|Disease progression|124
6847351|NCT00321464|10853959|FG001|Overall Study|Disease progression|124
6847352|NCT00321464|10853958|FG000|Overall Study|Withdrawal by Subject|117
6847353|NCT00321464|10853959|FG001|Overall Study|Withdrawal by Subject|118
6847354|NCT00321464|10853958|FG000|Overall Study|Participant request|57
6847355|NCT00321464|10853959|FG001|Overall Study|Participant request|61
6847356|NCT00321464|10853958|FG000|Overall Study|Adverse Event|43
6847357|NCT00321464|10853959|FG001|Overall Study|Adverse Event|28
6847358|NCT00321464|10853958|FG000|Overall Study|Physician Decision|15
6847359|NCT00321464|10853959|FG001|Overall Study|Physician Decision|14
6847360|NCT00321464|10853958|FG000|Overall Study|Noncompliance|4
6847361|NCT00321464|10853959|FG001|Overall Study|Noncompliance|10
6847362|NCT00321464|10853958|FG000|Overall Study|Lost to Follow-up|7
6847363|NCT00321464|10853959|FG001|Overall Study|Lost to Follow-up|8
6847364|NCT00321464|10853958|FG000|Overall Study|Protocol deviation|0
6847365|NCT00321464|10853959|FG001|Overall Study|Protocol deviation|2
6847366|NCT00321464|10853958|FG000|Overall Study|Ineligibility determined|2
6847367|NCT00321464|10853959|FG001|Overall Study|Ineligibility determined|1
6847368|NCT00321464|10853958|FG000|Overall Study|Other|21
6847369|NCT00321464|10853959|FG001|Overall Study|Other|18
6847370|NCT00321620|10853985|FG000|Overall Study|Death|269
6847371|NCT00321620|10853986|FG001|Overall Study|Death|294
6847372|NCT00321620|10853985|FG000|Overall Study|Withdrawal by Subject|164
6847373|NCT00321620|10853986|FG001|Overall Study|Withdrawal by Subject|147
6847374|NCT00321620|10853985|FG000|Overall Study|Disease progression|113
6847375|NCT00321620|10853986|FG001|Overall Study|Disease progression|117
6847376|NCT00321620|10853985|FG000|Overall Study|Adverse Event|43
6847377|NCT00321620|10853986|FG001|Overall Study|Adverse Event|56
6847378|NCT00321620|10853985|FG000|Overall Study|Lost to Follow-up|13
6847379|NCT00321620|10853986|FG001|Overall Study|Lost to Follow-up|9
6847380|NCT00321620|10853985|FG000|Overall Study|Physician Decision|4
6847381|NCT00321620|10853986|FG001|Overall Study|Physician Decision|1
6847382|NCT00321620|10853985|FG000|Overall Study|Noncompliance|14
6847383|NCT00321620|10853986|FG001|Overall Study|Noncompliance|7
6847384|NCT00321620|10853985|FG000|Overall Study|Protocol deviation|4
6847385|NCT00321620|10853986|FG001|Overall Study|Protocol deviation|3
6847386|NCT00321620|10853985|FG000|Overall Study|Ineligibility determined|2
6847387|NCT00321620|10853986|FG001|Overall Study|Ineligibility determined|3
6847388|NCT00321620|10853985|FG000|Overall Study|Participant request|75
6847389|NCT00321620|10853986|FG001|Overall Study|Participant request|52
6847390|NCT00321620|10853985|FG000|Overall Study|Other|42
6847391|NCT00321620|10853986|FG001|Overall Study|Other|33
6847392|NCT00321646|10853992|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
7077438|NCT02092285|11184996|FG000|Induction Phase|Relapse/Recurrence|7
7077439|NCT02092285|11184996|FG000|Induction Phase|Withdrawal by Subject|2
7077440|NCT02092285|11184996|FG000|Induction Phase|Lack of Efficacy|14
7151521|NCT03232567|11315567|FG000|Overall Study|Withdrawal by Subject|0
7151522|NCT03232567|11315568|FG001|Overall Study|Withdrawal by Subject|1
7151523|NCT03232567|11315569|FG002|Overall Study|Withdrawal by Subject|0
7151524|NCT03232567|11315570|FG003|Overall Study|Withdrawal by Subject|0
7151525|NCT03232983|11315603|FG000|Period 1|Physician Decision|0
7151526|NCT03232983|11315604|FG001|Period 1|Physician Decision|0
7151527|NCT03232983|11315605|FG002|Period 1|Physician Decision|1
7151528|NCT03232983|11315606|FG003|Period 1|Physician Decision|0
6847393|NCT00321646|10853992|FG000|Neoadjuvant Chemotherapy|Adverse Event|2
6847394|NCT00321646|10853992|FG000|Neoadjuvant Chemotherapy|Disease progression|1
6847395|NCT00321672|10854000|FG000|Overall Study|Withdrawal by Subject|5
7077441|NCT02092285|11184996|FG000|Maintenance Phase & Follow-up|Adverse Event|22
7077442|NCT02092285|11184996|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1
7077443|NCT02092285|11184996|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2
7077444|NCT02092285|11184996|FG000|Maintenance Phase & Follow-up|Physician Decision|10
7151529|NCT03232983|11315603|FG000|Washout Period 2|Physician Decision|0
6847396|NCT00321672|10854001|FG001|Overall Study|Withdrawal by Subject|1
6847397|NCT00321672|10854002|FG002|Overall Study|Withdrawal by Subject|2
6847398|NCT00321672|10854003|FG003|Overall Study|Withdrawal by Subject|0
6847399|NCT00321672|10854000|FG000|Overall Study|Noncompliance|1
7151530|NCT03232983|11315604|FG001|Washout Period 2|Physician Decision|0
7151531|NCT03232983|11315605|FG002|Washout Period 2|Physician Decision|1
6847400|NCT00321672|10854001|FG001|Overall Study|Noncompliance|2
6847401|NCT00321672|10854002|FG002|Overall Study|Noncompliance|1
6847402|NCT00321672|10854003|FG003|Overall Study|Noncompliance|0
6847403|NCT00321672|10854000|FG000|Overall Study|Adverse Event|1
6847404|NCT00321672|10854001|FG001|Overall Study|Adverse Event|1
6847405|NCT00321672|10854002|FG002|Overall Study|Adverse Event|0
6847406|NCT00321672|10854003|FG003|Overall Study|Adverse Event|0
6847407|NCT00321672|10854000|FG000|Overall Study|Lack of Efficacy|1
6847408|NCT00321672|10854001|FG001|Overall Study|Lack of Efficacy|1
6847409|NCT00321672|10854002|FG002|Overall Study|Lack of Efficacy|0
6847410|NCT00321672|10854003|FG003|Overall Study|Lack of Efficacy|0
6847411|NCT00321672|10854000|FG000|Overall Study|Lost to Follow-up|2
6847412|NCT00321672|10854001|FG001|Overall Study|Lost to Follow-up|0
6847413|NCT00321672|10854002|FG002|Overall Study|Lost to Follow-up|4
6847414|NCT00321672|10854003|FG003|Overall Study|Lost to Follow-up|2
6847415|NCT00321672|10854000|FG000|Overall Study|Death|1
6847416|NCT00321672|10854001|FG001|Overall Study|Death|0
6847417|NCT00321672|10854002|FG002|Overall Study|Death|0
6847418|NCT00321672|10854003|FG003|Overall Study|Death|0
6847419|NCT00321672|10854000|FG000|Overall Study|Too far to travel for visits|1
6847420|NCT00321672|10854001|FG001|Overall Study|Too far to travel for visits|0
6847421|NCT00321672|10854002|FG002|Overall Study|Too far to travel for visits|0
6847422|NCT00321672|10854003|FG003|Overall Study|Too far to travel for visits|0
6847423|NCT00321672|10854000|FG000|Overall Study|Incarcerated|0
6847424|NCT00321672|10854001|FG001|Overall Study|Incarcerated|0
6847425|NCT00321672|10854002|FG002|Overall Study|Incarcerated|2
6847426|NCT00321672|10854003|FG003|Overall Study|Incarcerated|0
6847427|NCT00321672|10854000|FG000|Overall Study|Moved out of state|0
6847428|NCT00321672|10854001|FG001|Overall Study|Moved out of state|1
6847429|NCT00321672|10854002|FG002|Overall Study|Moved out of state|1
6847430|NCT00321672|10854003|FG003|Overall Study|Moved out of state|0
6847431|NCT00321672|10854000|FG000|Overall Study|Protocol Violation|0
6847432|NCT00321672|10854001|FG001|Overall Study|Protocol Violation|0
6847433|NCT00321672|10854002|FG002|Overall Study|Protocol Violation|1
6847434|NCT00321672|10854003|FG003|Overall Study|Protocol Violation|0
6847435|NCT00321672|10854000|FG000|Overall Study|Diagnosis of testicular cancer|0
6847436|NCT00321672|10854001|FG001|Overall Study|Diagnosis of testicular cancer|1
6847437|NCT00321672|10854002|FG002|Overall Study|Diagnosis of testicular cancer|0
6847438|NCT00321672|10854003|FG003|Overall Study|Diagnosis of testicular cancer|0
6847439|NCT00321672|10854000|FG000|Overall Study|Extensive travel required for new job|0
6847440|NCT00321672|10854001|FG001|Overall Study|Extensive travel required for new job|1
6847441|NCT00321672|10854002|FG002|Overall Study|Extensive travel required for new job|0
6847442|NCT00321672|10854003|FG003|Overall Study|Extensive travel required for new job|0
6847443|NCT00321685|10854017|FG000|Overall Study|Adverse Event|18
6847444|NCT00321685|10854017|FG000|Overall Study|Death|2
6847445|NCT00321685|10854017|FG000|Overall Study|Withdrawal by Subject|8
6847446|NCT00321685|10854017|FG000|Overall Study|Alternative therapy|1
6847447|NCT00321685|10854017|FG000|Overall Study|Complicating disese|1
6847448|NCT00321685|10854017|FG000|Overall Study|Other|5
6847449|NCT00321685|10854017|FG000|Overall Study|Not start protocol therapy|2
6847450|NCT00321685|10854017|FG000|Overall Study|Ineligible|2
6847451|NCT00321711|10854026|FG000|Part A|Adverse Event|3
6966563|NCT00308685|11014579|FG001|Overall Study|Lost to Follow-up|0
6966564|NCT00308685|11014578|FG000|Overall Study|Need to administer prohibited medication|1
6966565|NCT00308685|11014579|FG001|Overall Study|Need to administer prohibited medication|2
6966566|NCT00308685|11014578|FG000|Overall Study|Other than specified|1
6966567|NCT00308685|11014579|FG001|Overall Study|Other than specified|3
6966568|NCT01125514|11014585|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1
6966569|NCT01125514|11014585|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1
6966570|NCT01125514|11014585|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3
6966571|NCT01125514|11014585|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2
6966572|NCT01125514|11014585|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1
6966573|NCT01125514|11014585|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1
6966574|NCT01125566|11014601|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182
6966575|NCT01125566|11014602|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119
6966576|NCT01125566|11014603|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0
6966577|NCT01125566|11014601|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6
6966578|NCT01125566|11014602|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6
6966579|NCT01125566|11014603|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0
6966580|NCT01125566|11014601|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25
6966581|NCT01125566|11014602|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5
6966582|NCT01125566|11014603|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0
6966583|NCT01125566|11014601|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0
6966584|NCT01125566|11014602|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2
6966585|NCT01125566|11014603|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0
6966586|NCT01125566|11014601|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24
6966587|NCT01125566|11014602|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23
6966588|NCT01125566|11014603|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0
7077445|NCT02092285|11184996|FG000|Maintenance Phase & Follow-up|Pregnancy|1
6847452|NCT00321711|10854027|FG001|Part A|Adverse Event|3
6847453|NCT00321711|10854028|FG002|Part A|Adverse Event|2
6847454|NCT00321711|10854029|FG003|Part A|Adverse Event|0
6847455|NCT00321711|10854030|FG004|Part A|Adverse Event|0
6847456|NCT00321711|10854026|FG000|Part A|Withdrawal by Subject|1
6847457|NCT00321711|10854027|FG001|Part A|Withdrawal by Subject|1
6847458|NCT00321711|10854028|FG002|Part A|Withdrawal by Subject|1
6847459|NCT00321711|10854029|FG003|Part A|Withdrawal by Subject|0
6847460|NCT00321711|10854030|FG004|Part A|Withdrawal by Subject|0
6847461|NCT00321711|10854026|FG000|Part A|Disease progression|0
6847462|NCT00321711|10854027|FG001|Part A|Disease progression|1
6847463|NCT00321711|10854028|FG002|Part A|Disease progression|0
6847464|NCT00321711|10854029|FG003|Part A|Disease progression|0
6847465|NCT00321711|10854030|FG004|Part A|Disease progression|0
6847466|NCT00321711|10854026|FG000|Part A|Requirement for alternative therapy|0
6847467|NCT00321711|10854027|FG001|Part A|Requirement for alternative therapy|2
6847468|NCT00321711|10854028|FG002|Part A|Requirement for alternative therapy|1
6847469|NCT00321711|10854029|FG003|Part A|Requirement for alternative therapy|0
6847470|NCT00321711|10854030|FG004|Part A|Requirement for alternative therapy|0
6847471|NCT00321711|10854026|FG000|Part A|Physician Decision|0
6847472|NCT00321711|10854027|FG001|Part A|Physician Decision|1
6847473|NCT00321711|10854028|FG002|Part A|Physician Decision|3
6847474|NCT00321711|10854029|FG003|Part A|Physician Decision|0
6847475|NCT00321711|10854030|FG004|Part A|Physician Decision|0
6847476|NCT00321711|10854026|FG000|Part A|Other|1
6847477|NCT00321711|10854027|FG001|Part A|Other|2
6847478|NCT00321711|10854028|FG002|Part A|Other|3
6847479|NCT00321711|10854029|FG003|Part A|Other|0
6847480|NCT00321711|10854030|FG004|Part A|Other|0
6847481|NCT00321711|10854026|FG000|Part A|Protocol deviation|0
6847482|NCT00321711|10854027|FG001|Part A|Protocol deviation|0
6847483|NCT00321711|10854028|FG002|Part A|Protocol deviation|1
6847484|NCT00321711|10854029|FG003|Part A|Protocol deviation|0
6847485|NCT00321711|10854030|FG004|Part A|Protocol deviation|0
6847486|NCT00321711|10854026|FG000|Part B|Noncompliance|0
6847487|NCT00321711|10854027|FG001|Part B|Noncompliance|0
6847488|NCT00321711|10854028|FG002|Part B|Noncompliance|0
6847489|NCT00321711|10854029|FG003|Part B|Noncompliance|0
6847490|NCT00321711|10854030|FG004|Part B|Noncompliance|1
6847491|NCT00321711|10854026|FG000|Part B|Adverse Event|0
6847492|NCT00321711|10854027|FG001|Part B|Adverse Event|0
6847493|NCT00321711|10854028|FG002|Part B|Adverse Event|0
6847494|NCT00321711|10854029|FG003|Part B|Adverse Event|2
6847495|NCT00321711|10854030|FG004|Part B|Adverse Event|1
6847496|NCT00321711|10854026|FG000|Part B|Disease progression|0
6847497|NCT00321711|10854027|FG001|Part B|Disease progression|0
6847498|NCT00321711|10854028|FG002|Part B|Disease progression|0
6847499|NCT00321711|10854029|FG003|Part B|Disease progression|1
6847500|NCT00321711|10854030|FG004|Part B|Disease progression|0
6847501|NCT00321711|10854026|FG000|Part B|Physician Decision|0
6847502|NCT00321711|10854027|FG001|Part B|Physician Decision|0
6847503|NCT00321711|10854028|FG002|Part B|Physician Decision|0
6847504|NCT00321711|10854029|FG003|Part B|Physician Decision|1
6847505|NCT00321711|10854030|FG004|Part B|Physician Decision|2
6847506|NCT00321711|10854026|FG000|Part B|Death|0
6847507|NCT00321711|10854027|FG001|Part B|Death|0
6847508|NCT00321711|10854028|FG002|Part B|Death|0
6847509|NCT00321711|10854029|FG003|Part B|Death|2
6847510|NCT00321711|10854030|FG004|Part B|Death|1
6847511|NCT00321737|10854045|FG000|Overall Study|Relapse of Erosive Esophagitis|76
6847512|NCT00321737|10854046|FG001|Overall Study|Relapse of Erosive Esophagitis|25
6847513|NCT00321737|10854047|FG002|Overall Study|Relapse of Erosive Esophagitis|19
6847514|NCT00321737|10854045|FG000|Overall Study|Adverse Event|11
6847515|NCT00321737|10854046|FG001|Overall Study|Adverse Event|3
6847516|NCT00321737|10854047|FG002|Overall Study|Adverse Event|6
6847517|NCT00321737|10854045|FG000|Overall Study|Lost to Follow-up|5
6847518|NCT00321737|10854046|FG001|Overall Study|Lost to Follow-up|5
6847519|NCT00321737|10854047|FG002|Overall Study|Lost to Follow-up|6
6847520|NCT00321737|10854045|FG000|Overall Study|Withdrawal by Subject|19
6847521|NCT00321737|10854046|FG001|Overall Study|Withdrawal by Subject|12
6847522|NCT00321737|10854047|FG002|Overall Study|Withdrawal by Subject|17
6847523|NCT00321737|10854045|FG000|Overall Study|Protocol Violation|0
6847524|NCT00321737|10854046|FG001|Overall Study|Protocol Violation|0
6847525|NCT00321737|10854047|FG002|Overall Study|Protocol Violation|1
6847526|NCT00321737|10854045|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1
6847527|NCT00321737|10854046|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0
6847528|NCT00321737|10854047|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0
6847529|NCT00321737|10854045|FG000|Overall Study|Possible Barrett's Esophagus|2
6847530|NCT00321737|10854046|FG001|Overall Study|Possible Barrett's Esophagus|1
6847531|NCT00321737|10854047|FG002|Overall Study|Possible Barrett's Esophagus|1
6847532|NCT00321737|10854045|FG000|Overall Study|Therapeutic Failure|6
6847533|NCT00321737|10854046|FG001|Overall Study|Therapeutic Failure|0
6847534|NCT00321737|10854047|FG002|Overall Study|Therapeutic Failure|2
6847535|NCT00321737|10854045|FG000|Overall Study|Pregnancy|0
6847536|NCT00321737|10854046|FG001|Overall Study|Pregnancy|2
6847537|NCT00321737|10854047|FG002|Overall Study|Pregnancy|0
6847538|NCT00321737|10854045|FG000|Overall Study|Noncompliance|2
6847539|NCT00321737|10854046|FG001|Overall Study|Noncompliance|0
6847540|NCT00321737|10854047|FG002|Overall Study|Noncompliance|0
6847541|NCT00321737|10854045|FG000|Overall Study|Subject Request/ Subject Unavailable|0
6847542|NCT00321737|10854046|FG001|Overall Study|Subject Request/ Subject Unavailable|0
6847543|NCT00321737|10854047|FG002|Overall Study|Subject Request/ Subject Unavailable|2
6847544|NCT00321763|10854059|FG000|Overall Study|Adverse Event|1
6847545|NCT00321763|10854060|FG001|Overall Study|Adverse Event|1
6847546|NCT00321763|10854061|FG002|Overall Study|Adverse Event|0
6847547|NCT00321763|10854062|FG003|Overall Study|Adverse Event|1
6847548|NCT00321763|10854059|FG000|Overall Study|Withdrawal by Subject|2
6847549|NCT00321763|10854060|FG001|Overall Study|Withdrawal by Subject|0
6847550|NCT00321763|10854061|FG002|Overall Study|Withdrawal by Subject|1
6847551|NCT00321763|10854062|FG003|Overall Study|Withdrawal by Subject|0
6847552|NCT00321763|10854059|FG000|Overall Study|Lost to Follow-up|3
6847553|NCT00321763|10854060|FG001|Overall Study|Lost to Follow-up|1
6847554|NCT00321763|10854061|FG002|Overall Study|Lost to Follow-up|5
6847555|NCT00321763|10854062|FG003|Overall Study|Lost to Follow-up|4
6847556|NCT00321789|10854076|FG000|Overall Study|Lost to Follow-up|4
6847557|NCT00321789|10854077|FG001|Overall Study|Lost to Follow-up|7
6847558|NCT00321789|10854076|FG000|Overall Study|Withdrawal by Subject|6
6847559|NCT00321789|10854077|FG001|Overall Study|Withdrawal by Subject|6
6847560|NCT00321789|10854076|FG000|Overall Study|Protocol Violation|5
6847561|NCT00321789|10854077|FG001|Overall Study|Protocol Violation|3
6847562|NCT00321828|10854083|FG000|Overall Study|Ineligible|3
6847563|NCT00321828|10854083|FG000|Overall Study|No follow up data|1
6847564|NCT00321854|10854089|FG000|Overall Study|Adverse Event|41
6847565|NCT00321854|10854090|FG001|Overall Study|Adverse Event|43
6847566|NCT00321854|10854089|FG000|Overall Study|Lack of Efficacy|9
6847567|NCT00321854|10854090|FG001|Overall Study|Lack of Efficacy|14
6847568|NCT00321854|10854089|FG000|Overall Study|Protocol Violation|6
6847569|NCT00321854|10854090|FG001|Overall Study|Protocol Violation|5
6847570|NCT00321854|10854089|FG000|Overall Study|Lost to Follow-up|0
6847571|NCT00321854|10854090|FG001|Overall Study|Lost to Follow-up|2
6847572|NCT00321854|10854089|FG000|Overall Study|Withdrawal by Subject|6
6847573|NCT00321854|10854090|FG001|Overall Study|Withdrawal by Subject|17
6847574|NCT00321854|10854089|FG000|Overall Study|Other|1
6847575|NCT00321854|10854090|FG001|Overall Study|Other|1
6847576|NCT00321893|10854100|FG000|Overall Study|Non-Compliance/Refusal|16
6847577|NCT00321893|10854101|FG001|Overall Study|Non-Compliance/Refusal|10
6847578|NCT00321893|10854100|FG000|Overall Study|Lost to Follow-up|2
6847579|NCT00321893|10854101|FG001|Overall Study|Lost to Follow-up|1
6847580|NCT00321893|10854100|FG000|Overall Study|Adverse Event|6
6847581|NCT00321893|10854101|FG001|Overall Study|Adverse Event|3
6847582|NCT00321906|10854109|FG000|Overall Study|Adverse Event|36
6847583|NCT00321906|10854110|FG001|Overall Study|Adverse Event|44
6847584|NCT00321906|10854109|FG000|Overall Study|Death|9
6847585|NCT00321906|10854110|FG001|Overall Study|Death|6
6847586|NCT00321906|10854109|FG000|Overall Study|Lost to Follow-up|1
6847587|NCT00321906|10854110|FG001|Overall Study|Lost to Follow-up|2
6847588|NCT00321906|10854109|FG000|Overall Study|Withdrawal by Subject|0
6847589|NCT00321906|10854110|FG001|Overall Study|Withdrawal by Subject|4
6847590|NCT00321919|10854118|FG000|Overall Study|Adverse Event|17
6847591|NCT00321919|10854119|FG001|Overall Study|Adverse Event|10
6847592|NCT00321919|10854118|FG000|Overall Study|Death|21
6847593|NCT00321919|10854119|FG001|Overall Study|Death|17
6847594|NCT00321919|10854118|FG000|Overall Study|Insufficient Therapeutic Response|1
6847595|NCT00321919|10854119|FG001|Overall Study|Insufficient Therapeutic Response|0
6847596|NCT00321919|10854118|FG000|Overall Study|Violation of Selection Criteria at Entry|1
6847597|NCT00321919|10854119|FG001|Overall Study|Violation of Selection Criteria at Entry|1
6847598|NCT00321919|10854118|FG000|Overall Study|Refused Treatment|23
6847599|NCT00321919|10854119|FG001|Overall Study|Refused Treatment|14
6847600|NCT00321919|10854118|FG000|Overall Study|Other Protocol Violation|2
6847601|NCT00321919|10854119|FG001|Overall Study|Other Protocol Violation|3
6847602|NCT00321919|10854118|FG000|Overall Study|Failure to Return|3
6847603|NCT00321919|10854119|FG001|Overall Study|Failure to Return|1
6847604|NCT00321919|10854118|FG000|Overall Study|Other withdrawal reason|7
6847605|NCT00321919|10854119|FG001|Overall Study|Other withdrawal reason|6
6847606|NCT00321932|10854128|FG000|Overall Study|Death|3
6847607|NCT00321932|10854129|FG001|Overall Study|Death|6
6847608|NCT00321932|10854128|FG000|Overall Study|Withdrawal by Subject|3
6847609|NCT00321932|10854129|FG001|Overall Study|Withdrawal by Subject|6
6847610|NCT00321932|10854128|FG000|Overall Study|Early relapse|2
7151532|NCT03232983|11315606|FG003|Washout Period 2|Physician Decision|0
7151533|NCT03232983|11315603|FG000|Washout Period 2|Withdrawal by Subject|0
7151534|NCT03232983|11315604|FG001|Washout Period 2|Withdrawal by Subject|0
6847611|NCT00321932|10854129|FG001|Overall Study|Early relapse|8
6847612|NCT00321932|10854128|FG000|Overall Study|Missing data|2
6847613|NCT00321932|10854129|FG001|Overall Study|Missing data|1
6847614|NCT00321984|10854148|FG000|Overall Study|Adverse Event|9
6847615|NCT00321984|10854149|FG001|Overall Study|Adverse Event|6
6847616|NCT00321984|10854150|FG002|Overall Study|Adverse Event|8
6847617|NCT00321984|10854148|FG000|Overall Study|Protocol Violation|0
6847618|NCT00321984|10854149|FG001|Overall Study|Protocol Violation|1
6847619|NCT00321984|10854150|FG002|Overall Study|Protocol Violation|1
6847620|NCT00321984|10854148|FG000|Overall Study|Lost to Follow-up|2
6847621|NCT00321984|10854149|FG001|Overall Study|Lost to Follow-up|4
6847622|NCT00321984|10854150|FG002|Overall Study|Lost to Follow-up|2
6847623|NCT00321984|10854148|FG000|Overall Study|Withdrawal by Subject|8
6847624|NCT00321984|10854149|FG001|Overall Study|Withdrawal by Subject|6
7151535|NCT03232983|11315605|FG002|Washout Period 2|Withdrawal by Subject|0
6847625|NCT00321984|10854150|FG002|Overall Study|Withdrawal by Subject|5
6847626|NCT00321984|10854148|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3
6847627|NCT00321984|10854149|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1
6847628|NCT00321984|10854150|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5
6847629|NCT00321984|10854148|FG000|Overall Study|Lack of Efficacy|3
6847630|NCT00321984|10854149|FG001|Overall Study|Lack of Efficacy|1
6847631|NCT00321984|10854150|FG002|Overall Study|Lack of Efficacy|3
6847632|NCT00321984|10854148|FG000|Overall Study|Noncompliant|0
6847633|NCT00321984|10854149|FG001|Overall Study|Noncompliant|0
6847634|NCT00321984|10854150|FG002|Overall Study|Noncompliant|2
6847635|NCT00321984|10854148|FG000|Overall Study|Pregnancy|0
6847636|NCT00321984|10854149|FG001|Overall Study|Pregnancy|1
6847637|NCT00321984|10854150|FG002|Overall Study|Pregnancy|0
6847638|NCT00321984|10854148|FG000|Overall Study|Per Subject Request|1
6847639|NCT00321984|10854149|FG001|Overall Study|Per Subject Request|0
6847640|NCT00321984|10854150|FG002|Overall Study|Per Subject Request|0
6847641|NCT00321984|10854148|FG000|Overall Study|Per Investigator Request|1
6847642|NCT00321984|10854149|FG001|Overall Study|Per Investigator Request|0
6847643|NCT00321984|10854150|FG002|Overall Study|Per Investigator Request|0
6847644|NCT00321984|10854148|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
6847645|NCT00321984|10854149|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1
6847646|NCT00321984|10854150|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
6847647|NCT00322023|10854161|FG000|Overall Study|various|0
6847648|NCT00322023|10854162|FG001|Overall Study|various|2
6847649|NCT00322023|10854163|FG002|Overall Study|various|6
6847650|NCT00322049|10854175|FG000|Overall Study|Moved out of area|0
6847651|NCT00322049|10854176|FG001|Overall Study|Moved out of area|0
6847652|NCT00322049|10854177|FG002|Overall Study|Moved out of area|0
6847653|NCT00322049|10854178|FG003|Overall Study|Moved out of area|1
6847654|NCT00322049|10854175|FG000|Overall Study|Infected with Dengue during study|0
6847655|NCT00322049|10854176|FG001|Overall Study|Infected with Dengue during study|1
6847656|NCT00322049|10854177|FG002|Overall Study|Infected with Dengue during study|0
6847657|NCT00322049|10854178|FG003|Overall Study|Infected with Dengue during study|0
6847658|NCT00322153|10854208|FG000|Overall Study|Adverse Event|21
6847659|NCT00322153|10854209|FG001|Overall Study|Adverse Event|34
6847660|NCT00322153|10854208|FG000|Overall Study|Protocol Violation|6
6847661|NCT00322153|10854209|FG001|Overall Study|Protocol Violation|14
6847662|NCT00322153|10854208|FG000|Overall Study|Withdrawal by Subject|18
6847663|NCT00322153|10854209|FG001|Overall Study|Withdrawal by Subject|10
6847664|NCT00322153|10854208|FG000|Overall Study|Lack of Efficacy|8
6847665|NCT00322153|10854209|FG001|Overall Study|Lack of Efficacy|3
6847666|NCT00322153|10854208|FG000|Overall Study|Lost to Follow-up|5
6847667|NCT00322153|10854209|FG001|Overall Study|Lost to Follow-up|4
6847668|NCT00322153|10854208|FG000|Overall Study|Withdrawn for other reasons|5
6847669|NCT00322153|10854209|FG001|Overall Study|Withdrawn for other reasons|4
6847670|NCT00322348|10854255|FG000|Overall Study|Adverse Event|0
6847671|NCT00322348|10854256|FG001|Overall Study|Adverse Event|1
6847672|NCT00322348|10854255|FG000|Overall Study|Withdrawal by Subject|1
6847673|NCT00322348|10854256|FG001|Overall Study|Withdrawal by Subject|4
6847674|NCT00322348|10854255|FG000|Overall Study|Lost to Follow-up|1
6847675|NCT00322348|10854256|FG001|Overall Study|Lost to Follow-up|0
6847676|NCT00322348|10854255|FG000|Overall Study|Death|0
6847677|NCT00322348|10854256|FG001|Overall Study|Death|2
6847678|NCT00322348|10854255|FG000|Overall Study|Disease Progression|30
6847679|NCT00322348|10854256|FG001|Overall Study|Disease Progression|25
6847680|NCT00322348|10854255|FG000|Overall Study|Reasons not specified|5
6847681|NCT00322348|10854256|FG001|Overall Study|Reasons not specified|1
6847682|NCT00322374|10854265|FG000|Starting Dose|Physician Decision|2
6847683|NCT00322374|10854266|FG001|Starting Dose|Physician Decision|0
6847684|NCT00322374|10854267|FG002|Starting Dose|Physician Decision|0
6847685|NCT00322374|10854268|FG003|Starting Dose|Physician Decision|0
6847686|NCT00322374|10854265|FG000|Starting Dose|Study Drug Toxicity|4
6847687|NCT00322374|10854266|FG001|Starting Dose|Study Drug Toxicity|0
6847688|NCT00322374|10854267|FG002|Starting Dose|Study Drug Toxicity|0
6847689|NCT00322374|10854268|FG003|Starting Dose|Study Drug Toxicity|0
6847690|NCT00322374|10854265|FG000|First Escalation|Documented Disease Progression|0
6847691|NCT00322374|10854266|FG001|First Escalation|Documented Disease Progression|6
6847692|NCT00322374|10854267|FG002|First Escalation|Documented Disease Progression|0
6847693|NCT00322374|10854268|FG003|First Escalation|Documented Disease Progression|0
6847694|NCT00322374|10854265|FG000|First Escalation|Physician Decision|0
6847695|NCT00322374|10854266|FG001|First Escalation|Physician Decision|12
6847696|NCT00322374|10854267|FG002|First Escalation|Physician Decision|0
6847697|NCT00322374|10854268|FG003|First Escalation|Physician Decision|0
6847698|NCT00322374|10854265|FG000|First Escalation|Study Drug Toxicity|0
6847699|NCT00322374|10854266|FG001|First Escalation|Study Drug Toxicity|11
6847700|NCT00322374|10854267|FG002|First Escalation|Study Drug Toxicity|0
6847701|NCT00322374|10854268|FG003|First Escalation|Study Drug Toxicity|0
6847702|NCT00322374|10854265|FG000|First Escalation|Participant Request|0
6847703|NCT00322374|10854266|FG001|First Escalation|Participant Request|1
6847704|NCT00322374|10854267|FG002|First Escalation|Participant Request|0
6847705|NCT00322374|10854268|FG003|First Escalation|Participant Request|0
6847706|NCT00322374|10854265|FG000|Second Escalation|Physician Decision|0
6847707|NCT00322374|10854266|FG001|Second Escalation|Physician Decision|0
6847708|NCT00322374|10854267|FG002|Second Escalation|Physician Decision|5
6847709|NCT00322374|10854268|FG003|Second Escalation|Physician Decision|0
6847710|NCT00322374|10854265|FG000|Second Escalation|Study Drug Toxicity|0
6847711|NCT00322374|10854266|FG001|Second Escalation|Study Drug Toxicity|0
6847712|NCT00322374|10854267|FG002|Second Escalation|Study Drug Toxicity|1
6847713|NCT00322374|10854268|FG003|Second Escalation|Study Drug Toxicity|0
6847714|NCT00322387|10854283|FG000|Treatment Period|Adverse Event|0
6847715|NCT00322387|10854284|FG001|Treatment Period|Adverse Event|1
6847716|NCT00322387|10854283|FG000|Follow-up Period|Final assessment not done|1
6847717|NCT00322387|10854284|FG001|Follow-up Period|Final assessment not done|3
6847718|NCT00322387|10854283|FG000|Follow-up Period|Death|1
6847719|NCT00322387|10854284|FG001|Follow-up Period|Death|0
6847720|NCT00322452|10854307|FG000|Overall Study|Eligibility criteria not fulfilled|0
6847721|NCT00322452|10854308|FG001|Overall Study|Eligibility criteria not fulfilled|1
6847722|NCT00322452|10854307|FG000|Overall Study|Lost to Follow-up|5
6847723|NCT00322452|10854308|FG001|Overall Study|Lost to Follow-up|2
6847724|NCT00322452|10854307|FG000|Overall Study|Withdrawal by Subject|19
6847725|NCT00322452|10854308|FG001|Overall Study|Withdrawal by Subject|46
6847726|NCT00322452|10854307|FG000|Overall Study|Death|223
6847727|NCT00322452|10854308|FG001|Overall Study|Death|227
6847728|NCT00322491|10854336|FG000|Overall Study|Adverse Event|1
6847729|NCT00322491|10854337|FG001|Overall Study|Adverse Event|0
6847730|NCT00322491|10854336|FG000|Overall Study|Death|1
6847731|NCT00322491|10854337|FG001|Overall Study|Death|2
6847732|NCT00322556|10854344|FG000|Overall Study|Adverse Event|1
6847733|NCT00322556|10854344|FG000|Overall Study|Withdrawal by Subject|1
6847734|NCT00322556|10854344|FG000|Overall Study|Lost to Follow-up|3
6847735|NCT00322556|10854344|FG000|Overall Study|Other Reason|7
6847736|NCT00322621|10854351|FG000|Period II - Acute Therapy Phase|Adverse Event|20
6847737|NCT00322621|10854352|FG001|Period II - Acute Therapy Phase|Adverse Event|0
6847738|NCT00322621|10854353|FG002|Period II - Acute Therapy Phase|Adverse Event|0
6847739|NCT00322621|10854351|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1
6847740|NCT00322621|10854352|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0
6847741|NCT00322621|10854353|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0
6847742|NCT00322621|10854351|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8
7151536|NCT03232983|11315606|FG003|Washout Period 2|Withdrawal by Subject|1
7151537|NCT03232983|11315603|FG000|Period 4|Withdrawal by Subject|1
7151538|NCT03232983|11315604|FG001|Period 4|Withdrawal by Subject|0
7151539|NCT03232983|11315605|FG002|Period 4|Withdrawal by Subject|0
7151540|NCT03232983|11315606|FG003|Period 4|Withdrawal by Subject|0
7151541|NCT03233009|11315618|FG000|Overall Study|Lost to Follow-up|1
7151542|NCT03233230|11315635|FG000|Overall Study|Adverse Event|6
7151543|NCT03233230|11315636|FG001|Overall Study|Adverse Event|3
7151544|NCT03233230|11315637|FG002|Overall Study|Adverse Event|6
7151545|NCT03233230|11315638|FG003|Overall Study|Adverse Event|3
7151546|NCT03233230|11315635|FG000|Overall Study|Protocol Violation|1
7151547|NCT03233230|11315636|FG001|Overall Study|Protocol Violation|2
7151548|NCT03233230|11315637|FG002|Overall Study|Protocol Violation|1
7151549|NCT03233230|11315638|FG003|Overall Study|Protocol Violation|1
7151550|NCT03233230|11315635|FG000|Overall Study|Lack of Efficacy|1
7151551|NCT03233230|11315636|FG001|Overall Study|Lack of Efficacy|0
7151552|NCT03233230|11315637|FG002|Overall Study|Lack of Efficacy|0
7151553|NCT03233230|11315638|FG003|Overall Study|Lack of Efficacy|0
7151554|NCT03233230|11315635|FG000|Overall Study|Other|5
7151555|NCT03233230|11315636|FG001|Overall Study|Other|5
7151556|NCT03233230|11315637|FG002|Overall Study|Other|5
7151557|NCT03233230|11315638|FG003|Overall Study|Other|3
7151558|NCT03233230|11315635|FG000|Overall Study|Withdrawal by Subject|2
7151559|NCT03233230|11315636|FG001|Overall Study|Withdrawal by Subject|2
7151560|NCT03233230|11315637|FG002|Overall Study|Withdrawal by Subject|0
7151561|NCT03233230|11315638|FG003|Overall Study|Withdrawal by Subject|1
7151562|NCT03233230|11315635|FG000|Overall Study|Lost to Follow-up|0
7151563|NCT03233230|11315636|FG001|Overall Study|Lost to Follow-up|3
7151564|NCT03233230|11315637|FG002|Overall Study|Lost to Follow-up|0
7151565|NCT03233230|11315638|FG003|Overall Study|Lost to Follow-up|0
7151566|NCT03233308|11315648|FG000|Overall Study|Adverse Event|1
7151567|NCT03233308|11315648|FG000|Overall Study|Protocol Violation|1
7151568|NCT03233438|11315661|FG000|Overall Study|Lost to Follow-up|4
6847743|NCT00322621|10854352|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0
6847744|NCT00322621|10854353|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0
6847745|NCT00322621|10854351|FG000|Period II - Acute Therapy Phase|Protocol Violation|2
6847746|NCT00322621|10854352|FG001|Period II - Acute Therapy Phase|Protocol Violation|0
6847747|NCT00322621|10854353|FG002|Period II - Acute Therapy Phase|Protocol Violation|0
6847748|NCT00322621|10854351|FG000|Period II - Acute Therapy Phase|Physician Decision|1
7151569|NCT03233438|11315662|FG001|Overall Study|Lost to Follow-up|9
7151570|NCT03233438|11315661|FG000|Overall Study|Withdrawal by Subject|2
7151571|NCT03233438|11315662|FG001|Overall Study|Withdrawal by Subject|1
7151572|NCT03233438|11315661|FG000|Overall Study|No recording of dalbavancin|0
7151573|NCT03233438|11315662|FG001|Overall Study|No recording of dalbavancin|1
7151574|NCT03233529|11315668|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1
6847749|NCT00322621|10854352|FG001|Period II - Acute Therapy Phase|Physician Decision|0
6847750|NCT00322621|10854353|FG002|Period II - Acute Therapy Phase|Physician Decision|0
7151575|NCT03233529|11315668|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1
7184118|NCT01755689|11384112|FG001|Overall Study|Withdrawal by Subject|3
6847751|NCT00322621|10854351|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0
6847752|NCT00322621|10854352|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14
6847753|NCT00322621|10854353|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5
6847754|NCT00322621|10854351|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0
6847755|NCT00322621|10854352|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4
6847756|NCT00322621|10854353|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24
6847757|NCT00322621|10854351|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0
6847758|NCT00322621|10854352|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7
6847759|NCT00322621|10854353|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1
6847760|NCT00322621|10854351|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0
6847761|NCT00322621|10854352|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2
6847762|NCT00322621|10854353|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5
6847763|NCT00322621|10854351|FG000|Period III - Maintenance / Rescue Phase|Death|0
6847764|NCT00322621|10854352|FG001|Period III - Maintenance / Rescue Phase|Death|1
6847765|NCT00322621|10854353|FG002|Period III - Maintenance / Rescue Phase|Death|0
6847766|NCT00322621|10854351|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0
6847767|NCT00322621|10854352|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
6847768|NCT00322621|10854353|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
6847769|NCT00322712|10854366|FG000|Overall Study|treated with bevacizumab not cetuximab|1
6847770|NCT00322842|10854381|FG000|Overall Study|Withdrawal by Subject|0
6847771|NCT00322842|10854382|FG001|Overall Study|Withdrawal by Subject|1
6847772|NCT00322842|10854381|FG000|Overall Study|Lost to Follow-up|0
6847773|NCT00322842|10854382|FG001|Overall Study|Lost to Follow-up|1
6847774|NCT00322842|10854381|FG000|Overall Study|Refused transplant|1
6847775|NCT00322842|10854382|FG001|Overall Study|Refused transplant|0
6847776|NCT00322842|10854381|FG000|Overall Study|Death|1
6847777|NCT00322842|10854382|FG001|Overall Study|Death|0
6847778|NCT00322868|10854389|FG000|Overall Study|disease progression|1
6847779|NCT00322881|10854394|FG000|Overall Study|Death|2
6847780|NCT00322881|10854394|FG000|Overall Study|Adverse Event|1
7077446|NCT02092285|11184996|FG000|Maintenance Phase & Follow-up|Protocol Violation|11
7077447|NCT02092285|11184996|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29
7077448|NCT02092285|11184996|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11
7077449|NCT02092285|11184996|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23
7077450|NCT02092324|11185015|FG000|Overall Study|Adverse Event|1
7077451|NCT02092324|11185015|FG000|Overall Study|Lack of Efficacy|6
6847781|NCT00322881|10854394|FG000|Overall Study|Disease Progression|2
6847782|NCT00323063|10854400|FG000|Overall Study|Adverse Event|1
6847783|NCT00323063|10854401|FG001|Overall Study|Adverse Event|0
6847784|NCT00323063|10854400|FG000|Overall Study|brain mets discovered prior to treatment|1
6847785|NCT00323063|10854401|FG001|Overall Study|brain mets discovered prior to treatment|0
6847786|NCT00323115|10854407|FG000|Vaccine Administration|Adverse Event|1
6847787|NCT00323115|10854407|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8
6847788|NCT00323258|10854427|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1
6847789|NCT00323258|10854428|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2
6847790|NCT00323258|10854427|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12
6847791|NCT00323258|10854428|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11
6847792|NCT00323258|10854427|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1
6847793|NCT00323258|10854428|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5
6847794|NCT00323258|10854427|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2
6847795|NCT00323258|10854428|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1
6847796|NCT00323258|10854427|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1
6847797|NCT00323258|10854428|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2
6847798|NCT00323258|10854427|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12
6847799|NCT00323258|10854428|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10
6847800|NCT00323258|10854427|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1
6847801|NCT00323258|10854428|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2
6847802|NCT00323297|10854454|FG000|Part A (Double Blind Randomized)|Reason unspecified|0
6847803|NCT00323297|10854455|FG001|Part A (Double Blind Randomized)|Reason unspecified|1
6847804|NCT00323297|10854454|FG000|Part A (Double Blind Randomized)|Death|0
6847805|NCT00323297|10854455|FG001|Part A (Double Blind Randomized)|Death|1
6847806|NCT00323297|10854454|FG000|Part A (Double Blind Randomized)|Protocol Violation|1
6847807|NCT00323297|10854455|FG001|Part A (Double Blind Randomized)|Protocol Violation|3
6847808|NCT00323297|10854454|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1
6847809|NCT00323297|10854455|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0
6847810|NCT00323297|10854454|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1
6847811|NCT00323297|10854455|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0
6847812|NCT00323297|10854454|FG000|Part A (Double Blind Randomized)|Related adverse event|2
6847813|NCT00323297|10854455|FG001|Part A (Double Blind Randomized)|Related adverse event|2
6847814|NCT00323297|10854454|FG000|Part B (Open-label)|Death|0
6847815|NCT00323297|10854455|FG001|Part B (Open-label)|Death|1
6847816|NCT00323297|10854454|FG000|Part B (Open-label)|Reason unspecified|0
6847817|NCT00323297|10854455|FG001|Part B (Open-label)|Reason unspecified|1
6847818|NCT00323297|10854454|FG000|Part B (Open-label)|Withdrawal by Subject|1
6847819|NCT00323297|10854455|FG001|Part B (Open-label)|Withdrawal by Subject|3
6847820|NCT00323297|10854454|FG000|Part B (Open-label)|Lack of Efficacy|3
6847821|NCT00323297|10854455|FG001|Part B (Open-label)|Lack of Efficacy|1
7151576|NCT03234036|11315701|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1
7151577|NCT03234036|11315702|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1
7151578|NCT03234036|11315703|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0
7151579|NCT03234036|11315704|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0
7151580|NCT03234465|11315731|FG000|Overall Study|Adverse Event|4
7151581|NCT03234465|11315732|FG001|Overall Study|Adverse Event|2
7151582|NCT03234465|11315731|FG000|Overall Study|Death|0
7151583|NCT03234465|11315732|FG001|Overall Study|Death|1
7151584|NCT03234465|11315731|FG000|Overall Study|Lost to Follow-up|1
6847822|NCT00323297|10854454|FG000|Part B (Open-label)|Adverse Event|5
6847823|NCT00323297|10854455|FG001|Part B (Open-label)|Adverse Event|5
6847824|NCT00323297|10854454|FG000|Part B (Open-label)|Protocol Violation|0
6847825|NCT00323297|10854455|FG001|Part B (Open-label)|Protocol Violation|1
6847826|NCT00323310|10854461|FG000|Overall Study|Withdrawal by Subject|1
6847827|NCT00323310|10854461|FG000|Overall Study|a parent refused blood draw|1
6847828|NCT00323310|10854461|FG000|Overall Study|did not complete the 24-hr f-up visit|1
6847829|NCT00323414|10854471|FG000|Overall Study|Withdrawal by Subject|0
6847830|NCT00323414|10854472|FG001|Overall Study|Withdrawal by Subject|1
6847831|NCT00323479|10854496|FG000|Overall Study|Adverse Event|2
6847832|NCT00323479|10854496|FG000|Overall Study|Withdrawal by Subject|2
6847833|NCT00323479|10854496|FG000|Overall Study|Protocol Violation|3
6847834|NCT00323479|10854496|FG000|Overall Study|house moving|1
6847835|NCT00323492|10854502|FG000|Study Phase 1|Adverse Event|2
6847836|NCT00323492|10854503|FG001|Study Phase 1|Adverse Event|0
6847837|NCT00323492|10854504|FG002|Study Phase 1|Adverse Event|0
6847838|NCT00323492|10854502|FG000|Study Phase 2|Adverse Event|1
6847839|NCT00323492|10854503|FG001|Study Phase 2|Adverse Event|0
6847840|NCT00323492|10854504|FG002|Study Phase 2|Adverse Event|0
6847841|NCT00323492|10854502|FG000|Study Phase 2|Physician Decision|1
6847842|NCT00323492|10854503|FG001|Study Phase 2|Physician Decision|0
6847843|NCT00323492|10854504|FG002|Study Phase 2|Physician Decision|0
6847844|NCT00323492|10854502|FG000|Study Phase 2|Lost to Follow-up|1
6847845|NCT00323492|10854503|FG001|Study Phase 2|Lost to Follow-up|0
6847846|NCT00323492|10854504|FG002|Study Phase 2|Lost to Follow-up|0
6847847|NCT00323492|10854502|FG000|Study Phase 2|Withdrawal by Subject|0
6847848|NCT00323492|10854503|FG001|Study Phase 2|Withdrawal by Subject|1
6847849|NCT00323492|10854504|FG002|Study Phase 2|Withdrawal by Subject|0
6847850|NCT00323492|10854502|FG000|Study Phase 2|Noncompliance with study schedule|0
6847851|NCT00323492|10854503|FG001|Study Phase 2|Noncompliance with study schedule|0
6847852|NCT00323492|10854504|FG002|Study Phase 2|Noncompliance with study schedule|1
6847853|NCT00323492|10854502|FG000|Study Phase 2|Protocol Violation|1
6847854|NCT00323492|10854503|FG001|Study Phase 2|Protocol Violation|0
6847855|NCT00323492|10854504|FG002|Study Phase 2|Protocol Violation|0
6847856|NCT00323557|10854513|FG000|Overall Study|Physician Decision|1
6847857|NCT00323557|10854514|FG001|Overall Study|Physician Decision|0
6847858|NCT00323609|10854523|FG000|Overall Study|Death|16
6847859|NCT00323609|10854524|FG001|Overall Study|Death|21
6847860|NCT00323609|10854525|FG002|Overall Study|Death|0
6847861|NCT00323609|10854526|FG003|Overall Study|Death|0
6847862|NCT00323609|10854523|FG000|Overall Study|Lost to Follow-up|9
6847863|NCT00323609|10854524|FG001|Overall Study|Lost to Follow-up|10
6847864|NCT00323609|10854525|FG002|Overall Study|Lost to Follow-up|0
6847865|NCT00323609|10854526|FG003|Overall Study|Lost to Follow-up|0
6847866|NCT00323609|10854523|FG000|Overall Study|Physician Decision|2
6847867|NCT00323609|10854524|FG001|Overall Study|Physician Decision|0
6847868|NCT00323609|10854525|FG002|Overall Study|Physician Decision|0
6847869|NCT00323609|10854526|FG003|Overall Study|Physician Decision|1
6847870|NCT00323609|10854523|FG000|Overall Study|Withdrawal by Subject|11
6847871|NCT00323609|10854524|FG001|Overall Study|Withdrawal by Subject|23
6847872|NCT00323609|10854525|FG002|Overall Study|Withdrawal by Subject|4
6847873|NCT00323609|10854526|FG003|Overall Study|Withdrawal by Subject|4
6847874|NCT00323609|10854523|FG000|Overall Study|Other non-VCF-related medical condition|3
6847875|NCT00323609|10854524|FG001|Overall Study|Other non-VCF-related medical condition|2
6847876|NCT00323609|10854525|FG002|Overall Study|Other non-VCF-related medical condition|0
6847877|NCT00323609|10854526|FG003|Overall Study|Other non-VCF-related medical condition|0
6847878|NCT00323609|10854523|FG000|Overall Study|Sponsor discontinued trial|29
6847879|NCT00323609|10854524|FG001|Overall Study|Sponsor discontinued trial|29
6847880|NCT00323609|10854525|FG002|Overall Study|Sponsor discontinued trial|0
6847881|NCT00323609|10854526|FG003|Overall Study|Sponsor discontinued trial|0
6847882|NCT00323609|10854523|FG000|Overall Study|Unrelenting or severe back pain|1
6847883|NCT00323609|10854524|FG001|Overall Study|Unrelenting or severe back pain|1
6847884|NCT00323609|10854525|FG002|Overall Study|Unrelenting or severe back pain|0
6847885|NCT00323609|10854526|FG003|Overall Study|Unrelenting or severe back pain|0
6847886|NCT00323609|10854523|FG000|Overall Study|Logistical withdrawal|9
6847887|NCT00323609|10854524|FG001|Overall Study|Logistical withdrawal|5
6847888|NCT00323609|10854525|FG002|Overall Study|Logistical withdrawal|0
7151585|NCT03234465|11315732|FG001|Overall Study|Lost to Follow-up|1
7151586|NCT03234465|11315731|FG000|Overall Study|Withdrawal by Subject|12
6847889|NCT00323609|10854526|FG003|Overall Study|Logistical withdrawal|1
6847890|NCT00323609|10854523|FG000|Overall Study|Other reason|11
6847891|NCT00323609|10854524|FG001|Overall Study|Other reason|8
6847892|NCT00323609|10854525|FG002|Overall Study|Other reason|4
6847893|NCT00323609|10854526|FG003|Overall Study|Other reason|9
7077452|NCT02092324|11185015|FG000|Overall Study|Proceed to Transplant|3
7077453|NCT02092324|11185015|FG000|Overall Study|Physician Decision|7
7151587|NCT03234465|11315732|FG001|Overall Study|Withdrawal by Subject|27
7151588|NCT03234465|11315731|FG000|Overall Study|Symptomatic deterioration|0
7151589|NCT03234465|11315732|FG001|Overall Study|Symptomatic deterioration|1
7151590|NCT03234465|11315731|FG000|Overall Study|Non-compliance|2
7151591|NCT03234465|11315732|FG001|Overall Study|Non-compliance|0
7151592|NCT03234465|11315731|FG000|Overall Study|Other|14
7151593|NCT03234465|11315732|FG001|Overall Study|Other|8
7151594|NCT03234608|11315740|FG000|Overall Study|Lost to Follow-up|23
7151595|NCT03234608|11315741|FG001|Overall Study|Lost to Follow-up|21
7151596|NCT03235050|11315752|FG000|Overall Study|Adverse Event|0
7151597|NCT03235050|11315753|FG001|Overall Study|Adverse Event|0
7151598|NCT03235050|11315754|FG002|Overall Study|Adverse Event|1
7151599|NCT03235050|11315755|FG003|Overall Study|Adverse Event|4
7151600|NCT03235050|11315756|FG004|Overall Study|Adverse Event|1
7151601|NCT03235050|11315752|FG000|Overall Study|Death|0
6847894|NCT00323622|10854540|FG000|Overall Study|Other|30
6847895|NCT00323622|10854541|FG001|Overall Study|Other|91
6847896|NCT00323622|10854542|FG002|Overall Study|Other|4
6847897|NCT00323622|10854543|FG003|Overall Study|Other|12
6847898|NCT00323622|10854544|FG004|Overall Study|Other|32
6847899|NCT00323622|10854545|FG005|Overall Study|Other|74
6847900|NCT00323622|10854546|FG006|Overall Study|Other|5
6847901|NCT00323622|10854547|FG007|Overall Study|Other|13
6847902|NCT00323622|10854540|FG000|Overall Study|Death|1
7077454|NCT02092324|11185015|FG000|Overall Study|Misdiagnosis|2
7077455|NCT02092350|11185024|FG000|Overall Study|Adverse Event|0
7151602|NCT03235050|11315753|FG001|Overall Study|Death|0
7151603|NCT03235050|11315754|FG002|Overall Study|Death|0
7151604|NCT03235050|11315755|FG003|Overall Study|Death|2
7151605|NCT03235050|11315756|FG004|Overall Study|Death|1
7151606|NCT03235050|11315752|FG000|Overall Study|Lost to Follow-up|1
7151607|NCT03235050|11315753|FG001|Overall Study|Lost to Follow-up|2
7151608|NCT03235050|11315754|FG002|Overall Study|Lost to Follow-up|1
7151609|NCT03235050|11315755|FG003|Overall Study|Lost to Follow-up|2
7151610|NCT03235050|11315756|FG004|Overall Study|Lost to Follow-up|0
7151611|NCT03235050|11315752|FG000|Overall Study|Withdrawal by Subject|3
7151612|NCT03235050|11315753|FG001|Overall Study|Withdrawal by Subject|2
7151613|NCT03235050|11315754|FG002|Overall Study|Withdrawal by Subject|2
7151614|NCT03235050|11315755|FG003|Overall Study|Withdrawal by Subject|5
7151615|NCT03235050|11315756|FG004|Overall Study|Withdrawal by Subject|7
7151616|NCT03235050|11315752|FG000|Overall Study|Other reasons|0
7151617|NCT03235050|11315753|FG001|Overall Study|Other reasons|1
7151618|NCT03235050|11315754|FG002|Overall Study|Other reasons|0
7151619|NCT03235050|11315755|FG003|Overall Study|Other reasons|1
7151620|NCT03235050|11315756|FG004|Overall Study|Other reasons|2
7151621|NCT03235089|11315768|FG000|Overall Study|Lost to Follow-up|1
7151622|NCT03235089|11315769|FG001|Overall Study|Lost to Follow-up|1
7151623|NCT03235089|11315768|FG000|Overall Study|Physician Decision|2
7151624|NCT03235089|11315769|FG001|Overall Study|Physician Decision|2
7151625|NCT03235115|11315776|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
7151626|NCT03235115|11315777|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
7151627|NCT03235115|11315778|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
7151628|NCT03235115|11315779|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
7151629|NCT03235115|11315780|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
7151630|NCT03235115|11315781|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1
7151631|NCT03235154|11315789|FG000|Overall Study|Withdrawal by Subject|1
7151632|NCT03235154|11315789|FG000|Overall Study|Adverse Event|1
7151633|NCT03235154|11315789|FG000|Overall Study|Lost to Follow-up|2
7151634|NCT03235284|11315802|FG000|Overall Study|Adverse Event|1
7151635|NCT03235284|11315803|FG001|Overall Study|Adverse Event|2
7151636|NCT03235284|11315804|FG002|Overall Study|Adverse Event|1
7151637|NCT03235349|11315812|FG000|Overall Study|Adverse Event|1
7151638|NCT03235349|11315812|FG000|Overall Study|Other|1
7151639|NCT03235479|11315822|FG000|Overall Study|Lost to Follow-up|8
7151640|NCT03235479|11315823|FG001|Overall Study|Lost to Follow-up|11
7151641|NCT03235479|11315822|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23
7151642|NCT03235479|11315823|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17
7151643|NCT03235479|11315822|FG000|Overall Study|Pregnancy|1
7151644|NCT03235479|11315823|FG001|Overall Study|Pregnancy|0
6847903|NCT00323622|10854541|FG001|Overall Study|Death|1
6847904|NCT00323622|10854542|FG002|Overall Study|Death|0
7077456|NCT02092350|11185025|FG001|Overall Study|Adverse Event|3
7151645|NCT03235479|11315822|FG000|Overall Study|Protocol Deviation|1
6847905|NCT00323622|10854543|FG003|Overall Study|Death|0
6847906|NCT00323622|10854544|FG004|Overall Study|Death|7
6847907|NCT00323622|10854545|FG005|Overall Study|Death|0
6847908|NCT00323622|10854546|FG006|Overall Study|Death|0
7077457|NCT02092350|11185024|FG000|Overall Study|Death|2
7077458|NCT02092350|11185025|FG001|Overall Study|Death|5
7077459|NCT02092350|11185024|FG000|Overall Study|Lost to Follow-up|3
7077460|NCT02092350|11185025|FG001|Overall Study|Lost to Follow-up|1
7077461|NCT02092350|11185024|FG000|Overall Study|Protocol Violation|1
6847909|NCT00323622|10854547|FG007|Overall Study|Death|2
6847910|NCT00323869|10854577|FG000|Overall Study|Death|1
6847911|NCT00323882|10854586|FG000|Overall Study|Adverse Event|2
6847912|NCT00323882|10854587|FG001|Overall Study|Adverse Event|1
6847913|NCT00323882|10854588|FG002|Overall Study|Adverse Event|1
6847914|NCT00323882|10854589|FG003|Overall Study|Adverse Event|1
6847915|NCT00323882|10854590|FG004|Overall Study|Adverse Event|3
6847916|NCT00323882|10854586|FG000|Overall Study|Disease Progression|6
6847917|NCT00323882|10854587|FG001|Overall Study|Disease Progression|4
6847918|NCT00323882|10854588|FG002|Overall Study|Disease Progression|10
6847919|NCT00323882|10854589|FG003|Overall Study|Disease Progression|5
6847920|NCT00323882|10854590|FG004|Overall Study|Disease Progression|22
6847921|NCT00323882|10854586|FG000|Overall Study|Death|0
6847922|NCT00323882|10854587|FG001|Overall Study|Death|1
6847923|NCT00323882|10854588|FG002|Overall Study|Death|1
6847924|NCT00323882|10854589|FG003|Overall Study|Death|0
6847925|NCT00323882|10854590|FG004|Overall Study|Death|5
6847926|NCT00323882|10854586|FG000|Overall Study|Lost to Follow-up|0
6847927|NCT00323882|10854587|FG001|Overall Study|Lost to Follow-up|0
7077462|NCT02092350|11185025|FG001|Overall Study|Protocol Violation|0
7151646|NCT03235479|11315823|FG001|Overall Study|Protocol Deviation|3
6847928|NCT00323882|10854588|FG002|Overall Study|Lost to Follow-up|1
6847929|NCT00323882|10854589|FG003|Overall Study|Lost to Follow-up|0
6847930|NCT00323882|10854590|FG004|Overall Study|Lost to Follow-up|1
6847931|NCT00323882|10854586|FG000|Overall Study|Other|0
6847932|NCT00323882|10854587|FG001|Overall Study|Other|0
6847933|NCT00323882|10854588|FG002|Overall Study|Other|0
6847934|NCT00323882|10854589|FG003|Overall Study|Other|1
6847935|NCT00323882|10854590|FG004|Overall Study|Other|1
6847936|NCT00324038|10854629|FG000|Overall Study|Adverse Event|38
6847937|NCT00324038|10854630|FG001|Overall Study|Adverse Event|23
6847938|NCT00324038|10854629|FG000|Overall Study|Lack of Efficacy|5
6847939|NCT00324038|10854630|FG001|Overall Study|Lack of Efficacy|13
6847940|NCT00324038|10854629|FG000|Overall Study|Lost to Follow-up|0
6847941|NCT00324038|10854630|FG001|Overall Study|Lost to Follow-up|2
6847942|NCT00324038|10854629|FG000|Overall Study|Other|6
6847943|NCT00324038|10854630|FG001|Overall Study|Other|13
6897994|NCT00643201|10917083|FG000|Completed Study Follow Up|Death|28
6897995|NCT00643201|10917084|FG001|Completed Study Follow Up|Death|34
6897996|NCT00643201|10917083|FG000|Completed Study Follow Up|Withdrawal by Subject|23
6897997|NCT00643201|10917084|FG001|Completed Study Follow Up|Withdrawal by Subject|29
6897998|NCT00643201|10917083|FG000|Completed Study Follow Up|Lost to Follow-up|18
6897999|NCT00643201|10917084|FG001|Completed Study Follow Up|Lost to Follow-up|16
6898000|NCT00643201|10917083|FG000|Completed Study Follow Up|non-specified|1
6898001|NCT00643201|10917084|FG001|Completed Study Follow Up|non-specified|0
6898002|NCT00643279|10917094|FG000|Overall Study|Death|13
6898003|NCT00643279|10917095|FG001|Overall Study|Death|11
6898004|NCT00643279|10917094|FG000|Overall Study|Withdrawal by Subject|3
6898005|NCT00643279|10917095|FG001|Overall Study|Withdrawal by Subject|0
6898006|NCT00643279|10917094|FG000|Overall Study|Lost to Follow-up|0
6898007|NCT00643279|10917095|FG001|Overall Study|Lost to Follow-up|1
6898008|NCT00643279|10917094|FG000|Overall Study|Physician Decision|0
6898009|NCT00643279|10917095|FG001|Overall Study|Physician Decision|1
7151647|NCT03235479|11315822|FG000|Overall Study|Technical Problems|3
7151648|NCT03235479|11315823|FG001|Overall Study|Technical Problems|2
7151649|NCT03235479|11315822|FG000|Overall Study|Withdrawal by Subject|2
7151650|NCT03235479|11315823|FG001|Overall Study|Withdrawal by Subject|2
7151651|NCT03235479|11315822|FG000|Overall Study|Other Reasons|3
7151652|NCT03235479|11315823|FG001|Overall Study|Other Reasons|5
6898010|NCT00643448|10917106|FG000|Overall Study|Lack of Efficacy|2
6898011|NCT00643448|10917107|FG001|Overall Study|Lack of Efficacy|0
6898012|NCT00643448|10917108|FG002|Overall Study|Lack of Efficacy|4
6898013|NCT00643448|10917106|FG000|Overall Study|Adverse Event|2
6898014|NCT00643448|10917107|FG001|Overall Study|Adverse Event|2
6898015|NCT00643448|10917108|FG002|Overall Study|Adverse Event|2
6898016|NCT00643448|10917106|FG000|Overall Study|QTcF>550 ms|0
6898017|NCT00643448|10917107|FG001|Overall Study|QTcF>550 ms|3
6898018|NCT00643448|10917108|FG002|Overall Study|QTcF>550 ms|0
6898019|NCT00643487|10917118|FG000|Overall Study|Technical difficulty|3
6898020|NCT00643565|10917124|FG000|Overall Study|Death|12
6898021|NCT00643565|10917125|FG001|Overall Study|Death|11
6898022|NCT00643565|10917124|FG000|Overall Study|Withdrawal by Subject|4
6898023|NCT00643565|10917125|FG001|Overall Study|Withdrawal by Subject|1
6898024|NCT00643565|10917124|FG000|Overall Study|Lost to Follow-up|0
6898025|NCT00643565|10917125|FG001|Overall Study|Lost to Follow-up|6
6898026|NCT00643565|10917124|FG000|Overall Study|Other|7
6898027|NCT00643565|10917125|FG001|Overall Study|Other|8
6898028|NCT00643565|10917124|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0
6898029|NCT00643565|10917125|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1
6898030|NCT00643565|10917124|FG000|Overall Study|Recurrence of Disease|2
6898031|NCT00643565|10917125|FG001|Overall Study|Recurrence of Disease|1
6898032|NCT00643565|10917124|FG000|Overall Study|Progression of Disease|18
6898033|NCT00643565|10917125|FG001|Overall Study|Progression of Disease|14
6898034|NCT00643565|10917124|FG000|Overall Study|Protocol Violation|3
7151653|NCT03235726|11315837|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
7151654|NCT03235726|11315838|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
7151655|NCT03235726|11315839|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
6847944|NCT00324116|10854636|FG000|Overall Study|Adverse Event|5
6847945|NCT00324116|10854636|FG000|Overall Study|Lack of Efficacy|17
6847946|NCT00324116|10854636|FG000|Overall Study|Withdrawal by Subject|5
6847947|NCT00324116|10854636|FG000|Overall Study|Other|5
6847948|NCT00324155|10854642|FG000|Enrolled and Randomized|No longer met study criteria|3
6847949|NCT00324155|10854643|FG001|Enrolled and Randomized|No longer met study criteria|0
6847950|NCT00324155|10854642|FG000|Enrolled and Randomized|Lost to Follow-up|0
6847951|NCT00324155|10854643|FG001|Enrolled and Randomized|Lost to Follow-up|1
6847952|NCT00324155|10854642|FG000|Received Treatment in Induction Phase|Disease Progression|88
6847953|NCT00324155|10854643|FG001|Received Treatment in Induction Phase|Disease Progression|152
6847954|NCT00324155|10854642|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83
6847955|NCT00324155|10854643|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10
6847956|NCT00324155|10854642|FG000|Received Treatment in Induction Phase|Death|8
6847957|NCT00324155|10854643|FG001|Received Treatment in Induction Phase|Death|15
6847958|NCT00324155|10854642|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9
6847959|NCT00324155|10854643|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8
6847960|NCT00324155|10854642|FG000|Received Treatment in Induction Phase|Adverse Event|6
6847961|NCT00324155|10854643|FG001|Received Treatment in Induction Phase|Adverse Event|7
6847962|NCT00324155|10854642|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6
6847963|NCT00324155|10854643|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5
6847964|NCT00324155|10854642|FG000|Received Treatment in Induction Phase|Physician Decision|2
6847965|NCT00324155|10854643|FG001|Received Treatment in Induction Phase|Physician Decision|0
6847966|NCT00324155|10854642|FG000|Received Treatment in Maintenance Phase|Disease Progression|26
6847967|NCT00324155|10854643|FG001|Received Treatment in Maintenance Phase|Disease Progression|41
7040895|NCT01721057|11124071|FG005|Rescue Period|Adverse Event|0
7151656|NCT03235726|11315840|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
7151657|NCT03235726|11315841|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1
7151658|NCT03235726|11315842|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
7151659|NCT03235726|11315843|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
7151660|NCT03235726|11315844|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
7151661|NCT03235726|11315845|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
7151662|NCT03235726|11315846|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
7151663|NCT03235726|11315837|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
7151664|NCT03235726|11315838|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
7151665|NCT03235726|11315839|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
7151666|NCT03235726|11315840|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
7151667|NCT03235726|11315841|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1
7151668|NCT03235726|11315842|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
7151669|NCT03235726|11315843|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
7151670|NCT03235726|11315844|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
7151671|NCT03235726|11315845|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
7151672|NCT03235726|11315846|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
7151673|NCT03236246|11315887|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8
7151674|NCT03236246|11315888|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7
7151675|NCT03236246|11315887|FG000|24-Week Dose Titration Period|Lost to Follow-up|0
7151676|NCT03236246|11315888|FG001|24-Week Dose Titration Period|Lost to Follow-up|2
7151677|NCT03236246|11315887|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3
7151678|NCT03236246|11315888|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2
7151679|NCT03236246|11315887|FG000|24-Week Dose Titration Period|Investigator Judgement|1
7151680|NCT03236246|11315888|FG001|24-Week Dose Titration Period|Investigator Judgement|1
7151681|NCT03236246|11315887|FG000|24-Week Dose Titration Period|Prohibited Therapy|1
7151682|NCT03236246|11315888|FG001|24-Week Dose Titration Period|Prohibited Therapy|1
7151683|NCT03236246|11315887|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0
7151684|NCT03236246|11315888|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1
7151685|NCT03236246|11315887|FG000|24-Week Dose Titration Period|Death|3
7151686|NCT03236246|11315888|FG001|24-Week Dose Titration Period|Death|1
7151687|NCT03236246|11315887|FG000|24-Week Dose Titration Period|Protocol Violation|0
7151688|NCT03236246|11315888|FG001|24-Week Dose Titration Period|Protocol Violation|2
7151689|NCT03236246|11315887|FG000|24-Week Dose Titration Period|Adverse Event|7
7151690|NCT03236246|11315888|FG001|24-Week Dose Titration Period|Adverse Event|8
7151691|NCT03236246|11315887|FG000|24-Week Dose Titration Period|Captured as Other|1
7151692|NCT03236246|11315888|FG001|24-Week Dose Titration Period|Captured as Other|2
7151693|NCT03236246|11315887|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1
6847968|NCT00324155|10854642|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4
6847969|NCT00324155|10854643|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0
6847970|NCT00324155|10854642|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1
6898035|NCT00643565|10917125|FG001|Overall Study|Protocol Violation|0
6898036|NCT00643565|10917124|FG000|Overall Study|Did Not Cooperate|0
6898037|NCT00643565|10917125|FG001|Overall Study|Did Not Cooperate|1
6847971|NCT00324155|10854643|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3
6847972|NCT00324155|10854642|FG000|Received Treatment in Maintenance Phase|Adverse Event|0
6847973|NCT00324155|10854643|FG001|Received Treatment in Maintenance Phase|Adverse Event|3
6847974|NCT00324155|10854642|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1
6847975|NCT00324155|10854643|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0
6847976|NCT00324155|10854642|FG000|Follow-up Phase|On-going participants still on drug|11
6847977|NCT00324155|10854643|FG001|Follow-up Phase|On-going participants still on drug|6
6847978|NCT00324168|10854664|FG000|Overall Study|Lost to Follow-up|19
6847979|NCT00324168|10854665|FG001|Overall Study|Lost to Follow-up|18
6847980|NCT00324168|10854664|FG000|Overall Study|Death|3
6847981|NCT00324168|10854665|FG001|Overall Study|Death|3
6847982|NCT00324168|10854664|FG000|Overall Study|Patient did not visit in f/u window|6
6847983|NCT00324168|10854665|FG001|Overall Study|Patient did not visit in f/u window|9
6847984|NCT00324233|10854673|FG000|First Period|unable to insert catheter|1
6847985|NCT00324233|10854674|FG001|First Period|unable to insert catheter|0
6847986|NCT00324233|10854673|FG000|Second Period|unable to insert catheter|1
6847987|NCT00324233|10854674|FG001|Second Period|unable to insert catheter|1
6847988|NCT00324233|10854673|FG000|Second Period|Protocol Violation|4
6847989|NCT00324233|10854674|FG001|Second Period|Protocol Violation|6
6847990|NCT00324649|10854724|FG000|Overall Study|Adverse Event|1
6847991|NCT00324649|10854725|FG001|Overall Study|Adverse Event|4
6847992|NCT00324649|10854724|FG000|Overall Study|Withdrawal by Subject|0
6847993|NCT00324649|10854725|FG001|Overall Study|Withdrawal by Subject|1
6847994|NCT00324649|10854724|FG000|Overall Study|Noncompliance|1
6847995|NCT00324649|10854725|FG001|Overall Study|Noncompliance|0
6847996|NCT00324675|10854733|FG000|Overall Study|Adverse Event|1
6847997|NCT00324675|10854734|FG001|Overall Study|Adverse Event|0
6847998|NCT00324740|10854749|FG000|Overall Study|Withdrawal by Subject|1
6847999|NCT00324740|10854750|FG001|Overall Study|Withdrawal by Subject|0
6848000|NCT00324740|10854751|FG002|Overall Study|Withdrawal by Subject|1
6848001|NCT00324961|10854803|FG000|Overall Study|Adverse Event|5
6848002|NCT00324961|10854803|FG000|Overall Study|Consent Withdrawn|11
6848003|NCT00324961|10854803|FG000|Overall Study|Lost to Follow-up|22
6848004|NCT00324961|10854803|FG000|Overall Study|Protocol Violation|3
6848005|NCT00324961|10854803|FG000|Overall Study|Other|2
6848006|NCT00324987|10854811|FG000|Overall Study|Adverse Event|2
6848007|NCT00324987|10854812|FG001|Overall Study|Adverse Event|1
6848008|NCT00324987|10854811|FG000|Overall Study|Withdrawal by Subject|1
6848009|NCT00324987|10854812|FG001|Overall Study|Withdrawal by Subject|1
6848010|NCT00324987|10854811|FG000|Overall Study|Progression|1
6848011|NCT00324987|10854812|FG001|Overall Study|Progression|1
6848012|NCT00324987|10854811|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2
6848013|NCT00324987|10854812|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3
6848014|NCT00325039|10854820|FG000|Overall Study|Lost to Follow-up|18
6848015|NCT00325039|10854821|FG001|Overall Study|Lost to Follow-up|14
6848016|NCT00325130|10854843|FG000|Overall Study|Lost to Follow-up|6
6848017|NCT00325130|10854844|FG001|Overall Study|Lost to Follow-up|14
6848018|NCT00325130|10854843|FG000|Overall Study|Withdrawal by Subject|12
6848019|NCT00325130|10854844|FG001|Overall Study|Withdrawal by Subject|14
6848020|NCT00325130|10854843|FG000|Overall Study|Protocol Deviation|0
6848021|NCT00325130|10854844|FG001|Overall Study|Protocol Deviation|1
6848022|NCT00325130|10854843|FG000|Overall Study|Moved|0
6848023|NCT00325130|10854844|FG001|Overall Study|Moved|1
6848024|NCT00325130|10854843|FG000|Overall Study|Patient Discontinued for Other|1
6848025|NCT00325130|10854844|FG001|Overall Study|Patient Discontinued for Other|0
6848026|NCT00325143|10854850|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13
6848027|NCT00325143|10854850|FG000|Overall Study|Migrated/moved from study area|1
6848028|NCT00325143|10854850|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4
6848029|NCT00325143|10854850|FG000|Overall Study|Withdrawal by Subject|8
6848030|NCT00325156|10854854|FG000|Overall Study|Protocol Violation|8
6848031|NCT00325156|10854854|FG000|Overall Study|Lost to follow-up (complete vaccination)|41
6848032|NCT00325156|10854854|FG000|Overall Study|Migrated/moved from study area|12
6848033|NCT00325156|10854854|FG000|Overall Study|Adverse event, non-fatal|3
6848034|NCT00325156|10854854|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16
6848035|NCT00325156|10854854|FG000|Overall Study|Other|1
6848036|NCT00325156|10854854|FG000|Overall Study|Withdrawal by Subject|31
6848037|NCT00325195|10854861|FG000|Randomized|Not dosed|5
6848038|NCT00325195|10854862|FG001|Randomized|Not dosed|5
6848039|NCT00325195|10854863|FG002|Randomized|Not dosed|3
6848040|NCT00325195|10854861|FG000|Received Intervention: ITT Population|Adverse Event|15
6848041|NCT00325195|10854862|FG001|Received Intervention: ITT Population|Adverse Event|17
6848042|NCT00325195|10854863|FG002|Received Intervention: ITT Population|Adverse Event|1
6848043|NCT00325195|10854861|FG000|Received Intervention: ITT Population|Death|3
6848044|NCT00325195|10854862|FG001|Received Intervention: ITT Population|Death|1
6848045|NCT00325195|10854863|FG002|Received Intervention: ITT Population|Death|0
6848046|NCT00325195|10854861|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7
6848047|NCT00325195|10854862|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6
6848048|NCT00325195|10854863|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1
6848049|NCT00325195|10854861|FG000|Received Intervention: ITT Population|Lost to Follow-up|0
6848050|NCT00325195|10854862|FG001|Received Intervention: ITT Population|Lost to Follow-up|0
6848051|NCT00325195|10854863|FG002|Received Intervention: ITT Population|Lost to Follow-up|2
6848052|NCT00325195|10854861|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1
6848053|NCT00325195|10854862|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1
6848054|NCT00325195|10854863|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0
6848055|NCT00325234|10854873|FG000|Overall Study|Adverse Event|10
6848056|NCT00325234|10854874|FG001|Overall Study|Adverse Event|7
6848057|NCT00325234|10854873|FG000|Overall Study|Death due to Study Disease|1
6848058|NCT00325234|10854874|FG001|Overall Study|Death due to Study Disease|0
6848059|NCT00325234|10854873|FG000|Overall Study|Entry Criteria Not Met|1
6848060|NCT00325234|10854874|FG001|Overall Study|Entry Criteria Not Met|2
6848061|NCT00325234|10854873|FG000|Overall Study|Subject Decision|6
6848062|NCT00325234|10854874|FG001|Overall Study|Subject Decision|8
6848063|NCT00325234|10854873|FG000|Overall Study|Physician Decision|17
6848064|NCT00325234|10854874|FG001|Overall Study|Physician Decision|12
6848065|NCT00325234|10854873|FG000|Overall Study|Progressive Disease|34
6848066|NCT00325234|10854874|FG001|Overall Study|Progressive Disease|37
6848067|NCT00325416|10854895|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8
6848068|NCT00325416|10854896|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9
6848069|NCT00325416|10854895|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7
6848070|NCT00325416|10854896|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4
6848071|NCT00325416|10854895|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7
6848072|NCT00325416|10854896|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2
6848073|NCT00325416|10854895|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0
6848074|NCT00325416|10854896|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1
6848075|NCT00325416|10854895|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0
6848076|NCT00325416|10854896|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1
6848077|NCT00325416|10854895|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0
6848078|NCT00325416|10854896|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1
6848079|NCT00325468|10854919|FG000|Overall Study|Adverse Event|1
6848080|NCT00325468|10854920|FG001|Overall Study|Adverse Event|1
6848081|NCT00325468|10854921|FG002|Overall Study|Adverse Event|0
6848082|NCT00325468|10854922|FG003|Overall Study|Adverse Event|5
6848083|NCT00325468|10854923|FG004|Overall Study|Adverse Event|1
6848084|NCT00325468|10854919|FG000|Overall Study|Death|2
6848085|NCT00325468|10854920|FG001|Overall Study|Death|0
6848086|NCT00325468|10854921|FG002|Overall Study|Death|2
6848087|NCT00325468|10854922|FG003|Overall Study|Death|4
6848088|NCT00325468|10854923|FG004|Overall Study|Death|0
6848089|NCT00325468|10854919|FG000|Overall Study|Lost to Follow-up|0
6848090|NCT00325468|10854920|FG001|Overall Study|Lost to Follow-up|0
6848091|NCT00325468|10854921|FG002|Overall Study|Lost to Follow-up|1
6848092|NCT00325468|10854922|FG003|Overall Study|Lost to Follow-up|2
6848093|NCT00325468|10854923|FG004|Overall Study|Lost to Follow-up|2
6848094|NCT00325468|10854919|FG000|Overall Study|Physician Decision|1
6848095|NCT00325468|10854920|FG001|Overall Study|Physician Decision|1
6848096|NCT00325468|10854921|FG002|Overall Study|Physician Decision|0
6848097|NCT00325468|10854922|FG003|Overall Study|Physician Decision|1
6848098|NCT00325468|10854923|FG004|Overall Study|Physician Decision|0
6848099|NCT00325468|10854919|FG000|Overall Study|Withdrawal by Subject|3
6848100|NCT00325468|10854920|FG001|Overall Study|Withdrawal by Subject|1
6848101|NCT00325468|10854921|FG002|Overall Study|Withdrawal by Subject|0
6848102|NCT00325468|10854922|FG003|Overall Study|Withdrawal by Subject|14
6848103|NCT00325468|10854923|FG004|Overall Study|Withdrawal by Subject|4
6848104|NCT00325468|10854919|FG000|Overall Study|site closure etc|4
6848105|NCT00325468|10854920|FG001|Overall Study|site closure etc|2
6848106|NCT00325468|10854921|FG002|Overall Study|site closure etc|1
6848107|NCT00325468|10854922|FG003|Overall Study|site closure etc|8
6848108|NCT00325468|10854923|FG004|Overall Study|site closure etc|1
6848109|NCT00325754|10854949|FG000|Overall Study|Adverse Event|4
6848110|NCT00325754|10854950|FG001|Overall Study|Adverse Event|1
6848111|NCT00325819|10854962|FG000|Overall Study|Study product lost in mail|2
6848112|NCT00325819|10854963|FG001|Overall Study|Study product lost in mail|1
6848113|NCT00325819|10854962|FG000|Overall Study|Did not take a dose of study product|4
6848114|NCT00325819|10854963|FG001|Overall Study|Did not take a dose of study product|9
6848115|NCT00325819|10854962|FG000|Overall Study|Lost to Follow-up|3
6848116|NCT00325819|10854963|FG001|Overall Study|Lost to Follow-up|3
6848117|NCT00325897|10854973|FG000|Overall Study|Lost to Follow-up|12
6848118|NCT00325897|10854974|FG001|Overall Study|Lost to Follow-up|13
6848119|NCT00326001|10854985|FG000|Overall Study|Adverse Event|4
6848120|NCT00326001|10854986|FG001|Overall Study|Adverse Event|5
6848121|NCT00326001|10854985|FG000|Overall Study|Physician Decision|3
6848122|NCT00326001|10854986|FG001|Overall Study|Physician Decision|3
6848123|NCT00326118|10854994|FG000|Active Phase|Withdrawal by Subject|4
6848124|NCT00326118|10854995|FG001|Active Phase|Withdrawal by Subject|1
6848125|NCT00326209|10855015|FG000|Overall Study|Adverse Event|28
6848126|NCT00326209|10855015|FG000|Overall Study|Withdrawal by Subject|22
6848127|NCT00326209|10855015|FG000|Overall Study|Lack of Efficacy|31
6848128|NCT00326209|10855015|FG000|Overall Study|Lost to Follow-up|18
6848129|NCT00326209|10855015|FG000|Overall Study|Participant non-compliant|6
6848130|NCT00326209|10855015|FG000|Overall Study|Sponsor closed study|173
6848131|NCT00326209|10855015|FG000|Overall Study|Prohibited medication use|1
6848132|NCT00326209|10855015|FG000|Overall Study|Violation of entry criteria|1
6848133|NCT00326209|10855015|FG000|Overall Study|Withdrawn in error|1
6848134|NCT00326209|10855015|FG000|Overall Study|Pregnancy|1
6848135|NCT00326417|10855021|FG000|Overall Study|Withdrawal by Subject|0
6848136|NCT00326417|10855022|FG001|Overall Study|Withdrawal by Subject|0
6848137|NCT00326417|10855023|FG002|Overall Study|Withdrawal by Subject|1
6848138|NCT00326417|10855024|FG003|Overall Study|Withdrawal by Subject|0
6848139|NCT00326417|10855021|FG000|Overall Study|Arm Closed|7
6848140|NCT00326417|10855022|FG001|Overall Study|Arm Closed|0
6848141|NCT00326417|10855023|FG002|Overall Study|Arm Closed|0
6848142|NCT00326417|10855024|FG003|Overall Study|Arm Closed|3
6848143|NCT00326417|10855021|FG000|Overall Study|Death|7
6848144|NCT00326417|10855022|FG001|Overall Study|Death|0
6848145|NCT00326417|10855023|FG002|Overall Study|Death|0
6848146|NCT00326417|10855024|FG003|Overall Study|Death|0
6848147|NCT00326495|10855032|FG000|Overall Study|Switched to alternative treatment|1
6848148|NCT00326495|10855032|FG000|Overall Study|Disease progression before treatment|1
6848149|NCT00326495|10855032|FG000|Overall Study|Refused further treatment|2
6848150|NCT00326495|10855032|FG000|Overall Study|Subject off study before assessment|1
6848151|NCT00326599|10855040|FG000|Overall Study|Withdrawal by Subject|1
6848152|NCT00326599|10855041|FG001|Overall Study|Withdrawal by Subject|0
6848153|NCT00326599|10855042|FG002|Overall Study|Withdrawal by Subject|5
6848154|NCT00326599|10855043|FG003|Overall Study|Withdrawal by Subject|2
6848155|NCT00326599|10855040|FG000|Overall Study|Adverse Event|1
6848156|NCT00326599|10855041|FG001|Overall Study|Adverse Event|0
6848157|NCT00326599|10855042|FG002|Overall Study|Adverse Event|32
6848158|NCT00326599|10855043|FG003|Overall Study|Adverse Event|3
6848159|NCT00326599|10855040|FG000|Overall Study|Disease Progression|3
6848160|NCT00326599|10855041|FG001|Overall Study|Disease Progression|1
6848161|NCT00326599|10855042|FG002|Overall Study|Disease Progression|13
6848162|NCT00326599|10855043|FG003|Overall Study|Disease Progression|11
6848163|NCT00326599|10855040|FG000|Overall Study|Alternate Treatment|1
6848164|NCT00326599|10855041|FG001|Overall Study|Alternate Treatment|0
6848165|NCT00326599|10855042|FG002|Overall Study|Alternate Treatment|0
6848166|NCT00326599|10855043|FG003|Overall Study|Alternate Treatment|0
6848167|NCT00326599|10855040|FG000|Overall Study|Death|0
6848168|NCT00326599|10855041|FG001|Overall Study|Death|0
6848169|NCT00326599|10855042|FG002|Overall Study|Death|1
6848170|NCT00326599|10855043|FG003|Overall Study|Death|2
6848171|NCT00326599|10855040|FG000|Overall Study|Other Unspecified Reason|0
6848172|NCT00326599|10855041|FG001|Overall Study|Other Unspecified Reason|0
6848173|NCT00326599|10855042|FG002|Overall Study|Other Unspecified Reason|2
6848174|NCT00326599|10855043|FG003|Overall Study|Other Unspecified Reason|1
6848175|NCT00326612|10855054|FG000|Overall Study|They did not have a seizure requiring tx|129
6848176|NCT00326612|10855055|FG001|Overall Study|They did not have a seizure requiring tx|137
6848177|NCT00326625|10855067|FG000|Overall Study|Adverse Event|20
6848178|NCT00326625|10855068|FG001|Overall Study|Adverse Event|9
6848179|NCT00326625|10855067|FG000|Overall Study|Withdrawal by Subject|15
6848180|NCT00326625|10855068|FG001|Overall Study|Withdrawal by Subject|12
6848181|NCT00326625|10855067|FG000|Overall Study|Death|18
7151694|NCT03236246|11315888|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3
7151695|NCT03236246|11315887|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1
7151696|NCT03236246|11315888|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1
7184119|NCT01755689|11384113|FG002|Overall Study|Withdrawal by Subject|2
6848182|NCT00326625|10855068|FG001|Overall Study|Death|16
6848183|NCT00326625|10855067|FG000|Overall Study|Lost to Follow-up|1
6848184|NCT00326625|10855068|FG001|Overall Study|Lost to Follow-up|0
6848185|NCT00326625|10855067|FG000|Overall Study|prescheduled medical intervention|0
6848186|NCT00326625|10855068|FG001|Overall Study|prescheduled medical intervention|1
6848187|NCT00326716|10855076|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1
6848188|NCT00326716|10855077|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2
6848189|NCT00326716|10855078|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
6848190|NCT00326716|10855079|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
6848191|NCT00326885|10855122|FG000|Overall Study|Adverse Event|1
6848192|NCT00326885|10855122|FG000|Overall Study|Withdrawal by Subject|3
6848193|NCT00326885|10855122|FG000|Overall Study|Physician Decision|1
6848194|NCT00326885|10855122|FG000|Overall Study|Hospice withdrew consent|2
6848195|NCT00326911|10855129|FG000|Overall Study|Hospitalization prior to treatment|0
6848196|NCT00326911|10855130|FG001|Overall Study|Hospitalization prior to treatment|1
6848197|NCT00326911|10855129|FG000|Overall Study|Physician decision prior to treatment|1
6848198|NCT00326911|10855130|FG001|Overall Study|Physician decision prior to treatment|0
6848199|NCT00326911|10855129|FG000|Overall Study|Withdrawal by subject prior to treatment|0
6848200|NCT00326911|10855130|FG001|Overall Study|Withdrawal by subject prior to treatment|1
6848201|NCT00326950|10855145|FG000|Overall Study|Progressive Disease|1
6848202|NCT00326963|10855149|FG000|Overall Study|Adverse Event|2
6848203|NCT00326963|10855149|FG000|Overall Study|Injection site reaction|1
6848204|NCT00326963|10855149|FG000|Overall Study|Death|1
6848205|NCT00326963|10855149|FG000|Overall Study|Failure to return|10
6848206|NCT00326963|10855149|FG000|Overall Study|Withdrawal by Subject|10
6848207|NCT00326963|10855149|FG000|Overall Study|Refused treatment / did not cooperate|5
6848208|NCT00326963|10855149|FG000|Overall Study|Violation of selection criteria at entry|2
6848209|NCT00326963|10855149|FG000|Overall Study|Other protocol violation|1
6848210|NCT00326963|10855149|FG000|Overall Study|Administrative / other|1
6848211|NCT00327015|10855158|FG000|Overall Study|Lack of Efficacy|18
7151697|NCT03236246|11315887|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1
6848212|NCT00327015|10855159|FG001|Overall Study|Lack of Efficacy|18
6848213|NCT00327015|10855160|FG002|Overall Study|Lack of Efficacy|35
6848214|NCT00327015|10855161|FG003|Overall Study|Lack of Efficacy|29
6848215|NCT00327015|10855158|FG000|Overall Study|Withdrawal of Consent by Subject|20
6848216|NCT00327015|10855159|FG001|Overall Study|Withdrawal of Consent by Subject|24
6848217|NCT00327015|10855160|FG002|Overall Study|Withdrawal of Consent by Subject|28
6848218|NCT00327015|10855161|FG003|Overall Study|Withdrawal of Consent by Subject|25
6848219|NCT00327015|10855158|FG000|Overall Study|Lost to Follow-up|22
6848220|NCT00327015|10855159|FG001|Overall Study|Lost to Follow-up|23
6848221|NCT00327015|10855160|FG002|Overall Study|Lost to Follow-up|29
6848222|NCT00327015|10855161|FG003|Overall Study|Lost to Follow-up|22
6848223|NCT00327015|10855158|FG000|Overall Study|Adverse Event|14
6848224|NCT00327015|10855159|FG001|Overall Study|Adverse Event|10
6848225|NCT00327015|10855160|FG002|Overall Study|Adverse Event|14
6848226|NCT00327015|10855161|FG003|Overall Study|Adverse Event|14
6848227|NCT00327015|10855158|FG000|Overall Study|Subject no longer meets study criteria|4
6848228|NCT00327015|10855159|FG001|Overall Study|Subject no longer meets study criteria|2
6848229|NCT00327015|10855160|FG002|Overall Study|Subject no longer meets study criteria|8
6848230|NCT00327015|10855161|FG003|Overall Study|Subject no longer meets study criteria|7
6848231|NCT00327015|10855158|FG000|Overall Study|Poor/Noncompliance|11
6848232|NCT00327015|10855159|FG001|Overall Study|Poor/Noncompliance|8
6848233|NCT00327015|10855160|FG002|Overall Study|Poor/Noncompliance|4
6848234|NCT00327015|10855161|FG003|Overall Study|Poor/Noncompliance|5
6848235|NCT00327015|10855158|FG000|Overall Study|Physician Decision|0
6848236|NCT00327015|10855159|FG001|Overall Study|Physician Decision|1
6848237|NCT00327015|10855160|FG002|Overall Study|Physician Decision|3
6848238|NCT00327015|10855161|FG003|Overall Study|Physician Decision|2
6848239|NCT00327015|10855158|FG000|Overall Study|Death|1
6848240|NCT00327015|10855159|FG001|Overall Study|Death|2
6848241|NCT00327015|10855160|FG002|Overall Study|Death|2
6848242|NCT00327015|10855161|FG003|Overall Study|Death|3
6848243|NCT00327015|10855158|FG000|Overall Study|Pregnancy|0
6848244|NCT00327015|10855159|FG001|Overall Study|Pregnancy|2
6848245|NCT00327015|10855160|FG002|Overall Study|Pregnancy|1
7151698|NCT03236246|11315888|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0
7151699|NCT03236246|11315887|FG000|24-Week Dose Maintenance Period|Death|0
7151700|NCT03236246|11315888|FG001|24-Week Dose Maintenance Period|Death|1
7151701|NCT03236246|11315887|FG000|24-Week Dose Maintenance Period|Adverse Event|0
7151702|NCT03236246|11315888|FG001|24-Week Dose Maintenance Period|Adverse Event|1
7151703|NCT03236506|11315897|FG000|Overall Study|Death|1
7151704|NCT03236506|11315898|FG001|Overall Study|Death|1
7151705|NCT03236506|11315899|FG002|Overall Study|Death|1
7151706|NCT03236506|11315897|FG000|Overall Study|Withdrawal by Subject|3
7151707|NCT03236506|11315898|FG001|Overall Study|Withdrawal by Subject|3
7151708|NCT03236506|11315899|FG002|Overall Study|Withdrawal by Subject|4
7151709|NCT03236506|11315897|FG000|Overall Study|Did not initiate treatment|2
7151710|NCT03236506|11315898|FG001|Overall Study|Did not initiate treatment|1
7151711|NCT03236506|11315899|FG002|Overall Study|Did not initiate treatment|2
7151712|NCT03236779|11315909|FG000|Overall Study|Lost to Follow-up|13
7151713|NCT03236779|11315910|FG001|Overall Study|Lost to Follow-up|21
7151714|NCT03237013|11315921|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43
7151715|NCT03237013|11315922|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30
7151716|NCT03237013|11315923|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37
7151717|NCT03237065|11315933|FG000|Overall Study|Adverse Event|0
7151718|NCT03237065|11315934|FG001|Overall Study|Adverse Event|2
7151719|NCT03237065|11315933|FG000|Overall Study|Protocol Violation|0
7151720|NCT03237065|11315934|FG001|Overall Study|Protocol Violation|1
7151721|NCT03237065|11315933|FG000|Overall Study|Withdrawal by Subject|3
7151722|NCT03237065|11315934|FG001|Overall Study|Withdrawal by Subject|0
7151723|NCT03237065|11315933|FG000|Overall Study|Lost to Follow-up|1
7151724|NCT03237065|11315934|FG001|Overall Study|Lost to Follow-up|0
7151725|NCT03237065|11315933|FG000|Overall Study|Unable to obtain venous access|0
7151726|NCT03237065|11315934|FG001|Overall Study|Unable to obtain venous access|1
7151727|NCT03237481|11315963|FG000|Overall Study|Lost to Follow-up|1
7151728|NCT03237481|11315964|FG001|Overall Study|Lost to Follow-up|0
7151729|NCT03237481|11315965|FG002|Overall Study|Lost to Follow-up|0
7151730|NCT03237481|11315963|FG000|Overall Study|Protocol Violation|1
7151731|NCT03237481|11315964|FG001|Overall Study|Protocol Violation|0
7151732|NCT03237481|11315965|FG002|Overall Study|Protocol Violation|0
7151733|NCT03237481|11315963|FG000|Overall Study|Withdrawal by Subject|3
6848246|NCT00327015|10855161|FG003|Overall Study|Pregnancy|1
6848247|NCT00327015|10855158|FG000|Overall Study|Administrative Reason by Sponsor|1
6848248|NCT00327015|10855159|FG001|Overall Study|Administrative Reason by Sponsor|2
7151734|NCT03237481|11315964|FG001|Overall Study|Withdrawal by Subject|2
7151735|NCT03237481|11315965|FG002|Overall Study|Withdrawal by Subject|1
7151736|NCT03237845|11315975|FG000|Overall Study|Adverse Event|0
6848249|NCT00327015|10855160|FG002|Overall Study|Administrative Reason by Sponsor|2
6848250|NCT00327015|10855161|FG003|Overall Study|Administrative Reason by Sponsor|1
6848251|NCT00327171|10855173|FG000|Overall Study|Did not receive study medication|3
6848252|NCT00327171|10855174|FG001|Overall Study|Did not receive study medication|0
6848253|NCT00327171|10855173|FG000|Overall Study|Adverse Event|23
6848254|NCT00327171|10855174|FG001|Overall Study|Adverse Event|23
6848255|NCT00327171|10855173|FG000|Overall Study|Disease progression/lack of efficacy|68
6848256|NCT00327171|10855174|FG001|Overall Study|Disease progression/lack of efficacy|69
6848257|NCT00327171|10855173|FG000|Overall Study|Investigator/participant request|1
6848258|NCT00327171|10855174|FG001|Overall Study|Investigator/participant request|8
6848259|NCT00327171|10855173|FG000|Overall Study|Clinical progression|12
6848260|NCT00327171|10855174|FG001|Overall Study|Clinical progression|8
6848261|NCT00327171|10855173|FG000|Overall Study|Undisclosed history of ischemia|0
6848262|NCT00327171|10855174|FG001|Overall Study|Undisclosed history of ischemia|1
6848263|NCT00327171|10855173|FG000|Overall Study|Other|1
6848264|NCT00327171|10855174|FG001|Overall Study|Other|0
6848265|NCT00327340|10855182|FG000|Overall Study|Withdrawal by Subject|1
6848266|NCT00327340|10855183|FG001|Overall Study|Withdrawal by Subject|5
6848267|NCT00327340|10855182|FG000|Overall Study|Physician Decision|1
6848268|NCT00327340|10855183|FG001|Overall Study|Physician Decision|1
6848269|NCT00327340|10855182|FG000|Overall Study|Disease Progression|10
6848270|NCT00327340|10855183|FG001|Overall Study|Disease Progression|19
6848271|NCT00327340|10855182|FG000|Overall Study|Symptomatic Disease|0
6848272|NCT00327340|10855183|FG001|Overall Study|Symptomatic Disease|2
6848273|NCT00327340|10855182|FG000|Overall Study|Adverse Event|3
7151737|NCT03237845|11315976|FG001|Overall Study|Adverse Event|1
7151738|NCT03237845|11315975|FG000|Overall Study|Lost to Follow-up|13
7151739|NCT03237845|11315976|FG001|Overall Study|Lost to Follow-up|10
7151740|NCT03237845|11315975|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26
7151741|NCT03237845|11315976|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31
7151742|NCT03237845|11315975|FG000|Overall Study|Non-Compliance With Study Treatment|0
7151743|NCT03237845|11315976|FG001|Overall Study|Non-Compliance With Study Treatment|1
7151744|NCT03237845|11315975|FG000|Overall Study|Physician Decision|1
7151745|NCT03237845|11315976|FG001|Overall Study|Physician Decision|2
7151746|NCT03237845|11315975|FG000|Overall Study|Pregnancy|1
7151747|NCT03237845|11315976|FG001|Overall Study|Pregnancy|0
7151748|NCT03237845|11315975|FG000|Overall Study|Protocol Deviation|0
7151749|NCT03237845|11315976|FG001|Overall Study|Protocol Deviation|1
7151750|NCT03237845|11315975|FG000|Overall Study|Technical Problems|8
7151751|NCT03237845|11315976|FG001|Overall Study|Technical Problems|1
7151752|NCT03237845|11315975|FG000|Overall Study|Withdrawal by Subject|3
7151753|NCT03237845|11315976|FG001|Overall Study|Withdrawal by Subject|3
7151754|NCT03237845|11315975|FG000|Overall Study|Other Reasons|4
7151755|NCT03237845|11315976|FG001|Overall Study|Other Reasons|0
7151756|NCT03238001|11315986|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2
7151757|NCT03238001|11315986|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2
7151758|NCT03238001|11315986|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16
7151759|NCT03238001|11315986|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2
7151760|NCT03238001|11315986|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3
7151761|NCT03238001|11315986|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3
7151762|NCT03238001|11315986|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1
7151763|NCT03238001|11315986|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4
7151764|NCT03238352|11316001|FG000|Overall Study|Lost to Follow-up|0
7151765|NCT03238352|11316002|FG001|Overall Study|Lost to Follow-up|2
7151766|NCT03238352|11316003|FG002|Overall Study|Lost to Follow-up|1
7151767|NCT03238352|11316001|FG000|Overall Study|Withdrawal by Subject|0
7151768|NCT03238352|11316002|FG001|Overall Study|Withdrawal by Subject|1
7151769|NCT03238352|11316003|FG002|Overall Study|Withdrawal by Subject|0
7151770|NCT03238417|11316013|FG000|Overall|non-response|955
7151771|NCT03238417|11316014|FG001|Overall|non-response|1920
7151772|NCT03238417|11316013|FG000|Overall|partial completion|48
7151773|NCT03238417|11316014|FG001|Overall|partial completion|68
7151774|NCT03238417|11316013|FG000|Baseline|Partial completion|17
7151775|NCT03238417|11316014|FG001|Baseline|Partial completion|48
7151776|NCT03238417|11316013|FG000|Baseline|non-response|372
7151777|NCT03238417|11316014|FG001|Baseline|non-response|669
7151778|NCT03238417|11316013|FG000|12-month|non-response|296
7151779|NCT03238417|11316014|FG001|12-month|non-response|669
7151780|NCT03238417|11316013|FG000|12-month|partial completion|23
7151781|NCT03238417|11316014|FG001|12-month|partial completion|37
7151782|NCT03238417|11316013|FG000|24-month|non-response|287
7151783|NCT03238417|11316014|FG001|24-month|non-response|594
7151784|NCT03238417|11316013|FG000|24-month|partial completion|8
7151785|NCT03238417|11316014|FG001|24-month|partial completion|31
7151786|NCT03238651|11316025|FG000|Overall Study|Other|0
6848274|NCT00327340|10855183|FG001|Overall Study|Adverse Event|3
6848275|NCT00327444|10855197|FG000|Double Blind Treatment (DB) Period|Disease progression|10
6848276|NCT00327444|10855198|FG001|Double Blind Treatment (DB) Period|Disease progression|13
6848277|NCT00327444|10855197|FG000|Double Blind Treatment (DB) Period|Adverse Event|5
7151787|NCT03238651|11316026|FG001|Overall Study|Other|0
7151788|NCT03238651|11316027|FG002|Overall Study|Other|0
7151789|NCT03238651|11316028|FG003|Overall Study|Other|0
7151790|NCT03238651|11316029|FG004|Overall Study|Other|1
7151791|NCT03238651|11316025|FG000|Overall Study|Progressive Disease|2
6966589|NCT01125566|11014601|FG000|Patients Before the Switch (26Apr2013)|Not treated|2
7151792|NCT03238651|11316026|FG001|Overall Study|Progressive Disease|2
7151793|NCT03238651|11316027|FG002|Overall Study|Progressive Disease|2
7151794|NCT03238651|11316028|FG003|Overall Study|Progressive Disease|2
6848278|NCT00327444|10855198|FG001|Double Blind Treatment (DB) Period|Adverse Event|5
6848279|NCT00327444|10855197|FG000|Double Blind Treatment (DB) Period|Subject request|0
6848280|NCT00327444|10855198|FG001|Double Blind Treatment (DB) Period|Subject request|1
6848281|NCT00327444|10855197|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11
6848282|NCT00327444|10855198|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10
6848283|NCT00327444|10855197|FG000|Open Label Treatment (OL) Period|Disease progression|8
6848284|NCT00327444|10855198|FG001|Open Label Treatment (OL) Period|Disease progression|7
6848285|NCT00327444|10855197|FG000|Open Label Treatment (OL) Period|Adverse Event|2
6848286|NCT00327444|10855198|FG001|Open Label Treatment (OL) Period|Adverse Event|2
6848287|NCT00327444|10855197|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0
6848288|NCT00327444|10855198|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1
6848289|NCT00327444|10855197|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1
6848290|NCT00327444|10855198|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0
6848291|NCT00327470|10855208|FG000|Overall Study|Randomized, but not treated|0
6848292|NCT00327470|10855209|FG001|Overall Study|Randomized, but not treated|2
6848293|NCT00327470|10855208|FG000|Overall Study|Adverse Event|9
6848294|NCT00327470|10855209|FG001|Overall Study|Adverse Event|14
6848295|NCT00327470|10855208|FG000|Overall Study|Lack of Efficacy|7
6848296|NCT00327470|10855209|FG001|Overall Study|Lack of Efficacy|19
6848297|NCT00327470|10855208|FG000|Overall Study|Other|5
6848298|NCT00327470|10855209|FG001|Overall Study|Other|9
6848299|NCT00327470|10855208|FG000|Overall Study|Lost to Follow-up|1
6848300|NCT00327470|10855209|FG001|Overall Study|Lost to Follow-up|3
6848301|NCT00327470|10855208|FG000|Overall Study|Withdrawal by Subject|6
6848302|NCT00327470|10855209|FG001|Overall Study|Withdrawal by Subject|12
6848303|NCT00327470|10855208|FG000|Overall Study|Death|1
6848304|NCT00327470|10855209|FG001|Overall Study|Death|4
6848305|NCT00327717|10855217|FG000|Overall Study|Adverse Event|6
6848306|NCT00327717|10855218|FG001|Overall Study|Adverse Event|6
6848307|NCT00327717|10855217|FG000|Overall Study|Lack of Efficacy|0
6848308|NCT00327717|10855218|FG001|Overall Study|Lack of Efficacy|1
6848309|NCT00327717|10855217|FG000|Overall Study|Withdrawal by Subject|3
7151795|NCT03238651|11316029|FG004|Overall Study|Progressive Disease|0
7151796|NCT03238651|11316025|FG000|Overall Study|Withdrawal by Subject|0
7151797|NCT03238651|11316026|FG001|Overall Study|Withdrawal by Subject|1
7151798|NCT03238651|11316027|FG002|Overall Study|Withdrawal by Subject|0
7151799|NCT03238651|11316028|FG003|Overall Study|Withdrawal by Subject|1
7151800|NCT03238651|11316029|FG004|Overall Study|Withdrawal by Subject|0
7151801|NCT03238651|11316025|FG000|Overall Study|Adverse Event|1
7151802|NCT03238651|11316026|FG001|Overall Study|Adverse Event|3
7151803|NCT03238651|11316027|FG002|Overall Study|Adverse Event|2
7151804|NCT03238651|11316028|FG003|Overall Study|Adverse Event|0
7151805|NCT03238651|11316029|FG004|Overall Study|Adverse Event|0
7151806|NCT03238781|11316045|FG000|Overall Study|Adverse Event|1
7151807|NCT03238781|11316046|FG001|Overall Study|Adverse Event|1
7151808|NCT03238781|11316047|FG002|Overall Study|Adverse Event|2
7151809|NCT03238781|11316045|FG000|Overall Study|Lost to Follow-up|2
7151810|NCT03238781|11316046|FG001|Overall Study|Lost to Follow-up|1
7151811|NCT03238781|11316047|FG002|Overall Study|Lost to Follow-up|2
7151812|NCT03238781|11316045|FG000|Overall Study|Withdrawal by Subject|23
7151813|NCT03238781|11316046|FG001|Overall Study|Withdrawal by Subject|14
7151814|NCT03238781|11316047|FG002|Overall Study|Withdrawal by Subject|16
7151815|NCT03238781|11316045|FG000|Overall Study|Decision by sponsor|0
7151816|NCT03238781|11316046|FG001|Overall Study|Decision by sponsor|1
7151817|NCT03238781|11316047|FG002|Overall Study|Decision by sponsor|0
7151818|NCT03238911|11316057|FG000|Overall Study|Withdrawal by Subject|1
7151819|NCT03238911|11316058|FG001|Overall Study|Withdrawal by Subject|2
7151820|NCT03238911|11316057|FG000|Overall Study|Lost to Follow-up|2
7151821|NCT03238911|11316058|FG001|Overall Study|Lost to Follow-up|1
7151822|NCT03238924|11316067|FG000|Overall Study|Withdrawal by Subject|2
7151823|NCT03238924|11316068|FG001|Overall Study|Withdrawal by Subject|2
7151824|NCT03238963|11316076|FG000|Overall Study|Prohibited medication given due to hospital stay|1
7151825|NCT03238963|11316077|FG001|Overall Study|Prohibited medication given due to hospital stay|0
7151826|NCT03238963|11316076|FG000|Overall Study|Withdrawal by Subject|1
7151827|NCT03238963|11316077|FG001|Overall Study|Withdrawal by Subject|1
7151828|NCT03238963|11316076|FG000|Overall Study|Lost to Follow-up|1
7151829|NCT03238963|11316077|FG001|Overall Study|Lost to Follow-up|0
7151830|NCT03238963|11316076|FG000|Overall Study|Protocol Violation|1
7151831|NCT03238963|11316077|FG001|Overall Study|Protocol Violation|1
7151832|NCT03238963|11316076|FG000|Overall Study|Adverse Event|1
7151833|NCT03238963|11316077|FG001|Overall Study|Adverse Event|0
7151834|NCT03239470|11316088|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1
6848310|NCT00327717|10855218|FG001|Overall Study|Withdrawal by Subject|7
7151835|NCT03239470|11316089|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0
7151836|NCT03239483|11316095|FG000|Overall Study|Lost to Follow-up|1
7151837|NCT03239483|11316096|FG001|Overall Study|Lost to Follow-up|0
7151838|NCT03239483|11316095|FG000|Overall Study|Withdrawal by Subject|1
7151839|NCT03239483|11316096|FG001|Overall Study|Withdrawal by Subject|0
6848311|NCT00328094|10855247|FG000|Overall Study|Physician Decision|3
6848312|NCT00328094|10855248|FG001|Overall Study|Physician Decision|3
6848313|NCT00328172|10855259|FG000|Overall Study|Adverse Event|3
6848314|NCT00328172|10855260|FG001|Overall Study|Adverse Event|2
6848315|NCT00328172|10855261|FG002|Overall Study|Adverse Event|1
6848316|NCT00328172|10855262|FG003|Overall Study|Adverse Event|2
6848317|NCT00328172|10855263|FG004|Overall Study|Adverse Event|1
6848318|NCT00328172|10855259|FG000|Overall Study|Protocol Violation|0
6848319|NCT00328172|10855260|FG001|Overall Study|Protocol Violation|1
6848320|NCT00328172|10855261|FG002|Overall Study|Protocol Violation|1
6848321|NCT00328172|10855262|FG003|Overall Study|Protocol Violation|0
6848322|NCT00328172|10855263|FG004|Overall Study|Protocol Violation|0
6848323|NCT00328172|10855259|FG000|Overall Study|Lost to Follow-up|1
6848324|NCT00328172|10855260|FG001|Overall Study|Lost to Follow-up|1
6848325|NCT00328172|10855261|FG002|Overall Study|Lost to Follow-up|2
6848326|NCT00328172|10855262|FG003|Overall Study|Lost to Follow-up|1
6848327|NCT00328172|10855263|FG004|Overall Study|Lost to Follow-up|1
6848328|NCT00328172|10855259|FG000|Overall Study|Withdrawal by Subject|1
6848329|NCT00328172|10855260|FG001|Overall Study|Withdrawal by Subject|1
6848330|NCT00328172|10855261|FG002|Overall Study|Withdrawal by Subject|1
6848331|NCT00328172|10855262|FG003|Overall Study|Withdrawal by Subject|6
6848332|NCT00328172|10855263|FG004|Overall Study|Withdrawal by Subject|0
6848333|NCT00328172|10855259|FG000|Overall Study|Lack of Efficacy|14
6848334|NCT00328172|10855260|FG001|Overall Study|Lack of Efficacy|9
6848335|NCT00328172|10855261|FG002|Overall Study|Lack of Efficacy|4
6848336|NCT00328172|10855262|FG003|Overall Study|Lack of Efficacy|4
6848337|NCT00328172|10855263|FG004|Overall Study|Lack of Efficacy|3
6848338|NCT00328172|10855259|FG000|Overall Study|Other reason (not specified)|3
6848339|NCT00328172|10855260|FG001|Overall Study|Other reason (not specified)|0
6848340|NCT00328172|10855261|FG002|Overall Study|Other reason (not specified)|1
6848341|NCT00328172|10855262|FG003|Overall Study|Other reason (not specified)|0
6848342|NCT00328172|10855263|FG004|Overall Study|Other reason (not specified)|0
6848343|NCT00328198|10855275|FG000|Treatment|Adverse Event|21
6848344|NCT00328198|10855275|FG000|Treatment|Death|1
6848345|NCT00328198|10855275|FG000|Treatment|Physician Decision|5
6848346|NCT00328198|10855275|FG000|Treatment|Withdrawal by Subject|5
6848347|NCT00328198|10855275|FG000|Treatment|Evidence of disease progression|2
6848348|NCT00328198|10855275|FG000|Treatment|Non-compliance|1
6848349|NCT00328198|10855275|FG000|Treatment|Confirmed complete response, MRD -|3
6848350|NCT00328198|10855275|FG000|Follow-up|Lost to Follow-up|4
6848351|NCT00328198|10855275|FG000|Follow-up|Death|31
6848352|NCT00328510|10855290|FG000|Overall Study|Gag disorder, could not use frame|4
6848353|NCT00328510|10855291|FG001|Overall Study|Gag disorder, could not use frame|0
6848354|NCT00328510|10855290|FG000|Overall Study|Dentition problems, could not use frame|1
6848355|NCT00328510|10855291|FG001|Overall Study|Dentition problems, could not use frame|0
6848356|NCT00328510|10855290|FG000|Overall Study|Withdrawal by Subject|4
6848357|NCT00328510|10855291|FG001|Overall Study|Withdrawal by Subject|2
6848358|NCT00328510|10855290|FG000|Overall Study|Severe kyphosis, could not use mask|0
6848359|NCT00328510|10855291|FG001|Overall Study|Severe kyphosis, could not use mask|1
6848360|NCT00328510|10855290|FG000|Overall Study|Treatment changed to a single fraction|1
6848361|NCT00328510|10855291|FG001|Overall Study|Treatment changed to a single fraction|1
6848362|NCT00328562|10855297|FG000|Overall Study|Disease progression|1
6848363|NCT00328627|10855333|FG000|Overall Study|Hyperglycemic Rescue|41
6848364|NCT00328627|10855334|FG001|Overall Study|Hyperglycemic Rescue|18
6848365|NCT00328627|10855335|FG002|Overall Study|Hyperglycemic Rescue|16
6848366|NCT00328627|10855336|FG003|Overall Study|Hyperglycemic Rescue|13
6966590|NCT01125566|11014602|FG001|Patients Before the Switch (26Apr2013)|Not treated|0
7077463|NCT02092350|11185024|FG000|Overall Study|Physician Decision|1
7077464|NCT02092350|11185025|FG001|Overall Study|Physician Decision|1
7077465|NCT02092350|11185024|FG000|Overall Study|Screen Failure|1
7077466|NCT02092350|11185025|FG001|Overall Study|Screen Failure|0
7077467|NCT02092350|11185024|FG000|Overall Study|Withdrawal by Subject|2
7077468|NCT02092350|11185025|FG001|Overall Study|Withdrawal by Subject|2
7077469|NCT02092389|11185033|FG000|Overall Study|Adverse Event|1
7077470|NCT02092389|11185033|FG000|Overall Study|Other|5
7077471|NCT02092467|11185054|FG000|Overall Study|Death|49
7077472|NCT02092467|11185055|FG001|Overall Study|Death|66
7077473|NCT02092467|11185056|FG002|Overall Study|Death|38
7151840|NCT03239873|11316149|FG000|Overall Study|Lost to Follow-up|15
7151841|NCT03239873|11316150|FG001|Overall Study|Lost to Follow-up|16
7151842|NCT03239873|11316149|FG000|Overall Study|Physician Decision|1
6966591|NCT01125566|11014603|FG002|Patients Before the Switch (26Apr2013)|Not treated|0
7151843|NCT03239873|11316150|FG001|Overall Study|Physician Decision|0
7151844|NCT03239873|11316149|FG000|Overall Study|Withdrawal by Parent/Guardian|12
6848367|NCT00328627|10855337|FG004|Overall Study|Hyperglycemic Rescue|6
7077474|NCT02092467|11185054|FG000|Overall Study|Lost to Follow-up|38
7077475|NCT02092467|11185055|FG001|Overall Study|Lost to Follow-up|35
7151845|NCT03239873|11316150|FG001|Overall Study|Withdrawal by Parent/Guardian|11
6848368|NCT00328627|10855338|FG005|Overall Study|Hyperglycemic Rescue|5
6848369|NCT00328627|10855339|FG006|Overall Study|Hyperglycemic Rescue|19
6848370|NCT00328627|10855340|FG007|Overall Study|Hyperglycemic Rescue|6
6848371|NCT00328627|10855341|FG008|Overall Study|Hyperglycemic Rescue|6
6848372|NCT00328627|10855342|FG009|Overall Study|Hyperglycemic Rescue|11
6848373|NCT00328627|10855343|FG010|Overall Study|Hyperglycemic Rescue|3
6848374|NCT00328627|10855344|FG011|Overall Study|Hyperglycemic Rescue|2
6848375|NCT00328627|10855333|FG000|Overall Study|Adverse Event|3
6848376|NCT00328627|10855334|FG001|Overall Study|Adverse Event|1
6848377|NCT00328627|10855335|FG002|Overall Study|Adverse Event|2
6848378|NCT00328627|10855336|FG003|Overall Study|Adverse Event|3
6848379|NCT00328627|10855337|FG004|Overall Study|Adverse Event|1
6848380|NCT00328627|10855338|FG005|Overall Study|Adverse Event|2
6848381|NCT00328627|10855339|FG006|Overall Study|Adverse Event|1
6848382|NCT00328627|10855340|FG007|Overall Study|Adverse Event|2
6848383|NCT00328627|10855341|FG008|Overall Study|Adverse Event|0
6848384|NCT00328627|10855342|FG009|Overall Study|Adverse Event|7
6848385|NCT00328627|10855343|FG010|Overall Study|Adverse Event|5
6848386|NCT00328627|10855344|FG011|Overall Study|Adverse Event|4
6848387|NCT00328627|10855333|FG000|Overall Study|Protocol Violation|2
6848388|NCT00328627|10855334|FG001|Overall Study|Protocol Violation|2
6848389|NCT00328627|10855335|FG002|Overall Study|Protocol Violation|2
6848390|NCT00328627|10855336|FG003|Overall Study|Protocol Violation|8
6848391|NCT00328627|10855337|FG004|Overall Study|Protocol Violation|5
6848392|NCT00328627|10855338|FG005|Overall Study|Protocol Violation|5
6848393|NCT00328627|10855339|FG006|Overall Study|Protocol Violation|6
6848394|NCT00328627|10855340|FG007|Overall Study|Protocol Violation|2
6848395|NCT00328627|10855341|FG008|Overall Study|Protocol Violation|1
6848396|NCT00328627|10855342|FG009|Overall Study|Protocol Violation|4
6848397|NCT00328627|10855343|FG010|Overall Study|Protocol Violation|6
6848398|NCT00328627|10855344|FG011|Overall Study|Protocol Violation|2
6848399|NCT00328627|10855333|FG000|Overall Study|Lost to Follow-up|4
6848400|NCT00328627|10855334|FG001|Overall Study|Lost to Follow-up|2
6848401|NCT00328627|10855335|FG002|Overall Study|Lost to Follow-up|2
6848402|NCT00328627|10855336|FG003|Overall Study|Lost to Follow-up|4
6848403|NCT00328627|10855337|FG004|Overall Study|Lost to Follow-up|0
6848404|NCT00328627|10855338|FG005|Overall Study|Lost to Follow-up|2
6848405|NCT00328627|10855339|FG006|Overall Study|Lost to Follow-up|3
6848406|NCT00328627|10855340|FG007|Overall Study|Lost to Follow-up|0
6848407|NCT00328627|10855341|FG008|Overall Study|Lost to Follow-up|3
6848408|NCT00328627|10855342|FG009|Overall Study|Lost to Follow-up|2
6848409|NCT00328627|10855343|FG010|Overall Study|Lost to Follow-up|0
6848410|NCT00328627|10855344|FG011|Overall Study|Lost to Follow-up|1
6848411|NCT00328627|10855333|FG000|Overall Study|Withdrawal by Subject|5
6848412|NCT00328627|10855334|FG001|Overall Study|Withdrawal by Subject|4
6848413|NCT00328627|10855335|FG002|Overall Study|Withdrawal by Subject|5
6848414|NCT00328627|10855336|FG003|Overall Study|Withdrawal by Subject|6
6848415|NCT00328627|10855337|FG004|Overall Study|Withdrawal by Subject|2
6848416|NCT00328627|10855338|FG005|Overall Study|Withdrawal by Subject|5
6848417|NCT00328627|10855339|FG006|Overall Study|Withdrawal by Subject|4
6848418|NCT00328627|10855340|FG007|Overall Study|Withdrawal by Subject|4
6848419|NCT00328627|10855341|FG008|Overall Study|Withdrawal by Subject|4
6848420|NCT00328627|10855342|FG009|Overall Study|Withdrawal by Subject|5
6848421|NCT00328627|10855343|FG010|Overall Study|Withdrawal by Subject|2
6848422|NCT00328627|10855344|FG011|Overall Study|Withdrawal by Subject|7
6848423|NCT00328627|10855333|FG000|Overall Study|Pregnancy|0
6848424|NCT00328627|10855334|FG001|Overall Study|Pregnancy|1
6848425|NCT00328627|10855335|FG002|Overall Study|Pregnancy|0
6848426|NCT00328627|10855336|FG003|Overall Study|Pregnancy|0
7151846|NCT03239873|11316149|FG000|Overall Study|Withdrawal by Subject|2
7151847|NCT03239873|11316150|FG001|Overall Study|Withdrawal by Subject|0
7151848|NCT03239873|11316149|FG000|Overall Study|Contraindication to study medication|1
7151849|NCT03239873|11316150|FG001|Overall Study|Contraindication to study medication|0
7151850|NCT03239873|11316149|FG000|Overall Study|Protocol Violation|1
7151851|NCT03239873|11316150|FG001|Overall Study|Protocol Violation|0
7151852|NCT03240081|11316158|FG000|Overall Study|Withdrawal by Subject|0
7151853|NCT03240081|11316159|FG001|Overall Study|Withdrawal by Subject|2
7151854|NCT03240081|11316158|FG000|Overall Study|Lost to Follow-up|0
7151855|NCT03240081|11316159|FG001|Overall Study|Lost to Follow-up|1
7151856|NCT03240133|11316168|FG000|Overall Study|Withdrawal by Subject|0
7151857|NCT03240133|11316169|FG001|Overall Study|Withdrawal by Subject|1
7151858|NCT03240133|11316170|FG002|Overall Study|Withdrawal by Subject|0
7151859|NCT03240133|11316168|FG000|Overall Study|Adverse Event|1
7151860|NCT03240133|11316169|FG001|Overall Study|Adverse Event|1
7151861|NCT03240133|11316170|FG002|Overall Study|Adverse Event|0
6848427|NCT00328627|10855337|FG004|Overall Study|Pregnancy|0
6848428|NCT00328627|10855338|FG005|Overall Study|Pregnancy|0
6848429|NCT00328627|10855339|FG006|Overall Study|Pregnancy|0
6848430|NCT00328627|10855340|FG007|Overall Study|Pregnancy|0
6848431|NCT00328627|10855341|FG008|Overall Study|Pregnancy|0
6848432|NCT00328627|10855342|FG009|Overall Study|Pregnancy|0
6848433|NCT00328627|10855343|FG010|Overall Study|Pregnancy|0
6848434|NCT00328627|10855344|FG011|Overall Study|Pregnancy|0
6848435|NCT00328627|10855333|FG000|Overall Study|Physician Decision|4
6848436|NCT00328627|10855334|FG001|Overall Study|Physician Decision|3
6848437|NCT00328627|10855335|FG002|Overall Study|Physician Decision|1
6848438|NCT00328627|10855336|FG003|Overall Study|Physician Decision|2
6848439|NCT00328627|10855337|FG004|Overall Study|Physician Decision|1
6848440|NCT00328627|10855338|FG005|Overall Study|Physician Decision|1
6848441|NCT00328627|10855339|FG006|Overall Study|Physician Decision|1
6848442|NCT00328627|10855340|FG007|Overall Study|Physician Decision|0
6848443|NCT00328627|10855341|FG008|Overall Study|Physician Decision|3
6848444|NCT00328627|10855342|FG009|Overall Study|Physician Decision|2
6848445|NCT00328627|10855343|FG010|Overall Study|Physician Decision|1
6848446|NCT00328627|10855344|FG011|Overall Study|Physician Decision|0
6848447|NCT00328627|10855333|FG000|Overall Study|Other|0
6848448|NCT00328627|10855334|FG001|Overall Study|Other|0
6848449|NCT00328627|10855335|FG002|Overall Study|Other|0
6848450|NCT00328627|10855336|FG003|Overall Study|Other|1
6848451|NCT00328627|10855337|FG004|Overall Study|Other|0
6848452|NCT00328627|10855338|FG005|Overall Study|Other|0
6848453|NCT00328627|10855339|FG006|Overall Study|Other|1
6848454|NCT00328627|10855340|FG007|Overall Study|Other|0
6848455|NCT00328627|10855341|FG008|Overall Study|Other|0
6848456|NCT00328627|10855342|FG009|Overall Study|Other|1
6848457|NCT00328627|10855343|FG010|Overall Study|Other|1
6848458|NCT00328627|10855344|FG011|Overall Study|Other|0
6848459|NCT00328783|10855383|FG000|Overall Study|Could not tolerate ABC|21
6848460|NCT00328783|10855383|FG000|Overall Study|No heart in RT field|4
6848461|NCT00328783|10855383|FG000|Overall Study|Withdrawal by Subject|1
6848462|NCT00328926|10855401|FG000|Overall Study|Pregnancy|2
6848463|NCT00328926|10855402|FG001|Overall Study|Pregnancy|1
6848464|NCT00328926|10855403|FG002|Overall Study|Pregnancy|0
7151862|NCT03240133|11316168|FG000|Overall Study|Rash|1
7151863|NCT03240133|11316169|FG001|Overall Study|Rash|0
7151864|NCT03240133|11316170|FG002|Overall Study|Rash|0
7151865|NCT03240133|11316168|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1
7151866|NCT03240133|11316169|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0
7151867|NCT03240133|11316170|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0
7151868|NCT03240133|11316168|FG000|Overall Study|Intercurrent illness.|0
7151869|NCT03240133|11316169|FG001|Overall Study|Intercurrent illness.|1
7151870|NCT03240133|11316170|FG002|Overall Study|Intercurrent illness.|0
7151871|NCT03240133|11316168|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0
7151872|NCT03240133|11316169|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0
7151873|NCT03240133|11316170|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1
7151874|NCT03240575|11316198|FG000|Overall Study|Adverse Event|0
7151875|NCT03240575|11316199|FG001|Overall Study|Adverse Event|2
7151876|NCT03240575|11316200|FG002|Overall Study|Adverse Event|0
7151877|NCT03240575|11316201|FG003|Overall Study|Adverse Event|1
7151878|NCT03240575|11316198|FG000|Overall Study|Withdrawal by Subject|2
7151879|NCT03240575|11316199|FG001|Overall Study|Withdrawal by Subject|11
7151880|NCT03240575|11316200|FG002|Overall Study|Withdrawal by Subject|0
7151881|NCT03240575|11316201|FG003|Overall Study|Withdrawal by Subject|1
7151882|NCT03240575|11316198|FG000|Overall Study|Other|0
7151883|NCT03240575|11316199|FG001|Overall Study|Other|1
7151884|NCT03240575|11316200|FG002|Overall Study|Other|0
7151885|NCT03240575|11316201|FG003|Overall Study|Other|0
7151886|NCT03241342|11316221|FG000|Overall Study|Adverse Event|5
7151887|NCT03241342|11316222|FG001|Overall Study|Adverse Event|8
7151888|NCT03241342|11316223|FG002|Overall Study|Adverse Event|4
7151889|NCT03241342|11316221|FG000|Overall Study|Lack of Efficacy|0
7151890|NCT03241342|11316222|FG001|Overall Study|Lack of Efficacy|0
7151891|NCT03241342|11316223|FG002|Overall Study|Lack of Efficacy|1
7151892|NCT03241342|11316221|FG000|Overall Study|noncompliance with study drug|2
7151893|NCT03241342|11316222|FG001|Overall Study|noncompliance with study drug|1
7151894|NCT03241342|11316223|FG002|Overall Study|noncompliance with study drug|1
7151895|NCT03241342|11316221|FG000|Overall Study|sponsor decision|0
7151896|NCT03241342|11316222|FG001|Overall Study|sponsor decision|1
7151897|NCT03241342|11316223|FG002|Overall Study|sponsor decision|2
7151898|NCT03241342|11316221|FG000|Overall Study|not reported|15
7151899|NCT03241342|11316222|FG001|Overall Study|not reported|21
7151900|NCT03241342|11316223|FG002|Overall Study|not reported|19
7151901|NCT03241368|11316231|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25
7151902|NCT03241368|11316231|FG000|Overall Study|Lost to Follow-up|1
7151903|NCT03241368|11316231|FG000|Overall Study|Physician Decision|6
7151904|NCT03241368|11316231|FG000|Overall Study|Withdrawal by Subject|6
7151905|NCT03241368|11316231|FG000|Overall Study|Protocol Violation|1
7151906|NCT03241927|11316263|FG000|Overall Study|study terminated|1
7151907|NCT03241927|11316264|FG001|Overall Study|study terminated|0
7151908|NCT03242018|11316273|FG000|Overall Study|Adverse Event|7
6848465|NCT00328926|10855401|FG000|Overall Study|Lost to Follow-up|0
6848466|NCT00328926|10855402|FG001|Overall Study|Lost to Follow-up|1
6848467|NCT00328926|10855403|FG002|Overall Study|Lost to Follow-up|0
6848468|NCT00328926|10855401|FG000|Overall Study|Death|0
6848469|NCT00328926|10855402|FG001|Overall Study|Death|0
7151909|NCT03242018|11316274|FG001|Overall Study|Adverse Event|7
7151910|NCT03242018|11316275|FG002|Overall Study|Adverse Event|6
7151911|NCT03242018|11316273|FG000|Overall Study|Lost to Follow-up|2
7151912|NCT03242018|11316274|FG001|Overall Study|Lost to Follow-up|2
7151913|NCT03242018|11316275|FG002|Overall Study|Lost to Follow-up|2
7151914|NCT03242018|11316273|FG000|Overall Study|At the Participant's Own Request|5
7151915|NCT03242018|11316274|FG001|Overall Study|At the Participant's Own Request|1
7151916|NCT03242018|11316275|FG002|Overall Study|At the Participant's Own Request|4
7151917|NCT03242018|11316273|FG000|Overall Study|Reason Not Specified|3
7151918|NCT03242018|11316274|FG001|Overall Study|Reason Not Specified|4
7151919|NCT03242018|11316275|FG002|Overall Study|Reason Not Specified|1
6848470|NCT00328926|10855403|FG002|Overall Study|Death|1
6848471|NCT00328926|10855401|FG000|Overall Study|In vitro fertilization treatment|0
6848472|NCT00328926|10855402|FG001|Overall Study|In vitro fertilization treatment|0
7151920|NCT03242018|11316273|FG000|Overall Study|Study Terminated by Sponsor|1
7151921|NCT03242018|11316274|FG001|Overall Study|Study Terminated by Sponsor|0
6848473|NCT00328926|10855403|FG002|Overall Study|In vitro fertilization treatment|1
6848474|NCT00328926|10855401|FG000|Overall Study|Lack of ovarian response|0
6848475|NCT00328926|10855402|FG001|Overall Study|Lack of ovarian response|1
6848476|NCT00328926|10855403|FG002|Overall Study|Lack of ovarian response|0
6848477|NCT00329030|10855413|FG000|Overall Study|Withdrawal by Subject|1
6848478|NCT00329030|10855414|FG001|Overall Study|Withdrawal by Subject|3
6848479|NCT00329030|10855413|FG000|Overall Study|Progressive Disease|6
6848480|NCT00329030|10855414|FG001|Overall Study|Progressive Disease|2
6848481|NCT00329030|10855413|FG000|Overall Study|Ineligible Pathology|1
6848482|NCT00329030|10855414|FG001|Overall Study|Ineligible Pathology|1
6848483|NCT00329160|10855420|FG000|Overall Study|Adverse Event|27
6848484|NCT00329160|10855420|FG000|Overall Study|Withdrawal by Subject|13
6848485|NCT00329160|10855420|FG000|Overall Study|Protocol Violation|2
6848486|NCT00329160|10855420|FG000|Overall Study|Did not Receive Study Drug|1
6848487|NCT00329160|10855420|FG000|Overall Study|Incomplete IVUS|45
6848488|NCT00329238|10855426|FG000|Overall Study|Adverse Event|147
6848489|NCT00329238|10855427|FG001|Overall Study|Adverse Event|129
6848490|NCT00329238|10855426|FG000|Overall Study|Protocol Violation|23
6848491|NCT00329238|10855427|FG001|Overall Study|Protocol Violation|34
6848492|NCT00329238|10855426|FG000|Overall Study|Lost to Follow-up|2
6848493|NCT00329238|10855427|FG001|Overall Study|Lost to Follow-up|6
6848494|NCT00329238|10855426|FG000|Overall Study|Withdrawal by Subject|64
6848495|NCT00329238|10855427|FG001|Overall Study|Withdrawal by Subject|58
6848496|NCT00329238|10855426|FG000|Overall Study|Other reason (not specified)|40
6848497|NCT00329238|10855427|FG001|Overall Study|Other reason (not specified)|54
6848498|NCT00329303|10855437|FG000|Overall Study|Lack of Efficacy|1
6848499|NCT00329303|10855438|FG001|Overall Study|Lack of Efficacy|0
6848500|NCT00329303|10855437|FG000|Overall Study|Decision of the sponsor|0
6848501|NCT00329303|10855438|FG001|Overall Study|Decision of the sponsor|1
6848502|NCT00329303|10855437|FG000|Overall Study|Patient no longer available|1
6848503|NCT00329303|10855438|FG001|Overall Study|Patient no longer available|0
6848504|NCT00329303|10855437|FG000|Overall Study|Patient relocated|0
6848505|NCT00329303|10855438|FG001|Overall Study|Patient relocated|1
6848506|NCT00329407|10855445|FG000|Overall Study|Withdrawal by Subject|1
6848507|NCT00329420|10855452|FG000|Re-induction Phase|Lack of Efficacy|0
6848508|NCT00329420|10855453|FG001|Re-induction Phase|Lack of Efficacy|1
6848509|NCT00329420|10855454|FG002|Re-induction Phase|Lack of Efficacy|0
6848510|NCT00329420|10855452|FG000|Re-induction Phase|Withdrawal of Consent|0
6848511|NCT00329420|10855453|FG001|Re-induction Phase|Withdrawal of Consent|0
7151922|NCT03242018|11316275|FG002|Overall Study|Study Terminated by Sponsor|1
7151923|NCT03242252|11316291|FG000|Overall Study|At the Participant's own Request|18
7151924|NCT03242252|11316292|FG001|Overall Study|At the Participant's own Request|10
7151925|NCT03242252|11316293|FG002|Overall Study|At the Participant's own Request|15
7151926|NCT03242252|11316291|FG000|Overall Study|Adverse Event|8
7151927|NCT03242252|11316292|FG001|Overall Study|Adverse Event|6
7151928|NCT03242252|11316293|FG002|Overall Study|Adverse Event|9
7151929|NCT03242252|11316291|FG000|Overall Study|Poor Compliance to Protocol|0
7151930|NCT03242252|11316292|FG001|Overall Study|Poor Compliance to Protocol|2
7151931|NCT03242252|11316293|FG002|Overall Study|Poor Compliance to Protocol|3
7151932|NCT03242252|11316291|FG000|Overall Study|Study Terminated by Sponsor|1
7151933|NCT03242252|11316292|FG001|Overall Study|Study Terminated by Sponsor|0
7151934|NCT03242252|11316293|FG002|Overall Study|Study Terminated by Sponsor|0
7151935|NCT03242252|11316291|FG000|Overall Study|Reason not Specified|4
7151936|NCT03242252|11316292|FG001|Overall Study|Reason not Specified|4
7151937|NCT03242252|11316293|FG002|Overall Study|Reason not Specified|1
7151938|NCT03242252|11316291|FG000|Overall Study|Lost to Follow-up|5
7151939|NCT03242252|11316292|FG001|Overall Study|Lost to Follow-up|1
7151940|NCT03242252|11316293|FG002|Overall Study|Lost to Follow-up|4
7151941|NCT03242434|11316313|FG000|Overall Study|Death|0
6848512|NCT00329420|10855454|FG002|Re-induction Phase|Withdrawal of Consent|1
6848513|NCT00329420|10855452|FG000|Re-induction Phase|Did not respond to re-induction|6
6848514|NCT00329420|10855453|FG001|Re-induction Phase|Did not respond to re-induction|5
6848515|NCT00329420|10855454|FG002|Re-induction Phase|Did not respond to re-induction|7
7151942|NCT03242434|11316314|FG001|Overall Study|Death|2
7151943|NCT03242759|11316327|FG000|Overall Study|Adverse Event|5
6848516|NCT00329420|10855452|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2
6848517|NCT00329420|10855453|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
6848518|NCT00329420|10855454|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
6848519|NCT00329420|10855452|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
6848520|NCT00329420|10855453|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
6848521|NCT00329420|10855454|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0
6848522|NCT00329420|10855452|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1
6848523|NCT00329420|10855453|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
6848524|NCT00329420|10855454|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
6848525|NCT00329550|10855480|FG000|Overall Study|Adverse Event|3
7151944|NCT03242759|11316328|FG001|Overall Study|Adverse Event|1
7151945|NCT03242759|11316327|FG000|Overall Study|Withdrawal by Subject|4
7151946|NCT03242759|11316328|FG001|Overall Study|Withdrawal by Subject|3
7151947|NCT03242759|11316327|FG000|Overall Study|Lost to Follow-up|3
7151948|NCT03242759|11316328|FG001|Overall Study|Lost to Follow-up|1
6848526|NCT00329550|10855481|FG001|Overall Study|Adverse Event|4
6848527|NCT00329550|10855482|FG002|Overall Study|Adverse Event|2
6848528|NCT00329550|10855480|FG000|Overall Study|Withdrawal of Consent|1
6848529|NCT00329550|10855481|FG001|Overall Study|Withdrawal of Consent|0
6848530|NCT00329550|10855482|FG002|Overall Study|Withdrawal of Consent|1
6848531|NCT00329550|10855480|FG000|Overall Study|Due to Relocation|0
6848532|NCT00329550|10855481|FG001|Overall Study|Due to Relocation|0
6848533|NCT00329550|10855482|FG002|Overall Study|Due to Relocation|1
6848534|NCT00329602|10855494|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119
6848535|NCT00329602|10855495|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99
6848536|NCT00329602|10855496|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0
6848537|NCT00329602|10855494|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0
6848538|NCT00329602|10855495|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0
6848539|NCT00329602|10855496|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20
6848540|NCT00329602|10855494|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
6848541|NCT00329602|10855495|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
6848542|NCT00329602|10855496|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1
6848543|NCT00329602|10855494|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0
6848544|NCT00329602|10855495|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0
6848545|NCT00329602|10855496|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2
7151949|NCT03242759|11316327|FG000|Overall Study|Administrative problems|1
7151950|NCT03242759|11316328|FG001|Overall Study|Administrative problems|1
7151951|NCT03242759|11316327|FG000|Overall Study|Death|22
7151952|NCT03242759|11316328|FG001|Overall Study|Death|0
7151953|NCT03242759|11316327|FG000|Overall Study|Change visit schedule|0
7151954|NCT03242759|11316328|FG001|Overall Study|Change visit schedule|1
7151955|NCT03242863|11316334|FG000|Study Week 1|Withdrawal by Subject|0
7151956|NCT03242863|11316335|FG001|Study Week 1|Withdrawal by Subject|1
7151957|NCT03242863|11316336|FG002|Study Week 1|Withdrawal by Subject|0
7151958|NCT03242863|11316337|FG003|Study Week 1|Withdrawal by Subject|0
7151959|NCT03242863|11316338|FG004|Study Week 1|Withdrawal by Subject|3
7151960|NCT03242863|11316339|FG005|Study Week 1|Withdrawal by Subject|0
7151961|NCT03242928|11316349|FG000|Overall Study|Adverse Event|2
7151962|NCT03242928|11316350|FG001|Overall Study|Adverse Event|1
7151963|NCT03242928|11316349|FG000|Overall Study|Lost to Follow-up|2
7151964|NCT03242928|11316350|FG001|Overall Study|Lost to Follow-up|0
7151965|NCT03242928|11316349|FG000|Overall Study|Physician Decision|0
7151966|NCT03242928|11316350|FG001|Overall Study|Physician Decision|1
7151967|NCT03242928|11316349|FG000|Overall Study|Withdrawal by Subject|5
7151968|NCT03242928|11316350|FG001|Overall Study|Withdrawal by Subject|3
7151969|NCT03243084|11316380|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1
7151970|NCT03243084|11316381|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0
7151971|NCT03243305|11316388|FG000|Overall Study|Lost to Follow-up|250
7151972|NCT03243305|11316388|FG000|Overall Study|Withdrawal by Subject|170
7040896|NCT01721057|11124072|FG006|Rescue Period|Adverse Event|0
7040897|NCT01721057|11124066|FG000|Rescue Period|Lack of Efficacy|0
7040898|NCT01721057|11124067|FG001|Rescue Period|Lack of Efficacy|0
7040899|NCT01721057|11124068|FG002|Rescue Period|Lack of Efficacy|0
7040900|NCT01721057|11124069|FG003|Rescue Period|Lack of Efficacy|2
7040901|NCT01721057|11124070|FG004|Rescue Period|Lack of Efficacy|0
7151973|NCT03243305|11316388|FG000|Overall Study|Pregnancy|104
7151974|NCT03243305|11316388|FG000|Overall Study|Non-Compliance with Study Drug|38
7151975|NCT03243305|11316388|FG000|Overall Study|Adverse Event|23
7151976|NCT03243305|11316388|FG000|Overall Study|No sexually active|26
7151977|NCT03243305|11316388|FG000|Overall Study|Physician Decision|22
7151978|NCT03243305|11316388|FG000|Overall Study|Protocol Violation|22
7151979|NCT03243305|11316388|FG000|Overall Study|Study method no longer primary method|12
7151980|NCT03243305|11316388|FG000|Overall Study|Study Terminated by Sponsor|1
7151981|NCT03243305|11316388|FG000|Overall Study|Early terminations|267
7151982|NCT03243630|11316392|FG000|Overall Study|Protocol Violation|1
7151983|NCT03243630|11316392|FG000|Overall Study|Physician Decision|1
7151984|NCT03244618|11316411|FG000|Overall Study|Lost to Follow-up|3
7151985|NCT03244618|11316412|FG001|Overall Study|Lost to Follow-up|4
7151986|NCT03244618|11316411|FG000|Overall Study|Protocol Violation|4
7151987|NCT03244618|11316412|FG001|Overall Study|Protocol Violation|3
7151988|NCT03244618|11316411|FG000|Overall Study|Withdrawal by Subject|0
7151989|NCT03244618|11316412|FG001|Overall Study|Withdrawal by Subject|2
7151990|NCT03244800|11316422|FG000|Overall Study|Adverse Event|0
7151991|NCT03244800|11316423|FG001|Overall Study|Adverse Event|1
7151992|NCT03244800|11316424|FG002|Overall Study|Adverse Event|0
6848546|NCT00329602|10855494|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
6848547|NCT00329602|10855495|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
7151993|NCT03244800|11316425|FG003|Overall Study|Adverse Event|1
7151994|NCT03244800|11316422|FG000|Overall Study|Withdrew treatment|0
7151995|NCT03244800|11316423|FG001|Overall Study|Withdrew treatment|0
7151996|NCT03244800|11316424|FG002|Overall Study|Withdrew treatment|0
7151997|NCT03244800|11316425|FG003|Overall Study|Withdrew treatment|1
7040902|NCT01721057|11124071|FG005|Rescue Period|Lack of Efficacy|0
7151998|NCT03244917|11316444|FG000|Overall Study|Lost to Follow-up|2
7151999|NCT03244917|11316445|FG001|Overall Study|Lost to Follow-up|2
7152000|NCT03245398|11316462|FG000|Overall Study|Travelled to another island|1
7152001|NCT03245398|11316463|FG001|Overall Study|Travelled to another island|0
7152002|NCT03245619|11316497|FG000|Part A (Up to Day 22)|Physician Decision|4
6848548|NCT00329602|10855496|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9
6848549|NCT00329602|10855494|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0
6848550|NCT00329602|10855495|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0
6848551|NCT00329602|10855496|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4
6848552|NCT00329641|10855512|FG000|Overall Study|Did not start treatment|1
6848553|NCT00329641|10855512|FG000|Overall Study|Not eligible|1
6848554|NCT00329641|10855512|FG000|Overall Study|Adverse Event|3
6848555|NCT00329641|10855512|FG000|Overall Study|Other reason, not protocol specified|1
6848556|NCT00329719|10855521|FG000|Overall Study|Lost to Follow-up|0
6848557|NCT00329719|10855522|FG001|Overall Study|Lost to Follow-up|0
6848558|NCT00329719|10855523|FG002|Overall Study|Lost to Follow-up|0
6848559|NCT00329719|10855524|FG003|Overall Study|Lost to Follow-up|1
6848560|NCT00329745|10855536|FG000|Overall Study|Protocol Violation|1
6848561|NCT00329745|10855537|FG001|Overall Study|Protocol Violation|0
6848562|NCT00329745|10855536|FG000|Overall Study|Withdrawal by Subject|0
6848563|NCT00329745|10855537|FG001|Overall Study|Withdrawal by Subject|1
6848564|NCT00329745|10855536|FG000|Overall Study|Lost to Follow-up|86
6848565|NCT00329745|10855537|FG001|Overall Study|Lost to Follow-up|101
6848566|NCT00329784|10855551|FG000|Overall Study|Lost to Follow-up|0
6848567|NCT00329784|10855552|FG001|Overall Study|Lost to Follow-up|1
6848568|NCT00329784|10855553|FG002|Overall Study|Lost to Follow-up|0
6848569|NCT00329784|10855554|FG003|Overall Study|Lost to Follow-up|0
7152003|NCT03245619|11316498|FG001|Part A (Up to Day 22)|Physician Decision|6
7152004|NCT03245619|11316499|FG002|Part A (Up to Day 22)|Physician Decision|6
7152005|NCT03245619|11316500|FG003|Part A (Up to Day 22)|Physician Decision|0
7152006|NCT03245619|11316501|FG004|Part A (Up to Day 22)|Physician Decision|0
7152007|NCT03245619|11316502|FG005|Part A (Up to Day 22)|Physician Decision|0
7152008|NCT03245619|11316503|FG006|Part A (Up to Day 22)|Physician Decision|0
7152009|NCT03245619|11316504|FG007|Part A (Up to Day 22)|Physician Decision|0
7152010|NCT03245619|11316505|FG008|Part A (Up to Day 22)|Physician Decision|0
7152011|NCT03245619|11316506|FG009|Part A (Up to Day 22)|Physician Decision|0
7152012|NCT03245619|11316507|FG010|Part A (Up to Day 22)|Physician Decision|0
7152013|NCT03245619|11316508|FG011|Part A (Up to Day 22)|Physician Decision|0
7152014|NCT03245619|11316509|FG012|Part A (Up to Day 22)|Physician Decision|0
7152015|NCT03245619|11316510|FG013|Part A (Up to Day 22)|Physician Decision|0
7152016|NCT03245619|11316511|FG014|Part A (Up to Day 22)|Physician Decision|0
7152017|NCT03245619|11316512|FG015|Part A (Up to Day 22)|Physician Decision|0
7152018|NCT03245619|11316513|FG016|Part A (Up to Day 22)|Physician Decision|0
7152019|NCT03245723|11316574|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1
7152020|NCT03245723|11316575|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0
7152021|NCT03245723|11316574|FG000|Overall Study|Claustrophobia from wearing the mask|1
7152022|NCT03245723|11316575|FG001|Overall Study|Claustrophobia from wearing the mask|0
7152023|NCT03245723|11316574|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2
7152024|NCT03245723|11316575|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0
7152025|NCT03245723|11316574|FG000|Overall Study|Image acquisition/reconstruction failure|1
7152026|NCT03245723|11316575|FG001|Overall Study|Image acquisition/reconstruction failure|1
7152027|NCT03245736|11316581|FG000|Overall Study|Adverse Event|1
7152028|NCT03245736|11316581|FG000|Overall Study|Progressive Disease|4
7152029|NCT03246061|11316596|FG000|Overall Study|Still in follow-up|15
7152030|NCT03246061|11316597|FG001|Overall Study|Still in follow-up|21
7152031|NCT03246152|11316605|FG000|Overall Study|Lost to Follow-up|2
7152032|NCT03246152|11316605|FG000|Overall Study|Protocol Violation|1
7152033|NCT03246646|11316611|FG000|Overall Study|deemed ineligible and administratively withdrawn|1
7152034|NCT03246646|11316612|FG001|Overall Study|deemed ineligible and administratively withdrawn|0
7152035|NCT03246646|11316611|FG000|Overall Study|Withdrawal by Subject|3
7152036|NCT03246646|11316612|FG001|Overall Study|Withdrawal by Subject|0
7152037|NCT03246646|11316611|FG000|Overall Study|Lost to Follow-up|7
7152038|NCT03246646|11316612|FG001|Overall Study|Lost to Follow-up|0
7152039|NCT03246672|11316618|FG000|Overall Study|Lost to Follow-up|2
7152040|NCT03246724|11316626|FG000|Overall Study|Withdrawal by Subject|5
7152041|NCT03246724|11316627|FG001|Overall Study|Withdrawal by Subject|2
7152042|NCT03246724|11316628|FG002|Overall Study|Withdrawal by Subject|4
7152043|NCT03246724|11316629|FG003|Overall Study|Withdrawal by Subject|2
7152044|NCT03246724|11316626|FG000|Overall Study|Ineligible on day of surgery|7
7152045|NCT03246724|11316627|FG001|Overall Study|Ineligible on day of surgery|2
7152046|NCT03246724|11316628|FG002|Overall Study|Ineligible on day of surgery|0
7152047|NCT03246724|11316629|FG003|Overall Study|Ineligible on day of surgery|3
7152048|NCT03246724|11316626|FG000|Overall Study|Study completed before surgical date|2
7152049|NCT03246724|11316627|FG001|Overall Study|Study completed before surgical date|1
7152050|NCT03246724|11316628|FG002|Overall Study|Study completed before surgical date|8
6848570|NCT00329784|10855551|FG000|Overall Study|Withdrawal by Subject|4
6848571|NCT00329784|10855552|FG001|Overall Study|Withdrawal by Subject|2
6848572|NCT00329784|10855553|FG002|Overall Study|Withdrawal by Subject|0
6848573|NCT00329784|10855554|FG003|Overall Study|Withdrawal by Subject|0
6848574|NCT00329784|10855551|FG000|Overall Study|Other|1
6848575|NCT00329784|10855552|FG001|Overall Study|Other|2
7152051|NCT03246724|11316629|FG003|Overall Study|Study completed before surgical date|1
6848576|NCT00329784|10855553|FG002|Overall Study|Other|0
6848577|NCT00329784|10855554|FG003|Overall Study|Other|0
6848578|NCT00329797|10855568|FG000|Overall Study|Protocol Violation|1
6848579|NCT00329797|10855569|FG001|Overall Study|Protocol Violation|0
6848580|NCT00329797|10855568|FG000|Overall Study|Withdrawal by Subject|6
6848581|NCT00329797|10855569|FG001|Overall Study|Withdrawal by Subject|6
6848582|NCT00329849|10855581|FG000|Overall Study|Withdrawal by Subject|6
6848583|NCT00329849|10855582|FG001|Overall Study|Withdrawal by Subject|4
6848584|NCT00329901|10855595|FG000|Overall Study|Withdrawal by Subject|4
6848585|NCT00329901|10855596|FG001|Overall Study|Withdrawal by Subject|3
6848586|NCT00329901|10855597|FG002|Overall Study|Withdrawal by Subject|2
6848587|NCT00329901|10855595|FG000|Overall Study|Lost to Follow-up|2
6848588|NCT00329901|10855596|FG001|Overall Study|Lost to Follow-up|0
6848589|NCT00329901|10855597|FG002|Overall Study|Lost to Follow-up|1
6848590|NCT00329901|10855595|FG000|Overall Study|Protocol Violation|1
6848591|NCT00329901|10855596|FG001|Overall Study|Protocol Violation|0
6848592|NCT00329901|10855597|FG002|Overall Study|Protocol Violation|1
6848593|NCT00329901|10855595|FG000|Overall Study|Unable to classify|2
6848594|NCT00329901|10855596|FG001|Overall Study|Unable to classify|2
6848595|NCT00329901|10855597|FG002|Overall Study|Unable to classify|0
6848596|NCT00330174|10855615|FG000|Overall Study|Withdrawal by Subject|7
6848597|NCT00330174|10855616|FG001|Overall Study|Withdrawal by Subject|7
6848598|NCT00330174|10855615|FG000|Overall Study|Lost to Follow-up|4
6848599|NCT00330174|10855616|FG001|Overall Study|Lost to Follow-up|1
6848600|NCT00330174|10855615|FG000|Overall Study|Clinical deterioration|1
6848601|NCT00330174|10855616|FG001|Overall Study|Clinical deterioration|2
6848602|NCT00330174|10855615|FG000|Overall Study|Excessive missed visits|3
6848603|NCT00330174|10855616|FG001|Overall Study|Excessive missed visits|8
6848604|NCT00330174|10855615|FG000|Overall Study|Miscellaneous reasons|7
6848605|NCT00330174|10855616|FG001|Overall Study|Miscellaneous reasons|1
6848606|NCT00330187|10855626|FG000|Overall Study|Lost to Follow-up|12
6848607|NCT00330187|10855627|FG001|Overall Study|Lost to Follow-up|13
6848608|NCT00330187|10855628|FG002|Overall Study|Lost to Follow-up|14
6848609|NCT00330187|10855629|FG003|Overall Study|Lost to Follow-up|10
6848610|NCT00330187|10855626|FG000|Overall Study|Withdrawal by Subject|8
6848611|NCT00330187|10855627|FG001|Overall Study|Withdrawal by Subject|5
6848612|NCT00330187|10855628|FG002|Overall Study|Withdrawal by Subject|4
6848613|NCT00330187|10855629|FG003|Overall Study|Withdrawal by Subject|4
6848614|NCT00330343|10855639|FG000|Overall Study|Lost to Follow-up|5
6848615|NCT00330460|10855660|FG000|Overall Study|Physician Decision|1
6848616|NCT00330460|10855661|FG001|Overall Study|Physician Decision|0
6848617|NCT00330460|10855660|FG000|Overall Study|Adverse Event|10
6848618|NCT00330460|10855661|FG001|Overall Study|Adverse Event|8
6848619|NCT00330460|10855660|FG000|Overall Study|Withdrawal by Subject|18
6848620|NCT00330460|10855661|FG001|Overall Study|Withdrawal by Subject|17
6848621|NCT00330460|10855660|FG000|Overall Study|Death|1
6848622|NCT00330460|10855661|FG001|Overall Study|Death|1
6848623|NCT00330460|10855660|FG000|Overall Study|Ineligibility determined|1
6848624|NCT00330460|10855661|FG001|Overall Study|Ineligibility determined|3
6848625|NCT00330460|10855660|FG000|Overall Study|Lost to Follow-up|8
6848626|NCT00330460|10855661|FG001|Overall Study|Lost to Follow-up|3
6848627|NCT00330460|10855660|FG000|Overall Study|Noncompliance|2
6848628|NCT00330460|10855661|FG001|Overall Study|Noncompliance|1
6848629|NCT00330460|10855660|FG000|Overall Study|Other|1
6848630|NCT00330460|10855661|FG001|Overall Study|Other|0
6898038|NCT00643565|10917124|FG000|Overall Study|Administrative|22
6898039|NCT00643565|10917125|FG001|Overall Study|Administrative|16
6898040|NCT00643565|10917124|FG000|Overall Study|Adverse Event|5
6898041|NCT00643565|10917125|FG001|Overall Study|Adverse Event|8
6898042|NCT00643604|10917141|FG000|Overall Study|Death|1
6898043|NCT00643682|10917147|FG000|Overall Study|did not keep appointment|522
6898044|NCT00643682|10917148|FG001|Overall Study|did not keep appointment|509
6966592|NCT01125566|11014601|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25
6966593|NCT01125566|11014602|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13
6966594|NCT01125566|11014603|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0
6966595|NCT01125566|11014601|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1
6966596|NCT01125566|11014602|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1
6966597|NCT01125566|11014603|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0
6966598|NCT01125566|11014601|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
6966599|NCT01125566|11014602|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
6966600|NCT01125566|11014603|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59
6966601|NCT01125566|11014601|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0
6966602|NCT01125566|11014602|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0
6966603|NCT01125566|11014603|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7
6966604|NCT01125566|11014601|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0
6966605|NCT01125566|11014602|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0
6966606|NCT01125566|11014603|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3
6966607|NCT01125566|11014601|FG000|Patients Who Switched From AV to TV|Other than listed above|0
6966608|NCT01125566|11014602|FG001|Patients Who Switched From AV to TV|Other than listed above|0
6966609|NCT01125566|11014603|FG002|Patients Who Switched From AV to TV|Other than listed above|4
6966610|NCT01125722|11014629|FG000|Overall Study|Withdrawal by Subject|2
6966611|NCT01125722|11014630|FG001|Overall Study|Withdrawal by Subject|1
6848631|NCT00330616|10855682|FG000|Overall Study|Adverse Event|13
6848632|NCT00330616|10855682|FG000|Overall Study|Lack of Efficacy|1
6848633|NCT00330616|10855682|FG000|Overall Study|Lost to Follow-up|2
6848634|NCT00330616|10855682|FG000|Overall Study|Withdrawal by Subject|4
6848635|NCT00330616|10855682|FG000|Overall Study|Other|1
6848636|NCT00330668|10855686|FG000|BID Dosing Period|Adverse Event|1
6848637|NCT00330668|10855686|FG000|BID Dosing Period|Lost to Follow-up|7
6848638|NCT00330668|10855686|FG000|BID Dosing Period|Non-Compliance|5
6848639|NCT00330668|10855686|FG000|BID Dosing Period|Withdrawal by Subject|19
6848640|NCT00330668|10855686|FG000|BID Dosing Period|Sponsor's decision|1
6848641|NCT00330668|10855686|FG000|BID Dosing Period|Other|3
6848642|NCT00330668|10855686|FG000|QD Dosing Period|Sponsor decision to terminate study|74
6848643|NCT00330668|10855686|FG000|QD Dosing Period|Other|1
6848644|NCT00330668|10855686|FG000|QD Dosing Period|Withdrawal by Subject|1
6848645|NCT00330668|10855686|FG000|QD Dosing Period|Lost to Follow-up|2
6848646|NCT00330681|10855692|FG000|Overall Study|Adverse Event|3
6848647|NCT00330681|10855693|FG001|Overall Study|Adverse Event|6
6848648|NCT00330681|10855692|FG000|Overall Study|Protocol Violation|0
6848649|NCT00330681|10855693|FG001|Overall Study|Protocol Violation|1
6848650|NCT00330681|10855692|FG000|Overall Study|Withdrawal by Subject|5
6848651|NCT00330681|10855693|FG001|Overall Study|Withdrawal by Subject|5
6848652|NCT00330681|10855692|FG000|Overall Study|Tracheotomy due to worsening of ALS|1
6848653|NCT00330681|10855693|FG001|Overall Study|Tracheotomy due to worsening of ALS|2
6848654|NCT00330759|10855710|FG000|Overall Study|Death|316
6848655|NCT00330759|10855711|FG001|Overall Study|Death|310
6848656|NCT00330759|10855710|FG000|Overall Study|Disease progression|104
6848657|NCT00330759|10855711|FG001|Overall Study|Disease progression|126
6848658|NCT00330759|10855710|FG000|Overall Study|Withdrawal by Subject|143
6848659|NCT00330759|10855711|FG001|Overall Study|Withdrawal by Subject|124
6848660|NCT00330759|10855710|FG000|Overall Study|Adverse Event|48
6848661|NCT00330759|10855711|FG001|Overall Study|Adverse Event|36
6848662|NCT00330759|10855710|FG000|Overall Study|Participant request|31
6848663|NCT00330759|10855711|FG001|Overall Study|Participant request|22
6848664|NCT00330759|10855710|FG000|Overall Study|Lost to Follow-up|16
6848665|NCT00330759|10855711|FG001|Overall Study|Lost to Follow-up|22
6848666|NCT00330759|10855710|FG000|Overall Study|Noncompliance|15
6848667|NCT00330759|10855711|FG001|Overall Study|Noncompliance|17
6848668|NCT00330759|10855710|FG000|Overall Study|Physician Decision|1
6848669|NCT00330759|10855711|FG001|Overall Study|Physician Decision|2
6848670|NCT00330759|10855710|FG000|Overall Study|Protocol deviation|0
6848671|NCT00330759|10855711|FG001|Overall Study|Protocol deviation|2
6848672|NCT00330759|10855710|FG000|Overall Study|Ineligibility determined|2
6848673|NCT00330759|10855711|FG001|Overall Study|Ineligibility determined|1
6848674|NCT00330759|10855710|FG000|Overall Study|Other|36
6848675|NCT00330759|10855711|FG001|Overall Study|Other|44
6848676|NCT00330928|10855737|FG000|Overall Study|Lost to Follow-up|6
6848677|NCT00330928|10855737|FG000|Overall Study|Physician Decision|9
6848678|NCT00330928|10855737|FG000|Overall Study|Death|1
6848679|NCT00330928|10855737|FG000|Overall Study|IVUS could not be performed.|1
6848680|NCT00330967|10855743|FG000|Overall Study|Withdrawal by Subject|0
6848681|NCT00330967|10855744|FG001|Overall Study|Withdrawal by Subject|5
6848682|NCT00330967|10855743|FG000|Overall Study|Physician Decision|0
6848683|NCT00330967|10855744|FG001|Overall Study|Physician Decision|9
6848684|NCT00331006|10855750|FG000|Screening Phase|Withdrawal by Subject|1
6848685|NCT00331006|10855750|FG000|Screening Phase|enrollment halted|1
6848686|NCT00331006|10855750|FG000|Screening Phase|Lost to Follow-up|1
6848687|NCT00331006|10855750|FG000|Screening Phase|Ineligible for treatment phase|4
6848688|NCT00331006|10855750|FG000|Treatment Phase|Withdrawal by Subject|1
6848689|NCT00331006|10855750|FG000|Follow-Up Phase I|Lost to Follow-up|1
6848690|NCT00331006|10855750|FG000|Follow-Up Phase II|Lost to Follow-up|3
6848691|NCT00331136|10855758|FG000|Overall Study|Adverse Event|3
6848692|NCT00331136|10855759|FG001|Overall Study|Adverse Event|5
6848693|NCT00331136|10855760|FG002|Overall Study|Adverse Event|0
6848694|NCT00331136|10855761|FG003|Overall Study|Adverse Event|1
6848695|NCT00331136|10855758|FG000|Overall Study|Withdrawal by Subject|0
6848696|NCT00331136|10855759|FG001|Overall Study|Withdrawal by Subject|1
6848697|NCT00331136|10855760|FG002|Overall Study|Withdrawal by Subject|0
6848698|NCT00331136|10855761|FG003|Overall Study|Withdrawal by Subject|0
6848699|NCT00331136|10855758|FG000|Overall Study|Lost to Follow-up|0
6848700|NCT00331136|10855759|FG001|Overall Study|Lost to Follow-up|1
6848701|NCT00331136|10855760|FG002|Overall Study|Lost to Follow-up|0
6848702|NCT00331136|10855761|FG003|Overall Study|Lost to Follow-up|0
6848703|NCT00331136|10855758|FG000|Overall Study|Protocol Violation|1
6848704|NCT00331136|10855759|FG001|Overall Study|Protocol Violation|0
6848705|NCT00331136|10855760|FG002|Overall Study|Protocol Violation|0
6848706|NCT00331136|10855761|FG003|Overall Study|Protocol Violation|0
6848707|NCT00331136|10855758|FG000|Overall Study|Not treated|1
6848708|NCT00331136|10855759|FG001|Overall Study|Not treated|0
6848709|NCT00331136|10855760|FG002|Overall Study|Not treated|0
6848710|NCT00331136|10855761|FG003|Overall Study|Not treated|0
6848711|NCT00331344|10855780|FG000|Phase I|Adverse Event|0
6848712|NCT00331344|10855781|FG001|Phase I|Adverse Event|0
6848713|NCT00331344|10855782|FG002|Phase I|Adverse Event|0
6848714|NCT00331344|10855783|FG003|Phase I|Adverse Event|1
6848715|NCT00331344|10855784|FG004|Phase I|Adverse Event|2
6848716|NCT00331344|10855785|FG005|Phase I|Adverse Event|2
6848717|NCT00331344|10855786|FG006|Phase I|Adverse Event|0
6848718|NCT00331344|10855787|FG007|Phase I|Adverse Event|1
6848719|NCT00331344|10855788|FG008|Phase I|Adverse Event|0
6848720|NCT00331344|10855780|FG000|Phase II|Death|0
6848721|NCT00331344|10855781|FG001|Phase II|Death|0
6848722|NCT00331344|10855782|FG002|Phase II|Death|0
6848723|NCT00331344|10855783|FG003|Phase II|Death|0
6848724|NCT00331344|10855784|FG004|Phase II|Death|0
6848725|NCT00331344|10855785|FG005|Phase II|Death|0
6848726|NCT00331344|10855786|FG006|Phase II|Death|0
6848727|NCT00331344|10855787|FG007|Phase II|Death|0
6848728|NCT00331344|10855788|FG008|Phase II|Death|4
6848729|NCT00331409|10855801|FG000|Overall Study|Lack of Efficacy|4
6848730|NCT00331422|10855805|FG000|Overall Study|Did not receive entire study regimen|5
6848731|NCT00331552|10855812|FG000|Period 3: Phase II|Neurological Symptoms|1
6848732|NCT00331552|10855813|FG001|Period 3: Phase II|Neurological Symptoms|0
6848733|NCT00331552|10855812|FG000|Period 3: Phase II|Severe Nausea|1
6848734|NCT00331552|10855813|FG001|Period 3: Phase II|Severe Nausea|0
6848735|NCT00331630|10855824|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1
6848736|NCT00331630|10855824|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1
6848737|NCT00331630|10855824|FG000|Follow up for 5 Years|Death|5
6848738|NCT00331630|10855824|FG000|Follow up for 5 Years|Data collection was stopped|24
6848739|NCT00331682|10855828|FG000|Overall Study|Adverse Event|1
6848740|NCT00331760|10855834|FG000|Overall Study|Ineligible / no protocol treatment|15
6848741|NCT00331760|10855835|FG001|Overall Study|Ineligible / no protocol treatment|8
6848742|NCT00331799|10855842|FG000|Overall Study|Withdrawal by Subject|2
6848743|NCT00331799|10855842|FG000|Overall Study|Sedation|1
6848744|NCT00331864|10855848|FG000|Overall Study|Adverse Event|30
6848745|NCT00331864|10855849|FG001|Overall Study|Adverse Event|1
6848746|NCT00331864|10855848|FG000|Overall Study|Lack of Efficacy|4
6848747|NCT00331864|10855849|FG001|Overall Study|Lack of Efficacy|0
6848748|NCT00331864|10855848|FG000|Overall Study|Protocol Violation|3
6848749|NCT00331864|10855849|FG001|Overall Study|Protocol Violation|0
6848750|NCT00331864|10855848|FG000|Overall Study|Withdrawal by Subject|10
6848751|NCT00331864|10855849|FG001|Overall Study|Withdrawal by Subject|0
6848752|NCT00331864|10855848|FG000|Overall Study|Lost to Follow-up|4
6848753|NCT00331864|10855849|FG001|Overall Study|Lost to Follow-up|3
6848754|NCT00331864|10855848|FG000|Overall Study|Administrative Problems|1
6848755|NCT00331864|10855849|FG001|Overall Study|Administrative Problems|0
6848756|NCT00331864|10855848|FG000|Overall Study|Death|6
6848757|NCT00331864|10855849|FG001|Overall Study|Death|0
6848758|NCT00332189|10855864|FG000|Overall Study|Adverse Event|3
6848759|NCT00332189|10855864|FG000|Overall Study|Uncooperative/Noncompliant|3
6848760|NCT00332189|10855864|FG000|Overall Study|Withdrawal by Subject|9
6848761|NCT00332189|10855864|FG000|Overall Study|Lack of Efficacy|4
6848762|NCT00332189|10855864|FG000|Overall Study|Moved out of country|2
6848763|NCT00332202|10855871|FG000|Overall Study|Adverse Event|72
6848764|NCT00332202|10855872|FG001|Overall Study|Adverse Event|28
6848765|NCT00332202|10855871|FG000|Overall Study|Lost to Follow-up|2
6848766|NCT00332202|10855872|FG001|Overall Study|Lost to Follow-up|1
6848767|NCT00332202|10855871|FG000|Overall Study|Physician Decision|6
6848768|NCT00332202|10855872|FG001|Overall Study|Physician Decision|8
6848769|NCT00332202|10855871|FG000|Overall Study|Protocol Entry Criteria Not Met|6
6848770|NCT00332202|10855872|FG001|Overall Study|Protocol Entry Criteria Not Met|5
6848771|NCT00332202|10855871|FG000|Overall Study|Protocol Violation|7
6848772|NCT00332202|10855872|FG001|Overall Study|Protocol Violation|2
6848773|NCT00332202|10855871|FG000|Overall Study|Sponsor Decision|1
6848774|NCT00332202|10855872|FG001|Overall Study|Sponsor Decision|2
6848775|NCT00332202|10855871|FG000|Overall Study|Withdrawal by Subject|36
6848776|NCT00332202|10855872|FG001|Overall Study|Withdrawal by Subject|17
6848777|NCT00332202|10855871|FG000|Overall Study|Progressive Disease|106
6848778|NCT00332202|10855872|FG001|Overall Study|Progressive Disease|60
6848779|NCT00332202|10855871|FG000|Overall Study|Death|5
6848780|NCT00332202|10855872|FG001|Overall Study|Death|2
6848781|NCT00332241|10855889|FG000|Overall Study|Lack of Efficacy|6
6848782|NCT00332241|10855890|FG001|Overall Study|Lack of Efficacy|1
6848783|NCT00332241|10855889|FG000|Overall Study|Adverse Event|3
6848784|NCT00332241|10855890|FG001|Overall Study|Adverse Event|5
6848785|NCT00332241|10855889|FG000|Overall Study|Withdrawal by Subject|2
6848786|NCT00332241|10855890|FG001|Overall Study|Withdrawal by Subject|1
6848787|NCT00332241|10855889|FG000|Overall Study|Lost to Follow-up|4
6848788|NCT00332241|10855890|FG001|Overall Study|Lost to Follow-up|1
6848789|NCT00332332|10855896|FG000|Overall Study|Adverse Event|13
6848790|NCT00332332|10855896|FG000|Overall Study|Death|1
6848791|NCT00332332|10855896|FG000|Overall Study|Withdrawal by Subject|8
6848792|NCT00332332|10855896|FG000|Overall Study|Physician Decision|1
6848793|NCT00332332|10855896|FG000|Overall Study|Lost to Follow-up|3
6848794|NCT00332332|10855896|FG000|Overall Study|Protocol deviation|4
6848795|NCT00332332|10855896|FG000|Overall Study|Noncompliance|2
6848796|NCT00332332|10855896|FG000|Overall Study|Disease progression|2
6848797|NCT00332332|10855896|FG000|Overall Study|Other|18
6848798|NCT00332332|10855896|FG000|Overall Study|Did not receive study treatment|16
6848799|NCT00332462|10855900|FG000|Overall Study|Adverse Event|5
6848800|NCT00332462|10855900|FG000|Overall Study|Abnormal Lab Value|1
6848801|NCT00332462|10855900|FG000|Overall Study|Unsatisfactory therapeutic effect|4
6848802|NCT00332462|10855900|FG000|Overall Study|no longer requires study drug|1
6848803|NCT00332462|10855900|FG000|Overall Study|Death|3
6848804|NCT00332462|10855900|FG000|Overall Study|Graft Loss|2
6848805|NCT00332488|10855910|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8
6848806|NCT00332488|10855911|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2
6848807|NCT00332488|10855912|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6
6848808|NCT00332488|10855910|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13
6848809|NCT00332488|10855911|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2
6848810|NCT00332488|10855912|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10
6848811|NCT00332488|10855910|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21
6848812|NCT00332488|10855911|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10
6848813|NCT00332488|10855912|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20
6848814|NCT00332488|10855910|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4
6848815|NCT00332488|10855911|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0
6848816|NCT00332488|10855912|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20
6848817|NCT00332488|10855910|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1
6848818|NCT00332488|10855911|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3
6848819|NCT00332488|10855912|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0
6848820|NCT00332488|10855910|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3
6848821|NCT00332488|10855911|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1
6848822|NCT00332488|10855912|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0
6848823|NCT00332488|10855910|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0
6848824|NCT00332488|10855911|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0
6848825|NCT00332488|10855912|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3
6848826|NCT00332488|10855910|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0
6848827|NCT00332488|10855911|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0
6848828|NCT00332488|10855912|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1
6848829|NCT00332488|10855910|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0
6848830|NCT00332488|10855911|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0
6848831|NCT00332488|10855912|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3
6848832|NCT00332488|10855910|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0
6848833|NCT00332488|10855911|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0
6848834|NCT00332488|10855912|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1
6848835|NCT00332488|10855910|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2
6848836|NCT00332488|10855911|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2
6848837|NCT00332488|10855912|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8
6848838|NCT00332488|10855910|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0
6848839|NCT00332488|10855911|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0
6848840|NCT00332488|10855912|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5
6848841|NCT00332696|10855971|FG000|Overall Study|Death|24
6848842|NCT00332696|10855972|FG001|Overall Study|Death|14
6848843|NCT00332696|10855971|FG000|Overall Study|Insufficient therapeutic effect|4
7152052|NCT03246724|11316626|FG000|Overall Study|Transferred to other arm|0
7152053|NCT03246724|11316627|FG001|Overall Study|Transferred to other arm|0
7152054|NCT03246724|11316628|FG002|Overall Study|Transferred to other arm|1
7152055|NCT03246724|11316629|FG003|Overall Study|Transferred to other arm|0
7152056|NCT03246724|11316626|FG000|Overall Study|Unable to obtain medication timely|0
7152057|NCT03246724|11316627|FG001|Overall Study|Unable to obtain medication timely|2
7152058|NCT03246724|11316628|FG002|Overall Study|Unable to obtain medication timely|2
7152059|NCT03246724|11316629|FG003|Overall Study|Unable to obtain medication timely|1
7152060|NCT03246724|11316626|FG000|Overall Study|Re-consented to participate|0
7152061|NCT03246724|11316627|FG001|Overall Study|Re-consented to participate|0
7152062|NCT03246724|11316628|FG002|Overall Study|Re-consented to participate|0
7152063|NCT03246724|11316629|FG003|Overall Study|Re-consented to participate|1
7152064|NCT03247517|11316653|FG000|Overall Study|Adverse Event|0
7152065|NCT03247517|11316654|FG001|Overall Study|Adverse Event|4
7152066|NCT03247517|11316655|FG002|Overall Study|Adverse Event|2
7152067|NCT03247517|11316653|FG000|Overall Study|Lost to Follow-up|2
7152068|NCT03247517|11316654|FG001|Overall Study|Lost to Follow-up|6
7152069|NCT03247517|11316655|FG002|Overall Study|Lost to Follow-up|4
7152070|NCT03247517|11316653|FG000|Overall Study|Consent withdrawn by caregiver|1
7152071|NCT03247517|11316654|FG001|Overall Study|Consent withdrawn by caregiver|4
7152072|NCT03247517|11316655|FG002|Overall Study|Consent withdrawn by caregiver|7
7152073|NCT03247517|11316653|FG000|Overall Study|Assent/consent withdrawn by subject|2
7152074|NCT03247517|11316654|FG001|Overall Study|Assent/consent withdrawn by subject|3
7152075|NCT03247517|11316655|FG002|Overall Study|Assent/consent withdrawn by subject|1
7152076|NCT03247517|11316653|FG000|Overall Study|Protocol Violation|0
7152077|NCT03247517|11316654|FG001|Overall Study|Protocol Violation|2
7152078|NCT03247517|11316655|FG002|Overall Study|Protocol Violation|0
7152079|NCT03247517|11316653|FG000|Overall Study|Multiple reasons|3
7152080|NCT03247517|11316654|FG001|Overall Study|Multiple reasons|1
7152081|NCT03247517|11316655|FG002|Overall Study|Multiple reasons|0
6848844|NCT00332696|10855972|FG001|Overall Study|Insufficient therapeutic effect|11
6848845|NCT00332696|10855971|FG000|Overall Study|Adverse Event|1
6848846|NCT00332696|10855972|FG001|Overall Study|Adverse Event|2
6848847|NCT00332696|10855971|FG000|Overall Study|Condition does not justify treatment|0
7152082|NCT03247530|11316666|FG000|Overall Study|Withdrawal by caregiver|19
6848848|NCT00332696|10855972|FG001|Overall Study|Condition does not justify treatment|2
6848849|NCT00332696|10855971|FG000|Overall Study|Lost to Follow-up|0
6848850|NCT00332696|10855972|FG001|Overall Study|Lost to Follow-up|1
6848851|NCT00332696|10855971|FG000|Overall Study|Withdrawal by Subject|1
6848852|NCT00332696|10855972|FG001|Overall Study|Withdrawal by Subject|0
6848853|NCT00332709|10855980|FG000|Overall Study|Adverse Event|11
6848854|NCT00332709|10855981|FG001|Overall Study|Adverse Event|14
6848855|NCT00332709|10855980|FG000|Overall Study|Withdrawal by Subject|2
6848856|NCT00332709|10855981|FG001|Overall Study|Withdrawal by Subject|3
6848857|NCT00332709|10855980|FG000|Overall Study|Lost to Follow-up|2
6848858|NCT00332709|10855981|FG001|Overall Study|Lost to Follow-up|0
6848859|NCT00332709|10855980|FG000|Overall Study|Administrative Problems|0
6848860|NCT00332709|10855981|FG001|Overall Study|Administrative Problems|3
6848861|NCT00332709|10855980|FG000|Overall Study|Abnormal test procedure result|1
6848862|NCT00332709|10855981|FG001|Overall Study|Abnormal test procedure result|0
6848863|NCT00332839|10855998|FG000|Core (Months 0 - 12)|Administrative problems|1
6848864|NCT00332839|10855999|FG001|Core (Months 0 - 12)|Administrative problems|1
6848865|NCT00332839|10855998|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3
6848866|NCT00332839|10855999|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1
6848867|NCT00332839|10855998|FG000|Core (Months 0 - 12)|Protocol deviation|1
6848868|NCT00332839|10855999|FG001|Core (Months 0 - 12)|Protocol deviation|1
6848869|NCT00332839|10855998|FG000|Core (Months 0 - 12)|Adverse Event|5
6848870|NCT00332839|10855999|FG001|Core (Months 0 - 12)|Adverse Event|15
6848871|NCT00332839|10855998|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
6848872|NCT00332839|10855999|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
6848873|NCT00332839|10855998|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2
6848874|NCT00332839|10855999|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1
6848875|NCT00332839|10855998|FG000|Follow-up (Months 12 - 60)|Death|1
6848876|NCT00332839|10855999|FG001|Follow-up (Months 12 - 60)|Death|1
6848877|NCT00333138|10856008|FG000|Core Study (6 Months)|Adverse Event|4
6848878|NCT00333138|10856009|FG001|Core Study (6 Months)|Adverse Event|5
6848879|NCT00333138|10856010|FG002|Core Study (6 Months)|Adverse Event|8
7077476|NCT02092467|11185056|FG002|Overall Study|Lost to Follow-up|40
7077477|NCT02092467|11185054|FG000|Overall Study|Global Deterioration of Health Status|1
7077478|NCT02092467|11185055|FG001|Overall Study|Global Deterioration of Health Status|0
7077479|NCT02092467|11185056|FG002|Overall Study|Global Deterioration of Health Status|0
7077480|NCT02092467|11185054|FG000|Overall Study|Other|32
7077481|NCT02092467|11185055|FG001|Overall Study|Other|30
7077482|NCT02092467|11185056|FG002|Overall Study|Other|24
7077483|NCT02092467|11185054|FG000|Overall Study|Withdrawal by Subject|282
7152083|NCT03247530|11316667|FG001|Overall Study|Withdrawal by caregiver|8
7152084|NCT03247530|11316668|FG002|Overall Study|Withdrawal by caregiver|10
7152085|NCT03247530|11316666|FG000|Overall Study|Lost to Follow-up|3
7152086|NCT03247530|11316667|FG001|Overall Study|Lost to Follow-up|9
7152087|NCT03247530|11316668|FG002|Overall Study|Lost to Follow-up|6
7152088|NCT03247530|11316666|FG000|Overall Study|Adverse Event|2
7152089|NCT03247530|11316667|FG001|Overall Study|Adverse Event|5
7152090|NCT03247530|11316668|FG002|Overall Study|Adverse Event|2
7152091|NCT03247530|11316666|FG000|Overall Study|Failure to follow procedure|1
7152092|NCT03247530|11316667|FG001|Overall Study|Failure to follow procedure|1
7152093|NCT03247530|11316668|FG002|Overall Study|Failure to follow procedure|1
7152094|NCT03247530|11316666|FG000|Overall Study|Withdrawal by Subject|1
7152095|NCT03247530|11316667|FG001|Overall Study|Withdrawal by Subject|1
7152096|NCT03247530|11316668|FG002|Overall Study|Withdrawal by Subject|0
7152097|NCT03247530|11316666|FG000|Overall Study|Study medication misuse|0
7152098|NCT03247530|11316667|FG001|Overall Study|Study medication misuse|1
7152099|NCT03247530|11316668|FG002|Overall Study|Study medication misuse|0
7152100|NCT03247530|11316666|FG000|Overall Study|Other, multiple categories|1
7152101|NCT03247530|11316667|FG001|Overall Study|Other, multiple categories|3
7152102|NCT03247530|11316668|FG002|Overall Study|Other, multiple categories|1
7152103|NCT03247543|11316682|FG000|Overall Study|Adverse Event|3
7152104|NCT03247543|11316683|FG001|Overall Study|Adverse Event|6
7077484|NCT02092467|11185055|FG001|Overall Study|Withdrawal by Subject|327
7077485|NCT02092467|11185056|FG002|Overall Study|Withdrawal by Subject|289
7152105|NCT03247543|11316684|FG002|Overall Study|Adverse Event|4
7152106|NCT03247543|11316682|FG000|Overall Study|Lost to Follow-up|10
7152107|NCT03247543|11316683|FG001|Overall Study|Lost to Follow-up|7
7152108|NCT03247543|11316684|FG002|Overall Study|Lost to Follow-up|8
7152109|NCT03247543|11316682|FG000|Overall Study|Consent withdrawn by caregiver|2
6848880|NCT00333138|10856008|FG000|Core Study (6 Months)|Withdrawal by Subject|1
6848881|NCT00333138|10856009|FG001|Core Study (6 Months)|Withdrawal by Subject|1
6848882|NCT00333138|10856010|FG002|Core Study (6 Months)|Withdrawal by Subject|2
6848883|NCT00333138|10856008|FG000|Core Study (6 Months)|Lack of Efficacy|1
7152110|NCT03247543|11316683|FG001|Overall Study|Consent withdrawn by caregiver|2
6848884|NCT00333138|10856009|FG001|Core Study (6 Months)|Lack of Efficacy|0
6848885|NCT00333138|10856010|FG002|Core Study (6 Months)|Lack of Efficacy|0
6848886|NCT00333138|10856008|FG000|Core Study (6 Months)|Protocol Violation|1
6848887|NCT00333138|10856009|FG001|Core Study (6 Months)|Protocol Violation|0
7152111|NCT03247543|11316684|FG002|Overall Study|Consent withdrawn by caregiver|9
7152112|NCT03247543|11316682|FG000|Overall Study|Withdrawal by Subject|0
6848888|NCT00333138|10856010|FG002|Core Study (6 Months)|Protocol Violation|1
7152113|NCT03247543|11316683|FG001|Overall Study|Withdrawal by Subject|0
6848889|NCT00333138|10856008|FG000|Core Study (6 Months)|Laboratory abnormality|0
6848890|NCT00333138|10856009|FG001|Core Study (6 Months)|Laboratory abnormality|0
6848891|NCT00333138|10856010|FG002|Core Study (6 Months)|Laboratory abnormality|1
6848892|NCT00333138|10856008|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3
6848893|NCT00333138|10856009|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
6848894|NCT00333138|10856010|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
6848895|NCT00333138|10856008|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1
6848896|NCT00333138|10856009|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1
6848897|NCT00333138|10856010|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2
6848898|NCT00333138|10856008|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15
6848899|NCT00333138|10856009|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19
6848900|NCT00333138|10856010|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15
6848901|NCT00333138|10856008|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0
6848902|NCT00333138|10856009|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0
6848903|NCT00333138|10856010|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3
6848904|NCT00333138|10856008|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
6848905|NCT00333138|10856009|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13
6848906|NCT00333138|10856010|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
6966612|NCT01125722|11014629|FG000|Overall Study|Lost to Follow-up|1
7152114|NCT03247543|11316684|FG002|Overall Study|Withdrawal by Subject|1
7152115|NCT03247543|11316682|FG000|Overall Study|Failure to Follow study procedures|1
7152116|NCT03247543|11316683|FG001|Overall Study|Failure to Follow study procedures|3
7152117|NCT03247543|11316684|FG002|Overall Study|Failure to Follow study procedures|1
7152118|NCT03247543|11316682|FG000|Overall Study|Lack of Efficacy|1
7152119|NCT03247543|11316683|FG001|Overall Study|Lack of Efficacy|0
7152120|NCT03247543|11316684|FG002|Overall Study|Lack of Efficacy|0
7152121|NCT03247543|11316682|FG000|Overall Study|Non-compliance with study visits|0
7152122|NCT03247543|11316683|FG001|Overall Study|Non-compliance with study visits|1
7152123|NCT03247543|11316684|FG002|Overall Study|Non-compliance with study visits|0
7152124|NCT03247556|11316697|FG000|Overall Study|Adverse Event|1
7152125|NCT03247556|11316698|FG001|Overall Study|Adverse Event|4
7152126|NCT03247556|11316699|FG002|Overall Study|Adverse Event|5
7152127|NCT03247556|11316697|FG000|Overall Study|Lost to Follow-up|5
7152128|NCT03247556|11316698|FG001|Overall Study|Lost to Follow-up|5
7152129|NCT03247556|11316699|FG002|Overall Study|Lost to Follow-up|4
7152130|NCT03247556|11316697|FG000|Overall Study|Consent Withdrawn by Caregiver|4
7152131|NCT03247556|11316698|FG001|Overall Study|Consent Withdrawn by Caregiver|1
7152132|NCT03247556|11316699|FG002|Overall Study|Consent Withdrawn by Caregiver|5
7152133|NCT03247556|11316697|FG000|Overall Study|Assent/consent Withdrawn by Subject|0
7152134|NCT03247556|11316698|FG001|Overall Study|Assent/consent Withdrawn by Subject|2
7152135|NCT03247556|11316699|FG002|Overall Study|Assent/consent Withdrawn by Subject|2
7152136|NCT03247556|11316697|FG000|Overall Study|Protocol Violation|2
7152137|NCT03247556|11316698|FG001|Overall Study|Protocol Violation|0
7152138|NCT03247556|11316699|FG002|Overall Study|Protocol Violation|1
7152139|NCT03247556|11316697|FG000|Overall Study|Subject did not meet inclusion criteria|0
7152140|NCT03247556|11316698|FG001|Overall Study|Subject did not meet inclusion criteria|0
7152141|NCT03247556|11316699|FG002|Overall Study|Subject did not meet inclusion criteria|1
7152142|NCT03247673|11316710|FG000|Overall Study|Withdrawal by Subject|1
7152143|NCT03247673|11316711|FG001|Overall Study|Withdrawal by Subject|0
7152144|NCT03247673|11316712|FG002|Overall Study|Withdrawal by Subject|3
7152145|NCT03247673|11316710|FG000|Overall Study|Lost to Follow-up|0
7152146|NCT03247673|11316711|FG001|Overall Study|Lost to Follow-up|0
7152147|NCT03247673|11316712|FG002|Overall Study|Lost to Follow-up|1
7152148|NCT03247686|11316722|FG000|Overall Study|Withdrawal by Subject|1
7152149|NCT03247686|11316723|FG001|Overall Study|Withdrawal by Subject|2
7152150|NCT03247816|11316747|FG000|Overall Study|Adverse Event|12
7152151|NCT03247816|11316747|FG000|Overall Study|Physician Decision|3
7152152|NCT03247816|11316747|FG000|Overall Study|Lack of Efficacy|1
7152153|NCT03247816|11316747|FG000|Overall Study|Lost to Follow-up|10
7152154|NCT03247816|11316747|FG000|Overall Study|Missing Feraccru stop date|3
7152155|NCT03248037|11316764|FG000|Overall Study|Withdrawal by Subject|6
7152156|NCT03248037|11316765|FG001|Overall Study|Withdrawal by Subject|9
7152157|NCT03248037|11316764|FG000|Overall Study|Adverse Event|15
7152158|NCT03248037|11316765|FG001|Overall Study|Adverse Event|0
7152159|NCT03248492|11316785|FG000|Overall Study|Ongoing|23
7152160|NCT03248492|11316786|FG001|Overall Study|Ongoing|26
7152161|NCT03248492|11316787|FG002|Overall Study|Ongoing|3
7152162|NCT03248492|11316788|FG003|Overall Study|Ongoing|85
7152163|NCT03248492|11316789|FG004|Overall Study|Ongoing|2
7152164|NCT03248492|11316785|FG000|Overall Study|Progressive disease per RECIST v1.1|16
7152165|NCT03248492|11316786|FG001|Overall Study|Progressive disease per RECIST v1.1|12
7152166|NCT03248492|11316787|FG002|Overall Study|Progressive disease per RECIST v1.1|9
7152167|NCT03248492|11316788|FG003|Overall Study|Progressive disease per RECIST v1.1|22
6966613|NCT01125722|11014630|FG001|Overall Study|Lost to Follow-up|0
7152168|NCT03248492|11316789|FG004|Overall Study|Progressive disease per RECIST v1.1|0
7152169|NCT03248492|11316785|FG000|Overall Study|Adverse Event|6
7152170|NCT03248492|11316786|FG001|Overall Study|Adverse Event|6
6848907|NCT00333138|10856008|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
6848908|NCT00333138|10856009|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4
6848909|NCT00333138|10856010|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
6848910|NCT00333138|10856008|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2
6848911|NCT00333138|10856009|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1
6848912|NCT00333138|10856010|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0
6848913|NCT00333138|10856008|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
6848914|NCT00333138|10856009|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
6848915|NCT00333138|10856010|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0
6848916|NCT00333138|10856008|FG000|Extension Study (Month6 to End of Study)|Death|0
6848917|NCT00333138|10856009|FG001|Extension Study (Month6 to End of Study)|Death|1
6848918|NCT00333138|10856010|FG002|Extension Study (Month6 to End of Study)|Death|0
6848919|NCT00333359|10856041|FG000|Overall Study|Adverse Event|29
6848920|NCT00333359|10856042|FG001|Overall Study|Adverse Event|35
6848921|NCT00333359|10856041|FG000|Overall Study|Withdrawal by Subject|19
6848922|NCT00333359|10856042|FG001|Overall Study|Withdrawal by Subject|37
6848923|NCT00333359|10856041|FG000|Overall Study|Physician Decision|2
6848924|NCT00333359|10856042|FG001|Overall Study|Physician Decision|2
6848925|NCT00333359|10856041|FG000|Overall Study|Protocol Non-compliance|2
6848926|NCT00333359|10856042|FG001|Overall Study|Protocol Non-compliance|8
6848927|NCT00333359|10856041|FG000|Overall Study|Lost to Follow-up|15
6848928|NCT00333359|10856042|FG001|Overall Study|Lost to Follow-up|25
6848929|NCT00333359|10856041|FG000|Overall Study|Termination or Withdrawal by Sponsor|1
6848930|NCT00333359|10856042|FG001|Overall Study|Termination or Withdrawal by Sponsor|1
6848931|NCT00333359|10856041|FG000|Overall Study|Treatment Failure|3
6848932|NCT00333359|10856042|FG001|Overall Study|Treatment Failure|8
7152171|NCT03248492|11316787|FG002|Overall Study|Adverse Event|8
7152172|NCT03248492|11316788|FG003|Overall Study|Adverse Event|8
7152173|NCT03248492|11316789|FG004|Overall Study|Adverse Event|1
7152174|NCT03248492|11316785|FG000|Overall Study|Withdrawal by Subject|3
7152175|NCT03248492|11316786|FG001|Overall Study|Withdrawal by Subject|3
7152176|NCT03248492|11316787|FG002|Overall Study|Withdrawal by Subject|0
7152177|NCT03248492|11316788|FG003|Overall Study|Withdrawal by Subject|3
7152178|NCT03248492|11316789|FG004|Overall Study|Withdrawal by Subject|1
7152179|NCT03248492|11316785|FG000|Overall Study|Physician Decision|1
7152180|NCT03248492|11316786|FG001|Overall Study|Physician Decision|0
7152181|NCT03248492|11316787|FG002|Overall Study|Physician Decision|1
7152182|NCT03248492|11316788|FG003|Overall Study|Physician Decision|2
7152183|NCT03248492|11316789|FG004|Overall Study|Physician Decision|0
7152184|NCT03248492|11316785|FG000|Overall Study|Death|1
7152185|NCT03248492|11316786|FG001|Overall Study|Death|0
7152186|NCT03248492|11316787|FG002|Overall Study|Death|0
7152187|NCT03248492|11316788|FG003|Overall Study|Death|6
7152188|NCT03248492|11316789|FG004|Overall Study|Death|0
7152189|NCT03248492|11316785|FG000|Overall Study|Other|0
7152190|NCT03248492|11316786|FG001|Overall Study|Other|1
7152191|NCT03248492|11316787|FG002|Overall Study|Other|0
7152192|NCT03248492|11316788|FG003|Overall Study|Other|4
7152193|NCT03248492|11316789|FG004|Overall Study|Other|0
7152194|NCT03248882|11316814|FG000|Overall Study|Adverse Event|3
7152195|NCT03248882|11316815|FG001|Overall Study|Adverse Event|3
7152196|NCT03248882|11316816|FG002|Overall Study|Adverse Event|2
7152197|NCT03248882|11316817|FG003|Overall Study|Adverse Event|6
7152198|NCT03248882|11316818|FG004|Overall Study|Adverse Event|9
7152199|NCT03248882|11316814|FG000|Overall Study|Lost to Follow-up|0
7152200|NCT03248882|11316815|FG001|Overall Study|Lost to Follow-up|0
7152201|NCT03248882|11316816|FG002|Overall Study|Lost to Follow-up|0
7152202|NCT03248882|11316817|FG003|Overall Study|Lost to Follow-up|0
7152203|NCT03248882|11316818|FG004|Overall Study|Lost to Follow-up|1
7152204|NCT03248882|11316814|FG000|Overall Study|Protocol Violation|2
7152205|NCT03248882|11316815|FG001|Overall Study|Protocol Violation|0
7152206|NCT03248882|11316816|FG002|Overall Study|Protocol Violation|2
7152207|NCT03248882|11316817|FG003|Overall Study|Protocol Violation|0
7152208|NCT03248882|11316818|FG004|Overall Study|Protocol Violation|1
7152209|NCT03248882|11316814|FG000|Overall Study|Withdrawal by Subject|2
7152210|NCT03248882|11316815|FG001|Overall Study|Withdrawal by Subject|2
7152211|NCT03248882|11316816|FG002|Overall Study|Withdrawal by Subject|3
7152212|NCT03248882|11316817|FG003|Overall Study|Withdrawal by Subject|4
7152213|NCT03248882|11316818|FG004|Overall Study|Withdrawal by Subject|2
7152214|NCT03249454|11316877|FG000|Overall Study|Withdrawal by Subject|0
7152215|NCT03249454|11316878|FG001|Overall Study|Withdrawal by Subject|0
7152216|NCT03249454|11316879|FG002|Overall Study|Withdrawal by Subject|0
7152217|NCT03249454|11316880|FG003|Overall Study|Withdrawal by Subject|0
6848933|NCT00333359|10856041|FG000|Overall Study|Withdrew before Receiving One Dose|2
7152218|NCT03249454|11316881|FG004|Overall Study|Withdrawal by Subject|0
7152219|NCT03249454|11316882|FG005|Overall Study|Withdrawal by Subject|0
7152220|NCT03249454|11316883|FG006|Overall Study|Withdrawal by Subject|0
7152221|NCT03249454|11316884|FG007|Overall Study|Withdrawal by Subject|0
7152222|NCT03249454|11316885|FG008|Overall Study|Withdrawal by Subject|0
7152223|NCT03249454|11316886|FG009|Overall Study|Withdrawal by Subject|1
7152224|NCT03249454|11316887|FG010|Overall Study|Withdrawal by Subject|1
7184120|NCT01755689|11384114|FG003|Overall Study|Withdrawal by Subject|1
6848934|NCT00333359|10856042|FG001|Overall Study|Withdrew before Receiving One Dose|6
6848935|NCT00333619|10856068|FG000|Overall Study|Death|12
6848936|NCT00333619|10856069|FG001|Overall Study|Death|6
6848937|NCT00333619|10856068|FG000|Overall Study|Withdrawal by Subject|6
6848938|NCT00333619|10856069|FG001|Overall Study|Withdrawal by Subject|1
6848939|NCT00333619|10856068|FG000|Overall Study|Lost to Follow-up|3
6848940|NCT00333619|10856069|FG001|Overall Study|Lost to Follow-up|3
6848941|NCT00333775|10856093|FG000|Overall Study|Death|144
6848942|NCT00333775|10856094|FG001|Overall Study|Death|149
6848943|NCT00333775|10856095|FG002|Overall Study|Death|143
6848944|NCT00333775|10856093|FG000|Overall Study|In Follow-up When Study Stopped|87
6848945|NCT00333775|10856094|FG001|Overall Study|In Follow-up When Study Stopped|92
6848946|NCT00333775|10856095|FG002|Overall Study|In Follow-up When Study Stopped|96
6848947|NCT00333775|10856093|FG000|Overall Study|Lost to Follow-up|10
6848948|NCT00333775|10856094|FG001|Overall Study|Lost to Follow-up|7
6848949|NCT00333775|10856095|FG002|Overall Study|Lost to Follow-up|8
6848950|NCT00333788|10856103|FG000|Overall Study|Adverse Event|44
6848951|NCT00333788|10856103|FG000|Overall Study|Lack of Efficacy|80
6848952|NCT00333788|10856103|FG000|Overall Study|Lost to Follow-up|2
6848953|NCT00333788|10856103|FG000|Overall Study|Withdrawal by Subject|24
6848954|NCT00333788|10856103|FG000|Overall Study|Other: Non-compliance|2
6848955|NCT00333788|10856103|FG000|Overall Study|Other: Moved|2
6848956|NCT00333788|10856103|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1
6848957|NCT00333788|10856103|FG000|Overall Study|Other: Investigator decision|1
6848958|NCT00333788|10856103|FG000|Overall Study|Other: Quality of life concern|1
6848959|NCT00333788|10856103|FG000|Overall Study|Other: Sponsor decision|1
6848960|NCT00333788|10856103|FG000|Overall Study|Other: Subject in need of an Entocort|1
6848961|NCT00333788|10856103|FG000|Overall Study|Other: Medical monitor decision|1
7152225|NCT03249909|11316913|FG000|Overall Study|Withdrawal by Subject|3
7152226|NCT03249909|11316914|FG001|Overall Study|Withdrawal by Subject|0
7152227|NCT03249909|11316915|FG002|Overall Study|Withdrawal by Subject|0
7152228|NCT03249909|11316913|FG000|Overall Study|Adverse Event|3
7152229|NCT03249909|11316914|FG001|Overall Study|Adverse Event|0
7152230|NCT03249909|11316915|FG002|Overall Study|Adverse Event|0
7152231|NCT03249909|11316913|FG000|Overall Study|Lost to Follow-up|0
7152232|NCT03249909|11316914|FG001|Overall Study|Lost to Follow-up|1
7152233|NCT03249909|11316915|FG002|Overall Study|Lost to Follow-up|0
7152234|NCT03249935|11316926|FG000|Overall Study|Discharged from facility early|36
7152235|NCT03249935|11316926|FG000|Overall Study|Negative for chlamydia at enrollment|4
7152236|NCT03249935|11316926|FG000|Overall Study|Protocol Violation|5
7152237|NCT03250182|11316932|FG000|Overall Study|Withdrawal by Subject|1
7152238|NCT03251482|11316966|FG000|Overall Study|Withdrawal by Subject|0
7152239|NCT03251482|11316967|FG001|Overall Study|Withdrawal by Subject|1
7152240|NCT03251482|11316968|FG002|Overall Study|Withdrawal by Subject|0
7152241|NCT03251482|11316969|FG003|Overall Study|Withdrawal by Subject|0
7152242|NCT03251482|11316970|FG004|Overall Study|Withdrawal by Subject|0
7152243|NCT03251963|11316988|FG000|Overall Study|inappropriate Xa level timing|6
7152244|NCT03251963|11316989|FG001|Overall Study|inappropriate Xa level timing|3
7152245|NCT03251963|11316988|FG000|Overall Study|no peak Xa level drawn|2
7152246|NCT03251963|11316989|FG001|Overall Study|no peak Xa level drawn|0
7152247|NCT03251963|11316988|FG000|Overall Study|bled prior to Xa level|1
7152248|NCT03251963|11316989|FG001|Overall Study|bled prior to Xa level|2
7152249|NCT03252015|11316999|FG000|Overall Study|Withdrawal by Subject|0
7152250|NCT03252015|11317000|FG001|Overall Study|Withdrawal by Subject|1
7152251|NCT03252015|11317001|FG002|Overall Study|Withdrawal by Subject|1
7152252|NCT03252015|11317002|FG003|Overall Study|Withdrawal by Subject|0
7152253|NCT03252015|11316999|FG000|Overall Study|Adverse Event|1
7152254|NCT03252015|11317000|FG001|Overall Study|Adverse Event|0
7152255|NCT03252015|11317001|FG002|Overall Study|Adverse Event|0
7152256|NCT03252015|11317002|FG003|Overall Study|Adverse Event|1
7152257|NCT03252145|11317028|FG000|Overall Study|Withdrawal by Subject|1
7152258|NCT03252145|11317029|FG001|Overall Study|Withdrawal by Subject|0
7152259|NCT03252145|11317028|FG000|Overall Study|Complicating Disease|1
7152260|NCT03252145|11317029|FG001|Overall Study|Complicating Disease|2
7152261|NCT03253094|11317066|FG000|Overall Study|Adverse Event|2
7152262|NCT03253094|11317067|FG001|Overall Study|Adverse Event|0
7152263|NCT03253094|11317068|FG002|Overall Study|Adverse Event|0
7152264|NCT03253094|11317069|FG003|Overall Study|Adverse Event|0
7152265|NCT03253094|11317070|FG004|Overall Study|Adverse Event|0
7152266|NCT03253094|11317071|FG005|Overall Study|Adverse Event|0
7152267|NCT03253094|11317066|FG000|Overall Study|Lack of Efficacy|0
7152268|NCT03253094|11317067|FG001|Overall Study|Lack of Efficacy|0
7152269|NCT03253094|11317068|FG002|Overall Study|Lack of Efficacy|2
7152270|NCT03253094|11317069|FG003|Overall Study|Lack of Efficacy|1
7152271|NCT03253094|11317070|FG004|Overall Study|Lack of Efficacy|2
6848962|NCT00333788|10856103|FG000|Overall Study|Other: Physician decision|1
6848963|NCT00333788|10856103|FG000|Overall Study|Other: Signed consent for another study|1
6848964|NCT00333801|10856109|FG000|Overall Study|Moved to another state|5
7152272|NCT03253094|11317071|FG005|Overall Study|Lack of Efficacy|1
6848965|NCT00333801|10856110|FG001|Overall Study|Moved to another state|3
6848966|NCT00333801|10856109|FG000|Overall Study|Lost to Follow-up|2
6848967|NCT00333801|10856110|FG001|Overall Study|Lost to Follow-up|0
6848968|NCT00333801|10856109|FG000|Overall Study|Incarcerated|1
6848969|NCT00333801|10856110|FG001|Overall Study|Incarcerated|2
6848970|NCT00333801|10856109|FG000|Overall Study|Withdrawal by Subject|0
6848971|NCT00333801|10856110|FG001|Overall Study|Withdrawal by Subject|1
6848972|NCT00333840|10856131|FG000|First-line Treatment Period|Adverse Event|38
6848973|NCT00333840|10856132|FG001|First-line Treatment Period|Adverse Event|37
6848974|NCT00333840|10856133|FG002|First-line Treatment Period|Adverse Event|0
7152273|NCT03253094|11317066|FG000|Overall Study|Lost to Follow-up|0
7152274|NCT03253094|11317067|FG001|Overall Study|Lost to Follow-up|0
7152275|NCT03253094|11317068|FG002|Overall Study|Lost to Follow-up|1
7152276|NCT03253094|11317069|FG003|Overall Study|Lost to Follow-up|1
7152277|NCT03253094|11317070|FG004|Overall Study|Lost to Follow-up|0
7152278|NCT03253094|11317071|FG005|Overall Study|Lost to Follow-up|1
7152279|NCT03253094|11317066|FG000|Overall Study|Physician Decision|1
7152280|NCT03253094|11317067|FG001|Overall Study|Physician Decision|0
7152281|NCT03253094|11317068|FG002|Overall Study|Physician Decision|0
7152282|NCT03253094|11317069|FG003|Overall Study|Physician Decision|1
7152283|NCT03253094|11317070|FG004|Overall Study|Physician Decision|0
7152284|NCT03253094|11317071|FG005|Overall Study|Physician Decision|2
7152285|NCT03253094|11317066|FG000|Overall Study|Withdrawal by Subject|1
7152286|NCT03253094|11317067|FG001|Overall Study|Withdrawal by Subject|2
7152287|NCT03253094|11317068|FG002|Overall Study|Withdrawal by Subject|1
7152288|NCT03253094|11317069|FG003|Overall Study|Withdrawal by Subject|0
7152289|NCT03253094|11317070|FG004|Overall Study|Withdrawal by Subject|3
7152290|NCT03253094|11317071|FG005|Overall Study|Withdrawal by Subject|0
7152291|NCT03253094|11317066|FG000|Overall Study|Other|0
7152292|NCT03253094|11317067|FG001|Overall Study|Other|1
7152293|NCT03253094|11317068|FG002|Overall Study|Other|2
7152294|NCT03253094|11317069|FG003|Overall Study|Other|1
7152295|NCT03253094|11317070|FG004|Overall Study|Other|0
7152296|NCT03253094|11317071|FG005|Overall Study|Other|0
7152297|NCT03254108|11317090|FG000|Overall Study|Adverse Event|0
7152298|NCT03254108|11317091|FG001|Overall Study|Adverse Event|2
7152299|NCT03254108|11317092|FG002|Overall Study|Adverse Event|0
7152300|NCT03254108|11317093|FG003|Overall Study|Adverse Event|1
7152301|NCT03254108|11317094|FG004|Overall Study|Adverse Event|1
7152302|NCT03254108|11317090|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0
7152303|NCT03254108|11317091|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0
7152304|NCT03254108|11317092|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0
7152305|NCT03254108|11317093|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0
7152306|NCT03254108|11317094|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2
7152307|NCT03254134|11317108|FG000|Overall Study|Not eligible patients|599
7152308|NCT03254134|11317109|FG001|Overall Study|Not eligible patients|3630
7152309|NCT03254459|11317121|FG000|Overall Study|Adverse Event|7
7152310|NCT03254459|11317122|FG001|Overall Study|Adverse Event|20
7152311|NCT03254459|11317121|FG000|Overall Study|Withdrawal by Subject Consent|3
7152312|NCT03254459|11317122|FG001|Overall Study|Withdrawal by Subject Consent|1
7152313|NCT03254459|11317121|FG000|Overall Study|Lost to Follow-up|0
7152314|NCT03254459|11317122|FG001|Overall Study|Lost to Follow-up|1
7152315|NCT03254459|11317121|FG000|Overall Study|Miscellaneous|0
7152316|NCT03254459|11317122|FG001|Overall Study|Miscellaneous|1
7152317|NCT03254602|11317128|FG000|Overall Study|Lost to Follow-up|4
7152318|NCT03255187|11317138|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1
7152319|NCT03255187|11317139|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3
7152320|NCT03255187|11317138|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0
7152321|NCT03255187|11317139|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1
7152322|NCT03255291|11317151|FG000|Overall Study|Determined to be ineligible|10
7152323|NCT03255291|11317152|FG001|Overall Study|Determined to be ineligible|12
7152324|NCT03255291|11317153|FG002|Overall Study|Determined to be ineligible|6
7152325|NCT03255291|11317154|FG003|Overall Study|Determined to be ineligible|6
7152326|NCT03255291|11317155|FG004|Overall Study|Determined to be ineligible|5
7152327|NCT03255291|11317156|FG005|Overall Study|Determined to be ineligible|10
7152328|NCT03255291|11317151|FG000|Overall Study|Baseline data collection issues|3
7152329|NCT03255291|11317152|FG001|Overall Study|Baseline data collection issues|0
7152330|NCT03255291|11317153|FG002|Overall Study|Baseline data collection issues|0
7152331|NCT03255291|11317154|FG003|Overall Study|Baseline data collection issues|0
7152332|NCT03255291|11317155|FG004|Overall Study|Baseline data collection issues|2
7152333|NCT03255291|11317156|FG005|Overall Study|Baseline data collection issues|0
6848975|NCT00333840|10856134|FG003|First-line Treatment Period|Adverse Event|0
7152334|NCT03255382|11317176|FG000|Overall Study|Adverse Event|3
7152335|NCT03255382|11317177|FG001|Overall Study|Adverse Event|0
7152336|NCT03255382|11317176|FG000|Overall Study|Lost to Follow-up|2
7152337|NCT03255382|11317177|FG001|Overall Study|Lost to Follow-up|0
7152338|NCT03255382|11317176|FG000|Overall Study|Withdrawal by Subject|2
7152339|NCT03255382|11317177|FG001|Overall Study|Withdrawal by Subject|0
7152340|NCT03255382|11317176|FG000|Overall Study|Other|6
7152341|NCT03255382|11317177|FG001|Overall Study|Other|0
7152342|NCT03255655|11317186|FG000|Overall Study|Lost to Follow-up|7
7152343|NCT03255655|11317187|FG001|Overall Study|Lost to Follow-up|4
7152344|NCT03255733|11317193|FG000|Overall Study|Lost to Follow-up|4
7152345|NCT03255824|11317199|FG000|Overall Study|Under-sedation|2
7152346|NCT03255824|11317200|FG001|Overall Study|Under-sedation|1
6848976|NCT00333840|10856131|FG000|First-line Treatment Period|Abnormal laboratory values|3
6848977|NCT00333840|10856132|FG001|First-line Treatment Period|Abnormal laboratory values|1
6848978|NCT00333840|10856133|FG002|First-line Treatment Period|Abnormal laboratory values|0
6848979|NCT00333840|10856134|FG003|First-line Treatment Period|Abnormal laboratory values|0
6848980|NCT00333840|10856131|FG000|First-line Treatment Period|Abnormal procedure|2
6848981|NCT00333840|10856132|FG001|First-line Treatment Period|Abnormal procedure|0
6848982|NCT00333840|10856133|FG002|First-line Treatment Period|Abnormal procedure|0
6848983|NCT00333840|10856134|FG003|First-line Treatment Period|Abnormal procedure|0
6848984|NCT00333840|10856131|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88
6848985|NCT00333840|10856132|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29
6848986|NCT00333840|10856133|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0
6848987|NCT00333840|10856134|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0
6848988|NCT00333840|10856131|FG000|First-line Treatment Period|No longer required study drug|21
6848989|NCT00333840|10856132|FG001|First-line Treatment Period|No longer required study drug|8
6848990|NCT00333840|10856133|FG002|First-line Treatment Period|No longer required study drug|0
6848991|NCT00333840|10856134|FG003|First-line Treatment Period|No longer required study drug|0
6848992|NCT00333840|10856131|FG000|First-line Treatment Period|Protocol Violation|17
6848993|NCT00333840|10856132|FG001|First-line Treatment Period|Protocol Violation|17
6848994|NCT00333840|10856133|FG002|First-line Treatment Period|Protocol Violation|0
7077486|NCT02092467|11185054|FG000|Overall Study|Randomized but not treated|2
7152347|NCT03255941|11317214|FG000|Overall Study|Not eligible or refused injection|37
7152348|NCT03255941|11317215|FG001|Overall Study|Not eligible or refused injection|44
7152349|NCT03255941|11317216|FG002|Overall Study|Not eligible or refused injection|5
7152350|NCT03255941|11317217|FG003|Overall Study|Not eligible or refused injection|6
7152351|NCT03255941|11317214|FG000|Overall Study|Did not complete exit interview|1
7152352|NCT03255941|11317215|FG001|Overall Study|Did not complete exit interview|2
7152353|NCT03255941|11317216|FG002|Overall Study|Did not complete exit interview|0
7152354|NCT03255941|11317217|FG003|Overall Study|Did not complete exit interview|0
7152355|NCT03255980|11317243|FG000|Overall Study|Grade =>3 Skin Toxicity|1
7152356|NCT03255980|11317244|FG001|Overall Study|Grade =>3 Skin Toxicity|4
7152357|NCT03255980|11317245|FG002|Overall Study|Grade =>3 Skin Toxicity|6
7152358|NCT03255980|11317246|FG003|Overall Study|Grade =>3 Skin Toxicity|5
7152359|NCT03255980|11317243|FG000|Overall Study|Adverse Event|1
7152360|NCT03255980|11317244|FG001|Overall Study|Adverse Event|1
7152361|NCT03255980|11317245|FG002|Overall Study|Adverse Event|0
7152362|NCT03255980|11317246|FG003|Overall Study|Adverse Event|1
7152363|NCT03255980|11317243|FG000|Overall Study|Lack of compliance to study or assessmen|0
7152364|NCT03255980|11317244|FG001|Overall Study|Lack of compliance to study or assessmen|1
7152365|NCT03255980|11317245|FG002|Overall Study|Lack of compliance to study or assessmen|0
7152366|NCT03255980|11317246|FG003|Overall Study|Lack of compliance to study or assessmen|0
7152367|NCT03255980|11317243|FG000|Overall Study|Lost to Follow-up|1
7152368|NCT03255980|11317244|FG001|Overall Study|Lost to Follow-up|1
7152369|NCT03255980|11317245|FG002|Overall Study|Lost to Follow-up|0
7152370|NCT03255980|11317246|FG003|Overall Study|Lost to Follow-up|3
6848995|NCT00333840|10856134|FG003|First-line Treatment Period|Protocol Violation|0
7077487|NCT02092467|11185055|FG001|Overall Study|Randomized but not treated|1
7077488|NCT02092467|11185056|FG002|Overall Study|Randomized but not treated|7
7077489|NCT02092662|11185086|FG000|Overall Study|Lost to Follow-up|13
7077490|NCT02092662|11185087|FG001|Overall Study|Lost to Follow-up|0
7077491|NCT02092909|11185111|FG000|Overall Study|Adverse Event|0
7077492|NCT02092909|11185112|FG001|Overall Study|Adverse Event|0
7077493|NCT02092909|11185113|FG002|Overall Study|Adverse Event|4
7077494|NCT02092909|11185114|FG003|Overall Study|Adverse Event|2
7077495|NCT02092909|11185111|FG000|Overall Study|Lack of Efficacy|0
7077496|NCT02092909|11185112|FG001|Overall Study|Lack of Efficacy|2
7077497|NCT02092909|11185113|FG002|Overall Study|Lack of Efficacy|1
7077498|NCT02092909|11185114|FG003|Overall Study|Lack of Efficacy|0
7077499|NCT02092909|11185111|FG000|Overall Study|Withdrawal by Subject|0
7077500|NCT02092909|11185112|FG001|Overall Study|Withdrawal by Subject|0
7077501|NCT02092909|11185113|FG002|Overall Study|Withdrawal by Subject|2
7077502|NCT02092909|11185114|FG003|Overall Study|Withdrawal by Subject|1
7077503|NCT02092909|11185111|FG000|Overall Study|Study terminated by Sponsor|0
7077504|NCT02092909|11185112|FG001|Overall Study|Study terminated by Sponsor|0
7077505|NCT02092909|11185113|FG002|Overall Study|Study terminated by Sponsor|0
7077506|NCT02092909|11185114|FG003|Overall Study|Study terminated by Sponsor|2
7077507|NCT02092909|11185111|FG000|Overall Study|Miscellaneous|1
7077508|NCT02092909|11185112|FG001|Overall Study|Miscellaneous|1
7077509|NCT02092909|11185113|FG002|Overall Study|Miscellaneous|2
7077510|NCT02092909|11185114|FG003|Overall Study|Miscellaneous|1
7077511|NCT02092961|11185127|FG000|Overall Study|Not reported|1
7077512|NCT02092961|11185128|FG001|Overall Study|Not reported|0
7077513|NCT02092961|11185129|FG002|Overall Study|Not reported|1
7077514|NCT02092961|11185127|FG000|Overall Study|Study stopped|13
7077515|NCT02092961|11185128|FG001|Overall Study|Study stopped|9
7152371|NCT03255980|11317243|FG000|Overall Study|Withdrawal by Subject|0
7152372|NCT03255980|11317244|FG001|Overall Study|Withdrawal by Subject|1
7152373|NCT03255980|11317245|FG002|Overall Study|Withdrawal by Subject|0
7152374|NCT03255980|11317246|FG003|Overall Study|Withdrawal by Subject|3
6848996|NCT00333840|10856131|FG000|First-line Treatment Period|Subject withdrew consent|57
6848997|NCT00333840|10856132|FG001|First-line Treatment Period|Subject withdrew consent|77
6848998|NCT00333840|10856133|FG002|First-line Treatment Period|Subject withdrew consent|0
6848999|NCT00333840|10856134|FG003|First-line Treatment Period|Subject withdrew consent|0
6849000|NCT00333840|10856131|FG000|First-line Treatment Period|Lost to Follow-up|15
6849001|NCT00333840|10856132|FG001|First-line Treatment Period|Lost to Follow-up|6
6849002|NCT00333840|10856133|FG002|First-line Treatment Period|Lost to Follow-up|0
6849003|NCT00333840|10856134|FG003|First-line Treatment Period|Lost to Follow-up|0
6849004|NCT00333840|10856131|FG000|First-line Treatment Period|Administrative problems|12
6849005|NCT00333840|10856132|FG001|First-line Treatment Period|Administrative problems|6
6849006|NCT00333840|10856133|FG002|First-line Treatment Period|Administrative problems|0
6849007|NCT00333840|10856134|FG003|First-line Treatment Period|Administrative problems|0
6849008|NCT00333840|10856131|FG000|First-line Treatment Period|Death|19
6849009|NCT00333840|10856132|FG001|First-line Treatment Period|Death|2
6849010|NCT00333840|10856133|FG002|First-line Treatment Period|Death|0
6849011|NCT00333840|10856134|FG003|First-line Treatment Period|Death|0
6849012|NCT00333840|10856131|FG000|First-line Treatment Period|Crossed over to other treatment arm|14
6849013|NCT00333840|10856132|FG001|First-line Treatment Period|Crossed over to other treatment arm|363
6966614|NCT01125748|11014638|FG000|Overall Study|Adverse Event|0
7152375|NCT03256526|11317289|FG000|Overall Study|Adverse Event|1
7152376|NCT03256526|11317290|FG001|Overall Study|Adverse Event|0
7152377|NCT03256526|11317291|FG002|Overall Study|Adverse Event|1
7152378|NCT03256526|11317289|FG000|Overall Study|Lost to Follow-up|1
7152379|NCT03256526|11317290|FG001|Overall Study|Lost to Follow-up|0
7152380|NCT03256526|11317291|FG002|Overall Study|Lost to Follow-up|2
7152381|NCT03256552|11317299|FG000|Overall Study|Protocol Violation|1
7152382|NCT03256552|11317299|FG000|Overall Study|Physician Decision|1
7152383|NCT03256552|11317299|FG000|Overall Study|Adverse Event|1
7152384|NCT03256552|11317299|FG000|Overall Study|Withdrawal by Subject|2
7152385|NCT03256578|11317311|FG000|Overall Study|Excluded Post Randomization|66
7152386|NCT03256578|11317312|FG001|Overall Study|Excluded Post Randomization|56
7152387|NCT03256695|11317318|FG000|Overall Study|Adverse Event|8
7152388|NCT03256695|11317318|FG000|Overall Study|Death|2
7152389|NCT03256695|11317318|FG000|Overall Study|Withdrawal by Subject|14
7152390|NCT03256695|11317318|FG000|Overall Study|Non-compliance with study drug|1
7152391|NCT03256695|11317318|FG000|Overall Study|Lost to Follow-up|3
7152392|NCT03256695|11317318|FG000|Overall Study|Lack of Efficacy|3
7152393|NCT03256695|11317318|FG000|Overall Study|Protocol Violation|5
7152394|NCT03256695|11317318|FG000|Overall Study|Other than specified|3
7152395|NCT03256851|11317328|FG000|Overall Study|Withdrawal by Subject|1
7152396|NCT03256851|11317329|FG001|Overall Study|Withdrawal by Subject|0
7152397|NCT03257358|11317355|FG000|Overall Study|Adverse Event|25
7152398|NCT03257358|11317356|FG001|Overall Study|Adverse Event|12
7152399|NCT03257358|11317355|FG000|Overall Study|Lack of Efficacy|1
7152400|NCT03257358|11317356|FG001|Overall Study|Lack of Efficacy|1
7152401|NCT03257358|11317355|FG000|Overall Study|Lost to Follow-up|12
7152402|NCT03257358|11317356|FG001|Overall Study|Lost to Follow-up|4
7152403|NCT03257358|11317355|FG000|Overall Study|Non-compliance with fingolimod treatment|4
7152404|NCT03257358|11317356|FG001|Overall Study|Non-compliance with fingolimod treatment|2
7152405|NCT03257358|11317355|FG000|Overall Study|Physician Decision|2
7152406|NCT03257358|11317356|FG001|Overall Study|Physician Decision|2
7152407|NCT03257358|11317355|FG000|Overall Study|Protocol Violation|5
7152408|NCT03257358|11317356|FG001|Overall Study|Protocol Violation|3
7152409|NCT03257358|11317355|FG000|Overall Study|Technical problems|4
7152410|NCT03257358|11317356|FG001|Overall Study|Technical problems|1
7152411|NCT03257358|11317355|FG000|Overall Study|Withdrawal by Subject|8
7152412|NCT03257358|11317356|FG001|Overall Study|Withdrawal by Subject|3
7152413|NCT03257358|11317355|FG000|Overall Study|Withdrawal of informed consent|9
7152414|NCT03257358|11317356|FG001|Overall Study|Withdrawal of informed consent|5
7152415|NCT03257358|11317355|FG000|Overall Study|New therapy for study indication|1
7152416|NCT03257358|11317356|FG001|Overall Study|New therapy for study indication|0
7152417|NCT03257358|11317355|FG000|Overall Study|No longer requires treatment|0
7152418|NCT03257358|11317356|FG001|Overall Study|No longer requires treatment|1
7152419|NCT03257371|11317362|FG000|Overall Study|Lost to Follow-up|1
7152420|NCT03257410|11317368|FG000|Overall Study|Adverse Event|2
7152421|NCT03257410|11317369|FG001|Overall Study|Adverse Event|3
7152422|NCT03257410|11317368|FG000|Overall Study|Protocol Violation|1
7152423|NCT03257410|11317369|FG001|Overall Study|Protocol Violation|2
7152424|NCT03257410|11317368|FG000|Overall Study|Lost to Follow-up|1
7152425|NCT03257410|11317369|FG001|Overall Study|Lost to Follow-up|0
6849014|NCT00333840|10856133|FG002|First-line Treatment Period|Crossed over to other treatment arm|0
6966615|NCT01125748|11014639|FG001|Overall Study|Adverse Event|2
7152426|NCT03257410|11317368|FG000|Overall Study|Withdrawal by Subject|1
7152427|NCT03257410|11317369|FG001|Overall Study|Withdrawal by Subject|2
7152428|NCT03257410|11317368|FG000|Overall Study|Physician Decision|1
7152429|NCT03257410|11317369|FG001|Overall Study|Physician Decision|1
7152430|NCT03257410|11317368|FG000|Overall Study|Renal transplantation|2
7152431|NCT03257410|11317369|FG001|Overall Study|Renal transplantation|0
7152432|NCT03257410|11317368|FG000|Overall Study|Switch to peritoneal dialysis|1
7152433|NCT03257410|11317369|FG001|Overall Study|Switch to peritoneal dialysis|0
7152434|NCT03257410|11317368|FG000|Overall Study|Death|3
6849015|NCT00333840|10856134|FG003|First-line Treatment Period|Crossed over to other treatment arm|0
6849016|NCT00333840|10856131|FG000|Second-line Treatment Period|Adverse Event|0
6849017|NCT00333840|10856132|FG001|Second-line Treatment Period|Adverse Event|0
6849018|NCT00333840|10856133|FG002|Second-line Treatment Period|Adverse Event|3
6849019|NCT00333840|10856134|FG003|Second-line Treatment Period|Adverse Event|34
6849020|NCT00333840|10856131|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0
6849021|NCT00333840|10856132|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0
6849022|NCT00333840|10856133|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0
6849023|NCT00333840|10856134|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3
6849024|NCT00333840|10856131|FG000|Second-line Treatment Period|Abnormal procedure|0
6849025|NCT00333840|10856132|FG001|Second-line Treatment Period|Abnormal procedure|0
6849026|NCT00333840|10856133|FG002|Second-line Treatment Period|Abnormal procedure|0
6849027|NCT00333840|10856134|FG003|Second-line Treatment Period|Abnormal procedure|1
6849028|NCT00333840|10856131|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
6849029|NCT00333840|10856132|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
6849030|NCT00333840|10856133|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9
6849031|NCT00333840|10856134|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70
6849032|NCT00333840|10856131|FG000|Second-line Treatment Period|No longer required study drug|0
6849033|NCT00333840|10856132|FG001|Second-line Treatment Period|No longer required study drug|0
6849034|NCT00333840|10856133|FG002|Second-line Treatment Period|No longer required study drug|1
6849035|NCT00333840|10856134|FG003|Second-line Treatment Period|No longer required study drug|14
6849036|NCT00333840|10856131|FG000|Second-line Treatment Period|Protocol Violation|0
6849037|NCT00333840|10856132|FG001|Second-line Treatment Period|Protocol Violation|0
6849038|NCT00333840|10856133|FG002|Second-line Treatment Period|Protocol Violation|1
6849039|NCT00333840|10856134|FG003|Second-line Treatment Period|Protocol Violation|10
6849040|NCT00333840|10856131|FG000|Second-line Treatment Period|Subject withdrew consent|0
6849041|NCT00333840|10856132|FG001|Second-line Treatment Period|Subject withdrew consent|0
6849042|NCT00333840|10856133|FG002|Second-line Treatment Period|Subject withdrew consent|0
6849043|NCT00333840|10856134|FG003|Second-line Treatment Period|Subject withdrew consent|34
6849044|NCT00333840|10856131|FG000|Second-line Treatment Period|Lost to Follow-up|0
6849045|NCT00333840|10856132|FG001|Second-line Treatment Period|Lost to Follow-up|0
6849046|NCT00333840|10856133|FG002|Second-line Treatment Period|Lost to Follow-up|0
6849047|NCT00333840|10856134|FG003|Second-line Treatment Period|Lost to Follow-up|6
6849048|NCT00333840|10856131|FG000|Second-line Treatment Period|Administrative problems|0
6849049|NCT00333840|10856132|FG001|Second-line Treatment Period|Administrative problems|0
6849050|NCT00333840|10856133|FG002|Second-line Treatment Period|Administrative problems|0
6849051|NCT00333840|10856134|FG003|Second-line Treatment Period|Administrative problems|7
6849052|NCT00333840|10856131|FG000|Second-line Treatment Period|Death|0
6849053|NCT00333840|10856132|FG001|Second-line Treatment Period|Death|0
6849054|NCT00333840|10856133|FG002|Second-line Treatment Period|Death|0
6849055|NCT00333840|10856134|FG003|Second-line Treatment Period|Death|9
6849056|NCT00333866|10856152|FG000|Overall Study|Adverse Event|23
6849057|NCT00333866|10856153|FG001|Overall Study|Adverse Event|37
6849058|NCT00333866|10856154|FG002|Overall Study|Adverse Event|38
6849059|NCT00333866|10856155|FG003|Overall Study|Adverse Event|47
6849060|NCT00333866|10856152|FG000|Overall Study|Other|3
6849061|NCT00333866|10856153|FG001|Overall Study|Other|2
6849062|NCT00333866|10856154|FG002|Overall Study|Other|2
6849063|NCT00333866|10856155|FG003|Overall Study|Other|2
6849064|NCT00333866|10856152|FG000|Overall Study|Lack of Efficacy|8
6849065|NCT00333866|10856153|FG001|Overall Study|Lack of Efficacy|6
6849066|NCT00333866|10856154|FG002|Overall Study|Lack of Efficacy|3
6849067|NCT00333866|10856155|FG003|Overall Study|Lack of Efficacy|5
6849068|NCT00333866|10856152|FG000|Overall Study|Lost to Follow-up|1
6849069|NCT00333866|10856153|FG001|Overall Study|Lost to Follow-up|2
6849070|NCT00333866|10856154|FG002|Overall Study|Lost to Follow-up|2
6849071|NCT00333866|10856155|FG003|Overall Study|Lost to Follow-up|2
6849072|NCT00333866|10856152|FG000|Overall Study|Withdrawal by Subject|8
6849073|NCT00333866|10856153|FG001|Overall Study|Withdrawal by Subject|14
6849074|NCT00333866|10856154|FG002|Overall Study|Withdrawal by Subject|4
6849075|NCT00333866|10856155|FG003|Overall Study|Withdrawal by Subject|9
6849076|NCT00333866|10856152|FG000|Overall Study|Randomized but not Treated|5
6849077|NCT00333866|10856153|FG001|Overall Study|Randomized but not Treated|3
6849078|NCT00333866|10856154|FG002|Overall Study|Randomized but not Treated|2
6849079|NCT00333866|10856155|FG003|Overall Study|Randomized but not Treated|1
6849080|NCT00333970|10856171|FG000|Overall Study|Withdrawal by Subject|13
6849081|NCT00333970|10856172|FG001|Overall Study|Withdrawal by Subject|7
6849082|NCT00333983|10856181|FG000|Overall Study|Lost to Follow-up|2
6849083|NCT00333983|10856182|FG001|Overall Study|Lost to Follow-up|1
6849084|NCT00333983|10856183|FG002|Overall Study|Lost to Follow-up|0
6849085|NCT00333983|10856181|FG000|Overall Study|Adverse Event|1
6849086|NCT00333983|10856182|FG001|Overall Study|Adverse Event|1
6849087|NCT00333983|10856183|FG002|Overall Study|Adverse Event|1
6849088|NCT00333983|10856181|FG000|Overall Study|Withdrawal by Subject|0
6849089|NCT00333983|10856182|FG001|Overall Study|Withdrawal by Subject|3
6849090|NCT00333983|10856183|FG002|Overall Study|Withdrawal by Subject|1
6849091|NCT00334113|10856202|FG000|Overall Study|Lost to Follow-up|2
6849092|NCT00334113|10856203|FG001|Overall Study|Lost to Follow-up|2
6849093|NCT00334113|10856202|FG000|Overall Study|Withdrawal by Subject|0
6849094|NCT00334113|10856203|FG001|Overall Study|Withdrawal by Subject|1
6849095|NCT00334282|10856216|FG000|Overall Study|Lost to Follow-up|11
6849096|NCT00334282|10856217|FG001|Overall Study|Lost to Follow-up|5
7152435|NCT03257410|11317369|FG001|Overall Study|Death|2
7152436|NCT03257410|11317368|FG000|Overall Study|Change to another dialysis center|2
7152437|NCT03257410|11317369|FG001|Overall Study|Change to another dialysis center|2
7152438|NCT03257410|11317368|FG000|Overall Study|Missing 3 consecutive study treatments|5
7152439|NCT03257410|11317369|FG001|Overall Study|Missing 3 consecutive study treatments|6
7152440|NCT03257410|11317368|FG000|Overall Study|Miscellaneous|2
7152441|NCT03257410|11317369|FG001|Overall Study|Miscellaneous|2
7152442|NCT03257410|11317368|FG000|Overall Study|Other|0
7152443|NCT03257410|11317369|FG001|Overall Study|Other|1
7152444|NCT03257657|11317377|FG000|Overall Study|Lost to Follow-up|0
7152445|NCT03257657|11317378|FG001|Overall Study|Lost to Follow-up|3
7152446|NCT03257657|11317377|FG000|Overall Study|Withdrawn|0
7152447|NCT03257657|11317378|FG001|Overall Study|Withdrawn|1
7152448|NCT03257657|11317377|FG000|Overall Study|Noted not eligible right after enrolled|0
7152449|NCT03257657|11317378|FG001|Overall Study|Noted not eligible right after enrolled|1
7152450|NCT03257813|11317387|FG000|Overall Study|Protocol Violation|6
7152451|NCT03257813|11317388|FG001|Overall Study|Protocol Violation|3
7152452|NCT03257865|11317399|FG000|Overall Study|Adverse Event|4
7152453|NCT03257865|11317400|FG001|Overall Study|Adverse Event|8
7152454|NCT03257865|11317399|FG000|Overall Study|Lack of Efficacy|1
7152455|NCT03257865|11317400|FG001|Overall Study|Lack of Efficacy|2
7152456|NCT03257865|11317399|FG000|Overall Study|Non-compliance with Study Drug|0
7152457|NCT03257865|11317400|FG001|Overall Study|Non-compliance with Study Drug|2
7152458|NCT03257865|11317399|FG000|Overall Study|Withdrawal by Subject|23
7152459|NCT03257865|11317400|FG001|Overall Study|Withdrawal by Subject|17
7152460|NCT03257865|11317399|FG000|Overall Study|Physician Decision|3
7152461|NCT03257865|11317400|FG001|Overall Study|Physician Decision|1
7152462|NCT03257865|11317399|FG000|Overall Study|Other|0
7152463|NCT03257865|11317400|FG001|Overall Study|Other|1
7152464|NCT03257865|11317399|FG000|Overall Study|Lost to Follow-up|4
7152465|NCT03257865|11317400|FG001|Overall Study|Lost to Follow-up|4
7152466|NCT03257995|11317406|FG000|Overall Study|Adverse Event|0
7152467|NCT03257995|11317407|FG001|Overall Study|Adverse Event|1
7152468|NCT03257995|11317408|FG002|Overall Study|Adverse Event|0
6849097|NCT00334282|10856216|FG000|Overall Study|Withdrawal by Subject|17
7152469|NCT03257995|11317409|FG003|Overall Study|Adverse Event|0
7152470|NCT03257995|11317410|FG004|Overall Study|Adverse Event|0
7152471|NCT03257995|11317411|FG005|Overall Study|Adverse Event|0
7152472|NCT03257995|11317406|FG000|Overall Study|Protocol deviation|0
7152473|NCT03257995|11317407|FG001|Overall Study|Protocol deviation|0
7152474|NCT03257995|11317408|FG002|Overall Study|Protocol deviation|0
7152475|NCT03257995|11317409|FG003|Overall Study|Protocol deviation|0
7152476|NCT03257995|11317410|FG004|Overall Study|Protocol deviation|0
7152477|NCT03257995|11317411|FG005|Overall Study|Protocol deviation|2
7152478|NCT03258710|11317433|FG000|Overall Study|Adverse Event|1
7152479|NCT03258710|11317433|FG000|Overall Study|Protocol-defined stopping criteria|1
7152480|NCT03258710|11317433|FG000|Overall Study|Physician Decision|1
7152481|NCT03258762|11317439|FG000|Overall Study|Lost to Follow-up|0
7152482|NCT03258762|11317440|FG001|Overall Study|Lost to Follow-up|1
7152483|NCT03258814|11317449|FG000|Overall Study|Early Termination|4
7152484|NCT03258814|11317450|FG001|Overall Study|Early Termination|3
7152485|NCT03258814|11317451|FG002|Overall Study|Early Termination|10
7152486|NCT03259087|11317463|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0
7152487|NCT03259087|11317464|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0
7152488|NCT03259087|11317465|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0
7152489|NCT03259087|11317466|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0
7152490|NCT03259087|11317467|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1
7152491|NCT03259087|11317463|FG000|Period 2 of Part 2|Adverse Event|0
7152492|NCT03259087|11317464|FG001|Period 2 of Part 2|Adverse Event|0
7152493|NCT03259087|11317465|FG002|Period 2 of Part 2|Adverse Event|0
7152494|NCT03259087|11317466|FG003|Period 2 of Part 2|Adverse Event|0
7152495|NCT03259087|11317467|FG004|Period 2 of Part 2|Adverse Event|1
7152496|NCT03259308|11317520|FG000|Overall Study|Adverse Event|5
7152497|NCT03259308|11317521|FG001|Overall Study|Adverse Event|4
7152498|NCT03259308|11317522|FG002|Overall Study|Adverse Event|1
7152499|NCT03259308|11317520|FG000|Overall Study|Withdrawal by Subject|2
7152500|NCT03259308|11317521|FG001|Overall Study|Withdrawal by Subject|1
7152501|NCT03259308|11317522|FG002|Overall Study|Withdrawal by Subject|3
7152502|NCT03259308|11317520|FG000|Overall Study|Lost to Follow-up|0
7152503|NCT03259308|11317521|FG001|Overall Study|Lost to Follow-up|0
7152504|NCT03259308|11317522|FG002|Overall Study|Lost to Follow-up|1
6849098|NCT00334282|10856217|FG001|Overall Study|Withdrawal by Subject|3
7152505|NCT03259308|11317520|FG000|Overall Study|Pregnancy|0
6849099|NCT00334282|10856216|FG000|Overall Study|Death|194
7152506|NCT03259308|11317521|FG001|Overall Study|Pregnancy|0
7152507|NCT03259308|11317522|FG002|Overall Study|Pregnancy|1
7152508|NCT03259308|11317520|FG000|Overall Study|Protocol Deviation|0
7152509|NCT03259308|11317521|FG001|Overall Study|Protocol Deviation|3
7152510|NCT03259308|11317522|FG002|Overall Study|Protocol Deviation|0
7152511|NCT03259308|11317520|FG000|Overall Study|Lack of Efficacy|0
7152512|NCT03259308|11317521|FG001|Overall Study|Lack of Efficacy|0
7152513|NCT03259308|11317522|FG002|Overall Study|Lack of Efficacy|1
6849100|NCT00334282|10856217|FG001|Overall Study|Death|100
6849101|NCT00334295|10856227|FG000|Overall Study|Patients received fewer than 3 injection|5
6849102|NCT00334542|10856231|FG000|Overall Study|Adverse Event|3
6849103|NCT00334542|10856231|FG000|Overall Study|Withdrawal by Subject|1
6849104|NCT00334542|10856231|FG000|Overall Study|New cancer diagnosis|1
6849105|NCT00334737|10856255|FG000|Hospital Phase|Death|1
6849106|NCT00334737|10856256|FG001|Hospital Phase|Death|2
6849107|NCT00334737|10856257|FG002|Hospital Phase|Death|3
7152514|NCT03259334|11317533|FG000|Overall Study|Adverse Event|3
7152515|NCT03259334|11317534|FG001|Overall Study|Adverse Event|8
7152516|NCT03259334|11317535|FG002|Overall Study|Adverse Event|5
7152517|NCT03259334|11317533|FG000|Overall Study|Withdrawal by Subject|4
7152518|NCT03259334|11317534|FG001|Overall Study|Withdrawal by Subject|2
7152519|NCT03259334|11317535|FG002|Overall Study|Withdrawal by Subject|4
7152520|NCT03259334|11317533|FG000|Overall Study|Physician Decision|1
7152521|NCT03259334|11317534|FG001|Overall Study|Physician Decision|0
7152522|NCT03259334|11317535|FG002|Overall Study|Physician Decision|0
7152523|NCT03259334|11317533|FG000|Overall Study|Lost to Follow-up|0
7152524|NCT03259334|11317534|FG001|Overall Study|Lost to Follow-up|2
7152525|NCT03259334|11317535|FG002|Overall Study|Lost to Follow-up|1
7152526|NCT03259334|11317533|FG000|Overall Study|Protocol Deviation|0
7152527|NCT03259334|11317534|FG001|Overall Study|Protocol Deviation|3
7152528|NCT03259334|11317535|FG002|Overall Study|Protocol Deviation|2
7152529|NCT03259334|11317533|FG000|Overall Study|Lack of Efficacy|2
7152530|NCT03259334|11317534|FG001|Overall Study|Lack of Efficacy|0
7152531|NCT03259334|11317535|FG002|Overall Study|Lack of Efficacy|1
7152532|NCT03259334|11317533|FG000|Overall Study|Randomized but never treated|0
7152533|NCT03259334|11317534|FG001|Overall Study|Randomized but never treated|2
7152534|NCT03259334|11317535|FG002|Overall Study|Randomized but never treated|0
7152535|NCT03259490|11317545|FG000|Period 1|Withdrawal by Subject|0
7152536|NCT03259490|11317546|FG001|Period 1|Withdrawal by Subject|1
7152537|NCT03259490|11317545|FG000|Period 2|Protocol Violation|1
7152538|NCT03259490|11317546|FG001|Period 2|Protocol Violation|0
7152539|NCT03259555|11317554|FG000|Overall Study|Adverse Event|6
7152540|NCT03259555|11317555|FG001|Overall Study|Adverse Event|4
7152541|NCT03259555|11317554|FG000|Overall Study|Lack of Efficacy|6
7152542|NCT03259555|11317555|FG001|Overall Study|Lack of Efficacy|4
7152543|NCT03259555|11317554|FG000|Overall Study|Lost to Follow-up|0
7152544|NCT03259555|11317555|FG001|Overall Study|Lost to Follow-up|2
7152545|NCT03259555|11317554|FG000|Overall Study|Non-Compliance With Study Drug|1
7152546|NCT03259555|11317555|FG001|Overall Study|Non-Compliance With Study Drug|0
7152547|NCT03259555|11317554|FG000|Overall Study|Progressive Disease|0
7152548|NCT03259555|11317555|FG001|Overall Study|Progressive Disease|2
7152549|NCT03259555|11317554|FG000|Overall Study|Withdrawal by Subject|19
7152550|NCT03259555|11317555|FG001|Overall Study|Withdrawal by Subject|16
7152551|NCT03259555|11317554|FG000|Overall Study|Physician Decision|1
7152552|NCT03259555|11317555|FG001|Overall Study|Physician Decision|2
7152553|NCT03259555|11317554|FG000|Overall Study|Other|1
7152554|NCT03259555|11317555|FG001|Overall Study|Other|0
7152555|NCT03259789|11317564|FG000|Overall Study|Adverse Event|3
7152556|NCT03259789|11317565|FG001|Overall Study|Adverse Event|2
7152557|NCT03259789|11317566|FG002|Overall Study|Adverse Event|1
7152558|NCT03259789|11317564|FG000|Overall Study|Withdrawal by Subject|9
7152559|NCT03259789|11317565|FG001|Overall Study|Withdrawal by Subject|5
7152560|NCT03259789|11317566|FG002|Overall Study|Withdrawal by Subject|1
7152561|NCT03259789|11317564|FG000|Overall Study|Lost to Follow-up|5
7152562|NCT03259789|11317565|FG001|Overall Study|Lost to Follow-up|9
7152563|NCT03259789|11317566|FG002|Overall Study|Lost to Follow-up|4
7152564|NCT03259789|11317564|FG000|Overall Study|Physician Decision|0
7152565|NCT03259789|11317565|FG001|Overall Study|Physician Decision|1
7152566|NCT03259789|11317566|FG002|Overall Study|Physician Decision|0
7152567|NCT03260205|11317580|FG000|Overall Study|Adverse Event|2
7152568|NCT03260205|11317581|FG001|Overall Study|Adverse Event|0
7152569|NCT03260205|11317582|FG002|Overall Study|Adverse Event|2
7152570|NCT03260205|11317583|FG003|Overall Study|Adverse Event|2
7152571|NCT03260205|11317584|FG004|Overall Study|Adverse Event|4
7152572|NCT03260205|11317580|FG000|Overall Study|Lost to Follow-up|2
7152573|NCT03260205|11317581|FG001|Overall Study|Lost to Follow-up|2
7152574|NCT03260205|11317582|FG002|Overall Study|Lost to Follow-up|1
7152575|NCT03260205|11317583|FG003|Overall Study|Lost to Follow-up|1
7152576|NCT03260205|11317584|FG004|Overall Study|Lost to Follow-up|5
7152577|NCT03260205|11317580|FG000|Overall Study|Protocol Violation|0
7152578|NCT03260205|11317581|FG001|Overall Study|Protocol Violation|0
7152579|NCT03260205|11317582|FG002|Overall Study|Protocol Violation|2
7152580|NCT03260205|11317583|FG003|Overall Study|Protocol Violation|0
7152581|NCT03260205|11317584|FG004|Overall Study|Protocol Violation|1
7152582|NCT03260205|11317580|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4
7152583|NCT03260205|11317581|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5
7152584|NCT03260205|11317582|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1
7152585|NCT03260205|11317583|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0
7152586|NCT03260205|11317584|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2
7152587|NCT03260205|11317580|FG000|Overall Study|Other: Unspecified|0
7152588|NCT03260205|11317581|FG001|Overall Study|Other: Unspecified|0
6849108|NCT00334737|10856255|FG000|Hospital Phase|Withdrawal by Subject|0
6849109|NCT00334737|10856256|FG001|Hospital Phase|Withdrawal by Subject|0
6849110|NCT00334737|10856257|FG002|Hospital Phase|Withdrawal by Subject|1
6849111|NCT00334737|10856255|FG000|Hospital Phase|Did not receive study drug|1
6849112|NCT00334737|10856256|FG001|Hospital Phase|Did not receive study drug|0
6849113|NCT00334737|10856257|FG002|Hospital Phase|Did not receive study drug|0
6849114|NCT00334737|10856255|FG000|Follow up Phase|Lost to Follow-up|5
6849115|NCT00334737|10856256|FG001|Follow up Phase|Lost to Follow-up|3
6849116|NCT00334737|10856257|FG002|Follow up Phase|Lost to Follow-up|6
6849117|NCT00334802|10856267|FG000|Overall Study|Progressive Disease|2
6849118|NCT00334802|10856268|FG001|Overall Study|Progressive Disease|24
6849119|NCT00334802|10856267|FG000|Overall Study|Toxicity|1
6849120|NCT00334802|10856268|FG001|Overall Study|Toxicity|5
6849121|NCT00334802|10856267|FG000|Overall Study|Lack of Efficacy|1
6849122|NCT00334802|10856268|FG001|Overall Study|Lack of Efficacy|3
6849123|NCT00334802|10856267|FG000|Overall Study|Patient Condition Aggrevated|1
6849124|NCT00334802|10856268|FG001|Overall Study|Patient Condition Aggrevated|0
6849125|NCT00334802|10856267|FG000|Overall Study|Physician Decision|1
6849126|NCT00334802|10856268|FG001|Overall Study|Physician Decision|0
6849127|NCT00334802|10856267|FG000|Overall Study|Withdrawal by Subject|0
6849128|NCT00334802|10856268|FG001|Overall Study|Withdrawal by Subject|4
6849129|NCT00334802|10856267|FG000|Overall Study|Adverse Event|0
6849130|NCT00334802|10856268|FG001|Overall Study|Adverse Event|3
6849131|NCT00334802|10856267|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0
6849132|NCT00334802|10856268|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1
6849133|NCT00334893|10856279|FG000|Overall Study|Not Treated|1
6849134|NCT00334893|10856280|FG001|Overall Study|Not Treated|0
6849135|NCT00334958|10856290|FG000|Overall Study|Medication Noncompliance|0
6849136|NCT00334958|10856291|FG001|Overall Study|Medication Noncompliance|3
6849137|NCT00334958|10856290|FG000|Overall Study|Protocol Violation|2
6849138|NCT00334958|10856291|FG001|Overall Study|Protocol Violation|2
6849139|NCT00334958|10856290|FG000|Overall Study|Request of the investigator or sponsor|0
6849140|NCT00334958|10856291|FG001|Overall Study|Request of the investigator or sponsor|1
6849141|NCT00334958|10856290|FG000|Overall Study|Withdrawal by Subject|7
6849142|NCT00334958|10856291|FG001|Overall Study|Withdrawal by Subject|4
6849143|NCT00334958|10856290|FG000|Overall Study|Adverse Event|27
6849144|NCT00334958|10856291|FG001|Overall Study|Adverse Event|12
6849145|NCT00334958|10856290|FG000|Overall Study|Other|1
6849146|NCT00334958|10856291|FG001|Overall Study|Other|2
6849147|NCT00335140|10856297|FG000|Overall Study|Ineligible|1
6849148|NCT00335153|10856301|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5
6849149|NCT00335153|10856301|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5
6849150|NCT00335153|10856301|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12
6849151|NCT00335153|10856301|FG000|Nasojejunal (NJ) Test Period|Administrative|1
6849152|NCT00335153|10856301|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7
6849153|NCT00335153|10856301|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22
6849154|NCT00335153|10856301|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2
6849155|NCT00335153|10856301|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13
6849156|NCT00335153|10856301|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13
6849157|NCT00335153|10856301|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2
6849158|NCT00335322|10856336|FG000|Overall Study|Randomised but withdrew prior to ART sta|1
6849159|NCT00335322|10856337|FG001|Overall Study|Randomised but withdrew prior to ART sta|2
6849160|NCT00335322|10856338|FG002|Overall Study|Randomised but withdrew prior to ART sta|2
6849161|NCT00335452|10856353|FG000|Overall Study|Death|156
6849162|NCT00335452|10856354|FG001|Overall Study|Death|144
6849163|NCT00335452|10856355|FG002|Overall Study|Death|158
6849164|NCT00335452|10856356|FG003|Overall Study|Death|129
6849165|NCT00335452|10856353|FG000|Overall Study|Lost to Follow-up|2
6849166|NCT00335452|10856354|FG001|Overall Study|Lost to Follow-up|3
6849167|NCT00335452|10856355|FG002|Overall Study|Lost to Follow-up|1
6849168|NCT00335452|10856356|FG003|Overall Study|Lost to Follow-up|2
6849169|NCT00335556|10856402|FG000|Overall Study|Death|0
6849170|NCT00335556|10856403|FG001|Overall Study|Death|5
6849171|NCT00335556|10856404|FG002|Overall Study|Death|0
6849172|NCT00335556|10856405|FG003|Overall Study|Death|0
6849173|NCT00335556|10856406|FG004|Overall Study|Death|1
6849174|NCT00335556|10856407|FG005|Overall Study|Death|0
6849175|NCT00335556|10856402|FG000|Overall Study|Lack of Efficacy|0
6849176|NCT00335556|10856403|FG001|Overall Study|Lack of Efficacy|19
6849177|NCT00335556|10856404|FG002|Overall Study|Lack of Efficacy|3
6849178|NCT00335556|10856405|FG003|Overall Study|Lack of Efficacy|3
6849179|NCT00335556|10856406|FG004|Overall Study|Lack of Efficacy|0
6849180|NCT00335556|10856407|FG005|Overall Study|Lack of Efficacy|1
6849181|NCT00335556|10856402|FG000|Overall Study|Physician Decision|0
6849182|NCT00335556|10856403|FG001|Overall Study|Physician Decision|6
6849183|NCT00335556|10856404|FG002|Overall Study|Physician Decision|2
6849184|NCT00335556|10856405|FG003|Overall Study|Physician Decision|1
6849185|NCT00335556|10856406|FG004|Overall Study|Physician Decision|0
6849186|NCT00335556|10856407|FG005|Overall Study|Physician Decision|0
6849187|NCT00335556|10856402|FG000|Overall Study|Ineligible|2
6849188|NCT00335556|10856403|FG001|Overall Study|Ineligible|0
6849189|NCT00335556|10856404|FG002|Overall Study|Ineligible|0
6849190|NCT00335556|10856405|FG003|Overall Study|Ineligible|0
6849191|NCT00335556|10856406|FG004|Overall Study|Ineligible|0
6849192|NCT00335556|10856407|FG005|Overall Study|Ineligible|0
6849193|NCT00335556|10856402|FG000|Overall Study|Refusal of further protocol therapy|0
6849194|NCT00335556|10856403|FG001|Overall Study|Refusal of further protocol therapy|4
6849195|NCT00335556|10856404|FG002|Overall Study|Refusal of further protocol therapy|0
6849196|NCT00335556|10856405|FG003|Overall Study|Refusal of further protocol therapy|1
6849197|NCT00335556|10856406|FG004|Overall Study|Refusal of further protocol therapy|0
6849198|NCT00335556|10856407|FG005|Overall Study|Refusal of further protocol therapy|0
6849199|NCT00335738|10856438|FG000|Overall Study|Physician Decision|6
6849200|NCT00335738|10856439|FG001|Overall Study|Physician Decision|0
6849201|NCT00335738|10856438|FG000|Overall Study|Withdrawal by Subject|2
6849202|NCT00335738|10856439|FG001|Overall Study|Withdrawal by Subject|0
6849203|NCT00335738|10856438|FG000|Overall Study|Ineligible|3
6849204|NCT00335738|10856439|FG001|Overall Study|Ineligible|4
6849205|NCT00335764|10856451|FG000|Overall Study|wrong histology|1
6849206|NCT00335764|10856452|FG001|Overall Study|wrong histology|0
6849207|NCT00335764|10856453|FG002|Overall Study|wrong histology|0
6849208|NCT00335764|10856454|FG003|Overall Study|wrong histology|0
6849209|NCT00335764|10856455|FG004|Overall Study|wrong histology|1
6849210|NCT00335829|10856491|FG000|Overall Study|Withdrawal by Subject|1
6849211|NCT00335829|10856491|FG000|Overall Study|Lost to Follow-up|1
6849212|NCT00335829|10856491|FG000|Overall Study|Adverse Event|1
6849213|NCT00335959|10856495|FG000|Overall Study|Adverse Event|2
6849214|NCT00335959|10856495|FG000|Overall Study|Ineligible|1
6849215|NCT00335972|10856502|FG000|Overall Study|not given treatments|0
6849216|NCT00335972|10856503|FG001|Overall Study|not given treatments|3
6849217|NCT00336024|10856511|FG000|Overall Study|Death|2
6849218|NCT00336024|10856512|FG001|Overall Study|Death|1
6849219|NCT00336024|10856511|FG000|Overall Study|Physician Decision|4
6849220|NCT00336024|10856512|FG001|Overall Study|Physician Decision|1
6849221|NCT00336024|10856511|FG000|Overall Study|Protocol Violation|1
6849222|NCT00336024|10856512|FG001|Overall Study|Protocol Violation|0
6849223|NCT00336024|10856511|FG000|Overall Study|Withdrawal by Subject|1
6849224|NCT00336024|10856512|FG001|Overall Study|Withdrawal by Subject|2
6849225|NCT00336024|10856511|FG000|Overall Study|Failure to fulfill consolidation|1
6849226|NCT00336024|10856512|FG001|Overall Study|Failure to fulfill consolidation|1
6849227|NCT00336024|10856511|FG000|Overall Study|Progressive Disease|4
6849228|NCT00336024|10856512|FG001|Overall Study|Progressive Disease|7
6849229|NCT00336024|10856511|FG000|Overall Study|Ineligible|7
6849230|NCT00336024|10856512|FG001|Overall Study|Ineligible|7
6849231|NCT00336284|10856524|FG000|Overall Study|Death|52
6849232|NCT00336284|10856525|FG001|Overall Study|Death|26
6849233|NCT00336284|10856524|FG000|Overall Study|Lost to Follow-up|82
6849234|NCT00336284|10856525|FG001|Overall Study|Lost to Follow-up|61
6849235|NCT00336284|10856524|FG000|Overall Study|Withdrawal by Physician or Subject|102
6849236|NCT00336284|10856525|FG001|Overall Study|Withdrawal by Physician or Subject|64
6849237|NCT00336479|10856560|FG000|Overall Study|Adverse Event|8
6849238|NCT00336479|10856561|FG001|Overall Study|Adverse Event|11
6849239|NCT00336479|10856562|FG002|Overall Study|Adverse Event|18
6849240|NCT00336479|10856563|FG003|Overall Study|Adverse Event|4
6849241|NCT00336479|10856560|FG000|Overall Study|Noncompliant|1
6849242|NCT00336479|10856561|FG001|Overall Study|Noncompliant|7
6849243|NCT00336479|10856562|FG002|Overall Study|Noncompliant|3
6849244|NCT00336479|10856563|FG003|Overall Study|Noncompliant|0
6849245|NCT00336479|10856560|FG000|Overall Study|Physician Decision|2
6849246|NCT00336479|10856561|FG001|Overall Study|Physician Decision|3
6849247|NCT00336479|10856562|FG002|Overall Study|Physician Decision|1
6849248|NCT00336479|10856563|FG003|Overall Study|Physician Decision|0
6849249|NCT00336479|10856560|FG000|Overall Study|Lost to Follow-up|3
6849250|NCT00336479|10856561|FG001|Overall Study|Lost to Follow-up|2
6849251|NCT00336479|10856562|FG002|Overall Study|Lost to Follow-up|0
7077516|NCT02092961|11185129|FG002|Overall Study|Study stopped|12
7077517|NCT02092961|11185127|FG000|Overall Study|Lack of therapeutic response|2
7077518|NCT02092961|11185128|FG001|Overall Study|Lack of therapeutic response|1
7077519|NCT02092961|11185129|FG002|Overall Study|Lack of therapeutic response|3
7077520|NCT02092961|11185127|FG000|Overall Study|Dev. of study specific discont. criteria|3
7077521|NCT02092961|11185128|FG001|Overall Study|Dev. of study specific discont. criteria|0
7077522|NCT02092961|11185129|FG002|Overall Study|Dev. of study specific discont. criteria|0
7077523|NCT02092961|11185127|FG000|Overall Study|Adverse Event|2
7077524|NCT02092961|11185128|FG001|Overall Study|Adverse Event|4
7077525|NCT02092961|11185129|FG002|Overall Study|Adverse Event|0
7077526|NCT02093026|11185150|FG000|Overall Study|Adverse Event|26
7077527|NCT02093026|11185150|FG000|Overall Study|Death|10
7077528|NCT02093026|11185150|FG000|Overall Study|Other|157
6849252|NCT00336479|10856563|FG003|Overall Study|Lost to Follow-up|0
6849253|NCT00336479|10856560|FG000|Overall Study|Withdrawal by Subject|3
6849254|NCT00336479|10856561|FG001|Overall Study|Withdrawal by Subject|2
6849255|NCT00336479|10856562|FG002|Overall Study|Withdrawal by Subject|3
6849256|NCT00336479|10856563|FG003|Overall Study|Withdrawal by Subject|0
6849257|NCT00336479|10856560|FG000|Overall Study|Other|0
6849258|NCT00336479|10856561|FG001|Overall Study|Other|0
6849259|NCT00336479|10856562|FG002|Overall Study|Other|1
6849260|NCT00336479|10856563|FG003|Overall Study|Other|0
6849261|NCT00336479|10856560|FG000|Overall Study|Virologic Stopping Rule|20
6849262|NCT00336479|10856561|FG001|Overall Study|Virologic Stopping Rule|0
6849263|NCT00336479|10856562|FG002|Overall Study|Virologic Stopping Rule|0
6849264|NCT00336479|10856563|FG003|Overall Study|Virologic Stopping Rule|0
7077529|NCT02093221|11185160|FG000|Overall Study|Adverse Event|1
7077530|NCT02093221|11185161|FG001|Overall Study|Adverse Event|0
7077531|NCT02093221|11185162|FG002|Overall Study|Adverse Event|0
7077532|NCT02093221|11185163|FG003|Overall Study|Adverse Event|0
7077533|NCT02093221|11185164|FG004|Overall Study|Adverse Event|0
7077534|NCT02093221|11185160|FG000|Overall Study|Withdrawal by Subject|1
7077535|NCT02093221|11185161|FG001|Overall Study|Withdrawal by Subject|1
7077536|NCT02093221|11185162|FG002|Overall Study|Withdrawal by Subject|4
7077537|NCT02093221|11185163|FG003|Overall Study|Withdrawal by Subject|1
7077538|NCT02093221|11185164|FG004|Overall Study|Withdrawal by Subject|1
7077539|NCT02093221|11185160|FG000|Overall Study|Lost to Follow-up|2
7077540|NCT02093221|11185161|FG001|Overall Study|Lost to Follow-up|0
7077541|NCT02093221|11185162|FG002|Overall Study|Lost to Follow-up|1
7077542|NCT02093221|11185163|FG003|Overall Study|Lost to Follow-up|1
7077543|NCT02093221|11185164|FG004|Overall Study|Lost to Follow-up|0
7077544|NCT02093221|11185160|FG000|Overall Study|Death|0
7077545|NCT02093221|11185161|FG001|Overall Study|Death|1
7077546|NCT02093221|11185162|FG002|Overall Study|Death|0
7077547|NCT02093221|11185163|FG003|Overall Study|Death|0
7077548|NCT02093221|11185164|FG004|Overall Study|Death|0
7077549|NCT02093221|11185160|FG000|Overall Study|Protocol Violation|0
7077550|NCT02093221|11185161|FG001|Overall Study|Protocol Violation|1
7077551|NCT02093221|11185162|FG002|Overall Study|Protocol Violation|0
7077552|NCT02093221|11185163|FG003|Overall Study|Protocol Violation|0
7077553|NCT02093221|11185164|FG004|Overall Study|Protocol Violation|0
7077554|NCT02093221|11185160|FG000|Overall Study|Study termination|6
7077555|NCT02093221|11185161|FG001|Overall Study|Study termination|5
7077556|NCT02093221|11185162|FG002|Overall Study|Study termination|4
7077557|NCT02093221|11185163|FG003|Overall Study|Study termination|6
7077558|NCT02093221|11185164|FG004|Overall Study|Study termination|7
7077559|NCT02093351|11185192|FG000|Part A|Adverse Event|0
7077560|NCT02093351|11185193|FG001|Part A|Adverse Event|1
7077561|NCT02093351|11185194|FG002|Part A|Adverse Event|1
7077562|NCT02093351|11185195|FG003|Part A|Adverse Event|0
7077563|NCT02093351|11185192|FG000|Part A|Condition under investigation worsened|2
7077564|NCT02093351|11185193|FG001|Part A|Condition under investigation worsened|0
7077565|NCT02093351|11185194|FG002|Part A|Condition under investigation worsened|2
7077566|NCT02093351|11185195|FG003|Part A|Condition under investigation worsened|0
7077567|NCT02093351|11185192|FG000|Part A|Death|0
7077568|NCT02093351|11185193|FG001|Part A|Death|1
7077569|NCT02093351|11185194|FG002|Part A|Death|0
6849265|NCT00336492|10856577|FG000|Overall Study|Adverse Event|4
6849266|NCT00336492|10856578|FG001|Overall Study|Adverse Event|3
6849267|NCT00336492|10856579|FG002|Overall Study|Adverse Event|6
6849268|NCT00336492|10856577|FG000|Overall Study|Lack of Efficacy|6
6849269|NCT00336492|10856578|FG001|Overall Study|Lack of Efficacy|1
6849270|NCT00336492|10856579|FG002|Overall Study|Lack of Efficacy|4
6849271|NCT00336492|10856577|FG000|Overall Study|Other|5
6849272|NCT00336492|10856578|FG001|Overall Study|Other|0
6849273|NCT00336492|10856579|FG002|Overall Study|Other|1
6849274|NCT00336505|10856589|FG000|Overall Study|Adverse Event|10
6849275|NCT00336505|10856590|FG001|Overall Study|Adverse Event|9
6849276|NCT00336505|10856589|FG000|Overall Study|Lack of Efficacy|8
6849277|NCT00336505|10856590|FG001|Overall Study|Lack of Efficacy|4
6849278|NCT00336505|10856589|FG000|Overall Study|Lost to Follow-up|7
6849279|NCT00336505|10856590|FG001|Overall Study|Lost to Follow-up|4
6849280|NCT00336505|10856589|FG000|Overall Study|Withdrawal by Subject|5
6849281|NCT00336505|10856590|FG001|Overall Study|Withdrawal by Subject|3
6849282|NCT00336505|10856589|FG000|Overall Study|Other|7
6849283|NCT00336505|10856590|FG001|Overall Study|Other|7
6849284|NCT00336544|10856598|FG000|Overall Study|Lack of Efficacy|8
6849285|NCT00336544|10856599|FG001|Overall Study|Lack of Efficacy|5
6849286|NCT00336544|10856598|FG000|Overall Study|Adverse Event|4
6849287|NCT00336544|10856599|FG001|Overall Study|Adverse Event|9
6849288|NCT00336544|10856598|FG000|Overall Study|Withdrawal by Subject|4
6849289|NCT00336544|10856599|FG001|Overall Study|Withdrawal by Subject|3
6849290|NCT00336544|10856598|FG000|Overall Study|Other|3
6849291|NCT00336544|10856599|FG001|Overall Study|Other|5
7077570|NCT02093351|11185195|FG003|Part A|Death|0
7077571|NCT02093351|11185192|FG000|Part B|Patient decision|0
7077572|NCT02093351|11185193|FG001|Part B|Patient decision|0
7077573|NCT02093351|11185194|FG002|Part B|Patient decision|0
7077574|NCT02093351|11185195|FG003|Part B|Patient decision|3
7077575|NCT02093351|11185192|FG000|Part B|Disease progression|0
7077576|NCT02093351|11185193|FG001|Part B|Disease progression|0
7077577|NCT02093351|11185194|FG002|Part B|Disease progression|0
7077578|NCT02093351|11185195|FG003|Part B|Disease progression|4
6849292|NCT00336583|10856605|FG000|Overall Study|Lost to Follow-up|1
6849293|NCT00336583|10856605|FG000|Overall Study|Death|1
6849294|NCT00336856|10856624|FG000|Overall Study|Withdrawal by Subject|3
6849295|NCT00336856|10856624|FG000|Overall Study|Found ineligible at time of analysis|1
6849296|NCT00336895|10856628|FG000|Overall Study|diarrhea|1
6849297|NCT00336895|10856628|FG000|Overall Study|nausea and upset stomach|1
6849298|NCT00336895|10856628|FG000|Overall Study|Physician Decision|1
6849299|NCT00336895|10856628|FG000|Overall Study|screen failed|1
6849300|NCT00337077|10856635|FG000|Overall Study|Progressive disease|25
7077579|NCT02093351|11185192|FG000|Part B|Complete response|0
7077580|NCT02093351|11185193|FG001|Part B|Complete response|0
7077581|NCT02093351|11185194|FG002|Part B|Complete response|0
7077582|NCT02093351|11185195|FG003|Part B|Complete response|1
6849301|NCT00337077|10856636|FG001|Overall Study|Progressive disease|37
6849302|NCT00337077|10856637|FG002|Overall Study|Progressive disease|19
6849303|NCT00337077|10856635|FG000|Overall Study|Adverse Event|7
6849304|NCT00337077|10856636|FG001|Overall Study|Adverse Event|7
6849305|NCT00337077|10856637|FG002|Overall Study|Adverse Event|1
6849306|NCT00337077|10856635|FG000|Overall Study|Death|0
6849307|NCT00337077|10856636|FG001|Overall Study|Death|1
6849308|NCT00337077|10856637|FG002|Overall Study|Death|0
6849309|NCT00337077|10856635|FG000|Overall Study|Withdrawal by Subject|7
6849310|NCT00337077|10856636|FG001|Overall Study|Withdrawal by Subject|2
6849311|NCT00337077|10856637|FG002|Overall Study|Withdrawal by Subject|2
6849312|NCT00337077|10856635|FG000|Overall Study|Alternative therapy|1
6849313|NCT00337077|10856636|FG001|Overall Study|Alternative therapy|0
6849314|NCT00337077|10856637|FG002|Overall Study|Alternative therapy|0
6849315|NCT00337077|10856635|FG000|Overall Study|Physician Decision|1
6849316|NCT00337077|10856636|FG001|Overall Study|Physician Decision|4
6849317|NCT00337077|10856637|FG002|Overall Study|Physician Decision|2
6849318|NCT00337077|10856635|FG000|Overall Study|Never started treatment|1
6849319|NCT00337077|10856636|FG001|Overall Study|Never started treatment|1
6849320|NCT00337077|10856637|FG002|Overall Study|Never started treatment|0
6849321|NCT00337077|10856635|FG000|Overall Study|Ineligible|1
6849322|NCT00337077|10856636|FG001|Overall Study|Ineligible|1
6849323|NCT00337077|10856637|FG002|Overall Study|Ineligible|1
6849324|NCT00337103|10856645|FG000|Overall Study|Progressive Disease|414
6849325|NCT00337103|10856646|FG001|Overall Study|Progressive Disease|410
6849326|NCT00337103|10856645|FG000|Overall Study|Adverse Event|45
6849327|NCT00337103|10856646|FG001|Overall Study|Adverse Event|59
6849328|NCT00337103|10856645|FG000|Overall Study|Subject Choice|34
6849329|NCT00337103|10856646|FG001|Overall Study|Subject Choice|27
6849330|NCT00337103|10856645|FG000|Overall Study|Clinical Progression|27
6849331|NCT00337103|10856646|FG001|Overall Study|Clinical Progression|24
6849332|NCT00337103|10856645|FG000|Overall Study|Physician Decision|15
6849333|NCT00337103|10856646|FG001|Overall Study|Physician Decision|14
6849334|NCT00337103|10856645|FG000|Overall Study|Withdrawal by Subject|8
6849335|NCT00337103|10856646|FG001|Overall Study|Withdrawal by Subject|5
6849336|NCT00337103|10856645|FG000|Overall Study|Other|5
6849337|NCT00337103|10856646|FG001|Overall Study|Other|6
6849338|NCT00337103|10856645|FG000|Overall Study|Entry Criteria Not Met|4
6849339|NCT00337103|10856646|FG001|Overall Study|Entry Criteria Not Met|1
6849340|NCT00337103|10856645|FG000|Overall Study|Lost to Follow-up|1
6849341|NCT00337103|10856646|FG001|Overall Study|Lost to Follow-up|2
6849342|NCT00337103|10856645|FG000|Overall Study|Death|1
6849343|NCT00337103|10856646|FG001|Overall Study|Death|0
6849344|NCT00337129|10856653|FG000|Overall Study|Adverse Event|4
6849345|NCT00337129|10856653|FG000|Overall Study|Withdrawal by Subject|1
6849346|NCT00337129|10856653|FG000|Overall Study|Lack of Efficacy|32
6849347|NCT00337129|10856653|FG000|Overall Study|Death|2
6849348|NCT00337129|10856653|FG000|Overall Study|not protocol specified|1
6849349|NCT00337168|10856657|FG000|Overall Study|Death|5
6849350|NCT00337168|10856657|FG000|Overall Study|Not protocol specified|2
6849351|NCT00337168|10856657|FG000|Overall Study|Did not start therapy|1
6849352|NCT00337194|10856673|FG000|Overall Study|Adverse Event|5
6849353|NCT00337194|10856674|FG001|Overall Study|Adverse Event|1
6849354|NCT00337194|10856673|FG000|Overall Study|Death|2
6849355|NCT00337194|10856674|FG001|Overall Study|Death|0
6849356|NCT00337194|10856673|FG000|Overall Study|Withdrawal by Subject|1
6849357|NCT00337194|10856674|FG001|Overall Study|Withdrawal by Subject|0
6849358|NCT00337194|10856673|FG000|Overall Study|Disease progression|1
6849359|NCT00337194|10856674|FG001|Overall Study|Disease progression|2
6849360|NCT00337194|10856673|FG000|Overall Study|Subsequent non-protocol therapy|3
6849361|NCT00337194|10856674|FG001|Overall Study|Subsequent non-protocol therapy|1
6966616|NCT01125748|11014638|FG000|Overall Study|Lost to Follow-up|0
6966617|NCT01125748|11014639|FG001|Overall Study|Lost to Follow-up|1
6966618|NCT01125748|11014638|FG000|Overall Study|Physician Decision|8
6966619|NCT01125748|11014639|FG001|Overall Study|Physician Decision|7
6966620|NCT01125748|11014638|FG000|Overall Study|Patient Decision to Withdraw|2
6966621|NCT01125748|11014639|FG001|Overall Study|Patient Decision to Withdraw|4
6966622|NCT01125800|11014661|FG000|Phase I|Protocol Violation|0
6966623|NCT01125800|11014662|FG001|Phase I|Protocol Violation|3
6966624|NCT01125800|11014663|FG002|Phase I|Protocol Violation|1
6966625|NCT01125800|11014664|FG003|Phase I|Protocol Violation|1
6966626|NCT01125800|11014665|FG004|Phase I|Protocol Violation|0
6966627|NCT01125800|11014661|FG000|Phase I|Adverse Event|2
6966628|NCT01125800|11014662|FG001|Phase I|Adverse Event|2
6966629|NCT01125800|11014663|FG002|Phase I|Adverse Event|1
6966630|NCT01125800|11014664|FG003|Phase I|Adverse Event|7
6966631|NCT01125800|11014665|FG004|Phase I|Adverse Event|0
6966632|NCT01125800|11014661|FG000|Phase I|Administrative problems|1
6966633|NCT01125800|11014662|FG001|Phase I|Administrative problems|0
6966634|NCT01125800|11014663|FG002|Phase I|Administrative problems|0
6966635|NCT01125800|11014664|FG003|Phase I|Administrative problems|0
6966636|NCT01125800|11014665|FG004|Phase I|Administrative problems|0
6966637|NCT01125800|11014661|FG000|Phase I|Withdrawal by Subject|0
6966638|NCT01125800|11014662|FG001|Phase I|Withdrawal by Subject|0
6966639|NCT01125800|11014663|FG002|Phase I|Withdrawal by Subject|1
6966640|NCT01125800|11014664|FG003|Phase I|Withdrawal by Subject|0
6966641|NCT01125800|11014665|FG004|Phase I|Withdrawal by Subject|0
6966642|NCT01125800|11014661|FG000|Phase I|Disease progression|5
6849362|NCT00337207|10856682|FG000|Overall Study|Withdrawal by Subject|3
6849363|NCT00337272|10856689|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2
7152589|NCT03260205|11317582|FG002|Overall Study|Other: Unspecified|3
7152590|NCT03260205|11317583|FG003|Overall Study|Other: Unspecified|1
6849364|NCT00337272|10856690|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0
6849365|NCT00337272|10856689|FG000|Screening Period (Pre-randomization)|Non-compliance|1
6849366|NCT00337272|10856690|FG001|Screening Period (Pre-randomization)|Non-compliance|0
6849367|NCT00337272|10856689|FG000|Screening Period (Pre-randomization)|Screen failure|3
6849368|NCT00337272|10856690|FG001|Screening Period (Pre-randomization)|Screen failure|0
6849369|NCT00337272|10856689|FG000|Treatment Period|Non-compliance|1
6849370|NCT00337272|10856690|FG001|Treatment Period|Non-compliance|1
6849371|NCT00337272|10856689|FG000|Treatment Period|Withdrawal by Subject|0
6849372|NCT00337272|10856690|FG001|Treatment Period|Withdrawal by Subject|1
6849373|NCT00337272|10856689|FG000|Withdrawal Period|Non-compliance|0
6966643|NCT01125800|11014662|FG001|Phase I|Disease progression|4
6966644|NCT01125800|11014663|FG002|Phase I|Disease progression|1
6966645|NCT01125800|11014664|FG003|Phase I|Disease progression|3
6966646|NCT01125800|11014665|FG004|Phase I|Disease progression|0
6966647|NCT01125800|11014661|FG000|Phase II|Protocol Violation|0
6966648|NCT01125800|11014662|FG001|Phase II|Protocol Violation|0
6966649|NCT01125800|11014663|FG002|Phase II|Protocol Violation|0
6966650|NCT01125800|11014664|FG003|Phase II|Protocol Violation|0
6966651|NCT01125800|11014665|FG004|Phase II|Protocol Violation|1
6966652|NCT01125800|11014661|FG000|Phase II|Adverse Event|0
6966653|NCT01125800|11014662|FG001|Phase II|Adverse Event|0
6966654|NCT01125800|11014663|FG002|Phase II|Adverse Event|0
6966655|NCT01125800|11014664|FG003|Phase II|Adverse Event|0
6966656|NCT01125800|11014665|FG004|Phase II|Adverse Event|2
6966657|NCT01125800|11014661|FG000|Phase II|Disease progression|0
6966658|NCT01125800|11014662|FG001|Phase II|Disease progression|0
6966659|NCT01125800|11014663|FG002|Phase II|Disease progression|0
6966660|NCT01125800|11014664|FG003|Phase II|Disease progression|1
6966661|NCT01125800|11014665|FG004|Phase II|Disease progression|8
6966662|NCT01125813|11014680|FG000|Overall Study|Death|1
6966663|NCT01125813|11014680|FG000|Overall Study|Withdrawal by Subject|1
6966664|NCT01125813|11014680|FG000|Overall Study|Screen Failures|4
6966665|NCT01125917|11014684|FG000|Overall Study|Adverse Event|43
6966666|NCT01125917|11014684|FG000|Overall Study|Lost to Follow-up|23
6966667|NCT01125917|11014684|FG000|Overall Study|Withdrawal by Subject|31
7152591|NCT03260205|11317584|FG004|Overall Study|Other: Unspecified|1
7152592|NCT03260205|11317580|FG000|Overall Study|Participant Who Did Not Received AnyDose|1
6849374|NCT00337272|10856690|FG001|Withdrawal Period|Non-compliance|1
6849375|NCT00337285|10856696|FG000|Overall Study|Withdrawal by Subject|42
6849376|NCT00337285|10856696|FG000|Overall Study|Lost to Follow-up|41
6849377|NCT00337285|10856696|FG000|Overall Study|Adverse Event|28
6849378|NCT00337285|10856696|FG000|Overall Study|Protocol Violation|27
6849379|NCT00337285|10856696|FG000|Overall Study|Lack of Efficacy|11
6849380|NCT00337285|10856696|FG000|Overall Study|Death|1
6849381|NCT00337285|10856696|FG000|Overall Study|Physician Decision|1
6849382|NCT00337285|10856696|FG000|Overall Study|Lack of protocol compliance|7
6849383|NCT00337428|10856711|FG000|Overall Study|Withdrawal by Subject|1
6849384|NCT00337428|10856712|FG001|Overall Study|Withdrawal by Subject|2
6849385|NCT00337428|10856711|FG000|Overall Study|Lack of Time|1
6849386|NCT00337428|10856712|FG001|Overall Study|Lack of Time|1
6849387|NCT00337428|10856711|FG000|Overall Study|Unwilling to Continue|1
6849388|NCT00337428|10856712|FG001|Overall Study|Unwilling to Continue|0
6849389|NCT00337428|10856711|FG000|Overall Study|Anorexia|1
6849390|NCT00337428|10856712|FG001|Overall Study|Anorexia|0
6849391|NCT00337467|10856718|FG000|Overall Study|Adverse Event|3
6849392|NCT00337467|10856718|FG000|Overall Study|Subject Withdrew Consent|2
6849393|NCT00337467|10856718|FG000|Overall Study|Pregnancy|1
6849394|NCT00337467|10856718|FG000|Overall Study|Lost to Follow-up|2
6849395|NCT00337467|10856718|FG000|Overall Study|Subject No Longer Met Study Criteria|2
6849396|NCT00337571|10856729|FG000|Overall Study|Lack of Efficacy|3
6849397|NCT00337571|10856730|FG001|Overall Study|Lack of Efficacy|0
6849398|NCT00337571|10856731|FG002|Overall Study|Lack of Efficacy|0
6849399|NCT00337571|10856732|FG003|Overall Study|Lack of Efficacy|0
6849400|NCT00337571|10856729|FG000|Overall Study|Adverse Event|4
6849401|NCT00337571|10856730|FG001|Overall Study|Adverse Event|5
6849402|NCT00337571|10856731|FG002|Overall Study|Adverse Event|8
6849403|NCT00337571|10856732|FG003|Overall Study|Adverse Event|4
6849404|NCT00337571|10856729|FG000|Overall Study|Withdrawal by Subject|2
6849405|NCT00337571|10856730|FG001|Overall Study|Withdrawal by Subject|2
6849406|NCT00337571|10856731|FG002|Overall Study|Withdrawal by Subject|1
6849407|NCT00337571|10856732|FG003|Overall Study|Withdrawal by Subject|0
6849408|NCT00337571|10856729|FG000|Overall Study|Lost to Follow-up|3
6849409|NCT00337571|10856730|FG001|Overall Study|Lost to Follow-up|1
6849410|NCT00337571|10856731|FG002|Overall Study|Lost to Follow-up|0
6849411|NCT00337571|10856732|FG003|Overall Study|Lost to Follow-up|1
6849412|NCT00337571|10856729|FG000|Overall Study|Poor/noncompliance|1
6966668|NCT01125917|11014684|FG000|Overall Study|Administrative|223
6966669|NCT01125917|11014684|FG000|Overall Study|Lack of Efficacy|19
6966670|NCT01125930|11014690|FG000|Overall Study|Adverse Event|0
6966671|NCT01125930|11014691|FG001|Overall Study|Adverse Event|1
6849413|NCT00337571|10856730|FG001|Overall Study|Poor/noncompliance|1
6849414|NCT00337571|10856731|FG002|Overall Study|Poor/noncompliance|1
6849415|NCT00337571|10856732|FG003|Overall Study|Poor/noncompliance|1
6849416|NCT00337571|10856729|FG000|Overall Study|No longer met study criteria|1
6849417|NCT00337571|10856730|FG001|Overall Study|No longer met study criteria|0
6849418|NCT00337571|10856731|FG002|Overall Study|No longer met study criteria|0
6849419|NCT00337571|10856732|FG003|Overall Study|No longer met study criteria|0
6849420|NCT00337571|10856729|FG000|Overall Study|High Potassium level|0
6849421|NCT00337571|10856730|FG001|Overall Study|High Potassium level|0
6849422|NCT00337571|10856731|FG002|Overall Study|High Potassium level|0
6849423|NCT00337571|10856732|FG003|Overall Study|High Potassium level|1
6849424|NCT00337610|10856744|FG000|Overall Study|Adverse Event|2
6849425|NCT00337610|10856745|FG001|Overall Study|Adverse Event|2
6849426|NCT00337610|10856744|FG000|Overall Study|Death|0
6849427|NCT00337610|10856745|FG001|Overall Study|Death|1
6849428|NCT00337610|10856744|FG000|Overall Study|Lack of Efficacy|6
6849429|NCT00337610|10856745|FG001|Overall Study|Lack of Efficacy|3
6849430|NCT00337610|10856744|FG000|Overall Study|Lost to Follow-up|3
6849431|NCT00337610|10856745|FG001|Overall Study|Lost to Follow-up|3
6849432|NCT00337610|10856744|FG000|Overall Study|Withdrawal by Subject|6
6849433|NCT00337610|10856745|FG001|Overall Study|Withdrawal by Subject|5
6849434|NCT00337662|10856754|FG000|Study Period II|Lost to Follow-up|0
6849435|NCT00337662|10856755|FG001|Study Period II|Lost to Follow-up|0
6849436|NCT00337662|10856756|FG002|Study Period II|Lost to Follow-up|0
6849437|NCT00337662|10856757|FG003|Study Period II|Lost to Follow-up|35
6849438|NCT00337662|10856754|FG000|Study Period II|Withdrawal by Subject|0
6849439|NCT00337662|10856755|FG001|Study Period II|Withdrawal by Subject|0
6849440|NCT00337662|10856756|FG002|Study Period II|Withdrawal by Subject|0
6849441|NCT00337662|10856757|FG003|Study Period II|Withdrawal by Subject|20
6849442|NCT00337662|10856754|FG000|Study Period II|Adverse Event|0
6849443|NCT00337662|10856755|FG001|Study Period II|Adverse Event|0
6849444|NCT00337662|10856756|FG002|Study Period II|Adverse Event|0
6849445|NCT00337662|10856757|FG003|Study Period II|Adverse Event|16
6849446|NCT00337662|10856754|FG000|Study Period II|Physician Decision|0
6849447|NCT00337662|10856755|FG001|Study Period II|Physician Decision|0
6849448|NCT00337662|10856756|FG002|Study Period II|Physician Decision|0
6849449|NCT00337662|10856757|FG003|Study Period II|Physician Decision|13
6849450|NCT00337662|10856754|FG000|Study Period II|Entry Criteria Not Met|0
6849451|NCT00337662|10856755|FG001|Study Period II|Entry Criteria Not Met|0
6849452|NCT00337662|10856756|FG002|Study Period II|Entry Criteria Not Met|0
6849453|NCT00337662|10856757|FG003|Study Period II|Entry Criteria Not Met|6
6849454|NCT00337662|10856754|FG000|Study Period II|Protocol Violation|0
6849455|NCT00337662|10856755|FG001|Study Period II|Protocol Violation|0
6849456|NCT00337662|10856756|FG002|Study Period II|Protocol Violation|0
6849457|NCT00337662|10856757|FG003|Study Period II|Protocol Violation|6
6849458|NCT00337662|10856754|FG000|Study Period II|Lack of Efficacy|0
6849459|NCT00337662|10856755|FG001|Study Period II|Lack of Efficacy|0
6849460|NCT00337662|10856756|FG002|Study Period II|Lack of Efficacy|0
6849461|NCT00337662|10856757|FG003|Study Period II|Lack of Efficacy|7
6849462|NCT00337662|10856754|FG000|Study Period II|Sponsor Decision|0
6849463|NCT00337662|10856755|FG001|Study Period II|Sponsor Decision|0
6849464|NCT00337662|10856756|FG002|Study Period II|Sponsor Decision|0
6849465|NCT00337662|10856757|FG003|Study Period II|Sponsor Decision|2
6849466|NCT00337662|10856754|FG000|Study Period II|Parent/Caregiver Decision|0
6849467|NCT00337662|10856755|FG001|Study Period II|Parent/Caregiver Decision|0
6849468|NCT00337662|10856756|FG002|Study Period II|Parent/Caregiver Decision|0
6849469|NCT00337662|10856757|FG003|Study Period II|Parent/Caregiver Decision|1
6849470|NCT00337662|10856754|FG000|Study Period III|Lost to Follow-up|14
6849471|NCT00337662|10856755|FG001|Study Period III|Lost to Follow-up|16
6849472|NCT00337662|10856756|FG002|Study Period III|Lost to Follow-up|14
6849473|NCT00337662|10856757|FG003|Study Period III|Lost to Follow-up|0
6849474|NCT00337662|10856754|FG000|Study Period III|Withdrawal by Subject|18
6849475|NCT00337662|10856755|FG001|Study Period III|Withdrawal by Subject|14
6849476|NCT00337662|10856756|FG002|Study Period III|Withdrawal by Subject|12
6849477|NCT00337662|10856757|FG003|Study Period III|Withdrawal by Subject|0
6849478|NCT00337662|10856754|FG000|Study Period III|Adverse Event|9
6849479|NCT00337662|10856755|FG001|Study Period III|Adverse Event|10
6849480|NCT00337662|10856756|FG002|Study Period III|Adverse Event|8
6849481|NCT00337662|10856757|FG003|Study Period III|Adverse Event|0
6849482|NCT00337662|10856754|FG000|Study Period III|Protocol Violation|3
6849483|NCT00337662|10856755|FG001|Study Period III|Protocol Violation|8
6849484|NCT00337662|10856756|FG002|Study Period III|Protocol Violation|2
6849485|NCT00337662|10856757|FG003|Study Period III|Protocol Violation|0
6849486|NCT00337662|10856754|FG000|Study Period III|Physician Decision|6
6849487|NCT00337662|10856755|FG001|Study Period III|Physician Decision|5
6849488|NCT00337662|10856756|FG002|Study Period III|Physician Decision|0
6849489|NCT00337662|10856757|FG003|Study Period III|Physician Decision|0
6849490|NCT00337662|10856754|FG000|Study Period III|Entry Criteria Not Met|4
6849491|NCT00337662|10856755|FG001|Study Period III|Entry Criteria Not Met|1
6849492|NCT00337662|10856756|FG002|Study Period III|Entry Criteria Not Met|3
6849493|NCT00337662|10856757|FG003|Study Period III|Entry Criteria Not Met|0
6849494|NCT00337662|10856754|FG000|Study Period III|Lack of Efficacy|4
6849495|NCT00337662|10856755|FG001|Study Period III|Lack of Efficacy|4
6849496|NCT00337662|10856756|FG002|Study Period III|Lack of Efficacy|2
7077583|NCT02093351|11185192|FG000|Part B|Adverse event + disease progression|0
7077584|NCT02093351|11185193|FG001|Part B|Adverse event + disease progression|0
7077585|NCT02093351|11185194|FG002|Part B|Adverse event + disease progression|0
7077586|NCT02093351|11185195|FG003|Part B|Adverse event + disease progression|1
7077587|NCT02093351|11185192|FG000|Part B|Lack of therapeutic response|0
6849497|NCT00337662|10856757|FG003|Study Period III|Lack of Efficacy|0
6849498|NCT00337662|10856754|FG000|Study Period III|Parent/Caregiver Decision|0
6849499|NCT00337662|10856755|FG001|Study Period III|Parent/Caregiver Decision|0
6849500|NCT00337662|10856756|FG002|Study Period III|Parent/Caregiver Decision|2
6849501|NCT00337662|10856757|FG003|Study Period III|Parent/Caregiver Decision|0
6849502|NCT00337662|10856754|FG000|Study Period III|Sponsor Decision|1
6849503|NCT00337662|10856755|FG001|Study Period III|Sponsor Decision|0
6849504|NCT00337662|10856756|FG002|Study Period III|Sponsor Decision|1
6849505|NCT00337662|10856757|FG003|Study Period III|Sponsor Decision|0
6849506|NCT00337662|10856754|FG000|Study Period III|Clinical Relapse|1
6849507|NCT00337662|10856755|FG001|Study Period III|Clinical Relapse|0
6849508|NCT00337662|10856756|FG002|Study Period III|Clinical Relapse|0
6849509|NCT00337662|10856757|FG003|Study Period III|Clinical Relapse|0
6849510|NCT00337727|10856770|FG000|Overall Study|Adverse Event|5
6849511|NCT00337727|10856771|FG001|Overall Study|Adverse Event|3
6849512|NCT00337727|10856770|FG000|Overall Study|Lost to Follow-up|5
6849513|NCT00337727|10856771|FG001|Overall Study|Lost to Follow-up|4
6849514|NCT00337727|10856770|FG000|Overall Study|Physician Decision|1
6849515|NCT00337727|10856771|FG001|Overall Study|Physician Decision|0
6849516|NCT00337727|10856770|FG000|Overall Study|Protocol Violation|4
6849517|NCT00337727|10856771|FG001|Overall Study|Protocol Violation|0
6849518|NCT00337727|10856770|FG000|Overall Study|Withdrawal by Subject|3
6849519|NCT00337727|10856771|FG001|Overall Study|Withdrawal by Subject|5
6849520|NCT00337779|10856779|FG000|Overall Study|Withdrawal by Subject|10
6849521|NCT00337779|10856780|FG001|Overall Study|Withdrawal by Subject|12
6849522|NCT00337779|10856779|FG000|Overall Study|Sponsor decision|1
6849523|NCT00337779|10856780|FG001|Overall Study|Sponsor decision|1
6849524|NCT00337779|10856779|FG000|Overall Study|Physician Decision|3
6849525|NCT00337779|10856780|FG001|Overall Study|Physician Decision|6
6849526|NCT00337779|10856779|FG000|Overall Study|Protocol Violation|1
6849527|NCT00337779|10856780|FG001|Overall Study|Protocol Violation|1
6849528|NCT00337779|10856779|FG000|Overall Study|Lost to Follow-up|6
6849529|NCT00337779|10856780|FG001|Overall Study|Lost to Follow-up|5
6849530|NCT00337779|10856779|FG000|Overall Study|Adverse Event|28
6849531|NCT00337779|10856780|FG001|Overall Study|Adverse Event|51
6849532|NCT00337779|10856779|FG000|Overall Study|Pregnancy|3
6849533|NCT00337779|10856780|FG001|Overall Study|Pregnancy|2
6849534|NCT00337779|10856779|FG000|Overall Study|Death|0
6849535|NCT00337779|10856780|FG001|Overall Study|Death|1
6849536|NCT00337818|10856789|FG000|Overall Study|Lost to Follow-up|289
6849537|NCT00337818|10856790|FG001|Overall Study|Lost to Follow-up|91
6849538|NCT00337818|10856791|FG002|Overall Study|Lost to Follow-up|107
6849539|NCT00337935|10856801|FG000|Overall Study|Adverse Event|2
6849540|NCT00337935|10856802|FG001|Overall Study|Adverse Event|5
6849541|NCT00337935|10856801|FG000|Overall Study|Death|2
6849542|NCT00337935|10856802|FG001|Overall Study|Death|8
6849543|NCT00337935|10856801|FG000|Overall Study|Physician Decision|1
6849544|NCT00337935|10856802|FG001|Overall Study|Physician Decision|1
6849545|NCT00337935|10856801|FG000|Overall Study|Lost to Follow-up|0
6849546|NCT00337935|10856802|FG001|Overall Study|Lost to Follow-up|1
6849547|NCT00337935|10856801|FG000|Overall Study|Protocol Violation|4
6849548|NCT00337935|10856802|FG001|Overall Study|Protocol Violation|3
6849549|NCT00337935|10856801|FG000|Overall Study|Withdrawal by Subject|1
6849550|NCT00337935|10856802|FG001|Overall Study|Withdrawal by Subject|7
6849551|NCT00337935|10856801|FG000|Overall Study|Other|0
6849552|NCT00337935|10856802|FG001|Overall Study|Other|1
6849553|NCT00337935|10856801|FG000|Overall Study|Lack of Efficacy|0
6849554|NCT00337935|10856802|FG001|Overall Study|Lack of Efficacy|1
6849555|NCT00338286|10856819|FG000|Overall Study|Withdrawal by Subject|50
6849556|NCT00338286|10856820|FG001|Overall Study|Withdrawal by Subject|54
6849557|NCT00338286|10856819|FG000|Overall Study|Lost to Follow-up|80
6849558|NCT00338286|10856820|FG001|Overall Study|Lost to Follow-up|66
7077588|NCT02093351|11185193|FG001|Part B|Lack of therapeutic response|0
7077589|NCT02093351|11185194|FG002|Part B|Lack of therapeutic response|0
6849559|NCT00338286|10856819|FG000|Overall Study|Other|103
6849560|NCT00338286|10856820|FG001|Overall Study|Other|93
6849561|NCT00338728|10856835|FG000|Overall Study|Screen Failure|14
6849562|NCT00338741|10856841|FG000|Overall Study|Lost to Follow-up|2
6849563|NCT00338741|10856842|FG001|Overall Study|Lost to Follow-up|0
6849564|NCT00338806|10856850|FG000|Acute Phase|Withdrawal by Subject|0
6849565|NCT00338806|10856851|FG001|Acute Phase|Withdrawal by Subject|1
6849566|NCT00338806|10856850|FG000|Follow-up|Lost to Follow-up|1
6849567|NCT00338806|10856851|FG001|Follow-up|Lost to Follow-up|3
6849568|NCT00338884|10856859|FG000|Overall Study|Objective Disease Progression or Relapse|44
6849569|NCT00338884|10856859|FG000|Overall Study|Adverse Event|14
6849570|NCT00338884|10856859|FG000|Overall Study|Death|8
6849571|NCT00338884|10856859|FG000|Overall Study|Other|4
6849572|NCT00338884|10856859|FG000|Overall Study|Global Deterioration of Health Status|3
6849573|NCT00338884|10856859|FG000|Overall Study|Withdrawal by Subject|3
6849574|NCT00338884|10856859|FG000|Overall Study|Lost to Follow-up|1
6849575|NCT00338884|10856859|FG000|Overall Study|Randomized But Did Not Receive Treatment|1
6849576|NCT00338949|10856865|FG000|Subject Screening|Screen failures|11
6849577|NCT00338949|10856866|FG001|Subject Screening|Screen failures|11
6849578|NCT00338949|10856865|FG000|Randomization|Withdrawal by Subject|1
6849579|NCT00338949|10856866|FG001|Randomization|Withdrawal by Subject|0
6849580|NCT00338949|10856865|FG000|Randomization|Adverse Event|0
6849581|NCT00338949|10856866|FG001|Randomization|Adverse Event|5
6849582|NCT00338962|10856876|FG000|Overall Study|Lost to Follow-up|3
6849583|NCT00338962|10856877|FG001|Overall Study|Lost to Follow-up|3
6849584|NCT00338962|10856878|FG002|Overall Study|Lost to Follow-up|2
6849585|NCT00338962|10856879|FG003|Overall Study|Lost to Follow-up|3
6849586|NCT00338962|10856876|FG000|Overall Study|Withdrawal by Subject|1
6849587|NCT00338962|10856877|FG001|Overall Study|Withdrawal by Subject|0
6849588|NCT00338962|10856878|FG002|Overall Study|Withdrawal by Subject|0
6849589|NCT00338962|10856879|FG003|Overall Study|Withdrawal by Subject|0
6849590|NCT00338962|10856876|FG000|Overall Study|No Transportation|2
6849591|NCT00338962|10856877|FG001|Overall Study|No Transportation|0
6849592|NCT00338962|10856878|FG002|Overall Study|No Transportation|0
6849593|NCT00338962|10856879|FG003|Overall Study|No Transportation|0
6849594|NCT00338962|10856876|FG000|Overall Study|Time Constraint|2
6849595|NCT00338962|10856877|FG001|Overall Study|Time Constraint|0
6849596|NCT00338962|10856878|FG002|Overall Study|Time Constraint|0
6849597|NCT00338962|10856879|FG003|Overall Study|Time Constraint|0
6849598|NCT00338962|10856876|FG000|Overall Study|Moved|0
6849599|NCT00338962|10856877|FG001|Overall Study|Moved|1
6849600|NCT00338962|10856878|FG002|Overall Study|Moved|0
6849601|NCT00338962|10856879|FG003|Overall Study|Moved|0
6849602|NCT00338962|10856876|FG000|Overall Study|Adverse Event|0
6849603|NCT00338962|10856877|FG001|Overall Study|Adverse Event|0
6849604|NCT00338962|10856878|FG002|Overall Study|Adverse Event|2
6849605|NCT00338962|10856879|FG003|Overall Study|Adverse Event|0
6849606|NCT00338962|10856876|FG000|Overall Study|Poor Compliance|0
6849607|NCT00338962|10856877|FG001|Overall Study|Poor Compliance|0
6849608|NCT00338962|10856878|FG002|Overall Study|Poor Compliance|2
6849609|NCT00338962|10856879|FG003|Overall Study|Poor Compliance|0
6849610|NCT00339040|10856896|FG000|Stage I|Not able to attend clinic|1
6849611|NCT00339040|10856897|FG001|Stage I|Not able to attend clinic|0
6849612|NCT00339040|10856896|FG000|Stage I|Protocol Violation|1
6849613|NCT00339040|10856897|FG001|Stage I|Protocol Violation|1
6849614|NCT00339040|10856896|FG000|Stage II|Lost to Follow-up|3
6849615|NCT00339040|10856897|FG001|Stage II|Lost to Follow-up|0
6849616|NCT00339040|10856896|FG000|Stage II|Withdrawal by Subject|1
6849617|NCT00339040|10856897|FG001|Stage II|Withdrawal by Subject|2
6849618|NCT00339040|10856896|FG000|Stage II|Protocol Violation|3
6849619|NCT00339040|10856897|FG001|Stage II|Protocol Violation|0
6849620|NCT00339040|10856896|FG000|Stage II|Not able to attend clinic|1
6849621|NCT00339040|10856897|FG001|Stage II|Not able to attend clinic|0
7152593|NCT03260205|11317581|FG001|Overall Study|Participant Who Did Not Received AnyDose|1
7152594|NCT03260205|11317582|FG002|Overall Study|Participant Who Did Not Received AnyDose|2
7152595|NCT03260205|11317583|FG003|Overall Study|Participant Who Did Not Received AnyDose|3
7152596|NCT03260205|11317584|FG004|Overall Study|Participant Who Did Not Received AnyDose|1
7152597|NCT03261037|11317645|FG000|Overall Study|Withdrawal by Subject|2
7152598|NCT03261037|11317646|FG001|Overall Study|Withdrawal by Subject|13
7152599|NCT03261037|11317647|FG002|Overall Study|Withdrawal by Subject|0
6849622|NCT00339040|10856896|FG000|Stage II|Site closing|2
6849623|NCT00339040|10856897|FG001|Stage II|Site closing|0
6849624|NCT00339144|10856927|FG000|Overall Study|Disease progression|5
6849625|NCT00339144|10856928|FG001|Overall Study|Disease progression|2
6849626|NCT00339144|10856929|FG002|Overall Study|Disease progression|2
6849627|NCT00339144|10856927|FG000|Overall Study|Study drug toxicity|3
6849628|NCT00339144|10856928|FG001|Overall Study|Study drug toxicity|1
6849629|NCT00339144|10856929|FG002|Overall Study|Study drug toxicity|1
6849630|NCT00339144|10856927|FG000|Overall Study|Participant's request to discontinuation|1
6849631|NCT00339144|10856928|FG001|Overall Study|Participant's request to discontinuation|0
6849632|NCT00339144|10856929|FG002|Overall Study|Participant's request to discontinuation|1
6849633|NCT00339183|10856940|FG000|Overall Study|Adverse Event|5
6849634|NCT00339183|10856941|FG001|Overall Study|Adverse Event|3
6849635|NCT00339183|10856940|FG000|Overall Study|Withdrawal by Subject|16
6849636|NCT00339183|10856941|FG001|Overall Study|Withdrawal by Subject|19
6849637|NCT00339183|10856940|FG000|Overall Study|Physician Decision|2
7152600|NCT03261037|11317648|FG003|Overall Study|Withdrawal by Subject|18
6849638|NCT00339183|10856941|FG001|Overall Study|Physician Decision|4
6849639|NCT00339183|10856940|FG000|Overall Study|Lost to Follow-up|17
6849640|NCT00339183|10856941|FG001|Overall Study|Lost to Follow-up|17
6849641|NCT00339183|10856940|FG000|Overall Study|Protocol-specified criteria|12
6849642|NCT00339183|10856941|FG001|Overall Study|Protocol-specified criteria|8
6849643|NCT00339183|10856940|FG000|Overall Study|Missing reason|3
6849644|NCT00339183|10856941|FG001|Overall Study|Missing reason|1
6849645|NCT00339183|10856940|FG000|Overall Study|Other|46
6849646|NCT00339183|10856941|FG001|Overall Study|Other|40
6849647|NCT00339183|10856940|FG000|Overall Study|Ongoing|20
6849648|NCT00339183|10856941|FG001|Overall Study|Ongoing|13
6849649|NCT00339833|10856953|FG000|Overall Study|Withdrawal by Subject|1
6849650|NCT00339833|10856954|FG001|Overall Study|Withdrawal by Subject|2
6849651|NCT00339833|10856953|FG000|Overall Study|toothache|0
6849652|NCT00339833|10856954|FG001|Overall Study|toothache|1
6849653|NCT00339833|10856953|FG000|Overall Study|indigestion|0
6849654|NCT00339833|10856954|FG001|Overall Study|indigestion|1
6849655|NCT00339833|10856953|FG000|Overall Study|Chest pain|0
6849656|NCT00339833|10856954|FG001|Overall Study|Chest pain|1
6849657|NCT00339833|10856953|FG000|Overall Study|minor infection|0
6849658|NCT00339833|10856954|FG001|Overall Study|minor infection|1
6849659|NCT00339833|10856953|FG000|Overall Study|Poor venous access|2
6849660|NCT00339833|10856954|FG001|Overall Study|Poor venous access|2
6849661|NCT00339833|10856953|FG000|Overall Study|anaemia or excess drop in glycaemia|2
6849662|NCT00339833|10856954|FG001|Overall Study|anaemia or excess drop in glycaemia|0
6849663|NCT00339833|10856953|FG000|Overall Study|Error in data records|1
6849664|NCT00339833|10856954|FG001|Overall Study|Error in data records|0
6849665|NCT00340678|10856973|FG000|Overall Study|Lost to Follow-up|1
6849666|NCT00340678|10856974|FG001|Overall Study|Lost to Follow-up|0
6849667|NCT00340678|10856975|FG002|Overall Study|Lost to Follow-up|0
6849668|NCT00340678|10856976|FG003|Overall Study|Lost to Follow-up|0
6849669|NCT00340704|10856993|FG000|PK Study|Adverse Event|0
6849670|NCT00340704|10856994|FG001|PK Study|Adverse Event|1
6849671|NCT00340704|10856995|FG002|PK Study|Adverse Event|0
6849672|NCT00340704|10856996|FG003|PK Study|Adverse Event|0
6849673|NCT00340704|10856997|FG004|PK Study|Adverse Event|0
6849674|NCT00340704|10856998|FG005|PK Study|Adverse Event|0
6849675|NCT00340704|10856999|FG006|PK Study|Adverse Event|0
6849676|NCT00340704|10857000|FG007|PK Study|Adverse Event|0
6849677|NCT00340704|10857001|FG008|PK Study|Adverse Event|0
6849678|NCT00340704|10856993|FG000|PK Study|Not treated|0
6849679|NCT00340704|10856994|FG001|PK Study|Not treated|0
6849680|NCT00340704|10856995|FG002|PK Study|Not treated|1
6849681|NCT00340704|10856996|FG003|PK Study|Not treated|0
6849682|NCT00340704|10856997|FG004|PK Study|Not treated|0
6849683|NCT00340704|10856998|FG005|PK Study|Not treated|0
6849684|NCT00340704|10856999|FG006|PK Study|Not treated|0
6849685|NCT00340704|10857000|FG007|PK Study|Not treated|0
6849686|NCT00340704|10857001|FG008|PK Study|Not treated|0
6849687|NCT00340704|10856993|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
6849688|NCT00340704|10856994|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
6849689|NCT00340704|10856995|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
6849690|NCT00340704|10856996|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2
6849691|NCT00340704|10856997|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4
6849692|NCT00340704|10856998|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
6849693|NCT00340704|10856999|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
6849694|NCT00340704|10857000|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
6849695|NCT00340704|10857001|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
6849696|NCT00340704|10856993|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
6849697|NCT00340704|10856994|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
6849698|NCT00340704|10856995|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
6849699|NCT00340704|10856996|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
6849700|NCT00340704|10856997|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
6849701|NCT00340704|10856998|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1
6849702|NCT00340704|10856999|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
6849703|NCT00340704|10857000|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
6849704|NCT00340704|10857001|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
6849705|NCT00340704|10856993|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
6849706|NCT00340704|10856994|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
6849707|NCT00340704|10856995|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
6849708|NCT00340704|10856996|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
6849709|NCT00340704|10856997|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1
6849710|NCT00340704|10856998|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3
6849711|NCT00340704|10856999|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
6849712|NCT00340704|10857000|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
6849713|NCT00340704|10857001|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
6849714|NCT00340704|10856993|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
6849715|NCT00340704|10856994|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
6849716|NCT00340704|10856995|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
6849717|NCT00340704|10856996|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
6849718|NCT00340704|10856997|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
6849719|NCT00340704|10856998|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3
6849720|NCT00340704|10856999|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53
6849721|NCT00340704|10857000|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11
6849722|NCT00340704|10857001|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28
6849723|NCT00340834|10857032|FG000|Core Phase of Study|Adverse Event|26
6849724|NCT00340834|10857033|FG001|Core Phase of Study|Adverse Event|9
6849725|NCT00340834|10857034|FG002|Core Phase of Study|Adverse Event|9
6849726|NCT00340834|10857035|FG003|Core Phase of Study|Adverse Event|0
6849727|NCT00340834|10857036|FG004|Core Phase of Study|Adverse Event|0
6966672|NCT01125930|11014690|FG000|Overall Study|Withdrawal by Subject|1
6849728|NCT00340834|10857032|FG000|Core Phase of Study|Withdrawal by Subject|11
6849729|NCT00340834|10857033|FG001|Core Phase of Study|Withdrawal by Subject|9
6849730|NCT00340834|10857034|FG002|Core Phase of Study|Withdrawal by Subject|16
6849731|NCT00340834|10857035|FG003|Core Phase of Study|Withdrawal by Subject|0
6849732|NCT00340834|10857036|FG004|Core Phase of Study|Withdrawal by Subject|0
6849733|NCT00340834|10857032|FG000|Core Phase of Study|Administrative Problems|6
6849734|NCT00340834|10857033|FG001|Core Phase of Study|Administrative Problems|2
7077590|NCT02093351|11185195|FG003|Part B|Lack of therapeutic response|12
7082901|NCT02147158|11193687|FG001|Off-Treatment Interval 1|Lack of Efficacy|0
6849735|NCT00340834|10857034|FG002|Core Phase of Study|Administrative Problems|7
6849736|NCT00340834|10857035|FG003|Core Phase of Study|Administrative Problems|0
6849737|NCT00340834|10857036|FG004|Core Phase of Study|Administrative Problems|0
6849738|NCT00340834|10857032|FG000|Core Phase of Study|Lack of Efficacy|3
6849739|NCT00340834|10857033|FG001|Core Phase of Study|Lack of Efficacy|3
6849740|NCT00340834|10857034|FG002|Core Phase of Study|Lack of Efficacy|7
6849741|NCT00340834|10857035|FG003|Core Phase of Study|Lack of Efficacy|0
6849742|NCT00340834|10857036|FG004|Core Phase of Study|Lack of Efficacy|0
6849743|NCT00340834|10857032|FG000|Core Phase of Study|Abnormal laboratory value(s)|4
6849744|NCT00340834|10857033|FG001|Core Phase of Study|Abnormal laboratory value(s)|6
6849745|NCT00340834|10857034|FG002|Core Phase of Study|Abnormal laboratory value(s)|1
6849746|NCT00340834|10857035|FG003|Core Phase of Study|Abnormal laboratory value(s)|0
6849747|NCT00340834|10857036|FG004|Core Phase of Study|Abnormal laboratory value(s)|0
6849748|NCT00340834|10857032|FG000|Core Phase of Study|Abnormal test procedure result(s)|4
6849749|NCT00340834|10857033|FG001|Core Phase of Study|Abnormal test procedure result(s)|3
6849750|NCT00340834|10857034|FG002|Core Phase of Study|Abnormal test procedure result(s)|3
6849751|NCT00340834|10857035|FG003|Core Phase of Study|Abnormal test procedure result(s)|0
6849752|NCT00340834|10857036|FG004|Core Phase of Study|Abnormal test procedure result(s)|0
6849753|NCT00340834|10857032|FG000|Core Phase of Study|Lost to Follow-up|1
6849754|NCT00340834|10857033|FG001|Core Phase of Study|Lost to Follow-up|1
6849755|NCT00340834|10857034|FG002|Core Phase of Study|Lost to Follow-up|4
6849756|NCT00340834|10857035|FG003|Core Phase of Study|Lost to Follow-up|0
6849757|NCT00340834|10857036|FG004|Core Phase of Study|Lost to Follow-up|0
6849758|NCT00340834|10857032|FG000|Core Phase of Study|Death|2
6849759|NCT00340834|10857033|FG001|Core Phase of Study|Death|0
6849760|NCT00340834|10857034|FG002|Core Phase of Study|Death|0
6849761|NCT00340834|10857035|FG003|Core Phase of Study|Death|0
6849762|NCT00340834|10857036|FG004|Core Phase of Study|Death|0
6849763|NCT00340834|10857032|FG000|Core Phase of Study|Protocol Violation|0
6849764|NCT00340834|10857033|FG001|Core Phase of Study|Protocol Violation|0
6849765|NCT00340834|10857034|FG002|Core Phase of Study|Protocol Violation|2
6849766|NCT00340834|10857035|FG003|Core Phase of Study|Protocol Violation|0
6849767|NCT00340834|10857036|FG004|Core Phase of Study|Protocol Violation|0
6849768|NCT00340834|10857032|FG000|Extension Phase of Study|Subject did not receive study drug|0
6849769|NCT00340834|10857033|FG001|Extension Phase of Study|Subject did not receive study drug|1
6849770|NCT00340834|10857034|FG002|Extension Phase of Study|Subject did not receive study drug|0
6849771|NCT00340834|10857035|FG003|Extension Phase of Study|Subject did not receive study drug|2
6849772|NCT00340834|10857036|FG004|Extension Phase of Study|Subject did not receive study drug|0
6849773|NCT00340834|10857032|FG000|Extension Phase of Study|Subject withdrew consent|26
6849774|NCT00340834|10857033|FG001|Extension Phase of Study|Subject withdrew consent|31
6849775|NCT00340834|10857034|FG002|Extension Phase of Study|Subject withdrew consent|0
6849776|NCT00340834|10857035|FG003|Extension Phase of Study|Subject withdrew consent|12
6849777|NCT00340834|10857036|FG004|Extension Phase of Study|Subject withdrew consent|15
6849778|NCT00340834|10857032|FG000|Extension Phase of Study|Adverse Event|21
6849779|NCT00340834|10857033|FG001|Extension Phase of Study|Adverse Event|22
6849780|NCT00340834|10857034|FG002|Extension Phase of Study|Adverse Event|0
6849781|NCT00340834|10857035|FG003|Extension Phase of Study|Adverse Event|19
6849782|NCT00340834|10857036|FG004|Extension Phase of Study|Adverse Event|7
6849783|NCT00340834|10857032|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14
6849784|NCT00340834|10857033|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13
6849785|NCT00340834|10857034|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0
6849786|NCT00340834|10857035|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13
6849787|NCT00340834|10857036|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4
6849788|NCT00340834|10857032|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13
6849789|NCT00340834|10857033|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7
6849790|NCT00340834|10857034|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0
6849791|NCT00340834|10857035|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4
6849792|NCT00340834|10857036|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9
6849793|NCT00340834|10857032|FG000|Extension Phase of Study|Lost to Follow-up|1
6849794|NCT00340834|10857033|FG001|Extension Phase of Study|Lost to Follow-up|1
6966673|NCT01125930|11014691|FG001|Overall Study|Withdrawal by Subject|6
6849795|NCT00340834|10857034|FG002|Extension Phase of Study|Lost to Follow-up|0
6849796|NCT00340834|10857035|FG003|Extension Phase of Study|Lost to Follow-up|2
6966674|NCT01125930|11014690|FG000|Overall Study|Protocol Violation|0
6849797|NCT00340834|10857036|FG004|Extension Phase of Study|Lost to Follow-up|3
6849798|NCT00340834|10857032|FG000|Extension Phase of Study|Subject no longer requires study drug|4
6849799|NCT00340834|10857033|FG001|Extension Phase of Study|Subject no longer requires study drug|0
6966675|NCT01125930|11014691|FG001|Overall Study|Protocol Violation|1
6849800|NCT00340834|10857034|FG002|Extension Phase of Study|Subject no longer requires study drug|0
6849801|NCT00340834|10857035|FG003|Extension Phase of Study|Subject no longer requires study drug|0
6849802|NCT00340834|10857036|FG004|Extension Phase of Study|Subject no longer requires study drug|2
6849803|NCT00340834|10857032|FG000|Extension Phase of Study|Administrative problems|3
6849804|NCT00340834|10857033|FG001|Extension Phase of Study|Administrative problems|0
6849805|NCT00340834|10857034|FG002|Extension Phase of Study|Administrative problems|0
6849806|NCT00340834|10857035|FG003|Extension Phase of Study|Administrative problems|1
6849807|NCT00340834|10857036|FG004|Extension Phase of Study|Administrative problems|1
6849808|NCT00340834|10857032|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0
6849809|NCT00340834|10857033|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1
6849810|NCT00340834|10857034|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0
6849811|NCT00340834|10857035|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0
6849812|NCT00340834|10857036|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2
6849813|NCT00340834|10857032|FG000|Extension Phase of Study|Protocol Violation|3
6849814|NCT00340834|10857033|FG001|Extension Phase of Study|Protocol Violation|0
6849815|NCT00340834|10857034|FG002|Extension Phase of Study|Protocol Violation|0
6849816|NCT00340834|10857035|FG003|Extension Phase of Study|Protocol Violation|0
6849817|NCT00340834|10857036|FG004|Extension Phase of Study|Protocol Violation|0
6849818|NCT00340834|10857032|FG000|Extension Phase of Study|Death|0
6849819|NCT00340834|10857033|FG001|Extension Phase of Study|Death|0
6849820|NCT00340834|10857034|FG002|Extension Phase of Study|Death|0
6849821|NCT00340834|10857035|FG003|Extension Phase of Study|Death|0
6849822|NCT00340834|10857036|FG004|Extension Phase of Study|Death|1
6849823|NCT00342628|10857085|FG000|Overall Study|Withdrawal by Subject|19
6849824|NCT00342628|10857086|FG001|Overall Study|Withdrawal by Subject|19
6849825|NCT00342628|10857087|FG002|Overall Study|Withdrawal by Subject|18
6849826|NCT00342628|10857085|FG000|Overall Study|Death|1
6849827|NCT00342628|10857086|FG001|Overall Study|Death|1
6849828|NCT00342628|10857087|FG002|Overall Study|Death|0
6849829|NCT00342628|10857085|FG000|Overall Study|moved residence|0
6849830|NCT00342628|10857086|FG001|Overall Study|moved residence|1
6849831|NCT00342628|10857087|FG002|Overall Study|moved residence|1
6849832|NCT00343252|10857106|FG000|6 Months (All Treated Participants)|Adverse Event|17
6849833|NCT00343252|10857107|FG001|6 Months (All Treated Participants)|Adverse Event|11
6849834|NCT00343252|10857106|FG000|6 Months (All Treated Participants)|Death|0
6849835|NCT00343252|10857107|FG001|6 Months (All Treated Participants)|Death|2
6849836|NCT00343252|10857106|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10
6849837|NCT00343252|10857107|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8
6849838|NCT00343252|10857106|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0
6849839|NCT00343252|10857107|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1
6849840|NCT00343252|10857106|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0
6849841|NCT00343252|10857107|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4
6849842|NCT00343252|10857106|FG000|6 Months (All Treated Participants)|Physician Decision|1
6849843|NCT00343252|10857107|FG001|6 Months (All Treated Participants)|Physician Decision|3
6849844|NCT00343252|10857106|FG000|6 Months (All Treated Participants)|Protocol Violation|2
6849845|NCT00343252|10857107|FG001|6 Months (All Treated Participants)|Protocol Violation|2
6849846|NCT00343252|10857106|FG000|6 Months (All Treated Participants)|Sponsor Decision|7
6849847|NCT00343252|10857107|FG001|6 Months (All Treated Participants)|Sponsor Decision|4
6849848|NCT00343252|10857106|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19
6849849|NCT00343252|10857107|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9
6849850|NCT00343252|10857106|FG000|12 Months (All Treated Participants)|Adverse Event|22
6849851|NCT00343252|10857107|FG001|12 Months (All Treated Participants)|Adverse Event|20
6849852|NCT00343252|10857106|FG000|12 Months (All Treated Participants)|Death|3
6849853|NCT00343252|10857107|FG001|12 Months (All Treated Participants)|Death|3
6849854|NCT00343252|10857106|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10
6849855|NCT00343252|10857107|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10
6849856|NCT00343252|10857106|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1
6849857|NCT00343252|10857107|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1
6849858|NCT00343252|10857106|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1
6849859|NCT00343252|10857107|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5
6849860|NCT00343252|10857106|FG000|12 Months (All Treated Participants)|Physician Decision|4
6849861|NCT00343252|10857107|FG001|12 Months (All Treated Participants)|Physician Decision|5
6849862|NCT00343252|10857106|FG000|12 Months (All Treated Participants)|Protocol Violation|3
6849863|NCT00343252|10857107|FG001|12 Months (All Treated Participants)|Protocol Violation|2
6849864|NCT00343252|10857106|FG000|12 Months (All Treated Participants)|Sponsor Decision|9
6849865|NCT00343252|10857107|FG001|12 Months (All Treated Participants)|Sponsor Decision|6
6849866|NCT00343252|10857106|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33
6849867|NCT00343252|10857107|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17
6849868|NCT00343252|10857106|FG000|18 Months (All Treated Participants)|Adverse Event|31
6849869|NCT00343252|10857107|FG001|18 Months (All Treated Participants)|Adverse Event|23
6849870|NCT00343252|10857106|FG000|18 Months (All Treated Participants)|Death|4
6849871|NCT00343252|10857107|FG001|18 Months (All Treated Participants)|Death|5
6966676|NCT01125930|11014690|FG000|Overall Study|Lost to Follow-up|0
6849872|NCT00343252|10857106|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11
6849873|NCT00343252|10857107|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10
6849874|NCT00343252|10857106|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1
6849875|NCT00343252|10857107|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1
6849876|NCT00343252|10857106|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3
6849877|NCT00343252|10857107|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7
6849878|NCT00343252|10857106|FG000|18 Months (All Treated Participants)|Physician Decision|4
6849879|NCT00343252|10857107|FG001|18 Months (All Treated Participants)|Physician Decision|7
6849880|NCT00343252|10857106|FG000|18 Months (All Treated Participants)|Protocol Violation|3
6849881|NCT00343252|10857107|FG001|18 Months (All Treated Participants)|Protocol Violation|3
6849882|NCT00343252|10857106|FG000|18 Months (All Treated Participants)|Sponsor Decision|8
6849883|NCT00343252|10857107|FG001|18 Months (All Treated Participants)|Sponsor Decision|5
6849884|NCT00343252|10857106|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36
6849885|NCT00343252|10857107|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20
6849886|NCT00343291|10857115|FG000|Overall Study|Adverse Event|13
6849887|NCT00343291|10857116|FG001|Overall Study|Adverse Event|13
6849888|NCT00343291|10857115|FG000|Overall Study|Death|3
6849889|NCT00343291|10857116|FG001|Overall Study|Death|2
6849890|NCT00343291|10857115|FG000|Overall Study|Progressive disease|33
6849891|NCT00343291|10857116|FG001|Overall Study|Progressive disease|34
6849892|NCT00343291|10857115|FG000|Overall Study|Withdrawal by Subject|0
6849893|NCT00343291|10857116|FG001|Overall Study|Withdrawal by Subject|2
6849894|NCT00343291|10857115|FG000|Overall Study|Other|8
6849895|NCT00343291|10857116|FG001|Overall Study|Other|5
6849896|NCT00343382|10857125|FG000|Overall Study|Adverse Event|2
6849897|NCT00343382|10857126|FG001|Overall Study|Adverse Event|10
6849898|NCT00343382|10857127|FG002|Overall Study|Adverse Event|7
6849899|NCT00343382|10857125|FG000|Overall Study|Withdrawal by Subject|1
6849900|NCT00343382|10857126|FG001|Overall Study|Withdrawal by Subject|2
6849901|NCT00343382|10857127|FG002|Overall Study|Withdrawal by Subject|6
6849902|NCT00343382|10857125|FG000|Overall Study|Other Reason Not Specified|1
6849903|NCT00343382|10857126|FG001|Overall Study|Other Reason Not Specified|2
6849904|NCT00343382|10857127|FG002|Overall Study|Other Reason Not Specified|4
6849905|NCT00343512|10857161|FG000|Overall Study|Withdrawal by Subject|2
6849906|NCT00343642|10857285|FG000|Overall Study|Lost to Follow-up|0
6849907|NCT00343642|10857286|FG001|Overall Study|Lost to Follow-up|1
6849908|NCT00343642|10857287|FG002|Overall Study|Lost to Follow-up|0
6849909|NCT00343642|10857285|FG000|Overall Study|Pregnancy|1
6849910|NCT00343642|10857286|FG001|Overall Study|Pregnancy|0
6849911|NCT00343642|10857287|FG002|Overall Study|Pregnancy|2
6849912|NCT00343642|10857285|FG000|Overall Study|Withdrawal by Subject|2
6849913|NCT00343642|10857286|FG001|Overall Study|Withdrawal by Subject|3
6849914|NCT00343642|10857287|FG002|Overall Study|Withdrawal by Subject|4
6849915|NCT00343642|10857285|FG000|Overall Study|Adverse Event|0
6849916|NCT00343642|10857286|FG001|Overall Study|Adverse Event|0
6849917|NCT00343642|10857287|FG002|Overall Study|Adverse Event|1
6849918|NCT00343642|10857285|FG000|Overall Study|Flare up|6
6849919|NCT00343642|10857286|FG001|Overall Study|Flare up|4
6849920|NCT00343642|10857287|FG002|Overall Study|Flare up|0
6849921|NCT00343889|10857316|FG000|Overall Study|Lost to Follow-up|2
6849922|NCT00343889|10857317|FG001|Overall Study|Lost to Follow-up|0
6849923|NCT00343889|10857316|FG000|Overall Study|Withdrawal by Subject|0
6849924|NCT00343889|10857317|FG001|Overall Study|Withdrawal by Subject|1
6849925|NCT00343889|10857316|FG000|Overall Study|Protocol Violation|1
6849926|NCT00343889|10857317|FG001|Overall Study|Protocol Violation|0
6849927|NCT00343915|10857325|FG000|Primary Study|Withdrawal by Subject|1
6849928|NCT00343915|10857326|FG001|Primary Study|Withdrawal by Subject|0
6849929|NCT00343915|10857325|FG000|Primary Study|Lost to Follow-up|2
6849930|NCT00343915|10857326|FG001|Primary Study|Lost to Follow-up|3
6849931|NCT00343915|10857325|FG000|Primary Study|Other|1
6849932|NCT00343915|10857326|FG001|Primary Study|Other|0
6849933|NCT00344032|10857337|FG000|Overall Study|Adverse Event|0
6849934|NCT00344032|10857338|FG001|Overall Study|Adverse Event|1
6849935|NCT00344032|10857337|FG000|Overall Study|Withdrawal by Subject|6
6849936|NCT00344032|10857338|FG001|Overall Study|Withdrawal by Subject|2
6849937|NCT00344032|10857337|FG000|Overall Study|Lost to Follow-up|4
6849938|NCT00344032|10857338|FG001|Overall Study|Lost to Follow-up|6
6849939|NCT00344032|10857337|FG000|Overall Study|Physician Decision|4
6849940|NCT00344032|10857338|FG001|Overall Study|Physician Decision|1
6849941|NCT00344305|10857355|FG000|Overall Study|Lost to Follow-up|2
6849942|NCT00344305|10857356|FG001|Overall Study|Lost to Follow-up|0
6849943|NCT00344305|10857355|FG000|Overall Study|Participant was not contacted in window|0
6849944|NCT00344305|10857356|FG001|Overall Study|Participant was not contacted in window|1
6849945|NCT00344318|10857367|FG000|Overall Study|Adverse Event|0
6849946|NCT00344318|10857368|FG001|Overall Study|Adverse Event|3
6849947|NCT00344318|10857369|FG002|Overall Study|Adverse Event|0
6849948|NCT00344318|10857370|FG003|Overall Study|Adverse Event|1
6849949|NCT00344318|10857367|FG000|Overall Study|Withdrawal by Subject|2
6966677|NCT01125930|11014691|FG001|Overall Study|Lost to Follow-up|2
6849950|NCT00344318|10857368|FG001|Overall Study|Withdrawal by Subject|2
6849951|NCT00344318|10857369|FG002|Overall Study|Withdrawal by Subject|0
6849952|NCT00344318|10857370|FG003|Overall Study|Withdrawal by Subject|2
6849953|NCT00344318|10857367|FG000|Overall Study|Lost to Follow-up|2
6849954|NCT00344318|10857368|FG001|Overall Study|Lost to Follow-up|0
6849955|NCT00344318|10857369|FG002|Overall Study|Lost to Follow-up|1
6849956|NCT00344318|10857370|FG003|Overall Study|Lost to Follow-up|0
6849957|NCT00344448|10857393|FG000|Screening|Withdrawal by Subject|0
6849958|NCT00344448|10857394|FG001|Screening|Withdrawal by Subject|1
6849959|NCT00344448|10857393|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1
6849960|NCT00344448|10857394|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0
7077591|NCT02093351|11185192|FG000|Part B|Condition under investigation worsened|0
7077592|NCT02093351|11185193|FG001|Part B|Condition under investigation worsened|0
7077593|NCT02093351|11185194|FG002|Part B|Condition under investigation worsened|0
7077594|NCT02093351|11185195|FG003|Part B|Condition under investigation worsened|39
7077595|NCT02093351|11185192|FG000|Part B|Adverse Event|0
7077596|NCT02093351|11185193|FG001|Part B|Adverse Event|0
7077597|NCT02093351|11185194|FG002|Part B|Adverse Event|0
7077598|NCT02093351|11185195|FG003|Part B|Adverse Event|2
7077599|NCT02093351|11185192|FG000|Part B|Death|0
7077600|NCT02093351|11185193|FG001|Part B|Death|0
7077601|NCT02093351|11185194|FG002|Part B|Death|0
7077602|NCT02093351|11185195|FG003|Part B|Death|1
7077603|NCT02093390|11185212|FG000|Overall Study|Withdrawal by Subject|0
7077604|NCT02093390|11185213|FG001|Overall Study|Withdrawal by Subject|1
7077605|NCT02093520|11185222|FG000|Overall Study|Not treated|6
7077606|NCT02093520|11185223|FG001|Overall Study|Not treated|22
7152601|NCT03261037|11317645|FG000|Overall Study|Non-compliance with study procedures|0
7152602|NCT03261037|11317646|FG001|Overall Study|Non-compliance with study procedures|2
7152603|NCT03261037|11317647|FG002|Overall Study|Non-compliance with study procedures|0
7152604|NCT03261037|11317648|FG003|Overall Study|Non-compliance with study procedures|6
7152605|NCT03261037|11317645|FG000|Overall Study|Participant moving away and can no longer be in study|0
7152606|NCT03261037|11317646|FG001|Overall Study|Participant moving away and can no longer be in study|1
7152607|NCT03261037|11317647|FG002|Overall Study|Participant moving away and can no longer be in study|0
7152608|NCT03261037|11317648|FG003|Overall Study|Participant moving away and can no longer be in study|0
7152609|NCT03261037|11317645|FG000|Overall Study|Participant came out of study due to investigator discretion|0
7184121|NCT01755689|11384115|FG004|Overall Study|Withdrawal by Subject|1
6849961|NCT00344448|10857393|FG000|Double Blind, Placebo Controlled|Study terminated|1
6849962|NCT00344448|10857394|FG001|Double Blind, Placebo Controlled|Study terminated|0
6849963|NCT00344448|10857393|FG000|Open Label|Withdrawal by Subject|1
6849964|NCT00344448|10857394|FG001|Open Label|Withdrawal by Subject|1
6849965|NCT00344448|10857393|FG000|Open Label|Study terminated|1
6849966|NCT00344448|10857394|FG001|Open Label|Study terminated|0
6849967|NCT00344461|10857400|FG000|Overall Study|Adverse Event|6
6849968|NCT00344461|10857400|FG000|Overall Study|Death|1
6849969|NCT00344461|10857400|FG000|Overall Study|Lack of Efficacy|2
6849970|NCT00344461|10857400|FG000|Overall Study|Lost to Follow-up|2
6849971|NCT00344461|10857400|FG000|Overall Study|Physician Decision|2
6849972|NCT00344461|10857400|FG000|Overall Study|Protocol Violation|6
6849973|NCT00344461|10857400|FG000|Overall Study|Withdrawal by Subject|2
6849974|NCT00344500|10857407|FG000|Overall Study|Adverse Event|6
6849975|NCT00344500|10857408|FG001|Overall Study|Adverse Event|2
6849976|NCT00344500|10857409|FG002|Overall Study|Adverse Event|0
6849977|NCT00344500|10857407|FG000|Overall Study|Lost to Follow-up|5
6849978|NCT00344500|10857408|FG001|Overall Study|Lost to Follow-up|13
6849979|NCT00344500|10857409|FG002|Overall Study|Lost to Follow-up|1
6849980|NCT00344500|10857407|FG000|Overall Study|Withdrawal by Subject|7
6849981|NCT00344500|10857408|FG001|Overall Study|Withdrawal by Subject|10
6849982|NCT00344500|10857409|FG002|Overall Study|Withdrawal by Subject|0
6849983|NCT00344500|10857407|FG000|Overall Study|Protocol Violation|4
6849984|NCT00344500|10857408|FG001|Overall Study|Protocol Violation|7
6849985|NCT00344500|10857409|FG002|Overall Study|Protocol Violation|1
6849986|NCT00344500|10857407|FG000|Overall Study|Not Noted|1
6849987|NCT00344500|10857408|FG001|Overall Study|Not Noted|3
6849988|NCT00344500|10857409|FG002|Overall Study|Not Noted|0
6849989|NCT00344773|10857425|FG000|Overall Study|Adverse Event|2
6849990|NCT00344773|10857425|FG000|Overall Study|Objective Disease Progression|16
6849991|NCT00344773|10857425|FG000|Overall Study|Withdrawal by Subject|1
6849992|NCT00344773|10857425|FG000|Overall Study|Not Eligible for the study|2
6849993|NCT00344968|10857432|FG000|Overall Study|Adverse Event|5
6849994|NCT00344968|10857433|FG001|Overall Study|Adverse Event|4
6849995|NCT00344968|10857434|FG002|Overall Study|Adverse Event|15
6849996|NCT00344968|10857432|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3
6849997|NCT00344968|10857433|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0
6849998|NCT00344968|10857434|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1
6849999|NCT00344968|10857432|FG000|Overall Study|Protocol Violation|2
6850000|NCT00344968|10857433|FG001|Overall Study|Protocol Violation|2
6850001|NCT00344968|10857434|FG002|Overall Study|Protocol Violation|5
6850002|NCT00344968|10857432|FG000|Overall Study|Withdrawal by Subject|14
6850003|NCT00344968|10857433|FG001|Overall Study|Withdrawal by Subject|31
6850004|NCT00344968|10857434|FG002|Overall Study|Withdrawal by Subject|27
7082902|NCT02147158|11193688|FG002|Off-Treatment Interval 1|Lack of Efficacy|2
7082903|NCT02147158|11193689|FG003|Off-Treatment Interval 1|Lack of Efficacy|0
7082904|NCT02147158|11193690|FG004|Off-Treatment Interval 1|Lack of Efficacy|1
6850005|NCT00344968|10857432|FG000|Overall Study|Lost to Follow-up|24
6850006|NCT00344968|10857433|FG001|Overall Study|Lost to Follow-up|37
6850007|NCT00344968|10857434|FG002|Overall Study|Lost to Follow-up|37
6850008|NCT00344968|10857432|FG000|Overall Study|Death|11
6850009|NCT00344968|10857433|FG001|Overall Study|Death|27
6850010|NCT00344968|10857434|FG002|Overall Study|Death|31
6850011|NCT00344968|10857432|FG000|Overall Study|Other|0
6850012|NCT00344968|10857433|FG001|Overall Study|Other|1
6850013|NCT00344968|10857434|FG002|Overall Study|Other|0
6850014|NCT00345046|10857455|FG000|Overall Study|Protocol Violation|1
6850015|NCT00345046|10857456|FG001|Overall Study|Protocol Violation|1
6850016|NCT00345046|10857457|FG002|Overall Study|Protocol Violation|2
6850017|NCT00345293|10857493|FG000|Overall Study|Unable to access line for sample|1
6850018|NCT00345293|10857494|FG001|Overall Study|Unable to access line for sample|0
6850019|NCT00345293|10857493|FG000|Overall Study|Withdrawal by Subject|1
6850020|NCT00345293|10857494|FG001|Overall Study|Withdrawal by Subject|0
6850021|NCT00345397|10857529|FG000|Overall Study|Death|1
6850022|NCT00345540|10857534|FG000|Overall Study|Withdrawal by Subject|1
6850023|NCT00345579|10857540|FG000|Overall Study|Adverse Event|9
6850024|NCT00345579|10857541|FG001|Overall Study|Adverse Event|6
6850025|NCT00345579|10857540|FG000|Overall Study|Protocol Violation|14
6850026|NCT00345579|10857541|FG001|Overall Study|Protocol Violation|5
6850027|NCT00345579|10857540|FG000|Overall Study|Withdrawal by Subject|50
6850028|NCT00345579|10857541|FG001|Overall Study|Withdrawal by Subject|17
6850029|NCT00345579|10857540|FG000|Overall Study|Lost to Follow-up|82
6850030|NCT00345579|10857541|FG001|Overall Study|Lost to Follow-up|36
6850031|NCT00345579|10857540|FG000|Overall Study|Other|9
6850032|NCT00345579|10857541|FG001|Overall Study|Other|1
6850033|NCT00345592|10857550|FG000|Overall Study|Death|14
6850034|NCT00345592|10857551|FG001|Overall Study|Death|16
6850035|NCT00345592|10857550|FG000|Overall Study|Withdrawal by Subject|11
6850036|NCT00345592|10857551|FG001|Overall Study|Withdrawal by Subject|8
6850037|NCT00345605|10857557|FG000|Arm 1|Adverse Event|0
6850038|NCT00345605|10857558|FG001|Arm 1|Adverse Event|1
6850039|NCT00345605|10857557|FG000|Arm 2, Opposite Treatment|Adverse Event|1
6850040|NCT00345605|10857558|FG001|Arm 2, Opposite Treatment|Adverse Event|0
6850041|NCT00345631|10857569|FG000|Overall Study|Withdrawal by Subject|1
6850042|NCT00345631|10857570|FG001|Overall Study|Withdrawal by Subject|0
6850043|NCT00345631|10857571|FG002|Overall Study|Withdrawal by Subject|1
6850044|NCT00345631|10857569|FG000|Overall Study|Adverse Event|0
6850045|NCT00345631|10857570|FG001|Overall Study|Adverse Event|1
6850046|NCT00345631|10857571|FG002|Overall Study|Adverse Event|0
6850047|NCT00345631|10857569|FG000|Overall Study|Lost to Follow-up|3
6850048|NCT00345631|10857570|FG001|Overall Study|Lost to Follow-up|7
6850049|NCT00345631|10857571|FG002|Overall Study|Lost to Follow-up|4
6850050|NCT00345631|10857569|FG000|Overall Study|Other reasons|0
6850051|NCT00345631|10857570|FG001|Overall Study|Other reasons|0
6850052|NCT00345631|10857571|FG002|Overall Study|Other reasons|1
6850053|NCT00345683|10857583|FG000|Overall Study|Lost to Follow-up|19
6850054|NCT00345683|10857584|FG001|Overall Study|Lost to Follow-up|7
6850055|NCT00345683|10857583|FG000|Overall Study|Other|6
6850056|NCT00345683|10857584|FG001|Overall Study|Other|2
6850057|NCT00345839|10857592|FG000|Overall Study|Withdrawal by Subject|91
6850058|NCT00345839|10857593|FG001|Overall Study|Withdrawal by Subject|98
6850059|NCT00345839|10857592|FG000|Overall Study|Lost to Follow-up|58
6850060|NCT00345839|10857593|FG001|Overall Study|Lost to Follow-up|61
6850061|NCT00345878|10857622|FG000|Overall Study|Adverse Event|1
6850062|NCT00345878|10857623|FG001|Overall Study|Adverse Event|0
6850063|NCT00345878|10857622|FG000|Overall Study|Lost to Follow-up|2
6850064|NCT00345878|10857623|FG001|Overall Study|Lost to Follow-up|1
6850065|NCT00345878|10857622|FG000|Overall Study|Other|1
6850066|NCT00345878|10857623|FG001|Overall Study|Other|0
6850067|NCT00346034|10857638|FG000|Overall Study|Adverse Event|34
6850068|NCT00346034|10857638|FG000|Overall Study|Lack of Efficacy|8
6850069|NCT00346034|10857638|FG000|Overall Study|Withdrawal by Subject|13
6850070|NCT00346034|10857638|FG000|Overall Study|Patient Stopped Taking Study Drug|1
6850071|NCT00346034|10857638|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1
6850072|NCT00346073|10857644|FG000|Overall Study|Serious Adverse Event|2
6850073|NCT00346073|10857645|FG001|Overall Study|Serious Adverse Event|0
6850074|NCT00346073|10857644|FG000|Overall Study|Lost to Follow-up|39
6850075|NCT00346073|10857645|FG001|Overall Study|Lost to Follow-up|24
6850076|NCT00346151|10857651|FG000|Overall Study|Withdrawal by Subject|3
6850077|NCT00346216|10857658|FG000|Overall Study|Other|181
6850078|NCT00346216|10857659|FG001|Overall Study|Other|231
6850079|NCT00346216|10857660|FG002|Overall Study|Other|205
6850080|NCT00346216|10857658|FG000|Overall Study|No longer willing to participate|600
6850081|NCT00346216|10857659|FG001|Overall Study|No longer willing to participate|606
6850082|NCT00346216|10857660|FG002|Overall Study|No longer willing to participate|585
6850083|NCT00346216|10857658|FG000|Overall Study|Withdrawal by Subject|661
6850084|NCT00346216|10857659|FG001|Overall Study|Withdrawal by Subject|692
6850085|NCT00346216|10857660|FG002|Overall Study|Withdrawal by Subject|651
6850086|NCT00346216|10857658|FG000|Overall Study|Lost to Follow-up|611
6850087|NCT00346216|10857659|FG001|Overall Study|Lost to Follow-up|588
6850088|NCT00346216|10857660|FG002|Overall Study|Lost to Follow-up|542
6850089|NCT00346216|10857658|FG000|Overall Study|Physician Decision|80
6850090|NCT00346216|10857659|FG001|Overall Study|Physician Decision|76
6850091|NCT00346216|10857660|FG002|Overall Study|Physician Decision|59
6850092|NCT00346216|10857658|FG000|Overall Study|Does not meet entrance criteria|13
6850093|NCT00346216|10857659|FG001|Overall Study|Does not meet entrance criteria|10
6850094|NCT00346216|10857660|FG002|Overall Study|Does not meet entrance criteria|8
6850095|NCT00346216|10857658|FG000|Overall Study|Death|189
6850096|NCT00346216|10857659|FG001|Overall Study|Death|192
6850097|NCT00346216|10857660|FG002|Overall Study|Death|228
6850098|NCT00346216|10857658|FG000|Overall Study|Study terminated by sponsor|11
6850099|NCT00346216|10857659|FG001|Overall Study|Study terminated by sponsor|4
6850100|NCT00346216|10857660|FG002|Overall Study|Study terminated by sponsor|8
6850101|NCT00346216|10857658|FG000|Overall Study|Missing Subject Summary Status|62
6850102|NCT00346216|10857659|FG001|Overall Study|Missing Subject Summary Status|61
6850103|NCT00346216|10857660|FG002|Overall Study|Missing Subject Summary Status|62
6850104|NCT00346268|10857670|FG000|Overall Study|Adverse Event|1
6850105|NCT00346268|10857671|FG001|Overall Study|Adverse Event|0
6850106|NCT00346268|10857670|FG000|Overall Study|Protocol Violation|1
6850107|NCT00346268|10857671|FG001|Overall Study|Protocol Violation|0
6850108|NCT00346268|10857670|FG000|Overall Study|Participant refused|0
6850109|NCT00346268|10857671|FG001|Overall Study|Participant refused|3
6850110|NCT00346333|10857679|FG000|Overall Study|Death|1
6850111|NCT00346333|10857680|FG001|Overall Study|Death|0
6850112|NCT00346333|10857679|FG000|Overall Study|unwilling or unable to continue|4
6850113|NCT00346333|10857680|FG001|Overall Study|unwilling or unable to continue|8
6850114|NCT00346398|10857690|FG000|Overall Study|Lost to Follow-up|3
6850115|NCT00346398|10857691|FG001|Overall Study|Lost to Follow-up|0
6850116|NCT00346398|10857690|FG000|Overall Study|Withdrawal by Subject|0
6850117|NCT00346398|10857691|FG001|Overall Study|Withdrawal by Subject|2
6850118|NCT00346632|10857703|FG000|Overall Study|Progressive Disease|2
6850119|NCT00346632|10857704|FG001|Overall Study|Progressive Disease|2
6850120|NCT00346632|10857705|FG002|Overall Study|Progressive Disease|4
6850121|NCT00346632|10857706|FG003|Overall Study|Progressive Disease|3
6850122|NCT00346632|10857707|FG004|Overall Study|Progressive Disease|3
6850123|NCT00346632|10857708|FG005|Overall Study|Progressive Disease|1
6850124|NCT00346632|10857709|FG006|Overall Study|Progressive Disease|2
6850125|NCT00346632|10857710|FG007|Overall Study|Progressive Disease|2
6850126|NCT00346632|10857711|FG008|Overall Study|Progressive Disease|2
6850127|NCT00346632|10857712|FG009|Overall Study|Progressive Disease|2
6850128|NCT00346632|10857703|FG000|Overall Study|Adverse Event|0
6850129|NCT00346632|10857704|FG001|Overall Study|Adverse Event|0
6850130|NCT00346632|10857705|FG002|Overall Study|Adverse Event|0
6850131|NCT00346632|10857706|FG003|Overall Study|Adverse Event|0
6850132|NCT00346632|10857707|FG004|Overall Study|Adverse Event|1
6850133|NCT00346632|10857708|FG005|Overall Study|Adverse Event|1
6850134|NCT00346632|10857709|FG006|Overall Study|Adverse Event|1
6850135|NCT00346632|10857710|FG007|Overall Study|Adverse Event|0
6850136|NCT00346632|10857711|FG008|Overall Study|Adverse Event|0
6850137|NCT00346632|10857712|FG009|Overall Study|Adverse Event|0
6850138|NCT00346632|10857703|FG000|Overall Study|Death|0
6850139|NCT00346632|10857704|FG001|Overall Study|Death|0
6850140|NCT00346632|10857705|FG002|Overall Study|Death|1
6850141|NCT00346632|10857706|FG003|Overall Study|Death|0
6850142|NCT00346632|10857707|FG004|Overall Study|Death|0
6850143|NCT00346632|10857708|FG005|Overall Study|Death|0
6850144|NCT00346632|10857709|FG006|Overall Study|Death|0
6850145|NCT00346632|10857710|FG007|Overall Study|Death|0
6850146|NCT00346632|10857711|FG008|Overall Study|Death|0
6850147|NCT00346632|10857712|FG009|Overall Study|Death|0
6850148|NCT00346632|10857703|FG000|Overall Study|Protocol Violation|0
6850149|NCT00346632|10857704|FG001|Overall Study|Protocol Violation|0
6850150|NCT00346632|10857705|FG002|Overall Study|Protocol Violation|0
6850151|NCT00346632|10857706|FG003|Overall Study|Protocol Violation|0
6850152|NCT00346632|10857707|FG004|Overall Study|Protocol Violation|0
6850153|NCT00346632|10857708|FG005|Overall Study|Protocol Violation|0
6850154|NCT00346632|10857709|FG006|Overall Study|Protocol Violation|1
6850155|NCT00346632|10857710|FG007|Overall Study|Protocol Violation|0
6850156|NCT00346632|10857711|FG008|Overall Study|Protocol Violation|0
6850157|NCT00346632|10857712|FG009|Overall Study|Protocol Violation|0
6850158|NCT00346632|10857703|FG000|Overall Study|Withdrawal by Subject|0
6850159|NCT00346632|10857704|FG001|Overall Study|Withdrawal by Subject|0
6850160|NCT00346632|10857705|FG002|Overall Study|Withdrawal by Subject|0
6850161|NCT00346632|10857706|FG003|Overall Study|Withdrawal by Subject|0
6850162|NCT00346632|10857707|FG004|Overall Study|Withdrawal by Subject|0
6850163|NCT00346632|10857708|FG005|Overall Study|Withdrawal by Subject|0
6850164|NCT00346632|10857709|FG006|Overall Study|Withdrawal by Subject|1
6850165|NCT00346632|10857710|FG007|Overall Study|Withdrawal by Subject|0
6850166|NCT00346632|10857711|FG008|Overall Study|Withdrawal by Subject|0
6850167|NCT00346632|10857712|FG009|Overall Study|Withdrawal by Subject|0
6850168|NCT00346632|10857703|FG000|Overall Study|Switched to alternative treatment|0
6850169|NCT00346632|10857704|FG001|Overall Study|Switched to alternative treatment|0
6850170|NCT00346632|10857705|FG002|Overall Study|Switched to alternative treatment|1
6850171|NCT00346632|10857706|FG003|Overall Study|Switched to alternative treatment|0
6850172|NCT00346632|10857707|FG004|Overall Study|Switched to alternative treatment|0
6850173|NCT00346632|10857708|FG005|Overall Study|Switched to alternative treatment|0
6850174|NCT00346632|10857709|FG006|Overall Study|Switched to alternative treatment|0
6850175|NCT00346632|10857710|FG007|Overall Study|Switched to alternative treatment|0
6850176|NCT00346632|10857711|FG008|Overall Study|Switched to alternative treatment|0
6850177|NCT00346632|10857712|FG009|Overall Study|Switched to alternative treatment|0
6850178|NCT00346632|10857703|FG000|Overall Study|Not Stated|1
6850179|NCT00346632|10857704|FG001|Overall Study|Not Stated|1
6850180|NCT00346632|10857705|FG002|Overall Study|Not Stated|0
6850181|NCT00346632|10857706|FG003|Overall Study|Not Stated|0
6850182|NCT00346632|10857707|FG004|Overall Study|Not Stated|0
6850183|NCT00346632|10857708|FG005|Overall Study|Not Stated|0
6850184|NCT00346632|10857709|FG006|Overall Study|Not Stated|0
6850185|NCT00346632|10857710|FG007|Overall Study|Not Stated|2
6850186|NCT00346632|10857711|FG008|Overall Study|Not Stated|2
6850187|NCT00346632|10857712|FG009|Overall Study|Not Stated|1
6850188|NCT00346697|10857776|FG000|Overall Study|Lost to Follow-up|0
6850189|NCT00346697|10857777|FG001|Overall Study|Lost to Follow-up|1
6850190|NCT00346775|10857785|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1
6850191|NCT00346775|10857786|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1
6850192|NCT00346775|10857785|FG000|Period 1: Intervention Period 1|Protocol Violation|3
6850193|NCT00346775|10857786|FG001|Period 1: Intervention Period 1|Protocol Violation|2
6850194|NCT00346775|10857785|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1
6850195|NCT00346775|10857786|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0
6850196|NCT00347009|10857800|FG000|Overall Study|Death|1
6850197|NCT00347009|10857800|FG000|Overall Study|Adverse Event|6
6850198|NCT00347009|10857800|FG000|Overall Study|Withdrawal by Subject|3
6850199|NCT00347009|10857800|FG000|Overall Study|Physician Decision|5
6850200|NCT00347009|10857800|FG000|Overall Study|Lost to Follow-up|4
6850201|NCT00347009|10857800|FG000|Overall Study|Protocol Violation|2
6850202|NCT00347009|10857800|FG000|Overall Study|Adverse Laboratory Experience|1
6850203|NCT00347009|10857800|FG000|Overall Study|Insufficient Viral Suppression|3
6850204|NCT00347009|10857800|FG000|Overall Study|Increased ALT/HBV DNA|1
6850205|NCT00347009|10857800|FG000|Overall Study|Serious Adverse Event|1
6850206|NCT00347269|10857815|FG000|Overall Study|Lost to Follow-up|74
6850207|NCT00347269|10857816|FG001|Overall Study|Lost to Follow-up|65
6850208|NCT00347269|10857815|FG000|Overall Study|Withdrawal by Subject|18
6850209|NCT00347269|10857816|FG001|Overall Study|Withdrawal by Subject|38
6850210|NCT00347269|10857815|FG000|Overall Study|Death|2
6850211|NCT00347269|10857816|FG001|Overall Study|Death|3
6850212|NCT00347360|10857841|FG000|Overall Study|Adverse Event|1
6850213|NCT00347360|10857842|FG001|Overall Study|Adverse Event|2
6850214|NCT00347360|10857843|FG002|Overall Study|Adverse Event|0
6850215|NCT00347360|10857844|FG003|Overall Study|Adverse Event|4
6850216|NCT00347360|10857845|FG004|Overall Study|Adverse Event|1
6850217|NCT00347360|10857846|FG005|Overall Study|Adverse Event|2
6850218|NCT00347360|10857847|FG006|Overall Study|Adverse Event|2
6850219|NCT00347360|10857848|FG007|Overall Study|Adverse Event|0
6850220|NCT00347360|10857849|FG008|Overall Study|Adverse Event|2
6850221|NCT00347360|10857850|FG009|Overall Study|Adverse Event|3
6850222|NCT00347360|10857851|FG010|Overall Study|Adverse Event|3
6850223|NCT00347360|10857852|FG011|Overall Study|Adverse Event|1
6850224|NCT00347360|10857853|FG012|Overall Study|Adverse Event|3
6850225|NCT00347360|10857854|FG013|Overall Study|Adverse Event|2
6850226|NCT00347360|10857855|FG014|Overall Study|Adverse Event|2
6850227|NCT00347360|10857841|FG000|Overall Study|Lost to Follow-up|0
6850228|NCT00347360|10857842|FG001|Overall Study|Lost to Follow-up|0
6850229|NCT00347360|10857843|FG002|Overall Study|Lost to Follow-up|0
6850230|NCT00347360|10857844|FG003|Overall Study|Lost to Follow-up|2
6850231|NCT00347360|10857845|FG004|Overall Study|Lost to Follow-up|1
6850232|NCT00347360|10857846|FG005|Overall Study|Lost to Follow-up|1
6850233|NCT00347360|10857847|FG006|Overall Study|Lost to Follow-up|0
6850234|NCT00347360|10857848|FG007|Overall Study|Lost to Follow-up|1
6850235|NCT00347360|10857849|FG008|Overall Study|Lost to Follow-up|1
6850236|NCT00347360|10857850|FG009|Overall Study|Lost to Follow-up|2
6850237|NCT00347360|10857851|FG010|Overall Study|Lost to Follow-up|0
6850238|NCT00347360|10857852|FG011|Overall Study|Lost to Follow-up|0
6850239|NCT00347360|10857853|FG012|Overall Study|Lost to Follow-up|1
6850240|NCT00347360|10857854|FG013|Overall Study|Lost to Follow-up|0
6850241|NCT00347360|10857855|FG014|Overall Study|Lost to Follow-up|0
6850242|NCT00347360|10857841|FG000|Overall Study|Protocol Violation|2
6850243|NCT00347360|10857842|FG001|Overall Study|Protocol Violation|3
6850244|NCT00347360|10857843|FG002|Overall Study|Protocol Violation|1
6850245|NCT00347360|10857844|FG003|Overall Study|Protocol Violation|2
6850246|NCT00347360|10857845|FG004|Overall Study|Protocol Violation|1
6850247|NCT00347360|10857846|FG005|Overall Study|Protocol Violation|2
6850248|NCT00347360|10857847|FG006|Overall Study|Protocol Violation|0
6850249|NCT00347360|10857848|FG007|Overall Study|Protocol Violation|0
6850250|NCT00347360|10857849|FG008|Overall Study|Protocol Violation|1
6850251|NCT00347360|10857850|FG009|Overall Study|Protocol Violation|2
6850252|NCT00347360|10857851|FG010|Overall Study|Protocol Violation|0
6850253|NCT00347360|10857852|FG011|Overall Study|Protocol Violation|0
6850254|NCT00347360|10857853|FG012|Overall Study|Protocol Violation|0
6850255|NCT00347360|10857854|FG013|Overall Study|Protocol Violation|1
6850256|NCT00347360|10857855|FG014|Overall Study|Protocol Violation|0
6850257|NCT00347360|10857841|FG000|Overall Study|Withdrawal by Subject|0
6850258|NCT00347360|10857842|FG001|Overall Study|Withdrawal by Subject|1
6850259|NCT00347360|10857843|FG002|Overall Study|Withdrawal by Subject|2
6850260|NCT00347360|10857844|FG003|Overall Study|Withdrawal by Subject|4
6850261|NCT00347360|10857845|FG004|Overall Study|Withdrawal by Subject|1
6850262|NCT00347360|10857846|FG005|Overall Study|Withdrawal by Subject|2
6850263|NCT00347360|10857847|FG006|Overall Study|Withdrawal by Subject|1
6850264|NCT00347360|10857848|FG007|Overall Study|Withdrawal by Subject|1
6850265|NCT00347360|10857849|FG008|Overall Study|Withdrawal by Subject|1
6850266|NCT00347360|10857850|FG009|Overall Study|Withdrawal by Subject|1
6850267|NCT00347360|10857851|FG010|Overall Study|Withdrawal by Subject|0
6850268|NCT00347360|10857852|FG011|Overall Study|Withdrawal by Subject|3
6850269|NCT00347360|10857853|FG012|Overall Study|Withdrawal by Subject|4
6850270|NCT00347360|10857854|FG013|Overall Study|Withdrawal by Subject|2
6850271|NCT00347360|10857855|FG014|Overall Study|Withdrawal by Subject|1
6850272|NCT00347360|10857841|FG000|Overall Study|Lack of Efficacy|1
6850273|NCT00347360|10857842|FG001|Overall Study|Lack of Efficacy|1
6850274|NCT00347360|10857843|FG002|Overall Study|Lack of Efficacy|3
6850275|NCT00347360|10857844|FG003|Overall Study|Lack of Efficacy|1
6850276|NCT00347360|10857845|FG004|Overall Study|Lack of Efficacy|0
6850277|NCT00347360|10857846|FG005|Overall Study|Lack of Efficacy|1
6850278|NCT00347360|10857847|FG006|Overall Study|Lack of Efficacy|0
6850279|NCT00347360|10857848|FG007|Overall Study|Lack of Efficacy|1
6850280|NCT00347360|10857849|FG008|Overall Study|Lack of Efficacy|1
6850281|NCT00347360|10857850|FG009|Overall Study|Lack of Efficacy|0
6850282|NCT00347360|10857851|FG010|Overall Study|Lack of Efficacy|0
6850283|NCT00347360|10857852|FG011|Overall Study|Lack of Efficacy|0
6850284|NCT00347360|10857853|FG012|Overall Study|Lack of Efficacy|0
6850285|NCT00347360|10857854|FG013|Overall Study|Lack of Efficacy|0
6850286|NCT00347360|10857855|FG014|Overall Study|Lack of Efficacy|0
6850287|NCT00347360|10857841|FG000|Overall Study|Reason not listed/blank|1
6850288|NCT00347360|10857842|FG001|Overall Study|Reason not listed/blank|0
6850289|NCT00347360|10857843|FG002|Overall Study|Reason not listed/blank|0
6850290|NCT00347360|10857844|FG003|Overall Study|Reason not listed/blank|0
6850291|NCT00347360|10857845|FG004|Overall Study|Reason not listed/blank|0
6850292|NCT00347360|10857846|FG005|Overall Study|Reason not listed/blank|0
6850293|NCT00347360|10857847|FG006|Overall Study|Reason not listed/blank|1
6850294|NCT00347360|10857848|FG007|Overall Study|Reason not listed/blank|0
6850295|NCT00347360|10857849|FG008|Overall Study|Reason not listed/blank|0
6850296|NCT00347360|10857850|FG009|Overall Study|Reason not listed/blank|0
6850297|NCT00347360|10857851|FG010|Overall Study|Reason not listed/blank|0
6850298|NCT00347360|10857852|FG011|Overall Study|Reason not listed/blank|0
6850299|NCT00347360|10857853|FG012|Overall Study|Reason not listed/blank|0
6850300|NCT00347360|10857854|FG013|Overall Study|Reason not listed/blank|1
6850301|NCT00347360|10857855|FG014|Overall Study|Reason not listed/blank|0
6850302|NCT00347360|10857841|FG000|Overall Study|Per sponsors instruction|0
6850303|NCT00347360|10857842|FG001|Overall Study|Per sponsors instruction|1
6850304|NCT00347360|10857843|FG002|Overall Study|Per sponsors instruction|0
6966678|NCT01126060|11014715|FG000|Overall Study|Protocol Violation|0
6966679|NCT01126060|11014716|FG001|Overall Study|Protocol Violation|2
6966680|NCT01126268|11014731|FG000|Overall Study|Adverse Event|1
6966681|NCT01126359|11014735|FG000|First Intervention (20-minutes)|Physician Decision|0
6966682|NCT01126359|11014736|FG001|First Intervention (20-minutes)|Physician Decision|1
6966683|NCT01126424|11014752|FG000|Overall Study|Adverse Event|0
6966684|NCT01126424|11014753|FG001|Overall Study|Adverse Event|0
6966685|NCT01126424|11014754|FG002|Overall Study|Adverse Event|0
6966686|NCT01126424|11014755|FG003|Overall Study|Adverse Event|0
6966687|NCT01126424|11014756|FG004|Overall Study|Adverse Event|1
6966688|NCT01126424|11014757|FG005|Overall Study|Adverse Event|0
6966689|NCT01126424|11014752|FG000|Overall Study|Withdrawal by Subject|0
6966690|NCT01126424|11014753|FG001|Overall Study|Withdrawal by Subject|0
6966691|NCT01126424|11014754|FG002|Overall Study|Withdrawal by Subject|1
6966692|NCT01126424|11014755|FG003|Overall Study|Withdrawal by Subject|3
6966693|NCT01126424|11014756|FG004|Overall Study|Withdrawal by Subject|1
6966694|NCT01126424|11014757|FG005|Overall Study|Withdrawal by Subject|0
6966695|NCT01126437|11014768|FG000|Overall Study|Not treated|11
6966696|NCT01126437|11014769|FG001|Overall Study|Not treated|18
6966697|NCT01126437|11014770|FG002|Overall Study|Not treated|19
6966698|NCT01126437|11014768|FG000|Overall Study|Sites with data irregularities/fraud|6
6966699|NCT01126437|11014769|FG001|Overall Study|Sites with data irregularities/fraud|6
6966700|NCT01126437|11014770|FG002|Overall Study|Sites with data irregularities/fraud|7
6966701|NCT01126437|11014768|FG000|Overall Study|Adverse Event|602
6966702|NCT01126437|11014769|FG001|Overall Study|Adverse Event|606
6966703|NCT01126437|11014770|FG002|Overall Study|Adverse Event|635
6966704|NCT01126437|11014768|FG000|Overall Study|Lack of Efficacy|65
6966705|NCT01126437|11014769|FG001|Overall Study|Lack of Efficacy|60
6966706|NCT01126437|11014770|FG002|Overall Study|Lack of Efficacy|59
6966707|NCT01126437|11014768|FG000|Overall Study|Protocol Violation|64
6966708|NCT01126437|11014769|FG001|Overall Study|Protocol Violation|66
6966709|NCT01126437|11014770|FG002|Overall Study|Protocol Violation|41
6850305|NCT00347360|10857844|FG003|Overall Study|Per sponsors instruction|0
6850306|NCT00347360|10857845|FG004|Overall Study|Per sponsors instruction|0
6850307|NCT00347360|10857846|FG005|Overall Study|Per sponsors instruction|0
6850308|NCT00347360|10857847|FG006|Overall Study|Per sponsors instruction|0
6966710|NCT01126437|11014768|FG000|Overall Study|Lost to Follow-up|52
6966711|NCT01126437|11014769|FG001|Overall Study|Lost to Follow-up|63
6966712|NCT01126437|11014770|FG002|Overall Study|Lost to Follow-up|55
6966713|NCT01126437|11014768|FG000|Overall Study|Withdrawal by Subject|331
6850309|NCT00347360|10857848|FG007|Overall Study|Per sponsors instruction|0
6966714|NCT01126437|11014769|FG001|Overall Study|Withdrawal by Subject|335
6966715|NCT01126437|11014770|FG002|Overall Study|Withdrawal by Subject|319
6966716|NCT01126437|11014768|FG000|Overall Study|Other reason not specified|210
6850310|NCT00347360|10857849|FG008|Overall Study|Per sponsors instruction|0
6850311|NCT00347360|10857850|FG009|Overall Study|Per sponsors instruction|0
6850312|NCT00347360|10857851|FG010|Overall Study|Per sponsors instruction|0
6850313|NCT00347360|10857852|FG011|Overall Study|Per sponsors instruction|0
6850314|NCT00347360|10857853|FG012|Overall Study|Per sponsors instruction|0
6850315|NCT00347360|10857854|FG013|Overall Study|Per sponsors instruction|0
6850316|NCT00347360|10857855|FG014|Overall Study|Per sponsors instruction|0
6850317|NCT00347360|10857841|FG000|Overall Study|P.I. recommended due to blood pressure|0
6850318|NCT00347360|10857842|FG001|Overall Study|P.I. recommended due to blood pressure|0
6850319|NCT00347360|10857843|FG002|Overall Study|P.I. recommended due to blood pressure|0
6850320|NCT00347360|10857844|FG003|Overall Study|P.I. recommended due to blood pressure|0
6850321|NCT00347360|10857845|FG004|Overall Study|P.I. recommended due to blood pressure|1
6850322|NCT00347360|10857846|FG005|Overall Study|P.I. recommended due to blood pressure|0
6850323|NCT00347360|10857847|FG006|Overall Study|P.I. recommended due to blood pressure|0
6850324|NCT00347360|10857848|FG007|Overall Study|P.I. recommended due to blood pressure|0
6850325|NCT00347360|10857849|FG008|Overall Study|P.I. recommended due to blood pressure|0
6850326|NCT00347360|10857850|FG009|Overall Study|P.I. recommended due to blood pressure|0
6850327|NCT00347360|10857851|FG010|Overall Study|P.I. recommended due to blood pressure|0
6850328|NCT00347360|10857852|FG011|Overall Study|P.I. recommended due to blood pressure|0
6850329|NCT00347360|10857853|FG012|Overall Study|P.I. recommended due to blood pressure|0
6850330|NCT00347360|10857854|FG013|Overall Study|P.I. recommended due to blood pressure|0
6850331|NCT00347360|10857855|FG014|Overall Study|P.I. recommended due to blood pressure|0
6850332|NCT00347360|10857841|FG000|Overall Study|Subject did not meet end of study ABPM|0
6850333|NCT00347360|10857842|FG001|Overall Study|Subject did not meet end of study ABPM|0
6850334|NCT00347360|10857843|FG002|Overall Study|Subject did not meet end of study ABPM|0
6850335|NCT00347360|10857844|FG003|Overall Study|Subject did not meet end of study ABPM|0
6850336|NCT00347360|10857845|FG004|Overall Study|Subject did not meet end of study ABPM|0
6850337|NCT00347360|10857846|FG005|Overall Study|Subject did not meet end of study ABPM|0
6850338|NCT00347360|10857847|FG006|Overall Study|Subject did not meet end of study ABPM|1
6850339|NCT00347360|10857848|FG007|Overall Study|Subject did not meet end of study ABPM|0
6850340|NCT00347360|10857849|FG008|Overall Study|Subject did not meet end of study ABPM|0
6850341|NCT00347360|10857850|FG009|Overall Study|Subject did not meet end of study ABPM|0
6850342|NCT00347360|10857851|FG010|Overall Study|Subject did not meet end of study ABPM|1
6850343|NCT00347360|10857852|FG011|Overall Study|Subject did not meet end of study ABPM|0
6850344|NCT00347360|10857853|FG012|Overall Study|Subject did not meet end of study ABPM|1
6850345|NCT00347360|10857854|FG013|Overall Study|Subject did not meet end of study ABPM|1
6850346|NCT00347360|10857855|FG014|Overall Study|Subject did not meet end of study ABPM|0
6850347|NCT00347360|10857841|FG000|Overall Study|Abnormal lab values|0
6850348|NCT00347360|10857842|FG001|Overall Study|Abnormal lab values|0
6850349|NCT00347360|10857843|FG002|Overall Study|Abnormal lab values|0
6850350|NCT00347360|10857844|FG003|Overall Study|Abnormal lab values|0
6850351|NCT00347360|10857845|FG004|Overall Study|Abnormal lab values|0
6850352|NCT00347360|10857846|FG005|Overall Study|Abnormal lab values|0
6850353|NCT00347360|10857847|FG006|Overall Study|Abnormal lab values|1
6850354|NCT00347360|10857848|FG007|Overall Study|Abnormal lab values|0
6850355|NCT00347360|10857849|FG008|Overall Study|Abnormal lab values|0
6850356|NCT00347360|10857850|FG009|Overall Study|Abnormal lab values|0
6850357|NCT00347360|10857851|FG010|Overall Study|Abnormal lab values|0
6850358|NCT00347360|10857852|FG011|Overall Study|Abnormal lab values|0
6850359|NCT00347360|10857853|FG012|Overall Study|Abnormal lab values|0
6850360|NCT00347360|10857854|FG013|Overall Study|Abnormal lab values|0
6850361|NCT00347360|10857855|FG014|Overall Study|Abnormal lab values|0
6850362|NCT00347360|10857841|FG000|Overall Study|PI recommended early withdrawal|0
6850363|NCT00347360|10857842|FG001|Overall Study|PI recommended early withdrawal|0
6850364|NCT00347360|10857843|FG002|Overall Study|PI recommended early withdrawal|0
6850365|NCT00347360|10857844|FG003|Overall Study|PI recommended early withdrawal|0
6850366|NCT00347360|10857845|FG004|Overall Study|PI recommended early withdrawal|0
6850367|NCT00347360|10857846|FG005|Overall Study|PI recommended early withdrawal|0
6850368|NCT00347360|10857847|FG006|Overall Study|PI recommended early withdrawal|0
6850369|NCT00347360|10857848|FG007|Overall Study|PI recommended early withdrawal|0
6850370|NCT00347360|10857849|FG008|Overall Study|PI recommended early withdrawal|0
6850371|NCT00347360|10857850|FG009|Overall Study|PI recommended early withdrawal|1
6850372|NCT00347360|10857851|FG010|Overall Study|PI recommended early withdrawal|0
6850373|NCT00347360|10857852|FG011|Overall Study|PI recommended early withdrawal|0
6850374|NCT00347360|10857853|FG012|Overall Study|PI recommended early withdrawal|0
6850375|NCT00347360|10857854|FG013|Overall Study|PI recommended early withdrawal|0
6850376|NCT00347360|10857855|FG014|Overall Study|PI recommended early withdrawal|0
6850377|NCT00347360|10857841|FG000|Overall Study|Did not meet criteria before ABPM|0
6850378|NCT00347360|10857842|FG001|Overall Study|Did not meet criteria before ABPM|0
6850379|NCT00347360|10857843|FG002|Overall Study|Did not meet criteria before ABPM|0
6850380|NCT00347360|10857844|FG003|Overall Study|Did not meet criteria before ABPM|0
6850381|NCT00347360|10857845|FG004|Overall Study|Did not meet criteria before ABPM|0
6850382|NCT00347360|10857846|FG005|Overall Study|Did not meet criteria before ABPM|0
6850383|NCT00347360|10857847|FG006|Overall Study|Did not meet criteria before ABPM|0
6850384|NCT00347360|10857848|FG007|Overall Study|Did not meet criteria before ABPM|0
6850385|NCT00347360|10857849|FG008|Overall Study|Did not meet criteria before ABPM|0
6850386|NCT00347360|10857850|FG009|Overall Study|Did not meet criteria before ABPM|0
6850387|NCT00347360|10857851|FG010|Overall Study|Did not meet criteria before ABPM|1
6850388|NCT00347360|10857852|FG011|Overall Study|Did not meet criteria before ABPM|0
6850389|NCT00347360|10857853|FG012|Overall Study|Did not meet criteria before ABPM|0
6850390|NCT00347360|10857854|FG013|Overall Study|Did not meet criteria before ABPM|0
6850391|NCT00347360|10857855|FG014|Overall Study|Did not meet criteria before ABPM|0
6850392|NCT00347360|10857841|FG000|Overall Study|Randomized in error|0
6850393|NCT00347360|10857842|FG001|Overall Study|Randomized in error|0
6850394|NCT00347360|10857843|FG002|Overall Study|Randomized in error|0
6850395|NCT00347360|10857844|FG003|Overall Study|Randomized in error|0
6850396|NCT00347360|10857845|FG004|Overall Study|Randomized in error|0
6850397|NCT00347360|10857846|FG005|Overall Study|Randomized in error|0
6850398|NCT00347360|10857847|FG006|Overall Study|Randomized in error|0
6850399|NCT00347360|10857848|FG007|Overall Study|Randomized in error|0
6850400|NCT00347360|10857849|FG008|Overall Study|Randomized in error|0
6850401|NCT00347360|10857850|FG009|Overall Study|Randomized in error|0
6850402|NCT00347360|10857851|FG010|Overall Study|Randomized in error|0
6850403|NCT00347360|10857852|FG011|Overall Study|Randomized in error|1
6850404|NCT00347360|10857853|FG012|Overall Study|Randomized in error|0
6850405|NCT00347360|10857854|FG013|Overall Study|Randomized in error|0
6850406|NCT00347360|10857855|FG014|Overall Study|Randomized in error|0
6850407|NCT00347360|10857841|FG000|Overall Study|Failed inclusion criteria #4|0
6850408|NCT00347360|10857842|FG001|Overall Study|Failed inclusion criteria #4|0
6850409|NCT00347360|10857843|FG002|Overall Study|Failed inclusion criteria #4|0
6850410|NCT00347360|10857844|FG003|Overall Study|Failed inclusion criteria #4|0
6850411|NCT00347360|10857845|FG004|Overall Study|Failed inclusion criteria #4|0
6850412|NCT00347360|10857846|FG005|Overall Study|Failed inclusion criteria #4|0
6850413|NCT00347360|10857847|FG006|Overall Study|Failed inclusion criteria #4|0
6850414|NCT00347360|10857848|FG007|Overall Study|Failed inclusion criteria #4|0
6850415|NCT00347360|10857849|FG008|Overall Study|Failed inclusion criteria #4|0
6850416|NCT00347360|10857850|FG009|Overall Study|Failed inclusion criteria #4|0
6850417|NCT00347360|10857851|FG010|Overall Study|Failed inclusion criteria #4|0
6850418|NCT00347360|10857852|FG011|Overall Study|Failed inclusion criteria #4|1
6850419|NCT00347360|10857853|FG012|Overall Study|Failed inclusion criteria #4|0
6850420|NCT00347360|10857854|FG013|Overall Study|Failed inclusion criteria #4|0
6850421|NCT00347360|10857855|FG014|Overall Study|Failed inclusion criteria #4|0
6850422|NCT00347360|10857841|FG000|Overall Study|Prolonged duration between visits|0
6850423|NCT00347360|10857842|FG001|Overall Study|Prolonged duration between visits|0
6850424|NCT00347360|10857843|FG002|Overall Study|Prolonged duration between visits|0
6850425|NCT00347360|10857844|FG003|Overall Study|Prolonged duration between visits|0
6850426|NCT00347360|10857845|FG004|Overall Study|Prolonged duration between visits|0
6850427|NCT00347360|10857846|FG005|Overall Study|Prolonged duration between visits|0
6850428|NCT00347360|10857847|FG006|Overall Study|Prolonged duration between visits|0
6850429|NCT00347360|10857848|FG007|Overall Study|Prolonged duration between visits|0
6850430|NCT00347360|10857849|FG008|Overall Study|Prolonged duration between visits|0
6850431|NCT00347360|10857850|FG009|Overall Study|Prolonged duration between visits|0
6850432|NCT00347360|10857851|FG010|Overall Study|Prolonged duration between visits|0
6850433|NCT00347360|10857852|FG011|Overall Study|Prolonged duration between visits|0
6850434|NCT00347360|10857853|FG012|Overall Study|Prolonged duration between visits|1
6850435|NCT00347360|10857854|FG013|Overall Study|Prolonged duration between visits|0
6850436|NCT00347360|10857855|FG014|Overall Study|Prolonged duration between visits|0
6850437|NCT00347360|10857841|FG000|Overall Study|Subject left town, ran out of study drug|0
6850438|NCT00347360|10857842|FG001|Overall Study|Subject left town, ran out of study drug|0
6850439|NCT00347360|10857843|FG002|Overall Study|Subject left town, ran out of study drug|0
6850440|NCT00347360|10857844|FG003|Overall Study|Subject left town, ran out of study drug|0
6850441|NCT00347360|10857845|FG004|Overall Study|Subject left town, ran out of study drug|0
6850442|NCT00347360|10857846|FG005|Overall Study|Subject left town, ran out of study drug|0
6850443|NCT00347360|10857847|FG006|Overall Study|Subject left town, ran out of study drug|0
6850444|NCT00347360|10857848|FG007|Overall Study|Subject left town, ran out of study drug|0
6850445|NCT00347360|10857849|FG008|Overall Study|Subject left town, ran out of study drug|0
6850446|NCT00347360|10857850|FG009|Overall Study|Subject left town, ran out of study drug|0
6850447|NCT00347360|10857851|FG010|Overall Study|Subject left town, ran out of study drug|0
6850448|NCT00347360|10857852|FG011|Overall Study|Subject left town, ran out of study drug|0
6850449|NCT00347360|10857853|FG012|Overall Study|Subject left town, ran out of study drug|0
6850450|NCT00347360|10857854|FG013|Overall Study|Subject left town, ran out of study drug|1
6850451|NCT00347360|10857855|FG014|Overall Study|Subject left town, ran out of study drug|0
6850452|NCT00347360|10857841|FG000|Overall Study|Subject refuse to sign updated consent|0
6850453|NCT00347360|10857842|FG001|Overall Study|Subject refuse to sign updated consent|0
6850454|NCT00347360|10857843|FG002|Overall Study|Subject refuse to sign updated consent|0
6850455|NCT00347360|10857844|FG003|Overall Study|Subject refuse to sign updated consent|0
6850456|NCT00347360|10857845|FG004|Overall Study|Subject refuse to sign updated consent|0
6850457|NCT00347360|10857846|FG005|Overall Study|Subject refuse to sign updated consent|0
6850458|NCT00347360|10857847|FG006|Overall Study|Subject refuse to sign updated consent|0
6850459|NCT00347360|10857848|FG007|Overall Study|Subject refuse to sign updated consent|0
6850460|NCT00347360|10857849|FG008|Overall Study|Subject refuse to sign updated consent|0
6850461|NCT00347360|10857850|FG009|Overall Study|Subject refuse to sign updated consent|0
6850462|NCT00347360|10857851|FG010|Overall Study|Subject refuse to sign updated consent|0
6850463|NCT00347360|10857852|FG011|Overall Study|Subject refuse to sign updated consent|0
6850464|NCT00347360|10857853|FG012|Overall Study|Subject refuse to sign updated consent|0
6850465|NCT00347360|10857854|FG013|Overall Study|Subject refuse to sign updated consent|0
6850466|NCT00347360|10857855|FG014|Overall Study|Subject refuse to sign updated consent|1
6850467|NCT00347360|10857841|FG000|Overall Study|Visits conflicted with new job|0
6850468|NCT00347360|10857842|FG001|Overall Study|Visits conflicted with new job|0
6850469|NCT00347360|10857843|FG002|Overall Study|Visits conflicted with new job|0
6850470|NCT00347360|10857844|FG003|Overall Study|Visits conflicted with new job|0
6850471|NCT00347360|10857845|FG004|Overall Study|Visits conflicted with new job|0
6850472|NCT00347360|10857846|FG005|Overall Study|Visits conflicted with new job|0
6850473|NCT00347360|10857847|FG006|Overall Study|Visits conflicted with new job|1
6850474|NCT00347360|10857848|FG007|Overall Study|Visits conflicted with new job|0
6850475|NCT00347360|10857849|FG008|Overall Study|Visits conflicted with new job|0
6850476|NCT00347360|10857850|FG009|Overall Study|Visits conflicted with new job|0
6850477|NCT00347360|10857851|FG010|Overall Study|Visits conflicted with new job|0
7184122|NCT01755689|11384111|FG000|Overall Study|Migrated/moved from study area|0
6850478|NCT00347360|10857852|FG011|Overall Study|Visits conflicted with new job|0
6850479|NCT00347360|10857853|FG012|Overall Study|Visits conflicted with new job|0
6850480|NCT00347360|10857854|FG013|Overall Study|Visits conflicted with new job|0
6850481|NCT00347360|10857855|FG014|Overall Study|Visits conflicted with new job|0
6850482|NCT00347438|10857887|FG000|Overall Study|Withdrawal by Subject|1
6850483|NCT00347438|10857887|FG000|Overall Study|Physician Decision|1
6850484|NCT00347776|10857894|FG000|1.5 Month Follow-up|Death|2
6850485|NCT00347776|10857895|FG001|1.5 Month Follow-up|Death|0
6850486|NCT00347776|10857896|FG002|1.5 Month Follow-up|Death|0
6850487|NCT00347776|10857894|FG000|1.5 Month Follow-up|reached the endpoint|12
6850488|NCT00347776|10857895|FG001|1.5 Month Follow-up|reached the endpoint|8
6850489|NCT00347776|10857896|FG002|1.5 Month Follow-up|reached the endpoint|12
6850490|NCT00347776|10857894|FG000|6 Month Follow-up|Death|2
6850491|NCT00347776|10857895|FG001|6 Month Follow-up|Death|1
6850492|NCT00347776|10857896|FG002|6 Month Follow-up|Death|3
6850493|NCT00347776|10857894|FG000|6 Month Follow-up|reached endpont|20
6850494|NCT00347776|10857895|FG001|6 Month Follow-up|reached endpont|12
6850495|NCT00347776|10857896|FG002|6 Month Follow-up|reached endpont|15
6850496|NCT00347776|10857894|FG000|12 Month Follow-up|Lost to Follow-up|7
6850497|NCT00347776|10857895|FG001|12 Month Follow-up|Lost to Follow-up|6
6850498|NCT00347776|10857896|FG002|12 Month Follow-up|Lost to Follow-up|6
6850499|NCT00347776|10857894|FG000|12 Month Follow-up|Death|3
6850500|NCT00347776|10857895|FG001|12 Month Follow-up|Death|4
6850501|NCT00347776|10857896|FG002|12 Month Follow-up|Death|4
6850502|NCT00347776|10857894|FG000|12 Month Follow-up|Reached endpoint|13
6850503|NCT00347776|10857895|FG001|12 Month Follow-up|Reached endpoint|6
6850504|NCT00347776|10857896|FG002|12 Month Follow-up|Reached endpoint|9
6850505|NCT00347919|10857907|FG000|Overall Study|Lost to Follow-up|11
6850506|NCT00347919|10857908|FG001|Overall Study|Lost to Follow-up|13
6850507|NCT00347919|10857909|FG002|Overall Study|Lost to Follow-up|0
6850508|NCT00347919|10857907|FG000|Overall Study|Withdrawal by Subject|6
6850509|NCT00347919|10857908|FG001|Overall Study|Withdrawal by Subject|8
6850510|NCT00347919|10857909|FG002|Overall Study|Withdrawal by Subject|0
6850511|NCT00347919|10857907|FG000|Overall Study|Physician Decision|1
6850512|NCT00347919|10857908|FG001|Overall Study|Physician Decision|1
6850513|NCT00347919|10857909|FG002|Overall Study|Physician Decision|0
6850514|NCT00347919|10857907|FG000|Overall Study|Sponsor terminated study|15
6850515|NCT00347919|10857908|FG001|Overall Study|Sponsor terminated study|10
6850516|NCT00347919|10857909|FG002|Overall Study|Sponsor terminated study|16
6850517|NCT00347919|10857907|FG000|Overall Study|Death|35
6850518|NCT00347919|10857908|FG001|Overall Study|Death|42
6850519|NCT00347919|10857909|FG002|Overall Study|Death|19
6850520|NCT00347919|10857907|FG000|Overall Study|Par. Started Other Treatment|1
6850521|NCT00347919|10857908|FG001|Overall Study|Par. Started Other Treatment|1
6850522|NCT00347919|10857909|FG002|Overall Study|Par. Started Other Treatment|1
6850523|NCT00347919|10857907|FG000|Overall Study|Missing|2
6850524|NCT00347919|10857908|FG001|Overall Study|Missing|1
6850525|NCT00347919|10857909|FG002|Overall Study|Missing|2
6850526|NCT00347932|10857921|FG000|Overall Study|Adverse Event|4
6850527|NCT00347932|10857922|FG001|Overall Study|Adverse Event|5
6850528|NCT00347932|10857921|FG000|Overall Study|Lack of Efficacy|3
6850529|NCT00347932|10857922|FG001|Overall Study|Lack of Efficacy|14
6850530|NCT00347932|10857921|FG000|Overall Study|Lost to Follow-up|10
6850531|NCT00347932|10857922|FG001|Overall Study|Lost to Follow-up|9
6850532|NCT00347932|10857921|FG000|Overall Study|Withdrawal by Subject|10
6850533|NCT00347932|10857922|FG001|Overall Study|Withdrawal by Subject|16
6850534|NCT00347932|10857921|FG000|Overall Study|Did not meet inclusion criteria|4
6850535|NCT00347932|10857922|FG001|Overall Study|Did not meet inclusion criteria|8
6966717|NCT01126437|11014769|FG001|Overall Study|Other reason not specified|176
6966718|NCT01126437|11014770|FG002|Overall Study|Other reason not specified|178
6966719|NCT01126541|11014781|FG000|Overall Study|Adverse Event|0
6966720|NCT01126541|11014782|FG001|Overall Study|Adverse Event|2
6966721|NCT01126541|11014783|FG002|Overall Study|Adverse Event|4
7152610|NCT03261037|11317646|FG001|Overall Study|Participant came out of study due to investigator discretion|2
7152611|NCT03261037|11317647|FG002|Overall Study|Participant came out of study due to investigator discretion|0
7152612|NCT03261037|11317648|FG003|Overall Study|Participant came out of study due to investigator discretion|0
6850536|NCT00347958|10857928|FG000|Overall Study|Adverse Event|1
6850537|NCT00347958|10857928|FG000|Overall Study|Protocol Violation|2
6850538|NCT00347958|10857928|FG000|Overall Study|Withdrawal by Subject|1
6850539|NCT00348140|10857935|FG000|Overall Study|Adverse Event|46
6850540|NCT00348140|10857936|FG001|Overall Study|Adverse Event|49
6850541|NCT00348140|10857937|FG002|Overall Study|Adverse Event|78
6850542|NCT00348140|10857935|FG000|Overall Study|Lost to Follow-up|4
6850543|NCT00348140|10857936|FG001|Overall Study|Lost to Follow-up|4
6850544|NCT00348140|10857937|FG002|Overall Study|Lost to Follow-up|4
6850545|NCT00348140|10857935|FG000|Overall Study|Protocol Violation|12
6850546|NCT00348140|10857936|FG001|Overall Study|Protocol Violation|13
6850547|NCT00348140|10857937|FG002|Overall Study|Protocol Violation|14
6850548|NCT00348140|10857935|FG000|Overall Study|Withdrawal by Subject|32
6850549|NCT00348140|10857936|FG001|Overall Study|Withdrawal by Subject|40
6850550|NCT00348140|10857937|FG002|Overall Study|Withdrawal by Subject|40
6850551|NCT00348140|10857935|FG000|Overall Study|Non-compliance|8
6850552|NCT00348140|10857936|FG001|Overall Study|Non-compliance|13
6850553|NCT00348140|10857937|FG002|Overall Study|Non-compliance|5
6850554|NCT00348140|10857935|FG000|Overall Study|Participant at risk due to study drug|2
6850555|NCT00348140|10857936|FG001|Overall Study|Participant at risk due to study drug|0
6850556|NCT00348140|10857937|FG002|Overall Study|Participant at risk due to study drug|0
6850557|NCT00348140|10857935|FG000|Overall Study|Conditional medication increased dose|1
6850558|NCT00348140|10857936|FG001|Overall Study|Conditional medication increased dose|0
6850559|NCT00348140|10857937|FG002|Overall Study|Conditional medication increased dose|0
6850560|NCT00348140|10857935|FG000|Overall Study|Caregiver related|4
6850561|NCT00348140|10857936|FG001|Overall Study|Caregiver related|7
6850562|NCT00348140|10857937|FG002|Overall Study|Caregiver related|3
6850563|NCT00348140|10857935|FG000|Overall Study|Participant hospitalised|3
6850564|NCT00348140|10857936|FG001|Overall Study|Participant hospitalised|0
6850565|NCT00348140|10857937|FG002|Overall Study|Participant hospitalised|0
6850566|NCT00348140|10857935|FG000|Overall Study|Efficacy related|1
6850567|NCT00348140|10857936|FG001|Overall Study|Efficacy related|1
6850568|NCT00348140|10857937|FG002|Overall Study|Efficacy related|0
6850569|NCT00348140|10857935|FG000|Overall Study|Administration related|3
6850570|NCT00348140|10857936|FG001|Overall Study|Administration related|1
6850571|NCT00348140|10857937|FG002|Overall Study|Administration related|1
6850572|NCT00348140|10857935|FG000|Overall Study|Unmet inclusion-exclusion criteria|1
6850573|NCT00348140|10857936|FG001|Overall Study|Unmet inclusion-exclusion criteria|0
6850574|NCT00348140|10857937|FG002|Overall Study|Unmet inclusion-exclusion criteria|1
6850575|NCT00348140|10857935|FG000|Overall Study|Participant unwell|1
6850576|NCT00348140|10857936|FG001|Overall Study|Participant unwell|0
6850577|NCT00348140|10857937|FG002|Overall Study|Participant unwell|0
6850578|NCT00348140|10857935|FG000|Overall Study|Screen failure|1
6850579|NCT00348140|10857936|FG001|Overall Study|Screen failure|0
6850580|NCT00348140|10857937|FG002|Overall Study|Screen failure|0
6850581|NCT00348140|10857935|FG000|Overall Study|Investigator decided to discontinue|4
6850582|NCT00348140|10857936|FG001|Overall Study|Investigator decided to discontinue|1
6850583|NCT00348140|10857937|FG002|Overall Study|Investigator decided to discontinue|4
6850584|NCT00348140|10857935|FG000|Overall Study|Decided to discontinue on their own|1
6850585|NCT00348140|10857936|FG001|Overall Study|Decided to discontinue on their own|4
6850586|NCT00348140|10857937|FG002|Overall Study|Decided to discontinue on their own|1
6850587|NCT00348140|10857935|FG000|Overall Study|Use of prohibited drug|1
6850588|NCT00348140|10857936|FG001|Overall Study|Use of prohibited drug|0
6850589|NCT00348140|10857937|FG002|Overall Study|Use of prohibited drug|2
6850590|NCT00348140|10857935|FG000|Overall Study|Disease progression|1
6850591|NCT00348140|10857936|FG001|Overall Study|Disease progression|2
6850592|NCT00348140|10857937|FG002|Overall Study|Disease progression|5
6850593|NCT00348140|10857935|FG000|Overall Study|Increased risk of cardiac infarction|0
6850594|NCT00348140|10857936|FG001|Overall Study|Increased risk of cardiac infarction|1
6850595|NCT00348140|10857937|FG002|Overall Study|Increased risk of cardiac infarction|0
6850596|NCT00348140|10857935|FG000|Overall Study|Serious adverse event|0
6850597|NCT00348140|10857936|FG001|Overall Study|Serious adverse event|1
6850598|NCT00348140|10857937|FG002|Overall Study|Serious adverse event|0
6850599|NCT00348140|10857935|FG000|Overall Study|Abnormal ECG|0
6850600|NCT00348140|10857936|FG001|Overall Study|Abnormal ECG|1
6850601|NCT00348140|10857937|FG002|Overall Study|Abnormal ECG|3
6850602|NCT00348140|10857935|FG000|Overall Study|Participant died|0
6850603|NCT00348140|10857936|FG001|Overall Study|Participant died|1
6850604|NCT00348140|10857937|FG002|Overall Study|Participant died|0
6850605|NCT00348140|10857935|FG000|Overall Study|Exclusion criteria met|0
7152613|NCT03261037|11317645|FG000|Overall Study|Diagnosed but protocol deviation|1
6850606|NCT00348140|10857936|FG001|Overall Study|Exclusion criteria met|0
6850607|NCT00348140|10857937|FG002|Overall Study|Exclusion criteria met|1
6850608|NCT00348140|10857935|FG000|Overall Study|Memory declined|0
6850609|NCT00348140|10857936|FG001|Overall Study|Memory declined|0
6850610|NCT00348140|10857937|FG002|Overall Study|Memory declined|1
6850611|NCT00348283|10857952|FG000|Induction|Adverse Event|0
6850612|NCT00348283|10857953|FG001|Induction|Adverse Event|2
6850613|NCT00348283|10857952|FG000|Induction|Protocol Violation|0
6850614|NCT00348283|10857953|FG001|Induction|Protocol Violation|4
6850615|NCT00348283|10857952|FG000|Double Blind|Adverse Event|2
6850616|NCT00348283|10857953|FG001|Double Blind|Adverse Event|5
6850617|NCT00348283|10857952|FG000|Double Blind|Withdrawal by Subject|1
6850618|NCT00348283|10857953|FG001|Double Blind|Withdrawal by Subject|1
6850619|NCT00348283|10857952|FG000|Double Blind|Protocol Violation|0
6850620|NCT00348283|10857953|FG001|Double Blind|Protocol Violation|1
6850621|NCT00348283|10857952|FG000|Double Blind|Lack of Efficacy|2
6850622|NCT00348283|10857953|FG001|Double Blind|Lack of Efficacy|2
6850623|NCT00348283|10857952|FG000|Double Blind|Pregnancy|0
6850624|NCT00348283|10857953|FG001|Double Blind|Pregnancy|1
6850625|NCT00348283|10857952|FG000|Open Label|Adverse Event|0
6850626|NCT00348283|10857953|FG001|Open Label|Adverse Event|8
6850627|NCT00348283|10857952|FG000|Open Label|Withdrawal by Subject|0
6850628|NCT00348283|10857953|FG001|Open Label|Withdrawal by Subject|4
6850629|NCT00348283|10857952|FG000|Open Label|Lost to Follow-up|0
6850630|NCT00348283|10857953|FG001|Open Label|Lost to Follow-up|1
6850631|NCT00348283|10857952|FG000|Open Label|Lack of Efficacy|0
6850632|NCT00348283|10857953|FG001|Open Label|Lack of Efficacy|13
6850633|NCT00348283|10857952|FG000|Open Label|Administrative reasons|0
6850634|NCT00348283|10857953|FG001|Open Label|Administrative reasons|5
6850635|NCT00348283|10857952|FG000|Open Label|Subject moved to the United States|0
6850636|NCT00348283|10857953|FG001|Open Label|Subject moved to the United States|1
6850637|NCT00348283|10857952|FG000|Open Label|Pregnancy|0
6850638|NCT00348283|10857953|FG001|Open Label|Pregnancy|1
6850639|NCT00348283|10857952|FG000|Open Label|Sponsor decision|0
6850640|NCT00348283|10857953|FG001|Open Label|Sponsor decision|1
6850641|NCT00348309|10857962|FG000|Overall Study|Adverse Event|56
6850642|NCT00348309|10857963|FG001|Overall Study|Adverse Event|28
6850643|NCT00348309|10857964|FG002|Overall Study|Adverse Event|63
6850644|NCT00348309|10857962|FG000|Overall Study|Lost to Follow-up|6
6850645|NCT00348309|10857963|FG001|Overall Study|Lost to Follow-up|7
6850646|NCT00348309|10857964|FG002|Overall Study|Lost to Follow-up|4
6850647|NCT00348309|10857962|FG000|Overall Study|Protocol Violation|7
6850648|NCT00348309|10857963|FG001|Overall Study|Protocol Violation|12
6850649|NCT00348309|10857964|FG002|Overall Study|Protocol Violation|7
6850650|NCT00348309|10857962|FG000|Overall Study|Withdrawal by Subject|33
6850651|NCT00348309|10857963|FG001|Overall Study|Withdrawal by Subject|37
6850652|NCT00348309|10857964|FG002|Overall Study|Withdrawal by Subject|40
6850653|NCT00348309|10857962|FG000|Overall Study|Non-compliance|8
6850654|NCT00348309|10857963|FG001|Overall Study|Non-compliance|6
6850655|NCT00348309|10857964|FG002|Overall Study|Non-compliance|8
6850656|NCT00348309|10857962|FG000|Overall Study|Death of caregiver|1
6850657|NCT00348309|10857963|FG001|Overall Study|Death of caregiver|0
6850658|NCT00348309|10857964|FG002|Overall Study|Death of caregiver|1
6850659|NCT00348309|10857962|FG000|Overall Study|Lack of insight, dementia|1
6850660|NCT00348309|10857963|FG001|Overall Study|Lack of insight, dementia|0
6850661|NCT00348309|10857964|FG002|Overall Study|Lack of insight, dementia|0
6850662|NCT00348309|10857962|FG000|Overall Study|Wrong bottle allocated|1
6850663|NCT00348309|10857963|FG001|Overall Study|Wrong bottle allocated|0
6850664|NCT00348309|10857964|FG002|Overall Study|Wrong bottle allocated|0
6850665|NCT00348309|10857962|FG000|Overall Study|Caregiver sick|1
6850666|NCT00348309|10857963|FG001|Overall Study|Caregiver sick|0
6850667|NCT00348309|10857964|FG002|Overall Study|Caregiver sick|0
6850668|NCT00348309|10857962|FG000|Overall Study|Use of prohibited medication|5
6850669|NCT00348309|10857963|FG001|Overall Study|Use of prohibited medication|2
6850670|NCT00348309|10857964|FG002|Overall Study|Use of prohibited medication|2
6850671|NCT00348309|10857962|FG000|Overall Study|Caregiver withdrawal|3
6850672|NCT00348309|10857963|FG001|Overall Study|Caregiver withdrawal|0
6850673|NCT00348309|10857964|FG002|Overall Study|Caregiver withdrawal|7
6850674|NCT00348309|10857962|FG000|Overall Study|Unable to complete ET visit|1
6850675|NCT00348309|10857963|FG001|Overall Study|Unable to complete ET visit|0
6850676|NCT00348309|10857964|FG002|Overall Study|Unable to complete ET visit|0
6850677|NCT00348309|10857962|FG000|Overall Study|PI closing medical practice|1
6850678|NCT00348309|10857963|FG001|Overall Study|PI closing medical practice|0
6850679|NCT00348309|10857964|FG002|Overall Study|PI closing medical practice|0
6850680|NCT00348309|10857962|FG000|Overall Study|Principal investigator's decision|1
6850681|NCT00348309|10857963|FG001|Overall Study|Principal investigator's decision|0
6850682|NCT00348309|10857964|FG002|Overall Study|Principal investigator's decision|0
6850683|NCT00348309|10857962|FG000|Overall Study|No disponibility of medication|1
6850684|NCT00348309|10857963|FG001|Overall Study|No disponibility of medication|0
6850685|NCT00348309|10857964|FG002|Overall Study|No disponibility of medication|0
6850686|NCT00348309|10857962|FG000|Overall Study|Worsened neurodegenerative disease|1
6850687|NCT00348309|10857963|FG001|Overall Study|Worsened neurodegenerative disease|0
6850688|NCT00348309|10857964|FG002|Overall Study|Worsened neurodegenerative disease|0
6850689|NCT00348309|10857962|FG000|Overall Study|Cognitive and behaviour worsening|2
6850690|NCT00348309|10857963|FG001|Overall Study|Cognitive and behaviour worsening|0
6850691|NCT00348309|10857964|FG002|Overall Study|Cognitive and behaviour worsening|0
6850692|NCT00348309|10857962|FG000|Overall Study|Worsening of alzheimer|1
6850693|NCT00348309|10857963|FG001|Overall Study|Worsening of alzheimer|0
6850694|NCT00348309|10857964|FG002|Overall Study|Worsening of alzheimer|1
6850695|NCT00348309|10857962|FG000|Overall Study|Did not appear in time for Visit 3|1
6850696|NCT00348309|10857963|FG001|Overall Study|Did not appear in time for Visit 3|0
6850697|NCT00348309|10857964|FG002|Overall Study|Did not appear in time for Visit 3|0
6850698|NCT00348309|10857962|FG000|Overall Study|Participant died|2
6850699|NCT00348309|10857963|FG001|Overall Study|Participant died|1
6850700|NCT00348309|10857964|FG002|Overall Study|Participant died|1
6850701|NCT00348309|10857962|FG000|Overall Study|Decision of sponsor|1
6850702|NCT00348309|10857963|FG001|Overall Study|Decision of sponsor|0
6850703|NCT00348309|10857964|FG002|Overall Study|Decision of sponsor|0
6850704|NCT00348309|10857962|FG000|Overall Study|Ineffectiveness of treatment|0
6850705|NCT00348309|10857963|FG001|Overall Study|Ineffectiveness of treatment|1
6850706|NCT00348309|10857964|FG002|Overall Study|Ineffectiveness of treatment|0
6850707|NCT00348309|10857962|FG000|Overall Study|A foul of exclusion criteria|0
6850708|NCT00348309|10857963|FG001|Overall Study|A foul of exclusion criteria|1
6850709|NCT00348309|10857964|FG002|Overall Study|A foul of exclusion criteria|0
6850710|NCT00348309|10857962|FG000|Overall Study|Participant was hospitalized|0
6850711|NCT00348309|10857963|FG001|Overall Study|Participant was hospitalized|1
6850712|NCT00348309|10857964|FG002|Overall Study|Participant was hospitalized|0
6850713|NCT00348309|10857962|FG000|Overall Study|Sponsor refuseal|0
6850714|NCT00348309|10857963|FG001|Overall Study|Sponsor refuseal|1
6850715|NCT00348309|10857964|FG002|Overall Study|Sponsor refuseal|1
6850716|NCT00348309|10857962|FG000|Overall Study|Forgot often medication|0
6850717|NCT00348309|10857963|FG001|Overall Study|Forgot often medication|1
6850718|NCT00348309|10857964|FG002|Overall Study|Forgot often medication|0
6850719|NCT00348309|10857962|FG000|Overall Study|Medical Monitor decision|0
6850720|NCT00348309|10857963|FG001|Overall Study|Medical Monitor decision|0
6850721|NCT00348309|10857964|FG002|Overall Study|Medical Monitor decision|1
6850722|NCT00348309|10857962|FG000|Overall Study|Increased dose of Aricept|0
6850723|NCT00348309|10857963|FG001|Overall Study|Increased dose of Aricept|0
6850724|NCT00348309|10857964|FG002|Overall Study|Increased dose of Aricept|1
6850725|NCT00348309|10857962|FG000|Overall Study|Site closure|0
6850726|NCT00348309|10857963|FG001|Overall Study|Site closure|0
6850727|NCT00348309|10857964|FG002|Overall Study|Site closure|1
6850728|NCT00348309|10857962|FG000|Overall Study|Adverse event not attended|0
6850729|NCT00348309|10857963|FG001|Overall Study|Adverse event not attended|0
6850730|NCT00348309|10857964|FG002|Overall Study|Adverse event not attended|1
6850731|NCT00348309|10857962|FG000|Overall Study|ECG abnormal|0
6850732|NCT00348309|10857963|FG001|Overall Study|ECG abnormal|0
6850733|NCT00348309|10857964|FG002|Overall Study|ECG abnormal|2
6850734|NCT00348309|10857962|FG000|Overall Study|Cardiologist recommendations|0
6850735|NCT00348309|10857963|FG001|Overall Study|Cardiologist recommendations|0
6850736|NCT00348309|10857964|FG002|Overall Study|Cardiologist recommendations|1
6850737|NCT00348309|10857962|FG000|Overall Study|HCV career|0
6850738|NCT00348309|10857963|FG001|Overall Study|HCV career|0
6850739|NCT00348309|10857964|FG002|Overall Study|HCV career|1
6850740|NCT00348348|10857975|FG000|Overall Study|Adverse event - unrelated to study drug|0
6850741|NCT00348348|10857976|FG001|Overall Study|Adverse event - unrelated to study drug|1
6850742|NCT00348348|10857975|FG000|Overall Study|Lack of Efficacy|1
6850743|NCT00348348|10857976|FG001|Overall Study|Lack of Efficacy|1
6850744|NCT00348348|10857975|FG000|Overall Study|Lost to Follow-up|8
6850745|NCT00348348|10857976|FG001|Overall Study|Lost to Follow-up|10
6850746|NCT00348348|10857975|FG000|Overall Study|Withdrawal by Subject|4
6850747|NCT00348348|10857976|FG001|Overall Study|Withdrawal by Subject|1
6850748|NCT00348348|10857975|FG000|Overall Study|Other|7
6850749|NCT00348348|10857976|FG001|Overall Study|Other|4
6850750|NCT00348348|10857975|FG000|Overall Study|Dissallowed Meds - unrelated to study|1
6850751|NCT00348348|10857976|FG001|Overall Study|Dissallowed Meds - unrelated to study|3
6850752|NCT00348348|10857975|FG000|Overall Study|Dissallowed Meds - unlikley related|1
6850753|NCT00348348|10857976|FG001|Overall Study|Dissallowed Meds - unlikley related|1
6850754|NCT00348348|10857975|FG000|Overall Study|Dissallowed Meds - possibly releated|1
6850755|NCT00348348|10857976|FG001|Overall Study|Dissallowed Meds - possibly releated|1
6850756|NCT00348348|10857975|FG000|Overall Study|Worsening of BC - Unrelated to study|0
6850757|NCT00348348|10857976|FG001|Overall Study|Worsening of BC - Unrelated to study|3
6850758|NCT00348348|10857975|FG000|Overall Study|Worsening of BC - Unlikely related|1
6850759|NCT00348348|10857976|FG001|Overall Study|Worsening of BC - Unlikely related|2
6850760|NCT00348348|10857975|FG000|Overall Study|Adverse event probably related to study|1
6850761|NCT00348348|10857976|FG001|Overall Study|Adverse event probably related to study|0
6850762|NCT00348374|10857984|FG000|Overall Study|Adverse Event|1
6850763|NCT00348374|10857985|FG001|Overall Study|Adverse Event|4
6850764|NCT00348374|10857984|FG000|Overall Study|Lost to Follow-up|1
6850765|NCT00348374|10857985|FG001|Overall Study|Lost to Follow-up|3
6850766|NCT00348374|10857984|FG000|Overall Study|Withdrawal by Subject|5
6850767|NCT00348374|10857985|FG001|Overall Study|Withdrawal by Subject|5
6850768|NCT00348374|10857984|FG000|Overall Study|Other|11
6850769|NCT00348374|10857985|FG001|Overall Study|Other|12
6850770|NCT00348374|10857984|FG000|Overall Study|ongoing at date of cutoff|1
6850771|NCT00348374|10857985|FG001|Overall Study|ongoing at date of cutoff|1
6850772|NCT00348374|10857984|FG000|Overall Study|randomized but did not receive treatment|0
6850773|NCT00348374|10857985|FG001|Overall Study|randomized but did not receive treatment|7
6850774|NCT00348595|10857994|FG000|Overall Study|Adverse Event|5
6850775|NCT00348595|10857995|FG001|Overall Study|Adverse Event|8
6850776|NCT00348673|10858009|FG000|Stage 1|Randomized but not Treated|0
6850777|NCT00348673|10858010|FG001|Stage 1|Randomized but not Treated|0
6850778|NCT00348673|10858011|FG002|Stage 1|Randomized but not Treated|1
6850779|NCT00348673|10858012|FG003|Stage 1|Randomized but not Treated|0
6850780|NCT00348673|10858013|FG004|Stage 1|Randomized but not Treated|0
6850781|NCT00348673|10858014|FG005|Stage 1|Randomized but not Treated|0
6850782|NCT00348673|10858015|FG006|Stage 1|Randomized but not Treated|0
6850783|NCT00348673|10858016|FG007|Stage 1|Randomized but not Treated|0
6850784|NCT00348673|10858017|FG008|Stage 1|Randomized but not Treated|0
6850785|NCT00348686|10858035|FG000|Overall Study|Withdrawal by Subject|45
6850786|NCT00348686|10858035|FG000|Overall Study|Adverse Event|5
6850787|NCT00348686|10858035|FG000|Overall Study|Protocol Violation|6
6850788|NCT00348686|10858035|FG000|Overall Study|Lost to Follow-up|2
6850789|NCT00348686|10858035|FG000|Overall Study|Multiple Reasons|8
6850790|NCT00348790|10858039|FG000|Completed Treatment|Withdrawal by Subject|4
6850791|NCT00348790|10858039|FG000|Completed Treatment|Disease progression|14
6850792|NCT00348790|10858039|FG000|Completed Treatment|Adverse Event|4
6850793|NCT00348790|10858039|FG000|Completed Treatment|Required surgery|2
6850794|NCT00348790|10858039|FG000|Completed Treatment|Unable to travel to study site|1
6850795|NCT00348816|10858044|FG000|Overall Study|Noncompliance with radiation treatment|1
6850796|NCT00348881|10858052|FG000|Overall Study|Lost to Follow-up|12
6850797|NCT00348881|10858053|FG001|Overall Study|Lost to Follow-up|6
6850798|NCT00348881|10858052|FG000|Overall Study|Withdrawal by Subject|3
6850799|NCT00348881|10858053|FG001|Overall Study|Withdrawal by Subject|4
6850800|NCT00348881|10858052|FG000|Overall Study|Adverse Event|2
6850801|NCT00348881|10858053|FG001|Overall Study|Adverse Event|0
6850802|NCT00348881|10858052|FG000|Overall Study|Serious Adverse Event|0
6850803|NCT00348881|10858053|FG001|Overall Study|Serious Adverse Event|2
6850804|NCT00348933|10858063|FG000|Overall Study|Withdrawal by Subject|10
6850805|NCT00348933|10858063|FG000|Overall Study|Lost to Follow-up|6
6850806|NCT00348933|10858063|FG000|Overall Study|Protocol Violation|2
6850807|NCT00348933|10858063|FG000|Overall Study|Adverse Event|7
6850808|NCT00349349|10858091|FG000|Overall Study|Adverse Event|5
6850809|NCT00349349|10858092|FG001|Overall Study|Adverse Event|6
6850810|NCT00349349|10858093|FG002|Overall Study|Adverse Event|2
6850811|NCT00349349|10858091|FG000|Overall Study|Withdrawal by Subject|5
6850812|NCT00349349|10858092|FG001|Overall Study|Withdrawal by Subject|2
6850813|NCT00349349|10858093|FG002|Overall Study|Withdrawal by Subject|1
6850814|NCT00349349|10858091|FG000|Overall Study|Withdrawn due to Disease Progression|27
6850815|NCT00349349|10858092|FG001|Overall Study|Withdrawn due to Disease Progression|37
6850816|NCT00349349|10858093|FG002|Overall Study|Withdrawn due to Disease Progression|1
6850817|NCT00349349|10858091|FG000|Overall Study|Death|13
6850818|NCT00349349|10858092|FG001|Overall Study|Death|10
6850819|NCT00349349|10858093|FG002|Overall Study|Death|1
6850820|NCT00349349|10858091|FG000|Overall Study|Other Treatment Selected|2
6850821|NCT00349349|10858092|FG001|Overall Study|Other Treatment Selected|0
6850822|NCT00349349|10858093|FG002|Overall Study|Other Treatment Selected|0
6850823|NCT00349349|10858091|FG000|Overall Study|Participant Reduced General Condition|0
6850824|NCT00349349|10858092|FG001|Overall Study|Participant Reduced General Condition|1
6850825|NCT00349349|10858093|FG002|Overall Study|Participant Reduced General Condition|0
6850826|NCT00349349|10858091|FG000|Overall Study|Physician Decision|1
6850827|NCT00349349|10858092|FG001|Overall Study|Physician Decision|2
6850828|NCT00349349|10858093|FG002|Overall Study|Physician Decision|1
6850829|NCT00349349|10858091|FG000|Overall Study|No Response|0
6850830|NCT00349349|10858092|FG001|Overall Study|No Response|3
6850831|NCT00349349|10858093|FG002|Overall Study|No Response|0
6850832|NCT00349349|10858091|FG000|Overall Study|New Malignancy (Bladder Cancer)|0
6850833|NCT00349349|10858092|FG001|Overall Study|New Malignancy (Bladder Cancer)|1
6850834|NCT00349349|10858093|FG002|Overall Study|New Malignancy (Bladder Cancer)|0
6850835|NCT00349622|10858114|FG000|Overall Study|Death|168
6850836|NCT00349622|10858115|FG001|Overall Study|Death|86
6850837|NCT00349622|10858114|FG000|Overall Study|Lost to Follow-up|5
6850838|NCT00349622|10858115|FG001|Overall Study|Lost to Follow-up|1
6850839|NCT00349622|10858114|FG000|Overall Study|Withdrawal by Subject|5
6850840|NCT00349622|10858115|FG001|Overall Study|Withdrawal by Subject|9
6850841|NCT00349752|10858136|FG000|Overall Study|Adverse Event|8
6850842|NCT00349752|10858137|FG001|Overall Study|Adverse Event|12
6850843|NCT00349752|10858136|FG000|Overall Study|Lack of Efficacy|37
6850844|NCT00349752|10858137|FG001|Overall Study|Lack of Efficacy|42
6850845|NCT00349752|10858136|FG000|Overall Study|Lost to Follow-up|4
6850846|NCT00349752|10858137|FG001|Overall Study|Lost to Follow-up|2
6850847|NCT00349752|10858136|FG000|Overall Study|Personal reasons|6
6850848|NCT00349752|10858137|FG001|Overall Study|Personal reasons|5
6850849|NCT00349752|10858136|FG000|Overall Study|Other: Required exclusionary medication|0
6850850|NCT00349752|10858137|FG001|Overall Study|Other: Required exclusionary medication|1
6850851|NCT00349752|10858136|FG000|Overall Study|Other: Non compliance|0
6850852|NCT00349752|10858137|FG001|Overall Study|Other: Non compliance|1
6850853|NCT00349752|10858136|FG000|Overall Study|Other: Patient stopped steroids|0
6850854|NCT00349752|10858137|FG001|Overall Study|Other: Patient stopped steroids|1
6850855|NCT00349752|10858136|FG000|Overall Study|Other: Patient's steroid use|1
6850856|NCT00349752|10858137|FG001|Overall Study|Other: Patient's steroid use|0
6850857|NCT00349752|10858136|FG000|Overall Study|Other: Ineligible|1
6850858|NCT00349752|10858137|FG001|Overall Study|Other: Ineligible|0
6966722|NCT01126541|11014781|FG000|Overall Study|Death|0
6850859|NCT00349752|10858136|FG000|Overall Study|Other: Inadvertently unblinded|1
6850860|NCT00349752|10858137|FG001|Overall Study|Other: Inadvertently unblinded|0
6850861|NCT00349752|10858136|FG000|Overall Study|Other:History of squamous cell carcinoma|1
6850862|NCT00349752|10858137|FG001|Overall Study|Other:History of squamous cell carcinoma|0
6850863|NCT00349908|10858149|FG000|Overall Study|Withdrawal by Subject|0
6850864|NCT00349908|10858150|FG001|Overall Study|Withdrawal by Subject|4
6850865|NCT00349921|10858161|FG000|First Spinal Injection|Physician Decision|1
7152614|NCT03261037|11317646|FG001|Overall Study|Diagnosed but protocol deviation|0
7152615|NCT03261037|11317647|FG002|Overall Study|Diagnosed but protocol deviation|0
7152616|NCT03261037|11317648|FG003|Overall Study|Diagnosed but protocol deviation|0
6850866|NCT00349921|10858162|FG001|First Spinal Injection|Physician Decision|0
6850867|NCT00349921|10858163|FG002|First Spinal Injection|Physician Decision|0
6850868|NCT00349921|10858164|FG003|First Spinal Injection|Physician Decision|0
6850869|NCT00349921|10858161|FG000|First Spinal Injection|Adverse Event|0
6850870|NCT00349921|10858162|FG001|First Spinal Injection|Adverse Event|0
6850871|NCT00349921|10858163|FG002|First Spinal Injection|Adverse Event|1
6850872|NCT00349921|10858164|FG003|First Spinal Injection|Adverse Event|0
6850873|NCT00349973|10858175|FG000|Overall Study|Adverse Event|3
6850874|NCT00349973|10858176|FG001|Overall Study|Adverse Event|3
6850875|NCT00349973|10858175|FG000|Overall Study|Withdrawal by Subject|1
6850876|NCT00349973|10858176|FG001|Overall Study|Withdrawal by Subject|0
6850877|NCT00350207|10858199|FG000|Overall Study|Adverse Event|5
6850878|NCT00350207|10858200|FG001|Overall Study|Adverse Event|2
6850879|NCT00350207|10858201|FG002|Overall Study|Adverse Event|2
6850880|NCT00350207|10858199|FG000|Overall Study|Lack of Efficacy|1
6850881|NCT00350207|10858200|FG001|Overall Study|Lack of Efficacy|0
6850882|NCT00350207|10858201|FG002|Overall Study|Lack of Efficacy|2
6850883|NCT00350207|10858199|FG000|Overall Study|Lost to Follow-up|1
6850884|NCT00350207|10858200|FG001|Overall Study|Lost to Follow-up|0
6850885|NCT00350207|10858201|FG002|Overall Study|Lost to Follow-up|1
6850886|NCT00350207|10858199|FG000|Overall Study|Withdrawal by Subject|0
6850887|NCT00350207|10858200|FG001|Overall Study|Withdrawal by Subject|1
6850888|NCT00350207|10858201|FG002|Overall Study|Withdrawal by Subject|1
6850889|NCT00350207|10858199|FG000|Overall Study|Other|1
6850890|NCT00350207|10858200|FG001|Overall Study|Other|3
6850891|NCT00350207|10858201|FG002|Overall Study|Other|1
6850892|NCT00350272|10858220|FG000|Blinded 12 Week Treatment|Adverse Event|1
6850893|NCT00350272|10858221|FG001|Blinded 12 Week Treatment|Adverse Event|0
6850894|NCT00350272|10858220|FG000|Blinded 12 Week Treatment|Death|1
6850895|NCT00350272|10858221|FG001|Blinded 12 Week Treatment|Death|0
6850896|NCT00350272|10858220|FG000|Blinded 12 Week Treatment|Lost to Follow-up|2
6850897|NCT00350272|10858221|FG001|Blinded 12 Week Treatment|Lost to Follow-up|0
6850898|NCT00350272|10858220|FG000|Blinded 12 Week Treatment|Withdrawal by Subject|3
6850899|NCT00350272|10858221|FG001|Blinded 12 Week Treatment|Withdrawal by Subject|0
6850900|NCT00350272|10858220|FG000|Blinded 12 Week Treatment|Physician Decision|2
6850901|NCT00350272|10858221|FG001|Blinded 12 Week Treatment|Physician Decision|1
6850902|NCT00350272|10858220|FG000|Blinded 12 Week Treatment|Sponsor decision|0
6850903|NCT00350272|10858221|FG001|Blinded 12 Week Treatment|Sponsor decision|1
6850904|NCT00350272|10858220|FG000|Open-Label 84 Week Treatment|Adverse Event|2
6850905|NCT00350272|10858221|FG001|Open-Label 84 Week Treatment|Adverse Event|1
6850906|NCT00350272|10858220|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3
6850907|NCT00350272|10858221|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2
6850908|NCT00350272|10858220|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1
6850909|NCT00350272|10858221|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2
6850910|NCT00350272|10858220|FG000|Open-Label 84 Week Treatment|Physician Decision|1
6850911|NCT00350272|10858221|FG001|Open-Label 84 Week Treatment|Physician Decision|2
6850912|NCT00350272|10858220|FG000|Open-Label 84 Week Treatment|Sponsor decision|2
6850913|NCT00350272|10858221|FG001|Open-Label 84 Week Treatment|Sponsor decision|1
6850914|NCT00350298|10858231|FG000|Overall Study|Death|7
6850915|NCT00350298|10858232|FG001|Overall Study|Death|8
6850916|NCT00350298|10858231|FG000|Overall Study|Lost to Follow-up|1
6850917|NCT00350298|10858232|FG001|Overall Study|Lost to Follow-up|2
6850918|NCT00350298|10858231|FG000|Overall Study|Withdrawal by Subject|1
6850919|NCT00350298|10858232|FG001|Overall Study|Withdrawal by Subject|3
6850920|NCT00350402|10858262|FG000|Overall Study|Lost to Follow-up|1
6850921|NCT00350402|10858263|FG001|Overall Study|Lost to Follow-up|1
6850922|NCT00350519|10858277|FG000|Overall Study|Death|0
6850923|NCT00350519|10858278|FG001|Overall Study|Death|1
6850924|NCT00350519|10858277|FG000|Overall Study|Physician Decision|0
6850925|NCT00350519|10858278|FG001|Overall Study|Physician Decision|1
6850926|NCT00350519|10858277|FG000|Overall Study|Protocol Violation|1
6850927|NCT00350519|10858278|FG001|Overall Study|Protocol Violation|2
6850928|NCT00350519|10858277|FG000|Overall Study|Withdrawal by Subject|3
7152617|NCT03261037|11317645|FG000|Overall Study|Participant did not want to continue the study|0
7152618|NCT03261037|11317646|FG001|Overall Study|Participant did not want to continue the study|1
6850929|NCT00350519|10858278|FG001|Overall Study|Withdrawal by Subject|2
6850930|NCT00350545|10858293|FG000|Overall Study|Withdrawal by Subject|2
6850931|NCT00350636|10858299|FG000|Overall Study|Adverse Event|19
6850932|NCT00350636|10858300|FG001|Overall Study|Adverse Event|13
6850933|NCT00350636|10858299|FG000|Overall Study|Protocol Violation|1
6850934|NCT00350636|10858300|FG001|Overall Study|Protocol Violation|3
6850935|NCT00350636|10858299|FG000|Overall Study|Withdrawal by Subject|13
6850936|NCT00350636|10858300|FG001|Overall Study|Withdrawal by Subject|17
6850937|NCT00350636|10858299|FG000|Overall Study|Lost to Follow-up|9
6850938|NCT00350636|10858300|FG001|Overall Study|Lost to Follow-up|8
6850939|NCT00350636|10858299|FG000|Overall Study|Physician Decision|0
6850940|NCT00350636|10858300|FG001|Overall Study|Physician Decision|2
6850941|NCT00350636|10858299|FG000|Overall Study|Other|1
6850942|NCT00350636|10858300|FG001|Overall Study|Other|2
6850943|NCT00350727|10858309|FG000|Phase I: Dose Escalation|Adverse Event|4
6850944|NCT00350727|10858310|FG001|Phase I: Dose Escalation|Adverse Event|0
6850945|NCT00350727|10858311|FG002|Phase I: Dose Escalation|Adverse Event|0
6850946|NCT00350727|10858309|FG000|Phase I: Dose Escalation|Lack of Efficacy|25
6850947|NCT00350727|10858310|FG001|Phase I: Dose Escalation|Lack of Efficacy|0
6850948|NCT00350727|10858311|FG002|Phase I: Dose Escalation|Lack of Efficacy|0
6850949|NCT00350727|10858309|FG000|Phase I: Dose Escalation|Death|1
6850950|NCT00350727|10858310|FG001|Phase I: Dose Escalation|Death|0
6850951|NCT00350727|10858311|FG002|Phase I: Dose Escalation|Death|0
6850952|NCT00350727|10858309|FG000|Phase I: Dose Escalation|Physician Decision|1
6850953|NCT00350727|10858310|FG001|Phase I: Dose Escalation|Physician Decision|0
6850954|NCT00350727|10858311|FG002|Phase I: Dose Escalation|Physician Decision|0
6850955|NCT00350727|10858309|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3
6850956|NCT00350727|10858310|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0
6850957|NCT00350727|10858311|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0
6850958|NCT00350727|10858309|FG000|Phase II|Disease Progression|0
6850959|NCT00350727|10858310|FG001|Phase II|Disease Progression|15
6850960|NCT00350727|10858311|FG002|Phase II|Disease Progression|16
6850961|NCT00350727|10858309|FG000|Phase II|Clinical Deterioration|0
6850962|NCT00350727|10858310|FG001|Phase II|Clinical Deterioration|1
6850963|NCT00350727|10858311|FG002|Phase II|Clinical Deterioration|0
6850964|NCT00350727|10858309|FG000|Phase II|Withdrawal by Subject|0
6850965|NCT00350727|10858310|FG001|Phase II|Withdrawal by Subject|2
6850966|NCT00350727|10858311|FG002|Phase II|Withdrawal by Subject|1
6850967|NCT00350727|10858309|FG000|Phase II|Adverse Event|0
6850968|NCT00350727|10858310|FG001|Phase II|Adverse Event|1
6850969|NCT00350727|10858311|FG002|Phase II|Adverse Event|1
6850970|NCT00350727|10858309|FG000|Phase II|Death|0
6850971|NCT00350727|10858310|FG001|Phase II|Death|0
6850972|NCT00350727|10858311|FG002|Phase II|Death|2
6850973|NCT00350727|10858309|FG000|Phase II|Sponsor Terminated Study|0
6850974|NCT00350727|10858310|FG001|Phase II|Sponsor Terminated Study|0
6850975|NCT00350727|10858311|FG002|Phase II|Sponsor Terminated Study|1
6850976|NCT00350727|10858309|FG000|Phase II|Enrolled in Rollover Study|0
6850977|NCT00350727|10858310|FG001|Phase II|Enrolled in Rollover Study|0
6850978|NCT00350727|10858311|FG002|Phase II|Enrolled in Rollover Study|1
6850979|NCT00350779|10858332|FG000|Overall Study|Adverse Event|4
6850980|NCT00350779|10858333|FG001|Overall Study|Adverse Event|2
6850981|NCT00350779|10858332|FG000|Overall Study|Lack of Efficacy|0
6850982|NCT00350779|10858333|FG001|Overall Study|Lack of Efficacy|4
6850983|NCT00350779|10858332|FG000|Overall Study|Lost to Follow-up|2
6850984|NCT00350779|10858333|FG001|Overall Study|Lost to Follow-up|0
6850985|NCT00350779|10858332|FG000|Overall Study|Physician Decision|2
6850986|NCT00350779|10858333|FG001|Overall Study|Physician Decision|4
6850987|NCT00350779|10858332|FG000|Overall Study|Protocol Violation|3
6850988|NCT00350779|10858333|FG001|Overall Study|Protocol Violation|1
6850989|NCT00350779|10858332|FG000|Overall Study|Withdrawal by Subject|9
6850990|NCT00350779|10858333|FG001|Overall Study|Withdrawal by Subject|8
6850991|NCT00350779|10858332|FG000|Overall Study|Patient Moved|2
6850992|NCT00350779|10858333|FG001|Overall Study|Patient Moved|1
6850993|NCT00350779|10858332|FG000|Overall Study|Non-compliance with study procedures|0
6850994|NCT00350779|10858333|FG001|Overall Study|Non-compliance with study procedures|1
6850995|NCT00350792|10858341|FG000|Overall Study|Adverse Event|11
6850996|NCT00350792|10858341|FG000|Overall Study|Death from Study Disease|1
6850997|NCT00350792|10858341|FG000|Overall Study|Death from Study Drug Toxicity|1
6850998|NCT00350792|10858341|FG000|Overall Study|Death Not Study Drug Related|2
6850999|NCT00350792|10858341|FG000|Overall Study|Protocol Violation|1
6851000|NCT00350792|10858341|FG000|Overall Study|Withdrawal by Subject|4
6851001|NCT00350792|10858341|FG000|Overall Study|Physician Decision|2
6851002|NCT00350792|10858341|FG000|Overall Study|Lack of Efficacy|11
7040903|NCT01721057|11124072|FG006|Rescue Period|Lack of Efficacy|0
6851003|NCT00350870|10858349|FG000|Overall Study|Withdrawal by Subject|21
6851004|NCT00350870|10858350|FG001|Overall Study|Withdrawal by Subject|17
6851005|NCT00350870|10858351|FG002|Overall Study|Withdrawal by Subject|15
6851006|NCT00350870|10858352|FG003|Overall Study|Withdrawal by Subject|14
6851007|NCT00350870|10858349|FG000|Overall Study|Physician Decision|1
6851008|NCT00350870|10858350|FG001|Overall Study|Physician Decision|0
6851009|NCT00350870|10858351|FG002|Overall Study|Physician Decision|1
6851010|NCT00350870|10858352|FG003|Overall Study|Physician Decision|1
6851011|NCT00351273|10858377|FG000|Overall Study|Lost to Follow-up|1
6851012|NCT00351273|10858378|FG001|Overall Study|Lost to Follow-up|2
6851013|NCT00351273|10858379|FG002|Overall Study|Lost to Follow-up|5
6851014|NCT00351351|10858407|FG000|Overall Study|surgical access pbs; device issues|9
6851015|NCT00351351|10858408|FG001|Overall Study|surgical access pbs; device issues|4
6851016|NCT00351377|10858414|FG000|Overall Study|Adverse Event|5
6851017|NCT00351377|10858414|FG000|Overall Study|Death|1
6966723|NCT01126541|11014782|FG001|Overall Study|Death|1
6851018|NCT00351377|10858414|FG000|Overall Study|Unsatisfactory therapeutic effect|1
6851019|NCT00351468|10858427|FG000|Overall Study|Adverse Event|42
6851020|NCT00351468|10858427|FG000|Overall Study|Withdrawal by Subject|39
6851021|NCT00351468|10858427|FG000|Overall Study|Various -follow up w clinical team|39
6851022|NCT00351468|10858427|FG000|Overall Study|Lack of Efficacy|32
6851023|NCT00351468|10858427|FG000|Overall Study|Non-compliance|8
6851024|NCT00351468|10858427|FG000|Overall Study|Lost to Follow-up|4
6851025|NCT00351468|10858427|FG000|Overall Study|Protocol Violation|3
6851026|NCT00351533|10858434|FG000|Overall Study|Extubated before first BAL|1
6851027|NCT00351533|10858435|FG001|Overall Study|Extubated before first BAL|0
6851028|NCT00351533|10858434|FG000|Overall Study|Lost to Follow-up|1
6851029|NCT00351533|10858435|FG001|Overall Study|Lost to Follow-up|3
6851030|NCT00351533|10858434|FG000|Overall Study|Physician Decision|0
6851031|NCT00351533|10858435|FG001|Overall Study|Physician Decision|1
6851032|NCT00351533|10858434|FG000|Overall Study|Withdrawal by Subject|0
6851033|NCT00351533|10858435|FG001|Overall Study|Withdrawal by Subject|1
6851034|NCT00351611|10858443|FG000|Overall Study|Adverse Event|11
6851035|NCT00351611|10858444|FG001|Overall Study|Adverse Event|3
6851036|NCT00351611|10858443|FG000|Overall Study|Death|1
6851037|NCT00351611|10858444|FG001|Overall Study|Death|0
6851038|NCT00351611|10858443|FG000|Overall Study|Lost to Follow-up|1
6851039|NCT00351611|10858444|FG001|Overall Study|Lost to Follow-up|0
6851040|NCT00351611|10858443|FG000|Overall Study|No Longer Willing to Participate in Study|0
6851041|NCT00351611|10858444|FG001|Overall Study|No Longer Willing to Participate in Study|5
6851042|NCT00351611|10858443|FG000|Overall Study|Other|1
6851043|NCT00351611|10858444|FG001|Overall Study|Other|0
6851044|NCT00351611|10858443|FG000|Overall Study|Protocol Violation|0
6851045|NCT00351611|10858444|FG001|Overall Study|Protocol Violation|2
6851046|NCT00351819|10858461|FG000|Overall Study|Lost to Follow-up|4
6851047|NCT00351819|10858462|FG001|Overall Study|Lost to Follow-up|4
6851048|NCT00351819|10858461|FG000|Overall Study|Withdrawal by Subject|0
6851049|NCT00351819|10858462|FG001|Overall Study|Withdrawal by Subject|4
6851050|NCT00351819|10858461|FG000|Overall Study|Elevated PSA|1
6851051|NCT00351819|10858462|FG001|Overall Study|Elevated PSA|1
6851052|NCT00351819|10858461|FG000|Overall Study|Traumatic ankle fracture|1
6851053|NCT00351819|10858462|FG001|Overall Study|Traumatic ankle fracture|0
6851054|NCT00351819|10858461|FG000|Overall Study|Unprofessional behavior|1
6851055|NCT00351819|10858462|FG001|Overall Study|Unprofessional behavior|0
6851056|NCT00351819|10858461|FG000|Overall Study|Non-compliance|0
6851057|NCT00351819|10858462|FG001|Overall Study|Non-compliance|1
6851058|NCT00351819|10858461|FG000|Overall Study|Incarcerated|0
6851059|NCT00351819|10858462|FG001|Overall Study|Incarcerated|1
6851060|NCT00351819|10858461|FG000|Overall Study|Enrolled in another trial|0
6851061|NCT00351819|10858462|FG001|Overall Study|Enrolled in another trial|1
6851062|NCT00352053|10858479|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14
6851063|NCT00352053|10858480|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10
6851064|NCT00352053|10858479|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2
6966724|NCT01126541|11014783|FG002|Overall Study|Death|0
6966725|NCT01126541|11014781|FG000|Overall Study|Lack of Efficacy|6
6966726|NCT01126541|11014782|FG001|Overall Study|Lack of Efficacy|1
6966727|NCT01126541|11014783|FG002|Overall Study|Lack of Efficacy|11
6966728|NCT01126541|11014781|FG000|Overall Study|Lost to Follow-up|1
6966729|NCT01126541|11014782|FG001|Overall Study|Lost to Follow-up|2
6966730|NCT01126541|11014783|FG002|Overall Study|Lost to Follow-up|2
6966731|NCT01126541|11014781|FG000|Overall Study|Withdrawal by Subject|2
6966732|NCT01126541|11014782|FG001|Overall Study|Withdrawal by Subject|5
6966733|NCT01126541|11014783|FG002|Overall Study|Withdrawal by Subject|6
6966734|NCT01126541|11014781|FG000|Overall Study|Protocol Violation|0
6966735|NCT01126541|11014782|FG001|Overall Study|Protocol Violation|0
6966736|NCT01126541|11014783|FG002|Overall Study|Protocol Violation|1
6966737|NCT01126541|11014781|FG000|Overall Study|Administrative reason or other|1
6966738|NCT01126541|11014782|FG001|Overall Study|Administrative reason or other|1
6966739|NCT01126541|11014783|FG002|Overall Study|Administrative reason or other|2
6966740|NCT01126580|11014796|FG000|Overall Study|Adverse Event|14
6966741|NCT01126580|11014797|FG001|Overall Study|Adverse Event|8
6966742|NCT01126580|11014798|FG002|Overall Study|Adverse Event|12
6966743|NCT01126580|11014796|FG000|Overall Study|Withdrawal by Subject|11
6966744|NCT01126580|11014797|FG001|Overall Study|Withdrawal by Subject|19
6851065|NCT00352053|10858480|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2
6851066|NCT00352053|10858479|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1
6851067|NCT00352053|10858480|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0
6851068|NCT00352053|10858479|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0
6851069|NCT00352053|10858480|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1
6851070|NCT00352053|10858479|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1
6851071|NCT00352053|10858480|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0
6851072|NCT00352053|10858479|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9
6851073|NCT00352053|10858480|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13
6851074|NCT00352053|10858479|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1
6851075|NCT00352053|10858480|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4
6851076|NCT00352053|10858479|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1
6966745|NCT01126580|11014798|FG002|Overall Study|Withdrawal by Subject|14
6851077|NCT00352053|10858480|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0
6851078|NCT00352053|10858479|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1
6851079|NCT00352053|10858480|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0
7152619|NCT03261037|11317647|FG002|Overall Study|Participant did not want to continue the study|0
7152620|NCT03261037|11317648|FG003|Overall Study|Participant did not want to continue the study|0
6851080|NCT00352053|10858479|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4
6851081|NCT00352053|10858480|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4
6851082|NCT00352053|10858479|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
6851083|NCT00352053|10858480|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
6851084|NCT00352053|10858479|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
6851085|NCT00352053|10858480|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
6851086|NCT00352053|10858479|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0
6851087|NCT00352053|10858480|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1
6851088|NCT00352105|10858494|FG000|Overall Study|Death|5
6851089|NCT00352105|10858494|FG000|Overall Study|Withdrawal by Subject|5
6851090|NCT00352105|10858494|FG000|Overall Study|Lack of Efficacy|9
6851091|NCT00352105|10858494|FG000|Overall Study|Adverse Event|19
6851092|NCT00352105|10858494|FG000|Overall Study|Protocol Violation|2
6851093|NCT00352365|10858498|FG000|Induction Therapy|Adverse Event|7
6851094|NCT00352365|10858498|FG000|Induction Therapy|Progression/Relapse|8
6851095|NCT00352365|10858498|FG000|Induction Therapy|Death|7
6851096|NCT00352365|10858498|FG000|Induction Therapy|Not protocol specified|1
6851097|NCT00352365|10858498|FG000|Induction Therapy|Not eligible|3
6851098|NCT00352365|10858498|FG000|Induction Therapy|Death before starting protocol therapy|1
6851099|NCT00352365|10858498|FG000|Maintenance Therapy|Progression/Relapse|3
6851100|NCT00352365|10858498|FG000|Maintenance Therapy|Death|2
6851101|NCT00352365|10858498|FG000|Maintenance Therapy|Not protocol specified|3
6851102|NCT00352365|10858498|FG000|Maintenance Therapy|Not eligible|4
6851103|NCT00352417|10858508|FG000|Overall Study|Adverse Event|1
6851104|NCT00352417|10858509|FG001|Overall Study|Adverse Event|0
6851105|NCT00352417|10858508|FG000|Overall Study|Protocol Violation|0
6851106|NCT00352417|10858509|FG001|Overall Study|Protocol Violation|2
6851107|NCT00352417|10858508|FG000|Overall Study|Withdrawal by Subject|1
6851108|NCT00352417|10858509|FG001|Overall Study|Withdrawal by Subject|2
6851109|NCT00352417|10858508|FG000|Overall Study|Lost to Follow-up|1
6851110|NCT00352417|10858509|FG001|Overall Study|Lost to Follow-up|0
6851111|NCT00352417|10858508|FG000|Overall Study|Schedule Change|2
6851112|NCT00352417|10858509|FG001|Overall Study|Schedule Change|1
6851113|NCT00352664|10858526|FG000|Overall Study|Withdrawal by Subject|7
6851114|NCT00352664|10858527|FG001|Overall Study|Withdrawal by Subject|0
6851115|NCT00352690|10858535|FG000|Overall Study|Determined to be ineligible|2
6851116|NCT00352690|10858536|FG001|Overall Study|Determined to be ineligible|0
6851117|NCT00352755|10858542|FG000|Overall Study|Physician Decision|1
6851118|NCT00352755|10858542|FG000|Overall Study|Adverse Event|1
6851119|NCT00352846|10858556|FG000|Overall Study|Disease progression|0
6851120|NCT00352846|10858557|FG001|Overall Study|Disease progression|2
6851121|NCT00352846|10858556|FG000|Overall Study|Withdrawal by Subject|3
6851122|NCT00352846|10858557|FG001|Overall Study|Withdrawal by Subject|8
6851123|NCT00352846|10858556|FG000|Overall Study|Ineligible|3
6851124|NCT00352846|10858557|FG001|Overall Study|Ineligible|2
6851125|NCT00352846|10858556|FG000|Overall Study|Non-compliance|2
6851126|NCT00352846|10858557|FG001|Overall Study|Non-compliance|0
6851127|NCT00352846|10858556|FG000|Overall Study|Death|0
6851128|NCT00352846|10858557|FG001|Overall Study|Death|1
6851129|NCT00352885|10858565|FG000|Overall Study|Withdrawal by Subject|0
6851130|NCT00352885|10858566|FG001|Overall Study|Withdrawal by Subject|3
6851131|NCT00352885|10858565|FG000|Overall Study|Development of major depression|0
6851132|NCT00352885|10858566|FG001|Overall Study|Development of major depression|1
6851133|NCT00352885|10858565|FG000|Overall Study|Progression of metastatic melanoma|5
6851134|NCT00352885|10858566|FG001|Overall Study|Progression of metastatic melanoma|3
6851135|NCT00352885|10858565|FG000|Overall Study|Side effects of IL-2 administration|1
6851136|NCT00352885|10858566|FG001|Overall Study|Side effects of IL-2 administration|0
6851137|NCT00353262|10858598|FG000|Overall Study|Adverse Event|8
6851138|NCT00353262|10858598|FG000|Overall Study|Withdrawal by Subject|2
6851139|NCT00353262|10858598|FG000|Overall Study|Insufficient Therapeutic Response|13
6851140|NCT00353262|10858598|FG000|Overall Study|Progression|1
6851141|NCT00353262|10858598|FG000|Overall Study|Surgery|4
6851142|NCT00353262|10858598|FG000|Overall Study|Break from Chemotherapy|1
6851143|NCT00353366|10858606|FG000|Overall Study|Adverse Event|8
6851144|NCT00353366|10858606|FG000|Overall Study|Protocol Violation|12
6851145|NCT00353366|10858606|FG000|Overall Study|Withdrawal by Subject|12
6851146|NCT00353366|10858606|FG000|Overall Study|Lost to Follow-up|92
6851147|NCT00353366|10858606|FG000|Overall Study|Other|19
6851148|NCT00353496|10858630|FG000|Overall Study|Adverse Event|1
6851149|NCT00353496|10858631|FG001|Overall Study|Adverse Event|0
7152621|NCT03261037|11317645|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0
7152622|NCT03261037|11317646|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0
7152623|NCT03261037|11317647|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0
7152624|NCT03261037|11317648|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1
6851150|NCT00353496|10858630|FG000|Overall Study|Protocol Violation|2
6851151|NCT00353496|10858631|FG001|Overall Study|Protocol Violation|2
6851152|NCT00353496|10858630|FG000|Overall Study|Withdrawal by Subject|3
6851153|NCT00353496|10858631|FG001|Overall Study|Withdrawal by Subject|4
6851154|NCT00353496|10858630|FG000|Overall Study|Physician Decision|6
6851155|NCT00353496|10858631|FG001|Overall Study|Physician Decision|9
6851156|NCT00353496|10858630|FG000|Overall Study|Not otherwise specified|4
6851157|NCT00353496|10858631|FG001|Overall Study|Not otherwise specified|2
6851158|NCT00353704|10858673|FG000|Overall Study|Protocol Violation|3
6851159|NCT00353704|10858674|FG001|Overall Study|Protocol Violation|1
6851160|NCT00353873|10858695|FG000|Overall Study|Protocol Violation|1
6851161|NCT00353873|10858696|FG001|Overall Study|Protocol Violation|2
6851162|NCT00353873|10858695|FG000|Overall Study|Exacerbation|1
6851163|NCT00353873|10858696|FG001|Overall Study|Exacerbation|0
6851164|NCT00353873|10858695|FG000|Overall Study|Adverse Event|1
6851165|NCT00353873|10858696|FG001|Overall Study|Adverse Event|0
6851166|NCT00353873|10858695|FG000|Overall Study|Physician Decision|2
6851167|NCT00353873|10858696|FG001|Overall Study|Physician Decision|0
6851168|NCT00353873|10858695|FG000|Overall Study|Withdrawal by Subject|1
6851169|NCT00353873|10858696|FG001|Overall Study|Withdrawal by Subject|1
6851170|NCT00354029|10858708|FG000|Overall Study|Protocol Violation|4
6851171|NCT00354029|10858709|FG001|Overall Study|Protocol Violation|2
6851172|NCT00354107|10858715|FG000|Overall Study|Adverse Event|2
6851173|NCT00354107|10858715|FG000|Overall Study|Physician Decision|2
6851174|NCT00354107|10858715|FG000|Overall Study|Withdrawal by Subject|1
6851175|NCT00354159|10858721|FG000|Randomized Study Period|Withdrawal by Subject|5
6851176|NCT00354159|10858722|FG001|Randomized Study Period|Withdrawal by Subject|3
6851177|NCT00354159|10858721|FG000|Randomized Study Period|Physician Decision|6
6851178|NCT00354159|10858722|FG001|Randomized Study Period|Physician Decision|10
6851179|NCT00354159|10858721|FG000|Randomized Study Period|Lost to Follow-up|4
6851180|NCT00354159|10858722|FG001|Randomized Study Period|Lost to Follow-up|0
6851181|NCT00354159|10858721|FG000|Randomized Study Period|Death|7
6851182|NCT00354159|10858722|FG001|Randomized Study Period|Death|9
6851183|NCT00354159|10858721|FG000|Long-term Follow-up|Withdrawal by Subject|9
6851184|NCT00354159|10858722|FG001|Long-term Follow-up|Withdrawal by Subject|9
6851185|NCT00354159|10858721|FG000|Long-term Follow-up|Physician Decision|127
6851186|NCT00354159|10858722|FG001|Long-term Follow-up|Physician Decision|122
6851187|NCT00354159|10858721|FG000|Long-term Follow-up|Lost to Follow-up|1
6851188|NCT00354159|10858722|FG001|Long-term Follow-up|Lost to Follow-up|0
6851189|NCT00354159|10858721|FG000|Long-term Follow-up|Death|14
6851190|NCT00354159|10858722|FG001|Long-term Follow-up|Death|11
6851191|NCT00354159|10858721|FG000|Long-term Follow-up|Study Closed|29
6851192|NCT00354159|10858722|FG001|Long-term Follow-up|Study Closed|34
6851193|NCT00354172|10858735|FG000|Overall Study|Did not receive transplant|1
6851194|NCT00354341|10858745|FG000|Overall Study|Adverse Event|1
6851195|NCT00354341|10858746|FG001|Overall Study|Adverse Event|0
6851196|NCT00354341|10858745|FG000|Overall Study|Death|0
6851197|NCT00354341|10858746|FG001|Overall Study|Death|2
6851198|NCT00354341|10858745|FG000|Overall Study|Refused treatment|1
6851199|NCT00354341|10858746|FG001|Overall Study|Refused treatment|2
6851200|NCT00354341|10858745|FG000|Overall Study|Failure to return|0
6851201|NCT00354341|10858746|FG001|Overall Study|Failure to return|1
6851202|NCT00354341|10858745|FG000|Overall Study|Other|1
6851203|NCT00354341|10858746|FG001|Overall Study|Other|2
6851204|NCT00354432|10858756|FG000|Overall Study|Adverse Event|3
6851205|NCT00354432|10858757|FG001|Overall Study|Adverse Event|1
6851206|NCT00354432|10858758|FG002|Overall Study|Adverse Event|5
6851207|NCT00354432|10858759|FG003|Overall Study|Adverse Event|5
6851208|NCT00354432|10858756|FG000|Overall Study|Off/Toxicity|3
6851209|NCT00354432|10858757|FG001|Overall Study|Off/Toxicity|7
6851210|NCT00354432|10858758|FG002|Overall Study|Off/Toxicity|5
6851211|NCT00354432|10858759|FG003|Overall Study|Off/Toxicity|5
6851212|NCT00354601|10858778|FG000|Overall Study|Protocol Violation|1
6851213|NCT00354601|10858778|FG000|Overall Study|progression|1
6851214|NCT00354614|10858782|FG000|Overall Study|Lack of Efficacy|28
6851215|NCT00354679|10858790|FG000|Overall Study|Patient Not Treated|1
6851216|NCT00354744|10858794|FG000|Overall Study|Adverse Event|2
6851217|NCT00354744|10858794|FG000|Overall Study|Death|2
6851218|NCT00354744|10858794|FG000|Overall Study|Lack of Efficacy|11
6851219|NCT00354744|10858794|FG000|Overall Study|Lost to Follow-up|2
6851220|NCT00354744|10858794|FG000|Overall Study|Physician Decision|11
6851221|NCT00354744|10858794|FG000|Overall Study|Withdrawal by Subject|14
6966746|NCT01126580|11014796|FG000|Overall Study|Sponsor Decision|5
6966747|NCT01126580|11014797|FG001|Overall Study|Sponsor Decision|4
6966748|NCT01126580|11014798|FG002|Overall Study|Sponsor Decision|7
6966749|NCT01126580|11014796|FG000|Overall Study|Physician Decision|1
6966750|NCT01126580|11014797|FG001|Overall Study|Physician Decision|1
6966751|NCT01126580|11014798|FG002|Overall Study|Physician Decision|2
6966752|NCT01126580|11014796|FG000|Overall Study|Entry Criteria Not Met|1
6966753|NCT01126580|11014797|FG001|Overall Study|Entry Criteria Not Met|1
6966754|NCT01126580|11014798|FG002|Overall Study|Entry Criteria Not Met|2
6966755|NCT01126580|11014796|FG000|Overall Study|Lack of Efficacy|2
6966756|NCT01126580|11014797|FG001|Overall Study|Lack of Efficacy|3
6966757|NCT01126580|11014798|FG002|Overall Study|Lack of Efficacy|4
6966758|NCT01126580|11014796|FG000|Overall Study|Protocol Violation|0
6966759|NCT01126580|11014797|FG001|Overall Study|Protocol Violation|1
6966760|NCT01126580|11014798|FG002|Overall Study|Protocol Violation|2
6851222|NCT00355030|10858823|FG000|Study Period 1 Treatment|Adverse Event|1
6851223|NCT00355030|10858824|FG001|Study Period 1 Treatment|Adverse Event|1
6851224|NCT00355030|10858823|FG000|Study Period 1 Treatment|Lost to Follow-up|3
6851225|NCT00355030|10858824|FG001|Study Period 1 Treatment|Lost to Follow-up|0
6851226|NCT00355030|10858823|FG000|Study Period 1 Treatment|Withdrawal by Subject|4
6851227|NCT00355030|10858824|FG001|Study Period 1 Treatment|Withdrawal by Subject|1
6851228|NCT00355030|10858823|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1
6851229|NCT00355030|10858824|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2
6851230|NCT00355030|10858823|FG000|Study Period 1 Treatment|Physician Decision|0
6851231|NCT00355030|10858824|FG001|Study Period 1 Treatment|Physician Decision|1
6851232|NCT00355030|10858823|FG000|Study Period 1 Treatment|Sponsor Decision|34
6851233|NCT00355030|10858824|FG001|Study Period 1 Treatment|Sponsor Decision|32
6851234|NCT00355030|10858823|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0
6851235|NCT00355030|10858824|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1
6851236|NCT00355030|10858823|FG000|Study Period 1 Treatment|Other|2
6851237|NCT00355030|10858824|FG001|Study Period 1 Treatment|Other|6
6851238|NCT00355030|10858823|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0
6851239|NCT00355030|10858824|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1
6851240|NCT00355030|10858823|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
6851241|NCT00355030|10858824|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
6851242|NCT00355056|10858832|FG000|Randomization Period|Early Termination|4
6851243|NCT00355056|10858833|FG001|Randomization Period|Early Termination|6
6851244|NCT00355082|10858849|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4
6851245|NCT00355082|10858850|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10
6851246|NCT00355082|10858851|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0
6851247|NCT00355082|10858849|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9
6851248|NCT00355082|10858850|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8
6851249|NCT00355082|10858851|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0
6851250|NCT00355082|10858849|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6
6851251|NCT00355082|10858850|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7
6851252|NCT00355082|10858851|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0
6851253|NCT00355082|10858849|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
6851254|NCT00355082|10858850|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4
6851255|NCT00355082|10858851|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
6851256|NCT00355082|10858849|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0
6851257|NCT00355082|10858850|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4
6851258|NCT00355082|10858851|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0
6851259|NCT00355082|10858849|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0
6851260|NCT00355082|10858850|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1
6851261|NCT00355082|10858851|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0
6851262|NCT00355082|10858849|FG000|Continuation Phase|Adverse Event|2
6851263|NCT00355082|10858850|FG001|Continuation Phase|Adverse Event|0
6851264|NCT00355082|10858851|FG002|Continuation Phase|Adverse Event|1
6851265|NCT00355082|10858849|FG000|Continuation Phase|Lost to Follow-up|2
6851266|NCT00355082|10858850|FG001|Continuation Phase|Lost to Follow-up|0
6851267|NCT00355082|10858851|FG002|Continuation Phase|Lost to Follow-up|1
6851268|NCT00355082|10858849|FG000|Continuation Phase|Protocol Violation|1
6851269|NCT00355082|10858850|FG001|Continuation Phase|Protocol Violation|0
6851270|NCT00355082|10858851|FG002|Continuation Phase|Protocol Violation|1
6851271|NCT00355082|10858849|FG000|Continuation Phase|Withdrawal by Subject|4
6851272|NCT00355082|10858850|FG001|Continuation Phase|Withdrawal by Subject|0
6851273|NCT00355082|10858851|FG002|Continuation Phase|Withdrawal by Subject|0
6851274|NCT00355082|10858849|FG000|Continuation Phase|Lack of Efficacy|5
6851275|NCT00355082|10858850|FG001|Continuation Phase|Lack of Efficacy|0
6851276|NCT00355082|10858851|FG002|Continuation Phase|Lack of Efficacy|0
6851277|NCT00355082|10858849|FG000|Continuation Phase|Site Closed by Sponsor|8
6851278|NCT00355082|10858850|FG001|Continuation Phase|Site Closed by Sponsor|0
6851279|NCT00355082|10858851|FG002|Continuation Phase|Site Closed by Sponsor|0
6851280|NCT00355082|10858849|FG000|Continuation Phase|Scheduling Error|1
6851281|NCT00355082|10858850|FG001|Continuation Phase|Scheduling Error|0
6851282|NCT00355082|10858851|FG002|Continuation Phase|Scheduling Error|0
6851283|NCT00355082|10858849|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1
6851284|NCT00355082|10858850|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0
6851285|NCT00355082|10858851|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0
6851286|NCT00355121|10858865|FG000|Overall Study|Did not receive study vaccine|1
6851287|NCT00355121|10858866|FG001|Overall Study|Did not receive study vaccine|0
6851288|NCT00355121|10858867|FG002|Overall Study|Did not receive study vaccine|1
6851289|NCT00355121|10858865|FG000|Overall Study|Adverse Event|0
6851290|NCT00355121|10858866|FG001|Overall Study|Adverse Event|1
6851291|NCT00355121|10858867|FG002|Overall Study|Adverse Event|0
7152625|NCT03261037|11317645|FG000|Overall Study|Participant presented clinical improvement|0
7152626|NCT03261037|11317646|FG001|Overall Study|Participant presented clinical improvement|2
7152627|NCT03261037|11317647|FG002|Overall Study|Participant presented clinical improvement|0
6851292|NCT00355121|10858865|FG000|Overall Study|Protocol Violation|7
6851293|NCT00355121|10858866|FG001|Overall Study|Protocol Violation|9
6851294|NCT00355121|10858867|FG002|Overall Study|Protocol Violation|1
6851295|NCT00355121|10858865|FG000|Overall Study|Lost to Follow-up|4
6851296|NCT00355121|10858866|FG001|Overall Study|Lost to Follow-up|7
6851297|NCT00355121|10858867|FG002|Overall Study|Lost to Follow-up|1
6851298|NCT00355121|10858865|FG000|Overall Study|Withdrawal by Subject|9
6851299|NCT00355121|10858866|FG001|Overall Study|Withdrawal by Subject|10
6851300|NCT00355121|10858867|FG002|Overall Study|Withdrawal by Subject|2
6851301|NCT00355121|10858865|FG000|Overall Study|Serious adverse events|0
6851302|NCT00355121|10858866|FG001|Overall Study|Serious adverse events|2
6851303|NCT00355121|10858867|FG002|Overall Study|Serious adverse events|0
6851304|NCT00355134|10858883|FG000|Core Phase|Withdrawal by Subject|35
6851305|NCT00355134|10858884|FG001|Core Phase|Withdrawal by Subject|24
6851306|NCT00355134|10858885|FG002|Core Phase|Withdrawal by Subject|35
6851307|NCT00355134|10858886|FG003|Core Phase|Withdrawal by Subject|0
6851308|NCT00355134|10858887|FG004|Core Phase|Withdrawal by Subject|0
6851309|NCT00355134|10858883|FG000|Core Phase|Adverse Event|28
6851310|NCT00355134|10858884|FG001|Core Phase|Adverse Event|22
6851311|NCT00355134|10858885|FG002|Core Phase|Adverse Event|16
6851312|NCT00355134|10858886|FG003|Core Phase|Adverse Event|0
6851313|NCT00355134|10858887|FG004|Core Phase|Adverse Event|0
6851314|NCT00355134|10858883|FG000|Core Phase|Lost to Follow-up|17
6851315|NCT00355134|10858884|FG001|Core Phase|Lost to Follow-up|13
6851316|NCT00355134|10858885|FG002|Core Phase|Lost to Follow-up|21
6851317|NCT00355134|10858886|FG003|Core Phase|Lost to Follow-up|0
6851318|NCT00355134|10858887|FG004|Core Phase|Lost to Follow-up|0
6851319|NCT00355134|10858883|FG000|Core Phase|Abnormal laboratory value(s)|19
6851320|NCT00355134|10858884|FG001|Core Phase|Abnormal laboratory value(s)|14
6851321|NCT00355134|10858885|FG002|Core Phase|Abnormal laboratory value(s)|2
6851322|NCT00355134|10858886|FG003|Core Phase|Abnormal laboratory value(s)|0
6851323|NCT00355134|10858887|FG004|Core Phase|Abnormal laboratory value(s)|0
6851324|NCT00355134|10858883|FG000|Core Phase|Unsatisfactory therapeutic effect|10
6851325|NCT00355134|10858884|FG001|Core Phase|Unsatisfactory therapeutic effect|6
6851326|NCT00355134|10858885|FG002|Core Phase|Unsatisfactory therapeutic effect|17
6851327|NCT00355134|10858886|FG003|Core Phase|Unsatisfactory therapeutic effect|0
6851328|NCT00355134|10858887|FG004|Core Phase|Unsatisfactory therapeutic effect|0
6851329|NCT00355134|10858883|FG000|Core Phase|Administrative problems|5
6851330|NCT00355134|10858884|FG001|Core Phase|Administrative problems|3
6851331|NCT00355134|10858885|FG002|Core Phase|Administrative problems|5
6851332|NCT00355134|10858886|FG003|Core Phase|Administrative problems|0
6851333|NCT00355134|10858887|FG004|Core Phase|Administrative problems|0
6851334|NCT00355134|10858883|FG000|Core Phase|Protocol Violation|3
6851335|NCT00355134|10858884|FG001|Core Phase|Protocol Violation|2
6851336|NCT00355134|10858885|FG002|Core Phase|Protocol Violation|2
6851337|NCT00355134|10858886|FG003|Core Phase|Protocol Violation|0
6851338|NCT00355134|10858887|FG004|Core Phase|Protocol Violation|0
6851339|NCT00355134|10858883|FG000|Core Phase|Abnormal test procedure result(s)|1
6851340|NCT00355134|10858884|FG001|Core Phase|Abnormal test procedure result(s)|2
6851341|NCT00355134|10858885|FG002|Core Phase|Abnormal test procedure result(s)|1
6851342|NCT00355134|10858886|FG003|Core Phase|Abnormal test procedure result(s)|0
6851343|NCT00355134|10858887|FG004|Core Phase|Abnormal test procedure result(s)|0
6851344|NCT00355134|10858883|FG000|Core Phase|Condition no longer requires study drug|1
6851345|NCT00355134|10858884|FG001|Core Phase|Condition no longer requires study drug|0
6851346|NCT00355134|10858885|FG002|Core Phase|Condition no longer requires study drug|1
6851347|NCT00355134|10858886|FG003|Core Phase|Condition no longer requires study drug|0
6851348|NCT00355134|10858887|FG004|Core Phase|Condition no longer requires study drug|0
6851349|NCT00355134|10858883|FG000|Extension Phase|Withdrawal by Subject|7
6851350|NCT00355134|10858884|FG001|Extension Phase|Withdrawal by Subject|11
6851351|NCT00355134|10858885|FG002|Extension Phase|Withdrawal by Subject|0
6851352|NCT00355134|10858886|FG003|Extension Phase|Withdrawal by Subject|7
6851353|NCT00355134|10858887|FG004|Extension Phase|Withdrawal by Subject|5
6851354|NCT00355134|10858883|FG000|Extension Phase|Adverse Event|13
6851355|NCT00355134|10858884|FG001|Extension Phase|Adverse Event|9
6851356|NCT00355134|10858885|FG002|Extension Phase|Adverse Event|0
6851357|NCT00355134|10858886|FG003|Extension Phase|Adverse Event|3
6851358|NCT00355134|10858887|FG004|Extension Phase|Adverse Event|5
6851359|NCT00355134|10858883|FG000|Extension Phase|Lost to Follow-up|2
6851360|NCT00355134|10858884|FG001|Extension Phase|Lost to Follow-up|6
6851361|NCT00355134|10858885|FG002|Extension Phase|Lost to Follow-up|0
6851362|NCT00355134|10858886|FG003|Extension Phase|Lost to Follow-up|2
6851363|NCT00355134|10858887|FG004|Extension Phase|Lost to Follow-up|4
6851364|NCT00355134|10858883|FG000|Extension Phase|Abnormal laboratory value(s)|4
6851365|NCT00355134|10858884|FG001|Extension Phase|Abnormal laboratory value(s)|2
6851366|NCT00355134|10858885|FG002|Extension Phase|Abnormal laboratory value(s)|0
6851367|NCT00355134|10858886|FG003|Extension Phase|Abnormal laboratory value(s)|2
6851368|NCT00355134|10858887|FG004|Extension Phase|Abnormal laboratory value(s)|2
6851369|NCT00355134|10858883|FG000|Extension Phase|Administrative problems|2
6851370|NCT00355134|10858884|FG001|Extension Phase|Administrative problems|4
6851371|NCT00355134|10858885|FG002|Extension Phase|Administrative problems|0
6851372|NCT00355134|10858886|FG003|Extension Phase|Administrative problems|1
6851373|NCT00355134|10858887|FG004|Extension Phase|Administrative problems|1
6851374|NCT00355134|10858883|FG000|Extension Phase|Unsatisfactory therapeutic effect|3
6851375|NCT00355134|10858884|FG001|Extension Phase|Unsatisfactory therapeutic effect|4
6851376|NCT00355134|10858885|FG002|Extension Phase|Unsatisfactory therapeutic effect|0
6851377|NCT00355134|10858886|FG003|Extension Phase|Unsatisfactory therapeutic effect|0
6851378|NCT00355134|10858887|FG004|Extension Phase|Unsatisfactory therapeutic effect|1
6851379|NCT00355134|10858883|FG000|Extension Phase|Abnormal test procedure result(s)|0
6851380|NCT00355134|10858884|FG001|Extension Phase|Abnormal test procedure result(s)|1
6851381|NCT00355134|10858885|FG002|Extension Phase|Abnormal test procedure result(s)|0
6851382|NCT00355134|10858886|FG003|Extension Phase|Abnormal test procedure result(s)|0
6851383|NCT00355134|10858887|FG004|Extension Phase|Abnormal test procedure result(s)|1
6851384|NCT00355134|10858883|FG000|Extension Phase|Protocol Violation|0
6851385|NCT00355134|10858884|FG001|Extension Phase|Protocol Violation|0
6851386|NCT00355134|10858885|FG002|Extension Phase|Protocol Violation|0
6851387|NCT00355134|10858886|FG003|Extension Phase|Protocol Violation|1
6851388|NCT00355134|10858887|FG004|Extension Phase|Protocol Violation|0
6851389|NCT00355147|10858899|FG000|Overall Study|Lost to Follow-up|10
6851390|NCT00355147|10858900|FG001|Overall Study|Lost to Follow-up|8
6851391|NCT00355147|10858899|FG000|Overall Study|Withdrawal by Subject|8
6851392|NCT00355147|10858900|FG001|Overall Study|Withdrawal by Subject|12
6851393|NCT00355264|10858919|FG000|Extension (Variable Duration)|Adverse Event|1
6851394|NCT00355264|10858919|FG000|Extension (Variable Duration)|Withdrew Consent|1
6851395|NCT00355342|10858930|FG000|Overall Study|Adverse Event|13
6851396|NCT00355342|10858931|FG001|Overall Study|Adverse Event|15
6851397|NCT00355342|10858930|FG000|Overall Study|Lost to Follow-up|4
6851398|NCT00355342|10858931|FG001|Overall Study|Lost to Follow-up|2
6851399|NCT00355342|10858930|FG000|Overall Study|Withdrawal by Subject|14
6851400|NCT00355342|10858931|FG001|Overall Study|Withdrawal by Subject|11
6851401|NCT00355342|10858930|FG000|Overall Study|Sponsor terminated study|2
6851402|NCT00355342|10858931|FG001|Overall Study|Sponsor terminated study|2
6851403|NCT00355342|10858930|FG000|Overall Study|Overcompliant-PI discretion|1
6851404|NCT00355342|10858931|FG001|Overall Study|Overcompliant-PI discretion|0
6851405|NCT00355342|10858930|FG000|Overall Study|Use of prohibited medication|1
6851406|NCT00355342|10858931|FG001|Overall Study|Use of prohibited medication|0
6851407|NCT00355342|10858930|FG000|Overall Study|COPD exacerbation|1
6851408|NCT00355342|10858931|FG001|Overall Study|COPD exacerbation|1
6851409|NCT00355342|10858930|FG000|Overall Study|Dispensed wrong study drug kit|1
6851410|NCT00355342|10858931|FG001|Overall Study|Dispensed wrong study drug kit|0
6851411|NCT00355342|10858930|FG000|Overall Study|Non-compliance with Dexa scans|1
6851412|NCT00355342|10858931|FG001|Overall Study|Non-compliance with Dexa scans|0
6851413|NCT00355342|10858930|FG000|Overall Study|Withdrawal by participant and physician|1
6851414|NCT00355342|10858931|FG001|Overall Study|Withdrawal by participant and physician|0
6851415|NCT00355342|10858930|FG000|Overall Study|Participant relocated|0
6851416|NCT00355342|10858931|FG001|Overall Study|Participant relocated|1
6851417|NCT00355342|10858930|FG000|Overall Study|Participant discontinued study drug|0
6851418|NCT00355342|10858931|FG001|Overall Study|Participant discontinued study drug|1
6851419|NCT00355342|10858930|FG000|Overall Study|Study management|0
6851420|NCT00355342|10858931|FG001|Overall Study|Study management|1
6851421|NCT00355342|10858930|FG000|Overall Study|Protocol Violation|0
6851422|NCT00355342|10858931|FG001|Overall Study|Protocol Violation|1
6851423|NCT00355342|10858930|FG000|Overall Study|Use of protocol excluded medication|0
6851424|NCT00355342|10858931|FG001|Overall Study|Use of protocol excluded medication|1
6851425|NCT00355368|10858939|FG000|Overall Study|Protocol Violation|8
6851426|NCT00355368|10858940|FG001|Overall Study|Protocol Violation|7
6851427|NCT00355368|10858939|FG000|Overall Study|cardiac arrest prior to intubation|2
6851428|NCT00355368|10858940|FG001|Overall Study|cardiac arrest prior to intubation|2
6851429|NCT00355472|10858957|FG000|Overall Study|Physician Decision|1
6851430|NCT00355615|10858973|FG000|Randomized Double Blind Period|Adverse Event|1
6851431|NCT00355615|10858974|FG001|Randomized Double Blind Period|Adverse Event|0
6851432|NCT00355615|10858975|FG002|Randomized Double Blind Period|Adverse Event|0
6851433|NCT00355615|10858976|FG003|Randomized Double Blind Period|Adverse Event|0
6851434|NCT00355615|10858977|FG004|Randomized Double Blind Period|Adverse Event|0
6851435|NCT00355615|10858973|FG000|Randomized Double Blind Period|Protocol Violation|0
6851436|NCT00355615|10858974|FG001|Randomized Double Blind Period|Protocol Violation|0
6851437|NCT00355615|10858975|FG002|Randomized Double Blind Period|Protocol Violation|1
6851438|NCT00355615|10858976|FG003|Randomized Double Blind Period|Protocol Violation|1
6851439|NCT00355615|10858977|FG004|Randomized Double Blind Period|Protocol Violation|0
6851440|NCT00355615|10858973|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0
6851441|NCT00355615|10858974|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0
6851442|NCT00355615|10858975|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0
6851443|NCT00355615|10858976|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0
6851444|NCT00355615|10858977|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4
6851445|NCT00355615|10858973|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0
6851446|NCT00355615|10858974|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0
6851447|NCT00355615|10858975|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0
6851448|NCT00355615|10858976|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0
6851449|NCT00355615|10858977|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1
6851450|NCT00355615|10858973|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
6851451|NCT00355615|10858974|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
6851452|NCT00355615|10858975|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
6851453|NCT00355615|10858976|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
6851454|NCT00355615|10858977|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3
6851455|NCT00355615|10858973|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0
6851456|NCT00355615|10858974|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0
6851457|NCT00355615|10858975|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0
6851458|NCT00355615|10858976|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0
6851459|NCT00355615|10858977|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1
6851460|NCT00355784|10859002|FG000|Overall Study|Withdrawal by Subject|0
6851461|NCT00355784|10859003|FG001|Overall Study|Withdrawal by Subject|0
6851462|NCT00355784|10859004|FG002|Overall Study|Withdrawal by Subject|2
6851463|NCT00356122|10859060|FG000|TREATMENT|Lack of Efficacy|26
6851464|NCT00356122|10859060|FG000|TREATMENT|Adverse Event|10
6851465|NCT00356122|10859060|FG000|TREATMENT|Subject's request|4
6851466|NCT00356122|10859060|FG000|TREATMENT|Other|4
6851467|NCT00356122|10859060|FG000|TREATMENT|Did not receive study medication|1
6851468|NCT00356122|10859060|FG000|FOLLOW-UP|Death|37
6851469|NCT00356122|10859060|FG000|FOLLOW-UP|Lost to Follow-up|2
6851470|NCT00356122|10859060|FG000|FOLLOW-UP|Other|2
6851471|NCT00356135|10859067|FG000|Overall Study|Protocol Violation|1
6851472|NCT00356135|10859068|FG001|Overall Study|Protocol Violation|0
6851473|NCT00356135|10859069|FG002|Overall Study|Protocol Violation|0
6851474|NCT00356135|10859067|FG000|Overall Study|Adverse Event|1
6851475|NCT00356135|10859068|FG001|Overall Study|Adverse Event|0
6851476|NCT00356135|10859069|FG002|Overall Study|Adverse Event|0
6851477|NCT00356135|10859067|FG000|Overall Study|Lost to Follow-up|0
6851478|NCT00356135|10859068|FG001|Overall Study|Lost to Follow-up|0
6851479|NCT00356135|10859069|FG002|Overall Study|Lost to Follow-up|1
6851480|NCT00356135|10859067|FG000|Overall Study|Physician Decision|1
6851481|NCT00356135|10859068|FG001|Overall Study|Physician Decision|1
6851482|NCT00356135|10859069|FG002|Overall Study|Physician Decision|1
6851483|NCT00356135|10859067|FG000|Overall Study|Subject non-compliance|1
6851484|NCT00356135|10859068|FG001|Overall Study|Subject non-compliance|1
6851485|NCT00356135|10859069|FG002|Overall Study|Subject non-compliance|3
6851486|NCT00356148|10859081|FG000|Overall Study|Reoperation within 30 days|2
6851487|NCT00356148|10859082|FG001|Overall Study|Reoperation within 30 days|1
6851488|NCT00356200|10859091|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1
6851489|NCT00356200|10859092|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0
6851490|NCT00356200|10859091|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0
6851491|NCT00356200|10859092|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2
6851492|NCT00356265|10859107|FG000|Overall Study|Withdrawal by Subject|0
6851493|NCT00356265|10859108|FG001|Overall Study|Withdrawal by Subject|0
6851494|NCT00356265|10859109|FG002|Overall Study|Withdrawal by Subject|1
6851495|NCT00356278|10859121|FG000|Overall Study|Withdrawal by Subject|25
6851496|NCT00356278|10859122|FG001|Overall Study|Withdrawal by Subject|15
6851497|NCT00356278|10859123|FG002|Overall Study|Withdrawal by Subject|19
6851498|NCT00356369|10859142|FG000|Active Phase|Withdrawal by Subject|2
6851499|NCT00356369|10859143|FG001|Active Phase|Withdrawal by Subject|1
6851500|NCT00356408|10859153|FG000|Overall Study|Adverse Event|9
6851501|NCT00356408|10859153|FG000|Overall Study|Lack of Efficacy|36
6851502|NCT00356408|10859153|FG000|Overall Study|Lost to Follow-up|2
6851503|NCT00356408|10859153|FG000|Overall Study|Withdrawal by Subject|6
6851504|NCT00356408|10859153|FG000|Overall Study|Other: Principal investigator discretion|3
6851505|NCT00356408|10859153|FG000|Overall Study|Other: Sponsor request|1
6851506|NCT00356408|10859153|FG000|Overall Study|Other: Azathioprine stopped|1
6851507|NCT00356408|10859153|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1
6851508|NCT00356408|10859153|FG000|Overall Study|Other: Subject chose commerical dosing|1
6851509|NCT00356525|10859178|FG000|Overall Study|Progressive Disease|8
6851510|NCT00356525|10859179|FG001|Overall Study|Progressive Disease|5
6851511|NCT00356525|10859180|FG002|Overall Study|Progressive Disease|4
6851512|NCT00356525|10859181|FG003|Overall Study|Progressive Disease|2
6851513|NCT00356525|10859178|FG000|Overall Study|Adverse Event|1
6851514|NCT00356525|10859179|FG001|Overall Study|Adverse Event|3
6851515|NCT00356525|10859180|FG002|Overall Study|Adverse Event|1
6851516|NCT00356525|10859181|FG003|Overall Study|Adverse Event|1
6851517|NCT00356525|10859178|FG000|Overall Study|Lost to Follow-up|1
6851518|NCT00356525|10859179|FG001|Overall Study|Lost to Follow-up|0
6851519|NCT00356525|10859180|FG002|Overall Study|Lost to Follow-up|0
6851520|NCT00356525|10859181|FG003|Overall Study|Lost to Follow-up|0
6851521|NCT00356525|10859178|FG000|Overall Study|Physician Decision|2
6851522|NCT00356525|10859179|FG001|Overall Study|Physician Decision|2
6851523|NCT00356525|10859180|FG002|Overall Study|Physician Decision|2
6851524|NCT00356525|10859181|FG003|Overall Study|Physician Decision|1
6851525|NCT00356525|10859178|FG000|Overall Study|Protocol Entry Criteria Not Met|1
6851526|NCT00356525|10859179|FG001|Overall Study|Protocol Entry Criteria Not Met|0
6851527|NCT00356525|10859180|FG002|Overall Study|Protocol Entry Criteria Not Met|0
6851528|NCT00356525|10859181|FG003|Overall Study|Protocol Entry Criteria Not Met|0
6851529|NCT00356525|10859178|FG000|Overall Study|Withdrawal by Subject|1
6851530|NCT00356525|10859179|FG001|Overall Study|Withdrawal by Subject|1
6851531|NCT00356525|10859180|FG002|Overall Study|Withdrawal by Subject|0
6851532|NCT00356525|10859181|FG003|Overall Study|Withdrawal by Subject|3
6851533|NCT00356525|10859178|FG000|Overall Study|Death|0
6851534|NCT00356525|10859179|FG001|Overall Study|Death|0
6851535|NCT00356525|10859180|FG002|Overall Study|Death|0
6851536|NCT00356525|10859181|FG003|Overall Study|Death|1
6851537|NCT00356525|10859178|FG000|Overall Study|Sponsor Decision|0
6851538|NCT00356525|10859179|FG001|Overall Study|Sponsor Decision|0
6851539|NCT00356525|10859180|FG002|Overall Study|Sponsor Decision|0
6851540|NCT00356525|10859181|FG003|Overall Study|Sponsor Decision|1
6851541|NCT00356590|10859191|FG000|Overall Study|Adverse Event|54
6851542|NCT00356590|10859191|FG000|Overall Study|Death|10
6851543|NCT00356590|10859191|FG000|Overall Study|Lost to Follow-up|35
6851544|NCT00356590|10859191|FG000|Overall Study|Physician Decision|46
6851545|NCT00356590|10859191|FG000|Overall Study|Withdrawal by Subject|41
6851546|NCT00356590|10859191|FG000|Overall Study|Completed month 12 only|2
6851547|NCT00356590|10859191|FG000|Overall Study|Protocol issues|6
6851548|NCT00356590|10859191|FG000|Overall Study|Response status|28
6851549|NCT00356590|10859191|FG000|Overall Study|Other|52
6851550|NCT00356603|10859197|FG000|Overall Study|Other|6
6851551|NCT00356603|10859198|FG001|Overall Study|Other|3
6851552|NCT00356759|10859208|FG000|Overall Study|Death|5
6851553|NCT00356759|10859209|FG001|Overall Study|Death|2
6851554|NCT00356759|10859208|FG000|Overall Study|Withdrawal by Subject|2
6851555|NCT00356759|10859209|FG001|Overall Study|Withdrawal by Subject|2
6851556|NCT00356759|10859208|FG000|Overall Study|Adverse Event|1
6851557|NCT00356759|10859209|FG001|Overall Study|Adverse Event|3
6851558|NCT00356759|10859208|FG000|Overall Study|Lost to Follow-up|1
6851559|NCT00356759|10859209|FG001|Overall Study|Lost to Follow-up|1
6851560|NCT00356759|10859208|FG000|Overall Study|Intercurrent disease or persistent extre|5
6851561|NCT00356759|10859209|FG001|Overall Study|Intercurrent disease or persistent extre|2
6851562|NCT00356811|10859215|FG000|Overall Study|Death|35
6851563|NCT00356811|10859215|FG000|Overall Study|Lost to Follow-up|2
6851564|NCT00356811|10859215|FG000|Overall Study|Withdrawal by Subject|6
6851565|NCT00356811|10859215|FG000|Overall Study|Participant Could Not Make a Checkup|1
6851566|NCT00356811|10859215|FG000|Overall Study|Study Is Terminating|3
6851567|NCT00356811|10859215|FG000|Overall Study|Site Closed during Follow-up|2
6851568|NCT00356863|10859222|FG000|Overall Study|Death|16
6851569|NCT00356863|10859223|FG001|Overall Study|Death|32
6851570|NCT00356863|10859222|FG000|Overall Study|Lost to Follow-up|76
6851571|NCT00356863|10859223|FG001|Overall Study|Lost to Follow-up|43
6851572|NCT00356889|10859233|FG000|Overall Study|Protocol Violation|2
6851573|NCT00356889|10859233|FG000|Overall Study|Adverse Event|1
6851574|NCT00356915|10859241|FG000|Overall Study|Non compliance|1
6851575|NCT00356915|10859242|FG001|Overall Study|Non compliance|2
6851576|NCT00356915|10859243|FG002|Overall Study|Non compliance|1
6851577|NCT00356915|10859241|FG000|Overall Study|Protocol Violation|2
6851578|NCT00356915|10859242|FG001|Overall Study|Protocol Violation|3
6851579|NCT00356915|10859243|FG002|Overall Study|Protocol Violation|2
6851580|NCT00356915|10859241|FG000|Overall Study|Withdrawal by Subject|14
6851581|NCT00356915|10859242|FG001|Overall Study|Withdrawal by Subject|14
6851582|NCT00356915|10859243|FG002|Overall Study|Withdrawal by Subject|10
6851583|NCT00356915|10859241|FG000|Overall Study|Lack of Efficacy|0
6851584|NCT00356915|10859242|FG001|Overall Study|Lack of Efficacy|0
6851585|NCT00356915|10859243|FG002|Overall Study|Lack of Efficacy|3
6851586|NCT00356915|10859241|FG000|Overall Study|Lost to Follow-up|27
6851587|NCT00356915|10859242|FG001|Overall Study|Lost to Follow-up|34
6851588|NCT00356915|10859243|FG002|Overall Study|Lost to Follow-up|14
6851589|NCT00356915|10859241|FG000|Overall Study|Administrative Decision|0
6851590|NCT00356915|10859242|FG001|Overall Study|Administrative Decision|0
6851591|NCT00356915|10859243|FG002|Overall Study|Administrative Decision|1
6851592|NCT00356915|10859241|FG000|Overall Study|Physician Decision|0
6851593|NCT00356915|10859242|FG001|Overall Study|Physician Decision|2
6851594|NCT00356915|10859243|FG002|Overall Study|Physician Decision|0
6851595|NCT00356915|10859241|FG000|Overall Study|Adverse Event|21
6851596|NCT00356915|10859242|FG001|Overall Study|Adverse Event|31
6851597|NCT00356915|10859243|FG002|Overall Study|Adverse Event|8
6851598|NCT00356915|10859241|FG000|Overall Study|Miscellaneous reasons|11
6851599|NCT00356915|10859242|FG001|Overall Study|Miscellaneous reasons|8
6851600|NCT00356915|10859243|FG002|Overall Study|Miscellaneous reasons|3
6851601|NCT00357006|10859264|FG000|Overall Study|Lost to Follow-up|1
6851602|NCT00357006|10859265|FG001|Overall Study|Lost to Follow-up|2
6851603|NCT00357006|10859266|FG002|Overall Study|Lost to Follow-up|1
6851604|NCT00357006|10859264|FG000|Overall Study|Withdrawal by Subject|1
6851605|NCT00357006|10859265|FG001|Overall Study|Withdrawal by Subject|3
6851606|NCT00357006|10859266|FG002|Overall Study|Withdrawal by Subject|2
6851607|NCT00357097|10859280|FG000|Overall Study|Did not meet inclusion criteria|5
6851608|NCT00357097|10859281|FG001|Overall Study|Did not meet inclusion criteria|3
6851609|NCT00357097|10859280|FG000|Overall Study|Adverse Event|34
6851610|NCT00357097|10859281|FG001|Overall Study|Adverse Event|6
6851611|NCT00357097|10859280|FG000|Overall Study|Withdrawal by Subject|8
6851612|NCT00357097|10859281|FG001|Overall Study|Withdrawal by Subject|7
6851613|NCT00357097|10859280|FG000|Overall Study|Non-compliance|1
6851614|NCT00357097|10859281|FG001|Overall Study|Non-compliance|2
6851615|NCT00357097|10859280|FG000|Overall Study|Lack of Efficacy|2
6851616|NCT00357097|10859281|FG001|Overall Study|Lack of Efficacy|8
6851617|NCT00357097|10859280|FG000|Overall Study|Met Exclusion Criteria|3
6851618|NCT00357097|10859281|FG001|Overall Study|Met Exclusion Criteria|1
6851619|NCT00357097|10859280|FG000|Overall Study|Other|1
6851620|NCT00357097|10859281|FG001|Overall Study|Other|1
6851621|NCT00357097|10859280|FG000|Overall Study|Increase of RLS Symptoms|0
6851622|NCT00357097|10859281|FG001|Overall Study|Increase of RLS Symptoms|1
6851623|NCT00357110|10859289|FG000|Overall Study|Early study termination|5
6851624|NCT00357110|10859290|FG001|Overall Study|Early study termination|5
6851625|NCT00357370|10859329|FG000|Cohort 2|Lack of Efficacy|0
7152628|NCT03261037|11317648|FG003|Overall Study|Participant presented clinical improvement|0
7152629|NCT03261037|11317645|FG000|Overall Study|Technical difficulties|0
7152630|NCT03261037|11317646|FG001|Overall Study|Technical difficulties|0
7152631|NCT03261037|11317647|FG002|Overall Study|Technical difficulties|0
7152632|NCT03261037|11317648|FG003|Overall Study|Technical difficulties|1
6851626|NCT00357370|10859330|FG001|Cohort 2|Lack of Efficacy|2
6851627|NCT00357370|10859331|FG002|Cohort 2|Lack of Efficacy|1
6851628|NCT00357370|10859329|FG000|Cohort 2|Adverse Event|1
6851629|NCT00357370|10859330|FG001|Cohort 2|Adverse Event|1
6851630|NCT00357370|10859331|FG002|Cohort 2|Adverse Event|1
6851631|NCT00357370|10859329|FG000|Cohort 2|Lost to Follow-up|0
6851632|NCT00357370|10859330|FG001|Cohort 2|Lost to Follow-up|1
6851633|NCT00357370|10859331|FG002|Cohort 2|Lost to Follow-up|0
6851634|NCT00357370|10859329|FG000|Cohort 2|non-compliance, not met criteria, etc|1
6851635|NCT00357370|10859330|FG001|Cohort 2|non-compliance, not met criteria, etc|1
6851636|NCT00357370|10859331|FG002|Cohort 2|non-compliance, not met criteria, etc|0
6851637|NCT00357370|10859329|FG000|Cohort 2|Withdrawal by Subject|0
6851638|NCT00357370|10859330|FG001|Cohort 2|Withdrawal by Subject|2
6851639|NCT00357370|10859331|FG002|Cohort 2|Withdrawal by Subject|0
6851640|NCT00357396|10859341|FG000|Overall Study|Adverse Event|1
6851641|NCT00357396|10859342|FG001|Overall Study|Adverse Event|0
6851642|NCT00357500|10859347|FG000|Overall Study|Adverse Event|3
6851643|NCT00357500|10859347|FG000|Overall Study|Withdrawal by Subject|5
6851644|NCT00357500|10859347|FG000|Overall Study|Progressive Disease|65
6851645|NCT00357500|10859347|FG000|Overall Study|Not Started Protocol Therapy|4
6851646|NCT00357552|10859351|FG000|Screening|Did not meet eligibility criteria|84
6851647|NCT00357552|10859351|FG000|Weeks 0 to 24|Death|1
6851648|NCT00357552|10859351|FG000|Weeks 24 to 104|Death|3
6851649|NCT00357552|10859351|FG000|Weeks 24 to 104|Not able to get to clinic|2
6851650|NCT00357656|10859361|FG000|Overall Study|Other, No surgery performed|0
6851651|NCT00357656|10859362|FG001|Overall Study|Other, No surgery performed|3
6851652|NCT00357760|10859386|FG000|Overall Study|Disease progression|44
6851653|NCT00357760|10859387|FG001|Overall Study|Disease progression|17
6851654|NCT00357760|10859386|FG000|Overall Study|Adverse Event|10
6851655|NCT00357760|10859387|FG001|Overall Study|Adverse Event|7
6851656|NCT00357760|10859386|FG000|Overall Study|Death|0
6851657|NCT00357760|10859387|FG001|Overall Study|Death|3
6851658|NCT00357760|10859386|FG000|Overall Study|Alternative therapy|1
6851659|NCT00357760|10859387|FG001|Overall Study|Alternative therapy|0
6851660|NCT00357760|10859386|FG000|Overall Study|Withdrawal by Subject|0
6851661|NCT00357760|10859387|FG001|Overall Study|Withdrawal by Subject|2
6851662|NCT00357760|10859386|FG000|Overall Study|Never started treatment|2
6851663|NCT00357760|10859387|FG001|Overall Study|Never started treatment|1
6851664|NCT00357760|10859386|FG000|Overall Study|Ineligible|0
6851665|NCT00357760|10859387|FG001|Overall Study|Ineligible|2
6851666|NCT00357760|10859386|FG000|Overall Study|Physician Decision|2
6851667|NCT00357760|10859387|FG001|Overall Study|Physician Decision|1
6851668|NCT00357760|10859386|FG000|Overall Study|Protocol Violation|0
6851669|NCT00357760|10859387|FG001|Overall Study|Protocol Violation|1
6851670|NCT00357760|10859386|FG000|Overall Study|To receive hospice care|0
6851671|NCT00357760|10859387|FG001|Overall Study|To receive hospice care|1
6851672|NCT00357877|10859395|FG000|Overall Study|Death|2
6851673|NCT00357877|10859396|FG001|Overall Study|Death|1
6851674|NCT00357877|10859395|FG000|Overall Study|Lost to Follow-up|20
6851675|NCT00357877|10859396|FG001|Overall Study|Lost to Follow-up|23
6851676|NCT00357877|10859395|FG000|Overall Study|Withdrawal by Subject|3
6851677|NCT00357877|10859396|FG001|Overall Study|Withdrawal by Subject|3
6851678|NCT00357877|10859395|FG000|Overall Study|Administrative withdrawal|1
6851679|NCT00357877|10859396|FG001|Overall Study|Administrative withdrawal|1
6851680|NCT00357877|10859395|FG000|Overall Study|Other|0
6851681|NCT00357877|10859396|FG001|Overall Study|Other|2
6851682|NCT00357903|10859406|FG000|Overall Study|Adverse Event|87
6851683|NCT00357903|10859407|FG001|Overall Study|Adverse Event|4
6851684|NCT00357903|10859406|FG000|Overall Study|Death|33
6851685|NCT00357903|10859407|FG001|Overall Study|Death|0
6851686|NCT00357903|10859406|FG000|Overall Study|Lost to Follow-up|23
6851687|NCT00357903|10859407|FG001|Overall Study|Lost to Follow-up|4
6851688|NCT00357903|10859406|FG000|Overall Study|Physician Decision|39
6851689|NCT00357903|10859407|FG001|Overall Study|Physician Decision|5
6851690|NCT00357903|10859406|FG000|Overall Study|Withdrawal by Subject|57
6851691|NCT00357903|10859407|FG001|Overall Study|Withdrawal by Subject|7
6851692|NCT00357903|10859406|FG000|Overall Study|Completed month 12 only|0
6851693|NCT00357903|10859407|FG001|Overall Study|Completed month 12 only|1
7152633|NCT03261037|11317645|FG000|Overall Study|Equipment failed to work|0
6851694|NCT00357903|10859406|FG000|Overall Study|Protocol issues|14
6851695|NCT00357903|10859407|FG001|Overall Study|Protocol issues|3
6851696|NCT00357903|10859406|FG000|Overall Study|Response status|61
6851697|NCT00357903|10859407|FG001|Overall Study|Response status|9
6851698|NCT00357903|10859406|FG000|Overall Study|Other|49
6851699|NCT00357903|10859407|FG001|Overall Study|Other|10
6851700|NCT00357968|10859425|FG000|First Maintenance Dose Phase|Not a PCI patient|47
6851701|NCT00357968|10859426|FG001|First Maintenance Dose Phase|Not a PCI patient|42
6851702|NCT00357968|10859425|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1
6851703|NCT00357968|10859426|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2
6851704|NCT00357994|10859449|FG000|Overall Study|Adverse Event|1
6851705|NCT00357994|10859450|FG001|Overall Study|Adverse Event|2
6851706|NCT00357994|10859449|FG000|Overall Study|Lack of Efficacy|0
6851707|NCT00357994|10859450|FG001|Overall Study|Lack of Efficacy|1
6851708|NCT00357994|10859449|FG000|Overall Study|Protocol Violation|1
6851709|NCT00357994|10859450|FG001|Overall Study|Protocol Violation|0
6851710|NCT00358150|10859460|FG000|Overall Study|Adverse Event|3
6851711|NCT00358150|10859460|FG000|Overall Study|Withdrawal by Subject|1
6851712|NCT00358150|10859460|FG000|Overall Study|Undefined|3
6851713|NCT00358215|10859469|FG000|Overall Study|Ineligibility determined|4
6851714|NCT00358215|10859470|FG001|Overall Study|Ineligibility determined|3
6851715|NCT00358215|10859469|FG000|Overall Study|Adverse Event|83
6851716|NCT00358215|10859470|FG001|Overall Study|Adverse Event|65
6851717|NCT00358215|10859469|FG000|Overall Study|Withdrawal by Subject|111
6851718|NCT00358215|10859470|FG001|Overall Study|Withdrawal by Subject|102
6851719|NCT00358215|10859469|FG000|Overall Study|Participant request|65
6851720|NCT00358215|10859470|FG001|Overall Study|Participant request|64
6851721|NCT00358215|10859469|FG000|Overall Study|Physician Decision|47
6851722|NCT00358215|10859470|FG001|Overall Study|Physician Decision|39
6851723|NCT00358215|10859469|FG000|Overall Study|Lost to Follow-up|16
6851724|NCT00358215|10859470|FG001|Overall Study|Lost to Follow-up|22
6851725|NCT00358215|10859469|FG000|Overall Study|Death|265
6851726|NCT00358215|10859470|FG001|Overall Study|Death|281
6851727|NCT00358215|10859469|FG000|Overall Study|Protocol Violation|64
6851728|NCT00358215|10859470|FG001|Overall Study|Protocol Violation|59
6851729|NCT00358215|10859469|FG000|Overall Study|Pregnancy|1
6851730|NCT00358215|10859470|FG001|Overall Study|Pregnancy|0
6851731|NCT00358215|10859469|FG000|Overall Study|Other|21
6851732|NCT00358215|10859470|FG001|Overall Study|Other|14
6851733|NCT00358215|10859469|FG000|Overall Study|Did not receive investigational product|2
6851734|NCT00358215|10859470|FG001|Overall Study|Did not receive investigational product|3
6851735|NCT00358436|10859495|FG000|Overall Study|Adverse Event|29
6851736|NCT00358436|10859496|FG001|Overall Study|Adverse Event|13
7077607|NCT02093663|11185229|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1
7077608|NCT02093663|11185230|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
7077609|NCT02093663|11185231|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
7152634|NCT03261037|11317646|FG001|Overall Study|Equipment failed to work|0
7152635|NCT03261037|11317647|FG002|Overall Study|Equipment failed to work|0
7152636|NCT03261037|11317648|FG003|Overall Study|Equipment failed to work|1
7152637|NCT03261037|11317645|FG000|Overall Study|End of study for participant and no follow up|0
7152638|NCT03261037|11317646|FG001|Overall Study|End of study for participant and no follow up|0
7152639|NCT03261037|11317647|FG002|Overall Study|End of study for participant and no follow up|0
7152640|NCT03261037|11317648|FG003|Overall Study|End of study for participant and no follow up|1
7152641|NCT03261037|11317645|FG000|Overall Study|Participant was too weak to continue in study|1
7152642|NCT03261037|11317646|FG001|Overall Study|Participant was too weak to continue in study|0
7152643|NCT03261037|11317647|FG002|Overall Study|Participant was too weak to continue in study|0
7152644|NCT03261037|11317648|FG003|Overall Study|Participant was too weak to continue in study|0
7152645|NCT03261167|11317661|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0
7077610|NCT02093663|11185232|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
7077611|NCT02093663|11185233|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
7077612|NCT02093663|11185229|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5
7077613|NCT02093663|11185230|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
7077614|NCT02093663|11185231|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
7077615|NCT02093663|11185232|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
7077616|NCT02093663|11185233|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
7077617|NCT02093663|11185229|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2
7077618|NCT02093663|11185230|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4
7077619|NCT02093663|11185231|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
7077620|NCT02093663|11185232|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
7077621|NCT02093663|11185233|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
7077622|NCT02093663|11185229|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0
7077623|NCT02093663|11185230|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0
7077624|NCT02093663|11185231|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1
7077625|NCT02093663|11185232|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0
7077626|NCT02093663|11185233|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0
7077627|NCT02093663|11185229|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
6851737|NCT00358436|10859495|FG000|Overall Study|Lack of Efficacy|34
6851738|NCT00358436|10859496|FG001|Overall Study|Lack of Efficacy|36
6851739|NCT00358436|10859495|FG000|Overall Study|Lost to Follow-up|11
6851740|NCT00358436|10859496|FG001|Overall Study|Lost to Follow-up|6
6851741|NCT00358436|10859495|FG000|Overall Study|Protocol Violation|8
6851742|NCT00358436|10859496|FG001|Overall Study|Protocol Violation|3
6851743|NCT00358436|10859495|FG000|Overall Study|Withdrawal by Subject|40
6851744|NCT00358436|10859496|FG001|Overall Study|Withdrawal by Subject|17
6851745|NCT00358436|10859495|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4
6851746|NCT00358436|10859496|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0
7077628|NCT02093663|11185230|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
7077629|NCT02093663|11185231|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5
7077630|NCT02093663|11185232|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
7077631|NCT02093663|11185233|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
7077632|NCT02093663|11185229|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
7077633|NCT02093663|11185230|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
7077634|NCT02093663|11185231|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
7077635|NCT02093663|11185232|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3
7077636|NCT02093663|11185233|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2
7077637|NCT02093663|11185229|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
7077638|NCT02093663|11185230|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
7077639|NCT02093663|11185231|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
7077640|NCT02093663|11185232|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6
7077641|NCT02093663|11185233|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7
7077642|NCT02093663|11185229|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
7077643|NCT02093663|11185230|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
7077644|NCT02093663|11185231|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
7077645|NCT02093663|11185232|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1
7077646|NCT02093663|11185233|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1
7077647|NCT02093663|11185229|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0
7077648|NCT02093663|11185230|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0
7077649|NCT02093663|11185231|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0
7077650|NCT02093663|11185232|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0
7077651|NCT02093663|11185233|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1
7077652|NCT02093897|11185315|FG000|Overall Study|Physician Decision|1
7077653|NCT02093897|11185315|FG000|Overall Study|Planned age group closure - no's reached|17
7077654|NCT02093897|11185315|FG000|Overall Study|Adverse event, non-fatal|1
7077655|NCT02093923|11185331|FG000|Overall Study|Lost to Follow-up|0
7077656|NCT02093923|11185332|FG001|Overall Study|Lost to Follow-up|0
7077657|NCT02093923|11185333|FG002|Overall Study|Lost to Follow-up|0
7077658|NCT02093923|11185334|FG003|Overall Study|Lost to Follow-up|1
7077659|NCT02093923|11185335|FG004|Overall Study|Lost to Follow-up|0
7077660|NCT02093923|11185331|FG000|Overall Study|Screen failure after randomization|0
7077661|NCT02093923|11185332|FG001|Overall Study|Screen failure after randomization|0
7077662|NCT02093923|11185333|FG002|Overall Study|Screen failure after randomization|0
7077663|NCT02093923|11185334|FG003|Overall Study|Screen failure after randomization|1
7077664|NCT02093923|11185335|FG004|Overall Study|Screen failure after randomization|0
7077665|NCT02094300|11185390|FG000|Overall Study|Death|7
7077666|NCT02094300|11185390|FG000|Overall Study|Lost to Follow-up|10
7077667|NCT02094300|11185390|FG000|Overall Study|Still be eligible for follow-up|3
7077668|NCT02094417|11185403|FG000|Overall Study|Adverse Event|0
7077669|NCT02094417|11185404|FG001|Overall Study|Adverse Event|0
7077670|NCT02094417|11185405|FG002|Overall Study|Adverse Event|0
7040904|NCT01721070|11124099|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1
7040905|NCT01721109|11124117|FG000|Overall Study|Lack of Efficacy|1
7040906|NCT01721109|11124117|FG000|Overall Study|Non- Compliance with Study Drug|3
7040907|NCT01721109|11124117|FG000|Overall Study|Withdrew Consent|1
7040908|NCT01721109|11124117|FG000|Overall Study|Lost to Follow-up|2
7077671|NCT02094417|11185406|FG003|Overall Study|Adverse Event|1
7077672|NCT02094417|11185403|FG000|Overall Study|Eligibility criteria|0
7077673|NCT02094417|11185404|FG001|Overall Study|Eligibility criteria|1
7077674|NCT02094417|11185405|FG002|Overall Study|Eligibility criteria|0
7077675|NCT02094417|11185406|FG003|Overall Study|Eligibility criteria|0
7077676|NCT02094417|11185403|FG000|Overall Study|No responder|4
7040909|NCT01721161|11124123|FG000|Overall Study|Adverse Event|2
7040910|NCT01721161|11124124|FG001|Overall Study|Adverse Event|3
7040911|NCT01721161|11124123|FG000|Overall Study|Lost to Follow-up|1
7040912|NCT01721161|11124124|FG001|Overall Study|Lost to Follow-up|2
7040913|NCT01721161|11124123|FG000|Overall Study|Withdrawal by Subject|1
7040914|NCT01721161|11124124|FG001|Overall Study|Withdrawal by Subject|1
7077677|NCT02094417|11185404|FG001|Overall Study|No responder|4
7077678|NCT02094417|11185405|FG002|Overall Study|No responder|4
7077679|NCT02094417|11185406|FG003|Overall Study|No responder|3
7077680|NCT02094417|11185403|FG000|Overall Study|Unable to conduct observations or assess|0
7077681|NCT02094417|11185404|FG001|Overall Study|Unable to conduct observations or assess|1
7077682|NCT02094417|11185405|FG002|Overall Study|Unable to conduct observations or assess|0
7077683|NCT02094417|11185406|FG003|Overall Study|Unable to conduct observations or assess|0
7077684|NCT02094417|11185403|FG000|Overall Study|Withdrawal by Subject|1
7077685|NCT02094417|11185404|FG001|Overall Study|Withdrawal by Subject|2
7077686|NCT02094417|11185405|FG002|Overall Study|Withdrawal by Subject|1
7077687|NCT02094417|11185406|FG003|Overall Study|Withdrawal by Subject|3
7077688|NCT02094573|11185436|FG000|Overall Study|Adverse Event|4
7077689|NCT02094573|11185437|FG001|Overall Study|Adverse Event|14
7077690|NCT02094573|11185436|FG000|Overall Study|Clinical Progressive Disease|9
7077691|NCT02094573|11185437|FG001|Overall Study|Clinical Progressive Disease|13
7040915|NCT01721161|11124123|FG000|Overall Study|Other|0
7077692|NCT02094573|11185436|FG000|Overall Study|Death|11
7077693|NCT02094573|11185437|FG001|Overall Study|Death|3
7077694|NCT02094573|11185436|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63
7077695|NCT02094573|11185437|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50
7077696|NCT02094573|11185436|FG000|Overall Study|Non-compliance with Study Drug|1
7077697|NCT02094573|11185437|FG001|Overall Study|Non-compliance with Study Drug|1
7077698|NCT02094573|11185436|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1
7077699|NCT02094573|11185437|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0
7077700|NCT02094573|11185436|FG000|Overall Study|Physician Decision|4
7077701|NCT02094573|11185437|FG001|Overall Study|Physician Decision|4
7077702|NCT02094573|11185436|FG000|Overall Study|Site Terminated by Sponsor|10
7077703|NCT02094573|11185437|FG001|Overall Study|Site Terminated by Sponsor|17
7077704|NCT02094573|11185436|FG000|Overall Study|Withdrawal by Subject|6
7077705|NCT02094573|11185437|FG001|Overall Study|Withdrawal by Subject|8
7077706|NCT02094573|11185436|FG000|Overall Study|Randomized but not Treated|3
7077707|NCT02094573|11185437|FG001|Overall Study|Randomized but not Treated|0
7077708|NCT02094612|11185474|FG000|Overall Study|Lost to Follow-up|47
7077709|NCT02094612|11185475|FG001|Overall Study|Lost to Follow-up|47
7077710|NCT02094612|11185474|FG000|Overall Study|Never started ADHD medication|32
7077711|NCT02094612|11185475|FG001|Overall Study|Never started ADHD medication|23
7077712|NCT02094677|11185492|FG000|Overall Study|Screening|3
7077713|NCT02094677|11185493|FG001|Overall Study|Screening|1
7077714|NCT02094885|11185516|FG000|Overall Study|Death|1
7077715|NCT02094885|11185517|FG001|Overall Study|Death|5
7077716|NCT02094885|11185516|FG000|Overall Study|Withdrawn due to age|1
7077717|NCT02094885|11185517|FG001|Overall Study|Withdrawn due to age|0
7077718|NCT02094898|11185523|FG000|Overall Study|Clinical Worsening|2
7077719|NCT02094898|11185523|FG000|Overall Study|Adverse Event|2
7077720|NCT02094898|11185523|FG000|Overall Study|Lack of Efficacy|1
7077721|NCT02094937|11185529|FG000|8 Weeks in Period 1|Adverse Event|9
7077722|NCT02094937|11185530|FG001|8 Weeks in Period 1|Adverse Event|0
7077723|NCT02094937|11185531|FG002|8 Weeks in Period 1|Adverse Event|0
7077724|NCT02094937|11185532|FG003|8 Weeks in Period 1|Adverse Event|0
7077725|NCT02094937|11185529|FG000|8 Weeks in Period 1|Lack of Efficacy|3
7077726|NCT02094937|11185530|FG001|8 Weeks in Period 1|Lack of Efficacy|0
7077727|NCT02094937|11185531|FG002|8 Weeks in Period 1|Lack of Efficacy|0
7077728|NCT02094937|11185532|FG003|8 Weeks in Period 1|Lack of Efficacy|0
7077729|NCT02094937|11185529|FG000|8 Weeks in Period 1|Protocol Violation|2
7077730|NCT02094937|11185530|FG001|8 Weeks in Period 1|Protocol Violation|0
7077731|NCT02094937|11185531|FG002|8 Weeks in Period 1|Protocol Violation|0
7077732|NCT02094937|11185532|FG003|8 Weeks in Period 1|Protocol Violation|0
7077733|NCT02094937|11185529|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41
7077734|NCT02094937|11185530|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0
7077735|NCT02094937|11185531|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0
7077736|NCT02094937|11185532|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0
7077737|NCT02094937|11185529|FG000|8 Weeks in Period 1|Physician Decision|1
7077738|NCT02094937|11185530|FG001|8 Weeks in Period 1|Physician Decision|0
7077739|NCT02094937|11185531|FG002|8 Weeks in Period 1|Physician Decision|0
7077740|NCT02094937|11185532|FG003|8 Weeks in Period 1|Physician Decision|0
7077741|NCT02094937|11185529|FG000|8 Weeks in Period 1|Withdrawal by Subject|4
7077742|NCT02094937|11185530|FG001|8 Weeks in Period 1|Withdrawal by Subject|0
7077743|NCT02094937|11185531|FG002|8 Weeks in Period 1|Withdrawal by Subject|0
7077744|NCT02094937|11185532|FG003|8 Weeks in Period 1|Withdrawal by Subject|0
7077745|NCT02094937|11185529|FG000|12 Weeks in Period 2|Adverse Event|0
7077746|NCT02094937|11185530|FG001|12 Weeks in Period 2|Adverse Event|2
7077747|NCT02094937|11185531|FG002|12 Weeks in Period 2|Adverse Event|4
7077748|NCT02094937|11185532|FG003|12 Weeks in Period 2|Adverse Event|1
7077749|NCT02094937|11185529|FG000|12 Weeks in Period 2|Lack of Efficacy|0
7077750|NCT02094937|11185530|FG001|12 Weeks in Period 2|Lack of Efficacy|1
7077751|NCT02094937|11185531|FG002|12 Weeks in Period 2|Lack of Efficacy|0
7077752|NCT02094937|11185532|FG003|12 Weeks in Period 2|Lack of Efficacy|0
7152646|NCT03261167|11317662|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3
7077753|NCT02094937|11185529|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0
7077754|NCT02094937|11185530|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5
7077755|NCT02094937|11185531|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6
7077756|NCT02094937|11185532|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11
7077757|NCT02094937|11185529|FG000|12 Weeks in Period 2|Withdrawal by Subject|0
7077758|NCT02094937|11185530|FG001|12 Weeks in Period 2|Withdrawal by Subject|2
7077759|NCT02094937|11185531|FG002|12 Weeks in Period 2|Withdrawal by Subject|2
7077760|NCT02094937|11185532|FG003|12 Weeks in Period 2|Withdrawal by Subject|0
7077761|NCT02094937|11185529|FG000|12 Weeks in Period 2|Randomized incorrectly|0
7077762|NCT02094937|11185530|FG001|12 Weeks in Period 2|Randomized incorrectly|1
7077763|NCT02094937|11185531|FG002|12 Weeks in Period 2|Randomized incorrectly|0
7077764|NCT02094937|11185532|FG003|12 Weeks in Period 2|Randomized incorrectly|0
7077765|NCT02095106|11185543|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0
7077766|NCT02095106|11185544|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1
7077767|NCT02095145|11185556|FG000|Overall Study|Withdrawal by Subject|1
7077768|NCT02095145|11185557|FG001|Overall Study|Withdrawal by Subject|0
7077769|NCT02095158|11185565|FG000|Overall Study|Adverse Event|14
7077770|NCT02095158|11185565|FG000|Overall Study|Lack of Efficacy|3
7187269|NCT00602667|11387788|FG000|Overall Study|Family request|3
7077771|NCT02095158|11185565|FG000|Overall Study|Pregnancy|1
7077772|NCT02095158|11185565|FG000|Overall Study|Lost to Follow-up|20
7077773|NCT02095158|11185565|FG000|Overall Study|Personal Reasons|35
7077774|NCT02095158|11185565|FG000|Overall Study|Protocol Violation|1
7077775|NCT02095158|11185565|FG000|Overall Study|Other Miscellaneous Reasons|1
7077776|NCT02095197|11185571|FG000|Overall Study|Lost to Follow-up|0
7077777|NCT02095197|11185572|FG001|Overall Study|Lost to Follow-up|3
6851747|NCT00358436|10859495|FG000|Overall Study|COPD exacerbation|22
6851748|NCT00358436|10859496|FG001|Overall Study|COPD exacerbation|10
6851749|NCT00358436|10859495|FG000|Overall Study|Other|6
6851750|NCT00358436|10859496|FG001|Overall Study|Other|1
6851751|NCT00358449|10859507|FG000|Overall Study|Adverse Event|1
6851752|NCT00358449|10859508|FG001|Overall Study|Adverse Event|0
6851753|NCT00358449|10859509|FG002|Overall Study|Adverse Event|1
6851754|NCT00358449|10859507|FG000|Overall Study|Lost to Follow-up|1
6851755|NCT00358449|10859508|FG001|Overall Study|Lost to Follow-up|0
6851756|NCT00358449|10859509|FG002|Overall Study|Lost to Follow-up|0
6851757|NCT00358449|10859507|FG000|Overall Study|Withdrawal by Subject|2
6851758|NCT00358449|10859508|FG001|Overall Study|Withdrawal by Subject|0
6851759|NCT00358449|10859509|FG002|Overall Study|Withdrawal by Subject|0
6851760|NCT00358449|10859507|FG000|Overall Study|Lack of Efficacy|0
6851761|NCT00358449|10859508|FG001|Overall Study|Lack of Efficacy|1
6851762|NCT00358449|10859509|FG002|Overall Study|Lack of Efficacy|0
6851763|NCT00358449|10859507|FG000|Overall Study|Steriod Inhaler was Increased|0
6851764|NCT00358449|10859508|FG001|Overall Study|Steriod Inhaler was Increased|0
6851765|NCT00358449|10859509|FG002|Overall Study|Steriod Inhaler was Increased|1
6851766|NCT00358644|10859557|FG000|Overall Study|Progressive Disease|21
6851767|NCT00358644|10859557|FG000|Overall Study|Adverse Event|7
6851768|NCT00358644|10859557|FG000|Overall Study|Death|11
6851769|NCT00358644|10859557|FG000|Overall Study|Withdrawal by Subject|4
6851770|NCT00358644|10859557|FG000|Overall Study|Physician Decision|6
6851771|NCT00358644|10859557|FG000|Overall Study|Patient not eligible for study|1
6851772|NCT00358670|10859567|FG000|Overall Study|Adverse Event|26
6851773|NCT00358670|10859568|FG001|Overall Study|Adverse Event|29
6851774|NCT00358670|10859567|FG000|Overall Study|Lack of Efficacy|20
6851775|NCT00358670|10859568|FG001|Overall Study|Lack of Efficacy|23
6851776|NCT00358670|10859567|FG000|Overall Study|Protocol Violation|6
6851777|NCT00358670|10859568|FG001|Overall Study|Protocol Violation|9
6851778|NCT00358670|10859567|FG000|Overall Study|Lost to Follow-up|4
6851779|NCT00358670|10859568|FG001|Overall Study|Lost to Follow-up|5
6851780|NCT00358670|10859567|FG000|Overall Study|Withdrawal by Subject|13
6851781|NCT00358670|10859568|FG001|Overall Study|Withdrawal by Subject|24
6851782|NCT00358670|10859567|FG000|Overall Study|Protocol Defined Clinical Event|0
6851783|NCT00358670|10859568|FG001|Overall Study|Protocol Defined Clinical Event|1
6851784|NCT00358670|10859567|FG000|Overall Study|Did Not Meet Protocol Eligibility|0
6851785|NCT00358670|10859568|FG001|Overall Study|Did Not Meet Protocol Eligibility|3
6851786|NCT00358670|10859567|FG000|Overall Study|Administrative|153
6851787|NCT00358670|10859568|FG001|Overall Study|Administrative|125
6851788|NCT00358826|10859587|FG000|Core Study|Adverse Event|1
6851789|NCT00358826|10859588|FG001|Core Study|Adverse Event|3
6851790|NCT00358826|10859589|FG002|Core Study|Adverse Event|1
6851791|NCT00358826|10859590|FG003|Core Study|Adverse Event|1
6851792|NCT00358826|10859591|FG004|Core Study|Adverse Event|0
6851793|NCT00358826|10859592|FG005|Core Study|Adverse Event|0
6851794|NCT00358826|10859593|FG006|Core Study|Adverse Event|0
6851795|NCT00358826|10859594|FG007|Core Study|Adverse Event|0
6851796|NCT00358826|10859587|FG000|Core Study|Withdrawal by Subject|2
6851797|NCT00358826|10859588|FG001|Core Study|Withdrawal by Subject|2
6851798|NCT00358826|10859589|FG002|Core Study|Withdrawal by Subject|0
6851799|NCT00358826|10859590|FG003|Core Study|Withdrawal by Subject|0
6851800|NCT00358826|10859591|FG004|Core Study|Withdrawal by Subject|0
6851801|NCT00358826|10859592|FG005|Core Study|Withdrawal by Subject|0
6851802|NCT00358826|10859593|FG006|Core Study|Withdrawal by Subject|0
6851803|NCT00358826|10859594|FG007|Core Study|Withdrawal by Subject|0
6851804|NCT00358826|10859587|FG000|Core Study|Lost to Follow-up|0
6851805|NCT00358826|10859588|FG001|Core Study|Lost to Follow-up|0
6851806|NCT00358826|10859589|FG002|Core Study|Lost to Follow-up|0
7077778|NCT02095223|11185580|FG000|Overall Study|Withdrawal by Subject|1
7077779|NCT02095223|11185581|FG001|Overall Study|Withdrawal by Subject|0
6851807|NCT00358826|10859590|FG003|Core Study|Lost to Follow-up|1
6851808|NCT00358826|10859591|FG004|Core Study|Lost to Follow-up|0
6851809|NCT00358826|10859592|FG005|Core Study|Lost to Follow-up|0
6851810|NCT00358826|10859593|FG006|Core Study|Lost to Follow-up|0
6851811|NCT00358826|10859594|FG007|Core Study|Lost to Follow-up|0
6851812|NCT00358826|10859587|FG000|Core Study|Physician Decision|0
6851813|NCT00358826|10859588|FG001|Core Study|Physician Decision|0
6851814|NCT00358826|10859589|FG002|Core Study|Physician Decision|1
6851815|NCT00358826|10859590|FG003|Core Study|Physician Decision|0
6851816|NCT00358826|10859591|FG004|Core Study|Physician Decision|0
6851817|NCT00358826|10859592|FG005|Core Study|Physician Decision|0
6851818|NCT00358826|10859593|FG006|Core Study|Physician Decision|0
6851819|NCT00358826|10859594|FG007|Core Study|Physician Decision|0
6851820|NCT00358826|10859587|FG000|MDCT Substudy|Adverse Event|0
6851821|NCT00358826|10859588|FG001|MDCT Substudy|Adverse Event|0
7077780|NCT02095535|11185601|FG000|Recruitment|Protocol Violation|2
6851822|NCT00358826|10859589|FG002|MDCT Substudy|Adverse Event|0
6851823|NCT00358826|10859590|FG003|MDCT Substudy|Adverse Event|0
6851824|NCT00358826|10859591|FG004|MDCT Substudy|Adverse Event|1
6851825|NCT00358826|10859592|FG005|MDCT Substudy|Adverse Event|0
6851826|NCT00358826|10859593|FG006|MDCT Substudy|Adverse Event|0
6851827|NCT00358826|10859594|FG007|MDCT Substudy|Adverse Event|0
6851828|NCT00358826|10859587|FG000|MDCT Substudy|Lost to Follow-up|0
6851829|NCT00358826|10859588|FG001|MDCT Substudy|Lost to Follow-up|0
6851830|NCT00358826|10859589|FG002|MDCT Substudy|Lost to Follow-up|0
6851831|NCT00358826|10859590|FG003|MDCT Substudy|Lost to Follow-up|0
6851832|NCT00358826|10859591|FG004|MDCT Substudy|Lost to Follow-up|0
6851833|NCT00358826|10859592|FG005|MDCT Substudy|Lost to Follow-up|1
6851834|NCT00358826|10859593|FG006|MDCT Substudy|Lost to Follow-up|0
6851835|NCT00358826|10859594|FG007|MDCT Substudy|Lost to Follow-up|0
6851836|NCT00358826|10859587|FG000|MDCT Substudy|Withdrawal by Subject|0
6851837|NCT00358826|10859588|FG001|MDCT Substudy|Withdrawal by Subject|0
6851838|NCT00358826|10859589|FG002|MDCT Substudy|Withdrawal by Subject|0
6851839|NCT00358826|10859590|FG003|MDCT Substudy|Withdrawal by Subject|0
6851840|NCT00358826|10859591|FG004|MDCT Substudy|Withdrawal by Subject|0
6851841|NCT00358826|10859592|FG005|MDCT Substudy|Withdrawal by Subject|1
6851842|NCT00358826|10859593|FG006|MDCT Substudy|Withdrawal by Subject|0
6851843|NCT00358826|10859594|FG007|MDCT Substudy|Withdrawal by Subject|0
6851844|NCT00358917|10859610|FG000|Overall Study|Adverse Event|14
6851845|NCT00358917|10859611|FG001|Overall Study|Adverse Event|21
6851846|NCT00358917|10859610|FG000|Overall Study|Withdrawal by Subject|5
6851847|NCT00358917|10859611|FG001|Overall Study|Withdrawal by Subject|7
6851848|NCT00358917|10859610|FG000|Overall Study|Lost to Follow-up|20
6851849|NCT00358917|10859611|FG001|Overall Study|Lost to Follow-up|17
6851850|NCT00358917|10859610|FG000|Overall Study|Noncompliance|12
6851851|NCT00358917|10859611|FG001|Overall Study|Noncompliance|11
6851852|NCT00358917|10859610|FG000|Overall Study|Death|2
6851853|NCT00358917|10859611|FG001|Overall Study|Death|3
6851854|NCT00358917|10859610|FG000|Overall Study|Virologic failure|11
6851855|NCT00358917|10859611|FG001|Overall Study|Virologic failure|8
6851856|NCT00358917|10859610|FG000|Overall Study|Unable to Continue Participation|2
6851857|NCT00358917|10859611|FG001|Overall Study|Unable to Continue Participation|2
6851858|NCT00358956|10859619|FG000|Overall Study|Adverse Event|3
6851859|NCT00358956|10859619|FG000|Overall Study|condition under investigation worsened|4
6851860|NCT00358956|10859619|FG000|Overall Study|Withdrawal by Subject|1
6851861|NCT00359021|10859625|FG000|Overall Study|Adverse Event|26
6851862|NCT00359021|10859626|FG001|Overall Study|Adverse Event|8
6851863|NCT00359021|10859625|FG000|Overall Study|Subject Non-Compliant|1
6851864|NCT00359021|10859626|FG001|Overall Study|Subject Non-Compliant|2
6851865|NCT00359021|10859625|FG000|Overall Study|Subject Ineligible To Continue The Trial|1
6851866|NCT00359021|10859626|FG001|Overall Study|Subject Ineligible To Continue The Trial|0
6851867|NCT00359021|10859625|FG000|Overall Study|Subject Reached A Virologic Endpoint|45
6851868|NCT00359021|10859626|FG001|Overall Study|Subject Reached A Virologic Endpoint|32
6851869|NCT00359021|10859625|FG000|Overall Study|Withdrawal by Subject|2
6851870|NCT00359021|10859626|FG001|Overall Study|Withdrawal by Subject|9
6851871|NCT00359021|10859625|FG000|Overall Study|Lost to Follow-up|1
6851872|NCT00359021|10859626|FG001|Overall Study|Lost to Follow-up|0
6851873|NCT00359021|10859625|FG000|Overall Study|Other|4
6851874|NCT00359021|10859626|FG001|Overall Study|Other|1
6851875|NCT00359021|10859625|FG000|Overall Study|Pregnancy|1
6851876|NCT00359021|10859626|FG001|Overall Study|Pregnancy|0
6851877|NCT00359073|10859636|FG000|Overall Study|Withdrawal by Subject|1
6851878|NCT00359073|10859637|FG001|Overall Study|Withdrawal by Subject|1
6851879|NCT00359073|10859636|FG000|Overall Study|Eligibility criteria no longer met|3
6851880|NCT00359073|10859637|FG001|Overall Study|Eligibility criteria no longer met|0
6851881|NCT00359073|10859636|FG000|Overall Study|developed RV16 antibody|0
6851882|NCT00359073|10859637|FG001|Overall Study|developed RV16 antibody|1
6851883|NCT00359281|10859663|FG000|Overall Study|Adverse Event|1
6851884|NCT00359281|10859664|FG001|Overall Study|Adverse Event|0
6851885|NCT00359281|10859665|FG002|Overall Study|Adverse Event|0
6851886|NCT00359281|10859666|FG003|Overall Study|Adverse Event|0
6851887|NCT00359281|10859667|FG004|Overall Study|Adverse Event|0
6851888|NCT00359281|10859668|FG005|Overall Study|Adverse Event|0
6851889|NCT00359281|10859669|FG006|Overall Study|Adverse Event|1
6851890|NCT00359281|10859670|FG007|Overall Study|Adverse Event|0
6851891|NCT00359281|10859671|FG008|Overall Study|Adverse Event|0
7152647|NCT03261167|11317661|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3
6851892|NCT00359281|10859663|FG000|Overall Study|Withdrawal by Subject|0
7187270|NCT00602667|11387789|FG001|Overall Study|Family request|25
6851893|NCT00359281|10859664|FG001|Overall Study|Withdrawal by Subject|0
6851894|NCT00359281|10859665|FG002|Overall Study|Withdrawal by Subject|0
6851895|NCT00359281|10859666|FG003|Overall Study|Withdrawal by Subject|0
6851896|NCT00359281|10859667|FG004|Overall Study|Withdrawal by Subject|0
6851897|NCT00359281|10859668|FG005|Overall Study|Withdrawal by Subject|0
6851898|NCT00359281|10859669|FG006|Overall Study|Withdrawal by Subject|1
6851899|NCT00359281|10859670|FG007|Overall Study|Withdrawal by Subject|0
6851900|NCT00359281|10859671|FG008|Overall Study|Withdrawal by Subject|0
6851901|NCT00359294|10859703|FG000|Overall Study|Progressive disease|1
6851902|NCT00359294|10859704|FG001|Overall Study|Progressive disease|1
6851903|NCT00359294|10859705|FG002|Overall Study|Progressive disease|2
6851904|NCT00359294|10859706|FG003|Overall Study|Progressive disease|3
6851905|NCT00359294|10859707|FG004|Overall Study|Progressive disease|2
6851906|NCT00359294|10859703|FG000|Overall Study|Withdrawal by Subject|0
6851907|NCT00359294|10859704|FG001|Overall Study|Withdrawal by Subject|0
6851908|NCT00359294|10859705|FG002|Overall Study|Withdrawal by Subject|0
6851909|NCT00359294|10859706|FG003|Overall Study|Withdrawal by Subject|0
6851910|NCT00359294|10859707|FG004|Overall Study|Withdrawal by Subject|1
6851911|NCT00359294|10859703|FG000|Overall Study|Not treated|0
6851912|NCT00359294|10859704|FG001|Overall Study|Not treated|0
6851913|NCT00359294|10859705|FG002|Overall Study|Not treated|0
6851914|NCT00359294|10859706|FG003|Overall Study|Not treated|1
6851915|NCT00359294|10859707|FG004|Overall Study|Not treated|0
6851916|NCT00359294|10859703|FG000|Overall Study|Physician Decision|0
6851917|NCT00359294|10859704|FG001|Overall Study|Physician Decision|0
6851918|NCT00359294|10859705|FG002|Overall Study|Physician Decision|1
6851919|NCT00359294|10859706|FG003|Overall Study|Physician Decision|0
6851920|NCT00359294|10859707|FG004|Overall Study|Physician Decision|0
6851921|NCT00359424|10859717|FG000|Overall Study|Death|99
6851922|NCT00359424|10859718|FG001|Overall Study|Death|58
6851923|NCT00359424|10859717|FG000|Overall Study|Lost to Follow-up|19
6851924|NCT00359424|10859718|FG001|Overall Study|Lost to Follow-up|7
6851925|NCT00359424|10859717|FG000|Overall Study|Withdrawal by Subject|10
6851926|NCT00359424|10859718|FG001|Overall Study|Withdrawal by Subject|2
6851927|NCT00359424|10859717|FG000|Overall Study|follow up not conducted|2
6851928|NCT00359424|10859718|FG001|Overall Study|follow up not conducted|0
6851929|NCT00359619|10859731|FG000|Overall Study|Adverse Event|0
6851930|NCT00359619|10859732|FG001|Overall Study|Adverse Event|0
6851931|NCT00359619|10859733|FG002|Overall Study|Adverse Event|1
6851932|NCT00359619|10859734|FG003|Overall Study|Adverse Event|0
6851933|NCT00359619|10859735|FG004|Overall Study|Adverse Event|0
6851934|NCT00359619|10859736|FG005|Overall Study|Adverse Event|0
6851935|NCT00359619|10859737|FG006|Overall Study|Adverse Event|1
6851936|NCT00359619|10859731|FG000|Overall Study|Withdrawal by Subject|3
6851937|NCT00359619|10859732|FG001|Overall Study|Withdrawal by Subject|1
6851938|NCT00359619|10859733|FG002|Overall Study|Withdrawal by Subject|4
6851939|NCT00359619|10859734|FG003|Overall Study|Withdrawal by Subject|2
6851940|NCT00359619|10859735|FG004|Overall Study|Withdrawal by Subject|2
6851941|NCT00359619|10859736|FG005|Overall Study|Withdrawal by Subject|0
6851942|NCT00359619|10859737|FG006|Overall Study|Withdrawal by Subject|3
6851943|NCT00359619|10859731|FG000|Overall Study|Other|1
6851944|NCT00359619|10859732|FG001|Overall Study|Other|0
6851945|NCT00359619|10859733|FG002|Overall Study|Other|0
6851946|NCT00359619|10859734|FG003|Overall Study|Other|0
6851947|NCT00359619|10859735|FG004|Overall Study|Other|0
6851948|NCT00359619|10859736|FG005|Overall Study|Other|0
6851949|NCT00359619|10859737|FG006|Overall Study|Other|0
6851950|NCT00359619|10859731|FG000|Overall Study|Lost to Follow-up|4
6851951|NCT00359619|10859732|FG001|Overall Study|Lost to Follow-up|4
6851952|NCT00359619|10859733|FG002|Overall Study|Lost to Follow-up|2
6851953|NCT00359619|10859734|FG003|Overall Study|Lost to Follow-up|1
6851954|NCT00359619|10859735|FG004|Overall Study|Lost to Follow-up|1
6851955|NCT00359619|10859736|FG005|Overall Study|Lost to Follow-up|5
6851956|NCT00359619|10859737|FG006|Overall Study|Lost to Follow-up|0
6851957|NCT00359632|10859755|FG000|Overall Study|Death|2
6851958|NCT00359632|10859756|FG001|Overall Study|Death|0
6851959|NCT00359632|10859755|FG000|Overall Study|Adverse Event|1
6851960|NCT00359632|10859756|FG001|Overall Study|Adverse Event|0
6851961|NCT00359632|10859755|FG000|Overall Study|Non-compliance with visit schedule|1
6851962|NCT00359632|10859756|FG001|Overall Study|Non-compliance with visit schedule|0
6851963|NCT00359762|10859775|FG000|Period II|Adverse Event|17
6851964|NCT00359762|10859776|FG001|Period II|Adverse Event|0
6851965|NCT00359762|10859777|FG002|Period II|Adverse Event|0
6851966|NCT00359762|10859778|FG003|Period II|Adverse Event|0
6851967|NCT00359762|10859779|FG004|Period II|Adverse Event|49
6851968|NCT00359762|10859775|FG000|Period II|Protocol Violation|18
6851969|NCT00359762|10859776|FG001|Period II|Protocol Violation|0
6851970|NCT00359762|10859777|FG002|Period II|Protocol Violation|0
6851971|NCT00359762|10859778|FG003|Period II|Protocol Violation|0
6851972|NCT00359762|10859779|FG004|Period II|Protocol Violation|11
6851973|NCT00359762|10859775|FG000|Period II|Physician Decision|17
6851974|NCT00359762|10859776|FG001|Period II|Physician Decision|0
6966761|NCT01126580|11014796|FG000|Overall Study|Lost to Follow-up|15
6966762|NCT01126580|11014797|FG001|Overall Study|Lost to Follow-up|13
6966763|NCT01126580|11014798|FG002|Overall Study|Lost to Follow-up|9
6966764|NCT01126580|11014796|FG000|Overall Study|Treatment Non-compliance|0
6966765|NCT01126580|11014797|FG001|Overall Study|Treatment Non-compliance|2
6966766|NCT01126580|11014798|FG002|Overall Study|Treatment Non-compliance|3
6851975|NCT00359762|10859777|FG002|Period II|Physician Decision|0
6851976|NCT00359762|10859778|FG003|Period II|Physician Decision|0
6851977|NCT00359762|10859779|FG004|Period II|Physician Decision|23
6851978|NCT00359762|10859775|FG000|Period II|Death|2
6851979|NCT00359762|10859776|FG001|Period II|Death|0
6851980|NCT00359762|10859777|FG002|Period II|Death|0
6966767|NCT01126619|11014820|FG000|Overall Study|Not eligible for the study|2
6851981|NCT00359762|10859778|FG003|Period II|Death|0
6851982|NCT00359762|10859779|FG004|Period II|Death|4
6851983|NCT00359762|10859775|FG000|Period II|Lack of Efficacy|11
6851984|NCT00359762|10859776|FG001|Period II|Lack of Efficacy|0
6851985|NCT00359762|10859777|FG002|Period II|Lack of Efficacy|0
6851986|NCT00359762|10859778|FG003|Period II|Lack of Efficacy|0
6851987|NCT00359762|10859779|FG004|Period II|Lack of Efficacy|8
6851988|NCT00359762|10859775|FG000|Period II|Lost to follow up|5
6851989|NCT00359762|10859776|FG001|Period II|Lost to follow up|0
6851990|NCT00359762|10859777|FG002|Period II|Lost to follow up|0
6851991|NCT00359762|10859778|FG003|Period II|Lost to follow up|0
6851992|NCT00359762|10859779|FG004|Period II|Lost to follow up|5
6851993|NCT00359762|10859775|FG000|Period II|Entry Criteria Not Met|8
6851994|NCT00359762|10859776|FG001|Period II|Entry Criteria Not Met|0
6851995|NCT00359762|10859777|FG002|Period II|Entry Criteria Not Met|0
6851996|NCT00359762|10859778|FG003|Period II|Entry Criteria Not Met|0
6851997|NCT00359762|10859779|FG004|Period II|Entry Criteria Not Met|4
6851998|NCT00359762|10859775|FG000|Period II|Subject Decision|50
6851999|NCT00359762|10859776|FG001|Period II|Subject Decision|0
6852000|NCT00359762|10859777|FG002|Period II|Subject Decision|0
6852001|NCT00359762|10859778|FG003|Period II|Subject Decision|0
6852002|NCT00359762|10859779|FG004|Period II|Subject Decision|70
6852003|NCT00359762|10859775|FG000|Period III|Protocol Violation|0
6852004|NCT00359762|10859776|FG001|Period III|Protocol Violation|5
6852005|NCT00359762|10859777|FG002|Period III|Protocol Violation|3
6852006|NCT00359762|10859778|FG003|Period III|Protocol Violation|8
6852007|NCT00359762|10859779|FG004|Period III|Protocol Violation|0
6852008|NCT00359762|10859775|FG000|Period III|Adverse Event|0
6852009|NCT00359762|10859776|FG001|Period III|Adverse Event|3
6852010|NCT00359762|10859777|FG002|Period III|Adverse Event|4
6852011|NCT00359762|10859778|FG003|Period III|Adverse Event|10
6852012|NCT00359762|10859779|FG004|Period III|Adverse Event|0
6852013|NCT00359762|10859775|FG000|Period III|Physician Decision|0
6852014|NCT00359762|10859776|FG001|Period III|Physician Decision|5
6852015|NCT00359762|10859777|FG002|Period III|Physician Decision|9
6852016|NCT00359762|10859778|FG003|Period III|Physician Decision|15
6852017|NCT00359762|10859779|FG004|Period III|Physician Decision|0
6852018|NCT00359762|10859775|FG000|Period III|Lack of Efficacy|0
6852019|NCT00359762|10859776|FG001|Period III|Lack of Efficacy|7
6852020|NCT00359762|10859777|FG002|Period III|Lack of Efficacy|5
6852021|NCT00359762|10859778|FG003|Period III|Lack of Efficacy|9
6852022|NCT00359762|10859779|FG004|Period III|Lack of Efficacy|0
6852023|NCT00359762|10859775|FG000|Period III|Lost to follow up|0
6852024|NCT00359762|10859776|FG001|Period III|Lost to follow up|1
6852025|NCT00359762|10859777|FG002|Period III|Lost to follow up|1
6852026|NCT00359762|10859778|FG003|Period III|Lost to follow up|2
6852027|NCT00359762|10859779|FG004|Period III|Lost to follow up|0
6852028|NCT00359762|10859775|FG000|Period III|Entry Criteria Not Met|0
6852029|NCT00359762|10859776|FG001|Period III|Entry Criteria Not Met|1
6852030|NCT00359762|10859777|FG002|Period III|Entry Criteria Not Met|0
6852031|NCT00359762|10859778|FG003|Period III|Entry Criteria Not Met|1
6852032|NCT00359762|10859779|FG004|Period III|Entry Criteria Not Met|0
6852033|NCT00359762|10859775|FG000|Period III|Subject Decision|0
6852034|NCT00359762|10859776|FG001|Period III|Subject Decision|7
6852035|NCT00359762|10859777|FG002|Period III|Subject Decision|8
6852036|NCT00359762|10859778|FG003|Period III|Subject Decision|20
6852037|NCT00359762|10859779|FG004|Period III|Subject Decision|0
6852038|NCT00359788|10859795|FG000|Overall Study|Adverse Event|11
6852039|NCT00359788|10859796|FG001|Overall Study|Adverse Event|10
6852040|NCT00359788|10859795|FG000|Overall Study|Lack of Efficacy|1
6852041|NCT00359788|10859796|FG001|Overall Study|Lack of Efficacy|2
6852042|NCT00359788|10859795|FG000|Overall Study|Lost to Follow-up|3
6852043|NCT00359788|10859796|FG001|Overall Study|Lost to Follow-up|2
6852044|NCT00359788|10859795|FG000|Overall Study|Withdrawal by Subject|4
6852045|NCT00359788|10859796|FG001|Overall Study|Withdrawal by Subject|1
6852046|NCT00359788|10859795|FG000|Overall Study|Protocol Violation|4
6852047|NCT00359788|10859796|FG001|Overall Study|Protocol Violation|2
6852048|NCT00359801|10859804|FG000|Overall Study|Lost to Follow-up|72
6852049|NCT00359801|10859805|FG001|Overall Study|Lost to Follow-up|58
6852050|NCT00359801|10859804|FG000|Overall Study|Withdrawal by Subject|143
6852051|NCT00359801|10859805|FG001|Overall Study|Withdrawal by Subject|96
6852052|NCT00359801|10859804|FG000|Overall Study|Other|66
6852053|NCT00359801|10859805|FG001|Overall Study|Other|46
6852054|NCT00359801|10859804|FG000|Overall Study|Final Status Unknown: missing data|7
6852055|NCT00359801|10859805|FG001|Overall Study|Final Status Unknown: missing data|4
6852056|NCT00359801|10859804|FG000|Overall Study|Sponsor Decision|17
6852057|NCT00359801|10859805|FG001|Overall Study|Sponsor Decision|16
6852058|NCT00360230|10859861|FG000|Overall Study|Withdrawal by Subject|1
6852059|NCT00360230|10859862|FG001|Overall Study|Withdrawal by Subject|1
6852060|NCT00360230|10859863|FG002|Overall Study|Withdrawal by Subject|0
6852061|NCT00360230|10859864|FG003|Overall Study|Withdrawal by Subject|1
6852062|NCT00360230|10859865|FG004|Overall Study|Withdrawal by Subject|1
6852063|NCT00360230|10859866|FG005|Overall Study|Withdrawal by Subject|1
6852064|NCT00360230|10859867|FG006|Overall Study|Withdrawal by Subject|0
6852065|NCT00360230|10859861|FG000|Overall Study|Migrated|4
6852066|NCT00360230|10859862|FG001|Overall Study|Migrated|1
6852067|NCT00360230|10859863|FG002|Overall Study|Migrated|3
6852068|NCT00360230|10859864|FG003|Overall Study|Migrated|1
6852069|NCT00360230|10859865|FG004|Overall Study|Migrated|4
6852070|NCT00360230|10859866|FG005|Overall Study|Migrated|1
6852071|NCT00360230|10859867|FG006|Overall Study|Migrated|1
6852072|NCT00360230|10859861|FG000|Overall Study|Other|1
6852073|NCT00360230|10859862|FG001|Overall Study|Other|0
6852074|NCT00360230|10859863|FG002|Overall Study|Other|0
6852075|NCT00360230|10859864|FG003|Overall Study|Other|0
6852076|NCT00360230|10859865|FG004|Overall Study|Other|0
6852077|NCT00360230|10859866|FG005|Overall Study|Other|0
6852078|NCT00360230|10859867|FG006|Overall Study|Other|0
6852079|NCT00360230|10859861|FG000|Overall Study|Protocol Violation|0
6852080|NCT00360230|10859862|FG001|Overall Study|Protocol Violation|0
6852081|NCT00360230|10859863|FG002|Overall Study|Protocol Violation|0
6852082|NCT00360230|10859864|FG003|Overall Study|Protocol Violation|0
6852083|NCT00360230|10859865|FG004|Overall Study|Protocol Violation|0
6852084|NCT00360230|10859866|FG005|Overall Study|Protocol Violation|1
6852085|NCT00360230|10859867|FG006|Overall Study|Protocol Violation|0
6852086|NCT00360230|10859861|FG000|Overall Study|Death|0
6852087|NCT00360230|10859862|FG001|Overall Study|Death|1
6852088|NCT00360230|10859863|FG002|Overall Study|Death|0
6852089|NCT00360230|10859864|FG003|Overall Study|Death|0
6852090|NCT00360230|10859865|FG004|Overall Study|Death|0
6852091|NCT00360230|10859866|FG005|Overall Study|Death|1
6852092|NCT00360230|10859867|FG006|Overall Study|Death|1
6852093|NCT00360269|10859904|FG000|Overall Study|Lost to Follow-up|7
6852094|NCT00360269|10859905|FG001|Overall Study|Lost to Follow-up|9
6852095|NCT00360269|10859904|FG000|Overall Study|Physician Decision|1
6852096|NCT00360269|10859905|FG001|Overall Study|Physician Decision|2
6852097|NCT00360269|10859904|FG000|Overall Study|Adverse Event|1
6852098|NCT00360269|10859905|FG001|Overall Study|Adverse Event|0
6852099|NCT00360269|10859904|FG000|Overall Study|Withdrawal by Subject|1
6852100|NCT00360269|10859905|FG001|Overall Study|Withdrawal by Subject|1
6852101|NCT00360282|10859911|FG000|Washout 1-3 Weeks|Lost to Follow-up|0
6852102|NCT00360282|10859912|FG001|Washout 1-3 Weeks|Lost to Follow-up|0
6852103|NCT00360282|10859913|FG002|Washout 1-3 Weeks|Lost to Follow-up|1
6852104|NCT00360282|10859914|FG003|Washout 1-3 Weeks|Lost to Follow-up|0
6852105|NCT00360282|10859911|FG000|Second Intervention|Adverse Event|0
6852106|NCT00360282|10859912|FG001|Second Intervention|Adverse Event|1
6852107|NCT00360282|10859913|FG002|Second Intervention|Adverse Event|0
6852108|NCT00360282|10859914|FG003|Second Intervention|Adverse Event|0
6852109|NCT00360308|10859925|FG000|Overall Study|Adverse Event|15
6852110|NCT00360308|10859926|FG001|Overall Study|Adverse Event|14
6852111|NCT00360308|10859927|FG002|Overall Study|Adverse Event|25
6852112|NCT00360308|10859925|FG000|Overall Study|Abnormal Laboratory Value(s)|0
6852113|NCT00360308|10859926|FG001|Overall Study|Abnormal Laboratory Value(s)|1
6852114|NCT00360308|10859927|FG002|Overall Study|Abnormal Laboratory Value(s)|0
6852115|NCT00360308|10859925|FG000|Overall Study|Protocol Violation|2
6852116|NCT00360308|10859926|FG001|Overall Study|Protocol Violation|1
6852117|NCT00360308|10859927|FG002|Overall Study|Protocol Violation|2
6852118|NCT00360308|10859925|FG000|Overall Study|Withdrawal by Subject|11
6852119|NCT00360308|10859926|FG001|Overall Study|Withdrawal by Subject|7
6852120|NCT00360308|10859927|FG002|Overall Study|Withdrawal by Subject|14
6852121|NCT00360308|10859925|FG000|Overall Study|Lack of Efficacy|3
6852122|NCT00360308|10859926|FG001|Overall Study|Lack of Efficacy|0
6852123|NCT00360308|10859927|FG002|Overall Study|Lack of Efficacy|2
6852124|NCT00360308|10859925|FG000|Overall Study|Other|2
6852125|NCT00360308|10859926|FG001|Overall Study|Other|1
6852126|NCT00360308|10859927|FG002|Overall Study|Other|1
6852127|NCT00360308|10859925|FG000|Overall Study|Study termination by sponsor|43
6852128|NCT00360308|10859926|FG001|Overall Study|Study termination by sponsor|55
6852129|NCT00360308|10859927|FG002|Overall Study|Study termination by sponsor|44
6852130|NCT00360334|10859941|FG000|Overall Study|Adverse Event|7
6852131|NCT00360334|10859942|FG001|Overall Study|Adverse Event|4
6852132|NCT00360334|10859941|FG000|Overall Study|Protocol Violation|1
6852133|NCT00360334|10859942|FG001|Overall Study|Protocol Violation|1
6852134|NCT00360334|10859941|FG000|Overall Study|Physician Decision|2
6852135|NCT00360334|10859942|FG001|Overall Study|Physician Decision|3
6852136|NCT00360334|10859941|FG000|Overall Study|Lack of Efficacy|0
6852137|NCT00360334|10859942|FG001|Overall Study|Lack of Efficacy|1
6852138|NCT00360334|10859941|FG000|Overall Study|Entry criterion not met|1
6852139|NCT00360334|10859942|FG001|Overall Study|Entry criterion not met|2
6852140|NCT00360334|10859941|FG000|Overall Study|Subject decision|8
6852141|NCT00360334|10859942|FG001|Overall Study|Subject decision|2
6852142|NCT00360412|10859967|FG000|Overall Study|Adverse Event|37
6852143|NCT00360412|10859968|FG001|Overall Study|Adverse Event|65
6852144|NCT00360412|10859967|FG000|Overall Study|Protocol Violation|2
6852145|NCT00360412|10859968|FG001|Overall Study|Protocol Violation|5
6852146|NCT00360412|10859967|FG000|Overall Study|Patient withdrew consent|27
6852147|NCT00360412|10859968|FG001|Overall Study|Patient withdrew consent|52
6852148|NCT00360412|10859967|FG000|Overall Study|Lack of therapeutic efficacy|46
6852149|NCT00360412|10859968|FG001|Overall Study|Lack of therapeutic efficacy|61
6852150|NCT00360412|10859967|FG000|Overall Study|Physician Decision|2
6852151|NCT00360412|10859968|FG001|Overall Study|Physician Decision|4
6852152|NCT00360412|10859967|FG000|Overall Study|Other|5
6852153|NCT00360412|10859968|FG001|Overall Study|Other|6
6852154|NCT00360412|10859967|FG000|Overall Study|Study termination by Sponsor|214
6852155|NCT00360412|10859968|FG001|Overall Study|Study termination by Sponsor|469
6852156|NCT00360490|10859976|FG000|Overall Study|Adverse Event|4
6852157|NCT00360490|10859977|FG001|Overall Study|Adverse Event|2
6852158|NCT00360490|10859976|FG000|Overall Study|Lost to Follow-up|2
6852159|NCT00360490|10859977|FG001|Overall Study|Lost to Follow-up|1
6852160|NCT00360490|10859976|FG000|Overall Study|Physician Decision|2
6852161|NCT00360490|10859977|FG001|Overall Study|Physician Decision|1
6852162|NCT00360490|10859976|FG000|Overall Study|Protocol Violation|0
6852163|NCT00360490|10859977|FG001|Overall Study|Protocol Violation|4
6852164|NCT00360490|10859976|FG000|Overall Study|Withdrawal by Subject|1
6852165|NCT00360490|10859977|FG001|Overall Study|Withdrawal by Subject|3
6966768|NCT01126619|11014820|FG000|Overall Study|Investigator decision|4
6966769|NCT01126619|11014820|FG000|Overall Study|Serious adverse event|1
6966770|NCT01126619|11014820|FG000|Overall Study|Withdrawal by Subject|9
6966771|NCT01126619|11014820|FG000|Overall Study|Non-compliance|1
6966772|NCT01127061|11014848|FG000|Overall Study|Lost to Follow-up|7
6966773|NCT01127061|11014849|FG001|Overall Study|Lost to Follow-up|10
6966774|NCT01127061|11014848|FG000|Overall Study|Physician Decision|3
6966775|NCT01127061|11014849|FG001|Overall Study|Physician Decision|3
6966776|NCT01127139|11014866|FG000|Overall Study|Adverse Event|40
6966777|NCT01127139|11014866|FG000|Overall Study|Incompliance|12
6966778|NCT01127139|11014866|FG000|Overall Study|Lack of Efficacy|4
6966779|NCT01127139|11014866|FG000|Overall Study|Reason not specified|1
6966780|NCT01127165|11014875|FG000|Overall Study|Adverse Event|2
6966781|NCT01127165|11014876|FG001|Overall Study|Adverse Event|2
6966782|NCT01127165|11014875|FG000|Overall Study|Lack of Efficacy|10
6966783|NCT01127165|11014876|FG001|Overall Study|Lack of Efficacy|8
6966784|NCT01127165|11014875|FG000|Overall Study|Lost to Follow-up|3
6966785|NCT01127165|11014876|FG001|Overall Study|Lost to Follow-up|5
6966786|NCT01127165|11014875|FG000|Overall Study|Withdrawal by Subject|1
6966787|NCT01127165|11014876|FG001|Overall Study|Withdrawal by Subject|3
6966788|NCT01127165|11014875|FG000|Overall Study|Protocol Violation|0
6966789|NCT01127165|11014876|FG001|Overall Study|Protocol Violation|1
6966790|NCT01127373|11014903|FG000|Overall Study|Not Treated|3
6966791|NCT01127373|11014903|FG000|Overall Study|Lost to Follow-up|7
6966792|NCT01127373|11014903|FG000|Overall Study|Withdrawal by Subject|1
6966793|NCT01127373|11014903|FG000|Overall Study|Disease progression|1
6966794|NCT01127607|11014939|FG000|Phase II (Between Subjects)|Lost to Follow-up|0
6966795|NCT01127607|11014940|FG001|Phase II (Between Subjects)|Lost to Follow-up|2
6966796|NCT01127607|11014939|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1
6966797|NCT01127607|11014940|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0
6966798|NCT01127633|11014965|FG000|Overall Study|Adverse Event|74
6966799|NCT01127633|11014966|FG001|Overall Study|Adverse Event|73
6966800|NCT01127633|11014965|FG000|Overall Study|Death|40
6966801|NCT01127633|11014966|FG001|Overall Study|Death|43
6966802|NCT01127633|11014965|FG000|Overall Study|Lost to Follow-up|4
6966803|NCT01127633|11014966|FG001|Overall Study|Lost to Follow-up|0
6966804|NCT01127633|11014965|FG000|Overall Study|Parent/Caregiver Decision|246
6966805|NCT01127633|11014966|FG001|Overall Study|Parent/Caregiver Decision|228
6966806|NCT01127633|11014965|FG000|Overall Study|Physician Decision|60
6966807|NCT01127633|11014966|FG001|Overall Study|Physician Decision|45
6966808|NCT01127633|11014965|FG000|Overall Study|Withdrawal by Subject|57
6966809|NCT01127633|11014966|FG001|Overall Study|Withdrawal by Subject|72
6966810|NCT01127633|11014965|FG000|Overall Study|Sponsor Decision|163
6966811|NCT01127633|11014966|FG001|Overall Study|Sponsor Decision|195
6966812|NCT01127633|11014965|FG000|Overall Study|Protocol Violation|8
6966813|NCT01127633|11014966|FG001|Overall Study|Protocol Violation|16
6966814|NCT01127633|11014965|FG000|Overall Study|Abnormal Lab/ECG Result|0
6966815|NCT01127633|11014966|FG001|Overall Study|Abnormal Lab/ECG Result|1
6966816|NCT01127633|11014965|FG000|Overall Study|Not treated|1
6966817|NCT01127633|11014966|FG001|Overall Study|Not treated|0
6966818|NCT01127646|11014974|FG000|Overall Study|Entry Criteria Not Met|1
6966819|NCT01127646|11014975|FG001|Overall Study|Entry Criteria Not Met|0
6966820|NCT01127646|11014974|FG000|Overall Study|Protocol Violation|0
6966821|NCT01127646|11014975|FG001|Overall Study|Protocol Violation|1
6966822|NCT01127763|11015017|FG000|Overall Study|Adverse Event|2
6966823|NCT01127763|11015017|FG000|Overall Study|Withdrawal by Subject|1
6966824|NCT01127763|11015017|FG000|Overall Study|Physician Decision|2
6966825|NCT01127893|11015025|FG000|Overall Study|Study Termination by the Sponsor|1
6966826|NCT01128153|11015044|FG000|Overall Study|Adverse Event|1
6966827|NCT01128153|11015045|FG001|Overall Study|Adverse Event|3
6966828|NCT01128153|11015044|FG000|Overall Study|Condition under investigation worsened|8
6966829|NCT01128153|11015045|FG001|Overall Study|Condition under investigation worsened|7
6966830|NCT01128153|11015044|FG000|Overall Study|Withdrawal by Subject|2
6966831|NCT01128153|11015045|FG001|Overall Study|Withdrawal by Subject|3
6966832|NCT01128153|11015044|FG000|Overall Study|Incorrect enrolment to study|2
6966833|NCT01128153|11015045|FG001|Overall Study|Incorrect enrolment to study|1
6966834|NCT01128153|11015044|FG000|Overall Study|Protocol Violation|2
6966835|NCT01128153|11015045|FG001|Overall Study|Protocol Violation|0
6966836|NCT01128153|11015044|FG000|Overall Study|Developed discontinuation criteria|1
6966837|NCT01128153|11015045|FG001|Overall Study|Developed discontinuation criteria|1
6966838|NCT01128179|11015053|FG000|Overall Study|Death|1
6966839|NCT01128179|11015054|FG001|Overall Study|Death|0
6966840|NCT01128179|11015053|FG000|Overall Study|Protocol Violation|1
6966841|NCT01128179|11015054|FG001|Overall Study|Protocol Violation|0
6966842|NCT01128244|11015075|FG000|Overall Study|Adverse Event|1
6966843|NCT01128244|11015075|FG000|Overall Study|Scheduling conflict|2
6966844|NCT01128296|11015095|FG000|Overall Study|Physician Decision|0
6966845|NCT01128296|11015096|FG001|Overall Study|Physician Decision|0
6966846|NCT01128296|11015097|FG002|Overall Study|Physician Decision|0
6966847|NCT01128296|11015098|FG003|Overall Study|Physician Decision|0
6966848|NCT01128296|11015099|FG004|Overall Study|Physician Decision|0
6966849|NCT01128296|11015100|FG005|Overall Study|Physician Decision|3
6966850|NCT01128296|11015095|FG000|Overall Study|Withdrawal by Subject|0
6852166|NCT00360529|10859986|FG000|Overall Study|Adverse Event|10
6852167|NCT00360529|10859987|FG001|Overall Study|Adverse Event|23
6852168|NCT00360529|10859988|FG002|Overall Study|Adverse Event|33
6852169|NCT00360529|10859986|FG000|Overall Study|Protocol Violation|3
6852170|NCT00360529|10859987|FG001|Overall Study|Protocol Violation|3
6852171|NCT00360529|10859988|FG002|Overall Study|Protocol Violation|11
6852172|NCT00360529|10859986|FG000|Overall Study|Lost to Follow-up|14
6852173|NCT00360529|10859987|FG001|Overall Study|Lost to Follow-up|10
6852174|NCT00360529|10859988|FG002|Overall Study|Lost to Follow-up|13
6852175|NCT00360529|10859986|FG000|Overall Study|Withdrawal by Subject|22
6852176|NCT00360529|10859987|FG001|Overall Study|Withdrawal by Subject|14
6852177|NCT00360529|10859988|FG002|Overall Study|Withdrawal by Subject|18
6852178|NCT00360529|10859986|FG000|Overall Study|Lack of Efficacy|8
6852179|NCT00360529|10859987|FG001|Overall Study|Lack of Efficacy|6
6852180|NCT00360529|10859988|FG002|Overall Study|Lack of Efficacy|5
6852181|NCT00360529|10859986|FG000|Overall Study|Reason discontinued not explained above|4
6852182|NCT00360529|10859987|FG001|Overall Study|Reason discontinued not explained above|9
6852183|NCT00360529|10859988|FG002|Overall Study|Reason discontinued not explained above|11
6852184|NCT00360568|10860015|FG000|Overall Study|Adverse Event|1
6852185|NCT00360568|10860016|FG001|Overall Study|Adverse Event|2
6852186|NCT00360568|10860015|FG000|Overall Study|Lack of Efficacy|1
6852187|NCT00360568|10860016|FG001|Overall Study|Lack of Efficacy|0
6852188|NCT00360568|10860015|FG000|Overall Study|Withdrawal by Subject|0
6852189|NCT00360568|10860016|FG001|Overall Study|Withdrawal by Subject|3
6852190|NCT00360698|10860040|FG000|Run-In|Physician Decision|0
6852191|NCT00360698|10860041|FG001|Run-In|Physician Decision|1
6852192|NCT00360698|10860040|FG000|Run-In|Withdrawal by Subject|0
6852193|NCT00360698|10860041|FG001|Run-In|Withdrawal by Subject|2
6852194|NCT00360698|10860040|FG000|Run-In|Non compliance with treatment procedure|0
6852195|NCT00360698|10860041|FG001|Run-In|Non compliance with treatment procedure|1
6852196|NCT00360698|10860040|FG000|Run-In|Sponsor request|0
6852197|NCT00360698|10860041|FG001|Run-In|Sponsor request|2
6852198|NCT00360698|10860040|FG000|Run-In|Patient did not meet inclusion criteria|0
6852199|NCT00360698|10860041|FG001|Run-In|Patient did not meet inclusion criteria|1
6852200|NCT00360698|10860040|FG000|Run-In|Patient personal reasons|0
6852201|NCT00360698|10860041|FG001|Run-In|Patient personal reasons|2
6852202|NCT00360698|10860040|FG000|Run-In|Need of insulin with meals|0
6852203|NCT00360698|10860041|FG001|Run-In|Need of insulin with meals|1
6852204|NCT00360698|10860040|FG000|Treatment Period|Non compliance with treatment procedure|1
6852205|NCT00360698|10860041|FG001|Treatment Period|Non compliance with treatment procedure|0
6852206|NCT00360698|10860040|FG000|Treatment Period|Early termination by error|0
6852207|NCT00360698|10860041|FG001|Treatment Period|Early termination by error|1
6852208|NCT00361218|10860085|FG000|Overall Study|Lost to Follow-up|11
6852209|NCT00361218|10860085|FG000|Overall Study|Personal Reasons|7
6852210|NCT00361218|10860085|FG000|Overall Study|terminated / withdrawn due to toxicity /|5
6852211|NCT00361231|10860089|FG000|Overall Study|Physician Decision|3
6852212|NCT00361231|10860089|FG000|Overall Study|Symptomatic deterioration|5
6852213|NCT00361231|10860089|FG000|Overall Study|Radiographic disease progression|16
6852214|NCT00361231|10860089|FG000|Overall Study|Withdrawal by Subject|4
6852215|NCT00361231|10860089|FG000|Overall Study|Adverse Event|6
6852216|NCT00361270|10860108|FG000|Overall Study|Death|0
6852217|NCT00361270|10860109|FG001|Overall Study|Death|0
6852218|NCT00361270|10860110|FG002|Overall Study|Death|0
6852219|NCT00361270|10860111|FG003|Overall Study|Death|2
6852220|NCT00361270|10860108|FG000|Overall Study|Lost to Follow-up|4
6852221|NCT00361270|10860109|FG001|Overall Study|Lost to Follow-up|1
6852222|NCT00361270|10860110|FG002|Overall Study|Lost to Follow-up|0
6852223|NCT00361270|10860111|FG003|Overall Study|Lost to Follow-up|0
6852224|NCT00361270|10860108|FG000|Overall Study|Physician Decision|0
6852225|NCT00361270|10860109|FG001|Overall Study|Physician Decision|0
6852226|NCT00361270|10860110|FG002|Overall Study|Physician Decision|1
6852227|NCT00361270|10860111|FG003|Overall Study|Physician Decision|0
6852228|NCT00361270|10860108|FG000|Overall Study|Protocol Violation|9
6852229|NCT00361270|10860109|FG001|Overall Study|Protocol Violation|4
6852230|NCT00361270|10860110|FG002|Overall Study|Protocol Violation|5
6852231|NCT00361270|10860111|FG003|Overall Study|Protocol Violation|4
6852232|NCT00361270|10860108|FG000|Overall Study|Withdrawal by Subject|6
6852233|NCT00361270|10860109|FG001|Overall Study|Withdrawal by Subject|6
6852234|NCT00361270|10860110|FG002|Overall Study|Withdrawal by Subject|3
6852235|NCT00361270|10860111|FG003|Overall Study|Withdrawal by Subject|7
6852236|NCT00361270|10860108|FG000|Overall Study|Afraid of Hypnosis|1
6852237|NCT00361270|10860109|FG001|Overall Study|Afraid of Hypnosis|2
6852238|NCT00361270|10860110|FG002|Overall Study|Afraid of Hypnosis|0
6852239|NCT00361270|10860111|FG003|Overall Study|Afraid of Hypnosis|0
6852240|NCT00361270|10860108|FG000|Overall Study|Problems with Transportation|4
6852241|NCT00361270|10860109|FG001|Overall Study|Problems with Transportation|0
6852242|NCT00361270|10860110|FG002|Overall Study|Problems with Transportation|0
6852243|NCT00361270|10860111|FG003|Overall Study|Problems with Transportation|0
6852244|NCT00361270|10860108|FG000|Overall Study|Adverse Event|0
6852245|NCT00361270|10860109|FG001|Overall Study|Adverse Event|1
6852246|NCT00361270|10860110|FG002|Overall Study|Adverse Event|1
6852247|NCT00361270|10860111|FG003|Overall Study|Adverse Event|0
6852248|NCT00361283|10860128|FG000|Overall Study|Lost to Follow-up|27
6852249|NCT00361296|10860132|FG000|Overall Study|Physician Decision|1
6852250|NCT00361296|10860132|FG000|Overall Study|Lack of Efficacy|2
6852251|NCT00361335|10860141|FG000|IV Period: Baseline to E0|Adverse Event|9
6852252|NCT00361335|10860142|FG001|IV Period: Baseline to E0|Adverse Event|4
6852253|NCT00361335|10860143|FG002|IV Period: Baseline to E0|Adverse Event|5
6852254|NCT00361335|10860144|FG003|IV Period: Baseline to E0|Adverse Event|9
6852255|NCT00361335|10860145|FG004|IV Period: Baseline to E0|Adverse Event|8
6852256|NCT00361335|10860146|FG005|IV Period: Baseline to E0|Adverse Event|0
6852257|NCT00361335|10860147|FG006|IV Period: Baseline to E0|Adverse Event|0
6852258|NCT00361335|10860141|FG000|IV Period: Baseline to E0|Lost to Follow-up|1
6852259|NCT00361335|10860142|FG001|IV Period: Baseline to E0|Lost to Follow-up|0
6852260|NCT00361335|10860143|FG002|IV Period: Baseline to E0|Lost to Follow-up|0
6852261|NCT00361335|10860144|FG003|IV Period: Baseline to E0|Lost to Follow-up|2
6852262|NCT00361335|10860145|FG004|IV Period: Baseline to E0|Lost to Follow-up|2
6852263|NCT00361335|10860146|FG005|IV Period: Baseline to E0|Lost to Follow-up|0
6852264|NCT00361335|10860147|FG006|IV Period: Baseline to E0|Lost to Follow-up|0
6852265|NCT00361335|10860141|FG000|IV Period: Baseline to E0|Death|1
6852266|NCT00361335|10860142|FG001|IV Period: Baseline to E0|Death|1
6852267|NCT00361335|10860143|FG002|IV Period: Baseline to E0|Death|1
6852268|NCT00361335|10860144|FG003|IV Period: Baseline to E0|Death|1
6852269|NCT00361335|10860145|FG004|IV Period: Baseline to E0|Death|0
6852270|NCT00361335|10860146|FG005|IV Period: Baseline to E0|Death|0
6852271|NCT00361335|10860147|FG006|IV Period: Baseline to E0|Death|0
6852272|NCT00361335|10860141|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2
6852273|NCT00361335|10860142|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1
6852274|NCT00361335|10860143|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1
6852275|NCT00361335|10860144|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1
6852276|NCT00361335|10860145|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2
6852277|NCT00361335|10860146|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0
6852278|NCT00361335|10860147|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0
6852279|NCT00361335|10860141|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0
6852280|NCT00361335|10860142|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0
6852281|NCT00361335|10860143|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1
6852282|NCT00361335|10860144|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0
6852283|NCT00361335|10860145|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0
6852284|NCT00361335|10860146|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0
6852285|NCT00361335|10860147|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0
6852286|NCT00361335|10860141|FG000|IV Period: Baseline to E0|Worsening of RA|0
6852287|NCT00361335|10860142|FG001|IV Period: Baseline to E0|Worsening of RA|5
6852288|NCT00361335|10860143|FG002|IV Period: Baseline to E0|Worsening of RA|1
6852289|NCT00361335|10860144|FG003|IV Period: Baseline to E0|Worsening of RA|4
6852290|NCT00361335|10860145|FG004|IV Period: Baseline to E0|Worsening of RA|2
6852291|NCT00361335|10860146|FG005|IV Period: Baseline to E0|Worsening of RA|0
6852292|NCT00361335|10860147|FG006|IV Period: Baseline to E0|Worsening of RA|0
6852293|NCT00361335|10860141|FG000|IV Period: Baseline to E0|Other|2
6852294|NCT00361335|10860142|FG001|IV Period: Baseline to E0|Other|9
6852295|NCT00361335|10860143|FG002|IV Period: Baseline to E0|Other|9
6852296|NCT00361335|10860144|FG003|IV Period: Baseline to E0|Other|3
6852297|NCT00361335|10860145|FG004|IV Period: Baseline to E0|Other|2
6852298|NCT00361335|10860146|FG005|IV Period: Baseline to E0|Other|0
6852299|NCT00361335|10860147|FG006|IV Period: Baseline to E0|Other|0
6852300|NCT00361335|10860141|FG000|IV Period: Baseline to E0|Lack of Efficacy|5
6852301|NCT00361335|10860142|FG001|IV Period: Baseline to E0|Lack of Efficacy|9
6852302|NCT00361335|10860143|FG002|IV Period: Baseline to E0|Lack of Efficacy|3
6852303|NCT00361335|10860144|FG003|IV Period: Baseline to E0|Lack of Efficacy|7
6852304|NCT00361335|10860145|FG004|IV Period: Baseline to E0|Lack of Efficacy|8
6852305|NCT00361335|10860146|FG005|IV Period: Baseline to E0|Lack of Efficacy|0
6852306|NCT00361335|10860147|FG006|IV Period: Baseline to E0|Lack of Efficacy|0
6852307|NCT00361335|10860141|FG000|SC Period: Week E0 to Week E24|Adverse Event|0
6852308|NCT00361335|10860142|FG001|SC Period: Week E0 to Week E24|Adverse Event|2
6852309|NCT00361335|10860143|FG002|SC Period: Week E0 to Week E24|Adverse Event|1
6852310|NCT00361335|10860144|FG003|SC Period: Week E0 to Week E24|Adverse Event|2
6852311|NCT00361335|10860145|FG004|SC Period: Week E0 to Week E24|Adverse Event|0
6852312|NCT00361335|10860146|FG005|SC Period: Week E0 to Week E24|Adverse Event|0
6852313|NCT00361335|10860147|FG006|SC Period: Week E0 to Week E24|Adverse Event|2
6852314|NCT00361335|10860141|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1
6852315|NCT00361335|10860142|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0
6852316|NCT00361335|10860143|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1
6852317|NCT00361335|10860144|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0
6852318|NCT00361335|10860145|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0
6852319|NCT00361335|10860146|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0
6852320|NCT00361335|10860147|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1
6852321|NCT00361335|10860141|FG000|SC Period: Week E0 to Week E24|Death|0
6852322|NCT00361335|10860142|FG001|SC Period: Week E0 to Week E24|Death|0
6852323|NCT00361335|10860143|FG002|SC Period: Week E0 to Week E24|Death|0
6852324|NCT00361335|10860144|FG003|SC Period: Week E0 to Week E24|Death|0
6852325|NCT00361335|10860145|FG004|SC Period: Week E0 to Week E24|Death|0
6852326|NCT00361335|10860146|FG005|SC Period: Week E0 to Week E24|Death|0
6852327|NCT00361335|10860147|FG006|SC Period: Week E0 to Week E24|Death|1
6852328|NCT00361335|10860141|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0
6852329|NCT00361335|10860142|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1
6852330|NCT00361335|10860143|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1
6852331|NCT00361335|10860144|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1
6852332|NCT00361335|10860145|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0
6852333|NCT00361335|10860146|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0
6852334|NCT00361335|10860147|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0
6852335|NCT00361335|10860141|FG000|SC Period: Week E0 to Week E24|Other|1
6852336|NCT00361335|10860142|FG001|SC Period: Week E0 to Week E24|Other|0
6852337|NCT00361335|10860143|FG002|SC Period: Week E0 to Week E24|Other|0
6852338|NCT00361335|10860144|FG003|SC Period: Week E0 to Week E24|Other|1
6852339|NCT00361335|10860145|FG004|SC Period: Week E0 to Week E24|Other|0
6852340|NCT00361335|10860146|FG005|SC Period: Week E0 to Week E24|Other|1
6852341|NCT00361335|10860147|FG006|SC Period: Week E0 to Week E24|Other|2
6852342|NCT00361335|10860141|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0
6852343|NCT00361335|10860142|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0
6852344|NCT00361335|10860143|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2
6852345|NCT00361335|10860144|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0
6852346|NCT00361335|10860145|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0
6852347|NCT00361335|10860146|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0
6852348|NCT00361335|10860147|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3
6852349|NCT00361504|10860187|FG000|Overall Study|Withdrawal by Subject|94
6852350|NCT00361504|10860188|FG001|Overall Study|Withdrawal by Subject|31
6852351|NCT00361504|10860187|FG000|Overall Study|Lost to Follow-up|40
6852352|NCT00361504|10860188|FG001|Overall Study|Lost to Follow-up|7
6852353|NCT00361504|10860187|FG000|Overall Study|Adverse Event|203
6852354|NCT00361504|10860188|FG001|Overall Study|Adverse Event|82
6852355|NCT00361504|10860187|FG000|Overall Study|Lack of Efficacy|72
6852356|NCT00361504|10860188|FG001|Overall Study|Lack of Efficacy|7
6852357|NCT00361504|10860187|FG000|Overall Study|Resolution of Pain|2
6852358|NCT00361504|10860188|FG001|Overall Study|Resolution of Pain|0
6852359|NCT00361504|10860187|FG000|Overall Study|Study medication non compliant|42
6852360|NCT00361504|10860188|FG001|Overall Study|Study medication non compliant|15
6852361|NCT00361504|10860187|FG000|Overall Study|All other|28
6852362|NCT00361504|10860188|FG001|Overall Study|All other|3
6852363|NCT00361569|10860198|FG000|Overall Study|Protocol Violation|3
6852364|NCT00361569|10860199|FG001|Overall Study|Protocol Violation|2
6852365|NCT00361569|10860200|FG002|Overall Study|Protocol Violation|4
6852366|NCT00361569|10860201|FG003|Overall Study|Protocol Violation|2
6852367|NCT00361569|10860198|FG000|Overall Study|Withdrawal by Subject|2
6852368|NCT00361569|10860199|FG001|Overall Study|Withdrawal by Subject|1
6852369|NCT00361569|10860200|FG002|Overall Study|Withdrawal by Subject|9
6852370|NCT00361569|10860201|FG003|Overall Study|Withdrawal by Subject|14
6852371|NCT00361569|10860198|FG000|Overall Study|Adverse Event|3
6852372|NCT00361569|10860199|FG001|Overall Study|Adverse Event|5
6852373|NCT00361569|10860200|FG002|Overall Study|Adverse Event|2
6852374|NCT00361569|10860201|FG003|Overall Study|Adverse Event|2
6852375|NCT00361569|10860198|FG000|Overall Study|Lost to Follow-up|2
6852376|NCT00361569|10860199|FG001|Overall Study|Lost to Follow-up|3
6852377|NCT00361569|10860200|FG002|Overall Study|Lost to Follow-up|3
6852378|NCT00361569|10860201|FG003|Overall Study|Lost to Follow-up|2
6852379|NCT00361569|10860198|FG000|Overall Study|Not specified by investigator|2
6852380|NCT00361569|10860199|FG001|Overall Study|Not specified by investigator|0
6852381|NCT00361569|10860200|FG002|Overall Study|Not specified by investigator|0
6852382|NCT00361569|10860201|FG003|Overall Study|Not specified by investigator|1
6852383|NCT00361634|10860215|FG000|Overall Study|Lost to Follow-up|1
6852384|NCT00361634|10860215|FG000|Overall Study|Withdrawal by Subject|1
6852385|NCT00361842|10860230|FG000|Overall Study|Withdrawal by Subject|2
6852386|NCT00361842|10860231|FG001|Overall Study|Withdrawal by Subject|3
6852387|NCT00361842|10860230|FG000|Overall Study|Death|2
6852388|NCT00361842|10860231|FG001|Overall Study|Death|1
6852389|NCT00361842|10860230|FG000|Overall Study|Disease progression|19
6852390|NCT00361842|10860231|FG001|Overall Study|Disease progression|20
6852391|NCT00361842|10860230|FG000|Overall Study|Adverse Event|2
6852392|NCT00361842|10860231|FG001|Overall Study|Adverse Event|3
6852393|NCT00361842|10860230|FG000|Overall Study|Occurrence of unacceptable toxicity|1
6852394|NCT00361842|10860231|FG001|Overall Study|Occurrence of unacceptable toxicity|5
6852395|NCT00361842|10860230|FG000|Overall Study|Other|1
6852396|NCT00361842|10860231|FG001|Overall Study|Other|0
6852397|NCT00361842|10860230|FG000|Overall Study|Other|0
6852398|NCT00361842|10860231|FG001|Overall Study|Other|2
6852399|NCT00362115|10860256|FG000|Overall Study|Adverse Event|0
6852400|NCT00362115|10860257|FG001|Overall Study|Adverse Event|1
6852401|NCT00362115|10860258|FG002|Overall Study|Adverse Event|1
6852402|NCT00362115|10860259|FG003|Overall Study|Adverse Event|1
6852403|NCT00362115|10860260|FG004|Overall Study|Adverse Event|2
6852404|NCT00362115|10860261|FG005|Overall Study|Adverse Event|2
6852405|NCT00362115|10860262|FG006|Overall Study|Adverse Event|1
6852406|NCT00362115|10860256|FG000|Overall Study|Protocol Violation|0
6852407|NCT00362115|10860257|FG001|Overall Study|Protocol Violation|0
6852408|NCT00362115|10860258|FG002|Overall Study|Protocol Violation|0
6852409|NCT00362115|10860259|FG003|Overall Study|Protocol Violation|0
6852410|NCT00362115|10860260|FG004|Overall Study|Protocol Violation|0
6852411|NCT00362115|10860261|FG005|Overall Study|Protocol Violation|1
6852412|NCT00362115|10860262|FG006|Overall Study|Protocol Violation|0
6852413|NCT00362115|10860256|FG000|Overall Study|Lost to Follow-up|0
6852414|NCT00362115|10860257|FG001|Overall Study|Lost to Follow-up|1
6852415|NCT00362115|10860258|FG002|Overall Study|Lost to Follow-up|0
6852416|NCT00362115|10860259|FG003|Overall Study|Lost to Follow-up|0
6852417|NCT00362115|10860260|FG004|Overall Study|Lost to Follow-up|2
6852418|NCT00362115|10860261|FG005|Overall Study|Lost to Follow-up|0
6852419|NCT00362115|10860262|FG006|Overall Study|Lost to Follow-up|1
6852420|NCT00362115|10860256|FG000|Overall Study|Withdrawal by Subject|1
6852421|NCT00362115|10860257|FG001|Overall Study|Withdrawal by Subject|3
6852422|NCT00362115|10860258|FG002|Overall Study|Withdrawal by Subject|1
6852423|NCT00362115|10860259|FG003|Overall Study|Withdrawal by Subject|0
6852424|NCT00362115|10860260|FG004|Overall Study|Withdrawal by Subject|1
6852425|NCT00362115|10860261|FG005|Overall Study|Withdrawal by Subject|3
6852426|NCT00362115|10860262|FG006|Overall Study|Withdrawal by Subject|4
6852427|NCT00362115|10860256|FG000|Overall Study|Lack of Efficacy|1
6852428|NCT00362115|10860257|FG001|Overall Study|Lack of Efficacy|0
6852429|NCT00362115|10860258|FG002|Overall Study|Lack of Efficacy|5
6852430|NCT00362115|10860259|FG003|Overall Study|Lack of Efficacy|2
6852431|NCT00362115|10860260|FG004|Overall Study|Lack of Efficacy|2
6852432|NCT00362115|10860261|FG005|Overall Study|Lack of Efficacy|0
6852433|NCT00362115|10860262|FG006|Overall Study|Lack of Efficacy|3
6852434|NCT00362115|10860256|FG000|Overall Study|Physician Decision|0
6852435|NCT00362115|10860257|FG001|Overall Study|Physician Decision|0
6852436|NCT00362115|10860258|FG002|Overall Study|Physician Decision|0
6852437|NCT00362115|10860259|FG003|Overall Study|Physician Decision|0
6852438|NCT00362115|10860260|FG004|Overall Study|Physician Decision|0
6852439|NCT00362115|10860261|FG005|Overall Study|Physician Decision|0
6852440|NCT00362115|10860262|FG006|Overall Study|Physician Decision|3
6852441|NCT00362115|10860256|FG000|Overall Study|Other|0
6852442|NCT00362115|10860257|FG001|Overall Study|Other|1
6852443|NCT00362115|10860258|FG002|Overall Study|Other|0
6852444|NCT00362115|10860259|FG003|Overall Study|Other|1
6852445|NCT00362115|10860260|FG004|Overall Study|Other|0
6852446|NCT00362115|10860261|FG005|Overall Study|Other|1
6852447|NCT00362115|10860262|FG006|Overall Study|Other|0
6852448|NCT00362180|10860291|FG000|Treated Period|Withdrawal by Subject|1
6852449|NCT00362180|10860292|FG001|Treated Period|Withdrawal by Subject|0
6852450|NCT00362180|10860293|FG002|Treated Period|Withdrawal by Subject|0
6852451|NCT00362180|10860294|FG003|Treated Period|Withdrawal by Subject|0
6852452|NCT00362180|10860295|FG004|Treated Period|Withdrawal by Subject|0
6852453|NCT00362180|10860296|FG005|Treated Period|Withdrawal by Subject|0
6852454|NCT00362180|10860297|FG006|Treated Period|Withdrawal by Subject|0
6852455|NCT00362180|10860298|FG007|Treated Period|Withdrawal by Subject|0
6852456|NCT00362180|10860299|FG008|Treated Period|Withdrawal by Subject|0
6852457|NCT00362180|10860291|FG000|Treated Period|Adverse Event|0
6852458|NCT00362180|10860292|FG001|Treated Period|Adverse Event|0
6852459|NCT00362180|10860293|FG002|Treated Period|Adverse Event|0
6852460|NCT00362180|10860294|FG003|Treated Period|Adverse Event|0
6852461|NCT00362180|10860295|FG004|Treated Period|Adverse Event|0
6852462|NCT00362180|10860296|FG005|Treated Period|Adverse Event|1
6852463|NCT00362180|10860297|FG006|Treated Period|Adverse Event|0
6852464|NCT00362180|10860298|FG007|Treated Period|Adverse Event|1
6852465|NCT00362180|10860299|FG008|Treated Period|Adverse Event|0
6852466|NCT00362232|10860319|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62
6852467|NCT00362232|10860320|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56
6852468|NCT00362232|10860319|FG000|Treatment (12 +/- 2 Days)|Death|1
6852469|NCT00362232|10860320|FG001|Treatment (12 +/- 2 Days)|Death|3
6852470|NCT00362232|10860319|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3
6852471|NCT00362232|10860320|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1
6852472|NCT00362232|10860319|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2
6852473|NCT00362232|10860320|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5
6852474|NCT00362232|10860319|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22
6852475|NCT00362232|10860320|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21
6852476|NCT00362232|10860319|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49
6852477|NCT00362232|10860320|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47
6852478|NCT00362232|10860319|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9
6852479|NCT00362232|10860320|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0
6852480|NCT00362232|10860319|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1
6852481|NCT00362232|10860320|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0
6852482|NCT00362232|10860319|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10
6852483|NCT00362232|10860320|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18
6852484|NCT00362232|10860319|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2
6852485|NCT00362232|10860320|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3
6852486|NCT00362232|10860319|FG000|Follow-up (30 (+ 5) Days)|Death|1
6852487|NCT00362232|10860320|FG001|Follow-up (30 (+ 5) Days)|Death|1
6852488|NCT00362232|10860319|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27
6852489|NCT00362232|10860320|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28
6852490|NCT00362232|10860319|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8
6852491|NCT00362232|10860320|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7
6852492|NCT00362297|10860328|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0
6852493|NCT00362297|10860329|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4
6852494|NCT00362336|10860338|FG000|Overall Study|Serious Adverse Event|1
6852495|NCT00362336|10860339|FG001|Overall Study|Serious Adverse Event|0
6852496|NCT00362336|10860340|FG002|Overall Study|Serious Adverse Event|1
6852497|NCT00362336|10860338|FG000|Overall Study|Protocol Violation|0
6852498|NCT00362336|10860339|FG001|Overall Study|Protocol Violation|0
6852499|NCT00362336|10860340|FG002|Overall Study|Protocol Violation|1
6852500|NCT00362336|10860338|FG000|Overall Study|Lost to Follow-up|6
6852501|NCT00362336|10860339|FG001|Overall Study|Lost to Follow-up|4
6852502|NCT00362336|10860340|FG002|Overall Study|Lost to Follow-up|0
6852503|NCT00362336|10860338|FG000|Overall Study|Withdrawal by Subject|3
6852504|NCT00362336|10860339|FG001|Overall Study|Withdrawal by Subject|3
6852505|NCT00362336|10860340|FG002|Overall Study|Withdrawal by Subject|1
6852506|NCT00362375|10860357|FG000|Overall Study|Lost to Follow-up|40
6852507|NCT00362375|10860358|FG001|Overall Study|Lost to Follow-up|35
6852508|NCT00362414|10860364|FG000|Overall Study|Death|2
6852509|NCT00362414|10860364|FG000|Overall Study|Adverse Event|1
6852510|NCT00362609|10860400|FG000|Overall Study|Withdrawal by Subject|0
6852511|NCT00362609|10860401|FG001|Overall Study|Withdrawal by Subject|1
6852512|NCT00362609|10860400|FG000|Overall Study|Protocol Violation|0
6852513|NCT00362609|10860401|FG001|Overall Study|Protocol Violation|1
6852514|NCT00362648|10860411|FG000|Overall Study|Adverse Event|12
6852515|NCT00362648|10860412|FG001|Overall Study|Adverse Event|21
6852516|NCT00362648|10860413|FG002|Overall Study|Adverse Event|1
6852517|NCT00362648|10860414|FG003|Overall Study|Adverse Event|0
6852518|NCT00362648|10860411|FG000|Overall Study|Lost to Follow-up|62
6852519|NCT00362648|10860412|FG001|Overall Study|Lost to Follow-up|69
6852520|NCT00362648|10860413|FG002|Overall Study|Lost to Follow-up|4
6852521|NCT00362648|10860414|FG003|Overall Study|Lost to Follow-up|3
6852522|NCT00362648|10860411|FG000|Overall Study|Protocol Violation|4
6852523|NCT00362648|10860412|FG001|Overall Study|Protocol Violation|2
6852524|NCT00362648|10860413|FG002|Overall Study|Protocol Violation|2
6852525|NCT00362648|10860414|FG003|Overall Study|Protocol Violation|2
6852526|NCT00362648|10860411|FG000|Overall Study|Withdrawal by Subject|48
6852527|NCT00362648|10860412|FG001|Overall Study|Withdrawal by Subject|42
6852528|NCT00362648|10860413|FG002|Overall Study|Withdrawal by Subject|2
6852529|NCT00362648|10860414|FG003|Overall Study|Withdrawal by Subject|6
6852530|NCT00363051|10860444|FG000|Overall Study|Adminstrative problems|1
6852531|NCT00363051|10860445|FG001|Overall Study|Adminstrative problems|1
6852532|NCT00363051|10860444|FG000|Overall Study|Adverse Event|21
6852533|NCT00363051|10860445|FG001|Overall Study|Adverse Event|12
6852534|NCT00363051|10860444|FG000|Overall Study|New Cancer Therapy|2
6852535|NCT00363051|10860445|FG001|Overall Study|New Cancer Therapy|1
6852536|NCT00363051|10860444|FG000|Overall Study|Withdrawal by Subject|11
6852537|NCT00363051|10860445|FG001|Overall Study|Withdrawal by Subject|3
6852538|NCT00363051|10860444|FG000|Overall Study|Lost to Follow-up|0
6852539|NCT00363051|10860445|FG001|Overall Study|Lost to Follow-up|1
6852540|NCT00363051|10860444|FG000|Overall Study|Protocol Violation|0
6852541|NCT00363051|10860445|FG001|Overall Study|Protocol Violation|2
6852542|NCT00363051|10860444|FG000|Overall Study|Death|3
6852543|NCT00363051|10860445|FG001|Overall Study|Death|2
6852544|NCT00363129|10860464|FG000|Overall Study|Withdrawal by Subject|11
6852545|NCT00363129|10860465|FG001|Overall Study|Withdrawal by Subject|18
6852546|NCT00363129|10860464|FG000|Overall Study|Adverse Event|8
6852547|NCT00363129|10860465|FG001|Overall Study|Adverse Event|3
6852548|NCT00363129|10860464|FG000|Overall Study|Alternate Treatment|2
6852549|NCT00363129|10860465|FG001|Overall Study|Alternate Treatment|4
6852550|NCT00363129|10860464|FG000|Overall Study|Other Medical Problems|2
6852551|NCT00363129|10860465|FG001|Overall Study|Other Medical Problems|4
6852552|NCT00363129|10860464|FG000|Overall Study|Death|0
6852553|NCT00363129|10860465|FG001|Overall Study|Death|1
6852554|NCT00363129|10860464|FG000|Overall Study|Other Reasons|6
6852555|NCT00363129|10860465|FG001|Overall Study|Other Reasons|3
6852556|NCT00363142|10860473|FG000|Overall Study|Adverse Event|2
6852557|NCT00363142|10860474|FG001|Overall Study|Adverse Event|0
6852558|NCT00363142|10860473|FG000|Overall Study|Lack of Efficacy|0
6852559|NCT00363142|10860474|FG001|Overall Study|Lack of Efficacy|1
6852560|NCT00363142|10860473|FG000|Overall Study|Lost to Follow-up|1
6852561|NCT00363142|10860474|FG001|Overall Study|Lost to Follow-up|0
6852562|NCT00363142|10860473|FG000|Overall Study|Non-compliance|1
6852563|NCT00363142|10860474|FG001|Overall Study|Non-compliance|1
6852564|NCT00363142|10860473|FG000|Overall Study|Withdrawal by Subject|3
6852565|NCT00363142|10860474|FG001|Overall Study|Withdrawal by Subject|1
6852566|NCT00363246|10860492|FG000|Overall Study|Death|40
6852567|NCT00363246|10860492|FG000|Overall Study|Withdrawal by Subject|19
6852568|NCT00363246|10860492|FG000|Overall Study|Lost to Follow-up|14
6852569|NCT00363246|10860492|FG000|Overall Study|Bad health|6
6852570|NCT00363246|10860492|FG000|Overall Study|Stopped using wheelchair|11
6852571|NCT00363246|10860492|FG000|Overall Study|Subject expressed security concerns|2
6852572|NCT00363246|10860492|FG000|Overall Study|Eligibility changed due to Hospice move|5
6852573|NCT00363298|10860499|FG000|First Study Week|Lack of Efficacy|6
6852574|NCT00363298|10860500|FG001|First Study Week|Lack of Efficacy|5
6852575|NCT00363298|10860499|FG000|4-week Study Continuation Phase|Lack of Efficacy|1
6852576|NCT00363298|10860500|FG001|4-week Study Continuation Phase|Lack of Efficacy|0
6852577|NCT00363311|10860509|FG000|Overall Study|Adverse Event|6
6852578|NCT00363311|10860510|FG001|Overall Study|Adverse Event|4
6852579|NCT00363311|10860509|FG000|Overall Study|Lost to Follow-up|3
6852580|NCT00363311|10860510|FG001|Overall Study|Lost to Follow-up|0
6852581|NCT00363311|10860509|FG000|Overall Study|Protocol Violation|1
6852582|NCT00363311|10860510|FG001|Overall Study|Protocol Violation|2
6852583|NCT00363311|10860509|FG000|Overall Study|Withdrawal by Subject|12
6852584|NCT00363311|10860510|FG001|Overall Study|Withdrawal by Subject|6
6852585|NCT00363311|10860509|FG000|Overall Study|Physician Decision|1
6852586|NCT00363311|10860510|FG001|Overall Study|Physician Decision|1
6852587|NCT00363311|10860509|FG000|Overall Study|Sponsor Terminated Study|2
6852588|NCT00363311|10860510|FG001|Overall Study|Sponsor Terminated Study|2
6852589|NCT00363311|10860509|FG000|Overall Study|Disease Progression|46
6852590|NCT00363311|10860510|FG001|Overall Study|Disease Progression|26
6852591|NCT00363311|10860509|FG000|Overall Study|Non-Compliance|1
6852592|NCT00363311|10860510|FG001|Overall Study|Non-Compliance|1
6852593|NCT00363311|10860509|FG000|Overall Study|Participant Refused Biopsy|1
6852594|NCT00363311|10860510|FG001|Overall Study|Participant Refused Biopsy|0
6852595|NCT00363311|10860509|FG000|Overall Study|Prostate Volume/PSA Doubled|1
6852596|NCT00363311|10860510|FG001|Overall Study|Prostate Volume/PSA Doubled|0
6852597|NCT00363311|10860509|FG000|Overall Study|Participant Opted for Treatment|1
6852598|NCT00363311|10860510|FG001|Overall Study|Participant Opted for Treatment|0
6852599|NCT00363311|10860509|FG000|Overall Study|Participant Moved to Another Country|1
6852600|NCT00363311|10860510|FG001|Overall Study|Participant Moved to Another Country|0
6852601|NCT00363311|10860509|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0
6852602|NCT00363311|10860510|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1
6852603|NCT00363311|10860509|FG000|Overall Study|Withdrawn per Instructions of Monitor|0
6852604|NCT00363311|10860510|FG001|Overall Study|Withdrawn per Instructions of Monitor|1
6852605|NCT00363311|10860509|FG000|Overall Study|Participant Moved to Louisiana|0
6852606|NCT00363311|10860510|FG001|Overall Study|Participant Moved to Louisiana|1
6852607|NCT00363415|10860518|FG000|Overall Study|Progressive Disease|196
6852608|NCT00363415|10860519|FG001|Overall Study|Progressive Disease|107
6852609|NCT00363415|10860518|FG000|Overall Study|Sponsor Decision|67
6852610|NCT00363415|10860519|FG001|Overall Study|Sponsor Decision|31
6852611|NCT00363415|10860518|FG000|Overall Study|Death|32
6852612|NCT00363415|10860519|FG001|Overall Study|Death|29
6852613|NCT00363415|10860518|FG000|Overall Study|Adverse Event|24
6852614|NCT00363415|10860519|FG001|Overall Study|Adverse Event|15
6852615|NCT00363415|10860518|FG000|Overall Study|Physician Decision|18
6852616|NCT00363415|10860519|FG001|Overall Study|Physician Decision|35
6852617|NCT00363415|10860518|FG000|Overall Study|Entry Criteria Not Met|11
6852618|NCT00363415|10860519|FG001|Overall Study|Entry Criteria Not Met|10
6852619|NCT00363415|10860518|FG000|Overall Study|Withdrawal by Subject|9
6852620|NCT00363415|10860519|FG001|Overall Study|Withdrawal by Subject|15
6852621|NCT00363415|10860518|FG000|Overall Study|Lost to Follow-up|3
6852622|NCT00363415|10860519|FG001|Overall Study|Lost to Follow-up|3
6852623|NCT00363415|10860518|FG000|Overall Study|Protocol Violation|1
6852624|NCT00363415|10860519|FG001|Overall Study|Protocol Violation|4
6852625|NCT00363467|10860525|FG000|Overall Study|Physician Decision|1
6852626|NCT00363480|10860529|FG000|Overall Study|Criteria for treatment period not fulfil|1
6852627|NCT00363480|10860529|FG000|Overall Study|Adverse Event|4
6852628|NCT00363480|10860529|FG000|Overall Study|Lost to Follow-up|5
6852629|NCT00363480|10860529|FG000|Overall Study|Withdrawal by Subject|5
6852630|NCT00363480|10860529|FG000|Overall Study|Non-compliance of subject|1
6852631|NCT00363480|10860529|FG000|Overall Study|Participant discontinued on its own|1
6852632|NCT00363545|10860535|FG000|Overall Study|Serious Adverse Event|0
6852633|NCT00363545|10860536|FG001|Overall Study|Serious Adverse Event|1
6852634|NCT00363545|10860535|FG000|Overall Study|Withdrawal by Subject|12
6852635|NCT00363545|10860536|FG001|Overall Study|Withdrawal by Subject|15
6852636|NCT00363545|10860535|FG000|Overall Study|Migrated/moved from study area|3
6852637|NCT00363545|10860536|FG001|Overall Study|Migrated/moved from study area|6
6852638|NCT00363545|10860535|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14
7187271|NCT00602667|11387790|FG002|Overall Study|Family request|6
6852639|NCT00363545|10860536|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18
6852640|NCT00363545|10860535|FG000|Overall Study|Lost to follow-up (complete vaccination)|14
6852641|NCT00363545|10860536|FG001|Overall Study|Lost to follow-up (complete vaccination)|17
6852642|NCT00363545|10860535|FG000|Overall Study|Others|1
6852643|NCT00363545|10860536|FG001|Overall Study|Others|0
6852644|NCT00363649|10860544|FG000|Overall Study|Withdrawal by Subject|1
6852645|NCT00363649|10860545|FG001|Overall Study|Withdrawal by Subject|1
6852646|NCT00363649|10860544|FG000|Overall Study|Adverse Event|6
6852647|NCT00363649|10860545|FG001|Overall Study|Adverse Event|0
6852648|NCT00363766|10860558|FG000|Overall Study|Progressive Disease|15
6852649|NCT00363766|10860559|FG001|Overall Study|Progressive Disease|9
6852650|NCT00363766|10860558|FG000|Overall Study|Adverse Event|10
6852651|NCT00363766|10860559|FG001|Overall Study|Adverse Event|2
6852652|NCT00363766|10860558|FG000|Overall Study|Disease Related Death|1
6852653|NCT00363766|10860559|FG001|Overall Study|Disease Related Death|3
6852654|NCT00363766|10860558|FG000|Overall Study|Not Disease Related Death|3
6852655|NCT00363766|10860559|FG001|Overall Study|Not Disease Related Death|4
6852656|NCT00363766|10860558|FG000|Overall Study|Withdrawal by Subject|2
6852657|NCT00363766|10860559|FG001|Overall Study|Withdrawal by Subject|0
6966851|NCT01128296|11015096|FG001|Overall Study|Withdrawal by Subject|0
6966852|NCT01128296|11015097|FG002|Overall Study|Withdrawal by Subject|0
6966853|NCT01128296|11015098|FG003|Overall Study|Withdrawal by Subject|0
6852658|NCT00363766|10860558|FG000|Overall Study|Physician Decision|1
6852659|NCT00363766|10860559|FG001|Overall Study|Physician Decision|2
6852660|NCT00363896|10860589|FG000|Overall Study|Withdrawal by Subject|29
6852661|NCT00363896|10860590|FG001|Overall Study|Withdrawal by Subject|16
6852662|NCT00363896|10860589|FG000|Overall Study|Adverse Event|24
6852663|NCT00363896|10860590|FG001|Overall Study|Adverse Event|13
6852664|NCT00363896|10860589|FG000|Overall Study|COPD exacerbation|13
6852665|NCT00363896|10860590|FG001|Overall Study|COPD exacerbation|7
6852666|NCT00363896|10860589|FG000|Overall Study|Lack of Efficacy|12
6852667|NCT00363896|10860590|FG001|Overall Study|Lack of Efficacy|8
6852668|NCT00363896|10860589|FG000|Overall Study|Protocol Violation|6
6966854|NCT01128296|11015099|FG004|Overall Study|Withdrawal by Subject|0
6966855|NCT01128296|11015100|FG005|Overall Study|Withdrawal by Subject|2
6966856|NCT01128361|11015113|FG000|Overall Study|Lost to Follow-up|0
6966857|NCT01128361|11015114|FG001|Overall Study|Lost to Follow-up|1
6966858|NCT01128361|11015113|FG000|Overall Study|Withdrawal by Subject|5
6966859|NCT01128361|11015114|FG001|Overall Study|Withdrawal by Subject|2
6966860|NCT01128387|11015122|FG000|Overall Study|Physician Decision|0
6966861|NCT01128387|11015123|FG001|Overall Study|Physician Decision|1
6966862|NCT01128400|11015132|FG000|Overall Study|Lost to Follow-up|1
6966863|NCT01128400|11015133|FG001|Overall Study|Lost to Follow-up|0
6966864|NCT01128400|11015134|FG002|Overall Study|Lost to Follow-up|1
6966865|NCT01128400|11015132|FG000|Overall Study|Screening failure|1
6966866|NCT01128400|11015133|FG001|Overall Study|Screening failure|0
6966867|NCT01128400|11015134|FG002|Overall Study|Screening failure|0
6966868|NCT01128400|11015132|FG000|Overall Study|were not invited to participate on taste|0
6966869|NCT01128400|11015133|FG001|Overall Study|were not invited to participate on taste|0
6966870|NCT01128400|11015134|FG002|Overall Study|were not invited to participate on taste|15
6966871|NCT01128400|11015132|FG000|Overall Study|Excluded due to sinus problems|0
6966872|NCT01128400|11015133|FG001|Overall Study|Excluded due to sinus problems|1
6966873|NCT01128400|11015134|FG002|Overall Study|Excluded due to sinus problems|0
6966874|NCT01128413|11015144|FG000|Overall Study|Withdrawal by Subject|1
6966875|NCT01128413|11015145|FG001|Overall Study|Withdrawal by Subject|0
6966876|NCT01128413|11015144|FG000|Overall Study|NICOM Monitor Problems|2
6966877|NCT01128413|11015145|FG001|Overall Study|NICOM Monitor Problems|1
6966878|NCT01128413|11015144|FG000|Overall Study|Pt made DNR|1
6966879|NCT01128413|11015145|FG001|Overall Study|Pt made DNR|0
6966880|NCT01128543|11015157|FG000|Overall Study|Withdrawal by Subject|3
6966881|NCT01128543|11015157|FG000|Overall Study|Protocol Violation|1
6966882|NCT01128569|11015161|FG000|Washout Period 1|Adverse Event|0
6966883|NCT01128569|11015162|FG001|Washout Period 1|Adverse Event|0
6966884|NCT01128569|11015163|FG002|Washout Period 1|Adverse Event|1
6966885|NCT01128569|11015164|FG003|Washout Period 1|Adverse Event|0
6966886|NCT01128569|11015165|FG004|Washout Period 1|Adverse Event|0
6966887|NCT01128569|11015166|FG005|Washout Period 1|Adverse Event|0
6966888|NCT01128569|11015161|FG000|Treatment Period 2|Withdrawal by Subject|0
6966889|NCT01128569|11015162|FG001|Treatment Period 2|Withdrawal by Subject|1
6966890|NCT01128569|11015163|FG002|Treatment Period 2|Withdrawal by Subject|0
6966891|NCT01128569|11015164|FG003|Treatment Period 2|Withdrawal by Subject|0
6966892|NCT01128569|11015165|FG004|Treatment Period 2|Withdrawal by Subject|0
6966893|NCT01128569|11015166|FG005|Treatment Period 2|Withdrawal by Subject|0
6966894|NCT01128595|11015174|FG000|Treatment Period 3|Withdrawal by Subject|0
6966895|NCT01128595|11015175|FG001|Treatment Period 3|Withdrawal by Subject|1
6966896|NCT01128595|11015176|FG002|Treatment Period 3|Withdrawal by Subject|0
6966897|NCT01128595|11015177|FG003|Treatment Period 3|Withdrawal by Subject|0
6966898|NCT01128621|11015190|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0
6966899|NCT01128621|11015191|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2
6966900|NCT01128738|11015215|FG000|First Treatment Phase (TP)|Lost to Follow-up|1
6966901|NCT01128738|11015216|FG001|First Treatment Phase (TP)|Lost to Follow-up|0
6966902|NCT01128738|11015215|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3
6966903|NCT01128738|11015216|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1
6966904|NCT01128738|11015215|FG000|Second TP|Lost to Follow-up|0
6966905|NCT01128738|11015216|FG001|Second TP|Lost to Follow-up|1
6966906|NCT01128738|11015215|FG000|Second TP|Withdrawal by Subject|0
6966907|NCT01128738|11015216|FG001|Second TP|Withdrawal by Subject|2
6966908|NCT01128842|11015228|FG000|Overall Study|Adverse Event|1
6966909|NCT01128842|11015228|FG000|Overall Study|Disease Progression|6
6966910|NCT01128894|11015235|FG000|Overall Study|Adverse Event|31
6966911|NCT01128894|11015236|FG001|Overall Study|Adverse Event|41
6966912|NCT01128894|11015235|FG000|Overall Study|Protocol Violation|2
6966913|NCT01128894|11015236|FG001|Overall Study|Protocol Violation|1
6966914|NCT01128894|11015235|FG000|Overall Study|Noncompliance|4
6966915|NCT01128894|11015236|FG001|Overall Study|Noncompliance|5
6966916|NCT01128894|11015235|FG000|Overall Study|Lost to Follow-up|8
6966917|NCT01128894|11015236|FG001|Overall Study|Lost to Follow-up|8
6966918|NCT01128894|11015235|FG000|Overall Study|Withdrawal by Subject|10
6852669|NCT00363896|10860590|FG001|Overall Study|Protocol Violation|1
6966919|NCT01128894|11015236|FG001|Overall Study|Withdrawal by Subject|12
6966920|NCT01128894|11015235|FG000|Overall Study|Physician Decision|2
6852670|NCT00363896|10860589|FG000|Overall Study|Lost to Follow-up|3
6852671|NCT00363896|10860590|FG001|Overall Study|Lost to Follow-up|0
6966921|NCT01128894|11015236|FG001|Overall Study|Physician Decision|1
6966922|NCT01128894|11015235|FG000|Overall Study|Conflicting HbA1c Results at Screening|1
6852672|NCT00363896|10860589|FG000|Overall Study|Non-fulfilment of entry criteria|1
6852673|NCT00363896|10860590|FG001|Overall Study|Non-fulfilment of entry criteria|0
6852674|NCT00363896|10860589|FG000|Overall Study|Other|1
6852675|NCT00363896|10860590|FG001|Overall Study|Other|2
6852676|NCT00364013|10860601|FG000|Overall Study|Ineligibility determined|4
6852677|NCT00364013|10860602|FG001|Overall Study|Ineligibility determined|2
6852678|NCT00364013|10860601|FG000|Overall Study|Adverse Event|4
6852679|NCT00364013|10860602|FG001|Overall Study|Adverse Event|3
6852680|NCT00364013|10860601|FG000|Overall Study|Withdrawal by Subject|13
6852681|NCT00364013|10860602|FG001|Overall Study|Withdrawal by Subject|18
6852682|NCT00364013|10860601|FG000|Overall Study|Physician Decision|3
6852683|NCT00364013|10860602|FG001|Overall Study|Physician Decision|3
6852684|NCT00364013|10860601|FG000|Overall Study|Lost to Follow-up|10
6852685|NCT00364013|10860602|FG001|Overall Study|Lost to Follow-up|3
6852686|NCT00364013|10860601|FG000|Overall Study|Protocol-specified criteria|6
6852687|NCT00364013|10860602|FG001|Overall Study|Protocol-specified criteria|6
6852688|NCT00364013|10860601|FG000|Overall Study|Other|41
6852689|NCT00364013|10860602|FG001|Overall Study|Other|47
6852690|NCT00364013|10860601|FG000|Overall Study|Ongoing|20
6852691|NCT00364013|10860602|FG001|Overall Study|Ongoing|13
6852692|NCT00364130|10860614|FG000|Intervention Period|Lost to Follow-up|4
6852693|NCT00364130|10860615|FG001|Intervention Period|Lost to Follow-up|3
6852694|NCT00364130|10860614|FG000|Intervention Period|Pregnancy|1
6852695|NCT00364130|10860615|FG001|Intervention Period|Pregnancy|0
6852696|NCT00364130|10860614|FG000|Intervention Period|Withdrawal by Subject|4
6852697|NCT00364130|10860615|FG001|Intervention Period|Withdrawal by Subject|5
6852698|NCT00364130|10860614|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5
6852699|NCT00364130|10860615|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11
6852700|NCT00364156|10860625|FG000|Overall Study|Withdrawal by Subject|73
6852701|NCT00364156|10860626|FG001|Overall Study|Withdrawal by Subject|80
6852702|NCT00364156|10860625|FG000|Overall Study|Protocol Violation|6
6852703|NCT00364156|10860626|FG001|Overall Study|Protocol Violation|1
6852704|NCT00364182|10860635|FG000|First Intervention|Secondary prophylaxis|1
6852705|NCT00364182|10860636|FG001|First Intervention|Secondary prophylaxis|0
6852706|NCT00364182|10860637|FG002|First Intervention|Secondary prophylaxis|0
6852707|NCT00364182|10860635|FG000|First Intervention|Withdrawal by Subject|2
6852708|NCT00364182|10860636|FG001|First Intervention|Withdrawal by Subject|0
6852709|NCT00364182|10860637|FG002|First Intervention|Withdrawal by Subject|0
6852710|NCT00364182|10860635|FG000|Second Intervention|non-compliance|0
6852711|NCT00364182|10860636|FG001|Second Intervention|non-compliance|1
6852712|NCT00364182|10860637|FG002|Second Intervention|non-compliance|1
6852713|NCT00364182|10860635|FG000|Second Intervention|Protocol Violation|0
6852714|NCT00364182|10860636|FG001|Second Intervention|Protocol Violation|1
6852715|NCT00364182|10860637|FG002|Second Intervention|Protocol Violation|0
6852716|NCT00364182|10860635|FG000|Second Intervention|Adverse Event|0
6852717|NCT00364182|10860636|FG001|Second Intervention|Adverse Event|0
6852718|NCT00364182|10860637|FG002|Second Intervention|Adverse Event|1
6852719|NCT00364182|10860635|FG000|Third Intervention|non-compliance|0
6852720|NCT00364182|10860636|FG001|Third Intervention|non-compliance|1
6852721|NCT00364182|10860637|FG002|Third Intervention|non-compliance|0
6852722|NCT00364182|10860635|FG000|Third Intervention|Lost to Follow-up|0
6852723|NCT00364182|10860636|FG001|Third Intervention|Lost to Follow-up|0
6852724|NCT00364182|10860637|FG002|Third Intervention|Lost to Follow-up|1
6852725|NCT00364286|10860647|FG000|Overall Study|Withdrawal by Subject|1
6852726|NCT00364286|10860647|FG000|Overall Study|Adverse Event|2
6852727|NCT00364351|10860653|FG000|Overall Study|Adverse Event|90
6852728|NCT00364351|10860654|FG001|Overall Study|Adverse Event|44
6852729|NCT00364351|10860653|FG000|Overall Study|Condition under investigation worsened|469
6852730|NCT00364351|10860654|FG001|Overall Study|Condition under investigation worsened|497
6852731|NCT00364351|10860653|FG000|Overall Study|Prohibited concomitant medication|0
6852732|NCT00364351|10860654|FG001|Overall Study|Prohibited concomitant medication|2
6852733|NCT00364351|10860653|FG000|Overall Study|Lost to Follow-up|1
6852734|NCT00364351|10860654|FG001|Overall Study|Lost to Follow-up|1
6852735|NCT00364351|10860653|FG000|Overall Study|Withdrawal by Subject|30
6852736|NCT00364351|10860654|FG001|Overall Study|Withdrawal by Subject|29
6852737|NCT00364351|10860653|FG000|Overall Study|Incorrect enrollment|1
6852738|NCT00364351|10860654|FG001|Overall Study|Incorrect enrollment|1
6852739|NCT00364351|10860653|FG000|Overall Study|Sponsor decision|1
6852740|NCT00364351|10860654|FG001|Overall Study|Sponsor decision|0
6852741|NCT00364351|10860653|FG000|Overall Study|Poor treatment compliance|0
6852742|NCT00364351|10860654|FG001|Overall Study|Poor treatment compliance|3
6852743|NCT00364351|10860653|FG000|Overall Study|Investigator error|0
6852744|NCT00364351|10860654|FG001|Overall Study|Investigator error|2
6852745|NCT00364351|10860653|FG000|Overall Study|Patient could not travel to site|0
6852746|NCT00364351|10860654|FG001|Overall Study|Patient could not travel to site|1
6852747|NCT00364351|10860653|FG000|Overall Study|Randomised treatment not started|0
6852748|NCT00364351|10860654|FG001|Overall Study|Randomised treatment not started|3
6852749|NCT00364533|10860674|FG000|Overall Study|Adverse Event|8
6852750|NCT00364533|10860675|FG001|Overall Study|Adverse Event|7
6852751|NCT00364533|10860676|FG002|Overall Study|Adverse Event|15
6852752|NCT00364533|10860677|FG003|Overall Study|Adverse Event|5
6852753|NCT00364533|10860678|FG004|Overall Study|Adverse Event|2
6852754|NCT00364533|10860674|FG000|Overall Study|Withdrawal by Subject|4
6852755|NCT00364533|10860675|FG001|Overall Study|Withdrawal by Subject|8
6852756|NCT00364533|10860676|FG002|Overall Study|Withdrawal by Subject|6
6852757|NCT00364533|10860677|FG003|Overall Study|Withdrawal by Subject|6
6852758|NCT00364533|10860678|FG004|Overall Study|Withdrawal by Subject|6
6852759|NCT00364533|10860674|FG000|Overall Study|Lack of Efficacy|22
6852760|NCT00364533|10860675|FG001|Overall Study|Lack of Efficacy|22
6852761|NCT00364533|10860676|FG002|Overall Study|Lack of Efficacy|21
6852762|NCT00364533|10860677|FG003|Overall Study|Lack of Efficacy|17
6852763|NCT00364533|10860678|FG004|Overall Study|Lack of Efficacy|42
6852764|NCT00364533|10860674|FG000|Overall Study|Subject discharged from hospital|4
6852765|NCT00364533|10860675|FG001|Overall Study|Subject discharged from hospital|1
6852766|NCT00364533|10860676|FG002|Overall Study|Subject discharged from hospital|2
6852767|NCT00364533|10860677|FG003|Overall Study|Subject discharged from hospital|3
6852768|NCT00364533|10860678|FG004|Overall Study|Subject discharged from hospital|1
6852769|NCT00364533|10860674|FG000|Overall Study|Variations in drug compliance|2
6852770|NCT00364533|10860675|FG001|Overall Study|Variations in drug compliance|1
6852771|NCT00364533|10860676|FG002|Overall Study|Variations in drug compliance|1
6852772|NCT00364533|10860677|FG003|Overall Study|Variations in drug compliance|0
6852773|NCT00364533|10860678|FG004|Overall Study|Variations in drug compliance|0
6852774|NCT00364533|10860674|FG000|Overall Study|Non-compliance|1
6852775|NCT00364533|10860675|FG001|Overall Study|Non-compliance|0
6852776|NCT00364533|10860676|FG002|Overall Study|Non-compliance|0
6852777|NCT00364533|10860677|FG003|Overall Study|Non-compliance|0
6852778|NCT00364533|10860678|FG004|Overall Study|Non-compliance|0
6852779|NCT00364533|10860674|FG000|Overall Study|Protocol Violation|1
6852780|NCT00364533|10860675|FG001|Overall Study|Protocol Violation|1
6852781|NCT00364533|10860676|FG002|Overall Study|Protocol Violation|0
6852782|NCT00364533|10860677|FG003|Overall Study|Protocol Violation|0
6852783|NCT00364533|10860678|FG004|Overall Study|Protocol Violation|0
6852784|NCT00364611|10860692|FG000|Overall Study|Did not receive study medication|0
6852785|NCT00364611|10860693|FG001|Overall Study|Did not receive study medication|1
6852786|NCT00364611|10860692|FG000|Overall Study|Adverse Event|7
6852787|NCT00364611|10860693|FG001|Overall Study|Adverse Event|4
6852788|NCT00364611|10860692|FG000|Overall Study|Participant's Request|3
6852789|NCT00364611|10860693|FG001|Overall Study|Participant's Request|4
6852790|NCT00364611|10860692|FG000|Overall Study|Disease Progression|38
6852791|NCT00364611|10860693|FG001|Overall Study|Disease Progression|8
6852792|NCT00364611|10860692|FG000|Overall Study|Investigator decision|2
6852793|NCT00364611|10860693|FG001|Overall Study|Investigator decision|2
6852794|NCT00364611|10860692|FG000|Overall Study|Found Ineligible|1
6852795|NCT00364611|10860693|FG001|Overall Study|Found Ineligible|0
6852796|NCT00364611|10860692|FG000|Overall Study|Presumed CR on Study|0
6852797|NCT00364611|10860693|FG001|Overall Study|Presumed CR on Study|1
6852798|NCT00364611|10860692|FG000|Overall Study|Receiving Liver Ablation|0
6852799|NCT00364611|10860693|FG001|Overall Study|Receiving Liver Ablation|1
6852800|NCT00364793|10860703|FG000|Overall Study|Adverse Event|2
6852801|NCT00364793|10860704|FG001|Overall Study|Adverse Event|0
6852802|NCT00364793|10860705|FG002|Overall Study|Adverse Event|0
6852803|NCT00364793|10860706|FG003|Overall Study|Adverse Event|0
6852804|NCT00364793|10860703|FG000|Overall Study|Death|1
6852805|NCT00364793|10860704|FG001|Overall Study|Death|0
6852806|NCT00364793|10860705|FG002|Overall Study|Death|1
6852807|NCT00364793|10860706|FG003|Overall Study|Death|0
6852808|NCT00364793|10860703|FG000|Overall Study|Lack of Efficacy|3
6852809|NCT00364793|10860704|FG001|Overall Study|Lack of Efficacy|3
6852810|NCT00364793|10860705|FG002|Overall Study|Lack of Efficacy|1
6852811|NCT00364793|10860706|FG003|Overall Study|Lack of Efficacy|1
6852812|NCT00364793|10860703|FG000|Overall Study|Lost to Follow-up|1
6852813|NCT00364793|10860704|FG001|Overall Study|Lost to Follow-up|0
6852814|NCT00364793|10860705|FG002|Overall Study|Lost to Follow-up|2
6852815|NCT00364793|10860706|FG003|Overall Study|Lost to Follow-up|0
6852816|NCT00364793|10860703|FG000|Overall Study|Poor or non-compliance|1
6852817|NCT00364793|10860704|FG001|Overall Study|Poor or non-compliance|1
6852818|NCT00364793|10860705|FG002|Overall Study|Poor or non-compliance|0
6852819|NCT00364793|10860706|FG003|Overall Study|Poor or non-compliance|1
6852820|NCT00364793|10860703|FG000|Overall Study|No longer meets criteria|0
6852821|NCT00364793|10860704|FG001|Overall Study|No longer meets criteria|0
6852822|NCT00364793|10860705|FG002|Overall Study|No longer meets criteria|0
6852823|NCT00364793|10860706|FG003|Overall Study|No longer meets criteria|1
6852824|NCT00364793|10860703|FG000|Overall Study|Withdrawal by Subject|0
6852825|NCT00364793|10860704|FG001|Overall Study|Withdrawal by Subject|1
6852826|NCT00364793|10860705|FG002|Overall Study|Withdrawal by Subject|0
6852827|NCT00364793|10860706|FG003|Overall Study|Withdrawal by Subject|0
6852828|NCT00364832|10860732|FG000|Core Period|Early Withdrawals|2
6852829|NCT00364832|10860733|FG001|Core Period|Early Withdrawals|2
6852830|NCT00364832|10860734|FG002|Core Period|Early Withdrawals|1
6852831|NCT00364832|10860735|FG003|Core Period|Early Withdrawals|1
6852832|NCT00364832|10860736|FG004|Core Period|Early Withdrawals|0
6852833|NCT00364832|10860737|FG005|Core Period|Early Withdrawals|0
6852834|NCT00364832|10860738|FG006|Core Period|Early Withdrawals|4
6852835|NCT00364832|10860739|FG007|Core Period|Early Withdrawals|1
6852836|NCT00364832|10860740|FG008|Core Period|Early Withdrawals|0
6852837|NCT00364832|10860741|FG009|Core Period|Early Withdrawals|0
6852838|NCT00364832|10860742|FG010|Core Period|Early Withdrawals|0
6852839|NCT00364832|10860743|FG011|Core Period|Early Withdrawals|0
6852840|NCT00364832|10860732|FG000|Extension Year 1|Early Withdrawals|0
6852841|NCT00364832|10860733|FG001|Extension Year 1|Early Withdrawals|0
6852842|NCT00364832|10860734|FG002|Extension Year 1|Early Withdrawals|0
6852843|NCT00364832|10860735|FG003|Extension Year 1|Early Withdrawals|0
6852844|NCT00364832|10860736|FG004|Extension Year 1|Early Withdrawals|0
6852845|NCT00364832|10860737|FG005|Extension Year 1|Early Withdrawals|0
6852846|NCT00364832|10860738|FG006|Extension Year 1|Early Withdrawals|0
6852847|NCT00364832|10860739|FG007|Extension Year 1|Early Withdrawals|0
6852848|NCT00364832|10860740|FG008|Extension Year 1|Early Withdrawals|0
6852849|NCT00364832|10860741|FG009|Extension Year 1|Early Withdrawals|4
6852850|NCT00364832|10860742|FG010|Extension Year 1|Early Withdrawals|2
6852851|NCT00364832|10860743|FG011|Extension Year 1|Early Withdrawals|10
6852852|NCT00364832|10860732|FG000|Extension Year 2|Early Withdrawals|0
6852853|NCT00364832|10860733|FG001|Extension Year 2|Early Withdrawals|0
6852854|NCT00364832|10860734|FG002|Extension Year 2|Early Withdrawals|0
6852855|NCT00364832|10860735|FG003|Extension Year 2|Early Withdrawals|0
6852856|NCT00364832|10860736|FG004|Extension Year 2|Early Withdrawals|0
6852857|NCT00364832|10860737|FG005|Extension Year 2|Early Withdrawals|0
6852858|NCT00364832|10860738|FG006|Extension Year 2|Early Withdrawals|0
6852859|NCT00364832|10860739|FG007|Extension Year 2|Early Withdrawals|0
6852860|NCT00364832|10860740|FG008|Extension Year 2|Early Withdrawals|0
6852861|NCT00364832|10860741|FG009|Extension Year 2|Early Withdrawals|5
6852862|NCT00364832|10860742|FG010|Extension Year 2|Early Withdrawals|5
6852863|NCT00364832|10860743|FG011|Extension Year 2|Early Withdrawals|3
6852864|NCT00364845|10860762|FG000|Overall Study|Adverse Event|1
6852865|NCT00364845|10860763|FG001|Overall Study|Adverse Event|0
6852866|NCT00364845|10860762|FG000|Overall Study|Withdrawal by Subject|2
6852867|NCT00364845|10860763|FG001|Overall Study|Withdrawal by Subject|1
6852868|NCT00364845|10860762|FG000|Overall Study|Physician Decision|8
6852869|NCT00364845|10860763|FG001|Overall Study|Physician Decision|8
6852870|NCT00364845|10860762|FG000|Overall Study|Lost to Follow-up|0
6852871|NCT00364845|10860763|FG001|Overall Study|Lost to Follow-up|1
6852872|NCT00364845|10860762|FG000|Overall Study|Death|0
6852873|NCT00364845|10860763|FG001|Overall Study|Death|1
6852874|NCT00364858|10860771|FG000|Overall Study|Adverse Event|1
6852875|NCT00364858|10860772|FG001|Overall Study|Adverse Event|5
6852876|NCT00364858|10860771|FG000|Overall Study|Withdrawal by Subject|1
6852877|NCT00364858|10860772|FG001|Overall Study|Withdrawal by Subject|1
6852878|NCT00364858|10860771|FG000|Overall Study|Pregnancy|1
6852879|NCT00364858|10860772|FG001|Overall Study|Pregnancy|1
6852880|NCT00364858|10860771|FG000|Overall Study|Clinical failure|2
6852881|NCT00364858|10860772|FG001|Overall Study|Clinical failure|13
6852882|NCT00364858|10860771|FG000|Overall Study|Discontinuation at baseline|1
6852883|NCT00364858|10860772|FG001|Overall Study|Discontinuation at baseline|0
6852884|NCT00364858|10860771|FG000|Overall Study|Non-compliant|1
6852885|NCT00364858|10860772|FG001|Overall Study|Non-compliant|0
6852886|NCT00364858|10860771|FG000|Overall Study|Return to Q2 regimen|0
6852887|NCT00364858|10860772|FG001|Overall Study|Return to Q2 regimen|1
6852888|NCT00364858|10860771|FG000|Overall Study|Clinical baseline issue|0
6852889|NCT00364858|10860772|FG001|Overall Study|Clinical baseline issue|1
6852890|NCT00364923|10860779|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4
6852891|NCT00364923|10860779|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24
6852892|NCT00365105|10860798|FG000|Overall Study|Protocol Violation|5
6852893|NCT00365105|10860799|FG001|Overall Study|Protocol Violation|8
6852894|NCT00365300|10860832|FG000|Open-label Phase|Adverse Event|4
6852895|NCT00365300|10860833|FG001|Open-label Phase|Adverse Event|0
6852896|NCT00365300|10860832|FG000|Open-label Phase|Failed to Return|1
6852897|NCT00365300|10860833|FG001|Open-label Phase|Failed to Return|0
6852898|NCT00365300|10860832|FG000|Open-label Phase|Physician Decision|1
6852899|NCT00365300|10860833|FG001|Open-label Phase|Physician Decision|0
6852900|NCT00365300|10860832|FG000|Open-label Phase|Noncompliance|9
6852901|NCT00365300|10860833|FG001|Open-label Phase|Noncompliance|0
6852902|NCT00365300|10860832|FG000|Open-label Phase|Parent/Legal Guardian Request|4
6852903|NCT00365300|10860833|FG001|Open-label Phase|Parent/Legal Guardian Request|0
6852904|NCT00365300|10860832|FG000|Open-label Phase|Protocol Violation|1
6852905|NCT00365300|10860833|FG001|Open-label Phase|Protocol Violation|0
6852906|NCT00365300|10860832|FG000|Open-label Phase|Lack of Efficacy|1
6852907|NCT00365300|10860833|FG001|Open-label Phase|Lack of Efficacy|0
6852908|NCT00365300|10860832|FG000|Open-label Phase|Patient skipped open label phase|1
6852909|NCT00365300|10860833|FG001|Open-label Phase|Patient skipped open label phase|0
6852910|NCT00365300|10860832|FG000|Double-blind Phase|Failed to return|1
6852911|NCT00365300|10860833|FG001|Double-blind Phase|Failed to return|0
6852912|NCT00365300|10860832|FG000|Double-blind Phase|Noncompliance|1
6852913|NCT00365300|10860833|FG001|Double-blind Phase|Noncompliance|1
6852914|NCT00365300|10860832|FG000|Double-blind Phase|Withdrawal by Subject|0
6852915|NCT00365300|10860833|FG001|Double-blind Phase|Withdrawal by Subject|1
6852916|NCT00365300|10860832|FG000|Double-blind Phase|Protocol Violation|3
6852917|NCT00365300|10860833|FG001|Double-blind Phase|Protocol Violation|1
6852918|NCT00365300|10860832|FG000|Double-blind Phase|Lack of Efficacy|6
6852919|NCT00365300|10860833|FG001|Double-blind Phase|Lack of Efficacy|6
6852920|NCT00365352|10860845|FG000|Overall Study|Adverse Event|6
6852921|NCT00365352|10860846|FG001|Overall Study|Adverse Event|7
6852922|NCT00365352|10860847|FG002|Overall Study|Adverse Event|8
6852923|NCT00365352|10860845|FG000|Overall Study|Participant Withdrew Consent|8
6852924|NCT00365352|10860846|FG001|Overall Study|Participant Withdrew Consent|3
6852925|NCT00365352|10860847|FG002|Overall Study|Participant Withdrew Consent|4
6852926|NCT00365352|10860845|FG000|Overall Study|Lack of Efficacy|3
6852927|NCT00365352|10860846|FG001|Overall Study|Lack of Efficacy|0
6852928|NCT00365352|10860847|FG002|Overall Study|Lack of Efficacy|0
6852929|NCT00365352|10860845|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
6852930|NCT00365352|10860846|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
6852931|NCT00365352|10860847|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2
6852932|NCT00365352|10860845|FG000|Overall Study|Non-Compliance (after Randomization)|1
6852933|NCT00365352|10860846|FG001|Overall Study|Non-Compliance (after Randomization)|0
6852934|NCT00365352|10860847|FG002|Overall Study|Non-Compliance (after Randomization)|1
6852935|NCT00365352|10860845|FG000|Overall Study|Lost to Follow-up|1
6852936|NCT00365352|10860846|FG001|Overall Study|Lost to Follow-up|1
6852937|NCT00365352|10860847|FG002|Overall Study|Lost to Follow-up|0
6852938|NCT00365352|10860845|FG000|Overall Study|Withdrawal of Participant by Sponsor|1
6852939|NCT00365352|10860846|FG001|Overall Study|Withdrawal of Participant by Sponsor|0
6852940|NCT00365352|10860847|FG002|Overall Study|Withdrawal of Participant by Sponsor|0
6852941|NCT00365365|10860861|FG000|Overall Study|Randomized but not treated|0
6852942|NCT00365365|10860862|FG001|Overall Study|Randomized but not treated|2
6852943|NCT00365365|10860863|FG002|Overall Study|Randomized but not treated|0
6852944|NCT00365365|10860861|FG000|Overall Study|Poor compliance to protocol|0
6852945|NCT00365365|10860862|FG001|Overall Study|Poor compliance to protocol|1
6852946|NCT00365365|10860863|FG002|Overall Study|Poor compliance to protocol|0
6852947|NCT00365365|10860861|FG000|Overall Study|Lost to Follow-up|3
6852948|NCT00365365|10860862|FG001|Overall Study|Lost to Follow-up|3
6852949|NCT00365365|10860863|FG002|Overall Study|Lost to Follow-up|3
6852950|NCT00365365|10860861|FG000|Overall Study|Death|1
6852951|NCT00365365|10860862|FG001|Overall Study|Death|3
6852952|NCT00365365|10860863|FG002|Overall Study|Death|0
6852953|NCT00365365|10860861|FG000|Overall Study|Subject's request|11
6852954|NCT00365365|10860862|FG001|Overall Study|Subject's request|13
6852955|NCT00365365|10860863|FG002|Overall Study|Subject's request|1
6852956|NCT00365365|10860861|FG000|Overall Study|Disease progression/relapse|9
6852957|NCT00365365|10860862|FG001|Overall Study|Disease progression/relapse|6
6852958|NCT00365365|10860863|FG002|Overall Study|Disease progression/relapse|7
6852959|NCT00365365|10860861|FG000|Overall Study|Adverse Event|6
6852960|NCT00365365|10860862|FG001|Overall Study|Adverse Event|6
6852961|NCT00365365|10860863|FG002|Overall Study|Adverse Event|3
6852962|NCT00365365|10860861|FG000|Overall Study|Moved|2
6852963|NCT00365365|10860862|FG001|Overall Study|Moved|0
6852964|NCT00365365|10860863|FG002|Overall Study|Moved|0
6852965|NCT00365365|10860861|FG000|Overall Study|New cancer|1
6852966|NCT00365365|10860862|FG001|Overall Study|New cancer|0
6852967|NCT00365365|10860863|FG002|Overall Study|New cancer|0
6852968|NCT00365365|10860861|FG000|Overall Study|Withdrew consent|1
6852969|NCT00365365|10860862|FG001|Overall Study|Withdrew consent|1
6852970|NCT00365365|10860863|FG002|Overall Study|Withdrew consent|0
6852971|NCT00365365|10860861|FG000|Overall Study|Second malignancy|0
6852972|NCT00365365|10860862|FG001|Overall Study|Second malignancy|1
6852973|NCT00365365|10860863|FG002|Overall Study|Second malignancy|0
6852974|NCT00365365|10860861|FG000|Overall Study|Patient/physician decision|0
6852975|NCT00365365|10860862|FG001|Overall Study|Patient/physician decision|0
6852976|NCT00365365|10860863|FG002|Overall Study|Patient/physician decision|1
6852977|NCT00365378|10860873|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11
6852978|NCT00365378|10860874|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7
6852979|NCT00365378|10860875|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0
6852980|NCT00365378|10860873|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4
6852981|NCT00365378|10860874|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5
6852982|NCT00365378|10860875|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0
6852983|NCT00365378|10860873|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88
6852984|NCT00365378|10860874|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75
6852985|NCT00365378|10860875|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0
6852986|NCT00365378|10860873|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19
7082905|NCT02147158|11193691|FG005|Off-Treatment Interval 1|Lack of Efficacy|0
6852987|NCT00365378|10860874|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14
6852988|NCT00365378|10860875|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0
6852989|NCT00365378|10860873|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22
6852990|NCT00365378|10860874|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13
6852991|NCT00365378|10860875|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0
6852992|NCT00365378|10860873|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50
6852993|NCT00365378|10860874|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44
6852994|NCT00365378|10860875|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0
6852995|NCT00365378|10860873|FG000|Vaccination (Day 1 to Month 7)|Other|17
6852996|NCT00365378|10860874|FG001|Vaccination (Day 1 to Month 7)|Other|9
6852997|NCT00365378|10860875|FG002|Vaccination (Day 1 to Month 7)|Other|0
6852998|NCT00365378|10860873|FG000|Follow-up (Month 7 Though Month 48)|Moved|6
6852999|NCT00365378|10860874|FG001|Follow-up (Month 7 Though Month 48)|Moved|5
7077793|NCT02095691|11185626|FG000|Overall Study|Physician Decision|1
7077794|NCT02095873|11185644|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1
7077795|NCT02095873|11185645|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0
7077796|NCT02095873|11185644|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1
7077797|NCT02095873|11185645|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0
7077798|NCT02095873|11185644|FG000|Second Intervention (8 Weeks)|Protocol Violation|1
7077799|NCT02095873|11185645|FG001|Second Intervention (8 Weeks)|Protocol Violation|0
7077800|NCT02095951|11185655|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9
7077801|NCT02095951|11185656|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6
7077802|NCT02096003|11185668|FG000|Overall Study|Protocol Violation|0
7077803|NCT02096003|11185669|FG001|Overall Study|Protocol Violation|2
7077804|NCT02096003|11185668|FG000|Overall Study|additional surgery|2
6853000|NCT00365378|10860875|FG002|Follow-up (Month 7 Though Month 48)|Moved|0
6853001|NCT00365378|10860873|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67
6853002|NCT00365378|10860874|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69
6853003|NCT00365378|10860875|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0
6853004|NCT00365378|10860873|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0
6853005|NCT00365378|10860874|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1
6853006|NCT00365378|10860875|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0
6853007|NCT00365378|10860873|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1
6853008|NCT00365378|10860874|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2
6853009|NCT00365378|10860875|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0
6853010|NCT00365378|10860873|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73
6853011|NCT00365378|10860874|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104
6853012|NCT00365378|10860875|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0
6966923|NCT01128894|11015236|FG001|Overall Study|Conflicting HbA1c Results at Screening|0
6966924|NCT01128946|11015242|FG000|Period I|Protocol Violation|0
6966925|NCT01128946|11015243|FG001|Period I|Protocol Violation|1
6966926|NCT01128946|11015244|FG002|Period I|Protocol Violation|0
6966927|NCT01128946|11015245|FG003|Period I|Protocol Violation|0
6966928|NCT01128946|11015242|FG000|Period I|Withdrawal by Subject|0
6966929|NCT01128946|11015243|FG001|Period I|Withdrawal by Subject|0
6966930|NCT01128946|11015244|FG002|Period I|Withdrawal by Subject|1
6966931|NCT01128946|11015245|FG003|Period I|Withdrawal by Subject|1
6966932|NCT01128946|11015242|FG000|Period II|Protocol Violation|0
6966933|NCT01128946|11015243|FG001|Period II|Protocol Violation|1
6966934|NCT01128946|11015244|FG002|Period II|Protocol Violation|0
6966935|NCT01128946|11015245|FG003|Period II|Protocol Violation|0
6966936|NCT01128946|11015242|FG000|Period II|Withdrawal by Subject|0
6966937|NCT01128946|11015243|FG001|Period II|Withdrawal by Subject|0
6966938|NCT01128946|11015244|FG002|Period II|Withdrawal by Subject|0
6966939|NCT01128946|11015245|FG003|Period II|Withdrawal by Subject|1
6966940|NCT01128946|11015242|FG000|Period III|Protocol Violation|1
6966941|NCT01128946|11015243|FG001|Period III|Protocol Violation|0
6966942|NCT01128946|11015244|FG002|Period III|Protocol Violation|0
6966943|NCT01128946|11015245|FG003|Period III|Protocol Violation|0
6966944|NCT01128959|11015256|FG000|Lead in Period|Adverse Event|3
6966945|NCT01128959|11015256|FG000|Treatment Period|Adverse Event|3
6966946|NCT01128959|11015256|FG000|Treatment Period|Withdrawal by Subject|1
7077805|NCT02096003|11185669|FG001|Overall Study|additional surgery|1
7077806|NCT02096263|11185705|FG000|Overall Study|Adverse Event|1
7077807|NCT02096263|11185706|FG001|Overall Study|Adverse Event|0
7077808|NCT02096263|11185707|FG002|Overall Study|Adverse Event|1
7077809|NCT02096263|11185705|FG000|Overall Study|Lost to Follow-up|14
7077810|NCT02096263|11185706|FG001|Overall Study|Lost to Follow-up|18
7077811|NCT02096263|11185707|FG002|Overall Study|Lost to Follow-up|15
7077812|NCT02096263|11185705|FG000|Overall Study|Other|7
7077813|NCT02096263|11185706|FG001|Overall Study|Other|9
7077814|NCT02096263|11185707|FG002|Overall Study|Other|6
7077815|NCT02096263|11185705|FG000|Overall Study|Sponsor study termination|0
7077816|NCT02096263|11185706|FG001|Overall Study|Sponsor study termination|0
7077817|NCT02096263|11185707|FG002|Overall Study|Sponsor study termination|1
7077818|NCT02096263|11185705|FG000|Overall Study|Protocol Violation|7
7077819|NCT02096263|11185706|FG001|Overall Study|Protocol Violation|2
7077820|NCT02096263|11185707|FG002|Overall Study|Protocol Violation|8
7077821|NCT02096263|11185705|FG000|Overall Study|Withdrawal by Subject|5
7077822|NCT02096263|11185706|FG001|Overall Study|Withdrawal by Subject|7
6966947|NCT01129024|11015284|FG000|Overall Study|Physician Decision|5
6966948|NCT01129024|11015284|FG000|Overall Study|Study Terminated by Sponsor|8
6966949|NCT01129024|11015284|FG000|Overall Study|Withdrawal by Subject|2
6853013|NCT00365378|10860873|FG000|Follow-up (Month 7 Though Month 48)|Other|11
6853014|NCT00365378|10860874|FG001|Follow-up (Month 7 Though Month 48)|Other|21
6853015|NCT00365378|10860875|FG002|Follow-up (Month 7 Though Month 48)|Other|0
6853016|NCT00365378|10860873|FG000|Extension|Adverse Event|0
6853017|NCT00365378|10860874|FG001|Extension|Adverse Event|0
6853018|NCT00365378|10860875|FG002|Extension|Adverse Event|1
6853019|NCT00365378|10860873|FG000|Extension|Moved|0
6853020|NCT00365378|10860874|FG001|Extension|Moved|0
6853021|NCT00365378|10860875|FG002|Extension|Moved|8
6853022|NCT00365378|10860873|FG000|Extension|Lost to Follow-up|0
6853023|NCT00365378|10860874|FG001|Extension|Lost to Follow-up|0
6853024|NCT00365378|10860875|FG002|Extension|Lost to Follow-up|57
6853025|NCT00365378|10860873|FG000|Extension|Protocol Violation|0
6853026|NCT00365378|10860874|FG001|Extension|Protocol Violation|0
6853027|NCT00365378|10860875|FG002|Extension|Protocol Violation|2
6853028|NCT00365378|10860873|FG000|Extension|Withdrawal by Subject|0
6853029|NCT00365378|10860874|FG001|Extension|Withdrawal by Subject|0
6853030|NCT00365378|10860875|FG002|Extension|Withdrawal by Subject|98
6853031|NCT00365378|10860873|FG000|Extension|Other|0
6853032|NCT00365378|10860874|FG001|Extension|Other|0
6853033|NCT00365378|10860875|FG002|Extension|Other|31
6853034|NCT00365456|10860891|FG000|Trial Period I (12 Months)|Adverse Event|84
6853035|NCT00365456|10860892|FG001|Trial Period I (12 Months)|Adverse Event|0
6853036|NCT00365456|10860891|FG000|Trial Period I (12 Months)|Non-compliance|3
6853037|NCT00365456|10860892|FG001|Trial Period I (12 Months)|Non-compliance|0
6853038|NCT00365456|10860891|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27
6853039|NCT00365456|10860892|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0
6853040|NCT00365456|10860891|FG000|Trial Period I (12 Months)|Other|11
6853041|NCT00365456|10860892|FG001|Trial Period I (12 Months)|Other|0
6853042|NCT00365456|10860891|FG000|Trial Period II (12 Months)|Adverse Event|0
6853043|NCT00365456|10860892|FG001|Trial Period II (12 Months)|Adverse Event|6
6853044|NCT00365456|10860891|FG000|Trial Period II (12 Months)|Non-compliance|0
6853045|NCT00365456|10860892|FG001|Trial Period II (12 Months)|Non-compliance|2
6853046|NCT00365456|10860891|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0
6853047|NCT00365456|10860892|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5
6853048|NCT00365456|10860891|FG000|Trial Period II (12 Months)|Other|0
6853049|NCT00365456|10860892|FG001|Trial Period II (12 Months)|Other|1
6853050|NCT00365456|10860891|FG000|Trial Period III (12 Months)|Adverse Event|13
6853051|NCT00365456|10860892|FG001|Trial Period III (12 Months)|Adverse Event|3
6853052|NCT00365456|10860891|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4
6853053|NCT00365456|10860892|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1
6853054|NCT00365456|10860891|FG000|Trial Period III (12 Months)|Other|1
6853055|NCT00365456|10860892|FG001|Trial Period III (12 Months)|Other|1
6853056|NCT00365508|10860900|FG000|Overall Study|Lost to Follow-up|139
6853057|NCT00365508|10860901|FG001|Overall Study|Lost to Follow-up|154
6853058|NCT00365547|10860907|FG000|Overall Study|Insurance did not cover Avastin|1
6853059|NCT00365547|10860907|FG000|Overall Study|Screen failure|1
6853060|NCT00365547|10860907|FG000|Overall Study|Withdrawal by Subject|1
6853061|NCT00365716|10860923|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1
6853062|NCT00365716|10860924|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2
6853063|NCT00365716|10860925|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
6853064|NCT00365716|10860926|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
6853065|NCT00365716|10860927|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
6853066|NCT00365716|10860928|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
6853067|NCT00365716|10860929|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
6853068|NCT00365716|10860923|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0
6853069|NCT00365716|10860924|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2
6853070|NCT00365716|10860925|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0
6853071|NCT00365716|10860926|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0
6853072|NCT00365716|10860927|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1
6853073|NCT00365716|10860928|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0
6853074|NCT00365716|10860929|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0
6853075|NCT00365716|10860923|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
6853076|NCT00365716|10860924|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
6853077|NCT00365716|10860925|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
6853078|NCT00365716|10860926|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
6853079|NCT00365716|10860927|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
6853080|NCT00365716|10860928|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
6853081|NCT00365716|10860929|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
6853082|NCT00365716|10860923|FG000|Base Study (Day 1 to Month 7)|Other|0
6853083|NCT00365716|10860924|FG001|Base Study (Day 1 to Month 7)|Other|1
6853084|NCT00365716|10860925|FG002|Base Study (Day 1 to Month 7)|Other|0
6853085|NCT00365716|10860926|FG003|Base Study (Day 1 to Month 7)|Other|0
6853086|NCT00365716|10860927|FG004|Base Study (Day 1 to Month 7)|Other|0
6853087|NCT00365716|10860928|FG005|Base Study (Day 1 to Month 7)|Other|0
6853088|NCT00365716|10860929|FG006|Base Study (Day 1 to Month 7)|Other|0
6853089|NCT00365716|10860923|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3
6853090|NCT00365716|10860924|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2
6853091|NCT00365716|10860925|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3
6853092|NCT00365716|10860926|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1
6853093|NCT00365716|10860927|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1
6853094|NCT00365716|10860928|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0
6853095|NCT00365716|10860929|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0
6853096|NCT00365716|10860923|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1
6853097|NCT00365716|10860924|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2
6853098|NCT00365716|10860925|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0
6853099|NCT00365716|10860926|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1
6853100|NCT00365716|10860927|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2
6853101|NCT00365716|10860928|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0
6853102|NCT00365716|10860929|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0
6853103|NCT00365716|10860923|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
6853104|NCT00365716|10860924|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9
6853105|NCT00365716|10860925|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
6853106|NCT00365716|10860926|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4
6853107|NCT00365716|10860927|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3
6853108|NCT00365716|10860928|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
6853109|NCT00365716|10860929|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
6853110|NCT00365716|10860923|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114
6853111|NCT00365716|10860924|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
6853112|NCT00365716|10860925|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
6853113|NCT00365716|10860926|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69
6853114|NCT00365716|10860927|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75
6853115|NCT00365716|10860928|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
6853116|NCT00365716|10860929|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
6853117|NCT00365716|10860923|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6
6853118|NCT00365716|10860924|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8
6853119|NCT00365716|10860925|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5
6853120|NCT00365716|10860926|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4
6853121|NCT00365716|10860927|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3
6853122|NCT00365716|10860928|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
6853123|NCT00365716|10860929|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
6853124|NCT00365716|10860923|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3
6853125|NCT00365716|10860924|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
6853126|NCT00365716|10860925|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1
6853127|NCT00365716|10860926|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
6853128|NCT00365716|10860927|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
6853129|NCT00365716|10860928|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
6853130|NCT00365716|10860929|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
6853131|NCT00365716|10860923|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2
6853132|NCT00365716|10860924|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0
6853133|NCT00365716|10860925|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0
6853134|NCT00365716|10860926|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0
6853135|NCT00365716|10860927|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1
6853136|NCT00365716|10860928|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0
6853137|NCT00365716|10860929|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0
6853138|NCT00365716|10860923|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
6853139|NCT00365716|10860924|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
6853140|NCT00365716|10860925|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
6853141|NCT00365716|10860926|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
6853142|NCT00365716|10860927|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
6853143|NCT00365716|10860928|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
6853144|NCT00365716|10860929|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
6853145|NCT00365716|10860923|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7
6853146|NCT00365716|10860924|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
6853147|NCT00365716|10860925|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13
6853148|NCT00365716|10860926|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
6853149|NCT00365716|10860927|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3
6853150|NCT00365716|10860928|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
6853151|NCT00365716|10860929|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
6853152|NCT00365716|10860923|FG000|Extension 1|Lost to Follow-up|0
6853153|NCT00365716|10860924|FG001|Extension 1|Lost to Follow-up|0
6853154|NCT00365716|10860925|FG002|Extension 1|Lost to Follow-up|0
6853155|NCT00365716|10860926|FG003|Extension 1|Lost to Follow-up|0
6853156|NCT00365716|10860927|FG004|Extension 1|Lost to Follow-up|0
6853157|NCT00365716|10860928|FG005|Extension 1|Lost to Follow-up|1
6853158|NCT00365716|10860929|FG006|Extension 1|Lost to Follow-up|0
6853159|NCT00365716|10860923|FG000|Extension 1|Other|0
6853160|NCT00365716|10860924|FG001|Extension 1|Other|0
6853161|NCT00365716|10860925|FG002|Extension 1|Other|0
6853162|NCT00365716|10860926|FG003|Extension 1|Other|0
6853163|NCT00365716|10860927|FG004|Extension 1|Other|0
6853164|NCT00365716|10860928|FG005|Extension 1|Other|9
7077823|NCT02096263|11185707|FG002|Overall Study|Withdrawal by Subject|8
7077824|NCT02096471|11185728|FG000|Overall Study|Adverse Event|1
6853165|NCT00365716|10860929|FG006|Extension 1|Other|0
6853166|NCT00365716|10860923|FG000|Extension 1|Moved|0
6853167|NCT00365716|10860924|FG001|Extension 1|Moved|0
6853168|NCT00365716|10860925|FG002|Extension 1|Moved|0
6966950|NCT01129024|11015284|FG000|Overall Study|Lack of Efficacy|3
6966951|NCT01129024|11015284|FG000|Overall Study|Needed a Platelet Transfusion|1
6966952|NCT01129102|11015291|FG000|Overall Study|No study drug treatment|2
6966953|NCT01129102|11015292|FG001|Overall Study|No study drug treatment|3
6966954|NCT01129102|11015293|FG002|Overall Study|No study drug treatment|1
6966955|NCT01129102|11015291|FG000|Overall Study|Withdrawal by Subject|2
6966956|NCT01129102|11015292|FG001|Overall Study|Withdrawal by Subject|0
6966957|NCT01129102|11015293|FG002|Overall Study|Withdrawal by Subject|3
6966958|NCT01129102|11015291|FG000|Overall Study|Protocol Violation|0
6966959|NCT01129102|11015292|FG001|Overall Study|Protocol Violation|1
6966960|NCT01129102|11015293|FG002|Overall Study|Protocol Violation|1
6966961|NCT01129102|11015291|FG000|Overall Study|Pregnancy|0
6966962|NCT01129102|11015292|FG001|Overall Study|Pregnancy|0
6966963|NCT01129102|11015293|FG002|Overall Study|Pregnancy|1
6966964|NCT01129102|11015291|FG000|Overall Study|Adverse Event|2
6966965|NCT01129102|11015292|FG001|Overall Study|Adverse Event|2
6966966|NCT01129102|11015293|FG002|Overall Study|Adverse Event|1
6966967|NCT01129102|11015291|FG000|Overall Study|Lost to Follow-up|2
6853169|NCT00365716|10860926|FG003|Extension 1|Moved|0
6853170|NCT00365716|10860927|FG004|Extension 1|Moved|0
6853171|NCT00365716|10860928|FG005|Extension 1|Moved|4
6853172|NCT00365716|10860929|FG006|Extension 1|Moved|0
6853173|NCT00365716|10860923|FG000|Extension 1|Withdrawal by Subject|0
6966968|NCT01129102|11015292|FG001|Overall Study|Lost to Follow-up|0
7040916|NCT01721161|11124124|FG001|Overall Study|Other|1
7040917|NCT01721200|11124133|FG000|Overall Study|Lost to Follow-up|3
6853174|NCT00365716|10860924|FG001|Extension 1|Withdrawal by Subject|0
6853175|NCT00365716|10860925|FG002|Extension 1|Withdrawal by Subject|0
6853176|NCT00365716|10860926|FG003|Extension 1|Withdrawal by Subject|0
6853177|NCT00365716|10860927|FG004|Extension 1|Withdrawal by Subject|0
6853178|NCT00365716|10860928|FG005|Extension 1|Withdrawal by Subject|3
6853179|NCT00365716|10860929|FG006|Extension 1|Withdrawal by Subject|0
6853180|NCT00365716|10860923|FG000|Extension 1|Pregnancy|0
6853181|NCT00365716|10860924|FG001|Extension 1|Pregnancy|0
6853182|NCT00365716|10860925|FG002|Extension 1|Pregnancy|0
6853183|NCT00365716|10860926|FG003|Extension 1|Pregnancy|0
6853184|NCT00365716|10860927|FG004|Extension 1|Pregnancy|0
6853185|NCT00365716|10860928|FG005|Extension 1|Pregnancy|4
6853186|NCT00365716|10860929|FG006|Extension 1|Pregnancy|0
6853187|NCT00365716|10860923|FG000|Extension 1|Protocol Violation|0
6853188|NCT00365716|10860924|FG001|Extension 1|Protocol Violation|0
6853189|NCT00365716|10860925|FG002|Extension 1|Protocol Violation|0
6853190|NCT00365716|10860926|FG003|Extension 1|Protocol Violation|0
6853191|NCT00365716|10860927|FG004|Extension 1|Protocol Violation|0
6853192|NCT00365716|10860928|FG005|Extension 1|Protocol Violation|1
6853193|NCT00365716|10860929|FG006|Extension 1|Protocol Violation|0
6853194|NCT00365716|10860923|FG000|Extension 2|Lost to Follow-up|0
6853195|NCT00365716|10860924|FG001|Extension 2|Lost to Follow-up|0
6853196|NCT00365716|10860925|FG002|Extension 2|Lost to Follow-up|0
6853197|NCT00365716|10860926|FG003|Extension 2|Lost to Follow-up|0
6853198|NCT00365716|10860927|FG004|Extension 2|Lost to Follow-up|0
6853199|NCT00365716|10860928|FG005|Extension 2|Lost to Follow-up|0
6853200|NCT00365716|10860929|FG006|Extension 2|Lost to Follow-up|2
6853201|NCT00365716|10860923|FG000|Extension 2|Other|0
6853202|NCT00365716|10860924|FG001|Extension 2|Other|0
6853203|NCT00365716|10860925|FG002|Extension 2|Other|0
6853204|NCT00365716|10860926|FG003|Extension 2|Other|0
6853205|NCT00365716|10860927|FG004|Extension 2|Other|0
6853206|NCT00365716|10860928|FG005|Extension 2|Other|0
6853207|NCT00365716|10860929|FG006|Extension 2|Other|3
6853208|NCT00365716|10860923|FG000|Extension 2|Withdrawal by Subject|0
6853209|NCT00365716|10860924|FG001|Extension 2|Withdrawal by Subject|0
6853210|NCT00365716|10860925|FG002|Extension 2|Withdrawal by Subject|0
6853211|NCT00365716|10860926|FG003|Extension 2|Withdrawal by Subject|0
6853212|NCT00365716|10860927|FG004|Extension 2|Withdrawal by Subject|0
6853213|NCT00365716|10860928|FG005|Extension 2|Withdrawal by Subject|0
6853214|NCT00365716|10860929|FG006|Extension 2|Withdrawal by Subject|5
6853215|NCT00365794|10860952|FG000|Overall Study|Withdrawal by Subject|2
6853216|NCT00365846|10860957|FG000|Overall Study|Lost to Follow-up|1
6966969|NCT01129102|11015293|FG002|Overall Study|Lost to Follow-up|0
6966970|NCT01129115|11015304|FG000|Overall Study|Adverse Event|1
6966971|NCT01129115|11015305|FG001|Overall Study|Adverse Event|2
7040918|NCT01721200|11124134|FG001|Overall Study|Lost to Follow-up|5
7040919|NCT01721317|11124156|FG000|Overall Study|Study Closed / Terminated|2
6853217|NCT00365976|10860992|FG000|Overall Study|Withdrawal by Subject|1
6853218|NCT00365976|10860993|FG001|Overall Study|Withdrawal by Subject|5
6853219|NCT00365989|10860999|FG000|Overall Study|Withdrawal by Subject|1
6853220|NCT00365989|10860999|FG000|Overall Study|Non-compliance|1
6966972|NCT01129115|11015306|FG002|Overall Study|Adverse Event|3
6966973|NCT01129115|11015307|FG003|Overall Study|Adverse Event|3
6966974|NCT01129115|11015304|FG000|Overall Study|Withdrawal by Subject|1
6966975|NCT01129115|11015305|FG001|Overall Study|Withdrawal by Subject|3
6966976|NCT01129115|11015306|FG002|Overall Study|Withdrawal by Subject|1
6966977|NCT01129115|11015307|FG003|Overall Study|Withdrawal by Subject|4
6966978|NCT01129115|11015304|FG000|Overall Study|Protocol Violation|0
6966979|NCT01129115|11015305|FG001|Overall Study|Protocol Violation|2
6853221|NCT00366249|10861021|FG000|Overall Study|Adverse Event|53
6853222|NCT00366249|10861022|FG001|Overall Study|Adverse Event|28
6853223|NCT00366249|10861021|FG000|Overall Study|Death|0
6853224|NCT00366249|10861022|FG001|Overall Study|Death|1
6853225|NCT00366249|10861021|FG000|Overall Study|Physician Decision|5
6853226|NCT00366249|10861022|FG001|Overall Study|Physician Decision|2
6853227|NCT00366249|10861021|FG000|Overall Study|Lost to Follow-up|2
6853228|NCT00366249|10861022|FG001|Overall Study|Lost to Follow-up|0
6853229|NCT00366249|10861021|FG000|Overall Study|Protocol Violation|1
6853230|NCT00366249|10861022|FG001|Overall Study|Protocol Violation|2
6853231|NCT00366249|10861021|FG000|Overall Study|Withdrawal by Subject|18
6853232|NCT00366249|10861022|FG001|Overall Study|Withdrawal by Subject|4
6853233|NCT00366249|10861021|FG000|Overall Study|Lack of Efficacy|21
6853234|NCT00366249|10861022|FG001|Overall Study|Lack of Efficacy|21
6853235|NCT00366249|10861021|FG000|Overall Study|Most due to osteomylitis status|31
6853236|NCT00366249|10861022|FG001|Overall Study|Most due to osteomylitis status|20
6853237|NCT00366301|10861036|FG000|Overall Study|Lost to Follow-up|4
6853238|NCT00366301|10861037|FG001|Overall Study|Lost to Follow-up|4
6853239|NCT00366301|10861038|FG002|Overall Study|Lost to Follow-up|3
6853240|NCT00366301|10861039|FG003|Overall Study|Lost to Follow-up|7
6853241|NCT00366301|10861036|FG000|Overall Study|Withdrawal by Subject|4
6853242|NCT00366301|10861037|FG001|Overall Study|Withdrawal by Subject|2
6853243|NCT00366301|10861038|FG002|Overall Study|Withdrawal by Subject|1
6853244|NCT00366301|10861039|FG003|Overall Study|Withdrawal by Subject|1
6853245|NCT00366340|10861051|FG000|Infant Series|Protocol Violation|3
6853246|NCT00366340|10861052|FG001|Infant Series|Protocol Violation|4
6853247|NCT00366340|10861051|FG000|Infant Series|Withdrawal by Subject|3
6853248|NCT00366340|10861052|FG001|Infant Series|Withdrawal by Subject|3
6853249|NCT00366340|10861051|FG000|Infant Series|Adverse Event|0
6853250|NCT00366340|10861052|FG001|Infant Series|Adverse Event|2
6853251|NCT00366340|10861051|FG000|Infant Series|Lost to Follow-up|1
6853252|NCT00366340|10861052|FG001|Infant Series|Lost to Follow-up|1
6853253|NCT00366340|10861051|FG000|Infant Series|Failure to return|1
6853254|NCT00366340|10861052|FG001|Infant Series|Failure to return|0
6853255|NCT00366340|10861051|FG000|After the Infant Series|Parent/legal guardian request|1
6853256|NCT00366340|10861052|FG001|After the Infant Series|Parent/legal guardian request|1
6853257|NCT00366340|10861051|FG000|After the Infant Series|Failed to return|0
6853258|NCT00366340|10861052|FG001|After the Infant Series|Failed to return|1
6853259|NCT00366340|10861051|FG000|After the Infant Series|Protocol Violation|2
6853260|NCT00366340|10861052|FG001|After the Infant Series|Protocol Violation|2
6853261|NCT00366340|10861051|FG000|After the Infant Series|Adverse Event|0
6853262|NCT00366340|10861052|FG001|After the Infant Series|Adverse Event|1
6853263|NCT00366340|10861051|FG000|After the Infant Series|Lost to Follow-up|0
6853264|NCT00366340|10861052|FG001|After the Infant Series|Lost to Follow-up|1
6853265|NCT00366340|10861051|FG000|Toddler Dose|Failed to return|1
6853266|NCT00366340|10861052|FG001|Toddler Dose|Failed to return|0
6853267|NCT00366340|10861051|FG000|Toddler Dose|Parent/legal guardian request|0
6853268|NCT00366340|10861052|FG001|Toddler Dose|Parent/legal guardian request|1
6853269|NCT00366444|10861084|FG000|Overall Study|Withdrawal by Subject|1
6853270|NCT00366444|10861085|FG001|Overall Study|Withdrawal by Subject|1
6853271|NCT00366444|10861084|FG000|Overall Study|Lack of Efficacy|0
6853272|NCT00366444|10861085|FG001|Overall Study|Lack of Efficacy|1
6853273|NCT00366457|10861091|FG000|Overall Study|never began study therapy|2
6853274|NCT00366535|10861097|FG000|First Phase: 12 Weeks|Adverse Event|1
6853275|NCT00366535|10861098|FG001|First Phase: 12 Weeks|Adverse Event|3
6853276|NCT00366535|10861097|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2
6853277|NCT00366535|10861098|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5
6853278|NCT00366535|10861097|FG000|Second Phase: 12 Weeks|Adverse Event|1
6853279|NCT00366535|10861098|FG001|Second Phase: 12 Weeks|Adverse Event|1
6853280|NCT00366535|10861097|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2
6853281|NCT00366535|10861098|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2
6853282|NCT00366548|10861114|FG000|Infant Series|Adverse Event|1
6853283|NCT00366548|10861115|FG001|Infant Series|Adverse Event|3
6853284|NCT00366548|10861114|FG000|Infant Series|Protocol Violation|0
6853285|NCT00366548|10861115|FG001|Infant Series|Protocol Violation|1
6853286|NCT00366548|10861114|FG000|Infant Series|Withdrawal by Subject|3
6853287|NCT00366548|10861115|FG001|Infant Series|Withdrawal by Subject|1
6853288|NCT00366548|10861114|FG000|After Infant Series|Withdrawal by Subject|3
6853289|NCT00366548|10861115|FG001|After Infant Series|Withdrawal by Subject|1
6853290|NCT00366548|10861114|FG000|After Infant Series|Adverse Event|2
6853291|NCT00366548|10861115|FG001|After Infant Series|Adverse Event|0
6853292|NCT00366548|10861114|FG000|After Infant Series|Lost to Follow-up|1
6853293|NCT00366548|10861115|FG001|After Infant Series|Lost to Follow-up|0
6853294|NCT00366678|10861152|FG000|Infant Series|Withdrawal by Subject|8
6853295|NCT00366678|10861153|FG001|Infant Series|Withdrawal by Subject|6
6853296|NCT00366678|10861154|FG002|Infant Series|Withdrawal by Subject|0
6853297|NCT00366678|10861152|FG000|Infant Series|Protocol Violation|4
6853298|NCT00366678|10861153|FG001|Infant Series|Protocol Violation|3
6853299|NCT00366678|10861154|FG002|Infant Series|Protocol Violation|0
6853300|NCT00366678|10861152|FG000|Infant Series|Failed to return|1
6853301|NCT00366678|10861153|FG001|Infant Series|Failed to return|1
6853302|NCT00366678|10861154|FG002|Infant Series|Failed to return|0
6853303|NCT00366678|10861152|FG000|Infant Series|Adverse Event|1
6853304|NCT00366678|10861153|FG001|Infant Series|Adverse Event|0
6853305|NCT00366678|10861154|FG002|Infant Series|Adverse Event|0
6853306|NCT00366678|10861152|FG000|After Infant|Withdrawal by Subject|8
6853307|NCT00366678|10861153|FG001|After Infant|Withdrawal by Subject|4
6853308|NCT00366678|10861154|FG002|After Infant|Withdrawal by Subject|0
6853309|NCT00366678|10861152|FG000|After Infant|Lost to Follow-up|2
6853310|NCT00366678|10861153|FG001|After Infant|Lost to Follow-up|1
6853311|NCT00366678|10861154|FG002|After Infant|Lost to Follow-up|0
6853312|NCT00366678|10861152|FG000|After Infant|Failed to return|5
6853313|NCT00366678|10861153|FG001|After Infant|Failed to return|5
6853314|NCT00366678|10861154|FG002|After Infant|Failed to return|0
6853315|NCT00366678|10861152|FG000|After Infant|Adverse Event|1
6853316|NCT00366678|10861153|FG001|After Infant|Adverse Event|0
6853317|NCT00366678|10861154|FG002|After Infant|Adverse Event|0
6853318|NCT00366678|10861152|FG000|After Infant|Protocol Violation|1
6853319|NCT00366678|10861153|FG001|After Infant|Protocol Violation|0
6853320|NCT00366678|10861154|FG002|After Infant|Protocol Violation|0
6853321|NCT00366678|10861152|FG000|Toddler Dose|Protocol Violation|2
6853322|NCT00366678|10861153|FG001|Toddler Dose|Protocol Violation|1
6853323|NCT00366678|10861154|FG002|Toddler Dose|Protocol Violation|0
6853324|NCT00366678|10861152|FG000|Toddler Dose|Failed to return|1
6853325|NCT00366678|10861153|FG001|Toddler Dose|Failed to return|0
6853326|NCT00366678|10861154|FG002|Toddler Dose|Failed to return|0
6853327|NCT00366678|10861152|FG000|Toddler Dose|Withdrawal by Subject|1
6853328|NCT00366678|10861153|FG001|Toddler Dose|Withdrawal by Subject|0
6853329|NCT00366678|10861154|FG002|Toddler Dose|Withdrawal by Subject|0
6853330|NCT00366678|10861152|FG000|Toddler Dose|protocol deviation|1
6853331|NCT00366678|10861153|FG001|Toddler Dose|protocol deviation|0
6853332|NCT00366678|10861154|FG002|Toddler Dose|protocol deviation|0
6853333|NCT00366899|10861201|FG000|Infant Series|Withdrawal by Subject|4
6853334|NCT00366899|10861202|FG001|Infant Series|Withdrawal by Subject|7
6853335|NCT00366899|10861201|FG000|Infant Series|Protocol Violation|2
6853336|NCT00366899|10861202|FG001|Infant Series|Protocol Violation|1
6853337|NCT00366899|10861201|FG000|Infant Series|Failed to return|1
6853338|NCT00366899|10861202|FG001|Infant Series|Failed to return|1
6853339|NCT00366899|10861201|FG000|Infant Series|Lost to Follow-up|0
6853340|NCT00366899|10861202|FG001|Infant Series|Lost to Follow-up|2
6853341|NCT00366899|10861201|FG000|Infant Series|Adverse Event|0
6853342|NCT00366899|10861202|FG001|Infant Series|Adverse Event|1
6853343|NCT00366899|10861201|FG000|Infant Series|Physician Decision|1
6853344|NCT00366899|10861202|FG001|Infant Series|Physician Decision|0
6853345|NCT00366899|10861201|FG000|Infant Series|Randomized but not consented|1
6853346|NCT00366899|10861202|FG001|Infant Series|Randomized but not consented|0
6853347|NCT00366899|10861201|FG000|After Infant Series|Lost to Follow-up|4
6853348|NCT00366899|10861202|FG001|After Infant Series|Lost to Follow-up|3
6853349|NCT00366899|10861201|FG000|After Infant Series|Withdrawal by Subject|1
6853350|NCT00366899|10861202|FG001|After Infant Series|Withdrawal by Subject|4
6853351|NCT00366899|10861201|FG000|After Infant Series|Adverse Event|1
6853352|NCT00366899|10861202|FG001|After Infant Series|Adverse Event|2
6853353|NCT00366899|10861201|FG000|After Infant Series|Protocol Violation|1
6853354|NCT00366899|10861202|FG001|After Infant Series|Protocol Violation|0
6853355|NCT00366899|10861201|FG000|Toddler Dose|Withdrawal by Subject|1
6853356|NCT00366899|10861202|FG001|Toddler Dose|Withdrawal by Subject|1
6853357|NCT00366899|10861201|FG000|Toddler Dose|Protocol Violation|1
6853358|NCT00366899|10861202|FG001|Toddler Dose|Protocol Violation|0
6853359|NCT00367055|10861251|FG000|Overall Study|Adverse Event|6
6853360|NCT00367055|10861252|FG001|Overall Study|Adverse Event|3
6853361|NCT00367055|10861251|FG000|Overall Study|Patient's Willing|3
6853362|NCT00367055|10861252|FG001|Overall Study|Patient's Willing|2
6853363|NCT00367055|10861251|FG000|Overall Study|Lack of Efficacy|1
6853364|NCT00367055|10861252|FG001|Overall Study|Lack of Efficacy|2
6853365|NCT00367055|10861251|FG000|Overall Study|Lost to Follow-up|1
6853366|NCT00367055|10861252|FG001|Overall Study|Lost to Follow-up|1
6853367|NCT00367055|10861251|FG000|Overall Study|Protocol Violation|0
6853368|NCT00367055|10861252|FG001|Overall Study|Protocol Violation|1
6853369|NCT00367055|10861251|FG000|Overall Study|Stopping Criterion Met|0
6853370|NCT00367055|10861252|FG001|Overall Study|Stopping Criterion Met|1
6853371|NCT00367055|10861251|FG000|Overall Study|Participant Living too Far from Hospital|0
6853372|NCT00367055|10861252|FG001|Overall Study|Participant Living too Far from Hospital|1
6853373|NCT00367133|10861261|FG000|2 Years|Death|20
6853374|NCT00367133|10861262|FG001|2 Years|Death|12
6853375|NCT00367133|10861263|FG002|2 Years|Death|12
6853376|NCT00367133|10861261|FG000|2 Years|Dropped|34
6853377|NCT00367133|10861262|FG001|2 Years|Dropped|19
6853378|NCT00367133|10861263|FG002|2 Years|Dropped|33
6853379|NCT00367133|10861261|FG000|2 Years|Missed visit|4
6853380|NCT00367133|10861262|FG001|2 Years|Missed visit|5
6853381|NCT00367133|10861263|FG002|2 Years|Missed visit|4
6853382|NCT00367237|10861273|FG000|Overall Study|Adverse Event|7
6853383|NCT00367237|10861274|FG001|Overall Study|Adverse Event|2
6853384|NCT00367237|10861273|FG000|Overall Study|Lost to Follow-up|1
6853385|NCT00367237|10861274|FG001|Overall Study|Lost to Follow-up|0
6853386|NCT00367237|10861273|FG000|Overall Study|Withdrawal by Subject|0
6853387|NCT00367237|10861274|FG001|Overall Study|Withdrawal by Subject|4
6853388|NCT00367237|10861273|FG000|Overall Study|Protocol Violation|2
6853389|NCT00367237|10861274|FG001|Overall Study|Protocol Violation|5
6853390|NCT00367341|10861282|FG000|Overall Study|Physician Decision|1
6853391|NCT00367341|10861283|FG001|Overall Study|Physician Decision|0
6853392|NCT00367341|10861282|FG000|Overall Study|Protocol Violation|1
6853393|NCT00367341|10861283|FG001|Overall Study|Protocol Violation|0
6853394|NCT00367432|10861302|FG000|First Period (16 Weeks)|Adverse Event|6
6853395|NCT00367432|10861303|FG001|First Period (16 Weeks)|Adverse Event|0
6853396|NCT00367432|10861302|FG000|First Period (16 Weeks)|Lack of Efficacy|24
6853397|NCT00367432|10861303|FG001|First Period (16 Weeks)|Lack of Efficacy|0
6853398|NCT00367432|10861302|FG000|First Period (16 Weeks)|Withdrawal by Subject|6
6853399|NCT00367432|10861303|FG001|First Period (16 Weeks)|Withdrawal by Subject|0
6853400|NCT00367432|10861302|FG000|First Period (16 Weeks)|Other Reason|2
6853401|NCT00367432|10861303|FG001|First Period (16 Weeks)|Other Reason|0
6853402|NCT00367432|10861302|FG000|Second Period (up to 54 Months)|Adverse Event|14
6853403|NCT00367432|10861303|FG001|Second Period (up to 54 Months)|Adverse Event|3
6853404|NCT00367432|10861302|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59
6853405|NCT00367432|10861303|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5
6853406|NCT00367432|10861302|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0
6853407|NCT00367432|10861303|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1
6853408|NCT00367432|10861302|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8
6853409|NCT00367432|10861303|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5
6853410|NCT00367432|10861302|FG000|Second Period (up to 54 Months)|Other Reason|6
6853411|NCT00367432|10861303|FG001|Second Period (up to 54 Months)|Other Reason|2
6853412|NCT00367458|10861309|FG000|First Intervention - 8 Weeks|Adverse Event|2
6853413|NCT00367458|10861310|FG001|First Intervention - 8 Weeks|Adverse Event|0
6853414|NCT00367484|10861316|FG000|Overall Study|Adverse Event|7
6853415|NCT00367484|10861316|FG000|Overall Study|Withdrew informed consent|5
6853416|NCT00367484|10861316|FG000|Overall Study|Travel to USA|1
6853417|NCT00367484|10861316|FG000|Overall Study|Lost to Follow-up|1
6853418|NCT00367484|10861316|FG000|Overall Study|Protocol Violation|1
6853419|NCT00367484|10861316|FG000|Overall Study|The choice of the patient|1
6853420|NCT00367484|10861316|FG000|Overall Study|Lack of Efficacy|1
6853421|NCT00367640|10861329|FG000|Overall Study|Adverse Event|3
6853422|NCT00367640|10861330|FG001|Overall Study|Adverse Event|6
6853423|NCT00367640|10861331|FG002|Overall Study|Adverse Event|8
6853424|NCT00367640|10861332|FG003|Overall Study|Adverse Event|0
6853425|NCT00367640|10861329|FG000|Overall Study|Withdrawal by Subject|8
6853426|NCT00367640|10861330|FG001|Overall Study|Withdrawal by Subject|11
6853427|NCT00367640|10861331|FG002|Overall Study|Withdrawal by Subject|8
6853428|NCT00367640|10861332|FG003|Overall Study|Withdrawal by Subject|6
6853429|NCT00367640|10861329|FG000|Overall Study|Any other reason not above-mentioned|7
6853430|NCT00367640|10861330|FG001|Overall Study|Any other reason not above-mentioned|5
6853431|NCT00367640|10861331|FG002|Overall Study|Any other reason not above-mentioned|3
6853432|NCT00367640|10861332|FG003|Overall Study|Any other reason not above-mentioned|4
6853433|NCT00367744|10861350|FG000|Overall Study|Lost to Follow-up|4
6853434|NCT00367744|10861351|FG001|Overall Study|Lost to Follow-up|5
6853435|NCT00367770|10861358|FG000|Overall Study|Adverse Event|1
6853436|NCT00367770|10861358|FG000|Overall Study|Withdrawal by Subject|1
6853437|NCT00367835|10861364|FG000|Overall Study|Adverse Event|14
6853438|NCT00367835|10861365|FG001|Overall Study|Adverse Event|1
6853439|NCT00367835|10861364|FG000|Overall Study|Protocol Violation|1
6853440|NCT00367835|10861365|FG001|Overall Study|Protocol Violation|7
6853441|NCT00367835|10861364|FG000|Overall Study|Withdrawal by Subject|7
6853442|NCT00367835|10861365|FG001|Overall Study|Withdrawal by Subject|6
6853443|NCT00367835|10861364|FG000|Overall Study|Lost to Follow-up|1
6853444|NCT00367835|10861365|FG001|Overall Study|Lost to Follow-up|4
6853445|NCT00367835|10861364|FG000|Overall Study|Lack of Efficacy|3
6853446|NCT00367835|10861365|FG001|Overall Study|Lack of Efficacy|12
6853447|NCT00367835|10861364|FG000|Overall Study|Subject in juvenile detention center|1
6853448|NCT00367835|10861365|FG001|Overall Study|Subject in juvenile detention center|0
6853449|NCT00367835|10861364|FG000|Overall Study|refused blood collection|1
6853450|NCT00367835|10861365|FG001|Overall Study|refused blood collection|0
6853451|NCT00367835|10861364|FG000|Overall Study|Did not respond to calls|1
6853452|NCT00367835|10861365|FG001|Overall Study|Did not respond to calls|0
6853453|NCT00367835|10861364|FG000|Overall Study|History of lead poisoning|0
6853454|NCT00367835|10861365|FG001|Overall Study|History of lead poisoning|1
6853455|NCT00367991|10861373|FG000|Overall Study|Withdrawal by Subject|1
6853456|NCT00367991|10861374|FG001|Overall Study|Withdrawal by Subject|1
6853457|NCT00367991|10861373|FG000|Overall Study|Adverse Event|1
6853458|NCT00367991|10861374|FG001|Overall Study|Adverse Event|1
6853459|NCT00368069|10861382|FG000|Overall Study|Adverse Event|5
6853460|NCT00368069|10861383|FG001|Overall Study|Adverse Event|2
6853461|NCT00368069|10861382|FG000|Overall Study|Lack of Efficacy|0
6853462|NCT00368069|10861383|FG001|Overall Study|Lack of Efficacy|1
6853463|NCT00368069|10861382|FG000|Overall Study|Lost to Follow-up|1
6853464|NCT00368069|10861383|FG001|Overall Study|Lost to Follow-up|0
7040920|NCT01721317|11124157|FG001|Overall Study|Study Closed / Terminated|2
6853465|NCT00368069|10861382|FG000|Overall Study|Protocol Violation|0
6853466|NCT00368069|10861383|FG001|Overall Study|Protocol Violation|2
6853467|NCT00368069|10861382|FG000|Overall Study|Withdrawal of Consent|2
6853468|NCT00368069|10861383|FG001|Overall Study|Withdrawal of Consent|1
6853469|NCT00368069|10861382|FG000|Overall Study|no blood sampling possible|0
6853470|NCT00368069|10861383|FG001|Overall Study|no blood sampling possible|1
6853471|NCT00368108|10861392|FG000|Overall Study|Adverse Event|38
6853472|NCT00368108|10861393|FG001|Overall Study|Adverse Event|26
6853473|NCT00368108|10861394|FG002|Overall Study|Adverse Event|44
6853474|NCT00368108|10861392|FG000|Overall Study|Abnormal Laboratory Value|0
6853475|NCT00368108|10861393|FG001|Overall Study|Abnormal Laboratory Value|0
6853476|NCT00368108|10861394|FG002|Overall Study|Abnormal Laboratory Value|3
6853477|NCT00368108|10861392|FG000|Overall Study|Protocol Violation|5
6853478|NCT00368108|10861393|FG001|Overall Study|Protocol Violation|9
6853479|NCT00368108|10861394|FG002|Overall Study|Protocol Violation|9
6853480|NCT00368108|10861392|FG000|Overall Study|Withdrawal by Subject|9
6853481|NCT00368108|10861393|FG001|Overall Study|Withdrawal by Subject|3
6853482|NCT00368108|10861394|FG002|Overall Study|Withdrawal by Subject|5
6853483|NCT00368108|10861392|FG000|Overall Study|Lack of Efficacy|7
6853484|NCT00368108|10861393|FG001|Overall Study|Lack of Efficacy|8
7040921|NCT01721317|11124156|FG000|Overall Study|Physician Decision|0
7040922|NCT01721317|11124157|FG001|Overall Study|Physician Decision|1
6853485|NCT00368108|10861394|FG002|Overall Study|Lack of Efficacy|5
6853486|NCT00368108|10861392|FG000|Overall Study|Physician Decision|2
6853487|NCT00368108|10861393|FG001|Overall Study|Physician Decision|0
6853488|NCT00368108|10861394|FG002|Overall Study|Physician Decision|1
6853489|NCT00368108|10861392|FG000|Overall Study|Other|3
6853490|NCT00368108|10861393|FG001|Overall Study|Other|7
6853491|NCT00368108|10861394|FG002|Overall Study|Other|1
6853492|NCT00368251|10861405|FG000|Overall Study|SAE, non-fatal|1
6853493|NCT00368251|10861406|FG001|Overall Study|SAE, non-fatal|0
6853494|NCT00368251|10861407|FG002|Overall Study|SAE, non-fatal|0
6853495|NCT00368251|10861405|FG000|Overall Study|AE, non-serious non-fatal|0
6853496|NCT00368251|10861406|FG001|Overall Study|AE, non-serious non-fatal|0
6853497|NCT00368251|10861407|FG002|Overall Study|AE, non-serious non-fatal|1
6853498|NCT00368277|10861417|FG000|Overall Study|Adverse Event|33
6853499|NCT00368277|10861418|FG001|Overall Study|Adverse Event|49
6853500|NCT00368277|10861417|FG000|Overall Study|Death|2
6853501|NCT00368277|10861418|FG001|Overall Study|Death|1
6853502|NCT00368277|10861417|FG000|Overall Study|Unsatisfactory therapeutic effect|31
6853503|NCT00368277|10861418|FG001|Overall Study|Unsatisfactory therapeutic effect|24
6853504|NCT00368277|10861417|FG000|Overall Study|Protocol deviation|7
6853505|NCT00368277|10861418|FG001|Overall Study|Protocol deviation|0
6853506|NCT00368277|10861417|FG000|Overall Study|Patient withdrew consent|32
6853507|NCT00368277|10861418|FG001|Overall Study|Patient withdrew consent|28
6853508|NCT00368277|10861417|FG000|Overall Study|Lost to Follow-up|8
6853509|NCT00368277|10861418|FG001|Overall Study|Lost to Follow-up|6
6853510|NCT00368355|10861444|FG000|Overall Study|Adverse Event|1
6853511|NCT00368355|10861445|FG001|Overall Study|Adverse Event|0
6853512|NCT00368355|10861444|FG000|Overall Study|Death|2
6853513|NCT00368355|10861445|FG001|Overall Study|Death|4
6853514|NCT00368355|10861444|FG000|Overall Study|Relapse|6
6853515|NCT00368355|10861445|FG001|Overall Study|Relapse|10
6853516|NCT00368355|10861444|FG000|Overall Study|Subsequent transplant|0
6853517|NCT00368355|10861445|FG001|Overall Study|Subsequent transplant|3
6853518|NCT00368355|10861444|FG000|Overall Study|Treatment - hematopoietic cell product|2
6853519|NCT00368355|10861445|FG001|Overall Study|Treatment - hematopoietic cell product|0
6853520|NCT00368472|10861460|FG000|Overall Study|Adverse Event|22
6853521|NCT00368472|10861460|FG000|Overall Study|Medication non-compliance|4
6853522|NCT00368472|10861460|FG000|Overall Study|Protocol Violation|2
6853523|NCT00368472|10861460|FG000|Overall Study|Request of Investigator or Sponsor|3
6853524|NCT00368472|10861460|FG000|Overall Study|Withdrawal by Subject|40
6853525|NCT00368472|10861460|FG000|Overall Study|Diary non-compliance|1
6853526|NCT00368472|10861460|FG000|Overall Study|Other|32
6853527|NCT00368472|10861460|FG000|Overall Study|Missing Final Disposition Date|1
6853528|NCT00368537|10861466|FG000|Randomization|No study drug dosed|13
6853529|NCT00368537|10861467|FG001|Randomization|No study drug dosed|6
6853530|NCT00368537|10861466|FG000|Baseline Participants|Lost to Follow-up|16
6853531|NCT00368537|10861467|FG001|Baseline Participants|Lost to Follow-up|17
6853532|NCT00368537|10861466|FG000|Baseline Participants|Withdrawal by Subject|6
6853533|NCT00368537|10861467|FG001|Baseline Participants|Withdrawal by Subject|4
6853534|NCT00368537|10861466|FG000|Baseline Participants|Death|1
6853535|NCT00368537|10861467|FG001|Baseline Participants|Death|2
6853536|NCT00368537|10861466|FG000|Baseline Participants|No susceptibility|1
6853537|NCT00368537|10861467|FG001|Baseline Participants|No susceptibility|0
6853538|NCT00368537|10861466|FG000|Baseline Participants|Patient uncompliant|0
6853539|NCT00368537|10861467|FG001|Baseline Participants|Patient uncompliant|1
6853540|NCT00368550|10861475|FG000|Overall Study|Adverse Event|7
6853541|NCT00368550|10861476|FG001|Overall Study|Adverse Event|4
6853542|NCT00368550|10861475|FG000|Overall Study|Lack of Efficacy|4
6853543|NCT00368550|10861476|FG001|Overall Study|Lack of Efficacy|9
6853544|NCT00368550|10861475|FG000|Overall Study|Withdrawal by Subject|17
6853545|NCT00368550|10861476|FG001|Overall Study|Withdrawal by Subject|10
6853546|NCT00368641|10861484|FG000|Overall Study|Adverse Event|2
6853547|NCT00368641|10861485|FG001|Overall Study|Adverse Event|1
6853548|NCT00368641|10861484|FG000|Overall Study|Death|1
6853549|NCT00368641|10861485|FG001|Overall Study|Death|0
6853550|NCT00368641|10861484|FG000|Overall Study|Withdrawal by Subject|1
6853551|NCT00368641|10861485|FG001|Overall Study|Withdrawal by Subject|0
6853552|NCT00368641|10861484|FG000|Overall Study|Sponsor decision to terminate study|2
6853553|NCT00368641|10861485|FG001|Overall Study|Sponsor decision to terminate study|5
6853554|NCT00368745|10861493|FG000|Double-blind Treatment Period|Adverse Event|6
6853555|NCT00368745|10861494|FG001|Double-blind Treatment Period|Adverse Event|6
6853556|NCT00368745|10861493|FG000|Double-blind Treatment Period|Lack of Efficacy|7
6853557|NCT00368745|10861494|FG001|Double-blind Treatment Period|Lack of Efficacy|16
6853558|NCT00368745|10861493|FG000|Double-blind Treatment Period|Lost to Follow-up|1
6853559|NCT00368745|10861494|FG001|Double-blind Treatment Period|Lost to Follow-up|0
6853560|NCT00368745|10861493|FG000|Double-blind Treatment Period|Withdrawal by Subject|5
6853561|NCT00368745|10861494|FG001|Double-blind Treatment Period|Withdrawal by Subject|3
6853562|NCT00368745|10861493|FG000|Double-blind Treatment Period|Other|7
6853563|NCT00368745|10861494|FG001|Double-blind Treatment Period|Other|6
6853564|NCT00368849|10861500|FG000|Overall Study|Withdrawal by Subject|0
6853565|NCT00368849|10861501|FG001|Overall Study|Withdrawal by Subject|1
6853566|NCT00368849|10861500|FG000|Overall Study|Physician Decision|0
6853567|NCT00368849|10861501|FG001|Overall Study|Physician Decision|1
6853568|NCT00368875|10861508|FG000|Overall Study|Adverse Event|0
6853569|NCT00368875|10861509|FG001|Overall Study|Adverse Event|12
6853570|NCT00368875|10861508|FG000|Overall Study|Progressive disease|3
6853571|NCT00368875|10861509|FG001|Overall Study|Progressive disease|27
6853572|NCT00368875|10861508|FG000|Overall Study|Withdrawal by Subject|2
6853573|NCT00368875|10861509|FG001|Overall Study|Withdrawal by Subject|6
6853574|NCT00368875|10861508|FG000|Overall Study|Other Reason|0
6853575|NCT00368875|10861509|FG001|Overall Study|Other Reason|2
6853576|NCT00368875|10861508|FG000|Overall Study|Alternative Therapy|1
6853577|NCT00368875|10861509|FG001|Overall Study|Alternative Therapy|1
6853578|NCT00368927|10861517|FG000|Overall Study|Lost to Follow-up|2
6853579|NCT00368927|10861518|FG001|Overall Study|Lost to Follow-up|0
6853580|NCT00368927|10861517|FG000|Overall Study|Adverse Event|1
6853581|NCT00368927|10861518|FG001|Overall Study|Adverse Event|1
6853582|NCT00368927|10861517|FG000|Overall Study|Withdrawal by Subject|1
6853583|NCT00368927|10861518|FG001|Overall Study|Withdrawal by Subject|2
6853584|NCT00368927|10861517|FG000|Overall Study|Physician Decision|1
6853585|NCT00368927|10861518|FG001|Overall Study|Physician Decision|0
6853586|NCT00368966|10861536|FG000|Infant Series|Withdrawal by Subject|11
6853587|NCT00368966|10861537|FG001|Infant Series|Withdrawal by Subject|6
6853588|NCT00368966|10861536|FG000|Infant Series|Protocol Violation|2
6853589|NCT00368966|10861537|FG001|Infant Series|Protocol Violation|1
6853590|NCT00368966|10861536|FG000|Infant Series|Lost to Follow-up|2
6853591|NCT00368966|10861537|FG001|Infant Series|Lost to Follow-up|0
6853592|NCT00368966|10861536|FG000|Infant Series|Randomization error|0
6853593|NCT00368966|10861537|FG001|Infant Series|Randomization error|1
6853594|NCT00368966|10861536|FG000|Infant Series|Failed to meet eligibility criteria|0
6853595|NCT00368966|10861537|FG001|Infant Series|Failed to meet eligibility criteria|1
6853596|NCT00368966|10861536|FG000|Infant Series|Adverse Event|0
6853597|NCT00368966|10861537|FG001|Infant Series|Adverse Event|1
6853598|NCT00368966|10861536|FG000|Infant Series|Failed to return|1
6853599|NCT00368966|10861537|FG001|Infant Series|Failed to return|0
6853600|NCT00368966|10861536|FG000|After Infant|Failed to return|3
6853601|NCT00368966|10861537|FG001|After Infant|Failed to return|1
6853602|NCT00368966|10861536|FG000|After Infant|Adverse Event|1
6853603|NCT00368966|10861537|FG001|After Infant|Adverse Event|2
6853604|NCT00368966|10861536|FG000|After Infant|Withdrawal by Subject|1
6853605|NCT00368966|10861537|FG001|After Infant|Withdrawal by Subject|1
6853606|NCT00368966|10861536|FG000|After Infant|Death|1
6853607|NCT00368966|10861537|FG001|After Infant|Death|0
6853608|NCT00368966|10861536|FG000|After Infant|Lost to Follow-up|0
6853609|NCT00368966|10861537|FG001|After Infant|Lost to Follow-up|1
6853610|NCT00368966|10861536|FG000|Toddler Dose|Withdrawal by Subject|1
6853611|NCT00368966|10861537|FG001|Toddler Dose|Withdrawal by Subject|1
6853612|NCT00368966|10861536|FG000|Toddler Dose|Lost to Follow-up|0
6853613|NCT00368966|10861537|FG001|Toddler Dose|Lost to Follow-up|2
6853614|NCT00368979|10861570|FG000|Overall Study|Adverse Event|9
6853615|NCT00368979|10861571|FG001|Overall Study|Adverse Event|16
6853616|NCT00368979|10861570|FG000|Overall Study|Lack of Efficacy|5
6853617|NCT00368979|10861571|FG001|Overall Study|Lack of Efficacy|3
6853618|NCT00368979|10861570|FG000|Overall Study|Other|3
6853619|NCT00368979|10861571|FG001|Overall Study|Other|1
6853620|NCT00368979|10861570|FG000|Overall Study|Lost to Follow-up|1
6853621|NCT00368979|10861571|FG001|Overall Study|Lost to Follow-up|0
6853622|NCT00368979|10861570|FG000|Overall Study|Protocol Violation|2
6853623|NCT00368979|10861571|FG001|Overall Study|Protocol Violation|1
6853624|NCT00368979|10861570|FG000|Overall Study|Withdrawal by Subject|5
6853625|NCT00368979|10861571|FG001|Overall Study|Withdrawal by Subject|9
6853626|NCT00368992|10861577|FG000|Overall Study|Ineligible|5
6853627|NCT00368992|10861577|FG000|Overall Study|Refused treatment|3
6853628|NCT00368992|10861577|FG000|Overall Study|Lack of Efficacy|63
6853629|NCT00368992|10861577|FG000|Overall Study|Adverse Event|26
6853630|NCT00368992|10861577|FG000|Overall Study|Death|4
6853631|NCT00368992|10861577|FG000|Overall Study|Other|9
6853632|NCT00369122|10861582|FG000|Overall Study|Ineligible|10
6853633|NCT00369122|10861582|FG000|Overall Study|No protocol treatment|1
6853634|NCT00369161|10861588|FG000|Overall Study|Adverse Event|15
6853635|NCT00369161|10861589|FG001|Overall Study|Adverse Event|13
6853636|NCT00369161|10861588|FG000|Overall Study|Abnormal laboratory value|0
6853637|NCT00369161|10861589|FG001|Overall Study|Abnormal laboratory value|1
6853638|NCT00369161|10861588|FG000|Overall Study|Lack of Efficacy|3
6853639|NCT00369161|10861589|FG001|Overall Study|Lack of Efficacy|1
6853640|NCT00369161|10861588|FG000|Overall Study|Protocol Violation|0
6853641|NCT00369161|10861589|FG001|Overall Study|Protocol Violation|2
6853642|NCT00369161|10861588|FG000|Overall Study|Withdrawal by Subject|2
6853643|NCT00369161|10861589|FG001|Overall Study|Withdrawal by Subject|3
6853644|NCT00369161|10861588|FG000|Overall Study|Death|1
6853645|NCT00369161|10861589|FG001|Overall Study|Death|2
6853646|NCT00369161|10861588|FG000|Overall Study|Graft loss|4
6853647|NCT00369161|10861589|FG001|Overall Study|Graft loss|0
6853648|NCT00369161|10861588|FG000|Overall Study|Administrative Problem|2
6853649|NCT00369161|10861589|FG001|Overall Study|Administrative Problem|2
6853650|NCT00369278|10861609|FG000|Overall Study|Adverse Event|14
6853651|NCT00369278|10861610|FG001|Overall Study|Adverse Event|11
6853652|NCT00369278|10861609|FG000|Overall Study|Unsatisfactory therapeutic effect|4
6853653|NCT00369278|10861610|FG001|Overall Study|Unsatisfactory therapeutic effect|5
6853654|NCT00369278|10861609|FG000|Overall Study|Protocol Violation|2
6853655|NCT00369278|10861610|FG001|Overall Study|Protocol Violation|1
6853656|NCT00369278|10861609|FG000|Overall Study|Withdrawal by Subject|2
6853657|NCT00369278|10861610|FG001|Overall Study|Withdrawal by Subject|2
6853658|NCT00369278|10861609|FG000|Overall Study|Lost to Follow-up|1
6853659|NCT00369278|10861610|FG001|Overall Study|Lost to Follow-up|0
6853660|NCT00369278|10861609|FG000|Overall Study|Graft loss|1
6853661|NCT00369278|10861610|FG001|Overall Study|Graft loss|2
6853662|NCT00369343|10861618|FG000|Double-blind Phase|Adverse Event|19
6853663|NCT00369343|10861619|FG001|Double-blind Phase|Adverse Event|4
6853664|NCT00369343|10861618|FG000|Double-blind Phase|Failed to return|2
6853665|NCT00369343|10861619|FG001|Double-blind Phase|Failed to return|0
6853666|NCT00369343|10861618|FG000|Double-blind Phase|Lost to Follow-up|9
6853667|NCT00369343|10861619|FG001|Double-blind Phase|Lost to Follow-up|2
6853668|NCT00369343|10861618|FG000|Double-blind Phase|Protocol Violation|2
6853669|NCT00369343|10861619|FG001|Double-blind Phase|Protocol Violation|0
6853670|NCT00369343|10861618|FG000|Double-blind Phase|Withdrawal by Subject|8
6853671|NCT00369343|10861619|FG001|Double-blind Phase|Withdrawal by Subject|6
6853672|NCT00369343|10861618|FG000|Double-blind Phase|Lack of Efficacy|0
6853673|NCT00369343|10861619|FG001|Double-blind Phase|Lack of Efficacy|4
6853674|NCT00369343|10861618|FG000|Double-blind Phase|Protocol deviation|4
6853675|NCT00369343|10861619|FG001|Double-blind Phase|Protocol deviation|0
6853676|NCT00369343|10861618|FG000|Open-label Phase|Adverse Event|19
6853677|NCT00369343|10861619|FG001|Open-label Phase|Adverse Event|7
6853678|NCT00369343|10861618|FG000|Open-label Phase|Failed to return|4
6853679|NCT00369343|10861619|FG001|Open-label Phase|Failed to return|0
6853680|NCT00369343|10861618|FG000|Open-label Phase|Physician Decision|2
6853681|NCT00369343|10861619|FG001|Open-label Phase|Physician Decision|0
6853682|NCT00369343|10861618|FG000|Open-label Phase|Lost to Follow-up|5
6853683|NCT00369343|10861619|FG001|Open-label Phase|Lost to Follow-up|3
6853684|NCT00369343|10861618|FG000|Open-label Phase|inadvertently reported study completers|3
6853685|NCT00369343|10861619|FG001|Open-label Phase|inadvertently reported study completers|2
6853686|NCT00369343|10861618|FG000|Open-label Phase|Protocol Violation|1
6853687|NCT00369343|10861619|FG001|Open-label Phase|Protocol Violation|3
6853688|NCT00369343|10861618|FG000|Open-label Phase|Withdrawal by Subject|15
6853689|NCT00369343|10861619|FG001|Open-label Phase|Withdrawal by Subject|6
6853690|NCT00369343|10861618|FG000|Open-label Phase|Lack of Efficacy|4
6853691|NCT00369343|10861619|FG001|Open-label Phase|Lack of Efficacy|3
6853692|NCT00369343|10861618|FG000|Open-label Phase|Lack of continuance tolerability|3
6853693|NCT00369343|10861619|FG001|Open-label Phase|Lack of continuance tolerability|4
6853694|NCT00369343|10861618|FG000|Open-label Phase|did not take study drug|1
6853695|NCT00369343|10861619|FG001|Open-label Phase|did not take study drug|2
6853696|NCT00369382|10861634|FG000|Overall Study|Death|0
6853697|NCT00369382|10861635|FG001|Overall Study|Death|2
6853698|NCT00369382|10861634|FG000|Overall Study|Physician Decision|2
6853699|NCT00369382|10861635|FG001|Overall Study|Physician Decision|1
6853700|NCT00369382|10861634|FG000|Overall Study|Withdrawal by Subject|5
6853701|NCT00369382|10861635|FG001|Overall Study|Withdrawal by Subject|0
6853702|NCT00369382|10861634|FG000|Overall Study|Randomized, not treated|2
6853703|NCT00369382|10861635|FG001|Overall Study|Randomized, not treated|0
6853704|NCT00369382|10861634|FG000|Overall Study|Other|1
6853705|NCT00369382|10861635|FG001|Overall Study|Other|0
6853706|NCT00369486|10861647|FG000|4-Week Visit|Missed visit|2
6853707|NCT00369486|10861648|FG001|4-Week Visit|Missed visit|2
6853708|NCT00369486|10861649|FG002|4-Week Visit|Missed visit|0
6853709|NCT00369486|10861650|FG003|4-Week Visit|Missed visit|2
6853710|NCT00369486|10861651|FG004|4-Week Visit|Missed visit|1
6853711|NCT00369486|10861647|FG000|4-Week Visit|Dropped|0
6853712|NCT00369486|10861648|FG001|4-Week Visit|Dropped|0
6853713|NCT00369486|10861649|FG002|4-Week Visit|Dropped|1
6853714|NCT00369486|10861650|FG003|4-Week Visit|Dropped|0
6853715|NCT00369486|10861651|FG004|4-Week Visit|Dropped|0
6853716|NCT00369486|10861647|FG000|8-Week Visit|Missed visit|0
6853717|NCT00369486|10861648|FG001|8-Week Visit|Missed visit|1
6853718|NCT00369486|10861649|FG002|8-Week Visit|Missed visit|0
6853719|NCT00369486|10861650|FG003|8-Week Visit|Missed visit|0
6853720|NCT00369486|10861651|FG004|8-Week Visit|Missed visit|1
6853721|NCT00369486|10861647|FG000|8-Week Visit|Dropped|0
6853722|NCT00369486|10861648|FG001|8-Week Visit|Dropped|0
6853723|NCT00369486|10861649|FG002|8-Week Visit|Dropped|0
6853724|NCT00369486|10861650|FG003|8-Week Visit|Dropped|1
6853725|NCT00369486|10861651|FG004|8-Week Visit|Dropped|0
6853726|NCT00369486|10861647|FG000|17-Week Visit|Missed visit|0
6853727|NCT00369486|10861648|FG001|17-Week Visit|Missed visit|0
6853728|NCT00369486|10861649|FG002|17-Week Visit|Missed visit|1
6853729|NCT00369486|10861650|FG003|17-Week Visit|Missed visit|1
6853730|NCT00369486|10861651|FG004|17-Week Visit|Missed visit|1
6853731|NCT00369486|10861647|FG000|34-Week Visit|Dropped|0
6853732|NCT00369486|10861648|FG001|34-Week Visit|Dropped|1
6853733|NCT00369486|10861649|FG002|34-Week Visit|Dropped|1
6853734|NCT00369486|10861650|FG003|34-Week Visit|Dropped|3
6853735|NCT00369486|10861651|FG004|34-Week Visit|Dropped|3
6853736|NCT00369577|10861683|FG000|Overall Study|Withdrawal by Subject|0
6853737|NCT00369577|10861684|FG001|Overall Study|Withdrawal by Subject|0
6853738|NCT00369577|10861685|FG002|Overall Study|Withdrawal by Subject|1
6853739|NCT00369629|10861701|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0
6853740|NCT00369629|10861702|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1
6853741|NCT00369629|10861703|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1
6853742|NCT00369629|10861704|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0
6853743|NCT00369629|10861701|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0
6853744|NCT00369629|10861702|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0
6853745|NCT00369629|10861703|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1
6853746|NCT00369629|10861704|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0
6853747|NCT00369629|10861701|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2
6853748|NCT00369629|10861702|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0
6853749|NCT00369629|10861703|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0
6853750|NCT00369629|10861704|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0
6853751|NCT00369629|10861701|FG000|Moved on to 4 More Cycles|Progressive Disease|0
6853752|NCT00369629|10861702|FG001|Moved on to 4 More Cycles|Progressive Disease|0
6853753|NCT00369629|10861703|FG002|Moved on to 4 More Cycles|Progressive Disease|1
6853754|NCT00369629|10861704|FG003|Moved on to 4 More Cycles|Progressive Disease|0
6853755|NCT00369629|10861701|FG000|Completed 4 More Cycles|Withdrawal by Subject|2
6853756|NCT00369629|10861702|FG001|Completed 4 More Cycles|Withdrawal by Subject|1
6853757|NCT00369629|10861703|FG002|Completed 4 More Cycles|Withdrawal by Subject|0
6853758|NCT00369629|10861704|FG003|Completed 4 More Cycles|Withdrawal by Subject|0
6853759|NCT00369629|10861701|FG000|Completed 4 More Cycles|Progressive disease|2
6853760|NCT00369629|10861702|FG001|Completed 4 More Cycles|Progressive disease|1
6853761|NCT00369629|10861703|FG002|Completed 4 More Cycles|Progressive disease|2
6853762|NCT00369629|10861704|FG003|Completed 4 More Cycles|Progressive disease|0
6853763|NCT00369629|10861701|FG000|Follow up for 1 Year|Death|2
6853764|NCT00369629|10861702|FG001|Follow up for 1 Year|Death|1
6853765|NCT00369629|10861703|FG002|Follow up for 1 Year|Death|1
6853766|NCT00369629|10861704|FG003|Follow up for 1 Year|Death|0
6853767|NCT00369629|10861701|FG000|Follow up for 1 Year|Lost to Follow-up|0
6853768|NCT00369629|10861702|FG001|Follow up for 1 Year|Lost to Follow-up|1
6853769|NCT00369629|10861703|FG002|Follow up for 1 Year|Lost to Follow-up|0
6853770|NCT00369629|10861704|FG003|Follow up for 1 Year|Lost to Follow-up|0
6853771|NCT00369629|10861701|FG000|Follow up for 1 Year|stopped being followed as study closed|0
6853772|NCT00369629|10861702|FG001|Follow up for 1 Year|stopped being followed as study closed|0
6853773|NCT00369629|10861703|FG002|Follow up for 1 Year|stopped being followed as study closed|2
6853774|NCT00369629|10861704|FG003|Follow up for 1 Year|stopped being followed as study closed|0
6853775|NCT00369655|10861714|FG000|Overall Study|Refusal of further treatment|2
6853776|NCT00369668|10861721|FG000|Overall Study|Lack of Efficacy|4
6853777|NCT00369668|10861722|FG001|Overall Study|Lack of Efficacy|5
6853778|NCT00369668|10861723|FG002|Overall Study|Lack of Efficacy|7
6853779|NCT00369681|10861734|FG000|Overall Study|Death|1
6853780|NCT00369707|10861738|FG000|Induction Part B (2 Cycles)|Adverse Event|3
6853781|NCT00369707|10861738|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2
6853782|NCT00369707|10861738|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1
6853783|NCT00369707|10861738|FG000|Induction Part B (2 Cycles)|Progressive disease|1
6853784|NCT00369707|10861738|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2
6853785|NCT00369707|10861738|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2
6853786|NCT00369707|10861738|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4
6853787|NCT00369707|10861738|FG000|Follow up for 2 Years After Treatment|Death|1
6853788|NCT00369707|10861738|FG000|Follow up for 2 Years After Treatment|Other|2
6853789|NCT00369785|10861753|FG000|Overall Study|Physician Decision|3
6853790|NCT00369785|10861754|FG001|Overall Study|Physician Decision|2
6853791|NCT00369785|10861753|FG000|Overall Study|Death|1
6853792|NCT00369785|10861754|FG001|Overall Study|Death|2
6853793|NCT00369785|10861753|FG000|Overall Study|Withdrawal by Subject|7
6853794|NCT00369785|10861754|FG001|Overall Study|Withdrawal by Subject|6
6853795|NCT00369785|10861753|FG000|Overall Study|Toxicity|6
6853796|NCT00369785|10861754|FG001|Overall Study|Toxicity|4
6853797|NCT00369785|10861753|FG000|Overall Study|Never started|0
6853798|NCT00369785|10861754|FG001|Overall Study|Never started|2
6853799|NCT00369785|10861753|FG000|Overall Study|Progression|4
6853800|NCT00369785|10861754|FG001|Overall Study|Progression|4
6853801|NCT00369785|10861753|FG000|Overall Study|Multiple reasons|6
6853802|NCT00369785|10861754|FG001|Overall Study|Multiple reasons|5
6853803|NCT00369824|10861766|FG000|Overall Study|Adverse Event|0
6853804|NCT00369824|10861767|FG001|Overall Study|Adverse Event|2
6853805|NCT00369824|10861768|FG002|Overall Study|Adverse Event|0
6853806|NCT00369824|10861769|FG003|Overall Study|Adverse Event|0
6853807|NCT00369824|10861770|FG004|Overall Study|Adverse Event|1
6853808|NCT00369824|10861771|FG005|Overall Study|Adverse Event|0
6853809|NCT00369824|10861766|FG000|Overall Study|Protocol Violation|0
6853810|NCT00369824|10861767|FG001|Overall Study|Protocol Violation|1
6853811|NCT00369824|10861768|FG002|Overall Study|Protocol Violation|0
6853812|NCT00369824|10861769|FG003|Overall Study|Protocol Violation|1
6853813|NCT00369824|10861770|FG004|Overall Study|Protocol Violation|1
6853814|NCT00369824|10861771|FG005|Overall Study|Protocol Violation|0
6853815|NCT00369824|10861766|FG000|Overall Study|Withdrawal by Subject|9
6853816|NCT00369824|10861767|FG001|Overall Study|Withdrawal by Subject|5
6853817|NCT00369824|10861768|FG002|Overall Study|Withdrawal by Subject|5
6853818|NCT00369824|10861769|FG003|Overall Study|Withdrawal by Subject|4
6853819|NCT00369824|10861770|FG004|Overall Study|Withdrawal by Subject|6
6853820|NCT00369824|10861771|FG005|Overall Study|Withdrawal by Subject|2
6853821|NCT00369824|10861766|FG000|Overall Study|Lost to Follow-up|6
6853822|NCT00369824|10861767|FG001|Overall Study|Lost to Follow-up|11
6853823|NCT00369824|10861768|FG002|Overall Study|Lost to Follow-up|7
6853824|NCT00369824|10861769|FG003|Overall Study|Lost to Follow-up|8
6853825|NCT00369824|10861770|FG004|Overall Study|Lost to Follow-up|9
6853826|NCT00369824|10861771|FG005|Overall Study|Lost to Follow-up|6
6853827|NCT00369824|10861766|FG000|Overall Study|Other|0
6853828|NCT00369824|10861767|FG001|Overall Study|Other|0
6853829|NCT00369824|10861768|FG002|Overall Study|Other|0
6853830|NCT00369824|10861769|FG003|Overall Study|Other|2
6853831|NCT00369824|10861770|FG004|Overall Study|Other|1
6853832|NCT00369824|10861771|FG005|Overall Study|Other|3
6853833|NCT00369915|10861787|FG000|Overall Study|expected side effects|2
6853834|NCT00369915|10861788|FG001|Overall Study|expected side effects|1
6853835|NCT00369915|10861787|FG000|Overall Study|Withdrawal by Subject|4
6853836|NCT00369915|10861788|FG001|Overall Study|Withdrawal by Subject|1
6853837|NCT00369915|10861787|FG000|Overall Study|W/drawl by investigators|0
6853838|NCT00369915|10861788|FG001|Overall Study|W/drawl by investigators|1
6853839|NCT00369941|10861809|FG000|Overall Study|Never Treated|1
6853840|NCT00369941|10861810|FG001|Overall Study|Never Treated|2
6853841|NCT00369941|10861809|FG000|Overall Study|Adverse Event|14
6853842|NCT00369941|10861810|FG001|Overall Study|Adverse Event|28
6853843|NCT00369941|10861809|FG000|Overall Study|Lack of Efficacy|6
6853844|NCT00369941|10861810|FG001|Overall Study|Lack of Efficacy|10
6853845|NCT00369941|10861809|FG000|Overall Study|Lost to Follow-up|12
6853846|NCT00369941|10861810|FG001|Overall Study|Lost to Follow-up|22
6853847|NCT00369941|10861809|FG000|Overall Study|Protocol Violation|5
6853848|NCT00369941|10861810|FG001|Overall Study|Protocol Violation|3
6853849|NCT00369941|10861809|FG000|Overall Study|Withdrawal by Subject|5
6853850|NCT00369941|10861810|FG001|Overall Study|Withdrawal by Subject|18
6853851|NCT00369941|10861809|FG000|Overall Study|Pregnancy|4
6966980|NCT01129115|11015306|FG002|Overall Study|Protocol Violation|2
6966981|NCT01129115|11015307|FG003|Overall Study|Protocol Violation|2
6966982|NCT01129128|11015320|FG000|Overall Study|Lost to Follow-up|2
7040923|NCT01721317|11124156|FG000|Overall Study|Withdrawal by Subject|0
7040924|NCT01721317|11124157|FG001|Overall Study|Withdrawal by Subject|1
7040925|NCT01721330|11124165|FG000|Overall Study|Withdrawal by Subject|0
7040926|NCT01721330|11124166|FG001|Overall Study|Withdrawal by Subject|1
7040927|NCT01721369|11124172|FG000|Overall Study|Not initial etiological diagnosis|12
7040928|NCT01721408|11124178|FG000|Overall Study|Adverse Event|6
7040929|NCT01721408|11124179|FG001|Overall Study|Adverse Event|1
7040930|NCT01721408|11124178|FG000|Overall Study|Death|1
7040931|NCT01721408|11124179|FG001|Overall Study|Death|0
7077825|NCT02096471|11185728|FG000|Overall Study|Lack of Efficacy|7
6966983|NCT01129128|11015321|FG001|Overall Study|Lost to Follow-up|2
6966984|NCT01129128|11015322|FG002|Overall Study|Lost to Follow-up|1
6966985|NCT01129128|11015320|FG000|Overall Study|Protocol Violation|0
6966986|NCT01129128|11015321|FG001|Overall Study|Protocol Violation|1
6966987|NCT01129128|11015322|FG002|Overall Study|Protocol Violation|0
6966988|NCT01129128|11015320|FG000|Overall Study|Withdrawal by Subject|0
6966989|NCT01129128|11015321|FG001|Overall Study|Withdrawal by Subject|1
6966990|NCT01129128|11015322|FG002|Overall Study|Withdrawal by Subject|3
6966991|NCT01129128|11015320|FG000|Overall Study|Physician Decision|1
6966992|NCT01129128|11015321|FG001|Overall Study|Physician Decision|0
6966993|NCT01129128|11015322|FG002|Overall Study|Physician Decision|0
6966994|NCT01129284|11015361|FG000|Overall Study|Adverse Event|2
6966995|NCT01129284|11015362|FG001|Overall Study|Adverse Event|0
6966996|NCT01129284|11015363|FG002|Overall Study|Adverse Event|1
6966997|NCT01129336|11015373|FG000|Overall Study|Protocol Violation|1
7077826|NCT02096471|11185728|FG000|Overall Study|Withdrawal by Subject|3
6853852|NCT00369941|10861810|FG001|Overall Study|Pregnancy|2
6853853|NCT00369941|10861809|FG000|Overall Study|Completed, Did Not Enter Extension|5
6853854|NCT00369941|10861810|FG001|Overall Study|Completed, Did Not Enter Extension|6
6853855|NCT00369941|10861809|FG000|Overall Study|Moved|11
6853856|NCT00369941|10861810|FG001|Overall Study|Moved|5
6853857|NCT00369941|10861809|FG000|Overall Study|Treatment with Prohibited Medication|3
6853858|NCT00369941|10861810|FG001|Overall Study|Treatment with Prohibited Medication|1
6853859|NCT00369941|10861809|FG000|Overall Study|Employment Interfered with Study Visits|1
6966998|NCT01129336|11015374|FG001|Overall Study|Protocol Violation|0
6966999|NCT01129336|11015373|FG000|Overall Study|Disease Progression|1
7077827|NCT02096471|11185728|FG000|Overall Study|Non-Compliant|2
7077828|NCT02096705|11185753|FG000|Treatment|Adverse Event|6
7077829|NCT02096705|11185754|FG001|Treatment|Adverse Event|3
7077830|NCT02096705|11185753|FG000|Treatment|Subject request to discontinue treatment|1
7077831|NCT02096705|11185754|FG001|Treatment|Subject request to discontinue treatment|1
6853860|NCT00369941|10861810|FG001|Overall Study|Employment Interfered with Study Visits|0
6853861|NCT00369941|10861809|FG000|Overall Study|Study Site Terminated|2
6853862|NCT00369941|10861810|FG001|Overall Study|Study Site Terminated|0
6853863|NCT00369941|10861809|FG000|Overall Study|Miscellaneous|3
6853864|NCT00369941|10861810|FG001|Overall Study|Miscellaneous|3
6853865|NCT00369967|10861819|FG000|Overall Study|Lost to Follow-up|23
6853866|NCT00369967|10861820|FG001|Overall Study|Lost to Follow-up|12
6853867|NCT00370032|10861832|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0
6853868|NCT00370032|10861833|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1
6853869|NCT00370032|10861832|FG000|Washout Period|Withdrawal by Subject|0
6853870|NCT00370032|10861833|FG001|Washout Period|Withdrawal by Subject|1
6853871|NCT00370032|10861832|FG000|Washout Period|Lost to Follow-up|0
6853872|NCT00370032|10861833|FG001|Washout Period|Lost to Follow-up|1
6853873|NCT00370032|10861832|FG000|Washout Period|Adverse Event|1
6853874|NCT00370032|10861833|FG001|Washout Period|Adverse Event|0
6853875|NCT00370032|10861832|FG000|Follow-up Period|Withdrawal by Subject|1
6853876|NCT00370032|10861833|FG001|Follow-up Period|Withdrawal by Subject|0
6853877|NCT00370071|10861848|FG000|Overall Study|Withdrawal by Subject|2
6853878|NCT00370149|10861854|FG000|Overall Study|Physician Decision|16
6853879|NCT00370149|10861855|FG001|Overall Study|Physician Decision|16
6853880|NCT00370149|10861854|FG000|Overall Study|Protocol Violation|1
6853881|NCT00370149|10861855|FG001|Overall Study|Protocol Violation|0
6853882|NCT00370149|10861854|FG000|Overall Study|Catheter inserted in wrong vessel-|2
6853883|NCT00370149|10861855|FG001|Overall Study|Catheter inserted in wrong vessel-|1
6853884|NCT00370149|10861854|FG000|Overall Study|Pre-existing infection|0
6853885|NCT00370149|10861855|FG001|Overall Study|Pre-existing infection|1
6853886|NCT00370149|10861854|FG000|Overall Study|Antibiotic coated dressing placed|0
6853887|NCT00370149|10861855|FG001|Overall Study|Antibiotic coated dressing placed|1
6853888|NCT00370292|10861866|FG000|Overall Study|Disease Progression|4
6853889|NCT00370292|10861866|FG000|Overall Study|Adverse Event|7
6853890|NCT00370292|10861866|FG000|Overall Study|Physician Decision|2
6967000|NCT01129336|11015374|FG001|Overall Study|Disease Progression|4
6967001|NCT01129336|11015373|FG000|Overall Study|Lost to Follow-up|1
6967002|NCT01129336|11015374|FG001|Overall Study|Lost to Follow-up|0
6967003|NCT01129336|11015373|FG000|Overall Study|Withdrawal by Subject|7
6967004|NCT01129336|11015374|FG001|Overall Study|Withdrawal by Subject|4
6967005|NCT01129336|11015373|FG000|Overall Study|Adverse Event|0
6967006|NCT01129336|11015374|FG001|Overall Study|Adverse Event|1
6967007|NCT01129336|11015373|FG000|Overall Study|Missing Study Completion Status|2
6967008|NCT01129336|11015374|FG001|Overall Study|Missing Study Completion Status|3
6967009|NCT01129336|11015373|FG000|Overall Study|Death|0
6967010|NCT01129336|11015374|FG001|Overall Study|Death|4
6967011|NCT01129557|11015410|FG000|Overall Study|Adverse Event|1
6967012|NCT01129557|11015411|FG001|Overall Study|Adverse Event|2
6967013|NCT01129557|11015412|FG002|Overall Study|Adverse Event|2
6967014|NCT01129557|11015410|FG000|Overall Study|Novartis terminated study early|3
6967015|NCT01129557|11015411|FG001|Overall Study|Novartis terminated study early|3
6967016|NCT01129557|11015412|FG002|Overall Study|Novartis terminated study early|2
6967017|NCT01129583|11015433|FG000|Overall Study|Death|1
6967018|NCT01129583|11015434|FG001|Overall Study|Death|0
6967019|NCT01129583|11015433|FG000|Overall Study|Lost to Follow-up|1
6967020|NCT01129583|11015434|FG001|Overall Study|Lost to Follow-up|1
6967021|NCT01129583|11015433|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1
6967022|NCT01129583|11015434|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1
6967023|NCT01129622|11015444|FG000|Overall Study|Withdrawal by Subject|2
6976895|NCT01202773|11029768|FG000|Overall Study|Lost to Follow-up|1
6976896|NCT01202773|11029769|FG001|Overall Study|Lost to Follow-up|2
6976897|NCT01202773|11029770|FG002|Overall Study|Lost to Follow-up|2
6976898|NCT01202773|11029768|FG000|Overall Study|Withdrawal by Subject|13
6976899|NCT01202773|11029769|FG001|Overall Study|Withdrawal by Subject|6
6976900|NCT01202773|11029770|FG002|Overall Study|Withdrawal by Subject|5
6976901|NCT01202773|11029768|FG000|Overall Study|Physician Decision|2
6976902|NCT01202773|11029769|FG001|Overall Study|Physician Decision|0
6976903|NCT01202773|11029770|FG002|Overall Study|Physician Decision|0
6976904|NCT01202773|11029768|FG000|Overall Study|Protocol Violation|11
6976905|NCT01202773|11029769|FG001|Overall Study|Protocol Violation|6
6976906|NCT01202773|11029770|FG002|Overall Study|Protocol Violation|10
6976907|NCT01202773|11029768|FG000|Overall Study|Sponsor Decision|19
6976908|NCT01202773|11029769|FG001|Overall Study|Sponsor Decision|20
6976909|NCT01202773|11029770|FG002|Overall Study|Sponsor Decision|23
6976910|NCT01202877|11029791|FG000|Overall Study|Disease Progression|0
7077832|NCT02096705|11185753|FG000|Treatment|Withdrawal by Subject|1
7077833|NCT02096705|11185754|FG001|Treatment|Withdrawal by Subject|0
6976911|NCT01202877|11029792|FG001|Overall Study|Disease Progression|1
6976912|NCT01202877|11029793|FG002|Overall Study|Disease Progression|2
6976913|NCT01202877|11029791|FG000|Overall Study|Adverse Event|0
6976914|NCT01202877|11029792|FG001|Overall Study|Adverse Event|0
6976915|NCT01202877|11029793|FG002|Overall Study|Adverse Event|2
7077834|NCT02096705|11185753|FG000|Treatment|Other|1
6853891|NCT04876274|10861879|FG000|Overall Study|Lost to Follow-up|9
6853892|NCT04876274|10861880|FG001|Overall Study|Lost to Follow-up|12
6853900|NCT04150341|10861908|FG000|Overall Study|Physician Decision|0
6853901|NCT04150341|10861909|FG001|Overall Study|Physician Decision|0
6853902|NCT04150341|10861910|FG002|Overall Study|Physician Decision|1
6853903|NCT04150341|10861911|FG003|Overall Study|Physician Decision|0
6853904|NCT04150341|10861912|FG004|Overall Study|Physician Decision|0
6853905|NCT04150341|10861913|FG005|Overall Study|Physician Decision|0
6853906|NCT04150341|10861908|FG000|Overall Study|Adverse Event|0
6853907|NCT04150341|10861909|FG001|Overall Study|Adverse Event|0
6853908|NCT04150341|10861910|FG002|Overall Study|Adverse Event|0
6853909|NCT04150341|10861911|FG003|Overall Study|Adverse Event|0
6853910|NCT04150341|10861912|FG004|Overall Study|Adverse Event|1
6853911|NCT04150341|10861913|FG005|Overall Study|Adverse Event|0
6853912|NCT04115839|10861926|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14
6853913|NCT04115839|10861927|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13
6853914|NCT04115839|10861928|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14
6853915|NCT04115839|10861929|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0
6853916|NCT04115839|10861930|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0
6853917|NCT04115839|10861931|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0
6853918|NCT04115839|10861932|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0
6853919|NCT04115839|10861926|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2
6853920|NCT04115839|10861927|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1
6853921|NCT04115839|10861928|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3
6853922|NCT04115839|10861929|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0
6853923|NCT04115839|10861930|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0
6853924|NCT04115839|10861931|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0
6853925|NCT04115839|10861932|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0
6853926|NCT04115839|10861926|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2
6853927|NCT04115839|10861927|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0
6853928|NCT04115839|10861928|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0
6853929|NCT04115839|10861929|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0
6853930|NCT04115839|10861930|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0
6853931|NCT04115839|10861931|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0
6853932|NCT04115839|10861932|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0
6853933|NCT04115839|10861926|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0
6853934|NCT04115839|10861927|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0
6853935|NCT04115839|10861928|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1
6853936|NCT04115839|10861929|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0
6853937|NCT04115839|10861930|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0
6853938|NCT04115839|10861931|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0
6853939|NCT04115839|10861932|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0
6853940|NCT04115839|10861926|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0
6853941|NCT04115839|10861927|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0
6853942|NCT04115839|10861928|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0
6853943|NCT04115839|10861929|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17
6853944|NCT04115839|10861930|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19
6853945|NCT04115839|10861931|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10
6853946|NCT04115839|10861932|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8
6853947|NCT04115839|10861926|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0
6853948|NCT04115839|10861927|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0
6853949|NCT04115839|10861928|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0
6853950|NCT04115839|10861929|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1
6853951|NCT04115839|10861930|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1
6853952|NCT04115839|10861931|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0
6853953|NCT04115839|10861932|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0
6853954|NCT04078126|10861957|FG000|Washout|Study put on hold due to COVID-19|0
6853955|NCT04078126|10861958|FG001|Washout|Study put on hold due to COVID-19|2
6853956|NCT04078126|10861957|FG000|Period 2|Study put on hold due to COVID-19|1
6853957|NCT04078126|10861958|FG001|Period 2|Study put on hold due to COVID-19|1
6853958|NCT03825341|10861966|FG000|Overall Study|Withdrawal by Subject|0
6853959|NCT03825341|10861967|FG001|Overall Study|Withdrawal by Subject|1
6853960|NCT03751631|10861975|FG000|Overall Study|Withdrawal by Subject|0
6853961|NCT03751631|10861976|FG001|Overall Study|Withdrawal by Subject|0
6853962|NCT03751631|10861977|FG002|Overall Study|Withdrawal by Subject|1
6853963|NCT03751631|10861978|FG003|Overall Study|Withdrawal by Subject|1
6853964|NCT03751631|10861979|FG004|Overall Study|Withdrawal by Subject|0
6853965|NCT03751631|10861980|FG005|Overall Study|Withdrawal by Subject|0
6853966|NCT03751098|10861991|FG000|Overall Study|Withdrawal by Subject|0
6853967|NCT03751098|10861992|FG001|Overall Study|Withdrawal by Subject|1
6853968|NCT03673345|10862008|FG000|Overall Study|Lost to Follow-up|1
6853969|NCT03673345|10862009|FG001|Overall Study|Lost to Follow-up|0
6853970|NCT03673345|10862010|FG002|Overall Study|Lost to Follow-up|3
6853971|NCT03673345|10862011|FG003|Overall Study|Lost to Follow-up|3
6853972|NCT03673345|10862012|FG004|Overall Study|Lost to Follow-up|2
6853973|NCT03673345|10862013|FG005|Overall Study|Lost to Follow-up|1
6853974|NCT03673345|10862014|FG006|Overall Study|Lost to Follow-up|0
6853893|NCT04656691|10861886|FG000|Overall Study|Adverse Event|1
6853894|NCT04555096|10861901|FG000|Overall Study|Death|4
6853895|NCT04555096|10861902|FG001|Overall Study|Death|4
6853896|NCT04555096|10861901|FG000|Overall Study|Withdrawal by Subject|1
6853897|NCT04555096|10861902|FG001|Overall Study|Withdrawal by Subject|0
6853898|NCT04555096|10861901|FG000|Overall Study|Other|0
6853899|NCT04555096|10861902|FG001|Overall Study|Other|1
6853975|NCT03673345|10862015|FG007|Overall Study|Lost to Follow-up|0
6853976|NCT03673345|10862008|FG000|Overall Study|Withdrawal by Subject|1
6853977|NCT03673345|10862009|FG001|Overall Study|Withdrawal by Subject|0
6853978|NCT03673345|10862010|FG002|Overall Study|Withdrawal by Subject|4
6853979|NCT03673345|10862011|FG003|Overall Study|Withdrawal by Subject|2
6853980|NCT03673345|10862012|FG004|Overall Study|Withdrawal by Subject|0
6853981|NCT03673345|10862013|FG005|Overall Study|Withdrawal by Subject|0
6853982|NCT03673345|10862014|FG006|Overall Study|Withdrawal by Subject|0
6853983|NCT03673345|10862015|FG007|Overall Study|Withdrawal by Subject|0
6853984|NCT03673345|10862008|FG000|Overall Study|Physician Decision|0
6853985|NCT03673345|10862009|FG001|Overall Study|Physician Decision|0
6853986|NCT03673345|10862010|FG002|Overall Study|Physician Decision|2
6853987|NCT03673345|10862011|FG003|Overall Study|Physician Decision|0
6853988|NCT03673345|10862012|FG004|Overall Study|Physician Decision|0
6853989|NCT03673345|10862013|FG005|Overall Study|Physician Decision|0
6853990|NCT03673345|10862014|FG006|Overall Study|Physician Decision|0
6853991|NCT03673345|10862015|FG007|Overall Study|Physician Decision|0
6853992|NCT03418675|10862035|FG000|Overall Study|Lost to Follow-up|13
6853993|NCT03418675|10862036|FG001|Overall Study|Lost to Follow-up|10
6853994|NCT03418675|10862035|FG000|Overall Study|Adverse Event|2
6853995|NCT03418675|10862036|FG001|Overall Study|Adverse Event|0
6853996|NCT03329690|10862051|FG000|Overall Study|Progressive disease per RECIST|85
6853997|NCT03329690|10862052|FG001|Overall Study|Progressive disease per RECIST|44
6853998|NCT03329690|10862053|FG002|Overall Study|Progressive disease per RECIST|6
6853999|NCT03329690|10862054|FG003|Overall Study|Progressive disease per RECIST|16
6854000|NCT03329690|10862055|FG004|Overall Study|Progressive disease per RECIST|20
6854001|NCT03329690|10862051|FG000|Overall Study|Clinical progression|7
6854002|NCT03329690|10862052|FG001|Overall Study|Clinical progression|4
6854003|NCT03329690|10862053|FG002|Overall Study|Clinical progression|1
6854004|NCT03329690|10862054|FG003|Overall Study|Clinical progression|1
6854005|NCT03329690|10862055|FG004|Overall Study|Clinical progression|1
6854006|NCT03329690|10862051|FG000|Overall Study|Adverse Event|22
6854007|NCT03329690|10862052|FG001|Overall Study|Adverse Event|4
6854008|NCT03329690|10862053|FG002|Overall Study|Adverse Event|0
6854009|NCT03329690|10862054|FG003|Overall Study|Adverse Event|1
6854010|NCT03329690|10862055|FG004|Overall Study|Adverse Event|2
6854011|NCT03329690|10862051|FG000|Overall Study|Death|2
6854012|NCT03329690|10862052|FG001|Overall Study|Death|0
6854013|NCT03329690|10862053|FG002|Overall Study|Death|0
6854014|NCT03329690|10862054|FG003|Overall Study|Death|1
6854015|NCT03329690|10862055|FG004|Overall Study|Death|0
6854016|NCT03329690|10862051|FG000|Overall Study|Withdrawal by Subject|2
6854017|NCT03329690|10862052|FG001|Overall Study|Withdrawal by Subject|3
6854018|NCT03329690|10862053|FG002|Overall Study|Withdrawal by Subject|0
6854019|NCT03329690|10862054|FG003|Overall Study|Withdrawal by Subject|1
6854020|NCT03329690|10862055|FG004|Overall Study|Withdrawal by Subject|0
6854021|NCT03329690|10862051|FG000|Overall Study|Physician Decision|1
6854022|NCT03329690|10862052|FG001|Overall Study|Physician Decision|0
6854023|NCT03329690|10862053|FG002|Overall Study|Physician Decision|0
6854024|NCT03329690|10862054|FG003|Overall Study|Physician Decision|0
6854025|NCT03329690|10862055|FG004|Overall Study|Physician Decision|1
6854026|NCT03329690|10862051|FG000|Overall Study|Miscellaneous|6
6854027|NCT03329690|10862052|FG001|Overall Study|Miscellaneous|0
6854028|NCT03329690|10862053|FG002|Overall Study|Miscellaneous|0
6854029|NCT03329690|10862054|FG003|Overall Study|Miscellaneous|0
6854030|NCT03329690|10862055|FG004|Overall Study|Miscellaneous|0
6854031|NCT03329690|10862051|FG000|Overall Study|Did not receive treatment|1
6854032|NCT03329690|10862052|FG001|Overall Study|Did not receive treatment|0
6854033|NCT03329690|10862053|FG002|Overall Study|Did not receive treatment|0
6854034|NCT03329690|10862054|FG003|Overall Study|Did not receive treatment|1
6854035|NCT03329690|10862055|FG004|Overall Study|Did not receive treatment|0
6854036|NCT03320564|10862073|FG000|Overall Study|Protocol Violation|1
6967024|NCT01129882|11015466|FG000|Overall Study|Adverse Event|39
6967025|NCT01129882|11015466|FG000|Overall Study|Death|6
6967026|NCT01129882|11015466|FG000|Overall Study|Lack of Efficacy|5
6967027|NCT01129882|11015466|FG000|Overall Study|Lost to Follow-up|13
6967028|NCT01129882|11015466|FG000|Overall Study|Physician Decision|27
6967029|NCT01129882|11015466|FG000|Overall Study|Protocol Deviation|3
6967030|NCT01129882|11015466|FG000|Overall Study|Withdrawal Criteria Met|19
6967031|NCT01129882|11015466|FG000|Overall Study|Trial Termination by Sponsor|6
6967032|NCT01129882|11015466|FG000|Overall Study|Withdrawal by Subject|160
6967033|NCT01129921|11015472|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2
6967034|NCT01129921|11015473|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1
6967035|NCT01129921|11015472|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0
6967036|NCT01129921|11015473|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1
6967037|NCT01129921|11015472|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0
6967038|NCT01129921|11015473|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4
6854037|NCT03165955|10862091|FG000|Treatment|Withdrawal by Subject|3
6854038|NCT03165955|10862091|FG000|Treatment|Death|1
6854039|NCT03165955|10862091|FG000|Treatment|Adverse Event|1
6854040|NCT03165955|10862091|FG000|Treatment|Progressive disease|3
6854041|NCT03133793|10862099|FG000|Overall Study|Withdrawal by Subject|0
6854042|NCT03133793|10862100|FG001|Overall Study|Withdrawal by Subject|4
6854043|NCT03133793|10862101|FG002|Overall Study|Withdrawal by Subject|2
6854044|NCT03133793|10862102|FG003|Overall Study|Withdrawal by Subject|4
6854045|NCT03133793|10862099|FG000|Overall Study|Lost to Follow-up|1
6854046|NCT03133793|10862100|FG001|Overall Study|Lost to Follow-up|0
6854047|NCT03133793|10862101|FG002|Overall Study|Lost to Follow-up|2
6854048|NCT03133793|10862102|FG003|Overall Study|Lost to Follow-up|0
6854049|NCT03133793|10862099|FG000|Overall Study|Death|0
6854050|NCT03133793|10862100|FG001|Overall Study|Death|0
6854051|NCT03133793|10862101|FG002|Overall Study|Death|0
6854052|NCT03133793|10862102|FG003|Overall Study|Death|1
6854053|NCT03103542|10862116|FG000|Overall Study|Physician Decision|2
6854054|NCT03103542|10862116|FG000|Overall Study|Adverse Event|2
6854055|NCT03103542|10862116|FG000|Overall Study|Other|2
6854056|NCT03103542|10862116|FG000|Overall Study|Withdrawal by Subject|1
6854057|NCT02676765|10862132|FG000|Overall Study|Lost to Follow-up|0
6854058|NCT02676765|10862133|FG001|Overall Study|Lost to Follow-up|1
6854059|NCT02362451|10862159|FG000|Overall Study|Withdrawal by Subject|0
6854060|NCT02362451|10862160|FG001|Overall Study|Withdrawal by Subject|1
6854061|NCT02362451|10862159|FG000|Overall Study|Lack of Efficacy|2
6854062|NCT02362451|10862160|FG001|Overall Study|Lack of Efficacy|0
6854063|NCT02362451|10862159|FG000|Overall Study|Progression|1
6854064|NCT02362451|10862160|FG001|Overall Study|Progression|0
6854065|NCT02362451|10862159|FG000|Overall Study|Participant chose other therapy.|1
6854066|NCT02362451|10862160|FG001|Overall Study|Participant chose other therapy.|0
6854067|NCT02282020|10862168|FG000|Overall Study|Objective Disease Progression|111
6854068|NCT02282020|10862169|FG001|Overall Study|Objective Disease Progression|30
6854069|NCT02282020|10862168|FG000|Overall Study|Adverse Event|13
6854070|NCT02282020|10862169|FG001|Overall Study|Adverse Event|15
6854071|NCT02282020|10862168|FG000|Overall Study|Withdrawal by Subject|5
6854072|NCT02282020|10862169|FG001|Overall Study|Withdrawal by Subject|10
6854073|NCT02282020|10862168|FG000|Overall Study|Miscellaneous|4
6854074|NCT02282020|10862169|FG001|Overall Study|Miscellaneous|17
6854075|NCT02282020|10862168|FG000|Overall Study|Severe Non-compliance to Protocol|1
6854076|NCT02282020|10862169|FG001|Overall Study|Severe Non-compliance to Protocol|0
6854077|NCT02282020|10862168|FG000|Overall Study|Developed Discontinuation Criteria|1
6854078|NCT02282020|10862169|FG001|Overall Study|Developed Discontinuation Criteria|3
6854079|NCT02282020|10862168|FG000|Overall Study|Withdrew Consent Prior to Dosing|0
6854080|NCT02282020|10862169|FG001|Overall Study|Withdrew Consent Prior to Dosing|12
6854081|NCT02180724|10862194|FG000|Overall Study|Death|12
6854082|NCT02180724|10862195|FG001|Overall Study|Death|1
6854083|NCT02180724|10862194|FG000|Overall Study|Lost to Follow-up|1
6854084|NCT02180724|10862195|FG001|Overall Study|Lost to Follow-up|0
6854085|NCT02180724|10862194|FG000|Overall Study|Withdrawal by Subject|1
6854086|NCT02180724|10862195|FG001|Overall Study|Withdrawal by Subject|2
6854087|NCT02180724|10862194|FG000|Overall Study|Ongoing Study|78
6854088|NCT02180724|10862195|FG001|Overall Study|Ongoing Study|11
6854089|NCT02038777|10862209|FG000|Overall Study|Death|0
6854090|NCT02038777|10862210|FG001|Overall Study|Death|2
6854091|NCT02038777|10862211|FG002|Overall Study|Death|0
6854092|NCT02038777|10862212|FG003|Overall Study|Death|1
6854093|NCT02038777|10862213|FG004|Overall Study|Death|2
6854094|NCT02038777|10862214|FG005|Overall Study|Death|4
6854095|NCT02038777|10862215|FG006|Overall Study|Death|0
6854096|NCT02038777|10862216|FG007|Overall Study|Death|10
6854097|NCT02038777|10862209|FG000|Overall Study|Lost to Follow-up|0
6854098|NCT02038777|10862210|FG001|Overall Study|Lost to Follow-up|0
6854099|NCT02038777|10862211|FG002|Overall Study|Lost to Follow-up|0
6854100|NCT02038777|10862212|FG003|Overall Study|Lost to Follow-up|1
6854101|NCT02038777|10862213|FG004|Overall Study|Lost to Follow-up|0
6854102|NCT02038777|10862214|FG005|Overall Study|Lost to Follow-up|0
6854103|NCT02038777|10862215|FG006|Overall Study|Lost to Follow-up|0
6854104|NCT02038777|10862216|FG007|Overall Study|Lost to Follow-up|0
6854105|NCT02038777|10862209|FG000|Overall Study|Other|0
6854106|NCT02038777|10862210|FG001|Overall Study|Other|1
6854107|NCT02038777|10862211|FG002|Overall Study|Other|0
6854108|NCT02038777|10862212|FG003|Overall Study|Other|2
6854109|NCT02038777|10862213|FG004|Overall Study|Other|1
6854110|NCT02038777|10862214|FG005|Overall Study|Other|0
6854111|NCT02038777|10862215|FG006|Overall Study|Other|0
6854112|NCT02038777|10862216|FG007|Overall Study|Other|0
6854113|NCT02038777|10862209|FG000|Overall Study|Randomized but not treated|0
6854114|NCT02038777|10862210|FG001|Overall Study|Randomized but not treated|1
6854115|NCT02038777|10862211|FG002|Overall Study|Randomized but not treated|0
6854116|NCT02038777|10862212|FG003|Overall Study|Randomized but not treated|0
6854117|NCT02038777|10862213|FG004|Overall Study|Randomized but not treated|0
6854118|NCT02038777|10862214|FG005|Overall Study|Randomized but not treated|0
6854119|NCT02038777|10862215|FG006|Overall Study|Randomized but not treated|0
6854120|NCT02038777|10862216|FG007|Overall Study|Randomized but not treated|0
6854121|NCT02038777|10862209|FG000|Overall Study|Started Chemotherapy|1
6854122|NCT02038777|10862210|FG001|Overall Study|Started Chemotherapy|0
6854123|NCT02038777|10862211|FG002|Overall Study|Started Chemotherapy|3
6854124|NCT02038777|10862212|FG003|Overall Study|Started Chemotherapy|0
6854125|NCT02038777|10862213|FG004|Overall Study|Started Chemotherapy|0
6854126|NCT02038777|10862214|FG005|Overall Study|Started Chemotherapy|0
6854127|NCT02038777|10862215|FG006|Overall Study|Started Chemotherapy|0
6854128|NCT02038777|10862216|FG007|Overall Study|Started Chemotherapy|0
6854129|NCT01927419|10862246|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0
6854130|NCT01927419|10862247|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1
6854131|NCT01927419|10862246|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1
6854132|NCT01927419|10862247|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0
6854133|NCT01927419|10862246|FG000|Treatment Period|Disease progression|17
6854134|NCT01927419|10862247|FG001|Treatment Period|Disease progression|20
6854135|NCT01927419|10862246|FG000|Treatment Period|Study drug toxicity|48
6854136|NCT01927419|10862247|FG001|Treatment Period|Study drug toxicity|10
6854137|NCT01927419|10862246|FG000|Treatment Period|Death|0
6854138|NCT01927419|10862247|FG001|Treatment Period|Death|1
6854139|NCT01927419|10862246|FG000|Treatment Period|Adverse event unrelated to study drug|6
6854140|NCT01927419|10862247|FG001|Treatment Period|Adverse event unrelated to study drug|3
6854141|NCT01927419|10862246|FG000|Treatment Period|Participant request to discontinue|12
6854142|NCT01927419|10862247|FG001|Treatment Period|Participant request to discontinue|4
6854143|NCT01927419|10862246|FG000|Treatment Period|Withdrawal by Subject|1
6854144|NCT01927419|10862247|FG001|Treatment Period|Withdrawal by Subject|1
6854145|NCT01927419|10862246|FG000|Treatment Period|Maximum Clinical Benefit|6
6854146|NCT01927419|10862247|FG001|Treatment Period|Maximum Clinical Benefit|2
6854147|NCT01927419|10862246|FG000|Treatment Period|Other reasons|3
6854148|NCT01927419|10862247|FG001|Treatment Period|Other reasons|4
6854149|NCT01927419|10862246|FG000|Treatment Period|Not Reported|1
6854150|NCT01927419|10862247|FG001|Treatment Period|Not Reported|1
6854151|NCT01924533|10862255|FG000|Overall Study|Death|181
6854152|NCT01924533|10862256|FG001|Overall Study|Death|200
6854153|NCT01924533|10862255|FG000|Overall Study|Lost to Follow-up|0
6854154|NCT01924533|10862256|FG001|Overall Study|Lost to Follow-up|1
6854155|NCT01924533|10862255|FG000|Overall Study|Withdrawal by Subject|7
6854156|NCT01924533|10862256|FG001|Overall Study|Withdrawal by Subject|3
6854157|NCT01924533|10862255|FG000|Overall Study|Other Eligibility criteria|1
6854158|NCT01924533|10862256|FG001|Overall Study|Other Eligibility criteria|1
6854159|NCT01711879|10862282|FG000|Overall Study|Death|1
6854160|NCT01711879|10862283|FG001|Overall Study|Death|0
6854161|NCT01697267|10862293|FG000|Overall Study|Death|3
6854162|NCT01697267|10862294|FG001|Overall Study|Death|1
6854163|NCT01697267|10862293|FG000|Overall Study|Withdrawal by Subject|5
6854164|NCT01697267|10862294|FG001|Overall Study|Withdrawal by Subject|5
6854165|NCT01697267|10862293|FG000|Overall Study|Adverse Event|2
6854166|NCT01697267|10862294|FG001|Overall Study|Adverse Event|1
6854167|NCT01697267|10862293|FG000|Overall Study|Lost to Follow-up|2
6854168|NCT01697267|10862294|FG001|Overall Study|Lost to Follow-up|4
6854169|NCT01697267|10862293|FG000|Overall Study|Physician Decision|2
6854170|NCT01697267|10862294|FG001|Overall Study|Physician Decision|4
6854171|NCT01527149|10862300|FG000|Overall Study|Death|2
6967039|NCT01129921|11015472|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0
6967040|NCT01129921|11015473|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1
6967041|NCT01129960|11015487|FG000|Overall Study|Withdrawal by Subject|3
6967042|NCT01129960|11015488|FG001|Overall Study|Withdrawal by Subject|0
6967043|NCT01129960|11015489|FG002|Overall Study|Withdrawal by Subject|3
6967044|NCT01129960|11015490|FG003|Overall Study|Withdrawal by Subject|2
6967045|NCT01129960|11015487|FG000|Overall Study|Lack of Efficacy|1
6967046|NCT01129960|11015488|FG001|Overall Study|Lack of Efficacy|1
6967047|NCT01129960|11015489|FG002|Overall Study|Lack of Efficacy|1
6967048|NCT01129960|11015490|FG003|Overall Study|Lack of Efficacy|1
6967049|NCT01129960|11015487|FG000|Overall Study|Adverse Event|23
6967050|NCT01129960|11015488|FG001|Overall Study|Adverse Event|16
6967051|NCT01129960|11015489|FG002|Overall Study|Adverse Event|16
6967052|NCT01129960|11015490|FG003|Overall Study|Adverse Event|7
7077835|NCT02096705|11185754|FG001|Treatment|Other|1
7077836|NCT02096705|11185753|FG000|Follow-up|Withdrawal by Subject|1
6967053|NCT01129960|11015487|FG000|Overall Study|Protocol Violation|1
6967054|NCT01129960|11015488|FG001|Overall Study|Protocol Violation|2
6967055|NCT01129960|11015489|FG002|Overall Study|Protocol Violation|3
6967056|NCT01129960|11015490|FG003|Overall Study|Protocol Violation|0
6967057|NCT01129960|11015487|FG000|Overall Study|Lost to Follow-up|0
6967058|NCT01129960|11015488|FG001|Overall Study|Lost to Follow-up|2
6967059|NCT01129960|11015489|FG002|Overall Study|Lost to Follow-up|3
6967060|NCT01129960|11015490|FG003|Overall Study|Lost to Follow-up|3
6967061|NCT01129960|11015487|FG000|Overall Study|Discontinuation of the study by Sponsor|0
7077837|NCT02096705|11185754|FG001|Follow-up|Withdrawal by Subject|0
6967062|NCT01129960|11015488|FG001|Overall Study|Discontinuation of the study by Sponsor|1
6967063|NCT01129960|11015489|FG002|Overall Study|Discontinuation of the study by Sponsor|0
6967064|NCT01129960|11015490|FG003|Overall Study|Discontinuation of the study by Sponsor|0
6967065|NCT01129960|11015487|FG000|Overall Study|Physician Decision|1
6967066|NCT01129960|11015488|FG001|Overall Study|Physician Decision|0
6967067|NCT01129960|11015489|FG002|Overall Study|Physician Decision|0
6967068|NCT01129960|11015490|FG003|Overall Study|Physician Decision|0
6967069|NCT01129960|11015487|FG000|Overall Study|Pregnancy|1
7077838|NCT02096705|11185753|FG000|Follow-up|Adverse Event|2
6854172|NCT00554840|10862330|FG000|Overall Study|Physician Decision|0
6854173|NCT00554840|10862331|FG001|Overall Study|Physician Decision|1
6854174|NCT00003656|10862341|FG000|Overall Study|Adverse Event|0
6854175|NCT00003656|10862342|FG001|Overall Study|Adverse Event|1
6854176|NCT00370331|10862351|FG000|Overall Study|Adverse Event|4
6854177|NCT00370331|10862352|FG001|Overall Study|Adverse Event|13
6854178|NCT00370331|10862351|FG000|Overall Study|Withdrawal by Subject|2
6854179|NCT00370331|10862352|FG001|Overall Study|Withdrawal by Subject|4
6854180|NCT00370331|10862351|FG000|Overall Study|Lost to Follow-up|0
6854181|NCT00370331|10862352|FG001|Overall Study|Lost to Follow-up|3
6854182|NCT00370331|10862351|FG000|Overall Study|Lack of Efficacy|0
6854183|NCT00370331|10862352|FG001|Overall Study|Lack of Efficacy|1
6854184|NCT00370331|10862351|FG000|Overall Study|Non-compliance|0
6854185|NCT00370331|10862352|FG001|Overall Study|Non-compliance|1
6854186|NCT00370331|10862351|FG000|Overall Study|Protocol Violation|1
6854187|NCT00370331|10862352|FG001|Overall Study|Protocol Violation|1
6854188|NCT00370396|10862361|FG000|Overall Study|Withdrawal by Subject|0
6854189|NCT00370396|10862362|FG001|Overall Study|Withdrawal by Subject|0
6854190|NCT00370396|10862363|FG002|Overall Study|Withdrawal by Subject|1
6854191|NCT00370396|10862361|FG000|Overall Study|Lost to Follow-up|11
6854192|NCT00370396|10862362|FG001|Overall Study|Lost to Follow-up|1
6854193|NCT00370396|10862363|FG002|Overall Study|Lost to Follow-up|0
6854194|NCT00370552|10862374|FG000|Overall Study|Adverse Event|2
6854195|NCT00370552|10862375|FG001|Overall Study|Adverse Event|2
6854196|NCT00370552|10862376|FG002|Overall Study|Adverse Event|2
6854197|NCT00370552|10862374|FG000|Overall Study|Disease progression|23
6854198|NCT00370552|10862375|FG001|Overall Study|Disease progression|23
6854199|NCT00370552|10862376|FG002|Overall Study|Disease progression|15
6854200|NCT00370552|10862374|FG000|Overall Study|Maximum clinical benefit|3
6854201|NCT00370552|10862375|FG001|Overall Study|Maximum clinical benefit|5
6854202|NCT00370552|10862376|FG002|Overall Study|Maximum clinical benefit|5
6854203|NCT00370552|10862374|FG000|Overall Study|Poor or noncompliance|0
6854204|NCT00370552|10862375|FG001|Overall Study|Poor or noncompliance|0
6854205|NCT00370552|10862376|FG002|Overall Study|Poor or noncompliance|1
6854206|NCT00370552|10862374|FG000|Overall Study|Study drug toxicity|11
6854207|NCT00370552|10862375|FG001|Overall Study|Study drug toxicity|8
6854208|NCT00370552|10862376|FG002|Overall Study|Study drug toxicity|6
6854209|NCT00370552|10862374|FG000|Overall Study|Withdrawal by Subject|2
6854210|NCT00370552|10862375|FG001|Overall Study|Withdrawal by Subject|0
6854211|NCT00370552|10862376|FG002|Overall Study|Withdrawal by Subject|1
6854212|NCT00370552|10862374|FG000|Overall Study|Still on treatment|1
6854213|NCT00370552|10862375|FG001|Overall Study|Still on treatment|3
6854214|NCT00370552|10862376|FG002|Overall Study|Still on treatment|2
6854215|NCT00370552|10862374|FG000|Overall Study|Never treated|1
6854216|NCT00370552|10862375|FG001|Overall Study|Never treated|0
6854217|NCT00370552|10862376|FG002|Overall Study|Never treated|0
6854218|NCT00370552|10862374|FG000|Overall Study|Physician Decision|1
6854219|NCT00370552|10862375|FG001|Overall Study|Physician Decision|1
6854220|NCT00370552|10862376|FG002|Overall Study|Physician Decision|0
6854221|NCT00370552|10862374|FG000|Overall Study|Investigator decision|2
6854222|NCT00370552|10862375|FG001|Overall Study|Investigator decision|1
6854223|NCT00370552|10862376|FG002|Overall Study|Investigator decision|0
6854224|NCT00370552|10862374|FG000|Overall Study|High risk of allergic reaction|0
6854225|NCT00370552|10862375|FG001|Overall Study|High risk of allergic reaction|1
6854226|NCT00370552|10862376|FG002|Overall Study|High risk of allergic reaction|0
6854227|NCT00370552|10862374|FG000|Overall Study|Planned radiation for palliation|0
6854228|NCT00370552|10862375|FG001|Overall Study|Planned radiation for palliation|1
6854229|NCT00370552|10862376|FG002|Overall Study|Planned radiation for palliation|0
6854230|NCT00370682|10862387|FG000|Overall Study|Moved from area|0
6854231|NCT00370682|10862388|FG001|Overall Study|Moved from area|2
6854232|NCT00370682|10862389|FG002|Overall Study|Moved from area|0
6854233|NCT00370682|10862387|FG000|Overall Study|Lost to Follow-up|0
6854234|NCT00370682|10862388|FG001|Overall Study|Lost to Follow-up|1
6854235|NCT00370682|10862389|FG002|Overall Study|Lost to Follow-up|1
6854236|NCT00371137|10862422|FG000|Overall Study|Adverse Event|20
6854237|NCT00371137|10862423|FG001|Overall Study|Adverse Event|35
6854238|NCT00371137|10862424|FG002|Overall Study|Adverse Event|42
6854239|NCT00371137|10862422|FG000|Overall Study|Withdrawal by Subject|11
6854240|NCT00371137|10862423|FG001|Overall Study|Withdrawal by Subject|10
6854241|NCT00371137|10862424|FG002|Overall Study|Withdrawal by Subject|15
6854242|NCT00371137|10862422|FG000|Overall Study|Lost to Follow-up|6
6854243|NCT00371137|10862423|FG001|Overall Study|Lost to Follow-up|3
6854244|NCT00371137|10862424|FG002|Overall Study|Lost to Follow-up|5
6854245|NCT00371137|10862422|FG000|Overall Study|Lack of Efficacy|30
6854246|NCT00371137|10862423|FG001|Overall Study|Lack of Efficacy|12
6854247|NCT00371137|10862424|FG002|Overall Study|Lack of Efficacy|13
6854248|NCT00371137|10862422|FG000|Overall Study|Sponsor Decision|2
6854249|NCT00371137|10862423|FG001|Overall Study|Sponsor Decision|1
6854250|NCT00371137|10862424|FG002|Overall Study|Sponsor Decision|2
6854251|NCT00371137|10862422|FG000|Overall Study|Physician Decision|1
6854252|NCT00371137|10862423|FG001|Overall Study|Physician Decision|1
6854253|NCT00371137|10862424|FG002|Overall Study|Physician Decision|1
6854254|NCT00371137|10862422|FG000|Overall Study|Protocol Violation|2
6854255|NCT00371137|10862423|FG001|Overall Study|Protocol Violation|1
6854256|NCT00371137|10862424|FG002|Overall Study|Protocol Violation|1
6854257|NCT00371150|10862434|FG000|Overall Study|Lost to Follow-up|3
6854258|NCT00371150|10862435|FG001|Overall Study|Lost to Follow-up|2
6854259|NCT00371254|10862456|FG000|Overall Study|Disease progression|13
6854260|NCT00371254|10862457|FG001|Overall Study|Disease progression|13
6854261|NCT00371254|10862456|FG000|Overall Study|Study drug toxicity|3
6854262|NCT00371254|10862457|FG001|Overall Study|Study drug toxicity|5
6854263|NCT00371254|10862456|FG000|Overall Study|Subject request|5
6854264|NCT00371254|10862457|FG001|Overall Study|Subject request|0
6854265|NCT00371254|10862456|FG000|Overall Study|Investigator Decision|2
6854266|NCT00371254|10862457|FG001|Overall Study|Investigator Decision|0
6854267|NCT00371254|10862456|FG000|Overall Study|Adverse event unrelated to study drug|0
6854268|NCT00371254|10862457|FG001|Overall Study|Adverse event unrelated to study drug|1
6854269|NCT00371254|10862456|FG000|Overall Study|Lost to Follow-up|0
6854270|NCT00371254|10862457|FG001|Overall Study|Lost to Follow-up|1
6854271|NCT00371254|10862456|FG000|Overall Study|Withdrawal by Subject|0
6854272|NCT00371254|10862457|FG001|Overall Study|Withdrawal by Subject|1
6854273|NCT00371345|10862488|FG000|Overall Study|Disease Progression|21
6854274|NCT00371345|10862489|FG001|Overall Study|Disease Progression|35
6854275|NCT00371345|10862488|FG000|Overall Study|Study Drug Toxicity|1
6854276|NCT00371345|10862489|FG001|Overall Study|Study Drug Toxicity|7
6854277|NCT00371345|10862488|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1
6854278|NCT00371345|10862489|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2
6854279|NCT00371345|10862488|FG000|Overall Study|Participant Request|1
6854280|NCT00371345|10862489|FG001|Overall Study|Participant Request|1
6854281|NCT00371345|10862488|FG000|Overall Study|Participant Withdrew Consent|0
6854282|NCT00371345|10862489|FG001|Overall Study|Participant Withdrew Consent|1
6854283|NCT00371397|10862509|FG000|Session 1|Withdrawal by Subject|1
6854284|NCT00371397|10862510|FG001|Session 1|Withdrawal by Subject|0
6854285|NCT00371397|10862511|FG002|Session 1|Withdrawal by Subject|0
6854286|NCT00371397|10862512|FG003|Session 1|Withdrawal by Subject|0
6854287|NCT00371397|10862513|FG004|Session 1|Withdrawal by Subject|0
6854288|NCT00371397|10862514|FG005|Session 1|Withdrawal by Subject|0
6854289|NCT00371397|10862515|FG006|Session 1|Withdrawal by Subject|0
6854290|NCT00371397|10862516|FG007|Session 1|Withdrawal by Subject|1
6854291|NCT00371397|10862517|FG008|Session 1|Withdrawal by Subject|0
6854292|NCT00371397|10862518|FG009|Session 1|Withdrawal by Subject|0
6854293|NCT00371397|10862519|FG010|Session 1|Withdrawal by Subject|0
6854294|NCT00371397|10862520|FG011|Session 1|Withdrawal by Subject|0
6854295|NCT00371566|10862552|FG000|Treatment Phase|Withdrawal by Subject|0
6854296|NCT00371566|10862553|FG001|Treatment Phase|Withdrawal by Subject|1
6854297|NCT00371566|10862552|FG000|Treatment Phase|Adverse Event|0
6854298|NCT00371566|10862553|FG001|Treatment Phase|Adverse Event|1
6854299|NCT00371566|10862552|FG000|Treatment Phase|Protocol Violation|0
6854300|NCT00371566|10862553|FG001|Treatment Phase|Protocol Violation|1
6854301|NCT00371566|10862552|FG000|Chemoradiation Phase|Physician Decision|2
6854302|NCT00371566|10862553|FG001|Chemoradiation Phase|Physician Decision|0
6854303|NCT00371566|10862552|FG000|Chemoradiation Phase|Withdrawal by Subject|0
6854304|NCT00371566|10862553|FG001|Chemoradiation Phase|Withdrawal by Subject|1
6854305|NCT00371566|10862552|FG000|Chemoradiation Phase|Non compliant|0
6854306|NCT00371566|10862553|FG001|Chemoradiation Phase|Non compliant|1
6854307|NCT00371566|10862552|FG000|Chemoradiation Phase|Progressive Disease|1
6854308|NCT00371566|10862553|FG001|Chemoradiation Phase|Progressive Disease|1
6854309|NCT00371566|10862552|FG000|Chemoradiation Phase|Death|2
6854310|NCT00371566|10862553|FG001|Chemoradiation Phase|Death|0
6854311|NCT00371566|10862552|FG000|Follow Up Phase|Death|0
6854312|NCT00371566|10862553|FG001|Follow Up Phase|Death|5
6854313|NCT00371566|10862552|FG000|Follow Up Phase|Disease progression|1
6854314|NCT00371566|10862553|FG001|Follow Up Phase|Disease progression|0
6854315|NCT00371566|10862552|FG000|Follow Up Phase|Withdrawal by Subject|0
6854316|NCT00371566|10862553|FG001|Follow Up Phase|Withdrawal by Subject|1
6854317|NCT00371566|10862552|FG000|Follow Up Phase|Physician Decision|1
6854318|NCT00371566|10862553|FG001|Follow Up Phase|Physician Decision|1
6854319|NCT00371566|10862552|FG000|Follow Up Phase|Lost to Follow-up|1
6854320|NCT00371566|10862553|FG001|Follow Up Phase|Lost to Follow-up|0
6854321|NCT00371683|10862574|FG000|DB Treatment Period-Randomized Patients|Death|1
7077839|NCT02096705|11185754|FG001|Follow-up|Adverse Event|2
6854322|NCT00371683|10862575|FG001|DB Treatment Period-Randomized Patients|Death|1
6854323|NCT00371683|10862574|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60
6854324|NCT00371683|10862575|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58
6967070|NCT01129960|11015488|FG001|Overall Study|Pregnancy|0
6854325|NCT00371683|10862574|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18
6854326|NCT00371683|10862575|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37
6854327|NCT00371683|10862574|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0
6854328|NCT00371683|10862575|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1
6854329|NCT00371683|10862574|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1
6854330|NCT00371683|10862575|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2
6854331|NCT00371683|10862574|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1
6854332|NCT00371683|10862575|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0
6854333|NCT00371683|10862574|FG000|DB Treatment Period-Randomized Patients|non-specified|9
6854334|NCT00371683|10862575|FG001|DB Treatment Period-Randomized Patients|non-specified|8
6854335|NCT00371683|10862574|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17
6854336|NCT00371683|10862575|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19
6854337|NCT00371683|10862574|FG000|Follow-Up Period - Randomized Patients|Death|0
6854338|NCT00371683|10862575|FG001|Follow-Up Period - Randomized Patients|Death|2
6854339|NCT00371683|10862574|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38
6854340|NCT00371683|10862575|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39
6854341|NCT00371683|10862574|FG000|Follow-Up Period - Randomized Patients|non-specified|6
6854342|NCT00371683|10862575|FG001|Follow-Up Period - Randomized Patients|non-specified|12
6854343|NCT00371761|10862593|FG000|Overall Study|Adverse Event|1
6854344|NCT00371761|10862594|FG001|Overall Study|Adverse Event|1
6854345|NCT00371761|10862593|FG000|Overall Study|Withdrawal by Subject|1
6854346|NCT00371761|10862594|FG001|Overall Study|Withdrawal by Subject|3
6854347|NCT00371761|10862593|FG000|Overall Study|Investigator Judgment|2
6854348|NCT00371761|10862594|FG001|Overall Study|Investigator Judgment|3
6854349|NCT00371761|10862593|FG000|Overall Study|Study termination|4
6854350|NCT00371761|10862594|FG001|Overall Study|Study termination|3
6854351|NCT00371787|10862602|FG000|Overall Study|Withdrawal by Subject|3
6854352|NCT00371787|10862603|FG001|Overall Study|Withdrawal by Subject|1
6854353|NCT00371826|10862612|FG000|Core Phase (12 Months)|Adverse Event|15
6854354|NCT00371826|10862613|FG001|Core Phase (12 Months)|Adverse Event|4
6854355|NCT00371826|10862614|FG002|Core Phase (12 Months)|Adverse Event|9
6854356|NCT00371826|10862612|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1
6854357|NCT00371826|10862613|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0
6854358|NCT00371826|10862614|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1
6854359|NCT00371826|10862612|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6
6854360|NCT00371826|10862613|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3
6854361|NCT00371826|10862614|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2
6854362|NCT00371826|10862612|FG000|Core Phase (12 Months)|Protocol Violation|1
6854363|NCT00371826|10862613|FG001|Core Phase (12 Months)|Protocol Violation|0
6854364|NCT00371826|10862614|FG002|Core Phase (12 Months)|Protocol Violation|1
6854365|NCT00371826|10862612|FG000|Core Phase (12 Months)|Subject withdrew consent|0
6854366|NCT00371826|10862613|FG001|Core Phase (12 Months)|Subject withdrew consent|0
6854367|NCT00371826|10862614|FG002|Core Phase (12 Months)|Subject withdrew consent|3
6854368|NCT00371826|10862612|FG000|Core Phase (12 Months)|Administrative problems|1
6854369|NCT00371826|10862613|FG001|Core Phase (12 Months)|Administrative problems|0
6854370|NCT00371826|10862614|FG002|Core Phase (12 Months)|Administrative problems|8
6854371|NCT00371826|10862612|FG000|Core Phase (12 Months)|Graft Loss|0
6854372|NCT00371826|10862613|FG001|Core Phase (12 Months)|Graft Loss|1
6854373|NCT00371826|10862614|FG002|Core Phase (12 Months)|Graft Loss|0
6854374|NCT00371826|10862612|FG000|Extension Phase (24 Months)|Adverse Event|4
6854375|NCT00371826|10862613|FG001|Extension Phase (24 Months)|Adverse Event|5
6854376|NCT00371826|10862614|FG002|Extension Phase (24 Months)|Adverse Event|0
6854377|NCT00371826|10862612|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
6854378|NCT00371826|10862613|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1
6854379|NCT00371826|10862614|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
6854380|NCT00371826|10862612|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
6854381|NCT00371826|10862613|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2
6854382|NCT00371826|10862614|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
6854383|NCT00371826|10862612|FG000|Extension Phase (24 Months)|Subject withdrew consent|1
6854384|NCT00371826|10862613|FG001|Extension Phase (24 Months)|Subject withdrew consent|2
6854385|NCT00371826|10862614|FG002|Extension Phase (24 Months)|Subject withdrew consent|0
6854386|NCT00371826|10862612|FG000|Extension Phase (24 Months)|Administrative problems|0
6854387|NCT00371826|10862613|FG001|Extension Phase (24 Months)|Administrative problems|0
6854388|NCT00371826|10862614|FG002|Extension Phase (24 Months)|Administrative problems|2
6854389|NCT00371839|10862625|FG000|Overall Study|Death|4
6854390|NCT00371839|10862626|FG001|Overall Study|Death|0
6854391|NCT00371839|10862627|FG002|Overall Study|Death|0
6854392|NCT00371839|10862625|FG000|Overall Study|Withdrawal by Subject|7
6854393|NCT00371839|10862626|FG001|Overall Study|Withdrawal by Subject|4
6854394|NCT00371839|10862627|FG002|Overall Study|Withdrawal by Subject|0
6854395|NCT00371839|10862625|FG000|Overall Study|Lost to Follow-up|6
6854396|NCT00371839|10862626|FG001|Overall Study|Lost to Follow-up|3
6854397|NCT00371839|10862627|FG002|Overall Study|Lost to Follow-up|2
6854398|NCT00371865|10862635|FG000|Overall Study|Lack of Efficacy|0
6854399|NCT00371865|10862636|FG001|Overall Study|Lack of Efficacy|2
6854400|NCT00371865|10862635|FG000|Overall Study|Protocol Violation|3
6854401|NCT00371865|10862636|FG001|Overall Study|Protocol Violation|2
6854402|NCT00371865|10862635|FG000|Overall Study|Withdrawal by Subject|12
6854403|NCT00371865|10862636|FG001|Overall Study|Withdrawal by Subject|10
6854404|NCT00372060|10862644|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2
6854405|NCT00372060|10862645|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0
6854406|NCT00372060|10862644|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0
6854407|NCT00372060|10862645|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1
6854408|NCT00372060|10862644|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1
6854409|NCT00372060|10862645|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0
6854410|NCT00372060|10862644|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3
6854411|NCT00372060|10862645|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0
6854412|NCT00372060|10862644|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9
6854413|NCT00372060|10862645|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8
6854414|NCT00372060|10862644|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2
6854415|NCT00372060|10862645|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0
6854416|NCT00372112|10862658|FG000|Overall Study|Adverse Event|0
6854417|NCT00372112|10862659|FG001|Overall Study|Adverse Event|1
6854418|NCT00372112|10862660|FG002|Overall Study|Adverse Event|1
6854419|NCT00372112|10862661|FG003|Overall Study|Adverse Event|1
6854420|NCT00372112|10862658|FG000|Overall Study|Withdrawal by Subject|0
6854421|NCT00372112|10862659|FG001|Overall Study|Withdrawal by Subject|0
6854422|NCT00372112|10862660|FG002|Overall Study|Withdrawal by Subject|2
6854423|NCT00372112|10862661|FG003|Overall Study|Withdrawal by Subject|1
6854424|NCT00372112|10862658|FG000|Overall Study|Exacerbation|0
6854425|NCT00372112|10862659|FG001|Overall Study|Exacerbation|0
6854426|NCT00372112|10862660|FG002|Overall Study|Exacerbation|0
6854427|NCT00372112|10862661|FG003|Overall Study|Exacerbation|1
6854428|NCT00372112|10862658|FG000|Overall Study|PR >240 at Visit 3|0
6854429|NCT00372112|10862659|FG001|Overall Study|PR >240 at Visit 3|0
6854430|NCT00372112|10862660|FG002|Overall Study|PR >240 at Visit 3|0
6854431|NCT00372112|10862661|FG003|Overall Study|PR >240 at Visit 3|1
6854432|NCT00372112|10862658|FG000|Overall Study|Hepatitis B|1
6854433|NCT00372112|10862659|FG001|Overall Study|Hepatitis B|0
6854434|NCT00372112|10862660|FG002|Overall Study|Hepatitis B|0
6854435|NCT00372112|10862661|FG003|Overall Study|Hepatitis B|0
6854436|NCT00372112|10862658|FG000|Overall Study|Other-protocol violation|0
6854437|NCT00372112|10862659|FG001|Overall Study|Other-protocol violation|0
6854438|NCT00372112|10862660|FG002|Overall Study|Other-protocol violation|1
6854439|NCT00372112|10862661|FG003|Overall Study|Other-protocol violation|0
6854440|NCT00372190|10862676|FG000|Overall Study|Lost to Follow-up|3
6854441|NCT00372190|10862677|FG001|Overall Study|Lost to Follow-up|1
6854442|NCT00372255|10862687|FG000|Overall Study|Withdrawn for other reasons|2
6854443|NCT00372255|10862688|FG001|Overall Study|Withdrawn for other reasons|1
6854444|NCT00372385|10862699|FG000|Overall Study|Adverse Event|6
6854445|NCT00372385|10862700|FG001|Overall Study|Adverse Event|11
6854446|NCT00372385|10862701|FG002|Overall Study|Adverse Event|9
6854447|NCT00372385|10862702|FG003|Overall Study|Adverse Event|7
6854448|NCT00372385|10862699|FG000|Overall Study|Noncompliance|0
6854449|NCT00372385|10862700|FG001|Overall Study|Noncompliance|1
6854450|NCT00372385|10862701|FG002|Overall Study|Noncompliance|1
6854451|NCT00372385|10862702|FG003|Overall Study|Noncompliance|1
6854452|NCT00372385|10862699|FG000|Overall Study|Physician Decision|1
6854453|NCT00372385|10862700|FG001|Overall Study|Physician Decision|0
6854454|NCT00372385|10862701|FG002|Overall Study|Physician Decision|0
6854455|NCT00372385|10862702|FG003|Overall Study|Physician Decision|0
6854456|NCT00372385|10862699|FG000|Overall Study|Lost to Follow-up|2
6854457|NCT00372385|10862700|FG001|Overall Study|Lost to Follow-up|0
6854458|NCT00372385|10862701|FG002|Overall Study|Lost to Follow-up|0
6854459|NCT00372385|10862702|FG003|Overall Study|Lost to Follow-up|0
6854460|NCT00372385|10862699|FG000|Overall Study|Withdrawal by Subject|2
6854461|NCT00372385|10862700|FG001|Overall Study|Withdrawal by Subject|1
6854462|NCT00372385|10862701|FG002|Overall Study|Withdrawal by Subject|0
6854463|NCT00372385|10862702|FG003|Overall Study|Withdrawal by Subject|0
6854464|NCT00372385|10862699|FG000|Overall Study|Refusal of Treatment|3
6854465|NCT00372385|10862700|FG001|Overall Study|Refusal of Treatment|6
6854466|NCT00372385|10862701|FG002|Overall Study|Refusal of Treatment|0
6854467|NCT00372385|10862702|FG003|Overall Study|Refusal of Treatment|0
6854468|NCT00372385|10862699|FG000|Overall Study|No Response|1
6854469|NCT00372385|10862700|FG001|Overall Study|No Response|1
6854470|NCT00372385|10862701|FG002|Overall Study|No Response|0
6854471|NCT00372385|10862702|FG003|Overall Study|No Response|0
6854472|NCT00372385|10862699|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1
6854473|NCT00372385|10862700|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0
6854474|NCT00372385|10862701|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0
6854475|NCT00372385|10862702|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0
6854476|NCT00372385|10862699|FG000|Overall Study|Virologic Stopping Rule|17
6854477|NCT00372385|10862700|FG001|Overall Study|Virologic Stopping Rule|0
6854478|NCT00372385|10862701|FG002|Overall Study|Virologic Stopping Rule|0
6854479|NCT00372385|10862702|FG003|Overall Study|Virologic Stopping Rule|0
6854480|NCT00372411|10862716|FG000|Overall Study|Withdrawal by Subject|3
6854481|NCT00372411|10862717|FG001|Overall Study|Withdrawal by Subject|4
6854482|NCT00372411|10862718|FG002|Overall Study|Withdrawal by Subject|1
6854483|NCT00372411|10862716|FG000|Overall Study|Death|0
6854484|NCT00372411|10862717|FG001|Overall Study|Death|2
6854485|NCT00372411|10862718|FG002|Overall Study|Death|1
6854486|NCT00372411|10862716|FG000|Overall Study|Lost to Follow-up|1
6854487|NCT00372411|10862717|FG001|Overall Study|Lost to Follow-up|1
6854488|NCT00372411|10862718|FG002|Overall Study|Lost to Follow-up|1
6854489|NCT00372411|10862716|FG000|Overall Study|Adverse Event|1
6854490|NCT00372411|10862717|FG001|Overall Study|Adverse Event|1
6854491|NCT00372411|10862718|FG002|Overall Study|Adverse Event|0
6854492|NCT00372424|10862726|FG000|Overall Study|Adverse Event|2
6854493|NCT00372424|10862726|FG000|Overall Study|Withdrawal by Subject|1
6854494|NCT00372424|10862726|FG000|Overall Study|Death|1
6854495|NCT00372424|10862726|FG000|Overall Study|Objective Progression or Relapse|14
6854496|NCT00372424|10862726|FG000|Overall Study|Other|7
6854497|NCT00372424|10862726|FG000|Overall Study|Enrolled, Not Treated|1
6854498|NCT00372489|10862730|FG000|Overall Study|Adverse Event|18
6854499|NCT00372489|10862730|FG000|Overall Study|Lack of Efficacy|1
6854500|NCT00372489|10862730|FG000|Overall Study|Lost to Follow-up|3
6854501|NCT00372489|10862730|FG000|Overall Study|Physician Decision|3
6854502|NCT00372489|10862730|FG000|Overall Study|Withdrawal by Subject|5
6854503|NCT00372489|10862730|FG000|Overall Study|Patient Relocation|2
6854504|NCT00372489|10862730|FG000|Overall Study|Renal transplant|6
6854505|NCT00372489|10862730|FG000|Overall Study|Sponsor Decision to Terminate Study|41
6854506|NCT00372528|10862734|FG000|Overall Study|Lack of Efficacy|1
6854507|NCT00372528|10862734|FG000|Overall Study|Adverse Event|1
6854508|NCT00372528|10862734|FG000|Overall Study|Study Terminated by Sponsor|18
6854509|NCT00372528|10862734|FG000|Overall Study|Other|1
6854510|NCT00372567|10862741|FG000|Phase 3 Study|Adverse Event|5
6854511|NCT00372567|10862742|FG001|Phase 3 Study|Adverse Event|1
6854512|NCT00372567|10862743|FG002|Phase 3 Study|Adverse Event|1
6854513|NCT00372567|10862741|FG000|Phase 3 Study|Death|1
6854514|NCT00372567|10862742|FG001|Phase 3 Study|Death|1
6854515|NCT00372567|10862743|FG002|Phase 3 Study|Death|0
6854516|NCT00372567|10862741|FG000|Phase 3 Study|Protocol Violation|0
6854517|NCT00372567|10862742|FG001|Phase 3 Study|Protocol Violation|0
6854518|NCT00372567|10862743|FG002|Phase 3 Study|Protocol Violation|1
6854519|NCT00372567|10862741|FG000|Phase 3 Study|Objective progression or relapse|10
6854520|NCT00372567|10862742|FG001|Phase 3 Study|Objective progression or relapse|13
6854521|NCT00372567|10862743|FG002|Phase 3 Study|Objective progression or relapse|4
6854522|NCT00372567|10862741|FG000|Phase 3 Study|Global deterioration of health status|0
6854523|NCT00372567|10862742|FG001|Phase 3 Study|Global deterioration of health status|1
6854524|NCT00372567|10862743|FG002|Phase 3 Study|Global deterioration of health status|0
6854525|NCT00372567|10862741|FG000|Phase 3 Study|Other|2
6854526|NCT00372567|10862742|FG001|Phase 3 Study|Other|2
6854527|NCT00372567|10862743|FG002|Phase 3 Study|Other|1
6854528|NCT00372567|10862741|FG000|Phase 3 Study|study terminated by sponsor|13
6854529|NCT00372567|10862742|FG001|Phase 3 Study|study terminated by sponsor|8
6854530|NCT00372567|10862743|FG002|Phase 3 Study|study terminated by sponsor|5
6854531|NCT00372593|10862754|FG000|Overall Study|Adverse Event|43
6854532|NCT00372593|10862755|FG001|Overall Study|Adverse Event|45
6854533|NCT00372593|10862756|FG002|Overall Study|Adverse Event|0
6854534|NCT00372593|10862754|FG000|Overall Study|Death|16
6854535|NCT00372593|10862755|FG001|Overall Study|Death|20
6854536|NCT00372593|10862756|FG002|Overall Study|Death|1
6854537|NCT00372593|10862754|FG000|Overall Study|Lack of Efficacy|82
6854538|NCT00372593|10862755|FG001|Overall Study|Lack of Efficacy|71
6854539|NCT00372593|10862756|FG002|Overall Study|Lack of Efficacy|2
6854540|NCT00372593|10862754|FG000|Overall Study|Lost to Follow-up|1
6854541|NCT00372593|10862755|FG001|Overall Study|Lost to Follow-up|0
6854542|NCT00372593|10862756|FG002|Overall Study|Lost to Follow-up|0
6854543|NCT00372593|10862754|FG000|Overall Study|Physician Decision|42
6854544|NCT00372593|10862755|FG001|Overall Study|Physician Decision|41
6854545|NCT00372593|10862756|FG002|Overall Study|Physician Decision|0
6854546|NCT00372593|10862754|FG000|Overall Study|Ineligible|20
6854547|NCT00372593|10862755|FG001|Overall Study|Ineligible|21
6854548|NCT00372593|10862756|FG002|Overall Study|Ineligible|1
6854549|NCT00372619|10862772|FG000|Overall Study|Ineligible|0
6854550|NCT00372619|10862773|FG001|Overall Study|Ineligible|0
6854551|NCT00372619|10862774|FG002|Overall Study|Ineligible|0
6854552|NCT00372619|10862775|FG003|Overall Study|Ineligible|0
6854553|NCT00372619|10862776|FG004|Overall Study|Ineligible|0
6854554|NCT00372619|10862777|FG005|Overall Study|Ineligible|2
6854555|NCT00372619|10862778|FG006|Overall Study|Ineligible|0
6854556|NCT00372619|10862772|FG000|Overall Study|Inevaluable|0
6854557|NCT00372619|10862773|FG001|Overall Study|Inevaluable|0
6854558|NCT00372619|10862774|FG002|Overall Study|Inevaluable|0
6854559|NCT00372619|10862775|FG003|Overall Study|Inevaluable|0
6854560|NCT00372619|10862776|FG004|Overall Study|Inevaluable|0
6854561|NCT00372619|10862777|FG005|Overall Study|Inevaluable|1
6854562|NCT00372619|10862778|FG006|Overall Study|Inevaluable|0
6854563|NCT00372697|10862796|FG000|Overall Study|Protocol Violation|1
6854564|NCT00372697|10862797|FG001|Overall Study|Protocol Violation|1
6854565|NCT00372775|10862803|FG000|Overall Study|Adverse Event|8
6854566|NCT00372775|10862803|FG000|Overall Study|Death|15
6854567|NCT00372775|10862803|FG000|Overall Study|Objective progression or relapse|30
6854568|NCT00372775|10862803|FG000|Overall Study|Global deterioration of health status|6
6854569|NCT00372775|10862803|FG000|Overall Study|Withdrawal by Subject|1
6854570|NCT00372775|10862803|FG000|Overall Study|Other|1
6854571|NCT00372775|10862803|FG000|Overall Study|Not Treated|2
6854572|NCT00372905|10862807|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2
6854573|NCT00372905|10862808|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
6854574|NCT00372905|10862809|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
6854575|NCT00372905|10862810|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
6854576|NCT00372905|10862807|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
6854577|NCT00372905|10862808|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
6854578|NCT00372905|10862809|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2
6854579|NCT00372905|10862810|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
6854580|NCT00372905|10862807|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
6854581|NCT00372905|10862808|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
6854582|NCT00372905|10862809|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1
6854583|NCT00372905|10862810|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
6854584|NCT00372905|10862807|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
6854585|NCT00372905|10862808|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
6854586|NCT00372905|10862809|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
6854587|NCT00372905|10862810|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2
6854588|NCT00372905|10862807|FG000|Follow up Until Relapse or Progression|Study closed|0
6854589|NCT00372905|10862808|FG001|Follow up Until Relapse or Progression|Study closed|0
6854590|NCT00372905|10862809|FG002|Follow up Until Relapse or Progression|Study closed|0
6854591|NCT00372905|10862810|FG003|Follow up Until Relapse or Progression|Study closed|3
6854592|NCT00372905|10862807|FG000|Follow up Until Relapse or Progression|Other|0
6854593|NCT00372905|10862808|FG001|Follow up Until Relapse or Progression|Other|1
6854594|NCT00372905|10862809|FG002|Follow up Until Relapse or Progression|Other|0
7077840|NCT02096705|11185753|FG000|Follow-up|Subjects not reporting status|1
7077841|NCT02096705|11185754|FG001|Follow-up|Subjects not reporting status|2
7077842|NCT02096744|11185786|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0
7077843|NCT02096744|11185787|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1
7077844|NCT02096744|11185786|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1
7077845|NCT02096744|11185787|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0
7077846|NCT02096744|11185786|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0
7077847|NCT02096744|11185787|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1
7077848|NCT02096835|11185798|FG000|Overall Study|Withdrawal by Subject|1
7077849|NCT02096835|11185799|FG001|Overall Study|Withdrawal by Subject|0
7077850|NCT02096835|11185800|FG002|Overall Study|Withdrawal by Subject|0
7077851|NCT02096835|11185798|FG000|Overall Study|converted to open procedures|1
7077852|NCT02096835|11185799|FG001|Overall Study|converted to open procedures|0
7077853|NCT02096835|11185800|FG002|Overall Study|converted to open procedures|0
7077854|NCT02096835|11185798|FG000|Overall Study|Lost to Follow-up|1
7077855|NCT02096835|11185799|FG001|Overall Study|Lost to Follow-up|0
7077856|NCT02096835|11185800|FG002|Overall Study|Lost to Follow-up|1
7077857|NCT02096900|11185829|FG000|Overall Study|Did not receive medication|3
7077858|NCT02096900|11185830|FG001|Overall Study|Did not receive medication|1
7077859|NCT02096900|11185829|FG000|Overall Study|Surgery cancelled- medication received|1
7077860|NCT02096900|11185830|FG001|Overall Study|Surgery cancelled- medication received|1
7077861|NCT02096952|11185836|FG000|Overall Study|Adverse Event|1
7077862|NCT02097030|11185842|FG000|First Intervention (3 Days)|Lost to Follow-up|1
7077863|NCT02097030|11185843|FG001|First Intervention (3 Days)|Lost to Follow-up|0
6854595|NCT00372905|10862810|FG003|Follow up Until Relapse or Progression|Other|0
6854596|NCT00372996|10862846|FG000|Overall Study|Death|11
6854597|NCT00372996|10862847|FG001|Overall Study|Death|4
6854598|NCT00372996|10862848|FG002|Overall Study|Death|8
6854599|NCT00372996|10862849|FG003|Overall Study|Death|7
6854600|NCT00372996|10862846|FG000|Overall Study|Lost to Follow-up|0
6854601|NCT00372996|10862847|FG001|Overall Study|Lost to Follow-up|2
6854602|NCT00372996|10862848|FG002|Overall Study|Lost to Follow-up|0
6854603|NCT00372996|10862849|FG003|Overall Study|Lost to Follow-up|1
6854604|NCT00372996|10862846|FG000|Overall Study|Withdrawal by Subject|12
6854605|NCT00372996|10862847|FG001|Overall Study|Withdrawal by Subject|6
6854606|NCT00372996|10862848|FG002|Overall Study|Withdrawal by Subject|9
6854607|NCT00372996|10862849|FG003|Overall Study|Withdrawal by Subject|5
6854608|NCT00372996|10862846|FG000|Overall Study|Study Terminated by Sponsor|4
6854609|NCT00372996|10862847|FG001|Overall Study|Study Terminated by Sponsor|0
6854610|NCT00372996|10862848|FG002|Overall Study|Study Terminated by Sponsor|4
6854611|NCT00372996|10862849|FG003|Overall Study|Study Terminated by Sponsor|0
6854612|NCT00372996|10862846|FG000|Overall Study|Other|10
6854613|NCT00372996|10862847|FG001|Overall Study|Other|2
6854614|NCT00372996|10862848|FG002|Overall Study|Other|7
6854615|NCT00372996|10862849|FG003|Overall Study|Other|7
6854616|NCT00373113|10862861|FG000|Overall Study|Death|1
6854617|NCT00373113|10862862|FG001|Overall Study|Death|7
6854618|NCT00373113|10862861|FG000|Overall Study|Adverse Event|38
6854619|NCT00373113|10862862|FG001|Overall Study|Adverse Event|24
6854620|NCT00373113|10862861|FG000|Overall Study|Study terminated by sponsor|9
6854621|NCT00373113|10862862|FG001|Overall Study|Study terminated by sponsor|1
6854622|NCT00373113|10862861|FG000|Overall Study|Global deterioration of health status|10
6854623|NCT00373113|10862862|FG001|Overall Study|Global deterioration of health status|7
6854624|NCT00373113|10862861|FG000|Overall Study|Lost to Follow-up|1
6854625|NCT00373113|10862862|FG001|Overall Study|Lost to Follow-up|3
6854626|NCT00373113|10862861|FG000|Overall Study|Objective progression or relapse|150
6854627|NCT00373113|10862862|FG001|Overall Study|Objective progression or relapse|169
6854628|NCT00373113|10862861|FG000|Overall Study|Other|14
6854629|NCT00373113|10862862|FG001|Overall Study|Other|17
6854630|NCT00373113|10862861|FG000|Overall Study|Protocol Violation|5
6854631|NCT00373113|10862862|FG001|Overall Study|Protocol Violation|1
6854632|NCT00373113|10862861|FG000|Overall Study|Withdrawal by Subject|10
7077864|NCT02097030|11185842|FG000|First Intervention (3 Days)|Visual Acuity|0
6854633|NCT00373113|10862862|FG001|Overall Study|Withdrawal by Subject|15
6854634|NCT00373256|10862870|FG000|Overall Study|Adverse Event (AE)|1
6854635|NCT00373256|10862871|FG001|Overall Study|Adverse Event (AE)|5
7152648|NCT03261167|11317662|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1
7152649|NCT03261167|11317661|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1
7152650|NCT03261167|11317662|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0
7152651|NCT03261167|11317661|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1
7152652|NCT03261167|11317662|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0
7152653|NCT03261167|11317661|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1
7152654|NCT03261167|11317662|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1
7152655|NCT03261336|11317674|FG000|Overall Study|Adverse Event|1
7152656|NCT03261947|11317683|FG000|Overall Study|Death|10
7152657|NCT03261947|11317684|FG001|Overall Study|Death|13
7152658|NCT03261947|11317685|FG002|Overall Study|Death|17
7152659|NCT03261947|11317686|FG003|Overall Study|Death|12
7152660|NCT03261947|11317687|FG004|Overall Study|Death|8
7152661|NCT03261947|11317683|FG000|Overall Study|Lost to Follow-up|0
7152662|NCT03261947|11317684|FG001|Overall Study|Lost to Follow-up|0
7152663|NCT03261947|11317685|FG002|Overall Study|Lost to Follow-up|2
7152664|NCT03261947|11317686|FG003|Overall Study|Lost to Follow-up|1
7152665|NCT03261947|11317687|FG004|Overall Study|Lost to Follow-up|0
7152666|NCT03261947|11317683|FG000|Overall Study|Withdrawal by Subject|0
7152667|NCT03261947|11317684|FG001|Overall Study|Withdrawal by Subject|0
7152668|NCT03261947|11317685|FG002|Overall Study|Withdrawal by Subject|3
7152669|NCT03261947|11317686|FG003|Overall Study|Withdrawal by Subject|0
7152670|NCT03261947|11317687|FG004|Overall Study|Withdrawal by Subject|1
7152671|NCT03261947|11317683|FG000|Overall Study|Site Terminated by Sponsor|0
7152672|NCT03261947|11317684|FG001|Overall Study|Site Terminated by Sponsor|0
6854636|NCT00373256|10862870|FG000|Overall Study|Lost to Follow-up|2
6854637|NCT00373256|10862871|FG001|Overall Study|Lost to Follow-up|1
6854638|NCT00373256|10862870|FG000|Overall Study|Death|9
6854639|NCT00373256|10862871|FG001|Overall Study|Death|8
6854640|NCT00373256|10862870|FG000|Overall Study|Objective Progression or Relapse|111
6854641|NCT00373256|10862871|FG001|Overall Study|Objective Progression or Relapse|104
6854642|NCT00373256|10862870|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4
6854643|NCT00373256|10862871|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7
6854644|NCT00373256|10862870|FG000|Overall Study|Other|73
6854645|NCT00373256|10862871|FG001|Overall Study|Other|107
6854646|NCT00373256|10862870|FG000|Overall Study|Protocol Violation|0
6854647|NCT00373256|10862871|FG001|Overall Study|Protocol Violation|2
6854648|NCT00373256|10862870|FG000|Overall Study|Study Terminated by Sponsor|41
6854649|NCT00373256|10862871|FG001|Overall Study|Study Terminated by Sponsor|13
6854650|NCT00373295|10862886|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0
6854651|NCT00373295|10862887|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2
6854652|NCT00373295|10862888|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0
6854653|NCT00373295|10862889|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0
6854654|NCT00373295|10862890|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1
6854655|NCT00373295|10862891|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0
6854656|NCT00373425|10862940|FG000|Overall Study|Relapse of NSCLC|116
6854657|NCT00373425|10862941|FG001|Overall Study|Relapse of NSCLC|104
6854658|NCT00373425|10862942|FG002|Overall Study|Relapse of NSCLC|19
6854659|NCT00373425|10862943|FG003|Overall Study|Relapse of NSCLC|2
6967071|NCT01129960|11015489|FG002|Overall Study|Pregnancy|0
6967072|NCT01129960|11015490|FG003|Overall Study|Pregnancy|0
6967073|NCT01130051|11015500|FG000|Washout Period of 14 Days|Withdrawal by Subject|0
6967074|NCT01130051|11015501|FG001|Washout Period of 14 Days|Withdrawal by Subject|1
6967075|NCT01130051|11015500|FG000|Washout Period of 14 Days|Protocol Violation|1
6967076|NCT01130051|11015501|FG001|Washout Period of 14 Days|Protocol Violation|1
7040932|NCT01721408|11124178|FG000|Overall Study|Insufficient clinical response|15
7040933|NCT01721408|11124179|FG001|Overall Study|Insufficient clinical response|6
7040934|NCT01721408|11124178|FG000|Overall Study|No longer willing to participate study|9
7040935|NCT01721408|11124179|FG001|Overall Study|No longer willing to participate study|10
7040936|NCT01721408|11124178|FG000|Overall Study|Protocol Violation|0
7040937|NCT01721408|11124179|FG001|Overall Study|Protocol Violation|2
7040938|NCT01721408|11124178|FG000|Overall Study|Other|3
7040939|NCT01721408|11124179|FG001|Overall Study|Other|3
7040940|NCT01721408|11124178|FG000|Overall Study|Lost to Follow-up|1
7040941|NCT01721408|11124179|FG001|Overall Study|Lost to Follow-up|2
7040942|NCT01721408|11124178|FG000|Overall Study|Does not meet entrance criteria|1
7040943|NCT01721408|11124179|FG001|Overall Study|Does not meet entrance criteria|0
7040944|NCT01721486|11124218|FG000|Overall Study|Protocol Violation|1
7040945|NCT01721486|11124219|FG001|Overall Study|Protocol Violation|0
7152673|NCT03261947|11317685|FG002|Overall Study|Site Terminated by Sponsor|4
6854660|NCT00373425|10862944|FG004|Overall Study|Relapse of NSCLC|26
6967077|NCT01130103|11015509|FG000|Randomized Treatment|Adverse Event|1
6967078|NCT01130103|11015510|FG001|Randomized Treatment|Adverse Event|1
6967079|NCT01130103|11015509|FG000|Randomized Treatment|Lost to Follow-up|1
6967080|NCT01130103|11015510|FG001|Randomized Treatment|Lost to Follow-up|0
6967081|NCT01130103|11015509|FG000|Randomized Treatment|Protocol Violation|3
6967082|NCT01130103|11015510|FG001|Randomized Treatment|Protocol Violation|2
6967083|NCT01130103|11015509|FG000|Randomized Treatment|Withdrawal by Subject|1
6967084|NCT01130103|11015510|FG001|Randomized Treatment|Withdrawal by Subject|2
6967085|NCT01130103|11015509|FG000|Maintenance Treatment|Lack of Efficacy|0
6854661|NCT00373425|10862940|FG000|Overall Study|Adverse Event|191
6854662|NCT00373425|10862941|FG001|Overall Study|Adverse Event|22
6854663|NCT00373425|10862942|FG002|Overall Study|Adverse Event|59
6854664|NCT00373425|10862943|FG003|Overall Study|Adverse Event|0
6854665|NCT00373425|10862944|FG004|Overall Study|Adverse Event|34
6854666|NCT00373425|10862940|FG000|Overall Study|Patient request|35
6854667|NCT00373425|10862941|FG001|Overall Study|Patient request|18
6854668|NCT00373425|10862942|FG002|Overall Study|Patient request|43
6854669|NCT00373425|10862943|FG003|Overall Study|Patient request|6
6854670|NCT00373425|10862944|FG004|Overall Study|Patient request|7
6854671|NCT00373425|10862940|FG000|Overall Study|Medical/ethical/noncompliance reason|21
6854672|NCT00373425|10862941|FG001|Overall Study|Medical/ethical/noncompliance reason|9
6854673|NCT00373425|10862942|FG002|Overall Study|Medical/ethical/noncompliance reason|10
6854674|NCT00373425|10862943|FG003|Overall Study|Medical/ethical/noncompliance reason|2
6854675|NCT00373425|10862944|FG004|Overall Study|Medical/ethical/noncompliance reason|5
6854676|NCT00373425|10862940|FG000|Overall Study|Death|7
6854677|NCT00373425|10862941|FG001|Overall Study|Death|0
6854678|NCT00373425|10862942|FG002|Overall Study|Death|3
6854679|NCT00373425|10862943|FG003|Overall Study|Death|1
6854680|NCT00373425|10862944|FG004|Overall Study|Death|0
6854681|NCT00373490|10862955|FG000|Overall Study|Adverse Event|0
6854682|NCT00373490|10862956|FG001|Overall Study|Adverse Event|1
6854683|NCT00373490|10862955|FG000|Overall Study|Lack of Efficacy|9
6854684|NCT00373490|10862956|FG001|Overall Study|Lack of Efficacy|4
6854685|NCT00373490|10862955|FG000|Overall Study|Withdrawal by Subject|0
6854686|NCT00373490|10862956|FG001|Overall Study|Withdrawal by Subject|1
6854687|NCT00373529|10862962|FG000|Overall Study|Physician Decision|19
6854688|NCT00373529|10862962|FG000|Overall Study|Withdrawal by Subject|7
6854689|NCT00373529|10862962|FG000|Overall Study|Adverse Event|7
6854690|NCT00373529|10862962|FG000|Overall Study|Treatment failure|36
6854691|NCT00373529|10862962|FG000|Overall Study|Disease recurrence|10
6854692|NCT00373529|10862962|FG000|Overall Study|Death|16
6854693|NCT00373529|10862962|FG000|Overall Study|Need for treatment prohibited by study|1
6854694|NCT00373529|10862962|FG000|Overall Study|Other|8
6854695|NCT00373529|10862962|FG000|Overall Study|Failed independent confirmation of AML|3
6854696|NCT00373529|10862962|FG000|Overall Study|Consent violation|1
6854697|NCT00373685|10862968|FG000|Overall Study|Death|2
6854698|NCT00373685|10862969|FG001|Overall Study|Death|1
6854699|NCT00373685|10862968|FG000|Overall Study|Adverse Event|278
6854700|NCT00373685|10862969|FG001|Overall Study|Adverse Event|253
6854701|NCT00373685|10862968|FG000|Overall Study|Insufficient clinical response|169
6854702|NCT00373685|10862969|FG001|Overall Study|Insufficient clinical response|119
6854703|NCT00373685|10862968|FG000|Overall Study|Did not meet entrance criteria|167
6854704|NCT00373685|10862969|FG001|Overall Study|Did not meet entrance criteria|184
6854705|NCT00373685|10862968|FG000|Overall Study|Lost to follow up|83
6854706|NCT00373685|10862969|FG001|Overall Study|Lost to follow up|103
6854707|NCT00373685|10862968|FG000|Overall Study|No longer willing to participate|337
6854708|NCT00373685|10862969|FG001|Overall Study|No longer willing to participate|352
6854709|NCT00373685|10862968|FG000|Overall Study|Other|149
6854710|NCT00373685|10862969|FG001|Overall Study|Other|146
6854711|NCT00373685|10862968|FG000|Overall Study|Protocol Violation|191
6854712|NCT00373685|10862969|FG001|Overall Study|Protocol Violation|182
6854713|NCT00373685|10862968|FG000|Overall Study|Final Status Unknown|12
6854714|NCT00373685|10862969|FG001|Overall Study|Final Status Unknown|4
6854715|NCT00373685|10862968|FG000|Overall Study|Randomized, not treated|51
6854716|NCT00373685|10862969|FG001|Overall Study|Randomized, not treated|77
6854717|NCT00373880|10862986|FG000|Overall Study|Physician Decision|3
6854718|NCT00373880|10862986|FG000|Overall Study|Arrested|1
6854719|NCT00373880|10862986|FG000|Overall Study|Protocol Violation|14
6854720|NCT00373958|10863000|FG000|Infant Series|Withdrawal by Subject|13
6854721|NCT00373958|10863001|FG001|Infant Series|Withdrawal by Subject|15
6854722|NCT00373958|10863000|FG000|Infant Series|Failed to return|8
6854723|NCT00373958|10863001|FG001|Infant Series|Failed to return|13
6854724|NCT00373958|10863000|FG000|Infant Series|Lost to Follow-up|6
6854725|NCT00373958|10863001|FG001|Infant Series|Lost to Follow-up|5
6854726|NCT00373958|10863000|FG000|Infant Series|Protocol Violation|3
6854727|NCT00373958|10863001|FG001|Infant Series|Protocol Violation|7
6854728|NCT00373958|10863000|FG000|Infant Series|Lost Kaiser coverage|4
6854729|NCT00373958|10863001|FG001|Infant Series|Lost Kaiser coverage|0
6854730|NCT00373958|10863000|FG000|Infant Series|Child relocated|1
6854731|NCT00373958|10863001|FG001|Infant Series|Child relocated|0
6854732|NCT00373958|10863000|FG000|Infant Series|Consent was not received|1
6854733|NCT00373958|10863001|FG001|Infant Series|Consent was not received|0
6854734|NCT00373958|10863000|FG000|Infant Series|Adverse Event|3
6854735|NCT00373958|10863001|FG001|Infant Series|Adverse Event|1
6854736|NCT00373958|10863000|FG000|Infant Series|Physician Decision|1
6854737|NCT00373958|10863001|FG001|Infant Series|Physician Decision|1
6854738|NCT00373958|10863000|FG000|Toddler Dose|Lost to Follow-up|5
6854739|NCT00373958|10863001|FG001|Toddler Dose|Lost to Follow-up|8
6854740|NCT00373958|10863000|FG000|Toddler Dose|Withdrawal by Subject|2
6854741|NCT00373958|10863001|FG001|Toddler Dose|Withdrawal by Subject|2
6854742|NCT00373958|10863000|FG000|Toddler Dose|Failed to return|1
6854743|NCT00373958|10863001|FG001|Toddler Dose|Failed to return|2
6854744|NCT00373958|10863000|FG000|Toddler Dose|Protocol Violation|0
6854745|NCT00373958|10863001|FG001|Toddler Dose|Protocol Violation|1
6854746|NCT00373958|10863000|FG000|Toddler Dose|Withdrawn after infant series|22
6854747|NCT00373958|10863001|FG001|Toddler Dose|Withdrawn after infant series|25
6854748|NCT00374127|10863039|FG000|Overall Study|Did not inhale during smoking procedure.|3
6854749|NCT00374127|10863039|FG000|Overall Study|Blood could not be drawn.|2
6854750|NCT00374127|10863039|FG000|Overall Study|Protocol Violation|5
6854751|NCT00374127|10863039|FG000|Overall Study|Pregnancy|1
6854752|NCT00374140|10863049|FG000|Overall Study|Lost to Follow-up|1
6854753|NCT00374140|10863049|FG000|Overall Study|Protocol Violation|1
6854754|NCT00374322|10863069|FG000|Overall Study|Lost to Follow-up|92
6854755|NCT00374322|10863070|FG001|Overall Study|Lost to Follow-up|90
6854756|NCT00374322|10863069|FG000|Overall Study|Protocol Violation|8
6854757|NCT00374322|10863070|FG001|Overall Study|Protocol Violation|3
6854758|NCT00374322|10863069|FG000|Overall Study|Withdrawal by Subject|235
6854759|NCT00374322|10863070|FG001|Overall Study|Withdrawal by Subject|167
6854760|NCT00374322|10863069|FG000|Overall Study|Sponsor Terminated Study|866
6854761|NCT00374322|10863070|FG001|Overall Study|Sponsor Terminated Study|990
6854762|NCT00374322|10863069|FG000|Overall Study|Physician Decision|36
6854763|NCT00374322|10863070|FG001|Overall Study|Physician Decision|32
6854764|NCT00374322|10863069|FG000|Overall Study|Par. Consented to Survival FU Only|3
6854765|NCT00374322|10863070|FG001|Overall Study|Par. Consented to Survival FU Only|1
6854766|NCT00374322|10863069|FG000|Overall Study|Sponsor Decision|2
6854767|NCT00374322|10863070|FG001|Overall Study|Sponsor Decision|3
6854768|NCT00374322|10863069|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2
6854769|NCT00374322|10863070|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3
6854770|NCT00374322|10863069|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1
6854771|NCT00374322|10863070|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0
6854772|NCT00374322|10863069|FG000|Overall Study|Severe Toxicity|1
6854773|NCT00374322|10863070|FG001|Overall Study|Severe Toxicity|0
6854774|NCT00374322|10863069|FG000|Overall Study|Site Closed|2
6854775|NCT00374322|10863070|FG001|Overall Study|Site Closed|2
6854776|NCT00374322|10863069|FG000|Overall Study|Participant Changed Physician|1
6854777|NCT00374322|10863070|FG001|Overall Study|Participant Changed Physician|0
6854778|NCT00374322|10863069|FG000|Overall Study|Started Another Chemotherapy Regimen|0
6854779|NCT00374322|10863070|FG001|Overall Study|Started Another Chemotherapy Regimen|1
6854780|NCT00374322|10863069|FG000|Overall Study|Noncompliance with Study Requirements|0
6854781|NCT00374322|10863070|FG001|Overall Study|Noncompliance with Study Requirements|1
6854782|NCT00374322|10863069|FG000|Overall Study|Withdrew Consent During Follow-up|0
6854783|NCT00374322|10863070|FG001|Overall Study|Withdrew Consent During Follow-up|5
6854784|NCT00374322|10863069|FG000|Overall Study|Did Not Receive Study Medication|8
6854785|NCT00374322|10863070|FG001|Overall Study|Did Not Receive Study Medication|6
6854786|NCT00374452|10863083|FG000|Overall Study|Left clinic before intervention started|4
6854787|NCT00374452|10863084|FG001|Overall Study|Left clinic before intervention started|1
6854788|NCT00374452|10863083|FG000|Overall Study|Change in job role before intervention|0
6854789|NCT00374452|10863084|FG001|Overall Study|Change in job role before intervention|1
6854790|NCT00374452|10863083|FG000|Overall Study|Left clinic after intervention started|1
6854791|NCT00374452|10863084|FG001|Overall Study|Left clinic after intervention started|1
6854792|NCT00374452|10863083|FG000|Overall Study|Withdrawal by Subject|0
6854793|NCT00374452|10863084|FG001|Overall Study|Withdrawal by Subject|2
6854794|NCT00374556|10863092|FG000|Overall Study|Lost to Follow-up|1
6854795|NCT00374556|10863093|FG001|Overall Study|Lost to Follow-up|0
6854796|NCT00374556|10863092|FG000|Overall Study|Removed at baseline due to medical cond|0
6854797|NCT00374556|10863093|FG001|Overall Study|Removed at baseline due to medical cond|1
6854798|NCT00374868|10863125|FG000|Overall Study|Adverse Event|12
6854799|NCT00374868|10863125|FG000|Overall Study|Progressive Disease|7
6854800|NCT00374868|10863125|FG000|Overall Study|Physician Decision|13
6854801|NCT00374868|10863125|FG000|Overall Study|Lost to Follow-up|1
6854802|NCT00374868|10863125|FG000|Overall Study|Death|2
6854803|NCT00374868|10863125|FG000|Overall Study|Other - Not Specified|1
6854804|NCT00374907|10863131|FG000|12-Week Short-term Period|Subject Withdrew Consent|3
6854805|NCT00374907|10863132|FG001|12-Week Short-term Period|Subject Withdrew Consent|1
6854806|NCT00374907|10863131|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8
6854807|NCT00374907|10863132|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9
6854808|NCT00374907|10863131|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4
6854809|NCT00374907|10863132|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2
6854810|NCT00374907|10863131|FG000|116-Week Short-term + Long-term Period|Adverse Event|0
6854811|NCT00374907|10863132|FG001|116-Week Short-term + Long-term Period|Adverse Event|2
6854812|NCT00374907|10863131|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1
6854813|NCT00374907|10863132|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1
6854814|NCT00375219|10863154|FG000|Overall Study|Failure to achieve a response|16
6854815|NCT00375219|10863155|FG001|Overall Study|Failure to achieve a response|2
6854816|NCT00375219|10863156|FG002|Overall Study|Failure to achieve a response|0
6854817|NCT00375219|10863154|FG000|Overall Study|Adverse Event|8
6854818|NCT00375219|10863155|FG001|Overall Study|Adverse Event|2
6854819|NCT00375219|10863156|FG002|Overall Study|Adverse Event|1
6854820|NCT00375219|10863154|FG000|Overall Study|Protocol Violation|1
6854821|NCT00375219|10863155|FG001|Overall Study|Protocol Violation|0
6854822|NCT00375219|10863156|FG002|Overall Study|Protocol Violation|1
6854823|NCT00375219|10863154|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5
6854824|NCT00375219|10863155|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3
6854825|NCT00375219|10863156|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0
6854826|NCT00375219|10863154|FG000|Overall Study|Lost to Follow-up|1
6854827|NCT00375219|10863155|FG001|Overall Study|Lost to Follow-up|1
6854828|NCT00375219|10863156|FG002|Overall Study|Lost to Follow-up|0
6854829|NCT00375219|10863154|FG000|Overall Study|Disease progression|18
6854830|NCT00375219|10863155|FG001|Overall Study|Disease progression|9
6854831|NCT00375219|10863156|FG002|Overall Study|Disease progression|12
6854832|NCT00375219|10863154|FG000|Overall Study|Death|4
6854833|NCT00375219|10863155|FG001|Overall Study|Death|3
6854834|NCT00375219|10863156|FG002|Overall Study|Death|7
6854835|NCT00375219|10863154|FG000|Overall Study|Hematologic resistance|1
6854836|NCT00375219|10863155|FG001|Overall Study|Hematologic resistance|0
6854837|NCT00375219|10863156|FG002|Overall Study|Hematologic resistance|0
6854838|NCT00375219|10863154|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1
6854839|NCT00375219|10863155|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0
6854840|NCT00375219|10863156|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0
6854841|NCT00375219|10863154|FG000|Overall Study|Allograft|2
6854842|NCT00375219|10863155|FG001|Overall Study|Allograft|0
6854843|NCT00375219|10863156|FG002|Overall Study|Allograft|0
6854844|NCT00375219|10863154|FG000|Overall Study|Cord blood transplantation|1
6854845|NCT00375219|10863155|FG001|Overall Study|Cord blood transplantation|0
6854846|NCT00375219|10863156|FG002|Overall Study|Cord blood transplantation|0
6854847|NCT00375219|10863154|FG000|Overall Study|Withdrawal by Subject|1
6854848|NCT00375219|10863155|FG001|Overall Study|Withdrawal by Subject|0
6854849|NCT00375219|10863156|FG002|Overall Study|Withdrawal by Subject|0
6854850|NCT00375427|10863165|FG000|Overall Study|Adverse Event|21
6854851|NCT00375427|10863166|FG001|Overall Study|Adverse Event|27
6854852|NCT00375427|10863165|FG000|Overall Study|Abnormal test procedure result(s)|0
6854853|NCT00375427|10863166|FG001|Overall Study|Abnormal test procedure result(s)|1
6854854|NCT00375427|10863165|FG000|Overall Study|Abnormal laboratory value(s)|1
6854855|NCT00375427|10863166|FG001|Overall Study|Abnormal laboratory value(s)|2
6854856|NCT00375427|10863165|FG000|Overall Study|Unsatisfactory therapeutic effect|4
6854857|NCT00375427|10863166|FG001|Overall Study|Unsatisfactory therapeutic effect|4
6854858|NCT00375427|10863165|FG000|Overall Study|Patient no longer requires study drug|3
6854859|NCT00375427|10863166|FG001|Overall Study|Patient no longer requires study drug|7
6854860|NCT00375427|10863165|FG000|Overall Study|Protocol Violation|10
6854861|NCT00375427|10863166|FG001|Overall Study|Protocol Violation|8
6854862|NCT00375427|10863165|FG000|Overall Study|Withdrawal by Subject|9
6854863|NCT00375427|10863166|FG001|Overall Study|Withdrawal by Subject|13
6854864|NCT00375427|10863165|FG000|Overall Study|Lost to Follow-up|1
6854865|NCT00375427|10863166|FG001|Overall Study|Lost to Follow-up|1
6854866|NCT00375427|10863165|FG000|Overall Study|Administrative reasons|0
6854867|NCT00375427|10863166|FG001|Overall Study|Administrative reasons|1
6854868|NCT00375427|10863165|FG000|Overall Study|Death|11
6854869|NCT00375427|10863166|FG001|Overall Study|Death|10
6854870|NCT00375492|10863174|FG000|Overall Study|Adverse Event|4
6854871|NCT00375492|10863175|FG001|Overall Study|Adverse Event|5
6854872|NCT00375492|10863174|FG000|Overall Study|Entry Criteria Not Met|0
6854873|NCT00375492|10863175|FG001|Overall Study|Entry Criteria Not Met|1
6854874|NCT00375492|10863174|FG000|Overall Study|Loss of Glucose Control|0
6854875|NCT00375492|10863175|FG001|Overall Study|Loss of Glucose Control|1
6854876|NCT00375492|10863174|FG000|Overall Study|Lost to Follow-up|10
6854877|NCT00375492|10863175|FG001|Overall Study|Lost to Follow-up|5
6854878|NCT00375492|10863174|FG000|Overall Study|Physician Decision|0
6854879|NCT00375492|10863175|FG001|Overall Study|Physician Decision|4
6854880|NCT00375492|10863174|FG000|Overall Study|Protocol Violation|6
6854881|NCT00375492|10863175|FG001|Overall Study|Protocol Violation|3
6854882|NCT00375492|10863174|FG000|Overall Study|Sponsor Decision|0
6854883|NCT00375492|10863175|FG001|Overall Study|Sponsor Decision|1
6854884|NCT00375492|10863174|FG000|Overall Study|Withdrawal by Subject|6
6854885|NCT00375492|10863175|FG001|Overall Study|Withdrawal by Subject|6
6854886|NCT00375505|10863183|FG000|Overall Study|Adverse Event|1
6854887|NCT00375505|10863184|FG001|Overall Study|Adverse Event|2
6854888|NCT00375518|10863192|FG000|Overall Study|Withdrawal by Subject|2
6854889|NCT00375518|10863193|FG001|Overall Study|Withdrawal by Subject|10
6854890|NCT00375518|10863192|FG000|Overall Study|Patient Not Treated|6
6854891|NCT00375518|10863193|FG001|Overall Study|Patient Not Treated|6
6854892|NCT00375518|10863192|FG000|Overall Study|Death|0
6854893|NCT00375518|10863193|FG001|Overall Study|Death|1
6854894|NCT00375609|10863202|FG000|Overall Study|Did not receive treatment|1
6854895|NCT00375609|10863203|FG001|Overall Study|Did not receive treatment|0
6854896|NCT00375609|10863204|FG002|Overall Study|Did not receive treatment|0
6854897|NCT00375609|10863202|FG000|Overall Study|Adverse Event|0
6854898|NCT00375609|10863203|FG001|Overall Study|Adverse Event|3
6854899|NCT00375609|10863204|FG002|Overall Study|Adverse Event|0
6854900|NCT00375609|10863202|FG000|Overall Study|Lost to Follow-up|1
6854901|NCT00375609|10863203|FG001|Overall Study|Lost to Follow-up|0
6854902|NCT00375609|10863204|FG002|Overall Study|Lost to Follow-up|0
6854903|NCT00375609|10863202|FG000|Overall Study|Physician Decision|0
6854904|NCT00375609|10863203|FG001|Overall Study|Physician Decision|0
6854905|NCT00375609|10863204|FG002|Overall Study|Physician Decision|1
6854906|NCT00375609|10863202|FG000|Overall Study|Withdrawal by Subject|1
6854907|NCT00375609|10863203|FG001|Overall Study|Withdrawal by Subject|4
6854908|NCT00375609|10863204|FG002|Overall Study|Withdrawal by Subject|0
6854909|NCT00375609|10863202|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1
6854910|NCT00375609|10863203|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0
6854911|NCT00375609|10863204|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0
6854912|NCT00375674|10863214|FG000|Overall Study|Other|26
6854913|NCT00375674|10863215|FG001|Overall Study|Other|18
6854914|NCT00375674|10863214|FG000|Overall Study|Death|67
6854915|NCT00375674|10863215|FG001|Overall Study|Death|76
6854916|NCT00375674|10863214|FG000|Overall Study|Participants refused further follow-up|31
6854917|NCT00375674|10863215|FG001|Overall Study|Participants refused further follow-up|30
6854918|NCT00375674|10863214|FG000|Overall Study|Lost to Follow-up|17
6854919|NCT00375674|10863215|FG001|Overall Study|Lost to Follow-up|15
6854920|NCT00375674|10863214|FG000|Overall Study|Enrolled but not treated|3
6854921|NCT00375674|10863215|FG001|Overall Study|Enrolled but not treated|2
6854922|NCT00375752|10863232|FG000|Overall Study|Lack of Efficacy|4
6854923|NCT00375752|10863233|FG001|Overall Study|Lack of Efficacy|4
6854924|NCT00375752|10863232|FG000|Overall Study|Adverse Event|1
6854925|NCT00375752|10863233|FG001|Overall Study|Adverse Event|6
6854926|NCT00375752|10863232|FG000|Overall Study|Withdrawal by Subject|6
6854927|NCT00375752|10863233|FG001|Overall Study|Withdrawal by Subject|1
6854928|NCT00375752|10863232|FG000|Overall Study|Abnormal Laboratory Value(s)|1
6854929|NCT00375752|10863233|FG001|Overall Study|Abnormal Laboratory Value(s)|1
6854930|NCT00375752|10863232|FG000|Overall Study|Protocol Violation|0
6854931|NCT00375752|10863233|FG001|Overall Study|Protocol Violation|2
6854932|NCT00375752|10863232|FG000|Overall Study|Administrative Problems|0
6854933|NCT00375752|10863233|FG001|Overall Study|Administrative Problems|1
6854934|NCT00375934|10863266|FG000|Overall Study|Adverse Event|1
6854935|NCT00375934|10863267|FG001|Overall Study|Adverse Event|1
6854936|NCT00375934|10863266|FG000|Overall Study|Withdrawal by Subject|2
6854937|NCT00375934|10863267|FG001|Overall Study|Withdrawal by Subject|2
6854938|NCT00375934|10863266|FG000|Overall Study|Lack of Efficacy|0
6854939|NCT00375934|10863267|FG001|Overall Study|Lack of Efficacy|2
6854940|NCT00375934|10863266|FG000|Overall Study|Physician Decision|0
6854941|NCT00375934|10863267|FG001|Overall Study|Physician Decision|1
6854942|NCT00376168|10863288|FG000|Overall Study|Adverse Event|1
6854943|NCT00376168|10863289|FG001|Overall Study|Adverse Event|1
6854944|NCT00376168|10863288|FG000|Overall Study|Pregnancy|1
6854945|NCT00376168|10863289|FG001|Overall Study|Pregnancy|0
6967086|NCT01130103|11015510|FG001|Maintenance Treatment|Lack of Efficacy|1
6967087|NCT01130103|11015509|FG000|Maintenance Treatment|Lost to Follow-up|1
6967088|NCT01130103|11015510|FG001|Maintenance Treatment|Lost to Follow-up|1
6967089|NCT01130103|11015509|FG000|Maintenance Treatment|Withdrawal by Subject|1
6967090|NCT01130103|11015510|FG001|Maintenance Treatment|Withdrawal by Subject|0
6967091|NCT01130168|11015516|FG000|Period 1|Withdrawal by Subject|0
6967092|NCT01130168|11015517|FG001|Period 1|Withdrawal by Subject|1
6967093|NCT01130168|11015518|FG002|Period 1|Withdrawal by Subject|0
6967094|NCT01130168|11015519|FG003|Period 1|Withdrawal by Subject|1
6967095|NCT01130168|11015520|FG004|Period 1|Withdrawal by Subject|0
6967096|NCT01130168|11015521|FG005|Period 1|Withdrawal by Subject|0
6967097|NCT01130168|11015516|FG000|Period 1|Discontinued For Other Reason|0
6967098|NCT01130168|11015517|FG001|Period 1|Discontinued For Other Reason|0
6967099|NCT01130168|11015518|FG002|Period 1|Discontinued For Other Reason|1
7077865|NCT02097030|11185843|FG001|First Intervention (3 Days)|Visual Acuity|1
7077866|NCT02097056|11185853|FG000|Overall Study|Protocol Violation|2
7077867|NCT02097056|11185853|FG000|Overall Study|Withdrawal by Subject|15
7077868|NCT02097056|11185853|FG000|Overall Study|Lost to Follow-up|2
7077869|NCT02097056|11185853|FG000|Overall Study|Adverse Event|37
7077870|NCT02097056|11185853|FG000|Overall Study|Other|2
7077871|NCT02097108|11185857|FG000|Overall Study|Adverse Event|1
7077872|NCT02097108|11185857|FG000|Overall Study|patient was abroad for 6 months|1
7077873|NCT02097238|11185861|FG000|Overall Study|Death|1
7077874|NCT02097238|11185861|FG000|Overall Study|Physician Decision|1
7077875|NCT02097238|11185861|FG000|Overall Study|Progressive Disease|17
7077876|NCT02097277|11185871|FG000|Overall Study|Subject no longer meets study criteria|0
7077877|NCT02097277|11185872|FG001|Overall Study|Subject no longer meets study criteria|1
7077878|NCT02097277|11185873|FG002|Overall Study|Subject no longer meets study criteria|0
7077879|NCT02097277|11185874|FG003|Overall Study|Subject no longer meets study criteria|1
7077880|NCT02097277|11185875|FG004|Overall Study|Subject no longer meets study criteria|0
6967100|NCT01130168|11015519|FG003|Period 1|Discontinued For Other Reason|1
6967101|NCT01130168|11015520|FG004|Period 1|Discontinued For Other Reason|0
6967102|NCT01130168|11015521|FG005|Period 1|Discontinued For Other Reason|0
6967103|NCT01130168|11015516|FG000|Period 1|Adverse Event|0
6967104|NCT01130168|11015517|FG001|Period 1|Adverse Event|0
6967105|NCT01130168|11015518|FG002|Period 1|Adverse Event|0
6967106|NCT01130168|11015519|FG003|Period 1|Adverse Event|1
6967107|NCT01130168|11015520|FG004|Period 1|Adverse Event|0
6967108|NCT01130168|11015521|FG005|Period 1|Adverse Event|0
6967109|NCT01130272|11015535|FG000|Overall Study|Adverse Event|2
6967110|NCT01130272|11015536|FG001|Overall Study|Adverse Event|5
6967111|NCT01130272|11015537|FG002|Overall Study|Adverse Event|6
6967112|NCT01130272|11015538|FG003|Overall Study|Adverse Event|22
6967113|NCT01130272|11015539|FG004|Overall Study|Adverse Event|7
7077881|NCT02097277|11185871|FG000|Overall Study|Subject request to discontinue treatment|0
7082997|NCT02147353|11193744|FG000|Overall Study|unable to make visits|4
6854946|NCT00376220|10863297|FG000|Overall Study|Lost to Follow-up|7
6854947|NCT00376220|10863298|FG001|Overall Study|Lost to Follow-up|10
6854948|NCT00376220|10863297|FG000|Overall Study|Withdrawal by Subject|3
6854949|NCT00376220|10863298|FG001|Overall Study|Withdrawal by Subject|2
6854950|NCT00376246|10863304|FG000|First Intervention (2 Weeks)|Adverse Event|2
6854951|NCT00376246|10863305|FG001|First Intervention (2 Weeks)|Adverse Event|0
6854952|NCT00376246|10863304|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1
6854953|NCT00376246|10863305|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2
6854954|NCT00376246|10863304|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1
6854955|NCT00376246|10863305|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0
6854956|NCT00376259|10863315|FG000|Overall Study|Sponsor request - study termination|21
6854957|NCT00376259|10863316|FG001|Overall Study|Sponsor request - study termination|21
6854958|NCT00376259|10863315|FG000|Overall Study|Patient request|1
6854959|NCT00376259|10863316|FG001|Overall Study|Patient request|0
6854960|NCT00376506|10863333|FG000|Overall Study|Death|0
6854961|NCT00376506|10863334|FG001|Overall Study|Death|2
6854962|NCT00376532|10863345|FG000|Overall Study|Lack sufficient blood sample|6
6854963|NCT00376532|10863346|FG001|Overall Study|Lack sufficient blood sample|6
6854964|NCT00376675|10863375|FG000|Overall Study|Withdrawal by Subject|9
6854965|NCT00376675|10863376|FG001|Overall Study|Withdrawal by Subject|2
6854966|NCT00376675|10863375|FG000|Overall Study|Adverse Event|10
6854967|NCT00376675|10863376|FG001|Overall Study|Adverse Event|5
6854968|NCT00376675|10863375|FG000|Overall Study|Other Reason|1
6854969|NCT00376675|10863376|FG001|Overall Study|Other Reason|7
6854970|NCT00376688|10863382|FG000|Overall Study|Adverse Event|3
6854971|NCT00376688|10863382|FG000|Overall Study|Death|1
6854972|NCT00376961|10863411|FG000|Initial Registration|Adverse Event|1
6854973|NCT00376961|10863412|FG001|Initial Registration|Adverse Event|0
6854974|NCT00376961|10863411|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2
6854975|NCT00376961|10863412|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0
6854976|NCT00376961|10863411|FG000|Initial Registration|Progression/relapse|1
6854977|NCT00376961|10863412|FG001|Initial Registration|Progression/relapse|0
6854978|NCT00376961|10863411|FG000|Initial Registration|Ineligible|3
6854979|NCT00376961|10863412|FG001|Initial Registration|Ineligible|0
6854980|NCT00376961|10863411|FG000|Maintenance|Adverse Event|0
6854981|NCT00376961|10863412|FG001|Maintenance|Adverse Event|1
6854982|NCT00376961|10863411|FG000|Maintenance|Refusal Unrelated to Adverse Event|0
6854983|NCT00376961|10863412|FG001|Maintenance|Refusal Unrelated to Adverse Event|1
6854984|NCT00376961|10863411|FG000|Maintenance|Progression/relapse|0
6854985|NCT00376961|10863412|FG001|Maintenance|Progression/relapse|18
6854986|NCT00376961|10863411|FG000|Maintenance|Ineligible|0
6854987|NCT00376961|10863412|FG001|Maintenance|Ineligible|3
6854988|NCT00377156|10863422|FG000|Overall Study|Death|23
6854989|NCT00377156|10863423|FG001|Overall Study|Death|19
6854990|NCT00377156|10863422|FG000|Overall Study|Withdrawal by Subject|16
6854991|NCT00377156|10863423|FG001|Overall Study|Withdrawal by Subject|24
6854992|NCT00377156|10863422|FG000|Overall Study|Had follow-up <90 d|3
6854993|NCT00377156|10863423|FG001|Overall Study|Had follow-up <90 d|6
6854994|NCT00377156|10863422|FG000|Overall Study|Cancellation|1
6854995|NCT00377156|10863423|FG001|Overall Study|Cancellation|0
6854996|NCT00377156|10863422|FG000|Overall Study|Refused testing|0
6854997|NCT00377156|10863423|FG001|Overall Study|Refused testing|1
6854998|NCT00377156|10863422|FG000|Overall Study|Ineligible|0
6854999|NCT00377156|10863423|FG001|Overall Study|Ineligible|1
6855000|NCT00377156|10863422|FG000|Overall Study|Disability or language problem|0
6855001|NCT00377156|10863423|FG001|Overall Study|Disability or language problem|1
6855002|NCT00377156|10863422|FG000|Overall Study|Other|5
6855003|NCT00377156|10863423|FG001|Overall Study|Other|2
6855004|NCT00377234|10863433|FG000|Overall Study|Adverse Event|14
6855005|NCT00377234|10863434|FG001|Overall Study|Adverse Event|17
6855006|NCT00377234|10863433|FG000|Overall Study|Withdrawal by Subject|11
6855007|NCT00377234|10863434|FG001|Overall Study|Withdrawal by Subject|9
6855008|NCT00377234|10863433|FG000|Overall Study|Lost to Follow-up|4
6855009|NCT00377234|10863434|FG001|Overall Study|Lost to Follow-up|2
6855010|NCT00377234|10863433|FG000|Overall Study|Administrative|2
6855011|NCT00377234|10863434|FG001|Overall Study|Administrative|1
6855012|NCT00377234|10863433|FG000|Overall Study|Not assigned|3
6855013|NCT00377234|10863434|FG001|Overall Study|Not assigned|2
6855014|NCT00377260|10863448|FG000|Overall Study|Lost to Follow-up|0
6855015|NCT00377260|10863449|FG001|Overall Study|Lost to Follow-up|1
6855016|NCT00377260|10863448|FG000|Overall Study|Withdrawal by Subject|2
6855017|NCT00377260|10863449|FG001|Overall Study|Withdrawal by Subject|4
6855018|NCT00377299|10863457|FG000|Overall Study|Lost to Follow-up|14
6855019|NCT00377299|10863458|FG001|Overall Study|Lost to Follow-up|19
6855020|NCT00377299|10863457|FG000|Overall Study|Adverse Event|0
6855021|NCT00377299|10863458|FG001|Overall Study|Adverse Event|1
6855022|NCT00377299|10863457|FG000|Overall Study|Withdrawal by Subject|5
6855023|NCT00377299|10863458|FG001|Overall Study|Withdrawal by Subject|4
6855024|NCT00377312|10863467|FG000|Overall Study|Adverse Event|1
6855025|NCT00377312|10863468|FG001|Overall Study|Adverse Event|1
6855026|NCT00377364|10863476|FG000|Overall Study|Lost to Follow-up|1
6855027|NCT00377364|10863477|FG001|Overall Study|Lost to Follow-up|0
6855028|NCT00377364|10863476|FG000|Overall Study|Withdrawal by Subject|1
6855029|NCT00377364|10863477|FG001|Overall Study|Withdrawal by Subject|0
6967114|NCT01130272|11015535|FG000|Overall Study|IVRS-confirmed constipation|0
6855030|NCT00377403|10863487|FG000|Overall Study|Unable to contact for telephone intervie|4
6855031|NCT00377403|10863488|FG001|Overall Study|Unable to contact for telephone intervie|7
6855032|NCT00377429|10863494|FG000|Overall Study|Withdrawal by Subject|5
6855033|NCT00377429|10863494|FG000|Overall Study|Adverse Event|8
6855034|NCT00377429|10863494|FG000|Overall Study|Physician Decision|1
6855035|NCT00377429|10863494|FG000|Overall Study|Patient non-compliance|1
6855036|NCT00377520|10863498|FG000|Overall Study|Ineligible (Prior radiation)|1
6855037|NCT00377611|10863513|FG000|Overall Study|Adverse Event|2
6855038|NCT00377611|10863514|FG001|Overall Study|Adverse Event|9
6855039|NCT00377611|10863513|FG000|Overall Study|Protocol Violation|2
6855040|NCT00377611|10863514|FG001|Overall Study|Protocol Violation|0
6855041|NCT00377611|10863513|FG000|Overall Study|Withdrawal by Subject|0
6855042|NCT00377611|10863514|FG001|Overall Study|Withdrawal by Subject|5
6855043|NCT00377611|10863513|FG000|Overall Study|Lost to Follow-up|18
6855044|NCT00377611|10863514|FG001|Overall Study|Lost to Follow-up|16
6855045|NCT00377611|10863513|FG000|Overall Study|Other|0
6855046|NCT00377611|10863514|FG001|Overall Study|Other|3
6855047|NCT00377637|10863525|FG000|Induction Phase|Adverse Event|12
6855048|NCT00377637|10863526|FG001|Induction Phase|Adverse Event|21
6855049|NCT00377637|10863527|FG002|Induction Phase|Adverse Event|0
6855050|NCT00377637|10863528|FG003|Induction Phase|Adverse Event|0
6855051|NCT00377637|10863525|FG000|Induction Phase|Deterioration/serum creatinine|2
6855052|NCT00377637|10863526|FG001|Induction Phase|Deterioration/serum creatinine|0
6855053|NCT00377637|10863527|FG002|Induction Phase|Deterioration/serum creatinine|0
6855054|NCT00377637|10863528|FG003|Induction Phase|Deterioration/serum creatinine|0
6855055|NCT00377637|10863525|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
6855056|NCT00377637|10863526|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1
6855057|NCT00377637|10863527|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
6855058|NCT00377637|10863528|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
6855059|NCT00377637|10863525|FG000|Induction Phase|Lost to Follow-up|2
6855060|NCT00377637|10863526|FG001|Induction Phase|Lost to Follow-up|1
6855061|NCT00377637|10863527|FG002|Induction Phase|Lost to Follow-up|0
6855062|NCT00377637|10863528|FG003|Induction Phase|Lost to Follow-up|0
6855063|NCT00377637|10863525|FG000|Induction Phase|Death|1
6855064|NCT00377637|10863526|FG001|Induction Phase|Death|3
6855065|NCT00377637|10863527|FG002|Induction Phase|Death|0
6855066|NCT00377637|10863528|FG003|Induction Phase|Death|0
6855067|NCT00377637|10863525|FG000|Induction Phase|Withdrawal by Subject|5
6855068|NCT00377637|10863526|FG001|Induction Phase|Withdrawal by Subject|6
6855069|NCT00377637|10863527|FG002|Induction Phase|Withdrawal by Subject|0
6855070|NCT00377637|10863528|FG003|Induction Phase|Withdrawal by Subject|0
6855071|NCT00377637|10863525|FG000|Induction Phase|Physician Decision|3
6855072|NCT00377637|10863526|FG001|Induction Phase|Physician Decision|1
6855073|NCT00377637|10863527|FG002|Induction Phase|Physician Decision|0
6855074|NCT00377637|10863528|FG003|Induction Phase|Physician Decision|0
6855075|NCT00377637|10863525|FG000|Induction Phase|Sponsor decision|1
6855076|NCT00377637|10863526|FG001|Induction Phase|Sponsor decision|2
6855077|NCT00377637|10863527|FG002|Induction Phase|Sponsor decision|0
6855078|NCT00377637|10863528|FG003|Induction Phase|Sponsor decision|0
6855079|NCT00377637|10863525|FG000|Induction Phase|Non-Compliance|1
6855080|NCT00377637|10863526|FG001|Induction Phase|Non-Compliance|0
6855081|NCT00377637|10863527|FG002|Induction Phase|Non-Compliance|0
6855082|NCT00377637|10863528|FG003|Induction Phase|Non-Compliance|0
6855083|NCT00377637|10863525|FG000|Induction Phase|Reason for withdrawal is not noted|2
6855084|NCT00377637|10863526|FG001|Induction Phase|Reason for withdrawal is not noted|0
6855085|NCT00377637|10863527|FG002|Induction Phase|Reason for withdrawal is not noted|0
6855086|NCT00377637|10863528|FG003|Induction Phase|Reason for withdrawal is not noted|0
6855087|NCT00377637|10863525|FG000|Maintenance Phase|Adverse Event|0
6855088|NCT00377637|10863526|FG001|Maintenance Phase|Adverse Event|0
6855089|NCT00377637|10863527|FG002|Maintenance Phase|Adverse Event|29
6855090|NCT00377637|10863528|FG003|Maintenance Phase|Adverse Event|43
6855091|NCT00377637|10863525|FG000|Maintenance Phase|Physician Decision|0
6855092|NCT00377637|10863526|FG001|Maintenance Phase|Physician Decision|0
6855093|NCT00377637|10863527|FG002|Maintenance Phase|Physician Decision|5
6855094|NCT00377637|10863528|FG003|Maintenance Phase|Physician Decision|4
6855095|NCT00377637|10863525|FG000|Maintenance Phase|Lost to Follow-up|0
6855096|NCT00377637|10863526|FG001|Maintenance Phase|Lost to Follow-up|0
6855097|NCT00377637|10863527|FG002|Maintenance Phase|Lost to Follow-up|3
6855098|NCT00377637|10863528|FG003|Maintenance Phase|Lost to Follow-up|1
6855099|NCT00377637|10863525|FG000|Maintenance Phase|Withdrawal by Subject|0
6855100|NCT00377637|10863526|FG001|Maintenance Phase|Withdrawal by Subject|0
6855101|NCT00377637|10863527|FG002|Maintenance Phase|Withdrawal by Subject|3
6855102|NCT00377637|10863528|FG003|Maintenance Phase|Withdrawal by Subject|3
6855103|NCT00377637|10863525|FG000|Maintenance Phase|Sponsor decision|0
6855104|NCT00377637|10863526|FG001|Maintenance Phase|Sponsor decision|0
6855105|NCT00377637|10863527|FG002|Maintenance Phase|Sponsor decision|2
6855106|NCT00377637|10863528|FG003|Maintenance Phase|Sponsor decision|3
6855107|NCT00377637|10863525|FG000|Maintenance Phase|Non-compliance|0
6855108|NCT00377637|10863526|FG001|Maintenance Phase|Non-compliance|0
6855109|NCT00377637|10863527|FG002|Maintenance Phase|Non-compliance|1
6855110|NCT00377637|10863528|FG003|Maintenance Phase|Non-compliance|1
6855111|NCT00377637|10863525|FG000|Maintenance Phase|Study medication stopped > 14 days|0
6855112|NCT00377637|10863526|FG001|Maintenance Phase|Study medication stopped > 14 days|0
6855113|NCT00377637|10863527|FG002|Maintenance Phase|Study medication stopped > 14 days|0
6855114|NCT00377637|10863528|FG003|Maintenance Phase|Study medication stopped > 14 days|1
6855115|NCT00377637|10863525|FG000|Maintenance Phase|Death|0
6855116|NCT00377637|10863526|FG001|Maintenance Phase|Death|0
6855117|NCT00377637|10863527|FG002|Maintenance Phase|Death|0
6855118|NCT00377637|10863528|FG003|Maintenance Phase|Death|1
6855119|NCT00377676|10863544|FG000|Overall Study|Adverse Event|498
6855120|NCT00377676|10863545|FG001|Overall Study|Adverse Event|107
6855121|NCT00377676|10863544|FG000|Overall Study|Protocol Violation|33
6855122|NCT00377676|10863545|FG001|Overall Study|Protocol Violation|27
6855123|NCT00377676|10863544|FG000|Overall Study|Death|5
6855124|NCT00377676|10863545|FG001|Overall Study|Death|2
6855125|NCT00377676|10863544|FG000|Overall Study|Withdrawal by Subject|187
6855126|NCT00377676|10863545|FG001|Overall Study|Withdrawal by Subject|72
6855127|NCT00377676|10863544|FG000|Overall Study|Lost to Follow-up|120
6855128|NCT00377676|10863545|FG001|Overall Study|Lost to Follow-up|56
6855129|NCT00377676|10863544|FG000|Overall Study|Other|118
6855130|NCT00377676|10863545|FG001|Overall Study|Other|58
6855131|NCT00377819|10863562|FG000|Overall Study|Adverse Event|2
6855132|NCT00377819|10863563|FG001|Overall Study|Adverse Event|3
6855133|NCT00377819|10863562|FG000|Overall Study|Withdrawal by Subject|10
6855134|NCT00377819|10863563|FG001|Overall Study|Withdrawal by Subject|4
6855135|NCT00377819|10863562|FG000|Overall Study|Death|0
6855136|NCT00377819|10863563|FG001|Overall Study|Death|1
6855137|NCT00377819|10863562|FG000|Overall Study|Lost to Follow-up|0
6855138|NCT00377819|10863563|FG001|Overall Study|Lost to Follow-up|1
6855139|NCT00377819|10863562|FG000|Overall Study|Protocol Violation|1
6855140|NCT00377819|10863563|FG001|Overall Study|Protocol Violation|1
6855141|NCT00377858|10863583|FG000|Overall Study|Withdrawal by Subject|12
6855142|NCT00377858|10863584|FG001|Overall Study|Withdrawal by Subject|11
6855143|NCT00377858|10863583|FG000|Overall Study|Lost to Follow-up|6
6855144|NCT00377858|10863584|FG001|Overall Study|Lost to Follow-up|1
6855145|NCT00377858|10863583|FG000|Overall Study|Physician Decision|5
6855146|NCT00377858|10863584|FG001|Overall Study|Physician Decision|5
6855147|NCT00377858|10863583|FG000|Overall Study|Protocol Violation|3
6855148|NCT00377858|10863584|FG001|Overall Study|Protocol Violation|4
6855149|NCT00377858|10863583|FG000|Overall Study|Adverse Event|2
6855150|NCT00377858|10863584|FG001|Overall Study|Adverse Event|1
6855151|NCT00377858|10863583|FG000|Overall Study|Entry Criteria Not Met|2
6855152|NCT00377858|10863584|FG001|Overall Study|Entry Criteria Not Met|0
6855153|NCT00377858|10863583|FG000|Overall Study|Sponsor Decision|1
6855154|NCT00377858|10863584|FG001|Overall Study|Sponsor Decision|2
6855155|NCT00377858|10863583|FG000|Overall Study|Death|0
6855156|NCT00377858|10863584|FG001|Overall Study|Death|3
6855157|NCT00377962|10863592|FG000|Core Study: 0-12 Months|Adverse Event|18
6855158|NCT00377962|10863593|FG001|Core Study: 0-12 Months|Adverse Event|2
6855159|NCT00377962|10863592|FG000|Core Study: 0-12 Months|Death|3
6855160|NCT00377962|10863593|FG001|Core Study: 0-12 Months|Death|0
6855161|NCT00377962|10863592|FG000|Core Study: 0-12 Months|Withdrew Consent|5
6855162|NCT00377962|10863593|FG001|Core Study: 0-12 Months|Withdrew Consent|2
6855163|NCT00377962|10863592|FG000|Core Study: 0-12 Months|Administrative Reason|1
6855164|NCT00377962|10863593|FG001|Core Study: 0-12 Months|Administrative Reason|1
6855165|NCT00377962|10863592|FG000|Core Study: 0-12 Months|Unspecified reasons|1
6855166|NCT00377962|10863593|FG001|Core Study: 0-12 Months|Unspecified reasons|4
6855167|NCT00377962|10863592|FG000|Extension Study: 12-24 Months|Death|1
6855168|NCT00377962|10863593|FG001|Extension Study: 12-24 Months|Death|1
6855169|NCT00377962|10863592|FG000|Extension Study: 12-24 Months|Adverse Event|8
6855170|NCT00377962|10863593|FG001|Extension Study: 12-24 Months|Adverse Event|0
6855171|NCT00377962|10863592|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1
6855172|NCT00377962|10863593|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0
6855173|NCT00377962|10863592|FG000|Extension Study: 12-24 Months|Unspecified reason|0
6855174|NCT00377962|10863593|FG001|Extension Study: 12-24 Months|Unspecified reason|3
6855175|NCT00378014|10863607|FG000|Core (Randomization to Month 11)|Adverse Event|1
6855176|NCT00378014|10863608|FG001|Core (Randomization to Month 11)|Adverse Event|0
6855177|NCT00378014|10863607|FG000|Core (Randomization to Month 11)|Graft loss|1
6855178|NCT00378014|10863608|FG001|Core (Randomization to Month 11)|Graft loss|2
6855179|NCT00378014|10863607|FG000|Core (Randomization to Month 11)|Death|5
6855180|NCT00378014|10863608|FG001|Core (Randomization to Month 11)|Death|3
6855181|NCT00378014|10863607|FG000|Core (Randomization to Month 11)|Administrative Problems|2
6855182|NCT00378014|10863608|FG001|Core (Randomization to Month 11)|Administrative Problems|2
6855183|NCT00378014|10863607|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0
6855184|NCT00378014|10863608|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1
6855185|NCT00378014|10863607|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5
6855186|NCT00378014|10863608|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2
6855187|NCT00378014|10863607|FG000|Core (Randomization to Month 11)|Protocol deviation|0
6855188|NCT00378014|10863608|FG001|Core (Randomization to Month 11)|Protocol deviation|1
6855189|NCT00378014|10863607|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0
6855190|NCT00378014|10863608|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1
6855191|NCT00378014|10863607|FG000|Extension (Month 12 to Month 59)|Adverse Event|8
6855192|NCT00378014|10863608|FG001|Extension (Month 12 to Month 59)|Adverse Event|7
6855193|NCT00378014|10863607|FG000|Extension (Month 12 to Month 59)|Death|1
6855194|NCT00378014|10863608|FG001|Extension (Month 12 to Month 59)|Death|2
6855195|NCT00378014|10863607|FG000|Extension (Month 12 to Month 59)|Administrative problems|1
6855196|NCT00378014|10863608|FG001|Extension (Month 12 to Month 59)|Administrative problems|0
6855197|NCT00378014|10863607|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1
6855198|NCT00378014|10863608|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1
6855199|NCT00378014|10863607|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0
6855200|NCT00378014|10863608|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3
6855201|NCT00378014|10863607|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3
6855202|NCT00378014|10863608|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1
6855203|NCT00378079|10863619|FG000|Overall Study|Lost to Follow-up|6
6855204|NCT00378079|10863620|FG001|Overall Study|Lost to Follow-up|1
6855205|NCT00378079|10863621|FG002|Overall Study|Lost to Follow-up|0
6855206|NCT00378105|10863631|FG000|Overall Study|Adverse Event|3
6855207|NCT00378105|10863632|FG001|Overall Study|Adverse Event|1
6855208|NCT00378105|10863631|FG000|Overall Study|Withdrawal by Subject|3
6855209|NCT00378105|10863632|FG001|Overall Study|Withdrawal by Subject|3
6855210|NCT00378105|10863631|FG000|Overall Study|Death|1
6855211|NCT00378105|10863632|FG001|Overall Study|Death|0
6855212|NCT00378105|10863631|FG000|Overall Study|Going to transplant|7
6855213|NCT00378105|10863632|FG001|Overall Study|Going to transplant|8
6855214|NCT00378105|10863631|FG000|Overall Study|Progressive disease|3
6855215|NCT00378105|10863632|FG001|Overall Study|Progressive disease|3
6855216|NCT00378105|10863631|FG000|Overall Study|remain on study|3
7040946|NCT01721486|11124218|FG000|Overall Study|Physician Decision|0
7040947|NCT01721486|11124219|FG001|Overall Study|Physician Decision|1
7040948|NCT01721772|11124239|FG000|Overall Study|Disease progression|96
7040949|NCT01721772|11124240|FG001|Overall Study|Disease progression|175
7040950|NCT01721772|11124239|FG000|Overall Study|Study drug toxicity|5
7040951|NCT01721772|11124240|FG001|Overall Study|Study drug toxicity|7
7040952|NCT01721772|11124239|FG000|Overall Study|Unrelated adverse event|2
7040953|NCT01721772|11124240|FG001|Overall Study|Unrelated adverse event|3
7040954|NCT01721772|11124239|FG000|Overall Study|Withdrawal by Subject|7
7040955|NCT01721772|11124240|FG001|Overall Study|Withdrawal by Subject|5
7040956|NCT01721772|11124239|FG000|Overall Study|Maximum clinical benefit|1
7040957|NCT01721772|11124240|FG001|Overall Study|Maximum clinical benefit|1
7040958|NCT01721772|11124239|FG000|Overall Study|Other|0
7040959|NCT01721772|11124240|FG001|Overall Study|Other|1
7040960|NCT01721876|11124252|FG000|Overall Study|Not treated|1
7040961|NCT01721876|11124253|FG001|Overall Study|Not treated|4
6855217|NCT00378105|10863632|FG001|Overall Study|remain on study|11
6855218|NCT00378105|10863631|FG000|Overall Study|Physician Decision|0
6855219|NCT00378105|10863632|FG001|Overall Study|Physician Decision|2
6855220|NCT00378105|10863631|FG000|Overall Study|Going non-protocol therapy|0
6855221|NCT00378105|10863632|FG001|Overall Study|Going non-protocol therapy|1
6855222|NCT00378105|10863631|FG000|Overall Study|necessity to increase lenalidomide dose|0
6855223|NCT00378105|10863632|FG001|Overall Study|necessity to increase lenalidomide dose|1
6855224|NCT00378209|10863639|FG000|Overall Study|Progressive disease|11
6855225|NCT00378209|10863639|FG000|Overall Study|Adverse Event|3
6855226|NCT00378209|10863639|FG000|Overall Study|Initiation of non-protocol therapy|3
6855227|NCT00378209|10863639|FG000|Overall Study|Physician Decision|3
6855228|NCT00378209|10863639|FG000|Overall Study|Death|1
6855229|NCT00378209|10863639|FG000|Overall Study|Treatment delay|1
6855230|NCT00378508|10863667|FG000|Overall Study|Withdrawal by Subject|1
6855231|NCT00378508|10863668|FG001|Overall Study|Withdrawal by Subject|3
6855232|NCT00378508|10863667|FG000|Overall Study|Lost to Follow-up|1
6855233|NCT00378508|10863668|FG001|Overall Study|Lost to Follow-up|0
6855234|NCT00378534|10863677|FG000|Overall Study|Participants did not receive transplant|3
6855235|NCT00378534|10863678|FG001|Overall Study|Participants did not receive transplant|0
6855236|NCT00378560|10863685|FG000|Overall Study|Adverse Event|1
6855237|NCT00378560|10863686|FG001|Overall Study|Adverse Event|0
6855238|NCT00378560|10863685|FG000|Overall Study|Lost to Follow-up|24
6855239|NCT00378560|10863686|FG001|Overall Study|Lost to Follow-up|29
6855240|NCT00378560|10863685|FG000|Overall Study|Protocol Violation|2
6855241|NCT00378560|10863686|FG001|Overall Study|Protocol Violation|0
6855242|NCT00378560|10863685|FG000|Overall Study|Withdrawal by Subject|17
6855243|NCT00378560|10863686|FG001|Overall Study|Withdrawal by Subject|21
6855244|NCT00378560|10863685|FG000|Overall Study|Moved|4
6855245|NCT00378560|10863686|FG001|Overall Study|Moved|3
6855246|NCT00378560|10863685|FG000|Overall Study|Pregnancy|7
6855247|NCT00378560|10863686|FG001|Overall Study|Pregnancy|5
6855248|NCT00378560|10863685|FG000|Overall Study|Laboratory test values abnormal|1
6855249|NCT00378560|10863686|FG001|Overall Study|Laboratory test values abnormal|0
6855250|NCT00378573|10863692|FG000|Treatment Period|Adverse Event|9
7040962|NCT01721876|11124252|FG000|Overall Study|Disease progression / relapse|123
7040963|NCT01721876|11124253|FG001|Overall Study|Disease progression / relapse|156
7040964|NCT01721876|11124252|FG000|Overall Study|Death|6
7040965|NCT01721876|11124253|FG001|Overall Study|Death|13
6855251|NCT00378573|10863692|FG000|Treatment Period|Physician Decision|1
6855252|NCT00378573|10863692|FG000|Treatment Period|Withdrawal by Subject|2
6855253|NCT00378573|10863692|FG000|Treatment Period|Disease Progression|4
6855254|NCT00378573|10863692|FG000|Treatment Period|Sponsor decision to close study|1
6855255|NCT00378573|10863692|FG000|Follow-up|Death|12
7040966|NCT01721876|11124252|FG000|Overall Study|Adverse Event|41
6855256|NCT00378573|10863692|FG000|Follow-up|Lost to Follow-up|1
6855257|NCT00378573|10863692|FG000|Follow-up|Withdrawal by Subject|1
6855258|NCT00378599|10863696|FG000|Overall Study|Adverse Event|38
6855259|NCT00378599|10863696|FG000|Overall Study|Protocol Violation|2
6855260|NCT00378599|10863696|FG000|Overall Study|Treatment failure|7
6855261|NCT00378599|10863696|FG000|Overall Study|Withdrawal by Subject|5
6855262|NCT00378703|10863704|FG000|Overall Study|Disease progression|59
6855263|NCT00378703|10863705|FG001|Overall Study|Disease progression|43
6855264|NCT00378703|10863706|FG002|Overall Study|Disease progression|48
6855265|NCT00378703|10863707|FG003|Overall Study|Disease progression|49
6855266|NCT00378703|10863704|FG000|Overall Study|Adverse Event|11
6855267|NCT00378703|10863705|FG001|Overall Study|Adverse Event|17
6855268|NCT00378703|10863706|FG002|Overall Study|Adverse Event|20
6855269|NCT00378703|10863707|FG003|Overall Study|Adverse Event|18
6855270|NCT00378703|10863704|FG000|Overall Study|Death|2
6855271|NCT00378703|10863705|FG001|Overall Study|Death|2
6855272|NCT00378703|10863706|FG002|Overall Study|Death|4
6855273|NCT00378703|10863707|FG003|Overall Study|Death|3
6855274|NCT00378703|10863704|FG000|Overall Study|Withdrawal by Subject|4
6855275|NCT00378703|10863705|FG001|Overall Study|Withdrawal by Subject|8
6855276|NCT00378703|10863706|FG002|Overall Study|Withdrawal by Subject|5
6855277|NCT00378703|10863707|FG003|Overall Study|Withdrawal by Subject|7
6855278|NCT00378703|10863704|FG000|Overall Study|Physician Decision|1
6855279|NCT00378703|10863705|FG001|Overall Study|Physician Decision|4
6855280|NCT00378703|10863706|FG002|Overall Study|Physician Decision|1
6855281|NCT00378703|10863707|FG003|Overall Study|Physician Decision|0
6855282|NCT00378703|10863704|FG000|Overall Study|Alternative therapy|4
6855283|NCT00378703|10863705|FG001|Overall Study|Alternative therapy|2
6855284|NCT00378703|10863706|FG002|Overall Study|Alternative therapy|0
6855285|NCT00378703|10863707|FG003|Overall Study|Alternative therapy|0
6855286|NCT00378703|10863704|FG000|Overall Study|Other complicated disease|0
7040967|NCT01721876|11124253|FG001|Overall Study|Adverse Event|165
7040968|NCT01721876|11124252|FG000|Overall Study|Protocol Violation|2
7040969|NCT01721876|11124253|FG001|Overall Study|Protocol Violation|1
7040970|NCT01721876|11124252|FG000|Overall Study|Withdrawal by Subject|15
7040971|NCT01721876|11124253|FG001|Overall Study|Withdrawal by Subject|38
7040972|NCT01721876|11124252|FG000|Overall Study|Reason not listed|34
7040973|NCT01721876|11124253|FG001|Overall Study|Reason not listed|63
7040974|NCT01721876|11124252|FG000|Overall Study|Sponsor terminated trial|0
7040975|NCT01721876|11124253|FG001|Overall Study|Sponsor terminated trial|4
7152674|NCT03261947|11317686|FG003|Overall Study|Site Terminated by Sponsor|7
6855287|NCT00378703|10863705|FG001|Overall Study|Other complicated disease|2
6967115|NCT01130272|11015536|FG001|Overall Study|IVRS-confirmed constipation|1
6967116|NCT01130272|11015537|FG002|Overall Study|IVRS-confirmed constipation|1
6967117|NCT01130272|11015538|FG003|Overall Study|IVRS-confirmed constipation|2
6967118|NCT01130272|11015539|FG004|Overall Study|IVRS-confirmed constipation|0
6967119|NCT01130272|11015535|FG000|Overall Study|Rescue medications due to diarrhea|3
6967120|NCT01130272|11015536|FG001|Overall Study|Rescue medications due to diarrhea|5
6967121|NCT01130272|11015537|FG002|Overall Study|Rescue medications due to diarrhea|8
6967122|NCT01130272|11015538|FG003|Overall Study|Rescue medications due to diarrhea|8
6967123|NCT01130272|11015539|FG004|Overall Study|Rescue medications due to diarrhea|6
6855288|NCT00378703|10863706|FG002|Overall Study|Other complicated disease|2
6855289|NCT00378703|10863707|FG003|Overall Study|Other complicated disease|0
6855290|NCT00378703|10863704|FG000|Overall Study|Symptomatic deterioration|0
6855291|NCT00378703|10863705|FG001|Overall Study|Symptomatic deterioration|1
6855292|NCT00378703|10863706|FG002|Overall Study|Symptomatic deterioration|0
6855293|NCT00378703|10863707|FG003|Overall Study|Symptomatic deterioration|2
6855294|NCT00378703|10863704|FG000|Overall Study|Surgery|1
6855295|NCT00378703|10863705|FG001|Overall Study|Surgery|0
6855296|NCT00378703|10863706|FG002|Overall Study|Surgery|0
6855297|NCT00378703|10863707|FG003|Overall Study|Surgery|1
6855298|NCT00378703|10863704|FG000|Overall Study|Joint decision of physician and patient|1
6855299|NCT00378703|10863705|FG001|Overall Study|Joint decision of physician and patient|0
6855300|NCT00378703|10863706|FG002|Overall Study|Joint decision of physician and patient|0
6855301|NCT00378703|10863707|FG003|Overall Study|Joint decision of physician and patient|0
6855302|NCT00378703|10863704|FG000|Overall Study|Adverse events and progressive disease|0
6855303|NCT00378703|10863705|FG001|Overall Study|Adverse events and progressive disease|0
6855304|NCT00378703|10863706|FG002|Overall Study|Adverse events and progressive disease|0
6855305|NCT00378703|10863707|FG003|Overall Study|Adverse events and progressive disease|1
6855306|NCT00378703|10863704|FG000|Overall Study|Relocation|0
6855307|NCT00378703|10863705|FG001|Overall Study|Relocation|0
6855308|NCT00378703|10863706|FG002|Overall Study|Relocation|1
6855309|NCT00378703|10863707|FG003|Overall Study|Relocation|0
6855310|NCT00378703|10863704|FG000|Overall Study|Ineligible|4
6855311|NCT00378703|10863705|FG001|Overall Study|Ineligible|7
6855312|NCT00378703|10863706|FG002|Overall Study|Ineligible|7
6855313|NCT00378703|10863707|FG003|Overall Study|Ineligible|7
6855314|NCT00378703|10863704|FG000|Overall Study|Never started treatment|1
6967124|NCT01130272|11015535|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1
7040976|NCT01721954|11124261|FG000|Overall Study|Death|58
6855315|NCT00378703|10863705|FG001|Overall Study|Never started treatment|4
6855316|NCT00378703|10863706|FG002|Overall Study|Never started treatment|0
6855317|NCT00378703|10863707|FG003|Overall Study|Never started treatment|0
7152675|NCT03261947|11317687|FG004|Overall Study|Site Terminated by Sponsor|5
6855318|NCT00378703|10863704|FG000|Overall Study|Other|1
6855319|NCT00378703|10863705|FG001|Overall Study|Other|1
6855320|NCT00378703|10863706|FG002|Overall Study|Other|2
6855321|NCT00378703|10863707|FG003|Overall Study|Other|3
6855322|NCT00378898|10863719|FG000|Overall Study|Withdrawal by Subject|10
6855323|NCT00378898|10863720|FG001|Overall Study|Withdrawal by Subject|5
6855324|NCT00378898|10863719|FG000|Overall Study|Protocol Violation|1
6855325|NCT00378898|10863720|FG001|Overall Study|Protocol Violation|1
6855326|NCT00379080|10863731|FG000|Overall Study|Withdrawal by Subject|0
6855327|NCT00379080|10863732|FG001|Overall Study|Withdrawal by Subject|4
6855328|NCT00379080|10863733|FG002|Overall Study|Withdrawal by Subject|0
6855329|NCT00379210|10863772|FG000|Overall Study|Withdrawal by Subject|10
6855330|NCT00379210|10863773|FG001|Overall Study|Withdrawal by Subject|7
6855331|NCT00379236|10863781|FG000|Double-blind|Adverse Event|11
6855332|NCT00379236|10863782|FG001|Double-blind|Adverse Event|6
6855333|NCT00379236|10863783|FG002|Double-blind|Adverse Event|0
6855334|NCT00379236|10863781|FG000|Double-blind|Protocol Violation|3
6855335|NCT00379236|10863782|FG001|Double-blind|Protocol Violation|3
6855336|NCT00379236|10863783|FG002|Double-blind|Protocol Violation|0
6855337|NCT00379236|10863781|FG000|Double-blind|Withdrawal by Subject|12
6855338|NCT00379236|10863782|FG001|Double-blind|Withdrawal by Subject|13
6855339|NCT00379236|10863783|FG002|Double-blind|Withdrawal by Subject|0
6855340|NCT00379236|10863781|FG000|Double-blind|Lost to Follow-up|4
6855341|NCT00379236|10863782|FG001|Double-blind|Lost to Follow-up|3
6855342|NCT00379236|10863783|FG002|Double-blind|Lost to Follow-up|0
6855343|NCT00379236|10863781|FG000|Double-blind|Use of exclusionary medication|1
6855344|NCT00379236|10863782|FG001|Double-blind|Use of exclusionary medication|2
6855345|NCT00379236|10863783|FG002|Double-blind|Use of exclusionary medication|0
6855346|NCT00379236|10863781|FG000|Double-blind|Other|3
6855347|NCT00379236|10863782|FG001|Double-blind|Other|7
6855348|NCT00379236|10863783|FG002|Double-blind|Other|0
6855349|NCT00379236|10863781|FG000|Double-blind|Data could not be retrieved|2
6855350|NCT00379236|10863782|FG001|Double-blind|Data could not be retrieved|2
6855351|NCT00379236|10863783|FG002|Double-blind|Data could not be retrieved|0
6855352|NCT00379236|10863781|FG000|Open-label Extension|Adverse Event|0
6855353|NCT00379236|10863782|FG001|Open-label Extension|Adverse Event|0
6855354|NCT00379236|10863783|FG002|Open-label Extension|Adverse Event|13
6855355|NCT00379236|10863781|FG000|Open-label Extension|Protocol Violation|0
6855356|NCT00379236|10863782|FG001|Open-label Extension|Protocol Violation|0
6855357|NCT00379236|10863783|FG002|Open-label Extension|Protocol Violation|7
6855358|NCT00379236|10863781|FG000|Open-label Extension|Withdrawal by Subject|0
6855359|NCT00379236|10863782|FG001|Open-label Extension|Withdrawal by Subject|0
6855360|NCT00379236|10863783|FG002|Open-label Extension|Withdrawal by Subject|13
6855361|NCT00379236|10863781|FG000|Open-label Extension|Lost to Follow-up|0
6855362|NCT00379236|10863782|FG001|Open-label Extension|Lost to Follow-up|0
6855363|NCT00379236|10863783|FG002|Open-label Extension|Lost to Follow-up|12
6855364|NCT00379236|10863781|FG000|Open-label Extension|Use of exclusionary medication|0
6855365|NCT00379236|10863782|FG001|Open-label Extension|Use of exclusionary medication|0
6855366|NCT00379236|10863783|FG002|Open-label Extension|Use of exclusionary medication|3
6855367|NCT00379236|10863781|FG000|Open-label Extension|Other|0
6855368|NCT00379236|10863782|FG001|Open-label Extension|Other|0
6855369|NCT00379236|10863783|FG002|Open-label Extension|Other|7
6855370|NCT00379353|10863797|FG000|Overall Study|Hospitalization|3
6855371|NCT00379353|10863798|FG001|Overall Study|Hospitalization|3
6855372|NCT00379353|10863797|FG000|Overall Study|Withdrawal by Subject|5
6855373|NCT00379353|10863798|FG001|Overall Study|Withdrawal by Subject|2
6855374|NCT00379353|10863797|FG000|Overall Study|Death|1
6855375|NCT00379353|10863798|FG001|Overall Study|Death|0
6855376|NCT00379353|10863797|FG000|Overall Study|Cardiac Tamponade|1
6855377|NCT00379353|10863798|FG001|Overall Study|Cardiac Tamponade|0
6855378|NCT00379353|10863797|FG000|Overall Study|Non-compliance|1
6855379|NCT00379353|10863798|FG001|Overall Study|Non-compliance|0
6855380|NCT00379353|10863797|FG000|Overall Study|Conflicting drug treatment|0
6855381|NCT00379353|10863798|FG001|Overall Study|Conflicting drug treatment|1
6855382|NCT00379587|10863818|FG000|Overall Study|Lost to Follow-up|2
6855383|NCT00379639|10863827|FG000|Overall Study|Disease Progression|3
6855384|NCT00379639|10863828|FG001|Overall Study|Disease Progression|3
6855385|NCT00379639|10863829|FG002|Overall Study|Disease Progression|3
6855386|NCT00379639|10863830|FG003|Overall Study|Disease Progression|4
6855387|NCT00379639|10863831|FG004|Overall Study|Disease Progression|4
6855388|NCT00379639|10863827|FG000|Overall Study|Physician Decision|0
6855389|NCT00379639|10863828|FG001|Overall Study|Physician Decision|2
6855390|NCT00379639|10863829|FG002|Overall Study|Physician Decision|1
6855391|NCT00379639|10863830|FG003|Overall Study|Physician Decision|1
6855392|NCT00379639|10863831|FG004|Overall Study|Physician Decision|0
6855393|NCT00379639|10863827|FG000|Overall Study|Symptomatic Deterioration|0
6855394|NCT00379639|10863828|FG001|Overall Study|Symptomatic Deterioration|0
6855395|NCT00379639|10863829|FG002|Overall Study|Symptomatic Deterioration|1
6855396|NCT00379639|10863830|FG003|Overall Study|Symptomatic Deterioration|0
6855397|NCT00379639|10863831|FG004|Overall Study|Symptomatic Deterioration|1
6855398|NCT00379639|10863827|FG000|Overall Study|Adverse Event|0
6855399|NCT00379639|10863828|FG001|Overall Study|Adverse Event|0
6855400|NCT00379639|10863829|FG002|Overall Study|Adverse Event|1
6855401|NCT00379639|10863830|FG003|Overall Study|Adverse Event|0
6855402|NCT00379639|10863831|FG004|Overall Study|Adverse Event|1
6855403|NCT00379639|10863827|FG000|Overall Study|Lost to Follow-up|0
6855404|NCT00379639|10863828|FG001|Overall Study|Lost to Follow-up|0
6855405|NCT00379639|10863829|FG002|Overall Study|Lost to Follow-up|0
6855406|NCT00379639|10863830|FG003|Overall Study|Lost to Follow-up|1
6855407|NCT00379639|10863831|FG004|Overall Study|Lost to Follow-up|0
6855408|NCT00379639|10863827|FG000|Overall Study|Other|0
6855409|NCT00379639|10863828|FG001|Overall Study|Other|0
6855410|NCT00379639|10863829|FG002|Overall Study|Other|3
6855411|NCT00379639|10863830|FG003|Overall Study|Other|0
6855412|NCT00379639|10863831|FG004|Overall Study|Other|0
6855413|NCT00379769|10863847|FG000|Main Study|Death|57
6855414|NCT00379769|10863848|FG001|Main Study|Death|67
6855415|NCT00379769|10863849|FG002|Main Study|Death|54
6855416|NCT00379769|10863850|FG003|Main Study|Death|72
6855417|NCT00379769|10863851|FG004|Main Study|Death|0
6855418|NCT00379769|10863852|FG005|Main Study|Death|0
6855419|NCT00379769|10863847|FG000|Main Study|Adverse Event|5
6855420|NCT00379769|10863848|FG001|Main Study|Adverse Event|8
6855421|NCT00379769|10863849|FG002|Main Study|Adverse Event|10
6855422|NCT00379769|10863850|FG003|Main Study|Adverse Event|11
6855423|NCT00379769|10863851|FG004|Main Study|Adverse Event|0
6855424|NCT00379769|10863852|FG005|Main Study|Adverse Event|0
6855425|NCT00379769|10863847|FG000|Main Study|Lost to Follow-up|29
6855426|NCT00379769|10863848|FG001|Main Study|Lost to Follow-up|29
6855427|NCT00379769|10863849|FG002|Main Study|Lost to Follow-up|25
6855428|NCT00379769|10863850|FG003|Main Study|Lost to Follow-up|26
6855429|NCT00379769|10863851|FG004|Main Study|Lost to Follow-up|0
6855430|NCT00379769|10863852|FG005|Main Study|Lost to Follow-up|0
6855431|NCT00379769|10863847|FG000|Main Study|Withdrawal by Subject|46
6855432|NCT00379769|10863848|FG001|Main Study|Withdrawal by Subject|56
6855433|NCT00379769|10863849|FG002|Main Study|Withdrawal by Subject|72
6855434|NCT00379769|10863850|FG003|Main Study|Withdrawal by Subject|70
6855435|NCT00379769|10863851|FG004|Main Study|Withdrawal by Subject|0
6855436|NCT00379769|10863852|FG005|Main Study|Withdrawal by Subject|0
6855437|NCT00379769|10863847|FG000|Main Study|Moved to survival status follow-up only|27
6855438|NCT00379769|10863848|FG001|Main Study|Moved to survival status follow-up only|25
6855439|NCT00379769|10863849|FG002|Main Study|Moved to survival status follow-up only|32
6855440|NCT00379769|10863850|FG003|Main Study|Moved to survival status follow-up only|36
6855441|NCT00379769|10863851|FG004|Main Study|Moved to survival status follow-up only|0
6855442|NCT00379769|10863852|FG005|Main Study|Moved to survival status follow-up only|0
6855443|NCT00379769|10863847|FG000|Main Study|Participant moved|3
6855444|NCT00379769|10863848|FG001|Main Study|Participant moved|2
6855445|NCT00379769|10863849|FG002|Main Study|Participant moved|3
6855446|NCT00379769|10863850|FG003|Main Study|Participant moved|3
6855447|NCT00379769|10863851|FG004|Main Study|Participant moved|0
6855448|NCT00379769|10863852|FG005|Main Study|Participant moved|0
6855449|NCT00379769|10863847|FG000|Main Study|Poor compliance|3
6855450|NCT00379769|10863848|FG001|Main Study|Poor compliance|2
6855451|NCT00379769|10863849|FG002|Main Study|Poor compliance|2
6855452|NCT00379769|10863850|FG003|Main Study|Poor compliance|1
6855453|NCT00379769|10863851|FG004|Main Study|Poor compliance|0
6855454|NCT00379769|10863852|FG005|Main Study|Poor compliance|0
6855455|NCT00379769|10863847|FG000|Main Study|Prohibited glucose lowering medication|0
6855456|NCT00379769|10863848|FG001|Main Study|Prohibited glucose lowering medication|3
6855457|NCT00379769|10863849|FG002|Main Study|Prohibited glucose lowering medication|0
6855458|NCT00379769|10863850|FG003|Main Study|Prohibited glucose lowering medication|1
6855459|NCT00379769|10863851|FG004|Main Study|Prohibited glucose lowering medication|0
6855460|NCT00379769|10863852|FG005|Main Study|Prohibited glucose lowering medication|0
6855461|NCT00379769|10863847|FG000|Main Study|Site closed|4
6855462|NCT00379769|10863848|FG001|Main Study|Site closed|4
6855463|NCT00379769|10863849|FG002|Main Study|Site closed|4
6855464|NCT00379769|10863850|FG003|Main Study|Site closed|8
6855465|NCT00379769|10863851|FG004|Main Study|Site closed|0
6855466|NCT00379769|10863852|FG005|Main Study|Site closed|0
6855467|NCT00379769|10863847|FG000|Main Study|Entry criteria violation|0
6855468|NCT00379769|10863848|FG001|Main Study|Entry criteria violation|0
6855469|NCT00379769|10863849|FG002|Main Study|Entry criteria violation|1
6855470|NCT00379769|10863850|FG003|Main Study|Entry criteria violation|1
6855471|NCT00379769|10863851|FG004|Main Study|Entry criteria violation|0
6855472|NCT00379769|10863852|FG005|Main Study|Entry criteria violation|0
6855473|NCT00379769|10863847|FG000|Main Study|Participant did not take study drug|0
6855474|NCT00379769|10863848|FG001|Main Study|Participant did not take study drug|0
6855475|NCT00379769|10863849|FG002|Main Study|Participant did not take study drug|1
6855476|NCT00379769|10863850|FG003|Main Study|Participant did not take study drug|0
6855477|NCT00379769|10863851|FG004|Main Study|Participant did not take study drug|0
6855478|NCT00379769|10863852|FG005|Main Study|Participant did not take study drug|0
6855479|NCT00379769|10863847|FG000|Main Study|Physician Decision|2
6855480|NCT00379769|10863848|FG001|Main Study|Physician Decision|2
6855481|NCT00379769|10863849|FG002|Main Study|Physician Decision|1
6855482|NCT00379769|10863850|FG003|Main Study|Physician Decision|1
6855483|NCT00379769|10863851|FG004|Main Study|Physician Decision|0
6855484|NCT00379769|10863852|FG005|Main Study|Physician Decision|0
6855485|NCT00379769|10863847|FG000|Main Study|Participant completed study at visit 27|1
6855486|NCT00379769|10863848|FG001|Main Study|Participant completed study at visit 27|0
6855487|NCT00379769|10863849|FG002|Main Study|Participant completed study at visit 27|0
6855488|NCT00379769|10863850|FG003|Main Study|Participant completed study at visit 27|0
6855489|NCT00379769|10863851|FG004|Main Study|Participant completed study at visit 27|0
6855490|NCT00379769|10863852|FG005|Main Study|Participant completed study at visit 27|0
6855491|NCT00379769|10863847|FG000|Main Study|Personal reasons|1
6855492|NCT00379769|10863848|FG001|Main Study|Personal reasons|0
6855493|NCT00379769|10863849|FG002|Main Study|Personal reasons|0
6855494|NCT00379769|10863850|FG003|Main Study|Personal reasons|0
6855495|NCT00379769|10863851|FG004|Main Study|Personal reasons|0
6855496|NCT00379769|10863852|FG005|Main Study|Personal reasons|0
6855497|NCT00379769|10863847|FG000|Main Study|Risk of heart failure|0
6855498|NCT00379769|10863848|FG001|Main Study|Risk of heart failure|1
6855499|NCT00379769|10863849|FG002|Main Study|Risk of heart failure|0
6855500|NCT00379769|10863850|FG003|Main Study|Risk of heart failure|0
6855501|NCT00379769|10863851|FG004|Main Study|Risk of heart failure|0
6855502|NCT00379769|10863852|FG005|Main Study|Risk of heart failure|0
6855503|NCT00379769|10863847|FG000|Main Study|Investigator refused to log temperature|0
6855504|NCT00379769|10863848|FG001|Main Study|Investigator refused to log temperature|0
6855505|NCT00379769|10863849|FG002|Main Study|Investigator refused to log temperature|1
6855506|NCT00379769|10863850|FG003|Main Study|Investigator refused to log temperature|0
6855507|NCT00379769|10863851|FG004|Main Study|Investigator refused to log temperature|0
6855508|NCT00379769|10863852|FG005|Main Study|Investigator refused to log temperature|0
6855509|NCT00379769|10863847|FG000|Main Study|Reason unspecified|0
6855510|NCT00379769|10863848|FG001|Main Study|Reason unspecified|0
6855511|NCT00379769|10863849|FG002|Main Study|Reason unspecified|1
6855512|NCT00379769|10863850|FG003|Main Study|Reason unspecified|0
6855513|NCT00379769|10863851|FG004|Main Study|Reason unspecified|0
6855514|NCT00379769|10863852|FG005|Main Study|Reason unspecified|0
6855515|NCT00379769|10863847|FG000|Observational Follow-up|Death|0
6855516|NCT00379769|10863848|FG001|Observational Follow-up|Death|0
6855517|NCT00379769|10863849|FG002|Observational Follow-up|Death|0
6855518|NCT00379769|10863850|FG003|Observational Follow-up|Death|0
6855519|NCT00379769|10863851|FG004|Observational Follow-up|Death|78
6855520|NCT00379769|10863852|FG005|Observational Follow-up|Death|70
6855521|NCT00379769|10863847|FG000|Observational Follow-up|Adverse Event|0
6855522|NCT00379769|10863848|FG001|Observational Follow-up|Adverse Event|0
6855523|NCT00379769|10863849|FG002|Observational Follow-up|Adverse Event|0
6855524|NCT00379769|10863850|FG003|Observational Follow-up|Adverse Event|0
6855525|NCT00379769|10863851|FG004|Observational Follow-up|Adverse Event|1
6855526|NCT00379769|10863852|FG005|Observational Follow-up|Adverse Event|0
6855527|NCT00379769|10863847|FG000|Observational Follow-up|Lost to Follow-up|0
6855528|NCT00379769|10863848|FG001|Observational Follow-up|Lost to Follow-up|0
6855529|NCT00379769|10863849|FG002|Observational Follow-up|Lost to Follow-up|0
6855530|NCT00379769|10863850|FG003|Observational Follow-up|Lost to Follow-up|0
6855531|NCT00379769|10863851|FG004|Observational Follow-up|Lost to Follow-up|25
6855532|NCT00379769|10863852|FG005|Observational Follow-up|Lost to Follow-up|27
6855533|NCT00379769|10863847|FG000|Observational Follow-up|Withdrawal by Subject|0
6855534|NCT00379769|10863848|FG001|Observational Follow-up|Withdrawal by Subject|0
6855535|NCT00379769|10863849|FG002|Observational Follow-up|Withdrawal by Subject|0
6855536|NCT00379769|10863850|FG003|Observational Follow-up|Withdrawal by Subject|0
6855537|NCT00379769|10863851|FG004|Observational Follow-up|Withdrawal by Subject|12
6855538|NCT00379769|10863852|FG005|Observational Follow-up|Withdrawal by Subject|12
6855539|NCT00379769|10863847|FG000|Observational Follow-up|Entered into Another Clinical Trial|0
6855540|NCT00379769|10863848|FG001|Observational Follow-up|Entered into Another Clinical Trial|0
6855541|NCT00379769|10863849|FG002|Observational Follow-up|Entered into Another Clinical Trial|0
6855542|NCT00379769|10863850|FG003|Observational Follow-up|Entered into Another Clinical Trial|0
6855543|NCT00379769|10863851|FG004|Observational Follow-up|Entered into Another Clinical Trial|18
6855544|NCT00379769|10863852|FG005|Observational Follow-up|Entered into Another Clinical Trial|22
6855545|NCT00379769|10863847|FG000|Observational Follow-up|Physician Decision|0
6855546|NCT00379769|10863848|FG001|Observational Follow-up|Physician Decision|0
6855547|NCT00379769|10863849|FG002|Observational Follow-up|Physician Decision|0
6855548|NCT00379769|10863850|FG003|Observational Follow-up|Physician Decision|0
6855549|NCT00379769|10863851|FG004|Observational Follow-up|Physician Decision|8
6855550|NCT00379769|10863852|FG005|Observational Follow-up|Physician Decision|8
6855551|NCT00379769|10863847|FG000|Observational Follow-up|Site Closed Early|0
6855552|NCT00379769|10863848|FG001|Observational Follow-up|Site Closed Early|0
6855553|NCT00379769|10863849|FG002|Observational Follow-up|Site Closed Early|0
6855554|NCT00379769|10863850|FG003|Observational Follow-up|Site Closed Early|0
6855555|NCT00379769|10863851|FG004|Observational Follow-up|Site Closed Early|6
6855556|NCT00379769|10863852|FG005|Observational Follow-up|Site Closed Early|7
6855557|NCT00379769|10863847|FG000|Observational Follow-up|Participant Moved|0
6855558|NCT00379769|10863848|FG001|Observational Follow-up|Participant Moved|0
6855559|NCT00379769|10863849|FG002|Observational Follow-up|Participant Moved|0
6855560|NCT00379769|10863850|FG003|Observational Follow-up|Participant Moved|0
6855561|NCT00379769|10863851|FG004|Observational Follow-up|Participant Moved|0
6855562|NCT00379769|10863852|FG005|Observational Follow-up|Participant Moved|1
6855563|NCT00379769|10863847|FG000|Observational Follow-up|Unknown; Reason Not Provided|0
6855564|NCT00379769|10863848|FG001|Observational Follow-up|Unknown; Reason Not Provided|0
6855565|NCT00379769|10863849|FG002|Observational Follow-up|Unknown; Reason Not Provided|0
6855566|NCT00379769|10863850|FG003|Observational Follow-up|Unknown; Reason Not Provided|0
6855567|NCT00379769|10863851|FG004|Observational Follow-up|Unknown; Reason Not Provided|1
6855568|NCT00379769|10863852|FG005|Observational Follow-up|Unknown; Reason Not Provided|1
6855569|NCT00379795|10863884|FG000|Overall Study|Death|31
6855570|NCT00379795|10863885|FG001|Overall Study|Death|8
6855571|NCT00379795|10863886|FG002|Overall Study|Death|6
6855572|NCT00379795|10863887|FG003|Overall Study|Death|4
7077882|NCT02097277|11185872|FG001|Overall Study|Subject request to discontinue treatment|0
6855573|NCT00379795|10863888|FG004|Overall Study|Death|7
6855574|NCT00379795|10863884|FG000|Overall Study|Adverse Event|17
6855575|NCT00379795|10863885|FG001|Overall Study|Adverse Event|3
6855576|NCT00379795|10863886|FG002|Overall Study|Adverse Event|3
6855577|NCT00379795|10863887|FG003|Overall Study|Adverse Event|1
6855578|NCT00379795|10863888|FG004|Overall Study|Adverse Event|4
6855579|NCT00379795|10863884|FG000|Overall Study|Lost to Follow-up|8
6855580|NCT00379795|10863885|FG001|Overall Study|Lost to Follow-up|1
6855581|NCT00379795|10863886|FG002|Overall Study|Lost to Follow-up|2
6855582|NCT00379795|10863887|FG003|Overall Study|Lost to Follow-up|1
6855583|NCT00379795|10863888|FG004|Overall Study|Lost to Follow-up|4
6855584|NCT00379795|10863884|FG000|Overall Study|Physician Decision|25
6855585|NCT00379795|10863885|FG001|Overall Study|Physician Decision|0
6855586|NCT00379795|10863886|FG002|Overall Study|Physician Decision|2
6855587|NCT00379795|10863887|FG003|Overall Study|Physician Decision|2
6855588|NCT00379795|10863888|FG004|Overall Study|Physician Decision|2
6855589|NCT00379795|10863884|FG000|Overall Study|Withdrawal by Subject|94
6855590|NCT00379795|10863885|FG001|Overall Study|Withdrawal by Subject|11
6855591|NCT00379795|10863886|FG002|Overall Study|Withdrawal by Subject|19
6855592|NCT00379795|10863887|FG003|Overall Study|Withdrawal by Subject|7
6855593|NCT00379795|10863888|FG004|Overall Study|Withdrawal by Subject|14
6855594|NCT00379795|10863884|FG000|Overall Study|Subject non-compliance|7
6855595|NCT00379795|10863885|FG001|Overall Study|Subject non-compliance|2
6855596|NCT00379795|10863886|FG002|Overall Study|Subject non-compliance|0
6855597|NCT00379795|10863887|FG003|Overall Study|Subject non-compliance|0
6855598|NCT00379795|10863888|FG004|Overall Study|Subject non-compliance|1
6855599|NCT00379795|10863884|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3
6855600|NCT00379795|10863885|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0
6855601|NCT00379795|10863886|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0
6855602|NCT00379795|10863887|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1
6855603|NCT00379795|10863888|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0
6855604|NCT00379795|10863884|FG000|Overall Study|Subjects condition mandated intervention|34
6855605|NCT00379795|10863885|FG001|Overall Study|Subjects condition mandated intervention|9
6967125|NCT01130272|11015536|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1
6967126|NCT01130272|11015537|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0
6967127|NCT01130272|11015538|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0
6855606|NCT00379795|10863886|FG002|Overall Study|Subjects condition mandated intervention|7
6855607|NCT00379795|10863887|FG003|Overall Study|Subjects condition mandated intervention|5
6855608|NCT00379795|10863888|FG004|Overall Study|Subjects condition mandated intervention|7
6855609|NCT00379795|10863884|FG000|Overall Study|Sponsor's decision|257
6855610|NCT00379795|10863885|FG001|Overall Study|Sponsor's decision|17
6855611|NCT00379795|10863886|FG002|Overall Study|Sponsor's decision|54
6855612|NCT00379795|10863887|FG003|Overall Study|Sponsor's decision|47
6855613|NCT00379795|10863888|FG004|Overall Study|Sponsor's decision|10
6855614|NCT00379808|10863903|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0
6855615|NCT00379808|10863904|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1
6855616|NCT00379834|10863934|FG000|Overall Study|Time constraints|2
6855617|NCT00379899|10863940|FG000|Overall Study|Adverse Event|7
6855618|NCT00379899|10863941|FG001|Overall Study|Adverse Event|3
6855619|NCT00379899|10863940|FG000|Overall Study|Death|10
6855620|NCT00379899|10863941|FG001|Overall Study|Death|10
6855621|NCT00379899|10863940|FG000|Overall Study|Lost to Follow-up|2
6855622|NCT00379899|10863941|FG001|Overall Study|Lost to Follow-up|4
6855623|NCT00379899|10863940|FG000|Overall Study|Physician Decision|3
6855624|NCT00379899|10863941|FG001|Overall Study|Physician Decision|4
6855625|NCT00379899|10863940|FG000|Overall Study|Withdrawal by Subject|5
6855626|NCT00379899|10863941|FG001|Overall Study|Withdrawal by Subject|5
6855627|NCT00379899|10863940|FG000|Overall Study|Ineligibility determined|0
6855628|NCT00379899|10863941|FG001|Overall Study|Ineligibility determined|1
6855629|NCT00379899|10863940|FG000|Overall Study|Noncompliance|1
7040977|NCT01721954|11124262|FG001|Overall Study|Death|64
7040978|NCT01721954|11124261|FG000|Overall Study|Withdrawal by Subject|8
7040979|NCT01721954|11124262|FG001|Overall Study|Withdrawal by Subject|4
7040980|NCT01721954|11124261|FG000|Overall Study|Adverse Event|2
7040981|NCT01721954|11124262|FG001|Overall Study|Adverse Event|0
7040982|NCT01721954|11124261|FG000|Overall Study|Lost to Follow-up|2
7040983|NCT01721954|11124262|FG001|Overall Study|Lost to Follow-up|1
7040984|NCT01722045|11124272|FG000|Overall Study|Adverse Event|8
7040985|NCT01722045|11124272|FG000|Overall Study|Death|3
6855630|NCT00379899|10863941|FG001|Overall Study|Noncompliance|1
6855631|NCT00379899|10863940|FG000|Overall Study|Parathyroidectomy|0
6855632|NCT00379899|10863941|FG001|Overall Study|Parathyroidectomy|2
6855633|NCT00379899|10863940|FG000|Overall Study|Renal transplantation|5
6855634|NCT00379899|10863941|FG001|Overall Study|Renal transplantation|4
6855635|NCT00379899|10863940|FG000|Overall Study|Coronary artery bypass graft|1
6855636|NCT00379899|10863941|FG001|Overall Study|Coronary artery bypass graft|1
6855637|NCT00379899|10863940|FG000|Overall Study|Other protocol-specified criteria|3
6855638|NCT00379899|10863941|FG001|Overall Study|Other protocol-specified criteria|4
6855639|NCT00379899|10863940|FG000|Overall Study|Other|3
6855640|NCT00379899|10863941|FG001|Overall Study|Other|1
6967128|NCT01130272|11015539|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2
6967129|NCT01130272|11015535|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
6967130|NCT01130272|11015536|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
6967131|NCT01130272|11015537|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
6967132|NCT01130272|11015538|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1
6967133|NCT01130272|11015539|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
6967134|NCT01130272|11015535|FG000|Overall Study|Protocol Violation|0
6967135|NCT01130272|11015536|FG001|Overall Study|Protocol Violation|0
6967136|NCT01130272|11015537|FG002|Overall Study|Protocol Violation|3
6967137|NCT01130272|11015538|FG003|Overall Study|Protocol Violation|5
6967138|NCT01130272|11015539|FG004|Overall Study|Protocol Violation|5
6967139|NCT01130272|11015535|FG000|Overall Study|Lost to Follow-up|4
6967140|NCT01130272|11015536|FG001|Overall Study|Lost to Follow-up|3
6967141|NCT01130272|11015537|FG002|Overall Study|Lost to Follow-up|4
6967142|NCT01130272|11015538|FG003|Overall Study|Lost to Follow-up|7
6967143|NCT01130272|11015539|FG004|Overall Study|Lost to Follow-up|6
6967144|NCT01130272|11015535|FG000|Overall Study|Withdrawal by Subject|4
6967145|NCT01130272|11015536|FG001|Overall Study|Withdrawal by Subject|11
6967146|NCT01130272|11015537|FG002|Overall Study|Withdrawal by Subject|10
6967147|NCT01130272|11015538|FG003|Overall Study|Withdrawal by Subject|9
6967148|NCT01130272|11015539|FG004|Overall Study|Withdrawal by Subject|8
6967149|NCT01130272|11015535|FG000|Overall Study|Physician Decision|1
6967150|NCT01130272|11015536|FG001|Overall Study|Physician Decision|1
6855641|NCT00379912|10863949|FG000|Overall Study|Lack of Efficacy|1
6855642|NCT00379912|10863950|FG001|Overall Study|Lack of Efficacy|0
6855643|NCT00380068|10863970|FG000|Overall Study|Adverse Event|40
6855644|NCT00380068|10863970|FG000|Overall Study|Withdrawal by Subject|10
6855645|NCT00380068|10863970|FG000|Overall Study|Not compliant|6
6855646|NCT00380068|10863970|FG000|Overall Study|Lost to Follow-up|1
6855647|NCT00380068|10863970|FG000|Overall Study|Addition of other PAH therapeutic agent|1
6855648|NCT00380068|10863970|FG000|Overall Study|Lung transplant|3
6855649|NCT00380068|10863970|FG000|Overall Study|Physician Decision|2
6855650|NCT00380068|10863970|FG000|Overall Study|Partipant moved away|1
6855651|NCT00380068|10863970|FG000|Overall Study|Lack of Efficacy|5
6855652|NCT00380081|10863980|FG000|Overall Study|Withdrawal by Subject|0
6855653|NCT00380081|10863981|FG001|Overall Study|Withdrawal by Subject|0
6855654|NCT00380081|10863982|FG002|Overall Study|Withdrawal by Subject|0
6855655|NCT00380081|10863983|FG003|Overall Study|Withdrawal by Subject|0
6855656|NCT00380081|10863984|FG004|Overall Study|Withdrawal by Subject|1
6855657|NCT00380081|10863985|FG005|Overall Study|Withdrawal by Subject|0
6855658|NCT00380081|10863980|FG000|Overall Study|Family Emergency|0
6855659|NCT00380081|10863981|FG001|Overall Study|Family Emergency|0
6855660|NCT00380081|10863982|FG002|Overall Study|Family Emergency|0
6855661|NCT00380081|10863983|FG003|Overall Study|Family Emergency|0
6855662|NCT00380081|10863984|FG004|Overall Study|Family Emergency|0
6855663|NCT00380081|10863985|FG005|Overall Study|Family Emergency|1
6855664|NCT00380250|10863995|FG000|Overall Study|Withdrawal by Subject|39
6855665|NCT00380250|10863996|FG001|Overall Study|Withdrawal by Subject|28
6855666|NCT00380250|10863995|FG000|Overall Study|Adverse Event|20
6855667|NCT00380250|10863996|FG001|Overall Study|Adverse Event|9
6855668|NCT00380250|10863995|FG000|Overall Study|Lack of Efficacy|10
6855669|NCT00380250|10863996|FG001|Overall Study|Lack of Efficacy|8
6855670|NCT00380250|10863995|FG000|Overall Study|Protocol Violation|15
6855671|NCT00380250|10863996|FG001|Overall Study|Protocol Violation|5
6855672|NCT00380250|10863995|FG000|Overall Study|Lost to Follow-up|14
6855673|NCT00380250|10863996|FG001|Overall Study|Lost to Follow-up|5
6855674|NCT00380250|10863995|FG000|Overall Study|Physician Decision|1
6855675|NCT00380250|10863996|FG001|Overall Study|Physician Decision|0
6855676|NCT00380367|10864002|FG000|Overall Study|Lost to Follow-up|1
6855677|NCT00380367|10864002|FG000|Overall Study|Withdrawal by Subject|1
6855678|NCT00380393|10864008|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6
6855679|NCT00380393|10864009|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5
6855680|NCT00380393|10864008|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0
6855681|NCT00380393|10864009|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1
6855682|NCT00380393|10864008|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37
6855683|NCT00380393|10864009|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29
6855684|NCT00380393|10864008|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1
6855685|NCT00380393|10864009|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1
6855686|NCT00380393|10864008|FG000|Month 8 (Cross-sectional Visit)|Others|5
6967151|NCT01130272|11015537|FG002|Overall Study|Physician Decision|0
6855687|NCT00380393|10864009|FG001|Month 8 (Cross-sectional Visit)|Others|4
6855688|NCT00380393|10864008|FG000|Month 14|Withdrawal by Subject|9
6855689|NCT00380393|10864009|FG001|Month 14|Withdrawal by Subject|7
6855690|NCT00380393|10864008|FG000|Month 14|Death|1
6855691|NCT00380393|10864009|FG001|Month 14|Death|0
6855692|NCT00380393|10864008|FG000|Month 14|Lost to Follow-up|0
6855693|NCT00380393|10864009|FG001|Month 14|Lost to Follow-up|1
6855694|NCT00380393|10864008|FG000|Month 14|Migrated/moved from study area|39
6855695|NCT00380393|10864009|FG001|Month 14|Migrated/moved from study area|42
6855696|NCT00380393|10864008|FG000|Month 14|Protocol Violation|2
6855697|NCT00380393|10864009|FG001|Month 14|Protocol Violation|0
6855698|NCT00380393|10864008|FG000|Month 14|Others|6
6855699|NCT00380393|10864009|FG001|Month 14|Others|6
6855700|NCT00380588|10864017|FG000|Overall Study|Unequivocal Disease Progression|25
6855701|NCT00380588|10864018|FG001|Overall Study|Unequivocal Disease Progression|34
6855702|NCT00380588|10864017|FG000|Overall Study|Next Cycle Not Started|4
6855703|NCT00380588|10864018|FG001|Overall Study|Next Cycle Not Started|0
6855704|NCT00380588|10864017|FG000|Overall Study|Adverse Event|7
6855705|NCT00380588|10864018|FG001|Overall Study|Adverse Event|3
6855706|NCT00380588|10864017|FG000|Overall Study|Withdrawal by Subject|1
6855707|NCT00380588|10864018|FG001|Overall Study|Withdrawal by Subject|3
6855708|NCT00380588|10864017|FG000|Overall Study|Physician Decision|2
7077883|NCT02097277|11185873|FG002|Overall Study|Subject request to discontinue treatment|0
7077884|NCT02097277|11185874|FG003|Overall Study|Subject request to discontinue treatment|0
7077885|NCT02097277|11185875|FG004|Overall Study|Subject request to discontinue treatment|1
7077886|NCT02097277|11185871|FG000|Overall Study|Lost to Follow-up|0
7077887|NCT02097277|11185872|FG001|Overall Study|Lost to Follow-up|1
7077888|NCT02097277|11185873|FG002|Overall Study|Lost to Follow-up|1
7077889|NCT02097277|11185874|FG003|Overall Study|Lost to Follow-up|0
7077890|NCT02097277|11185875|FG004|Overall Study|Lost to Follow-up|0
6855709|NCT00380588|10864018|FG001|Overall Study|Physician Decision|0
6855710|NCT00380692|10864026|FG000|Study Period II - Double Blind|Adverse Event|1
6855711|NCT00380692|10864027|FG001|Study Period II - Double Blind|Adverse Event|0
6855712|NCT00380692|10864026|FG000|Study Period II - Double Blind|Protocol Violation|2
6855713|NCT00380692|10864027|FG001|Study Period II - Double Blind|Protocol Violation|2
6855714|NCT00380692|10864026|FG000|Study Period II - Double Blind|Withdrawal by Subject|0
6855715|NCT00380692|10864027|FG001|Study Period II - Double Blind|Withdrawal by Subject|0
6855716|NCT00380692|10864026|FG000|Study Period II - Double Blind|Physician Decision|0
6855717|NCT00380692|10864027|FG001|Study Period II - Double Blind|Physician Decision|1
6855718|NCT00380692|10864026|FG000|Study Period II - Double Blind|Lack of Efficacy|1
6855719|NCT00380692|10864027|FG001|Study Period II - Double Blind|Lack of Efficacy|0
6855720|NCT00380692|10864026|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1
6855721|NCT00380692|10864027|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0
6855722|NCT00380692|10864026|FG000|Study Period III - Open Label|Adverse Event|5
6855723|NCT00380692|10864027|FG001|Study Period III - Open Label|Adverse Event|3
6855724|NCT00380692|10864026|FG000|Study Period III - Open Label|Protocol Violation|0
6855725|NCT00380692|10864027|FG001|Study Period III - Open Label|Protocol Violation|0
6855726|NCT00380692|10864026|FG000|Study Period III - Open Label|Withdrawal by Subject|0
6855727|NCT00380692|10864027|FG001|Study Period III - Open Label|Withdrawal by Subject|1
6855728|NCT00380692|10864026|FG000|Study Period III - Open Label|Physician Decision|0
6855729|NCT00380692|10864027|FG001|Study Period III - Open Label|Physician Decision|3
6855730|NCT00380692|10864026|FG000|Study Period III - Open Label|Lack of Efficacy|0
6855731|NCT00380692|10864027|FG001|Study Period III - Open Label|Lack of Efficacy|4
6855732|NCT00380692|10864026|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1
6855733|NCT00380692|10864027|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1
6855734|NCT00380718|10864033|FG000|Overall Study|Adverse Event|1
6855735|NCT00380718|10864033|FG000|Overall Study|Death after 30-day post-therapy followup|17
6855736|NCT00380744|10864044|FG000|Overall Study|Death|0
6855737|NCT00380744|10864045|FG001|Overall Study|Death|0
6855738|NCT00380744|10864046|FG002|Overall Study|Death|0
6855739|NCT00380744|10864047|FG003|Overall Study|Death|0
6855740|NCT00380744|10864048|FG004|Overall Study|Death|0
6855741|NCT00380744|10864049|FG005|Overall Study|Death|0
6855742|NCT00380744|10864050|FG006|Overall Study|Death|1
6855743|NCT00380744|10864044|FG000|Overall Study|Withdrawal by Subject|1
6855744|NCT00380744|10864045|FG001|Overall Study|Withdrawal by Subject|0
6855745|NCT00380744|10864046|FG002|Overall Study|Withdrawal by Subject|0
6855746|NCT00380744|10864047|FG003|Overall Study|Withdrawal by Subject|0
6855747|NCT00380744|10864048|FG004|Overall Study|Withdrawal by Subject|0
6855748|NCT00380744|10864049|FG005|Overall Study|Withdrawal by Subject|0
6967152|NCT01130272|11015538|FG003|Overall Study|Physician Decision|1
6967153|NCT01130272|11015539|FG004|Overall Study|Physician Decision|2
6967154|NCT01130272|11015535|FG000|Overall Study|Sponsor decision|6
6967155|NCT01130272|11015536|FG001|Overall Study|Sponsor decision|15
6967156|NCT01130272|11015537|FG002|Overall Study|Sponsor decision|16
6967157|NCT01130272|11015538|FG003|Overall Study|Sponsor decision|13
6855749|NCT00380744|10864050|FG006|Overall Study|Withdrawal by Subject|0
6855750|NCT00380874|10864078|FG000|Overall Study|Adverse Event|7
6855751|NCT00380874|10864079|FG001|Overall Study|Adverse Event|7
6855752|NCT00380874|10864078|FG000|Overall Study|Death|1
6855753|NCT00380874|10864079|FG001|Overall Study|Death|0
6855754|NCT00380874|10864078|FG000|Overall Study|Withdrawal by Subject|2
6967158|NCT01130272|11015539|FG004|Overall Study|Sponsor decision|16
6855755|NCT00380874|10864079|FG001|Overall Study|Withdrawal by Subject|1
6855756|NCT00380874|10864078|FG000|Overall Study|Not related to study drug|3
7077891|NCT02097277|11185871|FG000|Overall Study|Withdrawal by Subject|2
6967159|NCT01130272|11015535|FG000|Overall Study|Study arm discontinued|38
6967160|NCT01130272|11015536|FG001|Overall Study|Study arm discontinued|0
6967161|NCT01130272|11015537|FG002|Overall Study|Study arm discontinued|0
6967162|NCT01130272|11015538|FG003|Overall Study|Study arm discontinued|0
6967163|NCT01130272|11015539|FG004|Overall Study|Study arm discontinued|0
6967164|NCT01130337|11015551|FG000|Overall Study|Withdrawal by Subject|3
6967165|NCT01130337|11015551|FG000|Overall Study|Principal investigator decision|1
6855757|NCT00380874|10864079|FG001|Overall Study|Not related to study drug|2
6855758|NCT00380978|10864087|FG000|Overall Study|Refused allocated intervention|0
6855759|NCT00380978|10864088|FG001|Overall Study|Refused allocated intervention|6
6855760|NCT00380978|10864087|FG000|Overall Study|Wrong study envelope|0
6855761|NCT00380978|10864088|FG001|Overall Study|Wrong study envelope|2
6855762|NCT00380978|10864087|FG000|Overall Study|Allocation prior to analgesia request|1
6855763|NCT00380978|10864088|FG001|Overall Study|Allocation prior to analgesia request|2
6855764|NCT00380978|10864087|FG000|Overall Study|Parous patient|1
6855765|NCT00380978|10864088|FG001|Overall Study|Parous patient|0
6855766|NCT00381043|10864100|FG000|Overall Study|Lost to Follow-up|8
6855767|NCT00381043|10864101|FG001|Overall Study|Lost to Follow-up|6
6855768|NCT00381043|10864100|FG000|Overall Study|Withdrawal by Subject|3
6855769|NCT00381043|10864101|FG001|Overall Study|Withdrawal by Subject|1
6855770|NCT00381043|10864100|FG000|Overall Study|wanted more care|0
6855771|NCT00381043|10864101|FG001|Overall Study|wanted more care|1
6855772|NCT00381043|10864100|FG000|Overall Study|incarcerated|1
6855773|NCT00381043|10864101|FG001|Overall Study|incarcerated|0
6855774|NCT00381095|10864109|FG000|Overall Study|Death|3
6855775|NCT00381095|10864110|FG001|Overall Study|Death|4
6855776|NCT00381095|10864109|FG000|Overall Study|Lack of Efficacy|2
6855777|NCT00381095|10864110|FG001|Overall Study|Lack of Efficacy|4
6855778|NCT00381095|10864109|FG000|Overall Study|Other|2
6855779|NCT00381095|10864110|FG001|Overall Study|Other|2
6855780|NCT00381095|10864109|FG000|Overall Study|Protocol Violation|1
6855781|NCT00381095|10864110|FG001|Overall Study|Protocol Violation|1
6855782|NCT00381095|10864109|FG000|Overall Study|Withdrawal by Subject|3
6855783|NCT00381095|10864110|FG001|Overall Study|Withdrawal by Subject|3
6855784|NCT00381095|10864109|FG000|Overall Study|Adverse Event|2
6855785|NCT00381095|10864110|FG001|Overall Study|Adverse Event|7
6855786|NCT00381238|10864116|FG000|Overall Study|Adverse Event|3
6855787|NCT00381238|10864116|FG000|Overall Study|Protocol Violation|1
6855788|NCT00381238|10864116|FG000|Overall Study|Withdrawal by Subject|4
6855789|NCT00381238|10864116|FG000|Overall Study|Lack of Efficacy|2
6855790|NCT00381238|10864116|FG000|Overall Study|Withdrew by physician|1
6855791|NCT00381238|10864116|FG000|Overall Study|Disease progression|1
6855792|NCT00381303|10864122|FG000|Overall Study|Lost to Follow-up|25
6855793|NCT00381303|10864123|FG001|Overall Study|Lost to Follow-up|9
6855794|NCT00381303|10864122|FG000|Overall Study|AE/HIV-related event|22
6855795|NCT00381303|10864123|FG001|Overall Study|AE/HIV-related event|6
6855796|NCT00381303|10864122|FG000|Overall Study|Non-Adherence|13
6855797|NCT00381303|10864123|FG001|Overall Study|Non-Adherence|6
6855798|NCT00381303|10864122|FG000|Overall Study|Withdrawal by Subject|13
6855799|NCT00381303|10864123|FG001|Overall Study|Withdrawal by Subject|6
6855800|NCT00381303|10864122|FG000|Overall Study|Virologic failure|6
6855801|NCT00381303|10864123|FG001|Overall Study|Virologic failure|4
6855802|NCT00381303|10864122|FG000|Overall Study|Ineligible to continue the trial|2
6855803|NCT00381303|10864123|FG001|Overall Study|Ineligible to continue the trial|1
6855804|NCT00381303|10864122|FG000|Overall Study|Pregnancy|2
6855805|NCT00381303|10864123|FG001|Overall Study|Pregnancy|0
6855806|NCT00381303|10864122|FG000|Overall Study|Physician Decision|1
6855807|NCT00381303|10864123|FG001|Overall Study|Physician Decision|0
6855808|NCT00381303|10864122|FG000|Overall Study|Physician's decision to close the site|3
6855809|NCT00381303|10864123|FG001|Overall Study|Physician's decision to close the site|1
6855810|NCT00381303|10864122|FG000|Overall Study|Subject moved out of state|2
6855811|NCT00381303|10864123|FG001|Overall Study|Subject moved out of state|0
6855812|NCT00381303|10864122|FG000|Overall Study|Subject taking too many different meds|1
6855813|NCT00381303|10864123|FG001|Overall Study|Subject taking too many different meds|0
6855814|NCT00381303|10864122|FG000|Overall Study|No virologic response by week 12|1
6855815|NCT00381303|10864123|FG001|Overall Study|No virologic response by week 12|0
6855816|NCT00381303|10864122|FG000|Overall Study|Subject was too busy for appointments|1
6855817|NCT00381303|10864123|FG001|Overall Study|Subject was too busy for appointments|0
6855818|NCT00381303|10864122|FG000|Overall Study|Subject did not continue visits|1
6855819|NCT00381303|10864123|FG001|Overall Study|Subject did not continue visits|0
6855820|NCT00381303|10864122|FG000|Overall Study|Subject primary physician's decision|1
6855821|NCT00381303|10864123|FG001|Overall Study|Subject primary physician's decision|0
6855822|NCT00381563|10864147|FG000|Overall Study|Withdrawal by Subject|5
6855823|NCT00381563|10864148|FG001|Overall Study|Withdrawal by Subject|5
6855824|NCT00381563|10864147|FG000|Overall Study|Lost to Follow-up|2
6855825|NCT00381563|10864148|FG001|Overall Study|Lost to Follow-up|0
6855826|NCT00381563|10864147|FG000|Overall Study|Protocol Violation|0
6855827|NCT00381563|10864148|FG001|Overall Study|Protocol Violation|1
6855828|NCT00381615|10864157|FG000|Overall Study|Withdrawal by Subject|1
6855829|NCT00381615|10864158|FG001|Overall Study|Withdrawal by Subject|3
6855830|NCT00381615|10864159|FG002|Overall Study|Withdrawal by Subject|0
6855831|NCT00381615|10864160|FG003|Overall Study|Withdrawal by Subject|1
6967166|NCT01130337|11015551|FG000|Overall Study|Death|1
6967167|NCT01130337|11015551|FG000|Overall Study|Disease progression|1
6967168|NCT01130337|11015551|FG000|Overall Study|Toxicity, AE/intercurrent disease|7
6967169|NCT01130337|11015551|FG000|Overall Study|Surgical resection (R2)|1
6967170|NCT01130493|11015555|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1
6855832|NCT00381615|10864157|FG000|Overall Study|Lost to Follow-up|3
6967171|NCT01130493|11015556|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0
6967172|NCT01130493|11015557|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0
6967173|NCT01130493|11015555|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3
6967174|NCT01130493|11015556|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0
6967175|NCT01130493|11015557|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0
6967176|NCT01130493|11015555|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7
6967177|NCT01130493|11015556|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
6967178|NCT01130493|11015557|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
6967179|NCT01130493|11015555|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7
6967180|NCT01130493|11015556|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
6967181|NCT01130493|11015557|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
6967182|NCT01130493|11015555|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1
6967183|NCT01130493|11015556|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0
6967184|NCT01130493|11015557|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0
6967185|NCT01130493|11015555|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
6967186|NCT01130493|11015556|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1
6967187|NCT01130493|11015557|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
6967188|NCT01130493|11015555|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
6967189|NCT01130493|11015556|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1
6967190|NCT01130493|11015557|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
6967191|NCT01130493|11015555|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
6967192|NCT01130493|11015556|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1
6967193|NCT01130493|11015557|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
6967194|NCT01130493|11015555|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0
6967195|NCT01130493|11015556|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0
6967196|NCT01130493|11015557|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1
6967197|NCT01130493|11015555|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
6967198|NCT01130493|11015556|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
6967199|NCT01130493|11015557|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1
6967200|NCT01130493|11015555|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
6967201|NCT01130493|11015556|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
6855833|NCT00381615|10864158|FG001|Overall Study|Lost to Follow-up|2
6855834|NCT00381615|10864159|FG002|Overall Study|Lost to Follow-up|0
6855835|NCT00381615|10864160|FG003|Overall Study|Lost to Follow-up|1
6855836|NCT00381615|10864157|FG000|Overall Study|Protocol Violation|0
6855837|NCT00381615|10864158|FG001|Overall Study|Protocol Violation|0
6855838|NCT00381615|10864159|FG002|Overall Study|Protocol Violation|1
6855839|NCT00381615|10864160|FG003|Overall Study|Protocol Violation|0
6855840|NCT00381680|10864191|FG000|Overall Study|Adverse Event|9
6855841|NCT00381680|10864192|FG001|Overall Study|Adverse Event|3
6855842|NCT00381680|10864191|FG000|Overall Study|Death|10
6855843|NCT00381680|10864192|FG001|Overall Study|Death|7
6855844|NCT00381680|10864191|FG000|Overall Study|Lost to Follow-up|3
6855845|NCT00381680|10864192|FG001|Overall Study|Lost to Follow-up|2
6855846|NCT00381680|10864191|FG000|Overall Study|Physician Decision|25
6855847|NCT00381680|10864192|FG001|Overall Study|Physician Decision|6
6855848|NCT00381680|10864191|FG000|Overall Study|Withdrawal by Subject|3
6855849|NCT00381680|10864192|FG001|Overall Study|Withdrawal by Subject|1
6855850|NCT00381680|10864191|FG000|Overall Study|Entry onto another COG Trial|1
6855851|NCT00381680|10864192|FG001|Overall Study|Entry onto another COG Trial|2
6855852|NCT00381680|10864191|FG000|Overall Study|Alternative Therapy|11
6855853|NCT00381680|10864192|FG001|Overall Study|Alternative Therapy|5
6855854|NCT00381680|10864191|FG000|Overall Study|Secondary Malignancy|3
6855855|NCT00381680|10864192|FG001|Overall Study|Secondary Malignancy|0
6855856|NCT00381680|10864191|FG000|Overall Study|Delay initiation|1
6855857|NCT00381680|10864192|FG001|Overall Study|Delay initiation|0
6855858|NCT00381680|10864191|FG000|Overall Study|Stem Cell Transplant|26
6855859|NCT00381680|10864192|FG001|Overall Study|Stem Cell Transplant|10
6855860|NCT00381680|10864191|FG000|Overall Study|Relapse|18
6855861|NCT00381680|10864192|FG001|Overall Study|Relapse|9
6855862|NCT00381680|10864191|FG000|Overall Study|Induction Failure|4
6855863|NCT00381680|10864192|FG001|Overall Study|Induction Failure|1
6855864|NCT00381680|10864191|FG000|Overall Study|Progression|1
6855865|NCT00381680|10864192|FG001|Overall Study|Progression|1
6855866|NCT00381680|10864191|FG000|Overall Study|Other not otherwise specified|7
6855867|NCT00381680|10864192|FG001|Overall Study|Other not otherwise specified|2
6855868|NCT00381680|10864191|FG000|Overall Study|Ineligible|3
6855869|NCT00381680|10864192|FG001|Overall Study|Ineligible|1
6855870|NCT00381693|10864202|FG000|Overall Study|Death|1
6855871|NCT00381693|10864202|FG000|Overall Study|Adverse Event|4
6855872|NCT00381693|10864202|FG000|Overall Study|Patient Choice|1
6855873|NCT00381693|10864202|FG000|Overall Study|Progression|2
6855874|NCT00381706|10864212|FG000|Overall Study|Never treated|7
6855875|NCT00381706|10864213|FG001|Overall Study|Never treated|2
6855876|NCT00381706|10864214|FG002|Overall Study|Never treated|1
6855877|NCT00381797|10864233|FG000|Overall Study|Withdrawal by Subject|1
6855878|NCT00381797|10864234|FG001|Overall Study|Withdrawal by Subject|1
6855879|NCT00381797|10864235|FG002|Overall Study|Withdrawal by Subject|0
6855880|NCT00381797|10864236|FG003|Overall Study|Withdrawal by Subject|0
6855881|NCT00381797|10864237|FG004|Overall Study|Withdrawal by Subject|2
6855882|NCT00381797|10864233|FG000|Overall Study|Ineligible|0
6855883|NCT00381797|10864234|FG001|Overall Study|Ineligible|0
6855884|NCT00381797|10864235|FG002|Overall Study|Ineligible|0
6855885|NCT00381797|10864236|FG003|Overall Study|Ineligible|1
6855886|NCT00381797|10864237|FG004|Overall Study|Ineligible|0
6855887|NCT00381849|10864276|FG000|Wash Out|Withdrawal by Subject|0
6855888|NCT00381849|10864277|FG001|Wash Out|Withdrawal by Subject|1
6855889|NCT00381888|10864287|FG000|Overall Study|Death|1
6855890|NCT00381888|10864287|FG000|Overall Study|Withdrawal by Subject|1
6855891|NCT00381888|10864287|FG000|Overall Study|Physician Decision|1
6855892|NCT00381888|10864287|FG000|Overall Study|Protocol Violation|9
6855893|NCT00381888|10864287|FG000|Overall Study|Had laparoscopic surgery|2
6855894|NCT00381888|10864287|FG000|Overall Study|Surgery was cancelled|2
6855895|NCT00381888|10864287|FG000|Overall Study|Adverse Event|1
6855896|NCT00381940|10864291|FG000|Overall Study|Lack of Efficacy|3
6855897|NCT00381940|10864291|FG000|Overall Study|Protocol Violation|1
6855898|NCT00381940|10864291|FG000|Overall Study|Ineligible|1
6855899|NCT00382018|10864303|FG000|Overall Study|Progression|0
6855900|NCT00382018|10864304|FG001|Overall Study|Progression|136
6855901|NCT00382018|10864305|FG002|Overall Study|Progression|51
7077892|NCT02097277|11185872|FG001|Overall Study|Withdrawal by Subject|1
7077893|NCT02097277|11185873|FG002|Overall Study|Withdrawal by Subject|0
7077894|NCT02097277|11185874|FG003|Overall Study|Withdrawal by Subject|1
6855902|NCT00382018|10864306|FG003|Overall Study|Progression|43
6967202|NCT01130493|11015557|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1
6967203|NCT01130493|11015555|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0
6967204|NCT01130493|11015556|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0
6967205|NCT01130493|11015557|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1
6967206|NCT01130493|11015555|FG000|Part 2: OLE|Adverse Event|0
6967207|NCT01130493|11015556|FG001|Part 2: OLE|Adverse Event|2
6967208|NCT01130493|11015557|FG002|Part 2: OLE|Adverse Event|1
6967209|NCT01130493|11015555|FG000|Part 2: OLE|Withdrawal by Subject|0
6967210|NCT01130493|11015556|FG001|Part 2: OLE|Withdrawal by Subject|1
6967211|NCT01130493|11015557|FG002|Part 2: OLE|Withdrawal by Subject|4
6855903|NCT00382018|10864303|FG000|Overall Study|Death|0
6855904|NCT00382018|10864304|FG001|Overall Study|Death|9
6855905|NCT00382018|10864305|FG002|Overall Study|Death|7
6855906|NCT00382018|10864306|FG003|Overall Study|Death|11
6855907|NCT00382018|10864303|FG000|Overall Study|Withdrawal by Subject|0
6855908|NCT00382018|10864304|FG001|Overall Study|Withdrawal by Subject|4
6855909|NCT00382018|10864305|FG002|Overall Study|Withdrawal by Subject|3
6855910|NCT00382018|10864306|FG003|Overall Study|Withdrawal by Subject|4
6855911|NCT00382018|10864303|FG000|Overall Study|Other, not protocol specified|0
6855912|NCT00382018|10864304|FG001|Overall Study|Other, not protocol specified|16
6855913|NCT00382018|10864305|FG002|Overall Study|Other, not protocol specified|3
6855914|NCT00382018|10864306|FG003|Overall Study|Other, not protocol specified|1
6855915|NCT00382070|10864330|FG000|Overall Study|No follow up data mapped to Other|17
6855916|NCT00382070|10864331|FG001|Overall Study|No follow up data mapped to Other|19
6855917|NCT00382070|10864330|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7
6855918|NCT00382070|10864331|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0
6855919|NCT00382070|10864330|FG000|Overall Study|No clinical assessment|9
6855920|NCT00382070|10864331|FG001|Overall Study|No clinical assessment|11
6855921|NCT00382109|10864339|FG000|Overall Study|Adverse Event|3
6855922|NCT00382109|10864340|FG001|Overall Study|Adverse Event|0
6855923|NCT00382109|10864339|FG000|Overall Study|Physician Decision|6
6855924|NCT00382109|10864340|FG001|Overall Study|Physician Decision|1
6855925|NCT00382109|10864339|FG000|Overall Study|Withdrawal by Subject|1
6855926|NCT00382109|10864340|FG001|Overall Study|Withdrawal by Subject|0
6855927|NCT00382109|10864339|FG000|Overall Study|ineligible|2
6855928|NCT00382109|10864340|FG001|Overall Study|ineligible|0
6855929|NCT00382109|10864339|FG000|Overall Study|Other|0
6967212|NCT01130532|11015571|FG000|Period III (Weeks 0-12)|Adverse Event|3
6967213|NCT01130532|11015572|FG001|Period III (Weeks 0-12)|Adverse Event|3
6967214|NCT01130532|11015573|FG002|Period III (Weeks 0-12)|Adverse Event|2
6967215|NCT01130532|11015574|FG003|Period III (Weeks 0-12)|Adverse Event|0
6855930|NCT00382109|10864340|FG001|Overall Study|Other|2
6855931|NCT00382109|10864339|FG000|Overall Study|consent withdrawal|0
6855932|NCT00382109|10864340|FG001|Overall Study|consent withdrawal|1
6855933|NCT00382174|10864360|FG000|Overall Study|Lost to Follow-up|1
6967216|NCT01130532|11015571|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4
6855934|NCT00382174|10864361|FG001|Overall Study|Lost to Follow-up|4
6855935|NCT00382174|10864362|FG002|Overall Study|Lost to Follow-up|5
6855936|NCT00382174|10864360|FG000|Overall Study|Adverse Event|1
6855937|NCT00382174|10864361|FG001|Overall Study|Adverse Event|4
6855938|NCT00382174|10864362|FG002|Overall Study|Adverse Event|5
6967217|NCT01130532|11015572|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2
7077895|NCT02097277|11185875|FG004|Overall Study|Withdrawal by Subject|0
6967218|NCT01130532|11015573|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4
6967219|NCT01130532|11015574|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0
6967220|NCT01130532|11015571|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2
6967221|NCT01130532|11015572|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0
6967222|NCT01130532|11015573|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1
6967223|NCT01130532|11015574|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0
7077896|NCT02097277|11185871|FG000|Overall Study|Adverse Event|0
6855939|NCT00382174|10864360|FG000|Overall Study|Withdrawal by Subject|1
6855940|NCT00382174|10864361|FG001|Overall Study|Withdrawal by Subject|4
6855941|NCT00382174|10864362|FG002|Overall Study|Withdrawal by Subject|5
6855942|NCT00382174|10864360|FG000|Overall Study|Non compliance|1
6855943|NCT00382174|10864361|FG001|Overall Study|Non compliance|0
6855944|NCT00382174|10864362|FG002|Overall Study|Non compliance|1
6855945|NCT00382174|10864360|FG000|Overall Study|Physician Decision|0
6855946|NCT00382174|10864361|FG001|Overall Study|Physician Decision|2
6855947|NCT00382174|10864362|FG002|Overall Study|Physician Decision|2
6855948|NCT00382174|10864360|FG000|Overall Study|Failed to meet criteria|0
6855949|NCT00382174|10864361|FG001|Overall Study|Failed to meet criteria|1
6855950|NCT00382174|10864362|FG002|Overall Study|Failed to meet criteria|1
6855951|NCT00382174|10864360|FG000|Overall Study|Wounds merged|0
6855952|NCT00382174|10864361|FG001|Overall Study|Wounds merged|2
6855953|NCT00382174|10864362|FG002|Overall Study|Wounds merged|2
6967224|NCT01130532|11015571|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2
6967225|NCT01130532|11015572|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2
6967226|NCT01130532|11015573|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3
6967227|NCT01130532|11015574|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0
6967228|NCT01130532|11015571|FG000|Period III (Weeks 0-12)|Protocol Violation|0
6967229|NCT01130532|11015572|FG001|Period III (Weeks 0-12)|Protocol Violation|0
6967230|NCT01130532|11015573|FG002|Period III (Weeks 0-12)|Protocol Violation|1
6967231|NCT01130532|11015574|FG003|Period III (Weeks 0-12)|Protocol Violation|0
6967232|NCT01130532|11015571|FG000|Period III (Weeks 0-12)|Sponsor Decision|3
6967233|NCT01130532|11015572|FG001|Period III (Weeks 0-12)|Sponsor Decision|4
6967234|NCT01130532|11015573|FG002|Period III (Weeks 0-12)|Sponsor Decision|2
6967235|NCT01130532|11015574|FG003|Period III (Weeks 0-12)|Sponsor Decision|0
6967236|NCT01130532|11015571|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7
6967237|NCT01130532|11015572|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7
6967238|NCT01130532|11015573|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6
6967239|NCT01130532|11015574|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0
6967240|NCT01130532|11015571|FG000|Period IV (Weeks 13-16)|Adverse Event|0
6967241|NCT01130532|11015572|FG001|Period IV (Weeks 13-16)|Adverse Event|0
6967242|NCT01130532|11015573|FG002|Period IV (Weeks 13-16)|Adverse Event|0
6967243|NCT01130532|11015574|FG003|Period IV (Weeks 13-16)|Adverse Event|1
6967244|NCT01130532|11015571|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
6967245|NCT01130532|11015572|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
6967246|NCT01130532|11015573|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
6967247|NCT01130532|11015574|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1
6967248|NCT01130532|11015571|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0
6967249|NCT01130532|11015572|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0
6967250|NCT01130532|11015573|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0
6967251|NCT01130532|11015574|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5
6967252|NCT01130532|11015571|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0
6967253|NCT01130532|11015572|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0
6967254|NCT01130532|11015573|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0
6967255|NCT01130532|11015574|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3
6967256|NCT01130597|11015586|FG000|Overall Study|Protocol-specified (High K+)|1
6967257|NCT01130597|11015586|FG000|Overall Study|Adverse Event|4
6967258|NCT01130597|11015586|FG000|Overall Study|Death|1
6967259|NCT01130597|11015586|FG000|Overall Study|Protocol Violation|1
6967260|NCT01130831|11015599|FG000|Overall Study|Withdrawal by Subject|7
6967261|NCT01130831|11015599|FG000|Overall Study|Death|4
6967262|NCT01130831|11015599|FG000|Overall Study|Information was missing|3
6967263|NCT01130883|11015631|FG000|Overall Study|Patient Noncompliance|6
6967264|NCT01130883|11015631|FG000|Overall Study|Reason Unknown|1
6967265|NCT01130883|11015631|FG000|Overall Study|Adverse Event|3
6967266|NCT01130974|11015641|FG000|Overall Study|Protocol Violation|10
6967267|NCT01130974|11015642|FG001|Overall Study|Protocol Violation|10
6967268|NCT01130974|11015641|FG000|Overall Study|Withdrawal by Subject|0
6967269|NCT01130974|11015642|FG001|Overall Study|Withdrawal by Subject|1
6967270|NCT01130974|11015641|FG000|Overall Study|Ineligibility criteria|5
6967271|NCT01130974|11015642|FG001|Overall Study|Ineligibility criteria|2
6967272|NCT01131078|11015665|FG000|Overall Study|Adverse Event|22
6967273|NCT01131078|11015666|FG001|Overall Study|Adverse Event|12
6967274|NCT01131078|11015667|FG002|Overall Study|Adverse Event|17
6967275|NCT01131078|11015665|FG000|Overall Study|Progressive Disease|58
6967276|NCT01131078|11015666|FG001|Overall Study|Progressive Disease|77
6967277|NCT01131078|11015667|FG002|Overall Study|Progressive Disease|71
6967278|NCT01131078|11015665|FG000|Overall Study|Protocol Violation|1
6967279|NCT01131078|11015666|FG001|Overall Study|Protocol Violation|0
6967280|NCT01131078|11015667|FG002|Overall Study|Protocol Violation|0
6967281|NCT01131078|11015665|FG000|Overall Study|Lost to Follow-up|1
6967282|NCT01131078|11015666|FG001|Overall Study|Lost to Follow-up|1
7077897|NCT02097277|11185872|FG001|Overall Study|Adverse Event|0
6967283|NCT01131078|11015667|FG002|Overall Study|Lost to Follow-up|1
6967284|NCT01131078|11015665|FG000|Overall Study|Withdrawal by Subject|2
6967285|NCT01131078|11015666|FG001|Overall Study|Withdrawal by Subject|4
6967286|NCT01131078|11015667|FG002|Overall Study|Withdrawal by Subject|3
6967287|NCT01131078|11015665|FG000|Overall Study|Non-compliance|3
6967288|NCT01131078|11015666|FG001|Overall Study|Non-compliance|0
6967289|NCT01131078|11015667|FG002|Overall Study|Non-compliance|0
6967290|NCT01131078|11015665|FG000|Overall Study|Physician Decision|10
6855954|NCT00382291|10864386|FG000|Overall Study|Adverse Event|1
6855955|NCT00382291|10864387|FG001|Overall Study|Adverse Event|2
6855956|NCT00382291|10864388|FG002|Overall Study|Adverse Event|2
6855957|NCT00382291|10864386|FG000|Overall Study|Protocol Violation|1
6855958|NCT00382291|10864387|FG001|Overall Study|Protocol Violation|0
6855959|NCT00382291|10864388|FG002|Overall Study|Protocol Violation|0
6855960|NCT00382291|10864386|FG000|Overall Study|Temporary study suspension|2
6855961|NCT00382291|10864387|FG001|Overall Study|Temporary study suspension|2
6855962|NCT00382291|10864388|FG002|Overall Study|Temporary study suspension|5
6967291|NCT01131078|11015666|FG001|Overall Study|Physician Decision|6
6967292|NCT01131078|11015667|FG002|Overall Study|Physician Decision|8
6967293|NCT01131078|11015665|FG000|Overall Study|Death|4
6967294|NCT01131078|11015666|FG001|Overall Study|Death|0
6967295|NCT01131078|11015667|FG002|Overall Study|Death|2
6967296|NCT01131078|11015665|FG000|Overall Study|Other|0
6967297|NCT01131078|11015666|FG001|Overall Study|Other|1
6967298|NCT01131078|11015667|FG002|Overall Study|Other|0
6967299|NCT01131104|11015677|FG000|Overall Study|Withdrawal by Subject|3
6967300|NCT01131104|11015677|FG000|Overall Study|Physician Decision|4
6967301|NCT01131104|11015677|FG000|Overall Study|Information Not Available|5
6967302|NCT01131104|11015677|FG000|Overall Study|No Information on Index Date of Onset|1
6967303|NCT01131130|11015681|FG000|Period 1 - Baseline|Pregnancy|1
6967304|NCT01131130|11015681|FG000|Period 3- Crossover|+ Slit lamp finding|1
6967305|NCT01131182|11015691|FG000|Overall Study|Withdrawal by Subject|1
6967306|NCT01131182|11015692|FG001|Overall Study|Withdrawal by Subject|1
6967307|NCT01131182|11015691|FG000|Overall Study|Lost to Follow-up|14
6855963|NCT00382291|10864386|FG000|Overall Study|Withdrawal by Subject|0
6855964|NCT00382291|10864387|FG001|Overall Study|Withdrawal by Subject|2
6855965|NCT00382291|10864388|FG002|Overall Study|Withdrawal by Subject|0
6855966|NCT00382291|10864386|FG000|Overall Study|Physician Decision|0
6855967|NCT00382291|10864387|FG001|Overall Study|Physician Decision|1
6855968|NCT00382291|10864388|FG002|Overall Study|Physician Decision|0
6855969|NCT00382291|10864386|FG000|Overall Study|Lack of Efficacy|0
6855970|NCT00382291|10864387|FG001|Overall Study|Lack of Efficacy|0
6855971|NCT00382291|10864388|FG002|Overall Study|Lack of Efficacy|1
6855972|NCT00382408|10864400|FG000|Overall Study|Did not meet protocol requirement|3
6855973|NCT00382408|10864401|FG001|Overall Study|Did not meet protocol requirement|3
6855974|NCT00382408|10864400|FG000|Overall Study|Protocol Violation|2
6855975|NCT00382408|10864401|FG001|Overall Study|Protocol Violation|2
6855976|NCT00382408|10864400|FG000|Overall Study|Physician Decision|1
6855977|NCT00382408|10864401|FG001|Overall Study|Physician Decision|0
6855978|NCT00382408|10864400|FG000|Overall Study|Withdrawal by Subject|17
6855979|NCT00382408|10864401|FG001|Overall Study|Withdrawal by Subject|6
6855980|NCT00382408|10864400|FG000|Overall Study|Pregnancy|2
6855981|NCT00382408|10864401|FG001|Overall Study|Pregnancy|0
6855982|NCT00382408|10864400|FG000|Overall Study|Lost to Follow-up|19
6855983|NCT00382408|10864401|FG001|Overall Study|Lost to Follow-up|8
6855984|NCT00382408|10864400|FG000|Overall Study|Other|100
6855985|NCT00382408|10864401|FG001|Overall Study|Other|35
6855986|NCT00382720|10864419|FG000|Overall Study|Adverse Event|21
6855987|NCT00382720|10864420|FG001|Overall Study|Adverse Event|23
6855988|NCT00382720|10864421|FG002|Overall Study|Adverse Event|15
6855989|NCT00382720|10864419|FG000|Overall Study|Protocol Violation|2
6855990|NCT00382720|10864420|FG001|Overall Study|Protocol Violation|5
6855991|NCT00382720|10864421|FG002|Overall Study|Protocol Violation|1
6855992|NCT00382720|10864419|FG000|Overall Study|Death|0
6855993|NCT00382720|10864420|FG001|Overall Study|Death|1
6855994|NCT00382720|10864421|FG002|Overall Study|Death|2
6855995|NCT00382720|10864419|FG000|Overall Study|Progressive disease|37
6855996|NCT00382720|10864420|FG001|Overall Study|Progressive disease|28
6855997|NCT00382720|10864421|FG002|Overall Study|Progressive disease|38
6855998|NCT00382720|10864419|FG000|Overall Study|Withdrew consent|1
6855999|NCT00382720|10864420|FG001|Overall Study|Withdrew consent|1
6856000|NCT00382720|10864421|FG002|Overall Study|Withdrew consent|2
6856001|NCT00382720|10864419|FG000|Overall Study|Withdrawal by Subject|11
6856002|NCT00382720|10864420|FG001|Overall Study|Withdrawal by Subject|20
6856003|NCT00382720|10864421|FG002|Overall Study|Withdrawal by Subject|12
6856004|NCT00382720|10864419|FG000|Overall Study|Surgery|1
6856005|NCT00382720|10864420|FG001|Overall Study|Surgery|1
6856006|NCT00382720|10864421|FG002|Overall Study|Surgery|4
6967308|NCT01131182|11015692|FG001|Overall Study|Lost to Follow-up|15
6967309|NCT01131182|11015691|FG000|Overall Study|Other Reason|1
6967310|NCT01131182|11015692|FG001|Overall Study|Other Reason|0
6967311|NCT01131260|11015700|FG000|Overall Study|Randomization error|5
6856007|NCT00382720|10864419|FG000|Overall Study|Patient did not receive study medication|1
6856008|NCT00382720|10864420|FG001|Overall Study|Patient did not receive study medication|1
6856009|NCT00382720|10864421|FG002|Overall Study|Patient did not receive study medication|4
6967312|NCT01131260|11015701|FG001|Overall Study|Randomization error|1
6856010|NCT00382720|10864419|FG000|Overall Study|Clinically progressive disease|0
6856011|NCT00382720|10864420|FG001|Overall Study|Clinically progressive disease|1
6856012|NCT00382720|10864421|FG002|Overall Study|Clinically progressive disease|0
6856013|NCT00382720|10864419|FG000|Overall Study|Good prognosis|0
6856014|NCT00382720|10864420|FG001|Overall Study|Good prognosis|1
6856015|NCT00382720|10864421|FG002|Overall Study|Good prognosis|0
6856016|NCT00382720|10864419|FG000|Overall Study|Investigator/Clinical decision|5
6856017|NCT00382720|10864420|FG001|Overall Study|Investigator/Clinical decision|6
6856018|NCT00382720|10864421|FG002|Overall Study|Investigator/Clinical decision|6
6856019|NCT00382720|10864419|FG000|Overall Study|Discontinued at end of study|0
6856020|NCT00382720|10864420|FG001|Overall Study|Discontinued at end of study|1
6856021|NCT00382720|10864421|FG002|Overall Study|Discontinued at end of study|2
6856022|NCT00382733|10864429|FG000|Overall Study|Withdrawal by Subject|0
6856023|NCT00382733|10864430|FG001|Overall Study|Withdrawal by Subject|1
6856024|NCT00382733|10864431|FG002|Overall Study|Withdrawal by Subject|0
6856025|NCT00382733|10864432|FG003|Overall Study|Withdrawal by Subject|0
6856026|NCT00382733|10864433|FG004|Overall Study|Withdrawal by Subject|0
6856027|NCT00382863|10864466|FG000|Overall Study|Death|9
6856028|NCT00382863|10864467|FG001|Overall Study|Death|9
6856029|NCT00382863|10864466|FG000|Overall Study|Lost to Follow-up|1
6856030|NCT00382863|10864467|FG001|Overall Study|Lost to Follow-up|2
6856031|NCT00382863|10864466|FG000|Overall Study|Withdrawal by Subject|5
6856032|NCT00382863|10864467|FG001|Overall Study|Withdrawal by Subject|25
6856033|NCT00382967|10864489|FG000|Overall Study|Protocol Violation|1
6856034|NCT00382967|10864490|FG001|Overall Study|Protocol Violation|1
6856035|NCT00382993|10864496|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
6856036|NCT00382993|10864497|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2
6856037|NCT00382993|10864496|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1
6856038|NCT00382993|10864497|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3
6856039|NCT00382993|10864496|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0
6856040|NCT00382993|10864497|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5
6856041|NCT00382993|10864496|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
6856042|NCT00382993|10864497|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
6856043|NCT00382993|10864496|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3
6856044|NCT00382993|10864497|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5
6856045|NCT00382993|10864496|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
6856046|NCT00382993|10864497|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
6856047|NCT00382993|10864496|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0
6856048|NCT00382993|10864497|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1
6856049|NCT00382993|10864496|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0
6856050|NCT00382993|10864497|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1
6856051|NCT00382993|10864496|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0
6856052|NCT00382993|10864497|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1
6856053|NCT00382993|10864496|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
6856054|NCT00382993|10864497|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
6856055|NCT00383019|10864505|FG000|Overall Study|Adverse Event|5
6856056|NCT00383019|10864506|FG001|Overall Study|Adverse Event|1
6856057|NCT00383019|10864505|FG000|Overall Study|Withdrawal by Subject|0
6856058|NCT00383019|10864506|FG001|Overall Study|Withdrawal by Subject|1
6856059|NCT00383084|10864531|FG000|Overall Study|Withdrawal by Subject|12
6856060|NCT00383084|10864532|FG001|Overall Study|Withdrawal by Subject|10
6856061|NCT00383123|10864550|FG000|Overall Study|Adverse Event|1
6856062|NCT00383123|10864551|FG001|Overall Study|Adverse Event|0
6856063|NCT00383123|10864550|FG000|Overall Study|Lost to Follow-up|68
6856064|NCT00383123|10864551|FG001|Overall Study|Lost to Follow-up|61
6856065|NCT00383123|10864550|FG000|Overall Study|Protocol Violation|5
6856066|NCT00383123|10864551|FG001|Overall Study|Protocol Violation|1
6856067|NCT00383123|10864550|FG000|Overall Study|Withdrawal by Subject|27
6856068|NCT00383123|10864551|FG001|Overall Study|Withdrawal by Subject|18
6856069|NCT00383123|10864550|FG000|Overall Study|Other reason|10
6856070|NCT00383123|10864551|FG001|Overall Study|Other reason|6
6856071|NCT00383149|10864557|FG000|Overall Study|Adverse Event not Related to Study Drug|3
6856072|NCT00383149|10864557|FG000|Overall Study|Death|2
6856073|NCT00383149|10864557|FG000|Overall Study|Disease Progression|38
6856074|NCT00383149|10864557|FG000|Overall Study|Lost to Follow-up|1
6856075|NCT00383149|10864557|FG000|Overall Study|Other|1
6856076|NCT00383149|10864557|FG000|Overall Study|Study Drug Toxicity|4
6856077|NCT00383149|10864557|FG000|Overall Study|Request to Discontinue Treatment|4
6856078|NCT00383149|10864557|FG000|Overall Study|Participant Withdrew Consent|1
6856079|NCT00383162|10864563|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3
6856080|NCT00383162|10864564|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4
6856081|NCT00383162|10864563|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8
6856082|NCT00383162|10864564|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
6856083|NCT00383162|10864563|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4
6856084|NCT00383162|10864564|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2
6856085|NCT00383162|10864563|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2
6856086|NCT00383162|10864564|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0
6856087|NCT00383162|10864563|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3
6856088|NCT00383162|10864564|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0
6856089|NCT00383162|10864563|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1
6856090|NCT00383162|10864564|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3
6856091|NCT00383162|10864563|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
6856092|NCT00383162|10864564|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
6856093|NCT00383162|10864563|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1
6856094|NCT00383162|10864564|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0
6856095|NCT00383162|10864563|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0
6856096|NCT00383162|10864564|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3
6856097|NCT00383188|10864575|FG000|Overall Study|Adverse Event|4
6856098|NCT00383188|10864576|FG001|Overall Study|Adverse Event|7
6856099|NCT00383188|10864577|FG002|Overall Study|Adverse Event|9
6856100|NCT00383188|10864578|FG003|Overall Study|Adverse Event|8
6856101|NCT00383188|10864579|FG004|Overall Study|Adverse Event|8
6856102|NCT00383188|10864575|FG000|Overall Study|Lack of Efficacy|9
6856103|NCT00383188|10864576|FG001|Overall Study|Lack of Efficacy|3
6856104|NCT00383188|10864577|FG002|Overall Study|Lack of Efficacy|3
6856105|NCT00383188|10864578|FG003|Overall Study|Lack of Efficacy|2
6856106|NCT00383188|10864579|FG004|Overall Study|Lack of Efficacy|6
6856107|NCT00383188|10864575|FG000|Overall Study|Other|3
6856108|NCT00383188|10864576|FG001|Overall Study|Other|1
6856109|NCT00383188|10864577|FG002|Overall Study|Other|0
6856110|NCT00383188|10864578|FG003|Overall Study|Other|2
6856111|NCT00383188|10864579|FG004|Overall Study|Other|6
6856112|NCT00383188|10864575|FG000|Overall Study|No longer willing to participate|1
6856113|NCT00383188|10864576|FG001|Overall Study|No longer willing to participate|0
6856114|NCT00383188|10864577|FG002|Overall Study|No longer willing to participate|1
6856115|NCT00383188|10864578|FG003|Overall Study|No longer willing to participate|0
6856116|NCT00383188|10864579|FG004|Overall Study|No longer willing to participate|2
6856117|NCT00383188|10864575|FG000|Overall Study|Lost to Follow-up|0
6856118|NCT00383188|10864576|FG001|Overall Study|Lost to Follow-up|0
6856119|NCT00383188|10864577|FG002|Overall Study|Lost to Follow-up|0
6856120|NCT00383188|10864578|FG003|Overall Study|Lost to Follow-up|0
6856121|NCT00383188|10864579|FG004|Overall Study|Lost to Follow-up|1
6856122|NCT00383292|10864600|FG000|Overall Study|Adverse Event|4
6856123|NCT00383292|10864601|FG001|Overall Study|Adverse Event|1
6856124|NCT00383292|10864602|FG002|Overall Study|Adverse Event|2
6856125|NCT00383292|10864600|FG000|Overall Study|Death|3
6856126|NCT00383292|10864601|FG001|Overall Study|Death|3
6856127|NCT00383292|10864602|FG002|Overall Study|Death|3
6856128|NCT00383292|10864600|FG000|Overall Study|Physician Decision|4
6856129|NCT00383292|10864601|FG001|Overall Study|Physician Decision|0
6856130|NCT00383292|10864602|FG002|Overall Study|Physician Decision|1
6856131|NCT00383292|10864600|FG000|Overall Study|Withdrawal by Subject|3
6856132|NCT00383292|10864601|FG001|Overall Study|Withdrawal by Subject|2
6856133|NCT00383292|10864602|FG002|Overall Study|Withdrawal by Subject|2
6856134|NCT00383292|10864600|FG000|Overall Study|Other|1
6856135|NCT00383292|10864601|FG001|Overall Study|Other|0
6856136|NCT00383292|10864602|FG002|Overall Study|Other|0
6856137|NCT00383331|10864613|FG000|Overall Study|Protocol Violation|0
6856138|NCT00383331|10864614|FG001|Overall Study|Protocol Violation|1
6856139|NCT00383500|10864628|FG000|Overall Study|Withdrawal by Subject|8
6856140|NCT00383500|10864629|FG001|Overall Study|Withdrawal by Subject|3
6856141|NCT00383500|10864630|FG002|Overall Study|Withdrawal by Subject|0
6856142|NCT00383500|10864628|FG000|Overall Study|Lost to Follow-up|0
6856143|NCT00383500|10864629|FG001|Overall Study|Lost to Follow-up|0
6856144|NCT00383500|10864630|FG002|Overall Study|Lost to Follow-up|2
6856145|NCT00383786|10864681|FG000|Overall Study|Protocol Violation|2
6856146|NCT00383786|10864682|FG001|Overall Study|Protocol Violation|6
6856147|NCT00383786|10864681|FG000|Overall Study|Withdrawal by Subject|2
6856148|NCT00383786|10864682|FG001|Overall Study|Withdrawal by Subject|5
6856149|NCT00383786|10864681|FG000|Overall Study|Physician Decision|0
6856150|NCT00383786|10864682|FG001|Overall Study|Physician Decision|1
6856151|NCT00384033|10864701|FG000|Overall Study|Adverse Event|10
6856152|NCT00384033|10864702|FG001|Overall Study|Adverse Event|8
6856153|NCT00384033|10864703|FG002|Overall Study|Adverse Event|11
6856154|NCT00384033|10864704|FG003|Overall Study|Adverse Event|20
6856155|NCT00384033|10864701|FG000|Overall Study|Failed to return|1
6856156|NCT00384033|10864702|FG001|Overall Study|Failed to return|3
6856157|NCT00384033|10864703|FG002|Overall Study|Failed to return|2
6856158|NCT00384033|10864704|FG003|Overall Study|Failed to return|2
6856159|NCT00384033|10864701|FG000|Overall Study|Physician Decision|1
6856160|NCT00384033|10864702|FG001|Overall Study|Physician Decision|0
6856161|NCT00384033|10864703|FG002|Overall Study|Physician Decision|0
6856162|NCT00384033|10864704|FG003|Overall Study|Physician Decision|0
6856163|NCT00384033|10864701|FG000|Overall Study|Lost to Follow-up|6
6856164|NCT00384033|10864702|FG001|Overall Study|Lost to Follow-up|12
6856165|NCT00384033|10864703|FG002|Overall Study|Lost to Follow-up|7
6856166|NCT00384033|10864704|FG003|Overall Study|Lost to Follow-up|7
6856167|NCT00384033|10864701|FG000|Overall Study|Other|2
6856168|NCT00384033|10864702|FG001|Overall Study|Other|0
6856169|NCT00384033|10864703|FG002|Overall Study|Other|0
6856170|NCT00384033|10864704|FG003|Overall Study|Other|0
6856171|NCT00384033|10864701|FG000|Overall Study|Protocol Violation|5
6856172|NCT00384033|10864702|FG001|Overall Study|Protocol Violation|0
6856173|NCT00384033|10864703|FG002|Overall Study|Protocol Violation|5
6856174|NCT00384033|10864704|FG003|Overall Study|Protocol Violation|6
6856175|NCT00384033|10864701|FG000|Overall Study|Withdrawal by Subject|6
6856176|NCT00384033|10864702|FG001|Overall Study|Withdrawal by Subject|2
6856177|NCT00384033|10864703|FG002|Overall Study|Withdrawal by Subject|5
6856178|NCT00384033|10864704|FG003|Overall Study|Withdrawal by Subject|2
6856179|NCT00384033|10864701|FG000|Overall Study|Lack of Efficacy|7
6856180|NCT00384033|10864702|FG001|Overall Study|Lack of Efficacy|3
6856181|NCT00384033|10864703|FG002|Overall Study|Lack of Efficacy|3
6856182|NCT00384033|10864704|FG003|Overall Study|Lack of Efficacy|1
6856183|NCT00384033|10864701|FG000|Overall Study|Randomized but not treated|3
6856184|NCT00384033|10864702|FG001|Overall Study|Randomized but not treated|7
6856185|NCT00384033|10864703|FG002|Overall Study|Randomized but not treated|10
6856186|NCT00384033|10864704|FG003|Overall Study|Randomized but not treated|2
6856187|NCT00384059|10864716|FG000|Infant Series|Not consented|2
6856188|NCT00384059|10864717|FG001|Infant Series|Not consented|6
6856189|NCT00384059|10864716|FG000|Infant Series|Withdrawal by Subject|2
6856190|NCT00384059|10864717|FG001|Infant Series|Withdrawal by Subject|2
6856191|NCT00384059|10864716|FG000|Infant Series|Adverse Event|1
6856192|NCT00384059|10864717|FG001|Infant Series|Adverse Event|2
6856193|NCT00384059|10864716|FG000|Infant Series|Protocol Violation|1
6856194|NCT00384059|10864717|FG001|Infant Series|Protocol Violation|2
6856195|NCT00384059|10864716|FG000|Infant Series|Lost to Follow-up|0
6856196|NCT00384059|10864717|FG001|Infant Series|Lost to Follow-up|1
6856197|NCT00384059|10864716|FG000|After Infant Series|Protocol Violation|2
6856198|NCT00384059|10864717|FG001|After Infant Series|Protocol Violation|3
6856199|NCT00384059|10864716|FG000|After Infant Series|Withdrawal by Subject|2
6856200|NCT00384059|10864717|FG001|After Infant Series|Withdrawal by Subject|2
6856201|NCT00384059|10864716|FG000|After Infant Series|Failed to Return|0
6856202|NCT00384059|10864717|FG001|After Infant Series|Failed to Return|2
6856203|NCT00384059|10864716|FG000|After Infant Series|Adverse Event|0
6856204|NCT00384059|10864717|FG001|After Infant Series|Adverse Event|1
6856205|NCT00384059|10864716|FG000|After Infant Series|Physician Decision|0
6856206|NCT00384059|10864717|FG001|After Infant Series|Physician Decision|1
6856207|NCT00384059|10864716|FG000|After Infant Series|Lost to Follow-up|0
6856208|NCT00384059|10864717|FG001|After Infant Series|Lost to Follow-up|1
6856209|NCT00384059|10864716|FG000|Toddler Dose|Lost to Follow-up|1
6856210|NCT00384059|10864717|FG001|Toddler Dose|Lost to Follow-up|1
6856211|NCT00384059|10864716|FG000|Toddler Dose|Failed to return|0
6856212|NCT00384059|10864717|FG001|Toddler Dose|Failed to return|1
6856213|NCT00384085|10864747|FG000|Overall Study|Adverse Event|5
6856214|NCT00384085|10864748|FG001|Overall Study|Adverse Event|5
6856215|NCT00384085|10864749|FG002|Overall Study|Adverse Event|4
6856216|NCT00384085|10864747|FG000|Overall Study|Lack of Efficacy|0
6856217|NCT00384085|10864748|FG001|Overall Study|Lack of Efficacy|3
6856218|NCT00384085|10864749|FG002|Overall Study|Lack of Efficacy|2
6856219|NCT00384085|10864747|FG000|Overall Study|No longer Requires Study Treatment|1
6856220|NCT00384085|10864748|FG001|Overall Study|No longer Requires Study Treatment|0
7152676|NCT03261947|11317683|FG000|Overall Study|Reason not Specified|2
7152677|NCT03261947|11317684|FG001|Overall Study|Reason not Specified|0
7152678|NCT03261947|11317685|FG002|Overall Study|Reason not Specified|4
7152679|NCT03261947|11317686|FG003|Overall Study|Reason not Specified|1
7152680|NCT03261947|11317687|FG004|Overall Study|Reason not Specified|3
7152681|NCT03262012|11317724|FG000|Overall Study|Withdrawal by Subject|15
6856221|NCT00384085|10864749|FG002|Overall Study|No longer Requires Study Treatment|1
6856222|NCT00384085|10864747|FG000|Overall Study|Protocol Violation|2
6856223|NCT00384085|10864748|FG001|Overall Study|Protocol Violation|2
6856224|NCT00384085|10864749|FG002|Overall Study|Protocol Violation|2
6856225|NCT00384085|10864747|FG000|Overall Study|Lost to Follow-up|9
6856226|NCT00384085|10864748|FG001|Overall Study|Lost to Follow-up|9
6856227|NCT00384085|10864749|FG002|Overall Study|Lost to Follow-up|10
6856228|NCT00384085|10864747|FG000|Overall Study|Progressive Disease|0
6856229|NCT00384085|10864748|FG001|Overall Study|Progressive Disease|1
6856230|NCT00384085|10864749|FG002|Overall Study|Progressive Disease|0
6856231|NCT00384085|10864747|FG000|Overall Study|Withdrawal by Subject|14
6856232|NCT00384085|10864748|FG001|Overall Study|Withdrawal by Subject|19
6856233|NCT00384085|10864749|FG002|Overall Study|Withdrawal by Subject|29
6856234|NCT00384085|10864747|FG000|Overall Study|Patient non-compliant|4
6856235|NCT00384085|10864748|FG001|Overall Study|Patient non-compliant|4
6856236|NCT00384085|10864749|FG002|Overall Study|Patient non-compliant|5
6856237|NCT00384085|10864747|FG000|Overall Study|Physician Decision|1
6856238|NCT00384085|10864748|FG001|Overall Study|Physician Decision|0
6856239|NCT00384085|10864749|FG002|Overall Study|Physician Decision|0
6856240|NCT00384085|10864747|FG000|Overall Study|Loss of site personnel|1
6856241|NCT00384085|10864748|FG001|Overall Study|Loss of site personnel|0
6856242|NCT00384085|10864749|FG002|Overall Study|Loss of site personnel|1
6856243|NCT00384085|10864747|FG000|Overall Study|Sponsor decision|1
6856244|NCT00384085|10864748|FG001|Overall Study|Sponsor decision|2
6856245|NCT00384085|10864749|FG002|Overall Study|Sponsor decision|1
6856246|NCT00384085|10864747|FG000|Overall Study|Patient moved|1
6856247|NCT00384085|10864748|FG001|Overall Study|Patient moved|0
6856248|NCT00384085|10864749|FG002|Overall Study|Patient moved|1
6856249|NCT00384085|10864747|FG000|Overall Study|Patient required surgery|0
6856250|NCT00384085|10864748|FG001|Overall Study|Patient required surgery|1
6856251|NCT00384085|10864749|FG002|Overall Study|Patient required surgery|0
6856252|NCT00384176|10864762|FG000|Overall Study|Death|239
6856253|NCT00384176|10864763|FG001|Overall Study|Death|247
6856254|NCT00384176|10864764|FG002|Overall Study|Death|105
6856255|NCT00384176|10864762|FG000|Overall Study|Withdrawal by Subject|52
6856256|NCT00384176|10864763|FG001|Overall Study|Withdrawal by Subject|48
7077898|NCT02097277|11185873|FG002|Overall Study|Adverse Event|1
7077899|NCT02097277|11185874|FG003|Overall Study|Adverse Event|2
6856257|NCT00384176|10864764|FG002|Overall Study|Withdrawal by Subject|22
6856258|NCT00384176|10864762|FG000|Overall Study|Lost to Follow-up|16
6856259|NCT00384176|10864763|FG001|Overall Study|Lost to Follow-up|18
6856260|NCT00384176|10864764|FG002|Overall Study|Lost to Follow-up|4
6856261|NCT00384176|10864762|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2
6856262|NCT00384176|10864763|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3
6856263|NCT00384176|10864764|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0
6856264|NCT00384176|10864762|FG000|Overall Study|Longer QTC as Visit 1|1
6856265|NCT00384176|10864763|FG001|Overall Study|Longer QTC as Visit 1|0
6856266|NCT00384176|10864764|FG002|Overall Study|Longer QTC as Visit 1|0
6856267|NCT00384176|10864762|FG000|Overall Study|Toxicity of treatment|1
6856268|NCT00384176|10864763|FG001|Overall Study|Toxicity of treatment|0
6856269|NCT00384176|10864764|FG002|Overall Study|Toxicity of treatment|0
6856270|NCT00384176|10864762|FG000|Overall Study|Did not receive study treatment|0
6856271|NCT00384176|10864763|FG001|Overall Study|Did not receive study treatment|1
6856272|NCT00384176|10864764|FG002|Overall Study|Did not receive study treatment|1
6856273|NCT00384176|10864762|FG000|Overall Study|Physician Decision|0
6856274|NCT00384176|10864763|FG001|Overall Study|Physician Decision|2
6856275|NCT00384176|10864764|FG002|Overall Study|Physician Decision|0
7077900|NCT02097277|11185875|FG004|Overall Study|Adverse Event|0
7077901|NCT02097290|11185891|FG000|Overall Study|Death|6
7077902|NCT02097290|11185891|FG000|Overall Study|Total Withdrawals|3
7077903|NCT02097290|11185891|FG000|Overall Study|Attempt|8
7077904|NCT02097472|11185907|FG000|Received Vaccination 2|Adverse Event|0
7077905|NCT02097472|11185908|FG001|Received Vaccination 2|Adverse Event|0
6856276|NCT00384176|10864762|FG000|Overall Study|Liver metastases, colon resec. planned|1
6856277|NCT00384176|10864763|FG001|Overall Study|Liver metastases, colon resec. planned|0
6856278|NCT00384176|10864764|FG002|Overall Study|Liver metastases, colon resec. planned|0
6856279|NCT00384189|10864776|FG000|Overall Study|Reason Not Specified|50
6856280|NCT00384189|10864777|FG001|Overall Study|Reason Not Specified|57
6856281|NCT00384189|10864778|FG002|Overall Study|Reason Not Specified|58
6856282|NCT00384189|10864779|FG003|Overall Study|Reason Not Specified|40
6856283|NCT00384332|10864799|FG000|Overall Study|Lost to Follow-up|4
6856284|NCT00384332|10864800|FG001|Overall Study|Lost to Follow-up|0
6856285|NCT00384397|10864811|FG000|Overall Study|Adverse Event|0
6856286|NCT00384397|10864812|FG001|Overall Study|Adverse Event|1
6856287|NCT00384397|10864813|FG002|Overall Study|Adverse Event|2
6856288|NCT00384397|10864811|FG000|Overall Study|Protocol Violation|7
6856289|NCT00384397|10864812|FG001|Overall Study|Protocol Violation|15
6856290|NCT00384397|10864813|FG002|Overall Study|Protocol Violation|13
6856291|NCT00384397|10864811|FG000|Overall Study|Lost to Follow-up|11
6856292|NCT00384397|10864812|FG001|Overall Study|Lost to Follow-up|13
6856293|NCT00384397|10864813|FG002|Overall Study|Lost to Follow-up|3
6856294|NCT00384397|10864811|FG000|Overall Study|Withdrawal by Subject|14
6856295|NCT00384397|10864812|FG001|Overall Study|Withdrawal by Subject|17
6856296|NCT00384397|10864813|FG002|Overall Study|Withdrawal by Subject|15
6856297|NCT00384839|10864876|FG000|Overall Study|Adverse Event|4
6856298|NCT00384839|10864876|FG000|Overall Study|Investigator Request|1
6856299|NCT00384839|10864876|FG000|Overall Study|Patient Request|1
6856300|NCT00384839|10864876|FG000|Overall Study|Ineligible|2
6856301|NCT00384930|10864902|FG000|Overall Study|Adverse Event|5
6856302|NCT00384930|10864903|FG001|Overall Study|Adverse Event|4
6856303|NCT00384930|10864904|FG002|Overall Study|Adverse Event|12
6856304|NCT00384930|10864905|FG003|Overall Study|Adverse Event|11
6856305|NCT00384930|10864906|FG004|Overall Study|Adverse Event|14
6856306|NCT00384930|10864902|FG000|Overall Study|Entry Criteria Not Met|2
6856307|NCT00384930|10864903|FG001|Overall Study|Entry Criteria Not Met|6
6856308|NCT00384930|10864904|FG002|Overall Study|Entry Criteria Not Met|7
6856309|NCT00384930|10864905|FG003|Overall Study|Entry Criteria Not Met|8
6856310|NCT00384930|10864906|FG004|Overall Study|Entry Criteria Not Met|4
6856311|NCT00384930|10864902|FG000|Overall Study|Lack of Efficacy|1
6856312|NCT00384930|10864903|FG001|Overall Study|Lack of Efficacy|1
6856313|NCT00384930|10864904|FG002|Overall Study|Lack of Efficacy|2
6856314|NCT00384930|10864905|FG003|Overall Study|Lack of Efficacy|1
6856315|NCT00384930|10864906|FG004|Overall Study|Lack of Efficacy|2
6856316|NCT00384930|10864902|FG000|Overall Study|Lost to Follow-up|5
6856317|NCT00384930|10864903|FG001|Overall Study|Lost to Follow-up|3
6856318|NCT00384930|10864904|FG002|Overall Study|Lost to Follow-up|0
6856319|NCT00384930|10864905|FG003|Overall Study|Lost to Follow-up|4
6856320|NCT00384930|10864906|FG004|Overall Study|Lost to Follow-up|6
6856321|NCT00384930|10864902|FG000|Overall Study|Physician Decision|0
6856322|NCT00384930|10864903|FG001|Overall Study|Physician Decision|1
7077906|NCT02097472|11185909|FG002|Received Vaccination 2|Adverse Event|0
7077907|NCT02097472|11185910|FG003|Received Vaccination 2|Adverse Event|0
7077908|NCT02097472|11185911|FG004|Received Vaccination 2|Adverse Event|0
6856323|NCT00384930|10864904|FG002|Overall Study|Physician Decision|1
6856324|NCT00384930|10864905|FG003|Overall Study|Physician Decision|0
6856325|NCT00384930|10864906|FG004|Overall Study|Physician Decision|1
6856326|NCT00384930|10864902|FG000|Overall Study|Protocol Violation|1
6856327|NCT00384930|10864903|FG001|Overall Study|Protocol Violation|0
6856328|NCT00384930|10864904|FG002|Overall Study|Protocol Violation|1
6856329|NCT00384930|10864905|FG003|Overall Study|Protocol Violation|6
6856330|NCT00384930|10864906|FG004|Overall Study|Protocol Violation|4
6856331|NCT00384930|10864902|FG000|Overall Study|Sponsor Decision|3
6856332|NCT00384930|10864903|FG001|Overall Study|Sponsor Decision|4
6856333|NCT00384930|10864904|FG002|Overall Study|Sponsor Decision|0
6856334|NCT00384930|10864905|FG003|Overall Study|Sponsor Decision|5
6856335|NCT00384930|10864906|FG004|Overall Study|Sponsor Decision|0
6856336|NCT00384930|10864902|FG000|Overall Study|Withdrawal by Subject|9
6856337|NCT00384930|10864903|FG001|Overall Study|Withdrawal by Subject|7
6856338|NCT00384930|10864904|FG002|Overall Study|Withdrawal by Subject|7
6856339|NCT00384930|10864905|FG003|Overall Study|Withdrawal by Subject|6
6856340|NCT00384930|10864906|FG004|Overall Study|Withdrawal by Subject|16
6856341|NCT00384930|10864902|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1
6856342|NCT00384930|10864903|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1
6856343|NCT00384930|10864904|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0
6856344|NCT00384930|10864905|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0
6856345|NCT00384930|10864906|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0
6856346|NCT00384956|10864921|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3
6856347|NCT00385203|10864946|FG000|Overall Study|Adverse Event|5
6856348|NCT00385203|10864947|FG001|Overall Study|Adverse Event|4
6856349|NCT00385203|10864946|FG000|Overall Study|Death|1
6856350|NCT00385203|10864947|FG001|Overall Study|Death|0
6856351|NCT00385203|10864946|FG000|Overall Study|Condition under investigation worsened|18
6856352|NCT00385203|10864947|FG001|Overall Study|Condition under investigation worsened|3
6856353|NCT00385203|10864946|FG000|Overall Study|Incorrect enrollment|2
6856354|NCT00385203|10864947|FG001|Overall Study|Incorrect enrollment|0
6856355|NCT00385255|10864963|FG000|Overall Study|Serious Adverse Event|1
6856356|NCT00385255|10864964|FG001|Overall Study|Serious Adverse Event|2
6856357|NCT00385255|10864963|FG000|Overall Study|Protocol Violation|0
6856358|NCT00385255|10864964|FG001|Overall Study|Protocol Violation|4
6856359|NCT00385255|10864963|FG000|Overall Study|Withdrawal by Subject|0
6856360|NCT00385255|10864964|FG001|Overall Study|Withdrawal by Subject|8
6856361|NCT00385255|10864963|FG000|Overall Study|Migrated/moved from study area|0
6856362|NCT00385255|10864964|FG001|Overall Study|Migrated/moved from study area|1
6856363|NCT00385255|10864963|FG000|Overall Study|Lost to Follow-up|20
6856364|NCT00385255|10864964|FG001|Overall Study|Lost to Follow-up|58
6856365|NCT00385541|10864985|FG000|Overall Study|severe pain, clinician requested unblind|0
6856366|NCT00385541|10864986|FG001|Overall Study|severe pain, clinician requested unblind|1
6856367|NCT00385593|10865013|FG000|Overall Study|Adverse Event|3
6856368|NCT00385593|10865014|FG001|Overall Study|Adverse Event|2
6856369|NCT00385593|10865013|FG000|Overall Study|Withdrawal by Subject|17
6856370|NCT00385593|10865014|FG001|Overall Study|Withdrawal by Subject|7
6856371|NCT00385593|10865013|FG000|Overall Study|Lost to Follow-up|12
6856372|NCT00385593|10865014|FG001|Overall Study|Lost to Follow-up|8
6856373|NCT00385593|10865013|FG000|Overall Study|Protocol Violation|7
6856374|NCT00385593|10865014|FG001|Overall Study|Protocol Violation|4
6856375|NCT00385593|10865013|FG000|Overall Study|Several reasons|17
6856376|NCT00385593|10865014|FG001|Overall Study|Several reasons|15
6856377|NCT00385593|10865013|FG000|Overall Study|Incorrect inclusion|2
6856378|NCT00385593|10865014|FG001|Overall Study|Incorrect inclusion|0
6856379|NCT00385593|10865013|FG000|Overall Study|Incorrect randomization|0
6856380|NCT00385593|10865014|FG001|Overall Study|Incorrect randomization|1
6856381|NCT00385671|10865023|FG000|Overall Study|Adverse Event|14
6856382|NCT00385671|10865024|FG001|Overall Study|Adverse Event|27
6856383|NCT00385671|10865025|FG002|Overall Study|Adverse Event|18
6856384|NCT00385671|10865023|FG000|Overall Study|Lack of Efficacy|5
6856385|NCT00385671|10865024|FG001|Overall Study|Lack of Efficacy|9
6856386|NCT00385671|10865025|FG002|Overall Study|Lack of Efficacy|5
6856387|NCT00385671|10865023|FG000|Overall Study|Lost to Follow-up|6
6856388|NCT00385671|10865024|FG001|Overall Study|Lost to Follow-up|6
6856389|NCT00385671|10865025|FG002|Overall Study|Lost to Follow-up|5
6856390|NCT00385671|10865023|FG000|Overall Study|Physician Decision|2
6856391|NCT00385671|10865024|FG001|Overall Study|Physician Decision|1
6856392|NCT00385671|10865025|FG002|Overall Study|Physician Decision|2
6856393|NCT00385671|10865023|FG000|Overall Study|Protocol Violation|5
6856394|NCT00385671|10865024|FG001|Overall Study|Protocol Violation|2
6856395|NCT00385671|10865025|FG002|Overall Study|Protocol Violation|1
6856396|NCT00385671|10865023|FG000|Overall Study|Sponsor Decision|2
6856397|NCT00385671|10865024|FG001|Overall Study|Sponsor Decision|2
6856398|NCT00385671|10865025|FG002|Overall Study|Sponsor Decision|1
6856399|NCT00385671|10865023|FG000|Overall Study|Withdrawal by Subject|4
6856400|NCT00385671|10865024|FG001|Overall Study|Withdrawal by Subject|4
6856401|NCT00385671|10865025|FG002|Overall Study|Withdrawal by Subject|4
6856402|NCT00385684|10865035|FG000|FIRST INTERVENTION OF PHASE A|Death|1
6856403|NCT00385684|10865036|FG001|FIRST INTERVENTION OF PHASE A|Death|0
6856404|NCT00385684|10865035|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0
6856405|NCT00385684|10865036|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1
6856406|NCT00385684|10865035|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0
6856407|NCT00385684|10865036|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1
6856408|NCT00385723|10865045|FG000|Overall Study|Lost to Follow-up|1
6856409|NCT00385723|10865046|FG001|Overall Study|Lost to Follow-up|1
6856410|NCT00385723|10865047|FG002|Overall Study|Lost to Follow-up|0
6856411|NCT00385723|10865045|FG000|Overall Study|Withdrawal by Subject|1
6856412|NCT00385723|10865046|FG001|Overall Study|Withdrawal by Subject|0
6856413|NCT00385723|10865047|FG002|Overall Study|Withdrawal by Subject|2
6856414|NCT00385736|10865058|FG000|Efficacy Analysis Set - Induction|Adverse Event|5
6856415|NCT00385736|10865059|FG001|Efficacy Analysis Set - Induction|Adverse Event|6
6856416|NCT00385736|10865060|FG002|Efficacy Analysis Set - Induction|Adverse Event|4
6856417|NCT00385736|10865058|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0
6856418|NCT00385736|10865059|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2
6856419|NCT00385736|10865060|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1
6856420|NCT00385736|10865058|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0
6856421|NCT00385736|10865059|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2
6856422|NCT00385736|10865060|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0
6856423|NCT00385736|10865058|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4
6856424|NCT00385736|10865059|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2
6856425|NCT00385736|10865060|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1
6856426|NCT00385736|10865058|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0
6856427|NCT00385736|10865059|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0
6856428|NCT00385736|10865060|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2
6856429|NCT00385736|10865058|FG000|Efficacy Analysis Set - Induction|Other|0
6856430|NCT00385736|10865059|FG001|Efficacy Analysis Set - Induction|Other|0
6856431|NCT00385736|10865060|FG002|Efficacy Analysis Set - Induction|Other|1
6856432|NCT00385736|10865058|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23
6856433|NCT00385736|10865059|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15
6856434|NCT00385736|10865060|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23
6856435|NCT00385736|10865058|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
6856436|NCT00385736|10865059|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
6856437|NCT00385736|10865060|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14
6856438|NCT00385736|10865058|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0
6856439|NCT00385736|10865059|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
6856440|NCT00385736|10865060|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
6856441|NCT00385736|10865058|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38
6856442|NCT00385736|10865059|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16
6856443|NCT00385736|10865060|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31
6856444|NCT00385736|10865058|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2
6856445|NCT00385736|10865059|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1
6856446|NCT00385736|10865060|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6
6856447|NCT00385736|10865058|FG000|Efficacy Analysis Set - Maintenance|Other|0
6856448|NCT00385736|10865059|FG001|Efficacy Analysis Set - Maintenance|Other|4
6856449|NCT00385736|10865060|FG002|Efficacy Analysis Set - Maintenance|Other|4
6856450|NCT00385736|10865058|FG000|Safety Analysis Set|Adverse Event|23
6856451|NCT00385736|10865059|FG001|Safety Analysis Set|Adverse Event|15
6856452|NCT00385736|10865060|FG002|Safety Analysis Set|Adverse Event|23
6856453|NCT00385736|10865058|FG000|Safety Analysis Set|Withdrawal by Subject|6
6856454|NCT00385736|10865059|FG001|Safety Analysis Set|Withdrawal by Subject|6
6856455|NCT00385736|10865060|FG002|Safety Analysis Set|Withdrawal by Subject|14
6856456|NCT00385736|10865058|FG000|Safety Analysis Set|Lost to Follow-up|0
6856457|NCT00385736|10865059|FG001|Safety Analysis Set|Lost to Follow-up|2
6856458|NCT00385736|10865060|FG002|Safety Analysis Set|Lost to Follow-up|2
6856459|NCT00385736|10865058|FG000|Safety Analysis Set|Lack of Efficacy|38
6856460|NCT00385736|10865059|FG001|Safety Analysis Set|Lack of Efficacy|16
6856461|NCT00385736|10865060|FG002|Safety Analysis Set|Lack of Efficacy|31
6856462|NCT00385736|10865058|FG000|Safety Analysis Set|Protocol Violation|2
6856463|NCT00385736|10865059|FG001|Safety Analysis Set|Protocol Violation|1
6856464|NCT00385736|10865060|FG002|Safety Analysis Set|Protocol Violation|6
6856465|NCT00385736|10865058|FG000|Safety Analysis Set|Other|1
6856466|NCT00385736|10865059|FG001|Safety Analysis Set|Other|4
6856467|NCT00385736|10865060|FG002|Safety Analysis Set|Other|4
6856468|NCT00385762|10865071|FG000|Overall Study|Adverse Event|1
6856469|NCT00385762|10865071|FG000|Overall Study|Lost to Follow-up|1
6856470|NCT00385827|10865097|FG000|Part 1|Adverse Event|1
6856471|NCT00385827|10865098|FG001|Part 1|Adverse Event|0
6856472|NCT00385827|10865099|FG002|Part 1|Adverse Event|0
6856473|NCT00385827|10865097|FG000|Part 1|Death|2
6856474|NCT00385827|10865098|FG001|Part 1|Death|0
6856475|NCT00385827|10865099|FG002|Part 1|Death|0
6856476|NCT00385827|10865097|FG000|Part 1|Lack of Efficacy|5
6856477|NCT00385827|10865098|FG001|Part 1|Lack of Efficacy|0
6856478|NCT00385827|10865099|FG002|Part 1|Lack of Efficacy|0
6856479|NCT00385827|10865097|FG000|Part 1|Other|1
6856480|NCT00385827|10865098|FG001|Part 1|Other|0
6856481|NCT00385827|10865099|FG002|Part 1|Other|0
6856482|NCT00385827|10865097|FG000|Part 2|Adverse Event|0
6856483|NCT00385827|10865098|FG001|Part 2|Adverse Event|6
6856484|NCT00385827|10865099|FG002|Part 2|Adverse Event|10
6856485|NCT00385827|10865097|FG000|Part 2|Death|0
6856486|NCT00385827|10865098|FG001|Part 2|Death|0
6856487|NCT00385827|10865099|FG002|Part 2|Death|2
6856488|NCT00385827|10865097|FG000|Part 2|Lack of Efficacy|0
6856489|NCT00385827|10865098|FG001|Part 2|Lack of Efficacy|14
6856490|NCT00385827|10865099|FG002|Part 2|Lack of Efficacy|13
6856491|NCT00385827|10865097|FG000|Part 2|Randomized but not treated|0
6856492|NCT00385827|10865098|FG001|Part 2|Randomized but not treated|2
6856493|NCT00385827|10865099|FG002|Part 2|Randomized but not treated|2
6856494|NCT00385827|10865097|FG000|Part 2|Other|0
6856495|NCT00385827|10865098|FG001|Part 2|Other|11
6856496|NCT00385827|10865099|FG002|Part 2|Other|21
6856497|NCT00385840|10865111|FG000|Overall Study|Adverse Event|1
6856498|NCT00385840|10865112|FG001|Overall Study|Adverse Event|1
6856499|NCT00385840|10865111|FG000|Overall Study|Lost to Follow-up|3
6856500|NCT00385840|10865112|FG001|Overall Study|Lost to Follow-up|13
6856501|NCT00385918|10865120|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
6856502|NCT00385918|10865121|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
6856503|NCT00385918|10865122|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8
6856504|NCT00385918|10865120|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
6856505|NCT00385918|10865121|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
6856506|NCT00385918|10865122|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5
6856507|NCT00385918|10865120|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0
6856508|NCT00385918|10865121|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0
6856509|NCT00385918|10865122|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1
6856510|NCT00385918|10865120|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1
6856511|NCT00385918|10865121|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0
6856512|NCT00385918|10865122|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0
6856513|NCT00385918|10865120|FG000|Intervention Phase After Randomization|Physician Decision|1
6856514|NCT00385918|10865121|FG001|Intervention Phase After Randomization|Physician Decision|0
6856515|NCT00385918|10865122|FG002|Intervention Phase After Randomization|Physician Decision|0
6856516|NCT00385918|10865120|FG000|Intervention Phase After Randomization|Lost to Follow-up|1
6856517|NCT00385918|10865121|FG001|Intervention Phase After Randomization|Lost to Follow-up|0
6856518|NCT00385918|10865122|FG002|Intervention Phase After Randomization|Lost to Follow-up|0
6856519|NCT00385944|10865131|FG000|1st Maintenance Dose Period|Physician Decision|1
6856520|NCT00385944|10865132|FG001|1st Maintenance Dose Period|Physician Decision|0
6856521|NCT00385944|10865133|FG002|1st Maintenance Dose Period|Physician Decision|0
6856522|NCT00385944|10865131|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0
6856523|NCT00385944|10865132|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1
6856524|NCT00385944|10865133|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0
6856525|NCT00385944|10865131|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3
6856526|NCT00385944|10865132|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
6856527|NCT00385944|10865133|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
6856528|NCT00385944|10865131|FG000|2nd Maintenance Dose Period|Invalid PD Data|2
6856529|NCT00385944|10865132|FG001|2nd Maintenance Dose Period|Invalid PD Data|3
6856530|NCT00385944|10865133|FG002|2nd Maintenance Dose Period|Invalid PD Data|0
6856531|NCT00386009|10865155|FG000|Overall Study|Adverse Event|0
6856532|NCT00386009|10865156|FG001|Overall Study|Adverse Event|2
6856533|NCT00386009|10865155|FG000|Overall Study|Death|1
6856534|NCT00386009|10865156|FG001|Overall Study|Death|0
6856535|NCT00386009|10865155|FG000|Overall Study|Entry Criteria Not Met|0
6856536|NCT00386009|10865156|FG001|Overall Study|Entry Criteria Not Met|2
6856537|NCT00386009|10865155|FG000|Overall Study|Lost to Follow-up|1
6856538|NCT00386009|10865156|FG001|Overall Study|Lost to Follow-up|1
6856539|NCT00386009|10865155|FG000|Overall Study|Protocol Violation|1
6856540|NCT00386009|10865156|FG001|Overall Study|Protocol Violation|0
6856541|NCT00386009|10865155|FG000|Overall Study|Sponsor Decision|1
6856542|NCT00386009|10865156|FG001|Overall Study|Sponsor Decision|1
7152682|NCT03262012|11317725|FG001|Overall Study|Withdrawal by Subject|13
7152683|NCT03262012|11317726|FG002|Overall Study|Withdrawal by Subject|8
7152684|NCT03262012|11317727|FG003|Overall Study|Withdrawal by Subject|7
7152685|NCT03262012|11317724|FG000|Overall Study|Adverse Event|10
7152686|NCT03262012|11317725|FG001|Overall Study|Adverse Event|12
7152687|NCT03262012|11317726|FG002|Overall Study|Adverse Event|4
7152688|NCT03262012|11317727|FG003|Overall Study|Adverse Event|6
7152689|NCT03262012|11317724|FG000|Overall Study|Physician Decision|2
7152690|NCT03262012|11317725|FG001|Overall Study|Physician Decision|5
7152691|NCT03262012|11317726|FG002|Overall Study|Physician Decision|1
7152692|NCT03262012|11317727|FG003|Overall Study|Physician Decision|0
7152693|NCT03262012|11317724|FG000|Overall Study|Lack of Efficacy|0
7152694|NCT03262012|11317725|FG001|Overall Study|Lack of Efficacy|5
7152695|NCT03262012|11317726|FG002|Overall Study|Lack of Efficacy|1
6856543|NCT00386009|10865155|FG000|Overall Study|Withdrawal by Subject|5
6856544|NCT00386009|10865156|FG001|Overall Study|Withdrawal by Subject|4
6856545|NCT00386022|10865164|FG000|Plus Estrogen|Lost to Follow-up|2
6856546|NCT00386022|10865165|FG001|Plus Estrogen|Lost to Follow-up|0
6856547|NCT00386022|10865164|FG000|Plus Estrogen|Adverse Event|0
6856548|NCT00386022|10865165|FG001|Plus Estrogen|Adverse Event|1
7152696|NCT03262012|11317727|FG003|Overall Study|Lack of Efficacy|2
7152697|NCT03262012|11317724|FG000|Overall Study|Protocol Discontinuation Criteria|0
7152698|NCT03262012|11317725|FG001|Overall Study|Protocol Discontinuation Criteria|1
6856549|NCT00386100|10865175|FG000|Overall Study|Did not receive study medication|6
6856550|NCT00386100|10865176|FG001|Overall Study|Did not receive study medication|4
6856551|NCT00386100|10865175|FG000|Overall Study|Adverse Event|15
6856552|NCT00386100|10865176|FG001|Overall Study|Adverse Event|25
6856553|NCT00386100|10865175|FG000|Overall Study|Death|0
6856554|NCT00386100|10865176|FG001|Overall Study|Death|1
6856555|NCT00386100|10865175|FG000|Overall Study|Insufficient therapeutic effect|30
6856556|NCT00386100|10865176|FG001|Overall Study|Insufficient therapeutic effect|6
6856557|NCT00386100|10865175|FG000|Overall Study|Lost to Follow-up|29
6856558|NCT00386100|10865176|FG001|Overall Study|Lost to Follow-up|29
6856559|NCT00386100|10865175|FG000|Overall Study|Non-compliance|18
6856560|NCT00386100|10865176|FG001|Overall Study|Non-compliance|19
6856561|NCT00386100|10865175|FG000|Overall Study|Protocol Violation|5
6856562|NCT00386100|10865176|FG001|Overall Study|Protocol Violation|3
6856563|NCT00386100|10865175|FG000|Overall Study|Withdrawal by Subject|32
6856564|NCT00386100|10865176|FG001|Overall Study|Withdrawal by Subject|31
6856565|NCT00386100|10865175|FG000|Overall Study|Bone mass density (BMD) loss >6%|4
6856566|NCT00386100|10865176|FG001|Overall Study|Bone mass density (BMD) loss >6%|4
6856567|NCT00386100|10865175|FG000|Overall Study|BMD <2.5|1
6856568|NCT00386100|10865176|FG001|Overall Study|BMD <2.5|0
6856569|NCT00386100|10865175|FG000|Overall Study|Consecutive elevated Hba1C|1
6856570|NCT00386100|10865176|FG001|Overall Study|Consecutive elevated Hba1C|0
6856571|NCT00386100|10865175|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0
6856572|NCT00386100|10865176|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1
6856573|NCT00386100|10865175|FG000|Overall Study|Laboratory findings|1
6856574|NCT00386100|10865176|FG001|Overall Study|Laboratory findings|0
6856575|NCT00386100|10865175|FG000|Overall Study|Participant's concern due to CPK levels|1
6856576|NCT00386100|10865176|FG001|Overall Study|Participant's concern due to CPK levels|0
6856577|NCT00386100|10865175|FG000|Overall Study|Participant moving out of state|2
6856578|NCT00386100|10865176|FG001|Overall Study|Participant moving out of state|0
6856579|NCT00386100|10865175|FG000|Overall Study|Excessive bone loss vs. baseline value|0
6856580|NCT00386100|10865176|FG001|Overall Study|Excessive bone loss vs. baseline value|1
6856581|NCT00386100|10865175|FG000|Overall Study|Didn't meet entry criteria|1
6856582|NCT00386100|10865176|FG001|Overall Study|Didn't meet entry criteria|1
6856583|NCT00386100|10865175|FG000|Overall Study|Participant's PCP wanted to stop drug|1
6856584|NCT00386100|10865176|FG001|Overall Study|Participant's PCP wanted to stop drug|0
6856585|NCT00386100|10865175|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0
6856586|NCT00386100|10865176|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1
6856587|NCT00386100|10865175|FG000|Overall Study|Bad metabolic control & patient security|1
6856588|NCT00386100|10865176|FG001|Overall Study|Bad metabolic control & patient security|0
6856589|NCT00386100|10865175|FG000|Overall Study|Bone loss by DXA bone scan|1
6856590|NCT00386100|10865176|FG001|Overall Study|Bone loss by DXA bone scan|0
6856591|NCT00386100|10865175|FG000|Overall Study|DBP 93 mmHg at randomization|1
6856592|NCT00386100|10865176|FG001|Overall Study|DBP 93 mmHg at randomization|0
6856593|NCT00386100|10865175|FG000|Overall Study|7.6% bone loss|1
6856594|NCT00386100|10865176|FG001|Overall Study|7.6% bone loss|0
6856595|NCT00386100|10865175|FG000|Overall Study|Osteoporosis|0
6856596|NCT00386100|10865176|FG001|Overall Study|Osteoporosis|1
6856597|NCT00386100|10865175|FG000|Overall Study|Positive pregnancy test|1
6856598|NCT00386100|10865176|FG001|Overall Study|Positive pregnancy test|3
6856599|NCT00386100|10865175|FG000|Overall Study|Out of country for 5 months|1
6856600|NCT00386100|10865176|FG001|Overall Study|Out of country for 5 months|0
6856601|NCT00386100|10865175|FG000|Overall Study|Hb1Ac >8%|0
6856602|NCT00386100|10865176|FG001|Overall Study|Hb1Ac >8%|1
6856603|NCT00386100|10865175|FG000|Overall Study|Participant randomized in error|1
6856604|NCT00386100|10865176|FG001|Overall Study|Participant randomized in error|0
6856605|NCT00386152|10865185|FG000|Overall Study|Adverse Event|6
6856606|NCT00386152|10865186|FG001|Overall Study|Adverse Event|5
7152699|NCT03262012|11317726|FG002|Overall Study|Protocol Discontinuation Criteria|0
6856607|NCT00386152|10865187|FG002|Overall Study|Adverse Event|4
6856608|NCT00386152|10865185|FG000|Overall Study|Chang from original chemo stratification|4
6856609|NCT00386152|10865186|FG001|Overall Study|Chang from original chemo stratification|5
6856610|NCT00386152|10865187|FG002|Overall Study|Chang from original chemo stratification|6
6856611|NCT00386152|10865185|FG000|Overall Study|Death|3
6856612|NCT00386152|10865186|FG001|Overall Study|Death|0
6856613|NCT00386152|10865187|FG002|Overall Study|Death|1
6856614|NCT00386152|10865185|FG000|Overall Study|Disease progression|7
7152700|NCT03262012|11317727|FG003|Overall Study|Protocol Discontinuation Criteria|0
7152701|NCT03262038|11317739|FG000|Overall Study|Withdrawal by Subject|0
7152702|NCT03262038|11317740|FG001|Overall Study|Withdrawal by Subject|1
7152703|NCT03262233|11317750|FG000|Overall Study|Withdrawal by Subject|12
7152704|NCT03262233|11317751|FG001|Overall Study|Withdrawal by Subject|8
6856615|NCT00386152|10865186|FG001|Overall Study|Disease progression|4
6856616|NCT00386152|10865187|FG002|Overall Study|Disease progression|5
6856617|NCT00386152|10865185|FG000|Overall Study|Physician Decision|13
6856618|NCT00386152|10865186|FG001|Overall Study|Physician Decision|10
6856619|NCT00386152|10865187|FG002|Overall Study|Physician Decision|4
6856620|NCT00386152|10865185|FG000|Overall Study|Lost to Follow-up|1
6856621|NCT00386152|10865186|FG001|Overall Study|Lost to Follow-up|0
6856622|NCT00386152|10865187|FG002|Overall Study|Lost to Follow-up|0
6856623|NCT00386152|10865185|FG000|Overall Study|Completed chemotherapy|4
6856624|NCT00386152|10865186|FG001|Overall Study|Completed chemotherapy|5
6856625|NCT00386152|10865187|FG002|Overall Study|Completed chemotherapy|1
6856626|NCT00386152|10865185|FG000|Overall Study|Protocol Violation|3
6856627|NCT00386152|10865186|FG001|Overall Study|Protocol Violation|5
6856628|NCT00386152|10865187|FG002|Overall Study|Protocol Violation|2
6856629|NCT00386152|10865185|FG000|Overall Study|Withdrawal by Subject|3
6856630|NCT00386152|10865186|FG001|Overall Study|Withdrawal by Subject|6
6856631|NCT00386152|10865187|FG002|Overall Study|Withdrawal by Subject|10
6856632|NCT00386308|10865223|FG000|Overall Study|Adverse Event|3
6856633|NCT00386308|10865224|FG001|Overall Study|Adverse Event|3
6856634|NCT00386308|10865223|FG000|Overall Study|Protocol Violation|2
6856635|NCT00386308|10865224|FG001|Overall Study|Protocol Violation|5
6856636|NCT00386308|10865223|FG000|Overall Study|Lack of Efficacy|0
6856637|NCT00386308|10865224|FG001|Overall Study|Lack of Efficacy|2
6856638|NCT00386308|10865223|FG000|Overall Study|Lost to Follow-up|10
6856639|NCT00386308|10865224|FG001|Overall Study|Lost to Follow-up|6
6856640|NCT00386308|10865223|FG000|Overall Study|Withdrawal by Subject|6
6856641|NCT00386308|10865224|FG001|Overall Study|Withdrawal by Subject|2
6856642|NCT00386308|10865223|FG000|Overall Study|Other Event|8
7077909|NCT02097472|11185912|FG005|Received Vaccination 2|Adverse Event|0
7077910|NCT02097472|11185913|FG006|Received Vaccination 2|Adverse Event|1
6856643|NCT00386308|10865224|FG001|Overall Study|Other Event|1
6856644|NCT00386334|10865232|FG000|Double Blind Period|Adverse Event|9
6856645|NCT00386334|10865233|FG001|Double Blind Period|Adverse Event|14
6856646|NCT00386334|10865232|FG000|Double Blind Period|Protocol Violation|1
6856647|NCT00386334|10865233|FG001|Double Blind Period|Protocol Violation|1
6856648|NCT00386334|10865232|FG000|Double Blind Period|Withdrawal by Subject|9
6856649|NCT00386334|10865233|FG001|Double Blind Period|Withdrawal by Subject|13
6856650|NCT00386334|10865232|FG000|Double Blind Period|Lack of Efficacy|20
6856651|NCT00386334|10865233|FG001|Double Blind Period|Lack of Efficacy|11
6856652|NCT00386334|10865232|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4
6856653|NCT00386334|10865233|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5
6856654|NCT00386334|10865232|FG000|Double Blind Period|Other|3
6856655|NCT00386334|10865233|FG001|Double Blind Period|Other|3
6856656|NCT00386334|10865232|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3
6856657|NCT00386334|10865233|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1
6856658|NCT00386360|10865241|FG000|Overall Study|Adverse Event|4
6856659|NCT00386360|10865242|FG001|Overall Study|Adverse Event|2
6856660|NCT00386360|10865241|FG000|Overall Study|Physician Decision|2
6856661|NCT00386360|10865242|FG001|Overall Study|Physician Decision|2
6856662|NCT00386360|10865241|FG000|Overall Study|Lost to Follow-up|0
6856663|NCT00386360|10865242|FG001|Overall Study|Lost to Follow-up|2
6856664|NCT00386360|10865241|FG000|Overall Study|Protocol Violation|0
6856665|NCT00386360|10865242|FG001|Overall Study|Protocol Violation|3
6856666|NCT00386360|10865241|FG000|Overall Study|Withdrawal by Subject|3
6856667|NCT00386360|10865242|FG001|Overall Study|Withdrawal by Subject|6
6856668|NCT00386360|10865241|FG000|Overall Study|Did not take any study medication|0
6856669|NCT00386360|10865242|FG001|Overall Study|Did not take any study medication|2
6856670|NCT00386425|10865251|FG000|Overall Study|Physician Decision|3
6856671|NCT00386425|10865252|FG001|Overall Study|Physician Decision|0
6856672|NCT00386425|10865253|FG002|Overall Study|Physician Decision|0
6856673|NCT00386425|10865251|FG000|Overall Study|Withdrawal by Subject|0
6856674|NCT00386425|10865252|FG001|Overall Study|Withdrawal by Subject|1
6856675|NCT00386425|10865253|FG002|Overall Study|Withdrawal by Subject|0
6856676|NCT00386607|10865274|FG000|Core|Adverse Event|40
6856677|NCT00386607|10865275|FG001|Core|Adverse Event|0
6856678|NCT00386607|10865274|FG000|Core|Abnormal laboratory value(s)|3
6856679|NCT00386607|10865275|FG001|Core|Abnormal laboratory value(s)|0
6856680|NCT00386607|10865274|FG000|Core|Unsatisfactory therapeutic effect|23
6856681|NCT00386607|10865275|FG001|Core|Unsatisfactory therapeutic effect|0
6856682|NCT00386607|10865274|FG000|Core|Condition no longer requires study drug|4
6856683|NCT00386607|10865275|FG001|Core|Condition no longer requires study drug|0
6856684|NCT00386607|10865274|FG000|Core|Patient withdrew consent|15
6856685|NCT00386607|10865275|FG001|Core|Patient withdrew consent|0
6856686|NCT00386607|10865274|FG000|Core|Lost to Follow-up|23
6856687|NCT00386607|10865275|FG001|Core|Lost to Follow-up|0
6856688|NCT00386607|10865274|FG000|Core|Administrative problems|1
6856689|NCT00386607|10865275|FG001|Core|Administrative problems|0
6856690|NCT00386607|10865274|FG000|Core|Protocol Deviation|6
6856691|NCT00386607|10865275|FG001|Core|Protocol Deviation|0
6856692|NCT00386607|10865274|FG000|Extension|Adverse Event|0
6856693|NCT00386607|10865275|FG001|Extension|Adverse Event|6
6856694|NCT00386607|10865274|FG000|Extension|Abnormal laboratory value(s)|0
6856695|NCT00386607|10865275|FG001|Extension|Abnormal laboratory value(s)|1
6856696|NCT00386607|10865274|FG000|Extension|Administrative problems|0
6856697|NCT00386607|10865275|FG001|Extension|Administrative problems|1
6856698|NCT00386607|10865274|FG000|Extension|Lost to Follow-up|0
6856699|NCT00386607|10865275|FG001|Extension|Lost to Follow-up|3
6856700|NCT00386607|10865274|FG000|Extension|Patient withdrew consent|0
6856701|NCT00386607|10865275|FG001|Extension|Patient withdrew consent|5
6856702|NCT00386607|10865274|FG000|Extension|Unsatisfactory therapeutic effect|0
6856703|NCT00386607|10865275|FG001|Extension|Unsatisfactory therapeutic effect|1
6856704|NCT00386776|10865287|FG000|Overall Study|Withdrawal by Subject|8
7077911|NCT02097472|11185914|FG007|Received Vaccination 2|Adverse Event|0
6856705|NCT00387010|10865299|FG000|Dose Titration Period|Adverse Event|12
6856706|NCT00387010|10865299|FG000|Dose Titration Period|Lack of Efficacy|5
6856707|NCT00387010|10865299|FG000|Dose Titration Period|Withdrawal by Subject|3
6856708|NCT00387010|10865299|FG000|Dose Titration Period|Protocol Violation|1
6856709|NCT00387010|10865299|FG000|Dose Titration Period|Lost to Follow-up|2
6856710|NCT00387010|10865299|FG000|Dose Titration Period|Noncompliance with study medication|8
6856711|NCT00387010|10865299|FG000|Dose Titration Period|Noncompliance with study procedures|7
6856712|NCT00387010|10865299|FG000|Treatment Period|Adverse Event|4
6856713|NCT00387010|10865299|FG000|Treatment Period|Withdrawal by Subject|1
6856714|NCT00387010|10865299|FG000|Treatment Period|Noncompliance with study medication|2
6856715|NCT00387010|10865299|FG000|Treatment Period|Noncompliance with study procedures|3
6856716|NCT00387010|10865299|FG000|Treatment Period|Participant reported study drug stolen|1
6856717|NCT00387088|10865316|FG000|Overall Study|Adverse Event|143
6856718|NCT00387088|10865317|FG001|Overall Study|Adverse Event|156
6856719|NCT00387088|10865316|FG000|Overall Study|Protocol Violation|47
6856720|NCT00387088|10865317|FG001|Overall Study|Protocol Violation|35
6856721|NCT00387088|10865316|FG000|Overall Study|Withdrawal by Subject|20
6856722|NCT00387088|10865317|FG001|Overall Study|Withdrawal by Subject|35
6856723|NCT00387088|10865316|FG000|Overall Study|Lack of Efficacy|28
6856724|NCT00387088|10865317|FG001|Overall Study|Lack of Efficacy|67
6856725|NCT00387088|10865316|FG000|Overall Study|Lost to Follow-up|22
6856726|NCT00387088|10865317|FG001|Overall Study|Lost to Follow-up|28
6856727|NCT00387088|10865316|FG000|Overall Study|Other|58
6856728|NCT00387088|10865317|FG001|Overall Study|Other|52
6856729|NCT00387127|10865325|FG000|Overall Study|Lost to Follow-up|0
6856730|NCT00387127|10865326|FG001|Overall Study|Lost to Follow-up|4
6856731|NCT00387127|10865325|FG000|Overall Study|Death|16
6856732|NCT00387127|10865326|FG001|Overall Study|Death|16
6856733|NCT00387127|10865325|FG000|Overall Study|Physician Decision|0
6856734|NCT00387127|10865326|FG001|Overall Study|Physician Decision|1
6856735|NCT00387127|10865325|FG000|Overall Study|Withdrawal by Subject|3
6856736|NCT00387127|10865326|FG001|Overall Study|Withdrawal by Subject|2
6856737|NCT00387127|10865325|FG000|Overall Study|Required by Protocol Amendment #4|12
6856738|NCT00387127|10865326|FG001|Overall Study|Required by Protocol Amendment #4|10
6856739|NCT00387127|10865325|FG000|Overall Study|Serious Adverse Event|1
6856740|NCT00387127|10865326|FG001|Overall Study|Serious Adverse Event|1
6856741|NCT00387127|10865325|FG000|Overall Study|Sponsor Unblinded|1
6856742|NCT00387127|10865326|FG001|Overall Study|Sponsor Unblinded|0
6856743|NCT00387153|10865334|FG000|Overall Study|Adverse Event|1
6856744|NCT00387153|10865334|FG000|Overall Study|Disease Progression|3
6856745|NCT00387153|10865334|FG000|Overall Study|Lack of Response|4
6856746|NCT00387348|10865350|FG000|Overall Study|Death|1
6856747|NCT00387348|10865351|FG001|Overall Study|Death|1
6856748|NCT00387348|10865352|FG002|Overall Study|Death|0
6856749|NCT00387348|10865350|FG000|Overall Study|Physician Decision|1
6856750|NCT00387348|10865351|FG001|Overall Study|Physician Decision|0
6856751|NCT00387348|10865352|FG002|Overall Study|Physician Decision|1
6856752|NCT00387348|10865350|FG000|Overall Study|Withdrawal by Subject|0
6856753|NCT00387348|10865351|FG001|Overall Study|Withdrawal by Subject|2
6856754|NCT00387348|10865352|FG002|Overall Study|Withdrawal by Subject|2
6856755|NCT00387348|10865350|FG000|Overall Study|Adverse Event|1
6856756|NCT00387348|10865351|FG001|Overall Study|Adverse Event|0
6856757|NCT00387348|10865352|FG002|Overall Study|Adverse Event|1
6856758|NCT00387426|10865365|FG000|Overall Study|Lack of Response|7
6856759|NCT00387426|10865365|FG000|Overall Study|Toxicities|4
6856760|NCT00387426|10865365|FG000|Overall Study|Disease Progression|3
6856761|NCT00387465|10865372|FG000|Overall Study|Withdrawal by Subject|0
6856762|NCT00387465|10865373|FG001|Overall Study|Withdrawal by Subject|1
6856763|NCT00387465|10865374|FG002|Overall Study|Withdrawal by Subject|0
6856764|NCT00387647|10865398|FG000|Overall Study|Death|18
6856765|NCT00387712|10865413|FG000|Overall Study|Physician Decision|6
6856766|NCT00387712|10865414|FG001|Overall Study|Physician Decision|4
6856767|NCT00387712|10865413|FG000|Overall Study|Lost to Follow-up|17
6856768|NCT00387712|10865414|FG001|Overall Study|Lost to Follow-up|20
6856769|NCT00387712|10865413|FG000|Overall Study|Withdrawal by Subject|6
6856770|NCT00387712|10865414|FG001|Overall Study|Withdrawal by Subject|12
6856771|NCT00387725|10865424|FG000|Overall Study|Adverse Event|0
6856772|NCT00387725|10865425|FG001|Overall Study|Adverse Event|0
6856773|NCT00387725|10865426|FG002|Overall Study|Adverse Event|0
6856774|NCT00387725|10865427|FG003|Overall Study|Adverse Event|1
6856775|NCT00387725|10865424|FG000|Overall Study|Protocol Violation|0
6856776|NCT00387725|10865425|FG001|Overall Study|Protocol Violation|1
6856777|NCT00387725|10865426|FG002|Overall Study|Protocol Violation|0
6856778|NCT00387725|10865427|FG003|Overall Study|Protocol Violation|0
6856779|NCT00387725|10865424|FG000|Overall Study|Withdrawal by Subject|1
6856780|NCT00387725|10865425|FG001|Overall Study|Withdrawal by Subject|0
6856781|NCT00387725|10865426|FG002|Overall Study|Withdrawal by Subject|1
6856782|NCT00387725|10865427|FG003|Overall Study|Withdrawal by Subject|0
6856783|NCT00387725|10865424|FG000|Overall Study|Parent/legal guardian request|0
6856784|NCT00387725|10865425|FG001|Overall Study|Parent/legal guardian request|0
6856785|NCT00387725|10865426|FG002|Overall Study|Parent/legal guardian request|1
6856786|NCT00387725|10865427|FG003|Overall Study|Parent/legal guardian request|1
6856787|NCT00387764|10865443|FG000|Overall Study|Adverse Event|12
6856788|NCT00387764|10865443|FG000|Overall Study|Withdrawal by Subject|8
6856789|NCT00387764|10865443|FG000|Overall Study|Sponsor Terminated Study|1
6856790|NCT00387764|10865443|FG000|Overall Study|Physician Decision|1
6856791|NCT00387764|10865443|FG000|Overall Study|Other|2
6856792|NCT00387764|10865443|FG000|Overall Study|Death|7
6856793|NCT00387790|10865447|FG000|Overall Study|Adverse Event|5
6856794|NCT00387790|10865447|FG000|Overall Study|Lack of Efficacy|2
6856795|NCT00387790|10865447|FG000|Overall Study|Physician Decision|2
6856796|NCT00387790|10865447|FG000|Overall Study|Withdrawal by Subject|3
6856797|NCT00387790|10865447|FG000|Overall Study|Ineligible for study|2
6967313|NCT01131260|11015700|FG000|Overall Study|Declined to continue participation|8
6967314|NCT01131260|11015701|FG001|Overall Study|Declined to continue participation|13
6967315|NCT01131260|11015700|FG000|Overall Study|Physician Decision|22
6967316|NCT01131260|11015701|FG001|Overall Study|Physician Decision|24
6967317|NCT01131260|11015700|FG000|Overall Study|Technical problems|7
6967318|NCT01131260|11015701|FG001|Overall Study|Technical problems|6
6967319|NCT01131260|11015700|FG000|Overall Study|Staff error|2
6967320|NCT01131260|11015701|FG001|Overall Study|Staff error|1
6967321|NCT01131260|11015700|FG000|Overall Study|Ineligible|0
6967322|NCT01131260|11015701|FG001|Overall Study|Ineligible|2
6967323|NCT01131299|11015709|FG000|Overall Study|Withdrawal by Subject|4
6967324|NCT01131299|11015710|FG001|Overall Study|Withdrawal by Subject|7
6967325|NCT01131312|11015718|FG000|Overall Study|Lost to Follow-up|425
6967326|NCT01131312|11015719|FG001|Overall Study|Lost to Follow-up|229
6967327|NCT01131312|11015720|FG002|Overall Study|Lost to Follow-up|351
6967328|NCT01131325|11015728|FG000|Overall Study|Adverse Event|1
6967329|NCT01131325|11015728|FG000|Overall Study|The participants discontinued the study as the study got terminated|2
6967330|NCT01131351|11015734|FG000|Overall Study|Adverse Event|0
6967331|NCT01131351|11015735|FG001|Overall Study|Adverse Event|2
6967332|NCT01131351|11015734|FG000|Overall Study|Protocol Deviation|0
6967333|NCT01131351|11015735|FG001|Overall Study|Protocol Deviation|1
6967334|NCT01131494|11015741|FG000|Overall Study|Withdrawal by Subject|2
6967335|NCT01131507|11015746|FG000|Overall Study|Adverse Event|1
6967336|NCT01131507|11015746|FG000|Overall Study|Lost to Follow-up|1
6967337|NCT01131507|11015746|FG000|Overall Study|Withdrawal by Subject|1
6967338|NCT01131520|11015752|FG000|Overall Study|Computer problem|1
6967339|NCT01131520|11015753|FG001|Overall Study|Computer problem|0
6967340|NCT01131520|11015752|FG000|Overall Study|Counselor not available|0
6967341|NCT01131520|11015753|FG001|Overall Study|Counselor not available|3
6967342|NCT01131520|11015752|FG000|Overall Study|Subject changed history after enrollment|0
6967343|NCT01131520|11015753|FG001|Overall Study|Subject changed history after enrollment|1
6967344|NCT01131585|11015761|FG000|Overall Study|Adverse Event|0
6967345|NCT01131585|11015762|FG001|Overall Study|Adverse Event|2
6967346|NCT01131585|11015761|FG000|Overall Study|Abnormal laboratory value|1
6967347|NCT01131585|11015762|FG001|Overall Study|Abnormal laboratory value|0
6967348|NCT01131585|11015761|FG000|Overall Study|Unsatisfactory therapeutic effect|0
6967349|NCT01131585|11015762|FG001|Overall Study|Unsatisfactory therapeutic effect|3
6967350|NCT01131585|11015761|FG000|Overall Study|Protocol Violation|2
6967351|NCT01131585|11015762|FG001|Overall Study|Protocol Violation|1
6967352|NCT01131585|11015761|FG000|Overall Study|Withdrawal by Subject|3
6967353|NCT01131585|11015762|FG001|Overall Study|Withdrawal by Subject|3
6967354|NCT01131585|11015761|FG000|Overall Study|Lost to Follow-up|0
6967355|NCT01131585|11015762|FG001|Overall Study|Lost to Follow-up|1
6967356|NCT01131585|11015761|FG000|Overall Study|Administrative problems|1
6967357|NCT01131585|11015762|FG001|Overall Study|Administrative problems|1
6967358|NCT01131585|11015761|FG000|Overall Study|Study termination|78
6967359|NCT01131585|11015762|FG001|Overall Study|Study termination|32
7040986|NCT01722045|11124272|FG000|Overall Study|Withdrawal by Subject|8
7040987|NCT01722045|11124272|FG000|Overall Study|Lost to Follow-up|4
7040988|NCT01722045|11124272|FG000|Overall Study|Protocol Deviation|1
6967360|NCT01131676|11015771|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5
6967361|NCT01131676|11015772|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3
6967362|NCT01131676|11015773|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4
6967363|NCT01131676|11015771|FG000|Discontinuation From Treatment|Not treated|4
6967364|NCT01131676|11015772|FG001|Discontinuation From Treatment|Not treated|2
6967365|NCT01131676|11015773|FG002|Discontinuation From Treatment|Not treated|2
6967366|NCT01131676|11015771|FG000|Discontinuation From Treatment|Lack of Efficacy|11
6967367|NCT01131676|11015772|FG001|Discontinuation From Treatment|Lack of Efficacy|1
6967368|NCT01131676|11015773|FG002|Discontinuation From Treatment|Lack of Efficacy|0
6967369|NCT01131676|11015771|FG000|Discontinuation From Treatment|Non compliant with protocol|15
6967370|NCT01131676|11015772|FG001|Discontinuation From Treatment|Non compliant with protocol|15
6967371|NCT01131676|11015773|FG002|Discontinuation From Treatment|Non compliant with protocol|12
6967372|NCT01131676|11015771|FG000|Discontinuation From Treatment|Lost to Follow-up|15
6967373|NCT01131676|11015772|FG001|Discontinuation From Treatment|Lost to Follow-up|9
6967374|NCT01131676|11015773|FG002|Discontinuation From Treatment|Lost to Follow-up|6
6967375|NCT01131676|11015771|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172
6967376|NCT01131676|11015772|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118
6967377|NCT01131676|11015773|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122
6967378|NCT01131676|11015771|FG000|Discontinuation From Treatment|Other than those specified|162
6967379|NCT01131676|11015772|FG001|Discontinuation From Treatment|Other than those specified|142
6976916|NCT01202877|11029791|FG000|Overall Study|Withdrawal by Subject|0
6856798|NCT00387881|10865462|FG000|Overall Study|Lost to Follow-up|23
6856799|NCT00387881|10865463|FG001|Overall Study|Lost to Follow-up|23
6856800|NCT00387881|10865462|FG000|Overall Study|Protocol Violation|2
6856801|NCT00387881|10865463|FG001|Overall Study|Protocol Violation|12
6856802|NCT00387881|10865462|FG000|Overall Study|Withdrawal by Subject|15
6856803|NCT00387881|10865463|FG001|Overall Study|Withdrawal by Subject|18
6856804|NCT00387881|10865462|FG000|Overall Study|Sponsor terminated Study|0
6856805|NCT00387881|10865463|FG001|Overall Study|Sponsor terminated Study|1
6856806|NCT00387881|10865462|FG000|Overall Study|Not eligible|6
6856807|NCT00387881|10865463|FG001|Overall Study|Not eligible|7
6856808|NCT00387881|10865462|FG000|Overall Study|No opportunity to treat headache|32
6856809|NCT00387881|10865463|FG001|Overall Study|No opportunity to treat headache|34
6856810|NCT00387881|10865462|FG000|Overall Study|Not otherwise specified|11
6856811|NCT00387881|10865463|FG001|Overall Study|Not otherwise specified|7
6856812|NCT00387894|10865469|FG000|Overall Study|Withdrawal by Subject|1
6856813|NCT00388037|10865477|FG000|Overall Study|Protocol Violation|1
6856814|NCT00388154|10865481|FG000|Overall Study|Withdrawal by Subject|1
6856815|NCT00388297|10865489|FG000|Overall Study|Lost to Follow-up|16
6856816|NCT00388297|10865490|FG001|Overall Study|Lost to Follow-up|12
6856817|NCT00388297|10865491|FG002|Overall Study|Lost to Follow-up|11
6856818|NCT00388297|10865492|FG003|Overall Study|Lost to Follow-up|8
6856819|NCT00388349|10865502|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0
6856820|NCT00388349|10865503|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3
6856821|NCT00388362|10865511|FG000|Enrolled|Ineligible|1
6856822|NCT00388362|10865511|FG000|Enrolled|Adverse Event|9
6856823|NCT00388362|10865511|FG000|Enrolled|Death|1
6856824|NCT00388362|10865511|FG000|Enrolled|Loss insurance|1
6856825|NCT00388362|10865511|FG000|Enrolled|Withdrawal by Subject|1
6856826|NCT00388362|10865511|FG000|Remained on Study Median of 514 Days|Death|2
6856827|NCT00388505|10865541|FG000|Overall Study|Adverse Event or Death|43
6856828|NCT00388505|10865542|FG001|Overall Study|Adverse Event or Death|17
6856829|NCT00388505|10865541|FG000|Overall Study|Withdrawal by Subject|24
6856830|NCT00388505|10865542|FG001|Overall Study|Withdrawal by Subject|9
6856831|NCT00388505|10865541|FG000|Overall Study|Lost to Follow-up|5
6856832|NCT00388505|10865542|FG001|Overall Study|Lost to Follow-up|3
6856833|NCT00388505|10865541|FG000|Overall Study|Inappropriate Enrollment|0
6856834|NCT00388505|10865542|FG001|Overall Study|Inappropriate Enrollment|1
6856835|NCT00388505|10865541|FG000|Overall Study|Administrative Reason|1
6856836|NCT00388505|10865542|FG001|Overall Study|Administrative Reason|0
6856837|NCT00388505|10865541|FG000|Overall Study|Protocol Violation|6
6856838|NCT00388505|10865542|FG001|Overall Study|Protocol Violation|5
6856839|NCT00388505|10865541|FG000|Overall Study|Unable to classify|4
6856840|NCT00388505|10865542|FG001|Overall Study|Unable to classify|3
6856841|NCT00388583|10865550|FG000|Overall Study|Protocol Violation|1
6856842|NCT00388583|10865551|FG001|Overall Study|Protocol Violation|0
6967380|NCT01131676|11015773|FG002|Discontinuation From Treatment|Other than those specified|125
6967381|NCT01131676|11015771|FG000|Discontinuation From Treatment|Adverse Event|303
6967382|NCT01131676|11015772|FG001|Discontinuation From Treatment|Adverse Event|267
6967383|NCT01131676|11015773|FG002|Discontinuation From Treatment|Adverse Event|273
6967384|NCT01131676|11015771|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23
6967385|NCT01131676|11015772|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35
6967386|NCT01131676|11015773|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25
6967387|NCT01131676|11015771|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8
6967388|NCT01131676|11015772|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6
6967389|NCT01131676|11015773|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5
6967390|NCT01131676|11015771|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20
6967391|NCT01131676|11015772|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21
6967392|NCT01131676|11015773|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19
6967393|NCT01131676|11015771|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5
6967394|NCT01131676|11015772|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9
6856843|NCT00388583|10865550|FG000|Overall Study|Withdrawal by Subject|3
6856844|NCT00388583|10865551|FG001|Overall Study|Withdrawal by Subject|3
6856845|NCT00388583|10865550|FG000|Overall Study|Serious Adverse Event|2
6856846|NCT00388583|10865551|FG001|Overall Study|Serious Adverse Event|0
6856847|NCT00388583|10865550|FG000|Overall Study|Did not receive vaccine|0
6856848|NCT00388583|10865551|FG001|Overall Study|Did not receive vaccine|1
6856849|NCT00388674|10865559|FG000|Initial Treatment|Administrative Reason by Sponsor|241
6856850|NCT00388674|10865560|FG001|Initial Treatment|Administrative Reason by Sponsor|158
6856851|NCT00388674|10865559|FG000|Initial Treatment|Adverse Event|22
6856852|NCT00388674|10865560|FG001|Initial Treatment|Adverse Event|87
6856853|NCT00388674|10865559|FG000|Initial Treatment|Death|215
6856854|NCT00388674|10865560|FG001|Initial Treatment|Death|216
6856855|NCT00388674|10865559|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11
6856856|NCT00388674|10865560|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17
6856857|NCT00388674|10865559|FG000|Initial Treatment|HCC|12
6856858|NCT00388674|10865560|FG001|Initial Treatment|HCC|20
6856859|NCT00388674|10865559|FG000|Initial Treatment|Lost to Follow-up|526
6856860|NCT00388674|10865560|FG001|Initial Treatment|Lost to Follow-up|624
6856861|NCT00388674|10865559|FG000|Initial Treatment|Malignancy (Non-HCC)|7
6856862|NCT00388674|10865560|FG001|Initial Treatment|Malignancy (Non-HCC)|3
6856863|NCT00388674|10865559|FG000|Initial Treatment|Never Treated with Study Medication|1
6856864|NCT00388674|10865560|FG001|Initial Treatment|Never Treated with Study Medication|7
6856865|NCT00388674|10865559|FG000|Initial Treatment|Non-Study related Comorbidities|3
6856866|NCT00388674|10865560|FG001|Initial Treatment|Non-Study related Comorbidities|4
6856867|NCT00388674|10865559|FG000|Initial Treatment|Not Defined|125
6856868|NCT00388674|10865560|FG001|Initial Treatment|Not Defined|172
6856869|NCT00388674|10865559|FG000|Initial Treatment|Partial or inadequate Treatment|112
6856870|NCT00388674|10865560|FG001|Initial Treatment|Partial or inadequate Treatment|472
6856871|NCT00388674|10865559|FG000|Initial Treatment|Pregnancy|26
6856872|NCT00388674|10865560|FG001|Initial Treatment|Pregnancy|16
6856873|NCT00388674|10865559|FG000|Initial Treatment|Study Drug Toxicity|5
6856874|NCT00388674|10865560|FG001|Initial Treatment|Study Drug Toxicity|92
6856875|NCT00388674|10865559|FG000|Initial Treatment|Participant Request|501
6856876|NCT00388674|10865560|FG001|Initial Treatment|Participant Request|673
6856877|NCT00388674|10865559|FG000|Initial Treatment|No Off-Treatment Status Data|11
6856878|NCT00388674|10865560|FG001|Initial Treatment|No Off-Treatment Status Data|13
6856879|NCT00388674|10865559|FG000|Initial Treatment|Not Reported|10
6856880|NCT00388674|10865560|FG001|Initial Treatment|Not Reported|12
6856881|NCT00388674|10865559|FG000|End of Study|Administrative Reason By Sponsor|299
6856882|NCT00388674|10865560|FG001|End of Study|Administrative Reason By Sponsor|253
6856883|NCT00388674|10865559|FG000|End of Study|Death|239
6856884|NCT00388674|10865560|FG001|End of Study|Death|262
6856885|NCT00388674|10865559|FG000|End of Study|HBV Disease Progression (Non-HCC)|3
6856886|NCT00388674|10865560|FG001|End of Study|HBV Disease Progression (Non-HCC)|9
6856887|NCT00388674|10865559|FG000|End of Study|HCC|8
6856888|NCT00388674|10865560|FG001|End of Study|HCC|7
6856889|NCT00388674|10865559|FG000|End of Study|Lost to Follow-up|587
6856890|NCT00388674|10865560|FG001|End of Study|Lost to Follow-up|715
6856891|NCT00388674|10865559|FG000|End of Study|Malignancy (Non-HCC)|1
6856892|NCT00388674|10865560|FG001|End of Study|Malignancy (Non-HCC)|1
6856893|NCT00388674|10865559|FG000|End of Study|Non-Study Related Comorbidities|3
6856894|NCT00388674|10865560|FG001|End of Study|Non-Study Related Comorbidities|4
6856895|NCT00388674|10865559|FG000|End of Study|Not Defined|135
6856896|NCT00388674|10865560|FG001|End of Study|Not Defined|214
6856897|NCT00388674|10865559|FG000|End of Study|Participant Withdrew Consent|437
6856898|NCT00388674|10865560|FG001|End of Study|Participant Withdrew Consent|673
6856899|NCT00388674|10865559|FG000|End of Study|No Off-Treatment Status Data|22
6856900|NCT00388674|10865560|FG001|End of Study|No Off-Treatment Status Data|30
6856901|NCT00388674|10865559|FG000|End of Study|Not Reported|0
6856902|NCT00388674|10865560|FG001|End of Study|Not Reported|1
6856903|NCT00388726|10865568|FG000|Overall Study|Adverse Event|50
6856904|NCT00388726|10865569|FG001|Overall Study|Adverse Event|24
6856905|NCT00388726|10865568|FG000|Overall Study|Progressive Disease|336
6856906|NCT00388726|10865569|FG001|Overall Study|Progressive Disease|153
6856907|NCT00388726|10865568|FG000|Overall Study|Clinical Progression|61
6856908|NCT00388726|10865569|FG001|Overall Study|Clinical Progression|36
6856909|NCT00388726|10865568|FG000|Overall Study|Withdrawal by Subject|10
6856910|NCT00388726|10865569|FG001|Overall Study|Withdrawal by Subject|7
6856911|NCT00388726|10865568|FG000|Overall Study|Administrative|6
6856912|NCT00388726|10865569|FG001|Overall Study|Administrative|9
6856913|NCT00388726|10865568|FG000|Overall Study|Physician Decision|18
6856914|NCT00388726|10865569|FG001|Overall Study|Physician Decision|13
6856915|NCT00388726|10865568|FG000|Overall Study|Death|3
6856916|NCT00388726|10865569|FG001|Overall Study|Death|2
6856917|NCT00388947|10865584|FG000|Overall Study|Protocol Violation|47
6856918|NCT00388973|10865590|FG000|Overall Study|Adverse Event|16
6856919|NCT00388973|10865591|FG001|Overall Study|Adverse Event|6
6856920|NCT00388973|10865590|FG000|Overall Study|Lack of Efficacy|1
6856921|NCT00388973|10865591|FG001|Overall Study|Lack of Efficacy|12
6856922|NCT00388973|10865590|FG000|Overall Study|Protocol Violation|3
6856923|NCT00388973|10865591|FG001|Overall Study|Protocol Violation|0
6856924|NCT00388973|10865590|FG000|Overall Study|Withdrawal by Subject|14
6856925|NCT00388973|10865591|FG001|Overall Study|Withdrawal by Subject|17
6856926|NCT00388973|10865590|FG000|Overall Study|Study specific Discontinuation Criteria|0
6856927|NCT00388973|10865591|FG001|Overall Study|Study specific Discontinuation Criteria|1
6856928|NCT00388973|10865590|FG000|Overall Study|Did not complete 61 days of treatment|5
6856929|NCT00388973|10865591|FG001|Overall Study|Did not complete 61 days of treatment|4
6856930|NCT00388973|10865590|FG000|Overall Study|Left region|0
6856931|NCT00388973|10865591|FG001|Overall Study|Left region|1
6856932|NCT00388973|10865590|FG000|Overall Study|Did not complete 2-week follow-up visit|17
6856933|NCT00388973|10865591|FG001|Overall Study|Did not complete 2-week follow-up visit|17
7077912|NCT02097719|11186024|FG000|Overall Study|Subject Withdrew Consent|1
7077913|NCT02097719|11186025|FG001|Overall Study|Subject Withdrew Consent|0
7077914|NCT02097719|11186024|FG000|Overall Study|Lost to Follow-up|0
7077915|NCT02097719|11186025|FG001|Overall Study|Lost to Follow-up|1
6856934|NCT00389064|10865599|FG000|Overall Study|Adverse Event|11
6856935|NCT00389064|10865600|FG001|Overall Study|Adverse Event|3
6856936|NCT00389064|10865599|FG000|Overall Study|Lack of Efficacy|3
6856937|NCT00389064|10865600|FG001|Overall Study|Lack of Efficacy|14
6856938|NCT00389064|10865599|FG000|Overall Study|Withdrawal by Subject|17
6856939|NCT00389064|10865600|FG001|Overall Study|Withdrawal by Subject|27
6856940|NCT00389064|10865599|FG000|Overall Study|Physician Decision|2
6856941|NCT00389064|10865600|FG001|Overall Study|Physician Decision|2
6856942|NCT00389064|10865599|FG000|Overall Study|Lost to Follow-up|1
6856943|NCT00389064|10865600|FG001|Overall Study|Lost to Follow-up|2
6856944|NCT00389064|10865599|FG000|Overall Study|Protocol Violation|2
6856945|NCT00389064|10865600|FG001|Overall Study|Protocol Violation|0
6856946|NCT00389064|10865599|FG000|Overall Study|Multiple Reasons|9
6856947|NCT00389064|10865600|FG001|Overall Study|Multiple Reasons|11
6856948|NCT00389207|10865618|FG000|Overall Study|Adverse Event|26
6856949|NCT00389207|10865619|FG001|Overall Study|Adverse Event|32
6856950|NCT00389207|10865620|FG002|Overall Study|Adverse Event|10
6856951|NCT00389207|10865618|FG000|Overall Study|Protocol Violation|3
6856952|NCT00389207|10865619|FG001|Overall Study|Protocol Violation|1
6856953|NCT00389207|10865620|FG002|Overall Study|Protocol Violation|4
6856954|NCT00389207|10865618|FG000|Overall Study|Lost to Follow-up|12
6856955|NCT00389207|10865619|FG001|Overall Study|Lost to Follow-up|9
6856956|NCT00389207|10865620|FG002|Overall Study|Lost to Follow-up|7
6856957|NCT00389207|10865618|FG000|Overall Study|Withdrawal by Subject|5
6856958|NCT00389207|10865619|FG001|Overall Study|Withdrawal by Subject|7
6856959|NCT00389207|10865620|FG002|Overall Study|Withdrawal by Subject|11
6856960|NCT00389207|10865618|FG000|Overall Study|Other|17
6856961|NCT00389207|10865619|FG001|Overall Study|Other|23
6856962|NCT00389207|10865620|FG002|Overall Study|Other|9
6856963|NCT00389324|10865633|FG000|Run-In Phase|Adverse Event|1
6856964|NCT00389324|10865633|FG000|Run-In Phase|Lost to Follow-up|1
6856965|NCT00389324|10865633|FG000|Run-In Phase|Withdrawal by Subject|1
6856966|NCT00389324|10865633|FG000|Subcutaneous Phase|Adverse Event|2
6856967|NCT00389324|10865633|FG000|Subcutaneous Phase|Non-compliance with study medication|2
6856968|NCT00389324|10865633|FG000|Subcutaneous Phase|Withdrawal by Subject|2
6856969|NCT00389324|10865633|FG000|Subcutaneous Phase|Lost to Follow-up|1
6856970|NCT00389441|10865640|FG000|Overall Study|Adverse Event|7
6856971|NCT00389441|10865640|FG000|Overall Study|Death|4
6856972|NCT00389441|10865640|FG000|Overall Study|Lost to Follow-up|2
6856973|NCT00389441|10865640|FG000|Overall Study|Withdrawal by Subject|4
6856974|NCT00389441|10865640|FG000|Overall Study|Physician Decision|1
6856975|NCT00389441|10865640|FG000|Overall Study|Protocol Violation|1
6856976|NCT00389441|10865640|FG000|Overall Study|Global deterioration of health status|4
6856977|NCT00389441|10865640|FG000|Overall Study|Objective progression or relapse|26
6856978|NCT00389441|10865640|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2
6856979|NCT00389441|10865640|FG000|Overall Study|Clinical progression|1
6856980|NCT00389519|10865682|FG000|Placebo Run-In|Did not meet blood pressure criteria|119
6856981|NCT00389519|10865683|FG001|Placebo Run-In|Did not meet blood pressure criteria|0
6856982|NCT00389519|10865684|FG002|Placebo Run-In|Did not meet blood pressure criteria|0
6856983|NCT00389519|10865685|FG003|Placebo Run-In|Did not meet blood pressure criteria|0
6856984|NCT00389519|10865682|FG000|Placebo Run-In|Withdrawal by Subject|19
6856985|NCT00389519|10865683|FG001|Placebo Run-In|Withdrawal by Subject|0
6856986|NCT00389519|10865684|FG002|Placebo Run-In|Withdrawal by Subject|0
6856987|NCT00389519|10865685|FG003|Placebo Run-In|Withdrawal by Subject|0
6856988|NCT00389519|10865682|FG000|Placebo Run-In|Reason not specified|40
6856989|NCT00389519|10865683|FG001|Placebo Run-In|Reason not specified|0
6856990|NCT00389519|10865684|FG002|Placebo Run-In|Reason not specified|0
6856991|NCT00389519|10865685|FG003|Placebo Run-In|Reason not specified|0
6856992|NCT00389519|10865682|FG000|Randomized|Did not receive study drug|2
6856993|NCT00389519|10865683|FG001|Randomized|Did not receive study drug|0
6856994|NCT00389519|10865684|FG002|Randomized|Did not receive study drug|0
6856995|NCT00389519|10865685|FG003|Randomized|Did not receive study drug|0
6856996|NCT00389519|10865682|FG000|Treated|Adverse Event|1
6856997|NCT00389519|10865683|FG001|Treated|Adverse Event|0
6856998|NCT00389519|10865684|FG002|Treated|Adverse Event|0
6856999|NCT00389519|10865685|FG003|Treated|Adverse Event|2
6857000|NCT00389519|10865682|FG000|Treated|Reason not specified|1
6857001|NCT00389519|10865683|FG001|Treated|Reason not specified|1
6857002|NCT00389519|10865684|FG002|Treated|Reason not specified|0
6857003|NCT00389519|10865685|FG003|Treated|Reason not specified|2
6857004|NCT00389597|10865708|FG000|Overall Study|Lost to Follow-up|8
6857005|NCT00389597|10865709|FG001|Overall Study|Lost to Follow-up|6
6857006|NCT00389597|10865710|FG002|Overall Study|Lost to Follow-up|4
6857007|NCT00389597|10865711|FG003|Overall Study|Lost to Follow-up|6
6857008|NCT00389831|10865736|FG000|Overall Study|Lack of Efficacy|0
6857009|NCT00389831|10865737|FG001|Overall Study|Lack of Efficacy|2
6857010|NCT00389831|10865736|FG000|Overall Study|Did not receive treatment.|0
6857011|NCT00389831|10865737|FG001|Overall Study|Did not receive treatment.|2
6857012|NCT00389831|10865736|FG000|Overall Study|Other reasons|0
6857013|NCT00389831|10865737|FG001|Overall Study|Other reasons|2
6857014|NCT00389831|10865736|FG000|Overall Study|Lost to Follow-up|0
6857015|NCT00389831|10865737|FG001|Overall Study|Lost to Follow-up|1
6857016|NCT00390013|10865771|FG000|Phase 1|tired|0
6857017|NCT00390013|10865772|FG001|Phase 1|tired|0
6857018|NCT00390013|10865773|FG002|Phase 1|tired|0
6857019|NCT00390013|10865774|FG003|Phase 1|tired|1
6857020|NCT00390013|10865771|FG000|Phase 2 First Treatment|tired|1
6857021|NCT00390013|10865772|FG001|Phase 2 First Treatment|tired|0
6857022|NCT00390013|10865773|FG002|Phase 2 First Treatment|tired|0
6857023|NCT00390013|10865774|FG003|Phase 2 First Treatment|tired|0
6857024|NCT00390013|10865771|FG000|Phase 2 First Treatment|Withdrawal by Subject|0
6857025|NCT00390013|10865772|FG001|Phase 2 First Treatment|Withdrawal by Subject|1
6857026|NCT00390013|10865773|FG002|Phase 2 First Treatment|Withdrawal by Subject|0
6857027|NCT00390013|10865774|FG003|Phase 2 First Treatment|Withdrawal by Subject|0
6857028|NCT00390221|10865787|FG000|Overall Study|Lost to Follow-up|0
6857029|NCT00390221|10865788|FG001|Overall Study|Lost to Follow-up|3
6857030|NCT00390221|10865789|FG002|Overall Study|Lost to Follow-up|0
6857031|NCT00390221|10865787|FG000|Overall Study|Adverse Event|1
6857032|NCT00390221|10865788|FG001|Overall Study|Adverse Event|4
6857033|NCT00390221|10865789|FG002|Overall Study|Adverse Event|3
7152705|NCT03262233|11317752|FG002|Overall Study|Withdrawal by Subject|21
7152706|NCT03262233|11317753|FG003|Overall Study|Withdrawal by Subject|13
7152707|NCT03262233|11317750|FG000|Overall Study|Declined due to shock|1
7152708|NCT03262233|11317751|FG001|Overall Study|Declined due to shock|2
7152709|NCT03262233|11317752|FG002|Overall Study|Declined due to shock|2
7152710|NCT03262233|11317753|FG003|Overall Study|Declined due to shock|3
7152711|NCT03262233|11317750|FG000|Overall Study|Protocol Violation|5
7152712|NCT03262233|11317751|FG001|Overall Study|Protocol Violation|10
7152713|NCT03262233|11317752|FG002|Overall Study|Protocol Violation|2
7152714|NCT03262233|11317753|FG003|Overall Study|Protocol Violation|13
7152715|NCT03262233|11317750|FG000|Overall Study|data collection artifact|0
7152716|NCT03262233|11317751|FG001|Overall Study|data collection artifact|1
7152717|NCT03262233|11317752|FG002|Overall Study|data collection artifact|0
7152718|NCT03262233|11317753|FG003|Overall Study|data collection artifact|0
7152719|NCT03262389|11317764|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1
7152720|NCT03262389|11317764|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1
7152721|NCT03262389|11317764|FG000|Overall Study|opted out of PET/MR|1
7152722|NCT03262441|11317768|FG000|Overall Study|Withdrawal by Subject|1
7152723|NCT03263442|11317774|FG000|Inpatient Phase|Death|1
7152724|NCT03263442|11317775|FG001|Inpatient Phase|Death|0
7152725|NCT03263442|11317774|FG000|Inpatient Phase|Withdrawal by Subject|1
7152726|NCT03263442|11317775|FG001|Inpatient Phase|Withdrawal by Subject|0
7152727|NCT03263442|11317774|FG000|Inpatient Phase|Inadequate Drug Exposure|0
7152728|NCT03263442|11317775|FG001|Inpatient Phase|Inadequate Drug Exposure|1
7152729|NCT03263442|11317774|FG000|1-month Follow-Up|Lost to Follow-up|1
7152730|NCT03263442|11317775|FG001|1-month Follow-Up|Lost to Follow-up|0
6967395|NCT01131676|11015773|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7
6967396|NCT01131676|11015771|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7
6967397|NCT01131676|11015772|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6
6967398|NCT01131676|11015773|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5
7152731|NCT03263442|11317774|FG000|3-month Follow-Up|Lost to Follow-up|1
7152732|NCT03263442|11317775|FG001|3-month Follow-Up|Lost to Follow-up|3
7152733|NCT03263442|11317774|FG000|6-month Follow-Up|Lost to Follow-up|2
7152734|NCT03263442|11317775|FG001|6-month Follow-Up|Lost to Follow-up|2
7152735|NCT03263702|11317785|FG000|Overall Study|Lost to Follow-up|2
7152736|NCT03263702|11317786|FG001|Overall Study|Lost to Follow-up|2
7152737|NCT03263702|11317785|FG000|Overall Study|Withdrawal by Subject|1
7152738|NCT03263702|11317786|FG001|Overall Study|Withdrawal by Subject|2
7152739|NCT03263780|11317792|FG000|Overall Study|Withdrawal by Subject|3
7152740|NCT03263780|11317792|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7
7152741|NCT03264066|11317802|FG000|Overall Study|Adverse Event|1
7152742|NCT03264066|11317803|FG001|Overall Study|Adverse Event|1
7152743|NCT03264066|11317804|FG002|Overall Study|Adverse Event|0
7152744|NCT03264066|11317805|FG003|Overall Study|Adverse Event|0
7152745|NCT03264066|11317806|FG004|Overall Study|Adverse Event|0
7152746|NCT03264066|11317807|FG005|Overall Study|Adverse Event|0
7152747|NCT03264066|11317802|FG000|Overall Study|Death|12
7152748|NCT03264066|11317803|FG001|Overall Study|Death|12
7152749|NCT03264066|11317804|FG002|Overall Study|Death|8
7152750|NCT03264066|11317805|FG003|Overall Study|Death|10
7152751|NCT03264066|11317806|FG004|Overall Study|Death|6
7152752|NCT03264066|11317807|FG005|Overall Study|Death|1
7152753|NCT03264066|11317802|FG000|Overall Study|Lost to Follow-up|1
7152754|NCT03264066|11317803|FG001|Overall Study|Lost to Follow-up|0
7152755|NCT03264066|11317804|FG002|Overall Study|Lost to Follow-up|0
7152756|NCT03264066|11317805|FG003|Overall Study|Lost to Follow-up|0
7152757|NCT03264066|11317806|FG004|Overall Study|Lost to Follow-up|0
7152758|NCT03264066|11317807|FG005|Overall Study|Lost to Follow-up|0
7152759|NCT03264066|11317802|FG000|Overall Study|Progressive Disease|0
7152760|NCT03264066|11317803|FG001|Overall Study|Progressive Disease|2
7152761|NCT03264066|11317804|FG002|Overall Study|Progressive Disease|1
7152762|NCT03264066|11317805|FG003|Overall Study|Progressive Disease|0
7152763|NCT03264066|11317806|FG004|Overall Study|Progressive Disease|0
7152764|NCT03264066|11317807|FG005|Overall Study|Progressive Disease|0
7152765|NCT03264066|11317802|FG000|Overall Study|Study Terminated by Sponsor|5
6857034|NCT00390221|10865787|FG000|Overall Study|Investigator Decision|0
6857035|NCT00390221|10865788|FG001|Overall Study|Investigator Decision|0
7152766|NCT03264066|11317803|FG001|Overall Study|Study Terminated by Sponsor|5
7152767|NCT03264066|11317804|FG002|Overall Study|Study Terminated by Sponsor|8
7152768|NCT03264066|11317805|FG003|Overall Study|Study Terminated by Sponsor|5
7152769|NCT03264066|11317806|FG004|Overall Study|Study Terminated by Sponsor|1
7152770|NCT03264066|11317807|FG005|Overall Study|Study Terminated by Sponsor|2
7152771|NCT03264066|11317802|FG000|Overall Study|Withdrawal by Subject|1
6857036|NCT00390221|10865789|FG002|Overall Study|Investigator Decision|1
6857037|NCT00390221|10865787|FG000|Overall Study|Withdrawal by Subject|13
6857038|NCT00390221|10865788|FG001|Overall Study|Withdrawal by Subject|9
6857039|NCT00390221|10865789|FG002|Overall Study|Withdrawal by Subject|7
6857040|NCT00390221|10865787|FG000|Overall Study|Subject Non-compliance|1
6857041|NCT00390221|10865788|FG001|Overall Study|Subject Non-compliance|0
6857042|NCT00390221|10865789|FG002|Overall Study|Subject Non-compliance|2
6857043|NCT00390221|10865787|FG000|Overall Study|Other|3
6857044|NCT00390221|10865788|FG001|Overall Study|Other|4
6857045|NCT00390221|10865789|FG002|Overall Study|Other|2
6857046|NCT00390299|10865808|FG000|Overall Study|Cancellation|1
6857047|NCT00390299|10865809|FG001|Overall Study|Cancellation|0
6857048|NCT00390299|10865810|FG002|Overall Study|Cancellation|0
6857049|NCT00390299|10865811|FG003|Overall Study|Cancellation|0
6857050|NCT00390299|10865812|FG004|Overall Study|Cancellation|0
6857051|NCT00390416|10865830|FG000|Overall Study|Withdrawal by Subject|1
6857052|NCT00390416|10865830|FG000|Overall Study|Not treated|3
6857053|NCT00390455|10865853|FG000|Overall Study|Adverse Event|17
6857054|NCT00390455|10865854|FG001|Overall Study|Adverse Event|3
6857055|NCT00390455|10865853|FG000|Overall Study|Withdrawal by Subject|8
6857056|NCT00390455|10865854|FG001|Overall Study|Withdrawal by Subject|8
6857057|NCT00390455|10865853|FG000|Overall Study|Alternate Treatment|0
6857058|NCT00390455|10865854|FG001|Overall Study|Alternate Treatment|1
6857059|NCT00390455|10865853|FG000|Overall Study|Other Medical Reasons|7
6857060|NCT00390455|10865854|FG001|Overall Study|Other Medical Reasons|11
6857061|NCT00390468|10865860|FG000|Overall Study|Protocol Violation|2
6857062|NCT00390468|10865860|FG000|Overall Study|Lack of Efficacy|1
6857063|NCT00390546|10865866|FG000|Overall Study|Renal impairment|1
6857064|NCT00390546|10865867|FG001|Overall Study|Renal impairment|0
6857065|NCT00390546|10865866|FG000|Overall Study|Physician Decision|5
6857066|NCT00390546|10865867|FG001|Overall Study|Physician Decision|5
6857067|NCT00390572|10865886|FG000|Overall Study|Lost to Follow-up|8
6857068|NCT00390572|10865887|FG001|Overall Study|Lost to Follow-up|4
6857069|NCT00390572|10865886|FG000|Overall Study|health condition|0
6857070|NCT00390572|10865887|FG001|Overall Study|health condition|1
6857071|NCT00390689|10865907|FG000|Overall Study|Adverse Event|2
6857072|NCT00390689|10865908|FG001|Overall Study|Adverse Event|5
6857073|NCT00390689|10865909|FG002|Overall Study|Adverse Event|2
6857074|NCT00390689|10865907|FG000|Overall Study|Lack of Efficacy|0
6857075|NCT00390689|10865908|FG001|Overall Study|Lack of Efficacy|0
6857076|NCT00390689|10865909|FG002|Overall Study|Lack of Efficacy|1
6857077|NCT00390689|10865907|FG000|Overall Study|Protocol Violation|1
6857078|NCT00390689|10865908|FG001|Overall Study|Protocol Violation|0
6857079|NCT00390689|10865909|FG002|Overall Study|Protocol Violation|0
6857080|NCT00390689|10865907|FG000|Overall Study|Investigator's judgement|2
6857081|NCT00390689|10865908|FG001|Overall Study|Investigator's judgement|0
6857082|NCT00390689|10865909|FG002|Overall Study|Investigator's judgement|0
6857083|NCT00390780|10865928|FG000|Overall Study|Not completed|10
6857084|NCT00390780|10865929|FG001|Overall Study|Not completed|4
6857085|NCT00390780|10865928|FG000|Overall Study|Protocol Violation|6
6857086|NCT00390780|10865929|FG001|Overall Study|Protocol Violation|4
6857087|NCT00390780|10865928|FG000|Overall Study|Lost to Follow-up|3
6857088|NCT00390780|10865929|FG001|Overall Study|Lost to Follow-up|6
6857089|NCT00390780|10865928|FG000|Overall Study|Adverse Event|2
6857090|NCT00390780|10865929|FG001|Overall Study|Adverse Event|3
6857091|NCT00390780|10865928|FG000|Overall Study|Death|1
6857092|NCT00390780|10865929|FG001|Overall Study|Death|3
6857093|NCT00390780|10865928|FG000|Overall Study|Withdrawal by Subject|1
6857094|NCT00390780|10865929|FG001|Overall Study|Withdrawal by Subject|2
6857095|NCT00390780|10865928|FG000|Overall Study|Inclusion criteria not satisfied|0
6857096|NCT00390780|10865929|FG001|Overall Study|Inclusion criteria not satisfied|2
6857097|NCT00390780|10865928|FG000|Overall Study|Lost to follow up and other reasons|0
6857098|NCT00390780|10865929|FG001|Overall Study|Lost to follow up and other reasons|1
6857099|NCT00390780|10865928|FG000|Overall Study|Investigator decision, SAE, other reason|0
6857100|NCT00390780|10865929|FG001|Overall Study|Investigator decision, SAE, other reason|1
6857101|NCT00390780|10865928|FG000|Overall Study|SAE, death|0
6857102|NCT00390780|10865929|FG001|Overall Study|SAE, death|1
6857103|NCT00390806|10865937|FG000|Overall Study|Lost to Follow-up|7
6857104|NCT00390806|10865938|FG001|Overall Study|Lost to Follow-up|6
6857105|NCT00390806|10865937|FG000|Overall Study|Protocol Violation|2
6857106|NCT00390806|10865938|FG001|Overall Study|Protocol Violation|2
6857107|NCT00390806|10865937|FG000|Overall Study|Withdrawal by Subject|12
6857108|NCT00390806|10865938|FG001|Overall Study|Withdrawal by Subject|15
6857109|NCT00390806|10865937|FG000|Overall Study|Investigator Decision|4
6857110|NCT00390806|10865938|FG001|Overall Study|Investigator Decision|6
6857111|NCT00390806|10865937|FG000|Overall Study|Death|1
6857112|NCT00390806|10865938|FG001|Overall Study|Death|0
6857113|NCT00390806|10865937|FG000|Overall Study|Physician Decision|0
6857114|NCT00390806|10865938|FG001|Overall Study|Physician Decision|1
6857115|NCT00390806|10865937|FG000|Overall Study|Ongoing|4
6857116|NCT00390806|10865938|FG001|Overall Study|Ongoing|2
6857117|NCT00390858|10865946|FG000|Overall Study|Adverse Event|6
6857118|NCT00390858|10865947|FG001|Overall Study|Adverse Event|2
6857119|NCT00390858|10865946|FG000|Overall Study|Lack of Efficacy|0
6857120|NCT00390858|10865947|FG001|Overall Study|Lack of Efficacy|1
6857121|NCT00390858|10865946|FG000|Overall Study|Withdrawal by Subject|3
6857122|NCT00390858|10865947|FG001|Overall Study|Withdrawal by Subject|4
6857123|NCT00390884|10865955|FG000|Overall Study|Withdrawal by Subject|2
6857124|NCT00390884|10865956|FG001|Overall Study|Withdrawal by Subject|2
6857125|NCT00390910|10865965|FG000|Overall Study|Adverse Event|1
6857126|NCT00390910|10865966|FG001|Overall Study|Adverse Event|0
6857127|NCT00390910|10865967|FG002|Overall Study|Adverse Event|0
6857128|NCT00390910|10865965|FG000|Overall Study|Lost to Follow-up|0
6857129|NCT00390910|10865966|FG001|Overall Study|Lost to Follow-up|1
6857130|NCT00390910|10865967|FG002|Overall Study|Lost to Follow-up|5
6857131|NCT00390910|10865965|FG000|Overall Study|Withdrawal by Subject|1
6857132|NCT00390910|10865966|FG001|Overall Study|Withdrawal by Subject|3
6857133|NCT00390910|10865967|FG002|Overall Study|Withdrawal by Subject|2
6857134|NCT00390910|10865965|FG000|Overall Study|Migrated/moved from study area|0
7152772|NCT03264066|11317803|FG001|Overall Study|Withdrawal by Subject|0
6857135|NCT00390910|10865966|FG001|Overall Study|Migrated/moved from study area|0
6857136|NCT00390910|10865967|FG002|Overall Study|Migrated/moved from study area|3
6857137|NCT00391027|10865988|FG000|Overall Study|Adverse Event|8
6857138|NCT00391027|10865989|FG001|Overall Study|Adverse Event|8
6857139|NCT00391027|10865988|FG000|Overall Study|Lack of Efficacy|3
6857140|NCT00391027|10865989|FG001|Overall Study|Lack of Efficacy|0
6857141|NCT00391027|10865988|FG000|Overall Study|Withdrawal by Subject|10
6857142|NCT00391027|10865989|FG001|Overall Study|Withdrawal by Subject|1
6857143|NCT00391027|10865988|FG000|Overall Study|Other|4
6857144|NCT00391027|10865989|FG001|Overall Study|Other|3
6857145|NCT00391053|10865999|FG000|Overall Study|Serious Adverse Events|1
6857146|NCT00391053|10866000|FG001|Overall Study|Serious Adverse Events|0
6857147|NCT00391053|10866001|FG002|Overall Study|Serious Adverse Events|1
6857148|NCT00391053|10866002|FG003|Overall Study|Serious Adverse Events|4
6857149|NCT00391053|10865999|FG000|Overall Study|Protocol Violation|2
6857150|NCT00391053|10866000|FG001|Overall Study|Protocol Violation|0
6857151|NCT00391053|10866001|FG002|Overall Study|Protocol Violation|0
6857152|NCT00391053|10866002|FG003|Overall Study|Protocol Violation|0
6857153|NCT00391053|10865999|FG000|Overall Study|Lost to Follow-up|1
6857154|NCT00391053|10866000|FG001|Overall Study|Lost to Follow-up|0
6857155|NCT00391053|10866001|FG002|Overall Study|Lost to Follow-up|0
6857156|NCT00391053|10866002|FG003|Overall Study|Lost to Follow-up|5
6857157|NCT00391053|10865999|FG000|Overall Study|Withdrawal by Subject|5
6857158|NCT00391053|10866000|FG001|Overall Study|Withdrawal by Subject|1
6857159|NCT00391053|10866001|FG002|Overall Study|Withdrawal by Subject|1
6857160|NCT00391053|10866002|FG003|Overall Study|Withdrawal by Subject|1
6857161|NCT00391092|10866023|FG000|Overall Study|Death|78
6857162|NCT00391092|10866024|FG001|Overall Study|Death|81
6857163|NCT00391092|10866023|FG000|Overall Study|Lost to Follow-up|13
6857164|NCT00391092|10866024|FG001|Overall Study|Lost to Follow-up|18
6857165|NCT00391092|10866023|FG000|Overall Study|Alive on treatment|29
6857166|NCT00391092|10866024|FG001|Overall Study|Alive on treatment|33
6857167|NCT00391092|10866023|FG000|Overall Study|Alive in follow-up|88
6857168|NCT00391092|10866024|FG001|Overall Study|Alive in follow-up|84
6857169|NCT00391118|10866033|FG000|Overall Study|Adverse Event|3
6857170|NCT00391118|10866034|FG001|Overall Study|Adverse Event|10
6857171|NCT00391118|10866035|FG002|Overall Study|Adverse Event|7
6857172|NCT00391118|10866033|FG000|Overall Study|Lost to Follow-up|0
6857173|NCT00391118|10866034|FG001|Overall Study|Lost to Follow-up|2
6857174|NCT00391118|10866035|FG002|Overall Study|Lost to Follow-up|3
6857175|NCT00391118|10866033|FG000|Overall Study|Withdrawal by Subject|0
6857176|NCT00391118|10866034|FG001|Overall Study|Withdrawal by Subject|9
6857177|NCT00391118|10866035|FG002|Overall Study|Withdrawal by Subject|1
6857178|NCT00391118|10866033|FG000|Overall Study|Death|0
6857179|NCT00391118|10866034|FG001|Overall Study|Death|1
6857180|NCT00391118|10866035|FG002|Overall Study|Death|0
6857181|NCT00391118|10866033|FG000|Overall Study|Physician Decision|0
6857182|NCT00391118|10866034|FG001|Overall Study|Physician Decision|3
6857183|NCT00391118|10866035|FG002|Overall Study|Physician Decision|0
6857184|NCT00391118|10866033|FG000|Overall Study|Protocol Entry Criteria Not Met|0
6857185|NCT00391118|10866034|FG001|Overall Study|Protocol Entry Criteria Not Met|3
6857186|NCT00391118|10866035|FG002|Overall Study|Protocol Entry Criteria Not Met|1
6857187|NCT00391118|10866033|FG000|Overall Study|Progressive Disease|7
6857188|NCT00391118|10866034|FG001|Overall Study|Progressive Disease|26
6857189|NCT00391118|10866035|FG002|Overall Study|Progressive Disease|43
6857190|NCT00391118|10866033|FG000|Overall Study|Sponsor Decision|0
6857191|NCT00391118|10866034|FG001|Overall Study|Sponsor Decision|1
6857192|NCT00391118|10866035|FG002|Overall Study|Sponsor Decision|3
6857193|NCT00391118|10866033|FG000|Overall Study|Protocol Violation|1
6857194|NCT00391118|10866034|FG001|Overall Study|Protocol Violation|0
6857195|NCT00391118|10866035|FG002|Overall Study|Protocol Violation|0
6857196|NCT00391222|10866049|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
6857197|NCT00391222|10866050|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
6857198|NCT00391222|10866051|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
6857199|NCT00391222|10866052|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26
6857200|NCT00391222|10866049|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
6857201|NCT00391222|10866050|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
6857202|NCT00391222|10866051|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
6857203|NCT00391222|10866052|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5
6857204|NCT00391222|10866049|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0
6857205|NCT00391222|10866050|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0
6857206|NCT00391222|10866051|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0
6857207|NCT00391222|10866052|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10
6857208|NCT00391222|10866049|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0
6857209|NCT00391222|10866050|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0
6857210|NCT00391222|10866051|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0
6857211|NCT00391222|10866052|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97
6857212|NCT00391222|10866049|FG000|Period II (Open-label Risperidone LAI)|Other|0
6857213|NCT00391222|10866050|FG001|Period II (Open-label Risperidone LAI)|Other|0
6857214|NCT00391222|10866051|FG002|Period II (Open-label Risperidone LAI)|Other|0
6857215|NCT00391222|10866052|FG003|Period II (Open-label Risperidone LAI)|Other|24
6857216|NCT00391222|10866049|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15
6857217|NCT00391222|10866050|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12
6857218|NCT00391222|10866051|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6
6857219|NCT00391222|10866052|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0
6857220|NCT00391222|10866049|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2
6857221|NCT00391222|10866050|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4
6857222|NCT00391222|10866051|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4
6857223|NCT00391222|10866052|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0
6857224|NCT00391222|10866049|FG000|Period III (Double-Blind Treatment)|Adverse Event|5
6857225|NCT00391222|10866050|FG001|Period III (Double-Blind Treatment)|Adverse Event|2
6857226|NCT00391222|10866051|FG002|Period III (Double-Blind Treatment)|Adverse Event|4
6857227|NCT00391222|10866052|FG003|Period III (Double-Blind Treatment)|Adverse Event|0
6857228|NCT00391222|10866049|FG000|Period III (Double-Blind Treatment)|Pregnancy|0
6857229|NCT00391222|10866050|FG001|Period III (Double-Blind Treatment)|Pregnancy|2
6857230|NCT00391222|10866051|FG002|Period III (Double-Blind Treatment)|Pregnancy|0
6857231|NCT00391222|10866052|FG003|Period III (Double-Blind Treatment)|Pregnancy|0
6857232|NCT00391222|10866049|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
6857233|NCT00391222|10866050|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1
6857234|NCT00391222|10866051|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3
6857235|NCT00391222|10866052|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
6857236|NCT00391222|10866049|FG000|Period III (Double-Blind Treatment)|Other|6
6857237|NCT00391222|10866050|FG001|Period III (Double-Blind Treatment)|Other|1
6857238|NCT00391222|10866051|FG002|Period III (Double-Blind Treatment)|Other|6
6857239|NCT00391222|10866052|FG003|Period III (Double-Blind Treatment)|Other|0
6857240|NCT00391274|10866064|FG000|Overall Study|Death Due to Study Disease|55
6857241|NCT00391274|10866065|FG001|Overall Study|Death Due to Study Disease|45
6857242|NCT00391274|10866064|FG000|Overall Study|Lost to Follow-up|0
6857243|NCT00391274|10866065|FG001|Overall Study|Lost to Follow-up|3
6857244|NCT00391274|10866064|FG000|Overall Study|Physician Decision|4
7077916|NCT02097719|11186024|FG000|Overall Study|Adverse Event|2
6857245|NCT00391274|10866065|FG001|Overall Study|Physician Decision|2
6857246|NCT00391274|10866064|FG000|Overall Study|Withdrawal by Subject|0
6857247|NCT00391274|10866065|FG001|Overall Study|Withdrawal by Subject|3
6857248|NCT00391274|10866064|FG000|Overall Study|Death Due to Adverse Event|1
7077917|NCT02097719|11186025|FG001|Overall Study|Adverse Event|0
7077918|NCT02097745|11186041|FG000|Overall Study|Adverse Event|25
7077919|NCT02097745|11186041|FG000|Overall Study|Death|16
7077920|NCT02097745|11186041|FG000|Overall Study|Failure to Return|14
7077921|NCT02097745|11186041|FG000|Overall Study|Administrative/Other|27
6857249|NCT00391274|10866065|FG001|Overall Study|Death Due to Adverse Event|3
6857250|NCT00391274|10866064|FG000|Overall Study|Death Due to Indeterminate Cause|1
6857251|NCT00391274|10866065|FG001|Overall Study|Death Due to Indeterminate Cause|0
6857252|NCT00391274|10866064|FG000|Overall Study|Death Not Study Related|0
6857253|NCT00391274|10866065|FG001|Overall Study|Death Not Study Related|1
6857254|NCT00391391|10866075|FG000|Overall Study|Adverse Event|0
6857255|NCT00391391|10866076|FG001|Overall Study|Adverse Event|0
6857256|NCT00391391|10866077|FG002|Overall Study|Adverse Event|0
6857257|NCT00391391|10866078|FG003|Overall Study|Adverse Event|1
6857258|NCT00391391|10866075|FG000|Overall Study|Lost to Follow-up|1
6857259|NCT00391391|10866076|FG001|Overall Study|Lost to Follow-up|3
6857260|NCT00391391|10866077|FG002|Overall Study|Lost to Follow-up|7
6857261|NCT00391391|10866078|FG003|Overall Study|Lost to Follow-up|4
6857262|NCT00391391|10866075|FG000|Overall Study|Protocol Violation|2
6857263|NCT00391391|10866076|FG001|Overall Study|Protocol Violation|3
6857264|NCT00391391|10866077|FG002|Overall Study|Protocol Violation|6
6857265|NCT00391391|10866078|FG003|Overall Study|Protocol Violation|7
6857266|NCT00391391|10866075|FG000|Overall Study|Withdrawal by Subject|6
6857267|NCT00391391|10866076|FG001|Overall Study|Withdrawal by Subject|4
6857268|NCT00391391|10866077|FG002|Overall Study|Withdrawal by Subject|10
6857269|NCT00391391|10866078|FG003|Overall Study|Withdrawal by Subject|7
6857270|NCT00391586|10866110|FG000|Overall Study|Progressive disease|13
6857271|NCT00391586|10866110|FG000|Overall Study|Adverse Event|5
6857272|NCT00391586|10866110|FG000|Overall Study|Physician Decision|2
6857273|NCT00391586|10866110|FG000|Overall Study|Death|4
6857274|NCT00391625|10866125|FG000|Month 14|Withdrawal by Subject|1
7077922|NCT02097745|11186041|FG000|Overall Study|Reason Not Specified|96
6857275|NCT00391625|10866125|FG000|Month 50|Physician Decision|1
6857276|NCT00391768|10866172|FG000|Overall Study|Withdrawal by Subject|0
6857277|NCT00391768|10866173|FG001|Overall Study|Withdrawal by Subject|0
6857278|NCT00391768|10866174|FG002|Overall Study|Withdrawal by Subject|1
6857279|NCT00391768|10866175|FG003|Overall Study|Withdrawal by Subject|0
6857280|NCT00391768|10866176|FG004|Overall Study|Withdrawal by Subject|0
6857281|NCT00391768|10866177|FG005|Overall Study|Withdrawal by Subject|1
6857282|NCT00391768|10866178|FG006|Overall Study|Withdrawal by Subject|1
6857283|NCT00391768|10866172|FG000|Overall Study|Lost to Follow-up|0
6857284|NCT00391768|10866173|FG001|Overall Study|Lost to Follow-up|0
6857285|NCT00391768|10866174|FG002|Overall Study|Lost to Follow-up|0
6857286|NCT00391768|10866175|FG003|Overall Study|Lost to Follow-up|1
6857287|NCT00391768|10866176|FG004|Overall Study|Lost to Follow-up|2
6857288|NCT00391768|10866177|FG005|Overall Study|Lost to Follow-up|2
6857289|NCT00391768|10866178|FG006|Overall Study|Lost to Follow-up|3
6857290|NCT00391807|10866212|FG000|Overall Study|Did not receive study medication|23
6857291|NCT00391807|10866212|FG000|Overall Study|Adverse Event|177
6857292|NCT00391807|10866212|FG000|Overall Study|Pregnancy|25
6857293|NCT00391807|10866212|FG000|Overall Study|Lost to Follow-up|227
6857294|NCT00391807|10866212|FG000|Overall Study|Withdrawal by Subject|147
6857295|NCT00391807|10866212|FG000|Overall Study|Protocol Violation|20
6857296|NCT00391807|10866212|FG000|Overall Study|Various|96
6857297|NCT00391846|10866218|FG000|Overall Study|Adverse Event|4
6857298|NCT00391846|10866219|FG001|Overall Study|Adverse Event|1
6857299|NCT00391846|10866218|FG000|Overall Study|Did not meet the required elig. crit|2
6857300|NCT00391846|10866219|FG001|Overall Study|Did not meet the required elig. crit|2
6857301|NCT00391846|10866218|FG000|Overall Study|Withdrawal by Subject|2
6857302|NCT00391846|10866219|FG001|Overall Study|Withdrawal by Subject|3
6857303|NCT00391846|10866218|FG000|Overall Study|Developed study specific DC criteria|0
6857304|NCT00391846|10866219|FG001|Overall Study|Developed study specific DC criteria|1
6857305|NCT00391872|10866227|FG000|Overall Study|Protocol Violation|7
6857306|NCT00391872|10866228|FG001|Overall Study|Protocol Violation|2
6857307|NCT00391872|10866227|FG000|Overall Study|Withdrawal by Subject|296
6857308|NCT00391872|10866228|FG001|Overall Study|Withdrawal by Subject|249
6857309|NCT00391872|10866227|FG000|Overall Study|Reason unknown|2
6857310|NCT00391872|10866228|FG001|Overall Study|Reason unknown|4
6857311|NCT00391872|10866227|FG000|Overall Study|Lost to Follow-up|2
6857312|NCT00391872|10866228|FG001|Overall Study|Lost to Follow-up|0
6857313|NCT00391898|10866236|FG000|Overall Study|Adverse Event|3
6857314|NCT00391898|10866237|FG001|Overall Study|Adverse Event|0
6857315|NCT00391898|10866236|FG000|Overall Study|Other|8
6857316|NCT00391898|10866237|FG001|Overall Study|Other|10
6857317|NCT00391976|10866246|FG000|Overall Study|Adverse Event|0
6857318|NCT00391976|10866247|FG001|Overall Study|Adverse Event|0
6857319|NCT00391976|10866248|FG002|Overall Study|Adverse Event|1
6857320|NCT00391976|10866246|FG000|Overall Study|Withdrawal of consent|0
6857321|NCT00391976|10866247|FG001|Overall Study|Withdrawal of consent|1
6857322|NCT00391976|10866248|FG002|Overall Study|Withdrawal of consent|1
6857323|NCT00391976|10866246|FG000|Overall Study|Lost to Follow-up|1
6857324|NCT00391976|10866247|FG001|Overall Study|Lost to Follow-up|2
6857325|NCT00391976|10866248|FG002|Overall Study|Lost to Follow-up|0
6857326|NCT00391976|10866246|FG000|Overall Study|Inappropriate enrollment|1
6857327|NCT00391976|10866247|FG001|Overall Study|Inappropriate enrollment|1
6857328|NCT00391976|10866248|FG002|Overall Study|Inappropriate enrollment|0
6857329|NCT00391976|10866246|FG000|Overall Study|Protocol deviation/violation|4
6857330|NCT00391976|10866247|FG001|Overall Study|Protocol deviation/violation|2
6857331|NCT00391976|10866248|FG002|Overall Study|Protocol deviation/violation|1
6857332|NCT00391976|10866246|FG000|Overall Study|Recurrence/no eradication of infection|21
6857333|NCT00391976|10866247|FG001|Overall Study|Recurrence/no eradication of infection|19
6857334|NCT00391976|10866248|FG002|Overall Study|Recurrence/no eradication of infection|0
6857335|NCT00391976|10866246|FG000|Overall Study|Unable to classify|0
7077923|NCT02097823|11186050|FG000|Overall Study|Withdrawal by Subject|1
7077924|NCT02097823|11186051|FG001|Overall Study|Withdrawal by Subject|1
7077925|NCT02098109|11186084|FG000|Overall Study|Protocol Violation|3
7152773|NCT03264066|11317804|FG002|Overall Study|Withdrawal by Subject|0
7152774|NCT03264066|11317805|FG003|Overall Study|Withdrawal by Subject|5
7152775|NCT03264066|11317806|FG004|Overall Study|Withdrawal by Subject|0
7152776|NCT03264066|11317807|FG005|Overall Study|Withdrawal by Subject|0
7152777|NCT03264456|11317856|FG000|Overall Study|Withdrawal by Subject|3
7152778|NCT03264456|11317856|FG000|Overall Study|Lost to Follow-up|1
7152779|NCT03265119|11317862|FG000|Overall Study|Adverse Event|2
7152780|NCT03265119|11317863|FG001|Overall Study|Adverse Event|1
7152781|NCT03265119|11317862|FG000|Overall Study|Lack of Efficacy|3
6857336|NCT00391976|10866247|FG001|Overall Study|Unable to classify|0
6857337|NCT00391976|10866248|FG002|Overall Study|Unable to classify|1
6857338|NCT00391976|10866246|FG000|Overall Study|Positive P. aeruginosa antibody test|0
7152782|NCT03265119|11317863|FG001|Overall Study|Lack of Efficacy|0
6857339|NCT00391976|10866247|FG001|Overall Study|Positive P. aeruginosa antibody test|0
6857340|NCT00391976|10866248|FG002|Overall Study|Positive P. aeruginosa antibody test|31
6857341|NCT00392015|10866268|FG000|Overall Study|Lost to Follow-up|2
6857342|NCT00392015|10866269|FG001|Overall Study|Lost to Follow-up|0
6857343|NCT00392015|10866270|FG002|Overall Study|Lost to Follow-up|2
6857344|NCT00392015|10866271|FG003|Overall Study|Lost to Follow-up|1
6857345|NCT00392015|10866272|FG004|Overall Study|Lost to Follow-up|1
6857346|NCT00392015|10866273|FG005|Overall Study|Lost to Follow-up|0
6857347|NCT00392015|10866268|FG000|Overall Study|Withdrawal by Subject|0
6857348|NCT00392015|10866269|FG001|Overall Study|Withdrawal by Subject|0
6857349|NCT00392015|10866270|FG002|Overall Study|Withdrawal by Subject|2
6857350|NCT00392015|10866271|FG003|Overall Study|Withdrawal by Subject|0
6857351|NCT00392015|10866272|FG004|Overall Study|Withdrawal by Subject|0
6857352|NCT00392015|10866273|FG005|Overall Study|Withdrawal by Subject|0
6857353|NCT00392015|10866268|FG000|Overall Study|Adverse Event|0
6857354|NCT00392015|10866269|FG001|Overall Study|Adverse Event|0
6857355|NCT00392015|10866270|FG002|Overall Study|Adverse Event|0
6857356|NCT00392015|10866271|FG003|Overall Study|Adverse Event|0
6857357|NCT00392015|10866272|FG004|Overall Study|Adverse Event|1
6857358|NCT00392015|10866273|FG005|Overall Study|Adverse Event|0
6857359|NCT00392015|10866268|FG000|Overall Study|Previous trial recipient|0
6857360|NCT00392015|10866269|FG001|Overall Study|Previous trial recipient|0
6857361|NCT00392015|10866270|FG002|Overall Study|Previous trial recipient|0
6857362|NCT00392015|10866271|FG003|Overall Study|Previous trial recipient|0
6857363|NCT00392015|10866272|FG004|Overall Study|Previous trial recipient|1
6857364|NCT00392015|10866273|FG005|Overall Study|Previous trial recipient|0
6857365|NCT00392171|10866314|FG000|Overall Study|Did not meet inclusion criteria|4
6857366|NCT00392171|10866314|FG000|Overall Study|Disease progression|101
6857367|NCT00392197|10866320|FG000|Overall Study|Adverse Event|4
6857368|NCT00392197|10866321|FG001|Overall Study|Adverse Event|12
6857369|NCT00392197|10866320|FG000|Overall Study|Lack of Efficacy|3
6857370|NCT00392197|10866321|FG001|Overall Study|Lack of Efficacy|4
6857371|NCT00392197|10866320|FG000|Overall Study|Lost to Follow-up|0
6857372|NCT00392197|10866321|FG001|Overall Study|Lost to Follow-up|1
6857373|NCT00392197|10866320|FG000|Overall Study|Physician Decision|3
6857374|NCT00392197|10866321|FG001|Overall Study|Physician Decision|2
6857375|NCT00392197|10866320|FG000|Overall Study|Protocol Violation|7
6857376|NCT00392197|10866321|FG001|Overall Study|Protocol Violation|5
6857377|NCT00392197|10866320|FG000|Overall Study|Withdrawal by Subject|4
6857378|NCT00392197|10866321|FG001|Overall Study|Withdrawal by Subject|6
6857379|NCT00392210|10866329|FG000|First Voiding Trial|Physician Decision|2
6857380|NCT00392210|10866330|FG001|First Voiding Trial|Physician Decision|2
6857381|NCT00392223|10866338|FG000|Overall Study|Adverse Event|5
6857382|NCT00392223|10866339|FG001|Overall Study|Adverse Event|4
6857383|NCT00392223|10866338|FG000|Overall Study|Lost to Follow-up|1
6857384|NCT00392223|10866339|FG001|Overall Study|Lost to Follow-up|4
6857385|NCT00392223|10866338|FG000|Overall Study|Protocol Violation|0
6857386|NCT00392223|10866339|FG001|Overall Study|Protocol Violation|3
6857387|NCT00392223|10866338|FG000|Overall Study|Withdrawal by Subject|3
6857388|NCT00392223|10866339|FG001|Overall Study|Withdrawal by Subject|2
6857389|NCT00392288|10866357|FG000|Overall Study|Adverse Event|17
6857390|NCT00392288|10866358|FG001|Overall Study|Adverse Event|7
6857391|NCT00392288|10866359|FG002|Overall Study|Adverse Event|8
6857392|NCT00392288|10866357|FG000|Overall Study|Lack of Efficacy|8
6857393|NCT00392288|10866358|FG001|Overall Study|Lack of Efficacy|5
6857394|NCT00392288|10866359|FG002|Overall Study|Lack of Efficacy|3
6857395|NCT00392288|10866357|FG000|Overall Study|Protocol Violation|1
6857396|NCT00392288|10866358|FG001|Overall Study|Protocol Violation|3
6857397|NCT00392288|10866359|FG002|Overall Study|Protocol Violation|1
6857398|NCT00392288|10866357|FG000|Overall Study|Lost to Follow-up|1
6857399|NCT00392288|10866358|FG001|Overall Study|Lost to Follow-up|1
6857400|NCT00392288|10866359|FG002|Overall Study|Lost to Follow-up|1
6857401|NCT00392288|10866357|FG000|Overall Study|Withdrawal by Subject|1
6857402|NCT00392288|10866358|FG001|Overall Study|Withdrawal by Subject|0
6857403|NCT00392288|10866359|FG002|Overall Study|Withdrawal by Subject|2
6857404|NCT00392288|10866357|FG000|Overall Study|Parent/legal guardian withdrawal|1
6857405|NCT00392288|10866358|FG001|Overall Study|Parent/legal guardian withdrawal|2
6857406|NCT00392288|10866359|FG002|Overall Study|Parent/legal guardian withdrawal|1
6857407|NCT00392288|10866357|FG000|Overall Study|Other|3
6857408|NCT00392288|10866358|FG001|Overall Study|Other|4
6857409|NCT00392288|10866359|FG002|Overall Study|Other|1
6857410|NCT00392379|10866369|FG000|Overall Study|Withdrawal by Subject|17
6857411|NCT00392379|10866370|FG001|Overall Study|Withdrawal by Subject|28
6857412|NCT00392379|10866369|FG000|Overall Study|Lost to Follow-up|4
6857413|NCT00392379|10866370|FG001|Overall Study|Lost to Follow-up|9
6857414|NCT00392379|10866369|FG000|Overall Study|Adverse Event|1
6857415|NCT00392379|10866370|FG001|Overall Study|Adverse Event|1
6857416|NCT00392665|10866390|FG000|Overall Study|Death|16
6857417|NCT00392665|10866391|FG001|Overall Study|Death|14
6857418|NCT00392665|10866390|FG000|Overall Study|Lost to Follow-up|1
6857419|NCT00392665|10866391|FG001|Overall Study|Lost to Follow-up|1
6857420|NCT00392769|10866427|FG000|Overall Study|Clinical Deterioration|9
6857421|NCT00392769|10866427|FG000|Overall Study|Adverse Event|1
6857422|NCT00392808|10866439|FG000|Overall Study|Lost to Follow-up|3
6857423|NCT00392808|10866440|FG001|Overall Study|Lost to Follow-up|2
6857424|NCT00392808|10866441|FG002|Overall Study|Lost to Follow-up|1
6857425|NCT00392808|10866442|FG003|Overall Study|Lost to Follow-up|2
6857426|NCT00392808|10866439|FG000|Overall Study|Unable to withdraw blood|3
6857427|NCT00392808|10866440|FG001|Overall Study|Unable to withdraw blood|1
6857428|NCT00392808|10866441|FG002|Overall Study|Unable to withdraw blood|1
6857429|NCT00392808|10866442|FG003|Overall Study|Unable to withdraw blood|2
6857430|NCT00392925|10866465|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11
6857431|NCT00392925|10866466|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
6857432|NCT00392925|10866467|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
6857433|NCT00392925|10866468|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
6857434|NCT00392925|10866465|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5
6857435|NCT00392925|10866466|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
6857436|NCT00392925|10866467|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
6857437|NCT00392925|10866468|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
6857438|NCT00392925|10866465|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1
6857439|NCT00392925|10866466|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
6857440|NCT00392925|10866467|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
6857441|NCT00392925|10866468|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
6857442|NCT00392925|10866465|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5
6857443|NCT00392925|10866466|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
6857444|NCT00392925|10866467|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
6857445|NCT00392925|10866468|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
6857446|NCT00392925|10866465|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16
6857447|NCT00392925|10866466|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
6857448|NCT00392925|10866467|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
6857449|NCT00392925|10866468|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
6857450|NCT00392925|10866465|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0
6857451|NCT00392925|10866466|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2
6857452|NCT00392925|10866467|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6
6857453|NCT00392925|10866468|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8
6857454|NCT00392925|10866465|FG000|Randomization to Treatment Group Period|Adverse Event|0
6857455|NCT00392925|10866466|FG001|Randomization to Treatment Group Period|Adverse Event|3
6857456|NCT00392925|10866467|FG002|Randomization to Treatment Group Period|Adverse Event|3
6857457|NCT00392925|10866468|FG003|Randomization to Treatment Group Period|Adverse Event|5
6857458|NCT00392925|10866465|FG000|Randomization to Treatment Group Period|Protocol Violation|0
6857459|NCT00392925|10866466|FG001|Randomization to Treatment Group Period|Protocol Violation|0
6857460|NCT00392925|10866467|FG002|Randomization to Treatment Group Period|Protocol Violation|2
6857461|NCT00392925|10866468|FG003|Randomization to Treatment Group Period|Protocol Violation|1
6857462|NCT00392925|10866465|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0
6857463|NCT00392925|10866466|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3
6857464|NCT00392925|10866467|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8
6857465|NCT00392925|10866468|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4
6857466|NCT00392990|10866490|FG000|Treatment on Study|Adverse Event|3
6857467|NCT00392990|10866491|FG001|Treatment on Study|Adverse Event|1
6857468|NCT00392990|10866490|FG000|Follow up for 2 Years|Death|4
6857469|NCT00392990|10866491|FG001|Follow up for 2 Years|Death|0
6857470|NCT00393029|10866499|FG000|Overall Study|Not treated|0
6857471|NCT00393029|10866500|FG001|Overall Study|Not treated|1
6857472|NCT00393042|10866507|FG000|First Intervention|Withdrawal by Subject|1
6857473|NCT00393042|10866508|FG001|First Intervention|Withdrawal by Subject|2
6857474|NCT00393042|10866507|FG000|First Intervention|Lost to Follow-up|3
6857475|NCT00393042|10866508|FG001|First Intervention|Lost to Follow-up|3
6857476|NCT00393042|10866507|FG000|First Intervention|Protocol Violation|1
6857477|NCT00393042|10866508|FG001|First Intervention|Protocol Violation|0
6857478|NCT00393042|10866507|FG000|First Intervention|Adverse Event|0
6857479|NCT00393042|10866508|FG001|First Intervention|Adverse Event|1
6857480|NCT00393042|10866507|FG000|Second Intervetion|Adverse Event|0
6857481|NCT00393042|10866508|FG001|Second Intervetion|Adverse Event|3
6857482|NCT00393042|10866507|FG000|Second Intervetion|Withdrawal by Subject|0
6857483|NCT00393042|10866508|FG001|Second Intervetion|Withdrawal by Subject|2
6857484|NCT00393042|10866507|FG000|Second Intervetion|Lack of Efficacy|1
6857485|NCT00393042|10866508|FG001|Second Intervetion|Lack of Efficacy|0
6857486|NCT00393042|10866507|FG000|Second Intervetion|Lost to Follow-up|0
6857487|NCT00393042|10866508|FG001|Second Intervetion|Lost to Follow-up|2
6857488|NCT00393042|10866507|FG000|Second Intervetion|Protocol Violation|1
6857489|NCT00393042|10866508|FG001|Second Intervetion|Protocol Violation|1
6967399|NCT01131676|11015771|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
6967400|NCT01131676|11015772|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
6967401|NCT01131676|11015773|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2
6967402|NCT01132118|11015784|FG000|First Intervention (8 Weeks)|Adverse Event|1
6967403|NCT01132118|11015785|FG001|First Intervention (8 Weeks)|Adverse Event|0
6967404|NCT01132118|11015784|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2
6967405|NCT01132118|11015785|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3
6967406|NCT01132118|11015784|FG000|Second Intervention (8 Weeks)|Adverse Event|0
6967407|NCT01132118|11015785|FG001|Second Intervention (8 Weeks)|Adverse Event|1
6967408|NCT01132313|11015814|FG000|Overall Study|Lack of Efficacy|1
6967409|NCT01132313|11015815|FG001|Overall Study|Lack of Efficacy|0
6967410|NCT01132313|11015816|FG002|Overall Study|Lack of Efficacy|0
6967411|NCT01132313|11015817|FG003|Overall Study|Lack of Efficacy|0
6857490|NCT00393094|10866562|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1
6857491|NCT00393094|10866562|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1
6857492|NCT00393367|10866570|FG000|Overall Study|Protocol Violation|2
6857493|NCT00393367|10866571|FG001|Overall Study|Protocol Violation|5
6857494|NCT00393367|10866570|FG000|Overall Study|Withdrawal by Subject|0
6857495|NCT00393367|10866571|FG001|Overall Study|Withdrawal by Subject|2
6857496|NCT00393458|10866587|FG000|Overall Study|Adverse Event|35
6857497|NCT00393458|10866588|FG001|Overall Study|Adverse Event|24
6857498|NCT00393458|10866589|FG002|Overall Study|Adverse Event|40
6857499|NCT00393458|10866590|FG003|Overall Study|Adverse Event|35
6857500|NCT00393458|10866587|FG000|Overall Study|Subject withdrew consent|27
6857501|NCT00393458|10866588|FG001|Overall Study|Subject withdrew consent|40
6857502|NCT00393458|10866589|FG002|Overall Study|Subject withdrew consent|33
6857503|NCT00393458|10866590|FG003|Overall Study|Subject withdrew consent|50
6857504|NCT00393458|10866587|FG000|Overall Study|Unsatisfactory therapeutic effect|12
6857505|NCT00393458|10866588|FG001|Overall Study|Unsatisfactory therapeutic effect|9
6857506|NCT00393458|10866589|FG002|Overall Study|Unsatisfactory therapeutic effect|12
6857507|NCT00393458|10866590|FG003|Overall Study|Unsatisfactory therapeutic effect|30
6857508|NCT00393458|10866587|FG000|Overall Study|Protocol deviation|11
6857509|NCT00393458|10866588|FG001|Overall Study|Protocol deviation|11
6857510|NCT00393458|10866589|FG002|Overall Study|Protocol deviation|11
6857511|NCT00393458|10866590|FG003|Overall Study|Protocol deviation|10
6857512|NCT00393458|10866587|FG000|Overall Study|Administrative problems|7
6857513|NCT00393458|10866588|FG001|Overall Study|Administrative problems|8
6857514|NCT00393458|10866589|FG002|Overall Study|Administrative problems|5
6857515|NCT00393458|10866590|FG003|Overall Study|Administrative problems|2
6857516|NCT00393458|10866587|FG000|Overall Study|Lost to Follow-up|5
6857517|NCT00393458|10866588|FG001|Overall Study|Lost to Follow-up|6
6857518|NCT00393458|10866589|FG002|Overall Study|Lost to Follow-up|5
6857519|NCT00393458|10866590|FG003|Overall Study|Lost to Follow-up|3
6857520|NCT00393458|10866587|FG000|Overall Study|Abnormal laboratory value(s)|1
6857521|NCT00393458|10866588|FG001|Overall Study|Abnormal laboratory value(s)|1
6857522|NCT00393458|10866589|FG002|Overall Study|Abnormal laboratory value(s)|0
6857523|NCT00393458|10866590|FG003|Overall Study|Abnormal laboratory value(s)|0
6857524|NCT00393458|10866587|FG000|Overall Study|Death|1
6857525|NCT00393458|10866588|FG001|Overall Study|Death|1
6857526|NCT00393458|10866589|FG002|Overall Study|Death|5
6857527|NCT00393458|10866590|FG003|Overall Study|Death|5
6857528|NCT00393458|10866587|FG000|Overall Study|Abnormal test procedure result(s)|0
6857529|NCT00393458|10866588|FG001|Overall Study|Abnormal test procedure result(s)|1
6857530|NCT00393458|10866589|FG002|Overall Study|Abnormal test procedure result(s)|1
6857531|NCT00393458|10866590|FG003|Overall Study|Abnormal test procedure result(s)|2
6857532|NCT00393458|10866587|FG000|Overall Study|Subject no longer requires study drug|0
6857533|NCT00393458|10866588|FG001|Overall Study|Subject no longer requires study drug|1
6857534|NCT00393458|10866589|FG002|Overall Study|Subject no longer requires study drug|0
6857535|NCT00393458|10866590|FG003|Overall Study|Subject no longer requires study drug|0
6857536|NCT00393484|10866602|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0
6857537|NCT00393484|10866603|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1
6857538|NCT00393484|10866602|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2
6857539|NCT00393484|10866603|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0
6857540|NCT00393484|10866602|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0
6857541|NCT00393484|10866603|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3
6857542|NCT00393484|10866602|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0
6857543|NCT00393484|10866603|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6
6857544|NCT00393484|10866602|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0
6857545|NCT00393484|10866603|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2
6857546|NCT00393484|10866602|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4
6857547|NCT00393484|10866603|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1
6857548|NCT00393484|10866602|FG000|Open-label Period (Weeks 96 to 240)|Death|1
6857549|NCT00393484|10866603|FG001|Open-label Period (Weeks 96 to 240)|Death|0
6857550|NCT00393484|10866602|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1
6857551|NCT00393484|10866603|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2
6857552|NCT00393484|10866602|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2
6857553|NCT00393484|10866603|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2
6857554|NCT00393484|10866602|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0
6857555|NCT00393484|10866603|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18
6857556|NCT00393510|10866613|FG000|Overall Study|Physician Decision|3
6857557|NCT00393510|10866614|FG001|Overall Study|Physician Decision|9
6857558|NCT00393523|10866625|FG000|Overall Study|Lost to Follow-up|0
6857559|NCT00393523|10866626|FG001|Overall Study|Lost to Follow-up|0
7077926|NCT02098109|11186085|FG001|Overall Study|Protocol Violation|0
7077927|NCT02098369|11186100|FG000|Overall Study|Withdrawal by Subject|1
7152783|NCT03265119|11317862|FG000|Overall Study|Protocol Violation|1
6857560|NCT00393523|10866627|FG002|Overall Study|Lost to Follow-up|0
6857561|NCT00393523|10866628|FG003|Overall Study|Lost to Follow-up|2
6857562|NCT00393523|10866629|FG004|Overall Study|Lost to Follow-up|1
6857563|NCT00393523|10866625|FG000|Overall Study|Protocol Violation|6
7077928|NCT02098369|11186101|FG001|Overall Study|Withdrawal by Subject|5
6857564|NCT00393523|10866626|FG001|Overall Study|Protocol Violation|2
6857565|NCT00393523|10866627|FG002|Overall Study|Protocol Violation|0
6857566|NCT00393523|10866628|FG003|Overall Study|Protocol Violation|1
6857567|NCT00393523|10866629|FG004|Overall Study|Protocol Violation|0
6857568|NCT00393523|10866625|FG000|Overall Study|Withdrawal by Subject|6
6857569|NCT00393523|10866626|FG001|Overall Study|Withdrawal by Subject|7
6857570|NCT00393523|10866627|FG002|Overall Study|Withdrawal by Subject|2
6857571|NCT00393523|10866628|FG003|Overall Study|Withdrawal by Subject|3
6857572|NCT00393523|10866629|FG004|Overall Study|Withdrawal by Subject|0
6857573|NCT00393523|10866625|FG000|Overall Study|Difficulties in specimen collection|0
6857574|NCT00393523|10866626|FG001|Overall Study|Difficulties in specimen collection|0
6857575|NCT00393523|10866627|FG002|Overall Study|Difficulties in specimen collection|1
6857576|NCT00393523|10866628|FG003|Overall Study|Difficulties in specimen collection|0
6857577|NCT00393523|10866629|FG004|Overall Study|Difficulties in specimen collection|0
6857578|NCT00393523|10866625|FG000|Overall Study|Vaccine supply issue|0
6857579|NCT00393523|10866626|FG001|Overall Study|Vaccine supply issue|0
6857580|NCT00393523|10866627|FG002|Overall Study|Vaccine supply issue|1
6857581|NCT00393523|10866628|FG003|Overall Study|Vaccine supply issue|0
6857582|NCT00393523|10866629|FG004|Overall Study|Vaccine supply issue|0
6857583|NCT00393705|10866642|FG000|Overall Study|Adverse Event|0
6857584|NCT00393705|10866643|FG001|Overall Study|Adverse Event|2
6857585|NCT00393705|10866642|FG000|Overall Study|Death|0
6857586|NCT00393705|10866643|FG001|Overall Study|Death|1
6857587|NCT00393705|10866642|FG000|Overall Study|Lost to Follow-up|2
6857588|NCT00393705|10866643|FG001|Overall Study|Lost to Follow-up|2
6857589|NCT00393705|10866642|FG000|Overall Study|Entry Criteria Not Met|10
6857590|NCT00393705|10866643|FG001|Overall Study|Entry Criteria Not Met|10
6857591|NCT00393705|10866642|FG000|Overall Study|Protocol Violation|4
6857592|NCT00393705|10866643|FG001|Overall Study|Protocol Violation|3
6857593|NCT00393705|10866642|FG000|Overall Study|Withdrawal by Subject|5
6857594|NCT00393705|10866643|FG001|Overall Study|Withdrawal by Subject|3
6857595|NCT00393705|10866642|FG000|Overall Study|Physician Decision|2
6857596|NCT00393705|10866643|FG001|Overall Study|Physician Decision|2
6857597|NCT00393718|10866651|FG000|Overall Study|Adverse Event|20
6857598|NCT00393718|10866652|FG001|Overall Study|Adverse Event|8
6857599|NCT00393718|10866651|FG000|Overall Study|Protocol Violation|1
6857600|NCT00393718|10866652|FG001|Overall Study|Protocol Violation|2
6857601|NCT00393718|10866651|FG000|Overall Study|Lack of Efficacy|10
6857602|NCT00393718|10866652|FG001|Overall Study|Lack of Efficacy|9
6857603|NCT00393718|10866651|FG000|Overall Study|Hypoglycaemia|3
6857604|NCT00393718|10866652|FG001|Overall Study|Hypoglycaemia|2
6857605|NCT00393718|10866651|FG000|Overall Study|Subject decision|5
6857606|NCT00393718|10866652|FG001|Overall Study|Subject decision|0
6857607|NCT00393718|10866651|FG000|Overall Study|Withdrawal of consent|2
6857608|NCT00393718|10866652|FG001|Overall Study|Withdrawal of consent|1
6857609|NCT00393718|10866651|FG000|Overall Study|Missed measurement|1
6857610|NCT00393718|10866652|FG001|Overall Study|Missed measurement|0
6857611|NCT00393718|10866651|FG000|Overall Study|Move|1
6857612|NCT00393718|10866652|FG001|Overall Study|Move|0
6857613|NCT00393848|10866671|FG000|Overall Study|Surgical schedule|0
6857614|NCT00393848|10866672|FG001|Overall Study|Surgical schedule|0
6857615|NCT00393848|10866673|FG002|Overall Study|Surgical schedule|0
6857616|NCT00393848|10866674|FG003|Overall Study|Surgical schedule|1
6857617|NCT00393848|10866671|FG000|Overall Study|Personal reasons|0
6857618|NCT00393848|10866672|FG001|Overall Study|Personal reasons|0
6857619|NCT00393848|10866673|FG002|Overall Study|Personal reasons|2
6857620|NCT00393848|10866674|FG003|Overall Study|Personal reasons|0
6857621|NCT00393861|10866685|FG000|Overall Study|Adverse Event|2
6857622|NCT00393861|10866685|FG000|Overall Study|Disease Progression|24
6857623|NCT00393887|10866707|FG000|Overall Study|Physician Decision|5
6857624|NCT00393887|10866708|FG001|Overall Study|Physician Decision|0
6857625|NCT00393887|10866707|FG000|Overall Study|Lost to Follow-up|11
6857626|NCT00393887|10866708|FG001|Overall Study|Lost to Follow-up|9
6857627|NCT00393913|10866714|FG000|Initial Assessment|diagnosed with other sleep disorder|21
6857628|NCT00393913|10866714|FG000|Initial Assessment|Withdrawal by Subject|16
6857629|NCT00393913|10866714|FG000|CPAP|Withdrawal by Subject|3
6857630|NCT00393913|10866714|FG000|CPAP|Physician Decision|1
6857631|NCT00393913|10866714|FG000|CPAP|TEchnical problem with CPAP|3
6857632|NCT00393939|10866721|FG000|Overall Study|Protocol Violation|1
6857633|NCT00393939|10866722|FG001|Overall Study|Protocol Violation|1
6857634|NCT00393939|10866721|FG000|Overall Study|Lost to Follow-up|2
6857635|NCT00393939|10866722|FG001|Overall Study|Lost to Follow-up|4
6857636|NCT00393939|10866721|FG000|Overall Study|Death|10
6857637|NCT00393939|10866722|FG001|Overall Study|Death|4
6857638|NCT00393939|10866721|FG000|Overall Study|Sponsor|5
6857639|NCT00393939|10866722|FG001|Overall Study|Sponsor|13
6857640|NCT00393939|10866721|FG000|Overall Study|Objective progression or relapse|239
6857641|NCT00393939|10866722|FG001|Overall Study|Objective progression or relapse|223
6857642|NCT00393939|10866721|FG000|Overall Study|Withdrawal by Subject|2
6857643|NCT00393939|10866722|FG001|Overall Study|Withdrawal by Subject|7
6857644|NCT00393939|10866721|FG000|Overall Study|Other|37
6857645|NCT00393939|10866722|FG001|Overall Study|Other|45
6857646|NCT00394082|10866737|FG000|Overall Study|Unacceptable toxicity|15
6857647|NCT00394082|10866737|FG000|Overall Study|Adverse Event|4
6857648|NCT00394082|10866737|FG000|Overall Study|Physician Decision|4
6857649|NCT00394082|10866737|FG000|Overall Study|Withdrawal by Subject|2
6857650|NCT00394082|10866737|FG000|Overall Study|Other|1
6857651|NCT00394095|10866743|FG000|Overall Study|Adverse Event|1
6857652|NCT00394095|10866744|FG001|Overall Study|Adverse Event|0
6857653|NCT00394212|10866753|FG000|Overall Study|Lost to Follow-up|3
6857654|NCT00394212|10866754|FG001|Overall Study|Lost to Follow-up|0
6857655|NCT00394212|10866753|FG000|Overall Study|Withdrawal by Subject|4
6857656|NCT00394212|10866754|FG001|Overall Study|Withdrawal by Subject|1
6857657|NCT00394251|10866762|FG000|Overall Study|Adverse Event|7
6857658|NCT00394251|10866763|FG001|Overall Study|Adverse Event|5
6857659|NCT00394251|10866762|FG000|Overall Study|Unacceptable Toxicity|20
6857660|NCT00394251|10866763|FG001|Overall Study|Unacceptable Toxicity|18
6857661|NCT00394251|10866762|FG000|Overall Study|Physician Decision|1
6857662|NCT00394251|10866763|FG001|Overall Study|Physician Decision|1
6857663|NCT00394251|10866762|FG000|Overall Study|Protocol Violation|0
6857664|NCT00394251|10866763|FG001|Overall Study|Protocol Violation|1
6857665|NCT00394251|10866762|FG000|Overall Study|Withdrawal by Subject|7
6857666|NCT00394251|10866763|FG001|Overall Study|Withdrawal by Subject|11
6857667|NCT00394251|10866762|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2
6857668|NCT00394251|10866763|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2
6857669|NCT00394433|10866813|FG000|Overall Study|Adverse Event|2
6857670|NCT00394433|10866813|FG000|Overall Study|Alternative Therapy|1
6857671|NCT00394472|10866819|FG000|Overall Study|Protocol Violation|1
6857672|NCT00394472|10866820|FG001|Overall Study|Protocol Violation|3
6857673|NCT00394472|10866819|FG000|Overall Study|incorrect enrolment|4
6857674|NCT00394472|10866820|FG001|Overall Study|incorrect enrolment|2
6857675|NCT00394472|10866819|FG000|Overall Study|Adverse Event|4
6857676|NCT00394472|10866820|FG001|Overall Study|Adverse Event|2
6967412|NCT01132313|11015818|FG004|Overall Study|Lack of Efficacy|0
6967413|NCT01132313|11015819|FG005|Overall Study|Lack of Efficacy|0
6967414|NCT01132313|11015820|FG006|Overall Study|Lack of Efficacy|0
6967415|NCT01132313|11015821|FG007|Overall Study|Lack of Efficacy|3
6967416|NCT01132313|11015822|FG008|Overall Study|Lack of Efficacy|14
6967417|NCT01132313|11015823|FG009|Overall Study|Lack of Efficacy|16
6967418|NCT01132313|11015824|FG010|Overall Study|Lack of Efficacy|0
6967419|NCT01132313|11015825|FG011|Overall Study|Lack of Efficacy|0
6967420|NCT01132313|11015814|FG000|Overall Study|Not treated|2
6967421|NCT01132313|11015815|FG001|Overall Study|Not treated|0
6967422|NCT01132313|11015816|FG002|Overall Study|Not treated|0
6967423|NCT01132313|11015817|FG003|Overall Study|Not treated|0
6967424|NCT01132313|11015818|FG004|Overall Study|Not treated|2
6967425|NCT01132313|11015819|FG005|Overall Study|Not treated|1
7077929|NCT02098369|11186102|FG002|Overall Study|Withdrawal by Subject|0
7077930|NCT02098369|11186100|FG000|Overall Study|Lost to Follow-up|5
6967426|NCT01132313|11015820|FG006|Overall Study|Not treated|3
6967427|NCT01132313|11015821|FG007|Overall Study|Not treated|0
6967428|NCT01132313|11015822|FG008|Overall Study|Not treated|0
6967429|NCT01132313|11015823|FG009|Overall Study|Not treated|0
6967430|NCT01132313|11015824|FG010|Overall Study|Not treated|0
6967431|NCT01132313|11015825|FG011|Overall Study|Not treated|0
6967432|NCT01132313|11015814|FG000|Overall Study|Adverse Event|0
6967433|NCT01132313|11015815|FG001|Overall Study|Adverse Event|0
6967434|NCT01132313|11015816|FG002|Overall Study|Adverse Event|4
6967435|NCT01132313|11015817|FG003|Overall Study|Adverse Event|10
6967436|NCT01132313|11015818|FG004|Overall Study|Adverse Event|19
6967437|NCT01132313|11015819|FG005|Overall Study|Adverse Event|6
6967438|NCT01132313|11015820|FG006|Overall Study|Adverse Event|5
6967439|NCT01132313|11015821|FG007|Overall Study|Adverse Event|3
6967440|NCT01132313|11015822|FG008|Overall Study|Adverse Event|7
6967441|NCT01132313|11015823|FG009|Overall Study|Adverse Event|2
6967442|NCT01132313|11015824|FG010|Overall Study|Adverse Event|0
6967443|NCT01132313|11015825|FG011|Overall Study|Adverse Event|0
6967444|NCT01132313|11015814|FG000|Overall Study|Protocol Violation|0
6967445|NCT01132313|11015815|FG001|Overall Study|Protocol Violation|0
6967446|NCT01132313|11015816|FG002|Overall Study|Protocol Violation|0
6967447|NCT01132313|11015817|FG003|Overall Study|Protocol Violation|1
6967448|NCT01132313|11015818|FG004|Overall Study|Protocol Violation|0
6967449|NCT01132313|11015819|FG005|Overall Study|Protocol Violation|0
6967450|NCT01132313|11015820|FG006|Overall Study|Protocol Violation|0
7152784|NCT03265119|11317863|FG001|Overall Study|Protocol Violation|2
6967451|NCT01132313|11015821|FG007|Overall Study|Protocol Violation|0
6967452|NCT01132313|11015822|FG008|Overall Study|Protocol Violation|0
6967453|NCT01132313|11015823|FG009|Overall Study|Protocol Violation|0
6967454|NCT01132313|11015824|FG010|Overall Study|Protocol Violation|0
6857677|NCT00394472|10866819|FG000|Overall Study|Withdrawal by Subject|0
6857678|NCT00394472|10866820|FG001|Overall Study|Withdrawal by Subject|2
6857679|NCT00394472|10866819|FG000|Overall Study|Physician Decision|0
6857680|NCT00394472|10866820|FG001|Overall Study|Physician Decision|1
6857681|NCT00394472|10866819|FG000|Overall Study|Lost to Follow-up|0
6967455|NCT01132313|11015825|FG011|Overall Study|Protocol Violation|0
6967456|NCT01132313|11015814|FG000|Overall Study|Lost to Follow-up|0
6967457|NCT01132313|11015815|FG001|Overall Study|Lost to Follow-up|0
6967458|NCT01132313|11015816|FG002|Overall Study|Lost to Follow-up|1
6967459|NCT01132313|11015817|FG003|Overall Study|Lost to Follow-up|0
6967460|NCT01132313|11015818|FG004|Overall Study|Lost to Follow-up|0
6967461|NCT01132313|11015819|FG005|Overall Study|Lost to Follow-up|0
6967462|NCT01132313|11015820|FG006|Overall Study|Lost to Follow-up|0
6967463|NCT01132313|11015821|FG007|Overall Study|Lost to Follow-up|1
6967464|NCT01132313|11015822|FG008|Overall Study|Lost to Follow-up|0
7152785|NCT03265119|11317862|FG000|Overall Study|Withdrawal by Subject|2
7152786|NCT03265119|11317863|FG001|Overall Study|Withdrawal by Subject|4
7152787|NCT03265119|11317862|FG000|Overall Study|Lost to Follow-up|1
7152788|NCT03265119|11317863|FG001|Overall Study|Lost to Follow-up|0
7152789|NCT03265119|11317862|FG000|Overall Study|Lack of Compliance|1
7152790|NCT03265119|11317863|FG001|Overall Study|Lack of Compliance|0
7152791|NCT03265132|11317871|FG000|Overall Study|Adverse Event|0
7152792|NCT03265132|11317872|FG001|Overall Study|Adverse Event|1
7152793|NCT03265132|11317871|FG000|Overall Study|Lack of Efficacy|0
7152794|NCT03265132|11317872|FG001|Overall Study|Lack of Efficacy|2
7152795|NCT03265132|11317871|FG000|Overall Study|Progressive disease|0
7152796|NCT03265132|11317872|FG001|Overall Study|Progressive disease|2
7152797|NCT03265132|11317871|FG000|Overall Study|Withdrawal by Subject|0
7152798|NCT03265132|11317872|FG001|Overall Study|Withdrawal by Subject|1
7152799|NCT03265600|11317882|FG000|Overall Study|Lost to Follow-up|17
7152800|NCT03265600|11317883|FG001|Overall Study|Lost to Follow-up|5
7152801|NCT03265600|11317882|FG000|Overall Study|Withdrawal by Subject|4
7152802|NCT03265600|11317883|FG001|Overall Study|Withdrawal by Subject|2
7152803|NCT03265600|11317882|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3
7152804|NCT03265600|11317883|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5
7152805|NCT03265938|11317889|FG000|Overall Study|Withdrawal by Subject|1
7152806|NCT03265938|11317889|FG000|Overall Study|Physician Decision|1
7152807|NCT03265938|11317889|FG000|Overall Study|friable mass|6
7152808|NCT03266094|11317894|FG000|Overall Study|Lost to Follow-up|1
7152809|NCT03266094|11317894|FG000|Overall Study|Withdrawal by Subject|1
7152810|NCT03266107|11317900|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1
7152811|NCT03266107|11317900|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2
7152812|NCT03266107|11317900|FG000|3-Month Follow-up Visit|Lost to Follow-up|1
7152813|NCT03266107|11317900|FG000|12-Month Follow-up Visit|Lost to Follow-up|1
7152814|NCT03266172|11317909|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1
7152815|NCT03266172|11317910|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0
7152816|NCT03266172|11317911|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0
7152817|NCT03266172|11317909|FG000|Part A: Washout Period (7 Days)|Adverse Event|1
7152818|NCT03266172|11317910|FG001|Part A: Washout Period (7 Days)|Adverse Event|0
7152819|NCT03266172|11317911|FG002|Part A: Washout Period (7 Days)|Adverse Event|0
7152820|NCT03266172|11317909|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1
7152821|NCT03266172|11317910|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0
7152822|NCT03266172|11317911|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0
7152823|NCT03266172|11317909|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0
7152824|NCT03266172|11317910|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2
7152825|NCT03266172|11317911|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0
7152826|NCT03266172|11317909|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0
7152827|NCT03266172|11317910|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0
7152828|NCT03266172|11317911|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1
7152829|NCT03266172|11317909|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0
7152830|NCT03266172|11317910|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0
7152831|NCT03266172|11317911|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1
7152832|NCT03266588|11317973|FG000|Observational Period|Screen Failure: Eligibility Criteria|439
7152833|NCT03266588|11317974|FG001|Observational Period|Screen Failure: Eligibility Criteria|228
7152834|NCT03266588|11317975|FG002|Observational Period|Screen Failure: Eligibility Criteria|140
7152835|NCT03266588|11317973|FG000|Observational Period|Withdrawal by Subject|44
7152836|NCT03266588|11317974|FG001|Observational Period|Withdrawal by Subject|22
7152837|NCT03266588|11317975|FG002|Observational Period|Withdrawal by Subject|13
7152838|NCT03266588|11317973|FG000|Observational Period|Non-compliance|18
7152839|NCT03266588|11317974|FG001|Observational Period|Non-compliance|12
7152840|NCT03266588|11317975|FG002|Observational Period|Non-compliance|10
7152841|NCT03266588|11317973|FG000|Observational Period|Lost to Follow-up|8
7152842|NCT03266588|11317974|FG001|Observational Period|Lost to Follow-up|12
7152843|NCT03266588|11317975|FG002|Observational Period|Lost to Follow-up|4
7152844|NCT03266588|11317973|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3
7152845|NCT03266588|11317974|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1
7152846|NCT03266588|11317975|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0
7152847|NCT03266588|11317973|FG000|Observational Period|Protocol Deviation|1
7152848|NCT03266588|11317974|FG001|Observational Period|Protocol Deviation|0
7152849|NCT03266588|11317975|FG002|Observational Period|Protocol Deviation|0
7152850|NCT03266588|11317973|FG000|Observational Period|Other Reasons|3
7152851|NCT03266588|11317974|FG001|Observational Period|Other Reasons|0
7152852|NCT03266588|11317975|FG002|Observational Period|Other Reasons|1
7152853|NCT03266588|11317973|FG000|Long-term Treatment Period|Adverse Event|33
7152854|NCT03266588|11317974|FG001|Long-term Treatment Period|Adverse Event|17
7152855|NCT03266588|11317975|FG002|Long-term Treatment Period|Adverse Event|8
7152856|NCT03266588|11317973|FG000|Long-term Treatment Period|Lack of Efficacy|41
7152857|NCT03266588|11317974|FG001|Long-term Treatment Period|Lack of Efficacy|31
7152858|NCT03266588|11317975|FG002|Long-term Treatment Period|Lack of Efficacy|5
7152859|NCT03266588|11317973|FG000|Long-term Treatment Period|Lost to Follow-up|39
7152860|NCT03266588|11317974|FG001|Long-term Treatment Period|Lost to Follow-up|37
7152861|NCT03266588|11317975|FG002|Long-term Treatment Period|Lost to Follow-up|8
7152862|NCT03266588|11317973|FG000|Long-term Treatment Period|Non-Compliance|126
7152863|NCT03266588|11317974|FG001|Long-term Treatment Period|Non-Compliance|57
7152864|NCT03266588|11317975|FG002|Long-term Treatment Period|Non-Compliance|7
7152865|NCT03266588|11317973|FG000|Long-term Treatment Period|Pregnancy|11
7152866|NCT03266588|11317974|FG001|Long-term Treatment Period|Pregnancy|5
7152867|NCT03266588|11317975|FG002|Long-term Treatment Period|Pregnancy|0
7152868|NCT03266588|11317973|FG000|Long-term Treatment Period|Protocol Deviation|17
7152869|NCT03266588|11317974|FG001|Long-term Treatment Period|Protocol Deviation|10
7152870|NCT03266588|11317975|FG002|Long-term Treatment Period|Protocol Deviation|4
7152871|NCT03266588|11317973|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33
7152872|NCT03266588|11317974|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17
7152873|NCT03266588|11317975|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17
7152874|NCT03266588|11317973|FG000|Long-term Treatment Period|Withdrawal by Subject|100
7152875|NCT03266588|11317974|FG001|Long-term Treatment Period|Withdrawal by Subject|63
7152876|NCT03266588|11317975|FG002|Long-term Treatment Period|Withdrawal by Subject|16
7152877|NCT03266588|11317973|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1
7152878|NCT03266588|11317974|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2
7152879|NCT03266588|11317975|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0
7152880|NCT03266588|11317973|FG000|Long-term Treatment Period|Other Reasons|5
7152881|NCT03266588|11317974|FG001|Long-term Treatment Period|Other Reasons|0
7152882|NCT03266588|11317975|FG002|Long-term Treatment Period|Other Reasons|0
7152883|NCT03266588|11317973|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0
7152884|NCT03266588|11317974|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1
7152885|NCT03266588|11317975|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0
6857682|NCT00394472|10866820|FG001|Overall Study|Lost to Follow-up|1
6857683|NCT00394524|10866828|FG000|Overall Study|Protocol Violation|2
6857684|NCT00394524|10866829|FG001|Overall Study|Protocol Violation|3
6857685|NCT00394524|10866828|FG000|Overall Study|Death|1
6857686|NCT00394524|10866829|FG001|Overall Study|Death|0
6857687|NCT00394524|10866828|FG000|Overall Study|Withdrawal by Subject|0
6857688|NCT00394524|10866829|FG001|Overall Study|Withdrawal by Subject|1
6857689|NCT00394589|10866840|FG000|Overall Study|Adverse Event|2
6857690|NCT00394589|10866841|FG001|Overall Study|Adverse Event|1
6857691|NCT00394589|10866842|FG002|Overall Study|Adverse Event|2
6857692|NCT00394589|10866840|FG000|Overall Study|Lack of Efficacy|2
6857693|NCT00394589|10866841|FG001|Overall Study|Lack of Efficacy|2
6857694|NCT00394589|10866842|FG002|Overall Study|Lack of Efficacy|3
6857695|NCT00394589|10866840|FG000|Overall Study|Protocol Violation|4
6857696|NCT00394589|10866841|FG001|Overall Study|Protocol Violation|0
6857697|NCT00394589|10866842|FG002|Overall Study|Protocol Violation|2
6857698|NCT00394654|10866852|FG000|Overall Study|Lost to Follow-up|1
6857699|NCT00394654|10866853|FG001|Overall Study|Lost to Follow-up|0
6857700|NCT00394654|10866852|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1
6857701|NCT00394654|10866853|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0
6857702|NCT00394706|10866867|FG000|Overall Study|Withdrawal by Subject|2
6857703|NCT00394706|10866868|FG001|Overall Study|Withdrawal by Subject|0
6857704|NCT00394706|10866869|FG002|Overall Study|Withdrawal by Subject|1
6857705|NCT00394706|10866870|FG003|Overall Study|Withdrawal by Subject|0
6857706|NCT00394706|10866871|FG004|Overall Study|Withdrawal by Subject|0
6857707|NCT00394706|10866872|FG005|Overall Study|Withdrawal by Subject|2
6857708|NCT00394706|10866873|FG006|Overall Study|Withdrawal by Subject|1
6857709|NCT00394706|10866874|FG007|Overall Study|Withdrawal by Subject|0
6857710|NCT00394706|10866867|FG000|Overall Study|Lost to Follow-up|2
6857711|NCT00394706|10866868|FG001|Overall Study|Lost to Follow-up|2
6857712|NCT00394706|10866869|FG002|Overall Study|Lost to Follow-up|8
6857713|NCT00394706|10866870|FG003|Overall Study|Lost to Follow-up|1
6857714|NCT00394706|10866871|FG004|Overall Study|Lost to Follow-up|2
6857715|NCT00394706|10866872|FG005|Overall Study|Lost to Follow-up|5
6857716|NCT00394706|10866873|FG006|Overall Study|Lost to Follow-up|2
6857717|NCT00394706|10866874|FG007|Overall Study|Lost to Follow-up|0
6857718|NCT00394771|10866892|FG000|Overall Study|Did not meet protocol requirements|1
6857719|NCT00394771|10866893|FG001|Overall Study|Did not meet protocol requirements|0
6857720|NCT00394771|10866894|FG002|Overall Study|Did not meet protocol requirements|2
6857721|NCT00394771|10866895|FG003|Overall Study|Did not meet protocol requirements|0
6857722|NCT00394771|10866892|FG000|Overall Study|Protocol Violation|2
6857723|NCT00394771|10866893|FG001|Overall Study|Protocol Violation|4
6857724|NCT00394771|10866894|FG002|Overall Study|Protocol Violation|9
6857725|NCT00394771|10866895|FG003|Overall Study|Protocol Violation|7
6857726|NCT00394771|10866892|FG000|Overall Study|Withdrawal by Subject|10
6857727|NCT00394771|10866893|FG001|Overall Study|Withdrawal by Subject|6
6857728|NCT00394771|10866894|FG002|Overall Study|Withdrawal by Subject|8
6857729|NCT00394771|10866895|FG003|Overall Study|Withdrawal by Subject|12
6857730|NCT00394771|10866892|FG000|Overall Study|Adverse Event|10
6857731|NCT00394771|10866893|FG001|Overall Study|Adverse Event|5
6857732|NCT00394771|10866894|FG002|Overall Study|Adverse Event|12
6857733|NCT00394771|10866895|FG003|Overall Study|Adverse Event|8
6857734|NCT00394771|10866892|FG000|Overall Study|Participant pregnant|0
6857735|NCT00394771|10866893|FG001|Overall Study|Participant pregnant|1
6857736|NCT00394771|10866894|FG002|Overall Study|Participant pregnant|2
6857737|NCT00394771|10866895|FG003|Overall Study|Participant pregnant|2
7152886|NCT03267212|11317983|FG000|First Intervention|Lost to Follow-up|0
6857738|NCT00394771|10866892|FG000|Overall Study|Lost to Follow-up|15
6857739|NCT00394771|10866893|FG001|Overall Study|Lost to Follow-up|15
6857740|NCT00394771|10866894|FG002|Overall Study|Lost to Follow-up|13
6857741|NCT00394771|10866895|FG003|Overall Study|Lost to Follow-up|10
6857742|NCT00394771|10866892|FG000|Overall Study|Other|3
6857743|NCT00394771|10866893|FG001|Overall Study|Other|3
6857744|NCT00394771|10866894|FG002|Overall Study|Other|1
6857745|NCT00394771|10866895|FG003|Overall Study|Other|0
6857746|NCT00394836|10866907|FG000|Teatment or Follow-up Phase|Adverse Event|0
6857747|NCT00394836|10866908|FG001|Teatment or Follow-up Phase|Adverse Event|2
6857748|NCT00394836|10866907|FG000|Teatment or Follow-up Phase|Protocol Violation|0
6857749|NCT00394836|10866908|FG001|Teatment or Follow-up Phase|Protocol Violation|2
6857750|NCT00394836|10866907|FG000|Teatment or Follow-up Phase|Disease Progression|27
6857751|NCT00394836|10866908|FG001|Teatment or Follow-up Phase|Disease Progression|60
6857752|NCT00394836|10866907|FG000|Teatment or Follow-up Phase|Patient Refusal|1
6857753|NCT00394836|10866908|FG001|Teatment or Follow-up Phase|Patient Refusal|2
6857754|NCT00394836|10866907|FG000|Teatment or Follow-up Phase|Death|0
6857755|NCT00394836|10866908|FG001|Teatment or Follow-up Phase|Death|1
6857756|NCT00394836|10866907|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0
6857757|NCT00394836|10866908|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1
6857758|NCT00394836|10866907|FG000|Teatment or Follow-up Phase|Started alternative treatment|0
6857759|NCT00394836|10866908|FG001|Teatment or Follow-up Phase|Started alternative treatment|6
6857760|NCT00394836|10866907|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0
6857761|NCT00394836|10866908|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1
6857762|NCT00394836|10866907|FG000|Teatment or Follow-up Phase|Physician Decision|0
6857763|NCT00394836|10866908|FG001|Teatment or Follow-up Phase|Physician Decision|1
6857764|NCT00394836|10866907|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0
6857765|NCT00394836|10866908|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1
6857766|NCT00394836|10866907|FG000|Teatment or Follow-up Phase|Non compliance|0
6857767|NCT00394836|10866908|FG001|Teatment or Follow-up Phase|Non compliance|1
6857768|NCT00394836|10866907|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0
6857769|NCT00394836|10866908|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1
6857770|NCT00394836|10866907|FG000|Extended Follow-up Phase (2-5 Years)|Death|0
6857771|NCT00394836|10866908|FG001|Extended Follow-up Phase (2-5 Years)|Death|1
6857772|NCT00394836|10866907|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13
6857773|NCT00394836|10866908|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41
6857774|NCT00394836|10866907|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7
6857775|NCT00394836|10866908|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10
6857776|NCT00394901|10866931|FG000|Baseline Phase|Protocol Violation|0
6857777|NCT00394901|10866932|FG001|Baseline Phase|Protocol Violation|0
6857778|NCT00394901|10866933|FG002|Baseline Phase|Protocol Violation|1
6857779|NCT00394901|10866934|FG003|Baseline Phase|Protocol Violation|0
6857780|NCT00394901|10866931|FG000|Double-blind Phase|Adverse Event|5
6857781|NCT00394901|10866932|FG001|Double-blind Phase|Adverse Event|7
6857782|NCT00394901|10866933|FG002|Double-blind Phase|Adverse Event|16
6857783|NCT00394901|10866934|FG003|Double-blind Phase|Adverse Event|20
6857784|NCT00394901|10866931|FG000|Double-blind Phase|Lack of Efficacy|6
6857785|NCT00394901|10866932|FG001|Double-blind Phase|Lack of Efficacy|4
6857786|NCT00394901|10866933|FG002|Double-blind Phase|Lack of Efficacy|1
6857787|NCT00394901|10866934|FG003|Double-blind Phase|Lack of Efficacy|3
6857788|NCT00394901|10866931|FG000|Double-blind Phase|Withdrawal by Subject|2
6857789|NCT00394901|10866932|FG001|Double-blind Phase|Withdrawal by Subject|0
6857790|NCT00394901|10866933|FG002|Double-blind Phase|Withdrawal by Subject|0
6857791|NCT00394901|10866934|FG003|Double-blind Phase|Withdrawal by Subject|0
6857792|NCT00394901|10866931|FG000|Double-blind Phase|Lost to Follow-up|0
6857793|NCT00394901|10866932|FG001|Double-blind Phase|Lost to Follow-up|0
6857794|NCT00394901|10866933|FG002|Double-blind Phase|Lost to Follow-up|0
6857795|NCT00394901|10866934|FG003|Double-blind Phase|Lost to Follow-up|1
6857796|NCT00394901|10866931|FG000|Double-blind Phase|Protocol Violation|0
6857797|NCT00394901|10866932|FG001|Double-blind Phase|Protocol Violation|0
6857798|NCT00394901|10866933|FG002|Double-blind Phase|Protocol Violation|0
6857799|NCT00394901|10866934|FG003|Double-blind Phase|Protocol Violation|1
6857800|NCT00394901|10866931|FG000|Double-blind Phase|Death|1
6857801|NCT00394901|10866932|FG001|Double-blind Phase|Death|0
6857802|NCT00394901|10866933|FG002|Double-blind Phase|Death|0
6857803|NCT00394901|10866934|FG003|Double-blind Phase|Death|0
6857804|NCT00394901|10866931|FG000|Double-blind Phase|Subject's Personal Reason|1
6857805|NCT00394901|10866932|FG001|Double-blind Phase|Subject's Personal Reason|0
6857806|NCT00394901|10866933|FG002|Double-blind Phase|Subject's Personal Reason|0
6857807|NCT00394901|10866934|FG003|Double-blind Phase|Subject's Personal Reason|1
6857808|NCT00394901|10866931|FG000|Double-blind Phase|Lack of Compliance|0
6857809|NCT00394901|10866932|FG001|Double-blind Phase|Lack of Compliance|3
6857810|NCT00394901|10866933|FG002|Double-blind Phase|Lack of Compliance|0
6857811|NCT00394901|10866934|FG003|Double-blind Phase|Lack of Compliance|0
6857812|NCT00394901|10866931|FG000|Double-blind Phase|Entry into another study was found|0
6857813|NCT00394901|10866932|FG001|Double-blind Phase|Entry into another study was found|0
6857814|NCT00394901|10866933|FG002|Double-blind Phase|Entry into another study was found|1
6857815|NCT00394901|10866934|FG003|Double-blind Phase|Entry into another study was found|0
6857816|NCT00394901|10866931|FG000|Double-blind Phase|Found not to meet entrance criteria|0
6857817|NCT00394901|10866932|FG001|Double-blind Phase|Found not to meet entrance criteria|0
6857818|NCT00394901|10866933|FG002|Double-blind Phase|Found not to meet entrance criteria|0
6857819|NCT00394901|10866934|FG003|Double-blind Phase|Found not to meet entrance criteria|1
6857820|NCT00394914|10866949|FG000|Treatment Period|Adverse Event|0
6857821|NCT00394914|10866950|FG001|Treatment Period|Adverse Event|3
6857822|NCT00394914|10866951|FG002|Treatment Period|Adverse Event|1
7152887|NCT03267212|11317984|FG001|First Intervention|Lost to Follow-up|2
6857823|NCT00394914|10866949|FG000|Treatment Period|Lost to Follow-up|0
6857824|NCT00394914|10866950|FG001|Treatment Period|Lost to Follow-up|1
6857825|NCT00394914|10866951|FG002|Treatment Period|Lost to Follow-up|0
6857826|NCT00394914|10866949|FG000|Treatment Period|Withdrawal by Subject|0
6857827|NCT00394914|10866950|FG001|Treatment Period|Withdrawal by Subject|2
6857828|NCT00394914|10866951|FG002|Treatment Period|Withdrawal by Subject|2
6857829|NCT00394914|10866949|FG000|Treatment Period|Noncompliance with protocol|0
6857830|NCT00394914|10866950|FG001|Treatment Period|Noncompliance with protocol|3
6857831|NCT00394914|10866951|FG002|Treatment Period|Noncompliance with protocol|2
6857832|NCT00394914|10866949|FG000|Treatment Period|Did not meet protocol eligibility|0
6857833|NCT00394914|10866950|FG001|Treatment Period|Did not meet protocol eligibility|1
6857834|NCT00394914|10866951|FG002|Treatment Period|Did not meet protocol eligibility|1
6857835|NCT00394953|10866959|FG000|First Treatment Period|Adverse Event|1
6857836|NCT00394953|10866960|FG001|First Treatment Period|Adverse Event|2
6857837|NCT00394953|10866959|FG000|First Treatment Period|Death|6
6857838|NCT00394953|10866960|FG001|First Treatment Period|Death|7
6857839|NCT00394953|10866959|FG000|First Treatment Period|Lack of Efficacy|1
6857840|NCT00394953|10866960|FG001|First Treatment Period|Lack of Efficacy|1
6857841|NCT00394953|10866959|FG000|First Treatment Period|Withdrawal by Subject|6
6857842|NCT00394953|10866960|FG001|First Treatment Period|Withdrawal by Subject|3
6857843|NCT00394953|10866959|FG000|First Treatment Period|Lost to Follow-up|0
6857844|NCT00394953|10866960|FG001|First Treatment Period|Lost to Follow-up|1
6857845|NCT00394953|10866959|FG000|First Treatment Period|Renal transplant|11
6857846|NCT00394953|10866960|FG001|First Treatment Period|Renal transplant|7
6857847|NCT00394953|10866959|FG000|First Treatment Period|Not defined|4
6857848|NCT00394953|10866960|FG001|First Treatment Period|Not defined|1
6857849|NCT00394953|10866959|FG000|Second Treatment Period|Adverse Event|2
6857850|NCT00394953|10866960|FG001|Second Treatment Period|Adverse Event|5
6857851|NCT00394953|10866959|FG000|Second Treatment Period|Death|8
6857852|NCT00394953|10866960|FG001|Second Treatment Period|Death|4
6857853|NCT00394953|10866959|FG000|Second Treatment Period|Lack of Efficacy|9
6857854|NCT00394953|10866960|FG001|Second Treatment Period|Lack of Efficacy|47
6857855|NCT00394953|10866959|FG000|Second Treatment Period|Withdrawal by Subject|3
6857856|NCT00394953|10866960|FG001|Second Treatment Period|Withdrawal by Subject|3
6857857|NCT00394953|10866959|FG000|Second Treatment Period|Lost to Follow-up|0
6857858|NCT00394953|10866960|FG001|Second Treatment Period|Lost to Follow-up|1
6857859|NCT00394953|10866959|FG000|Second Treatment Period|Renal transplant|4
6857860|NCT00394953|10866960|FG001|Second Treatment Period|Renal transplant|6
6857861|NCT00394953|10866959|FG000|Second Treatment Period|Not defined|3
6857862|NCT00394953|10866960|FG001|Second Treatment Period|Not defined|8
6857863|NCT00395018|10866966|FG000|On-Treatment|Death|4
6857864|NCT00395018|10866966|FG000|On-Treatment|Other Reason|2
6857865|NCT00395018|10866966|FG000|On-Treatment|Poor/non-compliance|2
6857866|NCT00395018|10866966|FG000|On-Treatment|Subject no longer meets study criteria|2
6857867|NCT00395018|10866966|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1
6857868|NCT00395018|10866966|FG000|Off-Treatment Follow-up|Lost to Follow-up|2
6857869|NCT00395018|10866966|FG000|Off-Treatment Follow-up|Poor/non-compliance|1
6857870|NCT00395083|10866998|FG000|Overall Study|Withdrawal by Subject|6
6857871|NCT00395083|10866999|FG001|Overall Study|Withdrawal by Subject|5
6857872|NCT00395083|10866998|FG000|Overall Study|Developed another disease|4
6857873|NCT00395083|10866999|FG001|Overall Study|Developed another disease|3
6857874|NCT00395226|10867038|FG000|Overall Study|Adverse Event|4
6857875|NCT00395226|10867039|FG001|Overall Study|Adverse Event|3
6857876|NCT00395226|10867038|FG000|Overall Study|Withdrawal by Subject|0
6857877|NCT00395226|10867039|FG001|Overall Study|Withdrawal by Subject|1
6857878|NCT00395226|10867038|FG000|Overall Study|Lost to Follow-up|0
6857879|NCT00395226|10867039|FG001|Overall Study|Lost to Follow-up|1
6857880|NCT00395304|10867052|FG000|Treatment Period 1|Withdrawal by Subject|0
6857881|NCT00395304|10867053|FG001|Treatment Period 1|Withdrawal by Subject|3
6857882|NCT00395304|10867054|FG002|Treatment Period 1|Withdrawal by Subject|0
6857883|NCT00395304|10867055|FG003|Treatment Period 1|Withdrawal by Subject|2
6857884|NCT00395304|10867056|FG004|Treatment Period 1|Withdrawal by Subject|1
6857885|NCT00395304|10867057|FG005|Treatment Period 1|Withdrawal by Subject|1
6857886|NCT00395304|10867052|FG000|Treatment Period 1|Lost to Follow-up|1
6857887|NCT00395304|10867053|FG001|Treatment Period 1|Lost to Follow-up|0
6857888|NCT00395304|10867054|FG002|Treatment Period 1|Lost to Follow-up|0
6857889|NCT00395304|10867055|FG003|Treatment Period 1|Lost to Follow-up|1
6857890|NCT00395304|10867056|FG004|Treatment Period 1|Lost to Follow-up|0
6857891|NCT00395304|10867057|FG005|Treatment Period 1|Lost to Follow-up|1
6857892|NCT00395304|10867052|FG000|Treatment Period 1|Physician Decision|0
6857893|NCT00395304|10867053|FG001|Treatment Period 1|Physician Decision|1
7152888|NCT03267212|11317983|FG000|First Intervention|Withdrawal by Subject|1
6857894|NCT00395304|10867054|FG002|Treatment Period 1|Physician Decision|0
6857895|NCT00395304|10867055|FG003|Treatment Period 1|Physician Decision|0
6857896|NCT00395304|10867056|FG004|Treatment Period 1|Physician Decision|0
6857897|NCT00395304|10867057|FG005|Treatment Period 1|Physician Decision|0
6857898|NCT00395304|10867052|FG000|Treatment Period 2|Withdrawal by Subject|0
6857899|NCT00395304|10867053|FG001|Treatment Period 2|Withdrawal by Subject|0
6857900|NCT00395304|10867054|FG002|Treatment Period 2|Withdrawal by Subject|0
6857901|NCT00395304|10867055|FG003|Treatment Period 2|Withdrawal by Subject|1
6857902|NCT00395304|10867056|FG004|Treatment Period 2|Withdrawal by Subject|0
6857903|NCT00395304|10867057|FG005|Treatment Period 2|Withdrawal by Subject|2
6857904|NCT00395304|10867052|FG000|Treatment Period 2|Lost to Follow-up|0
6857905|NCT00395304|10867053|FG001|Treatment Period 2|Lost to Follow-up|3
6857906|NCT00395304|10867054|FG002|Treatment Period 2|Lost to Follow-up|0
6857907|NCT00395304|10867055|FG003|Treatment Period 2|Lost to Follow-up|0
6857908|NCT00395304|10867056|FG004|Treatment Period 2|Lost to Follow-up|0
6857909|NCT00395304|10867057|FG005|Treatment Period 2|Lost to Follow-up|0
6857910|NCT00395304|10867052|FG000|Treatment Period 2|Physician Decision|0
6857911|NCT00395304|10867053|FG001|Treatment Period 2|Physician Decision|0
6857912|NCT00395304|10867054|FG002|Treatment Period 2|Physician Decision|1
6857913|NCT00395304|10867055|FG003|Treatment Period 2|Physician Decision|0
6857914|NCT00395304|10867056|FG004|Treatment Period 2|Physician Decision|0
6857915|NCT00395304|10867057|FG005|Treatment Period 2|Physician Decision|0
6857916|NCT00395304|10867052|FG000|Treatment Period 2|Other|0
6857917|NCT00395304|10867053|FG001|Treatment Period 2|Other|1
6857918|NCT00395304|10867054|FG002|Treatment Period 2|Other|0
6857919|NCT00395304|10867055|FG003|Treatment Period 2|Other|0
6857920|NCT00395304|10867056|FG004|Treatment Period 2|Other|0
6857921|NCT00395304|10867057|FG005|Treatment Period 2|Other|0
6857922|NCT00395304|10867052|FG000|Treatment Period 3|Withdrawal by Subject|0
6857923|NCT00395304|10867053|FG001|Treatment Period 3|Withdrawal by Subject|0
6857924|NCT00395304|10867054|FG002|Treatment Period 3|Withdrawal by Subject|0
7152889|NCT03267212|11317984|FG001|First Intervention|Withdrawal by Subject|1
7152890|NCT03267212|11317983|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1
6857925|NCT00395304|10867055|FG003|Treatment Period 3|Withdrawal by Subject|1
6857926|NCT00395304|10867056|FG004|Treatment Period 3|Withdrawal by Subject|0
6857927|NCT00395304|10867057|FG005|Treatment Period 3|Withdrawal by Subject|1
6857928|NCT00395304|10867052|FG000|Treatment Period 3|Lost to Follow-up|1
6857929|NCT00395304|10867053|FG001|Treatment Period 3|Lost to Follow-up|1
6857930|NCT00395304|10867054|FG002|Treatment Period 3|Lost to Follow-up|0
6857931|NCT00395304|10867055|FG003|Treatment Period 3|Lost to Follow-up|0
6857932|NCT00395304|10867056|FG004|Treatment Period 3|Lost to Follow-up|0
6857933|NCT00395304|10867057|FG005|Treatment Period 3|Lost to Follow-up|0
6857934|NCT00395304|10867052|FG000|Treatment Period 3|Physician Decision|0
6857935|NCT00395304|10867053|FG001|Treatment Period 3|Physician Decision|1
6857936|NCT00395304|10867054|FG002|Treatment Period 3|Physician Decision|0
6857937|NCT00395304|10867055|FG003|Treatment Period 3|Physician Decision|0
6857938|NCT00395304|10867056|FG004|Treatment Period 3|Physician Decision|0
6857939|NCT00395304|10867057|FG005|Treatment Period 3|Physician Decision|0
6857940|NCT00395304|10867052|FG000|Treatment Period 3|Other|0
6857941|NCT00395304|10867053|FG001|Treatment Period 3|Other|0
6857942|NCT00395304|10867054|FG002|Treatment Period 3|Other|0
6857943|NCT00395304|10867055|FG003|Treatment Period 3|Other|1
6857944|NCT00395304|10867056|FG004|Treatment Period 3|Other|0
6857945|NCT00395304|10867057|FG005|Treatment Period 3|Other|0
6857946|NCT00395343|10867066|FG000|Overall Study|Adverse Event|13
6857947|NCT00395343|10867067|FG001|Overall Study|Adverse Event|5
6857948|NCT00395343|10867066|FG000|Overall Study|Lack of Efficacy|0
6857949|NCT00395343|10867067|FG001|Overall Study|Lack of Efficacy|1
6857950|NCT00395343|10867066|FG000|Overall Study|Lost to Follow-up|4
6857951|NCT00395343|10867067|FG001|Overall Study|Lost to Follow-up|4
6857952|NCT00395343|10867066|FG000|Overall Study|Physician Decision|2
6857953|NCT00395343|10867067|FG001|Overall Study|Physician Decision|4
6857954|NCT00395343|10867066|FG000|Overall Study|Protocol Violation|6
6857955|NCT00395343|10867067|FG001|Overall Study|Protocol Violation|8
6857956|NCT00395343|10867066|FG000|Overall Study|Withdrawal by Subject|11
6857957|NCT00395343|10867067|FG001|Overall Study|Withdrawal by Subject|12
6857958|NCT00395343|10867066|FG000|Overall Study|Other|5
6857959|NCT00395343|10867067|FG001|Overall Study|Other|2
6857960|NCT00395447|10867075|FG000|Overall Study|Death|37
6857961|NCT00395447|10867076|FG001|Overall Study|Death|32
6857962|NCT00395447|10867075|FG000|Overall Study|Lost to Follow-up|52
6857963|NCT00395447|10867076|FG001|Overall Study|Lost to Follow-up|43
6857964|NCT00395447|10867075|FG000|Overall Study|Withdrawal by Subject|24
6857965|NCT00395447|10867076|FG001|Overall Study|Withdrawal by Subject|19
6857966|NCT00395447|10867075|FG000|Overall Study|Withdrawl - Other (not subject)|8
6857967|NCT00395447|10867076|FG001|Overall Study|Withdrawl - Other (not subject)|17
6857968|NCT00395460|10867084|FG000|Overall Study|Withdrawal by Subject|1
6857969|NCT00395460|10867085|FG001|Overall Study|Withdrawal by Subject|0
6857970|NCT00395486|10867093|FG000|Overall Study|Adverse Event|1
6857971|NCT00395486|10867094|FG001|Overall Study|Adverse Event|2
6857972|NCT00395486|10867093|FG000|Overall Study|Withdrawal by Subject|5
6857973|NCT00395486|10867094|FG001|Overall Study|Withdrawal by Subject|2
6857974|NCT00395486|10867093|FG000|Overall Study|Lost to Follow-up|0
6857975|NCT00395486|10867094|FG001|Overall Study|Lost to Follow-up|1
6857976|NCT00395512|10867104|FG000|Overall Study|Adverse Event|3
6857977|NCT00395512|10867105|FG001|Overall Study|Adverse Event|8
6857978|NCT00395512|10867106|FG002|Overall Study|Adverse Event|6
6857979|NCT00395512|10867107|FG003|Overall Study|Adverse Event|6
6857980|NCT00395512|10867104|FG000|Overall Study|Protocol Violation|2
6857981|NCT00395512|10867105|FG001|Overall Study|Protocol Violation|3
6857982|NCT00395512|10867106|FG002|Overall Study|Protocol Violation|6
6857983|NCT00395512|10867107|FG003|Overall Study|Protocol Violation|7
6857984|NCT00395512|10867104|FG000|Overall Study|Lost to Follow-up|2
6857985|NCT00395512|10867105|FG001|Overall Study|Lost to Follow-up|6
6857986|NCT00395512|10867106|FG002|Overall Study|Lost to Follow-up|5
6857987|NCT00395512|10867107|FG003|Overall Study|Lost to Follow-up|5
6857988|NCT00395512|10867104|FG000|Overall Study|Withdrawal by Subject|6
6857989|NCT00395512|10867105|FG001|Overall Study|Withdrawal by Subject|5
6857990|NCT00395512|10867106|FG002|Overall Study|Withdrawal by Subject|5
6857991|NCT00395512|10867107|FG003|Overall Study|Withdrawal by Subject|12
6857992|NCT00395512|10867104|FG000|Overall Study|Physician Decision|6
6857993|NCT00395512|10867105|FG001|Overall Study|Physician Decision|4
6857994|NCT00395512|10867106|FG002|Overall Study|Physician Decision|2
6857995|NCT00395512|10867107|FG003|Overall Study|Physician Decision|2
6857996|NCT00395512|10867104|FG000|Overall Study|Other|1
6857997|NCT00395512|10867105|FG001|Overall Study|Other|1
6857998|NCT00395512|10867106|FG002|Overall Study|Other|0
6857999|NCT00395512|10867107|FG003|Overall Study|Other|0
6858000|NCT00395512|10867104|FG000|Overall Study|Hyperglycemic Rescue|18
6858001|NCT00395512|10867105|FG001|Overall Study|Hyperglycemic Rescue|10
6858002|NCT00395512|10867106|FG002|Overall Study|Hyperglycemic Rescue|4
6858003|NCT00395512|10867107|FG003|Overall Study|Hyperglycemic Rescue|6
6858004|NCT00395538|10867120|FG000|Overall Study|Did not re-consent to revised protocol|1
6858005|NCT00395538|10867121|FG001|Overall Study|Did not re-consent to revised protocol|10
6858006|NCT00395538|10867122|FG002|Overall Study|Did not re-consent to revised protocol|0
6858007|NCT00395538|10867120|FG000|Overall Study|FDA partial hold on PTH|0
6858008|NCT00395538|10867121|FG001|Overall Study|FDA partial hold on PTH|0
6858009|NCT00395538|10867122|FG002|Overall Study|FDA partial hold on PTH|11
6858010|NCT00395538|10867120|FG000|Overall Study|Failed screening|0
6858011|NCT00395538|10867121|FG001|Overall Study|Failed screening|0
6858012|NCT00395538|10867122|FG002|Overall Study|Failed screening|4
6858013|NCT00395538|10867120|FG000|Overall Study|Switch to Natpara|0
6858014|NCT00395538|10867121|FG001|Overall Study|Switch to Natpara|0
6858015|NCT00395538|10867122|FG002|Overall Study|Switch to Natpara|3
6858016|NCT00395538|10867120|FG000|Overall Study|Adverse Event|1
6858017|NCT00395538|10867121|FG001|Overall Study|Adverse Event|0
6858018|NCT00395538|10867122|FG002|Overall Study|Adverse Event|2
6858019|NCT00395538|10867120|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0
6858020|NCT00395538|10867121|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2
6858021|NCT00395538|10867122|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0
6858022|NCT00395538|10867120|FG000|Overall Study|Non-compliance with study protocol|0
6858023|NCT00395538|10867121|FG001|Overall Study|Non-compliance with study protocol|1
6858024|NCT00395538|10867122|FG002|Overall Study|Non-compliance with study protocol|0
6858025|NCT00395538|10867120|FG000|Overall Study|PTH resistance|0
6858026|NCT00395538|10867121|FG001|Overall Study|PTH resistance|0
6858027|NCT00395538|10867122|FG002|Overall Study|PTH resistance|1
6858028|NCT00395538|10867120|FG000|Overall Study|Pregnancy|1
6858029|NCT00395538|10867121|FG001|Overall Study|Pregnancy|0
6858030|NCT00395538|10867122|FG002|Overall Study|Pregnancy|0
6858031|NCT00395538|10867120|FG000|Overall Study|Partial recovery of parathyroid function|0
6858032|NCT00395538|10867121|FG001|Overall Study|Partial recovery of parathyroid function|0
6858033|NCT00395538|10867122|FG002|Overall Study|Partial recovery of parathyroid function|1
6858034|NCT00395538|10867120|FG000|Overall Study|Participant elected to discontinue|0
6858035|NCT00395538|10867121|FG001|Overall Study|Participant elected to discontinue|0
6858036|NCT00395538|10867122|FG002|Overall Study|Participant elected to discontinue|1
6858037|NCT00395629|10867133|FG000|Core Study|Adverse Event|0
6858038|NCT00395629|10867134|FG001|Core Study|Adverse Event|3
6858039|NCT00395629|10867135|FG002|Core Study|Adverse Event|4
6858040|NCT00395629|10867133|FG000|Core Study|Abnormal laboratory value(s)|0
6858041|NCT00395629|10867134|FG001|Core Study|Abnormal laboratory value(s)|0
6858042|NCT00395629|10867135|FG002|Core Study|Abnormal laboratory value(s)|1
6858043|NCT00395629|10867133|FG000|Core Study|Protocol Violation|1
6858044|NCT00395629|10867134|FG001|Core Study|Protocol Violation|0
6858045|NCT00395629|10867135|FG002|Core Study|Protocol Violation|0
6858046|NCT00395629|10867133|FG000|Core Study|Withdrawal by Subject|0
6858047|NCT00395629|10867134|FG001|Core Study|Withdrawal by Subject|1
6858048|NCT00395629|10867135|FG002|Core Study|Withdrawal by Subject|1
6858049|NCT00395629|10867133|FG000|Core Study|Lost to Follow-up|0
6858050|NCT00395629|10867134|FG001|Core Study|Lost to Follow-up|0
6858051|NCT00395629|10867135|FG002|Core Study|Lost to Follow-up|1
6858052|NCT00395629|10867133|FG000|Extension Study|Adverse Event|0
6858053|NCT00395629|10867134|FG001|Extension Study|Adverse Event|0
6858054|NCT00395629|10867135|FG002|Extension Study|Adverse Event|2
6858055|NCT00395629|10867133|FG000|Extension Study|Administrative problems|0
6858056|NCT00395629|10867134|FG001|Extension Study|Administrative problems|0
6858057|NCT00395629|10867135|FG002|Extension Study|Administrative problems|1
6858058|NCT00395642|10867146|FG000|Overall Study|Death|4
6858059|NCT00395642|10867146|FG000|Overall Study|Lost to Follow-up|1
6858060|NCT00395642|10867146|FG000|Overall Study|Physician Decision|7
6858061|NCT00395642|10867146|FG000|Overall Study|Withdrawal by Subject|1
6858062|NCT00395694|10867152|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1
6858063|NCT00395694|10867153|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2
6858064|NCT00395694|10867152|FG000|Continuation Phase|Adverse Event|1
6858065|NCT00395694|10867153|FG001|Continuation Phase|Adverse Event|0
6858066|NCT00395694|10867152|FG000|Continuation Phase|Lack of Efficacy|12
6858067|NCT00395694|10867153|FG001|Continuation Phase|Lack of Efficacy|11
6858068|NCT00395694|10867152|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1
6858069|NCT00395694|10867153|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0
6858070|NCT00395694|10867152|FG000|Continuation Phase|Poor Compliance|1
6858071|NCT00395694|10867153|FG001|Continuation Phase|Poor Compliance|0
6858072|NCT00395694|10867152|FG000|Continuation Phase|Withdrawal by Subject|0
6858073|NCT00395694|10867153|FG001|Continuation Phase|Withdrawal by Subject|2
6858074|NCT00395733|10867164|FG000|Period 2|Withdrawal by Subject|1
6858075|NCT00395733|10867165|FG001|Period 2|Withdrawal by Subject|2
6858076|NCT00395733|10867164|FG000|Period 2|Protocol Violation|0
6858077|NCT00395733|10867165|FG001|Period 2|Protocol Violation|1
6858078|NCT00395733|10867164|FG000|Period 2|Adverse Event|0
6858079|NCT00395733|10867165|FG001|Period 2|Adverse Event|2
6858080|NCT00395733|10867164|FG000|Period 2|Technical problems|1
6858081|NCT00395733|10867165|FG001|Period 2|Technical problems|0
6858082|NCT00395746|10867174|FG000|Overall Study|Adverse Event|5
6858083|NCT00395746|10867175|FG001|Overall Study|Adverse Event|2
6858084|NCT00395746|10867176|FG002|Overall Study|Adverse Event|2
6858085|NCT00395746|10867174|FG000|Overall Study|Protocol Violation|0
6858086|NCT00395746|10867175|FG001|Overall Study|Protocol Violation|1
6858087|NCT00395746|10867176|FG002|Overall Study|Protocol Violation|0
6858088|NCT00395746|10867174|FG000|Overall Study|Lack of Efficacy|2
6858089|NCT00395746|10867175|FG001|Overall Study|Lack of Efficacy|0
6858090|NCT00395746|10867176|FG002|Overall Study|Lack of Efficacy|17
6858091|NCT00395746|10867174|FG000|Overall Study|Hypoglycaemia|2
6858092|NCT00395746|10867175|FG001|Overall Study|Hypoglycaemia|1
6858093|NCT00395746|10867176|FG002|Overall Study|Hypoglycaemia|0
6858094|NCT00395746|10867174|FG000|Overall Study|Subject decision|0
6858095|NCT00395746|10867175|FG001|Overall Study|Subject decision|0
6858096|NCT00395746|10867176|FG002|Overall Study|Subject decision|1
6858097|NCT00395746|10867174|FG000|Overall Study|Withdrawal of consent|0
6858098|NCT00395746|10867175|FG001|Overall Study|Withdrawal of consent|0
6858099|NCT00395746|10867176|FG002|Overall Study|Withdrawal of consent|1
6858100|NCT00395746|10867174|FG000|Overall Study|Difficultulty in use of device|0
6858101|NCT00395746|10867175|FG001|Overall Study|Difficultulty in use of device|0
6858102|NCT00395746|10867176|FG002|Overall Study|Difficultulty in use of device|1
6858103|NCT00395746|10867174|FG000|Overall Study|Unable to visit site on schedule|1
6858104|NCT00395746|10867175|FG001|Overall Study|Unable to visit site on schedule|0
6858105|NCT00395746|10867176|FG002|Overall Study|Unable to visit site on schedule|0
6858106|NCT00395850|10867188|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6
6858107|NCT00395850|10867189|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
6858108|NCT00395850|10867190|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
6858109|NCT00395850|10867191|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
6858110|NCT00395850|10867188|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4
6858111|NCT00395850|10867189|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
6858112|NCT00395850|10867190|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
6858113|NCT00395850|10867191|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
6858114|NCT00395850|10867188|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1
6858115|NCT00395850|10867189|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0
6858116|NCT00395850|10867190|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0
6858117|NCT00395850|10867191|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0
6858118|NCT00395850|10867188|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
6858119|NCT00395850|10867189|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
6858120|NCT00395850|10867190|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6
6858121|NCT00395850|10867191|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4
6858122|NCT00395850|10867188|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1
6858123|NCT00395850|10867189|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
6858124|NCT00395850|10867190|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
6858125|NCT00395850|10867191|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
6858126|NCT00395850|10867188|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1
6858127|NCT00395850|10867189|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
6858128|NCT00395850|10867190|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
6858129|NCT00395850|10867191|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
6858130|NCT00395850|10867188|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1
6858131|NCT00395850|10867189|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
6858132|NCT00395850|10867190|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
6858133|NCT00395850|10867191|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
6858134|NCT00395863|10867203|FG000|Overall Study|Patients did not complete both exams|2
6858135|NCT00395863|10867204|FG001|Overall Study|Patients did not complete both exams|3
6858136|NCT00395967|10867222|FG000|Treatment Period|Failed Mobilization|1
6858137|NCT00395967|10867222|FG000|Follow-up Period|Death|1
6858138|NCT00395967|10867222|FG000|Follow-up Period|Lost to Follow-up|1
6858139|NCT00396084|10867269|FG000|Overall Study|Adverse Event|0
6858140|NCT00396084|10867270|FG001|Overall Study|Adverse Event|0
6858141|NCT00396084|10867271|FG002|Overall Study|Adverse Event|0
6858142|NCT00396084|10867272|FG003|Overall Study|Adverse Event|0
6858143|NCT00396084|10867273|FG004|Overall Study|Adverse Event|1
6858144|NCT00396084|10867274|FG005|Overall Study|Adverse Event|2
6858145|NCT00396084|10867269|FG000|Overall Study|Withdrawal by Subject|0
6858146|NCT00396084|10867270|FG001|Overall Study|Withdrawal by Subject|0
6858147|NCT00396084|10867271|FG002|Overall Study|Withdrawal by Subject|0
6858148|NCT00396084|10867272|FG003|Overall Study|Withdrawal by Subject|1
6858149|NCT00396084|10867273|FG004|Overall Study|Withdrawal by Subject|0
6858150|NCT00396084|10867274|FG005|Overall Study|Withdrawal by Subject|0
6858151|NCT00396097|10867294|FG000|Overall Study|Withdrawal by Subject|17
6858152|NCT00396097|10867295|FG001|Overall Study|Withdrawal by Subject|17
6858153|NCT00396097|10867294|FG000|Overall Study|Lost to Follow-up|4
6858154|NCT00396097|10867295|FG001|Overall Study|Lost to Follow-up|9
6858155|NCT00396097|10867294|FG000|Overall Study|Other|3
6858156|NCT00396097|10867295|FG001|Overall Study|Other|5
6858157|NCT00396097|10867294|FG000|Overall Study|Protocol Violation|0
6858158|NCT00396097|10867295|FG001|Overall Study|Protocol Violation|6
6858159|NCT00396097|10867294|FG000|Overall Study|Adverse Event|1
6858160|NCT00396097|10867295|FG001|Overall Study|Adverse Event|5
6858161|NCT00396097|10867294|FG000|Overall Study|Insufficient Clinical Response|1
6858162|NCT00396097|10867295|FG001|Overall Study|Insufficient Clinical Response|4
6858163|NCT00396136|10867305|FG000|Overall Study|Death|43
6858164|NCT00396136|10867305|FG000|Overall Study|Withdrawal by Subject|59
6858165|NCT00396136|10867305|FG000|Overall Study|Lost to Follow-up|15
6858166|NCT00396136|10867305|FG000|Overall Study|Study device explanted|8
6858167|NCT00396162|10867311|FG000|Overall Study|Withdrawal by Subject|2
6858168|NCT00396162|10867312|FG001|Overall Study|Withdrawal by Subject|3
6858169|NCT00396253|10867327|FG000|Overall Study|Protocol Violation|1
6858170|NCT00396253|10867327|FG000|Overall Study|Withdrawal by Subject|7
6858171|NCT00396253|10867327|FG000|Overall Study|Death|3
6858172|NCT00396253|10867327|FG000|Overall Study|Physician Decision|1
6858173|NCT00396253|10867327|FG000|Overall Study|Change in eligibility status|1
6858174|NCT00396279|10867344|FG000|Overall Study|Ongoing in study|26
6858175|NCT00396279|10867344|FG000|Overall Study|Disease progression|2
6858176|NCT00396279|10867344|FG000|Overall Study|Withdrawal by Subject|1
6858177|NCT00396279|10867344|FG000|Overall Study|Physician Decision|1
6858178|NCT00396318|10867357|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5
6858179|NCT00396331|10867365|FG000|Overall Study|Failed to mobilize - no transplant|8
6858180|NCT00396331|10867365|FG000|Overall Study|Did not go on to transplant|5
6858181|NCT00396331|10867365|FG000|Overall Study|Lost to Follow-up|3
6858182|NCT00396331|10867365|FG000|Overall Study|Death|16
6858183|NCT00396383|10867377|FG000|Overall Study|Death|2
6858184|NCT00396383|10867377|FG000|Overall Study|Lost to Follow-up|1
6858185|NCT00396409|10867383|FG000|Period 1 - 2007|Adverse Event|0
6858186|NCT00396409|10867384|FG001|Period 1 - 2007|Adverse Event|1
6858187|NCT00396409|10867383|FG000|Period 1 - 2007|Lack of Efficacy|0
6858188|NCT00396409|10867384|FG001|Period 1 - 2007|Lack of Efficacy|1
6858189|NCT00396409|10867383|FG000|Period 1 - 2007|Withdrawal by Subject|1
6858190|NCT00396409|10867384|FG001|Period 1 - 2007|Withdrawal by Subject|1
6858191|NCT00396409|10867383|FG000|Period 1 - 2007|Lost to Follow-up|2
6858192|NCT00396409|10867384|FG001|Period 1 - 2007|Lost to Follow-up|3
6858193|NCT00396409|10867383|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3
6858194|NCT00396409|10867384|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2
6858195|NCT00396409|10867383|FG000|Period 2 - 2008|Protocol Violation|1
6858196|NCT00396409|10867384|FG001|Period 2 - 2008|Protocol Violation|0
6858197|NCT00396409|10867383|FG000|Period 2 - 2008|Withdrawal by Subject|3
6858198|NCT00396409|10867384|FG001|Period 2 - 2008|Withdrawal by Subject|1
6858199|NCT00396409|10867383|FG000|Period 2 - 2008|Lost to Follow-up|3
6858200|NCT00396409|10867384|FG001|Period 2 - 2008|Lost to Follow-up|1
6858201|NCT00396565|10867395|FG000|Overall Study|Physician Decision|3
6858202|NCT00396565|10867396|FG001|Overall Study|Physician Decision|1
6858203|NCT00396565|10867397|FG002|Overall Study|Physician Decision|2
6858204|NCT00396565|10867395|FG000|Overall Study|Adverse Event|5
6858205|NCT00396565|10867396|FG001|Overall Study|Adverse Event|13
6858206|NCT00396565|10867397|FG002|Overall Study|Adverse Event|3
6858207|NCT00396565|10867395|FG000|Overall Study|Withdrawal by Subject|8
6858208|NCT00396565|10867396|FG001|Overall Study|Withdrawal by Subject|13
6858209|NCT00396565|10867397|FG002|Overall Study|Withdrawal by Subject|1
6858210|NCT00396565|10867395|FG000|Overall Study|Lack of Efficacy|32
6858211|NCT00396565|10867396|FG001|Overall Study|Lack of Efficacy|64
6858212|NCT00396565|10867397|FG002|Overall Study|Lack of Efficacy|11
6858213|NCT00396591|10867405|FG000|Overall Study|Disease Progression|13
6858214|NCT00396591|10867405|FG000|Overall Study|Adverse Event|2
6858215|NCT00396591|10867405|FG000|Overall Study|Participant request|1
6858216|NCT00396630|10867411|FG000|Overall Study|Lost to Follow-up|1
6858217|NCT00396630|10867412|FG001|Overall Study|Lost to Follow-up|1
6858218|NCT00396630|10867411|FG000|Overall Study|Withdrawal by Subject|1
6858219|NCT00396630|10867412|FG001|Overall Study|Withdrawal by Subject|1
6858220|NCT00396630|10867411|FG000|Overall Study|Not vaccinated at Visit 3|3
6858221|NCT00396630|10867412|FG001|Overall Study|Not vaccinated at Visit 3|3
6858222|NCT00396656|10867419|FG000|First Treatment Period|Withdrawal by Subject|0
6858223|NCT00396656|10867420|FG001|First Treatment Period|Withdrawal by Subject|2
6858224|NCT00396656|10867419|FG000|Second Treatment Period|Adverse Event|0
6858225|NCT00396656|10867420|FG001|Second Treatment Period|Adverse Event|1
6858226|NCT00396812|10867426|FG000|Overall Study|Physician Decision|1
6858227|NCT00396877|10867432|FG000|Overall Study|Lost to Follow-up|2
6858228|NCT00396877|10867433|FG001|Overall Study|Lost to Follow-up|1
6858229|NCT00396877|10867432|FG000|Overall Study|Parent(s)/guardian(s)'s request|4
6858230|NCT00396877|10867433|FG001|Overall Study|Parent(s)/guardian(s)'s request|7
6858231|NCT00397033|10867460|FG000|Overall Study|Adverse Event|7
6858232|NCT00397033|10867461|FG001|Overall Study|Adverse Event|10
6858233|NCT00397033|10867462|FG002|Overall Study|Adverse Event|4
6858234|NCT00397033|10867460|FG000|Overall Study|Lack of Efficacy|22
6858235|NCT00397033|10867461|FG001|Overall Study|Lack of Efficacy|12
6858236|NCT00397033|10867462|FG002|Overall Study|Lack of Efficacy|9
6858237|NCT00397033|10867460|FG000|Overall Study|Lost to Follow-up|3
6858238|NCT00397033|10867461|FG001|Overall Study|Lost to Follow-up|3
6858239|NCT00397033|10867462|FG002|Overall Study|Lost to Follow-up|3
6858240|NCT00397033|10867460|FG000|Overall Study|Withdrawal by Subject|12
6858241|NCT00397033|10867461|FG001|Overall Study|Withdrawal by Subject|7
6858242|NCT00397033|10867462|FG002|Overall Study|Withdrawal by Subject|5
6858243|NCT00397033|10867460|FG000|Overall Study|Other|0
6858244|NCT00397033|10867461|FG001|Overall Study|Other|5
6967465|NCT01132313|11015823|FG009|Overall Study|Lost to Follow-up|0
6967466|NCT01132313|11015824|FG010|Overall Study|Lost to Follow-up|0
6967467|NCT01132313|11015825|FG011|Overall Study|Lost to Follow-up|0
6967468|NCT01132313|11015814|FG000|Overall Study|Withdrawal by Subject|0
6967469|NCT01132313|11015815|FG001|Overall Study|Withdrawal by Subject|0
6967470|NCT01132313|11015816|FG002|Overall Study|Withdrawal by Subject|3
6967471|NCT01132313|11015817|FG003|Overall Study|Withdrawal by Subject|3
6967472|NCT01132313|11015818|FG004|Overall Study|Withdrawal by Subject|6
6967473|NCT01132313|11015819|FG005|Overall Study|Withdrawal by Subject|0
6967474|NCT01132313|11015820|FG006|Overall Study|Withdrawal by Subject|1
6967475|NCT01132313|11015821|FG007|Overall Study|Withdrawal by Subject|0
6967476|NCT01132313|11015822|FG008|Overall Study|Withdrawal by Subject|0
6967477|NCT01132313|11015823|FG009|Overall Study|Withdrawal by Subject|2
6967478|NCT01132313|11015824|FG010|Overall Study|Withdrawal by Subject|0
6967479|NCT01132313|11015825|FG011|Overall Study|Withdrawal by Subject|0
6967480|NCT01132313|11015814|FG000|Overall Study|Lack of antiviral response|0
6967481|NCT01132313|11015815|FG001|Overall Study|Lack of antiviral response|0
6967482|NCT01132313|11015816|FG002|Overall Study|Lack of antiviral response|12
6967483|NCT01132313|11015817|FG003|Overall Study|Lack of antiviral response|18
6967484|NCT01132313|11015818|FG004|Overall Study|Lack of antiviral response|18
6967485|NCT01132313|11015819|FG005|Overall Study|Lack of antiviral response|18
6967486|NCT01132313|11015820|FG006|Overall Study|Lack of antiviral response|21
6967487|NCT01132313|11015821|FG007|Overall Study|Lack of antiviral response|0
6967488|NCT01132313|11015822|FG008|Overall Study|Lack of antiviral response|0
6967489|NCT01132313|11015823|FG009|Overall Study|Lack of antiviral response|0
6967490|NCT01132313|11015824|FG010|Overall Study|Lack of antiviral response|1
6967491|NCT01132313|11015825|FG011|Overall Study|Lack of antiviral response|0
7152891|NCT03267212|11317984|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0
7152892|NCT03267264|11317994|FG000|Overall Study|Withdrawal by Subject|1
7152893|NCT03267264|11317995|FG001|Overall Study|Withdrawal by Subject|0
7152894|NCT03267264|11317996|FG002|Overall Study|Withdrawal by Subject|2
7152895|NCT03267264|11317997|FG003|Overall Study|Withdrawal by Subject|4
7152896|NCT03267511|11318014|FG000|Overall Study|Lost to Follow-up|0
7152897|NCT03267511|11318015|FG001|Overall Study|Lost to Follow-up|0
7152898|NCT03267511|11318016|FG002|Overall Study|Lost to Follow-up|0
7152899|NCT03267511|11318017|FG003|Overall Study|Lost to Follow-up|1
7152900|NCT03267576|11318031|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0
7152901|NCT03267576|11318032|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1
7152902|NCT03267576|11318031|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1
7152903|NCT03267576|11318032|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1
7184123|NCT01755689|11384112|FG001|Overall Study|Migrated/moved from study area|1
7184124|NCT01755689|11384113|FG002|Overall Study|Migrated/moved from study area|1
6858245|NCT00397033|10867462|FG002|Overall Study|Other|2
6858246|NCT00397046|10867474|FG000|Overall Study|Disease Progression|3
6858247|NCT00397046|10867475|FG001|Overall Study|Disease Progression|3
6858248|NCT00397046|10867476|FG002|Overall Study|Disease Progression|10
6858249|NCT00397046|10867477|FG003|Overall Study|Disease Progression|5
6858250|NCT00397189|10867499|FG000|3 Weeks Period|Lost to Follow-up|5
6967492|NCT01132313|11015814|FG000|Overall Study|Other reason not defined above|0
6967493|NCT01132313|11015815|FG001|Overall Study|Other reason not defined above|0
7184125|NCT01755689|11384114|FG003|Overall Study|Migrated/moved from study area|1
7184126|NCT01755689|11384115|FG004|Overall Study|Migrated/moved from study area|1
7184127|NCT01755689|11384111|FG000|Overall Study|Lost to Follow-up|1
6858251|NCT00397189|10867500|FG001|3 Weeks Period|Lost to Follow-up|4
6858252|NCT00397189|10867499|FG000|3 Weeks Period|Adverse Event|3
6858253|NCT00397189|10867500|FG001|3 Weeks Period|Adverse Event|2
6858254|NCT00397189|10867499|FG000|3 Weeks Period|Withdrawal by Subject|13
6858255|NCT00397189|10867500|FG001|3 Weeks Period|Withdrawal by Subject|9
6858256|NCT00397189|10867499|FG000|3 Weeks Period|Physician Decision|0
6858257|NCT00397189|10867500|FG001|3 Weeks Period|Physician Decision|2
6858258|NCT00397189|10867499|FG000|3 Weeks Period|Protocol Violation|0
6858259|NCT00397189|10867500|FG001|3 Weeks Period|Protocol Violation|3
6858260|NCT00397189|10867499|FG000|3 Weeks Period|Other|0
6858261|NCT00397189|10867500|FG001|3 Weeks Period|Other|2
6858262|NCT00397215|10867512|FG000|Month 0 (Day 0)|Adverse Event|0
6858263|NCT00397215|10867513|FG001|Month 0 (Day 0)|Adverse Event|1
6858264|NCT00397215|10867514|FG002|Month 0 (Day 0)|Adverse Event|0
6858265|NCT00397215|10867515|FG003|Month 0 (Day 0)|Adverse Event|0
6858266|NCT00397215|10867512|FG000|Month 0 (Day 0)|Withdrawal by Subject|3
6858267|NCT00397215|10867513|FG001|Month 0 (Day 0)|Withdrawal by Subject|3
6858268|NCT00397215|10867514|FG002|Month 0 (Day 0)|Withdrawal by Subject|3
6858269|NCT00397215|10867515|FG003|Month 0 (Day 0)|Withdrawal by Subject|1
6858270|NCT00397215|10867512|FG000|Month 0 (Day 0)|Other|4
6858271|NCT00397215|10867513|FG001|Month 0 (Day 0)|Other|1
6858272|NCT00397215|10867514|FG002|Month 0 (Day 0)|Other|3
6858273|NCT00397215|10867515|FG003|Month 0 (Day 0)|Other|3
6858274|NCT00397215|10867512|FG000|Month 6 (Day 180)|Adverse Event|0
6858275|NCT00397215|10867513|FG001|Month 6 (Day 180)|Adverse Event|3
6858276|NCT00397215|10867514|FG002|Month 6 (Day 180)|Adverse Event|2
6858277|NCT00397215|10867515|FG003|Month 6 (Day 180)|Adverse Event|0
6858278|NCT00397215|10867512|FG000|Month 6 (Day 180)|Other|2
6858279|NCT00397215|10867513|FG001|Month 6 (Day 180)|Other|0
6858280|NCT00397215|10867514|FG002|Month 6 (Day 180)|Other|3
6858281|NCT00397215|10867515|FG003|Month 6 (Day 180)|Other|0
6858282|NCT00397488|10867541|FG000|Overall Study|Withdrawal by Subject|3
6858283|NCT00397488|10867541|FG000|Overall Study|Adverse Event|3
6858284|NCT00397488|10867541|FG000|Overall Study|Death|1
6858285|NCT00397514|10867545|FG000|Overall Study|Withdrawal by Subject|1
6858286|NCT00397514|10867545|FG000|Overall Study|Pacing wire malfunction|1
6858287|NCT00397514|10867545|FG000|Overall Study|Not able to capture & pace LV intraoper.|4
6858288|NCT00397514|10867545|FG000|Overall Study|early extubation|2
6858289|NCT00397514|10867545|FG000|Overall Study|poor echocardiographic windows|1
6858290|NCT00397540|10867557|FG000|Overall Study|short follow-up duration < 12 months|1
6858291|NCT00397540|10867558|FG001|Overall Study|short follow-up duration < 12 months|0
6858292|NCT00397631|10867571|FG000|Overall Study|Adverse Event|5
6858293|NCT00397631|10867572|FG001|Overall Study|Adverse Event|6
6858294|NCT00397631|10867571|FG000|Overall Study|Lack of Efficacy|7
6858295|NCT00397631|10867572|FG001|Overall Study|Lack of Efficacy|10
6858296|NCT00397631|10867571|FG000|Overall Study|Lost to Follow-up|8
6858297|NCT00397631|10867572|FG001|Overall Study|Lost to Follow-up|9
6858298|NCT00397631|10867571|FG000|Overall Study|Physician Decision|2
6858299|NCT00397631|10867572|FG001|Overall Study|Physician Decision|0
6858300|NCT00397631|10867571|FG000|Overall Study|Protocol Violation|0
6858301|NCT00397631|10867572|FG001|Overall Study|Protocol Violation|1
6858302|NCT00397631|10867571|FG000|Overall Study|Withdrawal by Subject|7
6858303|NCT00397631|10867572|FG001|Overall Study|Withdrawal by Subject|14
6858304|NCT00397631|10867571|FG000|Overall Study|protocol discontinuation criteria|1
6858305|NCT00397631|10867572|FG001|Overall Study|protocol discontinuation criteria|4
6858306|NCT00397891|10867621|FG000|Overall Study|Withdrawal by Subject|1
6858307|NCT00397891|10867622|FG001|Overall Study|Withdrawal by Subject|0
6858308|NCT00397891|10867623|FG002|Overall Study|Withdrawal by Subject|0
6858309|NCT00397891|10867624|FG003|Overall Study|Withdrawal by Subject|0
6858310|NCT00397891|10867625|FG004|Overall Study|Withdrawal by Subject|1
6967494|NCT01132313|11015816|FG002|Overall Study|Other reason not defined above|0
6967495|NCT01132313|11015817|FG003|Overall Study|Other reason not defined above|0
6967496|NCT01132313|11015818|FG004|Overall Study|Other reason not defined above|0
6967497|NCT01132313|11015819|FG005|Overall Study|Other reason not defined above|0
6967498|NCT01132313|11015820|FG006|Overall Study|Other reason not defined above|0
6967499|NCT01132313|11015821|FG007|Overall Study|Other reason not defined above|1
6967500|NCT01132313|11015822|FG008|Overall Study|Other reason not defined above|0
6967501|NCT01132313|11015823|FG009|Overall Study|Other reason not defined above|0
6967502|NCT01132313|11015824|FG010|Overall Study|Other reason not defined above|0
6967503|NCT01132313|11015825|FG011|Overall Study|Other reason not defined above|0
6967504|NCT01132326|11015856|FG000|Overall Study|Lack of Efficacy|25
6967505|NCT01132326|11015856|FG000|Overall Study|Adverse Event|37
6967506|NCT01132326|11015856|FG000|Overall Study|Protocol Violation|1
6967507|NCT01132326|11015856|FG000|Overall Study|Lost to Follow-up|16
6967508|NCT01132326|11015856|FG000|Overall Study|Withdrawal by Subject|40
6967509|NCT01132326|11015856|FG000|Overall Study|Physician Decision|10
6967510|NCT01132326|11015856|FG000|Overall Study|Study Termination|80
6967511|NCT01132326|11015856|FG000|Overall Study|Declining Health|1
6967512|NCT01132326|11015856|FG000|Overall Study|Pregnancy|1
6967513|NCT01132326|11015856|FG000|Overall Study|Caregiver Withdrew Consent|1
6967514|NCT01132326|11015856|FG000|Overall Study|Death|5
6967515|NCT01132326|11015856|FG000|Overall Study|Subject Unable to Come To Visits|1
6967516|NCT01132482|11015867|FG000|Overall Study|Adverse Event|1
6967517|NCT01132482|11015868|FG001|Overall Study|Adverse Event|0
6967518|NCT01132495|11015878|FG000|Overall Study|Various reasons|40
6967519|NCT01132495|11015879|FG001|Overall Study|Various reasons|38
6967520|NCT01132495|11015880|FG002|Overall Study|Various reasons|20
6858311|NCT00397930|10867643|FG000|Overall Study|Personal reasons|14
6858312|NCT00397930|10867644|FG001|Overall Study|Personal reasons|8
6858313|NCT00397930|10867643|FG000|Overall Study|Other medical|9
6858314|NCT00397930|10867644|FG001|Overall Study|Other medical|4
6858315|NCT00397930|10867643|FG000|Overall Study|Unknown reasons|9
6858316|NCT00397930|10867644|FG001|Overall Study|Unknown reasons|14
6858317|NCT00397930|10867643|FG000|Overall Study|Noncompliant|3
6858318|NCT00397930|10867644|FG001|Overall Study|Noncompliant|2
6858319|NCT00397930|10867643|FG000|Overall Study|Too time-consuming|2
6858320|NCT00397930|10867644|FG001|Overall Study|Too time-consuming|9
6858321|NCT00397930|10867643|FG000|Overall Study|Started own yoga program|1
6858322|NCT00397930|10867644|FG001|Overall Study|Started own yoga program|1
6858323|NCT00397930|10867643|FG000|Overall Study|Did not want to be in control group|0
6858324|NCT00397930|10867644|FG001|Overall Study|Did not want to be in control group|1
6858325|NCT00397930|10867643|FG000|Overall Study|Withdrawal by Subject|0
6858326|NCT00397930|10867644|FG001|Overall Study|Withdrawal by Subject|8
6858327|NCT00397930|10867643|FG000|Overall Study|Missing data|0
6858328|NCT00397930|10867644|FG001|Overall Study|Missing data|4
6858329|NCT00397943|10867655|FG000|Overall Study|Unspecified reasons|12
6858330|NCT00397943|10867656|FG001|Overall Study|Unspecified reasons|9
6858331|NCT00397943|10867657|FG002|Overall Study|Unspecified reasons|0
6858332|NCT00397943|10867658|FG003|Overall Study|Unspecified reasons|0
6858333|NCT00397943|10867659|FG004|Overall Study|Unspecified reasons|0
6858334|NCT00397982|10867671|FG000|Overall Study|Withdrawal by Subject|1
6858335|NCT00397982|10867671|FG000|Overall Study|Adverse Event|1
6858336|NCT00397982|10867671|FG000|Overall Study|noncompliance|1
6858337|NCT00397982|10867671|FG000|Overall Study|Unrelated health issues|1
6858338|NCT00398047|10867676|FG000|Overall Study|all patient progressed before completion|3
6858339|NCT00398073|10867683|FG000|Overall Study|Withdrawal by Subject|1
6858340|NCT00398073|10867684|FG001|Overall Study|Withdrawal by Subject|0
6858341|NCT00398086|10867693|FG000|Overall Study|Unacceptable Toxicity|2
6858342|NCT00398086|10867694|FG001|Overall Study|Unacceptable Toxicity|8
6858343|NCT00398086|10867695|FG002|Overall Study|Unacceptable Toxicity|2
6858344|NCT00398086|10867693|FG000|Overall Study|Adverse Event|1
6858345|NCT00398086|10867694|FG001|Overall Study|Adverse Event|4
6858346|NCT00398086|10867695|FG002|Overall Study|Adverse Event|0
6858347|NCT00398086|10867693|FG000|Overall Study|Physician Decision|1
6858348|NCT00398086|10867694|FG001|Overall Study|Physician Decision|4
6858349|NCT00398086|10867695|FG002|Overall Study|Physician Decision|0
6858350|NCT00398086|10867693|FG000|Overall Study|Withdrawal by Subject|5
6858351|NCT00398086|10867694|FG001|Overall Study|Withdrawal by Subject|7
6858352|NCT00398086|10867695|FG002|Overall Study|Withdrawal by Subject|0
6858353|NCT00398112|10867703|FG000|Overall Study|Adverse Event|4
6858354|NCT00398112|10867703|FG000|Overall Study|Disease progression|9
6858355|NCT00398112|10867703|FG000|Overall Study|Alternative treatment|1
6858356|NCT00398112|10867703|FG000|Overall Study|Withdrawal by Subject|3
6858357|NCT00398112|10867703|FG000|Overall Study|Death|1
6858358|NCT00398138|10867707|FG000|Overall Study|Adverse Event|2
6858359|NCT00398216|10867716|FG000|Overall Study|Adverse Event|4
6858360|NCT00398216|10867717|FG001|Overall Study|Adverse Event|2
6858361|NCT00398216|10867718|FG002|Overall Study|Adverse Event|5
6858362|NCT00398216|10867719|FG003|Overall Study|Adverse Event|7
6858363|NCT00398216|10867720|FG004|Overall Study|Adverse Event|2
6858364|NCT00398216|10867716|FG000|Overall Study|Protocol Violation|2
6858365|NCT00398216|10867717|FG001|Overall Study|Protocol Violation|4
6858366|NCT00398216|10867718|FG002|Overall Study|Protocol Violation|5
6858367|NCT00398216|10867719|FG003|Overall Study|Protocol Violation|7
6858368|NCT00398216|10867720|FG004|Overall Study|Protocol Violation|5
6858369|NCT00398216|10867716|FG000|Overall Study|Lost to Follow-up|1
6858370|NCT00398216|10867717|FG001|Overall Study|Lost to Follow-up|6
6858371|NCT00398216|10867718|FG002|Overall Study|Lost to Follow-up|4
6858372|NCT00398216|10867719|FG003|Overall Study|Lost to Follow-up|4
6858373|NCT00398216|10867720|FG004|Overall Study|Lost to Follow-up|1
6858374|NCT00398216|10867716|FG000|Overall Study|Death|0
6858375|NCT00398216|10867717|FG001|Overall Study|Death|3
6858376|NCT00398216|10867718|FG002|Overall Study|Death|0
6858377|NCT00398216|10867719|FG003|Overall Study|Death|0
6858378|NCT00398216|10867720|FG004|Overall Study|Death|0
6858379|NCT00398216|10867716|FG000|Overall Study|Withdrawal by Subject|1
6858380|NCT00398216|10867717|FG001|Overall Study|Withdrawal by Subject|0
6858381|NCT00398216|10867718|FG002|Overall Study|Withdrawal by Subject|3
6858382|NCT00398216|10867719|FG003|Overall Study|Withdrawal by Subject|1
6858383|NCT00398216|10867720|FG004|Overall Study|Withdrawal by Subject|2
6858384|NCT00398216|10867716|FG000|Overall Study|administrative reasons|3
6858385|NCT00398216|10867717|FG001|Overall Study|administrative reasons|4
6858386|NCT00398216|10867718|FG002|Overall Study|administrative reasons|4
6858387|NCT00398216|10867719|FG003|Overall Study|administrative reasons|3
6858388|NCT00398216|10867720|FG004|Overall Study|administrative reasons|3
6858389|NCT00398216|10867716|FG000|Overall Study|entrance criteria|0
6858390|NCT00398216|10867717|FG001|Overall Study|entrance criteria|0
6858391|NCT00398216|10867718|FG002|Overall Study|entrance criteria|0
6858392|NCT00398216|10867719|FG003|Overall Study|entrance criteria|0
6858393|NCT00398216|10867720|FG004|Overall Study|entrance criteria|2
6858394|NCT00398320|10867732|FG000|Overall Study|Death|1
6858395|NCT00398320|10867732|FG000|Overall Study|Adverse Event|4
6858396|NCT00398320|10867732|FG000|Overall Study|Physician Decision|1
6858397|NCT00398411|10867742|FG000|Overall Study|Death|0
6858398|NCT00398411|10867743|FG001|Overall Study|Death|1
6858399|NCT00398567|10867761|FG000|Overall Study|Disease Progression|3
6858400|NCT00398567|10867762|FG001|Overall Study|Disease Progression|4
6858401|NCT00398567|10867763|FG002|Overall Study|Disease Progression|27
6858402|NCT00398567|10867761|FG000|Overall Study|Withdrawal by Subject|1
6858403|NCT00398567|10867762|FG001|Overall Study|Withdrawal by Subject|0
6858404|NCT00398567|10867763|FG002|Overall Study|Withdrawal by Subject|4
6858405|NCT00398567|10867761|FG000|Overall Study|Adverse Event|0
6858406|NCT00398567|10867762|FG001|Overall Study|Adverse Event|0
6858407|NCT00398567|10867763|FG002|Overall Study|Adverse Event|2
6858408|NCT00398567|10867761|FG000|Overall Study|Protocol Violation|0
6858409|NCT00398567|10867762|FG001|Overall Study|Protocol Violation|0
6858410|NCT00398567|10867763|FG002|Overall Study|Protocol Violation|1
6858411|NCT00398632|10867769|FG000|Overall Study|Withdrawal by Subject|1
6858412|NCT00398632|10867769|FG000|Overall Study|Lack of Efficacy|1
6858413|NCT00398866|10867777|FG000|Overall Study|Adverse Event|1
6858414|NCT00398866|10867778|FG001|Overall Study|Adverse Event|0
6858415|NCT00398866|10867779|FG002|Overall Study|Adverse Event|0
6858416|NCT00398866|10867777|FG000|Overall Study|Lack of Efficacy|0
6858417|NCT00398866|10867778|FG001|Overall Study|Lack of Efficacy|0
6858418|NCT00398866|10867779|FG002|Overall Study|Lack of Efficacy|1
6858419|NCT00398866|10867777|FG000|Overall Study|Lost to Follow-up|7
6858420|NCT00398866|10867778|FG001|Overall Study|Lost to Follow-up|6
6858421|NCT00398866|10867779|FG002|Overall Study|Lost to Follow-up|4
6858422|NCT00398866|10867777|FG000|Overall Study|Withdrawal by Subject|5
6858423|NCT00398866|10867778|FG001|Overall Study|Withdrawal by Subject|1
6858424|NCT00398866|10867779|FG002|Overall Study|Withdrawal by Subject|2
6858425|NCT00398866|10867777|FG000|Overall Study|Unable to complete requirements of study|1
6858426|NCT00398866|10867778|FG001|Overall Study|Unable to complete requirements of study|1
6858427|NCT00398866|10867779|FG002|Overall Study|Unable to complete requirements of study|1
6858428|NCT00399035|10867804|FG000|Overall Study|Death|289
6858429|NCT00399035|10867805|FG001|Overall Study|Death|141
6858430|NCT00399035|10867806|FG002|Overall Study|Death|234
6858431|NCT00399035|10867804|FG000|Overall Study|Lost to Follow-up|2
6858432|NCT00399035|10867805|FG001|Overall Study|Lost to Follow-up|1
6858433|NCT00399035|10867806|FG002|Overall Study|Lost to Follow-up|5
6858434|NCT00399035|10867804|FG000|Overall Study|Withdrawal by Subject|19
6858435|NCT00399035|10867805|FG001|Overall Study|Withdrawal by Subject|15
6858436|NCT00399035|10867806|FG002|Overall Study|Withdrawal by Subject|12
6858437|NCT00399035|10867804|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1
6858438|NCT00399035|10867805|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0
6858439|NCT00399035|10867806|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1
6858440|NCT00399035|10867804|FG000|Overall Study|Severe non-compliance with protocol|2
6858441|NCT00399035|10867805|FG001|Overall Study|Severe non-compliance with protocol|1
6858442|NCT00399035|10867806|FG002|Overall Study|Severe non-compliance with protocol|0
6858443|NCT00399360|10867830|FG000|Overall Study|Lost to Follow-up|2
6858444|NCT00399360|10867831|FG001|Overall Study|Lost to Follow-up|1
6858445|NCT00399360|10867832|FG002|Overall Study|Lost to Follow-up|2
6858446|NCT00399360|10867833|FG003|Overall Study|Lost to Follow-up|4
6858447|NCT00399360|10867830|FG000|Overall Study|Adverse Event|0
6858448|NCT00399360|10867831|FG001|Overall Study|Adverse Event|0
6858449|NCT00399360|10867832|FG002|Overall Study|Adverse Event|1
6858450|NCT00399360|10867833|FG003|Overall Study|Adverse Event|0
6858451|NCT00399360|10867830|FG000|Overall Study|Withdrawal by Subject|0
6858452|NCT00399360|10867831|FG001|Overall Study|Withdrawal by Subject|2
6858453|NCT00399360|10867832|FG002|Overall Study|Withdrawal by Subject|0
6858454|NCT00399360|10867833|FG003|Overall Study|Withdrawal by Subject|2
6858455|NCT00399490|10867848|FG000|Overall Study|Adverse Event|19
6858456|NCT00399490|10867848|FG000|Overall Study|Lack of Efficacy|31
6858457|NCT00399490|10867848|FG000|Overall Study|Lost to Follow-up|5
6858458|NCT00399490|10867848|FG000|Overall Study|Withdrawal by Subject|18
6858459|NCT00399490|10867848|FG000|Overall Study|Other|25
6858460|NCT00399516|10867854|FG000|Overall Study|Lost to Follow-up|2
6858461|NCT00399529|10867858|FG000|Overall Study|Off Study Prior to Treatment|2
6858462|NCT00399542|10867865|FG000|Overall Study|Adverse Event|18
6858463|NCT00399542|10867866|FG001|Overall Study|Adverse Event|15
6858464|NCT00399542|10867865|FG000|Overall Study|Protocol Violation|13
6858465|NCT00399542|10867866|FG001|Overall Study|Protocol Violation|3
6858466|NCT00399542|10867865|FG000|Overall Study|Withdrawal by Subject|28
6858467|NCT00399542|10867866|FG001|Overall Study|Withdrawal by Subject|10
6858468|NCT00399542|10867865|FG000|Overall Study|Lack of Efficacy|18
6858469|NCT00399542|10867866|FG001|Overall Study|Lack of Efficacy|8
6858470|NCT00399542|10867865|FG000|Overall Study|Lost to Follow-up|6
6858471|NCT00399542|10867866|FG001|Overall Study|Lost to Follow-up|6
6858472|NCT00399542|10867865|FG000|Overall Study|Other|1
6858473|NCT00399542|10867866|FG001|Overall Study|Other|0
6858474|NCT00399542|10867865|FG000|Overall Study|Physician Decision|0
6858475|NCT00399542|10867866|FG001|Overall Study|Physician Decision|1
6858476|NCT00399568|10867874|FG000|Overall Study|Adverse Event|1
6858477|NCT00399568|10867875|FG001|Overall Study|Adverse Event|2
6858478|NCT00399568|10867874|FG000|Overall Study|Withdrawal by Subject|7
6858479|NCT00399568|10867875|FG001|Overall Study|Withdrawal by Subject|3
6858480|NCT00399568|10867874|FG000|Overall Study|Protocol non-compliance|2
6858481|NCT00399568|10867875|FG001|Overall Study|Protocol non-compliance|2
6858482|NCT00399568|10867874|FG000|Overall Study|Lost to Follow-up|2
6858483|NCT00399568|10867875|FG001|Overall Study|Lost to Follow-up|2
6858484|NCT00399763|10867885|FG000|Overall Study|Lost to Follow-up|2
6858485|NCT00399763|10867886|FG001|Overall Study|Lost to Follow-up|3
6858486|NCT00399802|10867894|FG000|Overall Study|Adverse Event|0
6858487|NCT00399802|10867895|FG001|Overall Study|Adverse Event|2
6858488|NCT00399802|10867894|FG000|Overall Study|Participant discontinued by mistake|0
6858489|NCT00399802|10867895|FG001|Overall Study|Participant discontinued by mistake|1
6858490|NCT00399893|10867912|FG000|Overall Study|Withdrawal by Subject|1
6858491|NCT00399893|10867913|FG001|Overall Study|Withdrawal by Subject|0
6858492|NCT00400153|10867922|FG000|Overall Study|AE due to study disease worsening|14
6858493|NCT00400153|10867923|FG001|Overall Study|AE due to study disease worsening|19
6858494|NCT00400153|10867924|FG002|Overall Study|AE due to study disease worsening|20
6858495|NCT00400153|10867922|FG000|Overall Study|AE due to other disease worsening|2
6858496|NCT00400153|10867923|FG001|Overall Study|AE due to other disease worsening|1
6858497|NCT00400153|10867924|FG002|Overall Study|AE due to other disease worsening|0
6858498|NCT00400153|10867922|FG000|Overall Study|AE due to other condition|3
6858499|NCT00400153|10867923|FG001|Overall Study|AE due to other condition|14
6858500|NCT00400153|10867924|FG002|Overall Study|AE due to other condition|15
6858501|NCT00400153|10867922|FG000|Overall Study|Protocol Violation|7
6858502|NCT00400153|10867923|FG001|Overall Study|Protocol Violation|4
6858503|NCT00400153|10867924|FG002|Overall Study|Protocol Violation|9
6858504|NCT00400153|10867922|FG000|Overall Study|Lost to Follow-up|2
6858505|NCT00400153|10867923|FG001|Overall Study|Lost to Follow-up|1
6858506|NCT00400153|10867924|FG002|Overall Study|Lost to Follow-up|4
6858507|NCT00400153|10867922|FG000|Overall Study|Withdrawal by Subject|12
6858508|NCT00400153|10867923|FG001|Overall Study|Withdrawal by Subject|11
6858509|NCT00400153|10867924|FG002|Overall Study|Withdrawal by Subject|10
6858510|NCT00400153|10867922|FG000|Overall Study|Other reasons - not mentioned above|8
6858511|NCT00400153|10867923|FG001|Overall Study|Other reasons - not mentioned above|5
6858512|NCT00400153|10867924|FG002|Overall Study|Other reasons - not mentioned above|3
6858513|NCT00400179|10867939|FG000|Overall Study|Adverse Event|2
6858514|NCT00400179|10867940|FG001|Overall Study|Adverse Event|2
6858515|NCT00400179|10867939|FG000|Overall Study|Death|1
6858516|NCT00400179|10867940|FG001|Overall Study|Death|2
6858517|NCT00400179|10867939|FG000|Overall Study|Withdrew Consent|1
6858518|NCT00400179|10867940|FG001|Overall Study|Withdrew Consent|5
6858519|NCT00400179|10867939|FG000|Overall Study|Disease progression|1
6858520|NCT00400179|10867940|FG001|Overall Study|Disease progression|1
6858521|NCT00400179|10867939|FG000|Overall Study|Intercurrent illness|0
6858522|NCT00400179|10867940|FG001|Overall Study|Intercurrent illness|1
6858523|NCT00400179|10867939|FG000|Overall Study|Investigator judgment|0
6858524|NCT00400179|10867940|FG001|Overall Study|Investigator judgment|1
6858525|NCT00400179|10867939|FG000|Overall Study|Randomization error/patient ineligible|1
6858526|NCT00400179|10867940|FG001|Overall Study|Randomization error/patient ineligible|6
6858527|NCT00400400|10867953|FG000|Overall Study|Adverse Event|9
6858528|NCT00400400|10867954|FG001|Overall Study|Adverse Event|8
6858529|NCT00400400|10867953|FG000|Overall Study|Protocol Violation|2
6858530|NCT00400400|10867954|FG001|Overall Study|Protocol Violation|0
6858531|NCT00400400|10867953|FG000|Overall Study|Withdrawal by Subject|1
6858532|NCT00400400|10867954|FG001|Overall Study|Withdrawal by Subject|3
6858533|NCT00400400|10867953|FG000|Overall Study|Administrative Problem|1
6858534|NCT00400400|10867954|FG001|Overall Study|Administrative Problem|0
6858535|NCT00400400|10867953|FG000|Overall Study|Lost to Follow-up|0
6858536|NCT00400400|10867954|FG001|Overall Study|Lost to Follow-up|1
6858537|NCT00400400|10867953|FG000|Overall Study|Did not receive study drug|1
6858538|NCT00400400|10867954|FG001|Overall Study|Did not receive study drug|3
6858539|NCT00400517|10867969|FG000|Overall Study|Withdrawal by Subject|1
6858540|NCT00400517|10867969|FG000|Overall Study|Physician Decision|1
6858541|NCT00400569|10867973|FG000|Overall Study|Death|1
6858542|NCT00400712|10867995|FG000|Overall Study|Death|1
6858543|NCT00400712|10867996|FG001|Overall Study|Death|0
6858544|NCT00400712|10867995|FG000|Overall Study|Withdrawal by Subject|11
6858545|NCT00400712|10867996|FG001|Overall Study|Withdrawal by Subject|12
6858546|NCT00400712|10867995|FG000|Overall Study|Physician Decision|5
7152904|NCT03267940|11318044|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1
7152905|NCT03267940|11318045|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2
6858547|NCT00400712|10867996|FG001|Overall Study|Physician Decision|4
6858548|NCT00400764|10868009|FG000|Phase Ib|Adverse Event|1
6858549|NCT00400764|10868010|FG001|Phase Ib|Adverse Event|0
6858550|NCT00400764|10868011|FG002|Phase Ib|Adverse Event|0
6858551|NCT00400764|10868012|FG003|Phase Ib|Adverse Event|0
6858552|NCT00400764|10868013|FG004|Phase Ib|Adverse Event|0
6858553|NCT00400764|10868009|FG000|Phase Ib|Death|1
6858554|NCT00400764|10868010|FG001|Phase Ib|Death|0
6858555|NCT00400764|10868011|FG002|Phase Ib|Death|0
6858556|NCT00400764|10868012|FG003|Phase Ib|Death|0
6858557|NCT00400764|10868013|FG004|Phase Ib|Death|0
6858558|NCT00400764|10868009|FG000|Phase Ib|Disease Progression|4
6858559|NCT00400764|10868010|FG001|Phase Ib|Disease Progression|4
6858560|NCT00400764|10868011|FG002|Phase Ib|Disease Progression|0
6858561|NCT00400764|10868012|FG003|Phase Ib|Disease Progression|0
6858562|NCT00400764|10868013|FG004|Phase Ib|Disease Progression|0
6858563|NCT00400764|10868009|FG000|Phase II|Death|0
6858564|NCT00400764|10868010|FG001|Phase II|Death|0
6858565|NCT00400764|10868011|FG002|Phase II|Death|1
6858566|NCT00400764|10868012|FG003|Phase II|Death|2
6858567|NCT00400764|10868013|FG004|Phase II|Death|0
6858568|NCT00400764|10868009|FG000|Phase II|Lost to Follow-up|0
6858569|NCT00400764|10868010|FG001|Phase II|Lost to Follow-up|0
6858570|NCT00400764|10868011|FG002|Phase II|Lost to Follow-up|1
6858571|NCT00400764|10868012|FG003|Phase II|Lost to Follow-up|0
6858572|NCT00400764|10868013|FG004|Phase II|Lost to Follow-up|0
6858573|NCT00400764|10868009|FG000|Phase II|Physician Decision|0
6858574|NCT00400764|10868010|FG001|Phase II|Physician Decision|0
6858575|NCT00400764|10868011|FG002|Phase II|Physician Decision|1
6858576|NCT00400764|10868012|FG003|Phase II|Physician Decision|1
6858577|NCT00400764|10868013|FG004|Phase II|Physician Decision|0
6858578|NCT00400764|10868009|FG000|Phase II|Sponsor's decision to terminate|0
6858579|NCT00400764|10868010|FG001|Phase II|Sponsor's decision to terminate|0
6858580|NCT00400764|10868011|FG002|Phase II|Sponsor's decision to terminate|18
6858581|NCT00400764|10868012|FG003|Phase II|Sponsor's decision to terminate|22
6858582|NCT00400764|10868013|FG004|Phase II|Sponsor's decision to terminate|11
6858583|NCT00400764|10868009|FG000|Phase II|Patient began new, non-protocol, therapy|0
6858584|NCT00400764|10868010|FG001|Phase II|Patient began new, non-protocol, therapy|0
6858585|NCT00400764|10868011|FG002|Phase II|Patient began new, non-protocol, therapy|1
6858586|NCT00400764|10868012|FG003|Phase II|Patient began new, non-protocol, therapy|0
6858587|NCT00400764|10868013|FG004|Phase II|Patient began new, non-protocol, therapy|0
6858588|NCT00400764|10868009|FG000|Phase II|Withdrawal by Subject|0
6858589|NCT00400764|10868010|FG001|Phase II|Withdrawal by Subject|0
6858590|NCT00400764|10868011|FG002|Phase II|Withdrawal by Subject|1
6858591|NCT00400764|10868012|FG003|Phase II|Withdrawal by Subject|1
6858592|NCT00400764|10868013|FG004|Phase II|Withdrawal by Subject|0
6858593|NCT00400985|10868052|FG000|Overall Study|Withdrawal by Subject|5
6858594|NCT00400985|10868052|FG000|Overall Study|system modification|8
6858595|NCT00400985|10868052|FG000|Overall Study|Death|30
6858596|NCT00400985|10868052|FG000|Overall Study|Lost to Follow-up|9
6858597|NCT00401193|10868063|FG000|Overall Study|Adverse Event|1
6858598|NCT00401193|10868064|FG001|Overall Study|Adverse Event|3
6858599|NCT00401193|10868065|FG002|Overall Study|Adverse Event|1
6858600|NCT00401193|10868063|FG000|Overall Study|Protocol Violation|3
6858601|NCT00401193|10868064|FG001|Overall Study|Protocol Violation|1
6858602|NCT00401193|10868065|FG002|Overall Study|Protocol Violation|1
6858603|NCT00401193|10868063|FG000|Overall Study|Lost to Follow-up|6
6858604|NCT00401193|10868064|FG001|Overall Study|Lost to Follow-up|5
6858605|NCT00401193|10868065|FG002|Overall Study|Lost to Follow-up|1
6858606|NCT00401193|10868063|FG000|Overall Study|Withdrawal by Subject|2
6858607|NCT00401193|10868064|FG001|Overall Study|Withdrawal by Subject|0
6858608|NCT00401193|10868065|FG002|Overall Study|Withdrawal by Subject|1
6858609|NCT00401193|10868063|FG000|Overall Study|Other Event|3
6858610|NCT00401193|10868064|FG001|Overall Study|Other Event|2
6858611|NCT00401193|10868065|FG002|Overall Study|Other Event|2
6858612|NCT00401245|10868078|FG000|Double Blind Titration Phase|Adverse Event|3
6858613|NCT00401245|10868079|FG001|Double Blind Titration Phase|Adverse Event|2
6858614|NCT00401245|10868080|FG002|Double Blind Titration Phase|Adverse Event|5
6858615|NCT00401245|10868081|FG003|Double Blind Titration Phase|Adverse Event|12
6858616|NCT00401245|10868082|FG004|Double Blind Titration Phase|Adverse Event|0
6858617|NCT00401245|10868083|FG005|Double Blind Titration Phase|Adverse Event|0
6858618|NCT00401245|10868084|FG006|Double Blind Titration Phase|Adverse Event|0
6858619|NCT00401245|10868085|FG007|Double Blind Titration Phase|Adverse Event|0
6858620|NCT00401245|10868078|FG000|Double Blind Titration Phase|Other|0
6858621|NCT00401245|10868079|FG001|Double Blind Titration Phase|Other|0
6858622|NCT00401245|10868080|FG002|Double Blind Titration Phase|Other|1
6858623|NCT00401245|10868081|FG003|Double Blind Titration Phase|Other|0
6858624|NCT00401245|10868082|FG004|Double Blind Titration Phase|Other|0
6858625|NCT00401245|10868083|FG005|Double Blind Titration Phase|Other|0
6858626|NCT00401245|10868084|FG006|Double Blind Titration Phase|Other|0
6858627|NCT00401245|10868085|FG007|Double Blind Titration Phase|Other|0
6858628|NCT00401245|10868078|FG000|Double Blind Titration Phase|Protocol Violation|0
6858629|NCT00401245|10868079|FG001|Double Blind Titration Phase|Protocol Violation|0
6858630|NCT00401245|10868080|FG002|Double Blind Titration Phase|Protocol Violation|0
6858631|NCT00401245|10868081|FG003|Double Blind Titration Phase|Protocol Violation|1
6858632|NCT00401245|10868082|FG004|Double Blind Titration Phase|Protocol Violation|0
6858633|NCT00401245|10868083|FG005|Double Blind Titration Phase|Protocol Violation|0
6858634|NCT00401245|10868084|FG006|Double Blind Titration Phase|Protocol Violation|0
6858635|NCT00401245|10868085|FG007|Double Blind Titration Phase|Protocol Violation|0
6858636|NCT00401245|10868078|FG000|Double Blind Titration Phase|Withdrawal by Subject|1
6858637|NCT00401245|10868079|FG001|Double Blind Titration Phase|Withdrawal by Subject|1
6858638|NCT00401245|10868080|FG002|Double Blind Titration Phase|Withdrawal by Subject|0
6858639|NCT00401245|10868081|FG003|Double Blind Titration Phase|Withdrawal by Subject|2
6858640|NCT00401245|10868082|FG004|Double Blind Titration Phase|Withdrawal by Subject|0
6858641|NCT00401245|10868083|FG005|Double Blind Titration Phase|Withdrawal by Subject|0
6858642|NCT00401245|10868084|FG006|Double Blind Titration Phase|Withdrawal by Subject|0
6858643|NCT00401245|10868085|FG007|Double Blind Titration Phase|Withdrawal by Subject|0
6858644|NCT00401245|10868078|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0
6858645|NCT00401245|10868079|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2
6858646|NCT00401245|10868080|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0
6858647|NCT00401245|10868081|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2
6858648|NCT00401245|10868082|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0
6858649|NCT00401245|10868083|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0
6858650|NCT00401245|10868084|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0
6858651|NCT00401245|10868085|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0
6858652|NCT00401245|10868078|FG000|Open Label Phase|Adverse Event|5
6858653|NCT00401245|10868079|FG001|Open Label Phase|Adverse Event|14
6858654|NCT00401245|10868080|FG002|Open Label Phase|Adverse Event|6
6858655|NCT00401245|10868081|FG003|Open Label Phase|Adverse Event|7
6858656|NCT00401245|10868082|FG004|Open Label Phase|Adverse Event|0
6858657|NCT00401245|10868083|FG005|Open Label Phase|Adverse Event|0
6858658|NCT00401245|10868084|FG006|Open Label Phase|Adverse Event|0
6858659|NCT00401245|10868085|FG007|Open Label Phase|Adverse Event|0
6858660|NCT00401245|10868078|FG000|Open Label Phase|Lost to Follow-up|5
6858661|NCT00401245|10868079|FG001|Open Label Phase|Lost to Follow-up|7
6858662|NCT00401245|10868080|FG002|Open Label Phase|Lost to Follow-up|5
6858663|NCT00401245|10868081|FG003|Open Label Phase|Lost to Follow-up|4
6858664|NCT00401245|10868082|FG004|Open Label Phase|Lost to Follow-up|0
6858665|NCT00401245|10868083|FG005|Open Label Phase|Lost to Follow-up|0
6858666|NCT00401245|10868084|FG006|Open Label Phase|Lost to Follow-up|0
6858667|NCT00401245|10868085|FG007|Open Label Phase|Lost to Follow-up|0
6858668|NCT00401245|10868078|FG000|Open Label Phase|Other|4
6858669|NCT00401245|10868079|FG001|Open Label Phase|Other|8
6858670|NCT00401245|10868080|FG002|Open Label Phase|Other|7
6858671|NCT00401245|10868081|FG003|Open Label Phase|Other|8
7077931|NCT02098369|11186101|FG001|Overall Study|Lost to Follow-up|1
7077932|NCT02098369|11186102|FG002|Overall Study|Lost to Follow-up|3
6858672|NCT00401245|10868082|FG004|Open Label Phase|Other|0
6858673|NCT00401245|10868083|FG005|Open Label Phase|Other|0
6858674|NCT00401245|10868084|FG006|Open Label Phase|Other|0
6858675|NCT00401245|10868085|FG007|Open Label Phase|Other|0
6858676|NCT00401245|10868078|FG000|Open Label Phase|Protocol Violation|0
6858677|NCT00401245|10868079|FG001|Open Label Phase|Protocol Violation|1
6858678|NCT00401245|10868080|FG002|Open Label Phase|Protocol Violation|0
6858679|NCT00401245|10868081|FG003|Open Label Phase|Protocol Violation|1
6858680|NCT00401245|10868082|FG004|Open Label Phase|Protocol Violation|0
6858681|NCT00401245|10868083|FG005|Open Label Phase|Protocol Violation|0
6858682|NCT00401245|10868084|FG006|Open Label Phase|Protocol Violation|0
6858683|NCT00401245|10868085|FG007|Open Label Phase|Protocol Violation|0
6858684|NCT00401245|10868078|FG000|Open Label Phase|Withdrawal by Subject|3
6858685|NCT00401245|10868079|FG001|Open Label Phase|Withdrawal by Subject|3
6858686|NCT00401245|10868080|FG002|Open Label Phase|Withdrawal by Subject|2
6858687|NCT00401245|10868081|FG003|Open Label Phase|Withdrawal by Subject|1
6858688|NCT00401245|10868082|FG004|Open Label Phase|Withdrawal by Subject|0
6858689|NCT00401245|10868083|FG005|Open Label Phase|Withdrawal by Subject|0
6858690|NCT00401245|10868084|FG006|Open Label Phase|Withdrawal by Subject|0
6858691|NCT00401245|10868085|FG007|Open Label Phase|Withdrawal by Subject|0
6858692|NCT00401245|10868078|FG000|Open Label Phase|Lack of Efficacy|4
6858693|NCT00401245|10868079|FG001|Open Label Phase|Lack of Efficacy|2
6858694|NCT00401245|10868080|FG002|Open Label Phase|Lack of Efficacy|3
6858695|NCT00401245|10868081|FG003|Open Label Phase|Lack of Efficacy|0
6858696|NCT00401245|10868082|FG004|Open Label Phase|Lack of Efficacy|0
6858697|NCT00401245|10868083|FG005|Open Label Phase|Lack of Efficacy|0
6858698|NCT00401245|10868084|FG006|Open Label Phase|Lack of Efficacy|0
6858699|NCT00401245|10868085|FG007|Open Label Phase|Lack of Efficacy|0
6858700|NCT00401245|10868078|FG000|Double Blind Tapering Phase|Adverse Event|0
6858701|NCT00401245|10868079|FG001|Double Blind Tapering Phase|Adverse Event|0
6858702|NCT00401245|10868080|FG002|Double Blind Tapering Phase|Adverse Event|0
6858703|NCT00401245|10868081|FG003|Double Blind Tapering Phase|Adverse Event|0
6858704|NCT00401245|10868082|FG004|Double Blind Tapering Phase|Adverse Event|1
6858705|NCT00401245|10868083|FG005|Double Blind Tapering Phase|Adverse Event|1
6858706|NCT00401245|10868084|FG006|Double Blind Tapering Phase|Adverse Event|2
6858707|NCT00401245|10868085|FG007|Double Blind Tapering Phase|Adverse Event|4
6858708|NCT00401245|10868078|FG000|Double Blind Tapering Phase|Investigator request|0
6858709|NCT00401245|10868079|FG001|Double Blind Tapering Phase|Investigator request|0
6858710|NCT00401245|10868080|FG002|Double Blind Tapering Phase|Investigator request|0
6858711|NCT00401245|10868081|FG003|Double Blind Tapering Phase|Investigator request|0
6858712|NCT00401245|10868082|FG004|Double Blind Tapering Phase|Investigator request|0
6858713|NCT00401245|10868083|FG005|Double Blind Tapering Phase|Investigator request|0
6858714|NCT00401245|10868084|FG006|Double Blind Tapering Phase|Investigator request|0
6858715|NCT00401245|10868085|FG007|Double Blind Tapering Phase|Investigator request|1
6858716|NCT00401245|10868078|FG000|Double Blind Tapering Phase|Other|0
6858717|NCT00401245|10868079|FG001|Double Blind Tapering Phase|Other|0
6858718|NCT00401245|10868080|FG002|Double Blind Tapering Phase|Other|0
6858719|NCT00401245|10868081|FG003|Double Blind Tapering Phase|Other|0
6858720|NCT00401245|10868082|FG004|Double Blind Tapering Phase|Other|1
6858721|NCT00401245|10868083|FG005|Double Blind Tapering Phase|Other|0
6858722|NCT00401245|10868084|FG006|Double Blind Tapering Phase|Other|2
6858723|NCT00401245|10868085|FG007|Double Blind Tapering Phase|Other|2
6858724|NCT00401245|10868078|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0
6967521|NCT01132495|11015881|FG003|Overall Study|Various reasons|12
6858725|NCT00401245|10868079|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0
6858726|NCT00401245|10868080|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0
6858727|NCT00401245|10868081|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0
6858728|NCT00401245|10868082|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2
6858729|NCT00401245|10868083|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2
6858730|NCT00401245|10868084|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3
6858731|NCT00401245|10868085|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0
6858732|NCT00401245|10868078|FG000|Double Blind Tapering Phase|Lack of Efficacy|0
6858733|NCT00401245|10868079|FG001|Double Blind Tapering Phase|Lack of Efficacy|0
6858734|NCT00401245|10868080|FG002|Double Blind Tapering Phase|Lack of Efficacy|0
6858735|NCT00401245|10868081|FG003|Double Blind Tapering Phase|Lack of Efficacy|0
6858736|NCT00401245|10868082|FG004|Double Blind Tapering Phase|Lack of Efficacy|0
6858737|NCT00401245|10868083|FG005|Double Blind Tapering Phase|Lack of Efficacy|1
6858738|NCT00401245|10868084|FG006|Double Blind Tapering Phase|Lack of Efficacy|0
6858739|NCT00401245|10868085|FG007|Double Blind Tapering Phase|Lack of Efficacy|0
6858740|NCT00401258|10868105|FG000|Overall Study|Adverse Event|7
6858741|NCT00401375|10868112|FG000|Overall Study|Protocol Violation|2
6858742|NCT00401375|10868113|FG001|Overall Study|Protocol Violation|2
6858743|NCT00401375|10868114|FG002|Overall Study|Protocol Violation|1
6858744|NCT00401375|10868112|FG000|Overall Study|Adverse Event|6
6858745|NCT00401375|10868113|FG001|Overall Study|Adverse Event|11
6858746|NCT00401375|10868114|FG002|Overall Study|Adverse Event|10
6858747|NCT00401375|10868112|FG000|Overall Study|Withdrawal by Subject|9
6858748|NCT00401375|10868113|FG001|Overall Study|Withdrawal by Subject|7
6858749|NCT00401375|10868114|FG002|Overall Study|Withdrawal by Subject|7
6858750|NCT00401375|10868112|FG000|Overall Study|Lost to Follow-up|0
6858751|NCT00401375|10868113|FG001|Overall Study|Lost to Follow-up|1
6858752|NCT00401375|10868114|FG002|Overall Study|Lost to Follow-up|1
6858753|NCT00401375|10868112|FG000|Overall Study|Other than specified|2
6858754|NCT00401375|10868113|FG001|Overall Study|Other than specified|1
6858755|NCT00401375|10868114|FG002|Overall Study|Other than specified|3
6858756|NCT00401375|10868112|FG000|Overall Study|Randomized but not treated|3
6858757|NCT00401375|10868113|FG001|Overall Study|Randomized but not treated|3
6858758|NCT00401375|10868114|FG002|Overall Study|Randomized but not treated|3
6858759|NCT00401531|10868173|FG000|Overall Study|Adverse Event|2
6858760|NCT00401531|10868174|FG001|Overall Study|Adverse Event|0
6858761|NCT00401531|10868173|FG000|Overall Study|Protocol Violation|3
6858762|NCT00401531|10868174|FG001|Overall Study|Protocol Violation|7
6858763|NCT00401531|10868173|FG000|Overall Study|Lost to Follow-up|1
6858764|NCT00401531|10868174|FG001|Overall Study|Lost to Follow-up|1
6858765|NCT00401531|10868173|FG000|Overall Study|Withdrawal by Subject|3
6858766|NCT00401531|10868174|FG001|Overall Study|Withdrawal by Subject|2
6858767|NCT00401544|10868184|FG000|Overall Study|Adverse Event|5
6858768|NCT00401544|10868185|FG001|Overall Study|Adverse Event|1
6858769|NCT00401544|10868186|FG002|Overall Study|Adverse Event|1
6858770|NCT00401544|10868187|FG003|Overall Study|Adverse Event|1
6858771|NCT00401544|10868184|FG000|Overall Study|Death|3
6858772|NCT00401544|10868185|FG001|Overall Study|Death|6
6858773|NCT00401544|10868186|FG002|Overall Study|Death|2
6858774|NCT00401544|10868187|FG003|Overall Study|Death|5
6858775|NCT00401544|10868184|FG000|Overall Study|Lost to Follow-up|2
6858776|NCT00401544|10868185|FG001|Overall Study|Lost to Follow-up|0
6858777|NCT00401544|10868186|FG002|Overall Study|Lost to Follow-up|1
6858778|NCT00401544|10868187|FG003|Overall Study|Lost to Follow-up|1
6858779|NCT00401544|10868184|FG000|Overall Study|Withdrawal by Subject|7
6858780|NCT00401544|10868185|FG001|Overall Study|Withdrawal by Subject|6
6858781|NCT00401544|10868186|FG002|Overall Study|Withdrawal by Subject|6
6858782|NCT00401544|10868187|FG003|Overall Study|Withdrawal by Subject|5
6858783|NCT00401544|10868184|FG000|Overall Study|Physician Decision|1
6858784|NCT00401544|10868185|FG001|Overall Study|Physician Decision|3
6858785|NCT00401544|10868186|FG002|Overall Study|Physician Decision|0
6858786|NCT00401544|10868187|FG003|Overall Study|Physician Decision|0
6858787|NCT00401544|10868184|FG000|Overall Study|Ineligibility determined|0
6858788|NCT00401544|10868185|FG001|Overall Study|Ineligibility determined|1
6858789|NCT00401544|10868186|FG002|Overall Study|Ineligibility determined|0
6858790|NCT00401544|10868187|FG003|Overall Study|Ineligibility determined|2
6858791|NCT00401544|10868184|FG000|Overall Study|Disease progression|0
6858792|NCT00401544|10868185|FG001|Overall Study|Disease progression|1
6858793|NCT00401544|10868186|FG002|Overall Study|Disease progression|0
6858794|NCT00401544|10868187|FG003|Overall Study|Disease progression|0
6858795|NCT00401544|10868184|FG000|Overall Study|Other|0
6858796|NCT00401544|10868185|FG001|Overall Study|Other|0
6858797|NCT00401544|10868186|FG002|Overall Study|Other|2
6858798|NCT00401544|10868187|FG003|Overall Study|Other|2
6858799|NCT00401726|10868213|FG000|Overall Study|Adverse Event|34
6858800|NCT00401726|10868214|FG001|Overall Study|Adverse Event|45
6858801|NCT00401726|10868213|FG000|Overall Study|Death|0
6858802|NCT00401726|10868214|FG001|Overall Study|Death|3
6858803|NCT00401726|10868213|FG000|Overall Study|Sponsor Request|0
6858804|NCT00401726|10868214|FG001|Overall Study|Sponsor Request|1
6858805|NCT00401726|10868213|FG000|Overall Study|Physician Decision|3
6858806|NCT00401726|10868214|FG001|Overall Study|Physician Decision|6
6858807|NCT00401726|10868213|FG000|Overall Study|Lost to Follow-up|23
6858808|NCT00401726|10868214|FG001|Overall Study|Lost to Follow-up|20
6858809|NCT00401726|10868213|FG000|Overall Study|Protocol Violation|6
6858810|NCT00401726|10868214|FG001|Overall Study|Protocol Violation|3
6858811|NCT00401726|10868213|FG000|Overall Study|Withdrawal by Subject|18
6858812|NCT00401726|10868214|FG001|Overall Study|Withdrawal by Subject|24
6858813|NCT00401726|10868213|FG000|Overall Study|Lack of Efficacy|4
6858814|NCT00401726|10868214|FG001|Overall Study|Lack of Efficacy|6
6858815|NCT00401726|10868213|FG000|Overall Study|Protocol Deviation|9
6858816|NCT00401726|10868214|FG001|Overall Study|Protocol Deviation|4
6858817|NCT00401752|10868222|FG000|Overall Study|Adverse Event|2
6858818|NCT00401752|10868223|FG001|Overall Study|Adverse Event|5
6858819|NCT00401752|10868222|FG000|Overall Study|Withdrawal by Subject|2
6858820|NCT00401752|10868223|FG001|Overall Study|Withdrawal by Subject|6
6858821|NCT00401752|10868222|FG000|Overall Study|Lost to Follow-up|1
6858822|NCT00401752|10868223|FG001|Overall Study|Lost to Follow-up|4
6858823|NCT00401752|10868222|FG000|Overall Study|Development of any exclusion criteria|4
6858824|NCT00401752|10868223|FG001|Overall Study|Development of any exclusion criteria|2
6858825|NCT00401752|10868222|FG000|Overall Study|Physician Decision|1
6858826|NCT00401752|10868223|FG001|Overall Study|Physician Decision|1
6858827|NCT00401830|10868249|FG000|Overall Study|Adverse Event|10
6858828|NCT00401830|10868250|FG001|Overall Study|Adverse Event|18
6858829|NCT00401830|10868249|FG000|Overall Study|Lack of Efficacy|11
6858830|NCT00401830|10868250|FG001|Overall Study|Lack of Efficacy|5
6858831|NCT00401830|10868249|FG000|Overall Study|Withdrawal by Subject|4
6858832|NCT00401830|10868250|FG001|Overall Study|Withdrawal by Subject|3
6858833|NCT00401830|10868249|FG000|Overall Study|Protocol Violation|3
6858834|NCT00401830|10868250|FG001|Overall Study|Protocol Violation|3
6858835|NCT00401830|10868249|FG000|Overall Study|Non-compliance with drug study|1
6858836|NCT00401830|10868250|FG001|Overall Study|Non-compliance with drug study|0
6858837|NCT00401830|10868249|FG000|Overall Study|Lost to Follow-up|1
6858838|NCT00401830|10868250|FG001|Overall Study|Lost to Follow-up|3
6858839|NCT00401830|10868249|FG000|Overall Study|Other: Personal / Family problems|1
6858840|NCT00401830|10868250|FG001|Overall Study|Other: Personal / Family problems|0
6858841|NCT00401843|10868259|FG000|Overall Study|Achieved Complete Response|1
6858842|NCT00401843|10868260|FG001|Overall Study|Achieved Complete Response|5
6858843|NCT00401843|10868261|FG002|Overall Study|Achieved Complete Response|11
6858844|NCT00401843|10868259|FG000|Overall Study|Adverse Event|7
6858845|NCT00401843|10868260|FG001|Overall Study|Adverse Event|26
6858846|NCT00401843|10868261|FG002|Overall Study|Adverse Event|27
6858847|NCT00401843|10868259|FG000|Overall Study|Death|0
6858848|NCT00401843|10868260|FG001|Overall Study|Death|8
6858849|NCT00401843|10868261|FG002|Overall Study|Death|10
6858850|NCT00401843|10868259|FG000|Overall Study|Disease progression|10
6858851|NCT00401843|10868260|FG001|Overall Study|Disease progression|60
6858852|NCT00401843|10868261|FG002|Overall Study|Disease progression|49
6858853|NCT00401843|10868259|FG000|Overall Study|End of Study|1
6858854|NCT00401843|10868260|FG001|Overall Study|End of Study|1
6858855|NCT00401843|10868261|FG002|Overall Study|End of Study|2
6858856|NCT00401843|10868259|FG000|Overall Study|Lost to Follow-up|0
6858857|NCT00401843|10868260|FG001|Overall Study|Lost to Follow-up|0
6858858|NCT00401843|10868261|FG002|Overall Study|Lost to Follow-up|2
6858859|NCT00401843|10868259|FG000|Overall Study|Other Unspecified|0
6858860|NCT00401843|10868260|FG001|Overall Study|Other Unspecified|3
6858861|NCT00401843|10868261|FG002|Overall Study|Other Unspecified|5
6858862|NCT00401843|10868259|FG000|Overall Study|Physician Decision|0
6858863|NCT00401843|10868260|FG001|Overall Study|Physician Decision|16
6858864|NCT00401843|10868261|FG002|Overall Study|Physician Decision|10
6858865|NCT00401843|10868259|FG000|Overall Study|Protocol Violation|0
6858866|NCT00401843|10868260|FG001|Overall Study|Protocol Violation|0
6858867|NCT00401843|10868261|FG002|Overall Study|Protocol Violation|1
6858868|NCT00401843|10868259|FG000|Overall Study|Withdrawal by Subject|1
6858869|NCT00401843|10868260|FG001|Overall Study|Withdrawal by Subject|5
6858870|NCT00401843|10868261|FG002|Overall Study|Withdrawal by Subject|5
6858871|NCT00401843|10868259|FG000|Overall Study|Withdrawal of consent to study agent|1
6858872|NCT00401843|10868260|FG001|Overall Study|Withdrawal of consent to study agent|15
6858873|NCT00401843|10868261|FG002|Overall Study|Withdrawal of consent to study agent|17
6858874|NCT00401843|10868259|FG000|Overall Study|Randomized but not Treated|0
6858875|NCT00401843|10868260|FG001|Overall Study|Randomized but not Treated|2
6858876|NCT00401843|10868261|FG002|Overall Study|Randomized but not Treated|3
6858877|NCT00401843|10868259|FG000|Overall Study|Received incorrect treatment|0
6858878|NCT00401843|10868260|FG001|Overall Study|Received incorrect treatment|3
6858879|NCT00401843|10868261|FG002|Overall Study|Received incorrect treatment|0
6858880|NCT00401960|10868288|FG000|Overall Study|Lost to Follow-up|3
6858881|NCT00401960|10868289|FG001|Overall Study|Lost to Follow-up|0
6858882|NCT00401960|10868288|FG000|Overall Study|Death|2
6858883|NCT00401960|10868289|FG001|Overall Study|Death|0
6858884|NCT00401973|10868300|FG000|Overall Study|Adverse Event|2
6858885|NCT00401973|10868301|FG001|Overall Study|Adverse Event|8
6858886|NCT00401973|10868302|FG002|Overall Study|Adverse Event|4
6858887|NCT00401973|10868300|FG000|Overall Study|Clinical Relapse|0
6858888|NCT00401973|10868301|FG001|Overall Study|Clinical Relapse|1
6858889|NCT00401973|10868302|FG002|Overall Study|Clinical Relapse|1
6858890|NCT00401973|10868300|FG000|Overall Study|Lack of Efficacy|0
6858891|NCT00401973|10868301|FG001|Overall Study|Lack of Efficacy|0
6858892|NCT00401973|10868302|FG002|Overall Study|Lack of Efficacy|3
6858893|NCT00401973|10868300|FG000|Overall Study|Lost to Follow-up|2
6858894|NCT00401973|10868301|FG001|Overall Study|Lost to Follow-up|2
6858895|NCT00401973|10868302|FG002|Overall Study|Lost to Follow-up|2
6858896|NCT00401973|10868300|FG000|Overall Study|Physician Decision|2
6858897|NCT00401973|10868301|FG001|Overall Study|Physician Decision|0
6858898|NCT00401973|10868302|FG002|Overall Study|Physician Decision|1
6858899|NCT00401973|10868300|FG000|Overall Study|Protocol Violation|1
6858900|NCT00401973|10868301|FG001|Overall Study|Protocol Violation|2
6967522|NCT01132547|11015898|FG000|Overall Study|Withdrawal by Subject|3
6967523|NCT01132547|11015899|FG001|Overall Study|Withdrawal by Subject|1
6967524|NCT01132547|11015898|FG000|Overall Study|Death|1
6967525|NCT01132547|11015899|FG001|Overall Study|Death|0
6967526|NCT01132612|11015908|FG000|Overall Study|Death|0
6967527|NCT01132612|11015909|FG001|Overall Study|Death|0
6967528|NCT01132612|11015910|FG002|Overall Study|Death|1
6967529|NCT01132612|11015908|FG000|Overall Study|Protocol deviation|0
6967530|NCT01132612|11015909|FG001|Overall Study|Protocol deviation|0
6967531|NCT01132612|11015910|FG002|Overall Study|Protocol deviation|3
6967532|NCT01132612|11015908|FG000|Overall Study|Lost to Follow-up|2
6967533|NCT01132612|11015909|FG001|Overall Study|Lost to Follow-up|2
6967534|NCT01132612|11015910|FG002|Overall Study|Lost to Follow-up|7
6967535|NCT01132612|11015908|FG000|Overall Study|Adverse Event|5
6967536|NCT01132612|11015909|FG001|Overall Study|Adverse Event|2
6967537|NCT01132612|11015910|FG002|Overall Study|Adverse Event|15
6967538|NCT01132612|11015908|FG000|Overall Study|Withdrawal by Subject|5
6967539|NCT01132612|11015909|FG001|Overall Study|Withdrawal by Subject|8
6967540|NCT01132612|11015910|FG002|Overall Study|Withdrawal by Subject|19
6967541|NCT01132612|11015908|FG000|Overall Study|Administrative problems|5
6967542|NCT01132612|11015909|FG001|Overall Study|Administrative problems|1
6967543|NCT01132612|11015910|FG002|Overall Study|Administrative problems|52
6967544|NCT01132612|11015908|FG000|Overall Study|Lack of Efficacy|23
6967545|NCT01132612|11015909|FG001|Overall Study|Lack of Efficacy|22
6967546|NCT01132612|11015910|FG002|Overall Study|Lack of Efficacy|73
6967547|NCT01132651|11015920|FG000|Overall Study|Lost to Follow-up|1
6967548|NCT01132651|11015921|FG001|Overall Study|Lost to Follow-up|1
6967549|NCT01132664|11015932|FG000|Phase lb|Adverse Event|0
6967550|NCT01132664|11015933|FG001|Phase lb|Adverse Event|1
6967551|NCT01132664|11015934|FG002|Phase lb|Adverse Event|0
6967552|NCT01132664|11015935|FG003|Phase lb|Adverse Event|0
6967553|NCT01132664|11015936|FG004|Phase lb|Adverse Event|0
6967554|NCT01132664|11015932|FG000|Phase lb|Withdrawal by Subject|1
6967555|NCT01132664|11015933|FG001|Phase lb|Withdrawal by Subject|2
6967556|NCT01132664|11015934|FG002|Phase lb|Withdrawal by Subject|0
6967557|NCT01132664|11015935|FG003|Phase lb|Withdrawal by Subject|0
6967558|NCT01132664|11015936|FG004|Phase lb|Withdrawal by Subject|0
6967559|NCT01132664|11015932|FG000|Phase lb|Disease Progression|4
6967560|NCT01132664|11015933|FG001|Phase lb|Disease Progression|9
6967561|NCT01132664|11015934|FG002|Phase lb|Disease Progression|0
6967562|NCT01132664|11015935|FG003|Phase lb|Disease Progression|0
6967563|NCT01132664|11015936|FG004|Phase lb|Disease Progression|0
6967564|NCT01132664|11015932|FG000|Phase ll|Death|0
6967565|NCT01132664|11015933|FG001|Phase ll|Death|0
6967566|NCT01132664|11015934|FG002|Phase ll|Death|2
6967567|NCT01132664|11015935|FG003|Phase ll|Death|0
6967568|NCT01132664|11015936|FG004|Phase ll|Death|0
6967569|NCT01132664|11015932|FG000|Phase ll|Adverse Event|0
6967570|NCT01132664|11015933|FG001|Phase ll|Adverse Event|0
6967571|NCT01132664|11015934|FG002|Phase ll|Adverse Event|10
6967572|NCT01132664|11015935|FG003|Phase ll|Adverse Event|0
6967573|NCT01132664|11015936|FG004|Phase ll|Adverse Event|0
6967574|NCT01132664|11015932|FG000|Phase ll|Withdrawal by Subject|0
6967575|NCT01132664|11015933|FG001|Phase ll|Withdrawal by Subject|0
6967576|NCT01132664|11015934|FG002|Phase ll|Withdrawal by Subject|3
6967577|NCT01132664|11015935|FG003|Phase ll|Withdrawal by Subject|0
6967578|NCT01132664|11015936|FG004|Phase ll|Withdrawal by Subject|0
7077933|NCT02098369|11186100|FG000|Overall Study|Death|1
7077934|NCT02098369|11186101|FG001|Overall Study|Death|1
7077935|NCT02098369|11186102|FG002|Overall Study|Death|1
6967579|NCT01132664|11015932|FG000|Phase ll|Disease progression|0
6967580|NCT01132664|11015933|FG001|Phase ll|Disease progression|0
6967581|NCT01132664|11015934|FG002|Phase ll|Disease progression|35
6967582|NCT01132664|11015935|FG003|Phase ll|Disease progression|0
6967583|NCT01132664|11015936|FG004|Phase ll|Disease progression|0
6967584|NCT01132664|11015932|FG000|BM Cohort|Disease progression|0
6967585|NCT01132664|11015933|FG001|BM Cohort|Disease progression|0
6967586|NCT01132664|11015934|FG002|BM Cohort|Disease progression|0
6967587|NCT01132664|11015935|FG003|BM Cohort|Disease progression|3
6967588|NCT01132664|11015936|FG004|BM Cohort|Disease progression|4
6967589|NCT01132664|11015932|FG000|BM Cohort|Adverse Event|0
6967590|NCT01132664|11015933|FG001|BM Cohort|Adverse Event|0
6967591|NCT01132664|11015934|FG002|BM Cohort|Adverse Event|0
6967592|NCT01132664|11015935|FG003|BM Cohort|Adverse Event|0
6967593|NCT01132664|11015936|FG004|BM Cohort|Adverse Event|1
6967594|NCT01132664|11015932|FG000|BM Cohort|Withdrawal by Subject|0
6967595|NCT01132664|11015933|FG001|BM Cohort|Withdrawal by Subject|0
6967596|NCT01132664|11015934|FG002|BM Cohort|Withdrawal by Subject|0
6967597|NCT01132664|11015935|FG003|BM Cohort|Withdrawal by Subject|0
6967598|NCT01132664|11015936|FG004|BM Cohort|Withdrawal by Subject|1
6967599|NCT01132755|11015957|FG000|Overall Study|Procedure not done due to medical reason|23
6967600|NCT01132755|11015957|FG000|Overall Study|Protocol Violation|15
6967601|NCT01132755|11015957|FG000|Overall Study|Withdrawal by Subject|4
6976917|NCT01202877|11029792|FG001|Overall Study|Withdrawal by Subject|0
6858901|NCT00401973|10868302|FG002|Overall Study|Protocol Violation|3
6858902|NCT00401973|10868300|FG000|Overall Study|Sponsor Decision|0
6858903|NCT00401973|10868301|FG001|Overall Study|Sponsor Decision|1
6858904|NCT00401973|10868302|FG002|Overall Study|Sponsor Decision|0
6858905|NCT00401973|10868300|FG000|Overall Study|Withdrawal by Subject|4
6858906|NCT00401973|10868301|FG001|Overall Study|Withdrawal by Subject|12
6858907|NCT00401973|10868302|FG002|Overall Study|Withdrawal by Subject|9
6858908|NCT00402025|10868324|FG000|Overall Study|Adverse Event|0
6858909|NCT00402025|10868325|FG001|Overall Study|Adverse Event|0
6858910|NCT00402025|10868326|FG002|Overall Study|Adverse Event|2
6858911|NCT00402025|10868324|FG000|Overall Study|Death|0
6858912|NCT00402025|10868325|FG001|Overall Study|Death|1
6858913|NCT00402025|10868326|FG002|Overall Study|Death|5
6858914|NCT00402025|10868324|FG000|Overall Study|Disease Progression|1
6858915|NCT00402025|10868325|FG001|Overall Study|Disease Progression|1
6858916|NCT00402025|10868326|FG002|Overall Study|Disease Progression|2
6858917|NCT00402025|10868324|FG000|Overall Study|Physician Decision|1
6858918|NCT00402025|10868325|FG001|Overall Study|Physician Decision|1
6858919|NCT00402025|10868326|FG002|Overall Study|Physician Decision|0
6858920|NCT00402025|10868324|FG000|Overall Study|Participant Decision|0
6858921|NCT00402025|10868325|FG001|Overall Study|Participant Decision|0
6858922|NCT00402025|10868326|FG002|Overall Study|Participant Decision|1
6858923|NCT00402051|10868336|FG000|Overall Study|Progressive Disease|13
6858924|NCT00402051|10868337|FG001|Overall Study|Progressive Disease|20
6858925|NCT00402051|10868336|FG000|Overall Study|Adverse Event|11
6858926|NCT00402051|10868337|FG001|Overall Study|Adverse Event|4
6858927|NCT00402051|10868336|FG000|Overall Study|Physician Decision|7
6858928|NCT00402051|10868337|FG001|Overall Study|Physician Decision|3
6858929|NCT00402051|10868336|FG000|Overall Study|Withdrawal by Subject|3
6858930|NCT00402051|10868337|FG001|Overall Study|Withdrawal by Subject|3
6858931|NCT00402051|10868336|FG000|Overall Study|Death - Related to Study Drug|1
6858932|NCT00402051|10868337|FG001|Overall Study|Death - Related to Study Drug|2
6858933|NCT00402051|10868336|FG000|Overall Study|Death Due to Study Disease|2
6858934|NCT00402051|10868337|FG001|Overall Study|Death Due to Study Disease|1
6858935|NCT00402051|10868336|FG000|Overall Study|Death Due to Adverse Event|0
6858936|NCT00402051|10868337|FG001|Overall Study|Death Due to Adverse Event|2
6858937|NCT00402051|10868336|FG000|Overall Study|Lost to Follow-up|1
6858938|NCT00402051|10868337|FG001|Overall Study|Lost to Follow-up|0
6858939|NCT00402103|10868345|FG000|Overall Study|Adverse Event|60
6858940|NCT00402103|10868346|FG001|Overall Study|Adverse Event|7
6858941|NCT00402103|10868345|FG000|Overall Study|Unsatisfactory therapeutic effect|1
6858942|NCT00402103|10868346|FG001|Overall Study|Unsatisfactory therapeutic effect|2
6858943|NCT00402103|10868345|FG000|Overall Study|Condition no longer requires study drug|2
6858944|NCT00402103|10868346|FG001|Overall Study|Condition no longer requires study drug|0
6858945|NCT00402103|10868345|FG000|Overall Study|Protocol Deviation|8
6858946|NCT00402103|10868346|FG001|Overall Study|Protocol Deviation|0
6858947|NCT00402103|10868345|FG000|Overall Study|Patient withdrew consent|12
6858948|NCT00402103|10868346|FG001|Overall Study|Patient withdrew consent|1
6858949|NCT00402103|10868345|FG000|Overall Study|Lost to Follow-up|6
6858950|NCT00402103|10868346|FG001|Overall Study|Lost to Follow-up|3
6858951|NCT00402103|10868345|FG000|Overall Study|Administrative problems|2
6858952|NCT00402103|10868346|FG001|Overall Study|Administrative problems|0
6858953|NCT00402116|10868359|FG000|Overall Study|Jaw infection after surgery-other|1
6858954|NCT00402116|10868360|FG001|Overall Study|Jaw infection after surgery-other|0
6858955|NCT00402116|10868361|FG002|Overall Study|Jaw infection after surgery-other|0
6858956|NCT00402116|10868359|FG000|Overall Study|Withdrawal by Subject|1
6858957|NCT00402116|10868360|FG001|Overall Study|Withdrawal by Subject|0
6858958|NCT00402116|10868361|FG002|Overall Study|Withdrawal by Subject|5
6858959|NCT00402116|10868359|FG000|Overall Study|Treatment completed per protocol|1
6858960|NCT00402116|10868360|FG001|Overall Study|Treatment completed per protocol|1
6858961|NCT00402116|10868361|FG002|Overall Study|Treatment completed per protocol|2
6858962|NCT00402116|10868359|FG000|Overall Study|other complicating disease|0
6858963|NCT00402116|10868360|FG001|Overall Study|other complicating disease|0
6858964|NCT00402116|10868361|FG002|Overall Study|other complicating disease|2
6858965|NCT00402116|10868359|FG000|Overall Study|Disease Progression|0
6858966|NCT00402116|10868360|FG001|Overall Study|Disease Progression|4
6858967|NCT00402116|10868361|FG002|Overall Study|Disease Progression|38
6858968|NCT00402116|10868359|FG000|Overall Study|mistaken thrombocytopenia|0
6858969|NCT00402116|10868360|FG001|Overall Study|mistaken thrombocytopenia|0
6858970|NCT00402116|10868361|FG002|Overall Study|mistaken thrombocytopenia|1
6858971|NCT00402116|10868359|FG000|Overall Study|decline related hyponatremia/tumor|0
6858972|NCT00402116|10868360|FG001|Overall Study|decline related hyponatremia/tumor|0
6858973|NCT00402116|10868361|FG002|Overall Study|decline related hyponatremia/tumor|1
6858974|NCT00402116|10868359|FG000|Overall Study|Adverse Event|0
6858975|NCT00402116|10868360|FG001|Overall Study|Adverse Event|1
6858976|NCT00402116|10868361|FG002|Overall Study|Adverse Event|6
6858977|NCT00402168|10868391|FG000|Randomized|Lost to Follow-up|1
6858978|NCT00402168|10868392|FG001|Randomized|Lost to Follow-up|0
6858979|NCT00402168|10868391|FG000|Randomized|Withdrawal by Subject|0
6858980|NCT00402168|10868392|FG001|Randomized|Withdrawal by Subject|1
6858981|NCT00402168|10868391|FG000|Treatment (up to 12 Months)|Death|0
6858982|NCT00402168|10868392|FG001|Treatment (up to 12 Months)|Death|1
6858983|NCT00402168|10868391|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2
6858984|NCT00402168|10868392|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0
6858985|NCT00402168|10868391|FG000|Treatment (up to 12 Months)|non-specified|0
6858986|NCT00402168|10868392|FG001|Treatment (up to 12 Months)|non-specified|1
6858987|NCT00402168|10868391|FG000|Long Term (LT)|Adverse Event|1
6858988|NCT00402168|10868392|FG001|Long Term (LT)|Adverse Event|5
6858989|NCT00402168|10868391|FG000|Long Term (LT)|Withdrawal by Subject|4
6858990|NCT00402168|10868392|FG001|Long Term (LT)|Withdrawal by Subject|7
6858991|NCT00402168|10868391|FG000|Long Term (LT)|Pregnancy|0
6858992|NCT00402168|10868392|FG001|Long Term (LT)|Pregnancy|1
6858993|NCT00402168|10868391|FG000|Long Term (LT)|Lost to Follow-up|1
6858994|NCT00402168|10868392|FG001|Long Term (LT)|Lost to Follow-up|0
6858995|NCT00402168|10868391|FG000|Long Term (LT)|Death|4
6858996|NCT00402168|10868392|FG001|Long Term (LT)|Death|0
6858997|NCT00402168|10868391|FG000|Long Term (LT)|Lack of Efficacy|0
6858998|NCT00402168|10868392|FG001|Long Term (LT)|Lack of Efficacy|2
6858999|NCT00402168|10868391|FG000|Long Term (LT)|non-specified|1
6859000|NCT00402168|10868392|FG001|Long Term (LT)|non-specified|2
6859001|NCT00402168|10868391|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2
6859002|NCT00402168|10868392|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0
6859003|NCT00402168|10868391|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4
6859004|NCT00402168|10868392|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0
6859005|NCT00402233|10868419|FG000|Overall Study|Adverse Event|1
6859006|NCT00402233|10868420|FG001|Overall Study|Adverse Event|7
6859007|NCT00402233|10868421|FG002|Overall Study|Adverse Event|9
6859008|NCT00402233|10868422|FG003|Overall Study|Adverse Event|9
6859009|NCT00402233|10868419|FG000|Overall Study|Protocol Violation|0
6859010|NCT00402233|10868420|FG001|Overall Study|Protocol Violation|1
6859011|NCT00402233|10868421|FG002|Overall Study|Protocol Violation|0
6859012|NCT00402233|10868422|FG003|Overall Study|Protocol Violation|0
6859013|NCT00402233|10868419|FG000|Overall Study|Withdrawal by Subject|2
6859014|NCT00402233|10868420|FG001|Overall Study|Withdrawal by Subject|1
6859015|NCT00402233|10868421|FG002|Overall Study|Withdrawal by Subject|2
6859016|NCT00402233|10868422|FG003|Overall Study|Withdrawal by Subject|2
6859017|NCT00402233|10868419|FG000|Overall Study|Worsening of disease under study|2
6859018|NCT00402233|10868420|FG001|Overall Study|Worsening of disease under study|0
6859019|NCT00402233|10868421|FG002|Overall Study|Worsening of disease under study|0
6859020|NCT00402233|10868422|FG003|Overall Study|Worsening of disease under study|0
6859021|NCT00402233|10868419|FG000|Overall Study|Worsening of other pre-existing disease|0
6859022|NCT00402233|10868420|FG001|Overall Study|Worsening of other pre-existing disease|1
6859023|NCT00402233|10868421|FG002|Overall Study|Worsening of other pre-existing disease|0
6859024|NCT00402233|10868422|FG003|Overall Study|Worsening of other pre-existing disease|0
6859025|NCT00402246|10868434|FG000|Overall Study|Death|62
6859026|NCT00402246|10868435|FG001|Overall Study|Death|58
6859027|NCT00402246|10868434|FG000|Overall Study|Lost to Follow-up|20
6859028|NCT00402246|10868435|FG001|Overall Study|Lost to Follow-up|28
6859029|NCT00402246|10868434|FG000|Overall Study|Withdrawal by Subject|72
6859030|NCT00402246|10868435|FG001|Overall Study|Withdrawal by Subject|87
6859031|NCT00402246|10868434|FG000|Overall Study|Physician Decision|24
6859032|NCT00402246|10868435|FG001|Overall Study|Physician Decision|26
6859033|NCT00402246|10868434|FG000|Overall Study|Protocol Violation|25
6859034|NCT00402246|10868435|FG001|Overall Study|Protocol Violation|24
6859035|NCT00402246|10868434|FG000|Overall Study|Missed Final Visit|1
6859036|NCT00402246|10868435|FG001|Overall Study|Missed Final Visit|2
6859037|NCT00402246|10868434|FG000|Overall Study|Insurance Issues|2
6859038|NCT00402246|10868435|FG001|Overall Study|Insurance Issues|1
6859039|NCT00402246|10868434|FG000|Overall Study|Heart Transplant|0
6859040|NCT00402246|10868435|FG001|Overall Study|Heart Transplant|1
6859041|NCT00402246|10868434|FG000|Overall Study|Patient's device explanted|6
6859042|NCT00402246|10868435|FG001|Overall Study|Patient's device explanted|2
6859043|NCT00402246|10868434|FG000|Overall Study|Center Closure|5
6859044|NCT00402246|10868435|FG001|Overall Study|Center Closure|3
6859045|NCT00402246|10868434|FG000|Overall Study|Deterioriating Condition|3
6859046|NCT00402246|10868435|FG001|Overall Study|Deterioriating Condition|2
6859047|NCT00402285|10868446|FG000|Overall Study|insufficient RNA quality|7
6859048|NCT00402285|10868447|FG001|Overall Study|insufficient RNA quality|6
6859049|NCT00402285|10868448|FG002|Overall Study|insufficient RNA quality|2
6859050|NCT00402298|10868456|FG000|Overall Study|Withdrawal by Subject|1
6859051|NCT00402298|10868457|FG001|Overall Study|Withdrawal by Subject|0
6859052|NCT00402324|10868465|FG000|Overall Study|Lost to Follow-up|11
6859053|NCT00402324|10868466|FG001|Overall Study|Lost to Follow-up|11
6859054|NCT00402324|10868465|FG000|Overall Study|Protocol Entry Criteria Not Met|5
6859055|NCT00402324|10868466|FG001|Overall Study|Protocol Entry Criteria Not Met|4
6859056|NCT00402324|10868465|FG000|Overall Study|Protocol Violation|8
6859057|NCT00402324|10868466|FG001|Overall Study|Protocol Violation|7
6859058|NCT00402324|10868465|FG000|Overall Study|Withdrawal by Subject|5
6859059|NCT00402324|10868466|FG001|Overall Study|Withdrawal by Subject|2
6859060|NCT00402324|10868465|FG000|Overall Study|Physician Decision|2
6859061|NCT00402324|10868466|FG001|Overall Study|Physician Decision|4
6859062|NCT00402324|10868465|FG000|Overall Study|Sponsor Decision|4
6859063|NCT00402324|10868466|FG001|Overall Study|Sponsor Decision|5
6859064|NCT00402324|10868465|FG000|Overall Study|Lack of Efficacy|1
6859065|NCT00402324|10868466|FG001|Overall Study|Lack of Efficacy|4
6859066|NCT00402324|10868465|FG000|Overall Study|Adverse Event|6
6859067|NCT00402324|10868466|FG001|Overall Study|Adverse Event|4
6859068|NCT00402324|10868465|FG000|Overall Study|Death|1
6859069|NCT00402324|10868466|FG001|Overall Study|Death|0
6859070|NCT00402337|10868477|FG000|Overall Study|Adverse Event|0
6859071|NCT00402337|10868478|FG001|Overall Study|Adverse Event|2
6859072|NCT00402337|10868479|FG002|Overall Study|Adverse Event|2
6859073|NCT00402337|10868480|FG003|Overall Study|Adverse Event|3
6859074|NCT00402337|10868481|FG004|Overall Study|Adverse Event|2
6859075|NCT00402337|10868477|FG000|Overall Study|Noncompliance|0
6859076|NCT00402337|10868478|FG001|Overall Study|Noncompliance|0
6859077|NCT00402337|10868479|FG002|Overall Study|Noncompliance|0
6859078|NCT00402337|10868480|FG003|Overall Study|Noncompliance|0
6859079|NCT00402337|10868481|FG004|Overall Study|Noncompliance|2
6859080|NCT00402337|10868477|FG000|Overall Study|Withdrawal by Subject|5
6859081|NCT00402337|10868478|FG001|Overall Study|Withdrawal by Subject|3
6859082|NCT00402337|10868479|FG002|Overall Study|Withdrawal by Subject|1
6859083|NCT00402337|10868480|FG003|Overall Study|Withdrawal by Subject|6
6859084|NCT00402337|10868481|FG004|Overall Study|Withdrawal by Subject|4
6859085|NCT00402337|10868477|FG000|Overall Study|Lost to Follow-up|0
6859086|NCT00402337|10868478|FG001|Overall Study|Lost to Follow-up|0
6859087|NCT00402337|10868479|FG002|Overall Study|Lost to Follow-up|1
6859088|NCT00402337|10868480|FG003|Overall Study|Lost to Follow-up|2
6859089|NCT00402337|10868481|FG004|Overall Study|Lost to Follow-up|0
6859090|NCT00402337|10868477|FG000|Overall Study|Physician Decision|0
6859091|NCT00402337|10868478|FG001|Overall Study|Physician Decision|0
6859092|NCT00402337|10868479|FG002|Overall Study|Physician Decision|0
6859093|NCT00402337|10868480|FG003|Overall Study|Physician Decision|1
6859094|NCT00402337|10868481|FG004|Overall Study|Physician Decision|0
6859095|NCT00402337|10868477|FG000|Overall Study|Other Reason|0
6859096|NCT00402337|10868478|FG001|Overall Study|Other Reason|1
6859097|NCT00402337|10868479|FG002|Overall Study|Other Reason|0
6859098|NCT00402337|10868480|FG003|Overall Study|Other Reason|0
6859099|NCT00402337|10868481|FG004|Overall Study|Other Reason|0
6859100|NCT00402363|10868497|FG000|Overall Study|Adverse Event|9
6859101|NCT00402363|10868498|FG001|Overall Study|Adverse Event|14
6859102|NCT00402363|10868499|FG002|Overall Study|Adverse Event|2
6859103|NCT00402363|10868500|FG003|Overall Study|Adverse Event|2
6859104|NCT00402363|10868497|FG000|Overall Study|Withdrew Consent|10
6859105|NCT00402363|10868498|FG001|Overall Study|Withdrew Consent|5
6859106|NCT00402363|10868499|FG002|Overall Study|Withdrew Consent|2
6859107|NCT00402363|10868500|FG003|Overall Study|Withdrew Consent|1
6859108|NCT00402363|10868497|FG000|Overall Study|Protocol Violation|3
6859109|NCT00402363|10868498|FG001|Overall Study|Protocol Violation|5
6859110|NCT00402363|10868499|FG002|Overall Study|Protocol Violation|0
6859111|NCT00402363|10868500|FG003|Overall Study|Protocol Violation|3
6859112|NCT00402363|10868497|FG000|Overall Study|Lost to Follow-up|5
6859113|NCT00402363|10868498|FG001|Overall Study|Lost to Follow-up|4
6859114|NCT00402363|10868499|FG002|Overall Study|Lost to Follow-up|0
6859115|NCT00402363|10868500|FG003|Overall Study|Lost to Follow-up|2
6859116|NCT00402363|10868497|FG000|Overall Study|"Captured as Other"|6
6859117|NCT00402363|10868498|FG001|Overall Study|"Captured as Other"|2
6859118|NCT00402363|10868499|FG002|Overall Study|"Captured as Other"|2
6859119|NCT00402363|10868500|FG003|Overall Study|"Captured as Other"|2
6859120|NCT00402597|10868521|FG000|Overall Study|Death|15
6859121|NCT00402597|10868522|FG001|Overall Study|Death|7
6859122|NCT00402597|10868523|FG002|Overall Study|Death|6
6859123|NCT00402597|10868524|FG003|Overall Study|Death|4
6859124|NCT00402597|10868525|FG004|Overall Study|Death|6
6859125|NCT00402597|10868521|FG000|Overall Study|Adverse Event|81
6859126|NCT00402597|10868522|FG001|Overall Study|Adverse Event|18
6859127|NCT00402597|10868523|FG002|Overall Study|Adverse Event|106
6859128|NCT00402597|10868524|FG003|Overall Study|Adverse Event|39
6859129|NCT00402597|10868525|FG004|Overall Study|Adverse Event|71
6859130|NCT00402597|10868521|FG000|Overall Study|Lost to Follow-up|8
6859131|NCT00402597|10868522|FG001|Overall Study|Lost to Follow-up|1
6859132|NCT00402597|10868523|FG002|Overall Study|Lost to Follow-up|8
6859133|NCT00402597|10868524|FG003|Overall Study|Lost to Follow-up|2
6859134|NCT00402597|10868525|FG004|Overall Study|Lost to Follow-up|3
6859135|NCT00402597|10868521|FG000|Overall Study|Withdrawal by Subject|57
6859136|NCT00402597|10868522|FG001|Overall Study|Withdrawal by Subject|16
6859137|NCT00402597|10868523|FG002|Overall Study|Withdrawal by Subject|65
6859138|NCT00402597|10868524|FG003|Overall Study|Withdrawal by Subject|15
6859139|NCT00402597|10868525|FG004|Overall Study|Withdrawal by Subject|24
6859140|NCT00402597|10868521|FG000|Overall Study|reason not specified|30
6859141|NCT00402597|10868522|FG001|Overall Study|reason not specified|4
6859142|NCT00402597|10868523|FG002|Overall Study|reason not specified|27
6859143|NCT00402597|10868524|FG003|Overall Study|reason not specified|14
6859144|NCT00402597|10868525|FG004|Overall Study|reason not specified|20
6859145|NCT00402649|10868537|FG000|Overall Study|Lost to Follow-up|1
6859146|NCT00402649|10868537|FG000|Overall Study|Withdrawal by Subject|1
6859147|NCT00402688|10868544|FG000|Overall Study|Adverse Event|12
6859148|NCT00402688|10868545|FG001|Overall Study|Adverse Event|9
6859149|NCT00402688|10868546|FG002|Overall Study|Adverse Event|3
6859150|NCT00402688|10868544|FG000|Overall Study|Withdrawal by Subject|3
6859151|NCT00402688|10868545|FG001|Overall Study|Withdrawal by Subject|1
6859152|NCT00402688|10868546|FG002|Overall Study|Withdrawal by Subject|1
6859153|NCT00402688|10868544|FG000|Overall Study|Physician Decision|0
6859154|NCT00402688|10868545|FG001|Overall Study|Physician Decision|0
6859155|NCT00402688|10868546|FG002|Overall Study|Physician Decision|1
6859156|NCT00402688|10868544|FG000|Overall Study|Lack of Efficacy|4
6859157|NCT00402688|10868545|FG001|Overall Study|Lack of Efficacy|4
6859158|NCT00402688|10868546|FG002|Overall Study|Lack of Efficacy|5
6859159|NCT00402688|10868544|FG000|Overall Study|Protocol Violation|1
6859160|NCT00402688|10868545|FG001|Overall Study|Protocol Violation|1
6859161|NCT00402688|10868546|FG002|Overall Study|Protocol Violation|1
6859162|NCT00402688|10868544|FG000|Overall Study|Lost to Follow-up|1
6859163|NCT00402688|10868545|FG001|Overall Study|Lost to Follow-up|0
6859164|NCT00402688|10868546|FG002|Overall Study|Lost to Follow-up|2
6859165|NCT00402688|10868544|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0
6859166|NCT00402688|10868545|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1
6859167|NCT00402688|10868546|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0
6859168|NCT00402688|10868544|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
6859169|NCT00402688|10868545|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
6859170|NCT00402688|10868546|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1
6859171|NCT00402688|10868544|FG000|Overall Study|Patient Left Town and Forgot Medication|0
6859172|NCT00402688|10868545|FG001|Overall Study|Patient Left Town and Forgot Medication|0
6859173|NCT00402688|10868546|FG002|Overall Study|Patient Left Town and Forgot Medication|1
6859174|NCT00402727|10868567|FG000|Overall Study|Adverse Event|10
6859175|NCT00402727|10868568|FG001|Overall Study|Adverse Event|6
6859176|NCT00402727|10868567|FG000|Overall Study|Death|1
6859177|NCT00402727|10868568|FG001|Overall Study|Death|0
6859178|NCT00402727|10868567|FG000|Overall Study|Lack of Efficacy|1
6859179|NCT00402727|10868568|FG001|Overall Study|Lack of Efficacy|3
6859180|NCT00402727|10868567|FG000|Overall Study|Lost to Follow-up|24
6859181|NCT00402727|10868568|FG001|Overall Study|Lost to Follow-up|11
6859182|NCT00402727|10868567|FG000|Overall Study|Physician Decision|1
6859183|NCT00402727|10868568|FG001|Overall Study|Physician Decision|1
6859184|NCT00402727|10868567|FG000|Overall Study|Protocol Violation|0
6859185|NCT00402727|10868568|FG001|Overall Study|Protocol Violation|4
6859186|NCT00402727|10868567|FG000|Overall Study|Withdrawal by Subject|3
6859187|NCT00402727|10868568|FG001|Overall Study|Withdrawal by Subject|7
6859188|NCT00402727|10868567|FG000|Overall Study|supply problems|2
6859189|NCT00402727|10868568|FG001|Overall Study|supply problems|1
6859190|NCT00402727|10868567|FG000|Overall Study|non-compliance|0
6859191|NCT00402727|10868568|FG001|Overall Study|non-compliance|1
6859192|NCT00402740|10868574|FG000|Overall Study|Withdrawal by Subject|18
6859193|NCT00402740|10868574|FG000|Overall Study|Death|50
6859194|NCT00402740|10868574|FG000|Overall Study|Lost to Follow-up|6
6859195|NCT00402740|10868574|FG000|Overall Study|No stent. Completed FU at 30 days.|5
6859196|NCT00402740|10868574|FG000|Overall Study|Subject disposition unknown.|1
6859197|NCT00402779|10868584|FG000|Overall Study|Screen Failure|77
6859198|NCT00402779|10868585|FG001|Overall Study|Screen Failure|76
6859199|NCT00402831|10868593|FG000|Overall Study|Lost to Follow-up|1
6859200|NCT00402831|10868594|FG001|Overall Study|Lost to Follow-up|2
6859201|NCT00402831|10868593|FG000|Overall Study|Non-compliance with protocol|0
6859202|NCT00402831|10868594|FG001|Overall Study|Non-compliance with protocol|1
6859203|NCT00402987|10868610|FG000|Overall Study|Lack of Efficacy|0
6859204|NCT00402987|10868611|FG001|Overall Study|Lack of Efficacy|0
6859205|NCT00402987|10868612|FG002|Overall Study|Lack of Efficacy|1
6859206|NCT00402987|10868613|FG003|Overall Study|Lack of Efficacy|0
6859207|NCT00403130|10868668|FG000|2 Years From Start of Treatment|Not Eligible|3
6859208|NCT00403130|10868668|FG000|2 Years From Start of Treatment|Lost to Follow up|1
6859209|NCT00403130|10868668|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1
6859210|NCT00403130|10868668|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10
6859211|NCT00403234|10868676|FG000|Overall Study|Withdrawal by Subject|0
6859212|NCT00403234|10868677|FG001|Overall Study|Withdrawal by Subject|1
6859213|NCT00403234|10868678|FG002|Overall Study|Withdrawal by Subject|0
6859214|NCT00403234|10868679|FG003|Overall Study|Withdrawal by Subject|0
6859215|NCT00403234|10868676|FG000|Overall Study|Adverse Event|1
6859216|NCT00403234|10868677|FG001|Overall Study|Adverse Event|0
6859217|NCT00403234|10868678|FG002|Overall Study|Adverse Event|1
6859218|NCT00403234|10868679|FG003|Overall Study|Adverse Event|0
6859219|NCT00403260|10868691|FG000|Overall Study|Adverse Event|5
6859220|NCT00403260|10868692|FG001|Overall Study|Adverse Event|4
6859221|NCT00403260|10868691|FG000|Overall Study|Withdrawal by Subject|5
6859222|NCT00403260|10868692|FG001|Overall Study|Withdrawal by Subject|6
6859223|NCT00403260|10868691|FG000|Overall Study|Lost to Follow-up|49
6859224|NCT00403260|10868692|FG001|Overall Study|Lost to Follow-up|25
6859225|NCT00403260|10868691|FG000|Overall Study|Re-appearance of P. falciparum|34
6859226|NCT00403260|10868692|FG001|Overall Study|Re-appearance of P. falciparum|25
6859227|NCT00403260|10868691|FG000|Overall Study|P. vivax infection|26
6859228|NCT00403260|10868692|FG001|Overall Study|P. vivax infection|4
6859229|NCT00403260|10868691|FG000|Overall Study|Mixed infection with P. vivax|2
6859230|NCT00403260|10868692|FG001|Overall Study|Mixed infection with P. vivax|0
6859231|NCT00403260|10868691|FG000|Overall Study|Mixed infection with P. falciparum|1
6859232|NCT00403260|10868692|FG001|Overall Study|Mixed infection with P. falciparum|0
6859233|NCT00403260|10868691|FG000|Overall Study|P. vivax infection at screening|1
6859234|NCT00403260|10868692|FG001|Overall Study|P. vivax infection at screening|0
6859235|NCT00403260|10868691|FG000|Overall Study|P. ovale infection|1
6859236|NCT00403260|10868692|FG001|Overall Study|P. ovale infection|0
6859237|NCT00403260|10868691|FG000|Overall Study|Gametocyte re-appearance|1
6967602|NCT01132807|11015961|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9
6967603|NCT01132807|11015962|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0
6967604|NCT01132807|11015963|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0
6967605|NCT01132807|11015961|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6
6967606|NCT01132807|11015962|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0
6967607|NCT01132807|11015963|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0
6967608|NCT01132820|11015971|FG000|Overall Study|Ineligible: wrong cell type|1
6967609|NCT01132820|11015971|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1
6967610|NCT01132820|11015971|FG000|Overall Study|Ineligible:Inadequate pathology|1
6967611|NCT01132820|11015971|FG000|Overall Study|Never treated|1
6967612|NCT01132820|11015971|FG000|Overall Study|Inadequate data|1
6967613|NCT01133067|11015990|FG000|Overall Study|Death|136
6967614|NCT01133067|11015990|FG000|Overall Study|Lost to Follow-up|3
6967615|NCT01133171|11016003|FG000|Overall Study|Withdrawal by Subject|1
6967616|NCT01133171|11016004|FG001|Overall Study|Withdrawal by Subject|2
6967617|NCT01133171|11016005|FG002|Overall Study|Withdrawal by Subject|0
6967618|NCT01133275|11016013|FG000|Overall Study|Withdrawal by Subject|1
6967619|NCT01133275|11016013|FG000|Overall Study|Cerebrovascular accident (CVA)|1
6967620|NCT01133379|11016020|FG000|Overall Study|Withdrawal by Subject|0
6967621|NCT01133379|11016021|FG001|Overall Study|Withdrawal by Subject|1
6967622|NCT01133379|11016022|FG002|Overall Study|Withdrawal by Subject|1
6967623|NCT01133379|11016020|FG000|Overall Study|Lost to Follow-up|1
6967624|NCT01133379|11016021|FG001|Overall Study|Lost to Follow-up|1
6967625|NCT01133379|11016022|FG002|Overall Study|Lost to Follow-up|1
6967626|NCT01133392|11016032|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0
6967627|NCT01133392|11016033|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1
6967628|NCT01133392|11016032|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0
6967629|NCT01133392|11016033|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1
6967630|NCT01133405|11016049|FG000|Period 1|Withdrawal by Subject|0
6967631|NCT01133405|11016050|FG001|Period 1|Withdrawal by Subject|1
6967632|NCT01133405|11016051|FG002|Period 1|Withdrawal by Subject|0
6967633|NCT01133405|11016052|FG003|Period 1|Withdrawal by Subject|1
6967634|NCT01133405|11016053|FG004|Period 1|Withdrawal by Subject|0
6967635|NCT01133405|11016054|FG005|Period 1|Withdrawal by Subject|1
6967636|NCT01133405|11016055|FG006|Period 1|Withdrawal by Subject|0
6967637|NCT01133405|11016056|FG007|Period 1|Withdrawal by Subject|0
6967638|NCT01133405|11016057|FG008|Period 1|Withdrawal by Subject|0
6967639|NCT01133405|11016058|FG009|Period 1|Withdrawal by Subject|0
6967640|NCT01133405|11016049|FG000|Period 1|Physician Decision|0
6967641|NCT01133405|11016050|FG001|Period 1|Physician Decision|0
6967642|NCT01133405|11016051|FG002|Period 1|Physician Decision|0
6967643|NCT01133405|11016052|FG003|Period 1|Physician Decision|1
7077936|NCT02098369|11186100|FG000|Overall Study|Other|0
7077937|NCT02098369|11186101|FG001|Overall Study|Other|2
7077938|NCT02098369|11186102|FG002|Overall Study|Other|1
7077939|NCT02098395|11186114|FG000|Overall Study|Protocol Violation|2
7077940|NCT02098395|11186115|FG001|Overall Study|Protocol Violation|2
7077941|NCT02098395|11186116|FG002|Overall Study|Protocol Violation|0
7152906|NCT03267940|11318046|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
7077942|NCT02098395|11186117|FG003|Overall Study|Protocol Violation|7
7077943|NCT02098395|11186114|FG000|Overall Study|Withdrawal by Subject|10
7152907|NCT03267940|11318047|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
7152908|NCT03267940|11318048|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
7152909|NCT03267940|11318049|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
7152910|NCT03267940|11318044|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
7152911|NCT03267940|11318045|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1
7152912|NCT03267940|11318046|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
7152913|NCT03267940|11318047|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
7152914|NCT03267940|11318048|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
7152915|NCT03267940|11318049|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
7152916|NCT03267940|11318044|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
7152917|NCT03267940|11318045|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1
7152918|NCT03267940|11318046|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
7152919|NCT03267940|11318047|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
7152920|NCT03267940|11318048|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
7152921|NCT03267940|11318049|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
7152922|NCT03267940|11318044|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7
6967644|NCT01133405|11016053|FG004|Period 1|Physician Decision|0
6967645|NCT01133405|11016054|FG005|Period 1|Physician Decision|0
6967646|NCT01133405|11016055|FG006|Period 1|Physician Decision|0
6967647|NCT01133405|11016056|FG007|Period 1|Physician Decision|0
6967648|NCT01133405|11016057|FG008|Period 1|Physician Decision|0
6967649|NCT01133405|11016058|FG009|Period 1|Physician Decision|0
6967650|NCT01133405|11016049|FG000|Period 1|Discontinued after randomization|1
7077944|NCT02098395|11186115|FG001|Overall Study|Withdrawal by Subject|10
6859238|NCT00403260|10868692|FG001|Overall Study|Gametocyte re-appearance|1
6859239|NCT00403260|10868691|FG000|Overall Study|Withdrawn from study accidentally|0
6859240|NCT00403260|10868692|FG001|Overall Study|Withdrawn from study accidentally|1
6859241|NCT00403273|10868700|FG000|Overall Study|Lost to Follow-up|3
6859242|NCT00403273|10868701|FG001|Overall Study|Lost to Follow-up|2
6859243|NCT00403273|10868700|FG000|Overall Study|Physician Decision|0
6859244|NCT00403273|10868701|FG001|Overall Study|Physician Decision|1
6859245|NCT00403273|10868700|FG000|Overall Study|pt. wanted to have a surgical procedure|0
6859246|NCT00403273|10868701|FG001|Overall Study|pt. wanted to have a surgical procedure|1
6859247|NCT00403390|10868711|FG000|Overall Study|Withdrawal by Subject|1
6859248|NCT00403390|10868712|FG001|Overall Study|Withdrawal by Subject|0
6859249|NCT00403390|10868711|FG000|Overall Study|samples lost|1
6859250|NCT00403390|10868712|FG001|Overall Study|samples lost|0
6859251|NCT00403390|10868711|FG000|Overall Study|non-compliant|1
6859252|NCT00403390|10868712|FG001|Overall Study|non-compliant|0
6859253|NCT00403455|10868727|FG000|Overall Study|Withdrawal by Subject|1
6859254|NCT00403481|10868731|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1
6859255|NCT00403481|10868731|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1
6859256|NCT00403481|10868731|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3
6859257|NCT00403481|10868731|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1
6859258|NCT00403481|10868731|FG000|Olm 40 mg|Adverse Event|2
6859259|NCT00403481|10868731|FG000|Olm 40 mg|Protocol Violation|1
6859260|NCT00403481|10868731|FG000|Olm 40 mg|Withdrawal by Subject|1
6859261|NCT00403481|10868731|FG000|Olm 40 mg|Other|1
6859262|NCT00403481|10868731|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2
6859263|NCT00403481|10868731|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1
6859264|NCT00403481|10868731|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1
6859265|NCT00403481|10868731|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1
6859266|NCT00403481|10868731|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1
6859267|NCT00403481|10868731|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1
6859268|NCT00403494|10868740|FG000|Overall Study|Adverse Event|10
6859269|NCT00403494|10868741|FG001|Overall Study|Adverse Event|8
6859270|NCT00403494|10868740|FG000|Overall Study|Withdrew Consent|3
6859271|NCT00403494|10868741|FG001|Overall Study|Withdrew Consent|2
6859272|NCT00403494|10868740|FG000|Overall Study|Inappropriately enrolled|0
6859273|NCT00403494|10868741|FG001|Overall Study|Inappropriately enrolled|1
6859274|NCT00403494|10868740|FG000|Overall Study|Lost to Follow-up|0
6859275|NCT00403494|10868741|FG001|Overall Study|Lost to Follow-up|2
6859276|NCT00403494|10868740|FG000|Overall Study|Protocol noncompliance|0
6859277|NCT00403494|10868741|FG001|Overall Study|Protocol noncompliance|1
6859278|NCT00403494|10868740|FG000|Overall Study|Death|1
6859279|NCT00403494|10868741|FG001|Overall Study|Death|0
6859280|NCT00403494|10868740|FG000|Overall Study|Sponsor Request|1
6859281|NCT00403494|10868741|FG001|Overall Study|Sponsor Request|0
6859282|NCT00403546|10868751|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6
6859283|NCT00403546|10868752|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0
6859284|NCT00403546|10868753|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0
6859285|NCT00403546|10868751|FG000|Signed Informed Consent/Open-Label|Early Termination|8
6859286|NCT00403546|10868752|FG001|Signed Informed Consent/Open-Label|Early Termination|0
6859287|NCT00403546|10868753|FG002|Signed Informed Consent/Open-Label|Early Termination|0
6859288|NCT00403546|10868751|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9
6859289|NCT00403546|10868752|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0
6859290|NCT00403546|10868753|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0
6859291|NCT00403546|10868751|FG000|Signed Informed Consent/Open-Label|Adverse Event|5
6859292|NCT00403546|10868752|FG001|Signed Informed Consent/Open-Label|Adverse Event|0
6859293|NCT00403546|10868753|FG002|Signed Informed Consent/Open-Label|Adverse Event|0
6859294|NCT00403546|10868751|FG000|Screening Phase|Screening Failure|22
6859295|NCT00403546|10868752|FG001|Screening Phase|Screening Failure|0
6859296|NCT00403546|10868753|FG002|Screening Phase|Screening Failure|0
6859297|NCT00403546|10868751|FG000|Screening Phase|Adverse Event|1
6859298|NCT00403546|10868752|FG001|Screening Phase|Adverse Event|0
6859299|NCT00403546|10868753|FG002|Screening Phase|Adverse Event|0
6859300|NCT00403546|10868751|FG000|Screening Phase|Terminated Prior to Randomization|5
6859301|NCT00403546|10868752|FG001|Screening Phase|Terminated Prior to Randomization|0
6859302|NCT00403546|10868753|FG002|Screening Phase|Terminated Prior to Randomization|0
6859303|NCT00403546|10868751|FG000|Randomized Trial|Early Terminations|0
6859304|NCT00403546|10868752|FG001|Randomized Trial|Early Terminations|17
6859305|NCT00403546|10868753|FG002|Randomized Trial|Early Terminations|16
6967651|NCT01133405|11016050|FG001|Period 1|Discontinued after randomization|0
6967652|NCT01133405|11016051|FG002|Period 1|Discontinued after randomization|0
6967653|NCT01133405|11016052|FG003|Period 1|Discontinued after randomization|0
6967654|NCT01133405|11016053|FG004|Period 1|Discontinued after randomization|0
6967655|NCT01133405|11016054|FG005|Period 1|Discontinued after randomization|0
6967656|NCT01133405|11016055|FG006|Period 1|Discontinued after randomization|1
6967657|NCT01133405|11016056|FG007|Period 1|Discontinued after randomization|0
6967658|NCT01133405|11016057|FG008|Period 1|Discontinued after randomization|0
6967659|NCT01133405|11016058|FG009|Period 1|Discontinued after randomization|0
6967660|NCT01133405|11016049|FG000|Period 1|Received drug only in period 2|0
6967661|NCT01133405|11016050|FG001|Period 1|Received drug only in period 2|1
6859306|NCT00403585|10868762|FG000|Initial Treatment Phase|Lost to Follow-up|2
6859307|NCT00403585|10868762|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2
6859308|NCT00403585|10868762|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4
6859309|NCT00403754|10868766|FG000|Core Treatment Period 1|Withdrawal by Subject|0
6859310|NCT00403754|10868767|FG001|Core Treatment Period 1|Withdrawal by Subject|1
6859311|NCT00403754|10868768|FG002|Core Treatment Period 1|Withdrawal by Subject|0
6859312|NCT00403754|10868769|FG003|Core Treatment Period 1|Withdrawal by Subject|0
6859313|NCT00403754|10868766|FG000|Core Treatment Period 2|Lack of Efficacy|0
6859314|NCT00403754|10868767|FG001|Core Treatment Period 2|Lack of Efficacy|0
6859315|NCT00403754|10868768|FG002|Core Treatment Period 2|Lack of Efficacy|1
6859316|NCT00403754|10868769|FG003|Core Treatment Period 2|Lack of Efficacy|0
6859317|NCT00403767|10868783|FG000|Overall Study|Adverse Event|993
6859318|NCT00403767|10868784|FG001|Overall Study|Adverse Event|919
6859319|NCT00403767|10868783|FG000|Overall Study|Non-compliant with study medication|134
6859320|NCT00403767|10868784|FG001|Overall Study|Non-compliant with study medication|164
6859321|NCT00403767|10868783|FG000|Overall Study|Consent withdrawn|671
6859322|NCT00403767|10868784|FG001|Overall Study|Consent withdrawn|673
6859323|NCT00403767|10868783|FG000|Overall Study|Investigator dec./not protocol-related|191
6859324|NCT00403767|10868784|FG001|Overall Study|Investigator dec./not protocol-related|178
6859325|NCT00403767|10868783|FG000|Overall Study|Lost to Follow-up|6
6859326|NCT00403767|10868784|FG001|Overall Study|Lost to Follow-up|8
6859327|NCT00403767|10868783|FG000|Overall Study|Protocol Violation|142
6859328|NCT00403767|10868784|FG001|Overall Study|Protocol Violation|124
6859329|NCT00403767|10868783|FG000|Overall Study|Clinical efficacy endpoint reached|300
6859330|NCT00403767|10868784|FG001|Overall Study|Clinical efficacy endpoint reached|332
6859331|NCT00403767|10868783|FG000|Overall Study|Study terminated by sponsor|82
6859332|NCT00403767|10868784|FG001|Overall Study|Study terminated by sponsor|69
6859333|NCT00403767|10868783|FG000|Overall Study|Missing/incomplete data|1
6859334|NCT00403767|10868784|FG001|Overall Study|Missing/incomplete data|1
7077945|NCT02098395|11186116|FG002|Overall Study|Withdrawal by Subject|5
7077946|NCT02098395|11186117|FG003|Overall Study|Withdrawal by Subject|13
6859335|NCT00403845|10868790|FG000|Treatment Period 1|Subject withdrew consent|1
6859336|NCT00403845|10868791|FG001|Treatment Period 1|Subject withdrew consent|0
6859337|NCT00403845|10868792|FG002|Treatment Period 1|Subject withdrew consent|0
6859338|NCT00403845|10868793|FG003|Treatment Period 1|Subject withdrew consent|0
6859339|NCT00403845|10868790|FG000|Treatment Period 1|Subject no longer needs study drug|0
6859340|NCT00403845|10868791|FG001|Treatment Period 1|Subject no longer needs study drug|0
6859341|NCT00403845|10868792|FG002|Treatment Period 1|Subject no longer needs study drug|0
6859342|NCT00403845|10868793|FG003|Treatment Period 1|Subject no longer needs study drug|1
6859343|NCT00403845|10868790|FG000|Treatment Period 2|Subject withdrew consent|1
6859344|NCT00403845|10868791|FG001|Treatment Period 2|Subject withdrew consent|0
6859345|NCT00403845|10868792|FG002|Treatment Period 2|Subject withdrew consent|0
6859346|NCT00403845|10868793|FG003|Treatment Period 2|Subject withdrew consent|0
6859347|NCT00403845|10868790|FG000|Treatment Period 3|Subject withdrew consent|0
6859348|NCT00403845|10868791|FG001|Treatment Period 3|Subject withdrew consent|0
6859349|NCT00403845|10868792|FG002|Treatment Period 3|Subject withdrew consent|0
6859350|NCT00403845|10868793|FG003|Treatment Period 3|Subject withdrew consent|1
6859351|NCT00403845|10868790|FG000|Treatment Period 3|Adverse Event|0
6859352|NCT00403845|10868791|FG001|Treatment Period 3|Adverse Event|0
6859353|NCT00403845|10868792|FG002|Treatment Period 3|Adverse Event|0
6859354|NCT00403845|10868793|FG003|Treatment Period 3|Adverse Event|1
6859355|NCT00404066|10868803|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1
6859356|NCT00404066|10868803|FG000|Overall Study|Withdrawal by Subject - Adverse event|2
6859357|NCT00404079|10868809|FG000|Overall Study|Lost to follow up, adverse event etc|22
6859358|NCT00404079|10868810|FG001|Overall Study|Lost to follow up, adverse event etc|20
6859359|NCT00404092|10868820|FG000|Overall Study|Death|1
6859360|NCT00404092|10868821|FG001|Overall Study|Death|0
6859361|NCT00404092|10868822|FG002|Overall Study|Death|0
6859362|NCT00404092|10868823|FG003|Overall Study|Death|0
6859363|NCT00404092|10868820|FG000|Overall Study|Adverse Event|0
6859364|NCT00404092|10868821|FG001|Overall Study|Adverse Event|0
6859365|NCT00404092|10868822|FG002|Overall Study|Adverse Event|1
6859366|NCT00404092|10868823|FG003|Overall Study|Adverse Event|0
6859367|NCT00404235|10868835|FG000|Overall Study|Withdrawal by Subject|1
6859368|NCT00404235|10868836|FG001|Overall Study|Withdrawal by Subject|2
6859369|NCT00404248|10868845|FG000|Overall Study|pts declining status|0
6859370|NCT00404248|10868846|FG001|Overall Study|pts declining status|1
6859371|NCT00404248|10868847|FG002|Overall Study|pts declining status|0
6859372|NCT00404248|10868848|FG003|Overall Study|pts declining status|0
6859373|NCT00404248|10868849|FG004|Overall Study|pts declining status|0
6859374|NCT00404248|10868850|FG005|Overall Study|pts declining status|0
6859375|NCT00404248|10868851|FG006|Overall Study|pts declining status|0
7077947|NCT02098395|11186114|FG000|Overall Study|Adverse Event|12
7077948|NCT02098395|11186115|FG001|Overall Study|Adverse Event|19
7152923|NCT03267940|11318045|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3
6859376|NCT00404248|10868852|FG007|Overall Study|pts declining status|0
6859377|NCT00404248|10868853|FG008|Overall Study|pts declining status|0
6859378|NCT00404352|10868882|FG000|Double Blind (up to 24 Month)|Adverse Event|5
6859379|NCT00404352|10868883|FG001|Double Blind (up to 24 Month)|Adverse Event|4
6859380|NCT00404352|10868884|FG002|Double Blind (up to 24 Month)|Adverse Event|6
6859381|NCT00404352|10868885|FG003|Double Blind (up to 24 Month)|Adverse Event|0
6859382|NCT00404352|10868886|FG004|Double Blind (up to 24 Month)|Adverse Event|0
6859383|NCT00404352|10868887|FG005|Double Blind (up to 24 Month)|Adverse Event|0
6859384|NCT00404352|10868888|FG006|Double Blind (up to 24 Month)|Adverse Event|0
6859385|NCT00404352|10868889|FG007|Double Blind (up to 24 Month)|Adverse Event|0
6859386|NCT00404352|10868890|FG008|Double Blind (up to 24 Month)|Adverse Event|0
6859387|NCT00404352|10868882|FG000|Double Blind (up to 24 Month)|Pregnancy|0
6859388|NCT00404352|10868883|FG001|Double Blind (up to 24 Month)|Pregnancy|0
6859389|NCT00404352|10868884|FG002|Double Blind (up to 24 Month)|Pregnancy|2
6859390|NCT00404352|10868885|FG003|Double Blind (up to 24 Month)|Pregnancy|0
6859391|NCT00404352|10868886|FG004|Double Blind (up to 24 Month)|Pregnancy|0
6859392|NCT00404352|10868887|FG005|Double Blind (up to 24 Month)|Pregnancy|0
6859393|NCT00404352|10868888|FG006|Double Blind (up to 24 Month)|Pregnancy|0
6859394|NCT00404352|10868889|FG007|Double Blind (up to 24 Month)|Pregnancy|0
6859395|NCT00404352|10868890|FG008|Double Blind (up to 24 Month)|Pregnancy|0
6859396|NCT00404352|10868882|FG000|Double Blind (up to 24 Month)|Death|0
6859397|NCT00404352|10868883|FG001|Double Blind (up to 24 Month)|Death|0
6859398|NCT00404352|10868884|FG002|Double Blind (up to 24 Month)|Death|1
6859399|NCT00404352|10868885|FG003|Double Blind (up to 24 Month)|Death|0
6859400|NCT00404352|10868886|FG004|Double Blind (up to 24 Month)|Death|0
6859401|NCT00404352|10868887|FG005|Double Blind (up to 24 Month)|Death|0
6859402|NCT00404352|10868888|FG006|Double Blind (up to 24 Month)|Death|0
6859403|NCT00404352|10868889|FG007|Double Blind (up to 24 Month)|Death|0
6859404|NCT00404352|10868890|FG008|Double Blind (up to 24 Month)|Death|0
6859405|NCT00404352|10868882|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1
6859406|NCT00404352|10868883|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2
6859407|NCT00404352|10868884|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1
6859408|NCT00404352|10868885|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0
6859409|NCT00404352|10868886|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0
6859410|NCT00404352|10868887|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0
6859411|NCT00404352|10868888|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0
6859412|NCT00404352|10868889|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0
6859413|NCT00404352|10868890|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0
6859414|NCT00404352|10868882|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11
6859415|NCT00404352|10868883|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8
6859416|NCT00404352|10868884|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7
6859417|NCT00404352|10868885|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0
6859418|NCT00404352|10868886|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0
6859419|NCT00404352|10868887|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0
6859420|NCT00404352|10868888|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0
6859421|NCT00404352|10868889|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0
6859422|NCT00404352|10868890|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0
6859423|NCT00404352|10868882|FG000|Double Blind (up to 24 Month)|Disease progression|3
6859424|NCT00404352|10868883|FG001|Double Blind (up to 24 Month)|Disease progression|0
6859425|NCT00404352|10868884|FG002|Double Blind (up to 24 Month)|Disease progression|2
6859426|NCT00404352|10868885|FG003|Double Blind (up to 24 Month)|Disease progression|0
6859427|NCT00404352|10868886|FG004|Double Blind (up to 24 Month)|Disease progression|0
6859428|NCT00404352|10868887|FG005|Double Blind (up to 24 Month)|Disease progression|0
6859429|NCT00404352|10868888|FG006|Double Blind (up to 24 Month)|Disease progression|0
6859430|NCT00404352|10868889|FG007|Double Blind (up to 24 Month)|Disease progression|0
6859431|NCT00404352|10868890|FG008|Double Blind (up to 24 Month)|Disease progression|0
6859432|NCT00404352|10868882|FG000|Double Blind (up to 24 Month)|Poor compliance|1
6859433|NCT00404352|10868883|FG001|Double Blind (up to 24 Month)|Poor compliance|0
6859434|NCT00404352|10868884|FG002|Double Blind (up to 24 Month)|Poor compliance|0
6859435|NCT00404352|10868885|FG003|Double Blind (up to 24 Month)|Poor compliance|0
6859436|NCT00404352|10868886|FG004|Double Blind (up to 24 Month)|Poor compliance|0
6859437|NCT00404352|10868887|FG005|Double Blind (up to 24 Month)|Poor compliance|0
6859438|NCT00404352|10868888|FG006|Double Blind (up to 24 Month)|Poor compliance|0
6859439|NCT00404352|10868889|FG007|Double Blind (up to 24 Month)|Poor compliance|0
6859440|NCT00404352|10868890|FG008|Double Blind (up to 24 Month)|Poor compliance|0
6859441|NCT00404352|10868882|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31
6859442|NCT00404352|10868883|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30
6859443|NCT00404352|10868884|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59
6859444|NCT00404352|10868885|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0
6859445|NCT00404352|10868886|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0
7077949|NCT02098395|11186116|FG002|Overall Study|Adverse Event|34
7077950|NCT02098395|11186117|FG003|Overall Study|Adverse Event|2
7077951|NCT02098395|11186114|FG000|Overall Study|Lost to Follow-up|2
7077952|NCT02098395|11186115|FG001|Overall Study|Lost to Follow-up|1
7077953|NCT02098395|11186116|FG002|Overall Study|Lost to Follow-up|0
6859446|NCT00404352|10868887|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0
6859447|NCT00404352|10868888|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0
6859448|NCT00404352|10868889|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0
7077954|NCT02098395|11186117|FG003|Overall Study|Lost to Follow-up|3
7077955|NCT02098395|11186114|FG000|Overall Study|Unclassified|0
7077956|NCT02098395|11186115|FG001|Overall Study|Unclassified|0
6859449|NCT00404352|10868890|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0
6859450|NCT00404352|10868882|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0
6859451|NCT00404352|10868883|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2
6859452|NCT00404352|10868884|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0
6859453|NCT00404352|10868885|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0
6859454|NCT00404352|10868886|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0
6859455|NCT00404352|10868887|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0
6859456|NCT00404352|10868888|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0
6859457|NCT00404352|10868889|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0
6859458|NCT00404352|10868890|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0
6859459|NCT00404352|10868882|FG000|Double Blind (up to 24 Month)|Physician Decision|0
6859460|NCT00404352|10868883|FG001|Double Blind (up to 24 Month)|Physician Decision|0
6859461|NCT00404352|10868884|FG002|Double Blind (up to 24 Month)|Physician Decision|1
6859462|NCT00404352|10868885|FG003|Double Blind (up to 24 Month)|Physician Decision|0
6859463|NCT00404352|10868886|FG004|Double Blind (up to 24 Month)|Physician Decision|0
6859464|NCT00404352|10868887|FG005|Double Blind (up to 24 Month)|Physician Decision|0
6859465|NCT00404352|10868888|FG006|Double Blind (up to 24 Month)|Physician Decision|0
6859466|NCT00404352|10868889|FG007|Double Blind (up to 24 Month)|Physician Decision|0
6859467|NCT00404352|10868890|FG008|Double Blind (up to 24 Month)|Physician Decision|0
6859468|NCT00404352|10868882|FG000|Double Blind (up to 24 Month)|Other|0
6859469|NCT00404352|10868883|FG001|Double Blind (up to 24 Month)|Other|1
6859470|NCT00404352|10868884|FG002|Double Blind (up to 24 Month)|Other|0
6859471|NCT00404352|10868885|FG003|Double Blind (up to 24 Month)|Other|0
6859472|NCT00404352|10868886|FG004|Double Blind (up to 24 Month)|Other|0
6859473|NCT00404352|10868887|FG005|Double Blind (up to 24 Month)|Other|0
6859474|NCT00404352|10868888|FG006|Double Blind (up to 24 Month)|Other|0
6859475|NCT00404352|10868889|FG007|Double Blind (up to 24 Month)|Other|0
6859476|NCT00404352|10868890|FG008|Double Blind (up to 24 Month)|Other|0
6859477|NCT00404352|10868882|FG000|Open Label (up to 24 Month)|Adverse Event|0
6859478|NCT00404352|10868883|FG001|Open Label (up to 24 Month)|Adverse Event|0
6859479|NCT00404352|10868884|FG002|Open Label (up to 24 Month)|Adverse Event|0
6859480|NCT00404352|10868885|FG003|Open Label (up to 24 Month)|Adverse Event|2
6859481|NCT00404352|10868886|FG004|Open Label (up to 24 Month)|Adverse Event|1
6859482|NCT00404352|10868887|FG005|Open Label (up to 24 Month)|Adverse Event|1
6859483|NCT00404352|10868888|FG006|Open Label (up to 24 Month)|Adverse Event|0
6859484|NCT00404352|10868889|FG007|Open Label (up to 24 Month)|Adverse Event|0
6859485|NCT00404352|10868890|FG008|Open Label (up to 24 Month)|Adverse Event|0
6859486|NCT00404352|10868882|FG000|Open Label (up to 24 Month)|Pregnancy|0
6859487|NCT00404352|10868883|FG001|Open Label (up to 24 Month)|Pregnancy|0
6859488|NCT00404352|10868884|FG002|Open Label (up to 24 Month)|Pregnancy|0
6859489|NCT00404352|10868885|FG003|Open Label (up to 24 Month)|Pregnancy|0
6859490|NCT00404352|10868886|FG004|Open Label (up to 24 Month)|Pregnancy|0
6859491|NCT00404352|10868887|FG005|Open Label (up to 24 Month)|Pregnancy|1
6859492|NCT00404352|10868888|FG006|Open Label (up to 24 Month)|Pregnancy|0
6859493|NCT00404352|10868889|FG007|Open Label (up to 24 Month)|Pregnancy|0
6859494|NCT00404352|10868890|FG008|Open Label (up to 24 Month)|Pregnancy|0
6859495|NCT00404352|10868882|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0
6859496|NCT00404352|10868883|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0
6859497|NCT00404352|10868884|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0
6859498|NCT00404352|10868885|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0
6859499|NCT00404352|10868886|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1
6859500|NCT00404352|10868887|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0
6859501|NCT00404352|10868888|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0
6859502|NCT00404352|10868889|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0
6859503|NCT00404352|10868890|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0
6859504|NCT00404352|10868882|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0
6859505|NCT00404352|10868883|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0
6859506|NCT00404352|10868884|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0
6859507|NCT00404352|10868885|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0
6859508|NCT00404352|10868886|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0
6859509|NCT00404352|10868887|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5
6859510|NCT00404352|10868888|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0
6859511|NCT00404352|10868889|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0
6859512|NCT00404352|10868890|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0
6859513|NCT00404352|10868882|FG000|Open Label (up to 24 Month)|Disease progression|0
6859514|NCT00404352|10868883|FG001|Open Label (up to 24 Month)|Disease progression|0
6859515|NCT00404352|10868884|FG002|Open Label (up to 24 Month)|Disease progression|0
6859516|NCT00404352|10868885|FG003|Open Label (up to 24 Month)|Disease progression|1
6859517|NCT00404352|10868886|FG004|Open Label (up to 24 Month)|Disease progression|0
6859518|NCT00404352|10868887|FG005|Open Label (up to 24 Month)|Disease progression|0
6859519|NCT00404352|10868888|FG006|Open Label (up to 24 Month)|Disease progression|0
6859520|NCT00404352|10868889|FG007|Open Label (up to 24 Month)|Disease progression|0
6859521|NCT00404352|10868890|FG008|Open Label (up to 24 Month)|Disease progression|0
6859522|NCT00404352|10868882|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0
6859523|NCT00404352|10868883|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0
6859524|NCT00404352|10868884|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0
6859525|NCT00404352|10868885|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0
6859526|NCT00404352|10868886|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0
6859527|NCT00404352|10868887|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0
6859528|NCT00404352|10868888|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1
6859529|NCT00404352|10868889|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1
6859530|NCT00404352|10868890|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0
6859531|NCT00404352|10868882|FG000|Open Label Extension (up to 36 Months)|Other|0
6859532|NCT00404352|10868883|FG001|Open Label Extension (up to 36 Months)|Other|0
6859533|NCT00404352|10868884|FG002|Open Label Extension (up to 36 Months)|Other|0
6859534|NCT00404352|10868885|FG003|Open Label Extension (up to 36 Months)|Other|0
6859535|NCT00404352|10868886|FG004|Open Label Extension (up to 36 Months)|Other|0
6859536|NCT00404352|10868887|FG005|Open Label Extension (up to 36 Months)|Other|0
6859537|NCT00404352|10868888|FG006|Open Label Extension (up to 36 Months)|Other|0
6859538|NCT00404352|10868889|FG007|Open Label Extension (up to 36 Months)|Other|0
6859539|NCT00404352|10868890|FG008|Open Label Extension (up to 36 Months)|Other|2
6859540|NCT00404495|10868909|FG000|Overall Study|Death|37
6859541|NCT00404495|10868910|FG001|Overall Study|Death|11
6859542|NCT00404495|10868909|FG000|Overall Study|Lost to Follow-up|5
6859543|NCT00404495|10868910|FG001|Overall Study|Lost to Follow-up|0
6859544|NCT00404495|10868909|FG000|Overall Study|Other|1
6859545|NCT00404495|10868910|FG001|Overall Study|Other|0
6859546|NCT00404495|10868909|FG000|Overall Study|Withdrawal by Subject|1
6859547|NCT00404495|10868910|FG001|Overall Study|Withdrawal by Subject|0
6859548|NCT00404547|10868918|FG000|Overall Study|Adverse Event|39
6859549|NCT00404547|10868919|FG001|Overall Study|Adverse Event|6
6859550|NCT00404547|10868918|FG000|Overall Study|Withdrawal by Subject|19
6859551|NCT00404547|10868919|FG001|Overall Study|Withdrawal by Subject|2
6859552|NCT00404547|10868918|FG000|Overall Study|Protocol Violation|0
6859553|NCT00404547|10868919|FG001|Overall Study|Protocol Violation|1
6859554|NCT00404547|10868918|FG000|Overall Study|Lost to Follow-up|20
6859555|NCT00404547|10868919|FG001|Overall Study|Lost to Follow-up|9
6859556|NCT00404547|10868918|FG000|Overall Study|Lack of compliance|5
6859557|NCT00404547|10868919|FG001|Overall Study|Lack of compliance|1
6859558|NCT00404547|10868918|FG000|Overall Study|Other|4
6859559|NCT00404547|10868919|FG001|Overall Study|Other|0
6859560|NCT00404547|10868918|FG000|Overall Study|Reason not stated|3
6859561|NCT00404547|10868919|FG001|Overall Study|Reason not stated|6
6859562|NCT00404651|10868929|FG000|Overall Study|Serious Adverse Event|0
6859563|NCT00404651|10868930|FG001|Overall Study|Serious Adverse Event|0
6859564|NCT00404651|10868931|FG002|Overall Study|Serious Adverse Event|2
6859565|NCT00404651|10868932|FG003|Overall Study|Serious Adverse Event|0
6859566|NCT00404651|10868929|FG000|Overall Study|Protocol Violation|10
6859567|NCT00404651|10868930|FG001|Overall Study|Protocol Violation|5
6859568|NCT00404651|10868931|FG002|Overall Study|Protocol Violation|14
6859569|NCT00404651|10868932|FG003|Overall Study|Protocol Violation|5
6859570|NCT00404651|10868929|FG000|Overall Study|Lost to Follow-up|15
6859571|NCT00404651|10868930|FG001|Overall Study|Lost to Follow-up|11
6859572|NCT00404651|10868931|FG002|Overall Study|Lost to Follow-up|13
6859573|NCT00404651|10868932|FG003|Overall Study|Lost to Follow-up|10
6859574|NCT00404651|10868929|FG000|Overall Study|Withdrawal by Subject|14
6859575|NCT00404651|10868930|FG001|Overall Study|Withdrawal by Subject|12
6859576|NCT00404651|10868931|FG002|Overall Study|Withdrawal by Subject|16
6859577|NCT00404651|10868932|FG003|Overall Study|Withdrawal by Subject|6
6859578|NCT00404755|10868942|FG000|Phase I (Bupropion)|Adverse Event|3
6859579|NCT00404755|10868942|FG000|Phase I (Bupropion)|Other|1
6859580|NCT00404755|10868942|FG000|Phase II (Escitalopram)|Lost to Follow-up|2
6859581|NCT00404768|10868954|FG000|Part A and B|Withdrawn due to labor progression|1
6859582|NCT00404768|10868955|FG001|Part A and B|Withdrawn due to labor progression|0
6859583|NCT00404768|10868956|FG002|Part A and B|Withdrawn due to labor progression|0
6859584|NCT00404768|10868957|FG003|Part A and B|Withdrawn due to labor progression|0
6859585|NCT00404768|10868954|FG000|Part A and B|Withdrawn as delivery imminemnt|0
6859586|NCT00404768|10868955|FG001|Part A and B|Withdrawn as delivery imminemnt|1
6859587|NCT00404768|10868956|FG002|Part A and B|Withdrawn as delivery imminemnt|0
6859588|NCT00404768|10868957|FG003|Part A and B|Withdrawn as delivery imminemnt|0
6859589|NCT00404768|10868954|FG000|Part C|Adverse Event|0
6859590|NCT00404768|10868955|FG001|Part C|Adverse Event|0
6859591|NCT00404768|10868956|FG002|Part C|Adverse Event|0
6859592|NCT00404768|10868957|FG003|Part C|Adverse Event|3
6859593|NCT00404768|10868954|FG000|Part C|Lost to Follow-up|0
6859594|NCT00404768|10868955|FG001|Part C|Lost to Follow-up|0
6859595|NCT00404768|10868956|FG002|Part C|Lost to Follow-up|3
6859596|NCT00404768|10868957|FG003|Part C|Lost to Follow-up|1
6859597|NCT00404768|10868954|FG000|Part C|Withdrawal by Subject|0
6859598|NCT00404768|10868955|FG001|Part C|Withdrawal by Subject|0
6859599|NCT00404768|10868956|FG002|Part C|Withdrawal by Subject|2
6859600|NCT00404768|10868957|FG003|Part C|Withdrawal by Subject|1
6859601|NCT00404768|10868954|FG000|Part C|Early withdrawal from study medication|0
6859602|NCT00404768|10868955|FG001|Part C|Early withdrawal from study medication|0
6859603|NCT00404768|10868956|FG002|Part C|Early withdrawal from study medication|1
6859604|NCT00404768|10868957|FG003|Part C|Early withdrawal from study medication|0
6859605|NCT00404768|10868954|FG000|Part C|Participant did not respond to therapy|0
6859606|NCT00404768|10868955|FG001|Part C|Participant did not respond to therapy|0
6859607|NCT00404768|10868956|FG002|Part C|Participant did not respond to therapy|1
6859608|NCT00404768|10868957|FG003|Part C|Participant did not respond to therapy|1
6859609|NCT00404768|10868954|FG000|Part C|Physician withdrew the study medication|0
6859610|NCT00404768|10868955|FG001|Part C|Physician withdrew the study medication|0
6859611|NCT00404768|10868956|FG002|Part C|Physician withdrew the study medication|1
6859612|NCT00404768|10868957|FG003|Part C|Physician withdrew the study medication|0
6859613|NCT00404768|10868954|FG000|Part C|Participant delivered baby|0
6859614|NCT00404768|10868955|FG001|Part C|Participant delivered baby|0
6859615|NCT00404768|10868956|FG002|Part C|Participant delivered baby|0
6859616|NCT00404768|10868957|FG003|Part C|Participant delivered baby|1
6859617|NCT00404768|10868954|FG000|Part C|Unsatisfactory uterine response to IP|0
6859618|NCT00404768|10868955|FG001|Part C|Unsatisfactory uterine response to IP|0
6859619|NCT00404768|10868956|FG002|Part C|Unsatisfactory uterine response to IP|0
6859620|NCT00404768|10868957|FG003|Part C|Unsatisfactory uterine response to IP|1
6859621|NCT00404768|10868954|FG000|Part C|Active labor|0
6859622|NCT00404768|10868955|FG001|Part C|Active labor|0
6859623|NCT00404768|10868956|FG002|Part C|Active labor|0
6859624|NCT00404768|10868957|FG003|Part C|Active labor|1
6859625|NCT00404768|10868954|FG000|Part C|Lack of Efficacy|0
6859626|NCT00404768|10868955|FG001|Part C|Lack of Efficacy|0
6859627|NCT00404768|10868956|FG002|Part C|Lack of Efficacy|0
6859628|NCT00404768|10868957|FG003|Part C|Lack of Efficacy|2
6859629|NCT00404768|10868954|FG000|Part C|Treatment failure|0
6859630|NCT00404768|10868955|FG001|Part C|Treatment failure|0
6859631|NCT00404768|10868956|FG002|Part C|Treatment failure|0
6859632|NCT00404768|10868957|FG003|Part C|Treatment failure|1
6859633|NCT00404768|10868954|FG000|Part C|Investigator discretion|0
6859634|NCT00404768|10868955|FG001|Part C|Investigator discretion|0
6859635|NCT00404768|10868956|FG002|Part C|Investigator discretion|0
6859636|NCT00404768|10868957|FG003|Part C|Investigator discretion|1
6859637|NCT00404768|10868954|FG000|Part C|Researcher suspended study medication|0
6859638|NCT00404768|10868955|FG001|Part C|Researcher suspended study medication|0
6859639|NCT00404768|10868956|FG002|Part C|Researcher suspended study medication|0
6859640|NCT00404768|10868957|FG003|Part C|Researcher suspended study medication|1
6859641|NCT00404820|10868974|FG000|Overall Study|Adverse Event|4
6859642|NCT00404820|10868975|FG001|Overall Study|Adverse Event|16
6859643|NCT00404820|10868974|FG000|Overall Study|Withdrawal by Subject|5
6859644|NCT00404820|10868975|FG001|Overall Study|Withdrawal by Subject|3
6859645|NCT00404820|10868974|FG000|Overall Study|Lost to Follow-up|7
6859646|NCT00404820|10868975|FG001|Overall Study|Lost to Follow-up|3
6859647|NCT00404820|10868974|FG000|Overall Study|Administrative problems|2
6859648|NCT00404820|10868975|FG001|Overall Study|Administrative problems|0
6859649|NCT00404820|10868974|FG000|Overall Study|Death|1
6967662|NCT01133405|11016051|FG002|Period 1|Received drug only in period 2|0
6967663|NCT01133405|11016052|FG003|Period 1|Received drug only in period 2|2
6967664|NCT01133405|11016053|FG004|Period 1|Received drug only in period 2|0
6967665|NCT01133405|11016054|FG005|Period 1|Received drug only in period 2|1
6967666|NCT01133405|11016055|FG006|Period 1|Received drug only in period 2|0
6967667|NCT01133405|11016056|FG007|Period 1|Received drug only in period 2|0
6967668|NCT01133405|11016057|FG008|Period 1|Received drug only in period 2|0
6967669|NCT01133405|11016058|FG009|Period 1|Received drug only in period 2|0
6967670|NCT01133405|11016049|FG000|Period 1|Received drug only in period 3|0
6967671|NCT01133405|11016050|FG001|Period 1|Received drug only in period 3|1
6967672|NCT01133405|11016051|FG002|Period 1|Received drug only in period 3|1
6967673|NCT01133405|11016052|FG003|Period 1|Received drug only in period 3|0
6967674|NCT01133405|11016053|FG004|Period 1|Received drug only in period 3|0
7152924|NCT03267940|11318046|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0
7152925|NCT03267940|11318047|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0
6859650|NCT00404820|10868975|FG001|Overall Study|Death|0
6859651|NCT00404820|10868974|FG000|Overall Study|Other|0
6859652|NCT00404820|10868975|FG001|Overall Study|Other|2
6859653|NCT00404924|10868983|FG000|Overall Study|Adverse Event|75
6859654|NCT00404924|10868984|FG001|Overall Study|Adverse Event|16
6859655|NCT00404924|10868983|FG000|Overall Study|Condition under investigation worsened|475
6859656|NCT00404924|10868984|FG001|Overall Study|Condition under investigation worsened|264
6859657|NCT00404924|10868983|FG000|Overall Study|Lost to Follow-up|1
6859658|NCT00404924|10868984|FG001|Overall Study|Lost to Follow-up|1
7152926|NCT03267940|11318048|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0
7152927|NCT03267940|11318049|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0
6859659|NCT00404924|10868983|FG000|Overall Study|Withdrawal by Subject|26
6859660|NCT00404924|10868984|FG001|Overall Study|Withdrawal by Subject|13
6859661|NCT00404924|10868983|FG000|Overall Study|Other|25
6859662|NCT00404924|10868984|FG001|Overall Study|Other|11
6859663|NCT00404924|10868983|FG000|Overall Study|Randomised but not received treatment|1
6859664|NCT00404924|10868984|FG001|Overall Study|Randomised but not received treatment|1
6859665|NCT00405067|10868993|FG000|Overall Study|Adverse Event|4
6859666|NCT00405067|10868994|FG001|Overall Study|Adverse Event|9
6859667|NCT00405067|10868995|FG002|Overall Study|Adverse Event|4
6859668|NCT00405067|10868993|FG000|Overall Study|Lost to Follow-up|0
6859669|NCT00405067|10868994|FG001|Overall Study|Lost to Follow-up|0
6859670|NCT00405067|10868995|FG002|Overall Study|Lost to Follow-up|1
6859671|NCT00405275|10869005|FG000|Overall Study|Death|1
6859672|NCT00405275|10869006|FG001|Overall Study|Death|0
6859673|NCT00405275|10869005|FG000|Overall Study|Lost to Follow-up|5
6859674|NCT00405275|10869006|FG001|Overall Study|Lost to Follow-up|1
6859675|NCT00405275|10869005|FG000|Overall Study|Withdrawal by Subject|7
6859676|NCT00405275|10869006|FG001|Overall Study|Withdrawal by Subject|9
6859677|NCT00405275|10869005|FG000|Overall Study|Unwilling to continue|10
6859678|NCT00405275|10869006|FG001|Overall Study|Unwilling to continue|9
6859679|NCT00405392|10869027|FG000|Overall Study|Adverse Event|15
6859680|NCT00405392|10869028|FG001|Overall Study|Adverse Event|14
6859681|NCT00405392|10869027|FG000|Overall Study|Did not meet Eligibility criteria|7
6859682|NCT00405392|10869028|FG001|Overall Study|Did not meet Eligibility criteria|2
6859683|NCT00405392|10869027|FG000|Overall Study|Withdrawal by Subject|4
6859684|NCT00405392|10869028|FG001|Overall Study|Withdrawal by Subject|3
6859685|NCT00405392|10869027|FG000|Overall Study|Lost to Follow-up|1
6859686|NCT00405392|10869028|FG001|Overall Study|Lost to Follow-up|2
6859687|NCT00405392|10869027|FG000|Overall Study|Data missing|2
6859688|NCT00405392|10869028|FG001|Overall Study|Data missing|0
6859689|NCT00405392|10869027|FG000|Overall Study|Non-compliance|0
6859690|NCT00405392|10869028|FG001|Overall Study|Non-compliance|1
6859691|NCT00405392|10869027|FG000|Overall Study|Other|1
6859692|NCT00405392|10869028|FG001|Overall Study|Other|5
6859693|NCT00405548|10869054|FG000|Overall Study|Cognitive Memory problems on study day|1
6859694|NCT00405548|10869055|FG001|Overall Study|Cognitive Memory problems on study day|0
6859695|NCT00405548|10869054|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0
6859696|NCT00405548|10869055|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1
6859697|NCT00405548|10869054|FG000|Overall Study|Unable to self-administer shots|1
6859698|NCT00405548|10869055|FG001|Overall Study|Unable to self-administer shots|0
6859699|NCT00405548|10869054|FG000|Overall Study|Venous access failed during study day|1
6859700|NCT00405548|10869055|FG001|Overall Study|Venous access failed during study day|0
6859701|NCT00405548|10869054|FG000|Overall Study|Withdrawal by Subject|1
6859702|NCT00405548|10869055|FG001|Overall Study|Withdrawal by Subject|0
6859703|NCT00405587|10869065|FG000|Overall Study|Death|0
6859704|NCT00405587|10869066|FG001|Overall Study|Death|0
6859705|NCT00405587|10869067|FG002|Overall Study|Death|0
6859706|NCT00405587|10869068|FG003|Overall Study|Death|1
6859707|NCT00405587|10869065|FG000|Overall Study|Disease Progression|22
6859708|NCT00405587|10869066|FG001|Overall Study|Disease Progression|23
6859709|NCT00405587|10869067|FG002|Overall Study|Disease Progression|21
6859710|NCT00405587|10869068|FG003|Overall Study|Disease Progression|17
6859711|NCT00405587|10869065|FG000|Overall Study|Physician Decision|3
6859712|NCT00405587|10869066|FG001|Overall Study|Physician Decision|2
6859713|NCT00405587|10869067|FG002|Overall Study|Physician Decision|0
6859714|NCT00405587|10869068|FG003|Overall Study|Physician Decision|0
6859715|NCT00405587|10869065|FG000|Overall Study|Adverse Event|1
6859716|NCT00405587|10869066|FG001|Overall Study|Adverse Event|0
6859717|NCT00405587|10869067|FG002|Overall Study|Adverse Event|0
6859718|NCT00405587|10869068|FG003|Overall Study|Adverse Event|0
6859719|NCT00405587|10869065|FG000|Overall Study|Lost to Follow-up|0
6859720|NCT00405587|10869066|FG001|Overall Study|Lost to Follow-up|1
6859721|NCT00405587|10869067|FG002|Overall Study|Lost to Follow-up|1
6859722|NCT00405587|10869068|FG003|Overall Study|Lost to Follow-up|0
6859723|NCT00405587|10869065|FG000|Overall Study|Radiation induced necrosis|0
6859724|NCT00405587|10869066|FG001|Overall Study|Radiation induced necrosis|1
6859725|NCT00405587|10869067|FG002|Overall Study|Radiation induced necrosis|0
6859726|NCT00405587|10869068|FG003|Overall Study|Radiation induced necrosis|0
6859727|NCT00405587|10869065|FG000|Overall Study|Withdrawal by Subject|0
6859728|NCT00405587|10869066|FG001|Overall Study|Withdrawal by Subject|0
6859729|NCT00405587|10869067|FG002|Overall Study|Withdrawal by Subject|0
6859730|NCT00405587|10869068|FG003|Overall Study|Withdrawal by Subject|2
6859731|NCT00405587|10869065|FG000|Overall Study|Participant not dosed|0
6859732|NCT00405587|10869066|FG001|Overall Study|Participant not dosed|1
6859733|NCT00405587|10869067|FG002|Overall Study|Participant not dosed|0
6859734|NCT00405587|10869068|FG003|Overall Study|Participant not dosed|0
6859735|NCT00405639|10869106|FG000|Overall Study|Withdrawal by Subject|1
6859736|NCT00405639|10869107|FG001|Overall Study|Withdrawal by Subject|0
6859737|NCT00405639|10869106|FG000|Overall Study|Adverse Event|1
6859738|NCT00405639|10869107|FG001|Overall Study|Adverse Event|0
6859739|NCT00405639|10869106|FG000|Overall Study|Seizure prior to receiving BNP|1
6859740|NCT00405639|10869107|FG001|Overall Study|Seizure prior to receiving BNP|0
6859741|NCT00405652|10869113|FG000|Overall Study|Adverse Event|4
6859742|NCT00405756|10869130|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45
6859743|NCT00405756|10869131|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24
6859744|NCT00405756|10869132|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18
6859745|NCT00405756|10869130|FG000|Double-blind Treatment|Adverse Event|31
6859746|NCT00405756|10869131|FG001|Double-blind Treatment|Adverse Event|27
6859747|NCT00405756|10869132|FG002|Double-blind Treatment|Adverse Event|12
6859748|NCT00405756|10869130|FG000|Double-blind Treatment|Disease Progression|47
6859749|NCT00405756|10869131|FG001|Double-blind Treatment|Disease Progression|81
6859750|NCT00405756|10869132|FG002|Double-blind Treatment|Disease Progression|102
6859751|NCT00405756|10869130|FG000|Double-blind Treatment|Lack of Efficacy|1
6859752|NCT00405756|10869131|FG001|Double-blind Treatment|Lack of Efficacy|4
6859753|NCT00405756|10869132|FG002|Double-blind Treatment|Lack of Efficacy|2
6859754|NCT00405756|10869130|FG000|Double-blind Treatment|Withdrawal by Subject|15
6859755|NCT00405756|10869131|FG001|Double-blind Treatment|Withdrawal by Subject|9
6859756|NCT00405756|10869132|FG002|Double-blind Treatment|Withdrawal by Subject|10
6859757|NCT00405756|10869130|FG000|Double-blind Treatment|Lost to Follow-up|1
6859758|NCT00405756|10869131|FG001|Double-blind Treatment|Lost to Follow-up|0
6859759|NCT00405756|10869132|FG002|Double-blind Treatment|Lost to Follow-up|0
6859760|NCT00405756|10869130|FG000|Double-blind Treatment|Death|4
6859761|NCT00405756|10869131|FG001|Double-blind Treatment|Death|4
6859762|NCT00405756|10869132|FG002|Double-blind Treatment|Death|4
6859763|NCT00405756|10869130|FG000|Double-blind Treatment|Protocol Violation|1
6859764|NCT00405756|10869131|FG001|Double-blind Treatment|Protocol Violation|0
6859765|NCT00405756|10869132|FG002|Double-blind Treatment|Protocol Violation|2
6859766|NCT00405756|10869130|FG000|Double-blind Treatment|Other|7
6859767|NCT00405756|10869131|FG001|Double-blind Treatment|Other|4
6859768|NCT00405756|10869132|FG002|Double-blind Treatment|Other|4
6859769|NCT00405756|10869130|FG000|Open-label Extension|Ongoing in Open Label Period|7
6859770|NCT00405756|10869131|FG001|Open-label Extension|Ongoing in Open Label Period|15
6859771|NCT00405756|10869132|FG002|Open-label Extension|Ongoing in Open Label Period|25
6859772|NCT00405756|10869130|FG000|Open-label Extension|Adverse Event|1
6859773|NCT00405756|10869131|FG001|Open-label Extension|Adverse Event|3
6859774|NCT00405756|10869132|FG002|Open-label Extension|Adverse Event|7
6859775|NCT00405756|10869130|FG000|Open-label Extension|Disease Progression|8
6859776|NCT00405756|10869131|FG001|Open-label Extension|Disease Progression|23
6859777|NCT00405756|10869132|FG002|Open-label Extension|Disease Progression|26
6859778|NCT00405756|10869130|FG000|Open-label Extension|Withdrawal by Subject|2
6859779|NCT00405756|10869131|FG001|Open-label Extension|Withdrawal by Subject|3
6859780|NCT00405756|10869132|FG002|Open-label Extension|Withdrawal by Subject|3
6859781|NCT00405756|10869130|FG000|Open-label Extension|Death|1
6859782|NCT00405756|10869131|FG001|Open-label Extension|Death|2
6859783|NCT00405756|10869132|FG002|Open-label Extension|Death|4
6859784|NCT00405756|10869130|FG000|Open-label Extension|Other|0
6859785|NCT00405756|10869131|FG001|Open-label Extension|Other|1
6859786|NCT00405756|10869132|FG002|Open-label Extension|Other|7
6859787|NCT00405756|10869130|FG000|Follow-up|Ongoing in Follow-up Period|52
6859788|NCT00405756|10869131|FG001|Follow-up|Ongoing in Follow-up Period|51
6859789|NCT00405756|10869132|FG002|Follow-up|Ongoing in Follow-up Period|60
6859790|NCT00405756|10869130|FG000|Follow-up|Death|21
6859791|NCT00405756|10869131|FG001|Follow-up|Death|31
6859792|NCT00405756|10869132|FG002|Follow-up|Death|24
6859793|NCT00405756|10869130|FG000|Follow-up|Lost to Follow-up|2
6859794|NCT00405756|10869131|FG001|Follow-up|Lost to Follow-up|8
6859795|NCT00405756|10869132|FG002|Follow-up|Lost to Follow-up|4
6859796|NCT00405821|10869142|FG000|Overall Study|Death|5
6859797|NCT00405821|10869143|FG001|Overall Study|Death|7
6859798|NCT00405821|10869142|FG000|Overall Study|Lost to Follow-up|7
6859799|NCT00405821|10869143|FG001|Overall Study|Lost to Follow-up|7
6859800|NCT00405821|10869142|FG000|Overall Study|Protocol Violation|1
6859801|NCT00405821|10869143|FG001|Overall Study|Protocol Violation|0
6859802|NCT00405821|10869142|FG000|Overall Study|initiated ART|9
6859803|NCT00405821|10869143|FG001|Overall Study|initiated ART|8
6859804|NCT00405912|10869152|FG000|Overall Study|Withdrawal by Subject|12
6859805|NCT00405912|10869153|FG001|Overall Study|Withdrawal by Subject|11
6859806|NCT00405912|10869154|FG002|Overall Study|Withdrawal by Subject|12
6859807|NCT00405912|10869152|FG000|Overall Study|Lost to Follow-up|4
6859808|NCT00405912|10869153|FG001|Overall Study|Lost to Follow-up|8
6859809|NCT00405912|10869154|FG002|Overall Study|Lost to Follow-up|4
6859810|NCT00406029|10869176|FG000|Overall Study|Adverse Event|12
6859811|NCT00406029|10869177|FG001|Overall Study|Adverse Event|2
6859812|NCT00406029|10869178|FG002|Overall Study|Adverse Event|5
6859813|NCT00406029|10869179|FG003|Overall Study|Adverse Event|10
6859814|NCT00406029|10869180|FG004|Overall Study|Adverse Event|7
6859815|NCT00406029|10869176|FG000|Overall Study|Withdrawal by Subject|3
6859816|NCT00406029|10869177|FG001|Overall Study|Withdrawal by Subject|4
6859817|NCT00406029|10869178|FG002|Overall Study|Withdrawal by Subject|2
6859818|NCT00406029|10869179|FG003|Overall Study|Withdrawal by Subject|2
6859819|NCT00406029|10869180|FG004|Overall Study|Withdrawal by Subject|0
6859820|NCT00406029|10869176|FG000|Overall Study|Protocol Violation|1
6859821|NCT00406029|10869177|FG001|Overall Study|Protocol Violation|2
6859822|NCT00406029|10869178|FG002|Overall Study|Protocol Violation|0
6859823|NCT00406029|10869179|FG003|Overall Study|Protocol Violation|2
6859824|NCT00406029|10869180|FG004|Overall Study|Protocol Violation|0
6859825|NCT00406029|10869176|FG000|Overall Study|Did Not Meet Eligibility Criteria|0
6859826|NCT00406029|10869177|FG001|Overall Study|Did Not Meet Eligibility Criteria|0
6859827|NCT00406029|10869178|FG002|Overall Study|Did Not Meet Eligibility Criteria|1
6859828|NCT00406029|10869179|FG003|Overall Study|Did Not Meet Eligibility Criteria|0
6859829|NCT00406029|10869180|FG004|Overall Study|Did Not Meet Eligibility Criteria|0
6859830|NCT00406029|10869176|FG000|Overall Study|Randomized in Error|0
6859831|NCT00406029|10869177|FG001|Overall Study|Randomized in Error|0
6859832|NCT00406029|10869178|FG002|Overall Study|Randomized in Error|2
6859833|NCT00406029|10869179|FG003|Overall Study|Randomized in Error|3
6859834|NCT00406029|10869180|FG004|Overall Study|Randomized in Error|1
6859835|NCT00406315|10869229|FG000|Overall Study|Death|1
6859836|NCT00406315|10869229|FG000|Overall Study|Adverse Event|39
7152928|NCT03267940|11318044|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
7152929|NCT03267940|11318045|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
7152930|NCT03267940|11318046|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
7152931|NCT03267940|11318047|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3
7152932|NCT03267940|11318048|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2
7152933|NCT03267940|11318049|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
7152934|NCT03267940|11318044|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
7152935|NCT03267940|11318045|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
7152936|NCT03267940|11318046|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2
7152937|NCT03267940|11318047|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1
7152938|NCT03267940|11318048|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2
7152939|NCT03267940|11318049|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
7152940|NCT03267940|11318044|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0
7152941|NCT03267940|11318045|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0
7152942|NCT03267940|11318046|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2
7152943|NCT03267940|11318047|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
7152944|NCT03267940|11318048|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
7152945|NCT03267940|11318049|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
7152946|NCT03267940|11318044|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0
7152947|NCT03267940|11318045|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0
7152948|NCT03267940|11318046|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7
7152949|NCT03267940|11318047|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4
7152950|NCT03267940|11318048|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5
7152951|NCT03267940|11318049|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3
7152952|NCT03267940|11318044|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0
7152953|NCT03267940|11318045|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0
7152954|NCT03267940|11318046|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10
7152955|NCT03267940|11318047|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13
7152956|NCT03267940|11318048|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0
7152957|NCT03267940|11318049|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6
7152958|NCT03268590|11318075|FG000|Overall Study|Previously unknown exclusion criteria|1
7152959|NCT03268746|11318082|FG000|Overall Study|Withdrawal by Subject|1
7152960|NCT03268941|11318097|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
7152961|NCT03268941|11318098|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
7152962|NCT03268941|11318099|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
7152963|NCT03268941|11318100|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1
7152964|NCT03268941|11318101|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
6859837|NCT00406315|10869229|FG000|Overall Study|Laboratory Abnormality|4
6859838|NCT00406315|10869229|FG000|Overall Study|Lack of Efficacy|13
6859839|NCT00406315|10869229|FG000|Overall Study|Other|33
6967675|NCT01133405|11016054|FG005|Period 1|Received drug only in period 3|0
6967676|NCT01133405|11016055|FG006|Period 1|Received drug only in period 3|0
6967677|NCT01133405|11016056|FG007|Period 1|Received drug only in period 3|0
6967678|NCT01133405|11016057|FG008|Period 1|Received drug only in period 3|0
6967679|NCT01133405|11016058|FG009|Period 1|Received drug only in period 3|0
6967680|NCT01133405|11016049|FG000|Period 2|Adverse Event|0
6967681|NCT01133405|11016050|FG001|Period 2|Adverse Event|0
6967682|NCT01133405|11016051|FG002|Period 2|Adverse Event|1
6967683|NCT01133405|11016052|FG003|Period 2|Adverse Event|0
6967684|NCT01133405|11016053|FG004|Period 2|Adverse Event|0
6967685|NCT01133405|11016054|FG005|Period 2|Adverse Event|0
6967686|NCT01133405|11016055|FG006|Period 2|Adverse Event|0
6967687|NCT01133405|11016056|FG007|Period 2|Adverse Event|0
6967688|NCT01133405|11016057|FG008|Period 2|Adverse Event|0
6967689|NCT01133405|11016058|FG009|Period 2|Adverse Event|0
6967690|NCT01133405|11016049|FG000|Period 2|Withdrawal by Subject|0
6967691|NCT01133405|11016050|FG001|Period 2|Withdrawal by Subject|0
6967692|NCT01133405|11016051|FG002|Period 2|Withdrawal by Subject|0
6967693|NCT01133405|11016052|FG003|Period 2|Withdrawal by Subject|1
6967694|NCT01133405|11016053|FG004|Period 2|Withdrawal by Subject|0
6967695|NCT01133405|11016054|FG005|Period 2|Withdrawal by Subject|1
6967696|NCT01133405|11016055|FG006|Period 2|Withdrawal by Subject|0
6967697|NCT01133405|11016056|FG007|Period 2|Withdrawal by Subject|0
6967698|NCT01133405|11016057|FG008|Period 2|Withdrawal by Subject|0
6967699|NCT01133405|11016058|FG009|Period 2|Withdrawal by Subject|0
6967700|NCT01133405|11016049|FG000|Period 2|Entry Criteria Not Met|0
6967701|NCT01133405|11016050|FG001|Period 2|Entry Criteria Not Met|1
6967702|NCT01133405|11016051|FG002|Period 2|Entry Criteria Not Met|0
6967703|NCT01133405|11016052|FG003|Period 2|Entry Criteria Not Met|0
6859840|NCT00406315|10869229|FG000|Overall Study|Lost to Follow-up|21
6967704|NCT01133405|11016053|FG004|Period 2|Entry Criteria Not Met|0
6967705|NCT01133405|11016054|FG005|Period 2|Entry Criteria Not Met|0
6967706|NCT01133405|11016055|FG006|Period 2|Entry Criteria Not Met|0
6967707|NCT01133405|11016056|FG007|Period 2|Entry Criteria Not Met|0
6967708|NCT01133405|11016057|FG008|Period 2|Entry Criteria Not Met|0
6967709|NCT01133405|11016058|FG009|Period 2|Entry Criteria Not Met|0
6967710|NCT01133405|11016049|FG000|Period 2|Physician Decision|0
7152965|NCT03268941|11318102|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
7152966|NCT03268941|11318103|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
6859841|NCT00406315|10869229|FG000|Overall Study|Withdrawal by Subject|30
6859842|NCT00406354|10869236|FG000|All Randomized Patients|Protocol Violation|0
6859843|NCT00406354|10869237|FG001|All Randomized Patients|Protocol Violation|0
6859844|NCT00406354|10869238|FG002|All Randomized Patients|Protocol Violation|1
6859845|NCT00406354|10869236|FG000|All Randomized and Treated Patients|Lack of Efficacy|7
6859846|NCT00406354|10869237|FG001|All Randomized and Treated Patients|Lack of Efficacy|4
6859847|NCT00406354|10869238|FG002|All Randomized and Treated Patients|Lack of Efficacy|17
6859848|NCT00406354|10869236|FG000|All Randomized and Treated Patients|Adverse Event|6
6859849|NCT00406354|10869237|FG001|All Randomized and Treated Patients|Adverse Event|2
6859850|NCT00406354|10869238|FG002|All Randomized and Treated Patients|Adverse Event|1
6859851|NCT00406354|10869236|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2
6859852|NCT00406354|10869237|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6
6859853|NCT00406354|10869238|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1
6859854|NCT00406354|10869236|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1
6859855|NCT00406354|10869237|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1
6859856|NCT00406354|10869238|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2
6859857|NCT00406354|10869236|FG000|All Randomized and Treated Patients|Physician Decision|0
6859858|NCT00406354|10869237|FG001|All Randomized and Treated Patients|Physician Decision|0
6859859|NCT00406354|10869238|FG002|All Randomized and Treated Patients|Physician Decision|1
6859860|NCT00406367|10869248|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4
6859861|NCT00406367|10869249|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0
6859862|NCT00406367|10869248|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1
6859863|NCT00406367|10869249|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0
6859864|NCT00406367|10869248|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0
6859865|NCT00406367|10869249|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1
6859866|NCT00406367|10869248|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0
6859867|NCT00406367|10869249|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1
6859868|NCT00406367|10869248|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2
6859869|NCT00406367|10869249|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0
6859870|NCT00406367|10869248|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6
6859871|NCT00406367|10869249|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0
6859872|NCT00406367|10869248|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
6859873|NCT00406367|10869249|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
6859874|NCT00406367|10869248|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4
6859875|NCT00406367|10869249|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0
6859876|NCT00406367|10869248|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1
6859877|NCT00406367|10869249|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0
6859878|NCT00406367|10869248|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1
6859879|NCT00406367|10869249|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0
6859880|NCT00406367|10869248|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1
6859881|NCT00406367|10869249|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0
6859882|NCT00406367|10869248|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1
6859883|NCT00406367|10869249|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0
6859884|NCT00406393|10869257|FG000|Overall Study|Did not undergo transplantation|2
6859885|NCT00406393|10869258|FG001|Overall Study|Did not undergo transplantation|1
6859886|NCT00406419|10869267|FG000|Overall Study|Death|3
6859887|NCT00406419|10869268|FG001|Overall Study|Death|1
6859888|NCT00406419|10869269|FG002|Overall Study|Death|4
6859889|NCT00406419|10869267|FG000|Overall Study|Protocol Violation|6
6859890|NCT00406419|10869268|FG001|Overall Study|Protocol Violation|2
6859891|NCT00406419|10869269|FG002|Overall Study|Protocol Violation|5
6859892|NCT00406419|10869267|FG000|Overall Study|Study Terminated by Sponsor|260
6859893|NCT00406419|10869268|FG001|Overall Study|Study Terminated by Sponsor|288
6859894|NCT00406419|10869269|FG002|Overall Study|Study Terminated by Sponsor|282
6859895|NCT00406419|10869267|FG000|Overall Study|Withdrawal by Subject|17
6859896|NCT00406419|10869268|FG001|Overall Study|Withdrawal by Subject|24
6859897|NCT00406419|10869269|FG002|Overall Study|Withdrawal by Subject|26
6859898|NCT00406419|10869267|FG000|Overall Study|Lack of Efficacy|12
6859899|NCT00406419|10869268|FG001|Overall Study|Lack of Efficacy|1
6859900|NCT00406419|10869269|FG002|Overall Study|Lack of Efficacy|6
6859901|NCT00406419|10869267|FG000|Overall Study|Non-Compliance with Study Drug|5
6859902|NCT00406419|10869268|FG001|Overall Study|Non-Compliance with Study Drug|6
7152967|NCT03268941|11318097|FG000|Part 1 (Days 1 to 9)|Adverse Event|0
7152968|NCT03268941|11318098|FG001|Part 1 (Days 1 to 9)|Adverse Event|0
7152969|NCT03268941|11318099|FG002|Part 1 (Days 1 to 9)|Adverse Event|0
7152970|NCT03268941|11318100|FG003|Part 1 (Days 1 to 9)|Adverse Event|1
7152971|NCT03268941|11318101|FG004|Part 1 (Days 1 to 9)|Adverse Event|0
7152972|NCT03268941|11318102|FG005|Part 1 (Days 1 to 9)|Adverse Event|0
7152973|NCT03268941|11318103|FG006|Part 1 (Days 1 to 9)|Adverse Event|0
7152974|NCT03268941|11318097|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1
7152975|NCT03268941|11318098|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0
6859903|NCT00406419|10869269|FG002|Overall Study|Non-Compliance with Study Drug|3
6859904|NCT00406419|10869267|FG000|Overall Study|Adverse Event|10
6859905|NCT00406419|10869268|FG001|Overall Study|Adverse Event|12
6859906|NCT00406419|10869269|FG002|Overall Study|Adverse Event|16
6859907|NCT00406419|10869267|FG000|Overall Study|Lost to Follow-up|11
6859908|NCT00406419|10869268|FG001|Overall Study|Lost to Follow-up|10
6859909|NCT00406419|10869269|FG002|Overall Study|Lost to Follow-up|5
6859910|NCT00406640|10869279|FG000|Acute Phase|Adverse Event|18
6859911|NCT00406640|10869280|FG001|Acute Phase|Adverse Event|13
6859912|NCT00406640|10869279|FG000|Acute Phase|Failed to Return|5
6859913|NCT00406640|10869280|FG001|Acute Phase|Failed to Return|1
6859914|NCT00406640|10869279|FG000|Acute Phase|Physician Decision|0
6859915|NCT00406640|10869280|FG001|Acute Phase|Physician Decision|1
6859916|NCT00406640|10869279|FG000|Acute Phase|Lost to Follow-up|7
6859917|NCT00406640|10869280|FG001|Acute Phase|Lost to Follow-up|4
6859918|NCT00406640|10869279|FG000|Acute Phase|Protocol deviation|4
6859919|NCT00406640|10869280|FG001|Acute Phase|Protocol deviation|10
6859920|NCT00406640|10869279|FG000|Acute Phase|Protocol Violation|3
6859921|NCT00406640|10869280|FG001|Acute Phase|Protocol Violation|2
6859922|NCT00406640|10869279|FG000|Acute Phase|Withdrawal by Subject|11
6859923|NCT00406640|10869280|FG001|Acute Phase|Withdrawal by Subject|9
6859924|NCT00406640|10869279|FG000|Acute Phase|Lack of Efficacy|3
6859925|NCT00406640|10869280|FG001|Acute Phase|Lack of Efficacy|3
6859926|NCT00406640|10869279|FG000|DB Continuation Phase for Responders|Adverse Event|11
6859927|NCT00406640|10869280|FG001|DB Continuation Phase for Responders|Adverse Event|11
6859928|NCT00406640|10869279|FG000|DB Continuation Phase for Responders|Death|1
6859929|NCT00406640|10869280|FG001|DB Continuation Phase for Responders|Death|0
6859930|NCT00406640|10869279|FG000|DB Continuation Phase for Responders|Failed to Return|0
6859931|NCT00406640|10869280|FG001|DB Continuation Phase for Responders|Failed to Return|2
6859932|NCT00406640|10869279|FG000|DB Continuation Phase for Responders|Physician Decision|2
6859933|NCT00406640|10869280|FG001|DB Continuation Phase for Responders|Physician Decision|3
6859934|NCT00406640|10869279|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1
6859935|NCT00406640|10869280|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7
6859936|NCT00406640|10869279|FG000|DB Continuation Phase for Responders|non-compliance|7
6859937|NCT00406640|10869280|FG001|DB Continuation Phase for Responders|non-compliance|5
6859938|NCT00406640|10869279|FG000|DB Continuation Phase for Responders|Protocol Violation|2
6859939|NCT00406640|10869280|FG001|DB Continuation Phase for Responders|Protocol Violation|2
6859940|NCT00406640|10869279|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8
6859941|NCT00406640|10869280|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6
6859942|NCT00406640|10869279|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1
6859943|NCT00406640|10869280|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1
6859944|NCT00406640|10869279|FG000|OL Extension Phase for Non-Responders|Adverse Event|6
6859945|NCT00406640|10869280|FG001|OL Extension Phase for Non-Responders|Adverse Event|6
6859946|NCT00406640|10869279|FG000|OL Extension Phase for Non-Responders|Failed to Return|1
6859947|NCT00406640|10869280|FG001|OL Extension Phase for Non-Responders|Failed to Return|0
6859948|NCT00406640|10869279|FG000|OL Extension Phase for Non-Responders|Physician Decision|1
6859949|NCT00406640|10869280|FG001|OL Extension Phase for Non-Responders|Physician Decision|0
6859950|NCT00406640|10869279|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2
6859951|NCT00406640|10869280|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3
6859952|NCT00406640|10869279|FG000|OL Extension Phase for Non-Responders|non-compliance|3
6859953|NCT00406640|10869280|FG001|OL Extension Phase for Non-Responders|non-compliance|2
6859954|NCT00406640|10869279|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3
6859955|NCT00406640|10869280|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6
6859956|NCT00406640|10869279|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6
7077957|NCT02098395|11186116|FG002|Overall Study|Unclassified|3
7077958|NCT02098395|11186117|FG003|Overall Study|Unclassified|2
6859957|NCT00406640|10869280|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7
6859958|NCT00406653|10869296|FG000|Induction Period|Adverse Event|1
6859959|NCT00406653|10869297|FG001|Induction Period|Adverse Event|10
6859960|NCT00406653|10869298|FG002|Induction Period|Adverse Event|4
6859961|NCT00406653|10869299|FG003|Induction Period|Adverse Event|11
6859962|NCT00406653|10869300|FG004|Induction Period|Adverse Event|0
6859963|NCT00406653|10869301|FG005|Induction Period|Adverse Event|0
6859964|NCT00406653|10869302|FG006|Induction Period|Adverse Event|0
6859965|NCT00406653|10869296|FG000|Induction Period|Lack of Efficacy|11
6859966|NCT00406653|10869297|FG001|Induction Period|Lack of Efficacy|14
6859967|NCT00406653|10869298|FG002|Induction Period|Lack of Efficacy|8
6859968|NCT00406653|10869299|FG003|Induction Period|Lack of Efficacy|10
6859969|NCT00406653|10869300|FG004|Induction Period|Lack of Efficacy|0
6859970|NCT00406653|10869301|FG005|Induction Period|Lack of Efficacy|0
6859971|NCT00406653|10869302|FG006|Induction Period|Lack of Efficacy|0
6859972|NCT00406653|10869296|FG000|Induction Period|Lost to Follow-up|0
6859973|NCT00406653|10869297|FG001|Induction Period|Lost to Follow-up|2
6859974|NCT00406653|10869298|FG002|Induction Period|Lost to Follow-up|0
6859975|NCT00406653|10869299|FG003|Induction Period|Lost to Follow-up|0
6859976|NCT00406653|10869300|FG004|Induction Period|Lost to Follow-up|0
6859977|NCT00406653|10869301|FG005|Induction Period|Lost to Follow-up|0
6859978|NCT00406653|10869302|FG006|Induction Period|Lost to Follow-up|0
7077959|NCT02098733|11186127|FG000|Overall Study|Data Not Available|5
6859979|NCT00406653|10869296|FG000|Induction Period|Withdrawal of Consent|2
6859980|NCT00406653|10869297|FG001|Induction Period|Withdrawal of Consent|5
6859981|NCT00406653|10869298|FG002|Induction Period|Withdrawal of Consent|1
6859982|NCT00406653|10869299|FG003|Induction Period|Withdrawal of Consent|2
6859983|NCT00406653|10869300|FG004|Induction Period|Withdrawal of Consent|0
6859984|NCT00406653|10869301|FG005|Induction Period|Withdrawal of Consent|0
6859985|NCT00406653|10869302|FG006|Induction Period|Withdrawal of Consent|0
6859986|NCT00406653|10869296|FG000|Induction Period|Subject No Longer Meets Study Criteria|0
6859987|NCT00406653|10869297|FG001|Induction Period|Subject No Longer Meets Study Criteria|0
6859988|NCT00406653|10869298|FG002|Induction Period|Subject No Longer Meets Study Criteria|0
6859989|NCT00406653|10869299|FG003|Induction Period|Subject No Longer Meets Study Criteria|2
6859990|NCT00406653|10869300|FG004|Induction Period|Subject No Longer Meets Study Criteria|0
6859991|NCT00406653|10869301|FG005|Induction Period|Subject No Longer Meets Study Criteria|0
6859992|NCT00406653|10869302|FG006|Induction Period|Subject No Longer Meets Study Criteria|0
6859993|NCT00406653|10869296|FG000|Induction Period|Pregnancy|1
6859994|NCT00406653|10869297|FG001|Induction Period|Pregnancy|0
6859995|NCT00406653|10869298|FG002|Induction Period|Pregnancy|0
6859996|NCT00406653|10869299|FG003|Induction Period|Pregnancy|0
6859997|NCT00406653|10869300|FG004|Induction Period|Pregnancy|0
6859998|NCT00406653|10869301|FG005|Induction Period|Pregnancy|0
6859999|NCT00406653|10869302|FG006|Induction Period|Pregnancy|0
6860000|NCT00406653|10869296|FG000|Induction Period|Declined participation but followup done|0
6860001|NCT00406653|10869297|FG001|Induction Period|Declined participation but followup done|2
6860002|NCT00406653|10869298|FG002|Induction Period|Declined participation but followup done|1
6860003|NCT00406653|10869299|FG003|Induction Period|Declined participation but followup done|1
6860004|NCT00406653|10869300|FG004|Induction Period|Declined participation but followup done|0
6860005|NCT00406653|10869301|FG005|Induction Period|Declined participation but followup done|0
6860006|NCT00406653|10869302|FG006|Induction Period|Declined participation but followup done|0
6860007|NCT00406653|10869296|FG000|Induction Period|Given prohibited drug|0
6860008|NCT00406653|10869297|FG001|Induction Period|Given prohibited drug|1
6860009|NCT00406653|10869298|FG002|Induction Period|Given prohibited drug|2
6860010|NCT00406653|10869299|FG003|Induction Period|Given prohibited drug|0
6860011|NCT00406653|10869300|FG004|Induction Period|Given prohibited drug|0
6860012|NCT00406653|10869301|FG005|Induction Period|Given prohibited drug|0
6860013|NCT00406653|10869302|FG006|Induction Period|Given prohibited drug|0
6860014|NCT00406653|10869296|FG000|Induction Period|Incarcerated|0
6860015|NCT00406653|10869297|FG001|Induction Period|Incarcerated|0
6860016|NCT00406653|10869298|FG002|Induction Period|Incarcerated|1
6860017|NCT00406653|10869299|FG003|Induction Period|Incarcerated|0
6860018|NCT00406653|10869300|FG004|Induction Period|Incarcerated|0
6860019|NCT00406653|10869301|FG005|Induction Period|Incarcerated|0
6860020|NCT00406653|10869302|FG006|Induction Period|Incarcerated|0
6860021|NCT00406653|10869296|FG000|Induction Period|Patient relocated|0
6860022|NCT00406653|10869297|FG001|Induction Period|Patient relocated|0
6860023|NCT00406653|10869298|FG002|Induction Period|Patient relocated|1
6860024|NCT00406653|10869299|FG003|Induction Period|Patient relocated|0
6860025|NCT00406653|10869300|FG004|Induction Period|Patient relocated|0
6860026|NCT00406653|10869301|FG005|Induction Period|Patient relocated|0
6860027|NCT00406653|10869302|FG006|Induction Period|Patient relocated|0
6860028|NCT00406653|10869296|FG000|Maintenance Period|Adverse Event|0
6860029|NCT00406653|10869297|FG001|Maintenance Period|Adverse Event|0
6860030|NCT00406653|10869298|FG002|Maintenance Period|Adverse Event|0
6860031|NCT00406653|10869299|FG003|Maintenance Period|Adverse Event|0
6860032|NCT00406653|10869300|FG004|Maintenance Period|Adverse Event|1
6860033|NCT00406653|10869301|FG005|Maintenance Period|Adverse Event|1
6860034|NCT00406653|10869302|FG006|Maintenance Period|Adverse Event|0
6860035|NCT00406653|10869296|FG000|Maintenance Period|Lack of Efficacy|0
6860036|NCT00406653|10869297|FG001|Maintenance Period|Lack of Efficacy|0
6860037|NCT00406653|10869298|FG002|Maintenance Period|Lack of Efficacy|0
6860038|NCT00406653|10869299|FG003|Maintenance Period|Lack of Efficacy|0
6860039|NCT00406653|10869300|FG004|Maintenance Period|Lack of Efficacy|20
6860040|NCT00406653|10869301|FG005|Maintenance Period|Lack of Efficacy|26
6860041|NCT00406653|10869302|FG006|Maintenance Period|Lack of Efficacy|0
6860042|NCT00406653|10869296|FG000|Maintenance Period|Lost to Follow-up|0
6860043|NCT00406653|10869297|FG001|Maintenance Period|Lost to Follow-up|0
6860044|NCT00406653|10869298|FG002|Maintenance Period|Lost to Follow-up|0
6860045|NCT00406653|10869299|FG003|Maintenance Period|Lost to Follow-up|0
6860046|NCT00406653|10869300|FG004|Maintenance Period|Lost to Follow-up|2
6860047|NCT00406653|10869301|FG005|Maintenance Period|Lost to Follow-up|1
6860048|NCT00406653|10869302|FG006|Maintenance Period|Lost to Follow-up|0
6860049|NCT00406653|10869296|FG000|Maintenance Period|Withdrawal of Consent|0
6860050|NCT00406653|10869297|FG001|Maintenance Period|Withdrawal of Consent|0
6860051|NCT00406653|10869298|FG002|Maintenance Period|Withdrawal of Consent|0
6860052|NCT00406653|10869299|FG003|Maintenance Period|Withdrawal of Consent|0
6860053|NCT00406653|10869300|FG004|Maintenance Period|Withdrawal of Consent|2
6860054|NCT00406653|10869301|FG005|Maintenance Period|Withdrawal of Consent|0
6860055|NCT00406653|10869302|FG006|Maintenance Period|Withdrawal of Consent|0
6860056|NCT00406653|10869296|FG000|Maintenance Period|Pregnancy|0
6860057|NCT00406653|10869297|FG001|Maintenance Period|Pregnancy|0
6860058|NCT00406653|10869298|FG002|Maintenance Period|Pregnancy|0
6860059|NCT00406653|10869299|FG003|Maintenance Period|Pregnancy|0
6860060|NCT00406653|10869300|FG004|Maintenance Period|Pregnancy|0
6860061|NCT00406653|10869301|FG005|Maintenance Period|Pregnancy|1
6860062|NCT00406653|10869302|FG006|Maintenance Period|Pregnancy|0
6860063|NCT00406653|10869296|FG000|Maintenance Period|Administrative Reason By Sponsor|0
6860064|NCT00406653|10869297|FG001|Maintenance Period|Administrative Reason By Sponsor|0
6860065|NCT00406653|10869298|FG002|Maintenance Period|Administrative Reason By Sponsor|0
6860066|NCT00406653|10869299|FG003|Maintenance Period|Administrative Reason By Sponsor|0
6860067|NCT00406653|10869300|FG004|Maintenance Period|Administrative Reason By Sponsor|4
6860068|NCT00406653|10869301|FG005|Maintenance Period|Administrative Reason By Sponsor|7
6860069|NCT00406653|10869302|FG006|Maintenance Period|Administrative Reason By Sponsor|0
6860070|NCT00406653|10869296|FG000|Maintenance Period|Error in disease score evaluation|0
6860071|NCT00406653|10869297|FG001|Maintenance Period|Error in disease score evaluation|0
6860072|NCT00406653|10869298|FG002|Maintenance Period|Error in disease score evaluation|0
6860073|NCT00406653|10869299|FG003|Maintenance Period|Error in disease score evaluation|0
6860074|NCT00406653|10869300|FG004|Maintenance Period|Error in disease score evaluation|1
6860075|NCT00406653|10869301|FG005|Maintenance Period|Error in disease score evaluation|0
6860076|NCT00406653|10869302|FG006|Maintenance Period|Error in disease score evaluation|0
6860077|NCT00406653|10869296|FG000|Open-Label Period|Death|0
6860078|NCT00406653|10869297|FG001|Open-Label Period|Death|0
6860079|NCT00406653|10869298|FG002|Open-Label Period|Death|0
6860080|NCT00406653|10869299|FG003|Open-Label Period|Death|0
6860081|NCT00406653|10869300|FG004|Open-Label Period|Death|0
6860082|NCT00406653|10869301|FG005|Open-Label Period|Death|0
6860083|NCT00406653|10869302|FG006|Open-Label Period|Death|1
6860084|NCT00406653|10869296|FG000|Open-Label Period|Adverse Event|0
6860085|NCT00406653|10869297|FG001|Open-Label Period|Adverse Event|0
6860086|NCT00406653|10869298|FG002|Open-Label Period|Adverse Event|0
6860087|NCT00406653|10869299|FG003|Open-Label Period|Adverse Event|0
6860088|NCT00406653|10869300|FG004|Open-Label Period|Adverse Event|0
6860089|NCT00406653|10869301|FG005|Open-Label Period|Adverse Event|0
6860090|NCT00406653|10869302|FG006|Open-Label Period|Adverse Event|18
6860091|NCT00406653|10869296|FG000|Open-Label Period|Lack of Efficacy|0
7152976|NCT03268941|11318099|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0
7152977|NCT03268941|11318100|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0
7152978|NCT03268941|11318101|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0
7152979|NCT03268941|11318102|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0
7152980|NCT03268941|11318103|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0
7152981|NCT03268941|11318097|FG000|Part 2: Days 17 to 25|Reason not specified|0
7152982|NCT03268941|11318098|FG001|Part 2: Days 17 to 25|Reason not specified|0
7152983|NCT03268941|11318099|FG002|Part 2: Days 17 to 25|Reason not specified|0
7152984|NCT03268941|11318100|FG003|Part 2: Days 17 to 25|Reason not specified|0
7152985|NCT03268941|11318101|FG004|Part 2: Days 17 to 25|Reason not specified|0
7152986|NCT03268941|11318102|FG005|Part 2: Days 17 to 25|Reason not specified|0
7152987|NCT03268941|11318103|FG006|Part 2: Days 17 to 25|Reason not specified|1
7152988|NCT03268941|11318097|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0
7152989|NCT03268941|11318098|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0
7152990|NCT03268941|11318099|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0
7152991|NCT03268941|11318100|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0
7152992|NCT03268941|11318101|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0
7152993|NCT03268941|11318102|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0
7152994|NCT03268941|11318103|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1
7152995|NCT03269552|11318131|FG000|Overall Study|Adverse Event|2
7152996|NCT03270085|11318138|FG000|Overall Study|Withdrawal by Subject|1
7152997|NCT03270085|11318139|FG001|Overall Study|Withdrawal by Subject|0
7152998|NCT03270644|11318174|FG000|Day 1 Lasmiditan Reference|Physician Decision|1
7152999|NCT03270644|11318174|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1
7153000|NCT03270657|11318185|FG000|Overall Study|Withdrawal by Subject|1
7153001|NCT03271307|11318203|FG000|Overall Study|Lost to Follow-up|0
7153002|NCT03271307|11318204|FG001|Overall Study|Lost to Follow-up|0
7153003|NCT03271307|11318205|FG002|Overall Study|Lost to Follow-up|0
7153004|NCT03271307|11318206|FG003|Overall Study|Lost to Follow-up|28
7153005|NCT03271307|11318207|FG004|Overall Study|Lost to Follow-up|91
7153006|NCT03271528|11318239|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1
7153007|NCT03271528|11318240|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0
7153008|NCT03271528|11318239|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1
7153009|NCT03271528|11318240|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0
7153010|NCT03271528|11318239|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0
7153011|NCT03271528|11318240|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1
7153012|NCT03271528|11318239|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0
7153013|NCT03271528|11318240|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1
7153014|NCT03271528|11318239|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1
7153015|NCT03271528|11318240|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1
7153016|NCT03271528|11318239|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1
7153017|NCT03271528|11318240|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0
7153018|NCT03271528|11318239|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1
7153019|NCT03271528|11318240|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0
7040989|NCT01722045|11124272|FG000|Overall Study|Physician Decision|3
7040990|NCT01722045|11124272|FG000|Overall Study|Relocation (did not wish to transfer)|1
7040991|NCT01722071|11124276|FG000|Overall Study|Protocol Violation|1
7040992|NCT01722071|11124277|FG001|Overall Study|Protocol Violation|0
7040993|NCT01722097|11124285|FG000|Overall Study|Patient sheets not returned|6
7040994|NCT01722097|11124286|FG001|Overall Study|Patient sheets not returned|5
7040995|NCT01722162|11124294|FG000|Overall Study|Withdrawal by Subject|1
7040996|NCT01722162|11124295|FG001|Overall Study|Withdrawal by Subject|1
7040997|NCT01722162|11124294|FG000|Overall Study|Found ineligible|1
7040998|NCT01722162|11124295|FG001|Overall Study|Found ineligible|0
7040999|NCT01722162|11124294|FG000|Overall Study|Unrelated to study adverse event|2
7041000|NCT01722162|11124295|FG001|Overall Study|Unrelated to study adverse event|2
7041001|NCT01722162|11124294|FG000|Overall Study|Adverse Event|1
6860092|NCT00406653|10869297|FG001|Open-Label Period|Lack of Efficacy|0
6860093|NCT00406653|10869298|FG002|Open-Label Period|Lack of Efficacy|0
6860094|NCT00406653|10869299|FG003|Open-Label Period|Lack of Efficacy|0
6860095|NCT00406653|10869300|FG004|Open-Label Period|Lack of Efficacy|0
6860096|NCT00406653|10869301|FG005|Open-Label Period|Lack of Efficacy|0
6860097|NCT00406653|10869302|FG006|Open-Label Period|Lack of Efficacy|160
6860098|NCT00406653|10869296|FG000|Open-Label Period|Lost to Follow-up|0
6860099|NCT00406653|10869297|FG001|Open-Label Period|Lost to Follow-up|0
6860100|NCT00406653|10869298|FG002|Open-Label Period|Lost to Follow-up|0
6860101|NCT00406653|10869299|FG003|Open-Label Period|Lost to Follow-up|0
6860102|NCT00406653|10869300|FG004|Open-Label Period|Lost to Follow-up|0
6860103|NCT00406653|10869301|FG005|Open-Label Period|Lost to Follow-up|0
6860104|NCT00406653|10869302|FG006|Open-Label Period|Lost to Follow-up|6
6860105|NCT00406653|10869296|FG000|Open-Label Period|Withdrawal of Consent|0
6860106|NCT00406653|10869297|FG001|Open-Label Period|Withdrawal of Consent|0
6860107|NCT00406653|10869298|FG002|Open-Label Period|Withdrawal of Consent|0
6860108|NCT00406653|10869299|FG003|Open-Label Period|Withdrawal of Consent|0
6860109|NCT00406653|10869300|FG004|Open-Label Period|Withdrawal of Consent|0
6860110|NCT00406653|10869301|FG005|Open-Label Period|Withdrawal of Consent|0
6860111|NCT00406653|10869302|FG006|Open-Label Period|Withdrawal of Consent|11
6860112|NCT00406653|10869296|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0
6860113|NCT00406653|10869297|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0
6860114|NCT00406653|10869298|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0
6860115|NCT00406653|10869299|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0
6860116|NCT00406653|10869300|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0
6860117|NCT00406653|10869301|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0
6860118|NCT00406653|10869302|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1
6860119|NCT00406653|10869296|FG000|Open-Label Period|Pregnancy|0
6860120|NCT00406653|10869297|FG001|Open-Label Period|Pregnancy|0
6860121|NCT00406653|10869298|FG002|Open-Label Period|Pregnancy|0
6860122|NCT00406653|10869299|FG003|Open-Label Period|Pregnancy|0
6860123|NCT00406653|10869300|FG004|Open-Label Period|Pregnancy|0
6860124|NCT00406653|10869301|FG005|Open-Label Period|Pregnancy|0
6860125|NCT00406653|10869302|FG006|Open-Label Period|Pregnancy|2
6860126|NCT00406653|10869296|FG000|Open-Label Period|Administrative Reason By Sponsor|0
6860127|NCT00406653|10869297|FG001|Open-Label Period|Administrative Reason By Sponsor|0
6860128|NCT00406653|10869298|FG002|Open-Label Period|Administrative Reason By Sponsor|0
6860129|NCT00406653|10869299|FG003|Open-Label Period|Administrative Reason By Sponsor|0
6860130|NCT00406653|10869300|FG004|Open-Label Period|Administrative Reason By Sponsor|0
6860131|NCT00406653|10869301|FG005|Open-Label Period|Administrative Reason By Sponsor|0
6860132|NCT00406653|10869302|FG006|Open-Label Period|Administrative Reason By Sponsor|115
6860133|NCT00406653|10869296|FG000|Open-Label Period|Declined participation but followup done|0
6860134|NCT00406653|10869297|FG001|Open-Label Period|Declined participation but followup done|0
6860135|NCT00406653|10869298|FG002|Open-Label Period|Declined participation but followup done|0
6860136|NCT00406653|10869299|FG003|Open-Label Period|Declined participation but followup done|0
6860137|NCT00406653|10869300|FG004|Open-Label Period|Declined participation but followup done|0
6860138|NCT00406653|10869301|FG005|Open-Label Period|Declined participation but followup done|0
7077960|NCT02098733|11186127|FG000|Overall Study|Lost to Follow-up|5
7077961|NCT02098746|11186131|FG000|Overall Study|Changes of Investigator|2
7077962|NCT02098746|11186131|FG000|Overall Study|Other Miscellaneous Reasons|1
7077963|NCT02098746|11186131|FG000|Overall Study|Enrolled 15 Days After the First Dose|1
7077964|NCT02098746|11186131|FG000|Overall Study|Data Not Available After Treatment|1
6860139|NCT00406653|10869302|FG006|Open-Label Period|Declined participation but followup done|8
6860140|NCT00406653|10869296|FG000|Open-Label Period|Discontinued by Sponsor|0
6860141|NCT00406653|10869297|FG001|Open-Label Period|Discontinued by Sponsor|0
6860142|NCT00406653|10869298|FG002|Open-Label Period|Discontinued by Sponsor|0
6860143|NCT00406653|10869299|FG003|Open-Label Period|Discontinued by Sponsor|0
6860144|NCT00406653|10869300|FG004|Open-Label Period|Discontinued by Sponsor|0
6860145|NCT00406653|10869301|FG005|Open-Label Period|Discontinued by Sponsor|0
6860146|NCT00406653|10869302|FG006|Open-Label Period|Discontinued by Sponsor|1
7041002|NCT01722162|11124295|FG001|Overall Study|Adverse Event|1
7041003|NCT01722162|11124294|FG000|Overall Study|Insurance denial post enrollment|0
7041004|NCT01722162|11124295|FG001|Overall Study|Insurance denial post enrollment|1
7041005|NCT01722162|11124294|FG000|Overall Study|Noncompliance|0
7077965|NCT02099110|11186162|FG000|Overall Study|Protocol Violation|2
6860147|NCT00406653|10869296|FG000|Open-Label Period|Refused followup|0
6860148|NCT00406653|10869297|FG001|Open-Label Period|Refused followup|0
6860149|NCT00406653|10869298|FG002|Open-Label Period|Refused followup|0
6860150|NCT00406653|10869299|FG003|Open-Label Period|Refused followup|0
6860151|NCT00406653|10869300|FG004|Open-Label Period|Refused followup|0
6860152|NCT00406653|10869301|FG005|Open-Label Period|Refused followup|0
6860153|NCT00406653|10869302|FG006|Open-Label Period|Refused followup|1
6860154|NCT00406692|10869322|FG000|Overall Study|Withdrawal by Subject|4
6860155|NCT00406692|10869322|FG000|Overall Study|Physician Decision|1
6860156|NCT00406692|10869322|FG000|Overall Study|Adverse Event|1
6860157|NCT00406692|10869322|FG000|Overall Study|Lack of Efficacy|1
6860158|NCT00406718|10869329|FG000|Overall Study|Withdrawal by Subject|2
6860159|NCT00406718|10869330|FG001|Overall Study|Withdrawal by Subject|9
6860160|NCT00406718|10869331|FG002|Overall Study|Withdrawal by Subject|4
6860161|NCT00406718|10869329|FG000|Overall Study|Lost to Follow-up|2
6860162|NCT00406718|10869330|FG001|Overall Study|Lost to Follow-up|5
6860163|NCT00406718|10869331|FG002|Overall Study|Lost to Follow-up|4
6860164|NCT00406848|10869343|FG000|Overall Study|Withdrawal by Subject|27
6860165|NCT00406848|10869344|FG001|Overall Study|Withdrawal by Subject|22
6860166|NCT00406848|10869343|FG000|Overall Study|Adverse Event|38
6860167|NCT00406848|10869344|FG001|Overall Study|Adverse Event|7
6860168|NCT00406848|10869343|FG000|Overall Study|Lack of Efficacy|9
6860169|NCT00406848|10869344|FG001|Overall Study|Lack of Efficacy|14
6860170|NCT00406848|10869343|FG000|Overall Study|Protocol Violation|10
6860171|NCT00406848|10869344|FG001|Overall Study|Protocol Violation|6
6860172|NCT00406848|10869343|FG000|Overall Study|Lost to Follow-up|6
6860173|NCT00406848|10869344|FG001|Overall Study|Lost to Follow-up|2
6860174|NCT00406848|10869343|FG000|Overall Study|Physician Decision|2
6860175|NCT00406848|10869344|FG001|Overall Study|Physician Decision|2
6860176|NCT00406848|10869343|FG000|Overall Study|Sponsor Decision|1
6860177|NCT00406848|10869344|FG001|Overall Study|Sponsor Decision|1
6860178|NCT00407030|10869356|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2
6860179|NCT00407030|10869357|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1
6860180|NCT00407030|10869358|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0
6860181|NCT00407030|10869356|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
6860182|NCT00407030|10869357|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
6860183|NCT00407030|10869358|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3
6860184|NCT00407030|10869356|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
6860185|NCT00407030|10869357|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
6860186|NCT00407030|10869358|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
6860187|NCT00407030|10869356|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
6860188|NCT00407030|10869357|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
6860189|NCT00407030|10869358|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
6860190|NCT00407030|10869356|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
6860191|NCT00407030|10869357|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
6860192|NCT00407030|10869358|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1
6860193|NCT00407030|10869356|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1
6860194|NCT00407030|10869357|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0
6860195|NCT00407030|10869358|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0
6860196|NCT00407030|10869356|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
6860197|NCT00407030|10869357|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5
6860198|NCT00407030|10869358|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
6860199|NCT00407030|10869356|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11
6860200|NCT00407030|10869357|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11
6860201|NCT00407030|10869358|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0
6860202|NCT00407030|10869356|FG000|Extension Period - up to 68 Weeks|Adverse Event|1
6860203|NCT00407030|10869357|FG001|Extension Period - up to 68 Weeks|Adverse Event|0
6860204|NCT00407030|10869358|FG002|Extension Period - up to 68 Weeks|Adverse Event|0
6860205|NCT00407030|10869356|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4
6860206|NCT00407030|10869357|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4
6860207|NCT00407030|10869358|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0
6860208|NCT00407030|10869356|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5
7153020|NCT03273153|11318248|FG000|Overall Study|Remain on Study|161
7153021|NCT03273153|11318249|FG001|Overall Study|Remain on Study|159
7153022|NCT03273153|11318248|FG000|Overall Study|Death|41
7153023|NCT03273153|11318249|FG001|Overall Study|Death|45
7153024|NCT03273153|11318248|FG000|Overall Study|Lost to Follow-up|3
7153025|NCT03273153|11318249|FG001|Overall Study|Lost to Follow-up|3
7153026|NCT03273153|11318248|FG000|Overall Study|Protocol Violation|3
7153027|NCT03273153|11318249|FG001|Overall Study|Protocol Violation|0
7153028|NCT03273153|11318248|FG000|Overall Study|Withdrawal by Subject|16
7153029|NCT03273153|11318249|FG001|Overall Study|Withdrawal by Subject|13
7153030|NCT03273153|11318248|FG000|Overall Study|Symptomatic Deterioration|0
7153031|NCT03273153|11318249|FG001|Overall Study|Symptomatic Deterioration|1
7153032|NCT03273153|11318248|FG000|Overall Study|Other|0
6860209|NCT00407030|10869357|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5
6860210|NCT00407030|10869358|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0
6860211|NCT00407030|10869356|FG000|Extension Period - up to 68 Weeks|Patient Decision|1
7153033|NCT03273153|11318249|FG001|Overall Study|Other|1
6860212|NCT00407030|10869357|FG001|Extension Period - up to 68 Weeks|Patient Decision|2
6860213|NCT00407030|10869358|FG002|Extension Period - up to 68 Weeks|Patient Decision|0
6860214|NCT00407030|10869356|FG000|Extension Period - up to 68 Weeks|Physician Decision|1
6860215|NCT00407030|10869357|FG001|Extension Period - up to 68 Weeks|Physician Decision|2
6860216|NCT00407030|10869358|FG002|Extension Period - up to 68 Weeks|Physician Decision|0
6860217|NCT00407511|10869406|FG000|Overall Study|Adverse Event|9
6860218|NCT00407511|10869406|FG000|Overall Study|Lost to Follow-up|4
6860219|NCT00407511|10869406|FG000|Overall Study|Other|5
6860220|NCT00407511|10869406|FG000|Overall Study|Withdrawal by Subject|4
6860221|NCT00407537|10869412|FG000|Overall Study|Death|5
6860222|NCT00407537|10869413|FG001|Overall Study|Death|2
6860223|NCT00407537|10869412|FG000|Overall Study|Adverse Event|36
6860224|NCT00407537|10869413|FG001|Overall Study|Adverse Event|0
6860225|NCT00407537|10869412|FG000|Overall Study|Lost to Follow-up|12
6860226|NCT00407537|10869413|FG001|Overall Study|Lost to Follow-up|19
6860227|NCT00407537|10869412|FG000|Overall Study|Other|6
6860228|NCT00407537|10869413|FG001|Overall Study|Other|7
6860229|NCT00407537|10869412|FG000|Overall Study|Withdrawal by Subject|34
6860230|NCT00407537|10869413|FG001|Overall Study|Withdrawal by Subject|16
6860231|NCT00407550|10869421|FG000|Overall Study|Adverse Event|0
6860232|NCT00407550|10869422|FG001|Overall Study|Adverse Event|1
6860233|NCT00407550|10869421|FG000|Overall Study|Withdrawal by Subject|0
6860234|NCT00407550|10869422|FG001|Overall Study|Withdrawal by Subject|2
6860235|NCT00407550|10869421|FG000|Overall Study|Death|1
6860236|NCT00407550|10869422|FG001|Overall Study|Death|0
6860237|NCT00407550|10869421|FG000|Overall Study|Insurance or Other medical condition|2
6860238|NCT00407550|10869422|FG001|Overall Study|Insurance or Other medical condition|1
6860239|NCT00407563|10869428|FG000|Overall Study|Patient continues on treatment|1
6860240|NCT00407745|10869439|FG000|Overall Study|Lack of Efficacy|1
6860241|NCT00407745|10869440|FG001|Overall Study|Lack of Efficacy|2
6860242|NCT00407745|10869439|FG000|Overall Study|Withdrawal by Subject|3
6860243|NCT00407745|10869440|FG001|Overall Study|Withdrawal by Subject|3
6860244|NCT00407745|10869439|FG000|Overall Study|Protocol Violation|5
6860245|NCT00407745|10869440|FG001|Overall Study|Protocol Violation|3
6860246|NCT00407745|10869439|FG000|Overall Study|Adverse Event|8
6860247|NCT00407745|10869440|FG001|Overall Study|Adverse Event|8
6860248|NCT00407745|10869439|FG000|Overall Study|Other|2
6860249|NCT00407745|10869440|FG001|Overall Study|Other|0
6860250|NCT00407745|10869439|FG000|Overall Study|Randomized, unknown if treated|0
6860251|NCT00407745|10869440|FG001|Overall Study|Randomized, unknown if treated|1
6860252|NCT00407758|10869446|FG000|Overall Study|ineligible -improper prior treatment|1
6860253|NCT00407797|10869450|FG000|Overall Study|Lost to Follow-up|2
6860254|NCT00407797|10869450|FG000|Overall Study|Adverse Event|6
6860255|NCT00407797|10869450|FG000|Overall Study|Other|7
6860256|NCT00407797|10869450|FG000|Overall Study|Withdrawal by Subject|3
6860257|NCT00408317|10869475|FG000|First Intervention Period|Adverse Event|0
6860258|NCT00408317|10869476|FG001|First Intervention Period|Adverse Event|1
6860259|NCT00408317|10869475|FG000|Second Intervention Period|Adverse Event|2
6860260|NCT00408317|10869476|FG001|Second Intervention Period|Adverse Event|0
6860261|NCT00408317|10869475|FG000|Second Intervention Period|Protocol Violation|0
6860262|NCT00408317|10869476|FG001|Second Intervention Period|Protocol Violation|1
6860263|NCT00408317|10869475|FG000|Second Intervention Period|Withdrawal of consent|0
6860264|NCT00408317|10869476|FG001|Second Intervention Period|Withdrawal of consent|1
6860265|NCT00408408|10869488|FG000|Overall Study|No follow up data|2
6860266|NCT00408408|10869489|FG001|Overall Study|No follow up data|3
6860267|NCT00408408|10869490|FG002|Overall Study|No follow up data|0
6860268|NCT00408408|10869491|FG003|Overall Study|No follow up data|7
6860269|NCT00408408|10869492|FG004|Overall Study|No follow up data|5
6860270|NCT00408408|10869493|FG005|Overall Study|No follow up data|3
6860271|NCT00408421|10869509|FG000|Treatment Initial Randomization|Adverse Event|5
6860272|NCT00408421|10869510|FG001|Treatment Initial Randomization|Adverse Event|9
6860273|NCT00408421|10869511|FG002|Treatment Initial Randomization|Adverse Event|0
6860274|NCT00408421|10869509|FG000|Treatment Initial Randomization|Lack of Efficacy|2
6860275|NCT00408421|10869510|FG001|Treatment Initial Randomization|Lack of Efficacy|2
6860276|NCT00408421|10869511|FG002|Treatment Initial Randomization|Lack of Efficacy|0
6860277|NCT00408421|10869509|FG000|Treatment Initial Randomization|Lost to Follow-up|0
6860278|NCT00408421|10869510|FG001|Treatment Initial Randomization|Lost to Follow-up|3
6860279|NCT00408421|10869511|FG002|Treatment Initial Randomization|Lost to Follow-up|0
6860280|NCT00408421|10869509|FG000|Treatment Initial Randomization|Physician Decision|1
6860281|NCT00408421|10869510|FG001|Treatment Initial Randomization|Physician Decision|0
6860282|NCT00408421|10869511|FG002|Treatment Initial Randomization|Physician Decision|0
6860283|NCT00408421|10869509|FG000|Treatment Initial Randomization|Protocol Violation|0
6860284|NCT00408421|10869510|FG001|Treatment Initial Randomization|Protocol Violation|1
6860285|NCT00408421|10869511|FG002|Treatment Initial Randomization|Protocol Violation|0
6860286|NCT00408421|10869509|FG000|Treatment Initial Randomization|Withdrawal by Subject|7
6860287|NCT00408421|10869510|FG001|Treatment Initial Randomization|Withdrawal by Subject|7
6860288|NCT00408421|10869511|FG002|Treatment Initial Randomization|Withdrawal by Subject|0
6860289|NCT00408421|10869509|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1
6860290|NCT00408421|10869510|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0
6967711|NCT01133405|11016050|FG001|Period 2|Physician Decision|0
6860291|NCT00408421|10869511|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0
6860292|NCT00408421|10869509|FG000|Treatment Initial Randomization|Sponsor Decision|1
6860293|NCT00408421|10869510|FG001|Treatment Initial Randomization|Sponsor Decision|0
6860294|NCT00408421|10869511|FG002|Treatment Initial Randomization|Sponsor Decision|0
6860295|NCT00408421|10869509|FG000|Treatment Re-Randomization|Adverse Event|2
6860296|NCT00408421|10869510|FG001|Treatment Re-Randomization|Adverse Event|2
6860297|NCT00408421|10869511|FG002|Treatment Re-Randomization|Adverse Event|4
6860298|NCT00408421|10869509|FG000|Treatment Re-Randomization|Lack of Efficacy|1
6860299|NCT00408421|10869510|FG001|Treatment Re-Randomization|Lack of Efficacy|0
6860300|NCT00408421|10869511|FG002|Treatment Re-Randomization|Lack of Efficacy|0
6860301|NCT00408421|10869509|FG000|Treatment Re-Randomization|Lost to Follow-up|0
6860302|NCT00408421|10869510|FG001|Treatment Re-Randomization|Lost to Follow-up|0
6860303|NCT00408421|10869511|FG002|Treatment Re-Randomization|Lost to Follow-up|1
6860304|NCT00408421|10869509|FG000|Treatment Re-Randomization|Physician Decision|1
6860305|NCT00408421|10869510|FG001|Treatment Re-Randomization|Physician Decision|3
6860306|NCT00408421|10869511|FG002|Treatment Re-Randomization|Physician Decision|0
6860307|NCT00408421|10869509|FG000|Treatment Re-Randomization|Protocol Violation|1
6860308|NCT00408421|10869510|FG001|Treatment Re-Randomization|Protocol Violation|1
6860309|NCT00408421|10869511|FG002|Treatment Re-Randomization|Protocol Violation|0
6860310|NCT00408421|10869509|FG000|Treatment Re-Randomization|Withdrawal by Subject|2
6860311|NCT00408421|10869510|FG001|Treatment Re-Randomization|Withdrawal by Subject|1
6860312|NCT00408421|10869511|FG002|Treatment Re-Randomization|Withdrawal by Subject|0
6860313|NCT00408434|10869526|FG000|Overall Study|Adverse Event|0
6860314|NCT00408434|10869527|FG001|Overall Study|Adverse Event|0
6860315|NCT00408434|10869528|FG002|Overall Study|Adverse Event|1
6860316|NCT00408434|10869529|FG003|Overall Study|Adverse Event|0
6860317|NCT00408434|10869530|FG004|Overall Study|Adverse Event|0
6860318|NCT00408434|10869531|FG005|Overall Study|Adverse Event|0
6860319|NCT00408434|10869532|FG006|Overall Study|Adverse Event|0
6860320|NCT00408434|10869526|FG000|Overall Study|Progressive disease|6
6860321|NCT00408434|10869527|FG001|Overall Study|Progressive disease|3
6860322|NCT00408434|10869528|FG002|Overall Study|Progressive disease|4
6860323|NCT00408434|10869529|FG003|Overall Study|Progressive disease|3
6860324|NCT00408434|10869530|FG004|Overall Study|Progressive disease|3
6860325|NCT00408434|10869531|FG005|Overall Study|Progressive disease|1
6860326|NCT00408434|10869532|FG006|Overall Study|Progressive disease|4
6860327|NCT00408434|10869526|FG000|Overall Study|Other|0
6860328|NCT00408434|10869527|FG001|Overall Study|Other|0
6860329|NCT00408434|10869528|FG002|Overall Study|Other|1
6860330|NCT00408434|10869529|FG003|Overall Study|Other|0
6860331|NCT00408434|10869530|FG004|Overall Study|Other|2
6860332|NCT00408434|10869531|FG005|Overall Study|Other|1
6860333|NCT00408434|10869532|FG006|Overall Study|Other|0
6860334|NCT00408434|10869526|FG000|Overall Study|Terminated by Investigator|0
6860335|NCT00408434|10869527|FG001|Overall Study|Terminated by Investigator|0
6860336|NCT00408434|10869528|FG002|Overall Study|Terminated by Investigator|0
6860337|NCT00408434|10869529|FG003|Overall Study|Terminated by Investigator|0
6860338|NCT00408434|10869530|FG004|Overall Study|Terminated by Investigator|1
6860339|NCT00408434|10869531|FG005|Overall Study|Terminated by Investigator|1
6860340|NCT00408434|10869532|FG006|Overall Study|Terminated by Investigator|0
6860341|NCT00408499|10869553|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0
6860342|NCT00408499|10869554|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0
6860343|NCT00408499|10869555|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1
6860344|NCT00408499|10869556|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0
6860345|NCT00408499|10869557|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0
6860346|NCT00408499|10869553|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
6860347|NCT00408499|10869554|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
6860348|NCT00408499|10869555|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
6860349|NCT00408499|10869556|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
6860350|NCT00408499|10869557|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
6860351|NCT00408499|10869553|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1
6860352|NCT00408499|10869554|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1
6860353|NCT00408499|10869555|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0
6860354|NCT00408499|10869556|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0
6860355|NCT00408499|10869557|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0
6860356|NCT00408499|10869553|FG000|Phase II- MTD Expansion|Adverse Event|0
6860357|NCT00408499|10869554|FG001|Phase II- MTD Expansion|Adverse Event|0
6860358|NCT00408499|10869555|FG002|Phase II- MTD Expansion|Adverse Event|0
6860359|NCT00408499|10869556|FG003|Phase II- MTD Expansion|Adverse Event|0
6860360|NCT00408499|10869557|FG004|Phase II- MTD Expansion|Adverse Event|9
6860361|NCT00408499|10869553|FG000|Phase II- MTD Expansion|Death|0
6860362|NCT00408499|10869554|FG001|Phase II- MTD Expansion|Death|0
6860363|NCT00408499|10869555|FG002|Phase II- MTD Expansion|Death|0
6860364|NCT00408499|10869556|FG003|Phase II- MTD Expansion|Death|0
6860365|NCT00408499|10869557|FG004|Phase II- MTD Expansion|Death|2
6860366|NCT00408499|10869553|FG000|Phase II- MTD Expansion|Physician Decision|0
6860367|NCT00408499|10869554|FG001|Phase II- MTD Expansion|Physician Decision|0
6860368|NCT00408499|10869555|FG002|Phase II- MTD Expansion|Physician Decision|0
6860369|NCT00408499|10869556|FG003|Phase II- MTD Expansion|Physician Decision|0
6860370|NCT00408499|10869557|FG004|Phase II- MTD Expansion|Physician Decision|1
6967712|NCT01133405|11016051|FG002|Period 2|Physician Decision|0
6860371|NCT00408499|10869553|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0
6860372|NCT00408499|10869554|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0
6860373|NCT00408499|10869555|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0
6860374|NCT00408499|10869556|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0
6860375|NCT00408499|10869557|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5
6860376|NCT00408499|10869553|FG000|Phase II- MTD Expansion|treatment delay|0
6860377|NCT00408499|10869554|FG001|Phase II- MTD Expansion|treatment delay|0
6860378|NCT00408499|10869555|FG002|Phase II- MTD Expansion|treatment delay|0
6860379|NCT00408499|10869556|FG003|Phase II- MTD Expansion|treatment delay|0
6860380|NCT00408499|10869557|FG004|Phase II- MTD Expansion|treatment delay|3
6860381|NCT00408629|10869613|FG000|Overall Study|Adverse Event|13
6860382|NCT00408629|10869614|FG001|Overall Study|Adverse Event|27
6860383|NCT00408629|10869613|FG000|Overall Study|Withdrawal by Subject|8
6860384|NCT00408629|10869614|FG001|Overall Study|Withdrawal by Subject|4
6860385|NCT00408629|10869613|FG000|Overall Study|Lost to Follow-up|1
6860386|NCT00408629|10869614|FG001|Overall Study|Lost to Follow-up|1
6860387|NCT00408629|10869613|FG000|Overall Study|Lack of Efficacy|63
6860388|NCT00408629|10869614|FG001|Overall Study|Lack of Efficacy|73
6860389|NCT00408629|10869613|FG000|Overall Study|Protocol Violation|1
6860390|NCT00408629|10869614|FG001|Overall Study|Protocol Violation|5
6860391|NCT00408629|10869613|FG000|Overall Study|Miscellaneous|11
6860392|NCT00408629|10869614|FG001|Overall Study|Miscellaneous|15
6860393|NCT00408681|10869621|FG000|Overall Study|Lack of Efficacy|2
6860394|NCT00408681|10869621|FG000|Overall Study|Adverse Event|7
6860395|NCT00408694|10869626|FG000|Overall Study|Ineligible|1
6860396|NCT00408694|10869626|FG000|Overall Study|No protocol treatment|1
6860397|NCT00408876|10869634|FG000|Overall Study|Adverse Event|9
6860398|NCT00408876|10869635|FG001|Overall Study|Adverse Event|17
6860399|NCT00408876|10869636|FG002|Overall Study|Adverse Event|27
6860400|NCT00408876|10869637|FG003|Overall Study|Adverse Event|10
6860401|NCT00408876|10869634|FG000|Overall Study|Withdrawal by Subject|3
6860402|NCT00408876|10869635|FG001|Overall Study|Withdrawal by Subject|6
6860403|NCT00408876|10869636|FG002|Overall Study|Withdrawal by Subject|6
6860404|NCT00408876|10869637|FG003|Overall Study|Withdrawal by Subject|14
6860405|NCT00408876|10869634|FG000|Overall Study|Lack of Efficacy|2
6860406|NCT00408876|10869635|FG001|Overall Study|Lack of Efficacy|4
6860407|NCT00408876|10869636|FG002|Overall Study|Lack of Efficacy|5
6860408|NCT00408876|10869637|FG003|Overall Study|Lack of Efficacy|6
6860409|NCT00408876|10869634|FG000|Overall Study|Lost to Follow-up|1
6860410|NCT00408876|10869635|FG001|Overall Study|Lost to Follow-up|6
6860411|NCT00408876|10869636|FG002|Overall Study|Lost to Follow-up|5
6860412|NCT00408876|10869637|FG003|Overall Study|Lost to Follow-up|2
6860413|NCT00408876|10869634|FG000|Overall Study|Protocol Violation|0
6860414|NCT00408876|10869635|FG001|Overall Study|Protocol Violation|3
6860415|NCT00408876|10869636|FG002|Overall Study|Protocol Violation|4
6860416|NCT00408876|10869637|FG003|Overall Study|Protocol Violation|3
6860417|NCT00408876|10869634|FG000|Overall Study|Physician Decision|1
6860418|NCT00408876|10869635|FG001|Overall Study|Physician Decision|0
6860419|NCT00408876|10869636|FG002|Overall Study|Physician Decision|3
6860420|NCT00408876|10869637|FG003|Overall Study|Physician Decision|0
6860421|NCT00408902|10869647|FG000|Overall Study|Lack of Efficacy|7
6860422|NCT00408902|10869647|FG000|Overall Study|Adverse Event|3
6860423|NCT00408928|10869652|FG000|Overall Study|Withdrawal by Subject|1
6860424|NCT00408928|10869652|FG000|Overall Study|Death|1
6860425|NCT00408928|10869652|FG000|Overall Study|Infection indistinguishable from GVHD|1
6860426|NCT00408993|10869658|FG000|Overall Study|Adverse Event|15
6860427|NCT00408993|10869659|FG001|Overall Study|Adverse Event|4
6860428|NCT00408993|10869658|FG000|Overall Study|Protocol Violation|1
6860429|NCT00408993|10869659|FG001|Overall Study|Protocol Violation|6
6860430|NCT00408993|10869658|FG000|Overall Study|Lack of Efficacy|1
6860431|NCT00408993|10869659|FG001|Overall Study|Lack of Efficacy|4
6860432|NCT00408993|10869658|FG000|Overall Study|Withdrawal by Subject|2
6860433|NCT00408993|10869659|FG001|Overall Study|Withdrawal by Subject|3
6860434|NCT00409006|10869671|FG000|Overall Study|Death|15
6860435|NCT00409006|10869672|FG001|Overall Study|Death|6
6860436|NCT00409006|10869671|FG000|Overall Study|Lost to Follow-up|1
6860437|NCT00409006|10869672|FG001|Overall Study|Lost to Follow-up|2
6860438|NCT00409006|10869671|FG000|Overall Study|Withdrawal by Subject|3
6860439|NCT00409006|10869672|FG001|Overall Study|Withdrawal by Subject|2
6860440|NCT00409006|10869671|FG000|Overall Study|Physician Decision|1
6860441|NCT00409006|10869672|FG001|Overall Study|Physician Decision|2
6860442|NCT00409175|10869680|FG000|Overall Study|Adverse Event|4
6860443|NCT00409175|10869681|FG001|Overall Study|Adverse Event|3
6860444|NCT00409175|10869680|FG000|Overall Study|Withdrawal by Subject|1
6860445|NCT00409175|10869681|FG001|Overall Study|Withdrawal by Subject|2
6860446|NCT00409175|10869680|FG000|Overall Study|Negative genotype|0
6860447|NCT00409175|10869681|FG001|Overall Study|Negative genotype|1
6860448|NCT00409175|10869680|FG000|Overall Study|Liver transplantation|13
6860449|NCT00409175|10869681|FG001|Overall Study|Liver transplantation|13
6860450|NCT00409188|10869689|FG000|Overall Study|Ongoing at data cut-off|383
6860451|NCT00409188|10869690|FG001|Overall Study|Ongoing at data cut-off|175
6860452|NCT00409409|10869713|FG000|Overall Study|Adverse Event|7
6860453|NCT00409409|10869714|FG001|Overall Study|Adverse Event|2
6860454|NCT00409409|10869713|FG000|Overall Study|Withdrawal by Subject|1
6860455|NCT00409409|10869714|FG001|Overall Study|Withdrawal by Subject|1
6860456|NCT00409409|10869713|FG000|Overall Study|Any other reason not above-mentioned|0
6860457|NCT00409409|10869714|FG001|Overall Study|Any other reason not above-mentioned|1
6860458|NCT00409578|10869749|FG000|Overall Study|Adverse Event|27
6860459|NCT00409578|10869750|FG001|Overall Study|Adverse Event|37
6860460|NCT00409578|10869751|FG002|Overall Study|Adverse Event|25
6860461|NCT00409578|10869752|FG003|Overall Study|Adverse Event|33
6860462|NCT00409578|10869749|FG000|Overall Study|Abnormal laboratory value(s)|2
6860463|NCT00409578|10869750|FG001|Overall Study|Abnormal laboratory value(s)|2
6860464|NCT00409578|10869751|FG002|Overall Study|Abnormal laboratory value(s)|2
6860465|NCT00409578|10869752|FG003|Overall Study|Abnormal laboratory value(s)|4
6860466|NCT00409578|10869749|FG000|Overall Study|Lack of Efficacy|0
6860467|NCT00409578|10869750|FG001|Overall Study|Lack of Efficacy|0
6860468|NCT00409578|10869751|FG002|Overall Study|Lack of Efficacy|0
6860469|NCT00409578|10869752|FG003|Overall Study|Lack of Efficacy|2
6860470|NCT00409578|10869749|FG000|Overall Study|Subject no longer requires study drug|0
6860471|NCT00409578|10869750|FG001|Overall Study|Subject no longer requires study drug|0
6860472|NCT00409578|10869751|FG002|Overall Study|Subject no longer requires study drug|0
6860473|NCT00409578|10869752|FG003|Overall Study|Subject no longer requires study drug|1
6860474|NCT00409578|10869749|FG000|Overall Study|Withdrawal by Subject|8
6860475|NCT00409578|10869750|FG001|Overall Study|Withdrawal by Subject|15
6860476|NCT00409578|10869751|FG002|Overall Study|Withdrawal by Subject|16
6860477|NCT00409578|10869752|FG003|Overall Study|Withdrawal by Subject|17
6860478|NCT00409578|10869749|FG000|Overall Study|Lost to Follow-up|2
6860479|NCT00409578|10869750|FG001|Overall Study|Lost to Follow-up|0
6860480|NCT00409578|10869751|FG002|Overall Study|Lost to Follow-up|2
6860481|NCT00409578|10869752|FG003|Overall Study|Lost to Follow-up|2
6860482|NCT00409578|10869749|FG000|Overall Study|Administrative problems|8
6860483|NCT00409578|10869750|FG001|Overall Study|Administrative problems|9
6860484|NCT00409578|10869751|FG002|Overall Study|Administrative problems|2
6860485|NCT00409578|10869752|FG003|Overall Study|Administrative problems|4
6860486|NCT00409578|10869749|FG000|Overall Study|Death|2
6860487|NCT00409578|10869750|FG001|Overall Study|Death|4
6860488|NCT00409578|10869751|FG002|Overall Study|Death|4
6860489|NCT00409578|10869752|FG003|Overall Study|Death|2
6860490|NCT00409578|10869749|FG000|Overall Study|Protocol Violation|3
6860491|NCT00409578|10869750|FG001|Overall Study|Protocol Violation|2
6860492|NCT00409578|10869751|FG002|Overall Study|Protocol Violation|3
6860493|NCT00409578|10869752|FG003|Overall Study|Protocol Violation|1
6860494|NCT00409578|10869749|FG000|Overall Study|Missing|0
6860495|NCT00409578|10869750|FG001|Overall Study|Missing|1
6860496|NCT00409578|10869751|FG002|Overall Study|Missing|0
6860497|NCT00409578|10869752|FG003|Overall Study|Missing|1
6860498|NCT00409617|10869762|FG000|Overall Study|Adverse Event|57
6860499|NCT00409617|10869762|FG000|Overall Study|Lack of Efficacy|54
6860500|NCT00409617|10869762|FG000|Overall Study|Lost to Follow-up|2
6860501|NCT00409617|10869762|FG000|Overall Study|Protocol Violation|24
6860502|NCT00409617|10869762|FG000|Overall Study|Withdrawal by Subject|8
6860503|NCT00409617|10869762|FG000|Overall Study|Administrative reasons|1
6860504|NCT00409617|10869762|FG000|Overall Study|Not described|14
6860505|NCT00409682|10869769|FG000|Open-label Induction Period|Adverse Event|1
6860506|NCT00409682|10869770|FG001|Open-label Induction Period|Adverse Event|0
6860507|NCT00409682|10869771|FG002|Open-label Induction Period|Adverse Event|0
6860508|NCT00409682|10869769|FG000|Open-label Induction Period|Lack of Efficacy|1
6860509|NCT00409682|10869770|FG001|Open-label Induction Period|Lack of Efficacy|0
6860510|NCT00409682|10869771|FG002|Open-label Induction Period|Lack of Efficacy|0
6860511|NCT00409682|10869769|FG000|Open-label Induction Period|Protocol Violation|1
6860512|NCT00409682|10869770|FG001|Open-label Induction Period|Protocol Violation|0
6860513|NCT00409682|10869771|FG002|Open-label Induction Period|Protocol Violation|0
6860514|NCT00409682|10869769|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1
6860515|NCT00409682|10869770|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0
6860516|NCT00409682|10869771|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0
6860517|NCT00409682|10869769|FG000|EOW Double-blind Maintenance Period|Adverse Event|0
6860518|NCT00409682|10869770|FG001|EOW Double-blind Maintenance Period|Adverse Event|10
6860519|NCT00409682|10869771|FG002|EOW Double-blind Maintenance Period|Adverse Event|12
6860520|NCT00409682|10869769|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0
6860521|NCT00409682|10869770|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18
6860522|NCT00409682|10869771|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11
6860523|NCT00409682|10869769|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0
6860524|NCT00409682|10869770|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1
6860525|NCT00409682|10869771|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0
6860526|NCT00409682|10869769|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0
6860527|NCT00409682|10869770|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4
6860528|NCT00409682|10869771|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2
6860529|NCT00409682|10869769|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0
6860530|NCT00409682|10869770|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4
6860531|NCT00409682|10869771|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1
6860532|NCT00409682|10869769|FG000|EOW Double-blind Maintenance Period|Non-compliance|0
6860533|NCT00409682|10869770|FG001|EOW Double-blind Maintenance Period|Non-compliance|0
6967713|NCT01133405|11016052|FG003|Period 2|Physician Decision|0
6860534|NCT00409682|10869771|FG002|EOW Double-blind Maintenance Period|Non-compliance|1
6860535|NCT00409708|10869780|FG000|Treatment|Abnormal test procedure result(s)|1
6860536|NCT00409708|10869781|FG001|Treatment|Abnormal test procedure result(s)|0
6860537|NCT00409708|10869780|FG000|Treatment|Lack of Efficacy|0
6860538|NCT00409708|10869781|FG001|Treatment|Lack of Efficacy|1
6860539|NCT00409708|10869780|FG000|Treatment|Protocol Violation|6
6860540|NCT00409708|10869781|FG001|Treatment|Protocol Violation|2
6860541|NCT00409708|10869780|FG000|Treatment|Withdrawal by Subject|3
6860542|NCT00409708|10869781|FG001|Treatment|Withdrawal by Subject|8
6860543|NCT00409708|10869780|FG000|Treatment|Lost to Follow-up|0
6860544|NCT00409708|10869781|FG001|Treatment|Lost to Follow-up|6
6860545|NCT00409708|10869780|FG000|Treatment|Administrative problems|5
6860546|NCT00409708|10869781|FG001|Treatment|Administrative problems|0
6860547|NCT00409708|10869780|FG000|Washout|Lack of Efficacy|9
6860548|NCT00409708|10869781|FG001|Washout|Lack of Efficacy|1
6860549|NCT00409708|10869780|FG000|Washout|Protocol Violation|0
6860550|NCT00409708|10869781|FG001|Washout|Protocol Violation|1
6860551|NCT00409708|10869780|FG000|Washout|Withdrawal by Subject|11
6860552|NCT00409708|10869781|FG001|Washout|Withdrawal by Subject|5
6860553|NCT00409708|10869780|FG000|Washout|Lost to Follow-up|1
6860554|NCT00409708|10869781|FG001|Washout|Lost to Follow-up|3
6860555|NCT00409747|10869787|FG000|Overall Study|Withdrawal by Subject|1
6860556|NCT00409786|10869791|FG000|Overall Study|Withdrawal by Subject|3
6860557|NCT00409838|10869801|FG000|Short-term Period|Adverse Event|0
6860558|NCT00409838|10869802|FG001|Short-term Period|Adverse Event|1
6860559|NCT00409838|10869801|FG000|Short-term Period|Lost to Follow-up|0
6860560|NCT00409838|10869802|FG001|Short-term Period|Lost to Follow-up|1
6860561|NCT00409838|10869801|FG000|Short-term Period|Withdrawal by Subject|2
6860562|NCT00409838|10869802|FG001|Short-term Period|Withdrawal by Subject|3
6860563|NCT00409838|10869801|FG000|Short-term Period|Never Treated|1
6860564|NCT00409838|10869802|FG001|Short-term Period|Never Treated|0
6860565|NCT00409838|10869801|FG000|Long-term Extension Period|Adverse Event|10
6860566|NCT00409838|10869802|FG001|Long-term Extension Period|Adverse Event|0
6860567|NCT00409838|10869801|FG000|Long-term Extension Period|Death|1
6860568|NCT00409838|10869802|FG001|Long-term Extension Period|Death|0
6860569|NCT00409838|10869801|FG000|Long-term Extension Period|Lack of Efficacy|2
6860570|NCT00409838|10869802|FG001|Long-term Extension Period|Lack of Efficacy|0
6860571|NCT00409838|10869801|FG000|Long-term Extension Period|Withdrawal by Subject|3
6860572|NCT00409838|10869802|FG001|Long-term Extension Period|Withdrawal by Subject|0
6860573|NCT00409838|10869801|FG000|Long-term Extension Period|Poor compliance/noncompliance|1
6860574|NCT00409838|10869802|FG001|Long-term Extension Period|Poor compliance/noncompliance|0
6860575|NCT00409838|10869801|FG000|Long-term Extension Period|Pregnancy|1
6860576|NCT00409838|10869802|FG001|Long-term Extension Period|Pregnancy|0
6860577|NCT00410046|10869825|FG000|Overall Study|Adverse Event|3
6860578|NCT00410046|10869825|FG000|Overall Study|Withdrawal by Subject|1
6860579|NCT00410046|10869825|FG000|Overall Study|Lost to Follow-up|1
6860580|NCT00410072|10869836|FG000|Day 1 to Week 48|Adverse Event|1
6860581|NCT00410072|10869837|FG001|Day 1 to Week 48|Adverse Event|2
6860582|NCT00410072|10869836|FG000|Day 1 to Week 48|Lost to Follow-up|5
6860583|NCT00410072|10869837|FG001|Day 1 to Week 48|Lost to Follow-up|2
6860584|NCT00410072|10869836|FG000|Day 1 to Week 48|Other|0
6860585|NCT00410072|10869837|FG001|Day 1 to Week 48|Other|1
6860586|NCT00410072|10869836|FG000|Day 1 to Week 48|poor compliance/noncompliance|0
6860587|NCT00410072|10869837|FG001|Day 1 to Week 48|poor compliance/noncompliance|3
6860588|NCT00410072|10869836|FG000|Day 1 to Week 48|Pregnancy|0
6860589|NCT00410072|10869837|FG001|Day 1 to Week 48|Pregnancy|2
6860590|NCT00410072|10869836|FG000|Day 1 to Week 48|Withdrawal by Subject|0
6860591|NCT00410072|10869837|FG001|Day 1 to Week 48|Withdrawal by Subject|2
6860592|NCT00410072|10869836|FG000|After Week 48 to Week 96|Adverse Event|1
6860593|NCT00410072|10869837|FG001|After Week 48 to Week 96|Adverse Event|2
6860594|NCT00410072|10869836|FG000|After Week 48 to Week 96|Death|0
6860595|NCT00410072|10869837|FG001|After Week 48 to Week 96|Death|1
6860596|NCT00410072|10869836|FG000|After Week 48 to Week 96|Lack of Efficacy|1
6860597|NCT00410072|10869837|FG001|After Week 48 to Week 96|Lack of Efficacy|0
6860598|NCT00410072|10869836|FG000|After Week 48 to Week 96|Lost to Follow-up|2
6860599|NCT00410072|10869837|FG001|After Week 48 to Week 96|Lost to Follow-up|4
6860600|NCT00410072|10869836|FG000|After Week 48 to Week 96|Other|2
6860601|NCT00410072|10869837|FG001|After Week 48 to Week 96|Other|0
6860602|NCT00410072|10869836|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0
6860603|NCT00410072|10869837|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1
6860604|NCT00410072|10869836|FG000|After Week 48 to Week 96|Pregnancy|0
6860605|NCT00410072|10869837|FG001|After Week 48 to Week 96|Pregnancy|2
6860606|NCT00410072|10869836|FG000|After Week 48 to Week 96|Withdrawal by Subject|0
6860607|NCT00410072|10869837|FG001|After Week 48 to Week 96|Withdrawal by Subject|1
6860608|NCT00410124|10869845|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36
6860609|NCT00410124|10869846|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2
6860610|NCT00410124|10869845|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1
6860611|NCT00410124|10869846|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0
6860612|NCT00410124|10869845|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2
6860613|NCT00410124|10869846|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1
6860614|NCT00410124|10869845|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13
6860615|NCT00410124|10869846|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2
6860616|NCT00410124|10869845|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4
6860617|NCT00410124|10869846|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0
6860618|NCT00410124|10869845|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2
6860619|NCT00410124|10869846|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0
6860620|NCT00410124|10869845|FG000|Core Phase Double Blind (15 Months)|Death|7
6860621|NCT00410124|10869846|FG001|Core Phase Double Blind (15 Months)|Death|4
6860622|NCT00410124|10869845|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137
6860623|NCT00410124|10869846|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124
6860624|NCT00410124|10869845|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7
6860625|NCT00410124|10869846|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19
6860626|NCT00410124|10869845|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0
6860627|NCT00410124|10869846|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1
6860628|NCT00410124|10869845|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0
6860629|NCT00410124|10869846|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1
6860630|NCT00410124|10869845|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
6860631|NCT00410124|10869846|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
6860632|NCT00410124|10869845|FG000|Extension Phase - Open Label (45 Months)|Death|2
6860633|NCT00410124|10869846|FG001|Extension Phase - Open Label (45 Months)|Death|10
6860634|NCT00410124|10869845|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56
6860635|NCT00410124|10869846|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78
6860636|NCT00410124|10869845|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1
6860637|NCT00410124|10869846|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0
6860638|NCT00410124|10869845|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0
6860639|NCT00410124|10869846|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1
6967714|NCT01133405|11016053|FG004|Period 2|Physician Decision|0
6967715|NCT01133405|11016054|FG005|Period 2|Physician Decision|1
6967716|NCT01133405|11016055|FG006|Period 2|Physician Decision|0
6967717|NCT01133405|11016056|FG007|Period 2|Physician Decision|0
6967718|NCT01133405|11016057|FG008|Period 2|Physician Decision|0
6967719|NCT01133405|11016058|FG009|Period 2|Physician Decision|0
6967720|NCT01133418|11016090|FG000|Overall Study|Lost to Follow-up|5
6967721|NCT01133418|11016091|FG001|Overall Study|Lost to Follow-up|6
6967722|NCT01133522|11016107|FG000|Overall Study|Withdrawal by Subject|0
6967723|NCT01133522|11016108|FG001|Overall Study|Withdrawal by Subject|1
6967724|NCT01133522|11016109|FG002|Overall Study|Withdrawal by Subject|0
6967725|NCT01133522|11016110|FG003|Overall Study|Withdrawal by Subject|1
6967726|NCT01133522|11016111|FG004|Overall Study|Withdrawal by Subject|0
6967727|NCT01133522|11016112|FG005|Overall Study|Withdrawal by Subject|0
6967728|NCT01133522|11016113|FG006|Overall Study|Withdrawal by Subject|0
6967729|NCT01133522|11016114|FG007|Overall Study|Withdrawal by Subject|0
6967730|NCT01133522|11016115|FG008|Overall Study|Withdrawal by Subject|0
6967731|NCT01133522|11016116|FG009|Overall Study|Withdrawal by Subject|0
6967732|NCT01133522|11016107|FG000|Overall Study|Physician Decision|0
6967733|NCT01133522|11016108|FG001|Overall Study|Physician Decision|0
6967734|NCT01133522|11016109|FG002|Overall Study|Physician Decision|0
6967735|NCT01133522|11016110|FG003|Overall Study|Physician Decision|0
6967736|NCT01133522|11016111|FG004|Overall Study|Physician Decision|1
6967737|NCT01133522|11016112|FG005|Overall Study|Physician Decision|0
6967738|NCT01133522|11016113|FG006|Overall Study|Physician Decision|0
6967739|NCT01133522|11016114|FG007|Overall Study|Physician Decision|0
6967740|NCT01133522|11016115|FG008|Overall Study|Physician Decision|0
7077966|NCT02099110|11186163|FG001|Overall Study|Protocol Violation|1
7077967|NCT02099110|11186164|FG002|Overall Study|Protocol Violation|0
7077968|NCT02099110|11186165|FG003|Overall Study|Protocol Violation|3
6967741|NCT01133522|11016116|FG009|Overall Study|Physician Decision|0
6967742|NCT01133626|11016148|FG000|Overall Study|Adverse Event|0
6967743|NCT01133626|11016149|FG001|Overall Study|Adverse Event|1
6967744|NCT01133626|11016150|FG002|Overall Study|Adverse Event|0
6967745|NCT01133626|11016148|FG000|Overall Study|Withdrawal by Subject|1
6967746|NCT01133626|11016149|FG001|Overall Study|Withdrawal by Subject|2
6967747|NCT01133626|11016150|FG002|Overall Study|Withdrawal by Subject|2
6967748|NCT01133626|11016148|FG000|Overall Study|Other|0
6967749|NCT01133626|11016149|FG001|Overall Study|Other|2
6967750|NCT01133626|11016150|FG002|Overall Study|Other|0
6967751|NCT01133665|11016158|FG000|Overall Study|Physician Decision|2
6967752|NCT01133678|11016164|FG000|Overall Study|Death|1
6967753|NCT01133678|11016165|FG001|Overall Study|Death|1
6967754|NCT01133704|11016173|FG000|Overall Study|Death|44
6967755|NCT01133704|11016174|FG001|Overall Study|Death|26
6967756|NCT01133704|11016173|FG000|Overall Study|Patient refused to continue|4
6967757|NCT01133704|11016174|FG001|Overall Study|Patient refused to continue|0
6967758|NCT01133704|11016173|FG000|Overall Study|Study Closure|1
6967759|NCT01133704|11016174|FG001|Overall Study|Study Closure|0
6967760|NCT01133756|11016183|FG000|Overall Study|Adverse Event|1
6967761|NCT01133756|11016184|FG001|Overall Study|Adverse Event|2
7077969|NCT02099110|11186166|FG004|Overall Study|Protocol Violation|1
7077970|NCT02099110|11186162|FG000|Overall Study|Participant moved|1
7077971|NCT02099110|11186163|FG001|Overall Study|Participant moved|1
6860640|NCT00410163|10869867|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4
6860641|NCT00410163|10869868|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2
6860642|NCT00410163|10869867|FG000|Treatment and Follow-up Phase (2 Years)|Death|1
6860643|NCT00410163|10869868|FG001|Treatment and Follow-up Phase (2 Years)|Death|1
6860644|NCT00410163|10869867|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2
6860645|NCT00410163|10869868|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1
6860646|NCT00410163|10869867|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0
6860647|NCT00410163|10869868|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4
6860648|NCT00410163|10869867|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2
6860649|NCT00410163|10869868|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1
6860650|NCT00410163|10869867|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1
6860651|NCT00410163|10869868|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0
6860652|NCT00410163|10869867|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
6860653|NCT00410163|10869868|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
6860654|NCT00410163|10869867|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1
6860655|NCT00410163|10869868|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0
6860656|NCT00410163|10869867|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0
6860657|NCT00410163|10869868|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1
6860658|NCT00410163|10869867|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3
6860659|NCT00410163|10869868|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1
6860660|NCT00410163|10869867|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1
6860661|NCT00410163|10869868|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1
6860662|NCT00410163|10869867|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1
6860663|NCT00410163|10869868|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0
6860664|NCT00410163|10869867|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4
6860665|NCT00410163|10869868|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8
6860666|NCT00410163|10869867|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1
6860667|NCT00410163|10869868|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0
6860668|NCT00410202|10869885|FG000|On-Treatment|Continuing treatment|69
6860669|NCT00410202|10869886|FG001|On-Treatment|Continuing treatment|71
6860670|NCT00410202|10869887|FG002|On-Treatment|Continuing treatment|66
6860671|NCT00410202|10869885|FG000|On-Treatment|Adverse Event|1
6860672|NCT00410202|10869886|FG001|On-Treatment|Adverse Event|3
6860673|NCT00410202|10869887|FG002|On-Treatment|Adverse Event|2
6860674|NCT00410202|10869885|FG000|On-Treatment|Death|1
6860675|NCT00410202|10869886|FG001|On-Treatment|Death|0
6860676|NCT00410202|10869887|FG002|On-Treatment|Death|0
6860677|NCT00410202|10869885|FG000|On-Treatment|Lost to Follow-up|1
6860678|NCT00410202|10869886|FG001|On-Treatment|Lost to Follow-up|0
6860679|NCT00410202|10869887|FG002|On-Treatment|Lost to Follow-up|1
6860680|NCT00410202|10869885|FG000|On-Treatment|Lack of Efficacy|1
6860681|NCT00410202|10869886|FG001|On-Treatment|Lack of Efficacy|4
6860682|NCT00410202|10869887|FG002|On-Treatment|Lack of Efficacy|0
6860683|NCT00410202|10869885|FG000|On-Treatment|Withdrawal by Subject|2
6860684|NCT00410202|10869886|FG001|On-Treatment|Withdrawal by Subject|1
6860685|NCT00410202|10869887|FG002|On-Treatment|Withdrawal by Subject|1
6860686|NCT00410202|10869885|FG000|On-Treatment|Other Reason|0
6860687|NCT00410202|10869886|FG001|On-Treatment|Other Reason|0
6860688|NCT00410202|10869887|FG002|On-Treatment|Other Reason|1
6860689|NCT00410202|10869885|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10
6860690|NCT00410202|10869886|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8
6860691|NCT00410202|10869887|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11
6860692|NCT00410202|10869885|FG000|Off-treatment Follow up|Follow up not required per protocol|3
6860693|NCT00410202|10869886|FG001|Off-treatment Follow up|Follow up not required per protocol|0
6860694|NCT00410202|10869887|FG002|Off-treatment Follow up|Follow up not required per protocol|1
6860695|NCT00410202|10869885|FG000|Off-treatment Follow up|Lost to Follow-up|1
6860696|NCT00410202|10869886|FG001|Off-treatment Follow up|Lost to Follow-up|0
6860697|NCT00410202|10869887|FG002|Off-treatment Follow up|Lost to Follow-up|0
6860698|NCT00410384|10869908|FG000|Overall Study|Withdrawal by Subject|28
6860699|NCT00410384|10869909|FG001|Overall Study|Withdrawal by Subject|17
6860700|NCT00410384|10869910|FG002|Overall Study|Withdrawal by Subject|20
6860701|NCT00410384|10869908|FG000|Overall Study|Adverse Event|23
6860702|NCT00410384|10869909|FG001|Overall Study|Adverse Event|18
6860703|NCT00410384|10869910|FG002|Overall Study|Adverse Event|23
6860704|NCT00410384|10869908|FG000|Overall Study|Lack of Efficacy|20
6860705|NCT00410384|10869909|FG001|Overall Study|Lack of Efficacy|12
6860706|NCT00410384|10869910|FG002|Overall Study|Lack of Efficacy|17
6860707|NCT00410384|10869908|FG000|Overall Study|Lack of Compliance|2
6860708|NCT00410384|10869909|FG001|Overall Study|Lack of Compliance|2
6860709|NCT00410384|10869910|FG002|Overall Study|Lack of Compliance|2
6860710|NCT00410384|10869908|FG000|Overall Study|Lost to Follow-up|4
6860711|NCT00410384|10869909|FG001|Overall Study|Lost to Follow-up|6
6860712|NCT00410384|10869910|FG002|Overall Study|Lost to Follow-up|6
6860713|NCT00410384|10869908|FG000|Overall Study|Protocol Violation|6
6860714|NCT00410384|10869909|FG001|Overall Study|Protocol Violation|6
6860715|NCT00410384|10869910|FG002|Overall Study|Protocol Violation|6
7153034|NCT03273166|11318255|FG000|Overall Study|Withdrawn prior to Completion|31
7153035|NCT03273257|11318262|FG000|Overall Study|Death|0
7153036|NCT03273257|11318263|FG001|Overall Study|Death|1
6860716|NCT00410384|10869908|FG000|Overall Study|Physician Decision|3
6860717|NCT00410384|10869909|FG001|Overall Study|Physician Decision|3
6860718|NCT00410384|10869910|FG002|Overall Study|Physician Decision|4
6860719|NCT00410384|10869908|FG000|Overall Study|Other|3
6860720|NCT00410384|10869909|FG001|Overall Study|Other|8
6860721|NCT00410384|10869910|FG002|Overall Study|Other|4
6860722|NCT00410410|10869924|FG000|Induction Period (IP)|Death|1
6860723|NCT00410410|10869925|FG001|Induction Period (IP)|Death|0
6860724|NCT00410410|10869926|FG002|Induction Period (IP)|Death|0
6860725|NCT00410410|10869927|FG003|Induction Period (IP)|Death|0
6860726|NCT00410410|10869928|FG004|Induction Period (IP)|Death|0
6860727|NCT00410410|10869929|FG005|Induction Period (IP)|Death|0
6860728|NCT00410410|10869930|FG006|Induction Period (IP)|Death|0
6860729|NCT00410410|10869931|FG007|Induction Period (IP)|Death|0
6860730|NCT00410410|10869932|FG008|Induction Period (IP)|Death|0
6860731|NCT00410410|10869924|FG000|Induction Period (IP)|Adverse Event|3
6860732|NCT00410410|10869925|FG001|Induction Period (IP)|Adverse Event|4
6860733|NCT00410410|10869926|FG002|Induction Period (IP)|Adverse Event|2
6860734|NCT00410410|10869927|FG003|Induction Period (IP)|Adverse Event|4
6860735|NCT00410410|10869928|FG004|Induction Period (IP)|Adverse Event|1
6860736|NCT00410410|10869929|FG005|Induction Period (IP)|Adverse Event|0
6860737|NCT00410410|10869930|FG006|Induction Period (IP)|Adverse Event|0
6860738|NCT00410410|10869931|FG007|Induction Period (IP)|Adverse Event|0
6860739|NCT00410410|10869932|FG008|Induction Period (IP)|Adverse Event|0
6860740|NCT00410410|10869924|FG000|Induction Period (IP)|Lack of Efficacy|26
6860741|NCT00410410|10869925|FG001|Induction Period (IP)|Lack of Efficacy|24
6860742|NCT00410410|10869926|FG002|Induction Period (IP)|Lack of Efficacy|8
6860743|NCT00410410|10869927|FG003|Induction Period (IP)|Lack of Efficacy|8
6860744|NCT00410410|10869928|FG004|Induction Period (IP)|Lack of Efficacy|7
6860745|NCT00410410|10869929|FG005|Induction Period (IP)|Lack of Efficacy|7
6860746|NCT00410410|10869930|FG006|Induction Period (IP)|Lack of Efficacy|0
6860747|NCT00410410|10869931|FG007|Induction Period (IP)|Lack of Efficacy|0
6860748|NCT00410410|10869932|FG008|Induction Period (IP)|Lack of Efficacy|0
6860749|NCT00410410|10869924|FG000|Induction Period (IP)|Lost to Follow-up|2
6860750|NCT00410410|10869925|FG001|Induction Period (IP)|Lost to Follow-up|2
6860751|NCT00410410|10869926|FG002|Induction Period (IP)|Lost to Follow-up|2
6860752|NCT00410410|10869927|FG003|Induction Period (IP)|Lost to Follow-up|3
6860753|NCT00410410|10869928|FG004|Induction Period (IP)|Lost to Follow-up|0
6860754|NCT00410410|10869929|FG005|Induction Period (IP)|Lost to Follow-up|1
6860755|NCT00410410|10869930|FG006|Induction Period (IP)|Lost to Follow-up|0
6860756|NCT00410410|10869931|FG007|Induction Period (IP)|Lost to Follow-up|0
6860757|NCT00410410|10869932|FG008|Induction Period (IP)|Lost to Follow-up|0
6860758|NCT00410410|10869924|FG000|Induction Period (IP)|Withdrawal by Subject|3
6860759|NCT00410410|10869925|FG001|Induction Period (IP)|Withdrawal by Subject|5
6860760|NCT00410410|10869926|FG002|Induction Period (IP)|Withdrawal by Subject|3
6860761|NCT00410410|10869927|FG003|Induction Period (IP)|Withdrawal by Subject|5
6860762|NCT00410410|10869928|FG004|Induction Period (IP)|Withdrawal by Subject|2
6860763|NCT00410410|10869929|FG005|Induction Period (IP)|Withdrawal by Subject|0
6860764|NCT00410410|10869930|FG006|Induction Period (IP)|Withdrawal by Subject|0
6860765|NCT00410410|10869931|FG007|Induction Period (IP)|Withdrawal by Subject|0
6860766|NCT00410410|10869932|FG008|Induction Period (IP)|Withdrawal by Subject|0
6860767|NCT00410410|10869924|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
6860768|NCT00410410|10869925|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
6860769|NCT00410410|10869926|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1
6860770|NCT00410410|10869927|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
6860771|NCT00410410|10869928|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
6860772|NCT00410410|10869929|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
6860773|NCT00410410|10869930|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
6860774|NCT00410410|10869931|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
6860775|NCT00410410|10869932|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
6860776|NCT00410410|10869924|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0
6860777|NCT00410410|10869925|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0
6860778|NCT00410410|10869926|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0
6860779|NCT00410410|10869927|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0
6860780|NCT00410410|10869928|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22
6860781|NCT00410410|10869929|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21
6860782|NCT00410410|10869930|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0
6860783|NCT00410410|10869931|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0
6860784|NCT00410410|10869932|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0
6860785|NCT00410410|10869924|FG000|Induction Period (IP)|Other|0
6860786|NCT00410410|10869925|FG001|Induction Period (IP)|Other|0
6860787|NCT00410410|10869926|FG002|Induction Period (IP)|Other|1
6860788|NCT00410410|10869927|FG003|Induction Period (IP)|Other|0
6860789|NCT00410410|10869928|FG004|Induction Period (IP)|Other|0
6860790|NCT00410410|10869929|FG005|Induction Period (IP)|Other|0
7184128|NCT01755689|11384112|FG001|Overall Study|Lost to Follow-up|0
6860791|NCT00410410|10869930|FG006|Induction Period (IP)|Other|0
6860792|NCT00410410|10869931|FG007|Induction Period (IP)|Other|0
6860793|NCT00410410|10869932|FG008|Induction Period (IP)|Other|0
6860794|NCT00410410|10869924|FG000|Maintenance Period (MP)|Death|0
6860795|NCT00410410|10869925|FG001|Maintenance Period (MP)|Death|0
6860796|NCT00410410|10869926|FG002|Maintenance Period (MP)|Death|0
6860797|NCT00410410|10869927|FG003|Maintenance Period (MP)|Death|0
6860798|NCT00410410|10869928|FG004|Maintenance Period (MP)|Death|0
6860799|NCT00410410|10869929|FG005|Maintenance Period (MP)|Death|0
6860800|NCT00410410|10869930|FG006|Maintenance Period (MP)|Death|1
6860801|NCT00410410|10869931|FG007|Maintenance Period (MP)|Death|0
6860802|NCT00410410|10869932|FG008|Maintenance Period (MP)|Death|0
6860803|NCT00410410|10869924|FG000|Maintenance Period (MP)|Adverse Event|0
7077972|NCT02099110|11186164|FG002|Overall Study|Participant moved|1
7077973|NCT02099110|11186165|FG003|Overall Study|Participant moved|0
7077974|NCT02099110|11186166|FG004|Overall Study|Participant moved|2
7077975|NCT02099110|11186162|FG000|Overall Study|Withdrawal by Subject|7
6860804|NCT00410410|10869925|FG001|Maintenance Period (MP)|Adverse Event|0
6860805|NCT00410410|10869926|FG002|Maintenance Period (MP)|Adverse Event|0
6860806|NCT00410410|10869927|FG003|Maintenance Period (MP)|Adverse Event|0
6860807|NCT00410410|10869928|FG004|Maintenance Period (MP)|Adverse Event|0
6860808|NCT00410410|10869929|FG005|Maintenance Period (MP)|Adverse Event|0
6860809|NCT00410410|10869930|FG006|Maintenance Period (MP)|Adverse Event|1
7077976|NCT02099110|11186163|FG001|Overall Study|Withdrawal by Subject|11
7077977|NCT02099110|11186164|FG002|Overall Study|Withdrawal by Subject|13
7077978|NCT02099110|11186165|FG003|Overall Study|Withdrawal by Subject|9
7077979|NCT02099110|11186166|FG004|Overall Study|Withdrawal by Subject|13
7077980|NCT02099110|11186162|FG000|Overall Study|Adverse Event|3
7077981|NCT02099110|11186163|FG001|Overall Study|Adverse Event|5
7077982|NCT02099110|11186164|FG002|Overall Study|Adverse Event|2
7077983|NCT02099110|11186165|FG003|Overall Study|Adverse Event|3
7077984|NCT02099110|11186166|FG004|Overall Study|Adverse Event|2
7077985|NCT02099110|11186162|FG000|Overall Study|Lost to Follow-up|6
7077986|NCT02099110|11186163|FG001|Overall Study|Lost to Follow-up|12
6860810|NCT00410410|10869931|FG007|Maintenance Period (MP)|Adverse Event|3
6860811|NCT00410410|10869932|FG008|Maintenance Period (MP)|Adverse Event|0
6860812|NCT00410410|10869924|FG000|Maintenance Period (MP)|Lack of Efficacy|0
6860813|NCT00410410|10869925|FG001|Maintenance Period (MP)|Lack of Efficacy|0
6860814|NCT00410410|10869926|FG002|Maintenance Period (MP)|Lack of Efficacy|0
6860815|NCT00410410|10869927|FG003|Maintenance Period (MP)|Lack of Efficacy|0
6860816|NCT00410410|10869928|FG004|Maintenance Period (MP)|Lack of Efficacy|0
6860817|NCT00410410|10869929|FG005|Maintenance Period (MP)|Lack of Efficacy|0
6860818|NCT00410410|10869930|FG006|Maintenance Period (MP)|Lack of Efficacy|25
6860819|NCT00410410|10869931|FG007|Maintenance Period (MP)|Lack of Efficacy|24
6860820|NCT00410410|10869932|FG008|Maintenance Period (MP)|Lack of Efficacy|0
6860821|NCT00410410|10869924|FG000|Maintenance Period (MP)|Lost to Follow-up|0
6860822|NCT00410410|10869925|FG001|Maintenance Period (MP)|Lost to Follow-up|0
6860823|NCT00410410|10869926|FG002|Maintenance Period (MP)|Lost to Follow-up|0
6860824|NCT00410410|10869927|FG003|Maintenance Period (MP)|Lost to Follow-up|0
6860825|NCT00410410|10869928|FG004|Maintenance Period (MP)|Lost to Follow-up|0
6860826|NCT00410410|10869929|FG005|Maintenance Period (MP)|Lost to Follow-up|0
6860827|NCT00410410|10869930|FG006|Maintenance Period (MP)|Lost to Follow-up|1
6860828|NCT00410410|10869931|FG007|Maintenance Period (MP)|Lost to Follow-up|2
6860829|NCT00410410|10869932|FG008|Maintenance Period (MP)|Lost to Follow-up|0
6860830|NCT00410410|10869924|FG000|Maintenance Period (MP)|Withdrawal by Subject|0
6860831|NCT00410410|10869925|FG001|Maintenance Period (MP)|Withdrawal by Subject|0
6860832|NCT00410410|10869926|FG002|Maintenance Period (MP)|Withdrawal by Subject|0
6860833|NCT00410410|10869927|FG003|Maintenance Period (MP)|Withdrawal by Subject|0
6860834|NCT00410410|10869928|FG004|Maintenance Period (MP)|Withdrawal by Subject|0
6860835|NCT00410410|10869929|FG005|Maintenance Period (MP)|Withdrawal by Subject|0
6860836|NCT00410410|10869930|FG006|Maintenance Period (MP)|Withdrawal by Subject|1
6860837|NCT00410410|10869931|FG007|Maintenance Period (MP)|Withdrawal by Subject|1
6860838|NCT00410410|10869932|FG008|Maintenance Period (MP)|Withdrawal by Subject|0
6860839|NCT00410410|10869924|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0
6860840|NCT00410410|10869925|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0
6860841|NCT00410410|10869926|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0
6860842|NCT00410410|10869927|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0
6860843|NCT00410410|10869928|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0
6860844|NCT00410410|10869929|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0
6860845|NCT00410410|10869930|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21
6860846|NCT00410410|10869931|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25
6860847|NCT00410410|10869932|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0
6860848|NCT00410410|10869924|FG000|Open-Label Period (OL)|Death|0
6860849|NCT00410410|10869925|FG001|Open-Label Period (OL)|Death|0
6860850|NCT00410410|10869926|FG002|Open-Label Period (OL)|Death|0
6860851|NCT00410410|10869927|FG003|Open-Label Period (OL)|Death|0
6860852|NCT00410410|10869928|FG004|Open-Label Period (OL)|Death|0
6860853|NCT00410410|10869929|FG005|Open-Label Period (OL)|Death|0
6860854|NCT00410410|10869930|FG006|Open-Label Period (OL)|Death|0
7077987|NCT02099110|11186164|FG002|Overall Study|Lost to Follow-up|11
7077988|NCT02099110|11186165|FG003|Overall Study|Lost to Follow-up|5
6860855|NCT00410410|10869931|FG007|Open-Label Period (OL)|Death|0
6860856|NCT00410410|10869932|FG008|Open-Label Period (OL)|Death|1
6860857|NCT00410410|10869924|FG000|Open-Label Period (OL)|Adverse Event|0
6860858|NCT00410410|10869925|FG001|Open-Label Period (OL)|Adverse Event|0
6860859|NCT00410410|10869926|FG002|Open-Label Period (OL)|Adverse Event|0
6860860|NCT00410410|10869927|FG003|Open-Label Period (OL)|Adverse Event|0
6860861|NCT00410410|10869928|FG004|Open-Label Period (OL)|Adverse Event|0
6860862|NCT00410410|10869929|FG005|Open-Label Period (OL)|Adverse Event|0
6860863|NCT00410410|10869930|FG006|Open-Label Period (OL)|Adverse Event|0
6860864|NCT00410410|10869931|FG007|Open-Label Period (OL)|Adverse Event|0
6860865|NCT00410410|10869932|FG008|Open-Label Period (OL)|Adverse Event|10
6860866|NCT00410410|10869924|FG000|Open-Label Period (OL)|Lack of Efficacy|0
6860867|NCT00410410|10869925|FG001|Open-Label Period (OL)|Lack of Efficacy|0
6860868|NCT00410410|10869926|FG002|Open-Label Period (OL)|Lack of Efficacy|0
6860869|NCT00410410|10869927|FG003|Open-Label Period (OL)|Lack of Efficacy|0
6860870|NCT00410410|10869928|FG004|Open-Label Period (OL)|Lack of Efficacy|0
6860871|NCT00410410|10869929|FG005|Open-Label Period (OL)|Lack of Efficacy|0
6860872|NCT00410410|10869930|FG006|Open-Label Period (OL)|Lack of Efficacy|0
6860873|NCT00410410|10869931|FG007|Open-Label Period (OL)|Lack of Efficacy|0
6860874|NCT00410410|10869932|FG008|Open-Label Period (OL)|Lack of Efficacy|161
6860875|NCT00410410|10869924|FG000|Open-Label Period (OL)|Lost to Follow-up|0
6860876|NCT00410410|10869925|FG001|Open-Label Period (OL)|Lost to Follow-up|0
6860877|NCT00410410|10869926|FG002|Open-Label Period (OL)|Lost to Follow-up|0
6860878|NCT00410410|10869927|FG003|Open-Label Period (OL)|Lost to Follow-up|0
6860879|NCT00410410|10869928|FG004|Open-Label Period (OL)|Lost to Follow-up|0
6860880|NCT00410410|10869929|FG005|Open-Label Period (OL)|Lost to Follow-up|0
6860881|NCT00410410|10869930|FG006|Open-Label Period (OL)|Lost to Follow-up|0
6860882|NCT00410410|10869931|FG007|Open-Label Period (OL)|Lost to Follow-up|0
6860883|NCT00410410|10869932|FG008|Open-Label Period (OL)|Lost to Follow-up|4
6860884|NCT00410410|10869924|FG000|Open-Label Period (OL)|Withdrawal by Subject|0
6860885|NCT00410410|10869925|FG001|Open-Label Period (OL)|Withdrawal by Subject|0
6860886|NCT00410410|10869926|FG002|Open-Label Period (OL)|Withdrawal by Subject|0
6860887|NCT00410410|10869927|FG003|Open-Label Period (OL)|Withdrawal by Subject|0
6860888|NCT00410410|10869928|FG004|Open-Label Period (OL)|Withdrawal by Subject|0
6860889|NCT00410410|10869929|FG005|Open-Label Period (OL)|Withdrawal by Subject|0
6860890|NCT00410410|10869930|FG006|Open-Label Period (OL)|Withdrawal by Subject|0
6860891|NCT00410410|10869931|FG007|Open-Label Period (OL)|Withdrawal by Subject|0
6860892|NCT00410410|10869932|FG008|Open-Label Period (OL)|Withdrawal by Subject|20
6860893|NCT00410410|10869924|FG000|Open-Label Period (OL)|Pregnancy|0
6860894|NCT00410410|10869925|FG001|Open-Label Period (OL)|Pregnancy|0
6860895|NCT00410410|10869926|FG002|Open-Label Period (OL)|Pregnancy|0
6860896|NCT00410410|10869927|FG003|Open-Label Period (OL)|Pregnancy|0
6860897|NCT00410410|10869928|FG004|Open-Label Period (OL)|Pregnancy|0
6860898|NCT00410410|10869929|FG005|Open-Label Period (OL)|Pregnancy|0
6860899|NCT00410410|10869930|FG006|Open-Label Period (OL)|Pregnancy|0
6860900|NCT00410410|10869931|FG007|Open-Label Period (OL)|Pregnancy|0
6860901|NCT00410410|10869932|FG008|Open-Label Period (OL)|Pregnancy|1
6860902|NCT00410410|10869924|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0
6860903|NCT00410410|10869925|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0
6860904|NCT00410410|10869926|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0
6860905|NCT00410410|10869927|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0
6860906|NCT00410410|10869928|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0
6860907|NCT00410410|10869929|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0
6860908|NCT00410410|10869930|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0
6860909|NCT00410410|10869931|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0
6860910|NCT00410410|10869932|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145
6860911|NCT00410410|10869924|FG000|Open-Label Period (OL)|Other|0
6860912|NCT00410410|10869925|FG001|Open-Label Period (OL)|Other|0
6860913|NCT00410410|10869926|FG002|Open-Label Period (OL)|Other|0
6860914|NCT00410410|10869927|FG003|Open-Label Period (OL)|Other|0
6860915|NCT00410410|10869928|FG004|Open-Label Period (OL)|Other|0
6860916|NCT00410410|10869929|FG005|Open-Label Period (OL)|Other|0
6860917|NCT00410410|10869930|FG006|Open-Label Period (OL)|Other|0
6860918|NCT00410410|10869931|FG007|Open-Label Period (OL)|Other|0
6860919|NCT00410410|10869932|FG008|Open-Label Period (OL)|Other|7
6860920|NCT00410514|10869988|FG000|Overall Study|Adverse Event|2
6860921|NCT00410514|10869989|FG001|Overall Study|Adverse Event|2
6860922|NCT00410514|10869990|FG002|Overall Study|Adverse Event|2
6860923|NCT00410514|10869988|FG000|Overall Study|Protocol Violation|0
6860924|NCT00410514|10869989|FG001|Overall Study|Protocol Violation|1
6860925|NCT00410514|10869990|FG002|Overall Study|Protocol Violation|1
6860926|NCT00410514|10869988|FG000|Overall Study|Lost to Follow-up|0
6860927|NCT00410514|10869989|FG001|Overall Study|Lost to Follow-up|0
6860928|NCT00410514|10869990|FG002|Overall Study|Lost to Follow-up|2
6860929|NCT00410514|10869988|FG000|Overall Study|Non-compliant with study procedures|0
6860930|NCT00410514|10869989|FG001|Overall Study|Non-compliant with study procedures|0
6860931|NCT00410514|10869990|FG002|Overall Study|Non-compliant with study procedures|2
6860932|NCT00410605|10869998|FG000|Overall Study|Adverse Event|12
6860933|NCT00410605|10869998|FG000|Overall Study|Physician Decision|3
6860934|NCT00410605|10869998|FG000|Overall Study|Withdrawal by Subject|5
6860935|NCT00410605|10869998|FG000|Overall Study|Started Non-Protocol Therapy|3
7153037|NCT03273257|11318262|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1
7153038|NCT03273257|11318263|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1
7153039|NCT03273257|11318262|FG000|Overall Study|Study terminated|3
6860936|NCT00410605|10869998|FG000|Overall Study|Stopped treatmen to collect stem cells|1
6860937|NCT00410605|10869998|FG000|Overall Study|Transferred to another Institution|1
6860938|NCT00410761|10870004|FG000|Overall Study|Adverse Event|29
6860939|NCT00410761|10870005|FG001|Overall Study|Adverse Event|3
6860940|NCT00410761|10870004|FG000|Overall Study|objective disease progression|71
6860941|NCT00410761|10870005|FG001|Overall Study|objective disease progression|55
6860942|NCT00410761|10870004|FG000|Overall Study|Withdrawal by Subject|8
6860943|NCT00410761|10870005|FG001|Overall Study|Withdrawal by Subject|4
6860944|NCT00410761|10870004|FG000|Overall Study|Other|12
6860945|NCT00410761|10870005|FG001|Overall Study|Other|9
6860946|NCT00410761|10870004|FG000|Overall Study|Never received randomised treatment|0
6860947|NCT00410761|10870005|FG001|Overall Study|Never received randomised treatment|1
6860948|NCT00410813|10870013|FG000|Overall Study|Adverse Event|6
6860949|NCT00410813|10870014|FG001|Overall Study|Adverse Event|11
6860950|NCT00410813|10870013|FG000|Overall Study|Progression|32
6860951|NCT00410813|10870014|FG001|Overall Study|Progression|21
6860952|NCT00410813|10870013|FG000|Overall Study|Not protocol specified|3
6860953|NCT00410813|10870014|FG001|Overall Study|Not protocol specified|4
6860954|NCT00410813|10870013|FG000|Overall Study|Ineligible|2
6860955|NCT00410813|10870014|FG001|Overall Study|Ineligible|4
6860956|NCT00410813|10870013|FG000|Overall Study|Death|0
6860957|NCT00410813|10870014|FG001|Overall Study|Death|2
6860958|NCT00411151|10870070|FG000|Overall Study|Death|38
6860959|NCT00411151|10870070|FG000|Overall Study|Withdrawal by Subject|2
6860960|NCT00411151|10870070|FG000|Overall Study|Lost to Follow-up|2
6860961|NCT00411151|10870070|FG000|Overall Study|Protocol Violation|1
6860962|NCT00411151|10870070|FG000|Overall Study|Trial prematurely closed|4
6860963|NCT00411216|10870076|FG000|Overall Study|Ten participants were entered into the c|0
6860964|NCT00411216|10870077|FG001|Overall Study|Ten participants were entered into the c|2
6860965|NCT00411450|10870097|FG000|Overall Study|Ongoing at time of data cut-off.|3
6860966|NCT00411554|10870117|FG000|Overall Study|Adverse Event|2
6860967|NCT00411554|10870118|FG001|Overall Study|Adverse Event|4
6860968|NCT00411554|10870117|FG000|Overall Study|Lack of Efficacy|2
6860969|NCT00411554|10870118|FG001|Overall Study|Lack of Efficacy|5
6860970|NCT00411554|10870117|FG000|Overall Study|Withdrawal by Subject|3
6860971|NCT00411554|10870118|FG001|Overall Study|Withdrawal by Subject|0
6860972|NCT00411554|10870117|FG000|Overall Study|Patient Moved|1
6860973|NCT00411554|10870118|FG001|Overall Study|Patient Moved|0
6860974|NCT00411632|10870129|FG000|Overall Study|Death|1
6860975|NCT00411645|10870135|FG000|Overall Study|Consent Withdrawn|13
6860976|NCT00411645|10870136|FG001|Overall Study|Consent Withdrawn|22
6860977|NCT00411645|10870135|FG000|Overall Study|Death|56
6860978|NCT00411645|10870136|FG001|Overall Study|Death|135
6860979|NCT00411645|10870135|FG000|Overall Study|Investigator/Sponsor Decision|10
6860980|NCT00411645|10870136|FG001|Overall Study|Investigator/Sponsor Decision|7
6860981|NCT00411645|10870135|FG000|Overall Study|Lost to Follow-up|2
6860982|NCT00411645|10870136|FG001|Overall Study|Lost to Follow-up|0
6860983|NCT00411671|10870143|FG000|Overall Study|Adverse Event|15
6860984|NCT00411671|10870143|FG000|Overall Study|Death|2
6860985|NCT00411671|10870143|FG000|Overall Study|Lost to Follow-up|3
6860986|NCT00411762|10870164|FG000|Overall Study|Withdrawal by Subject|5
6860987|NCT00411788|10870168|FG000|Overall Study|Protocol Violation|1
6860988|NCT00411788|10870168|FG000|Overall Study|Adverse Event|1
6860989|NCT00412061|10870174|FG000|Double Blind Phase|Disease Progression|101
6860990|NCT00412061|10870175|FG001|Double Blind Phase|Disease Progression|154
6860991|NCT00412061|10870174|FG000|Double Blind Phase|Adverse Event|61
6860992|NCT00412061|10870175|FG001|Double Blind Phase|Adverse Event|16
6860993|NCT00412061|10870174|FG000|Double Blind Phase|Final Primary Analysis|26
6860994|NCT00412061|10870175|FG001|Double Blind Phase|Final Primary Analysis|14
6860995|NCT00412061|10870174|FG000|Double Blind Phase|Withdrawal by Subject|18
6860996|NCT00412061|10870175|FG001|Double Blind Phase|Withdrawal by Subject|20
6860997|NCT00412061|10870174|FG000|Double Blind Phase|Death|6
6860998|NCT00412061|10870175|FG001|Double Blind Phase|Death|3
6860999|NCT00412061|10870174|FG000|Double Blind Phase|Protocol Violation|3
6861000|NCT00412061|10870175|FG001|Double Blind Phase|Protocol Violation|4
6861001|NCT00412061|10870174|FG000|Double Blind Phase|New Cander Therapy|1
6861002|NCT00412061|10870175|FG001|Double Blind Phase|New Cander Therapy|1
6861003|NCT00412061|10870174|FG000|Double Blind Phase|Lost to Follow-up|0
6861004|NCT00412061|10870175|FG001|Double Blind Phase|Lost to Follow-up|1
6861005|NCT00412061|10870174|FG000|Open Label Phase|Disease Progression|0
6861006|NCT00412061|10870175|FG001|Open Label Phase|Disease Progression|86
6861007|NCT00412061|10870174|FG000|Open Label Phase|Adverse Event|0
6861008|NCT00412061|10870175|FG001|Open Label Phase|Adverse Event|46
6861009|NCT00412061|10870174|FG000|Open Label Phase|Withdrawal by Subject|0
6861010|NCT00412061|10870175|FG001|Open Label Phase|Withdrawal by Subject|15
6861011|NCT00412061|10870174|FG000|Open Label Phase|Administrative Problems|0
6861012|NCT00412061|10870175|FG001|Open Label Phase|Administrative Problems|13
6861013|NCT00412061|10870174|FG000|Open Label Phase|Death|0
6861014|NCT00412061|10870175|FG001|Open Label Phase|Death|7
6861015|NCT00412061|10870174|FG000|Open Label Phase|Lost to Follow-up|0
6861016|NCT00412061|10870175|FG001|Open Label Phase|Lost to Follow-up|2
6861017|NCT00412061|10870174|FG000|Open Label Phase|New Cancer Therapy|0
6861018|NCT00412061|10870175|FG001|Open Label Phase|New Cancer Therapy|1
6861019|NCT00412113|10870211|FG000|Overall Study|Adverse Event|11
6861020|NCT00412113|10870212|FG001|Overall Study|Adverse Event|15
6861021|NCT00412113|10870211|FG000|Overall Study|did not receive treatment|1
6861022|NCT00412113|10870212|FG001|Overall Study|did not receive treatment|0
6861023|NCT00412217|10870220|FG000|Overall Study|Insufficient Data Available|8
6861024|NCT00412217|10870221|FG001|Overall Study|Insufficient Data Available|3
6861025|NCT00412217|10870220|FG000|Overall Study|Death|5
6861026|NCT00412217|10870221|FG001|Overall Study|Death|4
6861027|NCT00412217|10870220|FG000|Overall Study|Disease Progression|2
6861028|NCT00412217|10870221|FG001|Overall Study|Disease Progression|3
6861029|NCT00412217|10870220|FG000|Overall Study|Investigator Decision|1
6861030|NCT00412217|10870221|FG001|Overall Study|Investigator Decision|0
6861031|NCT00412217|10870220|FG000|Overall Study|Withdrawal by Subject|2
6861032|NCT00412217|10870221|FG001|Overall Study|Withdrawal by Subject|0
6861033|NCT00412217|10870220|FG000|Overall Study|Lost to Follow-up|1
6861034|NCT00412217|10870221|FG001|Overall Study|Lost to Follow-up|4
6861035|NCT00412217|10870220|FG000|Overall Study|Study Terminated by Sponsor|26
6861036|NCT00412217|10870221|FG001|Overall Study|Study Terminated by Sponsor|33
6861037|NCT00412217|10870220|FG000|Overall Study|Other|1
6861038|NCT00412217|10870221|FG001|Overall Study|Other|1
6861039|NCT00412360|10870233|FG000|Overall Study|Lost to Follow-up|0
6861040|NCT00412360|10870234|FG001|Overall Study|Lost to Follow-up|1
6861041|NCT00412360|10870233|FG000|Overall Study|Not Transplanted|1
6861042|NCT00412360|10870234|FG001|Overall Study|Not Transplanted|2
6861043|NCT00412373|10870242|FG000|Overall Study|Adverse Event|8
6861044|NCT00412373|10870243|FG001|Overall Study|Adverse Event|13
6861045|NCT00412373|10870242|FG000|Overall Study|Lack of Efficacy|16
6861046|NCT00412373|10870243|FG001|Overall Study|Lack of Efficacy|22
6861047|NCT00412373|10870242|FG000|Overall Study|Lost to Follow-up|7
6861048|NCT00412373|10870243|FG001|Overall Study|Lost to Follow-up|13
6861049|NCT00412373|10870242|FG000|Overall Study|Withdrawal by Subject|8
6861050|NCT00412373|10870243|FG001|Overall Study|Withdrawal by Subject|27
6861051|NCT00412373|10870242|FG000|Overall Study|Other|2
6861052|NCT00412373|10870243|FG001|Overall Study|Other|2
6861053|NCT00412542|10870303|FG000|Overall Study|Withdrawal by Subject|0
6861054|NCT00412542|10870304|FG001|Overall Study|Withdrawal by Subject|2
6861055|NCT00412542|10870303|FG000|Overall Study|Not Eligible|0
6861056|NCT00412542|10870304|FG001|Overall Study|Not Eligible|1
6861057|NCT00412607|10870308|FG000|Overall Study|Withdrawal by Subject|9
6861058|NCT00412607|10870308|FG000|Overall Study|Lost to Follow-up|19
6861059|NCT00412607|10870308|FG000|Overall Study|Death|61
6861060|NCT00412607|10870308|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15
6861061|NCT00412737|10870317|FG000|Overall Study|Death|1
6861062|NCT00412737|10870318|FG001|Overall Study|Death|0
6861063|NCT00412737|10870317|FG000|Overall Study|Adverse Event|3
6861064|NCT00412737|10870318|FG001|Overall Study|Adverse Event|2
6861065|NCT00412737|10870317|FG000|Overall Study|Refused Treatment|6
6861066|NCT00412737|10870318|FG001|Overall Study|Refused Treatment|2
6861067|NCT00412737|10870317|FG000|Overall Study|Failure to Return|6
6861068|NCT00412737|10870318|FG001|Overall Study|Failure to Return|2
6861069|NCT00412750|10870327|FG000|Overall Study|Abnormal laboratory value(s)|1
6861070|NCT00412750|10870328|FG001|Overall Study|Abnormal laboratory value(s)|0
6861071|NCT00412750|10870329|FG002|Overall Study|Abnormal laboratory value(s)|0
6861072|NCT00412750|10870327|FG000|Overall Study|Administrative problems|21
6861073|NCT00412750|10870328|FG001|Overall Study|Administrative problems|17
6861074|NCT00412750|10870329|FG002|Overall Study|Administrative problems|14
6861075|NCT00412750|10870327|FG000|Overall Study|Adverse Event|8
6861076|NCT00412750|10870328|FG001|Overall Study|Adverse Event|3
6861077|NCT00412750|10870329|FG002|Overall Study|Adverse Event|3
6861078|NCT00412750|10870327|FG000|Overall Study|Lost to Follow-up|1
6861079|NCT00412750|10870328|FG001|Overall Study|Lost to Follow-up|0
6861080|NCT00412750|10870329|FG002|Overall Study|Lost to Follow-up|1
6861081|NCT00412750|10870327|FG000|Overall Study|Withdrawal by Subject|0
6861082|NCT00412750|10870328|FG001|Overall Study|Withdrawal by Subject|1
6861083|NCT00412750|10870329|FG002|Overall Study|Withdrawal by Subject|2
6861084|NCT00412750|10870327|FG000|Overall Study|Lack of Efficacy|0
6861085|NCT00412750|10870328|FG001|Overall Study|Lack of Efficacy|0
6861086|NCT00412750|10870329|FG002|Overall Study|Lack of Efficacy|3
6861087|NCT00412854|10870351|FG000|Overall Study|Withdrawn due to adverse events|1
6861088|NCT00412854|10870352|FG001|Overall Study|Withdrawn due to adverse events|5
6861089|NCT00412854|10870351|FG000|Overall Study|Withdrawn for other reasons|13
6861090|NCT00412854|10870352|FG001|Overall Study|Withdrawn for other reasons|11
6861091|NCT00412893|10870365|FG000|Overall Study|Adverse Event|31
6861092|NCT00412893|10870366|FG001|Overall Study|Adverse Event|53
6861093|NCT00412893|10870365|FG000|Overall Study|Death|17
6861094|NCT00412893|10870366|FG001|Overall Study|Death|21
6861095|NCT00412893|10870365|FG000|Overall Study|Insufficient Therapeutic Response|39
6861096|NCT00412893|10870366|FG001|Overall Study|Insufficient Therapeutic Response|23
6861097|NCT00412893|10870365|FG000|Overall Study|Lost to Follow-up|2
6861098|NCT00412893|10870366|FG001|Overall Study|Lost to Follow-up|1
6861099|NCT00412893|10870365|FG000|Overall Study|Violation of Selection at Entry|17
6861100|NCT00412893|10870366|FG001|Overall Study|Violation of Selection at Entry|10
6861101|NCT00412893|10870365|FG000|Overall Study|Other Protocol Violation|10
6861102|NCT00412893|10870366|FG001|Overall Study|Other Protocol Violation|6
6861103|NCT00412893|10870365|FG000|Overall Study|Did Not Cooperate|12
6861104|NCT00412893|10870366|FG001|Overall Study|Did Not Cooperate|9
6861105|NCT00412893|10870365|FG000|Overall Study|Administrative Reason|12
6861106|NCT00412893|10870366|FG001|Overall Study|Administrative Reason|15
6861107|NCT00412893|10870365|FG000|Overall Study|Randomized but Never Received Study Drug|5
6861108|NCT00412893|10870366|FG001|Overall Study|Randomized but Never Received Study Drug|6
6861109|NCT00412958|10870376|FG000|Overall Study|Withdrawal by Subject|3
6861110|NCT00412958|10870377|FG001|Overall Study|Withdrawal by Subject|0
6861111|NCT00412958|10870378|FG002|Overall Study|Withdrawal by Subject|0
6861112|NCT00412958|10870379|FG003|Overall Study|Withdrawal by Subject|1
6861113|NCT00412958|10870376|FG000|Overall Study|Adverse Event|0
6861114|NCT00412958|10870377|FG001|Overall Study|Adverse Event|1
6861115|NCT00412958|10870378|FG002|Overall Study|Adverse Event|0
6861116|NCT00412958|10870379|FG003|Overall Study|Adverse Event|0
6861117|NCT00412958|10870376|FG000|Overall Study|Lost to Follow-up|0
6861118|NCT00412958|10870377|FG001|Overall Study|Lost to Follow-up|1
6861119|NCT00412958|10870378|FG002|Overall Study|Lost to Follow-up|0
6861120|NCT00412958|10870379|FG003|Overall Study|Lost to Follow-up|0
6861121|NCT00412958|10870376|FG000|Overall Study|Death|0
6861122|NCT00412958|10870377|FG001|Overall Study|Death|1
6861123|NCT00412958|10870378|FG002|Overall Study|Death|0
6861124|NCT00412958|10870379|FG003|Overall Study|Death|0
6861125|NCT00412958|10870376|FG000|Overall Study|Transport issue|0
6861126|NCT00412958|10870377|FG001|Overall Study|Transport issue|1
6861127|NCT00412958|10870378|FG002|Overall Study|Transport issue|0
6861128|NCT00412958|10870379|FG003|Overall Study|Transport issue|0
6861129|NCT00412971|10870391|FG000|Overall Study|Lost to Follow-up|17
6861130|NCT00412971|10870392|FG001|Overall Study|Lost to Follow-up|9
6861131|NCT00412971|10870391|FG000|Overall Study|Protocol Violation|13
6861132|NCT00412971|10870392|FG001|Overall Study|Protocol Violation|1
6861133|NCT00412984|10870400|FG000|Overall Study|Death|331
6861134|NCT00412984|10870401|FG001|Overall Study|Death|349
6861135|NCT00412984|10870400|FG000|Overall Study|Adverse Event|679
6861136|NCT00412984|10870401|FG001|Overall Study|Adverse Event|738
6861137|NCT00412984|10870400|FG000|Overall Study|Withdrawal by Subject|921
6861138|NCT00412984|10870401|FG001|Overall Study|Withdrawal by Subject|989
6861139|NCT00412984|10870400|FG000|Overall Study|Lost to Follow-up|51
6861140|NCT00412984|10870401|FG001|Overall Study|Lost to Follow-up|39
6861141|NCT00412984|10870400|FG000|Overall Study|Poor/Noncompliance|57
6861142|NCT00412984|10870401|FG001|Overall Study|Poor/Noncompliance|77
6861143|NCT00412984|10870400|FG000|Overall Study|Pregnancy|1
6861144|NCT00412984|10870401|FG001|Overall Study|Pregnancy|0
6861145|NCT00412984|10870400|FG000|Overall Study|Subject No Longer Meets Study Criteria|87
6861146|NCT00412984|10870401|FG001|Overall Study|Subject No Longer Meets Study Criteria|100
6861147|NCT00412984|10870400|FG000|Overall Study|Administrative Reason by Sponsor|11
6861148|NCT00412984|10870401|FG001|Overall Study|Administrative Reason by Sponsor|8
6861149|NCT00412984|10870400|FG000|Overall Study|Physician Refused to Continue Treatment|81
6861150|NCT00412984|10870401|FG001|Overall Study|Physician Refused to Continue Treatment|89
6861151|NCT00412984|10870400|FG000|Overall Study|Other Reason|80
6861152|NCT00412984|10870401|FG001|Overall Study|Other Reason|92
6861153|NCT00412984|10870400|FG000|Overall Study|Not Reported|11
6861154|NCT00412984|10870401|FG001|Overall Study|Not Reported|12
6861155|NCT00413010|10870409|FG000|Overall Study|Adverse Event|8
6861156|NCT00413010|10870410|FG001|Overall Study|Adverse Event|4
6861157|NCT00413010|10870409|FG000|Overall Study|Laboratory abnormality|0
6861158|NCT00413010|10870410|FG001|Overall Study|Laboratory abnormality|2
6861159|NCT00413010|10870409|FG000|Overall Study|Lack of Efficacy|0
6861160|NCT00413010|10870410|FG001|Overall Study|Lack of Efficacy|3
6861161|NCT00413010|10870409|FG000|Overall Study|Lost to Follow-up|3
6861162|NCT00413010|10870410|FG001|Overall Study|Lost to Follow-up|0
6861163|NCT00413010|10870409|FG000|Overall Study|Withdrawal by Subject|7
6861164|NCT00413010|10870410|FG001|Overall Study|Withdrawal by Subject|2
6861165|NCT00413010|10870409|FG000|Overall Study|Due to termination of the study|54
6861166|NCT00413010|10870410|FG001|Overall Study|Due to termination of the study|52
6861167|NCT00413036|10870416|FG000|Overall Study|Adverse Event|44
6861168|NCT00413036|10870416|FG000|Overall Study|Lack of Efficacy|129
6861169|NCT00413036|10870416|FG000|Overall Study|Withdrawal by Subject|7
6861170|NCT00413036|10870416|FG000|Overall Study|Death|9
6861171|NCT00413036|10870416|FG000|Overall Study|Other|26
6861172|NCT00413036|10870416|FG000|Overall Study|Missing|2
6861173|NCT00413049|10870422|FG000|Overall Study|Adverse Event|10
6861174|NCT00413049|10870423|FG001|Overall Study|Adverse Event|8
6861175|NCT00413049|10870422|FG000|Overall Study|Withdrawal by Subject|7
6861176|NCT00413049|10870423|FG001|Overall Study|Withdrawal by Subject|5
6861177|NCT00413049|10870422|FG000|Overall Study|Lost to Follow-up|2
6861178|NCT00413049|10870423|FG001|Overall Study|Lost to Follow-up|3
6861179|NCT00413049|10870422|FG000|Overall Study|Protocol Violation|3
6861180|NCT00413049|10870423|FG001|Overall Study|Protocol Violation|1
6861181|NCT00413049|10870422|FG000|Overall Study|Subject no longer requires study drug|0
6861182|NCT00413049|10870423|FG001|Overall Study|Subject no longer requires study drug|1
6861183|NCT00413049|10870422|FG000|Overall Study|Abnormal laboratory value(s)|1
6861184|NCT00413049|10870423|FG001|Overall Study|Abnormal laboratory value(s)|0
6861185|NCT00413049|10870422|FG000|Overall Study|Lack of Efficacy|1
6861186|NCT00413049|10870423|FG001|Overall Study|Lack of Efficacy|0
6861187|NCT00413153|10870431|FG000|Overall Study|Withdrawal by Subject|1
6861188|NCT00413153|10870432|FG001|Overall Study|Withdrawal by Subject|1
6861189|NCT00413153|10870431|FG000|Overall Study|Adverse Event|1
6861190|NCT00413153|10870432|FG001|Overall Study|Adverse Event|0
6861191|NCT00413192|10870455|FG000|Overall Study|Disease progression|26
6861192|NCT00413192|10870456|FG001|Overall Study|Disease progression|31
6861193|NCT00413192|10870457|FG002|Overall Study|Disease progression|16
6861194|NCT00413192|10870458|FG003|Overall Study|Disease progression|25
6861195|NCT00413192|10870455|FG000|Overall Study|Toxicity|3
6861196|NCT00413192|10870456|FG001|Overall Study|Toxicity|2
6861197|NCT00413192|10870457|FG002|Overall Study|Toxicity|2
6861198|NCT00413192|10870458|FG003|Overall Study|Toxicity|2
6861199|NCT00413192|10870455|FG000|Overall Study|Withdrawal by Subject|3
6861200|NCT00413192|10870456|FG001|Overall Study|Withdrawal by Subject|5
6861201|NCT00413192|10870457|FG002|Overall Study|Withdrawal by Subject|0
6861202|NCT00413192|10870458|FG003|Overall Study|Withdrawal by Subject|1
6861203|NCT00413192|10870455|FG000|Overall Study|Intercurrent illness|0
6861204|NCT00413192|10870456|FG001|Overall Study|Intercurrent illness|0
6861205|NCT00413192|10870457|FG002|Overall Study|Intercurrent illness|0
6861206|NCT00413192|10870458|FG003|Overall Study|Intercurrent illness|1
6861207|NCT00413192|10870455|FG000|Overall Study|Intercurrent death|0
6861208|NCT00413192|10870456|FG001|Overall Study|Intercurrent death|1
6861209|NCT00413192|10870457|FG002|Overall Study|Intercurrent death|0
6861210|NCT00413192|10870458|FG003|Overall Study|Intercurrent death|0
6861211|NCT00413192|10870455|FG000|Overall Study|Other|5
6861212|NCT00413192|10870456|FG001|Overall Study|Other|1
6861213|NCT00413192|10870457|FG002|Overall Study|Other|1
6861214|NCT00413192|10870458|FG003|Overall Study|Other|2
6861215|NCT00413192|10870455|FG000|Overall Study|Not treated|0
6861216|NCT00413192|10870456|FG001|Overall Study|Not treated|0
6861217|NCT00413192|10870457|FG002|Overall Study|Not treated|0
6861218|NCT00413192|10870458|FG003|Overall Study|Not treated|1
6861219|NCT00413218|10870470|FG000|Overall Study|Randomized but didn't receive study drug|2
6861220|NCT00413218|10870471|FG001|Overall Study|Randomized but didn't receive study drug|8
6861221|NCT00413218|10870470|FG000|Overall Study|Death|57
6861222|NCT00413218|10870471|FG001|Overall Study|Death|56
6861223|NCT00413218|10870470|FG000|Overall Study|Lost to Follow-up|14
6861224|NCT00413218|10870471|FG001|Overall Study|Lost to Follow-up|17
6861225|NCT00413218|10870470|FG000|Overall Study|Admin|20
6861226|NCT00413218|10870471|FG001|Overall Study|Admin|14
6861227|NCT00413218|10870470|FG000|Overall Study|Missing|1
6861228|NCT00413218|10870471|FG001|Overall Study|Missing|0
6861229|NCT00413218|10870470|FG000|Overall Study|Withdrawal by Subject|9
6861230|NCT00413218|10870471|FG001|Overall Study|Withdrawal by Subject|1
6861231|NCT00413231|10870478|FG000|0 to 30-day Post Treatment|Death|5
6861232|NCT00413231|10870478|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3
6861233|NCT00413231|10870478|FG000|30-day to 365-day Post Treatment|Death|13
6861234|NCT00413231|10870478|FG000|365-day to 60-month Post Treatment|Death|36
6861235|NCT00413231|10870478|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5
6861236|NCT00413231|10870478|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4
6861237|NCT00413231|10870478|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1
6861238|NCT00413244|10870485|FG000|Overall Study|Withdrawal by Subject|10
6861239|NCT00413244|10870486|FG001|Overall Study|Withdrawal by Subject|1
6861240|NCT00413283|10870496|FG000|Overall Study|Withdrawal by Subject|1
6861241|NCT00413283|10870497|FG001|Overall Study|Withdrawal by Subject|0
6861242|NCT00413283|10870498|FG002|Overall Study|Withdrawal by Subject|0
6861243|NCT00413283|10870499|FG003|Overall Study|Withdrawal by Subject|1
6861244|NCT00413283|10870496|FG000|Overall Study|Death|0
6861245|NCT00413283|10870497|FG001|Overall Study|Death|0
6861246|NCT00413283|10870498|FG002|Overall Study|Death|1
6861247|NCT00413283|10870499|FG003|Overall Study|Death|1
6861248|NCT00413283|10870496|FG000|Overall Study|Adverse Event|0
6861249|NCT00413283|10870497|FG001|Overall Study|Adverse Event|0
6861250|NCT00413283|10870498|FG002|Overall Study|Adverse Event|0
6861251|NCT00413283|10870499|FG003|Overall Study|Adverse Event|1
6861252|NCT00413283|10870496|FG000|Overall Study|Ineligibility determined|0
6861253|NCT00413283|10870497|FG001|Overall Study|Ineligibility determined|0
6861254|NCT00413283|10870498|FG002|Overall Study|Ineligibility determined|0
6861255|NCT00413283|10870499|FG003|Overall Study|Ineligibility determined|1
6861256|NCT00413283|10870496|FG000|Overall Study|Protocol deviation|0
6861257|NCT00413283|10870497|FG001|Overall Study|Protocol deviation|1
6861258|NCT00413283|10870498|FG002|Overall Study|Protocol deviation|0
6861259|NCT00413283|10870499|FG003|Overall Study|Protocol deviation|0
6861260|NCT00413283|10870496|FG000|Overall Study|Requirement for alternative therapy|0
6861261|NCT00413283|10870497|FG001|Overall Study|Requirement for alternative therapy|2
6861262|NCT00413283|10870498|FG002|Overall Study|Requirement for alternative therapy|0
6861263|NCT00413283|10870499|FG003|Overall Study|Requirement for alternative therapy|0
6861264|NCT00413283|10870496|FG000|Overall Study|Other|0
6861265|NCT00413283|10870497|FG001|Overall Study|Other|0
6861266|NCT00413283|10870498|FG002|Overall Study|Other|1
6861267|NCT00413283|10870499|FG003|Overall Study|Other|0
6861268|NCT00413374|10870520|FG000|Overall Study|Ineligible due to screening criteria.|3
6861269|NCT00413374|10870521|FG001|Overall Study|Ineligible due to screening criteria.|0
6861270|NCT00413374|10870520|FG000|Overall Study|Adverse Event|1
6861271|NCT00413374|10870521|FG001|Overall Study|Adverse Event|0
6861272|NCT00413374|10870520|FG000|Overall Study|Lost to Follow-up|1
6861273|NCT00413374|10870521|FG001|Overall Study|Lost to Follow-up|0
6861274|NCT00413374|10870520|FG000|Overall Study|Surgery|1
6861275|NCT00413374|10870521|FG001|Overall Study|Surgery|0
6861276|NCT00413413|10870542|FG000|Single-Blind|Adverse Event|0
6861277|NCT00413413|10870543|FG001|Single-Blind|Adverse Event|9
6861278|NCT00413413|10870544|FG002|Single-Blind|Adverse Event|0
6861279|NCT00413413|10870542|FG000|Single-Blind|Lack of Efficacy|0
6861280|NCT00413413|10870543|FG001|Single-Blind|Lack of Efficacy|5
6861281|NCT00413413|10870544|FG002|Single-Blind|Lack of Efficacy|0
6861282|NCT00413413|10870542|FG000|Single-Blind|Subject no longer requires study drug|0
6861283|NCT00413413|10870543|FG001|Single-Blind|Subject no longer requires study drug|151
6861284|NCT00413413|10870544|FG002|Single-Blind|Subject no longer requires study drug|0
6861285|NCT00413413|10870542|FG000|Single-Blind|Protocol Violation|0
6861286|NCT00413413|10870543|FG001|Single-Blind|Protocol Violation|16
6861287|NCT00413413|10870544|FG002|Single-Blind|Protocol Violation|0
6861288|NCT00413413|10870542|FG000|Single-Blind|Withdrawal by Subject|0
6861289|NCT00413413|10870543|FG001|Single-Blind|Withdrawal by Subject|27
6861290|NCT00413413|10870544|FG002|Single-Blind|Withdrawal by Subject|0
6861291|NCT00413413|10870542|FG000|Single-Blind|Lost to Follow-up|0
6861292|NCT00413413|10870543|FG001|Single-Blind|Lost to Follow-up|8
6861293|NCT00413413|10870544|FG002|Single-Blind|Lost to Follow-up|0
6861294|NCT00413413|10870542|FG000|Double-Blind|Adverse Event|6
6861295|NCT00413413|10870543|FG001|Double-Blind|Adverse Event|0
6861296|NCT00413413|10870544|FG002|Double-Blind|Adverse Event|5
6861297|NCT00413413|10870542|FG000|Double-Blind|Unsatisfactory therapeutic effect|1
6861298|NCT00413413|10870543|FG001|Double-Blind|Unsatisfactory therapeutic effect|2
6861299|NCT00413413|10870544|FG002|Double-Blind|Unsatisfactory therapeutic effect|1
6861300|NCT00413413|10870542|FG000|Double-Blind|Protocol deviation|1
6861301|NCT00413413|10870543|FG001|Double-Blind|Protocol deviation|2
6861302|NCT00413413|10870544|FG002|Double-Blind|Protocol deviation|1
6861303|NCT00413413|10870542|FG000|Double-Blind|Subject withdrew consent|4
6861304|NCT00413413|10870543|FG001|Double-Blind|Subject withdrew consent|6
6861305|NCT00413413|10870544|FG002|Double-Blind|Subject withdrew consent|9
6861306|NCT00413413|10870542|FG000|Double-Blind|Lost to Follow-up|3
6861307|NCT00413413|10870543|FG001|Double-Blind|Lost to Follow-up|4
6861308|NCT00413413|10870544|FG002|Double-Blind|Lost to Follow-up|2
6861309|NCT00413660|10870583|FG000|Up To Week 12|Adverse Event|1
6861310|NCT00413660|10870584|FG001|Up To Week 12|Adverse Event|3
6861311|NCT00413660|10870585|FG002|Up To Week 12|Adverse Event|1
6861312|NCT00413660|10870586|FG003|Up To Week 12|Adverse Event|4
6861313|NCT00413660|10870587|FG004|Up To Week 12|Adverse Event|6
6861314|NCT00413660|10870588|FG005|Up To Week 12|Adverse Event|4
6861315|NCT00413660|10870589|FG006|Up To Week 12|Adverse Event|1
6861316|NCT00413660|10870590|FG007|Up To Week 12|Adverse Event|0
6861317|NCT00413660|10870591|FG008|Up To Week 12|Adverse Event|0
6861318|NCT00413660|10870592|FG009|Up To Week 12|Adverse Event|0
6861319|NCT00413660|10870593|FG010|Up To Week 12|Adverse Event|0
6861320|NCT00413660|10870583|FG000|Up To Week 12|Lack of Efficacy|2
6861321|NCT00413660|10870584|FG001|Up To Week 12|Lack of Efficacy|0
6861322|NCT00413660|10870585|FG002|Up To Week 12|Lack of Efficacy|0
6861323|NCT00413660|10870586|FG003|Up To Week 12|Lack of Efficacy|0
6861324|NCT00413660|10870587|FG004|Up To Week 12|Lack of Efficacy|0
6861325|NCT00413660|10870588|FG005|Up To Week 12|Lack of Efficacy|0
6861326|NCT00413660|10870589|FG006|Up To Week 12|Lack of Efficacy|5
6861327|NCT00413660|10870590|FG007|Up To Week 12|Lack of Efficacy|0
6861328|NCT00413660|10870591|FG008|Up To Week 12|Lack of Efficacy|0
6861329|NCT00413660|10870592|FG009|Up To Week 12|Lack of Efficacy|0
6861330|NCT00413660|10870593|FG010|Up To Week 12|Lack of Efficacy|0
6861331|NCT00413660|10870583|FG000|Up To Week 12|Lost to Follow-up|0
6861332|NCT00413660|10870584|FG001|Up To Week 12|Lost to Follow-up|1
6861333|NCT00413660|10870585|FG002|Up To Week 12|Lost to Follow-up|0
6861334|NCT00413660|10870586|FG003|Up To Week 12|Lost to Follow-up|0
6861335|NCT00413660|10870587|FG004|Up To Week 12|Lost to Follow-up|1
6861336|NCT00413660|10870588|FG005|Up To Week 12|Lost to Follow-up|0
6861337|NCT00413660|10870589|FG006|Up To Week 12|Lost to Follow-up|0
6861338|NCT00413660|10870590|FG007|Up To Week 12|Lost to Follow-up|0
6861339|NCT00413660|10870591|FG008|Up To Week 12|Lost to Follow-up|0
6861340|NCT00413660|10870592|FG009|Up To Week 12|Lost to Follow-up|0
6861341|NCT00413660|10870593|FG010|Up To Week 12|Lost to Follow-up|0
6861342|NCT00413660|10870583|FG000|Up To Week 12|Withdrawal by Subject|0
6861343|NCT00413660|10870584|FG001|Up To Week 12|Withdrawal by Subject|2
6861344|NCT00413660|10870585|FG002|Up To Week 12|Withdrawal by Subject|0
6861345|NCT00413660|10870586|FG003|Up To Week 12|Withdrawal by Subject|2
6861346|NCT00413660|10870587|FG004|Up To Week 12|Withdrawal by Subject|0
6861347|NCT00413660|10870588|FG005|Up To Week 12|Withdrawal by Subject|2
6861348|NCT00413660|10870589|FG006|Up To Week 12|Withdrawal by Subject|2
6861349|NCT00413660|10870590|FG007|Up To Week 12|Withdrawal by Subject|0
6861350|NCT00413660|10870591|FG008|Up To Week 12|Withdrawal by Subject|0
6861351|NCT00413660|10870592|FG009|Up To Week 12|Withdrawal by Subject|0
6861352|NCT00413660|10870593|FG010|Up To Week 12|Withdrawal by Subject|0
6861353|NCT00413660|10870583|FG000|Up To Week 12|Randomized, Not Treated|1
6861354|NCT00413660|10870584|FG001|Up To Week 12|Randomized, Not Treated|0
6861355|NCT00413660|10870585|FG002|Up To Week 12|Randomized, Not Treated|0
6861356|NCT00413660|10870586|FG003|Up To Week 12|Randomized, Not Treated|1
6861357|NCT00413660|10870587|FG004|Up To Week 12|Randomized, Not Treated|0
6861358|NCT00413660|10870588|FG005|Up To Week 12|Randomized, Not Treated|0
6861359|NCT00413660|10870589|FG006|Up To Week 12|Randomized, Not Treated|0
6861360|NCT00413660|10870590|FG007|Up To Week 12|Randomized, Not Treated|0
6861361|NCT00413660|10870591|FG008|Up To Week 12|Randomized, Not Treated|0
6861362|NCT00413660|10870592|FG009|Up To Week 12|Randomized, Not Treated|0
6861363|NCT00413660|10870593|FG010|Up To Week 12|Randomized, Not Treated|0
6861364|NCT00413660|10870583|FG000|Up To Week 12|Other|3
6861365|NCT00413660|10870584|FG001|Up To Week 12|Other|1
6861366|NCT00413660|10870585|FG002|Up To Week 12|Other|6
6861367|NCT00413660|10870586|FG003|Up To Week 12|Other|1
6861368|NCT00413660|10870587|FG004|Up To Week 12|Other|2
6861369|NCT00413660|10870588|FG005|Up To Week 12|Other|4
6861370|NCT00413660|10870589|FG006|Up To Week 12|Other|3
6861371|NCT00413660|10870590|FG007|Up To Week 12|Other|0
6861372|NCT00413660|10870591|FG008|Up To Week 12|Other|0
6861373|NCT00413660|10870592|FG009|Up To Week 12|Other|0
6861374|NCT00413660|10870593|FG010|Up To Week 12|Other|0
6861375|NCT00413660|10870583|FG000|Post Week 12|Adverse Event|2
6861376|NCT00413660|10870584|FG001|Post Week 12|Adverse Event|0
6861377|NCT00413660|10870585|FG002|Post Week 12|Adverse Event|2
6861378|NCT00413660|10870586|FG003|Post Week 12|Adverse Event|1
6861379|NCT00413660|10870587|FG004|Post Week 12|Adverse Event|4
6861380|NCT00413660|10870588|FG005|Post Week 12|Adverse Event|2
6861381|NCT00413660|10870589|FG006|Post Week 12|Adverse Event|2
6861382|NCT00413660|10870590|FG007|Post Week 12|Adverse Event|0
6861383|NCT00413660|10870591|FG008|Post Week 12|Adverse Event|0
6861384|NCT00413660|10870592|FG009|Post Week 12|Adverse Event|0
6861385|NCT00413660|10870593|FG010|Post Week 12|Adverse Event|0
6861386|NCT00413660|10870583|FG000|Post Week 12|Lack of Efficacy|0
6861387|NCT00413660|10870584|FG001|Post Week 12|Lack of Efficacy|0
6861388|NCT00413660|10870585|FG002|Post Week 12|Lack of Efficacy|1
6861389|NCT00413660|10870586|FG003|Post Week 12|Lack of Efficacy|0
6861390|NCT00413660|10870587|FG004|Post Week 12|Lack of Efficacy|0
6861391|NCT00413660|10870588|FG005|Post Week 12|Lack of Efficacy|0
6861392|NCT00413660|10870589|FG006|Post Week 12|Lack of Efficacy|0
6861393|NCT00413660|10870590|FG007|Post Week 12|Lack of Efficacy|0
6861394|NCT00413660|10870591|FG008|Post Week 12|Lack of Efficacy|0
6861395|NCT00413660|10870592|FG009|Post Week 12|Lack of Efficacy|1
6861396|NCT00413660|10870593|FG010|Post Week 12|Lack of Efficacy|0
6861397|NCT00413660|10870583|FG000|Post Week 12|Lost to Follow-up|0
6861398|NCT00413660|10870584|FG001|Post Week 12|Lost to Follow-up|1
6861399|NCT00413660|10870585|FG002|Post Week 12|Lost to Follow-up|1
6861400|NCT00413660|10870586|FG003|Post Week 12|Lost to Follow-up|0
6861401|NCT00413660|10870587|FG004|Post Week 12|Lost to Follow-up|0
6861402|NCT00413660|10870588|FG005|Post Week 12|Lost to Follow-up|0
6861403|NCT00413660|10870589|FG006|Post Week 12|Lost to Follow-up|0
6861404|NCT00413660|10870590|FG007|Post Week 12|Lost to Follow-up|0
6861405|NCT00413660|10870591|FG008|Post Week 12|Lost to Follow-up|0
6861406|NCT00413660|10870592|FG009|Post Week 12|Lost to Follow-up|0
6861407|NCT00413660|10870593|FG010|Post Week 12|Lost to Follow-up|0
6861408|NCT00413660|10870583|FG000|Post Week 12|Withdrawal by Subject|0
6861409|NCT00413660|10870584|FG001|Post Week 12|Withdrawal by Subject|1
6861410|NCT00413660|10870585|FG002|Post Week 12|Withdrawal by Subject|1
6861411|NCT00413660|10870586|FG003|Post Week 12|Withdrawal by Subject|0
6861412|NCT00413660|10870587|FG004|Post Week 12|Withdrawal by Subject|1
6861413|NCT00413660|10870588|FG005|Post Week 12|Withdrawal by Subject|0
6861414|NCT00413660|10870589|FG006|Post Week 12|Withdrawal by Subject|0
6861415|NCT00413660|10870590|FG007|Post Week 12|Withdrawal by Subject|0
6861416|NCT00413660|10870591|FG008|Post Week 12|Withdrawal by Subject|0
6861417|NCT00413660|10870592|FG009|Post Week 12|Withdrawal by Subject|0
6861418|NCT00413660|10870593|FG010|Post Week 12|Withdrawal by Subject|1
6861419|NCT00413660|10870583|FG000|Post Week 12|Other|1
6861420|NCT00413660|10870584|FG001|Post Week 12|Other|2
6861421|NCT00413660|10870585|FG002|Post Week 12|Other|3
6861422|NCT00413660|10870586|FG003|Post Week 12|Other|0
6861423|NCT00413660|10870587|FG004|Post Week 12|Other|1
6861424|NCT00413660|10870588|FG005|Post Week 12|Other|1
6861425|NCT00413660|10870589|FG006|Post Week 12|Other|1
7153040|NCT03273257|11318263|FG001|Overall Study|Study terminated|2
6861426|NCT00413660|10870590|FG007|Post Week 12|Other|0
6861427|NCT00413660|10870591|FG008|Post Week 12|Other|0
6861428|NCT00413660|10870592|FG009|Post Week 12|Other|0
6861429|NCT00413660|10870593|FG010|Post Week 12|Other|0
6861430|NCT00413777|10870625|FG000|Fixed-dose Period|Lost to Follow-up|1
6861431|NCT00413777|10870626|FG001|Fixed-dose Period|Lost to Follow-up|1
6861432|NCT00413777|10870625|FG000|Fixed-dose Period|Adverse Event|2
6861433|NCT00413777|10870626|FG001|Fixed-dose Period|Adverse Event|1
6861434|NCT00413777|10870625|FG000|Fixed-dose Period|Met Withdrawal Criteria|1
6861435|NCT00413777|10870626|FG001|Fixed-dose Period|Met Withdrawal Criteria|0
6861436|NCT00413777|10870625|FG000|Fixed-dose Period|Withdrew Consent|0
6861437|NCT00413777|10870626|FG001|Fixed-dose Period|Withdrew Consent|1
6861438|NCT00413894|10870632|FG000|Overall Study|Withdrawal by Subject|10
6861439|NCT00413894|10870632|FG000|Overall Study|Administrative Reasons|1
6861440|NCT00413894|10870632|FG000|Overall Study|Hb <10 grams/deciliter|12
6861441|NCT00413894|10870632|FG000|Overall Study|Adverse Event|28
6861442|NCT00413894|10870632|FG000|Overall Study|Protocol Violation|11
6861443|NCT00413894|10870632|FG000|Overall Study|Other|18
6861444|NCT00413920|10870641|FG000|Overall Study|Adverse Event|9
6861445|NCT00413920|10870642|FG001|Overall Study|Adverse Event|11
6861446|NCT00413920|10870641|FG000|Overall Study|Lack of Efficacy|11
6861447|NCT00413920|10870642|FG001|Overall Study|Lack of Efficacy|9
6861448|NCT00413920|10870641|FG000|Overall Study|Death|3
6861449|NCT00413920|10870642|FG001|Overall Study|Death|5
6861450|NCT00413920|10870641|FG000|Overall Study|Graft Loss|5
6861451|NCT00413920|10870642|FG001|Overall Study|Graft Loss|3
6861452|NCT00413959|10870648|FG000|Overall Study|Pt had only one cycle.|1
6861453|NCT00414011|10870652|FG000|Overall Study|Physician Decision|3
6861454|NCT00414011|10870652|FG000|Overall Study|Withdrawal by Subject|2
6861455|NCT00414050|10870661|FG000|Overall Study|Adverse Event|1
6861456|NCT00414050|10870662|FG001|Overall Study|Adverse Event|1
6861457|NCT00414050|10870663|FG002|Overall Study|Adverse Event|1
6861458|NCT00414050|10870664|FG003|Overall Study|Adverse Event|1
6861459|NCT00414050|10870661|FG000|Overall Study|Lost to Follow-up|2
6861460|NCT00414050|10870662|FG001|Overall Study|Lost to Follow-up|2
6861461|NCT00414050|10870663|FG002|Overall Study|Lost to Follow-up|1
6861462|NCT00414050|10870664|FG003|Overall Study|Lost to Follow-up|1
6861463|NCT00414050|10870661|FG000|Overall Study|Withdrawal by Subject|5
6861464|NCT00414050|10870662|FG001|Overall Study|Withdrawal by Subject|3
6861465|NCT00414050|10870663|FG002|Overall Study|Withdrawal by Subject|2
6861466|NCT00414050|10870664|FG003|Overall Study|Withdrawal by Subject|4
6861467|NCT00414050|10870661|FG000|Overall Study|Subject discontinued for other reason|1
6861468|NCT00414050|10870662|FG001|Overall Study|Subject discontinued for other reason|2
6861469|NCT00414050|10870663|FG002|Overall Study|Subject discontinued for other reason|2
6861470|NCT00414050|10870664|FG003|Overall Study|Subject discontinued for other reason|1
6861471|NCT00414050|10870661|FG000|Overall Study|Subject Moved|0
6861472|NCT00414050|10870662|FG001|Overall Study|Subject Moved|0
6861473|NCT00414050|10870663|FG002|Overall Study|Subject Moved|0
6861474|NCT00414050|10870664|FG003|Overall Study|Subject Moved|1
6861475|NCT00414076|10870676|FG000|Overall Study|Progression|1
6861476|NCT00414076|10870677|FG001|Overall Study|Progression|2
6861477|NCT00414076|10870676|FG000|Overall Study|Withdrawal by Subject|1
6861478|NCT00414076|10870677|FG001|Overall Study|Withdrawal by Subject|3
6861479|NCT00414076|10870676|FG000|Overall Study|Adverse Event|1
6861480|NCT00414076|10870677|FG001|Overall Study|Adverse Event|0
6861481|NCT00414310|10870713|FG000|Overall Study|Not treated|1
6861482|NCT00414310|10870714|FG001|Overall Study|Not treated|0
6861483|NCT00414388|10870722|FG000|Overall Study|Adverse Event|1
6861484|NCT00414440|10870729|FG000|Core Period|Withdrawal by Subject|70
6861485|NCT00414440|10870730|FG001|Core Period|Withdrawal by Subject|32
6861486|NCT00414440|10870729|FG000|Extension Period|Lost to Follow-up|44
6861487|NCT00414440|10870730|FG001|Extension Period|Lost to Follow-up|52
6861488|NCT00414440|10870729|FG000|Extension Period|Did not consent to continue follow up|61
6861489|NCT00414440|10870730|FG001|Extension Period|Did not consent to continue follow up|54
6861490|NCT00414440|10870729|FG000|Extension Period|Other|1
6861491|NCT00414440|10870730|FG001|Extension Period|Other|1
6861492|NCT00414440|10870729|FG000|Extension Period|Administrative|16
6861493|NCT00414440|10870730|FG001|Extension Period|Administrative|16
7153041|NCT03273387|11318289|FG000|Overall Study|Death|2
7153042|NCT03273387|11318290|FG001|Overall Study|Death|2
6861494|NCT00414440|10870729|FG000|Extension Period|Death|1
6861495|NCT00414440|10870730|FG001|Extension Period|Death|2
6861496|NCT00414440|10870729|FG000|Extension Period|Withdrawal by Subject|9
6861497|NCT00414440|10870730|FG001|Extension Period|Withdrawal by Subject|7
6861498|NCT00414440|10870729|FG000|Extension Period|Not included in follow up period|18
6861499|NCT00414440|10870730|FG001|Extension Period|Not included in follow up period|8
6861500|NCT00414466|10870740|FG000|Overall Study|Adverse Event|0
6861501|NCT00414466|10870741|FG001|Overall Study|Adverse Event|0
6861502|NCT00414466|10870742|FG002|Overall Study|Adverse Event|1
6861503|NCT00414466|10870743|FG003|Overall Study|Adverse Event|1
6861504|NCT00414466|10870740|FG000|Overall Study|Lack of Efficacy|1
6861505|NCT00414466|10870741|FG001|Overall Study|Lack of Efficacy|0
6861506|NCT00414466|10870742|FG002|Overall Study|Lack of Efficacy|0
6861507|NCT00414466|10870743|FG003|Overall Study|Lack of Efficacy|0
6861508|NCT00414466|10870740|FG000|Overall Study|Withdrawn by Sponsor|1
6861509|NCT00414466|10870741|FG001|Overall Study|Withdrawn by Sponsor|0
6861510|NCT00414466|10870742|FG002|Overall Study|Withdrawn by Sponsor|0
6861511|NCT00414466|10870743|FG003|Overall Study|Withdrawn by Sponsor|0
6861512|NCT00414544|10870769|FG000|Overall Study|Lost to Follow-up|14
6861513|NCT00414596|10870775|FG000|Overall Study|Protocol Violation|2
6861514|NCT00414609|10870781|FG000|Core Study|Adverse Event|9
6861515|NCT00414609|10870782|FG001|Core Study|Adverse Event|11
6861516|NCT00414609|10870783|FG002|Core Study|Adverse Event|0
6861517|NCT00414609|10870781|FG000|Core Study|Abnormal laboratory values|0
6861518|NCT00414609|10870782|FG001|Core Study|Abnormal laboratory values|1
6861519|NCT00414609|10870783|FG002|Core Study|Abnormal laboratory values|0
6861520|NCT00414609|10870781|FG000|Core Study|Abnormal test procedure results|1
6861521|NCT00414609|10870782|FG001|Core Study|Abnormal test procedure results|1
7153043|NCT03273387|11318289|FG000|Overall Study|Withdrawal by Subject|1
6861522|NCT00414609|10870783|FG002|Core Study|Abnormal test procedure results|0
6861523|NCT00414609|10870781|FG000|Core Study|Protocol deviation|0
7153044|NCT03273387|11318290|FG001|Overall Study|Withdrawal by Subject|1
7153045|NCT03273946|11318324|FG000|Overall Study|Withdrawal by Subject|5
7153046|NCT03273946|11318324|FG000|Overall Study|Unwillingness of the guardian|1
7153047|NCT03273946|11318324|FG000|Overall Study|Participant refused to use the drug|2
7153048|NCT03273946|11318324|FG000|Overall Study|Participant relative refused to use drug|1
6861524|NCT00414609|10870782|FG001|Core Study|Protocol deviation|1
6861525|NCT00414609|10870783|FG002|Core Study|Protocol deviation|0
6861526|NCT00414609|10870781|FG000|Core Study|Patient withdrew consent|10
6861527|NCT00414609|10870782|FG001|Core Study|Patient withdrew consent|11
6861528|NCT00414609|10870783|FG002|Core Study|Patient withdrew consent|0
6861529|NCT00414609|10870781|FG000|Core Study|Lost to Follow-up|7
6861530|NCT00414609|10870782|FG001|Core Study|Lost to Follow-up|4
6861531|NCT00414609|10870783|FG002|Core Study|Lost to Follow-up|0
6861532|NCT00414609|10870781|FG000|Core Study|Administrative problems|0
6861533|NCT00414609|10870782|FG001|Core Study|Administrative problems|2
6861534|NCT00414609|10870783|FG002|Core Study|Administrative problems|0
6861535|NCT00414609|10870781|FG000|Core Study|Death|7
6861536|NCT00414609|10870782|FG001|Core Study|Death|14
6861537|NCT00414609|10870783|FG002|Core Study|Death|0
6861538|NCT00414609|10870781|FG000|Extension Study|Adverse Event|0
6861539|NCT00414609|10870782|FG001|Extension Study|Adverse Event|0
6861540|NCT00414609|10870783|FG002|Extension Study|Adverse Event|14
6861541|NCT00414609|10870781|FG000|Extension Study|Unsatisfactory therapeutic effect|0
6861542|NCT00414609|10870782|FG001|Extension Study|Unsatisfactory therapeutic effect|0
6861543|NCT00414609|10870783|FG002|Extension Study|Unsatisfactory therapeutic effect|2
6861544|NCT00414609|10870781|FG000|Extension Study|Withdrawal by Subject|0
6861545|NCT00414609|10870782|FG001|Extension Study|Withdrawal by Subject|0
6861546|NCT00414609|10870783|FG002|Extension Study|Withdrawal by Subject|13
6861547|NCT00414609|10870781|FG000|Extension Study|Lost to Follow-up|0
6861548|NCT00414609|10870782|FG001|Extension Study|Lost to Follow-up|0
6861549|NCT00414609|10870783|FG002|Extension Study|Lost to Follow-up|10
6861550|NCT00414609|10870781|FG000|Extension Study|Administrative problems|0
6861551|NCT00414609|10870782|FG001|Extension Study|Administrative problems|0
6861552|NCT00414609|10870783|FG002|Extension Study|Administrative problems|1
6861553|NCT00414609|10870781|FG000|Extension Study|Death|0
6861554|NCT00414609|10870782|FG001|Extension Study|Death|0
6861555|NCT00414609|10870783|FG002|Extension Study|Death|17
6861556|NCT00414661|10870805|FG000|Overall Study|Death|2
6861557|NCT00414661|10870806|FG001|Overall Study|Death|5
6861558|NCT00414661|10870807|FG002|Overall Study|Death|0
6861559|NCT00414661|10870808|FG003|Overall Study|Death|0
6861560|NCT00414661|10870805|FG000|Overall Study|Lost to Follow-up|1
6861561|NCT00414661|10870806|FG001|Overall Study|Lost to Follow-up|4
6861562|NCT00414661|10870807|FG002|Overall Study|Lost to Follow-up|0
6861563|NCT00414661|10870808|FG003|Overall Study|Lost to Follow-up|1
6861564|NCT00414661|10870805|FG000|Overall Study|Withdrawal by Subject|5
6861565|NCT00414661|10870806|FG001|Overall Study|Withdrawal by Subject|2
6861566|NCT00414661|10870807|FG002|Overall Study|Withdrawal by Subject|2
6861567|NCT00414661|10870808|FG003|Overall Study|Withdrawal by Subject|2
6861568|NCT00414661|10870805|FG000|Overall Study|Other|6
6861569|NCT00414661|10870806|FG001|Overall Study|Other|3
6861570|NCT00414661|10870807|FG002|Overall Study|Other|0
6861571|NCT00414661|10870808|FG003|Overall Study|Other|0
6861572|NCT00414726|10870829|FG000|Overall Study|Withdrawal by Subject|0
6861573|NCT00414726|10870830|FG001|Overall Study|Withdrawal by Subject|1
6861574|NCT00414765|10870838|FG000|Overall Study|Adverse Event|5
7077989|NCT02099110|11186166|FG004|Overall Study|Lost to Follow-up|6
7077990|NCT02099110|11186162|FG000|Overall Study|Death|0
6861575|NCT00414765|10870839|FG001|Overall Study|Adverse Event|9
6967762|NCT01133756|11016185|FG002|Overall Study|Adverse Event|1
6967763|NCT01133756|11016183|FG000|Overall Study|Investigator Decision|1
7077991|NCT02099110|11186163|FG001|Overall Study|Death|1
7153049|NCT03274076|11318330|FG000|24 Weeks Double Blind|Withdrawal by Subject|0
7153050|NCT03274076|11318331|FG001|24 Weeks Double Blind|Withdrawal by Subject|1
7153051|NCT03274076|11318332|FG002|24 Weeks Double Blind|Withdrawal by Subject|0
7153052|NCT03274076|11318333|FG003|24 Weeks Double Blind|Withdrawal by Subject|0
7153053|NCT03274076|11318330|FG000|24 Weeks Open Label|Adverse Event|0
7153054|NCT03274076|11318331|FG001|24 Weeks Open Label|Adverse Event|0
7153055|NCT03274076|11318332|FG002|24 Weeks Open Label|Adverse Event|2
7153056|NCT03274076|11318333|FG003|24 Weeks Open Label|Adverse Event|0
7153057|NCT03274076|11318330|FG000|24 Weeks Open Label|Withdrawal by Subject|0
7153058|NCT03274076|11318331|FG001|24 Weeks Open Label|Withdrawal by Subject|0
7077992|NCT02099110|11186164|FG002|Overall Study|Death|0
7077993|NCT02099110|11186165|FG003|Overall Study|Death|0
7077994|NCT02099110|11186166|FG004|Overall Study|Death|0
6861576|NCT00414765|10870838|FG000|Overall Study|Withdrawal by Subject|1
6861577|NCT00414765|10870839|FG001|Overall Study|Withdrawal by Subject|1
6861578|NCT00414765|10870838|FG000|Overall Study|Disease Progression|0
6861579|NCT00414765|10870839|FG001|Overall Study|Disease Progression|1
6861580|NCT00414908|10870856|FG000|Overall Study|Protocol Violation|1
7077995|NCT02099110|11186162|FG000|Overall Study|Screen failure|0
7077996|NCT02099110|11186163|FG001|Overall Study|Screen failure|0
7077997|NCT02099110|11186164|FG002|Overall Study|Screen failure|0
7077998|NCT02099110|11186165|FG003|Overall Study|Screen failure|0
7077999|NCT02099110|11186166|FG004|Overall Study|Screen failure|1
7078000|NCT02099110|11186162|FG000|Overall Study|Non-compliance with study drug|2
6861581|NCT00414908|10870857|FG001|Overall Study|Protocol Violation|1
6861582|NCT00414960|10870867|FG000|Overall Study|Adverse Event|4
6861583|NCT00414960|10870868|FG001|Overall Study|Adverse Event|0
6861584|NCT00414960|10870867|FG000|Overall Study|Withdrawal by Subject|3
6861585|NCT00414960|10870868|FG001|Overall Study|Withdrawal by Subject|0
6861586|NCT00414960|10870867|FG000|Overall Study|Physician Decision|0
6861587|NCT00414960|10870868|FG001|Overall Study|Physician Decision|1
6967764|NCT01133756|11016184|FG001|Overall Study|Investigator Decision|0
6967765|NCT01133756|11016185|FG002|Overall Study|Investigator Decision|0
6967766|NCT01133756|11016183|FG000|Overall Study|Withdrawal by Subject|0
6967767|NCT01133756|11016184|FG001|Overall Study|Withdrawal by Subject|1
6967768|NCT01133756|11016185|FG002|Overall Study|Withdrawal by Subject|0
6967769|NCT01133756|11016183|FG000|Overall Study|Progression of Disease|0
6967770|NCT01133756|11016184|FG001|Overall Study|Progression of Disease|0
6967771|NCT01133756|11016185|FG002|Overall Study|Progression of Disease|1
6967772|NCT01133821|11016195|FG000|Overall Study|Lost to Follow-up|8
6967773|NCT01133821|11016196|FG001|Overall Study|Lost to Follow-up|11
6967774|NCT01133821|11016195|FG000|Overall Study|Withdrawal by Subject|8
6967775|NCT01133821|11016196|FG001|Overall Study|Withdrawal by Subject|3
6967776|NCT01133821|11016195|FG000|Overall Study|preferred other treatment|1
6967777|NCT01133821|11016196|FG001|Overall Study|preferred other treatment|1
6967778|NCT01133821|11016195|FG000|Overall Study|Protocol Violation|0
6967779|NCT01133821|11016196|FG001|Overall Study|Protocol Violation|1
6967780|NCT01133821|11016195|FG000|Overall Study|Refused participation|1
6967781|NCT01133821|11016196|FG001|Overall Study|Refused participation|3
6967782|NCT01133847|11016205|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5
6967783|NCT01133847|11016206|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1
6967784|NCT01133847|11016207|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3
6967785|NCT01133847|11016205|FG000|Follow-Up Phase|Lost to Follow-up|1
6967786|NCT01133847|11016206|FG001|Follow-Up Phase|Lost to Follow-up|3
6967787|NCT01133847|11016207|FG002|Follow-Up Phase|Lost to Follow-up|7
6967788|NCT01133977|11016226|FG000|Overall Study|Adverse Event|0
6967789|NCT01133977|11016227|FG001|Overall Study|Adverse Event|0
6967790|NCT01133977|11016228|FG002|Overall Study|Adverse Event|1
6967791|NCT01133977|11016229|FG003|Overall Study|Adverse Event|0
6967792|NCT01133977|11016230|FG004|Overall Study|Adverse Event|0
6967793|NCT01133977|11016226|FG000|Overall Study|Death|1
6967794|NCT01133977|11016227|FG001|Overall Study|Death|1
6967795|NCT01133977|11016228|FG002|Overall Study|Death|1
6967796|NCT01133977|11016229|FG003|Overall Study|Death|7
6967797|NCT01133977|11016230|FG004|Overall Study|Death|3
6967798|NCT01133977|11016226|FG000|Overall Study|Started a New Line of Therapy|2
6967799|NCT01133977|11016227|FG001|Overall Study|Started a New Line of Therapy|6
6967800|NCT01133977|11016228|FG002|Overall Study|Started a New Line of Therapy|4
6967801|NCT01133977|11016229|FG003|Overall Study|Started a New Line of Therapy|25
6967802|NCT01133977|11016230|FG004|Overall Study|Started a New Line of Therapy|33
6967803|NCT01133977|11016226|FG000|Overall Study|Lost to Follow-up|0
6967804|NCT01133977|11016227|FG001|Overall Study|Lost to Follow-up|0
6967805|NCT01133977|11016228|FG002|Overall Study|Lost to Follow-up|0
6967806|NCT01133977|11016229|FG003|Overall Study|Lost to Follow-up|2
6967807|NCT01133977|11016230|FG004|Overall Study|Lost to Follow-up|1
6967808|NCT01133977|11016226|FG000|Overall Study|Withdrawal by Subject|0
6967809|NCT01133977|11016227|FG001|Overall Study|Withdrawal by Subject|0
6967810|NCT01133977|11016228|FG002|Overall Study|Withdrawal by Subject|0
6967811|NCT01133977|11016229|FG003|Overall Study|Withdrawal by Subject|5
6967812|NCT01133977|11016230|FG004|Overall Study|Withdrawal by Subject|1
6967813|NCT01134042|11016281|FG000|Overall Study|Adverse Event|3
6967814|NCT01134042|11016282|FG001|Overall Study|Adverse Event|7
6967815|NCT01134042|11016283|FG002|Overall Study|Adverse Event|2
6967816|NCT01134042|11016281|FG000|Overall Study|Lack of Efficacy|21
6967817|NCT01134042|11016282|FG001|Overall Study|Lack of Efficacy|6
6967818|NCT01134042|11016283|FG002|Overall Study|Lack of Efficacy|18
6967819|NCT01134042|11016281|FG000|Overall Study|Protocol Violation|5
6967820|NCT01134042|11016282|FG001|Overall Study|Protocol Violation|3
6967821|NCT01134042|11016283|FG002|Overall Study|Protocol Violation|5
6967822|NCT01134042|11016281|FG000|Overall Study|Lost to Follow-up|2
6967823|NCT01134042|11016282|FG001|Overall Study|Lost to Follow-up|0
6967824|NCT01134042|11016283|FG002|Overall Study|Lost to Follow-up|1
6967825|NCT01134042|11016281|FG000|Overall Study|Physician Decision|4
6967826|NCT01134042|11016282|FG001|Overall Study|Physician Decision|8
6967827|NCT01134042|11016283|FG002|Overall Study|Physician Decision|1
6967828|NCT01134042|11016281|FG000|Overall Study|Withdrawal by Subject|13
6967829|NCT01134042|11016282|FG001|Overall Study|Withdrawal by Subject|4
6967830|NCT01134042|11016283|FG002|Overall Study|Withdrawal by Subject|7
6967831|NCT01134055|11016299|FG000|Overall Study|Adverse Event|5
6967832|NCT01134055|11016300|FG001|Overall Study|Adverse Event|2
6967833|NCT01134055|11016301|FG002|Overall Study|Adverse Event|2
6967834|NCT01134055|11016302|FG003|Overall Study|Adverse Event|2
6967835|NCT01134055|11016303|FG004|Overall Study|Adverse Event|5
6967836|NCT01134055|11016304|FG005|Overall Study|Adverse Event|7
6967837|NCT01134055|11016305|FG006|Overall Study|Adverse Event|2
6967838|NCT01134055|11016299|FG000|Overall Study|Lost to Follow-up|0
6967839|NCT01134055|11016300|FG001|Overall Study|Lost to Follow-up|1
6967840|NCT01134055|11016301|FG002|Overall Study|Lost to Follow-up|0
6967841|NCT01134055|11016302|FG003|Overall Study|Lost to Follow-up|1
6861588|NCT00414973|10870878|FG000|Overall Study|Withdrawal by Subject|14
6861589|NCT00414973|10870879|FG001|Overall Study|Withdrawal by Subject|4
6861590|NCT00414973|10870880|FG002|Overall Study|Withdrawal by Subject|1
6861591|NCT00414973|10870881|FG003|Overall Study|Withdrawal by Subject|0
6861592|NCT00414973|10870878|FG000|Overall Study|Adverse Event|10
6861593|NCT00414973|10870879|FG001|Overall Study|Adverse Event|0
6861594|NCT00414973|10870880|FG002|Overall Study|Adverse Event|1
6861595|NCT00414973|10870881|FG003|Overall Study|Adverse Event|0
6861596|NCT00414973|10870878|FG000|Overall Study|Protocol Violation|3
6861597|NCT00414973|10870879|FG001|Overall Study|Protocol Violation|4
6861598|NCT00414973|10870880|FG002|Overall Study|Protocol Violation|0
6861599|NCT00414973|10870881|FG003|Overall Study|Protocol Violation|0
6861600|NCT00414973|10870878|FG000|Overall Study|Lost to Follow-up|0
6861601|NCT00414973|10870879|FG001|Overall Study|Lost to Follow-up|2
6861602|NCT00414973|10870880|FG002|Overall Study|Lost to Follow-up|0
6861603|NCT00414973|10870881|FG003|Overall Study|Lost to Follow-up|0
6861604|NCT00414973|10870878|FG000|Overall Study|Sponsor Decision|1
6861605|NCT00414973|10870879|FG001|Overall Study|Sponsor Decision|0
6861606|NCT00414973|10870880|FG002|Overall Study|Sponsor Decision|0
6861607|NCT00414973|10870881|FG003|Overall Study|Sponsor Decision|0
6861608|NCT00414973|10870878|FG000|Overall Study|Death|0
6861609|NCT00414973|10870879|FG001|Overall Study|Death|0
6861610|NCT00414973|10870880|FG002|Overall Study|Death|1
6861611|NCT00414973|10870881|FG003|Overall Study|Death|0
6861612|NCT00415051|10870891|FG000|Overall Study|Protocol Violation|1
6861613|NCT00415168|10870895|FG000|Overall Study|Death|26
6861614|NCT00415168|10870895|FG000|Overall Study|Lost to Follow-up|3
6861615|NCT00415168|10870895|FG000|Overall Study|Physician Decision|13
6861616|NCT00415168|10870895|FG000|Overall Study|Sponsor Decision|4
6861617|NCT00415168|10870895|FG000|Overall Study|Withdrawal by Subject|6
6861618|NCT00415194|10870901|FG000|Overall Study|Adverse Event|37
6861619|NCT00415194|10870902|FG001|Overall Study|Adverse Event|32
6861620|NCT00415194|10870901|FG000|Overall Study|Entry Criteria Not Met|4
6861621|NCT00415194|10870902|FG001|Overall Study|Entry Criteria Not Met|8
6861622|NCT00415194|10870901|FG000|Overall Study|Lost to Follow-up|1
6861623|NCT00415194|10870902|FG001|Overall Study|Lost to Follow-up|0
6861624|NCT00415194|10870901|FG000|Overall Study|Physician Decision|10
6861625|NCT00415194|10870902|FG001|Overall Study|Physician Decision|16
6861626|NCT00415194|10870901|FG000|Overall Study|Progressive Disease|180
6861627|NCT00415194|10870902|FG001|Overall Study|Progressive Disease|217
6861628|NCT00415194|10870901|FG000|Overall Study|Protocol Violation|4
6861629|NCT00415194|10870902|FG001|Overall Study|Protocol Violation|2
6861630|NCT00415194|10870901|FG000|Overall Study|Withdrawal by Subject|28
6861631|NCT00415194|10870902|FG001|Overall Study|Withdrawal by Subject|21
6861632|NCT00415194|10870901|FG000|Overall Study|Death Due to Study Disease|26
6861633|NCT00415194|10870902|FG001|Overall Study|Death Due to Study Disease|29
6861634|NCT00415194|10870901|FG000|Overall Study|Death Due to Study Drug Related AE|11
6861635|NCT00415194|10870902|FG001|Overall Study|Death Due to Study Drug Related AE|1
6861636|NCT00415194|10870901|FG000|Overall Study|Death Due to Procedural Related AE|0
6861637|NCT00415194|10870902|FG001|Overall Study|Death Due to Procedural Related AE|1
6861638|NCT00415194|10870901|FG000|Overall Study|Death Due to AE (Other Causes)|27
6861639|NCT00415194|10870902|FG001|Overall Study|Death Due to AE (Other Causes)|15
6861640|NCT00415363|10870910|FG000|Overall Study|Withdrawal by Subject|4
6861641|NCT00415363|10870911|FG001|Overall Study|Withdrawal by Subject|4
6861642|NCT00415363|10870910|FG000|Overall Study|Adverse Event|4
6861643|NCT00415363|10870911|FG001|Overall Study|Adverse Event|4
6861644|NCT00415363|10870910|FG000|Overall Study|Lost to Follow-up|2
6861645|NCT00415363|10870911|FG001|Overall Study|Lost to Follow-up|1
6861646|NCT00415363|10870910|FG000|Overall Study|Physician Decision|3
6861647|NCT00415363|10870911|FG001|Overall Study|Physician Decision|1
6861648|NCT00415363|10870910|FG000|Overall Study|Death|16
6861649|NCT00415363|10870911|FG001|Overall Study|Death|12
6861650|NCT00415363|10870910|FG000|Overall Study|Progressive disease|26
6861651|NCT00415363|10870911|FG001|Overall Study|Progressive disease|32
6861652|NCT00415519|10870938|FG000|Overall Study|Adverse Event|1
6861653|NCT00415519|10870939|FG001|Overall Study|Adverse Event|0
6861654|NCT00415519|10870938|FG000|Overall Study|Withdrawal by Subject|2
6861655|NCT00415519|10870939|FG001|Overall Study|Withdrawal by Subject|0
6861656|NCT00415519|10870938|FG000|Overall Study|Patient's convenience|1
6861657|NCT00415519|10870939|FG001|Overall Study|Patient's convenience|0
6861658|NCT00415532|10870947|FG000|Treatment Period|Adverse Event|2
6861659|NCT00415532|10870948|FG001|Treatment Period|Adverse Event|3
6861660|NCT00415532|10870947|FG000|Treatment Period|Death|2
6861661|NCT00415532|10870948|FG001|Treatment Period|Death|1
6861662|NCT00415532|10870947|FG000|Treatment Period|Lost to Follow-up|1
6861663|NCT00415532|10870948|FG001|Treatment Period|Lost to Follow-up|1
6861664|NCT00415532|10870947|FG000|Treatment Period|Protocol Violation|1
6861665|NCT00415532|10870948|FG001|Treatment Period|Protocol Violation|0
6861666|NCT00415532|10870947|FG000|Treatment Period|Withdrawal by Subject|6
6861667|NCT00415532|10870948|FG001|Treatment Period|Withdrawal by Subject|6
6861668|NCT00415532|10870947|FG000|Treatment Period|Other|2
6861669|NCT00415532|10870948|FG001|Treatment Period|Other|2
6861670|NCT00415532|10870947|FG000|Treatment Period|Ineligibility determined|1
6861671|NCT00415532|10870948|FG001|Treatment Period|Ineligibility determined|1
6861672|NCT00415532|10870947|FG000|Treatment Period|Noncompliance|1
6861673|NCT00415532|10870948|FG001|Treatment Period|Noncompliance|1
6861674|NCT00415532|10870947|FG000|Treatment Period|Requirement for alternative therapy|1
6861675|NCT00415532|10870948|FG001|Treatment Period|Requirement for alternative therapy|0
6861676|NCT00415532|10870947|FG000|Safety Follow Up Period|Adverse Event|1
6861677|NCT00415532|10870948|FG001|Safety Follow Up Period|Adverse Event|3
6861678|NCT00415532|10870947|FG000|Safety Follow Up Period|Death|3
6861679|NCT00415532|10870948|FG001|Safety Follow Up Period|Death|0
6861680|NCT00415532|10870947|FG000|Safety Follow Up Period|Withdrawal by Subject|2
6861681|NCT00415532|10870948|FG001|Safety Follow Up Period|Withdrawal by Subject|3
6861682|NCT00415532|10870947|FG000|Safety Follow Up Period|Other|1
6861683|NCT00415532|10870948|FG001|Safety Follow Up Period|Other|4
6861684|NCT00415532|10870947|FG000|Safety Follow Up Period|Ineligibility determined|1
6861685|NCT00415532|10870948|FG001|Safety Follow Up Period|Ineligibility determined|1
6861686|NCT00415532|10870947|FG000|Safety Follow Up Period|Noncompliance|1
6861687|NCT00415532|10870948|FG001|Safety Follow Up Period|Noncompliance|0
6861688|NCT00415532|10870947|FG000|Safety Follow Up Period|Requirement for alternative therapy|0
6861689|NCT00415532|10870948|FG001|Safety Follow Up Period|Requirement for alternative therapy|1
6861690|NCT00415597|10870954|FG000|Enrollment|Withdrawal by Subject|1
6861691|NCT00415597|10870954|FG000|Enrollment|Protocol Violation|1
6861692|NCT00415597|10870954|FG000|Treatment|Adverse Event|110
6861693|NCT00415597|10870954|FG000|Treatment|Lack of Efficacy|39
6861694|NCT00415597|10870954|FG000|Treatment|Protocol Violation|67
6861695|NCT00415597|10870954|FG000|Treatment|Physician Decision|3
6861696|NCT00415597|10870954|FG000|Treatment|Withdrawal by Subject|51
6861697|NCT00415597|10870954|FG000|Treatment|Lost to Follow-up|28
6861698|NCT00415597|10870954|FG000|Treatment|Drug Screen|2
6861699|NCT00415597|10870954|FG000|Treatment|Administrative|3
6861700|NCT00415597|10870954|FG000|Treatment|Sponsor Decision|1
6861701|NCT00415597|10870954|FG000|Treatment|Multiple Reasons|1
6861702|NCT00415610|10870961|FG000|Overall Study|Death|3
6861703|NCT00415610|10870962|FG001|Overall Study|Death|2
6861704|NCT00415610|10870963|FG002|Overall Study|Death|5
6861705|NCT00415636|10870977|FG000|Overall Study|Symptomatic deterioration|1
6861706|NCT00415636|10870978|FG001|Overall Study|Symptomatic deterioration|0
6861707|NCT00415636|10870979|FG002|Overall Study|Symptomatic deterioration|1
6861708|NCT00415636|10870980|FG003|Overall Study|Symptomatic deterioration|2
6861709|NCT00415636|10870981|FG004|Overall Study|Symptomatic deterioration|0
6861710|NCT00415636|10870982|FG005|Overall Study|Symptomatic deterioration|1
6861711|NCT00415636|10870977|FG000|Overall Study|Adverse Event|0
6861712|NCT00415636|10870978|FG001|Overall Study|Adverse Event|0
6861713|NCT00415636|10870979|FG002|Overall Study|Adverse Event|0
6861714|NCT00415636|10870980|FG003|Overall Study|Adverse Event|1
6861715|NCT00415636|10870981|FG004|Overall Study|Adverse Event|1
6861716|NCT00415636|10870982|FG005|Overall Study|Adverse Event|0
6861717|NCT00415636|10870977|FG000|Overall Study|Withdrawal by Subject|0
6861718|NCT00415636|10870978|FG001|Overall Study|Withdrawal by Subject|0
6861719|NCT00415636|10870979|FG002|Overall Study|Withdrawal by Subject|0
7078001|NCT02099110|11186163|FG001|Overall Study|Non-compliance with study drug|0
7078002|NCT02099110|11186164|FG002|Overall Study|Non-compliance with study drug|0
6861720|NCT00415636|10870980|FG003|Overall Study|Withdrawal by Subject|0
6861721|NCT00415636|10870981|FG004|Overall Study|Withdrawal by Subject|1
6861722|NCT00415636|10870982|FG005|Overall Study|Withdrawal by Subject|0
6861723|NCT00415636|10870977|FG000|Overall Study|Disease progression|0
6861724|NCT00415636|10870978|FG001|Overall Study|Disease progression|0
6861725|NCT00415636|10870979|FG002|Overall Study|Disease progression|0
6861726|NCT00415636|10870980|FG003|Overall Study|Disease progression|3
6861727|NCT00415636|10870981|FG004|Overall Study|Disease progression|0
6861728|NCT00415636|10870982|FG005|Overall Study|Disease progression|1
6861729|NCT00415909|10871022|FG000|Overall Study|Withdrawal by Subject|2
6861730|NCT00415909|10871022|FG000|Overall Study|Death|1
6861731|NCT00416078|10871028|FG000|Overall Study|Death|3
6861732|NCT00416078|10871029|FG001|Overall Study|Death|4
6861733|NCT00416078|10871028|FG000|Overall Study|Withdrawal by Subject|3
6861734|NCT00416078|10871029|FG001|Overall Study|Withdrawal by Subject|2
6861735|NCT00416078|10871028|FG000|Overall Study|Physician Decision|1
6861736|NCT00416078|10871029|FG001|Overall Study|Physician Decision|0
6861737|NCT00416078|10871028|FG000|Overall Study|Lost to Follow-up|4
6861738|NCT00416078|10871029|FG001|Overall Study|Lost to Follow-up|2
6861739|NCT00416195|10871052|FG000|Overall Study|Adverse Event|1
6861740|NCT00416195|10871053|FG001|Overall Study|Adverse Event|2
6861741|NCT00416195|10871052|FG000|Overall Study|Protocol Violation|1
6861742|NCT00416195|10871053|FG001|Overall Study|Protocol Violation|1
7078003|NCT02099110|11186165|FG003|Overall Study|Non-compliance with study drug|0
6861743|NCT00416195|10871052|FG000|Overall Study|Other|0
6861744|NCT00416195|10871053|FG001|Overall Study|Other|1
6861745|NCT00416312|10871059|FG000|Overall Study|tumors not visible on imaging|2
6861746|NCT00416455|10871065|FG000|Overall Study|PET / CT not done|3
6861747|NCT00416455|10871066|FG001|Overall Study|PET / CT not done|5
6861748|NCT00416455|10871065|FG000|Overall Study|PET / CT poor quality|2
6861749|NCT00416455|10871066|FG001|Overall Study|PET / CT poor quality|1
6861750|NCT00416455|10871065|FG000|Overall Study|Inadequate pathology|11
6861751|NCT00416455|10871066|FG001|Overall Study|Inadequate pathology|2
6861752|NCT00416520|10871094|FG000|Open-label Period|Adverse Event|28
6861753|NCT00416520|10871095|FG001|Open-label Period|Adverse Event|10
6861754|NCT00416520|10871096|FG002|Open-label Period|Adverse Event|0
6861755|NCT00416520|10871097|FG003|Open-label Period|Adverse Event|0
6861756|NCT00416520|10871094|FG000|Open-label Period|Death|2
6861757|NCT00416520|10871095|FG001|Open-label Period|Death|1
6861758|NCT00416520|10871096|FG002|Open-label Period|Death|0
6861759|NCT00416520|10871097|FG003|Open-label Period|Death|0
6861760|NCT00416520|10871094|FG000|Open-label Period|Lack of Efficacy|8
6861761|NCT00416520|10871095|FG001|Open-label Period|Lack of Efficacy|1
6861762|NCT00416520|10871096|FG002|Open-label Period|Lack of Efficacy|0
6861763|NCT00416520|10871097|FG003|Open-label Period|Lack of Efficacy|0
6861764|NCT00416520|10871094|FG000|Open-label Period|Protocol Violation|3
6861765|NCT00416520|10871095|FG001|Open-label Period|Protocol Violation|3
6861766|NCT00416520|10871096|FG002|Open-label Period|Protocol Violation|0
6861767|NCT00416520|10871097|FG003|Open-label Period|Protocol Violation|0
6861768|NCT00416520|10871094|FG000|Open-label Period|Withdrawal by Subject|16
6861769|NCT00416520|10871095|FG001|Open-label Period|Withdrawal by Subject|5
6861770|NCT00416520|10871096|FG002|Open-label Period|Withdrawal by Subject|0
6861771|NCT00416520|10871097|FG003|Open-label Period|Withdrawal by Subject|0
6861772|NCT00416520|10871094|FG000|Open-label Period|Other Reasons|3
6861773|NCT00416520|10871095|FG001|Open-label Period|Other Reasons|12
6861774|NCT00416520|10871096|FG002|Open-label Period|Other Reasons|0
6861775|NCT00416520|10871097|FG003|Open-label Period|Other Reasons|0
6861776|NCT00416520|10871094|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0
6861777|NCT00416520|10871095|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0
6861778|NCT00416520|10871096|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0
6861779|NCT00416520|10871097|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1
6861780|NCT00416520|10871094|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
6861781|NCT00416520|10871095|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
6861782|NCT00416520|10871096|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
6861783|NCT00416520|10871097|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3
6861784|NCT00416520|10871094|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0
6861785|NCT00416520|10871095|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0
6861786|NCT00416520|10871096|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1
6861787|NCT00416520|10871097|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1
6861788|NCT00416598|10871120|FG000|Induction & Intensification|Adverse Event|38
6861789|NCT00416598|10871120|FG000|Induction & Intensification|Death|32
6861790|NCT00416598|10871120|FG000|Induction & Intensification|Withdrawal by Subject|46
6861791|NCT00416598|10871120|FG000|Induction & Intensification|Alternative Treatment|135
6861792|NCT00416598|10871120|FG000|Induction & Intensification|Physician discretion/other medical issue|45
6861793|NCT00416598|10871120|FG000|Induction & Intensification|Relapse/progression|29
6861794|NCT00416598|10871120|FG000|Induction & Intensification|Failed induction|87
6861795|NCT00416598|10871120|FG000|Decitabine Maintenance|Adverse Event|5
6861796|NCT00416598|10871120|FG000|Decitabine Maintenance|Withdrawal by Subject|18
6861797|NCT00416598|10871120|FG000|Decitabine Maintenance|Progression/relapse|38
6861798|NCT00416598|10871120|FG000|Decitabine Maintenance|Alternative treatment|2
6861799|NCT00416598|10871120|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9
6861800|NCT00416624|10871128|FG000|Overall Study|Withdrawal by Subject|1
6861801|NCT00416624|10871129|FG001|Overall Study|Withdrawal by Subject|6
6861802|NCT00416624|10871130|FG002|Overall Study|Withdrawal by Subject|4
6861803|NCT00416624|10871131|FG003|Overall Study|Withdrawal by Subject|9
6861804|NCT00416624|10871128|FG000|Overall Study|Death|4
6861805|NCT00416624|10871129|FG001|Overall Study|Death|7
6861806|NCT00416624|10871130|FG002|Overall Study|Death|7
6861807|NCT00416624|10871131|FG003|Overall Study|Death|1
6861808|NCT00416624|10871128|FG000|Overall Study|Adverse Event|8
6861809|NCT00416624|10871129|FG001|Overall Study|Adverse Event|3
6861810|NCT00416624|10871130|FG002|Overall Study|Adverse Event|2
6861811|NCT00416624|10871131|FG003|Overall Study|Adverse Event|2
6861812|NCT00416624|10871128|FG000|Overall Study|Other|8
6861813|NCT00416624|10871129|FG001|Overall Study|Other|11
6861814|NCT00416624|10871130|FG002|Overall Study|Other|5
6861815|NCT00416624|10871131|FG003|Overall Study|Other|5
6861816|NCT00416624|10871128|FG000|Overall Study|Cancel|1
6861817|NCT00416624|10871129|FG001|Overall Study|Cancel|0
6861818|NCT00416624|10871130|FG002|Overall Study|Cancel|0
6861819|NCT00416624|10871131|FG003|Overall Study|Cancel|0
7078004|NCT02099110|11186166|FG004|Overall Study|Non-compliance with study drug|1
7078005|NCT02099110|11186162|FG000|Overall Study|Physician Decision|3
6861820|NCT00416715|10871141|FG000|Overall Study|Not evaluable for joint aches|7
6861821|NCT00416715|10871141|FG000|Overall Study|Vitamin D levels not evaluable|8
6861822|NCT00416884|10871152|FG000|Overall Study|Study terminated due to low accrual|1
6861823|NCT00416949|10871156|FG000|Overall Study|Patients refused to participate|5
6861824|NCT00417027|10871163|FG000|Overall Study|Protocol Violation|0
6861825|NCT00417027|10871164|FG001|Overall Study|Protocol Violation|5
6861826|NCT00417027|10871165|FG002|Overall Study|Protocol Violation|5
6861827|NCT00417079|10871175|FG000|Overall Study|Disease progression|267
6861828|NCT00417079|10871176|FG001|Overall Study|Disease progression|180
7078006|NCT02099110|11186163|FG001|Overall Study|Physician Decision|0
7078007|NCT02099110|11186164|FG002|Overall Study|Physician Decision|1
6861829|NCT00417079|10871175|FG000|Overall Study|Adverse Event|32
6861830|NCT00417079|10871176|FG001|Overall Study|Adverse Event|67
6861831|NCT00417079|10871175|FG000|Overall Study|Non-compliance to protocol|0
6861832|NCT00417079|10871176|FG001|Overall Study|Non-compliance to protocol|1
6861833|NCT00417079|10871175|FG000|Overall Study|Lost to Follow-up|2
6861834|NCT00417079|10871176|FG001|Overall Study|Lost to Follow-up|0
6861835|NCT00417079|10871175|FG000|Overall Study|Withdrawal by Subject|17
6861836|NCT00417079|10871176|FG001|Overall Study|Withdrawal by Subject|8
6861837|NCT00417079|10871175|FG000|Overall Study|Not treated|6
6861838|NCT00417079|10871176|FG001|Overall Study|Not treated|7
6861839|NCT00417079|10871175|FG000|Overall Study|Screened failure|2
6861840|NCT00417079|10871176|FG001|Overall Study|Screened failure|1
6861841|NCT00417079|10871175|FG000|Overall Study|Investigator's decision|1
6861842|NCT00417079|10871176|FG001|Overall Study|Investigator's decision|4
6861843|NCT00417079|10871175|FG000|Overall Study|Non-confirmed Disease progression|1
6861844|NCT00417079|10871176|FG001|Overall Study|Non-confirmed Disease progression|1
6861845|NCT00417079|10871175|FG000|Overall Study|Clinical deterioration|1
6861846|NCT00417079|10871176|FG001|Overall Study|Clinical deterioration|0
6861847|NCT00417079|10871175|FG000|Overall Study|Screening error|2
6861848|NCT00417079|10871176|FG001|Overall Study|Screening error|1
6861849|NCT00417079|10871175|FG000|Overall Study|Withdrawal by subject's family|0
6861850|NCT00417079|10871176|FG001|Overall Study|Withdrawal by subject's family|1
6861851|NCT00417079|10871175|FG000|Overall Study|Patient unable to come to the clinic|0
6861852|NCT00417079|10871176|FG001|Overall Study|Patient unable to come to the clinic|1
6861853|NCT00417079|10871175|FG000|Overall Study|abnormal liver function tests|0
6861854|NCT00417079|10871176|FG001|Overall Study|abnormal liver function tests|1
6861855|NCT00417170|10871184|FG000|Overall Study|Adverse Event|1
6861856|NCT00417170|10871185|FG001|Overall Study|Adverse Event|1
6861857|NCT00417170|10871184|FG000|Overall Study|Withdrawal by Subject|1
6861858|NCT00417170|10871185|FG001|Overall Study|Withdrawal by Subject|1
6861859|NCT00417170|10871184|FG000|Overall Study|Lost to Follow-up|0
6861860|NCT00417170|10871185|FG001|Overall Study|Lost to Follow-up|1
6861861|NCT00417482|10871209|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14
6861862|NCT00417482|10871210|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8
6861863|NCT00417482|10871211|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24
6861864|NCT00417482|10871209|FG000|Phase B 1st 16 Weeks|Adverse Event|2
6861865|NCT00417482|10871210|FG001|Phase B 1st 16 Weeks|Adverse Event|0
6861866|NCT00417482|10871211|FG002|Phase B 1st 16 Weeks|Adverse Event|1
6861867|NCT00417482|10871209|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
6861868|NCT00417482|10871210|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3
6861869|NCT00417482|10871211|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
6861870|NCT00417482|10871209|FG000|Phase B 1st 16 Weeks|Death|1
6861871|NCT00417482|10871210|FG001|Phase B 1st 16 Weeks|Death|0
6861872|NCT00417482|10871211|FG002|Phase B 1st 16 Weeks|Death|0
6861873|NCT00417482|10871209|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1
6861874|NCT00417482|10871210|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12
6861875|NCT00417482|10871211|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2
6861876|NCT00417482|10871209|FG000|Phase B 2nd 16 Weeks|Adverse Event|0
6861877|NCT00417482|10871210|FG001|Phase B 2nd 16 Weeks|Adverse Event|0
6861878|NCT00417482|10871211|FG002|Phase B 2nd 16 Weeks|Adverse Event|1
6861879|NCT00417482|10871209|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1
6861880|NCT00417482|10871210|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0
6861881|NCT00417482|10871211|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0
6861882|NCT00417482|10871209|FG000|Phase B 2nd 16 Weeks|Death|1
6861883|NCT00417482|10871210|FG001|Phase B 2nd 16 Weeks|Death|1
6861884|NCT00417482|10871211|FG002|Phase B 2nd 16 Weeks|Death|0
6861885|NCT00417612|10871227|FG000|Overall Study|Errant diagnosis|0
6861886|NCT00417612|10871228|FG001|Overall Study|Errant diagnosis|1
6861887|NCT00417612|10871227|FG000|Overall Study|Adverse Event|2
6861888|NCT00417612|10871228|FG001|Overall Study|Adverse Event|0
6861889|NCT00417612|10871227|FG000|Overall Study|Protocol Violation|0
6861890|NCT00417612|10871228|FG001|Overall Study|Protocol Violation|2
6861891|NCT00417612|10871227|FG000|Overall Study|Lost to Follow-up|1
6861892|NCT00417612|10871228|FG001|Overall Study|Lost to Follow-up|0
6861893|NCT00417885|10871247|FG000|Overall Study|Adverse Event|1
6861894|NCT00417885|10871247|FG000|Overall Study|Objective Progression or Relapse|3
6861895|NCT00417885|10871247|FG000|Overall Study|Transferred to Another Sunitinib Study|2
6861896|NCT00417963|10871251|FG000|Overall Study|Lost to Follow-up|3
7078008|NCT02099110|11186165|FG003|Overall Study|Physician Decision|2
7078009|NCT02099110|11186166|FG004|Overall Study|Physician Decision|1
7078010|NCT02099682|11186198|FG000|Overall Study|Data Not Available|51
7078011|NCT02099682|11186198|FG000|Overall Study|Lost to Follow-up|31
7078012|NCT02099682|11186198|FG000|Overall Study|Other|29
7078013|NCT02099708|11186202|FG000|Overall Study|Data Not Available|30
7078014|NCT02099708|11186202|FG000|Overall Study|Lost to Follow-up|141
7078015|NCT02099708|11186202|FG000|Overall Study|Other|29
7078016|NCT02099838|11186252|FG000|Overall Study|Death|1
6861897|NCT00417963|10871251|FG000|Overall Study|Withdrawal by Subject|18
6861898|NCT00417963|10871251|FG000|Overall Study|Death|17
6861899|NCT00417963|10871251|FG000|Overall Study|Study device could not be deployed|3
7078017|NCT02099838|11186253|FG001|Overall Study|Death|0
6861900|NCT00417976|10871260|FG000|Overall Study|Non compliance unrelated to toxicity|1
6861901|NCT00417976|10871260|FG000|Overall Study|Treatment -related toxicity|2
6861902|NCT00417989|10871267|FG000|Overall Study|Withdrawal by Subject|13
6861903|NCT00417989|10871268|FG001|Overall Study|Withdrawal by Subject|13
6861904|NCT00417989|10871267|FG000|Overall Study|Lost to Follow-up|1
6861905|NCT00417989|10871268|FG001|Overall Study|Lost to Follow-up|6
7078018|NCT02099838|11186252|FG000|Overall Study|Lost to Follow-up|3
6861906|NCT00417989|10871267|FG000|Overall Study|Protocol Violation|1
6861907|NCT00417989|10871268|FG001|Overall Study|Protocol Violation|0
6861908|NCT00417989|10871267|FG000|Overall Study|Death|0
6861909|NCT00417989|10871268|FG001|Overall Study|Death|1
6861910|NCT00417989|10871267|FG000|Overall Study|Physician Decision|5
6861911|NCT00417989|10871268|FG001|Overall Study|Physician Decision|2
6861912|NCT00418184|10871308|FG000|Double-blind Phase|Withdrawal by Subject|22
6861913|NCT00418184|10871309|FG001|Double-blind Phase|Withdrawal by Subject|9
6861914|NCT00418184|10871308|FG000|Double-blind Phase|Adverse Event|2
6861915|NCT00418184|10871309|FG001|Double-blind Phase|Adverse Event|1
6861916|NCT00418184|10871308|FG000|Double-blind Phase|Poor compliance|3
6861917|NCT00418184|10871309|FG001|Double-blind Phase|Poor compliance|1
6861918|NCT00418314|10871325|FG000|Overall Study|Withdrawal by Subject|1
6861919|NCT00418314|10871326|FG001|Overall Study|Withdrawal by Subject|2
6861920|NCT00418379|10871335|FG000|Year 1|Adverse Event|9
6861921|NCT00418379|10871336|FG001|Year 1|Adverse Event|15
6861922|NCT00418379|10871337|FG002|Year 1|Adverse Event|3
6861923|NCT00418379|10871335|FG000|Year 1|Withdrawal by Subject|7
6861924|NCT00418379|10871336|FG001|Year 1|Withdrawal by Subject|8
6861925|NCT00418379|10871337|FG002|Year 1|Withdrawal by Subject|5
6861926|NCT00418379|10871335|FG000|Year 1|Any other reason not above-mentioned|2
6861927|NCT00418379|10871336|FG001|Year 1|Any other reason not above-mentioned|5
6861928|NCT00418379|10871337|FG002|Year 1|Any other reason not above-mentioned|7
6861929|NCT00418379|10871335|FG000|Year 2|Adverse Event|5
6861930|NCT00418379|10871336|FG001|Year 2|Adverse Event|2
6861931|NCT00418379|10871337|FG002|Year 2|Adverse Event|1
6861932|NCT00418379|10871335|FG000|Year 2|Withdrawal by Subject|1
6861933|NCT00418379|10871336|FG001|Year 2|Withdrawal by Subject|1
6861934|NCT00418379|10871337|FG002|Year 2|Withdrawal by Subject|3
6861935|NCT00418379|10871335|FG000|Year 2|Any other reason not above-mentioned|2
6861936|NCT00418379|10871336|FG001|Year 2|Any other reason not above-mentioned|1
6861937|NCT00418379|10871337|FG002|Year 2|Any other reason not above-mentioned|6
6861938|NCT00418379|10871335|FG000|Year 3|Withdrawal by Subject|1
6861939|NCT00418379|10871336|FG001|Year 3|Withdrawal by Subject|1
6861940|NCT00418379|10871337|FG002|Year 3|Withdrawal by Subject|2
6861941|NCT00418379|10871335|FG000|Year 3|Any other reason not above-mentioned|2
6861942|NCT00418379|10871336|FG001|Year 3|Any other reason not above-mentioned|1
6861943|NCT00418379|10871337|FG002|Year 3|Any other reason not above-mentioned|1
6861944|NCT00418379|10871335|FG000|Year 4|Adverse Event|0
6861945|NCT00418379|10871336|FG001|Year 4|Adverse Event|1
6861946|NCT00418379|10871337|FG002|Year 4|Adverse Event|0
6861947|NCT00418379|10871335|FG000|Year 4|Withdrawal by Subject|2
6861948|NCT00418379|10871336|FG001|Year 4|Withdrawal by Subject|3
6861949|NCT00418379|10871337|FG002|Year 4|Withdrawal by Subject|2
6861950|NCT00418379|10871335|FG000|Year 4|Any other reason not above-mentioned|1
6861951|NCT00418379|10871336|FG001|Year 4|Any other reason not above-mentioned|1
6861952|NCT00418379|10871337|FG002|Year 4|Any other reason not above-mentioned|0
6861953|NCT00418379|10871335|FG000|Year 5|Adverse Event|0
7078019|NCT02099838|11186253|FG001|Overall Study|Lost to Follow-up|1
7078020|NCT02099838|11186252|FG000|Overall Study|Withdrawal by Subject|0
7078021|NCT02099838|11186253|FG001|Overall Study|Withdrawal by Subject|1
7078022|NCT02100124|11186279|FG000|Overall Study|Lost to Follow-up|5
7078023|NCT02100124|11186280|FG001|Overall Study|Lost to Follow-up|11
7078024|NCT02100124|11186281|FG002|Overall Study|Lost to Follow-up|3
7078025|NCT02100124|11186279|FG000|Overall Study|Withdrawal by Subject|1
7078026|NCT02100124|11186280|FG001|Overall Study|Withdrawal by Subject|0
7078027|NCT02100124|11186281|FG002|Overall Study|Withdrawal by Subject|0
7078028|NCT02100228|11186295|FG000|Overall Study|Other|19
7078029|NCT02100228|11186296|FG001|Overall Study|Other|19
7078030|NCT02100228|11186295|FG000|Overall Study|Administrative reason|0
7078031|NCT02100228|11186296|FG001|Overall Study|Administrative reason|1
7078032|NCT02100228|11186295|FG000|Overall Study|Inclusion/Exclusion criteria not met|12
7078033|NCT02100228|11186296|FG001|Overall Study|Inclusion/Exclusion criteria not met|16
7078034|NCT02100228|11186295|FG000|Overall Study|Non-compliance|0
7078035|NCT02100228|11186296|FG001|Overall Study|Non-compliance|3
7078036|NCT02100228|11186295|FG000|Overall Study|Lost to Follow-up|0
7078037|NCT02100228|11186296|FG001|Overall Study|Lost to Follow-up|1
7078038|NCT02100228|11186295|FG000|Overall Study|Withdrawal by Subject|27
7078039|NCT02100228|11186296|FG001|Overall Study|Withdrawal by Subject|37
6861954|NCT00418379|10871336|FG001|Year 5|Adverse Event|1
6861955|NCT00418379|10871337|FG002|Year 5|Adverse Event|0
6861956|NCT00418379|10871335|FG000|Year 5|Any other reason not above-mentioned|2
6861957|NCT00418379|10871336|FG001|Year 5|Any other reason not above-mentioned|4
6861958|NCT00418379|10871337|FG002|Year 5|Any other reason not above-mentioned|3
6861959|NCT00418522|10871356|FG000|Overall Study|Adverse Event|7
6861960|NCT00418522|10871357|FG001|Overall Study|Adverse Event|1
6861961|NCT00418522|10871356|FG000|Overall Study|Lack of Efficacy|1
6861962|NCT00418522|10871357|FG001|Overall Study|Lack of Efficacy|3
6861963|NCT00418522|10871356|FG000|Overall Study|Lost to Follow-up|10
6861964|NCT00418522|10871357|FG001|Overall Study|Lost to Follow-up|4
6861965|NCT00418522|10871356|FG000|Overall Study|Withdrawal by Subject|31
7078040|NCT02100228|11186295|FG000|Overall Study|Adverse Event|16
7078041|NCT02100228|11186296|FG001|Overall Study|Adverse Event|12
7078042|NCT02100228|11186295|FG000|Overall Study|Death|1
7078043|NCT02100228|11186296|FG001|Overall Study|Death|1
6861966|NCT00418522|10871357|FG001|Overall Study|Withdrawal by Subject|7
6861967|NCT00418522|10871356|FG000|Overall Study|Other|27
6861968|NCT00418522|10871357|FG001|Overall Study|Other|23
6861969|NCT00418522|10871356|FG000|Overall Study|Randomized but did not receive treatment|7
6861970|NCT00418522|10871357|FG001|Overall Study|Randomized but did not receive treatment|4
6861971|NCT00418561|10871366|FG000|Overall Study|Participant's (guardian's) decision|0
6861972|NCT00418561|10871367|FG001|Overall Study|Participant's (guardian's) decision|1
6861973|NCT00418561|10871368|FG002|Overall Study|Participant's (guardian's) decision|0
6861974|NCT00418665|10871388|FG000|Treatment Period|Ineligibility determined|1
6861975|NCT00418665|10871389|FG001|Treatment Period|Ineligibility determined|1
6861976|NCT00418665|10871390|FG002|Treatment Period|Ineligibility determined|0
6861977|NCT00418665|10871388|FG000|Treatment Period|Adverse Event|2
6861978|NCT00418665|10871389|FG001|Treatment Period|Adverse Event|2
6861979|NCT00418665|10871390|FG002|Treatment Period|Adverse Event|0
6861980|NCT00418665|10871388|FG000|Treatment Period|Withdrawal by Subject|0
6861981|NCT00418665|10871389|FG001|Treatment Period|Withdrawal by Subject|3
6861982|NCT00418665|10871390|FG002|Treatment Period|Withdrawal by Subject|1
6861983|NCT00418665|10871388|FG000|Treatment Period|Requirement for alternative therapy|1
6861984|NCT00418665|10871389|FG001|Treatment Period|Requirement for alternative therapy|0
6861985|NCT00418665|10871390|FG002|Treatment Period|Requirement for alternative therapy|0
6861986|NCT00418665|10871388|FG000|Treatment Period|Physician Decision|1
6861987|NCT00418665|10871389|FG001|Treatment Period|Physician Decision|0
6861988|NCT00418665|10871390|FG002|Treatment Period|Physician Decision|3
6861989|NCT00418665|10871388|FG000|Treatment Extension|Adverse Event|1
6861990|NCT00418665|10871389|FG001|Treatment Extension|Adverse Event|0
6861991|NCT00418665|10871390|FG002|Treatment Extension|Adverse Event|0
6861992|NCT00418665|10871388|FG000|Treatment Extension|Withdrawal by Subject|1
6861993|NCT00418665|10871389|FG001|Treatment Extension|Withdrawal by Subject|0
6861994|NCT00418665|10871390|FG002|Treatment Extension|Withdrawal by Subject|0
6861995|NCT00418665|10871388|FG000|Treatment Extension|Requirement for alternative therapy|2
6861996|NCT00418665|10871389|FG001|Treatment Extension|Requirement for alternative therapy|2
6861997|NCT00418665|10871390|FG002|Treatment Extension|Requirement for alternative therapy|0
6861998|NCT00418665|10871388|FG000|Treatment Extension|Physician Decision|2
6861999|NCT00418665|10871389|FG001|Treatment Extension|Physician Decision|2
6862000|NCT00418665|10871390|FG002|Treatment Extension|Physician Decision|1
6862001|NCT00418665|10871388|FG000|Treatment Extension|Death|0
6862002|NCT00418665|10871389|FG001|Treatment Extension|Death|0
6862003|NCT00418665|10871390|FG002|Treatment Extension|Death|1
6862004|NCT00418691|10871401|FG000|Overall Study|Lost to Follow-up|1
6862005|NCT00418691|10871402|FG001|Overall Study|Lost to Follow-up|2
6862006|NCT00418691|10871403|FG002|Overall Study|Lost to Follow-up|3
6862007|NCT00418691|10871401|FG000|Overall Study|Started new medication voiding entry|0
6862008|NCT00418691|10871402|FG001|Overall Study|Started new medication voiding entry|0
6862009|NCT00418691|10871403|FG002|Overall Study|Started new medication voiding entry|1
6862010|NCT00418691|10871401|FG000|Overall Study|Progressive Disease|1
6862011|NCT00418691|10871402|FG001|Overall Study|Progressive Disease|0
6862012|NCT00418691|10871403|FG002|Overall Study|Progressive Disease|1
6862013|NCT00418717|10871411|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1
6862014|NCT00418717|10871411|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2
6862015|NCT00418886|10871417|FG000|Overall Study|discontinue treatment survival follow up|90
6862016|NCT00418886|10871418|FG001|Overall Study|discontinue treatment survival follow up|91
6862017|NCT00418886|10871417|FG000|Overall Study|Death|122
6862018|NCT00418886|10871418|FG001|Overall Study|Death|147
6862019|NCT00418886|10871417|FG000|Overall Study|Withdrawal by Subject|9
6862020|NCT00418886|10871418|FG001|Overall Study|Withdrawal by Subject|10
6862021|NCT00418886|10871417|FG000|Overall Study|Lost to Follow-up|4
6862022|NCT00418886|10871418|FG001|Overall Study|Lost to Follow-up|6
6862023|NCT00418886|10871417|FG000|Overall Study|withdrawn due to other reason|1
6862024|NCT00418886|10871418|FG001|Overall Study|withdrawn due to other reason|0
6862025|NCT00418886|10871417|FG000|Overall Study|randomised but no treatment received|0
6862026|NCT00418886|10871418|FG001|Overall Study|randomised but no treatment received|1
6862027|NCT00418938|10871426|FG000|Overall Study|Reimbursement|1
6862028|NCT00418938|10871427|FG001|Overall Study|Reimbursement|0
6862029|NCT00418938|10871426|FG000|Overall Study|Administrative decision|3
6862030|NCT00418938|10871427|FG001|Overall Study|Administrative decision|3
6862031|NCT00418938|10871426|FG000|Overall Study|Withdrawal by Subject|16
6862032|NCT00418938|10871427|FG001|Overall Study|Withdrawal by Subject|15
6862033|NCT00418938|10871426|FG000|Overall Study|Lost to Follow-up|1
6862034|NCT00418938|10871427|FG001|Overall Study|Lost to Follow-up|3
6862035|NCT00418938|10871426|FG000|Overall Study|Adverse Event|1
6862036|NCT00418938|10871427|FG001|Overall Study|Adverse Event|1
6862037|NCT00418938|10871426|FG000|Overall Study|On-going|1
6862038|NCT00418938|10871427|FG001|Overall Study|On-going|1
6862039|NCT00418938|10871426|FG000|Overall Study|Ineligibility Determined|1
6862040|NCT00418938|10871427|FG001|Overall Study|Ineligibility Determined|0
6862041|NCT00419003|10871470|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6
6862042|NCT00419003|10871471|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6
6862043|NCT00419003|10871470|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1
6862044|NCT00419003|10871471|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0
6862045|NCT00419094|10871482|FG000|Overall Study|Adverse Event|3
6862046|NCT00419094|10871483|FG001|Overall Study|Adverse Event|7
6862047|NCT00419094|10871482|FG000|Overall Study|Lack of Efficacy|1
6862048|NCT00419094|10871483|FG001|Overall Study|Lack of Efficacy|0
6862049|NCT00419094|10871482|FG000|Overall Study|Lost to Follow-up|0
6862050|NCT00419094|10871483|FG001|Overall Study|Lost to Follow-up|2
6862051|NCT00419094|10871482|FG000|Overall Study|Protocol Violation|1
6862052|NCT00419094|10871483|FG001|Overall Study|Protocol Violation|14
6862053|NCT00419094|10871482|FG000|Overall Study|Withdrawal of consent|1
6862054|NCT00419094|10871483|FG001|Overall Study|Withdrawal of consent|5
6862055|NCT00419094|10871482|FG000|Overall Study|Other: Error determining exit criteria|1
6862056|NCT00419094|10871483|FG001|Overall Study|Other: Error determining exit criteria|0
6862057|NCT00419094|10871482|FG000|Overall Study|Other: Patient non-compliant|0
6862058|NCT00419094|10871483|FG001|Overall Study|Other: Patient non-compliant|1
6862059|NCT00419094|10871482|FG000|Overall Study|Other: No contact for extended period|0
6862060|NCT00419094|10871483|FG001|Overall Study|Other: No contact for extended period|1
6862061|NCT00419120|10871489|FG000|Long Term Follow up Period|study ongoing|10
6862062|NCT00419159|10871495|FG000|Overall Study|Adverse Event|7
6862063|NCT00419159|10871496|FG001|Overall Study|Adverse Event|15
6862064|NCT00419159|10871495|FG000|Overall Study|Abnormal laboratory value(s)|0
6862065|NCT00419159|10871496|FG001|Overall Study|Abnormal laboratory value(s)|2
6862066|NCT00419159|10871495|FG000|Overall Study|Subject's no longer requires study drug|0
6862067|NCT00419159|10871496|FG001|Overall Study|Subject's no longer requires study drug|1
6862068|NCT00419159|10871495|FG000|Overall Study|Protocol Violation|1
6862069|NCT00419159|10871496|FG001|Overall Study|Protocol Violation|0
6862070|NCT00419159|10871495|FG000|Overall Study|Withdrawal by Subject|10
6862071|NCT00419159|10871496|FG001|Overall Study|Withdrawal by Subject|3
7041006|NCT01722162|11124295|FG001|Overall Study|Noncompliance|1
7041007|NCT01722266|11124305|FG000|Overall Study|Withdrawal by Subject|1
7041008|NCT01722266|11124306|FG001|Overall Study|Withdrawal by Subject|2
7041009|NCT01722266|11124307|FG002|Overall Study|Withdrawal by Subject|0
7041010|NCT01722266|11124308|FG003|Overall Study|Withdrawal by Subject|0
7041011|NCT01722266|11124305|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0
7041012|NCT01722266|11124306|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1
7041013|NCT01722266|11124307|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3
7041014|NCT01722266|11124308|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0
7041015|NCT01722266|11124305|FG000|Overall Study|Dropped out due to Nausea|0
7041016|NCT01722266|11124306|FG001|Overall Study|Dropped out due to Nausea|0
7041017|NCT01722266|11124307|FG002|Overall Study|Dropped out due to Nausea|2
7041018|NCT01722266|11124308|FG003|Overall Study|Dropped out due to Nausea|0
7041019|NCT01722669|11124417|FG000|Overall Study|Withdrawal by Subject|0
7041020|NCT01722669|11124418|FG001|Overall Study|Withdrawal by Subject|0
7041021|NCT01722669|11124419|FG002|Overall Study|Withdrawal by Subject|0
7041022|NCT01722669|11124420|FG003|Overall Study|Withdrawal by Subject|0
7041023|NCT01722669|11124421|FG004|Overall Study|Withdrawal by Subject|0
7041024|NCT01722669|11124422|FG005|Overall Study|Withdrawal by Subject|2
7041025|NCT01722877|11124455|FG000|Overall Study|Death|1
7041026|NCT01722877|11124455|FG000|Overall Study|Lost to Follow-up|1
7041027|NCT01722994|11124463|FG000|Overall Study|Missing data|25
7041028|NCT01722994|11124464|FG001|Overall Study|Missing data|17
7041029|NCT01723072|11124474|FG000|Overall Study|Withdrawal by Subject|7
7041030|NCT01723072|11124475|FG001|Overall Study|Withdrawal by Subject|13
7041031|NCT01723072|11124474|FG000|Overall Study|Discon for rescue medication after wk 24|0
7041032|NCT01723072|11124475|FG001|Overall Study|Discon for rescue medication after wk 24|5
7041033|NCT01723072|11124474|FG000|Overall Study|Other|4
7041034|NCT01723072|11124475|FG001|Overall Study|Other|3
7041035|NCT01723163|11124483|FG000|Treatment Phase|Withdrawal by Subject|14
7041036|NCT01723163|11124484|FG001|Treatment Phase|Withdrawal by Subject|6
7041037|NCT01723163|11124483|FG000|Treatment Phase|Withdrawal by PI|5
7041038|NCT01723163|11124484|FG001|Treatment Phase|Withdrawal by PI|1
7041039|NCT01723163|11124483|FG000|3-Month Follow-up|Withdrawal by Subject|1
7041040|NCT01723163|11124484|FG001|3-Month Follow-up|Withdrawal by Subject|0
7041041|NCT01723163|11124483|FG000|3-Month Follow-up|Unable to Contact|12
7041042|NCT01723163|11124484|FG001|3-Month Follow-up|Unable to Contact|19
7041043|NCT01723163|11124483|FG000|6-Month Follow-up|Death|1
7041044|NCT01723163|11124484|FG001|6-Month Follow-up|Death|0
7041045|NCT01723163|11124483|FG000|6-Month Follow-up|Unable to Contact|17
7041046|NCT01723163|11124484|FG001|6-Month Follow-up|Unable to Contact|15
7041047|NCT01723163|11124483|FG000|12-Month Follow-up|Death|1
7041048|NCT01723163|11124484|FG001|12-Month Follow-up|Death|0
7041049|NCT01723163|11124483|FG000|12-Month Follow-up|Unable to Contact|23
7041050|NCT01723163|11124484|FG001|12-Month Follow-up|Unable to Contact|28
7041051|NCT01723228|11124492|FG000|Overall Study|Adverse Event|2
7041052|NCT01723228|11124493|FG001|Overall Study|Adverse Event|6
7041053|NCT01723228|11124492|FG000|Overall Study|Withdrawal by Subject|2
7041054|NCT01723228|11124493|FG001|Overall Study|Withdrawal by Subject|1
7041055|NCT01723228|11124492|FG000|Overall Study|Protocol Violation|0
7041056|NCT01723228|11124493|FG001|Overall Study|Protocol Violation|2
7041057|NCT01723228|11124492|FG000|Overall Study|Lost to Follow-up|2
7041058|NCT01723228|11124493|FG001|Overall Study|Lost to Follow-up|1
7041059|NCT01723228|11124492|FG000|Overall Study|Other|2
7041060|NCT01723228|11124493|FG001|Overall Study|Other|1
7041061|NCT01723254|11124507|FG000|Overall Study|Conflict with work schedule|0
7041062|NCT01723254|11124508|FG001|Overall Study|Conflict with work schedule|0
7041063|NCT01723254|11124509|FG002|Overall Study|Conflict with work schedule|0
7041064|NCT01723254|11124510|FG003|Overall Study|Conflict with work schedule|0
7041065|NCT01723254|11124511|FG004|Overall Study|Conflict with work schedule|0
7041066|NCT01723254|11124512|FG005|Overall Study|Conflict with work schedule|0
7041067|NCT01723254|11124513|FG006|Overall Study|Conflict with work schedule|0
7041068|NCT01723254|11124514|FG007|Overall Study|Conflict with work schedule|1
6862072|NCT00419159|10871495|FG000|Overall Study|Lost to Follow-up|0
6862073|NCT00419159|10871496|FG001|Overall Study|Lost to Follow-up|1
6862074|NCT00419159|10871495|FG000|Overall Study|Death|2
6862075|NCT00419159|10871496|FG001|Overall Study|Death|2
6862076|NCT00419159|10871495|FG000|Overall Study|Disease progression|79
6862077|NCT00419159|10871496|FG001|Overall Study|Disease progression|76
6862078|NCT00419263|10871513|FG000|Overall Study|Lost to Follow-up|2
6862079|NCT00419263|10871514|FG001|Overall Study|Lost to Follow-up|1
6862080|NCT00419263|10871515|FG002|Overall Study|Lost to Follow-up|1
6862081|NCT00419263|10871513|FG000|Overall Study|Randomized in Error, Not Treated|1
6862082|NCT00419263|10871514|FG001|Overall Study|Randomized in Error, Not Treated|1
6862083|NCT00419263|10871515|FG002|Overall Study|Randomized in Error, Not Treated|0
6862084|NCT00419263|10871513|FG000|Overall Study|Adverse Event|0
6862085|NCT00419263|10871514|FG001|Overall Study|Adverse Event|0
6862086|NCT00419263|10871515|FG002|Overall Study|Adverse Event|1
6862087|NCT00419263|10871513|FG000|Overall Study|Withdrawal by Subject|0
6862088|NCT00419263|10871514|FG001|Overall Study|Withdrawal by Subject|0
6862089|NCT00419263|10871515|FG002|Overall Study|Withdrawal by Subject|1
7153059|NCT03274076|11318332|FG002|24 Weeks Open Label|Withdrawal by Subject|0
7153060|NCT03274076|11318333|FG003|24 Weeks Open Label|Withdrawal by Subject|1
7153061|NCT03274440|11318352|FG000|Overall Study|Time commitment too great|1
7153062|NCT03274440|11318353|FG001|Overall Study|Time commitment too great|0
7153063|NCT03274440|11318354|FG002|Overall Study|Time commitment too great|0
7153064|NCT03274440|11318355|FG003|Overall Study|Time commitment too great|1
7153065|NCT03274440|11318356|FG004|Overall Study|Time commitment too great|0
7153066|NCT03274440|11318357|FG005|Overall Study|Time commitment too great|0
7153067|NCT03274453|11318369|FG000|Overall Study|Lost to Follow-up|2
7153068|NCT03274453|11318370|FG001|Overall Study|Lost to Follow-up|5
7153069|NCT03274453|11318371|FG002|Overall Study|Lost to Follow-up|4
7153070|NCT03274453|11318372|FG003|Overall Study|Lost to Follow-up|1
7153071|NCT03274453|11318369|FG000|Overall Study|Physician Decision|2
7153072|NCT03274453|11318370|FG001|Overall Study|Physician Decision|0
7153073|NCT03274453|11318371|FG002|Overall Study|Physician Decision|0
7153074|NCT03274453|11318372|FG003|Overall Study|Physician Decision|3
7153075|NCT03274453|11318369|FG000|Overall Study|Surgery Cancelled|0
7153076|NCT03274453|11318370|FG001|Overall Study|Surgery Cancelled|1
7153077|NCT03274453|11318371|FG002|Overall Study|Surgery Cancelled|0
7153078|NCT03274453|11318372|FG003|Overall Study|Surgery Cancelled|0
7153079|NCT03274466|11318384|FG000|Overall Study|Withdrawal by Subject|7
7153080|NCT03274466|11318385|FG001|Overall Study|Withdrawal by Subject|3
7153081|NCT03274466|11318384|FG000|Overall Study|Protocol Specified Withdrawal|5
7153082|NCT03274466|11318385|FG001|Overall Study|Protocol Specified Withdrawal|11
7153083|NCT03274466|11318384|FG000|Overall Study|Lost to Follow-up|5
7153084|NCT03274466|11318385|FG001|Overall Study|Lost to Follow-up|7
7153085|NCT03274466|11318384|FG000|Overall Study|Subject Non-compliance|0
7153086|NCT03274466|11318385|FG001|Overall Study|Subject Non-compliance|1
7153087|NCT03274466|11318384|FG000|Overall Study|Adverse Event|3
7153088|NCT03274466|11318385|FG001|Overall Study|Adverse Event|3
7153089|NCT03274466|11318384|FG000|Overall Study|Physician Decision|0
7153090|NCT03274466|11318385|FG001|Overall Study|Physician Decision|1
7153091|NCT03274466|11318384|FG000|Overall Study|Protocol Violation|3
7153092|NCT03274466|11318385|FG001|Overall Study|Protocol Violation|3
7153093|NCT03274986|11318413|FG000|Overall Study|Withdrawal by Subject|0
7153094|NCT03274986|11318414|FG001|Overall Study|Withdrawal by Subject|1
7153095|NCT03274986|11318413|FG000|Overall Study|Lost to Follow-up|0
7153096|NCT03274986|11318414|FG001|Overall Study|Lost to Follow-up|1
7153097|NCT03275246|11318434|FG000|Overall Study|Protocol Violation|5
7153098|NCT03275246|11318434|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1
7153099|NCT03275389|11318448|FG000|Overall Study|Lost to Follow-up|10
7153100|NCT03275389|11318449|FG001|Overall Study|Lost to Follow-up|10
7153101|NCT03275389|11318450|FG002|Overall Study|Lost to Follow-up|19
7153102|NCT03275389|11318451|FG003|Overall Study|Lost to Follow-up|12
7153103|NCT03275389|11318452|FG004|Overall Study|Lost to Follow-up|11
7153104|NCT03275389|11318453|FG005|Overall Study|Lost to Follow-up|12
7153105|NCT03275389|11318454|FG006|Overall Study|Lost to Follow-up|21
7153106|NCT03275389|11318455|FG007|Overall Study|Lost to Follow-up|15
7153107|NCT03275389|11318456|FG008|Overall Study|Lost to Follow-up|12
7153108|NCT03275389|11318457|FG009|Overall Study|Lost to Follow-up|14
7153109|NCT03275389|11318448|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
7153110|NCT03275389|11318449|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
7153111|NCT03275389|11318450|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
7153112|NCT03275389|11318451|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
7153113|NCT03275389|11318452|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
6862090|NCT00419341|10871533|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8
7041069|NCT01723254|11124507|FG000|Overall Study|Personal issues|0
7041070|NCT01723254|11124508|FG001|Overall Study|Personal issues|0
7041071|NCT01723254|11124509|FG002|Overall Study|Personal issues|0
6862091|NCT00419341|10871533|FG000|Wash in/Wash Out Period|Adverse Event|2
6862092|NCT00419341|10871533|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1
6862093|NCT00419341|10871533|FG000|Efficacy Period|Withdrawal by Subject|6
6862094|NCT00419341|10871533|FG000|Efficacy Period|Protocol Violation|1
6862095|NCT00419341|10871533|FG000|Efficacy Period|Lost to Follow-up|1
6862096|NCT00419341|10871533|FG000|Efficacy Period|Non-compliance|1
6862097|NCT00419341|10871533|FG000|Efficacy Period|Termination of study site|1
6862098|NCT00419380|10871541|FG000|Overall Study|Lack of Efficacy|1
6862099|NCT00419380|10871542|FG001|Overall Study|Lack of Efficacy|7
6862100|NCT00419380|10871541|FG000|Overall Study|Physician Decision|0
6862101|NCT00419380|10871542|FG001|Overall Study|Physician Decision|1
6862102|NCT00419380|10871541|FG000|Overall Study|Lost to Follow-up|0
6862103|NCT00419380|10871542|FG001|Overall Study|Lost to Follow-up|1
6862104|NCT00419380|10871541|FG000|Overall Study|Withdrawal by Subject|0
6862105|NCT00419380|10871542|FG001|Overall Study|Withdrawal by Subject|1
6862106|NCT00419393|10871548|FG000|Overall Study|Adverse Event|5
6862107|NCT00419393|10871548|FG000|Overall Study|Protocol Violation|5
6862108|NCT00419393|10871548|FG000|Overall Study|Withdrawal by Subject|7
6862109|NCT00419393|10871548|FG000|Overall Study|Other: Sponsor request|3
6862110|NCT00419393|10871548|FG000|Overall Study|Other: Subject had temporal lobectomy|1
6862111|NCT00419393|10871548|FG000|Overall Study|Other: Site closure|1
6862112|NCT00419393|10871548|FG000|Overall Study|Other: Other health problems|1
6862113|NCT00419393|10871548|FG000|Overall Study|Other: Investigator decision|1
6862114|NCT00419562|10871567|FG000|Overall Study|Lost to Follow-up|12
6862115|NCT00419562|10871568|FG001|Overall Study|Lost to Follow-up|13
6862116|NCT00419562|10871567|FG000|Overall Study|Withdrawal by Subject|20
6862117|NCT00419562|10871568|FG001|Overall Study|Withdrawal by Subject|18
6862118|NCT00419562|10871567|FG000|Overall Study|Participant Institutionalized|1
6862119|NCT00419562|10871568|FG001|Overall Study|Participant Institutionalized|0
6862120|NCT00419744|10871581|FG000|Overall Study|Adverse Event|39
6862121|NCT00419744|10871582|FG001|Overall Study|Adverse Event|40
6862122|NCT00419744|10871583|FG002|Overall Study|Adverse Event|50
6862123|NCT00419744|10871581|FG000|Overall Study|Withdrawal by Subject|45
6862124|NCT00419744|10871582|FG001|Overall Study|Withdrawal by Subject|49
6862125|NCT00419744|10871583|FG002|Overall Study|Withdrawal by Subject|52
7078044|NCT02100319|11186313|FG000|Overall Study|Case Report Forms Uncollected|11
7078045|NCT02100319|11186313|FG000|Overall Study|Protocol Deviation|5
7078046|NCT02100475|11186336|FG000|Overall Study|Unclassified|1
7078047|NCT02100475|11186337|FG001|Overall Study|Unclassified|2
7078048|NCT02100475|11186336|FG000|Overall Study|Withdrawal criteria|1
7078049|NCT02100475|11186337|FG001|Overall Study|Withdrawal criteria|0
7082906|NCT02147158|11193686|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2
7082907|NCT02147158|11193687|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
7082908|NCT02147158|11193688|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3
7082909|NCT02147158|11193689|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2
7082910|NCT02147158|11193690|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
7082911|NCT02147158|11193691|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
7082912|NCT02147158|11193686|FG000|Treatment Course 2|Adverse Event|0
7082913|NCT02147158|11193687|FG001|Treatment Course 2|Adverse Event|4
7082914|NCT02147158|11193688|FG002|Treatment Course 2|Adverse Event|2
7082915|NCT02147158|11193689|FG003|Treatment Course 2|Adverse Event|1
7082916|NCT02147158|11193690|FG004|Treatment Course 2|Adverse Event|0
7082917|NCT02147158|11193691|FG005|Treatment Course 2|Adverse Event|1
7082918|NCT02147158|11193686|FG000|Treatment Course 2|Withdrawal of Consent|0
7082919|NCT02147158|11193687|FG001|Treatment Course 2|Withdrawal of Consent|1
7082920|NCT02147158|11193688|FG002|Treatment Course 2|Withdrawal of Consent|2
7082921|NCT02147158|11193689|FG003|Treatment Course 2|Withdrawal of Consent|3
7082922|NCT02147158|11193690|FG004|Treatment Course 2|Withdrawal of Consent|0
7082923|NCT02147158|11193691|FG005|Treatment Course 2|Withdrawal of Consent|0
7082924|NCT02147158|11193686|FG000|Treatment Course 2|Lost to Follow-up|1
7082925|NCT02147158|11193687|FG001|Treatment Course 2|Lost to Follow-up|0
7082926|NCT02147158|11193688|FG002|Treatment Course 2|Lost to Follow-up|1
7082927|NCT02147158|11193689|FG003|Treatment Course 2|Lost to Follow-up|1
7082928|NCT02147158|11193690|FG004|Treatment Course 2|Lost to Follow-up|0
7082929|NCT02147158|11193691|FG005|Treatment Course 2|Lost to Follow-up|1
7082930|NCT02147158|11193686|FG000|Off-Treatment Interval 2|Lack of Efficacy|0
7082931|NCT02147158|11193687|FG001|Off-Treatment Interval 2|Lack of Efficacy|1
7082932|NCT02147158|11193688|FG002|Off-Treatment Interval 2|Lack of Efficacy|1
7082933|NCT02147158|11193689|FG003|Off-Treatment Interval 2|Lack of Efficacy|0
7082934|NCT02147158|11193690|FG004|Off-Treatment Interval 2|Lack of Efficacy|0
7082935|NCT02147158|11193691|FG005|Off-Treatment Interval 2|Lack of Efficacy|0
7082936|NCT02147158|11193686|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4
7082937|NCT02147158|11193687|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0
7082938|NCT02147158|11193688|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5
7082939|NCT02147158|11193689|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4
6862126|NCT00419744|10871581|FG000|Overall Study|Lost to Follow-up|8
6862127|NCT00419744|10871582|FG001|Overall Study|Lost to Follow-up|10
7082940|NCT02147158|11193690|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0
7082941|NCT02147158|11193691|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1
6862128|NCT00419744|10871583|FG002|Overall Study|Lost to Follow-up|6
6862129|NCT00419744|10871581|FG000|Overall Study|Protocol Violation|4
6862130|NCT00419744|10871582|FG001|Overall Study|Protocol Violation|7
6862131|NCT00419744|10871583|FG002|Overall Study|Protocol Violation|8
6862132|NCT00419744|10871581|FG000|Overall Study|Randomized in error|9
6862133|NCT00419744|10871582|FG001|Overall Study|Randomized in error|6
6862134|NCT00419744|10871583|FG002|Overall Study|Randomized in error|7
6862135|NCT00419744|10871581|FG000|Overall Study|Moving out of state|2
6862136|NCT00419744|10871582|FG001|Overall Study|Moving out of state|0
6862137|NCT00419744|10871583|FG002|Overall Study|Moving out of state|1
6862138|NCT00419744|10871581|FG000|Overall Study|Physician Decision|10
6862139|NCT00419744|10871582|FG001|Overall Study|Physician Decision|5
6862140|NCT00419744|10871583|FG002|Overall Study|Physician Decision|6
6862141|NCT00419744|10871581|FG000|Overall Study|Spirometry mouthpiece issues|0
6862142|NCT00419744|10871582|FG001|Overall Study|Spirometry mouthpiece issues|1
6862143|NCT00419744|10871583|FG002|Overall Study|Spirometry mouthpiece issues|2
6862144|NCT00419744|10871581|FG000|Overall Study|Incorrect medication kit dispensed|0
6862145|NCT00419744|10871582|FG001|Overall Study|Incorrect medication kit dispensed|0
6862146|NCT00419744|10871583|FG002|Overall Study|Incorrect medication kit dispensed|1
6862147|NCT00419757|10871593|FG000|Overall Study|Adverse Event|1
6862148|NCT00419757|10871594|FG001|Overall Study|Adverse Event|4
6862149|NCT00419757|10871593|FG000|Overall Study|Lost to Follow-up|1
6862150|NCT00419757|10871594|FG001|Overall Study|Lost to Follow-up|4
6862151|NCT00419757|10871593|FG000|Overall Study|Withdrawal by Subject|7
6862152|NCT00419757|10871594|FG001|Overall Study|Withdrawal by Subject|1
6862153|NCT00419757|10871593|FG000|Overall Study|Protocol Violation|2
6862154|NCT00419757|10871594|FG001|Overall Study|Protocol Violation|3
6862155|NCT00419757|10871593|FG000|Overall Study|Study specific discontinuation criteria|4
6862156|NCT00419757|10871594|FG001|Overall Study|Study specific discontinuation criteria|8
6862157|NCT00419757|10871593|FG000|Overall Study|Multiple reasons|3
6862158|NCT00419757|10871594|FG001|Overall Study|Multiple reasons|1
6862159|NCT00419770|10871604|FG000|Overall Study|Withdrawal by Subject|5
6862160|NCT00419770|10871605|FG001|Overall Study|Withdrawal by Subject|1
6862161|NCT00419926|10871613|FG000|Overall Study|Withdrawal by Subject|7
6862162|NCT00419926|10871614|FG001|Overall Study|Withdrawal by Subject|3
6862163|NCT00419926|10871613|FG000|Overall Study|Administrative Problem|4
6862164|NCT00419926|10871614|FG001|Overall Study|Administrative Problem|4
6862165|NCT00419926|10871613|FG000|Overall Study|Lost to Follow-up|1
6862166|NCT00419926|10871614|FG001|Overall Study|Lost to Follow-up|2
6862167|NCT00419926|10871613|FG000|Overall Study|Death|2
6862168|NCT00419926|10871614|FG001|Overall Study|Death|1
6862169|NCT00419952|10871622|FG000|Overall Study|Adverse Event|8
6862170|NCT00419952|10871623|FG001|Overall Study|Adverse Event|10
6862171|NCT00419952|10871622|FG000|Overall Study|Withdrawal by Subject|44
6862172|NCT00419952|10871623|FG001|Overall Study|Withdrawal by Subject|43
6862173|NCT00419952|10871622|FG000|Overall Study|Lost to Follow-up|43
6862174|NCT00419952|10871623|FG001|Overall Study|Lost to Follow-up|34
6862175|NCT00419952|10871622|FG000|Overall Study|Protocol Violation|32
6967842|NCT01134055|11016303|FG004|Overall Study|Lost to Follow-up|0
7078050|NCT02100514|11186345|FG000|Treatment Period|Adverse Event|0
7078051|NCT02100514|11186346|FG001|Treatment Period|Adverse Event|5
7078052|NCT02100514|11186347|FG002|Treatment Period|Adverse Event|0
7078053|NCT02100514|11186348|FG003|Treatment Period|Adverse Event|0
7078054|NCT02100514|11186349|FG004|Treatment Period|Adverse Event|0
7078055|NCT02100514|11186345|FG000|Treatment Period|Death|2
7078056|NCT02100514|11186346|FG001|Treatment Period|Death|2
7153114|NCT03275389|11318453|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1
7153115|NCT03275389|11318454|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
7153116|NCT03275389|11318455|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
7153117|NCT03275389|11318456|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
7153118|NCT03275389|11318457|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1
7153119|NCT03275389|11318448|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1
7153120|NCT03275389|11318449|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
7153121|NCT03275389|11318450|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
7153122|NCT03275389|11318451|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5
7153123|NCT03275389|11318452|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3
7153124|NCT03275389|11318453|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3
7153125|NCT03275389|11318454|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3
6862176|NCT00419952|10871623|FG001|Overall Study|Protocol Violation|24
7078057|NCT02100514|11186347|FG002|Treatment Period|Death|0
7078058|NCT02100514|11186348|FG003|Treatment Period|Death|0
7078059|NCT02100514|11186349|FG004|Treatment Period|Death|0
7078060|NCT02100514|11186345|FG000|Treatment Period|Lost to Follow-up|5
6862177|NCT00419952|10871622|FG000|Overall Study|Pregnancy|4
6967843|NCT01134055|11016304|FG005|Overall Study|Lost to Follow-up|0
6862178|NCT00419952|10871623|FG001|Overall Study|Pregnancy|2
7078061|NCT02100514|11186346|FG001|Treatment Period|Lost to Follow-up|17
6862179|NCT00419952|10871622|FG000|Overall Study|Physician Decision|1
6862180|NCT00419952|10871623|FG001|Overall Study|Physician Decision|3
6862181|NCT00419952|10871622|FG000|Overall Study|Incorrectly enrolled|10
6862182|NCT00419952|10871623|FG001|Overall Study|Incorrectly enrolled|3
6862183|NCT00419952|10871622|FG000|Overall Study|Intake of prohibited medication|2
6862184|NCT00419952|10871623|FG001|Overall Study|Intake of prohibited medication|2
6862185|NCT00419952|10871622|FG000|Overall Study|Occurence of 2 or more exacerbations|2
6862186|NCT00419952|10871623|FG001|Overall Study|Occurence of 2 or more exacerbations|0
6862187|NCT00419952|10871622|FG000|Overall Study|Diary or medication non-compliance|2
6862188|NCT00419952|10871623|FG001|Overall Study|Diary or medication non-compliance|4
6862189|NCT00419952|10871622|FG000|Overall Study|Abnormal ECG|1
6862190|NCT00419952|10871623|FG001|Overall Study|Abnormal ECG|0
6862191|NCT00420004|10871632|FG000|Overall Study|Adverse Event|4
6862192|NCT00420004|10871633|FG001|Overall Study|Adverse Event|1
6862193|NCT00420004|10871634|FG002|Overall Study|Adverse Event|1
6862194|NCT00420004|10871632|FG000|Overall Study|Lack of Efficacy|5
6862195|NCT00420004|10871633|FG001|Overall Study|Lack of Efficacy|4
6862196|NCT00420004|10871634|FG002|Overall Study|Lack of Efficacy|1
6862197|NCT00420004|10871632|FG000|Overall Study|Lost to Follow-up|31
6862198|NCT00420004|10871633|FG001|Overall Study|Lost to Follow-up|12
6862199|NCT00420004|10871634|FG002|Overall Study|Lost to Follow-up|10
6862200|NCT00420004|10871632|FG000|Overall Study|Entry Criteria Not Met|0
6862201|NCT00420004|10871633|FG001|Overall Study|Entry Criteria Not Met|1
6862202|NCT00420004|10871634|FG002|Overall Study|Entry Criteria Not Met|0
6862203|NCT00420004|10871632|FG000|Overall Study|Physician Decision|14
6862204|NCT00420004|10871633|FG001|Overall Study|Physician Decision|4
6862205|NCT00420004|10871634|FG002|Overall Study|Physician Decision|2
6862206|NCT00420004|10871632|FG000|Overall Study|Protocol Violation|5
6862207|NCT00420004|10871633|FG001|Overall Study|Protocol Violation|4
6862208|NCT00420004|10871634|FG002|Overall Study|Protocol Violation|3
6862209|NCT00420004|10871632|FG000|Overall Study|Withdrawal by Subject|67
6862210|NCT00420004|10871633|FG001|Overall Study|Withdrawal by Subject|42
6862211|NCT00420004|10871634|FG002|Overall Study|Withdrawal by Subject|14
6862212|NCT00420004|10871632|FG000|Overall Study|Sponsor Decision|3
6862213|NCT00420004|10871633|FG001|Overall Study|Sponsor Decision|3
6862214|NCT00420004|10871634|FG002|Overall Study|Sponsor Decision|1
6862215|NCT00420056|10871655|FG000|Overall Study|Objective progression or relapse|17
6862216|NCT00420095|10871661|FG000|Overall Study|Adverse Event|1
6862217|NCT00420095|10871662|FG001|Overall Study|Adverse Event|0
6862218|NCT00420095|10871661|FG000|Overall Study|Protocol Violation|1
6862219|NCT00420095|10871662|FG001|Overall Study|Protocol Violation|1
6862220|NCT00420095|10871661|FG000|Overall Study|Lost to Follow-up|1
6862221|NCT00420095|10871662|FG001|Overall Study|Lost to Follow-up|0
6862222|NCT00420199|10871679|FG000|Overall Study|Participant no longer met study criteria|1
6862223|NCT00420199|10871680|FG001|Overall Study|Participant no longer met study criteria|0
6862224|NCT00420212|10871694|FG000|Overall Study|Adverse Event|22
6862225|NCT00420212|10871695|FG001|Overall Study|Adverse Event|40
6862226|NCT00420212|10871696|FG002|Overall Study|Adverse Event|36
6862227|NCT00420212|10871694|FG000|Overall Study|Lost to Follow-up|9
6862228|NCT00420212|10871695|FG001|Overall Study|Lost to Follow-up|11
6862229|NCT00420212|10871696|FG002|Overall Study|Lost to Follow-up|11
6862230|NCT00420212|10871694|FG000|Overall Study|Withdrawal by Subject|31
6862231|NCT00420212|10871695|FG001|Overall Study|Withdrawal by Subject|22
7041072|NCT01723254|11124510|FG003|Overall Study|Personal issues|0
7041073|NCT01723254|11124511|FG004|Overall Study|Personal issues|0
7041074|NCT01723254|11124512|FG005|Overall Study|Personal issues|1
7041075|NCT01723254|11124513|FG006|Overall Study|Personal issues|0
7041076|NCT01723254|11124514|FG007|Overall Study|Personal issues|0
7041077|NCT01723254|11124507|FG000|Overall Study|No longer have time to participate|0
6862232|NCT00420212|10871696|FG002|Overall Study|Withdrawal by Subject|19
6862233|NCT00420212|10871694|FG000|Overall Study|Physician Decision|4
6862234|NCT00420212|10871695|FG001|Overall Study|Physician Decision|4
6862235|NCT00420212|10871696|FG002|Overall Study|Physician Decision|3
6862236|NCT00420212|10871694|FG000|Overall Study|Protocol Violation|4
6862237|NCT00420212|10871695|FG001|Overall Study|Protocol Violation|4
6862238|NCT00420212|10871696|FG002|Overall Study|Protocol Violation|8
6862239|NCT00420212|10871694|FG000|Overall Study|Death|0
6862240|NCT00420212|10871695|FG001|Overall Study|Death|0
6862241|NCT00420212|10871696|FG002|Overall Study|Death|1
6862242|NCT00420212|10871694|FG000|Overall Study|Other-Unspecified|21
6862243|NCT00420212|10871695|FG001|Overall Study|Other-Unspecified|14
7041078|NCT01723254|11124508|FG001|Overall Study|No longer have time to participate|0
7041079|NCT01723254|11124509|FG002|Overall Study|No longer have time to participate|0
7041080|NCT01723254|11124510|FG003|Overall Study|No longer have time to participate|1
7041081|NCT01723254|11124511|FG004|Overall Study|No longer have time to participate|0
7041082|NCT01723254|11124512|FG005|Overall Study|No longer have time to participate|0
7041083|NCT01723254|11124513|FG006|Overall Study|No longer have time to participate|0
7041084|NCT01723254|11124514|FG007|Overall Study|No longer have time to participate|0
6862244|NCT00420212|10871696|FG002|Overall Study|Other-Unspecified|18
6862245|NCT00420238|10871709|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1
6862246|NCT00420238|10871710|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0
6862247|NCT00420238|10871709|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0
6862248|NCT00420238|10871710|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2
6862249|NCT00420238|10871709|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0
6862250|NCT00420238|10871710|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1
6862251|NCT00420238|10871709|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0
6862252|NCT00420238|10871710|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1
6862253|NCT00420238|10871709|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1
6862254|NCT00420238|10871710|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0
6862255|NCT00420238|10871709|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
6862256|NCT00420238|10871710|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
6862257|NCT00420290|10871724|FG000|Overall Study|Adverse Event|3
6862258|NCT00420290|10871725|FG001|Overall Study|Adverse Event|1
6862259|NCT00420290|10871724|FG000|Overall Study|Withdrawal by Subject|0
6862260|NCT00420290|10871725|FG001|Overall Study|Withdrawal by Subject|2
6862261|NCT00420290|10871724|FG000|Overall Study|did not meet inclusion/exclusion|1
6862262|NCT00420290|10871725|FG001|Overall Study|did not meet inclusion/exclusion|1
6862263|NCT00420303|10871733|FG000|Overall Study|Serious Adverse Event|1
6862264|NCT00420303|10871734|FG001|Overall Study|Serious Adverse Event|0
6862265|NCT00420303|10871733|FG000|Overall Study|Lack of Efficacy|0
6862266|NCT00420303|10871734|FG001|Overall Study|Lack of Efficacy|3
6862267|NCT00420303|10871733|FG000|Overall Study|Physician Decision|0
6862268|NCT00420303|10871734|FG001|Overall Study|Physician Decision|1
6862269|NCT00420316|10871742|FG000|Overall Study|Withdrawal by Subject|0
6862270|NCT00420316|10871743|FG001|Overall Study|Withdrawal by Subject|1
6862271|NCT00420316|10871742|FG000|Overall Study|Lost to Follow-up|12
6862272|NCT00420316|10871743|FG001|Overall Study|Lost to Follow-up|8
6862273|NCT00420342|10871752|FG000|Overall Study|Lost to Follow-up|1
6862274|NCT00420342|10871753|FG001|Overall Study|Lost to Follow-up|0
6862275|NCT00420342|10871754|FG002|Overall Study|Lost to Follow-up|1
6862276|NCT00420342|10871752|FG000|Overall Study|Withdrawal by Subject|0
6862277|NCT00420342|10871753|FG001|Overall Study|Withdrawal by Subject|2
6862278|NCT00420342|10871754|FG002|Overall Study|Withdrawal by Subject|0
6862279|NCT00420381|10871762|FG000|Overall Study|Protocol Violation|1
6862280|NCT00420407|10871768|FG000|Overall Study|Lost to Follow-up|0
6862281|NCT00420407|10871769|FG001|Overall Study|Lost to Follow-up|3
6862282|NCT00420407|10871768|FG000|Overall Study|Physician Decision|2
6862283|NCT00420407|10871769|FG001|Overall Study|Physician Decision|1
6862284|NCT00420407|10871768|FG000|Overall Study|subject identified as detainee|1
6862285|NCT00420407|10871769|FG001|Overall Study|subject identified as detainee|0
6862286|NCT00420407|10871768|FG000|Overall Study|subject identified as Jehovah's witness|1
6862287|NCT00420407|10871769|FG001|Overall Study|subject identified as Jehovah's witness|0
6862288|NCT00420407|10871768|FG000|Overall Study|Withdrawal by Subject|0
6862289|NCT00420407|10871769|FG001|Overall Study|Withdrawal by Subject|2
6862290|NCT00420420|10871778|FG000|Overall Study|Adverse Event|5
6862291|NCT00420420|10871779|FG001|Overall Study|Adverse Event|3
6862292|NCT00420420|10871778|FG000|Overall Study|Protocol Violation|1
6862293|NCT00420420|10871779|FG001|Overall Study|Protocol Violation|1
6862294|NCT00420420|10871778|FG000|Overall Study|Withdrawal by Subject|1
6862295|NCT00420420|10871779|FG001|Overall Study|Withdrawal by Subject|0
6862296|NCT00420420|10871778|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1
6862297|NCT00420420|10871779|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0
6862298|NCT00420511|10871793|FG000|Overall Study|Adverse Event|1
6862299|NCT00420511|10871794|FG001|Overall Study|Adverse Event|1
6862300|NCT00420511|10871793|FG000|Overall Study|Lost to Follow-up|1
6862301|NCT00420511|10871794|FG001|Overall Study|Lost to Follow-up|0
6862302|NCT00420628|10871804|FG000|Overall Study|Withdrawn by parent or gaurdian|5
6862303|NCT00420628|10871805|FG001|Overall Study|Withdrawn by parent or gaurdian|2
6862304|NCT00420628|10871804|FG000|Overall Study|Lost to Follow-up|3
6862305|NCT00420628|10871805|FG001|Overall Study|Lost to Follow-up|2
6862306|NCT00420628|10871804|FG000|Overall Study|Adverse Event|1
6862307|NCT00420628|10871805|FG001|Overall Study|Adverse Event|0
6862308|NCT00420641|10871814|FG000|Overall Study|Adverse Event|3
6862309|NCT00420641|10871815|FG001|Overall Study|Adverse Event|25
6862310|NCT00420641|10871816|FG002|Overall Study|Adverse Event|10
6862311|NCT00420641|10871814|FG000|Overall Study|Lost to Follow-up|2
6862312|NCT00420641|10871815|FG001|Overall Study|Lost to Follow-up|4
6862313|NCT00420641|10871816|FG002|Overall Study|Lost to Follow-up|2
6862314|NCT00420641|10871814|FG000|Overall Study|Protocol Violation|8
7153126|NCT03275389|11318455|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3
7153127|NCT03275389|11318456|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2
7153128|NCT03275389|11318457|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2
7153129|NCT03275389|11318448|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7153130|NCT03275389|11318449|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2
7153131|NCT03275389|11318450|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7153132|NCT03275389|11318451|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3
7153133|NCT03275389|11318452|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7153134|NCT03275389|11318453|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7153135|NCT03275389|11318454|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
7153136|NCT03275389|11318455|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7153137|NCT03275389|11318456|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7153138|NCT03275389|11318457|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7153139|NCT03275389|11318448|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
7153140|NCT03275389|11318449|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
7153141|NCT03275389|11318450|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1
6862315|NCT00420641|10871815|FG001|Overall Study|Protocol Violation|8
6862316|NCT00420641|10871816|FG002|Overall Study|Protocol Violation|7
6862317|NCT00420641|10871814|FG000|Overall Study|Withdrawal by Subject|15
7153142|NCT03275389|11318451|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
6862318|NCT00420641|10871815|FG001|Overall Study|Withdrawal by Subject|21
6862319|NCT00420641|10871816|FG002|Overall Study|Withdrawal by Subject|14
6862320|NCT00420641|10871814|FG000|Overall Study|Lack of Efficacy|6
6862321|NCT00420641|10871815|FG001|Overall Study|Lack of Efficacy|5
6862322|NCT00420641|10871816|FG002|Overall Study|Lack of Efficacy|4
6862323|NCT00420641|10871814|FG000|Overall Study|Non-compliance|7
6862324|NCT00420641|10871815|FG001|Overall Study|Non-compliance|5
6862325|NCT00420641|10871816|FG002|Overall Study|Non-compliance|4
6862326|NCT00420641|10871814|FG000|Overall Study|Other|4
6862327|NCT00420641|10871815|FG001|Overall Study|Other|4
6862328|NCT00420641|10871816|FG002|Overall Study|Other|3
6862329|NCT00420745|10871826|FG000|Overall Study|Adverse Event|2
6862330|NCT00420745|10871827|FG001|Overall Study|Adverse Event|2
6862331|NCT00420745|10871826|FG000|Overall Study|Lost to Follow-up|10
6862332|NCT00420745|10871827|FG001|Overall Study|Lost to Follow-up|2
6862333|NCT00420745|10871826|FG000|Overall Study|Protocol Violation|1
6862334|NCT00420745|10871827|FG001|Overall Study|Protocol Violation|0
6862335|NCT00420745|10871826|FG000|Overall Study|Physician Decision|1
6862336|NCT00420745|10871827|FG001|Overall Study|Physician Decision|1
6862337|NCT00420745|10871826|FG000|Overall Study|Recurrent pneumonia & bronchitis|0
6862338|NCT00420745|10871827|FG001|Overall Study|Recurrent pneumonia & bronchitis|1
6862339|NCT00420745|10871826|FG000|Overall Study|Age limit exceeded for Dose 2|1
6862340|NCT00420745|10871827|FG001|Overall Study|Age limit exceeded for Dose 2|0
6862341|NCT00420784|10871846|FG000|Overall Study|Adverse Event|11
6862342|NCT00420784|10871847|FG001|Overall Study|Adverse Event|29
6862343|NCT00420784|10871848|FG002|Overall Study|Adverse Event|10
6862344|NCT00420784|10871849|FG003|Overall Study|Adverse Event|5
6862345|NCT00420784|10871846|FG000|Overall Study|Withdrawal by Subject|0
6862346|NCT00420784|10871847|FG001|Overall Study|Withdrawal by Subject|1
6862347|NCT00420784|10871848|FG002|Overall Study|Withdrawal by Subject|0
6862348|NCT00420784|10871849|FG003|Overall Study|Withdrawal by Subject|0
6862349|NCT00420784|10871846|FG000|Overall Study|Lost to Follow-up|0
6862350|NCT00420784|10871847|FG001|Overall Study|Lost to Follow-up|0
6862351|NCT00420784|10871848|FG002|Overall Study|Lost to Follow-up|2
6862352|NCT00420784|10871849|FG003|Overall Study|Lost to Follow-up|1
6862353|NCT00420784|10871846|FG000|Overall Study|Virologic Stopping Rule|17
6862354|NCT00420784|10871847|FG001|Overall Study|Virologic Stopping Rule|26
6862355|NCT00420784|10871848|FG002|Overall Study|Virologic Stopping Rule|41
6862356|NCT00420784|10871849|FG003|Overall Study|Virologic Stopping Rule|67
6862357|NCT00420784|10871846|FG000|Overall Study|Other|1
7078062|NCT02100514|11186347|FG002|Treatment Period|Lost to Follow-up|0
7078063|NCT02100514|11186348|FG003|Treatment Period|Lost to Follow-up|0
7078064|NCT02100514|11186349|FG004|Treatment Period|Lost to Follow-up|0
7078065|NCT02100514|11186345|FG000|Treatment Period|Did Not Meet Entrance Criteria|0
7078066|NCT02100514|11186346|FG001|Treatment Period|Did Not Meet Entrance Criteria|1
7078067|NCT02100514|11186347|FG002|Treatment Period|Did Not Meet Entrance Criteria|0
7078068|NCT02100514|11186348|FG003|Treatment Period|Did Not Meet Entrance Criteria|0
7078069|NCT02100514|11186349|FG004|Treatment Period|Did Not Meet Entrance Criteria|0
7078070|NCT02100514|11186345|FG000|Treatment Period|Protocol Violation|1
7078071|NCT02100514|11186346|FG001|Treatment Period|Protocol Violation|1
7078072|NCT02100514|11186347|FG002|Treatment Period|Protocol Violation|0
7078073|NCT02100514|11186348|FG003|Treatment Period|Protocol Violation|0
7078074|NCT02100514|11186349|FG004|Treatment Period|Protocol Violation|0
7078075|NCT02100514|11186345|FG000|Treatment Period|Withdrawal by Subject|12
7078076|NCT02100514|11186346|FG001|Treatment Period|Withdrawal by Subject|37
7078077|NCT02100514|11186347|FG002|Treatment Period|Withdrawal by Subject|0
7078078|NCT02100514|11186348|FG003|Treatment Period|Withdrawal by Subject|0
7078079|NCT02100514|11186349|FG004|Treatment Period|Withdrawal by Subject|0
7078080|NCT02100514|11186345|FG000|Treatment Period|Other|9
7078081|NCT02100514|11186346|FG001|Treatment Period|Other|11
7078082|NCT02100514|11186347|FG002|Treatment Period|Other|0
7078083|NCT02100514|11186348|FG003|Treatment Period|Other|0
7078084|NCT02100514|11186349|FG004|Treatment Period|Other|0
7078085|NCT02100514|11186345|FG000|Extension Period|Withdrew consent|0
7078086|NCT02100514|11186346|FG001|Extension Period|Withdrew consent|0
7078087|NCT02100514|11186347|FG002|Extension Period|Withdrew consent|2
7078088|NCT02100514|11186348|FG003|Extension Period|Withdrew consent|0
7078089|NCT02100514|11186349|FG004|Extension Period|Withdrew consent|0
7078090|NCT02100631|11186375|FG000|Overall Study|Withdrawal by Subject|1
7078091|NCT02100631|11186376|FG001|Overall Study|Withdrawal by Subject|0
7078092|NCT02100631|11186377|FG002|Overall Study|Withdrawal by Subject|0
7078093|NCT02100631|11186375|FG000|Overall Study|Lost to Follow-up|3
7078094|NCT02100631|11186376|FG001|Overall Study|Lost to Follow-up|4
7078095|NCT02100631|11186377|FG002|Overall Study|Lost to Follow-up|0
7078096|NCT02100631|11186375|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3
6862358|NCT00420784|10871847|FG001|Overall Study|Other|2
6862359|NCT00420784|10871848|FG002|Overall Study|Other|0
6862360|NCT00420784|10871849|FG003|Overall Study|Other|5
6862361|NCT00420849|10871860|FG000|Overall Study|Lack of Efficacy|154
6862362|NCT00420849|10871860|FG000|Overall Study|Adverse Event|107
6862363|NCT00420849|10871860|FG000|Overall Study|Withdrawal by Subject|28
6862364|NCT00420849|10871860|FG000|Overall Study|Death|18
6862365|NCT00420849|10871860|FG000|Overall Study|Other|14
6862366|NCT00420849|10871860|FG000|Overall Study|Transplant|8
6862367|NCT00420849|10871860|FG000|Overall Study|Protocol Violation|1
7082998|NCT02147353|11193745|FG001|Overall Study|unable to make visits|0
6862368|NCT00420849|10871860|FG000|Overall Study|Lost to Follow-up|1
6967844|NCT01134055|11016305|FG006|Overall Study|Lost to Follow-up|0
6967845|NCT01134055|11016299|FG000|Overall Study|Withdrawal by Subject|3
7153143|NCT03275389|11318452|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
7153144|NCT03275389|11318453|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
7153145|NCT03275389|11318454|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
7153146|NCT03275389|11318455|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
7153147|NCT03275389|11318456|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
7153148|NCT03275389|11318457|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1
7153149|NCT03275389|11318448|FG000|Overall Study|Other|0
7153150|NCT03275389|11318449|FG001|Overall Study|Other|4
7153151|NCT03275389|11318450|FG002|Overall Study|Other|3
7153152|NCT03275389|11318451|FG003|Overall Study|Other|2
7153153|NCT03275389|11318452|FG004|Overall Study|Other|2
7153154|NCT03275389|11318453|FG005|Overall Study|Other|2
7153155|NCT03275389|11318454|FG006|Overall Study|Other|0
7153156|NCT03275389|11318455|FG007|Overall Study|Other|0
7153157|NCT03275389|11318456|FG008|Overall Study|Other|1
7153158|NCT03275389|11318457|FG009|Overall Study|Other|0
7153159|NCT03276026|11318511|FG000|Overall Study|Protocol Violation|1
7153160|NCT03276026|11318512|FG001|Overall Study|Protocol Violation|0
7153161|NCT03276078|11318518|FG000|Overall Study|Adverse Event|1
6967846|NCT01134055|11016300|FG001|Overall Study|Withdrawal by Subject|3
6967847|NCT01134055|11016301|FG002|Overall Study|Withdrawal by Subject|1
6967848|NCT01134055|11016302|FG003|Overall Study|Withdrawal by Subject|2
6967849|NCT01134055|11016303|FG004|Overall Study|Withdrawal by Subject|0
6967850|NCT01134055|11016304|FG005|Overall Study|Withdrawal by Subject|0
6967851|NCT01134055|11016305|FG006|Overall Study|Withdrawal by Subject|8
6967852|NCT01134055|11016299|FG000|Overall Study|Protocol Violation|0
6967853|NCT01134055|11016300|FG001|Overall Study|Protocol Violation|0
6967854|NCT01134055|11016301|FG002|Overall Study|Protocol Violation|0
6967855|NCT01134055|11016302|FG003|Overall Study|Protocol Violation|1
6967856|NCT01134055|11016303|FG004|Overall Study|Protocol Violation|1
6967857|NCT01134055|11016304|FG005|Overall Study|Protocol Violation|0
6967858|NCT01134055|11016305|FG006|Overall Study|Protocol Violation|0
6967859|NCT01134055|11016299|FG000|Overall Study|Physician Decision|0
6967860|NCT01134055|11016300|FG001|Overall Study|Physician Decision|0
6967861|NCT01134055|11016301|FG002|Overall Study|Physician Decision|0
7153162|NCT03276975|11318542|FG000|Overall Study|Withdrawal by Subject|1
7153163|NCT03276975|11318543|FG001|Overall Study|Withdrawal by Subject|0
7153164|NCT03277352|11318562|FG000|Overall Study|Study Terminated By Sponsor|2
7153165|NCT03277352|11318562|FG000|Overall Study|Withdrawal by Subject|4
7153166|NCT03277352|11318562|FG000|Overall Study|Death|4
7153167|NCT03277794|11318582|FG000|Overall Study|Lost to Follow-up|2
7153168|NCT03277794|11318583|FG001|Overall Study|Lost to Follow-up|4
7153169|NCT03277794|11318582|FG000|Overall Study|Withdrew due to high acuity|1
7153170|NCT03277794|11318583|FG001|Overall Study|Withdrew due to high acuity|0
7153171|NCT03277846|11318592|FG000|Overall Study|Inpatient stay too brief|12
7153172|NCT03277846|11318593|FG001|Overall Study|Inpatient stay too brief|11
7153173|NCT03278028|11318601|FG000|Overall Study|Lost to Follow-up|1
7153174|NCT03278028|11318602|FG001|Overall Study|Lost to Follow-up|0
7153175|NCT03278028|11318601|FG000|Overall Study|Withdrawal by Subject|3
7153176|NCT03278028|11318602|FG001|Overall Study|Withdrawal by Subject|1
7153177|NCT03278028|11318601|FG000|Overall Study|Pregnancy|0
7153178|NCT03278028|11318602|FG001|Overall Study|Pregnancy|1
7153179|NCT03278106|11318626|FG000|Overall Study|No protocol treatment|1
7153180|NCT03278613|11318641|FG000|Overall Study|Lost to Follow-up|3
7153181|NCT03278613|11318642|FG001|Overall Study|Lost to Follow-up|1
7153182|NCT03280108|11318680|FG000|Overall Study|Lost to Follow-up|2
7153183|NCT03280108|11318681|FG001|Overall Study|Lost to Follow-up|0
7153184|NCT03280121|11318692|FG000|Overall Study|Physician Decision|1
7153185|NCT03280121|11318692|FG000|Overall Study|Lost to Follow-up|1
7153186|NCT03280121|11318692|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4
7153187|NCT03280264|11318696|FG000|Overall Study|Adverse Event|1
7153188|NCT03280264|11318696|FG000|Overall Study|Physician Decision|1
7153189|NCT03280264|11318696|FG000|Overall Study|Withdrawal by Subject|1
7153190|NCT03280381|11318703|FG000|Overall Study|Physician Decision|0
7153191|NCT03280381|11318704|FG001|Overall Study|Physician Decision|2
7153192|NCT03280537|11318713|FG000|Overall Study|Withdrawal by Subject|2
7153193|NCT03280537|11318714|FG001|Overall Study|Withdrawal by Subject|4
7153194|NCT03280550|11318722|FG000|Overall Study|Withdrawal by Subject|2
7153195|NCT03280550|11318723|FG001|Overall Study|Withdrawal by Subject|2
7153196|NCT03280550|11318722|FG000|Overall Study|Physician Decision|0
7153197|NCT03280550|11318723|FG001|Overall Study|Physician Decision|1
7153198|NCT03280615|11318731|FG000|Overall Study|Lost to Follow-up|1
7153199|NCT03280615|11318732|FG001|Overall Study|Lost to Follow-up|2
7153200|NCT03280615|11318731|FG000|Overall Study|Adverse Event|1
6967862|NCT01134055|11016302|FG003|Overall Study|Physician Decision|0
6967863|NCT01134055|11016303|FG004|Overall Study|Physician Decision|0
7153201|NCT03280615|11318732|FG001|Overall Study|Adverse Event|1
7153202|NCT03280615|11318731|FG000|Overall Study|Withdrawal by Subject|2
7153203|NCT03280615|11318732|FG001|Overall Study|Withdrawal by Subject|2
7153204|NCT03281577|11318750|FG000|Overall Study|Adverse Event|0
6862369|NCT00420927|10871874|FG000|Period 1|Adverse Event|19
6862370|NCT00420927|10871875|FG001|Period 1|Adverse Event|15
6862371|NCT00420927|10871876|FG002|Period 1|Adverse Event|0
6862372|NCT00420927|10871877|FG003|Period 1|Adverse Event|0
6862373|NCT00420927|10871878|FG004|Period 1|Adverse Event|0
6862374|NCT00420927|10871879|FG005|Period 1|Adverse Event|0
6862375|NCT00420927|10871880|FG006|Period 1|Adverse Event|0
6862376|NCT00420927|10871874|FG000|Period 1|Withdrawal by Subject|7
6862377|NCT00420927|10871875|FG001|Period 1|Withdrawal by Subject|12
6862378|NCT00420927|10871876|FG002|Period 1|Withdrawal by Subject|0
6862379|NCT00420927|10871877|FG003|Period 1|Withdrawal by Subject|0
6862380|NCT00420927|10871878|FG004|Period 1|Withdrawal by Subject|0
6862381|NCT00420927|10871879|FG005|Period 1|Withdrawal by Subject|0
6862382|NCT00420927|10871880|FG006|Period 1|Withdrawal by Subject|0
6862383|NCT00420927|10871874|FG000|Period 1|Lost to Follow-up|8
6862384|NCT00420927|10871875|FG001|Period 1|Lost to Follow-up|6
6862385|NCT00420927|10871876|FG002|Period 1|Lost to Follow-up|0
6862386|NCT00420927|10871877|FG003|Period 1|Lost to Follow-up|0
6862387|NCT00420927|10871878|FG004|Period 1|Lost to Follow-up|0
6862388|NCT00420927|10871879|FG005|Period 1|Lost to Follow-up|0
6862389|NCT00420927|10871880|FG006|Period 1|Lost to Follow-up|0
6862390|NCT00420927|10871874|FG000|Period 1|Lack of efficacy/Loss of efficacy|1
6862391|NCT00420927|10871875|FG001|Period 1|Lack of efficacy/Loss of efficacy|6
6862392|NCT00420927|10871876|FG002|Period 1|Lack of efficacy/Loss of efficacy|0
6862393|NCT00420927|10871877|FG003|Period 1|Lack of efficacy/Loss of efficacy|0
6862394|NCT00420927|10871878|FG004|Period 1|Lack of efficacy/Loss of efficacy|0
6862395|NCT00420927|10871879|FG005|Period 1|Lack of efficacy/Loss of efficacy|0
6862396|NCT00420927|10871880|FG006|Period 1|Lack of efficacy/Loss of efficacy|0
6862397|NCT00420927|10871874|FG000|Period 1|Death|2
6862398|NCT00420927|10871875|FG001|Period 1|Death|0
6862399|NCT00420927|10871876|FG002|Period 1|Death|0
6862400|NCT00420927|10871877|FG003|Period 1|Death|0
6862401|NCT00420927|10871878|FG004|Period 1|Death|0
6862402|NCT00420927|10871879|FG005|Period 1|Death|0
6862403|NCT00420927|10871880|FG006|Period 1|Death|0
6862404|NCT00420927|10871874|FG000|Period 1|Subject moved/relocated|0
6862405|NCT00420927|10871875|FG001|Period 1|Subject moved/relocated|2
6862406|NCT00420927|10871876|FG002|Period 1|Subject moved/relocated|0
6862407|NCT00420927|10871877|FG003|Period 1|Subject moved/relocated|0
6862408|NCT00420927|10871878|FG004|Period 1|Subject moved/relocated|0
6862409|NCT00420927|10871879|FG005|Period 1|Subject moved/relocated|0
6862410|NCT00420927|10871880|FG006|Period 1|Subject moved/relocated|0
6862411|NCT00420927|10871874|FG000|Period 1|Noncompliant with study drug|1
6862412|NCT00420927|10871875|FG001|Period 1|Noncompliant with study drug|1
6862413|NCT00420927|10871876|FG002|Period 1|Noncompliant with study drug|0
6862414|NCT00420927|10871877|FG003|Period 1|Noncompliant with study drug|0
6862415|NCT00420927|10871878|FG004|Period 1|Noncompliant with study drug|0
6862416|NCT00420927|10871879|FG005|Period 1|Noncompliant with study drug|0
6862417|NCT00420927|10871880|FG006|Period 1|Noncompliant with study drug|0
6862418|NCT00420927|10871874|FG000|Period 1|Randomization error|1
6862419|NCT00420927|10871875|FG001|Period 1|Randomization error|0
6862420|NCT00420927|10871876|FG002|Period 1|Randomization error|0
6862421|NCT00420927|10871877|FG003|Period 1|Randomization error|0
6862422|NCT00420927|10871878|FG004|Period 1|Randomization error|0
6862423|NCT00420927|10871879|FG005|Period 1|Randomization error|0
6862424|NCT00420927|10871880|FG006|Period 1|Randomization error|0
6862425|NCT00420927|10871874|FG000|Period 1|Suspected tuberculosis/positive test|1
6862426|NCT00420927|10871875|FG001|Period 1|Suspected tuberculosis/positive test|1
6862427|NCT00420927|10871876|FG002|Period 1|Suspected tuberculosis/positive test|0
6862428|NCT00420927|10871877|FG003|Period 1|Suspected tuberculosis/positive test|0
7078097|NCT02100631|11186376|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0
6862429|NCT00420927|10871878|FG004|Period 1|Suspected tuberculosis/positive test|0
6862430|NCT00420927|10871879|FG005|Period 1|Suspected tuberculosis/positive test|0
6862431|NCT00420927|10871880|FG006|Period 1|Suspected tuberculosis/positive test|0
6862432|NCT00420927|10871874|FG000|Period 1|Study site closure|0
6862433|NCT00420927|10871875|FG001|Period 1|Study site closure|1
6862434|NCT00420927|10871876|FG002|Period 1|Study site closure|0
6862435|NCT00420927|10871877|FG003|Period 1|Study site closure|0
6862436|NCT00420927|10871878|FG004|Period 1|Study site closure|0
6862437|NCT00420927|10871879|FG005|Period 1|Study site closure|0
6862438|NCT00420927|10871880|FG006|Period 1|Study site closure|0
6862439|NCT00420927|10871874|FG000|Period 1|Subject received new diagnosis|0
6862440|NCT00420927|10871875|FG001|Period 1|Subject received new diagnosis|2
6862441|NCT00420927|10871876|FG002|Period 1|Subject received new diagnosis|0
6862442|NCT00420927|10871877|FG003|Period 1|Subject received new diagnosis|0
6862443|NCT00420927|10871878|FG004|Period 1|Subject received new diagnosis|0
6862444|NCT00420927|10871879|FG005|Period 1|Subject received new diagnosis|0
6862445|NCT00420927|10871880|FG006|Period 1|Subject received new diagnosis|0
6862446|NCT00420927|10871874|FG000|Period 1|Received wrong treatment/incorrect dose|0
6862447|NCT00420927|10871875|FG001|Period 1|Received wrong treatment/incorrect dose|1
6862448|NCT00420927|10871876|FG002|Period 1|Received wrong treatment/incorrect dose|0
6862449|NCT00420927|10871877|FG003|Period 1|Received wrong treatment/incorrect dose|0
6862450|NCT00420927|10871878|FG004|Period 1|Received wrong treatment/incorrect dose|0
6862451|NCT00420927|10871879|FG005|Period 1|Received wrong treatment/incorrect dose|0
6862452|NCT00420927|10871880|FG006|Period 1|Received wrong treatment/incorrect dose|0
6862453|NCT00420927|10871874|FG000|Period 1|Failed to meet entry criteria|8
6862454|NCT00420927|10871875|FG001|Period 1|Failed to meet entry criteria|7
6862455|NCT00420927|10871876|FG002|Period 1|Failed to meet entry criteria|0
6862456|NCT00420927|10871877|FG003|Period 1|Failed to meet entry criteria|0
6862457|NCT00420927|10871878|FG004|Period 1|Failed to meet entry criteria|0
6862458|NCT00420927|10871879|FG005|Period 1|Failed to meet entry criteria|0
6862459|NCT00420927|10871880|FG006|Period 1|Failed to meet entry criteria|0
6862460|NCT00420927|10871874|FG000|Period 1|Took prohibited medication|1
6862461|NCT00420927|10871875|FG001|Period 1|Took prohibited medication|3
6862462|NCT00420927|10871876|FG002|Period 1|Took prohibited medication|0
6862463|NCT00420927|10871877|FG003|Period 1|Took prohibited medication|0
6862464|NCT00420927|10871878|FG004|Period 1|Took prohibited medication|0
6862465|NCT00420927|10871879|FG005|Period 1|Took prohibited medication|0
6862466|NCT00420927|10871880|FG006|Period 1|Took prohibited medication|0
6862467|NCT00420927|10871874|FG000|Period 2|Adverse Event|0
6862468|NCT00420927|10871875|FG001|Period 2|Adverse Event|0
6862469|NCT00420927|10871876|FG002|Period 2|Adverse Event|7
6862470|NCT00420927|10871877|FG003|Period 2|Adverse Event|3
6862471|NCT00420927|10871878|FG004|Period 2|Adverse Event|17
6862472|NCT00420927|10871879|FG005|Period 2|Adverse Event|6
6862473|NCT00420927|10871880|FG006|Period 2|Adverse Event|20
6862474|NCT00420927|10871874|FG000|Period 2|Withdrawal by Subject|0
6862475|NCT00420927|10871875|FG001|Period 2|Withdrawal by Subject|0
6862476|NCT00420927|10871876|FG002|Period 2|Withdrawal by Subject|1
6862477|NCT00420927|10871877|FG003|Period 2|Withdrawal by Subject|3
6862478|NCT00420927|10871878|FG004|Period 2|Withdrawal by Subject|11
6862479|NCT00420927|10871879|FG005|Period 2|Withdrawal by Subject|2
6862480|NCT00420927|10871880|FG006|Period 2|Withdrawal by Subject|12
6862481|NCT00420927|10871874|FG000|Period 2|Lost to Follow-up|0
6862482|NCT00420927|10871875|FG001|Period 2|Lost to Follow-up|0
6862483|NCT00420927|10871876|FG002|Period 2|Lost to Follow-up|2
6862484|NCT00420927|10871877|FG003|Period 2|Lost to Follow-up|2
6862485|NCT00420927|10871878|FG004|Period 2|Lost to Follow-up|6
6862486|NCT00420927|10871879|FG005|Period 2|Lost to Follow-up|3
6862487|NCT00420927|10871880|FG006|Period 2|Lost to Follow-up|9
6862488|NCT00420927|10871874|FG000|Period 2|Lack of efficacy/Loss of efficacy|0
6862489|NCT00420927|10871875|FG001|Period 2|Lack of efficacy/Loss of efficacy|0
6862490|NCT00420927|10871876|FG002|Period 2|Lack of efficacy/Loss of efficacy|2
6862491|NCT00420927|10871877|FG003|Period 2|Lack of efficacy/Loss of efficacy|1
6862492|NCT00420927|10871878|FG004|Period 2|Lack of efficacy/Loss of efficacy|6
6862493|NCT00420927|10871879|FG005|Period 2|Lack of efficacy/Loss of efficacy|2
6862494|NCT00420927|10871880|FG006|Period 2|Lack of efficacy/Loss of efficacy|6
6862495|NCT00420927|10871874|FG000|Period 2|Received wrong treatment/incorrect dose|0
6862496|NCT00420927|10871875|FG001|Period 2|Received wrong treatment/incorrect dose|0
6862497|NCT00420927|10871876|FG002|Period 2|Received wrong treatment/incorrect dose|0
6862498|NCT00420927|10871877|FG003|Period 2|Received wrong treatment/incorrect dose|0
6862499|NCT00420927|10871878|FG004|Period 2|Received wrong treatment/incorrect dose|0
6862500|NCT00420927|10871879|FG005|Period 2|Received wrong treatment/incorrect dose|0
6862501|NCT00420927|10871880|FG006|Period 2|Received wrong treatment/incorrect dose|1
6862502|NCT00420927|10871874|FG000|Period 2|Subject unable to find transportation|0
6862503|NCT00420927|10871875|FG001|Period 2|Subject unable to find transportation|0
6862504|NCT00420927|10871876|FG002|Period 2|Subject unable to find transportation|0
6862505|NCT00420927|10871877|FG003|Period 2|Subject unable to find transportation|0
6862506|NCT00420927|10871878|FG004|Period 2|Subject unable to find transportation|0
6862507|NCT00420927|10871879|FG005|Period 2|Subject unable to find transportation|0
6862508|NCT00420927|10871880|FG006|Period 2|Subject unable to find transportation|1
6862509|NCT00420927|10871874|FG000|Period 2|Physician Decision|0
6862510|NCT00420927|10871875|FG001|Period 2|Physician Decision|0
6862511|NCT00420927|10871876|FG002|Period 2|Physician Decision|0
6862512|NCT00420927|10871877|FG003|Period 2|Physician Decision|0
6862513|NCT00420927|10871878|FG004|Period 2|Physician Decision|1
6862514|NCT00420927|10871879|FG005|Period 2|Physician Decision|1
6862515|NCT00420927|10871880|FG006|Period 2|Physician Decision|0
6862516|NCT00420927|10871874|FG000|Period 2|Sponsor decision|0
6862517|NCT00420927|10871875|FG001|Period 2|Sponsor decision|0
6862518|NCT00420927|10871876|FG002|Period 2|Sponsor decision|1
6862519|NCT00420927|10871877|FG003|Period 2|Sponsor decision|0
6862520|NCT00420927|10871878|FG004|Period 2|Sponsor decision|0
6862521|NCT00420927|10871879|FG005|Period 2|Sponsor decision|0
6862522|NCT00420927|10871880|FG006|Period 2|Sponsor decision|1
7078098|NCT02100631|11186377|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0
7078099|NCT02100644|11186385|FG000|LTG Escalation Phase|Adverse Event|9
7078100|NCT02100644|11186386|FG001|LTG Escalation Phase|Adverse Event|0
7078101|NCT02100644|11186387|FG002|LTG Escalation Phase|Adverse Event|0
6862523|NCT00420927|10871874|FG000|Period 2|Randomization error|0
6862524|NCT00420927|10871875|FG001|Period 2|Randomization error|0
6862525|NCT00420927|10871876|FG002|Period 2|Randomization error|0
6862526|NCT00420927|10871877|FG003|Period 2|Randomization error|0
6862527|NCT00420927|10871878|FG004|Period 2|Randomization error|1
6862528|NCT00420927|10871879|FG005|Period 2|Randomization error|1
6862529|NCT00420927|10871880|FG006|Period 2|Randomization error|0
6862530|NCT00420927|10871874|FG000|Period 2|Noncompliant with study drug|0
6862531|NCT00420927|10871875|FG001|Period 2|Noncompliant with study drug|0
6862532|NCT00420927|10871876|FG002|Period 2|Noncompliant with study drug|0
6862533|NCT00420927|10871877|FG003|Period 2|Noncompliant with study drug|1
6862534|NCT00420927|10871878|FG004|Period 2|Noncompliant with study drug|0
6862535|NCT00420927|10871879|FG005|Period 2|Noncompliant with study drug|0
6862536|NCT00420927|10871880|FG006|Period 2|Noncompliant with study drug|2
6862537|NCT00420927|10871874|FG000|Period 2|Methotrexate intolerance|0
6862538|NCT00420927|10871875|FG001|Period 2|Methotrexate intolerance|0
6862539|NCT00420927|10871876|FG002|Period 2|Methotrexate intolerance|0
6862540|NCT00420927|10871877|FG003|Period 2|Methotrexate intolerance|0
6862541|NCT00420927|10871878|FG004|Period 2|Methotrexate intolerance|0
6862542|NCT00420927|10871879|FG005|Period 2|Methotrexate intolerance|0
6862543|NCT00420927|10871880|FG006|Period 2|Methotrexate intolerance|1
6862544|NCT00420927|10871874|FG000|Period 2|Took prohibited medication|0
6862545|NCT00420927|10871875|FG001|Period 2|Took prohibited medication|0
6862546|NCT00420927|10871876|FG002|Period 2|Took prohibited medication|0
6862547|NCT00420927|10871877|FG003|Period 2|Took prohibited medication|0
6862548|NCT00420927|10871878|FG004|Period 2|Took prohibited medication|1
6862549|NCT00420927|10871879|FG005|Period 2|Took prohibited medication|0
6862550|NCT00420927|10871880|FG006|Period 2|Took prohibited medication|0
6862551|NCT00421148|10871924|FG000|Overall Study|Lost to Follow-up|0
6862552|NCT00421148|10871925|FG001|Overall Study|Lost to Follow-up|0
6862553|NCT00421148|10871926|FG002|Overall Study|Lost to Follow-up|0
6862554|NCT00421148|10871927|FG003|Overall Study|Lost to Follow-up|0
6862555|NCT00421148|10871928|FG004|Overall Study|Lost to Follow-up|0
6862556|NCT00421148|10871929|FG005|Overall Study|Lost to Follow-up|0
6862557|NCT00421148|10871930|FG006|Overall Study|Lost to Follow-up|0
6862558|NCT00421148|10871931|FG007|Overall Study|Lost to Follow-up|0
6862559|NCT00421148|10871932|FG008|Overall Study|Lost to Follow-up|0
7153205|NCT03281577|11318751|FG001|Overall Study|Adverse Event|0
7153206|NCT03281577|11318752|FG002|Overall Study|Adverse Event|0
7153207|NCT03281577|11318753|FG003|Overall Study|Adverse Event|1
7153208|NCT03281577|11318750|FG000|Overall Study|Withdrawal by Subject|1
7153209|NCT03281577|11318751|FG001|Overall Study|Withdrawal by Subject|0
7153210|NCT03281577|11318752|FG002|Overall Study|Withdrawal by Subject|0
7153211|NCT03281577|11318753|FG003|Overall Study|Withdrawal by Subject|0
7153212|NCT03281668|11318766|FG000|Overall Study|Physician Decision|1
7153213|NCT03281668|11318766|FG000|Overall Study|scheduling conflict, family circumstance|2
7153214|NCT03281668|11318766|FG000|Overall Study|Withdrawal by Subject|4
7153215|NCT03281668|11318766|FG000|Overall Study|Lost to Follow-up|1
7153216|NCT03281876|11318772|FG000|Overall Study|Adverse Event|4
7153217|NCT03281876|11318773|FG001|Overall Study|Adverse Event|15
7153218|NCT03281876|11318772|FG000|Overall Study|Lost to Follow-up|1
7153219|NCT03281876|11318773|FG001|Overall Study|Lost to Follow-up|4
7153220|NCT03281876|11318772|FG000|Overall Study|Withdrawal by Subject|11
7153221|NCT03281876|11318773|FG001|Overall Study|Withdrawal by Subject|15
7153222|NCT03281876|11318772|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2
7153223|NCT03281876|11318773|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7153224|NCT03281876|11318772|FG000|Overall Study|OTHER|5
7153225|NCT03281876|11318773|FG001|Overall Study|OTHER|5
7153226|NCT03282227|11318790|FG000|Overall Study|Exposure Goals Achieved|60
7153227|NCT03282227|11318790|FG000|Overall Study|Non-compliance w/ protocol requirements|79
7153228|NCT03282227|11318790|FG000|Overall Study|Adverse Event|15
7153229|NCT03282227|11318790|FG000|Overall Study|Lost to Follow-up|21
7153230|NCT03282227|11318790|FG000|Overall Study|Withdrawal by Subject|20
7153231|NCT03282227|11318790|FG000|Overall Study|Lack of Efficacy|12
7153232|NCT03282227|11318790|FG000|Overall Study|Sponsor decision|3
7153233|NCT03282227|11318790|FG000|Overall Study|Physician Decision|2
7153234|NCT03282227|11318790|FG000|Overall Study|Pregnancy|2
7153235|NCT03282227|11318790|FG000|Overall Study|Other|1
7153236|NCT03282357|11318794|FG000|Overall Study|Lost to Follow-up|3
7153237|NCT03282357|11318794|FG000|Overall Study|Withdrawal by Subject|4
7153238|NCT03282357|11318794|FG000|Overall Study|Adverse Event|1
7153239|NCT03282357|11318794|FG000|Overall Study|Other|9
7153240|NCT03283098|11318824|FG000|Overall Study|Withdrawal by Subject|0
7153241|NCT03283098|11318825|FG001|Overall Study|Withdrawal by Subject|1
7153242|NCT03283319|11318837|FG000|Overall Study|Lost to Follow-up|5
7153243|NCT03283319|11318838|FG001|Overall Study|Lost to Follow-up|4
7153244|NCT03283319|11318839|FG002|Overall Study|Lost to Follow-up|5
7153245|NCT03283319|11318840|FG003|Overall Study|Lost to Follow-up|5
7153246|NCT03283319|11318841|FG004|Overall Study|Lost to Follow-up|4
7153247|NCT03283319|11318842|FG005|Overall Study|Lost to Follow-up|3
7153248|NCT03283319|11318837|FG000|Overall Study|Withdrawal by Subject|2
7153249|NCT03283319|11318838|FG001|Overall Study|Withdrawal by Subject|2
7153250|NCT03283319|11318839|FG002|Overall Study|Withdrawal by Subject|2
7153251|NCT03283319|11318840|FG003|Overall Study|Withdrawal by Subject|1
7153252|NCT03283319|11318841|FG004|Overall Study|Withdrawal by Subject|0
6862560|NCT00421148|10871933|FG009|Overall Study|Lost to Follow-up|0
6862561|NCT00421148|10871934|FG010|Overall Study|Lost to Follow-up|0
6862562|NCT00421148|10871935|FG011|Overall Study|Lost to Follow-up|0
6862563|NCT00421148|10871936|FG012|Overall Study|Lost to Follow-up|0
6862564|NCT00421148|10871937|FG013|Overall Study|Lost to Follow-up|0
6862565|NCT00421148|10871938|FG014|Overall Study|Lost to Follow-up|0
6862566|NCT00421148|10871939|FG015|Overall Study|Lost to Follow-up|0
6862567|NCT00421148|10871940|FG016|Overall Study|Lost to Follow-up|0
7153253|NCT03283319|11318842|FG005|Overall Study|Withdrawal by Subject|1
7153254|NCT03283319|11318837|FG000|Overall Study|BARDA regulatory agency or IRB decision|0
7153255|NCT03283319|11318838|FG001|Overall Study|BARDA regulatory agency or IRB decision|0
7153256|NCT03283319|11318839|FG002|Overall Study|BARDA regulatory agency or IRB decision|0
7153257|NCT03283319|11318840|FG003|Overall Study|BARDA regulatory agency or IRB decision|1
7153258|NCT03283319|11318841|FG004|Overall Study|BARDA regulatory agency or IRB decision|0
7153259|NCT03283319|11318842|FG005|Overall Study|BARDA regulatory agency or IRB decision|0
7153260|NCT03283553|11318867|FG000|Patient Participant Flow|Death|5
7153261|NCT03283553|11318868|FG001|Patient Participant Flow|Death|10
7153262|NCT03283553|11318867|FG000|Patient Participant Flow|Withdrawal by Subject|4
7153263|NCT03283553|11318868|FG001|Patient Participant Flow|Withdrawal by Subject|2
6862568|NCT00421148|10871941|FG017|Overall Study|Lost to Follow-up|1
6862569|NCT00421148|10871942|FG018|Overall Study|Lost to Follow-up|0
6862570|NCT00421148|10871943|FG019|Overall Study|Lost to Follow-up|0
6862571|NCT00421148|10871924|FG000|Overall Study|Withdrawal by Subject|0
6862572|NCT00421148|10871925|FG001|Overall Study|Withdrawal by Subject|0
6862573|NCT00421148|10871926|FG002|Overall Study|Withdrawal by Subject|0
6862574|NCT00421148|10871927|FG003|Overall Study|Withdrawal by Subject|0
6862575|NCT00421148|10871928|FG004|Overall Study|Withdrawal by Subject|0
6862576|NCT00421148|10871929|FG005|Overall Study|Withdrawal by Subject|0
6862577|NCT00421148|10871930|FG006|Overall Study|Withdrawal by Subject|0
6862578|NCT00421148|10871931|FG007|Overall Study|Withdrawal by Subject|0
6862579|NCT00421148|10871932|FG008|Overall Study|Withdrawal by Subject|0
7078102|NCT02100644|11186385|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1
7078103|NCT02100644|11186386|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
7078104|NCT02100644|11186387|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
7078105|NCT02100644|11186385|FG000|LTG Escalation Phase|Withdrawal by Subject|3
7153264|NCT03283553|11318867|FG000|Patient Participant Flow|Lost to Follow-up|1
7153265|NCT03283553|11318868|FG001|Patient Participant Flow|Lost to Follow-up|1
7153266|NCT03283553|11318867|FG000|Care Partner Participant Flow|Withdrawal by Subject|4
7153267|NCT03283553|11318868|FG001|Care Partner Participant Flow|Withdrawal by Subject|3
6862580|NCT00421148|10871933|FG009|Overall Study|Withdrawal by Subject|0
6862581|NCT00421148|10871934|FG010|Overall Study|Withdrawal by Subject|0
6862582|NCT00421148|10871935|FG011|Overall Study|Withdrawal by Subject|0
6862583|NCT00421148|10871936|FG012|Overall Study|Withdrawal by Subject|0
6862584|NCT00421148|10871937|FG013|Overall Study|Withdrawal by Subject|0
6862585|NCT00421148|10871938|FG014|Overall Study|Withdrawal by Subject|0
6862586|NCT00421148|10871939|FG015|Overall Study|Withdrawal by Subject|0
6862587|NCT00421148|10871940|FG016|Overall Study|Withdrawal by Subject|0
6862588|NCT00421148|10871941|FG017|Overall Study|Withdrawal by Subject|1
6862589|NCT00421148|10871942|FG018|Overall Study|Withdrawal by Subject|0
6862590|NCT00421148|10871943|FG019|Overall Study|Withdrawal by Subject|0
6862591|NCT00421148|10871924|FG000|Overall Study|Protocol Violation|0
6862592|NCT00421148|10871925|FG001|Overall Study|Protocol Violation|0
6862593|NCT00421148|10871926|FG002|Overall Study|Protocol Violation|0
6862594|NCT00421148|10871927|FG003|Overall Study|Protocol Violation|0
6862595|NCT00421148|10871928|FG004|Overall Study|Protocol Violation|0
6862596|NCT00421148|10871929|FG005|Overall Study|Protocol Violation|1
6862597|NCT00421148|10871930|FG006|Overall Study|Protocol Violation|0
6862598|NCT00421148|10871931|FG007|Overall Study|Protocol Violation|0
6862599|NCT00421148|10871932|FG008|Overall Study|Protocol Violation|0
6862600|NCT00421148|10871933|FG009|Overall Study|Protocol Violation|0
6862601|NCT00421148|10871934|FG010|Overall Study|Protocol Violation|0
6862602|NCT00421148|10871935|FG011|Overall Study|Protocol Violation|0
7078106|NCT02100644|11186386|FG001|LTG Escalation Phase|Withdrawal by Subject|0
7078107|NCT02100644|11186387|FG002|LTG Escalation Phase|Withdrawal by Subject|0
7078108|NCT02100657|11186394|FG000|Cohort 1: Dose Level 1|Progressive disease|6
7078109|NCT02100657|11186395|FG001|Cohort 1: Dose Level 1|Progressive disease|0
7153268|NCT03283553|11318867|FG000|Care Partner Participant Flow|Lost to Follow-up|1
7078110|NCT02100657|11186396|FG002|Cohort 1: Dose Level 1|Progressive disease|0
7078111|NCT02100657|11186394|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1
7078112|NCT02100657|11186395|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0
7078113|NCT02100657|11186396|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0
7078114|NCT02100657|11186394|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1
7078115|NCT02100657|11186395|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0
7078116|NCT02100657|11186396|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0
7078117|NCT02100657|11186394|FG000|Cohort 2: Dose Level 2|Progressive disease|0
7078118|NCT02100657|11186395|FG001|Cohort 2: Dose Level 2|Progressive disease|2
7078119|NCT02100657|11186396|FG002|Cohort 2: Dose Level 2|Progressive disease|0
7078120|NCT02100657|11186394|FG000|Cohort 2: Dose Level 2|Physician Decision|0
7153269|NCT03283553|11318868|FG001|Care Partner Participant Flow|Lost to Follow-up|1
6862603|NCT00421148|10871936|FG012|Overall Study|Protocol Violation|0
6862604|NCT00421148|10871937|FG013|Overall Study|Protocol Violation|0
6862605|NCT00421148|10871938|FG014|Overall Study|Protocol Violation|0
6862606|NCT00421148|10871939|FG015|Overall Study|Protocol Violation|0
6862607|NCT00421148|10871940|FG016|Overall Study|Protocol Violation|0
6862608|NCT00421148|10871941|FG017|Overall Study|Protocol Violation|0
6862609|NCT00421148|10871942|FG018|Overall Study|Protocol Violation|1
6862610|NCT00421148|10871943|FG019|Overall Study|Protocol Violation|0
6862611|NCT00421174|10871987|FG000|Overall Study|Withdrawal by Subject|0
6862612|NCT00421174|10871988|FG001|Overall Study|Withdrawal by Subject|1
6862613|NCT00421174|10871987|FG000|Overall Study|Ineligible due to infection|2
6862614|NCT00421174|10871988|FG001|Overall Study|Ineligible due to infection|0
6862615|NCT00421304|10871997|FG000|Overall Study|Lost to Follow-up|5
6862616|NCT00421304|10871998|FG001|Overall Study|Lost to Follow-up|2
6862617|NCT00421304|10871999|FG002|Overall Study|Lost to Follow-up|5
6862618|NCT00421304|10871997|FG000|Overall Study|Withdrawal by Subject|2
6862619|NCT00421304|10871998|FG001|Overall Study|Withdrawal by Subject|2
6862620|NCT00421304|10871999|FG002|Overall Study|Withdrawal by Subject|2
6862621|NCT00421304|10871997|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1
6862622|NCT00421304|10871998|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0
6862623|NCT00421304|10871999|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0
6862624|NCT00421304|10871997|FG000|Overall Study|Did not attend Day 360 visit|0
6862625|NCT00421304|10871998|FG001|Overall Study|Did not attend Day 360 visit|0
6862626|NCT00421304|10871999|FG002|Overall Study|Did not attend Day 360 visit|1
6862627|NCT00421343|10872009|FG000|Overall Study|Death|1
6862628|NCT00421343|10872009|FG000|Overall Study|Withdrawal by Subject|2
6862629|NCT00421343|10872009|FG000|Overall Study|Lost to Follow-up|3
6862630|NCT00421408|10872015|FG000|Overall Study|Lost to Follow-up|30
6862631|NCT00421408|10872016|FG001|Overall Study|Lost to Follow-up|20
6862632|NCT00421408|10872015|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12
6862633|NCT00421408|10872016|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25
6862634|NCT00421707|10872033|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1
6862635|NCT00421707|10872034|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5
6862636|NCT00421707|10872033|FG000|Period 1: Treatment Period 1|Adverse Event|7
6862637|NCT00421707|10872034|FG001|Period 1: Treatment Period 1|Adverse Event|2
6862638|NCT00421707|10872033|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2
7153270|NCT03283553|11318867|FG000|Care Partner Participant Flow|Discontinued because patient death|5
7153271|NCT03283553|11318868|FG001|Care Partner Participant Flow|Discontinued because patient death|11
7153272|NCT03283696|11318878|FG000|Overall Study|Physician Decision|5
7153273|NCT03283696|11318879|FG001|Overall Study|Physician Decision|6
7153274|NCT03283696|11318878|FG000|Overall Study|Withdrawal by Subject|2
7153275|NCT03283696|11318879|FG001|Overall Study|Withdrawal by Subject|0
7153276|NCT03284229|11318901|FG000|Overall Study|Lost to Follow-up|3
7153277|NCT03284424|11318937|FG000|Overall Study|Death|56
7153278|NCT03284424|11318938|FG001|Overall Study|Death|13
7153279|NCT03284424|11318937|FG000|Overall Study|Lost to Follow-up|1
7153280|NCT03284424|11318938|FG001|Overall Study|Lost to Follow-up|0
7153281|NCT03284424|11318937|FG000|Overall Study|Physician Decision|1
7153282|NCT03284424|11318938|FG001|Overall Study|Physician Decision|0
7153283|NCT03284424|11318937|FG000|Overall Study|Withdrawal by Subject|3
7153284|NCT03284424|11318938|FG001|Overall Study|Withdrawal by Subject|2
7153285|NCT03284424|11318937|FG000|Overall Study|Ongoing in study|44
7153286|NCT03284424|11318938|FG001|Overall Study|Ongoing in study|39
7153287|NCT03284710|11318947|FG000|Overall Study|Withdrawal by Subject|1
7153288|NCT03284710|11318948|FG001|Overall Study|Withdrawal by Subject|0
7153289|NCT03284710|11318949|FG002|Overall Study|Withdrawal by Subject|1
7153290|NCT03284710|11318950|FG003|Overall Study|Withdrawal by Subject|6
7153291|NCT03284710|11318947|FG000|Overall Study|Lost to Follow-up|3
7153292|NCT03284710|11318948|FG001|Overall Study|Lost to Follow-up|3
7153293|NCT03284710|11318949|FG002|Overall Study|Lost to Follow-up|1
7153294|NCT03284710|11318950|FG003|Overall Study|Lost to Follow-up|0
7153295|NCT03284710|11318947|FG000|Overall Study|Physician Decision|1
7153296|NCT03284710|11318948|FG001|Overall Study|Physician Decision|0
7153297|NCT03284710|11318949|FG002|Overall Study|Physician Decision|0
7153298|NCT03284710|11318950|FG003|Overall Study|Physician Decision|0
7153299|NCT03284710|11318947|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1
7153300|NCT03284710|11318948|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0
7153301|NCT03284710|11318949|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0
7153302|NCT03284710|11318950|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1
7153303|NCT03284710|11318947|FG000|Overall Study|HIV Infection|0
7153304|NCT03284710|11318948|FG001|Overall Study|HIV Infection|2
7153305|NCT03284710|11318949|FG002|Overall Study|HIV Infection|2
7153306|NCT03284710|11318950|FG003|Overall Study|HIV Infection|1
7153307|NCT03285113|11318974|FG000|Overall Study|Unable to implant leads|2
7153308|NCT03285295|11318983|FG000|Alinity s HBsAg|Protocol Violation|11
7153309|NCT03285295|11318984|FG001|Alinity s HBsAg|Protocol Violation|0
7153310|NCT03285295|11318985|FG002|Alinity s HBsAg|Protocol Violation|0
7153311|NCT03285295|11318986|FG003|Alinity s HBsAg|Protocol Violation|0
7153312|NCT03285295|11318987|FG004|Alinity s HBsAg|Protocol Violation|0
6862639|NCT00421707|10872034|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2
6862640|NCT00421707|10872033|FG000|Period 1: Treatment Period 1|Protocol Violation|1
7153313|NCT03285295|11318983|FG000|Alinity s HBsAg|No Result on Comparator Assay|17
7153314|NCT03285295|11318984|FG001|Alinity s HBsAg|No Result on Comparator Assay|0
7153315|NCT03285295|11318985|FG002|Alinity s HBsAg|No Result on Comparator Assay|0
7153316|NCT03285295|11318986|FG003|Alinity s HBsAg|No Result on Comparator Assay|0
7153317|NCT03285295|11318987|FG004|Alinity s HBsAg|No Result on Comparator Assay|0
7153318|NCT03285295|11318983|FG000|Alinity s HBsAg|No Results Generated|74
6862641|NCT00421707|10872034|FG001|Period 1: Treatment Period 1|Protocol Violation|0
6862642|NCT00421707|10872033|FG000|Period 2: Washout|Adverse Event|1
6862643|NCT00421707|10872034|FG001|Period 2: Washout|Adverse Event|1
6862644|NCT00421707|10872033|FG000|Period 2: Washout|Withdrawal by Subject|0
6862645|NCT00421707|10872034|FG001|Period 2: Washout|Withdrawal by Subject|1
6862646|NCT00421707|10872033|FG000|Period 2: Washout|Lost to Follow-up|0
6862647|NCT00421707|10872034|FG001|Period 2: Washout|Lost to Follow-up|1
6862648|NCT00421707|10872033|FG000|Period 2: Washout|Other: Pregnancy|0
6862649|NCT00421707|10872034|FG001|Period 2: Washout|Other: Pregnancy|1
6862650|NCT00421707|10872033|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1
6862651|NCT00421707|10872034|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1
6862652|NCT00421707|10872033|FG000|Period 3:Treatment Period 2|Protocol Violation|1
6862653|NCT00421707|10872034|FG001|Period 3:Treatment Period 2|Protocol Violation|0
6862654|NCT00421707|10872033|FG000|Period 3:Treatment Period 2|Adverse Event|0
6862655|NCT00421707|10872034|FG001|Period 3:Treatment Period 2|Adverse Event|2
6862656|NCT00421733|10872046|FG000|Overall Study|Adverse Event|4
6862657|NCT00421733|10872047|FG001|Overall Study|Adverse Event|9
6862658|NCT00421733|10872048|FG002|Overall Study|Adverse Event|2
6862659|NCT00421733|10872046|FG000|Overall Study|Lost to Follow-up|1
6862660|NCT00421733|10872047|FG001|Overall Study|Lost to Follow-up|2
6862661|NCT00421733|10872048|FG002|Overall Study|Lost to Follow-up|4
6862662|NCT00421733|10872046|FG000|Overall Study|Withdrawal by Subject|1
6862663|NCT00421733|10872047|FG001|Overall Study|Withdrawal by Subject|2
6862664|NCT00421733|10872048|FG002|Overall Study|Withdrawal by Subject|7
6862665|NCT00421733|10872046|FG000|Overall Study|Death|0
6862666|NCT00421733|10872047|FG001|Overall Study|Death|3
6862667|NCT00421733|10872048|FG002|Overall Study|Death|0
6862668|NCT00421733|10872046|FG000|Overall Study|Required dialysis|1
6862669|NCT00421733|10872047|FG001|Overall Study|Required dialysis|0
6862670|NCT00421733|10872048|FG002|Overall Study|Required dialysis|0
6862671|NCT00421733|10872046|FG000|Overall Study|Administrative|2
6862672|NCT00421733|10872047|FG001|Overall Study|Administrative|0
6862673|NCT00421733|10872048|FG002|Overall Study|Administrative|0
6862674|NCT00421733|10872046|FG000|Overall Study|Did not satisfy entry criteria|1
6862675|NCT00421733|10872047|FG001|Overall Study|Did not satisfy entry criteria|3
6862676|NCT00421733|10872048|FG002|Overall Study|Did not satisfy entry criteria|2
6862677|NCT00421733|10872046|FG000|Overall Study|Sponsor request|1
6862678|NCT00421733|10872047|FG001|Overall Study|Sponsor request|0
6862679|NCT00421733|10872048|FG002|Overall Study|Sponsor request|3
6862680|NCT00421733|10872046|FG000|Overall Study|Protocol deviation|4
6862681|NCT00421733|10872047|FG001|Overall Study|Protocol deviation|7
6862682|NCT00421733|10872048|FG002|Overall Study|Protocol deviation|2
6862683|NCT00421889|10872069|FG000|Overall Study|Adverse Event|1
6862684|NCT00421889|10872070|FG001|Overall Study|Adverse Event|0
6862685|NCT00421889|10872071|FG002|Overall Study|Adverse Event|1
6862686|NCT00421889|10872072|FG003|Overall Study|Adverse Event|1
6862687|NCT00421889|10872073|FG004|Overall Study|Adverse Event|1
6862688|NCT00421889|10872074|FG005|Overall Study|Adverse Event|4
6862689|NCT00421889|10872075|FG006|Overall Study|Adverse Event|1
6862690|NCT00421889|10872076|FG007|Overall Study|Adverse Event|0
6862691|NCT00421889|10872077|FG008|Overall Study|Adverse Event|2
6862692|NCT00421889|10872069|FG000|Overall Study|Withdrawal by Subject|1
6862693|NCT00421889|10872070|FG001|Overall Study|Withdrawal by Subject|3
6862694|NCT00421889|10872071|FG002|Overall Study|Withdrawal by Subject|0
6862695|NCT00421889|10872072|FG003|Overall Study|Withdrawal by Subject|0
6862696|NCT00421889|10872073|FG004|Overall Study|Withdrawal by Subject|2
6862697|NCT00421889|10872074|FG005|Overall Study|Withdrawal by Subject|0
6862698|NCT00421889|10872075|FG006|Overall Study|Withdrawal by Subject|0
6862699|NCT00421889|10872076|FG007|Overall Study|Withdrawal by Subject|0
6862700|NCT00421889|10872077|FG008|Overall Study|Withdrawal by Subject|0
6862701|NCT00421889|10872069|FG000|Overall Study|Death|0
6862702|NCT00421889|10872070|FG001|Overall Study|Death|0
6862703|NCT00421889|10872071|FG002|Overall Study|Death|0
6862704|NCT00421889|10872072|FG003|Overall Study|Death|0
6862705|NCT00421889|10872073|FG004|Overall Study|Death|1
6862706|NCT00421889|10872074|FG005|Overall Study|Death|1
6862707|NCT00421889|10872075|FG006|Overall Study|Death|0
6862708|NCT00421889|10872076|FG007|Overall Study|Death|0
6862709|NCT00421889|10872077|FG008|Overall Study|Death|0
6862710|NCT00421889|10872069|FG000|Overall Study|Progressive disease|3
6862711|NCT00421889|10872070|FG001|Overall Study|Progressive disease|2
6862712|NCT00421889|10872071|FG002|Overall Study|Progressive disease|2
6862713|NCT00421889|10872072|FG003|Overall Study|Progressive disease|3
6862714|NCT00421889|10872073|FG004|Overall Study|Progressive disease|2
6862715|NCT00421889|10872074|FG005|Overall Study|Progressive disease|21
6862716|NCT00421889|10872075|FG006|Overall Study|Progressive disease|3
6862717|NCT00421889|10872076|FG007|Overall Study|Progressive disease|1
6862718|NCT00421889|10872077|FG008|Overall Study|Progressive disease|5
6862719|NCT00421889|10872069|FG000|Overall Study|Patient/Investigator request|0
6862720|NCT00421889|10872070|FG001|Overall Study|Patient/Investigator request|0
6862721|NCT00421889|10872071|FG002|Overall Study|Patient/Investigator request|0
6862722|NCT00421889|10872072|FG003|Overall Study|Patient/Investigator request|0
6862723|NCT00421889|10872073|FG004|Overall Study|Patient/Investigator request|0
6862724|NCT00421889|10872074|FG005|Overall Study|Patient/Investigator request|9
6862725|NCT00421889|10872075|FG006|Overall Study|Patient/Investigator request|0
6862726|NCT00421889|10872076|FG007|Overall Study|Patient/Investigator request|1
6862727|NCT00421889|10872077|FG008|Overall Study|Patient/Investigator request|3
6862728|NCT00421889|10872069|FG000|Overall Study|Lost to Follow-up|0
6862729|NCT00421889|10872070|FG001|Overall Study|Lost to Follow-up|0
6862730|NCT00421889|10872071|FG002|Overall Study|Lost to Follow-up|0
6862731|NCT00421889|10872072|FG003|Overall Study|Lost to Follow-up|0
6862732|NCT00421889|10872073|FG004|Overall Study|Lost to Follow-up|0
6862733|NCT00421889|10872074|FG005|Overall Study|Lost to Follow-up|0
6862734|NCT00421889|10872075|FG006|Overall Study|Lost to Follow-up|0
6862735|NCT00421889|10872076|FG007|Overall Study|Lost to Follow-up|0
6862736|NCT00421889|10872077|FG008|Overall Study|Lost to Follow-up|1
6862737|NCT00421928|10872104|FG000|Overall Study|Adverse Event|61
6862738|NCT00421928|10872105|FG001|Overall Study|Adverse Event|140
6862739|NCT00421928|10872106|FG002|Overall Study|Adverse Event|22
6862740|NCT00421928|10872104|FG000|Overall Study|Lost to Follow-up|5
6862741|NCT00421928|10872105|FG001|Overall Study|Lost to Follow-up|0
6862742|NCT00421928|10872106|FG002|Overall Study|Lost to Follow-up|3
6862743|NCT00421928|10872104|FG000|Overall Study|Withdrawal by Subject|50
6862744|NCT00421928|10872105|FG001|Overall Study|Withdrawal by Subject|48
6862745|NCT00421928|10872106|FG002|Overall Study|Withdrawal by Subject|43
6862746|NCT00421928|10872104|FG000|Overall Study|Lack of Efficacy|15
6862747|NCT00421928|10872105|FG001|Overall Study|Lack of Efficacy|7
6862748|NCT00421928|10872106|FG002|Overall Study|Lack of Efficacy|35
6862749|NCT00421928|10872104|FG000|Overall Study|Study drug non-compliant|6
6967864|NCT01134055|11016304|FG005|Overall Study|Physician Decision|0
6967865|NCT01134055|11016305|FG006|Overall Study|Physician Decision|1
6967866|NCT01134107|11016337|FG000|Period 1-First Treatment Intervention|Adverse Event|1
6967867|NCT01134107|11016338|FG001|Period 1-First Treatment Intervention|Adverse Event|0
6967868|NCT01134107|11016337|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
6967869|NCT01134107|11016338|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
6967870|NCT01134107|11016337|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3
6967871|NCT01134107|11016338|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4
6967872|NCT01134107|11016337|FG000|Period 1-First Treatment Intervention|Physician Decision|1
6967873|NCT01134107|11016338|FG001|Period 1-First Treatment Intervention|Physician Decision|0
6967874|NCT01134107|11016337|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2
6967875|NCT01134107|11016338|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0
6967876|NCT01134107|11016337|FG000|Period 2-Second Treatment Intervention|Physician Decision|1
6967877|NCT01134107|11016338|FG001|Period 2-Second Treatment Intervention|Physician Decision|0
6967878|NCT01134107|11016337|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1
6967879|NCT01134107|11016338|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0
6967880|NCT01134263|11016358|FG000|Overall Study|Serious adverse event|2
6967881|NCT01134263|11016359|FG001|Overall Study|Serious adverse event|1
6967882|NCT01134263|11016360|FG002|Overall Study|Serious adverse event|1
6967883|NCT01134263|11016361|FG003|Overall Study|Serious adverse event|1
6967884|NCT01134263|11016362|FG004|Overall Study|Serious adverse event|1
6967885|NCT01134263|11016358|FG000|Overall Study|Other adverse event|1
6967886|NCT01134263|11016359|FG001|Overall Study|Other adverse event|2
6967887|NCT01134263|11016360|FG002|Overall Study|Other adverse event|5
6967888|NCT01134263|11016361|FG003|Overall Study|Other adverse event|3
6967889|NCT01134263|11016362|FG004|Overall Study|Other adverse event|0
6967890|NCT01134263|11016358|FG000|Overall Study|Protocol Violation|8
6967891|NCT01134263|11016359|FG001|Overall Study|Protocol Violation|7
6967892|NCT01134263|11016360|FG002|Overall Study|Protocol Violation|2
6967893|NCT01134263|11016361|FG003|Overall Study|Protocol Violation|4
6967894|NCT01134263|11016362|FG004|Overall Study|Protocol Violation|2
6967895|NCT01134263|11016358|FG000|Overall Study|Lost to Follow-up|4
6967896|NCT01134263|11016359|FG001|Overall Study|Lost to Follow-up|3
6967897|NCT01134263|11016360|FG002|Overall Study|Lost to Follow-up|5
6967898|NCT01134263|11016361|FG003|Overall Study|Lost to Follow-up|3
6967899|NCT01134263|11016362|FG004|Overall Study|Lost to Follow-up|1
7078121|NCT02100657|11186395|FG001|Cohort 2: Dose Level 2|Physician Decision|1
7153319|NCT03285295|11318984|FG001|Alinity s HBsAg|No Results Generated|6
7153320|NCT03285295|11318985|FG002|Alinity s HBsAg|No Results Generated|0
7153321|NCT03285295|11318986|FG003|Alinity s HBsAg|No Results Generated|0
7153322|NCT03285295|11318987|FG004|Alinity s HBsAg|No Results Generated|0
6967900|NCT01134263|11016358|FG000|Overall Study|Withdrawal by Subject|8
6967901|NCT01134263|11016359|FG001|Overall Study|Withdrawal by Subject|6
6967902|NCT01134263|11016360|FG002|Overall Study|Withdrawal by Subject|16
6967903|NCT01134263|11016361|FG003|Overall Study|Withdrawal by Subject|7
6967904|NCT01134263|11016362|FG004|Overall Study|Withdrawal by Subject|5
6967905|NCT01134263|11016358|FG000|Overall Study|Enrolled, but not treated|1
6967906|NCT01134263|11016359|FG001|Overall Study|Enrolled, but not treated|1
6967907|NCT01134263|11016360|FG002|Overall Study|Enrolled, but not treated|0
6967908|NCT01134263|11016361|FG003|Overall Study|Enrolled, but not treated|1
6967909|NCT01134263|11016362|FG004|Overall Study|Enrolled, but not treated|0
6967910|NCT01134315|11016394|FG000|Overall Study|Adverse Event|1
6967911|NCT01134315|11016395|FG001|Overall Study|Adverse Event|2
6862750|NCT00421928|10872105|FG001|Overall Study|Study drug non-compliant|7
6862751|NCT00421928|10872106|FG002|Overall Study|Study drug non-compliant|4
6862752|NCT00421928|10872104|FG000|Overall Study|All other|26
6862753|NCT00421928|10872105|FG001|Overall Study|All other|21
6862754|NCT00421928|10872106|FG002|Overall Study|All other|27
6862755|NCT00421928|10872104|FG000|Overall Study|Death|0
6862756|NCT00421928|10872105|FG001|Overall Study|Death|1
6862757|NCT00421928|10872106|FG002|Overall Study|Death|0
6862758|NCT00421993|10872118|FG000|Overall Study|Withdrawal by Subject|22
6862759|NCT00421993|10872119|FG001|Overall Study|Withdrawal by Subject|23
6862760|NCT00421993|10872120|FG002|Overall Study|Withdrawal by Subject|23
6862761|NCT00421993|10872121|FG003|Overall Study|Withdrawal by Subject|24
6862762|NCT00421993|10872118|FG000|Overall Study|Lost to Follow-up|18
6862763|NCT00421993|10872119|FG001|Overall Study|Lost to Follow-up|19
6862764|NCT00421993|10872120|FG002|Overall Study|Lost to Follow-up|22
6862765|NCT00421993|10872121|FG003|Overall Study|Lost to Follow-up|20
6862766|NCT00421993|10872118|FG000|Overall Study|Adverse Event|11
6862767|NCT00421993|10872119|FG001|Overall Study|Adverse Event|1
6862768|NCT00421993|10872120|FG002|Overall Study|Adverse Event|6
6862769|NCT00421993|10872121|FG003|Overall Study|Adverse Event|4
6862770|NCT00421993|10872118|FG000|Overall Study|Protocol Violation|2
6862771|NCT00421993|10872119|FG001|Overall Study|Protocol Violation|2
6862772|NCT00421993|10872120|FG002|Overall Study|Protocol Violation|0
6862773|NCT00421993|10872121|FG003|Overall Study|Protocol Violation|1
6862774|NCT00421993|10872118|FG000|Overall Study|Lack of Efficacy|0
6862775|NCT00421993|10872119|FG001|Overall Study|Lack of Efficacy|3
6862776|NCT00421993|10872120|FG002|Overall Study|Lack of Efficacy|0
6862777|NCT00421993|10872121|FG003|Overall Study|Lack of Efficacy|5
6862778|NCT00421993|10872118|FG000|Overall Study|Pregnancy|0
6862779|NCT00421993|10872119|FG001|Overall Study|Pregnancy|1
6862780|NCT00421993|10872120|FG002|Overall Study|Pregnancy|1
6862781|NCT00421993|10872121|FG003|Overall Study|Pregnancy|2
6862782|NCT00421993|10872118|FG000|Overall Study|Subject transportation issues|0
6862783|NCT00421993|10872119|FG001|Overall Study|Subject transportation issues|0
6862784|NCT00421993|10872120|FG002|Overall Study|Subject transportation issues|0
6862785|NCT00421993|10872121|FG003|Overall Study|Subject transportation issues|1
6862786|NCT00422058|10872146|FG000|Double-Blind, Week 0-20|Adverse Event|3
6862787|NCT00422058|10872147|FG001|Double-Blind, Week 0-20|Adverse Event|4
6862788|NCT00422058|10872148|FG002|Double-Blind, Week 0-20|Adverse Event|5
6862789|NCT00422058|10872149|FG003|Double-Blind, Week 0-20|Adverse Event|9
6862790|NCT00422058|10872150|FG004|Double-Blind, Week 0-20|Adverse Event|5
6862791|NCT00422058|10872151|FG005|Double-Blind, Week 0-20|Adverse Event|3
6862792|NCT00422058|10872146|FG000|Double-Blind, Week 0-20|Protocol Violation|3
6862793|NCT00422058|10872147|FG001|Double-Blind, Week 0-20|Protocol Violation|2
6862794|NCT00422058|10872148|FG002|Double-Blind, Week 0-20|Protocol Violation|2
6862795|NCT00422058|10872149|FG003|Double-Blind, Week 0-20|Protocol Violation|3
6862796|NCT00422058|10872150|FG004|Double-Blind, Week 0-20|Protocol Violation|2
6862797|NCT00422058|10872151|FG005|Double-Blind, Week 0-20|Protocol Violation|2
6862798|NCT00422058|10872146|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2
6862799|NCT00422058|10872147|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1
6862800|NCT00422058|10872148|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1
6862801|NCT00422058|10872149|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0
6862802|NCT00422058|10872150|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0
6862803|NCT00422058|10872151|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1
6862804|NCT00422058|10872146|FG000|Double-Blind, Week 0-20|Other|11
6862805|NCT00422058|10872147|FG001|Double-Blind, Week 0-20|Other|3
6862806|NCT00422058|10872148|FG002|Double-Blind, Week 0-20|Other|8
6862807|NCT00422058|10872149|FG003|Double-Blind, Week 0-20|Other|8
6862808|NCT00422058|10872150|FG004|Double-Blind, Week 0-20|Other|4
6862809|NCT00422058|10872151|FG005|Double-Blind, Week 0-20|Other|10
6862810|NCT00422058|10872146|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12
6862811|NCT00422058|10872147|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17
6862812|NCT00422058|10872148|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15
6862813|NCT00422058|10872149|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8
7153323|NCT03285295|11318983|FG000|Alinity s HTLV I/II|Protocol Violation|6
7153324|NCT03285295|11318984|FG001|Alinity s HTLV I/II|Protocol Violation|0
7153325|NCT03285295|11318985|FG002|Alinity s HTLV I/II|Protocol Violation|0
7153326|NCT03285295|11318986|FG003|Alinity s HTLV I/II|Protocol Violation|0
7153327|NCT03285295|11318987|FG004|Alinity s HTLV I/II|Protocol Violation|0
7153328|NCT03285295|11318983|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15
7153329|NCT03285295|11318984|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0
7153330|NCT03285295|11318985|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0
7153331|NCT03285295|11318986|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0
7153332|NCT03285295|11318987|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0
7153333|NCT03285295|11318983|FG000|Alinity s HTLV I/II|No Results Generated|70
7153334|NCT03285295|11318984|FG001|Alinity s HTLV I/II|No Results Generated|0
7153335|NCT03285295|11318985|FG002|Alinity s HTLV I/II|No Results Generated|0
6862814|NCT00422058|10872150|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10
6862815|NCT00422058|10872151|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12
7153336|NCT03285295|11318986|FG003|Alinity s HTLV I/II|No Results Generated|0
7153337|NCT03285295|11318987|FG004|Alinity s HTLV I/II|No Results Generated|0
7153338|NCT03285295|11318983|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4
7153339|NCT03285295|11318984|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
6862816|NCT00422058|10872146|FG000|Open-Label Extension, Week 20-104|Adverse Event|3
6862817|NCT00422058|10872147|FG001|Open-Label Extension, Week 20-104|Adverse Event|4
6862818|NCT00422058|10872148|FG002|Open-Label Extension, Week 20-104|Adverse Event|7
6862819|NCT00422058|10872149|FG003|Open-Label Extension, Week 20-104|Adverse Event|4
6862820|NCT00422058|10872150|FG004|Open-Label Extension, Week 20-104|Adverse Event|4
6862821|NCT00422058|10872151|FG005|Open-Label Extension, Week 20-104|Adverse Event|0
6862822|NCT00422058|10872146|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1
6862823|NCT00422058|10872147|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2
6862824|NCT00422058|10872148|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3
6862825|NCT00422058|10872149|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1
6862826|NCT00422058|10872150|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5
6862827|NCT00422058|10872151|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3
7078122|NCT02100657|11186396|FG002|Cohort 2: Dose Level 2|Physician Decision|0
7078123|NCT02100657|11186394|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0
7078124|NCT02100657|11186395|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1
7078125|NCT02100657|11186396|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0
7078126|NCT02100657|11186394|FG000|Cohort 3: Dose Level 3|Progressive disease|0
7078127|NCT02100657|11186395|FG001|Cohort 3: Dose Level 3|Progressive disease|0
6862828|NCT00422058|10872146|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3
6862829|NCT00422058|10872147|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2
6862830|NCT00422058|10872148|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5
6862831|NCT00422058|10872149|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2
6862832|NCT00422058|10872150|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0
6862833|NCT00422058|10872151|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1
6862834|NCT00422058|10872146|FG000|Open-Label Extension, Week 20-104|Other|13
6862835|NCT00422058|10872147|FG001|Open-Label Extension, Week 20-104|Other|14
6862836|NCT00422058|10872148|FG002|Open-Label Extension, Week 20-104|Other|6
6862837|NCT00422058|10872149|FG003|Open-Label Extension, Week 20-104|Other|13
6862838|NCT00422058|10872150|FG004|Open-Label Extension, Week 20-104|Other|16
6862839|NCT00422058|10872151|FG005|Open-Label Extension, Week 20-104|Other|18
6862840|NCT00422084|10872167|FG000|Overall Study|Adverse Event|21
6862841|NCT00422084|10872168|FG001|Overall Study|Adverse Event|7
6862842|NCT00422084|10872167|FG000|Overall Study|Withdrawal by Subject|12
6862843|NCT00422084|10872168|FG001|Overall Study|Withdrawal by Subject|9
6862844|NCT00422084|10872167|FG000|Overall Study|Lost to Follow-up|14
6862845|NCT00422084|10872168|FG001|Overall Study|Lost to Follow-up|9
6862846|NCT00422084|10872167|FG000|Overall Study|Protocol Violation|4
6862847|NCT00422084|10872168|FG001|Overall Study|Protocol Violation|1
6862848|NCT00422084|10872167|FG000|Overall Study|Lack of Efficacy|40
6862849|NCT00422084|10872168|FG001|Overall Study|Lack of Efficacy|42
6862850|NCT00422084|10872167|FG000|Overall Study|P. vivax infection|3
6862851|NCT00422084|10872168|FG001|Overall Study|P. vivax infection|6
6862852|NCT00422084|10872167|FG000|Overall Study|Cyesis|1
6862853|NCT00422084|10872168|FG001|Overall Study|Cyesis|0
6862854|NCT00422084|10872167|FG000|Overall Study|Withdrawn from study accidentally|1
6862855|NCT00422084|10872168|FG001|Overall Study|Withdrawn from study accidentally|0
6862856|NCT00422084|10872167|FG000|Overall Study|Non-compliance|1
6862857|NCT00422084|10872168|FG001|Overall Study|Non-compliance|0
6862858|NCT00422084|10872167|FG000|Overall Study|Re-location|0
6862859|NCT00422084|10872168|FG001|Overall Study|Re-location|1
6862860|NCT00422084|10872167|FG000|Overall Study|Not defined|1
6862861|NCT00422084|10872168|FG001|Overall Study|Not defined|1
6862862|NCT00422097|10872180|FG000|Dose Level 2|Still on treatment|0
6862863|NCT00422097|10872181|FG001|Dose Level 2|Still on treatment|1
6862864|NCT00422097|10872182|FG002|Dose Level 2|Still on treatment|0
6862865|NCT00422097|10872183|FG003|Dose Level 2|Still on treatment|0
6862866|NCT00422097|10872184|FG004|Dose Level 2|Still on treatment|0
6862867|NCT00422097|10872185|FG005|Dose Level 2|Still on treatment|0
6862868|NCT00422097|10872186|FG006|Dose Level 2|Still on treatment|0
6862869|NCT00422097|10872187|FG007|Dose Level 2|Still on treatment|0
6862870|NCT00422162|10872213|FG000|Overall Study|Adverse Event|11
6862871|NCT00422162|10872214|FG001|Overall Study|Adverse Event|9
6862872|NCT00422162|10872213|FG000|Overall Study|Lack of Efficacy|4
6862873|NCT00422162|10872214|FG001|Overall Study|Lack of Efficacy|10
6862874|NCT00422162|10872213|FG000|Overall Study|Withdrawal by Subject|7
6862875|NCT00422162|10872214|FG001|Overall Study|Withdrawal by Subject|6
6862876|NCT00422162|10872213|FG000|Overall Study|Lost to Follow-up|1
6862877|NCT00422162|10872214|FG001|Overall Study|Lost to Follow-up|2
6862878|NCT00422162|10872213|FG000|Overall Study|Non-Compliant with Protocol|1
6862879|NCT00422162|10872214|FG001|Overall Study|Non-Compliant with Protocol|1
6862880|NCT00422162|10872213|FG000|Overall Study|Other|0
6862881|NCT00422162|10872214|FG001|Overall Study|Other|1
6862882|NCT00422162|10872213|FG000|Overall Study|Didn't Receive Treatment|0
6862883|NCT00422162|10872214|FG001|Overall Study|Didn't Receive Treatment|1
6862884|NCT00422227|10872237|FG000|Overall Study|Adverse Event|3
6862885|NCT00422227|10872238|FG001|Overall Study|Adverse Event|8
6862886|NCT00422227|10872237|FG000|Overall Study|Lost to Follow-up|1
6862887|NCT00422227|10872238|FG001|Overall Study|Lost to Follow-up|3
6862888|NCT00422227|10872237|FG000|Overall Study|Withdrawal by Subject|0
6862889|NCT00422227|10872238|FG001|Overall Study|Withdrawal by Subject|4
7078128|NCT02100657|11186396|FG002|Cohort 3: Dose Level 3|Progressive disease|15
7078129|NCT02100657|11186394|FG000|Cohort 3: Dose Level 3|Death|0
7078130|NCT02100657|11186395|FG001|Cohort 3: Dose Level 3|Death|0
7078131|NCT02100657|11186396|FG002|Cohort 3: Dose Level 3|Death|1
6862890|NCT00422292|10872259|FG000|Overall Study|Serious adverse events|1
6862891|NCT00422292|10872260|FG001|Overall Study|Serious adverse events|4
6862892|NCT00422292|10872261|FG002|Overall Study|Serious adverse events|0
6862893|NCT00422292|10872262|FG003|Overall Study|Serious adverse events|0
6862894|NCT00422292|10872259|FG000|Overall Study|Adverse Event|1
6862895|NCT00422292|10872260|FG001|Overall Study|Adverse Event|0
6862896|NCT00422292|10872261|FG002|Overall Study|Adverse Event|1
6862897|NCT00422292|10872262|FG003|Overall Study|Adverse Event|0
6862898|NCT00422292|10872259|FG000|Overall Study|Protocol Violation|4
6862899|NCT00422292|10872260|FG001|Overall Study|Protocol Violation|25
6862900|NCT00422292|10872261|FG002|Overall Study|Protocol Violation|8
6862901|NCT00422292|10872262|FG003|Overall Study|Protocol Violation|5
6862902|NCT00422292|10872259|FG000|Overall Study|Lost to Follow-up|6
6862903|NCT00422292|10872260|FG001|Overall Study|Lost to Follow-up|12
6862904|NCT00422292|10872261|FG002|Overall Study|Lost to Follow-up|6
6862905|NCT00422292|10872262|FG003|Overall Study|Lost to Follow-up|6
6862906|NCT00422292|10872259|FG000|Overall Study|Withdrawal by Subject|6
6862907|NCT00422292|10872260|FG001|Overall Study|Withdrawal by Subject|25
6862908|NCT00422292|10872261|FG002|Overall Study|Withdrawal by Subject|7
6862909|NCT00422292|10872262|FG003|Overall Study|Withdrawal by Subject|13
6862910|NCT00422383|10872277|FG000|Overall Study|Adverse Event|5
6862911|NCT00422383|10872278|FG001|Overall Study|Adverse Event|3
6862912|NCT00422383|10872279|FG002|Overall Study|Adverse Event|1
6862913|NCT00422383|10872280|FG003|Overall Study|Adverse Event|1
6862914|NCT00422383|10872281|FG004|Overall Study|Adverse Event|0
6862915|NCT00422383|10872277|FG000|Overall Study|Lack of Efficacy|4
6862916|NCT00422383|10872278|FG001|Overall Study|Lack of Efficacy|4
6862917|NCT00422383|10872279|FG002|Overall Study|Lack of Efficacy|2
6862918|NCT00422383|10872280|FG003|Overall Study|Lack of Efficacy|1
6862919|NCT00422383|10872281|FG004|Overall Study|Lack of Efficacy|1
6862920|NCT00422383|10872277|FG000|Overall Study|Lost to Follow-up|0
6862921|NCT00422383|10872278|FG001|Overall Study|Lost to Follow-up|1
6862922|NCT00422383|10872279|FG002|Overall Study|Lost to Follow-up|0
6862923|NCT00422383|10872280|FG003|Overall Study|Lost to Follow-up|0
6862924|NCT00422383|10872281|FG004|Overall Study|Lost to Follow-up|1
6862925|NCT00422383|10872277|FG000|Overall Study|Protocol Violation|1
6862926|NCT00422383|10872278|FG001|Overall Study|Protocol Violation|1
6862927|NCT00422383|10872279|FG002|Overall Study|Protocol Violation|1
6862928|NCT00422383|10872280|FG003|Overall Study|Protocol Violation|0
6862929|NCT00422383|10872281|FG004|Overall Study|Protocol Violation|0
6862930|NCT00422383|10872277|FG000|Overall Study|Withdrawal by Subject|5
6862931|NCT00422383|10872278|FG001|Overall Study|Withdrawal by Subject|5
6862932|NCT00422383|10872279|FG002|Overall Study|Withdrawal by Subject|0
6862933|NCT00422383|10872280|FG003|Overall Study|Withdrawal by Subject|0
6862934|NCT00422383|10872281|FG004|Overall Study|Withdrawal by Subject|1
6862935|NCT00422422|10872299|FG000|Overall Study|Lack of Efficacy|1
6862936|NCT00422422|10872299|FG000|Overall Study|Protocol Violation|1
6862937|NCT00422422|10872299|FG000|Overall Study|Withdrawal by Subject|2
6862938|NCT00422422|10872299|FG000|Overall Study|SAE, non-fatal|1
6862939|NCT00422422|10872299|FG000|Overall Study|AE, non-serious non-fatal|5
6862940|NCT00422461|10872313|FG000|Overall Study|Adverse Event|1
6862941|NCT00422461|10872314|FG001|Overall Study|Adverse Event|2
6862942|NCT00422461|10872315|FG002|Overall Study|Adverse Event|1
6862943|NCT00422461|10872316|FG003|Overall Study|Adverse Event|1
6862944|NCT00422461|10872313|FG000|Overall Study|Other|0
6862945|NCT00422461|10872314|FG001|Overall Study|Other|0
6862946|NCT00422461|10872315|FG002|Overall Study|Other|0
6862947|NCT00422461|10872316|FG003|Overall Study|Other|2
6862948|NCT00422461|10872313|FG000|Overall Study|Participants no longer willing to participate in study|1
6862949|NCT00422461|10872314|FG001|Overall Study|Participants no longer willing to participate in study|0
6862950|NCT00422461|10872315|FG002|Overall Study|Participants no longer willing to participate in study|0
6862951|NCT00422461|10872316|FG003|Overall Study|Participants no longer willing to participate in study|0
6862952|NCT00422461|10872313|FG000|Overall Study|Randomized but not treated|1
6862953|NCT00422461|10872314|FG001|Overall Study|Randomized but not treated|1
6862954|NCT00422461|10872315|FG002|Overall Study|Randomized but not treated|0
6862955|NCT00422461|10872316|FG003|Overall Study|Randomized but not treated|0
6862956|NCT00422513|10872328|FG000|Overall Study|Lack of Efficacy|4
6862957|NCT00422513|10872329|FG001|Overall Study|Lack of Efficacy|5
6862958|NCT00422513|10872328|FG000|Overall Study|Protocol Violation|23
6862959|NCT00422513|10872329|FG001|Overall Study|Protocol Violation|7
6862960|NCT00422513|10872328|FG000|Overall Study|Refused Treatment|4
6862961|NCT00422513|10872329|FG001|Overall Study|Refused Treatment|2
6862962|NCT00422513|10872328|FG000|Overall Study|Withdrawal by Subject|2
6862963|NCT00422513|10872329|FG001|Overall Study|Withdrawal by Subject|1
6862964|NCT00422513|10872328|FG000|Overall Study|early termination of the study|67
6862965|NCT00422513|10872329|FG001|Overall Study|early termination of the study|80
6862966|NCT00422513|10872328|FG000|Overall Study|Adverse Event|4
6862967|NCT00422513|10872329|FG001|Overall Study|Adverse Event|4
6862968|NCT00422513|10872328|FG000|Overall Study|Death|3
6862969|NCT00422513|10872329|FG001|Overall Study|Death|7
6862970|NCT00422591|10872335|FG000|Overall Study|Physician Decision|4
6862971|NCT00422591|10872335|FG000|Overall Study|Withdrawal by Subject|2
6862972|NCT00422734|10872354|FG000|Overall Study|Physician Decision|1
6862973|NCT00422734|10872355|FG001|Overall Study|Physician Decision|1
6862974|NCT00422734|10872354|FG000|Overall Study|Protocol Violation|1
6862975|NCT00422734|10872355|FG001|Overall Study|Protocol Violation|6
6862976|NCT00422734|10872354|FG000|Overall Study|Withdrawal by Subject|12
6862977|NCT00422734|10872355|FG001|Overall Study|Withdrawal by Subject|8
6862978|NCT00422734|10872354|FG000|Overall Study|Adverse Event|0
6862979|NCT00422734|10872355|FG001|Overall Study|Adverse Event|3
6862980|NCT00422734|10872354|FG000|Overall Study|Partner Decision|0
6862981|NCT00422734|10872355|FG001|Overall Study|Partner Decision|3
6862982|NCT00422799|10872361|FG000|Overall Study|Withdrawal by Subject|6
6862983|NCT00422799|10872361|FG000|Overall Study|Adverse Event|7
6862984|NCT00422903|10872384|FG000|Overall Study|Disease Progression|3
6862985|NCT00422903|10872385|FG001|Overall Study|Disease Progression|1
6862986|NCT00422903|10872384|FG000|Overall Study|Adverse Event|0
6862987|NCT00422903|10872385|FG001|Overall Study|Adverse Event|2
6862988|NCT00422903|10872384|FG000|Overall Study|Informed Consent Withdrawn|1
6862989|NCT00422903|10872385|FG001|Overall Study|Informed Consent Withdrawn|2
6862990|NCT00423046|10872393|FG000|Overall Study|Other|340
6862991|NCT00423046|10872394|FG001|Overall Study|Other|345
6862992|NCT00423085|10872405|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21
6862993|NCT00423085|10872406|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38
6862994|NCT00423085|10872407|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34
6862995|NCT00423085|10872408|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0
6862996|NCT00423085|10872405|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8
6862997|NCT00423085|10872406|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16
6862998|NCT00423085|10872407|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11
6862999|NCT00423085|10872408|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0
6863000|NCT00423085|10872405|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
6863001|NCT00423085|10872406|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6
6863002|NCT00423085|10872407|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
6863003|NCT00423085|10872408|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
6863004|NCT00423085|10872405|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8
6863005|NCT00423085|10872406|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3
6863006|NCT00423085|10872407|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7
6863007|NCT00423085|10872408|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0
6863008|NCT00423085|10872405|FG000|24-Week Double-Blind Treatment Phase|Death|1
6863009|NCT00423085|10872406|FG001|24-Week Double-Blind Treatment Phase|Death|1
6863010|NCT00423085|10872407|FG002|24-Week Double-Blind Treatment Phase|Death|0
6863011|NCT00423085|10872408|FG003|24-Week Double-Blind Treatment Phase|Death|0
6863012|NCT00423085|10872405|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1
6863013|NCT00423085|10872406|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
6863014|NCT00423085|10872407|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
6863015|NCT00423085|10872408|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
6863016|NCT00423085|10872405|FG000|52-Week Open-Label Extension Phase|Adverse Event|0
6863017|NCT00423085|10872406|FG001|52-Week Open-Label Extension Phase|Adverse Event|0
6863018|NCT00423085|10872407|FG002|52-Week Open-Label Extension Phase|Adverse Event|0
6863019|NCT00423085|10872408|FG003|52-Week Open-Label Extension Phase|Adverse Event|97
6863020|NCT00423085|10872405|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
6863021|NCT00423085|10872406|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
6863022|NCT00423085|10872407|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
6863023|NCT00423085|10872408|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37
6863024|NCT00423085|10872405|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
6863025|NCT00423085|10872406|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
6863026|NCT00423085|10872407|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
6863027|NCT00423085|10872408|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18
6863028|NCT00423085|10872405|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0
6863029|NCT00423085|10872406|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0
6863030|NCT00423085|10872407|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0
6863031|NCT00423085|10872408|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9
6863032|NCT00423085|10872405|FG000|52-Week Open-Label Extension Phase|Death|0
6863033|NCT00423085|10872406|FG001|52-Week Open-Label Extension Phase|Death|0
6863034|NCT00423085|10872407|FG002|52-Week Open-Label Extension Phase|Death|0
6863035|NCT00423085|10872408|FG003|52-Week Open-Label Extension Phase|Death|2
6863036|NCT00423098|10872420|FG000|Overall Study|Adverse Event|1
6863037|NCT00423098|10872421|FG001|Overall Study|Adverse Event|2
6863038|NCT00423098|10872420|FG000|Overall Study|Unsatisfactory therapeutic effect|0
6863039|NCT00423098|10872421|FG001|Overall Study|Unsatisfactory therapeutic effect|1
6863040|NCT00423098|10872420|FG000|Overall Study|Administrative problems|0
6863041|NCT00423098|10872421|FG001|Overall Study|Administrative problems|1
6863042|NCT00423098|10872420|FG000|Overall Study|Death|2
6863043|NCT00423098|10872421|FG001|Overall Study|Death|0
6863044|NCT00423137|10872431|FG000|Overall Study|Lost to Follow-up|0
6863045|NCT00423137|10872432|FG001|Overall Study|Lost to Follow-up|0
6863046|NCT00423137|10872433|FG002|Overall Study|Lost to Follow-up|1
6863047|NCT00423137|10872434|FG003|Overall Study|Lost to Follow-up|0
6863048|NCT00423137|10872431|FG000|Overall Study|Protocol Violation|0
6863049|NCT00423137|10872432|FG001|Overall Study|Protocol Violation|0
6863050|NCT00423137|10872433|FG002|Overall Study|Protocol Violation|0
6863051|NCT00423137|10872434|FG003|Overall Study|Protocol Violation|1
6863052|NCT00423137|10872431|FG000|Overall Study|Adverse Event Study disease worse|1
6863053|NCT00423137|10872432|FG001|Overall Study|Adverse Event Study disease worse|0
6863054|NCT00423137|10872433|FG002|Overall Study|Adverse Event Study disease worse|3
6863055|NCT00423137|10872434|FG003|Overall Study|Adverse Event Study disease worse|1
6863056|NCT00423137|10872431|FG000|Overall Study|Adverse Event Other|0
6863057|NCT00423137|10872432|FG001|Overall Study|Adverse Event Other|0
6863058|NCT00423137|10872433|FG002|Overall Study|Adverse Event Other|2
6863059|NCT00423137|10872434|FG003|Overall Study|Adverse Event Other|0
6863060|NCT00423150|10872447|FG000|Overall Study|Adverse Event|11
6863061|NCT00423150|10872447|FG000|Overall Study|Progression of disease being studied|69
6863062|NCT00423150|10872447|FG000|Overall Study|Withdrawal by Subject|1
6863063|NCT00423150|10872447|FG000|Overall Study|Non-compliance with protocol|1
6863064|NCT00423150|10872447|FG000|Overall Study|Administrative|4
6863065|NCT00423189|10872454|FG000|Overall Study|Death|0
6863066|NCT00423189|10872455|FG001|Overall Study|Death|1
6863067|NCT00423189|10872456|FG002|Overall Study|Death|0
6863068|NCT00423267|10872471|FG000|Period A|Withdrawal by Subject|0
6863069|NCT00423267|10872472|FG001|Period A|Withdrawal by Subject|1
6863070|NCT00423267|10872471|FG000|Period A|Non-compliance with protocol|1
7041085|NCT01723254|11124507|FG000|Overall Study|Move/Left to another country/city|0
7041086|NCT01723254|11124508|FG001|Overall Study|Move/Left to another country/city|0
7041087|NCT01723254|11124509|FG002|Overall Study|Move/Left to another country/city|2
7041088|NCT01723254|11124510|FG003|Overall Study|Move/Left to another country/city|1
7041089|NCT01723254|11124511|FG004|Overall Study|Move/Left to another country/city|1
7041090|NCT01723254|11124512|FG005|Overall Study|Move/Left to another country/city|0
7041091|NCT01723254|11124513|FG006|Overall Study|Move/Left to another country/city|0
7041092|NCT01723254|11124514|FG007|Overall Study|Move/Left to another country/city|0
7041093|NCT01723254|11124507|FG000|Overall Study|Protocol Violation|0
7041094|NCT01723254|11124508|FG001|Overall Study|Protocol Violation|1
7041095|NCT01723254|11124509|FG002|Overall Study|Protocol Violation|0
7041096|NCT01723254|11124510|FG003|Overall Study|Protocol Violation|0
7041097|NCT01723254|11124511|FG004|Overall Study|Protocol Violation|0
7041098|NCT01723254|11124512|FG005|Overall Study|Protocol Violation|0
7041099|NCT01723254|11124513|FG006|Overall Study|Protocol Violation|0
7041100|NCT01723254|11124514|FG007|Overall Study|Protocol Violation|0
7041101|NCT01723254|11124507|FG000|Overall Study|Withdrawal by Subject|1
7041102|NCT01723254|11124508|FG001|Overall Study|Withdrawal by Subject|2
7041103|NCT01723254|11124509|FG002|Overall Study|Withdrawal by Subject|1
7041104|NCT01723254|11124510|FG003|Overall Study|Withdrawal by Subject|0
7041105|NCT01723254|11124511|FG004|Overall Study|Withdrawal by Subject|1
7041106|NCT01723254|11124512|FG005|Overall Study|Withdrawal by Subject|1
7041107|NCT01723254|11124513|FG006|Overall Study|Withdrawal by Subject|1
7041108|NCT01723254|11124514|FG007|Overall Study|Withdrawal by Subject|2
7041109|NCT01723397|11124543|FG000|Study Period 1|Protocol Violation|0
7078132|NCT02100657|11186394|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0
7078133|NCT02100657|11186395|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0
7078134|NCT02100657|11186396|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1
6863071|NCT00423267|10872472|FG001|Period A|Non-compliance with protocol|0
6863072|NCT00423267|10872471|FG000|Period A|Administrative|1
6863073|NCT00423267|10872472|FG001|Period A|Administrative|0
6863074|NCT00423293|10872480|FG000|Overall Study|Ineligible / No protocol treatment|11
6863075|NCT00423319|10872486|FG000|Overall Study|Death|2
6863076|NCT00423319|10872487|FG001|Overall Study|Death|0
6863077|NCT00423319|10872486|FG000|Overall Study|Adverse Event|93
6863078|NCT00423319|10872487|FG001|Overall Study|Adverse Event|112
6863079|NCT00423319|10872486|FG000|Overall Study|Withdrawal by Subject|86
6863080|NCT00423319|10872487|FG001|Overall Study|Withdrawal by Subject|99
6863081|NCT00423319|10872486|FG000|Overall Study|Lost to Follow-up|4
7041110|NCT01723397|11124544|FG001|Study Period 1|Protocol Violation|1
7041111|NCT01723397|11124543|FG000|Study Period 2|Protocol Violation|0
7078135|NCT02100657|11186394|FG000|Cohort 3: Dose Level 3|Physician Decision|0
7078136|NCT02100657|11186395|FG001|Cohort 3: Dose Level 3|Physician Decision|0
7153340|NCT03285295|11318985|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
7153341|NCT03285295|11318986|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
6863082|NCT00423319|10872487|FG001|Overall Study|Lost to Follow-up|3
6863083|NCT00423319|10872486|FG000|Overall Study|Poor compliance or noncompliance|1
6863084|NCT00423319|10872487|FG001|Overall Study|Poor compliance or noncompliance|1
6863085|NCT00423319|10872486|FG000|Overall Study|No longer meets study criteria|15
6863086|NCT00423319|10872487|FG001|Overall Study|No longer meets study criteria|15
6863087|NCT00423319|10872486|FG000|Overall Study|Other|23
6863088|NCT00423319|10872487|FG001|Overall Study|Other|22
6863089|NCT00423332|10872496|FG000|Overall Study|Adverse Event|6
6863090|NCT00423332|10872497|FG001|Overall Study|Adverse Event|2
6863091|NCT00423332|10872496|FG000|Overall Study|Withdrawal by Subject|1
6863092|NCT00423332|10872497|FG001|Overall Study|Withdrawal by Subject|0
6863093|NCT00423332|10872496|FG000|Overall Study|Condition under investigation worsened|1
6863094|NCT00423332|10872497|FG001|Overall Study|Condition under investigation worsened|1
6863095|NCT00423332|10872496|FG000|Overall Study|Progressive at Week 6|0
6863096|NCT00423332|10872497|FG001|Overall Study|Progressive at Week 6|1
6863097|NCT00423332|10872496|FG000|Overall Study|Unblinded before 12 weeks|1
7078137|NCT02100657|11186396|FG002|Cohort 3: Dose Level 3|Physician Decision|1
7078138|NCT02100657|11186394|FG000|Cohort 3: Dose Level 3|Never were treated|0
7153342|NCT03285295|11318987|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
6863098|NCT00423332|10872497|FG001|Overall Study|Unblinded before 12 weeks|3
6863099|NCT00423449|10872522|FG000|Overall Study|Clinical Adverse Event|1
6863100|NCT00423449|10872523|FG001|Overall Study|Clinical Adverse Event|0
6863101|NCT00423449|10872524|FG002|Overall Study|Clinical Adverse Event|1
6863102|NCT00423449|10872525|FG003|Overall Study|Clinical Adverse Event|8
6863103|NCT00423449|10872526|FG004|Overall Study|Clinical Adverse Event|2
6863104|NCT00423449|10872522|FG000|Overall Study|Death|1
6863105|NCT00423449|10872523|FG001|Overall Study|Death|0
6863106|NCT00423449|10872524|FG002|Overall Study|Death|2
6863107|NCT00423449|10872525|FG003|Overall Study|Death|1
6863108|NCT00423449|10872526|FG004|Overall Study|Death|1
6863109|NCT00423449|10872522|FG000|Overall Study|Progressive Disease|1
6863110|NCT00423449|10872523|FG001|Overall Study|Progressive Disease|3
6863111|NCT00423449|10872524|FG002|Overall Study|Progressive Disease|8
6863112|NCT00423449|10872525|FG003|Overall Study|Progressive Disease|11
6863113|NCT00423449|10872526|FG004|Overall Study|Progressive Disease|4
6863114|NCT00423449|10872522|FG000|Overall Study|Laboratory Adverse Event|0
6863115|NCT00423449|10872523|FG001|Overall Study|Laboratory Adverse Event|1
6863116|NCT00423449|10872524|FG002|Overall Study|Laboratory Adverse Event|2
6863117|NCT00423449|10872525|FG003|Overall Study|Laboratory Adverse Event|0
6863118|NCT00423449|10872526|FG004|Overall Study|Laboratory Adverse Event|0
6863119|NCT00423449|10872522|FG000|Overall Study|Other|0
6863120|NCT00423449|10872523|FG001|Overall Study|Other|0
6863121|NCT00423449|10872524|FG002|Overall Study|Other|0
6863122|NCT00423449|10872525|FG003|Overall Study|Other|1
6863123|NCT00423449|10872526|FG004|Overall Study|Other|0
7078139|NCT02100657|11186395|FG001|Cohort 3: Dose Level 3|Never were treated|0
7078140|NCT02100657|11186396|FG002|Cohort 3: Dose Level 3|Never were treated|3
7078141|NCT02100657|11186394|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0
7078142|NCT02100657|11186395|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0
7078143|NCT02100657|11186396|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3
7078144|NCT02100657|11186394|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0
7078145|NCT02100657|11186395|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0
7078146|NCT02100657|11186396|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3
7078147|NCT02100670|11186409|FG000|Overall Study|Adverse Event|10
7078148|NCT02100670|11186410|FG001|Overall Study|Adverse Event|3
7078149|NCT02100670|11186411|FG002|Overall Study|Adverse Event|3
7153343|NCT03285295|11318983|FG000|Alinity s Anti-HCV|Protocol Violation|12
7153344|NCT03285295|11318984|FG001|Alinity s Anti-HCV|Protocol Violation|0
7153345|NCT03285295|11318985|FG002|Alinity s Anti-HCV|Protocol Violation|0
7153346|NCT03285295|11318986|FG003|Alinity s Anti-HCV|Protocol Violation|0
7153347|NCT03285295|11318987|FG004|Alinity s Anti-HCV|Protocol Violation|0
7078150|NCT02100670|11186412|FG003|Overall Study|Adverse Event|0
7078151|NCT02100670|11186409|FG000|Overall Study|Lost to Follow-up|1
7078152|NCT02100670|11186410|FG001|Overall Study|Lost to Follow-up|0
7078153|NCT02100670|11186411|FG002|Overall Study|Lost to Follow-up|0
7078154|NCT02100670|11186412|FG003|Overall Study|Lost to Follow-up|0
7078155|NCT02100670|11186409|FG000|Overall Study|Protocol Violation|0
7078156|NCT02100670|11186410|FG001|Overall Study|Protocol Violation|1
7078157|NCT02100670|11186411|FG002|Overall Study|Protocol Violation|0
7078158|NCT02100670|11186412|FG003|Overall Study|Protocol Violation|1
7078159|NCT02100670|11186409|FG000|Overall Study|Withdrawal of Consent|0
7078160|NCT02100670|11186410|FG001|Overall Study|Withdrawal of Consent|1
7078161|NCT02100670|11186411|FG002|Overall Study|Withdrawal of Consent|1
7078162|NCT02100670|11186412|FG003|Overall Study|Withdrawal of Consent|0
7078163|NCT02100670|11186409|FG000|Overall Study|No swelling no pain|1
7078164|NCT02100670|11186410|FG001|Overall Study|No swelling no pain|0
7078165|NCT02100670|11186411|FG002|Overall Study|No swelling no pain|0
7078166|NCT02100670|11186412|FG003|Overall Study|No swelling no pain|0
6863124|NCT00423449|10872522|FG000|Overall Study|Protocol Violation|0
6863125|NCT00423449|10872523|FG001|Overall Study|Protocol Violation|0
6863126|NCT00423449|10872524|FG002|Overall Study|Protocol Violation|2
6863127|NCT00423449|10872525|FG003|Overall Study|Protocol Violation|1
6863128|NCT00423449|10872526|FG004|Overall Study|Protocol Violation|0
6863129|NCT00423592|10872539|FG000|Overall Study|Adverse Event (through Week 12)|2
6863130|NCT00423592|10872539|FG000|Overall Study|Adverse Event (post Week 12)|5
6863131|NCT00423605|10872543|FG000|Overall Study|Adverse Event|129
6863132|NCT00423605|10872543|FG000|Overall Study|Withdrawal by Subject|36
6863133|NCT00423605|10872543|FG000|Overall Study|Lost to Follow-up|15
6863134|NCT00423605|10872543|FG000|Overall Study|Lack of Efficacy|38
6863135|NCT00423605|10872543|FG000|Overall Study|Sponsor Decision|3
6863136|NCT00423605|10872543|FG000|Overall Study|Physician Decision|8
6863137|NCT00423605|10872543|FG000|Overall Study|Protocol Violation|7
6863138|NCT00423605|10872543|FG000|Overall Study|Not one of the pre-specified options|5
6863139|NCT00423657|10872549|FG000|Overall Study|Withdrew consent|10
6863140|NCT00423657|10872550|FG001|Overall Study|Withdrew consent|8
6863141|NCT00423657|10872549|FG000|Overall Study|Non-compliance|0
6863142|NCT00423657|10872550|FG001|Overall Study|Non-compliance|1
6863143|NCT00423657|10872549|FG000|Overall Study|Other|15
6863144|NCT00423657|10872550|FG001|Overall Study|Other|16
6863145|NCT00423657|10872549|FG000|Overall Study|Request of sponsor/investigator|1
6863146|NCT00423657|10872550|FG001|Overall Study|Request of sponsor/investigator|0
6863147|NCT00423670|10872563|FG000|Treatment Period|Switched to Arm 8 at TW 24|36
6863148|NCT00423670|10872564|FG001|Treatment Period|Switched to Arm 8 at TW 24|0
6863149|NCT00423670|10872565|FG002|Treatment Period|Switched to Arm 8 at TW 24|0
6863150|NCT00423670|10872566|FG003|Treatment Period|Switched to Arm 8 at TW 24|0
6863151|NCT00423670|10872567|FG004|Treatment Period|Switched to Arm 8 at TW 24|0
6863152|NCT00423670|10872568|FG005|Treatment Period|Switched to Arm 8 at TW 24|0
6863153|NCT00423670|10872569|FG006|Treatment Period|Switched to Arm 8 at TW 24|0
6863154|NCT00423670|10872570|FG007|Treatment Period|Switched to Arm 8 at TW 24|0
6863155|NCT00423670|10872563|FG000|Treatment Period|Adverse Event|8
6863156|NCT00423670|10872564|FG001|Treatment Period|Adverse Event|12
6863157|NCT00423670|10872565|FG002|Treatment Period|Adverse Event|15
6863158|NCT00423670|10872566|FG003|Treatment Period|Adverse Event|20
6863159|NCT00423670|10872567|FG004|Treatment Period|Adverse Event|9
6863160|NCT00423670|10872568|FG005|Treatment Period|Adverse Event|4
6863161|NCT00423670|10872569|FG006|Treatment Period|Adverse Event|7
6863162|NCT00423670|10872570|FG007|Treatment Period|Adverse Event|2
6863163|NCT00423670|10872563|FG000|Treatment Period|Protocol-defined clinical event|0
6863164|NCT00423670|10872564|FG001|Treatment Period|Protocol-defined clinical event|7
6863165|NCT00423670|10872565|FG002|Treatment Period|Protocol-defined clinical event|4
6863166|NCT00423670|10872566|FG003|Treatment Period|Protocol-defined clinical event|12
6863167|NCT00423670|10872567|FG004|Treatment Period|Protocol-defined clinical event|5
6863168|NCT00423670|10872568|FG005|Treatment Period|Protocol-defined clinical event|4
6863169|NCT00423670|10872569|FG006|Treatment Period|Protocol-defined clinical event|16
7153348|NCT03285295|11318983|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13
7153349|NCT03285295|11318984|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0
7153350|NCT03285295|11318985|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0
7153351|NCT03285295|11318986|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0
6863170|NCT00423670|10872570|FG007|Treatment Period|Protocol-defined clinical event|15
7153352|NCT03285295|11318987|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0
7153353|NCT03285295|11318983|FG000|Alinity s Anti-HCV|No Results Generated|71
7153354|NCT03285295|11318984|FG001|Alinity s Anti-HCV|No Results Generated|0
7153355|NCT03285295|11318985|FG002|Alinity s Anti-HCV|No Results Generated|0
7153356|NCT03285295|11318986|FG003|Alinity s Anti-HCV|No Results Generated|0
7153357|NCT03285295|11318987|FG004|Alinity s Anti-HCV|No Results Generated|0
7153358|NCT03285295|11318983|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18
7153359|NCT03285295|11318984|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
7153360|NCT03285295|11318985|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
7153361|NCT03285295|11318986|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
7153362|NCT03285295|11318987|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
7153363|NCT03285295|11318983|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11
7153364|NCT03285295|11318984|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
7153365|NCT03285295|11318985|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
7153366|NCT03285295|11318986|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
7153367|NCT03285295|11318987|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
7153368|NCT03285295|11318983|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16
7153369|NCT03285295|11318984|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
7153370|NCT03285295|11318985|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
7153371|NCT03285295|11318986|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
7153372|NCT03285295|11318987|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
7153373|NCT03285295|11318983|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72
7153374|NCT03285295|11318984|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0
7153375|NCT03285295|11318985|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0
7153376|NCT03285295|11318986|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0
7153377|NCT03285295|11318987|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0
7153378|NCT03285295|11318983|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11
7153379|NCT03285295|11318984|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
7153380|NCT03285295|11318985|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
7153381|NCT03285295|11318986|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
7153382|NCT03285295|11318987|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
7153383|NCT03285295|11318983|FG000|Alinity s Anti-HBc|Protocol Violation|8
7153384|NCT03285295|11318984|FG001|Alinity s Anti-HBc|Protocol Violation|0
7153385|NCT03285295|11318985|FG002|Alinity s Anti-HBc|Protocol Violation|0
7153386|NCT03285295|11318986|FG003|Alinity s Anti-HBc|Protocol Violation|0
7153387|NCT03285295|11318987|FG004|Alinity s Anti-HBc|Protocol Violation|0
7153388|NCT03285295|11318983|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13
7153389|NCT03285295|11318984|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1
7153390|NCT03285295|11318985|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0
7153391|NCT03285295|11318986|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0
7153392|NCT03285295|11318987|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0
7153393|NCT03285295|11318983|FG000|Alinity s Anti-HBc|No Results Generated|70
7153394|NCT03285295|11318984|FG001|Alinity s Anti-HBc|No Results Generated|0
6863171|NCT00423670|10872563|FG000|Treatment Period|Lost to Follow-up|2
6863172|NCT00423670|10872564|FG001|Treatment Period|Lost to Follow-up|1
6863173|NCT00423670|10872565|FG002|Treatment Period|Lost to Follow-up|3
6863174|NCT00423670|10872566|FG003|Treatment Period|Lost to Follow-up|1
6863175|NCT00423670|10872567|FG004|Treatment Period|Lost to Follow-up|6
6863176|NCT00423670|10872568|FG005|Treatment Period|Lost to Follow-up|0
6863177|NCT00423670|10872569|FG006|Treatment Period|Lost to Follow-up|3
6863178|NCT00423670|10872570|FG007|Treatment Period|Lost to Follow-up|1
6863179|NCT00423670|10872563|FG000|Treatment Period|Subject withdrew (not treatment related)|3
6863180|NCT00423670|10872564|FG001|Treatment Period|Subject withdrew (not treatment related)|9
6863181|NCT00423670|10872565|FG002|Treatment Period|Subject withdrew (not treatment related)|4
6863182|NCT00423670|10872566|FG003|Treatment Period|Subject withdrew (not treatment related)|4
6863183|NCT00423670|10872567|FG004|Treatment Period|Subject withdrew (not treatment related)|5
6863184|NCT00423670|10872568|FG005|Treatment Period|Subject withdrew (not treatment related)|0
6863185|NCT00423670|10872569|FG006|Treatment Period|Subject withdrew (not treatment related)|3
6863186|NCT00423670|10872570|FG007|Treatment Period|Subject withdrew (not treatment related)|0
6863187|NCT00423670|10872563|FG000|Treatment Period|Investigator decision|0
6863188|NCT00423670|10872564|FG001|Treatment Period|Investigator decision|0
6863189|NCT00423670|10872565|FG002|Treatment Period|Investigator decision|0
6863190|NCT00423670|10872566|FG003|Treatment Period|Investigator decision|0
6863191|NCT00423670|10872567|FG004|Treatment Period|Investigator decision|0
6863192|NCT00423670|10872568|FG005|Treatment Period|Investigator decision|0
6863193|NCT00423670|10872569|FG006|Treatment Period|Investigator decision|0
6863194|NCT00423670|10872570|FG007|Treatment Period|Investigator decision|1
6863195|NCT00423670|10872563|FG000|Treatment Period|Non-compliance with protocol|3
6863196|NCT00423670|10872564|FG001|Treatment Period|Non-compliance with protocol|1
6863197|NCT00423670|10872565|FG002|Treatment Period|Non-compliance with protocol|1
6863198|NCT00423670|10872566|FG003|Treatment Period|Non-compliance with protocol|3
6863199|NCT00423670|10872567|FG004|Treatment Period|Non-compliance with protocol|2
6863200|NCT00423670|10872568|FG005|Treatment Period|Non-compliance with protocol|0
6863201|NCT00423670|10872569|FG006|Treatment Period|Non-compliance with protocol|2
6863202|NCT00423670|10872570|FG007|Treatment Period|Non-compliance with protocol|2
6863203|NCT00423670|10872563|FG000|Follow-up Period|Lost to Follow-up|0
6863204|NCT00423670|10872564|FG001|Follow-up Period|Lost to Follow-up|12
6863205|NCT00423670|10872565|FG002|Follow-up Period|Lost to Follow-up|8
6863206|NCT00423670|10872566|FG003|Follow-up Period|Lost to Follow-up|3
6863207|NCT00423670|10872567|FG004|Follow-up Period|Lost to Follow-up|1
6863208|NCT00423670|10872568|FG005|Follow-up Period|Lost to Follow-up|0
6863209|NCT00423670|10872569|FG006|Follow-up Period|Lost to Follow-up|5
6863210|NCT00423670|10872570|FG007|Follow-up Period|Lost to Follow-up|0
6863211|NCT00423670|10872563|FG000|Follow-up Period|Subject withdrew (not treatment related)|1
6863212|NCT00423670|10872564|FG001|Follow-up Period|Subject withdrew (not treatment related)|4
6863213|NCT00423670|10872565|FG002|Follow-up Period|Subject withdrew (not treatment related)|2
6863214|NCT00423670|10872566|FG003|Follow-up Period|Subject withdrew (not treatment related)|1
6863215|NCT00423670|10872567|FG004|Follow-up Period|Subject withdrew (not treatment related)|1
6863216|NCT00423670|10872568|FG005|Follow-up Period|Subject withdrew (not treatment related)|0
6863217|NCT00423670|10872569|FG006|Follow-up Period|Subject withdrew (not treatment related)|1
6863218|NCT00423670|10872570|FG007|Follow-up Period|Subject withdrew (not treatment related)|1
6863219|NCT00423670|10872563|FG000|Follow-up Period|Non-compliance with protocol|2
6863220|NCT00423670|10872564|FG001|Follow-up Period|Non-compliance with protocol|0
6863221|NCT00423670|10872565|FG002|Follow-up Period|Non-compliance with protocol|1
6863222|NCT00423670|10872566|FG003|Follow-up Period|Non-compliance with protocol|1
6863223|NCT00423670|10872567|FG004|Follow-up Period|Non-compliance with protocol|0
6863224|NCT00423670|10872568|FG005|Follow-up Period|Non-compliance with protocol|0
6863225|NCT00423670|10872569|FG006|Follow-up Period|Non-compliance with protocol|3
7153395|NCT03285295|11318985|FG002|Alinity s Anti-HBc|No Results Generated|0
7153396|NCT03285295|11318986|FG003|Alinity s Anti-HBc|No Results Generated|0
7153397|NCT03285295|11318987|FG004|Alinity s Anti-HBc|No Results Generated|0
7153398|NCT03285295|11318983|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14
7153399|NCT03285295|11318984|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
7153400|NCT03285295|11318985|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
7153401|NCT03285295|11318986|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
7153402|NCT03285295|11318987|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
7153403|NCT03285295|11318983|FG000|Alinity s Chagas|Protocol Violation|76
7153404|NCT03285295|11318984|FG001|Alinity s Chagas|Protocol Violation|0
7153405|NCT03285295|11318985|FG002|Alinity s Chagas|Protocol Violation|0
7153406|NCT03285295|11318986|FG003|Alinity s Chagas|Protocol Violation|0
7153407|NCT03285295|11318987|FG004|Alinity s Chagas|Protocol Violation|0
7153408|NCT03285295|11318983|FG000|Alinity s Chagas|No Results on Comparator Assay|38
7153409|NCT03285295|11318984|FG001|Alinity s Chagas|No Results on Comparator Assay|0
7153410|NCT03285295|11318985|FG002|Alinity s Chagas|No Results on Comparator Assay|0
7153411|NCT03285295|11318986|FG003|Alinity s Chagas|No Results on Comparator Assay|0
6863226|NCT00423670|10872570|FG007|Follow-up Period|Non-compliance with protocol|2
7153412|NCT03285295|11318987|FG004|Alinity s Chagas|No Results on Comparator Assay|0
6863227|NCT00423722|10872604|FG000|Overall Study|Death|4
6863228|NCT00423722|10872605|FG001|Overall Study|Death|4
6863229|NCT00423722|10872604|FG000|Overall Study|Declined to participate|2
7153413|NCT03285295|11318983|FG000|Alinity s Chagas|No Results Generated|105
7153414|NCT03285295|11318984|FG001|Alinity s Chagas|No Results Generated|0
7153415|NCT03285295|11318985|FG002|Alinity s Chagas|No Results Generated|0
6863230|NCT00423722|10872605|FG001|Overall Study|Declined to participate|3
6863231|NCT00423722|10872604|FG000|Overall Study|Unable to complete questionnaires|4
6863232|NCT00423722|10872605|FG001|Overall Study|Unable to complete questionnaires|4
6863233|NCT00423722|10872604|FG000|Overall Study|Withdrawal by Subject|4
6863234|NCT00423722|10872605|FG001|Overall Study|Withdrawal by Subject|2
6863235|NCT00423735|10872620|FG000|Overall Study|Ineligible / No protocol treatment|8
6863236|NCT00423735|10872621|FG001|Overall Study|Ineligible / No protocol treatment|6
6863237|NCT00423735|10872622|FG002|Overall Study|Ineligible / No protocol treatment|0
6863238|NCT00423800|10872634|FG000|Overall Study|Protocol Violation|0
6863239|NCT00423800|10872635|FG001|Overall Study|Protocol Violation|1
6863240|NCT00423813|10872645|FG000|Overall Study|Adverse Event|11
6863241|NCT00423813|10872646|FG001|Overall Study|Adverse Event|30
6863242|NCT00423813|10872647|FG002|Overall Study|Adverse Event|40
6863243|NCT00423813|10872645|FG000|Overall Study|Withdrawal by Subject|6
6863244|NCT00423813|10872646|FG001|Overall Study|Withdrawal by Subject|8
6863245|NCT00423813|10872647|FG002|Overall Study|Withdrawal by Subject|5
6863246|NCT00423813|10872645|FG000|Overall Study|Lost to Follow-up|5
6863247|NCT00423813|10872646|FG001|Overall Study|Lost to Follow-up|4
6863248|NCT00423813|10872647|FG002|Overall Study|Lost to Follow-up|4
6863249|NCT00423813|10872645|FG000|Overall Study|Lack of Efficacy|23
6863250|NCT00423813|10872646|FG001|Overall Study|Lack of Efficacy|18
6863251|NCT00423813|10872647|FG002|Overall Study|Lack of Efficacy|19
6863252|NCT00423813|10872645|FG000|Overall Study|Physician Decision|2
6863253|NCT00423813|10872646|FG001|Overall Study|Physician Decision|0
6863254|NCT00423813|10872647|FG002|Overall Study|Physician Decision|0
6863255|NCT00423813|10872645|FG000|Overall Study|Sponsor Decision|0
6863256|NCT00423813|10872646|FG001|Overall Study|Sponsor Decision|1
6863257|NCT00423813|10872647|FG002|Overall Study|Sponsor Decision|0
6863258|NCT00423813|10872645|FG000|Overall Study|Protocol Violation|9
6863259|NCT00423813|10872646|FG001|Overall Study|Protocol Violation|4
6863260|NCT00423813|10872647|FG002|Overall Study|Protocol Violation|4
6863261|NCT00423813|10872645|FG000|Overall Study|Pregnancy|0
6863262|NCT00423813|10872646|FG001|Overall Study|Pregnancy|0
6863263|NCT00423813|10872647|FG002|Overall Study|Pregnancy|1
6863264|NCT00423813|10872645|FG000|Overall Study|Subject started night shift work|1
6863265|NCT00423813|10872646|FG001|Overall Study|Subject started night shift work|0
6863266|NCT00423813|10872647|FG002|Overall Study|Subject started night shift work|0
6863267|NCT00423813|10872645|FG000|Overall Study|Will start exclusionary medications|0
6863268|NCT00423813|10872646|FG001|Overall Study|Will start exclusionary medications|1
6863269|NCT00423813|10872647|FG002|Overall Study|Will start exclusionary medications|0
6863270|NCT00423813|10872645|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0
6863271|NCT00423813|10872646|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0
6863272|NCT00423813|10872647|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1
6863273|NCT00423852|10872655|FG000|Overall Study|Removed pior to the high-dose portion|3
6863274|NCT00423891|10872671|FG000|Enrolled|Withdrawal by Subject|0
6863275|NCT00423891|10872672|FG001|Enrolled|Withdrawal by Subject|0
6863276|NCT00423891|10872673|FG002|Enrolled|Withdrawal by Subject|1
6863277|NCT00423891|10872671|FG000|Enrolled|Lost to Follow-up|0
6863278|NCT00423891|10872672|FG001|Enrolled|Lost to Follow-up|0
6863279|NCT00423891|10872673|FG002|Enrolled|Lost to Follow-up|1
6863280|NCT00423891|10872671|FG000|Enrolled|No longer met criteria|11
6863281|NCT00423891|10872672|FG001|Enrolled|No longer met criteria|2
6863282|NCT00423891|10872673|FG002|Enrolled|No longer met criteria|1
6863283|NCT00423891|10872671|FG000|Treatment|Withdrawal by Subject|1
6863284|NCT00423891|10872672|FG001|Treatment|Withdrawal by Subject|0
6863285|NCT00423891|10872673|FG002|Treatment|Withdrawal by Subject|0
6863286|NCT00423891|10872671|FG000|Treatment|Lost to Follow-up|1
6863287|NCT00423891|10872672|FG001|Treatment|Lost to Follow-up|0
6863288|NCT00423891|10872673|FG002|Treatment|Lost to Follow-up|0
6863289|NCT00423891|10872671|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0
6863290|NCT00423891|10872672|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3
6863291|NCT00423891|10872673|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2
6863292|NCT00423891|10872671|FG000|Post-Dosing Follow Up|Lost to Follow-up|2
6863293|NCT00423891|10872672|FG001|Post-Dosing Follow Up|Lost to Follow-up|0
6863294|NCT00423891|10872673|FG002|Post-Dosing Follow Up|Lost to Follow-up|0
6863295|NCT00423917|10872683|FG000|Overall Study|Cancel|2
6863296|NCT00423917|10872683|FG000|Overall Study|Ineligible|1
6863297|NCT00423930|10872687|FG000|Overall Study|Withdrawal by Subject|2
6863298|NCT00423943|10872693|FG000|Overall Study|Withdrawal by Subject|3
6863299|NCT00423943|10872694|FG001|Overall Study|Withdrawal by Subject|1
6863300|NCT00424021|10872704|FG000|NCT00046319 Study Period|Adverse Event|1
6863301|NCT00424021|10872705|FG001|NCT00046319 Study Period|Adverse Event|0
6863302|NCT00424021|10872706|FG002|NCT00046319 Study Period|Adverse Event|1
6863303|NCT00424021|10872707|FG003|NCT00046319 Study Period|Adverse Event|1
6863304|NCT00424021|10872704|FG000|NCT00046319 Study Period|Withdrawal by Subject|0
6863305|NCT00424021|10872705|FG001|NCT00046319 Study Period|Withdrawal by Subject|1
6863306|NCT00424021|10872706|FG002|NCT00046319 Study Period|Withdrawal by Subject|0
6863307|NCT00424021|10872707|FG003|NCT00046319 Study Period|Withdrawal by Subject|0
6863308|NCT00424021|10872704|FG000|NCT00046319 Study Period|Sponsor discretion|0
6863309|NCT00424021|10872705|FG001|NCT00046319 Study Period|Sponsor discretion|1
6863310|NCT00424021|10872706|FG002|NCT00046319 Study Period|Sponsor discretion|0
6863311|NCT00424021|10872707|FG003|NCT00046319 Study Period|Sponsor discretion|0
6863312|NCT00424021|10872704|FG000|NCT00046319 Study Period|Lost to Follow-up|0
6863313|NCT00424021|10872705|FG001|NCT00046319 Study Period|Lost to Follow-up|1
6863314|NCT00424021|10872706|FG002|NCT00046319 Study Period|Lost to Follow-up|0
6863315|NCT00424021|10872707|FG003|NCT00046319 Study Period|Lost to Follow-up|0
6863316|NCT00424021|10872704|FG000|AMB-220-E Study Period|Adverse Event|1
6863317|NCT00424021|10872705|FG001|AMB-220-E Study Period|Adverse Event|1
6863318|NCT00424021|10872706|FG002|AMB-220-E Study Period|Adverse Event|3
6863319|NCT00424021|10872707|FG003|AMB-220-E Study Period|Adverse Event|7
6863320|NCT00424021|10872704|FG000|AMB-220-E Study Period|Death|0
6863321|NCT00424021|10872705|FG001|AMB-220-E Study Period|Death|0
6863322|NCT00424021|10872706|FG002|AMB-220-E Study Period|Death|1
6863323|NCT00424021|10872707|FG003|AMB-220-E Study Period|Death|1
6863324|NCT00424021|10872704|FG000|AMB-220-E Study Period|Lost to Follow-up|0
6863325|NCT00424021|10872705|FG001|AMB-220-E Study Period|Lost to Follow-up|1
6863326|NCT00424021|10872706|FG002|AMB-220-E Study Period|Lost to Follow-up|1
6863327|NCT00424021|10872707|FG003|AMB-220-E Study Period|Lost to Follow-up|1
6863328|NCT00424021|10872704|FG000|AMB-220-E Study Period|Physician Decision|0
6863329|NCT00424021|10872705|FG001|AMB-220-E Study Period|Physician Decision|0
6863330|NCT00424021|10872706|FG002|AMB-220-E Study Period|Physician Decision|0
6863331|NCT00424021|10872707|FG003|AMB-220-E Study Period|Physician Decision|1
6863332|NCT00424047|10872726|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18
6863333|NCT00424047|10872727|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12
6863334|NCT00424047|10872726|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67
6863335|NCT00424047|10872727|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122
6863336|NCT00424047|10872726|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1
6863337|NCT00424047|10872727|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3
6863338|NCT00424047|10872726|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23
6863339|NCT00424047|10872727|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8
6863340|NCT00424047|10872726|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11
6863341|NCT00424047|10872727|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10
6863342|NCT00424047|10872726|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2
6863343|NCT00424047|10872727|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1
6863344|NCT00424047|10872726|FG000|On Study at Time of Unblinding|Adverse Event|22
6863345|NCT00424047|10872727|FG001|On Study at Time of Unblinding|Adverse Event|12
6863346|NCT00424047|10872726|FG000|On Study at Time of Unblinding|Progression of disease|92
6863347|NCT00424047|10872727|FG001|On Study at Time of Unblinding|Progression of disease|128
6863348|NCT00424047|10872726|FG000|On Study at Time of Unblinding|Lack of Efficacy|1
6863349|NCT00424047|10872727|FG001|On Study at Time of Unblinding|Lack of Efficacy|3
6863350|NCT00424047|10872726|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24
6863351|NCT00424047|10872727|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9
6863352|NCT00424047|10872726|FG000|On Study at Time of Unblinding|Death|11
6863353|NCT00424047|10872727|FG001|On Study at Time of Unblinding|Death|11
6863354|NCT00424047|10872726|FG000|On Study at Time of Unblinding|Other|5
6863355|NCT00424047|10872727|FG001|On Study at Time of Unblinding|Other|4
6863356|NCT00424047|10872726|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1
6863357|NCT00424047|10872727|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0
6863358|NCT00424047|10872726|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0
6863359|NCT00424047|10872727|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1
6863360|NCT00424047|10872726|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12
6863361|NCT00424047|10872727|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4
6863362|NCT00424047|10872726|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7
6863363|NCT00424047|10872727|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3
6863364|NCT00424047|10872726|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1
7153416|NCT03285295|11318986|FG003|Alinity s Chagas|No Results Generated|0
7153417|NCT03285295|11318987|FG004|Alinity s Chagas|No Results Generated|0
7153418|NCT03285295|11318983|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13
7153419|NCT03285295|11318984|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0
7153420|NCT03285295|11318985|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0
7153421|NCT03285295|11318986|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0
7153422|NCT03285295|11318987|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0
7153423|NCT03285308|11319018|FG000|Overall Study|Adverse Event|3
7153424|NCT03285308|11319019|FG001|Overall Study|Adverse Event|7
7153425|NCT03285308|11319018|FG000|Overall Study|Withdrawal by Subject|8
7153426|NCT03285308|11319019|FG001|Overall Study|Withdrawal by Subject|9
7153427|NCT03285308|11319018|FG000|Overall Study|Lost to Follow-up|3
7153428|NCT03285308|11319019|FG001|Overall Study|Lost to Follow-up|1
7153429|NCT03285308|11319018|FG000|Overall Study|Protocol Deviation|6
7153430|NCT03285308|11319019|FG001|Overall Study|Protocol Deviation|5
7153431|NCT03285308|11319018|FG000|Overall Study|Reason not Specified|0
7153432|NCT03285308|11319019|FG001|Overall Study|Reason not Specified|1
7153433|NCT03285477|11319040|FG000|Treatment and Response Assessment Period|Death|1
6863365|NCT00424047|10872727|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0
7153434|NCT03285477|11319041|FG001|Treatment and Response Assessment Period|Death|0
7153435|NCT03285477|11319040|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1
7153436|NCT03285477|11319041|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0
6967912|NCT01134315|11016394|FG000|Overall Study|Other Reason|8
6863366|NCT00424177|10872738|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8
6863367|NCT00424177|10872738|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1
6863368|NCT00424177|10872738|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1
6863369|NCT00424177|10872738|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1
6863370|NCT00424177|10872738|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2
6863371|NCT00424177|10872738|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1
6863372|NCT00424177|10872738|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
6863373|NCT00424177|10872738|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1
6863374|NCT00424177|10872738|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
6863375|NCT00424177|10872738|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1
6863376|NCT00424190|10872752|FG000|Overall Study|Withdrew consent|3
6863377|NCT00424190|10872753|FG001|Overall Study|Withdrew consent|4
6863378|NCT00424190|10872752|FG000|Overall Study|Death|3
6863379|NCT00424190|10872753|FG001|Overall Study|Death|0
6863380|NCT00424190|10872752|FG000|Overall Study|Noncompliance|1
6863381|NCT00424190|10872753|FG001|Overall Study|Noncompliance|2
6863382|NCT00424190|10872752|FG000|Overall Study|Request of sponsor or investigator|0
6863383|NCT00424190|10872753|FG001|Overall Study|Request of sponsor or investigator|2
6863384|NCT00424190|10872752|FG000|Overall Study|Diagnosis of osteomyelitis|0
6863385|NCT00424190|10872753|FG001|Overall Study|Diagnosis of osteomyelitis|1
6863386|NCT00424190|10872752|FG000|Overall Study|Other|15
6863387|NCT00424190|10872753|FG001|Overall Study|Other|21
6863388|NCT00424255|10872761|FG000|Overall Study|Death|115
6863389|NCT00424255|10872762|FG001|Overall Study|Death|111
6863390|NCT00424255|10872761|FG000|Overall Study|Lost to Follow-up|26
6863391|NCT00424255|10872762|FG001|Overall Study|Lost to Follow-up|20
6863392|NCT00424255|10872761|FG000|Overall Study|Protocol Violation|0
6863393|NCT00424255|10872762|FG001|Overall Study|Protocol Violation|1
6863394|NCT00424255|10872761|FG000|Overall Study|Withdrawal by Subject|34
6863395|NCT00424255|10872762|FG001|Overall Study|Withdrawal by Subject|38
6863396|NCT00424255|10872761|FG000|Overall Study|Physician Decision|3
6863397|NCT00424255|10872762|FG001|Overall Study|Physician Decision|7
6863398|NCT00424255|10872761|FG000|Overall Study|Cognitive Disturbance|1
6863399|NCT00424255|10872762|FG001|Overall Study|Cognitive Disturbance|0
6863400|NCT00424255|10872761|FG000|Overall Study|Non-compliance by Participants|1
6863401|NCT00424255|10872762|FG001|Overall Study|Non-compliance by Participants|0
6863402|NCT00424255|10872761|FG000|Overall Study|Fatigue|1
6863403|NCT00424255|10872762|FG001|Overall Study|Fatigue|0
6863404|NCT00424255|10872761|FG000|Overall Study|Disease Progression|0
6863405|NCT00424255|10872762|FG001|Overall Study|Disease Progression|2
6863406|NCT00424255|10872761|FG000|Overall Study|Sponsor Terminated Study|161
6863407|NCT00424255|10872762|FG001|Overall Study|Sponsor Terminated Study|167
6863408|NCT00424294|10872779|FG000|Overall Study|Adverse Event|4
6863409|NCT00424294|10872780|FG001|Overall Study|Adverse Event|10
6863410|NCT00424294|10872779|FG000|Overall Study|Lack of Efficacy|2
6863411|NCT00424294|10872780|FG001|Overall Study|Lack of Efficacy|1
6863412|NCT00424294|10872779|FG000|Overall Study|Withdrawal by Subject|1
6863413|NCT00424294|10872780|FG001|Overall Study|Withdrawal by Subject|2
6863414|NCT00424294|10872779|FG000|Overall Study|Other|0
6863415|NCT00424294|10872780|FG001|Overall Study|Other|2
6863416|NCT00424294|10872779|FG000|Overall Study|Randomized but not Treated|1
6863417|NCT00424294|10872780|FG001|Overall Study|Randomized but not Treated|0
6863418|NCT00424346|10872790|FG000|Core Study|Adverse Event|5
6863419|NCT00424346|10872791|FG001|Core Study|Adverse Event|3
6863420|NCT00424346|10872792|FG002|Core Study|Adverse Event|1
6863421|NCT00424346|10872793|FG003|Core Study|Adverse Event|1
6863422|NCT00424346|10872790|FG000|Core Study|Abnormal Laboratory Values|0
7153437|NCT03285477|11319040|FG000|Recurrence Follow-up Period|Lost to Follow-up|0
7153438|NCT03285477|11319041|FG001|Recurrence Follow-up Period|Lost to Follow-up|1
7153439|NCT03285477|11319040|FG000|Recurrence Follow-up Period|Withdrawal of consent|1
7153440|NCT03285477|11319041|FG001|Recurrence Follow-up Period|Withdrawal of consent|3
7153441|NCT03285477|11319040|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5
7153442|NCT03285477|11319041|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51
7153443|NCT03285490|11319050|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0
7153444|NCT03285490|11319051|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1
7153445|NCT03285490|11319050|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18
7153446|NCT03285490|11319051|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60
7153447|NCT03285594|11319088|FG000|Overall Study|At the Participant's Own Request|10
7153448|NCT03285594|11319089|FG001|Overall Study|At the Participant's Own Request|5
7153449|NCT03285594|11319090|FG002|Overall Study|At the Participant's Own Request|21
6863423|NCT00424346|10872791|FG001|Core Study|Abnormal Laboratory Values|1
6863424|NCT00424346|10872792|FG002|Core Study|Abnormal Laboratory Values|0
6863425|NCT00424346|10872793|FG003|Core Study|Abnormal Laboratory Values|0
6863426|NCT00424346|10872790|FG000|Core Study|Lack of Efficacy|1
6863427|NCT00424346|10872791|FG001|Core Study|Lack of Efficacy|3
6863428|NCT00424346|10872792|FG002|Core Study|Lack of Efficacy|0
6863429|NCT00424346|10872793|FG003|Core Study|Lack of Efficacy|4
7153450|NCT03285594|11319088|FG000|Overall Study|Adverse Event|2
6863430|NCT00424346|10872790|FG000|Core Study|Withdrawal by Subject|1
6863431|NCT00424346|10872791|FG001|Core Study|Withdrawal by Subject|0
6863432|NCT00424346|10872792|FG002|Core Study|Withdrawal by Subject|0
6863433|NCT00424346|10872793|FG003|Core Study|Withdrawal by Subject|2
6863434|NCT00424346|10872790|FG000|Core Study|Lost to Follow-up|1
6863435|NCT00424346|10872791|FG001|Core Study|Lost to Follow-up|1
6863436|NCT00424346|10872792|FG002|Core Study|Lost to Follow-up|0
6863437|NCT00424346|10872793|FG003|Core Study|Lost to Follow-up|0
6863438|NCT00424346|10872790|FG000|Core Study|Administrative Problems|1
6863439|NCT00424346|10872791|FG001|Core Study|Administrative Problems|0
6863440|NCT00424346|10872792|FG002|Core Study|Administrative Problems|1
7041112|NCT01723397|11124544|FG001|Study Period 2|Protocol Violation|1
7041113|NCT01723826|11124607|FG000|Overall Study|Adverse Event|4
7041114|NCT01723826|11124608|FG001|Overall Study|Adverse Event|1
7041115|NCT01723826|11124609|FG002|Overall Study|Adverse Event|4
7041116|NCT01723826|11124610|FG003|Overall Study|Adverse Event|5
7041117|NCT01723826|11124607|FG000|Overall Study|Death according to AE eCRF|2
7041118|NCT01723826|11124608|FG001|Overall Study|Death according to AE eCRF|3
7078167|NCT02100670|11186409|FG000|Overall Study|Poor Efficacy|0
7078168|NCT02100670|11186410|FG001|Overall Study|Poor Efficacy|1
7153451|NCT03285594|11319089|FG001|Overall Study|Adverse Event|2
7153452|NCT03285594|11319090|FG002|Overall Study|Adverse Event|6
7153453|NCT03285594|11319088|FG000|Overall Study|Poor Compliance to Protocol|0
7153454|NCT03285594|11319089|FG001|Overall Study|Poor Compliance to Protocol|0
7153455|NCT03285594|11319090|FG002|Overall Study|Poor Compliance to Protocol|1
7153456|NCT03285594|11319088|FG000|Overall Study|Lost to Follow-up|0
7153457|NCT03285594|11319089|FG001|Overall Study|Lost to Follow-up|0
7153458|NCT03285594|11319090|FG002|Overall Study|Lost to Follow-up|1
7153459|NCT03285594|11319088|FG000|Overall Study|Reason Not Specified|3
7153460|NCT03285594|11319089|FG001|Overall Study|Reason Not Specified|4
7153461|NCT03285594|11319090|FG002|Overall Study|Reason Not Specified|8
7184129|NCT01755689|11384113|FG002|Overall Study|Lost to Follow-up|1
7184130|NCT01755689|11384114|FG003|Overall Study|Lost to Follow-up|0
6863441|NCT00424346|10872793|FG003|Core Study|Administrative Problems|0
7041119|NCT01723826|11124609|FG002|Overall Study|Death according to AE eCRF|3
7184131|NCT01755689|11384115|FG004|Overall Study|Lost to Follow-up|2
7184132|NCT01755689|11384111|FG000|Overall Study|Pregnancy|1
7184133|NCT01755689|11384112|FG001|Overall Study|Pregnancy|1
7184134|NCT01755689|11384113|FG002|Overall Study|Pregnancy|2
7184135|NCT01755689|11384114|FG003|Overall Study|Pregnancy|4
7184136|NCT01755689|11384115|FG004|Overall Study|Pregnancy|2
7187272|NCT00602667|11387788|FG000|Overall Study|Excessive toxicity|1
7187273|NCT00602667|11387789|FG001|Overall Study|Excessive toxicity|1
7187274|NCT00602667|11387790|FG002|Overall Study|Excessive toxicity|0
7187275|NCT00602667|11387788|FG000|Overall Study|Second malignancy|0
7187276|NCT00602667|11387789|FG001|Overall Study|Second malignancy|1
7187277|NCT00602667|11387790|FG002|Overall Study|Second malignancy|0
7187278|NCT00602667|11387788|FG000|Overall Study|Physician Decision|2
7187279|NCT00602667|11387789|FG001|Overall Study|Physician Decision|3
7187280|NCT00602667|11387790|FG002|Overall Study|Physician Decision|8
7187281|NCT00602667|11387788|FG000|Overall Study|Progressive disease|13
7187282|NCT00602667|11387789|FG001|Overall Study|Progressive disease|48
7187283|NCT00602667|11387790|FG002|Overall Study|Progressive disease|45
7187284|NCT00602667|11387788|FG000|Overall Study|Progressive disease prior to therapy|0
7187285|NCT00602667|11387789|FG001|Overall Study|Progressive disease prior to therapy|0
7187286|NCT00602667|11387790|FG002|Overall Study|Progressive disease prior to therapy|1
7187287|NCT00472186|11387831|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1
7187288|NCT00472186|11387832|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0
7188265|NCT02906020|11388824|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4
7188266|NCT02906020|11388825|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0
7188267|NCT02906020|11388826|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1
7188268|NCT02906020|11388811|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7188269|NCT02906020|11388812|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7188270|NCT02906020|11388813|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7188271|NCT02906020|11388814|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
6863442|NCT00424346|10872790|FG000|Core Study|Protocol Violation|0
6863443|NCT00424346|10872791|FG001|Core Study|Protocol Violation|0
7041120|NCT01723826|11124610|FG003|Overall Study|Death according to AE eCRF|7
7041121|NCT01723826|11124607|FG000|Overall Study|Lost to Follow-up|1
7041122|NCT01723826|11124608|FG001|Overall Study|Lost to Follow-up|3
7041123|NCT01723826|11124609|FG002|Overall Study|Lost to Follow-up|1
7041124|NCT01723826|11124610|FG003|Overall Study|Lost to Follow-up|1
7041125|NCT01723826|11124607|FG000|Overall Study|Non-compliance|0
7041126|NCT01723826|11124608|FG001|Overall Study|Non-compliance|1
7041127|NCT01723826|11124609|FG002|Overall Study|Non-compliance|3
7041128|NCT01723826|11124610|FG003|Overall Study|Non-compliance|3
7041129|NCT01723826|11124607|FG000|Overall Study|Non-compliance With Study Drug|0
7041130|NCT01723826|11124608|FG001|Overall Study|Non-compliance With Study Drug|1
7078169|NCT02100670|11186411|FG002|Overall Study|Poor Efficacy|0
7078170|NCT02100670|11186412|FG003|Overall Study|Poor Efficacy|0
7188272|NCT02906020|11388815|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7188273|NCT02906020|11388816|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7188274|NCT02906020|11388817|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7188275|NCT02906020|11388818|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
6863444|NCT00424346|10872792|FG002|Core Study|Protocol Violation|2
6863445|NCT00424346|10872793|FG003|Core Study|Protocol Violation|0
6863446|NCT00424346|10872790|FG000|Extension Phase|Adverse Event|0
6863447|NCT00424346|10872791|FG001|Extension Phase|Adverse Event|9
6863448|NCT00424346|10872792|FG002|Extension Phase|Adverse Event|5
6863449|NCT00424346|10872793|FG003|Extension Phase|Adverse Event|4
6863450|NCT00424346|10872790|FG000|Extension Phase|Lack of Efficacy|0
6863451|NCT00424346|10872791|FG001|Extension Phase|Lack of Efficacy|16
6863452|NCT00424346|10872792|FG002|Extension Phase|Lack of Efficacy|14
6863453|NCT00424346|10872793|FG003|Extension Phase|Lack of Efficacy|11
6863454|NCT00424346|10872790|FG000|Extension Phase|Withdrawal by Subject|0
6863455|NCT00424346|10872791|FG001|Extension Phase|Withdrawal by Subject|5
6863456|NCT00424346|10872792|FG002|Extension Phase|Withdrawal by Subject|3
6863457|NCT00424346|10872793|FG003|Extension Phase|Withdrawal by Subject|4
6863458|NCT00424346|10872790|FG000|Extension Phase|Lost to Follow-up|0
6863459|NCT00424346|10872791|FG001|Extension Phase|Lost to Follow-up|2
6863460|NCT00424346|10872792|FG002|Extension Phase|Lost to Follow-up|0
6863461|NCT00424346|10872793|FG003|Extension Phase|Lost to Follow-up|0
6863462|NCT00424346|10872790|FG000|Extension Phase|Administrative Problems|0
6863463|NCT00424346|10872791|FG001|Extension Phase|Administrative Problems|69
6863464|NCT00424346|10872792|FG002|Extension Phase|Administrative Problems|32
6863465|NCT00424346|10872793|FG003|Extension Phase|Administrative Problems|35
6863466|NCT00424346|10872790|FG000|Extension Phase|Death|0
6863467|NCT00424346|10872791|FG001|Extension Phase|Death|0
6863468|NCT00424346|10872792|FG002|Extension Phase|Death|0
6863469|NCT00424346|10872793|FG003|Extension Phase|Death|1
6863470|NCT00424346|10872790|FG000|Extension Phase|Protocol Violation|0
7153462|NCT03285646|11319101|FG000|Overall Study|Adverse Event|1
7153463|NCT03285646|11319102|FG001|Overall Study|Adverse Event|0
7153464|NCT03285646|11319101|FG000|Overall Study|Withdrawal by Subject|10
7153465|NCT03285646|11319102|FG001|Overall Study|Withdrawal by Subject|2
7153466|NCT03285646|11319101|FG000|Overall Study|Lost to Follow-up|2
7153467|NCT03285646|11319102|FG001|Overall Study|Lost to Follow-up|1
7153468|NCT03285646|11319101|FG000|Overall Study|Investigator/Sponsor Decision|0
7153469|NCT03285646|11319102|FG001|Overall Study|Investigator/Sponsor Decision|1
7153470|NCT03285711|11319111|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2
7153471|NCT03285711|11319112|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1
7153472|NCT03285711|11319113|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0
7153473|NCT03285711|11319114|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0
7153474|NCT03285711|11319111|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1
7153475|NCT03285711|11319112|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0
7153476|NCT03285711|11319113|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0
7153477|NCT03285711|11319114|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0
7153478|NCT03285711|11319111|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0
7153479|NCT03285711|11319112|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0
7153480|NCT03285711|11319113|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1
7153481|NCT03285711|11319114|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0
7153482|NCT03285711|11319111|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0
7153483|NCT03285711|11319112|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1
7153484|NCT03285711|11319113|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0
7153485|NCT03285711|11319114|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0
7153486|NCT03285958|11319130|FG000|Overall Study|Lost to Follow-up|1
7153487|NCT03285958|11319131|FG001|Overall Study|Lost to Follow-up|1
7153488|NCT03285958|11319130|FG000|Overall Study|Withdrawal by Subject|1
7153489|NCT03285958|11319131|FG001|Overall Study|Withdrawal by Subject|0
7153490|NCT03285958|11319130|FG000|Overall Study|Not able to attend required orientation|3
7153491|NCT03285958|11319131|FG001|Overall Study|Not able to attend required orientation|0
7153492|NCT03286218|11319150|FG000|Qualification Phase Period 1|Adverse Event|1
7153493|NCT03286218|11319151|FG001|Qualification Phase Period 1|Adverse Event|0
7153494|NCT03286218|11319152|FG002|Qualification Phase Period 1|Adverse Event|0
7153495|NCT03286218|11319153|FG003|Qualification Phase Period 1|Adverse Event|0
7153496|NCT03286218|11319154|FG004|Qualification Phase Period 1|Adverse Event|0
7153497|NCT03286218|11319155|FG005|Qualification Phase Period 1|Adverse Event|0
7153498|NCT03286218|11319156|FG006|Qualification Phase Period 1|Adverse Event|0
7153499|NCT03286218|11319157|FG007|Qualification Phase Period 1|Adverse Event|0
7153500|NCT03286218|11319158|FG008|Qualification Phase Period 1|Adverse Event|0
7153501|NCT03286218|11319159|FG009|Qualification Phase Period 1|Adverse Event|0
7153502|NCT03286218|11319160|FG010|Qualification Phase Period 1|Adverse Event|0
7153503|NCT03286218|11319161|FG011|Qualification Phase Period 1|Adverse Event|0
7153504|NCT03286218|11319150|FG000|Qualification Phase Period 1|Withdrawal by Subject|0
7153505|NCT03286218|11319151|FG001|Qualification Phase Period 1|Withdrawal by Subject|1
7153506|NCT03286218|11319152|FG002|Qualification Phase Period 1|Withdrawal by Subject|0
7153507|NCT03286218|11319153|FG003|Qualification Phase Period 1|Withdrawal by Subject|0
7153508|NCT03286218|11319154|FG004|Qualification Phase Period 1|Withdrawal by Subject|0
6863471|NCT00424346|10872791|FG001|Extension Phase|Protocol Violation|1
6863472|NCT00424346|10872792|FG002|Extension Phase|Protocol Violation|1
6863473|NCT00424346|10872793|FG003|Extension Phase|Protocol Violation|0
6863474|NCT00424372|10872806|FG000|Overall Study|Death|1
6863475|NCT00424372|10872806|FG000|Overall Study|Adverse Event|18
6863476|NCT00424372|10872806|FG000|Overall Study|Lack of Efficacy|6
6863477|NCT00424372|10872806|FG000|Overall Study|Withdrawal by Subject|4
6863478|NCT00424372|10872806|FG000|Overall Study|Protocol Violation|1
6863479|NCT00424372|10872806|FG000|Overall Study|Health deterioration|1
6863480|NCT00424385|10872810|FG000|Cohort 0|Withdrawal by Subject|5
6863481|NCT00424385|10872810|FG000|Cohort 0|Physician Decision|1
6863482|NCT00424385|10872810|FG000|Cohort 1|Withdrawal by Subject|1
6863483|NCT00424398|10872819|FG000|Overall Study|Withdrawal by Subject|2
6863484|NCT00424398|10872820|FG001|Overall Study|Withdrawal by Subject|1
6863485|NCT00424398|10872821|FG002|Overall Study|Withdrawal by Subject|0
6863486|NCT00424398|10872819|FG000|Overall Study|Subject met exclusion criteria|1
6863487|NCT00424398|10872820|FG001|Overall Study|Subject met exclusion criteria|0
6863488|NCT00424398|10872821|FG002|Overall Study|Subject met exclusion criteria|0
6863489|NCT00424463|10872832|FG000|Overall Study|Adverse Event|2
6863490|NCT00424463|10872833|FG001|Overall Study|Adverse Event|3
6863491|NCT00424463|10872834|FG002|Overall Study|Adverse Event|2
6863492|NCT00424463|10872832|FG000|Overall Study|Physician Decision|0
6863493|NCT00424463|10872833|FG001|Overall Study|Physician Decision|2
6863494|NCT00424463|10872834|FG002|Overall Study|Physician Decision|2
6863495|NCT00424463|10872832|FG000|Overall Study|Withdrawal by Subject|4
6863496|NCT00424463|10872833|FG001|Overall Study|Withdrawal by Subject|2
6863497|NCT00424463|10872834|FG002|Overall Study|Withdrawal by Subject|5
6863498|NCT00424463|10872832|FG000|Overall Study|Tracheotomy due to worsening of ALS|1
6863499|NCT00424463|10872833|FG001|Overall Study|Tracheotomy due to worsening of ALS|7
7153509|NCT03286218|11319155|FG005|Qualification Phase Period 1|Withdrawal by Subject|0
7153510|NCT03286218|11319156|FG006|Qualification Phase Period 1|Withdrawal by Subject|0
7153511|NCT03286218|11319157|FG007|Qualification Phase Period 1|Withdrawal by Subject|0
7153512|NCT03286218|11319158|FG008|Qualification Phase Period 1|Withdrawal by Subject|0
7153513|NCT03286218|11319159|FG009|Qualification Phase Period 1|Withdrawal by Subject|0
7153514|NCT03286218|11319160|FG010|Qualification Phase Period 1|Withdrawal by Subject|0
7153515|NCT03286218|11319161|FG011|Qualification Phase Period 1|Withdrawal by Subject|0
7153516|NCT03286218|11319150|FG000|Qualification Phase Period 2|Adverse Event|0
7153517|NCT03286218|11319151|FG001|Qualification Phase Period 2|Adverse Event|1
7153518|NCT03286218|11319152|FG002|Qualification Phase Period 2|Adverse Event|0
7153519|NCT03286218|11319153|FG003|Qualification Phase Period 2|Adverse Event|0
7153520|NCT03286218|11319154|FG004|Qualification Phase Period 2|Adverse Event|0
7153521|NCT03286218|11319155|FG005|Qualification Phase Period 2|Adverse Event|0
7153522|NCT03286218|11319156|FG006|Qualification Phase Period 2|Adverse Event|0
7153523|NCT03286218|11319157|FG007|Qualification Phase Period 2|Adverse Event|0
7153524|NCT03286218|11319158|FG008|Qualification Phase Period 2|Adverse Event|0
7153525|NCT03286218|11319159|FG009|Qualification Phase Period 2|Adverse Event|0
7153526|NCT03286218|11319160|FG010|Qualification Phase Period 2|Adverse Event|0
7153527|NCT03286218|11319161|FG011|Qualification Phase Period 2|Adverse Event|0
7153528|NCT03286218|11319150|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14
7153529|NCT03286218|11319151|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15
7153530|NCT03286218|11319152|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0
7153531|NCT03286218|11319153|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0
7153532|NCT03286218|11319154|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0
7153533|NCT03286218|11319155|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0
7153534|NCT03286218|11319156|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0
7153535|NCT03286218|11319157|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0
7153536|NCT03286218|11319158|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0
7153537|NCT03286218|11319159|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0
7153538|NCT03286218|11319160|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0
7153539|NCT03286218|11319161|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0
7153540|NCT03286218|11319150|FG000|Qualification Phase Period 2|Lost to Follow-up|0
7153541|NCT03286218|11319151|FG001|Qualification Phase Period 2|Lost to Follow-up|1
7153542|NCT03286218|11319152|FG002|Qualification Phase Period 2|Lost to Follow-up|0
7153543|NCT03286218|11319153|FG003|Qualification Phase Period 2|Lost to Follow-up|0
7153544|NCT03286218|11319154|FG004|Qualification Phase Period 2|Lost to Follow-up|0
7153545|NCT03286218|11319155|FG005|Qualification Phase Period 2|Lost to Follow-up|0
7153546|NCT03286218|11319156|FG006|Qualification Phase Period 2|Lost to Follow-up|0
7153547|NCT03286218|11319157|FG007|Qualification Phase Period 2|Lost to Follow-up|0
7153548|NCT03286218|11319158|FG008|Qualification Phase Period 2|Lost to Follow-up|0
7153549|NCT03286218|11319159|FG009|Qualification Phase Period 2|Lost to Follow-up|0
7153550|NCT03286218|11319160|FG010|Qualification Phase Period 2|Lost to Follow-up|0
7153551|NCT03286218|11319161|FG011|Qualification Phase Period 2|Lost to Follow-up|0
7153552|NCT03286218|11319150|FG000|Qualification Phase Period 2|Protocol Violation|2
7153553|NCT03286218|11319151|FG001|Qualification Phase Period 2|Protocol Violation|0
7153554|NCT03286218|11319152|FG002|Qualification Phase Period 2|Protocol Violation|0
7153555|NCT03286218|11319153|FG003|Qualification Phase Period 2|Protocol Violation|0
7153556|NCT03286218|11319154|FG004|Qualification Phase Period 2|Protocol Violation|0
7153557|NCT03286218|11319155|FG005|Qualification Phase Period 2|Protocol Violation|0
6863500|NCT00424463|10872834|FG002|Overall Study|Tracheotomy due to worsening of ALS|6
6863501|NCT00424463|10872832|FG000|Overall Study|Patient's convenience|0
6863502|NCT00424463|10872833|FG001|Overall Study|Patient's convenience|0
6863503|NCT00424463|10872834|FG002|Overall Study|Patient's convenience|1
6863504|NCT00424476|10872845|FG000|Overall Study|Withdrawal by Subject|7
6863505|NCT00424476|10872846|FG001|Overall Study|Withdrawal by Subject|6
6863506|NCT00424476|10872847|FG002|Overall Study|Withdrawal by Subject|3
6863507|NCT00424476|10872845|FG000|Overall Study|Adverse Event|19
6863508|NCT00424476|10872846|FG001|Overall Study|Adverse Event|16
6863509|NCT00424476|10872847|FG002|Overall Study|Adverse Event|15
6863510|NCT00424476|10872845|FG000|Overall Study|Lack of Efficacy|16
6863511|NCT00424476|10872846|FG001|Overall Study|Lack of Efficacy|12
6863512|NCT00424476|10872847|FG002|Overall Study|Lack of Efficacy|12
6863513|NCT00424476|10872845|FG000|Overall Study|Lack of Compliance|1
6863514|NCT00424476|10872846|FG001|Overall Study|Lack of Compliance|1
7153558|NCT03286218|11319156|FG006|Qualification Phase Period 2|Protocol Violation|0
7153559|NCT03286218|11319157|FG007|Qualification Phase Period 2|Protocol Violation|0
7153560|NCT03286218|11319158|FG008|Qualification Phase Period 2|Protocol Violation|0
7153561|NCT03286218|11319159|FG009|Qualification Phase Period 2|Protocol Violation|0
7153562|NCT03286218|11319160|FG010|Qualification Phase Period 2|Protocol Violation|0
7153563|NCT03286218|11319161|FG011|Qualification Phase Period 2|Protocol Violation|0
7153564|NCT03286218|11319150|FG000|Qualification Phase Period 2|Withdrawal by Subject|1
7153565|NCT03286218|11319151|FG001|Qualification Phase Period 2|Withdrawal by Subject|2
7153566|NCT03286218|11319152|FG002|Qualification Phase Period 2|Withdrawal by Subject|0
7153567|NCT03286218|11319153|FG003|Qualification Phase Period 2|Withdrawal by Subject|0
7153568|NCT03286218|11319154|FG004|Qualification Phase Period 2|Withdrawal by Subject|0
7153569|NCT03286218|11319155|FG005|Qualification Phase Period 2|Withdrawal by Subject|0
7153570|NCT03286218|11319156|FG006|Qualification Phase Period 2|Withdrawal by Subject|0
7153571|NCT03286218|11319157|FG007|Qualification Phase Period 2|Withdrawal by Subject|0
7153572|NCT03286218|11319158|FG008|Qualification Phase Period 2|Withdrawal by Subject|0
7153573|NCT03286218|11319159|FG009|Qualification Phase Period 2|Withdrawal by Subject|0
7153574|NCT03286218|11319160|FG010|Qualification Phase Period 2|Withdrawal by Subject|0
7153575|NCT03286218|11319161|FG011|Qualification Phase Period 2|Withdrawal by Subject|0
7153576|NCT03286218|11319150|FG000|Treatment Phase Period 1|Withdrawal by Subject|0
7153577|NCT03286218|11319151|FG001|Treatment Phase Period 1|Withdrawal by Subject|0
7153578|NCT03286218|11319152|FG002|Treatment Phase Period 1|Withdrawal by Subject|1
7153579|NCT03286218|11319153|FG003|Treatment Phase Period 1|Withdrawal by Subject|1
7153580|NCT03286218|11319154|FG004|Treatment Phase Period 1|Withdrawal by Subject|0
7153581|NCT03286218|11319155|FG005|Treatment Phase Period 1|Withdrawal by Subject|1
7153582|NCT03286218|11319156|FG006|Treatment Phase Period 1|Withdrawal by Subject|0
7153583|NCT03286218|11319157|FG007|Treatment Phase Period 1|Withdrawal by Subject|0
7153584|NCT03286218|11319158|FG008|Treatment Phase Period 1|Withdrawal by Subject|0
7153585|NCT03286218|11319159|FG009|Treatment Phase Period 1|Withdrawal by Subject|0
7153586|NCT03286218|11319160|FG010|Treatment Phase Period 1|Withdrawal by Subject|0
7153587|NCT03286218|11319161|FG011|Treatment Phase Period 1|Withdrawal by Subject|1
7153588|NCT03286218|11319150|FG000|Treatment Phase Period 4|Withdrawal by Subject|0
7153589|NCT03286218|11319151|FG001|Treatment Phase Period 4|Withdrawal by Subject|0
7153590|NCT03286218|11319152|FG002|Treatment Phase Period 4|Withdrawal by Subject|0
7153591|NCT03286218|11319153|FG003|Treatment Phase Period 4|Withdrawal by Subject|0
7153592|NCT03286218|11319154|FG004|Treatment Phase Period 4|Withdrawal by Subject|0
7153593|NCT03286218|11319155|FG005|Treatment Phase Period 4|Withdrawal by Subject|0
7153594|NCT03286218|11319156|FG006|Treatment Phase Period 4|Withdrawal by Subject|0
7153595|NCT03286218|11319157|FG007|Treatment Phase Period 4|Withdrawal by Subject|0
7153596|NCT03286218|11319158|FG008|Treatment Phase Period 4|Withdrawal by Subject|0
7153597|NCT03286218|11319159|FG009|Treatment Phase Period 4|Withdrawal by Subject|0
7153598|NCT03286218|11319160|FG010|Treatment Phase Period 4|Withdrawal by Subject|0
7153599|NCT03286218|11319161|FG011|Treatment Phase Period 4|Withdrawal by Subject|1
7153600|NCT03286400|11319192|FG000|Overall Study|Death|10
7153601|NCT03286400|11319192|FG000|Overall Study|Lost to Follow-up|10
7153602|NCT03286400|11319192|FG000|Overall Study|Physician Decision|1
7153603|NCT03286400|11319192|FG000|Overall Study|Scheduling difficulty|4
7153604|NCT03286543|11319207|FG000|Consented|Screen failure before randomization|2
7153605|NCT03286543|11319208|FG001|Consented|Screen failure before randomization|0
7153606|NCT03286543|11319209|FG002|Consented|Screen failure before randomization|0
7153607|NCT03286543|11319207|FG000|Consented|Screen failure before enrollment|4
7153608|NCT03286543|11319208|FG001|Consented|Screen failure before enrollment|0
7153609|NCT03286543|11319209|FG002|Consented|Screen failure before enrollment|0
7153610|NCT03286543|11319207|FG000|Consented|TKA cancelled after enrollment|1
7153611|NCT03286543|11319208|FG001|Consented|TKA cancelled after enrollment|0
7153612|NCT03286543|11319209|FG002|Consented|TKA cancelled after enrollment|0
7153613|NCT03286543|11319207|FG000|Consented|Withdrawn from study|12
7153614|NCT03286543|11319208|FG001|Consented|Withdrawn from study|0
7153615|NCT03286543|11319209|FG002|Consented|Withdrawn from study|0
7153616|NCT03286543|11319207|FG000|Study Enrollment|TKA cancelled after enrollment|0
7153617|NCT03286543|11319208|FG001|Study Enrollment|TKA cancelled after enrollment|0
6863515|NCT00424476|10872847|FG002|Overall Study|Lack of Compliance|1
6863516|NCT00424476|10872845|FG000|Overall Study|Lost to Follow-up|4
7153618|NCT03286543|11319209|FG002|Study Enrollment|TKA cancelled after enrollment|1
7153619|NCT03286543|11319207|FG000|Study Enrollment|Withdrawn from study|0
6863517|NCT00424476|10872846|FG001|Overall Study|Lost to Follow-up|6
6863518|NCT00424476|10872847|FG002|Overall Study|Lost to Follow-up|3
6863519|NCT00424476|10872845|FG000|Overall Study|Protocol Violation|7
6863520|NCT00424476|10872846|FG001|Overall Study|Protocol Violation|2
7153620|NCT03286543|11319208|FG001|Study Enrollment|Withdrawn from study|6
7153621|NCT03286543|11319209|FG002|Study Enrollment|Withdrawn from study|6
7153622|NCT03286751|11319215|FG000|Washout Period 1|Withdrawal by Subject|0
7153623|NCT03286751|11319216|FG001|Washout Period 1|Withdrawal by Subject|0
7153624|NCT03286751|11319217|FG002|Washout Period 1|Withdrawal by Subject|0
7153625|NCT03286751|11319218|FG003|Washout Period 1|Withdrawal by Subject|0
7153626|NCT03286751|11319219|FG004|Washout Period 1|Withdrawal by Subject|1
7153627|NCT03286751|11319220|FG005|Washout Period 1|Withdrawal by Subject|0
7153628|NCT03286751|11319215|FG000|Washout Period 2|Personal Reasons|0
7153629|NCT03286751|11319216|FG001|Washout Period 2|Personal Reasons|1
7153630|NCT03286751|11319217|FG002|Washout Period 2|Personal Reasons|0
7153631|NCT03286751|11319218|FG003|Washout Period 2|Personal Reasons|0
7153632|NCT03286751|11319219|FG004|Washout Period 2|Personal Reasons|0
7153633|NCT03286751|11319220|FG005|Washout Period 2|Personal Reasons|0
7153634|NCT03286751|11319215|FG000|Washout Period 5|Adverse Event|0
7153635|NCT03286751|11319216|FG001|Washout Period 5|Adverse Event|0
7153636|NCT03286751|11319217|FG002|Washout Period 5|Adverse Event|0
7153637|NCT03286751|11319218|FG003|Washout Period 5|Adverse Event|0
7153638|NCT03286751|11319219|FG004|Washout Period 5|Adverse Event|1
7153639|NCT03286751|11319220|FG005|Washout Period 5|Adverse Event|0
7153640|NCT03287219|11319255|FG000|Overall Study|Protocol Violation|0
7153641|NCT03287219|11319256|FG001|Overall Study|Protocol Violation|2
7153642|NCT03287622|11319330|FG000|Overall Study|Withdrawal by Subject|1
7153643|NCT03287622|11319331|FG001|Overall Study|Withdrawal by Subject|0
7153644|NCT03287622|11319330|FG000|Overall Study|Lost to Follow-up|27
7153645|NCT03287622|11319331|FG001|Overall Study|Lost to Follow-up|15
7153646|NCT03287622|11319330|FG000|Overall Study|No prescripion after surgery|28
7153647|NCT03287622|11319331|FG001|Overall Study|No prescripion after surgery|31
7153648|NCT03287622|11319330|FG000|Overall Study|prolonged Length of stay|2
7153649|NCT03287622|11319331|FG001|Overall Study|prolonged Length of stay|0
7153650|NCT03287622|11319330|FG000|Overall Study|surgery related|0
7153651|NCT03287622|11319331|FG001|Overall Study|surgery related|2
7153652|NCT03287635|11319344|FG000|Overall Study|Lost to Follow-up|5
7153653|NCT03287635|11319344|FG000|Overall Study|Withdrawal by Subject|1
7153654|NCT03287635|11319344|FG000|Overall Study|Physician Decision|1
7153655|NCT03287791|11319356|FG000|Overall Study|Insufficient Therapeutic Response|0
7153656|NCT03287791|11319357|FG001|Overall Study|Insufficient Therapeutic Response|0
7153657|NCT03287791|11319358|FG002|Overall Study|Insufficient Therapeutic Response|1
7153658|NCT03287791|11319356|FG000|Overall Study|Adverse Event|0
7153659|NCT03287791|11319357|FG001|Overall Study|Adverse Event|4
7153660|NCT03287791|11319358|FG002|Overall Study|Adverse Event|3
7153661|NCT03287791|11319356|FG000|Overall Study|Withdrawal by Subject|12
7153662|NCT03287791|11319357|FG001|Overall Study|Withdrawal by Subject|12
7153663|NCT03287791|11319358|FG002|Overall Study|Withdrawal by Subject|17
7153664|NCT03287791|11319356|FG000|Overall Study|Missed more than 6 consecutive doses|3
7153665|NCT03287791|11319357|FG001|Overall Study|Missed more than 6 consecutive doses|2
7153666|NCT03287791|11319358|FG002|Overall Study|Missed more than 6 consecutive doses|2
7153667|NCT03287791|11319356|FG000|Overall Study|Lost to Follow-up|8
7153668|NCT03287791|11319357|FG001|Overall Study|Lost to Follow-up|14
7153669|NCT03287791|11319358|FG002|Overall Study|Lost to Follow-up|11
7153670|NCT03287791|11319356|FG000|Overall Study|Protocol Violation|7
7153671|NCT03287791|11319357|FG001|Overall Study|Protocol Violation|2
7153672|NCT03287791|11319358|FG002|Overall Study|Protocol Violation|1
7153673|NCT03287791|11319356|FG000|Overall Study|Participant was enrolled at 2 sites|1
7153674|NCT03287791|11319357|FG001|Overall Study|Participant was enrolled at 2 sites|0
7153675|NCT03287791|11319358|FG002|Overall Study|Participant was enrolled at 2 sites|1
7153676|NCT03287791|11319356|FG000|Overall Study|Too much time between 2 visits|0
7153677|NCT03287791|11319357|FG001|Overall Study|Too much time between 2 visits|1
7153678|NCT03287791|11319358|FG002|Overall Study|Too much time between 2 visits|0
7153679|NCT03287791|11319356|FG000|Overall Study|Non-compliance|0
7153680|NCT03287791|11319357|FG001|Overall Study|Non-compliance|1
7153681|NCT03287791|11319358|FG002|Overall Study|Non-compliance|0
7153682|NCT03287791|11319356|FG000|Overall Study|Did not meet inclusion criteria|1
7153683|NCT03287791|11319357|FG001|Overall Study|Did not meet inclusion criteria|0
7153684|NCT03287791|11319358|FG002|Overall Study|Did not meet inclusion criteria|0
7153685|NCT03287804|11319366|FG000|Overall Study|Death|1
7153686|NCT03287804|11319366|FG000|Overall Study|Physician Decision|2
7153687|NCT03287804|11319366|FG000|Overall Study|Progressive disease|8
7153688|NCT03287869|11319373|FG000|Overall Study|Adverse Event|14
7153689|NCT03287869|11319374|FG001|Overall Study|Adverse Event|12
6863521|NCT00424476|10872847|FG002|Overall Study|Protocol Violation|3
6863522|NCT00424476|10872845|FG000|Overall Study|Physician Decision|3
7153690|NCT03287869|11319373|FG000|Overall Study|Lack of Efficacy|1
7153691|NCT03287869|11319374|FG001|Overall Study|Lack of Efficacy|0
7153692|NCT03287869|11319373|FG000|Overall Study|Lost to Follow-up|13
7153693|NCT03287869|11319374|FG001|Overall Study|Lost to Follow-up|19
7153694|NCT03287869|11319373|FG000|Overall Study|Non-Compliance With Study Drug|5
7153695|NCT03287869|11319374|FG001|Overall Study|Non-Compliance With Study Drug|9
6863523|NCT00424476|10872846|FG001|Overall Study|Physician Decision|2
7153696|NCT03287869|11319373|FG000|Overall Study|Progressive Disease|1
7153697|NCT03287869|11319374|FG001|Overall Study|Progressive Disease|0
7153698|NCT03287869|11319373|FG000|Overall Study|Protocol Deviation|2
7153699|NCT03287869|11319374|FG001|Overall Study|Protocol Deviation|1
7153700|NCT03287869|11319373|FG000|Overall Study|Withdrawal by Subject|36
7153701|NCT03287869|11319374|FG001|Overall Study|Withdrawal by Subject|43
7153702|NCT03287869|11319373|FG000|Overall Study|Early Closure of the Site|0
7153703|NCT03287869|11319374|FG001|Overall Study|Early Closure of the Site|1
7153704|NCT03287869|11319373|FG000|Overall Study|Physician Decision|5
7153705|NCT03287869|11319374|FG001|Overall Study|Physician Decision|5
7153706|NCT03287869|11319373|FG000|Overall Study|Reason not Specified|6
7153707|NCT03287869|11319374|FG001|Overall Study|Reason not Specified|3
7153708|NCT03288714|11319382|FG000|Overall Study|Lost to Follow-up|2
7153709|NCT03288714|11319383|FG001|Overall Study|Lost to Follow-up|1
7153710|NCT03288714|11319382|FG000|Overall Study|Non-compliance with study schedule|2
7153711|NCT03288714|11319383|FG001|Overall Study|Non-compliance with study schedule|0
7153712|NCT03288714|11319382|FG000|Overall Study|Withdrawal by Subject|3
7153713|NCT03288714|11319383|FG001|Overall Study|Withdrawal by Subject|1
7153714|NCT03288714|11319382|FG000|Overall Study|Clinical Worsening|2
7153715|NCT03288714|11319383|FG001|Overall Study|Clinical Worsening|1
7153716|NCT03288714|11319382|FG000|Overall Study|Adverse Event|1
7153717|NCT03288714|11319383|FG001|Overall Study|Adverse Event|0
7153718|NCT03288779|11319391|FG000|Overall Study|Withdrawal by Subject|3
7153719|NCT03288987|11319397|FG000|Overall Study|Protocol Violation|10
7153720|NCT03288987|11319398|FG001|Overall Study|Protocol Violation|4
7153721|NCT03289208|11319420|FG000|Overall Study|Adverse Event|1
7153722|NCT03289208|11319421|FG001|Overall Study|Adverse Event|0
7153723|NCT03289208|11319422|FG002|Overall Study|Adverse Event|0
7153724|NCT03289455|11319446|FG000|Overall Study|Death|1
7153725|NCT03289455|11319447|FG001|Overall Study|Death|0
7153726|NCT03289455|11319448|FG002|Overall Study|Death|0
7153727|NCT03289455|11319446|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0
7153728|NCT03289455|11319447|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1
7153729|NCT03289455|11319448|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0
7153730|NCT03289455|11319446|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0
7153731|NCT03289455|11319447|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0
7153732|NCT03289455|11319448|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1
7153733|NCT03289455|11319446|FG000|Overall Study|Progressive disease|3
7153734|NCT03289455|11319447|FG001|Overall Study|Progressive disease|4
7153735|NCT03289455|11319448|FG002|Overall Study|Progressive disease|5
7153736|NCT03289533|11319467|FG000|Overall Study|Death|12
7153737|NCT03289533|11319467|FG000|Overall Study|Terminated from study by sponsor|10
7153738|NCT03289676|11319473|FG000|Overall Study|Withdrawal by Subject|2
7153739|NCT03289676|11319474|FG001|Overall Study|Withdrawal by Subject|0
7153740|NCT03289676|11319473|FG000|Overall Study|Protocol Violation|2
7153741|NCT03289676|11319474|FG001|Overall Study|Protocol Violation|0
7153742|NCT03289676|11319473|FG000|Overall Study|Lost to Follow-up|0
7153743|NCT03289676|11319474|FG001|Overall Study|Lost to Follow-up|1
7153744|NCT03290300|11319498|FG000|Overall Study|Lost to Follow-up|3
7153745|NCT03291288|11319551|FG000|Drug-drug Interaction Phase|Adverse Event|2
7153746|NCT03291288|11319552|FG001|Drug-drug Interaction Phase|Adverse Event|0
7153747|NCT03291288|11319551|FG000|Drug-drug Interaction Phase|Disease progression|1
7153748|NCT03291288|11319552|FG001|Drug-drug Interaction Phase|Disease progression|0
7153749|NCT03291288|11319551|FG000|Drug-drug Interaction Phase|Other|3
7153750|NCT03291288|11319552|FG001|Drug-drug Interaction Phase|Other|0
7153751|NCT03291288|11319551|FG000|Pexidartinib Only|Ongoing|0
7153752|NCT03291288|11319552|FG001|Pexidartinib Only|Ongoing|2
7153753|NCT03292016|11319581|FG000|Second Washout|Adverse Event|0
7153754|NCT03292016|11319582|FG001|Second Washout|Adverse Event|1
7153755|NCT03292016|11319583|FG002|Second Washout|Adverse Event|0
7153756|NCT03292016|11319584|FG003|Second Washout|Adverse Event|0
7153757|NCT03292016|11319585|FG004|Second Washout|Adverse Event|0
7153758|NCT03292016|11319586|FG005|Second Washout|Adverse Event|0
7153759|NCT03292406|11319597|FG000|Overall Study|Progressive Disease|6
7153760|NCT03292406|11319598|FG001|Overall Study|Progressive Disease|3
7153761|NCT03292406|11319599|FG002|Overall Study|Progressive Disease|4
7153762|NCT03292406|11319597|FG000|Overall Study|Adverse Event|7
7153763|NCT03292406|11319598|FG001|Overall Study|Adverse Event|1
7153764|NCT03292406|11319599|FG002|Overall Study|Adverse Event|4
7153765|NCT03292406|11319597|FG000|Overall Study|Withdrawal by Subject|0
7153766|NCT03292406|11319598|FG001|Overall Study|Withdrawal by Subject|7
7153767|NCT03292406|11319599|FG002|Overall Study|Withdrawal by Subject|2
7153768|NCT03292406|11319597|FG000|Overall Study|Protocol Violation|0
7153769|NCT03292406|11319598|FG001|Overall Study|Protocol Violation|1
7153770|NCT03292406|11319599|FG002|Overall Study|Protocol Violation|1
7153771|NCT03292406|11319597|FG000|Overall Study|Other|0
7153772|NCT03292406|11319598|FG001|Overall Study|Other|1
7153773|NCT03292406|11319599|FG002|Overall Study|Other|2
7153774|NCT03292432|11319609|FG000|Overall Study|Lost to Follow-up|11
7153775|NCT03292432|11319610|FG001|Overall Study|Lost to Follow-up|8
7153776|NCT03292432|11319609|FG000|Overall Study|Death|2
7153777|NCT03292432|11319610|FG001|Overall Study|Death|1
7153778|NCT03292432|11319609|FG000|Overall Study|Withdrawal by Subject|1
7153779|NCT03292432|11319610|FG001|Overall Study|Withdrawal by Subject|2
6863524|NCT00424476|10872847|FG002|Overall Study|Physician Decision|3
6863525|NCT00424476|10872845|FG000|Overall Study|Other|4
7153780|NCT03292432|11319609|FG000|Overall Study|Site closed before any data collected|1
7153781|NCT03292432|11319610|FG001|Overall Study|Site closed before any data collected|0
7153782|NCT03292640|11319631|FG000|Overall Study|Withdrawal by Subject|17
7153783|NCT03292640|11319632|FG001|Overall Study|Withdrawal by Subject|16
7153784|NCT03292640|11319631|FG000|Overall Study|Adverse Event|20
7153785|NCT03292640|11319632|FG001|Overall Study|Adverse Event|2
7153786|NCT03292640|11319631|FG000|Overall Study|Lost to Follow-up|24
7153787|NCT03292640|11319632|FG001|Overall Study|Lost to Follow-up|24
7153788|NCT03292653|11319645|FG000|Overall Study|Adverse Event|0
7153789|NCT03292653|11319646|FG001|Overall Study|Adverse Event|0
7153790|NCT03292653|11319647|FG002|Overall Study|Adverse Event|1
7153791|NCT03292653|11319645|FG000|Overall Study|Did not Receive Treatment|1
7153792|NCT03292653|11319646|FG001|Overall Study|Did not Receive Treatment|0
7153793|NCT03292653|11319647|FG002|Overall Study|Did not Receive Treatment|0
7153794|NCT03293394|11319706|FG000|Follow-up (6 Months)|Adverse Event|4
7153795|NCT03293394|11319707|FG001|Follow-up (6 Months)|Adverse Event|2
7153796|NCT03293485|11319713|FG000|Overall Study|Death|1
7153797|NCT03293485|11319713|FG000|Overall Study|Screen Failure|2
7153798|NCT03293485|11319713|FG000|Overall Study|Withdrawal by Subject|2
7153799|NCT03293654|11319722|FG000|Overall Study|Lost to Follow-up|0
7153800|NCT03293654|11319723|FG001|Overall Study|Lost to Follow-up|1
7153801|NCT03293654|11319724|FG002|Overall Study|Lost to Follow-up|0
7153802|NCT03294317|11319736|FG000|Overall Study|Physician Decision|1
7153803|NCT03294317|11319736|FG000|Overall Study|Withdrawal by Subject|6
7153804|NCT03294317|11319736|FG000|Overall Study|Lost to Follow-up|1
7153805|NCT03294317|11319736|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1
7153806|NCT03294317|11319736|FG000|Overall Study|Failed HB lead implant|8
7153807|NCT03294317|11319736|FG000|Overall Study|Received CRT instead|1
7153808|NCT03294317|11319736|FG000|Overall Study|Exited after lead revision|2
7153809|NCT03294538|11319743|FG000|Overall Study|Adverse Event|0
7153810|NCT03294538|11319744|FG001|Overall Study|Adverse Event|1
7153811|NCT03294538|11319745|FG002|Overall Study|Adverse Event|1
7153812|NCT03294538|11319743|FG000|Overall Study|Lost to Follow-up|1
7153813|NCT03294538|11319744|FG001|Overall Study|Lost to Follow-up|0
7153814|NCT03294538|11319745|FG002|Overall Study|Lost to Follow-up|0
7153815|NCT03294538|11319743|FG000|Overall Study|Outside of Visit Window|4
7153816|NCT03294538|11319744|FG001|Overall Study|Outside of Visit Window|4
7153817|NCT03294538|11319745|FG002|Overall Study|Outside of Visit Window|1
7153818|NCT03294681|11319762|FG000|Overall Study|Withdrawal by Subject|1
7153819|NCT03294941|11319777|FG000|Overall Study|Withdrawal by Subject|0
7153820|NCT03294941|11319778|FG001|Overall Study|Withdrawal by Subject|2
7153821|NCT03295201|11319787|FG000|Overall Study|Lost to Follow-up|1
7153822|NCT03295201|11319788|FG001|Overall Study|Lost to Follow-up|1
7153823|NCT03295201|11319787|FG000|Overall Study|Hospital admission|0
7153824|NCT03295201|11319788|FG001|Overall Study|Hospital admission|1
7153825|NCT03295318|11319806|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1
7153826|NCT03295318|11319807|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0
7153827|NCT03295318|11319808|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0
7153828|NCT03295318|11319806|FG000|Overall Study|Death|1
7153829|NCT03295318|11319807|FG001|Overall Study|Death|1
7153830|NCT03295318|11319808|FG002|Overall Study|Death|1
7153831|NCT03295318|11319806|FG000|Overall Study|Protocol Violation|4
7153832|NCT03295318|11319807|FG001|Overall Study|Protocol Violation|3
7153833|NCT03295318|11319808|FG002|Overall Study|Protocol Violation|3
7153834|NCT03295318|11319806|FG000|Overall Study|Withdrawal by Subject|0
7153835|NCT03295318|11319807|FG001|Overall Study|Withdrawal by Subject|0
7153836|NCT03295318|11319808|FG002|Overall Study|Withdrawal by Subject|1
7153837|NCT03295318|11319806|FG000|Overall Study|Subject discontinued due to travel|0
7153838|NCT03295318|11319807|FG001|Overall Study|Subject discontinued due to travel|1
7153839|NCT03295318|11319808|FG002|Overall Study|Subject discontinued due to travel|0
7153840|NCT03295721|11319842|FG000|Overall Study|Adverse Event|1
7153841|NCT03295721|11319843|FG001|Overall Study|Adverse Event|0
7153842|NCT03295721|11319844|FG002|Overall Study|Adverse Event|0
7153843|NCT03295721|11319842|FG000|Overall Study|Lost to Follow-up|1
7153844|NCT03295721|11319843|FG001|Overall Study|Lost to Follow-up|1
7153845|NCT03295721|11319844|FG002|Overall Study|Lost to Follow-up|1
7153846|NCT03295721|11319842|FG000|Overall Study|Withdrawal by Subject|1
7153847|NCT03295721|11319843|FG001|Overall Study|Withdrawal by Subject|0
7153848|NCT03295721|11319844|FG002|Overall Study|Withdrawal by Subject|1
7153849|NCT03295721|11319842|FG000|Overall Study|Death|0
7153850|NCT03295721|11319843|FG001|Overall Study|Death|0
7153851|NCT03295721|11319844|FG002|Overall Study|Death|1
6863526|NCT00424476|10872846|FG001|Overall Study|Other|3
7153852|NCT03296527|11319892|FG000|Overall Study|Adverse Event|15
7153853|NCT03296527|11319893|FG001|Overall Study|Adverse Event|33
7153854|NCT03296527|11319892|FG000|Overall Study|Protocol Deviation|4
7153855|NCT03296527|11319893|FG001|Overall Study|Protocol Deviation|0
7153856|NCT03296527|11319892|FG000|Overall Study|Subject withdrew consent|3
7153857|NCT03296527|11319893|FG001|Overall Study|Subject withdrew consent|1
7153858|NCT03296527|11319892|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9
6863527|NCT00424476|10872847|FG002|Overall Study|Other|9
7184137|NCT01762761|11384137|FG000|Overall Study|Adverse Event|15
6863528|NCT00424489|10872855|FG000|Overall Study|Death|3
6863529|NCT00424515|10872865|FG000|Overall Study|Progressive Disease|10
6863530|NCT00424515|10872866|FG001|Overall Study|Progressive Disease|11
6863531|NCT00424515|10872865|FG000|Overall Study|Adverse Event|0
6863532|NCT00424515|10872866|FG001|Overall Study|Adverse Event|1
6863533|NCT00424515|10872865|FG000|Overall Study|Intercurrent Illness|0
6863534|NCT00424515|10872866|FG001|Overall Study|Intercurrent Illness|1
6863535|NCT00424515|10872865|FG000|Overall Study|Withdrawal by Subject|1
6863536|NCT00424515|10872866|FG001|Overall Study|Withdrawal by Subject|0
6863537|NCT00424528|10872875|FG000|Overall Study|Adverse Event|2
6863538|NCT00424528|10872876|FG001|Overall Study|Adverse Event|1
6863539|NCT00424528|10872877|FG002|Overall Study|Adverse Event|2
6863540|NCT00424528|10872875|FG000|Overall Study|Protocol Violation|1
6863541|NCT00424528|10872876|FG001|Overall Study|Protocol Violation|1
6863542|NCT00424528|10872877|FG002|Overall Study|Protocol Violation|0
6863543|NCT00424528|10872875|FG000|Overall Study|Lost to Follow-up|0
6863544|NCT00424528|10872876|FG001|Overall Study|Lost to Follow-up|1
6863545|NCT00424528|10872877|FG002|Overall Study|Lost to Follow-up|0
6863546|NCT00424528|10872875|FG000|Overall Study|noncompliance with study requirements|2
6863547|NCT00424528|10872876|FG001|Overall Study|noncompliance with study requirements|1
6863548|NCT00424528|10872877|FG002|Overall Study|noncompliance with study requirements|2
6863549|NCT00424593|10872896|FG000|Acute Double-Blind Period|Adverse Event|16
6863550|NCT00424593|10872897|FG001|Acute Double-Blind Period|Adverse Event|7
6863551|NCT00424593|10872896|FG000|Acute Double-Blind Period|Withdrawal by Subject|11
6863552|NCT00424593|10872897|FG001|Acute Double-Blind Period|Withdrawal by Subject|10
6863553|NCT00424593|10872896|FG000|Acute Double-Blind Period|Protocol Violation|2
6863554|NCT00424593|10872897|FG001|Acute Double-Blind Period|Protocol Violation|2
6863555|NCT00424593|10872896|FG000|Acute Double-Blind Period|Physician Decision|1
6863556|NCT00424593|10872897|FG001|Acute Double-Blind Period|Physician Decision|2
6863557|NCT00424593|10872896|FG000|Acute Double-Blind Period|Lost to Follow-up|1
6863558|NCT00424593|10872897|FG001|Acute Double-Blind Period|Lost to Follow-up|1
6863559|NCT00424593|10872896|FG000|Acute Double-Blind Period|Lack of Efficacy|0
6863560|NCT00424593|10872897|FG001|Acute Double-Blind Period|Lack of Efficacy|1
6863561|NCT00424593|10872896|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19
7153859|NCT03296527|11319893|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14
7153860|NCT03296527|11319892|FG000|Overall Study|Discontinuations due to withdrawal from trial|2
7153861|NCT03296527|11319893|FG001|Overall Study|Discontinuations due to withdrawal from trial|3
7153862|NCT03296527|11319892|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0
7153863|NCT03296527|11319893|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2
7153864|NCT03296527|11319892|FG000|Overall Study|Discontinuation due to liquid in uterus|1
7153865|NCT03296527|11319893|FG001|Overall Study|Discontinuation due to liquid in uterus|0
7153866|NCT03296527|11319892|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1
7153867|NCT03296527|11319893|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0
7153868|NCT03296566|11319902|FG000|Overall Study|Lost to Follow-up|19
7153869|NCT03296566|11319903|FG001|Overall Study|Lost to Follow-up|46
7153870|NCT03296566|11319902|FG000|Overall Study|Withdrawal by Subject|0
7153871|NCT03296566|11319903|FG001|Overall Study|Withdrawal by Subject|3
7153872|NCT03297021|11319958|FG000|Overall Study|Incomplete/illegible data sheet|4
7153873|NCT03297021|11319959|FG001|Overall Study|Incomplete/illegible data sheet|2
7153874|NCT03297021|11319960|FG002|Overall Study|Incomplete/illegible data sheet|3
7153875|NCT03297021|11319958|FG000|Overall Study|Missing Post-Op Data|1
7153876|NCT03297021|11319959|FG001|Overall Study|Missing Post-Op Data|2
7153877|NCT03297021|11319960|FG002|Overall Study|Missing Post-Op Data|1
7153878|NCT03297216|11319974|FG000|Overall Study|Death|0
7153879|NCT03297216|11319975|FG001|Overall Study|Death|1
7153880|NCT03297216|11319974|FG000|Overall Study|Miscarriage|0
7153881|NCT03297216|11319975|FG001|Overall Study|Miscarriage|2
7153882|NCT03297216|11319974|FG000|Overall Study|Lost to Follow-up|3
7153883|NCT03297216|11319975|FG001|Overall Study|Lost to Follow-up|2
7153884|NCT03297294|11319990|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30
7153885|NCT03297294|11319991|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31
7153886|NCT03297294|11319992|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
7153887|NCT03297294|11319993|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
7153888|NCT03297294|11319994|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
7153889|NCT03297294|11319990|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4
7153890|NCT03297294|11319991|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4
7153891|NCT03297294|11319992|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
7153892|NCT03297294|11319993|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
7153893|NCT03297294|11319994|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
7153894|NCT03297294|11319990|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3
6863562|NCT00424593|10872897|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0
6863563|NCT00424593|10872896|FG000|Dose-Blind Extension Period|Adverse Event|18
6863564|NCT00424593|10872897|FG001|Dose-Blind Extension Period|Adverse Event|0
6863565|NCT00424593|10872896|FG000|Dose-Blind Extension Period|Lack of Efficacy|9
7153895|NCT03297294|11319991|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1
7153896|NCT03297294|11319992|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0
6863566|NCT00424593|10872897|FG001|Dose-Blind Extension Period|Lack of Efficacy|0
6863567|NCT00424593|10872896|FG000|Dose-Blind Extension Period|Protocol Violation|9
6863568|NCT00424593|10872897|FG001|Dose-Blind Extension Period|Protocol Violation|0
6863569|NCT00424593|10872896|FG000|Dose-Blind Extension Period|Lost to Follow-up|6
6863570|NCT00424593|10872897|FG001|Dose-Blind Extension Period|Lost to Follow-up|0
6863571|NCT00424593|10872896|FG000|Dose-Blind Extension Period|Physician Decision|3
6863572|NCT00424593|10872897|FG001|Dose-Blind Extension Period|Physician Decision|0
6863573|NCT00424632|10872918|FG000|Overall Study|Death|0
6863574|NCT00424632|10872919|FG001|Overall Study|Death|0
6863575|NCT00424632|10872920|FG002|Overall Study|Death|0
6863576|NCT00424632|10872921|FG003|Overall Study|Death|0
6863577|NCT00424632|10872922|FG004|Overall Study|Death|0
6863578|NCT00424632|10872923|FG005|Overall Study|Death|2
6863579|NCT00424632|10872924|FG006|Overall Study|Death|0
6863580|NCT00424632|10872925|FG007|Overall Study|Death|0
6863581|NCT00424632|10872926|FG008|Overall Study|Death|0
6863582|NCT00424632|10872927|FG009|Overall Study|Death|0
6863583|NCT00424632|10872918|FG000|Overall Study|Adverse Event|0
7153897|NCT03297294|11319993|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0
7153898|NCT03297294|11319994|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0
7153899|NCT03297294|11319990|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1
7153900|NCT03297294|11319991|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1
7153901|NCT03297294|11319992|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0
7153902|NCT03297294|11319993|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0
7153903|NCT03297294|11319994|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0
7153904|NCT03297294|11319990|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
7153905|NCT03297294|11319991|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
7153906|NCT03297294|11319992|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
7153907|NCT03297294|11319993|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1
7153908|NCT03297294|11319994|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
7153909|NCT03297398|11320009|FG000|Overall Study|Sponsor's decision|6
7153910|NCT03297398|11320010|FG001|Overall Study|Sponsor's decision|9
7153911|NCT03297398|11320011|FG002|Overall Study|Sponsor's decision|7
7153912|NCT03297398|11320009|FG000|Overall Study|Adverse Event|1
7153913|NCT03297398|11320010|FG001|Overall Study|Adverse Event|4
7153914|NCT03297398|11320011|FG002|Overall Study|Adverse Event|4
7153915|NCT03297398|11320009|FG000|Overall Study|Withdrawal by Subject|1
7153916|NCT03297398|11320010|FG001|Overall Study|Withdrawal by Subject|2
7153917|NCT03297398|11320011|FG002|Overall Study|Withdrawal by Subject|2
7153918|NCT03297398|11320009|FG000|Overall Study|Protocol Violation|0
7153919|NCT03297398|11320010|FG001|Overall Study|Protocol Violation|2
7153920|NCT03297398|11320011|FG002|Overall Study|Protocol Violation|0
7153921|NCT03297398|11320009|FG000|Overall Study|Physician Decision|0
7153922|NCT03297398|11320010|FG001|Overall Study|Physician Decision|0
7153923|NCT03297398|11320011|FG002|Overall Study|Physician Decision|1
7153924|NCT03297398|11320009|FG000|Overall Study|Lost to Follow-up|0
7153925|NCT03297398|11320010|FG001|Overall Study|Lost to Follow-up|0
7153926|NCT03297398|11320011|FG002|Overall Study|Lost to Follow-up|1
7153927|NCT03298412|11320059|FG000|Run-in Period|Other, Not Specified|1
7153928|NCT03298412|11320059|FG000|Run-in Period|Disease Progression|1
7153929|NCT03298412|11320059|FG000|Run-in Period|Ineligibility Determined|1
7153930|NCT03298412|11320059|FG000|Run-in Period|Decision by Sponsor|6
7153931|NCT03299101|11320084|FG000|Overall Study|Lost to Follow-up|1
7153932|NCT03299101|11320084|FG000|Overall Study|Withdrawal by Subject|5
7153933|NCT03299101|11320084|FG000|Overall Study|Surgery was changed|3
7153934|NCT03299101|11320084|FG000|Overall Study|Not enough time to complete prehab|1
7153935|NCT03299244|11320090|FG000|Overall Study|Withdrawal by Subject|34
7153936|NCT03299244|11320091|FG001|Overall Study|Withdrawal by Subject|29
7153937|NCT03299244|11320090|FG000|Overall Study|Decision by Sponsor|4
7153938|NCT03299244|11320091|FG001|Overall Study|Decision by Sponsor|5
7153939|NCT03299244|11320090|FG000|Overall Study|Death|9
7153940|NCT03299244|11320091|FG001|Overall Study|Death|4
7153941|NCT03299686|11320100|FG000|Treatment Epoch|Subject/Guardian Decision|2
7153942|NCT03299686|11320101|FG001|Treatment Epoch|Subject/Guardian Decision|0
7153943|NCT03299686|11320100|FG000|Treatment Epoch|Physician Decision|1
7153944|NCT03299686|11320101|FG001|Treatment Epoch|Physician Decision|0
7153945|NCT03299686|11320100|FG000|Treatment Epoch|Adverse Event|8
7153946|NCT03299686|11320101|FG001|Treatment Epoch|Adverse Event|4
7153947|NCT03299686|11320100|FG000|Follow-up Epoch|Subject/Guardian Decision|0
7153948|NCT03299686|11320101|FG001|Follow-up Epoch|Subject/Guardian Decision|1
7153949|NCT03299881|11320109|FG000|Overall Study|Study Termination|17
7153950|NCT03299881|11320110|FG001|Overall Study|Study Termination|13
6863584|NCT00424632|10872919|FG001|Overall Study|Adverse Event|0
6863585|NCT00424632|10872920|FG002|Overall Study|Adverse Event|0
7153951|NCT03300050|11320121|FG000|Overall Study|Lost to Follow-up|2
7153952|NCT03300050|11320122|FG001|Overall Study|Lost to Follow-up|1
7153953|NCT03300050|11320123|FG002|Overall Study|Lost to Follow-up|0
7153954|NCT03300050|11320124|FG003|Overall Study|Lost to Follow-up|0
7153955|NCT03300050|11320125|FG004|Overall Study|Lost to Follow-up|1
6863586|NCT00424632|10872921|FG003|Overall Study|Adverse Event|0
6863587|NCT00424632|10872922|FG004|Overall Study|Adverse Event|0
7153956|NCT03300050|11320121|FG000|Overall Study|Withdrawal by Subject|1
7153957|NCT03300050|11320122|FG001|Overall Study|Withdrawal by Subject|1
6863588|NCT00424632|10872923|FG005|Overall Study|Adverse Event|0
6863589|NCT00424632|10872924|FG006|Overall Study|Adverse Event|0
6863590|NCT00424632|10872925|FG007|Overall Study|Adverse Event|0
6863591|NCT00424632|10872926|FG008|Overall Study|Adverse Event|3
6863592|NCT00424632|10872927|FG009|Overall Study|Adverse Event|2
6863593|NCT00424632|10872918|FG000|Overall Study|Global deterioration of health status|0
6863594|NCT00424632|10872919|FG001|Overall Study|Global deterioration of health status|0
6863595|NCT00424632|10872920|FG002|Overall Study|Global deterioration of health status|0
6863596|NCT00424632|10872921|FG003|Overall Study|Global deterioration of health status|1
6863597|NCT00424632|10872922|FG004|Overall Study|Global deterioration of health status|1
6863598|NCT00424632|10872923|FG005|Overall Study|Global deterioration of health status|0
6863599|NCT00424632|10872924|FG006|Overall Study|Global deterioration of health status|0
6863600|NCT00424632|10872925|FG007|Overall Study|Global deterioration of health status|0
6863601|NCT00424632|10872926|FG008|Overall Study|Global deterioration of health status|0
6863602|NCT00424632|10872927|FG009|Overall Study|Global deterioration of health status|0
6863603|NCT00424632|10872918|FG000|Overall Study|Objective progression or relapse|1
6863604|NCT00424632|10872919|FG001|Overall Study|Objective progression or relapse|1
6863605|NCT00424632|10872920|FG002|Overall Study|Objective progression or relapse|1
6863606|NCT00424632|10872921|FG003|Overall Study|Objective progression or relapse|2
6863607|NCT00424632|10872922|FG004|Overall Study|Objective progression or relapse|2
6863608|NCT00424632|10872923|FG005|Overall Study|Objective progression or relapse|13
6863609|NCT00424632|10872924|FG006|Overall Study|Objective progression or relapse|7
6863610|NCT00424632|10872925|FG007|Overall Study|Objective progression or relapse|3
6863611|NCT00424632|10872926|FG008|Overall Study|Objective progression or relapse|12
6863612|NCT00424632|10872927|FG009|Overall Study|Objective progression or relapse|4
6863613|NCT00424632|10872918|FG000|Overall Study|Other|0
6863614|NCT00424632|10872919|FG001|Overall Study|Other|0
6863615|NCT00424632|10872920|FG002|Overall Study|Other|0
6863616|NCT00424632|10872921|FG003|Overall Study|Other|1
6863617|NCT00424632|10872922|FG004|Overall Study|Other|0
6863618|NCT00424632|10872923|FG005|Overall Study|Other|0
6863619|NCT00424632|10872924|FG006|Overall Study|Other|0
6863620|NCT00424632|10872925|FG007|Overall Study|Other|0
6863621|NCT00424632|10872926|FG008|Overall Study|Other|1
6863622|NCT00424632|10872927|FG009|Overall Study|Other|0
6863623|NCT00424749|10872958|FG000|Overall Study|Withdrawal by Subject|1
6863624|NCT00424762|10872964|FG000|Overall Study|Withdrawal by Subject|18
6863625|NCT00424762|10872965|FG001|Overall Study|Withdrawal by Subject|19
6863626|NCT00424762|10872964|FG000|Overall Study|Lost to Follow-up|2
6863627|NCT00424762|10872965|FG001|Overall Study|Lost to Follow-up|3
6863628|NCT00424775|10872971|FG000|Overall Study|Adverse Event|2
6863629|NCT00424775|10872972|FG001|Overall Study|Adverse Event|0
6863630|NCT00424775|10872971|FG000|Overall Study|Lack of Efficacy|1
6863631|NCT00424775|10872972|FG001|Overall Study|Lack of Efficacy|0
6863632|NCT00424827|10872976|FG000|Overall Study|Adverse Event|1
6863633|NCT00425061|10872996|FG000|Overall Study|Adverse Event|1
6863634|NCT00425061|10872997|FG001|Overall Study|Adverse Event|0
6863635|NCT00425061|10872998|FG002|Overall Study|Adverse Event|0
6863636|NCT00425061|10872999|FG003|Overall Study|Adverse Event|2
6863637|NCT00425061|10873000|FG004|Overall Study|Adverse Event|2
6863638|NCT00425061|10873001|FG005|Overall Study|Adverse Event|0
6863639|NCT00425061|10873002|FG006|Overall Study|Adverse Event|0
6863640|NCT00425061|10872996|FG000|Overall Study|Lost to Follow-up|0
6863641|NCT00425061|10872997|FG001|Overall Study|Lost to Follow-up|1
6863642|NCT00425061|10872998|FG002|Overall Study|Lost to Follow-up|0
6863643|NCT00425061|10872999|FG003|Overall Study|Lost to Follow-up|0
6863644|NCT00425061|10873000|FG004|Overall Study|Lost to Follow-up|0
6863645|NCT00425061|10873001|FG005|Overall Study|Lost to Follow-up|0
6863646|NCT00425061|10873002|FG006|Overall Study|Lost to Follow-up|0
6863647|NCT00425061|10872996|FG000|Overall Study|Protocol Violation|1
6967913|NCT01134315|11016395|FG001|Overall Study|Other Reason|17
6967914|NCT01134393|11016418|FG000|Overall Study|Adverse Event|18
6967915|NCT01134393|11016418|FG000|Overall Study|Lack of Efficacy|2
6967916|NCT01134393|11016418|FG000|Overall Study|Protocol Violation|12
6967917|NCT01134393|11016418|FG000|Overall Study|Lost to Follow-up|3
6967918|NCT01134393|11016418|FG000|Overall Study|Withdrawal by Subject|11
6967919|NCT01134393|11016418|FG000|Overall Study|Other|6
6967920|NCT01129011|11016437|FG000|Overall Study|Adverse Event|20
6967921|NCT01129011|11016438|FG001|Overall Study|Adverse Event|30
6967922|NCT01129011|11016437|FG000|Overall Study|Withdrawal by Subject|24
6967923|NCT01129011|11016438|FG001|Overall Study|Withdrawal by Subject|8
6967924|NCT01129011|11016437|FG000|Overall Study|Lost to Follow-up|6
6967925|NCT01129011|11016438|FG001|Overall Study|Lost to Follow-up|7
6863648|NCT00425061|10872997|FG001|Overall Study|Protocol Violation|0
6863649|NCT00425061|10872998|FG002|Overall Study|Protocol Violation|0
6863650|NCT00425061|10872999|FG003|Overall Study|Protocol Violation|0
6863651|NCT00425061|10873000|FG004|Overall Study|Protocol Violation|0
6863652|NCT00425061|10873001|FG005|Overall Study|Protocol Violation|0
6863653|NCT00425061|10873002|FG006|Overall Study|Protocol Violation|0
6863654|NCT00425061|10872996|FG000|Overall Study|Withdrawal by Subject|0
6863655|NCT00425061|10872997|FG001|Overall Study|Withdrawal by Subject|1
6863656|NCT00425061|10872998|FG002|Overall Study|Withdrawal by Subject|0
6863657|NCT00425061|10872999|FG003|Overall Study|Withdrawal by Subject|0
6967926|NCT01129011|11016437|FG000|Overall Study|Duodenal Ulcer|2
6863658|NCT00425061|10873000|FG004|Overall Study|Withdrawal by Subject|1
6863659|NCT00425061|10873001|FG005|Overall Study|Withdrawal by Subject|0
6863660|NCT00425061|10873002|FG006|Overall Study|Withdrawal by Subject|3
6863661|NCT00425061|10872996|FG000|Overall Study|Sponsor's request|0
6863662|NCT00425061|10872997|FG001|Overall Study|Sponsor's request|0
6863663|NCT00425061|10872998|FG002|Overall Study|Sponsor's request|0
6863664|NCT00425061|10872999|FG003|Overall Study|Sponsor's request|0
6863665|NCT00425061|10873000|FG004|Overall Study|Sponsor's request|19
6863666|NCT00425061|10873001|FG005|Overall Study|Sponsor's request|4
6863667|NCT00425061|10873002|FG006|Overall Study|Sponsor's request|15
6863668|NCT00425061|10872996|FG000|Overall Study|Physician Decision|0
6863669|NCT00425061|10872997|FG001|Overall Study|Physician Decision|0
7153958|NCT03300050|11320123|FG002|Overall Study|Withdrawal by Subject|1
7153959|NCT03300050|11320124|FG003|Overall Study|Withdrawal by Subject|0
7153960|NCT03300050|11320125|FG004|Overall Study|Withdrawal by Subject|0
7153961|NCT03300050|11320121|FG000|Overall Study|Death|0
7153962|NCT03300050|11320122|FG001|Overall Study|Death|0
7153963|NCT03300050|11320123|FG002|Overall Study|Death|1
7153964|NCT03300050|11320124|FG003|Overall Study|Death|0
7153965|NCT03300050|11320125|FG004|Overall Study|Death|0
7153966|NCT03300050|11320121|FG000|Overall Study|Not Eligible at Randomization|0
7153967|NCT03300050|11320122|FG001|Overall Study|Not Eligible at Randomization|0
7153968|NCT03300050|11320123|FG002|Overall Study|Not Eligible at Randomization|1
7153969|NCT03300050|11320124|FG003|Overall Study|Not Eligible at Randomization|1
7153970|NCT03300050|11320125|FG004|Overall Study|Not Eligible at Randomization|0
7153971|NCT03300570|11320148|FG000|Overall Study|Adverse Event|0
7153972|NCT03300570|11320149|FG001|Overall Study|Adverse Event|1
7153973|NCT03300570|11320148|FG000|Overall Study|Withdrawal by Subject|1
7153974|NCT03300570|11320149|FG001|Overall Study|Withdrawal by Subject|0
7153975|NCT03300570|11320148|FG000|Overall Study|Inadequate bowel prep|1
7153976|NCT03300570|11320149|FG001|Overall Study|Inadequate bowel prep|0
7153977|NCT03301155|11320180|FG000|Overall Study|Сompliance with exclusion criteria|8
7153978|NCT03301155|11320181|FG001|Overall Study|Сompliance with exclusion criteria|7
7184138|NCT01762761|11384138|FG001|Overall Study|Adverse Event|17
7184139|NCT01762761|11384137|FG000|Overall Study|Lack of Efficacy|9
7184140|NCT01762761|11384138|FG001|Overall Study|Lack of Efficacy|25
7184141|NCT01762761|11384137|FG000|Overall Study|Protocol Violation|1
7184142|NCT01762761|11384138|FG001|Overall Study|Protocol Violation|1
7184143|NCT01762761|11384137|FG000|Overall Study|Study closed/terminated|0
7184144|NCT01762761|11384138|FG001|Overall Study|Study closed/terminated|2
7184145|NCT01762761|11384137|FG000|Overall Study|Lost to Follow-up|3
7184146|NCT01762761|11384138|FG001|Overall Study|Lost to Follow-up|6
7184147|NCT01762761|11384137|FG000|Overall Study|Physician Decision|4
7184148|NCT01762761|11384138|FG001|Overall Study|Physician Decision|6
7184149|NCT01762761|11384137|FG000|Overall Study|Withdrawal by Subject|7
7184150|NCT01762761|11384138|FG001|Overall Study|Withdrawal by Subject|8
7187289|NCT03996876|11387842|FG000|Overall Study|Incomplete Data|2
7187290|NCT03996876|11387843|FG001|Overall Study|Incomplete Data|4
7187291|NCT03589976|11387852|FG000|Overall Study|Death|5
7187292|NCT03589976|11387853|FG001|Overall Study|Death|1
7187293|NCT03589976|11387852|FG000|Overall Study|Adverse Event|5
7187294|NCT03589976|11387853|FG001|Overall Study|Adverse Event|1
7187295|NCT03589976|11387852|FG000|Overall Study|Withdrawal by Subject|4
7187296|NCT03589976|11387853|FG001|Overall Study|Withdrawal by Subject|1
7187297|NCT03589976|11387852|FG000|Overall Study|Lost to Follow-up|1
7187298|NCT03589976|11387853|FG001|Overall Study|Lost to Follow-up|0
7187299|NCT03589976|11387852|FG000|Overall Study|Other|4
7187300|NCT03589976|11387853|FG001|Overall Study|Other|3
7187301|NCT03135262|11387900|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1
7187302|NCT03135262|11387901|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0
7187303|NCT03135262|11387902|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0
7187304|NCT03135262|11387903|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0
7187305|NCT03135262|11387904|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0
7187306|NCT03135262|11387900|FG000|Overall Study|Progression of disease|0
7187307|NCT03135262|11387901|FG001|Overall Study|Progression of disease|0
7187308|NCT03135262|11387902|FG002|Overall Study|Progression of disease|0
7187309|NCT03135262|11387903|FG003|Overall Study|Progression of disease|1
7187310|NCT03135262|11387904|FG004|Overall Study|Progression of disease|0
7187311|NCT03135262|11387900|FG000|Overall Study|Death|6
7187312|NCT03135262|11387901|FG001|Overall Study|Death|2
7187313|NCT03135262|11387902|FG002|Overall Study|Death|2
7187314|NCT03135262|11387903|FG003|Overall Study|Death|2
7187315|NCT03135262|11387904|FG004|Overall Study|Death|0
7187316|NCT03135262|11387900|FG000|Overall Study|Withdrawal by Subject|0
7187317|NCT03135262|11387901|FG001|Overall Study|Withdrawal by Subject|0
7187318|NCT03135262|11387902|FG002|Overall Study|Withdrawal by Subject|1
7187319|NCT03135262|11387903|FG003|Overall Study|Withdrawal by Subject|0
7187320|NCT03135262|11387904|FG004|Overall Study|Withdrawal by Subject|1
7187321|NCT03135262|11387900|FG000|Overall Study|Study terminated by sponsor|2
7187322|NCT03135262|11387901|FG001|Overall Study|Study terminated by sponsor|4
7187323|NCT03135262|11387902|FG002|Overall Study|Study terminated by sponsor|4
7187324|NCT03135262|11387903|FG003|Overall Study|Study terminated by sponsor|3
7187325|NCT03135262|11387904|FG004|Overall Study|Study terminated by sponsor|0
6863670|NCT00425061|10872998|FG002|Overall Study|Physician Decision|0
6863671|NCT00425061|10872999|FG003|Overall Study|Physician Decision|0
6863672|NCT00425061|10873000|FG004|Overall Study|Physician Decision|1
6863673|NCT00425061|10873001|FG005|Overall Study|Physician Decision|0
6863674|NCT00425061|10873002|FG006|Overall Study|Physician Decision|0
6863675|NCT00425061|10872996|FG000|Overall Study|Other|0
6863676|NCT00425061|10872997|FG001|Overall Study|Other|0
6863677|NCT00425061|10872998|FG002|Overall Study|Other|0
6863678|NCT00425061|10872999|FG003|Overall Study|Other|0
6863679|NCT00425061|10873000|FG004|Overall Study|Other|3
6863680|NCT00425061|10873001|FG005|Overall Study|Other|0
6863681|NCT00425061|10873002|FG006|Overall Study|Other|1
6863682|NCT00425113|10873022|FG000|Overall Study|uncontrolled diabetes mellitus|1
6863683|NCT00425113|10873023|FG001|Overall Study|uncontrolled diabetes mellitus|0
6863684|NCT00425113|10873022|FG000|Overall Study|diagnosis of abdominal TB|0
6863685|NCT00425113|10873023|FG001|Overall Study|diagnosis of abdominal TB|1
6863686|NCT00425113|10873022|FG000|Overall Study|missing study drug more than 14 days|0
6863687|NCT00425113|10873023|FG001|Overall Study|missing study drug more than 14 days|1
6863688|NCT00425113|10873022|FG000|Overall Study|Withdrawal by Subject|1
6863689|NCT00425113|10873023|FG001|Overall Study|Withdrawal by Subject|0
6863690|NCT00425269|10873032|FG000|Overall Study|Pregnancy|5
6863691|NCT00425269|10873033|FG001|Overall Study|Pregnancy|7
6863692|NCT00425269|10873032|FG000|Overall Study|Lost to Follow-up|9
6863693|NCT00425269|10873033|FG001|Overall Study|Lost to Follow-up|9
6863694|NCT00425269|10873032|FG000|Overall Study|moved or medical reason|5
6863695|NCT00425269|10873033|FG001|Overall Study|moved or medical reason|4
6863696|NCT00425308|10873041|FG000|Overall Study|Adverse Event|2
6863697|NCT00425308|10873042|FG001|Overall Study|Adverse Event|1
6863698|NCT00425308|10873041|FG000|Overall Study|Withdrawal by Subject|1
6863699|NCT00425308|10873042|FG001|Overall Study|Withdrawal by Subject|0
6863700|NCT00425308|10873041|FG000|Overall Study|Death|1
6863701|NCT00425308|10873042|FG001|Overall Study|Death|0
6863702|NCT00425373|10873057|FG000|Overall Study|Adverse Event|2
6863703|NCT00425373|10873058|FG001|Overall Study|Adverse Event|2
6863704|NCT00425373|10873059|FG002|Overall Study|Adverse Event|0
7153979|NCT03301623|11320228|FG000|Overall Study|Death|3
7153980|NCT03301623|11320229|FG001|Overall Study|Death|1
7153981|NCT03301623|11320228|FG000|Overall Study|Withdrawal by Subject|11
7153982|NCT03301623|11320229|FG001|Overall Study|Withdrawal by Subject|13
7153983|NCT03301623|11320228|FG000|Overall Study|Lost to Follow-up|3
7153984|NCT03301623|11320229|FG001|Overall Study|Lost to Follow-up|1
7153985|NCT03301649|11320238|FG000|Overall Study|Need alternate therapy due to live lice|17
7153986|NCT03301649|11320239|FG001|Overall Study|Need alternate therapy due to live lice|25
7153987|NCT03301649|11320240|FG002|Overall Study|Need alternate therapy due to live lice|81
7153988|NCT03301649|11320238|FG000|Overall Study|Lost to Follow-up|11
7153989|NCT03301649|11320239|FG001|Overall Study|Lost to Follow-up|11
7153990|NCT03301649|11320240|FG002|Overall Study|Lost to Follow-up|3
7153991|NCT03301649|11320238|FG000|Overall Study|Protocol Violation|0
7153992|NCT03301649|11320239|FG001|Overall Study|Protocol Violation|1
7153993|NCT03301649|11320240|FG002|Overall Study|Protocol Violation|1
7153994|NCT03301649|11320238|FG000|Overall Study|Withdrawal by Subject|10
7153995|NCT03301649|11320239|FG001|Overall Study|Withdrawal by Subject|4
7153996|NCT03301649|11320240|FG002|Overall Study|Withdrawal by Subject|0
7153997|NCT03301649|11320238|FG000|Overall Study|Other than specified|5
7153998|NCT03301649|11320239|FG001|Overall Study|Other than specified|3
7153999|NCT03301649|11320240|FG002|Overall Study|Other than specified|0
7154000|NCT03301714|11320251|FG000|Overall Study|Lost to Follow-up|10
7154001|NCT03301714|11320252|FG001|Overall Study|Lost to Follow-up|4
7154002|NCT03301714|11320253|FG002|Overall Study|Lost to Follow-up|4
7154003|NCT03301714|11320251|FG000|Overall Study|Did not receive allocated intervention|0
7154004|NCT03301714|11320252|FG001|Overall Study|Did not receive allocated intervention|2
7154005|NCT03301714|11320253|FG002|Overall Study|Did not receive allocated intervention|3
7154006|NCT03301740|11320266|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1
7154007|NCT03301740|11320267|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0
7154008|NCT03301740|11320266|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1
7154009|NCT03301740|11320267|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0
7154010|NCT03301831|11320282|FG000|Overall Study|Lost to Follow-up|5
7154011|NCT03301831|11320283|FG001|Overall Study|Lost to Follow-up|3
7154012|NCT03301831|11320282|FG000|Overall Study|Protocol Violation|4
7154013|NCT03301831|11320283|FG001|Overall Study|Protocol Violation|0
7154014|NCT03301831|11320282|FG000|Overall Study|Withdrawal by Subject|11
7154015|NCT03301831|11320283|FG001|Overall Study|Withdrawal by Subject|0
7154016|NCT03301844|11320291|FG000|Overall Study|suspected colon cancer|1
7154017|NCT03301844|11320292|FG001|Overall Study|suspected colon cancer|1
6863705|NCT00425373|10873060|FG003|Overall Study|Adverse Event|1
7154018|NCT03302559|11320311|FG000|Overall Study|Adverse Event|2
6863706|NCT00425373|10873061|FG004|Overall Study|Adverse Event|4
6863707|NCT00425373|10873062|FG005|Overall Study|Adverse Event|6
7154019|NCT03302559|11320311|FG000|Overall Study|Lost to Follow-up|1
7154020|NCT03302559|11320311|FG000|Overall Study|Withdrew Consent|3
7154021|NCT03302936|11320344|FG000|Overall Study|Protocol Violation|3
7154022|NCT03302936|11320345|FG001|Overall Study|Protocol Violation|4
7154023|NCT03302975|11320355|FG000|Overall Study|Lost to Follow-up|4
6863708|NCT00425373|10873063|FG006|Overall Study|Adverse Event|2
6863709|NCT00425373|10873064|FG007|Overall Study|Adverse Event|3
6863710|NCT00425373|10873065|FG008|Overall Study|Adverse Event|8
6863711|NCT00425373|10873057|FG000|Overall Study|Lost to Follow-up|0
6863712|NCT00425373|10873058|FG001|Overall Study|Lost to Follow-up|1
6863713|NCT00425373|10873059|FG002|Overall Study|Lost to Follow-up|0
6863714|NCT00425373|10873060|FG003|Overall Study|Lost to Follow-up|0
6863715|NCT00425373|10873061|FG004|Overall Study|Lost to Follow-up|1
6863716|NCT00425373|10873062|FG005|Overall Study|Lost to Follow-up|0
6863717|NCT00425373|10873063|FG006|Overall Study|Lost to Follow-up|0
6863718|NCT00425373|10873064|FG007|Overall Study|Lost to Follow-up|0
6863719|NCT00425373|10873065|FG008|Overall Study|Lost to Follow-up|0
6863720|NCT00425373|10873057|FG000|Overall Study|Protocol Violation|1
6863721|NCT00425373|10873058|FG001|Overall Study|Protocol Violation|0
6863722|NCT00425373|10873059|FG002|Overall Study|Protocol Violation|1
6863723|NCT00425373|10873060|FG003|Overall Study|Protocol Violation|0
6863724|NCT00425373|10873061|FG004|Overall Study|Protocol Violation|0
6863725|NCT00425373|10873062|FG005|Overall Study|Protocol Violation|0
6863726|NCT00425373|10873063|FG006|Overall Study|Protocol Violation|0
6863727|NCT00425373|10873064|FG007|Overall Study|Protocol Violation|5
6863728|NCT00425373|10873065|FG008|Overall Study|Protocol Violation|3
6863729|NCT00425373|10873057|FG000|Overall Study|Withdrawal by Subject|2
6863730|NCT00425373|10873058|FG001|Overall Study|Withdrawal by Subject|0
6863731|NCT00425373|10873059|FG002|Overall Study|Withdrawal by Subject|2
6863732|NCT00425373|10873060|FG003|Overall Study|Withdrawal by Subject|1
6863733|NCT00425373|10873061|FG004|Overall Study|Withdrawal by Subject|4
6863734|NCT00425373|10873062|FG005|Overall Study|Withdrawal by Subject|0
6863735|NCT00425373|10873063|FG006|Overall Study|Withdrawal by Subject|2
6863736|NCT00425373|10873064|FG007|Overall Study|Withdrawal by Subject|2
6863737|NCT00425373|10873065|FG008|Overall Study|Withdrawal by Subject|2
6863738|NCT00425373|10873057|FG000|Overall Study|Lack of Efficacy|0
6863739|NCT00425373|10873058|FG001|Overall Study|Lack of Efficacy|0
6863740|NCT00425373|10873059|FG002|Overall Study|Lack of Efficacy|0
6863741|NCT00425373|10873060|FG003|Overall Study|Lack of Efficacy|0
6863742|NCT00425373|10873061|FG004|Overall Study|Lack of Efficacy|1
6863743|NCT00425373|10873062|FG005|Overall Study|Lack of Efficacy|3
6863744|NCT00425373|10873063|FG006|Overall Study|Lack of Efficacy|3
6863745|NCT00425373|10873064|FG007|Overall Study|Lack of Efficacy|0
6863746|NCT00425373|10873065|FG008|Overall Study|Lack of Efficacy|5
6863747|NCT00425503|10873093|FG000|Overall Study|Adverse Event|2
6863748|NCT00425503|10873093|FG000|Overall Study|Protocol Violation|1
6863749|NCT00425555|10873099|FG000|Overall Study|Withdrawal by Subject|11
6863750|NCT00425555|10873100|FG001|Overall Study|Withdrawal by Subject|8
6863751|NCT00425555|10873099|FG000|Overall Study|Lost to Follow-up|0
6863752|NCT00425555|10873100|FG001|Overall Study|Lost to Follow-up|1
6863753|NCT00425555|10873099|FG000|Overall Study|Administrative problems|3
6863754|NCT00425555|10873100|FG001|Overall Study|Administrative problems|0
6863755|NCT00425555|10873099|FG000|Overall Study|Death|1
6863756|NCT00425555|10873100|FG001|Overall Study|Death|2
6863757|NCT00425555|10873099|FG000|Overall Study|New cancer therapy|2
6863758|NCT00425555|10873100|FG001|Overall Study|New cancer therapy|1
6863759|NCT00425555|10873099|FG000|Overall Study|Disease progression|36
6863760|NCT00425555|10873100|FG001|Overall Study|Disease progression|33
6863761|NCT00425555|10873099|FG000|Overall Study|Adverse Event|25
6863762|NCT00425555|10873100|FG001|Overall Study|Adverse Event|15
6863763|NCT00425555|10873099|FG000|Overall Study|Protocol Violation|1
6863764|NCT00425555|10873100|FG001|Overall Study|Protocol Violation|0
6863765|NCT00425607|10873109|FG000|Overall Study|Death|1
6863766|NCT00425607|10873109|FG000|Overall Study|Withdrawal by Subject|1
6863767|NCT00425698|10873119|FG000|Overall Study|Adverse Event|3
6863768|NCT00425698|10873120|FG001|Overall Study|Adverse Event|1
6863769|NCT00425698|10873119|FG000|Overall Study|Withdrawal by Subject|0
6863770|NCT00425698|10873120|FG001|Overall Study|Withdrawal by Subject|1
6967927|NCT01129011|11016438|FG001|Overall Study|Duodenal Ulcer|8
6967928|NCT01129011|11016437|FG000|Overall Study|misc|7
6967929|NCT01129011|11016438|FG001|Overall Study|misc|4
6967930|NCT01134562|11016475|FG000|Overall Study|Adverse Event|0
6967931|NCT01134562|11016476|FG001|Overall Study|Adverse Event|1
6967932|NCT01134562|11016477|FG002|Overall Study|Adverse Event|0
6967933|NCT01134562|11016478|FG003|Overall Study|Adverse Event|0
6967934|NCT01134562|11016479|FG004|Overall Study|Adverse Event|0
6967935|NCT01134627|11016514|FG000|Overall Study|Adverse Event|47
6967936|NCT01134627|11016515|FG001|Overall Study|Adverse Event|31
6967937|NCT01134627|11016514|FG000|Overall Study|Lost to Follow-up|1
6967938|NCT01134627|11016515|FG001|Overall Study|Lost to Follow-up|2
6967939|NCT01134627|11016514|FG000|Overall Study|Protocol Violation|3
6967940|NCT01134627|11016515|FG001|Overall Study|Protocol Violation|5
6967941|NCT01134627|11016514|FG000|Overall Study|Lack of Efficacy|2
6967942|NCT01134627|11016515|FG001|Overall Study|Lack of Efficacy|12
6967943|NCT01134627|11016514|FG000|Overall Study|Withdrawal by Subject|4
6967944|NCT01134627|11016515|FG001|Overall Study|Withdrawal by Subject|3
6967945|NCT01134627|11016514|FG000|Overall Study|Planning to become pregnant/pregnancy|1
6967946|NCT01134627|11016515|FG001|Overall Study|Planning to become pregnant/pregnancy|0
6967947|NCT01134627|11016514|FG000|Overall Study|Other|11
6967948|NCT01134627|11016515|FG001|Overall Study|Other|14
6967949|NCT01134705|11016523|FG000|Overall Study|Adverse Event|1
6967950|NCT01134705|11016524|FG001|Overall Study|Adverse Event|7
6967951|NCT01134705|11016523|FG000|Overall Study|Withdrawal by Subject|6
6863771|NCT00425750|10873126|FG000|Overall Study|Death|1
6863772|NCT00425750|10873126|FG000|Overall Study|Withdrawal by Subject|3
6863773|NCT00425750|10873126|FG000|Overall Study|Adverse Event|3
7078171|NCT02100670|11186409|FG000|Overall Study|Physician Decision|0
7154024|NCT03303079|11320362|FG000|Overall Study|Adverse Event|0
7154025|NCT03303079|11320363|FG001|Overall Study|Adverse Event|1
7154026|NCT03303079|11320364|FG002|Overall Study|Adverse Event|3
7154027|NCT03303079|11320362|FG000|Overall Study|Protocol Violation|5
7154028|NCT03303079|11320363|FG001|Overall Study|Protocol Violation|4
7154029|NCT03303079|11320364|FG002|Overall Study|Protocol Violation|7
7154030|NCT03303079|11320362|FG000|Overall Study|Withdrawal by Subject|2
7154031|NCT03303079|11320363|FG001|Overall Study|Withdrawal by Subject|4
7154032|NCT03303079|11320364|FG002|Overall Study|Withdrawal by Subject|2
7154033|NCT03303079|11320362|FG000|Overall Study|Other than specified|0
7154034|NCT03303079|11320363|FG001|Overall Study|Other than specified|2
7154035|NCT03303079|11320364|FG002|Overall Study|Other than specified|0
7154036|NCT03303092|11320375|FG000|Overall Study|Adverse Event|1
7154037|NCT03303092|11320376|FG001|Overall Study|Adverse Event|0
7154038|NCT03303092|11320377|FG002|Overall Study|Adverse Event|1
7154039|NCT03303092|11320375|FG000|Overall Study|Protocol Violation|1
7154040|NCT03303092|11320376|FG001|Overall Study|Protocol Violation|5
7154041|NCT03303092|11320377|FG002|Overall Study|Protocol Violation|1
7154042|NCT03303092|11320375|FG000|Overall Study|Withdrawal by Subject|1
7154043|NCT03303092|11320376|FG001|Overall Study|Withdrawal by Subject|1
7154044|NCT03303092|11320377|FG002|Overall Study|Withdrawal by Subject|3
7154045|NCT03303105|11320387|FG000|Overall Study|Adverse Event|0
7154046|NCT03303105|11320388|FG001|Overall Study|Adverse Event|2
7154047|NCT03303105|11320387|FG000|Overall Study|Lack of Efficacy|1
7154048|NCT03303105|11320388|FG001|Overall Study|Lack of Efficacy|0
7154049|NCT03303105|11320387|FG000|Overall Study|Protocol Violation|1
7154050|NCT03303105|11320388|FG001|Overall Study|Protocol Violation|0
7154051|NCT03303105|11320387|FG000|Overall Study|Withdrawal by Subject|0
7154052|NCT03303105|11320388|FG001|Overall Study|Withdrawal by Subject|2
7154053|NCT03303417|11320417|FG000|Overall Study|Withdrawal by Subject|1
7154054|NCT03303417|11320418|FG001|Overall Study|Withdrawal by Subject|1
7154055|NCT03303521|11320426|FG000|Overall Study|Withdrawal by Subject|2
7154056|NCT03303521|11320427|FG001|Overall Study|Withdrawal by Subject|0
7154057|NCT03303521|11320426|FG000|Overall Study|Death|1
7154058|NCT03303521|11320427|FG001|Overall Study|Death|0
7154059|NCT03303521|11320426|FG000|Overall Study|Kidney transplantation|0
7154060|NCT03303521|11320427|FG001|Overall Study|Kidney transplantation|1
7154061|NCT03303521|11320426|FG000|Overall Study|Investigational product discontinuation|0
7154062|NCT03303521|11320427|FG001|Overall Study|Investigational product discontinuation|1
7154063|NCT03303521|11320426|FG000|Overall Study|Transferred to non-study dialysis center|1
7154064|NCT03303521|11320427|FG001|Overall Study|Transferred to non-study dialysis center|0
7154065|NCT03303521|11320426|FG000|Overall Study|Non-comliance to study protocol|0
7154066|NCT03303521|11320427|FG001|Overall Study|Non-comliance to study protocol|1
7154067|NCT03303521|11320426|FG000|Overall Study|Adverse Event|1
7154068|NCT03303521|11320427|FG001|Overall Study|Adverse Event|0
7154069|NCT03304184|11320488|FG000|Overall Study|Withdrawal by Subject|1
7154070|NCT03304184|11320489|FG001|Overall Study|Withdrawal by Subject|2
7154071|NCT03304522|11320498|FG000|Overall Study|Adverse Event|0
7154072|NCT03304522|11320499|FG001|Overall Study|Adverse Event|4
7154073|NCT03304522|11320498|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1
7154074|NCT03304522|11320499|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1
7154075|NCT03304522|11320498|FG000|Overall Study|Withdrawal of consent (for other reason)|0
7154076|NCT03304522|11320499|FG001|Overall Study|Withdrawal of consent (for other reason)|2
7154077|NCT03304522|11320498|FG000|Overall Study|Other|0
7154078|NCT03304522|11320499|FG001|Overall Study|Other|1
7154079|NCT03304626|11320507|FG000|Overall Study|Adverse Event|1
7154080|NCT03304626|11320508|FG001|Overall Study|Adverse Event|0
7154081|NCT03304626|11320507|FG000|Overall Study|Lack of Efficacy|1
7154082|NCT03304626|11320508|FG001|Overall Study|Lack of Efficacy|1
7154083|NCT03304873|11320517|FG000|Overall Study|Lost to Follow-up|1
7154084|NCT03304873|11320518|FG001|Overall Study|Lost to Follow-up|8
7154085|NCT03305081|11320526|FG000|Overall Study|Lost to Follow-up|10
7154086|NCT03305081|11320527|FG001|Overall Study|Lost to Follow-up|15
7154087|NCT03305419|11320550|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
7154088|NCT03305419|11320551|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1
7154089|NCT03305419|11320552|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
7154090|NCT03305419|11320553|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
7154091|NCT03305419|11320554|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
7078172|NCT02100670|11186410|FG001|Overall Study|Physician Decision|1
7078173|NCT02100670|11186411|FG002|Overall Study|Physician Decision|0
7078174|NCT02100670|11186412|FG003|Overall Study|Physician Decision|0
7078175|NCT02100670|11186409|FG000|Overall Study|Withdrawal by Subject|1
7078176|NCT02100670|11186410|FG001|Overall Study|Withdrawal by Subject|0
7078177|NCT02100670|11186411|FG002|Overall Study|Withdrawal by Subject|0
7078178|NCT02100670|11186412|FG003|Overall Study|Withdrawal by Subject|0
7078179|NCT02100696|11186435|FG000|Induction Phase|Adverse Event|0
7078180|NCT02100696|11186436|FG001|Induction Phase|Adverse Event|0
7078181|NCT02100696|11186437|FG002|Induction Phase|Adverse Event|1
7078182|NCT02100696|11186438|FG003|Induction Phase|Adverse Event|0
6863774|NCT00425750|10873126|FG000|Overall Study|Progression of disease|18
6863775|NCT00425854|10873136|FG000|Overall Study|Progressive Disease|19
6863776|NCT00425854|10873137|FG001|Overall Study|Progressive Disease|12
6863777|NCT00425854|10873136|FG000|Overall Study|Dose reduction toxicity AE|8
7154092|NCT03305419|11320555|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
7154093|NCT03305419|11320556|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
7154094|NCT03305419|11320557|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
7154095|NCT03305419|11320550|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1
7154096|NCT03305419|11320551|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
7154097|NCT03305419|11320552|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
7154098|NCT03305419|11320553|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
7154099|NCT03305419|11320554|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
7154100|NCT03305419|11320555|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
7154101|NCT03305419|11320556|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
7154102|NCT03305419|11320557|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
7154103|NCT03305419|11320550|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1
7154104|NCT03305419|11320551|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
7154105|NCT03305419|11320552|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
7154106|NCT03305419|11320553|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
7154107|NCT03305419|11320554|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
7154108|NCT03305419|11320555|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
7154109|NCT03305419|11320556|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
7154110|NCT03305419|11320557|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
7154111|NCT03305419|11320550|FG000|Part B (14 Days)|Adverse Event|0
7154112|NCT03305419|11320551|FG001|Part B (14 Days)|Adverse Event|0
7154113|NCT03305419|11320552|FG002|Part B (14 Days)|Adverse Event|0
7154114|NCT03305419|11320553|FG003|Part B (14 Days)|Adverse Event|0
7154115|NCT03305419|11320554|FG004|Part B (14 Days)|Adverse Event|1
7154116|NCT03305419|11320555|FG005|Part B (14 Days)|Adverse Event|2
7154117|NCT03305419|11320556|FG006|Part B (14 Days)|Adverse Event|4
7154118|NCT03305419|11320557|FG007|Part B (14 Days)|Adverse Event|0
7154119|NCT03305419|11320550|FG000|Part B (14 Days)|Physician Decision|0
7154120|NCT03305419|11320551|FG001|Part B (14 Days)|Physician Decision|0
7154121|NCT03305419|11320552|FG002|Part B (14 Days)|Physician Decision|0
7154122|NCT03305419|11320553|FG003|Part B (14 Days)|Physician Decision|0
7154123|NCT03305419|11320554|FG004|Part B (14 Days)|Physician Decision|2
7154124|NCT03305419|11320555|FG005|Part B (14 Days)|Physician Decision|8
7154125|NCT03305419|11320556|FG006|Part B (14 Days)|Physician Decision|1
7154126|NCT03305419|11320557|FG007|Part B (14 Days)|Physician Decision|0
7154127|NCT03305575|11320582|FG000|Overall Study|Physician Decision|1
7154128|NCT03305575|11320583|FG001|Overall Study|Physician Decision|0
7154129|NCT03305666|11320595|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2
7154130|NCT03305666|11320596|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0
7154131|NCT03305731|11320602|FG000|Overall Study|Protocol Violation|1
7154132|NCT03305770|11320608|FG000|Overall Study|Physician Decision - prior to dispense|0
7154133|NCT03305770|11320609|FG001|Overall Study|Physician Decision - prior to dispense|1
7154134|NCT03305770|11320608|FG000|Overall Study|Subject moved|1
7154135|NCT03305770|11320609|FG001|Overall Study|Subject moved|0
7154136|NCT03305809|11320621|FG000|Overall Study|Adverse Event|2
7154137|NCT03305809|11320622|FG001|Overall Study|Adverse Event|2
7154138|NCT03305809|11320623|FG002|Overall Study|Adverse Event|6
7154139|NCT03305809|11320624|FG003|Overall Study|Adverse Event|6
7154140|NCT03305809|11320621|FG000|Overall Study|Death|0
7154141|NCT03305809|11320622|FG001|Overall Study|Death|0
7154142|NCT03305809|11320623|FG002|Overall Study|Death|1
7154143|NCT03305809|11320624|FG003|Overall Study|Death|1
7154144|NCT03305809|11320621|FG000|Overall Study|Lost to Follow-up|1
7154145|NCT03305809|11320622|FG001|Overall Study|Lost to Follow-up|2
7154146|NCT03305809|11320623|FG002|Overall Study|Lost to Follow-up|0
7154147|NCT03305809|11320624|FG003|Overall Study|Lost to Follow-up|0
7154148|NCT03305809|11320621|FG000|Overall Study|Sponsor Decision|1
7154149|NCT03305809|11320622|FG001|Overall Study|Sponsor Decision|0
7154150|NCT03305809|11320623|FG002|Overall Study|Sponsor Decision|1
7154151|NCT03305809|11320624|FG003|Overall Study|Sponsor Decision|8
7154152|NCT03305809|11320621|FG000|Overall Study|Physician Decision|0
7154153|NCT03305809|11320622|FG001|Overall Study|Physician Decision|0
7154154|NCT03305809|11320623|FG002|Overall Study|Physician Decision|2
7154155|NCT03305809|11320624|FG003|Overall Study|Physician Decision|4
7154156|NCT03305809|11320621|FG000|Overall Study|Progressive Disease|0
7154157|NCT03305809|11320622|FG001|Overall Study|Progressive Disease|0
7154158|NCT03305809|11320623|FG002|Overall Study|Progressive Disease|1
7154159|NCT03305809|11320624|FG003|Overall Study|Progressive Disease|0
7154160|NCT03305809|11320621|FG000|Overall Study|Protocol Violation|1
7154161|NCT03305809|11320622|FG001|Overall Study|Protocol Violation|0
7154162|NCT03305809|11320623|FG002|Overall Study|Protocol Violation|2
7154163|NCT03305809|11320624|FG003|Overall Study|Protocol Violation|3
7154164|NCT03305809|11320621|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0
7154165|NCT03305809|11320622|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0
6863778|NCT00425854|10873137|FG001|Overall Study|Dose reduction toxicity AE|7
6863779|NCT00425854|10873136|FG000|Overall Study|Other Adverse Event|2
6863780|NCT00425854|10873137|FG001|Overall Study|Other Adverse Event|2
6863781|NCT00425945|10873146|FG000|Overall Study|Concern about Supplement|2
6863782|NCT00425945|10873147|FG001|Overall Study|Concern about Supplement|0
7154166|NCT03305809|11320623|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0
7154167|NCT03305809|11320624|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2
7154168|NCT03305809|11320621|FG000|Overall Study|Withdrawal by Subject|2
7154169|NCT03305809|11320622|FG001|Overall Study|Withdrawal by Subject|4
7154170|NCT03305809|11320623|FG002|Overall Study|Withdrawal by Subject|5
7154171|NCT03305809|11320624|FG003|Overall Study|Withdrawal by Subject|2
7154172|NCT03305809|11320621|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0
7154173|NCT03305809|11320622|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0
7154174|NCT03305809|11320623|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1
7154175|NCT03305809|11320624|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1
7154176|NCT03306043|11320653|FG000|Overall Study|Adverse Event|1
7154177|NCT03306043|11320653|FG000|Overall Study|Lost to Follow-up|1
7154178|NCT03306043|11320653|FG000|Overall Study|Withdrawal by Subject|2
7154179|NCT03306277|11320661|FG000|Overall Study|Death|1
7154180|NCT03306277|11320661|FG000|Overall Study|Adverse Event|1
7154181|NCT03306277|11320661|FG000|Overall Study|Withdrawal by Subject|1
7154182|NCT03306433|11320686|FG000|Overall Study|Lost to Follow-up|3
7154183|NCT03306433|11320686|FG000|Overall Study|Patient did not have teeth extracted|1
7154184|NCT03306433|11320686|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3
7154185|NCT03307174|11320741|FG000|Overall Study|Unplanned ICU Administrion|5
7154186|NCT03307174|11320742|FG001|Overall Study|Unplanned ICU Administrion|3
7154187|NCT03307174|11320741|FG000|Overall Study|Aborted Surgery|1
7154188|NCT03307174|11320742|FG001|Overall Study|Aborted Surgery|2
7154189|NCT03307174|11320741|FG000|Overall Study|Hypotension|6
7154190|NCT03307174|11320742|FG001|Overall Study|Hypotension|0
7154191|NCT03307174|11320741|FG000|Overall Study|Nonfunctional epidural|1
7154192|NCT03307174|11320742|FG001|Overall Study|Nonfunctional epidural|1
7154193|NCT03307174|11320741|FG000|Overall Study|Planned epidural removal|1
7154194|NCT03307174|11320742|FG001|Overall Study|Planned epidural removal|0
7154195|NCT03307174|11320741|FG000|Overall Study|Intrathecal catheter placement|0
7154196|NCT03307174|11320742|FG001|Overall Study|Intrathecal catheter placement|1
7154197|NCT03307252|11320759|FG000|Part 2, Period 1|Treatment not received|0
7154198|NCT03307252|11320760|FG001|Part 2, Period 1|Treatment not received|0
7154199|NCT03307252|11320761|FG002|Part 2, Period 1|Treatment not received|0
7154200|NCT03307252|11320762|FG003|Part 2, Period 1|Treatment not received|0
7154201|NCT03307252|11320763|FG004|Part 2, Period 1|Treatment not received|0
7154202|NCT03307252|11320764|FG005|Part 2, Period 1|Treatment not received|1
7154203|NCT03307252|11320765|FG006|Part 2, Period 1|Treatment not received|0
7154204|NCT03307252|11320766|FG007|Part 2, Period 1|Treatment not received|0
7154205|NCT03307252|11320767|FG008|Part 2, Period 1|Treatment not received|0
7154206|NCT03307252|11320768|FG009|Part 2, Period 1|Treatment not received|0
7154207|NCT03307252|11320769|FG010|Part 2, Period 1|Treatment not received|0
7154208|NCT03307252|11320759|FG000|Part 2, Period 3|Other than listed|0
7154209|NCT03307252|11320760|FG001|Part 2, Period 3|Other than listed|0
7154210|NCT03307252|11320761|FG002|Part 2, Period 3|Other than listed|0
7154211|NCT03307252|11320762|FG003|Part 2, Period 3|Other than listed|0
7154212|NCT03307252|11320763|FG004|Part 2, Period 3|Other than listed|1
7154213|NCT03307252|11320764|FG005|Part 2, Period 3|Other than listed|0
7154214|NCT03307252|11320765|FG006|Part 2, Period 3|Other than listed|0
7154215|NCT03307252|11320766|FG007|Part 2, Period 3|Other than listed|0
7154216|NCT03307252|11320767|FG008|Part 2, Period 3|Other than listed|0
7154217|NCT03307252|11320768|FG009|Part 2, Period 3|Other than listed|0
7154218|NCT03307252|11320769|FG010|Part 2, Period 3|Other than listed|0
7154219|NCT03307252|11320759|FG000|Part 2, Period 4|Other than listed|0
7154220|NCT03307252|11320760|FG001|Part 2, Period 4|Other than listed|0
7154221|NCT03307252|11320761|FG002|Part 2, Period 4|Other than listed|0
7154222|NCT03307252|11320762|FG003|Part 2, Period 4|Other than listed|0
7154223|NCT03307252|11320763|FG004|Part 2, Period 4|Other than listed|0
7154224|NCT03307252|11320764|FG005|Part 2, Period 4|Other than listed|0
7154225|NCT03307252|11320765|FG006|Part 2, Period 4|Other than listed|1
7154226|NCT03307252|11320766|FG007|Part 2, Period 4|Other than listed|0
7154227|NCT03307252|11320767|FG008|Part 2, Period 4|Other than listed|0
7154228|NCT03307252|11320768|FG009|Part 2, Period 4|Other than listed|0
7154229|NCT03307252|11320769|FG010|Part 2, Period 4|Other than listed|0
7154230|NCT03307252|11320759|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
7154231|NCT03307252|11320760|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
7154232|NCT03307252|11320761|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
7154233|NCT03307252|11320762|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
7154234|NCT03307252|11320763|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
7154235|NCT03307252|11320764|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
6863783|NCT00425945|10873146|FG000|Overall Study|Inconvenience|0
7154236|NCT03307252|11320765|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
6863784|NCT00425945|10873147|FG001|Overall Study|Inconvenience|2
6863785|NCT00425945|10873146|FG000|Overall Study|Lost to Follow-up|0
6863786|NCT00425945|10873147|FG001|Overall Study|Lost to Follow-up|2
6863787|NCT00425945|10873146|FG000|Overall Study|Began hypertension medication|1
6863788|NCT00425945|10873147|FG001|Overall Study|Began hypertension medication|0
6863789|NCT00425945|10873146|FG000|Overall Study|Began cancer treatments|1
6863790|NCT00425945|10873147|FG001|Overall Study|Began cancer treatments|0
6863791|NCT00425945|10873146|FG000|Overall Study|Moved from area|0
6863792|NCT00425945|10873147|FG001|Overall Study|Moved from area|1
6863793|NCT00426127|10873155|FG000|Overall Study|Adverse Event|1
6863794|NCT00426127|10873155|FG000|Overall Study|Removed due to disease progression|1
6863795|NCT00426231|10873170|FG000|Overall Study|Withdrawal by Subject|9
6863796|NCT00426231|10873171|FG001|Overall Study|Withdrawal by Subject|12
6863797|NCT00426270|10873177|FG000|Overall Study|Incorrectly Enrolled in the Study|1
6863798|NCT00426270|10873177|FG000|Overall Study|Adverse Event|5
6863799|NCT00426361|10873197|FG000|Overall Study|Lost to Follow-up|3
6863800|NCT00426361|10873198|FG001|Overall Study|Lost to Follow-up|2
6863801|NCT00426361|10873199|FG002|Overall Study|Lost to Follow-up|5
6863802|NCT00426361|10873197|FG000|Overall Study|Withdrawal by Subject|1
6863803|NCT00426361|10873198|FG001|Overall Study|Withdrawal by Subject|3
6863804|NCT00426361|10873199|FG002|Overall Study|Withdrawal by Subject|0
6863805|NCT00426556|10873228|FG000|Phase I - Core Phase|Disease Progression|0
6863806|NCT00426556|10873229|FG001|Phase I - Core Phase|Disease Progression|6
6863807|NCT00426556|10873230|FG002|Phase I - Core Phase|Disease Progression|2
7041131|NCT01723826|11124609|FG002|Overall Study|Non-compliance With Study Drug|0
7041132|NCT01723826|11124610|FG003|Overall Study|Non-compliance With Study Drug|0
6863808|NCT00426556|10873231|FG003|Phase I - Core Phase|Disease Progression|0
6863809|NCT00426556|10873228|FG000|Phase I - Core Phase|Adverse Event|1
7041133|NCT01723826|11124607|FG000|Overall Study|Other Reason|8
7041134|NCT01723826|11124608|FG001|Overall Study|Other Reason|6
7041135|NCT01723826|11124609|FG002|Overall Study|Other Reason|12
7041136|NCT01723826|11124610|FG003|Overall Study|Other Reason|14
7041137|NCT01723826|11124607|FG000|Overall Study|Physician Decision|1
7041138|NCT01723826|11124608|FG001|Overall Study|Physician Decision|3
6863810|NCT00426556|10873229|FG001|Phase I - Core Phase|Adverse Event|3
6863811|NCT00426556|10873230|FG002|Phase I - Core Phase|Adverse Event|1
6863812|NCT00426556|10873231|FG003|Phase I - Core Phase|Adverse Event|0
6863813|NCT00426556|10873228|FG000|Phase I - Core Phase|Death|0
6863814|NCT00426556|10873229|FG001|Phase I - Core Phase|Death|1
6863815|NCT00426556|10873230|FG002|Phase I - Core Phase|Death|0
6863816|NCT00426556|10873231|FG003|Phase I - Core Phase|Death|0
6863817|NCT00426556|10873228|FG000|Phase I - Extension Phase|Adverse Event|0
6863818|NCT00426556|10873229|FG001|Phase I - Extension Phase|Adverse Event|1
6863819|NCT00426556|10873230|FG002|Phase I - Extension Phase|Adverse Event|1
6863820|NCT00426556|10873231|FG003|Phase I - Extension Phase|Adverse Event|0
6863821|NCT00426556|10873228|FG000|Phase I - Extension Phase|Disease Progression|5
6863822|NCT00426556|10873229|FG001|Phase I - Extension Phase|Disease Progression|5
6863823|NCT00426556|10873230|FG002|Phase I - Extension Phase|Disease Progression|6
6863824|NCT00426556|10873231|FG003|Phase I - Extension Phase|Disease Progression|0
6863825|NCT00426556|10873228|FG000|Phase II - Core Phase|Withdrawal by Subject|0
6863826|NCT00426556|10873229|FG001|Phase II - Core Phase|Withdrawal by Subject|0
6863827|NCT00426556|10873230|FG002|Phase II - Core Phase|Withdrawal by Subject|0
6863828|NCT00426556|10873231|FG003|Phase II - Core Phase|Withdrawal by Subject|3
6863829|NCT00426556|10873228|FG000|Phase II - Core Phase|Disease Progression|0
6863830|NCT00426556|10873229|FG001|Phase II - Core Phase|Disease Progression|0
6863831|NCT00426556|10873230|FG002|Phase II - Core Phase|Disease Progression|0
6863832|NCT00426556|10873231|FG003|Phase II - Core Phase|Disease Progression|16
6863833|NCT00426556|10873228|FG000|Phase II - Core Phase|Adverse Event|0
6863834|NCT00426556|10873229|FG001|Phase II - Core Phase|Adverse Event|0
6863835|NCT00426556|10873230|FG002|Phase II - Core Phase|Adverse Event|0
6863836|NCT00426556|10873231|FG003|Phase II - Core Phase|Adverse Event|8
6863837|NCT00426556|10873228|FG000|Phase II - Extension Phase|Disease Progression|0
6863838|NCT00426556|10873229|FG001|Phase II - Extension Phase|Disease Progression|0
6863839|NCT00426556|10873230|FG002|Phase II - Extension Phase|Disease Progression|0
6863840|NCT00426556|10873231|FG003|Phase II - Extension Phase|Disease Progression|21
6863841|NCT00426556|10873228|FG000|Phase II - Extension Phase|Adverse Event|0
6863842|NCT00426556|10873229|FG001|Phase II - Extension Phase|Adverse Event|0
6863843|NCT00426556|10873230|FG002|Phase II - Extension Phase|Adverse Event|0
6863844|NCT00426556|10873231|FG003|Phase II - Extension Phase|Adverse Event|2
6863845|NCT00426660|10873241|FG000|Overall Study|Death|14
6863846|NCT00426660|10873241|FG000|Overall Study|Adverse Event|23
6863847|NCT00426660|10873241|FG000|Overall Study|Insufficient Clinical Response|22
6863848|NCT00426660|10873241|FG000|Overall Study|Lost to Follow-up|15
6863849|NCT00426660|10873241|FG000|Overall Study|Other|23
6863850|NCT00426660|10873241|FG000|Overall Study|Withdrawal by Subject|18
6863851|NCT00426660|10873241|FG000|Overall Study|Protocol Violation|1
6863852|NCT00426660|10873241|FG000|Overall Study|Enrolled Not Treated|15
7041139|NCT01723826|11124609|FG002|Overall Study|Physician Decision|4
7041140|NCT01723826|11124610|FG003|Overall Study|Physician Decision|11
7041141|NCT01723826|11124607|FG000|Overall Study|Protocol Violation|1
7041142|NCT01723826|11124608|FG001|Overall Study|Protocol Violation|1
7041143|NCT01723826|11124609|FG002|Overall Study|Protocol Violation|3
7041144|NCT01723826|11124610|FG003|Overall Study|Protocol Violation|1
7041145|NCT01723826|11124607|FG000|Overall Study|Withdrawal by Subject|10
6863853|NCT00426751|10873247|FG000|Overall Study|Adverse Event|8
6863854|NCT00426751|10873248|FG001|Overall Study|Adverse Event|1
6863855|NCT00426751|10873247|FG000|Overall Study|Lost to Follow-up|7
6863856|NCT00426751|10873248|FG001|Overall Study|Lost to Follow-up|6
6863857|NCT00426751|10873247|FG000|Overall Study|Consent Withdrawn|0
6863858|NCT00426751|10873248|FG001|Overall Study|Consent Withdrawn|1
6863859|NCT00426751|10873247|FG000|Overall Study|Other Reasons|7
6863860|NCT00426751|10873248|FG001|Overall Study|Other Reasons|12
6863861|NCT00426764|10873254|FG000|Overall Study|Protocol Violation|1
6863862|NCT00426764|10873254|FG000|Overall Study|Withdrawal by Subject|4
6863863|NCT00426764|10873254|FG000|Overall Study|Physician Decision|6
6863864|NCT00426764|10873254|FG000|Overall Study|Compassionate Use|1
6863865|NCT00426764|10873254|FG000|Overall Study|Progressive Disease|83
6863866|NCT00426764|10873254|FG000|Overall Study|Adverse Event|24
6863867|NCT00426764|10873254|FG000|Overall Study|Other|1
6863868|NCT00426764|10873254|FG000|Overall Study|Death|1
6863869|NCT00426764|10873254|FG000|Overall Study|Other Reasons (Miscellaneous)|10
6863870|NCT00426842|10873264|FG000|Overall Study|Lost to Follow-up|1
6863871|NCT00427011|10873274|FG000|Overall Study|Adverse Event|10
6863872|NCT00427011|10873274|FG000|Overall Study|Withdrawal by Subject|1
6863873|NCT00427011|10873274|FG000|Overall Study|Lack of Efficacy|2
6863874|NCT00427011|10873274|FG000|Overall Study|Other|12
6863875|NCT00427349|10873303|FG000|Overall Study|Lack of Efficacy|23
6863876|NCT00427349|10873303|FG000|Overall Study|Adverse Event|14
6863877|NCT00427349|10873303|FG000|Overall Study|Death|1
7078183|NCT02100696|11186439|FG004|Induction Phase|Adverse Event|0
7078184|NCT02100696|11186440|FG005|Induction Phase|Adverse Event|0
6863878|NCT00427349|10873303|FG000|Overall Study|Withdrawal by Subject|3
6863879|NCT00427349|10873303|FG000|Overall Study|Alternative therapy|1
6863880|NCT00427349|10873303|FG000|Overall Study|Other|2
6863881|NCT00427349|10873303|FG000|Overall Study|Ineligible|1
6863882|NCT00427349|10873303|FG000|Overall Study|Never started therapy|1
6863883|NCT00427635|10873313|FG000|Treatment Phase|Withdrawal by Subject|1
6863884|NCT00427635|10873314|FG001|Treatment Phase|Withdrawal by Subject|0
6863885|NCT00427635|10873313|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0
6863886|NCT00427635|10873314|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1
6863887|NCT00427648|10873322|FG000|Overall Study|Protocol Violation|1
6863888|NCT00427648|10873323|FG001|Overall Study|Protocol Violation|2
6863889|NCT00427648|10873322|FG000|Overall Study|Adverse Event|0
6863890|NCT00427648|10873323|FG001|Overall Study|Adverse Event|1
6863891|NCT00427700|10873338|FG000|Overall Study|Lost to Follow-up|2
6863892|NCT00427700|10873339|FG001|Overall Study|Lost to Follow-up|5
6863893|NCT00427700|10873338|FG000|Overall Study|no induction of menses|1
6863894|NCT00427700|10873339|FG001|Overall Study|no induction of menses|4
6863895|NCT00427700|10873338|FG000|Overall Study|Pregnancy|0
6863896|NCT00427700|10873339|FG001|Overall Study|Pregnancy|2
6863897|NCT00427778|10873350|FG000|First Intervention (4 Weeks)|no longer interested|1
6863898|NCT00427778|10873351|FG001|First Intervention (4 Weeks)|no longer interested|0
6863899|NCT00427778|10873350|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2
6863900|NCT00427778|10873351|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0
6863901|NCT00427778|10873350|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0
6863902|NCT00427778|10873351|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1
6863903|NCT00427778|10873350|FG000|First Intervention (4 Weeks)|anxious about using ring|1
6863904|NCT00427778|10873351|FG001|First Intervention (4 Weeks)|anxious about using ring|0
6863905|NCT00427895|10873392|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
6863906|NCT00427895|10873393|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
6863907|NCT00427895|10873394|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
6863908|NCT00427895|10873395|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352
6863909|NCT00427895|10873396|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
6863910|NCT00427895|10873397|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
6863911|NCT00427895|10873398|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
6863912|NCT00427895|10873399|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
6863913|NCT00427895|10873392|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0
6863914|NCT00427895|10873393|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0
6863915|NCT00427895|10873394|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0
6863916|NCT00427895|10873395|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0
6863917|NCT00427895|10873396|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0
6863918|NCT00427895|10873397|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0
6863919|NCT00427895|10873398|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0
6863920|NCT00427895|10873399|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1
6863921|NCT00427895|10873392|FG000|Vax 2/Year 3 to 4|Protocol Violation|0
6863922|NCT00427895|10873393|FG001|Vax 2/Year 3 to 4|Protocol Violation|0
6863923|NCT00427895|10873394|FG002|Vax 2/Year 3 to 4|Protocol Violation|0
6863924|NCT00427895|10873395|FG003|Vax 2/Year 3 to 4|Protocol Violation|0
6863925|NCT00427895|10873396|FG004|Vax 2/Year 3 to 4|Protocol Violation|0
6863926|NCT00427895|10873397|FG005|Vax 2/Year 3 to 4|Protocol Violation|0
6863927|NCT00427895|10873398|FG006|Vax 2/Year 3 to 4|Protocol Violation|0
6863928|NCT00427895|10873399|FG007|Vax 2/Year 3 to 4|Protocol Violation|1
6863929|NCT00427895|10873392|FG000|Vax 2/Year 3 to 4|Failed to Return|0
6863930|NCT00427895|10873393|FG001|Vax 2/Year 3 to 4|Failed to Return|0
6863931|NCT00427895|10873394|FG002|Vax 2/Year 3 to 4|Failed to Return|0
6863932|NCT00427895|10873395|FG003|Vax 2/Year 3 to 4|Failed to Return|0
6863933|NCT00427895|10873396|FG004|Vax 2/Year 3 to 4|Failed to Return|1
6863934|NCT00427895|10873397|FG005|Vax 2/Year 3 to 4|Failed to Return|0
6863935|NCT00427895|10873398|FG006|Vax 2/Year 3 to 4|Failed to Return|0
6863936|NCT00427895|10873399|FG007|Vax 2/Year 3 to 4|Failed to Return|0
6863937|NCT00427895|10873392|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
6863938|NCT00427895|10873393|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1
6863939|NCT00427895|10873394|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4
6863940|NCT00427895|10873395|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32
6863941|NCT00427895|10873396|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
6863942|NCT00427895|10873397|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
6863943|NCT00427895|10873398|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
6863944|NCT00427895|10873399|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
6863945|NCT00427895|10873392|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4
6863946|NCT00427895|10873393|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
6863947|NCT00427895|10873394|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3
6863948|NCT00427895|10873395|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2
6863949|NCT00427895|10873396|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
6863950|NCT00427895|10873397|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
6863951|NCT00427895|10873398|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
6863952|NCT00427895|10873399|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
6863953|NCT00427895|10873392|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
6863954|NCT00427895|10873393|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
6863955|NCT00427895|10873394|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
6863956|NCT00427895|10873395|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
6863957|NCT00427895|10873396|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
6863958|NCT00427895|10873397|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
6863959|NCT00427895|10873398|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
6863960|NCT00427895|10873399|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
6863961|NCT00427895|10873392|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
6863962|NCT00427895|10873393|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
6863963|NCT00427895|10873394|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4
6863964|NCT00427895|10873395|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7
6863965|NCT00427895|10873396|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
6863966|NCT00427895|10873397|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
6863967|NCT00427895|10873398|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
6863968|NCT00427895|10873399|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
6863969|NCT00427895|10873392|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
6863970|NCT00427895|10873393|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
6863971|NCT00427895|10873394|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
6863972|NCT00427895|10873395|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2
6863973|NCT00427895|10873396|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
6863974|NCT00427895|10873397|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
6863975|NCT00427895|10873398|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
6863976|NCT00427895|10873399|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
6863977|NCT00427895|10873392|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
6863978|NCT00427895|10873393|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3
6863979|NCT00427895|10873394|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2
6863980|NCT00427895|10873395|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
6863981|NCT00427895|10873396|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
6863982|NCT00427895|10873397|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
6863983|NCT00427895|10873398|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
6863984|NCT00427895|10873399|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
6863985|NCT00427895|10873392|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0
6863986|NCT00427895|10873393|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0
6863987|NCT00427895|10873394|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1
6863988|NCT00427895|10873395|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2
6863989|NCT00427895|10873396|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0
6863990|NCT00427895|10873397|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0
6863991|NCT00427895|10873398|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0
6863992|NCT00427895|10873399|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0
6863993|NCT00427895|10873392|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
6863994|NCT00427895|10873393|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5
6863995|NCT00427895|10873394|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2
6863996|NCT00427895|10873395|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21
6863997|NCT00427895|10873396|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
6863998|NCT00427895|10873397|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
6863999|NCT00427895|10873398|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
6864000|NCT00427895|10873399|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
6864001|NCT00427895|10873392|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3
6967952|NCT01134705|11016524|FG001|Overall Study|Withdrawal by Subject|6
6967953|NCT01134705|11016523|FG000|Overall Study|Pregnancy|1
6864002|NCT00427895|10873393|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3
6864003|NCT00427895|10873394|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0
6864004|NCT00427895|10873395|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1
6864005|NCT00427895|10873396|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0
6864006|NCT00427895|10873397|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0
6864007|NCT00427895|10873398|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0
6864008|NCT00427895|10873399|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0
6864009|NCT00427895|10873392|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3
6864010|NCT00427895|10873393|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6
6864011|NCT00427895|10873394|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5
6864012|NCT00427895|10873395|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4
6864013|NCT00427895|10873396|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
6864014|NCT00427895|10873397|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
6864015|NCT00427895|10873398|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
6864016|NCT00427895|10873399|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
6864017|NCT00427895|10873392|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0
6864018|NCT00427895|10873393|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1
6864019|NCT00427895|10873394|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0
6864020|NCT00427895|10873395|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0
6864021|NCT00427895|10873396|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0
6864022|NCT00427895|10873397|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0
6864023|NCT00427895|10873398|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0
6864024|NCT00427895|10873399|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0
6864025|NCT00427895|10873392|FG000|Vax 1/Year 1 Follow-up|Death|1
6864026|NCT00427895|10873393|FG001|Vax 1/Year 1 Follow-up|Death|0
6864027|NCT00427895|10873394|FG002|Vax 1/Year 1 Follow-up|Death|0
6864028|NCT00427895|10873395|FG003|Vax 1/Year 1 Follow-up|Death|0
6864029|NCT00427895|10873396|FG004|Vax 1/Year 1 Follow-up|Death|0
6864030|NCT00427895|10873397|FG005|Vax 1/Year 1 Follow-up|Death|0
6864031|NCT00427895|10873398|FG006|Vax 1/Year 1 Follow-up|Death|0
6864032|NCT00427895|10873399|FG007|Vax 1/Year 1 Follow-up|Death|0
6864033|NCT00427895|10873392|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0
6864034|NCT00427895|10873393|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0
6864035|NCT00427895|10873394|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12
6864036|NCT00427895|10873395|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5
6864037|NCT00427895|10873396|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0
6864038|NCT00427895|10873397|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0
6864039|NCT00427895|10873398|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0
6864040|NCT00427895|10873399|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0
6864041|NCT00427895|10873392|FG000|Vax 1/Year 1 Follow-up|Other|0
6864042|NCT00427895|10873393|FG001|Vax 1/Year 1 Follow-up|Other|0
6864043|NCT00427895|10873394|FG002|Vax 1/Year 1 Follow-up|Other|0
6864044|NCT00427895|10873395|FG003|Vax 1/Year 1 Follow-up|Other|2
6864045|NCT00427895|10873396|FG004|Vax 1/Year 1 Follow-up|Other|0
6864046|NCT00427895|10873397|FG005|Vax 1/Year 1 Follow-up|Other|0
6864047|NCT00427895|10873398|FG006|Vax 1/Year 1 Follow-up|Other|0
6864048|NCT00427895|10873399|FG007|Vax 1/Year 1 Follow-up|Other|0
6864049|NCT00427895|10873392|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188
6864050|NCT00427895|10873393|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207
6864051|NCT00427895|10873394|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159
6864052|NCT00427895|10873395|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469
6864053|NCT00427895|10873396|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
6864054|NCT00427895|10873397|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
6864055|NCT00427895|10873398|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
6864056|NCT00427895|10873399|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
6864057|NCT00427908|10873442|FG000|Primary Phase|Lost to Follow-up|4
6864058|NCT00427908|10873443|FG001|Primary Phase|Lost to Follow-up|0
6864059|NCT00427908|10873444|FG002|Primary Phase|Lost to Follow-up|2
6864060|NCT00427908|10873445|FG003|Primary Phase|Lost to Follow-up|0
6864061|NCT00427908|10873442|FG000|Primary Phase|Withdrawal by Subject|1
6864062|NCT00427908|10873443|FG001|Primary Phase|Withdrawal by Subject|2
6864063|NCT00427908|10873444|FG002|Primary Phase|Withdrawal by Subject|1
6864064|NCT00427908|10873445|FG003|Primary Phase|Withdrawal by Subject|0
6864065|NCT00427908|10873442|FG000|Primary Phase|Adverse Event|0
6864066|NCT00427908|10873443|FG001|Primary Phase|Adverse Event|1
6864067|NCT00427908|10873444|FG002|Primary Phase|Adverse Event|0
6864068|NCT00427908|10873445|FG003|Primary Phase|Adverse Event|0
6864069|NCT00427921|10873480|FG000|Overall Study|Adverse Event|26
6864070|NCT00427921|10873480|FG000|Overall Study|Withdrawal by Subject|4
6864071|NCT00427921|10873480|FG000|Overall Study|Lost to Follow-up|2
6864072|NCT00427921|10873480|FG000|Overall Study|Other reason not specified|10
6864073|NCT00427921|10873480|FG000|Overall Study|Adverse Event + Hospitalization|1
6864074|NCT00427921|10873480|FG000|Overall Study|Adverse Event + Withdrew Consent|1
6864075|NCT00427921|10873480|FG000|Overall Study|Adverse Event + No Response|1
6864076|NCT00427921|10873480|FG000|Overall Study|Adverse Event + Worsening of CD|1
6864077|NCT00427921|10873480|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1
6864078|NCT00427921|10873480|FG000|Overall Study|Adverse Event + Lost Response|1
6864079|NCT00427921|10873480|FG000|Overall Study|Adverse Event + Withdrawn from Study|1
6864080|NCT00427921|10873480|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1
6864081|NCT00427934|10873488|FG000|Overall Study|Adverse Event|1
6864082|NCT00427934|10873489|FG001|Overall Study|Adverse Event|0
6864083|NCT00427934|10873490|FG002|Overall Study|Adverse Event|5
6864084|NCT00427934|10873491|FG003|Overall Study|Adverse Event|4
6864085|NCT00427934|10873488|FG000|Overall Study|Lack of Efficacy|0
6864086|NCT00427934|10873489|FG001|Overall Study|Lack of Efficacy|0
6864087|NCT00427934|10873490|FG002|Overall Study|Lack of Efficacy|5
6864088|NCT00427934|10873491|FG003|Overall Study|Lack of Efficacy|2
6864089|NCT00427934|10873488|FG000|Overall Study|Randomized But Did Not Receive Treatment|0
6864090|NCT00427934|10873489|FG001|Overall Study|Randomized But Did Not Receive Treatment|0
6864091|NCT00427934|10873490|FG002|Overall Study|Randomized But Did Not Receive Treatment|1
6864092|NCT00427934|10873491|FG003|Overall Study|Randomized But Did Not Receive Treatment|1
6864093|NCT00427934|10873488|FG000|Overall Study|Other|0
6864094|NCT00427934|10873489|FG001|Overall Study|Other|0
6864095|NCT00427934|10873490|FG002|Overall Study|Other|11
6864096|NCT00427934|10873491|FG003|Overall Study|Other|5
6864097|NCT00427934|10873488|FG000|Overall Study|Withdrawal by Subject|0
6864098|NCT00427934|10873489|FG001|Overall Study|Withdrawal by Subject|0
6864099|NCT00427934|10873490|FG002|Overall Study|Withdrawal by Subject|1
6864100|NCT00427934|10873491|FG003|Overall Study|Withdrawal by Subject|3
6864101|NCT00427960|10873505|FG000|Overall Study|Adverse Event|2
6864102|NCT00427960|10873506|FG001|Overall Study|Adverse Event|0
6864103|NCT00427960|10873505|FG000|Overall Study|Withdrawal by Subject|0
6864104|NCT00427960|10873506|FG001|Overall Study|Withdrawal by Subject|3
6864105|NCT00427960|10873505|FG000|Overall Study|Other|0
6864106|NCT00427960|10873506|FG001|Overall Study|Other|1
6864107|NCT00427999|10873516|FG000|Overall Study|Adverse Event|6
6864108|NCT00427999|10873516|FG000|Overall Study|Abnormal laboratory values|1
6864109|NCT00427999|10873516|FG000|Overall Study|Unsatisfactory therapeutic effect|13
6864110|NCT00427999|10873516|FG000|Overall Study|Protocol Violation|2
6864111|NCT00427999|10873516|FG000|Overall Study|Withdrawal by Subject|9
6864112|NCT00427999|10873516|FG000|Overall Study|Death|1
6864113|NCT00428090|10873529|FG000|Overall Study|Adverse Event|10
6864114|NCT00428090|10873530|FG001|Overall Study|Adverse Event|8
6864115|NCT00428090|10873531|FG002|Overall Study|Adverse Event|10
6864116|NCT00428090|10873532|FG003|Overall Study|Adverse Event|11
6864117|NCT00428090|10873529|FG000|Overall Study|Lost to Follow-up|3
6864118|NCT00428090|10873530|FG001|Overall Study|Lost to Follow-up|6
6864119|NCT00428090|10873531|FG002|Overall Study|Lost to Follow-up|1
6864120|NCT00428090|10873532|FG003|Overall Study|Lost to Follow-up|4
6864121|NCT00428090|10873529|FG000|Overall Study|Protocol Violation|3
6864122|NCT00428090|10873530|FG001|Overall Study|Protocol Violation|1
6864123|NCT00428090|10873531|FG002|Overall Study|Protocol Violation|3
6864124|NCT00428090|10873532|FG003|Overall Study|Protocol Violation|3
6864125|NCT00428090|10873529|FG000|Overall Study|Withdrawal by Subject|10
6864126|NCT00428090|10873530|FG001|Overall Study|Withdrawal by Subject|12
6864127|NCT00428090|10873531|FG002|Overall Study|Withdrawal by Subject|15
7078185|NCT02100696|11186435|FG000|Induction Phase|Lost to Follow-up|1
7078186|NCT02100696|11186436|FG001|Induction Phase|Lost to Follow-up|0
7078187|NCT02100696|11186437|FG002|Induction Phase|Lost to Follow-up|1
6864128|NCT00428090|10873532|FG003|Overall Study|Withdrawal by Subject|5
6864129|NCT00428090|10873529|FG000|Overall Study|Sponsor terminated study|0
6864130|NCT00428090|10873530|FG001|Overall Study|Sponsor terminated study|1
6864131|NCT00428090|10873531|FG002|Overall Study|Sponsor terminated study|0
6864132|NCT00428090|10873532|FG003|Overall Study|Sponsor terminated study|0
6864133|NCT00428090|10873529|FG000|Overall Study|Non-compliance|4
6864134|NCT00428090|10873530|FG001|Overall Study|Non-compliance|0
6864135|NCT00428090|10873531|FG002|Overall Study|Non-compliance|1
6864136|NCT00428090|10873532|FG003|Overall Study|Non-compliance|3
6864137|NCT00428090|10873529|FG000|Overall Study|Par. did not returned to visit|1
6864138|NCT00428090|10873530|FG001|Overall Study|Par. did not returned to visit|0
6864139|NCT00428090|10873531|FG002|Overall Study|Par. did not returned to visit|0
6864140|NCT00428090|10873532|FG003|Overall Study|Par. did not returned to visit|1
6864141|NCT00428090|10873529|FG000|Overall Study|Follow-Up visit not possible|1
6864142|NCT00428090|10873530|FG001|Overall Study|Follow-Up visit not possible|0
6864143|NCT00428090|10873531|FG002|Overall Study|Follow-Up visit not possible|0
6864144|NCT00428090|10873532|FG003|Overall Study|Follow-Up visit not possible|0
6864145|NCT00428090|10873529|FG000|Overall Study|Prohibited medication used for SAE|1
6864146|NCT00428090|10873530|FG001|Overall Study|Prohibited medication used for SAE|0
6864147|NCT00428090|10873531|FG002|Overall Study|Prohibited medication used for SAE|0
6864148|NCT00428090|10873532|FG003|Overall Study|Prohibited medication used for SAE|0
6864149|NCT00428090|10873529|FG000|Overall Study|Death of par.|1
6864150|NCT00428090|10873530|FG001|Overall Study|Death of par.|0
6864151|NCT00428090|10873531|FG002|Overall Study|Death of par.|1
6864152|NCT00428090|10873532|FG003|Overall Study|Death of par.|0
6864153|NCT00428090|10873529|FG000|Overall Study|Visit 7 exceed the visit window|0
6864154|NCT00428090|10873530|FG001|Overall Study|Visit 7 exceed the visit window|1
6864155|NCT00428090|10873531|FG002|Overall Study|Visit 7 exceed the visit window|0
6864156|NCT00428090|10873532|FG003|Overall Study|Visit 7 exceed the visit window|0
7154237|NCT03307252|11320766|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
6864157|NCT00428090|10873529|FG000|Overall Study|Medical monitor terminated par.|0
6864158|NCT00428090|10873530|FG001|Overall Study|Medical monitor terminated par.|1
6864159|NCT00428090|10873531|FG002|Overall Study|Medical monitor terminated par.|0
6864160|NCT00428090|10873532|FG003|Overall Study|Medical monitor terminated par.|0
6864161|NCT00428090|10873529|FG000|Overall Study|Mental status of par. was|0
6864162|NCT00428090|10873530|FG001|Overall Study|Mental status of par. was|1
6864163|NCT00428090|10873531|FG002|Overall Study|Mental status of par. was|0
6864164|NCT00428090|10873532|FG003|Overall Study|Mental status of par. was|0
6864165|NCT00428090|10873529|FG000|Overall Study|Worsening of AD|0
6864166|NCT00428090|10873530|FG001|Overall Study|Worsening of AD|0
6864167|NCT00428090|10873531|FG002|Overall Study|Worsening of AD|1
6864168|NCT00428090|10873532|FG003|Overall Study|Worsening of AD|0
6864169|NCT00428090|10873529|FG000|Overall Study|Excluded for concerning QTc value|0
6864170|NCT00428090|10873530|FG001|Overall Study|Excluded for concerning QTc value|0
6864171|NCT00428090|10873531|FG002|Overall Study|Excluded for concerning QTc value|1
6864172|NCT00428090|10873532|FG003|Overall Study|Excluded for concerning QTc value|0
6864173|NCT00428090|10873529|FG000|Overall Study|Insufficient AD documentation|0
6864174|NCT00428090|10873530|FG001|Overall Study|Insufficient AD documentation|0
6864175|NCT00428090|10873531|FG002|Overall Study|Insufficient AD documentation|1
6864176|NCT00428090|10873532|FG003|Overall Study|Insufficient AD documentation|0
6864177|NCT00428090|10873529|FG000|Overall Study|High MMSE scores|0
6864178|NCT00428090|10873530|FG001|Overall Study|High MMSE scores|0
6864179|NCT00428090|10873531|FG002|Overall Study|High MMSE scores|1
6864180|NCT00428090|10873532|FG003|Overall Study|High MMSE scores|0
6864181|NCT00428090|10873529|FG000|Overall Study|Deterioration of cognitive status|0
6864182|NCT00428090|10873530|FG001|Overall Study|Deterioration of cognitive status|0
6864183|NCT00428090|10873531|FG002|Overall Study|Deterioration of cognitive status|1
6864184|NCT00428090|10873532|FG003|Overall Study|Deterioration of cognitive status|0
6864185|NCT00428090|10873529|FG000|Overall Study|Serious adverse event|0
6864186|NCT00428090|10873530|FG001|Overall Study|Serious adverse event|0
6864187|NCT00428090|10873531|FG002|Overall Study|Serious adverse event|1
6864188|NCT00428090|10873532|FG003|Overall Study|Serious adverse event|0
6864189|NCT00428090|10873529|FG000|Overall Study|Excluded for heart insufficiency|0
6864190|NCT00428090|10873530|FG001|Overall Study|Excluded for heart insufficiency|0
6864191|NCT00428090|10873531|FG002|Overall Study|Excluded for heart insufficiency|1
6864192|NCT00428090|10873532|FG003|Overall Study|Excluded for heart insufficiency|0
6864193|NCT00428090|10873529|FG000|Overall Study|Raised Creatinine Value|0
6864194|NCT00428090|10873530|FG001|Overall Study|Raised Creatinine Value|0
6864195|NCT00428090|10873531|FG002|Overall Study|Raised Creatinine Value|0
6864196|NCT00428090|10873532|FG003|Overall Study|Raised Creatinine Value|1
6864197|NCT00428116|10873552|FG000|Overall Study|Death|1
6864198|NCT00428116|10873553|FG001|Overall Study|Death|0
6864199|NCT00428116|10873552|FG000|Overall Study|Withdrawal by Subject|1
6864200|NCT00428116|10873553|FG001|Overall Study|Withdrawal by Subject|0
6864201|NCT00428116|10873552|FG000|Overall Study|Lost to Follow-up|1
6864202|NCT00428116|10873553|FG001|Overall Study|Lost to Follow-up|0
6864203|NCT00428220|10873560|FG000|Overall Study|Participant died|8
6864204|NCT00428220|10873560|FG000|Overall Study|Global deterioration of health status|7
6864205|NCT00428220|10873560|FG000|Overall Study|Lost to Follow-up|4
6864206|NCT00428220|10873560|FG000|Overall Study|Objective progression or relapse|123
6864207|NCT00428220|10873560|FG000|Overall Study|Participant refused continued treatment|7
6864208|NCT00428220|10873560|FG000|Overall Study|Adverse Event|51
6864209|NCT00428220|10873560|FG000|Overall Study|Other|23
6864210|NCT00428246|10873578|FG000|Overall Study|Withdrawal by Subject|0
6864211|NCT00428246|10873579|FG001|Overall Study|Withdrawal by Subject|0
6864212|NCT00428246|10873580|FG002|Overall Study|Withdrawal by Subject|1
6864213|NCT00428246|10873578|FG000|Overall Study|Adverse Event|1
6864214|NCT00428246|10873579|FG001|Overall Study|Adverse Event|0
6864215|NCT00428246|10873580|FG002|Overall Study|Adverse Event|0
6864216|NCT00428389|10873601|FG000|Core Phase|Adverse Event|6
6864217|NCT00428389|10873602|FG001|Core Phase|Adverse Event|4
6864218|NCT00428389|10873601|FG000|Core Phase|Lack of Efficacy|2
6864219|NCT00428389|10873602|FG001|Core Phase|Lack of Efficacy|0
6864220|NCT00428389|10873601|FG000|Core Phase|Abnormal test procedure result(s)|0
6864221|NCT00428389|10873602|FG001|Core Phase|Abnormal test procedure result(s)|1
6864222|NCT00428389|10873601|FG000|Core Phase|Withdrawal by Subject|3
6864223|NCT00428389|10873602|FG001|Core Phase|Withdrawal by Subject|4
6864224|NCT00428389|10873601|FG000|Core Phase|Protocol deviation|0
6864225|NCT00428389|10873602|FG001|Core Phase|Protocol deviation|2
6864226|NCT00428389|10873601|FG000|Extension Phase|Adverse Event|17
6864227|NCT00428389|10873602|FG001|Extension Phase|Adverse Event|11
6864228|NCT00428389|10873601|FG000|Extension Phase|Lack of Efficacy|4
6864229|NCT00428389|10873602|FG001|Extension Phase|Lack of Efficacy|3
6864230|NCT00428389|10873601|FG000|Extension Phase|Withdrawal by Subject|6
6864231|NCT00428389|10873602|FG001|Extension Phase|Withdrawal by Subject|6
6864232|NCT00428389|10873601|FG000|Extension Phase|Lost to Follow-up|0
6864233|NCT00428389|10873602|FG001|Extension Phase|Lost to Follow-up|3
6864234|NCT00428389|10873601|FG000|Extension Phase|Death|1
6864235|NCT00428389|10873602|FG001|Extension Phase|Death|0
6864236|NCT00428389|10873601|FG000|Extension Phase|Protocol Violation|3
6864237|NCT00428389|10873602|FG001|Extension Phase|Protocol Violation|2
6864238|NCT00428389|10873601|FG000|Extension Phase|Administrative problems|1
6864239|NCT00428389|10873602|FG001|Extension Phase|Administrative problems|1
6864240|NCT00428441|10873608|FG000|Overall Study|Lost to Follow-up|1
6864241|NCT00428597|10873627|FG000|Overall Study|Randomized but not treated|3
6864242|NCT00428597|10873628|FG001|Overall Study|Randomized but not treated|3
6864243|NCT00428597|10873627|FG000|Overall Study|Objective Progression or Relapse|19
6864244|NCT00428597|10873628|FG001|Overall Study|Objective Progression or Relapse|47
6864245|NCT00428597|10873627|FG000|Overall Study|Study Terminated by Sponsor|41
6864246|NCT00428597|10873628|FG001|Overall Study|Study Terminated by Sponsor|16
6864247|NCT00428597|10873627|FG000|Overall Study|Adverse Event|15
6864248|NCT00428597|10873628|FG001|Overall Study|Adverse Event|7
6864249|NCT00428597|10873627|FG000|Overall Study|Global Deterioration of Health Status|1
6864250|NCT00428597|10873628|FG001|Overall Study|Global Deterioration of Health Status|5
6864251|NCT00428597|10873627|FG000|Overall Study|Protocol Violation|2
6864252|NCT00428597|10873628|FG001|Overall Study|Protocol Violation|1
6864253|NCT00428597|10873627|FG000|Overall Study|Withdrawal by Subject|2
6864254|NCT00428597|10873628|FG001|Overall Study|Withdrawal by Subject|1
6864255|NCT00428597|10873627|FG000|Overall Study|Other|1
6864256|NCT00428597|10873628|FG001|Overall Study|Other|1
6864257|NCT00428597|10873627|FG000|Overall Study|Lost to Follow-up|0
6864258|NCT00428597|10873628|FG001|Overall Study|Lost to Follow-up|1
6864259|NCT00428597|10873627|FG000|Overall Study|Pregnancy|1
6864260|NCT00428597|10873628|FG001|Overall Study|Pregnancy|0
6864261|NCT00428597|10873627|FG000|Overall Study|Death|1
6864262|NCT00428597|10873628|FG001|Overall Study|Death|3
6864263|NCT00428610|10873637|FG000|Overall Study|Death Due to Adverse Event|3
6864264|NCT00428610|10873638|FG001|Overall Study|Death Due to Adverse Event|0
6864265|NCT00428610|10873639|FG002|Overall Study|Death Due to Adverse Event|5
6864266|NCT00428610|10873637|FG000|Overall Study|Death Due to Progressive Disease|0
6864267|NCT00428610|10873638|FG001|Overall Study|Death Due to Progressive Disease|0
6864268|NCT00428610|10873639|FG002|Overall Study|Death Due to Progressive Disease|2
6864269|NCT00428610|10873637|FG000|Overall Study|Adverse Event|2
6864270|NCT00428610|10873638|FG001|Overall Study|Adverse Event|3
6864271|NCT00428610|10873639|FG002|Overall Study|Adverse Event|2
6864272|NCT00428610|10873637|FG000|Overall Study|Investigator Decision|2
6864273|NCT00428610|10873638|FG001|Overall Study|Investigator Decision|1
6864274|NCT00428610|10873639|FG002|Overall Study|Investigator Decision|1
6864275|NCT00428610|10873637|FG000|Overall Study|Progressive Disease|42
6864276|NCT00428610|10873638|FG001|Overall Study|Progressive Disease|14
6864277|NCT00428610|10873639|FG002|Overall Study|Progressive Disease|22
6864278|NCT00428610|10873637|FG000|Overall Study|Withdrawal by Subject|4
6864279|NCT00428610|10873638|FG001|Overall Study|Withdrawal by Subject|0
6864280|NCT00428610|10873639|FG002|Overall Study|Withdrawal by Subject|0
6864281|NCT00428714|10873649|FG000|Overall Study|Progressive Disease|28
6864282|NCT00428714|10873650|FG001|Overall Study|Progressive Disease|36
6864283|NCT00428714|10873649|FG000|Overall Study|Withdrawal by Subject|0
6864284|NCT00428714|10873650|FG001|Overall Study|Withdrawal by Subject|3
6864285|NCT00428714|10873649|FG000|Overall Study|Adverse Event|0
6864286|NCT00428714|10873650|FG001|Overall Study|Adverse Event|2
6864287|NCT00428714|10873649|FG000|Overall Study|Physician Decision|1
6864288|NCT00428714|10873650|FG001|Overall Study|Physician Decision|1
6864289|NCT00428714|10873649|FG000|Overall Study|Death due to Progressive Disease (PD)|1
6864290|NCT00428714|10873650|FG001|Overall Study|Death due to Progressive Disease (PD)|0
6864291|NCT00428714|10873649|FG000|Overall Study|Death due to other then PD|1
6864292|NCT00428714|10873650|FG001|Overall Study|Death due to other then PD|0
6864293|NCT00428792|10873659|FG000|Overall Study|Lack of Efficacy|1
6864294|NCT00428792|10873660|FG001|Overall Study|Lack of Efficacy|3
6864295|NCT00428792|10873659|FG000|Overall Study|Lost to Follow-up|0
6864296|NCT00428792|10873660|FG001|Overall Study|Lost to Follow-up|1
6864297|NCT00428844|10873669|FG000|Completed Study Drug Treatment|Adverse Event|2
6864298|NCT00428844|10873670|FG001|Completed Study Drug Treatment|Adverse Event|4
6864299|NCT00428844|10873671|FG002|Completed Study Drug Treatment|Adverse Event|4
6864300|NCT00428844|10873669|FG000|Completed Study Drug Treatment|Protocol Violation|0
6864301|NCT00428844|10873670|FG001|Completed Study Drug Treatment|Protocol Violation|1
6864302|NCT00428844|10873671|FG002|Completed Study Drug Treatment|Protocol Violation|1
6864303|NCT00428844|10873669|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0
6864304|NCT00428844|10873670|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1
6864305|NCT00428844|10873671|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1
6864306|NCT00428844|10873669|FG000|Completed Study Drug Treatment|Randomized Not Treated|0
6864307|NCT00428844|10873670|FG001|Completed Study Drug Treatment|Randomized Not Treated|0
6864308|NCT00428844|10873671|FG002|Completed Study Drug Treatment|Randomized Not Treated|1
6864309|NCT00428844|10873669|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0
6864310|NCT00428844|10873670|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1
6864311|NCT00428844|10873671|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1
6864312|NCT00428844|10873669|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0
6864313|NCT00428844|10873670|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0
6864314|NCT00428844|10873671|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1
6864315|NCT00428844|10873669|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1
6864316|NCT00428844|10873670|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
6864317|NCT00428844|10873671|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
6864318|NCT00428844|10873669|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2
6864319|NCT00428844|10873670|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
6967954|NCT01134705|11016524|FG001|Overall Study|Pregnancy|0
6864320|NCT00428844|10873671|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
6864321|NCT00428844|10873669|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
6864322|NCT00428844|10873670|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1
6864323|NCT00428844|10873671|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
6864324|NCT00428948|10873685|FG000|Overall Study|Lost to Follow-up|15
6864325|NCT00428948|10873686|FG001|Overall Study|Lost to Follow-up|8
6864326|NCT00428948|10873685|FG000|Overall Study|Adverse Event|148
6864327|NCT00428948|10873686|FG001|Overall Study|Adverse Event|24
6864328|NCT00428948|10873685|FG000|Overall Study|Subject Met Withdrawal Criteria|4
6864329|NCT00428948|10873686|FG001|Overall Study|Subject Met Withdrawal Criteria|0
6864330|NCT00428948|10873685|FG000|Overall Study|Investigator Withdrew Subject|3
6864331|NCT00428948|10873686|FG001|Overall Study|Investigator Withdrew Subject|4
6864332|NCT00428948|10873685|FG000|Overall Study|Subject Withdrew Consent|50
6864333|NCT00428948|10873686|FG001|Overall Study|Subject Withdrew Consent|30
6864334|NCT00428948|10873685|FG000|Overall Study|Protocol Deviation|1
6864335|NCT00428948|10873686|FG001|Overall Study|Protocol Deviation|1
6864336|NCT00429104|10873710|FG000|Overall Study|Protocol Violation|1
6864337|NCT00429169|10873720|FG000|Overall Study|Lost to Follow-up|0
6864338|NCT00429169|10873721|FG001|Overall Study|Lost to Follow-up|1
6864339|NCT00429169|10873720|FG000|Overall Study|Ineligibility discovered after entry|2
6864340|NCT00429169|10873721|FG001|Overall Study|Ineligibility discovered after entry|1
6864341|NCT00429182|10873729|FG000|Overall Study|Not evaluable, Disease Progression|2
6864342|NCT00429182|10873729|FG000|Overall Study|Not eligible|5
6864343|NCT00429273|10873736|FG000|Overall Study|Lost to Follow-up|1
6864344|NCT00429273|10873737|FG001|Overall Study|Lost to Follow-up|2
6864345|NCT00429273|10873738|FG002|Overall Study|Lost to Follow-up|2
6864346|NCT00429273|10873736|FG000|Overall Study|Physician Decision|6
6864347|NCT00429273|10873737|FG001|Overall Study|Physician Decision|5
6864348|NCT00429273|10873738|FG002|Overall Study|Physician Decision|5
6864349|NCT00429273|10873736|FG000|Overall Study|Adverse Event|1
6864350|NCT00429273|10873737|FG001|Overall Study|Adverse Event|1
7078188|NCT02100696|11186438|FG003|Induction Phase|Lost to Follow-up|0
7078189|NCT02100696|11186439|FG004|Induction Phase|Lost to Follow-up|0
7078190|NCT02100696|11186440|FG005|Induction Phase|Lost to Follow-up|0
6864351|NCT00429273|10873738|FG002|Overall Study|Adverse Event|2
6864352|NCT00429299|10873749|FG000|Overall Study|Disease Progression|1
6864353|NCT00429299|10873750|FG001|Overall Study|Disease Progression|1
6864354|NCT00429299|10873751|FG002|Overall Study|Disease Progression|0
6864355|NCT00429299|10873749|FG000|Overall Study|Adverse Event|2
6864356|NCT00429299|10873750|FG001|Overall Study|Adverse Event|5
6864357|NCT00429299|10873751|FG002|Overall Study|Adverse Event|1
6864358|NCT00429299|10873749|FG000|Overall Study|Protocol Violation|1
6864359|NCT00429299|10873750|FG001|Overall Study|Protocol Violation|0
6864360|NCT00429299|10873751|FG002|Overall Study|Protocol Violation|0
6864361|NCT00429299|10873749|FG000|Overall Study|Withdrawal by Subject|0
6864362|NCT00429299|10873750|FG001|Overall Study|Withdrawal by Subject|1
6864363|NCT00429299|10873751|FG002|Overall Study|Withdrawal by Subject|3
6864364|NCT00429364|10873761|FG000|Overall Study|Withdrawal by Subject|11
6864365|NCT00429364|10873762|FG001|Overall Study|Withdrawal by Subject|5
6864366|NCT00429364|10873761|FG000|Overall Study|Physician Decision|4
6864367|NCT00429364|10873762|FG001|Overall Study|Physician Decision|2
6864368|NCT00429364|10873761|FG000|Overall Study|Lost to Follow-up|7
6864369|NCT00429364|10873762|FG001|Overall Study|Lost to Follow-up|6
6864370|NCT00429364|10873761|FG000|Overall Study|Death|0
6864371|NCT00429364|10873762|FG001|Overall Study|Death|1
6864372|NCT00429364|10873761|FG000|Overall Study|Underwent aortic root surgery|10
6864373|NCT00429364|10873762|FG001|Overall Study|Underwent aortic root surgery|18
6864374|NCT00429364|10873761|FG000|Overall Study|Pregnancy|0
6864375|NCT00429364|10873762|FG001|Overall Study|Pregnancy|1
6864376|NCT00429416|10873777|FG000|Overall Study|Death|1
6864377|NCT00429494|10873781|FG000|Overall Study|Withdrawal by Subject|9
6864378|NCT00429494|10873781|FG000|Overall Study|Death|6
6864379|NCT00429572|10873789|FG000|Overall Study|Disease progression|1
6864380|NCT00429585|10873795|FG000|Overall Study|Death|1
6864381|NCT00429585|10873796|FG001|Overall Study|Death|0
6864382|NCT00429585|10873795|FG000|Overall Study|Lost to Follow-up|27
6864383|NCT00429585|10873796|FG001|Overall Study|Lost to Follow-up|20
6864384|NCT00429585|10873795|FG000|Overall Study|Physician Decision|2
6864385|NCT00429585|10873796|FG001|Overall Study|Physician Decision|0
6864386|NCT00429663|10873804|FG000|Overall Study|Lost to Follow-up|24
6864387|NCT00429663|10873805|FG001|Overall Study|Lost to Follow-up|31
6864388|NCT00429663|10873804|FG000|Overall Study|Physician Decision|6
6864389|NCT00429663|10873805|FG001|Overall Study|Physician Decision|3
6864390|NCT00429663|10873804|FG000|Overall Study|Withdrawal by Subject|2
6864391|NCT00429663|10873805|FG001|Overall Study|Withdrawal by Subject|5
6864392|NCT00429663|10873804|FG000|Overall Study|Death|4
6967955|NCT01134705|11016523|FG000|Overall Study|Lost to Follow-up|5
6864393|NCT00429663|10873805|FG001|Overall Study|Death|0
6864394|NCT00429793|10873820|FG000|Overall Study|Improper pre-protocol treatment|3
6864395|NCT00429793|10873820|FG000|Overall Study|Required test not done|1
6864396|NCT00429793|10873820|FG000|Overall Study|Never treated|1
7078191|NCT02100696|11186435|FG000|Induction Phase|Protocol Violation|0
6864397|NCT00429793|10873820|FG000|Overall Study|Non-measurable|1
6864398|NCT00430248|10873847|FG000|Overall Study|Adverse Event|49
6864399|NCT00430248|10873848|FG001|Overall Study|Adverse Event|61
6864400|NCT00430248|10873849|FG002|Overall Study|Adverse Event|64
6864401|NCT00430248|10873847|FG000|Overall Study|Protocol Violation|10
6864402|NCT00430248|10873848|FG001|Overall Study|Protocol Violation|2
6864403|NCT00430248|10873849|FG002|Overall Study|Protocol Violation|4
6864404|NCT00430248|10873847|FG000|Overall Study|Personal Reasons|12
6864405|NCT00430248|10873848|FG001|Overall Study|Personal Reasons|24
6864406|NCT00430248|10873849|FG002|Overall Study|Personal Reasons|9
6864407|NCT00430248|10873847|FG000|Overall Study|Lost to Follow-up|28
6864408|NCT00430248|10873848|FG001|Overall Study|Lost to Follow-up|33
6864409|NCT00430248|10873849|FG002|Overall Study|Lost to Follow-up|28
6864410|NCT00430248|10873847|FG000|Overall Study|Therapeutic Failure|1
6864411|NCT00430248|10873848|FG001|Overall Study|Therapeutic Failure|1
6864412|NCT00430248|10873849|FG002|Overall Study|Therapeutic Failure|1
6864413|NCT00430248|10873847|FG000|Overall Study|Withdrawal by Subject|14
6864414|NCT00430248|10873848|FG001|Overall Study|Withdrawal by Subject|20
6864415|NCT00430248|10873849|FG002|Overall Study|Withdrawal by Subject|16
6864416|NCT00430248|10873847|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0
6864417|NCT00430248|10873848|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2
6864418|NCT00430248|10873849|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0
6864419|NCT00430248|10873847|FG000|Overall Study|Gout Flare|3
6864420|NCT00430248|10873848|FG001|Overall Study|Gout Flare|7
6864421|NCT00430248|10873849|FG002|Overall Study|Gout Flare|2
6864422|NCT00430248|10873847|FG000|Overall Study|Reason Not Specified|8
6864423|NCT00430248|10873848|FG001|Overall Study|Reason Not Specified|8
6864424|NCT00430248|10873849|FG002|Overall Study|Reason Not Specified|11
6864425|NCT00430300|10873861|FG000|Overall Study|Adverse Event|0
6864426|NCT00430300|10873862|FG001|Overall Study|Adverse Event|2
6864427|NCT00430300|10873863|FG002|Overall Study|Adverse Event|1
6864428|NCT00430300|10873864|FG003|Overall Study|Adverse Event|1
6864429|NCT00430300|10873861|FG000|Overall Study|Withdrawal by Subject|1
6864430|NCT00430300|10873862|FG001|Overall Study|Withdrawal by Subject|0
6864431|NCT00430300|10873863|FG002|Overall Study|Withdrawal by Subject|5
6864432|NCT00430300|10873864|FG003|Overall Study|Withdrawal by Subject|0
6864433|NCT00430300|10873861|FG000|Overall Study|Laboratory abnormality|1
6864434|NCT00430300|10873862|FG001|Overall Study|Laboratory abnormality|0
6864435|NCT00430300|10873863|FG002|Overall Study|Laboratory abnormality|0
6864436|NCT00430300|10873864|FG003|Overall Study|Laboratory abnormality|0
6864437|NCT00430300|10873861|FG000|Overall Study|Other|0
6864438|NCT00430300|10873862|FG001|Overall Study|Other|0
6864439|NCT00430300|10873863|FG002|Overall Study|Other|0
6864440|NCT00430300|10873864|FG003|Overall Study|Other|1
6864441|NCT00430352|10873874|FG000|Overall Study|Disease progression|58
6864442|NCT00430352|10873874|FG000|Overall Study|Withdrawal by Subject|11
6864443|NCT00430352|10873874|FG000|Overall Study|Adverse Event|16
6864444|NCT00430352|10873874|FG000|Overall Study|Death|5
6864445|NCT00430352|10873874|FG000|Overall Study|Other|48
6864446|NCT00430482|10873880|FG000|Completed Treatment|Insufficient Treatment|7
6864447|NCT00430482|10873881|FG001|Completed Treatment|Insufficient Treatment|11
6864448|NCT00430495|10873891|FG000|Overall Study|Adverse Event|2
6864449|NCT00430495|10873892|FG001|Overall Study|Adverse Event|3
6864450|NCT00430495|10873893|FG002|Overall Study|Adverse Event|2
6864451|NCT00430495|10873894|FG003|Overall Study|Adverse Event|0
6864452|NCT00430495|10873891|FG000|Overall Study|Death|0
6864453|NCT00430495|10873892|FG001|Overall Study|Death|0
6864454|NCT00430495|10873893|FG002|Overall Study|Death|1
6864455|NCT00430495|10873894|FG003|Overall Study|Death|0
6864456|NCT00430495|10873891|FG000|Overall Study|Lost to Follow-up|0
6864457|NCT00430495|10873892|FG001|Overall Study|Lost to Follow-up|1
6864458|NCT00430495|10873893|FG002|Overall Study|Lost to Follow-up|4
6864459|NCT00430495|10873894|FG003|Overall Study|Lost to Follow-up|0
6864460|NCT00430495|10873891|FG000|Overall Study|Protocol Violation|1
6864461|NCT00430495|10873892|FG001|Overall Study|Protocol Violation|0
6864462|NCT00430495|10873893|FG002|Overall Study|Protocol Violation|1
6864463|NCT00430495|10873894|FG003|Overall Study|Protocol Violation|0
6864464|NCT00430495|10873891|FG000|Overall Study|Disease Progression|1
6864465|NCT00430495|10873892|FG001|Overall Study|Disease Progression|1
6864466|NCT00430495|10873893|FG002|Overall Study|Disease Progression|0
6864467|NCT00430495|10873894|FG003|Overall Study|Disease Progression|0
6864468|NCT00430495|10873891|FG000|Overall Study|Other|8
6864469|NCT00430495|10873892|FG001|Overall Study|Other|2
6864470|NCT00430495|10873893|FG002|Overall Study|Other|5
6864471|NCT00430495|10873894|FG003|Overall Study|Other|4
6864472|NCT00430495|10873891|FG000|Overall Study|Randomized but not Treated|2
6864473|NCT00430495|10873892|FG001|Overall Study|Randomized but not Treated|0
6864474|NCT00430495|10873893|FG002|Overall Study|Randomized but not Treated|0
6864475|NCT00430495|10873894|FG003|Overall Study|Randomized but not Treated|0
6864476|NCT00430521|10873912|FG000|Overall Study|Adverse Event|0
6864477|NCT00430521|10873913|FG001|Overall Study|Adverse Event|0
6864478|NCT00430521|10873914|FG002|Overall Study|Adverse Event|0
6864479|NCT00430521|10873915|FG003|Overall Study|Adverse Event|0
6864480|NCT00430521|10873916|FG004|Overall Study|Adverse Event|0
6864481|NCT00430521|10873917|FG005|Overall Study|Adverse Event|2
6864482|NCT00430521|10873918|FG006|Overall Study|Adverse Event|1
6864483|NCT00430521|10873919|FG007|Overall Study|Adverse Event|0
6864484|NCT00430521|10873912|FG000|Overall Study|Lost to Follow-up|7
6864485|NCT00430521|10873913|FG001|Overall Study|Lost to Follow-up|8
6864486|NCT00430521|10873914|FG002|Overall Study|Lost to Follow-up|3
6864487|NCT00430521|10873915|FG003|Overall Study|Lost to Follow-up|5
6864488|NCT00430521|10873916|FG004|Overall Study|Lost to Follow-up|5
6864489|NCT00430521|10873917|FG005|Overall Study|Lost to Follow-up|2
6864490|NCT00430521|10873918|FG006|Overall Study|Lost to Follow-up|8
6864491|NCT00430521|10873919|FG007|Overall Study|Lost to Follow-up|10
6864492|NCT00430521|10873912|FG000|Overall Study|Pregnancy|0
6864493|NCT00430521|10873913|FG001|Overall Study|Pregnancy|0
6864494|NCT00430521|10873914|FG002|Overall Study|Pregnancy|0
6864495|NCT00430521|10873915|FG003|Overall Study|Pregnancy|0
6864496|NCT00430521|10873916|FG004|Overall Study|Pregnancy|0
6864497|NCT00430521|10873917|FG005|Overall Study|Pregnancy|0
6864498|NCT00430521|10873918|FG006|Overall Study|Pregnancy|1
6864499|NCT00430521|10873919|FG007|Overall Study|Pregnancy|0
6864500|NCT00430521|10873912|FG000|Overall Study|Vaccine Expired|0
6864501|NCT00430521|10873913|FG001|Overall Study|Vaccine Expired|0
6864502|NCT00430521|10873914|FG002|Overall Study|Vaccine Expired|0
6864503|NCT00430521|10873915|FG003|Overall Study|Vaccine Expired|0
6864504|NCT00430521|10873916|FG004|Overall Study|Vaccine Expired|0
6864505|NCT00430521|10873917|FG005|Overall Study|Vaccine Expired|1
6864506|NCT00430521|10873918|FG006|Overall Study|Vaccine Expired|0
6864507|NCT00430521|10873919|FG007|Overall Study|Vaccine Expired|0
6864508|NCT00430521|10873912|FG000|Overall Study|Protocol Violation|1
6864509|NCT00430521|10873913|FG001|Overall Study|Protocol Violation|0
6864510|NCT00430521|10873914|FG002|Overall Study|Protocol Violation|0
6864511|NCT00430521|10873915|FG003|Overall Study|Protocol Violation|0
6864512|NCT00430521|10873916|FG004|Overall Study|Protocol Violation|0
6864513|NCT00430521|10873917|FG005|Overall Study|Protocol Violation|0
6864514|NCT00430521|10873918|FG006|Overall Study|Protocol Violation|0
6864515|NCT00430521|10873919|FG007|Overall Study|Protocol Violation|0
6864516|NCT00430521|10873912|FG000|Overall Study|Withdrawal by Subject|3
6864517|NCT00430521|10873913|FG001|Overall Study|Withdrawal by Subject|1
6864518|NCT00430521|10873914|FG002|Overall Study|Withdrawal by Subject|0
6864519|NCT00430521|10873915|FG003|Overall Study|Withdrawal by Subject|3
6864520|NCT00430521|10873916|FG004|Overall Study|Withdrawal by Subject|0
6864521|NCT00430521|10873917|FG005|Overall Study|Withdrawal by Subject|0
6864522|NCT00430521|10873918|FG006|Overall Study|Withdrawal by Subject|0
6864523|NCT00430521|10873919|FG007|Overall Study|Withdrawal by Subject|2
6864524|NCT00430573|10873950|FG000|Overall Study|Withdrawal by Subject|5
6864525|NCT00430638|10873967|FG000|Overall Study|Adverse Event|15
6864526|NCT00430638|10873968|FG001|Overall Study|Adverse Event|15
6864527|NCT00430638|10873967|FG000|Overall Study|Uncontrolled blood pressure|48
6864528|NCT00430638|10873968|FG001|Overall Study|Uncontrolled blood pressure|13
6967956|NCT01134705|11016524|FG001|Overall Study|Lost to Follow-up|2
6967957|NCT01134705|11016523|FG000|Overall Study|Protocol Violation|1
6967958|NCT01134705|11016524|FG001|Overall Study|Protocol Violation|1
6967959|NCT01134705|11016523|FG000|Overall Study|Other|1
6967960|NCT01134705|11016524|FG001|Overall Study|Other|6
6967961|NCT01134731|11016533|FG000|Overall Study|Adverse Event|3
6967962|NCT01134731|11016534|FG001|Overall Study|Adverse Event|2
6967963|NCT01134731|11016535|FG002|Overall Study|Adverse Event|1
6967964|NCT01134731|11016533|FG000|Overall Study|Physician Decision|2
6967965|NCT01134731|11016534|FG001|Overall Study|Physician Decision|2
6967966|NCT01134731|11016535|FG002|Overall Study|Physician Decision|2
6967967|NCT01134731|11016533|FG000|Overall Study|Lack of Efficacy|0
6967968|NCT01134731|11016534|FG001|Overall Study|Lack of Efficacy|0
6967969|NCT01134731|11016535|FG002|Overall Study|Lack of Efficacy|1
6967970|NCT01134731|11016533|FG000|Overall Study|Withdrawal by Subject|3
6967971|NCT01134731|11016534|FG001|Overall Study|Withdrawal by Subject|3
6967972|NCT01134731|11016535|FG002|Overall Study|Withdrawal by Subject|1
6967973|NCT01134731|11016533|FG000|Overall Study|Lost to Follow-up|5
6967974|NCT01134731|11016534|FG001|Overall Study|Lost to Follow-up|4
6967975|NCT01134731|11016535|FG002|Overall Study|Lost to Follow-up|3
6967976|NCT01134783|11016546|FG000|Overall Study|Pregnancy|16
6967977|NCT01134783|11016547|FG001|Overall Study|Pregnancy|8
6967978|NCT01134783|11016546|FG000|Overall Study|Withdrawal by Subject|15
6967979|NCT01134783|11016547|FG001|Overall Study|Withdrawal by Subject|9
6967980|NCT01134783|11016546|FG000|Overall Study|Lost to Follow-up|5
6967981|NCT01134783|11016547|FG001|Overall Study|Lost to Follow-up|20
6967982|NCT01134939|11016589|FG000|Overall Study|Adverse Event|9
6967983|NCT01134939|11016590|FG001|Overall Study|Adverse Event|3
6967984|NCT01134939|11016591|FG002|Overall Study|Adverse Event|4
6864529|NCT00430638|10873967|FG000|Overall Study|Lost to Follow-up|1
6864530|NCT00430638|10873968|FG001|Overall Study|Lost to Follow-up|7
6864531|NCT00430638|10873967|FG000|Overall Study|Protocol Violation|6
6864532|NCT00430638|10873968|FG001|Overall Study|Protocol Violation|4
6967985|NCT01134939|11016592|FG003|Overall Study|Adverse Event|5
6967986|NCT01134939|11016593|FG004|Overall Study|Adverse Event|5
6967987|NCT01134939|11016594|FG005|Overall Study|Adverse Event|5
6967988|NCT01134939|11016595|FG006|Overall Study|Adverse Event|1
6967989|NCT01134939|11016596|FG007|Overall Study|Adverse Event|0
6864533|NCT00430638|10873967|FG000|Overall Study|Withdrawal by Subject|4
6864534|NCT00430638|10873968|FG001|Overall Study|Withdrawal by Subject|6
6864535|NCT00430638|10873967|FG000|Overall Study|Non-compliant|2
6864536|NCT00430638|10873968|FG001|Overall Study|Non-compliant|1
6864537|NCT00430638|10873967|FG000|Overall Study|Other|2
6864538|NCT00430638|10873968|FG001|Overall Study|Other|2
6967990|NCT01134939|11016589|FG000|Overall Study|Lack of Efficacy|2
6967991|NCT01134939|11016590|FG001|Overall Study|Lack of Efficacy|5
6864539|NCT00430677|10873981|FG000|Short-term Period|Death|1
6864540|NCT00430677|10873982|FG001|Short-term Period|Death|1
6864541|NCT00430677|10873983|FG002|Short-term Period|Death|5
6864542|NCT00430677|10873981|FG000|Short-term Period|Adverse Event|15
6864543|NCT00430677|10873982|FG001|Short-term Period|Adverse Event|13
6864544|NCT00430677|10873983|FG002|Short-term Period|Adverse Event|9
7078192|NCT02100696|11186436|FG001|Induction Phase|Protocol Violation|1
7078193|NCT02100696|11186437|FG002|Induction Phase|Protocol Violation|1
7078194|NCT02100696|11186438|FG003|Induction Phase|Protocol Violation|0
7078195|NCT02100696|11186439|FG004|Induction Phase|Protocol Violation|0
7078196|NCT02100696|11186440|FG005|Induction Phase|Protocol Violation|0
7078197|NCT02100696|11186435|FG000|Induction Phase|Withdrawal by Subject|8
7078198|NCT02100696|11186436|FG001|Induction Phase|Withdrawal by Subject|2
6864545|NCT00430677|10873981|FG000|Short-term Period|Lack of Efficacy|5
6864546|NCT00430677|10873982|FG001|Short-term Period|Lack of Efficacy|6
6864547|NCT00430677|10873983|FG002|Short-term Period|Lack of Efficacy|4
6864548|NCT00430677|10873981|FG000|Short-term Period|Withdrawal by Subject|1
6864549|NCT00430677|10873982|FG001|Short-term Period|Withdrawal by Subject|1
6864550|NCT00430677|10873983|FG002|Short-term Period|Withdrawal by Subject|2
6864551|NCT00430677|10873981|FG000|Short-term Period|Participant no longer met study criteria|1
6864552|NCT00430677|10873982|FG001|Short-term Period|Participant no longer met study criteria|1
6864553|NCT00430677|10873983|FG002|Short-term Period|Participant no longer met study criteria|2
6864554|NCT00430677|10873981|FG000|Short-term Period|Poor compliance/ noncompliance|0
6864555|NCT00430677|10873982|FG001|Short-term Period|Poor compliance/ noncompliance|1
6864556|NCT00430677|10873983|FG002|Short-term Period|Poor compliance/ noncompliance|0
6864557|NCT00430677|10873981|FG000|Short-term Period|Pregnancy|0
6864558|NCT00430677|10873982|FG001|Short-term Period|Pregnancy|2
6864559|NCT00430677|10873983|FG002|Short-term Period|Pregnancy|0
6864560|NCT00430677|10873981|FG000|Long-term Extension Period|Death|1
6864561|NCT00430677|10873982|FG001|Long-term Extension Period|Death|0
6864562|NCT00430677|10873983|FG002|Long-term Extension Period|Death|0
6864563|NCT00430677|10873981|FG000|Long-term Extension Period|Adverse Event|3
6864564|NCT00430677|10873982|FG001|Long-term Extension Period|Adverse Event|2
6864565|NCT00430677|10873983|FG002|Long-term Extension Period|Adverse Event|5
6864566|NCT00430677|10873981|FG000|Long-term Extension Period|Lack of Efficacy|5
6864567|NCT00430677|10873982|FG001|Long-term Extension Period|Lack of Efficacy|3
6864568|NCT00430677|10873983|FG002|Long-term Extension Period|Lack of Efficacy|8
6864569|NCT00430677|10873981|FG000|Long-term Extension Period|Lost to Follow-up|1
6864570|NCT00430677|10873982|FG001|Long-term Extension Period|Lost to Follow-up|1
6864571|NCT00430677|10873983|FG002|Long-term Extension Period|Lost to Follow-up|1
6864572|NCT00430677|10873981|FG000|Long-term Extension Period|Withdrawal by Subject|5
6864573|NCT00430677|10873982|FG001|Long-term Extension Period|Withdrawal by Subject|1
6864574|NCT00430677|10873983|FG002|Long-term Extension Period|Withdrawal by Subject|2
6864575|NCT00430677|10873981|FG000|Long-term Extension Period|Pregnancy|1
6864576|NCT00430677|10873982|FG001|Long-term Extension Period|Pregnancy|1
6864577|NCT00430677|10873983|FG002|Long-term Extension Period|Pregnancy|0
6864578|NCT00430677|10873981|FG000|Long-term Extension Period|Administrative reason by sponsor|41
6864579|NCT00430677|10873982|FG001|Long-term Extension Period|Administrative reason by sponsor|49
6864580|NCT00430677|10873983|FG002|Long-term Extension Period|Administrative reason by sponsor|46
6864581|NCT00430677|10873981|FG000|Long-term Extension Period|Other|2
6864582|NCT00430677|10873982|FG001|Long-term Extension Period|Other|1
6864583|NCT00430677|10873983|FG002|Long-term Extension Period|Other|1
6864584|NCT00430677|10873981|FG000|Long-term Extension Period|Poor compliance/noncompliance|1
6864585|NCT00430677|10873982|FG001|Long-term Extension Period|Poor compliance/noncompliance|0
6864586|NCT00430677|10873983|FG002|Long-term Extension Period|Poor compliance/noncompliance|0
6864587|NCT00430716|10874012|FG000|Double Blind Phase|Death|1
6864588|NCT00430716|10874013|FG001|Double Blind Phase|Death|0
6864589|NCT00430716|10874014|FG002|Double Blind Phase|Death|0
6864590|NCT00430716|10874012|FG000|Double Blind Phase|No longer willing to participate|2
6864591|NCT00430716|10874013|FG001|Double Blind Phase|No longer willing to participate|1
6864592|NCT00430716|10874014|FG002|Double Blind Phase|No longer willing to participate|1
6864593|NCT00430716|10874012|FG000|Double Blind Phase|Other|0
6864594|NCT00430716|10874013|FG001|Double Blind Phase|Other|2
6864595|NCT00430716|10874014|FG002|Double Blind Phase|Other|0
6864596|NCT00430716|10874012|FG000|Double Blind Phase|Study terminated by sponsor|1
6864597|NCT00430716|10874013|FG001|Double Blind Phase|Study terminated by sponsor|1
6864598|NCT00430716|10874014|FG002|Double Blind Phase|Study terminated by sponsor|2
6864599|NCT00430716|10874012|FG000|Double Blind Phase|Adverse Event|1
6864600|NCT00430716|10874013|FG001|Double Blind Phase|Adverse Event|1
6864601|NCT00430716|10874014|FG002|Double Blind Phase|Adverse Event|3
6864602|NCT00430716|10874012|FG000|Double Blind Phase|Not treated|1
6864603|NCT00430716|10874013|FG001|Double Blind Phase|Not treated|0
6864604|NCT00430716|10874014|FG002|Double Blind Phase|Not treated|0
6864605|NCT00430716|10874012|FG000|Open Label Phase|Lost to Follow-up|1
6864606|NCT00430716|10874013|FG001|Open Label Phase|Lost to Follow-up|0
6864607|NCT00430716|10874014|FG002|Open Label Phase|Lost to Follow-up|1
6864608|NCT00430716|10874012|FG000|Open Label Phase|No longer willing to participate|0
6864609|NCT00430716|10874013|FG001|Open Label Phase|No longer willing to participate|1
7078199|NCT02100696|11186437|FG002|Induction Phase|Withdrawal by Subject|13
7078200|NCT02100696|11186438|FG003|Induction Phase|Withdrawal by Subject|0
6864610|NCT00430716|10874014|FG002|Open Label Phase|No longer willing to participate|1
6864611|NCT00430716|10874012|FG000|Open Label Phase|Other|3
6864612|NCT00430716|10874013|FG001|Open Label Phase|Other|1
6864613|NCT00430716|10874014|FG002|Open Label Phase|Other|1
6864614|NCT00430716|10874012|FG000|Open Label Phase|Protocol Violation|1
6864615|NCT00430716|10874013|FG001|Open Label Phase|Protocol Violation|0
6864616|NCT00430716|10874014|FG002|Open Label Phase|Protocol Violation|0
6864617|NCT00430716|10874012|FG000|Open Label Phase|Study terminated by sponsor|4
6864618|NCT00430716|10874013|FG001|Open Label Phase|Study terminated by sponsor|5
6864619|NCT00430716|10874014|FG002|Open Label Phase|Study terminated by sponsor|4
6864620|NCT00430755|10874022|FG000|Overall Study|Withdrawal by Subject|53
6864621|NCT00430781|10874048|FG000|Interim Analysis; 11 February 2008|Adverse Event|10
6864622|NCT00430781|10874049|FG001|Interim Analysis; 11 February 2008|Adverse Event|3
6864623|NCT00430781|10874050|FG002|Interim Analysis; 11 February 2008|Adverse Event|7
6864624|NCT00430781|10874048|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1
6864625|NCT00430781|10874049|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0
6864626|NCT00430781|10874050|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1
6864627|NCT00430781|10874048|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0
6864628|NCT00430781|10874049|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1
6864629|NCT00430781|10874050|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0
6864630|NCT00430781|10874048|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4
6864631|NCT00430781|10874049|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0
6864632|NCT00430781|10874050|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2
6864633|NCT00430781|10874048|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1
6864634|NCT00430781|10874049|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
6864635|NCT00430781|10874050|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
6864636|NCT00430781|10874048|FG000|Interim Analysis; 11 February 2008|Disease Progression|16
6864637|NCT00430781|10874049|FG001|Interim Analysis; 11 February 2008|Disease Progression|30
6864638|NCT00430781|10874050|FG002|Interim Analysis; 11 February 2008|Disease Progression|22
6864639|NCT00430781|10874048|FG000|Interim Analysis; 11 February 2008|Death|0
6864640|NCT00430781|10874049|FG001|Interim Analysis; 11 February 2008|Death|1
6864641|NCT00430781|10874050|FG002|Interim Analysis; 11 February 2008|Death|0
6864642|NCT00430781|10874048|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2
6864643|NCT00430781|10874049|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
6864644|NCT00430781|10874050|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
6864645|NCT00430781|10874048|FG000|Interim Analysis; 11 February 2008|Physician Decision|2
6864646|NCT00430781|10874049|FG001|Interim Analysis; 11 February 2008|Physician Decision|3
6864647|NCT00430781|10874050|FG002|Interim Analysis; 11 February 2008|Physician Decision|3
6864648|NCT00430781|10874048|FG000|Interim Analysis; 11 February 2008|Ongoing|23
6864649|NCT00430781|10874049|FG001|Interim Analysis; 11 February 2008|Ongoing|20
6864650|NCT00430781|10874050|FG002|Interim Analysis; 11 February 2008|Ongoing|25
6864651|NCT00430781|10874048|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0
6864652|NCT00430781|10874049|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0
6864653|NCT00430781|10874050|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3
6864654|NCT00430781|10874048|FG000|Final Analysis; 31 July 2008|Protocol Violation|0
6864655|NCT00430781|10874049|FG001|Final Analysis; 31 July 2008|Protocol Violation|1
6864656|NCT00430781|10874050|FG002|Final Analysis; 31 July 2008|Protocol Violation|0
6864657|NCT00430781|10874048|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0
6864658|NCT00430781|10874049|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2
6864659|NCT00430781|10874050|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7
6864660|NCT00430781|10874048|FG000|Final Analysis; 31 July 2008|Physician Decision|0
6864661|NCT00430781|10874049|FG001|Final Analysis; 31 July 2008|Physician Decision|6
6864662|NCT00430781|10874050|FG002|Final Analysis; 31 July 2008|Physician Decision|6
6864663|NCT00430781|10874048|FG000|Final Analysis; 31 July 2008|Other|0
6864664|NCT00430781|10874049|FG001|Final Analysis; 31 July 2008|Other|1
6864665|NCT00430781|10874050|FG002|Final Analysis; 31 July 2008|Other|0
6864666|NCT00430781|10874048|FG000|Final Analysis; 31 July 2008|Ongoing|0
6864667|NCT00430781|10874049|FG001|Final Analysis; 31 July 2008|Ongoing|29
6864668|NCT00430781|10874050|FG002|Final Analysis; 31 July 2008|Ongoing|32
6864669|NCT00430781|10874048|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5
6864670|NCT00430781|10874049|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
6864671|NCT00430781|10874050|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
6864672|NCT00430781|10874048|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
6864673|NCT00430781|10874049|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1
6864674|NCT00430781|10874050|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
6864675|NCT00430781|10874048|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
6864676|NCT00430781|10874049|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2
6864677|NCT00430781|10874050|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
6864678|NCT00430781|10874048|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
6864679|NCT00430781|10874049|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5
6864680|NCT00430781|10874050|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
6864681|NCT00430781|10874048|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4
6967992|NCT01134939|11016591|FG002|Overall Study|Lack of Efficacy|1
6864682|NCT00430781|10874049|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6
6864683|NCT00430781|10874050|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6
6864684|NCT00430781|10874048|FG000|End-of-Study Analysis; 28 July 2011|Other|4
6864685|NCT00430781|10874049|FG001|End-of-Study Analysis; 28 July 2011|Other|1
6864686|NCT00430781|10874050|FG002|End-of-Study Analysis; 28 July 2011|Other|0
6864687|NCT00430937|10874063|FG000|Overall Study|Adverse Event|3
6864688|NCT00430937|10874064|FG001|Overall Study|Adverse Event|8
6864689|NCT00430937|10874063|FG000|Overall Study|Death|0
6864690|NCT00430937|10874064|FG001|Overall Study|Death|1
6864691|NCT00430937|10874063|FG000|Overall Study|Lost to Follow-up|6
6864692|NCT00430937|10874064|FG001|Overall Study|Lost to Follow-up|6
6864693|NCT00430937|10874063|FG000|Overall Study|Withdrawal by Subject|5
6864694|NCT00430937|10874064|FG001|Overall Study|Withdrawal by Subject|2
6864695|NCT00430937|10874063|FG000|Overall Study|Protocol Violation|3
6864696|NCT00430937|10874064|FG001|Overall Study|Protocol Violation|2
6864697|NCT00430937|10874063|FG000|Overall Study|Lack of Efficacy|6
6864698|NCT00430937|10874064|FG001|Overall Study|Lack of Efficacy|5
6864699|NCT00430937|10874063|FG000|Overall Study|Inappropriate enrollment|2
6864700|NCT00430937|10874064|FG001|Overall Study|Inappropriate enrollment|1
6864701|NCT00430937|10874063|FG000|Overall Study|Administrative reasons|1
6864702|NCT00430937|10874064|FG001|Overall Study|Administrative reasons|0
6864703|NCT00430937|10874063|FG000|Overall Study|Protocol discontinuation criteria met|1
6864704|NCT00430937|10874064|FG001|Overall Study|Protocol discontinuation criteria met|2
6864705|NCT00430937|10874063|FG000|Overall Study|Unable to classify|0
6864706|NCT00430937|10874064|FG001|Overall Study|Unable to classify|1
6864707|NCT00430989|10874072|FG000|Overall Study|Lost to Follow-up|2
6864708|NCT00430989|10874073|FG001|Overall Study|Lost to Follow-up|3
6864709|NCT00430989|10874072|FG000|Overall Study|Withdrawal by Subject|15
6864710|NCT00430989|10874073|FG001|Overall Study|Withdrawal by Subject|14
6864711|NCT00430989|10874072|FG000|Overall Study|Protocol Violation|30
6864712|NCT00430989|10874073|FG001|Overall Study|Protocol Violation|37
6864713|NCT00430989|10874072|FG000|Overall Study|Not eligible|13
6864714|NCT00430989|10874073|FG001|Overall Study|Not eligible|6
6864715|NCT00431067|10874090|FG000|Overall Study|Other Adverse Event|9
6864716|NCT00431067|10874090|FG000|Overall Study|Progressive disease|30
6864717|NCT00431067|10874090|FG000|Overall Study|Non-compliance,lost to follow-up|2
6864718|NCT00431444|10874111|FG000|Overall Study|Protocol Violation|1
6864719|NCT00431444|10874112|FG001|Overall Study|Protocol Violation|4
6864720|NCT00431444|10874111|FG000|Overall Study|Adverse Event|2
6864721|NCT00431444|10874112|FG001|Overall Study|Adverse Event|1
6864722|NCT00431444|10874111|FG000|Overall Study|Withdrawal by Subject|1
6864723|NCT00431444|10874112|FG001|Overall Study|Withdrawal by Subject|1
6864724|NCT00431444|10874111|FG000|Overall Study|Lost to Follow-up|1
6864725|NCT00431444|10874112|FG001|Overall Study|Lost to Follow-up|0
6864726|NCT00431444|10874111|FG000|Overall Study|Administrative Problems|0
6864727|NCT00431444|10874112|FG001|Overall Study|Administrative Problems|1
6864728|NCT00431496|10874118|FG000|Overall Study|Adverse Event|3
6864729|NCT00431496|10874118|FG000|Overall Study|Lost to Follow-up|1
6864730|NCT00431496|10874118|FG000|Overall Study|Withdrawal by Subject|2
6864731|NCT00431496|10874118|FG000|Overall Study|Protocol-specified criteria|5
6864732|NCT00431834|10874131|FG000|Overall Study|Withdrawal by Subject|7
6864733|NCT00431834|10874131|FG000|Overall Study|Death|3
6864734|NCT00431834|10874131|FG000|Overall Study|Missed Endpoint Visit|2
6864735|NCT00431834|10874131|FG000|Overall Study|Lost to Follow-up|1
6864736|NCT00431847|10874142|FG000|Overall Study|completion of less than two study visits|6
6864737|NCT00431847|10874143|FG001|Overall Study|completion of less than two study visits|3
6864738|NCT00431847|10874144|FG002|Overall Study|completion of less than two study visits|4
6864739|NCT00431847|10874145|FG003|Overall Study|completion of less than two study visits|14
6864740|NCT00431847|10874146|FG004|Overall Study|completion of less than two study visits|0
6864741|NCT00431847|10874142|FG000|Overall Study|Protocol Violation|0
6864742|NCT00431847|10874143|FG001|Overall Study|Protocol Violation|0
6864743|NCT00431847|10874144|FG002|Overall Study|Protocol Violation|0
6864744|NCT00431847|10874145|FG003|Overall Study|Protocol Violation|0
6864745|NCT00431847|10874146|FG004|Overall Study|Protocol Violation|1
6864746|NCT00431951|10874160|FG000|Overall Study|Inability to follow study procedures|1
6864747|NCT00431951|10874161|FG001|Overall Study|Inability to follow study procedures|0
6864748|NCT00431951|10874162|FG002|Overall Study|Inability to follow study procedures|1
6864749|NCT00431951|10874163|FG003|Overall Study|Inability to follow study procedures|2
7041146|NCT01723826|11124608|FG001|Overall Study|Withdrawal by Subject|17
7041147|NCT01723826|11124609|FG002|Overall Study|Withdrawal by Subject|27
7041148|NCT01723826|11124610|FG003|Overall Study|Withdrawal by Subject|48
7041149|NCT01723904|11124620|FG000|Overall Study|Noncompliant|3
7041150|NCT01723904|11124620|FG000|Overall Study|Adverse Event|5
7041151|NCT01723904|11124620|FG000|Overall Study|Unable to follow protocol/ judged by inv|3
7041152|NCT01724021|11124626|FG000|Overall Study|Adverse Event|11
6864750|NCT00431951|10874160|FG000|Overall Study|Lost to Follow-up|0
6864751|NCT00431951|10874161|FG001|Overall Study|Lost to Follow-up|1
6864752|NCT00431951|10874162|FG002|Overall Study|Lost to Follow-up|0
6864753|NCT00431951|10874163|FG003|Overall Study|Lost to Follow-up|0
6864754|NCT00431951|10874160|FG000|Overall Study|Withdrawal by Subject|0
6864755|NCT00431951|10874161|FG001|Overall Study|Withdrawal by Subject|1
7041153|NCT01724021|11124627|FG001|Overall Study|Adverse Event|6
7041154|NCT01724021|11124626|FG000|Overall Study|Death|46
7041155|NCT01724021|11124627|FG001|Overall Study|Death|58
7041156|NCT01724021|11124626|FG000|Overall Study|Participant request/ Withdrew consent|18
7041157|NCT01724021|11124627|FG001|Overall Study|Participant request/ Withdrew consent|14
7041158|NCT01724021|11124626|FG000|Overall Study|Lost to Follow-up|15
7041159|NCT01724021|11124627|FG001|Overall Study|Lost to Follow-up|15
7041160|NCT01724021|11124626|FG000|Overall Study|Reason Not Specified|36
7041161|NCT01724021|11124627|FG001|Overall Study|Reason Not Specified|39
7041162|NCT01724021|11124626|FG000|Overall Study|Missing|1
7041163|NCT01724021|11124627|FG001|Overall Study|Missing|1
7041164|NCT01724177|11124668|FG000|Overall Study|Adverse Event|8
7041165|NCT01724177|11124668|FG000|Overall Study|Progressive disease or Relapsed Disease|16
7041166|NCT01724177|11124668|FG000|Overall Study|Nervous participant|1
7041167|NCT01724177|11124668|FG000|Overall Study|Serious Adverse Event Related|1
7041168|NCT01724216|11124673|FG000|Overall Study|Scan was not completed|1
6864756|NCT00431951|10874162|FG002|Overall Study|Withdrawal by Subject|0
6864757|NCT00431951|10874163|FG003|Overall Study|Withdrawal by Subject|0
6864758|NCT00431951|10874160|FG000|Overall Study|Adverse Event|0
6864759|NCT00431951|10874161|FG001|Overall Study|Adverse Event|0
6864760|NCT00431951|10874162|FG002|Overall Study|Adverse Event|1
6864761|NCT00431951|10874163|FG003|Overall Study|Adverse Event|0
6864762|NCT00431964|10874179|FG000|Overall Study|Adverse Event|1
6864763|NCT00431964|10874180|FG001|Overall Study|Adverse Event|0
6864764|NCT00431964|10874179|FG000|Overall Study|Lost to Follow-up|1
6864765|NCT00431964|10874180|FG001|Overall Study|Lost to Follow-up|2
6864766|NCT00431964|10874179|FG000|Overall Study|Physician Decision|2
6864767|NCT00431964|10874180|FG001|Overall Study|Physician Decision|2
6864768|NCT00431964|10874179|FG000|Overall Study|Withdrawal by Subject|2
6864769|NCT00431964|10874180|FG001|Overall Study|Withdrawal by Subject|1
6864770|NCT00431964|10874179|FG000|Overall Study|Parental Consent Withdrawn|0
6864771|NCT00431964|10874180|FG001|Overall Study|Parental Consent Withdrawn|2
6864772|NCT00431964|10874179|FG000|Overall Study|Due to Unstable Health|0
6864773|NCT00431964|10874180|FG001|Overall Study|Due to Unstable Health|1
6967993|NCT01134939|11016592|FG003|Overall Study|Lack of Efficacy|0
6967994|NCT01134939|11016593|FG004|Overall Study|Lack of Efficacy|3
6967995|NCT01134939|11016594|FG005|Overall Study|Lack of Efficacy|0
6967996|NCT01134939|11016595|FG006|Overall Study|Lack of Efficacy|1
6967997|NCT01134939|11016596|FG007|Overall Study|Lack of Efficacy|0
6967998|NCT01134939|11016589|FG000|Overall Study|Lost to Follow-up|2
6967999|NCT01134939|11016590|FG001|Overall Study|Lost to Follow-up|3
6968000|NCT01134939|11016591|FG002|Overall Study|Lost to Follow-up|0
6968001|NCT01134939|11016592|FG003|Overall Study|Lost to Follow-up|1
6968002|NCT01134939|11016593|FG004|Overall Study|Lost to Follow-up|2
6968003|NCT01134939|11016594|FG005|Overall Study|Lost to Follow-up|1
6968004|NCT01134939|11016595|FG006|Overall Study|Lost to Follow-up|0
6968005|NCT01134939|11016596|FG007|Overall Study|Lost to Follow-up|0
6968006|NCT01134939|11016589|FG000|Overall Study|Death|0
6968007|NCT01134939|11016590|FG001|Overall Study|Death|1
6968008|NCT01134939|11016591|FG002|Overall Study|Death|0
6968009|NCT01134939|11016592|FG003|Overall Study|Death|0
6968010|NCT01134939|11016593|FG004|Overall Study|Death|0
6968011|NCT01134939|11016594|FG005|Overall Study|Death|0
6968012|NCT01134939|11016595|FG006|Overall Study|Death|0
6968013|NCT01134939|11016596|FG007|Overall Study|Death|0
6968014|NCT01134939|11016589|FG000|Overall Study|Termination page not available|4
6968015|NCT01134939|11016590|FG001|Overall Study|Termination page not available|6
6968016|NCT01134939|11016591|FG002|Overall Study|Termination page not available|5
6968017|NCT01134939|11016592|FG003|Overall Study|Termination page not available|8
6968018|NCT01134939|11016593|FG004|Overall Study|Termination page not available|0
6968019|NCT01134939|11016594|FG005|Overall Study|Termination page not available|3
6968020|NCT01134939|11016595|FG006|Overall Study|Termination page not available|7
6968021|NCT01134939|11016596|FG007|Overall Study|Termination page not available|0
6968022|NCT01135017|11016620|FG000|Overall Study|Adverse Event|3
6968023|NCT01135017|11016621|FG001|Overall Study|Adverse Event|8
6968024|NCT01135017|11016620|FG000|Overall Study|Other than above|3
6968025|NCT01135017|11016621|FG001|Overall Study|Other than above|4
6976918|NCT01202877|11029793|FG002|Overall Study|Withdrawal by Subject|1
6976919|NCT01202877|11029791|FG000|Overall Study|Death|0
6976920|NCT01202877|11029792|FG001|Overall Study|Death|0
6976921|NCT01202877|11029793|FG002|Overall Study|Death|1
6976922|NCT01202903|11029803|FG000|Overall Study|Administrative Probelms|1
6976923|NCT01202903|11029804|FG001|Overall Study|Administrative Probelms|4
6976924|NCT01202903|11029803|FG000|Overall Study|Protocol Violation|0
6976925|NCT01202903|11029804|FG001|Overall Study|Protocol Violation|1
6976926|NCT01202903|11029803|FG000|Overall Study|Death|1
7041169|NCT01724359|11124677|FG000|Overall Study|Adverse Event|10
7041170|NCT01724359|11124677|FG000|Overall Study|Death|1
7041171|NCT01724359|11124677|FG000|Overall Study|Other|20
6976927|NCT01202903|11029804|FG001|Overall Study|Death|0
6976928|NCT01202903|11029803|FG000|Overall Study|Lost to Follow-up|1
6976929|NCT01202903|11029804|FG001|Overall Study|Lost to Follow-up|1
6976930|NCT01202903|11029803|FG000|Overall Study|Lack of Efficacy|1
6976931|NCT01202903|11029804|FG001|Overall Study|Lack of Efficacy|3
6976932|NCT01202903|11029803|FG000|Overall Study|Adverse Event|3
6976933|NCT01202903|11029804|FG001|Overall Study|Adverse Event|3
6976934|NCT01202903|11029803|FG000|Overall Study|Withdrawal by Subject|4
6976935|NCT01202903|11029804|FG001|Overall Study|Withdrawal by Subject|4
6864774|NCT00432042|10874189|FG000|Overall Study|Protocol Violation|2
6864775|NCT00432042|10874190|FG001|Overall Study|Protocol Violation|0
6864776|NCT00432042|10874191|FG002|Overall Study|Protocol Violation|0
6864777|NCT00432042|10874189|FG000|Overall Study|Withdrawal by Subject|0
6864778|NCT00432042|10874190|FG001|Overall Study|Withdrawal by Subject|0
6864779|NCT00432042|10874191|FG002|Overall Study|Withdrawal by Subject|2
6864780|NCT00432042|10874189|FG000|Overall Study|Lost to Follow-up|5
6864781|NCT00432042|10874190|FG001|Overall Study|Lost to Follow-up|1
6864782|NCT00432042|10874191|FG002|Overall Study|Lost to Follow-up|0
6864783|NCT00432159|10874204|FG000|Overall Study|Death|0
6864784|NCT00432159|10874205|FG001|Overall Study|Death|1
6864785|NCT00432159|10874206|FG002|Overall Study|Death|0
6864786|NCT00432159|10874207|FG003|Overall Study|Death|0
6864787|NCT00432159|10874208|FG004|Overall Study|Death|0
6864788|NCT00432159|10874204|FG000|Overall Study|Failure|9
6864789|NCT00432159|10874205|FG001|Overall Study|Failure|5
6864790|NCT00432159|10874206|FG002|Overall Study|Failure|3
6864791|NCT00432159|10874207|FG003|Overall Study|Failure|2
6864792|NCT00432159|10874208|FG004|Overall Study|Failure|3
6864793|NCT00432159|10874204|FG000|Overall Study|Missing NDI and/or neuro. assessment|13
6864794|NCT00432159|10874205|FG001|Overall Study|Missing NDI and/or neuro. assessment|24
6864795|NCT00432159|10874206|FG002|Overall Study|Missing NDI and/or neuro. assessment|1
6864796|NCT00432159|10874207|FG003|Overall Study|Missing NDI and/or neuro. assessment|3
6864797|NCT00432159|10874208|FG004|Overall Study|Missing NDI and/or neuro. assessment|7
6864798|NCT00432172|10874224|FG000|Overall Study|Physician Decision|0
6864799|NCT00432172|10874225|FG001|Overall Study|Physician Decision|0
6864800|NCT00432172|10874226|FG002|Overall Study|Physician Decision|2
6864801|NCT00432172|10874227|FG003|Overall Study|Physician Decision|0
6864802|NCT00432172|10874224|FG000|Overall Study|Adverse Event|4
6864803|NCT00432172|10874225|FG001|Overall Study|Adverse Event|2
6864804|NCT00432172|10874226|FG002|Overall Study|Adverse Event|4
6864805|NCT00432172|10874227|FG003|Overall Study|Adverse Event|3
6864806|NCT00432172|10874224|FG000|Overall Study|Disease progression|0
6864807|NCT00432172|10874225|FG001|Overall Study|Disease progression|2
6864808|NCT00432172|10874226|FG002|Overall Study|Disease progression|5
6864809|NCT00432172|10874227|FG003|Overall Study|Disease progression|1
6864810|NCT00432172|10874224|FG000|Overall Study|Withdrawal by Subject|0
6864811|NCT00432172|10874225|FG001|Overall Study|Withdrawal by Subject|1
6864812|NCT00432172|10874226|FG002|Overall Study|Withdrawal by Subject|0
6864813|NCT00432172|10874227|FG003|Overall Study|Withdrawal by Subject|2
6864814|NCT00432172|10874224|FG000|Overall Study|No treatment received|2
6864815|NCT00432172|10874225|FG001|Overall Study|No treatment received|2
6864816|NCT00432172|10874226|FG002|Overall Study|No treatment received|0
6864817|NCT00432172|10874227|FG003|Overall Study|No treatment received|1
6864818|NCT00432237|10874243|FG000|Overall Study|Adverse Event|0
6864819|NCT00432237|10874244|FG001|Overall Study|Adverse Event|0
6864820|NCT00432237|10874245|FG002|Overall Study|Adverse Event|0
6864821|NCT00432237|10874246|FG003|Overall Study|Adverse Event|1
6864822|NCT00432237|10874243|FG000|Overall Study|Lack of Efficacy|0
6864823|NCT00432237|10874244|FG001|Overall Study|Lack of Efficacy|0
6864824|NCT00432237|10874245|FG002|Overall Study|Lack of Efficacy|0
6864825|NCT00432237|10874246|FG003|Overall Study|Lack of Efficacy|1
6864826|NCT00432237|10874243|FG000|Overall Study|Lost to Follow-up|10
6864827|NCT00432237|10874244|FG001|Overall Study|Lost to Follow-up|10
6864828|NCT00432237|10874245|FG002|Overall Study|Lost to Follow-up|18
6864829|NCT00432237|10874246|FG003|Overall Study|Lost to Follow-up|18
6864830|NCT00432237|10874243|FG000|Overall Study|Physician Decision|1
6864831|NCT00432237|10874244|FG001|Overall Study|Physician Decision|3
6864832|NCT00432237|10874245|FG002|Overall Study|Physician Decision|2
6864833|NCT00432237|10874246|FG003|Overall Study|Physician Decision|1
6864834|NCT00432237|10874243|FG000|Overall Study|Pregnancy|0
6864835|NCT00432237|10874244|FG001|Overall Study|Pregnancy|1
6864836|NCT00432237|10874245|FG002|Overall Study|Pregnancy|0
6864837|NCT00432237|10874246|FG003|Overall Study|Pregnancy|0
6864838|NCT00432237|10874243|FG000|Overall Study|Protocol Violation|13
6864839|NCT00432237|10874244|FG001|Overall Study|Protocol Violation|10
6864840|NCT00432237|10874245|FG002|Overall Study|Protocol Violation|11
6864841|NCT00432237|10874246|FG003|Overall Study|Protocol Violation|8
6864842|NCT00432237|10874243|FG000|Overall Study|Withdrawal by Subject|5
6864843|NCT00432237|10874244|FG001|Overall Study|Withdrawal by Subject|6
6864844|NCT00432237|10874245|FG002|Overall Study|Withdrawal by Subject|9
6864845|NCT00432237|10874246|FG003|Overall Study|Withdrawal by Subject|11
6864846|NCT00432237|10874243|FG000|Overall Study|Lack of Qualifying Event|38
6864847|NCT00432237|10874244|FG001|Overall Study|Lack of Qualifying Event|71
6864848|NCT00432237|10874245|FG002|Overall Study|Lack of Qualifying Event|69
6864849|NCT00432237|10874246|FG003|Overall Study|Lack of Qualifying Event|84
6864850|NCT00432276|10874258|FG000|Overall Study|Hyperglycemic Rescue|44
6864851|NCT00432276|10874259|FG001|Overall Study|Hyperglycemic Rescue|87
6864852|NCT00432276|10874258|FG000|Overall Study|Adverse Event|13
6864853|NCT00432276|10874259|FG001|Overall Study|Adverse Event|16
6864854|NCT00432276|10874258|FG000|Overall Study|Protocol Violation|25
6864855|NCT00432276|10874259|FG001|Overall Study|Protocol Violation|20
6864856|NCT00432276|10874258|FG000|Overall Study|Lost to Follow-up|6
6864857|NCT00432276|10874259|FG001|Overall Study|Lost to Follow-up|2
6864858|NCT00432276|10874258|FG000|Overall Study|Withdrawal by Subject|25
6864859|NCT00432276|10874259|FG001|Overall Study|Withdrawal by Subject|20
6864860|NCT00432276|10874258|FG000|Overall Study|Physician Decision|6
6864861|NCT00432276|10874259|FG001|Overall Study|Physician Decision|8
6864862|NCT00432276|10874258|FG000|Overall Study|Other|2
6864863|NCT00432276|10874259|FG001|Overall Study|Other|3
6864864|NCT00432380|10874277|FG000|Overall Study|Migrated/moved from study area|3
6864865|NCT00432380|10874278|FG001|Overall Study|Migrated/moved from study area|4
6864866|NCT00432380|10874279|FG002|Overall Study|Migrated/moved from study area|1
6864867|NCT00432380|10874277|FG000|Overall Study|Adverse Event|1
6864868|NCT00432380|10874278|FG001|Overall Study|Adverse Event|0
6864869|NCT00432380|10874279|FG002|Overall Study|Adverse Event|0
6864870|NCT00432562|10874299|FG000|Overall Study|Death|3
6864871|NCT00432562|10874300|FG001|Overall Study|Death|0
6864872|NCT00432666|10874317|FG000|Main Period|Adverse Event|1
6864873|NCT00432666|10874318|FG001|Main Period|Adverse Event|1
6864874|NCT00432666|10874317|FG000|Main Period|Consent Withdrawn|1
6864875|NCT00432666|10874318|FG001|Main Period|Consent Withdrawn|0
6864876|NCT00432666|10874317|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1
6864877|NCT00432666|10874318|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0
6864878|NCT00432666|10874317|FG000|Open-Label Extension Period|Lack of Efficacy|6
6864879|NCT00432666|10874318|FG001|Open-Label Extension Period|Lack of Efficacy|0
6864880|NCT00432666|10874317|FG000|Open-Label Extension Period|Adverse Event|5
6864881|NCT00432666|10874318|FG001|Open-Label Extension Period|Adverse Event|0
6864882|NCT00432666|10874317|FG000|Open-Label Extension Period|Consent withdrawn|10
6864883|NCT00432666|10874318|FG001|Open-Label Extension Period|Consent withdrawn|0
6864884|NCT00432666|10874317|FG000|Open-Label Extension Period|Physician Decision|3
6864885|NCT00432666|10874318|FG001|Open-Label Extension Period|Physician Decision|0
6864886|NCT00432679|10874326|FG000|Overall Study|Adverse Event|2
6864887|NCT00432679|10874327|FG001|Overall Study|Adverse Event|1
6864888|NCT00432679|10874326|FG000|Overall Study|Withdrawal by Subject|3
6864889|NCT00432679|10874327|FG001|Overall Study|Withdrawal by Subject|2
6864890|NCT00432744|10874335|FG000|Months 0-6|Withdrawal by Subject|4
6864891|NCT00432744|10874336|FG001|Months 0-6|Withdrawal by Subject|4
6864892|NCT00432744|10874335|FG000|Months 0-6|Too disabled to score|1
6864893|NCT00432744|10874336|FG001|Months 0-6|Too disabled to score|0
6864894|NCT00432744|10874335|FG000|Months 7 - 12|Withdrawal by Subject|1
6864895|NCT00432744|10874336|FG001|Months 7 - 12|Withdrawal by Subject|0
6864896|NCT00432744|10874335|FG000|Months 7 - 12|Too disabled to score|0
6864897|NCT00432744|10874336|FG001|Months 7 - 12|Too disabled to score|1
6864898|NCT00432809|10874345|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2
6864899|NCT00432809|10874346|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0
6864900|NCT00432809|10874347|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0
6864901|NCT00432809|10874345|FG000|1 Year Follow-up|Withdrawal by Subject|7
6864902|NCT00432809|10874346|FG001|1 Year Follow-up|Withdrawal by Subject|0
6864903|NCT00432809|10874347|FG002|1 Year Follow-up|Withdrawal by Subject|1
6864904|NCT00432835|10874357|FG000|Overall Study|Adverse event: lead dislodgement.|6
6864905|NCT00432835|10874358|FG001|Overall Study|Adverse event: lead dislodgement.|7
6864906|NCT00432965|10874366|FG000|Overall Study|Lost to Follow-up|22
6864907|NCT00432965|10874367|FG001|Overall Study|Lost to Follow-up|19
6864908|NCT00432965|10874366|FG000|Overall Study|Withdrawal by Subject|13
6864909|NCT00432965|10874367|FG001|Overall Study|Withdrawal by Subject|13
6864910|NCT00432965|10874366|FG000|Overall Study|Physician Decision|14
6864911|NCT00432965|10874367|FG001|Overall Study|Physician Decision|13
6864912|NCT00432965|10874366|FG000|Overall Study|Lack of Efficacy|8
6864913|NCT00432965|10874367|FG001|Overall Study|Lack of Efficacy|13
6864914|NCT00432965|10874366|FG000|Overall Study|Non-compliance|7
6864915|NCT00432965|10874367|FG001|Overall Study|Non-compliance|0
6864916|NCT00432965|10874366|FG000|Overall Study|Adverse Event|22
6864917|NCT00432965|10874367|FG001|Overall Study|Adverse Event|19
6864918|NCT00432965|10874366|FG000|Overall Study|Death|3
6864919|NCT00432965|10874367|FG001|Overall Study|Death|4
6864920|NCT00432965|10874366|FG000|Overall Study|Exclusionary Methods|1
6864921|NCT00432965|10874367|FG001|Overall Study|Exclusionary Methods|2
6864922|NCT00432965|10874366|FG000|Overall Study|Incomplete Data|4
6864923|NCT00432965|10874367|FG001|Overall Study|Incomplete Data|3
6864924|NCT00432991|10874375|FG000|Overall Study|Protocol Violation|7
6864925|NCT00432991|10874376|FG001|Overall Study|Protocol Violation|12
6864926|NCT00433004|10874384|FG000|Overall Study|Lost to Follow-up|5
6864927|NCT00433004|10874385|FG001|Overall Study|Lost to Follow-up|7
6864928|NCT00433017|10874393|FG000|Overall Study|Adverse Event|5
6864929|NCT00433017|10874394|FG001|Overall Study|Adverse Event|3
6864930|NCT00433017|10874393|FG000|Overall Study|Withdrawal by Subject|4
6864931|NCT00433017|10874394|FG001|Overall Study|Withdrawal by Subject|5
6864932|NCT00433017|10874393|FG000|Overall Study|Lost to Follow-up|3
6864933|NCT00433017|10874394|FG001|Overall Study|Lost to Follow-up|4
6864934|NCT00433017|10874393|FG000|Overall Study|Administrative problems|80
6864935|NCT00433017|10874394|FG001|Overall Study|Administrative problems|86
6864936|NCT00433017|10874393|FG000|Overall Study|Protocol Violation|1
6864937|NCT00433017|10874394|FG001|Overall Study|Protocol Violation|0
6864938|NCT00433017|10874393|FG000|Overall Study|Death|2
6864939|NCT00433017|10874394|FG001|Overall Study|Death|2
6864940|NCT00433017|10874393|FG000|Overall Study|Subject no longer requires study drug|1
6864941|NCT00433017|10874394|FG001|Overall Study|Subject no longer requires study drug|1
6864942|NCT00433147|10874404|FG000|Overall Study|Adverse Event|0
6864943|NCT00433147|10874405|FG001|Overall Study|Adverse Event|1
6864944|NCT00433147|10874406|FG002|Overall Study|Adverse Event|0
6864945|NCT00433147|10874407|FG003|Overall Study|Adverse Event|0
6864946|NCT00433160|10874419|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6
6864947|NCT00433160|10874420|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2
6864948|NCT00433160|10874419|FG000|52-Week Double-Blind (DB) Period|Death|0
6864949|NCT00433160|10874420|FG001|52-Week Double-Blind (DB) Period|Death|0
6864950|NCT00433160|10874419|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
6864951|NCT00433160|10874420|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
6864952|NCT00433160|10874419|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0
6864953|NCT00433160|10874420|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1
6864954|NCT00433160|10874419|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0
6864955|NCT00433160|10874420|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2
6864956|NCT00433160|10874419|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6
6864957|NCT00433160|10874420|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1
6864958|NCT00433160|10874419|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4
6864959|NCT00433160|10874420|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2
6864960|NCT00433160|10874419|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0
6864961|NCT00433160|10874420|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0
6864962|NCT00433160|10874419|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1
6864963|NCT00433160|10874420|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2
6864964|NCT00433160|10874419|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3
6864965|NCT00433160|10874420|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1
6864966|NCT00433160|10874419|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1
6864967|NCT00433160|10874420|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2
6864968|NCT00433160|10874419|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2
6864969|NCT00433160|10874420|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0
6864970|NCT00433160|10874419|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0
6864971|NCT00433160|10874420|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1
6864972|NCT00433160|10874419|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2
6864973|NCT00433160|10874420|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0
6864974|NCT00433160|10874419|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8
6864975|NCT00433160|10874420|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2
6864976|NCT00433160|10874419|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0
6864977|NCT00433160|10874420|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1
6864978|NCT00433199|10874432|FG000|Double-Blind Period|Adverse Event|0
6864979|NCT00433199|10874433|FG001|Double-Blind Period|Adverse Event|25
6864980|NCT00433199|10874432|FG000|Double-Blind Period|Lack of Efficacy|0
6864981|NCT00433199|10874433|FG001|Double-Blind Period|Lack of Efficacy|2
6864982|NCT00433199|10874432|FG000|Double-Blind Period|Lost to Follow-up|2
6864983|NCT00433199|10874433|FG001|Double-Blind Period|Lost to Follow-up|5
6864984|NCT00433199|10874432|FG000|Double-Blind Period|Withdrawal by Subject|8
6864985|NCT00433199|10874433|FG001|Double-Blind Period|Withdrawal by Subject|19
6864986|NCT00433199|10874432|FG000|Double-Blind Period|Protocol Violation|1
6864987|NCT00433199|10874433|FG001|Double-Blind Period|Protocol Violation|10
6864988|NCT00433199|10874432|FG000|Double-Blind Period|Administrative|1
6864989|NCT00433199|10874433|FG001|Double-Blind Period|Administrative|5
6864990|NCT00433199|10874432|FG000|Open-Label Period|Adverse Event|0
6864991|NCT00433199|10874433|FG001|Open-Label Period|Adverse Event|19
6864992|NCT00433199|10874432|FG000|Open-Label Period|Lack of Efficacy|0
6864993|NCT00433199|10874433|FG001|Open-Label Period|Lack of Efficacy|2
6864994|NCT00433199|10874432|FG000|Open-Label Period|Lost to Follow-up|0
6864995|NCT00433199|10874433|FG001|Open-Label Period|Lost to Follow-up|3
6864996|NCT00433199|10874432|FG000|Open-Label Period|Withdrawal by Subject|0
6864997|NCT00433199|10874433|FG001|Open-Label Period|Withdrawal by Subject|7
6864998|NCT00433199|10874432|FG000|Open-Label Period|Protocol Violation|0
6864999|NCT00433199|10874433|FG001|Open-Label Period|Protocol Violation|2
6865000|NCT00433199|10874432|FG000|Open-Label Period|Administrative|0
6865001|NCT00433199|10874433|FG001|Open-Label Period|Administrative|1
6865002|NCT00433290|10874446|FG000|Overall Study|Adverse Event|24
6865003|NCT00433290|10874447|FG001|Overall Study|Adverse Event|7
6865004|NCT00433290|10874446|FG000|Overall Study|Lack of Efficacy|1
6865005|NCT00433290|10874447|FG001|Overall Study|Lack of Efficacy|5
6865006|NCT00433290|10874446|FG000|Overall Study|Withdrawal by Subject|4
6865007|NCT00433290|10874447|FG001|Overall Study|Withdrawal by Subject|2
6865008|NCT00433290|10874446|FG000|Overall Study|Protocol Violation|3
6865009|NCT00433290|10874447|FG001|Overall Study|Protocol Violation|2
6865010|NCT00433290|10874446|FG000|Overall Study|Physician Decision|2
6865011|NCT00433290|10874447|FG001|Overall Study|Physician Decision|0
6865012|NCT00433290|10874446|FG000|Overall Study|Entry Criteria Not Met|0
6865013|NCT00433290|10874447|FG001|Overall Study|Entry Criteria Not Met|1
6865014|NCT00433290|10874446|FG000|Overall Study|Lost to Follow-up|1
6865015|NCT00433290|10874447|FG001|Overall Study|Lost to Follow-up|0
6865016|NCT00433329|10874453|FG000|Overall Study|Adverse Event|9
6865017|NCT00433329|10874453|FG000|Overall Study|Death|4
6865018|NCT00433329|10874453|FG000|Overall Study|Withdrew consent|3
6865019|NCT00433329|10874453|FG000|Overall Study|Discontinued sildenafil|2
6865020|NCT00433329|10874453|FG000|Overall Study|Moved out of state|1
6865021|NCT00433329|10874453|FG000|Overall Study|Lost to Follow-up|1
6865022|NCT00433329|10874453|FG000|Overall Study|Physician Decision|1
6865023|NCT00433381|10874459|FG000|Overall Study|Ineligible / no protocol treatment|3
6865024|NCT00433381|10874460|FG001|Overall Study|Ineligible / no protocol treatment|3
6865025|NCT00433446|10874474|FG000|Overall Study|Adverse Event|4
6865026|NCT00433446|10874474|FG000|Overall Study|Refusal Unrelated to Adverse Event|1
6865027|NCT00433446|10874474|FG000|Overall Study|Progression|44
6865028|NCT00433446|10874474|FG000|Overall Study|Other - Not Protocol specified|3
6865029|NCT00433446|10874474|FG000|Overall Study|Ineligible|9
6865030|NCT00433537|10874478|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
6865031|NCT00433537|10874479|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0
6865032|NCT00433537|10874480|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
6865033|NCT00433537|10874478|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
6865034|NCT00433537|10874479|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
6865035|NCT00433537|10874480|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2
6865036|NCT00433537|10874478|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0
6865037|NCT00433537|10874479|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0
6865038|NCT00433537|10874480|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4
6865039|NCT00433537|10874478|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
6865040|NCT00433537|10874479|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
6865041|NCT00433537|10874480|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2
6865042|NCT00433537|10874478|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1
6865043|NCT00433537|10874479|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
6865044|NCT00433537|10874480|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
6865045|NCT00433537|10874478|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8
6865046|NCT00433537|10874479|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
6865047|NCT00433537|10874480|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
6865048|NCT00433537|10874478|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2
6865049|NCT00433537|10874479|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
6865050|NCT00433537|10874480|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
6865051|NCT00433537|10874478|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4
6865052|NCT00433537|10874479|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
6865053|NCT00433537|10874480|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
6865054|NCT00433537|10874478|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1
6865055|NCT00433537|10874479|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0
6865056|NCT00433537|10874480|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0
6865057|NCT00433654|10874502|FG000|Overall Study|Death|4
6865058|NCT00433654|10874503|FG001|Overall Study|Death|0
6865059|NCT00433654|10874502|FG000|Overall Study|Missed visit|6
6865060|NCT00433654|10874503|FG001|Overall Study|Missed visit|3
6865061|NCT00433654|10874502|FG000|Overall Study|Subject not yet due for visit|4
6865062|NCT00433654|10874503|FG001|Overall Study|Subject not yet due for visit|0
6865063|NCT00433654|10874502|FG000|Overall Study|Withdrawal by Subject|1
6865064|NCT00433654|10874503|FG001|Overall Study|Withdrawal by Subject|2
6865065|NCT00433771|10874520|FG000|Overall Study|screen fail|14
6865066|NCT00433771|10874520|FG000|Overall Study|Treated and later found to be ineligible|2
6865067|NCT00433771|10874520|FG000|Overall Study|Death|2
6865068|NCT00433771|10874520|FG000|Overall Study|Failure to deploy stent|1
6865069|NCT00433836|10874526|FG000|Overall Study|Adverse Event|7
6865070|NCT00433836|10874527|FG001|Overall Study|Adverse Event|0
6865071|NCT00433836|10874526|FG000|Overall Study|Lost to Follow-up|3
6865072|NCT00433836|10874527|FG001|Overall Study|Lost to Follow-up|0
6865073|NCT00433836|10874526|FG000|Overall Study|Withdrawal by Subject|2
6865074|NCT00433836|10874527|FG001|Overall Study|Withdrawal by Subject|1
6865075|NCT00433836|10874526|FG000|Overall Study|Unsatisfactory therapeutic effect|1
6865076|NCT00433836|10874527|FG001|Overall Study|Unsatisfactory therapeutic effect|1
6865077|NCT00433836|10874526|FG000|Overall Study|Protocol Violation|0
6865078|NCT00433836|10874527|FG001|Overall Study|Protocol Violation|2
6865079|NCT00433836|10874526|FG000|Overall Study|Condition no longer requires study drug|0
6865080|NCT00433836|10874527|FG001|Overall Study|Condition no longer requires study drug|1
6865081|NCT00433836|10874526|FG000|Overall Study|Abnormal laboratory values|0
6865082|NCT00433836|10874527|FG001|Overall Study|Abnormal laboratory values|1
6865083|NCT00433914|10874535|FG000|Overall Study|Withdrawal by Subject|0
6865084|NCT00433914|10874536|FG001|Overall Study|Withdrawal by Subject|2
6865085|NCT00433914|10874535|FG000|Overall Study|Lost to Follow-up|0
6865086|NCT00433914|10874536|FG001|Overall Study|Lost to Follow-up|1
6865087|NCT00433966|10874544|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40
6865088|NCT00433966|10874545|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43
6865089|NCT00433966|10874546|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
6865090|NCT00433966|10874547|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
6865091|NCT00433966|10874544|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97
6865092|NCT00433966|10874545|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103
6865093|NCT00433966|10874546|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0
6865094|NCT00433966|10874547|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0
6865095|NCT00433966|10874544|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29
6865096|NCT00433966|10874545|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28
6865097|NCT00433966|10874546|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
6865098|NCT00433966|10874547|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
6865099|NCT00433966|10874544|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0
7078201|NCT02100696|11186439|FG004|Induction Phase|Withdrawal by Subject|0
7078202|NCT02100696|11186440|FG005|Induction Phase|Withdrawal by Subject|0
7078203|NCT02100696|11186435|FG000|Induction Phase|Physician Decision|1
7078204|NCT02100696|11186436|FG001|Induction Phase|Physician Decision|0
7078205|NCT02100696|11186437|FG002|Induction Phase|Physician Decision|2
7078206|NCT02100696|11186438|FG003|Induction Phase|Physician Decision|0
7078207|NCT02100696|11186439|FG004|Induction Phase|Physician Decision|0
6865100|NCT00433966|10874545|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0
6865101|NCT00433966|10874546|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41
6865102|NCT00433966|10874547|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15
6865103|NCT00433966|10874544|FG000|Stent Intervention/Randomization|Lost to Follow-up|0
6865104|NCT00433966|10874545|FG001|Stent Intervention/Randomization|Lost to Follow-up|0
6865105|NCT00433966|10874546|FG002|Stent Intervention/Randomization|Lost to Follow-up|113
6865106|NCT00433966|10874547|FG003|Stent Intervention/Randomization|Lost to Follow-up|47
6865107|NCT00434057|10874580|FG000|Overall Study|Withdrawal by Subject|1
6865108|NCT00434109|10874584|FG000|Overall Study|Physician Decision|9
6865109|NCT00434109|10874584|FG000|Overall Study|Adverse Event|5
6865110|NCT00434109|10874584|FG000|Overall Study|Protocol Violation|1
6865111|NCT00434109|10874584|FG000|Overall Study|had embolism, did not receive sunitinib|3
6865112|NCT00434122|10874590|FG000|Overall Study|Non-compliance with protocol|0
6865113|NCT00434122|10874591|FG001|Overall Study|Non-compliance with protocol|1
6865114|NCT00434122|10874590|FG000|Overall Study|loss of subject contact|1
6865115|NCT00434122|10874591|FG001|Overall Study|loss of subject contact|1
6865116|NCT00434122|10874590|FG000|Overall Study|Personal reasons|1
6865117|NCT00434122|10874591|FG001|Overall Study|Personal reasons|1
6865118|NCT00434122|10874590|FG000|Overall Study|Large follicle size|2
6865119|NCT00434122|10874591|FG001|Overall Study|Large follicle size|2
6865120|NCT00434122|10874590|FG000|Overall Study|Low follicular response.|1
6865121|NCT00434122|10874591|FG001|Overall Study|Low follicular response.|2
6865122|NCT00434122|10874590|FG000|Overall Study|Travelling of subject.|1
6865123|NCT00434122|10874591|FG001|Overall Study|Travelling of subject.|0
6865124|NCT00434148|10874601|FG000|Overall Study|Adverse Event|18
6865125|NCT00434148|10874602|FG001|Overall Study|Adverse Event|18
6865126|NCT00434148|10874601|FG000|Overall Study|Lack of Efficacy|25
6865127|NCT00434148|10874602|FG001|Overall Study|Lack of Efficacy|28
6865128|NCT00434148|10874601|FG000|Overall Study|Withdrawal by Subject|15
6865129|NCT00434148|10874602|FG001|Overall Study|Withdrawal by Subject|15
6865130|NCT00434148|10874601|FG000|Overall Study|Protocol Violation|4
6865131|NCT00434148|10874602|FG001|Overall Study|Protocol Violation|0
6865132|NCT00434148|10874601|FG000|Overall Study|Administrative problems|6
6865133|NCT00434148|10874602|FG001|Overall Study|Administrative problems|10
6865134|NCT00434148|10874601|FG000|Overall Study|Lost to Follow-up|0
6865135|NCT00434148|10874602|FG001|Overall Study|Lost to Follow-up|1
6865136|NCT00434148|10874601|FG000|Overall Study|Condition no longer requires study drug|1
6865137|NCT00434148|10874602|FG001|Overall Study|Condition no longer requires study drug|0
6865138|NCT00434148|10874601|FG000|Overall Study|Abnormal test procedure result|0
6865139|NCT00434148|10874602|FG001|Overall Study|Abnormal test procedure result|1
6865140|NCT00434161|10874611|FG000|Overall Study|Adverse Event|5
6865141|NCT00434161|10874612|FG001|Overall Study|Adverse Event|1
6865142|NCT00434161|10874613|FG002|Overall Study|Adverse Event|4
6865143|NCT00434161|10874611|FG000|Overall Study|Lost to Follow-up|0
6865144|NCT00434161|10874612|FG001|Overall Study|Lost to Follow-up|1
6865145|NCT00434161|10874613|FG002|Overall Study|Lost to Follow-up|0
6865146|NCT00434161|10874611|FG000|Overall Study|Death|1
6865147|NCT00434161|10874612|FG001|Overall Study|Death|0
6865148|NCT00434161|10874613|FG002|Overall Study|Death|1
6865149|NCT00434161|10874611|FG000|Overall Study|Non-Compliance|1
6865150|NCT00434161|10874612|FG001|Overall Study|Non-Compliance|1
6865151|NCT00434161|10874613|FG002|Overall Study|Non-Compliance|0
6865152|NCT00434161|10874611|FG000|Overall Study|Withdrawal by Subject|2
6865153|NCT00434161|10874612|FG001|Overall Study|Withdrawal by Subject|0
6865154|NCT00434161|10874613|FG002|Overall Study|Withdrawal by Subject|3
6865155|NCT00434161|10874611|FG000|Overall Study|Logistical error study assessments|1
6865156|NCT00434161|10874612|FG001|Overall Study|Logistical error study assessments|0
6865157|NCT00434161|10874613|FG002|Overall Study|Logistical error study assessments|3
6865158|NCT00434213|10874628|FG000|Overall Study|Adverse Event|12
6865159|NCT00434213|10874628|FG000|Overall Study|Lack of Efficacy|9
6865160|NCT00434213|10874628|FG000|Overall Study|Lost to Follow-up|14
6865161|NCT00434213|10874628|FG000|Overall Study|Withdrawal by Subject|7
6865162|NCT00434213|10874628|FG000|Overall Study|Protocol Violation|3
6865163|NCT00434213|10874628|FG000|Overall Study|Unable to comply with study visit window|2
6865164|NCT00434213|10874628|FG000|Overall Study|Application site reaction|1
6865165|NCT00434213|10874628|FG000|Overall Study|Non-compliant to study schedule|1
6865166|NCT00434252|10874634|FG000|Overall Study|Lack of Efficacy|50
6865167|NCT00434252|10874635|FG001|Overall Study|Lack of Efficacy|100
6865168|NCT00434252|10874634|FG000|Overall Study|Adverse Event|6
6865169|NCT00434252|10874635|FG001|Overall Study|Adverse Event|13
6865170|NCT00434252|10874634|FG000|Overall Study|Death|1
6865171|NCT00434252|10874635|FG001|Overall Study|Death|2
6865172|NCT00434252|10874634|FG000|Overall Study|Lost to Follow-up|0
6865173|NCT00434252|10874635|FG001|Overall Study|Lost to Follow-up|1
6865174|NCT00434252|10874634|FG000|Overall Study|Physician Decision|4
6865175|NCT00434252|10874635|FG001|Overall Study|Physician Decision|8
6865176|NCT00434252|10874634|FG000|Overall Study|Withdrawal by Subject|3
6865177|NCT00434252|10874635|FG001|Overall Study|Withdrawal by Subject|7
6865178|NCT00434304|10874650|FG000|Overall Study|Adverse Event|14
6865179|NCT00434304|10874650|FG000|Overall Study|Lack of Efficacy|2
6865180|NCT00434304|10874650|FG000|Overall Study|Withdrawal by Subject|4
6865181|NCT00434330|10874661|FG000|Overall Study|Adverse Event|0
6865182|NCT00434330|10874662|FG001|Overall Study|Adverse Event|0
6865183|NCT00434330|10874663|FG002|Overall Study|Adverse Event|1
6865184|NCT00434330|10874664|FG003|Overall Study|Adverse Event|0
6865185|NCT00434330|10874665|FG004|Overall Study|Adverse Event|0
6865186|NCT00434330|10874666|FG005|Overall Study|Adverse Event|0
6865187|NCT00434330|10874661|FG000|Overall Study|Death|1
6865188|NCT00434330|10874662|FG001|Overall Study|Death|0
6865189|NCT00434330|10874663|FG002|Overall Study|Death|0
6865190|NCT00434330|10874664|FG003|Overall Study|Death|0
6865191|NCT00434330|10874665|FG004|Overall Study|Death|1
6865192|NCT00434330|10874666|FG005|Overall Study|Death|1
6865193|NCT00434330|10874661|FG000|Overall Study|Withdrawal by Subject|0
6865194|NCT00434330|10874662|FG001|Overall Study|Withdrawal by Subject|0
6865195|NCT00434330|10874663|FG002|Overall Study|Withdrawal by Subject|1
6865196|NCT00434330|10874664|FG003|Overall Study|Withdrawal by Subject|1
6865197|NCT00434330|10874665|FG004|Overall Study|Withdrawal by Subject|0
6865198|NCT00434330|10874666|FG005|Overall Study|Withdrawal by Subject|0
6865199|NCT00434330|10874661|FG000|Overall Study|Renal transplant|0
6865200|NCT00434330|10874662|FG001|Overall Study|Renal transplant|0
6865201|NCT00434330|10874663|FG002|Overall Study|Renal transplant|0
6865202|NCT00434330|10874664|FG003|Overall Study|Renal transplant|1
6865203|NCT00434330|10874665|FG004|Overall Study|Renal transplant|0
6865204|NCT00434330|10874666|FG005|Overall Study|Renal transplant|0
6865205|NCT00434330|10874661|FG000|Overall Study|Subject Not Compliant With Study|0
6865206|NCT00434330|10874662|FG001|Overall Study|Subject Not Compliant With Study|0
6865207|NCT00434330|10874663|FG002|Overall Study|Subject Not Compliant With Study|1
6865208|NCT00434330|10874664|FG003|Overall Study|Subject Not Compliant With Study|0
6865209|NCT00434330|10874665|FG004|Overall Study|Subject Not Compliant With Study|0
6865210|NCT00434330|10874666|FG005|Overall Study|Subject Not Compliant With Study|0
6865211|NCT00434421|10874689|FG000|Overall Study|Withdrawal by Subject|1
6865212|NCT00434421|10874689|FG000|Overall Study|Non-compliance with study treatment|1
6865213|NCT00434512|10874712|FG000|Overall Study|Migrated/moved from study area|0
6865214|NCT00434512|10874713|FG001|Overall Study|Migrated/moved from study area|0
6865215|NCT00434512|10874714|FG002|Overall Study|Migrated/moved from study area|0
6865216|NCT00434512|10874715|FG003|Overall Study|Migrated/moved from study area|1
6865217|NCT00434512|10874716|FG004|Overall Study|Migrated/moved from study area|1
6865218|NCT00434512|10874717|FG005|Overall Study|Migrated/moved from study area|1
6865219|NCT00434512|10874712|FG000|Overall Study|Other|0
6865220|NCT00434512|10874713|FG001|Overall Study|Other|1
6865221|NCT00434512|10874714|FG002|Overall Study|Other|0
6865222|NCT00434512|10874715|FG003|Overall Study|Other|0
6865223|NCT00434512|10874716|FG004|Overall Study|Other|0
6865224|NCT00434512|10874717|FG005|Overall Study|Other|0
6865225|NCT00434577|10874740|FG000|Months 0-3|Serious Adverse Event|0
6865226|NCT00434577|10874741|FG001|Months 0-3|Serious Adverse Event|0
6865227|NCT00434577|10874742|FG002|Months 0-3|Serious Adverse Event|1
6865228|NCT00434577|10874743|FG003|Months 0-3|Serious Adverse Event|0
6865229|NCT00434577|10874744|FG004|Months 0-3|Serious Adverse Event|0
6865230|NCT00434577|10874740|FG000|Months 0-3|Adverse Event|0
6865231|NCT00434577|10874741|FG001|Months 0-3|Adverse Event|1
6865232|NCT00434577|10874742|FG002|Months 0-3|Adverse Event|1
6865233|NCT00434577|10874743|FG003|Months 0-3|Adverse Event|0
6865234|NCT00434577|10874744|FG004|Months 0-3|Adverse Event|0
6865235|NCT00434577|10874740|FG000|Months 0-3|Lost to Follow-up|0
6865236|NCT00434577|10874741|FG001|Months 0-3|Lost to Follow-up|0
6865237|NCT00434577|10874742|FG002|Months 0-3|Lost to Follow-up|0
6865238|NCT00434577|10874743|FG003|Months 0-3|Lost to Follow-up|0
6865239|NCT00434577|10874744|FG004|Months 0-3|Lost to Follow-up|2
6865240|NCT00434577|10874740|FG000|Months 0-3|Protocol Violation|1
6865241|NCT00434577|10874741|FG001|Months 0-3|Protocol Violation|0
6865242|NCT00434577|10874742|FG002|Months 0-3|Protocol Violation|1
6865243|NCT00434577|10874743|FG003|Months 0-3|Protocol Violation|0
6865244|NCT00434577|10874744|FG004|Months 0-3|Protocol Violation|0
6865245|NCT00434577|10874740|FG000|Months 0-3|Withdrawal by Subject|2
6865246|NCT00434577|10874741|FG001|Months 0-3|Withdrawal by Subject|1
6865247|NCT00434577|10874742|FG002|Months 0-3|Withdrawal by Subject|1
6865248|NCT00434577|10874743|FG003|Months 0-3|Withdrawal by Subject|1
6865249|NCT00434577|10874744|FG004|Months 0-3|Withdrawal by Subject|1
6865250|NCT00434642|10874758|FG000|Blinded Treatment Phase|Adverse Event|12
6865251|NCT00434642|10874759|FG001|Blinded Treatment Phase|Adverse Event|58
6865252|NCT00434642|10874758|FG000|Blinded Treatment Phase|Clinical Disease Progression|4
6865253|NCT00434642|10874759|FG001|Blinded Treatment Phase|Clinical Disease Progression|5
6865254|NCT00434642|10874758|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168
6865255|NCT00434642|10874759|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109
6865256|NCT00434642|10874758|FG000|Blinded Treatment Phase|Physician Decision|19
6865257|NCT00434642|10874759|FG001|Blinded Treatment Phase|Physician Decision|27
6865258|NCT00434642|10874758|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3
6865259|NCT00434642|10874759|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0
6865260|NCT00434642|10874758|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32
6865261|NCT00434642|10874759|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29
6865262|NCT00434642|10874758|FG000|Blinded Treatment Phase|Did not Receive Treatment|4
6865263|NCT00434642|10874759|FG001|Blinded Treatment Phase|Did not Receive Treatment|1
6865264|NCT00434642|10874758|FG000|Open-label Treatment Phase|Adverse Event|0
6865265|NCT00434642|10874759|FG001|Open-label Treatment Phase|Adverse Event|5
6865266|NCT00434642|10874758|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0
6865267|NCT00434642|10874759|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6
6865268|NCT00434759|10874767|FG000|Overall Study|Lack of Efficacy|5
6865269|NCT00434759|10874768|FG001|Overall Study|Lack of Efficacy|4
6865270|NCT00434759|10874767|FG000|Overall Study|Withdrawal by Subject|17
6865271|NCT00434759|10874768|FG001|Overall Study|Withdrawal by Subject|1
6865272|NCT00434759|10874767|FG000|Overall Study|family affairs|2
6865273|NCT00434759|10874768|FG001|Overall Study|family affairs|0
6865274|NCT00434876|10874778|FG000|Overall Study|Lost to Follow-up|1
6865275|NCT00434876|10874779|FG001|Overall Study|Lost to Follow-up|1
6865276|NCT00434954|10874787|FG000|Overall Study|Adverse Event|17
6865277|NCT00434954|10874788|FG001|Overall Study|Adverse Event|2
6865278|NCT00434954|10874787|FG000|Overall Study|Entry criteria not met|14
6865279|NCT00434954|10874788|FG001|Overall Study|Entry criteria not met|16
6865280|NCT00434954|10874787|FG000|Overall Study|Lost to Follow-up|0
6865281|NCT00434954|10874788|FG001|Overall Study|Lost to Follow-up|1
6865282|NCT00434954|10874787|FG000|Overall Study|Physician Decision|6
6865283|NCT00434954|10874788|FG001|Overall Study|Physician Decision|3
6865284|NCT00434954|10874787|FG000|Overall Study|Protocol Violation|36
6865285|NCT00434954|10874788|FG001|Overall Study|Protocol Violation|27
6865286|NCT00434954|10874787|FG000|Overall Study|Sponsor decision|1
6865287|NCT00434954|10874788|FG001|Overall Study|Sponsor decision|0
6865288|NCT00434954|10874787|FG000|Overall Study|Subject decision|8
6865289|NCT00434954|10874788|FG001|Overall Study|Subject decision|22
6865290|NCT00434967|10874798|FG000|Overall Study|Adverse Event|2
6865291|NCT00434967|10874799|FG001|Overall Study|Adverse Event|4
6865292|NCT00434967|10874800|FG002|Overall Study|Adverse Event|3
6865293|NCT00434967|10874801|FG003|Overall Study|Adverse Event|3
6865294|NCT00434967|10874798|FG000|Overall Study|Lost to Follow-up|0
6865295|NCT00434967|10874799|FG001|Overall Study|Lost to Follow-up|0
6865296|NCT00434967|10874800|FG002|Overall Study|Lost to Follow-up|1
6865297|NCT00434967|10874801|FG003|Overall Study|Lost to Follow-up|0
6865298|NCT00434967|10874798|FG000|Overall Study|Withdrawal by Subject|2
6865299|NCT00434967|10874799|FG001|Overall Study|Withdrawal by Subject|2
6865300|NCT00434967|10874800|FG002|Overall Study|Withdrawal by Subject|4
6865301|NCT00434967|10874801|FG003|Overall Study|Withdrawal by Subject|6
6865302|NCT00434967|10874798|FG000|Overall Study|Randomized in error|0
6865303|NCT00434967|10874799|FG001|Overall Study|Randomized in error|0
6865304|NCT00434967|10874800|FG002|Overall Study|Randomized in error|0
6865305|NCT00434967|10874801|FG003|Overall Study|Randomized in error|1
6865306|NCT00434967|10874798|FG000|Overall Study|Protocol Violation|0
6865307|NCT00434967|10874799|FG001|Overall Study|Protocol Violation|1
6865308|NCT00434967|10874800|FG002|Overall Study|Protocol Violation|0
6865309|NCT00434967|10874801|FG003|Overall Study|Protocol Violation|1
6865310|NCT00434967|10874798|FG000|Overall Study|Physician Decision|1
6865311|NCT00434967|10874799|FG001|Overall Study|Physician Decision|1
6865312|NCT00434967|10874800|FG002|Overall Study|Physician Decision|1
6865313|NCT00434967|10874801|FG003|Overall Study|Physician Decision|0
6865314|NCT00434967|10874798|FG000|Overall Study|Patient Disposition Challenges|2
6865315|NCT00434967|10874799|FG001|Overall Study|Patient Disposition Challenges|0
6865316|NCT00434967|10874800|FG002|Overall Study|Patient Disposition Challenges|0
6865317|NCT00434967|10874801|FG003|Overall Study|Patient Disposition Challenges|3
6865318|NCT00435019|10874822|FG000|Overall Study|Adverse Event|1
6865319|NCT00435019|10874823|FG001|Overall Study|Adverse Event|0
7078208|NCT02100696|11186440|FG005|Induction Phase|Physician Decision|0
7078209|NCT02100696|11186435|FG000|Induction Phase|Multiple Reasons|5
6865320|NCT00435019|10874822|FG000|Overall Study|Lack of Efficacy|1
6865321|NCT00435019|10874823|FG001|Overall Study|Lack of Efficacy|2
6865322|NCT00435019|10874822|FG000|Overall Study|Protocol Violation|3
6865323|NCT00435019|10874823|FG001|Overall Study|Protocol Violation|1
6865324|NCT00435019|10874822|FG000|Overall Study|Personal reasons for withdrawal|8
6865325|NCT00435019|10874823|FG001|Overall Study|Personal reasons for withdrawal|7
6865326|NCT00435045|10874831|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
6865327|NCT00435045|10874832|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
6865328|NCT00435045|10874831|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
6865329|NCT00435045|10874832|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
6865330|NCT00435045|10874831|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2
6865331|NCT00435045|10874832|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1
6865332|NCT00435045|10874831|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1
6865333|NCT00435045|10874832|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0
6865334|NCT00435045|10874831|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0
6968026|NCT01135394|11016710|FG000|Screening|Lost to Follow-up|2
6865335|NCT00435045|10874832|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1
6865336|NCT00435045|10874831|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4
6865337|NCT00435045|10874832|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3
6865338|NCT00435045|10874831|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
6865339|NCT00435045|10874832|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
6865340|NCT00435045|10874831|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0
6865341|NCT00435045|10874832|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1
6865342|NCT00435045|10874831|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3
6865343|NCT00435045|10874832|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2
6865344|NCT00435045|10874831|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1
6865345|NCT00435045|10874832|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0
6865346|NCT00435045|10874831|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1
6865347|NCT00435045|10874832|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0
6865348|NCT00435162|10874841|FG000|Period 2 (2 Weeks)|Adverse Event|0
6865349|NCT00435162|10874842|FG001|Period 2 (2 Weeks)|Adverse Event|1
6865350|NCT00435162|10874843|FG002|Period 2 (2 Weeks)|Adverse Event|0
6865351|NCT00435162|10874844|FG003|Period 2 (2 Weeks)|Adverse Event|0
7184151|NCT01763788|11384149|FG000|Overall Study|Lost to Follow-up|0
6865352|NCT00435162|10874845|FG004|Period 2 (2 Weeks)|Adverse Event|0
6865353|NCT00435162|10874846|FG005|Period 2 (2 Weeks)|Adverse Event|0
6865354|NCT00435188|10874861|FG000|Overall Study|Death|1
6865355|NCT00435188|10874862|FG001|Overall Study|Death|6
6865356|NCT00435188|10874861|FG000|Overall Study|Withdrawal by Subject|16
6865357|NCT00435188|10874862|FG001|Overall Study|Withdrawal by Subject|11
6865358|NCT00435188|10874861|FG000|Overall Study|Lost to Follow-up|5
6865359|NCT00435188|10874862|FG001|Overall Study|Lost to Follow-up|6
6865360|NCT00435370|10874872|FG000|Overall Study|Adverse Event|8
6865361|NCT00435370|10874873|FG001|Overall Study|Adverse Event|8
6865362|NCT00435370|10874872|FG000|Overall Study|Withdrawal by Subject|10
6865363|NCT00435370|10874873|FG001|Overall Study|Withdrawal by Subject|10
6865364|NCT00435370|10874872|FG000|Overall Study|Antipsychotic medication changed|4
6865365|NCT00435370|10874873|FG001|Overall Study|Antipsychotic medication changed|2
6865366|NCT00435409|10874881|FG000|Overall Study|Protocol Violation|1
6865367|NCT00435409|10874882|FG001|Overall Study|Protocol Violation|2
6865368|NCT00435409|10874883|FG002|Overall Study|Protocol Violation|0
6865369|NCT00435409|10874881|FG000|Overall Study|Lost to Follow-up|1
6968027|NCT01135394|11016710|FG000|Screening|Withdrawal by Subject|10
6968028|NCT01135394|11016710|FG000|Screening|Screening failure|16
6968029|NCT01135394|11016710|FG000|Screening|Physician Decision|5
6968030|NCT01135394|11016710|FG000|Baseline Assessment|Withdrawal by Subject|9
6968031|NCT01135394|11016710|FG000|Baseline Assessment|Physician Decision|3
6968032|NCT01135394|11016710|FG000|Baseline Assessment|Lost to Follow-up|2
6968033|NCT01135394|11016710|FG000|Baseline Assessment|Adverse Event|1
6968034|NCT01135394|11016710|FG000|Study Treatment|Withdrawal by Subject|1
6968035|NCT01135394|11016710|FG000|Study Treatment|Physician Decision|1
6968036|NCT01135394|11016710|FG000|Study Treatment|Adverse Event|2
6968037|NCT01135498|11016723|FG000|Overall Study|Adverse Event|20
6968038|NCT01135498|11016723|FG000|Overall Study|Progressive disease|38
6968039|NCT01135498|11016723|FG000|Overall Study|Investigator judgement|25
6968040|NCT01135498|11016723|FG000|Overall Study|Withdrawal by Subject|4
6968041|NCT01135498|11016723|FG000|Overall Study|Death|1
6968042|NCT01135498|11016723|FG000|Overall Study|Ongoing at time of analysis|2
6968043|NCT01135511|11016737|FG000|Overall Study|Adverse Event|0
6968044|NCT01135511|11016738|FG001|Overall Study|Adverse Event|1
6968045|NCT01135511|11016739|FG002|Overall Study|Adverse Event|2
6968046|NCT01135511|11016740|FG003|Overall Study|Adverse Event|0
6968047|NCT01135511|11016741|FG004|Overall Study|Adverse Event|0
6968048|NCT01135511|11016742|FG005|Overall Study|Adverse Event|1
6968049|NCT01135511|11016743|FG006|Overall Study|Adverse Event|0
6968050|NCT01135511|11016744|FG007|Overall Study|Adverse Event|1
6968051|NCT01135511|11016745|FG008|Overall Study|Adverse Event|0
6968052|NCT01135511|11016737|FG000|Overall Study|Lack of Efficacy|0
6968053|NCT01135511|11016738|FG001|Overall Study|Lack of Efficacy|1
6968054|NCT01135511|11016739|FG002|Overall Study|Lack of Efficacy|1
6968055|NCT01135511|11016740|FG003|Overall Study|Lack of Efficacy|2
6968056|NCT01135511|11016741|FG004|Overall Study|Lack of Efficacy|0
6968057|NCT01135511|11016742|FG005|Overall Study|Lack of Efficacy|0
6968058|NCT01135511|11016743|FG006|Overall Study|Lack of Efficacy|0
7041172|NCT01724489|11124685|FG000|Overall Study|Adverse Event|8
7041173|NCT01724489|11124686|FG001|Overall Study|Adverse Event|3
7041174|NCT01724489|11124685|FG000|Overall Study|Surgery, medication|1
7041175|NCT01724489|11124686|FG001|Overall Study|Surgery, medication|1
7041176|NCT01724489|11124685|FG000|Overall Study|Lost to Follow-up|1
7041177|NCT01724489|11124686|FG001|Overall Study|Lost to Follow-up|2
7041178|NCT01724489|11124685|FG000|Overall Study|Withdrawal by Subject|6
7041179|NCT01724489|11124686|FG001|Overall Study|Withdrawal by Subject|6
7041180|NCT01724528|11124694|FG000|Overall Study|Death|3
7041181|NCT01724528|11124695|FG001|Overall Study|Death|0
6865370|NCT00435409|10874882|FG001|Overall Study|Lost to Follow-up|2
6968059|NCT01135511|11016744|FG007|Overall Study|Lack of Efficacy|0
6968060|NCT01135511|11016745|FG008|Overall Study|Lack of Efficacy|0
6968061|NCT01135511|11016737|FG000|Overall Study|Protocol Violation|0
6968062|NCT01135511|11016738|FG001|Overall Study|Protocol Violation|0
7041182|NCT01724528|11124694|FG000|Overall Study|Withdrawal by Subject|0
6865371|NCT00435409|10874883|FG002|Overall Study|Lost to Follow-up|0
6865372|NCT00435409|10874881|FG000|Overall Study|Death|8
6865373|NCT00435409|10874882|FG001|Overall Study|Death|6
6865374|NCT00435409|10874883|FG002|Overall Study|Death|6
6865375|NCT00435409|10874881|FG000|Overall Study|Objective progression or relapse|158
6865376|NCT00435409|10874882|FG001|Overall Study|Objective progression or relapse|93
6865377|NCT00435409|10874883|FG002|Overall Study|Objective progression or relapse|58
6865378|NCT00435409|10874881|FG000|Overall Study|Global deterioration of health status|0
6865379|NCT00435409|10874882|FG001|Overall Study|Global deterioration of health status|0
6865380|NCT00435409|10874883|FG002|Overall Study|Global deterioration of health status|4
6865381|NCT00435409|10874881|FG000|Overall Study|Withdrawal by Subject|8
6865382|NCT00435409|10874882|FG001|Overall Study|Withdrawal by Subject|7
6865383|NCT00435409|10874883|FG002|Overall Study|Withdrawal by Subject|1
6865384|NCT00435409|10874881|FG000|Overall Study|Other|45
6865385|NCT00435409|10874882|FG001|Overall Study|Other|30
6865386|NCT00435409|10874883|FG002|Overall Study|Other|1
6865387|NCT00435409|10874881|FG000|Overall Study|Adverse Event|0
6865388|NCT00435409|10874882|FG001|Overall Study|Adverse Event|0
6865389|NCT00435409|10874883|FG002|Overall Study|Adverse Event|8
6865390|NCT00435409|10874881|FG000|Overall Study|Sponsor decision|0
6865391|NCT00435409|10874882|FG001|Overall Study|Sponsor decision|3
6865392|NCT00435409|10874883|FG002|Overall Study|Sponsor decision|0
6865393|NCT00435461|10874892|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1
6865394|NCT00435461|10874893|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0
6865395|NCT00435461|10874894|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0
6865396|NCT00435461|10874892|FG000|Overall Study|Protocol Violation|6
6865397|NCT00435461|10874893|FG001|Overall Study|Protocol Violation|9
6865398|NCT00435461|10874894|FG002|Overall Study|Protocol Violation|10
6865399|NCT00435461|10874892|FG000|Overall Study|Participant randomized(inadequate score)|1
6865400|NCT00435461|10874893|FG001|Overall Study|Participant randomized(inadequate score)|0
6865401|NCT00435461|10874894|FG002|Overall Study|Participant randomized(inadequate score)|0
6865402|NCT00435461|10874892|FG000|Overall Study|Compliance less than 80 percent|1
6865403|NCT00435461|10874893|FG001|Overall Study|Compliance less than 80 percent|0
6865404|NCT00435461|10874894|FG002|Overall Study|Compliance less than 80 percent|0
6865405|NCT00435461|10874892|FG000|Overall Study|In error, two study medications switched|1
6865406|NCT00435461|10874893|FG001|Overall Study|In error, two study medications switched|0
6865407|NCT00435461|10874894|FG002|Overall Study|In error, two study medications switched|0
6865408|NCT00435461|10874892|FG000|Overall Study|Lack of Efficacy|2
6865409|NCT00435461|10874893|FG001|Overall Study|Lack of Efficacy|1
6865410|NCT00435461|10874894|FG002|Overall Study|Lack of Efficacy|0
6865411|NCT00435461|10874892|FG000|Overall Study|Withdrawal by Subject|1
6865412|NCT00435461|10874893|FG001|Overall Study|Withdrawal by Subject|0
6865413|NCT00435461|10874894|FG002|Overall Study|Withdrawal by Subject|2
6865414|NCT00435461|10874892|FG000|Overall Study|Randomized in error|1
6865415|NCT00435461|10874893|FG001|Overall Study|Randomized in error|0
6865416|NCT00435461|10874894|FG002|Overall Study|Randomized in error|0
6865417|NCT00435461|10874892|FG000|Overall Study|Participant could not tolerate symptoms|0
6865418|NCT00435461|10874893|FG001|Overall Study|Participant could not tolerate symptoms|0
6865419|NCT00435461|10874894|FG002|Overall Study|Participant could not tolerate symptoms|1
6865420|NCT00435461|10874892|FG000|Overall Study|Participant could not swallow capsule|0
6865421|NCT00435461|10874893|FG001|Overall Study|Participant could not swallow capsule|0
6865422|NCT00435461|10874894|FG002|Overall Study|Participant could not swallow capsule|1
6865423|NCT00435461|10874892|FG000|Overall Study|Pregnancy|2
6865424|NCT00435461|10874893|FG001|Overall Study|Pregnancy|0
6865425|NCT00435461|10874894|FG002|Overall Study|Pregnancy|0
6865426|NCT00435461|10874892|FG000|Overall Study|Participant moved eDiary,studymedication|1
6865427|NCT00435461|10874893|FG001|Overall Study|Participant moved eDiary,studymedication|0
6865428|NCT00435461|10874894|FG002|Overall Study|Participant moved eDiary,studymedication|0
6865429|NCT00435461|10874892|FG000|Overall Study|Participant ended study one day early|1
6865430|NCT00435461|10874893|FG001|Overall Study|Participant ended study one day early|0
6865431|NCT00435461|10874894|FG002|Overall Study|Participant ended study one day early|0
6865432|NCT00435461|10874892|FG000|Overall Study|Noncompliance with study requirements|1
6865433|NCT00435461|10874893|FG001|Overall Study|Noncompliance with study requirements|1
6865434|NCT00435461|10874894|FG002|Overall Study|Noncompliance with study requirements|1
6865435|NCT00435461|10874892|FG000|Overall Study|Adverse Event|1
6865436|NCT00435461|10874893|FG001|Overall Study|Adverse Event|2
6865437|NCT00435461|10874894|FG002|Overall Study|Adverse Event|6
6865438|NCT00435461|10874892|FG000|Overall Study|Non-Compliance of diary|2
6865439|NCT00435461|10874893|FG001|Overall Study|Non-Compliance of diary|0
6865440|NCT00435461|10874894|FG002|Overall Study|Non-Compliance of diary|1
6865441|NCT00435461|10874892|FG000|Overall Study|Lost to Follow-up|1
6865442|NCT00435461|10874893|FG001|Overall Study|Lost to Follow-up|1
6865443|NCT00435461|10874894|FG002|Overall Study|Lost to Follow-up|2
6865444|NCT00435487|10874904|FG000|Overall Study|Death|3
6865445|NCT00435487|10874905|FG001|Overall Study|Death|4
6865446|NCT00435487|10874904|FG000|Overall Study|Adverse Event|0
6865447|NCT00435487|10874905|FG001|Overall Study|Adverse Event|3
6865448|NCT00435487|10874904|FG000|Overall Study|Lost to Follow-up|2
6865449|NCT00435487|10874905|FG001|Overall Study|Lost to Follow-up|2
6865450|NCT00435487|10874904|FG000|Overall Study|Other|5
6865451|NCT00435487|10874905|FG001|Overall Study|Other|2
6865452|NCT00435487|10874904|FG000|Overall Study|Withdrawal by Subject|2
6865453|NCT00435487|10874905|FG001|Overall Study|Withdrawal by Subject|1
6865454|NCT00435487|10874904|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0
6865455|NCT00435487|10874905|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2
6865456|NCT00435487|10874904|FG000|Overall Study|Received Drug in Other Treatment Group|0
6865457|NCT00435487|10874905|FG001|Overall Study|Received Drug in Other Treatment Group|1
6865458|NCT00435825|10874964|FG000|Overall Study|Abnormality of Laboratory Test|0
6865459|NCT00435825|10874965|FG001|Overall Study|Abnormality of Laboratory Test|1
6865460|NCT00435825|10874966|FG002|Overall Study|Abnormality of Laboratory Test|0
6865461|NCT00435825|10874967|FG003|Overall Study|Abnormality of Laboratory Test|0
6865462|NCT00435825|10874964|FG000|Overall Study|Insufficient Therapeutic Response|3
6865463|NCT00435825|10874965|FG001|Overall Study|Insufficient Therapeutic Response|1
6865464|NCT00435825|10874966|FG002|Overall Study|Insufficient Therapeutic Response|0
6865465|NCT00435825|10874967|FG003|Overall Study|Insufficient Therapeutic Response|3
6865466|NCT00435825|10874964|FG000|Overall Study|Other Protocol Violation|1
6865467|NCT00435825|10874965|FG001|Overall Study|Other Protocol Violation|0
6865468|NCT00435825|10874966|FG002|Overall Study|Other Protocol Violation|0
6865469|NCT00435825|10874967|FG003|Overall Study|Other Protocol Violation|0
6865470|NCT00435825|10874964|FG000|Overall Study|Refused treatment|2
6865471|NCT00435825|10874965|FG001|Overall Study|Refused treatment|0
6865472|NCT00435825|10874966|FG002|Overall Study|Refused treatment|0
6865473|NCT00435825|10874967|FG003|Overall Study|Refused treatment|5
6865474|NCT00435825|10874964|FG000|Overall Study|Failure to return|5
6865475|NCT00435825|10874965|FG001|Overall Study|Failure to return|0
6865476|NCT00435825|10874966|FG002|Overall Study|Failure to return|4
6865477|NCT00435825|10874967|FG003|Overall Study|Failure to return|0
6865478|NCT00435825|10874964|FG000|Overall Study|Did not receive study drug|1
6865479|NCT00435825|10874965|FG001|Overall Study|Did not receive study drug|0
6865480|NCT00435825|10874966|FG002|Overall Study|Did not receive study drug|2
6865481|NCT00435825|10874967|FG003|Overall Study|Did not receive study drug|0
6865482|NCT00435825|10874964|FG000|Overall Study|Did not enter follow-up|0
6865483|NCT00435825|10874965|FG001|Overall Study|Did not enter follow-up|4
6865484|NCT00435825|10874966|FG002|Overall Study|Did not enter follow-up|1
6865485|NCT00435825|10874967|FG003|Overall Study|Did not enter follow-up|3
6865486|NCT00435825|10874964|FG000|Overall Study|Did not complete full follow-up period|6
6865487|NCT00435825|10874965|FG001|Overall Study|Did not complete full follow-up period|6
6865488|NCT00435825|10874966|FG002|Overall Study|Did not complete full follow-up period|4
6865489|NCT00435825|10874967|FG003|Overall Study|Did not complete full follow-up period|5
6865490|NCT00435942|10874988|FG000|Overall Study|Death|17
6865491|NCT00435942|10874989|FG001|Overall Study|Death|10
6865492|NCT00435942|10874988|FG000|Overall Study|Withdrawal by Subject|2
6865493|NCT00435942|10874989|FG001|Overall Study|Withdrawal by Subject|0
6865494|NCT00435942|10874988|FG000|Overall Study|Lost to Follow-up|0
6865495|NCT00435942|10874989|FG001|Overall Study|Lost to Follow-up|16
6865496|NCT00435942|10874988|FG000|Overall Study|Conversion to Open Repair|1
6865497|NCT00435942|10874989|FG001|Overall Study|Conversion to Open Repair|0
6865498|NCT00435942|10874988|FG000|Overall Study|Technical Failure|3
6865499|NCT00435942|10874989|FG001|Overall Study|Technical Failure|0
6865500|NCT00435942|10874988|FG000|Overall Study|Other|0
6865501|NCT00435942|10874989|FG001|Overall Study|Other|1
6865502|NCT00435994|10874998|FG000|Overall Study|Lost to Follow-up|7
6865503|NCT00435994|10874999|FG001|Overall Study|Lost to Follow-up|0
6865504|NCT00435994|10875000|FG002|Overall Study|Lost to Follow-up|0
6865505|NCT00436007|10875012|FG000|Overall Study|Withdrawal by Subject|5
6865506|NCT00436007|10875013|FG001|Overall Study|Withdrawal by Subject|3
6865507|NCT00436007|10875014|FG002|Overall Study|Withdrawal by Subject|4
6865508|NCT00436007|10875012|FG000|Overall Study|Lost to Follow-up|14
6865509|NCT00436007|10875013|FG001|Overall Study|Lost to Follow-up|10
6865510|NCT00436007|10875014|FG002|Overall Study|Lost to Follow-up|13
6865511|NCT00436007|10875012|FG000|Overall Study|Physician Decision|0
6865512|NCT00436007|10875013|FG001|Overall Study|Physician Decision|0
6865513|NCT00436007|10875014|FG002|Overall Study|Physician Decision|2
6865514|NCT00436007|10875012|FG000|Overall Study|Death|0
6865515|NCT00436007|10875013|FG001|Overall Study|Death|1
6865516|NCT00436007|10875014|FG002|Overall Study|Death|3
6865517|NCT00436007|10875012|FG000|Overall Study|Other|0
6865518|NCT00436007|10875013|FG001|Overall Study|Other|0
6865519|NCT00436007|10875014|FG002|Overall Study|Other|1
6865520|NCT00436163|10875040|FG000|Overall Study|Lost to Follow-up|2
6865521|NCT00436163|10875040|FG000|Overall Study|Adverse Event|1
6865522|NCT00436215|10875045|FG000|Overall Study|Refused further treatment|3
6865523|NCT00436215|10875045|FG000|Overall Study|Small bowel obstruction|1
6865524|NCT00436280|10875049|FG000|Period 1: Induction|Adverse Event|8
6865525|NCT00436280|10875049|FG000|Period 1: Induction|Progressive Disease|12
6865526|NCT00436280|10875049|FG000|Period 1: Induction|Stable Disease|6
6865527|NCT00436280|10875049|FG000|Period 1: Induction|Withdrawal by Subject|1
6865528|NCT00436280|10875049|FG000|Period 1: Induction|Death|1
6865529|NCT00436280|10875049|FG000|Period 2: Consolidation|Adverse Event|1
6865530|NCT00436280|10875049|FG000|Period 2: Consolidation|Progressive Disease|10
6865531|NCT00436280|10875049|FG000|Period 2: Consolidation|Stable Disease|1
6865532|NCT00436280|10875049|FG000|Period 2: Consolidation|Physician Decision|2
6865533|NCT00436280|10875049|FG000|Period 2: Consolidation|Withdrawal by Subject|2
6865534|NCT00436280|10875049|FG000|Period 2: Consolidation|Death|1
6865535|NCT00436280|10875049|FG000|Period 3: Maintenance|Adverse Event|6
6865536|NCT00436280|10875049|FG000|Period 3: Maintenance|Progressive Disease|12
6865537|NCT00436332|10875053|FG000|Overall Study|Adverse Event|9
6865538|NCT00436332|10875053|FG000|Overall Study|Withdrawal by Subject|2
6865539|NCT00436332|10875053|FG000|Overall Study|Progression|59
6865540|NCT00436332|10875053|FG000|Overall Study|Death|2
6865541|NCT00436332|10875053|FG000|Overall Study|Not Protocol Specified|6
6865542|NCT00436332|10875053|FG000|Overall Study|Ineligible|2
6865543|NCT00436332|10875053|FG000|Overall Study|Never Received Treatment|3
6865544|NCT00436345|10875059|FG000|Overall Study|ICU resident beyond follow-up period|3
6865545|NCT00436345|10875060|FG001|Overall Study|ICU resident beyond follow-up period|0
6865546|NCT00436436|10875067|FG000|Overall Study|Progression|4
6865547|NCT00436436|10875067|FG000|Overall Study|Adverse Event|2
6865548|NCT00436436|10875067|FG000|Overall Study|Death|6
6865549|NCT00436501|10875090|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0
6865550|NCT00436501|10875091|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2
6865551|NCT00436501|10875090|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0
6865552|NCT00436501|10875091|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1
6865553|NCT00436553|10875101|FG000|Overall Study|Adverse Event|4
6865554|NCT00436553|10875102|FG001|Overall Study|Adverse Event|3
6865555|NCT00436553|10875103|FG002|Overall Study|Adverse Event|4
6865556|NCT00436553|10875101|FG000|Overall Study|Death|3
6865557|NCT00436553|10875102|FG001|Overall Study|Death|1
6865558|NCT00436553|10875103|FG002|Overall Study|Death|3
6865559|NCT00436553|10875101|FG000|Overall Study|Lost to Follow-up|0
6865560|NCT00436553|10875102|FG001|Overall Study|Lost to Follow-up|2
6865561|NCT00436553|10875103|FG002|Overall Study|Lost to Follow-up|0
6865562|NCT00436553|10875101|FG000|Overall Study|Protocol Violation|1
6865563|NCT00436553|10875102|FG001|Overall Study|Protocol Violation|0
6865564|NCT00436553|10875103|FG002|Overall Study|Protocol Violation|0
6865565|NCT00436553|10875101|FG000|Overall Study|Withdrawal by Subject|5
6865566|NCT00436553|10875102|FG001|Overall Study|Withdrawal by Subject|6
6865567|NCT00436553|10875103|FG002|Overall Study|Withdrawal by Subject|3
6865568|NCT00436566|10875111|FG000|Overall Study|Withdrawal by Subject|2
6865569|NCT00436566|10875111|FG000|Overall Study|Protocol Violation|1
6865570|NCT00436605|10875115|FG000|Overall Study|Protocol Violation|3
6865571|NCT00436618|10875122|FG000|Overall Study|Withdrawal by Subject|5
6865572|NCT00436618|10875123|FG001|Overall Study|Withdrawal by Subject|8
6865573|NCT00436618|10875124|FG002|Overall Study|Withdrawal by Subject|11
6865574|NCT00436618|10875122|FG000|Overall Study|Adverse Event|8
6865575|NCT00436618|10875123|FG001|Overall Study|Adverse Event|8
6865576|NCT00436618|10875124|FG002|Overall Study|Adverse Event|9
6865577|NCT00436618|10875122|FG000|Overall Study|Alternate Treatment|3
6865578|NCT00436618|10875123|FG001|Overall Study|Alternate Treatment|4
6865579|NCT00436618|10875124|FG002|Overall Study|Alternate Treatment|12
6865580|NCT00436618|10875122|FG000|Overall Study|Other Medical Problems|3
6865581|NCT00436618|10875123|FG001|Overall Study|Other Medical Problems|1
6865582|NCT00436618|10875124|FG002|Overall Study|Other Medical Problems|7
6865583|NCT00436618|10875122|FG000|Overall Study|Death|4
6865584|NCT00436618|10875123|FG001|Overall Study|Death|2
6865585|NCT00436618|10875124|FG002|Overall Study|Death|3
6865586|NCT00436618|10875122|FG000|Overall Study|New Primary or Other Reasons|6
6865587|NCT00436618|10875123|FG001|Overall Study|New Primary or Other Reasons|2
6865588|NCT00436618|10875124|FG002|Overall Study|New Primary or Other Reasons|12
6865589|NCT00436618|10875122|FG000|Overall Study|Still on treatment|1
6865590|NCT00436618|10875123|FG001|Overall Study|Still on treatment|2
6865591|NCT00436618|10875124|FG002|Overall Study|Still on treatment|7
6865592|NCT00436644|10875132|FG000|Overall Study|Adverse Event|2
6865593|NCT00436644|10875132|FG000|Overall Study|Death|1
6865594|NCT00436748|10875138|FG000|Overall Study|Ineligibility Determined|1
6865595|NCT00436748|10875139|FG001|Overall Study|Ineligibility Determined|1
6865596|NCT00436748|10875138|FG000|Overall Study|Adverse Event|0
6865597|NCT00436748|10875139|FG001|Overall Study|Adverse Event|2
6865598|NCT00436748|10875138|FG000|Overall Study|Consent Withdrawn|1
6865599|NCT00436748|10875139|FG001|Overall Study|Consent Withdrawn|4
6865600|NCT00436748|10875138|FG000|Overall Study|Administrative Decision|1
6865601|NCT00436748|10875139|FG001|Overall Study|Administrative Decision|0
6865602|NCT00436748|10875138|FG000|Overall Study|Lost to Follow-up|0
6865603|NCT00436748|10875139|FG001|Overall Study|Lost to Follow-up|1
6865604|NCT00436748|10875138|FG000|Overall Study|Protocol-specified Criteria|5
6865605|NCT00436748|10875139|FG001|Overall Study|Protocol-specified Criteria|4
6865606|NCT00436748|10875138|FG000|Overall Study|Other|3
6865607|NCT00436748|10875139|FG001|Overall Study|Other|0
6865608|NCT00436852|10875147|FG000|Overall Study|Death|23
6865609|NCT00436852|10875148|FG001|Overall Study|Death|34
6865610|NCT00436852|10875147|FG000|Overall Study|Lack of Efficacy|9
6865611|NCT00436852|10875148|FG001|Overall Study|Lack of Efficacy|7
6865612|NCT00436852|10875147|FG000|Overall Study|Withdrawal by Subject|2
6865613|NCT00436852|10875148|FG001|Overall Study|Withdrawal by Subject|4
6865614|NCT00436852|10875147|FG000|Overall Study|Ineligible|1
6865615|NCT00436852|10875148|FG001|Overall Study|Ineligible|0
6865616|NCT00436917|10875161|FG000|Overall Study|Withdrawal by Subject|13
6865617|NCT00436917|10875161|FG000|Overall Study|Adverse Event|2
6865618|NCT00436917|10875161|FG000|Overall Study|Physician Decision|1
6865619|NCT00436917|10875161|FG000|Overall Study|Death|1
6865620|NCT00436917|10875161|FG000|Overall Study|Lost to Follow-up|1
6865621|NCT00436917|10875161|FG000|Overall Study|Treatment for polymyalgia rheumatic|1
6865622|NCT00436917|10875161|FG000|Overall Study|Increased creatinine|1
6865623|NCT00436917|10875161|FG000|Overall Study|Personal conflicts of patient|1
6865624|NCT00436956|10875165|FG000|Overall Study|Not evaluable|1
6865625|NCT00436956|10875166|FG001|Overall Study|Not evaluable|0
6865626|NCT00436982|10875184|FG000|Overall Study|Withdrawal by Subject|3
6865627|NCT00436982|10875185|FG001|Overall Study|Withdrawal by Subject|1
6865628|NCT00436982|10875184|FG000|Overall Study|Did not receive allocated intervention|0
6865629|NCT00436982|10875185|FG001|Overall Study|Did not receive allocated intervention|1
6865630|NCT00436982|10875184|FG000|Overall Study|no RSA data|1
6865631|NCT00436982|10875185|FG001|Overall Study|no RSA data|2
6865632|NCT00437034|10875195|FG000|Overall Study|Adverse Event|1
6865633|NCT00437034|10875195|FG000|Overall Study|Disease progression during treatment|5
6865634|NCT00437073|10875201|FG000|Overall Study|Sponsor Terminated Study|1
6865635|NCT00437073|10875202|FG001|Overall Study|Sponsor Terminated Study|0
6865636|NCT00437073|10875201|FG000|Overall Study|Physician Decision|0
6865637|NCT00437073|10875202|FG001|Overall Study|Physician Decision|1
6865638|NCT00437125|10875208|FG000|Overall Study|Adverse Event|12
6865639|NCT00437125|10875208|FG000|Overall Study|Death|1
6865640|NCT00437125|10875208|FG000|Overall Study|Clinical Relapse|1
6865641|NCT00437125|10875208|FG000|Overall Study|Lack of Efficacy|1
6865642|NCT00437125|10875208|FG000|Overall Study|Lost to Follow-up|1
6865643|NCT00437125|10875208|FG000|Overall Study|Withdrawal by Subject|13
6865644|NCT00437125|10875208|FG000|Overall Study|Withdrawal by Caregiver|2
6865645|NCT00437125|10875208|FG000|Overall Study|Physician Decision|1
6865646|NCT00437203|10875222|FG000|Overall Study|Death|0
6865647|NCT00437203|10875223|FG001|Overall Study|Death|0
6865648|NCT00437203|10875224|FG002|Overall Study|Death|1
6865649|NCT00437203|10875225|FG003|Overall Study|Death|0
6865650|NCT00437203|10875226|FG004|Overall Study|Death|0
6865651|NCT00437203|10875227|FG005|Overall Study|Death|0
6865652|NCT00437203|10875228|FG006|Overall Study|Death|0
6865653|NCT00437203|10875229|FG007|Overall Study|Death|1
6865654|NCT00437203|10875230|FG008|Overall Study|Death|0
6865655|NCT00437203|10875231|FG009|Overall Study|Death|1
6865656|NCT00437203|10875222|FG000|Overall Study|Adverse Event|1
6865657|NCT00437203|10875223|FG001|Overall Study|Adverse Event|1
6865658|NCT00437203|10875224|FG002|Overall Study|Adverse Event|0
6865659|NCT00437203|10875225|FG003|Overall Study|Adverse Event|0
6865660|NCT00437203|10875226|FG004|Overall Study|Adverse Event|0
6865661|NCT00437203|10875227|FG005|Overall Study|Adverse Event|0
6865662|NCT00437203|10875228|FG006|Overall Study|Adverse Event|0
6865663|NCT00437203|10875229|FG007|Overall Study|Adverse Event|1
7078210|NCT02100696|11186436|FG001|Induction Phase|Multiple Reasons|2
7184152|NCT01763788|11384150|FG001|Overall Study|Lost to Follow-up|0
6865664|NCT00437203|10875230|FG008|Overall Study|Adverse Event|0
6865665|NCT00437203|10875231|FG009|Overall Study|Adverse Event|1
6865666|NCT00437203|10875222|FG000|Overall Study|Study terminated by sponsor|0
6865667|NCT00437203|10875223|FG001|Overall Study|Study terminated by sponsor|0
6865668|NCT00437203|10875224|FG002|Overall Study|Study terminated by sponsor|0
6865669|NCT00437203|10875225|FG003|Overall Study|Study terminated by sponsor|0
6865670|NCT00437203|10875226|FG004|Overall Study|Study terminated by sponsor|0
6865671|NCT00437203|10875227|FG005|Overall Study|Study terminated by sponsor|0
6865672|NCT00437203|10875228|FG006|Overall Study|Study terminated by sponsor|0
6865673|NCT00437203|10875229|FG007|Overall Study|Study terminated by sponsor|0
6865674|NCT00437203|10875230|FG008|Overall Study|Study terminated by sponsor|1
6865675|NCT00437203|10875231|FG009|Overall Study|Study terminated by sponsor|0
6865676|NCT00437203|10875222|FG000|Overall Study|Objective progression or relapse|5
6865677|NCT00437203|10875223|FG001|Overall Study|Objective progression or relapse|6
6865678|NCT00437203|10875224|FG002|Overall Study|Objective progression or relapse|2
6865679|NCT00437203|10875225|FG003|Overall Study|Objective progression or relapse|3
6865680|NCT00437203|10875226|FG004|Overall Study|Objective progression or relapse|3
6865681|NCT00437203|10875227|FG005|Overall Study|Objective progression or relapse|3
6865682|NCT00437203|10875228|FG006|Overall Study|Objective progression or relapse|6
6865683|NCT00437203|10875229|FG007|Overall Study|Objective progression or relapse|1
6865684|NCT00437203|10875230|FG008|Overall Study|Objective progression or relapse|2
6968063|NCT01135511|11016739|FG002|Overall Study|Protocol Violation|3
6865685|NCT00437203|10875231|FG009|Overall Study|Objective progression or relapse|2
6865686|NCT00437203|10875222|FG000|Overall Study|Other|0
6865687|NCT00437203|10875223|FG001|Overall Study|Other|1
6865688|NCT00437203|10875224|FG002|Overall Study|Other|0
6865689|NCT00437203|10875225|FG003|Overall Study|Other|0
6865690|NCT00437203|10875226|FG004|Overall Study|Other|0
6865691|NCT00437203|10875227|FG005|Overall Study|Other|0
6865692|NCT00437203|10875228|FG006|Overall Study|Other|1
6865693|NCT00437203|10875229|FG007|Overall Study|Other|0
6865694|NCT00437203|10875230|FG008|Overall Study|Other|0
6865695|NCT00437203|10875231|FG009|Overall Study|Other|0
6865696|NCT00437268|10875264|FG000|Overall Study|Adverse Event|1
6865697|NCT00437268|10875265|FG001|Overall Study|Adverse Event|1
6865698|NCT00437268|10875264|FG000|Overall Study|Withdrawal by Subject|2
6865699|NCT00437268|10875265|FG001|Overall Study|Withdrawal by Subject|2
6865700|NCT00437268|10875264|FG000|Overall Study|Progressive disease|9
6865701|NCT00437268|10875265|FG001|Overall Study|Progressive disease|9
7078211|NCT02100696|11186437|FG002|Induction Phase|Multiple Reasons|8
6865702|NCT00437268|10875264|FG000|Overall Study|Physician Decision|1
6865703|NCT00437268|10875265|FG001|Overall Study|Physician Decision|0
6865704|NCT00437268|10875264|FG000|Overall Study|Death|0
6865705|NCT00437268|10875265|FG001|Overall Study|Death|1
6865706|NCT00437281|10875293|FG000|Overall Study|Adverse Event|0
6865707|NCT00437281|10875294|FG001|Overall Study|Adverse Event|0
6865708|NCT00437281|10875295|FG002|Overall Study|Adverse Event|0
6865709|NCT00437281|10875296|FG003|Overall Study|Adverse Event|1
6865710|NCT00437281|10875297|FG004|Overall Study|Adverse Event|0
6865711|NCT00437281|10875298|FG005|Overall Study|Adverse Event|1
6865712|NCT00437281|10875299|FG006|Overall Study|Adverse Event|0
6865713|NCT00437281|10875300|FG007|Overall Study|Adverse Event|0
6865714|NCT00437281|10875301|FG008|Overall Study|Adverse Event|0
6865715|NCT00437281|10875302|FG009|Overall Study|Adverse Event|1
6865716|NCT00437281|10875303|FG010|Overall Study|Adverse Event|0
6865717|NCT00437281|10875304|FG011|Overall Study|Adverse Event|0
6865718|NCT00437281|10875305|FG012|Overall Study|Adverse Event|0
6865719|NCT00437281|10875306|FG013|Overall Study|Adverse Event|1
6865720|NCT00437281|10875307|FG014|Overall Study|Adverse Event|1
6865721|NCT00437281|10875308|FG015|Overall Study|Adverse Event|0
6865722|NCT00437281|10875309|FG016|Overall Study|Adverse Event|0
6865723|NCT00437281|10875310|FG017|Overall Study|Adverse Event|0
6865724|NCT00437281|10875311|FG018|Overall Study|Adverse Event|1
6865725|NCT00437281|10875312|FG019|Overall Study|Adverse Event|0
6865726|NCT00437281|10875293|FG000|Overall Study|Lost to Follow-up|0
6865727|NCT00437281|10875294|FG001|Overall Study|Lost to Follow-up|0
6865728|NCT00437281|10875295|FG002|Overall Study|Lost to Follow-up|0
6865729|NCT00437281|10875296|FG003|Overall Study|Lost to Follow-up|0
6865730|NCT00437281|10875297|FG004|Overall Study|Lost to Follow-up|0
6865731|NCT00437281|10875298|FG005|Overall Study|Lost to Follow-up|0
6865732|NCT00437281|10875299|FG006|Overall Study|Lost to Follow-up|0
6865733|NCT00437281|10875300|FG007|Overall Study|Lost to Follow-up|0
6865734|NCT00437281|10875301|FG008|Overall Study|Lost to Follow-up|0
6865735|NCT00437281|10875302|FG009|Overall Study|Lost to Follow-up|0
6865736|NCT00437281|10875303|FG010|Overall Study|Lost to Follow-up|0
6865737|NCT00437281|10875304|FG011|Overall Study|Lost to Follow-up|0
6865738|NCT00437281|10875305|FG012|Overall Study|Lost to Follow-up|0
6865739|NCT00437281|10875306|FG013|Overall Study|Lost to Follow-up|0
6865740|NCT00437281|10875307|FG014|Overall Study|Lost to Follow-up|0
6865741|NCT00437281|10875308|FG015|Overall Study|Lost to Follow-up|0
6865742|NCT00437281|10875309|FG016|Overall Study|Lost to Follow-up|0
6865743|NCT00437281|10875310|FG017|Overall Study|Lost to Follow-up|0
6865744|NCT00437281|10875311|FG018|Overall Study|Lost to Follow-up|0
6865745|NCT00437281|10875312|FG019|Overall Study|Lost to Follow-up|1
6968064|NCT01135511|11016740|FG003|Overall Study|Protocol Violation|0
6968065|NCT01135511|11016741|FG004|Overall Study|Protocol Violation|0
6968066|NCT01135511|11016742|FG005|Overall Study|Protocol Violation|0
6968067|NCT01135511|11016743|FG006|Overall Study|Protocol Violation|0
6968068|NCT01135511|11016744|FG007|Overall Study|Protocol Violation|0
6968069|NCT01135511|11016745|FG008|Overall Study|Protocol Violation|0
6968070|NCT01135511|11016737|FG000|Overall Study|Pregnancy|0
6968071|NCT01135511|11016738|FG001|Overall Study|Pregnancy|0
6968072|NCT01135511|11016739|FG002|Overall Study|Pregnancy|0
6968073|NCT01135511|11016740|FG003|Overall Study|Pregnancy|1
6968074|NCT01135511|11016741|FG004|Overall Study|Pregnancy|0
6968075|NCT01135511|11016742|FG005|Overall Study|Pregnancy|0
6968076|NCT01135511|11016743|FG006|Overall Study|Pregnancy|0
6968077|NCT01135511|11016744|FG007|Overall Study|Pregnancy|0
6968078|NCT01135511|11016745|FG008|Overall Study|Pregnancy|0
6968079|NCT01135511|11016737|FG000|Overall Study|could not visit the clinic|0
6968080|NCT01135511|11016738|FG001|Overall Study|could not visit the clinic|1
6968081|NCT01135511|11016739|FG002|Overall Study|could not visit the clinic|2
6968082|NCT01135511|11016740|FG003|Overall Study|could not visit the clinic|0
6968083|NCT01135511|11016741|FG004|Overall Study|could not visit the clinic|0
6968084|NCT01135511|11016742|FG005|Overall Study|could not visit the clinic|0
6968085|NCT01135511|11016743|FG006|Overall Study|could not visit the clinic|0
6968086|NCT01135511|11016744|FG007|Overall Study|could not visit the clinic|0
7078212|NCT02100696|11186438|FG003|Induction Phase|Multiple Reasons|0
6968087|NCT01135511|11016745|FG008|Overall Study|could not visit the clinic|0
6968088|NCT01135511|11016737|FG000|Overall Study|noncompliance with study drug taken|0
6968089|NCT01135511|11016738|FG001|Overall Study|noncompliance with study drug taken|0
6968090|NCT01135511|11016739|FG002|Overall Study|noncompliance with study drug taken|0
6968091|NCT01135511|11016740|FG003|Overall Study|noncompliance with study drug taken|0
6968092|NCT01135511|11016741|FG004|Overall Study|noncompliance with study drug taken|1
6968093|NCT01135511|11016742|FG005|Overall Study|noncompliance with study drug taken|0
6968094|NCT01135511|11016743|FG006|Overall Study|noncompliance with study drug taken|0
6968095|NCT01135511|11016744|FG007|Overall Study|noncompliance with study drug taken|0
6968096|NCT01135511|11016745|FG008|Overall Study|noncompliance with study drug taken|0
6968097|NCT01135511|11016737|FG000|Overall Study|Withdrawal by Subject|0
6968098|NCT01135511|11016738|FG001|Overall Study|Withdrawal by Subject|0
6968099|NCT01135511|11016739|FG002|Overall Study|Withdrawal by Subject|0
6968100|NCT01135511|11016740|FG003|Overall Study|Withdrawal by Subject|0
6968101|NCT01135511|11016741|FG004|Overall Study|Withdrawal by Subject|0
6968102|NCT01135511|11016742|FG005|Overall Study|Withdrawal by Subject|0
6968103|NCT01135511|11016743|FG006|Overall Study|Withdrawal by Subject|1
6968104|NCT01135511|11016744|FG007|Overall Study|Withdrawal by Subject|0
6865746|NCT00437294|10875386|FG000|Overall Study|Adverse Event|5
6865747|NCT00437294|10875387|FG001|Overall Study|Adverse Event|4
6865748|NCT00437294|10875386|FG000|Overall Study|Death|5
6865749|NCT00437294|10875387|FG001|Overall Study|Death|2
6865750|NCT00437294|10875386|FG000|Overall Study|Physician Decision|0
6865751|NCT00437294|10875387|FG001|Overall Study|Physician Decision|3
6865752|NCT00437294|10875386|FG000|Overall Study|Withdrawal by Subject|5
6865753|NCT00437294|10875387|FG001|Overall Study|Withdrawal by Subject|0
6865754|NCT00437294|10875386|FG000|Overall Study|Progressive Disease|19
6865755|NCT00437294|10875387|FG001|Overall Study|Progressive Disease|23
6865756|NCT00437294|10875386|FG000|Overall Study|Sponsor Decision|8
6865757|NCT00437294|10875387|FG001|Overall Study|Sponsor Decision|9
6865758|NCT00437294|10875386|FG000|Overall Study|Protocol Violation|0
6865759|NCT00437294|10875387|FG001|Overall Study|Protocol Violation|1
6865760|NCT00437294|10875386|FG000|Overall Study|Entry criteria not met|1
6865761|NCT00437294|10875387|FG001|Overall Study|Entry criteria not met|1
6865762|NCT00437489|10875401|FG000|Overall Study|Study terminated by sponsor|23
6865763|NCT00437489|10875402|FG001|Overall Study|Study terminated by sponsor|21
6865764|NCT00437489|10875401|FG000|Overall Study|Lost to Follow-up|0
6865765|NCT00437489|10875402|FG001|Overall Study|Lost to Follow-up|1
7154238|NCT03307252|11320767|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
7154239|NCT03307252|11320768|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
7154240|NCT03307252|11320769|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1
7154241|NCT03307837|11320791|FG000|Overall Study|Withdrawal by Subject|0
6865766|NCT00437645|10875410|FG000|Overall Study|Adverse Event|15
6865767|NCT00437645|10875411|FG001|Overall Study|Adverse Event|84
6865768|NCT00437645|10875410|FG000|Overall Study|Withdrawal by Subject|10
6865769|NCT00437645|10875411|FG001|Overall Study|Withdrawal by Subject|22
6865770|NCT00437645|10875410|FG000|Overall Study|Protocol Violation|3
6865771|NCT00437645|10875411|FG001|Overall Study|Protocol Violation|3
6865772|NCT00437645|10875410|FG000|Overall Study|Lost to Follow-up|2
6865773|NCT00437645|10875411|FG001|Overall Study|Lost to Follow-up|3
6865774|NCT00437645|10875410|FG000|Overall Study|Administrative problems|2
6865775|NCT00437645|10875411|FG001|Overall Study|Administrative problems|1
6865776|NCT00437645|10875410|FG000|Overall Study|Lack of Efficacy|2
6865777|NCT00437645|10875411|FG001|Overall Study|Lack of Efficacy|1
6865778|NCT00437645|10875410|FG000|Overall Study|Condition no longer requires study drug|1
6865779|NCT00437645|10875411|FG001|Overall Study|Condition no longer requires study drug|1
6865780|NCT00437658|10875420|FG000|Treatment Period (24 Weeks)|Adverse Event|4
6865781|NCT00437658|10875421|FG001|Treatment Period (24 Weeks)|Adverse Event|7
6865782|NCT00437658|10875422|FG002|Treatment Period (24 Weeks)|Adverse Event|14
6865783|NCT00437658|10875420|FG000|Treatment Period (24 Weeks)|Non-compliance|1
6865784|NCT00437658|10875421|FG001|Treatment Period (24 Weeks)|Non-compliance|1
6865785|NCT00437658|10875422|FG002|Treatment Period (24 Weeks)|Non-compliance|4
6865786|NCT00437658|10875420|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9
6865787|NCT00437658|10875421|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7
7154242|NCT03307837|11320792|FG001|Overall Study|Withdrawal by Subject|0
7154243|NCT03307837|11320793|FG002|Overall Study|Withdrawal by Subject|1
7154244|NCT03307837|11320794|FG003|Overall Study|Withdrawal by Subject|0
6865788|NCT00437658|10875422|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7
6865789|NCT00437658|10875420|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4
6865790|NCT00437658|10875421|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2
6865791|NCT00437658|10875422|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3
6865792|NCT00437658|10875420|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5
6865793|NCT00437658|10875421|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4
6865794|NCT00437658|10875422|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5
6865795|NCT00437658|10875420|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5
6865796|NCT00437658|10875421|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1
6865797|NCT00437658|10875422|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0
6865798|NCT00437658|10875420|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1
6865799|NCT00437658|10875421|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0
6865800|NCT00437658|10875422|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1
6865801|NCT00437658|10875420|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3
6865802|NCT00437658|10875421|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0
6865803|NCT00437658|10875422|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1
6865804|NCT00437658|10875420|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12
6865805|NCT00437658|10875421|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6
6865806|NCT00437658|10875422|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8
6865807|NCT00437658|10875420|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0
6865808|NCT00437658|10875421|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2
6865809|NCT00437658|10875422|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2
6865810|NCT00437658|10875420|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5
6865811|NCT00437658|10875421|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0
6865812|NCT00437658|10875422|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1
6865813|NCT00437658|10875420|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3
6865814|NCT00437658|10875421|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0
6865815|NCT00437658|10875422|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1
6865816|NCT00437983|10875432|FG000|Overall Study|Adverse Event|6
6865817|NCT00437983|10875433|FG001|Overall Study|Adverse Event|6
6865818|NCT00437983|10875432|FG000|Overall Study|Protocol Violation|2
6865819|NCT00437983|10875433|FG001|Overall Study|Protocol Violation|1
6865820|NCT00437983|10875432|FG000|Overall Study|Withdrawal by Subject|5
6865821|NCT00437983|10875433|FG001|Overall Study|Withdrawal by Subject|6
6865822|NCT00438256|10875462|FG000|Overall Study|Ineligible for Resection|2
6865823|NCT00438256|10875463|FG001|Overall Study|Ineligible for Resection|1
6865824|NCT00438256|10875464|FG002|Overall Study|Ineligible for Resection|1
6865825|NCT00438256|10875465|FG003|Overall Study|Ineligible for Resection|7
6865826|NCT00438256|10875462|FG000|Overall Study|Excluded final Diagnosis|0
6865827|NCT00438256|10875463|FG001|Overall Study|Excluded final Diagnosis|0
6865828|NCT00438256|10875464|FG002|Overall Study|Excluded final Diagnosis|0
6865829|NCT00438256|10875465|FG003|Overall Study|Excluded final Diagnosis|2
6865830|NCT00438360|10875480|FG000|Overall Study|Adverse Event|6
6865831|NCT00438360|10875481|FG001|Overall Study|Adverse Event|1
6865832|NCT00438360|10875480|FG000|Overall Study|Lack of Efficacy|42
6865833|NCT00438360|10875481|FG001|Overall Study|Lack of Efficacy|27
6865834|NCT00438360|10875480|FG000|Overall Study|Other|24
6865835|NCT00438360|10875481|FG001|Overall Study|Other|15
6865836|NCT00438399|10875490|FG000|Overall Study|Lost to Follow-up|2
6865837|NCT00438399|10875491|FG001|Overall Study|Lost to Follow-up|2
6865838|NCT00438399|10875492|FG002|Overall Study|Lost to Follow-up|1
6865839|NCT00438399|10875493|FG003|Overall Study|Lost to Follow-up|1
6865840|NCT00438399|10875494|FG004|Overall Study|Lost to Follow-up|1
6865841|NCT00438399|10875495|FG005|Overall Study|Lost to Follow-up|1
6865842|NCT00438399|10875490|FG000|Overall Study|Adverse Event|0
6865843|NCT00438399|10875491|FG001|Overall Study|Adverse Event|0
6865844|NCT00438399|10875492|FG002|Overall Study|Adverse Event|1
6865845|NCT00438399|10875493|FG003|Overall Study|Adverse Event|1
6865846|NCT00438399|10875494|FG004|Overall Study|Adverse Event|0
6865847|NCT00438399|10875495|FG005|Overall Study|Adverse Event|1
6865848|NCT00438399|10875490|FG000|Overall Study|Withdrawal by Subject|5
6865849|NCT00438399|10875491|FG001|Overall Study|Withdrawal by Subject|6
6865850|NCT00438399|10875492|FG002|Overall Study|Withdrawal by Subject|3
6865851|NCT00438399|10875493|FG003|Overall Study|Withdrawal by Subject|2
6865852|NCT00438399|10875494|FG004|Overall Study|Withdrawal by Subject|2
6865853|NCT00438399|10875495|FG005|Overall Study|Withdrawal by Subject|2
6865854|NCT00438399|10875490|FG000|Overall Study|Protocol Violation|0
6865855|NCT00438399|10875491|FG001|Overall Study|Protocol Violation|0
6865856|NCT00438399|10875492|FG002|Overall Study|Protocol Violation|1
6865857|NCT00438399|10875493|FG003|Overall Study|Protocol Violation|0
6865858|NCT00438399|10875494|FG004|Overall Study|Protocol Violation|0
6865859|NCT00438399|10875495|FG005|Overall Study|Protocol Violation|1
6865860|NCT00438399|10875490|FG000|Overall Study|Subje stopped study|0
6865861|NCT00438399|10875491|FG001|Overall Study|Subje stopped study|0
6865862|NCT00438399|10875492|FG002|Overall Study|Subje stopped study|1
6865863|NCT00438399|10875493|FG003|Overall Study|Subje stopped study|0
6865864|NCT00438399|10875494|FG004|Overall Study|Subje stopped study|0
6865865|NCT00438399|10875495|FG005|Overall Study|Subje stopped study|0
6865866|NCT00438399|10875490|FG000|Overall Study|Pregnancy|0
6865867|NCT00438399|10875491|FG001|Overall Study|Pregnancy|0
6865868|NCT00438399|10875492|FG002|Overall Study|Pregnancy|0
6865869|NCT00438399|10875493|FG003|Overall Study|Pregnancy|0
6865870|NCT00438399|10875494|FG004|Overall Study|Pregnancy|0
6865871|NCT00438399|10875495|FG005|Overall Study|Pregnancy|1
6865872|NCT00438399|10875490|FG000|Overall Study|Patien stopped study at visit 4 by error|1
6865873|NCT00438399|10875491|FG001|Overall Study|Patien stopped study at visit 4 by error|0
6865874|NCT00438399|10875492|FG002|Overall Study|Patien stopped study at visit 4 by error|0
6865875|NCT00438399|10875493|FG003|Overall Study|Patien stopped study at visit 4 by error|0
6865876|NCT00438399|10875494|FG004|Overall Study|Patien stopped study at visit 4 by error|0
6865877|NCT00438399|10875495|FG005|Overall Study|Patien stopped study at visit 4 by error|0
6865878|NCT00438464|10875519|FG000|Overall Study|Terminated Early|14
6865879|NCT00438464|10875520|FG001|Overall Study|Terminated Early|5
7154245|NCT03307837|11320795|FG004|Overall Study|Withdrawal by Subject|0
6865880|NCT00438464|10875519|FG000|Overall Study|Incomplete data submission|0
6865881|NCT00438464|10875520|FG001|Overall Study|Incomplete data submission|2
6865882|NCT00438633|10875553|FG000|Overall Study|Withdrawal by Subject|1
6865883|NCT00438633|10875554|FG001|Overall Study|Withdrawal by Subject|0
6865884|NCT00438633|10875553|FG000|Overall Study|Lost to Follow-up|15
6865885|NCT00438633|10875554|FG001|Overall Study|Lost to Follow-up|17
6865886|NCT00438659|10875562|FG000|Overall Study|Discontinued Mometasone/Placebo|1
6865887|NCT00438659|10875563|FG001|Overall Study|Discontinued Mometasone/Placebo|2
6865888|NCT00438659|10875562|FG000|Overall Study|Cancel|5
6865889|NCT00438659|10875563|FG001|Overall Study|Cancel|2
6865890|NCT00438672|10875572|FG000|Overall Study|Lost to Follow-up|7
7041183|NCT01724528|11124695|FG001|Overall Study|Withdrawal by Subject|2
7154246|NCT03307837|11320796|FG005|Overall Study|Withdrawal by Subject|1
6865891|NCT00438672|10875573|FG001|Overall Study|Lost to Follow-up|9
6865892|NCT00438815|10875603|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30
6865893|NCT00438815|10875603|FG000|Overall Study|3-month follow-up no longer required|12
6865894|NCT00438815|10875603|FG000|Overall Study|Noncompliance with protocol requirements|9
6865895|NCT00438815|10875603|FG000|Overall Study|Transitioned to commercial C1INH-nf|6
6865896|NCT00438815|10875603|FG000|Overall Study|Lost to Follow-up|6
6865897|NCT00438815|10875603|FG000|Overall Study|Withdrawal by Subject|6
6865898|NCT00438815|10875603|FG000|Overall Study|Death|1
6865899|NCT00439140|10875645|FG000|Treatment Cycle 1|Lost to Follow-up|1
6865900|NCT00439140|10875646|FG001|Treatment Cycle 1|Lost to Follow-up|1
6865901|NCT00439140|10875647|FG002|Treatment Cycle 1|Lost to Follow-up|1
6865902|NCT00439140|10875645|FG000|Treatment Cycle 1|Personal reasons|0
6865903|NCT00439140|10875646|FG001|Treatment Cycle 1|Personal reasons|2
6865904|NCT00439140|10875647|FG002|Treatment Cycle 1|Personal reasons|0
6865905|NCT00439140|10875645|FG000|Treatment Cycle 1|Withdrawal by Subject|0
6865906|NCT00439140|10875646|FG001|Treatment Cycle 1|Withdrawal by Subject|1
6865907|NCT00439140|10875647|FG002|Treatment Cycle 1|Withdrawal by Subject|0
6865908|NCT00439140|10875645|FG000|Treatment Cycle 2|Withdrawal by Subject|1
6865909|NCT00439140|10875646|FG001|Treatment Cycle 2|Withdrawal by Subject|0
6865910|NCT00439140|10875647|FG002|Treatment Cycle 2|Withdrawal by Subject|0
6865911|NCT00439140|10875645|FG000|Treatment Cycle 2|Lost to Follow-up|1
6865912|NCT00439140|10875646|FG001|Treatment Cycle 2|Lost to Follow-up|1
6865913|NCT00439140|10875647|FG002|Treatment Cycle 2|Lost to Follow-up|0
6865914|NCT00439179|10875659|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0
6865915|NCT00439179|10875660|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2
6865916|NCT00439179|10875661|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0
6865917|NCT00439179|10875662|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0
6865918|NCT00439218|10875675|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1
6865919|NCT00439231|10875679|FG000|Overall Study|Lack of Efficacy|28
6865920|NCT00439244|10875686|FG000|Overall Study|Adverse Event|5
6865921|NCT00439244|10875687|FG001|Overall Study|Adverse Event|2
6865922|NCT00439244|10875688|FG002|Overall Study|Adverse Event|3
6865923|NCT00439244|10875686|FG000|Overall Study|Withdrawal by Subject|3
6865924|NCT00439244|10875687|FG001|Overall Study|Withdrawal by Subject|1
6865925|NCT00439244|10875688|FG002|Overall Study|Withdrawal by Subject|2
6865926|NCT00439244|10875686|FG000|Overall Study|Lost to Follow-up|2
6865927|NCT00439244|10875687|FG001|Overall Study|Lost to Follow-up|1
6865928|NCT00439244|10875688|FG002|Overall Study|Lost to Follow-up|2
6865929|NCT00439244|10875686|FG000|Overall Study|Death|0
6865930|NCT00439244|10875687|FG001|Overall Study|Death|1
6865931|NCT00439244|10875688|FG002|Overall Study|Death|0
6865932|NCT00439244|10875686|FG000|Overall Study|Protocol Violation|0
6865933|NCT00439244|10875687|FG001|Overall Study|Protocol Violation|1
6865934|NCT00439244|10875688|FG002|Overall Study|Protocol Violation|0
6865935|NCT00439244|10875686|FG000|Overall Study|Administrative problems|1
6865936|NCT00439244|10875687|FG001|Overall Study|Administrative problems|0
6865937|NCT00439244|10875688|FG002|Overall Study|Administrative problems|0
6865938|NCT00439270|10875701|FG000|Phase 1 (18.1 Months)|Disease progression|3
6865939|NCT00439270|10875702|FG001|Phase 1 (18.1 Months)|Disease progression|2
6865940|NCT00439270|10875703|FG002|Phase 1 (18.1 Months)|Disease progression|3
6865941|NCT00439270|10875704|FG003|Phase 1 (18.1 Months)|Disease progression|0
6865942|NCT00439270|10875705|FG004|Phase 1 (18.1 Months)|Disease progression|3
6865943|NCT00439270|10875701|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0
6865944|NCT00439270|10875702|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1
6865945|NCT00439270|10875703|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0
6865946|NCT00439270|10875704|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0
6865947|NCT00439270|10875705|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0
6865948|NCT00439270|10875701|FG000|Phase 2 (51.6 Months)|Disease progression|0
6865949|NCT00439270|10875702|FG001|Phase 2 (51.6 Months)|Disease progression|0
6865950|NCT00439270|10875703|FG002|Phase 2 (51.6 Months)|Disease progression|0
6865951|NCT00439270|10875704|FG003|Phase 2 (51.6 Months)|Disease progression|18
6865952|NCT00439270|10875705|FG004|Phase 2 (51.6 Months)|Disease progression|0
6865953|NCT00439270|10875701|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
6865954|NCT00439270|10875702|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
6865955|NCT00439270|10875703|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
6865956|NCT00439270|10875704|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1
6865957|NCT00439270|10875705|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
6865958|NCT00439270|10875701|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0
6865959|NCT00439270|10875702|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0
6865960|NCT00439270|10875703|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0
7078213|NCT02100696|11186439|FG004|Induction Phase|Multiple Reasons|0
6865961|NCT00439270|10875704|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6
6865962|NCT00439270|10875705|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0
6865963|NCT00439270|10875701|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0
6865964|NCT00439270|10875702|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0
7154247|NCT03307837|11320791|FG000|Overall Study|Lost to Follow-up|1
6865965|NCT00439270|10875703|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0
6865966|NCT00439270|10875704|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3
6865967|NCT00439270|10875705|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0
6865968|NCT00439270|10875701|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0
6865969|NCT00439270|10875702|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0
6865970|NCT00439270|10875703|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0
6865971|NCT00439270|10875704|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1
6865972|NCT00439270|10875705|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0
6865973|NCT00439270|10875701|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0
6865974|NCT00439270|10875702|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0
7154248|NCT03307837|11320792|FG001|Overall Study|Lost to Follow-up|1
6865975|NCT00439270|10875703|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0
6865976|NCT00439270|10875704|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2
6865977|NCT00439270|10875705|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0
6865978|NCT00439270|10875701|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
6865979|NCT00439270|10875702|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
6865980|NCT00439270|10875703|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
6865981|NCT00439270|10875704|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2
6865982|NCT00439270|10875705|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
6865983|NCT00439270|10875701|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
6865984|NCT00439270|10875702|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
6865985|NCT00439270|10875703|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
6865986|NCT00439270|10875704|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1
6865987|NCT00439270|10875705|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
6865988|NCT00439309|10875735|FG000|Follow-Up|Death|1
6865989|NCT00439309|10875736|FG001|Follow-Up|Death|0
6865990|NCT00439309|10875735|FG000|Follow-Up|Lost to Follow-up|2
6865991|NCT00439309|10875736|FG001|Follow-Up|Lost to Follow-up|0
6865992|NCT00439309|10875735|FG000|Follow-Up|Withdrawal by Subject|0
6865993|NCT00439309|10875736|FG001|Follow-Up|Withdrawal by Subject|1
6865994|NCT00439309|10875735|FG000|Follow-Up|Late response by subject|0
6865995|NCT00439309|10875736|FG001|Follow-Up|Late response by subject|1
6865996|NCT00439517|10875780|FG000|Overall Study|Subject on treatment|1
6865997|NCT00439517|10875781|FG001|Overall Study|Subject on treatment|0
6865998|NCT00439517|10875780|FG000|Overall Study|Subject in survival follow-up|1
6865999|NCT00439517|10875781|FG001|Overall Study|Subject in survival follow-up|0
6866000|NCT00439556|10875790|FG000|Overall Study|Patient was taken off study for non-comp|0
6866001|NCT00439556|10875791|FG001|Overall Study|Patient was taken off study for non-comp|1
6866002|NCT00439556|10875792|FG002|Overall Study|Patient was taken off study for non-comp|0
6866003|NCT00439647|10875807|FG000|Overall Study|Withdrawal by Subject|25
6866004|NCT00439647|10875808|FG001|Overall Study|Withdrawal by Subject|22
6866005|NCT00439647|10875807|FG000|Overall Study|Death|15
6866006|NCT00439647|10875808|FG001|Overall Study|Death|18
6866007|NCT00439647|10875807|FG000|Overall Study|Adverse Event|11
6866008|NCT00439647|10875808|FG001|Overall Study|Adverse Event|11
6866009|NCT00439647|10875807|FG000|Overall Study|Lost to Follow-up|4
6866010|NCT00439647|10875808|FG001|Overall Study|Lost to Follow-up|12
6866011|NCT00439647|10875807|FG000|Overall Study|Protocol Violation|3
6866012|NCT00439647|10875808|FG001|Overall Study|Protocol Violation|4
6866013|NCT00439647|10875807|FG000|Overall Study|Lack of Efficacy|0
6866014|NCT00439647|10875808|FG001|Overall Study|Lack of Efficacy|4
6866015|NCT00439725|10875820|FG000|Treatment Period|Withdrawal by Subject|22
6866016|NCT00439725|10875821|FG001|Treatment Period|Withdrawal by Subject|19
6866017|NCT00439725|10875820|FG000|Treatment Period|Study terminated by sponsor|156
6866018|NCT00439725|10875821|FG001|Treatment Period|Study terminated by sponsor|148
6866019|NCT00439725|10875820|FG000|Treatment Period|Site closed by investigator|1
6866020|NCT00439725|10875821|FG001|Treatment Period|Site closed by investigator|2
6866021|NCT00439725|10875820|FG000|Treatment Period|Adverse Event|39
6866022|NCT00439725|10875821|FG001|Treatment Period|Adverse Event|18
6866023|NCT00439725|10875820|FG000|Treatment Period|Physician Decision|1
6866024|NCT00439725|10875821|FG001|Treatment Period|Physician Decision|1
6866025|NCT00439725|10875820|FG000|Treatment Period|Protocol Violation|2
6866026|NCT00439725|10875821|FG001|Treatment Period|Protocol Violation|1
6866027|NCT00439725|10875820|FG000|Treatment Period|Clinical endpoint reached|6
6866028|NCT00439725|10875821|FG001|Treatment Period|Clinical endpoint reached|50
6866029|NCT00439725|10875820|FG000|Treatment Period|Technical problems|1
6866030|NCT00439725|10875821|FG001|Treatment Period|Technical problems|0
6866031|NCT00439725|10875820|FG000|Treatment Period|Lost to Follow-up|1
6866032|NCT00439725|10875821|FG001|Treatment Period|Lost to Follow-up|1
6866033|NCT00439725|10875820|FG000|Treatment Period|Participant convenience|1
6866034|NCT00439725|10875821|FG001|Treatment Period|Participant convenience|0
6866035|NCT00439725|10875820|FG000|Treatment Period|Protocol driven decision point|1
6866036|NCT00439725|10875821|FG001|Treatment Period|Protocol driven decision point|1
6866037|NCT00439725|10875820|FG000|Treatment Period|Death|1
6866038|NCT00439725|10875821|FG001|Treatment Period|Death|1
6866039|NCT00439725|10875820|FG000|Treatment Period|Participant did not receive treatment|4
6866040|NCT00439725|10875821|FG001|Treatment Period|Participant did not receive treatment|4
6866041|NCT00439725|10875820|FG000|Observational Period|Withdrawal by Subject|2
6866042|NCT00439725|10875821|FG001|Observational Period|Withdrawal by Subject|2
6866043|NCT00439725|10875820|FG000|Observational Period|Lost to Follow-up|0
6866044|NCT00439725|10875821|FG001|Observational Period|Lost to Follow-up|1
6866045|NCT00439725|10875820|FG000|Observational Period|Death|0
6866046|NCT00439725|10875821|FG001|Observational Period|Death|2
6866047|NCT00439725|10875820|FG000|Observational Period|Study termination by sponsor|1
6866048|NCT00439725|10875821|FG001|Observational Period|Study termination by sponsor|1
6866049|NCT00439725|10875820|FG000|Observational Period|Clinical endpoint reached|3
6866050|NCT00439725|10875821|FG001|Observational Period|Clinical endpoint reached|1
6866051|NCT00439725|10875820|FG000|Observational Period|Technical problems|1
6866052|NCT00439725|10875821|FG001|Observational Period|Technical problems|0
6866053|NCT00439725|10875820|FG000|Observational Period|Participant convenience|1
6866054|NCT00439725|10875821|FG001|Observational Period|Participant convenience|0
6866055|NCT00439777|10875829|FG000|Treatment Period|Death|29
6866056|NCT00439777|10875830|FG001|Treatment Period|Death|21
6866057|NCT00439777|10875829|FG000|Treatment Period|Study terminated by sponsor|125
6866058|NCT00439777|10875830|FG001|Treatment Period|Study terminated by sponsor|132
6866059|NCT00439777|10875829|FG000|Treatment Period|Site closed by investigator|0
6866060|NCT00439777|10875830|FG001|Treatment Period|Site closed by investigator|1
6866061|NCT00439777|10875829|FG000|Treatment Period|Did not take study treatment|7
6866062|NCT00439777|10875830|FG001|Treatment Period|Did not take study treatment|8
6866063|NCT00439777|10875829|FG000|Treatment Period|Adverse Event|111
6866064|NCT00439777|10875830|FG001|Treatment Period|Adverse Event|92
6866065|NCT00439777|10875829|FG000|Treatment Period|Protocol Violation|23
6866066|NCT00439777|10875830|FG001|Treatment Period|Protocol Violation|30
6866067|NCT00439777|10875829|FG000|Treatment Period|Withdrawal by Subject|66
6866068|NCT00439777|10875830|FG001|Treatment Period|Withdrawal by Subject|118
6866069|NCT00439777|10875829|FG000|Treatment Period|Lack of Efficacy|1
6866070|NCT00439777|10875830|FG001|Treatment Period|Lack of Efficacy|4
6866071|NCT00439777|10875829|FG000|Treatment Period|Lost to Follow-up|8
6866072|NCT00439777|10875830|FG001|Treatment Period|Lost to Follow-up|10
6866073|NCT00439777|10875829|FG000|Treatment Period|Protocol driven decision point|1
6866074|NCT00439777|10875830|FG001|Treatment Period|Protocol driven decision point|3
6866075|NCT00439777|10875829|FG000|Treatment Period|Physician Decision|7
6866076|NCT00439777|10875830|FG001|Treatment Period|Physician Decision|18
6866077|NCT00439777|10875829|FG000|Treatment Period|Clinical endpoint reached|26
6866078|NCT00439777|10875830|FG001|Treatment Period|Clinical endpoint reached|13
6866079|NCT00439777|10875829|FG000|Treatment Period|Technical problems|3
6866080|NCT00439777|10875830|FG001|Treatment Period|Technical problems|1
6866081|NCT00439777|10875829|FG000|Treatment Period|Participant convenience|12
6866082|NCT00439777|10875830|FG001|Treatment Period|Participant convenience|8
6866083|NCT00439777|10875829|FG000|Observational Period|Protocol Violation|0
6866084|NCT00439777|10875830|FG001|Observational Period|Protocol Violation|2
6866085|NCT00439777|10875829|FG000|Observational Period|Withdrawal by Subject|9
6866086|NCT00439777|10875830|FG001|Observational Period|Withdrawal by Subject|5
6866087|NCT00439777|10875829|FG000|Observational Period|Lost to Follow-up|1
6866088|NCT00439777|10875830|FG001|Observational Period|Lost to Follow-up|11
6866089|NCT00439777|10875829|FG000|Observational Period|Death|27
6866090|NCT00439777|10875830|FG001|Observational Period|Death|20
7078214|NCT02100696|11186440|FG005|Induction Phase|Multiple Reasons|0
7078215|NCT02100696|11186435|FG000|Maintenance Phase|Adverse Event|0
7078216|NCT02100696|11186436|FG001|Maintenance Phase|Adverse Event|0
6866091|NCT00439777|10875829|FG000|Observational Period|Study terminated by sponsor|3
6866092|NCT00439777|10875830|FG001|Observational Period|Study terminated by sponsor|1
6866093|NCT00439777|10875829|FG000|Observational Period|Protocol driven decision point|0
6866094|NCT00439777|10875830|FG001|Observational Period|Protocol driven decision point|1
6866095|NCT00439777|10875829|FG000|Observational Period|Lack of Efficacy|1
6866096|NCT00439777|10875830|FG001|Observational Period|Lack of Efficacy|0
6866097|NCT00439777|10875829|FG000|Observational Period|Technical problems|0
6866098|NCT00439777|10875830|FG001|Observational Period|Technical problems|1
6866099|NCT00440011|10875842|FG000|Overall Study|Adverse Event|2
6866100|NCT00440011|10875843|FG001|Overall Study|Adverse Event|0
6866101|NCT00440011|10875842|FG000|Overall Study|Lost to Follow-up|0
6866102|NCT00440011|10875843|FG001|Overall Study|Lost to Follow-up|2
6866103|NCT00440011|10875842|FG000|Overall Study|Protocol Violation|1
6866104|NCT00440011|10875843|FG001|Overall Study|Protocol Violation|1
6866105|NCT00440011|10875842|FG000|Overall Study|Withdrawal by Subject|1
6866106|NCT00440011|10875843|FG001|Overall Study|Withdrawal by Subject|0
6866107|NCT00440037|10875849|FG000|Overall Study|Withdrawal by Subject|6
6866108|NCT00440037|10875849|FG000|Overall Study|Administrative decision|3
6866109|NCT00440115|10875865|FG000|Overall Study|Death|7
6866110|NCT00440115|10875866|FG001|Overall Study|Death|9
6866111|NCT00440115|10875867|FG002|Overall Study|Death|5
6866112|NCT00440115|10875865|FG000|Overall Study|Incarceration|0
6866113|NCT00440115|10875866|FG001|Overall Study|Incarceration|2
6866114|NCT00440115|10875867|FG002|Overall Study|Incarceration|1
6866115|NCT00440193|10875886|FG000|Treatment Period|Adverse Event|74
6866116|NCT00440193|10875887|FG001|Treatment Period|Adverse Event|67
6866117|NCT00440193|10875886|FG000|Treatment Period|Death|19
6866118|NCT00440193|10875887|FG001|Treatment Period|Death|22
6866119|NCT00440193|10875886|FG000|Treatment Period|Lack of Efficacy|0
6866120|NCT00440193|10875887|FG001|Treatment Period|Lack of Efficacy|1
6866121|NCT00440193|10875886|FG000|Treatment Period|Lost to Follow-up|12
6866122|NCT00440193|10875887|FG001|Treatment Period|Lost to Follow-up|18
6866123|NCT00440193|10875886|FG000|Treatment Period|Physician Decision|3
6866124|NCT00440193|10875887|FG001|Treatment Period|Physician Decision|6
6866125|NCT00440193|10875886|FG000|Treatment Period|Protocol Violation|16
6866126|NCT00440193|10875887|FG001|Treatment Period|Protocol Violation|19
6866127|NCT00440193|10875886|FG000|Treatment Period|Withdrawal by Subject|36
6866128|NCT00440193|10875887|FG001|Treatment Period|Withdrawal by Subject|77
6866129|NCT00440193|10875886|FG000|Treatment Period|Clinical endpoint reached|28
6866130|NCT00440193|10875887|FG001|Treatment Period|Clinical endpoint reached|25
7078217|NCT02100696|11186437|FG002|Maintenance Phase|Adverse Event|0
6866131|NCT00440193|10875886|FG000|Treatment Period|Study terminated by sponsor|102
6866132|NCT00440193|10875887|FG001|Treatment Period|Study terminated by sponsor|94
6866133|NCT00440193|10875886|FG000|Treatment Period|Protocol driven decision point|2
6866134|NCT00440193|10875887|FG001|Treatment Period|Protocol driven decision point|2
6866135|NCT00440193|10875886|FG000|Treatment Period|Switch to commercial drug|0
6866136|NCT00440193|10875887|FG001|Treatment Period|Switch to commercial drug|2
6866137|NCT00440193|10875886|FG000|Treatment Period|Technical problems|1
6866138|NCT00440193|10875887|FG001|Treatment Period|Technical problems|1
6866139|NCT00440193|10875886|FG000|Treatment Period|Participant convenience|5
6866140|NCT00440193|10875887|FG001|Treatment Period|Participant convenience|2
6866141|NCT00440193|10875886|FG000|Treatment Period|Participant did not receive treatment|7
6866142|NCT00440193|10875887|FG001|Treatment Period|Participant did not receive treatment|13
6866143|NCT00440193|10875886|FG000|Treatment Period|Site closed by investigator|0
6866144|NCT00440193|10875887|FG001|Treatment Period|Site closed by investigator|2
6866145|NCT00440193|10875886|FG000|Observational Period|Adverse Event|2
6866146|NCT00440193|10875887|FG001|Observational Period|Adverse Event|2
6866147|NCT00440193|10875886|FG000|Observational Period|Death|15
6866148|NCT00440193|10875887|FG001|Observational Period|Death|20
6866149|NCT00440193|10875886|FG000|Observational Period|Lost to Follow-up|12
6866150|NCT00440193|10875887|FG001|Observational Period|Lost to Follow-up|8
6866151|NCT00440193|10875886|FG000|Observational Period|Protocol Violation|1
6866152|NCT00440193|10875887|FG001|Observational Period|Protocol Violation|0
6866153|NCT00440193|10875886|FG000|Observational Period|Withdrawal by Subject|11
6866154|NCT00440193|10875887|FG001|Observational Period|Withdrawal by Subject|8
6866155|NCT00440193|10875886|FG000|Observational Period|Physician Decision|1
6866156|NCT00440193|10875887|FG001|Observational Period|Physician Decision|0
6866157|NCT00440193|10875886|FG000|Observational Period|Clinical endpoint reached|1
6866158|NCT00440193|10875887|FG001|Observational Period|Clinical endpoint reached|0
6866159|NCT00440193|10875886|FG000|Observational Period|Participant convenience|2
6866160|NCT00440193|10875887|FG001|Observational Period|Participant convenience|0
6866161|NCT00440232|10875895|FG000|Overall Study|Lost to Follow-up|1
6866162|NCT00440232|10875896|FG001|Overall Study|Lost to Follow-up|1
6866163|NCT00440232|10875895|FG000|Overall Study|Unable to treat within allowed time|0
6866164|NCT00440232|10875896|FG001|Overall Study|Unable to treat within allowed time|1
6866165|NCT00440232|10875895|FG000|Overall Study|Onset of headache within 4 hours of fast|2
6866166|NCT00440232|10875896|FG001|Overall Study|Onset of headache within 4 hours of fast|2
6866167|NCT00440297|10875904|FG000|Overall Study|Adverse Event|8
6866168|NCT00440297|10875905|FG001|Overall Study|Adverse Event|5
6866169|NCT00440297|10875904|FG000|Overall Study|Lost to Follow-up|1
6866170|NCT00440297|10875905|FG001|Overall Study|Lost to Follow-up|0
6866171|NCT00440297|10875904|FG000|Overall Study|Physician Decision|1
6866172|NCT00440297|10875905|FG001|Overall Study|Physician Decision|0
6866173|NCT00440297|10875904|FG000|Overall Study|Protocol Violation|11
6866174|NCT00440297|10875905|FG001|Overall Study|Protocol Violation|7
6866175|NCT00440297|10875904|FG000|Overall Study|Withdrawal by Subject|1
6866176|NCT00440297|10875905|FG001|Overall Study|Withdrawal by Subject|6
6866177|NCT00440297|10875904|FG000|Overall Study|Randomized by mistake|1
6866178|NCT00440297|10875905|FG001|Overall Study|Randomized by mistake|0
6866179|NCT00440310|10875913|FG000|Overall Study|Lost to Follow-up|4
6866180|NCT00440310|10875914|FG001|Overall Study|Lost to Follow-up|5
6866181|NCT00440310|10875913|FG000|Overall Study|Protocol Violation|0
6866182|NCT00440310|10875914|FG001|Overall Study|Protocol Violation|1
6866183|NCT00440310|10875913|FG000|Overall Study|Withdrawal by Subject|15
6866184|NCT00440310|10875914|FG001|Overall Study|Withdrawal by Subject|14
6866185|NCT00440310|10875913|FG000|Overall Study|No Reply at EOS|7
6866186|NCT00440310|10875914|FG001|Overall Study|No Reply at EOS|7
6866187|NCT00440310|10875913|FG000|Overall Study|Other|1
6866188|NCT00440310|10875914|FG001|Overall Study|Other|0
6866189|NCT00440310|10875913|FG000|Overall Study|Status Unknown|1
6866190|NCT00440310|10875914|FG001|Overall Study|Status Unknown|3
6866191|NCT00440401|10875922|FG000|Overall Study|Adverse Event|2
6866192|NCT00440401|10875923|FG001|Overall Study|Adverse Event|1
6866193|NCT00440401|10875922|FG000|Overall Study|Other|2
6866194|NCT00440401|10875923|FG001|Overall Study|Other|5
6866195|NCT00440466|10875932|FG000|Overall Study|Death|3
6866196|NCT00440466|10875933|FG001|Overall Study|Death|2
6866197|NCT00440466|10875934|FG002|Overall Study|Death|9
6866198|NCT00440466|10875932|FG000|Overall Study|Adverse Event|3
6866199|NCT00440466|10875933|FG001|Overall Study|Adverse Event|4
6866200|NCT00440466|10875934|FG002|Overall Study|Adverse Event|11
6866201|NCT00440466|10875932|FG000|Overall Study|Lost to Follow-up|1
6866202|NCT00440466|10875933|FG001|Overall Study|Lost to Follow-up|0
6866203|NCT00440466|10875934|FG002|Overall Study|Lost to Follow-up|2
6866204|NCT00440466|10875932|FG000|Overall Study|Physician Decision|2
6866205|NCT00440466|10875933|FG001|Overall Study|Physician Decision|0
6866206|NCT00440466|10875934|FG002|Overall Study|Physician Decision|1
6866207|NCT00440466|10875932|FG000|Overall Study|Protocol Violation|2
6866208|NCT00440466|10875933|FG001|Overall Study|Protocol Violation|0
6866209|NCT00440466|10875934|FG002|Overall Study|Protocol Violation|4
6866210|NCT00440466|10875932|FG000|Overall Study|Withdrawal by Subject|2
6866211|NCT00440466|10875933|FG001|Overall Study|Withdrawal by Subject|5
6866212|NCT00440466|10875934|FG002|Overall Study|Withdrawal by Subject|9
6866213|NCT00440466|10875932|FG000|Overall Study|Began Dialysis|0
6866214|NCT00440466|10875933|FG001|Overall Study|Began Dialysis|0
6866215|NCT00440466|10875934|FG002|Overall Study|Began Dialysis|1
6866216|NCT00440466|10875932|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0
6866217|NCT00440466|10875933|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4
6866218|NCT00440466|10875934|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4
6866219|NCT00440518|10875958|FG000|Randomized /Titration Period|Lack of Efficacy|1
6866220|NCT00440518|10875959|FG001|Randomized /Titration Period|Lack of Efficacy|0
6866221|NCT00440518|10875960|FG002|Randomized /Titration Period|Lack of Efficacy|1
6866222|NCT00440518|10875958|FG000|Randomized /Titration Period|Subject Withdrew Consent|4
6866223|NCT00440518|10875959|FG001|Randomized /Titration Period|Subject Withdrew Consent|1
6866224|NCT00440518|10875960|FG002|Randomized /Titration Period|Subject Withdrew Consent|0
6866225|NCT00440518|10875958|FG000|Randomized /Titration Period|Protocol Deviation|1
6866226|NCT00440518|10875959|FG001|Randomized /Titration Period|Protocol Deviation|0
6866227|NCT00440518|10875960|FG002|Randomized /Titration Period|Protocol Deviation|0
6866228|NCT00440518|10875958|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2
6866229|NCT00440518|10875959|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3
6866230|NCT00440518|10875960|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2
6866231|NCT00440518|10875958|FG000|Randomized /Titration Period|Other|1
6866232|NCT00440518|10875959|FG001|Randomized /Titration Period|Other|0
6866233|NCT00440518|10875960|FG002|Randomized /Titration Period|Other|0
6866234|NCT00440518|10875958|FG000|Randomized /Titration Period|Lost to Follow-up|2
6866235|NCT00440518|10875959|FG001|Randomized /Titration Period|Lost to Follow-up|2
6866236|NCT00440518|10875960|FG002|Randomized /Titration Period|Lost to Follow-up|1
6866237|NCT00440518|10875958|FG000|Randomized /Titration Period|Adverse Event|2
6866238|NCT00440518|10875959|FG001|Randomized /Titration Period|Adverse Event|3
6866239|NCT00440518|10875960|FG002|Randomized /Titration Period|Adverse Event|0
6866240|NCT00440518|10875958|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3
6866241|NCT00440518|10875959|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4
6866242|NCT00440518|10875960|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2
6866243|NCT00440518|10875958|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0
6866244|NCT00440518|10875959|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
6866245|NCT00440518|10875960|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
6866246|NCT00440518|10875958|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3
6866247|NCT00440518|10875959|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2
6866248|NCT00440518|10875960|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4
6866249|NCT00440518|10875958|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0
6866250|NCT00440518|10875959|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3
6866251|NCT00440518|10875960|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6
6866252|NCT00440518|10875958|FG000|Maintenance and Safety Follow-up Periods|Other|0
6866253|NCT00440518|10875959|FG001|Maintenance and Safety Follow-up Periods|Other|0
6866254|NCT00440518|10875960|FG002|Maintenance and Safety Follow-up Periods|Other|2
6866255|NCT00440518|10875958|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1
6866256|NCT00440518|10875959|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2
6866257|NCT00440518|10875960|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0
6866258|NCT00440557|10875971|FG000|Overall Study|Withdrawal by Subject|10
6866259|NCT00440557|10875972|FG001|Overall Study|Withdrawal by Subject|5
6866260|NCT00440557|10875973|FG002|Overall Study|Withdrawal by Subject|11
6866261|NCT00440557|10875971|FG000|Overall Study|Lost to Follow-up|1
6866262|NCT00440557|10875972|FG001|Overall Study|Lost to Follow-up|2
6866263|NCT00440557|10875973|FG002|Overall Study|Lost to Follow-up|6
6866264|NCT00440557|10875971|FG000|Overall Study|Adverse Event|3
6866265|NCT00440557|10875972|FG001|Overall Study|Adverse Event|3
6866266|NCT00440557|10875973|FG002|Overall Study|Adverse Event|5
6866267|NCT00440557|10875971|FG000|Overall Study|Death|2
6866268|NCT00440557|10875972|FG001|Overall Study|Death|6
6866269|NCT00440557|10875973|FG002|Overall Study|Death|3
6866270|NCT00440557|10875971|FG000|Overall Study|Began Dialysis|4
6866271|NCT00440557|10875972|FG001|Overall Study|Began Dialysis|1
6866272|NCT00440557|10875973|FG002|Overall Study|Began Dialysis|4
6866273|NCT00440557|10875971|FG000|Overall Study|Principal Investigator decision|0
6866274|NCT00440557|10875972|FG001|Overall Study|Principal Investigator decision|3
6866275|NCT00440557|10875973|FG002|Overall Study|Principal Investigator decision|1
6866276|NCT00440557|10875971|FG000|Overall Study|Patient moved|1
6866277|NCT00440557|10875972|FG001|Overall Study|Patient moved|2
6866278|NCT00440557|10875973|FG002|Overall Study|Patient moved|1
6866279|NCT00440557|10875971|FG000|Overall Study|Principal Investigator's office closed|3
6866280|NCT00440557|10875972|FG001|Overall Study|Principal Investigator's office closed|6
6866281|NCT00440557|10875973|FG002|Overall Study|Principal Investigator's office closed|4
6866282|NCT00440557|10875971|FG000|Overall Study|Patient transferred to nursing home|0
6866283|NCT00440557|10875972|FG001|Overall Study|Patient transferred to nursing home|1
6866284|NCT00440557|10875973|FG002|Overall Study|Patient transferred to nursing home|0
6866285|NCT00440557|10875971|FG000|Overall Study|Patient had surgery|1
6866286|NCT00440557|10875972|FG001|Overall Study|Patient had surgery|0
6866287|NCT00440557|10875973|FG002|Overall Study|Patient had surgery|0
6866288|NCT00440700|10875995|FG000|Overall Study|Withdrawal by Subject|8
6866289|NCT00440700|10875996|FG001|Overall Study|Withdrawal by Subject|8
6866290|NCT00440700|10875997|FG002|Overall Study|Withdrawal by Subject|4
6866291|NCT00440726|10876008|FG000|Phase 1|Dose-Limiting Toxicity|0
6866292|NCT00440726|10876009|FG001|Phase 1|Dose-Limiting Toxicity|1
6866293|NCT00440726|10876010|FG002|Phase 1|Dose-Limiting Toxicity|0
6866294|NCT00440726|10876008|FG000|Phase 1|Physician Decision|1
6866295|NCT00440726|10876009|FG001|Phase 1|Physician Decision|0
6866296|NCT00440726|10876010|FG002|Phase 1|Physician Decision|0
6866297|NCT00440726|10876008|FG000|Phase 2|Death|0
6866298|NCT00440726|10876009|FG001|Phase 2|Death|0
6866299|NCT00440726|10876010|FG002|Phase 2|Death|1
6866300|NCT00440726|10876008|FG000|Phase 2|Adverse Event|0
6866301|NCT00440726|10876009|FG001|Phase 2|Adverse Event|0
6866302|NCT00440726|10876010|FG002|Phase 2|Adverse Event|1
6866303|NCT00440947|10876042|FG000|36-Week Induction Phase|Adverse Event|16
6866304|NCT00440947|10876043|FG001|36-Week Induction Phase|Adverse Event|0
6866305|NCT00440947|10876044|FG002|36-Week Induction Phase|Adverse Event|0
6866306|NCT00440947|10876045|FG003|36-Week Induction Phase|Adverse Event|0
6866307|NCT00440947|10876046|FG004|36-Week Induction Phase|Adverse Event|0
6866308|NCT00440947|10876042|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11
6866309|NCT00440947|10876043|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0
6866310|NCT00440947|10876044|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0
6866311|NCT00440947|10876045|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0
6866312|NCT00440947|10876046|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0
6866313|NCT00440947|10876042|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5
6866314|NCT00440947|10876043|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0
6866315|NCT00440947|10876044|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0
6866316|NCT00440947|10876045|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0
6866317|NCT00440947|10876046|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0
6866318|NCT00440947|10876042|FG000|36-Week Induction Phase|Non-compliance|10
6866319|NCT00440947|10876043|FG001|36-Week Induction Phase|Non-compliance|0
6866320|NCT00440947|10876044|FG002|36-Week Induction Phase|Non-compliance|0
6866321|NCT00440947|10876045|FG003|36-Week Induction Phase|Non-compliance|0
6866322|NCT00440947|10876046|FG004|36-Week Induction Phase|Non-compliance|0
6866323|NCT00440947|10876042|FG000|36-Week Induction Phase|Lost to Follow-up|16
6866324|NCT00440947|10876043|FG001|36-Week Induction Phase|Lost to Follow-up|0
6866325|NCT00440947|10876044|FG002|36-Week Induction Phase|Lost to Follow-up|0
6866326|NCT00440947|10876045|FG003|36-Week Induction Phase|Lost to Follow-up|0
6866327|NCT00440947|10876046|FG004|36-Week Induction Phase|Lost to Follow-up|0
6866328|NCT00440947|10876042|FG000|36-Week Induction Phase|Withdrawal by Subject|7
6866329|NCT00440947|10876043|FG001|36-Week Induction Phase|Withdrawal by Subject|0
6866330|NCT00440947|10876044|FG002|36-Week Induction Phase|Withdrawal by Subject|0
7078218|NCT02100696|11186438|FG003|Maintenance Phase|Adverse Event|0
7078219|NCT02100696|11186439|FG004|Maintenance Phase|Adverse Event|0
7078220|NCT02100696|11186440|FG005|Maintenance Phase|Adverse Event|2
7078221|NCT02100696|11186435|FG000|Maintenance Phase|Lost to Follow-up|0
7078222|NCT02100696|11186436|FG001|Maintenance Phase|Lost to Follow-up|0
7078223|NCT02100696|11186437|FG002|Maintenance Phase|Lost to Follow-up|0
7078224|NCT02100696|11186438|FG003|Maintenance Phase|Lost to Follow-up|0
7078225|NCT02100696|11186439|FG004|Maintenance Phase|Lost to Follow-up|1
7078226|NCT02100696|11186440|FG005|Maintenance Phase|Lost to Follow-up|0
7078227|NCT02100696|11186435|FG000|Maintenance Phase|Protocol Violation|0
7078228|NCT02100696|11186436|FG001|Maintenance Phase|Protocol Violation|0
6866331|NCT00440947|10876045|FG003|36-Week Induction Phase|Withdrawal by Subject|0
6866332|NCT00440947|10876046|FG004|36-Week Induction Phase|Withdrawal by Subject|0
6866333|NCT00440947|10876042|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1
6866334|NCT00440947|10876043|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
6866335|NCT00440947|10876044|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
6866336|NCT00440947|10876045|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
6866337|NCT00440947|10876046|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
6866338|NCT00440947|10876042|FG000|36-Week Induction Phase|Took Exclusionary Medications|1
6866339|NCT00440947|10876043|FG001|36-Week Induction Phase|Took Exclusionary Medications|0
6866340|NCT00440947|10876044|FG002|36-Week Induction Phase|Took Exclusionary Medications|0
6866341|NCT00440947|10876045|FG003|36-Week Induction Phase|Took Exclusionary Medications|0
6866342|NCT00440947|10876046|FG004|36-Week Induction Phase|Took Exclusionary Medications|0
6866343|NCT00440947|10876042|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1
6866344|NCT00440947|10876043|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
6866345|NCT00440947|10876044|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
6866346|NCT00440947|10876045|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
6866347|NCT00440947|10876046|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
6866348|NCT00440947|10876042|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1
6866349|NCT00440947|10876043|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
6866350|NCT00440947|10876044|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
6866351|NCT00440947|10876045|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
6866352|NCT00440947|10876046|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
6866353|NCT00440947|10876042|FG000|36-Week Induction Phase|Incarceration|3
7078229|NCT02100696|11186437|FG002|Maintenance Phase|Protocol Violation|0
6866354|NCT00440947|10876043|FG001|36-Week Induction Phase|Incarceration|0
6866355|NCT00440947|10876044|FG002|36-Week Induction Phase|Incarceration|0
6866356|NCT00440947|10876045|FG003|36-Week Induction Phase|Incarceration|0
6866357|NCT00440947|10876046|FG004|36-Week Induction Phase|Incarceration|0
6866358|NCT00440947|10876042|FG000|36-Week Induction Phase|Pregnancy|1
6866359|NCT00440947|10876043|FG001|36-Week Induction Phase|Pregnancy|0
6866360|NCT00440947|10876044|FG002|36-Week Induction Phase|Pregnancy|0
6866361|NCT00440947|10876045|FG003|36-Week Induction Phase|Pregnancy|0
6866362|NCT00440947|10876046|FG004|36-Week Induction Phase|Pregnancy|0
6866363|NCT00440947|10876042|FG000|48-Week Randomization Phase|Adverse Event|0
6866364|NCT00440947|10876043|FG001|48-Week Randomization Phase|Adverse Event|2
6866365|NCT00440947|10876044|FG002|48-Week Randomization Phase|Adverse Event|5
6866366|NCT00440947|10876045|FG003|48-Week Randomization Phase|Adverse Event|0
6866367|NCT00440947|10876046|FG004|48-Week Randomization Phase|Adverse Event|0
6866368|NCT00440947|10876042|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
6866369|NCT00440947|10876043|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
6866370|NCT00440947|10876044|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
6866371|NCT00440947|10876045|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
6866372|NCT00440947|10876046|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
6866373|NCT00440947|10876042|FG000|48-Week Randomization Phase|Non-compliance|0
6866374|NCT00440947|10876043|FG001|48-Week Randomization Phase|Non-compliance|3
6866375|NCT00440947|10876044|FG002|48-Week Randomization Phase|Non-compliance|4
6866376|NCT00440947|10876045|FG003|48-Week Randomization Phase|Non-compliance|0
6866377|NCT00440947|10876046|FG004|48-Week Randomization Phase|Non-compliance|0
6866378|NCT00440947|10876042|FG000|48-Week Randomization Phase|Lost to Follow-up|0
6866379|NCT00440947|10876043|FG001|48-Week Randomization Phase|Lost to Follow-up|2
6866380|NCT00440947|10876044|FG002|48-Week Randomization Phase|Lost to Follow-up|8
6866381|NCT00440947|10876045|FG003|48-Week Randomization Phase|Lost to Follow-up|0
6866382|NCT00440947|10876046|FG004|48-Week Randomization Phase|Lost to Follow-up|0
6866383|NCT00440947|10876042|FG000|48-Week Randomization Phase|Protocol Violation|0
6866384|NCT00440947|10876043|FG001|48-Week Randomization Phase|Protocol Violation|0
6866385|NCT00440947|10876044|FG002|48-Week Randomization Phase|Protocol Violation|1
6866386|NCT00440947|10876045|FG003|48-Week Randomization Phase|Protocol Violation|0
6866387|NCT00440947|10876046|FG004|48-Week Randomization Phase|Protocol Violation|0
6866388|NCT00440947|10876042|FG000|48-Week Randomization Phase|Withdrawal by Subject|0
6866389|NCT00440947|10876043|FG001|48-Week Randomization Phase|Withdrawal by Subject|2
6866390|NCT00440947|10876044|FG002|48-Week Randomization Phase|Withdrawal by Subject|4
6866391|NCT00440947|10876045|FG003|48-Week Randomization Phase|Withdrawal by Subject|0
6866392|NCT00440947|10876046|FG004|48-Week Randomization Phase|Withdrawal by Subject|0
6866393|NCT00440947|10876042|FG000|48-Week Randomization Phase|Pregnancy|0
6866394|NCT00440947|10876043|FG001|48-Week Randomization Phase|Pregnancy|0
6866395|NCT00440947|10876044|FG002|48-Week Randomization Phase|Pregnancy|1
6866396|NCT00440947|10876045|FG003|48-Week Randomization Phase|Pregnancy|0
6866397|NCT00440947|10876046|FG004|48-Week Randomization Phase|Pregnancy|0
6866398|NCT00440947|10876042|FG000|48-Week Randomization Phase|Incarceration|0
6866399|NCT00440947|10876043|FG001|48-Week Randomization Phase|Incarceration|3
6866400|NCT00440947|10876044|FG002|48-Week Randomization Phase|Incarceration|0
6866401|NCT00440947|10876045|FG003|48-Week Randomization Phase|Incarceration|0
6866402|NCT00440947|10876046|FG004|48-Week Randomization Phase|Incarceration|0
6866403|NCT00440947|10876042|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0
6866404|NCT00440947|10876043|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1
6866405|NCT00440947|10876044|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0
6866406|NCT00440947|10876045|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0
6866407|NCT00440947|10876046|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0
6866408|NCT00440947|10876042|FG000|48-Week Randomization Phase|Physician Decision|0
6866409|NCT00440947|10876043|FG001|48-Week Randomization Phase|Physician Decision|2
6866410|NCT00440947|10876044|FG002|48-Week Randomization Phase|Physician Decision|0
6866411|NCT00440947|10876045|FG003|48-Week Randomization Phase|Physician Decision|0
6866412|NCT00440947|10876046|FG004|48-Week Randomization Phase|Physician Decision|0
6866413|NCT00440947|10876042|FG000|Optional 60-Week Extension Phase|Adverse Event|0
6866414|NCT00440947|10876043|FG001|Optional 60-Week Extension Phase|Adverse Event|0
6866415|NCT00440947|10876044|FG002|Optional 60-Week Extension Phase|Adverse Event|0
6866416|NCT00440947|10876045|FG003|Optional 60-Week Extension Phase|Adverse Event|1
6866417|NCT00440947|10876046|FG004|Optional 60-Week Extension Phase|Adverse Event|3
6866418|NCT00440947|10876042|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
6866419|NCT00440947|10876043|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
6866420|NCT00440947|10876044|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
6866421|NCT00440947|10876045|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
6866422|NCT00440947|10876046|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
6866423|NCT00440947|10876042|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
6866424|NCT00440947|10876043|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
6866425|NCT00440947|10876044|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
6866426|NCT00440947|10876045|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3
6866427|NCT00440947|10876046|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2
6866428|NCT00440947|10876042|FG000|Optional 60-Week Extension Phase|Non-compliance|0
6866429|NCT00440947|10876043|FG001|Optional 60-Week Extension Phase|Non-compliance|0
6866430|NCT00440947|10876044|FG002|Optional 60-Week Extension Phase|Non-compliance|0
6866431|NCT00440947|10876045|FG003|Optional 60-Week Extension Phase|Non-compliance|1
6866432|NCT00440947|10876046|FG004|Optional 60-Week Extension Phase|Non-compliance|1
6866433|NCT00440947|10876042|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0
6866434|NCT00440947|10876043|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0
6866435|NCT00440947|10876044|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0
6866436|NCT00440947|10876045|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9
6866437|NCT00440947|10876046|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9
6866438|NCT00440947|10876042|FG000|Optional 60-Week Extension Phase|Protocol Violation|0
6866439|NCT00440947|10876043|FG001|Optional 60-Week Extension Phase|Protocol Violation|0
6866440|NCT00440947|10876044|FG002|Optional 60-Week Extension Phase|Protocol Violation|0
6866441|NCT00440947|10876045|FG003|Optional 60-Week Extension Phase|Protocol Violation|1
6866442|NCT00440947|10876046|FG004|Optional 60-Week Extension Phase|Protocol Violation|0
6866443|NCT00440947|10876042|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0
6866444|NCT00440947|10876043|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0
6866445|NCT00440947|10876044|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0
6866446|NCT00440947|10876045|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4
6866447|NCT00440947|10876046|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3
6866448|NCT00440947|10876042|FG000|Optional 60-Week Extension Phase|Pregnancy|0
6866449|NCT00440947|10876043|FG001|Optional 60-Week Extension Phase|Pregnancy|0
6866450|NCT00440947|10876044|FG002|Optional 60-Week Extension Phase|Pregnancy|0
6866451|NCT00440947|10876045|FG003|Optional 60-Week Extension Phase|Pregnancy|3
6866452|NCT00440947|10876046|FG004|Optional 60-Week Extension Phase|Pregnancy|0
6866453|NCT00440947|10876042|FG000|Optional 60-Week Extension Phase|Participant Moved|0
6866454|NCT00440947|10876043|FG001|Optional 60-Week Extension Phase|Participant Moved|0
6866455|NCT00440947|10876044|FG002|Optional 60-Week Extension Phase|Participant Moved|0
6866456|NCT00440947|10876045|FG003|Optional 60-Week Extension Phase|Participant Moved|1
6866457|NCT00440947|10876046|FG004|Optional 60-Week Extension Phase|Participant Moved|1
6866458|NCT00440947|10876042|FG000|Optional 60-Week Extension Phase|Sponsor Request|0
6866459|NCT00440947|10876043|FG001|Optional 60-Week Extension Phase|Sponsor Request|0
6866460|NCT00440947|10876044|FG002|Optional 60-Week Extension Phase|Sponsor Request|0
6866461|NCT00440947|10876045|FG003|Optional 60-Week Extension Phase|Sponsor Request|1
6866462|NCT00440947|10876046|FG004|Optional 60-Week Extension Phase|Sponsor Request|1
6866463|NCT00440947|10876042|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
6866464|NCT00440947|10876043|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
6866465|NCT00440947|10876044|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
6866466|NCT00440947|10876045|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
6866467|NCT00440947|10876046|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
6866468|NCT00440947|10876042|FG000|Optional 60-Week Extension Phase|Other|0
6866469|NCT00440947|10876043|FG001|Optional 60-Week Extension Phase|Other|0
6866470|NCT00440947|10876044|FG002|Optional 60-Week Extension Phase|Other|0
6866471|NCT00440947|10876045|FG003|Optional 60-Week Extension Phase|Other|1
6866472|NCT00440947|10876046|FG004|Optional 60-Week Extension Phase|Other|0
6866473|NCT00440947|10876042|FG000|Optional 60-Week Extension Phase|Physician Decision|0
6866474|NCT00440947|10876043|FG001|Optional 60-Week Extension Phase|Physician Decision|0
6866475|NCT00440947|10876044|FG002|Optional 60-Week Extension Phase|Physician Decision|0
6866476|NCT00440947|10876045|FG003|Optional 60-Week Extension Phase|Physician Decision|0
6866477|NCT00440947|10876046|FG004|Optional 60-Week Extension Phase|Physician Decision|1
6866478|NCT00440947|10876042|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
6866479|NCT00440947|10876043|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
6866480|NCT00440947|10876044|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
6866481|NCT00440947|10876045|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
6866482|NCT00440947|10876046|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1
6866483|NCT00440999|10876060|FG000|Overall Study|Adverse Event|0
6866484|NCT00440999|10876061|FG001|Overall Study|Adverse Event|2
6866485|NCT00440999|10876060|FG000|Overall Study|Lack of Efficacy|6
6866486|NCT00440999|10876061|FG001|Overall Study|Lack of Efficacy|7
6866487|NCT00440999|10876060|FG000|Overall Study|Lost to Follow-up|19
6866488|NCT00440999|10876061|FG001|Overall Study|Lost to Follow-up|12
6866489|NCT00440999|10876060|FG000|Overall Study|Protocol Violation|1
6866490|NCT00440999|10876061|FG001|Overall Study|Protocol Violation|0
6866491|NCT00440999|10876060|FG000|Overall Study|Withdrawal by Subject|2
6866492|NCT00440999|10876061|FG001|Overall Study|Withdrawal by Subject|5
6866493|NCT00440999|10876060|FG000|Overall Study|Subjets missed the visit|1
6866494|NCT00440999|10876061|FG001|Overall Study|Subjets missed the visit|0
6866495|NCT00440999|10876060|FG000|Overall Study|Mixed infection at entry|1
6866496|NCT00440999|10876061|FG001|Overall Study|Mixed infection at entry|0
6866497|NCT00440999|10876060|FG000|Overall Study|P. falciparum malaria|5
6866498|NCT00440999|10876061|FG001|Overall Study|P. falciparum malaria|14
6866499|NCT00440999|10876060|FG000|Overall Study|Subj left hosp without inform staff|0
6866500|NCT00440999|10876061|FG001|Overall Study|Subj left hosp without inform staff|1
6866501|NCT00441012|10876071|FG000|Overall Study|Adverse Event|0
6866502|NCT00441012|10876072|FG001|Overall Study|Adverse Event|1
6866503|NCT00441012|10876071|FG000|Overall Study|Lost to Follow-up|3
6866504|NCT00441012|10876072|FG001|Overall Study|Lost to Follow-up|3
6866505|NCT00441012|10876071|FG000|Overall Study|Protocol Violation|10
6866506|NCT00441012|10876072|FG001|Overall Study|Protocol Violation|9
6866507|NCT00441012|10876071|FG000|Overall Study|Withdrawal by Subject|4
6866508|NCT00441012|10876072|FG001|Overall Study|Withdrawal by Subject|0
6866509|NCT00441012|10876071|FG000|Overall Study|Subject Randomized but Not Vaccinated|1
6866510|NCT00441012|10876072|FG001|Overall Study|Subject Randomized but Not Vaccinated|0
6866511|NCT00441064|10876080|FG000|Overall Study|Adverse Event|1
6866512|NCT00441064|10876081|FG001|Overall Study|Adverse Event|0
6866513|NCT00441064|10876080|FG000|Overall Study|Abnormal laboratory values|0
6866514|NCT00441064|10876081|FG001|Overall Study|Abnormal laboratory values|2
6866515|NCT00441064|10876080|FG000|Overall Study|Abnormal test procedure results|0
6866516|NCT00441064|10876081|FG001|Overall Study|Abnormal test procedure results|1
6866517|NCT00441064|10876080|FG000|Overall Study|Unsatisfactory therapeutic effect|1
6866518|NCT00441064|10876081|FG001|Overall Study|Unsatisfactory therapeutic effect|0
6866519|NCT00441064|10876080|FG000|Overall Study|Protocol Deviation|3
6866520|NCT00441064|10876081|FG001|Overall Study|Protocol Deviation|2
6866521|NCT00441064|10876080|FG000|Overall Study|Patient withdrew consent|5
6866522|NCT00441064|10876081|FG001|Overall Study|Patient withdrew consent|2
6866523|NCT00441090|10876092|FG000|Overall Study|Adverse Event|0
6866524|NCT00441090|10876093|FG001|Overall Study|Adverse Event|1
6866525|NCT00441090|10876094|FG002|Overall Study|Adverse Event|1
6866526|NCT00441090|10876095|FG003|Overall Study|Adverse Event|0
6866527|NCT00441090|10876096|FG004|Overall Study|Adverse Event|0
6866528|NCT00441090|10876092|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0
6866529|NCT00441090|10876093|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0
6866530|NCT00441090|10876094|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0
6866531|NCT00441090|10876095|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2
6866532|NCT00441090|10876096|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0
6866533|NCT00441090|10876092|FG000|Overall Study|Withdrawal by Subject|1
6866534|NCT00441090|10876093|FG001|Overall Study|Withdrawal by Subject|0
6866535|NCT00441090|10876094|FG002|Overall Study|Withdrawal by Subject|1
6866536|NCT00441090|10876095|FG003|Overall Study|Withdrawal by Subject|0
6866537|NCT00441090|10876096|FG004|Overall Study|Withdrawal by Subject|0
6866538|NCT00441090|10876092|FG000|Overall Study|Lack of Efficacy|1
6866539|NCT00441090|10876093|FG001|Overall Study|Lack of Efficacy|0
6866540|NCT00441090|10876094|FG002|Overall Study|Lack of Efficacy|0
6866541|NCT00441090|10876095|FG003|Overall Study|Lack of Efficacy|0
6866542|NCT00441090|10876096|FG004|Overall Study|Lack of Efficacy|0
6866543|NCT00441103|10876110|FG000|Overall Study|Adverse Event|2
6866544|NCT00441103|10876111|FG001|Overall Study|Adverse Event|1
6866545|NCT00441103|10876110|FG000|Overall Study|Death|1
6866546|NCT00441103|10876111|FG001|Overall Study|Death|0
6866547|NCT00441103|10876110|FG000|Overall Study|Disease Progression|2
6866548|NCT00441103|10876111|FG001|Overall Study|Disease Progression|0
6866549|NCT00441103|10876110|FG000|Overall Study|Lost to Follow-up|1
6866550|NCT00441103|10876111|FG001|Overall Study|Lost to Follow-up|0
6866551|NCT00441103|10876110|FG000|Overall Study|Protocol Violation|1
6866552|NCT00441103|10876111|FG001|Overall Study|Protocol Violation|0
6866553|NCT00441103|10876110|FG000|Overall Study|Participant unable to use Rebiject II|1
6866554|NCT00441103|10876111|FG001|Overall Study|Participant unable to use Rebiject II|0
6866555|NCT00441103|10876110|FG000|Overall Study|Participant refused MRI|1
6866556|NCT00441103|10876111|FG001|Overall Study|Participant refused MRI|0
6866557|NCT00441103|10876110|FG000|Overall Study|Inclusion criteria absent|1
6866558|NCT00441103|10876111|FG001|Overall Study|Inclusion criteria absent|0
6866559|NCT00441103|10876110|FG000|Overall Study|Non-compliant|0
6866560|NCT00441103|10876111|FG001|Overall Study|Non-compliant|1
6866561|NCT00441103|10876110|FG000|Overall Study|Participant decided to withdraw|1
6866562|NCT00441103|10876111|FG001|Overall Study|Participant decided to withdraw|0
6866563|NCT00441103|10876110|FG000|Overall Study|Participant's reason|0
6866564|NCT00441103|10876111|FG001|Overall Study|Participant's reason|1
6866565|NCT00441103|10876110|FG000|Overall Study|Participant decided to stop|0
6866566|NCT00441103|10876111|FG001|Overall Study|Participant decided to stop|1
6866567|NCT00441116|10876120|FG000|Overall Study|Adverse Event|1
6866568|NCT00441116|10876121|FG001|Overall Study|Adverse Event|1
6866569|NCT00441116|10876120|FG000|Overall Study|Withdrawal by Subject|1
6866570|NCT00441116|10876121|FG001|Overall Study|Withdrawal by Subject|0
6866571|NCT00441116|10876120|FG000|Overall Study|Did not meet Eligibility Criteria|1
6866572|NCT00441116|10876121|FG001|Overall Study|Did not meet Eligibility Criteria|1
6866573|NCT00441129|10876129|FG000|Overall Study|Withdrawal by Subject|6
6866574|NCT00441129|10876130|FG001|Overall Study|Withdrawal by Subject|14
6866575|NCT00441142|10876140|FG000|Overall Study|Adverse Event|2
6866576|NCT00441142|10876141|FG001|Overall Study|Adverse Event|3
6866577|NCT00441142|10876142|FG002|Overall Study|Adverse Event|3
6866578|NCT00441142|10876143|FG003|Overall Study|Adverse Event|22
6866579|NCT00441142|10876140|FG000|Overall Study|Lack of Efficacy|3
6866580|NCT00441142|10876141|FG001|Overall Study|Lack of Efficacy|3
6866581|NCT00441142|10876142|FG002|Overall Study|Lack of Efficacy|17
6866582|NCT00441142|10876143|FG003|Overall Study|Lack of Efficacy|32
6866583|NCT00441142|10876140|FG000|Overall Study|Withdrawal by Subject|0
6866584|NCT00441142|10876141|FG001|Overall Study|Withdrawal by Subject|0
6866585|NCT00441142|10876142|FG002|Overall Study|Withdrawal by Subject|2
6866586|NCT00441142|10876143|FG003|Overall Study|Withdrawal by Subject|10
6866587|NCT00441142|10876140|FG000|Overall Study|Patient still receiving active study tx|1
6866588|NCT00441142|10876141|FG001|Overall Study|Patient still receiving active study tx|0
6866589|NCT00441142|10876142|FG002|Overall Study|Patient still receiving active study tx|0
6866590|NCT00441142|10876143|FG003|Overall Study|Patient still receiving active study tx|2
6866591|NCT00441142|10876140|FG000|Overall Study|Physician Decision|0
6866592|NCT00441142|10876141|FG001|Overall Study|Physician Decision|1
6866593|NCT00441142|10876142|FG002|Overall Study|Physician Decision|0
6866594|NCT00441142|10876143|FG003|Overall Study|Physician Decision|1
6866595|NCT00441142|10876140|FG000|Overall Study|Death|0
6866596|NCT00441142|10876141|FG001|Overall Study|Death|0
6866597|NCT00441142|10876142|FG002|Overall Study|Death|0
6866598|NCT00441142|10876143|FG003|Overall Study|Death|1
6866599|NCT00441168|10876157|FG000|Treatment Period|Death|3
6866600|NCT00441168|10876158|FG001|Treatment Period|Death|0
6866601|NCT00441168|10876157|FG000|Treatment Period|Adverse Event|1
6866602|NCT00441168|10876158|FG001|Treatment Period|Adverse Event|2
6866603|NCT00441168|10876157|FG000|Treatment Period|Progressive Disease|0
6866604|NCT00441168|10876158|FG001|Treatment Period|Progressive Disease|2
6866605|NCT00441168|10876157|FG000|Treatment Period|Protocol Violation|0
6866606|NCT00441168|10876158|FG001|Treatment Period|Protocol Violation|1
6866607|NCT00441168|10876157|FG000|Treatment Period|Lost to Follow-up|0
6866608|NCT00441168|10876158|FG001|Treatment Period|Lost to Follow-up|1
6866609|NCT00441168|10876157|FG000|Treatment Period|Withdrawal by Subject|3
6866610|NCT00441168|10876158|FG001|Treatment Period|Withdrawal by Subject|0
6866611|NCT00441168|10876157|FG000|Treatment Period|qualified for stem-cell transplantation|3
6866612|NCT00441168|10876158|FG001|Treatment Period|qualified for stem-cell transplantation|0
6866613|NCT00441168|10876157|FG000|Treatment Period|refractory disease|1
6866614|NCT00441168|10876158|FG001|Treatment Period|refractory disease|0
6866615|NCT00441168|10876157|FG000|Follow-up Period|Death|3
6866616|NCT00441168|10876158|FG001|Follow-up Period|Death|0
6866617|NCT00441168|10876157|FG000|Follow-up Period|Lost to Follow-up|5
6968105|NCT01135511|11016745|FG008|Overall Study|Withdrawal by Subject|1
6968106|NCT01135524|11016765|FG000|Overall Study|Withdrawal by Subject|14
6968107|NCT01135524|11016765|FG000|Overall Study|Adverse Event|20
6968108|NCT01135524|11016765|FG000|Overall Study|Lost to Follow-up|3
6968109|NCT01135524|11016765|FG000|Overall Study|Administrative|151
6968110|NCT01135524|11016765|FG000|Overall Study|Lack of Efficacy|8
6968111|NCT01135914|11016776|FG000|Overall Study|Withdrawal by Subject|1
6968112|NCT01135914|11016777|FG001|Overall Study|Withdrawal by Subject|3
6968113|NCT01135914|11016778|FG002|Overall Study|Withdrawal by Subject|6
6968114|NCT01135914|11016776|FG000|Overall Study|Lost to Follow-up|1
6968115|NCT01135914|11016777|FG001|Overall Study|Lost to Follow-up|0
6968116|NCT01135914|11016778|FG002|Overall Study|Lost to Follow-up|1
6968117|NCT01135914|11016776|FG000|Overall Study|Protocol Violation|0
6968118|NCT01135914|11016777|FG001|Overall Study|Protocol Violation|0
6968119|NCT01135914|11016778|FG002|Overall Study|Protocol Violation|3
6968120|NCT01135914|11016776|FG000|Overall Study|Lack of Efficacy|2
6968121|NCT01135914|11016777|FG001|Overall Study|Lack of Efficacy|1
6968122|NCT01135914|11016778|FG002|Overall Study|Lack of Efficacy|10
6968123|NCT01135914|11016776|FG000|Overall Study|Adverse Event|0
6968124|NCT01135914|11016777|FG001|Overall Study|Adverse Event|1
6968125|NCT01135914|11016778|FG002|Overall Study|Adverse Event|2
6968126|NCT01135992|11016786|FG000|Overall Study|Adverse Event|1
6968127|NCT01135992|11016786|FG000|Overall Study|Lack of Efficacy|1
6968128|NCT01135992|11016786|FG000|Overall Study|Protocol Violation|2
6968129|NCT01135992|11016786|FG000|Overall Study|Withdrawal criteria|10
6968130|NCT01135992|11016786|FG000|Overall Study|Unclassified|7
6968131|NCT01136174|11016794|FG000|Overall Study|Adverse Event|0
6866618|NCT00441168|10876158|FG001|Follow-up Period|Lost to Follow-up|6
6866619|NCT00441168|10876157|FG000|Follow-up Period|Withdrawal by Subject|3
6866620|NCT00441168|10876158|FG001|Follow-up Period|Withdrawal by Subject|0
6866621|NCT00441168|10876157|FG000|Follow-up Period|Other|1
6866622|NCT00441168|10876158|FG001|Follow-up Period|Other|3
6866623|NCT00441337|10876198|FG000|Overall Study|Disease Progression|6
6866624|NCT00441337|10876199|FG001|Overall Study|Disease Progression|6
6866625|NCT00441337|10876200|FG002|Overall Study|Disease Progression|4
6866626|NCT00441337|10876201|FG003|Overall Study|Disease Progression|18
6866627|NCT00441337|10876198|FG000|Overall Study|Lost to Follow-up|0
6866628|NCT00441337|10876199|FG001|Overall Study|Lost to Follow-up|0
6866629|NCT00441337|10876200|FG002|Overall Study|Lost to Follow-up|0
6866630|NCT00441337|10876201|FG003|Overall Study|Lost to Follow-up|1
6866631|NCT00441337|10876198|FG000|Overall Study|Sponsor Decision|0
6866632|NCT00441337|10876199|FG001|Overall Study|Sponsor Decision|0
6968132|NCT01136174|11016795|FG001|Overall Study|Adverse Event|0
6968133|NCT01136174|11016796|FG002|Overall Study|Adverse Event|0
6968134|NCT01136174|11016797|FG003|Overall Study|Adverse Event|4
6968135|NCT01136291|11016823|FG000|Overall Study|Lost to Follow-up|1
6968136|NCT01136291|11016824|FG001|Overall Study|Lost to Follow-up|1
6968137|NCT01136356|11016830|FG000|First 18-day Withdrawal|Withdrawal by Subject|3
6968138|NCT01136356|11016831|FG001|First 18-day Withdrawal|Withdrawal by Subject|0
6968139|NCT01136356|11016830|FG000|First 18-day Withdrawal|Physician Decision|1
6866633|NCT00441337|10876200|FG002|Overall Study|Sponsor Decision|1
6866634|NCT00441337|10876201|FG003|Overall Study|Sponsor Decision|2
6866635|NCT00441337|10876198|FG000|Overall Study|Did not meet inclusion criteria|0
6866636|NCT00441337|10876199|FG001|Overall Study|Did not meet inclusion criteria|0
6866637|NCT00441337|10876200|FG002|Overall Study|Did not meet inclusion criteria|1
6866638|NCT00441337|10876201|FG003|Overall Study|Did not meet inclusion criteria|0
6866639|NCT00441363|10876242|FG000|Overall Study|Adverse Event|4
6866640|NCT00441363|10876243|FG001|Overall Study|Adverse Event|2
6866641|NCT00441363|10876242|FG000|Overall Study|Withdrawal by Subject|3
6866642|NCT00441363|10876243|FG001|Overall Study|Withdrawal by Subject|4
6866643|NCT00441363|10876242|FG000|Overall Study|Physician Decision|6
6866644|NCT00441363|10876243|FG001|Overall Study|Physician Decision|7
6866645|NCT00441363|10876242|FG000|Overall Study|Lost to Follow-up|2
6866646|NCT00441363|10876243|FG001|Overall Study|Lost to Follow-up|2
6866647|NCT00441363|10876242|FG000|Overall Study|Other|2
6866648|NCT00441363|10876243|FG001|Overall Study|Other|0
6866649|NCT00441441|10876251|FG000|Overall Study|Adverse Event|2
6866650|NCT00441441|10876252|FG001|Overall Study|Adverse Event|1
6866651|NCT00441441|10876251|FG000|Overall Study|Protocol Violation|4
6866652|NCT00441441|10876252|FG001|Overall Study|Protocol Violation|6
6866653|NCT00441441|10876251|FG000|Overall Study|Exacerbation of asthma|1
6866654|NCT00441441|10876252|FG001|Overall Study|Exacerbation of asthma|2
6866655|NCT00441441|10876251|FG000|Overall Study|Withdrawal by Subject|1
6866656|NCT00441441|10876252|FG001|Overall Study|Withdrawal by Subject|2
6866657|NCT00441441|10876251|FG000|Overall Study|Other|3
6866658|NCT00441441|10876252|FG001|Overall Study|Other|3
6866659|NCT00441467|10876272|FG000|Overall Study|Adverse Event|6
6866660|NCT00441467|10876272|FG000|Overall Study|Withdrawal by Subject|3
6866661|NCT00441467|10876272|FG000|Overall Study|Progressive disease|9
6866662|NCT00441480|10876278|FG000|Overall Study|Protocol Violation|1
6866663|NCT00441480|10876279|FG001|Overall Study|Protocol Violation|1
6866664|NCT00441480|10876278|FG000|Overall Study|Withdrawal by Subject|2
6866665|NCT00441480|10876279|FG001|Overall Study|Withdrawal by Subject|3
6866666|NCT00441545|10876285|FG000|First Intervention|Adverse Event|6
6866667|NCT00441545|10876286|FG001|First Intervention|Adverse Event|5
6866668|NCT00441545|10876285|FG000|First Intervention|Protocol Violation|2
6866669|NCT00441545|10876286|FG001|First Intervention|Protocol Violation|2
6866670|NCT00441545|10876285|FG000|First Intervention|Withdrawal by Subject|3
6866671|NCT00441545|10876286|FG001|First Intervention|Withdrawal by Subject|3
6866672|NCT00441545|10876285|FG000|First Intervention|Kidney transplant|1
6866673|NCT00441545|10876286|FG001|First Intervention|Kidney transplant|1
6866674|NCT00441545|10876285|FG000|First Intervention|Lack of Efficacy|2
6866675|NCT00441545|10876286|FG001|First Intervention|Lack of Efficacy|0
6866676|NCT00441545|10876285|FG000|First Intervention|Subject exceeded safety criteria|0
6866677|NCT00441545|10876286|FG001|First Intervention|Subject exceeded safety criteria|1
6866678|NCT00441545|10876285|FG000|First Intervention|Subject met an exclusionary criteria|1
6866679|NCT00441545|10876286|FG001|First Intervention|Subject met an exclusionary criteria|0
6866680|NCT00441545|10876285|FG000|First Intervention|Extended hospitalization|1
6866681|NCT00441545|10876286|FG001|First Intervention|Extended hospitalization|0
6866682|NCT00441545|10876285|FG000|First Intervention|Site error|1
6866683|NCT00441545|10876286|FG001|First Intervention|Site error|0
6866684|NCT00441545|10876285|FG000|First Intervention|Sponsor's request|1
6866685|NCT00441545|10876286|FG001|First Intervention|Sponsor's request|0
6866686|NCT00441545|10876285|FG000|Second Intervention|Adverse Event|5
6866687|NCT00441545|10876286|FG001|Second Intervention|Adverse Event|2
6866688|NCT00441545|10876285|FG000|Second Intervention|Protocol Violation|4
6866689|NCT00441545|10876286|FG001|Second Intervention|Protocol Violation|1
6866690|NCT00441545|10876285|FG000|Second Intervention|Withdrawal by Subject|1
6866691|NCT00441545|10876286|FG001|Second Intervention|Withdrawal by Subject|1
6866692|NCT00441545|10876285|FG000|Second Intervention|Kidney Transplant|1
6866693|NCT00441545|10876286|FG001|Second Intervention|Kidney Transplant|1
6866694|NCT00441545|10876285|FG000|Second Intervention|Lack of Efficacy|0
6866695|NCT00441545|10876286|FG001|Second Intervention|Lack of Efficacy|1
6866696|NCT00441545|10876285|FG000|Second Intervention|Subject exceeded safety criteria|1
6866697|NCT00441545|10876286|FG001|Second Intervention|Subject exceeded safety criteria|0
6866698|NCT00441545|10876285|FG000|Second Intervention|Subject moved|0
6866699|NCT00441545|10876286|FG001|Second Intervention|Subject moved|1
6866700|NCT00441584|10876296|FG000|Overall Study|Lack of Efficacy|79
6866701|NCT00441584|10876296|FG000|Overall Study|Withdrawal by Subject|8
6866702|NCT00441584|10876296|FG000|Overall Study|Adverse Event|6
6866703|NCT00441584|10876296|FG000|Overall Study|Protocol Violation|5
6866704|NCT00441584|10876296|FG000|Overall Study|Lost to Follow-up|4
6866705|NCT00441584|10876296|FG000|Overall Study|Failure to meet eligibility criteria|3
6866706|NCT00441701|10876310|FG000|Overall Study|Adverse Event|3
6866707|NCT00441701|10876311|FG001|Overall Study|Adverse Event|2
6866708|NCT00441701|10876312|FG002|Overall Study|Adverse Event|1
6866709|NCT00441701|10876313|FG003|Overall Study|Adverse Event|0
6866710|NCT00441701|10876314|FG004|Overall Study|Adverse Event|2
6866711|NCT00441701|10876315|FG005|Overall Study|Adverse Event|2
6866712|NCT00441701|10876316|FG006|Overall Study|Adverse Event|0
6866713|NCT00441701|10876317|FG007|Overall Study|Adverse Event|0
6866714|NCT00441701|10876318|FG008|Overall Study|Adverse Event|0
6866715|NCT00441701|10876319|FG009|Overall Study|Adverse Event|0
6866716|NCT00441701|10876310|FG000|Overall Study|Lack of Efficacy|2
6866717|NCT00441701|10876311|FG001|Overall Study|Lack of Efficacy|0
6866718|NCT00441701|10876312|FG002|Overall Study|Lack of Efficacy|2
6866719|NCT00441701|10876313|FG003|Overall Study|Lack of Efficacy|2
6866720|NCT00441701|10876314|FG004|Overall Study|Lack of Efficacy|0
6866721|NCT00441701|10876315|FG005|Overall Study|Lack of Efficacy|1
6866722|NCT00441701|10876316|FG006|Overall Study|Lack of Efficacy|0
6866723|NCT00441701|10876317|FG007|Overall Study|Lack of Efficacy|0
6866724|NCT00441701|10876318|FG008|Overall Study|Lack of Efficacy|0
6866725|NCT00441701|10876319|FG009|Overall Study|Lack of Efficacy|0
6866726|NCT00441701|10876310|FG000|Overall Study|Withdrawal by Subject|0
6866727|NCT00441701|10876311|FG001|Overall Study|Withdrawal by Subject|2
6866728|NCT00441701|10876312|FG002|Overall Study|Withdrawal by Subject|1
6866729|NCT00441701|10876313|FG003|Overall Study|Withdrawal by Subject|1
6866730|NCT00441701|10876314|FG004|Overall Study|Withdrawal by Subject|0
6866731|NCT00441701|10876315|FG005|Overall Study|Withdrawal by Subject|0
6866732|NCT00441701|10876316|FG006|Overall Study|Withdrawal by Subject|0
6866733|NCT00441701|10876317|FG007|Overall Study|Withdrawal by Subject|0
6866734|NCT00441701|10876318|FG008|Overall Study|Withdrawal by Subject|0
6866735|NCT00441701|10876319|FG009|Overall Study|Withdrawal by Subject|0
6866736|NCT00441727|10876340|FG000|Overall Study|Protocol Violation|19
6866737|NCT00441727|10876341|FG001|Overall Study|Protocol Violation|28
6866738|NCT00441727|10876342|FG002|Overall Study|Protocol Violation|32
6866739|NCT00441727|10876340|FG000|Overall Study|Adverse Event|26
6866740|NCT00441727|10876341|FG001|Overall Study|Adverse Event|33
6866741|NCT00441727|10876342|FG002|Overall Study|Adverse Event|28
6866742|NCT00441727|10876340|FG000|Overall Study|Lack of Efficacy|7
6866743|NCT00441727|10876341|FG001|Overall Study|Lack of Efficacy|8
6866744|NCT00441727|10876342|FG002|Overall Study|Lack of Efficacy|48
6866745|NCT00441727|10876340|FG000|Overall Study|Withdrawal by Subject|40
6866746|NCT00441727|10876341|FG001|Overall Study|Withdrawal by Subject|34
6866747|NCT00441727|10876342|FG002|Overall Study|Withdrawal by Subject|47
6866748|NCT00441727|10876340|FG000|Overall Study|Lost to Follow-up|5
6866749|NCT00441727|10876341|FG001|Overall Study|Lost to Follow-up|6
6866750|NCT00441727|10876342|FG002|Overall Study|Lost to Follow-up|5
6866751|NCT00441727|10876340|FG000|Overall Study|Safety Reasons|3
6866752|NCT00441727|10876341|FG001|Overall Study|Safety Reasons|1
6866753|NCT00441727|10876342|FG002|Overall Study|Safety Reasons|3
6866754|NCT00441727|10876340|FG000|Overall Study|Various reason specified|6
6866755|NCT00441727|10876341|FG001|Overall Study|Various reason specified|8
6866756|NCT00441727|10876342|FG002|Overall Study|Various reason specified|5
6866757|NCT00441792|10876374|FG000|Overall Study|Lost to Follow-up|0
6866758|NCT00441792|10876375|FG001|Overall Study|Lost to Follow-up|2
6866759|NCT00441974|10876402|FG000|Overall Study|Adverse Event|6
6866760|NCT00441974|10876402|FG000|Overall Study|Consent Withdrawn|35
6866761|NCT00441974|10876402|FG000|Overall Study|Lost to Follow-up|80
6866762|NCT00441974|10876402|FG000|Overall Study|Protocol Violation|7
6866763|NCT00442286|10876447|FG000|Overall Study|Death|2
7078230|NCT02100696|11186438|FG003|Maintenance Phase|Protocol Violation|0
7078231|NCT02100696|11186439|FG004|Maintenance Phase|Protocol Violation|1
7078232|NCT02100696|11186440|FG005|Maintenance Phase|Protocol Violation|0
7078233|NCT02100696|11186435|FG000|Maintenance Phase|Withdrawal by Subject|0
7078234|NCT02100696|11186436|FG001|Maintenance Phase|Withdrawal by Subject|0
7078235|NCT02100696|11186437|FG002|Maintenance Phase|Withdrawal by Subject|0
6866764|NCT00442286|10876448|FG001|Overall Study|Death|2
6866765|NCT00442286|10876447|FG000|Overall Study|Lost to Follow-up|1
6866766|NCT00442286|10876448|FG001|Overall Study|Lost to Follow-up|0
6866767|NCT00442286|10876447|FG000|Overall Study|Withdrawal by Subject|2
6866768|NCT00442286|10876448|FG001|Overall Study|Withdrawal by Subject|0
6866769|NCT00442286|10876447|FG000|Overall Study|System explanted|1
6866770|NCT00442286|10876448|FG001|Overall Study|System explanted|0
6866771|NCT00442286|10876447|FG000|Overall Study|Patient Injury|1
6866772|NCT00442286|10876448|FG001|Overall Study|Patient Injury|0
6866773|NCT00442416|10876462|FG000|Overall Study|Adverse Event|4
6866774|NCT00442416|10876463|FG001|Overall Study|Adverse Event|1
6866775|NCT00442416|10876462|FG000|Overall Study|Death|1
6866776|NCT00442416|10876463|FG001|Overall Study|Death|0
6866777|NCT00442416|10876462|FG000|Overall Study|Lack of Efficacy|2
6866778|NCT00442416|10876463|FG001|Overall Study|Lack of Efficacy|0
6866779|NCT00442416|10876462|FG000|Overall Study|Protocol Violation|2
6866780|NCT00442416|10876463|FG001|Overall Study|Protocol Violation|3
6866781|NCT00442416|10876462|FG000|Overall Study|Withdrew consent|1
6866782|NCT00442416|10876463|FG001|Overall Study|Withdrew consent|2
6866783|NCT00442416|10876462|FG000|Overall Study|Administrative/Other|27
6866784|NCT00442416|10876463|FG001|Overall Study|Administrative/Other|33
6866785|NCT00442468|10876469|FG000|Overall Study|Adverse Event|4
6866786|NCT00442468|10876469|FG000|Overall Study|Withdrawal by Subject|91
6866787|NCT00442468|10876469|FG000|Overall Study|Did not complete all study procedures|88
6866788|NCT00442572|10876479|FG000|Overall Study|Relapse|8
6866789|NCT00442572|10876480|FG001|Overall Study|Relapse|1
6866790|NCT00442572|10876479|FG000|Overall Study|Lost to Follow-up|0
6866791|NCT00442572|10876480|FG001|Overall Study|Lost to Follow-up|1
6866792|NCT00442572|10876479|FG000|Overall Study|Withdrawal by Subject|0
6866793|NCT00442572|10876480|FG001|Overall Study|Withdrawal by Subject|1
6866794|NCT00442598|10876490|FG000|Overall Study|Adverse Event|1
7078236|NCT02100696|11186438|FG003|Maintenance Phase|Withdrawal by Subject|1
6866795|NCT00442598|10876491|FG001|Overall Study|Adverse Event|0
6866796|NCT00442598|10876492|FG002|Overall Study|Adverse Event|0
6866797|NCT00442598|10876490|FG000|Overall Study|Tumor progression|3
6866798|NCT00442598|10876491|FG001|Overall Study|Tumor progression|4
6866799|NCT00442598|10876492|FG002|Overall Study|Tumor progression|0
6866800|NCT00442598|10876490|FG000|Overall Study|Clinical deterioration|1
6866801|NCT00442598|10876491|FG001|Overall Study|Clinical deterioration|2
6866802|NCT00442598|10876492|FG002|Overall Study|Clinical deterioration|0
6866803|NCT00442598|10876490|FG000|Overall Study|CA125 progression|0
6866804|NCT00442598|10876491|FG001|Overall Study|CA125 progression|1
6866805|NCT00442598|10876492|FG002|Overall Study|CA125 progression|0
6866806|NCT00442598|10876490|FG000|Overall Study|Reduced creatinine clearance|1
6866807|NCT00442598|10876491|FG001|Overall Study|Reduced creatinine clearance|0
6866808|NCT00442598|10876492|FG002|Overall Study|Reduced creatinine clearance|0
6866809|NCT00442598|10876490|FG000|Overall Study|Death|0
6866810|NCT00442598|10876491|FG001|Overall Study|Death|1
6866811|NCT00442598|10876492|FG002|Overall Study|Death|0
6968140|NCT01136356|11016831|FG001|First 18-day Withdrawal|Physician Decision|0
6968141|NCT01136356|11016830|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0
6968142|NCT01136356|11016831|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1
6968143|NCT01136382|11016838|FG000|Overall Study|Other|8
6968144|NCT01136382|11016839|FG001|Overall Study|Other|3
6968145|NCT01136382|11016838|FG000|Overall Study|Study-Specific Withdrawal Criteria|48
6968146|NCT01136382|11016839|FG001|Overall Study|Study-Specific Withdrawal Criteria|25
6968147|NCT01136382|11016838|FG000|Overall Study|Severe Non-Compliance to Protocol|0
6968148|NCT01136382|11016839|FG001|Overall Study|Severe Non-Compliance to Protocol|2
6968149|NCT01136382|11016838|FG000|Overall Study|Withdrawal by Subject|4
6968150|NCT01136382|11016839|FG001|Overall Study|Withdrawal by Subject|1
6968151|NCT01136408|11016848|FG000|Overall Study|Adverse Event|4
6968152|NCT01136408|11016849|FG001|Overall Study|Adverse Event|8
6968153|NCT01136408|11016850|FG002|Overall Study|Adverse Event|4
6968154|NCT01136408|11016848|FG000|Overall Study|Protocol Violation|1
6968155|NCT01136408|11016849|FG001|Overall Study|Protocol Violation|1
6968156|NCT01136408|11016850|FG002|Overall Study|Protocol Violation|1
6968157|NCT01136655|11016866|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1
6968158|NCT01136655|11016866|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1
6968159|NCT01136655|11016866|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1
6968160|NCT01136655|11016866|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1
6968161|NCT01136733|11016886|FG000|Phase 1b|Adverse Event|0
6968162|NCT01136733|11016887|FG001|Phase 1b|Adverse Event|3
6968163|NCT01136733|11016888|FG002|Phase 1b|Adverse Event|1
6968164|NCT01136733|11016889|FG003|Phase 1b|Adverse Event|0
6968165|NCT01136733|11016890|FG004|Phase 1b|Adverse Event|0
6968166|NCT01136733|11016891|FG005|Phase 1b|Adverse Event|0
6968167|NCT01136733|11016892|FG006|Phase 1b|Adverse Event|0
6968168|NCT01136733|11016886|FG000|Phase 1b|Participant Choice|0
6968169|NCT01136733|11016887|FG001|Phase 1b|Participant Choice|0
6968170|NCT01136733|11016888|FG002|Phase 1b|Participant Choice|1
6968171|NCT01136733|11016889|FG003|Phase 1b|Participant Choice|0
6968172|NCT01136733|11016890|FG004|Phase 1b|Participant Choice|0
6968173|NCT01136733|11016891|FG005|Phase 1b|Participant Choice|0
6968174|NCT01136733|11016892|FG006|Phase 1b|Participant Choice|0
6968175|NCT01136733|11016886|FG000|Phase 1b|Administrative-Withdrew Consent|0
6968176|NCT01136733|11016887|FG001|Phase 1b|Administrative-Withdrew Consent|1
6968177|NCT01136733|11016888|FG002|Phase 1b|Administrative-Withdrew Consent|0
6968178|NCT01136733|11016889|FG003|Phase 1b|Administrative-Withdrew Consent|0
6968179|NCT01136733|11016890|FG004|Phase 1b|Administrative-Withdrew Consent|0
6968180|NCT01136733|11016891|FG005|Phase 1b|Administrative-Withdrew Consent|0
6968181|NCT01136733|11016892|FG006|Phase 1b|Administrative-Withdrew Consent|0
6968182|NCT01136733|11016886|FG000|Phase 1b|Clinical Progression|1
6968183|NCT01136733|11016887|FG001|Phase 1b|Clinical Progression|1
6968184|NCT01136733|11016888|FG002|Phase 1b|Clinical Progression|0
6968185|NCT01136733|11016889|FG003|Phase 1b|Clinical Progression|0
7078237|NCT02100696|11186439|FG004|Maintenance Phase|Withdrawal by Subject|4
7078238|NCT02100696|11186440|FG005|Maintenance Phase|Withdrawal by Subject|2
7078239|NCT02100696|11186435|FG000|Maintenance Phase|Physician Decision|0
7078240|NCT02100696|11186436|FG001|Maintenance Phase|Physician Decision|0
6968186|NCT01136733|11016890|FG004|Phase 1b|Clinical Progression|0
6968187|NCT01136733|11016891|FG005|Phase 1b|Clinical Progression|0
6968188|NCT01136733|11016892|FG006|Phase 1b|Clinical Progression|0
6968189|NCT01136733|11016886|FG000|Phase 2|Disease Progression|0
6968190|NCT01136733|11016887|FG001|Phase 2|Disease Progression|0
6968191|NCT01136733|11016888|FG002|Phase 2|Disease Progression|0
6968192|NCT01136733|11016889|FG003|Phase 2|Disease Progression|0
6968193|NCT01136733|11016890|FG004|Phase 2|Disease Progression|30
6968194|NCT01136733|11016891|FG005|Phase 2|Disease Progression|32
6968195|NCT01136733|11016892|FG006|Phase 2|Disease Progression|38
6968196|NCT01136733|11016886|FG000|Phase 2|Adverse Event|0
6968197|NCT01136733|11016887|FG001|Phase 2|Adverse Event|0
6968198|NCT01136733|11016888|FG002|Phase 2|Adverse Event|0
6968199|NCT01136733|11016889|FG003|Phase 2|Adverse Event|0
6968200|NCT01136733|11016890|FG004|Phase 2|Adverse Event|11
6968201|NCT01136733|11016891|FG005|Phase 2|Adverse Event|13
6968202|NCT01136733|11016892|FG006|Phase 2|Adverse Event|5
6968203|NCT01136733|11016886|FG000|Phase 2|Participant Choice|0
6866812|NCT00442702|10876523|FG000|Titration Period|Adverse Event|2
6866813|NCT00442702|10876524|FG001|Titration Period|Adverse Event|0
6866814|NCT00442702|10876523|FG000|Titration Period|Death|3
6866815|NCT00442702|10876524|FG001|Titration Period|Death|2
6866816|NCT00442702|10876523|FG000|Titration Period|Insufficient Therapeutic Response|1
6866817|NCT00442702|10876524|FG001|Titration Period|Insufficient Therapeutic Response|0
6866818|NCT00442702|10876523|FG000|Titration Period|Refused Treatment|4
6866819|NCT00442702|10876524|FG001|Titration Period|Refused Treatment|1
6866820|NCT00442702|10876523|FG000|Titration Period|Failure to return|1
6866821|NCT00442702|10876524|FG001|Titration Period|Failure to return|0
6866822|NCT00442702|10876523|FG000|Titration Period|Hospitalized in another hospital|1
6866823|NCT00442702|10876524|FG001|Titration Period|Hospitalized in another hospital|0
6866824|NCT00442702|10876523|FG000|Evaluation Period|Adverse Event|1
6866825|NCT00442702|10876524|FG001|Evaluation Period|Adverse Event|0
6866826|NCT00442702|10876523|FG000|Evaluation Period|Death|1
6866827|NCT00442702|10876524|FG001|Evaluation Period|Death|1
6866828|NCT00442702|10876523|FG000|Evaluation Period|Insufficient Therapeutic Response|1
6866829|NCT00442702|10876524|FG001|Evaluation Period|Insufficient Therapeutic Response|0
6866830|NCT00442702|10876523|FG000|Evaluation Period|Refused treatment|1
6866831|NCT00442702|10876524|FG001|Evaluation Period|Refused treatment|1
6866832|NCT00442702|10876523|FG000|Evaluation Period|Renal transplant|0
6866833|NCT00442702|10876524|FG001|Evaluation Period|Renal transplant|1
6866834|NCT00442702|10876523|FG000|Evaluation Period|Failure to return|1
6866835|NCT00442702|10876524|FG001|Evaluation Period|Failure to return|0
6866836|NCT00442702|10876523|FG000|Evaluation Period|Site closure|0
6866837|NCT00442702|10876524|FG001|Evaluation Period|Site closure|1
6866838|NCT00442936|10876540|FG000|Overall Study|Protocol Violation|1
6866839|NCT00442936|10876541|FG001|Overall Study|Protocol Violation|0
6866840|NCT00442936|10876542|FG002|Overall Study|Protocol Violation|1
6866841|NCT00442936|10876543|FG003|Overall Study|Protocol Violation|1
6866842|NCT00442962|10876553|FG000|Overall Study|Pregnancy|1
6866843|NCT00442962|10876553|FG000|Overall Study|Lost to Follow-up|7
6866844|NCT00443053|10876559|FG000|Overall Study|Adverse Event|2
6866845|NCT00443053|10876560|FG001|Overall Study|Adverse Event|1
6866846|NCT00443053|10876559|FG000|Overall Study|Withdrawal by Subject|9
6866847|NCT00443053|10876560|FG001|Overall Study|Withdrawal by Subject|18
6866848|NCT00443053|10876559|FG000|Overall Study|Lost to Follow-up|4
6866849|NCT00443053|10876560|FG001|Overall Study|Lost to Follow-up|5
6866850|NCT00443053|10876559|FG000|Overall Study|Did Not Meet Eligibility Criteria|1
6866851|NCT00443053|10876560|FG001|Overall Study|Did Not Meet Eligibility Criteria|0
6866852|NCT00443053|10876559|FG000|Overall Study|Noncompliance|2
6866853|NCT00443053|10876560|FG001|Overall Study|Noncompliance|1
6866854|NCT00443053|10876559|FG000|Overall Study|Other|3
6866855|NCT00443053|10876560|FG001|Overall Study|Other|4
6866856|NCT00443053|10876559|FG000|Overall Study|Physician Decision|0
6866857|NCT00443053|10876560|FG001|Overall Study|Physician Decision|4
6866858|NCT00443079|10876568|FG000|Overall Study|Lost to Follow-up|0
6866859|NCT00443079|10876569|FG001|Overall Study|Lost to Follow-up|1
6866860|NCT00443118|10876580|FG000|Overall Study|unknown primary outcome|3
6866861|NCT00443118|10876581|FG001|Overall Study|unknown primary outcome|1
6866862|NCT00443118|10876582|FG002|Overall Study|unknown primary outcome|0
6866863|NCT00443118|10876580|FG000|Overall Study|Withdrawal by Subject|1
6866864|NCT00443118|10876581|FG001|Overall Study|Withdrawal by Subject|0
6866865|NCT00443118|10876582|FG002|Overall Study|Withdrawal by Subject|0
6866866|NCT00443209|10876610|FG000|Months 1 to 12 Treatment Period|Adverse Event|22
6866867|NCT00443209|10876611|FG001|Months 1 to 12 Treatment Period|Adverse Event|11
6866868|NCT00443209|10876610|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14
6866869|NCT00443209|10876611|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7
7078241|NCT02100696|11186437|FG002|Maintenance Phase|Physician Decision|0
6866870|NCT00443209|10876610|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50
6866871|NCT00443209|10876611|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11
6866872|NCT00443209|10876610|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
6866873|NCT00443209|10876611|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
6866874|NCT00443209|10876610|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36
6866875|NCT00443209|10876611|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15
6866876|NCT00443209|10876610|FG000|Months 1 to 12 Treatment Period|Physician Decision|8
6866877|NCT00443209|10876611|FG001|Months 1 to 12 Treatment Period|Physician Decision|4
6866878|NCT00443209|10876610|FG000|Months 1 to 12 Treatment Period|Pregnancy|3
6866879|NCT00443209|10876611|FG001|Months 1 to 12 Treatment Period|Pregnancy|4
6866880|NCT00443209|10876610|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43
6866881|NCT00443209|10876611|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23
6866882|NCT00443209|10876610|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95
6866883|NCT00443209|10876611|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34
6866884|NCT00443209|10876610|FG000|Months 1 to 12 Treatment Period|Missing|2
6866885|NCT00443209|10876611|FG001|Months 1 to 12 Treatment Period|Missing|1
6866886|NCT00443209|10876610|FG000|Months 1 to 12 Treatment Period|Not Treated|71
6866887|NCT00443209|10876611|FG001|Months 1 to 12 Treatment Period|Not Treated|43
6866888|NCT00443209|10876610|FG000|Months 13 to 18 Treatment Period|Adverse Event|1
6866889|NCT00443209|10876611|FG001|Months 13 to 18 Treatment Period|Adverse Event|0
6866890|NCT00443209|10876610|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1
6866891|NCT00443209|10876611|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0
6866892|NCT00443209|10876610|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1
6866893|NCT00443209|10876611|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0
6866894|NCT00443209|10876610|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2
6866895|NCT00443209|10876611|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2
6866896|NCT00443209|10876610|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87
6866897|NCT00443209|10876611|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43
6866898|NCT00443209|10876610|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7
6866899|NCT00443209|10876611|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2
6866900|NCT00443261|10876617|FG000|Overall Study|Death|1
6866901|NCT00443430|10876627|FG000|Overall Study|Lack of Efficacy|3
6866902|NCT00443430|10876628|FG001|Overall Study|Lack of Efficacy|3
6866903|NCT00443430|10876627|FG000|Overall Study|Adverse Event|1
6866904|NCT00443430|10876628|FG001|Overall Study|Adverse Event|1
6866905|NCT00443456|10876634|FG000|Overall Study|Adverse Event|16
6866906|NCT00443456|10876634|FG000|Overall Study|Move|1
6866907|NCT00443456|10876634|FG000|Overall Study|Withdrawal by Subject|1
6866908|NCT00443534|10876642|FG000|Overall Study|Lack of Efficacy|67
6866909|NCT00443534|10876642|FG000|Overall Study|Adverse Event|16
6866910|NCT00443534|10876642|FG000|Overall Study|Death|9
6866911|NCT00443534|10876642|FG000|Overall Study|Withdrawal by Subject|8
6866912|NCT00443534|10876642|FG000|Overall Study|Study Terminated by Sponsor|12
6866913|NCT00443534|10876642|FG000|Overall Study|Other|10
6866914|NCT00443534|10876642|FG000|Overall Study|Enrolled, Not Treated|1
6866915|NCT00443560|10876665|FG000|Overall Study|No intrathecal dose|58
6866916|NCT00443560|10876666|FG001|Overall Study|No intrathecal dose|26
6866917|NCT00443560|10876665|FG000|Overall Study|Multiple pregnancies or fetal demise|2
6866918|NCT00443560|10876666|FG001|Overall Study|Multiple pregnancies or fetal demise|4
6866919|NCT00443599|10876674|FG000|Overall Study|Physician Decision|2
6866920|NCT00443599|10876675|FG001|Overall Study|Physician Decision|1
6866921|NCT00443599|10876674|FG000|Overall Study|Death|1
6866922|NCT00443599|10876675|FG001|Overall Study|Death|1
6866923|NCT00443599|10876674|FG000|Overall Study|Cardiopulmonary bypass canceled|3
6866924|NCT00443599|10876675|FG001|Overall Study|Cardiopulmonary bypass canceled|1
6866925|NCT00443651|10876683|FG000|Overall Study|Death|1
6866926|NCT00443651|10876684|FG001|Overall Study|Death|5
6866927|NCT00443651|10876683|FG000|Overall Study|Adverse Event|5
6866928|NCT00443651|10876684|FG001|Overall Study|Adverse Event|6
6866929|NCT00443651|10876683|FG000|Overall Study|Lost to Follow-up|18
6866930|NCT00443651|10876684|FG001|Overall Study|Lost to Follow-up|12
6866931|NCT00443651|10876683|FG000|Overall Study|Patient's/Guardian's Decision|58
6866932|NCT00443651|10876684|FG001|Overall Study|Patient's/Guardian's Decision|30
6866933|NCT00443651|10876683|FG000|Overall Study|Physician Decision|13
6866934|NCT00443651|10876684|FG001|Overall Study|Physician Decision|4
6866935|NCT00443651|10876683|FG000|Overall Study|Pregnancy|0
6866936|NCT00443651|10876684|FG001|Overall Study|Pregnancy|1
6866937|NCT00443703|10876692|FG000|Overall Study|Never Treated|3
6866938|NCT00443703|10876693|FG001|Overall Study|Never Treated|1
6866939|NCT00443703|10876692|FG000|Overall Study|Adverse Event|7
6866940|NCT00443703|10876693|FG001|Overall Study|Adverse Event|3
6866941|NCT00443703|10876692|FG000|Overall Study|Lack of Efficacy|3
6866942|NCT00443703|10876693|FG001|Overall Study|Lack of Efficacy|1
6866943|NCT00443703|10876692|FG000|Overall Study|Lost to Follow-up|0
6866944|NCT00443703|10876693|FG001|Overall Study|Lost to Follow-up|4
6866945|NCT00443703|10876692|FG000|Overall Study|Physician Decision|4
6866946|NCT00443703|10876693|FG001|Overall Study|Physician Decision|2
6866947|NCT00443703|10876692|FG000|Overall Study|Protocol Violation|1
6866948|NCT00443703|10876693|FG001|Overall Study|Protocol Violation|1
7154249|NCT03307837|11320793|FG002|Overall Study|Lost to Follow-up|0
7154250|NCT03307837|11320794|FG003|Overall Study|Lost to Follow-up|0
7154251|NCT03307837|11320795|FG004|Overall Study|Lost to Follow-up|0
7154252|NCT03307837|11320796|FG005|Overall Study|Lost to Follow-up|1
7154253|NCT03308942|11320872|FG000|Stage 1 (up to a Maximum of 29 Months)|Withdrawal by Subject|2
7154254|NCT03308942|11320873|FG001|Stage 1 (up to a Maximum of 29 Months)|Withdrawal by Subject|2
6866949|NCT00443703|10876692|FG000|Overall Study|Withdrawal by Subject|9
6866950|NCT00443703|10876693|FG001|Overall Study|Withdrawal by Subject|6
7154255|NCT03308942|11320874|FG002|Stage 1 (up to a Maximum of 29 Months)|Withdrawal by Subject|2
7154256|NCT03308942|11320875|FG003|Stage 1 (up to a Maximum of 29 Months)|Withdrawal by Subject|0
7154257|NCT03308942|11320876|FG004|Stage 1 (up to a Maximum of 29 Months)|Withdrawal by Subject|0
7154258|NCT03308942|11320872|FG000|Stage 1 (up to a Maximum of 29 Months)|Death|8
7154259|NCT03308942|11320873|FG001|Stage 1 (up to a Maximum of 29 Months)|Death|15
6866951|NCT00443703|10876692|FG000|Overall Study|Progressive Disease|1
6866952|NCT00443703|10876693|FG001|Overall Study|Progressive Disease|0
6866953|NCT00443729|10876701|FG000|Overall Study|Never Treated|0
7154260|NCT03308942|11320874|FG002|Stage 1 (up to a Maximum of 29 Months)|Death|1
6866954|NCT00443729|10876702|FG001|Overall Study|Never Treated|1
6866955|NCT00443729|10876701|FG000|Overall Study|Lack of Efficacy|4
6866956|NCT00443729|10876702|FG001|Overall Study|Lack of Efficacy|2
7154261|NCT03308942|11320875|FG003|Stage 1 (up to a Maximum of 29 Months)|Death|0
7154262|NCT03308942|11320876|FG004|Stage 1 (up to a Maximum of 29 Months)|Death|0
6866957|NCT00443729|10876701|FG000|Overall Study|Lost to Follow-up|0
6866958|NCT00443729|10876702|FG001|Overall Study|Lost to Follow-up|1
6866959|NCT00443729|10876701|FG000|Overall Study|Physician Decision|2
6866960|NCT00443729|10876702|FG001|Overall Study|Physician Decision|1
6866961|NCT00443729|10876701|FG000|Overall Study|Protocol Violation|1
6866962|NCT00443729|10876702|FG001|Overall Study|Protocol Violation|1
6866963|NCT00443729|10876701|FG000|Overall Study|Withdrawal by Subject|3
6866964|NCT00443729|10876702|FG001|Overall Study|Withdrawal by Subject|1
6866965|NCT00443755|10876710|FG000|Overall Study|Withdrawal by Subject|2
6866966|NCT00443755|10876711|FG001|Overall Study|Withdrawal by Subject|1
6866967|NCT00443781|10876717|FG000|Overall Study|Lost to Follow-up|10
6866968|NCT00443781|10876717|FG000|Overall Study|Physician Decision|2
6866969|NCT00443781|10876717|FG000|Overall Study|Protocol Violation|1
6866970|NCT00443781|10876717|FG000|Overall Study|Withdrawal by Subject|6
6866971|NCT00443781|10876717|FG000|Overall Study|Unable to comply with study follow up|2
6866972|NCT00443781|10876717|FG000|Overall Study|Investigator terminated participation|1
6866973|NCT00443781|10876717|FG000|Overall Study|Insurance not covered|2
6866974|NCT00443781|10876717|FG000|Overall Study|PD/FAD not done|1
6866975|NCT00443820|10876725|FG000|Overall Study|Adverse Event|1
6866976|NCT00443820|10876726|FG001|Overall Study|Adverse Event|1
6866977|NCT00443820|10876727|FG002|Overall Study|Adverse Event|0
6866978|NCT00443820|10876728|FG003|Overall Study|Adverse Event|0
6866979|NCT00443820|10876725|FG000|Overall Study|Lack of Efficacy|3
6866980|NCT00443820|10876726|FG001|Overall Study|Lack of Efficacy|2
6866981|NCT00443820|10876727|FG002|Overall Study|Lack of Efficacy|1
6866982|NCT00443820|10876728|FG003|Overall Study|Lack of Efficacy|1
6866983|NCT00443820|10876725|FG000|Overall Study|Protocol Violation|2
6866984|NCT00443820|10876726|FG001|Overall Study|Protocol Violation|1
6866985|NCT00443820|10876727|FG002|Overall Study|Protocol Violation|2
6866986|NCT00443820|10876728|FG003|Overall Study|Protocol Violation|1
6866987|NCT00443820|10876725|FG000|Overall Study|Withdrawal by Subject|6
7078242|NCT02100696|11186438|FG003|Maintenance Phase|Physician Decision|0
7078243|NCT02100696|11186439|FG004|Maintenance Phase|Physician Decision|1
6866988|NCT00443820|10876726|FG001|Overall Study|Withdrawal by Subject|7
6866989|NCT00443820|10876727|FG002|Overall Study|Withdrawal by Subject|8
6866990|NCT00443820|10876728|FG003|Overall Study|Withdrawal by Subject|9
6866991|NCT00443820|10876725|FG000|Overall Study|Lost to Follow-up|9
6866992|NCT00443820|10876726|FG001|Overall Study|Lost to Follow-up|8
6866993|NCT00443820|10876727|FG002|Overall Study|Lost to Follow-up|6
6866994|NCT00443820|10876728|FG003|Overall Study|Lost to Follow-up|5
6866995|NCT00443820|10876725|FG000|Overall Study|Administrative problems|0
6866996|NCT00443820|10876726|FG001|Overall Study|Administrative problems|0
6866997|NCT00443820|10876727|FG002|Overall Study|Administrative problems|0
6866998|NCT00443820|10876728|FG003|Overall Study|Administrative problems|1
6866999|NCT00443820|10876725|FG000|Overall Study|Death|0
6867000|NCT00443820|10876726|FG001|Overall Study|Death|0
6867001|NCT00443820|10876727|FG002|Overall Study|Death|1
6968204|NCT01136733|11016887|FG001|Phase 2|Participant Choice|0
6968205|NCT01136733|11016888|FG002|Phase 2|Participant Choice|0
6968206|NCT01136733|11016889|FG003|Phase 2|Participant Choice|0
6968207|NCT01136733|11016890|FG004|Phase 2|Participant Choice|3
6968208|NCT01136733|11016891|FG005|Phase 2|Participant Choice|0
6968209|NCT01136733|11016892|FG006|Phase 2|Participant Choice|1
6968210|NCT01136733|11016886|FG000|Phase 2|Administrative-Withdrew Consent|0
6968211|NCT01136733|11016887|FG001|Phase 2|Administrative-Withdrew Consent|0
6968212|NCT01136733|11016888|FG002|Phase 2|Administrative-Withdrew Consent|0
6968213|NCT01136733|11016889|FG003|Phase 2|Administrative-Withdrew Consent|0
6968214|NCT01136733|11016890|FG004|Phase 2|Administrative-Withdrew Consent|1
6968215|NCT01136733|11016891|FG005|Phase 2|Administrative-Withdrew Consent|0
6867002|NCT00443820|10876728|FG003|Overall Study|Death|0
6867003|NCT00443846|10876740|FG000|Overall Study|Withdrawn due to intercurrent disease|1
6867004|NCT00443846|10876741|FG001|Overall Study|Withdrawn due to intercurrent disease|0
6867005|NCT00443846|10876740|FG000|Overall Study|Not vaccinated, no blood sample drawn|1
6867006|NCT00443846|10876741|FG001|Overall Study|Not vaccinated, no blood sample drawn|0
6867007|NCT00443846|10876740|FG000|Overall Study|Adverse Event|0
6867008|NCT00443846|10876741|FG001|Overall Study|Adverse Event|1
6867009|NCT00443846|10876740|FG000|Overall Study|Personal reason|8
6867010|NCT00443846|10876741|FG001|Overall Study|Personal reason|3
6867011|NCT00443846|10876740|FG000|Overall Study|Lost to Follow-up|1
6867012|NCT00443846|10876741|FG001|Overall Study|Lost to Follow-up|2
6867013|NCT00443872|10876747|FG000|Overall Study|Protocol Violation|7
6867014|NCT00443872|10876747|FG000|Overall Study|Lost to Follow-up|2
6867015|NCT00443872|10876747|FG000|Overall Study|Adverse Event|8
6867016|NCT00443898|10876764|FG000|Overall Study|Adverse Event|0
6867017|NCT00443898|10876765|FG001|Overall Study|Adverse Event|0
6867018|NCT00443898|10876766|FG002|Overall Study|Adverse Event|1
6867019|NCT00443898|10876767|FG003|Overall Study|Adverse Event|1
6867020|NCT00443898|10876764|FG000|Overall Study|Lack of Efficacy|2
6867021|NCT00443898|10876765|FG001|Overall Study|Lack of Efficacy|3
6867022|NCT00443898|10876766|FG002|Overall Study|Lack of Efficacy|3
6867023|NCT00443898|10876767|FG003|Overall Study|Lack of Efficacy|1
6867024|NCT00443898|10876764|FG000|Overall Study|Protocol Violation|1
7078244|NCT02100696|11186440|FG005|Maintenance Phase|Physician Decision|0
6867025|NCT00443898|10876765|FG001|Overall Study|Protocol Violation|1
6867026|NCT00443898|10876766|FG002|Overall Study|Protocol Violation|1
6867027|NCT00443898|10876767|FG003|Overall Study|Protocol Violation|0
6968216|NCT01136733|11016892|FG006|Phase 2|Administrative-Withdrew Consent|0
6867028|NCT00443898|10876764|FG000|Overall Study|Withdrawal by Subject|11
6867029|NCT00443898|10876765|FG001|Overall Study|Withdrawal by Subject|10
6867030|NCT00443898|10876766|FG002|Overall Study|Withdrawal by Subject|10
6867031|NCT00443898|10876767|FG003|Overall Study|Withdrawal by Subject|6
6867032|NCT00443898|10876764|FG000|Overall Study|Lost to Follow-up|10
6867033|NCT00443898|10876765|FG001|Overall Study|Lost to Follow-up|10
6867034|NCT00443898|10876766|FG002|Overall Study|Lost to Follow-up|14
6867035|NCT00443898|10876767|FG003|Overall Study|Lost to Follow-up|10
6867036|NCT00443898|10876764|FG000|Overall Study|Death|0
6867037|NCT00443898|10876765|FG001|Overall Study|Death|1
6867038|NCT00443898|10876766|FG002|Overall Study|Death|0
6867039|NCT00443898|10876767|FG003|Overall Study|Death|0
6867040|NCT00444067|10876803|FG000|Overall Study|Lost to Follow-up|0
6867041|NCT00444067|10876804|FG001|Overall Study|Lost to Follow-up|1
6867042|NCT00444106|10876825|FG000|Overall Study|Lost to Follow-up|2
6867043|NCT00444106|10876826|FG001|Overall Study|Lost to Follow-up|1
6867044|NCT00444106|10876827|FG002|Overall Study|Lost to Follow-up|0
6867045|NCT00444106|10876825|FG000|Overall Study|Abnormal Test Procedure Results|0
6867046|NCT00444106|10876826|FG001|Overall Study|Abnormal Test Procedure Results|0
6867047|NCT00444106|10876827|FG002|Overall Study|Abnormal Test Procedure Results|1
6867048|NCT00444145|10876838|FG000|Overall Study|Withdrawal by Subject|2
6867049|NCT00444145|10876838|FG000|Overall Study|Lost to Follow-up|1
6867050|NCT00444145|10876838|FG000|Overall Study|non-compliant|11
6867051|NCT00444145|10876838|FG000|Overall Study|Screen Failures|5
6867052|NCT00444275|10876845|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0
6867053|NCT00444275|10876846|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0
6867054|NCT00444275|10876847|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22
6867055|NCT00444275|10876848|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17
6867056|NCT00444275|10876849|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29
6867057|NCT00444275|10876845|FG000|Maintenance Treatment Phase|Lost to Follow-up|0
6867058|NCT00444275|10876846|FG001|Maintenance Treatment Phase|Lost to Follow-up|0
6867059|NCT00444275|10876847|FG002|Maintenance Treatment Phase|Lost to Follow-up|8
6867060|NCT00444275|10876848|FG003|Maintenance Treatment Phase|Lost to Follow-up|14
6867061|NCT00444275|10876849|FG004|Maintenance Treatment Phase|Lost to Follow-up|10
6867062|NCT00444275|10876845|FG000|Maintenance Treatment Phase|Adverse Event|0
6867063|NCT00444275|10876846|FG001|Maintenance Treatment Phase|Adverse Event|0
6867064|NCT00444275|10876847|FG002|Maintenance Treatment Phase|Adverse Event|3
6867065|NCT00444275|10876848|FG003|Maintenance Treatment Phase|Adverse Event|2
7078245|NCT02100696|11186435|FG000|Maintenance Phase|Multiple Reasons|0
7078246|NCT02100696|11186436|FG001|Maintenance Phase|Multiple Reasons|0
6867066|NCT00444275|10876849|FG004|Maintenance Treatment Phase|Adverse Event|13
6867067|NCT00444275|10876845|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0
6867068|NCT00444275|10876846|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0
6867069|NCT00444275|10876847|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1
6867070|NCT00444275|10876848|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0
6867071|NCT00444275|10876849|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6
6867072|NCT00444275|10876845|FG000|Maintenance Treatment Phase|Patient's wish|0
6867073|NCT00444275|10876846|FG001|Maintenance Treatment Phase|Patient's wish|0
6867074|NCT00444275|10876847|FG002|Maintenance Treatment Phase|Patient's wish|19
6867075|NCT00444275|10876848|FG003|Maintenance Treatment Phase|Patient's wish|9
6867076|NCT00444275|10876849|FG004|Maintenance Treatment Phase|Patient's wish|20
6867077|NCT00444275|10876845|FG000|Maintenance Treatment Phase|Protocol Violation|0
6867078|NCT00444275|10876846|FG001|Maintenance Treatment Phase|Protocol Violation|0
6867079|NCT00444275|10876847|FG002|Maintenance Treatment Phase|Protocol Violation|103
6867080|NCT00444275|10876848|FG003|Maintenance Treatment Phase|Protocol Violation|88
6867081|NCT00444275|10876849|FG004|Maintenance Treatment Phase|Protocol Violation|87
6867082|NCT00444275|10876845|FG000|Maintenance Treatment Phase|Ineffectiveness|0
6867083|NCT00444275|10876846|FG001|Maintenance Treatment Phase|Ineffectiveness|0
6867084|NCT00444275|10876847|FG002|Maintenance Treatment Phase|Ineffectiveness|5
6867085|NCT00444275|10876848|FG003|Maintenance Treatment Phase|Ineffectiveness|3
6867086|NCT00444275|10876849|FG004|Maintenance Treatment Phase|Ineffectiveness|14
6867087|NCT00444457|10876868|FG000|Infant Series|Other|0
6867088|NCT00444457|10876869|FG001|Infant Series|Other|1
6867089|NCT00444457|10876870|FG002|Infant Series|Other|0
6867090|NCT00444457|10876871|FG003|Infant Series|Other|0
6867091|NCT00444457|10876868|FG000|Infant Series|Parent or legal guardian request|18
6867092|NCT00444457|10876869|FG001|Infant Series|Parent or legal guardian request|29
6867093|NCT00444457|10876870|FG002|Infant Series|Parent or legal guardian request|34
6867094|NCT00444457|10876871|FG003|Infant Series|Parent or legal guardian request|14
6867095|NCT00444457|10876868|FG000|Infant Series|Lost to Follow-up|10
6867096|NCT00444457|10876869|FG001|Infant Series|Lost to Follow-up|11
6867097|NCT00444457|10876870|FG002|Infant Series|Lost to Follow-up|7
6867098|NCT00444457|10876871|FG003|Infant Series|Lost to Follow-up|6
6867099|NCT00444457|10876868|FG000|Infant Series|Protocol Violation|16
6867100|NCT00444457|10876869|FG001|Infant Series|Protocol Violation|8
6867101|NCT00444457|10876870|FG002|Infant Series|Protocol Violation|6
6867102|NCT00444457|10876871|FG003|Infant Series|Protocol Violation|3
6867103|NCT00444457|10876868|FG000|Infant Series|Failed to return|5
7078247|NCT02100696|11186437|FG002|Maintenance Phase|Multiple Reasons|0
6867104|NCT00444457|10876869|FG001|Infant Series|Failed to return|4
6867105|NCT00444457|10876870|FG002|Infant Series|Failed to return|4
6867106|NCT00444457|10876871|FG003|Infant Series|Failed to return|2
6867107|NCT00444457|10876868|FG000|Infant Series|Investigator request|4
6867108|NCT00444457|10876869|FG001|Infant Series|Investigator request|3
6867109|NCT00444457|10876870|FG002|Infant Series|Investigator request|3
6867110|NCT00444457|10876871|FG003|Infant Series|Investigator request|2
6867111|NCT00444457|10876868|FG000|Infant Series|Other|0
6867112|NCT00444457|10876869|FG001|Infant Series|Other|2
6867113|NCT00444457|10876870|FG002|Infant Series|Other|4
6867114|NCT00444457|10876871|FG003|Infant Series|Other|0
7078248|NCT02100696|11186438|FG003|Maintenance Phase|Multiple Reasons|0
7078249|NCT02100696|11186439|FG004|Maintenance Phase|Multiple Reasons|2
7078250|NCT02100696|11186440|FG005|Maintenance Phase|Multiple Reasons|1
7078251|NCT02100813|11186518|FG000|Overall Study|Adverse Event|0
7078252|NCT02100813|11186519|FG001|Overall Study|Adverse Event|0
7078253|NCT02100813|11186520|FG002|Overall Study|Adverse Event|0
6867115|NCT00444457|10876868|FG000|Infant Series|Adverse Event|1
6867116|NCT00444457|10876869|FG001|Infant Series|Adverse Event|2
6867117|NCT00444457|10876870|FG002|Infant Series|Adverse Event|2
6867118|NCT00444457|10876871|FG003|Infant Series|Adverse Event|0
6867119|NCT00444457|10876868|FG000|Infant Series|Death|0
6867120|NCT00444457|10876869|FG001|Infant Series|Death|1
6867121|NCT00444457|10876870|FG002|Infant Series|Death|1
6867122|NCT00444457|10876871|FG003|Infant Series|Death|1
6867123|NCT00444457|10876868|FG000|After Infant Series|Other|0
6867124|NCT00444457|10876869|FG001|After Infant Series|Other|1
6867125|NCT00444457|10876870|FG002|After Infant Series|Other|1
6867126|NCT00444457|10876871|FG003|After Infant Series|Other|1
6867127|NCT00444457|10876868|FG000|After Infant Series|Parent or legal guardian request|4
6867128|NCT00444457|10876869|FG001|After Infant Series|Parent or legal guardian request|11
6867129|NCT00444457|10876870|FG002|After Infant Series|Parent or legal guardian request|6
6867130|NCT00444457|10876871|FG003|After Infant Series|Parent or legal guardian request|3
6867131|NCT00444457|10876868|FG000|After Infant Series|Failed to return|7
6867132|NCT00444457|10876869|FG001|After Infant Series|Failed to return|6
6867133|NCT00444457|10876870|FG002|After Infant Series|Failed to return|5
6867134|NCT00444457|10876871|FG003|After Infant Series|Failed to return|1
6867135|NCT00444457|10876868|FG000|After Infant Series|Lost to Follow-up|5
6867136|NCT00444457|10876869|FG001|After Infant Series|Lost to Follow-up|5
6867137|NCT00444457|10876870|FG002|After Infant Series|Lost to Follow-up|5
6867138|NCT00444457|10876871|FG003|After Infant Series|Lost to Follow-up|2
6867139|NCT00444457|10876868|FG000|After Infant Series|Protocol Violation|2
6867140|NCT00444457|10876869|FG001|After Infant Series|Protocol Violation|4
6867141|NCT00444457|10876870|FG002|After Infant Series|Protocol Violation|2
6867142|NCT00444457|10876871|FG003|After Infant Series|Protocol Violation|2
6867143|NCT00444457|10876868|FG000|After Infant Series|Adverse Event|2
6867144|NCT00444457|10876869|FG001|After Infant Series|Adverse Event|2
6867145|NCT00444457|10876870|FG002|After Infant Series|Adverse Event|0
6867146|NCT00444457|10876871|FG003|After Infant Series|Adverse Event|0
6867147|NCT00444457|10876868|FG000|After Infant Series|Investigator request|0
6867148|NCT00444457|10876869|FG001|After Infant Series|Investigator request|0
6867149|NCT00444457|10876870|FG002|After Infant Series|Investigator request|0
6867150|NCT00444457|10876871|FG003|After Infant Series|Investigator request|1
6867151|NCT00444457|10876868|FG000|After Infant Series|Other|0
6867152|NCT00444457|10876869|FG001|After Infant Series|Other|1
6867153|NCT00444457|10876870|FG002|After Infant Series|Other|0
6867154|NCT00444457|10876871|FG003|After Infant Series|Other|0
6867155|NCT00444457|10876868|FG000|Toddler Dose|Lost to Follow-up|4
6867156|NCT00444457|10876869|FG001|Toddler Dose|Lost to Follow-up|1
6867157|NCT00444457|10876870|FG002|Toddler Dose|Lost to Follow-up|1
6867158|NCT00444457|10876871|FG003|Toddler Dose|Lost to Follow-up|3
6867159|NCT00444457|10876868|FG000|Toddler Dose|Failed to return|2
6867160|NCT00444457|10876869|FG001|Toddler Dose|Failed to return|2
7078254|NCT02100813|11186521|FG003|Overall Study|Adverse Event|0
7078255|NCT02100813|11186522|FG004|Overall Study|Adverse Event|0
6867161|NCT00444457|10876870|FG002|Toddler Dose|Failed to return|1
6867162|NCT00444457|10876871|FG003|Toddler Dose|Failed to return|3
6867163|NCT00444457|10876868|FG000|Toddler Dose|Parent or legal guardian request|0
6867164|NCT00444457|10876869|FG001|Toddler Dose|Parent or legal guardian request|3
6867165|NCT00444457|10876870|FG002|Toddler Dose|Parent or legal guardian request|2
6867166|NCT00444457|10876871|FG003|Toddler Dose|Parent or legal guardian request|1
7078256|NCT02100813|11186523|FG005|Overall Study|Adverse Event|0
6867167|NCT00444457|10876868|FG000|Toddler Dose|Protocol Violation|1
6867168|NCT00444457|10876869|FG001|Toddler Dose|Protocol Violation|0
6867169|NCT00444457|10876870|FG002|Toddler Dose|Protocol Violation|0
6867170|NCT00444457|10876871|FG003|Toddler Dose|Protocol Violation|1
6867171|NCT00444535|10876892|FG000|Overall Study|Withdrawal by Subject|5
6867172|NCT00444535|10876892|FG000|Overall Study|Physician Decision|5
6867173|NCT00444535|10876892|FG000|Overall Study|progressive disease|1
6867174|NCT00444535|10876892|FG000|Overall Study|Adverse Event|2
6867175|NCT00444587|10876898|FG000|Overall Study|Death|2
7078257|NCT02100813|11186524|FG006|Overall Study|Adverse Event|0
6867176|NCT00444587|10876899|FG001|Overall Study|Death|1
6867177|NCT00444587|10876898|FG000|Overall Study|Progression of the disease|73
7078258|NCT02100813|11186525|FG007|Overall Study|Adverse Event|1
7078259|NCT02100839|11186552|FG000|Multiple Ascending Dose|Adverse Event|2
6867178|NCT00444587|10876899|FG001|Overall Study|Progression of the disease|8
6867179|NCT00444587|10876898|FG000|Overall Study|Refused treatment/did not cooperate|4
6867180|NCT00444587|10876899|FG001|Overall Study|Refused treatment/did not cooperate|1
6867181|NCT00444587|10876898|FG000|Overall Study|Investigator decision|3
6867182|NCT00444587|10876899|FG001|Overall Study|Investigator decision|0
6867183|NCT00444587|10876898|FG000|Overall Study|Protocol Violation|1
6867184|NCT00444587|10876899|FG001|Overall Study|Protocol Violation|0
6867185|NCT00444587|10876898|FG000|Overall Study|Missing|0
6867186|NCT00444587|10876899|FG001|Overall Study|Missing|5
6867187|NCT00444600|10876911|FG000|Overall Study|Death|7
6867188|NCT00444600|10876912|FG001|Overall Study|Death|5
6867189|NCT00444600|10876913|FG002|Overall Study|Death|3
6867190|NCT00444600|10876914|FG003|Overall Study|Death|2
6867191|NCT00444600|10876911|FG000|Overall Study|Dropped|11
6867192|NCT00444600|10876912|FG001|Overall Study|Dropped|11
6867193|NCT00444600|10876913|FG002|Overall Study|Dropped|7
6867194|NCT00444600|10876914|FG003|Overall Study|Dropped|7
6867195|NCT00444600|10876911|FG000|Overall Study|Missed visit|1
6867196|NCT00444600|10876912|FG001|Overall Study|Missed visit|0
6867197|NCT00444600|10876913|FG002|Overall Study|Missed visit|0
6867198|NCT00444600|10876914|FG003|Overall Study|Missed visit|1
6867199|NCT00444626|10876930|FG000|Initial Treatment Period|Withdrawal by Subject|2
6867200|NCT00444626|10876930|FG000|Initial Treatment Period|Adverse Event|1
6867201|NCT00444626|10876930|FG000|Initial Treatment Period|Lost to Follow-up|9
6867202|NCT00444678|10876943|FG000|Overall Study|Toxicity|11
6867203|NCT00444678|10876943|FG000|Overall Study|Disease Progression|12
6867204|NCT00444678|10876943|FG000|Overall Study|Death|3
6867205|NCT00444678|10876943|FG000|Overall Study|Physician Decision|3
6867206|NCT00444678|10876943|FG000|Overall Study|Withdrawal by Subject|2
6867207|NCT00444795|10876947|FG000|Overall Study|Not Treated|1
6867208|NCT00444795|10876947|FG000|Overall Study|Treated Prior to the Contract Date|2
6867209|NCT00444912|10876962|FG000|Overall Study|Death|1
6867210|NCT00444912|10876963|FG001|Overall Study|Death|2
6867211|NCT00444912|10876962|FG000|Overall Study|Lost to Follow-up|1
6867212|NCT00444912|10876963|FG001|Overall Study|Lost to Follow-up|0
6867213|NCT00444912|10876962|FG000|Overall Study|Participant Failed Mobilization|1
6867214|NCT00444912|10876963|FG001|Overall Study|Participant Failed Mobilization|0
6867215|NCT00444925|10876972|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3
6867216|NCT00444925|10876973|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6
6867217|NCT00444925|10876974|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6
6867218|NCT00444925|10876972|FG000|Double-blind Treatment Period|Death|2
6867219|NCT00444925|10876973|FG001|Double-blind Treatment Period|Death|0
6867220|NCT00444925|10876974|FG002|Double-blind Treatment Period|Death|0
6867221|NCT00444925|10876972|FG000|Double-blind Treatment Period|Adverse Event|6
6867222|NCT00444925|10876973|FG001|Double-blind Treatment Period|Adverse Event|28
6867223|NCT00444925|10876974|FG002|Double-blind Treatment Period|Adverse Event|44
6867224|NCT00444925|10876972|FG000|Double-blind Treatment Period|Lack of Efficacy|5
6867225|NCT00444925|10876973|FG001|Double-blind Treatment Period|Lack of Efficacy|5
6867226|NCT00444925|10876974|FG002|Double-blind Treatment Period|Lack of Efficacy|13
6867227|NCT00444925|10876972|FG000|Double-blind Treatment Period|Lost to Follow-up|4
6867228|NCT00444925|10876973|FG001|Double-blind Treatment Period|Lost to Follow-up|8
6867229|NCT00444925|10876974|FG002|Double-blind Treatment Period|Lost to Follow-up|5
6867230|NCT00444925|10876972|FG000|Double-blind Treatment Period|Withdrawal by Subject|6
6867231|NCT00444925|10876973|FG001|Double-blind Treatment Period|Withdrawal by Subject|8
6867232|NCT00444925|10876974|FG002|Double-blind Treatment Period|Withdrawal by Subject|7
6867233|NCT00444925|10876972|FG000|Double-blind Treatment Period|Other|7
6968217|NCT01136733|11016886|FG000|Phase 2|Other|0
6968218|NCT01136733|11016887|FG001|Phase 2|Other|0
6968219|NCT01136733|11016888|FG002|Phase 2|Other|0
6968220|NCT01136733|11016889|FG003|Phase 2|Other|0
6867234|NCT00444925|10876973|FG001|Double-blind Treatment Period|Other|7
6867235|NCT00444925|10876974|FG002|Double-blind Treatment Period|Other|12
6867236|NCT00444951|10876985|FG000|Overall Study|Lost to Follow-up|1
6867237|NCT00444951|10876986|FG001|Overall Study|Lost to Follow-up|1
6867238|NCT00444951|10876987|FG002|Overall Study|Lost to Follow-up|0
6867239|NCT00444951|10876985|FG000|Overall Study|Withdrawal by Subject|4
6867240|NCT00444951|10876986|FG001|Overall Study|Withdrawal by Subject|5
6867241|NCT00444951|10876987|FG002|Overall Study|Withdrawal by Subject|3
6867242|NCT00445003|10877002|FG000|Overall Study|Death|1
6867243|NCT00445003|10877003|FG001|Overall Study|Death|2
6867244|NCT00445003|10877004|FG002|Overall Study|Death|1
6867245|NCT00445003|10877002|FG000|Overall Study|Missed Visit|3
6867246|NCT00445003|10877003|FG001|Overall Study|Missed Visit|5
6867247|NCT00445003|10877004|FG002|Overall Study|Missed Visit|1
6867248|NCT00445003|10877002|FG000|Overall Study|Dropped|1
6867249|NCT00445003|10877003|FG001|Overall Study|Dropped|3
6867250|NCT00445003|10877004|FG002|Overall Study|Dropped|2
6867251|NCT00445068|10877012|FG000|Overall Study|Disease progression|26
6867252|NCT00445068|10877012|FG000|Overall Study|Adverse Event|5
6867253|NCT00445068|10877012|FG000|Overall Study|Abnormal laboratory value|2
6867254|NCT00445068|10877012|FG000|Overall Study|Withdrawal by Subject|2
6867255|NCT00445068|10877012|FG000|Overall Study|Death|1
6867256|NCT00445146|10877016|FG000|Overall Study|Withdrew Consent|29
6968221|NCT01136733|11016890|FG004|Phase 2|Other|6
6968222|NCT01136733|11016891|FG005|Phase 2|Other|7
6867257|NCT00445146|10877016|FG000|Overall Study|Lack of Efficacy|28
6867258|NCT00445146|10877016|FG000|Overall Study|Investigator's Discretion|22
6867259|NCT00445146|10877016|FG000|Overall Study|Adverse Event|13
6867260|NCT00445146|10877016|FG000|Overall Study|Lost to Follow-up|13
6867261|NCT00445146|10877016|FG000|Overall Study|Death|9
6867262|NCT00445146|10877016|FG000|Overall Study|Protocol Violation|4
6867263|NCT00445146|10877016|FG000|Overall Study|Pregnancy|1
6867264|NCT00445224|10877031|FG000|Specific Exercises|Withdrawal by Subject|3
6867265|NCT00445224|10877032|FG001|Specific Exercises|Withdrawal by Subject|3
6867266|NCT00445224|10877031|FG000|Specific Exercises|Withdrawal by Subject|1
6867267|NCT00445224|10877032|FG001|Specific Exercises|Withdrawal by Subject|0
6867268|NCT00445328|10877088|FG000|Overall Study|Death|0
6867269|NCT00445328|10877089|FG001|Overall Study|Death|1
6867270|NCT00445328|10877088|FG000|Overall Study|Adverse Event|0
6867271|NCT00445328|10877089|FG001|Overall Study|Adverse Event|3
6867272|NCT00445328|10877088|FG000|Overall Study|Other|0
6867273|NCT00445328|10877089|FG001|Overall Study|Other|2
6867274|NCT00445328|10877088|FG000|Overall Study|Withdrawal by Subject|2
6867275|NCT00445328|10877089|FG001|Overall Study|Withdrawal by Subject|0
6867276|NCT00445328|10877088|FG000|Overall Study|Protocol Violation|1
6867277|NCT00445328|10877089|FG001|Overall Study|Protocol Violation|0
6867278|NCT00445341|10877095|FG000|Overall Study|refused further treatment|1
6867279|NCT00445341|10877095|FG000|Overall Study|taken off treatment too early|1
6867280|NCT00445432|10877102|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1
6867281|NCT00445432|10877103|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2
6867282|NCT00445432|10877104|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7
6867283|NCT00445432|10877105|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0
6867284|NCT00445432|10877102|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
6867285|NCT00445432|10877103|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
6867286|NCT00445432|10877104|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2
6867287|NCT00445432|10877105|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
6867288|NCT00445432|10877102|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14
6867289|NCT00445432|10877103|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20
6867290|NCT00445432|10877104|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
6867291|NCT00445432|10877105|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
6867292|NCT00445432|10877102|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0
6867293|NCT00445432|10877103|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1
6867294|NCT00445432|10877104|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2
6867295|NCT00445432|10877105|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0
6867296|NCT00445432|10877102|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0
6867297|NCT00445432|10877103|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0
6867298|NCT00445432|10877104|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0
6867299|NCT00445432|10877105|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32
6867300|NCT00445432|10877102|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
6867301|NCT00445432|10877103|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
6867302|NCT00445432|10877104|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
6867303|NCT00445432|10877105|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3
6867304|NCT00445432|10877102|FG000|148 Weeks of Adalimumab Treatment|Other|0
6867305|NCT00445432|10877103|FG001|148 Weeks of Adalimumab Treatment|Other|0
6867306|NCT00445432|10877104|FG002|148 Weeks of Adalimumab Treatment|Other|0
6867307|NCT00445432|10877105|FG003|148 Weeks of Adalimumab Treatment|Other|9
6867308|NCT00445458|10877120|FG000|Overall Study|Disease Progression|3
6867309|NCT00445458|10877121|FG001|Overall Study|Disease Progression|4
6867310|NCT00445458|10877122|FG002|Overall Study|Disease Progression|54
6867311|NCT00445458|10877123|FG003|Overall Study|Disease Progression|27
6867312|NCT00445458|10877120|FG000|Overall Study|Withdrawal by Subject|0
6867313|NCT00445458|10877121|FG001|Overall Study|Withdrawal by Subject|0
6867314|NCT00445458|10877122|FG002|Overall Study|Withdrawal by Subject|7
6867315|NCT00445458|10877123|FG003|Overall Study|Withdrawal by Subject|0
6867316|NCT00445458|10877120|FG000|Overall Study|Adverse Event|0
6867317|NCT00445458|10877121|FG001|Overall Study|Adverse Event|0
6867318|NCT00445458|10877122|FG002|Overall Study|Adverse Event|3
6867319|NCT00445458|10877123|FG003|Overall Study|Adverse Event|0
6867320|NCT00445458|10877120|FG000|Overall Study|Death|0
6867321|NCT00445458|10877121|FG001|Overall Study|Death|1
6867322|NCT00445458|10877122|FG002|Overall Study|Death|2
6867323|NCT00445458|10877123|FG003|Overall Study|Death|0
6867324|NCT00445458|10877120|FG000|Overall Study|Physician Decision|0
6968223|NCT01136733|11016892|FG006|Phase 2|Other|6
6968224|NCT01136746|11016924|FG000|Overall Study|Lost to Follow-up|0
6867325|NCT00445458|10877121|FG001|Overall Study|Physician Decision|0
6867326|NCT00445458|10877122|FG002|Overall Study|Physician Decision|1
6867327|NCT00445458|10877123|FG003|Overall Study|Physician Decision|1
6867328|NCT00445458|10877120|FG000|Overall Study|Surgery|0
6867329|NCT00445458|10877121|FG001|Overall Study|Surgery|0
6867330|NCT00445458|10877122|FG002|Overall Study|Surgery|1
6867331|NCT00445458|10877123|FG003|Overall Study|Surgery|0
6867332|NCT00445549|10877145|FG000|Overall Study|progressive disease|12
6867333|NCT00445601|10877156|FG000|Overall Study|Withdrawal by Subject|11
6867334|NCT00445601|10877157|FG001|Overall Study|Withdrawal by Subject|11
6867335|NCT00445601|10877156|FG000|Overall Study|TURBT Complication|12
6867336|NCT00445601|10877157|FG001|Overall Study|TURBT Complication|8
6867337|NCT00445601|10877156|FG000|Overall Study|Incorrect Disease Status|6
6867338|NCT00445601|10877157|FG001|Overall Study|Incorrect Disease Status|6
6867339|NCT00445601|10877156|FG000|Overall Study|Drug Delivery Issue|2
6867340|NCT00445601|10877157|FG001|Overall Study|Drug Delivery Issue|2
6867341|NCT00445601|10877156|FG000|Overall Study|Adverse Event|2
6867342|NCT00445601|10877157|FG001|Overall Study|Adverse Event|0
6867343|NCT00445601|10877156|FG000|Overall Study|Death prior to TURBT|0
6867344|NCT00445601|10877157|FG001|Overall Study|Death prior to TURBT|1
6867345|NCT00445679|10877171|FG000|Overall Study|Adverse Event|22
6867346|NCT00445679|10877172|FG001|Overall Study|Adverse Event|12
6867347|NCT00445679|10877173|FG002|Overall Study|Adverse Event|30
6867348|NCT00445679|10877174|FG003|Overall Study|Adverse Event|19
6867349|NCT00445679|10877171|FG000|Overall Study|Failed to return|1
6867350|NCT00445679|10877172|FG001|Overall Study|Failed to return|3
6867351|NCT00445679|10877173|FG002|Overall Study|Failed to return|2
6867352|NCT00445679|10877174|FG003|Overall Study|Failed to return|2
6867353|NCT00445679|10877171|FG000|Overall Study|Physician Decision|0
6867354|NCT00445679|10877172|FG001|Overall Study|Physician Decision|0
6867355|NCT00445679|10877173|FG002|Overall Study|Physician Decision|1
6867356|NCT00445679|10877174|FG003|Overall Study|Physician Decision|0
6867357|NCT00445679|10877171|FG000|Overall Study|Lost to Follow-up|10
6867358|NCT00445679|10877172|FG001|Overall Study|Lost to Follow-up|6
6867359|NCT00445679|10877173|FG002|Overall Study|Lost to Follow-up|6
6867360|NCT00445679|10877174|FG003|Overall Study|Lost to Follow-up|5
6867361|NCT00445679|10877171|FG000|Overall Study|Compliance|3
6867362|NCT00445679|10877172|FG001|Overall Study|Compliance|2
6867363|NCT00445679|10877173|FG002|Overall Study|Compliance|1
6867364|NCT00445679|10877174|FG003|Overall Study|Compliance|2
6867365|NCT00445679|10877171|FG000|Overall Study|Withdrawal of Informed Consent|0
6867366|NCT00445679|10877172|FG001|Overall Study|Withdrawal of Informed Consent|0
6867367|NCT00445679|10877173|FG002|Overall Study|Withdrawal of Informed Consent|1
6867368|NCT00445679|10877174|FG003|Overall Study|Withdrawal of Informed Consent|0
6867369|NCT00445679|10877171|FG000|Overall Study|Protocol Violation|2
6867370|NCT00445679|10877172|FG001|Overall Study|Protocol Violation|3
6867371|NCT00445679|10877173|FG002|Overall Study|Protocol Violation|3
6867372|NCT00445679|10877174|FG003|Overall Study|Protocol Violation|1
6867373|NCT00445679|10877171|FG000|Overall Study|Withdrawal by Subject|8
6867374|NCT00445679|10877172|FG001|Overall Study|Withdrawal by Subject|14
6867375|NCT00445679|10877173|FG002|Overall Study|Withdrawal by Subject|20
6867376|NCT00445679|10877174|FG003|Overall Study|Withdrawal by Subject|18
6867377|NCT00445679|10877171|FG000|Overall Study|Lack of Efficacy|2
6867378|NCT00445679|10877172|FG001|Overall Study|Lack of Efficacy|6
6867379|NCT00445679|10877173|FG002|Overall Study|Lack of Efficacy|2
6867380|NCT00445679|10877174|FG003|Overall Study|Lack of Efficacy|0
6867381|NCT00445692|10877184|FG000|Overall Study|Adverse Event|11
6867382|NCT00445692|10877184|FG000|Overall Study|Lack of Efficacy|5
6867383|NCT00445770|10877214|FG000|Overall Study|Adverse Event|9
6968225|NCT01136746|11016925|FG001|Overall Study|Lost to Follow-up|2
6968226|NCT01136746|11016924|FG000|Overall Study|Protocol Violation|2
6968227|NCT01136746|11016925|FG001|Overall Study|Protocol Violation|1
6968228|NCT01136746|11016924|FG000|Overall Study|Death|1
6968229|NCT01136746|11016925|FG001|Overall Study|Death|0
6968230|NCT01136772|11016933|FG000|Overall Study|Adverse Event|15
6968231|NCT01136772|11016934|FG001|Overall Study|Adverse Event|14
6968232|NCT01136772|11016933|FG000|Overall Study|Lack of Efficacy|42
6968233|NCT01136772|11016934|FG001|Overall Study|Lack of Efficacy|39
6968234|NCT01136772|11016933|FG000|Overall Study|Administrative|14
6968235|NCT01136772|11016934|FG001|Overall Study|Administrative|12
6968236|NCT01136772|11016933|FG000|Overall Study|Withdrawal by Subject|33
6968237|NCT01136772|11016934|FG001|Overall Study|Withdrawal by Subject|36
6968238|NCT01136772|11016933|FG000|Overall Study|Did not receive injection|10
6968239|NCT01136772|11016934|FG001|Overall Study|Did not receive injection|7
6968240|NCT01136772|11016933|FG000|Overall Study|Did not follow up after first injection|2
6968241|NCT01136772|11016934|FG001|Overall Study|Did not follow up after first injection|2
6968242|NCT01136785|11016942|FG000|Overall Study|Protocol Violation|2
6968243|NCT01136785|11016943|FG001|Overall Study|Protocol Violation|1
6968244|NCT01136876|11016964|FG000|Overall Study|Lost to Follow-up|0
6968245|NCT01136876|11016965|FG001|Overall Study|Lost to Follow-up|1
6968246|NCT01136876|11016964|FG000|Overall Study|Physician Decision|3
6968247|NCT01136876|11016965|FG001|Overall Study|Physician Decision|5
6867384|NCT00445770|10877215|FG001|Overall Study|Adverse Event|15
6867385|NCT00445770|10877216|FG002|Overall Study|Adverse Event|19
6867386|NCT00445770|10877214|FG000|Overall Study|Lack of Efficacy|38
6867387|NCT00445770|10877215|FG001|Overall Study|Lack of Efficacy|13
6867388|NCT00445770|10877216|FG002|Overall Study|Lack of Efficacy|6
6867389|NCT00445770|10877214|FG000|Overall Study|Lost to Follow-up|0
6968248|NCT01136876|11016964|FG000|Overall Study|Missing NGAL measurement|2
6968249|NCT01136876|11016965|FG001|Overall Study|Missing NGAL measurement|5
6867390|NCT00445770|10877215|FG001|Overall Study|Lost to Follow-up|2
6867391|NCT00445770|10877216|FG002|Overall Study|Lost to Follow-up|0
6867392|NCT00445770|10877214|FG000|Overall Study|Other|6
6867393|NCT00445770|10877215|FG001|Overall Study|Other|5
6867394|NCT00445770|10877216|FG002|Overall Study|Other|6
6867395|NCT00445848|10877226|FG000|Overall Study|Adverse Event|14
6867396|NCT00445848|10877226|FG000|Overall Study|Withdrawal by Subject|4
6867397|NCT00445848|10877226|FG000|Overall Study|Progression|62
6867398|NCT00445848|10877226|FG000|Overall Study|Other-Not protocol specified|5
6867399|NCT00445939|10877252|FG000|Period A - Week 0 - Week 4|Adverse Event|1
6867400|NCT00445939|10877253|FG001|Period A - Week 0 - Week 4|Adverse Event|2
6867401|NCT00445939|10877254|FG002|Period A - Week 0 - Week 4|Adverse Event|0
6867402|NCT00445939|10877255|FG003|Period A - Week 0 - Week 4|Adverse Event|0
6867403|NCT00445939|10877252|FG000|Period B - Week 4 - Week 8|Adverse Event|2
6867404|NCT00445939|10877253|FG001|Period B - Week 4 - Week 8|Adverse Event|0
6867405|NCT00445939|10877254|FG002|Period B - Week 4 - Week 8|Adverse Event|0
6867406|NCT00445939|10877255|FG003|Period B - Week 4 - Week 8|Adverse Event|1
6867407|NCT00445978|10877275|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1
6867408|NCT00445978|10877275|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1
6867409|NCT00445978|10877275|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1
6867410|NCT00445978|10877275|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1
6867411|NCT00445978|10877275|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1
6867412|NCT00445978|10877275|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1
6867413|NCT00445978|10877275|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1
6867414|NCT00445978|10877275|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1
6867415|NCT00445978|10877275|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1
6867416|NCT00446030|10877288|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29
6867417|NCT00446030|10877289|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8
6867418|NCT00446030|10877288|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9
6867419|NCT00446030|10877289|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1
6867420|NCT00446030|10877288|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1
6867421|NCT00446030|10877289|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0
6867422|NCT00446030|10877288|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1
7154263|NCT03308942|11320872|FG000|Stage 1 (up to a Maximum of 29 Months)|Ongoing at the time of analysis|7
7154264|NCT03308942|11320873|FG001|Stage 1 (up to a Maximum of 29 Months)|Ongoing at the time of analysis|4
7154265|NCT03308942|11320874|FG002|Stage 1 (up to a Maximum of 29 Months)|Ongoing at the time of analysis|0
7154266|NCT03308942|11320875|FG003|Stage 1 (up to a Maximum of 29 Months)|Ongoing at the time of analysis|0
7184153|NCT01763788|11384151|FG002|Overall Study|Lost to Follow-up|1
6867423|NCT00446030|10877289|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0
6867424|NCT00446030|10877288|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1
6867425|NCT00446030|10877289|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0
6867426|NCT00446030|10877288|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1
6867427|NCT00446030|10877289|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0
6867428|NCT00446030|10877288|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1
6867429|NCT00446030|10877289|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0
6867430|NCT00446030|10877288|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1
6867431|NCT00446030|10877289|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0
6867432|NCT00446030|10877288|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9
6867433|NCT00446030|10877289|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4
6867434|NCT00446030|10877288|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5
6867435|NCT00446030|10877289|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0
6867436|NCT00446030|10877288|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4
6867437|NCT00446030|10877289|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0
6867438|NCT00446030|10877288|FG000|FOLLOW-UP (up to 2-years)|Death|2
6867439|NCT00446030|10877289|FG001|FOLLOW-UP (up to 2-years)|Death|2
6867440|NCT00446030|10877288|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3
6867441|NCT00446030|10877289|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2
6867442|NCT00446030|10877288|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2
6867443|NCT00446030|10877289|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0
6867444|NCT00446030|10877288|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2
6867445|NCT00446030|10877289|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0
6867446|NCT00446030|10877288|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1
6867447|NCT00446030|10877289|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0
6867448|NCT00446030|10877288|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1
6867449|NCT00446030|10877289|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0
6867450|NCT00446030|10877288|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1
6867451|NCT00446030|10877289|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0
6867452|NCT00446030|10877288|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0
6867453|NCT00446030|10877289|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1
6867454|NCT00446095|10877300|FG000|Phase II (8 Weeks)|Lost to Follow-up|1
6867455|NCT00446095|10877301|FG001|Phase II (8 Weeks)|Lost to Follow-up|0
6867456|NCT00446095|10877302|FG002|Phase II (8 Weeks)|Lost to Follow-up|0
6867457|NCT00446095|10877303|FG003|Phase II (8 Weeks)|Lost to Follow-up|0
6867458|NCT00446095|10877304|FG004|Phase II (8 Weeks)|Lost to Follow-up|0
6867459|NCT00446095|10877300|FG000|Phase II (8 Weeks)|Adverse Event|0
6867460|NCT00446095|10877301|FG001|Phase II (8 Weeks)|Adverse Event|1
6867461|NCT00446095|10877302|FG002|Phase II (8 Weeks)|Adverse Event|1
6867462|NCT00446095|10877303|FG003|Phase II (8 Weeks)|Adverse Event|0
6867463|NCT00446095|10877304|FG004|Phase II (8 Weeks)|Adverse Event|0
6867464|NCT00446095|10877300|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1
6867465|NCT00446095|10877301|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0
6867466|NCT00446095|10877302|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0
6867467|NCT00446095|10877303|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0
6867468|NCT00446095|10877304|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0
6867469|NCT00446095|10877300|FG000|Phase II (8 Weeks)|Physician Decision|1
6867470|NCT00446095|10877301|FG001|Phase II (8 Weeks)|Physician Decision|0
6867471|NCT00446095|10877302|FG002|Phase II (8 Weeks)|Physician Decision|0
6867472|NCT00446095|10877303|FG003|Phase II (8 Weeks)|Physician Decision|0
6867473|NCT00446095|10877304|FG004|Phase II (8 Weeks)|Physician Decision|0
6867474|NCT00446095|10877300|FG000|Phase II (8 Weeks)|Lack of Efficacy|9
6867475|NCT00446095|10877301|FG001|Phase II (8 Weeks)|Lack of Efficacy|2
6867476|NCT00446095|10877302|FG002|Phase II (8 Weeks)|Lack of Efficacy|1
6867477|NCT00446095|10877303|FG003|Phase II (8 Weeks)|Lack of Efficacy|0
6867478|NCT00446095|10877304|FG004|Phase II (8 Weeks)|Lack of Efficacy|0
6867479|NCT00446095|10877300|FG000|Phase II (8 Weeks)|Ongoing|0
6867480|NCT00446095|10877301|FG001|Phase II (8 Weeks)|Ongoing|0
6867481|NCT00446095|10877302|FG002|Phase II (8 Weeks)|Ongoing|1
6867482|NCT00446095|10877303|FG003|Phase II (8 Weeks)|Ongoing|0
6867483|NCT00446095|10877304|FG004|Phase II (8 Weeks)|Ongoing|0
6867484|NCT00446095|10877300|FG000|Phase I (28 Days)|Adverse Event|0
6867485|NCT00446095|10877301|FG001|Phase I (28 Days)|Adverse Event|0
6867486|NCT00446095|10877302|FG002|Phase I (28 Days)|Adverse Event|0
6867487|NCT00446095|10877303|FG003|Phase I (28 Days)|Adverse Event|1
6867488|NCT00446095|10877304|FG004|Phase I (28 Days)|Adverse Event|0
6867489|NCT00446095|10877300|FG000|Phase I (28 Days)|Lack of Efficacy|0
6867490|NCT00446095|10877301|FG001|Phase I (28 Days)|Lack of Efficacy|0
6867491|NCT00446095|10877302|FG002|Phase I (28 Days)|Lack of Efficacy|0
6867492|NCT00446095|10877303|FG003|Phase I (28 Days)|Lack of Efficacy|0
6867493|NCT00446095|10877304|FG004|Phase I (28 Days)|Lack of Efficacy|3
6867494|NCT00446134|10877319|FG000|Overall Study|Adverse Event|7
6867495|NCT00446134|10877320|FG001|Overall Study|Adverse Event|17
6867496|NCT00446134|10877321|FG002|Overall Study|Adverse Event|13
6867497|NCT00446134|10877322|FG003|Overall Study|Adverse Event|18
6867498|NCT00446134|10877319|FG000|Overall Study|Lack of Efficacy|19
6867499|NCT00446134|10877320|FG001|Overall Study|Lack of Efficacy|19
6867500|NCT00446134|10877321|FG002|Overall Study|Lack of Efficacy|24
6867501|NCT00446134|10877322|FG003|Overall Study|Lack of Efficacy|19
6867502|NCT00446134|10877319|FG000|Overall Study|Protocol Violation|0
6867503|NCT00446134|10877320|FG001|Overall Study|Protocol Violation|2
6867504|NCT00446134|10877321|FG002|Overall Study|Protocol Violation|1
6867505|NCT00446134|10877322|FG003|Overall Study|Protocol Violation|0
6867506|NCT00446134|10877319|FG000|Overall Study|Lost to Follow-up|1
6867507|NCT00446134|10877320|FG001|Overall Study|Lost to Follow-up|3
6867508|NCT00446134|10877321|FG002|Overall Study|Lost to Follow-up|1
6867509|NCT00446134|10877322|FG003|Overall Study|Lost to Follow-up|1
6867510|NCT00446134|10877319|FG000|Overall Study|Withdrawal by Subject|3
6867511|NCT00446134|10877320|FG001|Overall Study|Withdrawal by Subject|3
6867512|NCT00446134|10877321|FG002|Overall Study|Withdrawal by Subject|1
6867513|NCT00446134|10877322|FG003|Overall Study|Withdrawal by Subject|3
6867514|NCT00446134|10877319|FG000|Overall Study|Physician Decision|0
7078260|NCT02100839|11186553|FG001|Multiple Ascending Dose|Adverse Event|0
6867515|NCT00446134|10877320|FG001|Overall Study|Physician Decision|0
6867516|NCT00446134|10877321|FG002|Overall Study|Physician Decision|0
6867517|NCT00446134|10877322|FG003|Overall Study|Physician Decision|2
6867518|NCT00446134|10877319|FG000|Overall Study|Adverse Event-Diarrhea|1
6867519|NCT00446134|10877320|FG001|Overall Study|Adverse Event-Diarrhea|1
6867520|NCT00446134|10877321|FG002|Overall Study|Adverse Event-Diarrhea|2
6867521|NCT00446134|10877322|FG003|Overall Study|Adverse Event-Diarrhea|0
6867522|NCT00446134|10877319|FG000|Overall Study|Reason Not Completed|3
6867523|NCT00446134|10877320|FG001|Overall Study|Reason Not Completed|0
6867524|NCT00446134|10877321|FG002|Overall Study|Reason Not Completed|1
6867525|NCT00446134|10877322|FG003|Overall Study|Reason Not Completed|2
6867526|NCT00446199|10877345|FG000|Overall Study|Adverse Event|7
6867527|NCT00446199|10877346|FG001|Overall Study|Adverse Event|4
6867528|NCT00446199|10877347|FG002|Overall Study|Adverse Event|6
6867529|NCT00446199|10877348|FG003|Overall Study|Adverse Event|4
6867530|NCT00446199|10877345|FG000|Overall Study|Lost to Follow-up|4
6867531|NCT00446199|10877346|FG001|Overall Study|Lost to Follow-up|5
6867532|NCT00446199|10877347|FG002|Overall Study|Lost to Follow-up|2
6867533|NCT00446199|10877348|FG003|Overall Study|Lost to Follow-up|6
6867534|NCT00446199|10877345|FG000|Overall Study|Protocol Violation|1
6867535|NCT00446199|10877346|FG001|Overall Study|Protocol Violation|2
7078261|NCT02100839|11186552|FG000|Multiple Ascending Dose|Withdrawal by Subject|2
6867536|NCT00446199|10877347|FG002|Overall Study|Protocol Violation|1
6867537|NCT00446199|10877348|FG003|Overall Study|Protocol Violation|3
6867538|NCT00446199|10877345|FG000|Overall Study|Withdrawal by Subject|2
6867539|NCT00446199|10877346|FG001|Overall Study|Withdrawal by Subject|5
6867540|NCT00446199|10877347|FG002|Overall Study|Withdrawal by Subject|9
6867541|NCT00446199|10877348|FG003|Overall Study|Withdrawal by Subject|10
6867542|NCT00446199|10877345|FG000|Overall Study|Site termination|2
6867543|NCT00446199|10877346|FG001|Overall Study|Site termination|0
6867544|NCT00446199|10877347|FG002|Overall Study|Site termination|0
7078262|NCT02100839|11186553|FG001|Multiple Ascending Dose|Withdrawal by Subject|0
6867545|NCT00446199|10877348|FG003|Overall Study|Site termination|1
6867546|NCT00446199|10877345|FG000|Overall Study|Randomization in Error|2
6867547|NCT00446199|10877346|FG001|Overall Study|Randomization in Error|0
6867548|NCT00446199|10877347|FG002|Overall Study|Randomization in Error|1
6867549|NCT00446199|10877348|FG003|Overall Study|Randomization in Error|1
6867550|NCT00446199|10877345|FG000|Overall Study|Lack of Efficacy|1
6867551|NCT00446199|10877346|FG001|Overall Study|Lack of Efficacy|0
6867552|NCT00446199|10877347|FG002|Overall Study|Lack of Efficacy|0
6867553|NCT00446199|10877348|FG003|Overall Study|Lack of Efficacy|1
6867554|NCT00446199|10877345|FG000|Overall Study|Non-compliant with study drug|1
6867555|NCT00446199|10877346|FG001|Overall Study|Non-compliant with study drug|0
6867556|NCT00446199|10877347|FG002|Overall Study|Non-compliant with study drug|5
6867557|NCT00446199|10877348|FG003|Overall Study|Non-compliant with study drug|0
6867558|NCT00446199|10877345|FG000|Overall Study|Non-compliant with visit schedule|1
6867559|NCT00446199|10877346|FG001|Overall Study|Non-compliant with visit schedule|1
6867560|NCT00446199|10877347|FG002|Overall Study|Non-compliant with visit schedule|1
6867561|NCT00446199|10877348|FG003|Overall Study|Non-compliant with visit schedule|2
6867562|NCT00446199|10877345|FG000|Overall Study|Hormone fear|0
6867563|NCT00446199|10877346|FG001|Overall Study|Hormone fear|0
6867564|NCT00446199|10877347|FG002|Overall Study|Hormone fear|0
6867565|NCT00446199|10877348|FG003|Overall Study|Hormone fear|1
6867566|NCT00446199|10877345|FG000|Overall Study|Lost interest in study participation|0
6867567|NCT00446199|10877346|FG001|Overall Study|Lost interest in study participation|1
6867568|NCT00446199|10877347|FG002|Overall Study|Lost interest in study participation|0
6867569|NCT00446199|10877348|FG003|Overall Study|Lost interest in study participation|0
6867570|NCT00446199|10877345|FG000|Overall Study|In-/Exclusion criterion violated|2
6867571|NCT00446199|10877346|FG001|Overall Study|In-/Exclusion criterion violated|1
6867572|NCT00446199|10877347|FG002|Overall Study|In-/Exclusion criterion violated|2
6867573|NCT00446199|10877348|FG003|Overall Study|In-/Exclusion criterion violated|1
6867574|NCT00446199|10877345|FG000|Overall Study|Move|0
6867575|NCT00446199|10877346|FG001|Overall Study|Move|1
6867576|NCT00446199|10877347|FG002|Overall Study|Move|0
6867577|NCT00446199|10877348|FG003|Overall Study|Move|0
6867578|NCT00446251|10877358|FG000|Overall Study|On-study Transplants|2
6867579|NCT00446251|10877358|FG000|Overall Study|Rituximab Infusion Reaction|2
6867580|NCT00446251|10877358|FG000|Overall Study|Lost to Follow-up|1
6867581|NCT00446446|10877370|FG000|Overall Study|Death|10
6867582|NCT00446446|10877370|FG000|Overall Study|Withdrawal by Subject|6
6867583|NCT00446446|10877370|FG000|Overall Study|Other|4
6867584|NCT00446446|10877370|FG000|Overall Study|Disease Progession|2
6867585|NCT00446446|10877370|FG000|Overall Study|Adverse Event|1
6867586|NCT00446446|10877370|FG000|Overall Study|On Treatment at Time of Data Cut-off|1
6867587|NCT00446459|10877374|FG000|8 Months|Protocol Violation|12
6867588|NCT00446459|10877374|FG000|12 Months|Protocol Violation|4
6867589|NCT00446459|10877374|FG000|12 Months|14 subjects to MMF + Rituximab Study|14
6867590|NCT00446511|10877382|FG000|Overall Study|Adverse Event|7
6867591|NCT00446511|10877383|FG001|Overall Study|Adverse Event|2
6867592|NCT00446511|10877384|FG002|Overall Study|Adverse Event|3
6867593|NCT00446511|10877385|FG003|Overall Study|Adverse Event|1
6867594|NCT00446511|10877382|FG000|Overall Study|Protocol Violation|0
6867595|NCT00446511|10877383|FG001|Overall Study|Protocol Violation|0
6867596|NCT00446511|10877384|FG002|Overall Study|Protocol Violation|0
6867597|NCT00446511|10877385|FG003|Overall Study|Protocol Violation|1
6867598|NCT00446511|10877382|FG000|Overall Study|Withdrawal by Subject|0
6867599|NCT00446511|10877383|FG001|Overall Study|Withdrawal by Subject|0
6867600|NCT00446511|10877384|FG002|Overall Study|Withdrawal by Subject|0
6867601|NCT00446511|10877385|FG003|Overall Study|Withdrawal by Subject|3
6867602|NCT00446511|10877382|FG000|Overall Study|Administrative Problems|3
6867603|NCT00446511|10877383|FG001|Overall Study|Administrative Problems|0
6867604|NCT00446511|10877384|FG002|Overall Study|Administrative Problems|4
6867605|NCT00446511|10877385|FG003|Overall Study|Administrative Problems|1
6867606|NCT00446550|10877399|FG000|Overall Study|Adverse Event|1
6867607|NCT00446550|10877400|FG001|Overall Study|Adverse Event|0
6867608|NCT00446563|10877409|FG000|Overall Study|Adverse Event|4
6867609|NCT00446563|10877410|FG001|Overall Study|Adverse Event|3
6867610|NCT00446563|10877409|FG000|Overall Study|Abnormal laboratory value(s)|0
6867611|NCT00446563|10877410|FG001|Overall Study|Abnormal laboratory value(s)|1
6867612|NCT00446563|10877409|FG000|Overall Study|Abnormal test procedure result(s)|1
6867613|NCT00446563|10877410|FG001|Overall Study|Abnormal test procedure result(s)|0
6867614|NCT00446563|10877409|FG000|Overall Study|Unsatisfactory therapeutic effect|0
6867615|NCT00446563|10877410|FG001|Overall Study|Unsatisfactory therapeutic effect|3
6867616|NCT00446563|10877409|FG000|Overall Study|Withdrawal by Subject|2
6867617|NCT00446563|10877410|FG001|Overall Study|Withdrawal by Subject|1
6867618|NCT00446563|10877409|FG000|Overall Study|Administrative problems|0
6867619|NCT00446563|10877410|FG001|Overall Study|Administrative problems|1
6867620|NCT00446641|10877418|FG000|Overall Study|Withdrawal by Subject|8
6867621|NCT00446641|10877419|FG001|Overall Study|Withdrawal by Subject|3
6867622|NCT00446641|10877418|FG000|Overall Study|poor compliance|8
6867623|NCT00446641|10877419|FG001|Overall Study|poor compliance|6
6867624|NCT00446641|10877418|FG000|Overall Study|Lost to Follow-up|1
6867625|NCT00446641|10877419|FG001|Overall Study|Lost to Follow-up|1
6867626|NCT00446654|10877427|FG000|Overall Study|Withdrawal by Subject|1
6867627|NCT00446654|10877428|FG001|Overall Study|Withdrawal by Subject|0
6867628|NCT00446654|10877427|FG000|Overall Study|Adverse Event|1
6867629|NCT00446654|10877428|FG001|Overall Study|Adverse Event|0
6867630|NCT00446797|10877436|FG000|Overall Study|Lack of Efficacy|0
6867631|NCT00446797|10877437|FG001|Overall Study|Lack of Efficacy|2
6867632|NCT00446797|10877436|FG000|Overall Study|Lost to Follow-up|5
6867633|NCT00446797|10877437|FG001|Overall Study|Lost to Follow-up|3
6867634|NCT00446797|10877436|FG000|Overall Study|Withdrawal by Subject|2
6867635|NCT00446797|10877437|FG001|Overall Study|Withdrawal by Subject|2
6867636|NCT00446797|10877436|FG000|Overall Study|Protocol Violation|1
6867637|NCT00446797|10877437|FG001|Overall Study|Protocol Violation|3
6867638|NCT00446797|10877436|FG000|Overall Study|subject entered at another site|0
6867639|NCT00446797|10877437|FG001|Overall Study|subject entered at another site|1
6867640|NCT00446797|10877436|FG000|Overall Study|did not meet entrance criteria|0
6867641|NCT00446797|10877437|FG001|Overall Study|did not meet entrance criteria|1
6867642|NCT00446849|10877443|FG000|Acute Phase|Lack of Efficacy|64
6968250|NCT01136915|11016975|FG000|Overall Study|Lost to Follow-up|2
6968251|NCT01136915|11016976|FG001|Overall Study|Lost to Follow-up|0
6968252|NCT01136915|11016975|FG000|Overall Study|Exclusion criterion met|0
6968253|NCT01136915|11016976|FG001|Overall Study|Exclusion criterion met|1
6968254|NCT01136954|11016986|FG000|Overall Study|Adverse Event|3
6968255|NCT01136954|11016987|FG001|Overall Study|Adverse Event|2
6968256|NCT01136954|11016986|FG000|Overall Study|Withdrawal by Subject|6
6968257|NCT01136954|11016987|FG001|Overall Study|Withdrawal by Subject|2
6968258|NCT01136954|11016986|FG000|Overall Study|Lack of Efficacy|14
6968259|NCT01136954|11016987|FG001|Overall Study|Lack of Efficacy|13
6968260|NCT01136954|11016986|FG000|Overall Study|Physician Decision|0
6968261|NCT01136954|11016987|FG001|Overall Study|Physician Decision|1
6968262|NCT01136954|11016986|FG000|Overall Study|Other|1
6968263|NCT01136954|11016987|FG001|Overall Study|Other|3
6968264|NCT01137071|11017028|FG000|Overall Study|Disease Progression|11
6968265|NCT01137071|11017028|FG000|Overall Study|Withdrawal by Subject|2
6968266|NCT01137071|11017028|FG000|Overall Study|Wrongly Included|1
6968267|NCT01137110|11017039|FG000|Overall Study|Protocol Violation|1
6968268|NCT01137110|11017040|FG001|Overall Study|Protocol Violation|0
6968269|NCT01137292|11017046|FG000|Overall Study|Death|30
6968270|NCT01137292|11017046|FG000|Overall Study|Adverse Event|3
6968271|NCT01137292|11017046|FG000|Overall Study|Lack of Efficacy|13
6968272|NCT01137292|11017046|FG000|Overall Study|Lost to Follow-up|1
6968273|NCT01137292|11017046|FG000|Overall Study|Other|7
6968274|NCT01137474|11017072|FG000|Overall Study|Adverse Event|3
6968275|NCT01137474|11017073|FG001|Overall Study|Adverse Event|5
7078263|NCT02100969|11186563|FG000|Overall Study|Did not pass screening phase|1
6867643|NCT00446849|10877443|FG000|Acute Phase|Protocol Violation|10
6968276|NCT01137474|11017074|FG002|Overall Study|Adverse Event|1
6968277|NCT01137474|11017075|FG003|Overall Study|Adverse Event|3
6968278|NCT01137474|11017072|FG000|Overall Study|Withdrawal by Subject|7
6968279|NCT01137474|11017073|FG001|Overall Study|Withdrawal by Subject|2
6968280|NCT01137474|11017074|FG002|Overall Study|Withdrawal by Subject|6
6968281|NCT01137474|11017075|FG003|Overall Study|Withdrawal by Subject|9
6968282|NCT01137474|11017072|FG000|Overall Study|No longer met study criteria|6
6968283|NCT01137474|11017073|FG001|Overall Study|No longer met study criteria|1
6968284|NCT01137474|11017074|FG002|Overall Study|No longer met study criteria|0
6968285|NCT01137474|11017075|FG003|Overall Study|No longer met study criteria|5
6968286|NCT01137474|11017072|FG000|Overall Study|Lost to Follow-up|5
6968287|NCT01137474|11017073|FG001|Overall Study|Lost to Follow-up|1
6968288|NCT01137474|11017074|FG002|Overall Study|Lost to Follow-up|0
6968289|NCT01137474|11017075|FG003|Overall Study|Lost to Follow-up|2
6968290|NCT01137474|11017072|FG000|Overall Study|Lack of Efficacy|0
6968291|NCT01137474|11017073|FG001|Overall Study|Lack of Efficacy|0
6968292|NCT01137474|11017074|FG002|Overall Study|Lack of Efficacy|0
6968293|NCT01137474|11017075|FG003|Overall Study|Lack of Efficacy|2
6968294|NCT01137474|11017072|FG000|Overall Study|Other|3
6968295|NCT01137474|11017073|FG001|Overall Study|Other|1
6968296|NCT01137474|11017074|FG002|Overall Study|Other|0
6968297|NCT01137474|11017075|FG003|Overall Study|Other|0
6968298|NCT01137474|11017072|FG000|Overall Study|Pregnancy|0
6968299|NCT01137474|11017073|FG001|Overall Study|Pregnancy|1
6968300|NCT01137474|11017074|FG002|Overall Study|Pregnancy|0
6968301|NCT01137474|11017075|FG003|Overall Study|Pregnancy|0
6968302|NCT01137474|11017072|FG000|Overall Study|Administrative reason by sponsor|0
6968303|NCT01137474|11017073|FG001|Overall Study|Administrative reason by sponsor|1
6968304|NCT01137474|11017074|FG002|Overall Study|Administrative reason by sponsor|0
6968305|NCT01137474|11017075|FG003|Overall Study|Administrative reason by sponsor|0
6968306|NCT01137578|11017089|FG000|Overall Study|Participant requested to Discontinue|3
6968307|NCT01137578|11017090|FG001|Overall Study|Participant requested to Discontinue|0
6968308|NCT01137578|11017091|FG002|Overall Study|Participant requested to Discontinue|0
6968309|NCT01137578|11017089|FG000|Overall Study|Withdrawal by Subject|1
6968310|NCT01137578|11017090|FG001|Overall Study|Withdrawal by Subject|0
6968311|NCT01137578|11017091|FG002|Overall Study|Withdrawal by Subject|0
6968312|NCT01137578|11017089|FG000|Overall Study|Other|12
6968313|NCT01137578|11017090|FG001|Overall Study|Other|2
6968314|NCT01137578|11017091|FG002|Overall Study|Other|6
6867644|NCT00446849|10877443|FG000|Acute Phase|Consent withdrawn|4
6867645|NCT00446849|10877443|FG000|Acute Phase|Lost to Follow-up|2
6968315|NCT01137604|11017123|FG000|Overall Study|Adverse Event|1
6968316|NCT01137604|11017124|FG001|Overall Study|Adverse Event|6
6968317|NCT01137604|11017125|FG002|Overall Study|Adverse Event|9
6867646|NCT00446849|10877443|FG000|Acute Phase|Physician Decision|1
6867647|NCT00446849|10877443|FG000|Acute Phase|noncompliance|1
6867648|NCT00446849|10877443|FG000|Maintenance Phase|Lack of Efficacy|40
6867649|NCT00446849|10877443|FG000|Maintenance Phase|Protocol Violation|7
6867650|NCT00446849|10877443|FG000|Maintenance Phase|Adverse Event|6
6867651|NCT00446849|10877443|FG000|Maintenance Phase|Consent withdrawn|5
6867652|NCT00446849|10877443|FG000|Maintenance Phase|Lost to Follow-up|3
6867653|NCT00446849|10877443|FG000|Maintenance Phase|Pregnancy|1
6867654|NCT00446849|10877443|FG000|Maintenance Phase|noncompliance|2
6867655|NCT00446849|10877443|FG000|Maintenance Phase|prohibited medication use|2
6867656|NCT00446849|10877443|FG000|Maintenance Phase|antibiotic use|1
6867657|NCT00446849|10877443|FG000|Maintenance Phase|study closure|1
6867658|NCT00446849|10877443|FG000|Maintenance Phase|hydrocodone use|1
6867659|NCT00446849|10877443|FG000|Maintenance Phase|concomitant medication use|1
6867660|NCT00446966|10877450|FG000|Overall Study|Lost to Follow-up|10
6867661|NCT00446966|10877451|FG001|Overall Study|Lost to Follow-up|7
6867662|NCT00446992|10877457|FG000|Overall Study|Adverse Event|11
6867663|NCT00446992|10877457|FG000|Overall Study|Lost to Follow-up|5
6867664|NCT00447005|10877461|FG000|Overall Study|Adverse Event|1
6867665|NCT00447005|10877461|FG000|Overall Study|Lack of Efficacy|11
6867666|NCT00447057|10877469|FG000|Overall Study|Adverse Event|4
6867667|NCT00447057|10877470|FG001|Overall Study|Adverse Event|10
6867668|NCT00447057|10877471|FG002|Overall Study|Adverse Event|0
6867669|NCT00447057|10877472|FG003|Overall Study|Adverse Event|3
6867670|NCT00447057|10877469|FG000|Overall Study|Death due to study disease|6
6867671|NCT00447057|10877470|FG001|Overall Study|Death due to study disease|4
6867672|NCT00447057|10877471|FG002|Overall Study|Death due to study disease|1
6867673|NCT00447057|10877472|FG003|Overall Study|Death due to study disease|1
6867674|NCT00447057|10877469|FG000|Overall Study|Lost to Follow-up|0
6867675|NCT00447057|10877470|FG001|Overall Study|Lost to Follow-up|1
6867676|NCT00447057|10877471|FG002|Overall Study|Lost to Follow-up|0
6867677|NCT00447057|10877472|FG003|Overall Study|Lost to Follow-up|0
6867678|NCT00447057|10877469|FG000|Overall Study|Entry criteria not met|1
6867679|NCT00447057|10877470|FG001|Overall Study|Entry criteria not met|1
6867680|NCT00447057|10877471|FG002|Overall Study|Entry criteria not met|0
6867681|NCT00447057|10877472|FG003|Overall Study|Entry criteria not met|0
6867682|NCT00447057|10877469|FG000|Overall Study|Protocol Violation|0
6867683|NCT00447057|10877470|FG001|Overall Study|Protocol Violation|1
6867684|NCT00447057|10877471|FG002|Overall Study|Protocol Violation|0
6867685|NCT00447057|10877472|FG003|Overall Study|Protocol Violation|0
6867686|NCT00447057|10877469|FG000|Overall Study|Withdrawal by Subject|4
6867687|NCT00447057|10877470|FG001|Overall Study|Withdrawal by Subject|5
6867688|NCT00447057|10877471|FG002|Overall Study|Withdrawal by Subject|1
6867689|NCT00447057|10877472|FG003|Overall Study|Withdrawal by Subject|1
6867690|NCT00447057|10877469|FG000|Overall Study|Physician Decision|9
6867691|NCT00447057|10877470|FG001|Overall Study|Physician Decision|6
6867692|NCT00447057|10877471|FG002|Overall Study|Physician Decision|3
6867693|NCT00447057|10877472|FG003|Overall Study|Physician Decision|1
6867694|NCT00447057|10877469|FG000|Overall Study|Sponsor decision|1
6867695|NCT00447057|10877470|FG001|Overall Study|Sponsor decision|1
6867696|NCT00447057|10877471|FG002|Overall Study|Sponsor decision|0
6867697|NCT00447057|10877472|FG003|Overall Study|Sponsor decision|0
6867698|NCT00447057|10877469|FG000|Overall Study|Progressive disease|58
6867699|NCT00447057|10877470|FG001|Overall Study|Progressive disease|43
6867700|NCT00447057|10877471|FG002|Overall Study|Progressive disease|13
6867701|NCT00447057|10877472|FG003|Overall Study|Progressive disease|18
6867702|NCT00447057|10877469|FG000|Overall Study|Death due to adverse event|0
6867703|NCT00447057|10877470|FG001|Overall Study|Death due to adverse event|0
6867704|NCT00447057|10877471|FG002|Overall Study|Death due to adverse event|1
6867705|NCT00447057|10877472|FG003|Overall Study|Death due to adverse event|2
6867706|NCT00447057|10877469|FG000|Overall Study|Death, study drug related|0
6867707|NCT00447057|10877470|FG001|Overall Study|Death, study drug related|1
6867708|NCT00447057|10877471|FG002|Overall Study|Death, study drug related|0
6867709|NCT00447057|10877472|FG003|Overall Study|Death, study drug related|0
6867710|NCT00447226|10877493|FG000|12-Week Open-label Phase|Adverse Event|0
6867711|NCT00447226|10877494|FG001|12-Week Open-label Phase|Adverse Event|3
6867712|NCT00447226|10877493|FG000|12-Week Open-label Phase|Protocol Violation|0
6867713|NCT00447226|10877494|FG001|12-Week Open-label Phase|Protocol Violation|1
6867714|NCT00447226|10877493|FG000|12-Week Open-label Phase|Disease Progression|0
6867715|NCT00447226|10877494|FG001|12-Week Open-label Phase|Disease Progression|20
6867716|NCT00447226|10877493|FG000|12-Week Open-label Phase|Physician Decision|0
6867717|NCT00447226|10877494|FG001|12-Week Open-label Phase|Physician Decision|1
6867718|NCT00447226|10877493|FG000|Double-blind Phase|Disease Progression|4
6867719|NCT00447226|10877494|FG001|Double-blind Phase|Disease Progression|3
6867720|NCT00447265|10877509|FG000|Overall Study|Physician Decision|1
6867721|NCT00447265|10877510|FG001|Overall Study|Physician Decision|0
6867722|NCT00447278|10877516|FG000|Period II (6 Month Open-Label)|Adverse Event|7
6867723|NCT00447278|10877517|FG001|Period II (6 Month Open-Label)|Adverse Event|3
6867724|NCT00447278|10877516|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0
6867725|NCT00447278|10877517|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4
6867726|NCT00447278|10877516|FG000|Period II (6 Month Open-Label)|Protocol Violation|10
6867727|NCT00447278|10877517|FG001|Period II (6 Month Open-Label)|Protocol Violation|7
6867728|NCT00447278|10877516|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1
6867729|NCT00447278|10877517|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3
6867730|NCT00447278|10877516|FG000|Period II (6 Month Open-Label)|Physician Decision|4
6867731|NCT00447278|10877517|FG001|Period II (6 Month Open-Label)|Physician Decision|1
6867732|NCT00447278|10877516|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11
6867733|NCT00447278|10877517|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1
6867734|NCT00447278|10877516|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9
6867735|NCT00447278|10877517|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10
6867736|NCT00447278|10877516|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2
6867737|NCT00447278|10877517|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2
6867738|NCT00447278|10877516|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
6867739|NCT00447278|10877517|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
6867740|NCT00447278|10877516|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6
6867741|NCT00447278|10877517|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1
6867742|NCT00447278|10877516|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4
6867743|NCT00447278|10877517|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1
6867744|NCT00447278|10877516|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1
6867745|NCT00447278|10877517|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1
6867746|NCT00447278|10877516|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4
6867747|NCT00447278|10877517|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0
6867748|NCT00447278|10877516|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11
6867749|NCT00447278|10877517|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8
6867750|NCT00447382|10877531|FG000|Overall Study|Adverse Event|1
6867751|NCT00447382|10877532|FG001|Overall Study|Adverse Event|1
6867752|NCT00447382|10877531|FG000|Overall Study|Lack of Efficacy|1
6867753|NCT00447382|10877532|FG001|Overall Study|Lack of Efficacy|0
6867754|NCT00447382|10877531|FG000|Overall Study|Protocol Violation|2
6867755|NCT00447382|10877532|FG001|Overall Study|Protocol Violation|0
6867756|NCT00447382|10877531|FG000|Overall Study|Unclassified|2
6867757|NCT00447382|10877532|FG001|Overall Study|Unclassified|5
6867758|NCT00447499|10877538|FG000|Overall Study|Adverse Event|1
6867759|NCT00447499|10877538|FG000|Overall Study|Patient Decision|4
6867760|NCT00447499|10877538|FG000|Overall Study|Sponsor Decision|1
6867761|NCT00447499|10877538|FG000|Overall Study|Physician Decision|1
6867762|NCT00447590|10877544|FG000|Overall Study|Withdrawal by Subject|26
6867763|NCT00447590|10877544|FG000|Overall Study|Lost to Follow-up|24
6867764|NCT00447590|10877544|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10
6867765|NCT00447694|10877548|FG000|Overall Study|Adverse Event|2
6867766|NCT00447694|10877548|FG000|Overall Study|Abnormal laboratory value|1
6867767|NCT00447694|10877548|FG000|Overall Study|Abnormal test procedure result|1
6867768|NCT00447694|10877548|FG000|Overall Study|Withdrawal by Subject|2
6867769|NCT00447772|10877552|FG000|Overall Study|Lack of Efficacy|3
6867770|NCT00447772|10877552|FG000|Overall Study|Insufficient compliance|6
6867771|NCT00447772|10877552|FG000|Overall Study|Discontinuation of drug therapy|1
6867772|NCT00447772|10877552|FG000|Overall Study|Lost to Follow-up|9
6867773|NCT00447772|10877552|FG000|Overall Study|Withdrawal by Subject|1
6867774|NCT00447772|10877552|FG000|Overall Study|Unable to attend all study visits|2
6867775|NCT00447772|10877552|FG000|Overall Study|Adverse Event|1
6867776|NCT00447772|10877552|FG000|Overall Study|Patient relocated|1
6867777|NCT00447772|10877552|FG000|Overall Study|Incomplete documentation at visit 1|1
6867778|NCT00447772|10877552|FG000|Overall Study|Chemotherapy for lung cancer|1
6867779|NCT00447772|10877552|FG000|Overall Study|Premature re-injection required|1
6867780|NCT00447876|10877561|FG000|Overall Study|Withdrawal by Subject|1
6867781|NCT00447876|10877562|FG001|Overall Study|Withdrawal by Subject|4
6867782|NCT00447876|10877561|FG000|Overall Study|Lost to Follow-up|1
6867783|NCT00447876|10877562|FG001|Overall Study|Lost to Follow-up|0
6867784|NCT00447876|10877561|FG000|Overall Study|Deterioration of symptomology|1
6867785|NCT00447876|10877562|FG001|Overall Study|Deterioration of symptomology|0
6968318|NCT01137604|11017126|FG003|Overall Study|Adverse Event|9
6968319|NCT01137604|11017123|FG000|Overall Study|Withdrawal by Subject|0
6968320|NCT01137604|11017124|FG001|Overall Study|Withdrawal by Subject|2
6968321|NCT01137604|11017125|FG002|Overall Study|Withdrawal by Subject|2
6968322|NCT01137604|11017126|FG003|Overall Study|Withdrawal by Subject|1
6968323|NCT01137604|11017123|FG000|Overall Study|Clinical Progression|0
6968324|NCT01137604|11017124|FG001|Overall Study|Clinical Progression|2
6968325|NCT01137604|11017125|FG002|Overall Study|Clinical Progression|1
6968326|NCT01137604|11017126|FG003|Overall Study|Clinical Progression|0
6968327|NCT01137604|11017123|FG000|Overall Study|Participant's Decision|1
6968328|NCT01137604|11017124|FG001|Overall Study|Participant's Decision|0
6968329|NCT01137604|11017125|FG002|Overall Study|Participant's Decision|0
6968330|NCT01137604|11017126|FG003|Overall Study|Participant's Decision|0
6968331|NCT01137604|11017123|FG000|Overall Study|Clinical Decline|0
6968332|NCT01137604|11017124|FG001|Overall Study|Clinical Decline|0
6968333|NCT01137604|11017125|FG002|Overall Study|Clinical Decline|1
6968334|NCT01137604|11017126|FG003|Overall Study|Clinical Decline|1
6968335|NCT01137682|11017139|FG000|Overall Study|Adverse Event-CORE|2
6968336|NCT01137682|11017140|FG001|Overall Study|Adverse Event-CORE|4
6968337|NCT01137682|11017141|FG002|Overall Study|Adverse Event-CORE|0
6968338|NCT01137682|11017139|FG000|Overall Study|Withdrawal by Subject-CORE|2
6968339|NCT01137682|11017140|FG001|Overall Study|Withdrawal by Subject-CORE|2
6867786|NCT00447902|10877570|FG000|Overall Study|Adverse Event|0
6867787|NCT00447902|10877571|FG001|Overall Study|Adverse Event|3
6867788|NCT00447902|10877570|FG000|Overall Study|Protocol Violation|1
6867789|NCT00447902|10877571|FG001|Overall Study|Protocol Violation|0
6867790|NCT00447902|10877570|FG000|Overall Study|Withdrawal by Subject|0
6867791|NCT00447902|10877571|FG001|Overall Study|Withdrawal by Subject|1
6867792|NCT00447902|10877570|FG000|Overall Study|included patients who discontinued|1
6867793|NCT00447902|10877571|FG001|Overall Study|included patients who discontinued|1
6867794|NCT00447902|10877570|FG000|Overall Study|Lack of Efficacy|2
6867795|NCT00447902|10877571|FG001|Overall Study|Lack of Efficacy|1
6867796|NCT00448019|10877577|FG000|Overall Study|Withdrawal by Subject|3
6867797|NCT00448019|10877577|FG000|Overall Study|Disease progression|1
6867798|NCT00448019|10877577|FG000|Overall Study|Death|2
6867799|NCT00448019|10877577|FG000|Overall Study|Insurance Issues|1
6867800|NCT00448123|10877583|FG000|Overall Study|Lost to Follow-up|9
6867801|NCT00448123|10877584|FG001|Overall Study|Lost to Follow-up|6
6867802|NCT00448123|10877583|FG000|Overall Study|Physician Decision|6
6867803|NCT00448123|10877584|FG001|Overall Study|Physician Decision|6
6867804|NCT00448136|10877595|FG000|Overall Study|Death|3
6867805|NCT00448136|10877596|FG001|Overall Study|Death|8
6867806|NCT00448136|10877595|FG000|Overall Study|Investigator's decision (progression)|1
6867807|NCT00448136|10877596|FG001|Overall Study|Investigator's decision (progression)|0
6867808|NCT00448279|10877626|FG000|Overall Study|Lost to Follow-up|2
6867809|NCT00448279|10877627|FG001|Overall Study|Lost to Follow-up|2
6867810|NCT00448279|10877626|FG000|Overall Study|Adverse Event|1
6867811|NCT00448279|10877627|FG001|Overall Study|Adverse Event|1
6867812|NCT00448279|10877626|FG000|Overall Study|Disease progression|16
6867813|NCT00448279|10877627|FG001|Overall Study|Disease progression|18
6867814|NCT00448279|10877626|FG000|Overall Study|Withdrawal by Subject|4
6867815|NCT00448279|10877627|FG001|Overall Study|Withdrawal by Subject|3
6867816|NCT00448279|10877626|FG000|Overall Study|Other|6
6867817|NCT00448279|10877627|FG001|Overall Study|Other|4
6867818|NCT00448279|10877626|FG000|Overall Study|Protocol Violation|0
6867819|NCT00448279|10877627|FG001|Overall Study|Protocol Violation|1
6867820|NCT00448344|10877635|FG000|Overall Study|Lost to Follow-up|20
6867821|NCT00448344|10877636|FG001|Overall Study|Lost to Follow-up|22
6867822|NCT00448344|10877635|FG000|Overall Study|Withdrawal by Subject|6
6867823|NCT00448344|10877636|FG001|Overall Study|Withdrawal by Subject|8
6867824|NCT00448344|10877635|FG000|Overall Study|Death|3
6867825|NCT00448344|10877636|FG001|Overall Study|Death|4
6867826|NCT00448344|10877635|FG000|Overall Study|Physician Decision|1
6867827|NCT00448344|10877636|FG001|Overall Study|Physician Decision|2
6867828|NCT00448435|10877658|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1
6867829|NCT00448435|10877659|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0
6867830|NCT00448448|10877670|FG000|Overall Study|Withdrawal by Subject|13
6867831|NCT00448448|10877671|FG001|Overall Study|Withdrawal by Subject|2
6867832|NCT00448448|10877670|FG000|Overall Study|On protocol when study ended|83
7154267|NCT03308942|11320876|FG004|Stage 1 (up to a Maximum of 29 Months)|Ongoing at the time of analysis|0
7154268|NCT03308942|11320872|FG000|Stage 2 (up to a Maximum of 17 Months)|Withdrawal by Subject|0
7154269|NCT03308942|11320873|FG001|Stage 2 (up to a Maximum of 17 Months)|Withdrawal by Subject|0
6867833|NCT00448448|10877671|FG001|Overall Study|On protocol when study ended|36
6867834|NCT00448448|10877670|FG000|Overall Study|Lost to Follow-up|2
6867835|NCT00448448|10877671|FG001|Overall Study|Lost to Follow-up|1
6867836|NCT00448448|10877670|FG000|Overall Study|Wrong diagnosis (n=3) or other|2
6867837|NCT00448448|10877671|FG001|Overall Study|Wrong diagnosis (n=3) or other|1
6968340|NCT01137682|11017141|FG002|Overall Study|Withdrawal by Subject-CORE|2
6968341|NCT01137682|11017139|FG000|Overall Study|Administrative problems-CORE|2
6968342|NCT01137682|11017140|FG001|Overall Study|Administrative problems-CORE|1
6968343|NCT01137682|11017141|FG002|Overall Study|Administrative problems-CORE|0
6968344|NCT01137682|11017139|FG000|Overall Study|Protocol Violation-CORE|0
6968345|NCT01137682|11017140|FG001|Overall Study|Protocol Violation-CORE|1
6968346|NCT01137682|11017141|FG002|Overall Study|Protocol Violation-CORE|1
6968347|NCT01137682|11017139|FG000|Overall Study|Adverse Event-Extension|4
6968348|NCT01137682|11017140|FG001|Overall Study|Adverse Event-Extension|8
6968349|NCT01137682|11017141|FG002|Overall Study|Adverse Event-Extension|7
6968350|NCT01137682|11017139|FG000|Overall Study|Lack of Efficacy-Extension|15
6968351|NCT01137682|11017140|FG001|Overall Study|Lack of Efficacy-Extension|9
6968352|NCT01137682|11017141|FG002|Overall Study|Lack of Efficacy-Extension|13
6968353|NCT01137682|11017139|FG000|Overall Study|Withdrawal by Subject-Extension|6
6968354|NCT01137682|11017140|FG001|Overall Study|Withdrawal by Subject-Extension|8
6968355|NCT01137682|11017141|FG002|Overall Study|Withdrawal by Subject-Extension|8
6968356|NCT01137682|11017139|FG000|Overall Study|Lost to Follow Up-Extension|0
6968357|NCT01137682|11017140|FG001|Overall Study|Lost to Follow Up-Extension|1
6968358|NCT01137682|11017141|FG002|Overall Study|Lost to Follow Up-Extension|0
6867838|NCT00448448|10877670|FG000|Overall Study|Signed consent lost|0
6867839|NCT00448448|10877671|FG001|Overall Study|Signed consent lost|1
6968359|NCT01137682|11017139|FG000|Overall Study|Administrative problems-Extension|0
6968360|NCT01137682|11017140|FG001|Overall Study|Administrative problems-Extension|2
6976936|NCT01202955|11029812|FG000|Period 1: 10 Days|Withdrawal by Subject|0
6867840|NCT00448539|10877679|FG000|Overall Study|Medication non-compliance|4
6867841|NCT00448539|10877680|FG001|Overall Study|Medication non-compliance|1
6867842|NCT00448539|10877679|FG000|Overall Study|Protocol Violation|1
6867843|NCT00448539|10877680|FG001|Overall Study|Protocol Violation|0
6867844|NCT00448539|10877679|FG000|Overall Study|Request of the investigator or sponsor|67
6867845|NCT00448539|10877680|FG001|Overall Study|Request of the investigator or sponsor|54
6867846|NCT00448539|10877679|FG000|Overall Study|Withdrawal by Subject|20
6867847|NCT00448539|10877680|FG001|Overall Study|Withdrawal by Subject|24
6867848|NCT00448539|10877679|FG000|Overall Study|Diary non-compliance|1
6867849|NCT00448539|10877680|FG001|Overall Study|Diary non-compliance|0
6867850|NCT00448539|10877679|FG000|Overall Study|Adverse Event|9
6867851|NCT00448539|10877680|FG001|Overall Study|Adverse Event|26
6867852|NCT00448539|10877679|FG000|Overall Study|Lack of Efficacy|27
6867853|NCT00448539|10877680|FG001|Overall Study|Lack of Efficacy|40
6867854|NCT00448539|10877679|FG000|Overall Study|Miscellaneous|2
6867855|NCT00448539|10877680|FG001|Overall Study|Miscellaneous|1
6867856|NCT00448539|10877679|FG000|Overall Study|Change of meds|2
6867857|NCT00448539|10877680|FG001|Overall Study|Change of meds|3
6867858|NCT00448539|10877679|FG000|Overall Study|Lost to Follow-up|1
6867859|NCT00448539|10877680|FG001|Overall Study|Lost to Follow-up|3
6867860|NCT00448591|10877686|FG000|Overall Study|Withdrawal by Subject|178
6867861|NCT00448591|10877686|FG000|Overall Study|Progressive Disease|1382
6867862|NCT00448591|10877686|FG000|Overall Study|Adverse Event|382
6867863|NCT00448591|10877686|FG000|Overall Study|Protocol Violation|41
6867864|NCT00448591|10877686|FG000|Overall Study|Lost to Follow-up|19
6867865|NCT00448591|10877686|FG000|Overall Study|Treatment Regimen Completed|70
6867866|NCT00448591|10877686|FG000|Overall Study|Other|154
6867867|NCT00448591|10877686|FG000|Overall Study|Termination of Study|70
6867868|NCT00448669|10877694|FG000|Overall Study|Lost to Follow-up|52
6867869|NCT00448669|10877695|FG001|Overall Study|Lost to Follow-up|63
6867870|NCT00448669|10877694|FG000|Overall Study|Withdrawal by Subject|90
6867871|NCT00448669|10877695|FG001|Overall Study|Withdrawal by Subject|74
6867872|NCT00448669|10877694|FG000|Overall Study|Relocated|49
6867873|NCT00448669|10877695|FG001|Overall Study|Relocated|36
6867874|NCT00448669|10877694|FG000|Overall Study|Were withdrawn by investigator|10
6867875|NCT00448669|10877695|FG001|Overall Study|Were withdrawn by investigator|6
6867876|NCT00448669|10877694|FG000|Overall Study|Death|2
6867877|NCT00448669|10877695|FG001|Overall Study|Death|4
6867878|NCT00448669|10877694|FG000|Overall Study|Had other reasons|5
6867879|NCT00448669|10877695|FG001|Overall Study|Had other reasons|6
6867880|NCT00448669|10877694|FG000|Overall Study|HIV-infected at enrollment|1
6867881|NCT00448669|10877695|FG001|Overall Study|HIV-infected at enrollment|2
6867882|NCT00448669|10877694|FG000|Overall Study|Never started drug|9
6867883|NCT00448669|10877695|FG001|Overall Study|Never started drug|7
6867884|NCT00448708|10877705|FG000|Overall Study|Death|21
6867885|NCT00448708|10877706|FG001|Overall Study|Death|17
6867886|NCT00448708|10877705|FG000|Overall Study|Withdrawal by Subject|8
6867887|NCT00448708|10877706|FG001|Overall Study|Withdrawal by Subject|4
6867888|NCT00448708|10877705|FG000|Overall Study|Lost to Follow-up|6
6867889|NCT00448708|10877706|FG001|Overall Study|Lost to Follow-up|8
6867890|NCT00448708|10877705|FG000|Overall Study|not listed|0
6867891|NCT00448708|10877706|FG001|Overall Study|not listed|2
6867892|NCT00448747|10877714|FG000|Overall Study|collapsed veins|1
6867893|NCT00448747|10877715|FG001|Overall Study|collapsed veins|0
6867894|NCT00448760|10877731|FG000|Overall Study|Death|3
6867895|NCT00448812|10877737|FG000|Year 2|Missed visit but remained in study|4
6867896|NCT00448812|10877738|FG001|Year 2|Missed visit but remained in study|1
6867897|NCT00448812|10877737|FG000|Year 3|Withdrawal by Subject|1
6867898|NCT00448812|10877738|FG001|Year 3|Withdrawal by Subject|3
6867899|NCT00448812|10877737|FG000|Year 3|Lost to Follow-up|1
6867900|NCT00448812|10877738|FG001|Year 3|Lost to Follow-up|0
6867901|NCT00448812|10877737|FG000|Year 3|Missed visit but remained in study|2
6867902|NCT00448812|10877738|FG001|Year 3|Missed visit but remained in study|0
6867903|NCT00448812|10877737|FG000|Year 5|Missed visit but remained in study|1
6867904|NCT00448812|10877738|FG001|Year 5|Missed visit but remained in study|0
6867905|NCT00448864|10877759|FG000|Overall Study|Death|1
6867906|NCT00448864|10877760|FG001|Overall Study|Death|0
6867907|NCT00448864|10877761|FG002|Overall Study|Death|0
6867908|NCT00448864|10877759|FG000|Overall Study|Lost to Follow-up|3
6867909|NCT00448864|10877760|FG001|Overall Study|Lost to Follow-up|1
6867910|NCT00448864|10877761|FG002|Overall Study|Lost to Follow-up|0
6867911|NCT00448864|10877759|FG000|Overall Study|Physician Decision|1
6867912|NCT00448864|10877760|FG001|Overall Study|Physician Decision|0
6867913|NCT00448864|10877761|FG002|Overall Study|Physician Decision|1
6867914|NCT00448864|10877759|FG000|Overall Study|Withdrawal by Subject|0
6867915|NCT00448864|10877760|FG001|Overall Study|Withdrawal by Subject|2
6867916|NCT00448864|10877761|FG002|Overall Study|Withdrawal by Subject|0
7041184|NCT01724528|11124694|FG000|Overall Study|Protocol Violation|0
6867917|NCT00448864|10877759|FG000|Overall Study|Protocol Violation|0
6867918|NCT00448864|10877760|FG001|Overall Study|Protocol Violation|2
6867919|NCT00448864|10877761|FG002|Overall Study|Protocol Violation|0
6867920|NCT00448916|10877775|FG000|Overall Study|Adverse Event|2
6867921|NCT00448916|10877776|FG001|Overall Study|Adverse Event|2
6867922|NCT00448916|10877777|FG002|Overall Study|Adverse Event|3
6867923|NCT00448916|10877778|FG003|Overall Study|Adverse Event|2
6867924|NCT00448916|10877775|FG000|Overall Study|Lack of Efficacy|1
6867925|NCT00448916|10877776|FG001|Overall Study|Lack of Efficacy|0
6867926|NCT00448916|10877777|FG002|Overall Study|Lack of Efficacy|2
6867927|NCT00448916|10877778|FG003|Overall Study|Lack of Efficacy|1
6867928|NCT00448916|10877775|FG000|Overall Study|Withdrawal by Subject|3
6867929|NCT00448916|10877776|FG001|Overall Study|Withdrawal by Subject|3
6867930|NCT00448916|10877777|FG002|Overall Study|Withdrawal by Subject|1
6867931|NCT00448916|10877778|FG003|Overall Study|Withdrawal by Subject|1
6867932|NCT00448916|10877775|FG000|Overall Study|Other|1
6867933|NCT00448916|10877776|FG001|Overall Study|Other|0
6867934|NCT00448916|10877777|FG002|Overall Study|Other|0
6867935|NCT00448916|10877778|FG003|Overall Study|Other|0
6867936|NCT00448916|10877775|FG000|Overall Study|Lost to Follow-up|0
6867937|NCT00448916|10877776|FG001|Overall Study|Lost to Follow-up|1
6867938|NCT00448916|10877777|FG002|Overall Study|Lost to Follow-up|0
6867939|NCT00448916|10877778|FG003|Overall Study|Lost to Follow-up|1
6867940|NCT00448916|10877775|FG000|Overall Study|Protocol Violation|0
6867941|NCT00448916|10877776|FG001|Overall Study|Protocol Violation|0
6867942|NCT00448916|10877777|FG002|Overall Study|Protocol Violation|0
6867943|NCT00448916|10877778|FG003|Overall Study|Protocol Violation|1
6867944|NCT00449033|10877803|FG000|Treatment Period|Adverse Event|117
6867945|NCT00449033|10877804|FG001|Treatment Period|Adverse Event|83
6867946|NCT00449033|10877803|FG000|Treatment Period|Death|21
6867947|NCT00449033|10877804|FG001|Treatment Period|Death|12
6867948|NCT00449033|10877803|FG000|Treatment Period|Lost to Follow-up|0
6867949|NCT00449033|10877804|FG001|Treatment Period|Lost to Follow-up|2
6867950|NCT00449033|10877803|FG000|Treatment Period|Physician Decision|4
6867951|NCT00449033|10877804|FG001|Treatment Period|Physician Decision|5
6867952|NCT00449033|10877803|FG000|Treatment Period|Protocol Violation|8
6867953|NCT00449033|10877804|FG001|Treatment Period|Protocol Violation|7
6867954|NCT00449033|10877803|FG000|Treatment Period|Disease Progression|231
6867955|NCT00449033|10877804|FG001|Treatment Period|Disease Progression|288
6867956|NCT00449033|10877803|FG000|Treatment Period|Consent Withdrawn|36
6867957|NCT00449033|10877804|FG001|Treatment Period|Consent Withdrawn|20
6867958|NCT00449033|10877803|FG000|Treatment Period|Amended Protocol Criteria|22
6867959|NCT00449033|10877804|FG001|Treatment Period|Amended Protocol Criteria|18
6867960|NCT00449033|10877803|FG000|Treatment Period|Non-compliance|7
6867961|NCT00449033|10877804|FG001|Treatment Period|Non-compliance|8
6867962|NCT00449033|10877803|FG000|Treatment Period|Second Malignancy|0
6867963|NCT00449033|10877804|FG001|Treatment Period|Second Malignancy|1
6867964|NCT00449033|10877803|FG000|Treatment Period|Reason Missing|0
6867965|NCT00449033|10877804|FG001|Treatment Period|Reason Missing|4
6867966|NCT00449033|10877803|FG000|Treatment Period|Treatment Ongoing|6
6867967|NCT00449033|10877804|FG001|Treatment Period|Treatment Ongoing|4
6867968|NCT00449033|10877803|FG000|Follow-up Period|Death|299
6867969|NCT00449033|10877804|FG001|Follow-up Period|Death|311
6867970|NCT00449033|10877803|FG000|Follow-up Period|Lost to Follow-up|6
6867971|NCT00449033|10877804|FG001|Follow-up Period|Lost to Follow-up|10
6867972|NCT00449033|10877803|FG000|Follow-up Period|Reason Missing|120
6867973|NCT00449033|10877804|FG001|Follow-up Period|Reason Missing|113
7078264|NCT02101021|11186577|FG000|Overall Study|Death|4
7078265|NCT02101021|11186578|FG001|Overall Study|Death|3
7078266|NCT02101021|11186579|FG002|Overall Study|Death|6
7078267|NCT02101021|11186580|FG003|Overall Study|Death|0
7078268|NCT02101021|11186581|FG004|Overall Study|Death|3
7078269|NCT02101021|11186577|FG000|Overall Study|Withdrew Consent from study|1
7078270|NCT02101021|11186578|FG001|Overall Study|Withdrew Consent from study|1
7078271|NCT02101021|11186579|FG002|Overall Study|Withdrew Consent from study|0
7078272|NCT02101021|11186580|FG003|Overall Study|Withdrew Consent from study|2
7078273|NCT02101021|11186581|FG004|Overall Study|Withdrew Consent from study|0
7078274|NCT02101021|11186577|FG000|Overall Study|Lost to Follow-up|1
7078275|NCT02101021|11186578|FG001|Overall Study|Lost to Follow-up|0
7078276|NCT02101021|11186579|FG002|Overall Study|Lost to Follow-up|0
7078277|NCT02101021|11186580|FG003|Overall Study|Lost to Follow-up|0
7078278|NCT02101021|11186581|FG004|Overall Study|Lost to Follow-up|0
7078279|NCT02101021|11186577|FG000|Overall Study|Study Terminated by Sponsor|1
6867974|NCT00449072|10877816|FG000|Overall Study|Adverse Event|3
6867975|NCT00449072|10877817|FG001|Overall Study|Adverse Event|1
6867976|NCT00449072|10877816|FG000|Overall Study|Protocol Violation|14
6867977|NCT00449072|10877817|FG001|Overall Study|Protocol Violation|12
6867978|NCT00449072|10877816|FG000|Overall Study|Lost to Follow-up|5
6867979|NCT00449072|10877817|FG001|Overall Study|Lost to Follow-up|7
6867980|NCT00449072|10877816|FG000|Overall Study|Withdrawal by Subject|11
6867981|NCT00449072|10877817|FG001|Overall Study|Withdrawal by Subject|8
6867982|NCT00449072|10877816|FG000|Overall Study|Lack of Efficacy|1
6867983|NCT00449072|10877817|FG001|Overall Study|Lack of Efficacy|1
6867984|NCT00449072|10877816|FG000|Overall Study|Physician Decision|1
6867985|NCT00449072|10877817|FG001|Overall Study|Physician Decision|0
6867986|NCT00449072|10877816|FG000|Overall Study|Not treated|0
6867987|NCT00449072|10877817|FG001|Overall Study|Not treated|1
7078280|NCT02101021|11186578|FG001|Overall Study|Study Terminated by Sponsor|0
7078281|NCT02101021|11186579|FG002|Overall Study|Study Terminated by Sponsor|1
7078282|NCT02101021|11186580|FG003|Overall Study|Study Terminated by Sponsor|1
7078283|NCT02101021|11186581|FG004|Overall Study|Study Terminated by Sponsor|1
6867988|NCT00449072|10877816|FG000|Overall Study|Excluded medication|0
6867989|NCT00449072|10877817|FG001|Overall Study|Excluded medication|2
6867990|NCT00449072|10877816|FG000|Overall Study|Non-compliance|2
6867991|NCT00449072|10877817|FG001|Overall Study|Non-compliance|5
6867992|NCT00449072|10877816|FG000|Overall Study|Sponsor decision|1
6867993|NCT00449072|10877817|FG001|Overall Study|Sponsor decision|3
7078284|NCT02101060|11186595|FG000|Overall Study|Adverse Event|1
6867994|NCT00449072|10877816|FG000|Overall Study|Relocation|3
6867995|NCT00449072|10877817|FG001|Overall Study|Relocation|2
6867996|NCT00449150|10877826|FG000|Overall Study|Adverse Event|11
6867997|NCT00449150|10877827|FG001|Overall Study|Adverse Event|18
6867998|NCT00449150|10877828|FG002|Overall Study|Adverse Event|9
6867999|NCT00449150|10877826|FG000|Overall Study|Lack of Efficacy|1
6868000|NCT00449150|10877827|FG001|Overall Study|Lack of Efficacy|2
6868001|NCT00449150|10877828|FG002|Overall Study|Lack of Efficacy|2
6868002|NCT00449150|10877826|FG000|Overall Study|Other|16
6868003|NCT00449150|10877827|FG001|Overall Study|Other|13
6868004|NCT00449150|10877828|FG002|Overall Study|Other|14
6868005|NCT00449150|10877826|FG000|Overall Study|Withdrawal by Subject|17
6868006|NCT00449150|10877827|FG001|Overall Study|Withdrawal by Subject|18
6868007|NCT00449150|10877828|FG002|Overall Study|Withdrawal by Subject|21
6868008|NCT00449150|10877826|FG000|Overall Study|Protocol Violation|1
6868009|NCT00449150|10877827|FG001|Overall Study|Protocol Violation|2
6868010|NCT00449150|10877828|FG002|Overall Study|Protocol Violation|1
6868011|NCT00449163|10877839|FG000|Overall Study|Physician Decision|3
6868012|NCT00449176|10877846|FG000|Overall Study|Withdrawal by Subject|39
6868013|NCT00449176|10877847|FG001|Overall Study|Withdrawal by Subject|43
6868014|NCT00449176|10877848|FG002|Overall Study|Withdrawal by Subject|59
6868015|NCT00449176|10877846|FG000|Overall Study|Lost to Follow-up|13
6868016|NCT00449176|10877847|FG001|Overall Study|Lost to Follow-up|8
6868017|NCT00449176|10877848|FG002|Overall Study|Lost to Follow-up|12
6868018|NCT00449176|10877846|FG000|Overall Study|Adverse Event|51
6868019|NCT00449176|10877847|FG001|Overall Study|Adverse Event|107
6868020|NCT00449176|10877848|FG002|Overall Study|Adverse Event|15
6868021|NCT00449176|10877846|FG000|Overall Study|Lack of Efficacy|13
6868022|NCT00449176|10877847|FG001|Overall Study|Lack of Efficacy|7
6868023|NCT00449176|10877848|FG002|Overall Study|Lack of Efficacy|50
6868024|NCT00449176|10877846|FG000|Overall Study|Study drug non-compliant|14
6868025|NCT00449176|10877847|FG001|Overall Study|Study drug non-compliant|11
6868026|NCT00449176|10877848|FG002|Overall Study|Study drug non-compliant|11
6868027|NCT00449176|10877846|FG000|Overall Study|all other|22
6868028|NCT00449176|10877847|FG001|Overall Study|all other|19
6868029|NCT00449176|10877848|FG002|Overall Study|all other|20
6868030|NCT00449540|10877858|FG000|Pretreatment Phase|No migraine experienced|66
6868031|NCT00449540|10877859|FG001|Pretreatment Phase|No migraine experienced|0
6868032|NCT00449540|10877860|FG002|Pretreatment Phase|No migraine experienced|0
6868033|NCT00449540|10877858|FG000|Treatment Phase|did not experience or treat migraine|0
6868034|NCT00449540|10877859|FG001|Treatment Phase|did not experience or treat migraine|20
6868035|NCT00449540|10877860|FG002|Treatment Phase|did not experience or treat migraine|17
6868036|NCT00449644|10877872|FG000|Overall Study|Adverse Event|0
6868037|NCT00449644|10877873|FG001|Overall Study|Adverse Event|0
6868038|NCT00449644|10877874|FG002|Overall Study|Adverse Event|3
6868039|NCT00449644|10877875|FG003|Overall Study|Adverse Event|5
6868040|NCT00449644|10877872|FG000|Overall Study|Death|1
6868041|NCT00449644|10877873|FG001|Overall Study|Death|0
6868042|NCT00449644|10877874|FG002|Overall Study|Death|6
6868043|NCT00449644|10877875|FG003|Overall Study|Death|1
6868044|NCT00449644|10877872|FG000|Overall Study|Lost to Follow-up|1
6868045|NCT00449644|10877873|FG001|Overall Study|Lost to Follow-up|1
6868046|NCT00449644|10877874|FG002|Overall Study|Lost to Follow-up|5
6868047|NCT00449644|10877875|FG003|Overall Study|Lost to Follow-up|3
6868048|NCT00449644|10877872|FG000|Overall Study|Pregnancy|0
6868049|NCT00449644|10877873|FG001|Overall Study|Pregnancy|0
7078285|NCT02101060|11186596|FG001|Overall Study|Adverse Event|0
7078286|NCT02101060|11186595|FG000|Overall Study|Withdrawal by Subject|1
6868050|NCT00449644|10877874|FG002|Overall Study|Pregnancy|3
6868051|NCT00449644|10877875|FG003|Overall Study|Pregnancy|2
6868052|NCT00449644|10877872|FG000|Overall Study|Protocol Violation|4
6868053|NCT00449644|10877873|FG001|Overall Study|Protocol Violation|4
6868054|NCT00449644|10877874|FG002|Overall Study|Protocol Violation|3
6868055|NCT00449644|10877875|FG003|Overall Study|Protocol Violation|7
6868056|NCT00449644|10877872|FG000|Overall Study|Withdrawal by Subject|3
6868057|NCT00449644|10877873|FG001|Overall Study|Withdrawal by Subject|4
7154270|NCT03308942|11320874|FG002|Stage 2 (up to a Maximum of 17 Months)|Withdrawal by Subject|0
7154271|NCT03308942|11320875|FG003|Stage 2 (up to a Maximum of 17 Months)|Withdrawal by Subject|3
7154272|NCT03308942|11320876|FG004|Stage 2 (up to a Maximum of 17 Months)|Withdrawal by Subject|0
6868058|NCT00449644|10877874|FG002|Overall Study|Withdrawal by Subject|6
6868059|NCT00449644|10877875|FG003|Overall Study|Withdrawal by Subject|7
6868060|NCT00449644|10877872|FG000|Overall Study|Inclusion/exclusion criteria not met|0
6868061|NCT00449644|10877873|FG001|Overall Study|Inclusion/exclusion criteria not met|0
6868062|NCT00449644|10877874|FG002|Overall Study|Inclusion/exclusion criteria not met|2
6868063|NCT00449644|10877875|FG003|Overall Study|Inclusion/exclusion criteria not met|6
6868064|NCT00449644|10877872|FG000|Overall Study|Other|1
6868065|NCT00449644|10877873|FG001|Overall Study|Other|4
6868066|NCT00449644|10877874|FG002|Overall Study|Other|1
6868067|NCT00449644|10877875|FG003|Overall Study|Other|0
6868068|NCT00449644|10877872|FG000|Overall Study|Rolled-over to treatment with TMC207|0
6868069|NCT00449644|10877873|FG001|Overall Study|Rolled-over to treatment with TMC207|0
7078287|NCT02101060|11186596|FG001|Overall Study|Withdrawal by Subject|1
6868070|NCT00449644|10877874|FG002|Overall Study|Rolled-over to treatment with TMC207|0
6868071|NCT00449644|10877875|FG003|Overall Study|Rolled-over to treatment with TMC207|1
6868072|NCT00449670|10877890|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1
6868073|NCT00449670|10877891|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0
6868074|NCT00449670|10877890|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4
6868075|NCT00449670|10877891|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0
6868076|NCT00449670|10877890|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4
6868077|NCT00449670|10877891|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1
6868078|NCT00449670|10877890|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5
6868079|NCT00449670|10877891|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1
6868080|NCT00449670|10877890|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0
6868081|NCT00449670|10877891|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1
6868082|NCT00449670|10877890|FG000|Booster Phase (Study no.109873)|Other|0
6868083|NCT00449670|10877891|FG001|Booster Phase (Study no.109873)|Other|2
6868084|NCT00449696|10877906|FG000|Overall Study|Other Treatment Required|6
6868085|NCT00449696|10877907|FG001|Overall Study|Other Treatment Required|1
6868086|NCT00449696|10877906|FG000|Overall Study|Withdrawal by Subject|5
6868087|NCT00449696|10877907|FG001|Overall Study|Withdrawal by Subject|5
6868088|NCT00449696|10877906|FG000|Overall Study|Lost to Follow-up|2
6868089|NCT00449696|10877907|FG001|Overall Study|Lost to Follow-up|3
6868090|NCT00449696|10877906|FG000|Overall Study|Others|7
6868091|NCT00449696|10877907|FG001|Overall Study|Others|0
6868092|NCT00449761|10877917|FG000|Overall Study|Disease progression|12
6868093|NCT00449761|10877917|FG000|Overall Study|Death|5
6868094|NCT00449761|10877917|FG000|Overall Study|New cancer therapy|1
6868095|NCT00449787|10877924|FG000|Overall Study|Lost to Follow-up|10
6868096|NCT00449787|10877925|FG001|Overall Study|Lost to Follow-up|8
6868097|NCT00449787|10877924|FG000|Overall Study|Did not require medication|95
6868098|NCT00449787|10877925|FG001|Overall Study|Did not require medication|92
6868099|NCT00449865|10877935|FG000|Overall Study|Withdrawal by Subject|110
6868100|NCT00449865|10877936|FG001|Overall Study|Withdrawal by Subject|110
6868101|NCT00449865|10877935|FG000|Overall Study|Lost to Follow-up|36
6868102|NCT00449865|10877936|FG001|Overall Study|Lost to Follow-up|37
6868103|NCT00449865|10877935|FG000|Overall Study|Physician Decision|13
6868104|NCT00449865|10877936|FG001|Overall Study|Physician Decision|12
6868105|NCT00449865|10877935|FG000|Overall Study|Death|31
6868106|NCT00449865|10877936|FG001|Overall Study|Death|40
6868107|NCT00449865|10877935|FG000|Overall Study|Protocol Violation|8
6868108|NCT00449865|10877936|FG001|Overall Study|Protocol Violation|7
6868109|NCT00449865|10877935|FG000|Overall Study|Study was stopped|324
6868110|NCT00449865|10877936|FG001|Overall Study|Study was stopped|328
6868111|NCT00449930|10877944|FG000|Overall Study|Adverse Event|9
6868112|NCT00449930|10877945|FG001|Overall Study|Adverse Event|19
6868113|NCT00449930|10877944|FG000|Overall Study|Trial Terminated ( Site Closed)|1
6868114|NCT00449930|10877945|FG001|Overall Study|Trial Terminated ( Site Closed)|0
6868115|NCT00449930|10877944|FG000|Overall Study|Lack of Efficacy|10
6868116|NCT00449930|10877945|FG001|Overall Study|Lack of Efficacy|1
6868117|NCT00449930|10877944|FG000|Overall Study|Lost to Follow-up|9
6868118|NCT00449930|10877945|FG001|Overall Study|Lost to Follow-up|14
6868119|NCT00449930|10877944|FG000|Overall Study|Physician Decision|1
6868120|NCT00449930|10877945|FG001|Overall Study|Physician Decision|2
6868121|NCT00449930|10877944|FG000|Overall Study|Protocol Violation|14
6868122|NCT00449930|10877945|FG001|Overall Study|Protocol Violation|15
6868123|NCT00449930|10877944|FG000|Overall Study|Withdrawal by Subject|16
6868124|NCT00449930|10877945|FG001|Overall Study|Withdrawal by Subject|23
6868125|NCT00449930|10877944|FG000|Overall Study|Glycemic discontinuation criteria|1
6868126|NCT00449930|10877945|FG001|Overall Study|Glycemic discontinuation criteria|1
6868127|NCT00449956|10877954|FG000|Overall Study|Adverse Event|7
6868128|NCT00449956|10877955|FG001|Overall Study|Adverse Event|1
6868129|NCT00449956|10877956|FG002|Overall Study|Adverse Event|6
6868130|NCT00449956|10877954|FG000|Overall Study|Lack of Efficacy|0
6868131|NCT00449956|10877955|FG001|Overall Study|Lack of Efficacy|0
6868132|NCT00449956|10877956|FG002|Overall Study|Lack of Efficacy|1
6868133|NCT00449956|10877954|FG000|Overall Study|Protocol Violation|1
6868134|NCT00449956|10877955|FG001|Overall Study|Protocol Violation|1
6868135|NCT00449956|10877956|FG002|Overall Study|Protocol Violation|1
6868136|NCT00449956|10877954|FG000|Overall Study|Withdrawal by Subject|0
6868137|NCT00449956|10877955|FG001|Overall Study|Withdrawal by Subject|1
6868138|NCT00449956|10877956|FG002|Overall Study|Withdrawal by Subject|0
6868139|NCT00449956|10877954|FG000|Overall Study|Physician Decision|2
6868140|NCT00449956|10877955|FG001|Overall Study|Physician Decision|1
6868141|NCT00449956|10877956|FG002|Overall Study|Physician Decision|1
6868142|NCT00450112|10877979|FG000|Overall Study|Other Treatment Required|5
6868143|NCT00450112|10877980|FG001|Overall Study|Other Treatment Required|1
6868144|NCT00450112|10877979|FG000|Overall Study|Withdrawal by Subject|4
6868145|NCT00450112|10877980|FG001|Overall Study|Withdrawal by Subject|1
6868146|NCT00450112|10877979|FG000|Overall Study|Lost to Follow-up|2
6868147|NCT00450112|10877980|FG001|Overall Study|Lost to Follow-up|1
6868148|NCT00450112|10877979|FG000|Overall Study|Others|2
6868149|NCT00450112|10877980|FG001|Overall Study|Others|3
6868150|NCT00450177|10877988|FG000|Overall Study|Adverse Event|7
6868151|NCT00450177|10877989|FG001|Overall Study|Adverse Event|4
6868152|NCT00450177|10877988|FG000|Overall Study|Withdrawal by Subject|1
6868153|NCT00450177|10877989|FG001|Overall Study|Withdrawal by Subject|6
6868154|NCT00450177|10877988|FG000|Overall Study|Withdrawal by Primary Team|1
6868155|NCT00450177|10877989|FG001|Overall Study|Withdrawal by Primary Team|1
6868156|NCT00450190|10877995|FG000|Overall Study|Withdrawal by Subject|2
6868157|NCT00450216|10878001|FG000|Overall Study|Adverse Event|38
6868158|NCT00450216|10878002|FG001|Overall Study|Adverse Event|23
6868159|NCT00450216|10878001|FG000|Overall Study|Withdrawal by Subject|48
6868160|NCT00450216|10878002|FG001|Overall Study|Withdrawal by Subject|26
6868161|NCT00450216|10878001|FG000|Overall Study|Lost to Follow-up|16
6868162|NCT00450216|10878002|FG001|Overall Study|Lost to Follow-up|9
6868163|NCT00450216|10878001|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51
6868164|NCT00450216|10878002|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51
6868165|NCT00450216|10878001|FG000|Overall Study|misc|21
6868166|NCT00450216|10878002|FG001|Overall Study|misc|20
6868167|NCT00450255|10878019|FG000|Overall Study|Prior RFA ablation of liver|1
6868168|NCT00450372|10878029|FG000|Overall Study|Physician Decision|1
6868169|NCT00450385|10878036|FG000|Overall Study|Death|3
6868170|NCT00450385|10878036|FG000|Overall Study|Protocol Violation|1
6868171|NCT00450385|10878036|FG000|Overall Study|Withdrawal by Subject|2
6868172|NCT00450385|10878036|FG000|Overall Study|Lack of Efficacy|2
6868173|NCT00450385|10878036|FG000|Overall Study|Adverse Event|1
6868174|NCT00450385|10878036|FG000|Overall Study|Physician Decision|1
6868175|NCT00450385|10878036|FG000|Overall Study|Other|3
6868176|NCT00450437|10878052|FG000|Overall Study|Withdrawal by Subject|10
6868177|NCT00450437|10878053|FG001|Overall Study|Withdrawal by Subject|2
6868178|NCT00450437|10878054|FG002|Overall Study|Withdrawal by Subject|0
6868179|NCT00450437|10878055|FG003|Overall Study|Withdrawal by Subject|1
6868180|NCT00450437|10878052|FG000|Overall Study|Lost to Follow-up|31
6868181|NCT00450437|10878053|FG001|Overall Study|Lost to Follow-up|12
6868182|NCT00450437|10878054|FG002|Overall Study|Lost to Follow-up|19
6868183|NCT00450437|10878055|FG003|Overall Study|Lost to Follow-up|9
6868184|NCT00450437|10878052|FG000|Overall Study|Protocol Violation|0
6868185|NCT00450437|10878053|FG001|Overall Study|Protocol Violation|1
6868186|NCT00450437|10878054|FG002|Overall Study|Protocol Violation|0
6868187|NCT00450437|10878055|FG003|Overall Study|Protocol Violation|1
6868188|NCT00450437|10878052|FG000|Overall Study|Inappropriate enrollment|4
6868189|NCT00450437|10878053|FG001|Overall Study|Inappropriate enrollment|1
6868190|NCT00450437|10878054|FG002|Overall Study|Inappropriate enrollment|3
6868191|NCT00450437|10878055|FG003|Overall Study|Inappropriate enrollment|0
6868192|NCT00450437|10878052|FG000|Overall Study|Administrative reason|0
6868193|NCT00450437|10878053|FG001|Overall Study|Administrative reason|0
6868194|NCT00450437|10878054|FG002|Overall Study|Administrative reason|1
6868195|NCT00450437|10878055|FG003|Overall Study|Administrative reason|0
6868196|NCT00450437|10878052|FG000|Overall Study|Unable to Classify|1
6868197|NCT00450437|10878053|FG001|Overall Study|Unable to Classify|0
6868198|NCT00450437|10878054|FG002|Overall Study|Unable to Classify|1
6868199|NCT00450437|10878055|FG003|Overall Study|Unable to Classify|0
6868200|NCT00450580|10878083|FG000|Overall Study|Adverse Event|5
6868201|NCT00450580|10878084|FG001|Overall Study|Adverse Event|7
6868202|NCT00450580|10878083|FG000|Overall Study|Lost to Follow-up|4
6868203|NCT00450580|10878084|FG001|Overall Study|Lost to Follow-up|5
6868204|NCT00450580|10878083|FG000|Overall Study|Withdrawal by Subject|2
6868205|NCT00450580|10878084|FG001|Overall Study|Withdrawal by Subject|2
6868206|NCT00450580|10878083|FG000|Overall Study|Protocol Violation|1
6868207|NCT00450580|10878084|FG001|Overall Study|Protocol Violation|1
6868208|NCT00450580|10878083|FG000|Overall Study|Protocol-defined virologic failure|1
6868209|NCT00450580|10878084|FG001|Overall Study|Protocol-defined virologic failure|0
6868210|NCT00450580|10878083|FG000|Overall Study|Could not comply with scheduled visits|1
6868211|NCT00450580|10878084|FG001|Overall Study|Could not comply with scheduled visits|0
6868212|NCT00450580|10878083|FG000|Overall Study|Patient went to Brazil|1
6868213|NCT00450580|10878084|FG001|Overall Study|Patient went to Brazil|0
6868214|NCT00450580|10878083|FG000|Overall Study|Patient could not swallow Norvir|1
6868215|NCT00450580|10878084|FG001|Overall Study|Patient could not swallow Norvir|0
6868216|NCT00450580|10878083|FG000|Overall Study|Withdrawal due to pregnancy|0
6868217|NCT00450580|10878084|FG001|Overall Study|Withdrawal due to pregnancy|1
6868218|NCT00450619|10878092|FG000|Overall Study|refused treatment after randomization|2
6868219|NCT00450619|10878093|FG001|Overall Study|refused treatment after randomization|0
6868220|NCT00450619|10878092|FG000|Overall Study|did not progress; refused further trmt|1
6868221|NCT00450619|10878093|FG001|Overall Study|did not progress; refused further trmt|1
6868222|NCT00450619|10878092|FG000|Overall Study|Adverse Event|1
6868223|NCT00450619|10878093|FG001|Overall Study|Adverse Event|0
6868224|NCT00450658|10878102|FG000|Overall Study|Adverse Event|24
6868225|NCT00450658|10878103|FG001|Overall Study|Adverse Event|15
6968361|NCT01137682|11017141|FG002|Overall Study|Administrative problems-Extension|0
6868226|NCT00450658|10878102|FG000|Overall Study|Withdrawal by Subject|43
6868227|NCT00450658|10878103|FG001|Overall Study|Withdrawal by Subject|26
6868228|NCT00450658|10878102|FG000|Overall Study|Lost to Follow-up|22
6868229|NCT00450658|10878103|FG001|Overall Study|Lost to Follow-up|5
6868230|NCT00450658|10878102|FG000|Overall Study|UGI ulcer|33
6868231|NCT00450658|10878103|FG001|Overall Study|UGI ulcer|34
6868232|NCT00450658|10878102|FG000|Overall Study|misc|21
6868233|NCT00450658|10878103|FG001|Overall Study|misc|10
6868234|NCT00450723|10878109|FG000|Overall Study|Physician Decision|5
6868235|NCT00450749|10878117|FG000|Overall Study|Withdrawal by Subject|0
6868236|NCT00450749|10878118|FG001|Overall Study|Withdrawal by Subject|0
6868237|NCT00450749|10878119|FG002|Overall Study|Withdrawal by Subject|2
6868238|NCT00450749|10878117|FG000|Overall Study|Noncompliant|0
6868239|NCT00450749|10878118|FG001|Overall Study|Noncompliant|1
6868240|NCT00450749|10878119|FG002|Overall Study|Noncompliant|0
6868241|NCT00450801|10878127|FG000|Overall Study|Death|1
6868242|NCT00450814|10878146|FG000|Overall Study|Failed to complete the initial therapy|0
6868243|NCT00450814|10878147|FG001|Overall Study|Failed to complete the initial therapy|0
6868244|NCT00450814|10878148|FG002|Overall Study|Failed to complete the initial therapy|0
6868245|NCT00450814|10878149|FG003|Overall Study|Failed to complete the initial therapy|1
6868246|NCT00450814|10878150|FG004|Overall Study|Failed to complete the initial therapy|1
6868247|NCT00450814|10878151|FG005|Overall Study|Failed to complete the initial therapy|1
6868248|NCT00450814|10878152|FG006|Overall Study|Failed to complete the initial therapy|0
6868249|NCT00450814|10878153|FG007|Overall Study|Failed to complete the initial therapy|0
6868250|NCT00450814|10878154|FG008|Overall Study|Failed to complete the initial therapy|0
6868251|NCT00450814|10878155|FG009|Overall Study|Failed to complete the initial therapy|0
6868252|NCT00450814|10878156|FG010|Overall Study|Failed to complete the initial therapy|0
6868253|NCT00450814|10878146|FG000|Overall Study|Patient withdrawal prior to treatment|0
6868254|NCT00450814|10878147|FG001|Overall Study|Patient withdrawal prior to treatment|0
6868255|NCT00450814|10878148|FG002|Overall Study|Patient withdrawal prior to treatment|0
6868256|NCT00450814|10878149|FG003|Overall Study|Patient withdrawal prior to treatment|0
6868257|NCT00450814|10878150|FG004|Overall Study|Patient withdrawal prior to treatment|0
6868258|NCT00450814|10878151|FG005|Overall Study|Patient withdrawal prior to treatment|0
6868259|NCT00450814|10878152|FG006|Overall Study|Patient withdrawal prior to treatment|0
6868260|NCT00450814|10878153|FG007|Overall Study|Patient withdrawal prior to treatment|0
6868261|NCT00450814|10878154|FG008|Overall Study|Patient withdrawal prior to treatment|0
6868262|NCT00450814|10878155|FG009|Overall Study|Patient withdrawal prior to treatment|1
6868263|NCT00450814|10878156|FG010|Overall Study|Patient withdrawal prior to treatment|0
6868264|NCT00450866|10878181|FG000|Overall Study|Adverse Event|0
6868265|NCT00450866|10878182|FG001|Overall Study|Adverse Event|1
6868266|NCT00450866|10878181|FG000|Overall Study|Withdrawal by Subject|5
6868267|NCT00450866|10878182|FG001|Overall Study|Withdrawal by Subject|2
6868268|NCT00450866|10878181|FG000|Overall Study|Death|1
6868269|NCT00450866|10878182|FG001|Overall Study|Death|0
6868270|NCT00450866|10878181|FG000|Overall Study|Physician Decision|1
6868271|NCT00450866|10878182|FG001|Overall Study|Physician Decision|0
6868272|NCT00451035|10878192|FG000|Overall Study|Disease progression|11
6868273|NCT00451035|10878192|FG000|Overall Study|Death|3
6868274|NCT00451035|10878192|FG000|Overall Study|New anti-neoplastic therapy|3
6868275|NCT00451178|10878203|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6
6868276|NCT00451178|10878204|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6
6868277|NCT00451178|10878203|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4
6868278|NCT00451178|10878204|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3
6868279|NCT00451178|10878203|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2
6868280|NCT00451178|10878204|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1
6868281|NCT00451178|10878203|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1
6868282|NCT00451178|10878204|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2
6868283|NCT00451178|10878203|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4
6868284|NCT00451178|10878204|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3
6868285|NCT00451178|10878203|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1
6868286|NCT00451178|10878204|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2
6868287|NCT00451178|10878203|FG000|Prior to Maintenance Therapy|Physician Decision|2
6868288|NCT00451178|10878204|FG001|Prior to Maintenance Therapy|Physician Decision|0
6868289|NCT00451178|10878203|FG000|Prior to Maintenance Therapy|PD|2
6868290|NCT00451178|10878204|FG001|Prior to Maintenance Therapy|PD|0
6868291|NCT00451178|10878203|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4
6868292|NCT00451178|10878204|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0
6868293|NCT00451178|10878203|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5
6868294|NCT00451178|10878204|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0
6868295|NCT00451178|10878203|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1
6868296|NCT00451178|10878204|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0
6868297|NCT00451178|10878203|FG000|Maintenance Therapy (up to 3 Years)|Death|1
6868298|NCT00451178|10878204|FG001|Maintenance Therapy (up to 3 Years)|Death|0
6868299|NCT00451178|10878203|FG000|Maintenance Therapy (up to 3 Years)|PD|10
6868300|NCT00451178|10878204|FG001|Maintenance Therapy (up to 3 Years)|PD|0
6868301|NCT00451178|10878203|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9
6868302|NCT00451178|10878204|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0
6868303|NCT00451178|10878203|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6
6868304|NCT00451178|10878204|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26
7154273|NCT03308942|11320872|FG000|Stage 2 (up to a Maximum of 17 Months)|Death|0
6868305|NCT00451191|10878216|FG000|Overall Study|withdrawal or received alternate tx|15
6868306|NCT00451191|10878217|FG001|Overall Study|withdrawal or received alternate tx|11
6868307|NCT00451204|10878225|FG000|Overall Study|Adverse Event|4
6868308|NCT00451204|10878226|FG001|Overall Study|Adverse Event|6
6868309|NCT00451204|10878225|FG000|Overall Study|Lack of Efficacy|4
6868310|NCT00451204|10878226|FG001|Overall Study|Lack of Efficacy|4
6868311|NCT00451204|10878225|FG000|Overall Study|Lost to Follow-up|4
6868312|NCT00451204|10878226|FG001|Overall Study|Lost to Follow-up|4
6868313|NCT00451204|10878225|FG000|Overall Study|Protocol Violation|1
6868314|NCT00451204|10878226|FG001|Overall Study|Protocol Violation|0
6868315|NCT00451204|10878225|FG000|Overall Study|Patient refusal|8
6868316|NCT00451204|10878226|FG001|Overall Study|Patient refusal|4
6868317|NCT00451204|10878225|FG000|Overall Study|Other|1
6868318|NCT00451204|10878226|FG001|Overall Study|Other|2
6868319|NCT00451217|10878239|FG000|Overall Study|Lost to Follow-up|0
6868320|NCT00451217|10878240|FG001|Overall Study|Lost to Follow-up|1
6868321|NCT00451217|10878241|FG002|Overall Study|Lost to Follow-up|1
6868322|NCT00451217|10878242|FG003|Overall Study|Lost to Follow-up|1
6868323|NCT00451217|10878239|FG000|Overall Study|Withdrawal by Subject|1
6868324|NCT00451217|10878240|FG001|Overall Study|Withdrawal by Subject|0
6868325|NCT00451217|10878241|FG002|Overall Study|Withdrawal by Subject|0
6868326|NCT00451217|10878242|FG003|Overall Study|Withdrawal by Subject|0
6868327|NCT00451217|10878239|FG000|Overall Study|Not Treated|1
6868328|NCT00451217|10878240|FG001|Overall Study|Not Treated|1
6868329|NCT00451217|10878241|FG002|Overall Study|Not Treated|3
6868330|NCT00451217|10878242|FG003|Overall Study|Not Treated|4
6868331|NCT00451282|10878254|FG000|Overall Study|Lost to Follow-up|6
6868332|NCT00451282|10878255|FG001|Overall Study|Lost to Follow-up|5
6868333|NCT00451321|10878269|FG000|Overall Study|Lost to Follow-up|3
6868334|NCT00451321|10878270|FG001|Overall Study|Lost to Follow-up|3
6868335|NCT00451321|10878271|FG002|Overall Study|Lost to Follow-up|1
6868336|NCT00451321|10878272|FG003|Overall Study|Lost to Follow-up|3
6868337|NCT00451321|10878273|FG004|Overall Study|Lost to Follow-up|0
6868338|NCT00451321|10878274|FG005|Overall Study|Lost to Follow-up|1
6868339|NCT00451321|10878275|FG006|Overall Study|Lost to Follow-up|0
6868340|NCT00451321|10878276|FG007|Overall Study|Lost to Follow-up|0
6868341|NCT00451321|10878269|FG000|Overall Study|Withdrawal by Subject|3
6868342|NCT00451321|10878270|FG001|Overall Study|Withdrawal by Subject|1
6868343|NCT00451321|10878271|FG002|Overall Study|Withdrawal by Subject|0
6868344|NCT00451321|10878272|FG003|Overall Study|Withdrawal by Subject|4
6868345|NCT00451321|10878273|FG004|Overall Study|Withdrawal by Subject|0
6868346|NCT00451321|10878274|FG005|Overall Study|Withdrawal by Subject|0
6868347|NCT00451321|10878275|FG006|Overall Study|Withdrawal by Subject|0
6868348|NCT00451321|10878276|FG007|Overall Study|Withdrawal by Subject|0
6868349|NCT00451321|10878269|FG000|Overall Study|Study closed/terminated|1
6868350|NCT00451321|10878270|FG001|Overall Study|Study closed/terminated|1
6868351|NCT00451321|10878271|FG002|Overall Study|Study closed/terminated|17
6868352|NCT00451321|10878272|FG003|Overall Study|Study closed/terminated|5
6868353|NCT00451321|10878273|FG004|Overall Study|Study closed/terminated|7
6868354|NCT00451321|10878274|FG005|Overall Study|Study closed/terminated|7
6868355|NCT00451321|10878275|FG006|Overall Study|Study closed/terminated|5
6868356|NCT00451321|10878276|FG007|Overall Study|Study closed/terminated|3
6868357|NCT00451321|10878269|FG000|Overall Study|Sponsor decision to amend protocol|0
6868358|NCT00451321|10878270|FG001|Overall Study|Sponsor decision to amend protocol|0
6868359|NCT00451321|10878271|FG002|Overall Study|Sponsor decision to amend protocol|0
6868360|NCT00451321|10878272|FG003|Overall Study|Sponsor decision to amend protocol|0
6868361|NCT00451321|10878273|FG004|Overall Study|Sponsor decision to amend protocol|0
6868362|NCT00451321|10878274|FG005|Overall Study|Sponsor decision to amend protocol|1
6868363|NCT00451321|10878275|FG006|Overall Study|Sponsor decision to amend protocol|1
6868364|NCT00451321|10878276|FG007|Overall Study|Sponsor decision to amend protocol|3
6868365|NCT00451451|10878298|FG000|Overall Study|Adverse Event|11
6868366|NCT00451451|10878299|FG001|Overall Study|Adverse Event|21
6868367|NCT00451451|10878300|FG002|Overall Study|Adverse Event|26
6868368|NCT00451451|10878301|FG003|Overall Study|Adverse Event|10
6868369|NCT00451451|10878298|FG000|Overall Study|Lost to Follow-up|11
6868370|NCT00451451|10878299|FG001|Overall Study|Lost to Follow-up|9
6868371|NCT00451451|10878300|FG002|Overall Study|Lost to Follow-up|8
6868372|NCT00451451|10878301|FG003|Overall Study|Lost to Follow-up|11
6868373|NCT00451451|10878298|FG000|Overall Study|Consent Withdrawn|14
6868374|NCT00451451|10878299|FG001|Overall Study|Consent Withdrawn|9
6868375|NCT00451451|10878300|FG002|Overall Study|Consent Withdrawn|17
6868376|NCT00451451|10878301|FG003|Overall Study|Consent Withdrawn|17
6868377|NCT00451451|10878298|FG000|Overall Study|Investigator Decision|6
6868378|NCT00451451|10878299|FG001|Overall Study|Investigator Decision|2
6868379|NCT00451451|10878300|FG002|Overall Study|Investigator Decision|1
6868380|NCT00451451|10878301|FG003|Overall Study|Investigator Decision|2
6868381|NCT00451451|10878298|FG000|Overall Study|Subject Non-Compliance|8
6868382|NCT00451451|10878299|FG001|Overall Study|Subject Non-Compliance|4
6868383|NCT00451451|10878300|FG002|Overall Study|Subject Non-Compliance|3
6868384|NCT00451451|10878301|FG003|Overall Study|Subject Non-Compliance|3
6868385|NCT00451451|10878298|FG000|Overall Study|Death|1
6868386|NCT00451451|10878299|FG001|Overall Study|Death|0
6868387|NCT00451451|10878300|FG002|Overall Study|Death|0
6868388|NCT00451451|10878301|FG003|Overall Study|Death|1
6868389|NCT00451451|10878298|FG000|Overall Study|Other Reasons for Not Completing Study|34
6868390|NCT00451451|10878299|FG001|Overall Study|Other Reasons for Not Completing Study|30
6868391|NCT00451451|10878300|FG002|Overall Study|Other Reasons for Not Completing Study|17
6868392|NCT00451451|10878301|FG003|Overall Study|Other Reasons for Not Completing Study|14
6868393|NCT00451555|10878316|FG000|Overall Study|Protocol Violation|2
6868394|NCT00451555|10878317|FG001|Overall Study|Protocol Violation|2
6868395|NCT00451555|10878316|FG000|Overall Study|Adverse Event|3
6868396|NCT00451555|10878317|FG001|Overall Study|Adverse Event|1
6868397|NCT00451555|10878316|FG000|Overall Study|Withdrawal by Subject|6
6868398|NCT00451555|10878317|FG001|Overall Study|Withdrawal by Subject|0
6868399|NCT00451555|10878316|FG000|Overall Study|Physician Decision|2
6868400|NCT00451555|10878317|FG001|Overall Study|Physician Decision|1
6868401|NCT00451906|10878343|FG000|Overall Study|Adverse Event|515
6868402|NCT00451906|10878343|FG000|Overall Study|Lost to Follow-up|31
6868403|NCT00451906|10878343|FG000|Overall Study|Withdrawal by Subject|111
6868404|NCT00451906|10878343|FG000|Overall Study|Protocol Violation|21
6868405|NCT00451906|10878343|FG000|Overall Study|Progressive disease|1328
6868406|NCT00451906|10878343|FG000|Overall Study|Termination of the study|108
6868407|NCT00451906|10878343|FG000|Overall Study|Other Reasons|121
6868408|NCT00451906|10878343|FG000|Overall Study|Did not complete final visit|4
6868409|NCT00451958|10878351|FG000|CS21A (NCT00451958)|Adverse Event|21
6868410|NCT00451958|10878352|FG001|CS21A (NCT00451958)|Adverse Event|34
6868411|NCT00451958|10878353|FG002|CS21A (NCT00451958)|Adverse Event|14
6868412|NCT00451958|10878354|FG003|CS21A (NCT00451958)|Adverse Event|17
6868413|NCT00451958|10878355|FG004|CS21A (NCT00451958)|Adverse Event|0
6868414|NCT00451958|10878351|FG000|CS21A (NCT00451958)|Lost to Follow-up|6
6868415|NCT00451958|10878352|FG001|CS21A (NCT00451958)|Lost to Follow-up|5
6868416|NCT00451958|10878353|FG002|CS21A (NCT00451958)|Lost to Follow-up|1
6868417|NCT00451958|10878354|FG003|CS21A (NCT00451958)|Lost to Follow-up|1
6868418|NCT00451958|10878355|FG004|CS21A (NCT00451958)|Lost to Follow-up|0
6868419|NCT00451958|10878351|FG000|CS21A (NCT00451958)|Protocol Violation|1
6868420|NCT00451958|10878352|FG001|CS21A (NCT00451958)|Protocol Violation|3
6868421|NCT00451958|10878353|FG002|CS21A (NCT00451958)|Protocol Violation|2
6868422|NCT00451958|10878354|FG003|CS21A (NCT00451958)|Protocol Violation|0
6868423|NCT00451958|10878355|FG004|CS21A (NCT00451958)|Protocol Violation|0
6868424|NCT00451958|10878351|FG000|CS21A (NCT00451958)|Physician Decision|2
6868425|NCT00451958|10878352|FG001|CS21A (NCT00451958)|Physician Decision|4
6868426|NCT00451958|10878353|FG002|CS21A (NCT00451958)|Physician Decision|4
6868427|NCT00451958|10878354|FG003|CS21A (NCT00451958)|Physician Decision|4
6868428|NCT00451958|10878355|FG004|CS21A (NCT00451958)|Physician Decision|0
6868429|NCT00451958|10878351|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7
6868430|NCT00451958|10878352|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4
6868431|NCT00451958|10878353|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4
6868432|NCT00451958|10878354|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3
6868433|NCT00451958|10878355|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0
6868434|NCT00451958|10878351|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28
6868435|NCT00451958|10878352|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27
6868436|NCT00451958|10878353|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17
6868437|NCT00451958|10878354|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14
6868438|NCT00451958|10878355|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0
6868439|NCT00452114|10878371|FG000|Overall Study|Physician Decision|3
6868440|NCT00452114|10878372|FG001|Overall Study|Physician Decision|3
6868441|NCT00452348|10878396|FG000|Overall Study|Adverse Event|6
6868442|NCT00452348|10878397|FG001|Overall Study|Adverse Event|9
6868443|NCT00452348|10878396|FG000|Overall Study|Lack of Efficacy|10
6868444|NCT00452348|10878397|FG001|Overall Study|Lack of Efficacy|9
6868445|NCT00452348|10878396|FG000|Overall Study|Lost to Follow-up|14
6868446|NCT00452348|10878397|FG001|Overall Study|Lost to Follow-up|8
6868447|NCT00452348|10878396|FG000|Overall Study|Protocol Violation|22
6868448|NCT00452348|10878397|FG001|Overall Study|Protocol Violation|28
6868449|NCT00452348|10878396|FG000|Overall Study|Withdrawal by Subject|18
6868450|NCT00452348|10878397|FG001|Overall Study|Withdrawal by Subject|21
6868451|NCT00452348|10878396|FG000|Overall Study|Other|9
6868452|NCT00452348|10878397|FG001|Overall Study|Other|9
6868453|NCT00452400|10878418|FG000|Overall Study|Adverse Event|1
6868454|NCT00452400|10878419|FG001|Overall Study|Adverse Event|1
6868455|NCT00452400|10878420|FG002|Overall Study|Adverse Event|5
6868456|NCT00452400|10878421|FG003|Overall Study|Adverse Event|0
6868457|NCT00452400|10878422|FG004|Overall Study|Adverse Event|2
6868458|NCT00452400|10878418|FG000|Overall Study|Protocol Violation|0
6868459|NCT00452400|10878419|FG001|Overall Study|Protocol Violation|0
6868460|NCT00452400|10878420|FG002|Overall Study|Protocol Violation|1
6868461|NCT00452400|10878421|FG003|Overall Study|Protocol Violation|0
6868462|NCT00452400|10878422|FG004|Overall Study|Protocol Violation|0
6868463|NCT00452400|10878418|FG000|Overall Study|Lost to Follow-up|1
6868464|NCT00452400|10878419|FG001|Overall Study|Lost to Follow-up|0
6868465|NCT00452400|10878420|FG002|Overall Study|Lost to Follow-up|0
6868466|NCT00452400|10878421|FG003|Overall Study|Lost to Follow-up|0
6868467|NCT00452400|10878422|FG004|Overall Study|Lost to Follow-up|0
7078288|NCT02101060|11186595|FG000|Overall Study|Lost to Follow-up|3
7078289|NCT02101060|11186596|FG001|Overall Study|Lost to Follow-up|3
7078290|NCT02101112|11186602|FG000|Overall Study|Adverse Event|0
7078291|NCT02101112|11186603|FG001|Overall Study|Adverse Event|0
7078292|NCT02101112|11186604|FG002|Overall Study|Adverse Event|1
6868468|NCT00452400|10878418|FG000|Overall Study|Withdrawal by Subject|1
6868469|NCT00452400|10878419|FG001|Overall Study|Withdrawal by Subject|0
6868470|NCT00452400|10878420|FG002|Overall Study|Withdrawal by Subject|1
6868471|NCT00452400|10878421|FG003|Overall Study|Withdrawal by Subject|0
6868472|NCT00452400|10878422|FG004|Overall Study|Withdrawal by Subject|0
6868473|NCT00452400|10878418|FG000|Overall Study|Lack of Efficacy|2
6868474|NCT00452400|10878419|FG001|Overall Study|Lack of Efficacy|0
7078293|NCT02101112|11186605|FG003|Overall Study|Adverse Event|0
7078294|NCT02101112|11186606|FG004|Overall Study|Adverse Event|0
7078295|NCT02101112|11186607|FG005|Overall Study|Adverse Event|0
7078296|NCT02101112|11186602|FG000|Overall Study|Withdrawal by Subject|0
7078297|NCT02101112|11186603|FG001|Overall Study|Withdrawal by Subject|0
7078298|NCT02101112|11186604|FG002|Overall Study|Withdrawal by Subject|0
7078299|NCT02101112|11186605|FG003|Overall Study|Withdrawal by Subject|0
6868475|NCT00452400|10878420|FG002|Overall Study|Lack of Efficacy|0
6868476|NCT00452400|10878421|FG003|Overall Study|Lack of Efficacy|0
6868477|NCT00452400|10878422|FG004|Overall Study|Lack of Efficacy|0
6868478|NCT00452400|10878418|FG000|Overall Study|Other reasons not listed above|0
6868479|NCT00452400|10878419|FG001|Overall Study|Other reasons not listed above|0
6868480|NCT00452400|10878420|FG002|Overall Study|Other reasons not listed above|0
6868481|NCT00452400|10878421|FG003|Overall Study|Other reasons not listed above|1
6868482|NCT00452400|10878422|FG004|Overall Study|Other reasons not listed above|1
6868483|NCT00452413|10878437|FG000|Overall Study|Progressive Disease|4
6868484|NCT00452413|10878438|FG001|Overall Study|Progressive Disease|11
6868485|NCT00452413|10878439|FG002|Overall Study|Progressive Disease|30
6868486|NCT00452413|10878437|FG000|Overall Study|Withdrawal by Subject|0
6868487|NCT00452413|10878438|FG001|Overall Study|Withdrawal by Subject|1
6868488|NCT00452413|10878439|FG002|Overall Study|Withdrawal by Subject|4
6868489|NCT00452413|10878437|FG000|Overall Study|Adverse Event|0
6868490|NCT00452413|10878438|FG001|Overall Study|Adverse Event|0
6868491|NCT00452413|10878439|FG002|Overall Study|Adverse Event|5
6868492|NCT00452413|10878437|FG000|Overall Study|Physician Decision|0
6868493|NCT00452413|10878438|FG001|Overall Study|Physician Decision|0
6868494|NCT00452413|10878439|FG002|Overall Study|Physician Decision|4
6868495|NCT00452413|10878437|FG000|Overall Study|Death due to study disease|0
6868496|NCT00452413|10878438|FG001|Overall Study|Death due to study disease|0
6868497|NCT00452413|10878439|FG002|Overall Study|Death due to study disease|2
6868498|NCT00452413|10878437|FG000|Overall Study|Death due to adverse event (AE)|0
6868499|NCT00452413|10878438|FG001|Overall Study|Death due to adverse event (AE)|0
6868500|NCT00452413|10878439|FG002|Overall Study|Death due to adverse event (AE)|1
6868501|NCT00452413|10878437|FG000|Overall Study|On treatment|0
6868502|NCT00452413|10878438|FG001|Overall Study|On treatment|0
6868503|NCT00452413|10878439|FG002|Overall Study|On treatment|3
6868504|NCT00452439|10878459|FG000|Overall Study|Lost to Follow-up|1
6868505|NCT00452439|10878460|FG001|Overall Study|Lost to Follow-up|1
6868506|NCT00452439|10878459|FG000|Overall Study|Refused Treatment|4
6868507|NCT00452439|10878460|FG001|Overall Study|Refused Treatment|3
6868508|NCT00452439|10878459|FG000|Overall Study|Death|3
6868509|NCT00452439|10878460|FG001|Overall Study|Death|1
6868510|NCT00452439|10878459|FG000|Overall Study|Bone Marrow Transplant|0
6868511|NCT00452439|10878460|FG001|Overall Study|Bone Marrow Transplant|1
6868512|NCT00452439|10878459|FG000|Overall Study|Too Ill to Continue|0
6868513|NCT00452439|10878460|FG001|Overall Study|Too Ill to Continue|1
6868514|NCT00452439|10878459|FG000|Overall Study|Failed to achieve complete response|2
6868515|NCT00452439|10878460|FG001|Overall Study|Failed to achieve complete response|0
6868516|NCT00452439|10878459|FG000|Overall Study|Relapse|3
6868517|NCT00452439|10878460|FG001|Overall Study|Relapse|0
6868518|NCT00452439|10878459|FG000|Overall Study|Fracture|1
6868519|NCT00452439|10878460|FG001|Overall Study|Fracture|0
6868520|NCT00452452|10878469|FG000|Overall Study|Protocol Violation|0
6868521|NCT00452452|10878470|FG001|Overall Study|Protocol Violation|0
6868522|NCT00452452|10878471|FG002|Overall Study|Protocol Violation|1
6868523|NCT00452452|10878469|FG000|Overall Study|Withdrawal by Subject|1
6868524|NCT00452452|10878470|FG001|Overall Study|Withdrawal by Subject|0
6868525|NCT00452452|10878471|FG002|Overall Study|Withdrawal by Subject|0
6868526|NCT00452452|10878469|FG000|Overall Study|Lost to Follow-up|1
6868527|NCT00452452|10878470|FG001|Overall Study|Lost to Follow-up|0
6868528|NCT00452452|10878471|FG002|Overall Study|Lost to Follow-up|0
6868529|NCT00452530|10878487|FG000|Overall Study|Death|1
6868530|NCT00452530|10878488|FG001|Overall Study|Death|0
6868531|NCT00452530|10878487|FG000|Overall Study|Adverse Event|40
6868532|NCT00452530|10878488|FG001|Overall Study|Adverse Event|44
6868533|NCT00452530|10878487|FG000|Overall Study|Withdrawal by Subject|68
6868534|NCT00452530|10878488|FG001|Overall Study|Withdrawal by Subject|57
6868535|NCT00452530|10878487|FG000|Overall Study|Lost to Follow-up|1
6868536|NCT00452530|10878488|FG001|Overall Study|Lost to Follow-up|0
6868537|NCT00452530|10878487|FG000|Overall Study|Poor compliance/noncompliance|1
6868538|NCT00452530|10878488|FG001|Overall Study|Poor compliance/noncompliance|2
6868539|NCT00452530|10878487|FG000|Overall Study|No longer met study criteria|18
6868540|NCT00452530|10878488|FG001|Overall Study|No longer met study criteria|22
6868541|NCT00452530|10878487|FG000|Overall Study|Other|7
6868542|NCT00452530|10878488|FG001|Overall Study|Other|11
6868543|NCT00452673|10878511|FG000|Dose Escalation Period|Disease Progression|6
6868544|NCT00452673|10878512|FG001|Dose Escalation Period|Disease Progression|6
6868545|NCT00452673|10878513|FG002|Dose Escalation Period|Disease Progression|2
7078300|NCT02101112|11186606|FG004|Overall Study|Withdrawal by Subject|1
6868546|NCT00452673|10878514|FG003|Dose Escalation Period|Disease Progression|6
6868547|NCT00452673|10878515|FG004|Dose Escalation Period|Disease Progression|0
6868548|NCT00452673|10878511|FG000|Dose Escalation Period|study drug toxicity|1
6868549|NCT00452673|10878512|FG001|Dose Escalation Period|study drug toxicity|3
7078301|NCT02101112|11186607|FG005|Overall Study|Withdrawal by Subject|0
6868550|NCT00452673|10878513|FG002|Dose Escalation Period|study drug toxicity|3
6868551|NCT00452673|10878514|FG003|Dose Escalation Period|study drug toxicity|1
6868552|NCT00452673|10878515|FG004|Dose Escalation Period|study drug toxicity|0
6868553|NCT00452673|10878511|FG000|Dose Escalation Period|Other|0
6868554|NCT00452673|10878512|FG001|Dose Escalation Period|Other|0
6868555|NCT00452673|10878513|FG002|Dose Escalation Period|Other|1
6868556|NCT00452673|10878514|FG003|Dose Escalation Period|Other|0
6868557|NCT00452673|10878515|FG004|Dose Escalation Period|Other|0
6868558|NCT00452673|10878511|FG000|Dose Escalation Period|Adverse Event|0
6868559|NCT00452673|10878512|FG001|Dose Escalation Period|Adverse Event|0
6868560|NCT00452673|10878513|FG002|Dose Escalation Period|Adverse Event|0
6868561|NCT00452673|10878514|FG003|Dose Escalation Period|Adverse Event|1
6868562|NCT00452673|10878515|FG004|Dose Escalation Period|Adverse Event|0
7078302|NCT02101281|11186628|FG000|Overall Study|Adverse Event|0
7078303|NCT02101281|11186629|FG001|Overall Study|Adverse Event|1
7078304|NCT02101294|11186641|FG000|Overall Study|Withdrawal by Subject|5
7078305|NCT02101294|11186641|FG000|Overall Study|Lost to Follow-up|6
7078306|NCT02101359|11186650|FG000|Overall Study|Not included|23
7078307|NCT02101359|11186651|FG001|Overall Study|Not included|13
7078308|NCT02101359|11186650|FG000|Overall Study|Withdrawal by Subject|5
7078309|NCT02101359|11186651|FG001|Overall Study|Withdrawal by Subject|4
7078310|NCT02101359|11186650|FG000|Overall Study|Lost to Follow-up|1
6868563|NCT00452673|10878511|FG000|Dose Escalation Period|Withdrawal by Subject|0
6868564|NCT00452673|10878512|FG001|Dose Escalation Period|Withdrawal by Subject|0
6868565|NCT00452673|10878513|FG002|Dose Escalation Period|Withdrawal by Subject|0
6868566|NCT00452673|10878514|FG003|Dose Escalation Period|Withdrawal by Subject|1
6868567|NCT00452673|10878515|FG004|Dose Escalation Period|Withdrawal by Subject|0
6868568|NCT00452673|10878511|FG000|Dose Expansion Period|Disease Progression|0
6868569|NCT00452673|10878512|FG001|Dose Expansion Period|Disease Progression|0
6868570|NCT00452673|10878513|FG002|Dose Expansion Period|Disease Progression|0
6868571|NCT00452673|10878514|FG003|Dose Expansion Period|Disease Progression|0
6868572|NCT00452673|10878515|FG004|Dose Expansion Period|Disease Progression|19
6868573|NCT00452673|10878511|FG000|Dose Expansion Period|Other|0
6868574|NCT00452673|10878512|FG001|Dose Expansion Period|Other|0
6868575|NCT00452673|10878513|FG002|Dose Expansion Period|Other|0
6868576|NCT00452673|10878514|FG003|Dose Expansion Period|Other|0
6868577|NCT00452673|10878515|FG004|Dose Expansion Period|Other|2
6868578|NCT00452699|10878528|FG000|Overall Study|Adverse Event|10
6868579|NCT00452699|10878529|FG001|Overall Study|Adverse Event|3
6868580|NCT00452699|10878528|FG000|Overall Study|Lack of Efficacy|6
6868581|NCT00452699|10878529|FG001|Overall Study|Lack of Efficacy|4
6868582|NCT00452699|10878528|FG000|Overall Study|Lost to Follow-up|6
6868583|NCT00452699|10878529|FG001|Overall Study|Lost to Follow-up|9
6868584|NCT00452699|10878528|FG000|Overall Study|Protocol Violation|21
6868585|NCT00452699|10878529|FG001|Overall Study|Protocol Violation|25
6868586|NCT00452699|10878528|FG000|Overall Study|Withdrawal by Subject|26
6868587|NCT00452699|10878529|FG001|Overall Study|Withdrawal by Subject|25
6868588|NCT00452699|10878528|FG000|Overall Study|Other|12
6868589|NCT00452699|10878529|FG001|Overall Study|Other|7
6868590|NCT00452790|10878537|FG000|Infant Series|Clinical hold - consent withdrawn|118
6868591|NCT00452790|10878538|FG001|Infant Series|Clinical hold - consent withdrawn|123
6868592|NCT00452790|10878537|FG000|Infant Series|Parent/legal guardian request|8
6868593|NCT00452790|10878538|FG001|Infant Series|Parent/legal guardian request|6
6868594|NCT00452790|10878537|FG000|Infant Series|Failed to return|4
6868595|NCT00452790|10878538|FG001|Infant Series|Failed to return|1
6868596|NCT00452790|10878537|FG000|Infant Series|Protocol Violation|1
6868597|NCT00452790|10878538|FG001|Infant Series|Protocol Violation|3
6868598|NCT00452790|10878537|FG000|Infant Series|Lost to Follow-up|2
6868599|NCT00452790|10878538|FG001|Infant Series|Lost to Follow-up|2
6868600|NCT00452790|10878537|FG000|Infant Series|Adverse Event|1
6868601|NCT00452790|10878538|FG001|Infant Series|Adverse Event|2
6868602|NCT00452790|10878537|FG000|Infant Series|Other reasons|1
6868603|NCT00452790|10878538|FG001|Infant Series|Other reasons|2
6868604|NCT00452790|10878537|FG000|Infant Series|Investigator request|0
6868605|NCT00452790|10878538|FG001|Infant Series|Investigator request|1
6868606|NCT00452790|10878537|FG000|Infant Series|Death|0
6868607|NCT00452790|10878538|FG001|Infant Series|Death|1
6868608|NCT00452790|10878537|FG000|After Infant Series|Investigator request|10
6868609|NCT00452790|10878538|FG001|After Infant Series|Investigator request|10
6868610|NCT00452790|10878537|FG000|After Infant Series|Adverse Event|4
6868611|NCT00452790|10878538|FG001|After Infant Series|Adverse Event|1
6868612|NCT00452790|10878537|FG000|After Infant Series|Parent/legal guardian request|1
6868613|NCT00452790|10878538|FG001|After Infant Series|Parent/legal guardian request|3
6868614|NCT00452790|10878537|FG000|After Infant Series|Lost to Follow-up|4
6868615|NCT00452790|10878538|FG001|After Infant Series|Lost to Follow-up|0
6868616|NCT00452790|10878537|FG000|After Infant Series|Failed to return|1
6868617|NCT00452790|10878538|FG001|After Infant Series|Failed to return|0
6868618|NCT00452790|10878537|FG000|After Infant Series|Other reasons|1
6868619|NCT00452790|10878538|FG001|After Infant Series|Other reasons|0
6868620|NCT00452790|10878537|FG000|Toddler Dose|Failed to return|0
6868621|NCT00452790|10878538|FG001|Toddler Dose|Failed to return|1
7078311|NCT02101359|11186651|FG001|Overall Study|Lost to Follow-up|0
7078312|NCT02101359|11186650|FG000|Overall Study|Protocol Violation|0
7078313|NCT02101359|11186651|FG001|Overall Study|Protocol Violation|2
6868622|NCT00452790|10878537|FG000|Toddler Dose|Parent/legal guardian request|0
6868623|NCT00452790|10878538|FG001|Toddler Dose|Parent/legal guardian request|1
6868624|NCT00453102|10878552|FG000|Overall Study|Withdrawal by Subject|2
6868625|NCT00453154|10878559|FG000|Double BIind Maintenance|Adverse Event|0
6868626|NCT00453154|10878560|FG001|Double BIind Maintenance|Adverse Event|0
6868627|NCT00453154|10878561|FG002|Double BIind Maintenance|Adverse Event|3
6868628|NCT00453154|10878562|FG003|Double BIind Maintenance|Adverse Event|12
6868629|NCT00453154|10878559|FG000|Double BIind Maintenance|Death|0
6868630|NCT00453154|10878560|FG001|Double BIind Maintenance|Death|0
6868631|NCT00453154|10878561|FG002|Double BIind Maintenance|Death|2
6868632|NCT00453154|10878562|FG003|Double BIind Maintenance|Death|1
6868633|NCT00453154|10878559|FG000|Double BIind Maintenance|Withdrawal by Subject|0
6868634|NCT00453154|10878560|FG001|Double BIind Maintenance|Withdrawal by Subject|0
6868635|NCT00453154|10878561|FG002|Double BIind Maintenance|Withdrawal by Subject|4
6868636|NCT00453154|10878562|FG003|Double BIind Maintenance|Withdrawal by Subject|4
6868637|NCT00453154|10878559|FG000|Double BIind Maintenance|Progression|0
6868638|NCT00453154|10878560|FG001|Double BIind Maintenance|Progression|0
6868639|NCT00453154|10878561|FG002|Double BIind Maintenance|Progression|29
6868640|NCT00453154|10878562|FG003|Double BIind Maintenance|Progression|26
6868641|NCT00453154|10878559|FG000|Double BIind Maintenance|Medical Issues|0
6868642|NCT00453154|10878560|FG001|Double BIind Maintenance|Medical Issues|0
6868643|NCT00453154|10878561|FG002|Double BIind Maintenance|Medical Issues|3
6868644|NCT00453154|10878562|FG003|Double BIind Maintenance|Medical Issues|1
6868645|NCT00453154|10878559|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0
6868646|NCT00453154|10878560|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0
6868647|NCT00453154|10878561|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5
6868648|NCT00453154|10878562|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5
6868649|NCT00453180|10878573|FG000|Overall Study|Lost to Follow-up|2
6868650|NCT00453180|10878574|FG001|Overall Study|Lost to Follow-up|1
6868651|NCT00453180|10878573|FG000|Overall Study|Adverse Event|1
6868652|NCT00453180|10878574|FG001|Overall Study|Adverse Event|2
6868653|NCT00453206|10878584|FG000|Overall Study|Death|1
6868654|NCT00453310|10878588|FG000|Overall Study|Progression of Disease|10
6868655|NCT00453349|10878598|FG000|Randomized|Adverse Event|12
6868656|NCT00453349|10878599|FG001|Randomized|Adverse Event|11
6868657|NCT00453349|10878598|FG000|Randomized|Lack of Efficacy|2
6868658|NCT00453349|10878599|FG001|Randomized|Lack of Efficacy|1
6868659|NCT00453349|10878598|FG000|Randomized|Lost to Follow-up|7
6868660|NCT00453349|10878599|FG001|Randomized|Lost to Follow-up|5
6868661|NCT00453349|10878598|FG000|Randomized|Protocol Violation|1
6868662|NCT00453349|10878599|FG001|Randomized|Protocol Violation|1
6868663|NCT00453349|10878598|FG000|Randomized|Withdrawal by Subject|3
6868664|NCT00453349|10878599|FG001|Randomized|Withdrawal by Subject|5
6868665|NCT00453349|10878598|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10
6868666|NCT00453349|10878599|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11
6868667|NCT00453349|10878598|FG000|Completed Study|Adverse Event|12
6868668|NCT00453349|10878599|FG001|Completed Study|Adverse Event|11
6868669|NCT00453349|10878598|FG000|Completed Study|Lack of Efficacy|2
6868670|NCT00453349|10878599|FG001|Completed Study|Lack of Efficacy|1
6868671|NCT00453349|10878598|FG000|Completed Study|Lost to Follow-up|7
6868672|NCT00453349|10878599|FG001|Completed Study|Lost to Follow-up|5
6868673|NCT00453349|10878598|FG000|Completed Study|Protocol Violation|1
6868674|NCT00453349|10878599|FG001|Completed Study|Protocol Violation|1
6868675|NCT00453349|10878598|FG000|Completed Study|Withdrawal by Subject|3
6868676|NCT00453349|10878599|FG001|Completed Study|Withdrawal by Subject|5
6868677|NCT00453349|10878598|FG000|Completed Study|Lost to follow up after study treatment|2
6868678|NCT00453349|10878599|FG001|Completed Study|Lost to follow up after study treatment|11
6868679|NCT00453362|10878605|FG000|Overall Study|Adverse Event|5
6868680|NCT00453362|10878605|FG000|Overall Study|Death|7
6868681|NCT00453362|10878605|FG000|Overall Study|Physician Decision|2
6868682|NCT00453362|10878605|FG000|Overall Study|Withdrawal by Subject|3
6868683|NCT00453362|10878605|FG000|Overall Study|Progression of disease|56
6868684|NCT00453362|10878605|FG000|Overall Study|Screening Failure|14
6968362|NCT01137682|11017139|FG000|Overall Study|Death-Extension|2
6968363|NCT01137682|11017140|FG001|Overall Study|Death-Extension|0
6968364|NCT01137682|11017141|FG002|Overall Study|Death-Extension|0
6968365|NCT01137682|11017139|FG000|Overall Study|Protocol Violation-Extension|2
6968366|NCT01137682|11017140|FG001|Overall Study|Protocol Violation-Extension|1
6968367|NCT01137682|11017141|FG002|Overall Study|Protocol Violation-Extension|0
6968368|NCT01137682|11017139|FG000|Overall Study|Did not enter extension|2
6968369|NCT01137682|11017140|FG001|Overall Study|Did not enter extension|3
6968370|NCT01137682|11017141|FG002|Overall Study|Did not enter extension|2
6968371|NCT01137682|11017139|FG000|Overall Study|Did not receive treatment in extension|0
6968372|NCT01137682|11017140|FG001|Overall Study|Did not receive treatment in extension|0
6968373|NCT01137682|11017141|FG002|Overall Study|Did not receive treatment in extension|1
6968374|NCT01137786|11017155|FG000|Overall Study|Lost to Follow-up|0
6968375|NCT01137786|11017156|FG001|Overall Study|Lost to Follow-up|2
6968376|NCT01137786|11017155|FG000|Overall Study|Withdrawal by Subject|1
6968377|NCT01137786|11017156|FG001|Overall Study|Withdrawal by Subject|1
6968378|NCT01137812|11017166|FG000|Overall Study|Adverse Event|21
6968379|NCT01137812|11017167|FG001|Overall Study|Adverse Event|14
6868685|NCT00453921|10878661|FG000|Overall Study|Withdrawal by Subject|1
6868686|NCT00453921|10878662|FG001|Overall Study|Withdrawal by Subject|1
6868687|NCT00453921|10878663|FG002|Overall Study|Withdrawal by Subject|1
6868688|NCT00453921|10878664|FG003|Overall Study|Withdrawal by Subject|1
6868689|NCT00453921|10878661|FG000|Overall Study|Lost to Follow-up|0
6868690|NCT00453921|10878662|FG001|Overall Study|Lost to Follow-up|0
6868691|NCT00453921|10878663|FG002|Overall Study|Lost to Follow-up|1
6868692|NCT00453921|10878664|FG003|Overall Study|Lost to Follow-up|0
6868693|NCT00453973|10878680|FG000|Overall Study|Adverse Event|4
6868694|NCT00453973|10878681|FG001|Overall Study|Adverse Event|9
6868695|NCT00453973|10878680|FG000|Overall Study|Withdrawal by Subject|7
6868696|NCT00453973|10878681|FG001|Overall Study|Withdrawal by Subject|6
6868697|NCT00453973|10878680|FG000|Overall Study|PI Decision|0
6868698|NCT00453973|10878681|FG001|Overall Study|PI Decision|2
6868699|NCT00453973|10878680|FG000|Overall Study|Relocation|1
6868700|NCT00453973|10878681|FG001|Overall Study|Relocation|0
6868701|NCT00453973|10878680|FG000|Overall Study|Renal transplant|1
6868702|NCT00453973|10878681|FG001|Overall Study|Renal transplant|1
6868703|NCT00453973|10878680|FG000|Overall Study|Site closed by sponsor|3
6868704|NCT00453973|10878681|FG001|Overall Study|Site closed by sponsor|0
6868705|NCT00453973|10878680|FG000|Overall Study|Sponsor Decision to Terminate Study|35
6868706|NCT00453973|10878681|FG001|Overall Study|Sponsor Decision to Terminate Study|30
6868707|NCT00453986|10878692|FG000|Overall Study|Lost to Follow-up|6
6868708|NCT00453986|10878693|FG001|Overall Study|Lost to Follow-up|5
6868709|NCT00453986|10878694|FG002|Overall Study|Lost to Follow-up|6
6868710|NCT00453986|10878695|FG003|Overall Study|Lost to Follow-up|2
6868711|NCT00453986|10878696|FG004|Overall Study|Lost to Follow-up|0
6868712|NCT00453999|10878715|FG000|Overall Study|Adverse Event|1
6868713|NCT00453999|10878716|FG001|Overall Study|Adverse Event|2
6868714|NCT00453999|10878717|FG002|Overall Study|Adverse Event|1
6868715|NCT00453999|10878715|FG000|Overall Study|Lost to Follow-up|0
6868716|NCT00453999|10878716|FG001|Overall Study|Lost to Follow-up|1
6868717|NCT00453999|10878717|FG002|Overall Study|Lost to Follow-up|1
6868718|NCT00453999|10878715|FG000|Overall Study|Withdrawal by Subject|2
6868719|NCT00453999|10878716|FG001|Overall Study|Withdrawal by Subject|1
6868720|NCT00453999|10878717|FG002|Overall Study|Withdrawal by Subject|1
6868721|NCT00453999|10878715|FG000|Overall Study|Subject Request|2
6868722|NCT00453999|10878716|FG001|Overall Study|Subject Request|1
6868723|NCT00453999|10878717|FG002|Overall Study|Subject Request|0
6868724|NCT00454051|10878728|FG000|Overall Study|Adverse Event|1
6868725|NCT00454051|10878729|FG001|Overall Study|Adverse Event|2
6868726|NCT00454051|10878728|FG000|Overall Study|Withdrawal by Subject|1
6868727|NCT00454051|10878729|FG001|Overall Study|Withdrawal by Subject|0
6868728|NCT00454051|10878728|FG000|Overall Study|Protocol Violation|1
6868729|NCT00454051|10878729|FG001|Overall Study|Protocol Violation|1
6868730|NCT00454116|10878738|FG000|Overall Study|Adverse Event|5
6868731|NCT00454116|10878739|FG001|Overall Study|Adverse Event|11
6868732|NCT00454116|10878740|FG002|Overall Study|Adverse Event|9
6868733|NCT00454116|10878738|FG000|Overall Study|Condition under investigation worsened|17
6868734|NCT00454116|10878739|FG001|Overall Study|Condition under investigation worsened|13
6868735|NCT00454116|10878740|FG002|Overall Study|Condition under investigation worsened|18
6868736|NCT00454116|10878738|FG000|Overall Study|Withdrawal by Subject|3
6868737|NCT00454116|10878739|FG001|Overall Study|Withdrawal by Subject|3
6868738|NCT00454116|10878740|FG002|Overall Study|Withdrawal by Subject|1
6868739|NCT00454116|10878738|FG000|Overall Study|Other|2
6868740|NCT00454116|10878739|FG001|Overall Study|Other|2
6868741|NCT00454116|10878740|FG002|Overall Study|Other|0
6868742|NCT00454142|10878748|FG000|Overall Study|Withdrawal by Subject|1
6868743|NCT00454181|10878756|FG000|Overall Study|Adverse Event|1
6868744|NCT00454181|10878757|FG001|Overall Study|Adverse Event|1
6868745|NCT00454181|10878756|FG000|Overall Study|Lost to Follow-up|11
6868746|NCT00454181|10878757|FG001|Overall Study|Lost to Follow-up|1
6868747|NCT00454181|10878756|FG000|Overall Study|Protocol Violation|1
6868748|NCT00454181|10878757|FG001|Overall Study|Protocol Violation|1
6868749|NCT00454181|10878756|FG000|Overall Study|Withdrawal by Subject|2
6868750|NCT00454181|10878757|FG001|Overall Study|Withdrawal by Subject|0
6868751|NCT00454194|10878765|FG000|Overall Study|Adverse Event|7
6868752|NCT00454194|10878766|FG001|Overall Study|Adverse Event|2
6868753|NCT00454194|10878765|FG000|Overall Study|Withdrawal by Subject|12
6868754|NCT00454194|10878766|FG001|Overall Study|Withdrawal by Subject|8
6868755|NCT00454194|10878765|FG000|Overall Study|Other Medical Problems|1
6868756|NCT00454194|10878766|FG001|Overall Study|Other Medical Problems|2
6868757|NCT00454194|10878765|FG000|Overall Study|Other Unspecified Reason|2
6868758|NCT00454194|10878766|FG001|Overall Study|Other Unspecified Reason|2
6868759|NCT00454207|10878774|FG000|Overall Study|Adverse Event|3
6868760|NCT00454207|10878775|FG001|Overall Study|Adverse Event|1
6868761|NCT00454207|10878774|FG000|Overall Study|Lack of Efficacy|1
6868762|NCT00454207|10878775|FG001|Overall Study|Lack of Efficacy|0
6868763|NCT00454207|10878774|FG000|Overall Study|Protocol Violation|0
6868764|NCT00454207|10878775|FG001|Overall Study|Protocol Violation|1
6868765|NCT00454246|10878796|FG000|Overall Study|Adverse Event|2
6868766|NCT00454246|10878797|FG001|Overall Study|Adverse Event|2
6868767|NCT00454246|10878798|FG002|Overall Study|Adverse Event|0
6868768|NCT00454246|10878796|FG000|Overall Study|Violation of selection criteria at entry|6
6868769|NCT00454246|10878797|FG001|Overall Study|Violation of selection criteria at entry|0
6868770|NCT00454246|10878798|FG002|Overall Study|Violation of selection criteria at entry|0
6868771|NCT00454246|10878796|FG000|Overall Study|Protocol Violation|1
6868772|NCT00454246|10878797|FG001|Overall Study|Protocol Violation|0
6868773|NCT00454246|10878798|FG002|Overall Study|Protocol Violation|0
6868774|NCT00454246|10878796|FG000|Overall Study|Refused Treatment|1
6868775|NCT00454246|10878797|FG001|Overall Study|Refused Treatment|1
6868776|NCT00454246|10878798|FG002|Overall Study|Refused Treatment|0
6868777|NCT00454246|10878796|FG000|Overall Study|Failure to return|1
6868778|NCT00454246|10878797|FG001|Overall Study|Failure to return|0
6868779|NCT00454246|10878798|FG002|Overall Study|Failure to return|0
6868780|NCT00454246|10878796|FG000|Overall Study|Early termination of study|62
7154274|NCT03308942|11320873|FG001|Stage 2 (up to a Maximum of 17 Months)|Death|0
6868781|NCT00454246|10878797|FG001|Overall Study|Early termination of study|26
6868782|NCT00454246|10878798|FG002|Overall Study|Early termination of study|9
6868783|NCT00454363|10878817|FG000|Overall Study|Adverse Event|1
6868784|NCT00454363|10878818|FG001|Overall Study|Adverse Event|2
6868785|NCT00454363|10878817|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4
6868786|NCT00454363|10878818|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0
6868787|NCT00454584|10878843|FG000|Controlled Period|Adverse Event|5
6868788|NCT00454584|10878844|FG001|Controlled Period|Adverse Event|2
6868789|NCT00454584|10878845|FG002|Controlled Period|Adverse Event|1
6868790|NCT00454584|10878846|FG003|Controlled Period|Adverse Event|0
6868791|NCT00454584|10878847|FG004|Controlled Period|Adverse Event|0
6868792|NCT00454584|10878848|FG005|Controlled Period|Adverse Event|0
6868793|NCT00454584|10878843|FG000|Controlled Period|Lost to Follow-up|1
6868794|NCT00454584|10878844|FG001|Controlled Period|Lost to Follow-up|2
6868795|NCT00454584|10878845|FG002|Controlled Period|Lost to Follow-up|2
6868796|NCT00454584|10878846|FG003|Controlled Period|Lost to Follow-up|0
6868797|NCT00454584|10878847|FG004|Controlled Period|Lost to Follow-up|0
6868798|NCT00454584|10878848|FG005|Controlled Period|Lost to Follow-up|0
6868799|NCT00454584|10878843|FG000|Controlled Period|Other|5
6868800|NCT00454584|10878844|FG001|Controlled Period|Other|4
6868801|NCT00454584|10878845|FG002|Controlled Period|Other|2
6868802|NCT00454584|10878846|FG003|Controlled Period|Other|0
6868803|NCT00454584|10878847|FG004|Controlled Period|Other|0
6868804|NCT00454584|10878848|FG005|Controlled Period|Other|0
6868805|NCT00454584|10878843|FG000|After Controlled Period|Adverse Event|0
6868806|NCT00454584|10878844|FG001|After Controlled Period|Adverse Event|0
6868807|NCT00454584|10878845|FG002|After Controlled Period|Adverse Event|0
6868808|NCT00454584|10878846|FG003|After Controlled Period|Adverse Event|9
6868809|NCT00454584|10878847|FG004|After Controlled Period|Adverse Event|3
6868810|NCT00454584|10878848|FG005|After Controlled Period|Adverse Event|9
6868811|NCT00454584|10878843|FG000|After Controlled Period|Lack of Efficacy|0
6868812|NCT00454584|10878844|FG001|After Controlled Period|Lack of Efficacy|0
6868813|NCT00454584|10878845|FG002|After Controlled Period|Lack of Efficacy|0
6868814|NCT00454584|10878846|FG003|After Controlled Period|Lack of Efficacy|1
6868815|NCT00454584|10878847|FG004|After Controlled Period|Lack of Efficacy|0
6868816|NCT00454584|10878848|FG005|After Controlled Period|Lack of Efficacy|0
6868817|NCT00454584|10878843|FG000|After Controlled Period|Lost to Follow-up|0
6868818|NCT00454584|10878844|FG001|After Controlled Period|Lost to Follow-up|0
6868819|NCT00454584|10878845|FG002|After Controlled Period|Lost to Follow-up|0
6868820|NCT00454584|10878846|FG003|After Controlled Period|Lost to Follow-up|2
6868821|NCT00454584|10878847|FG004|After Controlled Period|Lost to Follow-up|4
6868822|NCT00454584|10878848|FG005|After Controlled Period|Lost to Follow-up|6
6868823|NCT00454584|10878843|FG000|After Controlled Period|Other|0
6868824|NCT00454584|10878844|FG001|After Controlled Period|Other|0
6868825|NCT00454584|10878845|FG002|After Controlled Period|Other|0
6868826|NCT00454584|10878846|FG003|After Controlled Period|Other|1
6868827|NCT00454584|10878847|FG004|After Controlled Period|Other|0
6868828|NCT00454584|10878848|FG005|After Controlled Period|Other|0
6868829|NCT00454584|10878843|FG000|After Controlled Period|Other|0
6868830|NCT00454584|10878844|FG001|After Controlled Period|Other|0
6868831|NCT00454584|10878845|FG002|After Controlled Period|Other|0
6868832|NCT00454584|10878846|FG003|After Controlled Period|Other|13
6868833|NCT00454584|10878847|FG004|After Controlled Period|Other|5
6868834|NCT00454584|10878848|FG005|After Controlled Period|Other|17
6868835|NCT00454636|10878866|FG000|Overall Study|Adverse Event|10
6868836|NCT00454636|10878867|FG001|Overall Study|Adverse Event|6
6868837|NCT00454636|10878868|FG002|Overall Study|Adverse Event|9
6868838|NCT00454636|10878869|FG003|Overall Study|Adverse Event|15
6868839|NCT00454636|10878866|FG000|Overall Study|Disease Progression|11
6868840|NCT00454636|10878867|FG001|Overall Study|Disease Progression|12
6868841|NCT00454636|10878868|FG002|Overall Study|Disease Progression|4
6868842|NCT00454636|10878869|FG003|Overall Study|Disease Progression|11
6868843|NCT00454636|10878866|FG000|Overall Study|Protocol Violation|3
6868844|NCT00454636|10878867|FG001|Overall Study|Protocol Violation|2
6868845|NCT00454636|10878868|FG002|Overall Study|Protocol Violation|3
6868846|NCT00454636|10878869|FG003|Overall Study|Protocol Violation|3
6868847|NCT00454636|10878866|FG000|Overall Study|Death|6
6868848|NCT00454636|10878867|FG001|Overall Study|Death|1
6868849|NCT00454636|10878868|FG002|Overall Study|Death|1
7154275|NCT03308942|11320874|FG002|Stage 2 (up to a Maximum of 17 Months)|Death|0
6868850|NCT00454636|10878869|FG003|Overall Study|Death|1
6868851|NCT00454636|10878866|FG000|Overall Study|Patient refusal|1
6868852|NCT00454636|10878867|FG001|Overall Study|Patient refusal|1
6868853|NCT00454636|10878868|FG002|Overall Study|Patient refusal|3
6868854|NCT00454636|10878869|FG003|Overall Study|Patient refusal|2
6868855|NCT00454636|10878866|FG000|Overall Study|Lost to Follow-up|0
6868856|NCT00454636|10878867|FG001|Overall Study|Lost to Follow-up|1
6868857|NCT00454636|10878868|FG002|Overall Study|Lost to Follow-up|0
6868858|NCT00454636|10878869|FG003|Overall Study|Lost to Follow-up|0
6868859|NCT00454649|10878889|FG000|Overall Study|Lack of Efficacy|2
6868860|NCT00454649|10878890|FG001|Overall Study|Lack of Efficacy|2
6868861|NCT00454649|10878891|FG002|Overall Study|Lack of Efficacy|10
6868862|NCT00454649|10878892|FG003|Overall Study|Lack of Efficacy|3
6868863|NCT00454649|10878893|FG004|Overall Study|Lack of Efficacy|0
6868864|NCT00454649|10878894|FG005|Overall Study|Lack of Efficacy|4
6868865|NCT00454649|10878895|FG006|Overall Study|Lack of Efficacy|5
6868866|NCT00454649|10878896|FG007|Overall Study|Lack of Efficacy|13
6868867|NCT00454649|10878897|FG008|Overall Study|Lack of Efficacy|10
6868868|NCT00454649|10878898|FG009|Overall Study|Lack of Efficacy|2
6868869|NCT00454649|10878889|FG000|Overall Study|Adverse Event|0
6868870|NCT00454649|10878890|FG001|Overall Study|Adverse Event|1
6868871|NCT00454649|10878891|FG002|Overall Study|Adverse Event|3
6868872|NCT00454649|10878892|FG003|Overall Study|Adverse Event|0
6868873|NCT00454649|10878893|FG004|Overall Study|Adverse Event|1
6868874|NCT00454649|10878894|FG005|Overall Study|Adverse Event|2
6868875|NCT00454649|10878895|FG006|Overall Study|Adverse Event|3
6868876|NCT00454649|10878896|FG007|Overall Study|Adverse Event|4
6868877|NCT00454649|10878897|FG008|Overall Study|Adverse Event|6
6868878|NCT00454649|10878898|FG009|Overall Study|Adverse Event|2
6868879|NCT00454649|10878889|FG000|Overall Study|Lost to Follow-up|0
6868880|NCT00454649|10878890|FG001|Overall Study|Lost to Follow-up|0
6868881|NCT00454649|10878891|FG002|Overall Study|Lost to Follow-up|1
6868882|NCT00454649|10878892|FG003|Overall Study|Lost to Follow-up|0
6868883|NCT00454649|10878893|FG004|Overall Study|Lost to Follow-up|0
6868884|NCT00454649|10878894|FG005|Overall Study|Lost to Follow-up|0
6868885|NCT00454649|10878895|FG006|Overall Study|Lost to Follow-up|1
6868886|NCT00454649|10878896|FG007|Overall Study|Lost to Follow-up|0
6868887|NCT00454649|10878897|FG008|Overall Study|Lost to Follow-up|0
6868888|NCT00454649|10878898|FG009|Overall Study|Lost to Follow-up|0
6868889|NCT00454649|10878889|FG000|Overall Study|Other|1
6868890|NCT00454649|10878890|FG001|Overall Study|Other|1
6868891|NCT00454649|10878891|FG002|Overall Study|Other|5
6868892|NCT00454649|10878892|FG003|Overall Study|Other|3
6868893|NCT00454649|10878893|FG004|Overall Study|Other|0
6868894|NCT00454649|10878894|FG005|Overall Study|Other|0
6868895|NCT00454649|10878895|FG006|Overall Study|Other|0
6868896|NCT00454649|10878896|FG007|Overall Study|Other|0
6868897|NCT00454649|10878897|FG008|Overall Study|Other|3
6868898|NCT00454649|10878898|FG009|Overall Study|Other|1
6868899|NCT00454649|10878889|FG000|Overall Study|Withdrawal by Subject|0
6868900|NCT00454649|10878890|FG001|Overall Study|Withdrawal by Subject|0
6868901|NCT00454649|10878891|FG002|Overall Study|Withdrawal by Subject|0
6868902|NCT00454649|10878892|FG003|Overall Study|Withdrawal by Subject|0
6868903|NCT00454649|10878893|FG004|Overall Study|Withdrawal by Subject|0
6868904|NCT00454649|10878894|FG005|Overall Study|Withdrawal by Subject|1
6868905|NCT00454649|10878895|FG006|Overall Study|Withdrawal by Subject|0
6868906|NCT00454649|10878896|FG007|Overall Study|Withdrawal by Subject|2
6868907|NCT00454649|10878897|FG008|Overall Study|Withdrawal by Subject|1
6868908|NCT00454649|10878898|FG009|Overall Study|Withdrawal by Subject|0
6868909|NCT00454779|10878941|FG000|First-line Treatment Phase|Lack of Efficacy|0
6868910|NCT00454779|10878942|FG001|First-line Treatment Phase|Lack of Efficacy|2
6868911|NCT00454779|10878941|FG000|First-line Treatment Phase|Withdrawal by Subject|2
6868912|NCT00454779|10878942|FG001|First-line Treatment Phase|Withdrawal by Subject|4
6868913|NCT00454779|10878941|FG000|First-line Treatment Phase|Lost to Follow-up|1
6868914|NCT00454779|10878942|FG001|First-line Treatment Phase|Lost to Follow-up|0
6868915|NCT00454779|10878941|FG000|First-line Treatment Phase|Protocol Violation|0
6868916|NCT00454779|10878942|FG001|First-line Treatment Phase|Protocol Violation|1
6868917|NCT00454779|10878941|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1
6868918|NCT00454779|10878942|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1
6868919|NCT00454779|10878941|FG000|First-line Treatment Phase|Ongoing|1
6868920|NCT00454779|10878942|FG001|First-line Treatment Phase|Ongoing|0
6868921|NCT00454779|10878941|FG000|Second-line Treatment Phase|Withdrawal by Subject|0
6868922|NCT00454779|10878942|FG001|Second-line Treatment Phase|Withdrawal by Subject|1
6868923|NCT00454779|10878941|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0
6868924|NCT00454779|10878942|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1
6868925|NCT00454779|10878941|FG000|Second-line Treatment Phase|Ongoing|0
6868926|NCT00454779|10878942|FG001|Second-line Treatment Phase|Ongoing|1
6868927|NCT00454805|10878950|FG000|Overall Study|Withdrawal by Subject|9
6868928|NCT00454805|10878951|FG001|Overall Study|Withdrawal by Subject|2
6868929|NCT00454805|10878950|FG000|Overall Study|Death|0
6868930|NCT00454805|10878951|FG001|Overall Study|Death|2
6868931|NCT00454805|10878950|FG000|Overall Study|Disease progression|16
6868932|NCT00454805|10878951|FG001|Overall Study|Disease progression|19
6868933|NCT00454805|10878950|FG000|Overall Study|In order to begin radiotherapy|1
6868934|NCT00454805|10878951|FG001|Overall Study|In order to begin radiotherapy|0
6868935|NCT00454818|10878965|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1
6868936|NCT00454818|10878966|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0
6868937|NCT00454818|10878967|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0
6868938|NCT00454818|10878968|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0
6868939|NCT00454818|10878969|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0
6868940|NCT00454818|10878965|FG000|Phase I: Open-label Dose-escalation|Death|0
6868941|NCT00454818|10878966|FG001|Phase I: Open-label Dose-escalation|Death|1
6868942|NCT00454818|10878967|FG002|Phase I: Open-label Dose-escalation|Death|0
6868943|NCT00454818|10878968|FG003|Phase I: Open-label Dose-escalation|Death|0
6868944|NCT00454818|10878969|FG004|Phase I: Open-label Dose-escalation|Death|0
6868945|NCT00454818|10878965|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
6868946|NCT00454818|10878966|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
6868947|NCT00454818|10878967|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
6868948|NCT00454818|10878968|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
6868949|NCT00454818|10878969|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
6868950|NCT00454818|10878965|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
6868951|NCT00454818|10878966|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
6868952|NCT00454818|10878967|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
6868953|NCT00454818|10878968|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
6868954|NCT00454818|10878969|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
6868955|NCT00454818|10878965|FG000|Phase 2: Randomized Double-blind|Death|0
6868956|NCT00454818|10878966|FG001|Phase 2: Randomized Double-blind|Death|1
6868957|NCT00454818|10878967|FG002|Phase 2: Randomized Double-blind|Death|0
6868958|NCT00454818|10878968|FG003|Phase 2: Randomized Double-blind|Death|0
6868959|NCT00454818|10878969|FG004|Phase 2: Randomized Double-blind|Death|1
6868960|NCT00454818|10878965|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0
6868961|NCT00454818|10878966|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0
6868962|NCT00454818|10878967|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2
6868963|NCT00454818|10878968|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0
6868964|NCT00454818|10878969|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1
6868965|NCT00454818|10878965|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
6868966|NCT00454818|10878966|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
6868967|NCT00454818|10878967|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1
6868968|NCT00454818|10878968|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
6868969|NCT00454818|10878969|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2
6868970|NCT00454857|10878986|FG000|Overall Study|Withdrawal by Subject|15
6868971|NCT00454857|10878986|FG000|Overall Study|Lost to Follow-up|16
6868972|NCT00454857|10878986|FG000|Overall Study|Noncompliance|6
7154276|NCT03308942|11320875|FG003|Stage 2 (up to a Maximum of 17 Months)|Death|4
7154277|NCT03308942|11320876|FG004|Stage 2 (up to a Maximum of 17 Months)|Death|0
7154278|NCT03308942|11320872|FG000|Stage 2 (up to a Maximum of 17 Months)|Ongoing at the time of analysis|0
7154279|NCT03308942|11320873|FG001|Stage 2 (up to a Maximum of 17 Months)|Ongoing at the time of analysis|0
7154280|NCT03308942|11320874|FG002|Stage 2 (up to a Maximum of 17 Months)|Ongoing at the time of analysis|0
7154281|NCT03308942|11320875|FG003|Stage 2 (up to a Maximum of 17 Months)|Ongoing at the time of analysis|5
6868973|NCT00454857|10878986|FG000|Overall Study|Death|5
6868974|NCT00454857|10878986|FG000|Overall Study|Other|11
6868975|NCT00454857|10878986|FG000|Overall Study|Reason unknown|1
6868976|NCT00454909|10878993|FG000|Overall Study|Withdrawal by Subject|1
6868977|NCT00454909|10878994|FG001|Overall Study|Withdrawal by Subject|0
6868978|NCT00454909|10878995|FG002|Overall Study|Withdrawal by Subject|0
6868979|NCT00454909|10878993|FG000|Overall Study|Migrated/moved from study area|0
6868980|NCT00454909|10878994|FG001|Overall Study|Migrated/moved from study area|0
6868981|NCT00454909|10878995|FG002|Overall Study|Migrated/moved from study area|1
6868982|NCT00454909|10878993|FG000|Overall Study|Lost to follow-up (complete vaccination)|5
6868983|NCT00454909|10878994|FG001|Overall Study|Lost to follow-up (complete vaccination)|3
6868984|NCT00454909|10878995|FG002|Overall Study|Lost to follow-up (complete vaccination)|1
6868985|NCT00454909|10878993|FG000|Overall Study|Others|1
6868986|NCT00454909|10878994|FG001|Overall Study|Others|0
6868987|NCT00454909|10878995|FG002|Overall Study|Others|0
6868988|NCT00454987|10879007|FG000|Booster Period (NCT00258700)|Adverse Event|1
6868989|NCT00454987|10879008|FG001|Booster Period (NCT00258700)|Adverse Event|0
6868990|NCT00454987|10879009|FG002|Booster Period (NCT00258700)|Adverse Event|0
6868991|NCT00454987|10879007|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0
6868992|NCT00454987|10879008|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1
6868993|NCT00454987|10879009|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0
6868994|NCT00454987|10879007|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1
6868995|NCT00454987|10879008|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0
6868996|NCT00454987|10879009|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0
6868997|NCT00455013|10879021|FG000|Short Term Period|Adverse Event|2
6868998|NCT00455013|10879022|FG001|Short Term Period|Adverse Event|5
6868999|NCT00455013|10879023|FG002|Short Term Period|Adverse Event|0
6869000|NCT00455013|10879021|FG000|Short Term Period|Withdrawal by Subject|0
6869001|NCT00455013|10879022|FG001|Short Term Period|Withdrawal by Subject|0
6869002|NCT00455013|10879023|FG002|Short Term Period|Withdrawal by Subject|1
6869003|NCT00455013|10879021|FG000|Short Term Period|Lack of Efficacy|4
6869004|NCT00455013|10879022|FG001|Short Term Period|Lack of Efficacy|0
6869005|NCT00455013|10879023|FG002|Short Term Period|Lack of Efficacy|0
6869006|NCT00455013|10879021|FG000|Short Term Period|Other|0
6869007|NCT00455013|10879022|FG001|Short Term Period|Other|0
6869008|NCT00455013|10879023|FG002|Short Term Period|Other|1
6869009|NCT00455013|10879021|FG000|Long Term Extension (LTE)|Adverse Event|0
6869010|NCT00455013|10879022|FG001|Long Term Extension (LTE)|Adverse Event|1
6869011|NCT00455013|10879023|FG002|Long Term Extension (LTE)|Adverse Event|1
6869012|NCT00455013|10879021|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1
6869013|NCT00455013|10879022|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0
6869014|NCT00455013|10879023|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1
6869015|NCT00455013|10879021|FG000|Long Term Extension (LTE)|Death|1
6869016|NCT00455013|10879022|FG001|Long Term Extension (LTE)|Death|1
7078314|NCT02101554|11186699|FG000|Overall Study|Protocol Violation|0
7154282|NCT03308942|11320876|FG004|Stage 2 (up to a Maximum of 17 Months)|Ongoing at the time of analysis|0
6869017|NCT00455013|10879023|FG002|Long Term Extension (LTE)|Death|0
6869018|NCT00455013|10879021|FG000|Long Term Extension (LTE)|No longer met criteria|0
6869019|NCT00455013|10879022|FG001|Long Term Extension (LTE)|No longer met criteria|0
6869020|NCT00455013|10879023|FG002|Long Term Extension (LTE)|No longer met criteria|1
6869021|NCT00455013|10879021|FG000|Long Term Extension (LTE)|Subject Request or refused|0
6869022|NCT00455013|10879022|FG001|Long Term Extension (LTE)|Subject Request or refused|0
6869023|NCT00455013|10879023|FG002|Long Term Extension (LTE)|Subject Request or refused|3
6869024|NCT00455013|10879021|FG000|Long Term Extension (LTE)|Poor non-compliance|0
6869025|NCT00455013|10879022|FG001|Long Term Extension (LTE)|Poor non-compliance|1
6869026|NCT00455013|10879023|FG002|Long Term Extension (LTE)|Poor non-compliance|0
6869027|NCT00455013|10879021|FG000|Long Term Extension (LTE)|non-specified|0
6869028|NCT00455013|10879022|FG001|Long Term Extension (LTE)|non-specified|0
6869029|NCT00455013|10879023|FG002|Long Term Extension (LTE)|non-specified|1
6869030|NCT00455195|10879033|FG000|Double-blind Study AGLU02704|Adverse Event|2
6869031|NCT00455195|10879034|FG001|Double-blind Study AGLU02704|Adverse Event|1
6869032|NCT00455195|10879033|FG000|Double-blind Study AGLU02704|Death|1
6869033|NCT00455195|10879034|FG001|Double-blind Study AGLU02704|Death|0
6869034|NCT00455195|10879033|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2
6869035|NCT00455195|10879034|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2
6869036|NCT00455195|10879033|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0
6869037|NCT00455195|10879034|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1
6869038|NCT00455312|10879042|FG000|Overall Study|Death|0
6869039|NCT00455312|10879043|FG001|Overall Study|Death|1
6869040|NCT00455429|10879053|FG000|Overall Study|Study Terminated by Sponsor|0
6869041|NCT00455429|10879054|FG001|Overall Study|Study Terminated by Sponsor|0
6869042|NCT00455429|10879055|FG002|Overall Study|Study Terminated by Sponsor|0
6869043|NCT00455429|10879056|FG003|Overall Study|Study Terminated by Sponsor|3
6869044|NCT00455429|10879053|FG000|Overall Study|Lost to Follow-up|1
6869045|NCT00455429|10879054|FG001|Overall Study|Lost to Follow-up|0
6869046|NCT00455429|10879055|FG002|Overall Study|Lost to Follow-up|0
6869047|NCT00455429|10879056|FG003|Overall Study|Lost to Follow-up|3
6869048|NCT00455429|10879053|FG000|Overall Study|Withdrawal by Subject|0
6869049|NCT00455429|10879054|FG001|Overall Study|Withdrawal by Subject|1
6869050|NCT00455429|10879055|FG002|Overall Study|Withdrawal by Subject|1
6869051|NCT00455429|10879056|FG003|Overall Study|Withdrawal by Subject|0
6869052|NCT00455429|10879053|FG000|Overall Study|Lack of Efficacy|0
6869053|NCT00455429|10879054|FG001|Overall Study|Lack of Efficacy|1
6968380|NCT01137812|11017166|FG000|Overall Study|Lost to Follow-up|6
6968381|NCT01137812|11017167|FG001|Overall Study|Lost to Follow-up|8
6968382|NCT01137812|11017166|FG000|Overall Study|Physician Decision|25
6968383|NCT01137812|11017167|FG001|Overall Study|Physician Decision|17
6968384|NCT01137812|11017166|FG000|Overall Study|Protocol Violation|5
6968385|NCT01137812|11017167|FG001|Overall Study|Protocol Violation|4
6968386|NCT01137812|11017166|FG000|Overall Study|Withdrawal by Subject|5
6968387|NCT01137812|11017167|FG001|Overall Study|Withdrawal by Subject|13
6968388|NCT01137812|11017166|FG000|Overall Study|Death|2
6968389|NCT01137812|11017167|FG001|Overall Study|Death|0
6968390|NCT01137812|11017166|FG000|Overall Study|Patient met glycemic withdrawal criteria|40
6968391|NCT01137812|11017167|FG001|Overall Study|Patient met glycemic withdrawal criteria|85
6968392|NCT01137812|11017166|FG000|Overall Study|Other|19
6968393|NCT01137812|11017167|FG001|Overall Study|Other|27
6968394|NCT01138007|11017231|FG000|Overall Study|Adverse Event|4
6968395|NCT01138007|11017232|FG001|Overall Study|Adverse Event|12
6968396|NCT01138007|11017233|FG002|Overall Study|Adverse Event|9
6968397|NCT01138007|11017231|FG000|Overall Study|Lack of Efficacy|2
6968398|NCT01138007|11017232|FG001|Overall Study|Lack of Efficacy|0
6968399|NCT01138007|11017233|FG002|Overall Study|Lack of Efficacy|6
6968400|NCT01138007|11017231|FG000|Overall Study|Protocol Violation|2
6968401|NCT01138007|11017232|FG001|Overall Study|Protocol Violation|3
6968402|NCT01138007|11017233|FG002|Overall Study|Protocol Violation|2
6869054|NCT00455429|10879055|FG002|Overall Study|Lack of Efficacy|0
6869055|NCT00455429|10879056|FG003|Overall Study|Lack of Efficacy|1
6968403|NCT01138007|11017231|FG000|Overall Study|Protocol-Defined Stopping Criteria|6
6968404|NCT01138007|11017232|FG001|Overall Study|Protocol-Defined Stopping Criteria|1
6968405|NCT01138007|11017233|FG002|Overall Study|Protocol-Defined Stopping Criteria|8
6968406|NCT01138007|11017231|FG000|Overall Study|Lost to Follow-up|3
6869056|NCT00455429|10879053|FG000|Overall Study|Adverse Event|0
6869057|NCT00455429|10879054|FG001|Overall Study|Adverse Event|1
6869058|NCT00455429|10879055|FG002|Overall Study|Adverse Event|0
6869059|NCT00455429|10879056|FG003|Overall Study|Adverse Event|3
6869060|NCT00455429|10879053|FG000|Overall Study|Randomly assigned but not treated|0
6869061|NCT00455429|10879054|FG001|Overall Study|Randomly assigned but not treated|0
6869062|NCT00455429|10879055|FG002|Overall Study|Randomly assigned but not treated|0
6869063|NCT00455429|10879056|FG003|Overall Study|Randomly assigned but not treated|2
6869064|NCT00455429|10879053|FG000|Overall Study|Personal Reason|1
6869065|NCT00455429|10879054|FG001|Overall Study|Personal Reason|0
6869066|NCT00455429|10879055|FG002|Overall Study|Personal Reason|0
6869067|NCT00455429|10879056|FG003|Overall Study|Personal Reason|0
6869068|NCT00455429|10879053|FG000|Overall Study|Non-compliance|0
6869069|NCT00455429|10879054|FG001|Overall Study|Non-compliance|0
6869070|NCT00455429|10879055|FG002|Overall Study|Non-compliance|0
6869071|NCT00455429|10879056|FG003|Overall Study|Non-compliance|1
6869072|NCT00455429|10879053|FG000|Overall Study|Other|0
6869073|NCT00455429|10879054|FG001|Overall Study|Other|2
6869074|NCT00455429|10879055|FG002|Overall Study|Other|0
6869075|NCT00455429|10879056|FG003|Overall Study|Other|1
6869076|NCT00455455|10879069|FG000|Washout|Withdrawal by Subject|0
6869077|NCT00455455|10879070|FG001|Washout|Withdrawal by Subject|1
6869078|NCT00455455|10879069|FG000|Washout|Withdrawal by Subject|1
6869079|NCT00455455|10879070|FG001|Washout|Withdrawal by Subject|0
6869080|NCT00455520|10879081|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24
6869081|NCT00455520|10879082|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0
6869082|NCT00455520|10879081|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3
6869083|NCT00455520|10879082|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0
6869084|NCT00455520|10879081|FG000|Open Label Tapentadol Extended Release|Adverse Event|100
6869085|NCT00455520|10879082|FG001|Open Label Tapentadol Extended Release|Adverse Event|0
6869086|NCT00455520|10879081|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23
6869087|NCT00455520|10879082|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0
6869088|NCT00455520|10879081|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13
6869089|NCT00455520|10879082|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0
6869090|NCT00455520|10879081|FG000|Open Label Tapentadol Extended Release|All other|33
6869091|NCT00455520|10879082|FG001|Open Label Tapentadol Extended Release|All other|0
6869092|NCT00455520|10879081|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29
6869093|NCT00455520|10879082|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15
6869094|NCT00455520|10879081|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8
6869095|NCT00455520|10879082|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29
6869096|NCT00455520|10879081|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15
6869097|NCT00455520|10879082|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7
6869098|NCT00455520|10879081|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
6869099|NCT00455520|10879082|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
6869100|NCT00455520|10879081|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4
6869101|NCT00455520|10879082|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2
6869102|NCT00455520|10879081|FG000|Double Blind Tapentadol ER vs Placebo|All other|4
6869103|NCT00455520|10879082|FG001|Double Blind Tapentadol ER vs Placebo|All other|6
6869104|NCT00455533|10879090|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1
6869105|NCT00455533|10879091|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
6869106|NCT00455533|10879092|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
6869107|NCT00455533|10879090|FG000|Period One: Initial Chemotherapy|Disease Progression|5
6869108|NCT00455533|10879091|FG001|Period One: Initial Chemotherapy|Disease Progression|0
6869109|NCT00455533|10879092|FG002|Period One: Initial Chemotherapy|Disease Progression|0
6869110|NCT00455533|10879090|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2
6869111|NCT00455533|10879091|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0
6869112|NCT00455533|10879092|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0
6869113|NCT00455533|10879090|FG000|Period One: Initial Chemotherapy|Not Reported|1
6869114|NCT00455533|10879091|FG001|Period One: Initial Chemotherapy|Not Reported|0
6869115|NCT00455533|10879092|FG002|Period One: Initial Chemotherapy|Not Reported|0
6869116|NCT00455533|10879090|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2
6869117|NCT00455533|10879091|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0
6869118|NCT00455533|10879092|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0
6869119|NCT00455533|10879090|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2
6869120|NCT00455533|10879091|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0
6869121|NCT00455533|10879092|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0
6869122|NCT00455533|10879090|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1
6869123|NCT00455533|10879091|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
6869124|NCT00455533|10879092|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
6869125|NCT00455533|10879090|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2
6869126|NCT00455533|10879091|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
6869127|NCT00455533|10879092|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
6869128|NCT00455533|10879090|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2
6869129|NCT00455533|10879091|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
6869130|NCT00455533|10879092|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
6869131|NCT00455533|10879090|FG000|Period Two: Randomized Period|Death|0
6869132|NCT00455533|10879091|FG001|Period Two: Randomized Period|Death|0
6869133|NCT00455533|10879092|FG002|Period Two: Randomized Period|Death|3
6869134|NCT00455533|10879090|FG000|Period Two: Randomized Period|Disease Progression|0
6869135|NCT00455533|10879091|FG001|Period Two: Randomized Period|Disease Progression|1
6869136|NCT00455533|10879092|FG002|Period Two: Randomized Period|Disease Progression|1
6869137|NCT00455533|10879090|FG000|Period Two: Randomized Period|Lost to Follow-up|0
6869138|NCT00455533|10879091|FG001|Period Two: Randomized Period|Lost to Follow-up|0
6869139|NCT00455533|10879092|FG002|Period Two: Randomized Period|Lost to Follow-up|1
6869140|NCT00455533|10879090|FG000|Period Two: Randomized Period|Other - need reasons|0
6869141|NCT00455533|10879091|FG001|Period Two: Randomized Period|Other - need reasons|1
6869142|NCT00455533|10879092|FG002|Period Two: Randomized Period|Other - need reasons|0
6869143|NCT00455533|10879090|FG000|Period Two: Randomized Period|Study Drug Toxicity|0
6869144|NCT00455533|10879091|FG001|Period Two: Randomized Period|Study Drug Toxicity|2
6869145|NCT00455533|10879092|FG002|Period Two: Randomized Period|Study Drug Toxicity|0
6869146|NCT00455533|10879090|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0
6869147|NCT00455533|10879091|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2
6869148|NCT00455533|10879092|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1
6869149|NCT00455741|10879155|FG000|Overall Study|Physician Decision|0
6869150|NCT00455741|10879156|FG001|Overall Study|Physician Decision|1
6869151|NCT00455858|10879172|FG000|Overall Study|Lost to Follow-up|2
6869152|NCT00455858|10879172|FG000|Overall Study|Protocol Violation|1
6869153|NCT00455858|10879172|FG000|Overall Study|Lack of Efficacy|1
6869154|NCT00455858|10879172|FG000|Overall Study|Well controlled FPG without insulin|1
6869155|NCT00455858|10879172|FG000|Overall Study|Withdrawal|1
6869156|NCT00455923|10879178|FG000|Overall Study|Pregnancy|0
6869157|NCT00455923|10879179|FG001|Overall Study|Pregnancy|2
6869158|NCT00455923|10879178|FG000|Overall Study|Other|3
6869159|NCT00455923|10879179|FG001|Overall Study|Other|1
6869160|NCT00456092|10879212|FG000|Extension Phase|Grade 2 or Greater AE|2
6869161|NCT00456092|10879213|FG001|Extension Phase|Grade 2 or Greater AE|2
6869162|NCT00456092|10879214|FG002|Extension Phase|Grade 2 or Greater AE|0
6869163|NCT00456092|10879215|FG003|Extension Phase|Grade 2 or Greater AE|0
6869164|NCT00456092|10879216|FG004|Extension Phase|Grade 2 or Greater AE|2
6869165|NCT00456092|10879212|FG000|Extension Phase|Flare of Psoriatic Arthritis|1
6869166|NCT00456092|10879213|FG001|Extension Phase|Flare of Psoriatic Arthritis|0
6869167|NCT00456092|10879214|FG002|Extension Phase|Flare of Psoriatic Arthritis|0
6869168|NCT00456092|10879215|FG003|Extension Phase|Flare of Psoriatic Arthritis|0
6869169|NCT00456092|10879216|FG004|Extension Phase|Flare of Psoriatic Arthritis|1
6869170|NCT00456092|10879212|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3
6869171|NCT00456092|10879213|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1
6869172|NCT00456092|10879214|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0
6869173|NCT00456092|10879215|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0
6869174|NCT00456092|10879216|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2
6869175|NCT00456092|10879212|FG000|Extension Phase|Withdrew Consent|2
6869176|NCT00456092|10879213|FG001|Extension Phase|Withdrew Consent|0
6869177|NCT00456092|10879214|FG002|Extension Phase|Withdrew Consent|0
6869178|NCT00456092|10879215|FG003|Extension Phase|Withdrew Consent|0
6869179|NCT00456092|10879216|FG004|Extension Phase|Withdrew Consent|0
6869180|NCT00456092|10879212|FG000|Extension Phase|Lost to Follow-up|1
6869181|NCT00456092|10879213|FG001|Extension Phase|Lost to Follow-up|1
6869182|NCT00456092|10879214|FG002|Extension Phase|Lost to Follow-up|0
6869183|NCT00456092|10879215|FG003|Extension Phase|Lost to Follow-up|0
6869184|NCT00456092|10879216|FG004|Extension Phase|Lost to Follow-up|1
6869185|NCT00456092|10879212|FG000|Extension Phase|Other|2
6869186|NCT00456092|10879213|FG001|Extension Phase|Other|0
6869187|NCT00456092|10879214|FG002|Extension Phase|Other|0
6869188|NCT00456092|10879215|FG003|Extension Phase|Other|1
6869189|NCT00456092|10879216|FG004|Extension Phase|Other|1
6869190|NCT00456092|10879212|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3
6869191|NCT00456092|10879213|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4
6869192|NCT00456092|10879214|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2
6869193|NCT00456092|10879215|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0
6869194|NCT00456092|10879216|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0
6869195|NCT00456092|10879212|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1
6869196|NCT00456092|10879213|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2
6869197|NCT00456092|10879214|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
6869198|NCT00456092|10879215|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
6869199|NCT00456092|10879216|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
6869200|NCT00456092|10879212|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2
6869201|NCT00456092|10879213|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
6869202|NCT00456092|10879214|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
6869203|NCT00456092|10879215|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
6869204|NCT00456092|10879216|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
6869205|NCT00456092|10879212|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
6869206|NCT00456092|10879213|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1
6869207|NCT00456092|10879214|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2
6869208|NCT00456092|10879215|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
6869209|NCT00456092|10879216|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
6869210|NCT00456092|10879212|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
6869211|NCT00456092|10879213|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3
6869212|NCT00456092|10879214|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3
6869213|NCT00456092|10879215|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
6869214|NCT00456092|10879216|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
6869215|NCT00456092|10879212|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
6869216|NCT00456092|10879213|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2
6869217|NCT00456092|10879214|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7
6869218|NCT00456092|10879215|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
6869219|NCT00456092|10879216|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
6869220|NCT00456092|10879212|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0
6869221|NCT00456092|10879213|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1
6869222|NCT00456092|10879214|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2
6869223|NCT00456092|10879215|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0
6869224|NCT00456092|10879216|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0
6869225|NCT00456092|10879212|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0
6869226|NCT00456092|10879213|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1
6869227|NCT00456092|10879214|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1
6869228|NCT00456092|10879215|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0
6869229|NCT00456092|10879216|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0
6869230|NCT00456092|10879212|FG000|Treatment Phase (12 Weeks)|Other|1
6869231|NCT00456092|10879213|FG001|Treatment Phase (12 Weeks)|Other|0
6869232|NCT00456092|10879214|FG002|Treatment Phase (12 Weeks)|Other|1
6869233|NCT00456092|10879215|FG003|Treatment Phase (12 Weeks)|Other|0
6869234|NCT00456092|10879216|FG004|Treatment Phase (12 Weeks)|Other|0
6869235|NCT00456300|10879230|FG000|Overall Study|Adverse Event|1
6869236|NCT00456300|10879231|FG001|Overall Study|Adverse Event|0
6869237|NCT00456365|10879241|FG000|Overall Study|Lost to Follow-up|1
6869238|NCT00456365|10879242|FG001|Overall Study|Lost to Follow-up|3
6869239|NCT00456365|10879241|FG000|Overall Study|Withdrawal by Subject|4
6869240|NCT00456365|10879242|FG001|Overall Study|Withdrawal by Subject|7
6869241|NCT00456365|10879241|FG000|Overall Study|Pregnancy|1
6869242|NCT00456365|10879242|FG001|Overall Study|Pregnancy|1
6869243|NCT00456365|10879241|FG000|Overall Study|oncologic diagnosis|1
6869244|NCT00456365|10879242|FG001|Overall Study|oncologic diagnosis|1
6869245|NCT00456495|10879250|FG000|Overall Study|Physician Decision|2
6869246|NCT00456521|10879261|FG000|Overall Study|Adverse Event|150
6869247|NCT00456521|10879262|FG001|Overall Study|Adverse Event|25
6869248|NCT00456521|10879261|FG000|Overall Study|Withdrawal by Subject|43
6869249|NCT00456521|10879262|FG001|Overall Study|Withdrawal by Subject|24
6869250|NCT00456521|10879261|FG000|Overall Study|Lost to Follow-up|22
6869251|NCT00456521|10879262|FG001|Overall Study|Lost to Follow-up|17
6869252|NCT00456521|10879261|FG000|Overall Study|Lack of Efficacy|3
6869253|NCT00456521|10879262|FG001|Overall Study|Lack of Efficacy|6
6869254|NCT00456521|10879261|FG000|Overall Study|Protocol Violation|4
6869255|NCT00456521|10879262|FG001|Overall Study|Protocol Violation|0
6869256|NCT00456521|10879261|FG000|Overall Study|Pregnancy|1
6869257|NCT00456521|10879262|FG001|Overall Study|Pregnancy|1
6869258|NCT00456521|10879261|FG000|Overall Study|Drug non-compliance, moved, other|26
6869259|NCT00456521|10879262|FG001|Overall Study|Drug non-compliance, moved, other|11
6869260|NCT00456599|10879278|FG000|Overall Study|Non-compliance|1
6869261|NCT00456599|10879278|FG000|Overall Study|Withdrawal by Subject|2
6869262|NCT00456755|10879288|FG000|Overall Study|Lost to Follow-up|2
6869263|NCT00456755|10879289|FG001|Overall Study|Lost to Follow-up|1
6869264|NCT00456846|10879306|FG000|Overall Study|Adverse Event|2
6869265|NCT00456846|10879307|FG001|Overall Study|Adverse Event|15
6869266|NCT00456846|10879306|FG000|Overall Study|Physician Decision|11
6869267|NCT00456846|10879307|FG001|Overall Study|Physician Decision|6
6869268|NCT00456846|10879306|FG000|Overall Study|Protocol Deviation|2
6869269|NCT00456846|10879307|FG001|Overall Study|Protocol Deviation|0
6869270|NCT00456846|10879306|FG000|Overall Study|Participant Discretion|1
6869271|NCT00456846|10879307|FG001|Overall Study|Participant Discretion|5
6869272|NCT00456846|10879306|FG000|Overall Study|Other|0
6869273|NCT00456846|10879307|FG001|Overall Study|Other|2
6869274|NCT00457002|10879321|FG000|Overall Study|Death|40
6869275|NCT00457002|10879322|FG001|Overall Study|Death|47
6869276|NCT00457002|10879321|FG000|Overall Study|Adverse Event|284
6869277|NCT00457002|10879322|FG001|Overall Study|Adverse Event|260
6869278|NCT00457002|10879321|FG000|Overall Study|Withdrawal by Subject|299
6869279|NCT00457002|10879322|FG001|Overall Study|Withdrawal by Subject|271
6869280|NCT00457002|10879321|FG000|Overall Study|Lost to Follow-up|72
6869281|NCT00457002|10879322|FG001|Overall Study|Lost to Follow-up|71
6869282|NCT00457002|10879321|FG000|Overall Study|Poor/Non-compliance|46
6869283|NCT00457002|10879322|FG001|Overall Study|Poor/Non-compliance|33
6869284|NCT00457002|10879321|FG000|Overall Study|No longer met criteria|41
6869285|NCT00457002|10879322|FG001|Overall Study|No longer met criteria|37
6869286|NCT00457002|10879321|FG000|Overall Study|Administrative reason by Sponsor|1
6869287|NCT00457002|10879322|FG001|Overall Study|Administrative reason by Sponsor|0
6869288|NCT00457002|10879321|FG000|Overall Study|non-specified|29
6869289|NCT00457002|10879322|FG001|Overall Study|non-specified|38
6869290|NCT00457002|10879321|FG000|Overall Study|treated for 1 day; missing status/reason|1
6869291|NCT00457002|10879322|FG001|Overall Study|treated for 1 day; missing status/reason|0
6869292|NCT00457015|10879330|FG000|Overall Study|Left study site against medical advice|0
6869293|NCT00457015|10879331|FG001|Overall Study|Left study site against medical advice|1
6869294|NCT00457249|10879348|FG000|Overall Study|Lost to Follow-up|3
6869295|NCT00457249|10879349|FG001|Overall Study|Lost to Follow-up|0
6869296|NCT00457249|10879348|FG000|Overall Study|Protocol Violation|4
6869297|NCT00457249|10879349|FG001|Overall Study|Protocol Violation|1
6869298|NCT00457249|10879348|FG000|Overall Study|Withdrawal by Subject|3
6869299|NCT00457249|10879349|FG001|Overall Study|Withdrawal by Subject|1
6869300|NCT00457249|10879348|FG000|Overall Study|Serious Adverse Events|2
6869301|NCT00457249|10879349|FG001|Overall Study|Serious Adverse Events|0
6869302|NCT00457301|10879359|FG000|Overall Study|Withdrawal by Subject|3
6869303|NCT00457301|10879360|FG001|Overall Study|Withdrawal by Subject|3
6869304|NCT00457301|10879359|FG000|Overall Study|Censored out of the study|15
6869305|NCT00457301|10879360|FG001|Overall Study|Censored out of the study|14
6869306|NCT00457301|10879359|FG000|Overall Study|Death|5
6869307|NCT00457301|10879360|FG001|Overall Study|Death|7
6869308|NCT00457392|10879377|FG000|Overall Study|Objective Progression or Relapse|229
6869309|NCT00457392|10879378|FG001|Overall Study|Objective Progression or Relapse|296
6869310|NCT00457392|10879377|FG000|Overall Study|Death|106
6869311|NCT00457392|10879378|FG001|Overall Study|Death|106
6869312|NCT00457392|10879377|FG000|Overall Study|Adverse Event|84
6869313|NCT00457392|10879378|FG001|Overall Study|Adverse Event|41
6869314|NCT00457392|10879377|FG000|Overall Study|Global Deterioration of Health Status|22
6869315|NCT00457392|10879378|FG001|Overall Study|Global Deterioration of Health Status|8
6869316|NCT00457392|10879377|FG000|Overall Study|Withdrawal by Subject|14
6869317|NCT00457392|10879378|FG001|Overall Study|Withdrawal by Subject|8
6869318|NCT00457392|10879377|FG000|Overall Study|Lost to Follow-up|6
6869319|NCT00457392|10879378|FG001|Overall Study|Lost to Follow-up|7
6869320|NCT00457392|10879377|FG000|Overall Study|Protocol Violation|4
6869321|NCT00457392|10879378|FG001|Overall Study|Protocol Violation|3
6869322|NCT00457392|10879377|FG000|Overall Study|Other|7
6869323|NCT00457392|10879378|FG001|Overall Study|Other|4
6869324|NCT00457392|10879377|FG000|Overall Study|Study Terminated by Sponsor|1
6869325|NCT00457392|10879378|FG001|Overall Study|Study Terminated by Sponsor|4
6869326|NCT00457392|10879377|FG000|Overall Study|Randomized, Not Treated|7
6869327|NCT00457392|10879378|FG001|Overall Study|Randomized, Not Treated|3
6869328|NCT00457418|10879384|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2
6869329|NCT00457418|10879384|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1
6869330|NCT00457418|10879384|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2
6869331|NCT00457418|10879384|FG000|Post PK Maintenance|Adverse Event|10
6869332|NCT00457418|10879384|FG000|Post PK Maintenance|Progression of Disease|6
6869333|NCT00457418|10879384|FG000|Post PK Maintenance|Withdrawal by Subject|11
6869334|NCT00457418|10879384|FG000|Post PK Maintenance|Lost to Follow-up|1
6869335|NCT00457626|10879388|FG000|Overall Study|Adverse Event|3
6869336|NCT00457626|10879388|FG000|Overall Study|Administrative Problems|2
6869337|NCT00457626|10879388|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1
6869338|NCT00457639|10879392|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3
7078315|NCT02101554|11186700|FG001|Overall Study|Protocol Violation|1
7078316|NCT02101554|11186701|FG002|Overall Study|Protocol Violation|0
7078317|NCT02101554|11186699|FG000|Overall Study|Insufficient Clinical Response|0
7078318|NCT02101554|11186700|FG001|Overall Study|Insufficient Clinical Response|2
7078319|NCT02101554|11186701|FG002|Overall Study|Insufficient Clinical Response|0
7078320|NCT02101554|11186699|FG000|Overall Study|Adverse Event|2
7078321|NCT02101554|11186700|FG001|Overall Study|Adverse Event|1
7078322|NCT02101554|11186701|FG002|Overall Study|Adverse Event|1
7078323|NCT02101554|11186699|FG000|Overall Study|Lost to Follow-up|0
7078324|NCT02101554|11186700|FG001|Overall Study|Lost to Follow-up|1
6869339|NCT00457639|10879393|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0
6869340|NCT00457639|10879392|FG000|Intervention 1 (6 Months)|unrelated illness|0
6869341|NCT00457639|10879393|FG001|Intervention 1 (6 Months)|unrelated illness|2
6869342|NCT00457639|10879392|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0
6869343|NCT00457639|10879393|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1
6869344|NCT00457665|10879401|FG000|12 Months|Drug allergy|1
6869345|NCT00457665|10879402|FG001|12 Months|Drug allergy|1
6869346|NCT00457665|10879401|FG000|12 Months|High HIV viral load|5
6869347|NCT00457665|10879402|FG001|12 Months|High HIV viral load|1
6869348|NCT00457665|10879401|FG000|12 Months|Lipodystrophy|2
6869349|NCT00457665|10879402|FG001|12 Months|Lipodystrophy|0
6869350|NCT00457665|10879401|FG000|12 Months|Withdrawal by Subject|0
6869351|NCT00457665|10879402|FG001|12 Months|Withdrawal by Subject|2
6869352|NCT00457665|10879401|FG000|12 Months|Abnormal Liver function tests|0
6869353|NCT00457665|10879402|FG001|12 Months|Abnormal Liver function tests|5
6869354|NCT00457665|10879401|FG000|24 Months|Withdrawal by Subject|3
7078325|NCT02101554|11186701|FG002|Overall Study|Lost to Follow-up|0
6869355|NCT00457665|10879402|FG001|24 Months|Withdrawal by Subject|2
6869356|NCT00457665|10879401|FG000|24 Months|Lipodystrophy|1
7078326|NCT02101554|11186699|FG000|Overall Study|Withdrawl by Parents/Guardians|1
6869357|NCT00457665|10879402|FG001|24 Months|Lipodystrophy|1
7078327|NCT02101554|11186700|FG001|Overall Study|Withdrawl by Parents/Guardians|0
7078328|NCT02101554|11186701|FG002|Overall Study|Withdrawl by Parents/Guardians|0
7078329|NCT02101983|11186715|FG000|Overall Study|Physician Decision|1
7078330|NCT02101983|11186716|FG001|Overall Study|Physician Decision|0
7078331|NCT02102204|11186731|FG000|Overall Study|Withdrawal by Subject|137
7078332|NCT02102204|11186731|FG000|Overall Study|Death|92
7078333|NCT02102204|11186731|FG000|Overall Study|Lost to Follow-up|65
7078334|NCT02102204|11186731|FG000|Overall Study|Sponsor Decision|5
7078335|NCT02102204|11186731|FG000|Overall Study|Ongoing|5
7078336|NCT02102399|11186751|FG000|Overall Study|Withdrawal by Subject|6
7078337|NCT02102399|11186752|FG001|Overall Study|Withdrawal by Subject|4
7078338|NCT02102464|11186765|FG000|Randomized Study|Withdrawal by Subject|0
7078339|NCT02102464|11186766|FG001|Randomized Study|Withdrawal by Subject|1
7078340|NCT02102464|11186767|FG002|Randomized Study|Withdrawal by Subject|0
7078341|NCT02102490|11186776|FG000|Overall Study|Death|6
7078342|NCT02102490|11186776|FG000|Overall Study|Lost to Follow-up|1
7078343|NCT02102724|11186782|FG000|Overall Study|Lost to Follow-up|1
7078344|NCT02102724|11186783|FG001|Overall Study|Lost to Follow-up|0
7078345|NCT02102724|11186782|FG000|Overall Study|surgery for brain aneurysm|1
7078346|NCT02102724|11186783|FG001|Overall Study|surgery for brain aneurysm|1
7078347|NCT02103062|11186824|FG000|Overall Study|Adverse Event|1
7078348|NCT02103062|11186825|FG001|Overall Study|Adverse Event|2
7078349|NCT02103062|11186824|FG000|Overall Study|Progressive Disease|17
7078350|NCT02103062|11186825|FG001|Overall Study|Progressive Disease|20
7078351|NCT02103062|11186824|FG000|Overall Study|Death|0
7078352|NCT02103062|11186825|FG001|Overall Study|Death|1
7078353|NCT02103439|11186894|FG000|Overall Study|Adverse Event|0
7078354|NCT02103439|11186895|FG001|Overall Study|Adverse Event|2
7078355|NCT02103439|11186894|FG000|Overall Study|Withdrawal by Subject|3
7078356|NCT02103439|11186895|FG001|Overall Study|Withdrawal by Subject|1
7078357|NCT02103478|11186912|FG000|Overall Study|Adverse Event|0
7078358|NCT02103478|11186913|FG001|Overall Study|Adverse Event|0
7078359|NCT02103478|11186914|FG002|Overall Study|Adverse Event|1
7078360|NCT02103478|11186915|FG003|Overall Study|Adverse Event|1
7078361|NCT02103478|11186916|FG004|Overall Study|Adverse Event|2
6869358|NCT00457665|10879401|FG000|24 Months|Abnormal liver function tests|1
6869359|NCT00457665|10879402|FG001|24 Months|Abnormal liver function tests|5
6869360|NCT00457691|10879410|FG000|Overall Study|Adverse Event|4
6869361|NCT00457691|10879411|FG001|Overall Study|Adverse Event|1
6869362|NCT00457691|10879410|FG000|Overall Study|Death|163
6869363|NCT00457691|10879411|FG001|Overall Study|Death|148
6869364|NCT00457691|10879410|FG000|Overall Study|Protocol Violation|1
6869365|NCT00457691|10879411|FG001|Overall Study|Protocol Violation|3
6869366|NCT00457691|10879410|FG000|Overall Study|Lost to Follow-up|23
6869367|NCT00457691|10879411|FG001|Overall Study|Lost to Follow-up|14
6869368|NCT00457691|10879410|FG000|Overall Study|Study terminated by Sponsor|1
6869369|NCT00457691|10879411|FG001|Overall Study|Study terminated by Sponsor|1
6869370|NCT00457691|10879410|FG000|Overall Study|Subject refused (reason other than AE)|14
6869371|NCT00457691|10879411|FG001|Overall Study|Subject refused (reason other than AE)|19
6869372|NCT00457691|10879410|FG000|Overall Study|Disease progression, study terminated|180
6869373|NCT00457691|10879411|FG001|Overall Study|Disease progression, study terminated|196
6869374|NCT00457743|10879433|FG000|Overall Study|Adverse Event|0
6869375|NCT00457743|10879434|FG001|Overall Study|Adverse Event|4
6869376|NCT00457743|10879435|FG002|Overall Study|Adverse Event|0
6869377|NCT00457743|10879433|FG000|Overall Study|Lack of Efficacy|3
6869378|NCT00457743|10879434|FG001|Overall Study|Lack of Efficacy|23
6869379|NCT00457743|10879435|FG002|Overall Study|Lack of Efficacy|3
6869380|NCT00457821|10879456|FG000|Part 2|Withdrawal by Subject|0
6869381|NCT00457821|10879457|FG001|Part 2|Withdrawal by Subject|0
6869382|NCT00457821|10879458|FG002|Part 2|Withdrawal by Subject|0
6869383|NCT00457821|10879459|FG003|Part 2|Withdrawal by Subject|0
6869384|NCT00457821|10879460|FG004|Part 2|Withdrawal by Subject|0
6869385|NCT00457821|10879461|FG005|Part 2|Withdrawal by Subject|0
6869386|NCT00457821|10879462|FG006|Part 2|Withdrawal by Subject|0
6869387|NCT00457821|10879463|FG007|Part 2|Withdrawal by Subject|1
6869388|NCT00458211|10879489|FG000|Overall Study|Lack of Efficacy|12
6869389|NCT00458211|10879489|FG000|Overall Study|Withdrawal by Subject|2
6869390|NCT00458211|10879489|FG000|Overall Study|Protocol Violation|2
6869391|NCT00458302|10879513|FG000|Overall Study|Adverse Event|4
6869392|NCT00458302|10879514|FG001|Overall Study|Adverse Event|14
6869393|NCT00458302|10879513|FG000|Overall Study|Pregnancy|2
6869394|NCT00458302|10879514|FG001|Overall Study|Pregnancy|1
6869395|NCT00458302|10879513|FG000|Overall Study|Protocol Violation|0
6869396|NCT00458302|10879514|FG001|Overall Study|Protocol Violation|2
7078362|NCT02103478|11186917|FG005|Overall Study|Adverse Event|1
7078363|NCT02103478|11186918|FG006|Overall Study|Adverse Event|0
7078364|NCT02103478|11186919|FG007|Overall Study|Adverse Event|0
7078365|NCT02103478|11186920|FG008|Overall Study|Adverse Event|0
7078366|NCT02103478|11186912|FG000|Overall Study|Death|2
6869397|NCT00458302|10879513|FG000|Overall Study|Withdrawal by Subject|6
6869398|NCT00458302|10879514|FG001|Overall Study|Withdrawal by Subject|4
6869399|NCT00458302|10879513|FG000|Overall Study|Inc/Exc Criteria Not Met|1
7078367|NCT02103478|11186913|FG001|Overall Study|Death|2
7078368|NCT02103478|11186914|FG002|Overall Study|Death|1
7078369|NCT02103478|11186915|FG003|Overall Study|Death|1
7078370|NCT02103478|11186916|FG004|Overall Study|Death|5
6869400|NCT00458302|10879514|FG001|Overall Study|Inc/Exc Criteria Not Met|1
6869401|NCT00458302|10879513|FG000|Overall Study|Study Termination By Sponsor|1
6869402|NCT00458302|10879514|FG001|Overall Study|Study Termination By Sponsor|0
6869403|NCT00458302|10879513|FG000|Overall Study|Lost to Follow-up|2
6869404|NCT00458302|10879514|FG001|Overall Study|Lost to Follow-up|0
6869405|NCT00458302|10879513|FG000|Overall Study|Other|4
6869406|NCT00458302|10879514|FG001|Overall Study|Other|2
6869407|NCT00458341|10879523|FG000|Cycle 1|Adverse Event|1
6869408|NCT00458341|10879524|FG001|Cycle 1|Adverse Event|0
6869409|NCT00458393|10879532|FG000|Overall Study|Withdrawal by Subject|67
6869410|NCT00458393|10879533|FG001|Overall Study|Withdrawal by Subject|80
6869411|NCT00458393|10879532|FG000|Overall Study|Physician Decision|31
6869412|NCT00458393|10879533|FG001|Overall Study|Physician Decision|22
6869413|NCT00458393|10879532|FG000|Overall Study|Relocated|77
6869414|NCT00458393|10879533|FG001|Overall Study|Relocated|81
6869415|NCT00458393|10879532|FG000|Overall Study|Lost to Follow-up|115
6869416|NCT00458393|10879533|FG001|Overall Study|Lost to Follow-up|92
6869417|NCT00458393|10879532|FG000|Overall Study|Sites marked other on the form.|19
6869418|NCT00458393|10879533|FG001|Overall Study|Sites marked other on the form.|20
6869419|NCT00458484|10879564|FG000|Overall Study|Not eligible b/c prior radiation history|0
6869420|NCT00458484|10879565|FG001|Overall Study|Not eligible b/c prior radiation history|0
6869421|NCT00458484|10879566|FG002|Overall Study|Not eligible b/c prior radiation history|0
6869422|NCT00458484|10879567|FG003|Overall Study|Not eligible b/c prior radiation history|0
6869423|NCT00458484|10879568|FG004|Overall Study|Not eligible b/c prior radiation history|0
6869424|NCT00458484|10879569|FG005|Overall Study|Not eligible b/c prior radiation history|1
6869425|NCT00458484|10879570|FG006|Overall Study|Not eligible b/c prior radiation history|0
6869426|NCT00458705|10879595|FG000|Overall Study|Adverse Event|4
6869427|NCT00458705|10879595|FG000|Overall Study|Not Treated|1
6869428|NCT00458783|10879601|FG000|Overall Study|Protocol Violation|1228
6869429|NCT00458783|10879602|FG001|Overall Study|Protocol Violation|1220
6869430|NCT00459043|10879625|FG000|Overall Study|Withdrawal by Subject|1
6869431|NCT00459043|10879626|FG001|Overall Study|Withdrawal by Subject|0
6869432|NCT00459056|10879634|FG000|First Intervention (First Three Months)|Lost to Follow-up|1
6869433|NCT00459056|10879635|FG001|First Intervention (First Three Months)|Lost to Follow-up|1
6869434|NCT00459108|10879641|FG000|Overall Study|Withdrawal by Subject|5
6869435|NCT00459108|10879641|FG000|Overall Study|Adverse Event|3
6869436|NCT00459108|10879641|FG000|Overall Study|Death|2
6869437|NCT00459108|10879641|FG000|Overall Study|Progression|1
6869438|NCT00459134|10879648|FG000|Overall Study|Physician Decision|1
6869439|NCT00459134|10879649|FG001|Overall Study|Physician Decision|1
6869440|NCT00459134|10879648|FG000|Overall Study|Withdrawal by Subject|8
6869441|NCT00459134|10879649|FG001|Overall Study|Withdrawal by Subject|7
6869442|NCT00459134|10879648|FG000|Overall Study|Lost to Follow-up|6
6869443|NCT00459134|10879649|FG001|Overall Study|Lost to Follow-up|7
6869444|NCT00459134|10879648|FG000|Overall Study|Surgery|1
6869445|NCT00459134|10879649|FG001|Overall Study|Surgery|2
6869446|NCT00459134|10879648|FG000|Overall Study|Toxicity|4
6869447|NCT00459134|10879649|FG001|Overall Study|Toxicity|5
6869448|NCT00459134|10879648|FG000|Overall Study|Progression|1
6869449|NCT00459134|10879649|FG001|Overall Study|Progression|0
6869450|NCT00459134|10879648|FG000|Overall Study|Multiple Reasons|2
6869451|NCT00459134|10879649|FG001|Overall Study|Multiple Reasons|3
6869452|NCT00459186|10879655|FG000|Single Agent RAD001|Withdrawal by Subject|1
6869453|NCT00459186|10879655|FG000|PET Imaging and Assessment|Adverse Event|3
6869454|NCT00459290|10879659|FG000|Overall Study|Adverse Event|3
6869455|NCT00459290|10879659|FG000|Overall Study|Ineligible|2
6869456|NCT00459316|10879682|FG000|Steps 1 & 2|Other eligibility failure|1
6869457|NCT00459316|10879683|FG001|Steps 1 & 2|Other eligibility failure|1
6869458|NCT00459316|10879684|FG002|Steps 1 & 2|Other eligibility failure|0
6869459|NCT00459316|10879682|FG000|Steps 1 & 2|Death|1
6869460|NCT00459316|10879683|FG001|Steps 1 & 2|Death|1
6869461|NCT00459316|10879684|FG002|Steps 1 & 2|Death|0
6869462|NCT00459316|10879682|FG000|Steps 1 & 2|Not able to get to clinic|7
6869463|NCT00459316|10879683|FG001|Steps 1 & 2|Not able to get to clinic|4
6869464|NCT00459316|10879684|FG002|Steps 1 & 2|Not able to get to clinic|0
6869465|NCT00459316|10879682|FG000|Steps 1 & 2|Withdrawal by Subject|6
6869466|NCT00459316|10879683|FG001|Steps 1 & 2|Withdrawal by Subject|1
6869467|NCT00459316|10879684|FG002|Steps 1 & 2|Withdrawal by Subject|0
6869468|NCT00459316|10879682|FG000|Steps 1 & 2|Not willing to adhere to regulations|1
6869469|NCT00459316|10879683|FG001|Steps 1 & 2|Not willing to adhere to regulations|0
6869470|NCT00459316|10879684|FG002|Steps 1 & 2|Not willing to adhere to regulations|0
6869471|NCT00459316|10879682|FG000|Steps 1 & 2|Lost to Follow-up|5
6869472|NCT00459316|10879683|FG001|Steps 1 & 2|Lost to Follow-up|0
6869473|NCT00459316|10879684|FG002|Steps 1 & 2|Lost to Follow-up|2
6869474|NCT00459316|10879682|FG000|Step 3|Withdrawal by Subject|3
6869475|NCT00459316|10879683|FG001|Step 3|Withdrawal by Subject|0
6869476|NCT00459316|10879684|FG002|Step 3|Withdrawal by Subject|1
6869477|NCT00459342|10879707|FG000|Overall Study|Not eligible|1
6869478|NCT00459355|10879713|FG000|Overall Study|Subject no longer met inc criteria|20
6869479|NCT00459355|10879714|FG001|Overall Study|Subject no longer met inc criteria|18
6869480|NCT00459537|10879739|FG000|Overall Study|Adverse Event|1
6869481|NCT00459537|10879740|FG001|Overall Study|Adverse Event|6
6869482|NCT00459537|10879739|FG000|Overall Study|Lack of Efficacy|10
6869483|NCT00459537|10879740|FG001|Overall Study|Lack of Efficacy|11
6869484|NCT00459537|10879739|FG000|Overall Study|Withdrawal by Subject|20
6869485|NCT00459537|10879740|FG001|Overall Study|Withdrawal by Subject|26
6869486|NCT00459537|10879739|FG000|Overall Study|Lost to Follow-up|27
6869487|NCT00459537|10879740|FG001|Overall Study|Lost to Follow-up|30
6869488|NCT00459537|10879739|FG000|Overall Study|Administrative problems|3
6869489|NCT00459537|10879740|FG001|Overall Study|Administrative problems|0
6869490|NCT00459537|10879739|FG000|Overall Study|Protocol Violation|4
6869491|NCT00459537|10879740|FG001|Overall Study|Protocol Violation|3
6869492|NCT00459537|10879739|FG000|Overall Study|Missing|1
6869493|NCT00459537|10879740|FG001|Overall Study|Missing|0
6869494|NCT00459667|10879749|FG000|Overall Study|Adverse Event|9
6869495|NCT00459667|10879750|FG001|Overall Study|Adverse Event|12
6869496|NCT00459667|10879751|FG002|Overall Study|Adverse Event|8
6869497|NCT00459667|10879749|FG000|Overall Study|Lost to Follow-up|5
6869498|NCT00459667|10879750|FG001|Overall Study|Lost to Follow-up|9
6869499|NCT00459667|10879751|FG002|Overall Study|Lost to Follow-up|3
6869500|NCT00459667|10879749|FG000|Overall Study|Pregnancy|1
6869501|NCT00459667|10879750|FG001|Overall Study|Pregnancy|1
6869502|NCT00459667|10879751|FG002|Overall Study|Pregnancy|1
6869503|NCT00459667|10879749|FG000|Overall Study|Protocol Violation|1
6869504|NCT00459667|10879750|FG001|Overall Study|Protocol Violation|0
6869505|NCT00459667|10879751|FG002|Overall Study|Protocol Violation|0
6869506|NCT00459667|10879749|FG000|Overall Study|Withdrawal by Subject|3
6869507|NCT00459667|10879750|FG001|Overall Study|Withdrawal by Subject|5
6869508|NCT00459667|10879751|FG002|Overall Study|Withdrawal by Subject|5
6869509|NCT00459667|10879749|FG000|Overall Study|Other disease modifying treatment|1
6869510|NCT00459667|10879750|FG001|Overall Study|Other disease modifying treatment|2
6869511|NCT00459667|10879751|FG002|Overall Study|Other disease modifying treatment|1
6869512|NCT00459667|10879749|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12
6869513|NCT00459667|10879750|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15
6869514|NCT00459667|10879751|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1
6869515|NCT00459667|10879749|FG000|Overall Study|No treatment administered|6
6869516|NCT00459667|10879750|FG001|Overall Study|No treatment administered|3
6869517|NCT00459667|10879751|FG002|Overall Study|No treatment administered|1
6869518|NCT00459706|10879761|FG000|Overall Study|Adverse Event|19
6869519|NCT00459706|10879762|FG001|Overall Study|Adverse Event|13
6869520|NCT00459706|10879761|FG000|Overall Study|Withdrawal by Subject|1
6869521|NCT00459706|10879762|FG001|Overall Study|Withdrawal by Subject|6
6869522|NCT00459706|10879761|FG000|Overall Study|Physician Decision|2
6869523|NCT00459706|10879762|FG001|Overall Study|Physician Decision|0
6869524|NCT00459706|10879761|FG000|Overall Study|Discontinuation of Study by Sponsor|1
6869525|NCT00459706|10879762|FG001|Overall Study|Discontinuation of Study by Sponsor|0
6869526|NCT00459706|10879761|FG000|Overall Study|Protocol Violation|2
6869527|NCT00459706|10879762|FG001|Overall Study|Protocol Violation|1
6869528|NCT00459706|10879761|FG000|Overall Study|Failed to Return|1
6869529|NCT00459706|10879762|FG001|Overall Study|Failed to Return|0
6869530|NCT00459706|10879761|FG000|Overall Study|Other|0
6869531|NCT00459706|10879762|FG001|Overall Study|Other|1
6968407|NCT01138007|11017232|FG001|Overall Study|Lost to Follow-up|3
6968408|NCT01138007|11017233|FG002|Overall Study|Lost to Follow-up|5
6968409|NCT01138007|11017231|FG000|Overall Study|Physician Decision|0
6968410|NCT01138007|11017232|FG001|Overall Study|Physician Decision|5
6968411|NCT01138007|11017233|FG002|Overall Study|Physician Decision|3
6968412|NCT01138007|11017231|FG000|Overall Study|Withdrawal by Subject|5
6968413|NCT01138007|11017232|FG001|Overall Study|Withdrawal by Subject|6
6968414|NCT01138007|11017233|FG002|Overall Study|Withdrawal by Subject|15
6968415|NCT01138046|11017243|FG000|Overall Study|Withdrawal due to death|6
6968416|NCT01138111|11017256|FG000|Overall Study|Withdrawal by Subject|5
6968417|NCT01138111|11017256|FG000|Overall Study|Adverse Event|1
6968418|NCT01138111|11017256|FG000|Overall Study|Death|1
6968419|NCT01138111|11017256|FG000|Overall Study|Lost to Follow-up|2
6968420|NCT01138150|11017302|FG000|Overall Study|blood unable to be processed|0
6968421|NCT01138150|11017303|FG001|Overall Study|blood unable to be processed|1
6968422|NCT01138150|11017302|FG000|Overall Study|Physician Decision|1
6968423|NCT01138150|11017303|FG001|Overall Study|Physician Decision|0
6968424|NCT01138501|11017338|FG000|Overall Study|Protocol Violation|2
6968425|NCT01138501|11017338|FG000|Overall Study|Withdrawal by Subject|3
6968426|NCT01138657|11017358|FG000|Overall Study|Adverse Event|3
6968427|NCT01138657|11017359|FG001|Overall Study|Adverse Event|10
6968428|NCT01138657|11017358|FG000|Overall Study|Lack of Efficacy|2
6968429|NCT01138657|11017359|FG001|Overall Study|Lack of Efficacy|1
6968430|NCT01138657|11017358|FG000|Overall Study|Lost to Follow-up|0
6968431|NCT01138657|11017359|FG001|Overall Study|Lost to Follow-up|3
6968432|NCT01138657|11017358|FG000|Overall Study|Miscellaneous Reasons|3
6968433|NCT01138657|11017359|FG001|Overall Study|Miscellaneous Reasons|4
6968434|NCT01138826|11017376|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1
6968435|NCT01138826|11017377|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1
6968436|NCT01138826|11017378|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0
6968437|NCT01138826|11017379|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0
6968438|NCT01138826|11017380|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1
6968439|NCT01138826|11017381|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0
7041185|NCT01724528|11124695|FG001|Overall Study|Protocol Violation|1
6968440|NCT01139008|11017416|FG000|Overall Study|Withdrawal by Subject|5
6968441|NCT01139008|11017416|FG000|Overall Study|Non-compliant, lost product|1
6968442|NCT01139021|11017429|FG000|Overall Study|Adverse Event|0
6869532|NCT00459875|10879785|FG000|Overall Study|Ineligible participant|1
6869533|NCT00459875|10879785|FG000|Overall Study|Adverse Event|2
6869534|NCT00459953|10879791|FG000|Overall Study|not analyzed-household member in study|1
6869535|NCT00459953|10879792|FG001|Overall Study|not analyzed-household member in study|1
6869536|NCT00459979|10879798|FG000|Overall Study|Withdrawal by Subject|1
6869537|NCT00459979|10879798|FG000|Overall Study|Protocol Violation|1
6869538|NCT00460031|10879802|FG000|Overall Study|Adverse Event|5
6869539|NCT00460031|10879802|FG000|Overall Study|Withdrawal by Subject|5
6869540|NCT00460031|10879802|FG000|Overall Study|Death|1
6869541|NCT00460109|10879806|FG000|Overall Study|Death|1
6869542|NCT00460239|10879810|FG000|Overall Study|Physician Decision|0
6869543|NCT00460239|10879811|FG001|Overall Study|Physician Decision|1
6869544|NCT00460239|10879812|FG002|Overall Study|Physician Decision|0
6869545|NCT00460239|10879813|FG003|Overall Study|Physician Decision|0
6869546|NCT00460239|10879814|FG004|Overall Study|Physician Decision|0
6869547|NCT00460239|10879815|FG005|Overall Study|Physician Decision|2
6869548|NCT00460239|10879816|FG006|Overall Study|Physician Decision|0
6869549|NCT00460239|10879817|FG007|Overall Study|Physician Decision|0
6869550|NCT00460239|10879818|FG008|Overall Study|Physician Decision|0
6869551|NCT00460239|10879810|FG000|Overall Study|Withdrawal by Subject|0
6869552|NCT00460239|10879811|FG001|Overall Study|Withdrawal by Subject|0
6869553|NCT00460239|10879812|FG002|Overall Study|Withdrawal by Subject|0
6869554|NCT00460239|10879813|FG003|Overall Study|Withdrawal by Subject|0
6869555|NCT00460239|10879814|FG004|Overall Study|Withdrawal by Subject|0
6869556|NCT00460239|10879815|FG005|Overall Study|Withdrawal by Subject|1
6869557|NCT00460239|10879816|FG006|Overall Study|Withdrawal by Subject|0
6869558|NCT00460239|10879817|FG007|Overall Study|Withdrawal by Subject|0
6869559|NCT00460239|10879818|FG008|Overall Study|Withdrawal by Subject|0
6869560|NCT00460265|10879833|FG000|Overall Study|Lost to Follow-up|14
6869561|NCT00460265|10879834|FG001|Overall Study|Lost to Follow-up|15
6869562|NCT00460265|10879833|FG000|Overall Study|Physician Decision|1
6869563|NCT00460265|10879834|FG001|Overall Study|Physician Decision|2
6869564|NCT00460265|10879833|FG000|Overall Study|Withdrawal by Subject|10
6869565|NCT00460265|10879834|FG001|Overall Study|Withdrawal by Subject|25
6869566|NCT00460265|10879833|FG000|Overall Study|Ongoing|60
6869567|NCT00460265|10879834|FG001|Overall Study|Ongoing|47
6869568|NCT00460408|10879844|FG000|Overall Study|Adverse Event|1
6869569|NCT00460408|10879845|FG001|Overall Study|Adverse Event|0
6869570|NCT00460408|10879846|FG002|Overall Study|Adverse Event|0
6869571|NCT00460408|10879847|FG003|Overall Study|Adverse Event|0
6869572|NCT00460408|10879844|FG000|Overall Study|Death|7
6869573|NCT00460408|10879845|FG001|Overall Study|Death|0
6869574|NCT00460408|10879846|FG002|Overall Study|Death|0
6869575|NCT00460408|10879847|FG003|Overall Study|Death|0
6869576|NCT00460408|10879844|FG000|Overall Study|Lost to Follow-up|11
6869577|NCT00460408|10879845|FG001|Overall Study|Lost to Follow-up|0
6869578|NCT00460408|10879846|FG002|Overall Study|Lost to Follow-up|1
6869579|NCT00460408|10879847|FG003|Overall Study|Lost to Follow-up|0
6869580|NCT00460408|10879844|FG000|Overall Study|Withdrawal by Subject|31
6869581|NCT00460408|10879845|FG001|Overall Study|Withdrawal by Subject|0
6869582|NCT00460408|10879846|FG002|Overall Study|Withdrawal by Subject|0
6869583|NCT00460408|10879847|FG003|Overall Study|Withdrawal by Subject|0
6869584|NCT00460408|10879844|FG000|Overall Study|Insufficient clinical response|5
6869585|NCT00460408|10879845|FG001|Overall Study|Insufficient clinical response|1
6869586|NCT00460408|10879846|FG002|Overall Study|Insufficient clinical response|5
6869587|NCT00460408|10879847|FG003|Overall Study|Insufficient clinical response|0
6869588|NCT00460408|10879844|FG000|Overall Study|Other|12
6869589|NCT00460408|10879845|FG001|Overall Study|Other|2
6869590|NCT00460408|10879846|FG002|Overall Study|Other|0
6869591|NCT00460408|10879847|FG003|Overall Study|Other|0
6869592|NCT00460434|10879871|FG000|Overall Study|Lost to Follow-up|3
6869593|NCT00460434|10879872|FG001|Overall Study|Lost to Follow-up|7
6869594|NCT00460564|10879895|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3
6869595|NCT00460564|10879896|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1
6869596|NCT00460564|10879897|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0
6869597|NCT00460564|10879898|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0
6869598|NCT00460564|10879899|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0
6869599|NCT00460564|10879900|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0
6869600|NCT00460564|10879901|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0
6869601|NCT00460564|10879902|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0
6869602|NCT00460564|10879895|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1
6869603|NCT00460564|10879896|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
6869604|NCT00460564|10879897|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
6869605|NCT00460564|10879898|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
6869606|NCT00460564|10879899|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
6869607|NCT00460564|10879900|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
6869608|NCT00460564|10879901|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
6869609|NCT00460564|10879902|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
6869610|NCT00460564|10879895|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0
6869611|NCT00460564|10879896|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0
6869612|NCT00460564|10879897|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0
6869613|NCT00460564|10879898|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0
6869614|NCT00460564|10879899|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3
6869615|NCT00460564|10879900|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5
6869616|NCT00460564|10879901|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2
6869617|NCT00460564|10879902|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0
6869618|NCT00460564|10879895|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
6869619|NCT00460564|10879896|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
6869620|NCT00460564|10879897|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
6869621|NCT00460564|10879898|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
6869622|NCT00460564|10879899|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5
6869623|NCT00460564|10879900|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1
6869624|NCT00460564|10879901|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
6869625|NCT00460564|10879902|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
6869626|NCT00460564|10879895|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
6869627|NCT00460564|10879896|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
6869628|NCT00460564|10879897|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
6869629|NCT00460564|10879898|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
6869630|NCT00460564|10879899|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1
6869631|NCT00460564|10879900|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
6869632|NCT00460564|10879901|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
6869633|NCT00460564|10879902|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
6869634|NCT00460577|10879924|FG000|Overall Study|Protocol Violation|2
6869635|NCT00460577|10879925|FG001|Overall Study|Protocol Violation|6
6869636|NCT00460603|10879943|FG000|Phase 1|Death|1
6869637|NCT00460603|10879944|FG001|Phase 1|Death|0
6869638|NCT00460603|10879945|FG002|Phase 1|Death|0
6869639|NCT00460603|10879946|FG003|Phase 1|Death|2
6869640|NCT00460603|10879947|FG004|Phase 1|Death|0
6869641|NCT00460603|10879948|FG005|Phase 1|Death|0
6869642|NCT00460603|10879949|FG006|Phase 1|Death|0
6869643|NCT00460603|10879950|FG007|Phase 1|Death|0
6869644|NCT00460603|10879951|FG008|Phase 1|Death|1
6869645|NCT00460603|10879952|FG009|Phase 1|Death|0
6869646|NCT00460603|10879953|FG010|Phase 1|Death|0
6869647|NCT00460603|10879954|FG011|Phase 1|Death|0
6869648|NCT00460603|10879943|FG000|Phase 1|Adverse Event|3
6869649|NCT00460603|10879944|FG001|Phase 1|Adverse Event|1
6869650|NCT00460603|10879945|FG002|Phase 1|Adverse Event|1
6869651|NCT00460603|10879946|FG003|Phase 1|Adverse Event|2
6869652|NCT00460603|10879947|FG004|Phase 1|Adverse Event|0
6869653|NCT00460603|10879948|FG005|Phase 1|Adverse Event|0
6869654|NCT00460603|10879949|FG006|Phase 1|Adverse Event|3
6869655|NCT00460603|10879950|FG007|Phase 1|Adverse Event|0
6869656|NCT00460603|10879951|FG008|Phase 1|Adverse Event|4
6869657|NCT00460603|10879952|FG009|Phase 1|Adverse Event|0
6869658|NCT00460603|10879953|FG010|Phase 1|Adverse Event|0
6869659|NCT00460603|10879954|FG011|Phase 1|Adverse Event|0
6869660|NCT00460603|10879943|FG000|Phase 1|Lack of Efficacy|1
6869661|NCT00460603|10879944|FG001|Phase 1|Lack of Efficacy|0
6869662|NCT00460603|10879945|FG002|Phase 1|Lack of Efficacy|1
6869663|NCT00460603|10879946|FG003|Phase 1|Lack of Efficacy|2
6869664|NCT00460603|10879947|FG004|Phase 1|Lack of Efficacy|2
6869665|NCT00460603|10879948|FG005|Phase 1|Lack of Efficacy|2
6869666|NCT00460603|10879949|FG006|Phase 1|Lack of Efficacy|2
6869667|NCT00460603|10879950|FG007|Phase 1|Lack of Efficacy|2
6869668|NCT00460603|10879951|FG008|Phase 1|Lack of Efficacy|11
6869669|NCT00460603|10879952|FG009|Phase 1|Lack of Efficacy|0
6869670|NCT00460603|10879953|FG010|Phase 1|Lack of Efficacy|0
6869671|NCT00460603|10879954|FG011|Phase 1|Lack of Efficacy|0
6869672|NCT00460603|10879943|FG000|Phase 1|Withdrawal by Subject|1
6869673|NCT00460603|10879944|FG001|Phase 1|Withdrawal by Subject|2
6869674|NCT00460603|10879945|FG002|Phase 1|Withdrawal by Subject|1
6869675|NCT00460603|10879946|FG003|Phase 1|Withdrawal by Subject|1
6869676|NCT00460603|10879947|FG004|Phase 1|Withdrawal by Subject|3
6869677|NCT00460603|10879948|FG005|Phase 1|Withdrawal by Subject|0
6869678|NCT00460603|10879949|FG006|Phase 1|Withdrawal by Subject|1
6869679|NCT00460603|10879950|FG007|Phase 1|Withdrawal by Subject|0
6869680|NCT00460603|10879951|FG008|Phase 1|Withdrawal by Subject|2
6869681|NCT00460603|10879952|FG009|Phase 1|Withdrawal by Subject|0
6869682|NCT00460603|10879953|FG010|Phase 1|Withdrawal by Subject|0
6869683|NCT00460603|10879954|FG011|Phase 1|Withdrawal by Subject|0
6869684|NCT00460603|10879943|FG000|Phase 1|Other|0
6869685|NCT00460603|10879944|FG001|Phase 1|Other|3
6869686|NCT00460603|10879945|FG002|Phase 1|Other|1
6869687|NCT00460603|10879946|FG003|Phase 1|Other|1
6869688|NCT00460603|10879947|FG004|Phase 1|Other|1
6869689|NCT00460603|10879948|FG005|Phase 1|Other|2
6869690|NCT00460603|10879949|FG006|Phase 1|Other|0
6869691|NCT00460603|10879950|FG007|Phase 1|Other|1
6869692|NCT00460603|10879951|FG008|Phase 1|Other|0
6869693|NCT00460603|10879952|FG009|Phase 1|Other|0
6869694|NCT00460603|10879953|FG010|Phase 1|Other|0
6869695|NCT00460603|10879954|FG011|Phase 1|Other|0
6869696|NCT00460603|10879943|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
6869697|NCT00460603|10879944|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
6869698|NCT00460603|10879945|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
6869699|NCT00460603|10879946|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
6869700|NCT00460603|10879947|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
6869701|NCT00460603|10879948|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
6869702|NCT00460603|10879949|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
6869703|NCT00460603|10879950|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
6869704|NCT00460603|10879951|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
6869705|NCT00460603|10879952|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1
6869706|NCT00460603|10879953|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
6869707|NCT00460603|10879954|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
6869708|NCT00460603|10879943|FG000|Phase 2|Adverse Event|0
6869709|NCT00460603|10879944|FG001|Phase 2|Adverse Event|0
6869710|NCT00460603|10879945|FG002|Phase 2|Adverse Event|0
6869711|NCT00460603|10879946|FG003|Phase 2|Adverse Event|0
6869712|NCT00460603|10879947|FG004|Phase 2|Adverse Event|0
6869713|NCT00460603|10879948|FG005|Phase 2|Adverse Event|0
6869714|NCT00460603|10879949|FG006|Phase 2|Adverse Event|0
6869715|NCT00460603|10879950|FG007|Phase 2|Adverse Event|0
6869716|NCT00460603|10879951|FG008|Phase 2|Adverse Event|0
6869717|NCT00460603|10879952|FG009|Phase 2|Adverse Event|12
6869718|NCT00460603|10879953|FG010|Phase 2|Adverse Event|9
6869719|NCT00460603|10879954|FG011|Phase 2|Adverse Event|10
6869720|NCT00460603|10879943|FG000|Phase 2|Death|0
6869721|NCT00460603|10879944|FG001|Phase 2|Death|0
6869722|NCT00460603|10879945|FG002|Phase 2|Death|0
6869723|NCT00460603|10879946|FG003|Phase 2|Death|0
6869724|NCT00460603|10879947|FG004|Phase 2|Death|0
6869725|NCT00460603|10879948|FG005|Phase 2|Death|0
6869726|NCT00460603|10879949|FG006|Phase 2|Death|0
6869727|NCT00460603|10879950|FG007|Phase 2|Death|0
6869728|NCT00460603|10879951|FG008|Phase 2|Death|0
6869729|NCT00460603|10879952|FG009|Phase 2|Death|4
6869730|NCT00460603|10879953|FG010|Phase 2|Death|2
6869731|NCT00460603|10879954|FG011|Phase 2|Death|2
6869732|NCT00460603|10879943|FG000|Phase 2|Protocol Violation|0
6869733|NCT00460603|10879944|FG001|Phase 2|Protocol Violation|0
6869734|NCT00460603|10879945|FG002|Phase 2|Protocol Violation|0
6869735|NCT00460603|10879946|FG003|Phase 2|Protocol Violation|0
6869736|NCT00460603|10879947|FG004|Phase 2|Protocol Violation|0
6869737|NCT00460603|10879948|FG005|Phase 2|Protocol Violation|0
6869738|NCT00460603|10879949|FG006|Phase 2|Protocol Violation|0
6869739|NCT00460603|10879950|FG007|Phase 2|Protocol Violation|0
6869740|NCT00460603|10879951|FG008|Phase 2|Protocol Violation|0
6869741|NCT00460603|10879952|FG009|Phase 2|Protocol Violation|1
6869742|NCT00460603|10879953|FG010|Phase 2|Protocol Violation|1
6869743|NCT00460603|10879954|FG011|Phase 2|Protocol Violation|0
6869744|NCT00460603|10879943|FG000|Phase 2|Lost to Follow-up|0
6869745|NCT00460603|10879944|FG001|Phase 2|Lost to Follow-up|0
6869746|NCT00460603|10879945|FG002|Phase 2|Lost to Follow-up|0
6869747|NCT00460603|10879946|FG003|Phase 2|Lost to Follow-up|0
6869748|NCT00460603|10879947|FG004|Phase 2|Lost to Follow-up|0
6869749|NCT00460603|10879948|FG005|Phase 2|Lost to Follow-up|0
6869750|NCT00460603|10879949|FG006|Phase 2|Lost to Follow-up|0
6869751|NCT00460603|10879950|FG007|Phase 2|Lost to Follow-up|0
6869752|NCT00460603|10879951|FG008|Phase 2|Lost to Follow-up|0
6869753|NCT00460603|10879952|FG009|Phase 2|Lost to Follow-up|1
6869754|NCT00460603|10879953|FG010|Phase 2|Lost to Follow-up|0
6869755|NCT00460603|10879954|FG011|Phase 2|Lost to Follow-up|0
6869756|NCT00460603|10879943|FG000|Phase 2|Other|0
6869757|NCT00460603|10879944|FG001|Phase 2|Other|0
6869758|NCT00460603|10879945|FG002|Phase 2|Other|0
6869759|NCT00460603|10879946|FG003|Phase 2|Other|0
6869760|NCT00460603|10879947|FG004|Phase 2|Other|0
6869761|NCT00460603|10879948|FG005|Phase 2|Other|0
6869762|NCT00460603|10879949|FG006|Phase 2|Other|0
6869763|NCT00460603|10879950|FG007|Phase 2|Other|0
6869764|NCT00460603|10879951|FG008|Phase 2|Other|0
6869765|NCT00460603|10879952|FG009|Phase 2|Other|6
6869766|NCT00460603|10879953|FG010|Phase 2|Other|16
6869767|NCT00460603|10879954|FG011|Phase 2|Other|7
6869768|NCT00460603|10879943|FG000|Phase 2|Objective Progression or Relapse|0
6869769|NCT00460603|10879944|FG001|Phase 2|Objective Progression or Relapse|0
6869770|NCT00460603|10879945|FG002|Phase 2|Objective Progression or Relapse|0
6869771|NCT00460603|10879946|FG003|Phase 2|Objective Progression or Relapse|0
6869772|NCT00460603|10879947|FG004|Phase 2|Objective Progression or Relapse|0
6869773|NCT00460603|10879948|FG005|Phase 2|Objective Progression or Relapse|0
6869774|NCT00460603|10879949|FG006|Phase 2|Objective Progression or Relapse|0
6869775|NCT00460603|10879950|FG007|Phase 2|Objective Progression or Relapse|0
6869776|NCT00460603|10879951|FG008|Phase 2|Objective Progression or Relapse|0
6869777|NCT00460603|10879952|FG009|Phase 2|Objective Progression or Relapse|9
6869778|NCT00460603|10879953|FG010|Phase 2|Objective Progression or Relapse|10
6869779|NCT00460603|10879954|FG011|Phase 2|Objective Progression or Relapse|17
6869780|NCT00460603|10879943|FG000|Phase 2|Global Deterioration of Health Status|0
6869781|NCT00460603|10879944|FG001|Phase 2|Global Deterioration of Health Status|0
6869782|NCT00460603|10879945|FG002|Phase 2|Global Deterioration of Health Status|0
6869783|NCT00460603|10879946|FG003|Phase 2|Global Deterioration of Health Status|0
6869784|NCT00460603|10879947|FG004|Phase 2|Global Deterioration of Health Status|0
6869785|NCT00460603|10879948|FG005|Phase 2|Global Deterioration of Health Status|0
6869786|NCT00460603|10879949|FG006|Phase 2|Global Deterioration of Health Status|0
6869787|NCT00460603|10879950|FG007|Phase 2|Global Deterioration of Health Status|0
6869788|NCT00460603|10879951|FG008|Phase 2|Global Deterioration of Health Status|0
6869789|NCT00460603|10879952|FG009|Phase 2|Global Deterioration of Health Status|0
6869790|NCT00460603|10879953|FG010|Phase 2|Global Deterioration of Health Status|1
6869791|NCT00460603|10879954|FG011|Phase 2|Global Deterioration of Health Status|0
6869792|NCT00460603|10879943|FG000|Phase 2|Withdrawal by Subject|0
6869793|NCT00460603|10879944|FG001|Phase 2|Withdrawal by Subject|0
6869794|NCT00460603|10879945|FG002|Phase 2|Withdrawal by Subject|0
6869795|NCT00460603|10879946|FG003|Phase 2|Withdrawal by Subject|0
6869796|NCT00460603|10879947|FG004|Phase 2|Withdrawal by Subject|0
6869797|NCT00460603|10879948|FG005|Phase 2|Withdrawal by Subject|0
6869798|NCT00460603|10879949|FG006|Phase 2|Withdrawal by Subject|0
6869799|NCT00460603|10879950|FG007|Phase 2|Withdrawal by Subject|0
6869800|NCT00460603|10879951|FG008|Phase 2|Withdrawal by Subject|0
6869801|NCT00460603|10879952|FG009|Phase 2|Withdrawal by Subject|5
6869802|NCT00460603|10879953|FG010|Phase 2|Withdrawal by Subject|4
6869803|NCT00460603|10879954|FG011|Phase 2|Withdrawal by Subject|5
6869804|NCT00460603|10879943|FG000|Phase 2|Randomized, but not treated|0
6869805|NCT00460603|10879944|FG001|Phase 2|Randomized, but not treated|0
6869806|NCT00460603|10879945|FG002|Phase 2|Randomized, but not treated|0
6869807|NCT00460603|10879946|FG003|Phase 2|Randomized, but not treated|0
6869808|NCT00460603|10879947|FG004|Phase 2|Randomized, but not treated|0
6869809|NCT00460603|10879948|FG005|Phase 2|Randomized, but not treated|0
6869810|NCT00460603|10879949|FG006|Phase 2|Randomized, but not treated|0
6869811|NCT00460603|10879950|FG007|Phase 2|Randomized, but not treated|0
6869812|NCT00460603|10879951|FG008|Phase 2|Randomized, but not treated|0
6869813|NCT00460603|10879952|FG009|Phase 2|Randomized, but not treated|3
6869814|NCT00460603|10879953|FG010|Phase 2|Randomized, but not treated|0
6869815|NCT00460603|10879954|FG011|Phase 2|Randomized, but not treated|0
6869816|NCT00460655|10879982|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3
6869817|NCT00460655|10879983|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0
6869818|NCT00460655|10879984|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0
6869819|NCT00460655|10879985|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0
6869820|NCT00460655|10879982|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3
6869821|NCT00460655|10879983|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
6869822|NCT00460655|10879984|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
6869823|NCT00460655|10879985|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
6869824|NCT00460655|10879982|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0
6869825|NCT00460655|10879983|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1
6869826|NCT00460655|10879984|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0
6869827|NCT00460655|10879985|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0
6869828|NCT00460655|10879982|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0
6869829|NCT00460655|10879983|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0
6869830|NCT00460655|10879984|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1
6869831|NCT00460655|10879985|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6
6968443|NCT01139021|11017430|FG001|Overall Study|Adverse Event|0
6968444|NCT01139021|11017431|FG002|Overall Study|Adverse Event|0
6968445|NCT01139021|11017432|FG003|Overall Study|Adverse Event|0
6968446|NCT01139021|11017433|FG004|Overall Study|Adverse Event|1
6968447|NCT01139021|11017434|FG005|Overall Study|Adverse Event|0
6968448|NCT01139021|11017429|FG000|Overall Study|Lost to Follow-up|0
6968449|NCT01139021|11017430|FG001|Overall Study|Lost to Follow-up|0
6968450|NCT01139021|11017431|FG002|Overall Study|Lost to Follow-up|0
6968451|NCT01139021|11017432|FG003|Overall Study|Lost to Follow-up|0
6968452|NCT01139021|11017433|FG004|Overall Study|Lost to Follow-up|2
6968453|NCT01139021|11017434|FG005|Overall Study|Lost to Follow-up|0
6968454|NCT01139021|11017429|FG000|Overall Study|Protocol Violation|1
6968455|NCT01139021|11017430|FG001|Overall Study|Protocol Violation|0
6968456|NCT01139021|11017431|FG002|Overall Study|Protocol Violation|0
6968457|NCT01139021|11017432|FG003|Overall Study|Protocol Violation|0
6968458|NCT01139021|11017433|FG004|Overall Study|Protocol Violation|2
6968459|NCT01139021|11017434|FG005|Overall Study|Protocol Violation|0
6968460|NCT01139021|11017429|FG000|Overall Study|Withdrawal by Subject|0
6968461|NCT01139021|11017430|FG001|Overall Study|Withdrawal by Subject|0
6968462|NCT01139021|11017431|FG002|Overall Study|Withdrawal by Subject|0
6968463|NCT01139021|11017432|FG003|Overall Study|Withdrawal by Subject|1
6968464|NCT01139021|11017433|FG004|Overall Study|Withdrawal by Subject|4
6968465|NCT01139021|11017434|FG005|Overall Study|Withdrawal by Subject|0
6968466|NCT01139047|11017449|FG000|Overall Study|Withdrawal by Subject|1
6968467|NCT01139164|11017459|FG000|Overall Study|Withdrawn prior to study start|0
6968468|NCT01139164|11017460|FG001|Overall Study|Withdrawn prior to study start|2
6968469|NCT01139164|11017461|FG002|Overall Study|Withdrawn prior to study start|0
6968470|NCT01139450|11017492|FG000|Overall Study|Withdrawal by Subject|7
6968471|NCT01139450|11017493|FG001|Overall Study|Withdrawal by Subject|10
6968472|NCT01139450|11017494|FG002|Overall Study|Withdrawal by Subject|13
6968473|NCT01139450|11017492|FG000|Overall Study|Lack of Efficacy|3
6968474|NCT01139450|11017493|FG001|Overall Study|Lack of Efficacy|1
6968475|NCT01139450|11017494|FG002|Overall Study|Lack of Efficacy|8
6968476|NCT01139450|11017492|FG000|Overall Study|Protocol Violation|6
6968477|NCT01139450|11017493|FG001|Overall Study|Protocol Violation|5
6869832|NCT00460655|10879982|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
6869833|NCT00460655|10879983|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
6869834|NCT00460655|10879984|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6
6869835|NCT00460655|10879985|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2
6869836|NCT00460655|10879982|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
6869837|NCT00460655|10879983|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
6968478|NCT01139450|11017494|FG002|Overall Study|Protocol Violation|2
6968479|NCT01139450|11017492|FG000|Overall Study|Lost to Follow-up|9
6869838|NCT00460655|10879984|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
6869839|NCT00460655|10879985|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1
6869840|NCT00460746|10879995|FG000|Overall Study|Adverse Event|1
6869841|NCT00460746|10879995|FG000|Overall Study|Lost to Follow-up|1
6869842|NCT00460798|10879999|FG000|Overall Study|Death|59
6869843|NCT00460798|10879999|FG000|Overall Study|Adverse Event|27
6869844|NCT00460798|10879999|FG000|Overall Study|Lost to Follow-up|19
6869845|NCT00460798|10879999|FG000|Overall Study|Progressive Disease|99
6869846|NCT00460798|10879999|FG000|Overall Study|Other|27
6869847|NCT00460798|10879999|FG000|Overall Study|Ongoing at Date of Cut-Off|82
6869848|NCT00460798|10879999|FG000|Overall Study|Missing/Incomplete Dosing Information|27
6869849|NCT00460811|10880008|FG000|Overall Study|Adverse Event|4
6869850|NCT00460811|10880009|FG001|Overall Study|Adverse Event|6
6869851|NCT00460811|10880010|FG002|Overall Study|Adverse Event|3
6869852|NCT00460811|10880011|FG003|Overall Study|Adverse Event|10
6869853|NCT00460811|10880012|FG004|Overall Study|Adverse Event|2
6869854|NCT00460811|10880008|FG000|Overall Study|Noncompliance|1
6869855|NCT00460811|10880009|FG001|Overall Study|Noncompliance|0
6869856|NCT00460811|10880010|FG002|Overall Study|Noncompliance|0
6869857|NCT00460811|10880011|FG003|Overall Study|Noncompliance|2
6869858|NCT00460811|10880012|FG004|Overall Study|Noncompliance|1
6869859|NCT00460811|10880008|FG000|Overall Study|Withdrawal by Subject|7
6869860|NCT00460811|10880009|FG001|Overall Study|Withdrawal by Subject|7
6869861|NCT00460811|10880010|FG002|Overall Study|Withdrawal by Subject|6
6869862|NCT00460811|10880011|FG003|Overall Study|Withdrawal by Subject|3
6869863|NCT00460811|10880012|FG004|Overall Study|Withdrawal by Subject|11
6869864|NCT00460811|10880008|FG000|Overall Study|Physician Decision|1
6869865|NCT00460811|10880009|FG001|Overall Study|Physician Decision|0
6869866|NCT00460811|10880010|FG002|Overall Study|Physician Decision|0
6869867|NCT00460811|10880011|FG003|Overall Study|Physician Decision|0
6869868|NCT00460811|10880012|FG004|Overall Study|Physician Decision|0
6869869|NCT00460811|10880008|FG000|Overall Study|Lost to Follow-up|3
6869870|NCT00460811|10880009|FG001|Overall Study|Lost to Follow-up|2
6869871|NCT00460811|10880010|FG002|Overall Study|Lost to Follow-up|5
6869872|NCT00460811|10880011|FG003|Overall Study|Lost to Follow-up|3
6869873|NCT00460811|10880012|FG004|Overall Study|Lost to Follow-up|6
6869874|NCT00461123|10880054|FG000|Overall Study|Adverse Event|1
6869875|NCT00461123|10880055|FG001|Overall Study|Adverse Event|0
6869876|NCT00461123|10880054|FG000|Overall Study|Lost to Follow-up|1
6869877|NCT00461123|10880055|FG001|Overall Study|Lost to Follow-up|1
6869878|NCT00461123|10880054|FG000|Overall Study|Protocol Violation|3
6869879|NCT00461123|10880055|FG001|Overall Study|Protocol Violation|2
6869880|NCT00461123|10880054|FG000|Overall Study|Withdrawal by Subject|1
6869881|NCT00461123|10880055|FG001|Overall Study|Withdrawal by Subject|3
6869882|NCT00461175|10880063|FG000|Overall Study|Protocol Violation|522
6869883|NCT00461175|10880064|FG001|Overall Study|Protocol Violation|365
6869884|NCT00461253|10880072|FG000|Overall Study|Death|985
6869885|NCT00461253|10880073|FG001|Overall Study|Death|0
6869886|NCT00461253|10880072|FG000|Overall Study|Protocol Violation|613
6869887|NCT00461253|10880073|FG001|Overall Study|Protocol Violation|236
6869888|NCT00461253|10880072|FG000|Overall Study|no response|2609
6869889|NCT00461253|10880073|FG001|Overall Study|no response|11789
6869890|NCT00461253|10880072|FG000|Overall Study|administrative|773
6869891|NCT00461253|10880073|FG001|Overall Study|administrative|7773
6869892|NCT00461305|10880094|FG000|Treatment|Adverse Event|26
6869893|NCT00461305|10880095|FG001|Treatment|Adverse Event|3
6869894|NCT00461305|10880094|FG000|Treatment|Lost to Follow-up|4
6869895|NCT00461305|10880095|FG001|Treatment|Lost to Follow-up|2
6869896|NCT00461305|10880094|FG000|Treatment|Protocol Violation|13
6869897|NCT00461305|10880095|FG001|Treatment|Protocol Violation|2
6869898|NCT00461305|10880094|FG000|Treatment|Withdrawal by Subject|48
6869899|NCT00461305|10880095|FG001|Treatment|Withdrawal by Subject|2
6869900|NCT00461305|10880094|FG000|Treatment|Never dispensed|5
6869901|NCT00461305|10880095|FG001|Treatment|Never dispensed|0
6869902|NCT00461305|10880094|FG000|Treatment|Study drug not taken|1
6869903|NCT00461305|10880095|FG001|Treatment|Study drug not taken|0
6869904|NCT00461305|10880094|FG000|Treatment|Partially missing diary|2
6968480|NCT01139450|11017493|FG001|Overall Study|Lost to Follow-up|7
6968481|NCT01139450|11017494|FG002|Overall Study|Lost to Follow-up|11
6869905|NCT00461305|10880095|FG001|Treatment|Partially missing diary|0
6869906|NCT00461305|10880094|FG000|Treatment|Other (missing drug etc)|2
6869907|NCT00461305|10880095|FG001|Treatment|Other (missing drug etc)|0
6869908|NCT00461305|10880094|FG000|Continued Treatment|Adverse Event|26
6869909|NCT00461305|10880095|FG001|Continued Treatment|Adverse Event|0
6869910|NCT00461305|10880094|FG000|Continued Treatment|Lost to Follow-up|4
6869911|NCT00461305|10880095|FG001|Continued Treatment|Lost to Follow-up|0
6869912|NCT00461305|10880094|FG000|Continued Treatment|Protocol Violation|13
6869913|NCT00461305|10880095|FG001|Continued Treatment|Protocol Violation|0
6869914|NCT00461305|10880094|FG000|Continued Treatment|Withdrawal by Subject|48
6869915|NCT00461305|10880095|FG001|Continued Treatment|Withdrawal by Subject|0
6869916|NCT00461305|10880094|FG000|Continued Treatment|Partially missing diary|2
6869917|NCT00461305|10880095|FG001|Continued Treatment|Partially missing diary|0
6869918|NCT00461305|10880094|FG000|Continued Treatment|Other (missing drug etc)|2
6869919|NCT00461305|10880095|FG001|Continued Treatment|Other (missing drug etc)|0
6869920|NCT00461500|10880112|FG000|Overall Study|Adverse Event|1
6869921|NCT00461500|10880113|FG001|Overall Study|Adverse Event|0
6869922|NCT00461500|10880112|FG000|Overall Study|Lack of Efficacy|0
6869923|NCT00461500|10880113|FG001|Overall Study|Lack of Efficacy|1
6869924|NCT00461500|10880112|FG000|Overall Study|Expired Drug Treatment|1
6869925|NCT00461500|10880113|FG001|Overall Study|Expired Drug Treatment|1
6869926|NCT00461500|10880112|FG000|Overall Study|Study Stopped|1
6869927|NCT00461500|10880113|FG001|Overall Study|Study Stopped|2
6869928|NCT00461500|10880112|FG000|Overall Study|Drug Treatment Misuse|1
6869929|NCT00461500|10880113|FG001|Overall Study|Drug Treatment Misuse|0
6869930|NCT00461500|10880112|FG000|Overall Study|No Longer Willing to Take Part in Study|1
6869931|NCT00461500|10880113|FG001|Overall Study|No Longer Willing to Take Part in Study|0
6869932|NCT00461500|10880112|FG000|Overall Study|Lost to Follow-up|2
6869933|NCT00461500|10880113|FG001|Overall Study|Lost to Follow-up|2
6869934|NCT00461552|10880134|FG000|Overall Study|Drug Dispensing error|0
6869935|NCT00461552|10880135|FG001|Overall Study|Drug Dispensing error|2
6869936|NCT00461630|10880152|FG000|Overall Study|Death|798
6869937|NCT00461630|10880153|FG001|Overall Study|Death|732
6869938|NCT00461630|10880152|FG000|Overall Study|Lost to Follow-up|108
6869939|NCT00461630|10880153|FG001|Overall Study|Lost to Follow-up|95
6869940|NCT00461708|10880161|FG000|Overall Study|Adverse Event|17
6869941|NCT00461708|10880162|FG001|Overall Study|Adverse Event|7
6869942|NCT00461708|10880161|FG000|Overall Study|Lack of Efficacy|68
6869943|NCT00461708|10880162|FG001|Overall Study|Lack of Efficacy|20
6869944|NCT00461708|10880161|FG000|Overall Study|Physician Decision|10
6869945|NCT00461708|10880162|FG001|Overall Study|Physician Decision|4
6869946|NCT00461708|10880161|FG000|Overall Study|Withdrawal by Subject|8
6869947|NCT00461708|10880162|FG001|Overall Study|Withdrawal by Subject|2
6869948|NCT00461708|10880161|FG000|Overall Study|Other|4
6869949|NCT00461708|10880162|FG001|Overall Study|Other|4
6869950|NCT00461708|10880161|FG000|Overall Study|Death|8
6869951|NCT00461708|10880162|FG001|Overall Study|Death|1
6869952|NCT00461786|10880194|FG000|Overall Study|Entry Criteria Not Met|2
6869953|NCT00461786|10880194|FG000|Overall Study|Inevaluable (Never Treated)|1
6869954|NCT00461981|10880204|FG000|Overall Study|Lost to Follow-up|9
6869955|NCT00461981|10880205|FG001|Overall Study|Lost to Follow-up|6
6869956|NCT00461981|10880204|FG000|Overall Study|Withdrawal by Subject|2
6869957|NCT00461981|10880205|FG001|Overall Study|Withdrawal by Subject|3
6869958|NCT00462306|10880270|FG000|Overall Study|insufficient data|0
6869959|NCT00462306|10880271|FG001|Overall Study|insufficient data|13
6869960|NCT00462345|10880290|FG000|Overall Study|Withdrawal by Subject|2
6869961|NCT00462345|10880290|FG000|Overall Study|Did not complete second course|1
6869962|NCT00462384|10880294|FG000|Overall Study|Adverse Event|2
6869963|NCT00462384|10880294|FG000|Overall Study|Death|2
6869964|NCT00462384|10880294|FG000|Overall Study|Withdrawal by Subject|1
6869965|NCT00462384|10880294|FG000|Overall Study|Other|4
6869966|NCT00462462|10880314|FG000|Overall Study|Physician Decision|0
6869967|NCT00462462|10880315|FG001|Overall Study|Physician Decision|1
6869968|NCT00462488|10880325|FG000|Overall Study|Protocol Violation|1
6869969|NCT00462488|10880326|FG001|Overall Study|Protocol Violation|0
6869970|NCT00462488|10880325|FG000|Overall Study|Lack of Efficacy|19
6869971|NCT00462488|10880326|FG001|Overall Study|Lack of Efficacy|17
6869972|NCT00462501|10880332|FG000|Overall Study|Not treated|3
6869973|NCT00462501|10880332|FG000|Overall Study|Adverse Event|2
6869974|NCT00462670|10880351|FG000|Overall Study|Adverse Event|3
6869975|NCT00462670|10880352|FG001|Overall Study|Adverse Event|5
6869976|NCT00462670|10880351|FG000|Overall Study|Lack of Efficacy|1
6869977|NCT00462670|10880352|FG001|Overall Study|Lack of Efficacy|0
6869978|NCT00462670|10880351|FG000|Overall Study|Protocol Violation|1
6869979|NCT00462670|10880352|FG001|Overall Study|Protocol Violation|0
6869980|NCT00462670|10880351|FG000|Overall Study|Resolution of signs and symptoms|0
6869981|NCT00462670|10880352|FG001|Overall Study|Resolution of signs and symptoms|2
6869982|NCT00462709|10880358|FG000|Overall Study|Transitioned to commercial C1INH-nf|40
6869983|NCT00462709|10880358|FG000|Overall Study|Lost to Follow-up|10
6869984|NCT00462709|10880358|FG000|Overall Study|Withdrawal by Subject|8
6869985|NCT00462709|10880358|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3
6869986|NCT00462709|10880358|FG000|Overall Study|Death|2
6869987|NCT00462709|10880358|FG000|Overall Study|Logistical reasons|2
6869988|NCT00462709|10880358|FG000|Overall Study|Physician Decision|1
6869989|NCT00462709|10880358|FG000|Overall Study|Withdrew to start treatment with Cetor|1
6869990|NCT00462761|10880380|FG000|Overall Study|Adverse Event|6
6869991|NCT00462761|10880380|FG000|Overall Study|Withdrawal by Subject|9
6869992|NCT00462761|10880380|FG000|Overall Study|Physician Decision|5
6869993|NCT00462761|10880380|FG000|Overall Study|Disease progression|43
6869994|NCT00462761|10880380|FG000|Overall Study|Death|12
6869995|NCT00462761|10880380|FG000|Overall Study|Other|1
6869996|NCT00462826|10880412|FG000|Overall Study|Ineligible - second primary|1
6869997|NCT00462826|10880412|FG000|Overall Study|Ineligible - wrong cell type|1
6869998|NCT00462826|10880412|FG000|Overall Study|Ineligible - wrong primary|2
6869999|NCT00462826|10880412|FG000|Overall Study|Never treated|1
6870000|NCT00462865|10880431|FG000|Overall Study|Adverse Event|1
6870001|NCT00462982|10880452|FG000|Overall Study|Adverse Event|1
6870002|NCT00462982|10880452|FG000|Overall Study|Patient Not Treated|2
6870003|NCT00463047|10880456|FG000|Titration Period 1|Adverse Event|10
6870004|NCT00463047|10880457|FG001|Titration Period 1|Adverse Event|8
6870005|NCT00463047|10880456|FG000|Titration Period 1|Lack of Efficacy|10
6870006|NCT00463047|10880457|FG001|Titration Period 1|Lack of Efficacy|4
6870007|NCT00463047|10880456|FG000|Titration Period 1|Lost to Follow-up|2
6870008|NCT00463047|10880457|FG001|Titration Period 1|Lost to Follow-up|0
6870009|NCT00463047|10880456|FG000|Titration Period 1|Non-compliance with study medication|3
6870010|NCT00463047|10880457|FG001|Titration Period 1|Non-compliance with study medication|5
6870011|NCT00463047|10880456|FG000|Titration Period 1|Protocol Violation|5
6870012|NCT00463047|10880457|FG001|Titration Period 1|Protocol Violation|5
6870013|NCT00463047|10880456|FG000|Titration Period 1|Withdrawal by Subject|3
6870014|NCT00463047|10880457|FG001|Titration Period 1|Withdrawal by Subject|5
6870015|NCT00463047|10880456|FG000|Titration Period 1|Non-compliance procedures|4
6870016|NCT00463047|10880457|FG001|Titration Period 1|Non-compliance procedures|10
6870017|NCT00463047|10880456|FG000|Titration Period 1|Other|0
6870018|NCT00463047|10880457|FG001|Titration Period 1|Other|2
6870019|NCT00463047|10880456|FG000|Titration Period 2|Adverse Event|9
6870020|NCT00463047|10880457|FG001|Titration Period 2|Adverse Event|9
6870021|NCT00463047|10880456|FG000|Titration Period 2|Lack of Efficacy|6
6870022|NCT00463047|10880457|FG001|Titration Period 2|Lack of Efficacy|4
6870023|NCT00463047|10880456|FG000|Titration Period 2|Withdrawal by Subject|1
6870024|NCT00463047|10880457|FG001|Titration Period 2|Withdrawal by Subject|0
6870025|NCT00463047|10880456|FG000|Titration Period 2|Protocol Violation|2
6870026|NCT00463047|10880457|FG001|Titration Period 2|Protocol Violation|3
6870027|NCT00463047|10880456|FG000|Titration Period 2|Lost to Follow-up|1
6870028|NCT00463047|10880457|FG001|Titration Period 2|Lost to Follow-up|2
6870029|NCT00463047|10880456|FG000|Titration Period 2|Non-compliance study medication|4
6870030|NCT00463047|10880457|FG001|Titration Period 2|Non-compliance study medication|2
6870031|NCT00463047|10880456|FG000|Titration Period 2|Non-compliance procedures|4
6870032|NCT00463047|10880457|FG001|Titration Period 2|Non-compliance procedures|1
6870033|NCT00463047|10880456|FG000|Titration Period 2|Other|3
6870034|NCT00463047|10880457|FG001|Titration Period 2|Other|2
6870035|NCT00463047|10880456|FG000|Double-Blind Treatment Period 1|Adverse Event|0
6870036|NCT00463047|10880457|FG001|Double-Blind Treatment Period 1|Adverse Event|2
6870037|NCT00463047|10880456|FG000|Double-Blind Treatment Period 1|Protocol Violation|1
6870038|NCT00463047|10880457|FG001|Double-Blind Treatment Period 1|Protocol Violation|2
6870039|NCT00463047|10880456|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1
6870040|NCT00463047|10880457|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0
6870041|NCT00463047|10880456|FG000|Double-Blind Treatment Period 1|Other|1
6870042|NCT00463047|10880457|FG001|Double-Blind Treatment Period 1|Other|0
6870043|NCT00463047|10880456|FG000|Double-Blind Treatment Period 2|Adverse Event|0
6870044|NCT00463047|10880457|FG001|Double-Blind Treatment Period 2|Adverse Event|1
6870045|NCT00463047|10880456|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0
6870046|NCT00463047|10880457|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1
6870047|NCT00463047|10880456|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1
6870048|NCT00463047|10880457|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0
6870049|NCT00463060|10880466|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5
6870050|NCT00463060|10880466|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1
6870051|NCT00463151|10880479|FG000|Overall Study|Adverse Event|0
6870052|NCT00463151|10880480|FG001|Overall Study|Adverse Event|0
6870053|NCT00463151|10880481|FG002|Overall Study|Adverse Event|1
6870054|NCT00463151|10880482|FG003|Overall Study|Adverse Event|0
6870055|NCT00463151|10880479|FG000|Overall Study|Lack of Efficacy|2
6870056|NCT00463151|10880480|FG001|Overall Study|Lack of Efficacy|5
6870057|NCT00463151|10880481|FG002|Overall Study|Lack of Efficacy|2
6870058|NCT00463151|10880482|FG003|Overall Study|Lack of Efficacy|5
6870059|NCT00463151|10880479|FG000|Overall Study|Protocol Violation|0
6870060|NCT00463151|10880480|FG001|Overall Study|Protocol Violation|0
6870061|NCT00463151|10880481|FG002|Overall Study|Protocol Violation|0
6870062|NCT00463151|10880482|FG003|Overall Study|Protocol Violation|1
6870063|NCT00463151|10880479|FG000|Overall Study|Withdrawal by Subject|0
6870064|NCT00463151|10880480|FG001|Overall Study|Withdrawal by Subject|0
6870065|NCT00463151|10880481|FG002|Overall Study|Withdrawal by Subject|0
6870066|NCT00463151|10880482|FG003|Overall Study|Withdrawal by Subject|1
6870067|NCT00463229|10880494|FG000|Overall Study|Lost to Follow-up|5
6870068|NCT00463229|10880495|FG001|Overall Study|Lost to Follow-up|7
6870069|NCT00463229|10880494|FG000|Overall Study|Death|4
6870070|NCT00463229|10880495|FG001|Overall Study|Death|3
6870071|NCT00463346|10880504|FG000|Overall Study|Withdrawal by Subject|3
6870072|NCT00463346|10880505|FG001|Overall Study|Withdrawal by Subject|3
6870073|NCT00463385|10880517|FG000|Overall Study|Other|4
6870074|NCT00463385|10880518|FG001|Overall Study|Other|3
6870075|NCT00463385|10880519|FG002|Overall Study|Other|6
6870076|NCT00463385|10880520|FG003|Overall Study|Other|4
6870077|NCT00463385|10880517|FG000|Overall Study|Adverse Event|5
6870078|NCT00463385|10880518|FG001|Overall Study|Adverse Event|8
6870079|NCT00463385|10880519|FG002|Overall Study|Adverse Event|4
6870080|NCT00463385|10880520|FG003|Overall Study|Adverse Event|2
6870081|NCT00463385|10880517|FG000|Overall Study|Lack of Efficacy|6
6870082|NCT00463385|10880518|FG001|Overall Study|Lack of Efficacy|6
6870083|NCT00463385|10880519|FG002|Overall Study|Lack of Efficacy|7
6870084|NCT00463385|10880520|FG003|Overall Study|Lack of Efficacy|9
6870085|NCT00463385|10880517|FG000|Overall Study|Withdrawal by Subject|3
6870086|NCT00463385|10880518|FG001|Overall Study|Withdrawal by Subject|3
6870087|NCT00463385|10880519|FG002|Overall Study|Withdrawal by Subject|3
6870088|NCT00463385|10880520|FG003|Overall Study|Withdrawal by Subject|4
6870089|NCT00463385|10880517|FG000|Overall Study|Lost to Follow-up|0
6870090|NCT00463385|10880518|FG001|Overall Study|Lost to Follow-up|0
6870091|NCT00463385|10880519|FG002|Overall Study|Lost to Follow-up|0
6870092|NCT00463385|10880520|FG003|Overall Study|Lost to Follow-up|1
6870093|NCT00463385|10880517|FG000|Overall Study|Death|2
6870094|NCT00463385|10880518|FG001|Overall Study|Death|1
6870095|NCT00463385|10880519|FG002|Overall Study|Death|2
6870096|NCT00463385|10880520|FG003|Overall Study|Death|0
6870097|NCT00463385|10880517|FG000|Overall Study|Missing|2
6870098|NCT00463385|10880518|FG001|Overall Study|Missing|0
6870099|NCT00463385|10880519|FG002|Overall Study|Missing|0
6870100|NCT00463385|10880520|FG003|Overall Study|Missing|2
6870101|NCT00463385|10880517|FG000|Overall Study|1 participant received commercial drug|0
6870102|NCT00463385|10880518|FG001|Overall Study|1 participant received commercial drug|1
6870103|NCT00463385|10880519|FG002|Overall Study|1 participant received commercial drug|0
6870104|NCT00463385|10880520|FG003|Overall Study|1 participant received commercial drug|0
6870105|NCT00463476|10880557|FG000|Overall Study|Withdrawal by Subject|1
6870106|NCT00463476|10880558|FG001|Overall Study|Withdrawal by Subject|2
6870107|NCT00463476|10880557|FG000|Overall Study|Lost to Follow-up|1
6870108|NCT00463476|10880558|FG001|Overall Study|Lost to Follow-up|1
6870109|NCT00463567|10880571|FG000|Overall Study|Adverse Event|29
6870110|NCT00463567|10880572|FG001|Overall Study|Adverse Event|26
6870111|NCT00463567|10880573|FG002|Overall Study|Adverse Event|17
6870112|NCT00463567|10880574|FG003|Overall Study|Adverse Event|46
6870113|NCT00463567|10880575|FG004|Overall Study|Adverse Event|10
6870114|NCT00463567|10880576|FG005|Overall Study|Adverse Event|10
6870115|NCT00463567|10880577|FG006|Overall Study|Adverse Event|4
6870116|NCT00463567|10880571|FG000|Overall Study|Withdrawal by Subject|29
6870117|NCT00463567|10880572|FG001|Overall Study|Withdrawal by Subject|22
6870118|NCT00463567|10880573|FG002|Overall Study|Withdrawal by Subject|20
6870119|NCT00463567|10880574|FG003|Overall Study|Withdrawal by Subject|37
6870120|NCT00463567|10880575|FG004|Overall Study|Withdrawal by Subject|6
6870121|NCT00463567|10880576|FG005|Overall Study|Withdrawal by Subject|5
6870122|NCT00463567|10880577|FG006|Overall Study|Withdrawal by Subject|1
6870123|NCT00463567|10880571|FG000|Overall Study|Protocol Deviation|13
6870124|NCT00463567|10880572|FG001|Overall Study|Protocol Deviation|9
6870125|NCT00463567|10880573|FG002|Overall Study|Protocol Deviation|14
6870126|NCT00463567|10880574|FG003|Overall Study|Protocol Deviation|11
6870127|NCT00463567|10880575|FG004|Overall Study|Protocol Deviation|1
6870128|NCT00463567|10880576|FG005|Overall Study|Protocol Deviation|1
6870129|NCT00463567|10880577|FG006|Overall Study|Protocol Deviation|2
6870130|NCT00463567|10880571|FG000|Overall Study|Lost to Follow-up|12
6870131|NCT00463567|10880572|FG001|Overall Study|Lost to Follow-up|6
6870132|NCT00463567|10880573|FG002|Overall Study|Lost to Follow-up|13
6870133|NCT00463567|10880574|FG003|Overall Study|Lost to Follow-up|8
6870134|NCT00463567|10880575|FG004|Overall Study|Lost to Follow-up|1
6870135|NCT00463567|10880576|FG005|Overall Study|Lost to Follow-up|1
6870136|NCT00463567|10880577|FG006|Overall Study|Lost to Follow-up|1
6870137|NCT00463567|10880571|FG000|Overall Study|Administrative problems|5
6870138|NCT00463567|10880572|FG001|Overall Study|Administrative problems|3
6870139|NCT00463567|10880573|FG002|Overall Study|Administrative problems|6
6870140|NCT00463567|10880574|FG003|Overall Study|Administrative problems|9
6870141|NCT00463567|10880575|FG004|Overall Study|Administrative problems|3
6870142|NCT00463567|10880576|FG005|Overall Study|Administrative problems|2
6870143|NCT00463567|10880577|FG006|Overall Study|Administrative problems|2
6870144|NCT00463567|10880571|FG000|Overall Study|Lack of Efficacy|4
6870145|NCT00463567|10880572|FG001|Overall Study|Lack of Efficacy|9
6870146|NCT00463567|10880573|FG002|Overall Study|Lack of Efficacy|9
6870147|NCT00463567|10880574|FG003|Overall Study|Lack of Efficacy|17
6870148|NCT00463567|10880575|FG004|Overall Study|Lack of Efficacy|1
6870149|NCT00463567|10880576|FG005|Overall Study|Lack of Efficacy|0
6870150|NCT00463567|10880577|FG006|Overall Study|Lack of Efficacy|1
6870151|NCT00463567|10880571|FG000|Overall Study|Abnormal lab value(s)|1
6870152|NCT00463567|10880572|FG001|Overall Study|Abnormal lab value(s)|1
6870153|NCT00463567|10880573|FG002|Overall Study|Abnormal lab value(s)|2
6870154|NCT00463567|10880574|FG003|Overall Study|Abnormal lab value(s)|1
6870155|NCT00463567|10880575|FG004|Overall Study|Abnormal lab value(s)|1
6870156|NCT00463567|10880576|FG005|Overall Study|Abnormal lab value(s)|0
6870157|NCT00463567|10880577|FG006|Overall Study|Abnormal lab value(s)|0
6870158|NCT00463567|10880571|FG000|Overall Study|Abnormal test procedure result(s)|1
6870159|NCT00463567|10880572|FG001|Overall Study|Abnormal test procedure result(s)|1
6870160|NCT00463567|10880573|FG002|Overall Study|Abnormal test procedure result(s)|6
6870161|NCT00463567|10880574|FG003|Overall Study|Abnormal test procedure result(s)|2
6870162|NCT00463567|10880575|FG004|Overall Study|Abnormal test procedure result(s)|0
6870163|NCT00463567|10880576|FG005|Overall Study|Abnormal test procedure result(s)|2
6870164|NCT00463567|10880577|FG006|Overall Study|Abnormal test procedure result(s)|0
6870165|NCT00463567|10880571|FG000|Overall Study|Death|1
6870166|NCT00463567|10880572|FG001|Overall Study|Death|0
6870167|NCT00463567|10880573|FG002|Overall Study|Death|2
6870168|NCT00463567|10880574|FG003|Overall Study|Death|0
6870169|NCT00463567|10880575|FG004|Overall Study|Death|0
6870170|NCT00463567|10880576|FG005|Overall Study|Death|0
6870171|NCT00463567|10880577|FG006|Overall Study|Death|0
6870172|NCT00463580|10880601|FG000|Overall Study|Lost to Follow-up|1
6870173|NCT00463580|10880602|FG001|Overall Study|Lost to Follow-up|0
6870174|NCT00463580|10880601|FG000|Overall Study|Schedule conflict|2
6870175|NCT00463580|10880602|FG001|Overall Study|Schedule conflict|0
6870176|NCT00463580|10880601|FG000|Overall Study|Medical/psychiatric complications|0
6870177|NCT00463580|10880602|FG001|Overall Study|Medical/psychiatric complications|2
6870178|NCT00463606|10880617|FG000|Overall Study|Adverse Event|21
6870179|NCT00463606|10880618|FG001|Overall Study|Adverse Event|18
6870180|NCT00463606|10880619|FG002|Overall Study|Adverse Event|11
6870181|NCT00463606|10880617|FG000|Overall Study|Withdrawal by Subject|11
6870182|NCT00463606|10880618|FG001|Overall Study|Withdrawal by Subject|11
6870183|NCT00463606|10880619|FG002|Overall Study|Withdrawal by Subject|5
6870184|NCT00463606|10880617|FG000|Overall Study|Lost to Follow-up|2
6870185|NCT00463606|10880618|FG001|Overall Study|Lost to Follow-up|2
6870186|NCT00463606|10880619|FG002|Overall Study|Lost to Follow-up|3
6870187|NCT00463606|10880617|FG000|Overall Study|Subject noncompliance|1
6870188|NCT00463606|10880618|FG001|Overall Study|Subject noncompliance|1
6870189|NCT00463606|10880619|FG002|Overall Study|Subject noncompliance|0
6870190|NCT00463606|10880617|FG000|Overall Study|Subject moved out of town|1
6870191|NCT00463606|10880618|FG001|Overall Study|Subject moved out of town|0
6870192|NCT00463606|10880619|FG002|Overall Study|Subject moved out of town|0
6870193|NCT00463606|10880617|FG000|Overall Study|Physician Decision|0
6870194|NCT00463606|10880618|FG001|Overall Study|Physician Decision|1
6870195|NCT00463606|10880619|FG002|Overall Study|Physician Decision|0
6870196|NCT00463606|10880617|FG000|Overall Study|Sponsor request|0
6870197|NCT00463606|10880618|FG001|Overall Study|Sponsor request|1
6870198|NCT00463606|10880619|FG002|Overall Study|Sponsor request|0
6870199|NCT00463606|10880617|FG000|Overall Study|Exclusion criteria violation|2
6870200|NCT00463606|10880618|FG001|Overall Study|Exclusion criteria violation|0
6870201|NCT00463606|10880619|FG002|Overall Study|Exclusion criteria violation|0
6870202|NCT00463606|10880617|FG000|Overall Study|Coordinator error|1
6870203|NCT00463606|10880618|FG001|Overall Study|Coordinator error|0
6870204|NCT00463606|10880619|FG002|Overall Study|Coordinator error|0
6870205|NCT00463606|10880617|FG000|Overall Study|Patient randomized in error|1
6870206|NCT00463606|10880618|FG001|Overall Study|Patient randomized in error|0
6870207|NCT00463606|10880619|FG002|Overall Study|Patient randomized in error|0
6870208|NCT00463606|10880617|FG000|Overall Study|Participation in another ABT-335 trial|1
6870209|NCT00463606|10880618|FG001|Overall Study|Participation in another ABT-335 trial|0
6870210|NCT00463606|10880619|FG002|Overall Study|Participation in another ABT-335 trial|0
6870211|NCT00463606|10880617|FG000|Overall Study|Protocol Violation|0
6870212|NCT00463606|10880618|FG001|Overall Study|Protocol Violation|0
6870213|NCT00463606|10880619|FG002|Overall Study|Protocol Violation|1
6870214|NCT00463684|10880627|FG000|Overall Study|Withdrawal by Subject|1
6870215|NCT00463684|10880627|FG000|Overall Study|Lost to Follow-up|3
6870216|NCT00463788|10880633|FG000|Overall Study|Progressive Disease|86
6870217|NCT00463788|10880634|FG001|Overall Study|Progressive Disease|42
6870218|NCT00463788|10880633|FG000|Overall Study|Adverse Event|6
6870219|NCT00463788|10880634|FG001|Overall Study|Adverse Event|2
6870220|NCT00463788|10880633|FG000|Overall Study|Withdrawal by Subject|6
6870221|NCT00463788|10880634|FG001|Overall Study|Withdrawal by Subject|2
6870222|NCT00463788|10880633|FG000|Overall Study|Death|4
6870223|NCT00463788|10880634|FG001|Overall Study|Death|3
6870224|NCT00463788|10880633|FG000|Overall Study|Symptomatic Deterioration|2
6870225|NCT00463788|10880634|FG001|Overall Study|Symptomatic Deterioration|3
6870226|NCT00463788|10880633|FG000|Overall Study|Lost to Follow-up|1
6870227|NCT00463788|10880634|FG001|Overall Study|Lost to Follow-up|0
6870228|NCT00463788|10880633|FG000|Overall Study|Protocol Violation|0
6870229|NCT00463788|10880634|FG001|Overall Study|Protocol Violation|1
6870230|NCT00463788|10880633|FG000|Overall Study|Other|3
6870231|NCT00463788|10880634|FG001|Overall Study|Other|0
6870232|NCT00463788|10880633|FG000|Overall Study|Randomized but not treated|1
6870233|NCT00463788|10880634|FG001|Overall Study|Randomized but not treated|1
6870234|NCT00463801|10880641|FG000|Overall Study|Protocol Violation|1
6870235|NCT00463801|10880641|FG000|Overall Study|Lack of Efficacy|2
6870236|NCT00463801|10880641|FG000|Overall Study|Adverse Event|4
6870237|NCT00463801|10880641|FG000|Overall Study|Lost to Follow-up|5
6870238|NCT00463801|10880641|FG000|Overall Study|No longer require therapy|1
6870239|NCT00463840|10880645|FG000|Overall Study|Disease progression|7
6870240|NCT00463840|10880645|FG000|Overall Study|Withdrawal by Subject|2
6870241|NCT00463840|10880645|FG000|Overall Study|Adverse Event|3
6870242|NCT00463866|10880651|FG000|Overall Study|Adverse Event|70
6870243|NCT00463866|10880652|FG001|Overall Study|Adverse Event|93
6870244|NCT00463866|10880651|FG000|Overall Study|Withdrawal by Subject|81
6870245|NCT00463866|10880652|FG001|Overall Study|Withdrawal by Subject|79
6870246|NCT00463866|10880651|FG000|Overall Study|Lost to Follow-up|46
6870247|NCT00463866|10880652|FG001|Overall Study|Lost to Follow-up|55
6870248|NCT00463866|10880651|FG000|Overall Study|Incorrect Enrolment|64
6870249|NCT00463866|10880652|FG001|Overall Study|Incorrect Enrolment|66
6870250|NCT00463866|10880651|FG000|Overall Study|Severe Non-Compliance to Protocol|25
6870251|NCT00463866|10880652|FG001|Overall Study|Severe Non-Compliance to Protocol|21
6870252|NCT00463866|10880651|FG000|Overall Study|Safety Reason|1
6870253|NCT00463866|10880652|FG001|Overall Study|Safety Reason|3
6870254|NCT00463866|10880651|FG000|Overall Study|Mis-Randomization of subject|0
6870255|NCT00463866|10880652|FG001|Overall Study|Mis-Randomization of subject|1
6870256|NCT00463866|10880651|FG000|Overall Study|Other|22
6870257|NCT00463866|10880652|FG001|Overall Study|Other|22
6870258|NCT00464087|10880661|FG000|Overall Study|No PCI per inclusion criteria|0
6870259|NCT00464087|10880662|FG001|Overall Study|No PCI per inclusion criteria|0
6870260|NCT00464087|10880663|FG002|Overall Study|No PCI per inclusion criteria|29
6870261|NCT00464269|10880686|FG000|Overall Study|Lack of Efficacy|1
6870262|NCT00464269|10880687|FG001|Overall Study|Lack of Efficacy|0
6870263|NCT00464269|10880688|FG002|Overall Study|Lack of Efficacy|0
6870264|NCT00464269|10880689|FG003|Overall Study|Lack of Efficacy|0
6870265|NCT00464269|10880686|FG000|Overall Study|Lost to Follow-up|0
6870266|NCT00464269|10880687|FG001|Overall Study|Lost to Follow-up|4
6870267|NCT00464269|10880688|FG002|Overall Study|Lost to Follow-up|0
6870268|NCT00464269|10880689|FG003|Overall Study|Lost to Follow-up|1
6870269|NCT00464269|10880686|FG000|Overall Study|Withdrawal by Subject|0
6870270|NCT00464269|10880687|FG001|Overall Study|Withdrawal by Subject|2
6870271|NCT00464269|10880688|FG002|Overall Study|Withdrawal by Subject|1
6870272|NCT00464269|10880689|FG003|Overall Study|Withdrawal by Subject|1
6870273|NCT00464269|10880686|FG000|Overall Study|Other reason|3
6870274|NCT00464269|10880687|FG001|Overall Study|Other reason|3
6870275|NCT00464269|10880688|FG002|Overall Study|Other reason|1
6870276|NCT00464269|10880689|FG003|Overall Study|Other reason|1
6870277|NCT00464269|10880686|FG000|Overall Study|AE, serious fatal|0
6870278|NCT00464269|10880687|FG001|Overall Study|AE, serious fatal|0
6870279|NCT00464269|10880688|FG002|Overall Study|AE, serious fatal|1
6870280|NCT00464269|10880689|FG003|Overall Study|AE, serious fatal|1
6870281|NCT00464269|10880686|FG000|Overall Study|SAE, non-fatal|0
6870282|NCT00464269|10880687|FG001|Overall Study|SAE, non-fatal|0
6870283|NCT00464269|10880688|FG002|Overall Study|SAE, non-fatal|0
6870284|NCT00464269|10880689|FG003|Overall Study|SAE, non-fatal|1
6870285|NCT00464269|10880686|FG000|Overall Study|AE, non-serious non-fatal|2
6870286|NCT00464269|10880687|FG001|Overall Study|AE, non-serious non-fatal|8
6870287|NCT00464269|10880688|FG002|Overall Study|AE, non-serious non-fatal|3
6870288|NCT00464269|10880689|FG003|Overall Study|AE, non-serious non-fatal|4
6870289|NCT00464269|10880686|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
6870290|NCT00464269|10880687|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
6870291|NCT00464269|10880688|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
6870292|NCT00464269|10880689|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
6870293|NCT00464308|10880704|FG000|Overall Study|Adverse Event|22
6870294|NCT00464308|10880705|FG001|Overall Study|Adverse Event|27
6870295|NCT00464308|10880706|FG002|Overall Study|Adverse Event|16
6870296|NCT00464308|10880704|FG000|Overall Study|Lost to Follow-up|29
6870297|NCT00464308|10880705|FG001|Overall Study|Lost to Follow-up|19
6870298|NCT00464308|10880706|FG002|Overall Study|Lost to Follow-up|20
6870299|NCT00464308|10880704|FG000|Overall Study|Patient discontinued and other reasons|17
6870300|NCT00464308|10880705|FG001|Overall Study|Patient discontinued and other reasons|17
6870301|NCT00464308|10880706|FG002|Overall Study|Patient discontinued and other reasons|23
6870302|NCT00464308|10880704|FG000|Overall Study|Physician Decision|1
6870303|NCT00464308|10880705|FG001|Overall Study|Physician Decision|0
6870304|NCT00464308|10880706|FG002|Overall Study|Physician Decision|0
6870305|NCT00464334|10880725|FG000|Overall Study|Adverse Event|0
6870306|NCT00464334|10880726|FG001|Overall Study|Adverse Event|0
6870307|NCT00464334|10880727|FG002|Overall Study|Adverse Event|0
6870308|NCT00464334|10880728|FG003|Overall Study|Adverse Event|1
6870309|NCT00464334|10880729|FG004|Overall Study|Adverse Event|1
6870310|NCT00464334|10880730|FG005|Overall Study|Adverse Event|1
6870311|NCT00464334|10880731|FG006|Overall Study|Adverse Event|0
6870312|NCT00464334|10880732|FG007|Overall Study|Adverse Event|0
6870313|NCT00464334|10880733|FG008|Overall Study|Adverse Event|2
6870314|NCT00464334|10880734|FG009|Overall Study|Adverse Event|1
6870315|NCT00464334|10880735|FG010|Overall Study|Adverse Event|2
6870316|NCT00464334|10880725|FG000|Overall Study|Lack of Efficacy|0
6870317|NCT00464334|10880726|FG001|Overall Study|Lack of Efficacy|1
6870318|NCT00464334|10880727|FG002|Overall Study|Lack of Efficacy|0
6870319|NCT00464334|10880728|FG003|Overall Study|Lack of Efficacy|0
6870320|NCT00464334|10880729|FG004|Overall Study|Lack of Efficacy|0
6870321|NCT00464334|10880730|FG005|Overall Study|Lack of Efficacy|0
6870322|NCT00464334|10880731|FG006|Overall Study|Lack of Efficacy|0
6870323|NCT00464334|10880732|FG007|Overall Study|Lack of Efficacy|0
6870324|NCT00464334|10880733|FG008|Overall Study|Lack of Efficacy|0
6870325|NCT00464334|10880734|FG009|Overall Study|Lack of Efficacy|0
6870326|NCT00464334|10880735|FG010|Overall Study|Lack of Efficacy|0
6870327|NCT00464334|10880725|FG000|Overall Study|Lost to Follow-up|0
6870328|NCT00464334|10880726|FG001|Overall Study|Lost to Follow-up|0
6870329|NCT00464334|10880727|FG002|Overall Study|Lost to Follow-up|1
6870330|NCT00464334|10880728|FG003|Overall Study|Lost to Follow-up|0
6870331|NCT00464334|10880729|FG004|Overall Study|Lost to Follow-up|1
6870332|NCT00464334|10880730|FG005|Overall Study|Lost to Follow-up|0
6870333|NCT00464334|10880731|FG006|Overall Study|Lost to Follow-up|1
6870334|NCT00464334|10880732|FG007|Overall Study|Lost to Follow-up|0
6870335|NCT00464334|10880733|FG008|Overall Study|Lost to Follow-up|0
6870336|NCT00464334|10880734|FG009|Overall Study|Lost to Follow-up|0
6870337|NCT00464334|10880735|FG010|Overall Study|Lost to Follow-up|2
6870338|NCT00464334|10880725|FG000|Overall Study|Progressive Disease|0
6870339|NCT00464334|10880726|FG001|Overall Study|Progressive Disease|0
6870340|NCT00464334|10880727|FG002|Overall Study|Progressive Disease|0
6870341|NCT00464334|10880728|FG003|Overall Study|Progressive Disease|0
6870342|NCT00464334|10880729|FG004|Overall Study|Progressive Disease|0
6870343|NCT00464334|10880730|FG005|Overall Study|Progressive Disease|1
6870344|NCT00464334|10880731|FG006|Overall Study|Progressive Disease|0
6870345|NCT00464334|10880732|FG007|Overall Study|Progressive Disease|0
6870346|NCT00464334|10880733|FG008|Overall Study|Progressive Disease|1
6870347|NCT00464334|10880734|FG009|Overall Study|Progressive Disease|0
6870348|NCT00464334|10880735|FG010|Overall Study|Progressive Disease|0
6870349|NCT00464334|10880725|FG000|Overall Study|Study Terminated by Sponsor|0
6870350|NCT00464334|10880726|FG001|Overall Study|Study Terminated by Sponsor|0
6870351|NCT00464334|10880727|FG002|Overall Study|Study Terminated by Sponsor|0
6870352|NCT00464334|10880728|FG003|Overall Study|Study Terminated by Sponsor|1
6870353|NCT00464334|10880729|FG004|Overall Study|Study Terminated by Sponsor|0
6870354|NCT00464334|10880730|FG005|Overall Study|Study Terminated by Sponsor|0
6870355|NCT00464334|10880731|FG006|Overall Study|Study Terminated by Sponsor|0
6870356|NCT00464334|10880732|FG007|Overall Study|Study Terminated by Sponsor|0
6870357|NCT00464334|10880733|FG008|Overall Study|Study Terminated by Sponsor|0
6870358|NCT00464334|10880734|FG009|Overall Study|Study Terminated by Sponsor|0
6870359|NCT00464334|10880735|FG010|Overall Study|Study Terminated by Sponsor|0
6870360|NCT00464334|10880725|FG000|Overall Study|Withdrawal by Subject|1
6870361|NCT00464334|10880726|FG001|Overall Study|Withdrawal by Subject|7
6870362|NCT00464334|10880727|FG002|Overall Study|Withdrawal by Subject|4
6870363|NCT00464334|10880728|FG003|Overall Study|Withdrawal by Subject|2
6870364|NCT00464334|10880729|FG004|Overall Study|Withdrawal by Subject|2
6870365|NCT00464334|10880730|FG005|Overall Study|Withdrawal by Subject|2
6870366|NCT00464334|10880731|FG006|Overall Study|Withdrawal by Subject|2
6870367|NCT00464334|10880732|FG007|Overall Study|Withdrawal by Subject|1
6870368|NCT00464334|10880733|FG008|Overall Study|Withdrawal by Subject|3
6870369|NCT00464334|10880734|FG009|Overall Study|Withdrawal by Subject|0
6870370|NCT00464334|10880735|FG010|Overall Study|Withdrawal by Subject|0
6870371|NCT00464490|10880790|FG000|Overall Study|Physician Decision|11
6870372|NCT00464490|10880791|FG001|Overall Study|Physician Decision|11
6870373|NCT00464542|10880797|FG000|Pre-treatment|Withdrawal by Subject|2
6870374|NCT00464568|10880801|FG000|Overall Study|Adverse Event|2
6870375|NCT00464620|10880818|FG000|Overall Study|Physician Decision|1
6870376|NCT00464620|10880819|FG001|Overall Study|Physician Decision|0
6870377|NCT00464620|10880820|FG002|Overall Study|Physician Decision|0
6870378|NCT00464620|10880818|FG000|Overall Study|Withdrawal by Subject|1
6870379|NCT00464620|10880819|FG001|Overall Study|Withdrawal by Subject|0
6870380|NCT00464620|10880820|FG002|Overall Study|Withdrawal by Subject|3
6870381|NCT00464620|10880818|FG000|Overall Study|Ineligible sarcoma subtype|0
6870382|NCT00464620|10880819|FG001|Overall Study|Ineligible sarcoma subtype|2
6870383|NCT00464620|10880820|FG002|Overall Study|Ineligible sarcoma subtype|2
6870384|NCT00464620|10880818|FG000|Overall Study|Use of prohibited concomitant medication|0
6870385|NCT00464620|10880819|FG001|Overall Study|Use of prohibited concomitant medication|0
6870386|NCT00464620|10880820|FG002|Overall Study|Use of prohibited concomitant medication|2
6870387|NCT00464672|10880845|FG000|Overall Study|withdrawal of consent|0
6870388|NCT00464672|10880846|FG001|Overall Study|withdrawal of consent|0
6870389|NCT00464672|10880847|FG002|Overall Study|withdrawal of consent|0
6870390|NCT00464672|10880848|FG003|Overall Study|withdrawal of consent|1
6870391|NCT00464672|10880849|FG004|Overall Study|withdrawal of consent|9
6870392|NCT00464672|10880850|FG005|Overall Study|withdrawal of consent|4
6870393|NCT00464672|10880845|FG000|Overall Study|Lost to Follow-up|25
6870394|NCT00464672|10880846|FG001|Overall Study|Lost to Follow-up|10
6870395|NCT00464672|10880847|FG002|Overall Study|Lost to Follow-up|0
6870396|NCT00464672|10880848|FG003|Overall Study|Lost to Follow-up|0
6870397|NCT00464672|10880849|FG004|Overall Study|Lost to Follow-up|1
6870398|NCT00464672|10880850|FG005|Overall Study|Lost to Follow-up|0
6870399|NCT00464737|10880900|FG000|Overall Study|Adverse Event|12
6870400|NCT00464737|10880901|FG001|Overall Study|Adverse Event|17
6968482|NCT01139450|11017492|FG000|Overall Study|Administrative|0
6968483|NCT01139450|11017493|FG001|Overall Study|Administrative|0
6968484|NCT01139450|11017494|FG002|Overall Study|Administrative|1
6968485|NCT01139450|11017492|FG000|Overall Study|Adverse Event|2
6968486|NCT01139450|11017493|FG001|Overall Study|Adverse Event|2
7078371|NCT02103478|11186917|FG005|Overall Study|Death|15
7078372|NCT02103478|11186918|FG006|Overall Study|Death|14
7078373|NCT02103478|11186919|FG007|Overall Study|Death|10
7078374|NCT02103478|11186920|FG008|Overall Study|Death|11
7078375|NCT02103478|11186912|FG000|Overall Study|Progressive Disease|2
7078376|NCT02103478|11186913|FG001|Overall Study|Progressive Disease|1
7078377|NCT02103478|11186914|FG002|Overall Study|Progressive Disease|2
7078378|NCT02103478|11186915|FG003|Overall Study|Progressive Disease|0
7078379|NCT02103478|11186916|FG004|Overall Study|Progressive Disease|9
6870401|NCT00464737|10880902|FG002|Overall Study|Adverse Event|33
6870402|NCT00464737|10880900|FG000|Overall Study|Lack of Efficacy|7
6870403|NCT00464737|10880901|FG001|Overall Study|Lack of Efficacy|7
6870404|NCT00464737|10880902|FG002|Overall Study|Lack of Efficacy|4
6870405|NCT00464737|10880900|FG000|Overall Study|Withdrawal by Subject|5
6870406|NCT00464737|10880901|FG001|Overall Study|Withdrawal by Subject|3
6870407|NCT00464737|10880902|FG002|Overall Study|Withdrawal by Subject|5
6968487|NCT01139450|11017494|FG002|Overall Study|Adverse Event|3
6968488|NCT01139580|11017517|FG000|Overall Study|Adverse Event|5
7078380|NCT02103478|11186917|FG005|Overall Study|Progressive Disease|1
7078381|NCT02103478|11186918|FG006|Overall Study|Progressive Disease|2
6870408|NCT00464737|10880900|FG000|Overall Study|Protocol Violation|1
6870409|NCT00464737|10880901|FG001|Overall Study|Protocol Violation|1
6870410|NCT00464737|10880902|FG002|Overall Study|Protocol Violation|5
6870411|NCT00464737|10880900|FG000|Overall Study|Non-compliance|0
6870412|NCT00464737|10880901|FG001|Overall Study|Non-compliance|1
6870413|NCT00464737|10880902|FG002|Overall Study|Non-compliance|1
6870414|NCT00464737|10880900|FG000|Overall Study|Lost to Follow-up|5
6870415|NCT00464737|10880901|FG001|Overall Study|Lost to Follow-up|2
6870416|NCT00464737|10880902|FG002|Overall Study|Lost to Follow-up|5
6870417|NCT00464737|10880900|FG000|Overall Study|Other: Subject's schedule doesn't permit|1
6870418|NCT00464737|10880901|FG001|Overall Study|Other: Subject's schedule doesn't permit|0
6870419|NCT00464737|10880902|FG002|Overall Study|Other: Subject's schedule doesn't permit|0
6870420|NCT00464737|10880900|FG000|Overall Study|Other: Subject left town; family illness|1
6870421|NCT00464737|10880901|FG001|Overall Study|Other: Subject left town; family illness|0
7078382|NCT02103478|11186919|FG007|Overall Study|Progressive Disease|0
7078383|NCT02103478|11186920|FG008|Overall Study|Progressive Disease|1
7078384|NCT02103478|11186912|FG000|Overall Study|Withdrawal by Subject|2
7078385|NCT02103478|11186913|FG001|Overall Study|Withdrawal by Subject|0
6870422|NCT00464737|10880902|FG002|Overall Study|Other: Subject left town; family illness|0
6870423|NCT00464737|10880900|FG000|Overall Study|Other: Study demands too great|0
6870424|NCT00464737|10880901|FG001|Overall Study|Other: Study demands too great|1
6870425|NCT00464737|10880902|FG002|Overall Study|Other: Study demands too great|0
6870426|NCT00464737|10880900|FG000|Overall Study|Other: Personal family reasons|0
6870427|NCT00464737|10880901|FG001|Overall Study|Other: Personal family reasons|0
6870428|NCT00464737|10880902|FG002|Overall Study|Other: Personal family reasons|1
6870429|NCT00464737|10880900|FG000|Overall Study|Other: Subject's disability per sponsor|0
6870430|NCT00464737|10880901|FG001|Overall Study|Other: Subject's disability per sponsor|0
6870431|NCT00464737|10880902|FG002|Overall Study|Other: Subject's disability per sponsor|1
6870432|NCT00464815|10880912|FG000|Overall Study|Withdrawal by Subject|6
6870433|NCT00464815|10880913|FG001|Overall Study|Withdrawal by Subject|3
6968489|NCT01139580|11017518|FG001|Overall Study|Adverse Event|4
6968490|NCT01139580|11017517|FG000|Overall Study|Lost to Follow-up|9
6968491|NCT01139580|11017518|FG001|Overall Study|Lost to Follow-up|1
6968492|NCT01139580|11017517|FG000|Overall Study|Lack of Efficacy|0
6968493|NCT01139580|11017518|FG001|Overall Study|Lack of Efficacy|2
6968494|NCT01139580|11017517|FG000|Overall Study|Withdrawal by Subject|6
6968495|NCT01139580|11017518|FG001|Overall Study|Withdrawal by Subject|9
6968496|NCT01139580|11017517|FG000|Overall Study|Used Excluded Medicine After Enrollment|1
6968497|NCT01139580|11017518|FG001|Overall Study|Used Excluded Medicine After Enrollment|0
6968498|NCT01139580|11017517|FG000|Overall Study|Did Not Meet Exclusion Criteria|1
6968499|NCT01139580|11017518|FG001|Overall Study|Did Not Meet Exclusion Criteria|0
6968500|NCT01139580|11017517|FG000|Overall Study|Misrandomized|1
6968501|NCT01139580|11017518|FG001|Overall Study|Misrandomized|0
6968502|NCT01139580|11017517|FG000|Overall Study|Beginning Study Exclusion Treatment|0
6968503|NCT01139580|11017518|FG001|Overall Study|Beginning Study Exclusion Treatment|1
6968504|NCT01139580|11017517|FG000|Overall Study|Participant Randomization in Error|0
6968505|NCT01139580|11017518|FG001|Overall Study|Participant Randomization in Error|1
6968506|NCT01139658|11017526|FG000|Overall Study|Adverse Event|10
6968507|NCT01139658|11017527|FG001|Overall Study|Adverse Event|27
6968508|NCT01139658|11017526|FG000|Overall Study|Lack of Efficacy|15
6968509|NCT01139658|11017527|FG001|Overall Study|Lack of Efficacy|7
6968510|NCT01139658|11017526|FG000|Overall Study|Withdrawal by Subject|2
6968511|NCT01139658|11017527|FG001|Overall Study|Withdrawal by Subject|4
6968512|NCT01139658|11017526|FG000|Overall Study|No documentation of treatment|1
6968513|NCT01139658|11017527|FG001|Overall Study|No documentation of treatment|0
6968514|NCT01139658|11017526|FG000|Overall Study|Other|28
6968515|NCT01139658|11017527|FG001|Overall Study|Other|75
6968516|NCT01139762|11017535|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258
6968517|NCT01139762|11017536|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
6968518|NCT01139762|11017537|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
6968519|NCT01139762|11017535|FG000|Washout and Placebo Lead-In Period|Adverse Event|1
6968520|NCT01139762|11017536|FG001|Washout and Placebo Lead-In Period|Adverse Event|0
6968521|NCT01139762|11017537|FG002|Washout and Placebo Lead-In Period|Adverse Event|0
6968522|NCT01139762|11017535|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83
6968523|NCT01139762|11017536|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
6968524|NCT01139762|11017537|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
6968525|NCT01139762|11017535|FG000|Washout and Placebo Lead-In Period|Physician Decision|12
6968526|NCT01139762|11017536|FG001|Washout and Placebo Lead-In Period|Physician Decision|0
6968527|NCT01139762|11017537|FG002|Washout and Placebo Lead-In Period|Physician Decision|0
6968528|NCT01139762|11017535|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10
6968529|NCT01139762|11017536|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0
6968530|NCT01139762|11017537|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0
6968531|NCT01139762|11017535|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10
6968532|NCT01139762|11017536|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0
6968533|NCT01139762|11017537|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0
6968534|NCT01139762|11017535|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0
6968535|NCT01139762|11017536|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4
6870434|NCT00464945|10880921|FG000|Infant Series|Withdrawal by parent/guardian request|2
6870435|NCT00464945|10880922|FG001|Infant Series|Withdrawal by parent/guardian request|1
6870436|NCT00464945|10880921|FG000|Infant Series|Protocol Violation|1
6870437|NCT00464945|10880922|FG001|Infant Series|Protocol Violation|0
6870438|NCT00464945|10880921|FG000|Infant Series|Lost to Follow-up|1
6870439|NCT00464945|10880922|FG001|Infant Series|Lost to Follow-up|0
6870440|NCT00464945|10880921|FG000|After Infant Series|Withdrawal by Subject|0
6870441|NCT00464945|10880922|FG001|After Infant Series|Withdrawal by Subject|2
6870442|NCT00464945|10880921|FG000|Toddler Dose|Lost to Follow-up|0
6870443|NCT00464945|10880922|FG001|Toddler Dose|Lost to Follow-up|1
6870444|NCT00465101|10880953|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3
6870445|NCT00465101|10880953|FG000|Overall Study|Change in health precluded follow up|4
6870446|NCT00465101|10880953|FG000|Overall Study|Did not meet study criteria|4
6870447|NCT00465101|10880953|FG000|Overall Study|Lost to Follow-up|5
6870448|NCT00465101|10880953|FG000|Overall Study|Other|6
6870449|NCT00465101|10880953|FG000|Overall Study|Pt. Insurance not accepted at center|2
6870450|NCT00465101|10880953|FG000|Overall Study|Patient postponed procedure|1
6870451|NCT00465101|10880953|FG000|Overall Study|Site closed due to IRB expiration|1
6870452|NCT00465101|10880953|FG000|Overall Study|Unable to obtain IRB approval|1
6870453|NCT00465101|10880953|FG000|Overall Study|Death|3
6870454|NCT00465101|10880953|FG000|Overall Study|Withdrawal by Subject|25
6870455|NCT00465101|10880953|FG000|Overall Study|Physician Decision|1
6870456|NCT00465101|10880953|FG000|Overall Study|Withdrew consent prior to procedure|3
6870457|NCT00465179|10880979|FG000|Overall Study|Adverse Event|4
6870458|NCT00465179|10880979|FG000|Overall Study|Withdrawal by Subject|2
6870459|NCT00465179|10880979|FG000|Overall Study|Progression of Disease|47
6870460|NCT00465270|10880985|FG000|Overall Study|Death|7
6870461|NCT00465270|10880986|FG001|Overall Study|Death|11
6870462|NCT00465270|10880985|FG000|Overall Study|Withdrawal by Subject|34
6870463|NCT00465270|10880986|FG001|Overall Study|Withdrawal by Subject|78
6870464|NCT00465270|10880985|FG000|Overall Study|Lost to Follow-up|60
6870465|NCT00465270|10880986|FG001|Overall Study|Lost to Follow-up|67
6870466|NCT00465270|10880985|FG000|Overall Study|Investigator request|3
6870467|NCT00465270|10880986|FG001|Overall Study|Investigator request|4
6870468|NCT00465361|10880992|FG000|Baseline Assessment|Personal Issues/Scheduling|4
6870469|NCT00465569|10881007|FG000|Overall Study|persistent eczema during dose escalation|1
6870470|NCT00465569|10881008|FG001|Overall Study|persistent eczema during dose escalation|0
6870471|NCT00465647|10881033|FG000|Overall Study|Administrative|2
6870472|NCT00465647|10881034|FG001|Overall Study|Administrative|2
6870473|NCT00465647|10881035|FG002|Overall Study|Administrative|3
6870474|NCT00465647|10881036|FG003|Overall Study|Administrative|2
6870475|NCT00465647|10881033|FG000|Overall Study|Adverse Event|2
6870476|NCT00465647|10881034|FG001|Overall Study|Adverse Event|0
6870477|NCT00465647|10881035|FG002|Overall Study|Adverse Event|3
6870478|NCT00465647|10881036|FG003|Overall Study|Adverse Event|2
6870479|NCT00465647|10881033|FG000|Overall Study|Withdrawal by Subject|1
6870480|NCT00465647|10881034|FG001|Overall Study|Withdrawal by Subject|2
6870481|NCT00465647|10881035|FG002|Overall Study|Withdrawal by Subject|2
6870482|NCT00465647|10881036|FG003|Overall Study|Withdrawal by Subject|7
6870483|NCT00465647|10881033|FG000|Overall Study|"The other reasons included loss of IV"|8
6870484|NCT00465647|10881034|FG001|Overall Study|"The other reasons included loss of IV"|4
6870485|NCT00465647|10881035|FG002|Overall Study|"The other reasons included loss of IV"|3
6870486|NCT00465647|10881036|FG003|Overall Study|"The other reasons included loss of IV"|2
6870487|NCT00465738|10881058|FG000|Overall Study|Lost to Follow-up|2
6870488|NCT00465738|10881059|FG001|Overall Study|Lost to Follow-up|0
6870489|NCT00465738|10881058|FG000|Overall Study|Adverse Event|0
6870490|NCT00465738|10881059|FG001|Overall Study|Adverse Event|1
6870491|NCT00465738|10881058|FG000|Overall Study|Withdrawal by Subject|2
6870492|NCT00465738|10881059|FG001|Overall Study|Withdrawal by Subject|0
6870493|NCT00465738|10881058|FG000|Overall Study|Other|2
6870494|NCT00465738|10881059|FG001|Overall Study|Other|5
6870495|NCT00465816|10881068|FG000|Overall Study|Lost to Follow-up|0
6870496|NCT00465816|10881069|FG001|Overall Study|Lost to Follow-up|0
6870497|NCT00465816|10881070|FG002|Overall Study|Lost to Follow-up|2
6870498|NCT00465894|10881081|FG000|Treatment For 12 Weeks|Lost to Follow-up|4
6870499|NCT00465894|10881082|FG001|Treatment For 12 Weeks|Lost to Follow-up|1
6870500|NCT00465894|10881081|FG000|Treatment For 12 Weeks|Family Issues|1
6870501|NCT00465894|10881082|FG001|Treatment For 12 Weeks|Family Issues|1
6870502|NCT00465894|10881081|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0
6870503|NCT00465894|10881082|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1
6870504|NCT00465972|10881106|FG000|Overall Study|Withdrawal by Subject|2
6870505|NCT00465972|10881107|FG001|Overall Study|Withdrawal by Subject|1
6870506|NCT00465985|10881115|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4
6870507|NCT00465985|10881116|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
6870508|NCT00465985|10881115|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0
6870509|NCT00465985|10881116|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12
6870510|NCT00465985|10881115|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1
6870511|NCT00465985|10881116|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
6870512|NCT00465985|10881115|FG000|Part III - Open-label Treatment Period|Adverse Event|1
6870513|NCT00465985|10881116|FG001|Part III - Open-label Treatment Period|Adverse Event|0
6870514|NCT00466167|10881133|FG000|Overall Study|Adverse Event|8
6870515|NCT00466167|10881134|FG001|Overall Study|Adverse Event|8
6870516|NCT00466167|10881135|FG002|Overall Study|Adverse Event|7
6870517|NCT00466167|10881133|FG000|Overall Study|Lack of Efficacy|2
6870518|NCT00466167|10881134|FG001|Overall Study|Lack of Efficacy|0
6870519|NCT00466167|10881135|FG002|Overall Study|Lack of Efficacy|3
6870520|NCT00466167|10881133|FG000|Overall Study|Protocol Violation|1
6870521|NCT00466167|10881134|FG001|Overall Study|Protocol Violation|1
6870522|NCT00466167|10881135|FG002|Overall Study|Protocol Violation|2
6870523|NCT00466167|10881133|FG000|Overall Study|Lost to Follow-up|3
6870524|NCT00466167|10881134|FG001|Overall Study|Lost to Follow-up|2
6870525|NCT00466167|10881135|FG002|Overall Study|Lost to Follow-up|2
6870526|NCT00466167|10881133|FG000|Overall Study|Withdrawal by Subject|4
6870527|NCT00466167|10881134|FG001|Overall Study|Withdrawal by Subject|1
6870528|NCT00466167|10881135|FG002|Overall Study|Withdrawal by Subject|6
6870529|NCT00466167|10881133|FG000|Overall Study|patient did not meet inclusion criteria|1
6870530|NCT00466167|10881134|FG001|Overall Study|patient did not meet inclusion criteria|0
6870531|NCT00466167|10881135|FG002|Overall Study|patient did not meet inclusion criteria|1
6870532|NCT00466167|10881133|FG000|Overall Study|Not treated|1
6870533|NCT00466167|10881134|FG001|Overall Study|Not treated|0
6870534|NCT00466167|10881135|FG002|Overall Study|Not treated|0
6870535|NCT00466193|10881145|FG000|Overall Study|Adverse Event|0
6870536|NCT00466193|10881146|FG001|Overall Study|Adverse Event|1
6870537|NCT00466193|10881145|FG000|Overall Study|Lost to Follow-up|2
6870538|NCT00466193|10881146|FG001|Overall Study|Lost to Follow-up|4
6870539|NCT00466193|10881145|FG000|Overall Study|Physician Decision|1
6870540|NCT00466193|10881146|FG001|Overall Study|Physician Decision|0
6870541|NCT00466193|10881145|FG000|Overall Study|Protocol Violation|1
6870542|NCT00466193|10881146|FG001|Overall Study|Protocol Violation|1
6870543|NCT00466193|10881145|FG000|Overall Study|Withdrawal by Subject|7
6870544|NCT00466193|10881146|FG001|Overall Study|Withdrawal by Subject|2
6870545|NCT00466193|10881145|FG000|Overall Study|Patient refused Visit 4 procedures|1
6870546|NCT00466193|10881146|FG001|Overall Study|Patient refused Visit 4 procedures|0
6870547|NCT00466440|10881184|FG000|Overall Study|Adverse Event|0
6870548|NCT00466440|10881185|FG001|Overall Study|Adverse Event|3
6870549|NCT00466440|10881186|FG002|Overall Study|Adverse Event|1
6870550|NCT00466440|10881184|FG000|Overall Study|Death|1
6870551|NCT00466440|10881185|FG001|Overall Study|Death|1
6870552|NCT00466440|10881186|FG002|Overall Study|Death|0
6870553|NCT00466440|10881184|FG000|Overall Study|Progressive disease|13
6870554|NCT00466440|10881185|FG001|Overall Study|Progressive disease|5
6870555|NCT00466440|10881186|FG002|Overall Study|Progressive disease|4
7078386|NCT02103478|11186914|FG002|Overall Study|Withdrawal by Subject|0
6870556|NCT00466440|10881184|FG000|Overall Study|Lost to Follow-up|0
6870557|NCT00466440|10881185|FG001|Overall Study|Lost to Follow-up|1
6870558|NCT00466440|10881186|FG002|Overall Study|Lost to Follow-up|0
6870559|NCT00466440|10881184|FG000|Overall Study|Physician Decision|0
6870560|NCT00466440|10881185|FG001|Overall Study|Physician Decision|1
6870561|NCT00466440|10881186|FG002|Overall Study|Physician Decision|2
6870562|NCT00466440|10881184|FG000|Overall Study|Protocol entry criteria not met|0
6870563|NCT00466440|10881185|FG001|Overall Study|Protocol entry criteria not met|0
6870564|NCT00466440|10881186|FG002|Overall Study|Protocol entry criteria not met|4
6870565|NCT00466440|10881184|FG000|Overall Study|Withdrawal by Subject|0
6870566|NCT00466440|10881185|FG001|Overall Study|Withdrawal by Subject|1
6870567|NCT00466440|10881186|FG002|Overall Study|Withdrawal by Subject|0
6870568|NCT00466440|10881184|FG000|Overall Study|Sponsor decision|0
6870569|NCT00466440|10881185|FG001|Overall Study|Sponsor decision|0
6870570|NCT00466440|10881186|FG002|Overall Study|Sponsor decision|1
6870571|NCT00466505|10881203|FG000|Overall Study|disease progression|13
6870572|NCT00466505|10881203|FG000|Overall Study|Adverse Event|4
6870573|NCT00466687|10881216|FG000|Overall Study|Adverse Event|1
6870574|NCT00466687|10881216|FG000|Overall Study|Other complicating illness|3
6870575|NCT00466687|10881216|FG000|Overall Study|Withdrawal by Subject|1
6870576|NCT00466687|10881216|FG000|Overall Study|Disease progression|29
6870577|NCT00466726|10881222|FG000|Overall Study|Not evaluable for response|14
6870578|NCT00466921|10881253|FG000|First 3 Cycles of Treatment|Adverse Event|2
6870579|NCT00466921|10881253|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5
6870580|NCT00466921|10881253|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2
6870581|NCT00466921|10881253|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2
6870582|NCT00466921|10881253|FG000|Completed 4 Cycles/Reached 1st Response|Other|1
6870583|NCT00466921|10881253|FG000|Follow up for a Minimum of 1 Year|Death|6
6870584|NCT00466947|10881259|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875
6870585|NCT00466947|10881260|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863
7078387|NCT02103478|11186915|FG003|Overall Study|Withdrawal by Subject|4
6870586|NCT00466947|10881259|FG000|Study End Analysis Period|Adverse Event|35
6870587|NCT00466947|10881260|FG001|Study End Analysis Period|Adverse Event|43
6870588|NCT00466947|10881259|FG000|Study End Analysis Period|Lost to Follow-up|1137
6870589|NCT00466947|10881260|FG001|Study End Analysis Period|Lost to Follow-up|1167
6870590|NCT00466947|10881259|FG000|Study End Analysis Period|Physician Decision|29
6870591|NCT00466947|10881260|FG001|Study End Analysis Period|Physician Decision|29
6870592|NCT00466947|10881259|FG000|Study End Analysis Period|Protocol Violation|9
6870593|NCT00466947|10881260|FG001|Study End Analysis Period|Protocol Violation|17
6870594|NCT00466947|10881259|FG000|Study End Analysis Period|Withdrawal by Subject|1264
6870595|NCT00466947|10881260|FG001|Study End Analysis Period|Withdrawal by Subject|1267
6870596|NCT00466947|10881259|FG000|Study End Analysis Period|Other - Forbidden vaccination|21
6870597|NCT00466947|10881260|FG001|Study End Analysis Period|Other - Forbidden vaccination|10
6870598|NCT00466947|10881259|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1
6870599|NCT00466947|10881260|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0
6870600|NCT00466947|10881259|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0
6870601|NCT00466947|10881260|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1
6870602|NCT00467051|10881281|FG000|Overall Study|Adverse Event|2
6870603|NCT00467259|10881292|FG000|Overall Study|Adverse Event|24
6870604|NCT00467259|10881293|FG001|Overall Study|Adverse Event|90
6870605|NCT00467259|10881292|FG000|Overall Study|Protocol Violation|1
6870606|NCT00467259|10881293|FG001|Overall Study|Protocol Violation|7
6870607|NCT00467259|10881292|FG000|Overall Study|Withdrawal by Subject|34
6870608|NCT00467259|10881293|FG001|Overall Study|Withdrawal by Subject|108
6870609|NCT00467259|10881292|FG000|Overall Study|Physician Decision|0
6870610|NCT00467259|10881293|FG001|Overall Study|Physician Decision|2
6870611|NCT00467259|10881292|FG000|Overall Study|Lost to Follow-up|14
6870612|NCT00467259|10881293|FG001|Overall Study|Lost to Follow-up|34
6870613|NCT00467259|10881292|FG000|Overall Study|Site Closed|2
6870614|NCT00467259|10881293|FG001|Overall Study|Site Closed|1
6870615|NCT00467272|10881299|FG000|Overall Study|Pneumonia|2
6870616|NCT00467272|10881299|FG000|Overall Study|Thrombophlebitis|1
6870617|NCT00467285|10881305|FG000|Overall Study|Lost to Follow-up|4
6870618|NCT00467285|10881306|FG001|Overall Study|Lost to Follow-up|4
6870619|NCT00467363|10881334|FG000|Overall Study|Lost to Follow-up|80
6870620|NCT00467363|10881335|FG001|Overall Study|Lost to Follow-up|70
6870621|NCT00467519|10881350|FG000|Overall Study|Protocol Violation|8
6870622|NCT00467519|10881351|FG001|Overall Study|Protocol Violation|4
6870623|NCT00467519|10881350|FG000|Overall Study|Lost to Follow-up|2
6870624|NCT00467519|10881351|FG001|Overall Study|Lost to Follow-up|9
6870625|NCT00467519|10881350|FG000|Overall Study|Withdrawal by Subject|4
6870626|NCT00467519|10881351|FG001|Overall Study|Withdrawal by Subject|10
6870627|NCT00467558|10881359|FG000|Overall Study|Lost to Follow-up|2
6870628|NCT00467558|10881360|FG001|Overall Study|Lost to Follow-up|0
6870629|NCT00467584|10881369|FG000|Overall Study|Withdrawal by Subject|4
6870630|NCT00467584|10881370|FG001|Overall Study|Withdrawal by Subject|5
6870631|NCT00467584|10881371|FG002|Overall Study|Withdrawal by Subject|1
6870632|NCT00467597|10881383|FG000|Overall Study|Withdrawal by Subject|2
6870633|NCT00467597|10881384|FG001|Overall Study|Withdrawal by Subject|0
6870634|NCT00467610|10881394|FG000|Overall Study|Withdrawal by Subject|1
6870635|NCT00467649|10881400|FG000|Phase 1 (Randomized Population)|Adverse Event|2
6870636|NCT00467649|10881401|FG001|Phase 1 (Randomized Population)|Adverse Event|0
6870637|NCT00467649|10881402|FG002|Phase 1 (Randomized Population)|Adverse Event|0
6870638|NCT00467649|10881403|FG003|Phase 1 (Randomized Population)|Adverse Event|0
6870639|NCT00467649|10881404|FG004|Phase 1 (Randomized Population)|Adverse Event|0
6870640|NCT00467649|10881405|FG005|Phase 1 (Randomized Population)|Adverse Event|0
6870641|NCT00467649|10881400|FG000|Phase 1 (Randomized Population)|Investigator Decision|1
6870642|NCT00467649|10881401|FG001|Phase 1 (Randomized Population)|Investigator Decision|0
6870643|NCT00467649|10881402|FG002|Phase 1 (Randomized Population)|Investigator Decision|0
6870644|NCT00467649|10881403|FG003|Phase 1 (Randomized Population)|Investigator Decision|0
6870645|NCT00467649|10881404|FG004|Phase 1 (Randomized Population)|Investigator Decision|0
6870646|NCT00467649|10881405|FG005|Phase 1 (Randomized Population)|Investigator Decision|0
6870647|NCT00467649|10881400|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2
6870648|NCT00467649|10881401|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4
6870649|NCT00467649|10881402|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0
6870650|NCT00467649|10881403|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0
6870651|NCT00467649|10881404|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0
6870652|NCT00467649|10881405|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0
6870653|NCT00467649|10881400|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4
6870654|NCT00467649|10881401|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2
6870655|NCT00467649|10881402|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0
6870656|NCT00467649|10881403|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0
6870657|NCT00467649|10881404|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0
6870658|NCT00467649|10881405|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0
6870659|NCT00467649|10881400|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
6870660|NCT00467649|10881401|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
6870661|NCT00467649|10881402|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
6870662|NCT00467649|10881403|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1
6870663|NCT00467649|10881404|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
6870664|NCT00467649|10881405|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
6870665|NCT00467649|10881400|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
6870666|NCT00467649|10881401|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
6870667|NCT00467649|10881402|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
6870668|NCT00467649|10881403|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1
6976937|NCT01202955|11029813|FG001|Period 1: 10 Days|Withdrawal by Subject|2
6870669|NCT00467649|10881404|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
6870670|NCT00467649|10881405|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
6870671|NCT00467649|10881400|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
6870672|NCT00467649|10881401|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
6870673|NCT00467649|10881402|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
6870674|NCT00467649|10881403|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
6870675|NCT00467649|10881404|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
6870676|NCT00467649|10881405|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1
6870677|NCT00467740|10881428|FG000|Overall Study|Adverse Event|0
6870678|NCT00467740|10881429|FG001|Overall Study|Adverse Event|0
6870679|NCT00467740|10881430|FG002|Overall Study|Adverse Event|1
6870680|NCT00467740|10881431|FG003|Overall Study|Adverse Event|0
6870681|NCT00467740|10881432|FG004|Overall Study|Adverse Event|0
6870682|NCT00467740|10881428|FG000|Overall Study|Protocol Violation|0
6870683|NCT00467740|10881429|FG001|Overall Study|Protocol Violation|0
6870684|NCT00467740|10881430|FG002|Overall Study|Protocol Violation|1
6870685|NCT00467740|10881431|FG003|Overall Study|Protocol Violation|0
6870686|NCT00467740|10881432|FG004|Overall Study|Protocol Violation|0
6870687|NCT00467740|10881428|FG000|Overall Study|Lost to Follow-up|0
6870688|NCT00467740|10881429|FG001|Overall Study|Lost to Follow-up|1
6870689|NCT00467740|10881430|FG002|Overall Study|Lost to Follow-up|0
6870690|NCT00467740|10881431|FG003|Overall Study|Lost to Follow-up|0
6870691|NCT00467740|10881432|FG004|Overall Study|Lost to Follow-up|0
6870692|NCT00467740|10881428|FG000|Overall Study|Withdrawal by Subject|1
6870693|NCT00467740|10881429|FG001|Overall Study|Withdrawal by Subject|1
6870694|NCT00467740|10881430|FG002|Overall Study|Withdrawal by Subject|0
6968536|NCT01139762|11017537|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10
6968537|NCT01139762|11017535|FG000|Double-Blind Randomized Active Treatment|Death|0
6968538|NCT01139762|11017536|FG001|Double-Blind Randomized Active Treatment|Death|1
6968539|NCT01139762|11017537|FG002|Double-Blind Randomized Active Treatment|Death|1
6968540|NCT01139762|11017535|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0
6968541|NCT01139762|11017536|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14
6968542|NCT01139762|11017537|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17
6968543|NCT01139762|11017535|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0
6968544|NCT01139762|11017536|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2
6968545|NCT01139762|11017537|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8
6968546|NCT01139762|11017535|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0
6968547|NCT01139762|11017536|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6
6968548|NCT01139762|11017537|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13
6968549|NCT01139762|11017535|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0
6968550|NCT01139762|11017536|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2
6968551|NCT01139762|11017537|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0
6968552|NCT01139762|11017535|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0
6968553|NCT01139762|11017536|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5
6968554|NCT01139762|11017537|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6
6968555|NCT01139762|11017535|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0
6968556|NCT01139762|11017536|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3
6968557|NCT01139762|11017537|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5
6968558|NCT01139762|11017535|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0
6968559|NCT01139762|11017536|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3
6968560|NCT01139762|11017537|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4
6968561|NCT01139775|11017547|FG000|Overall Study|Adverse Event|0
6968562|NCT01139775|11017548|FG001|Overall Study|Adverse Event|6
6968563|NCT01139775|11017549|FG002|Overall Study|Adverse Event|2
6968564|NCT01139775|11017547|FG000|Overall Study|Protocol Violation|0
6968565|NCT01139775|11017548|FG001|Overall Study|Protocol Violation|5
6968566|NCT01139775|11017549|FG002|Overall Study|Protocol Violation|0
6968567|NCT01139775|11017547|FG000|Overall Study|Withdrawal by Subject|1
6968568|NCT01139775|11017548|FG001|Overall Study|Withdrawal by Subject|0
6968569|NCT01139775|11017549|FG002|Overall Study|Withdrawal by Subject|2
6968570|NCT01139775|11017547|FG000|Overall Study|Physician Decision|0
6968571|NCT01139775|11017548|FG001|Overall Study|Physician Decision|2
6968572|NCT01139775|11017549|FG002|Overall Study|Physician Decision|2
6968573|NCT01140061|11017589|FG000|Part I|Adverse Event|1
6968574|NCT01140061|11017590|FG001|Part I|Adverse Event|0
6968575|NCT01140061|11017591|FG002|Part I|Adverse Event|0
6968576|NCT01140061|11017592|FG003|Part I|Adverse Event|0
6968577|NCT01140061|11017593|FG004|Part I|Adverse Event|0
6968578|NCT01140061|11017594|FG005|Part I|Adverse Event|0
6968579|NCT01140061|11017595|FG006|Part I|Adverse Event|0
6968580|NCT01140061|11017596|FG007|Part I|Adverse Event|0
6968581|NCT01140061|11017597|FG008|Part I|Adverse Event|0
6968582|NCT01140061|11017598|FG009|Part I|Adverse Event|0
7078388|NCT02103478|11186916|FG004|Overall Study|Withdrawal by Subject|0
6870695|NCT00467740|10881431|FG003|Overall Study|Withdrawal by Subject|1
6870696|NCT00467740|10881432|FG004|Overall Study|Withdrawal by Subject|0
6870697|NCT00467740|10881428|FG000|Overall Study|Lack of Efficacy|0
6870698|NCT00467740|10881429|FG001|Overall Study|Lack of Efficacy|1
6870699|NCT00467740|10881430|FG002|Overall Study|Lack of Efficacy|0
6870700|NCT00467740|10881431|FG003|Overall Study|Lack of Efficacy|0
6870701|NCT00467740|10881432|FG004|Overall Study|Lack of Efficacy|0
6870702|NCT00467779|10881459|FG000|Stage 1|Adverse Event|1
7154283|NCT03308968|11320892|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3
7154284|NCT03308968|11320893|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1
7078389|NCT02103478|11186917|FG005|Overall Study|Withdrawal by Subject|0
7154285|NCT03308968|11320894|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4
7154286|NCT03308968|11320892|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2
7154287|NCT03308968|11320893|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2
7154288|NCT03308968|11320894|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3
7154289|NCT03308968|11320892|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6
7154290|NCT03308968|11320893|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0
6870703|NCT00467779|10881460|FG001|Stage 1|Adverse Event|0
6870704|NCT00467779|10881461|FG002|Stage 1|Adverse Event|0
6870705|NCT00467779|10881462|FG003|Stage 1|Adverse Event|0
6870706|NCT00467779|10881463|FG004|Stage 1|Adverse Event|0
6870707|NCT00467779|10881464|FG005|Stage 1|Adverse Event|1
6870708|NCT00467779|10881465|FG006|Stage 1|Adverse Event|2
6870709|NCT00467779|10881466|FG007|Stage 1|Adverse Event|1
6870710|NCT00467779|10881467|FG008|Stage 1|Adverse Event|0
6870711|NCT00467779|10881468|FG009|Stage 1|Adverse Event|0
6870712|NCT00467779|10881469|FG010|Stage 1|Adverse Event|0
6870713|NCT00467779|10881470|FG011|Stage 1|Adverse Event|0
6870714|NCT00467779|10881471|FG012|Stage 1|Adverse Event|0
6870715|NCT00467779|10881472|FG013|Stage 1|Adverse Event|0
6870716|NCT00467779|10881473|FG014|Stage 1|Adverse Event|0
6870717|NCT00467779|10881459|FG000|Stage 1|Disease Progression|2
6870718|NCT00467779|10881460|FG001|Stage 1|Disease Progression|2
6870719|NCT00467779|10881461|FG002|Stage 1|Disease Progression|2
6870720|NCT00467779|10881462|FG003|Stage 1|Disease Progression|3
6870721|NCT00467779|10881463|FG004|Stage 1|Disease Progression|2
6870722|NCT00467779|10881464|FG005|Stage 1|Disease Progression|2
6870723|NCT00467779|10881465|FG006|Stage 1|Disease Progression|4
6870724|NCT00467779|10881466|FG007|Stage 1|Disease Progression|5
6870725|NCT00467779|10881467|FG008|Stage 1|Disease Progression|0
6870726|NCT00467779|10881468|FG009|Stage 1|Disease Progression|0
6870727|NCT00467779|10881469|FG010|Stage 1|Disease Progression|0
6870728|NCT00467779|10881470|FG011|Stage 1|Disease Progression|0
6870729|NCT00467779|10881471|FG012|Stage 1|Disease Progression|0
6870730|NCT00467779|10881472|FG013|Stage 1|Disease Progression|0
6870731|NCT00467779|10881473|FG014|Stage 1|Disease Progression|0
6870732|NCT00467779|10881459|FG000|Stage 1|Unspecified Reason|1
6870733|NCT00467779|10881460|FG001|Stage 1|Unspecified Reason|0
6870734|NCT00467779|10881461|FG002|Stage 1|Unspecified Reason|1
6870735|NCT00467779|10881462|FG003|Stage 1|Unspecified Reason|0
6870736|NCT00467779|10881463|FG004|Stage 1|Unspecified Reason|1
6870737|NCT00467779|10881464|FG005|Stage 1|Unspecified Reason|2
6870738|NCT00467779|10881465|FG006|Stage 1|Unspecified Reason|0
6870739|NCT00467779|10881466|FG007|Stage 1|Unspecified Reason|0
6870740|NCT00467779|10881467|FG008|Stage 1|Unspecified Reason|0
6870741|NCT00467779|10881468|FG009|Stage 1|Unspecified Reason|0
6870742|NCT00467779|10881469|FG010|Stage 1|Unspecified Reason|0
6870743|NCT00467779|10881470|FG011|Stage 1|Unspecified Reason|0
6870744|NCT00467779|10881471|FG012|Stage 1|Unspecified Reason|0
6870745|NCT00467779|10881472|FG013|Stage 1|Unspecified Reason|0
6870746|NCT00467779|10881473|FG014|Stage 1|Unspecified Reason|0
6870747|NCT00467779|10881459|FG000|Stage 1|Physician Decision|0
6870748|NCT00467779|10881460|FG001|Stage 1|Physician Decision|1
6870749|NCT00467779|10881461|FG002|Stage 1|Physician Decision|0
6870750|NCT00467779|10881462|FG003|Stage 1|Physician Decision|0
6870751|NCT00467779|10881463|FG004|Stage 1|Physician Decision|0
6870752|NCT00467779|10881464|FG005|Stage 1|Physician Decision|0
6870753|NCT00467779|10881465|FG006|Stage 1|Physician Decision|0
6870754|NCT00467779|10881466|FG007|Stage 1|Physician Decision|0
6870755|NCT00467779|10881467|FG008|Stage 1|Physician Decision|0
6870756|NCT00467779|10881468|FG009|Stage 1|Physician Decision|0
6870757|NCT00467779|10881469|FG010|Stage 1|Physician Decision|0
6870758|NCT00467779|10881470|FG011|Stage 1|Physician Decision|0
6870759|NCT00467779|10881471|FG012|Stage 1|Physician Decision|0
6870760|NCT00467779|10881472|FG013|Stage 1|Physician Decision|0
6870761|NCT00467779|10881473|FG014|Stage 1|Physician Decision|0
6870762|NCT00467779|10881459|FG000|Stage 1|Withdrawal by Subject|0
6870763|NCT00467779|10881460|FG001|Stage 1|Withdrawal by Subject|0
6870764|NCT00467779|10881461|FG002|Stage 1|Withdrawal by Subject|0
6870765|NCT00467779|10881462|FG003|Stage 1|Withdrawal by Subject|0
6870766|NCT00467779|10881463|FG004|Stage 1|Withdrawal by Subject|0
6870767|NCT00467779|10881464|FG005|Stage 1|Withdrawal by Subject|0
6870768|NCT00467779|10881465|FG006|Stage 1|Withdrawal by Subject|1
6870769|NCT00467779|10881466|FG007|Stage 1|Withdrawal by Subject|1
6870770|NCT00467779|10881467|FG008|Stage 1|Withdrawal by Subject|0
6870771|NCT00467779|10881468|FG009|Stage 1|Withdrawal by Subject|0
6870772|NCT00467779|10881469|FG010|Stage 1|Withdrawal by Subject|0
6870773|NCT00467779|10881470|FG011|Stage 1|Withdrawal by Subject|0
6870774|NCT00467779|10881471|FG012|Stage 1|Withdrawal by Subject|0
6870775|NCT00467779|10881472|FG013|Stage 1|Withdrawal by Subject|0
6870776|NCT00467779|10881473|FG014|Stage 1|Withdrawal by Subject|0
6870777|NCT00467779|10881459|FG000|Stage 1A|Adverse Event|0
6870778|NCT00467779|10881460|FG001|Stage 1A|Adverse Event|0
6870779|NCT00467779|10881461|FG002|Stage 1A|Adverse Event|0
6870780|NCT00467779|10881462|FG003|Stage 1A|Adverse Event|0
6870781|NCT00467779|10881463|FG004|Stage 1A|Adverse Event|0
6870782|NCT00467779|10881464|FG005|Stage 1A|Adverse Event|0
6870783|NCT00467779|10881465|FG006|Stage 1A|Adverse Event|0
6870784|NCT00467779|10881466|FG007|Stage 1A|Adverse Event|0
6870785|NCT00467779|10881467|FG008|Stage 1A|Adverse Event|0
6870786|NCT00467779|10881468|FG009|Stage 1A|Adverse Event|0
6870787|NCT00467779|10881469|FG010|Stage 1A|Adverse Event|0
6870788|NCT00467779|10881470|FG011|Stage 1A|Adverse Event|0
6870789|NCT00467779|10881471|FG012|Stage 1A|Adverse Event|1
6870790|NCT00467779|10881472|FG013|Stage 1A|Adverse Event|0
6870791|NCT00467779|10881473|FG014|Stage 1A|Adverse Event|0
6870792|NCT00467779|10881459|FG000|Stage 1A|Death|0
6870793|NCT00467779|10881460|FG001|Stage 1A|Death|0
6870794|NCT00467779|10881461|FG002|Stage 1A|Death|0
6870795|NCT00467779|10881462|FG003|Stage 1A|Death|0
6870796|NCT00467779|10881463|FG004|Stage 1A|Death|0
6870797|NCT00467779|10881464|FG005|Stage 1A|Death|0
6870798|NCT00467779|10881465|FG006|Stage 1A|Death|0
6870799|NCT00467779|10881466|FG007|Stage 1A|Death|0
6870800|NCT00467779|10881467|FG008|Stage 1A|Death|0
6870801|NCT00467779|10881468|FG009|Stage 1A|Death|0
6870802|NCT00467779|10881469|FG010|Stage 1A|Death|0
6870803|NCT00467779|10881470|FG011|Stage 1A|Death|1
6870804|NCT00467779|10881471|FG012|Stage 1A|Death|1
6870805|NCT00467779|10881472|FG013|Stage 1A|Death|0
6870806|NCT00467779|10881473|FG014|Stage 1A|Death|0
6870807|NCT00467779|10881459|FG000|Stage 1A|Disease Progression|0
6870808|NCT00467779|10881460|FG001|Stage 1A|Disease Progression|0
6870809|NCT00467779|10881461|FG002|Stage 1A|Disease Progression|0
6870810|NCT00467779|10881462|FG003|Stage 1A|Disease Progression|0
6870811|NCT00467779|10881463|FG004|Stage 1A|Disease Progression|0
6870812|NCT00467779|10881464|FG005|Stage 1A|Disease Progression|0
6870813|NCT00467779|10881465|FG006|Stage 1A|Disease Progression|0
6870814|NCT00467779|10881466|FG007|Stage 1A|Disease Progression|0
6870815|NCT00467779|10881467|FG008|Stage 1A|Disease Progression|0
6870816|NCT00467779|10881468|FG009|Stage 1A|Disease Progression|2
6870817|NCT00467779|10881469|FG010|Stage 1A|Disease Progression|2
6870818|NCT00467779|10881470|FG011|Stage 1A|Disease Progression|5
6870819|NCT00467779|10881471|FG012|Stage 1A|Disease Progression|2
6870820|NCT00467779|10881472|FG013|Stage 1A|Disease Progression|0
6870821|NCT00467779|10881473|FG014|Stage 1A|Disease Progression|0
6870822|NCT00467779|10881459|FG000|Stage 1A|Physician Decision|0
6870823|NCT00467779|10881460|FG001|Stage 1A|Physician Decision|0
6870824|NCT00467779|10881461|FG002|Stage 1A|Physician Decision|0
6870825|NCT00467779|10881462|FG003|Stage 1A|Physician Decision|0
6870826|NCT00467779|10881463|FG004|Stage 1A|Physician Decision|0
6870827|NCT00467779|10881464|FG005|Stage 1A|Physician Decision|0
6870828|NCT00467779|10881465|FG006|Stage 1A|Physician Decision|0
6870829|NCT00467779|10881466|FG007|Stage 1A|Physician Decision|0
6870830|NCT00467779|10881467|FG008|Stage 1A|Physician Decision|0
6870831|NCT00467779|10881468|FG009|Stage 1A|Physician Decision|1
6870832|NCT00467779|10881469|FG010|Stage 1A|Physician Decision|0
6870833|NCT00467779|10881470|FG011|Stage 1A|Physician Decision|0
6870834|NCT00467779|10881471|FG012|Stage 1A|Physician Decision|0
6870835|NCT00467779|10881472|FG013|Stage 1A|Physician Decision|0
6870836|NCT00467779|10881473|FG014|Stage 1A|Physician Decision|0
6870837|NCT00467779|10881459|FG000|Stage 1A|Withdrawal by Subject|0
6870838|NCT00467779|10881460|FG001|Stage 1A|Withdrawal by Subject|0
6870839|NCT00467779|10881461|FG002|Stage 1A|Withdrawal by Subject|0
6870840|NCT00467779|10881462|FG003|Stage 1A|Withdrawal by Subject|0
6870841|NCT00467779|10881463|FG004|Stage 1A|Withdrawal by Subject|0
6870842|NCT00467779|10881464|FG005|Stage 1A|Withdrawal by Subject|0
6870843|NCT00467779|10881465|FG006|Stage 1A|Withdrawal by Subject|0
6870844|NCT00467779|10881466|FG007|Stage 1A|Withdrawal by Subject|0
6870845|NCT00467779|10881467|FG008|Stage 1A|Withdrawal by Subject|0
6870846|NCT00467779|10881468|FG009|Stage 1A|Withdrawal by Subject|0
6870847|NCT00467779|10881469|FG010|Stage 1A|Withdrawal by Subject|1
6870848|NCT00467779|10881470|FG011|Stage 1A|Withdrawal by Subject|1
6870849|NCT00467779|10881471|FG012|Stage 1A|Withdrawal by Subject|1
6870850|NCT00467779|10881472|FG013|Stage 1A|Withdrawal by Subject|0
6870851|NCT00467779|10881473|FG014|Stage 1A|Withdrawal by Subject|0
6870852|NCT00467779|10881459|FG000|Stage 1A|Unspecified Reason|0
6870853|NCT00467779|10881460|FG001|Stage 1A|Unspecified Reason|0
6870854|NCT00467779|10881461|FG002|Stage 1A|Unspecified Reason|0
6870855|NCT00467779|10881462|FG003|Stage 1A|Unspecified Reason|0
6870856|NCT00467779|10881463|FG004|Stage 1A|Unspecified Reason|0
6870857|NCT00467779|10881464|FG005|Stage 1A|Unspecified Reason|0
6870858|NCT00467779|10881465|FG006|Stage 1A|Unspecified Reason|0
6870859|NCT00467779|10881466|FG007|Stage 1A|Unspecified Reason|0
6870860|NCT00467779|10881467|FG008|Stage 1A|Unspecified Reason|0
6870861|NCT00467779|10881468|FG009|Stage 1A|Unspecified Reason|0
6870862|NCT00467779|10881469|FG010|Stage 1A|Unspecified Reason|0
6870863|NCT00467779|10881470|FG011|Stage 1A|Unspecified Reason|1
6870864|NCT00467779|10881471|FG012|Stage 1A|Unspecified Reason|1
6870865|NCT00467779|10881472|FG013|Stage 1A|Unspecified Reason|0
6870866|NCT00467779|10881473|FG014|Stage 1A|Unspecified Reason|0
6870867|NCT00467779|10881459|FG000|Stage 2|Adverse Event|0
6870868|NCT00467779|10881460|FG001|Stage 2|Adverse Event|0
6870869|NCT00467779|10881461|FG002|Stage 2|Adverse Event|0
6870870|NCT00467779|10881462|FG003|Stage 2|Adverse Event|0
6870871|NCT00467779|10881463|FG004|Stage 2|Adverse Event|0
6870872|NCT00467779|10881464|FG005|Stage 2|Adverse Event|0
6870873|NCT00467779|10881465|FG006|Stage 2|Adverse Event|0
6870874|NCT00467779|10881466|FG007|Stage 2|Adverse Event|0
6870875|NCT00467779|10881467|FG008|Stage 2|Adverse Event|1
6870876|NCT00467779|10881468|FG009|Stage 2|Adverse Event|0
6870877|NCT00467779|10881469|FG010|Stage 2|Adverse Event|0
6870878|NCT00467779|10881470|FG011|Stage 2|Adverse Event|0
6870879|NCT00467779|10881471|FG012|Stage 2|Adverse Event|0
6870880|NCT00467779|10881472|FG013|Stage 2|Adverse Event|0
6870881|NCT00467779|10881473|FG014|Stage 2|Adverse Event|0
6870882|NCT00467779|10881459|FG000|Stage 2|Death|0
6870883|NCT00467779|10881460|FG001|Stage 2|Death|0
6870884|NCT00467779|10881461|FG002|Stage 2|Death|0
6870885|NCT00467779|10881462|FG003|Stage 2|Death|0
6870886|NCT00467779|10881463|FG004|Stage 2|Death|0
6870887|NCT00467779|10881464|FG005|Stage 2|Death|0
6870888|NCT00467779|10881465|FG006|Stage 2|Death|0
6870889|NCT00467779|10881466|FG007|Stage 2|Death|0
6870890|NCT00467779|10881467|FG008|Stage 2|Death|1
6870891|NCT00467779|10881468|FG009|Stage 2|Death|0
6870892|NCT00467779|10881469|FG010|Stage 2|Death|0
6870893|NCT00467779|10881470|FG011|Stage 2|Death|0
6870894|NCT00467779|10881471|FG012|Stage 2|Death|0
6870895|NCT00467779|10881472|FG013|Stage 2|Death|0
6870896|NCT00467779|10881473|FG014|Stage 2|Death|0
6870897|NCT00467779|10881459|FG000|Stage 2|Disease Progression|0
6870898|NCT00467779|10881460|FG001|Stage 2|Disease Progression|0
6870899|NCT00467779|10881461|FG002|Stage 2|Disease Progression|0
6870900|NCT00467779|10881462|FG003|Stage 2|Disease Progression|0
6870901|NCT00467779|10881463|FG004|Stage 2|Disease Progression|0
6870902|NCT00467779|10881464|FG005|Stage 2|Disease Progression|0
6870903|NCT00467779|10881465|FG006|Stage 2|Disease Progression|0
6870904|NCT00467779|10881466|FG007|Stage 2|Disease Progression|0
6870905|NCT00467779|10881467|FG008|Stage 2|Disease Progression|16
6870906|NCT00467779|10881468|FG009|Stage 2|Disease Progression|0
6870907|NCT00467779|10881469|FG010|Stage 2|Disease Progression|0
6870908|NCT00467779|10881470|FG011|Stage 2|Disease Progression|0
6870909|NCT00467779|10881471|FG012|Stage 2|Disease Progression|0
6870910|NCT00467779|10881472|FG013|Stage 2|Disease Progression|0
6870911|NCT00467779|10881473|FG014|Stage 2|Disease Progression|0
6870912|NCT00467779|10881459|FG000|Stage 2|Unspecified Reason|0
6870913|NCT00467779|10881460|FG001|Stage 2|Unspecified Reason|0
6870914|NCT00467779|10881461|FG002|Stage 2|Unspecified Reason|0
6870915|NCT00467779|10881462|FG003|Stage 2|Unspecified Reason|0
6870916|NCT00467779|10881463|FG004|Stage 2|Unspecified Reason|0
6870917|NCT00467779|10881464|FG005|Stage 2|Unspecified Reason|0
6870918|NCT00467779|10881465|FG006|Stage 2|Unspecified Reason|0
7078390|NCT02103478|11186918|FG006|Overall Study|Withdrawal by Subject|1
7078391|NCT02103478|11186919|FG007|Overall Study|Withdrawal by Subject|1
7078392|NCT02103478|11186920|FG008|Overall Study|Withdrawal by Subject|0
7078393|NCT02103478|11186912|FG000|Overall Study|Lost to Follow-up|0
7078394|NCT02103478|11186913|FG001|Overall Study|Lost to Follow-up|0
7078395|NCT02103478|11186914|FG002|Overall Study|Lost to Follow-up|0
7078396|NCT02103478|11186915|FG003|Overall Study|Lost to Follow-up|0
7078397|NCT02103478|11186916|FG004|Overall Study|Lost to Follow-up|0
7078398|NCT02103478|11186917|FG005|Overall Study|Lost to Follow-up|0
7078399|NCT02103478|11186918|FG006|Overall Study|Lost to Follow-up|0
7078400|NCT02103478|11186919|FG007|Overall Study|Lost to Follow-up|1
7078401|NCT02103478|11186920|FG008|Overall Study|Lost to Follow-up|0
7078402|NCT02103478|11186912|FG000|Overall Study|Other|1
7078403|NCT02103478|11186913|FG001|Overall Study|Other|3
7078404|NCT02103478|11186914|FG002|Overall Study|Other|2
7078405|NCT02103478|11186915|FG003|Overall Study|Other|0
6870919|NCT00467779|10881466|FG007|Stage 2|Unspecified Reason|0
6870920|NCT00467779|10881467|FG008|Stage 2|Unspecified Reason|3
6870921|NCT00467779|10881468|FG009|Stage 2|Unspecified Reason|0
6870922|NCT00467779|10881469|FG010|Stage 2|Unspecified Reason|0
6870923|NCT00467779|10881470|FG011|Stage 2|Unspecified Reason|0
6870924|NCT00467779|10881471|FG012|Stage 2|Unspecified Reason|0
6870925|NCT00467779|10881472|FG013|Stage 2|Unspecified Reason|0
6870926|NCT00467779|10881473|FG014|Stage 2|Unspecified Reason|0
6870927|NCT00467779|10881459|FG000|Stage 2A|Adverse Event|0
6870928|NCT00467779|10881460|FG001|Stage 2A|Adverse Event|0
6870929|NCT00467779|10881461|FG002|Stage 2A|Adverse Event|0
6870930|NCT00467779|10881462|FG003|Stage 2A|Adverse Event|0
6870931|NCT00467779|10881463|FG004|Stage 2A|Adverse Event|0
6870932|NCT00467779|10881464|FG005|Stage 2A|Adverse Event|0
6870933|NCT00467779|10881465|FG006|Stage 2A|Adverse Event|0
6870934|NCT00467779|10881466|FG007|Stage 2A|Adverse Event|0
6870935|NCT00467779|10881467|FG008|Stage 2A|Adverse Event|0
6870936|NCT00467779|10881468|FG009|Stage 2A|Adverse Event|0
6870937|NCT00467779|10881469|FG010|Stage 2A|Adverse Event|0
6870938|NCT00467779|10881470|FG011|Stage 2A|Adverse Event|0
6870939|NCT00467779|10881471|FG012|Stage 2A|Adverse Event|0
7078406|NCT02103478|11186916|FG004|Overall Study|Other|3
7078407|NCT02103478|11186917|FG005|Overall Study|Other|8
7078408|NCT02103478|11186918|FG006|Overall Study|Other|8
7078409|NCT02103478|11186919|FG007|Overall Study|Other|4
7078410|NCT02103478|11186920|FG008|Overall Study|Other|2
7078411|NCT02104505|11187011|FG000|First Intervention (14 Days)|Adverse Event|2
6870940|NCT00467779|10881472|FG013|Stage 2A|Adverse Event|2
6870941|NCT00467779|10881473|FG014|Stage 2A|Adverse Event|0
6870942|NCT00467779|10881459|FG000|Stage 2A|Death|0
6870943|NCT00467779|10881460|FG001|Stage 2A|Death|0
6870944|NCT00467779|10881461|FG002|Stage 2A|Death|0
6870945|NCT00467779|10881462|FG003|Stage 2A|Death|0
6870946|NCT00467779|10881463|FG004|Stage 2A|Death|0
6870947|NCT00467779|10881464|FG005|Stage 2A|Death|0
6870948|NCT00467779|10881465|FG006|Stage 2A|Death|0
6870949|NCT00467779|10881466|FG007|Stage 2A|Death|0
6870950|NCT00467779|10881467|FG008|Stage 2A|Death|0
6870951|NCT00467779|10881468|FG009|Stage 2A|Death|0
6870952|NCT00467779|10881469|FG010|Stage 2A|Death|0
6870953|NCT00467779|10881470|FG011|Stage 2A|Death|0
6870954|NCT00467779|10881471|FG012|Stage 2A|Death|0
6870955|NCT00467779|10881472|FG013|Stage 2A|Death|1
6870956|NCT00467779|10881473|FG014|Stage 2A|Death|0
6870957|NCT00467779|10881459|FG000|Stage 2A|Disease Progression|0
6870958|NCT00467779|10881460|FG001|Stage 2A|Disease Progression|0
6870959|NCT00467779|10881461|FG002|Stage 2A|Disease Progression|0
6870960|NCT00467779|10881462|FG003|Stage 2A|Disease Progression|0
6870961|NCT00467779|10881463|FG004|Stage 2A|Disease Progression|0
6870962|NCT00467779|10881464|FG005|Stage 2A|Disease Progression|0
6870963|NCT00467779|10881465|FG006|Stage 2A|Disease Progression|0
6870964|NCT00467779|10881466|FG007|Stage 2A|Disease Progression|0
6870965|NCT00467779|10881467|FG008|Stage 2A|Disease Progression|0
6870966|NCT00467779|10881468|FG009|Stage 2A|Disease Progression|0
6870967|NCT00467779|10881469|FG010|Stage 2A|Disease Progression|0
6870968|NCT00467779|10881470|FG011|Stage 2A|Disease Progression|0
6870969|NCT00467779|10881471|FG012|Stage 2A|Disease Progression|0
6870970|NCT00467779|10881472|FG013|Stage 2A|Disease Progression|10
6870971|NCT00467779|10881473|FG014|Stage 2A|Disease Progression|0
6870972|NCT00467779|10881459|FG000|Stage 2A|Unspecified Reason|0
6870973|NCT00467779|10881460|FG001|Stage 2A|Unspecified Reason|0
6870974|NCT00467779|10881461|FG002|Stage 2A|Unspecified Reason|0
6870975|NCT00467779|10881462|FG003|Stage 2A|Unspecified Reason|0
6870976|NCT00467779|10881463|FG004|Stage 2A|Unspecified Reason|0
6870977|NCT00467779|10881464|FG005|Stage 2A|Unspecified Reason|0
6870978|NCT00467779|10881465|FG006|Stage 2A|Unspecified Reason|0
6870979|NCT00467779|10881466|FG007|Stage 2A|Unspecified Reason|0
6870980|NCT00467779|10881467|FG008|Stage 2A|Unspecified Reason|0
6870981|NCT00467779|10881468|FG009|Stage 2A|Unspecified Reason|0
6870982|NCT00467779|10881469|FG010|Stage 2A|Unspecified Reason|0
6870983|NCT00467779|10881470|FG011|Stage 2A|Unspecified Reason|0
6870984|NCT00467779|10881471|FG012|Stage 2A|Unspecified Reason|0
6870985|NCT00467779|10881472|FG013|Stage 2A|Unspecified Reason|7
6870986|NCT00467779|10881473|FG014|Stage 2A|Unspecified Reason|0
6870987|NCT00467779|10881459|FG000|Stage 2A|Withdrawal by Subject|0
6870988|NCT00467779|10881460|FG001|Stage 2A|Withdrawal by Subject|0
6870989|NCT00467779|10881461|FG002|Stage 2A|Withdrawal by Subject|0
6870990|NCT00467779|10881462|FG003|Stage 2A|Withdrawal by Subject|0
6870991|NCT00467779|10881463|FG004|Stage 2A|Withdrawal by Subject|0
6870992|NCT00467779|10881464|FG005|Stage 2A|Withdrawal by Subject|0
6870993|NCT00467779|10881465|FG006|Stage 2A|Withdrawal by Subject|0
6870994|NCT00467779|10881466|FG007|Stage 2A|Withdrawal by Subject|0
6870995|NCT00467779|10881467|FG008|Stage 2A|Withdrawal by Subject|0
6870996|NCT00467779|10881468|FG009|Stage 2A|Withdrawal by Subject|0
6870997|NCT00467779|10881469|FG010|Stage 2A|Withdrawal by Subject|0
6870998|NCT00467779|10881470|FG011|Stage 2A|Withdrawal by Subject|0
6870999|NCT00467779|10881471|FG012|Stage 2A|Withdrawal by Subject|0
6871000|NCT00467779|10881472|FG013|Stage 2A|Withdrawal by Subject|1
6871001|NCT00467779|10881473|FG014|Stage 2A|Withdrawal by Subject|0
6871002|NCT00467779|10881459|FG000|Stage 3|Adverse Event|0
6871003|NCT00467779|10881460|FG001|Stage 3|Adverse Event|0
6871004|NCT00467779|10881461|FG002|Stage 3|Adverse Event|0
6871005|NCT00467779|10881462|FG003|Stage 3|Adverse Event|0
6871006|NCT00467779|10881463|FG004|Stage 3|Adverse Event|0
6871007|NCT00467779|10881464|FG005|Stage 3|Adverse Event|0
6871008|NCT00467779|10881465|FG006|Stage 3|Adverse Event|0
6871009|NCT00467779|10881466|FG007|Stage 3|Adverse Event|0
6871010|NCT00467779|10881467|FG008|Stage 3|Adverse Event|0
6871011|NCT00467779|10881468|FG009|Stage 3|Adverse Event|0
6871012|NCT00467779|10881469|FG010|Stage 3|Adverse Event|0
6871013|NCT00467779|10881470|FG011|Stage 3|Adverse Event|0
6871014|NCT00467779|10881471|FG012|Stage 3|Adverse Event|0
6871015|NCT00467779|10881472|FG013|Stage 3|Adverse Event|0
6871016|NCT00467779|10881473|FG014|Stage 3|Adverse Event|2
6871017|NCT00467779|10881459|FG000|Stage 3|Death|0
6871018|NCT00467779|10881460|FG001|Stage 3|Death|0
6871019|NCT00467779|10881461|FG002|Stage 3|Death|0
6871020|NCT00467779|10881462|FG003|Stage 3|Death|0
6871021|NCT00467779|10881463|FG004|Stage 3|Death|0
6871022|NCT00467779|10881464|FG005|Stage 3|Death|0
6871023|NCT00467779|10881465|FG006|Stage 3|Death|0
6871024|NCT00467779|10881466|FG007|Stage 3|Death|0
6871025|NCT00467779|10881467|FG008|Stage 3|Death|0
6871026|NCT00467779|10881468|FG009|Stage 3|Death|0
6871027|NCT00467779|10881469|FG010|Stage 3|Death|0
6871028|NCT00467779|10881470|FG011|Stage 3|Death|0
6871029|NCT00467779|10881471|FG012|Stage 3|Death|0
6871030|NCT00467779|10881472|FG013|Stage 3|Death|0
6871031|NCT00467779|10881473|FG014|Stage 3|Death|1
6871032|NCT00467779|10881459|FG000|Stage 3|Disease Progression|0
6871033|NCT00467779|10881460|FG001|Stage 3|Disease Progression|0
6871034|NCT00467779|10881461|FG002|Stage 3|Disease Progression|0
6871035|NCT00467779|10881462|FG003|Stage 3|Disease Progression|0
6871036|NCT00467779|10881463|FG004|Stage 3|Disease Progression|0
6871037|NCT00467779|10881464|FG005|Stage 3|Disease Progression|0
6871038|NCT00467779|10881465|FG006|Stage 3|Disease Progression|0
6871039|NCT00467779|10881466|FG007|Stage 3|Disease Progression|0
6871040|NCT00467779|10881467|FG008|Stage 3|Disease Progression|0
6871041|NCT00467779|10881468|FG009|Stage 3|Disease Progression|0
6871042|NCT00467779|10881469|FG010|Stage 3|Disease Progression|0
6871043|NCT00467779|10881470|FG011|Stage 3|Disease Progression|0
6871044|NCT00467779|10881471|FG012|Stage 3|Disease Progression|0
6871045|NCT00467779|10881472|FG013|Stage 3|Disease Progression|0
6871046|NCT00467779|10881473|FG014|Stage 3|Disease Progression|9
6871047|NCT00467779|10881459|FG000|Stage 3|Unspecified Reason|0
6871048|NCT00467779|10881460|FG001|Stage 3|Unspecified Reason|0
6871049|NCT00467779|10881461|FG002|Stage 3|Unspecified Reason|0
6871050|NCT00467779|10881462|FG003|Stage 3|Unspecified Reason|0
6871051|NCT00467779|10881463|FG004|Stage 3|Unspecified Reason|0
6871052|NCT00467779|10881464|FG005|Stage 3|Unspecified Reason|0
6871053|NCT00467779|10881465|FG006|Stage 3|Unspecified Reason|0
6871054|NCT00467779|10881466|FG007|Stage 3|Unspecified Reason|0
6871055|NCT00467779|10881467|FG008|Stage 3|Unspecified Reason|0
6871056|NCT00467779|10881468|FG009|Stage 3|Unspecified Reason|0
6871057|NCT00467779|10881469|FG010|Stage 3|Unspecified Reason|0
6871058|NCT00467779|10881470|FG011|Stage 3|Unspecified Reason|0
6871059|NCT00467779|10881471|FG012|Stage 3|Unspecified Reason|0
6871060|NCT00467779|10881472|FG013|Stage 3|Unspecified Reason|0
6871061|NCT00467779|10881473|FG014|Stage 3|Unspecified Reason|5
6871062|NCT00467818|10881513|FG000|Overall Study|Adverse Event|1
6871063|NCT00467818|10881514|FG001|Overall Study|Adverse Event|0
6871064|NCT00467818|10881513|FG000|Overall Study|Lost to Follow-up|2
6871065|NCT00467818|10881514|FG001|Overall Study|Lost to Follow-up|2
6871066|NCT00467831|10881522|FG000|Overall Study|Death|2
6871067|NCT00467831|10881522|FG000|Overall Study|Withdrawal by Subject|1
6871068|NCT00467857|10881544|FG000|Overall Study|Adverse Event|1
6871069|NCT00467857|10881545|FG001|Overall Study|Adverse Event|0
6871070|NCT00467857|10881544|FG000|Overall Study|Withdrew consent|2
7078412|NCT02104505|11187012|FG001|First Intervention (14 Days)|Adverse Event|0
7078413|NCT02104505|11187011|FG000|First Intervention (14 Days)|Withdrawal by Subject|0
7078414|NCT02104505|11187012|FG001|First Intervention (14 Days)|Withdrawal by Subject|1
7078415|NCT02104505|11187011|FG000|First Intervention (14 Days)|Lost to Follow-up|0
7078416|NCT02104505|11187012|FG001|First Intervention (14 Days)|Lost to Follow-up|1
7078417|NCT02104505|11187011|FG000|First Intervention (14 Days)|exclusionary condition|0
7078418|NCT02104505|11187012|FG001|First Intervention (14 Days)|exclusionary condition|1
7078419|NCT02104505|11187011|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0
7078420|NCT02104505|11187012|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1
7078421|NCT02104505|11187011|FG000|Second Intervention (14 Days)|Adverse Event|2
7078422|NCT02104505|11187012|FG001|Second Intervention (14 Days)|Adverse Event|0
7078423|NCT02104557|11187019|FG000|Overall Study|Adverse Event|24
7078424|NCT02104557|11187019|FG000|Overall Study|Lost to Follow-up|34
6871071|NCT00467857|10881545|FG001|Overall Study|Withdrew consent|0
6871072|NCT00467857|10881544|FG000|Overall Study|Death|0
6871073|NCT00467857|10881545|FG001|Overall Study|Death|1
6871074|NCT00467857|10881544|FG000|Overall Study|Discharged from court service|0
6871075|NCT00467857|10881545|FG001|Overall Study|Discharged from court service|1
6871076|NCT00467857|10881544|FG000|Overall Study|Emergency care required|0
6871077|NCT00467857|10881545|FG001|Overall Study|Emergency care required|1
6871078|NCT00467857|10881544|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0
6871079|NCT00467857|10881545|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2
6871080|NCT00467857|10881544|FG000|Overall Study|Discontinuation reason missing|0
6871081|NCT00467857|10881545|FG001|Overall Study|Discontinuation reason missing|3
6871082|NCT00467870|10881557|FG000|Overall Study|Adverse Event|13
6871083|NCT00467870|10881558|FG001|Overall Study|Adverse Event|9
6871084|NCT00467870|10881559|FG002|Overall Study|Adverse Event|1
6871085|NCT00467870|10881560|FG003|Overall Study|Adverse Event|15
6871086|NCT00467870|10881561|FG004|Overall Study|Adverse Event|15
6871087|NCT00467870|10881562|FG005|Overall Study|Adverse Event|1
6871088|NCT00467870|10881557|FG000|Overall Study|Protocol Violation|2
6871089|NCT00467870|10881558|FG001|Overall Study|Protocol Violation|1
7078425|NCT02104557|11187019|FG000|Overall Study|Violated the usage and dosage|14
6871090|NCT00467870|10881559|FG002|Overall Study|Protocol Violation|1
6871091|NCT00467870|10881560|FG003|Overall Study|Protocol Violation|2
6871092|NCT00467870|10881561|FG004|Overall Study|Protocol Violation|0
6871093|NCT00467870|10881562|FG005|Overall Study|Protocol Violation|0
6871094|NCT00467870|10881557|FG000|Overall Study|Withdrawal by Subject|14
6871095|NCT00467870|10881558|FG001|Overall Study|Withdrawal by Subject|21
6871096|NCT00467870|10881559|FG002|Overall Study|Withdrawal by Subject|0
6871097|NCT00467870|10881560|FG003|Overall Study|Withdrawal by Subject|9
6871098|NCT00467870|10881561|FG004|Overall Study|Withdrawal by Subject|10
6871099|NCT00467870|10881562|FG005|Overall Study|Withdrawal by Subject|1
6871100|NCT00467870|10881557|FG000|Overall Study|Lost to Follow-up|5
6871101|NCT00467870|10881558|FG001|Overall Study|Lost to Follow-up|3
6871102|NCT00467870|10881559|FG002|Overall Study|Lost to Follow-up|1
7078426|NCT02104557|11187019|FG000|Overall Study|No longer met inclusion/exclusion criteria|1
7082999|NCT02147353|11193744|FG000|Overall Study|medication noncompliance|3
6871103|NCT00467870|10881560|FG003|Overall Study|Lost to Follow-up|1
6871104|NCT00467870|10881561|FG004|Overall Study|Lost to Follow-up|3
6871105|NCT00467870|10881562|FG005|Overall Study|Lost to Follow-up|0
6871106|NCT00467870|10881557|FG000|Overall Study|Subject Non-compliance|3
6871107|NCT00467870|10881558|FG001|Overall Study|Subject Non-compliance|4
6871108|NCT00467870|10881559|FG002|Overall Study|Subject Non-compliance|0
6871109|NCT00467870|10881560|FG003|Overall Study|Subject Non-compliance|1
6871110|NCT00467870|10881561|FG004|Overall Study|Subject Non-compliance|5
6871111|NCT00467870|10881562|FG005|Overall Study|Subject Non-compliance|0
6871112|NCT00467870|10881557|FG000|Overall Study|Other/Unknown|8
6871113|NCT00467870|10881558|FG001|Overall Study|Other/Unknown|5
6871114|NCT00467870|10881559|FG002|Overall Study|Other/Unknown|1
6871115|NCT00467870|10881560|FG003|Overall Study|Other/Unknown|5
6871116|NCT00467870|10881561|FG004|Overall Study|Other/Unknown|4
6871117|NCT00467870|10881562|FG005|Overall Study|Other/Unknown|0
6871118|NCT00467896|10881572|FG000|Overall Study|Consent Withdrawal|18
6871119|NCT00467896|10881572|FG000|Overall Study|Adverse Event|7
6871120|NCT00467896|10881572|FG000|Overall Study|Serious Adverse Event|13
6871121|NCT00467896|10881572|FG000|Overall Study|Non-compliance|3
6871122|NCT00467896|10881572|FG000|Overall Study|Changed therapy|2
6871123|NCT00467896|10881572|FG000|Overall Study|Patient received transplant|2
6871124|NCT00467896|10881572|FG000|Overall Study|Patient had atrial septostomy|1
6871125|NCT00467896|10881572|FG000|Overall Study|Patient weaned off iloprost|1
6871126|NCT00467896|10881572|FG000|Overall Study|Mainly used Prodose not I-neb® device|1
6871127|NCT00467896|10881572|FG000|Overall Study|Started intravenous prostacyclin|1
6871128|NCT00467896|10881572|FG000|Overall Study|Started inhaled Remodulin|1
6871129|NCT00467896|10881572|FG000|Overall Study|Patient had no improvement|1
6871130|NCT00467961|10881578|FG000|Overall Study|Technical Failures|5
6871131|NCT00467961|10881578|FG000|Overall Study|Disease Progression|2
6871132|NCT00468052|10881584|FG000|Overall Study|Protocol Violation|7
6871133|NCT00468052|10881585|FG001|Overall Study|Protocol Violation|8
6871134|NCT00468104|10881593|FG000|First Intervention|Protocol Violation|2
6871135|NCT00468104|10881594|FG001|First Intervention|Protocol Violation|1
6871136|NCT00468104|10881593|FG000|First Intervention|bleeding at chest tube site--first dose|1
6871137|NCT00468104|10881594|FG001|First Intervention|bleeding at chest tube site--first dose|0
6871138|NCT00468104|10881593|FG000|First Intervention|died within 3 weeks|1
6871139|NCT00468104|10881594|FG001|First Intervention|died within 3 weeks|0
6871140|NCT00468104|10881593|FG000|First Intervention|malposition/blocked chest tube tube|2
6871141|NCT00468104|10881594|FG001|First Intervention|malposition/blocked chest tube tube|0
6871142|NCT00468104|10881593|FG000|First Intervention|large lung mass with minimal effusion|1
6871143|NCT00468104|10881594|FG001|First Intervention|large lung mass with minimal effusion|0
6871144|NCT00468104|10881593|FG000|First Intervention|associated prolonged pneumothorax|1
6871145|NCT00468104|10881594|FG001|First Intervention|associated prolonged pneumothorax|0
6871146|NCT00468104|10881593|FG000|First Intervention|trapped lung|1
6871147|NCT00468104|10881594|FG001|First Intervention|trapped lung|0
6871148|NCT00468104|10881593|FG000|Second Intervention|Withdrawal by Subject|5
6871149|NCT00468104|10881594|FG001|Second Intervention|Withdrawal by Subject|2
6871150|NCT00468104|10881593|FG000|Second Intervention|discarded for malposition of chest tube|0
6871151|NCT00468104|10881594|FG001|Second Intervention|discarded for malposition of chest tube|2
6871152|NCT00468143|10881603|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3
6871153|NCT00468143|10881604|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4
6871154|NCT00468143|10881603|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3
6871155|NCT00468143|10881604|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3
6871156|NCT00468169|10881612|FG000|Overall Study|Withdrawal by Subject|1
6871157|NCT00468169|10881613|FG001|Overall Study|Withdrawal by Subject|0
6871158|NCT00468286|10881627|FG000|Overall Study|Adverse Event|1
6871159|NCT00468286|10881628|FG001|Overall Study|Adverse Event|6
6871160|NCT00468286|10881627|FG000|Overall Study|Protocol Violation|2
6871161|NCT00468286|10881628|FG001|Overall Study|Protocol Violation|2
6871162|NCT00468286|10881627|FG000|Overall Study|Withdrawal by Subject|4
6871163|NCT00468286|10881628|FG001|Overall Study|Withdrawal by Subject|3
6871164|NCT00468286|10881627|FG000|Overall Study|Physician Decision|0
6871165|NCT00468286|10881628|FG001|Overall Study|Physician Decision|1
6871166|NCT00468299|10881636|FG000|Overall Study|Withdrawal by Subject|0
6871167|NCT00468299|10881637|FG001|Overall Study|Withdrawal by Subject|1
6871168|NCT00468481|10881647|FG000|Overall Study|Adverse Event|13
6871169|NCT00468481|10881648|FG001|Overall Study|Adverse Event|3
6871170|NCT00468481|10881647|FG000|Overall Study|Lost to Follow-up|25
6871171|NCT00468481|10881648|FG001|Overall Study|Lost to Follow-up|8
6871172|NCT00468481|10881647|FG000|Overall Study|Pregnancy|2
6871173|NCT00468481|10881648|FG001|Overall Study|Pregnancy|0
6871174|NCT00468481|10881647|FG000|Overall Study|Protocol Violation|18
6871175|NCT00468481|10881648|FG001|Overall Study|Protocol Violation|8
6871176|NCT00468481|10881647|FG000|Overall Study|Withdrawal by Subject|12
6871177|NCT00468481|10881648|FG001|Overall Study|Withdrawal by Subject|3
6871178|NCT00468481|10881647|FG000|Overall Study|susp/diag malignant/premalignant disease|1
6871179|NCT00468481|10881648|FG001|Overall Study|susp/diag malignant/premalignant disease|0
6871180|NCT00468481|10881647|FG000|Overall Study|Prohibited Medication|1
6871181|NCT00468481|10881648|FG001|Overall Study|Prohibited Medication|1
6871182|NCT00468481|10881647|FG000|Overall Study|Egg Donor|1
6871183|NCT00468481|10881648|FG001|Overall Study|Egg Donor|0
6871184|NCT00468481|10881647|FG000|Overall Study|Moved out of area|4
6871185|NCT00468481|10881648|FG001|Overall Study|Moved out of area|1
6871186|NCT00468481|10881647|FG000|Overall Study|Non-Compliance|5
6871187|NCT00468481|10881648|FG001|Overall Study|Non-Compliance|0
6871188|NCT00468481|10881647|FG000|Overall Study|Other|6
6871189|NCT00468481|10881648|FG001|Overall Study|Other|0
6871190|NCT00468546|10881656|FG000|Week 24 Analysis|Lack of Efficacy|83
6871191|NCT00468546|10881657|FG001|Week 24 Analysis|Lack of Efficacy|37
6871192|NCT00468546|10881656|FG000|Week 24 Analysis|Refused treatment|5
6871193|NCT00468546|10881657|FG001|Week 24 Analysis|Refused treatment|5
6871194|NCT00468546|10881656|FG000|Week 24 Analysis|Adverse Event|1
6871195|NCT00468546|10881657|FG001|Week 24 Analysis|Adverse Event|8
6871196|NCT00468546|10881656|FG000|Week 24 Analysis|Failure to return|3
6871197|NCT00468546|10881657|FG001|Week 24 Analysis|Failure to return|4
6871198|NCT00468546|10881656|FG000|Week 24 Analysis|Rescue therapy|2
6871199|NCT00468546|10881657|FG001|Week 24 Analysis|Rescue therapy|0
6871200|NCT00468546|10881656|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0
6871201|NCT00468546|10881657|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1
6871202|NCT00468546|10881656|FG000|Week 24 Analysis|Due to clinical hold|1
6871203|NCT00468546|10881657|FG001|Week 24 Analysis|Due to clinical hold|0
6871204|NCT00468546|10881656|FG000|Week 24 Analysis|Went onto rescue therapy|1
6871205|NCT00468546|10881657|FG001|Week 24 Analysis|Went onto rescue therapy|0
6871206|NCT00468546|10881656|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1
6871207|NCT00468546|10881657|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0
6871208|NCT00468546|10881656|FG000|Week 24 to Week 104 Analysis|Adverse Event|2
6871209|NCT00468546|10881657|FG001|Week 24 to Week 104 Analysis|Adverse Event|5
6871210|NCT00468546|10881656|FG000|Week 24 to Week 104 Analysis|Death|1
6871211|NCT00468546|10881657|FG001|Week 24 to Week 104 Analysis|Death|0
6871212|NCT00468546|10881656|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3
6871213|NCT00468546|10881657|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12
6871214|NCT00468546|10881656|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0
6871215|NCT00468546|10881657|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2
6871216|NCT00468546|10881656|FG000|Week 24 to Week 104 Analysis|Refused treatment|4
6871217|NCT00468546|10881657|FG001|Week 24 to Week 104 Analysis|Refused treatment|7
6871218|NCT00468546|10881656|FG000|Week 24 to Week 104 Analysis|Failure to return|1
6871219|NCT00468546|10881657|FG001|Week 24 to Week 104 Analysis|Failure to return|2
6871220|NCT00468546|10881656|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77
6871221|NCT00468546|10881657|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183
6871222|NCT00468546|10881656|FG000|Week 24 to Week 104 Analysis|Other|17
6871223|NCT00468546|10881657|FG001|Week 24 to Week 104 Analysis|Other|14
6871224|NCT00468559|10881665|FG000|Open-label Treatment Phase|Adverse Event|5
6871225|NCT00468559|10881666|FG001|Open-label Treatment Phase|Adverse Event|0
6871226|NCT00468559|10881667|FG002|Open-label Treatment Phase|Adverse Event|0
6871227|NCT00468559|10881665|FG000|Open-label Treatment Phase|Lack of Efficacy|9
6871228|NCT00468559|10881666|FG001|Open-label Treatment Phase|Lack of Efficacy|0
6871229|NCT00468559|10881667|FG002|Open-label Treatment Phase|Lack of Efficacy|0
6871230|NCT00468559|10881665|FG000|Open-label Treatment Phase|Withdrawal by Subject|4
6871231|NCT00468559|10881666|FG001|Open-label Treatment Phase|Withdrawal by Subject|0
6871232|NCT00468559|10881667|FG002|Open-label Treatment Phase|Withdrawal by Subject|0
6871233|NCT00468559|10881665|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0
6871234|NCT00468559|10881666|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8
6871235|NCT00468559|10881667|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17
6871236|NCT00468559|10881665|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
6871237|NCT00468559|10881666|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2
6871238|NCT00468559|10881667|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
6871239|NCT00468585|10881679|FG000|Overall Study|Patient not treated|1
6871240|NCT00468585|10881680|FG001|Overall Study|Patient not treated|0
6871241|NCT00468585|10881681|FG002|Overall Study|Patient not treated|1
6871242|NCT00468585|10881682|FG003|Overall Study|Patient not treated|0
6871243|NCT00468585|10881679|FG000|Overall Study|Patient found to be ineligible|0
6871244|NCT00468585|10881680|FG001|Overall Study|Patient found to be ineligible|0
6871245|NCT00468585|10881681|FG002|Overall Study|Patient found to be ineligible|1
6871246|NCT00468585|10881682|FG003|Overall Study|Patient found to be ineligible|0
7078427|NCT02104557|11187019|FG000|Overall Study|Administered Sayana prior to the contract|1
7078428|NCT02104557|11187019|FG000|Overall Study|Other|17
6871247|NCT00468585|10881679|FG000|Overall Study|Adverse Event|0
6871248|NCT00468585|10881680|FG001|Overall Study|Adverse Event|0
6871249|NCT00468585|10881681|FG002|Overall Study|Adverse Event|1
6871250|NCT00468585|10881682|FG003|Overall Study|Adverse Event|0
6871251|NCT00468585|10881679|FG000|Overall Study|Withdrawal by Subject|0
6871252|NCT00468585|10881680|FG001|Overall Study|Withdrawal by Subject|0
6871253|NCT00468585|10881681|FG002|Overall Study|Withdrawal by Subject|2
6871254|NCT00468585|10881682|FG003|Overall Study|Withdrawal by Subject|1
6871255|NCT00468650|10881692|FG000|Overall Study|Lost to Follow-up|4
6871256|NCT00468650|10881692|FG000|Overall Study|Withdrawal by Subject|2
7078429|NCT02104557|11187019|FG000|Overall Study|Change to other contraception methods|5
6871257|NCT00468650|10881692|FG000|Overall Study|Protocol Violation|1
6871258|NCT00468676|10881699|FG000|Overall Study|Lost to Follow-up|14
6871259|NCT00468676|10881700|FG001|Overall Study|Lost to Follow-up|11
6871260|NCT00468676|10881699|FG000|Overall Study|Death|2
6871261|NCT00468676|10881700|FG001|Overall Study|Death|1
6871262|NCT00468728|10881710|FG000|Treatment|criteria for mITT population|4
6871263|NCT00468728|10881711|FG001|Treatment|criteria for mITT population|11
6871264|NCT00468728|10881710|FG000|Follow-up|mITT failure|34
6871265|NCT00468728|10881711|FG001|Follow-up|mITT failure|31
6871266|NCT00468819|10881722|FG000|Overall Study|Withdrawal by Subject|4
6871267|NCT00468819|10881723|FG001|Overall Study|Withdrawal by Subject|0
6871268|NCT00468819|10881724|FG002|Overall Study|Withdrawal by Subject|1
6871269|NCT00468819|10881722|FG000|Overall Study|Lost to Follow-up|0
6871270|NCT00468819|10881723|FG001|Overall Study|Lost to Follow-up|0
6871271|NCT00468819|10881724|FG002|Overall Study|Lost to Follow-up|1
6871272|NCT00468819|10881722|FG000|Overall Study|Drop-outs (Treatment never received)|2
6871273|NCT00468819|10881723|FG001|Overall Study|Drop-outs (Treatment never received)|0
6871274|NCT00468819|10881724|FG002|Overall Study|Drop-outs (Treatment never received)|0
6871275|NCT00468845|10881737|FG000|Overall Study|Adverse Event|9
6871276|NCT00468845|10881738|FG001|Overall Study|Adverse Event|14
6871277|NCT00468845|10881739|FG002|Overall Study|Adverse Event|11
6871278|NCT00468845|10881737|FG000|Overall Study|Lost to Follow-up|2
6871279|NCT00468845|10881738|FG001|Overall Study|Lost to Follow-up|1
6871280|NCT00468845|10881739|FG002|Overall Study|Lost to Follow-up|2
6871281|NCT00468845|10881737|FG000|Overall Study|Other|4
6871282|NCT00468845|10881738|FG001|Overall Study|Other|9
6871283|NCT00468845|10881739|FG002|Overall Study|Other|5
6871284|NCT00468845|10881737|FG000|Overall Study|No longer willing to participate|5
6871285|NCT00468845|10881738|FG001|Overall Study|No longer willing to participate|6
7078430|NCT02104557|11187019|FG000|Overall Study|Discontinuation due to no pain|1
7078431|NCT02104557|11187019|FG000|Overall Study|Withdrawal consent|2
7078432|NCT02104557|11187019|FG000|Overall Study|Refusal of administration due to unknown reasons|69
7078433|NCT02104557|11187019|FG000|Overall Study|Discontinuation of contraception|9
7078434|NCT02104583|11187028|FG000|Overall Study|New ICD or CRT-D implanted|2
6871286|NCT00468845|10881739|FG002|Overall Study|No longer willing to participate|10
6871287|NCT00468845|10881737|FG000|Overall Study|Randomized, not treated|1
6871288|NCT00468845|10881738|FG001|Overall Study|Randomized, not treated|4
6871289|NCT00468845|10881739|FG002|Overall Study|Randomized, not treated|2
6871290|NCT00468858|10881750|FG000|Overall Study|Adverse Event|0
6871291|NCT00468858|10881751|FG001|Overall Study|Adverse Event|1
6871292|NCT00468858|10881752|FG002|Overall Study|Adverse Event|0
6871293|NCT00468858|10881750|FG000|Overall Study|Withdrawal by Subject|7
6871294|NCT00468858|10881751|FG001|Overall Study|Withdrawal by Subject|4
6871295|NCT00468858|10881752|FG002|Overall Study|Withdrawal by Subject|5
6871296|NCT00468858|10881750|FG000|Overall Study|Relocation|1
6871297|NCT00468858|10881751|FG001|Overall Study|Relocation|3
6871298|NCT00468858|10881752|FG002|Overall Study|Relocation|3
6871299|NCT00468858|10881750|FG000|Overall Study|Lost to Follow-up|1
6871300|NCT00468858|10881751|FG001|Overall Study|Lost to Follow-up|2
6871301|NCT00468858|10881752|FG002|Overall Study|Lost to Follow-up|5
6871302|NCT00468858|10881750|FG000|Overall Study|Other|0
6871303|NCT00468858|10881751|FG001|Overall Study|Other|0
6871304|NCT00468858|10881752|FG002|Overall Study|Other|1
6871305|NCT00468910|10881816|FG000|Overall Study|Lost to Follow-up|2
6871306|NCT00468910|10881817|FG001|Overall Study|Lost to Follow-up|1
6871307|NCT00468910|10881816|FG000|Overall Study|Withdrawal by Subject|2
6871308|NCT00468910|10881817|FG001|Overall Study|Withdrawal by Subject|1
6871309|NCT00468910|10881816|FG000|Overall Study|Medical Contraindication|0
6871310|NCT00468910|10881817|FG001|Overall Study|Medical Contraindication|1
6871311|NCT00469014|10881828|FG000|Initial Phase Randomization|Disease Progression|0
6871312|NCT00469014|10881829|FG001|Initial Phase Randomization|Disease Progression|1
6871313|NCT00469014|10881830|FG002|Initial Phase Randomization|Disease Progression|1
6871314|NCT00469014|10881831|FG003|Initial Phase Randomization|Disease Progression|0
6871315|NCT00469014|10881828|FG000|Initial Phase Randomization|No Response|1
6871316|NCT00469014|10881829|FG001|Initial Phase Randomization|No Response|0
6871317|NCT00469014|10881830|FG002|Initial Phase Randomization|No Response|0
6871318|NCT00469014|10881831|FG003|Initial Phase Randomization|No Response|1
6871319|NCT00469014|10881828|FG000|Adaptive Randomization|Not Evaluable|1
6871320|NCT00469014|10881829|FG001|Adaptive Randomization|Not Evaluable|0
6871321|NCT00469014|10881830|FG002|Adaptive Randomization|Not Evaluable|0
6871322|NCT00469014|10881831|FG003|Adaptive Randomization|Not Evaluable|1
6871323|NCT00469014|10881828|FG000|Adaptive Randomization|No Response|0
6871324|NCT00469014|10881829|FG001|Adaptive Randomization|No Response|1
6871325|NCT00469014|10881830|FG002|Adaptive Randomization|No Response|0
6871326|NCT00469014|10881831|FG003|Adaptive Randomization|No Response|0
6871327|NCT00469014|10881828|FG000|Adaptive Randomization|Death|0
6871328|NCT00469014|10881829|FG001|Adaptive Randomization|Death|0
6871329|NCT00469014|10881830|FG002|Adaptive Randomization|Death|1
6871330|NCT00469014|10881831|FG003|Adaptive Randomization|Death|0
6871331|NCT00469079|10881844|FG000|Overall Study|Lack of Efficacy|3
6871332|NCT00469079|10881845|FG001|Overall Study|Lack of Efficacy|8
7078435|NCT02104583|11187029|FG001|Overall Study|New ICD or CRT-D implanted|0
6871333|NCT00469079|10881846|FG002|Overall Study|Lack of Efficacy|5
6871334|NCT00469079|10881844|FG000|Overall Study|Adverse Event|1
6871335|NCT00469079|10881845|FG001|Overall Study|Adverse Event|3
6871336|NCT00469079|10881846|FG002|Overall Study|Adverse Event|2
6871337|NCT00469079|10881844|FG000|Overall Study|Lost to Follow-up|4
6871338|NCT00469079|10881845|FG001|Overall Study|Lost to Follow-up|8
6871339|NCT00469079|10881846|FG002|Overall Study|Lost to Follow-up|10
6871340|NCT00469079|10881844|FG000|Overall Study|Withdrawal by Subject|1
6871341|NCT00469079|10881845|FG001|Overall Study|Withdrawal by Subject|2
6871342|NCT00469079|10881846|FG002|Overall Study|Withdrawal by Subject|2
6871343|NCT00469079|10881844|FG000|Overall Study|Ineligible|0
6871344|NCT00469079|10881845|FG001|Overall Study|Ineligible|1
6871345|NCT00469079|10881846|FG002|Overall Study|Ineligible|0
6871346|NCT00469092|10881862|FG000|Overall Study|Adverse Event|5
6871347|NCT00469092|10881863|FG001|Overall Study|Adverse Event|4
6871348|NCT00469092|10881862|FG000|Overall Study|Lack of Efficacy|1
6871349|NCT00469092|10881863|FG001|Overall Study|Lack of Efficacy|0
6871350|NCT00469092|10881862|FG000|Overall Study|Lost to Follow-up|1
6871351|NCT00469092|10881863|FG001|Overall Study|Lost to Follow-up|2
6871352|NCT00469092|10881862|FG000|Overall Study|Protocol Violation|3
6871353|NCT00469092|10881863|FG001|Overall Study|Protocol Violation|3
6871354|NCT00469092|10881862|FG000|Overall Study|Withdrawal by Subject|4
6871355|NCT00469092|10881863|FG001|Overall Study|Withdrawal by Subject|4
6871356|NCT00469092|10881862|FG000|Overall Study|Withdrawal Criteria|3
6871357|NCT00469092|10881863|FG001|Overall Study|Withdrawal Criteria|4
6871358|NCT00469092|10881862|FG000|Overall Study|Incorrectly Randomised|4
6871359|NCT00469092|10881863|FG001|Overall Study|Incorrectly Randomised|3
6871360|NCT00469092|10881862|FG000|Overall Study|Contraindication metformin/glimepiride|1
6871361|NCT00469092|10881863|FG001|Overall Study|Contraindication metformin/glimepiride|0
6871362|NCT00469092|10881862|FG000|Overall Study|Use of lipid lowering drug|1
6871363|NCT00469092|10881863|FG001|Overall Study|Use of lipid lowering drug|0
6871364|NCT00469092|10881862|FG000|Overall Study|Hypoglycaemic Episodes|1
6871365|NCT00469092|10881863|FG001|Overall Study|Hypoglycaemic Episodes|1
6871366|NCT00469092|10881862|FG000|Overall Study|Abnormal lab value|1
6871367|NCT00469092|10881863|FG001|Overall Study|Abnormal lab value|0
6871368|NCT00469092|10881862|FG000|Overall Study|Use of Corticosteroid|1
6871369|NCT00469092|10881863|FG001|Overall Study|Use of Corticosteroid|0
6871370|NCT00469144|10881871|FG000|Overall Study|Death|0
6871371|NCT00469144|10881872|FG001|Overall Study|Death|1
6871372|NCT00469144|10881871|FG000|Overall Study|No Response|5
6871373|NCT00469144|10881872|FG001|Overall Study|No Response|5
6871374|NCT00469144|10881871|FG000|Overall Study|Progressive Disease|1
6871375|NCT00469144|10881872|FG001|Overall Study|Progressive Disease|0
6871376|NCT00469209|10881885|FG000|Overall Study|Adverse Event|1
6871377|NCT00469209|10881886|FG001|Overall Study|Adverse Event|0
6871378|NCT00469209|10881887|FG002|Overall Study|Adverse Event|1
6871379|NCT00469456|10881915|FG000|Overall Study|Adverse Event|4
6871380|NCT00469456|10881916|FG001|Overall Study|Adverse Event|3
6871381|NCT00469456|10881915|FG000|Overall Study|Protocol Violation|1
6871382|NCT00469456|10881916|FG001|Overall Study|Protocol Violation|0
6871383|NCT00469456|10881915|FG000|Overall Study|Withdrawal by Subject|4
6871384|NCT00469456|10881916|FG001|Overall Study|Withdrawal by Subject|1
6871385|NCT00469833|10881931|FG000|Overall Study|No IV access|2
6871386|NCT00469859|10881943|FG000|Overall Study|Inevaluable|0
6871387|NCT00469859|10881944|FG001|Overall Study|Inevaluable|2
6871388|NCT00469898|10881950|FG000|Overall Study|Adverse Event|7
6871389|NCT00469898|10881950|FG000|Overall Study|Withdrawal by Subject|4
6871390|NCT00469898|10881950|FG000|Overall Study|Death|4
6871391|NCT00469898|10881950|FG000|Overall Study|Disease progression|9
6871392|NCT00469898|10881950|FG000|Overall Study|Decreased performance status|1
6871393|NCT00470054|10881962|FG000|Overall Study|Ineligible|1
6871394|NCT00470093|10881966|FG000|Overall Study|Adverse Event|2
6871395|NCT00470158|10881996|FG000|Overall Study|Death|0
6871396|NCT00470158|10881997|FG001|Overall Study|Death|0
6871397|NCT00470158|10881998|FG002|Overall Study|Death|0
6871398|NCT00470158|10881999|FG003|Overall Study|Death|0
6871399|NCT00470158|10882000|FG004|Overall Study|Death|2
6871400|NCT00470158|10881996|FG000|Overall Study|Lost to Follow-up|7
6871401|NCT00470158|10881997|FG001|Overall Study|Lost to Follow-up|8
6871402|NCT00470158|10881998|FG002|Overall Study|Lost to Follow-up|8
6871403|NCT00470158|10881999|FG003|Overall Study|Lost to Follow-up|5
6871404|NCT00470158|10882000|FG004|Overall Study|Lost to Follow-up|4
6871405|NCT00470158|10881996|FG000|Overall Study|Protocol Violation|1
6871406|NCT00470158|10881997|FG001|Overall Study|Protocol Violation|0
6871407|NCT00470158|10881998|FG002|Overall Study|Protocol Violation|0
6871408|NCT00470158|10881999|FG003|Overall Study|Protocol Violation|0
6871409|NCT00470158|10882000|FG004|Overall Study|Protocol Violation|0
6871410|NCT00470184|10882012|FG000|Overall Study|Not Treated(became ineligible)|4
6871411|NCT00470184|10882012|FG000|Overall Study|Not treated (other)|1
6871412|NCT00470184|10882012|FG000|Overall Study|disease Progression|4
6871413|NCT00470184|10882012|FG000|Overall Study|Adverse Event|3
6871414|NCT00470184|10882012|FG000|Overall Study|Withdrawal by Subject|4
6871415|NCT00470184|10882012|FG000|Overall Study|other|5
6871416|NCT00470184|10882012|FG000|Overall Study|recurrence|1
6871417|NCT00470262|10882019|FG000|Overall Study|Withdrawal by Subject|2
6871418|NCT00470262|10882020|FG001|Overall Study|Withdrawal by Subject|0
6871419|NCT00470275|10882027|FG000|Overall Study|Death|1
6871420|NCT00470275|10882027|FG000|Overall Study|Lack of Efficacy|7
6871421|NCT00470275|10882027|FG000|Overall Study|Withdrawal by Subject|2
6871422|NCT00470366|10882036|FG000|Overall Study|Adverse Event|3
6871423|NCT00470366|10882036|FG000|Overall Study|Poor compliance|1
6871424|NCT00470418|10882052|FG000|Overall Study|Withdrawal by Subject|1
6871425|NCT00470418|10882053|FG001|Overall Study|Withdrawal by Subject|0
6871426|NCT00470470|10882059|FG000|Overall Study|Adverse Event|2
6871427|NCT00470470|10882059|FG000|Overall Study|Death|2
6871428|NCT00470470|10882059|FG000|Overall Study|Not treated|1
6871429|NCT00470535|10882063|FG000|Overall Study|Disease Progression|13
6871430|NCT00470535|10882063|FG000|Overall Study|Withdrawal by Subject|1
6871431|NCT00470535|10882063|FG000|Overall Study|Adverse Event|1
6871432|NCT00470535|10882063|FG000|Overall Study|Death|1
6871433|NCT00470535|10882063|FG000|Overall Study|Other|2
6968583|NCT01140061|11017589|FG000|Extension|Laboratory Adverse Event|0
6968584|NCT01140061|11017590|FG001|Extension|Laboratory Adverse Event|0
6968585|NCT01140061|11017591|FG002|Extension|Laboratory Adverse Event|0
6968586|NCT01140061|11017592|FG003|Extension|Laboratory Adverse Event|0
6968587|NCT01140061|11017593|FG004|Extension|Laboratory Adverse Event|0
6968588|NCT01140061|11017594|FG005|Extension|Laboratory Adverse Event|0
6968589|NCT01140061|11017595|FG006|Extension|Laboratory Adverse Event|0
6968590|NCT01140061|11017596|FG007|Extension|Laboratory Adverse Event|0
6968591|NCT01140061|11017597|FG008|Extension|Laboratory Adverse Event|0
6968592|NCT01140061|11017598|FG009|Extension|Laboratory Adverse Event|1
6968593|NCT01140347|11017630|FG000|Overall Study|Lost to Follow-up|5
6968594|NCT01140347|11017631|FG001|Overall Study|Lost to Follow-up|6
6968595|NCT01140347|11017630|FG000|Overall Study|Withdrawal by Subject|13
6968596|NCT01140347|11017631|FG001|Overall Study|Withdrawal by Subject|8
6968597|NCT01140477|11017643|FG000|Overall Study|Lost to Follow-up|4
6968598|NCT01140477|11017644|FG001|Overall Study|Lost to Follow-up|0
6968599|NCT01140477|11017643|FG000|Overall Study|Withdrawal by Subject|1
6968600|NCT01140477|11017644|FG001|Overall Study|Withdrawal by Subject|4
6968601|NCT01140477|11017643|FG000|Overall Study|Surgical complication preventing implant|2
6968602|NCT01140477|11017644|FG001|Overall Study|Surgical complication preventing implant|0
6968603|NCT01140477|11017643|FG000|Overall Study|Death|1
6968604|NCT01140477|11017644|FG001|Overall Study|Death|1
6968605|NCT01140477|11017643|FG000|Overall Study|Subject explanted|0
6968606|NCT01140477|11017644|FG001|Overall Study|Subject explanted|1
6968607|NCT01140503|11017650|FG000|Overall Study|Withdrawal by Subject|1
6968608|NCT01140568|11017654|FG000|Overall Study|disease progression|31
6968609|NCT01140568|11017654|FG000|Overall Study|Withdrawal by Subject|1
7078436|NCT02104583|11187030|FG002|Overall Study|New ICD or CRT-D implanted|1
7078437|NCT02104583|11187031|FG003|Overall Study|New ICD or CRT-D implanted|0
7078438|NCT02104583|11187032|FG004|Overall Study|New ICD or CRT-D implanted|0
7078439|NCT02104583|11187028|FG000|Overall Study|Death|2
7078440|NCT02104583|11187029|FG001|Overall Study|Death|1
7078441|NCT02104583|11187030|FG002|Overall Study|Death|3
6968610|NCT01140568|11017654|FG000|Overall Study|Screen Fail|4
6968611|NCT01140646|11017658|FG000|Overall Study|Adverse Event|4
6968612|NCT01140646|11017658|FG000|Overall Study|Refused Further Treatment|5
6968613|NCT01140880|11017675|FG000|Overall Study|Death|0
6968614|NCT01140880|11017676|FG001|Overall Study|Death|1
6968615|NCT01140880|11017675|FG000|Overall Study|Withdrawal by Subject|6
6968616|NCT01140880|11017676|FG001|Overall Study|Withdrawal by Subject|3
6968617|NCT01140880|11017675|FG000|Overall Study|Lost to Follow-up|8
6968618|NCT01140880|11017676|FG001|Overall Study|Lost to Follow-up|10
6968619|NCT01140880|11017675|FG000|Overall Study|Protocol Violation|0
6968620|NCT01140880|11017676|FG001|Overall Study|Protocol Violation|30
6968621|NCT01140906|11017686|FG000|Overall Study|Adverse Event|7
6968622|NCT01140906|11017687|FG001|Overall Study|Adverse Event|10
6968623|NCT01140906|11017688|FG002|Overall Study|Adverse Event|17
6968624|NCT01140906|11017689|FG003|Overall Study|Adverse Event|7
6968625|NCT01140906|11017686|FG000|Overall Study|Lack of Efficacy|6
6968626|NCT01140906|11017687|FG001|Overall Study|Lack of Efficacy|8
6968627|NCT01140906|11017688|FG002|Overall Study|Lack of Efficacy|2
6968628|NCT01140906|11017689|FG003|Overall Study|Lack of Efficacy|1
6968629|NCT01140906|11017686|FG000|Overall Study|Non-compliance|0
6968630|NCT01140906|11017687|FG001|Overall Study|Non-compliance|1
6968631|NCT01140906|11017688|FG002|Overall Study|Non-compliance|0
6968632|NCT01140906|11017689|FG003|Overall Study|Non-compliance|1
7078442|NCT02104583|11187031|FG003|Overall Study|Death|3
6968633|NCT01140906|11017686|FG000|Overall Study|Protocol Violation|5
6968634|NCT01140906|11017687|FG001|Overall Study|Protocol Violation|3
6968635|NCT01140906|11017688|FG002|Overall Study|Protocol Violation|2
6968636|NCT01140906|11017689|FG003|Overall Study|Protocol Violation|1
6968637|NCT01140906|11017686|FG000|Overall Study|Withdrawal of consent|6
6968638|NCT01140906|11017687|FG001|Overall Study|Withdrawal of consent|6
6968639|NCT01140906|11017688|FG002|Overall Study|Withdrawal of consent|2
6968640|NCT01140906|11017689|FG003|Overall Study|Withdrawal of consent|2
6968641|NCT01140906|11017686|FG000|Overall Study|Lost to Follow-up|1
6968642|NCT01140906|11017687|FG001|Overall Study|Lost to Follow-up|1
6968643|NCT01140906|11017688|FG002|Overall Study|Lost to Follow-up|0
6968644|NCT01140906|11017689|FG003|Overall Study|Lost to Follow-up|2
6968645|NCT01140906|11017686|FG000|Overall Study|Administrative or other reason|0
6968646|NCT01140906|11017687|FG001|Overall Study|Administrative or other reason|5
6968647|NCT01140906|11017688|FG002|Overall Study|Administrative or other reason|3
6968648|NCT01140906|11017689|FG003|Overall Study|Administrative or other reason|2
6968649|NCT01141205|11017714|FG000|Overall Study|Physician Decision|1
6968650|NCT01141205|11017715|FG001|Overall Study|Physician Decision|1
6968651|NCT01141205|11017714|FG000|Overall Study|Lost to Follow-up|1
7078443|NCT02104583|11187032|FG004|Overall Study|Death|5
6871434|NCT00470626|10882091|FG000|Overall Study|Lost to Follow-up|10
6871435|NCT00470626|10882091|FG000|Overall Study|Withdrawal by Subject|7
6871436|NCT00470834|10882101|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16
6871437|NCT00470834|10882102|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14
6871438|NCT00470834|10882101|FG000|Treatment Period (18 Months)|Adverse Event|7
7078444|NCT02104583|11187028|FG000|Overall Study|Subject required cardiac ablation|6
7078445|NCT02104583|11187029|FG001|Overall Study|Subject required cardiac ablation|4
7078446|NCT02104583|11187030|FG002|Overall Study|Subject required cardiac ablation|4
7078447|NCT02104583|11187031|FG003|Overall Study|Subject required cardiac ablation|5
7078448|NCT02104583|11187032|FG004|Overall Study|Subject required cardiac ablation|4
7078449|NCT02104583|11187028|FG000|Overall Study|Subject required prohibited medication|0
7078450|NCT02104583|11187029|FG001|Overall Study|Subject required prohibited medication|1
7078451|NCT02104583|11187030|FG002|Overall Study|Subject required prohibited medication|1
7078452|NCT02104583|11187031|FG003|Overall Study|Subject required prohibited medication|0
7078453|NCT02104583|11187032|FG004|Overall Study|Subject required prohibited medication|1
6871439|NCT00470834|10882102|FG001|Treatment Period (18 Months)|Adverse Event|6
6871440|NCT00470834|10882101|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4
6871441|NCT00470834|10882102|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5
6871442|NCT00470834|10882101|FG000|Treatment Period (18 Months)|Physician Decision|4
6871443|NCT00470834|10882102|FG001|Treatment Period (18 Months)|Physician Decision|4
6871444|NCT00470834|10882101|FG000|Treatment Period (18 Months)|Protocol Violation|3
6871445|NCT00470834|10882102|FG001|Treatment Period (18 Months)|Protocol Violation|1
6871446|NCT00470834|10882101|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1
6871447|NCT00470834|10882102|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1
6871448|NCT00470834|10882101|FG000|Treatment Period (18 Months)|Lost to Follow-up|1
6871449|NCT00470834|10882102|FG001|Treatment Period (18 Months)|Lost to Follow-up|0
6871450|NCT00470834|10882101|FG000|Treatment Period (18 Months)|Non-compliance|1
6871451|NCT00470834|10882102|FG001|Treatment Period (18 Months)|Non-compliance|0
6871452|NCT00470834|10882101|FG000|Treatment Period (18 Months)|Lack of Efficacy|1
6871453|NCT00470834|10882102|FG001|Treatment Period (18 Months)|Lack of Efficacy|0
6871454|NCT00470834|10882101|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6
6871455|NCT00470834|10882102|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7
6871456|NCT00470834|10882101|FG000|Extension Period (24 Months)|Adverse Event|3
6871457|NCT00470834|10882102|FG001|Extension Period (24 Months)|Adverse Event|4
6871458|NCT00470834|10882101|FG000|Extension Period (24 Months)|Withdrawal by Subject|2
6871459|NCT00470834|10882102|FG001|Extension Period (24 Months)|Withdrawal by Subject|5
6871460|NCT00470834|10882101|FG000|Extension Period (24 Months)|Physician Decision|4
7078454|NCT02104583|11187028|FG000|Overall Study|Withdrew Consent|3
6871461|NCT00470834|10882102|FG001|Extension Period (24 Months)|Physician Decision|3
6871462|NCT00470834|10882101|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0
6871463|NCT00470834|10882102|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1
6871464|NCT00470834|10882101|FG000|Extension Period (24 Months)|Lost to Follow-up|0
6871465|NCT00470834|10882102|FG001|Extension Period (24 Months)|Lost to Follow-up|1
6871466|NCT00470834|10882101|FG000|Extension Period (24 Months)|Non-compliance|0
6871467|NCT00470834|10882102|FG001|Extension Period (24 Months)|Non-compliance|1
6871468|NCT00470834|10882101|FG000|Extension Period (24 Months)|Disease Progression|0
6871469|NCT00470834|10882102|FG001|Extension Period (24 Months)|Disease Progression|1
6871470|NCT00470847|10882108|FG000|Overall Study|Pt still receiving treatment|1
6871471|NCT00471081|10882125|FG000|Active Phase|Protocol Violation|1
6871472|NCT00471081|10882126|FG001|Active Phase|Protocol Violation|1
6871473|NCT00471081|10882125|FG000|Active Phase|Withdrawal by Subject|0
6871474|NCT00471081|10882126|FG001|Active Phase|Withdrawal by Subject|3
6871475|NCT00471081|10882125|FG000|Active Phase|Lost to Follow-up|0
6871476|NCT00471081|10882126|FG001|Active Phase|Lost to Follow-up|1
6871477|NCT00471081|10882125|FG000|Active Phase|Lost health plan/insurance|1
6871478|NCT00471081|10882126|FG001|Active Phase|Lost health plan/insurance|8
6871479|NCT00471081|10882125|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1
6871480|NCT00471081|10882126|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4
6871481|NCT00471081|10882125|FG000|Extended Safety Follow-Up|Lost to Follow-up|1
6871482|NCT00471081|10882126|FG001|Extended Safety Follow-Up|Lost to Follow-up|8
6871483|NCT00471081|10882125|FG000|Extended Safety Follow-Up|Missing confirmed|0
6871484|NCT00471081|10882126|FG001|Extended Safety Follow-Up|Missing confirmed|1
6871485|NCT00471107|10882136|FG000|Overall Study|Technical problems/data loss|3
6871486|NCT00471107|10882137|FG001|Overall Study|Technical problems/data loss|1
6871487|NCT00471107|10882138|FG002|Overall Study|Technical problems/data loss|3
6871488|NCT00471146|10882148|FG000|Overall Study|Adverse Event|32
6871489|NCT00471146|10882149|FG001|Overall Study|Adverse Event|33
6871490|NCT00471146|10882148|FG000|Overall Study|Withdrawal by Subject|14
6871491|NCT00471146|10882149|FG001|Overall Study|Withdrawal by Subject|11
6871492|NCT00471146|10882148|FG000|Overall Study|Death|11
6871493|NCT00471146|10882149|FG001|Overall Study|Death|12
6871494|NCT00471146|10882148|FG000|Overall Study|Lost to Follow-up|4
6871495|NCT00471146|10882149|FG001|Overall Study|Lost to Follow-up|2
6871496|NCT00471146|10882148|FG000|Overall Study|Protocol Violation|2
6871497|NCT00471146|10882149|FG001|Overall Study|Protocol Violation|2
6871498|NCT00471146|10882148|FG000|Overall Study|Objective progression or relapse|84
6871499|NCT00471146|10882149|FG001|Overall Study|Objective progression or relapse|87
6871500|NCT00471146|10882148|FG000|Overall Study|Global deterioration of health status|12
6871501|NCT00471146|10882149|FG001|Overall Study|Global deterioration of health status|14
6871502|NCT00471146|10882148|FG000|Overall Study|Randomized but not treated|9
6871503|NCT00471146|10882149|FG001|Overall Study|Randomized but not treated|8
6871504|NCT00471146|10882148|FG000|Overall Study|Other|4
6871505|NCT00471146|10882149|FG001|Overall Study|Other|5
6871506|NCT00471237|10882162|FG000|Overall Study|Adverse Event|6
6871507|NCT00471237|10882163|FG001|Overall Study|Adverse Event|5
6871508|NCT00471237|10882164|FG002|Overall Study|Adverse Event|4
6871509|NCT00471237|10882165|FG003|Overall Study|Adverse Event|8
6871510|NCT00471237|10882166|FG004|Overall Study|Adverse Event|7
6871511|NCT00471237|10882167|FG005|Overall Study|Adverse Event|5
6871512|NCT00471237|10882168|FG006|Overall Study|Adverse Event|0
6871513|NCT00471237|10882162|FG000|Overall Study|Lost to Follow-up|1
6871514|NCT00471237|10882163|FG001|Overall Study|Lost to Follow-up|1
6871515|NCT00471237|10882164|FG002|Overall Study|Lost to Follow-up|0
6871516|NCT00471237|10882165|FG003|Overall Study|Lost to Follow-up|2
6871517|NCT00471237|10882166|FG004|Overall Study|Lost to Follow-up|3
6871518|NCT00471237|10882167|FG005|Overall Study|Lost to Follow-up|0
6871519|NCT00471237|10882168|FG006|Overall Study|Lost to Follow-up|0
6871520|NCT00471237|10882162|FG000|Overall Study|Protocol Violation|3
6871521|NCT00471237|10882163|FG001|Overall Study|Protocol Violation|6
6871522|NCT00471237|10882164|FG002|Overall Study|Protocol Violation|3
6871523|NCT00471237|10882165|FG003|Overall Study|Protocol Violation|2
6871524|NCT00471237|10882166|FG004|Overall Study|Protocol Violation|2
6871525|NCT00471237|10882167|FG005|Overall Study|Protocol Violation|4
6871526|NCT00471237|10882168|FG006|Overall Study|Protocol Violation|1
6871527|NCT00471237|10882162|FG000|Overall Study|Withdrawal by Subject|8
6871528|NCT00471237|10882163|FG001|Overall Study|Withdrawal by Subject|6
6871529|NCT00471237|10882164|FG002|Overall Study|Withdrawal by Subject|5
6871530|NCT00471237|10882165|FG003|Overall Study|Withdrawal by Subject|8
6871531|NCT00471237|10882166|FG004|Overall Study|Withdrawal by Subject|7
6871532|NCT00471237|10882167|FG005|Overall Study|Withdrawal by Subject|4
6871533|NCT00471237|10882168|FG006|Overall Study|Withdrawal by Subject|2
6871534|NCT00471237|10882162|FG000|Overall Study|Sponsor terminated study|20
6871535|NCT00471237|10882163|FG001|Overall Study|Sponsor terminated study|23
6871536|NCT00471237|10882164|FG002|Overall Study|Sponsor terminated study|19
6871537|NCT00471237|10882165|FG003|Overall Study|Sponsor terminated study|22
6871538|NCT00471237|10882166|FG004|Overall Study|Sponsor terminated study|18
6871539|NCT00471237|10882167|FG005|Overall Study|Sponsor terminated study|24
6871540|NCT00471237|10882168|FG006|Overall Study|Sponsor terminated study|0
6871541|NCT00471237|10882162|FG000|Overall Study|Non-compliance|0
6871542|NCT00471237|10882163|FG001|Overall Study|Non-compliance|1
6871543|NCT00471237|10882164|FG002|Overall Study|Non-compliance|0
6871544|NCT00471237|10882165|FG003|Overall Study|Non-compliance|1
6871545|NCT00471237|10882166|FG004|Overall Study|Non-compliance|0
6871546|NCT00471237|10882167|FG005|Overall Study|Non-compliance|0
6871547|NCT00471237|10882168|FG006|Overall Study|Non-compliance|0
6871548|NCT00471237|10882162|FG000|Overall Study|Met serum creatinine withdrawal criteria|1
6871549|NCT00471237|10882163|FG001|Overall Study|Met serum creatinine withdrawal criteria|0
6871550|NCT00471237|10882164|FG002|Overall Study|Met serum creatinine withdrawal criteria|2
6871551|NCT00471237|10882165|FG003|Overall Study|Met serum creatinine withdrawal criteria|2
6871552|NCT00471237|10882166|FG004|Overall Study|Met serum creatinine withdrawal criteria|0
6871553|NCT00471237|10882167|FG005|Overall Study|Met serum creatinine withdrawal criteria|0
6871554|NCT00471237|10882168|FG006|Overall Study|Met serum creatinine withdrawal criteria|0
6871555|NCT00471237|10882162|FG000|Overall Study|Early stopping due to non-efficacy|1
6871556|NCT00471237|10882163|FG001|Overall Study|Early stopping due to non-efficacy|0
6871557|NCT00471237|10882164|FG002|Overall Study|Early stopping due to non-efficacy|0
6871558|NCT00471237|10882165|FG003|Overall Study|Early stopping due to non-efficacy|0
6871559|NCT00471237|10882166|FG004|Overall Study|Early stopping due to non-efficacy|1
6871560|NCT00471237|10882167|FG005|Overall Study|Early stopping due to non-efficacy|0
6871561|NCT00471237|10882168|FG006|Overall Study|Early stopping due to non-efficacy|0
6871562|NCT00471237|10882162|FG000|Overall Study|Participant planned to travel to abraod|1
6871563|NCT00471237|10882163|FG001|Overall Study|Participant planned to travel to abraod|0
6871564|NCT00471237|10882164|FG002|Overall Study|Participant planned to travel to abraod|0
6871565|NCT00471237|10882165|FG003|Overall Study|Participant planned to travel to abraod|0
6871566|NCT00471237|10882166|FG004|Overall Study|Participant planned to travel to abraod|0
6871567|NCT00471237|10882167|FG005|Overall Study|Participant planned to travel to abraod|1
6871568|NCT00471237|10882168|FG006|Overall Study|Participant planned to travel to abraod|0
6871569|NCT00471237|10882162|FG000|Overall Study|High parathyroid hormone|0
6871570|NCT00471237|10882163|FG001|Overall Study|High parathyroid hormone|0
6871571|NCT00471237|10882164|FG002|Overall Study|High parathyroid hormone|1
6871572|NCT00471237|10882165|FG003|Overall Study|High parathyroid hormone|0
6871573|NCT00471237|10882166|FG004|Overall Study|High parathyroid hormone|0
6871574|NCT00471237|10882167|FG005|Overall Study|High parathyroid hormone|0
6871575|NCT00471237|10882168|FG006|Overall Study|High parathyroid hormone|0
6871576|NCT00471237|10882162|FG000|Overall Study|Participant lost medication|0
6871577|NCT00471237|10882163|FG001|Overall Study|Participant lost medication|0
6871578|NCT00471237|10882164|FG002|Overall Study|Participant lost medication|0
6871579|NCT00471237|10882165|FG003|Overall Study|Participant lost medication|0
6871580|NCT00471237|10882166|FG004|Overall Study|Participant lost medication|1
6871581|NCT00471237|10882167|FG005|Overall Study|Participant lost medication|0
6871582|NCT00471237|10882168|FG006|Overall Study|Participant lost medication|0
6871583|NCT00471237|10882162|FG000|Overall Study|Administration of prohibited medicine|0
6871584|NCT00471237|10882163|FG001|Overall Study|Administration of prohibited medicine|0
6871585|NCT00471237|10882164|FG002|Overall Study|Administration of prohibited medicine|0
6871586|NCT00471237|10882165|FG003|Overall Study|Administration of prohibited medicine|0
6871587|NCT00471237|10882166|FG004|Overall Study|Administration of prohibited medicine|1
6871588|NCT00471237|10882167|FG005|Overall Study|Administration of prohibited medicine|0
6871589|NCT00471237|10882168|FG006|Overall Study|Administration of prohibited medicine|0
6871590|NCT00471237|10882162|FG000|Overall Study|Participant shifted residence|0
6871591|NCT00471237|10882163|FG001|Overall Study|Participant shifted residence|0
6871592|NCT00471237|10882164|FG002|Overall Study|Participant shifted residence|0
6871593|NCT00471237|10882165|FG003|Overall Study|Participant shifted residence|0
6871594|NCT00471237|10882166|FG004|Overall Study|Participant shifted residence|1
6871595|NCT00471237|10882167|FG005|Overall Study|Participant shifted residence|0
6871596|NCT00471237|10882168|FG006|Overall Study|Participant shifted residence|0
6871597|NCT00471237|10882162|FG000|Overall Study|Participant's decision|0
6871598|NCT00471237|10882163|FG001|Overall Study|Participant's decision|0
6871599|NCT00471237|10882164|FG002|Overall Study|Participant's decision|0
6871600|NCT00471237|10882165|FG003|Overall Study|Participant's decision|0
6871601|NCT00471237|10882166|FG004|Overall Study|Participant's decision|0
6871602|NCT00471237|10882167|FG005|Overall Study|Participant's decision|1
6871603|NCT00471237|10882168|FG006|Overall Study|Participant's decision|0
6871604|NCT00471276|10882188|FG000|Overall Study|Death|2
6871605|NCT00471276|10882188|FG000|Overall Study|Adverse Event|16
6871606|NCT00471276|10882188|FG000|Overall Study|Protocol Violation|1
6871607|NCT00471276|10882188|FG000|Overall Study|Objective progression or relapse|54
6871608|NCT00471276|10882188|FG000|Overall Study|Global deterioration of health status|1
6871609|NCT00471276|10882188|FG000|Overall Study|Other|3
6871610|NCT00471276|10882188|FG000|Overall Study|Refused treatment|6
6871611|NCT00471315|10882192|FG000|Overall Study|Adverse Event|7
6871612|NCT00471315|10882192|FG000|Overall Study|Withdrawal by Subject|1
6871613|NCT00471328|10882198|FG000|Core Phase|Adverse Event|18
6871614|NCT00471328|10882199|FG001|Core Phase|Adverse Event|6
6871615|NCT00471328|10882198|FG000|Core Phase|Death|8
6871616|NCT00471328|10882199|FG001|Core Phase|Death|4
6871617|NCT00471328|10882198|FG000|Core Phase|Withdrawal by Subject|2
6871618|NCT00471328|10882199|FG001|Core Phase|Withdrawal by Subject|2
6871619|NCT00471328|10882198|FG000|Core Phase|Abnormal laboratory value|1
6871620|NCT00471328|10882199|FG001|Core Phase|Abnormal laboratory value|0
6871621|NCT00471328|10882198|FG000|Core Phase|Disease Progression|78
6871622|NCT00471328|10882199|FG001|Core Phase|Disease Progression|53
6871623|NCT00471328|10882198|FG000|Core Phase|Administrative Problem|0
6871624|NCT00471328|10882199|FG001|Core Phase|Administrative Problem|1
6871625|NCT00471328|10882198|FG000|Core Phase|Protocol Deviation|0
6871626|NCT00471328|10882199|FG001|Core Phase|Protocol Deviation|1
6871627|NCT00471328|10882198|FG000|Extension Phase|Adverse Event|3
6871628|NCT00471328|10882199|FG001|Extension Phase|Adverse Event|12
6871629|NCT00471328|10882198|FG000|Extension Phase|Withdrawal by Subject|0
6871630|NCT00471328|10882199|FG001|Extension Phase|Withdrawal by Subject|2
6871631|NCT00471328|10882198|FG000|Extension Phase|Death|1
6871632|NCT00471328|10882199|FG001|Extension Phase|Death|7
6871633|NCT00471328|10882198|FG000|Extension Phase|Protocol Deviation|3
6871634|NCT00471328|10882199|FG001|Extension Phase|Protocol Deviation|1
6871635|NCT00471328|10882198|FG000|Extension Phase|Treatment duration as per protocol|0
6871636|NCT00471328|10882199|FG001|Extension Phase|Treatment duration as per protocol|1
6871637|NCT00471328|10882198|FG000|Extension Phase|Disease Progression|32
6871638|NCT00471328|10882199|FG001|Extension Phase|Disease Progression|44
6871639|NCT00471328|10882198|FG000|Extension Phase|New cancer Therapy|1
6871640|NCT00471328|10882199|FG001|Extension Phase|New cancer Therapy|0
6871641|NCT00471328|10882198|FG000|Extension Phase|Administrative Problem|1
6871642|NCT00471328|10882199|FG001|Extension Phase|Administrative Problem|0
6871643|NCT00471354|10882207|FG000|Overall Study|Protocol Entry Criteria Not Met|1
6871644|NCT00471354|10882207|FG000|Overall Study|Adverse Event|13
6871645|NCT00471354|10882207|FG000|Overall Study|Protocol Violation|12
6871646|NCT00471354|10882207|FG000|Overall Study|Withdrawal by Subject|1
6871647|NCT00471354|10882207|FG000|Overall Study|Physician Decision|4
6871648|NCT00471354|10882207|FG000|Overall Study|Sponsor Decision|1
6871649|NCT00471354|10882207|FG000|Overall Study|Lost to Follow-up|3
6871650|NCT00471354|10882207|FG000|Overall Study|Lack of Efficacy|5
6871651|NCT00471354|10882207|FG000|Overall Study|Patient/Caregiver Decision|12
6871652|NCT00471445|10882220|FG000|Overall Study|Withdrawal by Subject|1
6871653|NCT00471445|10882221|FG001|Overall Study|Withdrawal by Subject|1
6871654|NCT00471445|10882220|FG000|Overall Study|Ineligible|1
6871655|NCT00471445|10882221|FG001|Overall Study|Ineligible|0
6871656|NCT00471445|10882220|FG000|Overall Study|Protocol Violation|0
6871657|NCT00471445|10882221|FG001|Overall Study|Protocol Violation|1
6871658|NCT00471497|10882230|FG000|Core Treatment Phase|Abnormal Laboratory Values|3
6871659|NCT00471497|10882231|FG001|Core Treatment Phase|Abnormal Laboratory Values|9
6871660|NCT00471497|10882232|FG002|Core Treatment Phase|Abnormal Laboratory Values|9
6871661|NCT00471497|10882230|FG000|Core Treatment Phase|Abnormal Test Procedures|1
6871662|NCT00471497|10882231|FG001|Core Treatment Phase|Abnormal Test Procedures|0
6871663|NCT00471497|10882232|FG002|Core Treatment Phase|Abnormal Test Procedures|1
6871664|NCT00471497|10882230|FG000|Core Treatment Phase|Condition no longer requires study drug|0
6871665|NCT00471497|10882231|FG001|Core Treatment Phase|Condition no longer requires study drug|1
6871666|NCT00471497|10882232|FG002|Core Treatment Phase|Condition no longer requires study drug|0
6871667|NCT00471497|10882230|FG000|Core Treatment Phase|Withdrawal by Subject|31
6871668|NCT00471497|10882231|FG001|Core Treatment Phase|Withdrawal by Subject|29
6871669|NCT00471497|10882232|FG002|Core Treatment Phase|Withdrawal by Subject|34
6871670|NCT00471497|10882230|FG000|Core Treatment Phase|Lost to Follow-up|6
6871671|NCT00471497|10882231|FG001|Core Treatment Phase|Lost to Follow-up|6
6871672|NCT00471497|10882232|FG002|Core Treatment Phase|Lost to Follow-up|3
6871673|NCT00471497|10882230|FG000|Core Treatment Phase|Death|3
6871674|NCT00471497|10882231|FG001|Core Treatment Phase|Death|9
6871675|NCT00471497|10882232|FG002|Core Treatment Phase|Death|3
6871676|NCT00471497|10882230|FG000|Core Treatment Phase|Disease Progression|10
6871677|NCT00471497|10882231|FG001|Core Treatment Phase|Disease Progression|2
6871678|NCT00471497|10882232|FG002|Core Treatment Phase|Disease Progression|4
6871679|NCT00471497|10882230|FG000|Core Treatment Phase|Protocol Violation|6
6871680|NCT00471497|10882231|FG001|Core Treatment Phase|Protocol Violation|15
6871681|NCT00471497|10882232|FG002|Core Treatment Phase|Protocol Violation|11
6871682|NCT00471497|10882230|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19
6871683|NCT00471497|10882231|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11
6871684|NCT00471497|10882232|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13
6871685|NCT00471497|10882230|FG000|Core Treatment Phase|Administrative problems|14
6871686|NCT00471497|10882231|FG001|Core Treatment Phase|Administrative problems|14
6871687|NCT00471497|10882232|FG002|Core Treatment Phase|Administrative problems|12
6871688|NCT00471497|10882230|FG000|Core Treatment Phase|Adverse Event|43
6871689|NCT00471497|10882231|FG001|Core Treatment Phase|Adverse Event|53
6871690|NCT00471497|10882232|FG002|Core Treatment Phase|Adverse Event|89
6871691|NCT00471497|10882230|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2
6871692|NCT00471497|10882231|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0
6871693|NCT00471497|10882232|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0
6871694|NCT00471497|10882230|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46
6871695|NCT00471497|10882231|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26
6871696|NCT00471497|10882232|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3
6871697|NCT00471497|10882230|FG000|Extension Phase|Adverse Event|9
6871698|NCT00471497|10882231|FG001|Extension Phase|Adverse Event|5
6871699|NCT00471497|10882232|FG002|Extension Phase|Adverse Event|1
6871700|NCT00471497|10882230|FG000|Extension Phase|Unsatisfactory therapeutic effect|8
6871701|NCT00471497|10882231|FG001|Extension Phase|Unsatisfactory therapeutic effect|6
6871702|NCT00471497|10882232|FG002|Extension Phase|Unsatisfactory therapeutic effect|0
6871703|NCT00471497|10882230|FG000|Extension Phase|Withdrawal by Subject|3
6871704|NCT00471497|10882231|FG001|Extension Phase|Withdrawal by Subject|1
6871705|NCT00471497|10882232|FG002|Extension Phase|Withdrawal by Subject|0
6871706|NCT00471497|10882230|FG000|Extension Phase|Lost to Follow-up|2
6871707|NCT00471497|10882231|FG001|Extension Phase|Lost to Follow-up|0
6871708|NCT00471497|10882232|FG002|Extension Phase|Lost to Follow-up|0
6871709|NCT00471497|10882230|FG000|Extension Phase|Death|1
6871710|NCT00471497|10882231|FG001|Extension Phase|Death|0
6871711|NCT00471497|10882232|FG002|Extension Phase|Death|0
6871712|NCT00471497|10882230|FG000|Extension Phase|Disease progression|2
6871713|NCT00471497|10882231|FG001|Extension Phase|Disease progression|0
6871714|NCT00471497|10882232|FG002|Extension Phase|Disease progression|0
6871715|NCT00471497|10882230|FG000|Extension Phase|Protocol Violation|2
6871716|NCT00471497|10882231|FG001|Extension Phase|Protocol Violation|2
6871717|NCT00471497|10882232|FG002|Extension Phase|Protocol Violation|0
6871718|NCT00471536|10882243|FG000|Overall Study|Withdrawal by Subject|1
6871719|NCT00471718|10882260|FG000|Overall Study|Adverse Event|3
6871720|NCT00471718|10882260|FG000|Overall Study|other complicating disease|1
6871721|NCT00471718|10882260|FG000|Overall Study|disease progression|22
6871722|NCT00471718|10882260|FG000|Overall Study|Withdrawal by Subject|1
6871723|NCT00471822|10882268|FG000|Overall Study|Protocol Violation|2
6871724|NCT00471887|10882276|FG000|Overall Study|Adverse Event|9
6871725|NCT00472030|10882282|FG000|Overall Study|Physician Decision|1
6871726|NCT00472030|10882283|FG001|Overall Study|Physician Decision|0
6871727|NCT00472199|10882310|FG000|Overall Study|Adverse Event|19
6871728|NCT00472199|10882311|FG001|Overall Study|Adverse Event|23
6871729|NCT00472199|10882310|FG000|Overall Study|Lack of Efficacy|4
6871730|NCT00472199|10882311|FG001|Overall Study|Lack of Efficacy|25
6871731|NCT00472199|10882310|FG000|Overall Study|Lost to Follow-up|2
6871732|NCT00472199|10882311|FG001|Overall Study|Lost to Follow-up|4
6871733|NCT00472199|10882310|FG000|Overall Study|Protocol Violation|3
6871734|NCT00472199|10882311|FG001|Overall Study|Protocol Violation|2
6871735|NCT00472199|10882310|FG000|Overall Study|Withdrawal by Subject|6
6871736|NCT00472199|10882311|FG001|Overall Study|Withdrawal by Subject|5
6871737|NCT00472199|10882310|FG000|Overall Study|personal reason|0
6871738|NCT00472199|10882311|FG001|Overall Study|personal reason|1
6871739|NCT00472199|10882310|FG000|Overall Study|patient was asymptomatic|1
6871740|NCT00472199|10882311|FG001|Overall Study|patient was asymptomatic|0
6871741|NCT00472290|10882317|FG000|Overall Study|Progression of Therapy-Related MDS|1
6871742|NCT00472290|10882317|FG000|Overall Study|Protocol Specified Criteria|7
6871743|NCT00472290|10882317|FG000|Overall Study|Administrative Decision|37
6871744|NCT00472290|10882317|FG000|Overall Study|Death|3
6871745|NCT00472290|10882317|FG000|Overall Study|Lost to Follow-up|1
6871746|NCT00472290|10882317|FG000|Overall Study|Lack of Efficacy|1
6871747|NCT00472290|10882317|FG000|Overall Study|Disease Progression|4
6871748|NCT00472290|10882317|FG000|Overall Study|Withdrawal by Subject|5
6871749|NCT00472290|10882317|FG000|Overall Study|Adverse Event|6
6871750|NCT00472290|10882317|FG000|Overall Study|Requirement for alternative therapy|7
6871751|NCT00472303|10882323|FG000|Titration Phase|Adverse Event|22
6871752|NCT00472303|10882324|FG001|Titration Phase|Adverse Event|12
6871753|NCT00472303|10882325|FG002|Titration Phase|Adverse Event|0
6871754|NCT00472303|10882323|FG000|Titration Phase|Death|4
6871755|NCT00472303|10882324|FG001|Titration Phase|Death|2
6871756|NCT00472303|10882325|FG002|Titration Phase|Death|0
6871757|NCT00472303|10882323|FG000|Titration Phase|Lack of Efficacy|10
6871758|NCT00472303|10882324|FG001|Titration Phase|Lack of Efficacy|0
6871759|NCT00472303|10882325|FG002|Titration Phase|Lack of Efficacy|0
6871760|NCT00472303|10882323|FG000|Titration Phase|Withdrawal by Subject|16
6871761|NCT00472303|10882324|FG001|Titration Phase|Withdrawal by Subject|13
6871762|NCT00472303|10882325|FG002|Titration Phase|Withdrawal by Subject|0
6871763|NCT00472303|10882323|FG000|Titration Phase|Trial Medication non-compliant|4
6871764|NCT00472303|10882324|FG001|Titration Phase|Trial Medication non-compliant|1
6871765|NCT00472303|10882325|FG002|Titration Phase|Trial Medication non-compliant|0
6871766|NCT00472303|10882323|FG000|Titration Phase|Other|3
6871767|NCT00472303|10882324|FG001|Titration Phase|Other|1
6871768|NCT00472303|10882325|FG002|Titration Phase|Other|0
6871769|NCT00472303|10882323|FG000|Discontinuations After Titration Phase|Adverse Event|6
6871770|NCT00472303|10882324|FG001|Discontinuations After Titration Phase|Adverse Event|0
6871771|NCT00472303|10882325|FG002|Discontinuations After Titration Phase|Adverse Event|0
6871772|NCT00472303|10882323|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48
6871773|NCT00472303|10882324|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17
6871774|NCT00472303|10882325|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0
6871775|NCT00472303|10882323|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2
6871776|NCT00472303|10882324|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2
6871777|NCT00472303|10882325|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0
6871778|NCT00472303|10882323|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0
6871779|NCT00472303|10882324|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1
6871780|NCT00472303|10882325|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0
6871781|NCT00472303|10882323|FG000|Discontinuations After Titration Phase|Other|5
6871782|NCT00472303|10882324|FG001|Discontinuations After Titration Phase|Other|0
6871783|NCT00472303|10882325|FG002|Discontinuations After Titration Phase|Other|0
6871784|NCT00472303|10882323|FG000|Maintenance Phase|Adverse Event|5
6871785|NCT00472303|10882324|FG001|Maintenance Phase|Adverse Event|6
6871786|NCT00472303|10882325|FG002|Maintenance Phase|Adverse Event|6
6871787|NCT00472303|10882323|FG000|Maintenance Phase|Death|3
6871788|NCT00472303|10882324|FG001|Maintenance Phase|Death|0
6871789|NCT00472303|10882325|FG002|Maintenance Phase|Death|2
6871790|NCT00472303|10882323|FG000|Maintenance Phase|Lack of Efficacy|2
6871791|NCT00472303|10882324|FG001|Maintenance Phase|Lack of Efficacy|2
6871792|NCT00472303|10882325|FG002|Maintenance Phase|Lack of Efficacy|4
6871793|NCT00472303|10882323|FG000|Maintenance Phase|Withdrawal by Subject|6
6871794|NCT00472303|10882324|FG001|Maintenance Phase|Withdrawal by Subject|7
6871795|NCT00472303|10882325|FG002|Maintenance Phase|Withdrawal by Subject|3
6871796|NCT00472303|10882323|FG000|Maintenance Phase|Trial medication non-compliant|0
6871797|NCT00472303|10882324|FG001|Maintenance Phase|Trial medication non-compliant|0
6871798|NCT00472303|10882325|FG002|Maintenance Phase|Trial medication non-compliant|1
6871799|NCT00472303|10882323|FG000|Maintenance Phase|Resolution of pain|0
6871800|NCT00472303|10882324|FG001|Maintenance Phase|Resolution of pain|0
6871801|NCT00472303|10882325|FG002|Maintenance Phase|Resolution of pain|1
6871802|NCT00472303|10882323|FG000|Maintenance Phase|Other|1
6871803|NCT00472303|10882324|FG001|Maintenance Phase|Other|1
6871804|NCT00472303|10882325|FG002|Maintenance Phase|Other|0
6871805|NCT00472420|10882353|FG000|Induction Treatment Period|Physician Decision|9
6871806|NCT00472420|10882353|FG000|Induction Treatment Period|Adverse Event|3
6871807|NCT00472420|10882353|FG000|Induction Treatment Period|Non-compliance|1
6871808|NCT00472420|10882353|FG000|Induction Treatment Period|Death|3
6871809|NCT00472420|10882353|FG000|Follow-up Period|Death|5
6871810|NCT00472420|10882353|FG000|Follow-up Period|Physician Decision|9
6871811|NCT00472420|10882353|FG000|Follow-up Period|Lost to Follow-up|2
6871812|NCT00472420|10882353|FG000|Follow-up Period|Protocol Violation|1
6871813|NCT00472446|10882361|FG000|Overall Study|Protocol Violation|0
6871814|NCT00472446|10882362|FG001|Overall Study|Protocol Violation|0
6871815|NCT00472446|10882363|FG002|Overall Study|Protocol Violation|0
6871816|NCT00472446|10882364|FG003|Overall Study|Protocol Violation|1
6871817|NCT00472446|10882361|FG000|Overall Study|Reintervention|0
6871818|NCT00472446|10882362|FG001|Overall Study|Reintervention|0
6871819|NCT00472446|10882363|FG002|Overall Study|Reintervention|1
6871820|NCT00472446|10882364|FG003|Overall Study|Reintervention|1
6871821|NCT00472446|10882361|FG000|Overall Study|Questionnaires not returned|5
6871822|NCT00472446|10882362|FG001|Overall Study|Questionnaires not returned|6
6871823|NCT00472446|10882363|FG002|Overall Study|Questionnaires not returned|6
6871824|NCT00472446|10882364|FG003|Overall Study|Questionnaires not returned|4
6871825|NCT00472641|10882383|FG000|Overall Study|Lack of Efficacy|3
6871826|NCT00472641|10882383|FG000|Overall Study|Adverse Event|3
6871827|NCT00472641|10882383|FG000|Overall Study|Lost to Follow-up|1
6871828|NCT00473083|10882420|FG000|Overall Study|Adverse Event|1
6871829|NCT00473083|10882421|FG001|Overall Study|Adverse Event|0
6871830|NCT00473083|10882422|FG002|Overall Study|Adverse Event|0
6871831|NCT00473265|10882433|FG000|Overall Study|Unrelated adverse event|5
6871832|NCT00473265|10882433|FG000|Overall Study|Off treatment early|15
6871833|NCT00473330|10882440|FG000|Core Study|Adverse Event|4
6871834|NCT00473330|10882441|FG001|Core Study|Adverse Event|4
6871835|NCT00473330|10882442|FG002|Core Study|Adverse Event|1
6871836|NCT00473330|10882440|FG000|Core Study|Death|6
6871837|NCT00473330|10882441|FG001|Core Study|Death|4
6871838|NCT00473330|10882442|FG002|Core Study|Death|4
6871839|NCT00473330|10882440|FG000|Core Study|Lost to Follow-up|5
6871840|NCT00473330|10882441|FG001|Core Study|Lost to Follow-up|5
6871841|NCT00473330|10882442|FG002|Core Study|Lost to Follow-up|10
6871842|NCT00473330|10882440|FG000|Core Study|Physician Decision|2
6871843|NCT00473330|10882441|FG001|Core Study|Physician Decision|1
6871844|NCT00473330|10882442|FG002|Core Study|Physician Decision|3
6871845|NCT00473330|10882440|FG000|Core Study|Subject Non-compliance|1
6871846|NCT00473330|10882441|FG001|Core Study|Subject Non-compliance|2
6871847|NCT00473330|10882442|FG002|Core Study|Subject Non-compliance|1
6871848|NCT00473330|10882440|FG000|Core Study|Subject Required Other Therapy|0
6871849|NCT00473330|10882441|FG001|Core Study|Subject Required Other Therapy|1
6871850|NCT00473330|10882442|FG002|Core Study|Subject Required Other Therapy|3
6871851|NCT00473330|10882440|FG000|Core Study|Subject's Decision|9
6871852|NCT00473330|10882441|FG001|Core Study|Subject's Decision|8
6871853|NCT00473330|10882442|FG002|Core Study|Subject's Decision|19
6871854|NCT00473330|10882440|FG000|Open-label Extension Through Month 48|Adverse Event|0
6871855|NCT00473330|10882441|FG001|Open-label Extension Through Month 48|Adverse Event|0
6871856|NCT00473330|10882442|FG002|Open-label Extension Through Month 48|Adverse Event|2
6871857|NCT00473330|10882440|FG000|Open-label Extension Through Month 48|Death|2
6871858|NCT00473330|10882441|FG001|Open-label Extension Through Month 48|Death|0
6871859|NCT00473330|10882442|FG002|Open-label Extension Through Month 48|Death|0
6871860|NCT00473330|10882440|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1
6871861|NCT00473330|10882441|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0
6871862|NCT00473330|10882442|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2
6871863|NCT00473330|10882440|FG000|Open-label Extension Through Month 48|Physician's Decision|2
6871864|NCT00473330|10882441|FG001|Open-label Extension Through Month 48|Physician's Decision|1
6871865|NCT00473330|10882442|FG002|Open-label Extension Through Month 48|Physician's Decision|3
6871866|NCT00473330|10882440|FG000|Open-label Extension Through Month 48|Subject's Decision|1
6871867|NCT00473330|10882441|FG001|Open-label Extension Through Month 48|Subject's Decision|3
6871868|NCT00473330|10882442|FG002|Open-label Extension Through Month 48|Subject's Decision|3
6871869|NCT00473330|10882440|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18
6871870|NCT00473330|10882441|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15
6871871|NCT00473330|10882442|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16
6871872|NCT00473330|10882440|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2
6871873|NCT00473330|10882441|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1
6871874|NCT00473330|10882442|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0
6871875|NCT00473330|10882440|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0
6871876|NCT00473330|10882441|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0
6871877|NCT00473330|10882442|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1
6871878|NCT00473330|10882440|FG000|Open-label Extension Through Month 60|Adverse Event|0
6871879|NCT00473330|10882441|FG001|Open-label Extension Through Month 60|Adverse Event|0
6871880|NCT00473330|10882442|FG002|Open-label Extension Through Month 60|Adverse Event|2
6871881|NCT00473330|10882440|FG000|Open-label Extension Through Month 60|Death|2
6871882|NCT00473330|10882441|FG001|Open-label Extension Through Month 60|Death|2
6871883|NCT00473330|10882442|FG002|Open-label Extension Through Month 60|Death|1
6871884|NCT00473330|10882440|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3
6871885|NCT00473330|10882441|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0
6871886|NCT00473330|10882442|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4
6871887|NCT00473330|10882440|FG000|Open-label Extension Through Month 60|Physician's Decision|2
6871888|NCT00473330|10882441|FG001|Open-label Extension Through Month 60|Physician's Decision|1
6871889|NCT00473330|10882442|FG002|Open-label Extension Through Month 60|Physician's Decision|3
6871890|NCT00473330|10882440|FG000|Open-label Extension Through Month 60|Subject's Decision|1
6871891|NCT00473330|10882441|FG001|Open-label Extension Through Month 60|Subject's Decision|3
6871892|NCT00473330|10882442|FG002|Open-label Extension Through Month 60|Subject's Decision|4
6871893|NCT00473330|10882440|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77
6871894|NCT00473330|10882441|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71
6871895|NCT00473330|10882442|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62
6968652|NCT01141205|11017715|FG001|Overall Study|Lost to Follow-up|0
6871896|NCT00473330|10882440|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2
6871897|NCT00473330|10882441|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1
6871898|NCT00473330|10882442|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0
6871899|NCT00473330|10882440|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1
6871900|NCT00473330|10882441|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0
6871901|NCT00473330|10882442|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1
6871902|NCT00473382|10882473|FG000|Core Study|Adverse Event|3
6871903|NCT00473382|10882474|FG001|Core Study|Adverse Event|1
6871904|NCT00473382|10882475|FG002|Core Study|Adverse Event|1
6871905|NCT00473382|10882473|FG000|Core Study|Death|3
6871906|NCT00473382|10882474|FG001|Core Study|Death|5
6871907|NCT00473382|10882475|FG002|Core Study|Death|10
6871908|NCT00473382|10882473|FG000|Core Study|Lost to Follow-up|3
6871909|NCT00473382|10882474|FG001|Core Study|Lost to Follow-up|3
6871910|NCT00473382|10882475|FG002|Core Study|Lost to Follow-up|3
6871911|NCT00473382|10882473|FG000|Core Study|Physician Decision|1
6871912|NCT00473382|10882474|FG001|Core Study|Physician Decision|2
6871913|NCT00473382|10882475|FG002|Core Study|Physician Decision|2
6871914|NCT00473382|10882473|FG000|Core Study|Subject non-compliance|5
6871915|NCT00473382|10882474|FG001|Core Study|Subject non-compliance|2
6871916|NCT00473382|10882475|FG002|Core Study|Subject non-compliance|1
6871917|NCT00473382|10882473|FG000|Core Study|Subject needed other treatment|1
6871918|NCT00473382|10882474|FG001|Core Study|Subject needed other treatment|3
6871919|NCT00473382|10882475|FG002|Core Study|Subject needed other treatment|2
6871920|NCT00473382|10882473|FG000|Core Study|Subject's decision|12
6871921|NCT00473382|10882474|FG001|Core Study|Subject's decision|11
6871922|NCT00473382|10882475|FG002|Core Study|Subject's decision|10
6871923|NCT00473382|10882473|FG000|Open-label Extension Through Month 48|Adverse Event|0
6871924|NCT00473382|10882474|FG001|Open-label Extension Through Month 48|Adverse Event|0
6871925|NCT00473382|10882475|FG002|Open-label Extension Through Month 48|Adverse Event|1
6871926|NCT00473382|10882473|FG000|Open-label Extension Through Month 48|Death|1
6871927|NCT00473382|10882474|FG001|Open-label Extension Through Month 48|Death|3
6871928|NCT00473382|10882475|FG002|Open-label Extension Through Month 48|Death|3
6871929|NCT00473382|10882473|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1
6871930|NCT00473382|10882474|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2
6871931|NCT00473382|10882475|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1
6871932|NCT00473382|10882473|FG000|Open-label Extension Through Month 48|Subject's Decision|5
6871933|NCT00473382|10882474|FG001|Open-label Extension Through Month 48|Subject's Decision|1
6871934|NCT00473382|10882475|FG002|Open-label Extension Through Month 48|Subject's Decision|6
6871935|NCT00473382|10882473|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41
6871936|NCT00473382|10882474|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34
6871937|NCT00473382|10882475|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36
6871938|NCT00473382|10882473|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2
6871939|NCT00473382|10882474|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1
6871940|NCT00473382|10882475|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0
6871941|NCT00473382|10882473|FG000|Open-label Extension Through Month 60|Adverse Event|0
6871942|NCT00473382|10882474|FG001|Open-label Extension Through Month 60|Adverse Event|0
6871943|NCT00473382|10882475|FG002|Open-label Extension Through Month 60|Adverse Event|2
6871944|NCT00473382|10882473|FG000|Open-label Extension Through Month 60|Death|1
6871945|NCT00473382|10882474|FG001|Open-label Extension Through Month 60|Death|7
6871946|NCT00473382|10882475|FG002|Open-label Extension Through Month 60|Death|4
6871947|NCT00473382|10882473|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1
6871948|NCT00473382|10882474|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3
6871949|NCT00473382|10882475|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1
6871950|NCT00473382|10882473|FG000|Open-label Extension Through Month 60|Subject's Decision|7
6871951|NCT00473382|10882474|FG001|Open-label Extension Through Month 60|Subject's Decision|1
6871952|NCT00473382|10882475|FG002|Open-label Extension Through Month 60|Subject's Decision|6
6871953|NCT00473382|10882473|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75
6871954|NCT00473382|10882474|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70
6871955|NCT00473382|10882475|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69
6871956|NCT00473382|10882473|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2
6871957|NCT00473382|10882474|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1
6871958|NCT00473382|10882475|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0
6871959|NCT00473434|10882501|FG000|Overall Study|Physician Decision|3
6871960|NCT00473434|10882501|FG000|Overall Study|Withdrawal by Subject|9
6871961|NCT00473434|10882501|FG000|Overall Study|Compliance|3
6871962|NCT00473434|10882501|FG000|Overall Study|Lack of Efficacy|3
6871963|NCT00473434|10882501|FG000|Overall Study|Adverse Event|3
6871964|NCT00473434|10882501|FG000|Overall Study|Patient was selling medication to others|1
6871965|NCT00473434|10882501|FG000|Overall Study|Safety evaluation|1
6871966|NCT00473434|10882501|FG000|Overall Study|Reason not specified|6
6871967|NCT00473434|10882501|FG000|Overall Study|Ceased in favor of Paliperidone|1
6871968|NCT00473434|10882501|FG000|Overall Study|Switching to trial medication|1
6871969|NCT00473434|10882501|FG000|Overall Study|No longer required|1
6871970|NCT00473512|10882523|FG000|Period 1 (Phase 1)|Adverse Event|0
6871971|NCT00473512|10882524|FG001|Period 1 (Phase 1)|Adverse Event|0
6871972|NCT00473512|10882525|FG002|Period 1 (Phase 1)|Adverse Event|0
6871973|NCT00473512|10882526|FG003|Period 1 (Phase 1)|Adverse Event|5
6871974|NCT00473512|10882527|FG004|Period 1 (Phase 1)|Adverse Event|0
6871975|NCT00473512|10882523|FG000|Period 1 (Phase 1)|Death|0
6871976|NCT00473512|10882524|FG001|Period 1 (Phase 1)|Death|0
6871977|NCT00473512|10882525|FG002|Period 1 (Phase 1)|Death|0
6871978|NCT00473512|10882526|FG003|Period 1 (Phase 1)|Death|1
6871979|NCT00473512|10882527|FG004|Period 1 (Phase 1)|Death|0
6871980|NCT00473512|10882523|FG000|Period 1 (Phase 1)|Disease Progression|1
6871981|NCT00473512|10882524|FG001|Period 1 (Phase 1)|Disease Progression|1
6871982|NCT00473512|10882525|FG002|Period 1 (Phase 1)|Disease Progression|0
6871983|NCT00473512|10882526|FG003|Period 1 (Phase 1)|Disease Progression|10
6871984|NCT00473512|10882527|FG004|Period 1 (Phase 1)|Disease Progression|1
6871985|NCT00473512|10882523|FG000|Period 1 (Phase 1)|Other|0
6871986|NCT00473512|10882524|FG001|Period 1 (Phase 1)|Other|0
6871987|NCT00473512|10882525|FG002|Period 1 (Phase 1)|Other|0
6871988|NCT00473512|10882526|FG003|Period 1 (Phase 1)|Other|1
6871989|NCT00473512|10882527|FG004|Period 1 (Phase 1)|Other|0
6871990|NCT00473512|10882523|FG000|Period 2 (Phase 2)|Adverse Event|0
6871991|NCT00473512|10882524|FG001|Period 2 (Phase 2)|Adverse Event|0
6871992|NCT00473512|10882525|FG002|Period 2 (Phase 2)|Adverse Event|0
6871993|NCT00473512|10882526|FG003|Period 2 (Phase 2)|Adverse Event|1
6871994|NCT00473512|10882527|FG004|Period 2 (Phase 2)|Adverse Event|0
6871995|NCT00473512|10882523|FG000|Period 2 (Phase 2)|Death|0
6871996|NCT00473512|10882524|FG001|Period 2 (Phase 2)|Death|0
6871997|NCT00473512|10882525|FG002|Period 2 (Phase 2)|Death|0
6871998|NCT00473512|10882526|FG003|Period 2 (Phase 2)|Death|1
6871999|NCT00473512|10882527|FG004|Period 2 (Phase 2)|Death|1
6872000|NCT00473512|10882523|FG000|Period 2 (Phase 2)|Disease Progression|0
6872001|NCT00473512|10882524|FG001|Period 2 (Phase 2)|Disease Progression|2
6872002|NCT00473512|10882525|FG002|Period 2 (Phase 2)|Disease Progression|2
6872003|NCT00473512|10882526|FG003|Period 2 (Phase 2)|Disease Progression|17
6872004|NCT00473512|10882527|FG004|Period 2 (Phase 2)|Disease Progression|1
6872005|NCT00473512|10882523|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0
6872006|NCT00473512|10882524|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0
6872007|NCT00473512|10882525|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0
6872008|NCT00473512|10882526|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1
6872009|NCT00473512|10882527|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0
6872010|NCT00473512|10882523|FG000|Period 2 (Phase 2)|Other|1
6872011|NCT00473512|10882524|FG001|Period 2 (Phase 2)|Other|0
6872012|NCT00473512|10882525|FG002|Period 2 (Phase 2)|Other|0
6872013|NCT00473512|10882526|FG003|Period 2 (Phase 2)|Other|3
6872014|NCT00473512|10882527|FG004|Period 2 (Phase 2)|Other|0
6872015|NCT00473564|10882547|FG000|Overall Study|robot surgery aborted in OR|23
6872016|NCT00473590|10882553|FG000|Overall Study|Adverse Event|3
6872017|NCT00473590|10882554|FG001|Overall Study|Adverse Event|3
6872018|NCT00473590|10882553|FG000|Overall Study|Death|4
6872019|NCT00473590|10882554|FG001|Overall Study|Death|2
6872020|NCT00473590|10882553|FG000|Overall Study|Progression not resulting in death|24
6872021|NCT00473590|10882554|FG001|Overall Study|Progression not resulting in death|20
6872022|NCT00473590|10882553|FG000|Overall Study|Non-protocol-specified therapy|7
6872023|NCT00473590|10882554|FG001|Overall Study|Non-protocol-specified therapy|5
6872024|NCT00473590|10882553|FG000|Overall Study|Physician Decision|2
6872025|NCT00473590|10882554|FG001|Overall Study|Physician Decision|4
6872026|NCT00473590|10882553|FG000|Overall Study|Withdrawal by Subject|5
6872027|NCT00473590|10882554|FG001|Overall Study|Withdrawal by Subject|3
6872028|NCT00473590|10882553|FG000|Overall Study|Other|0
6872029|NCT00473590|10882554|FG001|Overall Study|Other|1
6872030|NCT00473655|10882579|FG000|Overall Study|Lost to Follow-up|9
6872031|NCT00473655|10882580|FG001|Overall Study|Lost to Follow-up|5
6872032|NCT00473655|10882581|FG002|Overall Study|Lost to Follow-up|8
6872033|NCT00473668|10882592|FG000|Overall Study|Withdrawal by Subject|0
6872034|NCT00473668|10882593|FG001|Overall Study|Withdrawal by Subject|2
6872035|NCT00473668|10882594|FG002|Overall Study|Withdrawal by Subject|0
6872036|NCT00473668|10882592|FG000|Overall Study|Migrated/moved from study area|3
6872037|NCT00473668|10882593|FG001|Overall Study|Migrated/moved from study area|2
6872038|NCT00473668|10882594|FG002|Overall Study|Migrated/moved from study area|0
6872039|NCT00473668|10882592|FG000|Overall Study|Lost to Follow-up|0
6872040|NCT00473668|10882593|FG001|Overall Study|Lost to Follow-up|4
6872041|NCT00473668|10882594|FG002|Overall Study|Lost to Follow-up|6
6872042|NCT00473668|10882592|FG000|Overall Study|Other|2
6872043|NCT00473668|10882593|FG001|Overall Study|Other|3
6872044|NCT00473668|10882594|FG002|Overall Study|Other|4
6872045|NCT00473694|10882606|FG000|Overall Study|Adverse Event|0
6872046|NCT00473694|10882607|FG001|Overall Study|Adverse Event|1
6872047|NCT00473694|10882608|FG002|Overall Study|Adverse Event|0
6872048|NCT00473694|10882609|FG003|Overall Study|Adverse Event|0
6872049|NCT00473694|10882606|FG000|Overall Study|Participants did not receive treatment|11
6872050|NCT00473694|10882607|FG001|Overall Study|Participants did not receive treatment|3
6872051|NCT00473694|10882608|FG002|Overall Study|Participants did not receive treatment|5
6872052|NCT00473694|10882609|FG003|Overall Study|Participants did not receive treatment|6
6872053|NCT00473694|10882606|FG000|Overall Study|Lost to Follow-up|0
6872054|NCT00473694|10882607|FG001|Overall Study|Lost to Follow-up|0
6872055|NCT00473694|10882608|FG002|Overall Study|Lost to Follow-up|0
6872056|NCT00473694|10882609|FG003|Overall Study|Lost to Follow-up|1
6872057|NCT00473746|10882627|FG000|Period 1 (Phase 1)|Adverse Event|1
6872058|NCT00473746|10882628|FG001|Period 1 (Phase 1)|Adverse Event|0
6872059|NCT00473746|10882629|FG002|Period 1 (Phase 1)|Adverse Event|0
6872060|NCT00473746|10882630|FG003|Period 1 (Phase 1)|Adverse Event|0
6872061|NCT00473746|10882631|FG004|Period 1 (Phase 1)|Adverse Event|0
6872062|NCT00473746|10882627|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0
6872063|NCT00473746|10882628|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1
6872064|NCT00473746|10882629|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0
6872065|NCT00473746|10882630|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0
6872066|NCT00473746|10882631|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0
6872067|NCT00473746|10882627|FG000|Period 1 (Phase 1)|Progressive Disease|5
6872068|NCT00473746|10882628|FG001|Period 1 (Phase 1)|Progressive Disease|6
6872069|NCT00473746|10882629|FG002|Period 1 (Phase 1)|Progressive Disease|6
6872070|NCT00473746|10882630|FG003|Period 1 (Phase 1)|Progressive Disease|10
6872071|NCT00473746|10882631|FG004|Period 1 (Phase 1)|Progressive Disease|0
6872072|NCT00473746|10882627|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0
6872073|NCT00473746|10882628|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1
6872074|NCT00473746|10882629|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0
6872075|NCT00473746|10882630|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0
6872076|NCT00473746|10882631|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0
6872077|NCT00473746|10882627|FG000|Period 1 (Phase 1)|Reason not specified|0
6872078|NCT00473746|10882628|FG001|Period 1 (Phase 1)|Reason not specified|1
6872079|NCT00473746|10882629|FG002|Period 1 (Phase 1)|Reason not specified|0
6872080|NCT00473746|10882630|FG003|Period 1 (Phase 1)|Reason not specified|0
6872081|NCT00473746|10882631|FG004|Period 1 (Phase 1)|Reason not specified|0
6872082|NCT00473746|10882627|FG000|Period 2 (Phase 2)|Adverse Event|0
6872083|NCT00473746|10882628|FG001|Period 2 (Phase 2)|Adverse Event|0
6872084|NCT00473746|10882629|FG002|Period 2 (Phase 2)|Adverse Event|0
6872085|NCT00473746|10882630|FG003|Period 2 (Phase 2)|Adverse Event|0
6872086|NCT00473746|10882631|FG004|Period 2 (Phase 2)|Adverse Event|3
6872087|NCT00473746|10882627|FG000|Period 2 (Phase 2)|Death|0
6872088|NCT00473746|10882628|FG001|Period 2 (Phase 2)|Death|0
6872089|NCT00473746|10882629|FG002|Period 2 (Phase 2)|Death|0
6872090|NCT00473746|10882630|FG003|Period 2 (Phase 2)|Death|0
6872091|NCT00473746|10882631|FG004|Period 2 (Phase 2)|Death|1
6872092|NCT00473746|10882627|FG000|Period 2 (Phase 2)|Progressive Disease|0
6872093|NCT00473746|10882628|FG001|Period 2 (Phase 2)|Progressive Disease|0
6872094|NCT00473746|10882629|FG002|Period 2 (Phase 2)|Progressive Disease|0
6872095|NCT00473746|10882630|FG003|Period 2 (Phase 2)|Progressive Disease|0
6872096|NCT00473746|10882631|FG004|Period 2 (Phase 2)|Progressive Disease|20
6872097|NCT00473746|10882627|FG000|Period 2 (Phase 2)|Reason not specified|0
6872098|NCT00473746|10882628|FG001|Period 2 (Phase 2)|Reason not specified|0
6872099|NCT00473746|10882629|FG002|Period 2 (Phase 2)|Reason not specified|0
6872100|NCT00473746|10882630|FG003|Period 2 (Phase 2)|Reason not specified|0
6872101|NCT00473746|10882631|FG004|Period 2 (Phase 2)|Reason not specified|3
6872102|NCT00473824|10882647|FG000|Overall Study|Virologic Breakthrough|1
6872103|NCT00473824|10882648|FG001|Overall Study|Virologic Breakthrough|0
6872104|NCT00473824|10882647|FG000|Overall Study|Adverse Event|1
6872105|NCT00473824|10882648|FG001|Overall Study|Adverse Event|0
6872106|NCT00473824|10882647|FG000|Overall Study|Death|1
6872107|NCT00473824|10882648|FG001|Overall Study|Death|0
6872108|NCT00473824|10882647|FG000|Overall Study|Lost to Follow-up|1
6872109|NCT00473824|10882648|FG001|Overall Study|Lost to Follow-up|0
6872110|NCT00473824|10882647|FG000|Overall Study|Withdrawal by physician|1
6872111|NCT00473824|10882648|FG001|Overall Study|Withdrawal by physician|0
6872112|NCT00473876|10882665|FG000|Overall Study|Lost to Follow-up|3
6872113|NCT00473876|10882666|FG001|Overall Study|Lost to Follow-up|1
6872114|NCT00473889|10882676|FG000|Overall Study|Did not receive study medication|1
6872115|NCT00473889|10882677|FG001|Overall Study|Did not receive study medication|4
6872116|NCT00473889|10882676|FG000|Overall Study|Adverse Event|30
6872117|NCT00473889|10882677|FG001|Overall Study|Adverse Event|17
6872118|NCT00473889|10882676|FG000|Overall Study|Protocol Violation|4
6872119|NCT00473889|10882677|FG001|Overall Study|Protocol Violation|2
6872120|NCT00473889|10882676|FG000|Overall Study|Lack of Efficacy|28
6872121|NCT00473889|10882677|FG001|Overall Study|Lack of Efficacy|29
6872122|NCT00473889|10882676|FG000|Overall Study|Lost to Follow-up|2
6872123|NCT00473889|10882677|FG001|Overall Study|Lost to Follow-up|1
6872124|NCT00473889|10882676|FG000|Overall Study|Physician Decision|10
6872125|NCT00473889|10882677|FG001|Overall Study|Physician Decision|5
6872126|NCT00473889|10882676|FG000|Overall Study|Trial Terminated|3
6872127|NCT00473889|10882677|FG001|Overall Study|Trial Terminated|6
6872128|NCT00473889|10882676|FG000|Overall Study|Withdrawal by Subject|5
6872129|NCT00473889|10882677|FG001|Overall Study|Withdrawal by Subject|0
6872130|NCT00474045|10882685|FG000|Overall Study|Adverse Event|18
6872131|NCT00474045|10882686|FG001|Overall Study|Adverse Event|8
6872132|NCT00474045|10882685|FG000|Overall Study|Unclassified|1
6872133|NCT00474045|10882686|FG001|Overall Study|Unclassified|3
6872134|NCT00474045|10882685|FG000|Overall Study|Lack of Efficacy|0
6872135|NCT00474045|10882686|FG001|Overall Study|Lack of Efficacy|9
6872136|NCT00474045|10882685|FG000|Overall Study|Lost to Follow-up|1
6872137|NCT00474045|10882686|FG001|Overall Study|Lost to Follow-up|1
6872138|NCT00474045|10882685|FG000|Overall Study|Protocol Violation|10
6872139|NCT00474045|10882686|FG001|Overall Study|Protocol Violation|12
6872140|NCT00474045|10882685|FG000|Overall Study|Withdrawal by Subject|16
6872141|NCT00474045|10882686|FG001|Overall Study|Withdrawal by Subject|18
6872142|NCT00474045|10882685|FG000|Overall Study|Withdrawal criteria|60
6872143|NCT00474045|10882686|FG001|Overall Study|Withdrawal criteria|50
6872144|NCT00474058|10882694|FG000|Overall Study|Adverse Event|11
6872145|NCT00474058|10882695|FG001|Overall Study|Adverse Event|6
6872146|NCT00474058|10882694|FG000|Overall Study|Lack of Efficacy|0
6872147|NCT00474058|10882695|FG001|Overall Study|Lack of Efficacy|4
6872148|NCT00474058|10882694|FG000|Overall Study|Withdrawal by Subject|11
6872149|NCT00474058|10882695|FG001|Overall Study|Withdrawal by Subject|7
6872150|NCT00474058|10882694|FG000|Overall Study|Other|2
6872151|NCT00474058|10882695|FG001|Overall Study|Other|0
6872152|NCT00474175|10882713|FG000|Overall Study|Lack of Efficacy|0
6872153|NCT00474175|10882714|FG001|Overall Study|Lack of Efficacy|0
6872154|NCT00474175|10882715|FG002|Overall Study|Lack of Efficacy|1
6872155|NCT00474175|10882713|FG000|Overall Study|Withdrawal by Subject|0
6872156|NCT00474175|10882714|FG001|Overall Study|Withdrawal by Subject|1
6872157|NCT00474175|10882715|FG002|Overall Study|Withdrawal by Subject|1
6872158|NCT00474175|10882713|FG000|Overall Study|Ineligible|1
6872159|NCT00474175|10882714|FG001|Overall Study|Ineligible|3
6872160|NCT00474175|10882715|FG002|Overall Study|Ineligible|1
6872161|NCT00474175|10882713|FG000|Overall Study|Protocol Violation|0
6872162|NCT00474175|10882714|FG001|Overall Study|Protocol Violation|2
6872163|NCT00474175|10882715|FG002|Overall Study|Protocol Violation|1
6872164|NCT00474175|10882713|FG000|Overall Study|Administrative|0
6872165|NCT00474175|10882714|FG001|Overall Study|Administrative|1
6872166|NCT00474175|10882715|FG002|Overall Study|Administrative|0
6872167|NCT00474240|10882734|FG000|Overall Study|Withdrawal by Subject|1
6872168|NCT00474240|10882735|FG001|Overall Study|Withdrawal by Subject|1
6872169|NCT00474240|10882736|FG002|Overall Study|Withdrawal by Subject|0
6872170|NCT00474240|10882737|FG003|Overall Study|Withdrawal by Subject|2
6872171|NCT00474240|10882738|FG004|Overall Study|Withdrawal by Subject|3
6872172|NCT00474240|10882739|FG005|Overall Study|Withdrawal by Subject|1
6872173|NCT00474240|10882734|FG000|Overall Study|Adverse Event|0
6872174|NCT00474240|10882735|FG001|Overall Study|Adverse Event|0
6872175|NCT00474240|10882736|FG002|Overall Study|Adverse Event|9
6872176|NCT00474240|10882737|FG003|Overall Study|Adverse Event|14
6872177|NCT00474240|10882738|FG004|Overall Study|Adverse Event|5
6872178|NCT00474240|10882739|FG005|Overall Study|Adverse Event|16
6872179|NCT00474240|10882734|FG000|Overall Study|Removed due to lab value|0
6872180|NCT00474240|10882735|FG001|Overall Study|Removed due to lab value|0
6872181|NCT00474240|10882736|FG002|Overall Study|Removed due to lab value|0
6872182|NCT00474240|10882737|FG003|Overall Study|Removed due to lab value|0
6872183|NCT00474240|10882738|FG004|Overall Study|Removed due to lab value|0
6872184|NCT00474240|10882739|FG005|Overall Study|Removed due to lab value|1
6872185|NCT00474253|10882755|FG000|Overall Study|Withdrew consent|2
6872186|NCT00474253|10882756|FG001|Overall Study|Withdrew consent|0
6872187|NCT00474253|10882755|FG000|Overall Study|Withdrew due to surgery-related issues|0
6872188|NCT00474253|10882756|FG001|Overall Study|Withdrew due to surgery-related issues|3
6872189|NCT00474253|10882755|FG000|Overall Study|Lost to Follow-up|1
6872190|NCT00474253|10882756|FG001|Overall Study|Lost to Follow-up|0
6872191|NCT00474253|10882755|FG000|Overall Study|Discharged prior to study completion|0
6872192|NCT00474253|10882756|FG001|Overall Study|Discharged prior to study completion|1
6872193|NCT00474266|10882766|FG000|Overall Study|Withdrawal by Subject|7
6872194|NCT00474266|10882767|FG001|Overall Study|Withdrawal by Subject|20
6872195|NCT00474266|10882768|FG002|Overall Study|Withdrawal by Subject|4
6872196|NCT00474266|10882769|FG003|Overall Study|Withdrawal by Subject|7
6872197|NCT00474383|10882782|FG000|Main Study|Adverse Event|11
6872198|NCT00474383|10882783|FG001|Main Study|Adverse Event|0
6872199|NCT00474383|10882782|FG000|Main Study|Symptomatic Deterioration|1
6872200|NCT00474383|10882783|FG001|Main Study|Symptomatic Deterioration|0
6872201|NCT00474383|10882782|FG000|Main Study|Progressive Disease|23
6872202|NCT00474383|10882783|FG001|Main Study|Progressive Disease|0
6872203|NCT00474383|10882782|FG000|Main Study|Other|1
6872204|NCT00474383|10882783|FG001|Main Study|Other|0
6872205|NCT00474383|10882782|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6
6872206|NCT00474383|10882783|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0
6872207|NCT00474383|10882782|FG000|Extension|Progressive Disease|0
6872208|NCT00474383|10882783|FG001|Extension|Progressive Disease|5
6872209|NCT00474487|10882791|FG000|Overall Study|Withdrawal by Subject|6
6872210|NCT00474487|10882792|FG001|Overall Study|Withdrawal by Subject|0
6872211|NCT00474487|10882793|FG002|Overall Study|Withdrawal by Subject|0
6872212|NCT00474487|10882794|FG003|Overall Study|Withdrawal by Subject|0
6872213|NCT00474487|10882791|FG000|Overall Study|Lost to Follow-up|20
6872214|NCT00474487|10882792|FG001|Overall Study|Lost to Follow-up|1
6872215|NCT00474487|10882793|FG002|Overall Study|Lost to Follow-up|7
6872216|NCT00474487|10882794|FG003|Overall Study|Lost to Follow-up|0
6872217|NCT00474487|10882791|FG000|Overall Study|Inappropriate enrollment|4
6872218|NCT00474487|10882792|FG001|Overall Study|Inappropriate enrollment|0
6872219|NCT00474487|10882793|FG002|Overall Study|Inappropriate enrollment|7
6872220|NCT00474487|10882794|FG003|Overall Study|Inappropriate enrollment|0
6872221|NCT00474487|10882791|FG000|Overall Study|Death|0
6872222|NCT00474487|10882792|FG001|Overall Study|Death|1
6872223|NCT00474487|10882793|FG002|Overall Study|Death|0
6872224|NCT00474487|10882794|FG003|Overall Study|Death|0
6872225|NCT00474526|10882821|FG000|Overall Study|ADMINISTRATIVE REASON|11
6872226|NCT00474526|10882822|FG001|Overall Study|ADMINISTRATIVE REASON|9
6872227|NCT00474526|10882823|FG002|Overall Study|ADMINISTRATIVE REASON|9
6872228|NCT00474526|10882824|FG003|Overall Study|ADMINISTRATIVE REASON|20
6872229|NCT00474526|10882825|FG004|Overall Study|ADMINISTRATIVE REASON|9
6872230|NCT00474526|10882826|FG005|Overall Study|ADMINISTRATIVE REASON|1
6872231|NCT00474526|10882827|FG006|Overall Study|ADMINISTRATIVE REASON|1
6872232|NCT00474526|10882828|FG007|Overall Study|ADMINISTRATIVE REASON|0
6872233|NCT00474526|10882829|FG008|Overall Study|ADMINISTRATIVE REASON|2
6872234|NCT00474526|10882830|FG009|Overall Study|ADMINISTRATIVE REASON|1
6872235|NCT00474526|10882831|FG010|Overall Study|ADMINISTRATIVE REASON|1
6872236|NCT00474526|10882832|FG011|Overall Study|ADMINISTRATIVE REASON|1
6872237|NCT00474526|10882833|FG012|Overall Study|ADMINISTRATIVE REASON|1
6872238|NCT00474526|10882834|FG013|Overall Study|ADMINISTRATIVE REASON|1
6872239|NCT00474526|10882835|FG014|Overall Study|ADMINISTRATIVE REASON|2
6872240|NCT00474526|10882836|FG015|Overall Study|ADMINISTRATIVE REASON|0
6872241|NCT00474526|10882837|FG016|Overall Study|ADMINISTRATIVE REASON|0
6872242|NCT00474526|10882821|FG000|Overall Study|Adverse Event|2
6872243|NCT00474526|10882822|FG001|Overall Study|Adverse Event|0
6872244|NCT00474526|10882823|FG002|Overall Study|Adverse Event|2
6872245|NCT00474526|10882824|FG003|Overall Study|Adverse Event|4
6872246|NCT00474526|10882825|FG004|Overall Study|Adverse Event|2
6872247|NCT00474526|10882826|FG005|Overall Study|Adverse Event|1
6872248|NCT00474526|10882827|FG006|Overall Study|Adverse Event|1
6872249|NCT00474526|10882828|FG007|Overall Study|Adverse Event|0
6872250|NCT00474526|10882829|FG008|Overall Study|Adverse Event|0
6872251|NCT00474526|10882830|FG009|Overall Study|Adverse Event|0
6872252|NCT00474526|10882831|FG010|Overall Study|Adverse Event|0
6872253|NCT00474526|10882832|FG011|Overall Study|Adverse Event|0
6872254|NCT00474526|10882833|FG012|Overall Study|Adverse Event|0
6872255|NCT00474526|10882834|FG013|Overall Study|Adverse Event|0
6872256|NCT00474526|10882835|FG014|Overall Study|Adverse Event|1
6872257|NCT00474526|10882836|FG015|Overall Study|Adverse Event|1
6968653|NCT01141205|11017714|FG000|Overall Study|Withdrawal by Subject|1
6968654|NCT01141205|11017715|FG001|Overall Study|Withdrawal by Subject|1
6968655|NCT01141283|11017725|FG000|Overall Study|Adverse Event|56
6968656|NCT01141283|11017725|FG000|Overall Study|Lost to Follow-up|4
6968657|NCT01141283|11017725|FG000|Overall Study|Withdrawal by Subject|14
6968658|NCT01141283|11017725|FG000|Overall Study|Administrative|4
6968659|NCT01141283|11017725|FG000|Overall Study|Lack of Efficacy|10
6968660|NCT01141478|11017746|FG000|Overall Study|Withdrawal by Subject|1
6968661|NCT01141478|11017747|FG001|Overall Study|Withdrawal by Subject|1
6968662|NCT01141660|11017790|FG000|Overall Study|Physician Decision|0
6968663|NCT01141660|11017791|FG001|Overall Study|Physician Decision|12
6968664|NCT01142089|11017817|FG000|Overall Study|Physician Decision|1
6968665|NCT01142089|11017818|FG001|Overall Study|Physician Decision|0
6968666|NCT01142089|11017817|FG000|Overall Study|Withdrawal by Subject|1
6968667|NCT01142089|11017818|FG001|Overall Study|Withdrawal by Subject|2
6968668|NCT01142089|11017817|FG000|Overall Study|Use of prohibited medications|0
6968669|NCT01142089|11017818|FG001|Overall Study|Use of prohibited medications|1
6968670|NCT01142089|11017817|FG000|Overall Study|Noncompliance with study procedures|2
6968671|NCT01142089|11017818|FG001|Overall Study|Noncompliance with study procedures|1
6968672|NCT01142089|11017817|FG000|Overall Study|Patient required rescue medication|8
6968673|NCT01142089|11017818|FG001|Overall Study|Patient required rescue medication|17
6968674|NCT01142115|11017824|FG000|First Intervention|Lack of Efficacy|1
6968675|NCT01142115|11017825|FG001|First Intervention|Lack of Efficacy|1
6968676|NCT01142115|11017824|FG000|First Intervention|Adverse Event|1
6968677|NCT01142115|11017825|FG001|First Intervention|Adverse Event|0
6968678|NCT01142193|11017832|FG000|Overall Study|Adverse Event|12
6968679|NCT01142193|11017833|FG001|Overall Study|Adverse Event|4
6968680|NCT01142193|11017832|FG000|Overall Study|Lack of Efficacy|2
6968681|NCT01142193|11017833|FG001|Overall Study|Lack of Efficacy|1
6968682|NCT01142193|11017832|FG000|Overall Study|Physician Decision|1
6968683|NCT01142193|11017833|FG001|Overall Study|Physician Decision|1
6968684|NCT01142193|11017832|FG000|Overall Study|Withdrawal by Subject|4
6968685|NCT01142193|11017833|FG001|Overall Study|Withdrawal by Subject|3
6968686|NCT01142193|11017832|FG000|Overall Study|Protocol Discontinuation Criterion Met|1
6968687|NCT01142193|11017833|FG001|Overall Study|Protocol Discontinuation Criterion Met|0
6968688|NCT01142193|11017832|FG000|Overall Study|Other|1
6968689|NCT01142193|11017833|FG001|Overall Study|Other|2
6976938|NCT01203072|11029840|FG000|Overall Study|Adverse Event|5
6976939|NCT01203072|11029841|FG001|Overall Study|Adverse Event|3
6976940|NCT01203072|11029842|FG002|Overall Study|Adverse Event|2
6976941|NCT01203072|11029843|FG003|Overall Study|Adverse Event|4
6976942|NCT01203072|11029844|FG004|Overall Study|Adverse Event|2
6976943|NCT01203072|11029840|FG000|Overall Study|Lack of Efficacy|1
6872258|NCT00474526|10882837|FG016|Overall Study|Adverse Event|0
6872259|NCT00474526|10882821|FG000|Overall Study|Death|0
6976944|NCT01203072|11029841|FG001|Overall Study|Lack of Efficacy|0
6976945|NCT01203072|11029842|FG002|Overall Study|Lack of Efficacy|0
6872260|NCT00474526|10882822|FG001|Overall Study|Death|0
6872261|NCT00474526|10882823|FG002|Overall Study|Death|0
6872262|NCT00474526|10882824|FG003|Overall Study|Death|0
6872263|NCT00474526|10882825|FG004|Overall Study|Death|0
6872264|NCT00474526|10882826|FG005|Overall Study|Death|0
6872265|NCT00474526|10882827|FG006|Overall Study|Death|0
6872266|NCT00474526|10882828|FG007|Overall Study|Death|0
6872267|NCT00474526|10882829|FG008|Overall Study|Death|0
6872268|NCT00474526|10882830|FG009|Overall Study|Death|0
6872269|NCT00474526|10882831|FG010|Overall Study|Death|0
6872270|NCT00474526|10882832|FG011|Overall Study|Death|0
6872271|NCT00474526|10882833|FG012|Overall Study|Death|0
6872272|NCT00474526|10882834|FG013|Overall Study|Death|3
6872273|NCT00474526|10882835|FG014|Overall Study|Death|0
6872274|NCT00474526|10882836|FG015|Overall Study|Death|0
6872275|NCT00474526|10882837|FG016|Overall Study|Death|0
6872276|NCT00474526|10882821|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0
6872277|NCT00474526|10882822|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1
6872278|NCT00474526|10882823|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0
6872279|NCT00474526|10882824|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1
6872280|NCT00474526|10882825|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2
6872281|NCT00474526|10882826|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0
6872282|NCT00474526|10882827|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0
6872283|NCT00474526|10882828|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0
6872284|NCT00474526|10882829|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0
6872285|NCT00474526|10882830|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0
6872286|NCT00474526|10882831|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0
6872287|NCT00474526|10882832|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0
6872288|NCT00474526|10882833|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0
6872289|NCT00474526|10882834|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2
6872290|NCT00474526|10882835|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2
6872291|NCT00474526|10882836|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0
6872292|NCT00474526|10882837|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0
6872293|NCT00474526|10882821|FG000|Overall Study|Lost to Follow-up|8
6872294|NCT00474526|10882822|FG001|Overall Study|Lost to Follow-up|6
6872295|NCT00474526|10882823|FG002|Overall Study|Lost to Follow-up|13
6872296|NCT00474526|10882824|FG003|Overall Study|Lost to Follow-up|29
6872297|NCT00474526|10882825|FG004|Overall Study|Lost to Follow-up|11
6872298|NCT00474526|10882826|FG005|Overall Study|Lost to Follow-up|5
6872299|NCT00474526|10882827|FG006|Overall Study|Lost to Follow-up|8
6872300|NCT00474526|10882828|FG007|Overall Study|Lost to Follow-up|1
6872301|NCT00474526|10882829|FG008|Overall Study|Lost to Follow-up|0
6872302|NCT00474526|10882830|FG009|Overall Study|Lost to Follow-up|6
6872303|NCT00474526|10882831|FG010|Overall Study|Lost to Follow-up|2
6872304|NCT00474526|10882832|FG011|Overall Study|Lost to Follow-up|4
6872305|NCT00474526|10882833|FG012|Overall Study|Lost to Follow-up|6
6872306|NCT00474526|10882834|FG013|Overall Study|Lost to Follow-up|74
6872307|NCT00474526|10882835|FG014|Overall Study|Lost to Follow-up|29
6872308|NCT00474526|10882836|FG015|Overall Study|Lost to Follow-up|4
6872309|NCT00474526|10882837|FG016|Overall Study|Lost to Follow-up|5
6872310|NCT00474526|10882821|FG000|Overall Study|Protocol Violation|2
6872311|NCT00474526|10882822|FG001|Overall Study|Protocol Violation|6
6872312|NCT00474526|10882823|FG002|Overall Study|Protocol Violation|4
6872313|NCT00474526|10882824|FG003|Overall Study|Protocol Violation|12
6872314|NCT00474526|10882825|FG004|Overall Study|Protocol Violation|3
6872315|NCT00474526|10882826|FG005|Overall Study|Protocol Violation|1
6872316|NCT00474526|10882827|FG006|Overall Study|Protocol Violation|3
6872317|NCT00474526|10882828|FG007|Overall Study|Protocol Violation|0
6872318|NCT00474526|10882829|FG008|Overall Study|Protocol Violation|0
6872319|NCT00474526|10882830|FG009|Overall Study|Protocol Violation|4
6872320|NCT00474526|10882831|FG010|Overall Study|Protocol Violation|2
6872321|NCT00474526|10882832|FG011|Overall Study|Protocol Violation|2
6872322|NCT00474526|10882833|FG012|Overall Study|Protocol Violation|4
6872323|NCT00474526|10882834|FG013|Overall Study|Protocol Violation|19
6872324|NCT00474526|10882835|FG014|Overall Study|Protocol Violation|9
6872325|NCT00474526|10882836|FG015|Overall Study|Protocol Violation|6
6872326|NCT00474526|10882837|FG016|Overall Study|Protocol Violation|2
6872327|NCT00474526|10882821|FG000|Overall Study|UNABLE TO CLASSIFY|1
6872328|NCT00474526|10882822|FG001|Overall Study|UNABLE TO CLASSIFY|0
6872329|NCT00474526|10882823|FG002|Overall Study|UNABLE TO CLASSIFY|0
6872330|NCT00474526|10882824|FG003|Overall Study|UNABLE TO CLASSIFY|1
6872331|NCT00474526|10882825|FG004|Overall Study|UNABLE TO CLASSIFY|3
6872332|NCT00474526|10882826|FG005|Overall Study|UNABLE TO CLASSIFY|2
6872333|NCT00474526|10882827|FG006|Overall Study|UNABLE TO CLASSIFY|0
6872334|NCT00474526|10882828|FG007|Overall Study|UNABLE TO CLASSIFY|1
6872335|NCT00474526|10882829|FG008|Overall Study|UNABLE TO CLASSIFY|0
6872336|NCT00474526|10882830|FG009|Overall Study|UNABLE TO CLASSIFY|3
6872337|NCT00474526|10882831|FG010|Overall Study|UNABLE TO CLASSIFY|0
6872338|NCT00474526|10882832|FG011|Overall Study|UNABLE TO CLASSIFY|0
6872339|NCT00474526|10882833|FG012|Overall Study|UNABLE TO CLASSIFY|0
6872340|NCT00474526|10882834|FG013|Overall Study|UNABLE TO CLASSIFY|20
6872341|NCT00474526|10882835|FG014|Overall Study|UNABLE TO CLASSIFY|12
6872342|NCT00474526|10882836|FG015|Overall Study|UNABLE TO CLASSIFY|6
6872343|NCT00474526|10882837|FG016|Overall Study|UNABLE TO CLASSIFY|1
6872344|NCT00474526|10882821|FG000|Overall Study|Withdrawal by Subject|9
6872345|NCT00474526|10882822|FG001|Overall Study|Withdrawal by Subject|24
6872346|NCT00474526|10882823|FG002|Overall Study|Withdrawal by Subject|21
6872347|NCT00474526|10882824|FG003|Overall Study|Withdrawal by Subject|52
6872348|NCT00474526|10882825|FG004|Overall Study|Withdrawal by Subject|38
6872349|NCT00474526|10882826|FG005|Overall Study|Withdrawal by Subject|6
6872350|NCT00474526|10882827|FG006|Overall Study|Withdrawal by Subject|12
6872351|NCT00474526|10882828|FG007|Overall Study|Withdrawal by Subject|4
6872352|NCT00474526|10882829|FG008|Overall Study|Withdrawal by Subject|4
6872353|NCT00474526|10882830|FG009|Overall Study|Withdrawal by Subject|13
6872354|NCT00474526|10882831|FG010|Overall Study|Withdrawal by Subject|5
6872355|NCT00474526|10882832|FG011|Overall Study|Withdrawal by Subject|4
6872356|NCT00474526|10882833|FG012|Overall Study|Withdrawal by Subject|4
6872357|NCT00474526|10882834|FG013|Overall Study|Withdrawal by Subject|37
6872358|NCT00474526|10882835|FG014|Overall Study|Withdrawal by Subject|22
6872359|NCT00474526|10882836|FG015|Overall Study|Withdrawal by Subject|1
6872360|NCT00474526|10882837|FG016|Overall Study|Withdrawal by Subject|1
6872361|NCT00474539|10882925|FG000|Infant Series|Withdrawal by Subject|3
6872362|NCT00474539|10882926|FG001|Infant Series|Withdrawal by Subject|4
6872363|NCT00474539|10882925|FG000|Infant Series|Randomization error|5
6872364|NCT00474539|10882926|FG001|Infant Series|Randomization error|0
6872365|NCT00474539|10882925|FG000|Infant Series|Lost to Follow-up|2
6872366|NCT00474539|10882926|FG001|Infant Series|Lost to Follow-up|1
6872367|NCT00474539|10882925|FG000|Infant Series|Protocol Violation|0
6872368|NCT00474539|10882926|FG001|Infant Series|Protocol Violation|1
6872369|NCT00474539|10882925|FG000|After Infant Series|Lost to Follow-up|3
6872370|NCT00474539|10882926|FG001|After Infant Series|Lost to Follow-up|0
6872371|NCT00474539|10882925|FG000|After Infant Series|Withdrawal by Subject|1
6872372|NCT00474539|10882926|FG001|After Infant Series|Withdrawal by Subject|0
6872373|NCT00474539|10882925|FG000|Toddler Dose|Protocol Violation|1
6872374|NCT00474539|10882926|FG001|Toddler Dose|Protocol Violation|0
6872375|NCT00474630|10882972|FG000|Overall Study|Adverse Event|98
6872376|NCT00474630|10882973|FG001|Overall Study|Adverse Event|26
6872377|NCT00474630|10882972|FG000|Overall Study|Lost to Follow-up|22
6872378|NCT00474630|10882973|FG001|Overall Study|Lost to Follow-up|15
6872379|NCT00474630|10882972|FG000|Overall Study|Withdrawal by Subject|21
6872380|NCT00474630|10882973|FG001|Overall Study|Withdrawal by Subject|15
6872381|NCT00474630|10882972|FG000|Overall Study|Protocol Violation|3
6872382|NCT00474630|10882973|FG001|Overall Study|Protocol Violation|4
6872383|NCT00474630|10882972|FG000|Overall Study|Lack of Efficacy|5
6872384|NCT00474630|10882973|FG001|Overall Study|Lack of Efficacy|6
6872385|NCT00474630|10882972|FG000|Overall Study|Drug noncompliance, other|11
6872386|NCT00474630|10882973|FG001|Overall Study|Drug noncompliance, other|4
6872387|NCT00474708|10882982|FG000|Overall Study|Lack of Efficacy|11
6872388|NCT00474708|10882983|FG001|Overall Study|Lack of Efficacy|5
6872389|NCT00474708|10882982|FG000|Overall Study|Suicide ideation/behavior|0
6872390|NCT00474708|10882983|FG001|Overall Study|Suicide ideation/behavior|1
6872391|NCT00474708|10882982|FG000|Overall Study|Withdrawal by Subject|7
6872392|NCT00474708|10882983|FG001|Overall Study|Withdrawal by Subject|0
6872393|NCT00474708|10882982|FG000|Overall Study|Lack of compliance|12
6872394|NCT00474708|10882983|FG001|Overall Study|Lack of compliance|4
6872395|NCT00474708|10882982|FG000|Overall Study|Lost to Follow-up|18
6872396|NCT00474708|10882983|FG001|Overall Study|Lost to Follow-up|9
6872397|NCT00474708|10882982|FG000|Overall Study|Physician Decision|9
6872398|NCT00474708|10882983|FG001|Overall Study|Physician Decision|6
6872399|NCT00474760|10882996|FG000|Overall Study|Death|0
6872400|NCT00474760|10882997|FG001|Overall Study|Death|0
6872401|NCT00474760|10882998|FG002|Overall Study|Death|0
6872402|NCT00474760|10882999|FG003|Overall Study|Death|0
6872403|NCT00474760|10883000|FG004|Overall Study|Death|2
6872404|NCT00474760|10883001|FG005|Overall Study|Death|0
6872405|NCT00474760|10883002|FG006|Overall Study|Death|0
6872406|NCT00474760|10882996|FG000|Overall Study|Adverse Event|0
6872407|NCT00474760|10882997|FG001|Overall Study|Adverse Event|0
6872408|NCT00474760|10882998|FG002|Overall Study|Adverse Event|0
6872409|NCT00474760|10882999|FG003|Overall Study|Adverse Event|0
6872410|NCT00474760|10883000|FG004|Overall Study|Adverse Event|1
6872411|NCT00474760|10883001|FG005|Overall Study|Adverse Event|7
6872412|NCT00474760|10883002|FG006|Overall Study|Adverse Event|0
6872413|NCT00474760|10882996|FG000|Overall Study|Laboratory abnormality|0
6872414|NCT00474760|10882997|FG001|Overall Study|Laboratory abnormality|0
6872415|NCT00474760|10882998|FG002|Overall Study|Laboratory abnormality|0
6872416|NCT00474760|10882999|FG003|Overall Study|Laboratory abnormality|0
6872417|NCT00474760|10883000|FG004|Overall Study|Laboratory abnormality|0
6872418|NCT00474760|10883001|FG005|Overall Study|Laboratory abnormality|1
6872419|NCT00474760|10883002|FG006|Overall Study|Laboratory abnormality|0
6872420|NCT00474760|10882996|FG000|Overall Study|Withdrawal by Subject|0
6872421|NCT00474760|10882997|FG001|Overall Study|Withdrawal by Subject|0
7078455|NCT02104583|11187029|FG001|Overall Study|Withdrew Consent|2
7078456|NCT02104583|11187030|FG002|Overall Study|Withdrew Consent|0
7078457|NCT02104583|11187031|FG003|Overall Study|Withdrew Consent|2
7078458|NCT02104583|11187032|FG004|Overall Study|Withdrew Consent|1
6872422|NCT00474760|10882998|FG002|Overall Study|Withdrawal by Subject|0
6872423|NCT00474760|10882999|FG003|Overall Study|Withdrawal by Subject|1
6872424|NCT00474760|10883000|FG004|Overall Study|Withdrawal by Subject|0
6872425|NCT00474760|10883001|FG005|Overall Study|Withdrawal by Subject|1
6872426|NCT00474760|10883002|FG006|Overall Study|Withdrawal by Subject|1
6872427|NCT00474760|10882996|FG000|Overall Study|Other|0
6872428|NCT00474760|10882997|FG001|Overall Study|Other|1
7078459|NCT02104583|11187028|FG000|Overall Study|Investigator's Discretion|1
6872429|NCT00474760|10882998|FG002|Overall Study|Other|0
6872430|NCT00474760|10882999|FG003|Overall Study|Other|0
6872431|NCT00474760|10883000|FG004|Overall Study|Other|1
6872432|NCT00474760|10883001|FG005|Overall Study|Other|0
6872433|NCT00474760|10883002|FG006|Overall Study|Other|0
7154291|NCT03308968|11320894|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2
7154292|NCT03308968|11320892|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1
6872434|NCT00474760|10882996|FG000|Overall Study|Progressive disease|3
6872435|NCT00474760|10882997|FG001|Overall Study|Progressive disease|2
6872436|NCT00474760|10882998|FG002|Overall Study|Progressive disease|3
6872437|NCT00474760|10882999|FG003|Overall Study|Progressive disease|2
6872438|NCT00474760|10883000|FG004|Overall Study|Progressive disease|8
6872439|NCT00474760|10883001|FG005|Overall Study|Progressive disease|20
6872440|NCT00474760|10883002|FG006|Overall Study|Progressive disease|7
6872441|NCT00474760|10882996|FG000|Overall Study|Terminated by sponsor|0
6872442|NCT00474760|10882997|FG001|Overall Study|Terminated by sponsor|0
6872443|NCT00474760|10882998|FG002|Overall Study|Terminated by sponsor|0
6872444|NCT00474760|10882999|FG003|Overall Study|Terminated by sponsor|0
6872445|NCT00474760|10883000|FG004|Overall Study|Terminated by sponsor|0
6872446|NCT00474760|10883001|FG005|Overall Study|Terminated by sponsor|0
6872447|NCT00474760|10883002|FG006|Overall Study|Terminated by sponsor|2
6872448|NCT00474786|10883027|FG000|Overall Study|Not Meeting Study Criteria|0
6872449|NCT00474786|10883028|FG001|Overall Study|Not Meeting Study Criteria|1
6872450|NCT00474786|10883027|FG000|Overall Study|Investigator Request|2
6872451|NCT00474786|10883028|FG001|Overall Study|Investigator Request|1
6872452|NCT00474786|10883027|FG000|Overall Study|Death|189
6872453|NCT00474786|10883028|FG001|Overall Study|Death|170
6872454|NCT00474786|10883027|FG000|Overall Study|Discontinuation of Study by Sponsor|42
6872455|NCT00474786|10883028|FG001|Overall Study|Discontinuation of Study by Sponsor|59
6872456|NCT00474786|10883027|FG000|Overall Study|Lost to Follow-up|4
6872457|NCT00474786|10883028|FG001|Overall Study|Lost to Follow-up|7
6872458|NCT00474786|10883027|FG000|Overall Study|Protocol Violation|2
6872459|NCT00474786|10883028|FG001|Overall Study|Protocol Violation|0
6872460|NCT00474786|10883027|FG000|Overall Study|Withdrawal by Subject|15
6872461|NCT00474786|10883028|FG001|Overall Study|Withdrawal by Subject|15
6872462|NCT00474786|10883027|FG000|Overall Study|Other|5
6872463|NCT00474786|10883028|FG001|Overall Study|Other|0
6872464|NCT00474812|10883034|FG000|Overall Study|Withdrawal by Subject|5
6872465|NCT00474812|10883034|FG000|Overall Study|No Initiation of treatment|2
6872466|NCT00474903|10883051|FG000|Overall Study|Protocol Violation|1
7154293|NCT03308968|11320893|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1
7154294|NCT03308968|11320894|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0
7154295|NCT03308968|11320892|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1
7154296|NCT03308968|11320893|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0
7154297|NCT03308968|11320894|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0
7154298|NCT03308968|11320892|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1
7154299|NCT03308968|11320893|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1
7154300|NCT03308968|11320894|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0
6872467|NCT00474903|10883052|FG001|Overall Study|Protocol Violation|5
6872468|NCT00474903|10883053|FG002|Overall Study|Protocol Violation|2
6872469|NCT00474929|10883066|FG000|Overall Study|Withdrawal by Subject|0
6872470|NCT00474929|10883067|FG001|Overall Study|Withdrawal by Subject|1
6872471|NCT00474929|10883068|FG002|Overall Study|Withdrawal by Subject|0
6872472|NCT00474929|10883069|FG003|Overall Study|Withdrawal by Subject|0
6872473|NCT00474929|10883070|FG004|Overall Study|Withdrawal by Subject|0
6872474|NCT00474929|10883066|FG000|Overall Study|Unrelated medical condition|0
6872475|NCT00474929|10883067|FG001|Overall Study|Unrelated medical condition|0
6872476|NCT00474929|10883068|FG002|Overall Study|Unrelated medical condition|1
6872477|NCT00474929|10883069|FG003|Overall Study|Unrelated medical condition|0
6872478|NCT00474929|10883070|FG004|Overall Study|Unrelated medical condition|0
6872479|NCT00474929|10883066|FG000|Overall Study|Physician Decision|0
6872480|NCT00474929|10883067|FG001|Overall Study|Physician Decision|0
6872481|NCT00474929|10883068|FG002|Overall Study|Physician Decision|1
6872482|NCT00474929|10883069|FG003|Overall Study|Physician Decision|2
6872483|NCT00474929|10883070|FG004|Overall Study|Physician Decision|0
6872484|NCT00474955|10883083|FG000|Overall Study|Adverse Event|2
6872485|NCT00474955|10883083|FG000|Overall Study|Drug unavailability|1
6872486|NCT00474955|10883083|FG000|Overall Study|Personal reasons|5
6872487|NCT00474968|10883089|FG000|Overall Study|Withdrawal by Subject|8
6872488|NCT00474968|10883090|FG001|Overall Study|Withdrawal by Subject|7
6872489|NCT00474968|10883089|FG000|Overall Study|Protocol Violation|9
6872490|NCT00474968|10883090|FG001|Overall Study|Protocol Violation|8
6872491|NCT00474968|10883089|FG000|Overall Study|Sample not collected|1
6872492|NCT00474968|10883090|FG001|Overall Study|Sample not collected|1
6872493|NCT00474994|10883096|FG000|Overall Study|Patient Not treated|1
6872494|NCT00474994|10883096|FG000|Overall Study|Patient evaluable for toxicity only|3
6872495|NCT00474994|10883096|FG000|Overall Study|Patient found to be ineligible|1
6872496|NCT00475020|10883100|FG000|Overall Study|Physician Decision|3
6872497|NCT00475020|10883100|FG000|Overall Study|Insurance Denial|1
6872498|NCT00475020|10883100|FG000|Overall Study|Donor not able to donate the last minute|1
6872499|NCT00475033|10883106|FG000|Infant Series|Failed to return|3
6872500|NCT00475033|10883107|FG001|Infant Series|Failed to return|4
6872501|NCT00475033|10883106|FG000|Infant Series|Parent or legal guardian request|1
6872502|NCT00475033|10883107|FG001|Infant Series|Parent or legal guardian request|5
6872503|NCT00475033|10883106|FG000|Infant Series|Protocol Violation|1
6872504|NCT00475033|10883107|FG001|Infant Series|Protocol Violation|2
6872505|NCT00475033|10883106|FG000|Infant Series|Lost to Follow-up|2
6872506|NCT00475033|10883107|FG001|Infant Series|Lost to Follow-up|0
6872507|NCT00475033|10883106|FG000|Infant Series|Adverse Event|0
6872508|NCT00475033|10883107|FG001|Infant Series|Adverse Event|2
6872509|NCT00475033|10883106|FG000|After the Infant Series|Adverse Event|0
6872510|NCT00475033|10883107|FG001|After the Infant Series|Adverse Event|4
6872511|NCT00475033|10883106|FG000|After the Infant Series|Parent or legal guardian request|2
6872512|NCT00475033|10883107|FG001|After the Infant Series|Parent or legal guardian request|2
6872513|NCT00475033|10883106|FG000|After the Infant Series|Failed to return|2
6872514|NCT00475033|10883107|FG001|After the Infant Series|Failed to return|1
6872515|NCT00475033|10883106|FG000|After the Infant Series|Protocol Violation|1
6872516|NCT00475033|10883107|FG001|After the Infant Series|Protocol Violation|0
6872517|NCT00475033|10883106|FG000|After the Infant Series|Lost to Follow-up|1
6872518|NCT00475033|10883107|FG001|After the Infant Series|Lost to Follow-up|0
6872519|NCT00475033|10883106|FG000|After the Infant Series|Other|0
6872520|NCT00475033|10883107|FG001|After the Infant Series|Other|1
6872521|NCT00475033|10883106|FG000|Toddler Dose|Parent or legal guardian request|2
6872522|NCT00475033|10883107|FG001|Toddler Dose|Parent or legal guardian request|0
6872523|NCT00475033|10883106|FG000|Toddler Dose|Failed to return|1
6872524|NCT00475033|10883107|FG001|Toddler Dose|Failed to return|0
6872525|NCT00475033|10883106|FG000|Toddler Dose|Lost to Follow-up|1
6872526|NCT00475033|10883107|FG001|Toddler Dose|Lost to Follow-up|0
6872527|NCT00475176|10883145|FG000|Overall Study|Adverse Event|2
6872528|NCT00475176|10883145|FG000|Overall Study|Withdrawal by Subject|1
6872529|NCT00475176|10883145|FG000|Overall Study|Protocol Violation|1
6872530|NCT00475228|10883160|FG000|Overall Study|Lost to Follow-up|17
6872531|NCT00475228|10883161|FG001|Overall Study|Lost to Follow-up|17
6872532|NCT00475306|10883185|FG000|Overall Study|Protocol Violation|1
6872533|NCT00475306|10883186|FG001|Overall Study|Protocol Violation|1
6872534|NCT00475306|10883187|FG002|Overall Study|Protocol Violation|0
6872535|NCT00475306|10883188|FG003|Overall Study|Protocol Violation|1
6872536|NCT00475423|10883214|FG000|Overall Study|Protocol Violation|5
6872537|NCT00475423|10883214|FG000|Overall Study|Adverse Event|4
6872538|NCT00475423|10883214|FG000|Overall Study|Withdrawal by Subject|6
6872539|NCT00475423|10883214|FG000|Overall Study|Lack of Efficacy|8
6872540|NCT00475423|10883214|FG000|Overall Study|Death|1
6872541|NCT00475423|10883214|FG000|Overall Study|Reason not specified|1
6872542|NCT00475423|10883214|FG000|Overall Study|Lost to Follow-up|7
6872543|NCT00475644|10883267|FG000|Overall Study|Protocol Violation|13
6872544|NCT00475670|10883273|FG000|Overall Study|Death|0
6872545|NCT00475670|10883274|FG001|Overall Study|Death|1
6872546|NCT00475670|10883273|FG000|Overall Study|Lack of Efficacy|3
6872547|NCT00475670|10883274|FG001|Overall Study|Lack of Efficacy|34
6872548|NCT00475670|10883273|FG000|Overall Study|Refused treatment|0
6872549|NCT00475670|10883274|FG001|Overall Study|Refused treatment|2
6872550|NCT00475670|10883273|FG000|Overall Study|Failure to Return|0
6872551|NCT00475670|10883274|FG001|Overall Study|Failure to Return|1
6872552|NCT00475670|10883273|FG000|Overall Study|Other|0
6872553|NCT00475670|10883274|FG001|Overall Study|Other|3
6872554|NCT00475709|10883280|FG000|Overall Study|Did not meet eligibility criteria|8
6872555|NCT00475709|10883280|FG000|Overall Study|Death|41
6872556|NCT00475709|10883280|FG000|Overall Study|Device Explant|6
6872557|NCT00475709|10883280|FG000|Overall Study|Lost to Follow-up|21
6872558|NCT00475722|10883286|FG000|Overall Study|Withdrawal by Subject|12
6872559|NCT00475722|10883287|FG001|Overall Study|Withdrawal by Subject|12
6872560|NCT00475722|10883286|FG000|Overall Study|Protocol Violation|3
6872561|NCT00475722|10883287|FG001|Overall Study|Protocol Violation|0
6872562|NCT00475735|10883299|FG000|Treatment Period 1|Adverse Event|2
6872563|NCT00475735|10883300|FG001|Treatment Period 1|Adverse Event|0
6872564|NCT00475735|10883301|FG002|Treatment Period 1|Adverse Event|0
6872565|NCT00475735|10883302|FG003|Treatment Period 1|Adverse Event|0
6872566|NCT00475735|10883303|FG004|Treatment Period 1|Adverse Event|0
6872567|NCT00475735|10883304|FG005|Treatment Period 1|Adverse Event|0
6872568|NCT00475735|10883299|FG000|Treatment Period 1|Lack of Efficacy|1
6872569|NCT00475735|10883300|FG001|Treatment Period 1|Lack of Efficacy|0
6872570|NCT00475735|10883301|FG002|Treatment Period 1|Lack of Efficacy|0
6872571|NCT00475735|10883302|FG003|Treatment Period 1|Lack of Efficacy|0
6872572|NCT00475735|10883303|FG004|Treatment Period 1|Lack of Efficacy|0
6872573|NCT00475735|10883304|FG005|Treatment Period 1|Lack of Efficacy|0
6872574|NCT00475735|10883299|FG000|Treatment Period 1|Lost to Follow-up|0
6872575|NCT00475735|10883300|FG001|Treatment Period 1|Lost to Follow-up|0
6872576|NCT00475735|10883301|FG002|Treatment Period 1|Lost to Follow-up|0
6872577|NCT00475735|10883302|FG003|Treatment Period 1|Lost to Follow-up|0
6872578|NCT00475735|10883303|FG004|Treatment Period 1|Lost to Follow-up|0
6872579|NCT00475735|10883304|FG005|Treatment Period 1|Lost to Follow-up|1
6872580|NCT00475735|10883299|FG000|Treatment Period 1|Protocol Violation|0
6872581|NCT00475735|10883300|FG001|Treatment Period 1|Protocol Violation|0
6872582|NCT00475735|10883301|FG002|Treatment Period 1|Protocol Violation|0
6872583|NCT00475735|10883302|FG003|Treatment Period 1|Protocol Violation|1
6872584|NCT00475735|10883303|FG004|Treatment Period 1|Protocol Violation|0
6872585|NCT00475735|10883304|FG005|Treatment Period 1|Protocol Violation|0
6872586|NCT00475735|10883299|FG000|Treatment Period 1|Withdrawal by Subject|1
6872587|NCT00475735|10883300|FG001|Treatment Period 1|Withdrawal by Subject|1
6872588|NCT00475735|10883301|FG002|Treatment Period 1|Withdrawal by Subject|0
6872589|NCT00475735|10883302|FG003|Treatment Period 1|Withdrawal by Subject|0
6872590|NCT00475735|10883303|FG004|Treatment Period 1|Withdrawal by Subject|0
6872591|NCT00475735|10883304|FG005|Treatment Period 1|Withdrawal by Subject|0
6872592|NCT00475735|10883299|FG000|Treatment Period 1|DC due to AE but continuing|0
6872593|NCT00475735|10883300|FG001|Treatment Period 1|DC due to AE but continuing|0
6872594|NCT00475735|10883301|FG002|Treatment Period 1|DC due to AE but continuing|0
6872595|NCT00475735|10883302|FG003|Treatment Period 1|DC due to AE but continuing|1
6872596|NCT00475735|10883303|FG004|Treatment Period 1|DC due to AE but continuing|2
6872597|NCT00475735|10883304|FG005|Treatment Period 1|DC due to AE but continuing|2
6872598|NCT00475735|10883299|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0
6872599|NCT00475735|10883300|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1
6872600|NCT00475735|10883301|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0
6872601|NCT00475735|10883302|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0
6872602|NCT00475735|10883303|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0
6872603|NCT00475735|10883304|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0
6872604|NCT00475735|10883299|FG000|Treatment Washout|Lost to Follow-up|0
6872605|NCT00475735|10883300|FG001|Treatment Washout|Lost to Follow-up|1
6872606|NCT00475735|10883301|FG002|Treatment Washout|Lost to Follow-up|0
6872607|NCT00475735|10883302|FG003|Treatment Washout|Lost to Follow-up|0
6872608|NCT00475735|10883303|FG004|Treatment Washout|Lost to Follow-up|0
6872609|NCT00475735|10883304|FG005|Treatment Washout|Lost to Follow-up|0
6872610|NCT00475735|10883299|FG000|Treatment Washout|Protocol Violation|0
6872611|NCT00475735|10883300|FG001|Treatment Washout|Protocol Violation|1
6872612|NCT00475735|10883301|FG002|Treatment Washout|Protocol Violation|0
6872613|NCT00475735|10883302|FG003|Treatment Washout|Protocol Violation|0
6872614|NCT00475735|10883303|FG004|Treatment Washout|Protocol Violation|0
6872615|NCT00475735|10883304|FG005|Treatment Washout|Protocol Violation|0
6872616|NCT00475735|10883299|FG000|Treatment Period 2|Adverse Event|0
6872617|NCT00475735|10883300|FG001|Treatment Period 2|Adverse Event|1
6872618|NCT00475735|10883301|FG002|Treatment Period 2|Adverse Event|0
6872619|NCT00475735|10883302|FG003|Treatment Period 2|Adverse Event|2
6872620|NCT00475735|10883303|FG004|Treatment Period 2|Adverse Event|0
6872621|NCT00475735|10883304|FG005|Treatment Period 2|Adverse Event|0
6872622|NCT00475735|10883299|FG000|Treatment Period 2|Lack of Efficacy|0
6872623|NCT00475735|10883300|FG001|Treatment Period 2|Lack of Efficacy|0
6872624|NCT00475735|10883301|FG002|Treatment Period 2|Lack of Efficacy|0
6872625|NCT00475735|10883302|FG003|Treatment Period 2|Lack of Efficacy|0
6872626|NCT00475735|10883303|FG004|Treatment Period 2|Lack of Efficacy|0
6872627|NCT00475735|10883304|FG005|Treatment Period 2|Lack of Efficacy|1
6872628|NCT00475735|10883299|FG000|Treatment Period 2|Withdrawal by Subject|0
6872629|NCT00475735|10883300|FG001|Treatment Period 2|Withdrawal by Subject|0
6872630|NCT00475735|10883301|FG002|Treatment Period 2|Withdrawal by Subject|0
6872631|NCT00475735|10883302|FG003|Treatment Period 2|Withdrawal by Subject|0
6872632|NCT00475735|10883303|FG004|Treatment Period 2|Withdrawal by Subject|1
6872633|NCT00475735|10883304|FG005|Treatment Period 2|Withdrawal by Subject|0
6872634|NCT00475852|10883325|FG000|Overall Study|Death|444
6872635|NCT00475852|10883326|FG001|Overall Study|Death|456
6872636|NCT00475852|10883325|FG000|Overall Study|Withdrawal by Subject|19
6872637|NCT00475852|10883326|FG001|Overall Study|Withdrawal by Subject|24
6872638|NCT00475852|10883325|FG000|Overall Study|Lost to Follow-up|54
6872639|NCT00475852|10883326|FG001|Overall Study|Lost to Follow-up|68
6872640|NCT00475865|10883335|FG000|Overall Study|Adverse Event|0
6872641|NCT00475865|10883336|FG001|Overall Study|Adverse Event|3
6872642|NCT00475865|10883337|FG002|Overall Study|Adverse Event|4
6872643|NCT00475865|10883335|FG000|Overall Study|Lack of Efficacy|1
6872644|NCT00475865|10883336|FG001|Overall Study|Lack of Efficacy|0
6872645|NCT00475865|10883337|FG002|Overall Study|Lack of Efficacy|0
6872646|NCT00475865|10883335|FG000|Overall Study|Progressive disease|0
6872647|NCT00475865|10883336|FG001|Overall Study|Progressive disease|1
6872648|NCT00475865|10883337|FG002|Overall Study|Progressive disease|2
6872649|NCT00475865|10883335|FG000|Overall Study|Participant did not wish to continue|1
6872650|NCT00475865|10883336|FG001|Overall Study|Participant did not wish to continue|0
6872651|NCT00475865|10883337|FG002|Overall Study|Participant did not wish to continue|0
6872652|NCT00475865|10883335|FG000|Overall Study|Other than above|0
6872653|NCT00475865|10883336|FG001|Overall Study|Other than above|1
6872654|NCT00475865|10883337|FG002|Overall Study|Other than above|0
6872655|NCT00475982|10883373|FG000|Overall Study|surgery rescheduled|7
6872656|NCT00475982|10883374|FG001|Overall Study|surgery rescheduled|3
6968690|NCT01142232|11017844|FG000|Overall Study|Adverse Event|1
6968691|NCT01142232|11017845|FG001|Overall Study|Adverse Event|2
6968692|NCT01142232|11017846|FG002|Overall Study|Adverse Event|1
6968693|NCT01142232|11017847|FG003|Overall Study|Adverse Event|0
6968694|NCT01142232|11017848|FG004|Overall Study|Adverse Event|4
6968695|NCT01142232|11017844|FG000|Overall Study|Death|0
7078460|NCT02104583|11187029|FG001|Overall Study|Investigator's Discretion|0
7078461|NCT02104583|11187030|FG002|Overall Study|Investigator's Discretion|0
7078462|NCT02104583|11187031|FG003|Overall Study|Investigator's Discretion|0
6968696|NCT01142232|11017845|FG001|Overall Study|Death|0
6968697|NCT01142232|11017846|FG002|Overall Study|Death|0
6968698|NCT01142232|11017847|FG003|Overall Study|Death|0
6968699|NCT01142232|11017848|FG004|Overall Study|Death|1
6968700|NCT01142232|11017844|FG000|Overall Study|Disease Progression|2
6968701|NCT01142232|11017845|FG001|Overall Study|Disease Progression|0
6968702|NCT01142232|11017846|FG002|Overall Study|Disease Progression|1
6872657|NCT00476008|10883382|FG000|Overall Study|Adverse Event|4
6872658|NCT00476008|10883383|FG001|Overall Study|Adverse Event|4
6872659|NCT00476008|10883382|FG000|Overall Study|Placebo concerns|2
6872660|NCT00476008|10883383|FG001|Overall Study|Placebo concerns|2
6872661|NCT00476008|10883382|FG000|Overall Study|Physician Decision: Medication Noncompli|2
6872662|NCT00476008|10883383|FG001|Overall Study|Physician Decision: Medication Noncompli|1
6872663|NCT00476008|10883382|FG000|Overall Study|Withdrawal by Subject|0
6872664|NCT00476008|10883383|FG001|Overall Study|Withdrawal by Subject|1
6872665|NCT00476008|10883382|FG000|Overall Study|Death|1
6872666|NCT00476008|10883383|FG001|Overall Study|Death|0
6872667|NCT00476047|10883408|FG000|Overall Study|Lost to Follow-up|1
6872668|NCT00476086|10883414|FG000|Overall Study|Alternative therapy|1
6872669|NCT00476086|10883414|FG000|Overall Study|Progressive Disease|4
6872670|NCT00476151|10883422|FG000|Overall Study|Adverse Event|0
6872671|NCT00476151|10883423|FG001|Overall Study|Adverse Event|2
6872672|NCT00476151|10883422|FG000|Overall Study|Protocol Violation|1
6872673|NCT00476151|10883423|FG001|Overall Study|Protocol Violation|3
6872674|NCT00476151|10883422|FG000|Overall Study|Withdrawal by Subject|2
6872675|NCT00476151|10883423|FG001|Overall Study|Withdrawal by Subject|0
6872676|NCT00476151|10883422|FG000|Overall Study|Physician Decision|0
6872677|NCT00476151|10883423|FG001|Overall Study|Physician Decision|2
6872678|NCT00476229|10883429|FG000|Overall Study|Progressive shortness of breath|1
6872679|NCT00476476|10883446|FG000|Overall Study|Adverse Event|2
6872680|NCT00476476|10883447|FG001|Overall Study|Adverse Event|7
6872681|NCT00476476|10883446|FG000|Overall Study|Progressive Disease|0
6872682|NCT00476476|10883447|FG001|Overall Study|Progressive Disease|17
6872683|NCT00476593|10883456|FG000|Overall Study|Lost to Follow-up|10
6872684|NCT00476593|10883457|FG001|Overall Study|Lost to Follow-up|2
6872685|NCT00476593|10883458|FG002|Overall Study|Lost to Follow-up|8
6872686|NCT00476593|10883459|FG003|Overall Study|Lost to Follow-up|22
6872687|NCT00476957|10883479|FG000|Overall Study|Lost to Follow-up|176
6872688|NCT00476957|10883480|FG001|Overall Study|Lost to Follow-up|193
6872689|NCT00476996|10883489|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12
6872690|NCT00476996|10883490|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7
6872691|NCT00476996|10883491|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7
6872692|NCT00476996|10883492|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0
6872693|NCT00476996|10883489|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1
6872694|NCT00476996|10883490|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3
6872695|NCT00476996|10883491|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0
6872696|NCT00476996|10883492|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0
6872697|NCT00476996|10883489|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24
6872698|NCT00476996|10883490|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20
6872699|NCT00476996|10883491|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21
6872700|NCT00476996|10883492|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0
6872701|NCT00476996|10883489|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
6872702|NCT00476996|10883490|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2
6872703|NCT00476996|10883491|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
6872704|NCT00476996|10883492|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
6872705|NCT00476996|10883489|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0
6872706|NCT00476996|10883490|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4
6872707|NCT00476996|10883491|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3
6872708|NCT00476996|10883492|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0
6872709|NCT00476996|10883489|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22
7078463|NCT02104583|11187032|FG004|Overall Study|Investigator's Discretion|0
7078464|NCT02104583|11187028|FG000|Overall Study|Protocol Violation|0
7078465|NCT02104583|11187029|FG001|Overall Study|Protocol Violation|0
7078466|NCT02104583|11187030|FG002|Overall Study|Protocol Violation|1
7078467|NCT02104583|11187031|FG003|Overall Study|Protocol Violation|0
7078468|NCT02104583|11187032|FG004|Overall Study|Protocol Violation|0
7078469|NCT02104583|11187028|FG000|Overall Study|Adverse Event|3
7078470|NCT02104583|11187029|FG001|Overall Study|Adverse Event|3
7078471|NCT02104583|11187030|FG002|Overall Study|Adverse Event|6
7078472|NCT02104583|11187031|FG003|Overall Study|Adverse Event|6
6872710|NCT00476996|10883490|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5
6872711|NCT00476996|10883491|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6
6872712|NCT00476996|10883492|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0
6872713|NCT00476996|10883489|FG000|Blinded Treatment Phase (up to Week 48)|Death|2
6872714|NCT00476996|10883490|FG001|Blinded Treatment Phase (up to Week 48)|Death|1
6872715|NCT00476996|10883491|FG002|Blinded Treatment Phase (up to Week 48)|Death|1
6872716|NCT00476996|10883492|FG003|Blinded Treatment Phase (up to Week 48)|Death|0
6872717|NCT00476996|10883489|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11
7078473|NCT02104583|11187032|FG004|Overall Study|Adverse Event|1
6872718|NCT00476996|10883490|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13
6872719|NCT00476996|10883491|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7
6872720|NCT00476996|10883492|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0
7078474|NCT02104583|11187028|FG000|Overall Study|Lost to Follow-up|1
7078475|NCT02104583|11187029|FG001|Overall Study|Lost to Follow-up|0
6872721|NCT00476996|10883489|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0
6872722|NCT00476996|10883490|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0
6872723|NCT00476996|10883491|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0
6872724|NCT00476996|10883492|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50
6872725|NCT00476996|10883489|FG000|OLE Phase (From Week 48)|Adverse Event|0
6872726|NCT00476996|10883490|FG001|OLE Phase (From Week 48)|Adverse Event|0
6872727|NCT00476996|10883491|FG002|OLE Phase (From Week 48)|Adverse Event|0
6872728|NCT00476996|10883492|FG003|OLE Phase (From Week 48)|Adverse Event|8
6872729|NCT00476996|10883489|FG000|OLE Phase (From Week 48)|Death|0
6872730|NCT00476996|10883490|FG001|OLE Phase (From Week 48)|Death|0
6872731|NCT00476996|10883491|FG002|OLE Phase (From Week 48)|Death|0
6872732|NCT00476996|10883492|FG003|OLE Phase (From Week 48)|Death|7
6872733|NCT00476996|10883489|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0
6872734|NCT00476996|10883490|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0
6872735|NCT00476996|10883491|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0
6872736|NCT00476996|10883492|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13
6872737|NCT00476996|10883489|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0
6872738|NCT00476996|10883490|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0
6872739|NCT00476996|10883491|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0
6872740|NCT00476996|10883492|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4
6872741|NCT00476996|10883489|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
6872742|NCT00476996|10883490|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
6872743|NCT00476996|10883491|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
6872744|NCT00476996|10883492|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4
6872745|NCT00476996|10883489|FG000|OLE Phase (From Week 48)|Early termination of the study|0
6872746|NCT00476996|10883490|FG001|OLE Phase (From Week 48)|Early termination of the study|0
6872747|NCT00476996|10883491|FG002|OLE Phase (From Week 48)|Early termination of the study|0
6872748|NCT00476996|10883492|FG003|OLE Phase (From Week 48)|Early termination of the study|578
6872749|NCT00477152|10883505|FG000|Overall Study|Parent withdrew consent|2
6872750|NCT00477152|10883505|FG000|Overall Study|Adverse Event|1
6872751|NCT00477165|10883511|FG000|Overall Study|Adverse Event|7
6872752|NCT00477165|10883512|FG001|Overall Study|Adverse Event|2
6872753|NCT00477269|10883533|FG000|Core Study|Adverse Event|6
6872754|NCT00477269|10883534|FG001|Core Study|Adverse Event|4
6872755|NCT00477269|10883535|FG002|Core Study|Adverse Event|0
6872756|NCT00477269|10883533|FG000|Core Study|Death|3
6872757|NCT00477269|10883534|FG001|Core Study|Death|3
6872758|NCT00477269|10883535|FG002|Core Study|Death|0
6872759|NCT00477269|10883533|FG000|Core Study|Withdrawn Consent|0
6872760|NCT00477269|10883534|FG001|Core Study|Withdrawn Consent|1
6872761|NCT00477269|10883535|FG002|Core Study|Withdrawn Consent|0
6872762|NCT00477269|10883533|FG000|Open Label Extension|Adverse Event|0
6872763|NCT00477269|10883534|FG001|Open Label Extension|Adverse Event|0
6872764|NCT00477269|10883535|FG002|Open Label Extension|Adverse Event|4
6872765|NCT00477269|10883533|FG000|Open Label Extension|Abnormal laboratory values|0
6872766|NCT00477269|10883534|FG001|Open Label Extension|Abnormal laboratory values|0
6872767|NCT00477269|10883535|FG002|Open Label Extension|Abnormal laboratory values|1
6872768|NCT00477269|10883533|FG000|Open Label Extension|unsatisfactory therapeutic effects|0
6872769|NCT00477269|10883534|FG001|Open Label Extension|unsatisfactory therapeutic effects|0
6872770|NCT00477269|10883535|FG002|Open Label Extension|unsatisfactory therapeutic effects|2
6872771|NCT00477269|10883533|FG000|Open Label Extension|Adminiatrative problems|0
6872772|NCT00477269|10883534|FG001|Open Label Extension|Adminiatrative problems|0
6872773|NCT00477269|10883535|FG002|Open Label Extension|Adminiatrative problems|2
6872774|NCT00477269|10883533|FG000|Open Label Extension|Death|0
6872775|NCT00477269|10883534|FG001|Open Label Extension|Death|0
6872776|NCT00477269|10883535|FG002|Open Label Extension|Death|4
6872777|NCT00477295|10883545|FG000|Overall Study|Adverse Event|31
7154301|NCT03308968|11320892|FG000|Double-Blind Period (12 Weeks)|Other than specified|1
7154302|NCT03308968|11320893|FG001|Double-Blind Period (12 Weeks)|Other than specified|0
7154303|NCT03308968|11320894|FG002|Double-Blind Period (12 Weeks)|Other than specified|2
7154304|NCT03308968|11320892|FG000|Open-Label Period (12 Weeks)|Other than specified|1
7154305|NCT03308968|11320893|FG001|Open-Label Period (12 Weeks)|Other than specified|2
7154306|NCT03308968|11320894|FG002|Open-Label Period (12 Weeks)|Other than specified|1
7154307|NCT03308968|11320892|FG000|Open-Label Period (12 Weeks)|Adverse Event|4
7154308|NCT03308968|11320893|FG001|Open-Label Period (12 Weeks)|Adverse Event|1
7154309|NCT03308968|11320894|FG002|Open-Label Period (12 Weeks)|Adverse Event|1
7154310|NCT03308968|11320892|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5
7154311|NCT03308968|11320893|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5
7154312|NCT03308968|11320894|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7
7154313|NCT03308968|11320892|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0
7154314|NCT03308968|11320893|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1
7154315|NCT03308968|11320894|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1
7154316|NCT03308968|11320892|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0
6872778|NCT00477295|10883546|FG001|Overall Study|Adverse Event|35
6872779|NCT00477295|10883545|FG000|Overall Study|Withdrawal by Subject|35
6872780|NCT00477295|10883546|FG001|Overall Study|Withdrawal by Subject|24
6872781|NCT00477295|10883545|FG000|Overall Study|Lack of Efficacy|23
6872782|NCT00477295|10883546|FG001|Overall Study|Lack of Efficacy|23
7154317|NCT03308968|11320893|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0
7154318|NCT03308968|11320894|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1
6872783|NCT00477295|10883545|FG000|Overall Study|Protocol Violation|3
6872784|NCT00477295|10883546|FG001|Overall Study|Protocol Violation|8
6872785|NCT00477295|10883545|FG000|Overall Study|Physician Decision|4
6872786|NCT00477295|10883546|FG001|Overall Study|Physician Decision|5
6872787|NCT00477295|10883545|FG000|Overall Study|Lost to Follow-up|21
6872788|NCT00477295|10883546|FG001|Overall Study|Lost to Follow-up|11
6872789|NCT00477295|10883545|FG000|Overall Study|Other|4
6872790|NCT00477295|10883546|FG001|Overall Study|Other|3
6872791|NCT00477334|10883556|FG000|Overall Study|Discontinued prior to taking study drug|106
6872792|NCT00477334|10883557|FG001|Overall Study|Discontinued prior to taking study drug|53
6872793|NCT00477334|10883556|FG000|Overall Study|Adverse Event|1
6872794|NCT00477334|10883557|FG001|Overall Study|Adverse Event|2
6872795|NCT00477334|10883556|FG000|Overall Study|Withdrawal by Subject|2
6872796|NCT00477334|10883557|FG001|Overall Study|Withdrawal by Subject|1
6872797|NCT00477334|10883556|FG000|Overall Study|Lost to Follow-up|15
6872798|NCT00477334|10883557|FG001|Overall Study|Lost to Follow-up|4
6872799|NCT00477334|10883556|FG000|Overall Study|Administrative Problems|39
6872800|NCT00477334|10883557|FG001|Overall Study|Administrative Problems|15
6872801|NCT00477334|10883556|FG000|Overall Study|Protocol Violation|7
6872802|NCT00477334|10883557|FG001|Overall Study|Protocol Violation|1
6872803|NCT00477386|10883569|FG000|Overall Study|Adverse Event|4
6872804|NCT00477386|10883570|FG001|Overall Study|Adverse Event|8
6872805|NCT00477386|10883569|FG000|Overall Study|Disease progression, relapse|3
6872806|NCT00477386|10883570|FG001|Overall Study|Disease progression, relapse|4
6872807|NCT00477386|10883569|FG000|Overall Study|Disease progression, refractory|1
6872808|NCT00477386|10883570|FG001|Overall Study|Disease progression, refractory|3
6872809|NCT00477386|10883569|FG000|Overall Study|Other|1
6872810|NCT00477386|10883570|FG001|Overall Study|Other|2
6872811|NCT00477386|10883569|FG000|Overall Study|Physician Decision|1
6872812|NCT00477386|10883570|FG001|Overall Study|Physician Decision|0
6872813|NCT00477386|10883569|FG000|Overall Study|Withdrawal by Subject|1
6872814|NCT00477386|10883570|FG001|Overall Study|Withdrawal by Subject|0
6872815|NCT00477464|10883591|FG000|Overall Study|Lost to Follow-up|1
6872816|NCT00477464|10883591|FG000|Overall Study|Death|36
6872817|NCT00477464|10883591|FG000|Overall Study|Completion of protocol-defined follow-up|14
6872818|NCT00477490|10883602|FG000|Part I: 4 Week Efficacy|Adverse Event|1
6872819|NCT00477490|10883603|FG001|Part I: 4 Week Efficacy|Adverse Event|4
6872820|NCT00477490|10883604|FG002|Part I: 4 Week Efficacy|Adverse Event|0
6872821|NCT00477490|10883605|FG003|Part I: 4 Week Efficacy|Adverse Event|5
6872822|NCT00477490|10883606|FG004|Part I: 4 Week Efficacy|Adverse Event|6
6872823|NCT00477490|10883607|FG005|Part I: 4 Week Efficacy|Adverse Event|0
6872824|NCT00477490|10883608|FG006|Part I: 4 Week Efficacy|Adverse Event|0
6872825|NCT00477490|10883609|FG007|Part I: 4 Week Efficacy|Adverse Event|0
6872826|NCT00477490|10883610|FG008|Part I: 4 Week Efficacy|Adverse Event|0
6872827|NCT00477490|10883602|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1
6872828|NCT00477490|10883603|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
6872829|NCT00477490|10883604|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
6872830|NCT00477490|10883605|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5
6872831|NCT00477490|10883606|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4
6872832|NCT00477490|10883607|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
6872833|NCT00477490|10883608|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
6872834|NCT00477490|10883609|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
6872835|NCT00477490|10883610|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
6872836|NCT00477490|10883602|FG000|Part I: 4 Week Efficacy|Protocol Violation|2
6872837|NCT00477490|10883603|FG001|Part I: 4 Week Efficacy|Protocol Violation|0
6872838|NCT00477490|10883604|FG002|Part I: 4 Week Efficacy|Protocol Violation|0
6872839|NCT00477490|10883605|FG003|Part I: 4 Week Efficacy|Protocol Violation|0
6872840|NCT00477490|10883606|FG004|Part I: 4 Week Efficacy|Protocol Violation|1
6872841|NCT00477490|10883607|FG005|Part I: 4 Week Efficacy|Protocol Violation|0
6872842|NCT00477490|10883608|FG006|Part I: 4 Week Efficacy|Protocol Violation|0
6872843|NCT00477490|10883609|FG007|Part I: 4 Week Efficacy|Protocol Violation|0
6872844|NCT00477490|10883610|FG008|Part I: 4 Week Efficacy|Protocol Violation|0
6872845|NCT00477490|10883602|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6
6872846|NCT00477490|10883603|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5
6872847|NCT00477490|10883604|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6
6872848|NCT00477490|10883605|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4
6872849|NCT00477490|10883606|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9
7078476|NCT02104583|11187030|FG002|Overall Study|Lost to Follow-up|0
7078477|NCT02104583|11187031|FG003|Overall Study|Lost to Follow-up|0
7078478|NCT02104583|11187032|FG004|Overall Study|Lost to Follow-up|0
7078479|NCT02104583|11187028|FG000|Overall Study|Randomized but Never Treated|0
7078480|NCT02104583|11187029|FG001|Overall Study|Randomized but Never Treated|0
7078481|NCT02104583|11187030|FG002|Overall Study|Randomized but Never Treated|0
7078482|NCT02104583|11187031|FG003|Overall Study|Randomized but Never Treated|1
7078483|NCT02104583|11187032|FG004|Overall Study|Randomized but Never Treated|0
7078484|NCT02104752|11187071|FG000|Overall Study|Withdrawal by Subject|1
7078485|NCT02104752|11187072|FG001|Overall Study|Withdrawal by Subject|0
6872850|NCT00477490|10883607|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0
6872851|NCT00477490|10883608|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0
6872852|NCT00477490|10883609|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0
6872853|NCT00477490|10883610|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0
6872854|NCT00477490|10883602|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2
6872855|NCT00477490|10883603|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4
6872856|NCT00477490|10883604|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1
6872857|NCT00477490|10883605|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5
6872858|NCT00477490|10883606|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3
6872859|NCT00477490|10883607|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0
6872860|NCT00477490|10883608|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0
6872861|NCT00477490|10883609|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0
6872862|NCT00477490|10883610|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0
6872863|NCT00477490|10883602|FG000|Part I: 4 Week Efficacy|Other, not specified|2
6872864|NCT00477490|10883603|FG001|Part I: 4 Week Efficacy|Other, not specified|4
6872865|NCT00477490|10883604|FG002|Part I: 4 Week Efficacy|Other, not specified|0
6872866|NCT00477490|10883605|FG003|Part I: 4 Week Efficacy|Other, not specified|1
6872867|NCT00477490|10883606|FG004|Part I: 4 Week Efficacy|Other, not specified|1
6872868|NCT00477490|10883607|FG005|Part I: 4 Week Efficacy|Other, not specified|0
6872869|NCT00477490|10883608|FG006|Part I: 4 Week Efficacy|Other, not specified|0
6872870|NCT00477490|10883609|FG007|Part I: 4 Week Efficacy|Other, not specified|0
6872871|NCT00477490|10883610|FG008|Part I: 4 Week Efficacy|Other, not specified|0
6872872|NCT00477490|10883602|FG000|Part I: 4 Week Efficacy|Not Reported|1
6872873|NCT00477490|10883603|FG001|Part I: 4 Week Efficacy|Not Reported|2
6872874|NCT00477490|10883604|FG002|Part I: 4 Week Efficacy|Not Reported|3
6872875|NCT00477490|10883605|FG003|Part I: 4 Week Efficacy|Not Reported|0
6872876|NCT00477490|10883606|FG004|Part I: 4 Week Efficacy|Not Reported|1
6872877|NCT00477490|10883607|FG005|Part I: 4 Week Efficacy|Not Reported|0
6872878|NCT00477490|10883608|FG006|Part I: 4 Week Efficacy|Not Reported|0
6872879|NCT00477490|10883609|FG007|Part I: 4 Week Efficacy|Not Reported|0
6872880|NCT00477490|10883610|FG008|Part I: 4 Week Efficacy|Not Reported|0
6872881|NCT00477490|10883602|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0
6872882|NCT00477490|10883603|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15
6872883|NCT00477490|10883604|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
6872884|NCT00477490|10883605|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
6872885|NCT00477490|10883606|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10
6872886|NCT00477490|10883607|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4
6872887|NCT00477490|10883608|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
6872888|NCT00477490|10883609|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3
6872889|NCT00477490|10883610|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
6872890|NCT00477490|10883602|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0
6872891|NCT00477490|10883603|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2
6872892|NCT00477490|10883604|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3
6872893|NCT00477490|10883605|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1
6872894|NCT00477490|10883606|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1
6872895|NCT00477490|10883607|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1
6872896|NCT00477490|10883608|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1
6872897|NCT00477490|10883609|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1
6872898|NCT00477490|10883610|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4
6872899|NCT00477490|10883602|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
6872900|NCT00477490|10883603|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3
6872901|NCT00477490|10883604|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2
6872902|NCT00477490|10883605|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
6872903|NCT00477490|10883606|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5
6872904|NCT00477490|10883607|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
6872905|NCT00477490|10883608|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1
6872906|NCT00477490|10883609|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
6872907|NCT00477490|10883610|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
6872908|NCT00477490|10883602|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
6872909|NCT00477490|10883603|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
6872910|NCT00477490|10883604|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
6872911|NCT00477490|10883605|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
6872912|NCT00477490|10883606|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
6872913|NCT00477490|10883607|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
6872914|NCT00477490|10883608|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
6872915|NCT00477490|10883609|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
6872916|NCT00477490|10883610|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
6872917|NCT00477490|10883602|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0
6872918|NCT00477490|10883603|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1
6872919|NCT00477490|10883604|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0
6872920|NCT00477490|10883605|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0
6872921|NCT00477490|10883606|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0
6872922|NCT00477490|10883607|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0
6872923|NCT00477490|10883608|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0
6872924|NCT00477490|10883609|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0
6872925|NCT00477490|10883610|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0
6872926|NCT00477490|10883602|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0
6872927|NCT00477490|10883603|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4
6872928|NCT00477490|10883604|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2
6872929|NCT00477490|10883605|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4
6872930|NCT00477490|10883606|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2
6872931|NCT00477490|10883607|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1
6872932|NCT00477490|10883608|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1
6872933|NCT00477490|10883609|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0
6872934|NCT00477490|10883610|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1
6872935|NCT00477490|10883602|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0
6872936|NCT00477490|10883603|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3
6872937|NCT00477490|10883604|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1
6872938|NCT00477490|10883605|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0
6872939|NCT00477490|10883606|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1
6872940|NCT00477490|10883607|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0
6872941|NCT00477490|10883608|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0
6872942|NCT00477490|10883609|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0
6872943|NCT00477490|10883610|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0
6872944|NCT00477594|10883640|FG000|Year 1 and Year 2|Adverse Event|4
6872945|NCT00477594|10883641|FG001|Year 1 and Year 2|Adverse Event|2
6872946|NCT00477594|10883640|FG000|Year 1 and Year 2|Physician Decision|2
6872947|NCT00477594|10883641|FG001|Year 1 and Year 2|Physician Decision|1
6872948|NCT00477594|10883640|FG000|Year 1 and Year 2|Withdrawal by Subject|2
6872949|NCT00477594|10883641|FG001|Year 1 and Year 2|Withdrawal by Subject|1
6872950|NCT00477594|10883640|FG000|Year 1 and Year 2|Other|1
6872951|NCT00477594|10883641|FG001|Year 1 and Year 2|Other|0
6872952|NCT00477594|10883640|FG000|Year 3|Adverse Event|1
6872953|NCT00477594|10883641|FG001|Year 3|Adverse Event|0
6872954|NCT00477594|10883640|FG000|Year 3|Withdrawal by Subject|1
6872955|NCT00477594|10883641|FG001|Year 3|Withdrawal by Subject|0
6872956|NCT00477594|10883640|FG000|Follow-up Period|Withdrawal by Subject|2
6872957|NCT00477594|10883641|FG001|Follow-up Period|Withdrawal by Subject|1
6872958|NCT00477594|10883640|FG000|Follow-up Period|Other|1
6872959|NCT00477594|10883641|FG001|Follow-up Period|Other|0
6872960|NCT00477607|10883649|FG000|Overall Study|Lost to Follow-up|7
6872961|NCT00477607|10883650|FG001|Overall Study|Lost to Follow-up|7
6872962|NCT00477633|10883656|FG000|Overall Study|Did not receive treatment|23
6872963|NCT00477633|10883656|FG000|Overall Study|Adverse Event|143
6872964|NCT00477633|10883656|FG000|Overall Study|Pregnancy|23
6872965|NCT00477633|10883656|FG000|Overall Study|Lost to Follow-up|271
6872966|NCT00477633|10883656|FG000|Overall Study|Withdrawal by Subject|149
6872967|NCT00477633|10883656|FG000|Overall Study|Protocol Violation|25
6872968|NCT00477633|10883656|FG000|Overall Study|Various (Moving, Enrollment closed)|75
6872969|NCT00477672|10883667|FG000|Overall Study|Adverse Event|3
6872970|NCT00477672|10883668|FG001|Overall Study|Adverse Event|5
6872971|NCT00477672|10883669|FG002|Overall Study|Adverse Event|6
6872972|NCT00477672|10883667|FG000|Overall Study|Death|0
6872973|NCT00477672|10883668|FG001|Overall Study|Death|1
6872974|NCT00477672|10883669|FG002|Overall Study|Death|0
6872975|NCT00477672|10883667|FG000|Overall Study|Disease progression|0
6872976|NCT00477672|10883668|FG001|Overall Study|Disease progression|1
6872977|NCT00477672|10883669|FG002|Overall Study|Disease progression|0
6872978|NCT00477672|10883667|FG000|Overall Study|Physician Decision|1
6872979|NCT00477672|10883668|FG001|Overall Study|Physician Decision|0
6872980|NCT00477672|10883669|FG002|Overall Study|Physician Decision|0
6872981|NCT00477672|10883667|FG000|Overall Study|Protocol noncompliance|0
6872982|NCT00477672|10883668|FG001|Overall Study|Protocol noncompliance|2
6872983|NCT00477672|10883669|FG002|Overall Study|Protocol noncompliance|0
6872984|NCT00477672|10883667|FG000|Overall Study|Consent withdrawn|2
6872985|NCT00477672|10883668|FG001|Overall Study|Consent withdrawn|5
6872986|NCT00477672|10883669|FG002|Overall Study|Consent withdrawn|10
6872987|NCT00477672|10883667|FG000|Overall Study|Discretion of Sponsor|1
6872988|NCT00477672|10883668|FG001|Overall Study|Discretion of Sponsor|2
6872989|NCT00477672|10883669|FG002|Overall Study|Discretion of Sponsor|0
6872990|NCT00477750|10883681|FG000|Overall Study|Currently Receiving Treatment|11
6872991|NCT00477971|10883689|FG000|Overall Study|Disease progression|6
6872992|NCT00477971|10883690|FG001|Overall Study|Disease progression|0
6872993|NCT00477971|10883689|FG000|Overall Study|Withdrawal by Subject|3
6872994|NCT00477971|10883690|FG001|Overall Study|Withdrawal by Subject|1
6872995|NCT00477971|10883689|FG000|Overall Study|Adverse Event|3
6872996|NCT00477971|10883690|FG001|Overall Study|Adverse Event|0
6872997|NCT00477971|10883689|FG000|Overall Study|Death|2
6872998|NCT00477971|10883690|FG001|Overall Study|Death|4
6872999|NCT00477971|10883689|FG000|Overall Study|Alternative treatment|3
6873000|NCT00477971|10883690|FG001|Overall Study|Alternative treatment|1
6873001|NCT00478023|10883701|FG000|Overall Study|Adverse Event|11
6873002|NCT00478023|10883702|FG001|Overall Study|Adverse Event|7
6873003|NCT00478023|10883703|FG002|Overall Study|Adverse Event|8
6873004|NCT00478023|10883704|FG003|Overall Study|Adverse Event|14
6873005|NCT00478023|10883705|FG004|Overall Study|Adverse Event|6
6873006|NCT00478023|10883701|FG000|Overall Study|Death|1
6873007|NCT00478023|10883702|FG001|Overall Study|Death|0
6873008|NCT00478023|10883703|FG002|Overall Study|Death|0
6873009|NCT00478023|10883704|FG003|Overall Study|Death|0
6873010|NCT00478023|10883705|FG004|Overall Study|Death|0
6873011|NCT00478023|10883701|FG000|Overall Study|Lack of Efficacy|11
6873012|NCT00478023|10883702|FG001|Overall Study|Lack of Efficacy|10
6873013|NCT00478023|10883703|FG002|Overall Study|Lack of Efficacy|4
6873014|NCT00478023|10883704|FG003|Overall Study|Lack of Efficacy|5
6873015|NCT00478023|10883705|FG004|Overall Study|Lack of Efficacy|41
6873016|NCT00478023|10883701|FG000|Overall Study|Lost to Follow-up|3
6873017|NCT00478023|10883702|FG001|Overall Study|Lost to Follow-up|1
6873018|NCT00478023|10883703|FG002|Overall Study|Lost to Follow-up|1
6873019|NCT00478023|10883704|FG003|Overall Study|Lost to Follow-up|1
6873020|NCT00478023|10883705|FG004|Overall Study|Lost to Follow-up|0
6873021|NCT00478023|10883701|FG000|Overall Study|Withdrawal by Subject|2
6873022|NCT00478023|10883702|FG001|Overall Study|Withdrawal by Subject|3
6873023|NCT00478023|10883703|FG002|Overall Study|Withdrawal by Subject|2
6873024|NCT00478023|10883704|FG003|Overall Study|Withdrawal by Subject|4
6873025|NCT00478023|10883705|FG004|Overall Study|Withdrawal by Subject|5
6873026|NCT00478023|10883701|FG000|Overall Study|Lack of pain, Technical difficulties|7
6873027|NCT00478023|10883702|FG001|Overall Study|Lack of pain, Technical difficulties|3
6873028|NCT00478023|10883703|FG002|Overall Study|Lack of pain, Technical difficulties|5
6873029|NCT00478023|10883704|FG003|Overall Study|Lack of pain, Technical difficulties|6
6873030|NCT00478023|10883705|FG004|Overall Study|Lack of pain, Technical difficulties|3
6873031|NCT00478140|10883730|FG000|Overall Study|Clinical Disease Progression|1
6873032|NCT00478205|10883750|FG000|Overall Study|Adverse Event|182
6873033|NCT00478205|10883751|FG001|Overall Study|Adverse Event|39
6873034|NCT00478205|10883750|FG000|Overall Study|Medication Non-compliance|9
6873035|NCT00478205|10883751|FG001|Overall Study|Medication Non-compliance|4
6873036|NCT00478205|10883750|FG000|Overall Study|Protocol Violation|15
6873037|NCT00478205|10883751|FG001|Overall Study|Protocol Violation|5
6873038|NCT00478205|10883750|FG000|Overall Study|Request of Investigator or Sponsor|4
6873039|NCT00478205|10883751|FG001|Overall Study|Request of Investigator or Sponsor|5
6873040|NCT00478205|10883750|FG000|Overall Study|Withdrawal by Subject|61
6873041|NCT00478205|10883751|FG001|Overall Study|Withdrawal by Subject|22
6873042|NCT00478205|10883750|FG000|Overall Study|Lack of Efficacy|1
6873043|NCT00478205|10883751|FG001|Overall Study|Lack of Efficacy|0
6873044|NCT00478205|10883750|FG000|Overall Study|Other|24
6873045|NCT00478205|10883751|FG001|Overall Study|Other|12
6873046|NCT00478231|10883766|FG000|Overall Study|Death|7
6873047|NCT00478231|10883766|FG000|Overall Study|Lack of Efficacy|47
6873048|NCT00478231|10883766|FG000|Overall Study|Lost to Follow-up|7
6873049|NCT00478231|10883766|FG000|Overall Study|Withdrawal by Subject|6
6873050|NCT00478231|10883766|FG000|Overall Study|Other|9
6873051|NCT00478231|10883766|FG000|Overall Study|Adverse Event|5
6873052|NCT00478231|10883766|FG000|Overall Study|Randomized, not treated|3
6873053|NCT00478244|10883770|FG000|Overall Study|Did not receive transplant|1
6873054|NCT00478257|10883776|FG000|Overall Study|Withdrawal by Subject|8
6873055|NCT00478257|10883777|FG001|Overall Study|Withdrawal by Subject|3
6873056|NCT00478426|10883796|FG000|Overall Study|Withdrawal by Subject|1
6873057|NCT00478608|10883821|FG000|Overall Study|Adverse Event|1
6873058|NCT00478608|10883821|FG000|Overall Study|Serious Adverse Event|14
6873059|NCT00478608|10883821|FG000|Overall Study|Withdrawal by Subject|2
6873060|NCT00478608|10883821|FG000|Overall Study|Protocol Violation|3
6873061|NCT00478647|10883825|FG000|Overall Study|Adverse Event|1
6873062|NCT00478647|10883825|FG000|Overall Study|Withdrawal by Subject|1
6873063|NCT00478673|10883829|FG000|30-Days Post-Procedure|Death|2
6873064|NCT00478673|10883829|FG000|30-Days Post-Procedure|Withdrawal by Subject|1
6873065|NCT00478673|10883829|FG000|30-Days Post-Procedure|Missed Visit|7
6873066|NCT00478673|10883829|FG000|12-Months Post-Procedure|Death|23
6873067|NCT00478673|10883829|FG000|12-Months Post-Procedure|Lost to Follow-up|4
6873068|NCT00478673|10883829|FG000|12-Months Post-Procedure|Withdrawal by Subject|6
6873069|NCT00478673|10883829|FG000|12-Months Post-Procedure|Missed Visit|25
6873070|NCT00478673|10883829|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6
6873071|NCT00478777|10883833|FG000|Overall Study|Adverse Event|29
6873072|NCT00478777|10883833|FG000|Overall Study|Lack of Efficacy|23
6873073|NCT00478777|10883833|FG000|Overall Study|Withdrawal by Subject|4
6873074|NCT00478777|10883833|FG000|Overall Study|Death|3
6873075|NCT00478777|10883833|FG000|Overall Study|Protocol Violation|3
6873076|NCT00478777|10883833|FG000|Overall Study|Lost to Follow-up|3
6873077|NCT00478777|10883833|FG000|Overall Study|Physician Decision|1
6873078|NCT00478777|10883833|FG000|Overall Study|Intolerance of therapy|1
6873079|NCT00478777|10883833|FG000|Overall Study|Lack of compliance|1
6873080|NCT00478777|10883833|FG000|Overall Study|Lymphocytes infusion|1
6873081|NCT00478777|10883833|FG000|Overall Study|End of therapy|2
6873082|NCT00478777|10883833|FG000|Overall Study|Not treated with lenalidomide|6
6873083|NCT00478881|10883839|FG000|Overall Study|Adverse Event|31
6873084|NCT00478881|10883840|FG001|Overall Study|Adverse Event|12
6873085|NCT00478881|10883839|FG000|Overall Study|Lack of Efficacy|0
6873086|NCT00478881|10883840|FG001|Overall Study|Lack of Efficacy|3
6873087|NCT00478881|10883839|FG000|Overall Study|Lost to Follow-up|0
6873088|NCT00478881|10883840|FG001|Overall Study|Lost to Follow-up|1
6873089|NCT00478881|10883839|FG000|Overall Study|Protocol Violation|2
6873090|NCT00478881|10883840|FG001|Overall Study|Protocol Violation|2
6873091|NCT00478881|10883839|FG000|Overall Study|Withdrawal by Subject|6
6873092|NCT00478881|10883840|FG001|Overall Study|Withdrawal by Subject|2
6873093|NCT00478881|10883839|FG000|Overall Study|Non-Compliance with Study Medication|0
6873094|NCT00478881|10883840|FG001|Overall Study|Non-Compliance with Study Medication|2
6873095|NCT00478933|10883846|FG000|Overall Study|Protocol Violation|22
6873096|NCT00478933|10883846|FG000|Overall Study|Informed consent not verified|3
6873097|NCT00478933|10883846|FG000|Overall Study|Inadequate data available|53
6873098|NCT00479232|10883903|FG000|Overall Study|Adverse Event|0
6873099|NCT00479232|10883904|FG001|Overall Study|Adverse Event|0
6873100|NCT00479232|10883905|FG002|Overall Study|Adverse Event|5
6873101|NCT00479232|10883906|FG003|Overall Study|Adverse Event|0
6873102|NCT00479232|10883907|FG004|Overall Study|Adverse Event|0
6873103|NCT00479232|10883908|FG005|Overall Study|Adverse Event|10
6873104|NCT00479232|10883903|FG000|Overall Study|Deviation from Protocol|0
6873105|NCT00479232|10883904|FG001|Overall Study|Deviation from Protocol|0
6873106|NCT00479232|10883905|FG002|Overall Study|Deviation from Protocol|1
6873107|NCT00479232|10883906|FG003|Overall Study|Deviation from Protocol|0
6873108|NCT00479232|10883907|FG004|Overall Study|Deviation from Protocol|0
6873109|NCT00479232|10883908|FG005|Overall Study|Deviation from Protocol|0
6873110|NCT00479232|10883903|FG000|Overall Study|Lack of Efficacy|0
6873111|NCT00479232|10883904|FG001|Overall Study|Lack of Efficacy|0
6873112|NCT00479232|10883905|FG002|Overall Study|Lack of Efficacy|2
6873113|NCT00479232|10883906|FG003|Overall Study|Lack of Efficacy|0
6873114|NCT00479232|10883907|FG004|Overall Study|Lack of Efficacy|0
6873115|NCT00479232|10883908|FG005|Overall Study|Lack of Efficacy|4
6873116|NCT00479232|10883903|FG000|Overall Study|Physician Decision|0
6873117|NCT00479232|10883904|FG001|Overall Study|Physician Decision|0
6873118|NCT00479232|10883905|FG002|Overall Study|Physician Decision|2
6873119|NCT00479232|10883906|FG003|Overall Study|Physician Decision|0
6873120|NCT00479232|10883907|FG004|Overall Study|Physician Decision|0
6873121|NCT00479232|10883908|FG005|Overall Study|Physician Decision|1
6873122|NCT00479232|10883903|FG000|Overall Study|Progressive Disease|3
6873123|NCT00479232|10883904|FG001|Overall Study|Progressive Disease|1
6873124|NCT00479232|10883905|FG002|Overall Study|Progressive Disease|12
6873125|NCT00479232|10883906|FG003|Overall Study|Progressive Disease|3
6873126|NCT00479232|10883907|FG004|Overall Study|Progressive Disease|3
6873127|NCT00479232|10883908|FG005|Overall Study|Progressive Disease|12
6873128|NCT00479232|10883903|FG000|Overall Study|Withdrew Consent|0
6873129|NCT00479232|10883904|FG001|Overall Study|Withdrew Consent|2
6873130|NCT00479232|10883905|FG002|Overall Study|Withdrew Consent|6
6873131|NCT00479232|10883906|FG003|Overall Study|Withdrew Consent|0
6873132|NCT00479232|10883907|FG004|Overall Study|Withdrew Consent|1
6873133|NCT00479232|10883908|FG005|Overall Study|Withdrew Consent|3
6873134|NCT00479336|10883930|FG000|Overall Study|Adverse Event|1
6873135|NCT00479336|10883931|FG001|Overall Study|Adverse Event|1
6873136|NCT00479336|10883932|FG002|Overall Study|Adverse Event|1
6873137|NCT00479336|10883933|FG003|Overall Study|Adverse Event|3
6873138|NCT00479336|10883930|FG000|Overall Study|Lack of Efficacy|1
6873139|NCT00479336|10883931|FG001|Overall Study|Lack of Efficacy|0
6873140|NCT00479336|10883932|FG002|Overall Study|Lack of Efficacy|0
6873141|NCT00479336|10883933|FG003|Overall Study|Lack of Efficacy|0
6873142|NCT00479336|10883930|FG000|Overall Study|Protocol Violation|0
6873143|NCT00479336|10883931|FG001|Overall Study|Protocol Violation|1
6873144|NCT00479336|10883932|FG002|Overall Study|Protocol Violation|0
6873145|NCT00479336|10883933|FG003|Overall Study|Protocol Violation|0
6873146|NCT00479336|10883930|FG000|Overall Study|Withdrawal by Subject|1
6873147|NCT00479336|10883931|FG001|Overall Study|Withdrawal by Subject|2
6873148|NCT00479336|10883932|FG002|Overall Study|Withdrawal by Subject|0
6873149|NCT00479336|10883933|FG003|Overall Study|Withdrawal by Subject|0
6873150|NCT00479336|10883930|FG000|Overall Study|Physician Decision|0
6873151|NCT00479336|10883931|FG001|Overall Study|Physician Decision|1
6873152|NCT00479336|10883932|FG002|Overall Study|Physician Decision|0
6873153|NCT00479336|10883933|FG003|Overall Study|Physician Decision|2
6873154|NCT00479336|10883930|FG000|Overall Study|Resolution of all hepatic edema findings|1
6873155|NCT00479336|10883931|FG001|Overall Study|Resolution of all hepatic edema findings|1
6873156|NCT00479336|10883932|FG002|Overall Study|Resolution of all hepatic edema findings|0
6873157|NCT00479336|10883933|FG003|Overall Study|Resolution of all hepatic edema findings|0
6873158|NCT00479388|10883945|FG000|Overall Study|Adverse Event|90
6873159|NCT00479388|10883946|FG001|Overall Study|Adverse Event|45
6873160|NCT00479388|10883945|FG000|Overall Study|Lost to Follow-up|0
6873161|NCT00479388|10883946|FG001|Overall Study|Lost to Follow-up|2
6873162|NCT00479388|10883945|FG000|Overall Study|Protocol Violation|10
6873163|NCT00479388|10883946|FG001|Overall Study|Protocol Violation|9
6873164|NCT00479388|10883945|FG000|Overall Study|Withdrawal by Subject|32
6873165|NCT00479388|10883946|FG001|Overall Study|Withdrawal by Subject|17
6873166|NCT00479401|10883955|FG000|Overall Study|Adverse Event|24
6873167|NCT00479401|10883956|FG001|Overall Study|Adverse Event|20
6873168|NCT00479401|10883957|FG002|Overall Study|Adverse Event|4
6873169|NCT00479401|10883955|FG000|Overall Study|Lack of Efficacy|2
6873170|NCT00479401|10883956|FG001|Overall Study|Lack of Efficacy|2
6873171|NCT00479401|10883957|FG002|Overall Study|Lack of Efficacy|4
6873172|NCT00479401|10883955|FG000|Overall Study|Protocol Violation|2
6873173|NCT00479401|10883956|FG001|Overall Study|Protocol Violation|1
6873174|NCT00479401|10883957|FG002|Overall Study|Protocol Violation|1
6873175|NCT00479401|10883955|FG000|Overall Study|Lost to Follow-up|1
6873176|NCT00479401|10883956|FG001|Overall Study|Lost to Follow-up|1
6873177|NCT00479401|10883957|FG002|Overall Study|Lost to Follow-up|1
6873178|NCT00479401|10883955|FG000|Overall Study|Withdrawal by Subject|16
6873179|NCT00479401|10883956|FG001|Overall Study|Withdrawal by Subject|10
6873180|NCT00479401|10883957|FG002|Overall Study|Withdrawal by Subject|2
6873181|NCT00479401|10883955|FG000|Overall Study|Exclusion criteria, relocation|4
6873182|NCT00479401|10883956|FG001|Overall Study|Exclusion criteria, relocation|3
6873183|NCT00479401|10883957|FG002|Overall Study|Exclusion criteria, relocation|0
6873184|NCT00479466|10883971|FG000|Overall Study|Adverse Event|5
6873185|NCT00479466|10883972|FG001|Overall Study|Adverse Event|1
6873186|NCT00479466|10883973|FG002|Overall Study|Adverse Event|0
6873187|NCT00479466|10883974|FG003|Overall Study|Adverse Event|1
6873188|NCT00479466|10883975|FG004|Overall Study|Adverse Event|2
6873189|NCT00479466|10883976|FG005|Overall Study|Adverse Event|0
6873190|NCT00479466|10883971|FG000|Overall Study|Hyperglycemia|0
6873191|NCT00479466|10883972|FG001|Overall Study|Hyperglycemia|0
6873192|NCT00479466|10883973|FG002|Overall Study|Hyperglycemia|0
6873193|NCT00479466|10883974|FG003|Overall Study|Hyperglycemia|0
6873194|NCT00479466|10883975|FG004|Overall Study|Hyperglycemia|0
6873195|NCT00479466|10883976|FG005|Overall Study|Hyperglycemia|1
6873196|NCT00479466|10883971|FG000|Overall Study|Lack of Efficacy|2
6873197|NCT00479466|10883972|FG001|Overall Study|Lack of Efficacy|0
6873198|NCT00479466|10883973|FG002|Overall Study|Lack of Efficacy|1
6873199|NCT00479466|10883974|FG003|Overall Study|Lack of Efficacy|0
6873200|NCT00479466|10883975|FG004|Overall Study|Lack of Efficacy|0
6873201|NCT00479466|10883976|FG005|Overall Study|Lack of Efficacy|0
6873202|NCT00479466|10883971|FG000|Overall Study|Lost to Follow-up|0
6873203|NCT00479466|10883972|FG001|Overall Study|Lost to Follow-up|1
6873204|NCT00479466|10883973|FG002|Overall Study|Lost to Follow-up|1
6873205|NCT00479466|10883974|FG003|Overall Study|Lost to Follow-up|0
6873206|NCT00479466|10883975|FG004|Overall Study|Lost to Follow-up|2
6873207|NCT00479466|10883976|FG005|Overall Study|Lost to Follow-up|2
6873208|NCT00479466|10883971|FG000|Overall Study|Physician Decision|2
6873209|NCT00479466|10883972|FG001|Overall Study|Physician Decision|1
6873210|NCT00479466|10883973|FG002|Overall Study|Physician Decision|1
6873211|NCT00479466|10883974|FG003|Overall Study|Physician Decision|0
6873212|NCT00479466|10883975|FG004|Overall Study|Physician Decision|0
6873213|NCT00479466|10883976|FG005|Overall Study|Physician Decision|0
6873214|NCT00479466|10883971|FG000|Overall Study|Pregnancy|0
6873215|NCT00479466|10883972|FG001|Overall Study|Pregnancy|0
6873216|NCT00479466|10883973|FG002|Overall Study|Pregnancy|0
6873217|NCT00479466|10883974|FG003|Overall Study|Pregnancy|0
6873218|NCT00479466|10883975|FG004|Overall Study|Pregnancy|1
6873219|NCT00479466|10883976|FG005|Overall Study|Pregnancy|0
6873220|NCT00479466|10883971|FG000|Overall Study|Protocol Violation|1
6873221|NCT00479466|10883972|FG001|Overall Study|Protocol Violation|0
6873222|NCT00479466|10883973|FG002|Overall Study|Protocol Violation|0
6873223|NCT00479466|10883974|FG003|Overall Study|Protocol Violation|0
6873224|NCT00479466|10883975|FG004|Overall Study|Protocol Violation|0
6873225|NCT00479466|10883976|FG005|Overall Study|Protocol Violation|0
6873226|NCT00479466|10883971|FG000|Overall Study|Withdrawal by Subject|3
6873227|NCT00479466|10883972|FG001|Overall Study|Withdrawal by Subject|5
6873228|NCT00479466|10883973|FG002|Overall Study|Withdrawal by Subject|0
6873229|NCT00479466|10883974|FG003|Overall Study|Withdrawal by Subject|2
6873230|NCT00479466|10883975|FG004|Overall Study|Withdrawal by Subject|3
6873231|NCT00479466|10883976|FG005|Overall Study|Withdrawal by Subject|1
6873232|NCT00479557|10883997|FG000|Overall Study|Death|0
6873233|NCT00479557|10883998|FG001|Overall Study|Death|0
6873234|NCT00479557|10883999|FG002|Overall Study|Death|0
6873235|NCT00479557|10884000|FG003|Overall Study|Death|0
6873236|NCT00479557|10884001|FG004|Overall Study|Death|0
6873237|NCT00479557|10884002|FG005|Overall Study|Death|1
6873238|NCT00479557|10884003|FG006|Overall Study|Death|0
6873239|NCT00479557|10883997|FG000|Overall Study|Lack of Efficacy|1
6873240|NCT00479557|10883998|FG001|Overall Study|Lack of Efficacy|0
6873241|NCT00479557|10883999|FG002|Overall Study|Lack of Efficacy|0
6873242|NCT00479557|10884000|FG003|Overall Study|Lack of Efficacy|0
6873243|NCT00479557|10884001|FG004|Overall Study|Lack of Efficacy|0
6873244|NCT00479557|10884002|FG005|Overall Study|Lack of Efficacy|0
6873245|NCT00479557|10884003|FG006|Overall Study|Lack of Efficacy|0
6873246|NCT00479557|10883997|FG000|Overall Study|Lost to Follow-up|0
6873247|NCT00479557|10883998|FG001|Overall Study|Lost to Follow-up|2
6873248|NCT00479557|10883999|FG002|Overall Study|Lost to Follow-up|0
6873249|NCT00479557|10884000|FG003|Overall Study|Lost to Follow-up|2
6873250|NCT00479557|10884001|FG004|Overall Study|Lost to Follow-up|0
6873251|NCT00479557|10884002|FG005|Overall Study|Lost to Follow-up|0
6873252|NCT00479557|10884003|FG006|Overall Study|Lost to Follow-up|0
6873253|NCT00479557|10883997|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1
6873254|NCT00479557|10883998|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0
6873255|NCT00479557|10883999|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3
6873256|NCT00479557|10884000|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2
6873257|NCT00479557|10884001|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0
6873258|NCT00479557|10884002|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1
6873259|NCT00479557|10884003|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0
6873260|NCT00479557|10883997|FG000|Overall Study|AE not related to Study Drug|1
6873261|NCT00479557|10883998|FG001|Overall Study|AE not related to Study Drug|3
6873262|NCT00479557|10883999|FG002|Overall Study|AE not related to Study Drug|0
6873263|NCT00479557|10884000|FG003|Overall Study|AE not related to Study Drug|0
6873264|NCT00479557|10884001|FG004|Overall Study|AE not related to Study Drug|2
6873265|NCT00479557|10884002|FG005|Overall Study|AE not related to Study Drug|2
6873266|NCT00479557|10884003|FG006|Overall Study|AE not related to Study Drug|1
6873267|NCT00479557|10883997|FG000|Overall Study|Caregiver Request|2
6873268|NCT00479557|10883998|FG001|Overall Study|Caregiver Request|2
6873269|NCT00479557|10883999|FG002|Overall Study|Caregiver Request|2
6873270|NCT00479557|10884000|FG003|Overall Study|Caregiver Request|0
6873271|NCT00479557|10884001|FG004|Overall Study|Caregiver Request|1
6873272|NCT00479557|10884002|FG005|Overall Study|Caregiver Request|2
6873273|NCT00479557|10884003|FG006|Overall Study|Caregiver Request|0
6873274|NCT00479557|10883997|FG000|Overall Study|Investigator Request|0
6873275|NCT00479557|10883998|FG001|Overall Study|Investigator Request|0
6873276|NCT00479557|10883999|FG002|Overall Study|Investigator Request|1
6873277|NCT00479557|10884000|FG003|Overall Study|Investigator Request|0
6873278|NCT00479557|10884001|FG004|Overall Study|Investigator Request|0
6873279|NCT00479557|10884002|FG005|Overall Study|Investigator Request|0
6873280|NCT00479557|10884003|FG006|Overall Study|Investigator Request|0
6873281|NCT00479557|10883997|FG000|Overall Study|Subject Request|3
6873282|NCT00479557|10883998|FG001|Overall Study|Subject Request|0
6873283|NCT00479557|10883999|FG002|Overall Study|Subject Request|1
6873284|NCT00479557|10884000|FG003|Overall Study|Subject Request|1
6873285|NCT00479557|10884001|FG004|Overall Study|Subject Request|1
6873286|NCT00479557|10884002|FG005|Overall Study|Subject Request|4
6873287|NCT00479557|10884003|FG006|Overall Study|Subject Request|1
6873288|NCT00479557|10883997|FG000|Overall Study|Other|2
6873289|NCT00479557|10883998|FG001|Overall Study|Other|3
6873290|NCT00479557|10883999|FG002|Overall Study|Other|1
6873291|NCT00479557|10884000|FG003|Overall Study|Other|0
6873292|NCT00479557|10884001|FG004|Overall Study|Other|0
6873293|NCT00479557|10884002|FG005|Overall Study|Other|3
6873294|NCT00479557|10884003|FG006|Overall Study|Other|0
6873295|NCT00479674|10884025|FG000|Overall Study|Adverse Event|18
6873296|NCT00479674|10884025|FG000|Overall Study|Withdrawal by Subject|6
6873297|NCT00479674|10884025|FG000|Overall Study|Physician Decision|14
6873298|NCT00479674|10884025|FG000|Overall Study|none provided|3
6873299|NCT00479687|10884031|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0
6873300|NCT00479687|10884032|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2
6873301|NCT00479687|10884033|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0
6873302|NCT00479687|10884031|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0
6873303|NCT00479687|10884032|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1
6873304|NCT00479687|10884033|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0
6873305|NCT00479687|10884031|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4
6873306|NCT00479687|10884032|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5
6873307|NCT00479687|10884033|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0
6873308|NCT00479687|10884031|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2
6873309|NCT00479687|10884032|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0
6873310|NCT00479687|10884033|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0
6873311|NCT00479687|10884031|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19
6873312|NCT00479687|10884032|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11
6873313|NCT00479687|10884033|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0
6873314|NCT00479687|10884031|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0
6873315|NCT00479687|10884032|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0
6873316|NCT00479687|10884033|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4
6873317|NCT00479687|10884031|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0
6873318|NCT00479687|10884032|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0
6873319|NCT00479687|10884033|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3
6873320|NCT00479687|10884031|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0
6873321|NCT00479687|10884032|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0
6873322|NCT00479687|10884033|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1
6873323|NCT00479687|10884031|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0
6873324|NCT00479687|10884032|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0
6873325|NCT00479687|10884033|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1
6873326|NCT00479856|10884040|FG000|Overall Study|Adverse Event|1
6873327|NCT00479856|10884040|FG000|Overall Study|Withdrawal by Subject|1
6873328|NCT00479856|10884040|FG000|Overall Study|Physician Decision|1
6873329|NCT00479882|10884048|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96
6873330|NCT00479882|10884049|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99
6873331|NCT00479882|10884050|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98
6873332|NCT00479882|10884051|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87
6873333|NCT00479882|10884048|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0
6873334|NCT00479882|10884049|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
6873335|NCT00479882|10884050|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
6873336|NCT00479882|10884051|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
6873337|NCT00479882|10884048|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12
6873338|NCT00479882|10884049|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
6873339|NCT00479882|10884050|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
6873340|NCT00479882|10884051|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11
6873341|NCT00479882|10884048|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4
6873342|NCT00479882|10884049|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6
6873343|NCT00479882|10884050|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9
6873344|NCT00479882|10884051|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5
6873345|NCT00479882|10884048|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0
6873346|NCT00479882|10884049|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4
6873347|NCT00479882|10884050|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2
6873348|NCT00479882|10884051|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1
6873349|NCT00479882|10884048|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24
6873350|NCT00479882|10884049|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33
6873351|NCT00479882|10884050|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30
6873352|NCT00479882|10884051|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25
6873353|NCT00479882|10884048|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2
6873354|NCT00479882|10884049|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
6873355|NCT00479882|10884050|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5
6873356|NCT00479882|10884051|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
6873357|NCT00479882|10884048|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
6873358|NCT00479882|10884049|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13
6873359|NCT00479882|10884050|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
6873360|NCT00479882|10884051|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10
6873361|NCT00479882|10884048|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3
6873362|NCT00479882|10884049|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1
6873363|NCT00479882|10884050|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
6873364|NCT00479882|10884051|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
6873365|NCT00479882|10884048|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
6873366|NCT00479882|10884049|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2
6873367|NCT00479882|10884050|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
6873368|NCT00479882|10884051|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
6873369|NCT00479882|10884048|FG000|Crossover: Period III (Weeks 13-20)|Other|5
6873370|NCT00479882|10884049|FG001|Crossover: Period III (Weeks 13-20)|Other|0
6873371|NCT00479882|10884050|FG002|Crossover: Period III (Weeks 13-20)|Other|2
6873372|NCT00479882|10884051|FG003|Crossover: Period III (Weeks 13-20)|Other|2
6873373|NCT00479882|10884048|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1
6873374|NCT00479882|10884049|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2
6873375|NCT00479882|10884050|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1
6873376|NCT00479882|10884051|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0
6873377|NCT00479882|10884048|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
6873378|NCT00479882|10884049|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
6873379|NCT00479882|10884050|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1
6873380|NCT00479882|10884051|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
6873381|NCT00479882|10884048|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
6873382|NCT00479882|10884049|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
6873383|NCT00479882|10884050|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1
6873384|NCT00479882|10884051|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
6873385|NCT00480025|10884079|FG000|Overall Study|Protocol Violation|12
6873386|NCT00480025|10884080|FG001|Overall Study|Protocol Violation|7
6873387|NCT00480025|10884079|FG000|Overall Study|Patients remaining ongoing at Data Lock|101
6873388|NCT00480025|10884080|FG001|Overall Study|Patients remaining ongoing at Data Lock|55
6873389|NCT00480025|10884079|FG000|Overall Study|Disease Progression / Recurrence|449
6873390|NCT00480025|10884080|FG001|Overall Study|Disease Progression / Recurrence|224
6873391|NCT00480025|10884079|FG000|Overall Study|Adverse Event|44
6873392|NCT00480025|10884080|FG001|Overall Study|Adverse Event|12
6873393|NCT00480025|10884079|FG000|Overall Study|Other|70
6873394|NCT00480025|10884080|FG001|Overall Study|Other|29
6873395|NCT00480025|10884079|FG000|Overall Study|SAE including intercurrent illness|76
6873396|NCT00480025|10884080|FG001|Overall Study|SAE including intercurrent illness|42
6873397|NCT00480077|10884094|FG000|Overall Study|Death|19
6873398|NCT00480077|10884095|FG001|Overall Study|Death|15
6873399|NCT00480077|10884094|FG000|Overall Study|early exit|12
6873400|NCT00480077|10884095|FG001|Overall Study|early exit|11
6873401|NCT00480324|10884103|FG000|Overall Study|Adverse Event|1
6873402|NCT00480324|10884104|FG001|Overall Study|Adverse Event|1
6873403|NCT00480324|10884103|FG000|Overall Study|Protocol Violation|0
6873404|NCT00480324|10884104|FG001|Overall Study|Protocol Violation|1
6873405|NCT00480324|10884103|FG000|Overall Study|Withdrawal by Subject|14
6873406|NCT00480324|10884104|FG001|Overall Study|Withdrawal by Subject|5
6873407|NCT00480324|10884103|FG000|Overall Study|Lost to Follow-up|17
6873408|NCT00480324|10884104|FG001|Overall Study|Lost to Follow-up|8
6873409|NCT00480324|10884103|FG000|Overall Study|Subject's mother pregnant|0
6873410|NCT00480324|10884104|FG001|Overall Study|Subject's mother pregnant|1
6873411|NCT00480441|10884112|FG000|Screening|Not Eligible|37
6873412|NCT00480441|10884113|FG001|Screening|Not Eligible|0
6873413|NCT00480441|10884114|FG002|Screening|Not Eligible|0
6873414|NCT00480441|10884112|FG000|Baseline Functional MRI|Functional MRI data not usable|4
6873415|NCT00480441|10884113|FG001|Baseline Functional MRI|Functional MRI data not usable|0
6873416|NCT00480441|10884114|FG002|Baseline Functional MRI|Functional MRI data not usable|0
6873417|NCT00480441|10884112|FG000|Baseline Functional MRI|Lost to Follow-up|4
6873418|NCT00480441|10884113|FG001|Baseline Functional MRI|Lost to Follow-up|0
6873419|NCT00480441|10884114|FG002|Baseline Functional MRI|Lost to Follow-up|0
6873420|NCT00480441|10884112|FG000|Baseline Functional MRI|physical contraindication|4
6873421|NCT00480441|10884113|FG001|Baseline Functional MRI|physical contraindication|0
6873422|NCT00480441|10884114|FG002|Baseline Functional MRI|physical contraindication|0
6873423|NCT00480441|10884112|FG000|Randomization|Lost to Follow-up|0
6873424|NCT00480441|10884113|FG001|Randomization|Lost to Follow-up|7
6873425|NCT00480441|10884114|FG002|Randomization|Lost to Follow-up|2
6873426|NCT00480493|10884123|FG000|Overall Study|moved|2
6873427|NCT00480493|10884124|FG001|Overall Study|moved|7
6873428|NCT00480532|10884136|FG000|Overall Study|Withdrawal by Subject|2
6873429|NCT00480532|10884137|FG001|Overall Study|Withdrawal by Subject|4
6873430|NCT00480532|10884138|FG002|Overall Study|Withdrawal by Subject|3
6873431|NCT00480532|10884139|FG003|Overall Study|Withdrawal by Subject|1
6873432|NCT00480532|10884136|FG000|Overall Study|Protocol Violation|0
6873433|NCT00480532|10884137|FG001|Overall Study|Protocol Violation|0
6873434|NCT00480532|10884138|FG002|Overall Study|Protocol Violation|1
6873435|NCT00480532|10884139|FG003|Overall Study|Protocol Violation|0
6873436|NCT00480636|10884149|FG000|Overall Study|Death|12
6873437|NCT00480636|10884149|FG000|Overall Study|Lost to Follow-up|4
6873438|NCT00480636|10884149|FG000|Overall Study|Other|2
6873439|NCT00480636|10884149|FG000|Overall Study|Lost to follow-up; subsequently died|1
6873440|NCT00480779|10884168|FG000|Overall Study|Other|2
6873441|NCT00480779|10884169|FG001|Overall Study|Other|0
6873442|NCT00480779|10884168|FG000|Overall Study|Job and Health-related|0
6873443|NCT00480779|10884169|FG001|Overall Study|Job and Health-related|3
6873444|NCT00480857|10884175|FG000|Overall Study|Lack of Efficacy|2
6873445|NCT00481065|10884191|FG000|Overall Study|Adverse event or death|1
6873446|NCT00481065|10884192|FG001|Overall Study|Adverse event or death|1
6873447|NCT00481065|10884193|FG002|Overall Study|Adverse event or death|3
6873448|NCT00481065|10884194|FG003|Overall Study|Adverse event or death|0
6873449|NCT00481065|10884195|FG004|Overall Study|Adverse event or death|2
6873450|NCT00481065|10884196|FG005|Overall Study|Adverse event or death|0
6873451|NCT00481065|10884197|FG006|Overall Study|Adverse event or death|1
6873452|NCT00481065|10884198|FG007|Overall Study|Adverse event or death|1
6873453|NCT00481065|10884191|FG000|Overall Study|Withdrawal by Subject|11
6873454|NCT00481065|10884192|FG001|Overall Study|Withdrawal by Subject|12
6873455|NCT00481065|10884193|FG002|Overall Study|Withdrawal by Subject|7
6873456|NCT00481065|10884194|FG003|Overall Study|Withdrawal by Subject|11
6873457|NCT00481065|10884195|FG004|Overall Study|Withdrawal by Subject|13
6873458|NCT00481065|10884196|FG005|Overall Study|Withdrawal by Subject|12
6873459|NCT00481065|10884197|FG006|Overall Study|Withdrawal by Subject|9
6873460|NCT00481065|10884198|FG007|Overall Study|Withdrawal by Subject|10
6873461|NCT00481065|10884191|FG000|Overall Study|Lost to Follow-up|4
6873462|NCT00481065|10884192|FG001|Overall Study|Lost to Follow-up|2
6873463|NCT00481065|10884193|FG002|Overall Study|Lost to Follow-up|4
6873464|NCT00481065|10884194|FG003|Overall Study|Lost to Follow-up|3
6873465|NCT00481065|10884195|FG004|Overall Study|Lost to Follow-up|3
6873466|NCT00481065|10884196|FG005|Overall Study|Lost to Follow-up|3
6873467|NCT00481065|10884197|FG006|Overall Study|Lost to Follow-up|2
6873468|NCT00481065|10884198|FG007|Overall Study|Lost to Follow-up|5
6873469|NCT00481065|10884191|FG000|Overall Study|Inappropriate enrollment|4
6873470|NCT00481065|10884192|FG001|Overall Study|Inappropriate enrollment|0
6873471|NCT00481065|10884193|FG002|Overall Study|Inappropriate enrollment|2
6873472|NCT00481065|10884194|FG003|Overall Study|Inappropriate enrollment|0
6873473|NCT00481065|10884195|FG004|Overall Study|Inappropriate enrollment|2
6873474|NCT00481065|10884196|FG005|Overall Study|Inappropriate enrollment|1
6873475|NCT00481065|10884197|FG006|Overall Study|Inappropriate enrollment|0
6873476|NCT00481065|10884198|FG007|Overall Study|Inappropriate enrollment|1
6873477|NCT00481065|10884191|FG000|Overall Study|Administrative reason|0
6873478|NCT00481065|10884192|FG001|Overall Study|Administrative reason|0
6873479|NCT00481065|10884193|FG002|Overall Study|Administrative reason|0
6873480|NCT00481065|10884194|FG003|Overall Study|Administrative reason|0
6873481|NCT00481065|10884195|FG004|Overall Study|Administrative reason|0
6873482|NCT00481065|10884196|FG005|Overall Study|Administrative reason|2
6873483|NCT00481065|10884197|FG006|Overall Study|Administrative reason|1
6873484|NCT00481065|10884198|FG007|Overall Study|Administrative reason|0
6873485|NCT00481065|10884191|FG000|Overall Study|Protocol Violation|2
6873486|NCT00481065|10884192|FG001|Overall Study|Protocol Violation|1
6873487|NCT00481065|10884193|FG002|Overall Study|Protocol Violation|1
6873488|NCT00481065|10884194|FG003|Overall Study|Protocol Violation|1
6873489|NCT00481065|10884195|FG004|Overall Study|Protocol Violation|2
6873490|NCT00481065|10884196|FG005|Overall Study|Protocol Violation|6
6873491|NCT00481065|10884197|FG006|Overall Study|Protocol Violation|3
6873492|NCT00481065|10884198|FG007|Overall Study|Protocol Violation|2
6873493|NCT00481065|10884191|FG000|Overall Study|Unable to classify|0
6873494|NCT00481065|10884192|FG001|Overall Study|Unable to classify|1
6873495|NCT00481065|10884193|FG002|Overall Study|Unable to classify|2
6873496|NCT00481065|10884194|FG003|Overall Study|Unable to classify|0
6873497|NCT00481065|10884195|FG004|Overall Study|Unable to classify|1
6873498|NCT00481065|10884196|FG005|Overall Study|Unable to classify|0
6873499|NCT00481065|10884197|FG006|Overall Study|Unable to classify|0
6873500|NCT00481065|10884198|FG007|Overall Study|Unable to classify|0
6873501|NCT00481078|10884220|FG000|Overall Study|Progression of disease|11
6873502|NCT00481078|10884221|FG001|Overall Study|Progression of disease|11
6873503|NCT00481078|10884220|FG000|Overall Study|Adverse Event|15
6873504|NCT00481078|10884221|FG001|Overall Study|Adverse Event|3
6873505|NCT00481078|10884220|FG000|Overall Study|Death|5
6873506|NCT00481078|10884221|FG001|Overall Study|Death|3
6873507|NCT00481078|10884220|FG000|Overall Study|Intercurrent illness|1
6873508|NCT00481078|10884221|FG001|Overall Study|Intercurrent illness|0
6873509|NCT00481078|10884220|FG000|Overall Study|Withdrawal by Subject|7
6968703|NCT01142232|11017847|FG003|Overall Study|Disease Progression|2
6968704|NCT01142232|11017848|FG004|Overall Study|Disease Progression|12
6968705|NCT01142232|11017844|FG000|Overall Study|Withdrawal by Subject|0
6968706|NCT01142232|11017845|FG001|Overall Study|Withdrawal by Subject|0
6968707|NCT01142232|11017846|FG002|Overall Study|Withdrawal by Subject|0
6968708|NCT01142232|11017847|FG003|Overall Study|Withdrawal by Subject|1
6968709|NCT01142232|11017848|FG004|Overall Study|Withdrawal by Subject|3
6968710|NCT01142232|11017844|FG000|Overall Study|Physician Decision|0
6968711|NCT01142232|11017845|FG001|Overall Study|Physician Decision|1
6968712|NCT01142232|11017846|FG002|Overall Study|Physician Decision|0
6968713|NCT01142232|11017847|FG003|Overall Study|Physician Decision|2
6968714|NCT01142232|11017848|FG004|Overall Study|Physician Decision|10
6968715|NCT01142232|11017844|FG000|Overall Study|Alternative Therapy|0
6968716|NCT01142232|11017845|FG001|Overall Study|Alternative Therapy|1
6968717|NCT01142232|11017846|FG002|Overall Study|Alternative Therapy|1
6968718|NCT01142232|11017847|FG003|Overall Study|Alternative Therapy|0
6968719|NCT01142232|11017848|FG004|Overall Study|Alternative Therapy|1
6968720|NCT01142232|11017844|FG000|Overall Study|Off Trt for other complicating disease|0
6968721|NCT01142232|11017845|FG001|Overall Study|Off Trt for other complicating disease|0
6968722|NCT01142232|11017846|FG002|Overall Study|Off Trt for other complicating disease|0
6968723|NCT01142232|11017847|FG003|Overall Study|Off Trt for other complicating disease|0
6968724|NCT01142232|11017848|FG004|Overall Study|Off Trt for other complicating disease|1
6968725|NCT01142232|11017844|FG000|Overall Study|Noncompliance|0
6968726|NCT01142232|11017845|FG001|Overall Study|Noncompliance|0
6968727|NCT01142232|11017846|FG002|Overall Study|Noncompliance|0
6968728|NCT01142232|11017847|FG003|Overall Study|Noncompliance|0
6968729|NCT01142232|11017848|FG004|Overall Study|Noncompliance|2
6968730|NCT01142336|11017884|FG000|Overall Study|Adverse Event|1
6968731|NCT01142336|11017885|FG001|Overall Study|Adverse Event|1
6968732|NCT01142336|11017884|FG000|Overall Study|Lost to Follow-up|0
6968733|NCT01142336|11017885|FG001|Overall Study|Lost to Follow-up|1
6968734|NCT01142466|11017896|FG000|Overall Study|Adverse Event|2
6968735|NCT01142466|11017897|FG001|Overall Study|Adverse Event|1
6968736|NCT01142466|11017896|FG000|Overall Study|Withdrawal by Subject|1
6968737|NCT01142466|11017897|FG001|Overall Study|Withdrawal by Subject|1
6968738|NCT01142661|11017903|FG000|Overall Study|Adverse Event|2
6968739|NCT01142661|11017903|FG000|Overall Study|Withdrawal by Subject|1
6968740|NCT01142661|11017903|FG000|Overall Study|Physician Decision|1
6968741|NCT01142726|11017910|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
6968742|NCT01142726|11017911|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8
6968743|NCT01142726|11017912|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
6968744|NCT01142726|11017910|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4
6968745|NCT01142726|11017911|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9
6968746|NCT01142726|11017912|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3
6968747|NCT01142726|11017910|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
6968748|NCT01142726|11017911|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2
6968749|NCT01142726|11017912|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
6968750|NCT01142726|11017910|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1
6968751|NCT01142726|11017911|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
6968752|NCT01142726|11017912|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
6968753|NCT01142726|11017910|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5
6968754|NCT01142726|11017911|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6
6968755|NCT01142726|11017912|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11
6968756|NCT01142726|11017910|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
6968757|NCT01142726|11017911|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
6968758|NCT01142726|11017912|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1
6968759|NCT01142726|11017910|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
6968760|NCT01142726|11017911|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
6968761|NCT01142726|11017912|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2
6976946|NCT01203072|11029843|FG003|Overall Study|Lack of Efficacy|0
6873510|NCT00481078|10884221|FG001|Overall Study|Withdrawal by Subject|1
6873511|NCT00481078|10884220|FG000|Overall Study|Information not available|1
6873512|NCT00481078|10884221|FG001|Overall Study|Information not available|0
6873513|NCT00481078|10884220|FG000|Overall Study|Received other treatment|2
6873514|NCT00481078|10884221|FG001|Overall Study|Received other treatment|1
6873515|NCT00481078|10884220|FG000|Overall Study|Brain metastasis|0
6873516|NCT00481078|10884221|FG001|Overall Study|Brain metastasis|1
6873517|NCT00481195|10884229|FG000|Overall Study|Adverse Event|16
6873518|NCT00481195|10884230|FG001|Overall Study|Adverse Event|11
6873519|NCT00481195|10884229|FG000|Overall Study|Lack of Efficacy|1
6873520|NCT00481195|10884230|FG001|Overall Study|Lack of Efficacy|3
6873521|NCT00481195|10884229|FG000|Overall Study|Lost to Follow-up|4
6873522|NCT00481195|10884230|FG001|Overall Study|Lost to Follow-up|6
6873523|NCT00481195|10884229|FG000|Overall Study|Physician Decision|3
6873524|NCT00481195|10884230|FG001|Overall Study|Physician Decision|1
6873525|NCT00481195|10884229|FG000|Overall Study|Protocol Violation|10
6873526|NCT00481195|10884230|FG001|Overall Study|Protocol Violation|7
6873527|NCT00481195|10884229|FG000|Overall Study|Withdrawal by Subject|3
6873528|NCT00481195|10884230|FG001|Overall Study|Withdrawal by Subject|9
6873529|NCT00481195|10884229|FG000|Overall Study|Miscellaneous|2
6873530|NCT00481195|10884230|FG001|Overall Study|Miscellaneous|2
6873531|NCT00481247|10884238|FG000|Overall Study|Death|0
6873532|NCT00481247|10884239|FG001|Overall Study|Death|1
6873533|NCT00481247|10884238|FG000|Overall Study|Disease progression|18
6873534|NCT00481247|10884239|FG001|Overall Study|Disease progression|22
6873535|NCT00481247|10884238|FG000|Overall Study|Intolerance|42
6873536|NCT00481247|10884239|FG001|Overall Study|Intolerance|17
6873537|NCT00481247|10884238|FG000|Overall Study|Treatment failure|10
6873538|NCT00481247|10884239|FG001|Overall Study|Treatment failure|14
6873539|NCT00481247|10884238|FG000|Overall Study|AE unrelated to study drug|13
6873540|NCT00481247|10884239|FG001|Overall Study|AE unrelated to study drug|4
6873541|NCT00481247|10884238|FG000|Overall Study|Withdrawal by Subject|8
6873542|NCT00481247|10884239|FG001|Overall Study|Withdrawal by Subject|13
6873543|NCT00481247|10884238|FG000|Overall Study|Pregnancy|2
6873544|NCT00481247|10884239|FG001|Overall Study|Pregnancy|1
6873545|NCT00481247|10884238|FG000|Overall Study|Lost to Follow-up|1
6873546|NCT00481247|10884239|FG001|Overall Study|Lost to Follow-up|2
6873547|NCT00481247|10884238|FG000|Overall Study|Poor compliance/noncompliance|1
6873548|NCT00481247|10884239|FG001|Overall Study|Poor compliance/noncompliance|7
6873549|NCT00481247|10884238|FG000|Overall Study|Administrative reason by sponsor|157
6873550|NCT00481247|10884239|FG001|Overall Study|Administrative reason by sponsor|162
6873551|NCT00481247|10884238|FG000|Overall Study|Varied|6
6873552|NCT00481247|10884239|FG001|Overall Study|Varied|15
6873553|NCT00481247|10884238|FG000|Overall Study|Did not receive treatment|1
6873554|NCT00481247|10884239|FG001|Overall Study|Did not receive treatment|2
6873555|NCT00481676|10884265|FG000|Overall Study|Adverse Event|0
6873556|NCT00481676|10884266|FG001|Overall Study|Adverse Event|1
6873557|NCT00481676|10884265|FG000|Overall Study|Unsatisfactory therapeutic effect|1
6873558|NCT00481676|10884266|FG001|Overall Study|Unsatisfactory therapeutic effect|4
6873559|NCT00481676|10884265|FG000|Overall Study|Administrative problem|1
6873560|NCT00481676|10884266|FG001|Overall Study|Administrative problem|0
6873561|NCT00481767|10884274|FG000|Overall Study|Withdrawal by Subject|16
6873562|NCT00481767|10884275|FG001|Overall Study|Withdrawal by Subject|11
6873563|NCT00481767|10884274|FG000|Overall Study|Lost to Follow-up|16
6873564|NCT00481767|10884275|FG001|Overall Study|Lost to Follow-up|10
6873565|NCT00481832|10884281|FG000|Enrollment|Physician Decision|8
6873566|NCT00481832|10884281|FG000|Enrollment|Unable to collect enough stem cells|2
7154319|NCT03308968|11320892|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0
7154320|NCT03308968|11320893|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1
7154321|NCT03308968|11320894|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1
7154322|NCT03308968|11320892|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1
7154323|NCT03308968|11320893|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2
7154324|NCT03308968|11320894|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0
7154325|NCT03309020|11320907|FG000|Overall Study|Death|1
7154326|NCT03309020|11320908|FG001|Overall Study|Death|0
7154327|NCT03309020|11320907|FG000|Overall Study|Did not undergo surgery|2
7154328|NCT03309020|11320908|FG001|Overall Study|Did not undergo surgery|1
7154329|NCT03309202|11320920|FG000|Overall Study|Lost to Follow-up|1
7154330|NCT03309202|11320921|FG001|Overall Study|Lost to Follow-up|0
7154331|NCT03309202|11320922|FG002|Overall Study|Lost to Follow-up|0
7154332|NCT03309202|11320923|FG003|Overall Study|Lost to Follow-up|0
7154333|NCT03309605|11320954|FG000|Overall Study|Adverse Event|0
7154334|NCT03309605|11320955|FG001|Overall Study|Adverse Event|0
6873567|NCT00481832|10884281|FG000|Inter-transplant Period|Adverse Event|4
6873568|NCT00481832|10884281|FG000|Inter-transplant Period|Death|3
6873569|NCT00481832|10884281|FG000|Inter-transplant Period|Physician Decision|4
6873570|NCT00481832|10884281|FG000|Inter-transplant Period|Disease relapse|11
7154335|NCT03309605|11320956|FG002|Overall Study|Adverse Event|0
7154336|NCT03309605|11320957|FG003|Overall Study|Adverse Event|1
7154337|NCT03309605|11320958|FG004|Overall Study|Adverse Event|0
7154338|NCT03309605|11320959|FG005|Overall Study|Adverse Event|0
7154339|NCT03309605|11320960|FG006|Overall Study|Adverse Event|2
6873571|NCT00481832|10884281|FG000|Inter-transplant Period|Lack of allogeneic donor|5
6873572|NCT00481871|10884299|FG000|Overall Study|Progressive Disease - pt withdrew|0
7154340|NCT03309605|11320961|FG007|Overall Study|Adverse Event|1
6873573|NCT00481871|10884300|FG001|Overall Study|Progressive Disease - pt withdrew|0
6873574|NCT00481871|10884301|FG002|Overall Study|Progressive Disease - pt withdrew|1
6873575|NCT00481871|10884302|FG003|Overall Study|Progressive Disease - pt withdrew|0
6873576|NCT00481871|10884303|FG004|Overall Study|Progressive Disease - pt withdrew|0
6873577|NCT00481988|10884313|FG000|Overall Study|Withdrawal by Subject|1
6873578|NCT00481988|10884314|FG001|Overall Study|Withdrawal by Subject|1
6873579|NCT00482001|10884322|FG000|Overall Study|Protocol Violation|1
6873580|NCT00482001|10884323|FG001|Overall Study|Protocol Violation|1
6873581|NCT00482014|10884335|FG000|Overall Study|Withdrawal by Subject|1
7078486|NCT02104752|11187071|FG000|Overall Study|Weight gain; unrelated anxiety|0
7078487|NCT02104752|11187072|FG001|Overall Study|Weight gain; unrelated anxiety|2
7078488|NCT02104765|11187085|FG000|Overall Study|Lost to Follow-up|0
7078489|NCT02104765|11187086|FG001|Overall Study|Lost to Follow-up|0
7154341|NCT03309605|11320954|FG000|Overall Study|Withdrawal by Subject|0
7154342|NCT03309605|11320955|FG001|Overall Study|Withdrawal by Subject|0
6873582|NCT00482014|10884336|FG001|Overall Study|Withdrawal by Subject|2
6873583|NCT00482014|10884337|FG002|Overall Study|Withdrawal by Subject|3
6873584|NCT00482014|10884338|FG003|Overall Study|Withdrawal by Subject|4
6873585|NCT00482014|10884335|FG000|Overall Study|Adverse Event|3
6873586|NCT00482014|10884336|FG001|Overall Study|Adverse Event|0
6873587|NCT00482014|10884337|FG002|Overall Study|Adverse Event|2
6873588|NCT00482014|10884338|FG003|Overall Study|Adverse Event|8
6873589|NCT00482014|10884335|FG000|Overall Study|Death|1
6873590|NCT00482014|10884336|FG001|Overall Study|Death|2
6873591|NCT00482014|10884337|FG002|Overall Study|Death|1
6873592|NCT00482014|10884338|FG003|Overall Study|Death|4
6873593|NCT00482014|10884335|FG000|Overall Study|Lack of Efficacy|1
6873594|NCT00482014|10884336|FG001|Overall Study|Lack of Efficacy|0
6873595|NCT00482014|10884337|FG002|Overall Study|Lack of Efficacy|4
6873596|NCT00482014|10884338|FG003|Overall Study|Lack of Efficacy|6
6873597|NCT00482014|10884335|FG000|Overall Study|Sponsor Decision|1
6873598|NCT00482014|10884336|FG001|Overall Study|Sponsor Decision|2
6873599|NCT00482014|10884337|FG002|Overall Study|Sponsor Decision|1
6873600|NCT00482014|10884338|FG003|Overall Study|Sponsor Decision|1
6873601|NCT00482053|10884350|FG000|Inter-treatment Period|Disease progression|1
6873602|NCT00482170|10884356|FG000|Overall Study|Adverse Event|5
6873603|NCT00482170|10884357|FG001|Overall Study|Adverse Event|14
6873604|NCT00482170|10884356|FG000|Overall Study|Withdrawal by Subject|6
6873605|NCT00482170|10884357|FG001|Overall Study|Withdrawal by Subject|1
6873606|NCT00482170|10884356|FG000|Overall Study|Protocol Violation|2
6873607|NCT00482170|10884357|FG001|Overall Study|Protocol Violation|3
6873608|NCT00482170|10884356|FG000|Overall Study|Lost to Follow-up|2
6873609|NCT00482170|10884357|FG001|Overall Study|Lost to Follow-up|0
6873610|NCT00482170|10884356|FG000|Overall Study|Unspecified reason|0
6873611|NCT00482170|10884357|FG001|Overall Study|Unspecified reason|2
6873612|NCT00482274|10884363|FG000|Overall Study|Adverse Event|1
6873613|NCT00482391|10884367|FG000|Overall Study|Withdrawal by Subject|1
6873614|NCT00482391|10884367|FG000|Overall Study|Adverse Event|1
6873615|NCT00482391|10884367|FG000|Overall Study|Death|1
6873616|NCT00482612|10884385|FG000|In-treatment Period|No study medication administered|0
6873617|NCT00482612|10884386|FG001|In-treatment Period|No study medication administered|0
6873618|NCT00482612|10884387|FG002|In-treatment Period|No study medication administered|1
6873619|NCT00482612|10884388|FG003|In-treatment Period|No study medication administered|0
6873620|NCT00482612|10884385|FG000|Follow-up Period|Other|4
6873621|NCT00482612|10884386|FG001|Follow-up Period|Other|2
6873622|NCT00482612|10884387|FG002|Follow-up Period|Other|1
6873623|NCT00482612|10884388|FG003|Follow-up Period|Other|2
6873624|NCT00482612|10884385|FG000|Follow-up Period|Lack of compliance|0
6873625|NCT00482612|10884386|FG001|Follow-up Period|Lack of compliance|0
6873626|NCT00482612|10884387|FG002|Follow-up Period|Lack of compliance|1
6873627|NCT00482612|10884388|FG003|Follow-up Period|Lack of compliance|0
6873628|NCT00482612|10884385|FG000|Follow-up Period|Lost to Follow-up|0
6873629|NCT00482612|10884386|FG001|Follow-up Period|Lost to Follow-up|4
6873630|NCT00482612|10884387|FG002|Follow-up Period|Lost to Follow-up|2
6873631|NCT00482612|10884388|FG003|Follow-up Period|Lost to Follow-up|1
6873632|NCT00482612|10884385|FG000|Follow-up Period|Adverse Event|4
6873633|NCT00482612|10884386|FG001|Follow-up Period|Adverse Event|7
6873634|NCT00482612|10884387|FG002|Follow-up Period|Adverse Event|9
6873635|NCT00482612|10884388|FG003|Follow-up Period|Adverse Event|0
6873636|NCT00482612|10884385|FG000|Follow-up Period|Lack of Efficacy|2
6873637|NCT00482612|10884386|FG001|Follow-up Period|Lack of Efficacy|0
6873638|NCT00482612|10884387|FG002|Follow-up Period|Lack of Efficacy|1
6873639|NCT00482612|10884388|FG003|Follow-up Period|Lack of Efficacy|0
6873640|NCT00482612|10884385|FG000|Follow-up Period|Withdrawal by Subject|3
6873641|NCT00482612|10884386|FG001|Follow-up Period|Withdrawal by Subject|5
6873642|NCT00482612|10884387|FG002|Follow-up Period|Withdrawal by Subject|7
7154343|NCT03309605|11320956|FG002|Overall Study|Withdrawal by Subject|0
7154344|NCT03309605|11320957|FG003|Overall Study|Withdrawal by Subject|0
7154345|NCT03309605|11320958|FG004|Overall Study|Withdrawal by Subject|1
6873643|NCT00482612|10884388|FG003|Follow-up Period|Withdrawal by Subject|2
6873644|NCT00482612|10884385|FG000|Follow-up Period|Reasons not related to trial|1
6873645|NCT00482612|10884386|FG001|Follow-up Period|Reasons not related to trial|0
6873646|NCT00482612|10884387|FG002|Follow-up Period|Reasons not related to trial|1
7078490|NCT02104765|11187087|FG002|Overall Study|Lost to Follow-up|1
6873647|NCT00482612|10884388|FG003|Follow-up Period|Reasons not related to trial|3
6968762|NCT01142726|11017910|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
6968763|NCT01142726|11017911|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0
6968764|NCT01142726|11017912|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
6968765|NCT01142726|11017910|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2
6968766|NCT01142726|11017911|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
6968767|NCT01142726|11017912|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
6968768|NCT01142726|11017910|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1
6968769|NCT01142726|11017911|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
6968770|NCT01142726|11017912|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
6968771|NCT01142726|11017910|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65
6968772|NCT01142726|11017911|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54
6968773|NCT01142726|11017912|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53
6968774|NCT01142726|11017910|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0
6968775|NCT01142726|11017911|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1
6968776|NCT01142726|11017912|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1
6968777|NCT01142726|11017910|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
6968778|NCT01142726|11017911|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
6968779|NCT01142726|11017912|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1
6968780|NCT01142726|11017910|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
6968781|NCT01142726|11017911|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
6968782|NCT01142726|11017912|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
6968783|NCT01142726|11017910|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
6968784|NCT01142726|11017911|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
6968785|NCT01142726|11017912|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1
6968786|NCT01142726|11017910|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
6968787|NCT01142726|11017911|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1
6968788|NCT01142726|11017912|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
6968789|NCT01142791|11017928|FG000|Overall Study|Alternative Treatment|1
6968790|NCT01142791|11017929|FG001|Overall Study|Alternative Treatment|0
6968791|NCT01142791|11017928|FG000|Overall Study|Lost to Follow-up|1
6968792|NCT01142791|11017929|FG001|Overall Study|Lost to Follow-up|0
6968793|NCT01142791|11017928|FG000|Overall Study|Withdrawal by Subject|5
6968794|NCT01142791|11017929|FG001|Overall Study|Withdrawal by Subject|0
6968795|NCT01142791|11017928|FG000|Overall Study|Received only 1 sonication|0
6968796|NCT01142791|11017929|FG001|Overall Study|Received only 1 sonication|6
6968797|NCT01142908|11017935|FG000|Overall Study|Lost to Follow-up|19
6968798|NCT01142908|11017936|FG001|Overall Study|Lost to Follow-up|13
6968799|NCT01142908|11017935|FG000|Overall Study|Death|1
6968800|NCT01142908|11017936|FG001|Overall Study|Death|4
6968801|NCT01142908|11017935|FG000|Overall Study|Excluded - did not meet criteria|9
6968802|NCT01142908|11017936|FG001|Overall Study|Excluded - did not meet criteria|5
6968803|NCT01142908|11017935|FG000|Overall Study|Withdrawal by Subject|3
6968804|NCT01142908|11017936|FG001|Overall Study|Withdrawal by Subject|0
6968805|NCT01143038|11017946|FG000|Overall Study|Withdrawal by Subject|4
6968806|NCT01143038|11017946|FG000|Overall Study|Requirement for alternative therapy|5
6968807|NCT01143038|11017946|FG000|Overall Study|Adverse Event|3
6968808|NCT01143038|11017946|FG000|Overall Study|Lost to Follow-up|2
6968809|NCT01143038|11017946|FG000|Overall Study|Protocol Deviation|1
6968810|NCT01143038|11017946|FG000|Overall Study|Death|1
6968811|NCT01143051|11017956|FG000|3-14 Day Washout|Withdrawal by Subject|0
6968812|NCT01143051|11017957|FG001|3-14 Day Washout|Withdrawal by Subject|0
6968813|NCT01143051|11017958|FG002|3-14 Day Washout|Withdrawal by Subject|1
6968814|NCT01143051|11017959|FG003|3-14 Day Washout|Withdrawal by Subject|0
6968815|NCT01143051|11017960|FG004|3-14 Day Washout|Withdrawal by Subject|0
6968816|NCT01143051|11017961|FG005|3-14 Day Washout|Withdrawal by Subject|0
6968817|NCT01143051|11017956|FG000|3-14 Day Washout|Withdrawal by Subject|0
6968818|NCT01143051|11017957|FG001|3-14 Day Washout|Withdrawal by Subject|0
6968819|NCT01143051|11017958|FG002|3-14 Day Washout|Withdrawal by Subject|0
6968820|NCT01143051|11017959|FG003|3-14 Day Washout|Withdrawal by Subject|0
6968821|NCT01143051|11017960|FG004|3-14 Day Washout|Withdrawal by Subject|0
6968822|NCT01143051|11017961|FG005|3-14 Day Washout|Withdrawal by Subject|1
6968823|NCT01143077|11017974|FG000|Overall Study|Lack of Efficacy|0
6968824|NCT01143077|11017975|FG001|Overall Study|Lack of Efficacy|2
6968825|NCT01143077|11017976|FG002|Overall Study|Lack of Efficacy|1
6968826|NCT01143077|11017974|FG000|Overall Study|Adverse Event|5
6968827|NCT01143077|11017975|FG001|Overall Study|Adverse Event|6
6968828|NCT01143077|11017976|FG002|Overall Study|Adverse Event|5
6968829|NCT01143077|11017974|FG000|Overall Study|Lost to Follow-up|2
6968830|NCT01143077|11017975|FG001|Overall Study|Lost to Follow-up|3
6968831|NCT01143077|11017976|FG002|Overall Study|Lost to Follow-up|4
6968832|NCT01143077|11017974|FG000|Overall Study|Protocol Violation|2
6968833|NCT01143077|11017975|FG001|Overall Study|Protocol Violation|0
6968834|NCT01143077|11017976|FG002|Overall Study|Protocol Violation|0
6968835|NCT01143077|11017974|FG000|Overall Study|Withdrawal by Subject|4
6968836|NCT01143077|11017975|FG001|Overall Study|Withdrawal by Subject|3
6968837|NCT01143077|11017976|FG002|Overall Study|Withdrawal by Subject|3
6968838|NCT01143077|11017974|FG000|Overall Study|Non-compliance with study drug|0
6873648|NCT00482703|10884417|FG000|Overall Study|Poor compliance|1
6873649|NCT00482703|10884418|FG001|Overall Study|Poor compliance|0
6873650|NCT00482729|10884433|FG000|Overall Study|Adverse Event|29
6873651|NCT00482729|10884434|FG001|Overall Study|Adverse Event|33
6873652|NCT00482729|10884433|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0
6873653|NCT00482729|10884434|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2
6873654|NCT00482729|10884433|FG000|Overall Study|Hyperglycemia Criteria|7
6873655|NCT00482729|10884434|FG001|Overall Study|Hyperglycemia Criteria|5
6873656|NCT00482729|10884433|FG000|Overall Study|Lack of Efficacy|4
6873657|NCT00482729|10884434|FG001|Overall Study|Lack of Efficacy|16
6873658|NCT00482729|10884433|FG000|Overall Study|Lost to Follow-up|86
6873659|NCT00482729|10884434|FG001|Overall Study|Lost to Follow-up|66
6873660|NCT00482729|10884433|FG000|Overall Study|Physician Decision|10
6873661|NCT00482729|10884434|FG001|Overall Study|Physician Decision|7
6873662|NCT00482729|10884433|FG000|Overall Study|Pregnancy|4
6873663|NCT00482729|10884434|FG001|Overall Study|Pregnancy|2
6873664|NCT00482729|10884433|FG000|Overall Study|Protocol Violation|10
6873665|NCT00482729|10884434|FG001|Overall Study|Protocol Violation|18
6873666|NCT00482729|10884433|FG000|Overall Study|Withdrawal by Subject|67
6873667|NCT00482729|10884434|FG001|Overall Study|Withdrawal by Subject|69
6873668|NCT00483002|10884449|FG000|Overall Study|Adverse Event|68
6873669|NCT00483002|10884449|FG000|Overall Study|Lack of Efficacy|555
6873670|NCT00483002|10884449|FG000|Overall Study|Lost to Follow-up|962
6873671|NCT00483002|10884449|FG000|Overall Study|Other|2
6873672|NCT00483002|10884449|FG000|Overall Study|Other|967
6873673|NCT00483041|10884455|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0
6873674|NCT00483041|10884456|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1
6873675|NCT00483184|10884465|FG000|Overall Study|Withdrawal by Subject|2
6873676|NCT00483184|10884466|FG001|Overall Study|Withdrawal by Subject|2
6873677|NCT00483184|10884467|FG002|Overall Study|Withdrawal by Subject|0
6873678|NCT00483184|10884465|FG000|Overall Study|Lost to Follow-up|1
6873679|NCT00483184|10884466|FG001|Overall Study|Lost to Follow-up|0
6873680|NCT00483184|10884467|FG002|Overall Study|Lost to Follow-up|0
6873681|NCT00483184|10884465|FG000|Overall Study|Adverse Event|1
6873682|NCT00483184|10884466|FG001|Overall Study|Adverse Event|2
6873683|NCT00483184|10884467|FG002|Overall Study|Adverse Event|2
6873684|NCT00483184|10884465|FG000|Overall Study|Protocol Violation|1
6873685|NCT00483184|10884466|FG001|Overall Study|Protocol Violation|0
6873686|NCT00483184|10884467|FG002|Overall Study|Protocol Violation|1
6873687|NCT00483327|10884492|FG000|Overall Study|Adverse Event|1
6873688|NCT00483327|10884492|FG000|Overall Study|Withdrawal by Subject|3
6873689|NCT00483327|10884492|FG000|Overall Study|Lost to Follow-up|4
6873690|NCT00483327|10884492|FG000|Overall Study|Patient Non Compliance|2
6873691|NCT00483379|10884500|FG000|Treatment Period|Adverse Event|1
6873692|NCT00483379|10884501|FG001|Treatment Period|Adverse Event|0
6873693|NCT00483379|10884500|FG000|Treatment Period|Withdrawal by Subject|1
6873694|NCT00483379|10884501|FG001|Treatment Period|Withdrawal by Subject|0
6873695|NCT00483405|10884509|FG000|Overall Study|Adverse Event|8
6873696|NCT00483405|10884509|FG000|Overall Study|Lack of Efficacy|14
6873697|NCT00483405|10884509|FG000|Overall Study|Death|3
6873698|NCT00483405|10884509|FG000|Overall Study|Withdrawal by Subject|2
6873699|NCT00483405|10884509|FG000|Overall Study|Other complicating disease|1
6873700|NCT00483548|10884531|FG000|Overall Study|Randomized; not treated with study drug|1
6873701|NCT00483548|10884532|FG001|Overall Study|Randomized; not treated with study drug|3
6873702|NCT00483548|10884531|FG000|Overall Study|Adverse Event|25
6873703|NCT00483548|10884532|FG001|Overall Study|Adverse Event|14
6873704|NCT00483548|10884531|FG000|Overall Study|Laboratory abnormality|1
6873705|NCT00483548|10884532|FG001|Overall Study|Laboratory abnormality|2
6873706|NCT00483548|10884531|FG000|Overall Study|Lack of Efficacy|4
6873707|NCT00483548|10884532|FG001|Overall Study|Lack of Efficacy|8
6873708|NCT00483548|10884531|FG000|Overall Study|Protocol Violation|11
6873709|NCT00483548|10884532|FG001|Overall Study|Protocol Violation|7
6873710|NCT00483548|10884531|FG000|Overall Study|Pregnancy|1
6873711|NCT00483548|10884532|FG001|Overall Study|Pregnancy|0
6873712|NCT00483548|10884531|FG000|Overall Study|Protocol required discontinuation|6
6873713|NCT00483548|10884532|FG001|Overall Study|Protocol required discontinuation|6
6873714|NCT00483548|10884531|FG000|Overall Study|Unable to comply with protocol schedule|1
6873715|NCT00483548|10884532|FG001|Overall Study|Unable to comply with protocol schedule|0
6873716|NCT00483548|10884531|FG000|Overall Study|Non-compliance with medication|2
6873717|NCT00483548|10884532|FG001|Overall Study|Non-compliance with medication|0
6873718|NCT00483548|10884531|FG000|Overall Study|Lost to Follow-up|3
6873719|NCT00483548|10884532|FG001|Overall Study|Lost to Follow-up|4
6873720|NCT00483548|10884531|FG000|Overall Study|Withdrawal by Subject|5
6873721|NCT00483548|10884532|FG001|Overall Study|Withdrawal by Subject|2
6873722|NCT00483574|10884544|FG000|Overall Study|Adverse Event|6
6873723|NCT00483574|10884545|FG001|Overall Study|Adverse Event|0
6873724|NCT00483574|10884544|FG000|Overall Study|Protocol Violation|28
6873725|NCT00483574|10884545|FG001|Overall Study|Protocol Violation|9
6873726|NCT00483574|10884544|FG000|Overall Study|Lost to Follow-up|16
6873727|NCT00483574|10884545|FG001|Overall Study|Lost to Follow-up|4
6873728|NCT00483574|10884544|FG000|Overall Study|Withdrawal by Subject|52
6873729|NCT00483574|10884545|FG001|Overall Study|Withdrawal by Subject|0
6873730|NCT00483652|10884555|FG000|Double-blind Treatment Period|Protocol Violation|2
6873731|NCT00483652|10884556|FG001|Double-blind Treatment Period|Protocol Violation|1
6873732|NCT00483652|10884555|FG000|Double-blind Treatment Period|Adverse Event|3
6873733|NCT00483652|10884556|FG001|Double-blind Treatment Period|Adverse Event|4
6873734|NCT00483652|10884555|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1
6873735|NCT00483652|10884556|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0
6873736|NCT00483652|10884555|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1
6873737|NCT00483652|10884556|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0
6873738|NCT00483704|10884565|FG000|Randomization|Withdrawal by Subject|19
6873739|NCT00483704|10884566|FG001|Randomization|Withdrawal by Subject|28
6873740|NCT00483704|10884567|FG002|Randomization|Withdrawal by Subject|18
6873741|NCT00483704|10884565|FG000|Randomization|Protocol Violation|14
6873742|NCT00483704|10884566|FG001|Randomization|Protocol Violation|25
6873743|NCT00483704|10884567|FG002|Randomization|Protocol Violation|22
6873744|NCT00483704|10884565|FG000|Randomization|Lost to Follow-up|14
6873745|NCT00483704|10884566|FG001|Randomization|Lost to Follow-up|14
6873746|NCT00483704|10884567|FG002|Randomization|Lost to Follow-up|19
6873747|NCT00483704|10884565|FG000|Randomization|Pregnancy|1
6873748|NCT00483704|10884566|FG001|Randomization|Pregnancy|0
6873749|NCT00483704|10884567|FG002|Randomization|Pregnancy|0
6873750|NCT00483704|10884565|FG000|Randomization|Physician Decision|2
6873751|NCT00483704|10884566|FG001|Randomization|Physician Decision|4
6873752|NCT00483704|10884567|FG002|Randomization|Physician Decision|0
6873753|NCT00483704|10884565|FG000|Randomization|Progressive disease|0
6873754|NCT00483704|10884566|FG001|Randomization|Progressive disease|0
6873755|NCT00483704|10884567|FG002|Randomization|Progressive disease|1
6873756|NCT00483704|10884565|FG000|Randomization|Lack of qualifying migraines|21
6873757|NCT00483704|10884566|FG001|Randomization|Lack of qualifying migraines|25
6873758|NCT00483704|10884567|FG002|Randomization|Lack of qualifying migraines|31
6873759|NCT00483704|10884565|FG000|Treatment|Lack of qualifying migraines|101
6873760|NCT00483704|10884566|FG001|Treatment|Lack of qualifying migraines|99
6873761|NCT00483704|10884567|FG002|Treatment|Lack of qualifying migraines|116
6873762|NCT00483704|10884565|FG000|Treatment|Adverse Event|3
6873763|NCT00483704|10884566|FG001|Treatment|Adverse Event|5
6873764|NCT00483704|10884567|FG002|Treatment|Adverse Event|4
6873765|NCT00483704|10884565|FG000|Treatment|Withdrawal by Subject|16
6873766|NCT00483704|10884566|FG001|Treatment|Withdrawal by Subject|12
6873767|NCT00483704|10884567|FG002|Treatment|Withdrawal by Subject|21
6873768|NCT00483704|10884565|FG000|Treatment|Protocol Violation|6
6873769|NCT00483704|10884566|FG001|Treatment|Protocol Violation|3
6873770|NCT00483704|10884567|FG002|Treatment|Protocol Violation|5
6873771|NCT00483704|10884565|FG000|Treatment|Lost to Follow-up|2
6873772|NCT00483704|10884566|FG001|Treatment|Lost to Follow-up|7
6873773|NCT00483704|10884567|FG002|Treatment|Lost to Follow-up|5
6873774|NCT00483704|10884565|FG000|Treatment|Lack of Efficacy|1
6873775|NCT00483704|10884566|FG001|Treatment|Lack of Efficacy|1
6873776|NCT00483704|10884567|FG002|Treatment|Lack of Efficacy|1
6873777|NCT00483704|10884565|FG000|Treatment|Pregnancy|0
6873778|NCT00483704|10884566|FG001|Treatment|Pregnancy|1
6873779|NCT00483704|10884567|FG002|Treatment|Pregnancy|0
6873780|NCT00483704|10884565|FG000|Treatment|Physician Decision|0
6873781|NCT00483704|10884566|FG001|Treatment|Physician Decision|1
6873782|NCT00483704|10884567|FG002|Treatment|Physician Decision|4
6873783|NCT00483717|10884580|FG000|Overall Study|Protocol Violation|5
6873784|NCT00483717|10884581|FG001|Overall Study|Protocol Violation|7
6873785|NCT00483717|10884580|FG000|Overall Study|Time of dosing missing|1
6873786|NCT00483717|10884581|FG001|Overall Study|Time of dosing missing|1
6873787|NCT00483717|10884580|FG000|Overall Study|No treatment for migraine|16
6873788|NCT00483717|10884581|FG001|Overall Study|No treatment for migraine|13
6873789|NCT00483717|10884580|FG000|Overall Study|Lost to Follow-up|1
6873790|NCT00483717|10884581|FG001|Overall Study|Lost to Follow-up|0
6873791|NCT00483717|10884580|FG000|Overall Study|Withdrawal by Subject|1
6873792|NCT00483717|10884581|FG001|Overall Study|Withdrawal by Subject|0
6873793|NCT00483756|10884590|FG000|Overall Study|Death|2
6873794|NCT00483756|10884591|FG001|Overall Study|Death|0
6873795|NCT00483756|10884592|FG002|Overall Study|Death|1
6873796|NCT00483756|10884590|FG000|Overall Study|Adverse Event|19
6873797|NCT00483756|10884591|FG001|Overall Study|Adverse Event|38
6873798|NCT00483756|10884592|FG002|Overall Study|Adverse Event|40
6873799|NCT00483756|10884590|FG000|Overall Study|Lack of Efficacy|1
6873800|NCT00483756|10884591|FG001|Overall Study|Lack of Efficacy|0
6873801|NCT00483756|10884592|FG002|Overall Study|Lack of Efficacy|0
6873802|NCT00483756|10884590|FG000|Overall Study|Lost to Follow-up|3
6873803|NCT00483756|10884591|FG001|Overall Study|Lost to Follow-up|1
6873804|NCT00483756|10884592|FG002|Overall Study|Lost to Follow-up|0
6873805|NCT00483756|10884590|FG000|Overall Study|Withdrawal by Subject|5
6873806|NCT00483756|10884591|FG001|Overall Study|Withdrawal by Subject|3
6873807|NCT00483756|10884592|FG002|Overall Study|Withdrawal by Subject|4
6873808|NCT00483756|10884590|FG000|Overall Study|Other|2
6873809|NCT00483756|10884591|FG001|Overall Study|Other|4
6873810|NCT00483756|10884592|FG002|Overall Study|Other|3
6873811|NCT00483756|10884590|FG000|Overall Study|Randomized, Not Treated|1
6873812|NCT00483756|10884591|FG001|Overall Study|Randomized, Not Treated|4
6873813|NCT00483756|10884592|FG002|Overall Study|Randomized, Not Treated|4
6873814|NCT00483938|10884607|FG000|Overall Study|Protocol Violation|0
6873815|NCT00483938|10884608|FG001|Overall Study|Protocol Violation|0
6873816|NCT00483938|10884609|FG002|Overall Study|Protocol Violation|0
6873817|NCT00483938|10884610|FG003|Overall Study|Protocol Violation|0
6873818|NCT00483938|10884611|FG004|Overall Study|Protocol Violation|0
6873819|NCT00483938|10884612|FG005|Overall Study|Protocol Violation|0
6873820|NCT00483938|10884613|FG006|Overall Study|Protocol Violation|3
6873821|NCT00483938|10884607|FG000|Overall Study|Withdrawal by Subject|1
6873822|NCT00483938|10884608|FG001|Overall Study|Withdrawal by Subject|6
6873823|NCT00483938|10884609|FG002|Overall Study|Withdrawal by Subject|0
6873824|NCT00483938|10884610|FG003|Overall Study|Withdrawal by Subject|0
6873825|NCT00483938|10884611|FG004|Overall Study|Withdrawal by Subject|1
6873826|NCT00483938|10884612|FG005|Overall Study|Withdrawal by Subject|3
6873827|NCT00483938|10884613|FG006|Overall Study|Withdrawal by Subject|2
6873828|NCT00483938|10884607|FG000|Overall Study|Lost to Follow-up|1
6873829|NCT00483938|10884608|FG001|Overall Study|Lost to Follow-up|2
6873830|NCT00483938|10884609|FG002|Overall Study|Lost to Follow-up|0
6873831|NCT00483938|10884610|FG003|Overall Study|Lost to Follow-up|2
6873832|NCT00483938|10884611|FG004|Overall Study|Lost to Follow-up|1
6873833|NCT00483938|10884612|FG005|Overall Study|Lost to Follow-up|1
6873834|NCT00483938|10884613|FG006|Overall Study|Lost to Follow-up|3
6873835|NCT00483938|10884607|FG000|Overall Study|Death|0
6873836|NCT00483938|10884608|FG001|Overall Study|Death|2
6873837|NCT00483938|10884609|FG002|Overall Study|Death|0
6873838|NCT00483938|10884610|FG003|Overall Study|Death|0
6873839|NCT00483938|10884611|FG004|Overall Study|Death|0
6873840|NCT00483938|10884612|FG005|Overall Study|Death|0
6873841|NCT00483938|10884613|FG006|Overall Study|Death|0
6873842|NCT00483938|10884607|FG000|Overall Study|Other|3
6873843|NCT00483938|10884608|FG001|Overall Study|Other|9
6873844|NCT00483938|10884609|FG002|Overall Study|Other|0
6873845|NCT00483938|10884610|FG003|Overall Study|Other|4
6873846|NCT00483938|10884611|FG004|Overall Study|Other|0
6873847|NCT00483938|10884612|FG005|Overall Study|Other|4
6873848|NCT00483938|10884613|FG006|Overall Study|Other|32
6873849|NCT00484094|10884632|FG000|Overall Study|Discontinued|39
6873850|NCT00484094|10884632|FG000|Overall Study|Other|3
6873851|NCT00484159|10884639|FG000|Overall Study|Lost to Follow-up|1
6873852|NCT00484159|10884640|FG001|Overall Study|Lost to Follow-up|1
6873853|NCT00484159|10884641|FG002|Overall Study|Lost to Follow-up|0
6873854|NCT00484185|10884649|FG000|Overall Study|Lost to Follow-up|44
6873855|NCT00484185|10884649|FG000|Overall Study|Other|20
6873856|NCT00484185|10884649|FG000|Overall Study|Randomized but not treated|5
6873857|NCT00484185|10884649|FG000|Overall Study|Death|2
6873858|NCT00484198|10884657|FG000|Overall Study|Participant Withdrew Consent|12
6873859|NCT00484198|10884658|FG001|Overall Study|Participant Withdrew Consent|21
6873860|NCT00484198|10884659|FG002|Overall Study|Participant Withdrew Consent|47
7078491|NCT02104765|11187088|FG003|Overall Study|Lost to Follow-up|0
7078492|NCT02104765|11187089|FG004|Overall Study|Lost to Follow-up|0
7078493|NCT02104765|11187090|FG005|Overall Study|Lost to Follow-up|0
6873861|NCT00484198|10884660|FG003|Overall Study|Participant Withdrew Consent|59
6873862|NCT00484198|10884657|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16
6873863|NCT00484198|10884658|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17
6873864|NCT00484198|10884659|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29
6873865|NCT00484198|10884660|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38
6873866|NCT00484198|10884657|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3
6873867|NCT00484198|10884658|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2
6873868|NCT00484198|10884659|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6
6873869|NCT00484198|10884660|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8
6873870|NCT00484198|10884657|FG000|Overall Study|Adverse Event|3
6873871|NCT00484198|10884658|FG001|Overall Study|Adverse Event|11
6873872|NCT00484198|10884659|FG002|Overall Study|Adverse Event|32
6873873|NCT00484198|10884660|FG003|Overall Study|Adverse Event|31
6873874|NCT00484198|10884657|FG000|Overall Study|Protocol Violation|0
6873875|NCT00484198|10884658|FG001|Overall Study|Protocol Violation|5
6873876|NCT00484198|10884659|FG002|Overall Study|Protocol Violation|6
6873877|NCT00484198|10884660|FG003|Overall Study|Protocol Violation|8
6873878|NCT00484198|10884657|FG000|Overall Study|Other|7
6873879|NCT00484198|10884658|FG001|Overall Study|Other|10
6873880|NCT00484198|10884659|FG002|Overall Study|Other|31
6873881|NCT00484198|10884660|FG003|Overall Study|Other|28
6873882|NCT00484289|10884678|FG000|Long Term Phase|Adverse Event|1
6873883|NCT00484289|10884679|FG001|Long Term Phase|Adverse Event|17
6873884|NCT00484289|10884680|FG002|Long Term Phase|Adverse Event|5
6873885|NCT00484289|10884678|FG000|Long Term Phase|Withdrawal by Subject|0
6873886|NCT00484289|10884679|FG001|Long Term Phase|Withdrawal by Subject|7
6873887|NCT00484289|10884680|FG002|Long Term Phase|Withdrawal by Subject|6
6873888|NCT00484289|10884678|FG000|Long Term Phase|Inadequate response|2
6873889|NCT00484289|10884679|FG001|Long Term Phase|Inadequate response|7
6873890|NCT00484289|10884680|FG002|Long Term Phase|Inadequate response|4
7078494|NCT02104765|11187091|FG006|Overall Study|Lost to Follow-up|0
6873891|NCT00484289|10884678|FG000|Long Term Phase|Other Reason|0
6873892|NCT00484289|10884679|FG001|Long Term Phase|Other Reason|5
6873893|NCT00484289|10884680|FG002|Long Term Phase|Other Reason|1
6873894|NCT00484289|10884678|FG000|Post Marketing Phase|Adverse Event|0
6873895|NCT00484289|10884679|FG001|Post Marketing Phase|Adverse Event|1
7078495|NCT02104765|11187085|FG000|Overall Study|Withdrawal by Subject|0
6873896|NCT00484289|10884680|FG002|Post Marketing Phase|Adverse Event|0
6873897|NCT00484315|10884691|FG000|12-Month Clinical Follow-up|Death|6
6873898|NCT00484315|10884692|FG001|12-Month Clinical Follow-up|Death|2
7078496|NCT02104765|11187086|FG001|Overall Study|Withdrawal by Subject|0
7078497|NCT02104765|11187087|FG002|Overall Study|Withdrawal by Subject|0
7078498|NCT02104765|11187088|FG003|Overall Study|Withdrawal by Subject|1
7078499|NCT02104765|11187089|FG004|Overall Study|Withdrawal by Subject|1
7078500|NCT02104765|11187090|FG005|Overall Study|Withdrawal by Subject|0
7078501|NCT02104765|11187091|FG006|Overall Study|Withdrawal by Subject|1
7078502|NCT02104804|11187115|FG000|Overall Study|Did not take study medication|0
7078503|NCT02104804|11187116|FG001|Overall Study|Did not take study medication|1
7078504|NCT02104804|11187115|FG000|Overall Study|Study specific discontinuation criteria|6
7078505|NCT02104804|11187116|FG001|Overall Study|Study specific discontinuation criteria|1
6873899|NCT00484315|10884691|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4
6873900|NCT00484315|10884692|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0
6873901|NCT00484315|10884691|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2
7078506|NCT02104804|11187115|FG000|Overall Study|Other listed|2
6873902|NCT00484315|10884692|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1
6873903|NCT00484315|10884691|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13
6873904|NCT00484315|10884692|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4
6873905|NCT00484315|10884691|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3
6873906|NCT00484315|10884692|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2
6873907|NCT00484315|10884691|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25
6873908|NCT00484315|10884692|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11
6873909|NCT00484315|10884691|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3
6873910|NCT00484315|10884692|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2
6873911|NCT00484679|10884716|FG000|Overall Study|Withdrawal by Subject|3
6873912|NCT00484939|10884729|FG000|Overall Study|Death|9
6873913|NCT00484939|10884730|FG001|Overall Study|Death|13
6873914|NCT00484939|10884729|FG000|Overall Study|Adverse Event|22
6873915|NCT00484939|10884730|FG001|Overall Study|Adverse Event|12
6873916|NCT00484939|10884729|FG000|Overall Study|Patient Withdrew Consent|19
6873917|NCT00484939|10884730|FG001|Overall Study|Patient Withdrew Consent|10
6873918|NCT00484939|10884729|FG000|Overall Study|Protocol Violation|3
6873919|NCT00484939|10884730|FG001|Overall Study|Protocol Violation|3
6873920|NCT00484939|10884729|FG000|Overall Study|Lost to Follow-up|0
6873921|NCT00484939|10884730|FG001|Overall Study|Lost to Follow-up|3
6873922|NCT00484939|10884729|FG000|Overall Study|Discretion of Investigator or Sponsor|7
6873923|NCT00484939|10884730|FG001|Overall Study|Discretion of Investigator or Sponsor|3
6873924|NCT00484939|10884729|FG000|Overall Study|Disease progression|67
6873925|NCT00484939|10884730|FG001|Overall Study|Disease progression|88
6873926|NCT00484939|10884729|FG000|Overall Study|Screen Failure|2
6873927|NCT00484939|10884730|FG001|Overall Study|Screen Failure|2
6873928|NCT00484939|10884729|FG000|Overall Study|Reason Not Specified|11
6873929|NCT00484939|10884730|FG001|Overall Study|Reason Not Specified|6
6873930|NCT00485069|10884738|FG000|Overall Study|Adverse Event|10
6873931|NCT00485069|10884739|FG001|Overall Study|Adverse Event|4
6873932|NCT00485069|10884738|FG000|Overall Study|Lack of Efficacy|2
6873933|NCT00485069|10884739|FG001|Overall Study|Lack of Efficacy|1
6873934|NCT00485069|10884738|FG000|Overall Study|Protocol Violation|0
6873935|NCT00485069|10884739|FG001|Overall Study|Protocol Violation|1
6873936|NCT00485069|10884738|FG000|Overall Study|Withdrawal by Subject|6
6873937|NCT00485069|10884739|FG001|Overall Study|Withdrawal by Subject|6
6873938|NCT00485134|10884760|FG000|Overall Study|Lost to Follow-up|1
6873939|NCT00485134|10884761|FG001|Overall Study|Lost to Follow-up|0
6873940|NCT00485134|10884762|FG002|Overall Study|Lost to Follow-up|0
6873941|NCT00485134|10884763|FG003|Overall Study|Lost to Follow-up|0
6873942|NCT00485134|10884764|FG004|Overall Study|Lost to Follow-up|0
6873943|NCT00485134|10884765|FG005|Overall Study|Lost to Follow-up|0
6873944|NCT00485134|10884766|FG006|Overall Study|Lost to Follow-up|0
6873945|NCT00485134|10884767|FG007|Overall Study|Lost to Follow-up|0
6873946|NCT00485134|10884760|FG000|Overall Study|Withdrawal by Subject|0
6873947|NCT00485134|10884761|FG001|Overall Study|Withdrawal by Subject|1
6873948|NCT00485134|10884762|FG002|Overall Study|Withdrawal by Subject|0
6873949|NCT00485134|10884763|FG003|Overall Study|Withdrawal by Subject|0
6873950|NCT00485134|10884764|FG004|Overall Study|Withdrawal by Subject|0
6873951|NCT00485134|10884765|FG005|Overall Study|Withdrawal by Subject|0
6873952|NCT00485134|10884766|FG006|Overall Study|Withdrawal by Subject|0
6873953|NCT00485134|10884767|FG007|Overall Study|Withdrawal by Subject|0
6873954|NCT00485134|10884760|FG000|Overall Study|Change in health status|0
6873955|NCT00485134|10884761|FG001|Overall Study|Change in health status|1
6873956|NCT00485134|10884762|FG002|Overall Study|Change in health status|2
6873957|NCT00485134|10884763|FG003|Overall Study|Change in health status|1
7078507|NCT02104804|11187116|FG001|Overall Study|Other listed|1
7078508|NCT02104804|11187115|FG000|Overall Study|Protocol Violation|0
7078509|NCT02104804|11187116|FG001|Overall Study|Protocol Violation|1
6873958|NCT00485134|10884764|FG004|Overall Study|Change in health status|0
6873959|NCT00485134|10884765|FG005|Overall Study|Change in health status|1
6873960|NCT00485134|10884766|FG006|Overall Study|Change in health status|0
6873961|NCT00485134|10884767|FG007|Overall Study|Change in health status|0
6873962|NCT00485134|10884760|FG000|Overall Study|Withdrew for adverse event|0
7078510|NCT02104804|11187115|FG000|Overall Study|Adverse Event|4
6873963|NCT00485134|10884761|FG001|Overall Study|Withdrew for adverse event|0
6873964|NCT00485134|10884762|FG002|Overall Study|Withdrew for adverse event|1
6873965|NCT00485134|10884763|FG003|Overall Study|Withdrew for adverse event|0
6873966|NCT00485134|10884764|FG004|Overall Study|Withdrew for adverse event|0
6873967|NCT00485134|10884765|FG005|Overall Study|Withdrew for adverse event|0
6873968|NCT00485134|10884766|FG006|Overall Study|Withdrew for adverse event|0
6873969|NCT00485134|10884767|FG007|Overall Study|Withdrew for adverse event|0
6873970|NCT00485134|10884760|FG000|Overall Study|Positive drug test|0
6873971|NCT00485134|10884761|FG001|Overall Study|Positive drug test|0
6873972|NCT00485134|10884762|FG002|Overall Study|Positive drug test|0
6873973|NCT00485134|10884763|FG003|Overall Study|Positive drug test|0
6873974|NCT00485134|10884764|FG004|Overall Study|Positive drug test|2
6873975|NCT00485134|10884765|FG005|Overall Study|Positive drug test|1
6873976|NCT00485134|10884766|FG006|Overall Study|Positive drug test|0
6873977|NCT00485134|10884767|FG007|Overall Study|Positive drug test|0
6873978|NCT00485134|10884760|FG000|Overall Study|Non-compliance|0
6873979|NCT00485134|10884761|FG001|Overall Study|Non-compliance|0
6873980|NCT00485134|10884762|FG002|Overall Study|Non-compliance|0
6873981|NCT00485134|10884763|FG003|Overall Study|Non-compliance|0
6873982|NCT00485134|10884764|FG004|Overall Study|Non-compliance|1
6873983|NCT00485134|10884765|FG005|Overall Study|Non-compliance|2
6873984|NCT00485134|10884766|FG006|Overall Study|Non-compliance|2
6873985|NCT00485134|10884767|FG007|Overall Study|Non-compliance|0
6873986|NCT00485134|10884760|FG000|Overall Study|Unable to comply with study schedule|0
6873987|NCT00485134|10884761|FG001|Overall Study|Unable to comply with study schedule|0
6873988|NCT00485134|10884762|FG002|Overall Study|Unable to comply with study schedule|0
6873989|NCT00485134|10884763|FG003|Overall Study|Unable to comply with study schedule|0
6873990|NCT00485134|10884764|FG004|Overall Study|Unable to comply with study schedule|0
6873991|NCT00485134|10884765|FG005|Overall Study|Unable to comply with study schedule|0
6873992|NCT00485134|10884766|FG006|Overall Study|Unable to comply with study schedule|0
6873993|NCT00485134|10884767|FG007|Overall Study|Unable to comply with study schedule|1
6873994|NCT00485134|10884760|FG000|Overall Study|Pregnancy|0
6873995|NCT00485134|10884761|FG001|Overall Study|Pregnancy|0
6873996|NCT00485134|10884762|FG002|Overall Study|Pregnancy|0
6873997|NCT00485134|10884763|FG003|Overall Study|Pregnancy|0
6873998|NCT00485134|10884764|FG004|Overall Study|Pregnancy|0
6873999|NCT00485134|10884765|FG005|Overall Study|Pregnancy|0
6874000|NCT00485134|10884766|FG006|Overall Study|Pregnancy|1
6874001|NCT00485134|10884767|FG007|Overall Study|Pregnancy|0
6874002|NCT00485173|10884781|FG000|Overall Study|Death|4
6874003|NCT00485173|10884782|FG001|Overall Study|Death|3
6874004|NCT00485173|10884781|FG000|Overall Study|Lost to Follow-up|32
6874005|NCT00485173|10884782|FG001|Overall Study|Lost to Follow-up|61
6874006|NCT00485264|10884794|FG000|Overall Study|Enrolled But Not Given Treatment|0
6874007|NCT00485264|10884795|FG001|Overall Study|Enrolled But Not Given Treatment|0
6874008|NCT00485264|10884796|FG002|Overall Study|Enrolled But Not Given Treatment|0
6874009|NCT00485264|10884797|FG003|Overall Study|Enrolled But Not Given Treatment|0
6874010|NCT00485264|10884798|FG004|Overall Study|Enrolled But Not Given Treatment|1
6874011|NCT00485264|10884799|FG005|Overall Study|Enrolled But Not Given Treatment|0
6874012|NCT00485264|10884794|FG000|Overall Study|Death|1
6874013|NCT00485264|10884795|FG001|Overall Study|Death|0
6874014|NCT00485264|10884796|FG002|Overall Study|Death|0
6874015|NCT00485264|10884797|FG003|Overall Study|Death|0
6874016|NCT00485264|10884798|FG004|Overall Study|Death|1
6874017|NCT00485264|10884799|FG005|Overall Study|Death|0
6874018|NCT00485264|10884794|FG000|Overall Study|Adverse Event|1
6874019|NCT00485264|10884795|FG001|Overall Study|Adverse Event|0
6874020|NCT00485264|10884796|FG002|Overall Study|Adverse Event|2
6874021|NCT00485264|10884797|FG003|Overall Study|Adverse Event|3
6874022|NCT00485264|10884798|FG004|Overall Study|Adverse Event|1
6874023|NCT00485264|10884799|FG005|Overall Study|Adverse Event|3
6874024|NCT00485264|10884794|FG000|Overall Study|Pregnancy|4
6874025|NCT00485264|10884795|FG001|Overall Study|Pregnancy|0
6874026|NCT00485264|10884796|FG002|Overall Study|Pregnancy|0
6874027|NCT00485264|10884797|FG003|Overall Study|Pregnancy|0
6874028|NCT00485264|10884798|FG004|Overall Study|Pregnancy|0
6874029|NCT00485264|10884799|FG005|Overall Study|Pregnancy|0
6874030|NCT00485264|10884794|FG000|Overall Study|Disallowed Medication|0
6874031|NCT00485264|10884795|FG001|Overall Study|Disallowed Medication|0
6874032|NCT00485264|10884796|FG002|Overall Study|Disallowed Medication|0
6874033|NCT00485264|10884797|FG003|Overall Study|Disallowed Medication|0
6874034|NCT00485264|10884798|FG004|Overall Study|Disallowed Medication|0
6874035|NCT00485264|10884799|FG005|Overall Study|Disallowed Medication|1
6874036|NCT00485264|10884794|FG000|Overall Study|Number/Volume/Timing of Study Meds|2
6874037|NCT00485264|10884795|FG001|Overall Study|Number/Volume/Timing of Study Meds|1
6874038|NCT00485264|10884796|FG002|Overall Study|Number/Volume/Timing of Study Meds|1
6874039|NCT00485264|10884797|FG003|Overall Study|Number/Volume/Timing of Study Meds|0
6874040|NCT00485264|10884798|FG004|Overall Study|Number/Volume/Timing of Study Meds|0
6874041|NCT00485264|10884799|FG005|Overall Study|Number/Volume/Timing of Study Meds|0
6874042|NCT00485264|10884794|FG000|Overall Study|Lack of Efficacy|0
6874043|NCT00485264|10884795|FG001|Overall Study|Lack of Efficacy|1
6874044|NCT00485264|10884796|FG002|Overall Study|Lack of Efficacy|0
6874045|NCT00485264|10884797|FG003|Overall Study|Lack of Efficacy|0
6874046|NCT00485264|10884798|FG004|Overall Study|Lack of Efficacy|0
6874047|NCT00485264|10884799|FG005|Overall Study|Lack of Efficacy|0
6874048|NCT00485264|10884794|FG000|Overall Study|Guardian Consent Withdrawn|1
6874049|NCT00485264|10884795|FG001|Overall Study|Guardian Consent Withdrawn|0
6874050|NCT00485264|10884796|FG002|Overall Study|Guardian Consent Withdrawn|0
6874051|NCT00485264|10884797|FG003|Overall Study|Guardian Consent Withdrawn|0
6874052|NCT00485264|10884798|FG004|Overall Study|Guardian Consent Withdrawn|1
6874053|NCT00485264|10884799|FG005|Overall Study|Guardian Consent Withdrawn|0
6874054|NCT00485264|10884794|FG000|Overall Study|Physician Decision|0
6874055|NCT00485264|10884795|FG001|Overall Study|Physician Decision|2
6874056|NCT00485264|10884796|FG002|Overall Study|Physician Decision|0
6874057|NCT00485264|10884797|FG003|Overall Study|Physician Decision|0
6874058|NCT00485264|10884798|FG004|Overall Study|Physician Decision|0
6874059|NCT00485264|10884799|FG005|Overall Study|Physician Decision|0
6874060|NCT00485264|10884794|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0
6874061|NCT00485264|10884795|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0
6874062|NCT00485264|10884796|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1
6874063|NCT00485264|10884797|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0
6874064|NCT00485264|10884798|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0
6874065|NCT00485264|10884799|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0
6968839|NCT01143077|11017975|FG001|Overall Study|Non-compliance with study drug|1
6968840|NCT01143077|11017976|FG002|Overall Study|Non-compliance with study drug|1
6968841|NCT01143077|11017974|FG000|Overall Study|Administrative|1
6968842|NCT01143077|11017975|FG001|Overall Study|Administrative|0
6968843|NCT01143077|11017976|FG002|Overall Study|Administrative|0
6968844|NCT01143077|11017974|FG000|Overall Study|Principal Investigator Decision|2
6968845|NCT01143077|11017975|FG001|Overall Study|Principal Investigator Decision|0
6968846|NCT01143077|11017976|FG002|Overall Study|Principal Investigator Decision|1
6968847|NCT01143090|11017984|FG000|Overall Study|Lack of Efficacy|2
6968848|NCT01143090|11017984|FG000|Overall Study|Adverse Event|17
6968849|NCT01143090|11017984|FG000|Overall Study|Lost to Follow-up|9
6968850|NCT01143090|11017984|FG000|Overall Study|Protocol Violation|2
6968851|NCT01143090|11017984|FG000|Overall Study|Withdrawal by Subject|18
6968852|NCT01143090|11017984|FG000|Overall Study|Non-compliance with study drug|1
6968853|NCT01143090|11017984|FG000|Overall Study|Failure to meet eligibility criteria|1
6968854|NCT01143090|11017984|FG000|Overall Study|Administrative|1
6968855|NCT01143207|11018014|FG000|Overall Study|Lost to Follow-up|2
6968856|NCT01143259|11018020|FG000|Overall Study|Withdrawal by Subject|3
6968857|NCT01143259|11018021|FG001|Overall Study|Withdrawal by Subject|2
6968858|NCT01143259|11018020|FG000|Overall Study|Protocol Violation|13
6968859|NCT01143259|11018021|FG001|Overall Study|Protocol Violation|9
6968860|NCT01143259|11018020|FG000|Overall Study|Screen Failure|7
6968861|NCT01143259|11018021|FG001|Overall Study|Screen Failure|9
6968862|NCT01143324|11018036|FG000|Overall Study|Lost to Follow-up|11
6968863|NCT01143324|11018036|FG000|Overall Study|Withdrawal by Subject|4
6968864|NCT01143324|11018036|FG000|Overall Study|Explant of the device|4
6968865|NCT01143337|11018042|FG000|Overall Study|Adverse Event|3
6968866|NCT01143337|11018043|FG001|Overall Study|Adverse Event|9
6968867|NCT01143337|11018044|FG002|Overall Study|Adverse Event|5
6968868|NCT01143337|11018042|FG000|Overall Study|Lack of Efficacy|6
6968869|NCT01143337|11018043|FG001|Overall Study|Lack of Efficacy|2
6968870|NCT01143337|11018044|FG002|Overall Study|Lack of Efficacy|1
6968871|NCT01143337|11018042|FG000|Overall Study|Protocol Violation|1
6968872|NCT01143337|11018043|FG001|Overall Study|Protocol Violation|0
6968873|NCT01143337|11018044|FG002|Overall Study|Protocol Violation|0
6968874|NCT01143337|11018042|FG000|Overall Study|Withdrawal by Subject|0
6968875|NCT01143337|11018043|FG001|Overall Study|Withdrawal by Subject|0
6968876|NCT01143337|11018044|FG002|Overall Study|Withdrawal by Subject|1
6968877|NCT01143337|11018042|FG000|Overall Study|Other reason|0
6968878|NCT01143337|11018043|FG001|Overall Study|Other reason|0
6968879|NCT01143337|11018044|FG002|Overall Study|Other reason|5
6968880|NCT01143389|11018052|FG000|Overall Study|Lost to Follow-up|26
6968881|NCT01143389|11018053|FG001|Overall Study|Lost to Follow-up|25
6968882|NCT01143402|11018062|FG000|Overall Study|Rapid clinical decline|1
6968883|NCT01143402|11018063|FG001|Overall Study|Rapid clinical decline|1
6968884|NCT01143402|11018064|FG002|Overall Study|Rapid clinical decline|0
6968885|NCT01143402|11018062|FG000|Overall Study|Not Treated|0
6968886|NCT01143402|11018063|FG001|Overall Study|Not Treated|0
6968887|NCT01143402|11018064|FG002|Overall Study|Not Treated|1
6968888|NCT01143714|11018141|FG000|Overall Study|Adverse Event|4
6968889|NCT01143714|11018142|FG001|Overall Study|Adverse Event|2
6968890|NCT01143714|11018141|FG000|Overall Study|Withdrawal by Subject|1
6968891|NCT01143714|11018142|FG001|Overall Study|Withdrawal by Subject|0
6968892|NCT01143714|11018141|FG000|Overall Study|Subject non-compliance|0
6968893|NCT01143714|11018142|FG001|Overall Study|Subject non-compliance|1
6968894|NCT01143714|11018141|FG000|Overall Study|wound closed = deemed healed|1
6968895|NCT01143714|11018142|FG001|Overall Study|wound closed = deemed healed|0
6874066|NCT00485264|10884794|FG000|Overall Study|Not Able to Attend Clinic|5
6874067|NCT00485264|10884795|FG001|Overall Study|Not Able to Attend Clinic|0
6874068|NCT00485264|10884796|FG002|Overall Study|Not Able to Attend Clinic|0
6874069|NCT00485264|10884797|FG003|Overall Study|Not Able to Attend Clinic|1
6968896|NCT01143714|11018141|FG000|Overall Study|wound size increased|1
6968897|NCT01143714|11018142|FG001|Overall Study|wound size increased|0
6968898|NCT01143896|11018220|FG000|Overall Study|Did not complete Baseline Interview|5
6968899|NCT01143896|11018221|FG001|Overall Study|Did not complete Baseline Interview|4
6874070|NCT00485264|10884798|FG004|Overall Study|Not Able to Attend Clinic|1
6874071|NCT00485264|10884799|FG005|Overall Study|Not Able to Attend Clinic|2
6874072|NCT00485264|10884794|FG000|Overall Study|Non-Compliant|17
6874073|NCT00485264|10884795|FG001|Overall Study|Non-Compliant|2
6874074|NCT00485264|10884796|FG002|Overall Study|Non-Compliant|1
6874075|NCT00485264|10884797|FG003|Overall Study|Non-Compliant|0
6874076|NCT00485264|10884798|FG004|Overall Study|Non-Compliant|1
6874077|NCT00485264|10884799|FG005|Overall Study|Non-Compliant|0
6874078|NCT00485264|10884794|FG000|Overall Study|Lost to Follow-up|2
6874079|NCT00485264|10884795|FG001|Overall Study|Lost to Follow-up|1
6874080|NCT00485264|10884796|FG002|Overall Study|Lost to Follow-up|1
6874081|NCT00485264|10884797|FG003|Overall Study|Lost to Follow-up|0
6874082|NCT00485264|10884798|FG004|Overall Study|Lost to Follow-up|0
6874083|NCT00485264|10884799|FG005|Overall Study|Lost to Follow-up|1
6874084|NCT00485264|10884794|FG000|Overall Study|Other Reason|3
6874085|NCT00485264|10884795|FG001|Overall Study|Other Reason|0
6874086|NCT00485264|10884796|FG002|Overall Study|Other Reason|0
6874087|NCT00485264|10884797|FG003|Overall Study|Other Reason|0
6874088|NCT00485264|10884798|FG004|Overall Study|Other Reason|0
6874089|NCT00485264|10884799|FG005|Overall Study|Other Reason|0
6874090|NCT00485303|10884818|FG000|Overall Study|Adverse Event|5
6874091|NCT00485303|10884818|FG000|Overall Study|Progressive Disease|44
6874092|NCT00485303|10884818|FG000|Overall Study|Other|3
6874093|NCT00485303|10884818|FG000|Overall Study|Initiation of new anti-cancer treatment|2
6874094|NCT00485303|10884818|FG000|Overall Study|Treatment ongoing at cutoff date|2
6874095|NCT00485472|10884839|FG000|Overall Study|Adverse Event|8
6874096|NCT00485472|10884840|FG001|Overall Study|Adverse Event|5
6874097|NCT00485472|10884839|FG000|Overall Study|Lack of Efficacy|5
6874098|NCT00485472|10884840|FG001|Overall Study|Lack of Efficacy|4
6874099|NCT00485472|10884839|FG000|Overall Study|Withdrawal by Subject|1
6874100|NCT00485472|10884840|FG001|Overall Study|Withdrawal by Subject|0
6874101|NCT00485472|10884839|FG000|Overall Study|Protocol Violation|0
6874102|NCT00485472|10884840|FG001|Overall Study|Protocol Violation|1
6874103|NCT00485472|10884839|FG000|Overall Study|Other|2
6874104|NCT00485472|10884840|FG001|Overall Study|Other|1
6874105|NCT00485472|10884839|FG000|Overall Study|Lost to Follow-up|0
6874106|NCT00485472|10884840|FG001|Overall Study|Lost to Follow-up|1
6874107|NCT00485589|10884853|FG000|Overall Study|Death|2
6874108|NCT00485589|10884854|FG001|Overall Study|Death|2
6874109|NCT00485589|10884855|FG002|Overall Study|Death|0
6874110|NCT00485589|10884853|FG000|Overall Study|Failure to return|6
6874111|NCT00485589|10884854|FG001|Overall Study|Failure to return|5
6874112|NCT00485589|10884855|FG002|Overall Study|Failure to return|1
6874113|NCT00485589|10884853|FG000|Overall Study|Protocol Violation|1
6874114|NCT00485589|10884854|FG001|Overall Study|Protocol Violation|0
6874115|NCT00485589|10884855|FG002|Overall Study|Protocol Violation|0
6874116|NCT00485589|10884853|FG000|Overall Study|Violation of selection criteria at entry|0
6874117|NCT00485589|10884854|FG001|Overall Study|Violation of selection criteria at entry|3
6874118|NCT00485589|10884855|FG002|Overall Study|Violation of selection criteria at entry|1
6874119|NCT00485589|10884853|FG000|Overall Study|Administrative/Other|1
6874120|NCT00485589|10884854|FG001|Overall Study|Administrative/Other|2
6874121|NCT00485589|10884855|FG002|Overall Study|Administrative/Other|1
6874122|NCT00485589|10884853|FG000|Overall Study|Insufficient therapeutic response|10
6874123|NCT00485589|10884854|FG001|Overall Study|Insufficient therapeutic response|3
6874124|NCT00485589|10884855|FG002|Overall Study|Insufficient therapeutic response|1
6874125|NCT00485589|10884853|FG000|Overall Study|Refused treatment/did not cooperate|1
6874126|NCT00485589|10884854|FG001|Overall Study|Refused treatment/did not cooperate|0
6874127|NCT00485589|10884855|FG002|Overall Study|Refused treatment/did not cooperate|2
6874128|NCT00485589|10884853|FG000|Overall Study|Withdrawal by Subject|3
6874129|NCT00485589|10884854|FG001|Overall Study|Withdrawal by Subject|2
6874130|NCT00485589|10884855|FG002|Overall Study|Withdrawal by Subject|2
6874131|NCT00485589|10884853|FG000|Overall Study|Adverse Event|3
6874132|NCT00485589|10884854|FG001|Overall Study|Adverse Event|3
6874133|NCT00485589|10884855|FG002|Overall Study|Adverse Event|10
6874134|NCT00485732|10884874|FG000|Overall Study|Protocol Violation|1
6874135|NCT00485732|10884875|FG001|Overall Study|Protocol Violation|3
6874136|NCT00485732|10884874|FG000|Overall Study|Withdrawal by Subject|5
6874137|NCT00485732|10884875|FG001|Overall Study|Withdrawal by Subject|4
6874138|NCT00485732|10884874|FG000|Overall Study|Lost to Follow-up|2
6874139|NCT00485732|10884875|FG001|Overall Study|Lost to Follow-up|2
6874140|NCT00485758|10884883|FG000|Overall Study|Adverse Event|102
6874141|NCT00485758|10884884|FG001|Overall Study|Adverse Event|31
6874142|NCT00485758|10884883|FG000|Overall Study|Death|0
6874143|NCT00485758|10884884|FG001|Overall Study|Death|1
6874144|NCT00485758|10884883|FG000|Overall Study|Lost to Follow-up|5
6874145|NCT00485758|10884884|FG001|Overall Study|Lost to Follow-up|1
6874146|NCT00485758|10884883|FG000|Overall Study|Physician Decision|3
6874147|NCT00485758|10884884|FG001|Overall Study|Physician Decision|3
6874148|NCT00485758|10884883|FG000|Overall Study|Protocol Violation|11
6874149|NCT00485758|10884884|FG001|Overall Study|Protocol Violation|2
6874150|NCT00485758|10884883|FG000|Overall Study|Withdrawal by Subject|32
6874151|NCT00485758|10884884|FG001|Overall Study|Withdrawal by Subject|27
6874152|NCT00485758|10884883|FG000|Overall Study|Study Terminated by Sponsor|3
6874153|NCT00485758|10884884|FG001|Overall Study|Study Terminated by Sponsor|0
6874154|NCT00486044|10884934|FG000|Overall Study|Withdrawal by Subject|2
6874155|NCT00486044|10884935|FG001|Overall Study|Withdrawal by Subject|1
6874156|NCT00486044|10884934|FG000|Overall Study|Adverse Event|0
6874157|NCT00486044|10884935|FG001|Overall Study|Adverse Event|1
6874158|NCT00486044|10884934|FG000|Overall Study|Lost to Follow-up|0
6874159|NCT00486044|10884935|FG001|Overall Study|Lost to Follow-up|1
6874160|NCT00486226|10884941|FG000|Overall Study|Death|3
6874161|NCT00486226|10884941|FG000|Overall Study|Adverse Event|1
6874162|NCT00486226|10884941|FG000|Overall Study|Withdrawal by Subject|1
6874163|NCT00486226|10884941|FG000|Overall Study|Lost to Follow-up|8
6874164|NCT00486252|10884948|FG000|Overall Study|Adverse Event|7
6874165|NCT00486252|10884948|FG000|Overall Study|Lack of Efficacy|9
6874166|NCT00486252|10884948|FG000|Overall Study|Lost to Follow-up|24
6874167|NCT00486252|10884948|FG000|Overall Study|Other|18
6874168|NCT00486265|10884954|FG000|Overall Study|Adverse Event|1
6874169|NCT00486265|10884954|FG000|Overall Study|Lack of Efficacy|8
6874170|NCT00486278|10884958|FG000|Overall Study|Adverse Event|5
6874171|NCT00486278|10884958|FG000|Overall Study|Withdrawal by Subject|2
6874172|NCT00486278|10884958|FG000|Overall Study|Physician Decision|2
6874173|NCT00486291|10884974|FG000|Overall Study|Adverse Event|3
6874174|NCT00486291|10884975|FG001|Overall Study|Adverse Event|4
6874175|NCT00486291|10884974|FG000|Overall Study|Lost to Follow-up|3
6874176|NCT00486291|10884975|FG001|Overall Study|Lost to Follow-up|7
6874177|NCT00486291|10884974|FG000|Overall Study|protocol non-compliance|10
6874178|NCT00486291|10884975|FG001|Overall Study|protocol non-compliance|15
6874179|NCT00486291|10884974|FG000|Overall Study|requirement for restricted medication|0
6874180|NCT00486291|10884975|FG001|Overall Study|requirement for restricted medication|3
6874181|NCT00486330|10884981|FG000|Overall Study|Adverse Event|2
6874182|NCT00486434|10884987|FG000|Overall Study|Withdrawal by Subject|34
6874183|NCT00486434|10884988|FG001|Overall Study|Withdrawal by Subject|39
6874184|NCT00486434|10884987|FG000|Overall Study|Adverse Event|118
6874185|NCT00486434|10884988|FG001|Overall Study|Adverse Event|44
6874186|NCT00486434|10884987|FG000|Overall Study|Protocol Violation|22
6874187|NCT00486434|10884988|FG001|Overall Study|Protocol Violation|21
6874188|NCT00486434|10884987|FG000|Overall Study|Lack of Efficacy|12
6874189|NCT00486434|10884988|FG001|Overall Study|Lack of Efficacy|19
6874190|NCT00486434|10884987|FG000|Overall Study|Lost to Follow-up|2
6874191|NCT00486434|10884988|FG001|Overall Study|Lost to Follow-up|3
6874192|NCT00486434|10884987|FG000|Overall Study|Death|1
6874193|NCT00486434|10884988|FG001|Overall Study|Death|2
6874194|NCT00486434|10884987|FG000|Overall Study|Personal reasons|5
6874195|NCT00486434|10884988|FG001|Overall Study|Personal reasons|6
6874196|NCT00486603|10885011|FG000|Overall Study|Withdrawal by Subject|1
6874197|NCT00486603|10885012|FG001|Overall Study|Withdrawal by Subject|0
6874198|NCT00486603|10885013|FG002|Overall Study|Withdrawal by Subject|0
6874199|NCT00486603|10885014|FG003|Overall Study|Withdrawal by Subject|0
6874200|NCT00486603|10885015|FG004|Overall Study|Withdrawal by Subject|0
6874201|NCT00486603|10885011|FG000|Overall Study|Physician Decision|0
6874202|NCT00486603|10885012|FG001|Overall Study|Physician Decision|1
7041186|NCT01724528|11124694|FG000|Overall Study|Patient refused to attend last visit|1
7078511|NCT02104804|11187116|FG001|Overall Study|Adverse Event|3
7078512|NCT02104804|11187115|FG000|Overall Study|Withdrawal by Subject|4
7078513|NCT02104804|11187116|FG001|Overall Study|Withdrawal by Subject|12
7078514|NCT02104817|11187124|FG000|Overall Study|Death|363
7078515|NCT02104817|11187125|FG001|Overall Study|Death|330
7078516|NCT02104817|11187124|FG000|Overall Study|Lost to Follow-up|3
7078517|NCT02104817|11187125|FG001|Overall Study|Lost to Follow-up|2
7078518|NCT02104817|11187124|FG000|Overall Study|Protocol Violation|0
7078519|NCT02104817|11187125|FG001|Overall Study|Protocol Violation|1
7078520|NCT02104817|11187124|FG000|Overall Study|Study terminated by sponsor|5854
7078521|NCT02104817|11187125|FG001|Overall Study|Study terminated by sponsor|5901
6874203|NCT00486603|10885013|FG002|Overall Study|Physician Decision|0
6874204|NCT00486603|10885014|FG003|Overall Study|Physician Decision|0
6874205|NCT00486603|10885015|FG004|Overall Study|Physician Decision|0
6874206|NCT00486720|10885043|FG000|Overall Study|Adverse Event|1
6874207|NCT00486720|10885044|FG001|Overall Study|Adverse Event|2
6874208|NCT00486720|10885043|FG000|Overall Study|Lack of Efficacy|4
6874209|NCT00486720|10885044|FG001|Overall Study|Lack of Efficacy|6
6874210|NCT00486720|10885043|FG000|Overall Study|Physician Decision|1
6874211|NCT00486720|10885044|FG001|Overall Study|Physician Decision|2
6874212|NCT00486720|10885043|FG000|Overall Study|Protocol Violation|1
7041187|NCT01724528|11124695|FG001|Overall Study|Patient refused to attend last visit|0
7041188|NCT01725126|11124707|FG000|Overall Study|Protocol Violation|0
7041189|NCT01725126|11124708|FG001|Overall Study|Protocol Violation|1
7041190|NCT01725126|11124709|FG002|Overall Study|Protocol Violation|0
7041191|NCT01725126|11124710|FG003|Overall Study|Protocol Violation|0
7041192|NCT01725126|11124711|FG004|Overall Study|Protocol Violation|0
7041193|NCT01725126|11124712|FG005|Overall Study|Protocol Violation|0
7041194|NCT01725126|11124707|FG000|Overall Study|Withdrawal by Subject|0
7041195|NCT01725126|11124708|FG001|Overall Study|Withdrawal by Subject|0
7041196|NCT01725126|11124709|FG002|Overall Study|Withdrawal by Subject|0
7041197|NCT01725126|11124710|FG003|Overall Study|Withdrawal by Subject|1
7078522|NCT02104817|11187124|FG000|Overall Study|Withdrawal by Subject|111
6874213|NCT00486720|10885044|FG001|Overall Study|Protocol Violation|0
6874214|NCT00486720|10885043|FG000|Overall Study|Withdrawal by Subject|3
6874215|NCT00486720|10885044|FG001|Overall Study|Withdrawal by Subject|1
7078523|NCT02104817|11187125|FG001|Overall Study|Withdrawal by Subject|78
7078524|NCT02104817|11187124|FG000|Overall Study|Other reasons|128
7078525|NCT02104817|11187125|FG001|Overall Study|Other reasons|135
7078526|NCT02104895|11187146|FG000|Overall Study|Withdrawal by Subject|0
7078527|NCT02104895|11187147|FG001|Overall Study|Withdrawal by Subject|14
7078528|NCT02104947|11187155|FG000|Overall Study|Withdrawal by Subject|10
7078529|NCT02104947|11187156|FG001|Overall Study|Withdrawal by Subject|3
7078530|NCT02104947|11187155|FG000|Overall Study|Lost to Follow-up|4
7078531|NCT02104947|11187156|FG001|Overall Study|Lost to Follow-up|4
7078532|NCT02104947|11187155|FG000|Overall Study|Protocol Violation|6
7078533|NCT02104947|11187156|FG001|Overall Study|Protocol Violation|8
7078534|NCT02104947|11187155|FG000|Overall Study|Adverse Event|57
7078535|NCT02104947|11187156|FG001|Overall Study|Adverse Event|38
7078536|NCT02104947|11187155|FG000|Overall Study|Other than stated above|2
7078537|NCT02104947|11187156|FG001|Overall Study|Other than stated above|3
6874216|NCT00486720|10885043|FG000|Overall Study|Progressive Disease|0
6874217|NCT00486720|10885044|FG001|Overall Study|Progressive Disease|1
6874218|NCT00486759|10885052|FG000|Treatment|Adverse event/intercurrent illness|86
6874219|NCT00486759|10885053|FG001|Treatment|Adverse event/intercurrent illness|39
6874220|NCT00486759|10885052|FG000|Treatment|Insufficient therapeutic response|37
6874221|NCT00486759|10885053|FG001|Treatment|Insufficient therapeutic response|39
6874222|NCT00486759|10885052|FG000|Treatment|Death|17
6874223|NCT00486759|10885053|FG001|Treatment|Death|10
6874224|NCT00486759|10885052|FG000|Treatment|Withdrew consent|15
6874225|NCT00486759|10885053|FG001|Treatment|Withdrew consent|12
6874226|NCT00486759|10885052|FG000|Treatment|Administrative/reason not specified|17
6874227|NCT00486759|10885053|FG001|Treatment|Administrative/reason not specified|21
6874228|NCT00486759|10885052|FG000|Treatment|Refused treatment|10
6874229|NCT00486759|10885053|FG001|Treatment|Refused treatment|7
6874230|NCT00486759|10885052|FG000|Treatment|Violation of selection criteria at entry|3
6874231|NCT00486759|10885053|FG001|Treatment|Violation of selection criteria at entry|3
6874232|NCT00486759|10885052|FG000|Treatment|Other protocol violation|1
6874233|NCT00486759|10885053|FG001|Treatment|Other protocol violation|5
6874234|NCT00486759|10885052|FG000|Treatment|Failure to return|1
6874235|NCT00486759|10885053|FG001|Treatment|Failure to return|1
6874236|NCT00486759|10885052|FG000|Safety Follow-up|Insufficient therapeutic response|40
6874237|NCT00486759|10885053|FG001|Safety Follow-up|Insufficient therapeutic response|50
6874238|NCT00486759|10885052|FG000|Safety Follow-up|Death|40
6874239|NCT00486759|10885053|FG001|Safety Follow-up|Death|29
6874240|NCT00486759|10885052|FG000|Safety Follow-up|Withdrew consent|32
6874241|NCT00486759|10885053|FG001|Safety Follow-up|Withdrew consent|23
6874242|NCT00486759|10885052|FG000|Safety Follow-up|Failure to return|9
6874243|NCT00486759|10885053|FG001|Safety Follow-up|Failure to return|6
6874244|NCT00486759|10885052|FG000|Safety Follow-up|Administrative/not specified|8
6874245|NCT00486759|10885053|FG001|Safety Follow-up|Administrative/not specified|6
6874246|NCT00486759|10885052|FG000|Safety Follow-up|Refused treatment/did not cooperate|6
6874247|NCT00486759|10885053|FG001|Safety Follow-up|Refused treatment/did not cooperate|4
6874248|NCT00486759|10885052|FG000|Safety Follow-up|Adverse event/intercurrent illness|4
6874249|NCT00486759|10885053|FG001|Safety Follow-up|Adverse event/intercurrent illness|0
6874250|NCT00486811|10885062|FG000|Overall Study|Adverse Event|28
6874251|NCT00486811|10885063|FG001|Overall Study|Adverse Event|60
6874252|NCT00486811|10885064|FG002|Overall Study|Adverse Event|135
6874253|NCT00486811|10885062|FG000|Overall Study|Lack of Efficacy|34
6874254|NCT00486811|10885063|FG001|Overall Study|Lack of Efficacy|14
6874255|NCT00486811|10885064|FG002|Overall Study|Lack of Efficacy|7
6874256|NCT00486811|10885062|FG000|Overall Study|Lost to Follow-up|4
6874257|NCT00486811|10885063|FG001|Overall Study|Lost to Follow-up|6
6874258|NCT00486811|10885064|FG002|Overall Study|Lost to Follow-up|4
6874259|NCT00486811|10885062|FG000|Overall Study|Withdrawal by Subject|33
6874260|NCT00486811|10885063|FG001|Overall Study|Withdrawal by Subject|44
6874261|NCT00486811|10885064|FG002|Overall Study|Withdrawal by Subject|58
6874262|NCT00486811|10885062|FG000|Overall Study|Study drug non-compliant|5
6874263|NCT00486811|10885063|FG001|Overall Study|Study drug non-compliant|6
6874264|NCT00486811|10885064|FG002|Overall Study|Study drug non-compliant|3
6874265|NCT00486811|10885062|FG000|Overall Study|All other|18
6874266|NCT00486811|10885063|FG001|Overall Study|All other|11
6874267|NCT00486811|10885064|FG002|Overall Study|All other|7
6874268|NCT00486837|10885083|FG000|Overall Study|Withdrawal by Subject|1
6874269|NCT00486837|10885084|FG001|Overall Study|Withdrawal by Subject|0
6874270|NCT00486837|10885083|FG000|Overall Study|Adverse Event|1
6874271|NCT00486837|10885084|FG001|Overall Study|Adverse Event|1
6874272|NCT00486837|10885083|FG000|Overall Study|Protocol Violation|4
6874273|NCT00486837|10885084|FG001|Overall Study|Protocol Violation|2
7078538|NCT02105012|11187166|FG000|Overall Study|Withdrawal by Subject|11
6874274|NCT00486837|10885083|FG000|Overall Study|No sputum, devise issues, exacerbation|3
6874275|NCT00486837|10885084|FG001|Overall Study|No sputum, devise issues, exacerbation|4
6874276|NCT00486902|10885104|FG000|Overall Study|Withdrawal by Subject|1
7078539|NCT02105012|11187166|FG000|Overall Study|Protocol Specified Criteria|9
7078540|NCT02105012|11187166|FG000|Overall Study|Lost to Follow-up|4
7078541|NCT02105012|11187166|FG000|Overall Study|Protocol Violation|4
7078542|NCT02105012|11187166|FG000|Overall Study|Physician Decision|3
7078543|NCT02105012|11187166|FG000|Overall Study|Adverse Event|1
7078544|NCT02105012|11187166|FG000|Overall Study|Lack of Efficacy|1
6874277|NCT00486902|10885105|FG001|Overall Study|Withdrawal by Subject|2
6874278|NCT00486902|10885104|FG000|Overall Study|decision for postpartum tubal ligation|3
6874279|NCT00486902|10885105|FG001|Overall Study|decision for postpartum tubal ligation|1
6874280|NCT00486902|10885104|FG000|Overall Study|spinal anesthetic protocal violation|1
6874281|NCT00486902|10885105|FG001|Overall Study|spinal anesthetic protocal violation|1
6874282|NCT00486902|10885104|FG000|Overall Study|Did not meet inclusion criteria|1
6874283|NCT00486902|10885105|FG001|Overall Study|Did not meet inclusion criteria|0
6874284|NCT00486902|10885104|FG000|Overall Study|No toradol due to hemmorhage or allergy|3
6874285|NCT00486902|10885105|FG001|Overall Study|No toradol due to hemmorhage or allergy|1
6874286|NCT00486954|10885115|FG000|Pilot Part|Adverse Event|4
6874287|NCT00486954|10885116|FG001|Pilot Part|Adverse Event|0
6874288|NCT00486954|10885117|FG002|Pilot Part|Adverse Event|5
6874289|NCT00486954|10885118|FG003|Pilot Part|Adverse Event|0
6874290|NCT00486954|10885119|FG004|Pilot Part|Adverse Event|0
6874291|NCT00486954|10885115|FG000|Pilot Part|Disease Progression|2
6874292|NCT00486954|10885116|FG001|Pilot Part|Disease Progression|0
6874293|NCT00486954|10885117|FG002|Pilot Part|Disease Progression|1
6874294|NCT00486954|10885118|FG003|Pilot Part|Disease Progression|0
6874295|NCT00486954|10885119|FG004|Pilot Part|Disease Progression|0
6874296|NCT00486954|10885115|FG000|Randomized Part|Lost to Follow-up|0
6874297|NCT00486954|10885116|FG001|Randomized Part|Lost to Follow-up|0
6874298|NCT00486954|10885117|FG002|Randomized Part|Lost to Follow-up|0
6874299|NCT00486954|10885118|FG003|Randomized Part|Lost to Follow-up|0
6874300|NCT00486954|10885119|FG004|Randomized Part|Lost to Follow-up|1
6874301|NCT00486954|10885115|FG000|Randomized Part|Withdrawal by Subject|0
6874302|NCT00486954|10885116|FG001|Randomized Part|Withdrawal by Subject|0
7078545|NCT02105272|11187193|FG000|Overall Study|Adverse Event|1
7078546|NCT02105272|11187194|FG001|Overall Study|Adverse Event|2
7078547|NCT02105272|11187193|FG000|Overall Study|Physician Decision|0
7078548|NCT02105272|11187194|FG001|Overall Study|Physician Decision|1
7078549|NCT02105272|11187193|FG000|Overall Study|Protocol Violation|2
6874303|NCT00486954|10885117|FG002|Randomized Part|Withdrawal by Subject|0
6874304|NCT00486954|10885118|FG003|Randomized Part|Withdrawal by Subject|1
6874305|NCT00486954|10885119|FG004|Randomized Part|Withdrawal by Subject|0
6874306|NCT00486954|10885115|FG000|Randomized Part|Sponsor Terminated Study|0
6874307|NCT00486954|10885116|FG001|Randomized Part|Sponsor Terminated Study|0
6874308|NCT00486954|10885117|FG002|Randomized Part|Sponsor Terminated Study|0
6874309|NCT00486954|10885118|FG003|Randomized Part|Sponsor Terminated Study|19
6874310|NCT00486954|10885119|FG004|Randomized Part|Sponsor Terminated Study|13
6874311|NCT00487084|10885132|FG000|Overall Study|Did not receive intervention|4
6874312|NCT00487084|10885133|FG001|Overall Study|Did not receive intervention|3
6874313|NCT00487084|10885134|FG002|Overall Study|Did not receive intervention|5
6874314|NCT00487188|10885144|FG000|Induction Phase|Abnormality of Laboratory Test|0
6874315|NCT00487188|10885145|FG001|Induction Phase|Abnormality of Laboratory Test|1
6874316|NCT00487188|10885146|FG002|Induction Phase|Abnormality of Laboratory Test|0
6874317|NCT00487188|10885144|FG000|Induction Phase|Adverse Event|5
6874318|NCT00487188|10885145|FG001|Induction Phase|Adverse Event|0
6874319|NCT00487188|10885146|FG002|Induction Phase|Adverse Event|0
6874320|NCT00487188|10885144|FG000|Induction Phase|Lack of Efficacy|0
6874321|NCT00487188|10885145|FG001|Induction Phase|Lack of Efficacy|1
6874322|NCT00487188|10885146|FG002|Induction Phase|Lack of Efficacy|0
6874323|NCT00487188|10885144|FG000|Induction Phase|Protocol Violation|1
6874324|NCT00487188|10885145|FG001|Induction Phase|Protocol Violation|0
6874325|NCT00487188|10885146|FG002|Induction Phase|Protocol Violation|0
6874326|NCT00487188|10885144|FG000|Induction Phase|Refused Treatment|1
6874327|NCT00487188|10885145|FG001|Induction Phase|Refused Treatment|2
6874328|NCT00487188|10885146|FG002|Induction Phase|Refused Treatment|0
6874329|NCT00487188|10885144|FG000|Induction Phase|Lost to Follow-up|2
6874330|NCT00487188|10885145|FG001|Induction Phase|Lost to Follow-up|2
6874331|NCT00487188|10885146|FG002|Induction Phase|Lost to Follow-up|0
6874332|NCT00487188|10885144|FG000|Induction Phase|Administrative|0
6874333|NCT00487188|10885145|FG001|Induction Phase|Administrative|1
6874334|NCT00487188|10885146|FG002|Induction Phase|Administrative|0
6874335|NCT00487188|10885144|FG000|Maintenance Phase|Adverse Event|1
6874336|NCT00487188|10885145|FG001|Maintenance Phase|Adverse Event|0
6874337|NCT00487188|10885146|FG002|Maintenance Phase|Adverse Event|0
6874338|NCT00487188|10885144|FG000|Maintenance Phase|Death|1
6874339|NCT00487188|10885145|FG001|Maintenance Phase|Death|0
6874340|NCT00487188|10885146|FG002|Maintenance Phase|Death|0
6874341|NCT00487188|10885144|FG000|Maintenance Phase|Lost to Follow-up|1
6874342|NCT00487188|10885145|FG001|Maintenance Phase|Lost to Follow-up|0
6874343|NCT00487188|10885146|FG002|Maintenance Phase|Lost to Follow-up|0
6874344|NCT00487188|10885144|FG000|Maintenance Phase|Administrative|0
6874345|NCT00487188|10885145|FG001|Maintenance Phase|Administrative|0
6874346|NCT00487188|10885146|FG002|Maintenance Phase|Administrative|1
6874347|NCT00487240|10885164|FG000|Overall Study|Withdrawal by Subject|12
6874348|NCT00487240|10885165|FG001|Overall Study|Withdrawal by Subject|6
6874349|NCT00487240|10885164|FG000|Overall Study|Lost to Follow-up|7
6874350|NCT00487240|10885165|FG001|Overall Study|Lost to Follow-up|6
6874351|NCT00487240|10885164|FG000|Overall Study|Adverse Event|0
6874352|NCT00487240|10885165|FG001|Overall Study|Adverse Event|4
6874353|NCT00487240|10885164|FG000|Overall Study|Protocol Violation|5
7078550|NCT02105272|11187194|FG001|Overall Study|Protocol Violation|0
7078551|NCT02105272|11187193|FG000|Overall Study|Withdrawal by Subject|2
6874354|NCT00487240|10885165|FG001|Overall Study|Protocol Violation|5
6874355|NCT00487240|10885164|FG000|Overall Study|Entry Criteria Not Met|3
6874356|NCT00487240|10885165|FG001|Overall Study|Entry Criteria Not Met|4
6874357|NCT00487240|10885164|FG000|Overall Study|Sponsor Decision|2
6874358|NCT00487240|10885165|FG001|Overall Study|Sponsor Decision|1
6874359|NCT00487240|10885164|FG000|Overall Study|Physician Decision|2
6874360|NCT00487240|10885165|FG001|Overall Study|Physician Decision|0
6874361|NCT00487279|10885173|FG000|Overall Study|Death|1
6874362|NCT00487279|10885174|FG001|Overall Study|Death|0
6874363|NCT00487279|10885173|FG000|Overall Study|Withdrawal by Subject|0
6874364|NCT00487279|10885174|FG001|Overall Study|Withdrawal by Subject|2
6874365|NCT00487435|10885189|FG000|Overall Study|Adverse Event|146
6874366|NCT00487435|10885189|FG000|Overall Study|Death|2
6874367|NCT00487435|10885189|FG000|Overall Study|Lack of Efficacy|33
6874368|NCT00487435|10885189|FG000|Overall Study|Lost to Follow-up|54
6874369|NCT00487435|10885189|FG000|Overall Study|Pregnancy|2
6874370|NCT00487435|10885189|FG000|Overall Study|Withdrawal by Subject|132
6874371|NCT00487435|10885189|FG000|Overall Study|Resolution Of Pain|1
6874372|NCT00487435|10885189|FG000|Overall Study|Study Medication Non-Compliant|32
6874373|NCT00487435|10885189|FG000|Overall Study|Other|83
6874374|NCT00487539|10885197|FG000|Overall Study|Adverse Event|3
6874375|NCT00487539|10885198|FG001|Overall Study|Adverse Event|2
6874376|NCT00487539|10885199|FG002|Overall Study|Adverse Event|1
6874377|NCT00487539|10885200|FG003|Overall Study|Adverse Event|1
6874378|NCT00487539|10885197|FG000|Overall Study|Unsatisfactory therapeutic effect|1
6874379|NCT00487539|10885198|FG001|Overall Study|Unsatisfactory therapeutic effect|0
6874380|NCT00487539|10885199|FG002|Overall Study|Unsatisfactory therapeutic effect|0
6874381|NCT00487539|10885200|FG003|Overall Study|Unsatisfactory therapeutic effect|1
6874382|NCT00487539|10885197|FG000|Overall Study|Other|3
6874383|NCT00487539|10885198|FG001|Overall Study|Other|1
6874384|NCT00487539|10885199|FG002|Overall Study|Other|2
6874385|NCT00487539|10885200|FG003|Overall Study|Other|2
6874386|NCT00487552|10885209|FG000|Overall Study|Unsuccessful magnet placements|3
6874387|NCT00487552|10885209|FG000|Overall Study|Death due to progressive malignancy|2
6874388|NCT00487552|10885209|FG000|Overall Study|Stent not placed|1
6874389|NCT00487695|10885224|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1
6874390|NCT00487695|10885225|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0
6874391|NCT00487695|10885224|FG000|First Procedure|active wheezing (did not have procedure)|1
6874392|NCT00487695|10885225|FG001|First Procedure|active wheezing (did not have procedure)|0
6874393|NCT00487695|10885224|FG000|First Procedure|esophageal stricture found (excl crit)|1
6874394|NCT00487695|10885225|FG001|First Procedure|esophageal stricture found (excl crit)|0
6874395|NCT00487695|10885224|FG000|Second Procedure|active wheezing|0
6874396|NCT00487695|10885225|FG001|Second Procedure|active wheezing|1
6874397|NCT00487695|10885224|FG000|Second Procedure|Withdrawal by Subject|1
6874398|NCT00487695|10885225|FG001|Second Procedure|Withdrawal by Subject|2
6874399|NCT00487747|10885239|FG000|Overall Study|Adverse Event|1
6874400|NCT00487747|10885239|FG000|Overall Study|Lost to Follow-up|9
6874401|NCT00487747|10885239|FG000|Overall Study|Lack of Efficacy|1
6874402|NCT00487825|10885245|FG000|Overall Study|Adverse Event|2
6874403|NCT00487825|10885246|FG001|Overall Study|Adverse Event|2
6874404|NCT00487825|10885245|FG000|Overall Study|Lack of Efficacy|1
6874405|NCT00487825|10885246|FG001|Overall Study|Lack of Efficacy|1
6874406|NCT00487825|10885245|FG000|Overall Study|Other|3
6874407|NCT00487825|10885246|FG001|Overall Study|Other|2
6874408|NCT00487942|10885256|FG000|Overall Study|Adverse Event|1
6874409|NCT00487942|10885257|FG001|Overall Study|Adverse Event|1
6874410|NCT00487942|10885258|FG002|Overall Study|Adverse Event|1
6874411|NCT00487942|10885259|FG003|Overall Study|Adverse Event|1
6874412|NCT00487942|10885256|FG000|Overall Study|Lost to Follow-up|1
6874413|NCT00487942|10885257|FG001|Overall Study|Lost to Follow-up|0
6874414|NCT00487942|10885258|FG002|Overall Study|Lost to Follow-up|0
6874415|NCT00487942|10885259|FG003|Overall Study|Lost to Follow-up|1
6874416|NCT00487942|10885256|FG000|Overall Study|Protocol Violation|1
6874417|NCT00487942|10885257|FG001|Overall Study|Protocol Violation|1
6874418|NCT00487942|10885258|FG002|Overall Study|Protocol Violation|0
6874419|NCT00487942|10885259|FG003|Overall Study|Protocol Violation|0
6874420|NCT00487942|10885256|FG000|Overall Study|Withdrawal by Subject|0
6874421|NCT00487942|10885257|FG001|Overall Study|Withdrawal by Subject|1
6874422|NCT00487942|10885258|FG002|Overall Study|Withdrawal by Subject|2
6874423|NCT00487942|10885259|FG003|Overall Study|Withdrawal by Subject|0
6874424|NCT00488033|10885271|FG000|Overall Study|Withdrawal by Subject|1
6874425|NCT00488033|10885272|FG001|Overall Study|Withdrawal by Subject|0
6874426|NCT00488293|10885295|FG000|Overall Study|Lost to Follow-up|28
6874427|NCT00488293|10885296|FG001|Overall Study|Lost to Follow-up|25
6874428|NCT00488293|10885295|FG000|Overall Study|Withdrawal by Subject|5
6874429|NCT00488293|10885296|FG001|Overall Study|Withdrawal by Subject|3
6874430|NCT00488293|10885295|FG000|Overall Study|Death|2
6874431|NCT00488293|10885296|FG001|Overall Study|Death|1
6874432|NCT00488293|10885295|FG000|Overall Study|Misrandomization/Other Unspecified|1
6874433|NCT00488293|10885296|FG001|Overall Study|Misrandomization/Other Unspecified|1
6874434|NCT00488319|10885305|FG000|Overall Study|Adverse Event|1
6874435|NCT00488319|10885306|FG001|Overall Study|Adverse Event|2
6874436|NCT00488319|10885307|FG002|Overall Study|Adverse Event|23
6874437|NCT00488319|10885305|FG000|Overall Study|Lack of Efficacy|6
6874438|NCT00488319|10885306|FG001|Overall Study|Lack of Efficacy|12
6874439|NCT00488319|10885307|FG002|Overall Study|Lack of Efficacy|27
6874440|NCT00488319|10885305|FG000|Overall Study|Lost to Follow-up|3
6874441|NCT00488319|10885306|FG001|Overall Study|Lost to Follow-up|5
6874442|NCT00488319|10885307|FG002|Overall Study|Lost to Follow-up|16
6874443|NCT00488319|10885305|FG000|Overall Study|Withdrawal by Subject|5
6874444|NCT00488319|10885306|FG001|Overall Study|Withdrawal by Subject|20
6874445|NCT00488319|10885307|FG002|Overall Study|Withdrawal by Subject|44
6874446|NCT00488319|10885305|FG000|Overall Study|Other reasons for withdrawal|0
6874447|NCT00488319|10885306|FG001|Overall Study|Other reasons for withdrawal|4
6874448|NCT00488319|10885307|FG002|Overall Study|Other reasons for withdrawal|12
6874449|NCT00488345|10885319|FG000|Overall Study|Adverse Event|0
6874450|NCT00488345|10885320|FG001|Overall Study|Adverse Event|1
6874451|NCT00488345|10885321|FG002|Overall Study|Adverse Event|1
6874452|NCT00488345|10885319|FG000|Overall Study|Unable to administer antibiotics at home|0
6874453|NCT00488345|10885320|FG001|Overall Study|Unable to administer antibiotics at home|1
6874454|NCT00488345|10885321|FG002|Overall Study|Unable to administer antibiotics at home|0
6874455|NCT00488345|10885319|FG000|Overall Study|Institutional Review Board review|0
6874456|NCT00488345|10885320|FG001|Overall Study|Institutional Review Board review|0
6874457|NCT00488345|10885321|FG002|Overall Study|Institutional Review Board review|1
6874458|NCT00488345|10885319|FG000|Overall Study|Surgical team recommendation|0
6874459|NCT00488345|10885320|FG001|Overall Study|Surgical team recommendation|1
6874460|NCT00488345|10885321|FG002|Overall Study|Surgical team recommendation|0
6874461|NCT00488345|10885319|FG000|Overall Study|Parent/legal guardian request|0
6874462|NCT00488345|10885320|FG001|Overall Study|Parent/legal guardian request|1
6874463|NCT00488345|10885321|FG002|Overall Study|Parent/legal guardian request|1
6874464|NCT00488475|10885330|FG000|Overall Study|Other|1754
6874465|NCT00488514|10885338|FG000|Overall Study|Adverse Event|41
6874466|NCT00488514|10885338|FG000|Overall Study|Lost to Follow-up|44
6874467|NCT00488514|10885338|FG000|Overall Study|Protocol Violation|32
6874468|NCT00488514|10885338|FG000|Overall Study|Withdrawal by Subject|106
6874469|NCT00488514|10885338|FG000|Overall Study|Lack of Efficacy|28
6874470|NCT00488514|10885338|FG000|Overall Study|Did not meet criteria for treatment|30
6874471|NCT00488514|10885338|FG000|Overall Study|Postive drug screen|1
6874472|NCT00488514|10885338|FG000|Overall Study|Withdrawn per medical monitor decision|2
6874473|NCT00488514|10885338|FG000|Overall Study|Investigator decision|1
6874474|NCT00488514|10885338|FG000|Overall Study|Participant had too few migraines|5
6874475|NCT00488514|10885338|FG000|Overall Study|Increase in number of migraines|2
6874476|NCT00488514|10885338|FG000|Overall Study|Increased use of concomitant medication|1
6874477|NCT00488592|10885359|FG000|Overall Study|Withdrawal by Subject|1
6874478|NCT00488592|10885359|FG000|Overall Study|Disease progression|1
6874479|NCT00488592|10885359|FG000|Overall Study|Enrolled but not treated|1
6874480|NCT00488618|10885365|FG000|Overall Study|Adverse Event|13
6874481|NCT00488618|10885366|FG001|Overall Study|Adverse Event|17
6874482|NCT00488618|10885365|FG000|Overall Study|Insufficient Therapeutic Response|18
6874483|NCT00488618|10885366|FG001|Overall Study|Insufficient Therapeutic Response|11
6874484|NCT00488618|10885365|FG000|Overall Study|Protocol Violation|0
6874485|NCT00488618|10885366|FG001|Overall Study|Protocol Violation|2
6874486|NCT00488618|10885365|FG000|Overall Study|Withdrawal of Consent|15
6874487|NCT00488618|10885366|FG001|Overall Study|Withdrawal of Consent|13
6874488|NCT00488618|10885365|FG000|Overall Study|Lost to Follow-up|1
6874489|NCT00488618|10885366|FG001|Overall Study|Lost to Follow-up|0
6874490|NCT00488631|10885378|FG000|Double Blind Period (Week 0-54)|Adverse Event|17
6874491|NCT00488631|10885379|FG001|Double Blind Period (Week 0-54)|Adverse Event|12
6874492|NCT00488631|10885380|FG002|Double Blind Period (Week 0-54)|Adverse Event|12
6874493|NCT00488631|10885381|FG003|Double Blind Period (Week 0-54)|Adverse Event|12
6874494|NCT00488631|10885382|FG004|Double Blind Period (Week 0-54)|Adverse Event|30
6874495|NCT00488631|10885383|FG005|Double Blind Period (Week 0-54)|Adverse Event|50
6874496|NCT00488631|10885384|FG006|Double Blind Period (Week 0-54)|Adverse Event|0
6874497|NCT00488631|10885385|FG007|Double Blind Period (Week 0-54)|Adverse Event|0
6874498|NCT00488631|10885386|FG008|Double Blind Period (Week 0-54)|Adverse Event|0
6874499|NCT00488631|10885387|FG009|Double Blind Period (Week 0-54)|Adverse Event|0
6874500|NCT00488631|10885378|FG000|Double Blind Period (Week 0-54)|Death|0
6874501|NCT00488631|10885379|FG001|Double Blind Period (Week 0-54)|Death|0
6874502|NCT00488631|10885380|FG002|Double Blind Period (Week 0-54)|Death|0
6874503|NCT00488631|10885381|FG003|Double Blind Period (Week 0-54)|Death|0
6874504|NCT00488631|10885382|FG004|Double Blind Period (Week 0-54)|Death|0
6874505|NCT00488631|10885383|FG005|Double Blind Period (Week 0-54)|Death|1
6874506|NCT00488631|10885384|FG006|Double Blind Period (Week 0-54)|Death|0
6874507|NCT00488631|10885385|FG007|Double Blind Period (Week 0-54)|Death|0
6874508|NCT00488631|10885386|FG008|Double Blind Period (Week 0-54)|Death|0
6874509|NCT00488631|10885387|FG009|Double Blind Period (Week 0-54)|Death|0
6874510|NCT00488631|10885378|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19
6874511|NCT00488631|10885379|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17
6874512|NCT00488631|10885380|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22
6874513|NCT00488631|10885381|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18
6874514|NCT00488631|10885382|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56
6874515|NCT00488631|10885383|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124
6874516|NCT00488631|10885384|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
6874517|NCT00488631|10885385|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
6874518|NCT00488631|10885386|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
6874519|NCT00488631|10885387|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
6874520|NCT00488631|10885378|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1
6874521|NCT00488631|10885379|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2
6874522|NCT00488631|10885380|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1
6874523|NCT00488631|10885381|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0
6874524|NCT00488631|10885382|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3
6874525|NCT00488631|10885383|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7
6874526|NCT00488631|10885384|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0
6874527|NCT00488631|10885385|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0
6874528|NCT00488631|10885386|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0
6874529|NCT00488631|10885387|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0
6874530|NCT00488631|10885378|FG000|Double Blind Period (Week 0-54)|Other|6
6874531|NCT00488631|10885379|FG001|Double Blind Period (Week 0-54)|Other|12
6874532|NCT00488631|10885380|FG002|Double Blind Period (Week 0-54)|Other|10
6874533|NCT00488631|10885381|FG003|Double Blind Period (Week 0-54)|Other|11
6874534|NCT00488631|10885382|FG004|Double Blind Period (Week 0-54)|Other|14
6874535|NCT00488631|10885383|FG005|Double Blind Period (Week 0-54)|Other|34
6874536|NCT00488631|10885384|FG006|Double Blind Period (Week 0-54)|Other|0
6874537|NCT00488631|10885385|FG007|Double Blind Period (Week 0-54)|Other|0
6874538|NCT00488631|10885386|FG008|Double Blind Period (Week 0-54)|Other|0
6874539|NCT00488631|10885387|FG009|Double Blind Period (Week 0-54)|Other|0
6874540|NCT00488631|10885378|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0
6874541|NCT00488631|10885379|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0
6874542|NCT00488631|10885380|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0
6874543|NCT00488631|10885381|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0
6874544|NCT00488631|10885382|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0
6874545|NCT00488631|10885383|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0
6874546|NCT00488631|10885384|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10
6874547|NCT00488631|10885385|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8
6874548|NCT00488631|10885386|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54
6874549|NCT00488631|10885387|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0
6874550|NCT00488631|10885378|FG000|Open Label Study Extension (Week 54-228)|Death|0
6874551|NCT00488631|10885379|FG001|Open Label Study Extension (Week 54-228)|Death|0
6874552|NCT00488631|10885380|FG002|Open Label Study Extension (Week 54-228)|Death|0
6874553|NCT00488631|10885381|FG003|Open Label Study Extension (Week 54-228)|Death|0
6874554|NCT00488631|10885382|FG004|Open Label Study Extension (Week 54-228)|Death|0
6874555|NCT00488631|10885383|FG005|Open Label Study Extension (Week 54-228)|Death|0
6874556|NCT00488631|10885384|FG006|Open Label Study Extension (Week 54-228)|Death|0
6874557|NCT00488631|10885385|FG007|Open Label Study Extension (Week 54-228)|Death|0
6874558|NCT00488631|10885386|FG008|Open Label Study Extension (Week 54-228)|Death|1
6874559|NCT00488631|10885387|FG009|Open Label Study Extension (Week 54-228)|Death|0
6874560|NCT00488631|10885378|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
6874561|NCT00488631|10885379|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
6874562|NCT00488631|10885380|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
6874563|NCT00488631|10885381|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
6874564|NCT00488631|10885382|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
6874565|NCT00488631|10885383|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
6874566|NCT00488631|10885384|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
6874567|NCT00488631|10885385|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
6874568|NCT00488631|10885386|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34
6874569|NCT00488631|10885387|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3
6874570|NCT00488631|10885378|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
6874571|NCT00488631|10885379|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
6874572|NCT00488631|10885380|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
6874573|NCT00488631|10885381|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
6874574|NCT00488631|10885382|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
6874575|NCT00488631|10885383|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
6874576|NCT00488631|10885384|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2
6874577|NCT00488631|10885385|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
6874578|NCT00488631|10885386|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6
6874579|NCT00488631|10885387|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
6874580|NCT00488631|10885378|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
6874581|NCT00488631|10885379|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
6874582|NCT00488631|10885380|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
6874583|NCT00488631|10885381|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
6874584|NCT00488631|10885382|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
6874585|NCT00488631|10885383|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
6874586|NCT00488631|10885384|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63
6874587|NCT00488631|10885385|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14
6874588|NCT00488631|10885386|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87
6874589|NCT00488631|10885387|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
6874590|NCT00488644|10885410|FG000|Overall Study|Not Eligible|1
6874591|NCT00488644|10885410|FG000|Overall Study|Not Evaluable|1
6874592|NCT00488683|10885417|FG000|Overall Study|Withdrawal by Subject|1
6874593|NCT00488683|10885418|FG001|Overall Study|Withdrawal by Subject|2
6874594|NCT00488683|10885419|FG002|Overall Study|Withdrawal by Subject|2
6874595|NCT00488683|10885417|FG000|Overall Study|Lost to Follow-up|5
6874596|NCT00488683|10885418|FG001|Overall Study|Lost to Follow-up|3
6874597|NCT00488683|10885419|FG002|Overall Study|Lost to Follow-up|0
6874598|NCT00488683|10885417|FG000|Overall Study|Protocol Violation|5
6874599|NCT00488683|10885418|FG001|Overall Study|Protocol Violation|1
6874600|NCT00488683|10885419|FG002|Overall Study|Protocol Violation|0
6874601|NCT00488683|10885417|FG000|Overall Study|Unable to Classify|1
6874602|NCT00488683|10885418|FG001|Overall Study|Unable to Classify|0
6874603|NCT00488683|10885419|FG002|Overall Study|Unable to Classify|0
6874604|NCT00488774|10885435|FG000|Overall Study|Withdrawal of consent|2
6874605|NCT00488774|10885436|FG001|Overall Study|Withdrawal of consent|2
6874606|NCT00488774|10885437|FG002|Overall Study|Withdrawal of consent|2
6874607|NCT00488774|10885438|FG003|Overall Study|Withdrawal of consent|0
6874608|NCT00488774|10885435|FG000|Overall Study|Other|6
6874609|NCT00488774|10885436|FG001|Overall Study|Other|3
6874610|NCT00488774|10885437|FG002|Overall Study|Other|2
6874611|NCT00488774|10885438|FG003|Overall Study|Other|2
6874612|NCT00488774|10885435|FG000|Overall Study|Lost to Follow-up|0
6874613|NCT00488774|10885436|FG001|Overall Study|Lost to Follow-up|0
6874614|NCT00488774|10885437|FG002|Overall Study|Lost to Follow-up|1
6874615|NCT00488774|10885438|FG003|Overall Study|Lost to Follow-up|1
6874616|NCT00488826|10885452|FG000|Overall Study|Withdrawal by Subject|40
6874617|NCT00488826|10885453|FG001|Overall Study|Withdrawal by Subject|35
6874618|NCT00488826|10885454|FG002|Overall Study|Withdrawal by Subject|19
6874619|NCT00488826|10885452|FG000|Overall Study|Protocol Violation|0
6874620|NCT00488826|10885453|FG001|Overall Study|Protocol Violation|0
6874621|NCT00488826|10885454|FG002|Overall Study|Protocol Violation|2
6874622|NCT00488826|10885452|FG000|Overall Study|Adverse Event|9
6874623|NCT00488826|10885453|FG001|Overall Study|Adverse Event|15
6874624|NCT00488826|10885454|FG002|Overall Study|Adverse Event|4
6874625|NCT00488826|10885452|FG000|Overall Study|Lost to Follow-up|5
6874626|NCT00488826|10885453|FG001|Overall Study|Lost to Follow-up|1
6874627|NCT00488826|10885454|FG002|Overall Study|Lost to Follow-up|0
6874628|NCT00488826|10885452|FG000|Overall Study|Protocol Deviations|2
6874629|NCT00488826|10885453|FG001|Overall Study|Protocol Deviations|1
6874630|NCT00488826|10885454|FG002|Overall Study|Protocol Deviations|1
6874631|NCT00488982|10885466|FG000|Course 1|Physician Decision|0
6874632|NCT00488982|10885467|FG001|Course 1|Physician Decision|2
6874633|NCT00488982|10885468|FG002|Course 1|Physician Decision|4
6874634|NCT00488982|10885466|FG000|Course 1|Withdrawal by Subject|0
6874635|NCT00488982|10885467|FG001|Course 1|Withdrawal by Subject|8
6874636|NCT00488982|10885468|FG002|Course 1|Withdrawal by Subject|2
6874637|NCT00488982|10885466|FG000|Course 1|nonprotocol therapy|0
6874638|NCT00488982|10885467|FG001|Course 1|nonprotocol therapy|2
6874639|NCT00488982|10885468|FG002|Course 1|nonprotocol therapy|2
6874640|NCT00488982|10885466|FG000|Course 1|Adverse Event|0
6874641|NCT00488982|10885467|FG001|Course 1|Adverse Event|0
6874642|NCT00488982|10885468|FG002|Course 1|Adverse Event|6
6968900|NCT01143896|11018220|FG000|Overall Study|Lost to Follow-up|18
6968901|NCT01143896|11018221|FG001|Overall Study|Lost to Follow-up|13
6968902|NCT01143896|11018220|FG000|Overall Study|Withdrawal by Subject|13
6968903|NCT01143896|11018221|FG001|Overall Study|Withdrawal by Subject|5
6968904|NCT01143896|11018220|FG000|Overall Study|Death|6
6968905|NCT01143896|11018221|FG001|Overall Study|Death|3
6968906|NCT01144052|11018239|FG000|Overall Study|Withdrawal by Subject|1
6968907|NCT01144052|11018240|FG001|Overall Study|Withdrawal by Subject|1
6968908|NCT01144182|11018267|FG000|Overall Study|Death|5
6968909|NCT01144182|11018268|FG001|Overall Study|Death|6
6968910|NCT01144182|11018267|FG000|Overall Study|Withdrawal by Subject|3
6968911|NCT01144182|11018268|FG001|Overall Study|Withdrawal by Subject|6
6968912|NCT01144182|11018267|FG000|Overall Study|Lost to Follow-up|9
6968913|NCT01144182|11018268|FG001|Overall Study|Lost to Follow-up|9
6968914|NCT01144299|11018294|FG000|Overall Study|Lost to Follow-up|1
6968915|NCT01144299|11018295|FG001|Overall Study|Lost to Follow-up|0
6968916|NCT01144299|11018294|FG000|Overall Study|Withdrawal by Subject|1
6968917|NCT01144299|11018295|FG001|Overall Study|Withdrawal by Subject|0
6968918|NCT01144364|11018312|FG000|Induction Phase|Disease progression|14
7041198|NCT01725126|11124711|FG004|Overall Study|Withdrawal by Subject|0
6968919|NCT01144364|11018313|FG001|Induction Phase|Disease progression|0
6968920|NCT01144364|11018314|FG002|Induction Phase|Disease progression|0
6968921|NCT01144364|11018312|FG000|Induction Phase|Adverse Event|9
6968922|NCT01144364|11018313|FG001|Induction Phase|Adverse Event|0
6968923|NCT01144364|11018314|FG002|Induction Phase|Adverse Event|0
6968924|NCT01144364|11018312|FG000|Induction Phase|Death|1
6968925|NCT01144364|11018313|FG001|Induction Phase|Death|0
6968926|NCT01144364|11018314|FG002|Induction Phase|Death|0
6968927|NCT01144364|11018312|FG000|Induction Phase|Withdrawal by Subject|1
6874643|NCT00489216|10885486|FG000|Overall Study|Adverse Event|1
6874644|NCT00489255|10885492|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9
6874645|NCT00489255|10885493|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3
6874646|NCT00489255|10885492|FG000|Period 1: Days 1 to 28|Adverse Event|21
6874647|NCT00489255|10885493|FG001|Period 1: Days 1 to 28|Adverse Event|8
6874648|NCT00489255|10885492|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5
6874649|NCT00489255|10885493|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0
6874650|NCT00489255|10885492|FG000|Period 1: Days 1 to 28|Physician Decision|1
6874651|NCT00489255|10885493|FG001|Period 1: Days 1 to 28|Physician Decision|4
6874652|NCT00489255|10885492|FG000|Period 1: Days 1 to 28|Noncompliance|2
6874653|NCT00489255|10885493|FG001|Period 1: Days 1 to 28|Noncompliance|0
6874654|NCT00489255|10885492|FG000|Period 2: Days 29 to 56|Adverse Event|3
6874655|NCT00489255|10885493|FG001|Period 2: Days 29 to 56|Adverse Event|1
6874656|NCT00489255|10885492|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0
6874657|NCT00489255|10885493|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3
6874658|NCT00489255|10885492|FG000|Period 3: Days 57 to 84|Adverse Event|3
6874659|NCT00489255|10885493|FG001|Period 3: Days 57 to 84|Adverse Event|3
6874660|NCT00489255|10885492|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1
6874661|NCT00489255|10885493|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0
6874662|NCT00489255|10885492|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0
6874663|NCT00489255|10885493|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1
6874664|NCT00489359|10885531|FG000|Overall Study|Death|0
6874665|NCT00489359|10885532|FG001|Overall Study|Death|2
6874666|NCT00489359|10885531|FG000|Overall Study|Progressive Disease|5
6874667|NCT00489359|10885532|FG001|Overall Study|Progressive Disease|6
6874668|NCT00489359|10885531|FG000|Overall Study|Lost to Follow-up|1
6874669|NCT00489359|10885532|FG001|Overall Study|Lost to Follow-up|0
6874670|NCT00489359|10885531|FG000|Overall Study|Withdrawal by Subject|1
6874671|NCT00489359|10885532|FG001|Overall Study|Withdrawal by Subject|5
6874672|NCT00489359|10885531|FG000|Overall Study|Adverse Event|0
6874673|NCT00489359|10885532|FG001|Overall Study|Adverse Event|16
6874674|NCT00489411|10885545|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6
6874675|NCT00489411|10885546|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5
6874676|NCT00489411|10885545|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21
6874677|NCT00489411|10885546|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12
6874678|NCT00489411|10885545|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1
6874679|NCT00489411|10885546|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5
6874680|NCT00489411|10885545|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11
6874681|NCT00489411|10885546|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12
6874682|NCT00489411|10885545|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
6874683|NCT00489411|10885546|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
6874684|NCT00489424|10885555|FG000|Overall Study|Adverse Event|3
6874685|NCT00489424|10885556|FG001|Overall Study|Adverse Event|3
6874686|NCT00489424|10885557|FG002|Overall Study|Adverse Event|4
6874687|NCT00489424|10885555|FG000|Overall Study|Lack of Efficacy|1
6874688|NCT00489424|10885556|FG001|Overall Study|Lack of Efficacy|0
6874689|NCT00489424|10885557|FG002|Overall Study|Lack of Efficacy|0
6874690|NCT00489424|10885555|FG000|Overall Study|Administrative problems|0
6874691|NCT00489424|10885556|FG001|Overall Study|Administrative problems|2
6874692|NCT00489424|10885557|FG002|Overall Study|Administrative problems|1
6874693|NCT00489476|10885569|FG000|Overall Study|Lost to Follow-up|0
6874694|NCT00489476|10885570|FG001|Overall Study|Lost to Follow-up|1
6874695|NCT00489476|10885571|FG002|Overall Study|Lost to Follow-up|0
6874696|NCT00489476|10885572|FG003|Overall Study|Lost to Follow-up|0
6874697|NCT00489489|10885585|FG000|Overall Study|Not treated due to protocol violation|0
6874698|NCT00489489|10885586|FG001|Overall Study|Not treated due to protocol violation|1
6874699|NCT00489489|10885587|FG002|Overall Study|Not treated due to protocol violation|1
6874700|NCT00489489|10885585|FG000|Overall Study|Adverse Event|1
6874701|NCT00489489|10885586|FG001|Overall Study|Adverse Event|1
6874702|NCT00489489|10885587|FG002|Overall Study|Adverse Event|1
6874703|NCT00489489|10885585|FG000|Overall Study|Protocol Violation|1
6874704|NCT00489489|10885586|FG001|Overall Study|Protocol Violation|0
6874705|NCT00489489|10885587|FG002|Overall Study|Protocol Violation|1
6874706|NCT00489489|10885585|FG000|Overall Study|Progressive disease|0
6874707|NCT00489489|10885586|FG001|Overall Study|Progressive disease|1
6874708|NCT00489489|10885587|FG002|Overall Study|Progressive disease|0
6874709|NCT00489489|10885585|FG000|Overall Study|Participant did not wish to continue|1
6874710|NCT00489489|10885586|FG001|Overall Study|Participant did not wish to continue|1
6874711|NCT00489489|10885587|FG002|Overall Study|Participant did not wish to continue|0
6874712|NCT00489489|10885585|FG000|Overall Study|Other than above|0
6874713|NCT00489489|10885586|FG001|Overall Study|Other than above|1
6874714|NCT00489489|10885587|FG002|Overall Study|Other than above|0
6874715|NCT00489541|10885599|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2
6874716|NCT00489541|10885600|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3
6874717|NCT00489541|10885599|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2
6874718|NCT00489541|10885600|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0
6874719|NCT00489541|10885599|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2
6874720|NCT00489541|10885600|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0
6874721|NCT00489541|10885599|FG000|12-Month Clinical Follow-up|Death|3
6874722|NCT00489541|10885600|FG001|12-Month Clinical Follow-up|Death|2
6874723|NCT00489541|10885599|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23
6874724|NCT00489541|10885600|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12
6874725|NCT00489541|10885599|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4
6874726|NCT00489541|10885600|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5
6874727|NCT00489554|10885606|FG000|Overall Study|Adverse Event|2
6874728|NCT00489554|10885606|FG000|Overall Study|Withdrawal by Subject|1
6874729|NCT00489554|10885606|FG000|Overall Study|Lost to Follow-up|1
6874730|NCT00489736|10885612|FG000|Overall Study|Lack of Efficacy|53
6874731|NCT00489736|10885613|FG001|Overall Study|Lack of Efficacy|14
6874732|NCT00489736|10885612|FG000|Overall Study|Adverse Event|32
6874733|NCT00489736|10885613|FG001|Overall Study|Adverse Event|45
6874734|NCT00489736|10885612|FG000|Overall Study|Poor compliance|6
6874735|NCT00489736|10885613|FG001|Overall Study|Poor compliance|2
6874736|NCT00489736|10885612|FG000|Overall Study|Not coded/ Not pre-specified|5
6874737|NCT00489736|10885613|FG001|Overall Study|Not coded/ Not pre-specified|8
6874738|NCT00489853|10885619|FG000|Wash-out Period 1|Withdrawal by Subject|1
6874739|NCT00489853|10885620|FG001|Wash-out Period 1|Withdrawal by Subject|0
6874740|NCT00489853|10885621|FG002|Wash-out Period 1|Withdrawal by Subject|0
6874741|NCT00489853|10885619|FG000|Wash-out Period 1|Adverse Event|0
6874742|NCT00489853|10885620|FG001|Wash-out Period 1|Adverse Event|1
6874743|NCT00489853|10885621|FG002|Wash-out Period 1|Adverse Event|1
6874744|NCT00489853|10885619|FG000|Wash-out Period 1|Protocol Violation|0
6874745|NCT00489853|10885620|FG001|Wash-out Period 1|Protocol Violation|1
6874746|NCT00489853|10885621|FG002|Wash-out Period 1|Protocol Violation|1
6874747|NCT00489853|10885619|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0
6874748|NCT00489853|10885620|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1
6874749|NCT00489853|10885621|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4
6874750|NCT00489853|10885619|FG000|Wash-out Period 2|Adverse Event|1
6874751|NCT00489853|10885620|FG001|Wash-out Period 2|Adverse Event|1
6874752|NCT00489853|10885621|FG002|Wash-out Period 2|Adverse Event|0
6874753|NCT00489853|10885619|FG000|Wash-out Period 2|Study specific discontinuation criteria|3
6874754|NCT00489853|10885620|FG001|Wash-out Period 2|Study specific discontinuation criteria|2
6874755|NCT00489853|10885621|FG002|Wash-out Period 2|Study specific discontinuation criteria|2
6874756|NCT00489853|10885619|FG000|Treatment Period 3|Study specific discontinuation criteria|0
6874757|NCT00489853|10885620|FG001|Treatment Period 3|Study specific discontinuation criteria|1
6874758|NCT00489853|10885621|FG002|Treatment Period 3|Study specific discontinuation criteria|0
6874759|NCT00489918|10885651|FG000|Overall Study|Withdrawal by Subject|2
6874760|NCT00489918|10885652|FG001|Overall Study|Withdrawal by Subject|1
6874761|NCT00489918|10885653|FG002|Overall Study|Withdrawal by Subject|1
6874762|NCT00489918|10885654|FG003|Overall Study|Withdrawal by Subject|0
6874763|NCT00489918|10885655|FG004|Overall Study|Withdrawal by Subject|1
6874764|NCT00489918|10885651|FG000|Overall Study|Adverse Event|0
6874765|NCT00489918|10885652|FG001|Overall Study|Adverse Event|1
6874766|NCT00489918|10885653|FG002|Overall Study|Adverse Event|1
6874767|NCT00489918|10885654|FG003|Overall Study|Adverse Event|0
6874768|NCT00489918|10885655|FG004|Overall Study|Adverse Event|0
6874769|NCT00489918|10885651|FG000|Overall Study|Lost to Follow-up|0
6874770|NCT00489918|10885652|FG001|Overall Study|Lost to Follow-up|0
6874771|NCT00489918|10885653|FG002|Overall Study|Lost to Follow-up|1
6874772|NCT00489918|10885654|FG003|Overall Study|Lost to Follow-up|1
6874773|NCT00489918|10885655|FG004|Overall Study|Lost to Follow-up|0
6874774|NCT00489918|10885651|FG000|Overall Study|Physician Decision|0
6874775|NCT00489918|10885652|FG001|Overall Study|Physician Decision|0
6874776|NCT00489918|10885653|FG002|Overall Study|Physician Decision|1
6874777|NCT00489918|10885654|FG003|Overall Study|Physician Decision|0
6874778|NCT00489918|10885655|FG004|Overall Study|Physician Decision|0
6874779|NCT00489970|10885670|FG000|Persistence Year 9|Lost to Follow-up|2
6874780|NCT00489970|10885671|FG001|Persistence Year 9|Lost to Follow-up|2
6874781|NCT00489970|10885672|FG002|Persistence Year 9|Lost to Follow-up|3
6874782|NCT00489970|10885670|FG000|Persistence Year 9|Other|1
6874783|NCT00489970|10885671|FG001|Persistence Year 9|Other|0
6874784|NCT00489970|10885672|FG002|Persistence Year 9|Other|2
6874785|NCT00490022|10885690|FG000|Overall Study|Adverse Event|0
6874786|NCT00490022|10885691|FG001|Overall Study|Adverse Event|2
6874787|NCT00490022|10885690|FG000|Overall Study|Withdrawal by Subject|1
6874788|NCT00490022|10885691|FG001|Overall Study|Withdrawal by Subject|0
6874789|NCT00490022|10885690|FG000|Overall Study|Subject failed to disclose concommitant|0
6968928|NCT01144364|11018313|FG001|Induction Phase|Withdrawal by Subject|0
6968929|NCT01144364|11018314|FG002|Induction Phase|Withdrawal by Subject|0
6968930|NCT01144364|11018312|FG000|Induction Phase|Lost to Follow-up|2
6968931|NCT01144364|11018313|FG001|Induction Phase|Lost to Follow-up|0
6968932|NCT01144364|11018314|FG002|Induction Phase|Lost to Follow-up|0
6968933|NCT01144364|11018312|FG000|Induction Phase|Physician Decision|1
6968934|NCT01144364|11018313|FG001|Induction Phase|Physician Decision|0
6968935|NCT01144364|11018314|FG002|Induction Phase|Physician Decision|0
6968936|NCT01144364|11018312|FG000|Induction Phase|Stable disease|2
6968937|NCT01144364|11018313|FG001|Induction Phase|Stable disease|0
6968938|NCT01144364|11018314|FG002|Induction Phase|Stable disease|0
6968939|NCT01144364|11018312|FG000|Induction Phase|Secondary neoplasia|1
6874790|NCT00490022|10885691|FG001|Overall Study|Subject failed to disclose concommitant|1
6874791|NCT00490035|10885701|FG000|Overall Study|AE, non-serious non-fatal|3
6874792|NCT00490035|10885702|FG001|Overall Study|AE, non-serious non-fatal|4
6874793|NCT00490035|10885703|FG002|Overall Study|AE, non-serious non-fatal|4
6874794|NCT00490035|10885704|FG003|Overall Study|AE, non-serious non-fatal|5
6874795|NCT00490035|10885701|FG000|Overall Study|Lost to Follow-up|2
6874796|NCT00490035|10885702|FG001|Overall Study|Lost to Follow-up|0
6874797|NCT00490035|10885703|FG002|Overall Study|Lost to Follow-up|1
6874798|NCT00490035|10885704|FG003|Overall Study|Lost to Follow-up|0
6874799|NCT00490035|10885701|FG000|Overall Study|Withdrawal by Subject|2
6874800|NCT00490035|10885702|FG001|Overall Study|Withdrawal by Subject|1
6874801|NCT00490035|10885703|FG002|Overall Study|Withdrawal by Subject|1
6874802|NCT00490035|10885704|FG003|Overall Study|Withdrawal by Subject|0
6874803|NCT00490035|10885701|FG000|Overall Study|Other reason|0
6874804|NCT00490035|10885702|FG001|Overall Study|Other reason|1
6874805|NCT00490035|10885703|FG002|Overall Study|Other reason|3
6874806|NCT00490035|10885704|FG003|Overall Study|Other reason|1
6874807|NCT00490035|10885701|FG000|Overall Study|AE, serious fatal|1
6874808|NCT00490035|10885702|FG001|Overall Study|AE, serious fatal|0
6874809|NCT00490035|10885703|FG002|Overall Study|AE, serious fatal|0
6874810|NCT00490035|10885704|FG003|Overall Study|AE, serious fatal|0
6874811|NCT00490035|10885701|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0
6874812|NCT00490035|10885702|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0
6874813|NCT00490035|10885703|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1
6874814|NCT00490035|10885704|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0
6874815|NCT00490035|10885701|FG000|Overall Study|AE of unknown type|0
6874816|NCT00490035|10885702|FG001|Overall Study|AE of unknown type|0
6874817|NCT00490035|10885703|FG002|Overall Study|AE of unknown type|2
6874818|NCT00490035|10885704|FG003|Overall Study|AE of unknown type|0
6874819|NCT00490061|10885714|FG000|Overall Study|Physician Decision|1
6874820|NCT00490139|10885727|FG000|Overall Study|Death|106
6874821|NCT00490139|10885728|FG001|Overall Study|Death|119
6874822|NCT00490139|10885729|FG002|Overall Study|Death|168
6874823|NCT00490139|10885730|FG003|Overall Study|Death|135
6874824|NCT00490139|10885727|FG000|Overall Study|Lost to Follow-up|56
6874825|NCT00490139|10885728|FG001|Overall Study|Lost to Follow-up|46
6874826|NCT00490139|10885729|FG002|Overall Study|Lost to Follow-up|58
6874827|NCT00490139|10885730|FG003|Overall Study|Lost to Follow-up|56
6874828|NCT00490139|10885727|FG000|Overall Study|Participant Withdrew Consent|146
6874829|NCT00490139|10885728|FG001|Overall Study|Participant Withdrew Consent|110
6874830|NCT00490139|10885729|FG002|Overall Study|Participant Withdrew Consent|208
6874831|NCT00490139|10885730|FG003|Overall Study|Participant Withdrew Consent|116
6874832|NCT00490282|10885760|FG000|Overall Study|Withdrawal by Subject|3
6874833|NCT00490451|10885767|FG000|Overall Study|Adverse Event|3
6874834|NCT00490451|10885768|FG001|Overall Study|Adverse Event|3
6874835|NCT00490451|10885767|FG000|Overall Study|Death|3
6874836|NCT00490451|10885768|FG001|Overall Study|Death|1
6874837|NCT00490451|10885767|FG000|Overall Study|Withdrawal by Subject|2
6874838|NCT00490451|10885768|FG001|Overall Study|Withdrawal by Subject|0
6874839|NCT00490451|10885767|FG000|Overall Study|Investigator Decision|1
6874840|NCT00490451|10885768|FG001|Overall Study|Investigator Decision|0
6874841|NCT00490451|10885767|FG000|Overall Study|Protocol Violation|1
6874842|NCT00490451|10885768|FG001|Overall Study|Protocol Violation|0
6874843|NCT00490451|10885767|FG000|Overall Study|Progressive Disease|53
6874844|NCT00490451|10885768|FG001|Overall Study|Progressive Disease|34
6874845|NCT00490490|10885783|FG000|Completed Assessment for TTP|Withdrawal by Subject|1
6874846|NCT00490490|10885783|FG000|Completed Assessment for TTP|Lost to Follow-up|2
6874847|NCT00490529|10885787|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4
6874848|NCT00490529|10885787|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4
6874849|NCT00490529|10885787|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1
6874850|NCT00490529|10885787|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1
6874851|NCT00490529|10885787|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1
6874852|NCT00490529|10885787|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1
6874853|NCT00490542|10885793|FG000|Overall Study|Lost to Follow-up|3
6874854|NCT00490542|10885794|FG001|Overall Study|Lost to Follow-up|0
6874855|NCT00490542|10885793|FG000|Overall Study|Adverse Event|3
6874856|NCT00490542|10885794|FG001|Overall Study|Adverse Event|3
6874857|NCT00490542|10885793|FG000|Overall Study|Lack of Efficacy|1
6874858|NCT00490542|10885794|FG001|Overall Study|Lack of Efficacy|1
6874859|NCT00490555|10885804|FG000|Overall Study|noncompliant with drug administration|0
6874860|NCT00490555|10885805|FG001|Overall Study|noncompliant with drug administration|0
6874861|NCT00490555|10885806|FG002|Overall Study|noncompliant with drug administration|2
6874862|NCT00490555|10885807|FG003|Overall Study|noncompliant with drug administration|0
6874863|NCT00490568|10885817|FG000|Overall Study|Adverse Event|116
6874864|NCT00490568|10885817|FG000|Overall Study|Lost to Follow-up|13
6874865|NCT00490568|10885817|FG000|Overall Study|Protocol Violation|45
6874866|NCT00490568|10885817|FG000|Overall Study|Withdrawal by Subject|135
6874867|NCT00490568|10885817|FG000|Overall Study|Still in the study at termination|974
6874868|NCT00490568|10885817|FG000|Overall Study|Other|1
6874869|NCT00490568|10885817|FG000|Overall Study|Exclusion criteria met|1
6874870|NCT00490568|10885817|FG000|Overall Study|Caregiver related|20
6874871|NCT00490568|10885817|FG000|Overall Study|Abnormal ECG|25
6874872|NCT00490568|10885817|FG000|Overall Study|Participant refused follow-up|9
6874873|NCT00490568|10885817|FG000|Overall Study|Legal representative withdrew consent|1
6874874|NCT00490568|10885817|FG000|Overall Study|Disease progression|4
6874875|NCT00490568|10885817|FG000|Overall Study|Unmet inclusion-exclusion criteria|5
6874876|NCT00490568|10885817|FG000|Overall Study|Investigator decision|3
6874877|NCT00490568|10885817|FG000|Overall Study|Non-Compliance|7
6874878|NCT00490568|10885817|FG000|Overall Study|Efficacy related|3
6874879|NCT00490568|10885817|FG000|Overall Study|Participant died|1
6874880|NCT00490568|10885817|FG000|Overall Study|Participant withdrawal due to surgery|1
6874881|NCT00490646|10885824|FG000|Overall Study|Still on trastuzumab monotherapy|1
6874882|NCT00490646|10885825|FG001|Overall Study|Still on trastuzumab monotherapy|1
6874883|NCT00490646|10885824|FG000|Overall Study|Never Treated (had an adverse event)|1
6874884|NCT00490646|10885825|FG001|Overall Study|Never Treated (had an adverse event)|0
6874885|NCT00490646|10885824|FG000|Overall Study|Never Treated (withdrew consent)|0
6874886|NCT00490646|10885825|FG001|Overall Study|Never Treated (withdrew consent)|1
6874887|NCT00490698|10885831|FG000|Overall Study|Withdrawal by Subject|1
6874888|NCT00490698|10885831|FG000|Overall Study|Disease Progression|7
6874889|NCT00490698|10885831|FG000|Overall Study|Physician Decision|2
6874890|NCT00490724|10885838|FG000|Period I|Physician Decision|0
6874891|NCT00490724|10885839|FG001|Period I|Physician Decision|0
6874892|NCT00490724|10885840|FG002|Period I|Physician Decision|1
6874893|NCT00490724|10885838|FG000|Period II|Treatment Discontinuation|3
6874894|NCT00490724|10885839|FG001|Period II|Treatment Discontinuation|1
6874895|NCT00490724|10885840|FG002|Period II|Treatment Discontinuation|3
6874896|NCT00490815|10885860|FG000|Overall Study|Adverse Event|2
6874897|NCT00490815|10885861|FG001|Overall Study|Adverse Event|3
6874898|NCT00490815|10885860|FG000|Overall Study|Withdrawal by Subject|4
6874899|NCT00490815|10885861|FG001|Overall Study|Withdrawal by Subject|0
6874900|NCT00490815|10885860|FG000|Overall Study|Lost to Follow-up|1
6874901|NCT00490815|10885861|FG001|Overall Study|Lost to Follow-up|3
6874902|NCT00490815|10885860|FG000|Overall Study|Death|1
6874903|NCT00490815|10885861|FG001|Overall Study|Death|3
6874904|NCT00490841|10885867|FG000|Overall Study|Death|5
6874905|NCT00490841|10885867|FG000|Overall Study|Withdrawal by Subject|4
6874906|NCT00490841|10885867|FG000|Overall Study|Lost to Follow-up|1
6874907|NCT00490841|10885867|FG000|Overall Study|30 day f/u, only non-study stent used|3
6874908|NCT00490919|10885874|FG000|Open-label Run-in Period|Adverse Event|239
6874909|NCT00490919|10885875|FG001|Open-label Run-in Period|Adverse Event|0
6874910|NCT00490919|10885876|FG002|Open-label Run-in Period|Adverse Event|0
6874911|NCT00490919|10885874|FG000|Open-label Run-in Period|Withdrawal by Subject|37
6874912|NCT00490919|10885875|FG001|Open-label Run-in Period|Withdrawal by Subject|0
7078552|NCT02105272|11187194|FG001|Overall Study|Withdrawal by Subject|0
7078553|NCT02105285|11187203|FG000|Overall Study|Adverse Event|1
7078554|NCT02105285|11187204|FG001|Overall Study|Adverse Event|1
7078555|NCT02105285|11187205|FG002|Overall Study|Adverse Event|0
7078556|NCT02105285|11187203|FG000|Overall Study|Protocol Violation|0
7078557|NCT02105285|11187204|FG001|Overall Study|Protocol Violation|1
7078558|NCT02105285|11187205|FG002|Overall Study|Protocol Violation|0
7154346|NCT03309605|11320959|FG005|Overall Study|Withdrawal by Subject|0
7154347|NCT03309605|11320960|FG006|Overall Study|Withdrawal by Subject|1
7154348|NCT03309605|11320961|FG007|Overall Study|Withdrawal by Subject|1
7154349|NCT03309696|11320981|FG000|Overall Study|Analysis of TEP data could not be completed|0
6874913|NCT00490919|10885876|FG002|Open-label Run-in Period|Withdrawal by Subject|0
6874914|NCT00490919|10885874|FG000|Open-label Run-in Period|Lost to Follow-up|21
6874915|NCT00490919|10885875|FG001|Open-label Run-in Period|Lost to Follow-up|0
6874916|NCT00490919|10885876|FG002|Open-label Run-in Period|Lost to Follow-up|0
6874917|NCT00490919|10885874|FG000|Open-label Run-in Period|Lack of Efficacy|143
6874918|NCT00490919|10885875|FG001|Open-label Run-in Period|Lack of Efficacy|0
6874919|NCT00490919|10885876|FG002|Open-label Run-in Period|Lack of Efficacy|0
6874920|NCT00490919|10885874|FG000|Open-label Run-in Period|Administrative|40
6874921|NCT00490919|10885875|FG001|Open-label Run-in Period|Administrative|0
6874922|NCT00490919|10885876|FG002|Open-label Run-in Period|Administrative|0
6874923|NCT00490919|10885874|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3
6874924|NCT00490919|10885875|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0
6874925|NCT00490919|10885876|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0
6874926|NCT00490919|10885874|FG000|Double-blind Phase|Adverse Event|0
6874927|NCT00490919|10885875|FG001|Double-blind Phase|Adverse Event|40
6874928|NCT00490919|10885876|FG002|Double-blind Phase|Adverse Event|20
6874929|NCT00490919|10885874|FG000|Double-blind Phase|Withdrawal by Subject|0
6874930|NCT00490919|10885875|FG001|Double-blind Phase|Withdrawal by Subject|10
6874931|NCT00490919|10885876|FG002|Double-blind Phase|Withdrawal by Subject|11
7154350|NCT03309696|11320982|FG001|Overall Study|Analysis of TEP data could not be completed|5
6874932|NCT00490919|10885874|FG000|Double-blind Phase|Lost to Follow-up|0
6874933|NCT00490919|10885875|FG001|Double-blind Phase|Lost to Follow-up|8
6874934|NCT00490919|10885876|FG002|Double-blind Phase|Lost to Follow-up|11
6874935|NCT00490919|10885874|FG000|Double-blind Phase|Lack of Efficacy|0
6874936|NCT00490919|10885875|FG001|Double-blind Phase|Lack of Efficacy|22
6874937|NCT00490919|10885876|FG002|Double-blind Phase|Lack of Efficacy|36
6874938|NCT00490919|10885874|FG000|Double-blind Phase|Administrative|0
7078559|NCT02105285|11187203|FG000|Overall Study|Withdrawal by Subject|1
6874939|NCT00490919|10885875|FG001|Double-blind Phase|Administrative|6
6874940|NCT00490919|10885876|FG002|Double-blind Phase|Administrative|6
6874941|NCT00490945|10885888|FG000|Overall Study|Adverse Event|0
6874942|NCT00490945|10885889|FG001|Overall Study|Adverse Event|1
6874943|NCT00490945|10885890|FG002|Overall Study|Adverse Event|0
6874944|NCT00490945|10885891|FG003|Overall Study|Adverse Event|0
6874945|NCT00490945|10885892|FG004|Overall Study|Adverse Event|0
6874946|NCT00490971|10885912|FG000|Acute/Continuation|Adverse Event|62
6874947|NCT00490971|10885913|FG001|Acute/Continuation|Adverse Event|13
6874948|NCT00490971|10885914|FG002|Acute/Continuation|Adverse Event|0
6874949|NCT00490971|10885915|FG003|Acute/Continuation|Adverse Event|0
6874950|NCT00490971|10885916|FG004|Acute/Continuation|Adverse Event|0
6874951|NCT00490971|10885912|FG000|Acute/Continuation|Death|2
6874952|NCT00490971|10885913|FG001|Acute/Continuation|Death|0
6874953|NCT00490971|10885914|FG002|Acute/Continuation|Death|0
6874954|NCT00490971|10885915|FG003|Acute/Continuation|Death|0
6874955|NCT00490971|10885916|FG004|Acute/Continuation|Death|0
6874956|NCT00490971|10885912|FG000|Acute/Continuation|Lack of Efficacy|106
6874957|NCT00490971|10885913|FG001|Acute/Continuation|Lack of Efficacy|12
6874958|NCT00490971|10885914|FG002|Acute/Continuation|Lack of Efficacy|0
6874959|NCT00490971|10885915|FG003|Acute/Continuation|Lack of Efficacy|0
6874960|NCT00490971|10885916|FG004|Acute/Continuation|Lack of Efficacy|0
6874961|NCT00490971|10885912|FG000|Acute/Continuation|Lost to Follow-up|23
6874962|NCT00490971|10885913|FG001|Acute/Continuation|Lost to Follow-up|7
6874963|NCT00490971|10885914|FG002|Acute/Continuation|Lost to Follow-up|0
6874964|NCT00490971|10885915|FG003|Acute/Continuation|Lost to Follow-up|0
6874965|NCT00490971|10885916|FG004|Acute/Continuation|Lost to Follow-up|0
6874966|NCT00490971|10885912|FG000|Acute/Continuation|Protocol Violation|10
6874967|NCT00490971|10885913|FG001|Acute/Continuation|Protocol Violation|2
7154351|NCT03309696|11320983|FG002|Overall Study|Analysis of TEP data could not be completed|0
7184154|NCT01763788|11384152|FG003|Overall Study|Lost to Follow-up|0
6874968|NCT00490971|10885914|FG002|Acute/Continuation|Protocol Violation|0
6874969|NCT00490971|10885915|FG003|Acute/Continuation|Protocol Violation|0
6874970|NCT00490971|10885916|FG004|Acute/Continuation|Protocol Violation|0
7078560|NCT02105285|11187204|FG001|Overall Study|Withdrawal by Subject|0
7078561|NCT02105285|11187205|FG002|Overall Study|Withdrawal by Subject|0
6874971|NCT00490971|10885912|FG000|Acute/Continuation|Withdrawal by Subject|92
6874972|NCT00490971|10885913|FG001|Acute/Continuation|Withdrawal by Subject|24
6874973|NCT00490971|10885914|FG002|Acute/Continuation|Withdrawal by Subject|0
6874974|NCT00490971|10885915|FG003|Acute/Continuation|Withdrawal by Subject|0
6874975|NCT00490971|10885916|FG004|Acute/Continuation|Withdrawal by Subject|0
6874976|NCT00490971|10885912|FG000|Acute/Continuation|Other|11
6874977|NCT00490971|10885913|FG001|Acute/Continuation|Other|4
6874978|NCT00490971|10885914|FG002|Acute/Continuation|Other|0
6874979|NCT00490971|10885915|FG003|Acute/Continuation|Other|0
6874980|NCT00490971|10885916|FG004|Acute/Continuation|Other|0
6874981|NCT00490971|10885912|FG000|Maintenance|Adverse Event|0
6874982|NCT00490971|10885913|FG001|Maintenance|Adverse Event|0
6874983|NCT00490971|10885914|FG002|Maintenance|Adverse Event|4
6874984|NCT00490971|10885915|FG003|Maintenance|Adverse Event|5
6874985|NCT00490971|10885916|FG004|Maintenance|Adverse Event|7
6874986|NCT00490971|10885912|FG000|Maintenance|Death|0
6874987|NCT00490971|10885913|FG001|Maintenance|Death|0
6874988|NCT00490971|10885914|FG002|Maintenance|Death|0
6874989|NCT00490971|10885915|FG003|Maintenance|Death|2
6874990|NCT00490971|10885916|FG004|Maintenance|Death|0
6874991|NCT00490971|10885912|FG000|Maintenance|Lost to Follow-up|0
6874992|NCT00490971|10885913|FG001|Maintenance|Lost to Follow-up|0
6874993|NCT00490971|10885914|FG002|Maintenance|Lost to Follow-up|5
6874994|NCT00490971|10885915|FG003|Maintenance|Lost to Follow-up|8
6874995|NCT00490971|10885916|FG004|Maintenance|Lost to Follow-up|10
6874996|NCT00490971|10885912|FG000|Maintenance|Pregnancy|0
6874997|NCT00490971|10885913|FG001|Maintenance|Pregnancy|0
6874998|NCT00490971|10885914|FG002|Maintenance|Pregnancy|1
6874999|NCT00490971|10885915|FG003|Maintenance|Pregnancy|0
6875000|NCT00490971|10885916|FG004|Maintenance|Pregnancy|0
6875001|NCT00490971|10885912|FG000|Maintenance|Protocol Violation|0
6875002|NCT00490971|10885913|FG001|Maintenance|Protocol Violation|0
6875003|NCT00490971|10885914|FG002|Maintenance|Protocol Violation|4
6875004|NCT00490971|10885915|FG003|Maintenance|Protocol Violation|1
6875005|NCT00490971|10885916|FG004|Maintenance|Protocol Violation|1
6875006|NCT00490971|10885912|FG000|Maintenance|Withdrawal by Subject|0
6875007|NCT00490971|10885913|FG001|Maintenance|Withdrawal by Subject|0
6875008|NCT00490971|10885914|FG002|Maintenance|Withdrawal by Subject|26
6875009|NCT00490971|10885915|FG003|Maintenance|Withdrawal by Subject|28
6875010|NCT00490971|10885916|FG004|Maintenance|Withdrawal by Subject|18
6875011|NCT00490971|10885912|FG000|Maintenance|Other|0
6875012|NCT00490971|10885913|FG001|Maintenance|Other|0
6875013|NCT00490971|10885914|FG002|Maintenance|Other|11
7078562|NCT02105454|11187236|FG000|Overall Study|Withdrawal by Subject|1
7078563|NCT02105467|11187242|FG000|Period 1|Lost to Follow-up|1
7078564|NCT02105467|11187243|FG001|Period 1|Lost to Follow-up|0
7078565|NCT02105467|11187242|FG000|Period 1|Death|1
7078566|NCT02105467|11187243|FG001|Period 1|Death|0
7078567|NCT02105467|11187242|FG000|Period 2|Lost to Follow-up|1
7078568|NCT02105467|11187243|FG001|Period 2|Lost to Follow-up|0
7078569|NCT02105467|11187242|FG000|Period 2|Death|1
7078570|NCT02105467|11187243|FG001|Period 2|Death|0
7078571|NCT02105467|11187242|FG000|Period 2|Withdrawal by Subject|0
7078572|NCT02105467|11187243|FG001|Period 2|Withdrawal by Subject|2
6875014|NCT00490971|10885915|FG003|Maintenance|Other|9
6875015|NCT00490971|10885916|FG004|Maintenance|Other|3
6875016|NCT00491075|10885928|FG000|Overall Study|Withdrawal by Subject|1
6875017|NCT00491075|10885928|FG000|Overall Study|Physician Decision|1
6875018|NCT00491179|10885934|FG000|Overall Study|Adverse Event|5
6875019|NCT00491179|10885935|FG001|Overall Study|Adverse Event|1
6875020|NCT00491179|10885934|FG000|Overall Study|Withdrawal by Subject|2
6875021|NCT00491179|10885935|FG001|Overall Study|Withdrawal by Subject|1
7078573|NCT02105467|11187242|FG000|Period 3|Lost to Follow-up|0
6875022|NCT00491322|10885952|FG000|Overall Study|Protocol Violation|1
6875023|NCT00491322|10885953|FG001|Overall Study|Protocol Violation|0
6875024|NCT00491322|10885952|FG000|Overall Study|Pregnancy|0
6875025|NCT00491322|10885953|FG001|Overall Study|Pregnancy|1
6875026|NCT00491530|10885980|FG000|Overall Study|Adverse Event|6
6875027|NCT00491530|10885981|FG001|Overall Study|Adverse Event|1
6875028|NCT00491530|10885982|FG002|Overall Study|Adverse Event|2
6875029|NCT00491530|10885980|FG000|Overall Study|Withdrawal by Subject|3
6875030|NCT00491530|10885981|FG001|Overall Study|Withdrawal by Subject|0
6875031|NCT00491530|10885982|FG002|Overall Study|Withdrawal by Subject|0
6875032|NCT00491530|10885980|FG000|Overall Study|Lost to Follow-up|3
6875033|NCT00491530|10885981|FG001|Overall Study|Lost to Follow-up|2
6875034|NCT00491530|10885982|FG002|Overall Study|Lost to Follow-up|2
6875035|NCT00491530|10885980|FG000|Overall Study|Lack of Efficacy|0
6875036|NCT00491530|10885981|FG001|Overall Study|Lack of Efficacy|1
6875037|NCT00491530|10885982|FG002|Overall Study|Lack of Efficacy|0
6875038|NCT00491530|10885980|FG000|Overall Study|Investigator Discretion|0
6875039|NCT00491530|10885981|FG001|Overall Study|Investigator Discretion|1
6875040|NCT00491530|10885982|FG002|Overall Study|Investigator Discretion|0
6875041|NCT00491530|10885980|FG000|Overall Study|Patient Request|0
6875042|NCT00491530|10885981|FG001|Overall Study|Patient Request|1
6875043|NCT00491530|10885982|FG002|Overall Study|Patient Request|0
6875044|NCT00491530|10885980|FG000|Overall Study|Use of Prohibited Medication|0
6875045|NCT00491530|10885981|FG001|Overall Study|Use of Prohibited Medication|0
6875046|NCT00491530|10885982|FG002|Overall Study|Use of Prohibited Medication|1
6875047|NCT00491556|10885992|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1
6875048|NCT00491556|10885993|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0
6875049|NCT00491556|10885992|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1
6875050|NCT00491556|10885993|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0
6875051|NCT00491556|10885992|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1
6875052|NCT00491556|10885993|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0
6875053|NCT00491556|10885992|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2
6875054|NCT00491556|10885993|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0
6875055|NCT00491556|10885992|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11
6875056|NCT00491556|10885993|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0
6875057|NCT00491556|10885992|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2
6875058|NCT00491556|10885993|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0
6875059|NCT00491556|10885992|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2
6875060|NCT00491556|10885993|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0
6875061|NCT00491556|10885992|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3
6875062|NCT00491556|10885993|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0
6875063|NCT00491556|10885992|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3
6875064|NCT00491556|10885993|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0
6875065|NCT00491556|10885992|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
6875066|NCT00491556|10885993|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
6875067|NCT00491556|10885992|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2
6875068|NCT00491556|10885993|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0
6875069|NCT00491556|10885992|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2
6875070|NCT00491556|10885993|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1
6875071|NCT00491556|10885992|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5
6875072|NCT00491556|10885993|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0
6875073|NCT00491556|10885992|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2
6875074|NCT00491556|10885993|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0
6875075|NCT00491556|10885992|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5
6875076|NCT00491556|10885993|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0
6875077|NCT00491556|10885992|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2
6875078|NCT00491556|10885993|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0
6875079|NCT00491556|10885992|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2
6875080|NCT00491556|10885993|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0
6968940|NCT01144364|11018313|FG001|Induction Phase|Secondary neoplasia|0
7154352|NCT03309696|11320984|FG003|Overall Study|Analysis of TEP data could not be completed|0
7154353|NCT03309943|11321013|FG000|Overall Study|Withdrawal by Subject|0
7154354|NCT03309943|11321014|FG001|Overall Study|Withdrawal by Subject|1
7154355|NCT03309943|11321013|FG000|Overall Study|Inappropriate behavior towards staff|0
7154356|NCT03309943|11321014|FG001|Overall Study|Inappropriate behavior towards staff|1
7078574|NCT02105467|11187243|FG001|Period 3|Lost to Follow-up|1
7078575|NCT02105662|11187259|FG000|Overall Study|Lost to Follow-up|5
7154357|NCT03310021|11321040|FG000|Overall Study|Withdrawal by Subject|0
7154358|NCT03310021|11321041|FG001|Overall Study|Withdrawal by Subject|0
7154359|NCT03310021|11321042|FG002|Overall Study|Withdrawal by Subject|0
7154360|NCT03310021|11321043|FG003|Overall Study|Withdrawal by Subject|0
7154361|NCT03310021|11321044|FG004|Overall Study|Withdrawal by Subject|0
7154362|NCT03310021|11321045|FG005|Overall Study|Withdrawal by Subject|0
7154363|NCT03310021|11321046|FG006|Overall Study|Withdrawal by Subject|1
7154364|NCT03310021|11321047|FG007|Overall Study|Withdrawal by Subject|0
7154365|NCT03310021|11321048|FG008|Overall Study|Withdrawal by Subject|0
7154366|NCT03310021|11321049|FG009|Overall Study|Withdrawal by Subject|0
7154367|NCT03310021|11321050|FG010|Overall Study|Withdrawal by Subject|0
7154368|NCT03310021|11321051|FG011|Overall Study|Withdrawal by Subject|0
7154369|NCT03310021|11321052|FG012|Overall Study|Withdrawal by Subject|0
7154370|NCT03310021|11321053|FG013|Overall Study|Withdrawal by Subject|0
7154371|NCT03310021|11321054|FG014|Overall Study|Withdrawal by Subject|0
7154372|NCT03310021|11321055|FG015|Overall Study|Withdrawal by Subject|0
7154373|NCT03310021|11321056|FG016|Overall Study|Withdrawal by Subject|0
7154374|NCT03310021|11321057|FG017|Overall Study|Withdrawal by Subject|0
7154375|NCT03310021|11321058|FG018|Overall Study|Withdrawal by Subject|0
7154376|NCT03310021|11321059|FG019|Overall Study|Withdrawal by Subject|0
7154377|NCT03310021|11321040|FG000|Overall Study|Lost to Follow-up|0
7154378|NCT03310021|11321041|FG001|Overall Study|Lost to Follow-up|0
6875081|NCT00491556|10885992|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2
6875082|NCT00491556|10885993|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0
6875083|NCT00491556|10885992|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0
6875084|NCT00491556|10885993|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1
6875085|NCT00491556|10885992|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0
6875086|NCT00491556|10885993|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1
6875087|NCT00491608|10885999|FG000|Overall Study|Death|2
6875088|NCT00491608|10885999|FG000|Overall Study|Withdrawal by Subject|1
6875089|NCT00491764|10886024|FG000|Overall Study|Adverse Event|1
6875090|NCT00491764|10886025|FG001|Overall Study|Adverse Event|2
6875091|NCT00491764|10886026|FG002|Overall Study|Adverse Event|4
6875092|NCT00491764|10886027|FG003|Overall Study|Adverse Event|4
6875093|NCT00491764|10886028|FG004|Overall Study|Adverse Event|0
6875094|NCT00491764|10886029|FG005|Overall Study|Adverse Event|1
6875095|NCT00491764|10886024|FG000|Overall Study|Lost to Follow-up|0
6875096|NCT00491764|10886025|FG001|Overall Study|Lost to Follow-up|1
6875097|NCT00491764|10886026|FG002|Overall Study|Lost to Follow-up|0
6875098|NCT00491764|10886027|FG003|Overall Study|Lost to Follow-up|1
6875099|NCT00491764|10886028|FG004|Overall Study|Lost to Follow-up|0
6875100|NCT00491764|10886029|FG005|Overall Study|Lost to Follow-up|3
6875101|NCT00491764|10886024|FG000|Overall Study|Withdrawal by Subject|2
6875102|NCT00491764|10886025|FG001|Overall Study|Withdrawal by Subject|3
6875103|NCT00491764|10886026|FG002|Overall Study|Withdrawal by Subject|1
6875104|NCT00491764|10886027|FG003|Overall Study|Withdrawal by Subject|2
6875105|NCT00491764|10886028|FG004|Overall Study|Withdrawal by Subject|2
6875106|NCT00491764|10886029|FG005|Overall Study|Withdrawal by Subject|4
6875107|NCT00491764|10886024|FG000|Overall Study|Non Compliance with the Protocol|1
6875108|NCT00491764|10886025|FG001|Overall Study|Non Compliance with the Protocol|0
6875109|NCT00491764|10886026|FG002|Overall Study|Non Compliance with the Protocol|0
6875110|NCT00491764|10886027|FG003|Overall Study|Non Compliance with the Protocol|0
6875111|NCT00491764|10886028|FG004|Overall Study|Non Compliance with the Protocol|0
6875112|NCT00491764|10886029|FG005|Overall Study|Non Compliance with the Protocol|0
6875113|NCT00491764|10886024|FG000|Overall Study|Did not Meet Protocol Eligibility|0
6875114|NCT00491764|10886025|FG001|Overall Study|Did not Meet Protocol Eligibility|1
6875115|NCT00491764|10886026|FG002|Overall Study|Did not Meet Protocol Eligibility|1
6875116|NCT00491764|10886027|FG003|Overall Study|Did not Meet Protocol Eligibility|0
6875117|NCT00491764|10886028|FG004|Overall Study|Did not Meet Protocol Eligibility|1
6875118|NCT00491764|10886029|FG005|Overall Study|Did not Meet Protocol Eligibility|1
6875119|NCT00491764|10886024|FG000|Overall Study|Administrative|1
6875120|NCT00491764|10886025|FG001|Overall Study|Administrative|0
6875121|NCT00491764|10886026|FG002|Overall Study|Administrative|2
6875122|NCT00491764|10886027|FG003|Overall Study|Administrative|1
6875123|NCT00491764|10886028|FG004|Overall Study|Administrative|0
6875124|NCT00491764|10886029|FG005|Overall Study|Administrative|0
6875125|NCT00491894|10886056|FG000|Overall Study|Adverse Event|14
6875126|NCT00491894|10886056|FG000|Overall Study|Withdrawal by Subject|5
6875127|NCT00491894|10886056|FG000|Overall Study|Death|3
6875128|NCT00491894|10886056|FG000|Overall Study|Lost to Follow-up|3
6875129|NCT00491894|10886056|FG000|Overall Study|Lack of Efficacy|2
6875130|NCT00491894|10886056|FG000|Overall Study|Other-Failed to meet any criteria|2
7154379|NCT03310021|11321042|FG002|Overall Study|Lost to Follow-up|0
7154380|NCT03310021|11321043|FG003|Overall Study|Lost to Follow-up|0
7154381|NCT03310021|11321044|FG004|Overall Study|Lost to Follow-up|0
6875131|NCT00491894|10886056|FG000|Overall Study|Physician Decision|2
6875132|NCT00491894|10886056|FG000|Overall Study|Protocol Violation|2
6875133|NCT00491894|10886056|FG000|Overall Study|Other-Intake of prohibited medication|1
6875134|NCT00492024|10886062|FG000|Treatment|Adverse Event|3
6875135|NCT00492024|10886063|FG001|Treatment|Adverse Event|1
6875136|NCT00492024|10886062|FG000|Treatment|Lack of Efficacy|21
6875137|NCT00492024|10886063|FG001|Treatment|Lack of Efficacy|20
6875138|NCT00492024|10886062|FG000|Treatment|Lost to Follow-up|3
7078576|NCT02105662|11187259|FG000|Overall Study|Withdrawal by Subject|1
7078577|NCT02105688|11187265|FG000|Part A: Double-Blind|Adverse Event|1
7078578|NCT02105688|11187266|FG001|Part A: Double-Blind|Adverse Event|0
7078579|NCT02105688|11187265|FG000|Part A: Double-Blind|Death|0
7078580|NCT02105688|11187266|FG001|Part A: Double-Blind|Death|1
7078581|NCT02105688|11187265|FG000|Part A: Double-Blind|Lost to Follow-up|15
7078582|NCT02105688|11187266|FG001|Part A: Double-Blind|Lost to Follow-up|11
7078583|NCT02105688|11187265|FG000|Part A: Double-Blind|Physician Decision|0
7078584|NCT02105688|11187266|FG001|Part A: Double-Blind|Physician Decision|1
7078585|NCT02105688|11187265|FG000|Part A: Double-Blind|Status Unknown|0
7078586|NCT02105688|11187266|FG001|Part A: Double-Blind|Status Unknown|2
7078587|NCT02105688|11187265|FG000|Part A: Double-Blind|Withdrawal by Subject|4
6875139|NCT00492024|10886063|FG001|Treatment|Lost to Follow-up|1
6875140|NCT00492024|10886062|FG000|Treatment|Withdrawal by Subject|2
6875141|NCT00492024|10886063|FG001|Treatment|Withdrawal by Subject|0
6875142|NCT00492024|10886062|FG000|Follow up|Lack of Efficacy|0
6875143|NCT00492024|10886063|FG001|Follow up|Lack of Efficacy|1
6875144|NCT00492024|10886062|FG000|Follow up|Lost to Follow-up|1
6875145|NCT00492024|10886063|FG001|Follow up|Lost to Follow-up|1
6875146|NCT00492063|10886073|FG000|Overall Study|Death|0
6875147|NCT00492063|10886074|FG001|Overall Study|Death|0
6875148|NCT00492063|10886075|FG002|Overall Study|Death|1
6875149|NCT00492063|10886076|FG003|Overall Study|Death|2
6875150|NCT00492063|10886073|FG000|Overall Study|Withdrawal by Subject|4
6875151|NCT00492063|10886074|FG001|Overall Study|Withdrawal by Subject|3
6875152|NCT00492063|10886075|FG002|Overall Study|Withdrawal by Subject|5
6875153|NCT00492063|10886076|FG003|Overall Study|Withdrawal by Subject|4
6875154|NCT00492063|10886073|FG000|Overall Study|Lost to Follow-up|6
6875155|NCT00492063|10886074|FG001|Overall Study|Lost to Follow-up|11
6875156|NCT00492063|10886075|FG002|Overall Study|Lost to Follow-up|5
6875157|NCT00492063|10886076|FG003|Overall Study|Lost to Follow-up|3
6875158|NCT00492063|10886073|FG000|Overall Study|Protocol Violation|0
6875159|NCT00492063|10886074|FG001|Overall Study|Protocol Violation|0
6875160|NCT00492063|10886075|FG002|Overall Study|Protocol Violation|0
6875161|NCT00492063|10886076|FG003|Overall Study|Protocol Violation|1
6875162|NCT00492115|10886097|FG000|Overall Study|Withdrawal by Subject|3
6875163|NCT00492115|10886098|FG001|Overall Study|Withdrawal by Subject|4
6875164|NCT00492232|10886112|FG000|Placebo Run-in|Adverse Event|0
6875165|NCT00492232|10886113|FG001|Placebo Run-in|Adverse Event|2
6875166|NCT00492232|10886112|FG000|Placebo Run-in|Protocol Violation|0
6875167|NCT00492232|10886113|FG001|Placebo Run-in|Protocol Violation|3
6875168|NCT00492232|10886112|FG000|Placebo Run-in|Lost to Follow-up|0
6875169|NCT00492232|10886113|FG001|Placebo Run-in|Lost to Follow-up|3
6875170|NCT00492232|10886112|FG000|Placebo Run-in|Withdrawal by Subject|0
6875171|NCT00492232|10886113|FG001|Placebo Run-in|Withdrawal by Subject|8
6875172|NCT00492232|10886112|FG000|Placebo Run-in|Pregnancy|0
6875173|NCT00492232|10886113|FG001|Placebo Run-in|Pregnancy|1
6875174|NCT00492232|10886112|FG000|Placebo Run-in|Entrance criteria not met|0
6875175|NCT00492232|10886113|FG001|Placebo Run-in|Entrance criteria not met|45
6875176|NCT00492232|10886112|FG000|Placebo Run-in|Other|0
6875177|NCT00492232|10886113|FG001|Placebo Run-in|Other|6
6875178|NCT00492232|10886112|FG000|Placebo Run-in|Missing|0
6875179|NCT00492232|10886113|FG001|Placebo Run-in|Missing|2
6875180|NCT00492232|10886112|FG000|Double-Blind Treatment|Adverse Event|1
6875181|NCT00492232|10886113|FG001|Double-Blind Treatment|Adverse Event|2
6875182|NCT00492232|10886112|FG000|Double-Blind Treatment|Protocol Violation|3
6875183|NCT00492232|10886113|FG001|Double-Blind Treatment|Protocol Violation|7
6875184|NCT00492232|10886112|FG000|Double-Blind Treatment|Lost to Follow-up|2
6875185|NCT00492232|10886113|FG001|Double-Blind Treatment|Lost to Follow-up|3
6875186|NCT00492232|10886112|FG000|Double-Blind Treatment|Withdrawal by Subject|4
6875187|NCT00492232|10886113|FG001|Double-Blind Treatment|Withdrawal by Subject|8
6875188|NCT00492232|10886112|FG000|Double-Blind Treatment|Lack of Efficacy|1
6875189|NCT00492232|10886113|FG001|Double-Blind Treatment|Lack of Efficacy|0
6875190|NCT00492232|10886112|FG000|Double-Blind Treatment|Other|6
6875191|NCT00492232|10886113|FG001|Double-Blind Treatment|Other|5
6875192|NCT00492232|10886112|FG000|Double-Blind Treatment|Randomized not treated|1
6875193|NCT00492232|10886113|FG001|Double-Blind Treatment|Randomized not treated|0
6875194|NCT00492232|10886112|FG000|Open-Label Treatment|Withdrawal by Subject|1
6875195|NCT00492232|10886113|FG001|Open-Label Treatment|Withdrawal by Subject|0
6875196|NCT00492284|10886123|FG000|Overall Study|Adverse Event|0
6875197|NCT00492284|10886124|FG001|Overall Study|Adverse Event|1
6875198|NCT00492284|10886125|FG002|Overall Study|Adverse Event|1
6875199|NCT00492284|10886126|FG003|Overall Study|Adverse Event|2
6875200|NCT00492284|10886123|FG000|Overall Study|Lost to Follow-up|0
6875201|NCT00492284|10886124|FG001|Overall Study|Lost to Follow-up|0
6875202|NCT00492284|10886125|FG002|Overall Study|Lost to Follow-up|3
6875203|NCT00492284|10886126|FG003|Overall Study|Lost to Follow-up|1
6875204|NCT00492284|10886123|FG000|Overall Study|Death|0
6875205|NCT00492284|10886124|FG001|Overall Study|Death|3
6875206|NCT00492284|10886125|FG002|Overall Study|Death|2
6875207|NCT00492284|10886126|FG003|Overall Study|Death|5
6875208|NCT00492284|10886123|FG000|Overall Study|Withdrawal by Subject|1
6875209|NCT00492284|10886124|FG001|Overall Study|Withdrawal by Subject|0
6875210|NCT00492284|10886125|FG002|Overall Study|Withdrawal by Subject|0
6875211|NCT00492284|10886126|FG003|Overall Study|Withdrawal by Subject|2
6875212|NCT00492297|10886136|FG000|Treatment|Death|2
6875213|NCT00492297|10886136|FG000|Treatment|Study terminated by sponsor|3
6875214|NCT00492297|10886136|FG000|Active Follow-up 30(+4) Days Duration|Death|17
6875215|NCT00492297|10886136|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2
6875216|NCT00492297|10886136|FG000|Survival Only Follow-up|Death|46
6875217|NCT00492297|10886136|FG000|Survival Only Follow-up|Lack of Efficacy|1
6875218|NCT00492297|10886136|FG000|Survival Only Follow-up|Study terminated by sponsor|12
6875219|NCT00492531|10886157|FG000|Overall Study|Withdrawn(More than one reason selected)|22
6875220|NCT00492531|10886158|FG001|Overall Study|Withdrawn(More than one reason selected)|23
6875221|NCT00492557|10886170|FG000|Overall Study|Subject request|12
6875222|NCT00492557|10886171|FG001|Overall Study|Subject request|11
6875223|NCT00492557|10886170|FG000|Overall Study|Protocol Violation|7
6875224|NCT00492557|10886171|FG001|Overall Study|Protocol Violation|8
6875225|NCT00492557|10886170|FG000|Overall Study|Other|2
6875226|NCT00492557|10886171|FG001|Overall Study|Other|2
6875227|NCT00492557|10886170|FG000|Overall Study|Death|1
6875228|NCT00492557|10886171|FG001|Overall Study|Death|1
6875229|NCT00492557|10886170|FG000|Overall Study|Adverse Event|1
6875230|NCT00492557|10886171|FG001|Overall Study|Adverse Event|0
6875231|NCT00492557|10886170|FG000|Overall Study|Failed to return|1
6875232|NCT00492557|10886171|FG001|Overall Study|Failed to return|0
6875233|NCT00492557|10886170|FG000|Overall Study|Lost to Follow-up|0
6875234|NCT00492557|10886171|FG001|Overall Study|Lost to Follow-up|1
6875235|NCT00492648|10886199|FG000|Month 30 (109671 Study)|Protocol Violation|0
6875236|NCT00492648|10886200|FG001|Month 30 (109671 Study)|Protocol Violation|1
6875237|NCT00492726|10886208|FG000|Overall Study|Adverse Event|10
6875238|NCT00492726|10886209|FG001|Overall Study|Adverse Event|6
6875239|NCT00492726|10886208|FG000|Overall Study|Death|7
6875240|NCT00492726|10886209|FG001|Overall Study|Death|2
6875241|NCT00492726|10886208|FG000|Overall Study|Lack of Efficacy|0
6875242|NCT00492726|10886209|FG001|Overall Study|Lack of Efficacy|2
6875243|NCT00492726|10886208|FG000|Overall Study|Lost to Follow-up|27
6875244|NCT00492726|10886209|FG001|Overall Study|Lost to Follow-up|19
6875245|NCT00492726|10886208|FG000|Overall Study|Physician Decision|0
6875246|NCT00492726|10886209|FG001|Overall Study|Physician Decision|1
6875247|NCT00492726|10886208|FG000|Overall Study|Withdrawal by Subject|6
6875248|NCT00492726|10886209|FG001|Overall Study|Withdrawal by Subject|3
6875249|NCT00492726|10886208|FG000|Overall Study|Non compliant with study medication|0
6875250|NCT00492726|10886209|FG001|Overall Study|Non compliant with study medication|3
6875251|NCT00492752|10886217|FG000|Double Blind Treatment|Death|13
6875252|NCT00492752|10886218|FG001|Double Blind Treatment|Death|0
6875253|NCT00492752|10886219|FG002|Double Blind Treatment|Death|2
6875254|NCT00492752|10886220|FG003|Double Blind Treatment|Death|0
6875255|NCT00492752|10886217|FG000|Double Blind Treatment|Adverse Event|1
6875256|NCT00492752|10886218|FG001|Double Blind Treatment|Adverse Event|0
6875257|NCT00492752|10886219|FG002|Double Blind Treatment|Adverse Event|0
6875258|NCT00492752|10886220|FG003|Double Blind Treatment|Adverse Event|0
6875259|NCT00492752|10886217|FG000|Double Blind Treatment|Protocol Violation|0
6875260|NCT00492752|10886218|FG001|Double Blind Treatment|Protocol Violation|0
6875261|NCT00492752|10886219|FG002|Double Blind Treatment|Protocol Violation|1
6875262|NCT00492752|10886220|FG003|Double Blind Treatment|Protocol Violation|0
6875263|NCT00492752|10886217|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0
6875264|NCT00492752|10886218|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2
6875265|NCT00492752|10886219|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0
6875266|NCT00492752|10886220|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2
6875267|NCT00492752|10886217|FG000|Follow-up and/or Open Label Sorafenib|Death|75
6875268|NCT00492752|10886218|FG001|Follow-up and/or Open Label Sorafenib|Death|5
6875269|NCT00492752|10886219|FG002|Follow-up and/or Open Label Sorafenib|Death|45
6875270|NCT00492752|10886220|FG003|Follow-up and/or Open Label Sorafenib|Death|1
6875271|NCT00492752|10886217|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8
6875272|NCT00492752|10886218|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1
6875273|NCT00492752|10886219|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2
6875274|NCT00492752|10886220|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0
6875275|NCT00492752|10886217|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2
6875276|NCT00492752|10886218|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1
6875277|NCT00492752|10886219|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
6875278|NCT00492752|10886220|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
6875279|NCT00492752|10886217|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
6875280|NCT00492752|10886218|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1
6875281|NCT00492752|10886219|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
6875282|NCT00492752|10886220|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2
6875283|NCT00492752|10886217|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
6875284|NCT00492752|10886218|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
6875285|NCT00492752|10886219|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
6875286|NCT00492752|10886220|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1
6875287|NCT00492752|10886217|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
6875288|NCT00492752|10886218|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6
6875289|NCT00492752|10886219|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
6875290|NCT00492752|10886220|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
6875291|NCT00492752|10886217|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1
6875292|NCT00492752|10886218|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
6875293|NCT00492752|10886219|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
6875294|NCT00492752|10886220|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
6875295|NCT00492856|10886227|FG000|Induction|Adverse Event|2
6875296|NCT00492856|10886228|FG001|Induction|Adverse Event|0
6875297|NCT00492856|10886229|FG002|Induction|Adverse Event|0
6875298|NCT00492856|10886230|FG003|Induction|Adverse Event|0
6875299|NCT00492856|10886227|FG000|Induction|Withdrawal by Subject|1
6875300|NCT00492856|10886228|FG001|Induction|Withdrawal by Subject|0
6875301|NCT00492856|10886229|FG002|Induction|Withdrawal by Subject|0
6875302|NCT00492856|10886230|FG003|Induction|Withdrawal by Subject|0
6875303|NCT00492856|10886227|FG000|Induction|Death|3
6875304|NCT00492856|10886228|FG001|Induction|Death|0
6875305|NCT00492856|10886229|FG002|Induction|Death|0
6875306|NCT00492856|10886230|FG003|Induction|Death|0
6875307|NCT00492856|10886227|FG000|Consolidation|Adverse Event|6
6875308|NCT00492856|10886228|FG001|Consolidation|Adverse Event|0
6875309|NCT00492856|10886229|FG002|Consolidation|Adverse Event|0
6875310|NCT00492856|10886230|FG003|Consolidation|Adverse Event|0
6875311|NCT00492856|10886227|FG000|Consolidation|Not protocol specified|2
6875312|NCT00492856|10886228|FG001|Consolidation|Not protocol specified|0
6875313|NCT00492856|10886229|FG002|Consolidation|Not protocol specified|0
6875314|NCT00492856|10886230|FG003|Consolidation|Not protocol specified|0
6875315|NCT00492856|10886227|FG000|Consolidation|Lost to Follow-up|1
6875316|NCT00492856|10886228|FG001|Consolidation|Lost to Follow-up|0
6875317|NCT00492856|10886229|FG002|Consolidation|Lost to Follow-up|0
6875318|NCT00492856|10886230|FG003|Consolidation|Lost to Follow-up|0
6875319|NCT00492856|10886227|FG000|Post-consolidation|Adverse Event|0
6875320|NCT00492856|10886228|FG001|Post-consolidation|Adverse Event|4
6875321|NCT00492856|10886229|FG002|Post-consolidation|Adverse Event|0
6875322|NCT00492856|10886230|FG003|Post-consolidation|Adverse Event|1
6875323|NCT00492856|10886227|FG000|Post-consolidation|Withdrawal by Subject|0
6875324|NCT00492856|10886228|FG001|Post-consolidation|Withdrawal by Subject|4
6875325|NCT00492856|10886229|FG002|Post-consolidation|Withdrawal by Subject|0
6875326|NCT00492856|10886230|FG003|Post-consolidation|Withdrawal by Subject|0
6875327|NCT00492856|10886227|FG000|Post-consolidation|Death|0
6875328|NCT00492856|10886228|FG001|Post-consolidation|Death|1
6875329|NCT00492856|10886229|FG002|Post-consolidation|Death|0
6875330|NCT00492856|10886230|FG003|Post-consolidation|Death|0
6875331|NCT00492856|10886227|FG000|Post-consolidation|Not protocol specified|0
6875332|NCT00492856|10886228|FG001|Post-consolidation|Not protocol specified|1
6875333|NCT00492856|10886229|FG002|Post-consolidation|Not protocol specified|0
6875334|NCT00492856|10886230|FG003|Post-consolidation|Not protocol specified|0
6875335|NCT00492856|10886227|FG000|Post-consolidation|Lost to Follow-up|0
6875336|NCT00492856|10886228|FG001|Post-consolidation|Lost to Follow-up|2
6875337|NCT00492856|10886229|FG002|Post-consolidation|Lost to Follow-up|0
6875338|NCT00492856|10886230|FG003|Post-consolidation|Lost to Follow-up|0
6875339|NCT00492856|10886227|FG000|Post-consolidation|Observation Arm|0
6875340|NCT00492856|10886228|FG001|Post-consolidation|Observation Arm|0
6875341|NCT00492856|10886229|FG002|Post-consolidation|Observation Arm|27
6875342|NCT00492856|10886230|FG003|Post-consolidation|Observation Arm|0
6875343|NCT00492921|10886242|FG000|Overall Study|Death|1
6875344|NCT00492921|10886243|FG001|Overall Study|Death|0
6875345|NCT00492921|10886244|FG002|Overall Study|Death|1
6875346|NCT00493012|10886263|FG000|Overall Study|Lost to Follow-up|18
6875347|NCT00493012|10886264|FG001|Overall Study|Lost to Follow-up|17
6875348|NCT00493038|10886272|FG000|Treatment|Adverse Event|8
6875349|NCT00493038|10886273|FG001|Treatment|Adverse Event|4
6875350|NCT00493038|10886272|FG000|Treatment|Lost to Follow-up|5
6875351|NCT00493038|10886273|FG001|Treatment|Lost to Follow-up|3
6875352|NCT00493038|10886272|FG000|Treatment|Withdrawal by Subject|11
6875353|NCT00493038|10886273|FG001|Treatment|Withdrawal by Subject|12
6875354|NCT00493038|10886272|FG000|Treatment|Other|0
6875355|NCT00493038|10886273|FG001|Treatment|Other|1
6875356|NCT00493038|10886272|FG000|Follow-up|Lost to Follow-up|1
6875357|NCT00493038|10886273|FG001|Follow-up|Lost to Follow-up|0
6875358|NCT00493220|10886293|FG000|Third Intervention|Withdrawal by Subject|1
6875359|NCT00493220|10886294|FG001|Third Intervention|Withdrawal by Subject|0
6875360|NCT00493220|10886295|FG002|Third Intervention|Withdrawal by Subject|0
6875361|NCT00493220|10886296|FG003|Third Intervention|Withdrawal by Subject|0
6875362|NCT00493220|10886297|FG004|Third Intervention|Withdrawal by Subject|0
6875363|NCT00493220|10886298|FG005|Third Intervention|Withdrawal by Subject|0
6875364|NCT00493246|10886316|FG000|Overall Study|Withdrawal by Subject|0
6875365|NCT00493246|10886317|FG001|Overall Study|Withdrawal by Subject|0
6875366|NCT00493246|10886318|FG002|Overall Study|Withdrawal by Subject|0
6875367|NCT00493246|10886319|FG003|Overall Study|Withdrawal by Subject|0
6875368|NCT00493246|10886320|FG004|Overall Study|Withdrawal by Subject|1
6875369|NCT00493246|10886321|FG005|Overall Study|Withdrawal by Subject|0
6875370|NCT00493246|10886322|FG006|Overall Study|Withdrawal by Subject|0
6875371|NCT00493246|10886323|FG007|Overall Study|Withdrawal by Subject|0
6875372|NCT00493246|10886316|FG000|Overall Study|No access to draw blood|0
6875373|NCT00493246|10886317|FG001|Overall Study|No access to draw blood|0
6875374|NCT00493246|10886318|FG002|Overall Study|No access to draw blood|0
6875375|NCT00493246|10886319|FG003|Overall Study|No access to draw blood|0
6875376|NCT00493246|10886320|FG004|Overall Study|No access to draw blood|0
6875377|NCT00493246|10886321|FG005|Overall Study|No access to draw blood|1
6875378|NCT00493246|10886322|FG006|Overall Study|No access to draw blood|0
6875379|NCT00493246|10886323|FG007|Overall Study|No access to draw blood|0
6875380|NCT00493246|10886316|FG000|Overall Study|Lost to Follow-up|0
6875381|NCT00493246|10886317|FG001|Overall Study|Lost to Follow-up|0
6875382|NCT00493246|10886318|FG002|Overall Study|Lost to Follow-up|0
6875383|NCT00493246|10886319|FG003|Overall Study|Lost to Follow-up|0
6875384|NCT00493246|10886320|FG004|Overall Study|Lost to Follow-up|0
6875385|NCT00493246|10886321|FG005|Overall Study|Lost to Follow-up|0
6875386|NCT00493246|10886322|FG006|Overall Study|Lost to Follow-up|1
6875387|NCT00493246|10886323|FG007|Overall Study|Lost to Follow-up|0
6875388|NCT00493285|10886347|FG000|Overall Study|Lost to Follow-up|0
6875389|NCT00493285|10886348|FG001|Overall Study|Lost to Follow-up|0
6875390|NCT00493285|10886349|FG002|Overall Study|Lost to Follow-up|0
6875391|NCT00493285|10886350|FG003|Overall Study|Lost to Follow-up|0
6875392|NCT00493285|10886351|FG004|Overall Study|Lost to Follow-up|1
6875393|NCT00493285|10886352|FG005|Overall Study|Lost to Follow-up|0
6875394|NCT00493311|10886368|FG000|Overall Study|Need for rescue medication|2
6875395|NCT00493311|10886369|FG001|Overall Study|Need for rescue medication|2
6875396|NCT00493454|10886375|FG000|Overall Study|Withdrawal by Subject|1
6875397|NCT00493467|10886379|FG000|Overall Study|Death|1
6875398|NCT00493636|10886385|FG000|Overall Study|Withdrawal by Subject|1
6875399|NCT00493636|10886386|FG001|Overall Study|Withdrawal by Subject|0
6875400|NCT00493636|10886385|FG000|Overall Study|Disease progression/recurrence/relapse|0
6875401|NCT00493636|10886386|FG001|Overall Study|Disease progression/recurrence/relapse|1
6875402|NCT00493636|10886385|FG000|Overall Study|Mis-randomization|1
6875403|NCT00493636|10886386|FG001|Overall Study|Mis-randomization|1
6875404|NCT00493649|10886392|FG000|Overall Study|Adverse Event|44
6875405|NCT00493649|10886392|FG000|Overall Study|Patient Request|21
6875406|NCT00493649|10886392|FG000|Overall Study|Investigator Request|2
6875407|NCT00493649|10886392|FG000|Overall Study|Disease Progression|1
6875408|NCT00493649|10886392|FG000|Overall Study|Lost to Follow-up|1
6875409|NCT00493649|10886392|FG000|Overall Study|Other|13
6875410|NCT00493779|10886399|FG000|Overall Study|Logistical issue at site|1
6875411|NCT00493974|10886413|FG000|Overall Study|Death|1
6875412|NCT00493974|10886414|FG001|Overall Study|Death|2
6875413|NCT00493974|10886413|FG000|Overall Study|Withdrawal by Subject|8
6875414|NCT00493974|10886414|FG001|Overall Study|Withdrawal by Subject|6
6875415|NCT00493974|10886413|FG000|Overall Study|Lost to Follow-up|4
6875416|NCT00493974|10886414|FG001|Overall Study|Lost to Follow-up|6
6875417|NCT00494013|10886422|FG000|Overall Study|Adverse Event|0
6875418|NCT00494013|10886423|FG001|Overall Study|Adverse Event|1
6875419|NCT00494013|10886422|FG000|Overall Study|Entry Criteria Not Met|1
6875420|NCT00494013|10886423|FG001|Overall Study|Entry Criteria Not Met|4
6875421|NCT00494013|10886422|FG000|Overall Study|Lost to Follow-up|5
6875422|NCT00494013|10886423|FG001|Overall Study|Lost to Follow-up|6
6875423|NCT00494013|10886422|FG000|Overall Study|Physician Decision|3
6875424|NCT00494013|10886423|FG001|Overall Study|Physician Decision|5
6875425|NCT00494013|10886422|FG000|Overall Study|Protocol Violation|8
6875426|NCT00494013|10886423|FG001|Overall Study|Protocol Violation|5
6875427|NCT00494013|10886422|FG000|Overall Study|Withdrawal by Subject|13
6875428|NCT00494013|10886423|FG001|Overall Study|Withdrawal by Subject|14
6875429|NCT00494013|10886422|FG000|Overall Study|Sponsor Decision|0
6875430|NCT00494013|10886423|FG001|Overall Study|Sponsor Decision|1
6875431|NCT00494026|10886429|FG000|Overall Study|Sponsor Decision|4
6875432|NCT00494091|10886435|FG000|Overall Study|Death|5
6875433|NCT00494091|10886436|FG001|Overall Study|Death|54
6875434|NCT00494091|10886435|FG000|Overall Study|Lost to Follow-up|0
6875435|NCT00494091|10886436|FG001|Overall Study|Lost to Follow-up|4
6875436|NCT00494091|10886435|FG000|Overall Study|Other|1
6875437|NCT00494091|10886436|FG001|Overall Study|Other|11
6875438|NCT00494091|10886435|FG000|Overall Study|Withdrawal by Subject|0
6875439|NCT00494091|10886436|FG001|Overall Study|Withdrawal by Subject|7
6875440|NCT00494221|10886463|FG000|Overall Study|Death|15
6875441|NCT00494221|10886464|FG001|Overall Study|Death|9
6875442|NCT00494221|10886465|FG002|Overall Study|Death|14
6875443|NCT00494221|10886463|FG000|Overall Study|Withdrawal by Subject|1
6875444|NCT00494221|10886464|FG001|Overall Study|Withdrawal by Subject|2
6875445|NCT00494221|10886465|FG002|Overall Study|Withdrawal by Subject|0
6875446|NCT00494299|10886475|FG000|Overall Study|Adverse Event|93
6875447|NCT00494299|10886476|FG001|Overall Study|Adverse Event|13
6875448|NCT00494299|10886475|FG000|Overall Study|Lost to Follow-up|1
6875449|NCT00494299|10886476|FG001|Overall Study|Lost to Follow-up|0
6875450|NCT00494299|10886475|FG000|Overall Study|Physician Decision|0
6875451|NCT00494299|10886476|FG001|Overall Study|Physician Decision|2
6875452|NCT00494299|10886475|FG000|Overall Study|Protocol Violation|1
6875453|NCT00494299|10886476|FG001|Overall Study|Protocol Violation|2
6875454|NCT00494299|10886475|FG000|Overall Study|Withdrawal by Subject|8
6875455|NCT00494299|10886476|FG001|Overall Study|Withdrawal by Subject|3
6875456|NCT00494299|10886475|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109
6875457|NCT00494299|10886476|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185
6875458|NCT00494299|10886475|FG000|Overall Study|Participant Did Not Take Study Drug|0
6875459|NCT00494299|10886476|FG001|Overall Study|Participant Did Not Take Study Drug|2
6875460|NCT00494299|10886475|FG000|Overall Study|Site Closed by Sponsor|6
6875461|NCT00494299|10886476|FG001|Overall Study|Site Closed by Sponsor|0
6875462|NCT00494299|10886475|FG000|Overall Study|Protocol Driven Decision Point|11
6875463|NCT00494299|10886476|FG001|Overall Study|Protocol Driven Decision Point|22
6875464|NCT00494442|10886484|FG000|Overall Study|Death|1
6875465|NCT00494442|10886485|FG001|Overall Study|Death|1
6875466|NCT00494442|10886484|FG000|Overall Study|Lack of Efficacy|16
6875467|NCT00494442|10886485|FG001|Overall Study|Lack of Efficacy|10
6875468|NCT00494442|10886484|FG000|Overall Study|Adverse Event|0
6875469|NCT00494442|10886485|FG001|Overall Study|Adverse Event|2
6875470|NCT00494442|10886484|FG000|Overall Study|Physician Decision|0
6875471|NCT00494442|10886485|FG001|Overall Study|Physician Decision|1
6875472|NCT00494442|10886484|FG000|Overall Study|Non-compliance|0
6875473|NCT00494442|10886485|FG001|Overall Study|Non-compliance|1
6875474|NCT00494442|10886484|FG000|Overall Study|Intercurrent illness|0
6875475|NCT00494442|10886485|FG001|Overall Study|Intercurrent illness|1
6875476|NCT00494481|10886493|FG000|Overall Study|Condition under investigation worsened|11
6875477|NCT00494481|10886494|FG001|Overall Study|Condition under investigation worsened|13
6875478|NCT00494481|10886493|FG000|Overall Study|Adverse Event|15
6875479|NCT00494481|10886494|FG001|Overall Study|Adverse Event|11
6875480|NCT00494481|10886493|FG000|Overall Study|Other|1
6875481|NCT00494481|10886494|FG001|Overall Study|Other|0
6875482|NCT00494481|10886493|FG000|Overall Study|Never received IP|2
6875483|NCT00494481|10886494|FG001|Overall Study|Never received IP|0
6875484|NCT00494507|10886513|FG000|Double-Blind Phase|Adverse Event|2
6875485|NCT00494507|10886514|FG001|Double-Blind Phase|Adverse Event|0
6875486|NCT00494507|10886515|FG002|Double-Blind Phase|Adverse Event|1
6875487|NCT00494507|10886516|FG003|Double-Blind Phase|Adverse Event|0
6875488|NCT00494507|10886513|FG000|Double-Blind Phase|Withdrawal by Subject|1
6875489|NCT00494507|10886514|FG001|Double-Blind Phase|Withdrawal by Subject|0
6875490|NCT00494507|10886515|FG002|Double-Blind Phase|Withdrawal by Subject|0
6875491|NCT00494507|10886516|FG003|Double-Blind Phase|Withdrawal by Subject|0
6875492|NCT00494507|10886513|FG000|Double-Blind Phase|Subject Non-compliance|0
6875493|NCT00494507|10886514|FG001|Double-Blind Phase|Subject Non-compliance|0
6875494|NCT00494507|10886515|FG002|Double-Blind Phase|Subject Non-compliance|1
6875495|NCT00494507|10886516|FG003|Double-Blind Phase|Subject Non-compliance|0
6875496|NCT00494507|10886513|FG000|Double-Blind Phase|Negative DNA test|0
6875497|NCT00494507|10886514|FG001|Double-Blind Phase|Negative DNA test|0
6875498|NCT00494507|10886515|FG002|Double-Blind Phase|Negative DNA test|0
6875499|NCT00494507|10886516|FG003|Double-Blind Phase|Negative DNA test|1
6875500|NCT00494507|10886513|FG000|Open-Label Phase|Adverse Event|0
6875501|NCT00494507|10886514|FG001|Open-Label Phase|Adverse Event|1
6875502|NCT00494507|10886515|FG002|Open-Label Phase|Adverse Event|5
6875503|NCT00494507|10886516|FG003|Open-Label Phase|Adverse Event|3
6875504|NCT00494507|10886513|FG000|Open-Label Phase|Worsening Disease|0
6875505|NCT00494507|10886514|FG001|Open-Label Phase|Worsening Disease|0
6875506|NCT00494507|10886515|FG002|Open-Label Phase|Worsening Disease|0
6875507|NCT00494507|10886516|FG003|Open-Label Phase|Worsening Disease|2
6968941|NCT01144364|11018314|FG002|Induction Phase|Secondary neoplasia|0
6968942|NCT01144364|11018312|FG000|Induction Phase|Protocol Violation|1
6968943|NCT01144364|11018313|FG001|Induction Phase|Protocol Violation|0
6968944|NCT01144364|11018314|FG002|Induction Phase|Protocol Violation|0
6968945|NCT01144364|11018312|FG000|Follow-Up/Maintenance Phase|Disease progression|0
7078588|NCT02105688|11187266|FG001|Part A: Double-Blind|Withdrawal by Subject|2
7078589|NCT02105688|11187265|FG000|Part B: Observational Follow-up|Death|2
7078590|NCT02105688|11187266|FG001|Part B: Observational Follow-up|Death|1
7078591|NCT02105688|11187265|FG000|Part B: Observational Follow-up|Lost to Follow-up|23
7154382|NCT03310021|11321045|FG005|Overall Study|Lost to Follow-up|0
7154383|NCT03310021|11321046|FG006|Overall Study|Lost to Follow-up|0
7154384|NCT03310021|11321047|FG007|Overall Study|Lost to Follow-up|0
7154385|NCT03310021|11321048|FG008|Overall Study|Lost to Follow-up|0
7154386|NCT03310021|11321049|FG009|Overall Study|Lost to Follow-up|0
7078592|NCT02105688|11187266|FG001|Part B: Observational Follow-up|Lost to Follow-up|15
7078593|NCT02105688|11187265|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9
7078594|NCT02105688|11187266|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3
7078595|NCT02105688|11187265|FG000|Part B: Observational Follow-up|Physician Decision|3
7078596|NCT02105688|11187266|FG001|Part B: Observational Follow-up|Physician Decision|1
7078597|NCT02105701|11187277|FG000|Overall Study|Lost to Follow-up|1
7078598|NCT02105701|11187278|FG001|Overall Study|Lost to Follow-up|0
7154387|NCT03310021|11321050|FG010|Overall Study|Lost to Follow-up|1
7154388|NCT03310021|11321051|FG011|Overall Study|Lost to Follow-up|0
7154389|NCT03310021|11321052|FG012|Overall Study|Lost to Follow-up|0
6968946|NCT01144364|11018313|FG001|Follow-Up/Maintenance Phase|Disease progression|23
6968947|NCT01144364|11018314|FG002|Follow-Up/Maintenance Phase|Disease progression|29
6968948|NCT01144364|11018312|FG000|Follow-Up/Maintenance Phase|Adverse Event|0
6968949|NCT01144364|11018313|FG001|Follow-Up/Maintenance Phase|Adverse Event|3
6968950|NCT01144364|11018314|FG002|Follow-Up/Maintenance Phase|Adverse Event|1
6968951|NCT01144364|11018312|FG000|Follow-Up/Maintenance Phase|Death|0
6968952|NCT01144364|11018313|FG001|Follow-Up/Maintenance Phase|Death|2
6968953|NCT01144364|11018314|FG002|Follow-Up/Maintenance Phase|Death|0
7078599|NCT02105701|11187279|FG002|Overall Study|Lost to Follow-up|2
7078600|NCT02105701|11187280|FG003|Overall Study|Lost to Follow-up|1
7078601|NCT02105701|11187277|FG000|Overall Study|Protocol Violation|0
7078602|NCT02105701|11187278|FG001|Overall Study|Protocol Violation|0
7078603|NCT02105701|11187279|FG002|Overall Study|Protocol Violation|1
7078604|NCT02105701|11187280|FG003|Overall Study|Protocol Violation|0
7078605|NCT02105701|11187277|FG000|Overall Study|Withdrawal by Subject|2
7078606|NCT02105701|11187278|FG001|Overall Study|Withdrawal by Subject|1
7078607|NCT02105701|11187279|FG002|Overall Study|Withdrawal by Subject|0
7078608|NCT02105701|11187280|FG003|Overall Study|Withdrawal by Subject|1
7078609|NCT02105701|11187277|FG000|Overall Study|Death|1
7078610|NCT02105701|11187278|FG001|Overall Study|Death|0
7078611|NCT02105701|11187279|FG002|Overall Study|Death|0
7078612|NCT02105701|11187280|FG003|Overall Study|Death|0
7078613|NCT02105948|11187305|FG000|Overall Study|Adverse Event|10
7078614|NCT02105948|11187306|FG001|Overall Study|Adverse Event|7
7078615|NCT02105948|11187307|FG002|Overall Study|Adverse Event|11
7078616|NCT02105948|11187308|FG003|Overall Study|Adverse Event|11
7078617|NCT02105948|11187305|FG000|Overall Study|Lack of Efficacy|0
7078618|NCT02105948|11187306|FG001|Overall Study|Lack of Efficacy|1
7078619|NCT02105948|11187307|FG002|Overall Study|Lack of Efficacy|3
7078620|NCT02105948|11187308|FG003|Overall Study|Lack of Efficacy|2
7078621|NCT02105948|11187305|FG000|Overall Study|Lost to Follow-up|0
7078622|NCT02105948|11187306|FG001|Overall Study|Lost to Follow-up|0
7078623|NCT02105948|11187307|FG002|Overall Study|Lost to Follow-up|2
7078624|NCT02105948|11187308|FG003|Overall Study|Lost to Follow-up|1
7078625|NCT02105948|11187305|FG000|Overall Study|Physician Decision|2
7078626|NCT02105948|11187306|FG001|Overall Study|Physician Decision|2
7078627|NCT02105948|11187307|FG002|Overall Study|Physician Decision|2
7078628|NCT02105948|11187308|FG003|Overall Study|Physician Decision|2
7078629|NCT02105948|11187305|FG000|Overall Study|Withdrawal by Subject|15
7078630|NCT02105948|11187306|FG001|Overall Study|Withdrawal by Subject|10
7078631|NCT02105948|11187307|FG002|Overall Study|Withdrawal by Subject|10
7078632|NCT02105948|11187308|FG003|Overall Study|Withdrawal by Subject|11
7078633|NCT02105961|11187322|FG000|Overall Study|Adverse Event|18
7078634|NCT02105961|11187323|FG001|Overall Study|Adverse Event|7
7078635|NCT02105961|11187324|FG002|Overall Study|Adverse Event|13
7078636|NCT02105961|11187322|FG000|Overall Study|Lack of Efficacy|3
7078637|NCT02105961|11187323|FG001|Overall Study|Lack of Efficacy|0
7078638|NCT02105961|11187324|FG002|Overall Study|Lack of Efficacy|3
7078639|NCT02105961|11187322|FG000|Overall Study|Lost to Follow-up|2
7078640|NCT02105961|11187323|FG001|Overall Study|Lost to Follow-up|0
7078641|NCT02105961|11187324|FG002|Overall Study|Lost to Follow-up|1
7078642|NCT02105961|11187322|FG000|Overall Study|Physician Decision|3
7078643|NCT02105961|11187323|FG001|Overall Study|Physician Decision|3
7078644|NCT02105961|11187324|FG002|Overall Study|Physician Decision|2
7078645|NCT02105961|11187322|FG000|Overall Study|Withdrawal by Subject|15
7078646|NCT02105961|11187323|FG001|Overall Study|Withdrawal by Subject|7
7078647|NCT02105961|11187324|FG002|Overall Study|Withdrawal by Subject|11
7078648|NCT02105974|11187335|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158
7078649|NCT02105974|11187336|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0
7078650|NCT02105974|11187337|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0
7078651|NCT02105974|11187335|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603
7078652|NCT02105974|11187336|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
7078653|NCT02105974|11187337|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
7078654|NCT02105974|11187335|FG000|2 Week Run-in Period|Adverse Event|6
7078655|NCT02105974|11187336|FG001|2 Week Run-in Period|Adverse Event|0
7078656|NCT02105974|11187337|FG002|2 Week Run-in Period|Adverse Event|0
7078657|NCT02105974|11187335|FG000|2 Week Run-in Period|Study closed/terminated|1
7078658|NCT02105974|11187336|FG001|2 Week Run-in Period|Study closed/terminated|0
7078659|NCT02105974|11187337|FG002|2 Week Run-in Period|Study closed/terminated|0
7078660|NCT02105974|11187335|FG000|2 Week Run-in Period|Lost to Follow-up|2
7078661|NCT02105974|11187336|FG001|2 Week Run-in Period|Lost to Follow-up|0
7078662|NCT02105974|11187337|FG002|2 Week Run-in Period|Lost to Follow-up|0
7078663|NCT02105974|11187335|FG000|2 Week Run-in Period|Withdrew consent|23
7078664|NCT02105974|11187336|FG001|2 Week Run-in Period|Withdrew consent|0
7078665|NCT02105974|11187337|FG002|2 Week Run-in Period|Withdrew consent|0
7078666|NCT02105974|11187335|FG000|2 Week Run-in Period|Investigator discretion|8
7078667|NCT02105974|11187336|FG001|2 Week Run-in Period|Investigator discretion|0
7078668|NCT02105974|11187337|FG002|2 Week Run-in Period|Investigator discretion|0
7078669|NCT02105974|11187335|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0
7078670|NCT02105974|11187336|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14
7078671|NCT02105974|11187337|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18
6875508|NCT00494676|10886540|FG000|Allocation|Withdrawal by Subject|2
6976947|NCT01203072|11029844|FG004|Overall Study|Lack of Efficacy|0
7078672|NCT02105974|11187335|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0
7078673|NCT02105974|11187336|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6
7078674|NCT02105974|11187337|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9
7078675|NCT02105974|11187335|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0
7078676|NCT02105974|11187336|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2
7078677|NCT02105974|11187337|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6
6875509|NCT00494676|10886541|FG001|Allocation|Withdrawal by Subject|4
6875510|NCT00494676|10886540|FG000|First Intervention|Withdrawal by Subject|1
6875511|NCT00494676|10886541|FG001|First Intervention|Withdrawal by Subject|3
6875512|NCT00494676|10886540|FG000|Second Intervention|Withdrawal by Subject|1
6875513|NCT00494676|10886541|FG001|Second Intervention|Withdrawal by Subject|1
6875514|NCT00494780|10886549|FG000|Overall Study|Adverse Event|1
6875515|NCT00494780|10886550|FG001|Overall Study|Adverse Event|0
6875516|NCT00494780|10886549|FG000|Overall Study|Withdrew before Dosed|0
6875517|NCT00494780|10886550|FG001|Overall Study|Withdrew before Dosed|1
6875518|NCT00494780|10886549|FG000|Overall Study|Progression of Study Disease|7
6875519|NCT00494780|10886550|FG001|Overall Study|Progression of Study Disease|8
6875520|NCT00494780|10886549|FG000|Overall Study|New Treatment|2
6875521|NCT00494780|10886550|FG001|Overall Study|New Treatment|2
6875522|NCT00494780|10886549|FG000|Overall Study|Non-compliance|1
6875523|NCT00494780|10886550|FG001|Overall Study|Non-compliance|0
6875524|NCT00494780|10886549|FG000|Overall Study|Residual Tumour Mass|0
6875525|NCT00494780|10886550|FG001|Overall Study|Residual Tumour Mass|1
6875526|NCT00494780|10886549|FG000|Overall Study|Insurance Issues|0
6875527|NCT00494780|10886550|FG001|Overall Study|Insurance Issues|1
6875528|NCT00494871|10886569|FG000|Double-blind (DB) Treatment Period|Adverse Event|73
6875529|NCT00494871|10886570|FG001|Double-blind (DB) Treatment Period|Adverse Event|70
6875530|NCT00494871|10886569|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26
6875531|NCT00494871|10886570|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35
6875532|NCT00494871|10886569|FG000|Double-blind (DB) Treatment Period|Death|8
6875533|NCT00494871|10886570|FG001|Double-blind (DB) Treatment Period|Death|3
6875534|NCT00494871|10886569|FG000|Double-blind (DB) Treatment Period|Physician Decision|4
6875535|NCT00494871|10886570|FG001|Double-blind (DB) Treatment Period|Physician Decision|13
6875536|NCT00494871|10886569|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4
6875537|NCT00494871|10886570|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1
6875538|NCT00494871|10886569|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9
6875539|NCT00494871|10886570|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9
6875540|NCT00494871|10886569|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18
6875541|NCT00494871|10886570|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28
6875542|NCT00494871|10886569|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3
6875543|NCT00494871|10886570|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1
6875544|NCT00494871|10886569|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12
6875545|NCT00494871|10886570|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8
6875546|NCT00494871|10886569|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1
6875547|NCT00494871|10886570|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2
6875548|NCT00494871|10886569|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
6875549|NCT00494871|10886570|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
6875550|NCT00494871|10886569|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
6875551|NCT00494871|10886570|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
6875552|NCT00494871|10886569|FG000|Follow-up (FU) Period|Adverse Event|1
6875553|NCT00494871|10886570|FG001|Follow-up (FU) Period|Adverse Event|1
6875554|NCT00494871|10886569|FG000|Follow-up (FU) Period|Death|13
6875555|NCT00494871|10886570|FG001|Follow-up (FU) Period|Death|12
6875556|NCT00494871|10886569|FG000|Follow-up (FU) Period|Lost to Follow-up|6
6875557|NCT00494871|10886570|FG001|Follow-up (FU) Period|Lost to Follow-up|2
6875558|NCT00494871|10886569|FG000|Follow-up (FU) Period|Physician Decision|0
6875559|NCT00494871|10886570|FG001|Follow-up (FU) Period|Physician Decision|1
6875560|NCT00494871|10886569|FG000|Follow-up (FU) Period|Protocol Violation|1
6875561|NCT00494871|10886570|FG001|Follow-up (FU) Period|Protocol Violation|0
6875562|NCT00494871|10886569|FG000|Follow-up (FU) Period|Withdrawal by Subject|5
6875563|NCT00494871|10886570|FG001|Follow-up (FU) Period|Withdrawal by Subject|5
6875564|NCT00494871|10886569|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3
6875565|NCT00494871|10886570|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2
6875566|NCT00495040|10886587|FG000|Overall Study|Withdrawal by Subject|3
6875567|NCT00495170|10886611|FG000|Overall Study|Lost to Follow-up|9
6875568|NCT00495170|10886611|FG000|Overall Study|Withdrawal by Subject|3
6875569|NCT00495170|10886611|FG000|Overall Study|Inappropriate staging|8
6875570|NCT00495391|10886617|FG000|Overall Study|Lack of Efficacy|34
6875571|NCT00495391|10886618|FG001|Overall Study|Lack of Efficacy|18
6875572|NCT00495391|10886617|FG000|Overall Study|Withdrawal by Subject|2
6875573|NCT00495391|10886618|FG001|Overall Study|Withdrawal by Subject|3
6875574|NCT00495469|10886631|FG000|Overall Study|Adverse Event|0
6875575|NCT00495469|10886632|FG001|Overall Study|Adverse Event|1
6875576|NCT00495469|10886633|FG002|Overall Study|Adverse Event|3
6875577|NCT00495469|10886634|FG003|Overall Study|Adverse Event|0
6875578|NCT00495469|10886635|FG004|Overall Study|Adverse Event|1
6875579|NCT00495469|10886636|FG005|Overall Study|Adverse Event|1
6875580|NCT00495469|10886637|FG006|Overall Study|Adverse Event|1
6875581|NCT00495469|10886631|FG000|Overall Study|Lost to Follow-up|1
6875582|NCT00495469|10886632|FG001|Overall Study|Lost to Follow-up|1
6875583|NCT00495469|10886633|FG002|Overall Study|Lost to Follow-up|3
6875584|NCT00495469|10886634|FG003|Overall Study|Lost to Follow-up|1
6875585|NCT00495469|10886635|FG004|Overall Study|Lost to Follow-up|0
6875586|NCT00495469|10886636|FG005|Overall Study|Lost to Follow-up|0
6875587|NCT00495469|10886637|FG006|Overall Study|Lost to Follow-up|0
6875588|NCT00495469|10886631|FG000|Overall Study|Protocol Violation|0
6875589|NCT00495469|10886632|FG001|Overall Study|Protocol Violation|0
6875590|NCT00495469|10886633|FG002|Overall Study|Protocol Violation|0
6875591|NCT00495469|10886634|FG003|Overall Study|Protocol Violation|0
7078678|NCT02105974|11187335|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0
7078679|NCT02105974|11187336|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1
7078680|NCT02105974|11187337|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2
7078681|NCT02105974|11187335|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
7078682|NCT02105974|11187336|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
7078683|NCT02105974|11187337|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1
7078684|NCT02105974|11187335|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0
7078685|NCT02105974|11187336|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7
7078686|NCT02105974|11187337|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4
7078687|NCT02105974|11187335|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0
7078688|NCT02105974|11187336|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12
7078689|NCT02105974|11187337|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18
7078690|NCT02105987|11187345|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10
7078691|NCT02105987|11187346|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0
7078692|NCT02105987|11187347|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0
7078693|NCT02105987|11187348|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0
7078694|NCT02105987|11187349|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0
7078695|NCT02105987|11187350|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0
7078696|NCT02105987|11187345|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15
7078697|NCT02105987|11187346|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17
7078698|NCT02105987|11187347|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0
7078699|NCT02105987|11187348|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0
7154390|NCT03310021|11321053|FG013|Overall Study|Lost to Follow-up|0
7154391|NCT03310021|11321054|FG014|Overall Study|Lost to Follow-up|0
7154392|NCT03310021|11321055|FG015|Overall Study|Lost to Follow-up|0
7154393|NCT03310021|11321056|FG016|Overall Study|Lost to Follow-up|0
7154394|NCT03310021|11321057|FG017|Overall Study|Lost to Follow-up|0
7154395|NCT03310021|11321058|FG018|Overall Study|Lost to Follow-up|0
6875592|NCT00495469|10886635|FG004|Overall Study|Protocol Violation|1
6875593|NCT00495469|10886636|FG005|Overall Study|Protocol Violation|2
6875594|NCT00495469|10886637|FG006|Overall Study|Protocol Violation|0
6875595|NCT00495469|10886631|FG000|Overall Study|Withdrawal by Subject|5
6875596|NCT00495469|10886632|FG001|Overall Study|Withdrawal by Subject|3
6875597|NCT00495469|10886633|FG002|Overall Study|Withdrawal by Subject|1
6875598|NCT00495469|10886634|FG003|Overall Study|Withdrawal by Subject|3
6875599|NCT00495469|10886635|FG004|Overall Study|Withdrawal by Subject|3
6875600|NCT00495469|10886636|FG005|Overall Study|Withdrawal by Subject|2
6875601|NCT00495469|10886637|FG006|Overall Study|Withdrawal by Subject|3
6875602|NCT00495469|10886631|FG000|Overall Study|Lack of Efficacy|0
6875603|NCT00495469|10886632|FG001|Overall Study|Lack of Efficacy|0
6875604|NCT00495469|10886633|FG002|Overall Study|Lack of Efficacy|0
6875605|NCT00495469|10886634|FG003|Overall Study|Lack of Efficacy|0
6875606|NCT00495469|10886635|FG004|Overall Study|Lack of Efficacy|0
6875607|NCT00495469|10886636|FG005|Overall Study|Lack of Efficacy|0
6875608|NCT00495469|10886637|FG006|Overall Study|Lack of Efficacy|1
6875609|NCT00495469|10886631|FG000|Overall Study|Liver function test abnormality|0
6875610|NCT00495469|10886632|FG001|Overall Study|Liver function test abnormality|1
6875611|NCT00495469|10886633|FG002|Overall Study|Liver function test abnormality|0
6875612|NCT00495469|10886634|FG003|Overall Study|Liver function test abnormality|0
6875613|NCT00495469|10886635|FG004|Overall Study|Liver function test abnormality|0
6875614|NCT00495469|10886636|FG005|Overall Study|Liver function test abnormality|0
6875615|NCT00495469|10886637|FG006|Overall Study|Liver function test abnormality|0
6875616|NCT00495469|10886631|FG000|Overall Study|ST depression at randomisation in ECG|0
6875617|NCT00495469|10886632|FG001|Overall Study|ST depression at randomisation in ECG|1
6875618|NCT00495469|10886633|FG002|Overall Study|ST depression at randomisation in ECG|0
6875619|NCT00495469|10886634|FG003|Overall Study|ST depression at randomisation in ECG|0
6875620|NCT00495469|10886635|FG004|Overall Study|ST depression at randomisation in ECG|0
6875621|NCT00495469|10886636|FG005|Overall Study|ST depression at randomisation in ECG|0
6875622|NCT00495469|10886637|FG006|Overall Study|ST depression at randomisation in ECG|0
6875623|NCT00495495|10886660|FG000|Overall Study|Protocol Violation|99
6875624|NCT00495521|10886667|FG000|Overall Study|Physician Decision|0
6875625|NCT00495521|10886668|FG001|Overall Study|Physician Decision|1
6875626|NCT00495586|10886676|FG000|Overall Study|Withdrawal by Subject|4
6875627|NCT00495586|10886677|FG001|Overall Study|Withdrawal by Subject|4
6875628|NCT00495612|10886687|FG000|Overall Study|Lost to Follow-up|1
6875629|NCT00495612|10886688|FG001|Overall Study|Lost to Follow-up|0
6875630|NCT00495612|10886687|FG000|Overall Study|Subject's Decision to Withdraw|3
6875631|NCT00495612|10886688|FG001|Overall Study|Subject's Decision to Withdraw|0
6875632|NCT00495625|10886694|FG000|Overall Study|Did not complete at least 1 42 day cycle|10
6875633|NCT00495677|10886705|FG000|Stage 1 (25 Days)|Adverse Event|0
6875634|NCT00495677|10886706|FG001|Stage 1 (25 Days)|Adverse Event|0
6875635|NCT00495677|10886707|FG002|Stage 1 (25 Days)|Adverse Event|1
6875636|NCT00495677|10886708|FG003|Stage 1 (25 Days)|Adverse Event|0
6875637|NCT00495677|10886709|FG004|Stage 1 (25 Days)|Adverse Event|0
6875638|NCT00495677|10886710|FG005|Stage 1 (25 Days)|Adverse Event|0
6875639|NCT00495677|10886711|FG006|Stage 1 (25 Days)|Adverse Event|0
6875640|NCT00495755|10886727|FG000|Overall Study|Adverse Event|3
6875641|NCT00495794|10886734|FG000|Overall Study|Pharmacist did not activate patient|522
6875642|NCT00495794|10886735|FG001|Overall Study|Pharmacist did not activate patient|0
6875643|NCT00495820|10886743|FG000|Overall Study|Adverse Event|1
6875644|NCT00495820|10886744|FG001|Overall Study|Adverse Event|1
6875645|NCT00496015|10886755|FG000|Overall Study|Other|1
6875646|NCT00496015|10886756|FG001|Overall Study|Other|0
6875647|NCT00496015|10886757|FG002|Overall Study|Other|0
6875648|NCT00496015|10886758|FG003|Overall Study|Other|1
6875649|NCT00496015|10886759|FG004|Overall Study|Other|0
6875650|NCT00496054|10886779|FG000|Overall Study|Adverse Event|1
6875651|NCT00496054|10886779|FG000|Overall Study|Lost to Follow-up|7
6875652|NCT00496080|10886783|FG000|Overall Study|Lost to Follow-up|9
6875653|NCT00496080|10886783|FG000|Overall Study|Surgical re-intervention|7
6875654|NCT00496080|10886783|FG000|Overall Study|Withdrawal by Subject|5
6875655|NCT00496080|10886783|FG000|Overall Study|Physician Decision|6
6875656|NCT00496197|10886788|FG000|Overall Study|Discontinued study due to death|43
6875657|NCT00496197|10886788|FG000|Overall Study|Adverse Event|13
6875658|NCT00496197|10886788|FG000|Overall Study|Does not meet entrance criteria|5
6875659|NCT00496197|10886788|FG000|Overall Study|Insufficient clinical response|3
6875660|NCT00496197|10886788|FG000|Overall Study|Insufficient bacteriological response|10
6875661|NCT00496197|10886788|FG000|Overall Study|Lost to Follow-up|11
6875662|NCT00496197|10886788|FG000|Overall Study|Withdrawal by Subject|11
6875663|NCT00496197|10886788|FG000|Overall Study|Pathogen not isolated baseline specimen|4
6875664|NCT00496197|10886788|FG000|Overall Study|Other|14
6875665|NCT00496197|10886788|FG000|Overall Study|Protocol Violation|8
6875666|NCT00496366|10886802|FG000|Overall Study|Death|1
6875667|NCT00496470|10886812|FG000|Overall Study|Adverse Event|8
6875668|NCT00496470|10886813|FG001|Overall Study|Adverse Event|10
6875669|NCT00496470|10886812|FG000|Overall Study|Withdrawal by Subject|5
6875670|NCT00496470|10886813|FG001|Overall Study|Withdrawal by Subject|12
6875671|NCT00496470|10886812|FG000|Overall Study|Incorrectly enrolled|13
6875672|NCT00496470|10886813|FG001|Overall Study|Incorrectly enrolled|5
6875673|NCT00496470|10886812|FG000|Overall Study|Other reason|0
6875674|NCT00496470|10886813|FG001|Overall Study|Other reason|2
6875675|NCT00496483|10886819|FG000|Overall Study|Not dosed|9
6875676|NCT00496483|10886819|FG000|Overall Study|Adverse Event|2
6875677|NCT00496483|10886819|FG000|Overall Study|Lack of Efficacy|1
6875678|NCT00496587|10886826|FG000|Overall Study|Adverse Event|2
6875679|NCT00496587|10886826|FG000|Overall Study|Progressive Disease|24
6875680|NCT00496587|10886826|FG000|Overall Study|Withdrawal by Subject|2
6875681|NCT00496587|10886826|FG000|Overall Study|Death|1
6875682|NCT00496587|10886826|FG000|Overall Study|Complications unrelated|2
6875683|NCT00496626|10886832|FG000|Overall Study|Lost to Follow-up|0
6875684|NCT00496626|10886833|FG001|Overall Study|Lost to Follow-up|1
6875685|NCT00496626|10886832|FG000|Overall Study|Protocol Violation|1
6875686|NCT00496626|10886833|FG001|Overall Study|Protocol Violation|0
6875687|NCT00496626|10886832|FG000|Overall Study|Withdrawal by Subject|5
6875688|NCT00496626|10886833|FG001|Overall Study|Withdrawal by Subject|4
6875689|NCT00496626|10886832|FG000|Overall Study|Relocated|0
6875690|NCT00496626|10886833|FG001|Overall Study|Relocated|1
6875691|NCT00496769|10886845|FG000|Double Blind|>=1 reason assigned per patient|558
6875692|NCT00496769|10886846|FG001|Double Blind|>=1 reason assigned per patient|649
6875693|NCT00496769|10886847|FG002|Double Blind|>=1 reason assigned per patient|0
6875694|NCT00496769|10886845|FG000|Open Label|>=1 reason assigned per patient|0
6875695|NCT00496769|10886846|FG001|Open Label|>=1 reason assigned per patient|0
6875696|NCT00496769|10886847|FG002|Open Label|>=1 reason assigned per patient|1011
6875697|NCT00496873|10886873|FG000|Overall Study|Ineligible|2
6875698|NCT00496873|10886873|FG000|Overall Study|Death|2
6875699|NCT00496873|10886873|FG000|Overall Study|Withdrawal by Subject|3
6875700|NCT00496964|10886879|FG000|Overall Study|Withdrawal by Subject|0
6875701|NCT00496964|10886880|FG001|Overall Study|Withdrawal by Subject|1
6875702|NCT00497146|10886908|FG000|Treatment Period|Adverse Event|6
6875703|NCT00497146|10886909|FG001|Treatment Period|Adverse Event|2
6875704|NCT00497146|10886908|FG000|Treatment Period|Withdrawal by Subject|5
6875705|NCT00497146|10886909|FG001|Treatment Period|Withdrawal by Subject|9
6875706|NCT00497146|10886908|FG000|Treatment Period|Lost to Follow-up|1
6875707|NCT00497146|10886909|FG001|Treatment Period|Lost to Follow-up|3
6875708|NCT00497146|10886908|FG000|Treatment Period|Required dialysis|4
6875709|NCT00497146|10886909|FG001|Treatment Period|Required dialysis|1
6875710|NCT00497146|10886908|FG000|Treatment Period|Change in RAAS inhibitor therapy|5
6875711|NCT00497146|10886909|FG001|Treatment Period|Change in RAAS inhibitor therapy|2
6875712|NCT00497146|10886908|FG000|Treatment Period|Unable to dose reduce per protocol|4
6875713|NCT00497146|10886909|FG001|Treatment Period|Unable to dose reduce per protocol|1
6875714|NCT00497146|10886908|FG000|Treatment Period|Other Reason|2
6875715|NCT00497146|10886909|FG001|Treatment Period|Other Reason|3
6875716|NCT00497146|10886908|FG000|Long-term Follow-up Period|Adverse Event|2
6875717|NCT00497146|10886909|FG001|Long-term Follow-up Period|Adverse Event|2
6875718|NCT00497146|10886908|FG000|Long-term Follow-up Period|Withdrawal by Subject|8
6875719|NCT00497146|10886909|FG001|Long-term Follow-up Period|Withdrawal by Subject|2
6875720|NCT00497146|10886908|FG000|Long-term Follow-up Period|Lost to Follow-up|5
6875721|NCT00497146|10886909|FG001|Long-term Follow-up Period|Lost to Follow-up|1
6875722|NCT00497146|10886908|FG000|Long-term Follow-up Period|Other|0
6875723|NCT00497146|10886909|FG001|Long-term Follow-up Period|Other|1
6875724|NCT00497198|10886919|FG000|Overall Study|Adverse Event|4
6875725|NCT00497198|10886920|FG001|Overall Study|Adverse Event|2
6875726|NCT00497198|10886919|FG000|Overall Study|Physician Decision|1
6875727|NCT00497198|10886920|FG001|Overall Study|Physician Decision|2
6875728|NCT00497198|10886919|FG000|Overall Study|Withdrawal by Subject|0
6875729|NCT00497198|10886920|FG001|Overall Study|Withdrawal by Subject|1
6875730|NCT00497796|10886957|FG000|Overall Study|Adverse event (not related)|9
6875731|NCT00497796|10886958|FG001|Overall Study|Adverse event (not related)|9
6875732|NCT00497796|10886957|FG000|Overall Study|Adverse event (related)|5
6875733|NCT00497796|10886958|FG001|Overall Study|Adverse event (related)|4
6875734|NCT00497796|10886957|FG000|Overall Study|CMV infection or disease treatment|30
6875735|NCT00497796|10886958|FG001|Overall Study|CMV infection or disease treatment|4
6875736|NCT00497796|10886957|FG000|Overall Study|Consent withdrawn|10
6875737|NCT00497796|10886958|FG001|Overall Study|Consent withdrawn|3
6875738|NCT00497796|10886957|FG000|Overall Study|Investigator/sponsor discretion|31
6875739|NCT00497796|10886958|FG001|Overall Study|Investigator/sponsor discretion|34
6875740|NCT00497796|10886957|FG000|Overall Study|Lost to Follow-up|0
6875741|NCT00497796|10886958|FG001|Overall Study|Lost to Follow-up|1
6875742|NCT00497796|10886957|FG000|Overall Study|Not applicable (randomized not treated)|0
6875743|NCT00497796|10886958|FG001|Overall Study|Not applicable (randomized not treated)|4
6875744|NCT00497874|10886966|FG000|Overall Study|Withdrawal by Subject|48
6875745|NCT00497874|10886967|FG001|Overall Study|Withdrawal by Subject|17
6875746|NCT00497874|10886966|FG000|Overall Study|Illness|8
6875747|NCT00497874|10886967|FG001|Overall Study|Illness|4
6875748|NCT00497874|10886966|FG000|Overall Study|Death|2
6875749|NCT00497874|10886967|FG001|Overall Study|Death|4
6875750|NCT00497874|10886966|FG000|Overall Study|Unable to contact|52
6875751|NCT00497874|10886967|FG001|Overall Study|Unable to contact|67
6875752|NCT00497874|10886966|FG000|Overall Study|Unable to schedule|37
6875753|NCT00497874|10886967|FG001|Overall Study|Unable to schedule|24
6875754|NCT00498173|10886977|FG000|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2
6875755|NCT00498173|10886978|FG001|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1
6875756|NCT00498173|10886979|FG002|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0
6875757|NCT00498186|10886987|FG000|Overall Study|Protocol Violation|10
6875758|NCT00498186|10886987|FG000|Overall Study|Lack of Efficacy|31
6875759|NCT00498186|10886987|FG000|Overall Study|Adverse Event|89
6875760|NCT00498186|10886987|FG000|Overall Study|Unsatisfactory compliance of subject|12
6875761|NCT00498186|10886987|FG000|Overall Study|Withdrawal by Subject|18
6875762|NCT00498186|10886987|FG000|Overall Study|Lost to Follow-up|3
6875763|NCT00498186|10886987|FG000|Overall Study|Other|10
6875764|NCT00498355|10886991|FG000|Overall Study|Lost to Follow-up|1
6875765|NCT00498368|10886998|FG000|Overall Study|Withdrawal by Subject|3
6875766|NCT00498368|10886999|FG001|Overall Study|Withdrawal by Subject|2
6875767|NCT00498433|10887008|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2
6875768|NCT00498433|10887009|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
6875769|NCT00498433|10887010|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
6875770|NCT00498433|10887008|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2
6875771|NCT00498433|10887009|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
6875772|NCT00498433|10887010|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
6875773|NCT00498433|10887008|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15
6875774|NCT00498433|10887009|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
6875775|NCT00498433|10887010|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
6875776|NCT00498433|10887008|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1
6875777|NCT00498433|10887009|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
6875778|NCT00498433|10887010|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
6875779|NCT00498485|10887029|FG000|Overall Study|Adverse Event|1
6875780|NCT00498485|10887030|FG001|Overall Study|Adverse Event|5
6875781|NCT00498602|10887054|FG000|Overall Study|Death|0
6875782|NCT00498602|10887055|FG001|Overall Study|Death|0
6875783|NCT00498602|10887056|FG002|Overall Study|Death|0
6875784|NCT00498602|10887057|FG003|Overall Study|Death|0
6875785|NCT00498602|10887058|FG004|Overall Study|Death|0
6875786|NCT00498602|10887059|FG005|Overall Study|Death|1
6875787|NCT00498602|10887060|FG006|Overall Study|Death|0
6875788|NCT00498602|10887054|FG000|Overall Study|Lack of Efficacy|1
6875789|NCT00498602|10887055|FG001|Overall Study|Lack of Efficacy|0
6875790|NCT00498602|10887056|FG002|Overall Study|Lack of Efficacy|0
6875791|NCT00498602|10887057|FG003|Overall Study|Lack of Efficacy|0
6875792|NCT00498602|10887058|FG004|Overall Study|Lack of Efficacy|0
6875793|NCT00498602|10887059|FG005|Overall Study|Lack of Efficacy|0
6875794|NCT00498602|10887060|FG006|Overall Study|Lack of Efficacy|0
6875795|NCT00498602|10887054|FG000|Overall Study|Lost to Follow-up|0
6875796|NCT00498602|10887055|FG001|Overall Study|Lost to Follow-up|2
6875797|NCT00498602|10887056|FG002|Overall Study|Lost to Follow-up|0
6875798|NCT00498602|10887057|FG003|Overall Study|Lost to Follow-up|2
6875799|NCT00498602|10887058|FG004|Overall Study|Lost to Follow-up|0
6875800|NCT00498602|10887059|FG005|Overall Study|Lost to Follow-up|0
6875801|NCT00498602|10887060|FG006|Overall Study|Lost to Follow-up|0
6875802|NCT00498602|10887054|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1
6875803|NCT00498602|10887055|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0
6875804|NCT00498602|10887056|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3
6875805|NCT00498602|10887057|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2
6875806|NCT00498602|10887058|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0
6875807|NCT00498602|10887059|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1
7041199|NCT01725126|11124712|FG005|Overall Study|Withdrawal by Subject|0
7041200|NCT01725217|11124738|FG000|Overall Study|Withdrawal by Subject|1
7041201|NCT01725217|11124739|FG001|Overall Study|Withdrawal by Subject|0
7041202|NCT01725217|11124740|FG002|Overall Study|Withdrawal by Subject|0
7041203|NCT01725282|11124761|FG000|Overall Study|Adverse Event|1
7041204|NCT01725282|11124762|FG001|Overall Study|Adverse Event|3
7041205|NCT01725282|11124763|FG002|Overall Study|Adverse Event|6
7041206|NCT01725282|11124764|FG003|Overall Study|Adverse Event|4
7041207|NCT01725282|11124761|FG000|Overall Study|Exacerbation of Target Disease|1
7041208|NCT01725282|11124762|FG001|Overall Study|Exacerbation of Target Disease|0
7041209|NCT01725282|11124763|FG002|Overall Study|Exacerbation of Target Disease|0
7041210|NCT01725282|11124764|FG003|Overall Study|Exacerbation of Target Disease|1
7041211|NCT01725282|11124761|FG000|Overall Study|Met Exclusion Criteria|0
7041212|NCT01725282|11124762|FG001|Overall Study|Met Exclusion Criteria|0
6875808|NCT00498602|10887060|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0
6875809|NCT00498602|10887054|FG000|Overall Study|AE not related to Study Drug|1
6875810|NCT00498602|10887055|FG001|Overall Study|AE not related to Study Drug|3
6875811|NCT00498602|10887056|FG002|Overall Study|AE not related to Study Drug|0
6875812|NCT00498602|10887057|FG003|Overall Study|AE not related to Study Drug|0
6875813|NCT00498602|10887058|FG004|Overall Study|AE not related to Study Drug|2
6875814|NCT00498602|10887059|FG005|Overall Study|AE not related to Study Drug|2
6875815|NCT00498602|10887060|FG006|Overall Study|AE not related to Study Drug|1
6875816|NCT00498602|10887054|FG000|Overall Study|Caregiver Request|2
6875817|NCT00498602|10887055|FG001|Overall Study|Caregiver Request|2
6875818|NCT00498602|10887056|FG002|Overall Study|Caregiver Request|2
6875819|NCT00498602|10887057|FG003|Overall Study|Caregiver Request|0
6875820|NCT00498602|10887058|FG004|Overall Study|Caregiver Request|1
6875821|NCT00498602|10887059|FG005|Overall Study|Caregiver Request|2
6875822|NCT00498602|10887060|FG006|Overall Study|Caregiver Request|0
6875823|NCT00498602|10887054|FG000|Overall Study|Investigator Request|0
6875824|NCT00498602|10887055|FG001|Overall Study|Investigator Request|0
6875825|NCT00498602|10887056|FG002|Overall Study|Investigator Request|1
6875826|NCT00498602|10887057|FG003|Overall Study|Investigator Request|0
6875827|NCT00498602|10887058|FG004|Overall Study|Investigator Request|0
6875828|NCT00498602|10887059|FG005|Overall Study|Investigator Request|0
6875829|NCT00498602|10887060|FG006|Overall Study|Investigator Request|0
6875830|NCT00498602|10887054|FG000|Overall Study|Subject Request|3
6875831|NCT00498602|10887055|FG001|Overall Study|Subject Request|0
6875832|NCT00498602|10887056|FG002|Overall Study|Subject Request|1
6875833|NCT00498602|10887057|FG003|Overall Study|Subject Request|1
6875834|NCT00498602|10887058|FG004|Overall Study|Subject Request|1
6875835|NCT00498602|10887059|FG005|Overall Study|Subject Request|4
6875836|NCT00498602|10887060|FG006|Overall Study|Subject Request|1
6875837|NCT00498602|10887054|FG000|Overall Study|Other|2
6875838|NCT00498602|10887055|FG001|Overall Study|Other|3
6875839|NCT00498602|10887056|FG002|Overall Study|Other|1
6875840|NCT00498602|10887057|FG003|Overall Study|Other|0
6875841|NCT00498602|10887058|FG004|Overall Study|Other|0
6875842|NCT00498602|10887059|FG005|Overall Study|Other|3
6875843|NCT00498602|10887060|FG006|Overall Study|Other|0
6875844|NCT00498797|10887119|FG000|Overall Study|Withdrawal by Subject|4
6875845|NCT00498797|10887120|FG001|Overall Study|Withdrawal by Subject|2
6875846|NCT00498797|10887119|FG000|Overall Study|Adverse Event|12
6875847|NCT00498797|10887120|FG001|Overall Study|Adverse Event|5
6875848|NCT00498797|10887119|FG000|Overall Study|Condition under investigation worsened|19
6875849|NCT00498797|10887120|FG001|Overall Study|Condition under investigation worsened|21
6875850|NCT00498797|10887119|FG000|Overall Study|Other|3
6875851|NCT00498797|10887120|FG001|Overall Study|Other|1
6875852|NCT00499031|10887139|FG000|Overall Study|Improper pre-protocol treatment|1
6875853|NCT00499031|10887139|FG000|Overall Study|Required test not done|1
6875854|NCT00499031|10887139|FG000|Overall Study|Never treated|1
6875855|NCT00499083|10887143|FG000|Overall Study|Not evaluable|3
6875856|NCT00499122|10887170|FG000|Overall Study|Withdrawal by Subject|2
6875857|NCT00499174|10887177|FG000|Overall Study|Physician Decision|78
6875858|NCT00499174|10887178|FG001|Overall Study|Physician Decision|9
6875859|NCT00499252|10887186|FG000|Overall Study|Adverse Event|3
6875860|NCT00499252|10887186|FG000|Overall Study|Refused further treatment|2
6875861|NCT00499252|10887186|FG000|Overall Study|Ineligible|4
6875862|NCT00499252|10887186|FG000|Overall Study|<no further label>|3
7041213|NCT01725282|11124763|FG002|Overall Study|Met Exclusion Criteria|1
6875863|NCT00499369|10887208|FG000|Overall Study|Adverse Event|2
6875864|NCT00499369|10887209|FG001|Overall Study|Adverse Event|2
6875865|NCT00499369|10887210|FG002|Overall Study|Adverse Event|3
6875866|NCT00499369|10887211|FG003|Overall Study|Adverse Event|1
6875867|NCT00499369|10887212|FG004|Overall Study|Adverse Event|2
6875868|NCT00499369|10887208|FG000|Overall Study|Withdrawal by Subject|0
6875869|NCT00499369|10887209|FG001|Overall Study|Withdrawal by Subject|1
6875870|NCT00499369|10887210|FG002|Overall Study|Withdrawal by Subject|1
6875871|NCT00499369|10887211|FG003|Overall Study|Withdrawal by Subject|0
6875872|NCT00499369|10887212|FG004|Overall Study|Withdrawal by Subject|0
6875873|NCT00499369|10887208|FG000|Overall Study|Progression|10
6875874|NCT00499369|10887209|FG001|Overall Study|Progression|12
6875875|NCT00499369|10887210|FG002|Overall Study|Progression|9
6875876|NCT00499369|10887211|FG003|Overall Study|Progression|6
6875877|NCT00499369|10887212|FG004|Overall Study|Progression|10
6875878|NCT00499369|10887208|FG000|Overall Study|Death|0
6875879|NCT00499369|10887209|FG001|Overall Study|Death|1
6875880|NCT00499369|10887210|FG002|Overall Study|Death|0
6875881|NCT00499369|10887211|FG003|Overall Study|Death|0
6875882|NCT00499369|10887212|FG004|Overall Study|Death|0
6875883|NCT00499369|10887208|FG000|Overall Study|Not protocol specified|2
6875884|NCT00499369|10887209|FG001|Overall Study|Not protocol specified|0
6875885|NCT00499369|10887210|FG002|Overall Study|Not protocol specified|3
6875886|NCT00499369|10887211|FG003|Overall Study|Not protocol specified|1
6875887|NCT00499369|10887212|FG004|Overall Study|Not protocol specified|0
6875888|NCT00499369|10887208|FG000|Overall Study|Ineligible|2
6875889|NCT00499369|10887209|FG001|Overall Study|Ineligible|2
6875890|NCT00499369|10887210|FG002|Overall Study|Ineligible|1
6875891|NCT00499369|10887211|FG003|Overall Study|Ineligible|1
6875892|NCT00499369|10887212|FG004|Overall Study|Ineligible|0
6875893|NCT00499460|10887234|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1
6875894|NCT00499460|10887235|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0
6875895|NCT00499460|10887234|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1
6875896|NCT00499460|10887235|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0
6875897|NCT00499460|10887234|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0
6875898|NCT00499460|10887235|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1
6875899|NCT00499486|10887260|FG000|Overall Study|Withdrawal by Subject|16
6875900|NCT00499603|10887266|FG000|Overall Study|Adverse Event|0
6875901|NCT00499603|10887267|FG001|Overall Study|Adverse Event|1
6875902|NCT00499616|10887279|FG000|Overall Study|Death|1
6875903|NCT00499616|10887280|FG001|Overall Study|Death|5
6875904|NCT00499616|10887281|FG002|Overall Study|Death|3
6875905|NCT00499616|10887282|FG003|Overall Study|Death|1
6875906|NCT00499616|10887279|FG000|Overall Study|Lack of Efficacy|5
6875907|NCT00499616|10887280|FG001|Overall Study|Lack of Efficacy|0
6875908|NCT00499616|10887281|FG002|Overall Study|Lack of Efficacy|19
6875909|NCT00499616|10887282|FG003|Overall Study|Lack of Efficacy|0
6875910|NCT00499616|10887279|FG000|Overall Study|Lost to Follow-up|0
6875911|NCT00499616|10887280|FG001|Overall Study|Lost to Follow-up|0
6968954|NCT01144364|11018312|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0
6968955|NCT01144364|11018313|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
6968956|NCT01144364|11018314|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
6968957|NCT01144364|11018312|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0
6968958|NCT01144364|11018313|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1
6968959|NCT01144364|11018314|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4
6968960|NCT01144364|11018312|FG000|Follow-Up/Maintenance Phase|Relapse|0
6968961|NCT01144364|11018313|FG001|Follow-Up/Maintenance Phase|Relapse|5
6968962|NCT01144364|11018314|FG002|Follow-Up/Maintenance Phase|Relapse|5
6968963|NCT01144364|11018312|FG000|Follow-Up/Maintenance Phase|Physician Decision|0
6968964|NCT01144364|11018313|FG001|Follow-Up/Maintenance Phase|Physician Decision|0
6968965|NCT01144364|11018314|FG002|Follow-Up/Maintenance Phase|Physician Decision|1
6968966|NCT01144377|11018329|FG000|52 Week Treatment Period|Adverse Event|0
6968967|NCT01144377|11018330|FG001|52 Week Treatment Period|Adverse Event|0
6968968|NCT01144377|11018331|FG002|52 Week Treatment Period|Adverse Event|3
6968969|NCT01144377|11018332|FG003|52 Week Treatment Period|Adverse Event|2
6968970|NCT01144377|11018333|FG004|52 Week Treatment Period|Adverse Event|1
6968971|NCT01144377|11018329|FG000|52 Week Treatment Period|Entry Criteria Not Met|0
6968972|NCT01144377|11018330|FG001|52 Week Treatment Period|Entry Criteria Not Met|0
6968973|NCT01144377|11018331|FG002|52 Week Treatment Period|Entry Criteria Not Met|1
6968974|NCT01144377|11018332|FG003|52 Week Treatment Period|Entry Criteria Not Met|1
6968975|NCT01144377|11018333|FG004|52 Week Treatment Period|Entry Criteria Not Met|0
6968976|NCT01144377|11018329|FG000|52 Week Treatment Period|Protocol Violation|0
6968977|NCT01144377|11018330|FG001|52 Week Treatment Period|Protocol Violation|0
6968978|NCT01144377|11018331|FG002|52 Week Treatment Period|Protocol Violation|0
6968979|NCT01144377|11018332|FG003|52 Week Treatment Period|Protocol Violation|0
6968980|NCT01144377|11018333|FG004|52 Week Treatment Period|Protocol Violation|1
6968981|NCT01144377|11018329|FG000|52 Week Treatment Period|Lost to Follow-up|1
6968982|NCT01144377|11018330|FG001|52 Week Treatment Period|Lost to Follow-up|0
6968983|NCT01144377|11018331|FG002|52 Week Treatment Period|Lost to Follow-up|0
6875912|NCT00499616|10887281|FG002|Overall Study|Lost to Follow-up|1
6875913|NCT00499616|10887282|FG003|Overall Study|Lost to Follow-up|0
6875914|NCT00499616|10887279|FG000|Overall Study|Physician Decision|6
6875915|NCT00499616|10887280|FG001|Overall Study|Physician Decision|16
6875916|NCT00499616|10887281|FG002|Overall Study|Physician Decision|9
6875917|NCT00499616|10887282|FG003|Overall Study|Physician Decision|0
6875918|NCT00499616|10887279|FG000|Overall Study|Withdrawal by Subject|1
6875919|NCT00499616|10887280|FG001|Overall Study|Withdrawal by Subject|0
6875920|NCT00499616|10887281|FG002|Overall Study|Withdrawal by Subject|1
6875921|NCT00499616|10887282|FG003|Overall Study|Withdrawal by Subject|0
6968984|NCT01144377|11018332|FG003|52 Week Treatment Period|Lost to Follow-up|0
6968985|NCT01144377|11018333|FG004|52 Week Treatment Period|Lost to Follow-up|0
6875922|NCT00499616|10887279|FG000|Overall Study|Ineligible|1
6875923|NCT00499616|10887280|FG001|Overall Study|Ineligible|2
6875924|NCT00499616|10887281|FG002|Overall Study|Ineligible|0
6875925|NCT00499616|10887282|FG003|Overall Study|Ineligible|15
6875926|NCT00499616|10887279|FG000|Overall Study|Not evaluable|0
6875927|NCT00499616|10887280|FG001|Overall Study|Not evaluable|0
6875928|NCT00499616|10887281|FG002|Overall Study|Not evaluable|0
6875929|NCT00499616|10887282|FG003|Overall Study|Not evaluable|41
6875930|NCT00499616|10887279|FG000|Overall Study|Patient/Parent Refusal|1
6875931|NCT00499616|10887280|FG001|Overall Study|Patient/Parent Refusal|5
6875932|NCT00499616|10887281|FG002|Overall Study|Patient/Parent Refusal|3
6875933|NCT00499616|10887282|FG003|Overall Study|Patient/Parent Refusal|0
6875934|NCT00499681|10887307|FG000|Overall Study|toxicity|0
6875935|NCT00499681|10887308|FG001|Overall Study|toxicity|1
6875936|NCT00499681|10887307|FG000|Overall Study|disease progression|0
6875937|NCT00499681|10887308|FG001|Overall Study|disease progression|1
6875938|NCT00499694|10887314|FG000|Overall Study|Patient never received treatment.|1
6875939|NCT00499746|10887319|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7
6875940|NCT00499746|10887319|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3
6875941|NCT00499746|10887319|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1
6875942|NCT00499746|10887319|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1
6875943|NCT00499863|10887335|FG000|Overall Study|Lack of Efficacy|21
6875944|NCT00499863|10887336|FG001|Overall Study|Lack of Efficacy|27
6875945|NCT00499863|10887335|FG000|Overall Study|Protocol Violation|12
6875946|NCT00499863|10887336|FG001|Overall Study|Protocol Violation|7
6875947|NCT00499863|10887335|FG000|Overall Study|Withdrawal by Subject|6
6875948|NCT00499863|10887336|FG001|Overall Study|Withdrawal by Subject|4
6875949|NCT00499863|10887335|FG000|Overall Study|Adverse Event|8
6875950|NCT00499863|10887336|FG001|Overall Study|Adverse Event|2
6875951|NCT00499863|10887335|FG000|Overall Study|Sponsor decision|2
6875952|NCT00499863|10887336|FG001|Overall Study|Sponsor decision|2
6875953|NCT00499863|10887335|FG000|Overall Study|Lost to Follow-up|1
6875954|NCT00499863|10887336|FG001|Overall Study|Lost to Follow-up|1
6875955|NCT00499889|10887342|FG000|Overall Study|Infection prior to treatment|1
6875956|NCT00500110|10887355|FG000|Overall Study|Withdrawal by Subject|3
6875957|NCT00500149|10887359|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3
6875958|NCT00500149|10887360|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0
6875959|NCT00500149|10887359|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8
6875960|NCT00500149|10887360|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0
6875961|NCT00500149|10887359|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1
6875962|NCT00500149|10887360|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0
6875963|NCT00500149|10887359|FG000|First Intervention (Cross-over Phase)|Adverse Event|0
6875964|NCT00500149|10887360|FG001|First Intervention (Cross-over Phase)|Adverse Event|1
6875965|NCT00500149|10887359|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
6875966|NCT00500149|10887360|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
6875967|NCT00500149|10887359|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1
6875968|NCT00500149|10887360|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0
6875969|NCT00500149|10887359|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2
6875970|NCT00500149|10887360|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0
6875971|NCT00500266|10887377|FG000|Overall Study|Death|3
6875972|NCT00500266|10887377|FG000|Overall Study|Lost to Follow-up|3
6875973|NCT00500266|10887377|FG000|Overall Study|Withdrawal by Subject|3
6875974|NCT00500266|10887377|FG000|Overall Study|Assigned, not treated|4
6875975|NCT00500292|10887385|FG000|Overall Study|Adverse Event|3
6875976|NCT00500292|10887386|FG001|Overall Study|Adverse Event|6
6875977|NCT00500292|10887387|FG002|Overall Study|Adverse Event|4
6875978|NCT00500292|10887385|FG000|Overall Study|Condition under investigation worsened|21
6875979|NCT00500292|10887386|FG001|Overall Study|Condition under investigation worsened|23
6875980|NCT00500292|10887387|FG002|Overall Study|Condition under investigation worsened|19
6875981|NCT00500292|10887385|FG000|Overall Study|Withdrawal by Subject|0
6875982|NCT00500292|10887386|FG001|Overall Study|Withdrawal by Subject|1
6875983|NCT00500292|10887387|FG002|Overall Study|Withdrawal by Subject|0
6875984|NCT00500292|10887385|FG000|Overall Study|Other|1
6875985|NCT00500292|10887386|FG001|Overall Study|Other|1
6875986|NCT00500292|10887387|FG002|Overall Study|Other|4
6875987|NCT00500318|10887397|FG000|Overall Study|Adverse Event|3
6875988|NCT00500318|10887398|FG001|Overall Study|Adverse Event|8
6875989|NCT00500318|10887397|FG000|Overall Study|Protocol Violation|1
6875990|NCT00500318|10887398|FG001|Overall Study|Protocol Violation|3
6875991|NCT00500318|10887397|FG000|Overall Study|Withdrawal by Subject|1
6875992|NCT00500318|10887398|FG001|Overall Study|Withdrawal by Subject|2
6875993|NCT00500318|10887397|FG000|Overall Study|Lack of Efficacy|0
6875994|NCT00500318|10887398|FG001|Overall Study|Lack of Efficacy|3
6875995|NCT00500318|10887397|FG000|Overall Study|Other Reason|0
6875996|NCT00500318|10887398|FG001|Overall Study|Other Reason|1
6875997|NCT00500331|10887411|FG000|Overall Study|Adverse Event|0
6875998|NCT00500331|10887412|FG001|Overall Study|Adverse Event|2
6875999|NCT00500331|10887413|FG002|Overall Study|Adverse Event|0
6876000|NCT00500331|10887414|FG003|Overall Study|Adverse Event|1
6876001|NCT00500331|10887415|FG004|Overall Study|Adverse Event|2
6876002|NCT00500331|10887416|FG005|Overall Study|Adverse Event|2
6876003|NCT00500331|10887417|FG006|Overall Study|Adverse Event|0
6876004|NCT00500331|10887411|FG000|Overall Study|Lost to Follow-up|1
6876005|NCT00500331|10887412|FG001|Overall Study|Lost to Follow-up|1
6876006|NCT00500331|10887413|FG002|Overall Study|Lost to Follow-up|1
6876007|NCT00500331|10887414|FG003|Overall Study|Lost to Follow-up|2
6876008|NCT00500331|10887415|FG004|Overall Study|Lost to Follow-up|1
6876009|NCT00500331|10887416|FG005|Overall Study|Lost to Follow-up|0
6876010|NCT00500331|10887417|FG006|Overall Study|Lost to Follow-up|0
6876011|NCT00500331|10887411|FG000|Overall Study|Protocol Violation|3
6876012|NCT00500331|10887412|FG001|Overall Study|Protocol Violation|1
6876013|NCT00500331|10887413|FG002|Overall Study|Protocol Violation|1
6876014|NCT00500331|10887414|FG003|Overall Study|Protocol Violation|0
6876015|NCT00500331|10887415|FG004|Overall Study|Protocol Violation|1
6876016|NCT00500331|10887416|FG005|Overall Study|Protocol Violation|1
6876017|NCT00500331|10887417|FG006|Overall Study|Protocol Violation|1
6876018|NCT00500331|10887411|FG000|Overall Study|Withdrawal by Subject|4
6876019|NCT00500331|10887412|FG001|Overall Study|Withdrawal by Subject|0
6876020|NCT00500331|10887413|FG002|Overall Study|Withdrawal by Subject|1
6876021|NCT00500331|10887414|FG003|Overall Study|Withdrawal by Subject|5
6876022|NCT00500331|10887415|FG004|Overall Study|Withdrawal by Subject|0
6876023|NCT00500331|10887416|FG005|Overall Study|Withdrawal by Subject|1
6876024|NCT00500331|10887417|FG006|Overall Study|Withdrawal by Subject|1
6876025|NCT00500331|10887411|FG000|Overall Study|Lack of Efficacy|3
6876026|NCT00500331|10887412|FG001|Overall Study|Lack of Efficacy|1
6876027|NCT00500331|10887413|FG002|Overall Study|Lack of Efficacy|0
6876028|NCT00500331|10887414|FG003|Overall Study|Lack of Efficacy|0
6876029|NCT00500331|10887415|FG004|Overall Study|Lack of Efficacy|0
6876030|NCT00500331|10887416|FG005|Overall Study|Lack of Efficacy|0
6876031|NCT00500331|10887417|FG006|Overall Study|Lack of Efficacy|0
6876032|NCT00500331|10887411|FG000|Overall Study|Liver function test abnormality|0
6876033|NCT00500331|10887412|FG001|Overall Study|Liver function test abnormality|0
6876034|NCT00500331|10887413|FG002|Overall Study|Liver function test abnormality|1
6876035|NCT00500331|10887414|FG003|Overall Study|Liver function test abnormality|0
6876036|NCT00500331|10887415|FG004|Overall Study|Liver function test abnormality|0
6876037|NCT00500331|10887416|FG005|Overall Study|Liver function test abnormality|0
6876038|NCT00500331|10887417|FG006|Overall Study|Liver function test abnormality|0
6876039|NCT00500331|10887411|FG000|Overall Study|Increased serum creatinine from Baseline|0
6876040|NCT00500331|10887412|FG001|Overall Study|Increased serum creatinine from Baseline|0
6876041|NCT00500331|10887413|FG002|Overall Study|Increased serum creatinine from Baseline|0
6876042|NCT00500331|10887414|FG003|Overall Study|Increased serum creatinine from Baseline|0
6876043|NCT00500331|10887415|FG004|Overall Study|Increased serum creatinine from Baseline|0
6876044|NCT00500331|10887416|FG005|Overall Study|Increased serum creatinine from Baseline|1
6876045|NCT00500331|10887417|FG006|Overall Study|Increased serum creatinine from Baseline|0
6876046|NCT00500331|10887411|FG000|Overall Study|Didn't return for continuation of study|1
6876047|NCT00500331|10887412|FG001|Overall Study|Didn't return for continuation of study|0
7154396|NCT03310021|11321059|FG019|Overall Study|Lost to Follow-up|0
6876048|NCT00500331|10887413|FG002|Overall Study|Didn't return for continuation of study|0
6876049|NCT00500331|10887414|FG003|Overall Study|Didn't return for continuation of study|0
6876050|NCT00500331|10887415|FG004|Overall Study|Didn't return for continuation of study|0
6876051|NCT00500331|10887416|FG005|Overall Study|Didn't return for continuation of study|0
6876052|NCT00500331|10887417|FG006|Overall Study|Didn't return for continuation of study|0
6876053|NCT00500331|10887411|FG000|Overall Study|Exclusion citeria not met on Visit 4|1
6876054|NCT00500331|10887412|FG001|Overall Study|Exclusion citeria not met on Visit 4|0
6876055|NCT00500331|10887413|FG002|Overall Study|Exclusion citeria not met on Visit 4|0
6876056|NCT00500331|10887414|FG003|Overall Study|Exclusion citeria not met on Visit 4|0
6876057|NCT00500331|10887415|FG004|Overall Study|Exclusion citeria not met on Visit 4|0
6876058|NCT00500331|10887416|FG005|Overall Study|Exclusion citeria not met on Visit 4|0
6876059|NCT00500331|10887417|FG006|Overall Study|Exclusion citeria not met on Visit 4|0
6876060|NCT00500331|10887411|FG000|Overall Study|Sponsor decided to withdraw participant|1
6876061|NCT00500331|10887412|FG001|Overall Study|Sponsor decided to withdraw participant|0
6876062|NCT00500331|10887413|FG002|Overall Study|Sponsor decided to withdraw participant|0
6876063|NCT00500331|10887414|FG003|Overall Study|Sponsor decided to withdraw participant|0
6876064|NCT00500331|10887415|FG004|Overall Study|Sponsor decided to withdraw participant|0
6876065|NCT00500331|10887416|FG005|Overall Study|Sponsor decided to withdraw participant|0
6876066|NCT00500331|10887417|FG006|Overall Study|Sponsor decided to withdraw participant|0
6876067|NCT00500331|10887411|FG000|Overall Study|Participant was randomized by mistake|1
6876068|NCT00500331|10887412|FG001|Overall Study|Participant was randomized by mistake|0
6876069|NCT00500331|10887413|FG002|Overall Study|Participant was randomized by mistake|0
6876070|NCT00500331|10887414|FG003|Overall Study|Participant was randomized by mistake|0
6876071|NCT00500331|10887415|FG004|Overall Study|Participant was randomized by mistake|0
6876072|NCT00500331|10887416|FG005|Overall Study|Participant was randomized by mistake|0
6968986|NCT01144377|11018329|FG000|52 Week Treatment Period|Withdrawal by Subject|4
6876073|NCT00500331|10887417|FG006|Overall Study|Participant was randomized by mistake|0
6876074|NCT00500331|10887411|FG000|Overall Study|Diabetologist nurse in the study|0
6876075|NCT00500331|10887412|FG001|Overall Study|Diabetologist nurse in the study|0
6876076|NCT00500331|10887413|FG002|Overall Study|Diabetologist nurse in the study|1
6968987|NCT01144377|11018330|FG001|52 Week Treatment Period|Withdrawal by Subject|1
6876077|NCT00500331|10887414|FG003|Overall Study|Diabetologist nurse in the study|0
6876078|NCT00500331|10887415|FG004|Overall Study|Diabetologist nurse in the study|0
6876079|NCT00500331|10887416|FG005|Overall Study|Diabetologist nurse in the study|0
6876080|NCT00500331|10887417|FG006|Overall Study|Diabetologist nurse in the study|0
6876081|NCT00500331|10887411|FG000|Overall Study|State ban of biological samples export|0
6876082|NCT00500331|10887412|FG001|Overall Study|State ban of biological samples export|0
6876083|NCT00500331|10887413|FG002|Overall Study|State ban of biological samples export|0
6876084|NCT00500331|10887414|FG003|Overall Study|State ban of biological samples export|1
6876085|NCT00500331|10887415|FG004|Overall Study|State ban of biological samples export|0
6876086|NCT00500331|10887416|FG005|Overall Study|State ban of biological samples export|0
6876087|NCT00500331|10887417|FG006|Overall Study|State ban of biological samples export|0
6876088|NCT00500331|10887411|FG000|Overall Study|Protocol violated|0
6876089|NCT00500331|10887412|FG001|Overall Study|Protocol violated|0
6876090|NCT00500331|10887413|FG002|Overall Study|Protocol violated|0
6876091|NCT00500331|10887414|FG003|Overall Study|Protocol violated|1
6876092|NCT00500331|10887415|FG004|Overall Study|Protocol violated|0
6876093|NCT00500331|10887416|FG005|Overall Study|Protocol violated|0
6876094|NCT00500331|10887417|FG006|Overall Study|Protocol violated|0
6876095|NCT00500357|10887434|FG000|Overall Study|Death|1
6876096|NCT00500370|10887451|FG000|Overall Study|Adverse Event|9
6876097|NCT00500370|10887452|FG001|Overall Study|Adverse Event|3
6876098|NCT00500370|10887451|FG000|Overall Study|Lost to Follow-up|10
6876099|NCT00500370|10887452|FG001|Overall Study|Lost to Follow-up|10
6876100|NCT00500370|10887451|FG000|Overall Study|Protocol Violation|2
6876101|NCT00500370|10887452|FG001|Overall Study|Protocol Violation|4
6876102|NCT00500370|10887451|FG000|Overall Study|Sponsor Decision|2
6876103|NCT00500370|10887452|FG001|Overall Study|Sponsor Decision|0
6876104|NCT00500370|10887451|FG000|Overall Study|Subject Decision|10
6876105|NCT00500370|10887452|FG001|Overall Study|Subject Decision|17
6876106|NCT00500539|10887467|FG000|Treatment Period (24 Weeks)|Adverse Event|4
6876107|NCT00500539|10887467|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1
6876108|NCT00500539|10887467|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1
6876109|NCT00500539|10887467|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2
6876110|NCT00500539|10887467|FG000|Treatment Period (24 Weeks)|Administrative problems|2
6876111|NCT00500539|10887467|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5
6876112|NCT00500539|10887467|FG000|Follow-up Period (16 Weeks)|Adverse Event|1
6876113|NCT00500539|10887467|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2
6876114|NCT00500539|10887467|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3
6876115|NCT00500539|10887467|FG000|Follow-up Period (16 Weeks)|Administrative problems|1
6876116|NCT00500539|10887467|FG000|Follow-up Period (16 Weeks)|Death|1
6876117|NCT00500539|10887467|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1
7154397|NCT03310268|11321104|FG000|Overall Study|(Not specified)|1
6876118|NCT00500539|10887467|FG000|Follow-up Period (16 Weeks)|Missing|3
6876119|NCT00500760|10887502|FG000|Overall Study|Death|32
6876120|NCT00500760|10887503|FG001|Overall Study|Death|15
6876121|NCT00500760|10887502|FG000|Overall Study|Withdrawal by Subject|5
6876122|NCT00500760|10887503|FG001|Overall Study|Withdrawal by Subject|7
6876123|NCT00500760|10887502|FG000|Overall Study|Administrative decision|2
6876124|NCT00500760|10887503|FG001|Overall Study|Administrative decision|0
6876125|NCT00500760|10887502|FG000|Overall Study|Lost to Follow-up|3
6876126|NCT00500760|10887503|FG001|Overall Study|Lost to Follow-up|0
6876127|NCT00500760|10887502|FG000|Overall Study|Other|1
6876128|NCT00500760|10887503|FG001|Overall Study|Other|2
6876129|NCT00500903|10887512|FG000|Overall Study|Occurrence of Adverse Event(s)|10
6876130|NCT00500903|10887513|FG001|Overall Study|Occurrence of Adverse Event(s)|0
6876131|NCT00500903|10887514|FG002|Overall Study|Occurrence of Adverse Event(s)|0
6876132|NCT00500903|10887512|FG000|Overall Study|Unsatisfactory Therapeutic Response|2
6876133|NCT00500903|10887513|FG001|Overall Study|Unsatisfactory Therapeutic Response|0
6876134|NCT00500903|10887514|FG002|Overall Study|Unsatisfactory Therapeutic Response|0
6876135|NCT00500903|10887512|FG000|Overall Study|Progressive Disease|41
6876136|NCT00500903|10887513|FG001|Overall Study|Progressive Disease|2
6876137|NCT00500903|10887514|FG002|Overall Study|Progressive Disease|15
6876138|NCT00500903|10887512|FG000|Overall Study|Patient Declined Further Treatment|0
6876139|NCT00500903|10887513|FG001|Overall Study|Patient Declined Further Treatment|0
6876140|NCT00500903|10887514|FG002|Overall Study|Patient Declined Further Treatment|3
6876141|NCT00500903|10887512|FG000|Overall Study|Symptomatic Deterioration|2
6876142|NCT00500903|10887513|FG001|Overall Study|Symptomatic Deterioration|0
6876143|NCT00500903|10887514|FG002|Overall Study|Symptomatic Deterioration|0
6876144|NCT00500903|10887512|FG000|Overall Study|Reason Not Specified|10
6876145|NCT00500903|10887513|FG001|Overall Study|Reason Not Specified|0
6876146|NCT00500903|10887514|FG002|Overall Study|Reason Not Specified|2
6876147|NCT00501007|10887552|FG000|Overall Study|Inclusion criteria not met.|29
6876148|NCT00501007|10887553|FG001|Overall Study|Inclusion criteria not met.|25
6876149|NCT00501059|10887561|FG000|Overall Study|Protocol Violation|80
7154398|NCT03310268|11321105|FG001|Overall Study|(Not specified)|5
6876150|NCT00501059|10887562|FG001|Overall Study|Protocol Violation|69
6876151|NCT00501059|10887561|FG000|Overall Study|Death|140
6876152|NCT00501059|10887562|FG001|Overall Study|Death|137
6876153|NCT00501059|10887561|FG000|Overall Study|Other|236
6876154|NCT00501059|10887562|FG001|Overall Study|Other|239
6876155|NCT00501059|10887561|FG000|Overall Study|Missing end-of-study page|91
6876156|NCT00501059|10887562|FG001|Overall Study|Missing end-of-study page|92
6876157|NCT00501059|10887561|FG000|Overall Study|Clinical endpoint reached|110
6876158|NCT00501059|10887562|FG001|Overall Study|Clinical endpoint reached|123
6876159|NCT00501059|10887561|FG000|Overall Study|Insufficient therapeutic effect|4
6876160|NCT00501059|10887562|FG001|Overall Study|Insufficient therapeutic effect|5
6876161|NCT00501059|10887561|FG000|Overall Study|Consent withdrawn by subject|817
6876162|NCT00501059|10887562|FG001|Overall Study|Consent withdrawn by subject|873
6876163|NCT00501059|10887561|FG000|Overall Study|Non-compliant with study treatment|23
6876164|NCT00501059|10887562|FG001|Overall Study|Non-compliant with study treatment|16
6876165|NCT00501059|10887561|FG000|Overall Study|Reason not given|3
6876166|NCT00501059|10887562|FG001|Overall Study|Reason not given|1
6876167|NCT00501059|10887561|FG000|Overall Study|Adverse Event|129
6876168|NCT00501059|10887562|FG001|Overall Study|Adverse Event|122
6876169|NCT00501059|10887561|FG000|Overall Study|Lost to Follow-up|210
6876170|NCT00501059|10887562|FG001|Overall Study|Lost to Follow-up|198
6876171|NCT00501059|10887561|FG000|Overall Study|Not treated|25
6876172|NCT00501059|10887562|FG001|Overall Study|Not treated|17
6968988|NCT01144377|11018331|FG002|52 Week Treatment Period|Withdrawal by Subject|1
6968989|NCT01144377|11018332|FG003|52 Week Treatment Period|Withdrawal by Subject|1
6968990|NCT01144377|11018333|FG004|52 Week Treatment Period|Withdrawal by Subject|0
6968991|NCT01144377|11018329|FG000|52 Week Treatment Period|Sponsor Decision|0
6968992|NCT01144377|11018330|FG001|52 Week Treatment Period|Sponsor Decision|0
6968993|NCT01144377|11018331|FG002|52 Week Treatment Period|Sponsor Decision|0
6968994|NCT01144377|11018332|FG003|52 Week Treatment Period|Sponsor Decision|0
6968995|NCT01144377|11018333|FG004|52 Week Treatment Period|Sponsor Decision|1
6968996|NCT01144377|11018329|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0
6968997|NCT01144377|11018330|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1
6968998|NCT01144377|11018331|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0
6968999|NCT01144377|11018332|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0
6969000|NCT01144377|11018333|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1
6969001|NCT01144377|11018329|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
6969002|NCT01144377|11018330|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
6969003|NCT01144377|11018331|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
6969004|NCT01144377|11018332|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
6969005|NCT01144377|11018333|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1
6969006|NCT01144377|11018329|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1
6969007|NCT01144377|11018330|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
6969008|NCT01144377|11018331|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
6969009|NCT01144377|11018332|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
6969010|NCT01144377|11018333|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
6969011|NCT01144403|11018347|FG000|Overall Study|Lost to Follow-up|3
6969012|NCT01144403|11018347|FG000|Overall Study|Death|1
6969013|NCT01144403|11018347|FG000|Overall Study|Adverse Event|1
6969014|NCT01144663|11018419|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2
6969015|NCT01144663|11018420|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0
6969016|NCT01144663|11018421|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1
6969017|NCT01144663|11018422|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0
6969018|NCT01144663|11018419|FG000|Primary Vaccination Phase|Adverse Event|1
6969019|NCT01144663|11018420|FG001|Primary Vaccination Phase|Adverse Event|0
6969020|NCT01144663|11018421|FG002|Primary Vaccination Phase|Adverse Event|0
6969021|NCT01144663|11018422|FG003|Primary Vaccination Phase|Adverse Event|1
6969022|NCT01144663|11018419|FG000|Primary Vaccination Phase|Protocol Violation|2
6969023|NCT01144663|11018420|FG001|Primary Vaccination Phase|Protocol Violation|0
6969024|NCT01144663|11018421|FG002|Primary Vaccination Phase|Protocol Violation|1
6969025|NCT01144663|11018422|FG003|Primary Vaccination Phase|Protocol Violation|0
6969026|NCT01144663|11018419|FG000|Primary Vaccination Phase|Withdrawal by Subject|9
6969027|NCT01144663|11018420|FG001|Primary Vaccination Phase|Withdrawal by Subject|5
6969028|NCT01144663|11018421|FG002|Primary Vaccination Phase|Withdrawal by Subject|3
6969029|NCT01144663|11018422|FG003|Primary Vaccination Phase|Withdrawal by Subject|10
6969030|NCT01144663|11018419|FG000|Primary Vaccination Phase|Migrated/moved from study area|4
6969031|NCT01144663|11018420|FG001|Primary Vaccination Phase|Migrated/moved from study area|1
6969032|NCT01144663|11018421|FG002|Primary Vaccination Phase|Migrated/moved from study area|2
6969033|NCT01144663|11018422|FG003|Primary Vaccination Phase|Migrated/moved from study area|3
6969034|NCT01144663|11018419|FG000|Primary Vaccination Phase|Lost to Follow-up|2
6969035|NCT01144663|11018420|FG001|Primary Vaccination Phase|Lost to Follow-up|0
6969036|NCT01144663|11018421|FG002|Primary Vaccination Phase|Lost to Follow-up|1
6969037|NCT01144663|11018422|FG003|Primary Vaccination Phase|Lost to Follow-up|2
6969038|NCT01144663|11018419|FG000|Primary Vaccination Phase|Other|0
6969039|NCT01144663|11018420|FG001|Primary Vaccination Phase|Other|1
6969040|NCT01144663|11018421|FG002|Primary Vaccination Phase|Other|0
6969041|NCT01144663|11018422|FG003|Primary Vaccination Phase|Other|2
6969042|NCT01144663|11018419|FG000|Booster Vaccination Phase|Withdrawal by Subject|0
6969043|NCT01144663|11018420|FG001|Booster Vaccination Phase|Withdrawal by Subject|0
6969044|NCT01144663|11018421|FG002|Booster Vaccination Phase|Withdrawal by Subject|1
6969045|NCT01144663|11018422|FG003|Booster Vaccination Phase|Withdrawal by Subject|1
6969046|NCT01144663|11018419|FG000|Booster Vaccination Phase|Migrated/moved from study area|1
6876173|NCT00501085|10887570|FG000|Overall Study|Lost to Follow-up|195
6876174|NCT00501085|10887570|FG000|Overall Study|Withdrawal by Subject|34
6876175|NCT00501085|10887570|FG000|Overall Study|Subject Decision|1
6876176|NCT00501085|10887570|FG000|Overall Study|Revision Surgery|7
6876177|NCT00501085|10887570|FG000|Overall Study|Explantation Surgery|26
6876178|NCT00501085|10887570|FG000|Overall Study|Adverse Event|4
6876179|NCT00501085|10887570|FG000|Overall Study|Non-Compliance|24
6876180|NCT00501085|10887570|FG000|Overall Study|Study closed by sponsor|109
6876181|NCT00501085|10887570|FG000|Overall Study|Other loss to follow-up|32
6876182|NCT00501293|10887576|FG000|Optimization Period|Enrolled in error|1
6876183|NCT00501293|10887577|FG001|Optimization Period|Enrolled in error|0
6876184|NCT00501293|10887576|FG000|Maintenance Period|Withdrawal by Subject|14
6876185|NCT00501293|10887577|FG001|Maintenance Period|Withdrawal by Subject|13
6876186|NCT00501293|10887576|FG000|Maintenance Period|Lost to Follow-up|12
6876187|NCT00501293|10887577|FG001|Maintenance Period|Lost to Follow-up|7
6876188|NCT00501293|10887576|FG000|Maintenance Period|Adverse Event|6
6876189|NCT00501293|10887577|FG001|Maintenance Period|Adverse Event|6
6876190|NCT00501293|10887576|FG000|Maintenance Period|Protocol Violation|2
6876191|NCT00501293|10887577|FG001|Maintenance Period|Protocol Violation|1
6876192|NCT00501293|10887576|FG000|Maintenance Period|Lack of Efficacy|4
6876193|NCT00501293|10887577|FG001|Maintenance Period|Lack of Efficacy|1
6876194|NCT00501293|10887576|FG000|Maintenance Period|Noncompliant with study medication|5
6876195|NCT00501293|10887577|FG001|Maintenance Period|Noncompliant with study medication|0
6876196|NCT00501293|10887576|FG000|Maintenance Period|Went into rehabilitation|1
6876197|NCT00501293|10887577|FG001|Maintenance Period|Went into rehabilitation|0
6876198|NCT00501293|10887576|FG000|Maintenance Period|Would not wear patch|1
6876199|NCT00501293|10887577|FG001|Maintenance Period|Would not wear patch|0
6876200|NCT00501293|10887576|FG000|Maintenance Period|Application site reaction|1
6876201|NCT00501293|10887577|FG001|Maintenance Period|Application site reaction|0
6876202|NCT00501540|10887584|FG000|Overall Study|Death|5
6876203|NCT00501644|10887610|FG000|Overall Study|Adverse Event|4
6876204|NCT00501644|10887610|FG000|Overall Study|Withdrawal by Subject|1
6876205|NCT00501852|10887614|FG000|Overall Study|Adverse Event|3
6876206|NCT00501852|10887614|FG000|Overall Study|Withdrawal by Subject|2
6876207|NCT00501969|10887644|FG000|Overall Study|Major Protocol Violation|4
6876208|NCT00501969|10887644|FG000|Overall Study|Lack of Efficacy|29
6876209|NCT00501969|10887644|FG000|Overall Study|Adverse Event|76
6876210|NCT00501969|10887644|FG000|Overall Study|Unsatisfactory compliance of subject|7
6876211|NCT00501969|10887644|FG000|Overall Study|Subject withdrew consent|51
6876212|NCT00501969|10887644|FG000|Overall Study|Lost to Follow-up|4
6876213|NCT00501969|10887644|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1
6876214|NCT00501969|10887644|FG000|Overall Study|Other: Sponsors Request|10
6876215|NCT00501969|10887644|FG000|Overall Study|Other: Sponsor Termination at Site|1
6876216|NCT00501969|10887644|FG000|Overall Study|Other: Sponsor Stopped Study|12
6876217|NCT00501969|10887644|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1
6876218|NCT00501969|10887644|FG000|Overall Study|Other: Patients + Investigator Agreement|1
6876219|NCT00501969|10887644|FG000|Overall Study|Other: Patient is Going to Have DBS|1
6876220|NCT00501969|10887644|FG000|Overall Study|Other: Pat Pending Surgery for PD|1
6876221|NCT00501969|10887644|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1
6876222|NCT00501969|10887644|FG000|Overall Study|Other: As Required by Local EC|2
6876223|NCT00501969|10887644|FG000|Overall Study|Other: Admin Request from the Sponsor|3
6876224|NCT00501969|10887644|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1
6876225|NCT00502203|10887652|FG000|Overall Study|Inevaluable|1
6876226|NCT00502242|10887667|FG000|Overall Study|Lack of Efficacy|1
6876227|NCT00502242|10887668|FG001|Overall Study|Lack of Efficacy|11
6876228|NCT00502242|10887667|FG000|Overall Study|Adverse Event|31
6876229|NCT00502242|10887668|FG001|Overall Study|Adverse Event|20
6876230|NCT00502242|10887667|FG000|Overall Study|Physician Decision|2
6876231|NCT00502242|10887668|FG001|Overall Study|Physician Decision|3
6876232|NCT00502242|10887667|FG000|Overall Study|Other - Unspecified|8
6876233|NCT00502242|10887668|FG001|Overall Study|Other - Unspecified|14
6876234|NCT00502242|10887667|FG000|Overall Study|Protocol Violation|3
6876235|NCT00502242|10887668|FG001|Overall Study|Protocol Violation|1
6876236|NCT00502242|10887667|FG000|Overall Study|Withdrawal by Subject|6
6876237|NCT00502242|10887668|FG001|Overall Study|Withdrawal by Subject|7
6876238|NCT00502307|10887674|FG000|Open Label Period (16 Weeks)|Progressive disease|50
6876239|NCT00502307|10887675|FG001|Open Label Period (16 Weeks)|Progressive disease|0
6876240|NCT00502307|10887676|FG002|Open Label Period (16 Weeks)|Progressive disease|0
6876241|NCT00502307|10887674|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26
6876242|NCT00502307|10887675|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0
6876243|NCT00502307|10887676|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0
6876244|NCT00502307|10887674|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0
6876245|NCT00502307|10887675|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23
6876246|NCT00502307|10887676|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2
6876247|NCT00502307|10887674|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0
6876248|NCT00502307|10887675|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3
6876249|NCT00502307|10887676|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7
6876250|NCT00502307|10887674|FG000|Maintenance Period|Progressive disease|80
6876251|NCT00502307|10887675|FG001|Maintenance Period|Progressive disease|0
6876252|NCT00502307|10887676|FG002|Maintenance Period|Progressive disease|0
6876253|NCT00502307|10887674|FG000|Maintenance Period|Discontinued due to other reasons|68
6876254|NCT00502307|10887675|FG001|Maintenance Period|Discontinued due to other reasons|0
6876255|NCT00502307|10887676|FG002|Maintenance Period|Discontinued due to other reasons|0
6876256|NCT00502320|10887695|FG000|Overall Study|Lost to Follow-up|1
6876257|NCT00502320|10887696|FG001|Overall Study|Lost to Follow-up|1
6876258|NCT00502320|10887695|FG000|Overall Study|Withdrew Consent|1
6876259|NCT00502320|10887696|FG001|Overall Study|Withdrew Consent|0
6876260|NCT00502320|10887695|FG000|Overall Study|No longer met criteria|1
6876261|NCT00502320|10887696|FG001|Overall Study|No longer met criteria|0
6876262|NCT00502320|10887695|FG000|Overall Study|Screen Failure|0
6876263|NCT00502320|10887696|FG001|Overall Study|Screen Failure|1
6876264|NCT00502320|10887695|FG000|Overall Study|Adverse Event|3
6876265|NCT00502320|10887696|FG001|Overall Study|Adverse Event|5
6876266|NCT00502593|10887714|FG000|Overall Study|Withdrawn unspecified reason|1
6876267|NCT00502593|10887715|FG001|Overall Study|Withdrawn unspecified reason|1
6876268|NCT00502593|10887716|FG002|Overall Study|Withdrawn unspecified reason|3
6876269|NCT00502593|10887717|FG003|Overall Study|Withdrawn unspecified reason|1
6876270|NCT00502593|10887718|FG004|Overall Study|Withdrawn unspecified reason|2
6876271|NCT00502593|10887719|FG005|Overall Study|Withdrawn unspecified reason|0
6876272|NCT00502593|10887720|FG006|Overall Study|Withdrawn unspecified reason|2
6876273|NCT00502593|10887721|FG007|Overall Study|Withdrawn unspecified reason|0
6876274|NCT00502593|10887722|FG008|Overall Study|Withdrawn unspecified reason|0
6876275|NCT00502593|10887723|FG009|Overall Study|Withdrawn unspecified reason|0
6876276|NCT00502593|10887724|FG010|Overall Study|Withdrawn unspecified reason|0
6876277|NCT00502593|10887725|FG011|Overall Study|Withdrawn unspecified reason|0
6876278|NCT00502593|10887714|FG000|Overall Study|Withdrawal by Subject|0
6876279|NCT00502593|10887715|FG001|Overall Study|Withdrawal by Subject|0
6876280|NCT00502593|10887716|FG002|Overall Study|Withdrawal by Subject|6
6876281|NCT00502593|10887717|FG003|Overall Study|Withdrawal by Subject|2
6876282|NCT00502593|10887718|FG004|Overall Study|Withdrawal by Subject|2
6876283|NCT00502593|10887719|FG005|Overall Study|Withdrawal by Subject|0
6876284|NCT00502593|10887720|FG006|Overall Study|Withdrawal by Subject|3
6876285|NCT00502593|10887721|FG007|Overall Study|Withdrawal by Subject|0
6876286|NCT00502593|10887722|FG008|Overall Study|Withdrawal by Subject|3
6876287|NCT00502593|10887723|FG009|Overall Study|Withdrawal by Subject|0
6876288|NCT00502593|10887724|FG010|Overall Study|Withdrawal by Subject|1
6876289|NCT00502593|10887725|FG011|Overall Study|Withdrawal by Subject|0
6876290|NCT00502593|10887714|FG000|Overall Study|Lost to Follow-up|2
6876291|NCT00502593|10887715|FG001|Overall Study|Lost to Follow-up|1
6876292|NCT00502593|10887716|FG002|Overall Study|Lost to Follow-up|1
6876293|NCT00502593|10887717|FG003|Overall Study|Lost to Follow-up|1
6876294|NCT00502593|10887718|FG004|Overall Study|Lost to Follow-up|0
6876295|NCT00502593|10887719|FG005|Overall Study|Lost to Follow-up|0
6876296|NCT00502593|10887720|FG006|Overall Study|Lost to Follow-up|0
6876297|NCT00502593|10887721|FG007|Overall Study|Lost to Follow-up|0
6876298|NCT00502593|10887722|FG008|Overall Study|Lost to Follow-up|3
6876299|NCT00502593|10887723|FG009|Overall Study|Lost to Follow-up|0
6876300|NCT00502593|10887724|FG010|Overall Study|Lost to Follow-up|1
6876301|NCT00502593|10887725|FG011|Overall Study|Lost to Follow-up|0
6876302|NCT00502671|10887774|FG000|Overall Study|Disease Progression|13
6876303|NCT00502671|10887774|FG000|Overall Study|Personal Reasons|22
6876304|NCT00502671|10887774|FG000|Overall Study|Lost to Follow-up|7
6876305|NCT00502671|10887774|FG000|Overall Study|Protocol Violation|16
6876306|NCT00502671|10887774|FG000|Overall Study|Adverse Event|19
6876307|NCT00502697|10887780|FG000|Overall Study|Withdrawal by Subject|3
6876308|NCT00502697|10887781|FG001|Overall Study|Withdrawal by Subject|1
6876309|NCT00502697|10887780|FG000|Overall Study|disenrolled due to pregnancy loss|3
6876310|NCT00502697|10887781|FG001|Overall Study|disenrolled due to pregnancy loss|5
6876311|NCT00502697|10887780|FG000|Overall Study|found not to meet eligibility criteria|3
6876312|NCT00502697|10887781|FG001|Overall Study|found not to meet eligibility criteria|4
6876313|NCT00502697|10887780|FG000|Overall Study|did not meet assignment criteria|4
6876314|NCT00502697|10887781|FG001|Overall Study|did not meet assignment criteria|2
6876315|NCT00502775|10887790|FG000|Overall Study|Adverse Event|1
6876316|NCT00502775|10887791|FG001|Overall Study|Adverse Event|2
6876317|NCT00502775|10887792|FG002|Overall Study|Adverse Event|1
6876318|NCT00502775|10887790|FG000|Overall Study|Protocol Violation|1
6876319|NCT00502775|10887791|FG001|Overall Study|Protocol Violation|5
6876320|NCT00502775|10887792|FG002|Overall Study|Protocol Violation|2
6876321|NCT00502775|10887790|FG000|Overall Study|Withdrawal by Subject|1
6876322|NCT00502775|10887791|FG001|Overall Study|Withdrawal by Subject|1
6876323|NCT00502775|10887792|FG002|Overall Study|Withdrawal by Subject|2
6876324|NCT00502775|10887790|FG000|Overall Study|Sponsor Terminated Study|1
6876325|NCT00502775|10887791|FG001|Overall Study|Sponsor Terminated Study|0
6876326|NCT00502775|10887792|FG002|Overall Study|Sponsor Terminated Study|1
6876327|NCT00502775|10887790|FG000|Overall Study|Non-compliance with eDiary|4
6876328|NCT00502775|10887791|FG001|Overall Study|Non-compliance with eDiary|1
6876329|NCT00502775|10887792|FG002|Overall Study|Non-compliance with eDiary|1
6876330|NCT00502775|10887790|FG000|Overall Study|Subject unable to swallow capsule|1
6876331|NCT00502775|10887791|FG001|Overall Study|Subject unable to swallow capsule|0
6876332|NCT00502775|10887792|FG002|Overall Study|Subject unable to swallow capsule|1
6876333|NCT00502775|10887790|FG000|Overall Study|Logpad compliance <80%|1
6876334|NCT00502775|10887791|FG001|Overall Study|Logpad compliance <80%|0
6876335|NCT00502775|10887792|FG002|Overall Study|Logpad compliance <80%|0
6876336|NCT00502775|10887790|FG000|Overall Study|Randomized in error|0
7078700|NCT02105987|11187349|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0
7078701|NCT02105987|11187350|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0
7078702|NCT02105987|11187345|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4
7154399|NCT03310268|11321106|FG002|Overall Study|(Not specified)|0
6876337|NCT00502775|10887791|FG001|Overall Study|Randomized in error|1
6876338|NCT00502775|10887792|FG002|Overall Study|Randomized in error|1
6876339|NCT00502775|10887790|FG000|Overall Study|Non-compliance|0
6876340|NCT00502775|10887791|FG001|Overall Study|Non-compliance|2
6876341|NCT00502775|10887792|FG002|Overall Study|Non-compliance|2
6876342|NCT00502775|10887790|FG000|Overall Study|Outside pollen area more than 48 hours|0
6876343|NCT00502775|10887791|FG001|Overall Study|Outside pollen area more than 48 hours|1
6876344|NCT00502775|10887792|FG002|Overall Study|Outside pollen area more than 48 hours|0
6876345|NCT00502775|10887790|FG000|Overall Study|Declining pollen counts|0
6876346|NCT00502775|10887791|FG001|Overall Study|Declining pollen counts|1
6876347|NCT00502775|10887792|FG002|Overall Study|Declining pollen counts|1
6876348|NCT00502775|10887790|FG000|Overall Study|Subject in jail|0
6876349|NCT00502775|10887791|FG001|Overall Study|Subject in jail|1
6876350|NCT00502775|10887792|FG002|Overall Study|Subject in jail|0
6876351|NCT00502775|10887790|FG000|Overall Study|Subject took disallowed drug|0
6876352|NCT00502775|10887791|FG001|Overall Study|Subject took disallowed drug|0
6876353|NCT00502775|10887792|FG002|Overall Study|Subject took disallowed drug|1
6876354|NCT00502801|10887800|FG000|Treatment Period|Withdrawal by Subject|3
6876355|NCT00502801|10887800|FG000|Treatment Period|Adverse Event|7
6876356|NCT00502801|10887800|FG000|Treatment Period|Death|14
6876357|NCT00502801|10887800|FG000|Treatment Period|OTHER|30
6876358|NCT00502801|10887800|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1
6876359|NCT00502801|10887800|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2
6969047|NCT01144663|11018420|FG001|Booster Vaccination Phase|Migrated/moved from study area|1
6969048|NCT01144663|11018421|FG002|Booster Vaccination Phase|Migrated/moved from study area|1
6969049|NCT01144663|11018422|FG003|Booster Vaccination Phase|Migrated/moved from study area|0
6969050|NCT01144663|11018419|FG000|Booster Vaccination Phase|Lost to Follow-up|2
6969051|NCT01144663|11018420|FG001|Booster Vaccination Phase|Lost to Follow-up|1
6969052|NCT01144663|11018421|FG002|Booster Vaccination Phase|Lost to Follow-up|3
6969053|NCT01144663|11018422|FG003|Booster Vaccination Phase|Lost to Follow-up|0
6969054|NCT01144663|11018419|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0
6969055|NCT01144663|11018420|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0
6969056|NCT01144663|11018421|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1
6969057|NCT01144663|11018422|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1
6969058|NCT01144663|11018419|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1
6969059|NCT01144663|11018420|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3
6969060|NCT01144663|11018421|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1
6969061|NCT01144663|11018422|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0
6969062|NCT01144663|11018419|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4
6969063|NCT01144663|11018420|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6
6969064|NCT01144663|11018421|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5
6969065|NCT01144663|11018422|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0
6969066|NCT01144715|11018434|FG000|Overall Study|Lost to Follow-up|2
6969067|NCT01144715|11018435|FG001|Overall Study|Lost to Follow-up|1
6969068|NCT01144715|11018434|FG000|Overall Study|Withdrawal by Subject|2
6969069|NCT01144715|11018435|FG001|Overall Study|Withdrawal by Subject|1
6969070|NCT01144715|11018434|FG000|Overall Study|Adverse Event|0
6969071|NCT01144715|11018435|FG001|Overall Study|Adverse Event|1
6969072|NCT01145053|11018467|FG000|Overall Study|Adverse Event|22
6969073|NCT01145053|11018467|FG000|Overall Study|Lost to Follow-up|28
6969074|NCT01145053|11018467|FG000|Overall Study|Withdrawal by Subject|25
6969075|NCT01145053|11018467|FG000|Overall Study|Other|18
6969076|NCT01145066|11018474|FG000|Overall Study|To resume NSAIDs|2
6969077|NCT01145066|11018475|FG001|Overall Study|To resume NSAIDs|2
6969078|NCT01145066|11018476|FG002|Overall Study|To resume NSAIDs|1
6969079|NCT01145066|11018474|FG000|Overall Study|Non-related surgery|0
6969080|NCT01145066|11018475|FG001|Overall Study|Non-related surgery|0
6969081|NCT01145066|11018476|FG002|Overall Study|Non-related surgery|1
6969082|NCT01145066|11018474|FG000|Overall Study|Withdrawal by Subject|0
6969083|NCT01145066|11018475|FG001|Overall Study|Withdrawal by Subject|0
6969084|NCT01145066|11018476|FG002|Overall Study|Withdrawal by Subject|2
6969085|NCT01145066|11018474|FG000|Overall Study|To start new med|1
6969086|NCT01145066|11018475|FG001|Overall Study|To start new med|0
6969087|NCT01145066|11018476|FG002|Overall Study|To start new med|0
6969088|NCT01145066|11018474|FG000|Overall Study|problems swallowing capsule|1
7154400|NCT03310411|11321114|FG000|Period 1|Adverse Event|0
6876360|NCT00502801|10887800|FG000|End of Therapy to Test of Cure|Death|3
6876361|NCT00502801|10887800|FG000|End of Therapy to Test of Cure|OTHER|2
6876362|NCT00502840|10887804|FG000|Overall Study|Adverse Event|5
6876363|NCT00502840|10887804|FG000|Overall Study|Additional or changed therapy|48
6969089|NCT01145066|11018475|FG001|Overall Study|problems swallowing capsule|0
6876364|NCT00502840|10887804|FG000|Overall Study|Lack of Efficacy|11
6876365|NCT00502840|10887804|FG000|Overall Study|Protocol Violation|4
6876366|NCT00502840|10887804|FG000|Overall Study|Withdrawal by Subject|5
6876367|NCT00502840|10887804|FG000|Overall Study|Lost to Follow-up|6
6876368|NCT00502840|10887804|FG000|Overall Study|Administrative problems|1
6876369|NCT00502840|10887804|FG000|Overall Study|Other|20
6876370|NCT00502996|10887827|FG000|Overall Study|Lost to Follow-up|9
6876371|NCT00502996|10887827|FG000|Overall Study|Protocol Violation|2
6876372|NCT00502996|10887827|FG000|Overall Study|Treatment failure|25
6876373|NCT00502996|10887827|FG000|Overall Study|Withdrawal Informed Consent|6
6876374|NCT00502996|10887827|FG000|Overall Study|Adverse Event|2
6876375|NCT00503139|10887844|FG000|Overall Study|Case Report Forms were not collected|4
6876376|NCT00503139|10887844|FG000|Overall Study|Protocol Violation|4
6876377|NCT00503308|10887850|FG000|Overall Study|Protocol Violation|2
6876378|NCT00503308|10887851|FG001|Overall Study|Protocol Violation|1
6876379|NCT00503399|10887859|FG000|Overall Study|Death|2
6876380|NCT00503399|10887860|FG001|Overall Study|Death|1
6876381|NCT00503399|10887859|FG000|Overall Study|Protocol Violation|1
6876382|NCT00503399|10887860|FG001|Overall Study|Protocol Violation|0
6876383|NCT00503399|10887859|FG000|Overall Study|Withdrawal by Subject|4
6876384|NCT00503399|10887860|FG001|Overall Study|Withdrawal by Subject|2
6876385|NCT00503399|10887859|FG000|Overall Study|Adverse Event|0
6876386|NCT00503399|10887860|FG001|Overall Study|Adverse Event|3
6876387|NCT00503399|10887859|FG000|Overall Study|Lost to Follow-up|0
6876388|NCT00503399|10887860|FG001|Overall Study|Lost to Follow-up|2
6876389|NCT00503425|10887866|FG000|Overall Study|Participant files lost|6
6876390|NCT00503425|10887866|FG000|Overall Study|Adverse Event|5
6876391|NCT00503425|10887866|FG000|Overall Study|Lack of Efficacy|25
6876392|NCT00503425|10887866|FG000|Overall Study|Withdrawal by Subject|8
6876393|NCT00503425|10887866|FG000|Overall Study|Lost to Follow-up|3
6876394|NCT00503425|10887866|FG000|Overall Study|Death|3
6876395|NCT00503425|10887866|FG000|Overall Study|Missing Data/Unknown|4
6876396|NCT00503685|10887874|FG000|Overall Study|Adverse Event|0
6876397|NCT00503685|10887875|FG001|Overall Study|Adverse Event|0
6876398|NCT00503685|10887876|FG002|Overall Study|Adverse Event|2
6876399|NCT00503685|10887874|FG000|Overall Study|Withdrawal by Subject|0
6876400|NCT00503685|10887875|FG001|Overall Study|Withdrawal by Subject|1
6876401|NCT00503685|10887876|FG002|Overall Study|Withdrawal by Subject|0
6876402|NCT00503685|10887874|FG000|Overall Study|Protocol Violation|0
6876403|NCT00503685|10887875|FG001|Overall Study|Protocol Violation|1
6876404|NCT00503685|10887876|FG002|Overall Study|Protocol Violation|0
6876405|NCT00503685|10887874|FG000|Overall Study|Eligibility Criteria Not Met|0
6876406|NCT00503685|10887875|FG001|Overall Study|Eligibility Criteria Not Met|1
6876407|NCT00503685|10887876|FG002|Overall Study|Eligibility Criteria Not Met|0
6876408|NCT00503698|10887887|FG000|Overall Study|Protocol Violation|5
6876409|NCT00503698|10887888|FG001|Overall Study|Protocol Violation|6
6876410|NCT00503698|10887887|FG000|Overall Study|Adverse Event|52
6876411|NCT00503698|10887888|FG001|Overall Study|Adverse Event|41
6876412|NCT00503698|10887887|FG000|Overall Study|Death|1
6876413|NCT00503698|10887888|FG001|Overall Study|Death|0
6876414|NCT00503698|10887887|FG000|Overall Study|Lack of Efficacy|3
6876415|NCT00503698|10887888|FG001|Overall Study|Lack of Efficacy|4
6876416|NCT00503698|10887887|FG000|Overall Study|Trial terminated|216
6876417|NCT00503698|10887888|FG001|Overall Study|Trial terminated|253
6876418|NCT00503698|10887887|FG000|Overall Study|End hemodialysis due to renal transplant|10
6876419|NCT00503698|10887888|FG001|Overall Study|End hemodialysis due to renal transplant|4
6876420|NCT00503698|10887887|FG000|Overall Study|Pregnancy/intention to become pregnant|1
6876421|NCT00503698|10887888|FG001|Overall Study|Pregnancy/intention to become pregnant|0
6876422|NCT00503698|10887887|FG000|Overall Study|Any condition in exclusion criteria|4
6876423|NCT00503698|10887888|FG001|Overall Study|Any condition in exclusion criteria|6
6876424|NCT00503698|10887887|FG000|Overall Study|Switch to peritoneal or home dialysis|2
6876425|NCT00503698|10887888|FG001|Overall Study|Switch to peritoneal or home dialysis|2
6876426|NCT00503698|10887887|FG000|Overall Study|Move to nonparticipating dialysis center|2
6876427|NCT00503698|10887888|FG001|Overall Study|Move to nonparticipating dialysis center|1
6876428|NCT00503698|10887887|FG000|Overall Study|Critically ill|2
6876429|NCT00503698|10887888|FG001|Overall Study|Critically ill|0
6876430|NCT00503698|10887887|FG000|Overall Study|Unclassified|48
6876431|NCT00503698|10887888|FG001|Overall Study|Unclassified|32
6876432|NCT00503698|10887887|FG000|Overall Study|Not exposed to trial drug|11
6876433|NCT00503698|10887888|FG001|Overall Study|Not exposed to trial drug|6
6876434|NCT00503776|10887902|FG000|Overall Study|Withdrawal by Subject|1
6876435|NCT00503776|10887903|FG001|Overall Study|Withdrawal by Subject|0
6876436|NCT00503776|10887904|FG002|Overall Study|Withdrawal by Subject|1
6876437|NCT00503776|10887905|FG003|Overall Study|Withdrawal by Subject|1
6876438|NCT00503776|10887902|FG000|Overall Study|Physician Decision|0
6876439|NCT00503776|10887903|FG001|Overall Study|Physician Decision|0
6876440|NCT00503776|10887904|FG002|Overall Study|Physician Decision|1
6876441|NCT00503776|10887905|FG003|Overall Study|Physician Decision|1
6876442|NCT00503867|10887920|FG000|Overall Study|Lost to Follow-up|1
6876443|NCT00503867|10887920|FG000|Overall Study|Adverse Event|1
6876444|NCT00503906|10887924|FG000|Overall Study|Withdrawal by Subject|1
6876445|NCT00503984|10887931|FG000|Overall Study|Protocol Violation|0
6876446|NCT00503984|10887932|FG001|Overall Study|Protocol Violation|1
6876447|NCT00503984|10887933|FG002|Overall Study|Protocol Violation|0
6876448|NCT00503984|10887934|FG003|Overall Study|Protocol Violation|0
6876449|NCT00503984|10887935|FG004|Overall Study|Protocol Violation|0
6876450|NCT00503984|10887936|FG005|Overall Study|Protocol Violation|0
6876451|NCT00503984|10887931|FG000|Overall Study|Adverse Event|0
6876452|NCT00503984|10887932|FG001|Overall Study|Adverse Event|1
6876453|NCT00503984|10887933|FG002|Overall Study|Adverse Event|0
6876454|NCT00503984|10887934|FG003|Overall Study|Adverse Event|0
6876455|NCT00503984|10887935|FG004|Overall Study|Adverse Event|0
6876456|NCT00503984|10887936|FG005|Overall Study|Adverse Event|0
6876457|NCT00503984|10887931|FG000|Overall Study|Death|0
6876458|NCT00503984|10887932|FG001|Overall Study|Death|0
6876459|NCT00503984|10887933|FG002|Overall Study|Death|0
6876460|NCT00503984|10887934|FG003|Overall Study|Death|0
6876461|NCT00503984|10887935|FG004|Overall Study|Death|1
6876462|NCT00503984|10887936|FG005|Overall Study|Death|0
6876463|NCT00503997|10887960|FG000|Overall Study|disease progression|1
6876464|NCT00503997|10887960|FG000|Overall Study|Adverse Event|5
6876465|NCT00503997|10887960|FG000|Overall Study|Death|1
6876466|NCT00503997|10887960|FG000|Overall Study|Withdrawal by Subject|1
6876467|NCT00504075|10887968|FG000|Overall Study|Adverse Event|1
6876468|NCT00504075|10887968|FG000|Overall Study|Lost to Follow-up|5
6876469|NCT00504075|10887968|FG000|Overall Study|Withdrawal by Subject|1
6876470|NCT00504075|10887968|FG000|Overall Study|Required other therapeutic intervention|1
6876471|NCT00504153|10887973|FG000|Overall Study|Withdrawal by Subject|1
6876472|NCT00504153|10887973|FG000|Overall Study|Adverse Event|4
6876473|NCT00504153|10887973|FG000|Overall Study|Death|1
6876474|NCT00504166|10887979|FG000|Overall Study|Adverse Event|1
6876475|NCT00504166|10887980|FG001|Overall Study|Adverse Event|4
6876476|NCT00504166|10887979|FG000|Overall Study|Withdrawal by Subject|3
6876477|NCT00504166|10887980|FG001|Overall Study|Withdrawal by Subject|6
6876478|NCT00504166|10887979|FG000|Overall Study|Physician Decision|1
6876479|NCT00504166|10887980|FG001|Overall Study|Physician Decision|1
6876480|NCT00504166|10887979|FG000|Overall Study|Lost to Follow-up|1
6876481|NCT00504166|10887980|FG001|Overall Study|Lost to Follow-up|3
6876482|NCT00504231|10887990|FG000|Overall Study|Discrepant chart documentation re route|0
6876483|NCT00504231|10887991|FG001|Overall Study|Discrepant chart documentation re route|0
6876484|NCT00504231|10887992|FG002|Overall Study|Discrepant chart documentation re route|1
6876485|NCT00504231|10887993|FG003|Overall Study|Discrepant chart documentation re route|0
6876486|NCT00504257|10888007|FG000|Overall Study|Withdrawal by Subject|2
6876487|NCT00504257|10888007|FG000|Overall Study|ineligible histology|2
6876488|NCT00504309|10888017|FG000|Overall Study|Death|0
6876489|NCT00504309|10888018|FG001|Overall Study|Death|0
6876490|NCT00504309|10888019|FG002|Overall Study|Death|0
6876491|NCT00504309|10888020|FG003|Overall Study|Death|0
6876492|NCT00504309|10888021|FG004|Overall Study|Death|1
6876493|NCT00504309|10888022|FG005|Overall Study|Death|0
6876494|NCT00504309|10888017|FG000|Overall Study|Withdrawal by Subject|0
6876495|NCT00504309|10888018|FG001|Overall Study|Withdrawal by Subject|0
6876496|NCT00504309|10888019|FG002|Overall Study|Withdrawal by Subject|1
6876497|NCT00504309|10888020|FG003|Overall Study|Withdrawal by Subject|0
6876498|NCT00504309|10888021|FG004|Overall Study|Withdrawal by Subject|0
6876499|NCT00504309|10888022|FG005|Overall Study|Withdrawal by Subject|0
6876500|NCT00504348|10888034|FG000|Overall Study|Adverse Event|3
6876501|NCT00504348|10888034|FG000|Overall Study|Lack of Efficacy|4
6876502|NCT00504348|10888034|FG000|Overall Study|Physician Decision|1
6876503|NCT00504426|10888042|FG000|Overall Study|Adverse Event|0
6876504|NCT00504426|10888043|FG001|Overall Study|Adverse Event|0
6876505|NCT00504426|10888044|FG002|Overall Study|Adverse Event|2
6876506|NCT00504426|10888045|FG003|Overall Study|Adverse Event|0
6876507|NCT00504426|10888042|FG000|Overall Study|Protocol Violation|1
6876508|NCT00504426|10888043|FG001|Overall Study|Protocol Violation|1
6876509|NCT00504426|10888044|FG002|Overall Study|Protocol Violation|2
6876510|NCT00504426|10888045|FG003|Overall Study|Protocol Violation|0
6876511|NCT00504426|10888042|FG000|Overall Study|Withdrawal by Subject|2
6876512|NCT00504426|10888043|FG001|Overall Study|Withdrawal by Subject|0
6876513|NCT00504426|10888044|FG002|Overall Study|Withdrawal by Subject|0
6876514|NCT00504426|10888045|FG003|Overall Study|Withdrawal by Subject|0
6876515|NCT00504556|10888067|FG000|Overall Study|Adverse Event|11
6876516|NCT00504556|10888068|FG001|Overall Study|Adverse Event|11
6876517|NCT00504556|10888069|FG002|Overall Study|Adverse Event|14
6876518|NCT00504556|10888070|FG003|Overall Study|Adverse Event|13
6969090|NCT01145066|11018476|FG002|Overall Study|problems swallowing capsule|0
6969091|NCT01145066|11018474|FG000|Overall Study|Abdominal discomfort|0
6969092|NCT01145066|11018475|FG001|Overall Study|Abdominal discomfort|1
6969093|NCT01145066|11018476|FG002|Overall Study|Abdominal discomfort|0
6969094|NCT01145066|11018474|FG000|Overall Study|Low platelet count|0
6969095|NCT01145066|11018475|FG001|Overall Study|Low platelet count|1
6969096|NCT01145066|11018476|FG002|Overall Study|Low platelet count|0
6969097|NCT01145222|11018505|FG000|Overall Study|Procedure not done (no anesthesiologist)|0
6969098|NCT01145222|11018506|FG001|Overall Study|Procedure not done (no anesthesiologist)|0
6876519|NCT00504556|10888071|FG004|Overall Study|Adverse Event|5
6876520|NCT00504556|10888067|FG000|Overall Study|Death|3
6876521|NCT00504556|10888068|FG001|Overall Study|Death|3
6876522|NCT00504556|10888069|FG002|Overall Study|Death|1
6876523|NCT00504556|10888070|FG003|Overall Study|Death|0
6876524|NCT00504556|10888071|FG004|Overall Study|Death|2
6876525|NCT00504556|10888067|FG000|Overall Study|Protocol Violation|1
6876526|NCT00504556|10888068|FG001|Overall Study|Protocol Violation|3
6876527|NCT00504556|10888069|FG002|Overall Study|Protocol Violation|2
6876528|NCT00504556|10888070|FG003|Overall Study|Protocol Violation|1
6876529|NCT00504556|10888071|FG004|Overall Study|Protocol Violation|2
6876530|NCT00504556|10888067|FG000|Overall Study|Lost to Follow-up|0
6876531|NCT00504556|10888068|FG001|Overall Study|Lost to Follow-up|0
6876532|NCT00504556|10888069|FG002|Overall Study|Lost to Follow-up|1
6876533|NCT00504556|10888070|FG003|Overall Study|Lost to Follow-up|1
6876534|NCT00504556|10888071|FG004|Overall Study|Lost to Follow-up|1
6876535|NCT00504556|10888067|FG000|Overall Study|Withdrawal by Subject|16
6876536|NCT00504556|10888068|FG001|Overall Study|Withdrawal by Subject|16
6876537|NCT00504556|10888069|FG002|Overall Study|Withdrawal by Subject|7
6876538|NCT00504556|10888070|FG003|Overall Study|Withdrawal by Subject|8
6876539|NCT00504556|10888071|FG004|Overall Study|Withdrawal by Subject|12
6876540|NCT00504556|10888067|FG000|Overall Study|administrative reasons|0
6876541|NCT00504556|10888068|FG001|Overall Study|administrative reasons|2
6876542|NCT00504556|10888069|FG002|Overall Study|administrative reasons|2
6876543|NCT00504556|10888070|FG003|Overall Study|administrative reasons|1
6876544|NCT00504556|10888071|FG004|Overall Study|administrative reasons|2
6876545|NCT00504556|10888067|FG000|Overall Study|did not meet entry criteria|2
6876546|NCT00504556|10888068|FG001|Overall Study|did not meet entry criteria|0
6876547|NCT00504556|10888069|FG002|Overall Study|did not meet entry criteria|1
6876548|NCT00504556|10888070|FG003|Overall Study|did not meet entry criteria|1
6876549|NCT00504556|10888071|FG004|Overall Study|did not meet entry criteria|0
6876550|NCT00504556|10888067|FG000|Overall Study|data monitor committee decision|0
7154401|NCT03310411|11321115|FG001|Period 1|Adverse Event|0
7154402|NCT03310411|11321116|FG002|Period 1|Adverse Event|0
7154403|NCT03310411|11321117|FG003|Period 1|Adverse Event|1
7154404|NCT03310580|11321152|FG000|Overall Study|Adverse Event|0
6876551|NCT00504556|10888068|FG001|Overall Study|data monitor committee decision|0
6876552|NCT00504556|10888069|FG002|Overall Study|data monitor committee decision|0
6876553|NCT00504556|10888070|FG003|Overall Study|data monitor committee decision|100
6876554|NCT00504556|10888071|FG004|Overall Study|data monitor committee decision|0
6876555|NCT00504556|10888067|FG000|Overall Study|Other|2
6876556|NCT00504556|10888068|FG001|Overall Study|Other|2
6876557|NCT00504556|10888069|FG002|Overall Study|Other|2
6876558|NCT00504556|10888070|FG003|Overall Study|Other|3
6876559|NCT00504556|10888071|FG004|Overall Study|Other|0
6876560|NCT00504556|10888067|FG000|Overall Study|not in safety analysis set|0
6876561|NCT00504556|10888068|FG001|Overall Study|not in safety analysis set|1
6876562|NCT00504556|10888069|FG002|Overall Study|not in safety analysis set|1
6876563|NCT00504556|10888070|FG003|Overall Study|not in safety analysis set|0
6876564|NCT00504556|10888071|FG004|Overall Study|not in safety analysis set|1
6876565|NCT00504595|10888087|FG000|Overall Study|Lack of Efficacy|1
6876566|NCT00504595|10888088|FG001|Overall Study|Lack of Efficacy|0
6876567|NCT00504595|10888089|FG002|Overall Study|Lack of Efficacy|0
6876568|NCT00504595|10888090|FG003|Overall Study|Lack of Efficacy|0
6876569|NCT00504595|10888087|FG000|Overall Study|Other|0
6876570|NCT00504595|10888088|FG001|Overall Study|Other|0
6876571|NCT00504595|10888089|FG002|Overall Study|Other|2
6876572|NCT00504595|10888090|FG003|Overall Study|Other|0
6876573|NCT00504725|10888111|FG000|Overall Study|Protocol Violation|1
6876574|NCT00504725|10888112|FG001|Overall Study|Protocol Violation|0
6876575|NCT00504777|10888122|FG000|Overall Study|Adverse Event|1
6876576|NCT00504829|10888129|FG000|Overall Study|Protocol Violation|6
6876577|NCT00504829|10888130|FG001|Overall Study|Protocol Violation|4
6876578|NCT00504829|10888131|FG002|Overall Study|Protocol Violation|10
6876579|NCT00504881|10888141|FG000|Overall Study|Lack of Efficacy|1
6876580|NCT00504881|10888142|FG001|Overall Study|Lack of Efficacy|5
6876581|NCT00504881|10888141|FG000|Overall Study|Lost to Follow-up|0
6876582|NCT00504881|10888142|FG001|Overall Study|Lost to Follow-up|2
6876583|NCT00504881|10888141|FG000|Overall Study|Withdrawal by Subject|1
6876584|NCT00504881|10888142|FG001|Overall Study|Withdrawal by Subject|4
6876585|NCT00504881|10888141|FG000|Overall Study|Non-Compliance|1
6876586|NCT00504881|10888142|FG001|Overall Study|Non-Compliance|0
6876587|NCT00504881|10888141|FG000|Overall Study|No Birth Control|0
6876588|NCT00504881|10888142|FG001|Overall Study|No Birth Control|1
6876589|NCT00504881|10888141|FG000|Overall Study|Safety Visit not performed|0
6876590|NCT00504881|10888142|FG001|Overall Study|Safety Visit not performed|1
6876591|NCT00504881|10888141|FG000|Overall Study|AE, serious fatal|0
6876592|NCT00504881|10888142|FG001|Overall Study|AE, serious fatal|1
6876593|NCT00504881|10888141|FG000|Overall Study|SAE, non-fatal|2
6876594|NCT00504881|10888142|FG001|Overall Study|SAE, non-fatal|6
6876595|NCT00504881|10888141|FG000|Overall Study|AE, non-serious non-fatal|4
6876596|NCT00504881|10888142|FG001|Overall Study|AE, non-serious non-fatal|14
6876597|NCT00504881|10888141|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
6876598|NCT00504881|10888142|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2
6876599|NCT00504881|10888141|FG000|Overall Study|AE of unknown type|1
6876600|NCT00504881|10888142|FG001|Overall Study|AE of unknown type|0
6876601|NCT00504894|10888153|FG000|Overall Study|fMRI technical problems|1
6876602|NCT00504894|10888154|FG001|Overall Study|fMRI technical problems|1
6876603|NCT00504894|10888155|FG002|Overall Study|fMRI technical problems|0
6876604|NCT00504894|10888153|FG000|Overall Study|Withdrawal by Subject|0
6876605|NCT00504894|10888154|FG001|Overall Study|Withdrawal by Subject|1
7154405|NCT03310580|11321153|FG001|Overall Study|Adverse Event|1
7154406|NCT03310580|11321154|FG002|Overall Study|Adverse Event|0
6876606|NCT00504894|10888155|FG002|Overall Study|Withdrawal by Subject|0
7154407|NCT03310723|11321165|FG000|Overall Study|Withdrawal by Subject|0
7154408|NCT03310723|11321166|FG001|Overall Study|Withdrawal by Subject|1
7154409|NCT03310723|11321165|FG000|Overall Study|Protocol Violation|0
7154410|NCT03310723|11321166|FG001|Overall Study|Protocol Violation|2
7154411|NCT03310775|11321174|FG000|Overall Study|Lost to Follow-up|2
7154412|NCT03310775|11321175|FG001|Overall Study|Lost to Follow-up|3
7154413|NCT03310775|11321174|FG000|Overall Study|aggravation of depression|0
7154414|NCT03310775|11321175|FG001|Overall Study|aggravation of depression|1
7154415|NCT03310970|11321181|FG000|Overall Study|Withdrawal by Subject|0
7154416|NCT03310970|11321182|FG001|Overall Study|Withdrawal by Subject|1
7154417|NCT03311230|11321193|FG000|Overall Study|Withdrawal by Subject|1
7154418|NCT03311230|11321194|FG001|Overall Study|Withdrawal by Subject|4
7154419|NCT03311230|11321195|FG002|Overall Study|Withdrawal by Subject|2
7154420|NCT03311230|11321196|FG003|Overall Study|Withdrawal by Subject|7
7154421|NCT03311230|11321193|FG000|Overall Study|Unrelated injury|0
7154422|NCT03311230|11321194|FG001|Overall Study|Unrelated injury|1
6876607|NCT00504894|10888153|FG000|Overall Study|Infusion technical problems|0
6876608|NCT00504894|10888154|FG001|Overall Study|Infusion technical problems|1
6876609|NCT00504894|10888155|FG002|Overall Study|Infusion technical problems|0
6876610|NCT00504894|10888153|FG000|Overall Study|poor subject data|2
6876611|NCT00504894|10888154|FG001|Overall Study|poor subject data|0
6876612|NCT00504894|10888155|FG002|Overall Study|poor subject data|0
6876613|NCT00505076|10888166|FG000|Overall Study|Adverse Event|1
6876614|NCT00505076|10888167|FG001|Overall Study|Adverse Event|0
6876615|NCT00505076|10888168|FG002|Overall Study|Adverse Event|1
6876616|NCT00505076|10888166|FG000|Overall Study|Protocol Violation|2
6876617|NCT00505076|10888167|FG001|Overall Study|Protocol Violation|1
6876618|NCT00505076|10888168|FG002|Overall Study|Protocol Violation|2
6876619|NCT00505076|10888166|FG000|Overall Study|Withdrawal by Subject|0
6876620|NCT00505076|10888167|FG001|Overall Study|Withdrawal by Subject|1
6876621|NCT00505076|10888168|FG002|Overall Study|Withdrawal by Subject|2
6876622|NCT00505284|10888181|FG000|Overall Study|Adverse Event|3
6876623|NCT00505284|10888182|FG001|Overall Study|Adverse Event|7
6876624|NCT00505284|10888183|FG002|Overall Study|Adverse Event|9
6876625|NCT00505284|10888184|FG003|Overall Study|Adverse Event|14
6876626|NCT00505284|10888185|FG004|Overall Study|Adverse Event|22
6876627|NCT00505284|10888181|FG000|Overall Study|Protocol Violation|0
6876628|NCT00505284|10888182|FG001|Overall Study|Protocol Violation|1
6876629|NCT00505284|10888183|FG002|Overall Study|Protocol Violation|1
6876630|NCT00505284|10888184|FG003|Overall Study|Protocol Violation|0
6876631|NCT00505284|10888185|FG004|Overall Study|Protocol Violation|0
6876632|NCT00505284|10888181|FG000|Overall Study|Withdrawal by Subject|2
6876633|NCT00505284|10888182|FG001|Overall Study|Withdrawal by Subject|6
6876634|NCT00505284|10888183|FG002|Overall Study|Withdrawal by Subject|1
6876635|NCT00505284|10888184|FG003|Overall Study|Withdrawal by Subject|0
6876636|NCT00505284|10888185|FG004|Overall Study|Withdrawal by Subject|6
6876637|NCT00505284|10888181|FG000|Overall Study|Lack of Efficacy|0
6876638|NCT00505284|10888182|FG001|Overall Study|Lack of Efficacy|1
6876639|NCT00505284|10888183|FG002|Overall Study|Lack of Efficacy|1
6876640|NCT00505284|10888184|FG003|Overall Study|Lack of Efficacy|1
6876641|NCT00505284|10888185|FG004|Overall Study|Lack of Efficacy|1
6876642|NCT00505284|10888181|FG000|Overall Study|Physician Decision|0
6876643|NCT00505284|10888182|FG001|Overall Study|Physician Decision|1
6876644|NCT00505284|10888183|FG002|Overall Study|Physician Decision|0
6876645|NCT00505284|10888184|FG003|Overall Study|Physician Decision|0
6876646|NCT00505284|10888185|FG004|Overall Study|Physician Decision|0
6876647|NCT00505284|10888181|FG000|Overall Study|Other|5
6876648|NCT00505284|10888182|FG001|Overall Study|Other|0
6876649|NCT00505284|10888183|FG002|Overall Study|Other|0
6876650|NCT00505284|10888184|FG003|Overall Study|Other|4
6969099|NCT01145222|11018507|FG002|Overall Study|Procedure not done (no anesthesiologist)|1
6969100|NCT01145222|11018508|FG003|Overall Study|Procedure not done (no anesthesiologist)|0
6969101|NCT01145222|11018505|FG000|Overall Study|Poor bowel preparation|0
7154423|NCT03311230|11321195|FG002|Overall Study|Unrelated injury|0
7154424|NCT03311230|11321196|FG003|Overall Study|Unrelated injury|0
7154425|NCT03311373|11321206|FG000|Overall Study|Adverse Event|1
7154426|NCT03311373|11321206|FG000|Overall Study|Protocol Discontinuation Criteria|3
7154427|NCT03311373|11321206|FG000|Overall Study|Lost to Follow-up|1
6876651|NCT00505284|10888185|FG004|Overall Study|Other|4
6876652|NCT00505375|10888208|FG000|Overall Study|Death|1
6876653|NCT00505375|10888209|FG001|Overall Study|Death|0
6876654|NCT00505375|10888208|FG000|Overall Study|Withdrawal by Subject|2
6876655|NCT00505375|10888209|FG001|Overall Study|Withdrawal by Subject|2
6876656|NCT00505375|10888208|FG000|Overall Study|Lost to Follow-up|0
6876657|NCT00505375|10888209|FG001|Overall Study|Lost to Follow-up|2
6876658|NCT00505375|10888208|FG000|Overall Study|Pregnancy|1
6876659|NCT00505375|10888209|FG001|Overall Study|Pregnancy|0
6876660|NCT00505375|10888208|FG000|Overall Study|Travel issues|0
6876661|NCT00505375|10888209|FG001|Overall Study|Travel issues|1
6876662|NCT00505414|10888217|FG000|Titration Phase|Adverse Event|0
6876663|NCT00505414|10888218|FG001|Titration Phase|Adverse Event|0
6876664|NCT00505414|10888219|FG002|Titration Phase|Adverse Event|0
6876665|NCT00505414|10888220|FG003|Titration Phase|Adverse Event|8
6876666|NCT00505414|10888221|FG004|Titration Phase|Adverse Event|3
6876667|NCT00505414|10888217|FG000|Titration Phase|Death|0
6876668|NCT00505414|10888218|FG001|Titration Phase|Death|0
6876669|NCT00505414|10888219|FG002|Titration Phase|Death|0
6876670|NCT00505414|10888220|FG003|Titration Phase|Death|2
6876671|NCT00505414|10888221|FG004|Titration Phase|Death|0
6876672|NCT00505414|10888217|FG000|Titration Phase|Lack of Efficacy|0
6876673|NCT00505414|10888218|FG001|Titration Phase|Lack of Efficacy|0
6876674|NCT00505414|10888219|FG002|Titration Phase|Lack of Efficacy|0
6876675|NCT00505414|10888220|FG003|Titration Phase|Lack of Efficacy|10
6876676|NCT00505414|10888221|FG004|Titration Phase|Lack of Efficacy|1
6876677|NCT00505414|10888217|FG000|Titration Phase|Protocol Violation|0
6876678|NCT00505414|10888218|FG001|Titration Phase|Protocol Violation|0
6876679|NCT00505414|10888219|FG002|Titration Phase|Protocol Violation|0
6876680|NCT00505414|10888220|FG003|Titration Phase|Protocol Violation|0
6876681|NCT00505414|10888221|FG004|Titration Phase|Protocol Violation|1
6876682|NCT00505414|10888217|FG000|Titration Phase|Withdrawal by Subject|0
6876683|NCT00505414|10888218|FG001|Titration Phase|Withdrawal by Subject|0
6876684|NCT00505414|10888219|FG002|Titration Phase|Withdrawal by Subject|0
6876685|NCT00505414|10888220|FG003|Titration Phase|Withdrawal by Subject|3
6876686|NCT00505414|10888221|FG004|Titration Phase|Withdrawal by Subject|4
6876687|NCT00505414|10888217|FG000|Titration Phase|Underlying disease and therapy required|0
6876688|NCT00505414|10888218|FG001|Titration Phase|Underlying disease and therapy required|0
6876689|NCT00505414|10888219|FG002|Titration Phase|Underlying disease and therapy required|0
6876690|NCT00505414|10888220|FG003|Titration Phase|Underlying disease and therapy required|7
6876691|NCT00505414|10888221|FG004|Titration Phase|Underlying disease and therapy required|3
6876692|NCT00505414|10888217|FG000|Maintenance Phase|Adverse Event|2
6876693|NCT00505414|10888218|FG001|Maintenance Phase|Adverse Event|2
6876694|NCT00505414|10888219|FG002|Maintenance Phase|Adverse Event|3
6876695|NCT00505414|10888220|FG003|Maintenance Phase|Adverse Event|0
6876696|NCT00505414|10888221|FG004|Maintenance Phase|Adverse Event|0
6876697|NCT00505414|10888217|FG000|Maintenance Phase|Death|2
6876698|NCT00505414|10888218|FG001|Maintenance Phase|Death|0
6876699|NCT00505414|10888219|FG002|Maintenance Phase|Death|1
6876700|NCT00505414|10888220|FG003|Maintenance Phase|Death|0
6876701|NCT00505414|10888221|FG004|Maintenance Phase|Death|0
6876702|NCT00505414|10888217|FG000|Maintenance Phase|Lack of Efficacy|2
6876703|NCT00505414|10888218|FG001|Maintenance Phase|Lack of Efficacy|1
6876704|NCT00505414|10888219|FG002|Maintenance Phase|Lack of Efficacy|1
6876705|NCT00505414|10888220|FG003|Maintenance Phase|Lack of Efficacy|0
6876706|NCT00505414|10888221|FG004|Maintenance Phase|Lack of Efficacy|0
6876707|NCT00505414|10888217|FG000|Maintenance Phase|Withdrawal by Subject|0
6876708|NCT00505414|10888218|FG001|Maintenance Phase|Withdrawal by Subject|0
6876709|NCT00505414|10888219|FG002|Maintenance Phase|Withdrawal by Subject|1
6876710|NCT00505414|10888220|FG003|Maintenance Phase|Withdrawal by Subject|0
6876711|NCT00505414|10888221|FG004|Maintenance Phase|Withdrawal by Subject|0
6876712|NCT00505414|10888217|FG000|Maintenance Phase|underlying disease and therapy required|0
6876713|NCT00505414|10888218|FG001|Maintenance Phase|underlying disease and therapy required|2
6876714|NCT00505414|10888219|FG002|Maintenance Phase|underlying disease and therapy required|2
6876715|NCT00505414|10888220|FG003|Maintenance Phase|underlying disease and therapy required|0
6876716|NCT00505414|10888221|FG004|Maintenance Phase|underlying disease and therapy required|0
6876717|NCT00505622|10888240|FG000|Overall Study|Adverse Event|5
6876718|NCT00505622|10888241|FG001|Overall Study|Adverse Event|6
6876719|NCT00505622|10888242|FG002|Overall Study|Adverse Event|4
6876720|NCT00505622|10888240|FG000|Overall Study|Protocol Violation|1
6876721|NCT00505622|10888241|FG001|Overall Study|Protocol Violation|1
6876722|NCT00505622|10888242|FG002|Overall Study|Protocol Violation|0
6876723|NCT00505622|10888240|FG000|Overall Study|Withdrawal by Subject|0
6876724|NCT00505622|10888241|FG001|Overall Study|Withdrawal by Subject|3
6876725|NCT00505622|10888242|FG002|Overall Study|Withdrawal by Subject|2
6876726|NCT00505622|10888240|FG000|Overall Study|Study termination by sponsor|115
6876727|NCT00505622|10888241|FG001|Overall Study|Study termination by sponsor|98
6876728|NCT00505622|10888242|FG002|Overall Study|Study termination by sponsor|90
6876729|NCT00505661|10888254|FG000|Overall Study|Not Eligible|4
6876730|NCT00505687|10888258|FG000|Overall Study|Important protocol violation|2
6876731|NCT00505687|10888258|FG000|Overall Study|Lack of Efficacy|15
6876732|NCT00505687|10888258|FG000|Overall Study|Adverse Event|48
6876733|NCT00505687|10888258|FG000|Overall Study|Subject withdrew consent|15
6876734|NCT00505687|10888258|FG000|Overall Study|Lost to Follow-up|1
6876735|NCT00505687|10888258|FG000|Overall Study|Other: Underwent Implantation Of DBS|1
6876736|NCT00505687|10888258|FG000|Overall Study|Other: Scheduled DBS Surgery|1
6876737|NCT00505687|10888258|FG000|Overall Study|Other: Prolonged Hospitalization|1
6876738|NCT00505687|10888258|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1
6876739|NCT00505687|10888258|FG000|Overall Study|Other: Neupro Given In Hospital|1
6876740|NCT00505687|10888258|FG000|Overall Study|Other: Disease Progression|1
6876741|NCT00505687|10888258|FG000|Overall Study|Other: As Per Sponsor|8
6876742|NCT00505752|10888266|FG000|Overall Study|Adverse Event|1
6876743|NCT00505752|10888267|FG001|Overall Study|Adverse Event|0
6876744|NCT00505752|10888268|FG002|Overall Study|Adverse Event|1
6876745|NCT00505752|10888269|FG003|Overall Study|Adverse Event|0
6876746|NCT00505752|10888266|FG000|Overall Study|Lost to Follow-up|1
6876747|NCT00505752|10888267|FG001|Overall Study|Lost to Follow-up|0
6876748|NCT00505752|10888268|FG002|Overall Study|Lost to Follow-up|0
6876749|NCT00505752|10888269|FG003|Overall Study|Lost to Follow-up|0
6876750|NCT00505752|10888266|FG000|Overall Study|Lack of ovarian response|1
6876751|NCT00505752|10888267|FG001|Overall Study|Lack of ovarian response|3
6876752|NCT00505752|10888268|FG002|Overall Study|Lack of ovarian response|0
6876753|NCT00505752|10888269|FG003|Overall Study|Lack of ovarian response|0
6876754|NCT00505752|10888266|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1
6876755|NCT00505752|10888267|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1
6876756|NCT00505752|10888268|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3
6876757|NCT00505752|10888269|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1
6876758|NCT00505752|10888266|FG000|Overall Study|No oocytes retrieved|0
6876759|NCT00505752|10888267|FG001|Overall Study|No oocytes retrieved|2
6876760|NCT00505752|10888268|FG002|Overall Study|No oocytes retrieved|0
6876761|NCT00505752|10888269|FG003|Overall Study|No oocytes retrieved|1
6876762|NCT00505752|10888266|FG000|Overall Study|No Fertilization|1
6876763|NCT00505752|10888267|FG001|Overall Study|No Fertilization|1
6876764|NCT00505752|10888268|FG002|Overall Study|No Fertilization|2
6876765|NCT00505752|10888269|FG003|Overall Study|No Fertilization|1
6876766|NCT00505752|10888266|FG000|Overall Study|All embryos/blastocysts discarded|0
6876767|NCT00505752|10888267|FG001|Overall Study|All embryos/blastocysts discarded|0
6876768|NCT00505752|10888268|FG002|Overall Study|All embryos/blastocysts discarded|1
6876769|NCT00505752|10888269|FG003|Overall Study|All embryos/blastocysts discarded|1
6876770|NCT00505752|10888266|FG000|Overall Study|Other|1
6876771|NCT00505752|10888267|FG001|Overall Study|Other|2
6876772|NCT00505752|10888268|FG002|Overall Study|Other|1
6876773|NCT00505752|10888269|FG003|Overall Study|Other|2
6876774|NCT00505765|10888282|FG000|Overall Study|Withdrawal by Subject|1
6876775|NCT00505765|10888283|FG001|Overall Study|Withdrawal by Subject|0
6876776|NCT00505765|10888284|FG002|Overall Study|Withdrawal by Subject|0
6876777|NCT00505765|10888282|FG000|Overall Study|Adverse Event|1
6876778|NCT00505765|10888283|FG001|Overall Study|Adverse Event|2
6876779|NCT00505765|10888284|FG002|Overall Study|Adverse Event|0
6876780|NCT00505765|10888282|FG000|Overall Study|Noncompliance|0
6876781|NCT00505765|10888283|FG001|Overall Study|Noncompliance|1
6876782|NCT00505765|10888284|FG002|Overall Study|Noncompliance|3
6876783|NCT00505778|10888294|FG000|Overall Study|Adverse Event|2
6876784|NCT00505778|10888295|FG001|Overall Study|Adverse Event|7
6876785|NCT00505778|10888294|FG000|Overall Study|Physician Decision|8
6876786|NCT00505778|10888295|FG001|Overall Study|Physician Decision|14
6876787|NCT00505778|10888294|FG000|Overall Study|Lost to Follow-up|17
6876788|NCT00505778|10888295|FG001|Overall Study|Lost to Follow-up|23
6876789|NCT00505778|10888294|FG000|Overall Study|Unable to Meet Protocol Criteria|4
6876790|NCT00505778|10888295|FG001|Overall Study|Unable to Meet Protocol Criteria|1
6876791|NCT00505778|10888294|FG000|Overall Study|Protocol Violation|7
6876792|NCT00505778|10888295|FG001|Overall Study|Protocol Violation|9
6876793|NCT00505778|10888294|FG000|Overall Study|Withdrawal by Subject|29
6876794|NCT00505778|10888295|FG001|Overall Study|Withdrawal by Subject|14
6876795|NCT00505778|10888294|FG000|Overall Study|Relapse|65
6876796|NCT00505778|10888295|FG001|Overall Study|Relapse|65
6876797|NCT00505778|10888294|FG000|Overall Study|Took No Study Drug|2
6876798|NCT00505778|10888295|FG001|Overall Study|Took No Study Drug|2
6876799|NCT00505921|10888310|FG000|Overall Study|Ineligible|1
6876800|NCT00505921|10888310|FG000|Overall Study|Failed to Mobilize|8
6876801|NCT00505934|10888314|FG000|Overall Study|Adverse Event|1
6876802|NCT00505934|10888314|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1
6876803|NCT00505934|10888314|FG000|Overall Study|Other: IV dose needed to be changed|1
6876804|NCT00506077|10888333|FG000|Treatment Period 1|Adverse Event|2
6876805|NCT00506077|10888334|FG001|Treatment Period 1|Adverse Event|1
6876806|NCT00506077|10888333|FG000|Treatment Period 1|Lost to Follow-up|0
6876807|NCT00506077|10888334|FG001|Treatment Period 1|Lost to Follow-up|2
6876808|NCT00506077|10888333|FG000|Treatment Period 1|Withdrawal by Subject|2
6876809|NCT00506077|10888334|FG001|Treatment Period 1|Withdrawal by Subject|0
6876810|NCT00506077|10888333|FG000|Treatment Period 2|Adverse Event|0
6876811|NCT00506077|10888334|FG001|Treatment Period 2|Adverse Event|1
6876812|NCT00506077|10888333|FG000|Treatment Period 2|Withdrawal by Subject|1
6876813|NCT00506077|10888334|FG001|Treatment Period 2|Withdrawal by Subject|0
6876814|NCT00506129|10888340|FG000|Overall Study|Disease Progression/Relapse|15
6876815|NCT00506129|10888340|FG000|Overall Study|Death|7
6876816|NCT00506142|10888346|FG000|Overall Study|Adverse Event|8
6876817|NCT00506142|10888347|FG001|Overall Study|Adverse Event|7
6876818|NCT00506142|10888346|FG000|Overall Study|Lack of Efficacy|21
6876819|NCT00506142|10888347|FG001|Overall Study|Lack of Efficacy|7
6876820|NCT00506142|10888346|FG000|Overall Study|Withdrawal by Subject|4
6876821|NCT00506142|10888347|FG001|Overall Study|Withdrawal by Subject|5
6876822|NCT00506142|10888346|FG000|Overall Study|Physician Decision|1
6876823|NCT00506142|10888347|FG001|Overall Study|Physician Decision|0
6876824|NCT00506142|10888346|FG000|Overall Study|New health condition|1
6876825|NCT00506142|10888347|FG001|Overall Study|New health condition|0
6876826|NCT00506285|10888359|FG000|3 Week Screening Phase|Withdrawal by Subject|17
6876827|NCT00506285|10888360|FG001|3 Week Screening Phase|Withdrawal by Subject|10
6876828|NCT00506285|10888359|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4
6876829|NCT00506285|10888360|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3
6876830|NCT00506285|10888359|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5
6876831|NCT00506285|10888360|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2
6876832|NCT00506285|10888359|FG000|6-month Open Label Phase|Lost to Follow-up|1
6876833|NCT00506285|10888360|FG001|6-month Open Label Phase|Lost to Follow-up|7
6876834|NCT00506285|10888359|FG000|6-month Open Label Phase|Withdrawal by Subject|9
6876835|NCT00506285|10888360|FG001|6-month Open Label Phase|Withdrawal by Subject|5
6876836|NCT00506350|10888377|FG000|Overall Study|Serious Adverse Event|1
6876837|NCT00506350|10888378|FG001|Overall Study|Serious Adverse Event|0
6876838|NCT00506350|10888379|FG002|Overall Study|Serious Adverse Event|0
6876839|NCT00506350|10888380|FG003|Overall Study|Serious Adverse Event|0
6876840|NCT00506350|10888381|FG004|Overall Study|Serious Adverse Event|0
6876841|NCT00506350|10888382|FG005|Overall Study|Serious Adverse Event|0
6876842|NCT00506350|10888383|FG006|Overall Study|Serious Adverse Event|0
6876843|NCT00506350|10888384|FG007|Overall Study|Serious Adverse Event|0
6876844|NCT00506350|10888385|FG008|Overall Study|Serious Adverse Event|0
6876845|NCT00506350|10888377|FG000|Overall Study|Adverse Event|0
6876846|NCT00506350|10888378|FG001|Overall Study|Adverse Event|0
6876847|NCT00506350|10888379|FG002|Overall Study|Adverse Event|0
6876848|NCT00506350|10888380|FG003|Overall Study|Adverse Event|0
6876849|NCT00506350|10888381|FG004|Overall Study|Adverse Event|0
6876850|NCT00506350|10888382|FG005|Overall Study|Adverse Event|0
6876851|NCT00506350|10888383|FG006|Overall Study|Adverse Event|0
6876852|NCT00506350|10888384|FG007|Overall Study|Adverse Event|1
6876853|NCT00506350|10888385|FG008|Overall Study|Adverse Event|1
6876854|NCT00506350|10888377|FG000|Overall Study|Protocol Violation|0
6876855|NCT00506350|10888378|FG001|Overall Study|Protocol Violation|0
6876856|NCT00506350|10888379|FG002|Overall Study|Protocol Violation|1
6876857|NCT00506350|10888380|FG003|Overall Study|Protocol Violation|0
6876858|NCT00506350|10888381|FG004|Overall Study|Protocol Violation|0
6876859|NCT00506350|10888382|FG005|Overall Study|Protocol Violation|0
6876860|NCT00506350|10888383|FG006|Overall Study|Protocol Violation|1
6876861|NCT00506350|10888384|FG007|Overall Study|Protocol Violation|0
6876862|NCT00506350|10888385|FG008|Overall Study|Protocol Violation|0
6876863|NCT00506350|10888377|FG000|Overall Study|Withdrawal by Subject|0
6876864|NCT00506350|10888378|FG001|Overall Study|Withdrawal by Subject|1
6876865|NCT00506350|10888379|FG002|Overall Study|Withdrawal by Subject|1
6876866|NCT00506350|10888380|FG003|Overall Study|Withdrawal by Subject|1
6876867|NCT00506350|10888381|FG004|Overall Study|Withdrawal by Subject|4
6876868|NCT00506350|10888382|FG005|Overall Study|Withdrawal by Subject|1
6876869|NCT00506350|10888383|FG006|Overall Study|Withdrawal by Subject|1
6876870|NCT00506350|10888384|FG007|Overall Study|Withdrawal by Subject|2
6876871|NCT00506350|10888385|FG008|Overall Study|Withdrawal by Subject|0
6876872|NCT00506350|10888377|FG000|Overall Study|Lost to Follow-up|1
6876873|NCT00506350|10888378|FG001|Overall Study|Lost to Follow-up|1
6876874|NCT00506350|10888379|FG002|Overall Study|Lost to Follow-up|1
6876875|NCT00506350|10888380|FG003|Overall Study|Lost to Follow-up|1
6876876|NCT00506350|10888381|FG004|Overall Study|Lost to Follow-up|2
6876877|NCT00506350|10888382|FG005|Overall Study|Lost to Follow-up|1
6876878|NCT00506350|10888383|FG006|Overall Study|Lost to Follow-up|0
6876879|NCT00506350|10888384|FG007|Overall Study|Lost to Follow-up|0
6876880|NCT00506350|10888385|FG008|Overall Study|Lost to Follow-up|2
6876881|NCT00506350|10888377|FG000|Overall Study|Medical Reason|0
6876882|NCT00506350|10888378|FG001|Overall Study|Medical Reason|0
6876883|NCT00506350|10888379|FG002|Overall Study|Medical Reason|0
6876884|NCT00506350|10888380|FG003|Overall Study|Medical Reason|0
6876885|NCT00506350|10888381|FG004|Overall Study|Medical Reason|1
6876886|NCT00506350|10888382|FG005|Overall Study|Medical Reason|0
6876887|NCT00506350|10888383|FG006|Overall Study|Medical Reason|0
6876888|NCT00506350|10888384|FG007|Overall Study|Medical Reason|0
6876889|NCT00506350|10888385|FG008|Overall Study|Medical Reason|0
6876890|NCT00506350|10888377|FG000|Overall Study|Other|1
6876891|NCT00506350|10888378|FG001|Overall Study|Other|1
6876892|NCT00506350|10888379|FG002|Overall Study|Other|3
6876893|NCT00506350|10888380|FG003|Overall Study|Other|0
6876894|NCT00506350|10888381|FG004|Overall Study|Other|3
6876895|NCT00506350|10888382|FG005|Overall Study|Other|0
6876896|NCT00506350|10888383|FG006|Overall Study|Other|0
6876897|NCT00506350|10888384|FG007|Overall Study|Other|2
6876898|NCT00506350|10888385|FG008|Overall Study|Other|2
6876899|NCT00506389|10888415|FG000|In-treatment Period|Other|3
6876900|NCT00506389|10888416|FG001|In-treatment Period|Other|3
6876901|NCT00506389|10888417|FG002|In-treatment Period|Other|4
6876902|NCT00506389|10888415|FG000|In-treatment Period|Lost to Follow-up|0
6876903|NCT00506389|10888416|FG001|In-treatment Period|Lost to Follow-up|0
6876904|NCT00506389|10888417|FG002|In-treatment Period|Lost to Follow-up|1
6876905|NCT00506389|10888415|FG000|In-treatment Period|Lack of compliance|1
6876906|NCT00506389|10888416|FG001|In-treatment Period|Lack of compliance|0
6876907|NCT00506389|10888417|FG002|In-treatment Period|Lack of compliance|0
6876908|NCT00506389|10888415|FG000|In-treatment Period|Reasons not related to trial|4
6876909|NCT00506389|10888416|FG001|In-treatment Period|Reasons not related to trial|1
6876910|NCT00506389|10888417|FG002|In-treatment Period|Reasons not related to trial|0
6876911|NCT00506389|10888415|FG000|In-treatment Period|Withdrawal by Subject|3
6876912|NCT00506389|10888416|FG001|In-treatment Period|Withdrawal by Subject|3
6876913|NCT00506389|10888417|FG002|In-treatment Period|Withdrawal by Subject|4
6876914|NCT00506389|10888415|FG000|In-treatment Period|Lack of Efficacy|0
6876915|NCT00506389|10888416|FG001|In-treatment Period|Lack of Efficacy|2
6876916|NCT00506389|10888417|FG002|In-treatment Period|Lack of Efficacy|0
6876917|NCT00506389|10888415|FG000|In-treatment Period|Adverse Event|11
6876918|NCT00506389|10888416|FG001|In-treatment Period|Adverse Event|5
6876919|NCT00506389|10888417|FG002|In-treatment Period|Adverse Event|2
6876920|NCT00506389|10888415|FG000|In-treatment Period|Randomized but not treated|4
6876921|NCT00506389|10888416|FG001|In-treatment Period|Randomized but not treated|1
6876922|NCT00506389|10888417|FG002|In-treatment Period|Randomized but not treated|1
6876923|NCT00506415|10888428|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272
6876924|NCT00506415|10888429|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
6876925|NCT00506415|10888430|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
6876926|NCT00506415|10888431|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
6876927|NCT00506415|10888428|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1
6876928|NCT00506415|10888429|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
6876929|NCT00506415|10888430|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
6876930|NCT00506415|10888431|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
6876931|NCT00506415|10888428|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1
6876932|NCT00506415|10888429|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
6876933|NCT00506415|10888430|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
6876934|NCT00506415|10888431|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
6876935|NCT00506415|10888428|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58
6876936|NCT00506415|10888429|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
6876937|NCT00506415|10888430|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
6876938|NCT00506415|10888431|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
6876939|NCT00506415|10888428|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88
6876940|NCT00506415|10888429|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
6876941|NCT00506415|10888430|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
6876942|NCT00506415|10888431|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
6876943|NCT00506415|10888428|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22
6876944|NCT00506415|10888429|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
7154428|NCT03311373|11321206|FG000|Overall Study|Physician Decision|1
7154429|NCT03311373|11321206|FG000|Overall Study|Withdrawal by Subject|3
7154430|NCT03311646|11321216|FG000|Overall Study|Physician Decision|1
6876945|NCT00506415|10888430|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
6876946|NCT00506415|10888431|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
6876947|NCT00506415|10888428|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7
6876948|NCT00506415|10888429|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
6876949|NCT00506415|10888430|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
6876950|NCT00506415|10888431|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
6876951|NCT00506415|10888428|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22
6876952|NCT00506415|10888429|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0
6876953|NCT00506415|10888430|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0
6876954|NCT00506415|10888431|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0
6876955|NCT00506415|10888428|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28
6876956|NCT00506415|10888429|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
6876957|NCT00506415|10888430|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
6876958|NCT00506415|10888431|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
6876959|NCT00506415|10888428|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0
6876960|NCT00506415|10888429|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33
6876961|NCT00506415|10888430|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28
6876962|NCT00506415|10888431|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0
6876963|NCT00506415|10888428|FG000|Double Blind (Maximum 48 Weeks )|Death|0
6876964|NCT00506415|10888429|FG001|Double Blind (Maximum 48 Weeks )|Death|5
6876965|NCT00506415|10888430|FG002|Double Blind (Maximum 48 Weeks )|Death|3
6876966|NCT00506415|10888431|FG003|Double Blind (Maximum 48 Weeks )|Death|0
6876967|NCT00506415|10888428|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
6876968|NCT00506415|10888429|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
6876969|NCT00506415|10888430|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
6876970|NCT00506415|10888431|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
6876971|NCT00506415|10888428|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
6876972|NCT00506415|10888429|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5
6876973|NCT00506415|10888430|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3
6876974|NCT00506415|10888431|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
6876975|NCT00506415|10888428|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
6876976|NCT00506415|10888429|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4
6876977|NCT00506415|10888430|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6
6876978|NCT00506415|10888431|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
6876979|NCT00506415|10888428|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
6876980|NCT00506415|10888429|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20
6969102|NCT01145222|11018506|FG001|Overall Study|Poor bowel preparation|0
7154431|NCT03311646|11321216|FG000|Overall Study|Withdrawal by Subject|5
6876981|NCT00506415|10888430|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17
6876982|NCT00506415|10888431|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
6876983|NCT00506415|10888428|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0
6876984|NCT00506415|10888429|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3
6876985|NCT00506415|10888430|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2
6876986|NCT00506415|10888431|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0
6876987|NCT00506415|10888428|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
6876988|NCT00506415|10888429|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
6876989|NCT00506415|10888430|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1
6876990|NCT00506415|10888431|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
6876991|NCT00506415|10888428|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
6876992|NCT00506415|10888429|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
6969103|NCT01145222|11018507|FG002|Overall Study|Poor bowel preparation|0
6969104|NCT01145222|11018508|FG003|Overall Study|Poor bowel preparation|1
6876993|NCT00506415|10888430|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
6876994|NCT00506415|10888431|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4
6876995|NCT00506415|10888428|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
6876996|NCT00506415|10888429|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
7154432|NCT03311646|11321216|FG000|Overall Study|Lost to Follow-up|5
7154433|NCT03311646|11321216|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4
7154434|NCT03311659|11321221|FG000|Overall Study|Protocol Violation|1
7154435|NCT03311724|11321229|FG000|Overall Study|Physician Decision|0
7154436|NCT03311724|11321230|FG001|Overall Study|Physician Decision|0
7154437|NCT03311724|11321231|FG002|Overall Study|Physician Decision|0
6876997|NCT00506415|10888430|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
6876998|NCT00506415|10888431|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18
6876999|NCT00506415|10888428|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
6877000|NCT00506415|10888429|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
6877001|NCT00506415|10888430|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
6877002|NCT00506415|10888431|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8
6877003|NCT00506415|10888428|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
6877004|NCT00506415|10888429|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
6877005|NCT00506415|10888430|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
6877006|NCT00506415|10888431|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14
6877007|NCT00506415|10888428|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
6877008|NCT00506415|10888429|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
6877009|NCT00506415|10888430|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
6877010|NCT00506415|10888431|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5
6877011|NCT00506415|10888428|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
6877012|NCT00506415|10888429|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
6877013|NCT00506415|10888430|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
6877014|NCT00506415|10888431|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6
6877015|NCT00506415|10888428|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0
6877016|NCT00506415|10888429|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0
6877017|NCT00506415|10888430|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0
6877018|NCT00506415|10888431|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7
6877019|NCT00506441|10888444|FG000|Period 1; Open-label Period|Adverse Event|21
6877020|NCT00506441|10888445|FG001|Period 1; Open-label Period|Adverse Event|0
6877021|NCT00506441|10888444|FG000|Period 1; Open-label Period|Lack of Efficacy|13
6877022|NCT00506441|10888445|FG001|Period 1; Open-label Period|Lack of Efficacy|0
6877023|NCT00506441|10888444|FG000|Period 1; Open-label Period|Lost to Follow-up|2
6877024|NCT00506441|10888445|FG001|Period 1; Open-label Period|Lost to Follow-up|0
6877025|NCT00506441|10888444|FG000|Period 1; Open-label Period|Physician Decision|5
6877026|NCT00506441|10888445|FG001|Period 1; Open-label Period|Physician Decision|0
6877027|NCT00506441|10888444|FG000|Period 1; Open-label Period|Protocol Violation|9
6877028|NCT00506441|10888445|FG001|Period 1; Open-label Period|Protocol Violation|0
6877029|NCT00506441|10888444|FG000|Period 1; Open-label Period|Withdrawal by Subject|13
6877030|NCT00506441|10888445|FG001|Period 1; Open-label Period|Withdrawal by Subject|0
6877031|NCT00506441|10888444|FG000|Period 1; Open-label Period|Other Reasons|13
6877032|NCT00506441|10888445|FG001|Period 1; Open-label Period|Other Reasons|0
6877033|NCT00506441|10888444|FG000|Period 2; Double-blind Period|Adverse Event|0
6877034|NCT00506441|10888445|FG001|Period 2; Double-blind Period|Adverse Event|1
6877035|NCT00506441|10888444|FG000|Period 2; Double-blind Period|Lack of Efficacy|0
6877036|NCT00506441|10888445|FG001|Period 2; Double-blind Period|Lack of Efficacy|2
6877037|NCT00506441|10888444|FG000|Period 2; Double-blind Period|Physician Decision|1
6877038|NCT00506441|10888445|FG001|Period 2; Double-blind Period|Physician Decision|1
6877039|NCT00506441|10888444|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1
6877040|NCT00506441|10888445|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0
6877041|NCT00506441|10888444|FG000|Period 2; Double-blind Period|Other Reason|1
6877042|NCT00506441|10888445|FG001|Period 2; Double-blind Period|Other Reason|1
7154438|NCT03311724|11321232|FG003|Overall Study|Physician Decision|1
6877043|NCT00506454|10888455|FG000|Overall Study|Withdrawal by Subject|1
6877044|NCT00506454|10888456|FG001|Overall Study|Withdrawal by Subject|1
6877045|NCT00506493|10888462|FG000|Overall Study|Death|6
6877046|NCT00506493|10888462|FG000|Overall Study|Withdrawal by Subject|5
6877047|NCT00506519|10888471|FG000|Overall Study|Death|4
6877048|NCT00506519|10888472|FG001|Overall Study|Death|6
6877049|NCT00506519|10888473|FG002|Overall Study|Death|0
7154439|NCT03311724|11321229|FG000|Overall Study|Protocol Violation|1
7154440|NCT03311724|11321230|FG001|Overall Study|Protocol Violation|0
7154441|NCT03311724|11321231|FG002|Overall Study|Protocol Violation|1
7154442|NCT03311724|11321232|FG003|Overall Study|Protocol Violation|0
7154443|NCT03311724|11321229|FG000|Overall Study|Withdrawal by Subject|1
7154444|NCT03311724|11321230|FG001|Overall Study|Withdrawal by Subject|1
7154445|NCT03311724|11321231|FG002|Overall Study|Withdrawal by Subject|0
7154446|NCT03311724|11321232|FG003|Overall Study|Withdrawal by Subject|0
7154447|NCT03311724|11321229|FG000|Overall Study|Lost to Follow-up|1
7154448|NCT03311724|11321230|FG001|Overall Study|Lost to Follow-up|0
7154449|NCT03311724|11321231|FG002|Overall Study|Lost to Follow-up|0
7154450|NCT03311724|11321232|FG003|Overall Study|Lost to Follow-up|0
7154451|NCT03311724|11321229|FG000|Overall Study|Sponsor Decision|0
7154452|NCT03311724|11321230|FG001|Overall Study|Sponsor Decision|0
7154453|NCT03311724|11321231|FG002|Overall Study|Sponsor Decision|1
6877050|NCT00506519|10888471|FG000|Overall Study|Adverse Event|1
6877051|NCT00506519|10888472|FG001|Overall Study|Adverse Event|0
6877052|NCT00506519|10888473|FG002|Overall Study|Adverse Event|0
6877053|NCT00506662|10888490|FG000|Overall Study|Adverse Event|0
6877054|NCT00506662|10888491|FG001|Overall Study|Adverse Event|2
6877055|NCT00506662|10888490|FG000|Overall Study|Lack of Efficacy|1
6877056|NCT00506662|10888491|FG001|Overall Study|Lack of Efficacy|0
6877057|NCT00506662|10888490|FG000|Overall Study|Protocol Violation|2
6877058|NCT00506662|10888491|FG001|Overall Study|Protocol Violation|4
6877059|NCT00506662|10888490|FG000|Overall Study|Trial terminated|10
6877060|NCT00506662|10888491|FG001|Overall Study|Trial terminated|16
6877061|NCT00506662|10888490|FG000|Overall Study|Not recorded|4
6877062|NCT00506662|10888491|FG001|Overall Study|Not recorded|6
6877063|NCT00506753|10888519|FG000|Overall Study|Lost to Follow-up|21
6877064|NCT00506753|10888520|FG001|Overall Study|Lost to Follow-up|15
6877065|NCT00506779|10888528|FG000|Overall Study|Withdrawal by Subject|1
6877066|NCT00506779|10888529|FG001|Overall Study|Withdrawal by Subject|0
6877067|NCT00506779|10888530|FG002|Overall Study|Withdrawal by Subject|1
6877068|NCT00506779|10888531|FG003|Overall Study|Withdrawal by Subject|0
6877069|NCT00506779|10888528|FG000|Overall Study|Adverse Event|0
6877070|NCT00506779|10888529|FG001|Overall Study|Adverse Event|1
6877071|NCT00506779|10888530|FG002|Overall Study|Adverse Event|1
6877072|NCT00506779|10888531|FG003|Overall Study|Adverse Event|1
6877073|NCT00506831|10888542|FG000|Overall Study|Death|1
6877074|NCT00506831|10888542|FG000|Overall Study|Withdrawal by Subject|1
6877075|NCT00506883|10888554|FG000|Overall Study|Lost to Follow-up|1
6877076|NCT00506883|10888555|FG001|Overall Study|Lost to Follow-up|1
6877077|NCT00506883|10888556|FG002|Overall Study|Lost to Follow-up|1
6877078|NCT00506883|10888554|FG000|Overall Study|Withdrawal by Subject|1
6877079|NCT00506883|10888555|FG001|Overall Study|Withdrawal by Subject|0
6877080|NCT00506883|10888556|FG002|Overall Study|Withdrawal by Subject|1
6877081|NCT00506883|10888554|FG000|Overall Study|Lack of Efficacy|0
6877082|NCT00506883|10888555|FG001|Overall Study|Lack of Efficacy|1
7154454|NCT03311724|11321232|FG003|Overall Study|Sponsor Decision|0
7154455|NCT03311841|11321250|FG000|14-day Wash-out|Adverse Event|0
7154456|NCT03311841|11321251|FG001|14-day Wash-out|Adverse Event|1
7154457|NCT03311841|11321252|FG002|14-day Wash-out|Adverse Event|0
7154458|NCT03311841|11321253|FG003|14-day Wash-out|Adverse Event|0
7154459|NCT03311841|11321254|FG004|14-day Wash-out|Adverse Event|0
7154460|NCT03311841|11321250|FG000|14-day Wash-out|Non-Compliance With Study Drug|0
7154461|NCT03311841|11321251|FG001|14-day Wash-out|Non-Compliance With Study Drug|0
7154462|NCT03311841|11321252|FG002|14-day Wash-out|Non-Compliance With Study Drug|0
7154463|NCT03311841|11321253|FG003|14-day Wash-out|Non-Compliance With Study Drug|1
7154464|NCT03311841|11321254|FG004|14-day Wash-out|Non-Compliance With Study Drug|0
7154465|NCT03312114|11321293|FG000|Overall Study|All the five enrolled dropped out of the|5
7154466|NCT03312218|11321300|FG000|Overall Study|Never signed in to access the app|54
7154467|NCT03312218|11321301|FG001|Overall Study|Never signed in to access the app|58
7154468|NCT03312231|11321312|FG000|Overall Study|Lost to Follow-up|2
7154469|NCT03312231|11321313|FG001|Overall Study|Lost to Follow-up|6
7154470|NCT03312231|11321314|FG002|Overall Study|Lost to Follow-up|1
7154471|NCT03312231|11321315|FG003|Overall Study|Lost to Follow-up|3
7154472|NCT03312231|11321316|FG004|Overall Study|Lost to Follow-up|1
7154473|NCT03312231|11321312|FG000|Overall Study|Withdrawal by Subject|0
6877083|NCT00506883|10888556|FG002|Overall Study|Lack of Efficacy|1
6877084|NCT00506883|10888554|FG000|Overall Study|Other|5
6877085|NCT00506883|10888555|FG001|Overall Study|Other|1
6877086|NCT00506883|10888556|FG002|Overall Study|Other|1
6877087|NCT00506922|10888569|FG000|Overall Study|Physician Decision|0
6877088|NCT00506922|10888570|FG001|Overall Study|Physician Decision|0
6877089|NCT00506922|10888571|FG002|Overall Study|Physician Decision|0
6877090|NCT00506922|10888572|FG003|Overall Study|Physician Decision|2
7154474|NCT03312231|11321313|FG001|Overall Study|Withdrawal by Subject|3
7154475|NCT03312231|11321314|FG002|Overall Study|Withdrawal by Subject|1
6877091|NCT00506922|10888573|FG004|Overall Study|Physician Decision|0
6877092|NCT00506922|10888569|FG000|Overall Study|Withdrawal by Subject|0
6877093|NCT00506922|10888570|FG001|Overall Study|Withdrawal by Subject|0
6877094|NCT00506922|10888571|FG002|Overall Study|Withdrawal by Subject|0
6877095|NCT00506922|10888572|FG003|Overall Study|Withdrawal by Subject|0
6877096|NCT00506922|10888573|FG004|Overall Study|Withdrawal by Subject|1
6877097|NCT00506948|10888581|FG000|Overall Study|Death|4
6877098|NCT00506948|10888581|FG000|Overall Study|Adverse Event|5
6877099|NCT00506948|10888581|FG000|Overall Study|Physician Decision|1
6877100|NCT00507026|10888588|FG000|Overall Study|Lack of Efficacy|6
6877101|NCT00507026|10888589|FG001|Overall Study|Lack of Efficacy|4
6877102|NCT00507026|10888590|FG002|Overall Study|Lack of Efficacy|21
6877103|NCT00507026|10888588|FG000|Overall Study|Withdrawal by Subject|2
6877104|NCT00507026|10888589|FG001|Overall Study|Withdrawal by Subject|0
6877105|NCT00507026|10888590|FG002|Overall Study|Withdrawal by Subject|0
6877106|NCT00507026|10888588|FG000|Overall Study|Investigator Decision|1
6877107|NCT00507026|10888589|FG001|Overall Study|Investigator Decision|0
6877108|NCT00507026|10888590|FG002|Overall Study|Investigator Decision|0
6877109|NCT00507026|10888588|FG000|Overall Study|Adverse Event|2
6877110|NCT00507026|10888589|FG001|Overall Study|Adverse Event|0
6877111|NCT00507026|10888590|FG002|Overall Study|Adverse Event|0
6877112|NCT00507026|10888588|FG000|Overall Study|Protocol Violation|1
6877113|NCT00507026|10888589|FG001|Overall Study|Protocol Violation|0
6877114|NCT00507026|10888590|FG002|Overall Study|Protocol Violation|0
6877115|NCT00507026|10888588|FG000|Overall Study|Other|1
6877116|NCT00507026|10888589|FG001|Overall Study|Other|0
6877117|NCT00507026|10888590|FG002|Overall Study|Other|0
6877118|NCT00507130|10888602|FG000|Overall Study|Lost to Follow-up|0
6877119|NCT00507130|10888603|FG001|Overall Study|Lost to Follow-up|0
6877120|NCT00507130|10888604|FG002|Overall Study|Lost to Follow-up|1
6877121|NCT00507130|10888605|FG003|Overall Study|Lost to Follow-up|1
6877122|NCT00507130|10888602|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1
6877123|NCT00507130|10888603|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
6877124|NCT00507130|10888604|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
6877125|NCT00507130|10888605|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
6969105|NCT01145352|11018518|FG000|Overall Study|Found to have been registered twice|6
6969106|NCT01145352|11018518|FG000|Overall Study|Treated before marketing approval|4
6969107|NCT01145352|11018518|FG000|Overall Study|Syringe formulation was used|1
6969108|NCT01145417|11018535|FG000|Overall Study|Death|1
6969109|NCT01145417|11018536|FG001|Overall Study|Death|0
6969110|NCT01145417|11018535|FG000|Overall Study|Lost to Follow-up|2
6969111|NCT01145417|11018536|FG001|Overall Study|Lost to Follow-up|1
6969112|NCT01145417|11018535|FG000|Overall Study|Withdrawal by Subject|1
6969113|NCT01145417|11018536|FG001|Overall Study|Withdrawal by Subject|2
6969114|NCT01145417|11018535|FG000|Overall Study|Pregnancy|1
6969115|NCT01145417|11018536|FG001|Overall Study|Pregnancy|0
6969116|NCT01145417|11018535|FG000|Overall Study|Adverse Event|0
6969117|NCT01145417|11018536|FG001|Overall Study|Adverse Event|1
6969118|NCT01145417|11018535|FG000|Overall Study|Study terminated by sponsor|35
6969119|NCT01145417|11018536|FG001|Overall Study|Study terminated by sponsor|43
6969120|NCT01145417|11018535|FG000|Overall Study|Other|1
6969121|NCT01145417|11018536|FG001|Overall Study|Other|0
6969122|NCT01145482|11018544|FG000|First Intervention (1 Day)|Withdrawal by Subject|0
6969123|NCT01145482|11018545|FG001|First Intervention (1 Day)|Withdrawal by Subject|1
6969124|NCT01145508|11018553|FG000|Overall Study|Adverse Event|1
6969125|NCT01145508|11018554|FG001|Overall Study|Adverse Event|0
6969126|NCT01145508|11018553|FG000|Overall Study|Death|1
6969127|NCT01145508|11018554|FG001|Overall Study|Death|0
6969128|NCT01145508|11018553|FG000|Overall Study|Physician Decision|2
6969129|NCT01145508|11018554|FG001|Overall Study|Physician Decision|1
6969130|NCT01145508|11018553|FG000|Overall Study|Never started treatment|1
6969131|NCT01145508|11018554|FG001|Overall Study|Never started treatment|1
6969132|NCT01145560|11018570|FG000|Overall Study|Withdrawal by Subject|2
6969133|NCT01145560|11018571|FG001|Overall Study|Withdrawal by Subject|1
6969134|NCT01145560|11018572|FG002|Overall Study|Withdrawal by Subject|0
6969135|NCT01145560|11018570|FG000|Overall Study|Lost to Follow-up|1
6969136|NCT01145560|11018571|FG001|Overall Study|Lost to Follow-up|1
6969137|NCT01145560|11018572|FG002|Overall Study|Lost to Follow-up|1
7154476|NCT03312231|11321315|FG003|Overall Study|Withdrawal by Subject|0
7154477|NCT03312231|11321316|FG004|Overall Study|Withdrawal by Subject|0
7154478|NCT03312231|11321312|FG000|Overall Study|Death|0
6969138|NCT01145560|11018570|FG000|Overall Study|No study drug by 24h after organ failure|1
6969139|NCT01145560|11018571|FG001|Overall Study|No study drug by 24h after organ failure|0
6969140|NCT01145560|11018572|FG002|Overall Study|No study drug by 24h after organ failure|0
6969141|NCT01145560|11018570|FG000|Overall Study|Accidental unblinding of study treatment|0
6969142|NCT01145560|11018571|FG001|Overall Study|Accidental unblinding of study treatment|1
6969143|NCT01145560|11018572|FG002|Overall Study|Accidental unblinding of study treatment|0
6969144|NCT01145560|11018570|FG000|Overall Study|False insurance information|0
6969145|NCT01145560|11018571|FG001|Overall Study|False insurance information|1
6969146|NCT01145560|11018572|FG002|Overall Study|False insurance information|0
6969147|NCT01145560|11018570|FG000|Overall Study|Withdrawal of therapy|0
6969148|NCT01145560|11018571|FG001|Overall Study|Withdrawal of therapy|0
6969149|NCT01145560|11018572|FG002|Overall Study|Withdrawal of therapy|1
6877126|NCT00507416|10888627|FG000|Overall Study|Adverse Event|58
7078703|NCT02105987|11187346|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10
7083000|NCT02147353|11193745|FG001|Overall Study|medication noncompliance|0
7154479|NCT03312231|11321313|FG001|Overall Study|Death|1
6877127|NCT00507416|10888628|FG001|Overall Study|Adverse Event|67
6877128|NCT00507416|10888629|FG002|Overall Study|Adverse Event|65
6877129|NCT00507416|10888627|FG000|Overall Study|Protocol Violation|1
6877130|NCT00507416|10888628|FG001|Overall Study|Protocol Violation|2
6877131|NCT00507416|10888629|FG002|Overall Study|Protocol Violation|0
6877132|NCT00507416|10888627|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7
6877133|NCT00507416|10888628|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7
6877134|NCT00507416|10888629|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8
6877135|NCT00507416|10888627|FG000|Overall Study|Progressive Disease|20
6877136|NCT00507416|10888628|FG001|Overall Study|Progressive Disease|10
6877137|NCT00507416|10888629|FG002|Overall Study|Progressive Disease|13
6877138|NCT00507416|10888627|FG000|Overall Study|Patient declined further treatment|18
6877139|NCT00507416|10888628|FG001|Overall Study|Patient declined further treatment|14
6877140|NCT00507416|10888629|FG002|Overall Study|Patient declined further treatment|11
6877141|NCT00507416|10888627|FG000|Overall Study|Other|11
6877142|NCT00507416|10888628|FG001|Overall Study|Other|16
6877143|NCT00507416|10888629|FG002|Overall Study|Other|13
6877144|NCT00507416|10888627|FG000|Overall Study|Did not Receive Study Treatment|3
6877145|NCT00507416|10888628|FG001|Overall Study|Did not Receive Study Treatment|9
6877146|NCT00507416|10888629|FG002|Overall Study|Did not Receive Study Treatment|4
6877147|NCT00507429|10888639|FG000|Treatment Phase|Disease Progression|12
6877148|NCT00507429|10888640|FG001|Treatment Phase|Disease Progression|5
6877149|NCT00507429|10888639|FG000|Treatment Phase|Adverse Event|12
6877150|NCT00507429|10888640|FG001|Treatment Phase|Adverse Event|5
6877151|NCT00507429|10888639|FG000|Treatment Phase|Withdrawal by Subject|3
6877152|NCT00507429|10888640|FG001|Treatment Phase|Withdrawal by Subject|3
6877153|NCT00507429|10888639|FG000|Treatment Phase|Physician Decision|4
6877154|NCT00507429|10888640|FG001|Treatment Phase|Physician Decision|2
6877155|NCT00507429|10888639|FG000|Treatment Phase|Other|6
6877156|NCT00507429|10888640|FG001|Treatment Phase|Other|3
6877157|NCT00507429|10888639|FG000|Maintenance Phase|Progressive Disease|14
6877158|NCT00507429|10888640|FG001|Maintenance Phase|Progressive Disease|0
6877159|NCT00507442|10888652|FG000|Overall Study|Adverse Event|8
6877160|NCT00507442|10888653|FG001|Overall Study|Adverse Event|11
6877161|NCT00507442|10888654|FG002|Overall Study|Adverse Event|4
6877162|NCT00507442|10888655|FG003|Overall Study|Adverse Event|1
6877163|NCT00507442|10888652|FG000|Overall Study|Protocol Violation|0
6877164|NCT00507442|10888653|FG001|Overall Study|Protocol Violation|1
6877165|NCT00507442|10888654|FG002|Overall Study|Protocol Violation|0
6877166|NCT00507442|10888655|FG003|Overall Study|Protocol Violation|0
6877167|NCT00507442|10888652|FG000|Overall Study|Lost to Follow-up|0
6877168|NCT00507442|10888653|FG001|Overall Study|Lost to Follow-up|0
6877169|NCT00507442|10888654|FG002|Overall Study|Lost to Follow-up|1
6877170|NCT00507442|10888655|FG003|Overall Study|Lost to Follow-up|0
6877171|NCT00507442|10888652|FG000|Overall Study|Physician Decision|0
6877172|NCT00507442|10888653|FG001|Overall Study|Physician Decision|2
6877173|NCT00507442|10888654|FG002|Overall Study|Physician Decision|4
6877174|NCT00507442|10888655|FG003|Overall Study|Physician Decision|1
6877175|NCT00507442|10888652|FG000|Overall Study|Progressive Disease|2
6877176|NCT00507442|10888653|FG001|Overall Study|Progressive Disease|4
6877177|NCT00507442|10888654|FG002|Overall Study|Progressive Disease|2
6877178|NCT00507442|10888655|FG003|Overall Study|Progressive Disease|0
6877179|NCT00507442|10888652|FG000|Overall Study|Withdrawal by Subject|4
6877180|NCT00507442|10888653|FG001|Overall Study|Withdrawal by Subject|4
6877181|NCT00507442|10888654|FG002|Overall Study|Withdrawal by Subject|2
6877182|NCT00507442|10888655|FG003|Overall Study|Withdrawal by Subject|1
6877183|NCT00507442|10888652|FG000|Overall Study|Other|2
6877184|NCT00507442|10888653|FG001|Overall Study|Other|5
6877185|NCT00507442|10888654|FG002|Overall Study|Other|2
6877186|NCT00507442|10888655|FG003|Overall Study|Other|2
6877187|NCT00507455|10888672|FG000|Overall Study|Adverse Event|3
6877188|NCT00507455|10888673|FG001|Overall Study|Adverse Event|3
6877189|NCT00507455|10888674|FG002|Overall Study|Adverse Event|6
6877190|NCT00507455|10888672|FG000|Overall Study|Withdrawal by Subject|2
6877191|NCT00507455|10888673|FG001|Overall Study|Withdrawal by Subject|1
6877192|NCT00507455|10888674|FG002|Overall Study|Withdrawal by Subject|2
6877193|NCT00507455|10888672|FG000|Overall Study|Protocol Violation|4
6877194|NCT00507455|10888673|FG001|Overall Study|Protocol Violation|1
6877195|NCT00507455|10888674|FG002|Overall Study|Protocol Violation|1
6877196|NCT00507455|10888672|FG000|Overall Study|Lost to Follow-up|2
6877197|NCT00507455|10888673|FG001|Overall Study|Lost to Follow-up|0
6877198|NCT00507455|10888674|FG002|Overall Study|Lost to Follow-up|2
6877199|NCT00507455|10888672|FG000|Overall Study|Lack of Efficacy|0
6877200|NCT00507455|10888673|FG001|Overall Study|Lack of Efficacy|1
6877201|NCT00507455|10888674|FG002|Overall Study|Lack of Efficacy|0
6877202|NCT00507455|10888672|FG000|Overall Study|Other - miscellaneous reason|1
6877203|NCT00507455|10888673|FG001|Overall Study|Other - miscellaneous reason|0
6877204|NCT00507455|10888674|FG002|Overall Study|Other - miscellaneous reason|1
6877205|NCT00507507|10888684|FG000|Treatment Period|Lost to Follow-up|0
6877206|NCT00507507|10888685|FG001|Treatment Period|Lost to Follow-up|2
6877207|NCT00507507|10888684|FG000|Treatment Period|Physician Decision|4
6877208|NCT00507507|10888685|FG001|Treatment Period|Physician Decision|1
6877209|NCT00507507|10888684|FG000|Treatment Period|Protocol Violation|1
6877210|NCT00507507|10888685|FG001|Treatment Period|Protocol Violation|2
6877211|NCT00507507|10888684|FG000|Treatment Period|Adverse Event|1
6877212|NCT00507507|10888685|FG001|Treatment Period|Adverse Event|1
6877213|NCT00507507|10888684|FG000|Treatment Period|Withdrawal by Subject|46
6877214|NCT00507507|10888685|FG001|Treatment Period|Withdrawal by Subject|47
6877215|NCT00507507|10888684|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1
6877216|NCT00507507|10888685|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0
6877217|NCT00507507|10888684|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0
6877218|NCT00507507|10888685|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1
6877219|NCT00507507|10888684|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9
6877220|NCT00507507|10888685|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16
6877221|NCT00507546|10888695|FG000|Overall Study|Withdrawal by Subject|1
6877222|NCT00507546|10888696|FG001|Overall Study|Withdrawal by Subject|0
6877223|NCT00507546|10888695|FG000|Overall Study|Protocol Violation|1
6877224|NCT00507546|10888696|FG001|Overall Study|Protocol Violation|0
6877225|NCT00507546|10888695|FG000|Overall Study|Physician Decision|0
6877226|NCT00507546|10888696|FG001|Overall Study|Physician Decision|1
6877227|NCT00507689|10888711|FG000|Pre-Randomization Period|Adverse Event|1
6877228|NCT00507689|10888712|FG001|Pre-Randomization Period|Adverse Event|0
6877229|NCT00507689|10888711|FG000|Pre-Randomization Period|Physician Decision|1
6877230|NCT00507689|10888712|FG001|Pre-Randomization Period|Physician Decision|0
6877231|NCT00507689|10888711|FG000|Pre-Randomization Period|Withdrawal by Subject|1
6877232|NCT00507689|10888712|FG001|Pre-Randomization Period|Withdrawal by Subject|0
6877233|NCT00507689|10888711|FG000|Randomized Period|Adverse Event|1
6877234|NCT00507689|10888712|FG001|Randomized Period|Adverse Event|1
6877235|NCT00507689|10888711|FG000|Randomized Period|Withdrawal by Subject|0
6877236|NCT00507689|10888712|FG001|Randomized Period|Withdrawal by Subject|1
6877237|NCT00507728|10888722|FG000|Randomization to Month 3|Lost to Follow-up|15
6877238|NCT00507728|10888723|FG001|Randomization to Month 3|Lost to Follow-up|14
6877239|NCT00507728|10888724|FG002|Randomization to Month 3|Lost to Follow-up|20
6877240|NCT00507728|10888722|FG000|From 3 Months to 6 Months|Lost to Follow-up|6
6877241|NCT00507728|10888723|FG001|From 3 Months to 6 Months|Lost to Follow-up|10
6877242|NCT00507728|10888724|FG002|From 3 Months to 6 Months|Lost to Follow-up|9
6877243|NCT00507819|10888742|FG000|Washout (6 Weeks)|Withdrawal by Subject|1
6877244|NCT00507819|10888743|FG001|Washout (6 Weeks)|Withdrawal by Subject|0
6877245|NCT00508001|10888752|FG000|Overall Study|Adverse Event|2
6877246|NCT00508001|10888753|FG001|Overall Study|Adverse Event|0
6877247|NCT00508001|10888754|FG002|Overall Study|Adverse Event|4
6877248|NCT00508001|10888752|FG000|Overall Study|condition under investigation worsened|13
6877249|NCT00508001|10888753|FG001|Overall Study|condition under investigation worsened|7
6877250|NCT00508001|10888754|FG002|Overall Study|condition under investigation worsened|1
6877251|NCT00508001|10888752|FG000|Overall Study|Death|0
6877252|NCT00508001|10888753|FG001|Overall Study|Death|1
6877253|NCT00508001|10888754|FG002|Overall Study|Death|1
6877254|NCT00508001|10888752|FG000|Overall Study|Withdrawal by Subject|4
6877255|NCT00508001|10888753|FG001|Overall Study|Withdrawal by Subject|4
6877256|NCT00508001|10888754|FG002|Overall Study|Withdrawal by Subject|1
6877257|NCT00508027|10888762|FG000|Dose Level 1|Lost to Follow-up|4
6877258|NCT00508027|10888762|FG000|Dose Level 1|Withdrawal by Subject|2
6877259|NCT00508027|10888762|FG000|Dose Level 1|Physician Decision|2
6877260|NCT00508027|10888762|FG000|Dose Level 2|Lost to Follow-up|2
6877261|NCT00508027|10888762|FG000|Dose Level 2|Withdrawal by Subject|2
6877262|NCT00508144|10888795|FG000|Overall Study|Not eligible|6
6877263|NCT00508144|10888795|FG000|Overall Study|Death|5
6877264|NCT00508157|10888801|FG000|Overall Study|Adverse Event|0
6877265|NCT00508157|10888802|FG001|Overall Study|Adverse Event|1
6877266|NCT00508157|10888801|FG000|Overall Study|Subject Withdrew Consent|1
6877267|NCT00508157|10888802|FG001|Overall Study|Subject Withdrew Consent|0
6877268|NCT00508157|10888801|FG000|Overall Study|Lost to Follow-up|1
6877269|NCT00508157|10888802|FG001|Overall Study|Lost to Follow-up|0
6877270|NCT00508157|10888801|FG000|Overall Study|Subject no longer met study criteria|0
6877271|NCT00508157|10888802|FG001|Overall Study|Subject no longer met study criteria|1
6877272|NCT00508157|10888801|FG000|Overall Study|Other known cause|0
6877273|NCT00508157|10888802|FG001|Overall Study|Other known cause|1
6877274|NCT00508261|10888828|FG000|Overall Study|Other|0
6877275|NCT00508261|10888829|FG001|Overall Study|Other|1
6877276|NCT00508261|10888830|FG002|Overall Study|Other|1
6877277|NCT00508261|10888831|FG003|Overall Study|Other|0
6877278|NCT00508261|10888828|FG000|Overall Study|Serious Adverse Event|0
6877279|NCT00508261|10888829|FG001|Overall Study|Serious Adverse Event|1
6877280|NCT00508261|10888830|FG002|Overall Study|Serious Adverse Event|0
6877281|NCT00508261|10888831|FG003|Overall Study|Serious Adverse Event|0
6877282|NCT00508261|10888828|FG000|Overall Study|Withdrawal by Subject|3
6877283|NCT00508261|10888829|FG001|Overall Study|Withdrawal by Subject|4
6877284|NCT00508261|10888830|FG002|Overall Study|Withdrawal by Subject|4
6877285|NCT00508261|10888831|FG003|Overall Study|Withdrawal by Subject|0
6877286|NCT00508261|10888828|FG000|Overall Study|Migrated/ moved from study area|0
6877287|NCT00508261|10888829|FG001|Overall Study|Migrated/ moved from study area|1
6877288|NCT00508261|10888830|FG002|Overall Study|Migrated/ moved from study area|0
6877289|NCT00508261|10888831|FG003|Overall Study|Migrated/ moved from study area|0
6877290|NCT00508261|10888828|FG000|Overall Study|Lost to Follow-up|0
6877291|NCT00508261|10888829|FG001|Overall Study|Lost to Follow-up|1
6877292|NCT00508261|10888830|FG002|Overall Study|Lost to Follow-up|1
6877293|NCT00508261|10888831|FG003|Overall Study|Lost to Follow-up|1
6969150|NCT01145625|11018582|FG000|Overall Study|Lost to Follow-up|8
6969151|NCT01145625|11018583|FG001|Overall Study|Lost to Follow-up|9
6969152|NCT01145625|11018582|FG000|Overall Study|Adverse Event|6
6969153|NCT01145625|11018583|FG001|Overall Study|Adverse Event|4
6969154|NCT01145625|11018582|FG000|Overall Study|Protocol Violation|3
6969155|NCT01145625|11018583|FG001|Overall Study|Protocol Violation|1
6969156|NCT01145625|11018582|FG000|Overall Study|Withdrawal by Subject|7
6969157|NCT01145625|11018583|FG001|Overall Study|Withdrawal by Subject|16
6969158|NCT01145625|11018582|FG000|Overall Study|Pregnancy|0
6969159|NCT01145625|11018583|FG001|Overall Study|Pregnancy|1
6969160|NCT01145755|11018601|FG000|Overall Study|Adverse Event|2
6969161|NCT01145755|11018602|FG001|Overall Study|Adverse Event|4
6969162|NCT01145755|11018603|FG002|Overall Study|Adverse Event|2
6969163|NCT01145755|11018601|FG000|Overall Study|Withdrawal by Subject|2
6969164|NCT01145755|11018602|FG001|Overall Study|Withdrawal by Subject|2
6969165|NCT01145755|11018603|FG002|Overall Study|Withdrawal by Subject|2
6969166|NCT01145755|11018601|FG000|Overall Study|Lost to Follow-up|2
6969167|NCT01145755|11018602|FG001|Overall Study|Lost to Follow-up|3
6969168|NCT01145755|11018603|FG002|Overall Study|Lost to Follow-up|1
6969169|NCT01145755|11018601|FG000|Overall Study|Protocol Violation|0
6969170|NCT01145755|11018602|FG001|Overall Study|Protocol Violation|3
6969171|NCT01145755|11018603|FG002|Overall Study|Protocol Violation|1
6969172|NCT01145755|11018601|FG000|Overall Study|Study Closure|14
6969173|NCT01145755|11018602|FG001|Overall Study|Study Closure|14
6969174|NCT01145755|11018603|FG002|Overall Study|Study Closure|17
6969175|NCT01145755|11018601|FG000|Overall Study|Lack of Efficacy|0
6969176|NCT01145755|11018602|FG001|Overall Study|Lack of Efficacy|1
6969177|NCT01145755|11018603|FG002|Overall Study|Lack of Efficacy|0
6969178|NCT01145755|11018601|FG000|Overall Study|Patient could not swollow medication|0
6969179|NCT01145755|11018602|FG001|Overall Study|Patient could not swollow medication|0
6969180|NCT01145755|11018603|FG002|Overall Study|Patient could not swollow medication|1
6969181|NCT01145755|11018601|FG000|Overall Study|Withdrawal by Subject|0
6969182|NCT01145755|11018602|FG001|Overall Study|Withdrawal by Subject|0
6969183|NCT01145755|11018603|FG002|Overall Study|Withdrawal by Subject|1
6969184|NCT01145755|11018601|FG000|Overall Study|Positive urine ethanol|0
6969185|NCT01145755|11018602|FG001|Overall Study|Positive urine ethanol|1
6969186|NCT01145755|11018603|FG002|Overall Study|Positive urine ethanol|0
6969187|NCT01145885|11018620|FG000|Overall Study|Progressive Disease|7
6969188|NCT01145898|11018632|FG000|3-year Treatment|medication change by treating physician|3
6969189|NCT01145898|11018633|FG001|3-year Treatment|medication change by treating physician|16
6969190|NCT01146054|11018638|FG000|Overall Study|Did not meet dose constraints for SBRT|5
6969191|NCT01146054|11018638|FG000|Overall Study|Rapid tumor progression|2
6969192|NCT01146054|11018638|FG000|Overall Study|Other illness precluded treatment|2
6969193|NCT01146054|11018638|FG000|Overall Study|Lost to Follow-up|1
6969194|NCT01146288|11018649|FG000|First Intervention(1 Day)|Adverse Event|0
6969195|NCT01146288|11018650|FG001|First Intervention(1 Day)|Adverse Event|1
7154480|NCT03312231|11321314|FG002|Overall Study|Death|1
7154481|NCT03312231|11321315|FG003|Overall Study|Death|0
7154482|NCT03312231|11321316|FG004|Overall Study|Death|0
7154483|NCT03312231|11321312|FG000|Overall Study|Study Vaccination not Received|1
7154484|NCT03312231|11321313|FG001|Overall Study|Study Vaccination not Received|1
7154485|NCT03312231|11321314|FG002|Overall Study|Study Vaccination not Received|1
7154486|NCT03312231|11321315|FG003|Overall Study|Study Vaccination not Received|0
7154487|NCT03312231|11321316|FG004|Overall Study|Study Vaccination not Received|0
7154488|NCT03312543|11321347|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0
7154489|NCT03312543|11321348|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2
7154490|NCT03312543|11321347|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1
7154491|NCT03312543|11321348|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2
7154492|NCT03312543|11321347|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3
7154493|NCT03312543|11321348|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4
7154494|NCT03312543|11321347|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1
7154495|NCT03312543|11321348|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1
6969196|NCT01146561|11018705|FG000|Overall Study|Withdrawal by Subject|1
6969197|NCT01146561|11018705|FG000|Overall Study|Lost to Follow-up|1
6969198|NCT01146613|11018721|FG000|Overall Study|Lost to Follow-up|3
6969199|NCT01146613|11018722|FG001|Overall Study|Lost to Follow-up|8
6969200|NCT01146613|11018721|FG000|Overall Study|Lack of Efficacy|0
6969201|NCT01146613|11018722|FG001|Overall Study|Lack of Efficacy|1
6969202|NCT01146613|11018721|FG000|Overall Study|Death|1
6969203|NCT01146613|11018722|FG001|Overall Study|Death|0
6969204|NCT01146613|11018721|FG000|Overall Study|Physician Decision|1
6969205|NCT01146613|11018722|FG001|Overall Study|Physician Decision|0
6969206|NCT01146613|11018721|FG000|Overall Study|Withdrawal by Subject|0
6969207|NCT01146613|11018722|FG001|Overall Study|Withdrawal by Subject|3
6969208|NCT01146613|11018721|FG000|Overall Study|schedule conflict|1
6969209|NCT01146613|11018722|FG001|Overall Study|schedule conflict|0
6969210|NCT01146613|11018721|FG000|Overall Study|Outpatient detox|1
6877294|NCT00508274|10888845|FG000|Overall Study|Adverse Event|5
6877295|NCT00508274|10888845|FG000|Overall Study|Death|7
6877296|NCT00508274|10888845|FG000|Overall Study|Disease progression|32
6877297|NCT00508274|10888845|FG000|Overall Study|Withdrawal by Subject|1
6877298|NCT00508274|10888845|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2
6877299|NCT00508274|10888845|FG000|Overall Study|Missing|3
6877300|NCT00508391|10888860|FG000|First Treatment|Withdrawal by Subject|6
6877301|NCT00508391|10888861|FG001|First Treatment|Withdrawal by Subject|3
6877302|NCT00508391|10888860|FG000|Second Treatment|Withdrawal by Subject|2
6877303|NCT00508391|10888861|FG001|Second Treatment|Withdrawal by Subject|0
6877304|NCT00508404|10888869|FG000|Overall Study|Ongoing at Data Cut-off|12
6877305|NCT00508404|10888869|FG000|Overall Study|Adverse Event|2
6877306|NCT00508404|10888869|FG000|Overall Study|Death|16
6877307|NCT00508404|10888869|FG000|Overall Study|Physician Decision|2
6877308|NCT00508404|10888869|FG000|Overall Study|Withdrawal by Subject|3
6877309|NCT00508404|10888869|FG000|Overall Study|Protocol-specified Criteria|2
6877310|NCT00508404|10888869|FG000|Overall Study|Lost to Follow-up|2
6877311|NCT00508404|10888869|FG000|Overall Study|Other - Not Specified|3
6877312|NCT00508482|10888886|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9
6969211|NCT01146613|11018722|FG001|Overall Study|Outpatient detox|0
6969212|NCT01146665|11018730|FG000|Overall Study|Withdrawal by Subject|10
6969213|NCT01146665|11018731|FG001|Overall Study|Withdrawal by Subject|16
6969214|NCT01146782|11018755|FG000|Screening Cohort|Screen Failure|187
6969215|NCT01146782|11018755|FG000|Screening Cohort|Lost to Follow-up|4
6969216|NCT01146782|11018755|FG000|Screening Cohort|Physician Decision|1
6969217|NCT01146782|11018755|FG000|Screening Cohort|Withdrawal by Subject|29
6969218|NCT01146782|11018755|FG000|Safety Cohort|Screen Failure|61
6969219|NCT01146782|11018755|FG000|Safety Cohort|Withdrawal by Subject|4
6969220|NCT01146782|11018755|FG000|Safety Cohort|Control AHI <5|4
6969221|NCT01146782|11018755|FG000|Safety Cohort|TST <4 hrs|14
7078704|NCT02105987|11187347|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
7078705|NCT02105987|11187348|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
7078706|NCT02105987|11187349|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
7078707|NCT02105987|11187350|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
7078708|NCT02105987|11187345|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
7078709|NCT02105987|11187346|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
7078710|NCT02105987|11187347|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
7078711|NCT02105987|11187348|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
7078712|NCT02105987|11187349|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
7078713|NCT02105987|11187350|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
7078714|NCT02105987|11187345|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4
7078715|NCT02105987|11187346|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3
7078716|NCT02105987|11187347|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0
7078717|NCT02105987|11187348|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0
7078718|NCT02105987|11187349|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0
7078719|NCT02105987|11187350|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0
7078720|NCT02105987|11187345|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
7078721|NCT02105987|11187346|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1
7078722|NCT02105987|11187347|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
7078723|NCT02105987|11187348|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
7078724|NCT02105987|11187349|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
7078725|NCT02105987|11187350|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
7078726|NCT02105987|11187345|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0
7078727|NCT02105987|11187346|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0
7078728|NCT02105987|11187347|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10
7078729|NCT02105987|11187348|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4
7078730|NCT02105987|11187349|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0
7078731|NCT02105987|11187350|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0
7078732|NCT02105987|11187345|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0
7078733|NCT02105987|11187346|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0
7078734|NCT02105987|11187347|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15
7078735|NCT02105987|11187348|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1
7078736|NCT02105987|11187349|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0
7078737|NCT02105987|11187350|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0
7078738|NCT02105987|11187345|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
7078739|NCT02105987|11187346|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
7078740|NCT02105987|11187347|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6
7078741|NCT02105987|11187348|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5
7078742|NCT02105987|11187349|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
7078743|NCT02105987|11187350|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
7078744|NCT02105987|11187345|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
6877313|NCT00508482|10888887|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7
6969222|NCT01146782|11018755|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5
6976948|NCT01203072|11029840|FG000|Overall Study|Lost to Follow-up|0
6877314|NCT00508482|10888888|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4
6877315|NCT00508482|10888886|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12
7078745|NCT02105987|11187346|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
7078746|NCT02105987|11187347|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8
6877316|NCT00508482|10888887|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10
6877317|NCT00508482|10888888|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16
6877318|NCT00508482|10888886|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20
6877319|NCT00508482|10888887|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6
6877320|NCT00508482|10888888|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1
6877321|NCT00508651|10888903|FG000|Overall Study|Lost to Follow-up|3
6877322|NCT00508651|10888904|FG001|Overall Study|Lost to Follow-up|1
6877323|NCT00508651|10888903|FG000|Overall Study|Withdrawal by Subject|1
6877324|NCT00508651|10888904|FG001|Overall Study|Withdrawal by Subject|1
6877325|NCT00508742|10888921|FG000|Period 1: Infant Series|Adverse Event|5
6877326|NCT00508742|10888922|FG001|Period 1: Infant Series|Adverse Event|4
6877327|NCT00508742|10888921|FG000|Period 1: Infant Series|Protocol Violation|1
6877328|NCT00508742|10888922|FG001|Period 1: Infant Series|Protocol Violation|0
6877329|NCT00508742|10888921|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31
6877330|NCT00508742|10888922|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40
6877331|NCT00508742|10888921|FG000|Period 1: Infant Series|Physician Decision|1
6877332|NCT00508742|10888922|FG001|Period 1: Infant Series|Physician Decision|0
6877333|NCT00508742|10888921|FG000|Period 1: Infant Series|Other|4
6877334|NCT00508742|10888922|FG001|Period 1: Infant Series|Other|1
6877335|NCT00508742|10888921|FG000|Period 2: After Infant Series|Adverse Event|2
6877336|NCT00508742|10888922|FG001|Period 2: After Infant Series|Adverse Event|6
6877337|NCT00508742|10888921|FG000|Period 2: After Infant Series|Lost to Follow-up|1
6877338|NCT00508742|10888922|FG001|Period 2: After Infant Series|Lost to Follow-up|1
6877339|NCT00508742|10888921|FG000|Period 2: After Infant Series|Protocol Violation|1
6877340|NCT00508742|10888922|FG001|Period 2: After Infant Series|Protocol Violation|0
6877341|NCT00508742|10888921|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0
6877342|NCT00508742|10888922|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3
6877343|NCT00508742|10888921|FG000|Period 2: After Infant Series|Failed to Return|1
6877344|NCT00508742|10888922|FG001|Period 2: After Infant Series|Failed to Return|0
6877345|NCT00508742|10888921|FG000|Period 2: After Infant Series|Other|2
6877346|NCT00508742|10888922|FG001|Period 2: After Infant Series|Other|1
6877347|NCT00508742|10888921|FG000|Period 3: Toddler Dose|Adverse Event|1
6877348|NCT00508742|10888922|FG001|Period 3: Toddler Dose|Adverse Event|0
6877349|NCT00508742|10888921|FG000|Period 3: Toddler Dose|Lost to Follow-up|2
6877350|NCT00508742|10888922|FG001|Period 3: Toddler Dose|Lost to Follow-up|3
6877351|NCT00508742|10888921|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17
6877352|NCT00508742|10888922|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8
6877353|NCT00508742|10888921|FG000|Period 3: Toddler Dose|Other|5
6877354|NCT00508742|10888922|FG001|Period 3: Toddler Dose|Other|4
6877355|NCT00508755|10888934|FG000|Overall Study|Withdrawal by Subject|1
6877356|NCT00508820|10888942|FG000|Overall Study|Adverse Event|6
6877357|NCT00508820|10888943|FG001|Overall Study|Adverse Event|10
7078747|NCT02105987|11187348|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3
7078748|NCT02105987|11187349|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
7078749|NCT02105987|11187350|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
7078750|NCT02105987|11187345|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0
7078751|NCT02105987|11187346|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0
7078752|NCT02105987|11187347|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5
7078753|NCT02105987|11187348|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0
7078754|NCT02105987|11187349|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0
7078755|NCT02105987|11187350|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0
7078756|NCT02105987|11187345|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
7078757|NCT02105987|11187346|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
7078758|NCT02105987|11187347|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
7078759|NCT02105987|11187348|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1
7078760|NCT02105987|11187349|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
7078761|NCT02105987|11187350|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
6877358|NCT00508820|10888942|FG000|Overall Study|Death|6
6877359|NCT00508820|10888943|FG001|Overall Study|Death|8
6877360|NCT00508820|10888942|FG000|Overall Study|Lost to Follow-up|1
6877361|NCT00508820|10888943|FG001|Overall Study|Lost to Follow-up|1
6877362|NCT00508820|10888942|FG000|Overall Study|Physician Decision|8
6877363|NCT00508820|10888943|FG001|Overall Study|Physician Decision|2
6877364|NCT00508820|10888942|FG000|Overall Study|Pregnancy|0
6877365|NCT00508820|10888943|FG001|Overall Study|Pregnancy|2
6877366|NCT00508820|10888942|FG000|Overall Study|Protocol Violation|2
6877367|NCT00508820|10888943|FG001|Overall Study|Protocol Violation|0
6877368|NCT00508820|10888942|FG000|Overall Study|Withdrawal by Subject|10
6877369|NCT00508820|10888943|FG001|Overall Study|Withdrawal by Subject|12
6877370|NCT00508820|10888942|FG000|Overall Study|Other|11
6877371|NCT00508820|10888943|FG001|Overall Study|Other|2
6877372|NCT00508820|10888942|FG000|Overall Study|Noncompliance|1
6877373|NCT00508820|10888943|FG001|Overall Study|Noncompliance|0
6877374|NCT00508820|10888942|FG000|Overall Study|Requirement for alternative therapy|7
6877375|NCT00508820|10888943|FG001|Overall Study|Requirement for alternative therapy|15
6877376|NCT00508820|10888942|FG000|Overall Study|Protocol-specified Criteria|3
6877377|NCT00508820|10888943|FG001|Overall Study|Protocol-specified Criteria|12
6877378|NCT00508924|10888953|FG000|Overall Study|Protocol Violation|0
6877379|NCT00508924|10888954|FG001|Overall Study|Protocol Violation|0
6877380|NCT00508924|10888955|FG002|Overall Study|Protocol Violation|1
6877381|NCT00508924|10888956|FG003|Overall Study|Protocol Violation|1
6877382|NCT00509028|10888972|FG000|Overall Study|Adverse Event|2
6877383|NCT00509028|10888973|FG001|Overall Study|Adverse Event|0
6877384|NCT00509028|10888972|FG000|Overall Study|Withdrawal by Subject|4
7078762|NCT02105987|11187345|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0
7078763|NCT02105987|11187346|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0
7078764|NCT02105987|11187347|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1
7078765|NCT02105987|11187348|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0
7078766|NCT02105987|11187349|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0
7078767|NCT02105987|11187350|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0
7078768|NCT02105987|11187345|FG000|Continuation Phase|Protocol Violation|0
7078769|NCT02105987|11187346|FG001|Continuation Phase|Protocol Violation|0
7078770|NCT02105987|11187347|FG002|Continuation Phase|Protocol Violation|0
7078771|NCT02105987|11187348|FG003|Continuation Phase|Protocol Violation|0
7078772|NCT02105987|11187349|FG004|Continuation Phase|Protocol Violation|1
7078773|NCT02105987|11187350|FG005|Continuation Phase|Protocol Violation|0
7078774|NCT02106156|11187372|FG000|Overall Study|Patient Died|19
6877385|NCT00509028|10888973|FG001|Overall Study|Withdrawal by Subject|3
6877386|NCT00509028|10888972|FG000|Overall Study|Lost to Follow-up|0
6877387|NCT00509028|10888973|FG001|Overall Study|Lost to Follow-up|1
6877388|NCT00509028|10888972|FG000|Overall Study|Protocol Violation|4
6877389|NCT00509028|10888973|FG001|Overall Study|Protocol Violation|2
6877390|NCT00509028|10888972|FG000|Overall Study|Non-compliance|2
6877391|NCT00509028|10888973|FG001|Overall Study|Non-compliance|1
6877392|NCT00509067|10888985|FG000|Overall Study|Lost to Follow-up|1
6877393|NCT00509067|10888986|FG001|Overall Study|Lost to Follow-up|1
6877394|NCT00509067|10888985|FG000|Overall Study|Adverse Event|3
6877395|NCT00509067|10888986|FG001|Overall Study|Adverse Event|1
6877396|NCT00509067|10888985|FG000|Overall Study|Protocol Violation|0
6877397|NCT00509067|10888986|FG001|Overall Study|Protocol Violation|3
6877398|NCT00509093|10888996|FG000|Overall Study|Adverse Event|10
6877399|NCT00509093|10888996|FG000|Overall Study|Disease Progression|9
6877400|NCT00509093|10888996|FG000|Overall Study|Transformed into MDS|1
6877401|NCT00509093|10888996|FG000|Overall Study|Withdrawal by Subject|3
6877402|NCT00509093|10888996|FG000|Overall Study|Physician Decision|1
6877403|NCT00509106|10889002|FG000|Overall Study|Adverse Event|3
6877404|NCT00509106|10889003|FG001|Overall Study|Adverse Event|2
6877405|NCT00509106|10889002|FG000|Overall Study|Noncompliance|0
6877406|NCT00509106|10889003|FG001|Overall Study|Noncompliance|1
6877407|NCT00509106|10889002|FG000|Overall Study|At the request of sponsor/investigator|1
6877408|NCT00509106|10889003|FG001|Overall Study|At the request of sponsor/investigator|2
6877409|NCT00509106|10889002|FG000|Overall Study|Withdrew consent|4
6877410|NCT00509106|10889003|FG001|Overall Study|Withdrew consent|8
6877411|NCT00509106|10889002|FG000|Overall Study|Lost to Follow-up|16
6877412|NCT00509106|10889003|FG001|Overall Study|Lost to Follow-up|10
6877413|NCT00509106|10889002|FG000|Overall Study|Other|1
6877414|NCT00509106|10889003|FG001|Overall Study|Other|0
6877415|NCT00509106|10889002|FG000|Overall Study|Death|6
6877416|NCT00509106|10889003|FG001|Overall Study|Death|6
6877417|NCT00509145|10889011|FG000|Overall Study|Death|0
6877418|NCT00509145|10889012|FG001|Overall Study|Death|2
6877419|NCT00509145|10889011|FG000|Overall Study|Adverse Event|42
6877420|NCT00509145|10889012|FG001|Overall Study|Adverse Event|28
6877421|NCT00509145|10889011|FG000|Overall Study|Withdrawal by Subject|32
6877422|NCT00509145|10889012|FG001|Overall Study|Withdrawal by Subject|38
6877423|NCT00509145|10889011|FG000|Overall Study|Physician Decision|11
6877424|NCT00509145|10889012|FG001|Overall Study|Physician Decision|14
6877425|NCT00509145|10889011|FG000|Overall Study|Protocol Violation|1
6877426|NCT00509145|10889012|FG001|Overall Study|Protocol Violation|6
6877427|NCT00509145|10889011|FG000|Overall Study|Pregnancy|3
6877428|NCT00509145|10889012|FG001|Overall Study|Pregnancy|8
6877429|NCT00509145|10889011|FG000|Overall Study|Lost to Follow-up|6
6877430|NCT00509145|10889012|FG001|Overall Study|Lost to Follow-up|5
6877431|NCT00509145|10889011|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12
6877432|NCT00509145|10889012|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22
6877433|NCT00509145|10889011|FG000|Overall Study|Other|6
6877434|NCT00509145|10889012|FG001|Overall Study|Other|6
6877435|NCT00509223|10889040|FG000|Overall Study|Lost to Follow-up|1
6877436|NCT00509223|10889041|FG001|Overall Study|Lost to Follow-up|1
6877437|NCT00509223|10889040|FG000|Overall Study|Adverse Event|1
6877438|NCT00509223|10889041|FG001|Overall Study|Adverse Event|1
6877439|NCT00509223|10889040|FG000|Overall Study|Withdrawal by Subject|25
6877440|NCT00509223|10889041|FG001|Overall Study|Withdrawal by Subject|6
6877441|NCT00509223|10889040|FG000|Overall Study|Including: subject change of address|5
6877442|NCT00509223|10889041|FG001|Overall Study|Including: subject change of address|2
6877443|NCT00509223|10889040|FG000|Overall Study|Did not meet revised inclusion criteria|56
6877444|NCT00509223|10889041|FG001|Overall Study|Did not meet revised inclusion criteria|62
6877445|NCT00509236|10889049|FG000|Overall Study|Adverse Event|7
6877446|NCT00509236|10889050|FG001|Overall Study|Adverse Event|9
6877447|NCT00509236|10889049|FG000|Overall Study|Withdrawal by Subject|5
6877448|NCT00509236|10889050|FG001|Overall Study|Withdrawal by Subject|10
6877449|NCT00509236|10889049|FG000|Overall Study|Protocol Violation|3
6877450|NCT00509236|10889050|FG001|Overall Study|Protocol Violation|0
6877451|NCT00509236|10889049|FG000|Overall Study|Excluded Medication|1
6877452|NCT00509236|10889050|FG001|Overall Study|Excluded Medication|1
6877453|NCT00509236|10889049|FG000|Overall Study|Scheduled Kidney Transplant|1
6877454|NCT00509236|10889050|FG001|Overall Study|Scheduled Kidney Transplant|0
6877455|NCT00509262|10889062|FG000|Overall Study|Adverse Event|16
6877456|NCT00509262|10889063|FG001|Overall Study|Adverse Event|18
6877457|NCT00509262|10889062|FG000|Overall Study|Other|2
6877458|NCT00509262|10889063|FG001|Overall Study|Other|2
6877459|NCT00509262|10889062|FG000|Overall Study|Lack of Efficacy|1
6877460|NCT00509262|10889063|FG001|Overall Study|Lack of Efficacy|0
6877461|NCT00509262|10889062|FG000|Overall Study|Lost to Follow-up|1
6877462|NCT00509262|10889063|FG001|Overall Study|Lost to Follow-up|6
6877463|NCT00509262|10889062|FG000|Overall Study|Physician Decision|1
6877464|NCT00509262|10889063|FG001|Overall Study|Physician Decision|3
6877465|NCT00509262|10889062|FG000|Overall Study|Protocol Violation|2
6877466|NCT00509262|10889063|FG001|Overall Study|Protocol Violation|2
6877467|NCT00509262|10889062|FG000|Overall Study|Withdrawal by Subject|24
6877468|NCT00509262|10889063|FG001|Overall Study|Withdrawal by Subject|11
6877469|NCT00509366|10889083|FG000|Overall Study|Not Treated (Screen Failure)|1
6877470|NCT00509366|10889084|FG001|Overall Study|Not Treated (Screen Failure)|1
6877471|NCT00509366|10889085|FG002|Overall Study|Not Treated (Screen Failure)|1
6877472|NCT00509366|10889086|FG003|Overall Study|Not Treated (Screen Failure)|0
6877473|NCT00509366|10889087|FG004|Overall Study|Not Treated (Screen Failure)|0
6877474|NCT00509769|10889124|FG000|Overall Study|Progressive disease|77
6877475|NCT00509769|10889124|FG000|Overall Study|Adverse Event|4
6877476|NCT00509769|10889124|FG000|Overall Study|Patient's decision|1
6877477|NCT00509769|10889124|FG000|Overall Study|Physician Decision|8
6877478|NCT00509769|10889124|FG000|Overall Study|Use of prohibited therapies during study|1
6877479|NCT00509795|10889132|FG000|Overall Study|Adverse Event|4
6877480|NCT00509795|10889133|FG001|Overall Study|Adverse Event|3
6877481|NCT00509795|10889134|FG002|Overall Study|Adverse Event|5
6877482|NCT00509795|10889135|FG003|Overall Study|Adverse Event|4
6877483|NCT00509795|10889132|FG000|Overall Study|Death|3
6877484|NCT00509795|10889133|FG001|Overall Study|Death|1
6877485|NCT00509795|10889134|FG002|Overall Study|Death|2
6877486|NCT00509795|10889135|FG003|Overall Study|Death|7
6877487|NCT00509795|10889132|FG000|Overall Study|Lack of Efficacy|0
6877488|NCT00509795|10889133|FG001|Overall Study|Lack of Efficacy|0
6877489|NCT00509795|10889134|FG002|Overall Study|Lack of Efficacy|2
6877490|NCT00509795|10889135|FG003|Overall Study|Lack of Efficacy|2
6877491|NCT00509795|10889132|FG000|Overall Study|Lost to Follow-up|1
6877492|NCT00509795|10889133|FG001|Overall Study|Lost to Follow-up|2
6877493|NCT00509795|10889134|FG002|Overall Study|Lost to Follow-up|4
6877494|NCT00509795|10889135|FG003|Overall Study|Lost to Follow-up|4
6877495|NCT00509795|10889132|FG000|Overall Study|OTHER|1
6877496|NCT00509795|10889133|FG001|Overall Study|OTHER|0
6877497|NCT00509795|10889134|FG002|Overall Study|OTHER|4
6877498|NCT00509795|10889135|FG003|Overall Study|OTHER|1
6877499|NCT00509795|10889132|FG000|Overall Study|Protocol Violation|3
6877500|NCT00509795|10889133|FG001|Overall Study|Protocol Violation|0
6877501|NCT00509795|10889134|FG002|Overall Study|Protocol Violation|3
6877502|NCT00509795|10889135|FG003|Overall Study|Protocol Violation|1
6877503|NCT00509795|10889132|FG000|Overall Study|Withdrawal by Subject|10
6877504|NCT00509795|10889133|FG001|Overall Study|Withdrawal by Subject|5
6877505|NCT00509795|10889134|FG002|Overall Study|Withdrawal by Subject|7
6877506|NCT00509795|10889135|FG003|Overall Study|Withdrawal by Subject|8
6877507|NCT00509821|10889148|FG000|Study Period 1 (Induction)|Death|0
6877508|NCT00509821|10889149|FG001|Study Period 1 (Induction)|Death|1
6877509|NCT00509821|10889148|FG000|Study Period 1 (Induction)|Adverse Event|0
6877510|NCT00509821|10889149|FG001|Study Period 1 (Induction)|Adverse Event|2
6877511|NCT00509821|10889148|FG000|Study Period 1 (Induction)|Progressive Disease|0
6877512|NCT00509821|10889149|FG001|Study Period 1 (Induction)|Progressive Disease|1
6877513|NCT00509899|10889177|FG000|Overall Study|Progressive disease|1
6877514|NCT00509899|10889178|FG001|Overall Study|Progressive disease|3
6877515|NCT00509899|10889179|FG002|Overall Study|Progressive disease|5
6877516|NCT00509899|10889180|FG003|Overall Study|Progressive disease|1
6877517|NCT00509899|10889181|FG004|Overall Study|Progressive disease|0
6877518|NCT00509899|10889182|FG005|Overall Study|Progressive disease|1
6877519|NCT00509899|10889183|FG006|Overall Study|Progressive disease|0
6877520|NCT00509899|10889184|FG007|Overall Study|Progressive disease|0
6877521|NCT00509899|10889177|FG000|Overall Study|Unacceptable Toxicity|1
6877522|NCT00509899|10889178|FG001|Overall Study|Unacceptable Toxicity|0
6877523|NCT00509899|10889179|FG002|Overall Study|Unacceptable Toxicity|0
6877524|NCT00509899|10889180|FG003|Overall Study|Unacceptable Toxicity|2
6877525|NCT00509899|10889181|FG004|Overall Study|Unacceptable Toxicity|0
6877526|NCT00509899|10889182|FG005|Overall Study|Unacceptable Toxicity|0
6877527|NCT00509899|10889183|FG006|Overall Study|Unacceptable Toxicity|0
6877528|NCT00509899|10889184|FG007|Overall Study|Unacceptable Toxicity|0
6877529|NCT00509899|10889177|FG000|Overall Study|Withdrawal by Subject|6
6877530|NCT00509899|10889178|FG001|Overall Study|Withdrawal by Subject|2
6877531|NCT00509899|10889179|FG002|Overall Study|Withdrawal by Subject|3
6877532|NCT00509899|10889180|FG003|Overall Study|Withdrawal by Subject|0
6877533|NCT00509899|10889181|FG004|Overall Study|Withdrawal by Subject|3
6877534|NCT00509899|10889182|FG005|Overall Study|Withdrawal by Subject|2
6877535|NCT00509899|10889183|FG006|Overall Study|Withdrawal by Subject|0
6877536|NCT00509899|10889184|FG007|Overall Study|Withdrawal by Subject|0
6877537|NCT00509899|10889177|FG000|Overall Study|Physician Decision|4
6877538|NCT00509899|10889178|FG001|Overall Study|Physician Decision|2
6877539|NCT00509899|10889179|FG002|Overall Study|Physician Decision|7
6877540|NCT00509899|10889180|FG003|Overall Study|Physician Decision|0
6877541|NCT00509899|10889181|FG004|Overall Study|Physician Decision|1
6877542|NCT00509899|10889182|FG005|Overall Study|Physician Decision|4
6877543|NCT00509899|10889183|FG006|Overall Study|Physician Decision|0
6877544|NCT00509899|10889184|FG007|Overall Study|Physician Decision|0
6877545|NCT00509899|10889177|FG000|Overall Study|Intercurrent Illness|1
6877546|NCT00509899|10889178|FG001|Overall Study|Intercurrent Illness|0
6877547|NCT00509899|10889179|FG002|Overall Study|Intercurrent Illness|0
6877548|NCT00509899|10889180|FG003|Overall Study|Intercurrent Illness|1
6877549|NCT00509899|10889181|FG004|Overall Study|Intercurrent Illness|0
6877550|NCT00509899|10889182|FG005|Overall Study|Intercurrent Illness|1
6877551|NCT00509899|10889183|FG006|Overall Study|Intercurrent Illness|0
6877552|NCT00509899|10889184|FG007|Overall Study|Intercurrent Illness|0
6877553|NCT00509899|10889177|FG000|Overall Study|Death|2
6877554|NCT00509899|10889178|FG001|Overall Study|Death|2
6877555|NCT00509899|10889179|FG002|Overall Study|Death|3
6877556|NCT00509899|10889180|FG003|Overall Study|Death|0
6877557|NCT00509899|10889181|FG004|Overall Study|Death|1
6877558|NCT00509899|10889182|FG005|Overall Study|Death|1
6877559|NCT00509899|10889183|FG006|Overall Study|Death|1
6877560|NCT00509899|10889184|FG007|Overall Study|Death|1
6877561|NCT00509899|10889177|FG000|Overall Study|Lack of Efficacy|1
6877562|NCT00509899|10889178|FG001|Overall Study|Lack of Efficacy|0
6877563|NCT00509899|10889179|FG002|Overall Study|Lack of Efficacy|2
6877564|NCT00509899|10889180|FG003|Overall Study|Lack of Efficacy|0
6877565|NCT00509899|10889181|FG004|Overall Study|Lack of Efficacy|0
6877566|NCT00509899|10889182|FG005|Overall Study|Lack of Efficacy|1
6877567|NCT00509899|10889183|FG006|Overall Study|Lack of Efficacy|0
6877568|NCT00509899|10889184|FG007|Overall Study|Lack of Efficacy|0
6877569|NCT00509925|10889198|FG000|Overall Study|Personal reasons|0
6877570|NCT00509925|10889199|FG001|Overall Study|Personal reasons|1
6877571|NCT00510068|10889209|FG000|Double-blind Period|Disease progression|98
6877572|NCT00510068|10889210|FG001|Double-blind Period|Disease progression|169
6877573|NCT00510068|10889209|FG000|Double-blind Period|Final primary analysis|52
6877574|NCT00510068|10889210|FG001|Double-blind Period|Final primary analysis|18
6877575|NCT00510068|10889209|FG000|Double-blind Period|Adverse Event|37
6877576|NCT00510068|10889210|FG001|Double-blind Period|Adverse Event|7
6877577|NCT00510068|10889209|FG000|Double-blind Period|Withdrawal by Subject|8
6877578|NCT00510068|10889210|FG001|Double-blind Period|Withdrawal by Subject|6
6877579|NCT00510068|10889209|FG000|Double-blind Period|Death|4
6877580|NCT00510068|10889210|FG001|Double-blind Period|Death|3
6877581|NCT00510068|10889209|FG000|Double-blind Period|Abnormal test result (s)|1
6877582|NCT00510068|10889210|FG001|Double-blind Period|Abnormal test result (s)|0
6877583|NCT00510068|10889209|FG000|Double-blind Period|Lost to Follow-up|1
6877584|NCT00510068|10889210|FG001|Double-blind Period|Lost to Follow-up|0
6877585|NCT00510068|10889209|FG000|Double-blind Period|Protocol Violation|6
6877586|NCT00510068|10889210|FG001|Double-blind Period|Protocol Violation|0
6877587|NCT00510068|10889209|FG000|Open-label Period|Disease Progression|124
6877588|NCT00510068|10889210|FG001|Open-label Period|Disease Progression|0
6877589|NCT00510068|10889209|FG000|Open-label Period|Adverse Event|46
6877590|NCT00510068|10889210|FG001|Open-label Period|Adverse Event|0
6877591|NCT00510068|10889209|FG000|Open-label Period|Withdrawal by Subject|21
6877592|NCT00510068|10889210|FG001|Open-label Period|Withdrawal by Subject|0
6877593|NCT00510068|10889209|FG000|Open-label Period|Administrative problems|17
6877594|NCT00510068|10889210|FG001|Open-label Period|Administrative problems|0
6877595|NCT00510068|10889209|FG000|Open-label Period|Death|7
6877596|NCT00510068|10889210|FG001|Open-label Period|Death|0
6877597|NCT00510068|10889209|FG000|Open-label Period|New cancer therapy|7
6877598|NCT00510068|10889210|FG001|Open-label Period|New cancer therapy|0
6877599|NCT00510068|10889209|FG000|Open-label Period|Protocol Violation|2
6877600|NCT00510068|10889210|FG001|Open-label Period|Protocol Violation|0
6877601|NCT00510068|10889209|FG000|Open-label Period|Abnormal laboratory value (s)|1
6877602|NCT00510068|10889210|FG001|Open-label Period|Abnormal laboratory value (s)|0
6877603|NCT00510146|10889220|FG000|Double-Blind Treatment|Adverse Event|30
6877604|NCT00510146|10889221|FG001|Double-Blind Treatment|Adverse Event|13
6877605|NCT00510146|10889220|FG000|Double-Blind Treatment|Lack of Efficacy|6
6877606|NCT00510146|10889221|FG001|Double-Blind Treatment|Lack of Efficacy|13
6877607|NCT00510146|10889220|FG000|Double-Blind Treatment|Lost to Follow-up|3
6877608|NCT00510146|10889221|FG001|Double-Blind Treatment|Lost to Follow-up|7
6877609|NCT00510146|10889220|FG000|Double-Blind Treatment|Physician Decision|6
6877610|NCT00510146|10889221|FG001|Double-Blind Treatment|Physician Decision|0
6877611|NCT00510146|10889220|FG000|Double-Blind Treatment|Protocol Violation|1
6877612|NCT00510146|10889221|FG001|Double-Blind Treatment|Protocol Violation|2
6877613|NCT00510146|10889220|FG000|Double-Blind Treatment|Withdrawal by Subject|27
6877614|NCT00510146|10889221|FG001|Double-Blind Treatment|Withdrawal by Subject|13
6877615|NCT00510146|10889220|FG000|Double-Blind Treatment|Clinical Relapse|0
6877616|NCT00510146|10889221|FG001|Double-Blind Treatment|Clinical Relapse|1
6877617|NCT00510146|10889220|FG000|Double-Blind Treatment|Entry Criteria Not Met|3
6877618|NCT00510146|10889221|FG001|Double-Blind Treatment|Entry Criteria Not Met|0
6877619|NCT00510146|10889220|FG000|Open-Label Treatment|Adverse Event|22
6877620|NCT00510146|10889221|FG001|Open-Label Treatment|Adverse Event|8
6877621|NCT00510146|10889220|FG000|Open-Label Treatment|Death|1
6877622|NCT00510146|10889221|FG001|Open-Label Treatment|Death|1
6877623|NCT00510146|10889220|FG000|Open-Label Treatment|Lack of Efficacy|4
6877624|NCT00510146|10889221|FG001|Open-Label Treatment|Lack of Efficacy|0
6877625|NCT00510146|10889220|FG000|Open-Label Treatment|Lost to Follow-up|10
6877626|NCT00510146|10889221|FG001|Open-Label Treatment|Lost to Follow-up|1
6877627|NCT00510146|10889220|FG000|Open-Label Treatment|Physician Decision|3
6877628|NCT00510146|10889221|FG001|Open-Label Treatment|Physician Decision|1
6877629|NCT00510146|10889220|FG000|Open-Label Treatment|Protocol Violation|4
6877630|NCT00510146|10889221|FG001|Open-Label Treatment|Protocol Violation|2
6877631|NCT00510146|10889220|FG000|Open-Label Treatment|Withdrawal by Subject|24
6877632|NCT00510146|10889221|FG001|Open-Label Treatment|Withdrawal by Subject|12
6877633|NCT00510146|10889220|FG000|Open-Label Treatment|Clinical Relapse|1
6877634|NCT00510146|10889221|FG001|Open-Label Treatment|Clinical Relapse|1
6877635|NCT00510146|10889220|FG000|Open-Label Treatment|Sponsor Decision|2
6877636|NCT00510146|10889221|FG001|Open-Label Treatment|Sponsor Decision|0
6877637|NCT00510198|10889231|FG000|Overall Study|Withdrawal by Subject|5
6877638|NCT00510198|10889232|FG001|Overall Study|Withdrawal by Subject|4
6877639|NCT00510276|10889246|FG000|Acute Double-Blind Phase|Adverse Event|21
6877640|NCT00510276|10889247|FG001|Acute Double-Blind Phase|Adverse Event|6
6877641|NCT00510276|10889246|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1
6877642|NCT00510276|10889247|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1
6877643|NCT00510276|10889246|FG000|Acute Double-Blind Phase|Lack of Efficacy|3
6877644|NCT00510276|10889247|FG001|Acute Double-Blind Phase|Lack of Efficacy|4
6877645|NCT00510276|10889246|FG000|Acute Double-Blind Phase|Lost to Follow-up|48
6877646|NCT00510276|10889247|FG001|Acute Double-Blind Phase|Lost to Follow-up|49
6877647|NCT00510276|10889246|FG000|Acute Double-Blind Phase|Physician Decision|0
6877648|NCT00510276|10889247|FG001|Acute Double-Blind Phase|Physician Decision|3
6877649|NCT00510276|10889246|FG000|Acute Double-Blind Phase|Protocol Violation|4
6877650|NCT00510276|10889247|FG001|Acute Double-Blind Phase|Protocol Violation|3
6877651|NCT00510276|10889246|FG000|Acute Double-Blind Phase|Sponsor Decision|2
6877652|NCT00510276|10889247|FG001|Acute Double-Blind Phase|Sponsor Decision|1
6877653|NCT00510276|10889246|FG000|Acute Double-Blind Phase|Subject Decision|26
6877654|NCT00510276|10889247|FG001|Acute Double-Blind Phase|Subject Decision|28
6877655|NCT00510276|10889246|FG000|Extension Open-Label Phase|Adverse Event|9
6877656|NCT00510276|10889247|FG001|Extension Open-Label Phase|Adverse Event|18
6877657|NCT00510276|10889246|FG000|Extension Open-Label Phase|Lack of Efficacy|2
6877658|NCT00510276|10889247|FG001|Extension Open-Label Phase|Lack of Efficacy|7
6877659|NCT00510276|10889246|FG000|Extension Open-Label Phase|Lost to Follow-up|12
6877660|NCT00510276|10889247|FG001|Extension Open-Label Phase|Lost to Follow-up|10
6877661|NCT00510276|10889246|FG000|Extension Open-Label Phase|Physician Decision|2
6877662|NCT00510276|10889247|FG001|Extension Open-Label Phase|Physician Decision|3
6877663|NCT00510276|10889246|FG000|Extension Open-Label Phase|Protocol Violation|0
6877664|NCT00510276|10889247|FG001|Extension Open-Label Phase|Protocol Violation|1
6877665|NCT00510276|10889246|FG000|Extension Open-Label Phase|Sponsor Decision|1
6877666|NCT00510276|10889247|FG001|Extension Open-Label Phase|Sponsor Decision|0
6877667|NCT00510276|10889246|FG000|Extension Open-Label Phase|Subject Decision|7
6877668|NCT00510276|10889247|FG001|Extension Open-Label Phase|Subject Decision|9
6877669|NCT00510289|10889260|FG000|Overall Study|Withdrawal by Subject|7
6877670|NCT00510289|10889260|FG000|Overall Study|Refused bone marrow biopsy|2
6877671|NCT00510289|10889260|FG000|Overall Study|Lost to Follow-up|1
6877672|NCT00510289|10889260|FG000|Overall Study|Progressed prior to starting drug|2
6877673|NCT00510458|10889265|FG000|Overall Study|5 year not evaluable/missed|21
6877674|NCT00510458|10889265|FG000|Overall Study|Death|1
6877675|NCT00510458|10889265|FG000|Overall Study|Terminated|14
6877676|NCT00510458|10889265|FG000|Overall Study|Lost to Follow-up|6
6877677|NCT00510458|10889265|FG000|Overall Study|Withdrawal by Subject|3
6877678|NCT00510458|10889265|FG000|Overall Study|Revision|2
6877679|NCT00510484|10889272|FG000|Wash-out Period|Adverse Event|0
6877680|NCT00510484|10889273|FG001|Wash-out Period|Adverse Event|1
6877681|NCT00510510|10889286|FG000|Overall Study|Adverse Event|4
6877682|NCT00510510|10889287|FG001|Overall Study|Adverse Event|3
6877683|NCT00510510|10889288|FG002|Overall Study|Adverse Event|6
6877684|NCT00510510|10889286|FG000|Overall Study|Lack of Efficacy|0
6877685|NCT00510510|10889287|FG001|Overall Study|Lack of Efficacy|1
6877686|NCT00510510|10889288|FG002|Overall Study|Lack of Efficacy|1
6877687|NCT00510510|10889286|FG000|Overall Study|Subjects no longer requires study drug|0
6877688|NCT00510510|10889287|FG001|Overall Study|Subjects no longer requires study drug|0
6877689|NCT00510510|10889288|FG002|Overall Study|Subjects no longer requires study drug|2
6877690|NCT00510510|10889286|FG000|Overall Study|Withdrawal by Subject|1
6877691|NCT00510510|10889287|FG001|Overall Study|Withdrawal by Subject|2
6877692|NCT00510510|10889288|FG002|Overall Study|Withdrawal by Subject|3
6877693|NCT00510510|10889286|FG000|Overall Study|Lost to Follow-up|0
6877694|NCT00510510|10889287|FG001|Overall Study|Lost to Follow-up|0
6877695|NCT00510510|10889288|FG002|Overall Study|Lost to Follow-up|1
6877696|NCT00510510|10889286|FG000|Overall Study|Protocol Violation|0
6877697|NCT00510510|10889287|FG001|Overall Study|Protocol Violation|3
6877698|NCT00510510|10889288|FG002|Overall Study|Protocol Violation|4
6877699|NCT00510653|10889296|FG000|Overall Study|Withdrawal by Subject|8
6877700|NCT00510653|10889296|FG000|Overall Study|Monetary|3
6877701|NCT00510692|10889302|FG000|Overall Study|Adverse Event|1
6877702|NCT00510692|10889303|FG001|Overall Study|Adverse Event|3
6877703|NCT00510692|10889302|FG000|Overall Study|Withdrawal by Subject|1
6877704|NCT00510692|10889303|FG001|Overall Study|Withdrawal by Subject|0
6877705|NCT00510718|10889318|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1
6877706|NCT00510718|10889319|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8
6877707|NCT00510718|10889318|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3
6877708|NCT00510718|10889319|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6
6877709|NCT00510718|10889318|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8
6877710|NCT00510718|10889319|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11
6877711|NCT00510718|10889318|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1
6877712|NCT00510718|10889319|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3
6877713|NCT00510718|10889318|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1
6877714|NCT00510718|10889319|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3
6877715|NCT00510718|10889318|FG000|Multiple Dose Period: 12 Weeks|Other|1
6877716|NCT00510718|10889319|FG001|Multiple Dose Period: 12 Weeks|Other|1
6877717|NCT00510783|10889344|FG000|Overall Study|Lost to Follow-up|29
6877718|NCT00510783|10889345|FG001|Overall Study|Lost to Follow-up|25
6877719|NCT00510783|10889344|FG000|Overall Study|Withdrawal by Subject|2
7078775|NCT02106156|11187373|FG001|Overall Study|Patient Died|0
6877720|NCT00510783|10889345|FG001|Overall Study|Withdrawal by Subject|3
6877721|NCT00510783|10889344|FG000|Overall Study|Protocol Violation|0
6877722|NCT00510783|10889345|FG001|Overall Study|Protocol Violation|1
6877723|NCT00510835|10889367|FG000|Overall Study|Withdrawal by Subject|6
6877724|NCT00510835|10889368|FG001|Overall Study|Withdrawal by Subject|2
6877725|NCT00510835|10889369|FG002|Overall Study|Withdrawal by Subject|2
6877726|NCT00510874|10889384|FG000|Overall Study|Withdrawal by Subject|1
6877727|NCT00510874|10889385|FG001|Overall Study|Withdrawal by Subject|1
6877728|NCT00510874|10889386|FG002|Overall Study|Withdrawal by Subject|0
6877729|NCT00510874|10889387|FG003|Overall Study|Withdrawal by Subject|0
6877730|NCT00510874|10889388|FG004|Overall Study|Withdrawal by Subject|3
6877731|NCT00510874|10889389|FG005|Overall Study|Withdrawal by Subject|0
6877732|NCT00510874|10889390|FG006|Overall Study|Withdrawal by Subject|0
6877733|NCT00510874|10889384|FG000|Overall Study|Lost to Follow-up|2
6877734|NCT00510874|10889385|FG001|Overall Study|Lost to Follow-up|3
6877735|NCT00510874|10889386|FG002|Overall Study|Lost to Follow-up|1
6877736|NCT00510874|10889387|FG003|Overall Study|Lost to Follow-up|3
6877737|NCT00510874|10889388|FG004|Overall Study|Lost to Follow-up|4
6877738|NCT00510874|10889389|FG005|Overall Study|Lost to Follow-up|0
6877739|NCT00510874|10889390|FG006|Overall Study|Lost to Follow-up|1
6877740|NCT00510887|10889407|FG000|Overall Study|Lost to Follow-up|1
6877741|NCT00510952|10889413|FG000|Overall Study|Adverse Event|1
6877742|NCT00510952|10889414|FG001|Overall Study|Adverse Event|0
6877743|NCT00510952|10889413|FG000|Overall Study|Entry Criteria Not Met|3
6877744|NCT00510952|10889414|FG001|Overall Study|Entry Criteria Not Met|1
6877745|NCT00510952|10889413|FG000|Overall Study|Lost to Follow-up|5
6877746|NCT00510952|10889414|FG001|Overall Study|Lost to Follow-up|3
6877747|NCT00510952|10889413|FG000|Overall Study|Physician Decision|1
6877748|NCT00510952|10889414|FG001|Overall Study|Physician Decision|1
6877749|NCT00510952|10889413|FG000|Overall Study|Protocol Violation|7
6877750|NCT00510952|10889414|FG001|Overall Study|Protocol Violation|4
6877751|NCT00510952|10889413|FG000|Overall Study|Sponsor Decision|1
6877752|NCT00510952|10889414|FG001|Overall Study|Sponsor Decision|0
6877753|NCT00510952|10889413|FG000|Overall Study|Withdrawal by Subject|6
6877754|NCT00510952|10889414|FG001|Overall Study|Withdrawal by Subject|7
6877755|NCT00510952|10889413|FG000|Overall Study|Did Not Receive Study Drug|2
6877756|NCT00510952|10889414|FG001|Overall Study|Did Not Receive Study Drug|0
6877757|NCT00511004|10889423|FG000|Overall Study|Lost to Follow-up|0
6877758|NCT00511004|10889424|FG001|Overall Study|Lost to Follow-up|0
6877759|NCT00511004|10889425|FG002|Overall Study|Lost to Follow-up|4
6877760|NCT00511108|10889450|FG000|Overall Study|Adverse Event|2
6877761|NCT00511108|10889451|FG001|Overall Study|Adverse Event|0
6877762|NCT00511108|10889452|FG002|Overall Study|Adverse Event|1
6877763|NCT00511108|10889453|FG003|Overall Study|Adverse Event|2
6877764|NCT00511108|10889450|FG000|Overall Study|Lost to Follow-up|0
6877765|NCT00511108|10889451|FG001|Overall Study|Lost to Follow-up|2
6877766|NCT00511108|10889452|FG002|Overall Study|Lost to Follow-up|1
6877767|NCT00511108|10889453|FG003|Overall Study|Lost to Follow-up|0
6877768|NCT00511108|10889450|FG000|Overall Study|Physician Decision|0
6877769|NCT00511108|10889451|FG001|Overall Study|Physician Decision|0
6877770|NCT00511108|10889452|FG002|Overall Study|Physician Decision|0
6877771|NCT00511108|10889453|FG003|Overall Study|Physician Decision|1
6877772|NCT00511108|10889450|FG000|Overall Study|Withdrawal by Subject|4
6877773|NCT00511108|10889451|FG001|Overall Study|Withdrawal by Subject|0
6877774|NCT00511108|10889452|FG002|Overall Study|Withdrawal by Subject|3
6877775|NCT00511108|10889453|FG003|Overall Study|Withdrawal by Subject|2
6877776|NCT00511147|10889463|FG000|Overall Study|Withdrawal by Subject|1
6877777|NCT00511147|10889463|FG000|Overall Study|Disease progression|5
6877778|NCT00511147|10889463|FG000|Overall Study|Required platelet transfusion|1
6877779|NCT00511238|10889474|FG000|Overall Study|Adverse Event|13
6877780|NCT00511238|10889475|FG001|Overall Study|Adverse Event|33
6877781|NCT00511238|10889474|FG000|Overall Study|Withdrawal by Subject|2
6877782|NCT00511238|10889475|FG001|Overall Study|Withdrawal by Subject|22
6877783|NCT00511238|10889474|FG000|Overall Study|Progressive Disease|23
6877784|NCT00511238|10889475|FG001|Overall Study|Progressive Disease|157
6877785|NCT00511238|10889474|FG000|Overall Study|various reasons|4
6877786|NCT00511238|10889475|FG001|Overall Study|various reasons|14
6877787|NCT00511472|10889493|FG000|Overall Study|Clinical Adverse Event|1
6877788|NCT00511472|10889494|FG001|Overall Study|Clinical Adverse Event|2
6877789|NCT00511472|10889493|FG000|Overall Study|Laboratory Adverse Event|0
6877790|NCT00511472|10889494|FG001|Overall Study|Laboratory Adverse Event|2
6877791|NCT00511472|10889493|FG000|Overall Study|Not reported|2
6877792|NCT00511472|10889494|FG001|Overall Study|Not reported|2
6877793|NCT00511667|10889511|FG000|Overall Study|Adverse Event|1
6877794|NCT00511667|10889512|FG001|Overall Study|Adverse Event|0
6877795|NCT00511667|10889511|FG000|Overall Study|Protocol Violation|1
6877796|NCT00511667|10889512|FG001|Overall Study|Protocol Violation|1
6877797|NCT00511667|10889511|FG000|Overall Study|Withdrawal by Subject|2
6877798|NCT00511667|10889512|FG001|Overall Study|Withdrawal by Subject|0
6877799|NCT00511667|10889511|FG000|Overall Study|Site terminated|6
6877800|NCT00511667|10889512|FG001|Overall Study|Site terminated|1
6877801|NCT00511667|10889511|FG000|Overall Study|Other|2
6877802|NCT00511667|10889512|FG001|Overall Study|Other|1
6877803|NCT00511797|10889537|FG000|Overall Study|Adverse Event|1
6877804|NCT00511797|10889538|FG001|Overall Study|Adverse Event|2
6877805|NCT00511797|10889539|FG002|Overall Study|Adverse Event|2
6877806|NCT00511797|10889540|FG003|Overall Study|Adverse Event|2
6877807|NCT00511797|10889537|FG000|Overall Study|Lost to Follow-up|1
6877808|NCT00511797|10889538|FG001|Overall Study|Lost to Follow-up|0
6877809|NCT00511797|10889539|FG002|Overall Study|Lost to Follow-up|0
6877810|NCT00511797|10889540|FG003|Overall Study|Lost to Follow-up|1
6877811|NCT00511797|10889537|FG000|Overall Study|Pregnancy|0
6877812|NCT00511797|10889538|FG001|Overall Study|Pregnancy|0
6877813|NCT00511797|10889539|FG002|Overall Study|Pregnancy|0
6877814|NCT00511797|10889540|FG003|Overall Study|Pregnancy|1
6877815|NCT00511797|10889537|FG000|Overall Study|Protocol Violation|0
6877816|NCT00511797|10889538|FG001|Overall Study|Protocol Violation|2
6877817|NCT00511797|10889539|FG002|Overall Study|Protocol Violation|2
6877818|NCT00511797|10889540|FG003|Overall Study|Protocol Violation|3
6877819|NCT00511797|10889537|FG000|Overall Study|Withdrawal by Subject|3
6877820|NCT00511797|10889538|FG001|Overall Study|Withdrawal by Subject|3
6877821|NCT00511797|10889539|FG002|Overall Study|Withdrawal by Subject|4
6877822|NCT00511797|10889540|FG003|Overall Study|Withdrawal by Subject|2
6877823|NCT00511797|10889537|FG000|Overall Study|Never dispensed|1
6877824|NCT00511797|10889538|FG001|Overall Study|Never dispensed|0
6877825|NCT00511797|10889539|FG002|Overall Study|Never dispensed|1
6877826|NCT00511797|10889540|FG003|Overall Study|Never dispensed|3
6877827|NCT00511797|10889537|FG000|Overall Study|Study drug not taken|0
6877828|NCT00511797|10889538|FG001|Overall Study|Study drug not taken|1
6877829|NCT00511797|10889539|FG002|Overall Study|Study drug not taken|0
6877830|NCT00511797|10889540|FG003|Overall Study|Study drug not taken|1
6877831|NCT00511797|10889537|FG000|Overall Study|Partially missing diary|0
6877832|NCT00511797|10889538|FG001|Overall Study|Partially missing diary|0
6877833|NCT00511797|10889539|FG002|Overall Study|Partially missing diary|1
6877834|NCT00511797|10889540|FG003|Overall Study|Partially missing diary|0
6877835|NCT00511797|10889537|FG000|Overall Study|Other (moving etc)|1
6877836|NCT00511797|10889538|FG001|Overall Study|Other (moving etc)|0
6877837|NCT00511797|10889539|FG002|Overall Study|Other (moving etc)|1
7154496|NCT03312543|11321347|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1
7154497|NCT03312543|11321348|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1
7154498|NCT03312543|11321347|FG000|Regression (Week 12 to Week 24)|Death|0
7154499|NCT03312543|11321348|FG001|Regression (Week 12 to Week 24)|Death|1
7154500|NCT03312933|11321358|FG000|Overall Study|Protocol Violation|15
7154501|NCT03312933|11321358|FG000|Overall Study|Lost to Follow-up|36
7154502|NCT03312933|11321358|FG000|Overall Study|Withdrawal by Subject|3
7154503|NCT03313037|11321364|FG000|Overall Study|Protocol Violation|4
7154504|NCT03313037|11321365|FG001|Overall Study|Protocol Violation|1
7154505|NCT03313037|11321364|FG000|Overall Study|Other|1
7154506|NCT03313037|11321365|FG001|Overall Study|Other|1
7154507|NCT03313037|11321364|FG000|Overall Study|Withdrawal by Subject|4
7154508|NCT03313037|11321365|FG001|Overall Study|Withdrawal by Subject|3
7154509|NCT03313037|11321364|FG000|Overall Study|No longer meets eligibility criteria|1
7154510|NCT03313037|11321365|FG001|Overall Study|No longer meets eligibility criteria|7
7154511|NCT03313037|11321364|FG000|Overall Study|Lost to Follow-up|9
6877838|NCT00511797|10889540|FG003|Overall Study|Other (moving etc)|2
6877839|NCT00511810|10889552|FG000|Overall Study|Lost to Follow-up|1
6877840|NCT00511810|10889553|FG001|Overall Study|Lost to Follow-up|2
6877841|NCT00511810|10889552|FG000|Overall Study|Lack of Efficacy|0
6877842|NCT00511810|10889553|FG001|Overall Study|Lack of Efficacy|2
6877843|NCT00511810|10889552|FG000|Overall Study|Refused second scn|0
6877844|NCT00511810|10889553|FG001|Overall Study|Refused second scn|1
6877845|NCT00511836|10889561|FG000|Double-blind Period|Lost to Follow-up|1
6877846|NCT00511836|10889562|FG001|Double-blind Period|Lost to Follow-up|0
6877847|NCT00511875|10889586|FG000|Overall Study|Lost to Follow-up|4
7154512|NCT03313037|11321365|FG001|Overall Study|Lost to Follow-up|8
6877848|NCT00511875|10889587|FG001|Overall Study|Lost to Follow-up|0
6877849|NCT00511875|10889586|FG000|Overall Study|Missing variables|1
6877850|NCT00511875|10889587|FG001|Overall Study|Missing variables|0
6877851|NCT00511901|10889595|FG000|Overall Study|Withdrawal by Subject|1
6877852|NCT00511901|10889596|FG001|Overall Study|Withdrawal by Subject|3
6877853|NCT00512096|10889615|FG000|Overall Study|Adverse Event|2
6877854|NCT00512096|10889615|FG000|Overall Study|Withdrawal by Subject|2
6877855|NCT00512096|10889615|FG000|Overall Study|Lack of Efficacy|3
6877856|NCT00512135|10889619|FG000|Overall Study|Not Treated|5
6877857|NCT00512135|10889619|FG000|Overall Study|Lack of Efficacy|2
6877858|NCT00512135|10889619|FG000|Overall Study|Adverse Event|6
6877859|NCT00512135|10889619|FG000|Overall Study|Withdrawal by Subject|22
6877860|NCT00512135|10889619|FG000|Overall Study|Lost to Follow-up|27
6877861|NCT00512135|10889619|FG000|Overall Study|Other|22
6877862|NCT00512148|10889624|FG000|Primay Study Period|Withdrawal by Subject|1
6877863|NCT00512252|10889633|FG000|Overall Study|Lost to Follow-up|0
6877864|NCT00512252|10889634|FG001|Overall Study|Lost to Follow-up|0
6877865|NCT00512252|10889635|FG002|Overall Study|Lost to Follow-up|1
6877866|NCT00512252|10889633|FG000|Overall Study|Protocol Violation|0
6877867|NCT00512252|10889634|FG001|Overall Study|Protocol Violation|0
6877868|NCT00512252|10889635|FG002|Overall Study|Protocol Violation|1
6877869|NCT00512252|10889633|FG000|Overall Study|Death|0
6877870|NCT00512252|10889634|FG001|Overall Study|Death|0
6877871|NCT00512252|10889635|FG002|Overall Study|Death|1
6969223|NCT01146782|11018755|FG000|Primary Endpoint Cohort|Physician Decision|1
6969224|NCT01146795|11018760|FG000|Overall Study|Withdrawal by Subject|4
6969225|NCT01146795|11018760|FG000|Overall Study|Adverse Event|6
6969226|NCT01146795|11018760|FG000|Overall Study|Still in treatment at study closure|10
6969227|NCT01146860|11018791|FG000|Overall Study|Withdrawal by Subject|0
6969228|NCT01146860|11018792|FG001|Overall Study|Withdrawal by Subject|1
6969229|NCT01146873|11018800|FG000|Overall Study|Transfer out|0
6969230|NCT01146873|11018801|FG001|Overall Study|Transfer out|6
6969231|NCT01146912|11018814|FG000|Overall Study|Already received influenza vaccination|817
6969232|NCT01146912|11018815|FG001|Overall Study|Already received influenza vaccination|822
6969233|NCT01146912|11018816|FG002|Overall Study|Already received influenza vaccination|13
6969234|NCT01146912|11018817|FG003|Overall Study|Already received influenza vaccination|15
6969235|NCT01146912|11018818|FG004|Overall Study|Already received influenza vaccination|41
6969236|NCT01146912|11018819|FG005|Overall Study|Already received influenza vaccination|61
6969237|NCT01146912|11018820|FG006|Overall Study|Already received influenza vaccination|56
6969238|NCT01146912|11018821|FG007|Overall Study|Already received influenza vaccination|0
6969239|NCT01146912|11018814|FG000|Overall Study|< 14 weeks gestational age|0
6969240|NCT01146912|11018815|FG001|Overall Study|< 14 weeks gestational age|0
6969241|NCT01146912|11018816|FG002|Overall Study|< 14 weeks gestational age|3
6969242|NCT01146912|11018817|FG003|Overall Study|< 14 weeks gestational age|2
6969243|NCT01146912|11018818|FG004|Overall Study|< 14 weeks gestational age|0
6969244|NCT01146912|11018819|FG005|Overall Study|< 14 weeks gestational age|0
6969245|NCT01146912|11018820|FG006|Overall Study|< 14 weeks gestational age|0
6969246|NCT01146912|11018821|FG007|Overall Study|< 14 weeks gestational age|0
6969247|NCT01146912|11018814|FG000|Overall Study|Duplicate patient|0
6969248|NCT01146912|11018815|FG001|Overall Study|Duplicate patient|0
6969249|NCT01146912|11018816|FG002|Overall Study|Duplicate patient|1
6969250|NCT01146912|11018817|FG003|Overall Study|Duplicate patient|0
6969251|NCT01146912|11018818|FG004|Overall Study|Duplicate patient|0
6969252|NCT01146912|11018819|FG005|Overall Study|Duplicate patient|0
6969253|NCT01146912|11018820|FG006|Overall Study|Duplicate patient|0
6969254|NCT01146912|11018821|FG007|Overall Study|Duplicate patient|0
6969255|NCT01146951|11018842|FG000|Overall Study|Adverse Event|4
6969256|NCT01146951|11018843|FG001|Overall Study|Adverse Event|1
6969257|NCT01147055|11018849|FG000|First Intervention Period|Lost to Follow-up|1
6969258|NCT01147055|11018850|FG001|First Intervention Period|Lost to Follow-up|0
6969259|NCT01147068|11018863|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1
6969260|NCT01147068|11018864|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0
6969261|NCT01147068|11018865|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0
6969262|NCT01147068|11018866|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0
6969263|NCT01147068|11018867|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0
6969264|NCT01147068|11018868|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1
6969265|NCT01147068|11018869|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0
6969266|NCT01147068|11018863|FG000|Subjects That Received 2nd Dose|Ineligible|0
6969267|NCT01147068|11018864|FG001|Subjects That Received 2nd Dose|Ineligible|1
6969268|NCT01147068|11018865|FG002|Subjects That Received 2nd Dose|Ineligible|0
6969269|NCT01147068|11018866|FG003|Subjects That Received 2nd Dose|Ineligible|0
6969270|NCT01147068|11018867|FG004|Subjects That Received 2nd Dose|Ineligible|0
6969271|NCT01147068|11018868|FG005|Subjects That Received 2nd Dose|Ineligible|0
6969272|NCT01147068|11018869|FG006|Subjects That Received 2nd Dose|Ineligible|0
6969273|NCT01147068|11018863|FG000|Subjects That Received 2nd Dose|Did not complete the study|0
6969274|NCT01147068|11018864|FG001|Subjects That Received 2nd Dose|Did not complete the study|1
6969275|NCT01147068|11018865|FG002|Subjects That Received 2nd Dose|Did not complete the study|0
6969276|NCT01147068|11018866|FG003|Subjects That Received 2nd Dose|Did not complete the study|0
6969277|NCT01147068|11018867|FG004|Subjects That Received 2nd Dose|Did not complete the study|0
6969278|NCT01147068|11018868|FG005|Subjects That Received 2nd Dose|Did not complete the study|1
7078776|NCT02106156|11187374|FG002|Overall Study|Patient Died|0
7078777|NCT02106156|11187372|FG000|Overall Study|Lack of Tolerability|305
6877872|NCT00512707|10889663|FG000|Overall Study|Lost to Follow-up|5
6877873|NCT00512707|10889664|FG001|Overall Study|Lost to Follow-up|11
6877874|NCT00512707|10889663|FG000|Overall Study|Developed skin irritation|2
6877875|NCT00512707|10889664|FG001|Overall Study|Developed skin irritation|1
6877876|NCT00512707|10889663|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2
6877877|NCT00512707|10889664|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0
6877878|NCT00512707|10889663|FG000|Overall Study|Unable to tolerate the smell of the gel|1
6877879|NCT00512707|10889664|FG001|Overall Study|Unable to tolerate the smell of the gel|0
6877880|NCT00512798|10889672|FG000|Overall Study|Death|0
6877881|NCT00512798|10889673|FG001|Overall Study|Death|3
6877882|NCT00512798|10889672|FG000|Overall Study|Adverse Event|2
6877883|NCT00512798|10889673|FG001|Overall Study|Adverse Event|4
6877884|NCT00512798|10889672|FG000|Overall Study|Progression of disease|14
6877885|NCT00512798|10889673|FG001|Overall Study|Progression of disease|20
6877886|NCT00512798|10889672|FG000|Overall Study|Withdrawal by Subject|3
6877887|NCT00512798|10889673|FG001|Overall Study|Withdrawal by Subject|0
6877888|NCT00512902|10889684|FG000|Overall Study|Adverse Event|7
6877889|NCT00512902|10889684|FG000|Overall Study|Lost to Follow-up|1
6877890|NCT00513019|10889690|FG000|Overall Study|Adverse Event|1
6877891|NCT00513019|10889691|FG001|Overall Study|Adverse Event|0
6877892|NCT00513019|10889690|FG000|Overall Study|Withdrawal by Subject|4
6877893|NCT00513019|10889691|FG001|Overall Study|Withdrawal by Subject|5
6877894|NCT00513071|10889697|FG000|Overall Study|Adverse Event|1
6877895|NCT00513071|10889697|FG000|Overall Study|Withdrawal by Subject|1
6877896|NCT00513071|10889697|FG000|Overall Study|Physician Decision|3
6877897|NCT00513240|10889703|FG000|Overall Study|Did not have intended surgery|3
6877898|NCT00513240|10889704|FG001|Overall Study|Did not have intended surgery|0
6877899|NCT00513240|10889703|FG000|Overall Study|Death|3
6877900|NCT00513240|10889704|FG001|Overall Study|Death|3
6877901|NCT00513240|10889703|FG000|Overall Study|Withdrawal by Subject|7
6877902|NCT00513240|10889704|FG001|Overall Study|Withdrawal by Subject|4
6877903|NCT00513305|10889724|FG000|Overall Study|Adverse Event|6
6877904|NCT00513305|10889725|FG001|Overall Study|Adverse Event|2
6877905|NCT00513305|10889724|FG000|Overall Study|Death (through Consolidation Treatment)|2
6877906|NCT00513305|10889725|FG001|Overall Study|Death (through Consolidation Treatment)|2
6877907|NCT00513305|10889724|FG000|Overall Study|Lack of Efficacy|8
6877908|NCT00513305|10889725|FG001|Overall Study|Lack of Efficacy|13
6877909|NCT00513305|10889724|FG000|Overall Study|Withdrawal by Subject|1
6877910|NCT00513305|10889725|FG001|Overall Study|Withdrawal by Subject|2
6877911|NCT00513305|10889724|FG000|Overall Study|Disease progression|8
6969279|NCT01147068|11018869|FG006|Subjects That Received 2nd Dose|Did not complete the study|0
6969280|NCT01147068|11018863|FG000|Subjects That Received 2nd Dose|Other|0
6969281|NCT01147068|11018864|FG001|Subjects That Received 2nd Dose|Other|3
6969282|NCT01147068|11018865|FG002|Subjects That Received 2nd Dose|Other|3
6969283|NCT01147068|11018866|FG003|Subjects That Received 2nd Dose|Other|0
6969284|NCT01147068|11018867|FG004|Subjects That Received 2nd Dose|Other|1
6969285|NCT01147068|11018868|FG005|Subjects That Received 2nd Dose|Other|0
6969286|NCT01147068|11018869|FG006|Subjects That Received 2nd Dose|Other|0
6969287|NCT01147068|11018863|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
6969288|NCT01147068|11018864|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
6877912|NCT00513305|10889725|FG001|Overall Study|Disease progression|5
6877913|NCT00513305|10889724|FG000|Overall Study|Eligible for stem cell transplant|1
6877914|NCT00513305|10889725|FG001|Overall Study|Eligible for stem cell transplant|0
6877915|NCT00513305|10889724|FG000|Overall Study|Hematologic counts did not recover|1
6877916|NCT00513305|10889725|FG001|Overall Study|Hematologic counts did not recover|0
6877917|NCT00513305|10889724|FG000|Overall Study|Physician Decision|1
6877918|NCT00513305|10889725|FG001|Overall Study|Physician Decision|0
6877919|NCT00513305|10889724|FG000|Overall Study|Persistent hypocellularity|0
6877920|NCT00513305|10889725|FG001|Overall Study|Persistent hypocellularity|1
6877921|NCT00513305|10889724|FG000|Overall Study|Sponsor Decision|0
6877922|NCT00513305|10889725|FG001|Overall Study|Sponsor Decision|2
6877923|NCT00513357|10889741|FG000|Overall Study|did not receive allocated placebo|2
6877924|NCT00513357|10889742|FG001|Overall Study|did not receive allocated placebo|3
6877925|NCT00513357|10889741|FG000|Overall Study|Adverse Event|4
6877926|NCT00513357|10889742|FG001|Overall Study|Adverse Event|2
6877927|NCT00513357|10889741|FG000|Overall Study|Death|2
6877928|NCT00513357|10889742|FG001|Overall Study|Death|0
6877929|NCT00513357|10889741|FG000|Overall Study|Withdrawal by Subject|5
6877930|NCT00513357|10889742|FG001|Overall Study|Withdrawal by Subject|4
6877931|NCT00513357|10889741|FG000|Overall Study|Disease Progression|2
6877932|NCT00513357|10889742|FG001|Overall Study|Disease Progression|1
6877933|NCT00513409|10889756|FG000|Overall Study|Adverse Event|0
6877934|NCT00513409|10889757|FG001|Overall Study|Adverse Event|1
7078778|NCT02106156|11187373|FG001|Overall Study|Lack of Tolerability|3
7078779|NCT02106156|11187374|FG002|Overall Study|Lack of Tolerability|0
6877935|NCT00513409|10889756|FG000|Overall Study|Withdrawal by Subject|0
7078780|NCT02106156|11187372|FG000|Overall Study|Lack of Virological Response|1044
6877936|NCT00513409|10889757|FG001|Overall Study|Withdrawal by Subject|2
6877937|NCT00513409|10889756|FG000|Overall Study|Lost to Follow-up|0
6877938|NCT00513409|10889757|FG001|Overall Study|Lost to Follow-up|1
6877939|NCT00513409|10889756|FG000|Overall Study|Physician Decision|1
6877940|NCT00513409|10889757|FG001|Overall Study|Physician Decision|0
6877941|NCT00513409|10889756|FG000|Overall Study|Visit 3 not done|1
6877942|NCT00513409|10889757|FG001|Overall Study|Visit 3 not done|2
6877943|NCT00513474|10889778|FG000|Overall Study|Death|6
6877944|NCT00513474|10889779|FG001|Overall Study|Death|9
6877945|NCT00513474|10889778|FG000|Overall Study|Participant Withdrew Consent|1
6877946|NCT00513474|10889779|FG001|Overall Study|Participant Withdrew Consent|0
6877947|NCT00513500|10889787|FG000|Overall Study|Lost to Follow-up|35
6877948|NCT00513500|10889788|FG001|Overall Study|Lost to Follow-up|39
6877949|NCT00513500|10889787|FG000|Overall Study|Death|2
6877950|NCT00513500|10889788|FG001|Overall Study|Death|1
6877951|NCT00513500|10889787|FG000|Overall Study|Hospitalized|4
6877952|NCT00513500|10889788|FG001|Overall Study|Hospitalized|14
6877953|NCT00513604|10889805|FG000|Overall Study|Not treated|2
6877954|NCT00513604|10889806|FG001|Overall Study|Not treated|0
6877955|NCT00513604|10889807|FG002|Overall Study|Not treated|1
6877956|NCT00513604|10889808|FG003|Overall Study|Not treated|0
6877957|NCT00513604|10889809|FG004|Overall Study|Not treated|0
6877958|NCT00513604|10889805|FG000|Overall Study|Death during treatment|0
6877959|NCT00513604|10889806|FG001|Overall Study|Death during treatment|3
6877960|NCT00513604|10889807|FG002|Overall Study|Death during treatment|2
6877961|NCT00513604|10889808|FG003|Overall Study|Death during treatment|0
6877962|NCT00513604|10889809|FG004|Overall Study|Death during treatment|0
6877963|NCT00513682|10889821|FG000|Washout Phase|Adverse Event|2
6877964|NCT00513695|10889828|FG000|Overall Study|Discontinued therapy|2
6877965|NCT00513695|10889828|FG000|Overall Study|Progression prior to surgery|3
6877966|NCT00513708|10889835|FG000|Overall Study|Lost to Follow-up|4
6877967|NCT00513708|10889836|FG001|Overall Study|Lost to Follow-up|4
6877968|NCT00513708|10889837|FG002|Overall Study|Lost to Follow-up|4
6877969|NCT00514020|10889881|FG000|Overall Study|Adverse Event|6
6877970|NCT00514020|10889881|FG000|Overall Study|Withdrawal by Subject|3
6877971|NCT00514020|10889881|FG000|Overall Study|Physician Decision|1
6877972|NCT00514020|10889881|FG000|Overall Study|disease progression|9
6877973|NCT00514020|10889881|FG000|Overall Study|other complicating disease|2
6877974|NCT00514020|10889881|FG000|Overall Study|patient went to radiation treatment|1
6877975|NCT00514020|10889881|FG000|Overall Study|"patients moved to the no tx group"|6
6877976|NCT00514046|10889894|FG000|Overall Study|transferred to another protocol|2
6877977|NCT00514046|10889895|FG001|Overall Study|transferred to another protocol|1
6877978|NCT00514046|10889896|FG002|Overall Study|transferred to another protocol|3
6877979|NCT00514046|10889897|FG003|Overall Study|transferred to another protocol|0
6877980|NCT00514046|10889898|FG004|Overall Study|transferred to another protocol|1
6877981|NCT00514046|10889899|FG005|Overall Study|transferred to another protocol|0
6877982|NCT00514046|10889900|FG006|Overall Study|transferred to another protocol|0
6877983|NCT00514046|10889901|FG007|Overall Study|transferred to another protocol|0
6877984|NCT00514046|10889902|FG008|Overall Study|transferred to another protocol|0
6877985|NCT00514046|10889894|FG000|Overall Study|Getting vandetanib via the REMS program|1
6877986|NCT00514046|10889895|FG001|Overall Study|Getting vandetanib via the REMS program|0
6877987|NCT00514046|10889896|FG002|Overall Study|Getting vandetanib via the REMS program|0
6877988|NCT00514046|10889897|FG003|Overall Study|Getting vandetanib via the REMS program|0
6877989|NCT00514046|10889898|FG004|Overall Study|Getting vandetanib via the REMS program|0
6877990|NCT00514046|10889899|FG005|Overall Study|Getting vandetanib via the REMS program|0
6877991|NCT00514046|10889900|FG006|Overall Study|Getting vandetanib via the REMS program|0
6877992|NCT00514046|10889901|FG007|Overall Study|Getting vandetanib via the REMS program|1
6877993|NCT00514046|10889902|FG008|Overall Study|Getting vandetanib via the REMS program|1
6877994|NCT00514046|10889894|FG000|Overall Study|Disease progression on study|0
6877995|NCT00514046|10889895|FG001|Overall Study|Disease progression on study|0
6877996|NCT00514046|10889896|FG002|Overall Study|Disease progression on study|2
6877997|NCT00514046|10889897|FG003|Overall Study|Disease progression on study|0
6877998|NCT00514046|10889898|FG004|Overall Study|Disease progression on study|0
6877999|NCT00514046|10889899|FG005|Overall Study|Disease progression on study|1
6878000|NCT00514046|10889900|FG006|Overall Study|Disease progression on study|0
6878001|NCT00514046|10889901|FG007|Overall Study|Disease progression on study|0
6878002|NCT00514046|10889902|FG008|Overall Study|Disease progression on study|0
6878003|NCT00514449|10889934|FG000|Overall Study|Withdrawal by Subject|1
6878004|NCT00514449|10889935|FG001|Overall Study|Withdrawal by Subject|2
6878005|NCT00514449|10889934|FG000|Overall Study|Protocol Violation|1
6878006|NCT00514449|10889935|FG001|Overall Study|Protocol Violation|2
6878007|NCT00514449|10889934|FG000|Overall Study|Lost to Follow-up|1
6878008|NCT00514449|10889935|FG001|Overall Study|Lost to Follow-up|0
6878009|NCT00514514|10889951|FG000|Pre-phase|Death|10
6878010|NCT00514514|10889952|FG001|Pre-phase|Death|0
6878011|NCT00514514|10889953|FG002|Pre-phase|Death|0
6878012|NCT00514514|10889951|FG000|Pre-phase|administrative problems|2
6878013|NCT00514514|10889952|FG001|Pre-phase|administrative problems|0
6878014|NCT00514514|10889953|FG002|Pre-phase|administrative problems|0
6878015|NCT00514514|10889951|FG000|Pre-phase|Protocol Violation|6
6878016|NCT00514514|10889952|FG001|Pre-phase|Protocol Violation|0
6878017|NCT00514514|10889953|FG002|Pre-phase|Protocol Violation|0
6878018|NCT00514514|10889951|FG000|Pre-phase|condition no longer requires study drug|7
6878019|NCT00514514|10889952|FG001|Pre-phase|condition no longer requires study drug|0
6878020|NCT00514514|10889953|FG002|Pre-phase|condition no longer requires study drug|0
6878021|NCT00514514|10889951|FG000|Pre-phase|abnormal test procedure results|15
6878022|NCT00514514|10889952|FG001|Pre-phase|abnormal test procedure results|0
6878023|NCT00514514|10889953|FG002|Pre-phase|abnormal test procedure results|0
6878024|NCT00514514|10889951|FG000|Pre-phase|Lost to Follow-up|2
6878025|NCT00514514|10889952|FG001|Pre-phase|Lost to Follow-up|0
6878026|NCT00514514|10889953|FG002|Pre-phase|Lost to Follow-up|0
6878027|NCT00514514|10889951|FG000|Pre-phase|abnormal lab values|23
6878028|NCT00514514|10889952|FG001|Pre-phase|abnormal lab values|0
6878029|NCT00514514|10889953|FG002|Pre-phase|abnormal lab values|0
6878030|NCT00514514|10889951|FG000|Pre-phase|Lack of Efficacy|35
6878031|NCT00514514|10889952|FG001|Pre-phase|Lack of Efficacy|0
6878032|NCT00514514|10889953|FG002|Pre-phase|Lack of Efficacy|0
6878033|NCT00514514|10889951|FG000|Pre-phase|Adverse Event|137
6878034|NCT00514514|10889952|FG001|Pre-phase|Adverse Event|0
6878035|NCT00514514|10889953|FG002|Pre-phase|Adverse Event|0
6878036|NCT00514514|10889951|FG000|Pre-phase|Withdrawal by Subject|66
6878037|NCT00514514|10889952|FG001|Pre-phase|Withdrawal by Subject|0
6878038|NCT00514514|10889953|FG002|Pre-phase|Withdrawal by Subject|0
6878039|NCT00514514|10889951|FG000|Randomized - 9 Month|Death|3
6878040|NCT00514514|10889952|FG001|Randomized - 9 Month|Death|2
6878041|NCT00514514|10889953|FG002|Randomized - 9 Month|Death|2
6878042|NCT00514514|10889951|FG000|Randomized - 9 Month|Administrative problems|1
6878043|NCT00514514|10889952|FG001|Randomized - 9 Month|Administrative problems|1
6878044|NCT00514514|10889953|FG002|Randomized - 9 Month|Administrative problems|2
6878045|NCT00514514|10889951|FG000|Randomized - 9 Month|Withdrawal by Subject|7
6878046|NCT00514514|10889952|FG001|Randomized - 9 Month|Withdrawal by Subject|7
6878047|NCT00514514|10889953|FG002|Randomized - 9 Month|Withdrawal by Subject|5
6878048|NCT00514514|10889951|FG000|Randomized - 9 Month|Protocol Violation|1
6878049|NCT00514514|10889952|FG001|Randomized - 9 Month|Protocol Violation|1
6878050|NCT00514514|10889953|FG002|Randomized - 9 Month|Protocol Violation|0
6878051|NCT00514514|10889951|FG000|Randomized - 9 Month|Lack of Efficacy|2
6878052|NCT00514514|10889952|FG001|Randomized - 9 Month|Lack of Efficacy|3
6878053|NCT00514514|10889953|FG002|Randomized - 9 Month|Lack of Efficacy|1
6878054|NCT00514514|10889951|FG000|Randomized - 9 Month|Abnormal laboratory values|0
6878055|NCT00514514|10889952|FG001|Randomized - 9 Month|Abnormal laboratory values|3
6878056|NCT00514514|10889953|FG002|Randomized - 9 Month|Abnormal laboratory values|1
6878057|NCT00514514|10889951|FG000|Randomized - 9 Month|Adverse Event|25
6878058|NCT00514514|10889952|FG001|Randomized - 9 Month|Adverse Event|44
6878059|NCT00514514|10889953|FG002|Randomized - 9 Month|Adverse Event|27
6878060|NCT00514514|10889951|FG000|Extension - 4 Years|Withdrawal by Subject|5
6878061|NCT00514514|10889952|FG001|Extension - 4 Years|Withdrawal by Subject|2
6878062|NCT00514514|10889953|FG002|Extension - 4 Years|Withdrawal by Subject|2
6878063|NCT00514514|10889951|FG000|Extension - 4 Years|Lost to Follow-up|12
6878064|NCT00514514|10889952|FG001|Extension - 4 Years|Lost to Follow-up|10
7078781|NCT02106156|11187373|FG001|Overall Study|Lack of Virological Response|8
7078782|NCT02106156|11187374|FG002|Overall Study|Lack of Virological Response|0
7078783|NCT02106156|11187372|FG000|Overall Study|Concomitant Disease|74
7078784|NCT02106156|11187373|FG001|Overall Study|Concomitant Disease|2
7078785|NCT02106156|11187374|FG002|Overall Study|Concomitant Disease|0
7078786|NCT02106156|11187372|FG000|Overall Study|Lack of Compliance|211
7078787|NCT02106156|11187373|FG001|Overall Study|Lack of Compliance|7
6878065|NCT00514514|10889953|FG002|Extension - 4 Years|Lost to Follow-up|9
6878066|NCT00514514|10889951|FG000|Extension - 4 Years|Administrative problems|3
6878067|NCT00514514|10889952|FG001|Extension - 4 Years|Administrative problems|1
6878068|NCT00514514|10889953|FG002|Extension - 4 Years|Administrative problems|1
6878069|NCT00514514|10889951|FG000|Extension - 4 Years|Death|8
6878070|NCT00514514|10889952|FG001|Extension - 4 Years|Death|3
6878071|NCT00514514|10889953|FG002|Extension - 4 Years|Death|6
6878072|NCT00514514|10889951|FG000|Extension - 4 Years|Adverse Event|9
6878073|NCT00514514|10889952|FG001|Extension - 4 Years|Adverse Event|6
6878074|NCT00514514|10889953|FG002|Extension - 4 Years|Adverse Event|3
6878075|NCT00514540|10889961|FG000|First-Line Chemo|Withdrawal by Subject|1
6878076|NCT00514540|10889961|FG000|First-Line Chemo|Protocol Violation|7
6878077|NCT00514540|10889961|FG000|Second-Line|Physician/Patient Decision|31
6878078|NCT00514683|10889978|FG000|Overall Study|Not treated|2
6878079|NCT00514683|10889979|FG001|Overall Study|Not treated|1
6878080|NCT00514683|10889980|FG002|Overall Study|Not treated|0
6878081|NCT00514683|10889981|FG003|Overall Study|Not treated|0
6878082|NCT00514683|10889982|FG004|Overall Study|Not treated|1
6878083|NCT00514683|10889978|FG000|Overall Study|Adverse Event|21
6878084|NCT00514683|10889979|FG001|Overall Study|Adverse Event|20
7078788|NCT02106156|11187374|FG002|Overall Study|Lack of Compliance|0
7078789|NCT02106156|11187372|FG000|Overall Study|Patients Request|307
6878085|NCT00514683|10889980|FG002|Overall Study|Adverse Event|15
6878086|NCT00514683|10889981|FG003|Overall Study|Adverse Event|13
6878087|NCT00514683|10889982|FG004|Overall Study|Adverse Event|27
6878088|NCT00514683|10889978|FG000|Overall Study|Protocol Violation|1
6878089|NCT00514683|10889979|FG001|Overall Study|Protocol Violation|1
6878090|NCT00514683|10889980|FG002|Overall Study|Protocol Violation|0
6878091|NCT00514683|10889981|FG003|Overall Study|Protocol Violation|1
6878092|NCT00514683|10889982|FG004|Overall Study|Protocol Violation|0
6878093|NCT00514683|10889978|FG000|Overall Study|Withdrawal by Subject|2
6878094|NCT00514683|10889979|FG001|Overall Study|Withdrawal by Subject|2
7078790|NCT02106156|11187373|FG001|Overall Study|Patients Request|9
6878095|NCT00514683|10889980|FG002|Overall Study|Withdrawal by Subject|1
6878096|NCT00514683|10889981|FG003|Overall Study|Withdrawal by Subject|0
6878097|NCT00514683|10889982|FG004|Overall Study|Withdrawal by Subject|4
6878098|NCT00514683|10889978|FG000|Overall Study|Reason other than listed above|0
6878099|NCT00514683|10889979|FG001|Overall Study|Reason other than listed above|1
6878100|NCT00514683|10889980|FG002|Overall Study|Reason other than listed above|2
6878101|NCT00514683|10889981|FG003|Overall Study|Reason other than listed above|0
6878102|NCT00514683|10889982|FG004|Overall Study|Reason other than listed above|1
6878103|NCT00514735|10890011|FG000|Overall Study|Withdrawal by Subject|13
6878104|NCT00514735|10890012|FG001|Overall Study|Withdrawal by Subject|5
6878105|NCT00514735|10890011|FG000|Overall Study|Death|1
6878106|NCT00514735|10890012|FG001|Overall Study|Death|0
6878107|NCT00514735|10890011|FG000|Overall Study|Lost to Follow-up|0
6878108|NCT00514735|10890012|FG001|Overall Study|Lost to Follow-up|1
6878109|NCT00514904|10890031|FG000|Overall Study|Withdrawal by Subject|3
6878110|NCT00514904|10890032|FG001|Overall Study|Withdrawal by Subject|2
6878111|NCT00514904|10890031|FG000|Overall Study|Lost to Follow-up|21
6878112|NCT00514904|10890032|FG001|Overall Study|Lost to Follow-up|3
6878113|NCT00514917|10890040|FG000|Overall Study|Death|4
6878114|NCT00514917|10890041|FG001|Overall Study|Death|10
6878115|NCT00514917|10890040|FG000|Overall Study|Protocol Violation|1
6878116|NCT00514917|10890041|FG001|Overall Study|Protocol Violation|0
6878117|NCT00514917|10890040|FG000|Overall Study|Lost to Follow-up|4
6878118|NCT00514917|10890041|FG001|Overall Study|Lost to Follow-up|3
6878119|NCT00514917|10890040|FG000|Overall Study|Withdrawal by Subject|18
6878120|NCT00514917|10890041|FG001|Overall Study|Withdrawal by Subject|16
6878121|NCT00514917|10890040|FG000|Overall Study|Discontinued due to study closure|88
6878122|NCT00514917|10890041|FG001|Overall Study|Discontinued due to study closure|81
6878123|NCT00514917|10890040|FG000|Overall Study|Undefined|11
6878124|NCT00514917|10890041|FG001|Overall Study|Undefined|5
6878125|NCT00514943|10890051|FG000|Stage 1|Progressive disease|4
6878126|NCT00514943|10890052|FG001|Stage 1|Progressive disease|8
6878127|NCT00514943|10890051|FG000|Stage 1|Other Adverse Event|16
6878128|NCT00514943|10890052|FG001|Stage 1|Other Adverse Event|6
6878129|NCT00514943|10890051|FG000|Stage 1|Not treated|1
6878130|NCT00514943|10890052|FG001|Stage 1|Not treated|2
6878131|NCT00514943|10890051|FG000|Stage 1|Patient refused to continue study meds|8
6878132|NCT00514943|10890052|FG001|Stage 1|Patient refused to continue study meds|3
6878133|NCT00514943|10890051|FG000|Stage 1|Other than stated above|1
6878134|NCT00514943|10890052|FG001|Stage 1|Other than stated above|7
6878135|NCT00514943|10890051|FG000|Stage 2|Progressive disease|27
6878136|NCT00514943|10890052|FG001|Stage 2|Progressive disease|24
6878137|NCT00514943|10890051|FG000|Stage 2|Other Adverse Event|3
6878138|NCT00514943|10890052|FG001|Stage 2|Other Adverse Event|10
6878139|NCT00514943|10890051|FG000|Stage 2|Patient refused to continue study meds|2
6878140|NCT00514943|10890052|FG001|Stage 2|Patient refused to continue study meds|0
6878141|NCT00514943|10890051|FG000|Stage 2|Other than stated above|0
6878142|NCT00514943|10890052|FG001|Stage 2|Other than stated above|2
6878143|NCT00515008|10890075|FG000|Overall Study|Lost to Follow-up|1
6878144|NCT00515008|10890076|FG001|Overall Study|Lost to Follow-up|0
6878145|NCT00515008|10890075|FG000|Overall Study|Declined|0
6878146|NCT00515008|10890076|FG001|Overall Study|Declined|3
6878147|NCT00515008|10890075|FG000|Overall Study|Left the Boston Area|1
6878148|NCT00515008|10890076|FG001|Overall Study|Left the Boston Area|1
6878149|NCT00515008|10890075|FG000|Overall Study|Scheduling conflict|1
6878150|NCT00515008|10890076|FG001|Overall Study|Scheduling conflict|0
6878151|NCT00515034|10890100|FG000|Overall Study|Adverse Event|2
7154513|NCT03313037|11321364|FG000|Overall Study|Randomized but not treated|1
7154514|NCT03313037|11321365|FG001|Overall Study|Randomized but not treated|0
7154515|NCT03313050|11321375|FG000|Stage 2: 12 Months|Adverse Event|0
7154516|NCT03313050|11321376|FG001|Stage 2: 12 Months|Adverse Event|0
7154517|NCT03313050|11321377|FG002|Stage 2: 12 Months|Adverse Event|0
7154518|NCT03313050|11321378|FG003|Stage 2: 12 Months|Adverse Event|1
7154519|NCT03313050|11321375|FG000|Stage 2: 12 Months|Death|0
6878152|NCT00515034|10890101|FG001|Overall Study|Adverse Event|0
6878153|NCT00515034|10890102|FG002|Overall Study|Adverse Event|1
6878154|NCT00515034|10890103|FG003|Overall Study|Adverse Event|0
6878155|NCT00515034|10890100|FG000|Overall Study|Death|4
6878156|NCT00515034|10890101|FG001|Overall Study|Death|2
6878157|NCT00515034|10890102|FG002|Overall Study|Death|1
6878158|NCT00515034|10890103|FG003|Overall Study|Death|3
6878159|NCT00515034|10890100|FG000|Overall Study|Withdrawal by Subject|1
6878160|NCT00515034|10890101|FG001|Overall Study|Withdrawal by Subject|0
6878161|NCT00515034|10890102|FG002|Overall Study|Withdrawal by Subject|3
6878162|NCT00515034|10890103|FG003|Overall Study|Withdrawal by Subject|0
7154520|NCT03313050|11321376|FG001|Stage 2: 12 Months|Death|0
7154521|NCT03313050|11321377|FG002|Stage 2: 12 Months|Death|3
7154522|NCT03313050|11321378|FG003|Stage 2: 12 Months|Death|0
7154523|NCT03313050|11321375|FG000|Stage 2: 12 Months|Lost to Follow-up|0
6878163|NCT00515034|10890100|FG000|Overall Study|Physician Decision|0
6878164|NCT00515034|10890101|FG001|Overall Study|Physician Decision|0
7154524|NCT03313050|11321376|FG001|Stage 2: 12 Months|Lost to Follow-up|0
6878165|NCT00515034|10890102|FG002|Overall Study|Physician Decision|1
6878166|NCT00515034|10890103|FG003|Overall Study|Physician Decision|1
7154525|NCT03313050|11321377|FG002|Stage 2: 12 Months|Lost to Follow-up|1
7154526|NCT03313050|11321378|FG003|Stage 2: 12 Months|Lost to Follow-up|5
6878167|NCT00515034|10890100|FG000|Overall Study|Other|1
6878168|NCT00515034|10890101|FG001|Overall Study|Other|0
6878169|NCT00515034|10890102|FG002|Overall Study|Other|2
6878170|NCT00515034|10890103|FG003|Overall Study|Other|1
6878171|NCT00515073|10890113|FG000|Overall Study|Withdrawal by Subject|1
6878172|NCT00515073|10890113|FG000|Overall Study|Physician Decision|1
6878173|NCT00515086|10890121|FG000|Overall Study|Adverse Event|1
6878174|NCT00515086|10890122|FG001|Overall Study|Adverse Event|1
6878175|NCT00515086|10890123|FG002|Overall Study|Adverse Event|2
6878176|NCT00515086|10890124|FG003|Overall Study|Adverse Event|3
6878177|NCT00515086|10890121|FG000|Overall Study|Administrative|1
6878178|NCT00515086|10890122|FG001|Overall Study|Administrative|1
6878179|NCT00515086|10890123|FG002|Overall Study|Administrative|0
6878180|NCT00515086|10890124|FG003|Overall Study|Administrative|0
6878181|NCT00515086|10890121|FG000|Overall Study|Withdrawal by Subject|1
6878182|NCT00515086|10890122|FG001|Overall Study|Withdrawal by Subject|0
6878183|NCT00515086|10890123|FG002|Overall Study|Withdrawal by Subject|0
6878184|NCT00515086|10890124|FG003|Overall Study|Withdrawal by Subject|1
6878185|NCT00515086|10890121|FG000|Overall Study|Unsatisfactory therapeutic effect|18
6878186|NCT00515086|10890122|FG001|Overall Study|Unsatisfactory therapeutic effect|3
6878187|NCT00515086|10890123|FG002|Overall Study|Unsatisfactory therapeutic effect|3
6878188|NCT00515086|10890124|FG003|Overall Study|Unsatisfactory therapeutic effect|2
6878189|NCT00515086|10890121|FG000|Overall Study|Lost to Follow-up|1
6878190|NCT00515086|10890122|FG001|Overall Study|Lost to Follow-up|0
6878191|NCT00515086|10890123|FG002|Overall Study|Lost to Follow-up|0
6878192|NCT00515086|10890124|FG003|Overall Study|Lost to Follow-up|0
6878193|NCT00515086|10890121|FG000|Overall Study|Study drug no longer required|0
6878194|NCT00515086|10890122|FG001|Overall Study|Study drug no longer required|1
6878195|NCT00515086|10890123|FG002|Overall Study|Study drug no longer required|0
6878196|NCT00515086|10890124|FG003|Overall Study|Study drug no longer required|0
6878197|NCT00515086|10890121|FG000|Overall Study|Death|2
6878198|NCT00515086|10890122|FG001|Overall Study|Death|0
6878199|NCT00515086|10890123|FG002|Overall Study|Death|0
6878200|NCT00515086|10890124|FG003|Overall Study|Death|0
6878201|NCT00515099|10890142|FG000|Overall Study|Lost to Follow-up|0
6878202|NCT00515099|10890143|FG001|Overall Study|Lost to Follow-up|4
6878203|NCT00515099|10890142|FG000|Overall Study|Withdrawal by Subject|2
6878204|NCT00515099|10890143|FG001|Overall Study|Withdrawal by Subject|0
6878205|NCT00515099|10890142|FG000|Overall Study|IRB Recommendation|1
6878206|NCT00515099|10890143|FG001|Overall Study|IRB Recommendation|0
6878207|NCT00515216|10890168|FG000|Overall Study|Withdrawal by Subject|1
6878208|NCT00515294|10890177|FG000|Overall Study|Lost to Follow-up|3
6878209|NCT00515294|10890178|FG001|Overall Study|Lost to Follow-up|2
6878210|NCT00515294|10890179|FG002|Overall Study|Lost to Follow-up|3
6878211|NCT00515294|10890180|FG003|Overall Study|Lost to Follow-up|1
6878212|NCT00515294|10890177|FG000|Overall Study|Driver simulator problems|1
6878213|NCT00515294|10890178|FG001|Overall Study|Driver simulator problems|1
6878214|NCT00515294|10890179|FG002|Overall Study|Driver simulator problems|1
6878215|NCT00515294|10890180|FG003|Overall Study|Driver simulator problems|3
6878216|NCT00515294|10890177|FG000|Overall Study|Caffeine amount inaccurate|5
6878217|NCT00515294|10890178|FG001|Overall Study|Caffeine amount inaccurate|0
6878218|NCT00515294|10890179|FG002|Overall Study|Caffeine amount inaccurate|7
6878219|NCT00515294|10890180|FG003|Overall Study|Caffeine amount inaccurate|0
6878220|NCT00515463|10890222|FG000|Overall Study|Physician Decision|4
6878221|NCT00515463|10890223|FG001|Overall Study|Physician Decision|2
6878222|NCT00515463|10890222|FG000|Overall Study|Adverse Event|1
6878223|NCT00515463|10890223|FG001|Overall Study|Adverse Event|2
6878224|NCT00515463|10890222|FG000|Overall Study|Withdrawal by Subject|3
6878225|NCT00515463|10890223|FG001|Overall Study|Withdrawal by Subject|4
6878226|NCT00515463|10890222|FG000|Overall Study|Lost to Follow-up|6
6878227|NCT00515463|10890223|FG001|Overall Study|Lost to Follow-up|5
6878228|NCT00515463|10890222|FG000|Overall Study|Other|0
6878229|NCT00515463|10890223|FG001|Overall Study|Other|1
6878230|NCT00515502|10890230|FG000|Treatment Period 1|Adverse Event|0
6878231|NCT00515502|10890231|FG001|Treatment Period 1|Adverse Event|0
6878232|NCT00515502|10890232|FG002|Treatment Period 1|Adverse Event|0
6878233|NCT00515502|10890233|FG003|Treatment Period 1|Adverse Event|0
6878234|NCT00515502|10890234|FG004|Treatment Period 1|Adverse Event|0
6878235|NCT00515502|10890235|FG005|Treatment Period 1|Adverse Event|0
6969289|NCT01147068|11018865|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
6969290|NCT01147068|11018866|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
6969291|NCT01147068|11018867|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
6969292|NCT01147068|11018868|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
6976949|NCT01203072|11029841|FG001|Overall Study|Lost to Follow-up|1
6878236|NCT00515502|10890236|FG006|Treatment Period 1|Adverse Event|1
6878237|NCT00515502|10890237|FG007|Treatment Period 1|Adverse Event|0
6878238|NCT00515502|10890238|FG008|Treatment Period 1|Adverse Event|1
6878239|NCT00515502|10890239|FG009|Treatment Period 1|Adverse Event|0
6878240|NCT00515502|10890240|FG010|Treatment Period 1|Adverse Event|0
6878241|NCT00515502|10890241|FG011|Treatment Period 1|Adverse Event|1
6878242|NCT00515502|10890230|FG000|Treatment Period 2|Adverse Event|0
6878243|NCT00515502|10890231|FG001|Treatment Period 2|Adverse Event|1
6878244|NCT00515502|10890232|FG002|Treatment Period 2|Adverse Event|0
6878245|NCT00515502|10890233|FG003|Treatment Period 2|Adverse Event|0
6878246|NCT00515502|10890234|FG004|Treatment Period 2|Adverse Event|0
6878247|NCT00515502|10890235|FG005|Treatment Period 2|Adverse Event|0
6878248|NCT00515502|10890236|FG006|Treatment Period 2|Adverse Event|0
6878249|NCT00515502|10890237|FG007|Treatment Period 2|Adverse Event|0
6878250|NCT00515502|10890238|FG008|Treatment Period 2|Adverse Event|0
6878251|NCT00515502|10890239|FG009|Treatment Period 2|Adverse Event|0
6878252|NCT00515502|10890240|FG010|Treatment Period 2|Adverse Event|0
6878253|NCT00515502|10890241|FG011|Treatment Period 2|Adverse Event|0
6878254|NCT00515541|10890271|FG000|Overall Study|Physician Decision|0
6878255|NCT00515541|10890272|FG001|Overall Study|Physician Decision|2
6878256|NCT00515541|10890273|FG002|Overall Study|Physician Decision|0
6878257|NCT00515541|10890274|FG003|Overall Study|Physician Decision|1
6878258|NCT00515541|10890271|FG000|Overall Study|No show for appointments|0
6878259|NCT00515541|10890272|FG001|Overall Study|No show for appointments|1
6878260|NCT00515541|10890273|FG002|Overall Study|No show for appointments|0
6878261|NCT00515541|10890274|FG003|Overall Study|No show for appointments|2
6878262|NCT00515541|10890271|FG000|Overall Study|Withdrawal by Subject|0
6878263|NCT00515541|10890272|FG001|Overall Study|Withdrawal by Subject|2
6878264|NCT00515541|10890273|FG002|Overall Study|Withdrawal by Subject|0
6878265|NCT00515541|10890274|FG003|Overall Study|Withdrawal by Subject|2
6878266|NCT00515619|10890284|FG000|Overall Study|Adverse Event|34
6878267|NCT00515619|10890284|FG000|Overall Study|Lack of Efficacy|92
6878268|NCT00515619|10890284|FG000|Overall Study|Withdrawal by Subject|66
6878269|NCT00515619|10890284|FG000|Overall Study|Protocol Violation|3
6878270|NCT00515619|10890284|FG000|Overall Study|Lost to Follow-up|4
6878271|NCT00515619|10890284|FG000|Overall Study|Unsatisfactory compliance|6
6878272|NCT00515619|10890284|FG000|Overall Study|Other: Site discontinuing trials|2
6878273|NCT00515619|10890284|FG000|Overall Study|Other: Subject cannot attend visits|2
6878274|NCT00515619|10890284|FG000|Overall Study|Other: Subject required surgery|1
6878275|NCT00515619|10890284|FG000|Overall Study|Other: Subject moved to another country|1
6878276|NCT00515619|10890284|FG000|Overall Study|Other: Investigator decision|1
6878277|NCT00515619|10890284|FG000|Overall Study|Other: Subject became pregnant|1
6878278|NCT00515619|10890284|FG000|Overall Study|Other: Request from sponsor|1
6878279|NCT00515619|10890284|FG000|Overall Study|Other: Drug available on license|1
6878280|NCT00515619|10890284|FG000|Overall Study|Other: Subject interested in other AED|1
6878281|NCT00515827|10890312|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
6878282|NCT00515827|10890313|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
6878283|NCT00515827|10890312|FG000|Second Intervention (12 Weeks)|Consent withdraw|1
6878284|NCT00515827|10890313|FG001|Second Intervention (12 Weeks)|Consent withdraw|0
6878285|NCT00516048|10890334|FG000|Overall Study|Death|0
6878286|NCT00516048|10890335|FG001|Overall Study|Death|0
6878287|NCT00516048|10890336|FG002|Overall Study|Death|1
6878288|NCT00516048|10890334|FG000|Overall Study|Subject Decision|0
6878289|NCT00516048|10890335|FG001|Overall Study|Subject Decision|2
6878290|NCT00516048|10890336|FG002|Overall Study|Subject Decision|0
6878291|NCT00516074|10890346|FG000|Overall Study|Adverse Event|0
6878292|NCT00516074|10890347|FG001|Overall Study|Adverse Event|1
6878293|NCT00516074|10890346|FG000|Overall Study|Subject Decision|4
6878294|NCT00516074|10890347|FG001|Overall Study|Subject Decision|2
6878295|NCT00516074|10890346|FG000|Overall Study|Loss of Glucose Control|2
6878296|NCT00516074|10890347|FG001|Overall Study|Loss of Glucose Control|0
6878297|NCT00516139|10890353|FG000|Overall Study|Adverse Event|27
6878298|NCT00516139|10890353|FG000|Overall Study|Lost to Follow-up|1
6878299|NCT00516139|10890353|FG000|Overall Study|Protocol Violation|1
6878300|NCT00516139|10890353|FG000|Overall Study|Withdrawal by Subject|8
6878301|NCT00516139|10890353|FG000|Overall Study|Lack of Efficacy|1
6878302|NCT00516269|10890371|FG000|Overall Study|Adverse Event|2
6878303|NCT00516269|10890372|FG001|Overall Study|Adverse Event|1
6878304|NCT00516269|10890371|FG000|Overall Study|Lost to Follow-up|0
6878305|NCT00516269|10890372|FG001|Overall Study|Lost to Follow-up|1
6878306|NCT00516269|10890371|FG000|Overall Study|Protocol Violation|0
6878307|NCT00516269|10890372|FG001|Overall Study|Protocol Violation|1
6878308|NCT00516295|10890381|FG000|Overall Study|Lack of Efficacy|2
6878309|NCT00516295|10890382|FG001|Overall Study|Lack of Efficacy|0
6878310|NCT00516295|10890383|FG002|Overall Study|Lack of Efficacy|0
6878311|NCT00516295|10890381|FG000|Overall Study|Ineligible|1
6878312|NCT00516295|10890382|FG001|Overall Study|Ineligible|0
6878313|NCT00516295|10890383|FG002|Overall Study|Ineligible|0
6878314|NCT00516321|10890393|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11
6878315|NCT00516321|10890394|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
6878316|NCT00516321|10890395|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
6878317|NCT00516321|10890393|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9
6878318|NCT00516321|10890394|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
6878319|NCT00516321|10890395|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
6878320|NCT00516321|10890393|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1
6878321|NCT00516321|10890394|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
6878322|NCT00516321|10890395|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
6878323|NCT00516321|10890393|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2
6878324|NCT00516321|10890394|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
6878325|NCT00516321|10890395|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
6878326|NCT00516321|10890393|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7
6976950|NCT01203072|11029842|FG002|Overall Study|Lost to Follow-up|0
6878327|NCT00516321|10890394|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
6878328|NCT00516321|10890395|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
6878329|NCT00516321|10890393|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3
6878330|NCT00516321|10890394|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
6878331|NCT00516321|10890395|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
6878332|NCT00516321|10890393|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0
6878333|NCT00516321|10890394|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12
6878334|NCT00516321|10890395|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22
6878335|NCT00516321|10890393|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0
6878336|NCT00516321|10890394|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13
6878337|NCT00516321|10890395|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18
6878338|NCT00516321|10890393|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0
6878339|NCT00516321|10890394|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8
6878340|NCT00516321|10890395|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13
6878341|NCT00516321|10890393|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
6878342|NCT00516321|10890394|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
6878343|NCT00516321|10890395|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1
6878344|NCT00516321|10890393|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0
6878345|NCT00516321|10890394|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2
6878346|NCT00516321|10890395|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0
6878347|NCT00516386|10890403|FG000|Overall Study|not interested in the study|4
6878348|NCT00516386|10890403|FG000|Overall Study|Lost to Follow-up|2
6878349|NCT00516893|10890416|FG000|Overall Study|Lost to Follow-up|4
7078791|NCT02106156|11187374|FG002|Overall Study|Patients Request|0
7078792|NCT02106156|11187372|FG000|Overall Study|Lost to Follow-up|451
7078793|NCT02106156|11187373|FG001|Overall Study|Lost to Follow-up|8
7078794|NCT02106156|11187374|FG002|Overall Study|Lost to Follow-up|0
7078795|NCT02106156|11187372|FG000|Overall Study|Unplanned Event|82
7078796|NCT02106156|11187373|FG001|Overall Study|Unplanned Event|2
7078797|NCT02106156|11187374|FG002|Overall Study|Unplanned Event|0
7078798|NCT02106156|11187372|FG000|Overall Study|Change of Laboratory Parameter|10
7078799|NCT02106156|11187373|FG001|Overall Study|Change of Laboratory Parameter|0
7078800|NCT02106156|11187374|FG002|Overall Study|Change of Laboratory Parameter|0
7078801|NCT02106156|11187372|FG000|Overall Study|Hospitalization/Surgical Intervention|6
7078802|NCT02106156|11187373|FG001|Overall Study|Hospitalization/Surgical Intervention|0
7078803|NCT02106156|11187374|FG002|Overall Study|Hospitalization/Surgical Intervention|0
7078804|NCT02106156|11187372|FG000|Overall Study|Relocation/Change of Physician|40
7154527|NCT03313050|11321375|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0
6878350|NCT00516893|10890416|FG000|Overall Study|Adverse Event|3
6878351|NCT00516893|10890416|FG000|Overall Study|Withdrawal by Subject|2
6878352|NCT00516893|10890416|FG000|Overall Study|Noncompliance|2
6878353|NCT00516893|10890416|FG000|Overall Study|Death|1
6878354|NCT00516893|10890416|FG000|Overall Study|Persistent Antibodies per Protocol|6
6878355|NCT00516893|10890416|FG000|Overall Study|Relocated|1
6878356|NCT00516893|10890416|FG000|Overall Study|Pregnancy|1
6878357|NCT00516893|10890416|FG000|Overall Study|Received Medication From Another Study|1
6878358|NCT00516906|10890422|FG000|Overall Study|Final Dressing Removal Data not captured|6
6878359|NCT00516906|10890423|FG001|Overall Study|Final Dressing Removal Data not captured|2
6878360|NCT00517296|10890442|FG000|Overall Study|Withdrawal by Subject|1
6878361|NCT00517296|10890443|FG001|Overall Study|Withdrawal by Subject|0
6878362|NCT00517413|10890449|FG000|Overall Study|Adverse Event|7
6878363|NCT00517413|10890449|FG000|Overall Study|Death|13
6878364|NCT00517413|10890449|FG000|Overall Study|Protocol Violation|15
6878365|NCT00517413|10890449|FG000|Overall Study|Withdrawal by Subject|2
6878366|NCT00517413|10890449|FG000|Overall Study|Failure to return|1
6878367|NCT00517413|10890449|FG000|Overall Study|Other-Reasons|23
6878368|NCT00517634|10890510|FG000|Second Treatment Period|Withdrawal by Subject|0
6878369|NCT00517634|10890511|FG001|Second Treatment Period|Withdrawal by Subject|0
6878370|NCT00517634|10890512|FG002|Second Treatment Period|Withdrawal by Subject|0
6878371|NCT00517634|10890513|FG003|Second Treatment Period|Withdrawal by Subject|0
6878372|NCT00517634|10890514|FG004|Second Treatment Period|Withdrawal by Subject|1
6878373|NCT00517634|10890515|FG005|Second Treatment Period|Withdrawal by Subject|0
6878374|NCT00517751|10890523|FG000|Overall Study|Death|3
6878375|NCT00517751|10890523|FG000|Overall Study|Withdrawal by Subject|37
6878376|NCT00517751|10890523|FG000|Overall Study|Lost to Follow-up|4
6878377|NCT00517751|10890523|FG000|Overall Study|patient not over due|6
7154528|NCT03313050|11321376|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0
7154529|NCT03313050|11321377|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0
7154530|NCT03313050|11321378|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3
6878378|NCT00517751|10890523|FG000|Overall Study|Patient not due for visit|76
6878379|NCT00517751|10890523|FG000|Overall Study|Missing|3
6878380|NCT00517829|10890529|FG000|Overall Study|Adverse Event|22
6878381|NCT00517829|10890530|FG001|Overall Study|Adverse Event|34
6878382|NCT00517829|10890529|FG000|Overall Study|Disease Progression|39
6878383|NCT00517829|10890530|FG001|Overall Study|Disease Progression|32
6878384|NCT00517829|10890529|FG000|Overall Study|Patient Request|6
6878385|NCT00517829|10890530|FG001|Overall Study|Patient Request|5
6878386|NCT00517829|10890529|FG000|Overall Study|Investigator Request|5
6878387|NCT00517829|10890530|FG001|Overall Study|Investigator Request|3
6878388|NCT00517829|10890529|FG000|Overall Study|Other|3
6878389|NCT00517829|10890530|FG001|Overall Study|Other|1
6878390|NCT00517881|10890536|FG000|Overall Study|Protocol Violation|2
6878391|NCT00517881|10890536|FG000|Overall Study|Adverse Event|1
6878392|NCT00517881|10890536|FG000|Overall Study|Renal transplantation|2
6878393|NCT00517933|10890542|FG000|Period 1|Death|2
6878394|NCT00517933|10890543|FG001|Period 1|Death|1
6878395|NCT00517933|10890542|FG000|Period 1|Adverse Event|4
6878396|NCT00517933|10890543|FG001|Period 1|Adverse Event|4
6878397|NCT00517933|10890542|FG000|Period 1|Lost to Follow-up|2
6878398|NCT00517933|10890543|FG001|Period 1|Lost to Follow-up|0
6878399|NCT00517933|10890542|FG000|Period 1|Underwent lung transplant|0
6878400|NCT00517933|10890543|FG001|Period 1|Underwent lung transplant|1
6878401|NCT00517933|10890542|FG000|Period 2|Death|2
6878402|NCT00517933|10890543|FG001|Period 2|Death|4
6878403|NCT00517933|10890542|FG000|Period 2|Adverse Event|2
6878404|NCT00517933|10890543|FG001|Period 2|Adverse Event|4
6878405|NCT00517933|10890542|FG000|Period 2|Physician Decision|1
6878406|NCT00517933|10890543|FG001|Period 2|Physician Decision|0
6878407|NCT00517933|10890542|FG000|Period 2|Withdrawal by Subject|1
6878408|NCT00517933|10890543|FG001|Period 2|Withdrawal by Subject|3
6878409|NCT00517933|10890542|FG000|Period 2|Underwent lung transplant|0
6878410|NCT00517933|10890543|FG001|Period 2|Underwent lung transplant|2
6878411|NCT00518011|10890554|FG000|Overall Study|Death|1
6878412|NCT00518011|10890555|FG001|Overall Study|Death|1
6878413|NCT00518011|10890554|FG000|Overall Study|Adverse Event|2
6878414|NCT00518011|10890555|FG001|Overall Study|Adverse Event|3
6878415|NCT00518011|10890554|FG000|Overall Study|Disease Progression|2
6878416|NCT00518011|10890555|FG001|Overall Study|Disease Progression|2
6878417|NCT00518011|10890554|FG000|Overall Study|Other Reasons|3
6878418|NCT00518011|10890555|FG001|Overall Study|Other Reasons|2
6878419|NCT00518011|10890554|FG000|Overall Study|Withdrawal by Subject|1
6878420|NCT00518011|10890555|FG001|Overall Study|Withdrawal by Subject|0
6878421|NCT00518115|10890581|FG000|Overall Study|Adverse Event|6
6878422|NCT00518115|10890582|FG001|Overall Study|Adverse Event|1
6878423|NCT00518115|10890583|FG002|Overall Study|Adverse Event|5
6878424|NCT00518115|10890584|FG003|Overall Study|Adverse Event|6
6878425|NCT00518115|10890585|FG004|Overall Study|Adverse Event|5
6878426|NCT00518115|10890586|FG005|Overall Study|Adverse Event|5
6878427|NCT00518115|10890587|FG006|Overall Study|Adverse Event|5
6878428|NCT00518115|10890588|FG007|Overall Study|Adverse Event|10
6878429|NCT00518115|10890589|FG008|Overall Study|Adverse Event|2
6878430|NCT00518115|10890590|FG009|Overall Study|Adverse Event|9
6878431|NCT00518115|10890581|FG000|Overall Study|Lost to Follow-up|0
6878432|NCT00518115|10890582|FG001|Overall Study|Lost to Follow-up|0
6878433|NCT00518115|10890583|FG002|Overall Study|Lost to Follow-up|2
6878434|NCT00518115|10890584|FG003|Overall Study|Lost to Follow-up|3
6878435|NCT00518115|10890585|FG004|Overall Study|Lost to Follow-up|1
6878436|NCT00518115|10890586|FG005|Overall Study|Lost to Follow-up|3
6878437|NCT00518115|10890587|FG006|Overall Study|Lost to Follow-up|0
6878438|NCT00518115|10890588|FG007|Overall Study|Lost to Follow-up|1
6878439|NCT00518115|10890589|FG008|Overall Study|Lost to Follow-up|1
6878440|NCT00518115|10890590|FG009|Overall Study|Lost to Follow-up|1
6878441|NCT00518115|10890581|FG000|Overall Study|Protocol Violation|1
6878442|NCT00518115|10890582|FG001|Overall Study|Protocol Violation|3
6878443|NCT00518115|10890583|FG002|Overall Study|Protocol Violation|1
6878444|NCT00518115|10890584|FG003|Overall Study|Protocol Violation|0
6878445|NCT00518115|10890585|FG004|Overall Study|Protocol Violation|0
6878446|NCT00518115|10890586|FG005|Overall Study|Protocol Violation|0
6878447|NCT00518115|10890587|FG006|Overall Study|Protocol Violation|0
6878448|NCT00518115|10890588|FG007|Overall Study|Protocol Violation|0
6878449|NCT00518115|10890589|FG008|Overall Study|Protocol Violation|0
6878450|NCT00518115|10890590|FG009|Overall Study|Protocol Violation|0
6878451|NCT00518115|10890581|FG000|Overall Study|Withdrawal by Subject|1
6878452|NCT00518115|10890582|FG001|Overall Study|Withdrawal by Subject|1
6878453|NCT00518115|10890583|FG002|Overall Study|Withdrawal by Subject|5
6878454|NCT00518115|10890584|FG003|Overall Study|Withdrawal by Subject|0
6878455|NCT00518115|10890585|FG004|Overall Study|Withdrawal by Subject|2
6878456|NCT00518115|10890586|FG005|Overall Study|Withdrawal by Subject|1
6878457|NCT00518115|10890587|FG006|Overall Study|Withdrawal by Subject|0
6878458|NCT00518115|10890588|FG007|Overall Study|Withdrawal by Subject|2
6878459|NCT00518115|10890589|FG008|Overall Study|Withdrawal by Subject|1
6878460|NCT00518115|10890590|FG009|Overall Study|Withdrawal by Subject|3
6878461|NCT00518115|10890581|FG000|Overall Study|Lack of Efficacy|1
6878462|NCT00518115|10890582|FG001|Overall Study|Lack of Efficacy|0
6878463|NCT00518115|10890583|FG002|Overall Study|Lack of Efficacy|1
6878464|NCT00518115|10890584|FG003|Overall Study|Lack of Efficacy|1
6878465|NCT00518115|10890585|FG004|Overall Study|Lack of Efficacy|0
6878466|NCT00518115|10890586|FG005|Overall Study|Lack of Efficacy|0
6878467|NCT00518115|10890587|FG006|Overall Study|Lack of Efficacy|0
6878468|NCT00518115|10890588|FG007|Overall Study|Lack of Efficacy|1
6878469|NCT00518115|10890589|FG008|Overall Study|Lack of Efficacy|0
6878470|NCT00518115|10890590|FG009|Overall Study|Lack of Efficacy|0
6878471|NCT00518115|10890581|FG000|Overall Study|Non-Compliance|1
6878472|NCT00518115|10890582|FG001|Overall Study|Non-Compliance|0
6878473|NCT00518115|10890583|FG002|Overall Study|Non-Compliance|1
6878474|NCT00518115|10890584|FG003|Overall Study|Non-Compliance|0
6878475|NCT00518115|10890585|FG004|Overall Study|Non-Compliance|1
6878476|NCT00518115|10890586|FG005|Overall Study|Non-Compliance|1
6878477|NCT00518115|10890587|FG006|Overall Study|Non-Compliance|1
6878478|NCT00518115|10890588|FG007|Overall Study|Non-Compliance|1
6878479|NCT00518115|10890589|FG008|Overall Study|Non-Compliance|0
6878480|NCT00518115|10890590|FG009|Overall Study|Non-Compliance|1
6878481|NCT00518115|10890581|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1
6878482|NCT00518115|10890582|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1
6878483|NCT00518115|10890583|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0
6878484|NCT00518115|10890584|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0
6878485|NCT00518115|10890585|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0
6878486|NCT00518115|10890586|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4
6878487|NCT00518115|10890587|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0
6878488|NCT00518115|10890588|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0
6878489|NCT00518115|10890589|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0
6878490|NCT00518115|10890590|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0
6878491|NCT00518115|10890581|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1
6878492|NCT00518115|10890582|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0
6878493|NCT00518115|10890583|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0
6878494|NCT00518115|10890584|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0
6878495|NCT00518115|10890585|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0
6878496|NCT00518115|10890586|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0
6878497|NCT00518115|10890587|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0
6878498|NCT00518115|10890588|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0
6878499|NCT00518115|10890589|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0
6878500|NCT00518115|10890590|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0
6878501|NCT00518115|10890581|FG000|Overall Study|Different Monotherapy Diabetic Drug|0
6878502|NCT00518115|10890582|FG001|Overall Study|Different Monotherapy Diabetic Drug|0
6878503|NCT00518115|10890583|FG002|Overall Study|Different Monotherapy Diabetic Drug|1
6878504|NCT00518115|10890584|FG003|Overall Study|Different Monotherapy Diabetic Drug|0
6878505|NCT00518115|10890585|FG004|Overall Study|Different Monotherapy Diabetic Drug|0
6878506|NCT00518115|10890586|FG005|Overall Study|Different Monotherapy Diabetic Drug|0
6878507|NCT00518115|10890587|FG006|Overall Study|Different Monotherapy Diabetic Drug|0
6878508|NCT00518115|10890588|FG007|Overall Study|Different Monotherapy Diabetic Drug|0
6878509|NCT00518115|10890589|FG008|Overall Study|Different Monotherapy Diabetic Drug|1
6878510|NCT00518115|10890590|FG009|Overall Study|Different Monotherapy Diabetic Drug|0
6878511|NCT00518115|10890581|FG000|Overall Study|Wrong Monotherapy Administered|0
6878512|NCT00518115|10890582|FG001|Overall Study|Wrong Monotherapy Administered|0
6878513|NCT00518115|10890583|FG002|Overall Study|Wrong Monotherapy Administered|1
6878514|NCT00518115|10890584|FG003|Overall Study|Wrong Monotherapy Administered|0
6878515|NCT00518115|10890585|FG004|Overall Study|Wrong Monotherapy Administered|0
6878516|NCT00518115|10890586|FG005|Overall Study|Wrong Monotherapy Administered|0
6878517|NCT00518115|10890587|FG006|Overall Study|Wrong Monotherapy Administered|1
6878518|NCT00518115|10890588|FG007|Overall Study|Wrong Monotherapy Administered|0
6878519|NCT00518115|10890589|FG008|Overall Study|Wrong Monotherapy Administered|0
6878520|NCT00518115|10890590|FG009|Overall Study|Wrong Monotherapy Administered|0
6878521|NCT00518115|10890581|FG000|Overall Study|Violation of Exclusion Criteria|0
6878522|NCT00518115|10890582|FG001|Overall Study|Violation of Exclusion Criteria|0
6878523|NCT00518115|10890583|FG002|Overall Study|Violation of Exclusion Criteria|0
6878524|NCT00518115|10890584|FG003|Overall Study|Violation of Exclusion Criteria|1
6878525|NCT00518115|10890585|FG004|Overall Study|Violation of Exclusion Criteria|0
6878526|NCT00518115|10890586|FG005|Overall Study|Violation of Exclusion Criteria|0
6878527|NCT00518115|10890587|FG006|Overall Study|Violation of Exclusion Criteria|1
6878528|NCT00518115|10890588|FG007|Overall Study|Violation of Exclusion Criteria|0
6878529|NCT00518115|10890589|FG008|Overall Study|Violation of Exclusion Criteria|0
6878530|NCT00518115|10890590|FG009|Overall Study|Violation of Exclusion Criteria|0
6878531|NCT00518115|10890581|FG000|Overall Study|Family Emergency; Had to Go to England|0
6878532|NCT00518115|10890582|FG001|Overall Study|Family Emergency; Had to Go to England|0
6878533|NCT00518115|10890583|FG002|Overall Study|Family Emergency; Had to Go to England|0
6878534|NCT00518115|10890584|FG003|Overall Study|Family Emergency; Had to Go to England|0
6878535|NCT00518115|10890585|FG004|Overall Study|Family Emergency; Had to Go to England|1
6878536|NCT00518115|10890586|FG005|Overall Study|Family Emergency; Had to Go to England|0
6878537|NCT00518115|10890587|FG006|Overall Study|Family Emergency; Had to Go to England|0
6878538|NCT00518115|10890588|FG007|Overall Study|Family Emergency; Had to Go to England|0
6878539|NCT00518115|10890589|FG008|Overall Study|Family Emergency; Had to Go to England|0
6878540|NCT00518115|10890590|FG009|Overall Study|Family Emergency; Had to Go to England|0
6878541|NCT00518115|10890581|FG000|Overall Study|Withdrew Consent|0
6878542|NCT00518115|10890582|FG001|Overall Study|Withdrew Consent|0
6878543|NCT00518115|10890583|FG002|Overall Study|Withdrew Consent|0
6878544|NCT00518115|10890584|FG003|Overall Study|Withdrew Consent|0
6878545|NCT00518115|10890585|FG004|Overall Study|Withdrew Consent|0
6878546|NCT00518115|10890586|FG005|Overall Study|Withdrew Consent|1
6878547|NCT00518115|10890587|FG006|Overall Study|Withdrew Consent|0
6878548|NCT00518115|10890588|FG007|Overall Study|Withdrew Consent|0
6878549|NCT00518115|10890589|FG008|Overall Study|Withdrew Consent|0
6878550|NCT00518115|10890590|FG009|Overall Study|Withdrew Consent|0
6878551|NCT00518115|10890581|FG000|Overall Study|Moved Out of State|0
6878552|NCT00518115|10890582|FG001|Overall Study|Moved Out of State|0
6878553|NCT00518115|10890583|FG002|Overall Study|Moved Out of State|0
6878554|NCT00518115|10890584|FG003|Overall Study|Moved Out of State|0
6878555|NCT00518115|10890585|FG004|Overall Study|Moved Out of State|0
6878556|NCT00518115|10890586|FG005|Overall Study|Moved Out of State|0
6878557|NCT00518115|10890587|FG006|Overall Study|Moved Out of State|0
6878558|NCT00518115|10890588|FG007|Overall Study|Moved Out of State|0
6878559|NCT00518115|10890589|FG008|Overall Study|Moved Out of State|0
6878560|NCT00518115|10890590|FG009|Overall Study|Moved Out of State|1
6878561|NCT00518180|10890620|FG000|Overall Study|Withdrawal by Subject|29
6878562|NCT00518180|10890621|FG001|Overall Study|Withdrawal by Subject|30
6878563|NCT00518180|10890622|FG002|Overall Study|Withdrawal by Subject|42
6878564|NCT00518180|10890620|FG000|Overall Study|Lost to Follow-up|30
6878565|NCT00518180|10890621|FG001|Overall Study|Lost to Follow-up|28
6878566|NCT00518180|10890622|FG002|Overall Study|Lost to Follow-up|34
6878567|NCT00518180|10890620|FG000|Overall Study|Administrative reason|0
6878568|NCT00518180|10890621|FG001|Overall Study|Administrative reason|2
6878569|NCT00518180|10890622|FG002|Overall Study|Administrative reason|2
6878570|NCT00518180|10890620|FG000|Overall Study|Protocol Violation|5
6878571|NCT00518180|10890621|FG001|Overall Study|Protocol Violation|7
6878572|NCT00518180|10890622|FG002|Overall Study|Protocol Violation|4
6878573|NCT00518180|10890620|FG000|Overall Study|Unable to classify|0
6878574|NCT00518180|10890621|FG001|Overall Study|Unable to classify|2
6878575|NCT00518180|10890622|FG002|Overall Study|Unable to classify|0
6878576|NCT00518180|10890620|FG000|Overall Study|Adverse Event|1
6878577|NCT00518180|10890621|FG001|Overall Study|Adverse Event|0
6878578|NCT00518180|10890622|FG002|Overall Study|Adverse Event|0
6878579|NCT00518206|10890641|FG000|Overall Study|Disease Progression Requiring Therapy|6
6878580|NCT00518206|10890642|FG001|Overall Study|Disease Progression Requiring Therapy|6
6878581|NCT00518206|10890641|FG000|Overall Study|Withdrawal by Subject|2
6878582|NCT00518206|10890642|FG001|Overall Study|Withdrawal by Subject|0
6878583|NCT00518206|10890641|FG000|Overall Study|Drug Supply Issue|1
6878584|NCT00518206|10890642|FG001|Overall Study|Drug Supply Issue|0
6878585|NCT00518206|10890641|FG000|Overall Study|Reason Unknown|1
6878586|NCT00518206|10890642|FG001|Overall Study|Reason Unknown|0
6878587|NCT00518206|10890641|FG000|Overall Study|Completion Status Unknown|1
6878588|NCT00518206|10890642|FG001|Overall Study|Completion Status Unknown|0
6878589|NCT00518284|10890652|FG000|Overall Study|Adverse Event|0
6878590|NCT00518284|10890653|FG001|Overall Study|Adverse Event|1
6878591|NCT00518284|10890654|FG002|Overall Study|Adverse Event|0
6878592|NCT00518284|10890655|FG003|Overall Study|Adverse Event|0
6878593|NCT00518284|10890652|FG000|Overall Study|Study Termination|0
6878594|NCT00518284|10890653|FG001|Overall Study|Study Termination|2
6969293|NCT01147068|11018869|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
6969294|NCT01147068|11018863|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
6969295|NCT01147068|11018864|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
6969296|NCT01147068|11018865|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
6969297|NCT01147068|11018866|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2
6969298|NCT01147068|11018867|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
6969299|NCT01147068|11018868|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
6969300|NCT01147068|11018869|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
6969301|NCT01147068|11018863|FG000|Subjects That Completed Safety Follow-up|Ineligible|0
6969302|NCT01147068|11018864|FG001|Subjects That Completed Safety Follow-up|Ineligible|1
6969303|NCT01147068|11018865|FG002|Subjects That Completed Safety Follow-up|Ineligible|0
6969304|NCT01147068|11018866|FG003|Subjects That Completed Safety Follow-up|Ineligible|0
6969305|NCT01147068|11018867|FG004|Subjects That Completed Safety Follow-up|Ineligible|0
6969306|NCT01147068|11018868|FG005|Subjects That Completed Safety Follow-up|Ineligible|0
6969307|NCT01147068|11018869|FG006|Subjects That Completed Safety Follow-up|Ineligible|0
6969308|NCT01147107|11018887|FG000|Overall Study|Lack of Efficacy|5
6969309|NCT01147107|11018888|FG001|Overall Study|Lack of Efficacy|0
6969310|NCT01147107|11018887|FG000|Overall Study|Withdrawal by Subject|1
6969311|NCT01147107|11018888|FG001|Overall Study|Withdrawal by Subject|1
6969312|NCT01147172|11018894|FG000|Overall Study|Withdrawal by Subject|2
6969313|NCT01147172|11018894|FG000|Overall Study|Lost to Follow-up|2
7154531|NCT03313050|11321375|FG000|Stage 2: 12 Months|Protocol deviation|0
6878595|NCT00518284|10890654|FG002|Overall Study|Study Termination|1
6969314|NCT01147250|11018902|FG000|Overall Study|Lost to Follow-up|14
6969315|NCT01147250|11018903|FG001|Overall Study|Lost to Follow-up|11
6969316|NCT01147250|11018902|FG000|Overall Study|Withdrawal by Subject|83
6969317|NCT01147250|11018903|FG001|Overall Study|Withdrawal by Subject|88
6969318|NCT01147250|11018902|FG000|Overall Study|Site termination by sponsor|13
6969319|NCT01147250|11018903|FG001|Overall Study|Site termination by sponsor|5
6969320|NCT01147250|11018902|FG000|Overall Study|Other than specified|0
6969321|NCT01147250|11018903|FG001|Overall Study|Other than specified|1
7041214|NCT01725282|11124764|FG003|Overall Study|Met Exclusion Criteria|0
7041215|NCT01725282|11124761|FG000|Overall Study|Study Site Withdrawal|0
6878596|NCT00518284|10890655|FG003|Overall Study|Study Termination|2
6878597|NCT00518323|10890669|FG000|Overall Study|Lack of Efficacy|14
6878598|NCT00518323|10890670|FG001|Overall Study|Lack of Efficacy|2
6878599|NCT00518323|10890671|FG002|Overall Study|Lack of Efficacy|4
6878600|NCT00518323|10890672|FG003|Overall Study|Lack of Efficacy|20
6878601|NCT00518323|10890669|FG000|Overall Study|Withdrawal by Subject|1
6878602|NCT00518323|10890670|FG001|Overall Study|Withdrawal by Subject|2
6878603|NCT00518323|10890671|FG002|Overall Study|Withdrawal by Subject|4
6878604|NCT00518323|10890672|FG003|Overall Study|Withdrawal by Subject|2
6878605|NCT00518323|10890669|FG000|Overall Study|Lost to Follow-up|0
6878606|NCT00518323|10890670|FG001|Overall Study|Lost to Follow-up|2
6878607|NCT00518323|10890671|FG002|Overall Study|Lost to Follow-up|1
6878608|NCT00518323|10890672|FG003|Overall Study|Lost to Follow-up|3
6878609|NCT00518323|10890669|FG000|Overall Study|Adverse Event|1
6878610|NCT00518323|10890670|FG001|Overall Study|Adverse Event|1
6878611|NCT00518323|10890671|FG002|Overall Study|Adverse Event|1
6878612|NCT00518323|10890672|FG003|Overall Study|Adverse Event|0
6878613|NCT00518323|10890669|FG000|Overall Study|Prohibited medication and others|3
6878614|NCT00518323|10890670|FG001|Overall Study|Prohibited medication and others|1
6878615|NCT00518323|10890671|FG002|Overall Study|Prohibited medication and others|1
6878616|NCT00518323|10890672|FG003|Overall Study|Prohibited medication and others|0
6878617|NCT00518336|10890684|FG000|Year 7|Lost to Follow-up|2
6878618|NCT00518336|10890685|FG001|Year 7|Lost to Follow-up|0
6878619|NCT00518336|10890684|FG000|Year 7|Could not attend in time|0
6878620|NCT00518336|10890685|FG001|Year 7|Could not attend in time|3
6878621|NCT00518336|10890684|FG000|Year 8|Lost to Follow-up|1
6878622|NCT00518336|10890685|FG001|Year 8|Lost to Follow-up|1
6878623|NCT00518336|10890684|FG000|Year 8|Could not attend in time|0
6878624|NCT00518336|10890685|FG001|Year 8|Could not attend in time|1
6878625|NCT00518336|10890684|FG000|Year 9|Migrated/moved from study area|1
6878626|NCT00518336|10890685|FG001|Year 9|Migrated/moved from study area|1
6878627|NCT00518336|10890684|FG000|Year 9|Lost to Follow-up|3
6878628|NCT00518336|10890685|FG001|Year 9|Lost to Follow-up|0
6878629|NCT00518336|10890684|FG000|Year 9|Personal reasons|1
6878630|NCT00518336|10890685|FG001|Year 9|Personal reasons|0
6878631|NCT00518531|10890702|FG000|Treatment Period 1|Adverse Event|5
6878632|NCT00518531|10890703|FG001|Treatment Period 1|Adverse Event|0
6878633|NCT00518531|10890702|FG000|Treatment Period 1|Lost to Follow-up|5
6878634|NCT00518531|10890703|FG001|Treatment Period 1|Lost to Follow-up|3
6878635|NCT00518531|10890702|FG000|Treatment Period 1|Physician Decision|1
6878636|NCT00518531|10890703|FG001|Treatment Period 1|Physician Decision|0
6878637|NCT00518531|10890702|FG000|Treatment Period 1|Protocol Violation|2
6878638|NCT00518531|10890703|FG001|Treatment Period 1|Protocol Violation|0
6878639|NCT00518531|10890702|FG000|Treatment Period 1|Withdrawal by Subject|4
6878640|NCT00518531|10890703|FG001|Treatment Period 1|Withdrawal by Subject|6
6878641|NCT00518531|10890702|FG000|Treatment Period 1|Early crossover|1
6878642|NCT00518531|10890703|FG001|Treatment Period 1|Early crossover|3
7154532|NCT03313050|11321376|FG001|Stage 2: 12 Months|Protocol deviation|0
7154533|NCT03313050|11321377|FG002|Stage 2: 12 Months|Protocol deviation|7
7154534|NCT03313050|11321378|FG003|Stage 2: 12 Months|Protocol deviation|7
7154535|NCT03313050|11321375|FG000|Stage 2: 12 Months|Withdrawal by Subject|0
7154536|NCT03313050|11321376|FG001|Stage 2: 12 Months|Withdrawal by Subject|0
7154537|NCT03313050|11321377|FG002|Stage 2: 12 Months|Withdrawal by Subject|0
7154538|NCT03313050|11321378|FG003|Stage 2: 12 Months|Withdrawal by Subject|3
7154539|NCT03313050|11321375|FG000|Stage 2: 12 Months|Other|0
7154540|NCT03313050|11321376|FG001|Stage 2: 12 Months|Other|0
7154541|NCT03313050|11321377|FG002|Stage 2: 12 Months|Other|0
7154542|NCT03313050|11321378|FG003|Stage 2: 12 Months|Other|1
7154543|NCT03313076|11321392|FG000|Overall Study|Withdrawal by Subject|2
7154544|NCT03313076|11321393|FG001|Overall Study|Withdrawal by Subject|0
7154545|NCT03313076|11321394|FG002|Overall Study|Withdrawal by Subject|0
7154546|NCT03313076|11321395|FG003|Overall Study|Withdrawal by Subject|0
7154547|NCT03313076|11321392|FG000|Overall Study|Lost to Follow-up|0
7154548|NCT03313076|11321393|FG001|Overall Study|Lost to Follow-up|2
7154549|NCT03313076|11321394|FG002|Overall Study|Lost to Follow-up|2
7154550|NCT03313076|11321395|FG003|Overall Study|Lost to Follow-up|2
7154551|NCT03313310|11321413|FG000|Phase 2|Lost to Follow-up|4
7154552|NCT03313310|11321414|FG001|Phase 2|Lost to Follow-up|0
7154553|NCT03313310|11321413|FG000|Phase 3|Lost to Follow-up|0
7154554|NCT03313310|11321414|FG001|Phase 3|Lost to Follow-up|1
7154555|NCT03314233|11321420|FG000|Overall Study|No longer eligible at time of delivery|1
6878643|NCT00518531|10890702|FG000|Treatment Period 2|Withdrawal by Subject|0
6878644|NCT00518531|10890703|FG001|Treatment Period 2|Withdrawal by Subject|8
6878645|NCT00518531|10890702|FG000|Treatment Period 2|Complete out of scheduled visit window|1
7154556|NCT03314519|11321426|FG000|Overall Study|Protocol Violation|3
7154557|NCT03314519|11321427|FG001|Overall Study|Protocol Violation|2
7154558|NCT03314662|11321436|FG000|Overall Study|Withdrawal by Subject|1
6878646|NCT00518531|10890703|FG001|Treatment Period 2|Complete out of scheduled visit window|2
6878647|NCT00518531|10890702|FG000|Treatment Period 2|Adverse Event|1
6878648|NCT00518531|10890703|FG001|Treatment Period 2|Adverse Event|7
6878649|NCT00518531|10890702|FG000|Treatment Period 2|Protocol-specified criteria|0
6878650|NCT00518531|10890703|FG001|Treatment Period 2|Protocol-specified criteria|1
6878651|NCT00518531|10890702|FG000|Treatment Period 2|Non-compliance|1
6878652|NCT00518531|10890703|FG001|Treatment Period 2|Non-compliance|2
6878653|NCT00518622|10890719|FG000|Overall Study|Lost to Follow-up|0
6878654|NCT00518622|10890720|FG001|Overall Study|Lost to Follow-up|0
6878655|NCT00518622|10890721|FG002|Overall Study|Lost to Follow-up|1
6878656|NCT00518622|10890722|FG003|Overall Study|Lost to Follow-up|0
6878657|NCT00518622|10890723|FG004|Overall Study|Lost to Follow-up|0
6878658|NCT00518622|10890724|FG005|Overall Study|Lost to Follow-up|0
6878659|NCT00518622|10890725|FG006|Overall Study|Lost to Follow-up|0
6878660|NCT00518622|10890726|FG007|Overall Study|Lost to Follow-up|0
6878661|NCT00518622|10890719|FG000|Overall Study|Study medication taken incorrectly|0
6878662|NCT00518622|10890720|FG001|Overall Study|Study medication taken incorrectly|1
6878663|NCT00518622|10890721|FG002|Overall Study|Study medication taken incorrectly|0
6878664|NCT00518622|10890722|FG003|Overall Study|Study medication taken incorrectly|0
6878665|NCT00518622|10890723|FG004|Overall Study|Study medication taken incorrectly|0
6878666|NCT00518622|10890724|FG005|Overall Study|Study medication taken incorrectly|0
6878667|NCT00518622|10890725|FG006|Overall Study|Study medication taken incorrectly|0
6878668|NCT00518622|10890726|FG007|Overall Study|Study medication taken incorrectly|0
6878669|NCT00518687|10890746|FG000|Overall Study|Adverse Event|201
6878670|NCT00518687|10890747|FG001|Overall Study|Adverse Event|177
6878671|NCT00518687|10890746|FG000|Overall Study|Lost to Follow-up|144
6878672|NCT00518687|10890747|FG001|Overall Study|Lost to Follow-up|155
6878673|NCT00518687|10890746|FG000|Overall Study|Physician Decision|42
6878674|NCT00518687|10890747|FG001|Overall Study|Physician Decision|48
6878675|NCT00518687|10890746|FG000|Overall Study|Progressive disease|2
6878676|NCT00518687|10890747|FG001|Overall Study|Progressive disease|2
6878677|NCT00518687|10890746|FG000|Overall Study|Protocol Violation|8
6878678|NCT00518687|10890747|FG001|Overall Study|Protocol Violation|10
6878679|NCT00518687|10890746|FG000|Overall Study|Study terminated by sponsor|930
6878680|NCT00518687|10890747|FG001|Overall Study|Study terminated by sponsor|918
6878681|NCT00518687|10890746|FG000|Overall Study|Withdrawal by Subject|110
6878682|NCT00518687|10890747|FG001|Overall Study|Withdrawal by Subject|110
6969322|NCT01147341|11018920|FG000|Double Blind Period|Lack of Efficacy|1
6969323|NCT01147341|11018921|FG001|Double Blind Period|Lack of Efficacy|1
6969324|NCT01147341|11018920|FG000|Double Blind Period|Withdrawal by Subject|0
6969325|NCT01147341|11018921|FG001|Double Blind Period|Withdrawal by Subject|1
6969326|NCT01147341|11018920|FG000|Open Label Period|Lack of Efficacy|3
6969327|NCT01147341|11018921|FG001|Open Label Period|Lack of Efficacy|0
6969328|NCT01147341|11018920|FG000|Open Label Period|Subject moved|1
6969329|NCT01147341|11018921|FG001|Open Label Period|Subject moved|0
6976951|NCT01203072|11029843|FG003|Overall Study|Lost to Follow-up|0
6976952|NCT01203072|11029844|FG004|Overall Study|Lost to Follow-up|0
6976953|NCT01203072|11029840|FG000|Overall Study|Protocol Violation|2
6976954|NCT01203072|11029841|FG001|Overall Study|Protocol Violation|0
6976955|NCT01203072|11029842|FG002|Overall Study|Protocol Violation|0
6976956|NCT01203072|11029843|FG003|Overall Study|Protocol Violation|0
6976957|NCT01203072|11029844|FG004|Overall Study|Protocol Violation|1
6976958|NCT01203072|11029840|FG000|Overall Study|Withdrawal by Subject|2
6976959|NCT01203072|11029841|FG001|Overall Study|Withdrawal by Subject|2
6976960|NCT01203072|11029842|FG002|Overall Study|Withdrawal by Subject|1
6976961|NCT01203072|11029843|FG003|Overall Study|Withdrawal by Subject|2
6976962|NCT01203072|11029844|FG004|Overall Study|Withdrawal by Subject|3
6976963|NCT01203098|11029859|FG000|Overall Study|Adverse Event|3
6976964|NCT01203098|11029860|FG001|Overall Study|Adverse Event|1
6976965|NCT01203098|11029861|FG002|Overall Study|Adverse Event|7
6976966|NCT01203098|11029859|FG000|Overall Study|Lost to Follow-up|0
6976967|NCT01203098|11029860|FG001|Overall Study|Lost to Follow-up|0
6976968|NCT01203098|11029861|FG002|Overall Study|Lost to Follow-up|1
6976969|NCT01203098|11029859|FG000|Overall Study|Physician Decision|2
6976970|NCT01203098|11029860|FG001|Overall Study|Physician Decision|2
6976971|NCT01203098|11029861|FG002|Overall Study|Physician Decision|0
6976972|NCT01203098|11029859|FG000|Overall Study|Withdrawal by Subject|1
6976973|NCT01203098|11029860|FG001|Overall Study|Withdrawal by Subject|1
6976974|NCT01203098|11029861|FG002|Overall Study|Withdrawal by Subject|3
6976975|NCT01203787|11029916|FG000|Overall Study|Death|12
6976976|NCT01203787|11029917|FG001|Overall Study|Death|10
6976977|NCT01203787|11029916|FG000|Overall Study|Withdrawal by Subject|6
6976978|NCT01203787|11029917|FG001|Overall Study|Withdrawal by Subject|2
6976979|NCT01203787|11029916|FG000|Overall Study|Lost to Follow-up|2
6976980|NCT01203787|11029917|FG001|Overall Study|Lost to Follow-up|0
6976981|NCT01203787|11029916|FG000|Overall Study|Adverse Event|11
6976982|NCT01203787|11029917|FG001|Overall Study|Adverse Event|15
6976983|NCT01203852|11029934|FG000|Metoprolol 8 Weeks|Physician Decision|470
6976984|NCT01203852|11029934|FG000|Washout 2 Weeks|Physician Decision|46
6976985|NCT01203878|11029944|FG000|Overall Study|Withdrawal by Subject|0
6976986|NCT01203878|11029945|FG001|Overall Study|Withdrawal by Subject|0
6976987|NCT01203878|11029946|FG002|Overall Study|Withdrawal by Subject|1
6976988|NCT01203878|11029944|FG000|Overall Study|Adverse Event|0
6976989|NCT01203878|11029945|FG001|Overall Study|Adverse Event|0
6976990|NCT01203878|11029946|FG002|Overall Study|Adverse Event|2
6976991|NCT01203917|11029953|FG000|Overall Study|Death|29
6976992|NCT01203917|11029953|FG000|Overall Study|Lost to Follow-up|2
6976993|NCT01203917|11029953|FG000|Overall Study|Withdrawal by Subject|3
6976994|NCT01203917|11029953|FG000|Overall Study|Due to objective disease progression|1
6976995|NCT01203917|11029953|FG000|Overall Study|Due to EGFR M+I patient|1
6976996|NCT01203930|11029959|FG000|Overall Study|Disease Progression|0
6976997|NCT01203930|11029960|FG001|Overall Study|Disease Progression|4
6976998|NCT01203930|11029959|FG000|Overall Study|Death|3
6976999|NCT01203930|11029960|FG001|Overall Study|Death|1
6878683|NCT00518882|10890772|FG000|Double-Blind, Week 0-26|Adverse Event|23
6878684|NCT00518882|10890773|FG001|Double-Blind, Week 0-26|Adverse Event|31
6878685|NCT00518882|10890772|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1
6878686|NCT00518882|10890773|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0
6878687|NCT00518882|10890772|FG000|Double-Blind, Week 0-26|Protocol Violation|4
6878688|NCT00518882|10890773|FG001|Double-Blind, Week 0-26|Protocol Violation|3
6878689|NCT00518882|10890772|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1
6878690|NCT00518882|10890773|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1
6878691|NCT00518882|10890772|FG000|Double-Blind, Week 0-26|Lost to follow up|2
6878692|NCT00518882|10890773|FG001|Double-Blind, Week 0-26|Lost to follow up|1
6878693|NCT00518882|10890772|FG000|Double-Blind, Week 0-26|Subject decision|1
6878694|NCT00518882|10890773|FG001|Double-Blind, Week 0-26|Subject decision|1
6878695|NCT00518882|10890772|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1
6878696|NCT00518882|10890773|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3
6878697|NCT00518882|10890772|FG000|Double-Blind, Week 0-26|Loss of trust|0
6878698|NCT00518882|10890773|FG001|Double-Blind, Week 0-26|Loss of trust|1
6878699|NCT00518882|10890772|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0
6878700|NCT00518882|10890773|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1
6878701|NCT00518882|10890772|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0
6878702|NCT00518882|10890773|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2
6878703|NCT00518882|10890772|FG000|Double-Blind, Week 0-26|Mutual consent|0
6878704|NCT00518882|10890773|FG001|Double-Blind, Week 0-26|Mutual consent|1
6878705|NCT00518882|10890772|FG000|Open-Label Extension, Week 26-78|Adverse Event|3
6878706|NCT00518882|10890773|FG001|Open-Label Extension, Week 26-78|Adverse Event|9
6878707|NCT00518882|10890772|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6
6878708|NCT00518882|10890773|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5
6878709|NCT00518882|10890772|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3
6878710|NCT00518882|10890773|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4
6878711|NCT00518882|10890772|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1
6878712|NCT00518882|10890773|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2
6878713|NCT00518882|10890772|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0
6878714|NCT00518882|10890773|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1
6878715|NCT00518882|10890772|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1
6878716|NCT00518882|10890773|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1
6878717|NCT00518882|10890772|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2
6878718|NCT00518882|10890773|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1
6878719|NCT00518882|10890772|FG000|Open-Label Extension, Week 26-78|Change in treatment|1
6878720|NCT00518882|10890773|FG001|Open-Label Extension, Week 26-78|Change in treatment|1
6878721|NCT00518882|10890772|FG000|Open-Label Extension, Week 26-78|Creatine increased|1
6878722|NCT00518882|10890773|FG001|Open-Label Extension, Week 26-78|Creatine increased|0
6878723|NCT00518882|10890772|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1
6878724|NCT00518882|10890773|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0
6878725|NCT00518882|10890772|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2
6878726|NCT00518882|10890773|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0
6878727|NCT00518882|10890772|FG000|Open-Label Extension, Week 26-78|Subject decision|2
6878728|NCT00518882|10890773|FG001|Open-Label Extension, Week 26-78|Subject decision|0
6878729|NCT00518882|10890772|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18
6878730|NCT00518882|10890773|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25
6878731|NCT00518973|10890781|FG000|Overall Study|Withdrawal by Subject|3
6878732|NCT00518973|10890782|FG001|Overall Study|Withdrawal by Subject|2
6878733|NCT00518986|10890790|FG000|Overall Study|Adverse Event|12
6878734|NCT00518986|10890791|FG001|Overall Study|Adverse Event|7
6878735|NCT00518986|10890790|FG000|Overall Study|Lack of Efficacy|0
6878736|NCT00518986|10890791|FG001|Overall Study|Lack of Efficacy|2
6878737|NCT00518986|10890790|FG000|Overall Study|Lost to Follow-up|3
6878738|NCT00518986|10890791|FG001|Overall Study|Lost to Follow-up|2
6878739|NCT00518986|10890790|FG000|Overall Study|Physician Decision|0
6878740|NCT00518986|10890791|FG001|Overall Study|Physician Decision|3
6878741|NCT00518986|10890790|FG000|Overall Study|Protocol Violation|5
6878742|NCT00518986|10890791|FG001|Overall Study|Protocol Violation|7
6878743|NCT00518986|10890790|FG000|Overall Study|Withdrawal by Subject|4
6878744|NCT00518986|10890791|FG001|Overall Study|Withdrawal by Subject|4
6878745|NCT00518986|10890790|FG000|Overall Study|Non-Specific|2
6878746|NCT00518986|10890791|FG001|Overall Study|Non-Specific|1
6878747|NCT00519077|10890797|FG000|Overall Study|Death|6
6878748|NCT00519077|10890797|FG000|Overall Study|Other|2
6878749|NCT00519194|10890801|FG000|Overall Study|Withdrawal by Subject|9
6878750|NCT00519194|10890801|FG000|Overall Study|Death|9
6878751|NCT00519194|10890801|FG000|Overall Study|Lost to Follow-up|3
6878752|NCT00519285|10890807|FG000|Overall Study|Adverse Event|127
7041216|NCT01725282|11124762|FG001|Overall Study|Study Site Withdrawal|1
6878753|NCT00519285|10890808|FG001|Overall Study|Adverse Event|266
6878754|NCT00519285|10890807|FG000|Overall Study|Disease progression|334
6878755|NCT00519285|10890808|FG001|Overall Study|Disease progression|186
6878756|NCT00519285|10890807|FG000|Overall Study|Physician Decision|75
6878757|NCT00519285|10890808|FG001|Overall Study|Physician Decision|47
6878758|NCT00519285|10890807|FG000|Overall Study|Participant's request|53
7041217|NCT01725282|11124763|FG002|Overall Study|Study Site Withdrawal|0
6878759|NCT00519285|10890808|FG001|Overall Study|Participant's request|84
6878760|NCT00519285|10890807|FG000|Overall Study|Consent withdrawn|4
6878761|NCT00519285|10890808|FG001|Overall Study|Consent withdrawn|5
6878762|NCT00519285|10890807|FG000|Overall Study|Poor compliance to protocol|5
6878763|NCT00519285|10890808|FG001|Overall Study|Poor compliance to protocol|7
6878764|NCT00519285|10890807|FG000|Overall Study|Reason unspecified|5
6878765|NCT00519285|10890808|FG001|Overall Study|Reason unspecified|8
6878766|NCT00519285|10890807|FG000|Overall Study|Not treated|8
6878767|NCT00519285|10890808|FG001|Overall Study|Not treated|7
6878768|NCT00519285|10890807|FG000|Overall Study|Treatment ongoing|1
6878769|NCT00519285|10890808|FG001|Overall Study|Treatment ongoing|2
6878770|NCT00519376|10890814|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
6878771|NCT00519376|10890815|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
6878772|NCT00519376|10890816|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
6878773|NCT00519376|10890817|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
6878774|NCT00519376|10890818|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
6878775|NCT00519376|10890819|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
6878776|NCT00519376|10890820|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
6878777|NCT00519376|10890821|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
6878778|NCT00519376|10890822|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
6878779|NCT00519376|10890823|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
6878780|NCT00519376|10890824|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
6878781|NCT00519376|10890825|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
6878782|NCT00519376|10890826|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1
6878783|NCT00519376|10890827|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
6878784|NCT00519376|10890828|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
6878785|NCT00519376|10890829|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
6878786|NCT00519376|10890814|FG000|Treatment Period 4|Lost to Follow-up|0
6878787|NCT00519376|10890815|FG001|Treatment Period 4|Lost to Follow-up|0
6878788|NCT00519376|10890816|FG002|Treatment Period 4|Lost to Follow-up|1
6878789|NCT00519376|10890817|FG003|Treatment Period 4|Lost to Follow-up|0
6878790|NCT00519376|10890818|FG004|Treatment Period 4|Lost to Follow-up|0
6878791|NCT00519376|10890819|FG005|Treatment Period 4|Lost to Follow-up|0
6878792|NCT00519376|10890820|FG006|Treatment Period 4|Lost to Follow-up|0
6878793|NCT00519376|10890821|FG007|Treatment Period 4|Lost to Follow-up|0
6878794|NCT00519376|10890822|FG008|Treatment Period 4|Lost to Follow-up|0
6878795|NCT00519376|10890823|FG009|Treatment Period 4|Lost to Follow-up|0
6878796|NCT00519376|10890824|FG010|Treatment Period 4|Lost to Follow-up|0
6878797|NCT00519376|10890825|FG011|Treatment Period 4|Lost to Follow-up|0
6878798|NCT00519376|10890826|FG012|Treatment Period 4|Lost to Follow-up|0
6878799|NCT00519376|10890827|FG013|Treatment Period 4|Lost to Follow-up|0
6878800|NCT00519376|10890828|FG014|Treatment Period 4|Lost to Follow-up|0
6878801|NCT00519376|10890829|FG015|Treatment Period 4|Lost to Follow-up|0
6878802|NCT00519428|10890844|FG000|Overall Study|Adverse Event|5
6878803|NCT00519428|10890845|FG001|Overall Study|Adverse Event|2
6878804|NCT00519428|10890846|FG002|Overall Study|Adverse Event|10
6878805|NCT00519428|10890844|FG000|Overall Study|Lost to Follow-up|7
6878806|NCT00519428|10890845|FG001|Overall Study|Lost to Follow-up|7
6878807|NCT00519428|10890846|FG002|Overall Study|Lost to Follow-up|6
6878808|NCT00519428|10890844|FG000|Overall Study|Withdrawal by Subject|8
6878809|NCT00519428|10890845|FG001|Overall Study|Withdrawal by Subject|3
6878810|NCT00519428|10890846|FG002|Overall Study|Withdrawal by Subject|7
6878811|NCT00519428|10890844|FG000|Overall Study|unstated|1
6878812|NCT00519428|10890845|FG001|Overall Study|unstated|3
6878813|NCT00519428|10890846|FG002|Overall Study|unstated|2
6878814|NCT00519532|10890857|FG000|Overall Study|Adverse Event|11
7078805|NCT02106156|11187373|FG001|Overall Study|Relocation/Change of Physician|1
7078806|NCT02106156|11187374|FG002|Overall Study|Relocation/Change of Physician|0
7078807|NCT02106325|11187383|FG000|Phase 1|Lost to Follow-up|2
7078808|NCT02106325|11187384|FG001|Phase 1|Lost to Follow-up|2
7078809|NCT02106325|11187383|FG000|Phase 2|Lost to Follow-up|2
7078810|NCT02106325|11187384|FG001|Phase 2|Lost to Follow-up|3
7078811|NCT02106325|11187383|FG000|Phase 3|Lost to Follow-up|2
7078812|NCT02106325|11187384|FG001|Phase 3|Lost to Follow-up|1
7078813|NCT02106351|11187393|FG000|Treatment Cycle 1|Adverse Event|2
7078814|NCT02106351|11187394|FG001|Treatment Cycle 1|Adverse Event|0
7078815|NCT02106351|11187395|FG002|Treatment Cycle 1|Adverse Event|0
7078816|NCT02106351|11187393|FG000|Treatment Cycle 1|Consent withdrawn|1
7078817|NCT02106351|11187394|FG001|Treatment Cycle 1|Consent withdrawn|0
6878815|NCT00519532|10890857|FG000|Overall Study|Withdrawal by Subject|5
6878816|NCT00519532|10890857|FG000|Overall Study|Lost to Follow-up|2
6878817|NCT00519623|10890878|FG000|Overall Study|Adverse Event|1
6878818|NCT00519636|10890886|FG000|Treatment Period 1|Adverse Event|1
6878819|NCT00519636|10890887|FG001|Treatment Period 1|Adverse Event|0
6878820|NCT00519636|10890888|FG002|Treatment Period 1|Adverse Event|1
6878821|NCT00519636|10890889|FG003|Treatment Period 1|Adverse Event|0
6878822|NCT00519636|10890886|FG000|Treatment Period 1|Sponsor request due to missed visit|1
6878823|NCT00519636|10890887|FG001|Treatment Period 1|Sponsor request due to missed visit|0
7078818|NCT02106351|11187395|FG002|Treatment Cycle 1|Consent withdrawn|2
7078819|NCT02106351|11187393|FG000|Treatment Cycle 1|Lost to Follow-up|1
6878824|NCT00519636|10890888|FG002|Treatment Period 1|Sponsor request due to missed visit|0
6878825|NCT00519636|10890889|FG003|Treatment Period 1|Sponsor request due to missed visit|0
6878826|NCT00519636|10890886|FG000|Washout Period|Adverse Event|2
6878827|NCT00519636|10890887|FG001|Washout Period|Adverse Event|1
6878828|NCT00519636|10890888|FG002|Washout Period|Adverse Event|1
6878829|NCT00519636|10890889|FG003|Washout Period|Adverse Event|0
6878830|NCT00519636|10890886|FG000|Washout Period|Lost to Follow-up|1
6878831|NCT00519636|10890887|FG001|Washout Period|Lost to Follow-up|0
6878832|NCT00519636|10890888|FG002|Washout Period|Lost to Follow-up|0
6878833|NCT00519636|10890889|FG003|Washout Period|Lost to Follow-up|0
6878834|NCT00519636|10890886|FG000|Washout Period|Protocol Violation|0
6878835|NCT00519636|10890887|FG001|Washout Period|Protocol Violation|0
6878836|NCT00519636|10890888|FG002|Washout Period|Protocol Violation|1
6878837|NCT00519636|10890889|FG003|Washout Period|Protocol Violation|2
6878838|NCT00519636|10890886|FG000|Washout Period|Withdrawal by Subject|1
6878839|NCT00519636|10890887|FG001|Washout Period|Withdrawal by Subject|0
6878840|NCT00519636|10890888|FG002|Washout Period|Withdrawal by Subject|1
6878841|NCT00519636|10890889|FG003|Washout Period|Withdrawal by Subject|0
6878842|NCT00519636|10890886|FG000|Washout Period|Failed to meet continuation criteria|14
6878843|NCT00519636|10890887|FG001|Washout Period|Failed to meet continuation criteria|11
6878844|NCT00519636|10890888|FG002|Washout Period|Failed to meet continuation criteria|9
6878845|NCT00519636|10890889|FG003|Washout Period|Failed to meet continuation criteria|3
6878846|NCT00519636|10890886|FG000|Washout Period|Out of pollen area > 48 hours|1
6878847|NCT00519636|10890887|FG001|Washout Period|Out of pollen area > 48 hours|0
6878848|NCT00519636|10890888|FG002|Washout Period|Out of pollen area > 48 hours|0
6878849|NCT00519636|10890889|FG003|Washout Period|Out of pollen area > 48 hours|0
6878850|NCT00519636|10890886|FG000|Washout Period|Participating in study at another site|1
6878851|NCT00519636|10890887|FG001|Washout Period|Participating in study at another site|0
6878852|NCT00519636|10890888|FG002|Washout Period|Participating in study at another site|0
6878853|NCT00519636|10890889|FG003|Washout Period|Participating in study at another site|0
6878854|NCT00519636|10890886|FG000|Washout Period|Non-compliant|0
6878855|NCT00519636|10890887|FG001|Washout Period|Non-compliant|1
6878856|NCT00519636|10890888|FG002|Washout Period|Non-compliant|0
6878857|NCT00519636|10890889|FG003|Washout Period|Non-compliant|0
6878858|NCT00519636|10890886|FG000|Washout Period|Per doctors request|0
6878859|NCT00519636|10890887|FG001|Washout Period|Per doctors request|1
6878860|NCT00519636|10890888|FG002|Washout Period|Per doctors request|0
6878861|NCT00519636|10890889|FG003|Washout Period|Per doctors request|0
6878862|NCT00519636|10890886|FG000|Washout Period|Subject randomized in error|0
6878863|NCT00519636|10890887|FG001|Washout Period|Subject randomized in error|0
6878864|NCT00519636|10890888|FG002|Washout Period|Subject randomized in error|1
6878865|NCT00519636|10890889|FG003|Washout Period|Subject randomized in error|0
6878866|NCT00519636|10890886|FG000|Washout Period|Prohibited medications|0
6878867|NCT00519636|10890887|FG001|Washout Period|Prohibited medications|0
6878868|NCT00519636|10890888|FG002|Washout Period|Prohibited medications|1
6878869|NCT00519636|10890889|FG003|Washout Period|Prohibited medications|0
6878870|NCT00519636|10890886|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0
6878871|NCT00519636|10890887|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0
6878872|NCT00519636|10890888|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0
6878873|NCT00519636|10890889|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1
6878874|NCT00519636|10890886|FG000|Treatment Period 2|Subject randomized in error|0
6878875|NCT00519636|10890887|FG001|Treatment Period 2|Subject randomized in error|1
6878876|NCT00519636|10890888|FG002|Treatment Period 2|Subject randomized in error|0
6878877|NCT00519636|10890889|FG003|Treatment Period 2|Subject randomized in error|0
6878878|NCT00519636|10890886|FG000|Treatment Period 2|Per doctors request|0
6878879|NCT00519636|10890887|FG001|Treatment Period 2|Per doctors request|0
6878880|NCT00519636|10890888|FG002|Treatment Period 2|Per doctors request|1
6878881|NCT00519636|10890889|FG003|Treatment Period 2|Per doctors request|0
6878882|NCT00519636|10890886|FG000|Treatment Period 2|Subject misrandomized|0
6878883|NCT00519636|10890887|FG001|Treatment Period 2|Subject misrandomized|0
6878884|NCT00519636|10890888|FG002|Treatment Period 2|Subject misrandomized|0
6878885|NCT00519636|10890889|FG003|Treatment Period 2|Subject misrandomized|1
6878886|NCT00519636|10890886|FG000|Post Study Period|Subject randomized in error|0
6878887|NCT00519636|10890887|FG001|Post Study Period|Subject randomized in error|0
6878888|NCT00519636|10890888|FG002|Post Study Period|Subject randomized in error|0
6878889|NCT00519636|10890889|FG003|Post Study Period|Subject randomized in error|1
6878890|NCT00519649|10890903|FG000|Overall Study|Withdrawal by Subject|1
6878891|NCT00519779|10890909|FG000|Overall Study|Withdrawal by Subject|0
6878892|NCT00519779|10890910|FG001|Overall Study|Withdrawal by Subject|1
6878893|NCT00519831|10890916|FG000|Overall Study|Adverse Event|3
6878894|NCT00519896|10890920|FG000|Overall Study|Protocol Violation|1
6878895|NCT00519896|10890920|FG000|Overall Study|Adverse Event|1
6878896|NCT00520013|10890927|FG000|Overall Study|Withdrawal by Subject|0
6878897|NCT00520013|10890928|FG001|Overall Study|Withdrawal by Subject|0
6878898|NCT00520013|10890929|FG002|Overall Study|Withdrawal by Subject|1
6878899|NCT00520013|10890927|FG000|Overall Study|Adverse Event|2
6878900|NCT00520013|10890928|FG001|Overall Study|Adverse Event|10
6878901|NCT00520013|10890929|FG002|Overall Study|Adverse Event|7
6878902|NCT00520013|10890927|FG000|Overall Study|Progressive Disease|7
6878903|NCT00520013|10890928|FG001|Overall Study|Progressive Disease|3
6878904|NCT00520013|10890929|FG002|Overall Study|Progressive Disease|0
6878905|NCT00520013|10890927|FG000|Overall Study|Clinical Progression|3
7078820|NCT02106351|11187394|FG001|Treatment Cycle 1|Lost to Follow-up|0
7154559|NCT03314662|11321437|FG001|Overall Study|Withdrawal by Subject|1
6878906|NCT00520013|10890928|FG001|Overall Study|Clinical Progression|1
6878907|NCT00520013|10890929|FG002|Overall Study|Clinical Progression|0
6878908|NCT00520013|10890927|FG000|Overall Study|Death|0
6878909|NCT00520013|10890928|FG001|Overall Study|Death|1
6878910|NCT00520013|10890929|FG002|Overall Study|Death|0
6878911|NCT00520013|10890927|FG000|Overall Study|Physician Decision|0
6878912|NCT00520013|10890928|FG001|Overall Study|Physician Decision|0
6878913|NCT00520013|10890929|FG002|Overall Study|Physician Decision|3
6878914|NCT00520039|10890937|FG000|Overall Study|Exclusion criteria met at first visit|7
6878915|NCT00520039|10890938|FG001|Overall Study|Exclusion criteria met at first visit|5
6878916|NCT00520130|10890948|FG000|Overall Study|Disease progression on study|4
6878917|NCT00520130|10890949|FG001|Overall Study|Disease progression on study|0
6878918|NCT00520130|10890948|FG000|Overall Study|Physician Decision|1
6878919|NCT00520130|10890949|FG001|Overall Study|Physician Decision|1
6878920|NCT00520299|10890981|FG000|Overall Study|Withdrawal by Subject|0
6878921|NCT00520299|10890982|FG001|Overall Study|Withdrawal by Subject|0
6878922|NCT00520299|10890983|FG002|Overall Study|Withdrawal by Subject|2
6878923|NCT00520299|10890981|FG000|Overall Study|Progressive disease|0
6878924|NCT00520299|10890982|FG001|Overall Study|Progressive disease|3
6878925|NCT00520299|10890983|FG002|Overall Study|Progressive disease|4
6878926|NCT00520351|10890993|FG000|First Intervention|Withdrawal by Subject|1
6878927|NCT00520351|10890994|FG001|First Intervention|Withdrawal by Subject|1
6878928|NCT00520403|10891000|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6
6878929|NCT00520403|10891000|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4
6878930|NCT00520403|10891000|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4
6878931|NCT00520403|10891000|FG000|Bevacizumab + IFN/Vinblastine|Death|2
6878932|NCT00520403|10891000|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1
6878933|NCT00520403|10891000|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1
6878934|NCT00520403|10891000|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1
6878935|NCT00520403|10891000|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1
6878936|NCT00520481|10891010|FG000|Overall Study|Adverse Event|4
6878937|NCT00520481|10891011|FG001|Overall Study|Adverse Event|1
6878938|NCT00520481|10891010|FG000|Overall Study|Withdrawal by Subject|3
6878939|NCT00520481|10891011|FG001|Overall Study|Withdrawal by Subject|0
6878940|NCT00520494|10891019|FG000|Overall Study|Withdrawal by Subject|1
6878941|NCT00520533|10891023|FG000|Overall Study|Death|1
6878942|NCT00520533|10891023|FG000|Overall Study|Suspension of the study for safety reasons|1
6878943|NCT00520533|10891023|FG000|Overall Study|Withdrawal by Subject|1
6878944|NCT00520533|10891023|FG000|Overall Study|Physician Decision|1
6878945|NCT00520546|10891028|FG000|Overall Study|Withdrawal by Subject|1
6878946|NCT00520546|10891028|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5
6878947|NCT00520572|10891043|FG000|Overall Study|Adverse Event|9
6878948|NCT00520572|10891044|FG001|Overall Study|Adverse Event|3
6878949|NCT00520572|10891045|FG002|Overall Study|Adverse Event|6
6878950|NCT00520572|10891046|FG003|Overall Study|Adverse Event|9
6878951|NCT00520572|10891047|FG004|Overall Study|Adverse Event|7
6878952|NCT00520572|10891048|FG005|Overall Study|Adverse Event|2
6878953|NCT00520572|10891043|FG000|Overall Study|Withdrawal by Subject|0
6878954|NCT00520572|10891044|FG001|Overall Study|Withdrawal by Subject|9
6878955|NCT00520572|10891045|FG002|Overall Study|Withdrawal by Subject|5
6878956|NCT00520572|10891046|FG003|Overall Study|Withdrawal by Subject|2
6878957|NCT00520572|10891047|FG004|Overall Study|Withdrawal by Subject|2
6878958|NCT00520572|10891048|FG005|Overall Study|Withdrawal by Subject|0
6878959|NCT00520572|10891043|FG000|Overall Study|Protocol Violation|0
6878960|NCT00520572|10891044|FG001|Overall Study|Protocol Violation|0
6878961|NCT00520572|10891045|FG002|Overall Study|Protocol Violation|1
6878962|NCT00520572|10891046|FG003|Overall Study|Protocol Violation|0
6878963|NCT00520572|10891047|FG004|Overall Study|Protocol Violation|0
6878964|NCT00520572|10891048|FG005|Overall Study|Protocol Violation|0
6878965|NCT00520572|10891043|FG000|Overall Study|Lack of Efficacy|1
6878966|NCT00520572|10891044|FG001|Overall Study|Lack of Efficacy|1
6878967|NCT00520572|10891045|FG002|Overall Study|Lack of Efficacy|1
7154560|NCT03314662|11321438|FG002|Overall Study|Withdrawal by Subject|1
6878968|NCT00520572|10891046|FG003|Overall Study|Lack of Efficacy|2
6878969|NCT00520572|10891047|FG004|Overall Study|Lack of Efficacy|1
6878970|NCT00520572|10891048|FG005|Overall Study|Lack of Efficacy|0
6878971|NCT00520572|10891043|FG000|Overall Study|Lost to Follow-up|0
6878972|NCT00520572|10891044|FG001|Overall Study|Lost to Follow-up|0
6878973|NCT00520572|10891045|FG002|Overall Study|Lost to Follow-up|0
6878974|NCT00520572|10891046|FG003|Overall Study|Lost to Follow-up|0
6878975|NCT00520572|10891047|FG004|Overall Study|Lost to Follow-up|1
6878976|NCT00520572|10891048|FG005|Overall Study|Lost to Follow-up|0
6878977|NCT00520572|10891043|FG000|Overall Study|Incorrect enrollment|1
6878978|NCT00520572|10891044|FG001|Overall Study|Incorrect enrollment|0
6878979|NCT00520572|10891045|FG002|Overall Study|Incorrect enrollment|1
6878980|NCT00520572|10891046|FG003|Overall Study|Incorrect enrollment|0
6878981|NCT00520572|10891047|FG004|Overall Study|Incorrect enrollment|1
6878982|NCT00520572|10891048|FG005|Overall Study|Incorrect enrollment|0
6878983|NCT00520572|10891043|FG000|Overall Study|Oral corticotherapy for acute urticaria|0
6878984|NCT00520572|10891044|FG001|Overall Study|Oral corticotherapy for acute urticaria|1
6878985|NCT00520572|10891045|FG002|Overall Study|Oral corticotherapy for acute urticaria|0
6878986|NCT00520572|10891046|FG003|Overall Study|Oral corticotherapy for acute urticaria|0
6878987|NCT00520572|10891047|FG004|Overall Study|Oral corticotherapy for acute urticaria|0
6878988|NCT00520572|10891048|FG005|Overall Study|Oral corticotherapy for acute urticaria|0
6878989|NCT00520572|10891043|FG000|Overall Study|Long break in taking Medication|0
6878990|NCT00520572|10891044|FG001|Overall Study|Long break in taking Medication|0
6878991|NCT00520572|10891045|FG002|Overall Study|Long break in taking Medication|0
6878992|NCT00520572|10891046|FG003|Overall Study|Long break in taking Medication|1
6878993|NCT00520572|10891047|FG004|Overall Study|Long break in taking Medication|0
6878994|NCT00520572|10891048|FG005|Overall Study|Long break in taking Medication|0
6878995|NCT00520572|10891043|FG000|Overall Study|Did not receive Treatment|1
6878996|NCT00520572|10891044|FG001|Overall Study|Did not receive Treatment|0
6878997|NCT00520572|10891045|FG002|Overall Study|Did not receive Treatment|1
6878998|NCT00520572|10891046|FG003|Overall Study|Did not receive Treatment|0
6878999|NCT00520572|10891047|FG004|Overall Study|Did not receive Treatment|0
6879000|NCT00520572|10891048|FG005|Overall Study|Did not receive Treatment|0
6879001|NCT00520676|10891064|FG000|Overall Study|Death|84
6879002|NCT00520676|10891065|FG001|Overall Study|Death|81
6879003|NCT00520676|10891064|FG000|Overall Study|Lost to Follow-up|6
6879004|NCT00520676|10891065|FG001|Overall Study|Lost to Follow-up|10
6879005|NCT00520676|10891064|FG000|Overall Study|Physician Decision|4
6879006|NCT00520676|10891065|FG001|Overall Study|Physician Decision|1
6879007|NCT00520676|10891064|FG000|Overall Study|Withdrawal by Subject|7
6879008|NCT00520676|10891065|FG001|Overall Study|Withdrawal by Subject|11
6879009|NCT00520741|10891073|FG000|Overall Study|Adverse Event|16
6879010|NCT00520741|10891074|FG001|Overall Study|Adverse Event|56
6879011|NCT00520741|10891073|FG000|Overall Study|Lack of Efficacy|11
6879012|NCT00520741|10891074|FG001|Overall Study|Lack of Efficacy|30
6879013|NCT00520741|10891073|FG000|Overall Study|Withdrawal by Subject|0
6879014|NCT00520741|10891074|FG001|Overall Study|Withdrawal by Subject|11
6879015|NCT00520741|10891073|FG000|Overall Study|Protocol Violation|2
6879016|NCT00520741|10891074|FG001|Overall Study|Protocol Violation|15
6879017|NCT00520741|10891073|FG000|Overall Study|Unsatisfactory compliance of subject|4
6879018|NCT00520741|10891074|FG001|Overall Study|Unsatisfactory compliance of subject|3
6879019|NCT00520741|10891073|FG000|Overall Study|Lost to Follow-up|4
6879020|NCT00520741|10891074|FG001|Overall Study|Lost to Follow-up|4
6969330|NCT01147458|11018964|FG000|First Intervention|Study terminated by sponsor|8
6969331|NCT01147458|11018965|FG001|First Intervention|Study terminated by sponsor|8
6969332|NCT01147458|11018966|FG002|First Intervention|Study terminated by sponsor|7
6969333|NCT01147458|11018967|FG003|First Intervention|Study terminated by sponsor|8
6969334|NCT01147458|11018964|FG000|First Intervention|Protocol Violation|2
6879021|NCT00520741|10891073|FG000|Overall Study|Other reasons for premature termination|0
6879022|NCT00520741|10891074|FG001|Overall Study|Other reasons for premature termination|6
6879023|NCT00520845|10891082|FG000|Overall Study|Death|3
6879024|NCT00520845|10891082|FG000|Overall Study|Adverse Event|4
6879025|NCT00520845|10891082|FG000|Overall Study|Disease Progression, relapse|13
6879026|NCT00520845|10891082|FG000|Overall Study|Withdrawal by Subject|1
6879027|NCT00520845|10891082|FG000|Overall Study|Alternative Therapy|1
6879028|NCT00520936|10891115|FG000|Overall Study|Physician Decision|0
6879029|NCT00520936|10891116|FG001|Overall Study|Physician Decision|2
6879030|NCT00520936|10891117|FG002|Overall Study|Physician Decision|1
6879031|NCT00520936|10891118|FG003|Overall Study|Physician Decision|0
6879032|NCT00520936|10891119|FG004|Overall Study|Physician Decision|0
6879033|NCT00520936|10891120|FG005|Overall Study|Physician Decision|0
6879034|NCT00520936|10891121|FG006|Overall Study|Physician Decision|0
6879035|NCT00520936|10891122|FG007|Overall Study|Physician Decision|0
6879036|NCT00520936|10891115|FG000|Overall Study|Withdrawal by Subject|0
6879037|NCT00520936|10891116|FG001|Overall Study|Withdrawal by Subject|0
6879038|NCT00520936|10891117|FG002|Overall Study|Withdrawal by Subject|0
6879039|NCT00520936|10891118|FG003|Overall Study|Withdrawal by Subject|0
6879040|NCT00520936|10891119|FG004|Overall Study|Withdrawal by Subject|0
6879041|NCT00520936|10891120|FG005|Overall Study|Withdrawal by Subject|0
6879042|NCT00520936|10891121|FG006|Overall Study|Withdrawal by Subject|0
6879043|NCT00520936|10891122|FG007|Overall Study|Withdrawal by Subject|1
6879044|NCT00520936|10891115|FG000|Overall Study|Toxicity Requiring Removal from Study|0
6879045|NCT00520936|10891116|FG001|Overall Study|Toxicity Requiring Removal from Study|1
6879046|NCT00520936|10891117|FG002|Overall Study|Toxicity Requiring Removal from Study|0
6879047|NCT00520936|10891118|FG003|Overall Study|Toxicity Requiring Removal from Study|0
6969335|NCT01147458|11018965|FG001|First Intervention|Protocol Violation|3
6879048|NCT00520936|10891119|FG004|Overall Study|Toxicity Requiring Removal from Study|0
6879049|NCT00520936|10891120|FG005|Overall Study|Toxicity Requiring Removal from Study|0
6879050|NCT00520936|10891121|FG006|Overall Study|Toxicity Requiring Removal from Study|2
6879051|NCT00520936|10891122|FG007|Overall Study|Toxicity Requiring Removal from Study|0
6879052|NCT00520936|10891115|FG000|Overall Study|Death|0
6879053|NCT00520936|10891116|FG001|Overall Study|Death|0
6879054|NCT00520936|10891117|FG002|Overall Study|Death|0
6879055|NCT00520936|10891118|FG003|Overall Study|Death|0
6879056|NCT00520936|10891119|FG004|Overall Study|Death|0
6879057|NCT00520936|10891120|FG005|Overall Study|Death|0
6879058|NCT00520936|10891121|FG006|Overall Study|Death|1
6879059|NCT00520936|10891122|FG007|Overall Study|Death|0
6879060|NCT00520936|10891115|FG000|Overall Study|Protocol Violation|0
6879061|NCT00520936|10891116|FG001|Overall Study|Protocol Violation|1
6879062|NCT00520936|10891117|FG002|Overall Study|Protocol Violation|1
6879063|NCT00520936|10891118|FG003|Overall Study|Protocol Violation|0
6879064|NCT00520936|10891119|FG004|Overall Study|Protocol Violation|1
6879065|NCT00520936|10891120|FG005|Overall Study|Protocol Violation|0
6879066|NCT00520936|10891121|FG006|Overall Study|Protocol Violation|1
6879067|NCT00520936|10891122|FG007|Overall Study|Protocol Violation|0
6879068|NCT00520975|10891135|FG000|Overall Study|Disease progression|31
6879069|NCT00520975|10891136|FG001|Overall Study|Disease progression|23
6879070|NCT00520975|10891135|FG000|Overall Study|Adverse Event|7
6879071|NCT00520975|10891136|FG001|Overall Study|Adverse Event|10
6879072|NCT00520975|10891135|FG000|Overall Study|Death|0
6879073|NCT00520975|10891136|FG001|Overall Study|Death|2
6879074|NCT00520975|10891135|FG000|Overall Study|Withdrawal by Subject|3
6879075|NCT00520975|10891136|FG001|Overall Study|Withdrawal by Subject|5
6879076|NCT00520975|10891135|FG000|Overall Study|Other therapy|2
6879077|NCT00520975|10891136|FG001|Overall Study|Other therapy|4
6879078|NCT00520975|10891135|FG000|Overall Study|Other reasons|4
6879079|NCT00520975|10891136|FG001|Overall Study|Other reasons|2
6879080|NCT00520975|10891135|FG000|Overall Study|Not start protocol therapy|1
6879081|NCT00520975|10891136|FG001|Overall Study|Not start protocol therapy|2
6879082|NCT00521001|10891142|FG000|Overall Study|Ineligible|1
6879083|NCT00521014|10891146|FG000|Overall Study|Inevaluable, not treated|1
6879084|NCT00521053|10891150|FG000|Observation Phase|Disease Progression|55
6879085|NCT00521053|10891150|FG000|Observation Phase|Additional PV-10 via alternate protocol|8
6879086|NCT00521053|10891150|FG000|Observation Phase|Death|2
6879087|NCT00521053|10891150|FG000|Observation Phase|Adverse Event|1
6879088|NCT00521053|10891150|FG000|Observation Phase|Other non-study melanoma treatment|1
6879089|NCT00521053|10891150|FG000|Observation Phase|Physician Decision|1
6879090|NCT00521079|10891159|FG000|Overall Study|Adverse Event|7
6879091|NCT00521079|10891160|FG001|Overall Study|Adverse Event|1
6879092|NCT00521079|10891159|FG000|Overall Study|Lost to Follow-up|2
6879093|NCT00521079|10891160|FG001|Overall Study|Lost to Follow-up|1
6879094|NCT00521079|10891159|FG000|Overall Study|Withdrawal by Subject|5
6879095|NCT00521079|10891160|FG001|Overall Study|Withdrawal by Subject|3
6879096|NCT00521144|10891171|FG000|Overall Study|Not Treated|0
6879097|NCT00521144|10891172|FG001|Overall Study|Not Treated|0
6879098|NCT00521144|10891173|FG002|Overall Study|Not Treated|0
6879099|NCT00521144|10891174|FG003|Overall Study|Not Treated|1
6879100|NCT00521144|10891175|FG004|Overall Study|Not Treated|0
6879101|NCT00521144|10891171|FG000|Overall Study|Adverse Event|0
6879102|NCT00521144|10891172|FG001|Overall Study|Adverse Event|1
6879103|NCT00521144|10891173|FG002|Overall Study|Adverse Event|0
6879104|NCT00521144|10891174|FG003|Overall Study|Adverse Event|0
6879105|NCT00521144|10891175|FG004|Overall Study|Adverse Event|1
6879106|NCT00521144|10891171|FG000|Overall Study|Progressive Disease|4
6879107|NCT00521144|10891172|FG001|Overall Study|Progressive Disease|2
6879108|NCT00521144|10891173|FG002|Overall Study|Progressive Disease|2
6879109|NCT00521144|10891174|FG003|Overall Study|Progressive Disease|0
6879110|NCT00521144|10891175|FG004|Overall Study|Progressive Disease|6
6879111|NCT00521339|10891187|FG000|Treatment Phase|Adverse Event|2
6879112|NCT00521339|10891188|FG001|Treatment Phase|Adverse Event|0
6879113|NCT00521339|10891189|FG002|Treatment Phase|Adverse Event|0
6879114|NCT00521339|10891187|FG000|Treatment Phase|Intolerability to study drug|2
6879115|NCT00521339|10891188|FG001|Treatment Phase|Intolerability to study drug|0
6879116|NCT00521339|10891189|FG002|Treatment Phase|Intolerability to study drug|0
6879117|NCT00521339|10891187|FG000|Treatment Phase|Lack of Efficacy|3
6879118|NCT00521339|10891188|FG001|Treatment Phase|Lack of Efficacy|0
6879119|NCT00521339|10891189|FG002|Treatment Phase|Lack of Efficacy|0
6879120|NCT00521339|10891187|FG000|Treatment Phase|Withdrawal by Subject|3
6879121|NCT00521339|10891188|FG001|Treatment Phase|Withdrawal by Subject|0
6879122|NCT00521339|10891189|FG002|Treatment Phase|Withdrawal by Subject|0
6879123|NCT00521339|10891187|FG000|Treatment Phase|Lost to Follow-up|1
6879124|NCT00521339|10891188|FG001|Treatment Phase|Lost to Follow-up|0
6879125|NCT00521339|10891189|FG002|Treatment Phase|Lost to Follow-up|0
6879126|NCT00521339|10891187|FG000|Treatment Phase|Protocol Violation|1
6879127|NCT00521339|10891188|FG001|Treatment Phase|Protocol Violation|0
6879128|NCT00521339|10891189|FG002|Treatment Phase|Protocol Violation|0
6879129|NCT00521339|10891187|FG000|Treatment Extension Phase|Withdrawal by Subject|0
6879130|NCT00521339|10891188|FG001|Treatment Extension Phase|Withdrawal by Subject|0
6879131|NCT00521339|10891189|FG002|Treatment Extension Phase|Withdrawal by Subject|2
6879132|NCT00521339|10891187|FG000|Treatment Extension Phase|Death|0
6879133|NCT00521339|10891188|FG001|Treatment Extension Phase|Death|0
6879134|NCT00521339|10891189|FG002|Treatment Extension Phase|Death|1
6879135|NCT00521365|10891219|FG000|Overall Study|Adverse Event|3
6879136|NCT00521365|10891219|FG000|Overall Study|Lost to Follow-up|6
6879137|NCT00521365|10891219|FG000|Overall Study|Protocol deviation|2
6879138|NCT00521365|10891219|FG000|Overall Study|Drug compliance|3
6879139|NCT00521365|10891219|FG000|Overall Study|Usage of not allowed drugs|6
6879140|NCT00521404|10891223|FG000|Overall Study|Adverse Event|13
6879141|NCT00521404|10891223|FG000|Overall Study|Disease Progression|33
6879142|NCT00521404|10891223|FG000|Overall Study|Investigator decision|5
6879143|NCT00521404|10891223|FG000|Overall Study|Withdrawal of consent|3
6879144|NCT00521404|10891223|FG000|Overall Study|Noncompliance or lack of cooperation|1
6879145|NCT00521404|10891223|FG000|Overall Study|Other|7
6879146|NCT00521586|10891238|FG000|Initial Vaccination (Year 0)|Subject request|8
6879147|NCT00521586|10891239|FG001|Initial Vaccination (Year 0)|Subject request|11
6879148|NCT00521586|10891238|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5
6879149|NCT00521586|10891239|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10
6879150|NCT00521586|10891238|FG000|Initial Vaccination (Year 0)|Protocol Violation|2
6879151|NCT00521586|10891239|FG001|Initial Vaccination (Year 0)|Protocol Violation|5
6879152|NCT00521586|10891238|FG000|Initial Vaccination (Year 0)|Other, unspecified|3
6879153|NCT00521586|10891239|FG001|Initial Vaccination (Year 0)|Other, unspecified|1
6879154|NCT00521586|10891238|FG000|Initial Vaccination (Year 0)|Investigator request|2
6879155|NCT00521586|10891239|FG001|Initial Vaccination (Year 0)|Investigator request|0
6879156|NCT00521586|10891238|FG000|Initial Vaccination (Year 0)|Adverse Event|0
6879157|NCT00521586|10891239|FG001|Initial Vaccination (Year 0)|Adverse Event|1
6879158|NCT00521586|10891238|FG000|Initial Vaccination (Year 0)|Death|1
6879159|NCT00521586|10891239|FG001|Initial Vaccination (Year 0)|Death|0
6879160|NCT00521586|10891238|FG000|Initial Vaccination (Year 0)|Failed to return|0
6879161|NCT00521586|10891239|FG001|Initial Vaccination (Year 0)|Failed to return|1
6879162|NCT00521586|10891238|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5
6879163|NCT00521586|10891239|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1
6879164|NCT00521586|10891238|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5
6879165|NCT00521586|10891239|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2
6879166|NCT00521586|10891238|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7
6879167|NCT00521586|10891239|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3
6879168|NCT00521586|10891238|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
6879169|NCT00521586|10891239|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
6879170|NCT00521586|10891238|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55
6879171|NCT00521586|10891239|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56
6879172|NCT00521586|10891238|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22
6879173|NCT00521586|10891239|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26
6879174|NCT00521586|10891238|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18
6879175|NCT00521586|10891239|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22
6879176|NCT00521586|10891238|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54
6879177|NCT00521586|10891239|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57
6879178|NCT00521586|10891238|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0
6879179|NCT00521586|10891239|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1
6879180|NCT00521586|10891238|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1
6879181|NCT00521586|10891239|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4
6879182|NCT00521586|10891238|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2
6879183|NCT00521586|10891239|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7
6879184|NCT00522041|10891284|FG000|Overall Study|Adverse Event|9
6879185|NCT00522041|10891285|FG001|Overall Study|Adverse Event|3
6879186|NCT00522041|10891284|FG000|Overall Study|Protocol Violation|2
6879187|NCT00522041|10891285|FG001|Overall Study|Protocol Violation|0
6879188|NCT00522041|10891284|FG000|Overall Study|Lost to Follow-up|1
6879189|NCT00522041|10891285|FG001|Overall Study|Lost to Follow-up|4
6879190|NCT00522041|10891284|FG000|Overall Study|Voluntary withdrawal|5
6879191|NCT00522041|10891285|FG001|Overall Study|Voluntary withdrawal|4
6879192|NCT00522041|10891284|FG000|Overall Study|Did not receive treatment|0
6879193|NCT00522041|10891285|FG001|Overall Study|Did not receive treatment|1
6879194|NCT00522275|10891301|FG000|Overall Study|Adverse Event|35
6879195|NCT00522275|10891301|FG000|Overall Study|Lack of Efficacy|80
6879196|NCT00522275|10891301|FG000|Overall Study|Subject withdrew consent|16
6879197|NCT00522275|10891301|FG000|Overall Study|Protocol deviation|1
6879198|NCT00522275|10891301|FG000|Overall Study|Unsatisfactory compliance|11
6879199|NCT00522275|10891301|FG000|Overall Study|Lost to Follow-up|8
6879200|NCT00522275|10891301|FG000|Overall Study|Other: Subject wants to become pregnant|2
6879201|NCT00522275|10891301|FG000|Overall Study|Other: Subject is pregnant|2
6879202|NCT00522275|10891301|FG000|Overall Study|Other: Subject relocated|2
6879203|NCT00522275|10891301|FG000|Overall Study|Other: Subject arrested|1
6879204|NCT00522275|10891301|FG000|Overall Study|Other: Site / clinic closed|4
6879205|NCT00522275|10891301|FG000|Overall Study|Other: Travel to / from site difficulty|3
7154561|NCT03314662|11321436|FG000|Overall Study|Lost to Follow-up|5
7154562|NCT03314662|11321437|FG001|Overall Study|Lost to Follow-up|4
7154563|NCT03314662|11321438|FG002|Overall Study|Lost to Follow-up|4
7154564|NCT03314662|11321436|FG000|Overall Study|Death|2
7154565|NCT03314662|11321437|FG001|Overall Study|Death|0
6879206|NCT00522275|10891301|FG000|Overall Study|Other: Sponsor request|2
6879207|NCT00522275|10891301|FG000|Overall Study|Other: Subject ran out of medication|1
6879208|NCT00522275|10891301|FG000|Overall Study|Other: Subject had surgery for epilepsy|2
6879209|NCT00522379|10891310|FG000|Overall Study|Adverse Event|12
6879210|NCT00522379|10891311|FG001|Overall Study|Adverse Event|15
6879211|NCT00522379|10891312|FG002|Overall Study|Adverse Event|12
6879212|NCT00522379|10891313|FG003|Overall Study|Adverse Event|5
7154566|NCT03314662|11321438|FG002|Overall Study|Death|0
6879213|NCT00522379|10891314|FG004|Overall Study|Adverse Event|17
6879214|NCT00522379|10891310|FG000|Overall Study|Lack of Efficacy|3
6879215|NCT00522379|10891311|FG001|Overall Study|Lack of Efficacy|0
6879216|NCT00522379|10891312|FG002|Overall Study|Lack of Efficacy|2
6879217|NCT00522379|10891313|FG003|Overall Study|Lack of Efficacy|2
6879218|NCT00522379|10891314|FG004|Overall Study|Lack of Efficacy|7
6879219|NCT00522379|10891310|FG000|Overall Study|Withdrawal by Subject|2
6879220|NCT00522379|10891311|FG001|Overall Study|Withdrawal by Subject|3
6879221|NCT00522379|10891312|FG002|Overall Study|Withdrawal by Subject|1
6879222|NCT00522379|10891313|FG003|Overall Study|Withdrawal by Subject|2
6879223|NCT00522379|10891314|FG004|Overall Study|Withdrawal by Subject|0
6879224|NCT00522379|10891310|FG000|Overall Study|Protocol Violation|1
6879225|NCT00522379|10891311|FG001|Overall Study|Protocol Violation|1
6879226|NCT00522379|10891312|FG002|Overall Study|Protocol Violation|2
6879227|NCT00522379|10891313|FG003|Overall Study|Protocol Violation|0
6879228|NCT00522379|10891314|FG004|Overall Study|Protocol Violation|0
6879229|NCT00522379|10891310|FG000|Overall Study|Unsatisfactory Subject Compliance|1
6879230|NCT00522379|10891311|FG001|Overall Study|Unsatisfactory Subject Compliance|2
6879231|NCT00522379|10891312|FG002|Overall Study|Unsatisfactory Subject Compliance|0
6879232|NCT00522379|10891313|FG003|Overall Study|Unsatisfactory Subject Compliance|0
6879233|NCT00522379|10891314|FG004|Overall Study|Unsatisfactory Subject Compliance|0
6879234|NCT00522379|10891310|FG000|Overall Study|Lost to Follow-up|1
6879235|NCT00522379|10891311|FG001|Overall Study|Lost to Follow-up|0
6879236|NCT00522379|10891312|FG002|Overall Study|Lost to Follow-up|4
6879237|NCT00522379|10891313|FG003|Overall Study|Lost to Follow-up|2
6879238|NCT00522379|10891314|FG004|Overall Study|Lost to Follow-up|2
6879239|NCT00522379|10891310|FG000|Overall Study|Randomization error|0
7078821|NCT02106351|11187395|FG002|Treatment Cycle 1|Lost to Follow-up|0
7078822|NCT02106351|11187393|FG000|Treatment Cycle 1|Other|0
7078823|NCT02106351|11187394|FG001|Treatment Cycle 1|Other|3
7078824|NCT02106351|11187395|FG002|Treatment Cycle 1|Other|1
7078825|NCT02106351|11187393|FG000|Treatment Cycle 1|Randomised but not treated|1
7078826|NCT02106351|11187394|FG001|Treatment Cycle 1|Randomised but not treated|0
7078827|NCT02106351|11187395|FG002|Treatment Cycle 1|Randomised but not treated|1
7078828|NCT02106351|11187393|FG000|Treatment Cycle 2|Adverse Event|0
7078829|NCT02106351|11187394|FG001|Treatment Cycle 2|Adverse Event|2
7078830|NCT02106351|11187395|FG002|Treatment Cycle 2|Adverse Event|0
7078831|NCT02106351|11187393|FG000|Treatment Cycle 2|Consent withdrawn|0
7078832|NCT02106351|11187394|FG001|Treatment Cycle 2|Consent withdrawn|1
7078833|NCT02106351|11187395|FG002|Treatment Cycle 2|Consent withdrawn|1
7078834|NCT02106351|11187393|FG000|Treatment Cycle 2|Other|0
7078835|NCT02106351|11187394|FG001|Treatment Cycle 2|Other|2
7078836|NCT02106351|11187395|FG002|Treatment Cycle 2|Other|2
7078837|NCT02106351|11187393|FG000|Treatment Cycle 3|Adverse Event|0
7078838|NCT02106351|11187394|FG001|Treatment Cycle 3|Adverse Event|1
7154567|NCT03314857|11321463|FG000|Overall Study|Death|4
7154568|NCT03314857|11321463|FG000|Overall Study|Physician Decision|1
6879240|NCT00522379|10891311|FG001|Overall Study|Randomization error|0
6879241|NCT00522379|10891312|FG002|Overall Study|Randomization error|0
6879242|NCT00522379|10891313|FG003|Overall Study|Randomization error|0
6879243|NCT00522379|10891314|FG004|Overall Study|Randomization error|1
6879244|NCT00522379|10891310|FG000|Overall Study|Dispensing error|1
6879245|NCT00522379|10891311|FG001|Overall Study|Dispensing error|0
6879246|NCT00522379|10891312|FG002|Overall Study|Dispensing error|0
7154569|NCT03315208|11321482|FG000|Overall Study|Lost to Follow-up|11
7154570|NCT03315208|11321483|FG001|Overall Study|Lost to Follow-up|6
6879247|NCT00522379|10891313|FG003|Overall Study|Dispensing error|1
6879248|NCT00522379|10891314|FG004|Overall Study|Dispensing error|0
6879249|NCT00522379|10891310|FG000|Overall Study|Subject Moved|1
6879250|NCT00522379|10891311|FG001|Overall Study|Subject Moved|1
6879251|NCT00522379|10891312|FG002|Overall Study|Subject Moved|0
6879252|NCT00522379|10891313|FG003|Overall Study|Subject Moved|0
6879253|NCT00522379|10891314|FG004|Overall Study|Subject Moved|0
6879254|NCT00522379|10891310|FG000|Overall Study|Sponsor Request|0
7078839|NCT02106351|11187395|FG002|Treatment Cycle 3|Adverse Event|0
7078840|NCT02106351|11187393|FG000|Treatment Cycle 3|Consent withdrawn|0
7154571|NCT03315208|11321482|FG000|Overall Study|Withdrawal by Subject|2
7154572|NCT03315208|11321483|FG001|Overall Study|Withdrawal by Subject|0
6879255|NCT00522379|10891311|FG001|Overall Study|Sponsor Request|1
6879256|NCT00522379|10891312|FG002|Overall Study|Sponsor Request|0
6879257|NCT00522379|10891313|FG003|Overall Study|Sponsor Request|0
6879258|NCT00522379|10891314|FG004|Overall Study|Sponsor Request|0
6879259|NCT00522379|10891310|FG000|Overall Study|Family Problem|0
6879260|NCT00522379|10891311|FG001|Overall Study|Family Problem|0
6879261|NCT00522379|10891312|FG002|Overall Study|Family Problem|1
6879262|NCT00522379|10891313|FG003|Overall Study|Family Problem|0
6879263|NCT00522379|10891314|FG004|Overall Study|Family Problem|0
6879264|NCT00522379|10891310|FG000|Overall Study|Site Closed|0
6879265|NCT00522379|10891311|FG001|Overall Study|Site Closed|0
6879266|NCT00522379|10891312|FG002|Overall Study|Site Closed|0
6879267|NCT00522379|10891313|FG003|Overall Study|Site Closed|1
7078841|NCT02106351|11187394|FG001|Treatment Cycle 3|Consent withdrawn|0
7078842|NCT02106351|11187395|FG002|Treatment Cycle 3|Consent withdrawn|2
7078843|NCT02106351|11187393|FG000|Treatment Cycle 3|Lost to Follow-up|0
7078844|NCT02106351|11187394|FG001|Treatment Cycle 3|Lost to Follow-up|1
7154573|NCT03315286|11321492|FG000|Overall Study|Lost to Follow-up|0
6879268|NCT00522379|10891314|FG004|Overall Study|Site Closed|0
6879269|NCT00522379|10891310|FG000|Overall Study|Subject Withdrawal|0
6879270|NCT00522379|10891311|FG001|Overall Study|Subject Withdrawal|0
6879271|NCT00522379|10891312|FG002|Overall Study|Subject Withdrawal|0
6879272|NCT00522379|10891313|FG003|Overall Study|Subject Withdrawal|1
6879273|NCT00522379|10891314|FG004|Overall Study|Subject Withdrawal|0
6879274|NCT00522392|10891328|FG000|Overall Study|Disease progression|0
6879275|NCT00522392|10891329|FG001|Overall Study|Disease progression|3
6879276|NCT00522392|10891328|FG000|Overall Study|Adverse Event|7
6879277|NCT00522392|10891329|FG001|Overall Study|Adverse Event|7
6879278|NCT00522392|10891328|FG000|Overall Study|Withdrawal by Subject|1
6879279|NCT00522392|10891329|FG001|Overall Study|Withdrawal by Subject|1
6879280|NCT00522392|10891328|FG000|Overall Study|Physician Decision|0
6879281|NCT00522392|10891329|FG001|Overall Study|Physician Decision|1
6879282|NCT00522392|10891328|FG000|Overall Study|Non-compliance|0
6879283|NCT00522392|10891329|FG001|Overall Study|Non-compliance|1
6879284|NCT00522418|10891337|FG000|Overall Study|Local IRB Consent Violation|5
6879285|NCT00522418|10891338|FG001|Overall Study|Local IRB Consent Violation|5
6879286|NCT00522418|10891337|FG000|Overall Study|Early Study Termination|46
6879287|NCT00522418|10891338|FG001|Overall Study|Early Study Termination|47
6879288|NCT00522418|10891337|FG000|Overall Study|Noncompliance|2
6879289|NCT00522418|10891338|FG001|Overall Study|Noncompliance|2
6879290|NCT00522418|10891337|FG000|Overall Study|Reason Not Specified|3
6879291|NCT00522418|10891338|FG001|Overall Study|Reason Not Specified|1
6879292|NCT00522418|10891337|FG000|Overall Study|Consent Withdraw|1
6879293|NCT00522418|10891338|FG001|Overall Study|Consent Withdraw|2
6879294|NCT00522418|10891337|FG000|Overall Study|Lack of Efficacy|0
6879295|NCT00522418|10891338|FG001|Overall Study|Lack of Efficacy|1
6879296|NCT00522431|10891346|FG000|Overall Study|Adverse Event|5
6879297|NCT00522431|10891346|FG000|Overall Study|Protocol Violation|2
6879298|NCT00522431|10891346|FG000|Overall Study|Withdrawal by Subject|2
6879299|NCT00522431|10891346|FG000|Overall Study|Subject non-compliance|1
6879300|NCT00522431|10891346|FG000|Overall Study|Other/unknown|1
6879301|NCT00522548|10891352|FG000|Overall Study|Adverse Event|2
6879302|NCT00522548|10891353|FG001|Overall Study|Adverse Event|2
6879303|NCT00522548|10891352|FG000|Overall Study|Withdrawal by Subject|0
6879304|NCT00522548|10891353|FG001|Overall Study|Withdrawal by Subject|2
6879305|NCT00522626|10891359|FG000|Overall Study|Lost to Follow-up|7
6879306|NCT00522873|10891369|FG000|Overall Study|Adverse Event|41
6879307|NCT00522873|10891370|FG001|Overall Study|Adverse Event|26
6879308|NCT00522873|10891369|FG000|Overall Study|Withdrawal by Subject|20
6879309|NCT00522873|10891370|FG001|Overall Study|Withdrawal by Subject|9
6879310|NCT00522873|10891369|FG000|Overall Study|Protocol Violation|14
6879311|NCT00522873|10891370|FG001|Overall Study|Protocol Violation|4
6879312|NCT00522873|10891369|FG000|Overall Study|Lost to Follow-up|11
6879313|NCT00522873|10891370|FG001|Overall Study|Lost to Follow-up|3
6879314|NCT00522873|10891369|FG000|Overall Study|Personal Reasons|8
6879315|NCT00522873|10891370|FG001|Overall Study|Personal Reasons|1
6879316|NCT00522873|10891369|FG000|Overall Study|Medication Errors|1
6879317|NCT00522873|10891370|FG001|Overall Study|Medication Errors|1
6879318|NCT00522873|10891369|FG000|Overall Study|Never Received Medication|1
6879319|NCT00522873|10891370|FG001|Overall Study|Never Received Medication|0
6879320|NCT00522951|10891389|FG000|Period 1|body motion|0
6879321|NCT00522951|10891390|FG001|Period 1|body motion|1
6879322|NCT00522951|10891389|FG000|Washout Period|Adverse Event|0
6879323|NCT00522951|10891390|FG001|Washout Period|Adverse Event|1
6879324|NCT00522951|10891389|FG000|Washout Period|Death|0
6879325|NCT00522951|10891390|FG001|Washout Period|Death|1
6879326|NCT00522951|10891389|FG000|Period 2|Withdrawal by Subject|1
6879327|NCT00522951|10891390|FG001|Period 2|Withdrawal by Subject|0
6879328|NCT00522951|10891389|FG000|Period 2|residual contrast medium|1
6879329|NCT00522951|10891390|FG001|Period 2|residual contrast medium|1
6879330|NCT00523341|10891415|FG000|Overall Study|Withdrawal by Subject|399
6879331|NCT00523341|10891416|FG001|Overall Study|Withdrawal by Subject|427
6879332|NCT00523341|10891415|FG000|Overall Study|Other|181
6879333|NCT00523341|10891416|FG001|Overall Study|Other|198
6879334|NCT00523341|10891415|FG000|Overall Study|Adverse Event|122
6879335|NCT00523341|10891416|FG001|Overall Study|Adverse Event|155
6879336|NCT00523341|10891415|FG000|Overall Study|Death|101
6879337|NCT00523341|10891416|FG001|Overall Study|Death|110
6879338|NCT00523341|10891415|FG000|Overall Study|Lost to Follow-up|73
6879339|NCT00523341|10891416|FG001|Overall Study|Lost to Follow-up|61
6879340|NCT00523341|10891415|FG000|Overall Study|Non-compliance|20
6879341|NCT00523341|10891416|FG001|Overall Study|Non-compliance|13
6879342|NCT00523341|10891415|FG000|Overall Study|Physician Decision|14
6879343|NCT00523341|10891416|FG001|Overall Study|Physician Decision|13
6879344|NCT00523341|10891415|FG000|Overall Study|Requirement for Alternative Therapy|4
6879345|NCT00523341|10891416|FG001|Overall Study|Requirement for Alternative Therapy|14
6879346|NCT00523341|10891415|FG000|Overall Study|Protocol Deviation|6
6879347|NCT00523341|10891416|FG001|Overall Study|Protocol Deviation|5
6879348|NCT00523341|10891415|FG000|Overall Study|Ineligibility Determined|3
6879349|NCT00523341|10891416|FG001|Overall Study|Ineligibility Determined|4
6879350|NCT00523341|10891415|FG000|Overall Study|Disease Progression|1
6879351|NCT00523341|10891416|FG001|Overall Study|Disease Progression|0
6879352|NCT00523367|10891422|FG000|Overall Study|19 screen failures|19
6879353|NCT00523367|10891422|FG000|Overall Study|4 Withdrawn by PI|4
6879354|NCT00523419|10891426|FG000|Overall Study|Adverse Event|1
6879355|NCT00523419|10891426|FG000|Overall Study|Withdrawal by Subject|1
6879356|NCT00523419|10891426|FG000|Overall Study|Physician Decision|2
6879357|NCT00523419|10891426|FG000|Overall Study|Progressive Disease|22
6879358|NCT00523419|10891426|FG000|Overall Study|Death due to Study Disease|4
6879359|NCT00523419|10891426|FG000|Overall Study|Death due to Adverse Event|2
6879360|NCT00523549|10891432|FG000|Overall Study|Adverse Event|6
6879361|NCT00523549|10891433|FG001|Overall Study|Adverse Event|3
6879362|NCT00523549|10891432|FG000|Overall Study|Unsatisfactory therapeutic effect|0
6879363|NCT00523549|10891433|FG001|Overall Study|Unsatisfactory therapeutic effect|1
6879364|NCT00523549|10891432|FG000|Overall Study|Protocol Deviation|3
6879365|NCT00523549|10891433|FG001|Overall Study|Protocol Deviation|1
6879366|NCT00523549|10891432|FG000|Overall Study|Patient withdrew consent|7
6879367|NCT00523549|10891433|FG001|Overall Study|Patient withdrew consent|6
6879368|NCT00523549|10891432|FG000|Overall Study|Lost to Follow-up|3
6879369|NCT00523549|10891433|FG001|Overall Study|Lost to Follow-up|5
6879370|NCT00523640|10891448|FG000|Overall Study|Death|1
6879371|NCT00523705|10891454|FG000|Overall Study|No time for study.|0
6879372|NCT00523705|10891455|FG001|Overall Study|No time for study.|1
6879373|NCT00523718|10891463|FG000|Overall Study|Withdrawal by Subject|1
6879374|NCT00523718|10891464|FG001|Overall Study|Withdrawal by Subject|0
6879375|NCT00523718|10891463|FG000|Overall Study|Protocol Violation|2
6879376|NCT00523718|10891464|FG001|Overall Study|Protocol Violation|0
6879377|NCT00523744|10891470|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2
6879378|NCT00523744|10891470|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1
6879379|NCT00523744|10891470|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2
6879380|NCT00523744|10891470|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1
6879381|NCT00523744|10891470|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2
6879382|NCT00523744|10891470|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1
6879383|NCT00523848|10891477|FG000|Overall Study|Adverse Event|11
6879384|NCT00523848|10891477|FG000|Overall Study|Withdrawal by Subject|2
6879385|NCT00523848|10891477|FG000|Overall Study|NOT TREATED (Became ineligible)|2
6879386|NCT00523848|10891477|FG000|Overall Study|Disease Progression|5
6879387|NCT00523848|10891477|FG000|Overall Study|Other, unspecified|4
7154574|NCT03315286|11321493|FG001|Overall Study|Lost to Follow-up|3
7154575|NCT03315286|11321492|FG000|Overall Study|Withdrawal by Subject|1
7154576|NCT03315286|11321493|FG001|Overall Study|Withdrawal by Subject|0
7154577|NCT03315286|11321492|FG000|Overall Study|Protocol Violation|0
7154578|NCT03315286|11321493|FG001|Overall Study|Protocol Violation|1
7154579|NCT03315689|11321518|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1
7154580|NCT03315689|11321519|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0
7154581|NCT03315689|11321518|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0
7154582|NCT03315689|11321519|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2
7154583|NCT03315689|11321518|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0
7154584|NCT03315689|11321519|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1
7154585|NCT03315793|11321541|FG000|Overall Study|Adverse Event|4
7154586|NCT03315793|11321542|FG001|Overall Study|Adverse Event|2
7154587|NCT03315793|11321541|FG000|Overall Study|Protocol Deviation|1
7154588|NCT03315793|11321542|FG001|Overall Study|Protocol Deviation|0
7154589|NCT03315793|11321541|FG000|Overall Study|Difficult for regular visit|0
7154590|NCT03315793|11321542|FG001|Overall Study|Difficult for regular visit|1
7154591|NCT03316131|11321559|FG000|Treatment Period 2|Protocol deviation|1
7154592|NCT03316131|11321560|FG001|Treatment Period 2|Protocol deviation|0
7154593|NCT03316170|11321568|FG000|Overall Study|Death|1
7154594|NCT03316170|11321569|FG001|Overall Study|Death|0
7154595|NCT03316170|11321568|FG000|Overall Study|Lost to Follow-up|6
7154596|NCT03316170|11321569|FG001|Overall Study|Lost to Follow-up|7
7154597|NCT03316547|11321588|FG000|Overall Study|Death|3
7154598|NCT03316547|11321589|FG001|Overall Study|Death|1
7154599|NCT03316547|11321588|FG000|Overall Study|Lost to Follow-up|6
7154600|NCT03316547|11321589|FG001|Overall Study|Lost to Follow-up|6
7154601|NCT03316547|11321588|FG000|Overall Study|Withdrawal by Subject|3
7154602|NCT03316547|11321589|FG001|Overall Study|Withdrawal by Subject|2
7154603|NCT03316547|11321588|FG000|Overall Study|Transfer to another hospital|6
7154604|NCT03316547|11321589|FG001|Overall Study|Transfer to another hospital|4
7154605|NCT03316911|11321599|FG000|Overall Study|Lost to Follow-up|33
7154606|NCT03316911|11321600|FG001|Overall Study|Lost to Follow-up|29
7154607|NCT03317379|11321649|FG000|Overall Study|Lost to Follow-up|0
7154608|NCT03317379|11321650|FG001|Overall Study|Lost to Follow-up|3
7154609|NCT03317379|11321651|FG002|Overall Study|Lost to Follow-up|2
7154610|NCT03318315|11321675|FG000|Overall Study|Lost to Follow-up|3
7154611|NCT03318315|11321676|FG001|Overall Study|Lost to Follow-up|2
7154612|NCT03318315|11321677|FG002|Overall Study|Lost to Follow-up|1
7154613|NCT03318315|11321675|FG000|Overall Study|Protocol Violation|1
7154614|NCT03318315|11321676|FG001|Overall Study|Protocol Violation|1
7154615|NCT03318315|11321677|FG002|Overall Study|Protocol Violation|1
7154616|NCT03318315|11321675|FG000|Overall Study|Withdrawal by Subject|0
7154617|NCT03318315|11321676|FG001|Overall Study|Withdrawal by Subject|0
6879388|NCT00523978|10891483|FG000|Overall Study|Withdrawal by Subject|3
6879389|NCT00523978|10891484|FG001|Overall Study|Withdrawal by Subject|7
6879390|NCT00523978|10891483|FG000|Overall Study|Screen Failures|5
6879391|NCT00523978|10891484|FG001|Overall Study|Screen Failures|1
6879392|NCT00523978|10891483|FG000|Overall Study|Death|1
6879393|NCT00523978|10891484|FG001|Overall Study|Death|0
6879394|NCT00523991|10891493|FG000|Overall Study|Adverse Event|6
6879395|NCT00523991|10891494|FG001|Overall Study|Adverse Event|5
6879396|NCT00523991|10891493|FG000|Overall Study|Protocol Violation|1
6879397|NCT00523991|10891494|FG001|Overall Study|Protocol Violation|4
6879398|NCT00523991|10891493|FG000|Overall Study|Lost to Follow-up|4
7078845|NCT02106351|11187395|FG002|Treatment Cycle 3|Lost to Follow-up|0
7154618|NCT03318315|11321677|FG002|Overall Study|Withdrawal by Subject|2
6879399|NCT00523991|10891494|FG001|Overall Study|Lost to Follow-up|1
6879400|NCT00523991|10891493|FG000|Overall Study|Withdrawal by Subject|7
6879401|NCT00523991|10891494|FG001|Overall Study|Withdrawal by Subject|17
6879402|NCT00523991|10891493|FG000|Overall Study|Other reason (not specified)|3
6879403|NCT00523991|10891494|FG001|Overall Study|Other reason (not specified)|0
6879404|NCT00524030|10891511|FG000|Overall Study|Lack of Efficacy|10
6879405|NCT00524030|10891512|FG001|Overall Study|Lack of Efficacy|24
6879406|NCT00524030|10891511|FG000|Overall Study|Lost to Follow-up|0
6879407|NCT00524030|10891512|FG001|Overall Study|Lost to Follow-up|2
6879408|NCT00524030|10891511|FG000|Overall Study|Withdrawal by Subject|3
6879409|NCT00524030|10891512|FG001|Overall Study|Withdrawal by Subject|8
6879410|NCT00524030|10891511|FG000|Overall Study|Noncompliance/Investigator discretion|0
6879411|NCT00524030|10891512|FG001|Overall Study|Noncompliance/Investigator discretion|2
6879412|NCT00524030|10891511|FG000|Overall Study|Protocol Violation|0
6879413|NCT00524030|10891512|FG001|Overall Study|Protocol Violation|1
6879414|NCT00524030|10891511|FG000|Overall Study|Pregnancy|1
6879415|NCT00524030|10891512|FG001|Overall Study|Pregnancy|0
6879416|NCT00524030|10891511|FG000|Overall Study|Adverse Event|3
6879417|NCT00524030|10891512|FG001|Overall Study|Adverse Event|21
6879418|NCT00524030|10891511|FG000|Overall Study|Death|0
6879419|NCT00524030|10891512|FG001|Overall Study|Death|1
6879420|NCT00524043|10891522|FG000|Overall Study|Lack of Efficacy|15
6879421|NCT00524043|10891523|FG001|Overall Study|Lack of Efficacy|13
6879422|NCT00524043|10891524|FG002|Overall Study|Lack of Efficacy|14
6879423|NCT00524043|10891522|FG000|Overall Study|Withdrawal by Subject|5
6879424|NCT00524043|10891523|FG001|Overall Study|Withdrawal by Subject|7
6879425|NCT00524043|10891524|FG002|Overall Study|Withdrawal by Subject|7
6879426|NCT00524043|10891522|FG000|Overall Study|Adverse Event|5
6879427|NCT00524043|10891523|FG001|Overall Study|Adverse Event|2
6879428|NCT00524043|10891524|FG002|Overall Study|Adverse Event|7
6879429|NCT00524043|10891522|FG000|Overall Study|Lost to Follow-up|3
6879430|NCT00524043|10891523|FG001|Overall Study|Lost to Follow-up|5
6879431|NCT00524043|10891524|FG002|Overall Study|Lost to Follow-up|3
6879432|NCT00524043|10891522|FG000|Overall Study|Various (eg, incarceration)|2
6879433|NCT00524043|10891523|FG001|Overall Study|Various (eg, incarceration)|1
6879434|NCT00524043|10891524|FG002|Overall Study|Various (eg, incarceration)|0
6879435|NCT00524121|10891532|FG000|Overall Study|Disease progression|6
6879436|NCT00524121|10891532|FG000|Overall Study|Adverse Event|4
6879437|NCT00524121|10891532|FG000|Overall Study|Patient refused|2
6879438|NCT00524121|10891532|FG000|Overall Study|Other|1
6879439|NCT00524121|10891532|FG000|Overall Study|Death|1
6879440|NCT00524121|10891532|FG000|Overall Study|Not treated (became ineligible)|4
6879441|NCT00524121|10891532|FG000|Overall Study|Not treated (changed mind)|1
6879442|NCT00524173|10891549|FG000|Overall Study|Lost to Follow-up|0
6879443|NCT00524173|10891550|FG001|Overall Study|Lost to Follow-up|1
6879444|NCT00524173|10891549|FG000|Overall Study|Death|1
6879445|NCT00524173|10891550|FG001|Overall Study|Death|0
6879446|NCT00524173|10891549|FG000|Overall Study|Had not reached endpoint at study close|4
6879447|NCT00524173|10891550|FG001|Overall Study|Had not reached endpoint at study close|1
6879448|NCT00524303|10891573|FG000|Overall Study|Lost to Follow-up|6
6879449|NCT00524303|10891574|FG001|Overall Study|Lost to Follow-up|0
6879450|NCT00524303|10891575|FG002|Overall Study|Lost to Follow-up|3
6879451|NCT00524303|10891573|FG000|Overall Study|Protocol Violation|0
6879452|NCT00524303|10891574|FG001|Overall Study|Protocol Violation|1
6879453|NCT00524303|10891575|FG002|Overall Study|Protocol Violation|1
6879454|NCT00524303|10891573|FG000|Overall Study|Withdrawal by Subject|3
6879455|NCT00524303|10891574|FG001|Overall Study|Withdrawal by Subject|0
7078846|NCT02106351|11187393|FG000|Treatment Cycle 3|Other|0
7154619|NCT03318783|11321699|FG000|Overall Study|Withdrawal by Subject|0
7154620|NCT03318783|11321700|FG001|Overall Study|Withdrawal by Subject|1
7154621|NCT03318783|11321699|FG000|Overall Study|Death|0
7154622|NCT03318783|11321700|FG001|Overall Study|Death|1
6879456|NCT00524303|10891575|FG002|Overall Study|Withdrawal by Subject|4
6879457|NCT00524303|10891573|FG000|Overall Study|Death|0
6879458|NCT00524303|10891574|FG001|Overall Study|Death|2
6879459|NCT00524303|10891575|FG002|Overall Study|Death|3
6879460|NCT00524303|10891573|FG000|Overall Study|Adverse Event|1
6879461|NCT00524303|10891574|FG001|Overall Study|Adverse Event|2
6879462|NCT00524303|10891575|FG002|Overall Study|Adverse Event|3
6879463|NCT00524303|10891573|FG000|Overall Study|Did not Complete Study Dosing|1
6879464|NCT00524303|10891574|FG001|Overall Study|Did not Complete Study Dosing|0
7154623|NCT03319212|11321734|FG000|Overall Study|Discontinued as moving out of local area|0
6879465|NCT00524303|10891575|FG002|Overall Study|Did not Complete Study Dosing|0
6879466|NCT00524303|10891573|FG000|Overall Study|Worsening Peripheral Neuropathy|1
6879467|NCT00524303|10891574|FG001|Overall Study|Worsening Peripheral Neuropathy|0
6879468|NCT00524303|10891575|FG002|Overall Study|Worsening Peripheral Neuropathy|0
6879469|NCT00524303|10891573|FG000|Overall Study|Disease Progression|0
6879470|NCT00524303|10891574|FG001|Overall Study|Disease Progression|4
6879471|NCT00524303|10891575|FG002|Overall Study|Disease Progression|1
6879472|NCT00524303|10891573|FG000|Overall Study|Disease Recurrence|0
6879473|NCT00524303|10891574|FG001|Overall Study|Disease Recurrence|1
6879474|NCT00524303|10891575|FG002|Overall Study|Disease Recurrence|0
6879475|NCT00524303|10891573|FG000|Overall Study|Sponsor Request|0
6879476|NCT00524303|10891574|FG001|Overall Study|Sponsor Request|0
6879477|NCT00524303|10891575|FG002|Overall Study|Sponsor Request|1
6879478|NCT00524303|10891573|FG000|Overall Study|Physician Decision|0
6879479|NCT00524303|10891574|FG001|Overall Study|Physician Decision|0
6879480|NCT00524303|10891575|FG002|Overall Study|Physician Decision|1
6879481|NCT00524303|10891573|FG000|Overall Study|Completed 5 years|0
6879482|NCT00524303|10891574|FG001|Overall Study|Completed 5 years|0
6879483|NCT00524303|10891575|FG002|Overall Study|Completed 5 years|1
6879484|NCT00524316|10891586|FG000|Overall Study|Withdrawal by Subject|2
6879485|NCT00524316|10891586|FG000|Overall Study|Adverse Event|7
6879486|NCT00524316|10891586|FG000|Overall Study|Disease Progression|7
6879487|NCT00524368|10891596|FG000|Overall Study|Adverse Event|10
6879488|NCT00524368|10891597|FG001|Overall Study|Adverse Event|12
6879489|NCT00524368|10891596|FG000|Overall Study|Lost to Follow-up|9
6879490|NCT00524368|10891597|FG001|Overall Study|Lost to Follow-up|13
6879491|NCT00524368|10891596|FG000|Overall Study|Withdrawal by Subject|4
6879492|NCT00524368|10891597|FG001|Overall Study|Withdrawal by Subject|5
6879493|NCT00524368|10891596|FG000|Overall Study|Non-compliant|8
6879494|NCT00524368|10891597|FG001|Overall Study|Non-compliant|9
6879495|NCT00524368|10891596|FG000|Overall Study|Reached a Virologic Endpoint|3
7041218|NCT01725282|11124764|FG003|Overall Study|Study Site Withdrawal|0
7154624|NCT03319212|11321735|FG001|Overall Study|Discontinued as moving out of local area|1
7154625|NCT03319212|11321734|FG000|Overall Study|Adverse Event|2
7154626|NCT03319212|11321735|FG001|Overall Study|Adverse Event|2
7154627|NCT03319212|11321734|FG000|Overall Study|Withdrawal by Subject|0
7154628|NCT03319212|11321735|FG001|Overall Study|Withdrawal by Subject|1
7154629|NCT03319212|11321734|FG000|Overall Study|Lost to Follow-up|0
7154630|NCT03319212|11321735|FG001|Overall Study|Lost to Follow-up|1
7154631|NCT03319212|11321734|FG000|Overall Study|Physician Decision|1
7154632|NCT03319212|11321735|FG001|Overall Study|Physician Decision|0
7154633|NCT03319719|11321749|FG000|Overall Study|Lost to Follow-up|1
7154634|NCT03319953|11321763|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1
7154635|NCT03319953|11321764|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0
7154636|NCT03319953|11321765|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0
7154637|NCT03319953|11321766|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0
7154638|NCT03319953|11321763|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0
7154639|NCT03319953|11321764|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0
7154640|NCT03319953|11321765|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1
7154641|NCT03319953|11321766|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1
7154642|NCT03320057|11321774|FG000|Overall Study|Lost to Follow-up|4
7154643|NCT03320057|11321775|FG001|Overall Study|Lost to Follow-up|17
7154644|NCT03320057|11321774|FG000|Overall Study|Did not take mifepristone or misoprostol|2
7154645|NCT03320057|11321775|FG001|Overall Study|Did not take mifepristone or misoprostol|0
7154646|NCT03320369|11321785|FG000|Overall Study|Adverse Event|1
7154647|NCT03320369|11321785|FG000|Overall Study|Withdrawal by Subject|2
7154648|NCT03320824|11321791|FG000|Overall Study|Withdrawal by Subject|8
7154649|NCT03320824|11321792|FG001|Overall Study|Withdrawal by Subject|1
7154650|NCT03320824|11321791|FG000|Overall Study|Lost to Follow-up|10
7154651|NCT03320824|11321792|FG001|Overall Study|Lost to Follow-up|1
7154652|NCT03320824|11321791|FG000|Overall Study|moved out of state|0
7154653|NCT03320824|11321792|FG001|Overall Study|moved out of state|1
7154654|NCT03320824|11321791|FG000|Overall Study|could not complete final visit|0
7154655|NCT03320824|11321792|FG001|Overall Study|could not complete final visit|1
7154656|NCT03320850|11321808|FG000|Overall Study|Lost to Follow-up|0
7154657|NCT03320850|11321809|FG001|Overall Study|Lost to Follow-up|0
7154658|NCT03320850|11321810|FG002|Overall Study|Lost to Follow-up|0
7154659|NCT03320850|11321811|FG003|Overall Study|Lost to Follow-up|0
7154660|NCT03320850|11321812|FG004|Overall Study|Lost to Follow-up|1
7154661|NCT03320850|11321813|FG005|Overall Study|Lost to Follow-up|2
7154662|NCT03320850|11321814|FG006|Overall Study|Lost to Follow-up|2
7154663|NCT03320850|11321815|FG007|Overall Study|Lost to Follow-up|0
7154664|NCT03320850|11321816|FG008|Overall Study|Lost to Follow-up|6
7154665|NCT03320850|11321817|FG009|Overall Study|Lost to Follow-up|4
7154666|NCT03320850|11321808|FG000|Overall Study|Withdrawal by Subject|0
7154667|NCT03320850|11321809|FG001|Overall Study|Withdrawal by Subject|0
7154668|NCT03320850|11321810|FG002|Overall Study|Withdrawal by Subject|0
6879496|NCT00524368|10891597|FG001|Overall Study|Reached a Virologic Endpoint|2
6879497|NCT00524368|10891596|FG000|Overall Study|Sponsor's Decision|2
6879498|NCT00524368|10891597|FG001|Overall Study|Sponsor's Decision|0
6879499|NCT00524368|10891596|FG000|Overall Study|Ineligible to Continue the study|2
6879500|NCT00524368|10891597|FG001|Overall Study|Ineligible to Continue the study|5
6879501|NCT00524368|10891596|FG000|Overall Study|Other|3
6879502|NCT00524368|10891597|FG001|Overall Study|Other|2
6879503|NCT00524420|10891605|FG000|Overall Study|Lack of Efficacy|1
6879504|NCT00524420|10891606|FG001|Overall Study|Lack of Efficacy|0
6879505|NCT00524589|10891636|FG000|Overall Study|Withdrawal by Subject|2
6879506|NCT00524589|10891636|FG000|Overall Study|Disease Progression|16
7154669|NCT03320850|11321811|FG003|Overall Study|Withdrawal by Subject|0
7154670|NCT03320850|11321812|FG004|Overall Study|Withdrawal by Subject|1
7154671|NCT03320850|11321813|FG005|Overall Study|Withdrawal by Subject|2
6879507|NCT00524680|10891644|FG000|Overall Study|progression|0
6879508|NCT00524680|10891645|FG001|Overall Study|progression|0
6879509|NCT00524680|10891646|FG002|Overall Study|progression|0
6879510|NCT00524680|10891647|FG003|Overall Study|progression|1
6879511|NCT00524680|10891644|FG000|Overall Study|Adverse Event|2
6879512|NCT00524680|10891645|FG001|Overall Study|Adverse Event|0
6879513|NCT00524680|10891646|FG002|Overall Study|Adverse Event|0
6879514|NCT00524680|10891647|FG003|Overall Study|Adverse Event|1
6879515|NCT00524680|10891644|FG000|Overall Study|Other|0
6879516|NCT00524680|10891645|FG001|Overall Study|Other|1
6879517|NCT00524680|10891646|FG002|Overall Study|Other|2
6879518|NCT00524680|10891647|FG003|Overall Study|Other|3
6879519|NCT00524680|10891644|FG000|Overall Study|Withdrawal by Subject|1
6879520|NCT00524680|10891645|FG001|Overall Study|Withdrawal by Subject|0
6879521|NCT00524680|10891646|FG002|Overall Study|Withdrawal by Subject|1
6879522|NCT00524680|10891647|FG003|Overall Study|Withdrawal by Subject|1
6879523|NCT00524745|10891661|FG000|Overall Study|subject withdrawal or lost to follow up|34
6879524|NCT00524745|10891662|FG001|Overall Study|subject withdrawal or lost to follow up|13
6879525|NCT00524745|10891663|FG002|Overall Study|subject withdrawal or lost to follow up|29
6879526|NCT00524745|10891664|FG003|Overall Study|subject withdrawal or lost to follow up|22
6879527|NCT00524771|10891676|FG000|Overall Study|Protocol Violation|220
6879528|NCT00524771|10891677|FG001|Overall Study|Protocol Violation|585
6879529|NCT00525031|10891690|FG000|Overall Study|Disease Progression|1
6879530|NCT00525031|10891691|FG001|Overall Study|Disease Progression|1
6879531|NCT00525044|10891700|FG000|Overall Study|Lost to Follow-up|0
6879532|NCT00525044|10891701|FG001|Overall Study|Lost to Follow-up|1
6969336|NCT01147458|11018966|FG002|First Intervention|Protocol Violation|2
6969337|NCT01147458|11018967|FG003|First Intervention|Protocol Violation|3
6969338|NCT01147458|11018964|FG000|First Intervention|Withdrawal by Subject|3
6969339|NCT01147458|11018965|FG001|First Intervention|Withdrawal by Subject|0
6969340|NCT01147458|11018966|FG002|First Intervention|Withdrawal by Subject|1
6969341|NCT01147458|11018967|FG003|First Intervention|Withdrawal by Subject|0
6969342|NCT01147458|11018964|FG000|First Intervention|Adverse Event|0
6969343|NCT01147458|11018965|FG001|First Intervention|Adverse Event|3
6969344|NCT01147458|11018966|FG002|First Intervention|Adverse Event|2
6969345|NCT01147458|11018967|FG003|First Intervention|Adverse Event|3
6969346|NCT01147458|11018964|FG000|First Intervention|Other|1
6969347|NCT01147458|11018965|FG001|First Intervention|Other|2
6969348|NCT01147458|11018966|FG002|First Intervention|Other|0
6969349|NCT01147458|11018967|FG003|First Intervention|Other|0
6969350|NCT01147458|11018964|FG000|Second Intervention|Study terminated by sponsor|7
6969351|NCT01147458|11018965|FG001|Second Intervention|Study terminated by sponsor|5
6969352|NCT01147458|11018966|FG002|Second Intervention|Study terminated by sponsor|5
6969353|NCT01147458|11018967|FG003|Second Intervention|Study terminated by sponsor|3
6969354|NCT01147458|11018964|FG000|Second Intervention|Protocol Violation|0
6969355|NCT01147458|11018965|FG001|Second Intervention|Protocol Violation|1
6969356|NCT01147458|11018966|FG002|Second Intervention|Protocol Violation|1
6969357|NCT01147458|11018967|FG003|Second Intervention|Protocol Violation|0
6969358|NCT01147458|11018964|FG000|Second Intervention|Withdrawal by Subject|0
6969359|NCT01147458|11018965|FG001|Second Intervention|Withdrawal by Subject|1
6969360|NCT01147458|11018966|FG002|Second Intervention|Withdrawal by Subject|0
6969361|NCT01147458|11018967|FG003|Second Intervention|Withdrawal by Subject|0
6969362|NCT01147458|11018964|FG000|Second Intervention|Adverse Event|2
6969363|NCT01147458|11018965|FG001|Second Intervention|Adverse Event|0
6969364|NCT01147458|11018966|FG002|Second Intervention|Adverse Event|1
6969365|NCT01147458|11018967|FG003|Second Intervention|Adverse Event|1
6969366|NCT01147458|11018964|FG000|Second Intervention|Other|0
6969367|NCT01147458|11018965|FG001|Second Intervention|Other|0
6969368|NCT01147458|11018966|FG002|Second Intervention|Other|1
6969369|NCT01147458|11018967|FG003|Second Intervention|Other|0
6969370|NCT01147471|11018981|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0
6969371|NCT01147471|11018982|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1
6969372|NCT01147471|11018981|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0
6969373|NCT01147471|11018982|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1
6969374|NCT01147471|11018981|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0
6969375|NCT01147471|11018982|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1
6969376|NCT01147471|11018981|FG000|3 Month Follow Up|Lost to Follow-up|1
6969377|NCT01147471|11018982|FG001|3 Month Follow Up|Lost to Follow-up|1
6969378|NCT01147471|11018981|FG000|3 Month Follow Up|Physician Decision|0
6969379|NCT01147471|11018982|FG001|3 Month Follow Up|Physician Decision|1
6969380|NCT01147471|11018981|FG000|6 Month Follow Up|Lost to Follow-up|4
6969381|NCT01147471|11018982|FG001|6 Month Follow Up|Lost to Follow-up|2
6969382|NCT01147497|11018990|FG000|Overall Study|failed insertion|2
6969383|NCT01147497|11018991|FG001|Overall Study|failed insertion|0
6969384|NCT01147640|11019021|FG000|Overall Study|Adverse Event|2
6969385|NCT01147640|11019022|FG001|Overall Study|Adverse Event|0
6969386|NCT01147640|11019021|FG000|Overall Study|Physician Decision|1
6969387|NCT01147640|11019022|FG001|Overall Study|Physician Decision|0
6969388|NCT01147640|11019021|FG000|Overall Study|Withdrawal by Subject|1
6969389|NCT01147640|11019022|FG001|Overall Study|Withdrawal by Subject|0
6969390|NCT01147640|11019021|FG000|Overall Study|Lost to Follow-up|0
6969391|NCT01147640|11019022|FG001|Overall Study|Lost to Follow-up|1
6969392|NCT01147640|11019021|FG000|Overall Study|Didn't meet eligibility criteria|1
6879533|NCT00525148|10891724|FG000|Overall Study|Other Adverse Event|3
6879534|NCT00525148|10891725|FG001|Overall Study|Other Adverse Event|5
6879535|NCT00525148|10891726|FG002|Overall Study|Other Adverse Event|1
6879536|NCT00525148|10891727|FG003|Overall Study|Other Adverse Event|8
6879537|NCT00525148|10891724|FG000|Overall Study|Progressive disease|18
6879538|NCT00525148|10891725|FG001|Overall Study|Progressive disease|30
6879539|NCT00525148|10891726|FG002|Overall Study|Progressive disease|6
6879540|NCT00525148|10891727|FG003|Overall Study|Progressive disease|49
6879541|NCT00525148|10891724|FG000|Overall Study|Refused continuation of study medication|0
6879542|NCT00525148|10891725|FG001|Overall Study|Refused continuation of study medication|2
6879543|NCT00525148|10891726|FG002|Overall Study|Refused continuation of study medication|0
6879544|NCT00525148|10891727|FG003|Overall Study|Refused continuation of study medication|1
6879545|NCT00525148|10891724|FG000|Overall Study|Other than stated|2
6879546|NCT00525148|10891725|FG001|Overall Study|Other than stated|1
6879547|NCT00525148|10891726|FG002|Overall Study|Other than stated|0
6879548|NCT00525148|10891727|FG003|Overall Study|Other than stated|3
6879549|NCT00525161|10891737|FG000|Overall Study|Adverse Event|1
6879550|NCT00525265|10891752|FG000|Overall Study|Protocol Violation|1
6879551|NCT00525265|10891753|FG001|Overall Study|Protocol Violation|0
6879552|NCT00525499|10891772|FG000|Overall Study|Lost to Follow-up|2
6879553|NCT00525499|10891773|FG001|Overall Study|Lost to Follow-up|4
6879554|NCT00525499|10891774|FG002|Overall Study|Lost to Follow-up|1
6879555|NCT00525499|10891775|FG003|Overall Study|Lost to Follow-up|4
6879556|NCT00525499|10891772|FG000|Overall Study|Adverse Event|0
6879557|NCT00525499|10891773|FG001|Overall Study|Adverse Event|1
6879558|NCT00525499|10891774|FG002|Overall Study|Adverse Event|0
6879559|NCT00525499|10891775|FG003|Overall Study|Adverse Event|1
6879560|NCT00525499|10891772|FG000|Overall Study|Withdrawal by Subject|5
6879561|NCT00525499|10891773|FG001|Overall Study|Withdrawal by Subject|1
6879562|NCT00525499|10891774|FG002|Overall Study|Withdrawal by Subject|5
6879563|NCT00525499|10891775|FG003|Overall Study|Withdrawal by Subject|2
6879564|NCT00525499|10891772|FG000|Overall Study|Protocol Violation|0
6879565|NCT00525499|10891773|FG001|Overall Study|Protocol Violation|1
6879566|NCT00525499|10891774|FG002|Overall Study|Protocol Violation|1
6879567|NCT00525499|10891775|FG003|Overall Study|Protocol Violation|0
6879568|NCT00525512|10891787|FG000|Double-Blind Phase|Adverse Event|48
6879569|NCT00525512|10891788|FG001|Double-Blind Phase|Adverse Event|28
6879570|NCT00525512|10891789|FG002|Double-Blind Phase|Adverse Event|0
6879571|NCT00525512|10891790|FG003|Double-Blind Phase|Adverse Event|0
6879572|NCT00525512|10891787|FG000|Double-Blind Phase|Protocol Violation|3
6879573|NCT00525512|10891788|FG001|Double-Blind Phase|Protocol Violation|1
6879574|NCT00525512|10891789|FG002|Double-Blind Phase|Protocol Violation|0
6879575|NCT00525512|10891790|FG003|Double-Blind Phase|Protocol Violation|0
6879576|NCT00525512|10891787|FG000|Double-Blind Phase|Lost to Follow-up|3
6879577|NCT00525512|10891788|FG001|Double-Blind Phase|Lost to Follow-up|7
6879578|NCT00525512|10891789|FG002|Double-Blind Phase|Lost to Follow-up|0
6879579|NCT00525512|10891790|FG003|Double-Blind Phase|Lost to Follow-up|0
6879580|NCT00525512|10891787|FG000|Double-Blind Phase|Withdrawal by Subject|17
6879581|NCT00525512|10891788|FG001|Double-Blind Phase|Withdrawal by Subject|12
6879582|NCT00525512|10891789|FG002|Double-Blind Phase|Withdrawal by Subject|0
6879583|NCT00525512|10891790|FG003|Double-Blind Phase|Withdrawal by Subject|0
6879584|NCT00525512|10891787|FG000|Double-Blind Phase|Lack of Efficacy|13
6879585|NCT00525512|10891788|FG001|Double-Blind Phase|Lack of Efficacy|5
6879586|NCT00525512|10891789|FG002|Double-Blind Phase|Lack of Efficacy|0
6879587|NCT00525512|10891790|FG003|Double-Blind Phase|Lack of Efficacy|0
6879588|NCT00525512|10891787|FG000|Double-Blind Phase|Other reason (not specified)|12
6879589|NCT00525512|10891788|FG001|Double-Blind Phase|Other reason (not specified)|13
6879590|NCT00525512|10891789|FG002|Double-Blind Phase|Other reason (not specified)|0
6879591|NCT00525512|10891790|FG003|Double-Blind Phase|Other reason (not specified)|0
6879592|NCT00525512|10891787|FG000|Open-Label Phase|Adverse Event|0
6879593|NCT00525512|10891788|FG001|Open-Label Phase|Adverse Event|0
6879594|NCT00525512|10891789|FG002|Open-Label Phase|Adverse Event|1
6879595|NCT00525512|10891790|FG003|Open-Label Phase|Adverse Event|0
6879596|NCT00525512|10891787|FG000|Open-Label Phase|Lost to Follow-up|0
6879597|NCT00525512|10891788|FG001|Open-Label Phase|Lost to Follow-up|0
6879598|NCT00525512|10891789|FG002|Open-Label Phase|Lost to Follow-up|1
6879599|NCT00525512|10891790|FG003|Open-Label Phase|Lost to Follow-up|0
6879600|NCT00525512|10891787|FG000|Open-Label Phase|Other reason (not specified)|0
6879601|NCT00525512|10891788|FG001|Open-Label Phase|Other reason (not specified)|0
6879602|NCT00525512|10891789|FG002|Open-Label Phase|Other reason (not specified)|4
6879603|NCT00525512|10891790|FG003|Open-Label Phase|Other reason (not specified)|5
6879604|NCT00525590|10891811|FG000|Overall Study|Adverse Event|3
6879605|NCT00525590|10891811|FG000|Overall Study|Physician Decision|3
6879606|NCT00525590|10891811|FG000|Overall Study|Withdrawal by Subject|16
6879607|NCT00525590|10891811|FG000|Overall Study|Lost to Follow-up|1
6879608|NCT00525590|10891811|FG000|Overall Study|Death|9
6879609|NCT00525590|10891811|FG000|Overall Study|Other|13
6879610|NCT00525785|10891835|FG000|Overall Study|Withdrawal by Subject|1
6879611|NCT00525785|10891835|FG000|Overall Study|Lack of Efficacy|1
6879612|NCT00525785|10891835|FG000|Overall Study|Physician Decision|1
6879613|NCT00525824|10891852|FG000|Overall Study|Adverse Event|7
6879614|NCT00525824|10891853|FG001|Overall Study|Adverse Event|11
6879615|NCT00525824|10891854|FG002|Overall Study|Adverse Event|6
6879616|NCT00525824|10891855|FG003|Overall Study|Adverse Event|7
6879617|NCT00525824|10891852|FG000|Overall Study|Withdrawal by Subject|5
6879618|NCT00525824|10891853|FG001|Overall Study|Withdrawal by Subject|9
6879619|NCT00525824|10891854|FG002|Overall Study|Withdrawal by Subject|3
6879620|NCT00525824|10891855|FG003|Overall Study|Withdrawal by Subject|4
6879621|NCT00525824|10891852|FG000|Overall Study|Lost to Follow-up|4
6879622|NCT00525824|10891853|FG001|Overall Study|Lost to Follow-up|2
6879623|NCT00525824|10891854|FG002|Overall Study|Lost to Follow-up|4
6879624|NCT00525824|10891855|FG003|Overall Study|Lost to Follow-up|0
6879625|NCT00525824|10891852|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1
6879626|NCT00525824|10891853|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2
6879627|NCT00525824|10891854|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1
6879628|NCT00525824|10891855|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2
6879629|NCT00525824|10891852|FG000|Overall Study|Severe non-compliance|0
6879630|NCT00525824|10891853|FG001|Overall Study|Severe non-compliance|1
6879631|NCT00525824|10891854|FG002|Overall Study|Severe non-compliance|1
6879632|NCT00525824|10891855|FG003|Overall Study|Severe non-compliance|1
6969393|NCT01147640|11019022|FG001|Overall Study|Didn't meet eligibility criteria|0
6969394|NCT01147744|11019035|FG000|Overall Study|Protocol Violation|1
6879633|NCT00525824|10891852|FG000|Overall Study|Safety reasons|1
6879634|NCT00525824|10891853|FG001|Overall Study|Safety reasons|0
6879635|NCT00525824|10891854|FG002|Overall Study|Safety reasons|1
6879636|NCT00525824|10891855|FG003|Overall Study|Safety reasons|0
6879637|NCT00525824|10891852|FG000|Overall Study|Other|1
6969395|NCT01147744|11019036|FG001|Overall Study|Protocol Violation|0
6969396|NCT01147744|11019037|FG002|Overall Study|Protocol Violation|1
6969397|NCT01147744|11019038|FG003|Overall Study|Protocol Violation|0
6969398|NCT01147744|11019039|FG004|Overall Study|Protocol Violation|1
6969399|NCT01147744|11019040|FG005|Overall Study|Protocol Violation|3
6969400|NCT01147744|11019041|FG006|Overall Study|Protocol Violation|1
6969401|NCT01147744|11019035|FG000|Overall Study|Physician Decision|0
6969402|NCT01147744|11019036|FG001|Overall Study|Physician Decision|1
6969403|NCT01147744|11019037|FG002|Overall Study|Physician Decision|1
6969404|NCT01147744|11019038|FG003|Overall Study|Physician Decision|0
6969405|NCT01147744|11019039|FG004|Overall Study|Physician Decision|0
6969406|NCT01147744|11019040|FG005|Overall Study|Physician Decision|0
6969407|NCT01147744|11019041|FG006|Overall Study|Physician Decision|1
6969408|NCT01147744|11019035|FG000|Overall Study|Lack of Efficacy|11
6969409|NCT01147744|11019036|FG001|Overall Study|Lack of Efficacy|11
6969410|NCT01147744|11019037|FG002|Overall Study|Lack of Efficacy|9
6969411|NCT01147744|11019038|FG003|Overall Study|Lack of Efficacy|11
6969412|NCT01147744|11019039|FG004|Overall Study|Lack of Efficacy|13
6969413|NCT01147744|11019040|FG005|Overall Study|Lack of Efficacy|8
6969414|NCT01147744|11019041|FG006|Overall Study|Lack of Efficacy|7
6969415|NCT01147744|11019035|FG000|Overall Study|Adverse Event|1
6969416|NCT01147744|11019036|FG001|Overall Study|Adverse Event|2
6969417|NCT01147744|11019037|FG002|Overall Study|Adverse Event|3
6969418|NCT01147744|11019038|FG003|Overall Study|Adverse Event|0
7154672|NCT03320850|11321814|FG006|Overall Study|Withdrawal by Subject|4
7154673|NCT03320850|11321815|FG007|Overall Study|Withdrawal by Subject|5
7154674|NCT03320850|11321816|FG008|Overall Study|Withdrawal by Subject|2
7154675|NCT03320850|11321817|FG009|Overall Study|Withdrawal by Subject|1
7154676|NCT03320850|11321808|FG000|Overall Study|Lack of Efficacy|0
7154677|NCT03320850|11321809|FG001|Overall Study|Lack of Efficacy|0
7154678|NCT03320850|11321810|FG002|Overall Study|Lack of Efficacy|0
7154679|NCT03320850|11321811|FG003|Overall Study|Lack of Efficacy|1
7154680|NCT03320850|11321812|FG004|Overall Study|Lack of Efficacy|0
7154681|NCT03320850|11321813|FG005|Overall Study|Lack of Efficacy|1
7154682|NCT03320850|11321814|FG006|Overall Study|Lack of Efficacy|0
7154683|NCT03320850|11321815|FG007|Overall Study|Lack of Efficacy|2
7154684|NCT03320850|11321816|FG008|Overall Study|Lack of Efficacy|0
7154685|NCT03320850|11321817|FG009|Overall Study|Lack of Efficacy|3
7154686|NCT03320850|11321808|FG000|Overall Study|Failure to Meet Randomization Criteria|0
7154687|NCT03320850|11321809|FG001|Overall Study|Failure to Meet Randomization Criteria|0
7154688|NCT03320850|11321810|FG002|Overall Study|Failure to Meet Randomization Criteria|0
7154689|NCT03320850|11321811|FG003|Overall Study|Failure to Meet Randomization Criteria|0
7154690|NCT03320850|11321812|FG004|Overall Study|Failure to Meet Randomization Criteria|0
7154691|NCT03320850|11321813|FG005|Overall Study|Failure to Meet Randomization Criteria|1
7154692|NCT03320850|11321814|FG006|Overall Study|Failure to Meet Randomization Criteria|0
7154693|NCT03320850|11321815|FG007|Overall Study|Failure to Meet Randomization Criteria|0
7154694|NCT03320850|11321816|FG008|Overall Study|Failure to Meet Randomization Criteria|0
6969419|NCT01147744|11019039|FG004|Overall Study|Adverse Event|2
7154695|NCT03320850|11321817|FG009|Overall Study|Failure to Meet Randomization Criteria|0
7154696|NCT03320850|11321808|FG000|Overall Study|Adverse Event|0
7154697|NCT03320850|11321809|FG001|Overall Study|Adverse Event|0
6879638|NCT00525824|10891853|FG001|Overall Study|Other|3
6879639|NCT00525824|10891854|FG002|Overall Study|Other|3
6879640|NCT00525824|10891855|FG003|Overall Study|Other|1
6879641|NCT00525902|10891883|FG000|Overall Study|Lack of Efficacy|1
6879642|NCT00525915|10891889|FG000|Overall Study|Non-Compliance|0
6969420|NCT01147744|11019040|FG005|Overall Study|Adverse Event|1
6879643|NCT00525915|10891890|FG001|Overall Study|Non-Compliance|1
6879644|NCT00525915|10891889|FG000|Overall Study|Disease Progression|5
6969421|NCT01147744|11019041|FG006|Overall Study|Adverse Event|2
6969422|NCT01147744|11019035|FG000|Overall Study|Withdrawal by Subject|8
6879645|NCT00525915|10891890|FG001|Overall Study|Disease Progression|6
6879646|NCT00525915|10891889|FG000|Overall Study|Withdrawal by Subject|1
6879647|NCT00525915|10891890|FG001|Overall Study|Withdrawal by Subject|0
6879648|NCT00525915|10891889|FG000|Overall Study|Refused Surgery|1
6879649|NCT00525915|10891890|FG001|Overall Study|Refused Surgery|2
6879650|NCT00525915|10891889|FG000|Overall Study|Unrelated illness|1
6879651|NCT00525915|10891890|FG001|Overall Study|Unrelated illness|0
6879652|NCT00526071|10891905|FG000|Overall Study|Adverse Event|1
6879653|NCT00526071|10891905|FG000|Overall Study|Withdrawal by Subject|1
6879654|NCT00526071|10891905|FG000|Overall Study|Lack of Response to Study Drug|4
6879655|NCT00526097|10891915|FG000|Overall Study|Adverse Event|6
6879656|NCT00526097|10891916|FG001|Overall Study|Adverse Event|44
6879657|NCT00526097|10891915|FG000|Overall Study|Protocol Violation|4
6879658|NCT00526097|10891916|FG001|Overall Study|Protocol Violation|10
6879659|NCT00526097|10891915|FG000|Overall Study|Withdrawal by Subject|3
6879660|NCT00526097|10891916|FG001|Overall Study|Withdrawal by Subject|1
6879661|NCT00526097|10891915|FG000|Overall Study|Other|2
6879662|NCT00526097|10891916|FG001|Overall Study|Other|1
6879663|NCT00526110|10891924|FG000|Overall Study|Adverse Event|2
6879664|NCT00526110|10891925|FG001|Overall Study|Adverse Event|9
6879665|NCT00526110|10891924|FG000|Overall Study|Disease Progression|0
6879666|NCT00526110|10891925|FG001|Overall Study|Disease Progression|19
6879667|NCT00526110|10891924|FG000|Overall Study|Maximal Response|0
6879668|NCT00526110|10891925|FG001|Overall Study|Maximal Response|6
6969423|NCT01147744|11019036|FG001|Overall Study|Withdrawal by Subject|4
7078847|NCT02106351|11187394|FG001|Treatment Cycle 3|Other|2
7078848|NCT02106351|11187395|FG002|Treatment Cycle 3|Other|3
7078849|NCT02106351|11187393|FG000|Treatment Cycle 4|Consent withdrawn|0
7078850|NCT02106351|11187394|FG001|Treatment Cycle 4|Consent withdrawn|0
7078851|NCT02106351|11187395|FG002|Treatment Cycle 4|Consent withdrawn|2
7154698|NCT03320850|11321810|FG002|Overall Study|Adverse Event|0
7154699|NCT03320850|11321811|FG003|Overall Study|Adverse Event|0
7154700|NCT03320850|11321812|FG004|Overall Study|Adverse Event|0
7154701|NCT03320850|11321813|FG005|Overall Study|Adverse Event|2
7154702|NCT03320850|11321814|FG006|Overall Study|Adverse Event|1
7154703|NCT03320850|11321815|FG007|Overall Study|Adverse Event|0
7154704|NCT03320850|11321816|FG008|Overall Study|Adverse Event|2
7154705|NCT03320850|11321817|FG009|Overall Study|Adverse Event|0
7154706|NCT03320850|11321808|FG000|Overall Study|Reason Not Specified|0
7154707|NCT03320850|11321809|FG001|Overall Study|Reason Not Specified|0
7078852|NCT02106351|11187393|FG000|Treatment Cycle 4|Other|0
7078853|NCT02106351|11187394|FG001|Treatment Cycle 4|Other|1
7078854|NCT02106351|11187395|FG002|Treatment Cycle 4|Other|0
7078855|NCT02106390|11187412|FG000|Overall Study|Withdrawal by Subject|15
7078856|NCT02106390|11187413|FG001|Overall Study|Withdrawal by Subject|16
7078857|NCT02106390|11187414|FG002|Overall Study|Withdrawal by Subject|15
7154708|NCT03320850|11321810|FG002|Overall Study|Reason Not Specified|0
7154709|NCT03320850|11321811|FG003|Overall Study|Reason Not Specified|0
7154710|NCT03320850|11321812|FG004|Overall Study|Reason Not Specified|0
7154711|NCT03320850|11321813|FG005|Overall Study|Reason Not Specified|1
7154712|NCT03320850|11321814|FG006|Overall Study|Reason Not Specified|0
7154713|NCT03320850|11321815|FG007|Overall Study|Reason Not Specified|0
7154714|NCT03320850|11321816|FG008|Overall Study|Reason Not Specified|0
7154715|NCT03320850|11321817|FG009|Overall Study|Reason Not Specified|1
7154716|NCT03320941|11321849|FG000|Overall Study|subject/guardian decision|0
7154717|NCT03320941|11321850|FG001|Overall Study|subject/guardian decision|0
7154718|NCT03320941|11321851|FG002|Overall Study|subject/guardian decision|0
7154719|NCT03320941|11321852|FG003|Overall Study|subject/guardian decision|1
7154720|NCT03320941|11321853|FG004|Overall Study|subject/guardian decision|0
7154721|NCT03321006|11321867|FG000|Overall Study|Death|1
7154722|NCT03321006|11321868|FG001|Overall Study|Death|0
7154723|NCT03321006|11321867|FG000|Overall Study|Lack of Efficacy|1
7154724|NCT03321006|11321868|FG001|Overall Study|Lack of Efficacy|0
7154725|NCT03321396|11321887|FG000|Overall Study|Physician Decision|1
7154726|NCT03321721|11321894|FG000|Overall Study|Lost to Follow-up|4
7154727|NCT03321721|11321895|FG001|Overall Study|Lost to Follow-up|8
6879669|NCT00526110|10891924|FG000|Overall Study|Withdrawal by Subject|0
7154728|NCT03321721|11321896|FG002|Overall Study|Lost to Follow-up|11
7154729|NCT03322423|11321905|FG000|Period 1|Subject no longer eligible|0
7154730|NCT03322423|11321906|FG001|Period 1|Subject no longer eligible|1
7154731|NCT03322423|11321905|FG000|Period 1|Withdrawal by Subject|0
7154732|NCT03322423|11321906|FG001|Period 1|Withdrawal by Subject|1
7154733|NCT03322423|11321905|FG000|Period 1|Incorrect Lens Dispensed|1
7154734|NCT03322423|11321906|FG001|Period 1|Incorrect Lens Dispensed|0
7154735|NCT03322423|11321905|FG000|Period 1|Unsatisfactory Lens Fitting|1
7154736|NCT03322423|11321906|FG001|Period 1|Unsatisfactory Lens Fitting|0
7154737|NCT03322423|11321905|FG000|Period 2|Dispensed incorrect lens in left eye|0
7154738|NCT03322423|11321906|FG001|Period 2|Dispensed incorrect lens in left eye|1
6879670|NCT00526110|10891925|FG001|Overall Study|Withdrawal by Subject|2
6879671|NCT00526110|10891924|FG000|Overall Study|Poor Tolerance|0
6879672|NCT00526110|10891925|FG001|Overall Study|Poor Tolerance|5
6879673|NCT00526162|10891940|FG000|Overall Study|Device not implanted|3
6879674|NCT00526630|10891976|FG000|First Intervention Period - 12 Weeks|Withdrawn|0
7078858|NCT02106390|11187412|FG000|Overall Study|Lost to Follow-up|25
7078859|NCT02106390|11187413|FG001|Overall Study|Lost to Follow-up|20
6879675|NCT00526630|10891977|FG001|First Intervention Period - 12 Weeks|Withdrawn|3
6879676|NCT00526630|10891976|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2
6879677|NCT00526630|10891977|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1
6879678|NCT00526656|10891985|FG000|Overall Study|Death|1
6879679|NCT00526656|10891985|FG000|Overall Study|Refused surgery|1
6879680|NCT00526669|10891990|FG000|Combined Treatment Phase|Lost to Follow-up|0
6879681|NCT00526669|10891991|FG001|Combined Treatment Phase|Lost to Follow-up|2
6879682|NCT00526669|10891990|FG000|Combined Treatment Phase|Withdrawal by Subject|0
6879683|NCT00526669|10891991|FG001|Combined Treatment Phase|Withdrawal by Subject|2
6879684|NCT00526669|10891990|FG000|Combined Treatment Phase|Sponsor Terminated Study|0
6879685|NCT00526669|10891991|FG001|Combined Treatment Phase|Sponsor Terminated Study|2
6879686|NCT00526669|10891990|FG000|Combined Treatment Phase|Death|0
6879687|NCT00526669|10891991|FG001|Combined Treatment Phase|Death|2
6879688|NCT00526799|10891999|FG000|Overall Study|Withdrawal by Subject|1
6879689|NCT00526799|10892000|FG001|Overall Study|Withdrawal by Subject|0
6879690|NCT00526799|10891999|FG000|Overall Study|Intercurrent Complicating Disease|0
6879691|NCT00526799|10892000|FG001|Overall Study|Intercurrent Complicating Disease|1
6879692|NCT00526890|10892006|FG000|Overall Study|Adverse Event|2
6879693|NCT00526994|10892013|FG000|Overall Study|Lost to Follow-up|98
6879694|NCT00526994|10892014|FG001|Overall Study|Lost to Follow-up|108
6879695|NCT00526994|10892015|FG002|Overall Study|Lost to Follow-up|96
6879696|NCT00526994|10892013|FG000|Overall Study|Death|4
6879697|NCT00526994|10892014|FG001|Overall Study|Death|3
6879698|NCT00526994|10892015|FG002|Overall Study|Death|3
6879699|NCT00526994|10892013|FG000|Overall Study|Withdrawal by Subject|2
6879700|NCT00526994|10892014|FG001|Overall Study|Withdrawal by Subject|7
6879701|NCT00526994|10892015|FG002|Overall Study|Withdrawal by Subject|5
6879702|NCT00526994|10892013|FG000|Overall Study|incarcerated, impaired, incomplete|4
6879703|NCT00526994|10892014|FG001|Overall Study|incarcerated, impaired, incomplete|3
6879704|NCT00526994|10892015|FG002|Overall Study|incarcerated, impaired, incomplete|3
6879705|NCT00527072|10892023|FG000|Overall Study|Adverse Event|13
6879706|NCT00527072|10892023|FG000|Overall Study|Lack of Efficacy|11
6879707|NCT00527072|10892023|FG000|Overall Study|Lost to Follow-up|3
6879708|NCT00527072|10892023|FG000|Overall Study|Protocol Violation|2
6879709|NCT00527072|10892023|FG000|Overall Study|Withdrawal by Subject|7
6879710|NCT00527111|10892038|FG000|Overall Study|Adverse Event|14
6879711|NCT00527111|10892039|FG001|Overall Study|Adverse Event|13
6879712|NCT00527111|10892038|FG000|Overall Study|Death|0
6879713|NCT00527111|10892039|FG001|Overall Study|Death|1
6879714|NCT00527111|10892038|FG000|Overall Study|Investigator Request|2
6879715|NCT00527111|10892039|FG001|Overall Study|Investigator Request|1
6879716|NCT00527111|10892038|FG000|Overall Study|Patient Request|2
6879717|NCT00527111|10892039|FG001|Overall Study|Patient Request|5
6879718|NCT00527111|10892038|FG000|Overall Study|Other|2
6879719|NCT00527111|10892039|FG001|Overall Study|Other|2
6879720|NCT00527319|10892057|FG000|Overall Study|Withdrawal by Subject|5
6879721|NCT00527319|10892058|FG001|Overall Study|Withdrawal by Subject|0
6879722|NCT00527319|10892059|FG002|Overall Study|Withdrawal by Subject|1
6879723|NCT00527319|10892057|FG000|Overall Study|Lost to Follow-up|1
6879724|NCT00527319|10892058|FG001|Overall Study|Lost to Follow-up|0
6879725|NCT00527319|10892059|FG002|Overall Study|Lost to Follow-up|0
6879726|NCT00527319|10892057|FG000|Overall Study|Death|0
6879727|NCT00527319|10892058|FG001|Overall Study|Death|3
6879728|NCT00527319|10892059|FG002|Overall Study|Death|1
6879729|NCT00527319|10892057|FG000|Overall Study|Intercurrent Medical Illness|0
6879730|NCT00527319|10892058|FG001|Overall Study|Intercurrent Medical Illness|1
6879731|NCT00527319|10892059|FG002|Overall Study|Intercurrent Medical Illness|3
6879732|NCT00527319|10892057|FG000|Overall Study|Adverse Event|0
6879733|NCT00527319|10892058|FG001|Overall Study|Adverse Event|0
6879734|NCT00527319|10892059|FG002|Overall Study|Adverse Event|1
6879735|NCT00527332|10892069|FG000|Overall Study|Protocol Violation|4
6879736|NCT00527332|10892070|FG001|Overall Study|Protocol Violation|8
6879737|NCT00527332|10892069|FG000|Overall Study|Withdrew consent|5
6969424|NCT01147744|11019037|FG002|Overall Study|Withdrawal by Subject|2
6879738|NCT00527332|10892070|FG001|Overall Study|Withdrew consent|1
6879739|NCT00527397|10892076|FG000|Overall Study|Adverse Event|3
6879740|NCT00527397|10892076|FG000|Overall Study|Lack of Efficacy|1
6879741|NCT00527397|10892076|FG000|Overall Study|Protocol Violation|1
6879742|NCT00527397|10892076|FG000|Overall Study|Withdrawal by Subject|6
6879743|NCT00527397|10892076|FG000|Overall Study|Study terminated by sponsor|13
6879744|NCT00527423|10892083|FG000|Overall Study|Protocol Violation|1
6879745|NCT00527423|10892083|FG000|Overall Study|Adverse Event|5
6879746|NCT00527423|10892083|FG000|Overall Study|Physician Decision|4
6879747|NCT00527423|10892083|FG000|Overall Study|Withdrawal by Subject|10
6879748|NCT00527423|10892083|FG000|Overall Study|Lost to Follow-up|4
6879749|NCT00527423|10892083|FG000|Overall Study|OTHER|4
6879750|NCT00527423|10892083|FG000|Overall Study|Death|9
6879751|NCT00527488|10892102|FG000|Overall Study|Withdrawn prior to dosing|0
6879752|NCT00527488|10892103|FG001|Overall Study|Withdrawn prior to dosing|1
6879753|NCT00527488|10892104|FG002|Overall Study|Withdrawn prior to dosing|1
6879754|NCT00527488|10892105|FG003|Overall Study|Withdrawn prior to dosing|0
6879755|NCT00527514|10892115|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1
6879756|NCT00527514|10892115|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2
6879757|NCT00527514|10892115|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1
6879758|NCT00527514|10892115|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1
6879759|NCT00527514|10892115|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1
6879760|NCT00527514|10892115|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1
6879761|NCT00527514|10892115|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1
6879762|NCT00527605|10892140|FG000|Overall Study|Adverse Event|3
6879763|NCT00527605|10892141|FG001|Overall Study|Adverse Event|0
6879764|NCT00527605|10892140|FG000|Overall Study|Withdrawal by Subject|3
6879765|NCT00527605|10892141|FG001|Overall Study|Withdrawal by Subject|7
6879766|NCT00527605|10892140|FG000|Overall Study|Lost to Follow-up|6
6879767|NCT00527605|10892141|FG001|Overall Study|Lost to Follow-up|2
6879768|NCT00527605|10892140|FG000|Overall Study|Protocol Violation|1
6879769|NCT00527605|10892141|FG001|Overall Study|Protocol Violation|2
6879770|NCT00527618|10892147|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3
6879771|NCT00527618|10892148|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1
6879772|NCT00527618|10892147|FG000|Week 1-12 (First Intervention)|Adverse Event|0
6879773|NCT00527618|10892148|FG001|Week 1-12 (First Intervention)|Adverse Event|1
6879774|NCT00527618|10892147|FG000|Week 13-14 (Washout)|Lost to Follow-up|1
6879775|NCT00527618|10892148|FG001|Week 13-14 (Washout)|Lost to Follow-up|0
6879776|NCT00527618|10892147|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0
6879777|NCT00527618|10892148|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1
6879778|NCT00527618|10892147|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0
6879779|NCT00527618|10892148|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1
6879780|NCT00527618|10892147|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0
6879781|NCT00527618|10892148|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1
6879782|NCT00527735|10892171|FG000|Overall Study|Disease progression|47
6879783|NCT00527735|10892172|FG001|Overall Study|Disease progression|61
6879784|NCT00527735|10892173|FG002|Overall Study|Disease progression|53
7154739|NCT03322423|11321905|FG000|Period 2|Protocol Violation|1
7154740|NCT03322423|11321906|FG001|Period 2|Protocol Violation|0
7154741|NCT03322423|11321905|FG000|Period 2|Subject not eligible for Pytergiumectomy|0
7154742|NCT03322423|11321906|FG001|Period 2|Subject not eligible for Pytergiumectomy|1
7154743|NCT03322462|11321912|FG000|Overall Study|Technical difficulties|2
7154744|NCT03322462|11321912|FG000|Overall Study|Other|1
7154745|NCT03322514|11321920|FG000|Overall Study|Withdrawal by Subject|1
7154746|NCT03322514|11321921|FG001|Overall Study|Withdrawal by Subject|1
7154747|NCT03323086|11321947|FG000|Overall Study|Lost to Follow-up|3
7154748|NCT03323086|11321948|FG001|Overall Study|Lost to Follow-up|2
7154749|NCT03323164|11321956|FG000|Overall Study|Poor quality imaging/scans|2
7154750|NCT03323164|11321957|FG001|Overall Study|Poor quality imaging/scans|2
7154751|NCT03324581|11322002|FG000|Overall Study|Adverse Event|18
7154752|NCT03324581|11322003|FG001|Overall Study|Adverse Event|11
7154753|NCT03324581|11322004|FG002|Overall Study|Adverse Event|7
7154754|NCT03324581|11322002|FG000|Overall Study|Lack of Efficacy|0
7154755|NCT03324581|11322003|FG001|Overall Study|Lack of Efficacy|1
7154756|NCT03324581|11322004|FG002|Overall Study|Lack of Efficacy|0
7154757|NCT03324581|11322002|FG000|Overall Study|Lost to Follow-up|5
7154758|NCT03324581|11322003|FG001|Overall Study|Lost to Follow-up|3
7154759|NCT03324581|11322004|FG002|Overall Study|Lost to Follow-up|6
7154760|NCT03324581|11322002|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2
7154761|NCT03324581|11322003|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2
7154762|NCT03324581|11322004|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0
7154763|NCT03324581|11322002|FG000|Overall Study|Physician Decision|0
7154764|NCT03324581|11322003|FG001|Overall Study|Physician Decision|1
7154765|NCT03324581|11322004|FG002|Overall Study|Physician Decision|2
7154766|NCT03324581|11322002|FG000|Overall Study|Protocol Deviation|8
7154767|NCT03324581|11322003|FG001|Overall Study|Protocol Deviation|9
7154768|NCT03324581|11322004|FG002|Overall Study|Protocol Deviation|4
7154769|NCT03324581|11322002|FG000|Overall Study|Withdrawal by Subject|6
7154770|NCT03324581|11322003|FG001|Overall Study|Withdrawal by Subject|8
7154771|NCT03324581|11322004|FG002|Overall Study|Withdrawal by Subject|6
7154772|NCT03324581|11322002|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0
7154773|NCT03324581|11322003|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1
7154774|NCT03324581|11322004|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0
7154775|NCT03325010|11322021|FG000|Overall Study|Adverse Event|3
7154776|NCT03325010|11322022|FG001|Overall Study|Adverse Event|8
7154777|NCT03325010|11322021|FG000|Overall Study|Protocol Violation|1
7154778|NCT03325010|11322022|FG001|Overall Study|Protocol Violation|8
7154779|NCT03325010|11322021|FG000|Overall Study|Withdrawal by Subject|1
7154780|NCT03325010|11322022|FG001|Overall Study|Withdrawal by Subject|3
7154781|NCT03325010|11322021|FG000|Overall Study|Lost to Follow-up|1
7154782|NCT03325010|11322022|FG001|Overall Study|Lost to Follow-up|0
7154783|NCT03325010|11322021|FG000|Overall Study|Physician Decision|1
7154784|NCT03325010|11322022|FG001|Overall Study|Physician Decision|1
7154785|NCT03325010|11322021|FG000|Overall Study|Lack of Efficacy|2
7154786|NCT03325010|11322022|FG001|Overall Study|Lack of Efficacy|0
6879785|NCT00527735|10892171|FG000|Overall Study|Death|23
6879786|NCT00527735|10892172|FG001|Overall Study|Death|13
6879787|NCT00527735|10892173|FG002|Overall Study|Death|15
6879788|NCT00527735|10892171|FG000|Overall Study|Completed treatment in treatment phase|14
6879789|NCT00527735|10892172|FG001|Overall Study|Completed treatment in treatment phase|13
6879790|NCT00527735|10892173|FG002|Overall Study|Completed treatment in treatment phase|18
6879791|NCT00527735|10892171|FG000|Overall Study|Adverse Event|10
6879792|NCT00527735|10892172|FG001|Overall Study|Adverse Event|6
6879793|NCT00527735|10892173|FG002|Overall Study|Adverse Event|7
6879794|NCT00527735|10892171|FG000|Overall Study|Not identified|5
6879795|NCT00527735|10892172|FG001|Overall Study|Not identified|5
6879796|NCT00527735|10892173|FG002|Overall Study|Not identified|5
6879797|NCT00527735|10892171|FG000|Overall Study|Withdrawal by Subject|5
6879798|NCT00527735|10892172|FG001|Overall Study|Withdrawal by Subject|4
6879799|NCT00527735|10892173|FG002|Overall Study|Withdrawal by Subject|3
6879800|NCT00527735|10892171|FG000|Overall Study|No longer met study criteria|2
6879801|NCT00527735|10892172|FG001|Overall Study|No longer met study criteria|2
6879802|NCT00527735|10892173|FG002|Overall Study|No longer met study criteria|1
6879803|NCT00527735|10892171|FG000|Overall Study|Lost to Follow-up|0
6879804|NCT00527735|10892172|FG001|Overall Study|Lost to Follow-up|0
6879805|NCT00527735|10892173|FG002|Overall Study|Lost to Follow-up|3
6879806|NCT00527735|10892171|FG000|Overall Study|Poor compliance or noncompliance|0
6879807|NCT00527735|10892172|FG001|Overall Study|Poor compliance or noncompliance|1
6879808|NCT00527735|10892173|FG002|Overall Study|Poor compliance or noncompliance|1
6879809|NCT00527735|10892171|FG000|Overall Study|Completed treatment during maintenance|2
6879810|NCT00527735|10892172|FG001|Overall Study|Completed treatment during maintenance|2
6879811|NCT00527735|10892173|FG002|Overall Study|Completed treatment during maintenance|1
6879812|NCT00527787|10892195|FG000|Overall Study|Adverse Event|14
6879813|NCT00527787|10892196|FG001|Overall Study|Adverse Event|24
7154787|NCT03325556|11322028|FG000|Open-label Period|Lack of Response in OL period|70
7154788|NCT03325556|11322029|FG001|Open-label Period|Lack of Response in OL period|0
7154789|NCT03325556|11322030|FG002|Open-label Period|Lack of Response in OL period|0
7154790|NCT03325556|11322028|FG000|Open-label Period|Adverse Event|27
7154791|NCT03325556|11322029|FG001|Open-label Period|Adverse Event|0
7154792|NCT03325556|11322030|FG002|Open-label Period|Adverse Event|0
7154793|NCT03325556|11322028|FG000|Open-label Period|Death|1
7154794|NCT03325556|11322029|FG001|Open-label Period|Death|0
7154795|NCT03325556|11322030|FG002|Open-label Period|Death|0
7154796|NCT03325556|11322028|FG000|Open-label Period|Lost to Follow-up|1
7154797|NCT03325556|11322029|FG001|Open-label Period|Lost to Follow-up|0
7154798|NCT03325556|11322030|FG002|Open-label Period|Lost to Follow-up|0
7154799|NCT03325556|11322028|FG000|Open-label Period|Non-compliance with study drug|5
7154800|NCT03325556|11322029|FG001|Open-label Period|Non-compliance with study drug|0
7154801|NCT03325556|11322030|FG002|Open-label Period|Non-compliance with study drug|0
7154802|NCT03325556|11322028|FG000|Open-label Period|Use of prohibited medication|1
7154803|NCT03325556|11322029|FG001|Open-label Period|Use of prohibited medication|0
7154804|NCT03325556|11322030|FG002|Open-label Period|Use of prohibited medication|0
7154805|NCT03325556|11322028|FG000|Open-label Period|Protocol Violation|4
7154806|NCT03325556|11322029|FG001|Open-label Period|Protocol Violation|0
7154807|NCT03325556|11322030|FG002|Open-label Period|Protocol Violation|0
7154808|NCT03325556|11322028|FG000|Open-label Period|Withdrawal by Subject|17
7154809|NCT03325556|11322029|FG001|Open-label Period|Withdrawal by Subject|0
7154810|NCT03325556|11322030|FG002|Open-label Period|Withdrawal by Subject|0
7154811|NCT03325556|11322028|FG000|Open-label Period|Not otherwise specified|8
7154812|NCT03325556|11322029|FG001|Open-label Period|Not otherwise specified|0
7154813|NCT03325556|11322030|FG002|Open-label Period|Not otherwise specified|0
7154814|NCT03325556|11322028|FG000|Open-label Period|Administrative discont. at study termination|41
7154815|NCT03325556|11322029|FG001|Open-label Period|Administrative discont. at study termination|0
7154816|NCT03325556|11322030|FG002|Open-label Period|Administrative discont. at study termination|0
7154817|NCT03325556|11322028|FG000|Double-blind Period|Relapse|0
7154818|NCT03325556|11322029|FG001|Double-blind Period|Relapse|15
7154819|NCT03325556|11322030|FG002|Double-blind Period|Relapse|34
7154820|NCT03325556|11322028|FG000|Double-blind Period|Adverse Event|0
7154821|NCT03325556|11322029|FG001|Double-blind Period|Adverse Event|3
7154822|NCT03325556|11322030|FG002|Double-blind Period|Adverse Event|1
7154823|NCT03325556|11322028|FG000|Double-blind Period|Noncompliance with study drug|0
7154824|NCT03325556|11322029|FG001|Double-blind Period|Noncompliance with study drug|0
7154825|NCT03325556|11322030|FG002|Double-blind Period|Noncompliance with study drug|1
7154826|NCT03325556|11322028|FG000|Double-blind Period|Use of prohibited medication|0
7154827|NCT03325556|11322029|FG001|Double-blind Period|Use of prohibited medication|1
7154828|NCT03325556|11322030|FG002|Double-blind Period|Use of prohibited medication|0
7154829|NCT03325556|11322028|FG000|Double-blind Period|Physician Decision|0
7154830|NCT03325556|11322029|FG001|Double-blind Period|Physician Decision|0
7154831|NCT03325556|11322030|FG002|Double-blind Period|Physician Decision|1
7154832|NCT03325556|11322028|FG000|Double-blind Period|Withdrawal by Subject|0
7154833|NCT03325556|11322029|FG001|Double-blind Period|Withdrawal by Subject|6
7154834|NCT03325556|11322030|FG002|Double-blind Period|Withdrawal by Subject|4
7154835|NCT03325556|11322028|FG000|Double-blind Period|Not otherwise specified|0
7154836|NCT03325556|11322029|FG001|Double-blind Period|Not otherwise specified|1
6879814|NCT00527787|10892195|FG000|Overall Study|Withdrawal by Subject|13
6879815|NCT00527787|10892196|FG001|Overall Study|Withdrawal by Subject|25
6879816|NCT00527787|10892195|FG000|Overall Study|Lost to Follow-up|5
6879817|NCT00527787|10892196|FG001|Overall Study|Lost to Follow-up|2
6879818|NCT00527787|10892195|FG000|Overall Study|Duodenal Ulcer|1
6879819|NCT00527787|10892196|FG001|Overall Study|Duodenal Ulcer|10
6879820|NCT00527787|10892195|FG000|Overall Study|misc|5
6879821|NCT00527787|10892196|FG001|Overall Study|misc|2
6879822|NCT00527826|10892204|FG000|Overall Study|Adverse Event|10
6879823|NCT00527826|10892205|FG001|Overall Study|Adverse Event|10
6879824|NCT00527826|10892204|FG000|Overall Study|Lost to Follow-up|3
6879825|NCT00527826|10892205|FG001|Overall Study|Lost to Follow-up|2
6879826|NCT00527826|10892204|FG000|Overall Study|Withdrawal by Subject|5
6879827|NCT00527826|10892205|FG001|Overall Study|Withdrawal by Subject|8
6879828|NCT00527826|10892204|FG000|Overall Study|Inclusion Criteria Not Met|3
6879829|NCT00527826|10892205|FG001|Overall Study|Inclusion Criteria Not Met|3
6879830|NCT00527826|10892204|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0
6879831|NCT00527826|10892205|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1
6879832|NCT00527826|10892204|FG000|Overall Study|Additional Intake of Viani forte|0
6879833|NCT00527826|10892205|FG001|Overall Study|Additional Intake of Viani forte|1
6879834|NCT00527826|10892204|FG000|Overall Study|Participant moved away|0
6879835|NCT00527826|10892205|FG001|Overall Study|Participant moved away|1
6879836|NCT00527904|10892221|FG000|Overall Study|Adverse Event|45
6879837|NCT00527904|10892221|FG000|Overall Study|Withdrawal by Subject|21
6879838|NCT00527904|10892221|FG000|Overall Study|Lost to Follow-up|8
6879839|NCT00527904|10892221|FG000|Overall Study|misc|22
6879844|NCT00528112|10892253|FG000|Treatment up to 3 Years|Adverse Event|313
6879845|NCT00528112|10892254|FG001|Treatment up to 3 Years|Adverse Event|278
6879846|NCT00528112|10892253|FG000|Treatment up to 3 Years|Withdrawal by Subject|26
6879847|NCT00528112|10892254|FG001|Treatment up to 3 Years|Withdrawal by Subject|31
6879848|NCT00528112|10892253|FG000|Treatment up to 3 Years|Protocol Violation|16
6879849|NCT00528112|10892254|FG001|Treatment up to 3 Years|Protocol Violation|16
6879850|NCT00528112|10892253|FG000|Treatment up to 3 Years|Death|0
6879851|NCT00528112|10892254|FG001|Treatment up to 3 Years|Death|1
6879852|NCT00528112|10892253|FG000|Treatment up to 3 Years|Lost to Follow-up|63
6879853|NCT00528112|10892254|FG001|Treatment up to 3 Years|Lost to Follow-up|61
6879854|NCT00528112|10892253|FG000|Treatment up to 3 Years|Pregnancy|9
6879855|NCT00528112|10892254|FG001|Treatment up to 3 Years|Pregnancy|10
6879856|NCT00528112|10892253|FG000|Treatment up to 3 Years|Other reasons|186
6879857|NCT00528112|10892254|FG001|Treatment up to 3 Years|Other reasons|186
6879858|NCT00528112|10892253|FG000|Extension Phase|Withdrawal by Subject|0
6879859|NCT00528112|10892254|FG001|Extension Phase|Withdrawal by Subject|3
6879860|NCT00528112|10892253|FG000|Extension Phase|Other reasons|0
6879861|NCT00528112|10892254|FG001|Extension Phase|Other reasons|100
6879862|NCT00528112|10892253|FG000|Extension Phase|Pregnancy|0
6879863|NCT00528112|10892254|FG001|Extension Phase|Pregnancy|3
6879864|NCT00528112|10892253|FG000|Extension Phase|Lost to Follow-up|0
6879865|NCT00528112|10892254|FG001|Extension Phase|Lost to Follow-up|12
6879866|NCT00528112|10892253|FG000|Extension Phase|Death|0
6879867|NCT00528112|10892254|FG001|Extension Phase|Death|1
6879868|NCT00528112|10892253|FG000|Extension Phase|Adverse Event|0
6879869|NCT00528112|10892254|FG001|Extension Phase|Adverse Event|36
6879870|NCT00528112|10892253|FG000|Extension Phase|Protocol Violation|0
6879871|NCT00528112|10892254|FG001|Extension Phase|Protocol Violation|2
6879872|NCT00528372|10892289|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2
6879873|NCT00528372|10892290|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
6879874|NCT00528372|10892291|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
6879875|NCT00528372|10892292|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
6879876|NCT00528372|10892293|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
7154837|NCT03325556|11322030|FG002|Double-blind Period|Not otherwise specified|5
7154838|NCT03325556|11322028|FG000|Double-blind Period|Administrative discont. at study termination|0
6879877|NCT00528372|10892294|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
6879878|NCT00528372|10892295|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
6879879|NCT00528372|10892296|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
6879880|NCT00528372|10892297|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
6879881|NCT00528372|10892289|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
6879882|NCT00528372|10892290|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
6879883|NCT00528372|10892291|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
6879884|NCT00528372|10892292|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6
6879885|NCT00528372|10892293|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
6879886|NCT00528372|10892294|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
6879887|NCT00528372|10892295|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
6879888|NCT00528372|10892296|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
6879889|NCT00528372|10892297|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
6879890|NCT00528372|10892289|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
6879891|NCT00528372|10892290|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
6879892|NCT00528372|10892291|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7
6879893|NCT00528372|10892292|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
6879894|NCT00528372|10892293|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
6879895|NCT00528372|10892294|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
6879896|NCT00528372|10892295|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
6879897|NCT00528372|10892296|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
6879898|NCT00528372|10892297|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
6879899|NCT00528372|10892289|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5
7078860|NCT02106390|11187414|FG002|Overall Study|Lost to Follow-up|13
7078861|NCT02106390|11187412|FG000|Overall Study|Other: Administrative Reason|8
7078862|NCT02106390|11187413|FG001|Overall Study|Other: Administrative Reason|5
6879900|NCT00528372|10892290|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
6879901|NCT00528372|10892291|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
6879902|NCT00528372|10892292|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
6879903|NCT00528372|10892293|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
6879904|NCT00528372|10892294|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
6879905|NCT00528372|10892295|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
6879906|NCT00528372|10892296|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
6879907|NCT00528372|10892297|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
6879908|NCT00528372|10892289|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
6879909|NCT00528372|10892290|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
6879910|NCT00528372|10892291|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
6879911|NCT00528372|10892292|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2
6879912|NCT00528372|10892293|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
6879913|NCT00528372|10892294|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1
6879914|NCT00528372|10892295|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
6879915|NCT00528372|10892296|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
6879916|NCT00528372|10892297|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
6879917|NCT00528372|10892289|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
6879918|NCT00528372|10892290|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
6879919|NCT00528372|10892291|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
6879920|NCT00528372|10892292|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
6879921|NCT00528372|10892293|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
6879922|NCT00528372|10892294|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
6879923|NCT00528372|10892295|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
6879924|NCT00528372|10892296|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
6879925|NCT00528372|10892297|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
6879926|NCT00528372|10892289|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3
6879927|NCT00528372|10892290|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0
6879928|NCT00528372|10892291|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0
6879929|NCT00528372|10892292|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1
6879930|NCT00528372|10892293|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0
7078863|NCT02106390|11187414|FG002|Overall Study|Other: Administrative Reason|12
7154839|NCT03325556|11322029|FG001|Double-blind Period|Administrative discont. at study termination|35
7154840|NCT03325556|11322030|FG002|Double-blind Period|Administrative discont. at study termination|31
7154841|NCT03325673|11322039|FG000|Overall Study|Adverse Event|4
7154842|NCT03325673|11322040|FG001|Overall Study|Adverse Event|0
7154843|NCT03325881|11322059|FG000|Overall Study|Protocol Violation|0
7154844|NCT03325881|11322060|FG001|Overall Study|Protocol Violation|1
7154845|NCT03325881|11322059|FG000|Overall Study|Withdrawal by Subject|0
7154846|NCT03325881|11322060|FG001|Overall Study|Withdrawal by Subject|2
7154847|NCT03325881|11322059|FG000|Overall Study|Lack of Efficacy|2
7154848|NCT03325881|11322060|FG001|Overall Study|Lack of Efficacy|0
7154849|NCT03325881|11322059|FG000|Overall Study|Not treated|1
7154850|NCT03325881|11322060|FG001|Overall Study|Not treated|0
7154851|NCT03325894|11322070|FG000|Overall Study|Adverse Event|2
7154852|NCT03325894|11322071|FG001|Overall Study|Adverse Event|3
7154853|NCT03325894|11322070|FG000|Overall Study|Protocol Violation|1
7154854|NCT03325894|11322071|FG001|Overall Study|Protocol Violation|2
7154855|NCT03325894|11322070|FG000|Overall Study|Withdrawal by Subject|10
7154856|NCT03325894|11322071|FG001|Overall Study|Withdrawal by Subject|6
7154857|NCT03325894|11322070|FG000|Overall Study|Lost to Follow-up|4
7154858|NCT03325894|11322071|FG001|Overall Study|Lost to Follow-up|9
7154859|NCT03325894|11322070|FG000|Overall Study|Lack of Efficacy|8
7154860|NCT03325894|11322071|FG001|Overall Study|Lack of Efficacy|14
7154861|NCT03325894|11322070|FG000|Overall Study|Study Terminated by Sponsor|38
7154862|NCT03325894|11322071|FG001|Overall Study|Study Terminated by Sponsor|43
7154863|NCT03325894|11322070|FG000|Overall Study|Other (Not received Treatment)|1
7154864|NCT03325894|11322071|FG001|Overall Study|Other (Not received Treatment)|0
7154865|NCT03326323|11322080|FG000|Overall Study|Unable to receive ANH protocol|3
7154866|NCT03326518|11322087|FG000|Overall Study|Protocol Violation|1
7154867|NCT03326518|11322088|FG001|Overall Study|Protocol Violation|0
7078864|NCT02106390|11187412|FG000|Overall Study|Other: Unspecified|1
7078865|NCT02106390|11187413|FG001|Overall Study|Other: Unspecified|4
7078866|NCT02106390|11187414|FG002|Overall Study|Other: Unspecified|2
7078867|NCT02106390|11187412|FG000|Overall Study|Adverse Event|0
7078868|NCT02106390|11187413|FG001|Overall Study|Adverse Event|2
7078869|NCT02106390|11187414|FG002|Overall Study|Adverse Event|1
6879931|NCT00528372|10892294|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0
6879932|NCT00528372|10892295|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0
6879933|NCT00528372|10892296|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1
6879934|NCT00528372|10892297|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0
6879935|NCT00528372|10892289|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
6879936|NCT00528372|10892290|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
6879937|NCT00528372|10892291|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1
6879938|NCT00528372|10892292|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
6879939|NCT00528372|10892293|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
6879940|NCT00528372|10892294|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
6879941|NCT00528372|10892295|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2
6879942|NCT00528372|10892296|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
6879943|NCT00528372|10892297|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
6879944|NCT00528372|10892289|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
6879945|NCT00528372|10892290|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
6879946|NCT00528372|10892291|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
6879947|NCT00528372|10892292|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
6879948|NCT00528372|10892293|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2
6879949|NCT00528372|10892294|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
6879950|NCT00528372|10892295|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4
6879951|NCT00528372|10892296|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
7078870|NCT02106390|11187412|FG000|Overall Study|Protocol Violation|0
7078871|NCT02106390|11187413|FG001|Overall Study|Protocol Violation|1
7078872|NCT02106390|11187414|FG002|Overall Study|Protocol Violation|0
7154868|NCT03326518|11322089|FG002|Overall Study|Protocol Violation|0
7154869|NCT03326518|11322087|FG000|Overall Study|Withdrawal by Subject|1
7154870|NCT03326518|11322088|FG001|Overall Study|Withdrawal by Subject|0
7154871|NCT03326518|11322089|FG002|Overall Study|Withdrawal by Subject|0
7154872|NCT03326518|11322087|FG000|Overall Study|Lost to Follow-up|1
7154873|NCT03326518|11322088|FG001|Overall Study|Lost to Follow-up|0
7154874|NCT03326518|11322089|FG002|Overall Study|Lost to Follow-up|1
7154875|NCT03327220|11322172|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1
7154876|NCT03327220|11322173|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2
7154877|NCT03327220|11322172|FG000|Overall Study|Investigator Decision|2
7154878|NCT03327220|11322173|FG001|Overall Study|Investigator Decision|0
7154879|NCT03327220|11322172|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0
7154880|NCT03327220|11322173|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1
7154881|NCT03327220|11322172|FG000|Overall Study|Fungal infection|1
7154882|NCT03327220|11322173|FG001|Overall Study|Fungal infection|0
7154883|NCT03327220|11322172|FG000|Overall Study|Discharged to Rehabilitation|0
7154884|NCT03327220|11322173|FG001|Overall Study|Discharged to Rehabilitation|1
7154885|NCT03327220|11322172|FG000|Overall Study|Missing|1
7154886|NCT03327220|11322173|FG001|Overall Study|Missing|0
7154887|NCT03327402|11322179|FG000|Overall Study|Withdrawal by Subject|1
7154888|NCT03327402|11322179|FG000|Overall Study|Other (Visit Out-Of-Window)|1
7154889|NCT03328182|11322193|FG000|Overall Study|Withdrawal by Subject|1
7154890|NCT03328182|11322193|FG000|Overall Study|Protocol Violation|2
7154891|NCT03328182|11322193|FG000|Overall Study|No Product Evaluated|1
7154892|NCT03328325|11322206|FG000|Overall Study|Lost to Follow-up|4
7154893|NCT03328325|11322206|FG000|Overall Study|Physician Decision|1
7154894|NCT03328325|11322206|FG000|Overall Study|Withdrawal by Subject|3
7154895|NCT03328325|11322206|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3
7154896|NCT03328832|11322216|FG000|Overall Study|Lost to Follow-up|0
7154897|NCT03328832|11322217|FG001|Overall Study|Lost to Follow-up|1
7154898|NCT03328897|11322226|FG000|Randomized-treatment Epoch|Adverse Event|4
7154899|NCT03328897|11322227|FG001|Randomized-treatment Epoch|Adverse Event|1
7154900|NCT03328897|11322228|FG002|Randomized-treatment Epoch|Adverse Event|1
7154901|NCT03328897|11322226|FG000|Randomized-treatment Epoch|Lost to Follow-up|0
7154902|NCT03328897|11322227|FG001|Randomized-treatment Epoch|Lost to Follow-up|1
7154903|NCT03328897|11322228|FG002|Randomized-treatment Epoch|Lost to Follow-up|0
7154904|NCT03328897|11322226|FG000|Randomized-treatment Epoch|Pregnancy|3
7154905|NCT03328897|11322227|FG001|Randomized-treatment Epoch|Pregnancy|0
7154906|NCT03328897|11322228|FG002|Randomized-treatment Epoch|Pregnancy|0
7154907|NCT03328897|11322226|FG000|Randomized-treatment Epoch|Patient/guardian decision|8
7154908|NCT03328897|11322227|FG001|Randomized-treatment Epoch|Patient/guardian decision|3
7154909|NCT03328897|11322228|FG002|Randomized-treatment Epoch|Patient/guardian decision|1
6879952|NCT00528372|10892297|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
6879953|NCT00528372|10892289|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
7078873|NCT02106403|11187425|FG000|Follow-Up Visit 3|Other Reason|0
7078874|NCT02106403|11187426|FG001|Follow-Up Visit 3|Other Reason|0
7078875|NCT02106403|11187427|FG002|Follow-Up Visit 3|Other Reason|0
7078876|NCT02106403|11187428|FG003|Follow-Up Visit 3|Other Reason|0
7078877|NCT02106403|11187429|FG004|Follow-Up Visit 3|Other Reason|0
7078878|NCT02106403|11187430|FG005|Follow-Up Visit 3|Other Reason|1
7078879|NCT02106442|11187440|FG000|Overall Study|Case Report Forms Uncollected|7
7078880|NCT02106442|11187440|FG000|Overall Study|Protocol Deviation|30
7078881|NCT02106455|11187444|FG000|Overall Study|Case Report Form Uncollected|6
7154910|NCT03328897|11322226|FG000|Randomized-treatment Epoch|Lack of Efficacy|1
7154911|NCT03328897|11322227|FG001|Randomized-treatment Epoch|Lack of Efficacy|0
7154912|NCT03328897|11322228|FG002|Randomized-treatment Epoch|Lack of Efficacy|0
7154913|NCT03328897|11322226|FG000|Follow-up Epoch|Adverse Event|4
7154914|NCT03328897|11322227|FG001|Follow-up Epoch|Adverse Event|0
7154915|NCT03328897|11322228|FG002|Follow-up Epoch|Adverse Event|1
7154916|NCT03328897|11322226|FG000|Follow-up Epoch|Lack of Efficacy|1
7154917|NCT03328897|11322227|FG001|Follow-up Epoch|Lack of Efficacy|1
7154918|NCT03328897|11322228|FG002|Follow-up Epoch|Lack of Efficacy|1
7154919|NCT03328897|11322226|FG000|Follow-up Epoch|Lost to Follow-up|0
7154920|NCT03328897|11322227|FG001|Follow-up Epoch|Lost to Follow-up|1
7078882|NCT02106455|11187444|FG000|Overall Study|Protocol Deviation|2
7078883|NCT02106832|11187478|FG000|Overall Study|Adverse Event|1
7078884|NCT02106832|11187479|FG001|Overall Study|Adverse Event|2
7078885|NCT02106832|11187480|FG002|Overall Study|Adverse Event|3
7078886|NCT02106832|11187481|FG003|Overall Study|Adverse Event|0
7078887|NCT02106832|11187478|FG000|Overall Study|Death|4
7078888|NCT02106832|11187479|FG001|Overall Study|Death|4
7078889|NCT02106832|11187480|FG002|Overall Study|Death|1
7078890|NCT02106832|11187481|FG003|Overall Study|Death|4
7078891|NCT02106832|11187478|FG000|Overall Study|Deterioration of general conditions|0
7078892|NCT02106832|11187479|FG001|Overall Study|Deterioration of general conditions|0
7078893|NCT02106832|11187480|FG002|Overall Study|Deterioration of general conditions|1
7078894|NCT02106832|11187481|FG003|Overall Study|Deterioration of general conditions|0
7078895|NCT02106832|11187478|FG000|Overall Study|Lost to Follow-up|0
7078896|NCT02106832|11187479|FG001|Overall Study|Lost to Follow-up|1
7078897|NCT02106832|11187480|FG002|Overall Study|Lost to Follow-up|1
7078898|NCT02106832|11187481|FG003|Overall Study|Lost to Follow-up|3
7078899|NCT02106832|11187478|FG000|Overall Study|Physician Decision|1
7078900|NCT02106832|11187479|FG001|Overall Study|Physician Decision|0
7078901|NCT02106832|11187480|FG002|Overall Study|Physician Decision|0
7078902|NCT02106832|11187481|FG003|Overall Study|Physician Decision|0
7078903|NCT02106832|11187478|FG000|Overall Study|Protocol Violation|0
7078904|NCT02106832|11187479|FG001|Overall Study|Protocol Violation|0
7078905|NCT02106832|11187480|FG002|Overall Study|Protocol Violation|0
7078906|NCT02106832|11187481|FG003|Overall Study|Protocol Violation|1
7078907|NCT02106832|11187478|FG000|Overall Study|Withdrawal by Subject|17
7154921|NCT03328897|11322228|FG002|Follow-up Epoch|Lost to Follow-up|0
7154922|NCT03328897|11322226|FG000|Follow-up Epoch|Pregnancy|1
7154923|NCT03328897|11322227|FG001|Follow-up Epoch|Pregnancy|0
7154924|NCT03328897|11322228|FG002|Follow-up Epoch|Pregnancy|0
7154925|NCT03328897|11322226|FG000|Follow-up Epoch|Patient/guardian decision|2
7154926|NCT03328897|11322227|FG001|Follow-up Epoch|Patient/guardian decision|1
7154927|NCT03328897|11322228|FG002|Follow-up Epoch|Patient/guardian decision|0
7154928|NCT03329196|11322243|FG000|Overall Study|Adverse Event|10
7154929|NCT03329196|11322244|FG001|Overall Study|Adverse Event|5
7154930|NCT03329196|11322243|FG000|Overall Study|Physician Decision|2
7154931|NCT03329196|11322244|FG001|Overall Study|Physician Decision|2
7154932|NCT03329196|11322243|FG000|Overall Study|Withdrawal by Subject|11
7154933|NCT03329196|11322244|FG001|Overall Study|Withdrawal by Subject|3
7154934|NCT03329196|11322243|FG000|Overall Study|Hepatic function abnormalities|0
7154935|NCT03329196|11322244|FG001|Overall Study|Hepatic function abnormalities|1
7154936|NCT03329196|11322243|FG000|Overall Study|Conducting rescue therapy before Week 24|2
7154937|NCT03329196|11322244|FG001|Overall Study|Conducting rescue therapy before Week 24|1
7154938|NCT03329196|11322243|FG000|Overall Study|Difficult to control Hb|2
7154939|NCT03329196|11322244|FG001|Overall Study|Difficult to control Hb|3
7154940|NCT03329196|11322243|FG000|Overall Study|Dialysis or renal transplant|13
7154941|NCT03329196|11322244|FG001|Overall Study|Dialysis or renal transplant|15
7154942|NCT03329573|11322264|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
7154943|NCT03329573|11322265|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1
7154944|NCT03329573|11322266|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
7154945|NCT03329573|11322267|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
7154946|NCT03329573|11322264|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1
7154947|NCT03329573|11322265|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2
7154948|NCT03329573|11322266|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0
7154949|NCT03329573|11322267|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0
7154950|NCT03329573|11322264|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1
7154951|NCT03329573|11322265|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
7154952|NCT03329573|11322266|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
7154953|NCT03329573|11322267|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
7154954|NCT03329573|11322264|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
7078908|NCT02106832|11187479|FG001|Overall Study|Withdrawal by Subject|17
7078909|NCT02106832|11187480|FG002|Overall Study|Withdrawal by Subject|10
7078910|NCT02106832|11187481|FG003|Overall Study|Withdrawal by Subject|7
7078911|NCT02106832|11187478|FG000|Overall Study|Technical problems|0
7154955|NCT03329573|11322265|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1
7154956|NCT03329573|11322266|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
7154957|NCT03329573|11322267|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
7078912|NCT02106832|11187479|FG001|Overall Study|Technical problems|1
7078913|NCT02106832|11187480|FG002|Overall Study|Technical problems|0
7078914|NCT02106832|11187481|FG003|Overall Study|Technical problems|0
7078915|NCT02106884|11187495|FG000|Overall Study|Change of diagnosis/exclusion|0
7078916|NCT02106884|11187496|FG001|Overall Study|Change of diagnosis/exclusion|1
7078917|NCT02106910|11187507|FG000|Overall Study|Lost to Follow-up|1
7078918|NCT02106910|11187508|FG001|Overall Study|Lost to Follow-up|1
7078919|NCT02106923|11187518|FG000|Overall Study|Protocol Violation|0
7078920|NCT02106923|11187519|FG001|Overall Study|Protocol Violation|0
7078921|NCT02106923|11187520|FG002|Overall Study|Protocol Violation|0
7078922|NCT02106923|11187521|FG003|Overall Study|Protocol Violation|0
7078923|NCT02106923|11187522|FG004|Overall Study|Protocol Violation|0
7078924|NCT02106923|11187523|FG005|Overall Study|Protocol Violation|1
7078925|NCT02106975|11187550|FG000|Overall Study|Death|25
7078926|NCT02106975|11187551|FG001|Overall Study|Death|39
7154958|NCT03329846|11322279|FG000|Overall Study|Disease progression|4
7154959|NCT03329846|11322280|FG001|Overall Study|Disease progression|6
7154960|NCT03329846|11322279|FG000|Overall Study|Study drug toxicity|1
7154961|NCT03329846|11322280|FG001|Overall Study|Study drug toxicity|0
7154962|NCT03329846|11322279|FG000|Overall Study|Participant request to discontinue treatment|0
7154963|NCT03329846|11322280|FG001|Overall Study|Participant request to discontinue treatment|1
7154964|NCT03329846|11322279|FG000|Overall Study|Participant withdrew consent|1
7154965|NCT03329846|11322280|FG001|Overall Study|Participant withdrew consent|0
7154966|NCT03329846|11322279|FG000|Overall Study|Other reasons|2
7078927|NCT02107014|11187557|FG000|Overall Study|Withdrew before drug: moving interstate|1
7078928|NCT02107092|11187561|FG000|Overall Study|Miscellaneous|3
7078929|NCT02107092|11187561|FG000|Overall Study|Subject compliance|3
7078930|NCT02107092|11187561|FG000|Overall Study|Hypo-or hyperkalemia|2
7078931|NCT02107092|11187561|FG000|Overall Study|Met ECG withdrawal criteria|3
7078932|NCT02107092|11187561|FG000|Overall Study|Physician Decision|3
7078933|NCT02107092|11187561|FG000|Overall Study|Lost to Follow-up|2
7078934|NCT02107092|11187561|FG000|Overall Study|Withdrawal by Subject|9
7078935|NCT02107092|11187561|FG000|Overall Study|Adverse Event|7
7078936|NCT02107092|11187561|FG000|Overall Study|Expected progression of CKD|12
7154967|NCT03329846|11322280|FG001|Overall Study|Other reasons|2
7154968|NCT03329885|11322292|FG000|Overall Study|Sponsor discontinued the study early|0
7154969|NCT03329885|11322293|FG001|Overall Study|Sponsor discontinued the study early|0
7154970|NCT03329885|11322294|FG002|Overall Study|Sponsor discontinued the study early|0
7154971|NCT03329885|11322295|FG003|Overall Study|Sponsor discontinued the study early|0
7154972|NCT03329885|11322296|FG004|Overall Study|Sponsor discontinued the study early|0
7154973|NCT03329885|11322297|FG005|Overall Study|Sponsor discontinued the study early|0
7154974|NCT03329885|11322298|FG006|Overall Study|Sponsor discontinued the study early|1
7154975|NCT03329885|11322299|FG007|Overall Study|Sponsor discontinued the study early|1
7154976|NCT03329885|11322300|FG008|Overall Study|Sponsor discontinued the study early|0
7154977|NCT03329989|11322333|FG000|Overall Study|Withdrawal by Subject|9
7154978|NCT03329989|11322333|FG000|Overall Study|Lost to Follow-up|8
7154979|NCT03329989|11322333|FG000|Overall Study|Adverse Event|5
7154980|NCT03329989|11322333|FG000|Overall Study|Protocol Violation|1
7154981|NCT03330002|11322337|FG000|Overall Study|Lost to Follow-up|15
7154982|NCT03330002|11322337|FG000|Overall Study|Death|7
7154983|NCT03330119|11322349|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166
7154984|NCT03330119|11322350|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282
7154985|NCT03330236|11322358|FG000|Overall Study|Death|2
7154986|NCT03330236|11322359|FG001|Overall Study|Death|1
7154987|NCT03330236|11322358|FG000|Overall Study|Withdrawal by Subject|2
7154988|NCT03330236|11322359|FG001|Overall Study|Withdrawal by Subject|4
7154989|NCT03330236|11322358|FG000|Overall Study|Lost to Follow-up|0
7154990|NCT03330236|11322359|FG001|Overall Study|Lost to Follow-up|2
7154991|NCT03330236|11322358|FG000|Overall Study|Physician Decision|2
7154992|NCT03330236|11322359|FG001|Overall Study|Physician Decision|0
7154993|NCT03330236|11322358|FG000|Overall Study|Protocol Violation|4
7154994|NCT03330236|11322359|FG001|Overall Study|Protocol Violation|3
7154995|NCT03330236|11322358|FG000|Overall Study|SedLine malfunction/blinding|19
7154996|NCT03330236|11322359|FG001|Overall Study|SedLine malfunction/blinding|14
7154997|NCT03330236|11322358|FG000|Overall Study|Volatile anesthetics used|11
7154998|NCT03330236|11322359|FG001|Overall Study|Volatile anesthetics used|8
7154999|NCT03330236|11322358|FG000|Overall Study|Surgery aborted/converted to open|60
7155000|NCT03330236|11322359|FG001|Overall Study|Surgery aborted/converted to open|52
7155001|NCT03330288|11322396|FG000|Overall Study|Other reason|1
7155002|NCT03330288|11322397|FG001|Overall Study|Other reason|1
7155003|NCT03330288|11322396|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1
7155004|NCT03330288|11322397|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0
7155005|NCT03330288|11322396|FG000|Overall Study|Adverse Event|1
7155006|NCT03330288|11322397|FG001|Overall Study|Adverse Event|0
7155007|NCT03330288|11322396|FG000|Overall Study|Withdrawal by Subject|1
7155008|NCT03330288|11322397|FG001|Overall Study|Withdrawal by Subject|0
7078937|NCT02107131|11187567|FG000|Overall Study|Lost to Follow-up|4
7078938|NCT02107131|11187568|FG001|Overall Study|Lost to Follow-up|4
7078939|NCT02107131|11187567|FG000|Overall Study|Physician Decision|1
7078940|NCT02107131|11187568|FG001|Overall Study|Physician Decision|0
7078941|NCT02107131|11187567|FG000|Overall Study|Withdrawal by Subject|2
7078942|NCT02107131|11187568|FG001|Overall Study|Withdrawal by Subject|0
7078943|NCT02107131|11187567|FG000|Overall Study|mental instability|1
7155009|NCT03330288|11322396|FG000|Overall Study|Lost to Follow-up|26
7155010|NCT03330288|11322397|FG001|Overall Study|Lost to Follow-up|7
7155011|NCT03331042|11322428|FG000|Overall Study|Protocol Violation|1
7078944|NCT02107131|11187568|FG001|Overall Study|mental instability|0
7078945|NCT02107131|11187567|FG000|Overall Study|Death|0
7078946|NCT02107131|11187568|FG001|Overall Study|Death|1
7078947|NCT02107131|11187567|FG000|Overall Study|Protocol Violation|0
7078948|NCT02107131|11187568|FG001|Overall Study|Protocol Violation|4
7082942|NCT02147158|11193686|FG000|Off-Treatment Interval 2|Lost to Follow-up|0
7082943|NCT02147158|11193687|FG001|Off-Treatment Interval 2|Lost to Follow-up|0
7082944|NCT02147158|11193688|FG002|Off-Treatment Interval 2|Lost to Follow-up|3
7155012|NCT03331042|11322429|FG001|Overall Study|Protocol Violation|0
7155013|NCT03331042|11322430|FG002|Overall Study|Protocol Violation|0
7155014|NCT03331042|11322431|FG003|Overall Study|Protocol Violation|0
7155015|NCT03331042|11322428|FG000|Overall Study|Physician Decision|0
7155016|NCT03331042|11322429|FG001|Overall Study|Physician Decision|0
7155017|NCT03331042|11322430|FG002|Overall Study|Physician Decision|1
7155018|NCT03331042|11322431|FG003|Overall Study|Physician Decision|0
7155019|NCT03331042|11322428|FG000|Overall Study|Lost to Follow-up|0
7155020|NCT03331042|11322429|FG001|Overall Study|Lost to Follow-up|0
7155021|NCT03331042|11322430|FG002|Overall Study|Lost to Follow-up|0
7155022|NCT03331042|11322431|FG003|Overall Study|Lost to Follow-up|1
7184155|NCT01774370|11384162|FG000|Overall Study|Never taken the PRADAXA during the study|4
7184156|NCT01774370|11384162|FG000|Overall Study|Administered prior to the contract date|4
7184157|NCT01774370|11384162|FG000|Overall Study|Subjects of contraindications|34
7184158|NCT01774370|11384162|FG000|Overall Study|Violated inclusion/exclusion criteria|53
7184159|NCT01774370|11384162|FG000|Overall Study|Follow-up failure|34
7187326|NCT03104075|11387936|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1
7187327|NCT03104075|11387937|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0
7187328|NCT03038087|11387944|FG000|Overall Study|lost data|1
7187329|NCT02662985|11387984|FG000|Treatment Period 1|Adverse Event|0
7187330|NCT02662985|11387985|FG001|Treatment Period 1|Adverse Event|2
7187331|NCT02662985|11387984|FG000|Treatment Period 1|Protocol Violation|0
7187332|NCT02662985|11387985|FG001|Treatment Period 1|Protocol Violation|1
7187333|NCT02662985|11387984|FG000|Treatment Period 1|Physician Decision|1
7187334|NCT02662985|11387985|FG001|Treatment Period 1|Physician Decision|0
7187335|NCT02662985|11387984|FG000|Treatment Period 1|Withdrawal by Subject|0
7187336|NCT02662985|11387985|FG001|Treatment Period 1|Withdrawal by Subject|1
7187337|NCT02662985|11387984|FG000|Treatment Period 2|Lack of Efficacy|0
7187338|NCT02662985|11387985|FG001|Treatment Period 2|Lack of Efficacy|1
7187339|NCT02662985|11387984|FG000|Treatment Period 2|Lost to Follow-up|1
7187340|NCT02662985|11387985|FG001|Treatment Period 2|Lost to Follow-up|0
7187341|NCT02662985|11387984|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4
7187342|NCT02662985|11387985|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4
7187343|NCT02662985|11387984|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1
7187344|NCT02662985|11387985|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1
7187345|NCT02662985|11387984|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0
7187346|NCT02662985|11387985|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1
7187347|NCT02662985|11387984|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1
7187348|NCT02662985|11387985|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2
7187349|NCT02662985|11387984|FG000|Treatment Period 3 (Extension Period)|Death|0
7187350|NCT02662985|11387985|FG001|Treatment Period 3 (Extension Period)|Death|1
7187351|NCT02606461|11387995|FG000|Overall Study|Withdrawal by Subject|3
7187352|NCT02606461|11387996|FG001|Overall Study|Withdrawal by Subject|2
7187353|NCT02606461|11387997|FG002|Overall Study|Withdrawal by Subject|14
7187354|NCT02606461|11387998|FG003|Overall Study|Withdrawal by Subject|11
7187355|NCT02606461|11387995|FG000|Overall Study|Death|16
7187356|NCT02606461|11387996|FG001|Overall Study|Death|25
7187357|NCT02606461|11387997|FG002|Overall Study|Death|105
7187358|NCT02606461|11387998|FG003|Overall Study|Death|58
7187359|NCT02606461|11387995|FG000|Overall Study|Lost to Follow-up|2
7187360|NCT02606461|11387996|FG001|Overall Study|Lost to Follow-up|2
7187361|NCT02606461|11387997|FG002|Overall Study|Lost to Follow-up|4
7187362|NCT02606461|11387998|FG003|Overall Study|Lost to Follow-up|1
7187363|NCT02606461|11387995|FG000|Overall Study|Physician Decision|0
7187364|NCT02606461|11387996|FG001|Overall Study|Physician Decision|0
7187365|NCT02606461|11387997|FG002|Overall Study|Physician Decision|1
7187366|NCT02606461|11387998|FG003|Overall Study|Physician Decision|1
7187367|NCT02606461|11387995|FG000|Overall Study|Disease Progression|1
7187368|NCT02606461|11387996|FG001|Overall Study|Disease Progression|0
7187369|NCT02606461|11387997|FG002|Overall Study|Disease Progression|0
7187370|NCT02606461|11387998|FG003|Overall Study|Disease Progression|0
7187371|NCT02606461|11387995|FG000|Overall Study|No treatment|0
7187372|NCT02606461|11387996|FG001|Overall Study|No treatment|0
7187373|NCT02606461|11387997|FG002|Overall Study|No treatment|1
7187374|NCT02606461|11387998|FG003|Overall Study|No treatment|0
7187375|NCT02606461|11387995|FG000|Overall Study|Ongoing|5
7082945|NCT02147158|11193689|FG003|Off-Treatment Interval 2|Lost to Follow-up|2
7187376|NCT02606461|11387996|FG001|Overall Study|Ongoing|1
7187377|NCT02606461|11387997|FG002|Overall Study|Ongoing|63
7187378|NCT02606461|11387998|FG003|Overall Study|Ongoing|26
7187379|NCT02536339|11388011|FG000|Overall Study|Death|20
7078949|NCT02107196|11187591|FG000|12-week Treatment Period|Adverse Event|6
7078950|NCT02107196|11187592|FG001|12-week Treatment Period|Adverse Event|3
7155023|NCT03331315|11322458|FG000|Overall Study|Physician Decision|18
7155024|NCT03331315|11322459|FG001|Overall Study|Physician Decision|14
6879954|NCT00528372|10892290|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
6879955|NCT00528372|10892291|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
6879956|NCT00528372|10892292|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
6879957|NCT00528372|10892293|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7
6879958|NCT00528372|10892294|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0
6879959|NCT00528372|10892295|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
6879960|NCT00528372|10892296|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2
6879961|NCT00528372|10892297|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
6879962|NCT00528372|10892289|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
6879963|NCT00528372|10892290|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
6879964|NCT00528372|10892291|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
6879965|NCT00528372|10892292|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
6879966|NCT00528372|10892293|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0
6879967|NCT00528372|10892294|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4
6879968|NCT00528372|10892295|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
6879969|NCT00528372|10892296|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
6879970|NCT00528372|10892297|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
6879971|NCT00528372|10892289|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
6879972|NCT00528372|10892290|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
6879973|NCT00528372|10892291|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
6879974|NCT00528372|10892292|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
6879975|NCT00528372|10892293|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
6879976|NCT00528372|10892294|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
6879977|NCT00528372|10892295|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
6879978|NCT00528372|10892296|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
6879979|NCT00528372|10892297|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
6879980|NCT00528372|10892289|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
6879981|NCT00528372|10892290|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
6879982|NCT00528372|10892291|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
6879983|NCT00528372|10892292|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
6879984|NCT00528372|10892293|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2
6879985|NCT00528372|10892294|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1
6879986|NCT00528372|10892295|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
6879987|NCT00528372|10892296|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
6879988|NCT00528372|10892297|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
6879989|NCT00528372|10892289|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
6879990|NCT00528372|10892290|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
6879991|NCT00528372|10892291|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
6879992|NCT00528372|10892292|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
6879993|NCT00528372|10892293|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
6879994|NCT00528372|10892294|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
6879995|NCT00528372|10892295|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
6879996|NCT00528372|10892296|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
6879997|NCT00528372|10892297|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
6879998|NCT00528372|10892289|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2
6879999|NCT00528372|10892290|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2
6880000|NCT00528372|10892291|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1
6880001|NCT00528372|10892292|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2
6880002|NCT00528372|10892293|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3
6880003|NCT00528372|10892294|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0
7078951|NCT02107196|11187591|FG000|12-week Treatment Period|Lack of Efficacy|2
7078952|NCT02107196|11187592|FG001|12-week Treatment Period|Lack of Efficacy|1
7078953|NCT02107196|11187591|FG000|12-week Treatment Period|Lost to Follow-up|3
7078954|NCT02107196|11187592|FG001|12-week Treatment Period|Lost to Follow-up|6
7078955|NCT02107196|11187591|FG000|12-week Treatment Period|Physician Decision|0
7078956|NCT02107196|11187592|FG001|12-week Treatment Period|Physician Decision|1
7078957|NCT02107196|11187591|FG000|12-week Treatment Period|Withdrawal by Subject|15
7155025|NCT03331666|11322469|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2
7155026|NCT03331666|11322470|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2
7155027|NCT03332160|11322496|FG000|Overall Study|Withdrawal by Subject|1
7155028|NCT03332160|11322497|FG001|Overall Study|Withdrawal by Subject|1
7078958|NCT02107196|11187592|FG001|12-week Treatment Period|Withdrawal by Subject|12
7078959|NCT02107196|11187591|FG000|12-week Treatment Period|Protocol Violation|7
6880004|NCT00528372|10892295|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3
6880005|NCT00528372|10892296|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1
6880006|NCT00528372|10892297|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0
6880007|NCT00528411|10892350|FG000|Overall Study|Adverse Event|4
6880008|NCT00528411|10892351|FG001|Overall Study|Adverse Event|0
6880009|NCT00528411|10892352|FG002|Overall Study|Adverse Event|1
6880010|NCT00528411|10892350|FG000|Overall Study|Incorrect Enrolment|1
6880011|NCT00528411|10892351|FG001|Overall Study|Incorrect Enrolment|1
6880012|NCT00528411|10892352|FG002|Overall Study|Incorrect Enrolment|0
6880013|NCT00528411|10892350|FG000|Overall Study|Severe non-compliance to protocol|0
6880014|NCT00528411|10892351|FG001|Overall Study|Severe non-compliance to protocol|1
6880015|NCT00528411|10892352|FG002|Overall Study|Severe non-compliance to protocol|0
6880016|NCT00528411|10892350|FG000|Overall Study|Prior commitment medication|0
6880017|NCT00528411|10892351|FG001|Overall Study|Prior commitment medication|1
6880018|NCT00528411|10892352|FG002|Overall Study|Prior commitment medication|0
6880019|NCT00528424|10892360|FG000|Overall Study|Lost to Follow-up|13
6880020|NCT00528424|10892360|FG000|Overall Study|Withdrew consent|2
6880021|NCT00528424|10892360|FG000|Overall Study|Administrative reason|2
6880022|NCT00528424|10892360|FG000|Overall Study|Other|12
6880023|NCT00528528|10892372|FG000|Overall Study|Lost to Follow-up|0
6880024|NCT00528528|10892373|FG001|Overall Study|Lost to Follow-up|0
6880025|NCT00528528|10892374|FG002|Overall Study|Lost to Follow-up|1
6880026|NCT00528528|10892375|FG003|Overall Study|Lost to Follow-up|1
6880027|NCT00528528|10892372|FG000|Overall Study|Ineligible to continue the trial|0
6880028|NCT00528528|10892373|FG001|Overall Study|Ineligible to continue the trial|0
6880029|NCT00528528|10892374|FG002|Overall Study|Ineligible to continue the trial|0
6880030|NCT00528528|10892375|FG003|Overall Study|Ineligible to continue the trial|1
6880031|NCT00528528|10892372|FG000|Overall Study|Other|0
6880032|NCT00528528|10892373|FG001|Overall Study|Other|1
6880033|NCT00528528|10892374|FG002|Overall Study|Other|0
6880034|NCT00528528|10892375|FG003|Overall Study|Other|0
6880035|NCT00528528|10892372|FG000|Overall Study|Withdrawal by Subject|3
6880036|NCT00528528|10892373|FG001|Overall Study|Withdrawal by Subject|2
6880037|NCT00528528|10892374|FG002|Overall Study|Withdrawal by Subject|1
6880038|NCT00528528|10892375|FG003|Overall Study|Withdrawal by Subject|1
6880039|NCT00528528|10892372|FG000|Overall Study|Ongoing participant|0
6880040|NCT00528528|10892373|FG001|Overall Study|Ongoing participant|0
6880041|NCT00528528|10892374|FG002|Overall Study|Ongoing participant|1
6880042|NCT00528528|10892375|FG003|Overall Study|Ongoing participant|0
6880043|NCT00528567|10892398|FG000|Overall Study|Death|4
6880044|NCT00528567|10892399|FG001|Overall Study|Death|5
6880045|NCT00528567|10892398|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30
6880046|NCT00528567|10892399|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60
6880047|NCT00528567|10892398|FG000|Overall Study|Adverse Event/Intermittent Illness|255
6880048|NCT00528567|10892399|FG001|Overall Study|Adverse Event/Intermittent Illness|29
6880049|NCT00528567|10892398|FG000|Overall Study|Violation Criteria at Entry|3
6880050|NCT00528567|10892399|FG001|Overall Study|Violation Criteria at Entry|17
6880051|NCT00528567|10892398|FG000|Overall Study|Withdrew Consent|59
6880052|NCT00528567|10892399|FG001|Overall Study|Withdrew Consent|55
6880053|NCT00528567|10892398|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52
6880054|NCT00528567|10892399|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42
6880055|NCT00528567|10892398|FG000|Overall Study|Failure to Return|1
6880056|NCT00528567|10892399|FG001|Overall Study|Failure to Return|4
6880057|NCT00528567|10892398|FG000|Overall Study|Other Protocol Violation|5
6880058|NCT00528567|10892399|FG001|Overall Study|Other Protocol Violation|21
6880059|NCT00528567|10892398|FG000|Overall Study|Administrative/Other|22
6880060|NCT00528567|10892399|FG001|Overall Study|Administrative/Other|75
6880061|NCT00528606|10892423|FG000|Overall Study|Withdrew consent|4
6880062|NCT00528606|10892424|FG001|Overall Study|Withdrew consent|3
6880063|NCT00528606|10892423|FG000|Overall Study|Lost to Follow-up|4
6880064|NCT00528606|10892424|FG001|Overall Study|Lost to Follow-up|1
6880065|NCT00528606|10892423|FG000|Overall Study|Adverse Event|3
6880066|NCT00528606|10892424|FG001|Overall Study|Adverse Event|0
6880067|NCT00528606|10892423|FG000|Overall Study|Other|2
6880068|NCT00528606|10892424|FG001|Overall Study|Other|0
6880069|NCT00528645|10892430|FG000|Overall Study|Adverse Event|3
6880070|NCT00528801|10892441|FG000|Overall Study|Withdrawal by Subject|1
6880071|NCT00528801|10892442|FG001|Overall Study|Withdrawal by Subject|1
6880072|NCT00528801|10892441|FG000|Overall Study|Protocol Violation|11
6880073|NCT00528801|10892442|FG001|Overall Study|Protocol Violation|5
6880074|NCT00528801|10892441|FG000|Overall Study|Lost to Follow-up|15
6880075|NCT00528801|10892442|FG001|Overall Study|Lost to Follow-up|4
6880076|NCT00528801|10892441|FG000|Overall Study|Administrative Reasons|0
6880077|NCT00528801|10892442|FG001|Overall Study|Administrative Reasons|1
6880078|NCT00528840|10892448|FG000|Overall Study|Lost to Follow-up|10
6880079|NCT00528840|10892448|FG000|Overall Study|Adverse Event|1
6880080|NCT00528840|10892448|FG000|Overall Study|Withdrawal by Subject|17
6880081|NCT00528840|10892448|FG000|Overall Study|Death|2
6880082|NCT00528840|10892448|FG000|Overall Study|Administrative Reasons|1
6880083|NCT00528840|10892448|FG000|Overall Study|Other|2
6880084|NCT00528866|10892452|FG000|Overall Study|Protocol Violation|6
6880085|NCT00528879|10892461|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3
6880086|NCT00528879|10892462|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
6880087|NCT00528879|10892463|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1
6880088|NCT00528879|10892464|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
6880089|NCT00528879|10892461|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4
6880090|NCT00528879|10892462|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4
6880091|NCT00528879|10892463|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2
6880092|NCT00528879|10892464|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4
6880093|NCT00528879|10892461|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7
6880094|NCT00528879|10892462|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
6880095|NCT00528879|10892463|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
6880096|NCT00528879|10892464|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3
6880097|NCT00528879|10892461|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
6880098|NCT00528879|10892462|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
6880099|NCT00528879|10892463|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
6880100|NCT00528879|10892464|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
6880101|NCT00528879|10892461|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
6880102|NCT00528879|10892462|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
6880103|NCT00528879|10892463|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2
6880104|NCT00528879|10892464|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
6880105|NCT00528879|10892461|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
6880106|NCT00528879|10892462|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3
6880107|NCT00528879|10892463|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
6880108|NCT00528879|10892464|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
6880109|NCT00528879|10892461|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
6880110|NCT00528879|10892462|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
6880111|NCT00528879|10892463|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0
6880112|NCT00528879|10892464|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
6880113|NCT00528879|10892461|FG000|Short-term Period (Day 1 to Week 24)|Other|0
6880114|NCT00528879|10892462|FG001|Short-term Period (Day 1 to Week 24)|Other|0
6880115|NCT00528879|10892463|FG002|Short-term Period (Day 1 to Week 24)|Other|1
6880116|NCT00528879|10892464|FG003|Short-term Period (Day 1 to Week 24)|Other|1
6880117|NCT00528879|10892461|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27
6880118|NCT00528879|10892462|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16
6880119|NCT00528879|10892463|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17
6880120|NCT00528879|10892464|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9
6880121|NCT00528879|10892461|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5
6880122|NCT00528879|10892462|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4
6880123|NCT00528879|10892463|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3
6880124|NCT00528879|10892464|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2
6880125|NCT00528879|10892461|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
7155029|NCT03332160|11322496|FG000|Overall Study|Adverse Event|0
7155030|NCT03332160|11322497|FG001|Overall Study|Adverse Event|1
7155031|NCT03332160|11322496|FG000|Overall Study|Developed Exclusion Criteria|0
7155032|NCT03332160|11322497|FG001|Overall Study|Developed Exclusion Criteria|1
7155033|NCT03332160|11322496|FG000|Overall Study|Non-adherence to treatment|0
7155034|NCT03332160|11322497|FG001|Overall Study|Non-adherence to treatment|2
7155035|NCT03332212|11322508|FG000|Overall Study|Not treated|0
7155036|NCT03332212|11322509|FG001|Overall Study|Not treated|1
7155037|NCT03332212|11322510|FG002|Overall Study|Not treated|0
7155038|NCT03332212|11322511|FG003|Overall Study|Not treated|0
7155039|NCT03332212|11322508|FG000|Overall Study|Adverse Event|0
7155040|NCT03332212|11322509|FG001|Overall Study|Adverse Event|0
7155041|NCT03332212|11322510|FG002|Overall Study|Adverse Event|0
7155042|NCT03332212|11322511|FG003|Overall Study|Adverse Event|1
7155043|NCT03332212|11322508|FG000|Overall Study|worsening of disease under study|1
7155044|NCT03332212|11322509|FG001|Overall Study|worsening of disease under study|1
7155045|NCT03332212|11322510|FG002|Overall Study|worsening of disease under study|0
7155046|NCT03332212|11322511|FG003|Overall Study|worsening of disease under study|0
7155047|NCT03332628|11322532|FG000|Overall Study|Physician Decision|2
7155048|NCT03332771|11322541|FG000|Overall Study|Adverse Event|6
7155049|NCT03332771|11322542|FG001|Overall Study|Adverse Event|4
7155050|NCT03332771|11322543|FG002|Overall Study|Adverse Event|1
7155051|NCT03332771|11322544|FG003|Overall Study|Adverse Event|3
7155052|NCT03332771|11322541|FG000|Overall Study|Poor Compliance to Protocol|0
7155053|NCT03332771|11322542|FG001|Overall Study|Poor Compliance to Protocol|1
7155054|NCT03332771|11322543|FG002|Overall Study|Poor Compliance to Protocol|0
7155055|NCT03332771|11322544|FG003|Overall Study|Poor Compliance to Protocol|1
7155056|NCT03332771|11322541|FG000|Overall Study|Lost to Follow-up|2
7155057|NCT03332771|11322542|FG001|Overall Study|Lost to Follow-up|2
7155058|NCT03332771|11322543|FG002|Overall Study|Lost to Follow-up|1
7155059|NCT03332771|11322544|FG003|Overall Study|Lost to Follow-up|2
7155060|NCT03332771|11322541|FG000|Overall Study|At the Participant's own request|20
7155061|NCT03332771|11322542|FG001|Overall Study|At the Participant's own request|26
7155062|NCT03332771|11322543|FG002|Overall Study|At the Participant's own request|14
7155063|NCT03332771|11322544|FG003|Overall Study|At the Participant's own request|23
7155064|NCT03332771|11322541|FG000|Overall Study|Reason Not Specified|6
6880126|NCT00528879|10892462|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6
6880127|NCT00528879|10892463|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8
6880128|NCT00528879|10892464|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
6880129|NCT00528879|10892461|FG000|Long-term Period (Weeks 24 to 102)|Death|0
6880130|NCT00528879|10892462|FG001|Long-term Period (Weeks 24 to 102)|Death|1
6880131|NCT00528879|10892463|FG002|Long-term Period (Weeks 24 to 102)|Death|0
6880132|NCT00528879|10892464|FG003|Long-term Period (Weeks 24 to 102)|Death|0
6880133|NCT00528879|10892461|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4
6880134|NCT00528879|10892462|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5
6880135|NCT00528879|10892463|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3
6880136|NCT00528879|10892464|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7
6880137|NCT00528879|10892461|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0
6880138|NCT00528879|10892462|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5
6880139|NCT00528879|10892463|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1
6880140|NCT00528879|10892464|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2
6880141|NCT00528879|10892461|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1
6880142|NCT00528879|10892462|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0
6880143|NCT00528879|10892463|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0
6880144|NCT00528879|10892464|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0
6880145|NCT00528879|10892461|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
6880146|NCT00528879|10892462|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
7155065|NCT03332771|11322542|FG001|Overall Study|Reason Not Specified|18
7155066|NCT03332771|11322543|FG002|Overall Study|Reason Not Specified|16
7155067|NCT03332771|11322544|FG003|Overall Study|Reason Not Specified|19
7155068|NCT03332784|11322574|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7155069|NCT03332784|11322575|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1
7155070|NCT03332784|11322576|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7155071|NCT03332784|11322577|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7155072|NCT03332784|11322578|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7155073|NCT03332784|11322579|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7155074|NCT03332784|11322580|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7155075|NCT03332784|11322581|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7155076|NCT03332784|11322582|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7155077|NCT03332784|11322583|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7155078|NCT03332784|11322584|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7155079|NCT03332784|11322585|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7155080|NCT03332784|11322586|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7155081|NCT03332784|11322587|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7155082|NCT03332784|11322588|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1
7155083|NCT03332784|11322589|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7155084|NCT03332784|11322590|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7155085|NCT03332784|11322591|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7155086|NCT03332784|11322592|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7155087|NCT03332784|11322593|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7155088|NCT03333109|11322654|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0
6880147|NCT00528879|10892463|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
6880148|NCT00528879|10892464|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0
6880149|NCT00528931|10892474|FG000|Overall Study|Lost to Follow-up|1
6880150|NCT00528957|10892481|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2
6880151|NCT00528957|10892482|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1
6880152|NCT00528957|10892481|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2
6880153|NCT00528957|10892482|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0
7155089|NCT03333109|11322655|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0
7155090|NCT03333109|11322656|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2
7155091|NCT03333109|11322654|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0
7155092|NCT03333109|11322655|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0
7155093|NCT03333109|11322656|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1
7155094|NCT03333109|11322654|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4
7155095|NCT03333109|11322655|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0
7155096|NCT03333109|11322656|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1
7155097|NCT03333109|11322654|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1
7155098|NCT03333109|11322655|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0
7155099|NCT03333109|11322656|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0
7155100|NCT03333109|11322654|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9
7155101|NCT03333109|11322655|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6
7155102|NCT03333109|11322656|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5
7155103|NCT03333109|11322654|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3
7155104|NCT03333109|11322655|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0
7155105|NCT03333109|11322656|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3
7155106|NCT03333109|11322654|FG000|Safety Follow-up Period|Lost to Follow-up|6
7155107|NCT03333109|11322655|FG001|Safety Follow-up Period|Lost to Follow-up|2
6880154|NCT00528957|10892481|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2
6880155|NCT00528957|10892482|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0
6880156|NCT00528957|10892481|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1
6880157|NCT00528957|10892482|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0
6880158|NCT00528957|10892481|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0
6880159|NCT00528957|10892482|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1
6880160|NCT00528957|10892481|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4
6880161|NCT00528957|10892482|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3
6880162|NCT00528957|10892481|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3
6880163|NCT00528957|10892482|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0
6880164|NCT00528957|10892481|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5
7155108|NCT03333109|11322656|FG002|Safety Follow-up Period|Lost to Follow-up|1
7155109|NCT03333109|11322654|FG000|Safety Follow-up Period|Withdrawal by Subject|7
7155110|NCT03333109|11322655|FG001|Safety Follow-up Period|Withdrawal by Subject|2
7155111|NCT03333109|11322656|FG002|Safety Follow-up Period|Withdrawal by Subject|12
7155112|NCT03333876|11322685|FG000|Screening Period|Screen Failure|4
7155113|NCT03333876|11322685|FG000|Nasal Dilator|Bed Partner Lost to follow up|6
7155114|NCT03333876|11322685|FG000|Mandibular Advancement|Adverse Event|2
7155115|NCT03333876|11322685|FG000|Mandibular Advancement|Product Damage|2
7155116|NCT03333941|11322698|FG000|Overall Study|Lost to Follow-up|10
7155117|NCT03333941|11322698|FG000|Overall Study|Death|2
7155118|NCT03333941|11322698|FG000|Overall Study|Adverse Event|1
7155119|NCT03334175|11322704|FG000|Overall Study|Lost to Follow-up|0
7155120|NCT03334175|11322705|FG001|Overall Study|Lost to Follow-up|1
7155121|NCT03334188|11322713|FG000|Overall Study|Withdrawal by Subject|0
7155122|NCT03334188|11322714|FG001|Overall Study|Withdrawal by Subject|1
7155123|NCT03334188|11322713|FG000|Overall Study|Death|1
7155124|NCT03334188|11322714|FG001|Overall Study|Death|0
7155125|NCT03334188|11322713|FG000|Overall Study|Never had qualifying clinic visit|7
7155126|NCT03334188|11322714|FG001|Overall Study|Never had qualifying clinic visit|7
7155127|NCT03334214|11322723|FG000|Overall Study|Adverse Event or Serious Adverse Event|0
7155128|NCT03334214|11322724|FG001|Overall Study|Adverse Event or Serious Adverse Event|1
7155129|NCT03334214|11322723|FG000|Overall Study|Withdrawal by Subject|0
7155130|NCT03334214|11322724|FG001|Overall Study|Withdrawal by Subject|1
7155131|NCT03334214|11322723|FG000|Overall Study|Other|1
7155132|NCT03334214|11322724|FG001|Overall Study|Other|0
7155133|NCT03334396|11322739|FG000|Overall Study|Adverse Event|1
7155134|NCT03334396|11322740|FG001|Overall Study|Adverse Event|0
7155135|NCT03334396|11322741|FG002|Overall Study|Adverse Event|1
7155136|NCT03334396|11322742|FG003|Overall Study|Adverse Event|0
7155137|NCT03334396|11322743|FG004|Overall Study|Adverse Event|0
7155138|NCT03334396|11322744|FG005|Overall Study|Adverse Event|0
7155139|NCT03334396|11322745|FG006|Overall Study|Adverse Event|0
7155140|NCT03334396|11322746|FG007|Overall Study|Adverse Event|0
7155141|NCT03334396|11322739|FG000|Overall Study|Lack of Efficacy|10
7155142|NCT03334396|11322740|FG001|Overall Study|Lack of Efficacy|4
7155143|NCT03334396|11322741|FG002|Overall Study|Lack of Efficacy|1
7155144|NCT03334396|11322742|FG003|Overall Study|Lack of Efficacy|3
7155145|NCT03334396|11322743|FG004|Overall Study|Lack of Efficacy|1
7155146|NCT03334396|11322744|FG005|Overall Study|Lack of Efficacy|0
7155147|NCT03334396|11322745|FG006|Overall Study|Lack of Efficacy|0
7155148|NCT03334396|11322746|FG007|Overall Study|Lack of Efficacy|1
7155149|NCT03334396|11322739|FG000|Overall Study|Lost to Follow-up|0
7155150|NCT03334396|11322740|FG001|Overall Study|Lost to Follow-up|0
7155151|NCT03334396|11322741|FG002|Overall Study|Lost to Follow-up|1
7155152|NCT03334396|11322742|FG003|Overall Study|Lost to Follow-up|0
7155153|NCT03334396|11322743|FG004|Overall Study|Lost to Follow-up|0
7155154|NCT03334396|11322744|FG005|Overall Study|Lost to Follow-up|0
7155155|NCT03334396|11322745|FG006|Overall Study|Lost to Follow-up|1
7155156|NCT03334396|11322746|FG007|Overall Study|Lost to Follow-up|0
7155157|NCT03334396|11322739|FG000|Overall Study|Physician Decision|1
7155158|NCT03334396|11322740|FG001|Overall Study|Physician Decision|0
7155159|NCT03334396|11322741|FG002|Overall Study|Physician Decision|0
7155160|NCT03334396|11322742|FG003|Overall Study|Physician Decision|0
7155161|NCT03334396|11322743|FG004|Overall Study|Physician Decision|0
7155162|NCT03334396|11322744|FG005|Overall Study|Physician Decision|0
7155163|NCT03334396|11322745|FG006|Overall Study|Physician Decision|0
7155164|NCT03334396|11322746|FG007|Overall Study|Physician Decision|0
7155165|NCT03334396|11322739|FG000|Overall Study|Withdrawal by Subject|10
7155166|NCT03334396|11322740|FG001|Overall Study|Withdrawal by Subject|5
7155167|NCT03334396|11322741|FG002|Overall Study|Withdrawal by Subject|7
7155168|NCT03334396|11322742|FG003|Overall Study|Withdrawal by Subject|2
7155169|NCT03334396|11322743|FG004|Overall Study|Withdrawal by Subject|2
7155170|NCT03334396|11322744|FG005|Overall Study|Withdrawal by Subject|1
7155171|NCT03334396|11322745|FG006|Overall Study|Withdrawal by Subject|2
7155172|NCT03334396|11322746|FG007|Overall Study|Withdrawal by Subject|0
7155173|NCT03334396|11322739|FG000|Overall Study|Pregnancy|0
7155174|NCT03334396|11322740|FG001|Overall Study|Pregnancy|1
7155175|NCT03334396|11322741|FG002|Overall Study|Pregnancy|0
7155176|NCT03334396|11322742|FG003|Overall Study|Pregnancy|0
7155177|NCT03334396|11322743|FG004|Overall Study|Pregnancy|0
7155178|NCT03334396|11322744|FG005|Overall Study|Pregnancy|0
6880165|NCT00528957|10892482|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4
6880166|NCT00528957|10892481|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0
6880167|NCT00528957|10892482|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3
6880168|NCT00528957|10892481|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
7078960|NCT02107196|11187592|FG001|12-week Treatment Period|Protocol Violation|8
7155179|NCT03334396|11322745|FG006|Overall Study|Pregnancy|0
7155180|NCT03334396|11322746|FG007|Overall Study|Pregnancy|0
7155181|NCT03334396|11322739|FG000|Overall Study|Ineligible|0
7155182|NCT03334396|11322740|FG001|Overall Study|Ineligible|1
7155183|NCT03334396|11322741|FG002|Overall Study|Ineligible|0
7155184|NCT03334396|11322742|FG003|Overall Study|Ineligible|0
7155185|NCT03334396|11322743|FG004|Overall Study|Ineligible|0
7155186|NCT03334396|11322744|FG005|Overall Study|Ineligible|0
7155187|NCT03334396|11322745|FG006|Overall Study|Ineligible|0
7155188|NCT03334396|11322746|FG007|Overall Study|Ineligible|0
7155189|NCT03334396|11322739|FG000|Overall Study|Started New Job|1
7155190|NCT03334396|11322740|FG001|Overall Study|Started New Job|0
7155191|NCT03334396|11322741|FG002|Overall Study|Started New Job|0
7155192|NCT03334396|11322742|FG003|Overall Study|Started New Job|0
7155193|NCT03334396|11322743|FG004|Overall Study|Started New Job|0
7155194|NCT03334396|11322744|FG005|Overall Study|Started New Job|0
7155195|NCT03334396|11322745|FG006|Overall Study|Started New Job|0
7155196|NCT03334396|11322746|FG007|Overall Study|Started New Job|0
7155197|NCT03334422|11322767|FG000|Overall Study|Adverse Event|1
7155198|NCT03334422|11322768|FG001|Overall Study|Adverse Event|3
7155199|NCT03334422|11322769|FG002|Overall Study|Adverse Event|2
7155200|NCT03334422|11322770|FG003|Overall Study|Adverse Event|2
7155201|NCT03334422|11322767|FG000|Overall Study|Lack of Efficacy|10
7155202|NCT03334422|11322768|FG001|Overall Study|Lack of Efficacy|2
7155203|NCT03334422|11322769|FG002|Overall Study|Lack of Efficacy|7
7155204|NCT03334422|11322770|FG003|Overall Study|Lack of Efficacy|3
7155205|NCT03334422|11322767|FG000|Overall Study|Withdrawal by Subject|8
7155206|NCT03334422|11322768|FG001|Overall Study|Withdrawal by Subject|3
7155207|NCT03334422|11322769|FG002|Overall Study|Withdrawal by Subject|1
7155208|NCT03334422|11322770|FG003|Overall Study|Withdrawal by Subject|0
7155209|NCT03334422|11322767|FG000|Overall Study|Lost to Follow-up|0
7155210|NCT03334422|11322768|FG001|Overall Study|Lost to Follow-up|0
7155211|NCT03334422|11322769|FG002|Overall Study|Lost to Follow-up|0
7155212|NCT03334422|11322770|FG003|Overall Study|Lost to Follow-up|1
7155213|NCT03334422|11322767|FG000|Overall Study|Inability to obtain laboratory samples|0
7155214|NCT03334422|11322768|FG001|Overall Study|Inability to obtain laboratory samples|1
7155215|NCT03334422|11322769|FG002|Overall Study|Inability to obtain laboratory samples|0
7078961|NCT02107196|11187591|FG000|12-week Treatment Period|Reason Missing|11
7078962|NCT02107196|11187592|FG001|12-week Treatment Period|Reason Missing|8
7078963|NCT02107196|11187591|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2
7078964|NCT02107196|11187592|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0
7078965|NCT02107196|11187591|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1
7078966|NCT02107196|11187592|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0
7078967|NCT02107196|11187591|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2
7078968|NCT02107196|11187592|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0
7078969|NCT02107196|11187591|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18
7078970|NCT02107196|11187592|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5
7078971|NCT02107274|11187600|FG000|Treatment vs. Placebo|Adverse Event|3
7078972|NCT02107274|11187601|FG001|Treatment vs. Placebo|Adverse Event|0
6880169|NCT00528957|10892482|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
6880170|NCT00528957|10892481|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0
6880171|NCT00528957|10892482|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1
7078973|NCT02107274|11187600|FG000|Treatment vs. Placebo|Lost to Follow-up|0
7155216|NCT03334422|11322770|FG003|Overall Study|Inability to obtain laboratory samples|0
7155217|NCT03334422|11322767|FG000|Overall Study|Pregnancy|0
7155218|NCT03334422|11322768|FG001|Overall Study|Pregnancy|1
7155219|NCT03334422|11322769|FG002|Overall Study|Pregnancy|0
7155220|NCT03334422|11322770|FG003|Overall Study|Pregnancy|0
7155221|NCT03334448|11322785|FG000|Washout|Personal Reason|0
7155222|NCT03334448|11322786|FG001|Washout|Personal Reason|1
7155223|NCT03334448|11322787|FG002|Washout|Personal Reason|0
7155224|NCT03334448|11322788|FG003|Washout|Personal Reason|0
7155225|NCT03334448|11322785|FG000|Washout|Protocol Violation|0
7155226|NCT03334448|11322786|FG001|Washout|Protocol Violation|0
7155227|NCT03334448|11322787|FG002|Washout|Protocol Violation|0
7155228|NCT03334448|11322788|FG003|Washout|Protocol Violation|1
7155229|NCT03334630|11322796|FG000|Overall Study|Withdrawal by Subject|7
7155230|NCT03334630|11322797|FG001|Overall Study|Withdrawal by Subject|7
7155231|NCT03334630|11322796|FG000|Overall Study|Lost to Follow-up|3
7155232|NCT03334630|11322797|FG001|Overall Study|Lost to Follow-up|1
7155233|NCT03334630|11322796|FG000|Overall Study|Adverse Event|0
7155234|NCT03334630|11322797|FG001|Overall Study|Adverse Event|1
7155235|NCT03334630|11322796|FG000|Overall Study|Physician Decision|1
7155236|NCT03334630|11322797|FG001|Overall Study|Physician Decision|1
7155237|NCT03334630|11322796|FG000|Overall Study|Enrollment closed|2
7155238|NCT03334630|11322797|FG001|Overall Study|Enrollment closed|1
7155239|NCT03334630|11322796|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0
6880172|NCT00528957|10892481|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0
6880173|NCT00528957|10892482|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1
6880174|NCT00528957|10892481|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4
6880175|NCT00528957|10892482|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10
6880176|NCT00528957|10892481|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3
6880177|NCT00528957|10892482|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5
6880178|NCT00528957|10892481|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2
6880179|NCT00528957|10892482|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1
6880180|NCT00528957|10892481|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
6880181|NCT00528957|10892482|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
6880182|NCT00528970|10892501|FG000|Overall Study|Adverse Event|6
6880183|NCT00528970|10892502|FG001|Overall Study|Adverse Event|8
6880184|NCT00528970|10892503|FG002|Overall Study|Adverse Event|5
6880185|NCT00528970|10892501|FG000|Overall Study|Lost to Follow-up|0
6880186|NCT00528970|10892502|FG001|Overall Study|Lost to Follow-up|0
6880187|NCT00528970|10892503|FG002|Overall Study|Lost to Follow-up|1
6880188|NCT00528970|10892501|FG000|Overall Study|Other than specified|2
6880189|NCT00528970|10892502|FG001|Overall Study|Other than specified|3
7078974|NCT02107274|11187601|FG001|Treatment vs. Placebo|Lost to Follow-up|2
7155240|NCT03334630|11322797|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1
7155241|NCT03334630|11322796|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1
7155242|NCT03334630|11322797|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1
7155243|NCT03334695|11322805|FG000|Overall Study|Lost to Follow-up|3
7155244|NCT03334695|11322806|FG001|Overall Study|Lost to Follow-up|3
7155245|NCT03334695|11322805|FG000|Overall Study|Physician Decision|1
7155246|NCT03334695|11322806|FG001|Overall Study|Physician Decision|2
7155247|NCT03334695|11322805|FG000|Overall Study|Protocol Violation|0
7155248|NCT03334695|11322806|FG001|Overall Study|Protocol Violation|1
7155249|NCT03334721|11322816|FG000|Overall Study|Withdrawal by Subject|1
7155250|NCT03334721|11322817|FG001|Overall Study|Withdrawal by Subject|0
7155251|NCT03334721|11322816|FG000|Overall Study|No longer met inclusion/exclusion criter|1
7155252|NCT03334721|11322817|FG001|Overall Study|No longer met inclusion/exclusion criter|0
7155253|NCT03334747|11322849|FG000|Treatment Phase|Technical problems|0
7155254|NCT03334747|11322850|FG001|Treatment Phase|Technical problems|0
7155255|NCT03334747|11322851|FG002|Treatment Phase|Technical problems|0
7155256|NCT03334747|11322852|FG003|Treatment Phase|Technical problems|0
7155257|NCT03334747|11322853|FG004|Treatment Phase|Technical problems|1
7155258|NCT03334747|11322854|FG005|Treatment Phase|Technical problems|0
7155259|NCT03334747|11322855|FG006|Treatment Phase|Technical problems|0
7155260|NCT03334747|11322856|FG007|Treatment Phase|Technical problems|0
7155261|NCT03334747|11322857|FG008|Treatment Phase|Technical problems|0
7155262|NCT03334747|11322849|FG000|Treatment Phase|Subject/guardian decision|1
7155263|NCT03334747|11322850|FG001|Treatment Phase|Subject/guardian decision|0
7155264|NCT03334747|11322851|FG002|Treatment Phase|Subject/guardian decision|0
7155265|NCT03334747|11322852|FG003|Treatment Phase|Subject/guardian decision|0
7155266|NCT03334747|11322853|FG004|Treatment Phase|Subject/guardian decision|0
7155267|NCT03334747|11322854|FG005|Treatment Phase|Subject/guardian decision|1
7155268|NCT03334747|11322855|FG006|Treatment Phase|Subject/guardian decision|0
7155269|NCT03334747|11322856|FG007|Treatment Phase|Subject/guardian decision|0
7155270|NCT03334747|11322857|FG008|Treatment Phase|Subject/guardian decision|0
7155271|NCT03334747|11322849|FG000|Follow-Up Phase|Subject/guardian decision|0
7155272|NCT03334747|11322850|FG001|Follow-Up Phase|Subject/guardian decision|0
7155273|NCT03334747|11322851|FG002|Follow-Up Phase|Subject/guardian decision|0
7155274|NCT03334747|11322852|FG003|Follow-Up Phase|Subject/guardian decision|0
7155275|NCT03334747|11322853|FG004|Follow-Up Phase|Subject/guardian decision|0
7155276|NCT03334747|11322854|FG005|Follow-Up Phase|Subject/guardian decision|0
7155277|NCT03334747|11322855|FG006|Follow-Up Phase|Subject/guardian decision|1
7155278|NCT03334747|11322856|FG007|Follow-Up Phase|Subject/guardian decision|0
7155279|NCT03334747|11322857|FG008|Follow-Up Phase|Subject/guardian decision|1
7155280|NCT03334903|11322899|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1
7155281|NCT03334903|11322900|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0
7155282|NCT03334903|11322899|FG000|Overall Study|Protocol Violation|1
7155283|NCT03334903|11322900|FG001|Overall Study|Protocol Violation|3
7155284|NCT03334903|11322899|FG000|Overall Study|Surgery postponed|1
6880190|NCT00528970|10892503|FG002|Overall Study|Other than specified|3
6880191|NCT00528970|10892501|FG000|Overall Study|Protocol Violation|2
6969425|NCT01147744|11019038|FG003|Overall Study|Withdrawal by Subject|2
7078975|NCT02107274|11187600|FG000|Control Phase|Lost to Follow-up|1
7078976|NCT02107274|11187601|FG001|Control Phase|Lost to Follow-up|1
7078977|NCT02107274|11187600|FG000|Control Phase|Death|2
7078978|NCT02107274|11187601|FG001|Control Phase|Death|0
7078979|NCT02107274|11187600|FG000|Control Phase|Adverse Event|0
7078980|NCT02107274|11187601|FG001|Control Phase|Adverse Event|1
7078981|NCT02107313|11187616|FG000|Overall Study|One participant did not do the FED cohor|0
7078982|NCT02107313|11187617|FG001|Overall Study|One participant did not do the FED cohor|1
7078983|NCT02107443|11187634|FG000|Overall Study|Death|42
7078984|NCT02107443|11187635|FG001|Overall Study|Death|30
7078985|NCT02107443|11187634|FG000|Overall Study|Study Protocol Violation|3
6880192|NCT00528970|10892502|FG001|Overall Study|Protocol Violation|1
6880193|NCT00528970|10892503|FG002|Overall Study|Protocol Violation|4
6880194|NCT00528970|10892501|FG000|Overall Study|Lack of Efficacy|0
6880195|NCT00528970|10892502|FG001|Overall Study|Lack of Efficacy|0
6880196|NCT00528970|10892503|FG002|Overall Study|Lack of Efficacy|1
6880197|NCT00528970|10892501|FG000|Overall Study|Withdrawal by Subject|4
6880198|NCT00528970|10892502|FG001|Overall Study|Withdrawal by Subject|3
6880199|NCT00528970|10892503|FG002|Overall Study|Withdrawal by Subject|5
6880200|NCT00528970|10892501|FG000|Overall Study|Randomized but not treated|0
6880201|NCT00528970|10892502|FG001|Overall Study|Randomized but not treated|0
6880202|NCT00528970|10892503|FG002|Overall Study|Randomized but not treated|1
6880203|NCT00528996|10892516|FG000|Overall Study|Other reasons than listing|6
6880204|NCT00528996|10892517|FG001|Overall Study|Other reasons than listing|7
6880205|NCT00528996|10892518|FG002|Overall Study|Other reasons than listing|14
6880206|NCT00528996|10892519|FG003|Overall Study|Other reasons than listing|11
6880207|NCT00528996|10892520|FG004|Overall Study|Other reasons than listing|5
6880208|NCT00528996|10892516|FG000|Overall Study|Refused continue medication|16
6880209|NCT00528996|10892517|FG001|Overall Study|Refused continue medication|0
6880210|NCT00528996|10892518|FG002|Overall Study|Refused continue medication|3
6880211|NCT00528996|10892519|FG003|Overall Study|Refused continue medication|3
6880212|NCT00528996|10892520|FG004|Overall Study|Refused continue medication|6
6880213|NCT00528996|10892516|FG000|Overall Study|Lost to Follow-up|2
6880214|NCT00528996|10892517|FG001|Overall Study|Lost to Follow-up|0
6880215|NCT00528996|10892518|FG002|Overall Study|Lost to Follow-up|4
6880216|NCT00528996|10892519|FG003|Overall Study|Lost to Follow-up|1
6880217|NCT00528996|10892520|FG004|Overall Study|Lost to Follow-up|3
6880218|NCT00528996|10892516|FG000|Overall Study|Protocol Violation|1
6880219|NCT00528996|10892517|FG001|Overall Study|Protocol Violation|2
6880220|NCT00528996|10892518|FG002|Overall Study|Protocol Violation|3
6880221|NCT00528996|10892519|FG003|Overall Study|Protocol Violation|3
6880222|NCT00528996|10892520|FG004|Overall Study|Protocol Violation|2
6880223|NCT00528996|10892516|FG000|Overall Study|Lack of Efficacy|7
6880224|NCT00528996|10892517|FG001|Overall Study|Lack of Efficacy|2
6880225|NCT00528996|10892518|FG002|Overall Study|Lack of Efficacy|1
6880226|NCT00528996|10892519|FG003|Overall Study|Lack of Efficacy|3
6880227|NCT00528996|10892520|FG004|Overall Study|Lack of Efficacy|3
6880228|NCT00528996|10892516|FG000|Overall Study|Adverse Event|32
6880229|NCT00528996|10892517|FG001|Overall Study|Adverse Event|13
6880230|NCT00528996|10892518|FG002|Overall Study|Adverse Event|18
6880231|NCT00528996|10892519|FG003|Overall Study|Adverse Event|29
6880232|NCT00528996|10892520|FG004|Overall Study|Adverse Event|18
6880233|NCT00529035|10892535|FG000|Overall Study|Withdrawal by Subject|1
6880234|NCT00529087|10892549|FG000|Overall Study|Adverse Event|10
6880235|NCT00529087|10892550|FG001|Overall Study|Adverse Event|13
6880236|NCT00529087|10892551|FG002|Overall Study|Adverse Event|4
6880237|NCT00529087|10892549|FG000|Overall Study|Lost to Follow-up|6
6880238|NCT00529087|10892550|FG001|Overall Study|Lost to Follow-up|4
6880239|NCT00529087|10892551|FG002|Overall Study|Lost to Follow-up|1
6880240|NCT00529087|10892549|FG000|Overall Study|Protocol Violation|8
6880241|NCT00529087|10892550|FG001|Overall Study|Protocol Violation|7
6880242|NCT00529087|10892551|FG002|Overall Study|Protocol Violation|6
6880243|NCT00529087|10892549|FG000|Overall Study|Withdrawal by Subject|3
6880244|NCT00529087|10892550|FG001|Overall Study|Withdrawal by Subject|3
6880245|NCT00529087|10892551|FG002|Overall Study|Withdrawal by Subject|3
6880246|NCT00529087|10892549|FG000|Overall Study|Protocol deviation|1
6880247|NCT00529087|10892550|FG001|Overall Study|Protocol deviation|1
6880248|NCT00529087|10892551|FG002|Overall Study|Protocol deviation|2
7155285|NCT03334903|11322900|FG001|Overall Study|Surgery postponed|0
7155286|NCT03334903|11322899|FG000|Overall Study|Adverse Event|1
7155287|NCT03334903|11322900|FG001|Overall Study|Adverse Event|1
7155288|NCT03334903|11322899|FG000|Overall Study|Withdrawal by Subject|0
7155289|NCT03334903|11322900|FG001|Overall Study|Withdrawal by Subject|1
7155290|NCT03335150|11322908|FG000|Overall Study|Withdrawal by Subject|10
7155291|NCT03335150|11322909|FG001|Overall Study|Withdrawal by Subject|4
7155292|NCT03335150|11322908|FG000|Overall Study|Adverse Event|0
7155293|NCT03335150|11322909|FG001|Overall Study|Adverse Event|1
7155294|NCT03335566|11322985|FG000|Overall Study|Adverse Event|0
7155295|NCT03335566|11322986|FG001|Overall Study|Adverse Event|1
7155296|NCT03335566|11322985|FG000|Overall Study|Lost to Follow-up|1
7155297|NCT03335566|11322986|FG001|Overall Study|Lost to Follow-up|0
7155298|NCT03335566|11322985|FG000|Overall Study|Technical Problems|1
7155299|NCT03335566|11322986|FG001|Overall Study|Technical Problems|0
6880249|NCT00529100|10892572|FG000|Overall Study|Adverse Event|0
6880250|NCT00529100|10892573|FG001|Overall Study|Adverse Event|5
6880251|NCT00529100|10892572|FG000|Overall Study|Protocol Violation|0
6880252|NCT00529100|10892573|FG001|Overall Study|Protocol Violation|1
6880253|NCT00529100|10892572|FG000|Overall Study|Progressive Disease|0
6880254|NCT00529100|10892573|FG001|Overall Study|Progressive Disease|1
6880255|NCT00529100|10892572|FG000|Overall Study|Withdrawal by Subject|0
6880256|NCT00529100|10892573|FG001|Overall Study|Withdrawal by Subject|1
6880257|NCT00529100|10892572|FG000|Overall Study|Participant Ineligibility|0
6880258|NCT00529100|10892573|FG001|Overall Study|Participant Ineligibility|1
6880259|NCT00529217|10892622|FG000|Overall Study|Lack of Efficacy|2
6880260|NCT00529217|10892622|FG000|Overall Study|Unable to adhere to study schedule|2
6880261|NCT00529243|10892627|FG000|Overall Study|Adverse Event|1
6880262|NCT00529243|10892627|FG000|Overall Study|Death|1
6880263|NCT00529243|10892627|FG000|Overall Study|Relocated|1
7155300|NCT03335566|11322985|FG000|Overall Study|Protocol Violation|1
7155301|NCT03335566|11322986|FG001|Overall Study|Protocol Violation|0
7155302|NCT03335566|11322985|FG000|Overall Study|Other than specified above|1
7155303|NCT03335566|11322986|FG001|Overall Study|Other than specified above|2
7155304|NCT03336502|11323015|FG000|Overall Study|Physician Decision|0
7155305|NCT03336502|11323016|FG001|Overall Study|Physician Decision|1
7155306|NCT03336502|11323015|FG000|Overall Study|Prohibited Drugs|1
7155307|NCT03336502|11323016|FG001|Overall Study|Prohibited Drugs|1
7155308|NCT03336502|11323015|FG000|Overall Study|Death|1
7155309|NCT03336502|11323016|FG001|Overall Study|Death|2
7155310|NCT03336502|11323015|FG000|Overall Study|Adverse Event|2
7155311|NCT03336502|11323016|FG001|Overall Study|Adverse Event|5
7155312|NCT03337139|11323037|FG000|Phase I|Withdrawal by Subject|10
7155313|NCT03337139|11323038|FG001|Phase I|Withdrawal by Subject|0
7155314|NCT03337152|11323046|FG000|Overall Study|Physician Decision|1
7155315|NCT03337152|11323047|FG001|Overall Study|Physician Decision|0
7155316|NCT03337152|11323046|FG000|Overall Study|Lost to Follow-up|1
7155317|NCT03337152|11323047|FG001|Overall Study|Lost to Follow-up|3
7155318|NCT03337152|11323046|FG000|Overall Study|Adverse Event|3
7155319|NCT03337152|11323047|FG001|Overall Study|Adverse Event|1
7155320|NCT03337152|11323046|FG000|Overall Study|Stopped drug dosing due to study halt|6
7155321|NCT03337152|11323047|FG001|Overall Study|Stopped drug dosing due to study halt|7
7155322|NCT03337308|11323059|FG000|Overall Study|Adverse Event|2
7155323|NCT03337308|11323060|FG001|Overall Study|Adverse Event|3
7155324|NCT03337308|11323061|FG002|Overall Study|Adverse Event|3
7155325|NCT03337308|11323062|FG003|Overall Study|Adverse Event|1
7155326|NCT03337308|11323059|FG000|Overall Study|Lost to Follow-up|1
7155327|NCT03337308|11323060|FG001|Overall Study|Lost to Follow-up|2
7155328|NCT03337308|11323061|FG002|Overall Study|Lost to Follow-up|0
7155329|NCT03337308|11323062|FG003|Overall Study|Lost to Follow-up|0
7155330|NCT03337308|11323059|FG000|Overall Study|Withdrawal by Subject|2
7155331|NCT03337308|11323060|FG001|Overall Study|Withdrawal by Subject|1
7155332|NCT03337308|11323061|FG002|Overall Study|Withdrawal by Subject|2
7155333|NCT03337308|11323062|FG003|Overall Study|Withdrawal by Subject|1
7155334|NCT03337308|11323059|FG000|Overall Study|Protocol Violation|0
7155335|NCT03337308|11323060|FG001|Overall Study|Protocol Violation|1
7155336|NCT03337308|11323061|FG002|Overall Study|Protocol Violation|0
7155337|NCT03337308|11323062|FG003|Overall Study|Protocol Violation|0
7155338|NCT03337477|11323074|FG000|Overall Study|not categorized into the listed ones|11
7155339|NCT03337477|11323075|FG001|Overall Study|not categorized into the listed ones|9
7155340|NCT03337477|11323074|FG000|Overall Study|Withdrawal by Subject|0
7155341|NCT03337477|11323075|FG001|Overall Study|Withdrawal by Subject|1
7155342|NCT03337477|11323074|FG000|Overall Study|Death|0
7155343|NCT03337477|11323075|FG001|Overall Study|Death|1
7155344|NCT03337477|11323074|FG000|Overall Study|Lost to Follow-up|0
7155345|NCT03337477|11323075|FG001|Overall Study|Lost to Follow-up|2
7155346|NCT03337490|11323086|FG000|Overall Study|Withdrawal by Subject|1
7155347|NCT03337490|11323087|FG001|Overall Study|Withdrawal by Subject|0
7155348|NCT03337490|11323088|FG002|Overall Study|Withdrawal by Subject|0
7155349|NCT03337490|11323086|FG000|Overall Study|Lack of Efficacy|10
7155350|NCT03337490|11323087|FG001|Overall Study|Lack of Efficacy|12
7155351|NCT03337490|11323088|FG002|Overall Study|Lack of Efficacy|35
7155352|NCT03337490|11323086|FG000|Overall Study|Physician Decision|0
7155353|NCT03337490|11323087|FG001|Overall Study|Physician Decision|1
7155354|NCT03337490|11323088|FG002|Overall Study|Physician Decision|0
7155355|NCT03337490|11323086|FG000|Overall Study|Lost to Follow-up|0
7155356|NCT03337490|11323087|FG001|Overall Study|Lost to Follow-up|1
7155357|NCT03337490|11323088|FG002|Overall Study|Lost to Follow-up|0
7155358|NCT03337542|11323096|FG000|Overall Study|Withdrew Consent|17
7155359|NCT03337542|11323096|FG000|Overall Study|Allergic Adverse Event|1
7155360|NCT03337542|11323096|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1
7155361|NCT03337542|11323096|FG000|Overall Study|Lost to Follow-up|1
7155362|NCT03337542|11323096|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1
7155363|NCT03338010|11323103|FG000|Overall Study|Withdrawal by Subject|14
7155364|NCT03338010|11323104|FG001|Overall Study|Withdrawal by Subject|8
7155365|NCT03338010|11323103|FG000|Overall Study|Lost to Follow-up|4
7155366|NCT03338010|11323104|FG001|Overall Study|Lost to Follow-up|2
7155367|NCT03338010|11323103|FG000|Overall Study|Adverse Event|3
7155368|NCT03338010|11323104|FG001|Overall Study|Adverse Event|2
7155369|NCT03338010|11323103|FG000|Overall Study|Physician Decision|2
7155370|NCT03338010|11323104|FG001|Overall Study|Physician Decision|2
7155371|NCT03338010|11323103|FG000|Overall Study|Non-Compliance with Study Drug|0
7155372|NCT03338010|11323104|FG001|Overall Study|Non-Compliance with Study Drug|3
7155373|NCT03338010|11323103|FG000|Overall Study|Protocol Violation|0
7155374|NCT03338010|11323104|FG001|Overall Study|Protocol Violation|1
7155375|NCT03338023|11323112|FG000|Overall Study|Withdrawal by Subject|3
7155376|NCT03338023|11323113|FG001|Overall Study|Withdrawal by Subject|4
7155377|NCT03338023|11323112|FG000|Overall Study|Protocol Violation|3
7155378|NCT03338023|11323113|FG001|Overall Study|Protocol Violation|3
7155379|NCT03338023|11323112|FG000|Overall Study|Lost to Follow-up|2
7155380|NCT03338023|11323113|FG001|Overall Study|Lost to Follow-up|1
7155381|NCT03338023|11323112|FG000|Overall Study|Physician Decision|1
7155382|NCT03338023|11323113|FG001|Overall Study|Physician Decision|2
6880264|NCT00529308|10892633|FG000|Overall Study|Withdrawal by Subject|1
6880265|NCT00529308|10892634|FG001|Overall Study|Withdrawal by Subject|1
6880266|NCT00529373|10892642|FG000|Base Study|Adverse Event|525
6880267|NCT00529373|10892643|FG001|Base Study|Adverse Event|470
6880268|NCT00529373|10892642|FG000|Base Study|Lack of Efficacy|16
6880269|NCT00529373|10892643|FG001|Base Study|Lack of Efficacy|75
7155383|NCT03338062|11323136|FG000|Overall Study|Alternative Therapy|1
7155384|NCT03338062|11323137|FG001|Overall Study|Alternative Therapy|0
7155385|NCT03338296|11323146|FG000|Overall Study|Adverse Event|0
7155386|NCT03338296|11323147|FG001|Overall Study|Adverse Event|1
7155387|NCT03338296|11323146|FG000|Overall Study|Withdrawal by Subject|14
7155388|NCT03338296|11323147|FG001|Overall Study|Withdrawal by Subject|13
7155389|NCT03338296|11323146|FG000|Overall Study|Lost to Follow-up|10
7155390|NCT03338296|11323147|FG001|Overall Study|Lost to Follow-up|10
7155391|NCT03338296|11323146|FG000|Overall Study|Study Terminated by Sponsor|77
7155392|NCT03338296|11323147|FG001|Overall Study|Study Terminated by Sponsor|76
7155393|NCT03338296|11323146|FG000|Overall Study|Other|2
7155394|NCT03338296|11323147|FG001|Overall Study|Other|7
7155395|NCT03338296|11323146|FG000|Overall Study|Missing|0
7155396|NCT03338296|11323147|FG001|Overall Study|Missing|1
7155397|NCT03338400|11323155|FG000|Overall Study|Lost to Follow-up|1
7155398|NCT03338400|11323156|FG001|Overall Study|Lost to Follow-up|2
7155399|NCT03338569|11323189|FG000|Overall Study|Physician Decision|8
7155400|NCT03338569|11323190|FG001|Overall Study|Physician Decision|3
7155401|NCT03338569|11323189|FG000|Overall Study|Withdrawal by Subject|0
7155402|NCT03338569|11323190|FG001|Overall Study|Withdrawal by Subject|1
7155403|NCT03338569|11323189|FG000|Overall Study|Lost to Follow-up|0
7155404|NCT03338569|11323190|FG001|Overall Study|Lost to Follow-up|1
7155405|NCT03338673|11323198|FG000|Overall Study|Lost to Follow-up|1
7155406|NCT03338673|11323199|FG001|Overall Study|Lost to Follow-up|1
7155407|NCT03338855|11323223|FG000|Overall Study|Withdrawn as birth control pill stopped|1
7155408|NCT03338855|11323224|FG001|Overall Study|Withdrawn as birth control pill stopped|0
7155409|NCT03338894|11323230|FG000|Overall Study|not able able to attend 9 or more classes|10
7155410|NCT03338998|11323236|FG000|Treatment Period|Withdrawal by Subject|1
7155411|NCT03338998|11323237|FG001|Treatment Period|Withdrawal by Subject|1
7155412|NCT03338998|11323236|FG000|Treatment Period|Adverse Event|0
7155413|NCT03338998|11323237|FG001|Treatment Period|Adverse Event|2
7155414|NCT03338998|11323236|FG000|Treatment Period|Protocol deviation|1
7155415|NCT03338998|11323237|FG001|Treatment Period|Protocol deviation|0
7155416|NCT03338998|11323236|FG000|Treatment Period|Physician Decision|2
7155417|NCT03338998|11323237|FG001|Treatment Period|Physician Decision|0
7155418|NCT03338998|11323236|FG000|Treatment Period|Subject failed swallow test|4
7155419|NCT03338998|11323237|FG001|Treatment Period|Subject failed swallow test|0
7155420|NCT03338998|11323236|FG000|Safety Follow-Up Period|Adverse Event|0
7155421|NCT03338998|11323237|FG001|Safety Follow-Up Period|Adverse Event|1
7155422|NCT03338998|11323236|FG000|Safety Follow-Up Period|Protocol deviation|1
7155423|NCT03338998|11323237|FG001|Safety Follow-Up Period|Protocol deviation|0
7155424|NCT03338998|11323236|FG000|Safety Follow-Up Period|Lost to Follow-up|1
7155425|NCT03338998|11323237|FG001|Safety Follow-Up Period|Lost to Follow-up|0
7155426|NCT03339219|11323257|FG000|Overall Study|Death|12
7155427|NCT03339219|11323257|FG000|Overall Study|Site Terminated by Sponsor|22
7155428|NCT03339219|11323257|FG000|Overall Study|Withdrawal by Subject|1
7155429|NCT03339297|11323263|FG000|Overall Study|Relapse of Hematologic Disease|1
7155430|NCT03339297|11323264|FG001|Overall Study|Relapse of Hematologic Disease|0
7155431|NCT03339297|11323263|FG000|Overall Study|Death|10
7155432|NCT03339297|11323264|FG001|Overall Study|Death|7
7155433|NCT03339297|11323263|FG000|Overall Study|Hepatic Candidosis|1
7155434|NCT03339297|11323264|FG001|Overall Study|Hepatic Candidosis|0
7155435|NCT03339297|11323263|FG000|Overall Study|Adverse Event, Serious Fatal|0
7155436|NCT03339297|11323264|FG001|Overall Study|Adverse Event, Serious Fatal|2
7155437|NCT03339297|11323263|FG000|Overall Study|Consent Withdrawn by Participant|3
7155438|NCT03339297|11323264|FG001|Overall Study|Consent Withdrawn by Participant|3
7155439|NCT03339297|11323263|FG000|Overall Study|Disease Relapse|2
7155440|NCT03339297|11323264|FG001|Overall Study|Disease Relapse|0
7155441|NCT03339297|11323263|FG000|Overall Study|Physician Decision|1
7155442|NCT03339297|11323264|FG001|Overall Study|Physician Decision|1
7155443|NCT03339297|11323263|FG000|Overall Study|Relapse of Disease New Transplant Performed|1
7155444|NCT03339297|11323264|FG001|Overall Study|Relapse of Disease New Transplant Performed|0
7155445|NCT03339297|11323263|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1
7155446|NCT03339297|11323264|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0
7155447|NCT03339297|11323263|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1
7155448|NCT03339297|11323264|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0
6880270|NCT00529373|10892642|FG000|Base Study|Lost to Follow-up|221
6880271|NCT00529373|10892643|FG001|Base Study|Lost to Follow-up|208
7155449|NCT03339297|11323263|FG000|Overall Study|Adverse Event, Non-fatal|1
7155450|NCT03339297|11323264|FG001|Overall Study|Adverse Event, Non-fatal|0
7155451|NCT03339297|11323263|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0
7155452|NCT03339297|11323264|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1
7155453|NCT03339297|11323263|FG000|Overall Study|Patient Was Not Eligible|1
6880272|NCT00529373|10892642|FG000|Base Study|Other Protocol Specified Criteria|19
6880273|NCT00529373|10892643|FG001|Base Study|Other Protocol Specified Criteria|20
6880274|NCT00529373|10892642|FG000|Base Study|Physician Decision|60
6880275|NCT00529373|10892643|FG001|Base Study|Physician Decision|52
6880276|NCT00529373|10892642|FG000|Base Study|Protocol Violation|48
6880277|NCT00529373|10892643|FG001|Base Study|Protocol Violation|38
6880278|NCT00529373|10892642|FG000|Base Study|Withdrawal by Subject|1062
6880279|NCT00529373|10892643|FG001|Base Study|Withdrawal by Subject|967
6880280|NCT00529373|10892642|FG000|Base Study|Did not continue into Extension|1795
6880281|NCT00529373|10892643|FG001|Base Study|Did not continue into Extension|2238
6880282|NCT00529373|10892642|FG000|First Extension Study|Adverse Event|162
6880283|NCT00529373|10892643|FG001|First Extension Study|Adverse Event|142
7155454|NCT03339297|11323264|FG001|Overall Study|Patient Was Not Eligible|0
7155455|NCT03339453|11323272|FG000|First Visit of Glucagon Treatment|Adverse Event|0
7155456|NCT03339453|11323273|FG001|First Visit of Glucagon Treatment|Adverse Event|1
7155457|NCT03339583|11323294|FG000|First Intervention (14 Days)|Adverse Event|1
7155458|NCT03339583|11323295|FG001|First Intervention (14 Days)|Adverse Event|0
7155459|NCT03339583|11323294|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0
7155460|NCT03339583|11323295|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1
7155461|NCT03339583|11323294|FG000|Second Intervention (14 Days)|Adverse Event|0
7155462|NCT03339583|11323295|FG001|Second Intervention (14 Days)|Adverse Event|1
7155463|NCT03339583|11323294|FG000|Follow-up (14 Days)|Physician Decision|6
7155464|NCT03339583|11323295|FG001|Follow-up (14 Days)|Physician Decision|3
7155465|NCT03339713|11323305|FG000|Overall Study|Lost to Follow-up|2
7155466|NCT03339713|11323306|FG001|Overall Study|Lost to Follow-up|1
7155467|NCT03339713|11323305|FG000|Overall Study|Protocol Violation|1
7155468|NCT03339713|11323306|FG001|Overall Study|Protocol Violation|0
7155469|NCT03339713|11323305|FG000|Overall Study|Withdrawal by Subject|1
7155470|NCT03339713|11323306|FG001|Overall Study|Withdrawal by Subject|1
7155471|NCT03339726|11323317|FG000|Overall Study|Withdrawal by Subject|1
7155472|NCT03339726|11323318|FG001|Overall Study|Withdrawal by Subject|0
7155473|NCT03339726|11323319|FG002|Overall Study|Withdrawal by Subject|0
7155474|NCT03339726|11323317|FG000|Overall Study|Lost to Follow-up|0
7155475|NCT03339726|11323318|FG001|Overall Study|Lost to Follow-up|1
7155476|NCT03339726|11323319|FG002|Overall Study|Lost to Follow-up|0
7155477|NCT03339999|11323331|FG000|Overall Study|Adverse Event|1
7155478|NCT03339999|11323332|FG001|Overall Study|Adverse Event|2
7155479|NCT03339999|11323333|FG002|Overall Study|Adverse Event|2
7155480|NCT03339999|11323334|FG003|Overall Study|Adverse Event|1
7155481|NCT03339999|11323331|FG000|Overall Study|Lack of Efficacy|0
7155482|NCT03339999|11323332|FG001|Overall Study|Lack of Efficacy|1
7155483|NCT03339999|11323333|FG002|Overall Study|Lack of Efficacy|0
7155484|NCT03339999|11323334|FG003|Overall Study|Lack of Efficacy|0
7155485|NCT03339999|11323331|FG000|Overall Study|Lost to Follow-up|0
7155486|NCT03339999|11323332|FG001|Overall Study|Lost to Follow-up|0
7155487|NCT03339999|11323333|FG002|Overall Study|Lost to Follow-up|0
7155488|NCT03339999|11323334|FG003|Overall Study|Lost to Follow-up|1
7155489|NCT03339999|11323331|FG000|Overall Study|Study Terminated by Sponsor|6
7155490|NCT03339999|11323332|FG001|Overall Study|Study Terminated by Sponsor|3
7155491|NCT03339999|11323333|FG002|Overall Study|Study Terminated by Sponsor|4
7155492|NCT03339999|11323334|FG003|Overall Study|Study Terminated by Sponsor|3
7155493|NCT03340025|11323349|FG000|Overall Study|Lost to Follow-up|2
7155494|NCT03340025|11323350|FG001|Overall Study|Lost to Follow-up|2
7155495|NCT03340961|11323434|FG000|Overall Study|Adverse Event|1
7155496|NCT03340961|11323435|FG001|Overall Study|Adverse Event|3
7155497|NCT03340961|11323436|FG002|Overall Study|Adverse Event|2
7155498|NCT03340961|11323437|FG003|Overall Study|Adverse Event|4
7155499|NCT03340961|11323434|FG000|Overall Study|Lost to Follow-up|0
7155500|NCT03340961|11323435|FG001|Overall Study|Lost to Follow-up|1
7155501|NCT03340961|11323436|FG002|Overall Study|Lost to Follow-up|0
7155502|NCT03340961|11323437|FG003|Overall Study|Lost to Follow-up|1
7155503|NCT03340961|11323434|FG000|Overall Study|Withdrawal by Subject|3
7155504|NCT03340961|11323435|FG001|Overall Study|Withdrawal by Subject|2
7155505|NCT03340961|11323436|FG002|Overall Study|Withdrawal by Subject|4
7155506|NCT03340961|11323437|FG003|Overall Study|Withdrawal by Subject|7
7155507|NCT03340961|11323434|FG000|Overall Study|Use of prohibited treatment|0
7155508|NCT03340961|11323435|FG001|Overall Study|Use of prohibited treatment|3
7155509|NCT03340961|11323436|FG002|Overall Study|Use of prohibited treatment|2
7155510|NCT03340961|11323437|FG003|Overall Study|Use of prohibited treatment|4
7155511|NCT03340961|11323434|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0
7155512|NCT03340961|11323435|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1
6880284|NCT00529373|10892642|FG000|First Extension Study|Lack of Efficacy|65
6880285|NCT00529373|10892643|FG001|First Extension Study|Lack of Efficacy|427
7155513|NCT03340961|11323436|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0
7155514|NCT03340961|11323437|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1
7155515|NCT03340961|11323434|FG000|Overall Study|Subject developed an exclusion criterion|0
7155516|NCT03340961|11323435|FG001|Overall Study|Subject developed an exclusion criterion|1
6880286|NCT00529373|10892642|FG000|First Extension Study|Lost to Follow-up|41
7155517|NCT03340961|11323436|FG002|Overall Study|Subject developed an exclusion criterion|0
7155518|NCT03340961|11323437|FG003|Overall Study|Subject developed an exclusion criterion|0
7155519|NCT03340961|11323434|FG000|Overall Study|Protocol Violation|1
7155520|NCT03340961|11323435|FG001|Overall Study|Protocol Violation|0
7155521|NCT03340961|11323436|FG002|Overall Study|Protocol Violation|1
6880287|NCT00529373|10892643|FG001|First Extension Study|Lost to Follow-up|37
6880288|NCT00529373|10892642|FG000|First Extension Study|Other|27
6880289|NCT00529373|10892643|FG001|First Extension Study|Other|47
6880290|NCT00529373|10892642|FG000|First Extension Study|Physician Decision|50
6880291|NCT00529373|10892643|FG001|First Extension Study|Physician Decision|45
6880292|NCT00529373|10892642|FG000|First Extension Study|Protocol Violation|16
6880293|NCT00529373|10892643|FG001|First Extension Study|Protocol Violation|13
6880294|NCT00529373|10892642|FG000|First Extension Study|Withdrawal by Subject|296
6880295|NCT00529373|10892643|FG001|First Extension Study|Withdrawal by Subject|287
6880296|NCT00529373|10892642|FG000|First Extension Study|Disposition record non-existing|0
7155522|NCT03340961|11323437|FG003|Overall Study|Protocol Violation|0
7155523|NCT03340961|11323434|FG000|Overall Study|Adverse Event|1
7155524|NCT03340961|11323435|FG001|Overall Study|Adverse Event|1
7155525|NCT03340961|11323436|FG002|Overall Study|Adverse Event|0
7155526|NCT03340961|11323437|FG003|Overall Study|Adverse Event|0
7155527|NCT03340961|11323434|FG000|Overall Study|Lack of Efficacy|0
7155528|NCT03340961|11323435|FG001|Overall Study|Lack of Efficacy|0
7155529|NCT03340961|11323436|FG002|Overall Study|Lack of Efficacy|0
7155530|NCT03340961|11323437|FG003|Overall Study|Lack of Efficacy|1
7155531|NCT03341273|11323449|FG000|Overall Study|Lost to Follow-up|7
7155532|NCT03341273|11323450|FG001|Overall Study|Lost to Follow-up|7
7155533|NCT03341273|11323449|FG000|Overall Study|Withdrawal by Subject|4
7155534|NCT03341273|11323450|FG001|Overall Study|Withdrawal by Subject|2
7155535|NCT03341273|11323449|FG000|Overall Study|Physician Decision|1
7155536|NCT03341273|11323450|FG001|Overall Study|Physician Decision|0
7155537|NCT03341273|11323449|FG000|Overall Study|Protocol Violation|0
7155538|NCT03341273|11323450|FG001|Overall Study|Protocol Violation|1
7155539|NCT03341273|11323449|FG000|Overall Study|Enrolled but Treatment Not Administered|6
7155540|NCT03341273|11323450|FG001|Overall Study|Enrolled but Treatment Not Administered|1
7155541|NCT03341273|11323449|FG000|Overall Study|Became ineligible after enrollment|1
7155542|NCT03341273|11323450|FG001|Overall Study|Became ineligible after enrollment|0
7155543|NCT03341273|11323449|FG000|Overall Study|Not Eligible at Enrollment|0
7155544|NCT03341273|11323450|FG001|Overall Study|Not Eligible at Enrollment|1
7155545|NCT03341273|11323449|FG000|Overall Study|Participant incarcerated|1
7155546|NCT03341273|11323450|FG001|Overall Study|Participant incarcerated|0
7155547|NCT03341299|11323456|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0
7155548|NCT03341299|11323457|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0
7155549|NCT03341299|11323458|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1
7155550|NCT03341299|11323459|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0
7155551|NCT03341312|11323471|FG000|Period 1|Withdrawal by Subject|0
7155552|NCT03341312|11323472|FG001|Period 1|Withdrawal by Subject|1
7155553|NCT03341312|11323473|FG002|Period 1|Withdrawal by Subject|0
7155554|NCT03341312|11323474|FG003|Period 1|Withdrawal by Subject|0
7155555|NCT03341507|11323486|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34
7155556|NCT03341533|11323492|FG000|Overall Study|Withdrawal by Subject|1
7155557|NCT03341533|11323493|FG001|Overall Study|Withdrawal by Subject|1
7155558|NCT03341533|11323492|FG000|Overall Study|Not eligible after randomization|2
7155559|NCT03341533|11323493|FG001|Overall Study|Not eligible after randomization|1
7155560|NCT03341637|11323505|FG000|Overall Study|Lost to Follow-up|1
7155561|NCT03341637|11323506|FG001|Overall Study|Lost to Follow-up|0
7155562|NCT03341637|11323505|FG000|Overall Study|Withdrawal by Subject|3
7155563|NCT03341637|11323506|FG001|Overall Study|Withdrawal by Subject|3
7155564|NCT03341637|11323505|FG000|Overall Study|Reason not Specified|1
7155565|NCT03341637|11323506|FG001|Overall Study|Reason not Specified|1
7155566|NCT03341923|11323536|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0
7155567|NCT03341923|11323537|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1
7155568|NCT03342404|11323556|FG000|Overall Study|Withdrawal by Subject|9
7155569|NCT03342404|11323557|FG001|Overall Study|Withdrawal by Subject|10
7155570|NCT03342404|11323556|FG000|Overall Study|Lack of Efficacy|1
7155571|NCT03342404|11323557|FG001|Overall Study|Lack of Efficacy|17
7155572|NCT03342404|11323556|FG000|Overall Study|Adverse Event|3
7155573|NCT03342404|11323557|FG001|Overall Study|Adverse Event|4
7155574|NCT03342404|11323556|FG000|Overall Study|Noncompliance with study drug|1
7155575|NCT03342404|11323557|FG001|Overall Study|Noncompliance with study drug|0
7155576|NCT03342404|11323556|FG000|Overall Study|Other reasons|1
7155577|NCT03342404|11323557|FG001|Overall Study|Other reasons|0
7155578|NCT03342469|11323565|FG000|Overall Study|Withdrawal by Subject|0
7155579|NCT03342469|11323566|FG001|Overall Study|Withdrawal by Subject|1
7155580|NCT03342469|11323567|FG002|Overall Study|Withdrawal by Subject|0
7155581|NCT03342469|11323568|FG003|Overall Study|Withdrawal by Subject|0
7155582|NCT03342560|11323579|FG000|Overall Study|Lost to Follow-up|2
7155583|NCT03342690|11323587|FG000|Overall Study|Missing Information|9
7155584|NCT03342690|11323587|FG000|Overall Study|Protocol Violation|16
7155585|NCT03342898|11323594|FG000|Overall Study|Adverse Event|3
6880297|NCT00529373|10892643|FG001|First Extension Study|Disposition record non-existing|1
6880298|NCT00529373|10892642|FG000|First Extension Study|Discontinued after 5 years completion|208
7155586|NCT03342898|11323595|FG001|Overall Study|Adverse Event|1
7155587|NCT03342898|11323596|FG002|Overall Study|Adverse Event|0
7155588|NCT03342898|11323594|FG000|Overall Study|Lost to Follow-up|44
7155589|NCT03342898|11323595|FG001|Overall Study|Lost to Follow-up|40
7155590|NCT03342898|11323596|FG002|Overall Study|Lost to Follow-up|42
7155591|NCT03342898|11323594|FG000|Overall Study|Withdrawal of Consent|5
7155592|NCT03342898|11323595|FG001|Overall Study|Withdrawal of Consent|9
6880299|NCT00529373|10892643|FG001|First Extension Study|Discontinued after 5 years completion|346
6880300|NCT00529373|10892642|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256
6880301|NCT00529373|10892643|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281
6880302|NCT00529373|10892642|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32
6880303|NCT00529373|10892643|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25
6880304|NCT00529373|10892642|FG000|Second Extension Study|Adverse Event|101
6880305|NCT00529373|10892643|FG001|Second Extension Study|Adverse Event|51
6880306|NCT00529373|10892642|FG000|Second Extension Study|Lack of Efficacy|7
6880307|NCT00529373|10892643|FG001|Second Extension Study|Lack of Efficacy|15
6880308|NCT00529373|10892642|FG000|Second Extension Study|Lost to Follow-up|18
6880309|NCT00529373|10892643|FG001|Second Extension Study|Lost to Follow-up|12
6880310|NCT00529373|10892642|FG000|Second Extension Study|Other|7
6880311|NCT00529373|10892643|FG001|Second Extension Study|Other|12
6880312|NCT00529373|10892642|FG000|Second Extension Study|Physician Decision|63
6880313|NCT00529373|10892643|FG001|Second Extension Study|Physician Decision|26
6880314|NCT00529373|10892642|FG000|Second Extension Study|Protocol Violation|2
6880315|NCT00529373|10892643|FG001|Second Extension Study|Protocol Violation|1
6880316|NCT00529373|10892642|FG000|Second Extension Study|Withdrawal by Subject|97
7078986|NCT02107443|11187635|FG001|Overall Study|Study Protocol Violation|1
7078987|NCT02107443|11187634|FG000|Overall Study|Registered but Not Eligible|0
7078988|NCT02107443|11187635|FG001|Overall Study|Registered but Not Eligible|1
6880317|NCT00529373|10892643|FG001|Second Extension Study|Withdrawal by Subject|75
6880318|NCT00529373|10892642|FG000|Second Extension Study|Status Missing|5
6880319|NCT00529373|10892643|FG001|Second Extension Study|Status Missing|5
7078989|NCT02107443|11187634|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28
7078990|NCT02107443|11187635|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28
7078991|NCT02107443|11187634|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1
7078992|NCT02107443|11187635|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2
6880320|NCT00529386|10892657|FG000|Overall Study|Lost to Follow-up|1
6880321|NCT00529399|10892664|FG000|Overall Study|Lost to Follow-up|1
6880322|NCT00529399|10892665|FG001|Overall Study|Lost to Follow-up|0
6880323|NCT00529399|10892666|FG002|Overall Study|Lost to Follow-up|1
6880324|NCT00529399|10892664|FG000|Overall Study|Withdrawal by Subject|1
6880325|NCT00529399|10892665|FG001|Overall Study|Withdrawal by Subject|0
6880326|NCT00529399|10892666|FG002|Overall Study|Withdrawal by Subject|1
6880327|NCT00529399|10892664|FG000|Overall Study|Non-compliant|0
6880328|NCT00529399|10892665|FG001|Overall Study|Non-compliant|1
6880329|NCT00529399|10892666|FG002|Overall Study|Non-compliant|0
6880330|NCT00529451|10892678|FG000|Overall Study|Subject withdrew consent|16
6880331|NCT00529451|10892679|FG001|Overall Study|Subject withdrew consent|21
6880332|NCT00529451|10892680|FG002|Overall Study|Subject withdrew consent|13
6880333|NCT00529451|10892681|FG003|Overall Study|Subject withdrew consent|12
6880334|NCT00529451|10892678|FG000|Overall Study|Adverse Event|9
6880335|NCT00529451|10892679|FG001|Overall Study|Adverse Event|16
6880336|NCT00529451|10892680|FG002|Overall Study|Adverse Event|14
6880337|NCT00529451|10892681|FG003|Overall Study|Adverse Event|8
6880338|NCT00529451|10892678|FG000|Overall Study|Unsatisfactory therapeutic response|6
6880339|NCT00529451|10892679|FG001|Overall Study|Unsatisfactory therapeutic response|2
6880340|NCT00529451|10892680|FG002|Overall Study|Unsatisfactory therapeutic response|5
6880341|NCT00529451|10892681|FG003|Overall Study|Unsatisfactory therapeutic response|4
6880342|NCT00529451|10892678|FG000|Overall Study|Lost to Follow-up|4
6880343|NCT00529451|10892679|FG001|Overall Study|Lost to Follow-up|7
6880344|NCT00529451|10892680|FG002|Overall Study|Lost to Follow-up|4
6880345|NCT00529451|10892681|FG003|Overall Study|Lost to Follow-up|4
6880346|NCT00529451|10892678|FG000|Overall Study|Protocol deviation|1
6880347|NCT00529451|10892679|FG001|Overall Study|Protocol deviation|1
6880348|NCT00529451|10892680|FG002|Overall Study|Protocol deviation|4
6880349|NCT00529451|10892681|FG003|Overall Study|Protocol deviation|1
6880350|NCT00529451|10892678|FG000|Overall Study|Administrative problems|1
6880351|NCT00529451|10892679|FG001|Overall Study|Administrative problems|1
6880352|NCT00529451|10892680|FG002|Overall Study|Administrative problems|0
6880353|NCT00529451|10892681|FG003|Overall Study|Administrative problems|2
6880354|NCT00529516|10892697|FG000|Overall Study|Adverse Event|2
6880355|NCT00529516|10892698|FG001|Overall Study|Adverse Event|1
6880356|NCT00529516|10892699|FG002|Overall Study|Adverse Event|0
6880357|NCT00529516|10892697|FG000|Overall Study|Withdrawal by Subject|1
6880358|NCT00529516|10892698|FG001|Overall Study|Withdrawal by Subject|1
6880359|NCT00529516|10892699|FG002|Overall Study|Withdrawal by Subject|0
6880360|NCT00529516|10892697|FG000|Overall Study|Lost to Follow-up|0
6880361|NCT00529516|10892698|FG001|Overall Study|Lost to Follow-up|0
7155593|NCT03342898|11323596|FG002|Overall Study|Withdrawal of Consent|11
6880362|NCT00529516|10892699|FG002|Overall Study|Lost to Follow-up|1
6880363|NCT00529529|10892710|FG000|Overall Study|Adverse Event|12
6880364|NCT00529529|10892711|FG001|Overall Study|Adverse Event|17
6880365|NCT00529529|10892712|FG002|Overall Study|Adverse Event|8
6880366|NCT00529529|10892710|FG000|Overall Study|Subject withdrew consent|12
6880367|NCT00529529|10892711|FG001|Overall Study|Subject withdrew consent|9
6880368|NCT00529529|10892712|FG002|Overall Study|Subject withdrew consent|12
6880369|NCT00529529|10892710|FG000|Overall Study|Protocol deviation|8
6880370|NCT00529529|10892711|FG001|Overall Study|Protocol deviation|12
6880371|NCT00529529|10892712|FG002|Overall Study|Protocol deviation|5
6880372|NCT00529529|10892710|FG000|Overall Study|Lost to Follow-up|5
6880373|NCT00529529|10892711|FG001|Overall Study|Lost to Follow-up|3
6880374|NCT00529529|10892712|FG002|Overall Study|Lost to Follow-up|1
6880375|NCT00529529|10892710|FG000|Overall Study|Unsatisfactory therapeutic effect|2
6880376|NCT00529529|10892711|FG001|Overall Study|Unsatisfactory therapeutic effect|2
6880377|NCT00529529|10892712|FG002|Overall Study|Unsatisfactory therapeutic effect|2
6880378|NCT00529529|10892710|FG000|Overall Study|Death|2
6880379|NCT00529529|10892711|FG001|Overall Study|Death|0
6880380|NCT00529529|10892712|FG002|Overall Study|Death|0
6880381|NCT00529529|10892710|FG000|Overall Study|Abnormal test procedure result(s)|1
6880382|NCT00529529|10892711|FG001|Overall Study|Abnormal test procedure result(s)|0
6880383|NCT00529529|10892712|FG002|Overall Study|Abnormal test procedure result(s)|0
6880384|NCT00529529|10892710|FG000|Overall Study|Administrative problems|1
6880385|NCT00529529|10892711|FG001|Overall Study|Administrative problems|0
6880386|NCT00529529|10892712|FG002|Overall Study|Administrative problems|3
6880387|NCT00529542|10892722|FG000|Overall Study|Withdrawal by Subject|1
6880388|NCT00529542|10892723|FG001|Overall Study|Withdrawal by Subject|0
6880389|NCT00529542|10892722|FG000|Overall Study|Lost to Follow-up|0
6880390|NCT00529542|10892723|FG001|Overall Study|Lost to Follow-up|1
6969426|NCT01147744|11019039|FG004|Overall Study|Withdrawal by Subject|2
6969427|NCT01147744|11019040|FG005|Overall Study|Withdrawal by Subject|5
6969428|NCT01147744|11019041|FG006|Overall Study|Withdrawal by Subject|2
6969429|NCT01147744|11019035|FG000|Overall Study|Lost to Follow-up|0
6969430|NCT01147744|11019036|FG001|Overall Study|Lost to Follow-up|1
6969431|NCT01147744|11019037|FG002|Overall Study|Lost to Follow-up|0
6969432|NCT01147744|11019038|FG003|Overall Study|Lost to Follow-up|0
6969433|NCT01147744|11019039|FG004|Overall Study|Lost to Follow-up|0
6969434|NCT01147744|11019040|FG005|Overall Study|Lost to Follow-up|0
6969435|NCT01147744|11019041|FG006|Overall Study|Lost to Follow-up|0
6969436|NCT01147744|11019035|FG000|Overall Study|Sponsor decision to amend protocol|7
6969437|NCT01147744|11019036|FG001|Overall Study|Sponsor decision to amend protocol|4
6969438|NCT01147744|11019037|FG002|Overall Study|Sponsor decision to amend protocol|2
6969439|NCT01147744|11019038|FG003|Overall Study|Sponsor decision to amend protocol|5
6969440|NCT01147744|11019039|FG004|Overall Study|Sponsor decision to amend protocol|7
6969441|NCT01147744|11019040|FG005|Overall Study|Sponsor decision to amend protocol|2
6969442|NCT01147744|11019041|FG006|Overall Study|Sponsor decision to amend protocol|6
6969443|NCT01147744|11019035|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1
6969444|NCT01147744|11019036|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0
6969445|NCT01147744|11019037|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0
6969446|NCT01147744|11019038|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0
6969447|NCT01147744|11019039|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0
6969448|NCT01147744|11019040|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1
6969449|NCT01147744|11019041|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0
6969450|NCT01147809|11019069|FG000|Phase I (168 Days)|Adverse Event|0
6969451|NCT01147809|11019070|FG001|Phase I (168 Days)|Adverse Event|0
6969452|NCT01147809|11019071|FG002|Phase I (168 Days)|Adverse Event|0
6969453|NCT01147809|11019072|FG003|Phase I (168 Days)|Adverse Event|1
6969454|NCT01147809|11019073|FG004|Phase I (168 Days)|Adverse Event|0
6969455|NCT01147809|11019074|FG005|Phase I (168 Days)|Adverse Event|0
6969456|NCT01147809|11019069|FG000|Phase I (168 Days)|Lost to Follow-up|1
6969457|NCT01147809|11019070|FG001|Phase I (168 Days)|Lost to Follow-up|0
6969458|NCT01147809|11019071|FG002|Phase I (168 Days)|Lost to Follow-up|0
6969459|NCT01147809|11019072|FG003|Phase I (168 Days)|Lost to Follow-up|1
6969460|NCT01147809|11019073|FG004|Phase I (168 Days)|Lost to Follow-up|0
6969461|NCT01147809|11019074|FG005|Phase I (168 Days)|Lost to Follow-up|0
6969462|NCT01147809|11019069|FG000|Phase I (168 Days)|Physician Decision|0
6969463|NCT01147809|11019070|FG001|Phase I (168 Days)|Physician Decision|1
6969464|NCT01147809|11019071|FG002|Phase I (168 Days)|Physician Decision|2
6969465|NCT01147809|11019072|FG003|Phase I (168 Days)|Physician Decision|0
6969466|NCT01147809|11019073|FG004|Phase I (168 Days)|Physician Decision|0
6969467|NCT01147809|11019074|FG005|Phase I (168 Days)|Physician Decision|0
6969468|NCT01147809|11019069|FG000|Phase I (168 Days)|Withdrawal by Subject|0
6969469|NCT01147809|11019070|FG001|Phase I (168 Days)|Withdrawal by Subject|0
6969470|NCT01147809|11019071|FG002|Phase I (168 Days)|Withdrawal by Subject|0
6969471|NCT01147809|11019072|FG003|Phase I (168 Days)|Withdrawal by Subject|3
6969472|NCT01147809|11019073|FG004|Phase I (168 Days)|Withdrawal by Subject|0
6969473|NCT01147809|11019074|FG005|Phase I (168 Days)|Withdrawal by Subject|0
6969474|NCT01147809|11019069|FG000|Phase II (168 Days)|Adverse Event|0
6969475|NCT01147809|11019070|FG001|Phase II (168 Days)|Adverse Event|0
6969476|NCT01147809|11019071|FG002|Phase II (168 Days)|Adverse Event|0
6969477|NCT01147809|11019072|FG003|Phase II (168 Days)|Adverse Event|0
6969478|NCT01147809|11019073|FG004|Phase II (168 Days)|Adverse Event|3
6969479|NCT01147809|11019074|FG005|Phase II (168 Days)|Adverse Event|6
6969480|NCT01147809|11019069|FG000|Phase II (168 Days)|Protocol Violation|0
6969481|NCT01147809|11019070|FG001|Phase II (168 Days)|Protocol Violation|0
6969482|NCT01147809|11019071|FG002|Phase II (168 Days)|Protocol Violation|0
6969483|NCT01147809|11019072|FG003|Phase II (168 Days)|Protocol Violation|0
6969484|NCT01147809|11019073|FG004|Phase II (168 Days)|Protocol Violation|0
6969485|NCT01147809|11019074|FG005|Phase II (168 Days)|Protocol Violation|1
6969486|NCT01147809|11019069|FG000|Phase II (168 Days)|Physician Decision|0
6969487|NCT01147809|11019070|FG001|Phase II (168 Days)|Physician Decision|0
6880391|NCT00529568|10892744|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5
6880392|NCT00529568|10892745|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
6880393|NCT00529568|10892746|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
6880394|NCT00529568|10892744|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12
6880395|NCT00529568|10892745|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
6880396|NCT00529568|10892746|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
6880397|NCT00529568|10892744|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5
6880398|NCT00529568|10892745|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
6880399|NCT00529568|10892746|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
6880400|NCT00529568|10892744|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8
6880401|NCT00529568|10892745|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
6880402|NCT00529568|10892746|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
6969488|NCT01147809|11019071|FG002|Phase II (168 Days)|Physician Decision|0
7078993|NCT02107443|11187634|FG000|Overall Study|Withdrawal: Changed Mind|2
6969489|NCT01147809|11019072|FG003|Phase II (168 Days)|Physician Decision|0
6969490|NCT01147809|11019073|FG004|Phase II (168 Days)|Physician Decision|5
6969491|NCT01147809|11019074|FG005|Phase II (168 Days)|Physician Decision|11
6969492|NCT01147809|11019069|FG000|Phase II (168 Days)|Withdrawal by Subject|0
6969493|NCT01147809|11019070|FG001|Phase II (168 Days)|Withdrawal by Subject|0
6969494|NCT01147809|11019071|FG002|Phase II (168 Days)|Withdrawal by Subject|0
6969495|NCT01147809|11019072|FG003|Phase II (168 Days)|Withdrawal by Subject|0
6969496|NCT01147809|11019073|FG004|Phase II (168 Days)|Withdrawal by Subject|7
6969497|NCT01147809|11019074|FG005|Phase II (168 Days)|Withdrawal by Subject|15
6969498|NCT01147809|11019069|FG000|Phase II (168 Days)|Ongoing|0
6969499|NCT01147809|11019070|FG001|Phase II (168 Days)|Ongoing|0
6969500|NCT01147809|11019071|FG002|Phase II (168 Days)|Ongoing|0
6969501|NCT01147809|11019072|FG003|Phase II (168 Days)|Ongoing|0
6969502|NCT01147809|11019073|FG004|Phase II (168 Days)|Ongoing|1
6969503|NCT01147809|11019074|FG005|Phase II (168 Days)|Ongoing|0
6969504|NCT01147848|11019091|FG000|Run-in Period|Screen Failure|623
6969505|NCT01147848|11019092|FG001|Run-in Period|Screen Failure|0
6969506|NCT01147848|11019093|FG002|Run-in Period|Screen Failure|0
6969507|NCT01147848|11019091|FG000|Run-in Period|Run-in Failure|135
6969508|NCT01147848|11019092|FG001|Run-in Period|Run-in Failure|0
6969509|NCT01147848|11019093|FG002|Run-in Period|Run-in Failure|0
6969510|NCT01147848|11019091|FG000|Randomized Phase|Adverse Event|0
6969511|NCT01147848|11019092|FG001|Randomized Phase|Adverse Event|6
6969512|NCT01147848|11019093|FG002|Randomized Phase|Adverse Event|8
6969513|NCT01147848|11019091|FG000|Randomized Phase|Lack of Efficacy|0
6969514|NCT01147848|11019092|FG001|Randomized Phase|Lack of Efficacy|20
6969515|NCT01147848|11019093|FG002|Randomized Phase|Lack of Efficacy|11
6969516|NCT01147848|11019091|FG000|Randomized Phase|Protocol Violation|0
6969517|NCT01147848|11019092|FG001|Randomized Phase|Protocol Violation|7
6969518|NCT01147848|11019093|FG002|Randomized Phase|Protocol Violation|10
6969519|NCT01147848|11019091|FG000|Randomized Phase|Lost to Follow-up|0
6969520|NCT01147848|11019092|FG001|Randomized Phase|Lost to Follow-up|5
6969521|NCT01147848|11019093|FG002|Randomized Phase|Lost to Follow-up|7
6969522|NCT01147848|11019091|FG000|Randomized Phase|Physician Decision|0
6969523|NCT01147848|11019092|FG001|Randomized Phase|Physician Decision|0
6969524|NCT01147848|11019093|FG002|Randomized Phase|Physician Decision|1
6969525|NCT01147848|11019091|FG000|Randomized Phase|Withdrawal by Subject|0
6969526|NCT01147848|11019092|FG001|Randomized Phase|Withdrawal by Subject|7
6969527|NCT01147848|11019093|FG002|Randomized Phase|Withdrawal by Subject|9
6969528|NCT01147874|11019100|FG000|Overall Study|Adverse Event|5
6969529|NCT01147874|11019100|FG000|Overall Study|Investigator's Request|1
6969530|NCT01147874|11019100|FG000|Overall Study|Lost to Follow-up|25
6969531|NCT01147874|11019100|FG000|Overall Study|Other|5
6969532|NCT01147874|11019100|FG000|Overall Study|Protocol Violation|5
6969533|NCT01147874|11019100|FG000|Overall Study|Sponsor's Decision|2
6969534|NCT01147874|11019100|FG000|Overall Study|Withdrawal by Subject|24
6969535|NCT01147900|11019107|FG000|At Year 10|Lost to Follow-up|0
6969536|NCT01147900|11019108|FG001|At Year 10|Lost to Follow-up|1
6969537|NCT01147900|11019109|FG002|At Year 10|Lost to Follow-up|0
6969538|NCT01147926|11019119|FG000|Overall Study|Subject Withdrew Consent|9
6969539|NCT01147926|11019120|FG001|Overall Study|Subject Withdrew Consent|10
6969540|NCT01147926|11019119|FG000|Overall Study|Adverse Event|7
6969541|NCT01147926|11019120|FG001|Overall Study|Adverse Event|6
6969542|NCT01147926|11019119|FG000|Overall Study|Subject Non-Compliant|5
6969543|NCT01147926|11019120|FG001|Overall Study|Subject Non-Compliant|4
6969544|NCT01147926|11019119|FG000|Overall Study|Principal investigator left hospital|1
6969545|NCT01147926|11019120|FG001|Overall Study|Principal investigator left hospital|3
6969546|NCT01147926|11019119|FG000|Overall Study|Selection criteria not met|3
6969547|NCT01147926|11019120|FG001|Overall Study|Selection criteria not met|1
7078994|NCT02107443|11187635|FG001|Overall Study|Withdrawal: Changed Mind|0
6969548|NCT01147926|11019119|FG000|Overall Study|Lost to Follow-up|0
6969549|NCT01147926|11019120|FG001|Overall Study|Lost to Follow-up|2
6969550|NCT01147926|11019119|FG000|Overall Study|Sponsor's Decision|0
6969551|NCT01147926|11019120|FG001|Overall Study|Sponsor's Decision|1
6969552|NCT01147926|11019119|FG000|Overall Study|Lack of Efficacy|1
6969553|NCT01147926|11019120|FG001|Overall Study|Lack of Efficacy|0
6969554|NCT01147926|11019119|FG000|Overall Study|Too busy, no time for study|1
6880403|NCT00529568|10892744|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13
6880404|NCT00529568|10892745|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
6880405|NCT00529568|10892746|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
6880406|NCT00529568|10892744|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3
6880407|NCT00529568|10892745|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
6880408|NCT00529568|10892746|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
6880409|NCT00529568|10892744|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0
6880410|NCT00529568|10892745|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10
6880411|NCT00529568|10892746|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27
6880412|NCT00529568|10892744|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
6880413|NCT00529568|10892745|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1
6880414|NCT00529568|10892746|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
6880415|NCT00529568|10892744|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0
6880416|NCT00529568|10892745|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15
6880417|NCT00529568|10892746|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48
6880418|NCT00529568|10892744|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0
6880419|NCT00529568|10892745|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5
6880420|NCT00529568|10892746|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8
6880421|NCT00529568|10892744|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0
6880422|NCT00529568|10892745|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17
6880423|NCT00529568|10892746|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19
6880424|NCT00529633|10892757|FG000|Overall Study|Withdrawal by Subject|1
6880425|NCT00529633|10892758|FG001|Overall Study|Withdrawal by Subject|1
6880426|NCT00529659|10892766|FG000|Overall Study|Adverse Event|8
6880427|NCT00529659|10892767|FG001|Overall Study|Adverse Event|7
6880428|NCT00529659|10892766|FG000|Overall Study|Lost to Follow-up|0
6880429|NCT00529659|10892767|FG001|Overall Study|Lost to Follow-up|2
6880430|NCT00529659|10892766|FG000|Overall Study|Physician Decision|0
6880431|NCT00529659|10892767|FG001|Overall Study|Physician Decision|2
6880432|NCT00529659|10892766|FG000|Overall Study|Protocol Violation|2
6880433|NCT00529659|10892767|FG001|Overall Study|Protocol Violation|6
6880434|NCT00529659|10892766|FG000|Overall Study|Withdrawal by Subject|1
6880435|NCT00529659|10892767|FG001|Overall Study|Withdrawal by Subject|6
6880436|NCT00529789|10892773|FG000|Study Period II/III|Parent/Caregiver Decision|9
6880437|NCT00529789|10892773|FG000|Study Period II/III|Adverse Event|3
6880438|NCT00529789|10892773|FG000|Study Period II/III|Lack of Efficacy|2
6880439|NCT00529789|10892773|FG000|Study Period II/III|Withdrawal by Subject|1
6880440|NCT00529789|10892773|FG000|Study Period II/III|Protocol Violation|3
6880441|NCT00529789|10892773|FG000|Study Period II/III|Physician Decision|3
6880442|NCT00529789|10892773|FG000|Study Period II/III|Lost to Follow-up|3
6880443|NCT00529789|10892773|FG000|Study Period IV|Parent/Caregiver Decision|1
6880444|NCT00529789|10892773|FG000|Study Period IV|Adverse Event|1
6880445|NCT00529789|10892773|FG000|Study Period IV|Lack of Efficacy|1
6880446|NCT00529789|10892773|FG000|Study Period IV|Lost to Follow-up|3
6880447|NCT00529802|10892783|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3
6880448|NCT00529802|10892783|FG000|Evaluable for Primary Endpoint|Worsening performance status|2
6880449|NCT00529802|10892783|FG000|Evaluable for Primary Endpoint|Adverse Event|2
6880450|NCT00529802|10892783|FG000|Evaluable for Primary Endpoint|Death|1
6880451|NCT00529802|10892783|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1
6880452|NCT00529802|10892783|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1
6880453|NCT00529802|10892783|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2
6880454|NCT00529958|10892792|FG000|2-Year Follow-up|Lost to Follow-up|1
6880455|NCT00529958|10892793|FG001|2-Year Follow-up|Lost to Follow-up|2
6880456|NCT00529958|10892794|FG002|2-Year Follow-up|Lost to Follow-up|2
6880457|NCT00529958|10892792|FG000|2-Year Follow-up|Withdrawal by Subject|3
6880458|NCT00529958|10892793|FG001|2-Year Follow-up|Withdrawal by Subject|0
6880459|NCT00529958|10892794|FG002|2-Year Follow-up|Withdrawal by Subject|0
6880460|NCT00529958|10892792|FG000|5-Year Follow-up|Lost to Follow-up|2
6880461|NCT00529958|10892793|FG001|5-Year Follow-up|Lost to Follow-up|3
6880462|NCT00529958|10892794|FG002|5-Year Follow-up|Lost to Follow-up|1
6880463|NCT00529958|10892792|FG000|5-Year Follow-up|Withdrawal by Subject|1
6880464|NCT00529958|10892793|FG001|5-Year Follow-up|Withdrawal by Subject|0
6880465|NCT00529958|10892794|FG002|5-Year Follow-up|Withdrawal by Subject|0
6880466|NCT00530023|10892804|FG000|Overall Study|Withdrawal by Subject|0
6880467|NCT00530023|10892805|FG001|Overall Study|Withdrawal by Subject|1
6880468|NCT00530075|10892811|FG000|Overall Study|Adverse Event|1
6880469|NCT00530075|10892811|FG000|Overall Study|Death|1
6880470|NCT00530075|10892811|FG000|Overall Study|Lack of Efficacy|3
6880471|NCT00530075|10892811|FG000|Overall Study|Protocol Violation|1
6880472|NCT00530075|10892811|FG000|Overall Study|Withdrawal by Subject|1
6880473|NCT00530088|10892815|FG000|Overall Study|Disease Progression|4
6880474|NCT00530088|10892815|FG000|Overall Study|Physician Decision|4
6880475|NCT00530088|10892815|FG000|Overall Study|Other Not Specified|2
6880476|NCT00530218|10892819|FG000|Overall Study|CMV Not Detected|13
6880477|NCT00530218|10892819|FG000|Overall Study|Death|12
6880478|NCT00530257|10892826|FG000|Overall Study|Lost to Follow-up|1
6880479|NCT00530270|10892835|FG000|Overall Study|Protocol Violation|1
6880480|NCT00530270|10892836|FG001|Overall Study|Protocol Violation|0
6880481|NCT00530335|10892842|FG000|Overall Study|Adverse Event|3
6880482|NCT00530335|10892842|FG000|Overall Study|Protocol Violation|1
6880483|NCT00530335|10892842|FG000|Overall Study|Withdrawal by Subject|1
6880484|NCT00530335|10892842|FG000|Overall Study|Physician Decision|1
6880485|NCT00530348|10892848|FG000|Overall Study|Adverse Event|5
6880486|NCT00530348|10892849|FG001|Overall Study|Adverse Event|1
6880487|NCT00530348|10892848|FG000|Overall Study|Death|0
6880488|NCT00530348|10892849|FG001|Overall Study|Death|1
6880489|NCT00530348|10892848|FG000|Overall Study|Lack of Efficacy|2
6880490|NCT00530348|10892849|FG001|Overall Study|Lack of Efficacy|0
6880491|NCT00530348|10892848|FG000|Overall Study|Lost to Follow-up|0
6880492|NCT00530348|10892849|FG001|Overall Study|Lost to Follow-up|2
6880493|NCT00530348|10892848|FG000|Overall Study|Physician Decision|1
6880494|NCT00530348|10892849|FG001|Overall Study|Physician Decision|2
6880495|NCT00530348|10892848|FG000|Overall Study|Pregnancy|1
6880496|NCT00530348|10892849|FG001|Overall Study|Pregnancy|0
6880497|NCT00530348|10892848|FG000|Overall Study|Withdrawal by Subject|12
6880498|NCT00530348|10892849|FG001|Overall Study|Withdrawal by Subject|12
6880499|NCT00530348|10892848|FG000|Overall Study|Randomised in error|1
6880500|NCT00530348|10892849|FG001|Overall Study|Randomised in error|0
6880501|NCT00530348|10892848|FG000|Overall Study|Noncompliance with inclusion criterion 3|0
6880502|NCT00530348|10892849|FG001|Overall Study|Noncompliance with inclusion criterion 3|1
6880503|NCT00530439|10892857|FG000|Overall Study|GDM|9
6880504|NCT00530439|10892858|FG001|Overall Study|GDM|3
6880505|NCT00530439|10892857|FG000|Overall Study|Withdraw|18
6880506|NCT00530439|10892858|FG001|Overall Study|Withdraw|14
6880507|NCT00530439|10892857|FG000|Overall Study|Missed abortion|1
6880508|NCT00530439|10892858|FG001|Overall Study|Missed abortion|4
6880509|NCT00530439|10892857|FG000|Overall Study|Misclassification|2
6880510|NCT00530439|10892858|FG001|Overall Study|Misclassification|0
6880511|NCT00530439|10892857|FG000|Overall Study|Twin pregnancy|0
6880512|NCT00530439|10892858|FG001|Overall Study|Twin pregnancy|2
6880513|NCT00530439|10892857|FG000|Overall Study|Severe malformation/abortion|0
6880514|NCT00530439|10892858|FG001|Overall Study|Severe malformation/abortion|3
6880515|NCT00530504|10892864|FG000|Overall Study|Death|54
6880516|NCT00530504|10892864|FG000|Overall Study|Lost to Follow-up|26
6880517|NCT00530504|10892864|FG000|Overall Study|Withdrawal by Subject|39
6880518|NCT00530504|10892864|FG000|Overall Study|Exited study due to other reasons|33
6880519|NCT00530621|10892870|FG000|Overall Study|Adverse Event|11
6880520|NCT00530621|10892871|FG001|Overall Study|Adverse Event|8
6880521|NCT00530621|10892870|FG000|Overall Study|Physician Decision|2
6880522|NCT00530621|10892871|FG001|Overall Study|Physician Decision|4
6880523|NCT00530621|10892870|FG000|Overall Study|Progressive Disease (PD)|47
6880524|NCT00530621|10892871|FG001|Overall Study|Progressive Disease (PD)|40
6880525|NCT00530621|10892870|FG000|Overall Study|Sponsor Decision|12
6880526|NCT00530621|10892871|FG001|Overall Study|Sponsor Decision|15
6880527|NCT00530621|10892870|FG000|Overall Study|Subject Decision|4
6880528|NCT00530621|10892871|FG001|Overall Study|Subject Decision|7
6880529|NCT00530621|10892870|FG000|Overall Study|Death|3
6880530|NCT00530621|10892871|FG001|Overall Study|Death|6
6880531|NCT00530621|10892870|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1
6880532|NCT00530621|10892871|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0
6880533|NCT00530712|10892885|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2
6880534|NCT00530712|10892885|FG000|30 Day Follow-up Visit|Missed Visit|5
6880535|NCT00530712|10892885|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4
6880536|NCT00530712|10892885|FG000|6 Month Follow-up Visit|Missed Visit|3
6880537|NCT00530712|10892885|FG000|6 Month Follow-up Visit|Lost to Follow-up|3
6880538|NCT00530712|10892885|FG000|6 Month Follow-up Visit|Death|2
6880539|NCT00530712|10892885|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5
6880540|NCT00530712|10892885|FG000|12 Month Follow-up Visit|Missed Visit|3
6880541|NCT00530712|10892885|FG000|12 Month Follow-up Visit|Lost to Follow-up|7
6880542|NCT00530712|10892885|FG000|12 Month Follow-up Visit|Death|9
6880543|NCT00530777|10892912|FG000|Overall Study|Lost to Follow-up|0
6880544|NCT00530777|10892913|FG001|Overall Study|Lost to Follow-up|1
6880545|NCT00530777|10892912|FG000|Overall Study|Death|1
6880546|NCT00530777|10892913|FG001|Overall Study|Death|2
6880547|NCT00530777|10892912|FG000|Overall Study|Physician Decision|1
6880548|NCT00530777|10892913|FG001|Overall Study|Physician Decision|0
6880549|NCT00530777|10892912|FG000|Overall Study|Withdrawal by Subject|0
6880550|NCT00530777|10892913|FG001|Overall Study|Withdrawal by Subject|1
6880551|NCT00530777|10892912|FG000|Overall Study|Unable to adhere to visit schedule|5
6880552|NCT00530777|10892913|FG001|Overall Study|Unable to adhere to visit schedule|1
6880553|NCT00530790|10892919|FG000|Overall Study|Adverse Event|2
6880554|NCT00530790|10892919|FG000|Overall Study|Withdrawal by Subject|2
6880555|NCT00530790|10892919|FG000|Overall Study|Physician Decision|1
6880556|NCT00530816|10892935|FG000|Overall Study|Progressive Disease|16
6880557|NCT00530816|10892936|FG001|Overall Study|Progressive Disease|24
6880558|NCT00530816|10892937|FG002|Overall Study|Progressive Disease|24
6880559|NCT00530816|10892935|FG000|Overall Study|Adverse Event|6
6880560|NCT00530816|10892936|FG001|Overall Study|Adverse Event|13
6880561|NCT00530816|10892937|FG002|Overall Study|Adverse Event|7
6880562|NCT00530816|10892935|FG000|Overall Study|Other|3
6880563|NCT00530816|10892936|FG001|Overall Study|Other|3
6880564|NCT00530816|10892937|FG002|Overall Study|Other|4
6880565|NCT00530816|10892935|FG000|Overall Study|Withdrawal by Subject|1
6880566|NCT00530816|10892936|FG001|Overall Study|Withdrawal by Subject|2
6880567|NCT00530816|10892937|FG002|Overall Study|Withdrawal by Subject|6
6880568|NCT00530842|10892947|FG000|Overall Study|Adverse Event|10
6880569|NCT00530842|10892948|FG001|Overall Study|Adverse Event|6
6880570|NCT00530842|10892947|FG000|Overall Study|Lack of Efficacy|2
6880571|NCT00530842|10892948|FG001|Overall Study|Lack of Efficacy|1
6880572|NCT00530842|10892947|FG000|Overall Study|Lost to Follow-up|0
6880573|NCT00530842|10892948|FG001|Overall Study|Lost to Follow-up|4
6880574|NCT00530842|10892947|FG000|Overall Study|Protocol Violation|3
6880575|NCT00530842|10892948|FG001|Overall Study|Protocol Violation|2
6880576|NCT00530842|10892947|FG000|Overall Study|Withdrawal by Subject|4
6880577|NCT00530842|10892948|FG001|Overall Study|Withdrawal by Subject|5
6880578|NCT00530842|10892947|FG000|Overall Study|Individual different reasons|4
7155594|NCT03342898|11323594|FG000|Overall Study|Death|0
6880579|NCT00530842|10892948|FG001|Overall Study|Individual different reasons|3
6880580|NCT00530842|10892947|FG000|Period 1|Adverse Event|7
6880581|NCT00530842|10892948|FG001|Period 1|Adverse Event|3
6880582|NCT00530842|10892947|FG000|Period 1|Lack of Efficacy|1
6880583|NCT00530842|10892948|FG001|Period 1|Lack of Efficacy|1
6880584|NCT00530842|10892947|FG000|Period 1|Protocol Violation|2
6880585|NCT00530842|10892948|FG001|Period 1|Protocol Violation|1
6880586|NCT00530842|10892947|FG000|Period 1|Withdrawal by Subject|2
6880587|NCT00530842|10892948|FG001|Period 1|Withdrawal by Subject|3
6880588|NCT00530842|10892947|FG000|Period 1|Individual different reasons|2
6880589|NCT00530842|10892948|FG001|Period 1|Individual different reasons|3
6880590|NCT00530842|10892947|FG000|Period 2|Adverse Event|3
6880591|NCT00530842|10892948|FG001|Period 2|Adverse Event|3
6880592|NCT00530842|10892947|FG000|Period 2|Lack of Efficacy|1
6880593|NCT00530842|10892948|FG001|Period 2|Lack of Efficacy|0
6880594|NCT00530842|10892947|FG000|Period 2|Lost to Follow-up|0
6880595|NCT00530842|10892948|FG001|Period 2|Lost to Follow-up|4
6880596|NCT00530842|10892947|FG000|Period 2|Protocol Violation|1
6880597|NCT00530842|10892948|FG001|Period 2|Protocol Violation|0
6880598|NCT00530842|10892947|FG000|Period 2|Withdrawal by Subject|1
6880599|NCT00530842|10892948|FG001|Period 2|Withdrawal by Subject|2
6880600|NCT00530842|10892947|FG000|Period 2|Individual different reasons|2
6880601|NCT00530842|10892948|FG001|Period 2|Individual different reasons|0
6880602|NCT00530855|10892956|FG000|Overall Study|Lack of Efficacy|20
6880603|NCT00530855|10892956|FG000|Overall Study|Withdrawal by Subject|30
6880604|NCT00530855|10892956|FG000|Overall Study|Fatal Serious AE|3
6880605|NCT00530855|10892956|FG000|Overall Study|Non Fatal Serious AE|7
6880606|NCT00530855|10892956|FG000|Overall Study|Non Fatal Non Serious AE|12
6880607|NCT00530855|10892956|FG000|Overall Study|Protocol Violation|3
6880608|NCT00530855|10892956|FG000|Overall Study|Unsatisfactory compliance of subject|11
6880609|NCT00530855|10892956|FG000|Overall Study|Lost to Follow-up|9
6880610|NCT00530855|10892956|FG000|Overall Study|Other reason for premature termination|17
6880611|NCT00530894|10892964|FG000|Overall Study|Death|84
6880612|NCT00530894|10892965|FG001|Overall Study|Death|89
6880613|NCT00530894|10892966|FG002|Overall Study|Death|55
6880614|NCT00530894|10892967|FG003|Overall Study|Death|89
6880615|NCT00530894|10892964|FG000|Overall Study|Lost to Follow-up|1
6880616|NCT00530894|10892965|FG001|Overall Study|Lost to Follow-up|3
6880617|NCT00530894|10892966|FG002|Overall Study|Lost to Follow-up|0
6880618|NCT00530894|10892967|FG003|Overall Study|Lost to Follow-up|0
6880619|NCT00530894|10892964|FG000|Overall Study|Withdrawal by Subject|1
6880620|NCT00530894|10892965|FG001|Overall Study|Withdrawal by Subject|23
6880621|NCT00530894|10892966|FG002|Overall Study|Withdrawal by Subject|0
6880622|NCT00530894|10892967|FG003|Overall Study|Withdrawal by Subject|5
6880623|NCT00530894|10892964|FG000|Overall Study|Alive and censored prior to 1 year|2
6880624|NCT00530894|10892965|FG001|Overall Study|Alive and censored prior to 1 year|0
6880625|NCT00530894|10892966|FG002|Overall Study|Alive and censored prior to 1 year|0
6880626|NCT00530894|10892967|FG003|Overall Study|Alive and censored prior to 1 year|0
6880627|NCT00530920|10892982|FG000|Overall Study|Randomized but not treated|0
6880628|NCT00530920|10892983|FG001|Overall Study|Randomized but not treated|2
6880629|NCT00530920|10892984|FG002|Overall Study|Randomized but not treated|0
6880630|NCT00530920|10892982|FG000|Overall Study|Adverse Event|0
6880631|NCT00530920|10892983|FG001|Overall Study|Adverse Event|0
6880632|NCT00530920|10892984|FG002|Overall Study|Adverse Event|3
6880633|NCT00530920|10892982|FG000|Overall Study|Withdrawal by Subject|0
6880634|NCT00530920|10892983|FG001|Overall Study|Withdrawal by Subject|0
6880635|NCT00530920|10892984|FG002|Overall Study|Withdrawal by Subject|1
6880636|NCT00530946|10892997|FG000|Overall Study|Adverse Event|1
6880637|NCT00530946|10892998|FG001|Overall Study|Adverse Event|2
6880638|NCT00530946|10892999|FG002|Overall Study|Adverse Event|1
6880639|NCT00530946|10893000|FG003|Overall Study|Adverse Event|1
6880640|NCT00530946|10892997|FG000|Overall Study|Protocol Violation|0
6880641|NCT00530946|10892998|FG001|Overall Study|Protocol Violation|0
6880642|NCT00530946|10892999|FG002|Overall Study|Protocol Violation|0
6880643|NCT00530946|10893000|FG003|Overall Study|Protocol Violation|1
6880644|NCT00530946|10892997|FG000|Overall Study|Noncompliance|1
6880645|NCT00530946|10892998|FG001|Overall Study|Noncompliance|0
6880646|NCT00530946|10892999|FG002|Overall Study|Noncompliance|0
6880647|NCT00530946|10893000|FG003|Overall Study|Noncompliance|0
6880648|NCT00531011|10893012|FG000|Overall Study|Withdrawal by Subject|2
6880649|NCT00531011|10893013|FG001|Overall Study|Withdrawal by Subject|4
6880650|NCT00531011|10893012|FG000|Overall Study|Death|1
6880651|NCT00531011|10893013|FG001|Overall Study|Death|0
6880652|NCT00531011|10893012|FG000|Overall Study|Lost to Follow-up|1
6880653|NCT00531011|10893013|FG001|Overall Study|Lost to Follow-up|0
6880654|NCT00531011|10893012|FG000|Overall Study|Physician Decision|0
6880655|NCT00531011|10893013|FG001|Overall Study|Physician Decision|3
6880656|NCT00531050|10893025|FG000|Part 1: Period 1|Adverse Event|0
6880657|NCT00531050|10893026|FG001|Part 1: Period 1|Adverse Event|1
6880658|NCT00531050|10893027|FG002|Part 1: Period 1|Adverse Event|0
6880659|NCT00531050|10893028|FG003|Part 1: Period 1|Adverse Event|0
6880660|NCT00531050|10893029|FG004|Part 1: Period 1|Adverse Event|0
6880661|NCT00531050|10893030|FG005|Part 1: Period 1|Adverse Event|0
6880662|NCT00531050|10893025|FG000|Part 1: Period 1|Protocol Deviation|0
6880663|NCT00531050|10893026|FG001|Part 1: Period 1|Protocol Deviation|0
6880664|NCT00531050|10893027|FG002|Part 1: Period 1|Protocol Deviation|0
6880665|NCT00531050|10893028|FG003|Part 1: Period 1|Protocol Deviation|1
6880666|NCT00531050|10893029|FG004|Part 1: Period 1|Protocol Deviation|0
6880667|NCT00531050|10893030|FG005|Part 1: Period 1|Protocol Deviation|0
6880668|NCT00531050|10893025|FG000|Part 1: Period 3|Adverse Event|1
6880669|NCT00531050|10893026|FG001|Part 1: Period 3|Adverse Event|0
6880670|NCT00531050|10893027|FG002|Part 1: Period 3|Adverse Event|0
6880671|NCT00531050|10893028|FG003|Part 1: Period 3|Adverse Event|0
6880672|NCT00531050|10893029|FG004|Part 1: Period 3|Adverse Event|0
6880673|NCT00531050|10893030|FG005|Part 1: Period 3|Adverse Event|0
6880674|NCT00531050|10893025|FG000|Part 2: Period 1|Adverse Event|0
6880675|NCT00531050|10893026|FG001|Part 2: Period 1|Adverse Event|0
6880676|NCT00531050|10893027|FG002|Part 2: Period 1|Adverse Event|0
6880677|NCT00531050|10893028|FG003|Part 2: Period 1|Adverse Event|0
6880678|NCT00531050|10893029|FG004|Part 2: Period 1|Adverse Event|0
6880679|NCT00531050|10893030|FG005|Part 2: Period 1|Adverse Event|1
6880680|NCT00531050|10893025|FG000|Part 2: Period 3|Abnormal test procedure|1
6880681|NCT00531050|10893026|FG001|Part 2: Period 3|Abnormal test procedure|0
6880682|NCT00531050|10893027|FG002|Part 2: Period 3|Abnormal test procedure|0
6880683|NCT00531050|10893028|FG003|Part 2: Period 3|Abnormal test procedure|0
6880684|NCT00531050|10893029|FG004|Part 2: Period 3|Abnormal test procedure|0
6880685|NCT00531050|10893030|FG005|Part 2: Period 3|Abnormal test procedure|1
6880686|NCT00531206|10893047|FG000|Overall Study|Adverse Event related|5
6880687|NCT00531206|10893047|FG000|Overall Study|Lack of Efficacy|2
6880688|NCT00531206|10893047|FG000|Overall Study|Lost to Follow-up|5
6880689|NCT00531206|10893047|FG000|Overall Study|including non-related adverse events|8
6880690|NCT00531284|10893068|FG000|Overall Study|Progressive Disease|1
6880691|NCT00531284|10893069|FG001|Overall Study|Progressive Disease|3
6880692|NCT00531284|10893070|FG002|Overall Study|Progressive Disease|5
6880693|NCT00531284|10893071|FG003|Overall Study|Progressive Disease|42
6880694|NCT00531284|10893072|FG004|Overall Study|Progressive Disease|4
6880695|NCT00531284|10893073|FG005|Overall Study|Progressive Disease|4
6880696|NCT00531284|10893074|FG006|Overall Study|Progressive Disease|3
6880697|NCT00531284|10893075|FG007|Overall Study|Progressive Disease|8
6880698|NCT00531284|10893076|FG008|Overall Study|Progressive Disease|6
6880699|NCT00531284|10893077|FG009|Overall Study|Progressive Disease|3
6880700|NCT00531284|10893078|FG010|Overall Study|Progressive Disease|3
6880701|NCT00531284|10893079|FG011|Overall Study|Progressive Disease|14
6880702|NCT00531284|10893080|FG012|Overall Study|Progressive Disease|2
6880703|NCT00531284|10893081|FG013|Overall Study|Progressive Disease|1
6880704|NCT00531284|10893082|FG014|Overall Study|Progressive Disease|2
6880705|NCT00531284|10893083|FG015|Overall Study|Progressive Disease|11
6880706|NCT00531284|10893084|FG016|Overall Study|Progressive Disease|5
6880707|NCT00531284|10893068|FG000|Overall Study|Adverse Event|0
6880708|NCT00531284|10893069|FG001|Overall Study|Adverse Event|1
6880709|NCT00531284|10893070|FG002|Overall Study|Adverse Event|1
6880710|NCT00531284|10893071|FG003|Overall Study|Adverse Event|7
6880711|NCT00531284|10893072|FG004|Overall Study|Adverse Event|0
6880712|NCT00531284|10893073|FG005|Overall Study|Adverse Event|2
6880713|NCT00531284|10893074|FG006|Overall Study|Adverse Event|3
6880714|NCT00531284|10893075|FG007|Overall Study|Adverse Event|2
6880715|NCT00531284|10893076|FG008|Overall Study|Adverse Event|3
6880716|NCT00531284|10893077|FG009|Overall Study|Adverse Event|0
6880717|NCT00531284|10893078|FG010|Overall Study|Adverse Event|0
6880718|NCT00531284|10893079|FG011|Overall Study|Adverse Event|5
6880719|NCT00531284|10893080|FG012|Overall Study|Adverse Event|0
6880720|NCT00531284|10893081|FG013|Overall Study|Adverse Event|1
6880721|NCT00531284|10893082|FG014|Overall Study|Adverse Event|1
6880722|NCT00531284|10893083|FG015|Overall Study|Adverse Event|0
6880723|NCT00531284|10893084|FG016|Overall Study|Adverse Event|2
6880724|NCT00531284|10893068|FG000|Overall Study|Withdrawal by Subject|1
6880725|NCT00531284|10893069|FG001|Overall Study|Withdrawal by Subject|0
6880726|NCT00531284|10893070|FG002|Overall Study|Withdrawal by Subject|0
6880727|NCT00531284|10893071|FG003|Overall Study|Withdrawal by Subject|4
6880728|NCT00531284|10893072|FG004|Overall Study|Withdrawal by Subject|0
6880729|NCT00531284|10893073|FG005|Overall Study|Withdrawal by Subject|0
6880730|NCT00531284|10893074|FG006|Overall Study|Withdrawal by Subject|0
6880731|NCT00531284|10893075|FG007|Overall Study|Withdrawal by Subject|0
6880732|NCT00531284|10893076|FG008|Overall Study|Withdrawal by Subject|0
6880733|NCT00531284|10893077|FG009|Overall Study|Withdrawal by Subject|0
6880734|NCT00531284|10893078|FG010|Overall Study|Withdrawal by Subject|0
6880735|NCT00531284|10893079|FG011|Overall Study|Withdrawal by Subject|3
6880736|NCT00531284|10893080|FG012|Overall Study|Withdrawal by Subject|0
6880737|NCT00531284|10893081|FG013|Overall Study|Withdrawal by Subject|1
6880738|NCT00531284|10893082|FG014|Overall Study|Withdrawal by Subject|0
6880739|NCT00531284|10893083|FG015|Overall Study|Withdrawal by Subject|1
6880740|NCT00531284|10893084|FG016|Overall Study|Withdrawal by Subject|1
6880741|NCT00531284|10893068|FG000|Overall Study|Other|1
6880742|NCT00531284|10893069|FG001|Overall Study|Other|0
6880743|NCT00531284|10893070|FG002|Overall Study|Other|0
6880744|NCT00531284|10893071|FG003|Overall Study|Other|10
6880745|NCT00531284|10893072|FG004|Overall Study|Other|2
6880746|NCT00531284|10893073|FG005|Overall Study|Other|1
6880747|NCT00531284|10893074|FG006|Overall Study|Other|0
6880748|NCT00531284|10893075|FG007|Overall Study|Other|0
6880749|NCT00531284|10893076|FG008|Overall Study|Other|2
6880750|NCT00531284|10893077|FG009|Overall Study|Other|1
6880751|NCT00531284|10893078|FG010|Overall Study|Other|0
6880752|NCT00531284|10893079|FG011|Overall Study|Other|2
6880753|NCT00531284|10893080|FG012|Overall Study|Other|0
6880754|NCT00531284|10893081|FG013|Overall Study|Other|0
6880755|NCT00531284|10893082|FG014|Overall Study|Other|1
6880756|NCT00531284|10893083|FG015|Overall Study|Other|0
6880757|NCT00531284|10893084|FG016|Overall Study|Other|0
6880758|NCT00531427|10893142|FG000|Overall Study|Withdrawal by Subject|7
6880759|NCT00531427|10893143|FG001|Overall Study|Withdrawal by Subject|13
7078995|NCT02107443|11187634|FG000|Overall Study|Withdrawal: Changed MD/Facility|1
7078996|NCT02107443|11187635|FG001|Overall Study|Withdrawal: Changed MD/Facility|3
7078997|NCT02107443|11187634|FG000|Overall Study|Withdrawal: Too Many Forms|3
7078998|NCT02107443|11187635|FG001|Overall Study|Withdrawal: Too Many Forms|1
6880760|NCT00531427|10893142|FG000|Overall Study|Adverse Event|44
7078999|NCT02107443|11187634|FG000|Overall Study|Withdrawal: Too Time Consuming|3
7079000|NCT02107443|11187635|FG001|Overall Study|Withdrawal: Too Time Consuming|6
7079001|NCT02107443|11187634|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2
7079002|NCT02107443|11187635|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1
7079003|NCT02107443|11187634|FG000|Overall Study|Withdrawal: Other Medical|9
7079004|NCT02107443|11187635|FG001|Overall Study|Withdrawal: Other Medical|5
7079005|NCT02107443|11187634|FG000|Overall Study|Withdrawal: Disease Progression|4
7079006|NCT02107443|11187635|FG001|Overall Study|Withdrawal: Disease Progression|2
7079007|NCT02107443|11187634|FG000|Overall Study|Withdrawal: Personal Issues|0
7079008|NCT02107443|11187635|FG001|Overall Study|Withdrawal: Personal Issues|3
7079009|NCT02107482|11187642|FG000|Overall Study|inconveinence|2
7079010|NCT02107482|11187642|FG000|Overall Study|Lost to Follow-up|1
7079011|NCT02107482|11187642|FG000|Overall Study|Lack of Efficacy|1
7079012|NCT02107703|11187655|FG000|Overall Study|Withdrawal by Subject|36
7155595|NCT03342898|11323595|FG001|Overall Study|Death|1
6880761|NCT00531427|10893143|FG001|Overall Study|Adverse Event|30
6880762|NCT00531427|10893142|FG000|Overall Study|Lost to Follow-up|4
6880763|NCT00531427|10893143|FG001|Overall Study|Lost to Follow-up|3
6880764|NCT00531427|10893142|FG000|Overall Study|Lack of Efficacy|14
6880765|NCT00531427|10893143|FG001|Overall Study|Lack of Efficacy|39
6880766|NCT00531427|10893142|FG000|Overall Study|Administrative|4
6880767|NCT00531427|10893143|FG001|Overall Study|Administrative|9
6880768|NCT00531479|10893161|FG000|Overall Study|Death|68
6880769|NCT00531479|10893162|FG001|Overall Study|Death|71
6880770|NCT00531479|10893161|FG000|Overall Study|Lost to Follow-up|0
6880771|NCT00531479|10893162|FG001|Overall Study|Lost to Follow-up|2
6880772|NCT00531479|10893161|FG000|Overall Study|Other|0
6880773|NCT00531479|10893162|FG001|Overall Study|Other|1
6880774|NCT00531479|10893161|FG000|Overall Study|Withdrawal by Subject|6
6880775|NCT00531479|10893162|FG001|Overall Study|Withdrawal by Subject|6
6880776|NCT00531479|10893161|FG000|Overall Study|Did not receive treatment|2
6880777|NCT00531479|10893162|FG001|Overall Study|Did not receive treatment|3
6880778|NCT00531752|10893193|FG000|First Double-blind Intervention Period|Adverse Event|2
6880779|NCT00531752|10893194|FG001|First Double-blind Intervention Period|Adverse Event|0
7079013|NCT02107703|11187656|FG001|Overall Study|Withdrawal by Subject|19
7079014|NCT02107703|11187655|FG000|Overall Study|Lost to Follow-up|6
7079015|NCT02107703|11187656|FG001|Overall Study|Lost to Follow-up|4
7155596|NCT03342898|11323596|FG002|Overall Study|Death|1
7155597|NCT03342898|11323594|FG000|Overall Study|Reason not Specified|2
7155598|NCT03342898|11323595|FG001|Overall Study|Reason not Specified|2
7155599|NCT03342898|11323596|FG002|Overall Study|Reason not Specified|0
7155600|NCT03342963|11323608|FG000|Overall Study|Adverse Event|1
7155601|NCT03342963|11323609|FG001|Overall Study|Adverse Event|2
7155602|NCT03342963|11323610|FG002|Overall Study|Adverse Event|0
6880780|NCT00531752|10893195|FG002|First Double-blind Intervention Period|Adverse Event|1
6880781|NCT00531752|10893196|FG003|First Double-blind Intervention Period|Adverse Event|1
6880782|NCT00531752|10893193|FG000|First Double-blind Intervention Period|Other|1
6880783|NCT00531752|10893194|FG001|First Double-blind Intervention Period|Other|4
6880784|NCT00531752|10893195|FG002|First Double-blind Intervention Period|Other|4
6880785|NCT00531752|10893196|FG003|First Double-blind Intervention Period|Other|0
6880786|NCT00531752|10893193|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2
6880787|NCT00531752|10893194|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0
6880788|NCT00531752|10893195|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1
6880789|NCT00531752|10893196|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1
6880790|NCT00531752|10893193|FG000|First Double-blind Intervention Period|Lost to Follow-up|0
6880791|NCT00531752|10893194|FG001|First Double-blind Intervention Period|Lost to Follow-up|0
6880792|NCT00531752|10893195|FG002|First Double-blind Intervention Period|Lost to Follow-up|1
6880793|NCT00531752|10893196|FG003|First Double-blind Intervention Period|Lost to Follow-up|1
6880794|NCT00531752|10893193|FG000|First Double-blind Intervention Period|Randomized but not treated|1
6880795|NCT00531752|10893194|FG001|First Double-blind Intervention Period|Randomized but not treated|0
6880796|NCT00531752|10893195|FG002|First Double-blind Intervention Period|Randomized but not treated|0
6880797|NCT00531752|10893196|FG003|First Double-blind Intervention Period|Randomized but not treated|0
6880798|NCT00531752|10893193|FG000|Second Double-blind Intervention Period|Adverse Event|1
6880799|NCT00531752|10893194|FG001|Second Double-blind Intervention Period|Adverse Event|1
6880800|NCT00531752|10893195|FG002|Second Double-blind Intervention Period|Adverse Event|0
6880801|NCT00531752|10893196|FG003|Second Double-blind Intervention Period|Adverse Event|0
6880802|NCT00531752|10893193|FG000|Second Double-blind Intervention Period|Other|1
6880803|NCT00531752|10893194|FG001|Second Double-blind Intervention Period|Other|1
6880804|NCT00531752|10893195|FG002|Second Double-blind Intervention Period|Other|0
6880805|NCT00531752|10893196|FG003|Second Double-blind Intervention Period|Other|0
6880806|NCT00531752|10893193|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0
6880807|NCT00531752|10893194|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0
6880808|NCT00531752|10893195|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0
6880809|NCT00531752|10893196|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1
6880810|NCT00531752|10893193|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0
6880811|NCT00531752|10893194|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0
6880812|NCT00531752|10893195|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0
6880813|NCT00531752|10893196|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1
6880814|NCT00531934|10893238|FG000|Overall Study|Adverse Event|4
6880815|NCT00531934|10893239|FG001|Overall Study|Adverse Event|8
6880816|NCT00531934|10893238|FG000|Overall Study|Progression|52
6880817|NCT00531934|10893239|FG001|Overall Study|Progression|42
6880818|NCT00531934|10893238|FG000|Overall Study|Death|7
6880819|NCT00531934|10893239|FG001|Overall Study|Death|10
6880820|NCT00531934|10893238|FG000|Overall Study|Withdrawal by Subject|1
6880821|NCT00531934|10893239|FG001|Overall Study|Withdrawal by Subject|1
6880822|NCT00531934|10893238|FG000|Overall Study|Other|2
6880823|NCT00531934|10893239|FG001|Overall Study|Other|2
6880824|NCT00531947|10893247|FG000|Overall Study|Adverse Event|5
6880825|NCT00531947|10893248|FG001|Overall Study|Adverse Event|10
6880826|NCT00531947|10893247|FG000|Overall Study|Lost to Follow-up|12
6880827|NCT00531947|10893248|FG001|Overall Study|Lost to Follow-up|9
6880828|NCT00531947|10893247|FG000|Overall Study|Withdrawal by Subject|14
6880829|NCT00531947|10893248|FG001|Overall Study|Withdrawal by Subject|19
6880830|NCT00531947|10893247|FG000|Overall Study|Protocol Violation|2
6880831|NCT00531947|10893248|FG001|Overall Study|Protocol Violation|1
6880832|NCT00531947|10893247|FG000|Overall Study|Non-Compliance|4
6880833|NCT00531947|10893248|FG001|Overall Study|Non-Compliance|7
6880834|NCT00531947|10893247|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5
6880835|NCT00531947|10893248|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5
6880836|NCT00531960|10893256|FG000|Overall Study|Adverse Event|5
6880837|NCT00531960|10893257|FG001|Overall Study|Adverse Event|4
6880838|NCT00531960|10893256|FG000|Overall Study|Death|3
6880839|NCT00531960|10893257|FG001|Overall Study|Death|2
6880840|NCT00531960|10893256|FG000|Overall Study|Lack of Efficacy|42
6880841|NCT00531960|10893257|FG001|Overall Study|Lack of Efficacy|41
6880842|NCT00531960|10893256|FG000|Overall Study|Violation of Selection Criteria|2
6880843|NCT00531960|10893257|FG001|Overall Study|Violation of Selection Criteria|0
6880844|NCT00531960|10893256|FG000|Overall Study|Refused Treatment|5
6880845|NCT00531960|10893257|FG001|Overall Study|Refused Treatment|6
6880846|NCT00531960|10893256|FG000|Overall Study|Other|4
6880847|NCT00531960|10893257|FG001|Overall Study|Other|10
6880848|NCT00532129|10893263|FG000|Treatment Period|Adverse event/Serious adverse event|25
6880849|NCT00532129|10893263|FG000|Treatment Period|Physician Decision|15
6880850|NCT00532129|10893263|FG000|Treatment Period|Disease progression|3
6880851|NCT00532129|10893263|FG000|Treatment Period|Protocol Violation|1
6880852|NCT00532129|10893263|FG000|Treatment Period|Other|5
6880853|NCT00532129|10893263|FG000|Follow-up Period|Adverse event/Serious adverse event|1
6880854|NCT00532129|10893263|FG000|Follow-up Period|Disease progression|57
6880855|NCT00532129|10893263|FG000|Follow-up Period|Lost to Follow-up|1
6880856|NCT00532129|10893263|FG000|Follow-up Period|Other|6
6880857|NCT00532155|10893269|FG000|Overall Study|Adverse Event|66
6880858|NCT00532155|10893270|FG001|Overall Study|Adverse Event|123
6880859|NCT00532155|10893269|FG000|Overall Study|Lack of Efficacy|332
6880860|NCT00532155|10893270|FG001|Overall Study|Lack of Efficacy|255
6880861|NCT00532155|10893269|FG000|Overall Study|Protocol Violation|1
6880862|NCT00532155|10893270|FG001|Overall Study|Protocol Violation|3
6880863|NCT00532155|10893269|FG000|Overall Study|Lost to Follow-up|2
6880864|NCT00532155|10893270|FG001|Overall Study|Lost to Follow-up|0
6880865|NCT00532155|10893269|FG000|Overall Study|Physician Decision|16
6880866|NCT00532155|10893270|FG001|Overall Study|Physician Decision|15
6880867|NCT00532155|10893269|FG000|Overall Study|Withdrawal by Subject|23
6880868|NCT00532155|10893270|FG001|Overall Study|Withdrawal by Subject|44
6880869|NCT00532155|10893269|FG000|Overall Study|Consent withdrawn|5
6880870|NCT00532155|10893270|FG001|Overall Study|Consent withdrawn|7
6880871|NCT00532155|10893269|FG000|Overall Study|Moved|1
6880872|NCT00532155|10893270|FG001|Overall Study|Moved|0
6880873|NCT00532155|10893269|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1
6880874|NCT00532155|10893270|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0
6880875|NCT00532155|10893269|FG000|Overall Study|Occurence of a second cancer|0
6880876|NCT00532155|10893270|FG001|Overall Study|Occurence of a second cancer|1
6880877|NCT00532155|10893269|FG000|Overall Study|Occurence of a secondary cancer|0
6880878|NCT00532155|10893270|FG001|Overall Study|Occurence of a secondary cancer|1
6880879|NCT00532155|10893269|FG000|Overall Study|Promotor ended study|1
6880880|NCT00532155|10893270|FG001|Overall Study|Promotor ended study|0
6880881|NCT00532155|10893269|FG000|Overall Study|Progressive disease (by incorrect scan)|0
6880882|NCT00532155|10893270|FG001|Overall Study|Progressive disease (by incorrect scan)|1
6880883|NCT00532155|10893269|FG000|Overall Study|Had brain metastasis, was mis-randomized|1
6880884|NCT00532155|10893270|FG001|Overall Study|Had brain metastasis, was mis-randomized|0
6880885|NCT00532155|10893269|FG000|Overall Study|Study stopped|1
6880886|NCT00532155|10893270|FG001|Overall Study|Study stopped|0
6880887|NCT00532155|10893269|FG000|Overall Study|Study terminated by sponsor|1
6880888|NCT00532155|10893270|FG001|Overall Study|Study terminated by sponsor|0
6880889|NCT00532155|10893269|FG000|Overall Study|Study termination stop further treatment|4
6880890|NCT00532155|10893270|FG001|Overall Study|Study termination stop further treatment|0
6880891|NCT00532155|10893269|FG000|Overall Study|Did not receive study medication|2
6880892|NCT00532155|10893270|FG001|Overall Study|Did not receive study medication|6
6880893|NCT00532259|10893276|FG000|Overall Study|Withdrawal by Subject|2
6880894|NCT00532259|10893276|FG000|Overall Study|Adverse Event|1
6880895|NCT00532259|10893276|FG000|Overall Study|Death|1
6880896|NCT00532259|10893276|FG000|Overall Study|Lack of Efficacy|21
6880897|NCT00532259|10893276|FG000|Overall Study|Lost to Follow-up|3
6880898|NCT00532259|10893276|FG000|Overall Study|Physician Decision|3
6880899|NCT00532259|10893276|FG000|Overall Study|Protocol Violation|1
6880900|NCT00532298|10893287|FG000|Overall Study|Adverse Event|1
6880901|NCT00532298|10893288|FG001|Overall Study|Adverse Event|0
6880902|NCT00532298|10893289|FG002|Overall Study|Adverse Event|0
6880903|NCT00532298|10893290|FG003|Overall Study|Adverse Event|0
6880904|NCT00532298|10893291|FG004|Overall Study|Adverse Event|1
6880905|NCT00532298|10893292|FG005|Overall Study|Adverse Event|1
6880906|NCT00532298|10893287|FG000|Overall Study|Lost to Follow-up|1
6880907|NCT00532298|10893288|FG001|Overall Study|Lost to Follow-up|1
6880908|NCT00532298|10893289|FG002|Overall Study|Lost to Follow-up|1
6880909|NCT00532298|10893290|FG003|Overall Study|Lost to Follow-up|0
6880910|NCT00532298|10893291|FG004|Overall Study|Lost to Follow-up|0
6880911|NCT00532298|10893292|FG005|Overall Study|Lost to Follow-up|1
6880912|NCT00532441|10893306|FG000|Overall Study|Death|1
6880913|NCT00532441|10893307|FG001|Overall Study|Death|0
6880914|NCT00532493|10893322|FG000|Overall Study|Death|1
6880915|NCT00532493|10893323|FG001|Overall Study|Death|1
6880916|NCT00532493|10893322|FG000|Overall Study|Lost to Follow-up|10
6880917|NCT00532493|10893323|FG001|Overall Study|Lost to Follow-up|7
6880918|NCT00532493|10893322|FG000|Overall Study|Withdrawal by Subject|7
6880919|NCT00532493|10893323|FG001|Overall Study|Withdrawal by Subject|9
6880920|NCT00532493|10893322|FG000|Overall Study|Physician Decision|1
6880921|NCT00532493|10893323|FG001|Overall Study|Physician Decision|6
6880922|NCT00532493|10893322|FG000|Overall Study|Adverse Event|6
6880923|NCT00532493|10893323|FG001|Overall Study|Adverse Event|5
6880924|NCT00532493|10893322|FG000|Overall Study|Protocol Deviation|1
6880925|NCT00532493|10893323|FG001|Overall Study|Protocol Deviation|0
6880926|NCT00532493|10893322|FG000|Overall Study|Subject Moved Away|3
6880927|NCT00532493|10893323|FG001|Overall Study|Subject Moved Away|1
6880928|NCT00532493|10893322|FG000|Overall Study|Contraindicative Medication|1
6880929|NCT00532493|10893323|FG001|Overall Study|Contraindicative Medication|0
6880930|NCT00532779|10893334|FG000|Overall Study|Adverse Event|122
6880931|NCT00532779|10893335|FG001|Overall Study|Adverse Event|112
6880932|NCT00532779|10893336|FG002|Overall Study|Adverse Event|56
6880933|NCT00532779|10893334|FG000|Overall Study|Lost to Follow-up|76
6880934|NCT00532779|10893335|FG001|Overall Study|Lost to Follow-up|65
6880935|NCT00532779|10893336|FG002|Overall Study|Lost to Follow-up|66
6880936|NCT00532779|10893334|FG000|Overall Study|Withdrawal by Subject|63
6880937|NCT00532779|10893335|FG001|Overall Study|Withdrawal by Subject|60
6880938|NCT00532779|10893336|FG002|Overall Study|Withdrawal by Subject|90
6880939|NCT00532779|10893334|FG000|Overall Study|Lack of Efficacy|12
6880940|NCT00532779|10893335|FG001|Overall Study|Lack of Efficacy|12
6880941|NCT00532779|10893336|FG002|Overall Study|Lack of Efficacy|40
6880942|NCT00532779|10893334|FG000|Overall Study|Protocol Violation|5
6880943|NCT00532779|10893335|FG001|Overall Study|Protocol Violation|9
6880944|NCT00532779|10893336|FG002|Overall Study|Protocol Violation|7
6880945|NCT00532779|10893334|FG000|Overall Study|Pregnancy|2
6880946|NCT00532779|10893335|FG001|Overall Study|Pregnancy|5
6880947|NCT00532779|10893336|FG002|Overall Study|Pregnancy|3
6880948|NCT00532779|10893334|FG000|Overall Study|Death|0
6880949|NCT00532779|10893335|FG001|Overall Study|Death|1
6880950|NCT00532779|10893336|FG002|Overall Study|Death|0
6880951|NCT00532779|10893334|FG000|Overall Study|Drug noncompliance, moved, other|14
6880952|NCT00532779|10893335|FG001|Overall Study|Drug noncompliance, moved, other|23
6880953|NCT00532779|10893336|FG002|Overall Study|Drug noncompliance, moved, other|29
6880954|NCT00532844|10893346|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0
6880955|NCT00532844|10893347|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1
6880956|NCT00532844|10893346|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1
6880957|NCT00532844|10893347|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0
6880958|NCT00532844|10893346|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1
6880959|NCT00532844|10893347|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0
6880960|NCT00532844|10893346|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1
6880961|NCT00532844|10893347|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0
6880962|NCT00532844|10893346|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1
6880963|NCT00532844|10893347|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0
6880964|NCT00532883|10893370|FG000|Overall Study|Adverse Event|1
6880965|NCT00532883|10893371|FG001|Overall Study|Adverse Event|0
6880966|NCT00532883|10893372|FG002|Overall Study|Adverse Event|0
6880967|NCT00532883|10893373|FG003|Overall Study|Adverse Event|1
6880968|NCT00532883|10893370|FG000|Overall Study|Lost to Follow-up|1
6880969|NCT00532883|10893371|FG001|Overall Study|Lost to Follow-up|1
6880970|NCT00532883|10893372|FG002|Overall Study|Lost to Follow-up|1
6880971|NCT00532883|10893373|FG003|Overall Study|Lost to Follow-up|0
6880972|NCT00532883|10893370|FG000|Overall Study|Withdrawal by Subject|0
6880973|NCT00532883|10893371|FG001|Overall Study|Withdrawal by Subject|1
6880974|NCT00532883|10893372|FG002|Overall Study|Withdrawal by Subject|1
6880975|NCT00532883|10893373|FG003|Overall Study|Withdrawal by Subject|0
6880976|NCT00532883|10893370|FG000|Overall Study|Subject was Nonadherent|0
6880977|NCT00532883|10893371|FG001|Overall Study|Subject was Nonadherent|1
6880978|NCT00532883|10893372|FG002|Overall Study|Subject was Nonadherent|1
6880979|NCT00532883|10893373|FG003|Overall Study|Subject was Nonadherent|0
6880980|NCT00532883|10893370|FG000|Overall Study|Early Study Termination|4
6880981|NCT00532883|10893371|FG001|Overall Study|Early Study Termination|4
6880982|NCT00532883|10893372|FG002|Overall Study|Early Study Termination|1
6880983|NCT00532883|10893373|FG003|Overall Study|Early Study Termination|4
6880984|NCT00532935|10893385|FG000|Overall Study|Adverse Event|11
6880985|NCT00532935|10893386|FG001|Overall Study|Adverse Event|12
6880986|NCT00532935|10893385|FG000|Overall Study|Lack of Efficacy|0
6880987|NCT00532935|10893386|FG001|Overall Study|Lack of Efficacy|3
6880988|NCT00532935|10893385|FG000|Overall Study|Lost to Follow-up|10
6880989|NCT00532935|10893386|FG001|Overall Study|Lost to Follow-up|6
6880990|NCT00532935|10893385|FG000|Overall Study|Physician Decision|4
6880991|NCT00532935|10893386|FG001|Overall Study|Physician Decision|5
6880992|NCT00532935|10893385|FG000|Overall Study|Pregnancy|1
6880993|NCT00532935|10893386|FG001|Overall Study|Pregnancy|0
6880994|NCT00532935|10893385|FG000|Overall Study|Protocol Violation|4
6880995|NCT00532935|10893386|FG001|Overall Study|Protocol Violation|2
6880996|NCT00532935|10893385|FG000|Overall Study|Withdrawal by Subject|10
6880997|NCT00532935|10893386|FG001|Overall Study|Withdrawal by Subject|9
6880998|NCT00532935|10893385|FG000|Overall Study|Protocol Specific Criteria|11
6880999|NCT00532935|10893386|FG001|Overall Study|Protocol Specific Criteria|15
6881000|NCT00532948|10893395|FG000|Overall Study|Protocol Violation|1
6881001|NCT00532948|10893396|FG001|Overall Study|Protocol Violation|0
6881002|NCT00532948|10893397|FG002|Overall Study|Protocol Violation|0
6881003|NCT00532948|10893395|FG000|Overall Study|Death|3
6881004|NCT00532948|10893396|FG001|Overall Study|Death|3
6881005|NCT00532948|10893397|FG002|Overall Study|Death|4
6881006|NCT00532948|10893395|FG000|Overall Study|Violation of selection criteria at entry|0
6881007|NCT00532948|10893396|FG001|Overall Study|Violation of selection criteria at entry|1
6881008|NCT00532948|10893397|FG002|Overall Study|Violation of selection criteria at entry|0
6881009|NCT00532948|10893395|FG000|Overall Study|Failure to return|0
6881010|NCT00532948|10893396|FG001|Overall Study|Failure to return|1
6881011|NCT00532948|10893397|FG002|Overall Study|Failure to return|0
6881012|NCT00533273|10893428|FG000|Double-blind|Withdrew consent|0
6881013|NCT00533273|10893429|FG001|Double-blind|Withdrew consent|2
6881014|NCT00533273|10893428|FG000|Open-label|Withdrawal by Subject|6
6881015|NCT00533273|10893429|FG001|Open-label|Withdrawal by Subject|0
6881016|NCT00533429|10893437|FG000|Overall Study|Adverse Event|3
6881017|NCT00533429|10893438|FG001|Overall Study|Adverse Event|1
6881018|NCT00533429|10893437|FG000|Overall Study|Death|1
6881019|NCT00533429|10893438|FG001|Overall Study|Death|0
6881020|NCT00533429|10893437|FG000|Overall Study|Withdrawal by Subject|2
6881021|NCT00533429|10893438|FG001|Overall Study|Withdrawal by Subject|0
6881022|NCT00533429|10893437|FG000|Overall Study|Progressive Disease|12
6881023|NCT00533429|10893438|FG001|Overall Study|Progressive Disease|13
6881024|NCT00533429|10893437|FG000|Overall Study|Symptomatic deterioration|1
6881025|NCT00533429|10893438|FG001|Overall Study|Symptomatic deterioration|2
6881026|NCT00533507|10893457|FG000|Overall Study|Withdrawal by Subject|1
6881027|NCT00533702|10893468|FG000|Overall Study|Withdrawal by Subject|3
6881028|NCT00533702|10893469|FG001|Overall Study|Withdrawal by Subject|1
6881029|NCT00533702|10893468|FG000|Overall Study|Found ineligible after randomization|2
6881030|NCT00533702|10893469|FG001|Overall Study|Found ineligible after randomization|1
6881031|NCT00533845|10893477|FG000|Overall Study|Physician Decision|1
6881032|NCT00533845|10893478|FG001|Overall Study|Physician Decision|0
6881033|NCT00533897|10893487|FG000|Lead-in (LI) Period 1|Adverse Event|1
6881034|NCT00533897|10893488|FG001|Lead-in (LI) Period 1|Adverse Event|0
6881035|NCT00533897|10893489|FG002|Lead-in (LI) Period 1|Adverse Event|0
6881036|NCT00533897|10893490|FG003|Lead-in (LI) Period 1|Adverse Event|0
6881037|NCT00533897|10893491|FG004|Lead-in (LI) Period 1|Adverse Event|0
6881038|NCT00533897|10893492|FG005|Lead-in (LI) Period 1|Adverse Event|0
6881039|NCT00533897|10893493|FG006|Lead-in (LI) Period 1|Adverse Event|0
6881040|NCT00533897|10893494|FG007|Lead-in (LI) Period 1|Adverse Event|0
6881041|NCT00533897|10893487|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2
6881042|NCT00533897|10893488|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0
6881043|NCT00533897|10893489|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0
6881044|NCT00533897|10893490|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0
6881045|NCT00533897|10893491|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0
6881046|NCT00533897|10893492|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0
6881047|NCT00533897|10893493|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0
6881048|NCT00533897|10893494|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0
6881049|NCT00533897|10893487|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1
6881050|NCT00533897|10893488|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0
6881051|NCT00533897|10893489|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0
6881052|NCT00533897|10893490|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0
6881053|NCT00533897|10893491|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0
6881054|NCT00533897|10893492|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0
6881055|NCT00533897|10893493|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0
6881056|NCT00533897|10893494|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0
6881057|NCT00533897|10893487|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2
6881058|NCT00533897|10893488|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
6881059|NCT00533897|10893489|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
6881060|NCT00533897|10893490|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
6881061|NCT00533897|10893491|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
6881062|NCT00533897|10893492|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
6881063|NCT00533897|10893493|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
6881064|NCT00533897|10893494|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
6881065|NCT00533897|10893487|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3
6881066|NCT00533897|10893488|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0
6881067|NCT00533897|10893489|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0
6881068|NCT00533897|10893490|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0
6881069|NCT00533897|10893491|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0
6881070|NCT00533897|10893492|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0
6881071|NCT00533897|10893493|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0
6881072|NCT00533897|10893494|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0
6881073|NCT00533897|10893487|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1
6881074|NCT00533897|10893488|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
6881075|NCT00533897|10893489|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
6881076|NCT00533897|10893490|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
6881077|NCT00533897|10893491|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
6881078|NCT00533897|10893492|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
6881079|NCT00533897|10893493|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
6881080|NCT00533897|10893494|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
6881081|NCT00533897|10893487|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
6881082|NCT00533897|10893488|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1
6881083|NCT00533897|10893489|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2
6881084|NCT00533897|10893490|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
6881085|NCT00533897|10893491|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
6881086|NCT00533897|10893492|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
6881087|NCT00533897|10893493|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
6881088|NCT00533897|10893494|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
6881089|NCT00533897|10893487|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
6881090|NCT00533897|10893488|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
6881091|NCT00533897|10893489|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1
6881092|NCT00533897|10893490|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
6881093|NCT00533897|10893491|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
6881094|NCT00533897|10893492|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
6881095|NCT00533897|10893493|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
6881096|NCT00533897|10893494|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
6881097|NCT00533897|10893487|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
6881098|NCT00533897|10893488|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
6881099|NCT00533897|10893489|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
6881100|NCT00533897|10893490|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
6881101|NCT00533897|10893491|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
6881102|NCT00533897|10893492|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1
6881103|NCT00533897|10893493|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
6881104|NCT00533897|10893494|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
6881105|NCT00533897|10893487|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
6881106|NCT00533897|10893488|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
6881107|NCT00533897|10893489|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
6881108|NCT00533897|10893490|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
6881109|NCT00533897|10893491|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
6881110|NCT00533897|10893492|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1
6881111|NCT00533897|10893493|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
6881112|NCT00533897|10893494|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
6881113|NCT00533897|10893487|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0
6881114|NCT00533897|10893488|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0
6881115|NCT00533897|10893489|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0
6881116|NCT00533897|10893490|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0
6881117|NCT00533897|10893491|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0
6881118|NCT00533897|10893492|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0
6881119|NCT00533897|10893493|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2
6881120|NCT00533897|10893494|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5
6881121|NCT00533897|10893487|FG000|Long Term Extension (LTE)|Death|0
6881122|NCT00533897|10893488|FG001|Long Term Extension (LTE)|Death|0
6881123|NCT00533897|10893489|FG002|Long Term Extension (LTE)|Death|0
6881124|NCT00533897|10893490|FG003|Long Term Extension (LTE)|Death|0
6881125|NCT00533897|10893491|FG004|Long Term Extension (LTE)|Death|0
6881126|NCT00533897|10893492|FG005|Long Term Extension (LTE)|Death|0
6881127|NCT00533897|10893493|FG006|Long Term Extension (LTE)|Death|1
6881128|NCT00533897|10893494|FG007|Long Term Extension (LTE)|Death|3
6881129|NCT00533897|10893487|FG000|Long Term Extension (LTE)|Lack of Efficacy|0
6881130|NCT00533897|10893488|FG001|Long Term Extension (LTE)|Lack of Efficacy|0
6881131|NCT00533897|10893489|FG002|Long Term Extension (LTE)|Lack of Efficacy|0
6881132|NCT00533897|10893490|FG003|Long Term Extension (LTE)|Lack of Efficacy|0
6881133|NCT00533897|10893491|FG004|Long Term Extension (LTE)|Lack of Efficacy|0
6881134|NCT00533897|10893492|FG005|Long Term Extension (LTE)|Lack of Efficacy|0
6881135|NCT00533897|10893493|FG006|Long Term Extension (LTE)|Lack of Efficacy|5
6881136|NCT00533897|10893494|FG007|Long Term Extension (LTE)|Lack of Efficacy|3
6881137|NCT00533897|10893487|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0
6881138|NCT00533897|10893488|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0
6881139|NCT00533897|10893489|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0
6881140|NCT00533897|10893490|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0
6881141|NCT00533897|10893491|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0
6881142|NCT00533897|10893492|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0
6881143|NCT00533897|10893493|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1
6881144|NCT00533897|10893494|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0
6881145|NCT00533897|10893487|FG000|Long Term Extension (LTE)|Adverse Event|0
6881146|NCT00533897|10893488|FG001|Long Term Extension (LTE)|Adverse Event|0
6881147|NCT00533897|10893489|FG002|Long Term Extension (LTE)|Adverse Event|0
6881148|NCT00533897|10893490|FG003|Long Term Extension (LTE)|Adverse Event|0
6881149|NCT00533897|10893491|FG004|Long Term Extension (LTE)|Adverse Event|0
6881150|NCT00533897|10893492|FG005|Long Term Extension (LTE)|Adverse Event|0
6881151|NCT00533897|10893493|FG006|Long Term Extension (LTE)|Adverse Event|2
6881152|NCT00533897|10893494|FG007|Long Term Extension (LTE)|Adverse Event|5
6881153|NCT00533897|10893487|FG000|Long Term Extension (LTE)|Pregnancy|0
6881154|NCT00533897|10893488|FG001|Long Term Extension (LTE)|Pregnancy|0
6881155|NCT00533897|10893489|FG002|Long Term Extension (LTE)|Pregnancy|0
6881156|NCT00533897|10893490|FG003|Long Term Extension (LTE)|Pregnancy|0
6881157|NCT00533897|10893491|FG004|Long Term Extension (LTE)|Pregnancy|0
6881158|NCT00533897|10893492|FG005|Long Term Extension (LTE)|Pregnancy|0
6881159|NCT00533897|10893493|FG006|Long Term Extension (LTE)|Pregnancy|0
6881160|NCT00533897|10893494|FG007|Long Term Extension (LTE)|Pregnancy|2
6881161|NCT00533897|10893487|FG000|Long Term Extension (LTE)|Lost to Follow-up|0
6881162|NCT00533897|10893488|FG001|Long Term Extension (LTE)|Lost to Follow-up|0
6881163|NCT00533897|10893489|FG002|Long Term Extension (LTE)|Lost to Follow-up|0
6881164|NCT00533897|10893490|FG003|Long Term Extension (LTE)|Lost to Follow-up|0
6881165|NCT00533897|10893491|FG004|Long Term Extension (LTE)|Lost to Follow-up|0
6881166|NCT00533897|10893492|FG005|Long Term Extension (LTE)|Lost to Follow-up|0
6881167|NCT00533897|10893493|FG006|Long Term Extension (LTE)|Lost to Follow-up|1
6881168|NCT00533897|10893494|FG007|Long Term Extension (LTE)|Lost to Follow-up|1
6881169|NCT00533897|10893487|FG000|Long Term Extension (LTE)|Other|0
6881170|NCT00533897|10893488|FG001|Long Term Extension (LTE)|Other|0
6881171|NCT00533897|10893489|FG002|Long Term Extension (LTE)|Other|0
6881172|NCT00533897|10893490|FG003|Long Term Extension (LTE)|Other|0
6881173|NCT00533897|10893491|FG004|Long Term Extension (LTE)|Other|0
6881174|NCT00533897|10893492|FG005|Long Term Extension (LTE)|Other|0
6881175|NCT00533897|10893493|FG006|Long Term Extension (LTE)|Other|1
6881176|NCT00533897|10893494|FG007|Long Term Extension (LTE)|Other|6
6881177|NCT00534092|10893545|FG000|Overall Study|Lost to Follow-up|1
6881178|NCT00534092|10893546|FG001|Overall Study|Lost to Follow-up|0
6881179|NCT00534092|10893545|FG000|Overall Study|personal reasons/family concerns|1
6881180|NCT00534092|10893546|FG001|Overall Study|personal reasons/family concerns|0
7155603|NCT03342963|11323611|FG003|Overall Study|Adverse Event|0
7155604|NCT03342963|11323608|FG000|Overall Study|Withdrawal by Subject|1
6881181|NCT00534105|10893556|FG000|Overall Study|Lost to Follow-up|23
6881182|NCT00534105|10893557|FG001|Overall Study|Lost to Follow-up|39
6881183|NCT00534248|10893592|FG000|Overall Study|Adverse Event|19
6881184|NCT00534248|10893593|FG001|Overall Study|Adverse Event|29
6881185|NCT00534248|10893592|FG000|Overall Study|Lost to Follow-up|353
6881186|NCT00534248|10893593|FG001|Overall Study|Lost to Follow-up|375
6881187|NCT00534248|10893592|FG000|Overall Study|Other protocol specified criteria|13
6881188|NCT00534248|10893593|FG001|Overall Study|Other protocol specified criteria|3
7079016|NCT02107703|11187655|FG000|Overall Study|On study treatment/follow up|319
7079017|NCT02107703|11187656|FG001|Overall Study|On study treatment/follow up|152
6881189|NCT00534248|10893592|FG000|Overall Study|Physician Decision|10
6881190|NCT00534248|10893593|FG001|Overall Study|Physician Decision|7
6881191|NCT00534248|10893592|FG000|Overall Study|Protocol Violation|3
6881192|NCT00534248|10893593|FG001|Overall Study|Protocol Violation|4
6881193|NCT00534248|10893592|FG000|Overall Study|Withdrawal by Subject|263
6881194|NCT00534248|10893593|FG001|Overall Study|Withdrawal by Subject|255
6881195|NCT00534313|10893603|FG000|Short-term Period|Adverse Event|1
6881196|NCT00534313|10893604|FG001|Short-term Period|Adverse Event|2
6881197|NCT00534313|10893605|FG002|Short-term Period|Adverse Event|1
6881198|NCT00534313|10893606|FG003|Short-term Period|Adverse Event|3
6881199|NCT00534313|10893603|FG000|Short-term Period|Lack of Efficacy|3
6881200|NCT00534313|10893604|FG001|Short-term Period|Lack of Efficacy|4
6881201|NCT00534313|10893605|FG002|Short-term Period|Lack of Efficacy|0
6881202|NCT00534313|10893606|FG003|Short-term Period|Lack of Efficacy|3
6881203|NCT00534313|10893603|FG000|Short-term Period|Participant not meeting study criteria|0
6881204|NCT00534313|10893604|FG001|Short-term Period|Participant not meeting study criteria|0
6881205|NCT00534313|10893605|FG002|Short-term Period|Participant not meeting study criteria|0
6881206|NCT00534313|10893606|FG003|Short-term Period|Participant not meeting study criteria|1
6881207|NCT00534313|10893603|FG000|Short-term Period|Participant withdrew consent|2
6881208|NCT00534313|10893604|FG001|Short-term Period|Participant withdrew consent|0
6881209|NCT00534313|10893605|FG002|Short-term Period|Participant withdrew consent|0
6881210|NCT00534313|10893606|FG003|Short-term Period|Participant withdrew consent|2
6881211|NCT00534313|10893603|FG000|Short-term Period|Pregnancy|0
6881212|NCT00534313|10893604|FG001|Short-term Period|Pregnancy|0
6881213|NCT00534313|10893605|FG002|Short-term Period|Pregnancy|1
6881214|NCT00534313|10893606|FG003|Short-term Period|Pregnancy|0
6881215|NCT00534313|10893603|FG000|Long-term Period|Adverse Event|2
6881216|NCT00534313|10893604|FG001|Long-term Period|Adverse Event|1
6881217|NCT00534313|10893605|FG002|Long-term Period|Adverse Event|0
6881218|NCT00534313|10893606|FG003|Long-term Period|Adverse Event|1
6881219|NCT00534313|10893603|FG000|Long-term Period|Lack of Efficacy|14
6881220|NCT00534313|10893604|FG001|Long-term Period|Lack of Efficacy|10
6881221|NCT00534313|10893605|FG002|Long-term Period|Lack of Efficacy|14
6881222|NCT00534313|10893606|FG003|Long-term Period|Lack of Efficacy|12
6881223|NCT00534313|10893603|FG000|Long-term Period|Lost to Follow-up|1
6881224|NCT00534313|10893604|FG001|Long-term Period|Lost to Follow-up|2
6881225|NCT00534313|10893605|FG002|Long-term Period|Lost to Follow-up|0
6881226|NCT00534313|10893606|FG003|Long-term Period|Lost to Follow-up|0
6881227|NCT00534313|10893603|FG000|Long-term Period|Withdrawal by Subject|2
6881228|NCT00534313|10893604|FG001|Long-term Period|Withdrawal by Subject|2
6881229|NCT00534313|10893605|FG002|Long-term Period|Withdrawal by Subject|0
6881230|NCT00534313|10893606|FG003|Long-term Period|Withdrawal by Subject|0
6881231|NCT00534313|10893603|FG000|Long-term Period|No longer meets study criteria|0
6881232|NCT00534313|10893604|FG001|Long-term Period|No longer meets study criteria|1
6881233|NCT00534313|10893605|FG002|Long-term Period|No longer meets study criteria|0
6881234|NCT00534313|10893606|FG003|Long-term Period|No longer meets study criteria|0
6881235|NCT00534313|10893603|FG000|Long-term Period|Poor compliance/noncompliance|0
6881236|NCT00534313|10893604|FG001|Long-term Period|Poor compliance/noncompliance|1
6881237|NCT00534313|10893605|FG002|Long-term Period|Poor compliance/noncompliance|1
6881238|NCT00534313|10893606|FG003|Long-term Period|Poor compliance/noncompliance|0
6881239|NCT00534313|10893603|FG000|Long-term Period|Administrative reason by sponsor|17
6881240|NCT00534313|10893604|FG001|Long-term Period|Administrative reason by sponsor|15
6881241|NCT00534313|10893605|FG002|Long-term Period|Administrative reason by sponsor|26
6881242|NCT00534313|10893606|FG003|Long-term Period|Administrative reason by sponsor|18
6881243|NCT00534313|10893603|FG000|Long-term Period|Other|1
7079018|NCT02107859|11187665|FG000|Overall Study|Withdrawal by Subject|14
7079019|NCT02107859|11187665|FG000|Overall Study|Adverse Event|3
7079020|NCT02107859|11187665|FG000|Overall Study|Study closure|41
7079021|NCT02107859|11187665|FG000|Overall Study|Other than specified|3
7079022|NCT02107898|11187671|FG000|Overall Study|Adverse Event|4
7079023|NCT02107898|11187672|FG001|Overall Study|Adverse Event|7
7079024|NCT02107898|11187671|FG000|Overall Study|Poor compliance to protocol|0
7079025|NCT02107898|11187672|FG001|Overall Study|Poor compliance to protocol|1
7079026|NCT02107898|11187671|FG000|Overall Study|Participant moved|0
6881244|NCT00534313|10893604|FG001|Long-term Period|Other|2
6881245|NCT00534313|10893605|FG002|Long-term Period|Other|2
6881246|NCT00534313|10893606|FG003|Long-term Period|Other|2
6881247|NCT00534352|10893651|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1
6881248|NCT00534352|10893651|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1
6881249|NCT00534352|10893651|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1
7079027|NCT02107898|11187672|FG001|Overall Study|Participant moved|2
7079028|NCT02107898|11187671|FG000|Overall Study|Consent withdrawn by participant|2
7079029|NCT02107898|11187672|FG001|Overall Study|Consent withdrawn by participant|1
7079030|NCT02107898|11187671|FG000|Overall Study|Randomized but not treated|0
6881250|NCT00534352|10893651|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1
6881251|NCT00534352|10893651|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2
6881252|NCT00534352|10893651|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1
6881253|NCT00534404|10893678|FG000|Overall Study|Death|0
6881254|NCT00534404|10893679|FG001|Overall Study|Death|0
6881255|NCT00534404|10893680|FG002|Overall Study|Death|2
6881256|NCT00534404|10893678|FG000|Overall Study|Withdrawal by Subject|8
6881257|NCT00534404|10893679|FG001|Overall Study|Withdrawal by Subject|2
6881258|NCT00534404|10893680|FG002|Overall Study|Withdrawal by Subject|38
6881259|NCT00534404|10893678|FG000|Overall Study|Removed by study staff|2
6881260|NCT00534404|10893679|FG001|Overall Study|Removed by study staff|3
6881261|NCT00534404|10893680|FG002|Overall Study|Removed by study staff|1
6881262|NCT00534404|10893678|FG000|Overall Study|Lost to Follow-up|170
6881263|NCT00534404|10893679|FG001|Overall Study|Lost to Follow-up|138
6881264|NCT00534404|10893680|FG002|Overall Study|Lost to Follow-up|201
6881265|NCT00534495|10893694|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0
6881266|NCT00534495|10893695|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1
6881267|NCT00534495|10893696|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0
6881268|NCT00534495|10893694|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1
6881269|NCT00534495|10893695|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0
6881270|NCT00534495|10893696|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0
6881271|NCT00534495|10893694|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1
6881272|NCT00534495|10893695|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7
6881273|NCT00534495|10893696|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0
6881274|NCT00534495|10893694|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
6881275|NCT00534495|10893695|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
6881276|NCT00534495|10893696|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0
6881277|NCT00534495|10893694|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
6881278|NCT00534495|10893695|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
6881279|NCT00534495|10893696|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0
6881280|NCT00534495|10893694|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
6881281|NCT00534495|10893695|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
6881282|NCT00534495|10893696|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1
6881283|NCT00534495|10893694|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
6881284|NCT00534495|10893695|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
6881285|NCT00534495|10893696|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5
6881286|NCT00534495|10893694|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
6881287|NCT00534495|10893695|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
6881288|NCT00534495|10893696|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3
6881289|NCT00534495|10893694|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0
6881290|NCT00534495|10893695|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0
6881291|NCT00534495|10893696|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2
6881292|NCT00534599|10893709|FG000|Overall Study|Adverse Event|25
6881293|NCT00534599|10893710|FG001|Overall Study|Adverse Event|4
6881294|NCT00534599|10893709|FG000|Overall Study|Incorrect enrollment|2
6881295|NCT00534599|10893710|FG001|Overall Study|Incorrect enrollment|1
6881296|NCT00534599|10893709|FG000|Overall Study|Mis-randomization|2
6881297|NCT00534599|10893710|FG001|Overall Study|Mis-randomization|2
6881298|NCT00534599|10893709|FG000|Overall Study|Developed study-specific d/c criteria|5
6881299|NCT00534599|10893710|FG001|Overall Study|Developed study-specific d/c criteria|0
6881300|NCT00534599|10893709|FG000|Overall Study|Lack of Efficacy|0
6881301|NCT00534599|10893710|FG001|Overall Study|Lack of Efficacy|1
6881302|NCT00534599|10893709|FG000|Overall Study|Generalized anxiety disorder worsened|0
6881303|NCT00534599|10893710|FG001|Overall Study|Generalized anxiety disorder worsened|1
6881304|NCT00534599|10893709|FG000|Overall Study|Protocol Violation|1
6881305|NCT00534599|10893710|FG001|Overall Study|Protocol Violation|3
6881306|NCT00534599|10893709|FG000|Overall Study|Lost to Follow-up|11
6881307|NCT00534599|10893710|FG001|Overall Study|Lost to Follow-up|14
6881308|NCT00534599|10893709|FG000|Overall Study|Withdrawal by Subject|4
6881309|NCT00534599|10893710|FG001|Overall Study|Withdrawal by Subject|6
6881310|NCT00534599|10893709|FG000|Overall Study|Other|7
6881311|NCT00534599|10893710|FG001|Overall Study|Other|0
6881312|NCT00534638|10893718|FG000|Overall Study|Withdrawal by Subject|3
6881313|NCT00534638|10893719|FG001|Overall Study|Withdrawal by Subject|4
6881314|NCT00534638|10893718|FG000|Overall Study|Migrated/moved from study area|13
6881315|NCT00534638|10893719|FG001|Overall Study|Migrated/moved from study area|11
6881316|NCT00534638|10893718|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83
6881317|NCT00534638|10893719|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117
6881318|NCT00534638|10893718|FG000|Overall Study|Lost to follow-up, complete vaccination|4707
6881319|NCT00534638|10893719|FG001|Overall Study|Lost to follow-up, complete vaccination|10757
6881320|NCT00534638|10893718|FG000|Overall Study|Other|1685
6881321|NCT00534638|10893719|FG001|Overall Study|Other|902
6881322|NCT00535132|10893803|FG000|Safety Analysis Set|Did Not Receive Study Medication|2
6881323|NCT00535132|10893804|FG001|Safety Analysis Set|Did Not Receive Study Medication|2
6881324|NCT00535132|10893803|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
6881325|NCT00535132|10893804|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
6881326|NCT00535145|10893812|FG000|Phase I|Adverse Event|3
6881327|NCT00535145|10893812|FG000|Phase I|Lost to Follow-up|7
6881328|NCT00535145|10893812|FG000|Phase I|Withdrawal by Subject|6
6881329|NCT00535145|10893812|FG000|Phase I|(eligibility)|8
6881330|NCT00535145|10893812|FG000|Phase I|(protocol violation)|1
6881331|NCT00535145|10893812|FG000|Phase I|(PI decision)|1
6881332|NCT00535145|10893812|FG000|Phase I|(diagnosis)|3
6881333|NCT00535145|10893812|FG000|Phase II|Adverse Event|2
6881334|NCT00535145|10893812|FG000|Phase II|Lack of Efficacy|1
6881335|NCT00535145|10893812|FG000|Phase II|Lost to Follow-up|5
6881336|NCT00535145|10893812|FG000|Phase II|Withdrawal by Subject|5
6881337|NCT00535145|10893812|FG000|Phase II|Subject non-compliance|2
6881338|NCT00535223|10893822|FG000|Overall Study|Withdrawal by Subject|4
6881339|NCT00535223|10893823|FG001|Overall Study|Withdrawal by Subject|1
6881340|NCT00535236|10893839|FG000|Overall Study|Adverse Event|1
6881341|NCT00535236|10893840|FG001|Overall Study|Adverse Event|0
6881342|NCT00535236|10893841|FG002|Overall Study|Adverse Event|9
6881343|NCT00535236|10893842|FG003|Overall Study|Adverse Event|3
6881344|NCT00535236|10893843|FG004|Overall Study|Adverse Event|3
6881345|NCT00535236|10893844|FG005|Overall Study|Adverse Event|0
6881346|NCT00535236|10893845|FG006|Overall Study|Adverse Event|5
6881347|NCT00535236|10893846|FG007|Overall Study|Adverse Event|1
6881348|NCT00535236|10893847|FG008|Overall Study|Adverse Event|2
6881349|NCT00535236|10893848|FG009|Overall Study|Adverse Event|1
6881350|NCT00535236|10893839|FG000|Overall Study|Lost to Follow-up|1
6881351|NCT00535236|10893840|FG001|Overall Study|Lost to Follow-up|2
6881352|NCT00535236|10893841|FG002|Overall Study|Lost to Follow-up|0
6881353|NCT00535236|10893842|FG003|Overall Study|Lost to Follow-up|0
6969555|NCT01147926|11019120|FG001|Overall Study|Too busy, no time for study|0
6969556|NCT01147926|11019119|FG000|Overall Study|Went on holiday|0
6969557|NCT01147926|11019120|FG001|Overall Study|Went on holiday|1
6969558|NCT01147926|11019119|FG000|Overall Study|Colonoscopy result|0
6969559|NCT01147926|11019120|FG001|Overall Study|Colonoscopy result|1
6969560|NCT01148017|11019130|FG000|Overall Study|Withdrawal by Subject|31
6969561|NCT01148017|11019131|FG001|Overall Study|Withdrawal by Subject|14
6969562|NCT01148017|11019132|FG002|Overall Study|Withdrawal by Subject|0
6969563|NCT01148017|11019133|FG003|Overall Study|Withdrawal by Subject|0
6969564|NCT01148017|11019130|FG000|Overall Study|Lost to Follow-up|23
6969565|NCT01148017|11019131|FG001|Overall Study|Lost to Follow-up|10
6969566|NCT01148017|11019132|FG002|Overall Study|Lost to Follow-up|0
6969567|NCT01148017|11019133|FG003|Overall Study|Lost to Follow-up|0
6969568|NCT01148017|11019130|FG000|Overall Study|Inappropriate enrollment|1
6969569|NCT01148017|11019131|FG001|Overall Study|Inappropriate enrollment|0
6969570|NCT01148017|11019132|FG002|Overall Study|Inappropriate enrollment|0
6969571|NCT01148017|11019133|FG003|Overall Study|Inappropriate enrollment|0
6969572|NCT01148017|11019130|FG000|Overall Study|Administrative reason|22
6969573|NCT01148017|11019131|FG001|Overall Study|Administrative reason|9
6969574|NCT01148017|11019132|FG002|Overall Study|Administrative reason|0
6969575|NCT01148017|11019133|FG003|Overall Study|Administrative reason|0
6969576|NCT01148017|11019130|FG000|Overall Study|Unable to classify|3
6969577|NCT01148017|11019131|FG001|Overall Study|Unable to classify|1
6969578|NCT01148017|11019132|FG002|Overall Study|Unable to classify|0
6969579|NCT01148017|11019133|FG003|Overall Study|Unable to classify|0
6969580|NCT01148225|11019144|FG000|Overall Study|Other|185
6969581|NCT01148459|11019158|FG000|Overall Study|Serious Adverse Event|5
6969582|NCT01148459|11019159|FG001|Overall Study|Serious Adverse Event|4
6969583|NCT01148459|11019158|FG000|Overall Study|Withdrawal by Subject|1
6969584|NCT01148459|11019159|FG001|Overall Study|Withdrawal by Subject|0
6969585|NCT01148459|11019158|FG000|Overall Study|Migrated/moved from study area|3
6969586|NCT01148459|11019159|FG001|Overall Study|Migrated/moved from study area|6
6969587|NCT01148459|11019158|FG000|Overall Study|Lost to Follow-up|2
6969588|NCT01148459|11019159|FG001|Overall Study|Lost to Follow-up|0
6969589|NCT01148459|11019158|FG000|Overall Study|Refusal|1
6969590|NCT01148459|11019159|FG001|Overall Study|Refusal|0
6969591|NCT01148459|11019158|FG000|Overall Study|Failure to comply with study procedures|0
6969592|NCT01148459|11019159|FG001|Overall Study|Failure to comply with study procedures|1
6969593|NCT01148511|11019167|FG000|Exposed to Study Drug|Protocol Violation|2
6969594|NCT01148511|11019168|FG001|Exposed to Study Drug|Protocol Violation|0
6969595|NCT01148511|11019169|FG002|Exposed to Study Drug|Protocol Violation|0
6969596|NCT01148511|11019167|FG000|Exposed to Study Drug|Lost to Follow-up|4
6969597|NCT01148511|11019168|FG001|Exposed to Study Drug|Lost to Follow-up|0
6969598|NCT01148511|11019169|FG002|Exposed to Study Drug|Lost to Follow-up|0
6881354|NCT00535236|10893843|FG004|Overall Study|Lost to Follow-up|2
6881355|NCT00535236|10893844|FG005|Overall Study|Lost to Follow-up|0
6969599|NCT01148511|11019167|FG000|Randomized|Adverse Event|0
6969600|NCT01148511|11019168|FG001|Randomized|Adverse Event|1
6969601|NCT01148511|11019169|FG002|Randomized|Adverse Event|0
6969602|NCT01148511|11019167|FG000|Randomized|Protocol Violation|0
6969603|NCT01148511|11019168|FG001|Randomized|Protocol Violation|2
6969604|NCT01148511|11019169|FG002|Randomized|Protocol Violation|1
6969605|NCT01148511|11019167|FG000|Randomized|Lost to Follow-up|0
6881356|NCT00535236|10893845|FG006|Overall Study|Lost to Follow-up|0
6881357|NCT00535236|10893846|FG007|Overall Study|Lost to Follow-up|0
6881358|NCT00535236|10893847|FG008|Overall Study|Lost to Follow-up|6
6881359|NCT00535236|10893848|FG009|Overall Study|Lost to Follow-up|1
6881360|NCT00535236|10893839|FG000|Overall Study|Physician Decision|0
6969606|NCT01148511|11019168|FG001|Randomized|Lost to Follow-up|1
6881361|NCT00535236|10893840|FG001|Overall Study|Physician Decision|0
6881362|NCT00535236|10893841|FG002|Overall Study|Physician Decision|0
6881363|NCT00535236|10893842|FG003|Overall Study|Physician Decision|0
6881364|NCT00535236|10893843|FG004|Overall Study|Physician Decision|1
6881365|NCT00535236|10893844|FG005|Overall Study|Physician Decision|0
6881366|NCT00535236|10893845|FG006|Overall Study|Physician Decision|1
6881367|NCT00535236|10893846|FG007|Overall Study|Physician Decision|0
6881368|NCT00535236|10893847|FG008|Overall Study|Physician Decision|0
6881369|NCT00535236|10893848|FG009|Overall Study|Physician Decision|0
6881370|NCT00535236|10893839|FG000|Overall Study|Protocol Violation|2
6881371|NCT00535236|10893840|FG001|Overall Study|Protocol Violation|0
6881372|NCT00535236|10893841|FG002|Overall Study|Protocol Violation|1
6881373|NCT00535236|10893842|FG003|Overall Study|Protocol Violation|0
6881374|NCT00535236|10893843|FG004|Overall Study|Protocol Violation|0
6881375|NCT00535236|10893844|FG005|Overall Study|Protocol Violation|0
6881376|NCT00535236|10893845|FG006|Overall Study|Protocol Violation|0
6881377|NCT00535236|10893846|FG007|Overall Study|Protocol Violation|0
6881378|NCT00535236|10893847|FG008|Overall Study|Protocol Violation|1
6881379|NCT00535236|10893848|FG009|Overall Study|Protocol Violation|0
6881380|NCT00535236|10893839|FG000|Overall Study|Withdrawal by Subject|3
6881381|NCT00535236|10893840|FG001|Overall Study|Withdrawal by Subject|0
6881382|NCT00535236|10893841|FG002|Overall Study|Withdrawal by Subject|2
6881383|NCT00535236|10893842|FG003|Overall Study|Withdrawal by Subject|1
6881384|NCT00535236|10893843|FG004|Overall Study|Withdrawal by Subject|6
6881385|NCT00535236|10893844|FG005|Overall Study|Withdrawal by Subject|1
6881386|NCT00535236|10893845|FG006|Overall Study|Withdrawal by Subject|5
6881387|NCT00535236|10893846|FG007|Overall Study|Withdrawal by Subject|0
6881388|NCT00535236|10893847|FG008|Overall Study|Withdrawal by Subject|4
6881389|NCT00535236|10893848|FG009|Overall Study|Withdrawal by Subject|2
6881390|NCT00535288|10893878|FG000|Overall Study|Adverse Event|20
6881391|NCT00535288|10893879|FG001|Overall Study|Adverse Event|19
6881392|NCT00535288|10893880|FG002|Overall Study|Adverse Event|25
6881393|NCT00535288|10893881|FG003|Overall Study|Adverse Event|20
6881394|NCT00535288|10893882|FG004|Overall Study|Adverse Event|30
6881395|NCT00535288|10893878|FG000|Overall Study|Lost to Follow-up|0
6881396|NCT00535288|10893879|FG001|Overall Study|Lost to Follow-up|3
6881397|NCT00535288|10893880|FG002|Overall Study|Lost to Follow-up|0
6881398|NCT00535288|10893881|FG003|Overall Study|Lost to Follow-up|0
6881399|NCT00535288|10893882|FG004|Overall Study|Lost to Follow-up|0
6881400|NCT00535288|10893878|FG000|Overall Study|Lack of Efficacy|26
6881401|NCT00535288|10893879|FG001|Overall Study|Lack of Efficacy|3
6881402|NCT00535288|10893880|FG002|Overall Study|Lack of Efficacy|4
6881403|NCT00535288|10893881|FG003|Overall Study|Lack of Efficacy|4
6881404|NCT00535288|10893882|FG004|Overall Study|Lack of Efficacy|7
6881405|NCT00535288|10893878|FG000|Overall Study|Unwilling to cooperate|6
6881406|NCT00535288|10893879|FG001|Overall Study|Unwilling to cooperate|6
6881407|NCT00535288|10893880|FG002|Overall Study|Unwilling to cooperate|3
6881408|NCT00535288|10893881|FG003|Overall Study|Unwilling to cooperate|3
6881409|NCT00535288|10893882|FG004|Overall Study|Unwilling to cooperate|4
6881410|NCT00535288|10893878|FG000|Overall Study|Other|2
6881411|NCT00535288|10893879|FG001|Overall Study|Other|1
6881412|NCT00535288|10893880|FG002|Overall Study|Other|1
6881413|NCT00535288|10893881|FG003|Overall Study|Other|2
6881414|NCT00535288|10893882|FG004|Overall Study|Other|1
6881415|NCT00535496|10893916|FG000|Overall Study|Lost to Follow-up|0
6881416|NCT00535496|10893917|FG001|Overall Study|Lost to Follow-up|1
6881417|NCT00535496|10893918|FG002|Overall Study|Lost to Follow-up|0
6881418|NCT00535496|10893919|FG003|Overall Study|Lost to Follow-up|0
6881419|NCT00535496|10893916|FG000|Overall Study|Not treated with sugammadex|0
6881420|NCT00535496|10893917|FG001|Overall Study|Not treated with sugammadex|1
6881421|NCT00535496|10893918|FG002|Overall Study|Not treated with sugammadex|0
6881422|NCT00535496|10893919|FG003|Overall Study|Not treated with sugammadex|0
6881423|NCT00535626|10893950|FG000|Overall Study|Death|15
6881424|NCT00535626|10893950|FG000|Overall Study|Lost to Follow-up|29
6881425|NCT00535626|10893950|FG000|Overall Study|Withdrawal by Subject|20
6881426|NCT00535626|10893950|FG000|Overall Study|Removal/revision of study component|8
6881427|NCT00535626|10893950|FG000|Overall Study|Subject terminated|31
6881428|NCT00535626|10893950|FG000|Overall Study|Unable to return|2
6881429|NCT00535730|10893961|FG000|Overall Study|Adverse Event|1
6881430|NCT00535730|10893962|FG001|Overall Study|Adverse Event|1
6881431|NCT00535730|10893961|FG000|Overall Study|Lost to Follow-up|0
6881432|NCT00535730|10893962|FG001|Overall Study|Lost to Follow-up|1
6881433|NCT00535730|10893961|FG000|Overall Study|Physician Decision|0
6881434|NCT00535730|10893962|FG001|Overall Study|Physician Decision|1
6881435|NCT00535730|10893961|FG000|Overall Study|Protocol Violation|1
6881436|NCT00535730|10893962|FG001|Overall Study|Protocol Violation|0
6881437|NCT00535730|10893961|FG000|Overall Study|Withdrawal by Subject|0
6881438|NCT00535730|10893962|FG001|Overall Study|Withdrawal by Subject|4
6969607|NCT01148511|11019169|FG002|Randomized|Lost to Follow-up|1
6969608|NCT01148511|11019167|FG000|Randomized|Consent withdrawal|0
6969609|NCT01148511|11019168|FG001|Randomized|Consent withdrawal|5
6969610|NCT01148511|11019169|FG002|Randomized|Consent withdrawal|3
6969611|NCT01148511|11019167|FG000|Randomized|Other|0
6969612|NCT01148511|11019168|FG001|Randomized|Other|1
6969613|NCT01148511|11019169|FG002|Randomized|Other|1
6969614|NCT01148537|11019216|FG000|Overall Study|Withdrawal by Subject|1
6969615|NCT01148537|11019217|FG001|Overall Study|Withdrawal by Subject|0
6881439|NCT00535847|10894099|FG000|Overall Study|Adverse Event|5
6881440|NCT00535847|10894100|FG001|Overall Study|Adverse Event|3
6881441|NCT00535847|10894101|FG002|Overall Study|Adverse Event|2
6881442|NCT00535847|10894099|FG000|Overall Study|Non compliance|1
6881443|NCT00535847|10894100|FG001|Overall Study|Non compliance|1
6881444|NCT00535847|10894101|FG002|Overall Study|Non compliance|0
6881445|NCT00535847|10894099|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16
6881446|NCT00535847|10894100|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10
6881447|NCT00535847|10894101|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0
6881448|NCT00536107|10894139|FG000|Overall Study|Death|5
6881449|NCT00536107|10894140|FG001|Overall Study|Death|1
6881450|NCT00536107|10894139|FG000|Overall Study|Incorrect enrolment|1
6881451|NCT00536107|10894140|FG001|Overall Study|Incorrect enrolment|0
6881452|NCT00536107|10894139|FG000|Overall Study|Withdrawal by Subject|0
6881453|NCT00536107|10894140|FG001|Overall Study|Withdrawal by Subject|1
6881454|NCT00536107|10894139|FG000|Overall Study|Study Termination|2
6881455|NCT00536107|10894140|FG001|Overall Study|Study Termination|4
6881456|NCT00536120|10894148|FG000|Overall Study|Lost to Follow-up|1
6881457|NCT00536120|10894149|FG001|Overall Study|Lost to Follow-up|0
6881458|NCT00536120|10894148|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3
6881459|NCT00536120|10894149|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0
6881460|NCT00536120|10894148|FG000|Overall Study|Non-compliance|1
6881461|NCT00536120|10894149|FG001|Overall Study|Non-compliance|0
6881462|NCT00536120|10894148|FG000|Overall Study|Sponsor Decision Due to Lab Values|1
6881463|NCT00536120|10894149|FG001|Overall Study|Sponsor Decision Due to Lab Values|0
6881464|NCT00536120|10894148|FG000|Overall Study|Steroid Use|0
6881465|NCT00536120|10894149|FG001|Overall Study|Steroid Use|2
6881466|NCT00536120|10894148|FG000|Overall Study|Missed Study Visit|0
6881467|NCT00536120|10894149|FG001|Overall Study|Missed Study Visit|1
6881468|NCT00536198|10894166|FG000|Overall Study|Lost to Follow-up|15
6881469|NCT00536198|10894167|FG001|Overall Study|Lost to Follow-up|14
6881470|NCT00536198|10894166|FG000|Overall Study|Withdrawal by Subject|16
6881471|NCT00536198|10894167|FG001|Overall Study|Withdrawal by Subject|12
6881472|NCT00536198|10894166|FG000|Overall Study|Adverse Event|2
6881473|NCT00536198|10894167|FG001|Overall Study|Adverse Event|2
6881474|NCT00536198|10894166|FG000|Overall Study|Rescue|3
6881475|NCT00536198|10894167|FG001|Overall Study|Rescue|9
6881476|NCT00536198|10894166|FG000|Overall Study|Pregnancy|1
6881477|NCT00536198|10894167|FG001|Overall Study|Pregnancy|1
6881478|NCT00536198|10894166|FG000|Overall Study|Protocol Violation|0
6881479|NCT00536198|10894167|FG001|Overall Study|Protocol Violation|1
6881480|NCT00536263|10894178|FG000|Overall Study|Adverse Event|5
6881481|NCT00536263|10894179|FG001|Overall Study|Adverse Event|5
6881482|NCT00536263|10894180|FG002|Overall Study|Adverse Event|7
6881483|NCT00536263|10894178|FG000|Overall Study|Lost to Follow-up|3
6881484|NCT00536263|10894179|FG001|Overall Study|Lost to Follow-up|4
6881485|NCT00536263|10894180|FG002|Overall Study|Lost to Follow-up|4
6881486|NCT00536263|10894178|FG000|Overall Study|Subject withdrew - not treatment related|2
6881487|NCT00536263|10894179|FG001|Overall Study|Subject withdrew - not treatment related|0
6881488|NCT00536263|10894180|FG002|Overall Study|Subject withdrew - not treatment related|5
6881489|NCT00536263|10894178|FG000|Overall Study|Subject withdrew - treatment related|0
6881490|NCT00536263|10894179|FG001|Overall Study|Subject withdrew - treatment related|3
6881491|NCT00536263|10894180|FG002|Overall Study|Subject withdrew - treatment related|2
6881492|NCT00536263|10894178|FG000|Overall Study|Noncompliance with protocol|0
6881493|NCT00536263|10894179|FG001|Overall Study|Noncompliance with protocol|0
6881494|NCT00536263|10894180|FG002|Overall Study|Noncompliance with protocol|1
6881495|NCT00536263|10894178|FG000|Overall Study|Did not meet protocol eligibility|1
6881496|NCT00536263|10894179|FG001|Overall Study|Did not meet protocol eligibility|2
6881497|NCT00536263|10894180|FG002|Overall Study|Did not meet protocol eligibility|2
6881498|NCT00536471|10894202|FG000|Overall Study|Lost to Follow-up|48
6881499|NCT00536471|10894203|FG001|Overall Study|Lost to Follow-up|23
6881500|NCT00536471|10894204|FG002|Overall Study|Lost to Follow-up|48
6881501|NCT00536471|10894205|FG003|Overall Study|Lost to Follow-up|22
6881502|NCT00536471|10894202|FG000|Overall Study|Adverse Event|32
6881503|NCT00536471|10894203|FG001|Overall Study|Adverse Event|16
6881504|NCT00536471|10894204|FG002|Overall Study|Adverse Event|28
6881505|NCT00536471|10894205|FG003|Overall Study|Adverse Event|13
6881506|NCT00536471|10894202|FG000|Overall Study|Withdrawal by Subject|40
6881507|NCT00536471|10894203|FG001|Overall Study|Withdrawal by Subject|24
6881508|NCT00536471|10894204|FG002|Overall Study|Withdrawal by Subject|43
6881509|NCT00536471|10894205|FG003|Overall Study|Withdrawal by Subject|21
6881510|NCT00536471|10894202|FG000|Overall Study|Lack of Efficacy|17
6881511|NCT00536471|10894203|FG001|Overall Study|Lack of Efficacy|18
6881512|NCT00536471|10894204|FG002|Overall Study|Lack of Efficacy|11
6881513|NCT00536471|10894205|FG003|Overall Study|Lack of Efficacy|9
6881514|NCT00536471|10894202|FG000|Overall Study|Protocol Violation|8
6881515|NCT00536471|10894203|FG001|Overall Study|Protocol Violation|1
6881516|NCT00536471|10894204|FG002|Overall Study|Protocol Violation|2
6881517|NCT00536471|10894205|FG003|Overall Study|Protocol Violation|3
6881518|NCT00536471|10894202|FG000|Overall Study|Physician Decision|11
6881519|NCT00536471|10894203|FG001|Overall Study|Physician Decision|1
6881520|NCT00536471|10894204|FG002|Overall Study|Physician Decision|3
6881521|NCT00536471|10894205|FG003|Overall Study|Physician Decision|2
6881522|NCT00536471|10894202|FG000|Overall Study|Death|0
6881523|NCT00536471|10894203|FG001|Overall Study|Death|0
6881524|NCT00536471|10894204|FG002|Overall Study|Death|1
6881525|NCT00536471|10894205|FG003|Overall Study|Death|2
6881526|NCT00536471|10894202|FG000|Overall Study|Sponsor Decision|0
6881527|NCT00536471|10894203|FG001|Overall Study|Sponsor Decision|1
6881528|NCT00536471|10894204|FG002|Overall Study|Sponsor Decision|3
6881529|NCT00536471|10894205|FG003|Overall Study|Sponsor Decision|2
6881530|NCT00536484|10894224|FG000|Overall Study|Adverse Event|21
6881531|NCT00536484|10894225|FG001|Overall Study|Adverse Event|34
6881532|NCT00536484|10894224|FG000|Overall Study|Withdrawal by Subject|11
6881533|NCT00536484|10894225|FG001|Overall Study|Withdrawal by Subject|11
6881534|NCT00536484|10894224|FG000|Overall Study|Lost to Follow-up|8
6881535|NCT00536484|10894225|FG001|Overall Study|Lost to Follow-up|6
6881536|NCT00536484|10894224|FG000|Overall Study|Lack of Efficacy|16
6881537|NCT00536484|10894225|FG001|Overall Study|Lack of Efficacy|5
6881538|NCT00536484|10894224|FG000|Overall Study|Other|4
6881539|NCT00536484|10894225|FG001|Overall Study|Other|0
6881540|NCT00536510|10894233|FG000|Overall Study|Adverse Event|27
6881541|NCT00536510|10894234|FG001|Overall Study|Adverse Event|4
6881542|NCT00536510|10894233|FG000|Overall Study|Lost to Follow-up|11
6881543|NCT00536510|10894234|FG001|Overall Study|Lost to Follow-up|8
6881544|NCT00536510|10894233|FG000|Overall Study|Protocol Violation|4
6881545|NCT00536510|10894234|FG001|Overall Study|Protocol Violation|5
6881546|NCT00536510|10894233|FG000|Overall Study|Withdrawal by Subject|16
6881547|NCT00536510|10894234|FG001|Overall Study|Withdrawal by Subject|9
6881548|NCT00536510|10894233|FG000|Overall Study|Flushing with Product|20
6881549|NCT00536510|10894234|FG001|Overall Study|Flushing with Product|0
6881550|NCT00536510|10894233|FG000|Overall Study|Laboratory Adverse Event|2
6881551|NCT00536510|10894234|FG001|Overall Study|Laboratory Adverse Event|1
6881552|NCT00536510|10894233|FG000|Overall Study|Patient Discontinued for Other Reasons|2
6881553|NCT00536510|10894234|FG001|Overall Study|Patient Discontinued for Other Reasons|2
6881554|NCT00536575|10894240|FG000|Overall Study|Withdrawal by Subject|1
6881555|NCT00536575|10894240|FG000|Overall Study|Death|1
6881556|NCT00536731|10894268|FG000|Overall Study|Adverse Event|3
6881557|NCT00536731|10894269|FG001|Overall Study|Adverse Event|2
6881558|NCT00536731|10894270|FG002|Overall Study|Adverse Event|3
6881559|NCT00536731|10894268|FG000|Overall Study|Withdrawal by Subject|0
6881560|NCT00536731|10894269|FG001|Overall Study|Withdrawal by Subject|2
6881561|NCT00536731|10894270|FG002|Overall Study|Withdrawal by Subject|0
6881562|NCT00536731|10894268|FG000|Overall Study|Intake of prohibited conc. medication|0
6881563|NCT00536731|10894269|FG001|Overall Study|Intake of prohibited conc. medication|0
6881564|NCT00536731|10894270|FG002|Overall Study|Intake of prohibited conc. medication|1
6881565|NCT00536731|10894268|FG000|Overall Study|Safety reasons|0
6881566|NCT00536731|10894269|FG001|Overall Study|Safety reasons|0
6881567|NCT00536731|10894270|FG002|Overall Study|Safety reasons|1
6881568|NCT00536731|10894268|FG000|Overall Study|Other|1
6881569|NCT00536731|10894269|FG001|Overall Study|Other|1
6881570|NCT00536731|10894270|FG002|Overall Study|Other|0
6881571|NCT00536744|10894280|FG000|Overall Study|Adverse Event|13
6881572|NCT00536744|10894281|FG001|Overall Study|Adverse Event|10
6881573|NCT00536744|10894280|FG000|Overall Study|Death|2
6881574|NCT00536744|10894281|FG001|Overall Study|Death|1
6881575|NCT00536744|10894280|FG000|Overall Study|Physician Decision|3
6881576|NCT00536744|10894281|FG001|Overall Study|Physician Decision|1
6881577|NCT00536744|10894280|FG000|Overall Study|Lost to Follow-up|3
6881578|NCT00536744|10894281|FG001|Overall Study|Lost to Follow-up|5
6881579|NCT00536744|10894280|FG000|Overall Study|Withdrawal by Subject|7
6881580|NCT00536744|10894281|FG001|Overall Study|Withdrawal by Subject|8
6881581|NCT00536744|10894280|FG000|Overall Study|PI tried alternative treatment|1
6881582|NCT00536744|10894281|FG001|Overall Study|PI tried alternative treatment|3
6881583|NCT00536809|10894287|FG000|Phase II|Adverse Event|1
6881584|NCT00536809|10894287|FG000|Phase II|Referred for surgical resection|1
6881585|NCT00536874|10894291|FG000|Overall Study|Adverse Event|1
6881586|NCT00536874|10894291|FG000|Overall Study|Death|2
6881587|NCT00536874|10894291|FG000|Overall Study|Withdrawal by Subject|1
6881588|NCT00536939|10894304|FG000|Overall Study|Withdrawal by Subject|1
6881589|NCT00536939|10894305|FG001|Overall Study|Withdrawal by Subject|0
6881590|NCT00536939|10894304|FG000|Overall Study|Other Complicating Disease|1
6881591|NCT00536939|10894305|FG001|Overall Study|Other Complicating Disease|0
6881592|NCT00536991|10894310|FG000|Overall Study|Withdrawal by Subject|10
6881593|NCT00536991|10894310|FG000|Overall Study|Physician Decision|1
6881594|NCT00536991|10894310|FG000|Overall Study|patient ineligible|2
6881595|NCT00537017|10894315|FG000|Treatment Phase|Adverse Event|19
6881596|NCT00537017|10894315|FG000|Treatment Phase|Withdrawal by Subject|13
6881597|NCT00537017|10894315|FG000|Treatment Phase|Protocol Violation|2
6881598|NCT00537017|10894315|FG000|Follow-up Phase|Withdrawal by Subject|9
6881599|NCT00537030|10894319|FG000|Overall Study|Physician Decision|2
6881600|NCT00537030|10894319|FG000|Overall Study|Withdrawal by Subject|2
6881601|NCT00537030|10894319|FG000|Overall Study|≥ Grade 2 allergy|7
6881602|NCT00537030|10894319|FG000|Overall Study|Disease progression/ relapse during Tx|1
6881603|NCT00537030|10894319|FG000|Overall Study|Ineligible|2
6881604|NCT00537030|10894319|FG000|Overall Study|Inevaluable|2
6881605|NCT00537056|10894323|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5
6881606|NCT00537082|10894332|FG000|Overall Study|Adverse Event|6
6881607|NCT00537082|10894333|FG001|Overall Study|Adverse Event|6
6881608|NCT00537082|10894334|FG002|Overall Study|Adverse Event|3
6881609|NCT00537082|10894332|FG000|Overall Study|Protocol Violation|0
6881610|NCT00537082|10894333|FG001|Overall Study|Protocol Violation|2
6881611|NCT00537082|10894334|FG002|Overall Study|Protocol Violation|1
6881612|NCT00537082|10894332|FG000|Overall Study|Lack of Efficacy|0
6881613|NCT00537082|10894333|FG001|Overall Study|Lack of Efficacy|0
6881614|NCT00537082|10894334|FG002|Overall Study|Lack of Efficacy|2
6881615|NCT00537082|10894332|FG000|Overall Study|Withdrawal by Subject|0
6881616|NCT00537082|10894333|FG001|Overall Study|Withdrawal by Subject|1
6881617|NCT00537082|10894334|FG002|Overall Study|Withdrawal by Subject|0
6881618|NCT00537082|10894332|FG000|Overall Study|Discontinued before initiating treatment|3
6881619|NCT00537082|10894333|FG001|Overall Study|Discontinued before initiating treatment|0
6881620|NCT00537082|10894334|FG002|Overall Study|Discontinued before initiating treatment|0
6881621|NCT00537095|10894344|FG000|Overall Study|surgery|1
6881622|NCT00537095|10894345|FG001|Overall Study|surgery|0
6881623|NCT00537095|10894344|FG000|Overall Study|Adverse Event|24
6881624|NCT00537095|10894345|FG001|Overall Study|Adverse Event|4
6881625|NCT00537095|10894344|FG000|Overall Study|disease progression|21
6881626|NCT00537095|10894345|FG001|Overall Study|disease progression|48
6881627|NCT00537095|10894344|FG000|Overall Study|Death|3
6881628|NCT00537095|10894345|FG001|Overall Study|Death|1
6881629|NCT00537095|10894344|FG000|Overall Study|Withdrawal by Subject|2
6881630|NCT00537095|10894345|FG001|Overall Study|Withdrawal by Subject|2
6881631|NCT00537095|10894344|FG000|Overall Study|subjective disease progression|0
6881632|NCT00537095|10894345|FG001|Overall Study|subjective disease progression|1
6881633|NCT00537095|10894344|FG000|Overall Study|Incorrect enrolment|0
6881634|NCT00537095|10894345|FG001|Overall Study|Incorrect enrolment|1
6881635|NCT00537238|10894353|FG000|Overall Study|Death|1
6881636|NCT00537238|10894354|FG001|Overall Study|Death|2
6881637|NCT00537238|10894353|FG000|Overall Study|Adverse Event|31
6881638|NCT00537238|10894354|FG001|Overall Study|Adverse Event|22
6881639|NCT00537238|10894353|FG000|Overall Study|Lack of Efficacy|20
6881640|NCT00537238|10894354|FG001|Overall Study|Lack of Efficacy|21
6881641|NCT00537238|10894353|FG000|Overall Study|Lost to Follow-up|12
6881642|NCT00537238|10894354|FG001|Overall Study|Lost to Follow-up|8
6881643|NCT00537238|10894353|FG000|Overall Study|Withdrawal by Subject|51
6881644|NCT00537238|10894354|FG001|Overall Study|Withdrawal by Subject|47
6881645|NCT00537238|10894353|FG000|Overall Study|Protocol Violation|15
6881646|NCT00537238|10894354|FG001|Overall Study|Protocol Violation|19
6881647|NCT00537238|10894353|FG000|Overall Study|Does not meet entrance criteria|0
6881648|NCT00537238|10894354|FG001|Overall Study|Does not meet entrance criteria|2
6881649|NCT00537238|10894353|FG000|Overall Study|Other|44
6881650|NCT00537238|10894354|FG001|Overall Study|Other|52
6881651|NCT00537277|10894360|FG000|Overall Study|Adverse Event|1
6881652|NCT00537277|10894360|FG000|Overall Study|Lack of Efficacy|2
6881653|NCT00537277|10894360|FG000|Overall Study|Lost to Follow-up|12
6881654|NCT00537277|10894360|FG000|Overall Study|Protocol Violation|11
6881655|NCT00537277|10894360|FG000|Overall Study|Unclassified|4
6881656|NCT00537277|10894360|FG000|Overall Study|Inability to tolerate trial medication|4
6881657|NCT00537277|10894360|FG000|Overall Study|Non-compliance with trial procedures|15
6881658|NCT00537303|10894370|FG000|Overall Study|Adverse Event|1
6881659|NCT00537303|10894371|FG001|Overall Study|Adverse Event|4
6881660|NCT00537303|10894370|FG000|Overall Study|Lack of Efficacy|6
6881661|NCT00537303|10894371|FG001|Overall Study|Lack of Efficacy|7
6881662|NCT00537303|10894370|FG000|Overall Study|Protocol Violation|8
6881663|NCT00537303|10894371|FG001|Overall Study|Protocol Violation|4
6881664|NCT00537303|10894370|FG000|Overall Study|Withdrawal criteria|3
6881665|NCT00537303|10894371|FG001|Overall Study|Withdrawal criteria|3
6881666|NCT00537303|10894370|FG000|Overall Study|Unclassified|8
6881667|NCT00537303|10894371|FG001|Overall Study|Unclassified|7
6881668|NCT00537316|10894383|FG000|Part 1|Adverse Event|7
6881669|NCT00537316|10894384|FG001|Part 1|Adverse Event|11
6881670|NCT00537316|10894385|FG002|Part 1|Adverse Event|8
6881671|NCT00537316|10894386|FG003|Part 1|Adverse Event|0
6881672|NCT00537316|10894387|FG004|Part 1|Adverse Event|0
6881673|NCT00537316|10894388|FG005|Part 1|Adverse Event|0
6881674|NCT00537316|10894389|FG006|Part 1|Adverse Event|0
6881675|NCT00537316|10894383|FG000|Part 1|Protocol defined clinical event|1
6881676|NCT00537316|10894384|FG001|Part 1|Protocol defined clinical event|0
6881677|NCT00537316|10894385|FG002|Part 1|Protocol defined clinical event|0
6881678|NCT00537316|10894386|FG003|Part 1|Protocol defined clinical event|0
6881679|NCT00537316|10894387|FG004|Part 1|Protocol defined clinical event|0
6881680|NCT00537316|10894388|FG005|Part 1|Protocol defined clinical event|0
6881681|NCT00537316|10894389|FG006|Part 1|Protocol defined clinical event|0
6881682|NCT00537316|10894383|FG000|Part 1|Lost to Follow-up|1
6881683|NCT00537316|10894384|FG001|Part 1|Lost to Follow-up|0
6881684|NCT00537316|10894385|FG002|Part 1|Lost to Follow-up|0
6881685|NCT00537316|10894386|FG003|Part 1|Lost to Follow-up|0
6881686|NCT00537316|10894387|FG004|Part 1|Lost to Follow-up|0
6881687|NCT00537316|10894388|FG005|Part 1|Lost to Follow-up|0
6881688|NCT00537316|10894389|FG006|Part 1|Lost to Follow-up|0
6881689|NCT00537316|10894383|FG000|Part 1|Withdrawal by Subject|3
6881690|NCT00537316|10894384|FG001|Part 1|Withdrawal by Subject|8
6881691|NCT00537316|10894385|FG002|Part 1|Withdrawal by Subject|4
6881692|NCT00537316|10894386|FG003|Part 1|Withdrawal by Subject|0
6881693|NCT00537316|10894387|FG004|Part 1|Withdrawal by Subject|0
6881694|NCT00537316|10894388|FG005|Part 1|Withdrawal by Subject|0
6881695|NCT00537316|10894389|FG006|Part 1|Withdrawal by Subject|0
6881696|NCT00537316|10894383|FG000|Part 1|Protocol Violation|1
6881697|NCT00537316|10894384|FG001|Part 1|Protocol Violation|5
6881698|NCT00537316|10894385|FG002|Part 1|Protocol Violation|1
6881699|NCT00537316|10894386|FG003|Part 1|Protocol Violation|0
6881700|NCT00537316|10894387|FG004|Part 1|Protocol Violation|0
6881701|NCT00537316|10894388|FG005|Part 1|Protocol Violation|0
6881702|NCT00537316|10894389|FG006|Part 1|Protocol Violation|0
6881703|NCT00537316|10894383|FG000|Part 1|Did not meet protocol eligibility|1
6881704|NCT00537316|10894384|FG001|Part 1|Did not meet protocol eligibility|3
6881705|NCT00537316|10894385|FG002|Part 1|Did not meet protocol eligibility|2
6881706|NCT00537316|10894386|FG003|Part 1|Did not meet protocol eligibility|0
6881707|NCT00537316|10894387|FG004|Part 1|Did not meet protocol eligibility|0
6881708|NCT00537316|10894388|FG005|Part 1|Did not meet protocol eligibility|0
6881709|NCT00537316|10894389|FG006|Part 1|Did not meet protocol eligibility|0
6881710|NCT00537316|10894383|FG000|Part 1|Administrative|0
6881711|NCT00537316|10894384|FG001|Part 1|Administrative|0
6881712|NCT00537316|10894385|FG002|Part 1|Administrative|2
6881713|NCT00537316|10894386|FG003|Part 1|Administrative|0
6881714|NCT00537316|10894387|FG004|Part 1|Administrative|0
6881715|NCT00537316|10894388|FG005|Part 1|Administrative|0
6881716|NCT00537316|10894389|FG006|Part 1|Administrative|0
6881717|NCT00537316|10894383|FG000|Part 2|Never entered follow-up|0
6881718|NCT00537316|10894384|FG001|Part 2|Never entered follow-up|0
6881719|NCT00537316|10894385|FG002|Part 2|Never entered follow-up|0
6881720|NCT00537316|10894386|FG003|Part 2|Never entered follow-up|0
6881721|NCT00537316|10894387|FG004|Part 2|Never entered follow-up|0
6881722|NCT00537316|10894388|FG005|Part 2|Never entered follow-up|0
6881723|NCT00537316|10894389|FG006|Part 2|Never entered follow-up|1
6881724|NCT00537316|10894383|FG000|Part 2|Adverse Event|4
6881725|NCT00537316|10894384|FG001|Part 2|Adverse Event|0
6881726|NCT00537316|10894385|FG002|Part 2|Adverse Event|2
6881727|NCT00537316|10894386|FG003|Part 2|Adverse Event|0
6881728|NCT00537316|10894387|FG004|Part 2|Adverse Event|0
6881729|NCT00537316|10894388|FG005|Part 2|Adverse Event|0
6881730|NCT00537316|10894389|FG006|Part 2|Adverse Event|0
6881731|NCT00537316|10894383|FG000|Part 2|Lost to Follow-up|1
6881732|NCT00537316|10894384|FG001|Part 2|Lost to Follow-up|0
6881733|NCT00537316|10894385|FG002|Part 2|Lost to Follow-up|2
6881734|NCT00537316|10894386|FG003|Part 2|Lost to Follow-up|0
6881735|NCT00537316|10894387|FG004|Part 2|Lost to Follow-up|0
6881736|NCT00537316|10894388|FG005|Part 2|Lost to Follow-up|0
6881737|NCT00537316|10894389|FG006|Part 2|Lost to Follow-up|0
6881738|NCT00537316|10894383|FG000|Part 2|Withdrawal by Subject|5
6881739|NCT00537316|10894384|FG001|Part 2|Withdrawal by Subject|1
6881740|NCT00537316|10894385|FG002|Part 2|Withdrawal by Subject|4
6881741|NCT00537316|10894386|FG003|Part 2|Withdrawal by Subject|0
6881742|NCT00537316|10894387|FG004|Part 2|Withdrawal by Subject|0
6881743|NCT00537316|10894388|FG005|Part 2|Withdrawal by Subject|0
6881744|NCT00537316|10894389|FG006|Part 2|Withdrawal by Subject|0
6881745|NCT00537316|10894383|FG000|Part 2|Administrative|16
6881746|NCT00537316|10894384|FG001|Part 2|Administrative|8
6881747|NCT00537316|10894385|FG002|Part 2|Administrative|24
6881748|NCT00537316|10894386|FG003|Part 2|Administrative|3
6881749|NCT00537316|10894387|FG004|Part 2|Administrative|1
6881750|NCT00537316|10894388|FG005|Part 2|Administrative|4
6881751|NCT00537316|10894389|FG006|Part 2|Administrative|1
6881752|NCT00537329|10894408|FG000|Overall Study|Death|10
6881753|NCT00537329|10894408|FG000|Overall Study|Adverse Event|3
7079031|NCT02107898|11187672|FG001|Overall Study|Randomized but not treated|1
6881754|NCT00537329|10894408|FG000|Overall Study|Lack of Efficacy|2
6881755|NCT00537329|10894408|FG000|Overall Study|Lost to Follow-up|6
6881756|NCT00537329|10894408|FG000|Overall Study|Withdrawal by Subject|4
6881757|NCT00537329|10894408|FG000|Overall Study|Other|1
6881758|NCT00537381|10894414|FG000|Overall Study|Adverse Event|13
6881759|NCT00537381|10894415|FG001|Overall Study|Adverse Event|9
6881760|NCT00537381|10894414|FG000|Overall Study|Death|3
6881761|NCT00537381|10894415|FG001|Overall Study|Death|3
6881762|NCT00537381|10894414|FG000|Overall Study|Withdrawal by Subject|5
6881763|NCT00537381|10894415|FG001|Overall Study|Withdrawal by Subject|14
6881764|NCT00537381|10894414|FG000|Overall Study|Physician Decision|7
6881765|NCT00537381|10894415|FG001|Overall Study|Physician Decision|6
6881766|NCT00537381|10894414|FG000|Overall Study|Disease Progression|9
6881767|NCT00537381|10894415|FG001|Overall Study|Disease Progression|18
6881768|NCT00537381|10894414|FG000|Overall Study|Sponsor decision|14
6881769|NCT00537381|10894415|FG001|Overall Study|Sponsor decision|9
6881770|NCT00537381|10894414|FG000|Overall Study|Other|5
6881771|NCT00537381|10894415|FG001|Overall Study|Other|3
6881772|NCT00537394|10894426|FG000|First Year of Follow-up|Death|7
6881773|NCT00537394|10894427|FG001|First Year of Follow-up|Death|0
6881774|NCT00537394|10894428|FG002|First Year of Follow-up|Death|0
6881775|NCT00537394|10894426|FG000|First Year of Follow-up|Severe debilitation|1
6881776|NCT00537394|10894427|FG001|First Year of Follow-up|Severe debilitation|0
6881777|NCT00537394|10894428|FG002|First Year of Follow-up|Severe debilitation|1
6881778|NCT00537394|10894426|FG000|First Year of Follow-up|Withdrawal by Subject|3
6881779|NCT00537394|10894427|FG001|First Year of Follow-up|Withdrawal by Subject|6
6881780|NCT00537394|10894428|FG002|First Year of Follow-up|Withdrawal by Subject|1
6881781|NCT00537394|10894426|FG000|First Year of Follow-up|Lost to Follow-up|1
6881782|NCT00537394|10894427|FG001|First Year of Follow-up|Lost to Follow-up|5
6881783|NCT00537394|10894428|FG002|First Year of Follow-up|Lost to Follow-up|1
6881784|NCT00537394|10894426|FG000|2nd Year of Follow-up|Death|4
6881785|NCT00537394|10894427|FG001|2nd Year of Follow-up|Death|1
6881786|NCT00537394|10894428|FG002|2nd Year of Follow-up|Death|2
6881787|NCT00537394|10894426|FG000|2nd Year of Follow-up|Withdrawal by Subject|0
6881788|NCT00537394|10894427|FG001|2nd Year of Follow-up|Withdrawal by Subject|1
6881789|NCT00537394|10894428|FG002|2nd Year of Follow-up|Withdrawal by Subject|2
6881790|NCT00537394|10894426|FG000|2nd Year of Follow-up|Lost to Follow-up|6
6881791|NCT00537394|10894427|FG001|2nd Year of Follow-up|Lost to Follow-up|7
6881792|NCT00537394|10894428|FG002|2nd Year of Follow-up|Lost to Follow-up|2
6881793|NCT00537394|10894426|FG000|2nd Year of Follow-up|Clinic site closure|1
6881794|NCT00537394|10894427|FG001|2nd Year of Follow-up|Clinic site closure|0
6881795|NCT00537394|10894428|FG002|2nd Year of Follow-up|Clinic site closure|0
6881796|NCT00537485|10894461|FG000|Overall Study|Adverse Event|10
6881797|NCT00537485|10894462|FG001|Overall Study|Adverse Event|5
6881798|NCT00537485|10894461|FG000|Overall Study|Withdrawal by Subject|3
6881799|NCT00537485|10894462|FG001|Overall Study|Withdrawal by Subject|2
6881800|NCT00537485|10894461|FG000|Overall Study|Withdrawal by Subject|1
6881801|NCT00537485|10894462|FG001|Overall Study|Withdrawal by Subject|3
6881802|NCT00537485|10894461|FG000|Overall Study|Physician Decision|1
6881803|NCT00537485|10894462|FG001|Overall Study|Physician Decision|0
6881804|NCT00537745|10894523|FG000|Overall Study|Did not meet eligibility criteria|2
6881805|NCT00537745|10894523|FG000|Overall Study|Withdrawal by Subject|2
6881806|NCT00537745|10894523|FG000|Overall Study|Subject unable to provide Interlock info|1
6881807|NCT00537771|10894530|FG000|Overall Study|Withdrawal by Subject|6
6881808|NCT00537771|10894531|FG001|Overall Study|Withdrawal by Subject|23
6881809|NCT00537771|10894530|FG000|Overall Study|Adverse Event|8
6881810|NCT00537771|10894531|FG001|Overall Study|Adverse Event|15
6881811|NCT00537771|10894530|FG000|Overall Study|Lost to Follow-up|9
6881812|NCT00537771|10894531|FG001|Overall Study|Lost to Follow-up|15
6881813|NCT00537771|10894530|FG000|Overall Study|Protocol Violation|2
6881814|NCT00537771|10894531|FG001|Overall Study|Protocol Violation|6
6881815|NCT00537771|10894530|FG000|Overall Study|Severe Non-Compliance to Protocol|4
6881816|NCT00537771|10894531|FG001|Overall Study|Severe Non-Compliance to Protocol|2
6881817|NCT00537810|10894541|FG000|Overall Study|Withdrawal by Subject|4
6881818|NCT00537810|10894542|FG001|Overall Study|Withdrawal by Subject|11
6881819|NCT00537810|10894543|FG002|Overall Study|Withdrawal by Subject|4
6881820|NCT00537810|10894544|FG003|Overall Study|Withdrawal by Subject|3
6881821|NCT00537810|10894541|FG000|Overall Study|Medically withdrawn|2
6881822|NCT00537810|10894542|FG001|Overall Study|Medically withdrawn|2
6881823|NCT00537810|10894543|FG002|Overall Study|Medically withdrawn|0
6881824|NCT00537810|10894544|FG003|Overall Study|Medically withdrawn|1
6881825|NCT00537823|10894556|FG000|Overall Study|Adverse Event|2
6881826|NCT00537823|10894557|FG001|Overall Study|Adverse Event|0
6881827|NCT00537940|10894566|FG000|Overall Study|Adverse Event|20
6881828|NCT00537940|10894567|FG001|Overall Study|Adverse Event|19
6881829|NCT00537940|10894566|FG000|Overall Study|Lack of Efficacy|8
6881830|NCT00537940|10894567|FG001|Overall Study|Lack of Efficacy|16
6881831|NCT00537940|10894566|FG000|Overall Study|Lost to Follow-up|23
6881832|NCT00537940|10894567|FG001|Overall Study|Lost to Follow-up|29
6881833|NCT00537940|10894566|FG000|Overall Study|Withdrawal by Subject|113
6881834|NCT00537940|10894567|FG001|Overall Study|Withdrawal by Subject|95
6881835|NCT00537940|10894566|FG000|Overall Study|Protocol Violation|6
6881836|NCT00537940|10894567|FG001|Overall Study|Protocol Violation|4
6881837|NCT00537940|10894566|FG000|Overall Study|Pregnancy|1
6881838|NCT00537940|10894567|FG001|Overall Study|Pregnancy|1
6881839|NCT00537940|10894566|FG000|Overall Study|Study terminated by sponsor|2
6881840|NCT00537940|10894567|FG001|Overall Study|Study terminated by sponsor|3
6881841|NCT00537940|10894566|FG000|Overall Study|Other|10
6881842|NCT00537940|10894567|FG001|Overall Study|Other|12
6881843|NCT00537979|10894575|FG000|Overall Study|Adverse Event|2
6881844|NCT00537979|10894576|FG001|Overall Study|Adverse Event|2
6881845|NCT00537979|10894575|FG000|Overall Study|Withdrawal by Subject|1
6881846|NCT00537979|10894576|FG001|Overall Study|Withdrawal by Subject|4
6881847|NCT00537979|10894575|FG000|Overall Study|Lost to Follow-up|1
6881848|NCT00537979|10894576|FG001|Overall Study|Lost to Follow-up|4
6881849|NCT00537979|10894575|FG000|Overall Study|Lack of Efficacy|0
6881850|NCT00537979|10894576|FG001|Overall Study|Lack of Efficacy|1
6881851|NCT00537979|10894575|FG000|Overall Study|Non-compliance with treatment/procedure|2
6881852|NCT00537979|10894576|FG001|Overall Study|Non-compliance with treatment/procedure|2
6881853|NCT00537979|10894575|FG000|Overall Study|Death|0
6881854|NCT00537979|10894576|FG001|Overall Study|Death|3
6881855|NCT00537979|10894575|FG000|Overall Study|Kidney transplant|0
6881856|NCT00537979|10894576|FG001|Overall Study|Kidney transplant|3
6881857|NCT00537979|10894575|FG000|Overall Study|Heart failure|0
6881858|NCT00537979|10894576|FG001|Overall Study|Heart failure|1
6881859|NCT00538291|10894597|FG000|Overall Study|Adverse Event|2
6881860|NCT00538291|10894597|FG000|Overall Study|Withdrawal by Subject|1
6881861|NCT00538473|10894630|FG000|Overall Study|Adverse Event|1
6881862|NCT00538473|10894631|FG001|Overall Study|Adverse Event|0
6881863|NCT00538590|10894652|FG000|Overall Study|Death|1
6881864|NCT00538590|10894653|FG001|Overall Study|Death|0
6881865|NCT00538629|10894668|FG000|Overall Study|At subject's request|1
6881866|NCT00538629|10894668|FG000|Overall Study|Adverse Event|2
6881867|NCT00538629|10894668|FG000|Overall Study|Lack of Efficacy|12
6881868|NCT00538629|10894668|FG000|Overall Study|Lost to Follow-up|6
6881869|NCT00538629|10894668|FG000|Overall Study|Subject's untimely distrust of medicine|1
6881870|NCT00538681|10894686|FG000|Overall Study|Progressive Disease|7
6881871|NCT00538681|10894687|FG001|Overall Study|Progressive Disease|0
6881872|NCT00538681|10894688|FG002|Overall Study|Progressive Disease|1
7079032|NCT02108262|11187708|FG000|Overall Study|Non-compliance|0
6881873|NCT00538681|10894689|FG003|Overall Study|Progressive Disease|0
6881874|NCT00538681|10894686|FG000|Overall Study|Sponsor Decision|1
6881875|NCT00538681|10894687|FG001|Overall Study|Sponsor Decision|3
6881876|NCT00538681|10894688|FG002|Overall Study|Sponsor Decision|8
6881877|NCT00538681|10894689|FG003|Overall Study|Sponsor Decision|9
6881878|NCT00538681|10894686|FG000|Overall Study|Adverse Event|1
6881879|NCT00538681|10894687|FG001|Overall Study|Adverse Event|1
6881880|NCT00538681|10894688|FG002|Overall Study|Adverse Event|1
6881881|NCT00538681|10894689|FG003|Overall Study|Adverse Event|0
6881882|NCT00538681|10894686|FG000|Overall Study|Death|0
6881883|NCT00538681|10894687|FG001|Overall Study|Death|0
6881884|NCT00538681|10894688|FG002|Overall Study|Death|1
6881885|NCT00538681|10894689|FG003|Overall Study|Death|1
6881886|NCT00538681|10894686|FG000|Overall Study|Investigator Decision|0
6881887|NCT00538681|10894687|FG001|Overall Study|Investigator Decision|0
6881888|NCT00538681|10894688|FG002|Overall Study|Investigator Decision|0
6881889|NCT00538681|10894689|FG003|Overall Study|Investigator Decision|1
6881890|NCT00538733|10894700|FG000|Overall Study|Adverse Event|8
6881891|NCT00538733|10894700|FG000|Overall Study|Death|1
6881892|NCT00538733|10894700|FG000|Overall Study|declined to participate|2
6881893|NCT00538733|10894700|FG000|Overall Study|still on therapy|1
6881894|NCT00538785|10894718|FG000|Overall Study|Death|9
6881895|NCT00538785|10894719|FG001|Overall Study|Death|10
6881896|NCT00538785|10894718|FG000|Overall Study|Withdrawal of consent|9
6881897|NCT00538785|10894719|FG001|Overall Study|Withdrawal of consent|7
6881898|NCT00538785|10894718|FG000|Overall Study|Lost to Follow-up|1
6881899|NCT00538785|10894719|FG001|Overall Study|Lost to Follow-up|0
6881900|NCT00538902|10894746|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1
6881901|NCT00538902|10894747|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2
6881902|NCT00538902|10894748|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3
6881903|NCT00538902|10894746|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
6881904|NCT00538902|10894747|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
6881905|NCT00538902|10894748|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1
6881906|NCT00538902|10894746|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
6881907|NCT00538902|10894747|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
6881908|NCT00538902|10894748|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1
6881909|NCT00538902|10894746|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
6881910|NCT00538902|10894747|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
6881911|NCT00538902|10894748|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
6881912|NCT00538902|10894746|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2
6881913|NCT00538902|10894747|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10
6881914|NCT00538902|10894748|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11
7079033|NCT02108262|11187709|FG001|Overall Study|Non-compliance|2
7079034|NCT02108262|11187710|FG002|Overall Study|Non-compliance|1
7079035|NCT02108262|11187711|FG003|Overall Study|Non-compliance|1
7079036|NCT02108262|11187708|FG000|Overall Study|Randomized by error/screen failure|0
7079037|NCT02108262|11187709|FG001|Overall Study|Randomized by error/screen failure|0
6881915|NCT00538902|10894746|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15
6881916|NCT00538902|10894747|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19
6881917|NCT00538902|10894748|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25
6881918|NCT00538902|10894746|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1
6881919|NCT00538902|10894747|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10
6881920|NCT00538902|10894748|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6
6881921|NCT00538902|10894746|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18
6881922|NCT00538902|10894747|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25
6881923|NCT00538902|10894748|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22
6881924|NCT00539006|10894766|FG000|Pre-treatment|Other|0
6881925|NCT00539006|10894767|FG001|Pre-treatment|Other|1
6881926|NCT00539006|10894768|FG002|Pre-treatment|Other|0
6881927|NCT00539006|10894769|FG003|Pre-treatment|Other|0
6881928|NCT00539006|10894766|FG000|Treatment Period 1|Lost to Follow-up|0
6881929|NCT00539006|10894767|FG001|Treatment Period 1|Lost to Follow-up|0
6881930|NCT00539006|10894768|FG002|Treatment Period 1|Lost to Follow-up|1
6881931|NCT00539006|10894769|FG003|Treatment Period 1|Lost to Follow-up|0
6881932|NCT00539006|10894766|FG000|Treatment Period 1|Protocol Violation|0
6881933|NCT00539006|10894767|FG001|Treatment Period 1|Protocol Violation|0
6881934|NCT00539006|10894768|FG002|Treatment Period 1|Protocol Violation|1
6881935|NCT00539006|10894769|FG003|Treatment Period 1|Protocol Violation|0
6881936|NCT00539006|10894766|FG000|Treatment Period 1|Lack of Efficacy|0
6881937|NCT00539006|10894767|FG001|Treatment Period 1|Lack of Efficacy|0
6881938|NCT00539006|10894768|FG002|Treatment Period 1|Lack of Efficacy|0
6881939|NCT00539006|10894769|FG003|Treatment Period 1|Lack of Efficacy|1
6881940|NCT00539006|10894766|FG000|Washout|Adverse Event|2
6881941|NCT00539006|10894767|FG001|Washout|Adverse Event|1
6881942|NCT00539006|10894768|FG002|Washout|Adverse Event|0
6881943|NCT00539006|10894769|FG003|Washout|Adverse Event|0
6881944|NCT00539006|10894766|FG000|Washout|Protocol Violation|1
6881945|NCT00539006|10894767|FG001|Washout|Protocol Violation|1
6881946|NCT00539006|10894768|FG002|Washout|Protocol Violation|0
6881947|NCT00539006|10894769|FG003|Washout|Protocol Violation|0
6881948|NCT00539006|10894766|FG000|Washout|Withdrawal by Subject|0
6881949|NCT00539006|10894767|FG001|Washout|Withdrawal by Subject|2
6881950|NCT00539006|10894768|FG002|Washout|Withdrawal by Subject|0
6881951|NCT00539006|10894769|FG003|Washout|Withdrawal by Subject|0
6881952|NCT00539006|10894766|FG000|Washout|Failed to meet continuation criteria|16
6881953|NCT00539006|10894767|FG001|Washout|Failed to meet continuation criteria|5
6881954|NCT00539006|10894768|FG002|Washout|Failed to meet continuation criteria|14
6881955|NCT00539006|10894769|FG003|Washout|Failed to meet continuation criteria|6
6881956|NCT00539006|10894766|FG000|Washout|Other|1
6881957|NCT00539006|10894767|FG001|Washout|Other|1
6881958|NCT00539006|10894768|FG002|Washout|Other|2
6881959|NCT00539006|10894769|FG003|Washout|Other|3
6881960|NCT00539006|10894766|FG000|Treatment Period 2|Protocol Violation|1
6881961|NCT00539006|10894767|FG001|Treatment Period 2|Protocol Violation|0
6881962|NCT00539006|10894768|FG002|Treatment Period 2|Protocol Violation|0
6881963|NCT00539006|10894769|FG003|Treatment Period 2|Protocol Violation|0
6881964|NCT00539006|10894766|FG000|Treatment Period 2|Other|0
6881965|NCT00539006|10894767|FG001|Treatment Period 2|Other|1
6881966|NCT00539006|10894768|FG002|Treatment Period 2|Other|0
6881967|NCT00539006|10894769|FG003|Treatment Period 2|Other|0
6881968|NCT00539032|10894787|FG000|Overall Study|Withdrawal by Subject|2
6881969|NCT00539032|10894788|FG001|Overall Study|Withdrawal by Subject|1
6881970|NCT00539188|10894805|FG000|Overall Study|Withdrawal by Subject|1
6881971|NCT00539188|10894806|FG001|Overall Study|Withdrawal by Subject|0
6881972|NCT00539188|10894805|FG000|Overall Study|Lost to Follow-up|2
6881973|NCT00539188|10894806|FG001|Overall Study|Lost to Follow-up|1
6881974|NCT00539240|10894815|FG000|Overall Study|Withdrawal by Subject|0
6881975|NCT00539240|10894816|FG001|Overall Study|Withdrawal by Subject|2
6881976|NCT00539240|10894817|FG002|Overall Study|Withdrawal by Subject|0
6881977|NCT00539240|10894815|FG000|Overall Study|Protocol Violation|1
6881978|NCT00539240|10894816|FG001|Overall Study|Protocol Violation|1
6881979|NCT00539240|10894817|FG002|Overall Study|Protocol Violation|4
6881980|NCT00539240|10894815|FG000|Overall Study|Lost to Follow-up|2
6881981|NCT00539240|10894816|FG001|Overall Study|Lost to Follow-up|3
6881982|NCT00539240|10894817|FG002|Overall Study|Lost to Follow-up|1
6881983|NCT00539240|10894815|FG000|Overall Study|Adverse Event|3
6881984|NCT00539240|10894816|FG001|Overall Study|Adverse Event|1
6881985|NCT00539240|10894817|FG002|Overall Study|Adverse Event|10
6881986|NCT00539279|10894831|FG000|Treatment|Withdrawal by Subject|10
6881987|NCT00539279|10894832|FG001|Treatment|Withdrawal by Subject|8
6881988|NCT00539279|10894831|FG000|Treatment|Death|1
6881989|NCT00539279|10894832|FG001|Treatment|Death|0
6881990|NCT00539279|10894831|FG000|Post-Treatment Assessment|Lost to Follow-up|12
6881991|NCT00539279|10894832|FG001|Post-Treatment Assessment|Lost to Follow-up|9
6881992|NCT00539279|10894831|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1
6881993|NCT00539279|10894832|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7
6881994|NCT00539305|10894840|FG000|Overall Study|Adverse Event|1
6881995|NCT00539305|10894841|FG001|Overall Study|Adverse Event|0
6881996|NCT00539305|10894840|FG000|Overall Study|Substance Use|0
6881997|NCT00539305|10894841|FG001|Overall Study|Substance Use|1
6881998|NCT00539305|10894840|FG000|Overall Study|Withdrawal by Subject|0
6881999|NCT00539305|10894841|FG001|Overall Study|Withdrawal by Subject|1
6882000|NCT00539500|10894847|FG000|Overall Study|Disease Progression|1
6882001|NCT00539500|10894847|FG000|Overall Study|Lost to Follow-up|2
6882002|NCT00539513|10894853|FG000|Overall Study|Withdrawal by Subject|2
6882003|NCT00539513|10894854|FG001|Overall Study|Withdrawal by Subject|1
6882004|NCT00539513|10894853|FG000|Overall Study|Lost to Follow-up|0
6882005|NCT00539513|10894854|FG001|Overall Study|Lost to Follow-up|1
6882006|NCT00539734|10894890|FG000|Overall Study|Protocol Violation|1
6882007|NCT00539864|10894896|FG000|Overall Study|Lost to Follow-up|0
6882008|NCT00539864|10894897|FG001|Overall Study|Lost to Follow-up|1
6882009|NCT00539864|10894896|FG000|Overall Study|Withdrawal by Subject|1
6882010|NCT00539864|10894897|FG001|Overall Study|Withdrawal by Subject|1
6882011|NCT00539994|10894915|FG000|Overall Study|Lost to Follow-up|2
6882012|NCT00539994|10894916|FG001|Overall Study|Lost to Follow-up|1
6882013|NCT00539994|10894917|FG002|Overall Study|Lost to Follow-up|0
6882014|NCT00539994|10894915|FG000|Overall Study|Withdrawal by Subject|1
6882015|NCT00539994|10894916|FG001|Overall Study|Withdrawal by Subject|0
6882016|NCT00539994|10894917|FG002|Overall Study|Withdrawal by Subject|1
6882017|NCT00539994|10894915|FG000|Overall Study|Physician Decision|0
6882018|NCT00539994|10894916|FG001|Overall Study|Physician Decision|0
6882019|NCT00539994|10894917|FG002|Overall Study|Physician Decision|1
6882020|NCT00540046|10894944|FG000|Overall Study|Lost to Follow-up|33
6882021|NCT00540046|10894945|FG001|Overall Study|Lost to Follow-up|23
6882022|NCT00540124|10894956|FG000|Overall Study|Adverse Event|0
6882023|NCT00540124|10894957|FG001|Overall Study|Adverse Event|2
6882024|NCT00540124|10894958|FG002|Overall Study|Adverse Event|1
6882025|NCT00540124|10894956|FG000|Overall Study|Entry Criteria Not Met|2
6882026|NCT00540124|10894957|FG001|Overall Study|Entry Criteria Not Met|0
6882027|NCT00540124|10894958|FG002|Overall Study|Entry Criteria Not Met|0
6882028|NCT00540124|10894956|FG000|Overall Study|Lack of Efficacy|1
6882029|NCT00540124|10894957|FG001|Overall Study|Lack of Efficacy|0
6882030|NCT00540124|10894958|FG002|Overall Study|Lack of Efficacy|0
6882031|NCT00540124|10894956|FG000|Overall Study|Withdrawal by Subject|1
6882032|NCT00540124|10894957|FG001|Overall Study|Withdrawal by Subject|1
6882033|NCT00540124|10894958|FG002|Overall Study|Withdrawal by Subject|0
6882034|NCT00540228|10894971|FG000|Overall Study|Adverse Event|2
6882035|NCT00540228|10894972|FG001|Overall Study|Adverse Event|0
6882036|NCT00540228|10894973|FG002|Overall Study|Adverse Event|0
6882037|NCT00540228|10894974|FG003|Overall Study|Adverse Event|0
6882038|NCT00540228|10894975|FG004|Overall Study|Adverse Event|0
6882039|NCT00540228|10894971|FG000|Overall Study|Lost to Follow-up|1
6882040|NCT00540228|10894972|FG001|Overall Study|Lost to Follow-up|1
6882041|NCT00540228|10894973|FG002|Overall Study|Lost to Follow-up|0
6882042|NCT00540228|10894974|FG003|Overall Study|Lost to Follow-up|0
6882043|NCT00540228|10894975|FG004|Overall Study|Lost to Follow-up|0
6882044|NCT00540293|10894987|FG000|Overall Study|Adverse event related to study drug|10
6882045|NCT00540293|10894987|FG000|Overall Study|Adverse event not related to study drug|7
6882046|NCT00540293|10894987|FG000|Overall Study|Withdrawal by Subject|6
6882047|NCT00540293|10894987|FG000|Overall Study|Protocol violation, & subject schedule|12
6882048|NCT00540423|10894999|FG000|Double-Blind Treatment Period|Adverse Event|0
6882049|NCT00540423|10895000|FG001|Double-Blind Treatment Period|Adverse Event|1
6882050|NCT00540423|10895001|FG002|Double-Blind Treatment Period|Adverse Event|0
6882051|NCT00540423|10894999|FG000|Open-Label Treatment Period|Lack of Efficacy|0
6882052|NCT00540423|10895000|FG001|Open-Label Treatment Period|Lack of Efficacy|0
6882053|NCT00540423|10895001|FG002|Open-Label Treatment Period|Lack of Efficacy|2
6882054|NCT00540436|10895019|FG000|First 12-Week Treatment Period|Adverse Event|1
6882055|NCT00540436|10895019|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1
6882056|NCT00540436|10895019|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1
6882057|NCT00540436|10895019|FG000|Second 12-Week Treatment Period|Adverse Event|1
6882058|NCT00540449|10895025|FG000|Overall Study|Adverse Event|12
6882059|NCT00540449|10895026|FG001|Overall Study|Adverse Event|32
6882060|NCT00540449|10895025|FG000|Overall Study|Sponsor's Decision|1
6882061|NCT00540449|10895026|FG001|Overall Study|Sponsor's Decision|1
6882062|NCT00540449|10895025|FG000|Overall Study|Subject Ineligible To Continue The Trial|2
6882063|NCT00540449|10895026|FG001|Overall Study|Subject Ineligible To Continue The Trial|1
6882064|NCT00540449|10895025|FG000|Overall Study|Lost to Follow-up|19
6882065|NCT00540449|10895026|FG001|Overall Study|Lost to Follow-up|17
6882066|NCT00540449|10895025|FG000|Overall Study|Subject Non-Compliant|7
6882067|NCT00540449|10895026|FG001|Overall Study|Subject Non-Compliant|5
6882068|NCT00540449|10895025|FG000|Overall Study|Subject Reached A Virologic Endpoint|32
6882069|NCT00540449|10895026|FG001|Overall Study|Subject Reached A Virologic Endpoint|8
6882070|NCT00540449|10895025|FG000|Overall Study|Withdrawal by Subject|10
6882071|NCT00540449|10895026|FG001|Overall Study|Withdrawal by Subject|10
6882072|NCT00540449|10895025|FG000|Overall Study|Other|1
6882073|NCT00540449|10895026|FG001|Overall Study|Other|4
6882074|NCT00540514|10895034|FG000|Overall Study|Still on treatment|3
6882075|NCT00540514|10895035|FG001|Overall Study|Still on treatment|0
6882076|NCT00540514|10895034|FG000|Overall Study|Unacceptable Toxicity|61
6882077|NCT00540514|10895035|FG001|Overall Study|Unacceptable Toxicity|62
6882078|NCT00540514|10895034|FG000|Overall Study|Adverse Event|20
6882079|NCT00540514|10895035|FG001|Overall Study|Adverse Event|24
6882080|NCT00540514|10895034|FG000|Overall Study|Physician Decision|86
6882081|NCT00540514|10895035|FG001|Overall Study|Physician Decision|99
6882082|NCT00540514|10895034|FG000|Overall Study|Protocol Deviation|3
6882083|NCT00540514|10895035|FG001|Overall Study|Protocol Deviation|4
6882084|NCT00540514|10895034|FG000|Overall Study|Lost to Follow-up|1
6882085|NCT00540514|10895035|FG001|Overall Study|Lost to Follow-up|1
6882086|NCT00540514|10895034|FG000|Overall Study|Withdrawal by Subject|65
6882087|NCT00540514|10895035|FG001|Overall Study|Withdrawal by Subject|67
6882088|NCT00540514|10895034|FG000|Overall Study|Excluded prior to treatment|7
6882089|NCT00540514|10895035|FG001|Overall Study|Excluded prior to treatment|7
6882090|NCT00540514|10895034|FG000|Overall Study|Paclitaxel not available|0
6882091|NCT00540514|10895035|FG001|Overall Study|Paclitaxel not available|2
6882092|NCT00540592|10895056|FG000|Overall Study|Adverse Event|0
6882093|NCT00540592|10895057|FG001|Overall Study|Adverse Event|1
6882094|NCT00540592|10895058|FG002|Overall Study|Adverse Event|0
6882095|NCT00540592|10895059|FG003|Overall Study|Adverse Event|0
6882096|NCT00540592|10895060|FG004|Overall Study|Adverse Event|1
6882097|NCT00540592|10895061|FG005|Overall Study|Adverse Event|0
6882098|NCT00540592|10895062|FG006|Overall Study|Adverse Event|0
6882099|NCT00540592|10895063|FG007|Overall Study|Adverse Event|1
6882100|NCT00540592|10895064|FG008|Overall Study|Adverse Event|1
6882101|NCT00540592|10895065|FG009|Overall Study|Adverse Event|2
6882102|NCT00540592|10895056|FG000|Overall Study|Lost to Follow-up|2
6882103|NCT00540592|10895057|FG001|Overall Study|Lost to Follow-up|0
6882104|NCT00540592|10895058|FG002|Overall Study|Lost to Follow-up|0
6882105|NCT00540592|10895059|FG003|Overall Study|Lost to Follow-up|0
6882106|NCT00540592|10895060|FG004|Overall Study|Lost to Follow-up|0
6882107|NCT00540592|10895061|FG005|Overall Study|Lost to Follow-up|0
6882108|NCT00540592|10895062|FG006|Overall Study|Lost to Follow-up|0
6882109|NCT00540592|10895063|FG007|Overall Study|Lost to Follow-up|0
6882110|NCT00540592|10895064|FG008|Overall Study|Lost to Follow-up|0
6882111|NCT00540592|10895065|FG009|Overall Study|Lost to Follow-up|0
6882112|NCT00540592|10895056|FG000|Overall Study|Withdrawal by Subject|0
6882113|NCT00540592|10895057|FG001|Overall Study|Withdrawal by Subject|0
6882114|NCT00540592|10895058|FG002|Overall Study|Withdrawal by Subject|1
6882115|NCT00540592|10895059|FG003|Overall Study|Withdrawal by Subject|1
6882116|NCT00540592|10895060|FG004|Overall Study|Withdrawal by Subject|0
6882117|NCT00540592|10895061|FG005|Overall Study|Withdrawal by Subject|0
6882118|NCT00540592|10895062|FG006|Overall Study|Withdrawal by Subject|0
6882119|NCT00540592|10895063|FG007|Overall Study|Withdrawal by Subject|0
6882120|NCT00540592|10895064|FG008|Overall Study|Withdrawal by Subject|0
6882121|NCT00540592|10895065|FG009|Overall Study|Withdrawal by Subject|0
6882122|NCT00540644|10895089|FG000|Overall Study|Adverse Event|3
6882123|NCT00540644|10895090|FG001|Overall Study|Adverse Event|1
6882124|NCT00540644|10895089|FG000|Overall Study|Disease Progression|3
6882125|NCT00540644|10895090|FG001|Overall Study|Disease Progression|1
6882126|NCT00540644|10895089|FG000|Overall Study|Physician Decision|0
6882127|NCT00540644|10895090|FG001|Overall Study|Physician Decision|5
6882128|NCT00540644|10895089|FG000|Overall Study|Withdrawal by Subject|2
6882129|NCT00540644|10895090|FG001|Overall Study|Withdrawal by Subject|2
6882130|NCT00540644|10895089|FG000|Overall Study|Noncomplilance|1
6882131|NCT00540644|10895090|FG001|Overall Study|Noncomplilance|0
6969616|NCT01148537|11019218|FG002|Overall Study|Withdrawal by Subject|2
6969617|NCT01148537|11019216|FG000|Overall Study|Adverse Event|2
6969618|NCT01148537|11019217|FG001|Overall Study|Adverse Event|0
6969619|NCT01148537|11019218|FG002|Overall Study|Adverse Event|1
6969620|NCT01148693|11019239|FG000|Overall Study|Attempts for cannulation were failed|13
6969621|NCT01148693|11019240|FG001|Overall Study|Attempts for cannulation were failed|10
6969622|NCT01148771|11019254|FG000|Washout Period|Withdrawal by Subject|0
6969623|NCT01148771|11019255|FG001|Washout Period|Withdrawal by Subject|1
6969624|NCT01148810|11019267|FG000|Overall Study|Adverse Event|0
6969625|NCT01148810|11019268|FG001|Overall Study|Adverse Event|2
6969626|NCT01148810|11019267|FG000|Overall Study|Lack of Efficacy|0
6969627|NCT01148810|11019268|FG001|Overall Study|Lack of Efficacy|1
6969628|NCT01148810|11019267|FG000|Overall Study|Withdrawal by Subject|0
6969629|NCT01148810|11019268|FG001|Overall Study|Withdrawal by Subject|2
6969630|NCT01148810|11019267|FG000|Overall Study|Protocol Violation|1
6969631|NCT01148810|11019268|FG001|Overall Study|Protocol Violation|0
6969632|NCT01148862|11019284|FG000|Second Intervention|Withdrawal by Subject|0
6969633|NCT01148862|11019285|FG001|Second Intervention|Withdrawal by Subject|2
6969634|NCT01148979|11019305|FG000|Overall Study|Lost to Follow-up|0
6969635|NCT01148979|11019306|FG001|Overall Study|Lost to Follow-up|1
6969636|NCT01149057|11019312|FG000|Overall Study|Lack of Efficacy|16
6969637|NCT01149057|11019312|FG000|Overall Study|Adverse Event|13
6969638|NCT01149057|11019312|FG000|Overall Study|Withdrawal by Subject|9
6969639|NCT01149057|11019312|FG000|Overall Study|Positive Hepatitis B Core Antibody|5
6969640|NCT01149057|11019312|FG000|Overall Study|B Cell Depletion|4
6969641|NCT01149057|11019312|FG000|Overall Study|Participant Non-Compliance|2
6969642|NCT01149057|11019312|FG000|Overall Study|Lost to Follow-up|1
6969643|NCT01149057|11019312|FG000|Overall Study|High Parathyroid Hormone Value|1
6969644|NCT01149057|11019312|FG000|Overall Study|Other|6
6969645|NCT01149096|11019318|FG000|Overall Study|Lost to Follow-up|0
6969646|NCT01149096|11019319|FG001|Overall Study|Lost to Follow-up|1
6969647|NCT01149148|11019328|FG000|Overall Study|Lost to Follow-up|1
6969648|NCT01149148|11019329|FG001|Overall Study|Lost to Follow-up|2
6969649|NCT01149148|11019328|FG000|Overall Study|Death|1
6969650|NCT01149148|11019329|FG001|Overall Study|Death|0
6969651|NCT01149343|11019340|FG000|Overall Study|Withdrawal by Subject|1
6969652|NCT01149343|11019341|FG001|Overall Study|Withdrawal by Subject|1
6969653|NCT01149343|11019342|FG002|Overall Study|Withdrawal by Subject|1
6969654|NCT01149343|11019343|FG003|Overall Study|Withdrawal by Subject|5
6969655|NCT01149343|11019340|FG000|Overall Study|Death|10
6969656|NCT01149343|11019341|FG001|Overall Study|Death|13
6969657|NCT01149343|11019342|FG002|Overall Study|Death|18
6969658|NCT01149343|11019343|FG003|Overall Study|Death|18
6969659|NCT01149343|11019340|FG000|Overall Study|Lost to Follow-up|1
6969660|NCT01149343|11019341|FG001|Overall Study|Lost to Follow-up|0
6969661|NCT01149343|11019342|FG002|Overall Study|Lost to Follow-up|0
6969662|NCT01149343|11019343|FG003|Overall Study|Lost to Follow-up|1
6969663|NCT01149343|11019340|FG000|Overall Study|Other|8
6969664|NCT01149343|11019341|FG001|Overall Study|Other|10
6969665|NCT01149343|11019342|FG002|Overall Study|Other|2
6969666|NCT01149343|11019343|FG003|Overall Study|Other|14
6969667|NCT01149343|11019340|FG000|Overall Study|Sponsor study termination|0
6969668|NCT01149343|11019341|FG001|Overall Study|Sponsor study termination|0
6969669|NCT01149343|11019342|FG002|Overall Study|Sponsor study termination|0
6969670|NCT01149343|11019343|FG003|Overall Study|Sponsor study termination|2
6969671|NCT01149343|11019340|FG000|Overall Study|Recurrence / Progressive disease|0
6969672|NCT01149343|11019341|FG001|Overall Study|Recurrence / Progressive disease|0
6969673|NCT01149343|11019342|FG002|Overall Study|Recurrence / Progressive disease|1
6969674|NCT01149343|11019343|FG003|Overall Study|Recurrence / Progressive disease|0
6969675|NCT01149369|11019359|FG000|Overall Study|Adverse Event|6
6969676|NCT01149369|11019360|FG001|Overall Study|Adverse Event|3
6969677|NCT01149421|11019369|FG000|Overall Study|Adverse Event|22
6969678|NCT01149421|11019370|FG001|Overall Study|Adverse Event|6
6969679|NCT01149421|11019371|FG002|Overall Study|Adverse Event|11
6969680|NCT01149421|11019369|FG000|Overall Study|Withdrawal by Subject|20
6882132|NCT00541034|10895123|FG000|Overall Study|Non-Compliance|3
6882133|NCT00541099|10895127|FG000|Overall Study|Ineligible|3
6882134|NCT00541229|10895148|FG000|Treatment Period I (Week 1)|Physician Decision|0
6882135|NCT00541229|10895149|FG001|Treatment Period I (Week 1)|Physician Decision|0
6882136|NCT00541229|10895150|FG002|Treatment Period I (Week 1)|Physician Decision|1
6882137|NCT00541229|10895151|FG003|Treatment Period I (Week 1)|Physician Decision|0
6882138|NCT00541229|10895152|FG004|Treatment Period I (Week 1)|Physician Decision|0
6882139|NCT00541229|10895153|FG005|Treatment Period I (Week 1)|Physician Decision|0
6882140|NCT00541229|10895148|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0
6882141|NCT00541229|10895149|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0
6882142|NCT00541229|10895150|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0
6882143|NCT00541229|10895151|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0
6882144|NCT00541229|10895152|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0
6882145|NCT00541229|10895153|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1
6882146|NCT00541229|10895148|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0
6882147|NCT00541229|10895149|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0
6882148|NCT00541229|10895150|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0
6882149|NCT00541229|10895151|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0
6882150|NCT00541229|10895152|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0
6882151|NCT00541229|10895153|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1
6882152|NCT00541229|10895148|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
6882153|NCT00541229|10895149|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
6882154|NCT00541229|10895150|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2
6882155|NCT00541229|10895151|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
6882156|NCT00541229|10895152|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
6882157|NCT00541229|10895153|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
6882158|NCT00541229|10895148|FG000|Washout Period I (Week 2-5)|Adverse Event|1
6882159|NCT00541229|10895149|FG001|Washout Period I (Week 2-5)|Adverse Event|0
6882160|NCT00541229|10895150|FG002|Washout Period I (Week 2-5)|Adverse Event|1
6882161|NCT00541229|10895151|FG003|Washout Period I (Week 2-5)|Adverse Event|0
6882162|NCT00541229|10895152|FG004|Washout Period I (Week 2-5)|Adverse Event|0
6882163|NCT00541229|10895153|FG005|Washout Period I (Week 2-5)|Adverse Event|0
6882164|NCT00541229|10895148|FG000|Washout Period I (Week 2-5)|Physician Decision|0
6882165|NCT00541229|10895149|FG001|Washout Period I (Week 2-5)|Physician Decision|0
6882166|NCT00541229|10895150|FG002|Washout Period I (Week 2-5)|Physician Decision|0
6882167|NCT00541229|10895151|FG003|Washout Period I (Week 2-5)|Physician Decision|1
6882168|NCT00541229|10895152|FG004|Washout Period I (Week 2-5)|Physician Decision|0
6882169|NCT00541229|10895153|FG005|Washout Period I (Week 2-5)|Physician Decision|0
6882170|NCT00541229|10895148|FG000|Washout Period I (Week 2-5)|Protocol Violation|0
6882171|NCT00541229|10895149|FG001|Washout Period I (Week 2-5)|Protocol Violation|0
6882172|NCT00541229|10895150|FG002|Washout Period I (Week 2-5)|Protocol Violation|0
6882173|NCT00541229|10895151|FG003|Washout Period I (Week 2-5)|Protocol Violation|0
6882174|NCT00541229|10895152|FG004|Washout Period I (Week 2-5)|Protocol Violation|0
6882175|NCT00541229|10895153|FG005|Washout Period I (Week 2-5)|Protocol Violation|1
6882176|NCT00541229|10895148|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
6882177|NCT00541229|10895149|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2
6882178|NCT00541229|10895150|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
6882179|NCT00541229|10895151|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
6882180|NCT00541229|10895152|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1
6882181|NCT00541229|10895153|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4
6882182|NCT00541229|10895148|FG000|Treatment Period II (Week 6)|Protocol Violation|0
6882183|NCT00541229|10895149|FG001|Treatment Period II (Week 6)|Protocol Violation|0
6882184|NCT00541229|10895150|FG002|Treatment Period II (Week 6)|Protocol Violation|0
6882185|NCT00541229|10895151|FG003|Treatment Period II (Week 6)|Protocol Violation|0
6882186|NCT00541229|10895152|FG004|Treatment Period II (Week 6)|Protocol Violation|1
6882187|NCT00541229|10895153|FG005|Treatment Period II (Week 6)|Protocol Violation|1
6882188|NCT00541229|10895148|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
6882189|NCT00541229|10895149|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
6882190|NCT00541229|10895150|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
6882191|NCT00541229|10895151|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
6882192|NCT00541229|10895152|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
6882193|NCT00541229|10895153|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
6882194|NCT00541229|10895148|FG000|Washout Period II (Week 7-10)|Protocol Violation|1
6882195|NCT00541229|10895149|FG001|Washout Period II (Week 7-10)|Protocol Violation|0
6882196|NCT00541229|10895150|FG002|Washout Period II (Week 7-10)|Protocol Violation|0
6882197|NCT00541229|10895151|FG003|Washout Period II (Week 7-10)|Protocol Violation|0
6969681|NCT01149421|11019370|FG001|Overall Study|Withdrawal by Subject|12
6969682|NCT01149421|11019371|FG002|Overall Study|Withdrawal by Subject|13
6969683|NCT01149421|11019369|FG000|Overall Study|Sponsor Decision|0
6969684|NCT01149421|11019370|FG001|Overall Study|Sponsor Decision|1
6969685|NCT01149421|11019371|FG002|Overall Study|Sponsor Decision|1
6969686|NCT01149421|11019369|FG000|Overall Study|Lost to Follow-up|2
6969687|NCT01149421|11019370|FG001|Overall Study|Lost to Follow-up|4
6969688|NCT01149421|11019371|FG002|Overall Study|Lost to Follow-up|5
6969689|NCT01149421|11019369|FG000|Overall Study|Physician Decision|5
6882198|NCT00541229|10895152|FG004|Washout Period II (Week 7-10)|Protocol Violation|0
6882199|NCT00541229|10895153|FG005|Washout Period II (Week 7-10)|Protocol Violation|0
6882200|NCT00541229|10895148|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0
6882201|NCT00541229|10895149|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0
6882202|NCT00541229|10895150|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0
6882203|NCT00541229|10895151|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0
6882204|NCT00541229|10895152|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1
6882205|NCT00541229|10895153|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0
6882206|NCT00541229|10895148|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
6882207|NCT00541229|10895149|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
6882208|NCT00541229|10895150|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2
6882209|NCT00541229|10895151|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
6882210|NCT00541229|10895152|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
6882211|NCT00541229|10895153|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
6882212|NCT00541229|10895148|FG000|Treatment Period III (Week 11)|Adverse Event|0
6882213|NCT00541229|10895149|FG001|Treatment Period III (Week 11)|Adverse Event|0
6882214|NCT00541229|10895150|FG002|Treatment Period III (Week 11)|Adverse Event|0
6882215|NCT00541229|10895151|FG003|Treatment Period III (Week 11)|Adverse Event|0
6882216|NCT00541229|10895152|FG004|Treatment Period III (Week 11)|Adverse Event|1
6882217|NCT00541229|10895153|FG005|Treatment Period III (Week 11)|Adverse Event|0
6882218|NCT00541229|10895148|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0
6882219|NCT00541229|10895149|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0
6882220|NCT00541229|10895150|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0
6882221|NCT00541229|10895151|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0
6882222|NCT00541229|10895152|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0
6882223|NCT00541229|10895153|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1
6882224|NCT00541229|10895148|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
6882225|NCT00541229|10895149|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
6882226|NCT00541229|10895150|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1
6882227|NCT00541229|10895151|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
6882228|NCT00541229|10895152|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
6882229|NCT00541229|10895153|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
6882230|NCT00541307|10895170|FG000|Overall Study|Death|5
6882231|NCT00541307|10895170|FG000|Overall Study|Physician Decision|3
6882232|NCT00541307|10895170|FG000|Overall Study|Withdrawal by Subject|6
6882233|NCT00541307|10895170|FG000|Overall Study|Lost to Follow-up|4
6882234|NCT00541307|10895170|FG000|Overall Study|Subject returned early (outside window)|1
6882235|NCT00541307|10895170|FG000|Overall Study|Surgical Bypass|5
6882236|NCT00541346|10895174|FG000|Follow-up|Adverse Event|1
6882237|NCT00541385|10895180|FG000|Overall Study|Adverse Event|6
6882238|NCT00541385|10895181|FG001|Overall Study|Adverse Event|3
6882239|NCT00541385|10895180|FG000|Overall Study|Withdrawal by Subject|2
6882240|NCT00541385|10895181|FG001|Overall Study|Withdrawal by Subject|2
6882241|NCT00541385|10895180|FG000|Overall Study|Lost to Follow-up|6
6882242|NCT00541385|10895181|FG001|Overall Study|Lost to Follow-up|1
6882243|NCT00541385|10895180|FG000|Overall Study|Parasite reappearance/malaria|67
6882244|NCT00541385|10895181|FG001|Overall Study|Parasite reappearance/malaria|32
6882245|NCT00541450|10895189|FG000|Phase A|Adverse Event|3
6882246|NCT00541450|10895190|FG001|Phase A|Adverse Event|0
6882247|NCT00541450|10895189|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0
6882248|NCT00541450|10895190|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2
6882249|NCT00541450|10895189|FG000|Phase A|Hyperglycemia|0
6882250|NCT00541450|10895190|FG001|Phase A|Hyperglycemia|1
6882251|NCT00541450|10895189|FG000|Phase A|Lost to Follow-up|6
6882252|NCT00541450|10895190|FG001|Phase A|Lost to Follow-up|4
6882253|NCT00541450|10895189|FG000|Phase A|Physician Decision|2
6882254|NCT00541450|10895190|FG001|Phase A|Physician Decision|0
6882255|NCT00541450|10895189|FG000|Phase A|Protocol Violation|2
6882256|NCT00541450|10895190|FG001|Phase A|Protocol Violation|3
6882257|NCT00541450|10895189|FG000|Phase A|Withdrawal by Subject|7
6882258|NCT00541450|10895190|FG001|Phase A|Withdrawal by Subject|7
6882259|NCT00541450|10895189|FG000|Phase B|Adverse Event|6
6882260|NCT00541450|10895190|FG001|Phase B|Adverse Event|6
6882261|NCT00541450|10895189|FG000|Phase B|Hyperglycemia|10
6882262|NCT00541450|10895190|FG001|Phase B|Hyperglycemia|9
6882263|NCT00541450|10895189|FG000|Phase B|Lost to Follow-up|6
6882264|NCT00541450|10895190|FG001|Phase B|Lost to Follow-up|4
6882265|NCT00541450|10895189|FG000|Phase B|Physician Decision|4
6882266|NCT00541450|10895190|FG001|Phase B|Physician Decision|2
6882267|NCT00541450|10895189|FG000|Phase B|Pregnancy|0
6882268|NCT00541450|10895190|FG001|Phase B|Pregnancy|1
6882269|NCT00541450|10895189|FG000|Phase B|Protocol Violation|3
7155605|NCT03342963|11323609|FG001|Overall Study|Withdrawal by Subject|0
6882270|NCT00541450|10895190|FG001|Phase B|Protocol Violation|3
6882271|NCT00541450|10895189|FG000|Phase B|Withdrawal by Subject|8
6882272|NCT00541450|10895190|FG001|Phase B|Withdrawal by Subject|6
6882273|NCT00541658|10895207|FG000|Overall Study|Adverse Event|28
6882274|NCT00541658|10895208|FG001|Overall Study|Adverse Event|37
6882275|NCT00541658|10895209|FG002|Overall Study|Adverse Event|25
6882276|NCT00541658|10895207|FG000|Overall Study|Physician Decision|0
6882277|NCT00541658|10895208|FG001|Overall Study|Physician Decision|0
6882278|NCT00541658|10895209|FG002|Overall Study|Physician Decision|4
6882279|NCT00541658|10895207|FG000|Overall Study|Lost to Follow-up|3
6882280|NCT00541658|10895208|FG001|Overall Study|Lost to Follow-up|3
7155606|NCT03342963|11323610|FG002|Overall Study|Withdrawal by Subject|0
7155607|NCT03342963|11323611|FG003|Overall Study|Withdrawal by Subject|0
7155608|NCT03343067|11323624|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0
7155609|NCT03343067|11323625|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3
7155610|NCT03343067|11323626|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1
7155611|NCT03343639|11323645|FG000|Overall Study|Withdrawal by Subject|10
7155612|NCT03343639|11323646|FG001|Overall Study|Withdrawal by Subject|6
7155613|NCT03343639|11323645|FG000|Overall Study|Lost to Follow-up|4
7155614|NCT03343639|11323646|FG001|Overall Study|Lost to Follow-up|5
7155615|NCT03343639|11323645|FG000|Overall Study|Protocol Violation|0
7155616|NCT03343639|11323646|FG001|Overall Study|Protocol Violation|1
7155617|NCT03344172|11323654|FG000|Overall Study|Received <1 dose of treatment|1
7155618|NCT03344172|11323655|FG001|Overall Study|Received <1 dose of treatment|0
7155619|NCT03344640|11323671|FG000|Overall Study|Adverse Event|1
7155620|NCT03344640|11323672|FG001|Overall Study|Adverse Event|0
7155621|NCT03344640|11323671|FG000|Overall Study|Physician Decision|1
7155622|NCT03344640|11323672|FG001|Overall Study|Physician Decision|1
7155623|NCT03344640|11323671|FG000|Overall Study|Withdrawal by Subject|1
7155624|NCT03344640|11323672|FG001|Overall Study|Withdrawal by Subject|2
7155625|NCT03344640|11323671|FG000|Follow-up Epoch|Withdrawal by Subject|0
7155626|NCT03344640|11323672|FG001|Follow-up Epoch|Withdrawal by Subject|2
7184160|NCT01777295|11384168|FG000|Overall Study|Withdrawal by Subject|2
6882281|NCT00541658|10895209|FG002|Overall Study|Lost to Follow-up|6
6882282|NCT00541658|10895207|FG000|Overall Study|Protocol Violation|0
6882283|NCT00541658|10895208|FG001|Overall Study|Protocol Violation|1
6882284|NCT00541658|10895209|FG002|Overall Study|Protocol Violation|1
6882285|NCT00541658|10895207|FG000|Overall Study|Withdrawal by Subject|28
6882286|NCT00541658|10895208|FG001|Overall Study|Withdrawal by Subject|32
6882287|NCT00541658|10895209|FG002|Overall Study|Withdrawal by Subject|32
6882288|NCT00541658|10895207|FG000|Overall Study|Took No Study Drug|1
6882289|NCT00541658|10895208|FG001|Overall Study|Took No Study Drug|0
6882290|NCT00541658|10895209|FG002|Overall Study|Took No Study Drug|0
6882291|NCT00541775|10895231|FG000|Overall Study|Adverse Event|3
6882292|NCT00541775|10895232|FG001|Overall Study|Adverse Event|2
6882293|NCT00541775|10895233|FG002|Overall Study|Adverse Event|1
6882294|NCT00541775|10895231|FG000|Overall Study|Lack of Efficacy|0
6882295|NCT00541775|10895232|FG001|Overall Study|Lack of Efficacy|0
6882296|NCT00541775|10895233|FG002|Overall Study|Lack of Efficacy|3
6882297|NCT00541775|10895231|FG000|Overall Study|Lost to Follow-up|0
6882298|NCT00541775|10895232|FG001|Overall Study|Lost to Follow-up|0
6882299|NCT00541775|10895233|FG002|Overall Study|Lost to Follow-up|2
6882300|NCT00541775|10895231|FG000|Overall Study|Protocol Violation|1
7041219|NCT01725282|11124761|FG000|Overall Study|Withdrawal by Subject|0
7041220|NCT01725282|11124762|FG001|Overall Study|Withdrawal by Subject|0
7041221|NCT01725282|11124763|FG002|Overall Study|Withdrawal by Subject|1
7041222|NCT01725282|11124764|FG003|Overall Study|Withdrawal by Subject|1
7041223|NCT01725282|11124761|FG000|Overall Study|Lack of Efficacy|0
7041224|NCT01725282|11124762|FG001|Overall Study|Lack of Efficacy|1
7041225|NCT01725282|11124763|FG002|Overall Study|Lack of Efficacy|0
7041226|NCT01725282|11124764|FG003|Overall Study|Lack of Efficacy|1
7041227|NCT01725308|11124777|FG000|Treatment Period I|Did Not Receive Drug|1
7041228|NCT01725308|11124778|FG001|Treatment Period I|Did Not Receive Drug|0
7041229|NCT01725308|11124779|FG002|Treatment Period I|Did Not Receive Drug|0
7041230|NCT01725308|11124777|FG000|Treatment Period I|Adverse Event|5
7041231|NCT01725308|11124778|FG001|Treatment Period I|Adverse Event|4
7041232|NCT01725308|11124779|FG002|Treatment Period I|Adverse Event|21
7041233|NCT01725308|11124777|FG000|Treatment Period I|Insufficient Response|7
7041234|NCT01725308|11124778|FG001|Treatment Period I|Insufficient Response|0
7041235|NCT01725308|11124779|FG002|Treatment Period I|Insufficient Response|5
7041236|NCT01725308|11124777|FG000|Treatment Period I|Worsening of the Target Disease|8
7041237|NCT01725308|11124778|FG001|Treatment Period I|Worsening of the Target Disease|0
7041238|NCT01725308|11124779|FG002|Treatment Period I|Worsening of the Target Disease|2
7041239|NCT01725308|11124777|FG000|Treatment Period I|Changes in the Episodes|3
7041240|NCT01725308|11124778|FG001|Treatment Period I|Changes in the Episodes|0
7041241|NCT01725308|11124779|FG002|Treatment Period I|Changes in the Episodes|2
7041242|NCT01725308|11124777|FG000|Treatment Period I|Withdrawal of Consent|12
7041243|NCT01725308|11124778|FG001|Treatment Period I|Withdrawal of Consent|7
7041244|NCT01725308|11124779|FG002|Treatment Period I|Withdrawal of Consent|5
7041245|NCT01725308|11124777|FG000|Treatment Period I|Lost to Follow-up|3
7041246|NCT01725308|11124778|FG001|Treatment Period I|Lost to Follow-up|2
7041247|NCT01725308|11124779|FG002|Treatment Period I|Lost to Follow-up|2
7041248|NCT01725308|11124777|FG000|Treatment Period I|Protocol Deviations|3
7041249|NCT01725308|11124778|FG001|Treatment Period I|Protocol Deviations|1
7041250|NCT01725308|11124779|FG002|Treatment Period I|Protocol Deviations|1
7041251|NCT01725308|11124777|FG000|Treatment Period I|Miscellaneous|2
7041252|NCT01725308|11124778|FG001|Treatment Period I|Miscellaneous|0
6882301|NCT00541775|10895232|FG001|Overall Study|Protocol Violation|0
6882302|NCT00541775|10895233|FG002|Overall Study|Protocol Violation|0
6882303|NCT00541775|10895231|FG000|Overall Study|Withdrawal by Subject and Other|5
6882304|NCT00541775|10895232|FG001|Overall Study|Withdrawal by Subject and Other|0
6882305|NCT00541775|10895233|FG002|Overall Study|Withdrawal by Subject and Other|2
6882306|NCT00541866|10895246|FG000|Overall Study|Adverse Event|3
6882307|NCT00541866|10895247|FG001|Overall Study|Adverse Event|0
6882308|NCT00541866|10895248|FG002|Overall Study|Adverse Event|0
6882309|NCT00541866|10895249|FG003|Overall Study|Adverse Event|0
6882310|NCT00541866|10895250|FG004|Overall Study|Adverse Event|0
6882311|NCT00541866|10895246|FG000|Overall Study|Death|1
6882312|NCT00541866|10895247|FG001|Overall Study|Death|0
6882313|NCT00541866|10895248|FG002|Overall Study|Death|0
6882314|NCT00541866|10895249|FG003|Overall Study|Death|0
6882315|NCT00541866|10895250|FG004|Overall Study|Death|0
6882316|NCT00541866|10895246|FG000|Overall Study|Lack of Efficacy|19
6882317|NCT00541866|10895247|FG001|Overall Study|Lack of Efficacy|15
6882318|NCT00541866|10895248|FG002|Overall Study|Lack of Efficacy|10
6882319|NCT00541866|10895249|FG003|Overall Study|Lack of Efficacy|12
6882320|NCT00541866|10895250|FG004|Overall Study|Lack of Efficacy|14
6882321|NCT00541866|10895246|FG000|Overall Study|Not Reported or Other|11
6882322|NCT00541866|10895247|FG001|Overall Study|Not Reported or Other|3
6882323|NCT00541866|10895248|FG002|Overall Study|Not Reported or Other|3
6882324|NCT00541866|10895249|FG003|Overall Study|Not Reported or Other|3
6882325|NCT00541866|10895250|FG004|Overall Study|Not Reported or Other|1
6882326|NCT00541866|10895246|FG000|Overall Study|Physician Decision|0
6882327|NCT00541866|10895247|FG001|Overall Study|Physician Decision|0
6882328|NCT00541866|10895248|FG002|Overall Study|Physician Decision|2
6882329|NCT00541866|10895249|FG003|Overall Study|Physician Decision|1
6882330|NCT00541866|10895250|FG004|Overall Study|Physician Decision|0
6882331|NCT00541931|10895280|FG000|Overall Study|Adverse Event|1
6882332|NCT00541931|10895281|FG001|Overall Study|Adverse Event|0
6882333|NCT00541931|10895280|FG000|Overall Study|Lost to Follow-up|3
6882334|NCT00541931|10895281|FG001|Overall Study|Lost to Follow-up|3
6882335|NCT00541931|10895280|FG000|Overall Study|Withdrawal by Subject|1
6882336|NCT00541931|10895281|FG001|Overall Study|Withdrawal by Subject|0
6882337|NCT00541931|10895280|FG000|Overall Study|Transportation Issue|0
6882338|NCT00541931|10895281|FG001|Overall Study|Transportation Issue|1
6882339|NCT00541970|10895293|FG000|Month 7|Protocol Violation|9
6882340|NCT00541970|10895294|FG001|Month 7|Protocol Violation|13
6882341|NCT00541970|10895295|FG002|Month 7|Protocol Violation|11
6882342|NCT00541970|10895296|FG003|Month 7|Protocol Violation|5
6882343|NCT00541970|10895293|FG000|Month 12|Adverse Event|0
6882344|NCT00541970|10895294|FG001|Month 12|Adverse Event|1
6882345|NCT00541970|10895295|FG002|Month 12|Adverse Event|1
6882346|NCT00541970|10895296|FG003|Month 12|Adverse Event|1
6882347|NCT00541970|10895293|FG000|Month 12|Protocol Violation|12
6882348|NCT00541970|10895294|FG001|Month 12|Protocol Violation|21
6882349|NCT00541970|10895295|FG002|Month 12|Protocol Violation|20
6882350|NCT00541970|10895296|FG003|Month 12|Protocol Violation|15
6882351|NCT00541970|10895293|FG000|Month 18|Adverse Event|0
6882352|NCT00541970|10895294|FG001|Month 18|Adverse Event|1
6882353|NCT00541970|10895295|FG002|Month 18|Adverse Event|1
6882354|NCT00541970|10895296|FG003|Month 18|Adverse Event|1
6882355|NCT00541970|10895293|FG000|Month 18|Protocol Violation|14
6882356|NCT00541970|10895294|FG001|Month 18|Protocol Violation|23
6882357|NCT00541970|10895295|FG002|Month 18|Protocol Violation|24
6882358|NCT00541970|10895296|FG003|Month 18|Protocol Violation|16
6882359|NCT00541970|10895293|FG000|Month 24|Adverse Event|0
6882360|NCT00541970|10895294|FG001|Month 24|Adverse Event|1
6882361|NCT00541970|10895295|FG002|Month 24|Adverse Event|1
6882362|NCT00541970|10895296|FG003|Month 24|Adverse Event|1
6882363|NCT00541970|10895293|FG000|Month 24|Protocol Violation|29
6882364|NCT00541970|10895294|FG001|Month 24|Protocol Violation|31
6882365|NCT00541970|10895295|FG002|Month 24|Protocol Violation|31
6882366|NCT00541970|10895296|FG003|Month 24|Protocol Violation|21
6882367|NCT00541970|10895293|FG000|Month 36|Protocol Violation|61
6882368|NCT00541970|10895294|FG001|Month 36|Protocol Violation|66
6882369|NCT00541970|10895295|FG002|Month 36|Protocol Violation|66
6882370|NCT00541970|10895296|FG003|Month 36|Protocol Violation|60
6882371|NCT00541970|10895293|FG000|Month 48|Withdrawal by Subject|2
6882372|NCT00541970|10895294|FG001|Month 48|Withdrawal by Subject|4
6882373|NCT00541970|10895295|FG002|Month 48|Withdrawal by Subject|4
6882374|NCT00541970|10895296|FG003|Month 48|Withdrawal by Subject|2
6882375|NCT00541970|10895293|FG000|Month 48|Other|3
6882376|NCT00541970|10895294|FG001|Month 48|Other|1
6882377|NCT00541970|10895295|FG002|Month 48|Other|1
6882378|NCT00541970|10895296|FG003|Month 48|Other|0
6882379|NCT00541970|10895293|FG000|Month 48|Lost to Follow-up|66
6882380|NCT00541970|10895294|FG001|Month 48|Lost to Follow-up|68
6882381|NCT00541970|10895295|FG002|Month 48|Lost to Follow-up|68
6882382|NCT00541970|10895296|FG003|Month 48|Lost to Follow-up|73
6882383|NCT00541970|10895293|FG000|Month 60|Protocol Violation|78
6882384|NCT00541970|10895294|FG001|Month 60|Protocol Violation|77
6882385|NCT00541970|10895295|FG002|Month 60|Protocol Violation|82
6882386|NCT00541970|10895296|FG003|Month 60|Protocol Violation|72
6882387|NCT00542178|10895312|FG000|Overall Study|did not complete year 4 follow-up|75
6882388|NCT00542178|10895313|FG001|Overall Study|did not complete year 4 follow-up|80
6882389|NCT00542178|10895314|FG002|Overall Study|did not complete year 4 follow-up|74
6882390|NCT00542178|10895315|FG003|Overall Study|did not complete year 4 follow-up|62
7079038|NCT02108262|11187710|FG002|Overall Study|Randomized by error/screen failure|1
6882391|NCT00542178|10895316|FG004|Overall Study|did not complete year 4 follow-up|64
6882392|NCT00542178|10895317|FG005|Overall Study|did not complete year 4 follow-up|89
6882393|NCT00542178|10895318|FG006|Overall Study|did not complete year 4 follow-up|87
6882394|NCT00542178|10895319|FG007|Overall Study|did not complete year 4 follow-up|85
6882395|NCT00542191|10895333|FG000|Overall Study|Death|3
6882396|NCT00542269|10895340|FG000|Overall Study|Adverse Event|10
6882397|NCT00542269|10895341|FG001|Overall Study|Adverse Event|4
6882398|NCT00542269|10895342|FG002|Overall Study|Adverse Event|5
6882399|NCT00542269|10895340|FG000|Overall Study|Protocol Violation|1
6882400|NCT00542269|10895341|FG001|Overall Study|Protocol Violation|1
6882401|NCT00542269|10895342|FG002|Overall Study|Protocol Violation|0
6882402|NCT00542269|10895340|FG000|Overall Study|Withdrawal by Subject|1
6882403|NCT00542269|10895341|FG001|Overall Study|Withdrawal by Subject|0
6882404|NCT00542269|10895342|FG002|Overall Study|Withdrawal by Subject|0
6882405|NCT00542269|10895340|FG000|Overall Study|Administrative problems|1
6882406|NCT00542269|10895341|FG001|Overall Study|Administrative problems|1
6882407|NCT00542269|10895342|FG002|Overall Study|Administrative problems|1
6882408|NCT00542321|10895358|FG000|Overall Study|Death|0
6882409|NCT00542321|10895359|FG001|Overall Study|Death|1
6882410|NCT00542386|10895371|FG000|Overall Study|Adverse Event|1
6882411|NCT00542386|10895372|FG001|Overall Study|Adverse Event|7
6882412|NCT00542386|10895373|FG002|Overall Study|Adverse Event|7
6882413|NCT00542386|10895374|FG003|Overall Study|Adverse Event|8
6882414|NCT00542386|10895375|FG004|Overall Study|Adverse Event|13
6882415|NCT00542386|10895376|FG005|Overall Study|Adverse Event|4
6882416|NCT00542386|10895371|FG000|Overall Study|Death|0
6882417|NCT00542386|10895372|FG001|Overall Study|Death|0
6882418|NCT00542386|10895373|FG002|Overall Study|Death|1
6882419|NCT00542386|10895374|FG003|Overall Study|Death|2
6882420|NCT00542386|10895375|FG004|Overall Study|Death|1
6882421|NCT00542386|10895376|FG005|Overall Study|Death|2
6882422|NCT00542386|10895371|FG000|Overall Study|Lack of Efficacy|32
6882423|NCT00542386|10895372|FG001|Overall Study|Lack of Efficacy|12
6882424|NCT00542386|10895373|FG002|Overall Study|Lack of Efficacy|10
6882425|NCT00542386|10895374|FG003|Overall Study|Lack of Efficacy|13
6882426|NCT00542386|10895375|FG004|Overall Study|Lack of Efficacy|7
6882427|NCT00542386|10895376|FG005|Overall Study|Lack of Efficacy|31
6882428|NCT00542386|10895371|FG000|Overall Study|Physician Decision|1
7079039|NCT02108262|11187711|FG003|Overall Study|Randomized by error/screen failure|0
6882429|NCT00542386|10895372|FG001|Overall Study|Physician Decision|0
6882430|NCT00542386|10895373|FG002|Overall Study|Physician Decision|0
6882431|NCT00542386|10895374|FG003|Overall Study|Physician Decision|1
6882432|NCT00542386|10895375|FG004|Overall Study|Physician Decision|0
6882433|NCT00542386|10895376|FG005|Overall Study|Physician Decision|0
6882434|NCT00542386|10895371|FG000|Overall Study|Protocol Violation|0
6882435|NCT00542386|10895372|FG001|Overall Study|Protocol Violation|0
6882436|NCT00542386|10895373|FG002|Overall Study|Protocol Violation|1
6882437|NCT00542386|10895374|FG003|Overall Study|Protocol Violation|0
6882438|NCT00542386|10895375|FG004|Overall Study|Protocol Violation|0
6882439|NCT00542386|10895376|FG005|Overall Study|Protocol Violation|4
6882440|NCT00542386|10895371|FG000|Overall Study|Withdrawal by Subject|5
6882441|NCT00542386|10895372|FG001|Overall Study|Withdrawal by Subject|8
6882442|NCT00542386|10895373|FG002|Overall Study|Withdrawal by Subject|10
6882443|NCT00542386|10895374|FG003|Overall Study|Withdrawal by Subject|11
6882444|NCT00542386|10895375|FG004|Overall Study|Withdrawal by Subject|15
6882445|NCT00542386|10895376|FG005|Overall Study|Withdrawal by Subject|7
6882446|NCT00542386|10895371|FG000|Overall Study|Other Reasons|4
6882447|NCT00542386|10895372|FG001|Overall Study|Other Reasons|1
6882448|NCT00542386|10895373|FG002|Overall Study|Other Reasons|4
6882449|NCT00542386|10895374|FG003|Overall Study|Other Reasons|3
6882450|NCT00542386|10895375|FG004|Overall Study|Other Reasons|4
6882451|NCT00542386|10895376|FG005|Overall Study|Other Reasons|2
6882452|NCT00542425|10895395|FG000|Initial 24 Weeks|Administrative reasons|0
6882453|NCT00542425|10895396|FG001|Initial 24 Weeks|Administrative reasons|0
6882454|NCT00542425|10895397|FG002|Initial 24 Weeks|Administrative reasons|1
6882455|NCT00542425|10895398|FG003|Initial 24 Weeks|Administrative reasons|1
6882456|NCT00542425|10895399|FG004|Initial 24 Weeks|Administrative reasons|0
7079040|NCT02108262|11187708|FG000|Overall Study|Distance to center|0
7079041|NCT02108262|11187709|FG001|Overall Study|Distance to center|1
7079042|NCT02108262|11187710|FG002|Overall Study|Distance to center|1
6882457|NCT00542425|10895395|FG000|Initial 24 Weeks|Adverse Event|0
6882458|NCT00542425|10895396|FG001|Initial 24 Weeks|Adverse Event|1
6882459|NCT00542425|10895397|FG002|Initial 24 Weeks|Adverse Event|1
6882460|NCT00542425|10895398|FG003|Initial 24 Weeks|Adverse Event|3
6882461|NCT00542425|10895399|FG004|Initial 24 Weeks|Adverse Event|2
6882462|NCT00542425|10895395|FG000|Initial 24 Weeks|Inability to complete procedures|0
6882463|NCT00542425|10895396|FG001|Initial 24 Weeks|Inability to complete procedures|3
6882464|NCT00542425|10895397|FG002|Initial 24 Weeks|Inability to complete procedures|2
6882465|NCT00542425|10895398|FG003|Initial 24 Weeks|Inability to complete procedures|1
6882466|NCT00542425|10895399|FG004|Initial 24 Weeks|Inability to complete procedures|2
6882467|NCT00542425|10895395|FG000|Initial 24 Weeks|Lost to Follow-up|2
6882468|NCT00542425|10895396|FG001|Initial 24 Weeks|Lost to Follow-up|2
6882469|NCT00542425|10895397|FG002|Initial 24 Weeks|Lost to Follow-up|1
6882470|NCT00542425|10895398|FG003|Initial 24 Weeks|Lost to Follow-up|0
6882471|NCT00542425|10895399|FG004|Initial 24 Weeks|Lost to Follow-up|0
6882472|NCT00542425|10895395|FG000|Initial 24 Weeks|Non-compliance|0
6882473|NCT00542425|10895396|FG001|Initial 24 Weeks|Non-compliance|0
6882474|NCT00542425|10895397|FG002|Initial 24 Weeks|Non-compliance|0
6882475|NCT00542425|10895398|FG003|Initial 24 Weeks|Non-compliance|1
6882476|NCT00542425|10895399|FG004|Initial 24 Weeks|Non-compliance|1
6882477|NCT00542425|10895395|FG000|Initial 24 Weeks|Protocol Violation|0
6882478|NCT00542425|10895396|FG001|Initial 24 Weeks|Protocol Violation|0
6882479|NCT00542425|10895397|FG002|Initial 24 Weeks|Protocol Violation|0
6882480|NCT00542425|10895398|FG003|Initial 24 Weeks|Protocol Violation|1
6882481|NCT00542425|10895399|FG004|Initial 24 Weeks|Protocol Violation|0
6882482|NCT00542425|10895395|FG000|Initial 24 Weeks|Refusal of treatment|2
6882483|NCT00542425|10895396|FG001|Initial 24 Weeks|Refusal of treatment|2
6882484|NCT00542425|10895397|FG002|Initial 24 Weeks|Refusal of treatment|1
6882485|NCT00542425|10895398|FG003|Initial 24 Weeks|Refusal of treatment|4
6882486|NCT00542425|10895399|FG004|Initial 24 Weeks|Refusal of treatment|1
6882487|NCT00542425|10895395|FG000|Initial 24 Weeks|Other|0
6882488|NCT00542425|10895396|FG001|Initial 24 Weeks|Other|2
6882489|NCT00542425|10895397|FG002|Initial 24 Weeks|Other|1
6882490|NCT00542425|10895398|FG003|Initial 24 Weeks|Other|0
6882491|NCT00542425|10895399|FG004|Initial 24 Weeks|Other|0
6882492|NCT00542425|10895395|FG000|Extended 24 Weeks of Treatment|Adverse Event|0
6882493|NCT00542425|10895396|FG001|Extended 24 Weeks of Treatment|Adverse Event|0
6882494|NCT00542425|10895397|FG002|Extended 24 Weeks of Treatment|Adverse Event|1
6882495|NCT00542425|10895398|FG003|Extended 24 Weeks of Treatment|Adverse Event|1
6882496|NCT00542425|10895399|FG004|Extended 24 Weeks of Treatment|Adverse Event|0
6882497|NCT00542425|10895395|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0
6882498|NCT00542425|10895396|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0
6882499|NCT00542425|10895397|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1
6882500|NCT00542425|10895398|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0
6882501|NCT00542425|10895399|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0
6882502|NCT00542425|10895395|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0
6882503|NCT00542425|10895396|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1
6882504|NCT00542425|10895397|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0
6882505|NCT00542425|10895398|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0
6882506|NCT00542425|10895399|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0
6882507|NCT00542425|10895395|FG000|Extended 24 Weeks of Treatment|Other|1
6882508|NCT00542425|10895396|FG001|Extended 24 Weeks of Treatment|Other|1
6882509|NCT00542425|10895397|FG002|Extended 24 Weeks of Treatment|Other|0
6882510|NCT00542425|10895398|FG003|Extended 24 Weeks of Treatment|Other|0
6882511|NCT00542425|10895399|FG004|Extended 24 Weeks of Treatment|Other|1
6882512|NCT00542789|10895430|FG000|Overall Study|Adverse Event|18
6882513|NCT00542789|10895431|FG001|Overall Study|Adverse Event|17
6882514|NCT00542789|10895430|FG000|Overall Study|Withdrawal by Subject|7
6882515|NCT00542789|10895431|FG001|Overall Study|Withdrawal by Subject|3
6882516|NCT00542789|10895430|FG000|Overall Study|Protocol Violation|8
6882517|NCT00542789|10895431|FG001|Overall Study|Protocol Violation|1
6882518|NCT00542789|10895430|FG000|Overall Study|Recurrence of Gastric Ulcer|8
6882519|NCT00542789|10895431|FG001|Overall Study|Recurrence of Gastric Ulcer|57
6882520|NCT00542815|10895440|FG000|Overall Study|Adverse Event|19
6882521|NCT00542815|10895441|FG001|Overall Study|Adverse Event|6
6882522|NCT00542815|10895442|FG002|Overall Study|Adverse Event|9
6882523|NCT00542815|10895440|FG000|Overall Study|Death|10
6882524|NCT00542815|10895441|FG001|Overall Study|Death|7
6882525|NCT00542815|10895442|FG002|Overall Study|Death|3
6882526|NCT00542815|10895440|FG000|Overall Study|Lack of Efficacy|9
6882527|NCT00542815|10895441|FG001|Overall Study|Lack of Efficacy|2
6882528|NCT00542815|10895442|FG002|Overall Study|Lack of Efficacy|0
6882529|NCT00542815|10895440|FG000|Overall Study|Physician Decision|2
6882530|NCT00542815|10895441|FG001|Overall Study|Physician Decision|1
6882531|NCT00542815|10895442|FG002|Overall Study|Physician Decision|0
6882532|NCT00542815|10895440|FG000|Overall Study|Protocol Violation|1
6882533|NCT00542815|10895441|FG001|Overall Study|Protocol Violation|1
6882534|NCT00542815|10895442|FG002|Overall Study|Protocol Violation|2
6882535|NCT00542815|10895440|FG000|Overall Study|Withdrawal by Subject|41
6882536|NCT00542815|10895441|FG001|Overall Study|Withdrawal by Subject|5
6882537|NCT00542815|10895442|FG002|Overall Study|Withdrawal by Subject|8
6882538|NCT00542815|10895440|FG000|Overall Study|Other reasons|24
6882539|NCT00542815|10895441|FG001|Overall Study|Other reasons|10
6882540|NCT00542815|10895442|FG002|Overall Study|Other reasons|10
6882541|NCT00542828|10895450|FG000|Overall Study|Physician Decision|1
6882542|NCT00542828|10895450|FG000|Overall Study|Need for Prohibited Treatment|3
6882543|NCT00542828|10895450|FG000|Overall Study|Study Prematurely Discontinued|7
6882544|NCT00542828|10895450|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2
6882545|NCT00542880|10895456|FG000|Period 1|Eligibility criteria not fulfilled|2
6882546|NCT00542880|10895457|FG001|Period 1|Eligibility criteria not fulfilled|6
6882547|NCT00542880|10895456|FG000|Period 1|Adverse Event|2
6882548|NCT00542880|10895457|FG001|Period 1|Adverse Event|2
6882549|NCT00542880|10895456|FG000|Period 1|Development of study-specific criteria|1
6882550|NCT00542880|10895457|FG001|Period 1|Development of study-specific criteria|2
6882551|NCT00542880|10895456|FG000|Period 1|Withdrawal by Subject|1
6882552|NCT00542880|10895457|FG001|Period 1|Withdrawal by Subject|1
6882553|NCT00542880|10895456|FG000|Period 1|Protocol Violation|0
6882554|NCT00542880|10895457|FG001|Period 1|Protocol Violation|1
6882555|NCT00542880|10895456|FG000|Period 2|Adverse Event|5
6882556|NCT00542880|10895457|FG001|Period 2|Adverse Event|7
6882557|NCT00542880|10895456|FG000|Period 2|Eligibility not fulfilled|0
6882558|NCT00542880|10895457|FG001|Period 2|Eligibility not fulfilled|1
6882559|NCT00542880|10895456|FG000|Period 2|Discontinuation criteria|2
6882560|NCT00542880|10895457|FG001|Period 2|Discontinuation criteria|0
6882561|NCT00542880|10895456|FG000|Period 2|Severe non-compliance|0
6882562|NCT00542880|10895457|FG001|Period 2|Severe non-compliance|1
6882563|NCT00542880|10895456|FG000|Period 2|Other|0
6882564|NCT00542880|10895457|FG001|Period 2|Other|1
6882565|NCT00542880|10895456|FG000|Period 3|Adverse Event|0
6882566|NCT00542880|10895457|FG001|Period 3|Adverse Event|2
6882567|NCT00542919|10895467|FG000|Overall Study|Adverse Event|1
6882568|NCT00542919|10895468|FG001|Overall Study|Adverse Event|5
6882569|NCT00542919|10895469|FG002|Overall Study|Adverse Event|1
6882570|NCT00542919|10895467|FG000|Overall Study|Withdrawal by Subject|1
6882571|NCT00542919|10895468|FG001|Overall Study|Withdrawal by Subject|0
6882572|NCT00542919|10895469|FG002|Overall Study|Withdrawal by Subject|3
6882573|NCT00542919|10895467|FG000|Overall Study|Physician Decision|2
6882574|NCT00542919|10895468|FG001|Overall Study|Physician Decision|2
6882575|NCT00542919|10895469|FG002|Overall Study|Physician Decision|1
6882576|NCT00542919|10895467|FG000|Overall Study|Sponsor Decision|1
6882577|NCT00542919|10895468|FG001|Overall Study|Sponsor Decision|0
6882578|NCT00542919|10895469|FG002|Overall Study|Sponsor Decision|0
6882579|NCT00542919|10895467|FG000|Overall Study|Lost to Follow-up|2
6882580|NCT00542919|10895468|FG001|Overall Study|Lost to Follow-up|0
6882581|NCT00542919|10895469|FG002|Overall Study|Lost to Follow-up|1
6882582|NCT00542997|10895496|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2
6882583|NCT00542997|10895496|FG000|Wash in / Wash Out Period|Adverse Event|3
6882584|NCT00542997|10895496|FG000|Efficacy Period|Adverse Event|3
6882585|NCT00543062|10895503|FG000|Overall Study|Withdrawal by Subject|1
6882586|NCT00543062|10895504|FG001|Overall Study|Withdrawal by Subject|0
6882587|NCT00543062|10895505|FG002|Overall Study|Withdrawal by Subject|2
6882588|NCT00543062|10895506|FG003|Overall Study|Withdrawal by Subject|0
6882589|NCT00543062|10895503|FG000|Overall Study|Adverse Event|0
6882590|NCT00543062|10895504|FG001|Overall Study|Adverse Event|1
6882591|NCT00543062|10895505|FG002|Overall Study|Adverse Event|1
6882592|NCT00543062|10895506|FG003|Overall Study|Adverse Event|1
6882593|NCT00543062|10895503|FG000|Overall Study|Protocol Violation|1
6882594|NCT00543062|10895504|FG001|Overall Study|Protocol Violation|0
6969690|NCT01149421|11019370|FG001|Overall Study|Physician Decision|3
6969691|NCT01149421|11019371|FG002|Overall Study|Physician Decision|6
6969692|NCT01149421|11019369|FG000|Overall Study|Entry Criteria Not Met|1
6969693|NCT01149421|11019370|FG001|Overall Study|Entry Criteria Not Met|1
6969694|NCT01149421|11019371|FG002|Overall Study|Entry Criteria Not Met|2
7155627|NCT03345407|11323715|FG000|Overall Study|Withdrawal by Subject|11
6969695|NCT01149421|11019369|FG000|Overall Study|Protocol Violation|2
6969696|NCT01149421|11019370|FG001|Overall Study|Protocol Violation|2
6969697|NCT01149421|11019371|FG002|Overall Study|Protocol Violation|6
6969698|NCT01149460|11019391|FG000|Overall Study|Withdrawal by Subject|0
6969699|NCT01149460|11019392|FG001|Overall Study|Withdrawal by Subject|2
6969700|NCT01149473|11019400|FG000|First Intervention|Adverse Event|1
6969701|NCT01149473|11019401|FG001|First Intervention|Adverse Event|1
6969702|NCT01149473|11019400|FG000|Washout of 7 Days|Withdrawal by Subject|1
6969703|NCT01149473|11019401|FG001|Washout of 7 Days|Withdrawal by Subject|1
6969704|NCT01149486|11019409|FG000|First Intervention|Adverse Event|0
6969705|NCT01149486|11019410|FG001|First Intervention|Adverse Event|1
6969706|NCT01149538|11019422|FG000|Overall Study|Lost to Follow-up|0
6969707|NCT01149538|11019423|FG001|Overall Study|Lost to Follow-up|1
6969708|NCT01149538|11019422|FG000|Overall Study|Withdrawal by Subject|5
6969709|NCT01149538|11019423|FG001|Overall Study|Withdrawal by Subject|3
6969710|NCT01149655|11019442|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1
6969711|NCT01149655|11019443|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0
6969712|NCT01149655|11019444|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0
6969713|NCT01149655|11019445|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0
6969714|NCT01149655|11019442|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4
6969715|NCT01149655|11019443|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
6969716|NCT01149655|11019444|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
6969717|NCT01149655|11019445|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
7155628|NCT03345407|11323716|FG001|Overall Study|Withdrawal by Subject|1
6882595|NCT00543062|10895505|FG002|Overall Study|Protocol Violation|0
6882596|NCT00543062|10895506|FG003|Overall Study|Protocol Violation|0
6882597|NCT00543140|10895543|FG000|Overall Study|Lost to Follow-up|33
6882598|NCT00543140|10895543|FG000|Overall Study|Withdrawal by Subject|13
6882599|NCT00543140|10895543|FG000|Overall Study|Protocol Violation|10
6882600|NCT00543140|10895543|FG000|Overall Study|Insufficient weight loss|10
6882601|NCT00543140|10895543|FG000|Overall Study|SAE leading to explant of SAGB|3
6882602|NCT00543140|10895543|FG000|Overall Study|Death|1
6882603|NCT00543140|10895543|FG000|Overall Study|Subject moved|1
6882604|NCT00543140|10895543|FG000|Overall Study|Conversion to different procedure|1
6882605|NCT00543296|10895547|FG000|Overall Study|Physician Decision|7
6882606|NCT00543309|10895554|FG000|Overall Study|Physician Decision|0
6882607|NCT00543309|10895555|FG001|Overall Study|Physician Decision|1
6882608|NCT00543309|10895556|FG002|Overall Study|Physician Decision|0
6882609|NCT00543387|10895574|FG000|Panel 1 + Panel 2|Adverse Event|0
6882610|NCT00543387|10895575|FG001|Panel 1 + Panel 2|Adverse Event|1
6882611|NCT00543387|10895576|FG002|Panel 1 + Panel 2|Adverse Event|0
6882612|NCT00543387|10895577|FG003|Panel 1 + Panel 2|Adverse Event|0
6882613|NCT00543387|10895578|FG004|Panel 1 + Panel 2|Adverse Event|0
6882614|NCT00543387|10895579|FG005|Panel 1 + Panel 2|Adverse Event|0
6882615|NCT00543387|10895580|FG006|Panel 1 + Panel 2|Adverse Event|0
6882616|NCT00543387|10895581|FG007|Panel 1 + Panel 2|Adverse Event|1
6882617|NCT00543387|10895582|FG008|Panel 1 + Panel 2|Adverse Event|1
6882618|NCT00543387|10895583|FG009|Panel 1 + Panel 2|Adverse Event|0
6882619|NCT00543387|10895584|FG010|Panel 1 + Panel 2|Adverse Event|0
6882620|NCT00543387|10895574|FG000|Panel 1 + Panel 2|Physician Decision|0
6882621|NCT00543387|10895575|FG001|Panel 1 + Panel 2|Physician Decision|0
6882622|NCT00543387|10895576|FG002|Panel 1 + Panel 2|Physician Decision|1
6882623|NCT00543387|10895577|FG003|Panel 1 + Panel 2|Physician Decision|0
6882624|NCT00543387|10895578|FG004|Panel 1 + Panel 2|Physician Decision|0
6882625|NCT00543387|10895579|FG005|Panel 1 + Panel 2|Physician Decision|0
6882626|NCT00543387|10895580|FG006|Panel 1 + Panel 2|Physician Decision|0
6882627|NCT00543387|10895581|FG007|Panel 1 + Panel 2|Physician Decision|1
6882628|NCT00543387|10895582|FG008|Panel 1 + Panel 2|Physician Decision|0
6882629|NCT00543387|10895583|FG009|Panel 1 + Panel 2|Physician Decision|0
6882630|NCT00543387|10895584|FG010|Panel 1 + Panel 2|Physician Decision|0
6882631|NCT00543387|10895574|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3
6882632|NCT00543387|10895575|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2
6882633|NCT00543387|10895576|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2
6882634|NCT00543387|10895577|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3
6882635|NCT00543387|10895578|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3
6882636|NCT00543387|10895579|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3
6882637|NCT00543387|10895580|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5
6882638|NCT00543387|10895581|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4
6882639|NCT00543387|10895582|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4
6882640|NCT00543387|10895583|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0
6882641|NCT00543387|10895584|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0
6882642|NCT00543387|10895574|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0
6882643|NCT00543387|10895575|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0
6882644|NCT00543387|10895576|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0
6882645|NCT00543387|10895577|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0
6882646|NCT00543387|10895578|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0
6882647|NCT00543387|10895579|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0
6882648|NCT00543387|10895580|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1
6882649|NCT00543387|10895581|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0
6882650|NCT00543387|10895582|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0
6882651|NCT00543387|10895583|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0
6882652|NCT00543387|10895584|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0
6882653|NCT00543387|10895574|FG000|Crossover Participants|Progressive Disease|0
6882654|NCT00543387|10895575|FG001|Crossover Participants|Progressive Disease|0
6882655|NCT00543387|10895576|FG002|Crossover Participants|Progressive Disease|0
6882656|NCT00543387|10895577|FG003|Crossover Participants|Progressive Disease|0
6882657|NCT00543387|10895578|FG004|Crossover Participants|Progressive Disease|0
6882658|NCT00543387|10895579|FG005|Crossover Participants|Progressive Disease|0
6882659|NCT00543387|10895580|FG006|Crossover Participants|Progressive Disease|0
6882660|NCT00543387|10895581|FG007|Crossover Participants|Progressive Disease|0
6882661|NCT00543387|10895582|FG008|Crossover Participants|Progressive Disease|0
6882662|NCT00543387|10895583|FG009|Crossover Participants|Progressive Disease|1
6882663|NCT00543387|10895584|FG010|Crossover Participants|Progressive Disease|2
6882664|NCT00543387|10895574|FG000|Crossover Participants|Study Terminated by Sponsor|0
6882665|NCT00543387|10895575|FG001|Crossover Participants|Study Terminated by Sponsor|0
6882666|NCT00543387|10895576|FG002|Crossover Participants|Study Terminated by Sponsor|0
6882667|NCT00543387|10895577|FG003|Crossover Participants|Study Terminated by Sponsor|0
6882668|NCT00543387|10895578|FG004|Crossover Participants|Study Terminated by Sponsor|0
6882669|NCT00543387|10895579|FG005|Crossover Participants|Study Terminated by Sponsor|0
6882670|NCT00543387|10895580|FG006|Crossover Participants|Study Terminated by Sponsor|0
6882671|NCT00543387|10895581|FG007|Crossover Participants|Study Terminated by Sponsor|0
6882672|NCT00543387|10895582|FG008|Crossover Participants|Study Terminated by Sponsor|0
6882673|NCT00543387|10895583|FG009|Crossover Participants|Study Terminated by Sponsor|0
6882674|NCT00543387|10895584|FG010|Crossover Participants|Study Terminated by Sponsor|1
6882675|NCT00543439|10895628|FG000|Period 1|Adverse Event|0
6882676|NCT00543439|10895629|FG001|Period 1|Adverse Event|2
6882677|NCT00543439|10895630|FG002|Period 1|Adverse Event|1
6882678|NCT00543439|10895628|FG000|Period 1|Withdrawal by Subject|1
6882679|NCT00543439|10895629|FG001|Period 1|Withdrawal by Subject|1
6882680|NCT00543439|10895630|FG002|Period 1|Withdrawal by Subject|0
6882681|NCT00543439|10895628|FG000|Period 1|Physician Decision|0
6882682|NCT00543439|10895629|FG001|Period 1|Physician Decision|0
6882683|NCT00543439|10895630|FG002|Period 1|Physician Decision|1
6882684|NCT00543439|10895628|FG000|Period 2|Protocol Violation|1
6882685|NCT00543439|10895629|FG001|Period 2|Protocol Violation|0
6882686|NCT00543439|10895630|FG002|Period 2|Protocol Violation|1
6882687|NCT00543439|10895628|FG000|Period 2|Adverse Event|0
6882688|NCT00543439|10895629|FG001|Period 2|Adverse Event|1
6882689|NCT00543439|10895630|FG002|Period 2|Adverse Event|1
6882690|NCT00543543|10895651|FG000|Base Study|Adverse Event|1
6882691|NCT00543543|10895652|FG001|Base Study|Adverse Event|11
6882692|NCT00543543|10895653|FG002|Base Study|Adverse Event|0
6882693|NCT00543543|10895654|FG003|Base Study|Adverse Event|5
6882694|NCT00543543|10895651|FG000|Base Study|Lost to Follow-up|12
6882695|NCT00543543|10895652|FG001|Base Study|Lost to Follow-up|749
6882696|NCT00543543|10895653|FG002|Base Study|Lost to Follow-up|9
6882697|NCT00543543|10895654|FG003|Base Study|Lost to Follow-up|701
6882698|NCT00543543|10895651|FG000|Base Study|Physician Decision|0
6882699|NCT00543543|10895652|FG001|Base Study|Physician Decision|4
6882700|NCT00543543|10895653|FG002|Base Study|Physician Decision|0
6882701|NCT00543543|10895654|FG003|Base Study|Physician Decision|7
6882702|NCT00543543|10895651|FG000|Base Study|Protocol Violation|0
6882703|NCT00543543|10895652|FG001|Base Study|Protocol Violation|6
6882704|NCT00543543|10895653|FG002|Base Study|Protocol Violation|0
6882705|NCT00543543|10895654|FG003|Base Study|Protocol Violation|6
6882706|NCT00543543|10895651|FG000|Base Study|Withdrawal by Subject|7
6882707|NCT00543543|10895652|FG001|Base Study|Withdrawal by Subject|482
6882708|NCT00543543|10895653|FG002|Base Study|Withdrawal by Subject|5
6882709|NCT00543543|10895654|FG003|Base Study|Withdrawal by Subject|503
6882710|NCT00543543|10895651|FG000|Extension Study|Adverse Event|0
6882711|NCT00543543|10895652|FG001|Extension Study|Adverse Event|0
6882712|NCT00543543|10895653|FG002|Extension Study|Adverse Event|0
6882713|NCT00543543|10895654|FG003|Extension Study|Adverse Event|5
6882714|NCT00543543|10895651|FG000|Extension Study|Lost to Follow-up|0
6882715|NCT00543543|10895652|FG001|Extension Study|Lost to Follow-up|0
6882716|NCT00543543|10895653|FG002|Extension Study|Lost to Follow-up|0
6882717|NCT00543543|10895654|FG003|Extension Study|Lost to Follow-up|77
6882718|NCT00543543|10895651|FG000|Extension Study|Physician Decision|0
6882719|NCT00543543|10895652|FG001|Extension Study|Physician Decision|0
6882720|NCT00543543|10895653|FG002|Extension Study|Physician Decision|0
6882721|NCT00543543|10895654|FG003|Extension Study|Physician Decision|7
6882722|NCT00543543|10895651|FG000|Extension Study|Pregnancy|0
6882723|NCT00543543|10895652|FG001|Extension Study|Pregnancy|0
6882724|NCT00543543|10895653|FG002|Extension Study|Pregnancy|0
6882725|NCT00543543|10895654|FG003|Extension Study|Pregnancy|6
6882726|NCT00543543|10895651|FG000|Extension Study|Protocol Violation|0
6882727|NCT00543543|10895652|FG001|Extension Study|Protocol Violation|0
6882728|NCT00543543|10895653|FG002|Extension Study|Protocol Violation|0
6882729|NCT00543543|10895654|FG003|Extension Study|Protocol Violation|11
6882730|NCT00543543|10895651|FG000|Extension Study|Withdrawal by Subject|0
6882731|NCT00543543|10895652|FG001|Extension Study|Withdrawal by Subject|0
6882732|NCT00543543|10895653|FG002|Extension Study|Withdrawal by Subject|0
6882733|NCT00543543|10895654|FG003|Extension Study|Withdrawal by Subject|120
6882734|NCT00543569|10895673|FG000|Overall Study|Death|2
6882735|NCT00543569|10895674|FG001|Overall Study|Death|2
6882736|NCT00543569|10895675|FG002|Overall Study|Death|3
6882737|NCT00543569|10895676|FG003|Overall Study|Death|1
6882738|NCT00543569|10895673|FG000|Overall Study|Lost to Follow-up|0
6882739|NCT00543569|10895674|FG001|Overall Study|Lost to Follow-up|0
6882740|NCT00543569|10895675|FG002|Overall Study|Lost to Follow-up|1
6882741|NCT00543569|10895676|FG003|Overall Study|Lost to Follow-up|1
6882742|NCT00543569|10895673|FG000|Overall Study|Miscellaneous Reasons|7
6882743|NCT00543569|10895674|FG001|Overall Study|Miscellaneous Reasons|3
6882744|NCT00543569|10895675|FG002|Overall Study|Miscellaneous Reasons|11
6882745|NCT00543569|10895676|FG003|Overall Study|Miscellaneous Reasons|4
6882746|NCT00543569|10895673|FG000|Overall Study|Randomized but never received study drug|3
6882747|NCT00543569|10895674|FG001|Overall Study|Randomized but never received study drug|3
6882748|NCT00543569|10895675|FG002|Overall Study|Randomized but never received study drug|5
6882749|NCT00543569|10895676|FG003|Overall Study|Randomized but never received study drug|3
6882750|NCT00543725|10895688|FG000|Overall Study|Adverse Event|18
6882751|NCT00543725|10895689|FG001|Overall Study|Adverse Event|27
6882752|NCT00543725|10895688|FG000|Overall Study|Sponsor's Decision|0
6882753|NCT00543725|10895689|FG001|Overall Study|Sponsor's Decision|1
6882754|NCT00543725|10895688|FG000|Overall Study|Subject Non-Compliant|4
6882755|NCT00543725|10895689|FG001|Overall Study|Subject Non-Compliant|4
6882756|NCT00543725|10895688|FG000|Overall Study|Subject Ineligible To Continue The Trial|2
6882757|NCT00543725|10895689|FG001|Overall Study|Subject Ineligible To Continue The Trial|0
6882758|NCT00543725|10895688|FG000|Overall Study|Subject Reached A Virologic Endpoint|22
6882759|NCT00543725|10895689|FG001|Overall Study|Subject Reached A Virologic Endpoint|14
6882760|NCT00543725|10895688|FG000|Overall Study|Protocol Violation|0
6882761|NCT00543725|10895689|FG001|Overall Study|Protocol Violation|1
6882762|NCT00543725|10895688|FG000|Overall Study|Withdrawal by Subject|4
6882763|NCT00543725|10895689|FG001|Overall Study|Withdrawal by Subject|13
6882764|NCT00543725|10895688|FG000|Overall Study|Lost to Follow-up|15
6882765|NCT00543725|10895689|FG001|Overall Study|Lost to Follow-up|11
6882766|NCT00543725|10895688|FG000|Overall Study|Other|3
6882767|NCT00543725|10895689|FG001|Overall Study|Other|3
6882768|NCT00543803|10895708|FG000|Overall Study|Adverse Event|14
6882769|NCT00543803|10895708|FG000|Overall Study|Lack of Efficacy|22
6882770|NCT00543803|10895708|FG000|Overall Study|Lost to Follow-up|20
6882771|NCT00543803|10895708|FG000|Overall Study|Other|86
6882772|NCT00543855|10895718|FG000|Overall Study|Adverse Event|3
6882773|NCT00543855|10895719|FG001|Overall Study|Adverse Event|1
6882774|NCT00543855|10895720|FG002|Overall Study|Adverse Event|3
6882775|NCT00543855|10895721|FG003|Overall Study|Adverse Event|4
6882776|NCT00543855|10895718|FG000|Overall Study|Lost to Follow-up|0
6882777|NCT00543855|10895719|FG001|Overall Study|Lost to Follow-up|0
6882778|NCT00543855|10895720|FG002|Overall Study|Lost to Follow-up|1
6882779|NCT00543855|10895721|FG003|Overall Study|Lost to Follow-up|0
6882780|NCT00543855|10895718|FG000|Overall Study|Withdrawal by Subject|0
6882781|NCT00543855|10895719|FG001|Overall Study|Withdrawal by Subject|1
6882782|NCT00543855|10895720|FG002|Overall Study|Withdrawal by Subject|2
6882783|NCT00543855|10895721|FG003|Overall Study|Withdrawal by Subject|0
6882784|NCT00543855|10895718|FG000|Overall Study|Protocol Violation|1
6882785|NCT00543855|10895719|FG001|Overall Study|Protocol Violation|0
6882786|NCT00543855|10895720|FG002|Overall Study|Protocol Violation|0
6882787|NCT00543855|10895721|FG003|Overall Study|Protocol Violation|0
6882788|NCT00543985|10895731|FG000|Overall Study|Withdrawal by Subject|4
6882789|NCT00544167|10895752|FG000|Overall Study|Adverse Event|21
6882790|NCT00544167|10895752|FG000|Overall Study|Physician Decision|8
6882791|NCT00544440|10895756|FG000|Overall Study|Other|1
6882792|NCT00544440|10895756|FG000|Overall Study|Adverse Event|1
6882793|NCT00544440|10895756|FG000|Overall Study|Withdrawal by Subject|2
6882794|NCT00544440|10895756|FG000|Overall Study|Subject Non-compliance|1
6882795|NCT00544440|10895756|FG000|Overall Study|Progressive Disease|47
6882796|NCT00544440|10895756|FG000|Overall Study|Other|5
6882797|NCT00544544|10895760|FG000|Overall Study|Withdrawal by Subject|1
6882798|NCT00544544|10895760|FG000|Overall Study|Adverse Event|1
6882799|NCT00544544|10895760|FG000|Overall Study|Lost to Follow-up|1
6882800|NCT00544557|10895764|FG000|Overall Study|Adverse Event|140
6882801|NCT00544557|10895764|FG000|Overall Study|Lack of Efficacy|196
6882802|NCT00544557|10895764|FG000|Overall Study|Other|98
6882803|NCT00544648|10895770|FG000|Overall Study|Withdrawal by Subject|1
6882804|NCT00544648|10895771|FG001|Overall Study|Withdrawal by Subject|0
6882805|NCT00544648|10895770|FG000|Overall Study|Adverse Event|1
6882806|NCT00544648|10895771|FG001|Overall Study|Adverse Event|1
6882807|NCT00544648|10895770|FG000|Overall Study|progression of disease|1
6882808|NCT00544648|10895771|FG001|Overall Study|progression of disease|0
6882809|NCT00544817|10895796|FG000|Combined Modality|Lack of Efficacy|2
6882810|NCT00544817|10895796|FG000|Combined Modality|Worsening Neurologic Symptoms|2
6882811|NCT00544817|10895796|FG000|Combined Modality|Adverse Event|2
6882812|NCT00544817|10895796|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1
6882813|NCT00544817|10895796|FG000|No Treatment Interval|Lack of Efficacy|8
6882814|NCT00544817|10895796|FG000|No Treatment Interval|Physician Decision|3
6882815|NCT00544817|10895796|FG000|No Treatment Interval|Adverse Event|1
6882816|NCT00544817|10895796|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15
6882817|NCT00544817|10895796|FG000|Follow-up Systemic Therapy|Physician Decision|3
6882818|NCT00544817|10895796|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1
6882819|NCT00544869|10895803|FG000|Overall Study|Rsolution of congenitive symptoms|3
6882820|NCT00544869|10895804|FG001|Overall Study|Rsolution of congenitive symptoms|0
6882821|NCT00544869|10895805|FG002|Overall Study|Rsolution of congenitive symptoms|0
6882822|NCT00544869|10895803|FG000|Overall Study|Adverse Event|6
6882823|NCT00544869|10895804|FG001|Overall Study|Adverse Event|1
6882824|NCT00544869|10895805|FG002|Overall Study|Adverse Event|0
6882825|NCT00544869|10895803|FG000|Overall Study|Lack of Efficacy|1
6882826|NCT00544869|10895804|FG001|Overall Study|Lack of Efficacy|1
6882827|NCT00544869|10895805|FG002|Overall Study|Lack of Efficacy|0
6882828|NCT00544869|10895803|FG000|Overall Study|Physician Decision|2
6882829|NCT00544869|10895804|FG001|Overall Study|Physician Decision|0
6882830|NCT00544869|10895805|FG002|Overall Study|Physician Decision|0
6882831|NCT00544882|10895815|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2
6882832|NCT00544882|10895816|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
6882833|NCT00544882|10895817|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
6882834|NCT00544882|10895815|FG000|Cycle 1: Run-in Cycle|Adverse Event|1
6882835|NCT00544882|10895816|FG001|Cycle 1: Run-in Cycle|Adverse Event|0
6882836|NCT00544882|10895817|FG002|Cycle 1: Run-in Cycle|Adverse Event|0
6882837|NCT00544882|10895815|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
6882838|NCT00544882|10895816|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1
6882839|NCT00544882|10895817|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
6882840|NCT00544882|10895815|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
6882841|NCT00544882|10895816|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
6882842|NCT00544882|10895817|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1
6882843|NCT00544882|10895815|FG000|Cycle 3: Follow-up|Noncompliance|0
6882844|NCT00544882|10895816|FG001|Cycle 3: Follow-up|Noncompliance|1
6882845|NCT00544882|10895817|FG002|Cycle 3: Follow-up|Noncompliance|0
6882846|NCT00544882|10895815|FG000|Cycle 3: Follow-up|Pregnancy|0
6882847|NCT00544882|10895816|FG001|Cycle 3: Follow-up|Pregnancy|1
6882848|NCT00544882|10895817|FG002|Cycle 3: Follow-up|Pregnancy|0
6882849|NCT00545051|10895838|FG000|Overall Study|Adverse Event|7
6882850|NCT00545051|10895839|FG001|Overall Study|Adverse Event|3
6882851|NCT00545051|10895838|FG000|Overall Study|Death|1
6882852|NCT00545051|10895839|FG001|Overall Study|Death|0
6882853|NCT00545051|10895838|FG000|Overall Study|Violation of inclusion/exclusion|0
6882854|NCT00545051|10895839|FG001|Overall Study|Violation of inclusion/exclusion|2
6882855|NCT00545051|10895838|FG000|Overall Study|Protocol Violation|1
6882856|NCT00545051|10895839|FG001|Overall Study|Protocol Violation|0
6882857|NCT00545051|10895838|FG000|Overall Study|Withdrawal by Subject|0
6882858|NCT00545051|10895839|FG001|Overall Study|Withdrawal by Subject|1
6882859|NCT00545051|10895838|FG000|Overall Study|Administrative reasons|0
6882860|NCT00545051|10895839|FG001|Overall Study|Administrative reasons|1
6882861|NCT00545064|10895845|FG000|Overall Study|Lost to Follow-up|3
6882862|NCT00545064|10895845|FG000|Overall Study|Withdrawal by Subject|2
6882863|NCT00545064|10895845|FG000|Overall Study|did not complete course of treatment|1
6882864|NCT00545064|10895845|FG000|Overall Study|cancel all appointments, no rebooking|1
6882865|NCT00545064|10895845|FG000|Overall Study|inclement weather|1
6882866|NCT00545077|10895853|FG000|Overall Study|Treatment not received|5
6882867|NCT00545077|10895854|FG001|Overall Study|Treatment not received|1
6882868|NCT00545077|10895853|FG000|Overall Study|Disease Progression|131
6882869|NCT00545077|10895854|FG001|Overall Study|Disease Progression|98
6882870|NCT00545077|10895853|FG000|Overall Study|Withdrawal by Subject|3
6882871|NCT00545077|10895854|FG001|Overall Study|Withdrawal by Subject|14
6882872|NCT00545077|10895853|FG000|Overall Study|Physician Decision|6
6882873|NCT00545077|10895854|FG001|Overall Study|Physician Decision|3
6882874|NCT00545077|10895853|FG000|Overall Study|Lost to Follow-up|2
6882875|NCT00545077|10895854|FG001|Overall Study|Lost to Follow-up|0
6882876|NCT00545077|10895853|FG000|Overall Study|Protocol Violation|1
6882877|NCT00545077|10895854|FG001|Overall Study|Protocol Violation|0
6882878|NCT00545077|10895853|FG000|Overall Study|Adverse Event|0
6882879|NCT00545077|10895854|FG001|Overall Study|Adverse Event|31
6882880|NCT00545077|10895853|FG000|Overall Study|Death|0
6882881|NCT00545077|10895854|FG001|Overall Study|Death|8
6882882|NCT00545103|10895864|FG000|Overall Study|Lack of Efficacy|48
6882883|NCT00545103|10895865|FG001|Overall Study|Lack of Efficacy|45
6882884|NCT00545103|10895866|FG002|Overall Study|Lack of Efficacy|31
6882885|NCT00545103|10895867|FG003|Overall Study|Lack of Efficacy|27
6882886|NCT00545103|10895864|FG000|Overall Study|Withdrawal by Subject|6
6882887|NCT00545103|10895865|FG001|Overall Study|Withdrawal by Subject|10
6882888|NCT00545103|10895866|FG002|Overall Study|Withdrawal by Subject|18
6882889|NCT00545103|10895867|FG003|Overall Study|Withdrawal by Subject|22
6882890|NCT00545103|10895864|FG000|Overall Study|Adverse Event|11
6882891|NCT00545103|10895865|FG001|Overall Study|Adverse Event|12
6882892|NCT00545103|10895866|FG002|Overall Study|Adverse Event|17
6882893|NCT00545103|10895867|FG003|Overall Study|Adverse Event|10
6882894|NCT00545103|10895864|FG000|Overall Study|Lost to Follow-up|4
6882895|NCT00545103|10895865|FG001|Overall Study|Lost to Follow-up|6
6882896|NCT00545103|10895866|FG002|Overall Study|Lost to Follow-up|3
6882897|NCT00545103|10895867|FG003|Overall Study|Lost to Follow-up|4
6882898|NCT00545103|10895864|FG000|Overall Study|Protocol Violation|1
6882899|NCT00545103|10895865|FG001|Overall Study|Protocol Violation|2
6882900|NCT00545103|10895866|FG002|Overall Study|Protocol Violation|3
6882901|NCT00545103|10895867|FG003|Overall Study|Protocol Violation|0
6882902|NCT00545103|10895864|FG000|Overall Study|Suspected recurrence of diverticulitis|1
6882903|NCT00545103|10895865|FG001|Overall Study|Suspected recurrence of diverticulitis|0
6882904|NCT00545103|10895866|FG002|Overall Study|Suspected recurrence of diverticulitis|0
6882905|NCT00545103|10895867|FG003|Overall Study|Suspected recurrence of diverticulitis|3
6882906|NCT00545103|10895864|FG000|Overall Study|Difficult to open package|0
6882907|NCT00545103|10895865|FG001|Overall Study|Difficult to open package|0
6882908|NCT00545103|10895866|FG002|Overall Study|Difficult to open package|0
6882909|NCT00545103|10895867|FG003|Overall Study|Difficult to open package|1
6882910|NCT00545103|10895864|FG000|Overall Study|Investigational product not taken|1
6882911|NCT00545103|10895865|FG001|Overall Study|Investigational product not taken|0
6882912|NCT00545103|10895866|FG002|Overall Study|Investigational product not taken|0
6882913|NCT00545103|10895867|FG003|Overall Study|Investigational product not taken|1
6882914|NCT00545103|10895864|FG000|Overall Study|Wish to start a family|0
6882915|NCT00545103|10895865|FG001|Overall Study|Wish to start a family|0
6882916|NCT00545103|10895866|FG002|Overall Study|Wish to start a family|0
7041253|NCT01725308|11124779|FG002|Treatment Period I|Miscellaneous|3
7041254|NCT01725308|11124777|FG000|Treatment Period II|Did Not Meet Transition Criteria|0
7041255|NCT01725308|11124778|FG001|Treatment Period II|Did Not Meet Transition Criteria|3
7041256|NCT01725308|11124779|FG002|Treatment Period II|Did Not Meet Transition Criteria|4
7041257|NCT01725308|11124777|FG000|Treatment Period II|Did Not Receive Drug|4
7041258|NCT01725308|11124778|FG001|Treatment Period II|Did Not Receive Drug|0
6882917|NCT00545103|10895867|FG003|Overall Study|Wish to start a family|1
6882918|NCT00545103|10895864|FG000|Overall Study|Diverticulitis crisis|0
6882919|NCT00545103|10895865|FG001|Overall Study|Diverticulitis crisis|0
6882920|NCT00545103|10895866|FG002|Overall Study|Diverticulitis crisis|0
6882921|NCT00545103|10895867|FG003|Overall Study|Diverticulitis crisis|1
6882922|NCT00545103|10895864|FG000|Overall Study|Personal reasons|1
6882923|NCT00545103|10895865|FG001|Overall Study|Personal reasons|0
6882924|NCT00545103|10895866|FG002|Overall Study|Personal reasons|0
6882925|NCT00545103|10895867|FG003|Overall Study|Personal reasons|0
6882926|NCT00545103|10895864|FG000|Overall Study|Subject's decision|1
6882927|NCT00545103|10895865|FG001|Overall Study|Subject's decision|0
6882928|NCT00545103|10895866|FG002|Overall Study|Subject's decision|0
6882929|NCT00545103|10895867|FG003|Overall Study|Subject's decision|0
6882930|NCT00545103|10895864|FG000|Overall Study|Noncompliance|0
6882931|NCT00545103|10895865|FG001|Overall Study|Noncompliance|1
6882932|NCT00545103|10895866|FG002|Overall Study|Noncompliance|0
6882933|NCT00545103|10895867|FG003|Overall Study|Noncompliance|0
6882934|NCT00545103|10895864|FG000|Overall Study|Investigator decision|0
6882935|NCT00545103|10895865|FG001|Overall Study|Investigator decision|0
6882936|NCT00545103|10895866|FG002|Overall Study|Investigator decision|1
6882937|NCT00545103|10895867|FG003|Overall Study|Investigator decision|0
6882938|NCT00545103|10895864|FG000|Overall Study|Subject moved|0
6882939|NCT00545103|10895865|FG001|Overall Study|Subject moved|1
6882940|NCT00545103|10895866|FG002|Overall Study|Subject moved|0
6882941|NCT00545103|10895867|FG003|Overall Study|Subject moved|0
6882942|NCT00545103|10895864|FG000|Overall Study|Use of prohibited medication|0
6882943|NCT00545103|10895865|FG001|Overall Study|Use of prohibited medication|0
6882944|NCT00545103|10895866|FG002|Overall Study|Use of prohibited medication|1
6882945|NCT00545103|10895867|FG003|Overall Study|Use of prohibited medication|0
6882946|NCT00545103|10895864|FG000|Overall Study|Does not want to take study drug anymore|1
6882947|NCT00545103|10895865|FG001|Overall Study|Does not want to take study drug anymore|0
6882948|NCT00545103|10895866|FG002|Overall Study|Does not want to take study drug anymore|1
6882949|NCT00545103|10895867|FG003|Overall Study|Does not want to take study drug anymore|0
6882950|NCT00545103|10895864|FG000|Overall Study|Subject met endpoint under protocol v. 1|0
6882951|NCT00545103|10895865|FG001|Overall Study|Subject met endpoint under protocol v. 1|0
6882952|NCT00545103|10895866|FG002|Overall Study|Subject met endpoint under protocol v. 1|1
6882953|NCT00545103|10895867|FG003|Overall Study|Subject met endpoint under protocol v. 1|0
6882954|NCT00545103|10895864|FG000|Overall Study|Death|0
6882955|NCT00545103|10895865|FG001|Overall Study|Death|1
6882956|NCT00545103|10895866|FG002|Overall Study|Death|0
6882957|NCT00545103|10895867|FG003|Overall Study|Death|0
6882958|NCT00545168|10895884|FG000|Overall Study|Lost to Follow-up|5
6882959|NCT00545168|10895885|FG001|Overall Study|Lost to Follow-up|5
6882960|NCT00545168|10895886|FG002|Overall Study|Lost to Follow-up|5
6882961|NCT00545168|10895884|FG000|Overall Study|Withdrawal by Subject|9
6882962|NCT00545168|10895885|FG001|Overall Study|Withdrawal by Subject|0
6882963|NCT00545168|10895886|FG002|Overall Study|Withdrawal by Subject|13
6882964|NCT00545168|10895884|FG000|Overall Study|Protocol Violation|1
6882965|NCT00545168|10895885|FG001|Overall Study|Protocol Violation|0
6882966|NCT00545168|10895886|FG002|Overall Study|Protocol Violation|1
6882967|NCT00545168|10895884|FG000|Overall Study|Visit for Day 21 was not done in error|1
6882968|NCT00545168|10895885|FG001|Overall Study|Visit for Day 21 was not done in error|0
6882969|NCT00545168|10895886|FG002|Overall Study|Visit for Day 21 was not done in error|2
7079043|NCT02108262|11187711|FG003|Overall Study|Distance to center|0
7079044|NCT02108262|11187708|FG000|Overall Study|Adverse Event|0
7079045|NCT02108262|11187709|FG001|Overall Study|Adverse Event|11
7079046|NCT02108262|11187710|FG002|Overall Study|Adverse Event|6
7079047|NCT02108262|11187711|FG003|Overall Study|Adverse Event|12
7079048|NCT02108262|11187708|FG000|Overall Study|Death|0
7079049|NCT02108262|11187709|FG001|Overall Study|Death|2
7079050|NCT02108262|11187710|FG002|Overall Study|Death|2
7079051|NCT02108262|11187711|FG003|Overall Study|Death|1
7079052|NCT02108262|11187708|FG000|Overall Study|Lost to Follow-up|0
7079053|NCT02108262|11187709|FG001|Overall Study|Lost to Follow-up|0
7079054|NCT02108262|11187710|FG002|Overall Study|Lost to Follow-up|1
7079055|NCT02108262|11187711|FG003|Overall Study|Lost to Follow-up|0
7079056|NCT02108262|11187708|FG000|Overall Study|Physician Decision|0
7079057|NCT02108262|11187709|FG001|Overall Study|Physician Decision|0
7079058|NCT02108262|11187710|FG002|Overall Study|Physician Decision|2
7079059|NCT02108262|11187711|FG003|Overall Study|Physician Decision|0
7079060|NCT02108262|11187708|FG000|Overall Study|Withdrawal by Subject|0
7079061|NCT02108262|11187709|FG001|Overall Study|Withdrawal by Subject|7
7079062|NCT02108262|11187710|FG002|Overall Study|Withdrawal by Subject|3
7079063|NCT02108262|11187711|FG003|Overall Study|Withdrawal by Subject|4
6882970|NCT00545233|10895906|FG000|Overall Study|Adverse Event|10
6882971|NCT00545233|10895907|FG001|Overall Study|Adverse Event|5
6882972|NCT00545233|10895906|FG000|Overall Study|Violation of Selection Criteria at Entry|5
6882973|NCT00545233|10895907|FG001|Overall Study|Violation of Selection Criteria at Entry|1
6882974|NCT00545233|10895906|FG000|Overall Study|Protocol Violation|2
6882975|NCT00545233|10895907|FG001|Overall Study|Protocol Violation|0
6882976|NCT00545233|10895906|FG000|Overall Study|Refused Treatment|9
6882977|NCT00545233|10895907|FG001|Overall Study|Refused Treatment|7
6882978|NCT00545233|10895906|FG000|Overall Study|Failure to Return|4
6882979|NCT00545233|10895907|FG001|Overall Study|Failure to Return|6
6882980|NCT00545233|10895906|FG000|Overall Study|Insufficient response|14
7079064|NCT02108262|11187708|FG000|Overall Study|Due to key hepatic values|0
6882981|NCT00545233|10895907|FG001|Overall Study|Insufficient response|15
6882982|NCT00545233|10895906|FG000|Overall Study|Physician Decision|2
6882983|NCT00545233|10895907|FG001|Overall Study|Physician Decision|1
6882984|NCT00545272|10895920|FG000|Overall Study|Protocol deviation|0
6882985|NCT00545272|10895921|FG001|Overall Study|Protocol deviation|1
6882986|NCT00545272|10895922|FG002|Overall Study|Protocol deviation|0
6882987|NCT00545272|10895923|FG003|Overall Study|Protocol deviation|1
6882988|NCT00545272|10895924|FG004|Overall Study|Protocol deviation|0
6882989|NCT00545272|10895925|FG005|Overall Study|Protocol deviation|1
6882990|NCT00545272|10895920|FG000|Overall Study|Adverse Event|0
6882991|NCT00545272|10895921|FG001|Overall Study|Adverse Event|0
6882992|NCT00545272|10895922|FG002|Overall Study|Adverse Event|1
6882993|NCT00545272|10895923|FG003|Overall Study|Adverse Event|0
6882994|NCT00545272|10895924|FG004|Overall Study|Adverse Event|0
7079065|NCT02108262|11187709|FG001|Overall Study|Due to key hepatic values|1
6882995|NCT00545272|10895925|FG005|Overall Study|Adverse Event|1
6882996|NCT00545272|10895920|FG000|Overall Study|Abnormal laboratory value(s)|0
6882997|NCT00545272|10895921|FG001|Overall Study|Abnormal laboratory value(s)|0
6882998|NCT00545272|10895922|FG002|Overall Study|Abnormal laboratory value(s)|0
6882999|NCT00545272|10895923|FG003|Overall Study|Abnormal laboratory value(s)|0
6883000|NCT00545272|10895924|FG004|Overall Study|Abnormal laboratory value(s)|0
6883001|NCT00545272|10895925|FG005|Overall Study|Abnormal laboratory value(s)|1
6883002|NCT00545272|10895920|FG000|Overall Study|Abnormal test procedure result(s)|0
6883003|NCT00545272|10895921|FG001|Overall Study|Abnormal test procedure result(s)|0
6883004|NCT00545272|10895922|FG002|Overall Study|Abnormal test procedure result(s)|0
6883005|NCT00545272|10895923|FG003|Overall Study|Abnormal test procedure result(s)|0
6883006|NCT00545272|10895924|FG004|Overall Study|Abnormal test procedure result(s)|1
6883007|NCT00545272|10895925|FG005|Overall Study|Abnormal test procedure result(s)|0
6883008|NCT00545272|10895920|FG000|Overall Study|Lost to Follow-up|0
6883009|NCT00545272|10895921|FG001|Overall Study|Lost to Follow-up|0
6883010|NCT00545272|10895922|FG002|Overall Study|Lost to Follow-up|0
6883011|NCT00545272|10895923|FG003|Overall Study|Lost to Follow-up|0
6883012|NCT00545272|10895924|FG004|Overall Study|Lost to Follow-up|1
6883013|NCT00545272|10895925|FG005|Overall Study|Lost to Follow-up|0
6883014|NCT00545298|10895942|FG000|Overall Study|Issues with Standard of Care|2
6883015|NCT00545298|10895943|FG001|Overall Study|Issues with Standard of Care|0
6883016|NCT00545298|10895944|FG002|Overall Study|Issues with Standard of Care|1
6883017|NCT00545363|10895957|FG000|Overall Study|Adverse Event|6
6883018|NCT00545363|10895958|FG001|Overall Study|Adverse Event|7
6883019|NCT00545363|10895957|FG000|Overall Study|Withdrawal by Subject|6
6883020|NCT00545363|10895958|FG001|Overall Study|Withdrawal by Subject|5
6883021|NCT00545363|10895957|FG000|Overall Study|Non-compliance|3
6883022|NCT00545363|10895958|FG001|Overall Study|Non-compliance|1
6883023|NCT00545363|10895957|FG000|Overall Study|Did not meet entry criteria|1
6883024|NCT00545363|10895958|FG001|Overall Study|Did not meet entry criteria|1
6883025|NCT00545363|10895957|FG000|Overall Study|Lost to Follow-up|2
6883026|NCT00545363|10895958|FG001|Overall Study|Lost to Follow-up|0
6883027|NCT00545363|10895957|FG000|Overall Study|Other|1
6883028|NCT00545363|10895958|FG001|Overall Study|Other|1
6883029|NCT00545402|10895966|FG000|Overall Study|Discontinuation of treatment|17
6883030|NCT00545402|10895967|FG001|Overall Study|Discontinuation of treatment|9
6883031|NCT00545402|10895966|FG000|Overall Study|Use of unauthorized immunosuppressant|8
6883032|NCT00545402|10895967|FG001|Overall Study|Use of unauthorized immunosuppressant|7
6883033|NCT00545402|10895966|FG000|Overall Study|Death|5
6883034|NCT00545402|10895967|FG001|Overall Study|Death|7
6883035|NCT00545402|10895966|FG000|Overall Study|Graft loss|2
6883036|NCT00545402|10895967|FG001|Overall Study|Graft loss|4
6883037|NCT00545402|10895966|FG000|Overall Study|Withdrawal by Subject|0
6883038|NCT00545402|10895967|FG001|Overall Study|Withdrawal by Subject|1
6883039|NCT00545402|10895966|FG000|Overall Study|Protocol Violation|1
6883040|NCT00545402|10895967|FG001|Overall Study|Protocol Violation|0
6883041|NCT00545402|10895966|FG000|Overall Study|Reason not specified|1
6883042|NCT00545402|10895967|FG001|Overall Study|Reason not specified|1
6883043|NCT00545441|10895975|FG000|Overall Study|Fistula draining at 6 months|2
6883044|NCT00545441|10895976|FG001|Overall Study|Fistula draining at 6 months|4
6883045|NCT00545441|10895975|FG000|Overall Study|Lost to Follow-up|9
6883046|NCT00545441|10895976|FG001|Overall Study|Lost to Follow-up|5
6883047|NCT00545441|10895975|FG000|Overall Study|Technical failure|0
6883048|NCT00545441|10895976|FG001|Overall Study|Technical failure|1
6883049|NCT00545441|10895975|FG000|Overall Study|Withdrawal by Subject|1
6883050|NCT00545441|10895976|FG001|Overall Study|Withdrawal by Subject|1
6883051|NCT00545441|10895975|FG000|Overall Study|Persistence or recurrence of fistula|5
6883052|NCT00545441|10895976|FG001|Overall Study|Persistence or recurrence of fistula|2
6883053|NCT00545441|10895975|FG000|Overall Study|Patients were not treated|1
6883054|NCT00545441|10895976|FG001|Overall Study|Patients were not treated|3
6883055|NCT00545532|10895984|FG000|Overall Study|Withdrawal by Subject|1
6883056|NCT00545532|10895985|FG001|Overall Study|Withdrawal by Subject|3
6883057|NCT00545532|10895984|FG000|Overall Study|Lost to Follow-up|5
6883058|NCT00545532|10895985|FG001|Overall Study|Lost to Follow-up|6
6883059|NCT00545532|10895984|FG000|Overall Study|Death|0
6883060|NCT00545532|10895985|FG001|Overall Study|Death|1
6883061|NCT00545571|10895993|FG000|Overall Study|Administrative Reasons|1
6883062|NCT00545571|10895993|FG000|Overall Study|Adverse Event|2
6883063|NCT00545571|10895993|FG000|Overall Study|Death|5
6883064|NCT00545571|10895993|FG000|Overall Study|Lack of Efficacy|1
6883065|NCT00545571|10895993|FG000|Overall Study|Protocol Violation|2
6883066|NCT00545571|10895993|FG000|Overall Study|Refused Treatment|1
6883067|NCT00545571|10895993|FG000|Overall Study|Screen Failure|16
6883068|NCT00545571|10895993|FG000|Overall Study|Transfusion|12
6883069|NCT00545571|10895993|FG000|Overall Study|Early Termination of Study|24
6883070|NCT00545571|10895993|FG000|Overall Study|Kidney Transplantation|3
6883071|NCT00545584|10896000|FG000|Overall Study|Only one reason for discontinuation|62
6883072|NCT00545584|10896001|FG001|Overall Study|Only one reason for discontinuation|61
6883073|NCT00545584|10896002|FG002|Overall Study|Only one reason for discontinuation|48
6883074|NCT00545584|10896000|FG000|Overall Study|Two or more reasons for discontinuation|17
6883075|NCT00545584|10896001|FG001|Overall Study|Two or more reasons for discontinuation|19
6883076|NCT00545584|10896002|FG002|Overall Study|Two or more reasons for discontinuation|8
7155629|NCT03345407|11323717|FG002|Overall Study|Withdrawal by Subject|5
7079066|NCT02108262|11187710|FG002|Overall Study|Due to key hepatic values|0
7079067|NCT02108262|11187711|FG003|Overall Study|Due to key hepatic values|0
7079068|NCT02108262|11187708|FG000|Overall Study|Unable to contact patient|0
6883077|NCT00545688|10896040|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1
6883078|NCT00545688|10896041|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2
6883079|NCT00545688|10896042|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1
6883080|NCT00545688|10896043|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1
6883081|NCT00545688|10896040|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1
6883082|NCT00545688|10896041|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1
6883083|NCT00545688|10896042|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4
6883084|NCT00545688|10896043|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1
6883085|NCT00545688|10896040|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1
6883086|NCT00545688|10896041|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
6883087|NCT00545688|10896042|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
6883088|NCT00545688|10896043|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
6883089|NCT00545688|10896040|FG000|Neo-Adjuvant Treatment Period|Death|0
6883090|NCT00545688|10896041|FG001|Neo-Adjuvant Treatment Period|Death|1
6883091|NCT00545688|10896042|FG002|Neo-Adjuvant Treatment Period|Death|0
6883092|NCT00545688|10896043|FG003|Neo-Adjuvant Treatment Period|Death|0
6883093|NCT00545688|10896040|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0
6883094|NCT00545688|10896041|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1
6883095|NCT00545688|10896042|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7
6883096|NCT00545688|10896043|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2
6883097|NCT00545688|10896040|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1
6883098|NCT00545688|10896041|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0
6883099|NCT00545688|10896042|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0
6883100|NCT00545688|10896043|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0
6883101|NCT00545688|10896040|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0
6883102|NCT00545688|10896041|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0
6883103|NCT00545688|10896042|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2
6883104|NCT00545688|10896043|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2
6883105|NCT00545688|10896040|FG000|Adjuvant Treatment Period|Disease Progression|3
6883106|NCT00545688|10896041|FG001|Adjuvant Treatment Period|Disease Progression|3
6883107|NCT00545688|10896042|FG002|Adjuvant Treatment Period|Disease Progression|0
6883108|NCT00545688|10896043|FG003|Adjuvant Treatment Period|Disease Progression|7
6883109|NCT00545688|10896040|FG000|Adjuvant Treatment Period|Refused Treatment|1
6883110|NCT00545688|10896041|FG001|Adjuvant Treatment Period|Refused Treatment|1
6883111|NCT00545688|10896042|FG002|Adjuvant Treatment Period|Refused Treatment|1
6883112|NCT00545688|10896043|FG003|Adjuvant Treatment Period|Refused Treatment|5
6883113|NCT00545688|10896040|FG000|Adjuvant Treatment Period|Lost to Follow-up|1
6883114|NCT00545688|10896041|FG001|Adjuvant Treatment Period|Lost to Follow-up|0
6883115|NCT00545688|10896042|FG002|Adjuvant Treatment Period|Lost to Follow-up|1
6883116|NCT00545688|10896043|FG003|Adjuvant Treatment Period|Lost to Follow-up|0
6883117|NCT00545688|10896040|FG000|Adjuvant Treatment Period|Adverse Event|0
6883118|NCT00545688|10896041|FG001|Adjuvant Treatment Period|Adverse Event|3
6883119|NCT00545688|10896042|FG002|Adjuvant Treatment Period|Adverse Event|2
6883120|NCT00545688|10896043|FG003|Adjuvant Treatment Period|Adverse Event|2
6883121|NCT00545688|10896040|FG000|Adjuvant Treatment Period|Unknown Reason|0
6883122|NCT00545688|10896041|FG001|Adjuvant Treatment Period|Unknown Reason|1
6883123|NCT00545688|10896042|FG002|Adjuvant Treatment Period|Unknown Reason|0
6883124|NCT00545688|10896043|FG003|Adjuvant Treatment Period|Unknown Reason|0
6883125|NCT00545688|10896040|FG000|Follow-Up Period|Death|4
6883126|NCT00545688|10896041|FG001|Follow-Up Period|Death|2
6883127|NCT00545688|10896042|FG002|Follow-Up Period|Death|2
6883128|NCT00545688|10896043|FG003|Follow-Up Period|Death|6
6883129|NCT00545688|10896040|FG000|Follow-Up Period|Disease Progression|6
6883130|NCT00545688|10896041|FG001|Follow-Up Period|Disease Progression|5
6883131|NCT00545688|10896042|FG002|Follow-Up Period|Disease Progression|9
6883132|NCT00545688|10896043|FG003|Follow-Up Period|Disease Progression|9
6883133|NCT00545688|10896040|FG000|Follow-Up Period|Refused Treatment|6
6883134|NCT00545688|10896041|FG001|Follow-Up Period|Refused Treatment|2
6883135|NCT00545688|10896042|FG002|Follow-Up Period|Refused Treatment|0
6883136|NCT00545688|10896043|FG003|Follow-Up Period|Refused Treatment|2
6883137|NCT00545688|10896040|FG000|Follow-Up Period|Lost to Follow-up|3
6883138|NCT00545688|10896041|FG001|Follow-Up Period|Lost to Follow-up|3
6883139|NCT00545688|10896042|FG002|Follow-Up Period|Lost to Follow-up|3
6883140|NCT00545688|10896043|FG003|Follow-Up Period|Lost to Follow-up|1
6883141|NCT00545688|10896040|FG000|Follow-Up Period|Unspecified Reason|2
6883142|NCT00545688|10896041|FG001|Follow-Up Period|Unspecified Reason|5
6883143|NCT00545688|10896042|FG002|Follow-Up Period|Unspecified Reason|6
6883144|NCT00545688|10896043|FG003|Follow-Up Period|Unspecified Reason|8
6883145|NCT00545688|10896040|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0
6883146|NCT00545688|10896041|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2
6883147|NCT00545688|10896042|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0
6883148|NCT00545688|10896043|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1
7079069|NCT02108262|11187709|FG001|Overall Study|Unable to contact patient|3
7079070|NCT02108262|11187710|FG002|Overall Study|Unable to contact patient|1
6883149|NCT00545714|10896056|FG000|Induction Phase (6 Months)|Physician Decision|3
6883150|NCT00545714|10896056|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6
6883151|NCT00545714|10896056|FG000|Induction Phase (6 Months)|Disease Progression|1
6883152|NCT00545714|10896056|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2
6883153|NCT00545714|10896056|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16
6883154|NCT00545714|10896056|FG000|Maintenance Phase (36 Months)|Disease Progression|9
6883155|NCT00545714|10896056|FG000|Maintenance Phase (36 Months)|Physician Decision|1
6883156|NCT00545714|10896056|FG000|Maintenance Phase (36 Months)|Protocol Violation|1
6883157|NCT00545714|10896056|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3
6883158|NCT00545714|10896056|FG000|Maintenance Phase (36 Months)|Death|2
6883159|NCT00545740|10896064|FG000|Overall Study|Lack of Efficacy|34
6883160|NCT00545740|10896065|FG001|Overall Study|Lack of Efficacy|35
6883161|NCT00545740|10896066|FG002|Overall Study|Lack of Efficacy|47
6883162|NCT00545740|10896067|FG003|Overall Study|Lack of Efficacy|36
6883163|NCT00545740|10896064|FG000|Overall Study|Withdrawal by Subject|17
6883164|NCT00545740|10896065|FG001|Overall Study|Withdrawal by Subject|15
6883165|NCT00545740|10896066|FG002|Overall Study|Withdrawal by Subject|16
6883166|NCT00545740|10896067|FG003|Overall Study|Withdrawal by Subject|18
6883167|NCT00545740|10896064|FG000|Overall Study|Adverse Event|10
6883168|NCT00545740|10896065|FG001|Overall Study|Adverse Event|18
6883169|NCT00545740|10896066|FG002|Overall Study|Adverse Event|19
6883170|NCT00545740|10896067|FG003|Overall Study|Adverse Event|9
6883171|NCT00545740|10896064|FG000|Overall Study|Lost to Follow-up|7
6883172|NCT00545740|10896065|FG001|Overall Study|Lost to Follow-up|5
6883173|NCT00545740|10896066|FG002|Overall Study|Lost to Follow-up|5
6883174|NCT00545740|10896067|FG003|Overall Study|Lost to Follow-up|6
6883175|NCT00545740|10896064|FG000|Overall Study|Protocol Violation|1
6883176|NCT00545740|10896065|FG001|Overall Study|Protocol Violation|3
6883177|NCT00545740|10896066|FG002|Overall Study|Protocol Violation|1
6883178|NCT00545740|10896067|FG003|Overall Study|Protocol Violation|0
6883179|NCT00545740|10896064|FG000|Overall Study|Non-compliance|0
6883180|NCT00545740|10896065|FG001|Overall Study|Non-compliance|2
6883181|NCT00545740|10896066|FG002|Overall Study|Non-compliance|1
6883182|NCT00545740|10896067|FG003|Overall Study|Non-compliance|0
6883183|NCT00545740|10896064|FG000|Overall Study|Moved|2
6883184|NCT00545740|10896065|FG001|Overall Study|Moved|0
6883185|NCT00545740|10896066|FG002|Overall Study|Moved|1
6883186|NCT00545740|10896067|FG003|Overall Study|Moved|0
6883187|NCT00545740|10896064|FG000|Overall Study|Diverticulitis attack|0
6883188|NCT00545740|10896065|FG001|Overall Study|Diverticulitis attack|0
6883189|NCT00545740|10896066|FG002|Overall Study|Diverticulitis attack|1
6883190|NCT00545740|10896067|FG003|Overall Study|Diverticulitis attack|1
6883191|NCT00545740|10896064|FG000|Overall Study|Suspected Diverticulitis Recurrence|1
6883192|NCT00545740|10896065|FG001|Overall Study|Suspected Diverticulitis Recurrence|1
6883193|NCT00545740|10896066|FG002|Overall Study|Suspected Diverticulitis Recurrence|1
6883194|NCT00545740|10896067|FG003|Overall Study|Suspected Diverticulitis Recurrence|1
6883195|NCT00545740|10896064|FG000|Overall Study|Site closure|1
6883196|NCT00545740|10896065|FG001|Overall Study|Site closure|0
6883197|NCT00545740|10896066|FG002|Overall Study|Site closure|0
6883198|NCT00545740|10896067|FG003|Overall Study|Site closure|0
6883199|NCT00545740|10896064|FG000|Overall Study|Missed visit|1
6883200|NCT00545740|10896065|FG001|Overall Study|Missed visit|0
6883201|NCT00545740|10896066|FG002|Overall Study|Missed visit|0
6883202|NCT00545740|10896067|FG003|Overall Study|Missed visit|0
6883203|NCT00545740|10896064|FG000|Overall Study|Physician Decision|0
6883204|NCT00545740|10896065|FG001|Overall Study|Physician Decision|0
6883205|NCT00545740|10896066|FG002|Overall Study|Physician Decision|3
6883206|NCT00545740|10896067|FG003|Overall Study|Physician Decision|0
6883207|NCT00545740|10896064|FG000|Overall Study|Accepted only monthly telephone calls|1
6883208|NCT00545740|10896065|FG001|Overall Study|Accepted only monthly telephone calls|0
6883209|NCT00545740|10896066|FG002|Overall Study|Accepted only monthly telephone calls|0
7079071|NCT02108262|11187711|FG003|Overall Study|Unable to contact patient|2
7079072|NCT02108262|11187708|FG000|Overall Study|Patient unable to come to site/attend visit|0
7079073|NCT02108262|11187709|FG001|Overall Study|Patient unable to come to site/attend visit|6
7079074|NCT02108262|11187710|FG002|Overall Study|Patient unable to come to site/attend visit|11
7079075|NCT02108262|11187711|FG003|Overall Study|Patient unable to come to site/attend visit|6
7079076|NCT02108262|11187708|FG000|Overall Study|Patient did not want another infusion|0
7079077|NCT02108262|11187709|FG001|Overall Study|Patient did not want another infusion|3
6883210|NCT00545740|10896067|FG003|Overall Study|Accepted only monthly telephone calls|0
6883211|NCT00545740|10896064|FG000|Overall Study|Sponsor decision|0
6883212|NCT00545740|10896065|FG001|Overall Study|Sponsor decision|1
6883213|NCT00545740|10896066|FG002|Overall Study|Sponsor decision|0
6883214|NCT00545740|10896067|FG003|Overall Study|Sponsor decision|0
6883215|NCT00545740|10896064|FG000|Overall Study|Lack of time|0
6883216|NCT00545740|10896065|FG001|Overall Study|Lack of time|1
6883217|NCT00545740|10896066|FG002|Overall Study|Lack of time|0
6883218|NCT00545740|10896067|FG003|Overall Study|Lack of time|0
6883219|NCT00545740|10896064|FG000|Overall Study|Non-adherence to visits|0
6883220|NCT00545740|10896065|FG001|Overall Study|Non-adherence to visits|1
6883221|NCT00545740|10896066|FG002|Overall Study|Non-adherence to visits|0
6883222|NCT00545740|10896067|FG003|Overall Study|Non-adherence to visits|0
6883223|NCT00545740|10896064|FG000|Overall Study|Patient difficulties|0
7079078|NCT02108262|11187710|FG002|Overall Study|Patient did not want another infusion|3
7079079|NCT02108262|11187711|FG003|Overall Study|Patient did not want another infusion|2
7079080|NCT02108262|11187708|FG000|Overall Study|Vacation|0
7079081|NCT02108262|11187709|FG001|Overall Study|Vacation|1
7079082|NCT02108262|11187710|FG002|Overall Study|Vacation|0
7079083|NCT02108262|11187711|FG003|Overall Study|Vacation|0
7079084|NCT02108262|11187708|FG000|Overall Study|Patient decision|0
7079085|NCT02108262|11187709|FG001|Overall Study|Patient decision|7
7079086|NCT02108262|11187710|FG002|Overall Study|Patient decision|9
7079087|NCT02108262|11187711|FG003|Overall Study|Patient decision|14
7079088|NCT02108262|11187708|FG000|Overall Study|Missed IV due to pharmacy error|0
6883224|NCT00545740|10896065|FG001|Overall Study|Patient difficulties|1
6883225|NCT00545740|10896066|FG002|Overall Study|Patient difficulties|0
6883226|NCT00545740|10896067|FG003|Overall Study|Patient difficulties|0
6883227|NCT00545740|10896064|FG000|Overall Study|Husband against study|0
6883228|NCT00545740|10896065|FG001|Overall Study|Husband against study|0
6883229|NCT00545740|10896066|FG002|Overall Study|Husband against study|1
6883230|NCT00545740|10896067|FG003|Overall Study|Husband against study|0
6883231|NCT00545753|10896080|FG000|Overall Study|Withdrawal by Subject|0
6883232|NCT00545753|10896081|FG001|Overall Study|Withdrawal by Subject|1
6883233|NCT00545753|10896082|FG002|Overall Study|Withdrawal by Subject|10
6883234|NCT00545753|10896080|FG000|Overall Study|Lost to Follow-up|13
6883235|NCT00545753|10896081|FG001|Overall Study|Lost to Follow-up|3
6883236|NCT00545753|10896082|FG002|Overall Study|Lost to Follow-up|12
6883237|NCT00545753|10896080|FG000|Overall Study|Protocol Violation|3
6883238|NCT00545753|10896081|FG001|Overall Study|Protocol Violation|1
6883239|NCT00545753|10896082|FG002|Overall Study|Protocol Violation|4
6883240|NCT00545779|10896091|FG000|Overall Study|Violation of selection criteria at entry|8
6883241|NCT00545779|10896091|FG000|Overall Study|Other protocol violation|1
6883242|NCT00545779|10896091|FG000|Overall Study|Did not cooperate|7
6883243|NCT00545779|10896091|FG000|Overall Study|Withdrawal by Subject|20
6883244|NCT00545779|10896091|FG000|Overall Study|Adverse Event/intercurrent illness|5
6883245|NCT00545779|10896091|FG000|Overall Study|Failure to return|3
6883246|NCT00545792|10896095|FG000|Overall Study|Withdrawal by Subject|1
6883247|NCT00545818|10896101|FG000|Overall Study|Protocol Violation|1
6883248|NCT00545818|10896102|FG001|Overall Study|Protocol Violation|0
6883249|NCT00545818|10896101|FG000|Overall Study|Adverse Event|1
6883250|NCT00545818|10896102|FG001|Overall Study|Adverse Event|1
6883251|NCT00545818|10896101|FG000|Overall Study|Lost to Follow-up|1
6883252|NCT00545818|10896102|FG001|Overall Study|Lost to Follow-up|6
6883253|NCT00545948|10896111|FG000|Overall Study|Not Treated|1
6883254|NCT00545948|10896112|FG001|Overall Study|Not Treated|1
6883255|NCT00545948|10896113|FG002|Overall Study|Not Treated|7
6883256|NCT00546000|10896131|FG000|Overall Study|Adverse Event|1
6883257|NCT00546000|10896131|FG000|Overall Study|Lost to Follow-up|1
6883258|NCT00546000|10896131|FG000|Overall Study|Baseline HPA Axis Supression|2
6883259|NCT00546078|10896137|FG000|Overall Study|Lost to Follow-up|1
6883260|NCT00546078|10896138|FG001|Overall Study|Lost to Follow-up|3
6883261|NCT00546078|10896137|FG000|Overall Study|Withdrawal by Subject|2
6883262|NCT00546078|10896138|FG001|Overall Study|Withdrawal by Subject|3
6883263|NCT00546078|10896137|FG000|Overall Study|Other reason|1
6883264|NCT00546078|10896138|FG001|Overall Study|Other reason|1
6883265|NCT00546117|10896150|FG000|Overall Study|Withdrawal by Subject|3
6883266|NCT00546117|10896151|FG001|Overall Study|Withdrawal by Subject|0
6883267|NCT00546117|10896150|FG000|Overall Study|Inability to schedule follow-up visit|1
6883268|NCT00546117|10896151|FG001|Overall Study|Inability to schedule follow-up visit|0
6883269|NCT00546260|10896169|FG000|Overall Study|Drug not given pre diagnostic angiogr|8
6883270|NCT00546260|10896170|FG001|Overall Study|Drug not given pre diagnostic angiogr|2
6883271|NCT00546351|10896176|FG000|Overall Study|Adverse Event|76
6883272|NCT00546351|10896176|FG000|Overall Study|Lack of Efficacy|15
6883273|NCT00546351|10896176|FG000|Overall Study|Withdrawal by Subject|109
6883274|NCT00546351|10896176|FG000|Overall Study|Lost to Follow-up|9
6883275|NCT00546351|10896176|FG000|Overall Study|Protocol Deviation|1
6883276|NCT00546351|10896176|FG000|Overall Study|Unsatisfactory compliance|9
6883277|NCT00546351|10896176|FG000|Overall Study|Other reasons for premature termination|17
6883278|NCT00546364|10896183|FG000|Overall Study|Disease progression|5
6883279|NCT00546364|10896184|FG001|Overall Study|Disease progression|11
6883280|NCT00546364|10896185|FG002|Overall Study|Disease progression|8
6883281|NCT00546364|10896183|FG000|Overall Study|Completed and off treatment|1
6883282|NCT00546364|10896184|FG001|Overall Study|Completed and off treatment|0
6883283|NCT00546364|10896185|FG002|Overall Study|Completed and off treatment|2
6883284|NCT00546364|10896183|FG000|Overall Study|Administrative reason by sponsor|1
6883285|NCT00546364|10896184|FG001|Overall Study|Administrative reason by sponsor|0
7079089|NCT02108262|11187709|FG001|Overall Study|Missed IV due to pharmacy error|0
6883286|NCT00546364|10896185|FG002|Overall Study|Administrative reason by sponsor|0
6883287|NCT00546364|10896183|FG000|Overall Study|Poor compliance/noncompliance|0
6883288|NCT00546364|10896184|FG001|Overall Study|Poor compliance/noncompliance|0
6883289|NCT00546364|10896185|FG002|Overall Study|Poor compliance/noncompliance|1
6883290|NCT00546364|10896183|FG000|Overall Study|No longer meets study criteria|1
6883291|NCT00546364|10896184|FG001|Overall Study|No longer meets study criteria|1
6883292|NCT00546364|10896185|FG002|Overall Study|No longer meets study criteria|0
6883293|NCT00546364|10896183|FG000|Overall Study|Withdrawal by Subject|5
6883294|NCT00546364|10896184|FG001|Overall Study|Withdrawal by Subject|6
6883295|NCT00546364|10896185|FG002|Overall Study|Withdrawal by Subject|3
6883296|NCT00546364|10896183|FG000|Overall Study|Prior taxotere|1
6883297|NCT00546364|10896184|FG001|Overall Study|Prior taxotere|0
6883298|NCT00546364|10896185|FG002|Overall Study|Prior taxotere|0
6883299|NCT00546364|10896183|FG000|Overall Study|Mixed response|1
6883300|NCT00546364|10896184|FG001|Overall Study|Mixed response|0
6883301|NCT00546364|10896185|FG002|Overall Study|Mixed response|0
6883302|NCT00546364|10896183|FG000|Overall Study|Palliative treatment|1
6883303|NCT00546364|10896184|FG001|Overall Study|Palliative treatment|0
6883304|NCT00546364|10896185|FG002|Overall Study|Palliative treatment|1
6883305|NCT00546364|10896183|FG000|Overall Study|Target lesions resected|1
6883306|NCT00546364|10896184|FG001|Overall Study|Target lesions resected|0
6883307|NCT00546364|10896185|FG002|Overall Study|Target lesions resected|0
6883308|NCT00546364|10896183|FG000|Overall Study|Physician Decision|0
6883309|NCT00546364|10896184|FG001|Overall Study|Physician Decision|0
6883310|NCT00546364|10896185|FG002|Overall Study|Physician Decision|1
6883311|NCT00546364|10896183|FG000|Overall Study|Sponsor decision|0
6883312|NCT00546364|10896184|FG001|Overall Study|Sponsor decision|0
6883313|NCT00546364|10896185|FG002|Overall Study|Sponsor decision|1
6969718|NCT01149655|11019442|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
6969719|NCT01149655|11019443|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
6969720|NCT01149655|11019444|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
6969721|NCT01149655|11019445|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
6969722|NCT01149655|11019442|FG000|Period 1 - Conversion Phase|Physician Decision|2
6969723|NCT01149655|11019443|FG001|Period 1 - Conversion Phase|Physician Decision|0
6969724|NCT01149655|11019444|FG002|Period 1 - Conversion Phase|Physician Decision|0
6969725|NCT01149655|11019445|FG003|Period 1 - Conversion Phase|Physician Decision|0
6969726|NCT01149655|11019442|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7
6969727|NCT01149655|11019443|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0
6969728|NCT01149655|11019444|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0
6969729|NCT01149655|11019445|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0
6969730|NCT01149655|11019442|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3
6969731|NCT01149655|11019443|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
6969732|NCT01149655|11019444|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
6969733|NCT01149655|11019445|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
6969734|NCT01149655|11019442|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
6969735|NCT01149655|11019443|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16
6969736|NCT01149655|11019444|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
6969737|NCT01149655|11019445|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
6969738|NCT01149655|11019442|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
6969739|NCT01149655|11019443|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7
6969740|NCT01149655|11019444|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
6969741|NCT01149655|11019445|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
6969742|NCT01149655|11019442|FG000|Period 2-Stabilization Phase|Physician Decision|0
6969743|NCT01149655|11019443|FG001|Period 2-Stabilization Phase|Physician Decision|3
6969744|NCT01149655|11019444|FG002|Period 2-Stabilization Phase|Physician Decision|0
6969745|NCT01149655|11019445|FG003|Period 2-Stabilization Phase|Physician Decision|0
6969746|NCT01149655|11019442|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0
6969747|NCT01149655|11019443|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5
6969748|NCT01149655|11019444|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0
6969749|NCT01149655|11019445|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0
6969750|NCT01149655|11019442|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
6969751|NCT01149655|11019443|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6
6969752|NCT01149655|11019444|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
6969753|NCT01149655|11019445|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
6969754|NCT01149655|11019442|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
6969755|NCT01149655|11019443|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
6969756|NCT01149655|11019444|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58
6969757|NCT01149655|11019445|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19
6969758|NCT01149655|11019442|FG000|Period 3-DB Maintenance Phase|Physician Decision|0
6969759|NCT01149655|11019443|FG001|Period 3-DB Maintenance Phase|Physician Decision|0
6969760|NCT01149655|11019444|FG002|Period 3-DB Maintenance Phase|Physician Decision|1
6969761|NCT01149655|11019445|FG003|Period 3-DB Maintenance Phase|Physician Decision|0
6969762|NCT01149655|11019442|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
6969763|NCT01149655|11019443|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
6969764|NCT01149655|11019444|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
6969765|NCT01149655|11019445|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
6969766|NCT01149655|11019442|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
6969767|NCT01149655|11019443|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
6969768|NCT01149655|11019444|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
6969769|NCT01149655|11019445|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
6969770|NCT01149655|11019442|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0
6969771|NCT01149655|11019443|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0
6883314|NCT00546377|10896193|FG000|Overall Study|Deemed ineligible|1
6883315|NCT00546377|10896193|FG000|Overall Study|Adverse Event|6
6883316|NCT00546481|10896213|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1
6883317|NCT00546481|10896214|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
6883318|NCT00546481|10896215|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
6883319|NCT00546481|10896213|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1
6883320|NCT00546481|10896214|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3
6883321|NCT00546481|10896215|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0
6883322|NCT00546481|10896213|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1
6883323|NCT00546481|10896214|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
6883324|NCT00546481|10896215|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
6883325|NCT00546481|10896213|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2
6883326|NCT00546481|10896214|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
6883327|NCT00546481|10896215|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
6883328|NCT00546481|10896213|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
6883329|NCT00546481|10896214|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
6883330|NCT00546481|10896215|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0
6883331|NCT00546481|10896213|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
6883332|NCT00546481|10896214|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1
6883333|NCT00546481|10896215|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
6883334|NCT00546481|10896213|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0
6883335|NCT00546481|10896214|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0
6883336|NCT00546481|10896215|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2
6883337|NCT00546481|10896213|FG000|Maintenance Phase (CERA)|Kidney transplantation|0
6883338|NCT00546481|10896214|FG001|Maintenance Phase (CERA)|Kidney transplantation|0
6883339|NCT00546481|10896215|FG002|Maintenance Phase (CERA)|Kidney transplantation|1
6883340|NCT00546481|10896213|FG000|Maintenance Phase (CERA)|Other Reason|0
6883341|NCT00546481|10896214|FG001|Maintenance Phase (CERA)|Other Reason|0
6883342|NCT00546481|10896215|FG002|Maintenance Phase (CERA)|Other Reason|1
6883343|NCT00546572|10896225|FG000|Vax 1 / Year 0|Randomized, not treated|1
6883344|NCT00546572|10896226|FG001|Vax 1 / Year 0|Randomized, not treated|1
6883345|NCT00546572|10896225|FG000|Vax 1 / Year 0|Withdrawal by Subject|3
6883346|NCT00546572|10896226|FG001|Vax 1 / Year 0|Withdrawal by Subject|2
6883347|NCT00546572|10896225|FG000|Vax 1 / Year 0|Protocol Violation|3
6883348|NCT00546572|10896226|FG001|Vax 1 / Year 0|Protocol Violation|4
6883349|NCT00546572|10896225|FG000|Vax 1 / Year 0|Death|2
6883350|NCT00546572|10896226|FG001|Vax 1 / Year 0|Death|2
6883351|NCT00546572|10896225|FG000|Vax 1 / Year 0|Adverse Event|0
6883352|NCT00546572|10896226|FG001|Vax 1 / Year 0|Adverse Event|1
6883353|NCT00546572|10896225|FG000|Vax 1 / Year 0|Lost to Follow-up|0
6883354|NCT00546572|10896226|FG001|Vax 1 / Year 0|Lost to Follow-up|1
6883355|NCT00546572|10896225|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64
6883356|NCT00546572|10896226|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59
6883357|NCT00546572|10896225|FG000|Vax 2 / Year 1|Other|1
6883358|NCT00546572|10896226|FG001|Vax 2 / Year 1|Other|1
6883359|NCT00546572|10896225|FG000|Vax 2 / Year 1|Adverse Event|1
6883360|NCT00546572|10896226|FG001|Vax 2 / Year 1|Adverse Event|0
6883361|NCT00546572|10896225|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2
6883362|NCT00546572|10896226|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1
6883363|NCT00546637|10896245|FG000|Overall Study|Adverse Event|46
6883364|NCT00546637|10896246|FG001|Overall Study|Adverse Event|20
6883365|NCT00546637|10896245|FG000|Overall Study|Lack of Efficacy|5
6883366|NCT00546637|10896246|FG001|Overall Study|Lack of Efficacy|5
6883367|NCT00546637|10896245|FG000|Overall Study|Lost to Follow-up|2
6883368|NCT00546637|10896246|FG001|Overall Study|Lost to Follow-up|2
6883369|NCT00546637|10896245|FG000|Overall Study|Other|10
6883370|NCT00546637|10896246|FG001|Overall Study|Other|12
6883371|NCT00546637|10896245|FG000|Overall Study|Withdrawal by Subject|7
6883372|NCT00546637|10896246|FG001|Overall Study|Withdrawal by Subject|9
6883373|NCT00546637|10896245|FG000|Overall Study|Randomized, but not treated|3
6883374|NCT00546637|10896246|FG001|Overall Study|Randomized, but not treated|1
6883375|NCT00546715|10896256|FG000|Overall Study|Withdrawal by Subject|0
6883376|NCT00546715|10896257|FG001|Overall Study|Withdrawal by Subject|1
6883377|NCT00546715|10896258|FG002|Overall Study|Withdrawal by Subject|0
6883378|NCT00546715|10896259|FG003|Overall Study|Withdrawal by Subject|0
6883379|NCT00546819|10896280|FG000|Overall Study|Adverse Event|2
6883380|NCT00546819|10896281|FG001|Overall Study|Adverse Event|3
6883381|NCT00546819|10896280|FG000|Overall Study|Lost to Follow-up|2
6883382|NCT00546819|10896281|FG001|Overall Study|Lost to Follow-up|1
6883383|NCT00546819|10896280|FG000|Overall Study|Withdrawal by Subject|4
6883384|NCT00546819|10896281|FG001|Overall Study|Withdrawal by Subject|2
6883385|NCT00546871|10896287|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1
6883386|NCT00546871|10896288|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0
6883387|NCT00546871|10896287|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1
6883388|NCT00546871|10896288|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2
6883389|NCT00546871|10896287|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0
6883390|NCT00546871|10896288|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1
6883391|NCT00546871|10896287|FG000|Study Extension Period|Protocol Violation|1
6883392|NCT00546871|10896288|FG001|Study Extension Period|Protocol Violation|0
6883393|NCT00546871|10896287|FG000|Study Extension Period|Withdrawal by Subject|0
6883394|NCT00546871|10896288|FG001|Study Extension Period|Withdrawal by Subject|1
6883395|NCT00546910|10896337|FG000|Overall Study|Adverse Event|2
6883396|NCT00546910|10896338|FG001|Overall Study|Adverse Event|3
6883397|NCT00546910|10896337|FG000|Overall Study|Lack of Efficacy|5
6883398|NCT00546910|10896338|FG001|Overall Study|Lack of Efficacy|7
6883399|NCT00546910|10896337|FG000|Overall Study|Physician Decision|0
6883400|NCT00546910|10896338|FG001|Overall Study|Physician Decision|1
6883401|NCT00546910|10896337|FG000|Overall Study|Withdrawal by Subject|2
6883402|NCT00546910|10896338|FG001|Overall Study|Withdrawal by Subject|0
6883403|NCT00547118|10896350|FG000|Overall Study|Did not qualify prior to starting drug|1
6883404|NCT00547118|10896351|FG001|Overall Study|Did not qualify prior to starting drug|1
6883405|NCT00547118|10896350|FG000|Overall Study|Study suspended|7
6883406|NCT00547118|10896351|FG001|Overall Study|Study suspended|8
6883407|NCT00547157|10896361|FG000|Overall Study|Other|1
6883408|NCT00547157|10896362|FG001|Overall Study|Other|0
6883409|NCT00547157|10896361|FG000|Overall Study|Death|38
6883410|NCT00547157|10896362|FG001|Overall Study|Death|18
6883411|NCT00547157|10896361|FG000|Overall Study|Withdrawal by Subject|3
6883412|NCT00547157|10896362|FG001|Overall Study|Withdrawal by Subject|1
6883413|NCT00547157|10896361|FG000|Overall Study|Administrative decision|3
6883414|NCT00547157|10896362|FG001|Overall Study|Administrative decision|2
6883415|NCT00547157|10896361|FG000|Overall Study|Lost to Follow-up|4
6883416|NCT00547157|10896362|FG001|Overall Study|Lost to Follow-up|2
6883417|NCT00547248|10896372|FG000|Overall Study|Protocol Violation|0
6883418|NCT00547248|10896373|FG001|Overall Study|Protocol Violation|0
6883419|NCT00547248|10896374|FG002|Overall Study|Protocol Violation|1
6883420|NCT00547248|10896375|FG003|Overall Study|Protocol Violation|1
6883421|NCT00547248|10896372|FG000|Overall Study|Migrated/moved from study area|0
6883422|NCT00547248|10896373|FG001|Overall Study|Migrated/moved from study area|0
6883423|NCT00547248|10896374|FG002|Overall Study|Migrated/moved from study area|2
6883424|NCT00547248|10896375|FG003|Overall Study|Migrated/moved from study area|0
6883425|NCT00547248|10896372|FG000|Overall Study|Withdrawal by Subject|0
6883426|NCT00547248|10896373|FG001|Overall Study|Withdrawal by Subject|0
6883427|NCT00547248|10896374|FG002|Overall Study|Withdrawal by Subject|7
6883428|NCT00547248|10896375|FG003|Overall Study|Withdrawal by Subject|1
6883429|NCT00547365|10896388|FG000|Overall Study|Physician Decision|1
6883430|NCT00547365|10896388|FG000|Overall Study|Lost to Follow-up|1
6883431|NCT00547365|10896388|FG000|Overall Study|Protocol Violation|2
6883432|NCT00547365|10896388|FG000|Overall Study|death (not related to study)|4
6883433|NCT00547378|10896396|FG000|Randomized Cohort|Withdrawal by Subject|7
6883434|NCT00547378|10896397|FG001|Randomized Cohort|Withdrawal by Subject|5
6883435|NCT00547378|10896398|FG002|Randomized Cohort|Withdrawal by Subject|0
6883436|NCT00547378|10896396|FG000|Randomized Cohort|Death|0
6883437|NCT00547378|10896397|FG001|Randomized Cohort|Death|1
6883438|NCT00547378|10896398|FG002|Randomized Cohort|Death|0
6883439|NCT00547378|10896396|FG000|Randomized Cohort|Lost to Follow-up|1
6883440|NCT00547378|10896397|FG001|Randomized Cohort|Lost to Follow-up|0
6883441|NCT00547378|10896398|FG002|Randomized Cohort|Lost to Follow-up|0
6883442|NCT00547378|10896396|FG000|Randomized Cohort|Adverse Event|1
6883443|NCT00547378|10896397|FG001|Randomized Cohort|Adverse Event|0
6883444|NCT00547378|10896398|FG002|Randomized Cohort|Adverse Event|0
6883445|NCT00547378|10896396|FG000|Randomized Cohort|Other reasons|2
6883446|NCT00547378|10896397|FG001|Randomized Cohort|Other reasons|0
6883447|NCT00547378|10896398|FG002|Randomized Cohort|Other reasons|0
6883448|NCT00547378|10896396|FG000|All Implanted Cohort|Withdrawal by Subject|5
6883449|NCT00547378|10896397|FG001|All Implanted Cohort|Withdrawal by Subject|4
6883450|NCT00547378|10896398|FG002|All Implanted Cohort|Withdrawal by Subject|27
6883451|NCT00547378|10896396|FG000|All Implanted Cohort|Adverse Event|4
6883452|NCT00547378|10896397|FG001|All Implanted Cohort|Adverse Event|10
6883453|NCT00547378|10896398|FG002|All Implanted Cohort|Adverse Event|17
6883454|NCT00547378|10896396|FG000|All Implanted Cohort|Lost to Follow-up|0
6883455|NCT00547378|10896397|FG001|All Implanted Cohort|Lost to Follow-up|1
6883456|NCT00547378|10896398|FG002|All Implanted Cohort|Lost to Follow-up|14
6883457|NCT00547378|10896396|FG000|All Implanted Cohort|Death|3
6883458|NCT00547378|10896397|FG001|All Implanted Cohort|Death|1
6883459|NCT00547378|10896398|FG002|All Implanted Cohort|Death|4
6883460|NCT00547378|10896396|FG000|All Implanted Cohort|Physician Decision|0
6883461|NCT00547378|10896397|FG001|All Implanted Cohort|Physician Decision|2
6883462|NCT00547378|10896398|FG002|All Implanted Cohort|Physician Decision|6
6883463|NCT00547378|10896396|FG000|All Implanted Cohort|Site closure|2
6883464|NCT00547378|10896397|FG001|All Implanted Cohort|Site closure|0
6883465|NCT00547378|10896398|FG002|All Implanted Cohort|Site closure|1
6883466|NCT00547378|10896396|FG000|All Implanted Cohort|Other reasons|1
6883467|NCT00547378|10896397|FG001|All Implanted Cohort|Other reasons|0
6883468|NCT00547378|10896398|FG002|All Implanted Cohort|Other reasons|1
6883469|NCT00547521|10896408|FG000|Short Term Study (4 Months)|Adverse Event|1
6883470|NCT00547521|10896409|FG001|Short Term Study (4 Months)|Adverse Event|0
6883471|NCT00547521|10896408|FG000|Short Term Study (4 Months)|Lack of Efficacy|0
6883472|NCT00547521|10896409|FG001|Short Term Study (4 Months)|Lack of Efficacy|2
6883473|NCT00547521|10896408|FG000|Short Term Study (4 Months)|Withdrawal of consent|0
6883474|NCT00547521|10896409|FG001|Short Term Study (4 Months)|Withdrawal of consent|1
6883475|NCT00547521|10896408|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0
6883476|NCT00547521|10896409|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1
6883477|NCT00547521|10896408|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0
6883478|NCT00547521|10896409|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14
6883479|NCT00547521|10896408|FG000|Long Term Extension (LTE) Study|Adverse Event|0
6883480|NCT00547521|10896409|FG001|Long Term Extension (LTE) Study|Adverse Event|9
6883481|NCT00547521|10896408|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0
6883482|NCT00547521|10896409|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3
6883483|NCT00547521|10896408|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0
6883484|NCT00547521|10896409|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2
6883485|NCT00547521|10896408|FG000|Long Term Extension (LTE) Study|Other|0
6883486|NCT00547521|10896409|FG001|Long Term Extension (LTE) Study|Other|2
6883487|NCT00547521|10896408|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0
6883488|NCT00547521|10896409|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1
6883489|NCT00547534|10896422|FG000|Overall Study|Adverse Event|7
6883490|NCT00547534|10896422|FG000|Overall Study|Disease Progression|4
6883491|NCT00547703|10896459|FG000|Overall Study|Lost to Follow-up|1
6883492|NCT00547703|10896460|FG001|Overall Study|Lost to Follow-up|0
6883493|NCT00547911|10896493|FG000|Overall Study|Adverse Event|0
6883494|NCT00547911|10896494|FG001|Overall Study|Adverse Event|0
6883495|NCT00547911|10896495|FG002|Overall Study|Adverse Event|0
6883496|NCT00547911|10896496|FG003|Overall Study|Adverse Event|1
6883497|NCT00547911|10896497|FG004|Overall Study|Adverse Event|0
6883498|NCT00547911|10896498|FG005|Overall Study|Adverse Event|0
6883499|NCT00548145|10896528|FG000|Overall Study|Death|0
6883500|NCT00548145|10896529|FG001|Overall Study|Death|1
6883501|NCT00548145|10896528|FG000|Overall Study|Withdrawal by Subject|0
6883502|NCT00548145|10896529|FG001|Overall Study|Withdrawal by Subject|2
6883503|NCT00548145|10896528|FG000|Overall Study|Physician Decision|1
6883504|NCT00548145|10896529|FG001|Overall Study|Physician Decision|1
6883505|NCT00548184|10896544|FG000|Overall Study|Adverse Event|3
6883506|NCT00548184|10896544|FG000|Overall Study|took other drug|1
6883507|NCT00548184|10896544|FG000|Overall Study|Found Her2 negative|1
6883508|NCT00548249|10896564|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3
6883509|NCT00548249|10896565|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
6883510|NCT00548249|10896566|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
6883511|NCT00548249|10896567|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2
6883512|NCT00548249|10896568|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
6883513|NCT00548249|10896564|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5
6883514|NCT00548249|10896565|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1
6883515|NCT00548249|10896566|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3
6883516|NCT00548249|10896567|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1
6883517|NCT00548249|10896568|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2
6883518|NCT00548249|10896564|FG000|Overall Study|Protocol Violation|1
6883519|NCT00548249|10896565|FG001|Overall Study|Protocol Violation|1
6883520|NCT00548249|10896566|FG002|Overall Study|Protocol Violation|4
6883521|NCT00548249|10896567|FG003|Overall Study|Protocol Violation|0
6883522|NCT00548249|10896568|FG004|Overall Study|Protocol Violation|3
6883523|NCT00548249|10896564|FG000|Overall Study|Miscellaneous|2
6883524|NCT00548249|10896565|FG001|Overall Study|Miscellaneous|3
6883525|NCT00548249|10896566|FG002|Overall Study|Miscellaneous|2
6883526|NCT00548249|10896567|FG003|Overall Study|Miscellaneous|0
6883527|NCT00548249|10896568|FG004|Overall Study|Miscellaneous|2
6883528|NCT00548249|10896564|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
6883529|NCT00548249|10896565|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
6883530|NCT00548249|10896566|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2
6883531|NCT00548249|10896567|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1
6883532|NCT00548249|10896568|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4
6883533|NCT00548249|10896564|FG000|Overall Study|Adverse Event|2
6883534|NCT00548249|10896565|FG001|Overall Study|Adverse Event|2
6883535|NCT00548249|10896566|FG002|Overall Study|Adverse Event|0
6883536|NCT00548249|10896567|FG003|Overall Study|Adverse Event|1
6883537|NCT00548249|10896568|FG004|Overall Study|Adverse Event|1
6883538|NCT00548249|10896564|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0
6883539|NCT00548249|10896565|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0
6883540|NCT00548249|10896566|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1
6883541|NCT00548249|10896567|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3
6883542|NCT00548249|10896568|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2
6969772|NCT01149655|11019444|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19
6969773|NCT01149655|11019445|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18
6969774|NCT01149681|11019453|FG000|Overall Study|Withdrawal by Subject|7
6969775|NCT01149681|11019453|FG000|Overall Study|Progressive disease|1
6969776|NCT01149681|11019453|FG000|Overall Study|Physician Decision|2
6969777|NCT01149681|11019453|FG000|Overall Study|adverse events nonrelated study drug|2
6969778|NCT01149863|11019489|FG000|Overall Study|Missing data or Not receiveing studydrug|3
6969779|NCT01150097|11019514|FG000|Months 24 to 36 Post-transplantation|Death|2
6969780|NCT01150097|11019515|FG001|Months 24 to 36 Post-transplantation|Death|0
6969781|NCT01150097|11019516|FG002|Months 24 to 36 Post-transplantation|Death|0
6969782|NCT01150097|11019514|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5
6883543|NCT00548249|10896564|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0
6883544|NCT00548249|10896565|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0
6883545|NCT00548249|10896566|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1
6883546|NCT00548249|10896567|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2
6883547|NCT00548249|10896568|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2
6883548|NCT00548249|10896564|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
6883549|NCT00548249|10896565|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
6883550|NCT00548249|10896566|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
6883551|NCT00548249|10896567|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
6883552|NCT00548249|10896568|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0
6883553|NCT00548249|10896564|FG000|Overall Study|Prolonged hospitalization|0
6883554|NCT00548249|10896565|FG001|Overall Study|Prolonged hospitalization|0
6883555|NCT00548249|10896566|FG002|Overall Study|Prolonged hospitalization|2
6883556|NCT00548249|10896567|FG003|Overall Study|Prolonged hospitalization|1
6883557|NCT00548249|10896568|FG004|Overall Study|Prolonged hospitalization|0
6883558|NCT00548249|10896564|FG000|Overall Study|Withdrawal by Subject|2
6883559|NCT00548249|10896565|FG001|Overall Study|Withdrawal by Subject|0
6883560|NCT00548249|10896566|FG002|Overall Study|Withdrawal by Subject|0
6883561|NCT00548249|10896567|FG003|Overall Study|Withdrawal by Subject|0
6883562|NCT00548249|10896568|FG004|Overall Study|Withdrawal by Subject|0
6883563|NCT00548249|10896564|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
6883564|NCT00548249|10896565|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
6883565|NCT00548249|10896566|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
6883566|NCT00548249|10896567|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
6883567|NCT00548249|10896568|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
6883568|NCT00548249|10896564|FG000|Overall Study|Sponsor's request|0
6883569|NCT00548249|10896565|FG001|Overall Study|Sponsor's request|0
6883570|NCT00548249|10896566|FG002|Overall Study|Sponsor's request|0
6883571|NCT00548249|10896567|FG003|Overall Study|Sponsor's request|1
6883572|NCT00548249|10896568|FG004|Overall Study|Sponsor's request|0
6883573|NCT00548262|10896580|FG000|Overall Study|Death|21
6883574|NCT00548262|10896580|FG000|Overall Study|Adverse Event|2
6883575|NCT00548262|10896580|FG000|Overall Study|Lack of Efficacy|4
6883576|NCT00548262|10896580|FG000|Overall Study|Lost to Follow-up|1
6883577|NCT00548262|10896580|FG000|Overall Study|Other|3
6883578|NCT00548262|10896580|FG000|Overall Study|Withdrawal by Subject|1
6883579|NCT00548340|10896587|FG000|Overall Study|Protocol Violation|2
6883580|NCT00548340|10896588|FG001|Overall Study|Protocol Violation|3
6883581|NCT00548340|10896589|FG002|Overall Study|Protocol Violation|3
6883582|NCT00548340|10896587|FG000|Overall Study|Adverse Event|2
6883583|NCT00548340|10896588|FG001|Overall Study|Adverse Event|2
6883584|NCT00548340|10896589|FG002|Overall Study|Adverse Event|2
6883585|NCT00548340|10896587|FG000|Overall Study|Lost to Follow-up|1
6883586|NCT00548340|10896588|FG001|Overall Study|Lost to Follow-up|1
6883587|NCT00548340|10896589|FG002|Overall Study|Lost to Follow-up|0
6883588|NCT00548340|10896587|FG000|Overall Study|Withdrawal by Subject|2
6883589|NCT00548340|10896588|FG001|Overall Study|Withdrawal by Subject|4
6883590|NCT00548340|10896589|FG002|Overall Study|Withdrawal by Subject|3
6883591|NCT00548340|10896587|FG000|Overall Study|Other|1
6883592|NCT00548340|10896588|FG001|Overall Study|Other|1
6883593|NCT00548340|10896589|FG002|Overall Study|Other|1
6883594|NCT00548405|10896600|FG000|Overall Study|Adverse Event|6
6883595|NCT00548405|10896601|FG001|Overall Study|Adverse Event|2
6883596|NCT00548405|10896602|FG002|Overall Study|Adverse Event|0
6883597|NCT00548405|10896600|FG000|Overall Study|Lack of Efficacy|6
6883598|NCT00548405|10896601|FG001|Overall Study|Lack of Efficacy|0
6883599|NCT00548405|10896602|FG002|Overall Study|Lack of Efficacy|0
6883600|NCT00548405|10896600|FG000|Overall Study|Physician Decision|3
6883601|NCT00548405|10896601|FG001|Overall Study|Physician Decision|4
6883602|NCT00548405|10896602|FG002|Overall Study|Physician Decision|1
6883603|NCT00548405|10896600|FG000|Overall Study|Pregnancy|1
6883604|NCT00548405|10896601|FG001|Overall Study|Pregnancy|0
6883605|NCT00548405|10896602|FG002|Overall Study|Pregnancy|0
6883606|NCT00548405|10896600|FG000|Overall Study|Protocol Violation|1
6883607|NCT00548405|10896601|FG001|Overall Study|Protocol Violation|0
6883608|NCT00548405|10896602|FG002|Overall Study|Protocol Violation|0
6883609|NCT00548405|10896600|FG000|Overall Study|Withdrawal by Subject|36
6883610|NCT00548405|10896601|FG001|Overall Study|Withdrawal by Subject|12
6883611|NCT00548405|10896602|FG002|Overall Study|Withdrawal by Subject|5
6883612|NCT00548405|10896600|FG000|Overall Study|Lost to Follow-up|1
6883613|NCT00548405|10896601|FG001|Overall Study|Lost to Follow-up|1
6883614|NCT00548405|10896602|FG002|Overall Study|Lost to Follow-up|2
6883615|NCT00548405|10896600|FG000|Overall Study|Death|0
6883616|NCT00548405|10896601|FG001|Overall Study|Death|1
6883617|NCT00548405|10896602|FG002|Overall Study|Death|1
6883618|NCT00548405|10896600|FG000|Overall Study|Sponsor decision|1
6883619|NCT00548405|10896601|FG001|Overall Study|Sponsor decision|0
6883620|NCT00548405|10896602|FG002|Overall Study|Sponsor decision|0
6883621|NCT00548405|10896600|FG000|Overall Study|Randomized but not treated|1
6883622|NCT00548405|10896601|FG001|Overall Study|Randomized but not treated|0
6883623|NCT00548405|10896602|FG002|Overall Study|Randomized but not treated|0
6883624|NCT00548548|10896625|FG000|Overall Study|Death|345
6883625|NCT00548548|10896626|FG001|Overall Study|Death|348
6883626|NCT00548548|10896625|FG000|Overall Study|Lost to Follow-up|17
6883627|NCT00548548|10896626|FG001|Overall Study|Lost to Follow-up|18
6883628|NCT00548717|10896656|FG000|Overall Study|Death|5
6883629|NCT00548717|10896657|FG001|Overall Study|Death|2
6883630|NCT00548717|10896656|FG000|Overall Study|Relapse|3
6883631|NCT00548717|10896657|FG001|Overall Study|Relapse|0
6883632|NCT00548717|10896656|FG000|Overall Study|Alternative treatment for GVHD|1
6883633|NCT00548717|10896657|FG001|Overall Study|Alternative treatment for GVHD|0
6883634|NCT00548808|10896668|FG000|Overall Study|Lost to Follow-up|9
6883635|NCT00548808|10896669|FG001|Overall Study|Lost to Follow-up|3
6883636|NCT00548808|10896668|FG000|Overall Study|Protocol Violation|8
6883637|NCT00548808|10896669|FG001|Overall Study|Protocol Violation|8
6883638|NCT00548808|10896668|FG000|Overall Study|Withdrawal by Subject|8
6883639|NCT00548808|10896669|FG001|Overall Study|Withdrawal by Subject|4
6883640|NCT00548808|10896668|FG000|Overall Study|Physician Decision|6
6883641|NCT00548808|10896669|FG001|Overall Study|Physician Decision|3
6883642|NCT00548808|10896668|FG000|Overall Study|Adverse Event|4
6883643|NCT00548808|10896669|FG001|Overall Study|Adverse Event|5
6883644|NCT00548808|10896668|FG000|Overall Study|Death|2
6883645|NCT00548808|10896669|FG001|Overall Study|Death|0
6883646|NCT00548808|10896668|FG000|Overall Study|Entry Criteria Not Met|2
6883647|NCT00548808|10896669|FG001|Overall Study|Entry Criteria Not Met|2
6883648|NCT00548808|10896668|FG000|Overall Study|Lack of Efficacy|2
6883649|NCT00548808|10896669|FG001|Overall Study|Lack of Efficacy|0
6883650|NCT00548808|10896668|FG000|Overall Study|Sponsor Decision|1
6883651|NCT00548808|10896669|FG001|Overall Study|Sponsor Decision|1
6883652|NCT00548847|10896675|FG000|Overall Study|Disease progression|7
6883653|NCT00549055|10896698|FG000|Overall Study|Adverse Event|4
6883654|NCT00549055|10896698|FG000|Overall Study|Lack of Efficacy|18
6883655|NCT00549055|10896698|FG000|Overall Study|Stabilization|5
6883656|NCT00549055|10896698|FG000|Overall Study|Progression to fibrosis|2
6883657|NCT00549055|10896698|FG000|Overall Study|Decrease of size|1
6883658|NCT00549055|10896698|FG000|Overall Study|Active choroidal neovascula increased|1
6883659|NCT00549055|10896698|FG000|Overall Study|Vitreous hemorrhage|1
6883660|NCT00549055|10896698|FG000|Overall Study|Growth choroidal neovascularisation|1
6883661|NCT00549055|10896698|FG000|Overall Study|Choroidal neovascularization|1
6883662|NCT00549055|10896698|FG000|Overall Study|Very low visual acuity (VA)|1
6883663|NCT00549198|10896713|FG000|Overall Study|Adverse Event|28
6883664|NCT00549198|10896714|FG001|Overall Study|Adverse Event|26
6883665|NCT00549198|10896713|FG000|Overall Study|Insufficient Viral Load Response|4
6883666|NCT00549198|10896714|FG001|Overall Study|Insufficient Viral Load Response|2
6883667|NCT00549198|10896713|FG000|Overall Study|Protocol-defined Virological Failure|7
6883668|NCT00549198|10896714|FG001|Overall Study|Protocol-defined Virological Failure|0
6883669|NCT00549198|10896713|FG000|Overall Study|Non-compliance|2
6883670|NCT00549198|10896714|FG001|Overall Study|Non-compliance|4
6883671|NCT00549198|10896713|FG000|Overall Study|Lost to Follow-up|7
6883672|NCT00549198|10896714|FG001|Overall Study|Lost to Follow-up|8
6883673|NCT00549198|10896713|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3
6883674|NCT00549198|10896714|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0
6883675|NCT00549198|10896713|FG000|Overall Study|Protocol Violation|7
6883676|NCT00549198|10896714|FG001|Overall Study|Protocol Violation|2
6883677|NCT00549198|10896713|FG000|Overall Study|Investigator Decision|4
6883678|NCT00549198|10896714|FG001|Overall Study|Investigator Decision|3
6883679|NCT00549198|10896713|FG000|Overall Study|Withdrawal by Subject|7
6883680|NCT00549198|10896714|FG001|Overall Study|Withdrawal by Subject|7
6883681|NCT00549198|10896713|FG000|Overall Study|Disease Progression|1
6883682|NCT00549198|10896714|FG001|Overall Study|Disease Progression|0
6883683|NCT00549198|10896713|FG000|Overall Study|Participant Moved|2
6883684|NCT00549198|10896714|FG001|Overall Study|Participant Moved|0
6883685|NCT00549198|10896713|FG000|Overall Study|Participant not able to perform Week 96|1
6883686|NCT00549198|10896714|FG001|Overall Study|Participant not able to perform Week 96|0
6883687|NCT00549198|10896713|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1
6883688|NCT00549198|10896714|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0
6883689|NCT00549198|10896713|FG000|Overall Study|Prohibited Medication|1
6883690|NCT00549198|10896714|FG001|Overall Study|Prohibited Medication|2
6883691|NCT00549198|10896713|FG000|Overall Study|Participant planning pregnancy|1
6883692|NCT00549198|10896714|FG001|Overall Study|Participant planning pregnancy|0
6883693|NCT00549198|10896713|FG000|Overall Study|Participant overweight, no scan possible|1
6883694|NCT00549198|10896714|FG001|Overall Study|Participant overweight, no scan possible|0
6883695|NCT00549198|10896713|FG000|Overall Study|No scan facilities|0
6883696|NCT00549198|10896714|FG001|Overall Study|No scan facilities|2
6883697|NCT00549198|10896713|FG000|Overall Study|Pregnancy|0
6883698|NCT00549198|10896714|FG001|Overall Study|Pregnancy|3
6883699|NCT00549198|10896713|FG000|Overall Study|Not Exposed to Study Drug|3
6883700|NCT00549198|10896714|FG001|Overall Study|Not Exposed to Study Drug|4
6883701|NCT00549302|10896722|FG000|Double-Blind|Death|2
6883702|NCT00549302|10896723|FG001|Double-Blind|Death|9
6883703|NCT00549302|10896724|FG002|Double-Blind|Death|0
6883704|NCT00549302|10896722|FG000|Double-Blind|Adverse Event|3
6883705|NCT00549302|10896723|FG001|Double-Blind|Adverse Event|16
6883706|NCT00549302|10896724|FG002|Double-Blind|Adverse Event|0
6883707|NCT00549302|10896722|FG000|Double-Blind|Withdrawal by Subject|3
6883708|NCT00549302|10896723|FG001|Double-Blind|Withdrawal by Subject|8
6883709|NCT00549302|10896724|FG002|Double-Blind|Withdrawal by Subject|0
6883710|NCT00549302|10896722|FG000|Double-Blind|Investigator Decision|1
6883711|NCT00549302|10896723|FG001|Double-Blind|Investigator Decision|5
6883712|NCT00549302|10896724|FG002|Double-Blind|Investigator Decision|0
6883713|NCT00549302|10896722|FG000|Double-Blind|Sponsor Decision|0
6883714|NCT00549302|10896723|FG001|Double-Blind|Sponsor Decision|1
6883715|NCT00549302|10896724|FG002|Double-Blind|Sponsor Decision|0
6883716|NCT00549302|10896722|FG000|Double-Blind|Lost to Follow-up|1
6883717|NCT00549302|10896723|FG001|Double-Blind|Lost to Follow-up|2
6883718|NCT00549302|10896724|FG002|Double-Blind|Lost to Follow-up|0
6883719|NCT00549302|10896722|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1
6883720|NCT00549302|10896723|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10
6883721|NCT00549302|10896724|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0
6883722|NCT00549302|10896722|FG000|Double-Blind|New condition or starts new therapy|0
6883723|NCT00549302|10896723|FG001|Double-Blind|New condition or starts new therapy|2
6883724|NCT00549302|10896724|FG002|Double-Blind|New condition or starts new therapy|0
6883725|NCT00549302|10896722|FG000|Open-Label|Adverse Event|0
6883726|NCT00549302|10896723|FG001|Open-Label|Adverse Event|0
6883727|NCT00549302|10896724|FG002|Open-Label|Adverse Event|11
6883728|NCT00549302|10896722|FG000|Open-Label|Death|0
6883729|NCT00549302|10896723|FG001|Open-Label|Death|0
6883730|NCT00549302|10896724|FG002|Open-Label|Death|40
6883731|NCT00549302|10896722|FG000|Open-Label|Investigator Decision|0
6883732|NCT00549302|10896723|FG001|Open-Label|Investigator Decision|0
6883733|NCT00549302|10896724|FG002|Open-Label|Investigator Decision|5
6883734|NCT00549302|10896722|FG000|Open-Label|Lost to Follow-up|0
6883735|NCT00549302|10896723|FG001|Open-Label|Lost to Follow-up|0
6883736|NCT00549302|10896724|FG002|Open-Label|Lost to Follow-up|2
6883737|NCT00549302|10896722|FG000|Open-Label|Other|0
6883738|NCT00549302|10896723|FG001|Open-Label|Other|0
6883739|NCT00549302|10896724|FG002|Open-Label|Other|3
6883740|NCT00549302|10896722|FG000|Open-Label|New drug pulmonary atrial hypertension|0
6883741|NCT00549302|10896723|FG001|Open-Label|New drug pulmonary atrial hypertension|0
6883742|NCT00549302|10896724|FG002|Open-Label|New drug pulmonary atrial hypertension|2
6883743|NCT00549302|10896722|FG000|Open-Label|Withdrawal by Subject|0
6883744|NCT00549302|10896723|FG001|Open-Label|Withdrawal by Subject|0
6883745|NCT00549302|10896724|FG002|Open-Label|Withdrawal by Subject|6
6883746|NCT00549445|10896745|FG000|Overall Study|Sputum & Blood Samples Not Available|15
6883747|NCT00549445|10896746|FG001|Overall Study|Sputum & Blood Samples Not Available|17
6883748|NCT00549549|10896756|FG000|Overall Study|Adverse Event|5
6883749|NCT00549549|10896757|FG001|Overall Study|Adverse Event|3
6883750|NCT00549549|10896758|FG002|Overall Study|Adverse Event|1
6883751|NCT00549549|10896759|FG003|Overall Study|Adverse Event|9
6883752|NCT00549549|10896756|FG000|Overall Study|Lack of Efficacy|9
6883753|NCT00549549|10896757|FG001|Overall Study|Lack of Efficacy|6
6883754|NCT00549549|10896758|FG002|Overall Study|Lack of Efficacy|4
6883755|NCT00549549|10896759|FG003|Overall Study|Lack of Efficacy|2
6883756|NCT00549549|10896756|FG000|Overall Study|Lost to Follow-up|1
6883757|NCT00549549|10896757|FG001|Overall Study|Lost to Follow-up|0
6883758|NCT00549549|10896758|FG002|Overall Study|Lost to Follow-up|1
6883759|NCT00549549|10896759|FG003|Overall Study|Lost to Follow-up|2
6883760|NCT00549549|10896756|FG000|Overall Study|Withdrawal by Subject|0
6883761|NCT00549549|10896757|FG001|Overall Study|Withdrawal by Subject|4
6883762|NCT00549549|10896758|FG002|Overall Study|Withdrawal by Subject|1
6883763|NCT00549549|10896759|FG003|Overall Study|Withdrawal by Subject|0
6883764|NCT00549549|10896756|FG000|Overall Study|Other|9
6883765|NCT00549549|10896757|FG001|Overall Study|Other|9
6883766|NCT00549549|10896758|FG002|Overall Study|Other|9
6883767|NCT00549549|10896759|FG003|Overall Study|Other|11
6883768|NCT00549549|10896756|FG000|Overall Study|Randomized but not treated|0
6883769|NCT00549549|10896757|FG001|Overall Study|Randomized but not treated|0
6883770|NCT00549549|10896758|FG002|Overall Study|Randomized but not treated|1
6883771|NCT00549549|10896759|FG003|Overall Study|Randomized but not treated|1
6883772|NCT00549562|10896769|FG000|Overall Study|Adverse Event|1
6883773|NCT00549562|10896769|FG000|Overall Study|Lack of Efficacy|1
6883774|NCT00549601|10896776|FG000|Randomized|Protocol Violation|0
6883775|NCT00549601|10896777|FG001|Randomized|Protocol Violation|0
6883776|NCT00549601|10896778|FG002|Randomized|Protocol Violation|1
6883777|NCT00549601|10896776|FG000|Randomized|Withdrawal by Subject|0
6883778|NCT00549601|10896777|FG001|Randomized|Withdrawal by Subject|1
6883779|NCT00549601|10896778|FG002|Randomized|Withdrawal by Subject|1
6883780|NCT00549601|10896776|FG000|Received Study Drug|Adverse Event|2
6883781|NCT00549601|10896777|FG001|Received Study Drug|Adverse Event|5
6883782|NCT00549601|10896778|FG002|Received Study Drug|Adverse Event|1
6883783|NCT00549601|10896776|FG000|Received Study Drug|Death|0
6883784|NCT00549601|10896777|FG001|Received Study Drug|Death|1
6883785|NCT00549601|10896778|FG002|Received Study Drug|Death|0
6883786|NCT00549601|10896776|FG000|Received Study Drug|Lost to Follow-up|0
6883787|NCT00549601|10896777|FG001|Received Study Drug|Lost to Follow-up|1
6883788|NCT00549601|10896778|FG002|Received Study Drug|Lost to Follow-up|1
6883789|NCT00549601|10896776|FG000|Received Study Drug|Protocol Violation|3
6883790|NCT00549601|10896777|FG001|Received Study Drug|Protocol Violation|4
6883791|NCT00549601|10896778|FG002|Received Study Drug|Protocol Violation|1
6883792|NCT00549601|10896776|FG000|Received Study Drug|Withdrawal by Subject|2
6883793|NCT00549601|10896777|FG001|Received Study Drug|Withdrawal by Subject|0
6883794|NCT00549601|10896778|FG002|Received Study Drug|Withdrawal by Subject|1
6883795|NCT00549640|10896790|FG000|Overall Study|Withdrawal by Subject|6
6883796|NCT00549640|10896791|FG001|Overall Study|Withdrawal by Subject|12
6883797|NCT00549640|10896790|FG000|Overall Study|Adverse Event|5
6883798|NCT00549640|10896791|FG001|Overall Study|Adverse Event|0
6883799|NCT00549640|10896790|FG000|Overall Study|Lost to Follow-up|7
6883800|NCT00549640|10896791|FG001|Overall Study|Lost to Follow-up|4
6883801|NCT00549718|10896801|FG000|Overall Study|Insufficient clinical response|20
6883802|NCT00549718|10896802|FG001|Overall Study|Insufficient clinical response|7
6883803|NCT00549718|10896803|FG002|Overall Study|Insufficient clinical response|18
6883804|NCT00549718|10896804|FG003|Overall Study|Insufficient clinical response|32
6883805|NCT00549718|10896801|FG000|Overall Study|Adverse Event|6
6883806|NCT00549718|10896802|FG001|Overall Study|Adverse Event|8
6883807|NCT00549718|10896803|FG002|Overall Study|Adverse Event|7
6883808|NCT00549718|10896804|FG003|Overall Study|Adverse Event|3
6883809|NCT00549718|10896801|FG000|Overall Study|Lost to Follow-up|4
6883810|NCT00549718|10896802|FG001|Overall Study|Lost to Follow-up|2
6883811|NCT00549718|10896803|FG002|Overall Study|Lost to Follow-up|0
6883812|NCT00549718|10896804|FG003|Overall Study|Lost to Follow-up|6
6883813|NCT00549718|10896801|FG000|Overall Study|Withdrawal by Subject|9
6883814|NCT00549718|10896802|FG001|Overall Study|Withdrawal by Subject|18
6883815|NCT00549718|10896803|FG002|Overall Study|Withdrawal by Subject|12
6883816|NCT00549718|10896804|FG003|Overall Study|Withdrawal by Subject|13
6883817|NCT00549718|10896801|FG000|Overall Study|Administrative|2
6883818|NCT00549718|10896802|FG001|Overall Study|Administrative|2
6883819|NCT00549718|10896803|FG002|Overall Study|Administrative|2
6883820|NCT00549718|10896804|FG003|Overall Study|Administrative|1
6883821|NCT00549757|10896816|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590
6883822|NCT00549757|10896817|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462
6883823|NCT00549757|10896816|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98
6883824|NCT00549757|10896817|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58
6883825|NCT00549757|10896816|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
6883826|NCT00549757|10896817|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
6883827|NCT00549757|10896816|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47
6883828|NCT00549757|10896817|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53
6883829|NCT00549757|10896816|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
6883830|NCT00549757|10896817|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
6883831|NCT00549757|10896816|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41
6883832|NCT00549757|10896817|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29
6883833|NCT00549757|10896816|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857
6883834|NCT00549757|10896817|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019
6883835|NCT00549757|10896816|FG000|Active Treatment Phase: Max. 50 Months|Death|188
6883836|NCT00549757|10896817|FG001|Active Treatment Phase: Max. 50 Months|Death|200
6883837|NCT00549757|10896816|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353
6883838|NCT00549757|10896817|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380
6883839|NCT00549757|10896816|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69
6883840|NCT00549757|10896817|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55
6883841|NCT00549757|10896816|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8
6883842|NCT00549757|10896817|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9
6883843|NCT00549757|10896816|FG000|Extension Period (in Average 9 Months)|Death|143
6883844|NCT00549757|10896817|FG001|Extension Period (in Average 9 Months)|Death|136
6883845|NCT00549757|10896816|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52
6883846|NCT00549757|10896817|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47
6883847|NCT00549757|10896816|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9
6883848|NCT00549757|10896817|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16
6883849|NCT00549757|10896816|FG000|Extension Period (in Average 9 Months)|Patient's request|421
6883850|NCT00549757|10896817|FG001|Extension Period (in Average 9 Months)|Patient's request|436
6883851|NCT00549770|10896837|FG000|Overall Study|Protocol deviation|1
6883852|NCT00549770|10896838|FG001|Overall Study|Protocol deviation|1
6883853|NCT00549770|10896839|FG002|Overall Study|Protocol deviation|1
6883854|NCT00549770|10896840|FG003|Overall Study|Protocol deviation|2
6883855|NCT00549770|10896841|FG004|Overall Study|Protocol deviation|2
6883856|NCT00549770|10896842|FG005|Overall Study|Protocol deviation|2
6883857|NCT00549770|10896843|FG006|Overall Study|Protocol deviation|1
6883858|NCT00549770|10896844|FG007|Overall Study|Protocol deviation|2
6883859|NCT00549770|10896837|FG000|Overall Study|Administrative problems|0
6883860|NCT00549770|10896838|FG001|Overall Study|Administrative problems|1
6883861|NCT00549770|10896839|FG002|Overall Study|Administrative problems|0
6883862|NCT00549770|10896840|FG003|Overall Study|Administrative problems|0
6883863|NCT00549770|10896841|FG004|Overall Study|Administrative problems|0
6883864|NCT00549770|10896842|FG005|Overall Study|Administrative problems|0
6883865|NCT00549770|10896843|FG006|Overall Study|Administrative problems|0
6883866|NCT00549770|10896844|FG007|Overall Study|Administrative problems|1
6883867|NCT00549770|10896837|FG000|Overall Study|Lost to Follow-up|0
6883868|NCT00549770|10896838|FG001|Overall Study|Lost to Follow-up|0
6883869|NCT00549770|10896839|FG002|Overall Study|Lost to Follow-up|2
6883870|NCT00549770|10896840|FG003|Overall Study|Lost to Follow-up|2
6883871|NCT00549770|10896841|FG004|Overall Study|Lost to Follow-up|3
6883872|NCT00549770|10896842|FG005|Overall Study|Lost to Follow-up|2
6883873|NCT00549770|10896843|FG006|Overall Study|Lost to Follow-up|0
6883874|NCT00549770|10896844|FG007|Overall Study|Lost to Follow-up|0
6883875|NCT00549770|10896837|FG000|Overall Study|Withdrawal by Subject|4
6883876|NCT00549770|10896838|FG001|Overall Study|Withdrawal by Subject|6
6883877|NCT00549770|10896839|FG002|Overall Study|Withdrawal by Subject|4
6883878|NCT00549770|10896840|FG003|Overall Study|Withdrawal by Subject|5
6883879|NCT00549770|10896841|FG004|Overall Study|Withdrawal by Subject|6
6883880|NCT00549770|10896842|FG005|Overall Study|Withdrawal by Subject|6
6883881|NCT00549770|10896843|FG006|Overall Study|Withdrawal by Subject|4
6883882|NCT00549770|10896844|FG007|Overall Study|Withdrawal by Subject|9
6883883|NCT00549770|10896837|FG000|Overall Study|Lack of Efficacy|1
6883884|NCT00549770|10896838|FG001|Overall Study|Lack of Efficacy|0
6883885|NCT00549770|10896839|FG002|Overall Study|Lack of Efficacy|2
6883886|NCT00549770|10896840|FG003|Overall Study|Lack of Efficacy|3
6883887|NCT00549770|10896841|FG004|Overall Study|Lack of Efficacy|5
6883888|NCT00549770|10896842|FG005|Overall Study|Lack of Efficacy|1
6883889|NCT00549770|10896843|FG006|Overall Study|Lack of Efficacy|3
6883890|NCT00549770|10896844|FG007|Overall Study|Lack of Efficacy|8
6883891|NCT00549770|10896837|FG000|Overall Study|Abnormal test procedure results|0
6883892|NCT00549770|10896838|FG001|Overall Study|Abnormal test procedure results|0
6883893|NCT00549770|10896839|FG002|Overall Study|Abnormal test procedure results|0
6883894|NCT00549770|10896840|FG003|Overall Study|Abnormal test procedure results|2
6883895|NCT00549770|10896841|FG004|Overall Study|Abnormal test procedure results|0
6883896|NCT00549770|10896842|FG005|Overall Study|Abnormal test procedure results|1
6883897|NCT00549770|10896843|FG006|Overall Study|Abnormal test procedure results|1
6883898|NCT00549770|10896844|FG007|Overall Study|Abnormal test procedure results|1
6883899|NCT00549770|10896837|FG000|Overall Study|Abnormal laboratory values|0
6883900|NCT00549770|10896838|FG001|Overall Study|Abnormal laboratory values|0
6883901|NCT00549770|10896839|FG002|Overall Study|Abnormal laboratory values|0
6883902|NCT00549770|10896840|FG003|Overall Study|Abnormal laboratory values|0
6883903|NCT00549770|10896841|FG004|Overall Study|Abnormal laboratory values|0
6883904|NCT00549770|10896842|FG005|Overall Study|Abnormal laboratory values|1
6883905|NCT00549770|10896843|FG006|Overall Study|Abnormal laboratory values|0
6883906|NCT00549770|10896844|FG007|Overall Study|Abnormal laboratory values|0
6883907|NCT00549770|10896837|FG000|Overall Study|Adverse Event|1
6883908|NCT00549770|10896838|FG001|Overall Study|Adverse Event|3
6883909|NCT00549770|10896839|FG002|Overall Study|Adverse Event|1
6883910|NCT00549770|10896840|FG003|Overall Study|Adverse Event|2
6883911|NCT00549770|10896841|FG004|Overall Study|Adverse Event|1
6883912|NCT00549770|10896842|FG005|Overall Study|Adverse Event|0
6883913|NCT00549770|10896843|FG006|Overall Study|Adverse Event|5
6883914|NCT00549770|10896844|FG007|Overall Study|Adverse Event|4
6883915|NCT00549900|10896875|FG000|Overall Study|Adverse Event|1
6883916|NCT00549939|10896882|FG000|12-week Double Blind Treatment Period|Adverse Event|1
6883917|NCT00549939|10896883|FG001|12-week Double Blind Treatment Period|Adverse Event|1
6883918|NCT00549939|10896884|FG002|12-week Double Blind Treatment Period|Adverse Event|2
6883919|NCT00549939|10896882|FG000|12-week Double Blind Treatment Period|Too many blood draws|0
6883920|NCT00549939|10896883|FG001|12-week Double Blind Treatment Period|Too many blood draws|1
6883921|NCT00549939|10896884|FG002|12-week Double Blind Treatment Period|Too many blood draws|0
6883922|NCT00549939|10896882|FG000|40-week Open Label Treatment Period|Adverse Event|0
6883923|NCT00549939|10896883|FG001|40-week Open Label Treatment Period|Adverse Event|2
6883924|NCT00549939|10896884|FG002|40-week Open Label Treatment Period|Adverse Event|1
6883925|NCT00549939|10896882|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0
6883926|NCT00549939|10896883|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1
6883927|NCT00549939|10896884|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0
6883928|NCT00549939|10896882|FG000|40-week Open Label Treatment Period|Protocol Violation|0
6883929|NCT00549939|10896883|FG001|40-week Open Label Treatment Period|Protocol Violation|1
6883930|NCT00549939|10896884|FG002|40-week Open Label Treatment Period|Protocol Violation|0
6883931|NCT00549939|10896882|FG000|40-week Open Label Treatment Period|Other|0
6883932|NCT00549939|10896883|FG001|40-week Open Label Treatment Period|Other|1
6883933|NCT00549939|10896884|FG002|40-week Open Label Treatment Period|Other|4
6883934|NCT00550043|10896899|FG000|Overall Study|Adverse Event|0
6883935|NCT00550043|10896900|FG001|Overall Study|Adverse Event|0
6883936|NCT00550043|10896901|FG002|Overall Study|Adverse Event|0
6883937|NCT00550043|10896902|FG003|Overall Study|Adverse Event|1
6883938|NCT00550043|10896903|FG004|Overall Study|Adverse Event|1
6883939|NCT00550043|10896899|FG000|Overall Study|Subject Withdrew Consent|0
6883940|NCT00550043|10896900|FG001|Overall Study|Subject Withdrew Consent|2
6883941|NCT00550043|10896901|FG002|Overall Study|Subject Withdrew Consent|1
6883942|NCT00550043|10896902|FG003|Overall Study|Subject Withdrew Consent|0
6883943|NCT00550043|10896903|FG004|Overall Study|Subject Withdrew Consent|0
6883944|NCT00550043|10896899|FG000|Overall Study|Other Reasons- Unspecified|0
6883945|NCT00550043|10896900|FG001|Overall Study|Other Reasons- Unspecified|1
6883946|NCT00550043|10896901|FG002|Overall Study|Other Reasons- Unspecified|0
6883947|NCT00550043|10896902|FG003|Overall Study|Other Reasons- Unspecified|1
6883948|NCT00550043|10896903|FG004|Overall Study|Other Reasons- Unspecified|0
6883949|NCT00550147|10896915|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4
6883950|NCT00550147|10896915|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2
6883951|NCT00550147|10896915|FG000|Quetiapine Addition Treatment Period|Adverse Event|3
6883952|NCT00550147|10896915|FG000|Quetiapine Addition Treatment Period|Noncompliance|2
6883953|NCT00550147|10896915|FG000|Quetiapine Addition Treatment Period|Moved out of state|1
6883954|NCT00550173|10896931|FG000|Overall Study|Death|45
6883955|NCT00550173|10896932|FG001|Overall Study|Death|38
6883956|NCT00550173|10896933|FG002|Overall Study|Death|50
6883957|NCT00550173|10896931|FG000|Overall Study|Physician Decision|1
6883958|NCT00550173|10896932|FG001|Overall Study|Physician Decision|2
6883959|NCT00550173|10896933|FG002|Overall Study|Physician Decision|2
6883960|NCT00550173|10896931|FG000|Overall Study|Withdrawal by Subject|9
6883961|NCT00550173|10896932|FG001|Overall Study|Withdrawal by Subject|12
6883962|NCT00550173|10896933|FG002|Overall Study|Withdrawal by Subject|17
6883963|NCT00550173|10896931|FG000|Overall Study|Sponsor Decision|13
6883964|NCT00550173|10896932|FG001|Overall Study|Sponsor Decision|7
6883965|NCT00550173|10896933|FG002|Overall Study|Sponsor Decision|1
6883966|NCT00550173|10896931|FG000|Overall Study|Lost to Follow-up|4
6883967|NCT00550173|10896932|FG001|Overall Study|Lost to Follow-up|4
6883968|NCT00550173|10896933|FG002|Overall Study|Lost to Follow-up|3
6883969|NCT00550238|10896942|FG000|Overall Study|Adverse Event|88
6883970|NCT00550238|10896942|FG000|Overall Study|Death|34
6883971|NCT00550238|10896942|FG000|Overall Study|Disease progression|46
6883972|NCT00550238|10896942|FG000|Overall Study|Withdrawal by Subject|167
6883973|NCT00550238|10896942|FG000|Overall Study|Physician Decision|31
6883974|NCT00550238|10896942|FG000|Overall Study|Patient noncompliance|25
6883975|NCT00550238|10896942|FG000|Overall Study|Lost to Follow-up|13
6883976|NCT00550238|10896942|FG000|Overall Study|Sponsor decision|55
6883977|NCT00550407|10896981|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55
6883978|NCT00550407|10896982|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
6883979|NCT00550407|10896983|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
6883980|NCT00550407|10896981|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39
6883981|NCT00550407|10896982|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
6883982|NCT00550407|10896983|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
6883983|NCT00550407|10896981|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1
6883984|NCT00550407|10896982|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
6883985|NCT00550407|10896983|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
6883986|NCT00550407|10896981|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1
6883987|NCT00550407|10896982|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
6883988|NCT00550407|10896983|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
6883989|NCT00550407|10896981|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1
6883990|NCT00550407|10896982|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
6883991|NCT00550407|10896983|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
6883992|NCT00550407|10896981|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8
6883993|NCT00550407|10896982|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
6883994|NCT00550407|10896983|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
6883995|NCT00550407|10896981|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6
6883996|NCT00550407|10896982|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
6883997|NCT00550407|10896983|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
6883998|NCT00550407|10896981|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1
6883999|NCT00550407|10896982|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
6884000|NCT00550407|10896983|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
6884001|NCT00550407|10896981|FG000|26-Week Randomized Phase|Adverse Event|0
6884002|NCT00550407|10896982|FG001|26-Week Randomized Phase|Adverse Event|5
6884003|NCT00550407|10896983|FG002|26-Week Randomized Phase|Adverse Event|2
6884004|NCT00550407|10896981|FG000|26-Week Randomized Phase|Lack of Efficacy|0
6884005|NCT00550407|10896982|FG001|26-Week Randomized Phase|Lack of Efficacy|36
6884006|NCT00550407|10896983|FG002|26-Week Randomized Phase|Lack of Efficacy|19
6884007|NCT00550407|10896981|FG000|26-Week Randomized Phase|Investigator Discretion|0
6884008|NCT00550407|10896982|FG001|26-Week Randomized Phase|Investigator Discretion|1
6884009|NCT00550407|10896983|FG002|26-Week Randomized Phase|Investigator Discretion|0
6884010|NCT00550407|10896981|FG000|26-Week Randomized Phase|Withdrawal by Subject|0
6884011|NCT00550407|10896982|FG001|26-Week Randomized Phase|Withdrawal by Subject|1
6884012|NCT00550407|10896983|FG002|26-Week Randomized Phase|Withdrawal by Subject|3
6884013|NCT00550420|10896991|FG000|Overall Study|Adverse Event|28
6884014|NCT00550420|10896991|FG000|Overall Study|Lost to Follow-up|8
6884015|NCT00550420|10896991|FG000|Overall Study|Protocol Violation|11
6884016|NCT00550420|10896991|FG000|Overall Study|Withdrawal by Subject|30
6884017|NCT00550420|10896991|FG000|Overall Study|Still in study at termination|206
6884018|NCT00550420|10896991|FG000|Overall Study|Missing|2
6884019|NCT00550420|10896991|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12
6884020|NCT00550420|10896991|FG000|Overall Study|Investigators opinion|1
6884021|NCT00550420|10896991|FG000|Overall Study|Lack of curative effect|1
6884022|NCT00550420|10896991|FG000|Overall Study|Unethical stop of enrollment|2
6884023|NCT00550420|10896991|FG000|Overall Study|Caregiver's decision to withdraw|1
6884024|NCT00550420|10896991|FG000|Overall Study|Out of Electrocardiogram criteria|1
6884025|NCT00550420|10896991|FG000|Overall Study|Exclusion criteria|1
6884026|NCT00550420|10896991|FG000|Overall Study|Prohibited medicine|1
6969783|NCT01150097|11019515|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2
6884027|NCT00550446|10897004|FG000|Up To Week 12|Adverse Event|2
6884028|NCT00550446|10897005|FG001|Up To Week 12|Adverse Event|2
6884029|NCT00550446|10897006|FG002|Up To Week 12|Adverse Event|0
6884030|NCT00550446|10897007|FG003|Up To Week 12|Adverse Event|0
6884031|NCT00550446|10897008|FG004|Up To Week 12|Adverse Event|2
6884032|NCT00550446|10897009|FG005|Up To Week 12|Adverse Event|2
6884033|NCT00550446|10897010|FG006|Up To Week 12|Adverse Event|1
6884034|NCT00550446|10897011|FG007|Up To Week 12|Adverse Event|0
6884035|NCT00550446|10897012|FG008|Up To Week 12|Adverse Event|0
6884036|NCT00550446|10897013|FG009|Up To Week 12|Adverse Event|0
6884037|NCT00550446|10897014|FG010|Up To Week 12|Adverse Event|0
6884038|NCT00550446|10897004|FG000|Up To Week 12|Lack of Efficacy|3
6884039|NCT00550446|10897005|FG001|Up To Week 12|Lack of Efficacy|1
6884040|NCT00550446|10897006|FG002|Up To Week 12|Lack of Efficacy|0
6884041|NCT00550446|10897007|FG003|Up To Week 12|Lack of Efficacy|1
6884042|NCT00550446|10897008|FG004|Up To Week 12|Lack of Efficacy|0
6884043|NCT00550446|10897009|FG005|Up To Week 12|Lack of Efficacy|3
6884044|NCT00550446|10897010|FG006|Up To Week 12|Lack of Efficacy|3
6884045|NCT00550446|10897011|FG007|Up To Week 12|Lack of Efficacy|0
6884046|NCT00550446|10897012|FG008|Up To Week 12|Lack of Efficacy|0
6884047|NCT00550446|10897013|FG009|Up To Week 12|Lack of Efficacy|0
6884048|NCT00550446|10897014|FG010|Up To Week 12|Lack of Efficacy|0
6884049|NCT00550446|10897004|FG000|Up To Week 12|Lost to Follow-up|0
6884050|NCT00550446|10897005|FG001|Up To Week 12|Lost to Follow-up|1
6884051|NCT00550446|10897006|FG002|Up To Week 12|Lost to Follow-up|0
6884052|NCT00550446|10897007|FG003|Up To Week 12|Lost to Follow-up|0
6884053|NCT00550446|10897008|FG004|Up To Week 12|Lost to Follow-up|1
6884054|NCT00550446|10897009|FG005|Up To Week 12|Lost to Follow-up|1
6884055|NCT00550446|10897010|FG006|Up To Week 12|Lost to Follow-up|2
6884056|NCT00550446|10897011|FG007|Up To Week 12|Lost to Follow-up|0
6884057|NCT00550446|10897012|FG008|Up To Week 12|Lost to Follow-up|0
6884058|NCT00550446|10897013|FG009|Up To Week 12|Lost to Follow-up|0
6884059|NCT00550446|10897014|FG010|Up To Week 12|Lost to Follow-up|0
6884060|NCT00550446|10897004|FG000|Up To Week 12|Withdrawal by Subject|2
6884061|NCT00550446|10897005|FG001|Up To Week 12|Withdrawal by Subject|0
6884062|NCT00550446|10897006|FG002|Up To Week 12|Withdrawal by Subject|3
6884063|NCT00550446|10897007|FG003|Up To Week 12|Withdrawal by Subject|2
6884064|NCT00550446|10897008|FG004|Up To Week 12|Withdrawal by Subject|0
6884065|NCT00550446|10897009|FG005|Up To Week 12|Withdrawal by Subject|1
6884066|NCT00550446|10897010|FG006|Up To Week 12|Withdrawal by Subject|3
6884067|NCT00550446|10897011|FG007|Up To Week 12|Withdrawal by Subject|0
6884068|NCT00550446|10897012|FG008|Up To Week 12|Withdrawal by Subject|0
6884069|NCT00550446|10897013|FG009|Up To Week 12|Withdrawal by Subject|0
6884070|NCT00550446|10897014|FG010|Up To Week 12|Withdrawal by Subject|0
6884071|NCT00550446|10897004|FG000|Up To Week 12|Other|3
6884072|NCT00550446|10897005|FG001|Up To Week 12|Other|0
6884073|NCT00550446|10897006|FG002|Up To Week 12|Other|0
6884074|NCT00550446|10897007|FG003|Up To Week 12|Other|0
6884075|NCT00550446|10897008|FG004|Up To Week 12|Other|0
6884076|NCT00550446|10897009|FG005|Up To Week 12|Other|1
6884077|NCT00550446|10897010|FG006|Up To Week 12|Other|4
6884078|NCT00550446|10897011|FG007|Up To Week 12|Other|0
6884079|NCT00550446|10897012|FG008|Up To Week 12|Other|0
6884080|NCT00550446|10897013|FG009|Up To Week 12|Other|0
6884081|NCT00550446|10897014|FG010|Up To Week 12|Other|0
6884082|NCT00550446|10897004|FG000|Up To Week 12|Randomized not treated|0
6884083|NCT00550446|10897005|FG001|Up To Week 12|Randomized not treated|1
6884084|NCT00550446|10897006|FG002|Up To Week 12|Randomized not treated|1
6884085|NCT00550446|10897007|FG003|Up To Week 12|Randomized not treated|0
6884086|NCT00550446|10897008|FG004|Up To Week 12|Randomized not treated|0
6884087|NCT00550446|10897009|FG005|Up To Week 12|Randomized not treated|0
6884088|NCT00550446|10897010|FG006|Up To Week 12|Randomized not treated|0
6884089|NCT00550446|10897011|FG007|Up To Week 12|Randomized not treated|0
6884090|NCT00550446|10897012|FG008|Up To Week 12|Randomized not treated|0
6884091|NCT00550446|10897013|FG009|Up To Week 12|Randomized not treated|0
6884092|NCT00550446|10897014|FG010|Up To Week 12|Randomized not treated|0
6884093|NCT00550446|10897004|FG000|Post Week 12|Adverse Event|2
6884094|NCT00550446|10897005|FG001|Post Week 12|Adverse Event|1
6884095|NCT00550446|10897006|FG002|Post Week 12|Adverse Event|1
6884096|NCT00550446|10897007|FG003|Post Week 12|Adverse Event|1
6884097|NCT00550446|10897008|FG004|Post Week 12|Adverse Event|1
6884098|NCT00550446|10897009|FG005|Post Week 12|Adverse Event|1
6884099|NCT00550446|10897010|FG006|Post Week 12|Adverse Event|0
6884100|NCT00550446|10897011|FG007|Post Week 12|Adverse Event|0
6884101|NCT00550446|10897012|FG008|Post Week 12|Adverse Event|0
6884102|NCT00550446|10897013|FG009|Post Week 12|Adverse Event|4
6884103|NCT00550446|10897014|FG010|Post Week 12|Adverse Event|0
6884104|NCT00550446|10897004|FG000|Post Week 12|Lack of Efficacy|0
6884105|NCT00550446|10897005|FG001|Post Week 12|Lack of Efficacy|0
6884106|NCT00550446|10897006|FG002|Post Week 12|Lack of Efficacy|1
6884107|NCT00550446|10897007|FG003|Post Week 12|Lack of Efficacy|0
6884108|NCT00550446|10897008|FG004|Post Week 12|Lack of Efficacy|0
6884109|NCT00550446|10897009|FG005|Post Week 12|Lack of Efficacy|0
6884110|NCT00550446|10897010|FG006|Post Week 12|Lack of Efficacy|0
6884111|NCT00550446|10897011|FG007|Post Week 12|Lack of Efficacy|1
6884112|NCT00550446|10897012|FG008|Post Week 12|Lack of Efficacy|1
6884113|NCT00550446|10897013|FG009|Post Week 12|Lack of Efficacy|2
6884114|NCT00550446|10897014|FG010|Post Week 12|Lack of Efficacy|1
6884115|NCT00550446|10897004|FG000|Post Week 12|Lost to Follow-up|0
6884116|NCT00550446|10897005|FG001|Post Week 12|Lost to Follow-up|0
6884117|NCT00550446|10897006|FG002|Post Week 12|Lost to Follow-up|1
6884118|NCT00550446|10897007|FG003|Post Week 12|Lost to Follow-up|1
6884119|NCT00550446|10897008|FG004|Post Week 12|Lost to Follow-up|0
6884120|NCT00550446|10897009|FG005|Post Week 12|Lost to Follow-up|0
6884121|NCT00550446|10897010|FG006|Post Week 12|Lost to Follow-up|1
6884122|NCT00550446|10897011|FG007|Post Week 12|Lost to Follow-up|0
6884123|NCT00550446|10897012|FG008|Post Week 12|Lost to Follow-up|0
6884124|NCT00550446|10897013|FG009|Post Week 12|Lost to Follow-up|0
6884125|NCT00550446|10897014|FG010|Post Week 12|Lost to Follow-up|0
6884126|NCT00550446|10897004|FG000|Post Week 12|Withdrawal by Subject|0
6884127|NCT00550446|10897005|FG001|Post Week 12|Withdrawal by Subject|0
6884128|NCT00550446|10897006|FG002|Post Week 12|Withdrawal by Subject|0
6884129|NCT00550446|10897007|FG003|Post Week 12|Withdrawal by Subject|0
6884130|NCT00550446|10897008|FG004|Post Week 12|Withdrawal by Subject|1
6884131|NCT00550446|10897009|FG005|Post Week 12|Withdrawal by Subject|0
6884132|NCT00550446|10897010|FG006|Post Week 12|Withdrawal by Subject|0
6884133|NCT00550446|10897011|FG007|Post Week 12|Withdrawal by Subject|0
6884134|NCT00550446|10897012|FG008|Post Week 12|Withdrawal by Subject|0
6884135|NCT00550446|10897013|FG009|Post Week 12|Withdrawal by Subject|0
6884136|NCT00550446|10897014|FG010|Post Week 12|Withdrawal by Subject|0
6884137|NCT00550446|10897004|FG000|Post Week 12|Other|1
6884138|NCT00550446|10897005|FG001|Post Week 12|Other|1
6884139|NCT00550446|10897006|FG002|Post Week 12|Other|0
6884140|NCT00550446|10897007|FG003|Post Week 12|Other|1
6884141|NCT00550446|10897008|FG004|Post Week 12|Other|0
6884142|NCT00550446|10897009|FG005|Post Week 12|Other|0
6884143|NCT00550446|10897010|FG006|Post Week 12|Other|1
6884144|NCT00550446|10897011|FG007|Post Week 12|Other|0
6884145|NCT00550446|10897012|FG008|Post Week 12|Other|1
6884146|NCT00550446|10897013|FG009|Post Week 12|Other|1
6884147|NCT00550446|10897014|FG010|Post Week 12|Other|0
6884148|NCT00550459|10897054|FG000|Overall Study|Adverse Event|0
6884149|NCT00550459|10897055|FG001|Overall Study|Adverse Event|2
6884150|NCT00550459|10897054|FG000|Overall Study|Withdrawal by Subject|1
6884151|NCT00550459|10897055|FG001|Overall Study|Withdrawal by Subject|1
6884152|NCT00550537|10897061|FG000|Overall Study|Death|18
6884153|NCT00550537|10897061|FG000|Overall Study|Adverse Event|20
6884154|NCT00550537|10897061|FG000|Overall Study|Disease progression before|46
6884155|NCT00550537|10897061|FG000|Overall Study|Withdrawal by Subject|7
6884156|NCT00550537|10897061|FG000|Overall Study|Change in treatment plan|4
6884157|NCT00550537|10897061|FG000|Overall Study|Other complicating ilness|3
6884158|NCT00550537|10897061|FG000|Overall Study|Declining performance status|2
6884159|NCT00550537|10897061|FG000|Overall Study|Treated closer to home|4
6884160|NCT00550550|10897072|FG000|Overall Study|Adverse Event|13
6884161|NCT00550550|10897073|FG001|Overall Study|Adverse Event|5
6884162|NCT00550550|10897072|FG000|Overall Study|Treatment Failure|0
6884163|NCT00550550|10897073|FG001|Overall Study|Treatment Failure|1
6884164|NCT00550550|10897072|FG000|Overall Study|Lost to Follow-up|4
6884165|NCT00550550|10897073|FG001|Overall Study|Lost to Follow-up|0
6884166|NCT00550550|10897072|FG000|Overall Study|Withdrawal by Subject|10
6884167|NCT00550550|10897073|FG001|Overall Study|Withdrawal by Subject|8
7079090|NCT02108262|11187710|FG002|Overall Study|Missed IV due to pharmacy error|1
7079091|NCT02108262|11187711|FG003|Overall Study|Missed IV due to pharmacy error|0
7079092|NCT02108600|11187748|FG000|Overall Study|Withdrawal by Subject|2
7079093|NCT02108600|11187749|FG001|Overall Study|Withdrawal by Subject|0
7079094|NCT02108600|11187748|FG000|Overall Study|Lost to Follow-up|1
7079095|NCT02108600|11187749|FG001|Overall Study|Lost to Follow-up|1
7079096|NCT02108912|11187772|FG000|Overall Study|Lost to Follow-up|1
6884168|NCT00550550|10897072|FG000|Overall Study|Protocol Violation|5
6884169|NCT00550550|10897073|FG001|Overall Study|Protocol Violation|14
6884170|NCT00550550|10897072|FG000|Overall Study|Did Not Meet Protocol Eligibility|1
6884171|NCT00550550|10897073|FG001|Overall Study|Did Not Meet Protocol Eligibility|1
6884172|NCT00550550|10897072|FG000|Overall Study|Randomized But Not Treated|1
6884173|NCT00550550|10897073|FG001|Overall Study|Randomized But Not Treated|0
6884174|NCT00550615|10897087|FG000|Overall Study|Withdrawal by Subject|0
6884175|NCT00550615|10897088|FG001|Overall Study|Withdrawal by Subject|0
6884176|NCT00550615|10897089|FG002|Overall Study|Withdrawal by Subject|2
6884177|NCT00550615|10897090|FG003|Overall Study|Withdrawal by Subject|3
6884178|NCT00550615|10897087|FG000|Overall Study|Not evaluable|0
6884179|NCT00550615|10897088|FG001|Overall Study|Not evaluable|0
6884180|NCT00550615|10897089|FG002|Overall Study|Not evaluable|2
6884181|NCT00550615|10897090|FG003|Overall Study|Not evaluable|7
6884182|NCT00550680|10897100|FG000|Overall Study|Administrative Reasons|1
6884183|NCT00550680|10897100|FG000|Overall Study|Adverse Event|5
6884184|NCT00550680|10897100|FG000|Overall Study|Death|3
7079097|NCT02108912|11187773|FG001|Overall Study|Lost to Follow-up|1
7079098|NCT02108912|11187772|FG000|Overall Study|lack of transportation|1
6884185|NCT00550680|10897100|FG000|Overall Study|Early Improvement|1
6884186|NCT00550680|10897100|FG000|Overall Study|Lost to Follow-up|3
6884187|NCT00550680|10897100|FG000|Overall Study|Lack of Efficacy|1
6884188|NCT00550680|10897100|FG000|Overall Study|Other|10
6884189|NCT00550680|10897100|FG000|Overall Study|Protocol Violation|7
7079099|NCT02108912|11187773|FG001|Overall Study|lack of transportation|0
6884190|NCT00550680|10897100|FG000|Overall Study|Refused Treatment|19
6884191|NCT00550680|10897100|FG000|Overall Study|Screen Failure|6
6884192|NCT00550732|10897104|FG000|Overall Study|Death|4
6884193|NCT00550732|10897104|FG000|Overall Study|Withdrawal by Subject|2
6884194|NCT00550732|10897104|FG000|Overall Study|Physician Decision|2
6884195|NCT00550732|10897104|FG000|Overall Study|Lost to Follow-up|1
6884196|NCT00550732|10897104|FG000|Overall Study|Palliative care|1
6884197|NCT00550732|10897104|FG000|Overall Study|Adverse Event|1
6884198|NCT00550745|10897111|FG000|Overall Study|Death|20
6884199|NCT00550745|10897112|FG001|Overall Study|Death|16
6884200|NCT00550745|10897111|FG000|Overall Study|Lost to Follow-up|45
6884201|NCT00550745|10897112|FG001|Overall Study|Lost to Follow-up|30
6884202|NCT00550745|10897111|FG000|Overall Study|Physician Decision|0
6884203|NCT00550745|10897112|FG001|Overall Study|Physician Decision|2
6884204|NCT00550745|10897111|FG000|Overall Study|Protocol Violation|4
6884205|NCT00550745|10897112|FG001|Overall Study|Protocol Violation|2
6884206|NCT00550745|10897111|FG000|Overall Study|Withdrawal by Subject|17
6884207|NCT00550745|10897112|FG001|Overall Study|Withdrawal by Subject|10
6884208|NCT00550745|10897111|FG000|Overall Study|Screen failure|1
6884209|NCT00550745|10897112|FG001|Overall Study|Screen failure|0
6884210|NCT00550771|10897120|FG000|Overall Study|Adverse Event|11
6884211|NCT00550771|10897121|FG001|Overall Study|Adverse Event|3
6884212|NCT00550771|10897120|FG000|Overall Study|Discontinued for study-related reasons|0
6884213|NCT00550771|10897121|FG001|Overall Study|Discontinued for study-related reasons|1
6884214|NCT00550771|10897120|FG000|Overall Study|Physician Decision|2
6884215|NCT00550771|10897121|FG001|Overall Study|Physician Decision|0
6884216|NCT00550771|10897120|FG000|Overall Study|Withdrawal by Subject|0
6884217|NCT00550771|10897121|FG001|Overall Study|Withdrawal by Subject|1
6884218|NCT00550771|10897120|FG000|Overall Study|Protocol Violation|4
6884219|NCT00550771|10897121|FG001|Overall Study|Protocol Violation|5
6884220|NCT00550836|10897129|FG000|Overall Study|Withdrawal by Subject|3
6884221|NCT00550836|10897130|FG001|Overall Study|Withdrawal by Subject|9
6884222|NCT00550953|10897155|FG000|Overall Study|Adverse Event|4
6884223|NCT00550953|10897156|FG001|Overall Study|Adverse Event|3
6884224|NCT00550953|10897155|FG000|Overall Study|Not able to visit the site|2
6884225|NCT00550953|10897156|FG001|Overall Study|Not able to visit the site|3
6884226|NCT00551031|10897167|FG000|Overall Study|Adverse Event|0
6884227|NCT00551031|10897168|FG001|Overall Study|Adverse Event|1
6884228|NCT00551031|10897169|FG002|Overall Study|Adverse Event|0
6884229|NCT00551031|10897170|FG003|Overall Study|Adverse Event|0
6884230|NCT00551031|10897171|FG004|Overall Study|Adverse Event|0
6884231|NCT00551031|10897167|FG000|Overall Study|Protocol Violation|1
6884232|NCT00551031|10897168|FG001|Overall Study|Protocol Violation|1
6884233|NCT00551031|10897169|FG002|Overall Study|Protocol Violation|0
6884234|NCT00551031|10897170|FG003|Overall Study|Protocol Violation|0
6884235|NCT00551031|10897171|FG004|Overall Study|Protocol Violation|0
6884236|NCT00551031|10897167|FG000|Overall Study|Lost to Follow-up|0
6884237|NCT00551031|10897168|FG001|Overall Study|Lost to Follow-up|1
6884238|NCT00551031|10897169|FG002|Overall Study|Lost to Follow-up|0
6884239|NCT00551031|10897170|FG003|Overall Study|Lost to Follow-up|1
6884240|NCT00551031|10897171|FG004|Overall Study|Lost to Follow-up|1
6884241|NCT00551031|10897167|FG000|Overall Study|Withdrawal by Subject|0
6884242|NCT00551031|10897168|FG001|Overall Study|Withdrawal by Subject|4
6884243|NCT00551031|10897169|FG002|Overall Study|Withdrawal by Subject|1
6884244|NCT00551031|10897170|FG003|Overall Study|Withdrawal by Subject|2
6884245|NCT00551031|10897171|FG004|Overall Study|Withdrawal by Subject|0
6884246|NCT00551031|10897167|FG000|Overall Study|Serious Adverse Event|0
6884247|NCT00551031|10897168|FG001|Overall Study|Serious Adverse Event|2
6884248|NCT00551031|10897169|FG002|Overall Study|Serious Adverse Event|1
6884249|NCT00551031|10897170|FG003|Overall Study|Serious Adverse Event|0
6884250|NCT00551031|10897171|FG004|Overall Study|Serious Adverse Event|0
6884251|NCT00551031|10897167|FG000|Overall Study|Did not receive vaccine|1
6884252|NCT00551031|10897168|FG001|Overall Study|Did not receive vaccine|2
6884253|NCT00551031|10897169|FG002|Overall Study|Did not receive vaccine|0
6884254|NCT00551031|10897170|FG003|Overall Study|Did not receive vaccine|0
6884255|NCT00551031|10897171|FG004|Overall Study|Did not receive vaccine|0
6884256|NCT00551135|10897191|FG000|Overall Study|Adverse Event|1
6884257|NCT00551135|10897192|FG001|Overall Study|Adverse Event|0
6884258|NCT00551135|10897193|FG002|Overall Study|Adverse Event|1
6884259|NCT00551135|10897194|FG003|Overall Study|Adverse Event|1
6884260|NCT00551135|10897191|FG000|Overall Study|Lost to Follow-up|0
6884261|NCT00551135|10897192|FG001|Overall Study|Lost to Follow-up|0
6884262|NCT00551135|10897193|FG002|Overall Study|Lost to Follow-up|0
6884263|NCT00551135|10897194|FG003|Overall Study|Lost to Follow-up|1
6884264|NCT00551135|10897191|FG000|Overall Study|Other|3
6884265|NCT00551135|10897192|FG001|Overall Study|Other|2
6884266|NCT00551135|10897193|FG002|Overall Study|Other|1
6884267|NCT00551135|10897194|FG003|Overall Study|Other|2
6884268|NCT00551135|10897191|FG000|Overall Study|Withdrawal by Subject|1
6884269|NCT00551135|10897192|FG001|Overall Study|Withdrawal by Subject|0
6884270|NCT00551135|10897193|FG002|Overall Study|Withdrawal by Subject|3
6884271|NCT00551135|10897194|FG003|Overall Study|Withdrawal by Subject|1
6884272|NCT00551161|10897204|FG000|Overall Study|Withdrawal by Subject|1
6884273|NCT00551213|10897229|FG000|Overall Study|Adverse Event|6
6884274|NCT00551213|10897230|FG001|Overall Study|Adverse Event|3
6884275|NCT00551213|10897229|FG000|Overall Study|Progressive Disease|41
6884276|NCT00551213|10897230|FG001|Overall Study|Progressive Disease|12
6884277|NCT00551213|10897229|FG000|Overall Study|Withdrawal by Subject|2
6884278|NCT00551213|10897230|FG001|Overall Study|Withdrawal by Subject|0
6884279|NCT00551213|10897229|FG000|Overall Study|Not Treated|1
6884280|NCT00551213|10897230|FG001|Overall Study|Not Treated|2
6884281|NCT00551291|10897236|FG000|Overall Study|Physician Decision|1
6884282|NCT00551369|10897240|FG000|Overall Study|Protocol Violation|5
6884283|NCT00551369|10897240|FG000|Overall Study|Withdrawal by Subject|1
6884284|NCT00551369|10897240|FG000|Overall Study|Not treated per protocol and re|1
6884285|NCT00551421|10897244|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1
6969784|NCT01150097|11019516|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2
6969785|NCT01150097|11019514|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
6969786|NCT01150097|11019515|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
6969787|NCT01150097|11019516|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3
6969788|NCT01150097|11019514|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
6969789|NCT01150097|11019515|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0
6969790|NCT01150097|11019516|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
6969791|NCT01150097|11019514|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5
6969792|NCT01150097|11019515|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4
6969793|NCT01150097|11019516|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0
6969794|NCT01150097|11019514|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4
6969795|NCT01150097|11019515|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
6969796|NCT01150097|11019516|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
6969797|NCT01150097|11019514|FG000|Months 24 to 48 Post-transplantation|Death|2
6969798|NCT01150097|11019515|FG001|Months 24 to 48 Post-transplantation|Death|0
6969799|NCT01150097|11019516|FG002|Months 24 to 48 Post-transplantation|Death|0
6969800|NCT01150123|11019544|FG000|Overall Study|Withdrawal by Subject|1
6969801|NCT01150123|11019545|FG001|Overall Study|Withdrawal by Subject|1
6969802|NCT01150123|11019546|FG002|Overall Study|Withdrawal by Subject|2
6969803|NCT01150123|11019547|FG003|Overall Study|Withdrawal by Subject|1
6969804|NCT01150123|11019548|FG004|Overall Study|Withdrawal by Subject|1
6969805|NCT01150123|11019549|FG005|Overall Study|Withdrawal by Subject|1
6969806|NCT01150123|11019550|FG006|Overall Study|Withdrawal by Subject|0
6969807|NCT01150123|11019551|FG007|Overall Study|Withdrawal by Subject|3
6969808|NCT01150123|11019552|FG008|Overall Study|Withdrawal by Subject|2
6969809|NCT01150123|11019553|FG009|Overall Study|Withdrawal by Subject|0
6969810|NCT01150123|11019554|FG010|Overall Study|Withdrawal by Subject|1
6969811|NCT01150123|11019555|FG011|Overall Study|Withdrawal by Subject|0
6969812|NCT01150123|11019556|FG012|Overall Study|Withdrawal by Subject|1
6969813|NCT01150123|11019557|FG013|Overall Study|Withdrawal by Subject|0
6969814|NCT01150123|11019558|FG014|Overall Study|Withdrawal by Subject|0
6969815|NCT01150123|11019559|FG015|Overall Study|Withdrawal by Subject|1
6969816|NCT01150123|11019560|FG016|Overall Study|Withdrawal by Subject|0
6969817|NCT01150123|11019561|FG017|Overall Study|Withdrawal by Subject|1
6969818|NCT01150123|11019544|FG000|Overall Study|Lost to Follow-up|2
6969819|NCT01150123|11019545|FG001|Overall Study|Lost to Follow-up|1
6969820|NCT01150123|11019546|FG002|Overall Study|Lost to Follow-up|2
6969821|NCT01150123|11019547|FG003|Overall Study|Lost to Follow-up|2
6969822|NCT01150123|11019548|FG004|Overall Study|Lost to Follow-up|2
6969823|NCT01150123|11019549|FG005|Overall Study|Lost to Follow-up|5
6969824|NCT01150123|11019550|FG006|Overall Study|Lost to Follow-up|0
7155630|NCT03345407|11323718|FG003|Overall Study|Withdrawal by Subject|6
7155631|NCT03345407|11323719|FG004|Overall Study|Withdrawal by Subject|3
7155632|NCT03345407|11323720|FG005|Overall Study|Withdrawal by Subject|6
7155633|NCT03345407|11323721|FG006|Overall Study|Withdrawal by Subject|16
7155634|NCT03345407|11323715|FG000|Overall Study|Physician Decision|3
7155635|NCT03345407|11323716|FG001|Overall Study|Physician Decision|1
7155636|NCT03345407|11323717|FG002|Overall Study|Physician Decision|0
7155637|NCT03345407|11323718|FG003|Overall Study|Physician Decision|0
7155638|NCT03345407|11323719|FG004|Overall Study|Physician Decision|1
7155639|NCT03345407|11323720|FG005|Overall Study|Physician Decision|2
6884286|NCT00551460|10897249|FG000|Overall Study|Adverse Event|1
6884287|NCT00551460|10897249|FG000|Overall Study|Withdrawal by Subject|1
6884288|NCT00551460|10897249|FG000|Overall Study|Physician Decision|1
6884289|NCT00551460|10897249|FG000|Overall Study|Death|7
6884290|NCT00551460|10897249|FG000|Overall Study|Ineligible|4
6884291|NCT00551460|10897249|FG000|Overall Study|Not analyzable (did not start treatment)|4
6969825|NCT01150123|11019551|FG007|Overall Study|Lost to Follow-up|0
6969826|NCT01150123|11019552|FG008|Overall Study|Lost to Follow-up|3
6969827|NCT01150123|11019553|FG009|Overall Study|Lost to Follow-up|1
6969828|NCT01150123|11019554|FG010|Overall Study|Lost to Follow-up|1
6969829|NCT01150123|11019555|FG011|Overall Study|Lost to Follow-up|1
6969830|NCT01150123|11019556|FG012|Overall Study|Lost to Follow-up|2
6969831|NCT01150123|11019557|FG013|Overall Study|Lost to Follow-up|0
6969832|NCT01150123|11019558|FG014|Overall Study|Lost to Follow-up|0
6969833|NCT01150123|11019559|FG015|Overall Study|Lost to Follow-up|0
6969834|NCT01150123|11019560|FG016|Overall Study|Lost to Follow-up|0
6969835|NCT01150123|11019561|FG017|Overall Study|Lost to Follow-up|0
6969836|NCT01150357|11019621|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0
7155640|NCT03345407|11323721|FG006|Overall Study|Physician Decision|3
6969837|NCT01150357|11019622|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1
6969838|NCT01150357|11019623|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1
6969839|NCT01150357|11019621|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1
6969840|NCT01150357|11019622|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
6969841|NCT01150357|11019623|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
6969842|NCT01150357|11019621|FG000|Dose Response Phase (Phase 1)|Adverse Event|0
6969843|NCT01150357|11019622|FG001|Dose Response Phase (Phase 1)|Adverse Event|0
6969844|NCT01150357|11019623|FG002|Dose Response Phase (Phase 1)|Adverse Event|1
6969845|NCT01150357|11019621|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0
6969846|NCT01150357|11019622|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2
6969847|NCT01150357|11019623|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1
6977000|NCT01203930|11029959|FG000|Overall Study|Withdrew Consent|1
7079100|NCT02108912|11187772|FG000|Overall Study|high blood pressure|1
7079101|NCT02108912|11187773|FG001|Overall Study|high blood pressure|0
6884292|NCT00551525|10897253|FG000|Overall Study|Protocol Violation|5
6884293|NCT00551642|10897259|FG000|Treatment Period|Protocol Deviation|6
6884294|NCT00551642|10897260|FG001|Treatment Period|Protocol Deviation|11
6884295|NCT00551642|10897259|FG000|Treatment Period|Delivery device failure|1
6884296|NCT00551642|10897260|FG001|Treatment Period|Delivery device failure|3
6884297|NCT00551642|10897259|FG000|Treatment Period|Physician Decision|0
6884298|NCT00551642|10897260|FG001|Treatment Period|Physician Decision|1
6884299|NCT00551642|10897259|FG000|Treatment Period|Death|33
6884300|NCT00551642|10897260|FG001|Treatment Period|Death|31
6884301|NCT00551642|10897259|FG000|Treatment Period|Inclusion/Exclusion criteria|4
6884302|NCT00551642|10897260|FG001|Treatment Period|Inclusion/Exclusion criteria|4
6884303|NCT00551642|10897259|FG000|Treatment Period|Adverse Event|15
6884304|NCT00551642|10897260|FG001|Treatment Period|Adverse Event|12
6884305|NCT00551642|10897259|FG000|Treatment Period|Withdrawal by Subject|2
6884306|NCT00551642|10897260|FG001|Treatment Period|Withdrawal by Subject|1
6884307|NCT00551759|10897298|FG000|Overall Study|Adverse Event|7
6884308|NCT00551759|10897298|FG000|Overall Study|Death|5
6884309|NCT00551759|10897298|FG000|Overall Study|Ineligible|1
6884310|NCT00552058|10897304|FG000|Overall Study|Adverse Event|8
6884311|NCT00552058|10897305|FG001|Overall Study|Adverse Event|7
6884312|NCT00552058|10897304|FG000|Overall Study|Lack of Efficacy|1
6884313|NCT00552058|10897305|FG001|Overall Study|Lack of Efficacy|5
6884314|NCT00552058|10897304|FG000|Overall Study|Lost to Follow-up|1
6884315|NCT00552058|10897305|FG001|Overall Study|Lost to Follow-up|0
6884316|NCT00552058|10897304|FG000|Overall Study|Withdrawal by Subject|4
6884317|NCT00552058|10897305|FG001|Overall Study|Withdrawal by Subject|4
6884318|NCT00552058|10897304|FG000|Overall Study|Other: Protocol Violation|0
6884319|NCT00552058|10897305|FG001|Overall Study|Other: Protocol Violation|1
6884320|NCT00552058|10897304|FG000|Overall Study|Other: Non Compliance|1
6884321|NCT00552058|10897305|FG001|Overall Study|Other: Non Compliance|2
6884322|NCT00552058|10897304|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0
6884323|NCT00552058|10897305|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1
6884324|NCT00552058|10897304|FG000|Overall Study|Other: Low CDAI score, entry violation|0
6884325|NCT00552058|10897305|FG001|Overall Study|Other: Low CDAI score, entry violation|1
6884326|NCT00552058|10897304|FG000|Overall Study|Other: Positive Stool Result|0
6884327|NCT00552058|10897305|FG001|Overall Study|Other: Positive Stool Result|1
6884328|NCT00552058|10897304|FG000|Overall Study|Other: Randomized in error|0
6884329|NCT00552058|10897305|FG001|Overall Study|Other: Randomized in error|1
6884330|NCT00552058|10897304|FG000|Overall Study|Other: Sponsors Decision|0
6884331|NCT00552058|10897305|FG001|Overall Study|Other: Sponsors Decision|1
6884332|NCT00552058|10897304|FG000|Overall Study|Other: Early Roll Over|1
6884333|NCT00552058|10897305|FG001|Overall Study|Other: Early Roll Over|0
6884334|NCT00552071|10897313|FG000|Overall Study|Adverse Event|1
6884335|NCT00552071|10897314|FG001|Overall Study|Adverse Event|0
6884336|NCT00552071|10897313|FG000|Overall Study|Lack of Efficacy|1
6884337|NCT00552071|10897314|FG001|Overall Study|Lack of Efficacy|0
6884338|NCT00552071|10897313|FG000|Overall Study|Physician Decision|1
6884339|NCT00552071|10897314|FG001|Overall Study|Physician Decision|0
6884340|NCT00552071|10897313|FG000|Overall Study|Pregnancy|1
6884341|NCT00552071|10897314|FG001|Overall Study|Pregnancy|0
6884342|NCT00552071|10897313|FG000|Overall Study|Death|0
7079102|NCT02108951|11187779|FG000|Overall Study|Lost to Follow-up|1
7079103|NCT02108951|11187779|FG000|Overall Study|Patient's/guardian's decision|1
6884343|NCT00552071|10897314|FG001|Overall Study|Death|1
6884344|NCT00552071|10897313|FG000|Overall Study|Withdrawal by Subject|0
6884345|NCT00552071|10897314|FG001|Overall Study|Withdrawal by Subject|1
6884346|NCT00552084|10897324|FG000|Overall Study|Adverse Event|2
6884347|NCT00552084|10897325|FG001|Overall Study|Adverse Event|3
6884348|NCT00552084|10897324|FG000|Overall Study|Withdrawal by Subject|4
6884349|NCT00552084|10897325|FG001|Overall Study|Withdrawal by Subject|5
6884350|NCT00552084|10897324|FG000|Overall Study|Protocol Violation|1
6884351|NCT00552084|10897325|FG001|Overall Study|Protocol Violation|0
6884352|NCT00552084|10897324|FG000|Overall Study|change in anti-arrythmic drug|1
6884353|NCT00552084|10897325|FG001|Overall Study|change in anti-arrythmic drug|1
6884354|NCT00552110|10897336|FG000|Overall Study|Serious or Life-Threatening AE|0
6884355|NCT00552110|10897337|FG001|Overall Study|Serious or Life-Threatening AE|0
6884356|NCT00552110|10897338|FG002|Overall Study|Serious or Life-Threatening AE|1
6884357|NCT00552110|10897339|FG003|Overall Study|Serious or Life-Threatening AE|0
6884358|NCT00552110|10897340|FG004|Overall Study|Serious or Life-Threatening AE|0
6884359|NCT00552110|10897336|FG000|Overall Study|Lack of Efficacy|1
6884360|NCT00552110|10897337|FG001|Overall Study|Lack of Efficacy|0
6884361|NCT00552110|10897338|FG002|Overall Study|Lack of Efficacy|0
6884362|NCT00552110|10897339|FG003|Overall Study|Lack of Efficacy|1
6884363|NCT00552110|10897340|FG004|Overall Study|Lack of Efficacy|4
6884364|NCT00552110|10897336|FG000|Overall Study|Withdrawal by Subject|0
6884365|NCT00552110|10897337|FG001|Overall Study|Withdrawal by Subject|2
6884366|NCT00552110|10897338|FG002|Overall Study|Withdrawal by Subject|0
6884367|NCT00552110|10897339|FG003|Overall Study|Withdrawal by Subject|3
6884368|NCT00552110|10897340|FG004|Overall Study|Withdrawal by Subject|2
6884369|NCT00552110|10897336|FG000|Overall Study|Lost to Follow-up|0
6884370|NCT00552110|10897337|FG001|Overall Study|Lost to Follow-up|0
6884371|NCT00552110|10897338|FG002|Overall Study|Lost to Follow-up|0
6884372|NCT00552110|10897339|FG003|Overall Study|Lost to Follow-up|1
6884373|NCT00552110|10897340|FG004|Overall Study|Lost to Follow-up|1
6884374|NCT00552110|10897336|FG000|Overall Study|Failed to Comply With Study Requirements|1
6884375|NCT00552110|10897337|FG001|Overall Study|Failed to Comply With Study Requirements|1
6884376|NCT00552110|10897338|FG002|Overall Study|Failed to Comply With Study Requirements|1
6884377|NCT00552110|10897339|FG003|Overall Study|Failed to Comply With Study Requirements|0
6884378|NCT00552110|10897340|FG004|Overall Study|Failed to Comply With Study Requirements|1
6884379|NCT00552110|10897336|FG000|Overall Study|Withdrawn per Sponsor|0
6884380|NCT00552110|10897337|FG001|Overall Study|Withdrawn per Sponsor|1
6884381|NCT00552110|10897338|FG002|Overall Study|Withdrawn per Sponsor|0
6884382|NCT00552110|10897339|FG003|Overall Study|Withdrawn per Sponsor|0
6884383|NCT00552110|10897340|FG004|Overall Study|Withdrawn per Sponsor|1
6884384|NCT00552110|10897336|FG000|Overall Study|Use of Prohibited Medication|1
6884385|NCT00552110|10897337|FG001|Overall Study|Use of Prohibited Medication|1
6884386|NCT00552110|10897338|FG002|Overall Study|Use of Prohibited Medication|0
6884387|NCT00552110|10897339|FG003|Overall Study|Use of Prohibited Medication|0
6884388|NCT00552110|10897340|FG004|Overall Study|Use of Prohibited Medication|0
6884389|NCT00552110|10897336|FG000|Overall Study|Delay of Study due to Relabeling|0
6884390|NCT00552110|10897337|FG001|Overall Study|Delay of Study due to Relabeling|0
6884391|NCT00552110|10897338|FG002|Overall Study|Delay of Study due to Relabeling|0
6884392|NCT00552110|10897339|FG003|Overall Study|Delay of Study due to Relabeling|1
6884393|NCT00552110|10897340|FG004|Overall Study|Delay of Study due to Relabeling|0
6884394|NCT00552110|10897336|FG000|Overall Study|Increased Blood Pressure at Visit 2|0
6884395|NCT00552110|10897337|FG001|Overall Study|Increased Blood Pressure at Visit 2|0
6884396|NCT00552110|10897338|FG002|Overall Study|Increased Blood Pressure at Visit 2|0
6884397|NCT00552110|10897339|FG003|Overall Study|Increased Blood Pressure at Visit 2|1
6884398|NCT00552110|10897340|FG004|Overall Study|Increased Blood Pressure at Visit 2|0
6884399|NCT00552110|10897336|FG000|Overall Study|Nonserious Adverse Event (AE)|1
6884400|NCT00552110|10897337|FG001|Overall Study|Nonserious Adverse Event (AE)|0
6884401|NCT00552110|10897338|FG002|Overall Study|Nonserious Adverse Event (AE)|0
6884402|NCT00552110|10897339|FG003|Overall Study|Nonserious Adverse Event (AE)|1
6884403|NCT00552110|10897340|FG004|Overall Study|Nonserious Adverse Event (AE)|0
6884404|NCT00552175|10897355|FG000|Overall Study|Lack of Efficacy|2
6884405|NCT00552175|10897356|FG001|Overall Study|Lack of Efficacy|0
6884406|NCT00552175|10897357|FG002|Overall Study|Lack of Efficacy|1
6884407|NCT00552175|10897355|FG000|Overall Study|Adverse Event|9
6884408|NCT00552175|10897356|FG001|Overall Study|Adverse Event|9
6884409|NCT00552175|10897357|FG002|Overall Study|Adverse Event|10
6884410|NCT00552175|10897355|FG000|Overall Study|Withdrawal by Subject|2
6884411|NCT00552175|10897356|FG001|Overall Study|Withdrawal by Subject|2
6884412|NCT00552175|10897357|FG002|Overall Study|Withdrawal by Subject|1
6884413|NCT00552175|10897355|FG000|Overall Study|Lost to Follow-up|0
6884414|NCT00552175|10897356|FG001|Overall Study|Lost to Follow-up|0
6884415|NCT00552175|10897357|FG002|Overall Study|Lost to Follow-up|1
6884416|NCT00552175|10897355|FG000|Overall Study|Entry Criteria Not Met|1
6884417|NCT00552175|10897356|FG001|Overall Study|Entry Criteria Not Met|1
6884418|NCT00552175|10897357|FG002|Overall Study|Entry Criteria Not Met|0
6884419|NCT00552175|10897355|FG000|Overall Study|Reason Not Specified|3
6884420|NCT00552175|10897356|FG001|Overall Study|Reason Not Specified|1
6884421|NCT00552175|10897357|FG002|Overall Study|Reason Not Specified|1
6884422|NCT00552188|10897368|FG000|Overall Study|Adverse Event|0
6884423|NCT00552188|10897369|FG001|Overall Study|Adverse Event|2
6884424|NCT00552188|10897368|FG000|Overall Study|Lost to Follow-up|2
6884425|NCT00552188|10897369|FG001|Overall Study|Lost to Follow-up|1
6884426|NCT00552188|10897368|FG000|Overall Study|Withdrawal of consent|0
6884427|NCT00552188|10897369|FG001|Overall Study|Withdrawal of consent|1
6884428|NCT00552188|10897368|FG000|Overall Study|Subject returned to home country|0
6884429|NCT00552188|10897369|FG001|Overall Study|Subject returned to home country|1
6884430|NCT00552240|10897377|FG000|Overall Study|Adverse Event|9
6884431|NCT00552240|10897378|FG001|Overall Study|Adverse Event|9
6884432|NCT00552240|10897377|FG000|Overall Study|Protocol Violation|1
6884433|NCT00552240|10897378|FG001|Overall Study|Protocol Violation|1
6884434|NCT00552240|10897377|FG000|Overall Study|Lost to Follow-up|5
6884435|NCT00552240|10897378|FG001|Overall Study|Lost to Follow-up|6
6884436|NCT00552240|10897377|FG000|Overall Study|Withdrawal by Subject|2
6884437|NCT00552240|10897378|FG001|Overall Study|Withdrawal by Subject|2
6884438|NCT00552240|10897377|FG000|Overall Study|Lack of Efficacy|6
6884439|NCT00552240|10897378|FG001|Overall Study|Lack of Efficacy|0
6884440|NCT00552240|10897377|FG000|Overall Study|Other|1
6884441|NCT00552240|10897378|FG001|Overall Study|Other|0
6884442|NCT00552279|10897386|FG000|Overall Study|Adverse Event|0
6884443|NCT00552279|10897387|FG001|Overall Study|Adverse Event|1
6884444|NCT00552279|10897386|FG000|Overall Study|Withdrawal by Subject|12
6884445|NCT00552279|10897387|FG001|Overall Study|Withdrawal by Subject|1
6884446|NCT00552279|10897386|FG000|Overall Study|Lost to Follow-up|1
6884447|NCT00552279|10897387|FG001|Overall Study|Lost to Follow-up|0
6884448|NCT00552279|10897386|FG000|Overall Study|Other|1
6884449|NCT00552279|10897387|FG001|Overall Study|Other|1
6884450|NCT00552305|10897393|FG000|Overall Study|Adverse Event|43
6884451|NCT00552305|10897393|FG000|Overall Study|Lack of Efficacy|120
6884452|NCT00552305|10897393|FG000|Overall Study|Lost to Follow-up|4
6884453|NCT00552305|10897393|FG000|Overall Study|Protocol Violation|3
6884454|NCT00552305|10897393|FG000|Overall Study|Withdrawal by Subject|44
6884455|NCT00552305|10897393|FG000|Overall Study|Lack of efficacy/withdrew consent|1
6884456|NCT00552305|10897393|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3
6884457|NCT00552305|10897393|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2
6884458|NCT00552305|10897393|FG000|Overall Study|Unsatisfactory compliance|11
6884459|NCT00552305|10897393|FG000|Overall Study|Poor compliance/lost to follow-up|1
6884460|NCT00552305|10897393|FG000|Overall Study|AE/Other: prohibited drug required|1
6884461|NCT00552305|10897393|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1
6884462|NCT00552305|10897393|FG000|Overall Study|Other: Site closed|4
6884463|NCT00552305|10897393|FG000|Overall Study|Other: Personal problems|1
6884464|NCT00552305|10897393|FG000|Overall Study|Other: Unable to attend visits|1
6884465|NCT00552305|10897393|FG000|Overall Study|Other: Subject underwent surgery|4
6884466|NCT00552305|10897393|FG000|Overall Study|Other: Subject became pregnant|1
6884467|NCT00552305|10897393|FG000|Overall Study|Other: Health problems, not drug related|1
6884468|NCT00552305|10897393|FG000|Overall Study|Other: Subject moved from area|2
6884469|NCT00552305|10897393|FG000|Overall Study|Other: Subject incarcerated|1
6884470|NCT00552305|10897393|FG000|Overall Study|Other: Subject went to rehab|1
6884471|NCT00552344|10897397|FG000|Overall Study|Lack of Efficacy|55
6884472|NCT00552344|10897397|FG000|Overall Study|Loss of efficacy|75
6884473|NCT00552344|10897397|FG000|Overall Study|Lost to Follow-up|8
6884474|NCT00552344|10897397|FG000|Overall Study|Withdrawal by Subject|48
6884475|NCT00552344|10897397|FG000|Overall Study|SAE, non-fatal|6
6884476|NCT00552344|10897397|FG000|Overall Study|AE, non-serious non-fatal|38
7079104|NCT02108951|11187779|FG000|Overall Study|Study Terminated by Sponsor|14
6884477|NCT00552344|10897397|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62
6884478|NCT00552344|10897397|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1
6884479|NCT00552344|10897397|FG000|Overall Study|Other Reason|22
6884480|NCT00552396|10897409|FG000|Overall Study|protocol withdrawal criteria|3
6884481|NCT00552396|10897410|FG001|Overall Study|protocol withdrawal criteria|3
6884482|NCT00552396|10897411|FG002|Overall Study|protocol withdrawal criteria|3
6884483|NCT00552396|10897412|FG003|Overall Study|protocol withdrawal criteria|6
6884484|NCT00552396|10897413|FG004|Overall Study|protocol withdrawal criteria|3
6884485|NCT00552396|10897414|FG005|Overall Study|protocol withdrawal criteria|3
6884486|NCT00552396|10897415|FG006|Overall Study|protocol withdrawal criteria|9
6884487|NCT00552578|10897473|FG000|Overall Study|Lost to Follow-up|1
6884488|NCT00552578|10897474|FG001|Overall Study|Lost to Follow-up|1
6884489|NCT00552617|10897490|FG000|Overall Study|Not Treated|0
6884490|NCT00552617|10897491|FG001|Overall Study|Not Treated|0
6884491|NCT00552617|10897492|FG002|Overall Study|Not Treated|1
6884492|NCT00552617|10897493|FG003|Overall Study|Not Treated|0
6884493|NCT00552617|10897494|FG004|Overall Study|Not Treated|0
6884494|NCT00552617|10897495|FG005|Overall Study|Not Treated|0
6884495|NCT00552617|10897496|FG006|Overall Study|Not Treated|0
6884496|NCT00552617|10897497|FG007|Overall Study|Not Treated|0
6884497|NCT00552617|10897498|FG008|Overall Study|Not Treated|0
6884498|NCT00552617|10897499|FG009|Overall Study|Not Treated|1
6884499|NCT00552617|10897490|FG000|Overall Study|Lost to Follow-up|0
6884500|NCT00552617|10897491|FG001|Overall Study|Lost to Follow-up|0
6884501|NCT00552617|10897492|FG002|Overall Study|Lost to Follow-up|0
6884502|NCT00552617|10897493|FG003|Overall Study|Lost to Follow-up|1
6884503|NCT00552617|10897494|FG004|Overall Study|Lost to Follow-up|0
6884504|NCT00552617|10897495|FG005|Overall Study|Lost to Follow-up|2
6884505|NCT00552617|10897496|FG006|Overall Study|Lost to Follow-up|0
6884506|NCT00552617|10897497|FG007|Overall Study|Lost to Follow-up|0
6884507|NCT00552617|10897498|FG008|Overall Study|Lost to Follow-up|2
6884508|NCT00552617|10897499|FG009|Overall Study|Lost to Follow-up|0
6884509|NCT00552669|10897523|FG000|Overall Study|Death|3
6884510|NCT00552669|10897524|FG001|Overall Study|Death|7
6884511|NCT00552760|10897541|FG000|Overall Study|Adverse Event|3
6884512|NCT00552760|10897542|FG001|Overall Study|Adverse Event|5
6884513|NCT00552760|10897541|FG000|Overall Study|Relapsed- Depressed Event|10
6884514|NCT00552760|10897542|FG001|Overall Study|Relapsed- Depressed Event|16
6884515|NCT00552760|10897541|FG000|Overall Study|Relapse- Manic Event|3
6884516|NCT00552760|10897542|FG001|Overall Study|Relapse- Manic Event|3
6884517|NCT00552760|10897541|FG000|Overall Study|Relapsed- Mixed Event|3
6884518|NCT00552760|10897542|FG001|Overall Study|Relapsed- Mixed Event|5
6884519|NCT00552760|10897541|FG000|Overall Study|Protocol Violation|0
7079105|NCT02109029|11187797|FG000|Part B|Adverse Event|0
6884520|NCT00552760|10897542|FG001|Overall Study|Protocol Violation|1
6884521|NCT00552760|10897541|FG000|Overall Study|Lost to Follow-up|1
6884522|NCT00552760|10897542|FG001|Overall Study|Lost to Follow-up|1
6884523|NCT00552760|10897541|FG000|Overall Study|Non-compliance|1
6884524|NCT00552760|10897542|FG001|Overall Study|Non-compliance|1
6884525|NCT00552760|10897541|FG000|Overall Study|Medical Condition|1
6884526|NCT00552760|10897542|FG001|Overall Study|Medical Condition|1
6884527|NCT00552760|10897541|FG000|Overall Study|Withdrawal by Subject|3
6884528|NCT00552760|10897542|FG001|Overall Study|Withdrawal by Subject|0
6884529|NCT00552760|10897541|FG000|Overall Study|Medication Change|1
6884530|NCT00552760|10897542|FG001|Overall Study|Medication Change|0
6884531|NCT00552929|10897571|FG000|Overall Study|Lost to Follow-up|0
6884532|NCT00552929|10897572|FG001|Overall Study|Lost to Follow-up|0
6884533|NCT00552929|10897573|FG002|Overall Study|Lost to Follow-up|0
6884534|NCT00552929|10897574|FG003|Overall Study|Lost to Follow-up|0
6884535|NCT00552929|10897575|FG004|Overall Study|Lost to Follow-up|0
6884536|NCT00552929|10897576|FG005|Overall Study|Lost to Follow-up|0
6884537|NCT00552929|10897577|FG006|Overall Study|Lost to Follow-up|0
6884538|NCT00552929|10897578|FG007|Overall Study|Lost to Follow-up|0
6884539|NCT00552929|10897579|FG008|Overall Study|Lost to Follow-up|1
6884540|NCT00552929|10897580|FG009|Overall Study|Lost to Follow-up|0
6884541|NCT00552929|10897571|FG000|Overall Study|Not Eligible|0
6884542|NCT00552929|10897572|FG001|Overall Study|Not Eligible|0
6884543|NCT00552929|10897573|FG002|Overall Study|Not Eligible|0
6884544|NCT00552929|10897574|FG003|Overall Study|Not Eligible|0
6884545|NCT00552929|10897575|FG004|Overall Study|Not Eligible|0
6884546|NCT00552929|10897576|FG005|Overall Study|Not Eligible|1
6884547|NCT00552929|10897577|FG006|Overall Study|Not Eligible|0
6884548|NCT00552929|10897578|FG007|Overall Study|Not Eligible|0
6884549|NCT00552929|10897579|FG008|Overall Study|Not Eligible|0
6884550|NCT00552929|10897580|FG009|Overall Study|Not Eligible|0
6884551|NCT00553059|10897604|FG000|Overall Study|Deemed ineligible|1
6884552|NCT00553059|10897605|FG001|Overall Study|Deemed ineligible|1
6884553|NCT00553059|10897604|FG000|Overall Study|Drug supply not available|0
6884554|NCT00553059|10897605|FG001|Overall Study|Drug supply not available|1
6884555|NCT00553150|10897621|FG000|Overall Study|Withdrawal by Subject|0
6884556|NCT00553150|10897622|FG001|Overall Study|Withdrawal by Subject|0
6884557|NCT00553150|10897623|FG002|Overall Study|Withdrawal by Subject|0
6884558|NCT00553150|10897624|FG003|Overall Study|Withdrawal by Subject|2
6884559|NCT00553150|10897621|FG000|Overall Study|Protocol Violation|0
6884560|NCT00553150|10897622|FG001|Overall Study|Protocol Violation|0
6884561|NCT00553150|10897623|FG002|Overall Study|Protocol Violation|0
6884562|NCT00553150|10897624|FG003|Overall Study|Protocol Violation|1
6884563|NCT00553150|10897621|FG000|Overall Study|Ineligible|0
6884564|NCT00553150|10897622|FG001|Overall Study|Ineligible|0
6884565|NCT00553150|10897623|FG002|Overall Study|Ineligible|0
6884566|NCT00553150|10897624|FG003|Overall Study|Ineligible|1
6884567|NCT00553202|10897646|FG000|Overall Study|Death|16
6884568|NCT00553202|10897646|FG000|Overall Study|Lost to Follow-up|1
6884569|NCT00553202|10897646|FG000|Overall Study|Physician Decision|28
6884570|NCT00553202|10897646|FG000|Overall Study|Withdrawal by Subject|1
6884571|NCT00553202|10897646|FG000|Overall Study|No donor identified|16
6884572|NCT00553202|10897646|FG000|Overall Study|Fails to meet organ function|6
6884573|NCT00553254|10897653|FG000|Overall Study|Death|3
6884574|NCT00553254|10897654|FG001|Overall Study|Death|6
6884575|NCT00553254|10897655|FG002|Overall Study|Death|25
6884576|NCT00553254|10897653|FG000|Overall Study|Lost to Follow-up|0
6884577|NCT00553254|10897654|FG001|Overall Study|Lost to Follow-up|0
6884578|NCT00553254|10897655|FG002|Overall Study|Lost to Follow-up|2
6884579|NCT00553254|10897653|FG000|Overall Study|Withdrawal by Subject|2
6884580|NCT00553254|10897654|FG001|Overall Study|Withdrawal by Subject|0
6884581|NCT00553254|10897655|FG002|Overall Study|Withdrawal by Subject|2
6884582|NCT00553254|10897653|FG000|Overall Study|Study terminated by Sponsor|0
6884583|NCT00553254|10897654|FG001|Overall Study|Study terminated by Sponsor|0
6884584|NCT00553254|10897655|FG002|Overall Study|Study terminated by Sponsor|1
6884585|NCT00553254|10897653|FG000|Overall Study|Other|1
6884586|NCT00553254|10897654|FG001|Overall Study|Other|0
6884587|NCT00553254|10897655|FG002|Overall Study|Other|13
6884588|NCT00553267|10897670|FG000|Overall Study|Adverse Event|8
6884589|NCT00553267|10897671|FG001|Overall Study|Adverse Event|10
6884590|NCT00553267|10897672|FG002|Overall Study|Adverse Event|5
6884591|NCT00553267|10897670|FG000|Overall Study|Non compliant with protocol|3
6884592|NCT00553267|10897671|FG001|Overall Study|Non compliant with protocol|3
6884593|NCT00553267|10897672|FG002|Overall Study|Non compliant with protocol|2
6884594|NCT00553267|10897670|FG000|Overall Study|Lost to Follow-up|0
6884595|NCT00553267|10897671|FG001|Overall Study|Lost to Follow-up|0
6884596|NCT00553267|10897672|FG002|Overall Study|Lost to Follow-up|1
6884597|NCT00553267|10897670|FG000|Overall Study|Consent withdrawn|2
6884598|NCT00553267|10897671|FG001|Overall Study|Consent withdrawn|3
6884599|NCT00553267|10897672|FG002|Overall Study|Consent withdrawn|1
6884600|NCT00553267|10897670|FG000|Overall Study|Specified category|1
6884601|NCT00553267|10897671|FG001|Overall Study|Specified category|2
6884602|NCT00553267|10897672|FG002|Overall Study|Specified category|1
6884603|NCT00553280|10897680|FG000|Overall Study|Adverse Event|19
6884604|NCT00553280|10897680|FG000|Overall Study|Lack of Efficacy|3
6884605|NCT00553280|10897680|FG000|Overall Study|Withdrawal by Subject|3
6884606|NCT00553280|10897680|FG000|Overall Study|Physician Decision|1
6884607|NCT00553319|10897687|FG000|Overall Study|Lost to Follow-up|10
6884608|NCT00553319|10897688|FG001|Overall Study|Lost to Follow-up|9
6884609|NCT00553319|10897689|FG002|Overall Study|Lost to Follow-up|5
6884610|NCT00553319|10897687|FG000|Overall Study|wanted treatment elsewhere|2
6884611|NCT00553319|10897688|FG001|Overall Study|wanted treatment elsewhere|1
6884612|NCT00553319|10897689|FG002|Overall Study|wanted treatment elsewhere|1
6884613|NCT00553319|10897687|FG000|Overall Study|non-compliance|0
6884614|NCT00553319|10897688|FG001|Overall Study|non-compliance|0
6884615|NCT00553319|10897689|FG002|Overall Study|non-compliance|2
6884616|NCT00553319|10897687|FG000|Overall Study|incarceration|1
6884617|NCT00553319|10897688|FG001|Overall Study|incarceration|0
6884618|NCT00553319|10897689|FG002|Overall Study|incarceration|0
6884619|NCT00553319|10897687|FG000|Overall Study|moved|1
6884620|NCT00553319|10897688|FG001|Overall Study|moved|0
6884621|NCT00553319|10897689|FG002|Overall Study|moved|1
6884622|NCT00553332|10897697|FG000|Overall Study|ineligible, incorrect diagnosis|1
6884623|NCT00553358|10897704|FG000|Overall Study|Randomized but did not receive treatment|3
6884624|NCT00553358|10897705|FG001|Overall Study|Randomized but did not receive treatment|3
6884625|NCT00553358|10897706|FG002|Overall Study|Randomized but did not receive treatment|1
6884626|NCT00553358|10897704|FG000|Overall Study|Lost to Follow-up|22
6884627|NCT00553358|10897705|FG001|Overall Study|Lost to Follow-up|26
6884628|NCT00553358|10897706|FG002|Overall Study|Lost to Follow-up|18
6884629|NCT00553358|10897704|FG000|Overall Study|Withdrew completely|23
6884630|NCT00553358|10897705|FG001|Overall Study|Withdrew completely|33
6884631|NCT00553358|10897706|FG002|Overall Study|Withdrew completely|34
6884632|NCT00553358|10897704|FG000|Overall Study|Died during clinical follow-up|25
6884633|NCT00553358|10897705|FG001|Overall Study|Died during clinical follow-up|29
6884634|NCT00553358|10897706|FG002|Overall Study|Died during clinical follow-up|32
6884635|NCT00553358|10897704|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4
6884636|NCT00553358|10897705|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2
6884637|NCT00553358|10897706|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2
6884638|NCT00553358|10897704|FG000|Overall Study|Died after clinical follow-up ended|1
6884639|NCT00553358|10897705|FG001|Overall Study|Died after clinical follow-up ended|2
6884640|NCT00553358|10897706|FG002|Overall Study|Died after clinical follow-up ended|0
6884641|NCT00553358|10897704|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1
6884642|NCT00553358|10897705|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1
6884643|NCT00553358|10897706|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1
6884644|NCT00553436|10897729|FG000|Overall Study|Conversion to another procedure|1
6884645|NCT00553462|10897733|FG000|Overall Study|Adverse Event|4
6884646|NCT00553462|10897733|FG000|Overall Study|Progression|4
6884647|NCT00553462|10897733|FG000|Overall Study|Withdrawal by Subject|5
6884648|NCT00553462|10897733|FG000|Overall Study|Physician Decision|1
6884649|NCT00553475|10897740|FG000|Overall Study|Adverse Event|7
6884650|NCT00553475|10897741|FG001|Overall Study|Adverse Event|17
6884651|NCT00553475|10897742|FG002|Overall Study|Adverse Event|13
6884652|NCT00553475|10897740|FG000|Overall Study|Lack of Efficacy|7
6884653|NCT00553475|10897741|FG001|Overall Study|Lack of Efficacy|1
6884654|NCT00553475|10897742|FG002|Overall Study|Lack of Efficacy|0
6884655|NCT00553475|10897740|FG000|Overall Study|Withdrawal by Subject|1
6884656|NCT00553475|10897741|FG001|Overall Study|Withdrawal by Subject|1
6884657|NCT00553475|10897742|FG002|Overall Study|Withdrawal by Subject|0
6884658|NCT00553475|10897740|FG000|Overall Study|Physician Decision|1
6884659|NCT00553475|10897741|FG001|Overall Study|Physician Decision|0
6884660|NCT00553475|10897742|FG002|Overall Study|Physician Decision|0
7079106|NCT02109029|11187798|FG001|Part B|Adverse Event|0
7079107|NCT02109029|11187799|FG002|Part B|Adverse Event|0
7079108|NCT02109029|11187800|FG003|Part B|Adverse Event|0
7079109|NCT02109029|11187801|FG004|Part B|Adverse Event|1
7079110|NCT02109029|11187802|FG005|Part B|Adverse Event|1
7079111|NCT02109042|11187813|FG000|Overall Study|Sponsor Decision|15
7079112|NCT02109107|11187818|FG000|Overall Study|Lost to Follow-up|2
7079113|NCT02109133|11187824|FG000|Overall Study|Lost to Follow-up|1
7079114|NCT02109133|11187825|FG001|Overall Study|Lost to Follow-up|0
7079115|NCT02109432|11187848|FG000|Overall Study|Withdrawal by Subject|1
7079116|NCT02109445|11187852|FG000|Overall Study|Symptomatic deterioration|2
7079117|NCT02109445|11187852|FG000|Overall Study|Adverse Event|1
6884661|NCT00553475|10897740|FG000|Overall Study|Due to moving|0
6884662|NCT00553475|10897741|FG001|Overall Study|Due to moving|1
6884663|NCT00553475|10897742|FG002|Overall Study|Due to moving|0
6884664|NCT00553501|10897752|FG000|Overall Study|Adverse Event|2
6884665|NCT00553501|10897752|FG000|Overall Study|Death|1
6884666|NCT00553501|10897752|FG000|Overall Study|Progression|1
6884667|NCT00553514|10897761|FG000|Overall Study|Protocol deviation|0
6884668|NCT00553514|10897762|FG001|Overall Study|Protocol deviation|0
7079118|NCT02109484|11187868|FG000|Overall Study|Lost to Follow-up|0
7079119|NCT02109484|11187869|FG001|Overall Study|Lost to Follow-up|0
7155641|NCT03345407|11323715|FG000|Overall Study|Lost to Follow-up|2
6884669|NCT00553514|10897763|FG002|Overall Study|Protocol deviation|0
6884670|NCT00553514|10897764|FG003|Overall Study|Protocol deviation|1
6884671|NCT00553514|10897765|FG004|Overall Study|Protocol deviation|0
7079120|NCT02109484|11187870|FG002|Overall Study|Lost to Follow-up|0
7079121|NCT02109484|11187871|FG003|Overall Study|Lost to Follow-up|1
6884672|NCT00553514|10897761|FG000|Overall Study|Lack of ovarian response|4
6884673|NCT00553514|10897762|FG001|Overall Study|Lack of ovarian response|5
6884674|NCT00553514|10897763|FG002|Overall Study|Lack of ovarian response|5
6884675|NCT00553514|10897764|FG003|Overall Study|Lack of ovarian response|5
6884676|NCT00553514|10897765|FG004|Overall Study|Lack of ovarian response|6
6884677|NCT00553514|10897761|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3
6884678|NCT00553514|10897762|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0
6884679|NCT00553514|10897763|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1
6884680|NCT00553514|10897764|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0
6884681|NCT00553514|10897765|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0
6884682|NCT00553514|10897761|FG000|Overall Study|Risk of multiple pregnancy|0
6884683|NCT00553514|10897762|FG001|Overall Study|Risk of multiple pregnancy|2
6884684|NCT00553514|10897763|FG002|Overall Study|Risk of multiple pregnancy|0
6884685|NCT00553514|10897764|FG003|Overall Study|Risk of multiple pregnancy|1
6884686|NCT00553514|10897765|FG004|Overall Study|Risk of multiple pregnancy|0
6884687|NCT00553514|10897761|FG000|Overall Study|Other|1
6884688|NCT00553514|10897762|FG001|Overall Study|Other|1
6884689|NCT00553514|10897763|FG002|Overall Study|Other|0
6884690|NCT00553514|10897764|FG003|Overall Study|Other|0
6884691|NCT00553514|10897765|FG004|Overall Study|Other|1
6884692|NCT00553540|10897779|FG000|Overall Study|discharged after first visit|2
6884693|NCT00553540|10897780|FG001|Overall Study|discharged after first visit|5
6884694|NCT00553605|10897788|FG000|Overall Study|Did not meet entrance criteria|1
6884695|NCT00553605|10897789|FG001|Overall Study|Did not meet entrance criteria|3
6884696|NCT00553605|10897788|FG000|Overall Study|Did not receive full dose|1
6884697|NCT00553605|10897789|FG001|Overall Study|Did not receive full dose|0
6884698|NCT00553605|10897788|FG000|Overall Study|Randomized but not treated|2
6884699|NCT00553605|10897789|FG001|Overall Study|Randomized but not treated|0
6884700|NCT00553631|10897797|FG000|Overall Study|Withdrawal by Subject|0
6884701|NCT00553631|10897798|FG001|Overall Study|Withdrawal by Subject|1
6884702|NCT00553631|10897797|FG000|Overall Study|Lost to Follow-up|1
6884703|NCT00553631|10897798|FG001|Overall Study|Lost to Follow-up|0
6884704|NCT00553644|10897804|FG000|Overall Study|Adverse Event|17
6884705|NCT00553644|10897804|FG000|Overall Study|Withdrawal by Subject|4
6884706|NCT00553644|10897804|FG000|Overall Study|Physician Decision|1
6884707|NCT00553644|10897804|FG000|Overall Study|Alternative therapy|6
6884708|NCT00553696|10897812|FG000|Overall Study|Adverse Event|2
6884709|NCT00553696|10897813|FG001|Overall Study|Adverse Event|4
6884710|NCT00553696|10897814|FG002|Overall Study|Adverse Event|0
6884711|NCT00553696|10897815|FG003|Overall Study|Adverse Event|1
6884712|NCT00553696|10897812|FG000|Overall Study|Global deterioration of health status|0
6884713|NCT00553696|10897813|FG001|Overall Study|Global deterioration of health status|2
6884714|NCT00553696|10897814|FG002|Overall Study|Global deterioration of health status|0
6884715|NCT00553696|10897815|FG003|Overall Study|Global deterioration of health status|0
6884716|NCT00553696|10897812|FG000|Overall Study|Objective progression or relapse|2
6884717|NCT00553696|10897813|FG001|Overall Study|Objective progression or relapse|9
6884718|NCT00553696|10897814|FG002|Overall Study|Objective progression or relapse|6
6884719|NCT00553696|10897815|FG003|Overall Study|Objective progression or relapse|0
6884720|NCT00553696|10897812|FG000|Overall Study|Withdrawal by Subject|0
6884721|NCT00553696|10897813|FG001|Overall Study|Withdrawal by Subject|1
6884722|NCT00553696|10897814|FG002|Overall Study|Withdrawal by Subject|0
6884723|NCT00553696|10897815|FG003|Overall Study|Withdrawal by Subject|0
6884724|NCT00553787|10897838|FG000|Overall Study|Adverse Event|34
6884725|NCT00553787|10897839|FG001|Overall Study|Adverse Event|21
6884726|NCT00553787|10897840|FG002|Overall Study|Adverse Event|67
6884727|NCT00553787|10897838|FG000|Overall Study|Lost to Follow-up|132
6884728|NCT00553787|10897839|FG001|Overall Study|Lost to Follow-up|44
6884729|NCT00553787|10897840|FG002|Overall Study|Lost to Follow-up|78
6884730|NCT00553787|10897838|FG000|Overall Study|Withdrawal by Subject|151
6884731|NCT00553787|10897839|FG001|Overall Study|Withdrawal by Subject|40
6884732|NCT00553787|10897840|FG002|Overall Study|Withdrawal by Subject|83
6884733|NCT00553787|10897838|FG000|Overall Study|Lack of Efficacy|31
6884734|NCT00553787|10897839|FG001|Overall Study|Lack of Efficacy|1
6884735|NCT00553787|10897840|FG002|Overall Study|Lack of Efficacy|3
6884736|NCT00553787|10897838|FG000|Overall Study|Pregnancy|0
6884737|NCT00553787|10897839|FG001|Overall Study|Pregnancy|1
6884738|NCT00553787|10897840|FG002|Overall Study|Pregnancy|2
6884739|NCT00553787|10897838|FG000|Overall Study|non compliance|4
6884740|NCT00553787|10897839|FG001|Overall Study|non compliance|0
6884741|NCT00553787|10897840|FG002|Overall Study|non compliance|11
6884742|NCT00553787|10897838|FG000|Overall Study|Requirement for restricted medication|8
6884743|NCT00553787|10897839|FG001|Overall Study|Requirement for restricted medication|7
6884744|NCT00553787|10897840|FG002|Overall Study|Requirement for restricted medication|5
6884745|NCT00553787|10897838|FG000|Overall Study|Other|18
6884746|NCT00553787|10897839|FG001|Overall Study|Other|10
6884747|NCT00553787|10897840|FG002|Overall Study|Other|13
6884748|NCT00554099|10897872|FG000|Treatment Period (12 Weeks)|Adverse Event|3
6884749|NCT00554099|10897873|FG001|Treatment Period (12 Weeks)|Adverse Event|5
6884750|NCT00554099|10897874|FG002|Treatment Period (12 Weeks)|Adverse Event|1
6884751|NCT00554099|10897872|FG000|Treatment Period (12 Weeks)|Physician Decision|3
6884752|NCT00554099|10897873|FG001|Treatment Period (12 Weeks)|Physician Decision|0
6884753|NCT00554099|10897874|FG002|Treatment Period (12 Weeks)|Physician Decision|0
6884754|NCT00554099|10897872|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1
6884755|NCT00554099|10897873|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0
6884756|NCT00554099|10897874|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2
6884757|NCT00554099|10897872|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1
6884758|NCT00554099|10897873|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2
6884759|NCT00554099|10897874|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0
6884760|NCT00554099|10897872|FG000|Treatment Period (12 Weeks)|Protocol Violation|0
6884761|NCT00554099|10897873|FG001|Treatment Period (12 Weeks)|Protocol Violation|0
6884762|NCT00554099|10897874|FG002|Treatment Period (12 Weeks)|Protocol Violation|2
6884763|NCT00554099|10897872|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4
6884764|NCT00554099|10897873|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1
6884765|NCT00554099|10897874|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4
6884766|NCT00554099|10897872|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1
6884767|NCT00554099|10897873|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2
6884768|NCT00554099|10897874|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0
6884769|NCT00554099|10897872|FG000|Non-Treatment Phase (9 Months)|Relapse|2
6884770|NCT00554099|10897873|FG001|Non-Treatment Phase (9 Months)|Relapse|1
6884771|NCT00554099|10897874|FG002|Non-Treatment Phase (9 Months)|Relapse|1
6884772|NCT00554099|10897872|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4
6884773|NCT00554099|10897873|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
6884774|NCT00554099|10897874|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
6884775|NCT00554216|10897885|FG000|Overall Study|Lost to Follow-up|92
6884776|NCT00554216|10897886|FG001|Overall Study|Lost to Follow-up|31
6884777|NCT00554216|10897887|FG002|Overall Study|Lost to Follow-up|63
6884778|NCT00554216|10897885|FG000|Overall Study|Adverse Event|16
6884779|NCT00554216|10897886|FG001|Overall Study|Adverse Event|16
6884780|NCT00554216|10897887|FG002|Overall Study|Adverse Event|36
6884781|NCT00554216|10897885|FG000|Overall Study|Withdrawal by Subject|92
6884782|NCT00554216|10897886|FG001|Overall Study|Withdrawal by Subject|31
6884783|NCT00554216|10897887|FG002|Overall Study|Withdrawal by Subject|43
6884784|NCT00554216|10897885|FG000|Overall Study|Non compliance|10
6884785|NCT00554216|10897886|FG001|Overall Study|Non compliance|4
6884786|NCT00554216|10897887|FG002|Overall Study|Non compliance|5
6884787|NCT00554216|10897885|FG000|Overall Study|Pregnancy|2
6884788|NCT00554216|10897886|FG001|Overall Study|Pregnancy|1
6884789|NCT00554216|10897887|FG002|Overall Study|Pregnancy|14
6884790|NCT00554216|10897885|FG000|Overall Study|Restricted med|3
6884791|NCT00554216|10897886|FG001|Overall Study|Restricted med|1
6884792|NCT00554216|10897887|FG002|Overall Study|Restricted med|1
6884793|NCT00554216|10897885|FG000|Overall Study|Other|12
6884794|NCT00554216|10897886|FG001|Overall Study|Other|7
6884795|NCT00554216|10897887|FG002|Overall Study|Other|10
6884796|NCT00554216|10897885|FG000|Overall Study|Lack of Efficacy|15
6884797|NCT00554216|10897886|FG001|Overall Study|Lack of Efficacy|3
6884798|NCT00554216|10897887|FG002|Overall Study|Lack of Efficacy|0
6884799|NCT00554229|10897897|FG000|Overall Study|Lost to Follow-up|3
6884800|NCT00554229|10897898|FG001|Overall Study|Lost to Follow-up|6
6884801|NCT00554229|10897897|FG000|Overall Study|Withdrawal by Subject|29
6884802|NCT00554229|10897898|FG001|Overall Study|Withdrawal by Subject|37
6884803|NCT00554229|10897897|FG000|Overall Study|Adverse Event|71
6884804|NCT00554229|10897898|FG001|Overall Study|Adverse Event|39
6884805|NCT00554229|10897897|FG000|Overall Study|Protocol Violation|3
6884806|NCT00554229|10897898|FG001|Overall Study|Protocol Violation|3
6884807|NCT00554229|10897897|FG000|Overall Study|Reason not otherwise captured, eg; death|119
7079122|NCT02109484|11187872|FG004|Overall Study|Lost to Follow-up|1
7079123|NCT02109484|11187873|FG005|Overall Study|Lost to Follow-up|0
7079124|NCT02109484|11187874|FG006|Overall Study|Lost to Follow-up|1
7079125|NCT02109484|11187875|FG007|Overall Study|Lost to Follow-up|0
6884808|NCT00554229|10897898|FG001|Overall Study|Reason not otherwise captured, eg; death|140
6884809|NCT00554229|10897897|FG000|Overall Study|Randomised but no treatment received|1
6884810|NCT00554229|10897898|FG001|Overall Study|Randomised but no treatment received|0
6884811|NCT00554515|10897919|FG000|Overall Study|Withdrawal by Subject|3
6884812|NCT00554515|10897919|FG000|Overall Study|Disease progression|52
6884813|NCT00554515|10897919|FG000|Overall Study|Physician Decision|18
6884814|NCT00554515|10897919|FG000|Overall Study|Withdrawal by Subject|11
6884815|NCT00554515|10897919|FG000|Overall Study|Adverse Event|9
6884816|NCT00554515|10897919|FG000|Overall Study|Death|2
6884817|NCT00554515|10897919|FG000|Overall Study|Achieved Stable Disease|7
6884818|NCT00554515|10897919|FG000|Overall Study|Other|1
6884819|NCT00554515|10897919|FG000|Overall Study|Misc|15
6884820|NCT00554619|10897944|FG000|Overall Study|Adverse Event|1
6884821|NCT00554619|10897944|FG000|Overall Study|Physician Decision|1
6884822|NCT00554619|10897944|FG000|Overall Study|Liver Function Test Abnormality|1
6884823|NCT00554788|10897965|FG000|Overall Study|Adverse Event|0
6884824|NCT00554788|10897966|FG001|Overall Study|Adverse Event|1
6884825|NCT00554788|10897967|FG002|Overall Study|Adverse Event|2
6884826|NCT00554788|10897965|FG000|Overall Study|Lost to Follow-up|4
6884827|NCT00554788|10897966|FG001|Overall Study|Lost to Follow-up|3
6884828|NCT00554788|10897967|FG002|Overall Study|Lost to Follow-up|3
6884829|NCT00554788|10897965|FG000|Overall Study|Physician Decision|1
6884830|NCT00554788|10897966|FG001|Overall Study|Physician Decision|1
6884831|NCT00554788|10897967|FG002|Overall Study|Physician Decision|3
6884832|NCT00554788|10897965|FG000|Overall Study|Withdrawal by Subject|0
6884833|NCT00554788|10897966|FG001|Overall Study|Withdrawal by Subject|0
6884834|NCT00554788|10897967|FG002|Overall Study|Withdrawal by Subject|1
6884835|NCT00554788|10897965|FG000|Overall Study|Refusal of further protocol therapy|0
6884836|NCT00554788|10897966|FG001|Overall Study|Refusal of further protocol therapy|1
6884837|NCT00554788|10897967|FG002|Overall Study|Refusal of further protocol therapy|1
6884838|NCT00554788|10897965|FG000|Overall Study|Progressive disease|0
6884839|NCT00554788|10897966|FG001|Overall Study|Progressive disease|0
6884840|NCT00554788|10897967|FG002|Overall Study|Progressive disease|3
7079126|NCT02109484|11187868|FG000|Overall Study|Withdrawal by Subject|0
7079127|NCT02109484|11187869|FG001|Overall Study|Withdrawal by Subject|0
7079128|NCT02109484|11187870|FG002|Overall Study|Withdrawal by Subject|0
6884841|NCT00554788|10897965|FG000|Overall Study|Ineligible|2
6884842|NCT00554788|10897966|FG001|Overall Study|Ineligible|0
6884843|NCT00554788|10897967|FG002|Overall Study|Ineligible|1
6884844|NCT00554801|10897978|FG000|Overall Study|left area before completion|5
6884845|NCT00554801|10897979|FG001|Overall Study|left area before completion|0
6884846|NCT00554801|10897978|FG000|Overall Study|Withdrawal by Subject|14
6884847|NCT00554801|10897979|FG001|Overall Study|Withdrawal by Subject|0
6884848|NCT00555061|10898027|FG000|Overall Study|Adverse Event|3
6884849|NCT00555061|10898027|FG000|Overall Study|Protocol Violation|1
6884850|NCT00555061|10898027|FG000|Overall Study|Lost to Follow-up|2
6884851|NCT00555061|10898027|FG000|Overall Study|Withdrawal by Subject|2
6884852|NCT00555061|10898027|FG000|Overall Study|Participant enrolled, but never treated|1
6884853|NCT00555217|10898050|FG000|Overall Study|Withdrawal by Subject|35
6884854|NCT00555217|10898051|FG001|Overall Study|Withdrawal by Subject|31
6884855|NCT00555217|10898050|FG000|Overall Study|Lost to Follow-up|19
6884856|NCT00555217|10898051|FG001|Overall Study|Lost to Follow-up|20
6884857|NCT00555217|10898050|FG000|Overall Study|close out sites|21
6884858|NCT00555217|10898051|FG001|Overall Study|close out sites|17
6884859|NCT00555321|10898062|FG000|Treatment Phase up to 12-months|Adverse Event|6
6884860|NCT00555321|10898063|FG001|Treatment Phase up to 12-months|Adverse Event|7
6884861|NCT00555321|10898064|FG002|Treatment Phase up to 12-months|Adverse Event|11
6884862|NCT00555321|10898065|FG003|Treatment Phase up to 12-months|Adverse Event|7
6884863|NCT00555321|10898066|FG004|Treatment Phase up to 12-months|Adverse Event|18
6884864|NCT00555321|10898062|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1
6884865|NCT00555321|10898063|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0
6884866|NCT00555321|10898064|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1
6884867|NCT00555321|10898065|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0
6884868|NCT00555321|10898066|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0
6884869|NCT00555321|10898062|FG000|Treatment Phase up to 12-months|Death|2
6884870|NCT00555321|10898063|FG001|Treatment Phase up to 12-months|Death|1
6884871|NCT00555321|10898064|FG002|Treatment Phase up to 12-months|Death|4
6884872|NCT00555321|10898065|FG003|Treatment Phase up to 12-months|Death|0
6884873|NCT00555321|10898066|FG004|Treatment Phase up to 12-months|Death|0
6884874|NCT00555321|10898062|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9
6884875|NCT00555321|10898063|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8
6884876|NCT00555321|10898064|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5
6884877|NCT00555321|10898065|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0
6884878|NCT00555321|10898066|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0
6884879|NCT00555321|10898062|FG000|Treatment Phase up to 12-months|Other Reason|1
6884880|NCT00555321|10898063|FG001|Treatment Phase up to 12-months|Other Reason|3
6884881|NCT00555321|10898064|FG002|Treatment Phase up to 12-months|Other Reason|2
6884882|NCT00555321|10898065|FG003|Treatment Phase up to 12-months|Other Reason|0
6884883|NCT00555321|10898066|FG004|Treatment Phase up to 12-months|Other Reason|0
6884884|NCT00555321|10898062|FG000|Treatment Phase up to 12-months|Never treated|2
6884885|NCT00555321|10898063|FG001|Treatment Phase up to 12-months|Never treated|3
6884886|NCT00555321|10898064|FG002|Treatment Phase up to 12-months|Never treated|1
6884887|NCT00555321|10898065|FG003|Treatment Phase up to 12-months|Never treated|0
6884888|NCT00555321|10898066|FG004|Treatment Phase up to 12-months|Never treated|4
6884889|NCT00555321|10898062|FG000|Long-term Extension Phase|Adverse Event|2
6884890|NCT00555321|10898063|FG001|Long-term Extension Phase|Adverse Event|5
6884891|NCT00555321|10898064|FG002|Long-term Extension Phase|Adverse Event|2
6884892|NCT00555321|10898065|FG003|Long-term Extension Phase|Adverse Event|1
6884893|NCT00555321|10898066|FG004|Long-term Extension Phase|Adverse Event|0
6884894|NCT00555321|10898062|FG000|Long-term Extension Phase|Withdrawal by Subject|2
6884895|NCT00555321|10898063|FG001|Long-term Extension Phase|Withdrawal by Subject|1
6884896|NCT00555321|10898064|FG002|Long-term Extension Phase|Withdrawal by Subject|2
6884897|NCT00555321|10898065|FG003|Long-term Extension Phase|Withdrawal by Subject|3
6884898|NCT00555321|10898066|FG004|Long-term Extension Phase|Withdrawal by Subject|2
6884899|NCT00555321|10898062|FG000|Long-term Extension Phase|Administrative reason by sponsor|23
7079129|NCT02109484|11187871|FG003|Overall Study|Withdrawal by Subject|0
6884900|NCT00555321|10898063|FG001|Long-term Extension Phase|Administrative reason by sponsor|21
6884901|NCT00555321|10898064|FG002|Long-term Extension Phase|Administrative reason by sponsor|18
6884902|NCT00555321|10898065|FG003|Long-term Extension Phase|Administrative reason by sponsor|31
6884903|NCT00555321|10898066|FG004|Long-term Extension Phase|Administrative reason by sponsor|23
6884904|NCT00555321|10898062|FG000|Long-term Extension Phase|Death|2
6884905|NCT00555321|10898063|FG001|Long-term Extension Phase|Death|0
6884906|NCT00555321|10898064|FG002|Long-term Extension Phase|Death|0
6884907|NCT00555321|10898065|FG003|Long-term Extension Phase|Death|3
6884908|NCT00555321|10898066|FG004|Long-term Extension Phase|Death|0
6884909|NCT00555321|10898062|FG000|Long-term Extension Phase|Participant did not meet study criteria|0
6884910|NCT00555321|10898063|FG001|Long-term Extension Phase|Participant did not meet study criteria|0
6884911|NCT00555321|10898064|FG002|Long-term Extension Phase|Participant did not meet study criteria|0
6884912|NCT00555321|10898065|FG003|Long-term Extension Phase|Participant did not meet study criteria|0
6884913|NCT00555321|10898066|FG004|Long-term Extension Phase|Participant did not meet study criteria|1
6884914|NCT00555321|10898062|FG000|Long-term Extension Phase|Other Reason|1
6884915|NCT00555321|10898063|FG001|Long-term Extension Phase|Other Reason|0
6884916|NCT00555321|10898064|FG002|Long-term Extension Phase|Other Reason|2
6884917|NCT00555321|10898065|FG003|Long-term Extension Phase|Other Reason|0
6884918|NCT00555321|10898066|FG004|Long-term Extension Phase|Other Reason|0
6884919|NCT00555425|10898095|FG000|Overall Study|Missed Medication > 1 wk|34
6884920|NCT00555425|10898096|FG001|Overall Study|Missed Medication > 1 wk|15
6884921|NCT00555425|10898095|FG000|Overall Study|Missed 3 physician management visits|1
6884922|NCT00555425|10898096|FG001|Overall Study|Missed 3 physician management visits|0
6884923|NCT00555425|10898095|FG000|Overall Study|Met criteria for protective transfer|16
6884924|NCT00555425|10898096|FG001|Overall Study|Met criteria for protective transfer|3
6884925|NCT00555425|10898095|FG000|Overall Study|Became pregnant and transferred care|0
6884926|NCT00555425|10898096|FG001|Overall Study|Became pregnant and transferred care|1
6884927|NCT00555438|10898102|FG000|10 Days Post-operative|Death|4
6884928|NCT00555438|10898102|FG000|Between 10 Days and 30 Days Postoperativ|Death|5
6884929|NCT00555477|10898117|FG000|Overall Study|Adverse Event|0
6884930|NCT00555477|10898118|FG001|Overall Study|Adverse Event|9
6884931|NCT00555477|10898117|FG000|Overall Study|Withdrawal by Subject|1
6884932|NCT00555477|10898118|FG001|Overall Study|Withdrawal by Subject|2
6884933|NCT00555477|10898117|FG000|Overall Study|Physician Decision|1
6884934|NCT00555477|10898118|FG001|Overall Study|Physician Decision|2
6884935|NCT00555568|10898126|FG000|Overall Study|Lost to Follow-up|26
6884936|NCT00555568|10898127|FG001|Overall Study|Lost to Follow-up|16
6884937|NCT00555568|10898128|FG002|Overall Study|Lost to Follow-up|16
6884938|NCT00555620|10898146|FG000|Overall Study|Death|0
6884939|NCT00555620|10898147|FG001|Overall Study|Death|1
6884940|NCT00555620|10898148|FG002|Overall Study|Death|0
6884941|NCT00555620|10898149|FG003|Overall Study|Death|0
6884942|NCT00555620|10898150|FG004|Overall Study|Death|0
6884943|NCT00555620|10898151|FG005|Overall Study|Death|1
6884944|NCT00555620|10898146|FG000|Overall Study|Study terminated by sponsor|0
6884945|NCT00555620|10898147|FG001|Overall Study|Study terminated by sponsor|0
6884946|NCT00555620|10898148|FG002|Overall Study|Study terminated by sponsor|1
6884947|NCT00555620|10898149|FG003|Overall Study|Study terminated by sponsor|0
6884948|NCT00555620|10898150|FG004|Overall Study|Study terminated by sponsor|0
6884949|NCT00555620|10898151|FG005|Overall Study|Study terminated by sponsor|0
6884950|NCT00555620|10898146|FG000|Overall Study|Adverse Event|0
6884951|NCT00555620|10898147|FG001|Overall Study|Adverse Event|0
6884952|NCT00555620|10898148|FG002|Overall Study|Adverse Event|1
6884953|NCT00555620|10898149|FG003|Overall Study|Adverse Event|5
6884954|NCT00555620|10898150|FG004|Overall Study|Adverse Event|0
6884955|NCT00555620|10898151|FG005|Overall Study|Adverse Event|1
6884956|NCT00555620|10898146|FG000|Overall Study|Objective progression or relapse|6
6884957|NCT00555620|10898147|FG001|Overall Study|Objective progression or relapse|5
6884958|NCT00555620|10898148|FG002|Overall Study|Objective progression or relapse|12
6884959|NCT00555620|10898149|FG003|Overall Study|Objective progression or relapse|17
6884960|NCT00555620|10898150|FG004|Overall Study|Objective progression or relapse|3
6884961|NCT00555620|10898151|FG005|Overall Study|Objective progression or relapse|16
6884962|NCT00555620|10898146|FG000|Overall Study|Participant refused treatment|0
6884963|NCT00555620|10898147|FG001|Overall Study|Participant refused treatment|1
6884964|NCT00555620|10898148|FG002|Overall Study|Participant refused treatment|1
6884965|NCT00555620|10898149|FG003|Overall Study|Participant refused treatment|0
6884966|NCT00555620|10898150|FG004|Overall Study|Participant refused treatment|0
6884967|NCT00555620|10898151|FG005|Overall Study|Participant refused treatment|1
6884968|NCT00555620|10898146|FG000|Overall Study|Other|0
6884969|NCT00555620|10898147|FG001|Overall Study|Other|0
6884970|NCT00555620|10898148|FG002|Overall Study|Other|0
6884971|NCT00555620|10898149|FG003|Overall Study|Other|1
6884972|NCT00555620|10898150|FG004|Overall Study|Other|0
6884973|NCT00555620|10898151|FG005|Overall Study|Other|3
6884974|NCT00555672|10898171|FG000|Overall Study|Death|0
6884975|NCT00555672|10898172|FG001|Overall Study|Death|2
6884976|NCT00555672|10898171|FG000|Overall Study|Adverse Event|8
6884977|NCT00555672|10898172|FG001|Overall Study|Adverse Event|2
6884978|NCT00555672|10898171|FG000|Overall Study|Objective progression or relapse|11
6884979|NCT00555672|10898172|FG001|Overall Study|Objective progression or relapse|5
6884980|NCT00555672|10898171|FG000|Overall Study|Other|3
6884981|NCT00555672|10898172|FG001|Overall Study|Other|1
6884982|NCT00555672|10898171|FG000|Overall Study|Participant refused|2
6884983|NCT00555672|10898172|FG001|Overall Study|Participant refused|0
6884984|NCT00555906|10898209|FG000|Phase 1|Objective Progression or Relapse|3
6884985|NCT00555906|10898210|FG001|Phase 1|Objective Progression or Relapse|5
6884986|NCT00555906|10898211|FG002|Phase 1|Objective Progression or Relapse|3
6884987|NCT00555906|10898212|FG003|Phase 1|Objective Progression or Relapse|1
6884988|NCT00555906|10898213|FG004|Phase 1|Objective Progression or Relapse|0
6884989|NCT00555906|10898209|FG000|Phase 1|Global Deterioration of Health Status|0
6884990|NCT00555906|10898210|FG001|Phase 1|Global Deterioration of Health Status|1
6884991|NCT00555906|10898211|FG002|Phase 1|Global Deterioration of Health Status|1
6884992|NCT00555906|10898212|FG003|Phase 1|Global Deterioration of Health Status|1
6884993|NCT00555906|10898213|FG004|Phase 1|Global Deterioration of Health Status|0
6884994|NCT00555906|10898209|FG000|Phase 1|Adverse Event|0
6884995|NCT00555906|10898210|FG001|Phase 1|Adverse Event|0
6884996|NCT00555906|10898211|FG002|Phase 1|Adverse Event|3
6884997|NCT00555906|10898212|FG003|Phase 1|Adverse Event|2
6884998|NCT00555906|10898213|FG004|Phase 1|Adverse Event|0
6884999|NCT00555906|10898209|FG000|Phase 1|Withdrawal by Subject|0
6885000|NCT00555906|10898210|FG001|Phase 1|Withdrawal by Subject|0
6885001|NCT00555906|10898211|FG002|Phase 1|Withdrawal by Subject|0
6885002|NCT00555906|10898212|FG003|Phase 1|Withdrawal by Subject|1
6885003|NCT00555906|10898213|FG004|Phase 1|Withdrawal by Subject|0
6885004|NCT00555906|10898209|FG000|Phase 2|Adverse Event|0
6885005|NCT00555906|10898210|FG001|Phase 2|Adverse Event|0
6885006|NCT00555906|10898211|FG002|Phase 2|Adverse Event|0
6885007|NCT00555906|10898212|FG003|Phase 2|Adverse Event|0
6885008|NCT00555906|10898213|FG004|Phase 2|Adverse Event|4
6885009|NCT00555906|10898209|FG000|Phase 2|Global Deterioration of Health Status|0
6885010|NCT00555906|10898210|FG001|Phase 2|Global Deterioration of Health Status|0
6885011|NCT00555906|10898211|FG002|Phase 2|Global Deterioration of Health Status|0
6885012|NCT00555906|10898212|FG003|Phase 2|Global Deterioration of Health Status|0
6885013|NCT00555906|10898213|FG004|Phase 2|Global Deterioration of Health Status|2
6885014|NCT00555906|10898209|FG000|Phase 2|Objective Progression or Relapse|0
6885015|NCT00555906|10898210|FG001|Phase 2|Objective Progression or Relapse|0
6885016|NCT00555906|10898211|FG002|Phase 2|Objective Progression or Relapse|0
6885017|NCT00555906|10898212|FG003|Phase 2|Objective Progression or Relapse|0
6885018|NCT00555906|10898213|FG004|Phase 2|Objective Progression or Relapse|16
6885019|NCT00555906|10898209|FG000|Phase 2|Withdrawal by Subject|0
6885020|NCT00555906|10898210|FG001|Phase 2|Withdrawal by Subject|0
6885021|NCT00555906|10898211|FG002|Phase 2|Withdrawal by Subject|0
6885022|NCT00555906|10898212|FG003|Phase 2|Withdrawal by Subject|0
6885023|NCT00555906|10898213|FG004|Phase 2|Withdrawal by Subject|2
6885024|NCT00555906|10898209|FG000|Phase 2|Other|0
6885025|NCT00555906|10898210|FG001|Phase 2|Other|0
6885026|NCT00555906|10898211|FG002|Phase 2|Other|0
6885027|NCT00555906|10898212|FG003|Phase 2|Other|0
6885028|NCT00555906|10898213|FG004|Phase 2|Other|6
6885029|NCT00555906|10898209|FG000|Phase 2|Randomized but not Treated|0
6885030|NCT00555906|10898210|FG001|Phase 2|Randomized but not Treated|0
6885031|NCT00555906|10898211|FG002|Phase 2|Randomized but not Treated|0
6885032|NCT00555906|10898212|FG003|Phase 2|Randomized but not Treated|0
6885033|NCT00555906|10898213|FG004|Phase 2|Randomized but not Treated|2
6885034|NCT00555971|10898230|FG000|Overall Study|Adverse Event|1
6885035|NCT00555971|10898231|FG001|Overall Study|Adverse Event|1
6885036|NCT00556322|10898265|FG000|Overall Study|Insufficient therapeutic response|158
6885037|NCT00556322|10898266|FG001|Overall Study|Insufficient therapeutic response|168
6885038|NCT00556322|10898265|FG000|Overall Study|Adverse Event|7
6885039|NCT00556322|10898266|FG001|Overall Study|Adverse Event|4
6885040|NCT00556322|10898265|FG000|Overall Study|Other|4
6885041|NCT00556322|10898266|FG001|Overall Study|Other|1
6885042|NCT00556322|10898265|FG000|Overall Study|Lost to Follow-up|5
6885043|NCT00556322|10898266|FG001|Overall Study|Lost to Follow-up|3
6885044|NCT00556322|10898265|FG000|Overall Study|Withdrawal by Subject|19
6885045|NCT00556322|10898266|FG001|Overall Study|Withdrawal by Subject|7
6885046|NCT00556322|10898265|FG000|Overall Study|Protocol Violation|5
6885047|NCT00556322|10898266|FG001|Overall Study|Protocol Violation|1
6885048|NCT00556322|10898265|FG000|Overall Study|Ongoing at data cutoff|3
6885049|NCT00556322|10898266|FG001|Overall Study|Ongoing at data cutoff|5
6885050|NCT00556322|10898265|FG000|Overall Study|Death|20
6885051|NCT00556322|10898266|FG001|Overall Study|Death|14
6885052|NCT00556374|10898277|FG000|Overall Study|Withdrawal by Subject|190
6885053|NCT00556374|10898278|FG001|Overall Study|Withdrawal by Subject|172
6885054|NCT00556374|10898277|FG000|Overall Study|Death|50
6885055|NCT00556374|10898278|FG001|Overall Study|Death|43
6885056|NCT00556374|10898277|FG000|Overall Study|Lost to Follow-up|7
6885057|NCT00556374|10898278|FG001|Overall Study|Lost to Follow-up|5
6885058|NCT00556426|10898284|FG000|Overall Study|Withdrawal by Subject|3
6885059|NCT00556426|10898284|FG000|Overall Study|Death|6
6885060|NCT00556439|10898293|FG000|Study Entry to Week 12|Lack of Efficacy|5
6885061|NCT00556439|10898294|FG001|Study Entry to Week 12|Lack of Efficacy|0
6885062|NCT00556439|10898295|FG002|Study Entry to Week 12|Lack of Efficacy|6
6885063|NCT00556439|10898296|FG003|Study Entry to Week 12|Lack of Efficacy|0
6885064|NCT00556439|10898293|FG000|Study Entry to Week 12|Physician Decision|1
6885065|NCT00556439|10898294|FG001|Study Entry to Week 12|Physician Decision|0
6885066|NCT00556439|10898295|FG002|Study Entry to Week 12|Physician Decision|0
6885067|NCT00556439|10898296|FG003|Study Entry to Week 12|Physician Decision|0
6885068|NCT00556439|10898293|FG000|Study Entry to Week 12|Withdrawal by Subject|1
6885069|NCT00556439|10898294|FG001|Study Entry to Week 12|Withdrawal by Subject|0
6885070|NCT00556439|10898295|FG002|Study Entry to Week 12|Withdrawal by Subject|1
6885071|NCT00556439|10898296|FG003|Study Entry to Week 12|Withdrawal by Subject|0
6885072|NCT00556439|10898293|FG000|Study Entry to Week 12|Recurrent infection|1
6885073|NCT00556439|10898294|FG001|Study Entry to Week 12|Recurrent infection|0
6885074|NCT00556439|10898295|FG002|Study Entry to Week 12|Recurrent infection|0
6885075|NCT00556439|10898296|FG003|Study Entry to Week 12|Recurrent infection|0
6885076|NCT00556439|10898293|FG000|Study Entry to Week 12|Malignancy|0
6885077|NCT00556439|10898294|FG001|Study Entry to Week 12|Malignancy|0
6885078|NCT00556439|10898295|FG002|Study Entry to Week 12|Malignancy|1
6885079|NCT00556439|10898296|FG003|Study Entry to Week 12|Malignancy|0
6885080|NCT00556439|10898293|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1
6885081|NCT00556439|10898294|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3
6885082|NCT00556439|10898295|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
6885083|NCT00556439|10898296|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
6885084|NCT00556439|10898293|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1
6885085|NCT00556439|10898294|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0
6885086|NCT00556439|10898295|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0
6885087|NCT00556439|10898296|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0
6885088|NCT00556439|10898293|FG000|After Week 12 (Randomized Study Period)|Malignancy|0
6885089|NCT00556439|10898294|FG001|After Week 12 (Randomized Study Period)|Malignancy|1
6885090|NCT00556439|10898295|FG002|After Week 12 (Randomized Study Period)|Malignancy|0
6885091|NCT00556439|10898296|FG003|After Week 12 (Randomized Study Period)|Malignancy|1
6885092|NCT00556439|10898293|FG000|After Week 12 (Randomized Study Period)|Severe infection|1
6885093|NCT00556439|10898294|FG001|After Week 12 (Randomized Study Period)|Severe infection|0
6885094|NCT00556439|10898295|FG002|After Week 12 (Randomized Study Period)|Severe infection|0
6885095|NCT00556439|10898296|FG003|After Week 12 (Randomized Study Period)|Severe infection|0
6885096|NCT00556673|10898365|FG000|Overall Study|Protocol deviation|3
6885097|NCT00556673|10898366|FG001|Overall Study|Protocol deviation|2
6885098|NCT00556712|10898376|FG000|Overall Study|Adverse Event|7
6885099|NCT00556712|10898377|FG001|Overall Study|Adverse Event|19
6885100|NCT00556712|10898376|FG000|Overall Study|Death|5
6885101|NCT00556712|10898377|FG001|Overall Study|Death|10
6885102|NCT00556712|10898376|FG000|Overall Study|Progressive Disease|383
6885103|NCT00556712|10898377|FG001|Overall Study|Progressive Disease|320
6885104|NCT00556712|10898376|FG000|Overall Study|Protocol Violation|3
6885105|NCT00556712|10898377|FG001|Overall Study|Protocol Violation|2
6885106|NCT00556712|10898376|FG000|Overall Study|Refused Treatment|17
6885107|NCT00556712|10898377|FG001|Overall Study|Refused Treatment|16
6885108|NCT00556712|10898376|FG000|Overall Study|Failure to Return|2
6885109|NCT00556712|10898377|FG001|Overall Study|Failure to Return|3
6885110|NCT00556712|10898376|FG000|Overall Study|Other|2
6885111|NCT00556712|10898377|FG001|Overall Study|Other|2
6885112|NCT00556712|10898376|FG000|Overall Study|Ongoing at Data Cutoff|32
6885113|NCT00556712|10898377|FG001|Overall Study|Ongoing at Data Cutoff|66
6969848|NCT01150357|11019621|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
6969849|NCT01150357|11019622|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
6969850|NCT01150357|11019623|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2
6969851|NCT01150357|11019621|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2
6969852|NCT01150357|11019622|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
6969853|NCT01150357|11019623|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
6969854|NCT01150357|11019621|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1
6969855|NCT01150357|11019622|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
6969856|NCT01150357|11019623|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
6969857|NCT01150474|11019654|FG000|Overall Study|Withdrawal by Subject|5
6969858|NCT01150474|11019655|FG001|Overall Study|Withdrawal by Subject|2
6969859|NCT01150474|11019654|FG000|Overall Study|Cancer found|1
6969860|NCT01150474|11019655|FG001|Overall Study|Cancer found|0
6969861|NCT01150474|11019654|FG000|Overall Study|Multiple Studies|0
6969862|NCT01150474|11019655|FG001|Overall Study|Multiple Studies|1
6969863|NCT01150474|11019654|FG000|Overall Study|Rectotomy|1
6969864|NCT01150474|11019655|FG001|Overall Study|Rectotomy|0
6969865|NCT01150474|11019654|FG000|Overall Study|Drug did not arrive in time|1
6969866|NCT01150474|11019655|FG001|Overall Study|Drug did not arrive in time|0
6969867|NCT01150474|11019654|FG000|Overall Study|Drug not administered|1
6969868|NCT01150474|11019655|FG001|Overall Study|Drug not administered|0
6969869|NCT01150474|11019654|FG000|Overall Study|Surgery Changed|1
6969870|NCT01150474|11019655|FG001|Overall Study|Surgery Changed|0
6969871|NCT01151020|11019710|FG000|Overall Study|Death|25
6969872|NCT01151020|11019710|FG000|Overall Study|Conversion to open repair|1
6969873|NCT01151020|11019710|FG000|Overall Study|Lost to Follow-up|4
6969874|NCT01151020|11019710|FG000|Overall Study|Withdrawal by Subject|22
6969875|NCT01151020|11019710|FG000|Overall Study|Patients did not receive the device|2
6969876|NCT01151085|11019727|FG000|Overall Study|Lost to Follow-up|31
6969877|NCT01151085|11019727|FG000|Overall Study|Protocol Violation|25
6969878|NCT01151098|11019738|FG000|Overall Study|Adverse Event|82
6969879|NCT01151098|11019738|FG000|Overall Study|Lost to Follow-up|6
6969880|NCT01151098|11019738|FG000|Overall Study|Lack of Efficacy|15
6969881|NCT01151098|11019738|FG000|Overall Study|Protocol Violation|1
6969882|NCT01151098|11019738|FG000|Overall Study|Miscellaneous|13
6969883|NCT01151137|11019744|FG000|Overall Study|Death|15
6969884|NCT01151137|11019745|FG001|Overall Study|Death|27
6969885|NCT01151137|11019744|FG000|Overall Study|Lost to Follow-up|1
6969886|NCT01151137|11019745|FG001|Overall Study|Lost to Follow-up|1
6885114|NCT00556894|10898403|FG000|Overall Study|Adverse Event|2
6885115|NCT00556894|10898404|FG001|Overall Study|Adverse Event|3
6885116|NCT00556894|10898405|FG002|Overall Study|Adverse Event|3
6885117|NCT00556894|10898403|FG000|Overall Study|Death|1
6885118|NCT00556894|10898404|FG001|Overall Study|Death|0
6885119|NCT00556894|10898405|FG002|Overall Study|Death|0
6885120|NCT00556894|10898403|FG000|Overall Study|regulatory decision in Bulgaria|10
6885121|NCT00556894|10898404|FG001|Overall Study|regulatory decision in Bulgaria|14
6885122|NCT00556894|10898405|FG002|Overall Study|regulatory decision in Bulgaria|13
6885123|NCT00556894|10898403|FG000|Overall Study|Change in therapy|2
6885124|NCT00556894|10898404|FG001|Overall Study|Change in therapy|1
6885125|NCT00556894|10898405|FG002|Overall Study|Change in therapy|2
6885126|NCT00556894|10898403|FG000|Overall Study|Withdrawal by Subject|1
6885127|NCT00556894|10898404|FG001|Overall Study|Withdrawal by Subject|1
6885128|NCT00556894|10898405|FG002|Overall Study|Withdrawal by Subject|1
6885129|NCT00556933|10898417|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2
6885130|NCT00556933|10898418|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3
6885131|NCT00556933|10898419|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3
6885132|NCT00556933|10898420|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0
6885133|NCT00556933|10898417|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
6885134|NCT00556933|10898418|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
6885135|NCT00556933|10898419|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1
6885136|NCT00556933|10898420|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
6885137|NCT00556933|10898417|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0
6885138|NCT00556933|10898418|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
6885139|NCT00556933|10898419|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
6885140|NCT00556933|10898420|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
6885141|NCT00556933|10898417|FG000|Single vs. Divided-dose rATG Induction|Death|0
6885142|NCT00556933|10898418|FG001|Single vs. Divided-dose rATG Induction|Death|1
6885143|NCT00556933|10898419|FG002|Single vs. Divided-dose rATG Induction|Death|0
6885144|NCT00556933|10898420|FG003|Single vs. Divided-dose rATG Induction|Death|0
6885145|NCT00556933|10898417|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
6885146|NCT00556933|10898418|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1
6885147|NCT00556933|10898419|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
6885148|NCT00556933|10898420|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
6885149|NCT00556933|10898417|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
6885150|NCT00556933|10898418|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1
6885151|NCT00556933|10898419|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
6885152|NCT00556933|10898420|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
6885153|NCT00556933|10898417|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
6885154|NCT00556933|10898418|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
6885155|NCT00556933|10898419|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
6885156|NCT00556933|10898420|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
6885157|NCT00556933|10898417|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
6885158|NCT00556933|10898418|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
6885159|NCT00556933|10898419|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
6885160|NCT00556933|10898420|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
6885161|NCT00556933|10898417|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
6885162|NCT00556933|10898418|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
6885163|NCT00556933|10898419|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
6885164|NCT00556933|10898420|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
6885165|NCT00556933|10898417|FG000|CNI Withdrawal vs. Minimization|Graft loss|0
6885166|NCT00556933|10898418|FG001|CNI Withdrawal vs. Minimization|Graft loss|1
6885167|NCT00556933|10898419|FG002|CNI Withdrawal vs. Minimization|Graft loss|2
6885168|NCT00556933|10898420|FG003|CNI Withdrawal vs. Minimization|Graft loss|0
6885169|NCT00556933|10898417|FG000|CNI Withdrawal vs. Minimization|Death|0
6885170|NCT00556933|10898418|FG001|CNI Withdrawal vs. Minimization|Death|0
6885171|NCT00556933|10898419|FG002|CNI Withdrawal vs. Minimization|Death|0
6885172|NCT00556933|10898420|FG003|CNI Withdrawal vs. Minimization|Death|1
6885173|NCT00556998|10898447|FG000|Voriconazole Intravenous (IV)|Adverse Event|1
6885174|NCT00556998|10898447|FG000|Voriconazole Intravenous (IV)|Other|4
6885175|NCT00556998|10898447|FG000|Voriconazole Oral|Adverse Event|1
6885176|NCT00556998|10898447|FG000|Voriconazole Oral|Intolerant of oral treatment|1
6885177|NCT00557076|10898457|FG000|Overall Study|Unblinding|0
6885178|NCT00557076|10898458|FG001|Overall Study|Unblinding|1
6885179|NCT00557245|10898467|FG000|Overall Study|Lost to Follow-up|7
6885180|NCT00557245|10898468|FG001|Overall Study|Lost to Follow-up|8
6885181|NCT00557245|10898469|FG002|Overall Study|Lost to Follow-up|10
6885182|NCT00557245|10898467|FG000|Overall Study|Ineligible|5
6885183|NCT00557245|10898468|FG001|Overall Study|Ineligible|4
6885184|NCT00557245|10898469|FG002|Overall Study|Ineligible|2
6885185|NCT00557310|10898489|FG000|Main Study (0 - 18 Months)|Adverse Event|4
6885186|NCT00557310|10898489|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1
6885187|NCT00557310|10898489|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1
6885188|NCT00557310|10898489|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1
6885189|NCT00557310|10898489|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2
6885190|NCT00557310|10898489|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1
6885191|NCT00557323|10898493|FG000|Overall Study|Death|3
6885192|NCT00557323|10898493|FG000|Overall Study|Withdrawal by Subject|2
6885193|NCT00557323|10898493|FG000|Overall Study|Administrative change|2
6885194|NCT00557440|10898529|FG000|Treatment Period 1|Adverse Event|0
6885195|NCT00557440|10898530|FG001|Treatment Period 1|Adverse Event|0
6885196|NCT00557440|10898531|FG002|Treatment Period 1|Adverse Event|1
6885197|NCT00557466|10898545|FG000|Overall Study|Adverse Event|3
6885198|NCT00557466|10898546|FG001|Overall Study|Adverse Event|1
6885199|NCT00557466|10898547|FG002|Overall Study|Adverse Event|4
6885200|NCT00557466|10898548|FG003|Overall Study|Adverse Event|1
6885201|NCT00557466|10898549|FG004|Overall Study|Adverse Event|2
6885202|NCT00557466|10898550|FG005|Overall Study|Adverse Event|4
6885203|NCT00557466|10898545|FG000|Overall Study|Abnormal laboratory value(s)|1
6885204|NCT00557466|10898546|FG001|Overall Study|Abnormal laboratory value(s)|2
6885205|NCT00557466|10898547|FG002|Overall Study|Abnormal laboratory value(s)|0
6885206|NCT00557466|10898548|FG003|Overall Study|Abnormal laboratory value(s)|0
6885207|NCT00557466|10898549|FG004|Overall Study|Abnormal laboratory value(s)|0
6885208|NCT00557466|10898550|FG005|Overall Study|Abnormal laboratory value(s)|0
6885209|NCT00557466|10898545|FG000|Overall Study|Protocol deviation|0
6885210|NCT00557466|10898546|FG001|Overall Study|Protocol deviation|1
6885211|NCT00557466|10898547|FG002|Overall Study|Protocol deviation|0
6885212|NCT00557466|10898548|FG003|Overall Study|Protocol deviation|2
6885213|NCT00557466|10898549|FG004|Overall Study|Protocol deviation|0
6885214|NCT00557466|10898550|FG005|Overall Study|Protocol deviation|0
6885215|NCT00557466|10898545|FG000|Overall Study|Subject withdrew consent|0
6885216|NCT00557466|10898546|FG001|Overall Study|Subject withdrew consent|0
6885217|NCT00557466|10898547|FG002|Overall Study|Subject withdrew consent|0
6885218|NCT00557466|10898548|FG003|Overall Study|Subject withdrew consent|0
6885219|NCT00557466|10898549|FG004|Overall Study|Subject withdrew consent|1
6885220|NCT00557466|10898550|FG005|Overall Study|Subject withdrew consent|2
6885221|NCT00557466|10898545|FG000|Overall Study|Administrative problems|0
6885222|NCT00557466|10898546|FG001|Overall Study|Administrative problems|1
6885223|NCT00557466|10898547|FG002|Overall Study|Administrative problems|1
6885224|NCT00557466|10898548|FG003|Overall Study|Administrative problems|0
6885225|NCT00557466|10898549|FG004|Overall Study|Administrative problems|0
6885226|NCT00557466|10898550|FG005|Overall Study|Administrative problems|0
6885227|NCT00557466|10898545|FG000|Overall Study|Abnormal test procedure results|0
6885228|NCT00557466|10898546|FG001|Overall Study|Abnormal test procedure results|0
6885229|NCT00557466|10898547|FG002|Overall Study|Abnormal test procedure results|1
6885230|NCT00557466|10898548|FG003|Overall Study|Abnormal test procedure results|0
6885231|NCT00557466|10898549|FG004|Overall Study|Abnormal test procedure results|0
6885232|NCT00557466|10898550|FG005|Overall Study|Abnormal test procedure results|0
6885233|NCT00557466|10898545|FG000|Overall Study|Lost to Follow-up|0
6885234|NCT00557466|10898546|FG001|Overall Study|Lost to Follow-up|0
6885235|NCT00557466|10898547|FG002|Overall Study|Lost to Follow-up|0
6885236|NCT00557466|10898548|FG003|Overall Study|Lost to Follow-up|1
6885237|NCT00557466|10898549|FG004|Overall Study|Lost to Follow-up|0
6885238|NCT00557466|10898550|FG005|Overall Study|Lost to Follow-up|0
6885239|NCT00557492|10898564|FG000|Overall Study|Change in health insurance|1
6885240|NCT00557505|10898577|FG000|Overall Study|Death|0
6885241|NCT00557505|10898578|FG001|Overall Study|Death|0
6885242|NCT00557505|10898579|FG002|Overall Study|Death|0
6885243|NCT00557505|10898580|FG003|Overall Study|Death|0
6885244|NCT00557505|10898581|FG004|Overall Study|Death|0
6885245|NCT00557505|10898582|FG005|Overall Study|Death|0
6885246|NCT00557505|10898583|FG006|Overall Study|Death|0
6885247|NCT00557505|10898584|FG007|Overall Study|Death|0
6885248|NCT00557505|10898585|FG008|Overall Study|Death|1
6885249|NCT00557505|10898577|FG000|Overall Study|Adverse Event|0
6885250|NCT00557505|10898578|FG001|Overall Study|Adverse Event|0
6885251|NCT00557505|10898579|FG002|Overall Study|Adverse Event|1
6885252|NCT00557505|10898580|FG003|Overall Study|Adverse Event|0
6885253|NCT00557505|10898581|FG004|Overall Study|Adverse Event|0
6885254|NCT00557505|10898582|FG005|Overall Study|Adverse Event|0
6885255|NCT00557505|10898583|FG006|Overall Study|Adverse Event|1
6885256|NCT00557505|10898584|FG007|Overall Study|Adverse Event|0
6885257|NCT00557505|10898585|FG008|Overall Study|Adverse Event|0
6885258|NCT00557505|10898577|FG000|Overall Study|Global deterioration of health|1
6885259|NCT00557505|10898578|FG001|Overall Study|Global deterioration of health|0
6885260|NCT00557505|10898579|FG002|Overall Study|Global deterioration of health|0
6885261|NCT00557505|10898580|FG003|Overall Study|Global deterioration of health|0
6885262|NCT00557505|10898581|FG004|Overall Study|Global deterioration of health|0
6885263|NCT00557505|10898582|FG005|Overall Study|Global deterioration of health|0
6885264|NCT00557505|10898583|FG006|Overall Study|Global deterioration of health|0
6885265|NCT00557505|10898584|FG007|Overall Study|Global deterioration of health|0
6885266|NCT00557505|10898585|FG008|Overall Study|Global deterioration of health|0
6885267|NCT00557505|10898577|FG000|Overall Study|Objective progression or relapse|2
6885268|NCT00557505|10898578|FG001|Overall Study|Objective progression or relapse|3
6885269|NCT00557505|10898579|FG002|Overall Study|Objective progression or relapse|3
6885270|NCT00557505|10898580|FG003|Overall Study|Objective progression or relapse|2
6885271|NCT00557505|10898581|FG004|Overall Study|Objective progression or relapse|2
6885272|NCT00557505|10898582|FG005|Overall Study|Objective progression or relapse|3
6885273|NCT00557505|10898583|FG006|Overall Study|Objective progression or relapse|2
6885274|NCT00557505|10898584|FG007|Overall Study|Objective progression or relapse|5
6885275|NCT00557505|10898585|FG008|Overall Study|Objective progression or relapse|15
6885276|NCT00557505|10898577|FG000|Overall Study|Withdrawal by Subject|0
6885277|NCT00557505|10898578|FG001|Overall Study|Withdrawal by Subject|0
6885278|NCT00557505|10898579|FG002|Overall Study|Withdrawal by Subject|0
6885279|NCT00557505|10898580|FG003|Overall Study|Withdrawal by Subject|1
6885280|NCT00557505|10898581|FG004|Overall Study|Withdrawal by Subject|0
6885281|NCT00557505|10898582|FG005|Overall Study|Withdrawal by Subject|0
6885282|NCT00557505|10898583|FG006|Overall Study|Withdrawal by Subject|0
6885283|NCT00557505|10898584|FG007|Overall Study|Withdrawal by Subject|0
6885284|NCT00557505|10898585|FG008|Overall Study|Withdrawal by Subject|1
6885285|NCT00557622|10898610|FG000|4-Week Run-in Phase|Withdrawal by Subject|1
6885286|NCT00557622|10898611|FG001|4-Week Run-in Phase|Withdrawal by Subject|0
6885287|NCT00557622|10898610|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1
6885288|NCT00557622|10898611|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0
6885289|NCT00557622|10898610|FG000|12-Week Treatment Phase|Lost to Follow-up|0
6885290|NCT00557622|10898611|FG001|12-Week Treatment Phase|Lost to Follow-up|1
6885291|NCT00557830|10898620|FG000|Screening Treatment Phase|Withdrawal by Subject|1
6885292|NCT00557830|10898621|FG001|Screening Treatment Phase|Withdrawal by Subject|0
6885293|NCT00557830|10898622|FG002|Screening Treatment Phase|Withdrawal by Subject|0
6885294|NCT00557830|10898620|FG000|Screening Treatment Phase|Adverse Event|2
6885295|NCT00557830|10898621|FG001|Screening Treatment Phase|Adverse Event|0
6885296|NCT00557830|10898622|FG002|Screening Treatment Phase|Adverse Event|0
6885297|NCT00557830|10898620|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3
6885298|NCT00557830|10898621|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0
6885299|NCT00557830|10898622|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0
6885300|NCT00557856|10898630|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3
6885301|NCT00557856|10898631|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5
6885302|NCT00557856|10898632|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3
6885303|NCT00557856|10898633|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1
6885304|NCT00557856|10898634|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3
6885305|NCT00557856|10898635|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2
6885306|NCT00557856|10898636|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5
6885307|NCT00557856|10898637|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3
6885308|NCT00557856|10898638|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0
6885309|NCT00557856|10898630|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
6885310|NCT00557856|10898631|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
6885311|NCT00557856|10898632|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
6885312|NCT00557856|10898633|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
6885313|NCT00557856|10898634|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
6885314|NCT00557856|10898635|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
6885315|NCT00557856|10898636|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
6885316|NCT00557856|10898637|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
6885317|NCT00557856|10898638|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
6885318|NCT00557856|10898630|FG000|Part 1: Dose Escalation Phase|Adverse Event|1
6885319|NCT00557856|10898631|FG001|Part 1: Dose Escalation Phase|Adverse Event|0
6885320|NCT00557856|10898632|FG002|Part 1: Dose Escalation Phase|Adverse Event|1
6885321|NCT00557856|10898633|FG003|Part 1: Dose Escalation Phase|Adverse Event|1
6885322|NCT00557856|10898634|FG004|Part 1: Dose Escalation Phase|Adverse Event|1
6885323|NCT00557856|10898635|FG005|Part 1: Dose Escalation Phase|Adverse Event|3
6885324|NCT00557856|10898636|FG006|Part 1: Dose Escalation Phase|Adverse Event|1
6969887|NCT01151215|11019763|FG000|Overall Study|Worsening of condition under study|1
7079130|NCT02109484|11187872|FG004|Overall Study|Withdrawal by Subject|1
7079131|NCT02109484|11187873|FG005|Overall Study|Withdrawal by Subject|1
7079132|NCT02109484|11187874|FG006|Overall Study|Withdrawal by Subject|1
7079133|NCT02109484|11187875|FG007|Overall Study|Withdrawal by Subject|0
7079134|NCT02109484|11187868|FG000|Overall Study|Physician Decision|0
7079135|NCT02109484|11187869|FG001|Overall Study|Physician Decision|0
7079136|NCT02109484|11187870|FG002|Overall Study|Physician Decision|0
7079137|NCT02109484|11187871|FG003|Overall Study|Physician Decision|0
7079138|NCT02109484|11187872|FG004|Overall Study|Physician Decision|2
7079139|NCT02109484|11187873|FG005|Overall Study|Physician Decision|0
7079140|NCT02109484|11187874|FG006|Overall Study|Physician Decision|0
7155642|NCT03345407|11323716|FG001|Overall Study|Lost to Follow-up|0
7155643|NCT03345407|11323717|FG002|Overall Study|Lost to Follow-up|1
7155644|NCT03345407|11323718|FG003|Overall Study|Lost to Follow-up|0
7155645|NCT03345407|11323719|FG004|Overall Study|Lost to Follow-up|1
7155646|NCT03345407|11323720|FG005|Overall Study|Lost to Follow-up|2
7155647|NCT03345407|11323721|FG006|Overall Study|Lost to Follow-up|3
7155648|NCT03345407|11323715|FG000|Overall Study|Protocol-defined stopping criteria|9
7155649|NCT03345407|11323716|FG001|Overall Study|Protocol-defined stopping criteria|0
7155650|NCT03345407|11323717|FG002|Overall Study|Protocol-defined stopping criteria|0
7155651|NCT03345407|11323718|FG003|Overall Study|Protocol-defined stopping criteria|0
7184161|NCT01777295|11384169|FG001|Overall Study|Withdrawal by Subject|2
6885325|NCT00557856|10898637|FG007|Part 1: Dose Escalation Phase|Adverse Event|2
6885326|NCT00557856|10898638|FG008|Part 1: Dose Escalation Phase|Adverse Event|0
6885327|NCT00557856|10898630|FG000|Part 1: Dose Escalation Phase|Other|0
6885328|NCT00557856|10898631|FG001|Part 1: Dose Escalation Phase|Other|0
6885329|NCT00557856|10898632|FG002|Part 1: Dose Escalation Phase|Other|1
6885330|NCT00557856|10898633|FG003|Part 1: Dose Escalation Phase|Other|1
6885331|NCT00557856|10898634|FG004|Part 1: Dose Escalation Phase|Other|0
6885332|NCT00557856|10898635|FG005|Part 1: Dose Escalation Phase|Other|0
6885333|NCT00557856|10898636|FG006|Part 1: Dose Escalation Phase|Other|0
6885334|NCT00557856|10898637|FG007|Part 1: Dose Escalation Phase|Other|1
6885335|NCT00557856|10898638|FG008|Part 1: Dose Escalation Phase|Other|0
6885336|NCT00557856|10898630|FG000|Part 1: Dose Escalation Phase|Death|0
6885337|NCT00557856|10898631|FG001|Part 1: Dose Escalation Phase|Death|0
6885338|NCT00557856|10898632|FG002|Part 1: Dose Escalation Phase|Death|0
6885339|NCT00557856|10898633|FG003|Part 1: Dose Escalation Phase|Death|0
6885340|NCT00557856|10898634|FG004|Part 1: Dose Escalation Phase|Death|0
6885341|NCT00557856|10898635|FG005|Part 1: Dose Escalation Phase|Death|1
6885342|NCT00557856|10898636|FG006|Part 1: Dose Escalation Phase|Death|0
6885343|NCT00557856|10898637|FG007|Part 1: Dose Escalation Phase|Death|0
6885344|NCT00557856|10898638|FG008|Part 1: Dose Escalation Phase|Death|0
6885345|NCT00557856|10898630|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0
6885346|NCT00557856|10898631|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0
6885347|NCT00557856|10898632|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0
6885348|NCT00557856|10898633|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0
6885349|NCT00557856|10898634|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0
6885350|NCT00557856|10898635|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2
6885351|NCT00557856|10898636|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1
6885352|NCT00557856|10898637|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0
6885353|NCT00557856|10898638|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0
6885354|NCT00557856|10898630|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2
6885355|NCT00557856|10898631|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0
6885356|NCT00557856|10898632|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0
6885357|NCT00557856|10898633|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0
6885358|NCT00557856|10898634|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0
6885359|NCT00557856|10898635|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0
6885360|NCT00557856|10898636|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0
6885361|NCT00557856|10898637|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0
6885362|NCT00557856|10898638|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0
6885363|NCT00557856|10898630|FG000|Part 2: Exploratory Phase|objective progression or relapse|0
6885364|NCT00557856|10898631|FG001|Part 2: Exploratory Phase|objective progression or relapse|0
6885365|NCT00557856|10898632|FG002|Part 2: Exploratory Phase|objective progression or relapse|0
6885366|NCT00557856|10898633|FG003|Part 2: Exploratory Phase|objective progression or relapse|0
6885367|NCT00557856|10898634|FG004|Part 2: Exploratory Phase|objective progression or relapse|0
6885368|NCT00557856|10898635|FG005|Part 2: Exploratory Phase|objective progression or relapse|0
6885369|NCT00557856|10898636|FG006|Part 2: Exploratory Phase|objective progression or relapse|0
6885370|NCT00557856|10898637|FG007|Part 2: Exploratory Phase|objective progression or relapse|0
6885371|NCT00557856|10898638|FG008|Part 2: Exploratory Phase|objective progression or relapse|15
6885372|NCT00557856|10898630|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0
6885373|NCT00557856|10898631|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0
6885374|NCT00557856|10898632|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0
6885375|NCT00557856|10898633|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0
6885376|NCT00557856|10898634|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0
6885377|NCT00557856|10898635|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0
6885378|NCT00557856|10898636|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0
6885379|NCT00557856|10898637|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0
6885380|NCT00557856|10898638|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1
6885381|NCT00557856|10898630|FG000|Part 2: Exploratory Phase|Adverse Event|0
6885382|NCT00557856|10898631|FG001|Part 2: Exploratory Phase|Adverse Event|0
6885383|NCT00557856|10898632|FG002|Part 2: Exploratory Phase|Adverse Event|0
6885384|NCT00557856|10898633|FG003|Part 2: Exploratory Phase|Adverse Event|0
6885385|NCT00557856|10898634|FG004|Part 2: Exploratory Phase|Adverse Event|0
6885386|NCT00557856|10898635|FG005|Part 2: Exploratory Phase|Adverse Event|0
6885387|NCT00557856|10898636|FG006|Part 2: Exploratory Phase|Adverse Event|0
6885388|NCT00557856|10898637|FG007|Part 2: Exploratory Phase|Adverse Event|0
6885389|NCT00557856|10898638|FG008|Part 2: Exploratory Phase|Adverse Event|4
6885390|NCT00557856|10898630|FG000|Part 2: Exploratory Phase|Other|0
6885391|NCT00557856|10898631|FG001|Part 2: Exploratory Phase|Other|0
7155652|NCT03345407|11323719|FG004|Overall Study|Protocol-defined stopping criteria|2
7155653|NCT03345407|11323720|FG005|Overall Study|Protocol-defined stopping criteria|1
7155654|NCT03345407|11323721|FG006|Overall Study|Protocol-defined stopping criteria|1
7155655|NCT03345407|11323715|FG000|Overall Study|Protocol Violation|2
7155656|NCT03345407|11323716|FG001|Overall Study|Protocol Violation|0
7155657|NCT03345407|11323717|FG002|Overall Study|Protocol Violation|0
7155658|NCT03345407|11323718|FG003|Overall Study|Protocol Violation|0
7155659|NCT03345407|11323719|FG004|Overall Study|Protocol Violation|1
7155660|NCT03345407|11323720|FG005|Overall Study|Protocol Violation|0
7155661|NCT03345407|11323721|FG006|Overall Study|Protocol Violation|3
7155662|NCT03345407|11323715|FG000|Overall Study|Lack of Efficacy|1
7155663|NCT03345407|11323716|FG001|Overall Study|Lack of Efficacy|1
7155664|NCT03345407|11323717|FG002|Overall Study|Lack of Efficacy|1
7155665|NCT03345407|11323718|FG003|Overall Study|Lack of Efficacy|1
7155666|NCT03345407|11323719|FG004|Overall Study|Lack of Efficacy|1
7155667|NCT03345407|11323720|FG005|Overall Study|Lack of Efficacy|0
7155668|NCT03345407|11323721|FG006|Overall Study|Lack of Efficacy|3
7155669|NCT03345407|11323715|FG000|Overall Study|Adverse Event|4
7155670|NCT03345407|11323716|FG001|Overall Study|Adverse Event|0
7155671|NCT03345407|11323717|FG002|Overall Study|Adverse Event|5
7155672|NCT03345407|11323718|FG003|Overall Study|Adverse Event|4
7155673|NCT03345407|11323719|FG004|Overall Study|Adverse Event|6
7155674|NCT03345407|11323720|FG005|Overall Study|Adverse Event|5
7155675|NCT03345407|11323721|FG006|Overall Study|Adverse Event|16
6885392|NCT00557856|10898632|FG002|Part 2: Exploratory Phase|Other|0
6885393|NCT00557856|10898633|FG003|Part 2: Exploratory Phase|Other|0
6885394|NCT00557856|10898634|FG004|Part 2: Exploratory Phase|Other|0
6885395|NCT00557856|10898635|FG005|Part 2: Exploratory Phase|Other|0
6885396|NCT00557856|10898636|FG006|Part 2: Exploratory Phase|Other|0
6885397|NCT00557856|10898637|FG007|Part 2: Exploratory Phase|Other|0
6885398|NCT00557856|10898638|FG008|Part 2: Exploratory Phase|Other|1
6885399|NCT00557856|10898630|FG000|Part 2: Exploratory Phase|Death|0
6885400|NCT00557856|10898631|FG001|Part 2: Exploratory Phase|Death|0
6885401|NCT00557856|10898632|FG002|Part 2: Exploratory Phase|Death|0
6885402|NCT00557856|10898633|FG003|Part 2: Exploratory Phase|Death|0
6885403|NCT00557856|10898634|FG004|Part 2: Exploratory Phase|Death|0
6885404|NCT00557856|10898635|FG005|Part 2: Exploratory Phase|Death|0
6885405|NCT00557856|10898636|FG006|Part 2: Exploratory Phase|Death|0
6885406|NCT00557856|10898637|FG007|Part 2: Exploratory Phase|Death|0
6885407|NCT00557856|10898638|FG008|Part 2: Exploratory Phase|Death|2
6885408|NCT00557856|10898630|FG000|Part 2: Exploratory Phase|global deterioration of health status|0
6885409|NCT00557856|10898631|FG001|Part 2: Exploratory Phase|global deterioration of health status|0
6885410|NCT00557856|10898632|FG002|Part 2: Exploratory Phase|global deterioration of health status|0
6885411|NCT00557856|10898633|FG003|Part 2: Exploratory Phase|global deterioration of health status|0
6885412|NCT00557856|10898634|FG004|Part 2: Exploratory Phase|global deterioration of health status|0
6885413|NCT00557856|10898635|FG005|Part 2: Exploratory Phase|global deterioration of health status|0
6885414|NCT00557856|10898636|FG006|Part 2: Exploratory Phase|global deterioration of health status|0
7079141|NCT02109484|11187875|FG007|Overall Study|Physician Decision|0
7079142|NCT02109484|11187868|FG000|Overall Study|Death|0
7079143|NCT02109484|11187869|FG001|Overall Study|Death|0
7079144|NCT02109484|11187870|FG002|Overall Study|Death|0
6885415|NCT00557856|10898637|FG007|Part 2: Exploratory Phase|global deterioration of health status|0
6885416|NCT00557856|10898638|FG008|Part 2: Exploratory Phase|global deterioration of health status|1
6885417|NCT00558025|10898681|FG000|Overall Study|Adverse Event|1
6885418|NCT00558025|10898682|FG001|Overall Study|Adverse Event|1
6885419|NCT00558025|10898681|FG000|Overall Study|Withdrawal by Subject|2
6885420|NCT00558025|10898682|FG001|Overall Study|Withdrawal by Subject|2
6885421|NCT00558025|10898681|FG000|Overall Study|Protocol Violation|1
6885422|NCT00558025|10898682|FG001|Overall Study|Protocol Violation|0
6885423|NCT00558064|10898690|FG000|Overall Study|Adverse Event|3
6885424|NCT00558064|10898691|FG001|Overall Study|Adverse Event|2
6885425|NCT00558064|10898690|FG000|Overall Study|Lack of Efficacy|0
6885426|NCT00558064|10898691|FG001|Overall Study|Lack of Efficacy|1
6885427|NCT00558064|10898690|FG000|Overall Study|Protocol Violation|1
7041259|NCT01725308|11124779|FG002|Treatment Period II|Did Not Receive Drug|0
6885428|NCT00558064|10898691|FG001|Overall Study|Protocol Violation|0
6885429|NCT00558064|10898690|FG000|Overall Study|Lost to Follow-up|0
6885430|NCT00558064|10898691|FG001|Overall Study|Lost to Follow-up|1
7041260|NCT01725308|11124777|FG000|Treatment Period II|Adverse Event|13
7041261|NCT01725308|11124778|FG001|Treatment Period II|Adverse Event|8
7041262|NCT01725308|11124779|FG002|Treatment Period II|Adverse Event|20
7041263|NCT01725308|11124777|FG000|Treatment Period II|Insufficient Response|2
7041264|NCT01725308|11124778|FG001|Treatment Period II|Insufficient Response|4
7041265|NCT01725308|11124779|FG002|Treatment Period II|Insufficient Response|6
7041266|NCT01725308|11124777|FG000|Treatment Period II|Worsening of the Target Disease|1
7041267|NCT01725308|11124778|FG001|Treatment Period II|Worsening of the Target Disease|4
7041268|NCT01725308|11124779|FG002|Treatment Period II|Worsening of the Target Disease|2
7041269|NCT01725308|11124777|FG000|Treatment Period II|Changes in the Episodes|1
7041270|NCT01725308|11124778|FG001|Treatment Period II|Changes in the Episodes|0
7079145|NCT02109484|11187871|FG003|Overall Study|Death|0
7079146|NCT02109484|11187872|FG004|Overall Study|Death|0
7079147|NCT02109484|11187873|FG005|Overall Study|Death|0
7079148|NCT02109484|11187874|FG006|Overall Study|Death|0
7079149|NCT02109484|11187875|FG007|Overall Study|Death|2
7079150|NCT02109484|11187868|FG000|Overall Study|Moved away from study area|0
7079151|NCT02109484|11187869|FG001|Overall Study|Moved away from study area|0
7079152|NCT02109484|11187870|FG002|Overall Study|Moved away from study area|0
7079153|NCT02109484|11187871|FG003|Overall Study|Moved away from study area|0
7079154|NCT02109484|11187872|FG004|Overall Study|Moved away from study area|0
7079155|NCT02109484|11187873|FG005|Overall Study|Moved away from study area|0
6885431|NCT00558064|10898690|FG000|Overall Study|Withdrawal by Subject|0
6885432|NCT00558064|10898691|FG001|Overall Study|Withdrawal by Subject|1
6885433|NCT00558064|10898690|FG000|Overall Study|No visit within allowance period|1
6885434|NCT00558064|10898691|FG001|Overall Study|No visit within allowance period|0
6885435|NCT00558103|10898702|FG000|Randomized Treatment Phase|Lost to Follow-up|2
6885436|NCT00558103|10898703|FG001|Randomized Treatment Phase|Lost to Follow-up|2
6885437|NCT00558103|10898704|FG002|Randomized Treatment Phase|Lost to Follow-up|2
6885438|NCT00558103|10898705|FG003|Randomized Treatment Phase|Lost to Follow-up|1
6885439|NCT00558103|10898706|FG004|Randomized Treatment Phase|Lost to Follow-up|3
6885440|NCT00558103|10898707|FG005|Randomized Treatment Phase|Lost to Follow-up|0
6885441|NCT00558103|10898702|FG000|Randomized Treatment Phase|Withdrawal by Subject|2
6885442|NCT00558103|10898703|FG001|Randomized Treatment Phase|Withdrawal by Subject|2
6885443|NCT00558103|10898704|FG002|Randomized Treatment Phase|Withdrawal by Subject|0
6885444|NCT00558103|10898705|FG003|Randomized Treatment Phase|Withdrawal by Subject|0
6885445|NCT00558103|10898706|FG004|Randomized Treatment Phase|Withdrawal by Subject|1
6885446|NCT00558103|10898707|FG005|Randomized Treatment Phase|Withdrawal by Subject|0
6885447|NCT00558103|10898702|FG000|Randomized Treatment Phase|Disease Progression|1
6885448|NCT00558103|10898703|FG001|Randomized Treatment Phase|Disease Progression|0
6885449|NCT00558103|10898704|FG002|Randomized Treatment Phase|Disease Progression|1
6885450|NCT00558103|10898705|FG003|Randomized Treatment Phase|Disease Progression|0
7079156|NCT02109484|11187874|FG006|Overall Study|Moved away from study area|1
7079157|NCT02109484|11187875|FG007|Overall Study|Moved away from study area|1
6885451|NCT00558103|10898706|FG004|Randomized Treatment Phase|Disease Progression|0
6885452|NCT00558103|10898707|FG005|Randomized Treatment Phase|Disease Progression|0
6885453|NCT00558103|10898702|FG000|Randomized Treatment Phase|Adverse Event|0
6885454|NCT00558103|10898703|FG001|Randomized Treatment Phase|Adverse Event|0
6885455|NCT00558103|10898704|FG002|Randomized Treatment Phase|Adverse Event|0
6885456|NCT00558103|10898705|FG003|Randomized Treatment Phase|Adverse Event|1
6885457|NCT00558103|10898706|FG004|Randomized Treatment Phase|Adverse Event|1
6885458|NCT00558103|10898707|FG005|Randomized Treatment Phase|Adverse Event|0
6885459|NCT00558103|10898702|FG000|Monotherapy Extension Phase|Protocol Violation|0
6885460|NCT00558103|10898703|FG001|Monotherapy Extension Phase|Protocol Violation|0
6885461|NCT00558103|10898704|FG002|Monotherapy Extension Phase|Protocol Violation|0
6885462|NCT00558103|10898705|FG003|Monotherapy Extension Phase|Protocol Violation|0
6885463|NCT00558103|10898706|FG004|Monotherapy Extension Phase|Protocol Violation|0
6885464|NCT00558103|10898707|FG005|Monotherapy Extension Phase|Protocol Violation|1
6885465|NCT00558103|10898702|FG000|Monotherapy Extension Phase|Disease Progression|0
6885466|NCT00558103|10898703|FG001|Monotherapy Extension Phase|Disease Progression|0
6885467|NCT00558103|10898704|FG002|Monotherapy Extension Phase|Disease Progression|0
6885468|NCT00558103|10898705|FG003|Monotherapy Extension Phase|Disease Progression|0
6885469|NCT00558103|10898706|FG004|Monotherapy Extension Phase|Disease Progression|0
6885470|NCT00558103|10898707|FG005|Monotherapy Extension Phase|Disease Progression|8
6885471|NCT00558259|10898729|FG000|Overall Study|Adverse Event|50
6885472|NCT00558259|10898730|FG001|Overall Study|Adverse Event|81
6885473|NCT00558259|10898729|FG000|Overall Study|Protocol Violation|9
6885474|NCT00558259|10898730|FG001|Overall Study|Protocol Violation|5
6885475|NCT00558259|10898729|FG000|Overall Study|Withdrawal by Subject|12
6885476|NCT00558259|10898730|FG001|Overall Study|Withdrawal by Subject|13
6885477|NCT00558272|10898738|FG000|Overall Study|Adverse Event|10
6885478|NCT00558272|10898739|FG001|Overall Study|Adverse Event|0
6885479|NCT00558272|10898738|FG000|Overall Study|Death|1
6885480|NCT00558272|10898739|FG001|Overall Study|Death|0
6885481|NCT00558272|10898738|FG000|Overall Study|Dev. of study specific discon. criteria|1
6885482|NCT00558272|10898739|FG001|Overall Study|Dev. of study specific discon. criteria|0
6885483|NCT00558272|10898738|FG000|Overall Study|AZ study team decision|0
6885484|NCT00558272|10898739|FG001|Overall Study|AZ study team decision|1
6885485|NCT00558272|10898738|FG000|Overall Study|Incorrectly enrolled|1
6885486|NCT00558272|10898739|FG001|Overall Study|Incorrectly enrolled|0
6885487|NCT00558272|10898738|FG000|Overall Study|Withdrawal by Subject|0
6885488|NCT00558272|10898739|FG001|Overall Study|Withdrawal by Subject|1
6885489|NCT00558285|10898750|FG000|Overall Study|Adverse Event|1
6885490|NCT00558285|10898751|FG001|Overall Study|Adverse Event|1
6885491|NCT00558285|10898752|FG002|Overall Study|Adverse Event|4
6885492|NCT00558285|10898753|FG003|Overall Study|Adverse Event|1
6885493|NCT00558285|10898754|FG004|Overall Study|Adverse Event|2
6885494|NCT00558285|10898750|FG000|Overall Study|Abnormal test procedure result(s)|1
6885495|NCT00558285|10898751|FG001|Overall Study|Abnormal test procedure result(s)|0
7079158|NCT02109562|11187917|FG000|Overall Study|Insufficient clinical response|2
7079159|NCT02109562|11187918|FG001|Overall Study|Insufficient clinical response|0
6885496|NCT00558285|10898752|FG002|Overall Study|Abnormal test procedure result(s)|0
7083001|NCT02147561|11193760|FG000|Overall Study|Lost to Follow-up|3
6885497|NCT00558285|10898753|FG003|Overall Study|Abnormal test procedure result(s)|0
6885498|NCT00558285|10898754|FG004|Overall Study|Abnormal test procedure result(s)|0
6885499|NCT00558285|10898750|FG000|Overall Study|Subject withdrew consent|2
6885500|NCT00558285|10898751|FG001|Overall Study|Subject withdrew consent|0
6885501|NCT00558285|10898752|FG002|Overall Study|Subject withdrew consent|1
6885502|NCT00558285|10898753|FG003|Overall Study|Subject withdrew consent|1
6885503|NCT00558285|10898754|FG004|Overall Study|Subject withdrew consent|1
6885504|NCT00558285|10898750|FG000|Overall Study|Lost to Follow-up|1
6885505|NCT00558285|10898751|FG001|Overall Study|Lost to Follow-up|1
6885506|NCT00558285|10898752|FG002|Overall Study|Lost to Follow-up|0
6885507|NCT00558285|10898753|FG003|Overall Study|Lost to Follow-up|0
6885508|NCT00558285|10898754|FG004|Overall Study|Lost to Follow-up|0
6885509|NCT00558285|10898750|FG000|Overall Study|Administrative problems|0
6885510|NCT00558285|10898751|FG001|Overall Study|Administrative problems|0
6885511|NCT00558285|10898752|FG002|Overall Study|Administrative problems|0
6885512|NCT00558285|10898753|FG003|Overall Study|Administrative problems|1
6885513|NCT00558285|10898754|FG004|Overall Study|Administrative problems|1
6885514|NCT00558285|10898750|FG000|Overall Study|Protocol deviation|1
6885515|NCT00558285|10898751|FG001|Overall Study|Protocol deviation|1
6885516|NCT00558285|10898752|FG002|Overall Study|Protocol deviation|0
6885517|NCT00558285|10898753|FG003|Overall Study|Protocol deviation|1
6885518|NCT00558285|10898754|FG004|Overall Study|Protocol deviation|0
6885519|NCT00558363|10898768|FG000|Overall Study|Physician Decision|18
6885520|NCT00558363|10898769|FG001|Overall Study|Physician Decision|4
6885521|NCT00558363|10898768|FG000|Overall Study|Withdrawal by Subject|11
6885522|NCT00558363|10898769|FG001|Overall Study|Withdrawal by Subject|4
6885523|NCT00558363|10898768|FG000|Overall Study|Adverse Event|5
6885524|NCT00558363|10898769|FG001|Overall Study|Adverse Event|5
6885525|NCT00558363|10898768|FG000|Overall Study|Lack of Efficacy|2
6885526|NCT00558363|10898769|FG001|Overall Study|Lack of Efficacy|2
6885527|NCT00558363|10898768|FG000|Overall Study|Protocol Violation|2
6885528|NCT00558363|10898769|FG001|Overall Study|Protocol Violation|1
6885529|NCT00558363|10898768|FG000|Overall Study|Lost to Follow-up|0
6885530|NCT00558363|10898769|FG001|Overall Study|Lost to Follow-up|1
6885531|NCT00558363|10898768|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32
6885532|NCT00558363|10898769|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16
6885533|NCT00558363|10898768|FG000|Overall Study|Randomized in Error|1
6885534|NCT00558363|10898769|FG001|Overall Study|Randomized in Error|2
6885535|NCT00558363|10898768|FG000|Overall Study|Hospitalized; Unable to Continue|0
6885536|NCT00558363|10898769|FG001|Overall Study|Hospitalized; Unable to Continue|1
6885537|NCT00558428|10898779|FG000|Overall Study|Adverse Event|6
6885538|NCT00558428|10898780|FG001|Overall Study|Adverse Event|22
6885539|NCT00558428|10898781|FG002|Overall Study|Adverse Event|3
6885540|NCT00558428|10898782|FG003|Overall Study|Adverse Event|4
6885541|NCT00558428|10898779|FG000|Overall Study|Lost to Follow-up|0
6885542|NCT00558428|10898780|FG001|Overall Study|Lost to Follow-up|1
6885543|NCT00558428|10898781|FG002|Overall Study|Lost to Follow-up|0
6885544|NCT00558428|10898782|FG003|Overall Study|Lost to Follow-up|0
6885545|NCT00558428|10898779|FG000|Overall Study|Lack of Efficacy|0
6885546|NCT00558428|10898780|FG001|Overall Study|Lack of Efficacy|0
6885547|NCT00558428|10898781|FG002|Overall Study|Lack of Efficacy|1
6885548|NCT00558428|10898782|FG003|Overall Study|Lack of Efficacy|2
6885549|NCT00558428|10898779|FG000|Overall Study|Non compliant with protocol|1
6885550|NCT00558428|10898780|FG001|Overall Study|Non compliant with protocol|0
6885551|NCT00558428|10898781|FG002|Overall Study|Non compliant with protocol|0
6885552|NCT00558428|10898782|FG003|Overall Study|Non compliant with protocol|3
6885553|NCT00558428|10898779|FG000|Overall Study|Consent withdrawn|2
6885554|NCT00558428|10898780|FG001|Overall Study|Consent withdrawn|1
6885555|NCT00558428|10898781|FG002|Overall Study|Consent withdrawn|0
6885556|NCT00558428|10898782|FG003|Overall Study|Consent withdrawn|1
6885557|NCT00558428|10898779|FG000|Overall Study|Other|3
6885558|NCT00558428|10898780|FG001|Overall Study|Other|0
6885559|NCT00558428|10898781|FG002|Overall Study|Other|0
6885560|NCT00558428|10898782|FG003|Overall Study|Other|1
6885561|NCT00558467|10898794|FG000|Overall Study|Adverse Event|1
6885562|NCT00558467|10898795|FG001|Overall Study|Adverse Event|2
6885563|NCT00558467|10898794|FG000|Overall Study|Lack of Efficacy|0
6885564|NCT00558467|10898795|FG001|Overall Study|Lack of Efficacy|1
6885565|NCT00558467|10898794|FG000|Overall Study|Patient moving out of state|0
6885566|NCT00558467|10898795|FG001|Overall Study|Patient moving out of state|1
6885567|NCT00558519|10898801|FG000|Overall Study|Ph+|20
6885568|NCT00558519|10898801|FG000|Overall Study|Ineligible|1
6885569|NCT00558519|10898801|FG000|Overall Study|Insufficient data|1
6885570|NCT00558519|10898801|FG000|Overall Study|Never received treatment|1
6885571|NCT00558636|10898835|FG000|Treatment|Adverse Event|9
6885572|NCT00558636|10898836|FG001|Treatment|Adverse Event|2
6885573|NCT00558636|10898835|FG000|Treatment|Withdrawal by Subject|2
6885574|NCT00558636|10898836|FG001|Treatment|Withdrawal by Subject|0
6885575|NCT00558636|10898835|FG000|Treatment|Premature termination of the study|35
6885576|NCT00558636|10898836|FG001|Treatment|Premature termination of the study|37
6885577|NCT00558636|10898835|FG000|Treatment|Disease progression|1
6885578|NCT00558636|10898836|FG001|Treatment|Disease progression|5
6885579|NCT00558636|10898835|FG000|Follow-up|Premature termination of the study|12
6885580|NCT00558636|10898836|FG001|Follow-up|Premature termination of the study|7
6885581|NCT00558701|10898844|FG000|Overall Study|Protocol Deviations|1
6885582|NCT00558701|10898845|FG001|Overall Study|Protocol Deviations|4
6885583|NCT00558753|10898853|FG000|Overall Study|Lost to Follow-up|5
6885584|NCT00558753|10898854|FG001|Overall Study|Lost to Follow-up|7
6885585|NCT00558831|10898876|FG000|Overall Study|Lost to Follow-up|1
6885586|NCT00558896|10898911|FG000|Overall Study|Adverse Event|1
6885587|NCT00558896|10898912|FG001|Overall Study|Adverse Event|1
6885588|NCT00558896|10898913|FG002|Overall Study|Adverse Event|1
6885589|NCT00558896|10898914|FG003|Overall Study|Adverse Event|3
6885590|NCT00558896|10898915|FG004|Overall Study|Adverse Event|4
6885591|NCT00558896|10898916|FG005|Overall Study|Adverse Event|10
6885592|NCT00558896|10898917|FG006|Overall Study|Adverse Event|3
6885593|NCT00558896|10898911|FG000|Overall Study|Death|3
6885594|NCT00558896|10898912|FG001|Overall Study|Death|0
6885595|NCT00558896|10898913|FG002|Overall Study|Death|2
6885596|NCT00558896|10898914|FG003|Overall Study|Death|3
6885597|NCT00558896|10898915|FG004|Overall Study|Death|2
6885598|NCT00558896|10898916|FG005|Overall Study|Death|2
6885599|NCT00558896|10898917|FG006|Overall Study|Death|6
6885600|NCT00558896|10898911|FG000|Overall Study|Withdrawal by Subject|2
6885601|NCT00558896|10898912|FG001|Overall Study|Withdrawal by Subject|1
6885602|NCT00558896|10898913|FG002|Overall Study|Withdrawal by Subject|1
6885603|NCT00558896|10898914|FG003|Overall Study|Withdrawal by Subject|1
6885604|NCT00558896|10898915|FG004|Overall Study|Withdrawal by Subject|1
6885605|NCT00558896|10898916|FG005|Overall Study|Withdrawal by Subject|5
6885606|NCT00558896|10898917|FG006|Overall Study|Withdrawal by Subject|5
6885607|NCT00558896|10898911|FG000|Overall Study|Alternative Treatment|2
6885608|NCT00558896|10898912|FG001|Overall Study|Alternative Treatment|2
6885609|NCT00558896|10898913|FG002|Overall Study|Alternative Treatment|0
6885610|NCT00558896|10898914|FG003|Overall Study|Alternative Treatment|2
6885611|NCT00558896|10898915|FG004|Overall Study|Alternative Treatment|6
6885612|NCT00558896|10898916|FG005|Overall Study|Alternative Treatment|7
6885613|NCT00558896|10898917|FG006|Overall Study|Alternative Treatment|1
6885614|NCT00558896|10898911|FG000|Overall Study|Physician discretion|3
6885615|NCT00558896|10898912|FG001|Overall Study|Physician discretion|2
6885616|NCT00558896|10898913|FG002|Overall Study|Physician discretion|1
6885617|NCT00558896|10898914|FG003|Overall Study|Physician discretion|2
6885618|NCT00558896|10898915|FG004|Overall Study|Physician discretion|1
6885619|NCT00558896|10898916|FG005|Overall Study|Physician discretion|3
6885620|NCT00558896|10898917|FG006|Overall Study|Physician discretion|3
6969888|NCT01151215|11019764|FG001|Overall Study|Worsening of condition under study|1
6969889|NCT01151215|11019765|FG002|Overall Study|Worsening of condition under study|1
6969890|NCT01151215|11019763|FG000|Overall Study|Death|16
6969891|NCT01151215|11019764|FG001|Overall Study|Death|20
6969892|NCT01151215|11019765|FG002|Overall Study|Death|11
6969893|NCT01151215|11019763|FG000|Overall Study|Lost to Follow-up|0
6969894|NCT01151215|11019764|FG001|Overall Study|Lost to Follow-up|0
6969895|NCT01151215|11019765|FG002|Overall Study|Lost to Follow-up|3
6969896|NCT01151215|11019763|FG000|Overall Study|Withdrawal by Subject|3
6969897|NCT01151215|11019764|FG001|Overall Study|Withdrawal by Subject|1
6969898|NCT01151215|11019765|FG002|Overall Study|Withdrawal by Subject|2
6969899|NCT01151215|11019763|FG000|Overall Study|Disease progression|0
6969900|NCT01151215|11019764|FG001|Overall Study|Disease progression|1
6969901|NCT01151215|11019765|FG002|Overall Study|Disease progression|1
6969902|NCT01151215|11019763|FG000|Overall Study|Safety as judged by the investigator|0
6969903|NCT01151215|11019764|FG001|Overall Study|Safety as judged by the investigator|0
6969904|NCT01151215|11019765|FG002|Overall Study|Safety as judged by the investigator|1
6969905|NCT01151280|11019773|FG000|Overall Study|Adverse Event|1
6969906|NCT01151280|11019773|FG000|Overall Study|Lack of Efficacy|3
6969907|NCT01151345|11019777|FG000|First Intervention Period|Protocol Violation|0
6969908|NCT01151345|11019778|FG001|First Intervention Period|Protocol Violation|1
6969909|NCT01151410|11019799|FG000|Overall Study|Withdrawal by Subject|3
6969910|NCT01151410|11019800|FG001|Overall Study|Withdrawal by Subject|5
6969911|NCT01151410|11019799|FG000|Overall Study|Lost to Follow-up|3
6969912|NCT01151410|11019800|FG001|Overall Study|Lost to Follow-up|4
6969913|NCT01151410|11019799|FG000|Overall Study|Adverse Event|1
6969914|NCT01151410|11019800|FG001|Overall Study|Adverse Event|2
6969915|NCT01151410|11019799|FG000|Overall Study|Protocol deviation|2
6969916|NCT01151410|11019800|FG001|Overall Study|Protocol deviation|1
6969917|NCT01151410|11019799|FG000|Overall Study|Administrative problems|1
6969918|NCT01151410|11019800|FG001|Overall Study|Administrative problems|1
6969919|NCT01151410|11019799|FG000|Overall Study|Unsatisfactory therapeutic effect|1
6969920|NCT01151410|11019800|FG001|Overall Study|Unsatisfactory therapeutic effect|1
6969921|NCT01151410|11019799|FG000|Overall Study|Abnormal laboratory value(s)|0
6969922|NCT01151410|11019800|FG001|Overall Study|Abnormal laboratory value(s)|1
6969923|NCT01151423|11019808|FG000|Overall Study|Study terminated by Sponsor|9
6969924|NCT01151423|11019809|FG001|Overall Study|Study terminated by Sponsor|10
6969925|NCT01151423|11019808|FG000|Overall Study|Protocol Violation|0
6969926|NCT01151423|11019809|FG001|Overall Study|Protocol Violation|1
6969927|NCT01151423|11019808|FG000|Overall Study|Physician Decision|1
6969928|NCT01151423|11019809|FG001|Overall Study|Physician Decision|1
6969929|NCT01151423|11019808|FG000|Overall Study|Pregnancy|0
6969930|NCT01151423|11019809|FG001|Overall Study|Pregnancy|1
6969931|NCT01151423|11019808|FG000|Overall Study|Death|0
7044833|NCT01757704|11130860|FG000|Overall Study|Protocol Violation|1
6885621|NCT00558896|10898911|FG000|Overall Study|Continues on treatment|10
6885622|NCT00558896|10898912|FG001|Overall Study|Continues on treatment|1
6885623|NCT00558896|10898913|FG002|Overall Study|Continues on treatment|0
6885624|NCT00558896|10898914|FG003|Overall Study|Continues on treatment|1
6885625|NCT00558896|10898915|FG004|Overall Study|Continues on treatment|9
6885626|NCT00558896|10898916|FG005|Overall Study|Continues on treatment|25
6885627|NCT00558896|10898917|FG006|Overall Study|Continues on treatment|6
6885628|NCT00559104|10898939|FG000|Overall Study|Lack of Efficacy|9
6885629|NCT00559104|10898940|FG001|Overall Study|Lack of Efficacy|0
6885630|NCT00559273|10898948|FG000|Correction Period (20 Weeks)|Death|3
6885631|NCT00559273|10898949|FG001|Correction Period (20 Weeks)|Death|4
6885632|NCT00559273|10898948|FG000|Correction Period (20 Weeks)|Adverse Event|2
6885633|NCT00559273|10898949|FG001|Correction Period (20 Weeks)|Adverse Event|1
6885634|NCT00559273|10898948|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2
6885635|NCT00559273|10898949|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6
6885636|NCT00559273|10898948|FG000|Correction Period (20 Weeks)|Participant treated by another center|0
6885637|NCT00559273|10898949|FG001|Correction Period (20 Weeks)|Participant treated by another center|1
6885638|NCT00559273|10898948|FG000|Correction Period (20 Weeks)|Did not received study treatment|2
6885639|NCT00559273|10898949|FG001|Correction Period (20 Weeks)|Did not received study treatment|0
6885640|NCT00559273|10898948|FG000|Evaluation Period (8 Weeks)|Death|1
6885641|NCT00559273|10898949|FG001|Evaluation Period (8 Weeks)|Death|3
6885642|NCT00559273|10898948|FG000|Evaluation Period (8 Weeks)|Adverse Event|0
6885643|NCT00559273|10898949|FG001|Evaluation Period (8 Weeks)|Adverse Event|1
6885644|NCT00559273|10898948|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2
6885645|NCT00559273|10898949|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0
6885646|NCT00559273|10898948|FG000|Evaluation Period (8 Weeks)|Physician Decision|0
6885647|NCT00559273|10898949|FG001|Evaluation Period (8 Weeks)|Physician Decision|1
6885648|NCT00559364|10898957|FG000|Overall Study|Inclusion/exclusion criteria failure|1
6885649|NCT00559364|10898958|FG001|Overall Study|Inclusion/exclusion criteria failure|0
6885650|NCT00559377|10898964|FG000|Overall Study|Withdrawal by Subject|9
6885651|NCT00559507|10898980|FG000|Overall Study|Not treated, patient ineligible|3
6885652|NCT00559585|10898986|FG000|Double Blind ST Period Main Study|Adverse Event|17
6885653|NCT00559585|10898987|FG001|Double Blind ST Period Main Study|Adverse Event|25
6885654|NCT00559585|10898986|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11
6885655|NCT00559585|10898987|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5
6885656|NCT00559585|10898986|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0
6885657|NCT00559585|10898987|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6
6885658|NCT00559585|10898986|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1
6885659|NCT00559585|10898987|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0
6885660|NCT00559585|10898986|FG000|Double Blind ST Period Main Study|Death|1
6885661|NCT00559585|10898987|FG001|Double Blind ST Period Main Study|Death|1
6885662|NCT00559585|10898986|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2
6885663|NCT00559585|10898987|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1
6885664|NCT00559585|10898986|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6
6885665|NCT00559585|10898987|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1
6885666|NCT00559585|10898986|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3
6885667|NCT00559585|10898987|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0
6885668|NCT00559585|10898986|FG000|Double Blind ST Period Main Study|Missed Doses|0
6885669|NCT00559585|10898987|FG001|Double Blind ST Period Main Study|Missed Doses|1
6885670|NCT00559585|10898986|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0
6885671|NCT00559585|10898987|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1
6885672|NCT00559585|10898986|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0
6885673|NCT00559585|10898987|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1
6885674|NCT00559585|10898986|FG000|Double Blind ST Period Main Study|Early Discontinuation|0
6885675|NCT00559585|10898987|FG001|Double Blind ST Period Main Study|Early Discontinuation|1
6885676|NCT00559585|10898986|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1
6885677|NCT00559585|10898987|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0
6885678|NCT00559585|10898986|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0
6885679|NCT00559585|10898987|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1
6885680|NCT00559585|10898986|FG000|Double Blind ST Period Main Study|Investigator Decision|0
6885681|NCT00559585|10898987|FG001|Double Blind ST Period Main Study|Investigator Decision|1
6885682|NCT00559585|10898986|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1
6885683|NCT00559585|10898987|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0
6885684|NCT00559585|10898986|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
6885685|NCT00559585|10898987|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
6885686|NCT00559585|10898986|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100
6885687|NCT00559585|10898987|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0
6885688|NCT00559585|10898986|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81
6885689|NCT00559585|10898987|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0
6885690|NCT00559585|10898986|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16
6885691|NCT00559585|10898987|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0
6885692|NCT00559585|10898986|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32
6885693|NCT00559585|10898987|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0
6885694|NCT00559585|10898986|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9
6885695|NCT00559585|10898987|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0
6885696|NCT00559585|10898986|FG000|Open Label LT Period Main + Sub-Study|Death|20
6885697|NCT00559585|10898987|FG001|Open Label LT Period Main + Sub-Study|Death|0
6885698|NCT00559585|10898986|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1
6885699|NCT00559585|10898987|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0
6885700|NCT00559585|10898986|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89
6885701|NCT00559585|10898987|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0
6885702|NCT00559585|10898986|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8
6885703|NCT00559585|10898987|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0
6885704|NCT00559585|10898986|FG000|Open Label LT Period Main + Sub-Study|non-specified|71
6885705|NCT00559585|10898987|FG001|Open Label LT Period Main + Sub-Study|non-specified|0
6885706|NCT00559585|10898986|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1
6885707|NCT00559585|10898987|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0
6885708|NCT00559637|10899004|FG000|Overall Study|Adverse Event|22
6885709|NCT00559637|10899004|FG000|Overall Study|Withdrawal by Subject|4
6885710|NCT00559637|10899004|FG000|Overall Study|Protocol Violation|6
6885711|NCT00559637|10899004|FG000|Overall Study|Withdrawal criteria fulfilled|4
6885712|NCT00559637|10899004|FG000|Overall Study|Failure to return|6
6885713|NCT00559637|10899004|FG000|Overall Study|Insufficient response|3
6885714|NCT00559637|10899004|FG000|Overall Study|Started requiring dialysis after month 7|2
6885715|NCT00559637|10899004|FG000|Overall Study|Suspected lung cancer|1
6885716|NCT00559637|10899004|FG000|Overall Study|Participation in another study|1
6885717|NCT00559637|10899004|FG000|Overall Study|Delayed administration of C.E.R.A|1
6885718|NCT00559637|10899004|FG000|Overall Study|Change of center|1
6885719|NCT00559637|10899004|FG000|Overall Study|Change of home|1
6885720|NCT00559637|10899004|FG000|Overall Study|Inclusion or exclusion criteria violated|2
6885721|NCT00559754|10899008|FG000|Overall Study|Disease progression|1
6885722|NCT00559754|10899008|FG000|Overall Study|Adverse Event|5
6885723|NCT00559754|10899008|FG000|Overall Study|Protocol Violation|1
6885724|NCT00559754|10899008|FG000|Overall Study|Investigator criteria|2
6885725|NCT00559754|10899008|FG000|Overall Study|Withdrawal by Subject|2
6885726|NCT00559845|10899012|FG000|Overall Study|Withdrew Consent|1
6885727|NCT00559845|10899012|FG000|Overall Study|Disease Progression|1
6885728|NCT00559845|10899012|FG000|Overall Study|Adverse Event|3
6885729|NCT00559845|10899012|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1
6885730|NCT00559845|10899012|FG000|Overall Study|Premature Surgery-Investigator Decision|1
6885731|NCT00559949|10899016|FG000|Overall Study|Progressive Disease during cycle 1|1
6885732|NCT00559949|10899016|FG000|Overall Study|Adverse Event|1
6885733|NCT00559949|10899016|FG000|Overall Study|Withdrawal by Subject|4
6885734|NCT00559949|10899016|FG000|Overall Study|No disease evaluation per protocol|1
6885735|NCT00559962|10899028|FG000|Overall Study|Adverse Event|1
6885736|NCT00559962|10899029|FG001|Overall Study|Adverse Event|7
6885737|NCT00559962|10899030|FG002|Overall Study|Adverse Event|8
6885738|NCT00559962|10899031|FG003|Overall Study|Adverse Event|5
6885739|NCT00559962|10899032|FG004|Overall Study|Adverse Event|11
6885740|NCT00559962|10899033|FG005|Overall Study|Adverse Event|4
6885741|NCT00559962|10899034|FG006|Overall Study|Adverse Event|4
6885742|NCT00559962|10899035|FG007|Overall Study|Adverse Event|2
6885743|NCT00559962|10899028|FG000|Overall Study|Lost to Follow-up|0
6885744|NCT00559962|10899029|FG001|Overall Study|Lost to Follow-up|1
6885745|NCT00559962|10899030|FG002|Overall Study|Lost to Follow-up|0
6885746|NCT00559962|10899031|FG003|Overall Study|Lost to Follow-up|0
6885747|NCT00559962|10899032|FG004|Overall Study|Lost to Follow-up|0
6885748|NCT00559962|10899033|FG005|Overall Study|Lost to Follow-up|0
6885749|NCT00559962|10899034|FG006|Overall Study|Lost to Follow-up|0
6885750|NCT00559962|10899035|FG007|Overall Study|Lost to Follow-up|0
6885751|NCT00559962|10899028|FG000|Overall Study|Withdrawal by Subject|1
6885752|NCT00559962|10899029|FG001|Overall Study|Withdrawal by Subject|1
6885753|NCT00559962|10899030|FG002|Overall Study|Withdrawal by Subject|2
6885754|NCT00559962|10899031|FG003|Overall Study|Withdrawal by Subject|0
6885755|NCT00559962|10899032|FG004|Overall Study|Withdrawal by Subject|3
6885756|NCT00559962|10899033|FG005|Overall Study|Withdrawal by Subject|1
6885757|NCT00559962|10899034|FG006|Overall Study|Withdrawal by Subject|0
6885758|NCT00559962|10899035|FG007|Overall Study|Withdrawal by Subject|2
6885759|NCT00559962|10899028|FG000|Overall Study|Inclusion/exclusion criteria not met|0
6885760|NCT00559962|10899029|FG001|Overall Study|Inclusion/exclusion criteria not met|0
6885761|NCT00559962|10899030|FG002|Overall Study|Inclusion/exclusion criteria not met|0
6885762|NCT00559962|10899031|FG003|Overall Study|Inclusion/exclusion criteria not met|0
6885763|NCT00559962|10899032|FG004|Overall Study|Inclusion/exclusion criteria not met|0
6885764|NCT00559962|10899033|FG005|Overall Study|Inclusion/exclusion criteria not met|0
6885765|NCT00559962|10899034|FG006|Overall Study|Inclusion/exclusion criteria not met|1
6885766|NCT00559962|10899035|FG007|Overall Study|Inclusion/exclusion criteria not met|0
6885767|NCT00559988|10899056|FG000|Overall Study|Death|147
6885768|NCT00559988|10899057|FG001|Overall Study|Death|140
6885769|NCT00559988|10899056|FG000|Overall Study|Withdrawal by Subject|152
6885770|NCT00559988|10899057|FG001|Overall Study|Withdrawal by Subject|139
6885771|NCT00559988|10899056|FG000|Overall Study|Lost to Follow-up|42
6885772|NCT00559988|10899057|FG001|Overall Study|Lost to Follow-up|56
6885773|NCT00559988|10899056|FG000|Overall Study|ICD device explanted|10
6885774|NCT00559988|10899057|FG001|Overall Study|ICD device explanted|17
6885775|NCT00560066|10899065|FG000|Overall Study|Death|2
6885776|NCT00560066|10899066|FG001|Overall Study|Death|1
6885777|NCT00560066|10899065|FG000|Overall Study|Withdrawal by Subject|0
6885778|NCT00560066|10899066|FG001|Overall Study|Withdrawal by Subject|3
6885779|NCT00560066|10899065|FG000|Overall Study|Lost to Follow-up|4
6885780|NCT00560066|10899066|FG001|Overall Study|Lost to Follow-up|10
6885781|NCT00560066|10899065|FG000|Overall Study|Protocol Violation|0
6885782|NCT00560066|10899066|FG001|Overall Study|Protocol Violation|1
6885783|NCT00560066|10899065|FG000|Overall Study|Administrative reason|0
6885784|NCT00560066|10899066|FG001|Overall Study|Administrative reason|5
6885785|NCT00560066|10899065|FG000|Overall Study|Missing primary reason|0
6885786|NCT00560066|10899066|FG001|Overall Study|Missing primary reason|2
6885787|NCT00560105|10899079|FG000|Overall Study|musculoskeletal chest discomfort with us|1
6885788|NCT00560105|10899080|FG001|Overall Study|musculoskeletal chest discomfort with us|2
6885789|NCT00560235|10899089|FG000|Phase 1|Discontinued|8
6885790|NCT00560235|10899090|FG001|Phase 1|Discontinued|0
6885791|NCT00560235|10899091|FG002|Phase 1|Discontinued|0
6885792|NCT00560235|10899089|FG000|Phase 1B|Discontinued|0
6885793|NCT00560235|10899090|FG001|Phase 1B|Discontinued|19
6885794|NCT00560235|10899091|FG002|Phase 1B|Discontinued|0
6885795|NCT00560235|10899089|FG000|Phase 2|Discontinued|0
6885796|NCT00560235|10899090|FG001|Phase 2|Discontinued|0
6885797|NCT00560235|10899091|FG002|Phase 2|Discontinued|96
6885798|NCT00560235|10899089|FG000|Phase 2|Ongoing at Date of Cut-Off|0
6885799|NCT00560235|10899090|FG001|Phase 2|Ongoing at Date of Cut-Off|0
6885800|NCT00560235|10899091|FG002|Phase 2|Ongoing at Date of Cut-Off|1
6885801|NCT00560313|10899109|FG000|Overall Study|Adverse Events or Death|2
6885802|NCT00560313|10899109|FG000|Overall Study|Withdrawal by Subject|2
6885803|NCT00560313|10899109|FG000|Overall Study|Lost to Follow-up|1
6885804|NCT00560313|10899109|FG000|Overall Study|Protocol Violation|1
6885805|NCT00560352|10899131|FG000|Overall Study|Adverse event unrelated to study drug|2
6885806|NCT00560352|10899132|FG001|Overall Study|Adverse event unrelated to study drug|1
6885807|NCT00560352|10899133|FG002|Overall Study|Adverse event unrelated to study drug|1
6885808|NCT00560352|10899131|FG000|Overall Study|Study drug toxicity|3
6885809|NCT00560352|10899132|FG001|Overall Study|Study drug toxicity|0
6885810|NCT00560352|10899133|FG002|Overall Study|Study drug toxicity|1
6885811|NCT00560352|10899131|FG000|Overall Study|Disease progression|0
6885812|NCT00560352|10899132|FG001|Overall Study|Disease progression|1
6885813|NCT00560352|10899133|FG002|Overall Study|Disease progression|1
6885814|NCT00560352|10899131|FG000|Overall Study|Withdrawal by Subject|1
6885815|NCT00560352|10899132|FG001|Overall Study|Withdrawal by Subject|1
6885816|NCT00560352|10899133|FG002|Overall Study|Withdrawal by Subject|1
6885817|NCT00560352|10899131|FG000|Overall Study|Maximum clinical benefit|1
6885818|NCT00560352|10899132|FG001|Overall Study|Maximum clinical benefit|0
6885819|NCT00560352|10899133|FG002|Overall Study|Maximum clinical benefit|0
6885820|NCT00560391|10899150|FG000|Overall Study|Still on treatment|0
6885821|NCT00560391|10899151|FG001|Overall Study|Still on treatment|0
6885822|NCT00560391|10899152|FG002|Overall Study|Still on treatment|0
6885823|NCT00560391|10899153|FG003|Overall Study|Still on treatment|1
6885824|NCT00560391|10899154|FG004|Overall Study|Still on treatment|2
6885825|NCT00560404|10899169|FG000|Overall Study|Adverse Event|2
6885826|NCT00560404|10899170|FG001|Overall Study|Adverse Event|3
6885827|NCT00560404|10899169|FG000|Overall Study|Death|3
6885828|NCT00560404|10899170|FG001|Overall Study|Death|3
6885829|NCT00560404|10899169|FG000|Overall Study|Protocol Violation|12
6885830|NCT00560404|10899170|FG001|Overall Study|Protocol Violation|7
6885831|NCT00560404|10899169|FG000|Overall Study|Administrative Reasons|1
6885832|NCT00560404|10899170|FG001|Overall Study|Administrative Reasons|1
6885833|NCT00560404|10899169|FG000|Overall Study|Withdrew Consent|4
6885834|NCT00560404|10899170|FG001|Overall Study|Withdrew Consent|0
6885835|NCT00560404|10899169|FG000|Overall Study|Failure to return|1
6885836|NCT00560404|10899170|FG001|Overall Study|Failure to return|2
6885837|NCT00560404|10899169|FG000|Overall Study|Other withdrawal reason|13
6885838|NCT00560404|10899170|FG001|Overall Study|Other withdrawal reason|5
6885839|NCT00560417|10899178|FG000|Overall Study|Adverse Event|3
6885840|NCT00560417|10899179|FG001|Overall Study|Adverse Event|2
6885841|NCT00560417|10899178|FG000|Overall Study|Entry Criteria Not Met|1
6885842|NCT00560417|10899179|FG001|Overall Study|Entry Criteria Not Met|0
6885843|NCT00560417|10899178|FG000|Overall Study|Lost to Follow-up|0
6885844|NCT00560417|10899179|FG001|Overall Study|Lost to Follow-up|1
6885845|NCT00560417|10899178|FG000|Overall Study|Physician Decision|2
6885846|NCT00560417|10899179|FG001|Overall Study|Physician Decision|6
6885847|NCT00560417|10899178|FG000|Overall Study|Protocol Violation|6
6885848|NCT00560417|10899179|FG001|Overall Study|Protocol Violation|5
6885849|NCT00560417|10899178|FG000|Overall Study|Sponsor Decision|2
6885850|NCT00560417|10899179|FG001|Overall Study|Sponsor Decision|0
6885851|NCT00560417|10899178|FG000|Overall Study|Withdrawal by Subject|3
7044834|NCT01757704|11130861|FG001|Overall Study|Protocol Violation|3
6885852|NCT00560417|10899179|FG001|Overall Study|Withdrawal by Subject|3
6885853|NCT00560508|10899187|FG000|12 Week Double-blind Period|Adverse Event|3
6885854|NCT00560508|10899188|FG001|12 Week Double-blind Period|Adverse Event|2
6885855|NCT00560508|10899187|FG000|12 Week Double-blind Period|Protocol Violation|1
6885856|NCT00560508|10899188|FG001|12 Week Double-blind Period|Protocol Violation|0
6885857|NCT00560508|10899187|FG000|12 Week Double-blind Period|Withdrawal by Subject|1
6885858|NCT00560508|10899188|FG001|12 Week Double-blind Period|Withdrawal by Subject|1
6885859|NCT00560508|10899187|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6
6885860|NCT00560508|10899188|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6
6885861|NCT00560508|10899187|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
6885862|NCT00560508|10899188|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
6885863|NCT00560508|10899187|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0
6885864|NCT00560508|10899188|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3
6885865|NCT00560508|10899187|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
6885866|NCT00560508|10899188|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
6885867|NCT00560573|10899208|FG000|Overall Study|Death|4
6885868|NCT00560573|10899209|FG001|Overall Study|Death|1
6885869|NCT00560573|10899210|FG002|Overall Study|Death|4
6885870|NCT00560573|10899211|FG003|Overall Study|Death|5
6885871|NCT00560573|10899212|FG004|Overall Study|Death|1
6885872|NCT00560573|10899213|FG005|Overall Study|Death|10
6885873|NCT00560573|10899208|FG000|Overall Study|Lost to Follow-up|0
6885874|NCT00560573|10899209|FG001|Overall Study|Lost to Follow-up|0
6885875|NCT00560573|10899210|FG002|Overall Study|Lost to Follow-up|0
6885876|NCT00560573|10899211|FG003|Overall Study|Lost to Follow-up|1
6885877|NCT00560573|10899212|FG004|Overall Study|Lost to Follow-up|1
6885878|NCT00560573|10899213|FG005|Overall Study|Lost to Follow-up|0
6885879|NCT00560573|10899208|FG000|Overall Study|Withdrawal by Subject|0
6885880|NCT00560573|10899209|FG001|Overall Study|Withdrawal by Subject|0
6885881|NCT00560573|10899210|FG002|Overall Study|Withdrawal by Subject|0
7079160|NCT02109562|11187919|FG002|Overall Study|Insufficient clinical response|4
7079161|NCT02109562|11187917|FG000|Overall Study|Adverse Event|0
7079162|NCT02109562|11187918|FG001|Overall Study|Adverse Event|2
7079163|NCT02109562|11187919|FG002|Overall Study|Adverse Event|3
6885882|NCT00560573|10899211|FG003|Overall Study|Withdrawal by Subject|1
6885883|NCT00560573|10899212|FG004|Overall Study|Withdrawal by Subject|1
6885884|NCT00560573|10899213|FG005|Overall Study|Withdrawal by Subject|0
6885885|NCT00560573|10899208|FG000|Overall Study|Other|2
6885886|NCT00560573|10899209|FG001|Overall Study|Other|2
6885887|NCT00560573|10899210|FG002|Overall Study|Other|2
6885888|NCT00560573|10899211|FG003|Overall Study|Other|3
6885889|NCT00560573|10899212|FG004|Overall Study|Other|3
6885890|NCT00560573|10899213|FG005|Overall Study|Other|3
7079164|NCT02109562|11187917|FG000|Overall Study|Lost to Follow-up|1
7079165|NCT02109562|11187918|FG001|Overall Study|Lost to Follow-up|0
7079166|NCT02109562|11187919|FG002|Overall Study|Lost to Follow-up|1
7079167|NCT02109562|11187917|FG000|Overall Study|Protocol Violation|0
7079168|NCT02109562|11187918|FG001|Overall Study|Protocol Violation|3
7079169|NCT02109562|11187919|FG002|Overall Study|Protocol Violation|1
7079170|NCT02109562|11187917|FG000|Overall Study|Withdrawal by Subject|20
7079171|NCT02109562|11187918|FG001|Overall Study|Withdrawal by Subject|25
7079172|NCT02109562|11187919|FG002|Overall Study|Withdrawal by Subject|21
7079173|NCT02109562|11187917|FG000|Overall Study|Physician Decision|3
6885891|NCT00560573|10899208|FG000|Overall Study|Enrolled, not treated|0
6885892|NCT00560573|10899209|FG001|Overall Study|Enrolled, not treated|0
6885893|NCT00560573|10899210|FG002|Overall Study|Enrolled, not treated|0
6885894|NCT00560573|10899211|FG003|Overall Study|Enrolled, not treated|0
6885895|NCT00560573|10899212|FG004|Overall Study|Enrolled, not treated|1
6885896|NCT00560573|10899213|FG005|Overall Study|Enrolled, not treated|0
6885897|NCT00560703|10899254|FG000|Overall Study|Adverse Event|0
6885898|NCT00560703|10899255|FG001|Overall Study|Adverse Event|2
6885899|NCT00560703|10899254|FG000|Overall Study|Protocol Violation|0
6885900|NCT00560703|10899255|FG001|Overall Study|Protocol Violation|2
6885901|NCT00560703|10899254|FG000|Overall Study|Withdrawal by Subject|0
6885902|NCT00560703|10899255|FG001|Overall Study|Withdrawal by Subject|1
6885903|NCT00560703|10899254|FG000|Overall Study|non-compliance|0
6885904|NCT00560703|10899255|FG001|Overall Study|non-compliance|1
6885905|NCT00560755|10899261|FG000|Overall Study|Protocol Violation|15
6885906|NCT00560755|10899261|FG000|Overall Study|Withdrawal by Subject|26
6885907|NCT00560755|10899261|FG000|Overall Study|Lost to Follow-up|9
6885908|NCT00560755|10899261|FG000|Overall Study|Adverse Event|8
6885909|NCT00560755|10899261|FG000|Overall Study|Physician Decision|2
6885910|NCT00560794|10899266|FG000|Overall Study|Adverse Event|2
6885911|NCT00560794|10899266|FG000|Overall Study|Patient was not Compliant|1
6885912|NCT00560794|10899266|FG000|Overall Study|Minimal Residual Disease Relapse|1
6885913|NCT00560794|10899266|FG000|Overall Study|Hematological Relapse|1
6885914|NCT00560794|10899266|FG000|Overall Study|Received Bone Marrow Transplant|6
6885915|NCT00560833|10899277|FG000|Overall Study|Adverse Event|16
6885916|NCT00560833|10899278|FG001|Overall Study|Adverse Event|10
6885917|NCT00560833|10899279|FG002|Overall Study|Adverse Event|25
6885918|NCT00560833|10899280|FG003|Overall Study|Adverse Event|23
6885919|NCT00560833|10899281|FG004|Overall Study|Adverse Event|35
6885920|NCT00560833|10899277|FG000|Overall Study|Lost to Follow-up|0
6885921|NCT00560833|10899278|FG001|Overall Study|Lost to Follow-up|0
6885922|NCT00560833|10899279|FG002|Overall Study|Lost to Follow-up|1
6885923|NCT00560833|10899280|FG003|Overall Study|Lost to Follow-up|0
6885924|NCT00560833|10899281|FG004|Overall Study|Lost to Follow-up|0
6885925|NCT00560833|10899277|FG000|Overall Study|Lack of Efficacy|22
6885926|NCT00560833|10899278|FG001|Overall Study|Lack of Efficacy|9
6885927|NCT00560833|10899279|FG002|Overall Study|Lack of Efficacy|6
6885928|NCT00560833|10899280|FG003|Overall Study|Lack of Efficacy|4
6885929|NCT00560833|10899281|FG004|Overall Study|Lack of Efficacy|4
6885930|NCT00560833|10899277|FG000|Overall Study|Participant uncooperative|5
7079174|NCT02109562|11187918|FG001|Overall Study|Physician Decision|4
7079175|NCT02109562|11187919|FG002|Overall Study|Physician Decision|5
7079176|NCT02110225|11187981|FG000|Overall Study|Lost to Follow-up|0
6885931|NCT00560833|10899278|FG001|Overall Study|Participant uncooperative|5
6885932|NCT00560833|10899279|FG002|Overall Study|Participant uncooperative|4
6885933|NCT00560833|10899280|FG003|Overall Study|Participant uncooperative|4
6885934|NCT00560833|10899281|FG004|Overall Study|Participant uncooperative|2
6885935|NCT00560833|10899277|FG000|Overall Study|Other|1
6885936|NCT00560833|10899278|FG001|Overall Study|Other|1
6885937|NCT00560833|10899279|FG002|Overall Study|Other|3
6885938|NCT00560833|10899280|FG003|Overall Study|Other|0
6885939|NCT00560833|10899281|FG004|Overall Study|Other|0
6885940|NCT00560833|10899277|FG000|Overall Study|Never received drug|0
6885941|NCT00560833|10899278|FG001|Overall Study|Never received drug|1
6885942|NCT00560833|10899279|FG002|Overall Study|Never received drug|0
6885943|NCT00560833|10899280|FG003|Overall Study|Never received drug|0
6885944|NCT00560833|10899281|FG004|Overall Study|Never received drug|1
6885945|NCT00560885|10899303|FG000|Overall Study|Death|7
6885946|NCT00560885|10899303|FG000|Overall Study|Withdrawal by Subject|1
6885947|NCT00560937|10899309|FG000|Overall Study|Withdrawal by Subject|0
6885948|NCT00560937|10899310|FG001|Overall Study|Withdrawal by Subject|1
6885949|NCT00560937|10899309|FG000|Overall Study|Physician Decision|1
6885950|NCT00560937|10899310|FG001|Overall Study|Physician Decision|1
6885951|NCT00560950|10899318|FG000|Overall Study|Lost to Follow-up|1
6885952|NCT00560950|10899319|FG001|Overall Study|Lost to Follow-up|0
6885953|NCT00561015|10899342|FG000|Overall Study|Adverse Event|0
6885954|NCT00561015|10899343|FG001|Overall Study|Adverse Event|0
6885955|NCT00561015|10899344|FG002|Overall Study|Adverse Event|0
6885956|NCT00561015|10899345|FG003|Overall Study|Adverse Event|0
6885957|NCT00561015|10899346|FG004|Overall Study|Adverse Event|1
6885958|NCT00561015|10899347|FG005|Overall Study|Adverse Event|0
6885959|NCT00561015|10899342|FG000|Overall Study|Lost to Follow-up|2
6885960|NCT00561015|10899343|FG001|Overall Study|Lost to Follow-up|0
6885961|NCT00561015|10899344|FG002|Overall Study|Lost to Follow-up|0
6885962|NCT00561015|10899345|FG003|Overall Study|Lost to Follow-up|1
6885963|NCT00561015|10899346|FG004|Overall Study|Lost to Follow-up|0
6885964|NCT00561015|10899347|FG005|Overall Study|Lost to Follow-up|3
6885965|NCT00561015|10899342|FG000|Overall Study|Participant non-compliance|2
6885966|NCT00561015|10899343|FG001|Overall Study|Participant non-compliance|0
6885967|NCT00561015|10899344|FG002|Overall Study|Participant non-compliance|0
6885968|NCT00561015|10899345|FG003|Overall Study|Participant non-compliance|0
6885969|NCT00561015|10899346|FG004|Overall Study|Participant non-compliance|0
6885970|NCT00561015|10899347|FG005|Overall Study|Participant non-compliance|0
6885971|NCT00561080|10899368|FG000|Vaccination Period (up to Month 4)|Adverse Event|0
6885972|NCT00561080|10899369|FG001|Vaccination Period (up to Month 4)|Adverse Event|4
6885973|NCT00561080|10899370|FG002|Vaccination Period (up to Month 4)|Adverse Event|6
6885974|NCT00561080|10899368|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0
6885975|NCT00561080|10899369|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2
6885976|NCT00561080|10899370|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3
6885977|NCT00561080|10899368|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0
6885978|NCT00561080|10899369|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1
6885979|NCT00561080|10899370|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3
6885980|NCT00561080|10899368|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3
6885981|NCT00561080|10899369|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16
6885982|NCT00561080|10899370|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13
6885983|NCT00561080|10899368|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0
6885984|NCT00561080|10899369|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1
6885985|NCT00561080|10899370|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0
6885986|NCT00561080|10899368|FG000|Vaccination Period (up to Month 4)|Other|0
6885987|NCT00561080|10899369|FG001|Vaccination Period (up to Month 4)|Other|2
6885988|NCT00561080|10899370|FG002|Vaccination Period (up to Month 4)|Other|1
6885989|NCT00561080|10899368|FG000|12-month Post Last Dose Follow-up|Adverse Event|3
6885990|NCT00561080|10899369|FG001|12-month Post Last Dose Follow-up|Adverse Event|3
6885991|NCT00561080|10899370|FG002|12-month Post Last Dose Follow-up|Adverse Event|1
6885992|NCT00561080|10899368|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0
6885993|NCT00561080|10899369|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0
6885994|NCT00561080|10899370|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4
6885995|NCT00561080|10899368|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2
6885996|NCT00561080|10899369|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6
6885997|NCT00561080|10899370|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5
6885998|NCT00561080|10899368|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2
6885999|NCT00561080|10899369|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0
6886000|NCT00561080|10899370|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0
6886001|NCT00561340|10899391|FG000|Overall Study|refused to drink pediasure|6
6969932|NCT01151423|11019809|FG001|Overall Study|Death|1
6969933|NCT01151423|11019808|FG000|Overall Study|Adverse Event|3
6969934|NCT01151423|11019809|FG001|Overall Study|Adverse Event|0
6969935|NCT01151423|11019808|FG000|Overall Study|Withdrawal by Subject|1
6969936|NCT01151423|11019809|FG001|Overall Study|Withdrawal by Subject|3
6969937|NCT01151423|11019808|FG000|Overall Study|Lost to Follow-up|1
6969938|NCT01151423|11019809|FG001|Overall Study|Lost to Follow-up|0
6969939|NCT01151423|11019808|FG000|Overall Study|Diagnosed as non-TTP patient|0
6969940|NCT01151423|11019809|FG001|Overall Study|Diagnosed as non-TTP patient|1
6969941|NCT01151423|11019808|FG000|Overall Study|Participated in other clinical trial|1
6969942|NCT01151423|11019809|FG001|Overall Study|Participated in other clinical trial|0
6886002|NCT00561340|10899392|FG001|Overall Study|refused to drink pediasure|0
6886003|NCT00561353|10899408|FG000|Overall Study|Subject reached a virologic endpoint|2
6886004|NCT00561353|10899409|FG001|Overall Study|Subject reached a virologic endpoint|1
6886005|NCT00561353|10899410|FG002|Overall Study|Subject reached a virologic endpoint|1
6886006|NCT00561353|10899411|FG003|Overall Study|Subject reached a virologic endpoint|4
6886007|NCT00561353|10899412|FG004|Overall Study|Subject reached a virologic endpoint|1
6886008|NCT00561353|10899413|FG005|Overall Study|Subject reached a virologic endpoint|3
6886009|NCT00561353|10899414|FG006|Overall Study|Subject reached a virologic endpoint|4
6886010|NCT00561353|10899415|FG007|Overall Study|Subject reached a virologic endpoint|4
6886011|NCT00561353|10899416|FG008|Overall Study|Subject reached a virologic endpoint|5
6886012|NCT00561353|10899417|FG009|Overall Study|Subject reached a virologic endpoint|0
6886013|NCT00561353|10899408|FG000|Overall Study|Subject ineligible to continue the trial|0
6886014|NCT00561353|10899409|FG001|Overall Study|Subject ineligible to continue the trial|0
6886015|NCT00561353|10899410|FG002|Overall Study|Subject ineligible to continue the trial|0
6886016|NCT00561353|10899411|FG003|Overall Study|Subject ineligible to continue the trial|0
6886017|NCT00561353|10899412|FG004|Overall Study|Subject ineligible to continue the trial|0
6886018|NCT00561353|10899413|FG005|Overall Study|Subject ineligible to continue the trial|1
6886019|NCT00561353|10899414|FG006|Overall Study|Subject ineligible to continue the trial|1
6886020|NCT00561353|10899415|FG007|Overall Study|Subject ineligible to continue the trial|0
6886021|NCT00561353|10899416|FG008|Overall Study|Subject ineligible to continue the trial|2
6886022|NCT00561353|10899417|FG009|Overall Study|Subject ineligible to continue the trial|1
6886023|NCT00561353|10899408|FG000|Overall Study|Other|1
6886024|NCT00561353|10899409|FG001|Overall Study|Other|0
6886025|NCT00561353|10899410|FG002|Overall Study|Other|1
6886026|NCT00561353|10899411|FG003|Overall Study|Other|0
6886027|NCT00561353|10899412|FG004|Overall Study|Other|0
6886028|NCT00561353|10899413|FG005|Overall Study|Other|2
6886029|NCT00561353|10899414|FG006|Overall Study|Other|0
6886030|NCT00561353|10899415|FG007|Overall Study|Other|0
6886031|NCT00561353|10899416|FG008|Overall Study|Other|0
6886032|NCT00561353|10899417|FG009|Overall Study|Other|0
6886033|NCT00561353|10899408|FG000|Overall Study|Adverse Event|0
6886034|NCT00561353|10899409|FG001|Overall Study|Adverse Event|0
6886035|NCT00561353|10899410|FG002|Overall Study|Adverse Event|0
6886036|NCT00561353|10899411|FG003|Overall Study|Adverse Event|2
6886037|NCT00561353|10899412|FG004|Overall Study|Adverse Event|0
6886038|NCT00561353|10899413|FG005|Overall Study|Adverse Event|0
6886039|NCT00561353|10899414|FG006|Overall Study|Adverse Event|1
6886040|NCT00561353|10899415|FG007|Overall Study|Adverse Event|0
6886041|NCT00561353|10899416|FG008|Overall Study|Adverse Event|0
6886042|NCT00561353|10899417|FG009|Overall Study|Adverse Event|1
6886043|NCT00561353|10899408|FG000|Overall Study|Lost to Follow-up|2
6886044|NCT00561353|10899409|FG001|Overall Study|Lost to Follow-up|0
6886045|NCT00561353|10899410|FG002|Overall Study|Lost to Follow-up|1
6886046|NCT00561353|10899411|FG003|Overall Study|Lost to Follow-up|0
6886047|NCT00561353|10899412|FG004|Overall Study|Lost to Follow-up|0
6886048|NCT00561353|10899413|FG005|Overall Study|Lost to Follow-up|0
6886049|NCT00561353|10899414|FG006|Overall Study|Lost to Follow-up|0
6886050|NCT00561353|10899415|FG007|Overall Study|Lost to Follow-up|0
6886051|NCT00561353|10899416|FG008|Overall Study|Lost to Follow-up|0
6886052|NCT00561353|10899417|FG009|Overall Study|Lost to Follow-up|0
6886053|NCT00561353|10899408|FG000|Overall Study|Withdrawal by Subject|0
6886054|NCT00561353|10899409|FG001|Overall Study|Withdrawal by Subject|2
6886055|NCT00561353|10899410|FG002|Overall Study|Withdrawal by Subject|0
6886056|NCT00561353|10899411|FG003|Overall Study|Withdrawal by Subject|0
6886057|NCT00561353|10899412|FG004|Overall Study|Withdrawal by Subject|0
6886058|NCT00561353|10899413|FG005|Overall Study|Withdrawal by Subject|0
6886059|NCT00561353|10899414|FG006|Overall Study|Withdrawal by Subject|0
6886060|NCT00561353|10899415|FG007|Overall Study|Withdrawal by Subject|0
6886061|NCT00561353|10899416|FG008|Overall Study|Withdrawal by Subject|0
6886062|NCT00561353|10899417|FG009|Overall Study|Withdrawal by Subject|0
6886063|NCT00561392|10899479|FG000|Overall Study|Adverse Event|38
6886064|NCT00561392|10899479|FG000|Overall Study|Lack of Efficacy|2
6886065|NCT00561392|10899479|FG000|Overall Study|Protocol Violation|1
6886066|NCT00561392|10899479|FG000|Overall Study|Withdrawal by Subject|8
6886067|NCT00561392|10899479|FG000|Overall Study|Administrative problems|4
6886068|NCT00561470|10899502|FG000|Overall Study|Adverse Event|74
6886069|NCT00561470|10899503|FG001|Overall Study|Adverse Event|163
6886070|NCT00561470|10899502|FG000|Overall Study|Disease progression|437
6886071|NCT00561470|10899503|FG001|Overall Study|Disease progression|305
6886072|NCT00561470|10899502|FG000|Overall Study|poor compliance to protocol|4
6886073|NCT00561470|10899503|FG001|Overall Study|poor compliance to protocol|4
6886074|NCT00561470|10899502|FG000|Overall Study|Lost to Follow-up|2
6886075|NCT00561470|10899503|FG001|Overall Study|Lost to Follow-up|0
6886076|NCT00561470|10899502|FG000|Overall Study|Physician Decision|21
6886077|NCT00561470|10899503|FG001|Overall Study|Physician Decision|20
6886078|NCT00561470|10899502|FG000|Overall Study|Consent Withdrawn|2
6886079|NCT00561470|10899503|FG001|Overall Study|Consent Withdrawn|6
6886080|NCT00561470|10899502|FG000|Overall Study|Subject request|43
6886081|NCT00561470|10899503|FG001|Overall Study|Subject request|77
6886082|NCT00561470|10899502|FG000|Overall Study|Metastatic surgery|10
6886083|NCT00561470|10899503|FG001|Overall Study|Metastatic surgery|12
6886084|NCT00561470|10899502|FG000|Overall Study|Unauthorized procedure|3
6886085|NCT00561470|10899503|FG001|Overall Study|Unauthorized procedure|1
6886086|NCT00561470|10899502|FG000|Overall Study|Randomized but not treated|5
6886087|NCT00561470|10899503|FG001|Overall Study|Randomized but not treated|5
6886088|NCT00561470|10899502|FG000|Overall Study|Missed visit window|1
6886089|NCT00561470|10899503|FG001|Overall Study|Missed visit window|4
6886090|NCT00561470|10899502|FG000|Overall Study|Planning surgery|1
6886091|NCT00561470|10899503|FG001|Overall Study|Planning surgery|1
6886092|NCT00561470|10899502|FG000|Overall Study|Ongoing Treatment|11
6886093|NCT00561470|10899503|FG001|Overall Study|Ongoing Treatment|14
6886094|NCT00561574|10899513|FG000|Overall Study|Adverse Event|21
6886095|NCT00561574|10899514|FG001|Overall Study|Adverse Event|24
6886096|NCT00561574|10899513|FG000|Overall Study|Lack of Efficacy|11
6886097|NCT00561574|10899514|FG001|Overall Study|Lack of Efficacy|21
6886098|NCT00561574|10899513|FG000|Overall Study|Withdrawal by Subject|4
6886099|NCT00561574|10899514|FG001|Overall Study|Withdrawal by Subject|4
6886100|NCT00561574|10899513|FG000|Overall Study|Reason Unrelated to Trial|6
6886101|NCT00561574|10899514|FG001|Overall Study|Reason Unrelated to Trial|2
6886102|NCT00561574|10899513|FG000|Overall Study|Lost to Follow-up|1
6886103|NCT00561574|10899514|FG001|Overall Study|Lost to Follow-up|0
6886104|NCT00561574|10899513|FG000|Overall Study|Other|5
6886105|NCT00561574|10899514|FG001|Overall Study|Other|7
6886106|NCT00561652|10899533|FG000|Overall Study|Withdrawal by Subject|0
6886107|NCT00561652|10899534|FG001|Overall Study|Withdrawal by Subject|1
6886108|NCT00561678|10899542|FG000|Overall Study|Withdrawal by Subject|4
6886109|NCT00561678|10899543|FG001|Overall Study|Withdrawal by Subject|3
6886110|NCT00561678|10899542|FG000|Overall Study|surgery cancelled|1
6886111|NCT00561678|10899543|FG001|Overall Study|surgery cancelled|1
6886112|NCT00561678|10899542|FG000|Overall Study|surgery rescheduled to different site|2
6886113|NCT00561678|10899543|FG001|Overall Study|surgery rescheduled to different site|2
6886114|NCT00561678|10899542|FG000|Overall Study|anesthesia provider refusal|1
6886115|NCT00561678|10899543|FG001|Overall Study|anesthesia provider refusal|0
6886116|NCT00561730|10899549|FG000|Overall Study|Adverse Event|2
6886117|NCT00561730|10899549|FG000|Overall Study|Handling of the drug|1
6886118|NCT00561730|10899549|FG000|Overall Study|Lost to Follow-up|5
6886119|NCT00561730|10899549|FG000|Overall Study|Not specified reasons|1
6886120|NCT00561821|10899559|FG000|Overall Study|Not treated|0
6886121|NCT00561821|10899560|FG001|Overall Study|Not treated|0
6886122|NCT00561821|10899561|FG002|Overall Study|Not treated|1
6886123|NCT00561821|10899562|FG003|Overall Study|Not treated|0
6886124|NCT00561821|10899559|FG000|Overall Study|Withdrawal by Subject|0
6886125|NCT00561821|10899560|FG001|Overall Study|Withdrawal by Subject|1
6886126|NCT00561821|10899561|FG002|Overall Study|Withdrawal by Subject|0
6886127|NCT00561821|10899562|FG003|Overall Study|Withdrawal by Subject|2
6886128|NCT00561821|10899559|FG000|Overall Study|Reasons not related to trial|2
6886129|NCT00561821|10899560|FG001|Overall Study|Reasons not related to trial|1
6886130|NCT00561821|10899561|FG002|Overall Study|Reasons not related to trial|0
6886131|NCT00561821|10899562|FG003|Overall Study|Reasons not related to trial|0
6886132|NCT00561821|10899559|FG000|Overall Study|Other (reason not specified)|1
6886133|NCT00561821|10899560|FG001|Overall Study|Other (reason not specified)|1
6886134|NCT00561821|10899561|FG002|Overall Study|Other (reason not specified)|0
6886135|NCT00561821|10899562|FG003|Overall Study|Other (reason not specified)|0
6886136|NCT00561821|10899559|FG000|Overall Study|Adverse Event|2
6886137|NCT00561821|10899560|FG001|Overall Study|Adverse Event|3
6886138|NCT00561821|10899561|FG002|Overall Study|Adverse Event|1
6886139|NCT00561821|10899562|FG003|Overall Study|Adverse Event|1
6886140|NCT00561925|10899579|FG000|14 Day Lead-In Period|Adverse Event|38
6886141|NCT00561925|10899580|FG001|14 Day Lead-In Period|Adverse Event|0
6886142|NCT00561925|10899581|FG002|14 Day Lead-In Period|Adverse Event|0
6886143|NCT00561925|10899582|FG003|14 Day Lead-In Period|Adverse Event|0
6886144|NCT00561925|10899583|FG004|14 Day Lead-In Period|Adverse Event|0
6886145|NCT00561925|10899579|FG000|14 Day Lead-In Period|In/Exclusion criteria|4
6886146|NCT00561925|10899580|FG001|14 Day Lead-In Period|In/Exclusion criteria|0
6886147|NCT00561925|10899581|FG002|14 Day Lead-In Period|In/Exclusion criteria|0
6886148|NCT00561925|10899582|FG003|14 Day Lead-In Period|In/Exclusion criteria|0
6886149|NCT00561925|10899583|FG004|14 Day Lead-In Period|In/Exclusion criteria|0
6886150|NCT00561925|10899579|FG000|14 Day Lead-In Period|Lost to Follow-up|4
6886151|NCT00561925|10899580|FG001|14 Day Lead-In Period|Lost to Follow-up|0
6886152|NCT00561925|10899581|FG002|14 Day Lead-In Period|Lost to Follow-up|0
6886153|NCT00561925|10899582|FG003|14 Day Lead-In Period|Lost to Follow-up|0
6886154|NCT00561925|10899583|FG004|14 Day Lead-In Period|Lost to Follow-up|0
6886155|NCT00561925|10899579|FG000|14 Day Lead-In Period|Withdrawal by Subject|4
6886156|NCT00561925|10899580|FG001|14 Day Lead-In Period|Withdrawal by Subject|0
6886157|NCT00561925|10899581|FG002|14 Day Lead-In Period|Withdrawal by Subject|0
6886158|NCT00561925|10899582|FG003|14 Day Lead-In Period|Withdrawal by Subject|0
6886159|NCT00561925|10899583|FG004|14 Day Lead-In Period|Withdrawal by Subject|0
6886160|NCT00561925|10899579|FG000|14 Day Lead-In Period|Other|5
6886161|NCT00561925|10899580|FG001|14 Day Lead-In Period|Other|0
6886162|NCT00561925|10899581|FG002|14 Day Lead-In Period|Other|0
6886163|NCT00561925|10899582|FG003|14 Day Lead-In Period|Other|0
6886164|NCT00561925|10899583|FG004|14 Day Lead-In Period|Other|0
6886165|NCT00561925|10899579|FG000|144-week Double-blind, Double-dummy|Adverse Event|0
6886166|NCT00561925|10899580|FG001|144-week Double-blind, Double-dummy|Adverse Event|48
6886167|NCT00561925|10899581|FG002|144-week Double-blind, Double-dummy|Adverse Event|43
6886168|NCT00561925|10899582|FG003|144-week Double-blind, Double-dummy|Adverse Event|0
6886169|NCT00561925|10899583|FG004|144-week Double-blind, Double-dummy|Adverse Event|0
6886170|NCT00561925|10899579|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0
6886171|NCT00561925|10899580|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15
6886172|NCT00561925|10899581|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9
6886173|NCT00561925|10899582|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0
6886174|NCT00561925|10899583|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0
6886175|NCT00561925|10899579|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0
6886176|NCT00561925|10899580|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15
6886177|NCT00561925|10899581|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12
6886178|NCT00561925|10899582|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0
6886179|NCT00561925|10899583|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0
6886180|NCT00561925|10899579|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
6886181|NCT00561925|10899580|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19
6886182|NCT00561925|10899581|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7
6886183|NCT00561925|10899582|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
6886184|NCT00561925|10899583|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
6886185|NCT00561925|10899579|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0
6886186|NCT00561925|10899580|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36
6886187|NCT00561925|10899581|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33
6886188|NCT00561925|10899582|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0
6886189|NCT00561925|10899583|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0
6886190|NCT00561925|10899579|FG000|144-week Double-blind, Double-dummy|Pregnancy|0
6886191|NCT00561925|10899580|FG001|144-week Double-blind, Double-dummy|Pregnancy|1
6886192|NCT00561925|10899581|FG002|144-week Double-blind, Double-dummy|Pregnancy|9
6886193|NCT00561925|10899582|FG003|144-week Double-blind, Double-dummy|Pregnancy|0
6886194|NCT00561925|10899583|FG004|144-week Double-blind, Double-dummy|Pregnancy|0
6886195|NCT00561925|10899579|FG000|144-week Double-blind, Double-dummy|Death|0
6886196|NCT00561925|10899580|FG001|144-week Double-blind, Double-dummy|Death|6
6886197|NCT00561925|10899581|FG002|144-week Double-blind, Double-dummy|Death|3
6886198|NCT00561925|10899582|FG003|144-week Double-blind, Double-dummy|Death|0
6886199|NCT00561925|10899583|FG004|144-week Double-blind, Double-dummy|Death|0
6886200|NCT00561925|10899579|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0
6886201|NCT00561925|10899580|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2
6886202|NCT00561925|10899581|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0
6886203|NCT00561925|10899582|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0
6886204|NCT00561925|10899583|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0
6886205|NCT00561925|10899579|FG000|144-week Double-blind, Double-dummy|Other|0
6886206|NCT00561925|10899580|FG001|144-week Double-blind, Double-dummy|Other|8
6886207|NCT00561925|10899581|FG002|144-week Double-blind, Double-dummy|Other|11
6886208|NCT00561925|10899582|FG003|144-week Double-blind, Double-dummy|Other|0
6886209|NCT00561925|10899583|FG004|144-week Double-blind, Double-dummy|Other|0
6886210|NCT00561925|10899579|FG000|Open-Label Extension Period|Declined entry into extension period|0
6886211|NCT00561925|10899580|FG001|Open-Label Extension Period|Declined entry into extension period|0
6886212|NCT00561925|10899581|FG002|Open-Label Extension Period|Declined entry into extension period|0
6886213|NCT00561925|10899582|FG003|Open-Label Extension Period|Declined entry into extension period|43
6886214|NCT00561925|10899583|FG004|Open-Label Extension Period|Declined entry into extension period|50
6886215|NCT00561951|10899604|FG000|Overall Study|Adverse Event|11
6886216|NCT00561951|10899605|FG001|Overall Study|Adverse Event|14
6886217|NCT00561951|10899606|FG002|Overall Study|Adverse Event|14
6886218|NCT00561951|10899604|FG000|Overall Study|Lack of Efficacy|5
6886219|NCT00561951|10899605|FG001|Overall Study|Lack of Efficacy|3
6886220|NCT00561951|10899606|FG002|Overall Study|Lack of Efficacy|2
6886221|NCT00561951|10899604|FG000|Overall Study|Lost to Follow-up|1
6886222|NCT00561951|10899605|FG001|Overall Study|Lost to Follow-up|1
6886223|NCT00561951|10899606|FG002|Overall Study|Lost to Follow-up|0
6886224|NCT00561951|10899604|FG000|Overall Study|Withdrawal by Subject|10
6886225|NCT00561951|10899605|FG001|Overall Study|Withdrawal by Subject|9
6886226|NCT00561951|10899606|FG002|Overall Study|Withdrawal by Subject|10
6886227|NCT00561951|10899604|FG000|Overall Study|Protocol Violation|4
6886228|NCT00561951|10899605|FG001|Overall Study|Protocol Violation|3
6886229|NCT00561951|10899606|FG002|Overall Study|Protocol Violation|4
6886230|NCT00561951|10899604|FG000|Overall Study|Physician Decision|1
6886231|NCT00561951|10899605|FG001|Overall Study|Physician Decision|0
6886232|NCT00561951|10899606|FG002|Overall Study|Physician Decision|0
6886233|NCT00561951|10899604|FG000|Overall Study|Pregnancy|0
6886234|NCT00561951|10899605|FG001|Overall Study|Pregnancy|1
6886235|NCT00561951|10899606|FG002|Overall Study|Pregnancy|0
6886236|NCT00561951|10899604|FG000|Overall Study|Meet Withdrawal Criterion|0
6886237|NCT00561951|10899605|FG001|Overall Study|Meet Withdrawal Criterion|1
6886238|NCT00561951|10899606|FG002|Overall Study|Meet Withdrawal Criterion|1
6886239|NCT00561951|10899604|FG000|Overall Study|Adverse Event Occured Before Treatment|1
6886240|NCT00561951|10899605|FG001|Overall Study|Adverse Event Occured Before Treatment|2
6886241|NCT00561951|10899606|FG002|Overall Study|Adverse Event Occured Before Treatment|1
6886242|NCT00561977|10899617|FG000|Overall Study|Withdrawal by Subject|0
6886243|NCT00561977|10899618|FG001|Overall Study|Withdrawal by Subject|2
6886244|NCT00561977|10899619|FG002|Overall Study|Withdrawal by Subject|1
6886245|NCT00561977|10899617|FG000|Overall Study|Pregnancy|0
6886246|NCT00561977|10899618|FG001|Overall Study|Pregnancy|1
6886247|NCT00561977|10899619|FG002|Overall Study|Pregnancy|1
6886248|NCT00562094|10899627|FG000|Overall Study|Lost to Follow-up|62
6886249|NCT00562120|10899635|FG000|First Intervention Period|Adverse Event|1
6886250|NCT00562120|10899636|FG001|First Intervention Period|Adverse Event|0
6886251|NCT00562120|10899637|FG002|First Intervention Period|Adverse Event|0
6886252|NCT00562120|10899638|FG003|First Intervention Period|Adverse Event|0
6886253|NCT00562120|10899635|FG000|First Intervention Period|Randomized but not Treated|1
6886254|NCT00562120|10899636|FG001|First Intervention Period|Randomized but not Treated|0
6886255|NCT00562120|10899637|FG002|First Intervention Period|Randomized but not Treated|0
6886256|NCT00562120|10899638|FG003|First Intervention Period|Randomized but not Treated|0
6886257|NCT00562159|10899650|FG000|Overall Study|Adverse Event|11
6886258|NCT00562159|10899651|FG001|Overall Study|Adverse Event|8
6886259|NCT00562159|10899650|FG000|Overall Study|Lost to Follow-up|5
6886260|NCT00562159|10899651|FG001|Overall Study|Lost to Follow-up|4
6886261|NCT00562159|10899650|FG000|Overall Study|Withdrawal by Subject|9
6886262|NCT00562159|10899651|FG001|Overall Study|Withdrawal by Subject|8
6886263|NCT00562159|10899650|FG000|Overall Study|Protocol Violation|12
6886264|NCT00562159|10899651|FG001|Overall Study|Protocol Violation|12
6886265|NCT00562159|10899650|FG000|Overall Study|Did not meet protocol eligibility|1
6886266|NCT00562159|10899651|FG001|Overall Study|Did not meet protocol eligibility|1
6969943|NCT01151540|11019823|FG000|Overall Study|Other|2
6969944|NCT01151540|11019823|FG000|Overall Study|Adverse event, non-fatal|4
6969945|NCT01151540|11019823|FG000|Overall Study|Withdrawal by Subject|7
6969946|NCT01151579|11019829|FG000|Overall Study|Physician Decision|3
6969947|NCT01151579|11019830|FG001|Overall Study|Physician Decision|1
6969948|NCT01151579|11019829|FG000|Overall Study|Withdrawal by Subject|3
6969949|NCT01151579|11019830|FG001|Overall Study|Withdrawal by Subject|2
6969950|NCT01151579|11019829|FG000|Overall Study|Not meet inclusion criteria|6
6969951|NCT01151579|11019830|FG001|Overall Study|Not meet inclusion criteria|4
6969952|NCT01151618|11019836|FG000|Overall Study|Adverse Event|2
6969953|NCT01151618|11019836|FG000|Overall Study|Withdrawal by Subject|7
7041271|NCT01725308|11124779|FG002|Treatment Period II|Changes in the Episodes|5
7041272|NCT01725308|11124777|FG000|Treatment Period II|Withdrawal of Consent|28
7041273|NCT01725308|11124778|FG001|Treatment Period II|Withdrawal of Consent|2
7041274|NCT01725308|11124779|FG002|Treatment Period II|Withdrawal of Consent|16
7041275|NCT01725308|11124777|FG000|Treatment Period II|Lost to Follow-up|1
7041276|NCT01725308|11124778|FG001|Treatment Period II|Lost to Follow-up|5
7041277|NCT01725308|11124779|FG002|Treatment Period II|Lost to Follow-up|3
7041278|NCT01725308|11124777|FG000|Treatment Period II|Protocol Deviations|0
7041279|NCT01725308|11124778|FG001|Treatment Period II|Protocol Deviations|0
7041280|NCT01725308|11124779|FG002|Treatment Period II|Protocol Deviations|1
7041281|NCT01725308|11124777|FG000|Treatment Period II|Miscellaneous|5
7041282|NCT01725308|11124778|FG001|Treatment Period II|Miscellaneous|3
7041283|NCT01725308|11124779|FG002|Treatment Period II|Miscellaneous|7
7041284|NCT01725386|11124796|FG000|Overall Study|Death|84
7041285|NCT01725386|11124797|FG001|Overall Study|Death|40
7041286|NCT01725386|11124796|FG000|Overall Study|Lost to Follow-up|81
7041287|NCT01725386|11124797|FG001|Overall Study|Lost to Follow-up|6
7041288|NCT01725386|11124796|FG000|Overall Study|Withdrawal by Subject|10
7041289|NCT01725386|11124797|FG001|Overall Study|Withdrawal by Subject|0
7041290|NCT01725451|11124803|FG000|Period 1|Withdrawal by Subject|1
7041291|NCT01725451|11124804|FG001|Period 1|Withdrawal by Subject|0
7041292|NCT01725451|11124805|FG002|Period 1|Withdrawal by Subject|0
7041293|NCT01725451|11124806|FG003|Period 1|Withdrawal by Subject|0
7041294|NCT01725451|11124803|FG000|Washout From Period 3|Protocol Violation|0
7041295|NCT01725451|11124804|FG001|Washout From Period 3|Protocol Violation|0
7041296|NCT01725451|11124805|FG002|Washout From Period 3|Protocol Violation|1
7041297|NCT01725451|11124806|FG003|Washout From Period 3|Protocol Violation|0
7041298|NCT01725451|11124803|FG000|Washout From Period 3|Adverse Event|0
7041299|NCT01725451|11124804|FG001|Washout From Period 3|Adverse Event|1
7041300|NCT01725451|11124805|FG002|Washout From Period 3|Adverse Event|0
7041301|NCT01725451|11124806|FG003|Washout From Period 3|Adverse Event|0
7041302|NCT01725451|11124803|FG000|Period 4|Adverse Event|0
7041303|NCT01725451|11124804|FG001|Period 4|Adverse Event|0
7041304|NCT01725451|11124805|FG002|Period 4|Adverse Event|1
6969954|NCT01152021|11019863|FG000|Overall Study|Adverse Event|4
6969955|NCT01152021|11019864|FG001|Overall Study|Adverse Event|4
6969956|NCT01152021|11019863|FG000|Overall Study|Study drug had expired|1
6969957|NCT01152021|11019864|FG001|Overall Study|Study drug had expired|0
6969958|NCT01152021|11019863|FG000|Overall Study|Physician Decision|1
7041305|NCT01725451|11124806|FG003|Period 4|Adverse Event|0
7041306|NCT01725529|11124824|FG000|Overall Study|Adverse Event|1
6969959|NCT01152021|11019864|FG001|Overall Study|Physician Decision|1
6969960|NCT01152021|11019863|FG000|Overall Study|No access to study drug in Pharmacy|0
6969961|NCT01152021|11019864|FG001|Overall Study|No access to study drug in Pharmacy|1
6969962|NCT01152190|11019883|FG000|Overall Study|Adverse Event|2
6886267|NCT00562302|10899660|FG000|Overall Study|Lost to Follow-up|3
6886268|NCT00562302|10899661|FG001|Overall Study|Lost to Follow-up|3
6886269|NCT00562302|10899660|FG000|Overall Study|Adverse Event|0
6886270|NCT00562302|10899661|FG001|Overall Study|Adverse Event|6
6886271|NCT00562302|10899660|FG000|Overall Study|Non-compliance|1
6886272|NCT00562302|10899661|FG001|Overall Study|Non-compliance|2
6886273|NCT00562302|10899660|FG000|Overall Study|Withdrawal by Subject|7
6886274|NCT00562302|10899661|FG001|Overall Study|Withdrawal by Subject|8
6886275|NCT00562302|10899660|FG000|Overall Study|Death|1
6886276|NCT00562302|10899661|FG001|Overall Study|Death|2
6886277|NCT00562302|10899660|FG000|Overall Study|Lung resection prior to study completion|7
6886278|NCT00562302|10899661|FG001|Overall Study|Lung resection prior to study completion|7
6886279|NCT00562302|10899660|FG000|Overall Study|Not stated|1
6886280|NCT00562302|10899661|FG001|Overall Study|Not stated|4
6886281|NCT00562354|10899679|FG000|Overall Study|Physician Decision|0
6886282|NCT00562354|10899680|FG001|Overall Study|Physician Decision|1
6886283|NCT00562354|10899679|FG000|Overall Study|Lost to Follow-up|0
6886284|NCT00562354|10899680|FG001|Overall Study|Lost to Follow-up|1
6886285|NCT00562484|10899690|FG000|Overall Study|Adverse Event|6
6886286|NCT00562484|10899691|FG001|Overall Study|Adverse Event|1
6886287|NCT00562484|10899690|FG000|Overall Study|Protocol Violation|11
6886288|NCT00562484|10899691|FG001|Overall Study|Protocol Violation|2
6886289|NCT00562484|10899690|FG000|Overall Study|Withdrawal by Subject|12
6886290|NCT00562484|10899691|FG001|Overall Study|Withdrawal by Subject|9
6886291|NCT00562484|10899690|FG000|Overall Study|Moved away from the study area|20
6886292|NCT00562484|10899691|FG001|Overall Study|Moved away from the study area|9
6886293|NCT00562484|10899690|FG000|Overall Study|Lost to Follow-up|132
6886294|NCT00562484|10899691|FG001|Overall Study|Lost to Follow-up|71
6886295|NCT00562484|10899690|FG000|Overall Study|Reason not provided or not specified|25
6886296|NCT00562484|10899691|FG001|Overall Study|Reason not provided or not specified|12
6886297|NCT00562588|10899699|FG000|Overall Study|Adverse Event|40
6886298|NCT00562588|10899700|FG001|Overall Study|Adverse Event|58
6886299|NCT00562588|10899699|FG000|Overall Study|Protocol Violation|30
6886300|NCT00562588|10899700|FG001|Overall Study|Protocol Violation|26
6886301|NCT00562588|10899699|FG000|Overall Study|Lost to Follow-up|12
6886302|NCT00562588|10899700|FG001|Overall Study|Lost to Follow-up|4
6886303|NCT00562588|10899699|FG000|Overall Study|Withdrawal by Subject|10
6886304|NCT00562588|10899700|FG001|Overall Study|Withdrawal by Subject|9
6886305|NCT00562588|10899699|FG000|Overall Study|Other|0
6886306|NCT00562588|10899700|FG001|Overall Study|Other|2
6886307|NCT00562627|10899709|FG000|Overall Study|Protocol Violation|1
6886308|NCT00562627|10899710|FG001|Overall Study|Protocol Violation|1
6886309|NCT00562627|10899711|FG002|Overall Study|Protocol Violation|1
6886310|NCT00562718|10899719|FG000|Overall Study|Death|1
6886311|NCT00562718|10899719|FG000|Overall Study|Withdrawal by Subject|3
6886312|NCT00562718|10899719|FG000|Overall Study|Adverse Event|4
6886313|NCT00562718|10899719|FG000|Overall Study|Lack of Efficacy|2
6886314|NCT00562718|10899719|FG000|Overall Study|not stated|1
6886315|NCT00562861|10899725|FG000|Overall Study|Adverse Event|1
6886316|NCT00562861|10899726|FG001|Overall Study|Adverse Event|1
6886317|NCT00562861|10899725|FG000|Overall Study|Lack of Efficacy|5
6886318|NCT00562861|10899726|FG001|Overall Study|Lack of Efficacy|5
6886319|NCT00562861|10899725|FG000|Overall Study|noncompliance, moved|7
6886320|NCT00562861|10899726|FG001|Overall Study|noncompliance, moved|2
6886321|NCT00562861|10899725|FG000|Overall Study|Lost to Follow-up|7
6886322|NCT00562861|10899726|FG001|Overall Study|Lost to Follow-up|3
6886323|NCT00562965|10899734|FG000|Overall Study|Withdrawal by Subject|0
6886324|NCT00562965|10899735|FG001|Overall Study|Withdrawal by Subject|1
6886325|NCT00562965|10899734|FG000|Overall Study|Death|2
6886326|NCT00562965|10899735|FG001|Overall Study|Death|4
6886327|NCT00562965|10899734|FG000|Overall Study|Lost to Follow-up|1
6886328|NCT00562965|10899735|FG001|Overall Study|Lost to Follow-up|0
6886329|NCT00562965|10899734|FG000|Overall Study|Other|0
6886330|NCT00562965|10899735|FG001|Overall Study|Other|1
6886331|NCT00562978|10899743|FG000|Overall Study|Patient had imaging dose only|1
6886332|NCT00562978|10899744|FG001|Overall Study|Patient had imaging dose only|11
6886333|NCT00563186|10899752|FG000|Overall Study|LOS<48 hours|97
6886334|NCT00563186|10899753|FG001|Overall Study|LOS<48 hours|74
6886335|NCT00563186|10899752|FG000|Overall Study|Incomplete data|1
6886336|NCT00563186|10899753|FG001|Overall Study|Incomplete data|1
6886337|NCT00563316|10899773|FG000|Overall Study|Adverse Event|2
6886338|NCT00563316|10899773|FG000|Overall Study|Physician Decision|1
6886339|NCT00563316|10899773|FG000|Overall Study|Lost to Follow-up|2
6886340|NCT00563316|10899773|FG000|Overall Study|Death|1
6886341|NCT00563316|10899773|FG000|Overall Study|On-going in study as of 16 July 2009.|5
6886342|NCT00563316|10899773|FG000|Overall Study|Other|1
6886343|NCT00563368|10899788|FG000|Overall Study|Lost to Follow-up|14
6886344|NCT00563368|10899789|FG001|Overall Study|Lost to Follow-up|14
6886345|NCT00563368|10899790|FG002|Overall Study|Lost to Follow-up|12
6886346|NCT00563368|10899791|FG003|Overall Study|Lost to Follow-up|6
6886347|NCT00563368|10899792|FG004|Overall Study|Lost to Follow-up|9
6886348|NCT00563368|10899793|FG005|Overall Study|Lost to Follow-up|8
6886349|NCT00563368|10899794|FG006|Overall Study|Lost to Follow-up|9
6886350|NCT00563368|10899788|FG000|Overall Study|Adverse Event|3
6886351|NCT00563368|10899789|FG001|Overall Study|Adverse Event|4
6886352|NCT00563368|10899790|FG002|Overall Study|Adverse Event|5
6886353|NCT00563368|10899791|FG003|Overall Study|Adverse Event|9
6886354|NCT00563368|10899792|FG004|Overall Study|Adverse Event|6
6886355|NCT00563368|10899793|FG005|Overall Study|Adverse Event|10
6886356|NCT00563368|10899794|FG006|Overall Study|Adverse Event|17
6886357|NCT00563368|10899788|FG000|Overall Study|Withdrawal by Subject|11
6886358|NCT00563368|10899789|FG001|Overall Study|Withdrawal by Subject|6
6886359|NCT00563368|10899790|FG002|Overall Study|Withdrawal by Subject|5
6886360|NCT00563368|10899791|FG003|Overall Study|Withdrawal by Subject|7
6886361|NCT00563368|10899792|FG004|Overall Study|Withdrawal by Subject|8
6886362|NCT00563368|10899793|FG005|Overall Study|Withdrawal by Subject|5
6886363|NCT00563368|10899794|FG006|Overall Study|Withdrawal by Subject|4
6886364|NCT00563368|10899788|FG000|Overall Study|protocol non-compliance|1
6886365|NCT00563368|10899789|FG001|Overall Study|protocol non-compliance|1
6886366|NCT00563368|10899790|FG002|Overall Study|protocol non-compliance|2
6886367|NCT00563368|10899791|FG003|Overall Study|protocol non-compliance|1
6886368|NCT00563368|10899792|FG004|Overall Study|protocol non-compliance|0
6886369|NCT00563368|10899793|FG005|Overall Study|protocol non-compliance|1
6886370|NCT00563368|10899794|FG006|Overall Study|protocol non-compliance|3
6886371|NCT00563368|10899788|FG000|Overall Study|Pregnancy|1
6886372|NCT00563368|10899789|FG001|Overall Study|Pregnancy|0
6886373|NCT00563368|10899790|FG002|Overall Study|Pregnancy|1
6886374|NCT00563368|10899791|FG003|Overall Study|Pregnancy|2
6886375|NCT00563368|10899792|FG004|Overall Study|Pregnancy|1
6886376|NCT00563368|10899793|FG005|Overall Study|Pregnancy|2
6886377|NCT00563368|10899794|FG006|Overall Study|Pregnancy|0
6886378|NCT00563368|10899788|FG000|Overall Study|requirement for restricted medication|0
6886379|NCT00563368|10899789|FG001|Overall Study|requirement for restricted medication|0
6886380|NCT00563368|10899790|FG002|Overall Study|requirement for restricted medication|2
6886381|NCT00563368|10899791|FG003|Overall Study|requirement for restricted medication|0
6886382|NCT00563368|10899792|FG004|Overall Study|requirement for restricted medication|0
6886383|NCT00563368|10899793|FG005|Overall Study|requirement for restricted medication|0
6886384|NCT00563368|10899794|FG006|Overall Study|requirement for restricted medication|0
6886385|NCT00563368|10899788|FG000|Overall Study|Other|5
6886386|NCT00563368|10899789|FG001|Overall Study|Other|5
6886387|NCT00563368|10899790|FG002|Overall Study|Other|3
6886388|NCT00563368|10899791|FG003|Overall Study|Other|4
6886389|NCT00563368|10899792|FG004|Overall Study|Other|4
6886390|NCT00563368|10899793|FG005|Overall Study|Other|4
6886391|NCT00563368|10899794|FG006|Overall Study|Other|0
6886392|NCT00563381|10899812|FG000|Overall Study|Adverse Event|264
6886393|NCT00563381|10899813|FG001|Overall Study|Adverse Event|292
6886394|NCT00563381|10899812|FG000|Overall Study|Protocol Violation|66
6886395|NCT00563381|10899813|FG001|Overall Study|Protocol Violation|74
6886396|NCT00563381|10899812|FG000|Overall Study|Lost to Follow-up|7
6886397|NCT00563381|10899813|FG001|Overall Study|Lost to Follow-up|15
6886398|NCT00563381|10899812|FG000|Overall Study|Withdrawal by Subject|192
6886399|NCT00563381|10899813|FG001|Overall Study|Withdrawal by Subject|209
6886400|NCT00563381|10899812|FG000|Overall Study|Lack of Efficacy|32
6886401|NCT00563381|10899813|FG001|Overall Study|Lack of Efficacy|24
6886402|NCT00563381|10899812|FG000|Overall Study|Individual different reasons|24
6886403|NCT00563381|10899813|FG001|Overall Study|Individual different reasons|34
6886404|NCT00563706|10899828|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4
6886405|NCT00563706|10899829|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
6886406|NCT00563706|10899830|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
6886407|NCT00563706|10899831|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
6886408|NCT00563706|10899832|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
6886409|NCT00563706|10899833|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
6886410|NCT00563706|10899834|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
6886411|NCT00563706|10899835|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
6886412|NCT00563706|10899836|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5
6886413|NCT00563706|10899828|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
6886414|NCT00563706|10899829|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
6886415|NCT00563706|10899830|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
6886416|NCT00563706|10899831|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4
6886417|NCT00563706|10899832|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
6886418|NCT00563706|10899833|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
6886419|NCT00563706|10899834|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
6886420|NCT00563706|10899835|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5
6886421|NCT00563706|10899836|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
6886422|NCT00563706|10899828|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9
6886423|NCT00563706|10899829|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
6886424|NCT00563706|10899830|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2
6886425|NCT00563706|10899831|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5
6886426|NCT00563706|10899832|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4
6886427|NCT00563706|10899833|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
6886428|NCT00563706|10899834|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1
6886429|NCT00563706|10899835|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6
6886430|NCT00563706|10899836|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
6886431|NCT00563706|10899828|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2
6886432|NCT00563706|10899829|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
6886433|NCT00563706|10899830|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
6886434|NCT00563706|10899831|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
6886435|NCT00563706|10899832|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
6886436|NCT00563706|10899833|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
6886437|NCT00563706|10899834|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
6886438|NCT00563706|10899835|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1
6886439|NCT00563706|10899836|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
6886440|NCT00563706|10899828|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0
6886441|NCT00563706|10899829|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0
6886442|NCT00563706|10899830|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0
6886443|NCT00563706|10899831|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0
6886444|NCT00563706|10899832|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0
6886445|NCT00563706|10899833|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0
6886446|NCT00563706|10899834|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0
6886447|NCT00563706|10899835|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1
6886448|NCT00563706|10899836|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2
6886449|NCT00563784|10899856|FG000|Overall Study|Withdrawal by Subject|2
6886450|NCT00563784|10899856|FG000|Overall Study|Screen Failures|20
6886451|NCT00563797|10899862|FG000|Overall Study|Lost to Follow-up|7
6886452|NCT00563797|10899863|FG001|Overall Study|Lost to Follow-up|2
6886453|NCT00564018|10899874|FG000|Overall Study|Withdrawal by Subject|2
6886454|NCT00564018|10899875|FG001|Overall Study|Withdrawal by Subject|3
6886455|NCT00564018|10899876|FG002|Overall Study|Withdrawal by Subject|1
6886456|NCT00564070|10899886|FG000|Overall Study|Lost to Follow-up|9
6886457|NCT00564070|10899887|FG001|Overall Study|Lost to Follow-up|7
6886458|NCT00564070|10899886|FG000|Overall Study|Worsening depression, referred to care|3
6886459|NCT00564070|10899887|FG001|Overall Study|Worsening depression, referred to care|0
6886460|NCT00564278|10899899|FG000|Overall Study|Lost to Follow-up|35
6886461|NCT00564278|10899900|FG001|Overall Study|Lost to Follow-up|33
6886462|NCT00564278|10899899|FG000|Overall Study|Physician Decision|1
6886463|NCT00564278|10899900|FG001|Overall Study|Physician Decision|2
6886464|NCT00564278|10899899|FG000|Overall Study|Withdrawal by Subject|11
6886465|NCT00564278|10899900|FG001|Overall Study|Withdrawal by Subject|7
6886466|NCT00564395|10899906|FG000|First Intervention (10 Days)|Withdrawal by Subject|1
6886467|NCT00564395|10899907|FG001|First Intervention (10 Days)|Withdrawal by Subject|0
6886468|NCT00564395|10899906|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1
6886469|NCT00564395|10899907|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2
6886470|NCT00564486|10899949|FG000|Overall Study|Adverse Event|0
6886471|NCT00564486|10899950|FG001|Overall Study|Adverse Event|1
6886472|NCT00564486|10899951|FG002|Overall Study|Adverse Event|0
6886473|NCT00564486|10899952|FG003|Overall Study|Adverse Event|0
6886474|NCT00564486|10899949|FG000|Overall Study|Withdrawal by Subject|4
6886475|NCT00564486|10899950|FG001|Overall Study|Withdrawal by Subject|0
6886476|NCT00564486|10899951|FG002|Overall Study|Withdrawal by Subject|0
6886477|NCT00564486|10899952|FG003|Overall Study|Withdrawal by Subject|5
6886478|NCT00564486|10899949|FG000|Overall Study|Subject refused to have blood drawn|0
6886479|NCT00564486|10899950|FG001|Overall Study|Subject refused to have blood drawn|0
6886480|NCT00564486|10899951|FG002|Overall Study|Subject refused to have blood drawn|1
6886481|NCT00564486|10899952|FG003|Overall Study|Subject refused to have blood drawn|0
6886482|NCT00564486|10899949|FG000|Overall Study|Lost to Follow-up|3
6886483|NCT00564486|10899950|FG001|Overall Study|Lost to Follow-up|0
6886484|NCT00564486|10899951|FG002|Overall Study|Lost to Follow-up|2
6886485|NCT00564486|10899952|FG003|Overall Study|Lost to Follow-up|2
6886486|NCT00564629|10899968|FG000|Overall Study|Vomited within 2 hours of receiving drug|15
6886487|NCT00564629|10899969|FG001|Overall Study|Vomited within 2 hours of receiving drug|9
6886488|NCT00564733|10899991|FG000|Overall Study|Withdrawal by Subject|4
6886489|NCT00564733|10899991|FG000|Overall Study|Ineligible|5
6886490|NCT00564850|10899995|FG000|Overall Study|Protocol Violation|2
6886491|NCT00564889|10899999|FG000|Overall Study|Death|7
6886492|NCT00564889|10899999|FG000|Overall Study|Adverse Event|12
6886493|NCT00564889|10899999|FG000|Overall Study|Alternative treatment|3
6886494|NCT00564889|10899999|FG000|Overall Study|Disease progression|3
6886495|NCT00564889|10899999|FG000|Overall Study|Other, not specified|4
6886496|NCT00564902|10900006|FG000|Overall Study|Withdrawal by Subject|0
6886497|NCT00564902|10900007|FG001|Overall Study|Withdrawal by Subject|3
6886498|NCT00564902|10900008|FG002|Overall Study|Withdrawal by Subject|4
6886499|NCT00564902|10900006|FG000|Overall Study|Death|1
6886500|NCT00564902|10900007|FG001|Overall Study|Death|1
6886501|NCT00564902|10900008|FG002|Overall Study|Death|0
6886502|NCT00565058|10900036|FG000|Overall Study|Adverse Event|1
6886503|NCT00565058|10900037|FG001|Overall Study|Adverse Event|0
6886504|NCT00565136|10900062|FG000|Overall Study|Lost to Follow-up|1
6886505|NCT00565136|10900062|FG000|Overall Study|Withdrawal by Subject|1
6886506|NCT00565136|10900062|FG000|Overall Study|Protocol Violation|1
6886507|NCT00565409|10900078|FG000|Period 1 Open Label|Adverse Event|17
6886508|NCT00565409|10900079|FG001|Period 1 Open Label|Adverse Event|0
6886509|NCT00565409|10900080|FG002|Period 1 Open Label|Adverse Event|0
6886510|NCT00565409|10900081|FG003|Period 1 Open Label|Adverse Event|0
6886511|NCT00565409|10900078|FG000|Period 1 Open Label|Death|2
6886512|NCT00565409|10900079|FG001|Period 1 Open Label|Death|0
6886513|NCT00565409|10900080|FG002|Period 1 Open Label|Death|0
6886514|NCT00565409|10900081|FG003|Period 1 Open Label|Death|0
6886515|NCT00565409|10900078|FG000|Period 1 Open Label|Lost to Follow-up|1
6886516|NCT00565409|10900079|FG001|Period 1 Open Label|Lost to Follow-up|0
6886517|NCT00565409|10900080|FG002|Period 1 Open Label|Lost to Follow-up|0
6886518|NCT00565409|10900081|FG003|Period 1 Open Label|Lost to Follow-up|0
6886519|NCT00565409|10900078|FG000|Period 1 Open Label|Other|21
6886520|NCT00565409|10900079|FG001|Period 1 Open Label|Other|0
6886521|NCT00565409|10900080|FG002|Period 1 Open Label|Other|0
6886522|NCT00565409|10900081|FG003|Period 1 Open Label|Other|0
6886523|NCT00565409|10900078|FG000|Period 1 Open Label|Protocol Violation|14
6886524|NCT00565409|10900079|FG001|Period 1 Open Label|Protocol Violation|0
6886525|NCT00565409|10900080|FG002|Period 1 Open Label|Protocol Violation|0
6886526|NCT00565409|10900081|FG003|Period 1 Open Label|Protocol Violation|0
6886527|NCT00565409|10900078|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22
6886528|NCT00565409|10900079|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
6886529|NCT00565409|10900080|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
6886530|NCT00565409|10900081|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
6886531|NCT00565409|10900078|FG000|Period 1 Open Label|no conclusion of participation record|1
6886532|NCT00565409|10900079|FG001|Period 1 Open Label|no conclusion of participation record|0
6886533|NCT00565409|10900080|FG002|Period 1 Open Label|no conclusion of participation record|0
6886534|NCT00565409|10900081|FG003|Period 1 Open Label|no conclusion of participation record|0
6886535|NCT00565409|10900078|FG000|After Period 1, Prior to Period 2|did not meet criteria|152
6886536|NCT00565409|10900079|FG001|After Period 1, Prior to Period 2|did not meet criteria|0
6886537|NCT00565409|10900080|FG002|After Period 1, Prior to Period 2|did not meet criteria|0
6886538|NCT00565409|10900081|FG003|After Period 1, Prior to Period 2|did not meet criteria|0
6969963|NCT01152190|11019884|FG001|Overall Study|Adverse Event|4
6969964|NCT01152190|11019883|FG000|Overall Study|Death|1
6969965|NCT01152190|11019884|FG001|Overall Study|Death|0
6969966|NCT01152190|11019883|FG000|Overall Study|Protocol Violation|1
6969967|NCT01152190|11019884|FG001|Overall Study|Protocol Violation|1
6969968|NCT01152190|11019883|FG000|Overall Study|Withdrawal by Subject|1
6886539|NCT00565409|10900078|FG000|Period 2 Double-Blind|Adverse Event|0
6886540|NCT00565409|10900079|FG001|Period 2 Double-Blind|Adverse Event|7
6886541|NCT00565409|10900080|FG002|Period 2 Double-Blind|Adverse Event|4
6886542|NCT00565409|10900081|FG003|Period 2 Double-Blind|Adverse Event|5
6886543|NCT00565409|10900078|FG000|Period 2 Double-Blind|Death|0
6886544|NCT00565409|10900079|FG001|Period 2 Double-Blind|Death|2
6886545|NCT00565409|10900080|FG002|Period 2 Double-Blind|Death|0
6886546|NCT00565409|10900081|FG003|Period 2 Double-Blind|Death|0
6886547|NCT00565409|10900078|FG000|Period 2 Double-Blind|Protocol Violation|0
6886548|NCT00565409|10900079|FG001|Period 2 Double-Blind|Protocol Violation|4
6886549|NCT00565409|10900080|FG002|Period 2 Double-Blind|Protocol Violation|6
6886550|NCT00565409|10900081|FG003|Period 2 Double-Blind|Protocol Violation|2
6886551|NCT00565409|10900078|FG000|Period 2 Double-Blind|Lost to Follow-up|0
6886552|NCT00565409|10900079|FG001|Period 2 Double-Blind|Lost to Follow-up|0
6886553|NCT00565409|10900080|FG002|Period 2 Double-Blind|Lost to Follow-up|1
6886554|NCT00565409|10900081|FG003|Period 2 Double-Blind|Lost to Follow-up|0
6886555|NCT00565409|10900078|FG000|Period 2 Double-Blind|Other|0
6886556|NCT00565409|10900079|FG001|Period 2 Double-Blind|Other|4
6886557|NCT00565409|10900080|FG002|Period 2 Double-Blind|Other|5
6886558|NCT00565409|10900081|FG003|Period 2 Double-Blind|Other|9
6886559|NCT00565409|10900078|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0
6886560|NCT00565409|10900079|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4
6886561|NCT00565409|10900080|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11
6886562|NCT00565409|10900081|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43
6886563|NCT00565448|10900093|FG000|Overall Study|Adverse Event|1
6886564|NCT00565448|10900094|FG001|Overall Study|Adverse Event|2
6886565|NCT00565448|10900093|FG000|Overall Study|Disease progression|1
6886566|NCT00565448|10900094|FG001|Overall Study|Disease progression|0
6886567|NCT00565448|10900093|FG000|Overall Study|Withdrawal by Subject|1
6886568|NCT00565448|10900094|FG001|Overall Study|Withdrawal by Subject|0
6886569|NCT00565604|10900103|FG000|Overall Study|Failure to treat|2
6886570|NCT00565604|10900103|FG000|Overall Study|Lost to Follow-up|2
6886571|NCT00565721|10900126|FG000|Overall Study|Screen Failure|2
6886572|NCT00565721|10900126|FG000|Overall Study|Lost to Follow-up|6
6886573|NCT00565721|10900126|FG000|Overall Study|Technical Problems|1
6886574|NCT00565721|10900126|FG000|Overall Study|Physician Decision|2
6886575|NCT00565721|10900126|FG000|Overall Study|Other reasons|6
6886576|NCT00565747|10900147|FG000|Overall Study|No embryo transfer|67
6969969|NCT01152190|11019884|FG001|Overall Study|Withdrawal by Subject|3
6969970|NCT01152385|11019921|FG000|Overall Study|Withdrawal by Subject|3
6969971|NCT01152385|11019922|FG001|Overall Study|Withdrawal by Subject|1
6886577|NCT00565747|10900148|FG001|Overall Study|No embryo transfer|73
6886578|NCT00565773|10900154|FG000|Overall Study|Withdrawal by Subject|1
6886579|NCT00565773|10900154|FG000|Overall Study|Physician Decision|1
6886580|NCT00565812|10900161|FG000|Overall Study|Death|2
6886581|NCT00565812|10900162|FG001|Overall Study|Death|1
6886582|NCT00565812|10900163|FG002|Overall Study|Death|3
6886583|NCT00565812|10900161|FG000|Overall Study|Did not Meet Entrance Criteria|1
6886584|NCT00565812|10900162|FG001|Overall Study|Did not Meet Entrance Criteria|0
6886585|NCT00565812|10900163|FG002|Overall Study|Did not Meet Entrance Criteria|1
6886586|NCT00565812|10900161|FG000|Overall Study|Lost to Follow-up|10
6886587|NCT00565812|10900162|FG001|Overall Study|Lost to Follow-up|8
6886588|NCT00565812|10900163|FG002|Overall Study|Lost to Follow-up|8
6886589|NCT00565812|10900161|FG000|Overall Study|Withdrawal by Subject|58
6886590|NCT00565812|10900162|FG001|Overall Study|Withdrawal by Subject|47
6886591|NCT00565812|10900163|FG002|Overall Study|Withdrawal by Subject|48
6886592|NCT00565812|10900161|FG000|Overall Study|Work Schedule|5
6886593|NCT00565812|10900162|FG001|Overall Study|Work Schedule|3
6886594|NCT00565812|10900163|FG002|Overall Study|Work Schedule|1
6886595|NCT00565812|10900161|FG000|Overall Study|Protocol Violation|2
6886596|NCT00565812|10900162|FG001|Overall Study|Protocol Violation|6
6886597|NCT00565812|10900163|FG002|Overall Study|Protocol Violation|4
6886598|NCT00565812|10900161|FG000|Overall Study|Adverse Event|41
6886599|NCT00565812|10900162|FG001|Overall Study|Adverse Event|54
6886600|NCT00565812|10900163|FG002|Overall Study|Adverse Event|40
6886601|NCT00565812|10900161|FG000|Overall Study|Jury Duty|1
6886602|NCT00565812|10900162|FG001|Overall Study|Jury Duty|0
6886603|NCT00565812|10900163|FG002|Overall Study|Jury Duty|0
6886604|NCT00565812|10900161|FG000|Overall Study|Relocated Out of Area|5
6886605|NCT00565812|10900162|FG001|Overall Study|Relocated Out of Area|8
6886606|NCT00565812|10900163|FG002|Overall Study|Relocated Out of Area|9
6886607|NCT00565812|10900161|FG000|Overall Study|Sponsor Decision|1
6886608|NCT00565812|10900162|FG001|Overall Study|Sponsor Decision|5
6886609|NCT00565812|10900163|FG002|Overall Study|Sponsor Decision|1
6886610|NCT00565812|10900161|FG000|Overall Study|Domestic Reasons|7
6886611|NCT00565812|10900162|FG001|Overall Study|Domestic Reasons|1
6886612|NCT00565812|10900163|FG002|Overall Study|Domestic Reasons|3
6886613|NCT00565812|10900161|FG000|Overall Study|Research Site Closure|6
6886614|NCT00565812|10900162|FG001|Overall Study|Research Site Closure|1
6886615|NCT00565812|10900163|FG002|Overall Study|Research Site Closure|8
6886616|NCT00565812|10900161|FG000|Overall Study|Surgical Intervention|0
6886617|NCT00565812|10900162|FG001|Overall Study|Surgical Intervention|1
6886618|NCT00565812|10900163|FG002|Overall Study|Surgical Intervention|2
6886619|NCT00565812|10900161|FG000|Overall Study|Low Compliance|1
6886620|NCT00565812|10900162|FG001|Overall Study|Low Compliance|0
6886621|NCT00565812|10900163|FG002|Overall Study|Low Compliance|1
6886622|NCT00565812|10900161|FG000|Overall Study|Follow-up Visit Not Completed|2
6886623|NCT00565812|10900162|FG001|Overall Study|Follow-up Visit Not Completed|0
6886624|NCT00565812|10900163|FG002|Overall Study|Follow-up Visit Not Completed|1
6886625|NCT00565812|10900161|FG000|Overall Study|Physician Decision|2
6886626|NCT00565812|10900162|FG001|Overall Study|Physician Decision|0
6886627|NCT00565812|10900163|FG002|Overall Study|Physician Decision|0
6886628|NCT00566020|10900195|FG000|6-week Dosage Adjustment Phase|Adverse Event|5
6886629|NCT00566020|10900196|FG001|6-week Dosage Adjustment Phase|Adverse Event|0
6886630|NCT00566020|10900195|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2
6886631|NCT00566020|10900196|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0
6886632|NCT00566020|10900195|FG000|46-week Long-term Administration Phase|Adverse Event|0
6886633|NCT00566020|10900196|FG001|46-week Long-term Administration Phase|Adverse Event|7
6886634|NCT00566020|10900195|FG000|46-week Long-term Administration Phase|Physician Decision|0
6886635|NCT00566020|10900196|FG001|46-week Long-term Administration Phase|Physician Decision|7
6886636|NCT00566020|10900195|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0
6969972|NCT01152385|11019923|FG002|Overall Study|Withdrawal by Subject|1
6969973|NCT01152385|11019924|FG003|Overall Study|Withdrawal by Subject|1
6969974|NCT01152385|11019921|FG000|Overall Study|Protocol Violation|0
6969975|NCT01152385|11019922|FG001|Overall Study|Protocol Violation|0
6969976|NCT01152385|11019923|FG002|Overall Study|Protocol Violation|0
6969977|NCT01152385|11019924|FG003|Overall Study|Protocol Violation|1
6969978|NCT01152385|11019921|FG000|Overall Study|Adverse Event|1
6969979|NCT01152385|11019922|FG001|Overall Study|Adverse Event|1
6969980|NCT01152385|11019923|FG002|Overall Study|Adverse Event|0
6969981|NCT01152385|11019924|FG003|Overall Study|Adverse Event|0
6969982|NCT01152385|11019921|FG000|Overall Study|Study-specific withdrawal criteria|1
6969983|NCT01152385|11019922|FG001|Overall Study|Study-specific withdrawal criteria|1
6969984|NCT01152385|11019923|FG002|Overall Study|Study-specific withdrawal criteria|2
6969985|NCT01152385|11019924|FG003|Overall Study|Study-specific withdrawal criteria|0
6969986|NCT01152385|11019921|FG000|Overall Study|Other|4
6969987|NCT01152385|11019922|FG001|Overall Study|Other|3
6969988|NCT01152385|11019923|FG002|Overall Study|Other|2
6969989|NCT01152385|11019924|FG003|Overall Study|Other|3
6969990|NCT01152437|11019941|FG000|Overall Study|Other Adverse Event|8
6969991|NCT01152437|11019942|FG001|Overall Study|Other Adverse Event|1
6886637|NCT00566020|10900196|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2
6886638|NCT00566020|10900195|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0
6886639|NCT00566020|10900196|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1
6886640|NCT00566098|10900201|FG000|Collection of MILs|Withdrawal by Subject|1
6886641|NCT00566098|10900201|FG000|Collection of MILs|Relapsed|1
6886642|NCT00566098|10900201|FG000|Generation of MILs Product|Relapsed|1
6886643|NCT00566098|10900201|FG000|Administration of ASCT+MILs|Death|10
6886644|NCT00566098|10900201|FG000|Administration of ASCT+MILs|Lack of Efficacy|8
6886645|NCT00566111|10900208|FG000|Overall Study|Adverse Event|0
6886646|NCT00566111|10900209|FG001|Overall Study|Adverse Event|2
6886647|NCT00566228|10900226|FG000|Overall Study|Withdrawal by Subject|1
6886648|NCT00566228|10900227|FG001|Overall Study|Withdrawal by Subject|0
6886649|NCT00566228|10900226|FG000|Overall Study|Attempt to mobilize stem cells failed|2
6886650|NCT00566228|10900227|FG001|Overall Study|Attempt to mobilize stem cells failed|2
6886651|NCT00566228|10900226|FG000|Overall Study|Unable to collect sufficient CD34 cells|3
6886652|NCT00566228|10900227|FG001|Overall Study|Unable to collect sufficient CD34 cells|2
6886653|NCT00566228|10900226|FG000|Overall Study|progressed before infusion could occur|0
6886654|NCT00566228|10900227|FG001|Overall Study|progressed before infusion could occur|1
6886655|NCT00566254|10900235|FG000|Overall Study|Adverse Event|3
6886656|NCT00566254|10900236|FG001|Overall Study|Adverse Event|1
6886657|NCT00566254|10900235|FG000|Overall Study|Protocol Violation|1
6886658|NCT00566254|10900236|FG001|Overall Study|Protocol Violation|3
6886659|NCT00566254|10900235|FG000|Overall Study|Withdrawal by Subject|1
6886660|NCT00566254|10900236|FG001|Overall Study|Withdrawal by Subject|2
6886661|NCT00566254|10900235|FG000|Overall Study|Lack of Efficacy|5
6886662|NCT00566254|10900236|FG001|Overall Study|Lack of Efficacy|6
6886663|NCT00566254|10900235|FG000|Overall Study|Other|0
6886664|NCT00566254|10900236|FG001|Overall Study|Other|2
6886665|NCT00566501|10900244|FG000|Overall Study|Adverse Event|68
6886666|NCT00566501|10900245|FG001|Overall Study|Adverse Event|59
6886667|NCT00566501|10900244|FG000|Overall Study|Medication Non-compliance|5
6886668|NCT00566501|10900245|FG001|Overall Study|Medication Non-compliance|0
6886669|NCT00566501|10900244|FG000|Overall Study|Protocol Violation|2
6886670|NCT00566501|10900245|FG001|Overall Study|Protocol Violation|2
6886671|NCT00566501|10900244|FG000|Overall Study|Request of Investigator or Sponsor|6
6886672|NCT00566501|10900245|FG001|Overall Study|Request of Investigator or Sponsor|7
6886673|NCT00566501|10900244|FG000|Overall Study|Withdrawal by Subject|33
6886674|NCT00566501|10900245|FG001|Overall Study|Withdrawal by Subject|30
6886675|NCT00566501|10900244|FG000|Overall Study|Lack of Efficacy|8
6886676|NCT00566501|10900245|FG001|Overall Study|Lack of Efficacy|3
6886677|NCT00566501|10900244|FG000|Overall Study|Other|25
6886678|NCT00566501|10900245|FG001|Overall Study|Other|21
6886679|NCT00566527|10900254|FG000|Overall Study|Reason not provided|3
6886680|NCT00566527|10900255|FG001|Overall Study|Reason not provided|11
6886681|NCT00566527|10900256|FG002|Overall Study|Reason not provided|10
6886682|NCT00566527|10900254|FG000|Overall Study|Adverse Event|2
6886683|NCT00566527|10900255|FG001|Overall Study|Adverse Event|0
6886684|NCT00566527|10900256|FG002|Overall Study|Adverse Event|1
6886685|NCT00566527|10900254|FG000|Overall Study|Physician Decision|3
6886686|NCT00566527|10900255|FG001|Overall Study|Physician Decision|8
6886687|NCT00566527|10900256|FG002|Overall Study|Physician Decision|20
6886688|NCT00566527|10900254|FG000|Overall Study|Lost to Follow-up|3
6886689|NCT00566527|10900255|FG001|Overall Study|Lost to Follow-up|4
6886690|NCT00566527|10900256|FG002|Overall Study|Lost to Follow-up|4
6886691|NCT00566527|10900254|FG000|Overall Study|Withdrawal by Subject|6
6886692|NCT00566527|10900255|FG001|Overall Study|Withdrawal by Subject|43
6886693|NCT00566527|10900256|FG002|Overall Study|Withdrawal by Subject|43
6886694|NCT00566631|10900279|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18
6886695|NCT00566631|10900279|FG000|Part 1: Core Treatment Phase|Physician Decision|1
6886696|NCT00566631|10900279|FG000|Part 1: Core Treatment Phase|Adverse Event|9
6886697|NCT00566631|10900279|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4
6886698|NCT00566631|10900279|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26
6886699|NCT00566631|10900279|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1
6886700|NCT00566631|10900279|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1
6886701|NCT00566631|10900279|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95
6886702|NCT00566631|10900279|FG000|Part 2: Extension Phase|Lack of Efficacy|25
6886703|NCT00566631|10900279|FG000|Part 2: Extension Phase|Withdrawal by Subject|34
6886704|NCT00566631|10900279|FG000|Part 2: Extension Phase|Adverse Event|11
6886705|NCT00566631|10900279|FG000|Part 2: Extension Phase|Lost to Follow-up|6
6886706|NCT00566631|10900279|FG000|Part 2: Extension Phase|Death|1
6886707|NCT00566631|10900279|FG000|Part 2: Extension Phase|Other|5
6886708|NCT00566696|10900283|FG000|Overall Study|Met Exclusion Criteria|2
6886709|NCT00566696|10900283|FG000|Overall Study|Muromonab not available|1
6886710|NCT00566696|10900283|FG000|Overall Study|Health Status Change|1
6886711|NCT00566696|10900283|FG000|Overall Study|Physician Decision|1
6886712|NCT00566696|10900283|FG000|Overall Study|Non-Patient Donors|37
6886713|NCT00566709|10900289|FG000|Overall Study|Protocol Violation|5
6886714|NCT00566709|10900290|FG001|Overall Study|Protocol Violation|0
6886715|NCT00566722|10900299|FG000|Overall Study|Adverse Event|0
6886716|NCT00566722|10900300|FG001|Overall Study|Adverse Event|1
6886717|NCT00566722|10900301|FG002|Overall Study|Adverse Event|0
6886718|NCT00566722|10900299|FG000|Overall Study|Withdrawal by Subject|0
6886719|NCT00566722|10900300|FG001|Overall Study|Withdrawal by Subject|0
6886720|NCT00566722|10900301|FG002|Overall Study|Withdrawal by Subject|1
6886721|NCT00566722|10900299|FG000|Overall Study|Lost to Follow-up|1
6886722|NCT00566722|10900300|FG001|Overall Study|Lost to Follow-up|1
6886723|NCT00566722|10900301|FG002|Overall Study|Lost to Follow-up|1
6886724|NCT00566722|10900299|FG000|Overall Study|Lack of Efficacy|1
6886725|NCT00566722|10900300|FG001|Overall Study|Lack of Efficacy|2
6886726|NCT00566722|10900301|FG002|Overall Study|Lack of Efficacy|4
6886727|NCT00566722|10900299|FG000|Overall Study|Did not meet exclusion criteria|0
6886728|NCT00566722|10900300|FG001|Overall Study|Did not meet exclusion criteria|0
6886729|NCT00566722|10900301|FG002|Overall Study|Did not meet exclusion criteria|2
6886730|NCT00566722|10900299|FG000|Overall Study|Serious adverse event|0
6886731|NCT00566722|10900300|FG001|Overall Study|Serious adverse event|1
6886732|NCT00566722|10900301|FG002|Overall Study|Serious adverse event|0
6886733|NCT00566722|10900299|FG000|Overall Study|Noncompliant with drug administration|0
6886734|NCT00566722|10900300|FG001|Overall Study|Noncompliant with drug administration|0
6886735|NCT00566722|10900301|FG002|Overall Study|Noncompliant with drug administration|1
6886736|NCT00566735|10900314|FG000|Overall Study|Withdrawal by Subject|0
6886737|NCT00566735|10900315|FG001|Overall Study|Withdrawal by Subject|1
6886738|NCT00566735|10900314|FG000|Overall Study|Refused neuropsychological testing|2
6886739|NCT00566735|10900315|FG001|Overall Study|Refused neuropsychological testing|5
6886740|NCT00566735|10900314|FG000|Overall Study|Switched into a manic episode|0
6886741|NCT00566735|10900315|FG001|Overall Study|Switched into a manic episode|1
6886742|NCT00566852|10900332|FG000|Overall Study|Protocol Violation|22
6886743|NCT00566852|10900333|FG001|Overall Study|Protocol Violation|24
6886744|NCT00566852|10900332|FG000|Overall Study|Death|95
6886745|NCT00566852|10900333|FG001|Overall Study|Death|78
6886746|NCT00566852|10900332|FG000|Overall Study|Withdrawal by Subject|30
6886747|NCT00566852|10900333|FG001|Overall Study|Withdrawal by Subject|25
6886748|NCT00566852|10900332|FG000|Overall Study|Patient refusal|37
6886749|NCT00566852|10900333|FG001|Overall Study|Patient refusal|37
6886750|NCT00566852|10900332|FG000|Overall Study|Not tested due to disability|6
6886751|NCT00566852|10900333|FG001|Overall Study|Not tested due to disability|12
6886752|NCT00566852|10900332|FG000|Overall Study|Missing reason not specified|1
6886753|NCT00566852|10900333|FG001|Overall Study|Missing reason not specified|2
6886754|NCT00566852|10900332|FG000|Overall Study|Missing reason not reported|16
6886755|NCT00566852|10900333|FG001|Overall Study|Missing reason not reported|20
6886756|NCT00566982|10900382|FG000|Overall Study|Adverse Event|6
6886757|NCT00566982|10900383|FG001|Overall Study|Adverse Event|48
6886758|NCT00566982|10900382|FG000|Overall Study|Withdrawal by Subject|1
6886759|NCT00566982|10900383|FG001|Overall Study|Withdrawal by Subject|14
6886760|NCT00566982|10900382|FG000|Overall Study|Protocol Violation|1
6886761|NCT00566982|10900383|FG001|Overall Study|Protocol Violation|4
6886762|NCT00566982|10900382|FG000|Overall Study|Lost to Follow-up|0
6886763|NCT00566982|10900383|FG001|Overall Study|Lost to Follow-up|1
6886764|NCT00566982|10900382|FG000|Overall Study|Other-family problems & doctor's request|0
6886765|NCT00566982|10900383|FG001|Overall Study|Other-family problems & doctor's request|2
6886766|NCT00567112|10900401|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0
6886767|NCT00567112|10900402|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1
6886768|NCT00567112|10900403|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0
6886769|NCT00567112|10900401|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2
6886770|NCT00567112|10900402|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0
6886771|NCT00567112|10900403|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0
6886772|NCT00567112|10900401|FG000|Washout Period 3 (3 Days)|Protocol Violation|1
6886773|NCT00567112|10900402|FG001|Washout Period 3 (3 Days)|Protocol Violation|0
6886774|NCT00567112|10900403|FG002|Washout Period 3 (3 Days)|Protocol Violation|0
6886775|NCT00567164|10900415|FG000|Overall Study|Withdrawal by Subject|171
6886776|NCT00567164|10900416|FG001|Overall Study|Withdrawal by Subject|21
6886777|NCT00567164|10900417|FG002|Overall Study|Withdrawal by Subject|17
6886778|NCT00567164|10900415|FG000|Overall Study|Protocol Violation|23
6886779|NCT00567164|10900416|FG001|Overall Study|Protocol Violation|4
6886780|NCT00567164|10900417|FG002|Overall Study|Protocol Violation|2
6886781|NCT00567164|10900415|FG000|Overall Study|Adverse Event|92
6886782|NCT00567164|10900416|FG001|Overall Study|Adverse Event|13
6886783|NCT00567164|10900417|FG002|Overall Study|Adverse Event|9
6886784|NCT00567164|10900415|FG000|Overall Study|Death|0
6886785|NCT00567164|10900416|FG001|Overall Study|Death|0
6886786|NCT00567164|10900417|FG002|Overall Study|Death|1
6886787|NCT00567164|10900415|FG000|Overall Study|Lost to Follow-up|202
6886788|NCT00567164|10900416|FG001|Overall Study|Lost to Follow-up|23
6886789|NCT00567164|10900417|FG002|Overall Study|Lost to Follow-up|21
6886790|NCT00567164|10900415|FG000|Overall Study|Pregnancy|20
6886791|NCT00567164|10900416|FG001|Overall Study|Pregnancy|4
6886792|NCT00567164|10900417|FG002|Overall Study|Pregnancy|6
6886793|NCT00567164|10900415|FG000|Overall Study|Primary Reason coded as 'Other'|37
6886794|NCT00567164|10900416|FG001|Overall Study|Primary Reason coded as 'Other'|8
6886795|NCT00567164|10900417|FG002|Overall Study|Primary Reason coded as 'Other'|16
6886796|NCT00567164|10900415|FG000|Overall Study|Missing|1
6886797|NCT00567164|10900416|FG001|Overall Study|Missing|0
6886798|NCT00567164|10900417|FG002|Overall Study|Missing|0
6886799|NCT00567190|10900431|FG000|Overall Study|Death|235
6886800|NCT00567190|10900432|FG001|Overall Study|Death|280
6886801|NCT00567190|10900431|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48
6886802|NCT00567190|10900432|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53
6886803|NCT00567255|10900458|FG000|Overall Study|Adverse Event|241
6886804|NCT00567255|10900459|FG001|Overall Study|Adverse Event|68
6886805|NCT00567255|10900458|FG000|Overall Study|Lost to Follow-up|77
6886806|NCT00567255|10900459|FG001|Overall Study|Lost to Follow-up|48
6886807|NCT00567255|10900458|FG000|Overall Study|Withdrawal by Subject|75
6886808|NCT00567255|10900459|FG001|Overall Study|Withdrawal by Subject|56
6886809|NCT00567255|10900458|FG000|Overall Study|Lack of Efficacy|19
6886810|NCT00567255|10900459|FG001|Overall Study|Lack of Efficacy|33
6886811|NCT00567255|10900458|FG000|Overall Study|Protocol Violation|20
6886812|NCT00567255|10900459|FG001|Overall Study|Protocol Violation|8
6886813|NCT00567255|10900458|FG000|Overall Study|Pregnancy|6
6886814|NCT00567255|10900459|FG001|Overall Study|Pregnancy|0
6886815|NCT00567255|10900458|FG000|Overall Study|Drug noncompliance,moved,other|25
6886816|NCT00567255|10900459|FG001|Overall Study|Drug noncompliance,moved,other|15
6886817|NCT00567268|10900465|FG000|Overall Study|Protocol Violation|7
6886818|NCT00567268|10900465|FG000|Overall Study|Lost to Follow-up|36
6886819|NCT00567268|10900465|FG000|Overall Study|No Visit After First Day of Treatment|2
6886820|NCT00567268|10900465|FG000|Overall Study|No Drug Administration|4
6886821|NCT00567268|10900465|FG000|Overall Study|"Safety Evaluation Not Assessable"|1
6886822|NCT00567359|10900522|FG000|Overall Study|Withdrawal by Subject|1
6886823|NCT00567398|10900528|FG000|Overall Study|Adverse Event|6
6886824|NCT00567398|10900529|FG001|Overall Study|Adverse Event|14
6886825|NCT00567398|10900528|FG000|Overall Study|Physician Decision|0
6886826|NCT00567398|10900529|FG001|Overall Study|Physician Decision|4
6886827|NCT00567398|10900528|FG000|Overall Study|Withdrawal by Subject|0
6886828|NCT00567398|10900529|FG001|Overall Study|Withdrawal by Subject|2
6886829|NCT00567398|10900528|FG000|Overall Study|Renal Transplantation|0
6886830|NCT00567398|10900529|FG001|Overall Study|Renal Transplantation|3
6886831|NCT00567398|10900528|FG000|Overall Study|Other|1
6886832|NCT00567398|10900529|FG001|Overall Study|Other|0
6886833|NCT00567476|10900537|FG000|Overall Study|Adverse Event|2
6886834|NCT00567476|10900538|FG001|Overall Study|Adverse Event|0
6886835|NCT00567476|10900537|FG000|Overall Study|Pregnancy|1
6886836|NCT00567476|10900538|FG001|Overall Study|Pregnancy|0
6886837|NCT00567476|10900537|FG000|Overall Study|Protocol Violation|4
6886838|NCT00567476|10900538|FG001|Overall Study|Protocol Violation|1
6886839|NCT00567476|10900537|FG000|Overall Study|Lost to Follow-up|0
6886840|NCT00567476|10900538|FG001|Overall Study|Lost to Follow-up|1
6886841|NCT00567476|10900537|FG000|Overall Study|Administrative issues|1
6886842|NCT00567476|10900538|FG001|Overall Study|Administrative issues|0
6886843|NCT00567476|10900537|FG000|Overall Study|Medical Decision|0
6886844|NCT00567476|10900538|FG001|Overall Study|Medical Decision|1
6886845|NCT00567476|10900537|FG000|Overall Study|Non-adherence to protocol|0
6886846|NCT00567476|10900538|FG001|Overall Study|Non-adherence to protocol|1
6886847|NCT00567489|10900546|FG000|Overall Study|Adverse Event|6
6886848|NCT00567489|10900547|FG001|Overall Study|Adverse Event|14
6886849|NCT00567489|10900546|FG000|Overall Study|Physician Decision|0
6886850|NCT00567489|10900547|FG001|Overall Study|Physician Decision|4
6886851|NCT00567489|10900546|FG000|Overall Study|Withdrawal by Subject|0
6886852|NCT00567489|10900547|FG001|Overall Study|Withdrawal by Subject|2
6886853|NCT00567489|10900546|FG000|Overall Study|Renal Transplantation|0
6886854|NCT00567489|10900547|FG001|Overall Study|Renal Transplantation|3
6886855|NCT00567489|10900546|FG000|Overall Study|Other|1
6886856|NCT00567489|10900547|FG001|Overall Study|Other|0
6886857|NCT00567502|10900557|FG000|Overall Study|Lost to Follow-up|91
6886858|NCT00567502|10900558|FG001|Overall Study|Lost to Follow-up|14
6886859|NCT00567502|10900559|FG002|Overall Study|Lost to Follow-up|351
6886860|NCT00567502|10900560|FG003|Overall Study|Lost to Follow-up|2
6886861|NCT00567502|10900557|FG000|Overall Study|Death|65
6886862|NCT00567502|10900558|FG001|Overall Study|Death|16
6886863|NCT00567502|10900559|FG002|Overall Study|Death|360
6886864|NCT00567502|10900560|FG003|Overall Study|Death|5
6886865|NCT00567502|10900557|FG000|Overall Study|Other|64
6886866|NCT00567502|10900558|FG001|Overall Study|Other|2
6886867|NCT00567502|10900559|FG002|Overall Study|Other|134
6886868|NCT00567502|10900560|FG003|Overall Study|Other|6
6886869|NCT00567502|10900557|FG000|Overall Study|Participant request|12
6886870|NCT00567502|10900558|FG001|Overall Study|Participant request|1
6886871|NCT00567502|10900559|FG002|Overall Study|Participant request|33
6886872|NCT00567502|10900560|FG003|Overall Study|Participant request|1
6886873|NCT00567502|10900557|FG000|Overall Study|Sponsor request|9
6886874|NCT00567502|10900558|FG001|Overall Study|Sponsor request|0
6886875|NCT00567502|10900559|FG002|Overall Study|Sponsor request|30
6886876|NCT00567502|10900560|FG003|Overall Study|Sponsor request|1
6886877|NCT00567502|10900557|FG000|Overall Study|Never Initiated Treatment|0
6886878|NCT00567502|10900558|FG001|Overall Study|Never Initiated Treatment|0
6886879|NCT00567502|10900559|FG002|Overall Study|Never Initiated Treatment|0
6886880|NCT00567502|10900560|FG003|Overall Study|Never Initiated Treatment|72
6886881|NCT00567541|10900583|FG000|Overall Study|Adverse Event|0
6886882|NCT00567541|10900584|FG001|Overall Study|Adverse Event|1
6886883|NCT00567593|10900590|FG000|Overall Study|Adverse Event|1
6886884|NCT00567593|10900590|FG000|Overall Study|Physician Decision|1
6886885|NCT00567879|10900621|FG000|Overall Study|Adverse Event|2
6886886|NCT00567879|10900622|FG001|Overall Study|Adverse Event|0
6886887|NCT00567879|10900623|FG002|Overall Study|Adverse Event|1
6886888|NCT00567879|10900624|FG003|Overall Study|Adverse Event|0
6886889|NCT00567879|10900625|FG004|Overall Study|Adverse Event|1
6886890|NCT00567879|10900626|FG005|Overall Study|Adverse Event|0
6886891|NCT00567879|10900621|FG000|Overall Study|Abnormal test procedure(s)|0
6886892|NCT00567879|10900622|FG001|Overall Study|Abnormal test procedure(s)|0
6886893|NCT00567879|10900623|FG002|Overall Study|Abnormal test procedure(s)|1
6886894|NCT00567879|10900624|FG003|Overall Study|Abnormal test procedure(s)|0
6886895|NCT00567879|10900625|FG004|Overall Study|Abnormal test procedure(s)|0
6886896|NCT00567879|10900626|FG005|Overall Study|Abnormal test procedure(s)|0
6886897|NCT00567879|10900621|FG000|Overall Study|Withdrawal by Subject|0
6886898|NCT00567879|10900622|FG001|Overall Study|Withdrawal by Subject|0
6886899|NCT00567879|10900623|FG002|Overall Study|Withdrawal by Subject|3
6886900|NCT00567879|10900624|FG003|Overall Study|Withdrawal by Subject|1
6886901|NCT00567879|10900625|FG004|Overall Study|Withdrawal by Subject|0
6886902|NCT00567879|10900626|FG005|Overall Study|Withdrawal by Subject|0
6886903|NCT00567879|10900621|FG000|Overall Study|New cancer therapy|0
6886904|NCT00567879|10900622|FG001|Overall Study|New cancer therapy|0
6886905|NCT00567879|10900623|FG002|Overall Study|New cancer therapy|1
6886906|NCT00567879|10900624|FG003|Overall Study|New cancer therapy|0
6886907|NCT00567879|10900625|FG004|Overall Study|New cancer therapy|0
6886908|NCT00567879|10900626|FG005|Overall Study|New cancer therapy|0
6886909|NCT00567879|10900621|FG000|Overall Study|Disease progression|5
6886910|NCT00567879|10900622|FG001|Overall Study|Disease progression|7
6886911|NCT00567879|10900623|FG002|Overall Study|Disease progression|15
6886912|NCT00567879|10900624|FG003|Overall Study|Disease progression|5
6886913|NCT00567879|10900625|FG004|Overall Study|Disease progression|11
6886914|NCT00567879|10900626|FG005|Overall Study|Disease progression|3
6886915|NCT00567892|10900646|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
6886916|NCT00567892|10900647|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
6886917|NCT00567892|10900648|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
6886918|NCT00567892|10900649|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4
6886919|NCT00567892|10900646|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
6886920|NCT00567892|10900647|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
6886921|NCT00567892|10900648|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
6886922|NCT00567892|10900649|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
6886923|NCT00567996|10900664|FG000|Overall Study|Adverse Event|18
6886924|NCT00567996|10900665|FG001|Overall Study|Adverse Event|16
6886925|NCT00567996|10900666|FG002|Overall Study|Adverse Event|13
6886926|NCT00567996|10900664|FG000|Overall Study|Protocol Deviation|9
6886927|NCT00567996|10900665|FG001|Overall Study|Protocol Deviation|11
6886928|NCT00567996|10900666|FG002|Overall Study|Protocol Deviation|13
6886929|NCT00567996|10900664|FG000|Overall Study|Withdrawal by Subject|8
6886930|NCT00567996|10900665|FG001|Overall Study|Withdrawal by Subject|12
6886931|NCT00567996|10900666|FG002|Overall Study|Withdrawal by Subject|22
6886932|NCT00567996|10900664|FG000|Overall Study|Abnormal Lab value(s)|2
6886933|NCT00567996|10900665|FG001|Overall Study|Abnormal Lab value(s)|1
6886934|NCT00567996|10900666|FG002|Overall Study|Abnormal Lab value(s)|2
6886935|NCT00567996|10900664|FG000|Overall Study|Abnormal test procedure result(s)|2
6886936|NCT00567996|10900665|FG001|Overall Study|Abnormal test procedure result(s)|1
6886937|NCT00567996|10900666|FG002|Overall Study|Abnormal test procedure result(s)|1
6886938|NCT00567996|10900664|FG000|Overall Study|Lost to Follow-up|2
6886939|NCT00567996|10900665|FG001|Overall Study|Lost to Follow-up|5
6886940|NCT00567996|10900666|FG002|Overall Study|Lost to Follow-up|2
6886941|NCT00567996|10900664|FG000|Overall Study|Unsatisfactory therapeutic effect|1
6886942|NCT00567996|10900665|FG001|Overall Study|Unsatisfactory therapeutic effect|2
6886943|NCT00567996|10900666|FG002|Overall Study|Unsatisfactory therapeutic effect|15
6886944|NCT00567996|10900664|FG000|Overall Study|Administrative problems|1
6886945|NCT00567996|10900665|FG001|Overall Study|Administrative problems|1
6886946|NCT00567996|10900666|FG002|Overall Study|Administrative problems|0
6886947|NCT00567996|10900664|FG000|Overall Study|Death|1
6886948|NCT00567996|10900665|FG001|Overall Study|Death|0
6886949|NCT00567996|10900666|FG002|Overall Study|Death|2
6886950|NCT00567996|10900664|FG000|Overall Study|Patient's inability to use the device|0
6886951|NCT00567996|10900665|FG001|Overall Study|Patient's inability to use the device|1
6886952|NCT00567996|10900666|FG002|Overall Study|Patient's inability to use the device|0
6886953|NCT00568061|10900690|FG000|Overall Study|Inclusion / exclusion criteria|5
6886954|NCT00568061|10900691|FG001|Overall Study|Inclusion / exclusion criteria|1
6886955|NCT00568061|10900690|FG000|Overall Study|Adverse Event|0
6886956|NCT00568061|10900691|FG001|Overall Study|Adverse Event|1
6886957|NCT00568126|10900709|FG000|Overall Study|Adverse Event|3
6886958|NCT00568126|10900710|FG001|Overall Study|Adverse Event|0
6886959|NCT00568126|10900709|FG000|Overall Study|Withdrawal by Subject|2
6886960|NCT00568126|10900710|FG001|Overall Study|Withdrawal by Subject|3
6886961|NCT00568126|10900709|FG000|Overall Study|Lost to Follow-up|4
6886962|NCT00568126|10900710|FG001|Overall Study|Lost to Follow-up|3
6886963|NCT00568126|10900709|FG000|Overall Study|Lack of Efficacy|0
6886964|NCT00568126|10900710|FG001|Overall Study|Lack of Efficacy|1
6886965|NCT00568126|10900709|FG000|Overall Study|Physician Decision|2
6886966|NCT00568126|10900710|FG001|Overall Study|Physician Decision|2
6886967|NCT00568321|10900719|FG000|Overall Study|Adverse Event|1
6886968|NCT00568321|10900720|FG001|Overall Study|Adverse Event|0
6886969|NCT00568321|10900721|FG002|Overall Study|Adverse Event|0
6886970|NCT00568321|10900719|FG000|Overall Study|Lack of Efficacy|8
6886971|NCT00568321|10900720|FG001|Overall Study|Lack of Efficacy|5
6886972|NCT00568321|10900721|FG002|Overall Study|Lack of Efficacy|6
6886973|NCT00568321|10900719|FG000|Overall Study|Lost to Follow-up|0
6886974|NCT00568321|10900720|FG001|Overall Study|Lost to Follow-up|0
6886975|NCT00568321|10900721|FG002|Overall Study|Lost to Follow-up|1
6886976|NCT00568321|10900719|FG000|Overall Study|Withdrawal by Subject|2
6886977|NCT00568321|10900720|FG001|Overall Study|Withdrawal by Subject|0
6886978|NCT00568321|10900721|FG002|Overall Study|Withdrawal by Subject|0
6886979|NCT00568321|10900719|FG000|Overall Study|Protocol Violation|0
6886980|NCT00568321|10900720|FG001|Overall Study|Protocol Violation|0
6886981|NCT00568321|10900721|FG002|Overall Study|Protocol Violation|1
6886982|NCT00568321|10900719|FG000|Overall Study|Randomized, not treated|2
6886983|NCT00568321|10900720|FG001|Overall Study|Randomized, not treated|0
6886984|NCT00568321|10900721|FG002|Overall Study|Randomized, not treated|1
6886985|NCT00568334|10900733|FG000|Overall Study|Withdrawal by Subject|0
6886986|NCT00568334|10900734|FG001|Overall Study|Withdrawal by Subject|1
6886987|NCT00568334|10900733|FG000|Overall Study|Lost to Follow-up|1
6886988|NCT00568334|10900734|FG001|Overall Study|Lost to Follow-up|0
6969992|NCT01152437|11019943|FG002|Overall Study|Other Adverse Event|7
6969993|NCT01152437|11019941|FG000|Overall Study|Not treated|0
6969994|NCT01152437|11019942|FG001|Overall Study|Not treated|1
6969995|NCT01152437|11019943|FG002|Overall Study|Not treated|2
6969996|NCT01152437|11019941|FG000|Overall Study|Progressive disease|27
6969997|NCT01152437|11019942|FG001|Overall Study|Progressive disease|13
6969998|NCT01152437|11019943|FG002|Overall Study|Progressive disease|32
6969999|NCT01152437|11019941|FG000|Overall Study|Refusal to continue taking trial medicat|1
6970000|NCT01152437|11019942|FG001|Overall Study|Refusal to continue taking trial medicat|0
6970001|NCT01152437|11019943|FG002|Overall Study|Refusal to continue taking trial medicat|2
6970002|NCT01152450|11019953|FG000|Period 1 (4 Weeks)|Adverse Event|0
6970003|NCT01152450|11019954|FG001|Period 1 (4 Weeks)|Adverse Event|0
6970004|NCT01152450|11019955|FG002|Period 1 (4 Weeks)|Adverse Event|0
6970005|NCT01152450|11019956|FG003|Period 1 (4 Weeks)|Adverse Event|0
6970006|NCT01152450|11019957|FG004|Period 1 (4 Weeks)|Adverse Event|1
6970007|NCT01152450|11019958|FG005|Period 1 (4 Weeks)|Adverse Event|1
6970008|NCT01152450|11019953|FG000|Period 1 (4 Weeks)|Protocol Violation|0
6970009|NCT01152450|11019954|FG001|Period 1 (4 Weeks)|Protocol Violation|0
6970010|NCT01152450|11019955|FG002|Period 1 (4 Weeks)|Protocol Violation|0
6970011|NCT01152450|11019956|FG003|Period 1 (4 Weeks)|Protocol Violation|0
6970012|NCT01152450|11019957|FG004|Period 1 (4 Weeks)|Protocol Violation|1
6970013|NCT01152450|11019958|FG005|Period 1 (4 Weeks)|Protocol Violation|0
6970014|NCT01152450|11019953|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0
6970015|NCT01152450|11019954|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1
6970016|NCT01152450|11019955|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1
6970017|NCT01152450|11019956|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0
6970018|NCT01152450|11019957|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0
6970019|NCT01152450|11019958|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0
6970020|NCT01152554|11019977|FG000|Overall Study|Withdrawal by Subject|73
6970021|NCT01152554|11019978|FG001|Overall Study|Withdrawal by Subject|28
6970022|NCT01152554|11019977|FG000|Overall Study|Eligiblity criteria not fulfilled|0
6970023|NCT01152554|11019978|FG001|Overall Study|Eligiblity criteria not fulfilled|1
6970024|NCT01152554|11019977|FG000|Overall Study|Adverse Event|67
6970025|NCT01152554|11019978|FG001|Overall Study|Adverse Event|14
6970026|NCT01152554|11019977|FG000|Overall Study|Severe non-compliance to protocol|36
6970027|NCT01152554|11019978|FG001|Overall Study|Severe non-compliance to protocol|14
6970028|NCT01152554|11019977|FG000|Overall Study|Condition under investigation worsened|5
6970029|NCT01152554|11019978|FG001|Overall Study|Condition under investigation worsened|2
6970030|NCT01152554|11019977|FG000|Overall Study|Lack of Efficacy|20
6970031|NCT01152554|11019978|FG001|Overall Study|Lack of Efficacy|3
6970032|NCT01152554|11019977|FG000|Overall Study|Study-specific withdrawal criteria|17
6970033|NCT01152554|11019978|FG001|Overall Study|Study-specific withdrawal criteria|8
6970034|NCT01152554|11019977|FG000|Overall Study|Lost to Follow-up|87
6970035|NCT01152554|11019978|FG001|Overall Study|Lost to Follow-up|32
6970036|NCT01152554|11019977|FG000|Overall Study|Other|28
6970037|NCT01152554|11019978|FG001|Overall Study|Other|8
6970038|NCT01152554|11019977|FG000|Overall Study|Death|1
6970039|NCT01152554|11019978|FG001|Overall Study|Death|1
6970040|NCT01152580|11019986|FG000|Overall Study|Withdrawal by Subject|0
6970041|NCT01152580|11019987|FG001|Overall Study|Withdrawal by Subject|1
6970042|NCT01152788|11019999|FG000|Overall Study|Withdrawal by Subject|0
6970043|NCT01152788|11020000|FG001|Overall Study|Withdrawal by Subject|3
6970044|NCT01152788|11019999|FG000|Overall Study|No treatment|0
6970045|NCT01152788|11020000|FG001|Overall Study|No treatment|1
6970046|NCT01152814|11020006|FG000|Overall Study|Lost to Follow-up|2
6970047|NCT01152996|11020010|FG000|Overall Study|Withdrawal by Subject|142
6970048|NCT01152996|11020010|FG000|Overall Study|Adverse Event|115
6970049|NCT01152996|11020010|FG000|Overall Study|Lost to Follow-up|112
6970050|NCT01152996|11020010|FG000|Overall Study|Lack of Efficacy|68
6970051|NCT01152996|11020010|FG000|Overall Study|Noncompliance|41
6970052|NCT01152996|11020010|FG000|Overall Study|Other|36
6970053|NCT01152996|11020010|FG000|Overall Study|Protocol Violation|22
6970054|NCT01152996|11020010|FG000|Overall Study|Elevated liver enzymes|1
6970055|NCT01153009|11020018|FG000|Overall Study|Adverse Event|4
6970056|NCT01153009|11020019|FG001|Overall Study|Adverse Event|14
6970057|NCT01153009|11020020|FG002|Overall Study|Adverse Event|14
6970058|NCT01153009|11020021|FG003|Overall Study|Adverse Event|10
6970059|NCT01153009|11020018|FG000|Overall Study|Lack of Efficacy|9
6970060|NCT01153009|11020019|FG001|Overall Study|Lack of Efficacy|0
6970061|NCT01153009|11020020|FG002|Overall Study|Lack of Efficacy|2
6970062|NCT01153009|11020021|FG003|Overall Study|Lack of Efficacy|1
6970063|NCT01153009|11020018|FG000|Overall Study|Noncompliance with Study Medication|1
6886989|NCT00568399|10900749|FG000|Overall Study|Death|2
6886990|NCT00568399|10900749|FG000|Overall Study|Adverse Event|5
6886991|NCT00568399|10900749|FG000|Overall Study|Withdrawal by Subject|8
6886992|NCT00568451|10900757|FG000|Overall Study|Disease Progression|0
6886993|NCT00568451|10900758|FG001|Overall Study|Disease Progression|0
6886994|NCT00568451|10900759|FG002|Overall Study|Disease Progression|2
6886995|NCT00568451|10900760|FG003|Overall Study|Disease Progression|7
6886996|NCT00568555|10900773|FG000|Overall Study|Withdrawal by Subject|1
6886997|NCT00568555|10900774|FG001|Overall Study|Withdrawal by Subject|1
6886998|NCT00568685|10900794|FG000|Overall Study|Adverse Event|2
6886999|NCT00568685|10900795|FG001|Overall Study|Adverse Event|3
6887000|NCT00568685|10900796|FG002|Overall Study|Adverse Event|3
6887001|NCT00568685|10900794|FG000|Overall Study|Withdrawal by Subject|7
6887002|NCT00568685|10900795|FG001|Overall Study|Withdrawal by Subject|2
6887003|NCT00568685|10900796|FG002|Overall Study|Withdrawal by Subject|2
6887004|NCT00568685|10900794|FG000|Overall Study|Protocol Violation|1
6887005|NCT00568685|10900795|FG001|Overall Study|Protocol Violation|0
6887006|NCT00568685|10900796|FG002|Overall Study|Protocol Violation|0
6887007|NCT00568776|10900812|FG000|Overall Study|Adverse Event|8
6887008|NCT00568776|10900813|FG001|Overall Study|Adverse Event|8
6887009|NCT00568776|10900814|FG002|Overall Study|Adverse Event|10
6887010|NCT00568776|10900815|FG003|Overall Study|Adverse Event|8
6887011|NCT00568776|10900812|FG000|Overall Study|Death|0
6887012|NCT00568776|10900813|FG001|Overall Study|Death|1
6887013|NCT00568776|10900814|FG002|Overall Study|Death|4
6887014|NCT00568776|10900815|FG003|Overall Study|Death|3
6887015|NCT00568776|10900812|FG000|Overall Study|Physician Decision|0
6887016|NCT00568776|10900813|FG001|Overall Study|Physician Decision|2
6887017|NCT00568776|10900814|FG002|Overall Study|Physician Decision|0
6887018|NCT00568776|10900815|FG003|Overall Study|Physician Decision|0
6887019|NCT00568776|10900812|FG000|Overall Study|Lack of Efficacy|2
6887020|NCT00568776|10900813|FG001|Overall Study|Lack of Efficacy|2
6887021|NCT00568776|10900814|FG002|Overall Study|Lack of Efficacy|2
6887022|NCT00568776|10900815|FG003|Overall Study|Lack of Efficacy|4
6887023|NCT00568776|10900812|FG000|Overall Study|Lost to Follow-up|1
6887024|NCT00568776|10900813|FG001|Overall Study|Lost to Follow-up|1
6887025|NCT00568776|10900814|FG002|Overall Study|Lost to Follow-up|1
6887026|NCT00568776|10900815|FG003|Overall Study|Lost to Follow-up|1
6887027|NCT00568776|10900812|FG000|Overall Study|Protocol Violation|1
6887028|NCT00568776|10900813|FG001|Overall Study|Protocol Violation|0
6887029|NCT00568776|10900814|FG002|Overall Study|Protocol Violation|1
6887030|NCT00568776|10900815|FG003|Overall Study|Protocol Violation|1
6887031|NCT00568776|10900812|FG000|Overall Study|Withdrawal by Subject|13
6887032|NCT00568776|10900813|FG001|Overall Study|Withdrawal by Subject|15
6887033|NCT00568776|10900814|FG002|Overall Study|Withdrawal by Subject|13
6887034|NCT00568776|10900815|FG003|Overall Study|Withdrawal by Subject|7
6887035|NCT00568776|10900812|FG000|Overall Study|Loss of Caregiver|0
6887036|NCT00568776|10900813|FG001|Overall Study|Loss of Caregiver|2
6887037|NCT00568776|10900814|FG002|Overall Study|Loss of Caregiver|1
6887038|NCT00568776|10900815|FG003|Overall Study|Loss of Caregiver|2
6887039|NCT00568776|10900812|FG000|Overall Study|Sponsor Decision|2
6887040|NCT00568776|10900813|FG001|Overall Study|Sponsor Decision|2
6887041|NCT00568776|10900814|FG002|Overall Study|Sponsor Decision|41
6887042|NCT00568776|10900815|FG003|Overall Study|Sponsor Decision|42
6887043|NCT00568776|10900812|FG000|Overall Study|Miscellaeneous|3
6887044|NCT00568776|10900813|FG001|Overall Study|Miscellaeneous|3
6887045|NCT00568776|10900814|FG002|Overall Study|Miscellaeneous|1
6887046|NCT00568776|10900815|FG003|Overall Study|Miscellaeneous|4
6970064|NCT01153009|11020019|FG001|Overall Study|Noncompliance with Study Medication|3
6970065|NCT01153009|11020020|FG002|Overall Study|Noncompliance with Study Medication|4
6970066|NCT01153009|11020021|FG003|Overall Study|Noncompliance with Study Medication|1
6970067|NCT01153009|11020018|FG000|Overall Study|Protocol Deviations|4
6970068|NCT01153009|11020019|FG001|Overall Study|Protocol Deviations|3
6970069|NCT01153009|11020020|FG002|Overall Study|Protocol Deviations|3
6970070|NCT01153009|11020021|FG003|Overall Study|Protocol Deviations|2
6970071|NCT01153009|11020018|FG000|Overall Study|Withdrawal of Consent|5
6970072|NCT01153009|11020019|FG001|Overall Study|Withdrawal of Consent|5
6970073|NCT01153009|11020020|FG002|Overall Study|Withdrawal of Consent|4
6970074|NCT01153009|11020021|FG003|Overall Study|Withdrawal of Consent|6
6970075|NCT01153009|11020018|FG000|Overall Study|Lost to Follow-up|8
6970076|NCT01153009|11020019|FG001|Overall Study|Lost to Follow-up|8
6970077|NCT01153009|11020020|FG002|Overall Study|Lost to Follow-up|11
6970078|NCT01153009|11020021|FG003|Overall Study|Lost to Follow-up|15
6970079|NCT01153009|11020018|FG000|Overall Study|Other|1
6970080|NCT01153009|11020019|FG001|Overall Study|Other|1
6970081|NCT01153009|11020020|FG002|Overall Study|Other|3
6970082|NCT01153009|11020021|FG003|Overall Study|Other|2
6970083|NCT01153269|11020031|FG000|Overall Study|Withdrawal by Subject|1
6970084|NCT01153269|11020031|FG000|Overall Study|Antiretroviral therapy break|1
6970085|NCT01153321|11020040|FG000|Overall Study|Development of study withdrawal criteria|0
6970086|NCT01153321|11020041|FG001|Overall Study|Development of study withdrawal criteria|1
6970087|NCT01153321|11020040|FG000|Overall Study|Withdrawal by Subject|0
6970088|NCT01153321|11020041|FG001|Overall Study|Withdrawal by Subject|1
6970089|NCT01153321|11020040|FG000|Overall Study|Adverse Event|1
6970090|NCT01153321|11020041|FG001|Overall Study|Adverse Event|1
6977001|NCT01203930|11029960|FG001|Overall Study|Withdrew Consent|10
6887047|NCT04274192|10900827|FG000|Overall Study|Protocol Violation|1
6887048|NCT04274192|10900828|FG001|Overall Study|Protocol Violation|0
6887049|NCT04110314|10900846|FG000|Overall Study|Did not meet inclusion criteria|35255
6887050|NCT04110314|10900847|FG001|Overall Study|Did not meet inclusion criteria|35104
6887051|NCT04110314|10900848|FG002|Overall Study|Did not meet inclusion criteria|35636
6887052|NCT04110314|10900849|FG003|Overall Study|Did not meet inclusion criteria|35135
6887053|NCT04110314|10900850|FG004|Overall Study|Did not meet inclusion criteria|35247
6887054|NCT04110314|10900851|FG005|Overall Study|Did not meet inclusion criteria|35727
6887055|NCT04086472|10900868|FG000|Overall Study|Lost to Follow-up|1
6887056|NCT04086472|10900869|FG001|Overall Study|Lost to Follow-up|0
6887057|NCT04086472|10900870|FG002|Overall Study|Lost to Follow-up|0
6887058|NCT04086472|10900871|FG003|Overall Study|Lost to Follow-up|0
6887059|NCT04086472|10900872|FG004|Overall Study|Lost to Follow-up|1
6887060|NCT04086472|10900868|FG000|Overall Study|Physician Decision|0
6887061|NCT04086472|10900869|FG001|Overall Study|Physician Decision|1
6887062|NCT04086472|10900870|FG002|Overall Study|Physician Decision|1
6887063|NCT04086472|10900871|FG003|Overall Study|Physician Decision|0
6887064|NCT04086472|10900872|FG004|Overall Study|Physician Decision|0
6887065|NCT04086472|10900868|FG000|Overall Study|Withdrawal by Subject|1
6887066|NCT04086472|10900869|FG001|Overall Study|Withdrawal by Subject|1
6887067|NCT04086472|10900870|FG002|Overall Study|Withdrawal by Subject|1
6887068|NCT04086472|10900871|FG003|Overall Study|Withdrawal by Subject|0
6887069|NCT04086472|10900872|FG004|Overall Study|Withdrawal by Subject|0
6887070|NCT04086472|10900868|FG000|Overall Study|Various reasons|2
6887071|NCT04086472|10900869|FG001|Overall Study|Various reasons|0
6887072|NCT04086472|10900870|FG002|Overall Study|Various reasons|0
6887073|NCT04086472|10900871|FG003|Overall Study|Various reasons|3
6887074|NCT04086472|10900872|FG004|Overall Study|Various reasons|1
6887075|NCT03961204|10900893|FG000|Overall Study|Withdrawal by Subject|2
6887076|NCT03961204|10900893|FG000|Overall Study|Lost to Follow-up|3
6887077|NCT03961204|10900893|FG000|Overall Study|Other|1
6887078|NCT03961204|10900893|FG000|Overall Study|Missing|1
6887079|NCT03895840|10900897|FG000|Overall Study|Withdrawal by Subject|21
6887080|NCT03818399|10900901|FG000|Overall Study|Lost to Follow-up|11
6887081|NCT03818399|10900901|FG000|Overall Study|Withdrawal by Subject|1
6887082|NCT03818399|10900901|FG000|Overall Study|Protocol Violation|2
6887083|NCT03603496|10900907|FG000|Overall Study|Death|19
6887084|NCT03603496|10900908|FG001|Overall Study|Death|24
6887085|NCT03603496|10900907|FG000|Overall Study|Lost to Follow-up|141
6887086|NCT03603496|10900908|FG001|Overall Study|Lost to Follow-up|141
6887087|NCT03603496|10900907|FG000|Overall Study|Withdrawal by Subject|26
6887088|NCT03603496|10900908|FG001|Overall Study|Withdrawal by Subject|20
6887089|NCT03480802|10900916|FG000|Overall Study|Lost to Follow-up|5
6887090|NCT03480802|10900917|FG001|Overall Study|Lost to Follow-up|1
6887091|NCT03480802|10900916|FG000|Overall Study|Withdrawal by Subject|2
6887092|NCT03480802|10900917|FG001|Overall Study|Withdrawal by Subject|1
6887093|NCT03480802|10900916|FG000|Overall Study|Relocated|0
6887094|NCT03480802|10900917|FG001|Overall Study|Relocated|1
6887095|NCT03472521|10900927|FG000|Overall Study|Lost to Follow-up|3
6887096|NCT03472521|10900928|FG001|Overall Study|Lost to Follow-up|2
6887097|NCT03472521|10900927|FG000|Overall Study|Discontinued intervention|3
6887098|NCT03472521|10900928|FG001|Overall Study|Discontinued intervention|1
6887099|NCT02664441|10900959|FG000|Randomization|Withdrawal by Subject|0
6887100|NCT02664441|10900960|FG001|Randomization|Withdrawal by Subject|1
6887101|NCT02664441|10900959|FG000|36-week Randomized Trial|Adverse Event|2
6887102|NCT02664441|10900960|FG001|36-week Randomized Trial|Adverse Event|0
6887103|NCT02664441|10900959|FG000|36-week Randomized Trial|Lost to Follow-up|1
6887104|NCT02664441|10900960|FG001|36-week Randomized Trial|Lost to Follow-up|0
6887105|NCT02664441|10900959|FG000|36-week Randomized Trial|Withdrawal by Subject|0
6887106|NCT02664441|10900960|FG001|36-week Randomized Trial|Withdrawal by Subject|3
6887107|NCT02664441|10900959|FG000|18-week Open Label Extension|Adverse Event|1
6887108|NCT02664441|10900960|FG001|18-week Open Label Extension|Adverse Event|0
6887109|NCT02664441|10900959|FG000|18-week Open Label Extension|Physician Decision|1
6887110|NCT02664441|10900960|FG001|18-week Open Label Extension|Physician Decision|0
6887111|NCT02664441|10900959|FG000|18-week Open Label Extension|Death|1
6887112|NCT02664441|10900960|FG001|18-week Open Label Extension|Death|0
6887113|NCT02664441|10900959|FG000|18-week Open Label Extension|Lost to Follow-up|0
6887114|NCT02664441|10900960|FG001|18-week Open Label Extension|Lost to Follow-up|1
6887115|NCT02513472|10900980|FG000|Overall Study|Radiological Disease Progression|45
6887116|NCT02513472|10900981|FG001|Overall Study|Radiological Disease Progression|57
6887117|NCT02513472|10900980|FG000|Overall Study|Clinical Disease Progression|5
6887118|NCT02513472|10900981|FG001|Overall Study|Clinical Disease Progression|13
6887119|NCT02513472|10900980|FG000|Overall Study|Adverse Event|8
6887120|NCT02513472|10900981|FG001|Overall Study|Adverse Event|11
6887121|NCT02513472|10900980|FG000|Overall Study|Withdrawal by Subject|0
6887122|NCT02513472|10900981|FG001|Overall Study|Withdrawal by Subject|4
6887123|NCT02513472|10900980|FG000|Overall Study|Subject Choice|2
6887124|NCT02513472|10900981|FG001|Overall Study|Subject Choice|7
6887125|NCT02513472|10900980|FG000|Overall Study|Treatment Completed as per Protocol|3
6887126|NCT02513472|10900981|FG001|Overall Study|Treatment Completed as per Protocol|3
6887127|NCT02513472|10900980|FG000|Overall Study|Other|3
6887128|NCT02513472|10900981|FG001|Overall Study|Other|6
6887129|NCT01559935|10901020|FG000|Car Phase|Toxicity|4
6887130|NCT01559935|10901020|FG000|Car Phase|Death|1
6887131|NCT01559935|10901020|FG000|Car Phase|Lack of Efficacy|2
6887132|NCT01559935|10901020|FG000|Car Phase|Lost to Follow-up|1
6887133|NCT01559935|10901020|FG000|Car Phase|Physician Decision|1
6887134|NCT01559935|10901020|FG000|Car Phase|Withdrawal by Subject|2
6887135|NCT01559935|10901020|FG000|Car Phase|Per protocol|1
6887136|NCT01559935|10901020|FG000|Car Phase|Insurance|1
6887137|NCT01559935|10901020|FG000|Car Phase|non-compliance|1
6887138|NCT01559935|10901020|FG000|BiRD Phase|Toxicity|1
6887139|NCT01559935|10901020|FG000|BiRD Phase|Lack of Efficacy|1
6887140|NCT01559935|10901020|FG000|BiRD Phase|Withdrawal by Subject|2
6887141|NCT01559935|10901020|FG000|Maintenance Phase|Remains on study|28
6887142|NCT01559935|10901020|FG000|Maintenance Phase|Toxicity|1
6887143|NCT01559935|10901020|FG000|Maintenance Phase|Lack of Efficacy|18
6887144|NCT01559935|10901020|FG000|Maintenance Phase|Withdrawal by Subject|5
6887145|NCT01559935|10901020|FG000|Maintenance Phase|Non-compliance|2
6887146|NCT01067144|10901035|FG000|Treatment|Did not receive allocated intervention|4
6887147|NCT01067144|10901036|FG001|Treatment|Did not receive allocated intervention|7
6887148|NCT01067144|10901035|FG000|Follow-up|Lost to Follow-up|22
6887149|NCT01067144|10901036|FG001|Follow-up|Lost to Follow-up|12
6887150|NCT01067144|10901035|FG000|Follow-up|Censored owing to second surgery|19
6887151|NCT01067144|10901036|FG001|Follow-up|Censored owing to second surgery|28
6887152|NCT01067144|10901035|FG000|Follow-up|Withdrawal by Subject|18
6887153|NCT01067144|10901036|FG001|Follow-up|Withdrawal by Subject|14
6887154|NCT01067144|10901035|FG000|Follow-up|Surgery cancelled|0
6887155|NCT01067144|10901036|FG001|Follow-up|Surgery cancelled|1
6887156|NCT01067144|10901035|FG000|Follow-up|Death|0
6887157|NCT01067144|10901036|FG001|Follow-up|Death|1
6887158|NCT00600483|10901044|FG000|Overall Study|Lost to Follow-up|26
6887159|NCT00600483|10901045|FG001|Overall Study|Lost to Follow-up|47
6887160|NCT00600483|10901044|FG000|Overall Study|Randomized but not treated|10
6887161|NCT00600483|10901045|FG001|Overall Study|Randomized but not treated|0
6887162|NCT00568958|10901062|FG000|Allocation|Withdrawal by Subject|7
6970091|NCT01153347|11020051|FG000|Overall Study|Withdrawal by Subject|7
6970092|NCT01153347|11020052|FG001|Overall Study|Withdrawal by Subject|7
6970093|NCT01153347|11020053|FG002|Overall Study|Withdrawal by Subject|7
6970094|NCT01153347|11020054|FG003|Overall Study|Withdrawal by Subject|7
6970095|NCT01153347|11020051|FG000|Overall Study|Eligibility criteria not fulfilled|0
6970096|NCT01153347|11020052|FG001|Overall Study|Eligibility criteria not fulfilled|1
6970097|NCT01153347|11020053|FG002|Overall Study|Eligibility criteria not fulfilled|2
6970098|NCT01153347|11020054|FG003|Overall Study|Eligibility criteria not fulfilled|1
6970099|NCT01153347|11020051|FG000|Overall Study|Adverse Event|3
6970100|NCT01153347|11020052|FG001|Overall Study|Adverse Event|9
6970101|NCT01153347|11020053|FG002|Overall Study|Adverse Event|21
6970102|NCT01153347|11020054|FG003|Overall Study|Adverse Event|7
6970103|NCT01153347|11020051|FG000|Overall Study|Severe non-compliance to protocol|6
6970104|NCT01153347|11020052|FG001|Overall Study|Severe non-compliance to protocol|7
6970105|NCT01153347|11020053|FG002|Overall Study|Severe non-compliance to protocol|4
6970106|NCT01153347|11020054|FG003|Overall Study|Severe non-compliance to protocol|3
6970107|NCT01153347|11020051|FG000|Overall Study|Condition under investigation worsened|1
6970108|NCT01153347|11020052|FG001|Overall Study|Condition under investigation worsened|1
6970109|NCT01153347|11020053|FG002|Overall Study|Condition under investigation worsened|0
6970110|NCT01153347|11020054|FG003|Overall Study|Condition under investigation worsened|0
6970111|NCT01153347|11020051|FG000|Overall Study|Lack of Efficacy|2
6970112|NCT01153347|11020052|FG001|Overall Study|Lack of Efficacy|2
6970113|NCT01153347|11020053|FG002|Overall Study|Lack of Efficacy|0
6887163|NCT00568958|10901063|FG001|Allocation|Withdrawal by Subject|3
6887164|NCT00568958|10901062|FG000|Allocation|Physician Decision|2
6887165|NCT00568958|10901063|FG001|Allocation|Physician Decision|0
6887166|NCT00568958|10901062|FG000|Follow-Up|Withdrawal by Subject|6
6887167|NCT00568958|10901063|FG001|Follow-Up|Withdrawal by Subject|6
6887168|NCT00568958|10901062|FG000|Follow-Up|Physician Decision|1
6887169|NCT00568958|10901063|FG001|Follow-Up|Physician Decision|1
6887170|NCT00568958|10901062|FG000|Follow-Up|Family Emergency|1
6887171|NCT00568958|10901063|FG001|Follow-Up|Family Emergency|0
6887172|NCT00568958|10901062|FG000|Follow-Up|Adverse Event|1
6970114|NCT01153347|11020054|FG003|Overall Study|Lack of Efficacy|4
6970115|NCT01153347|11020051|FG000|Overall Study|Study-specific withdrawal criteria|4
6887173|NCT00568958|10901063|FG001|Follow-Up|Adverse Event|0
6887174|NCT00569166|10901089|FG000|Overall Study|Withdrawal by Subject|7
6887175|NCT00569166|10901090|FG001|Overall Study|Withdrawal by Subject|5
6887176|NCT00569166|10901091|FG002|Overall Study|Withdrawal by Subject|3
6887177|NCT00569166|10901089|FG000|Overall Study|Lost to Follow-up|2
6887178|NCT00569166|10901090|FG001|Overall Study|Lost to Follow-up|1
6887179|NCT00569166|10901091|FG002|Overall Study|Lost to Follow-up|1
6887180|NCT00569231|10901112|FG000|Overall Study|Study unrelated surgery|1
6887181|NCT00569231|10901112|FG000|Overall Study|Airfare expense|2
6887182|NCT00569231|10901112|FG000|Overall Study|Withdrawal by Subject|1
6887183|NCT00569231|10901112|FG000|Overall Study|Car accident injury|1
6887184|NCT00569231|10901112|FG000|Overall Study|Non-compliance|2
6887185|NCT00569270|10901116|FG000|Period: First Intervention|Protocol Violation|0
6887186|NCT00569270|10901117|FG001|Period: First Intervention|Protocol Violation|1
6887187|NCT00569374|10901136|FG000|Overall Study|Withdrawal by Subject|4
6887188|NCT00569582|10901149|FG000|Overall Study|Withdrawal by Subject|5
6887189|NCT00569582|10901149|FG000|Overall Study|Death|2
6887190|NCT00569582|10901149|FG000|Overall Study|Adverse Event|7
6887191|NCT00569582|10901149|FG000|Overall Study|Subject was too ill to travel.|1
6887192|NCT00569582|10901149|FG000|Overall Study|Subject was non-compliant.|1
6887193|NCT00569777|10901163|FG000|Overall Study|Withdrawal by Subject|4
6887194|NCT00569777|10901164|FG001|Overall Study|Withdrawal by Subject|0
6887195|NCT00569777|10901163|FG000|Overall Study|Adverse Event|3
6887196|NCT00569777|10901164|FG001|Overall Study|Adverse Event|0
6887197|NCT00569777|10901163|FG000|Overall Study|Lost to Follow-up|1
6887198|NCT00569777|10901164|FG001|Overall Study|Lost to Follow-up|0
6887199|NCT00569777|10901163|FG000|Overall Study|scheduled eye surgery|0
6887200|NCT00569777|10901164|FG001|Overall Study|scheduled eye surgery|1
6887201|NCT00569777|10901163|FG000|Overall Study|did not meet exclusion criteria|1
6887202|NCT00569777|10901164|FG001|Overall Study|did not meet exclusion criteria|2
6887203|NCT00569777|10901163|FG000|Overall Study|pregnant|1
6887204|NCT00569777|10901164|FG001|Overall Study|pregnant|0
6887205|NCT00569803|10901178|FG000|Overall Study|Lost to Follow-up|1
6887206|NCT00569803|10901179|FG001|Overall Study|Lost to Follow-up|0
6887207|NCT00569803|10901180|FG002|Overall Study|Lost to Follow-up|0
6887208|NCT00569803|10901181|FG003|Overall Study|Lost to Follow-up|0
6887209|NCT00569803|10901182|FG004|Overall Study|Lost to Follow-up|0
6887210|NCT00569803|10901183|FG005|Overall Study|Lost to Follow-up|0
6887211|NCT00569803|10901184|FG006|Overall Study|Lost to Follow-up|0
6887212|NCT00569803|10901185|FG007|Overall Study|Lost to Follow-up|0
6887213|NCT00569803|10901178|FG000|Overall Study|injection syringe leaked during dosing|0
6887214|NCT00569803|10901179|FG001|Overall Study|injection syringe leaked during dosing|0
6887215|NCT00569803|10901180|FG002|Overall Study|injection syringe leaked during dosing|0
6887216|NCT00569803|10901181|FG003|Overall Study|injection syringe leaked during dosing|1
6887217|NCT00569803|10901182|FG004|Overall Study|injection syringe leaked during dosing|0
6887218|NCT00569803|10901183|FG005|Overall Study|injection syringe leaked during dosing|0
6887219|NCT00569803|10901184|FG006|Overall Study|injection syringe leaked during dosing|0
6887220|NCT00569803|10901185|FG007|Overall Study|injection syringe leaked during dosing|0
6887221|NCT00569803|10901178|FG000|Overall Study|Withdrawal by Subject|0
6887222|NCT00569803|10901179|FG001|Overall Study|Withdrawal by Subject|0
6887223|NCT00569803|10901180|FG002|Overall Study|Withdrawal by Subject|0
6887224|NCT00569803|10901181|FG003|Overall Study|Withdrawal by Subject|0
6887225|NCT00569803|10901182|FG004|Overall Study|Withdrawal by Subject|0
6887226|NCT00569803|10901183|FG005|Overall Study|Withdrawal by Subject|0
6887227|NCT00569803|10901184|FG006|Overall Study|Withdrawal by Subject|0
6887228|NCT00569803|10901185|FG007|Overall Study|Withdrawal by Subject|1
6887229|NCT00569946|10901211|FG000|Overall Study|Adverse Event|16
6887230|NCT00569946|10901211|FG000|Overall Study|Objective Progression or Relapse|42
6887231|NCT00569946|10901211|FG000|Overall Study|Global Deterioration of Health Status|1
6887232|NCT00570037|10901217|FG000|Overall Study|Could not reach for 6-8 week contact|44
6887233|NCT00570037|10901218|FG001|Overall Study|Could not reach for 6-8 week contact|69
6887234|NCT00570063|10901226|FG000|Overall Study|Adverse Event|4
6887235|NCT00570063|10901227|FG001|Overall Study|Adverse Event|1
6887236|NCT00570063|10901226|FG000|Overall Study|Lack of Efficacy|0
6887237|NCT00570063|10901227|FG001|Overall Study|Lack of Efficacy|1
6887238|NCT00570063|10901226|FG000|Overall Study|Withdrawal by Subject|4
6887239|NCT00570063|10901227|FG001|Overall Study|Withdrawal by Subject|3
6887240|NCT00570063|10901226|FG000|Overall Study|Sponsor's Decision|7
6887241|NCT00570063|10901227|FG001|Overall Study|Sponsor's Decision|3
6887242|NCT00570128|10901244|FG000|Overall Study|Adverse Event|1
6887243|NCT00570128|10901245|FG001|Overall Study|Adverse Event|0
6887244|NCT00570128|10901244|FG000|Overall Study|Lost to Follow-up|1
6887245|NCT00570128|10901245|FG001|Overall Study|Lost to Follow-up|0
6887246|NCT00570128|10901244|FG000|Overall Study|Withdrawal by Subject|2
6887247|NCT00570128|10901245|FG001|Overall Study|Withdrawal by Subject|0
6887248|NCT00570141|10901251|FG000|Overall Study|Adverse Event|1
6887249|NCT00570141|10901251|FG000|Overall Study|Missed visits|1
6887250|NCT00570141|10901251|FG000|Overall Study|Lost to Follow-up|1
6887251|NCT00570232|10901255|FG000|Overall Study|Adverse Event|10
7155676|NCT03345472|11323743|FG000|Implant to 3 Months|Withdrawal by Subject|2
7155677|NCT03345472|11323743|FG000|Implant to 3 Months|Physician Decision|1
7155678|NCT03345472|11323743|FG000|Implant to 3 Months|Adverse Event|1
7155679|NCT03345472|11323743|FG000|3 Months to 12 Months|Physician Decision|3
7155680|NCT03345472|11323743|FG000|3 Months to 12 Months|Lost to Follow-up|2
6887252|NCT00570232|10901255|FG000|Overall Study|discontinued due to medical condition|3
6887253|NCT00570232|10901255|FG000|Overall Study|discontinued due to recurrence|8
6887254|NCT00570232|10901255|FG000|Overall Study|discontinued due to noncompliance|2
6887255|NCT00570310|10901261|FG000|Overall Study|Adverse Event|1
6887256|NCT00570310|10901262|FG001|Overall Study|Adverse Event|2
6887257|NCT00570310|10901261|FG000|Overall Study|Lack of Efficacy|1
6887258|NCT00570310|10901262|FG001|Overall Study|Lack of Efficacy|4
6887259|NCT00570323|10901270|FG000|Started Treatment After Randomization|Withdrawal by Subject|0
6887260|NCT00570323|10901271|FG001|Started Treatment After Randomization|Withdrawal by Subject|1
6887261|NCT00570323|10901270|FG000|Started Treatment After Randomization|Protocol Violation|1
6887262|NCT00570323|10901271|FG001|Started Treatment After Randomization|Protocol Violation|0
6887263|NCT00570323|10901270|FG000|Started Treatment After Randomization|Physician Decision|1
6887264|NCT00570323|10901271|FG001|Started Treatment After Randomization|Physician Decision|0
6887265|NCT00570323|10901270|FG000|Complete Study After Start|Lost to Follow-up|0
6887266|NCT00570323|10901271|FG001|Complete Study After Start|Lost to Follow-up|1
6887267|NCT00570323|10901270|FG000|Complete Study After Start|Withdrawal by Subject|2
6887268|NCT00570323|10901271|FG001|Complete Study After Start|Withdrawal by Subject|0
6887269|NCT00570323|10901270|FG000|Complete Study After Start|Physician Decision|1
6887270|NCT00570323|10901271|FG001|Complete Study After Start|Physician Decision|0
6887271|NCT00570401|10901301|FG000|Overall Study|Adverse Event|2
6887272|NCT00570492|10901307|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98
6887273|NCT00570492|10901308|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
6887274|NCT00570492|10901309|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
6887275|NCT00570492|10901307|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263
6887276|NCT00570492|10901308|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
6887277|NCT00570492|10901309|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
6887278|NCT00570492|10901307|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56
6887279|NCT00570492|10901308|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0
6887280|NCT00570492|10901309|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0
6887281|NCT00570492|10901307|FG000|16-week Single-blind Baseline Period|Protocol Violation|15
6887282|NCT00570492|10901308|FG001|16-week Single-blind Baseline Period|Protocol Violation|0
6887283|NCT00570492|10901309|FG002|16-week Single-blind Baseline Period|Protocol Violation|0
6887284|NCT00570492|10901307|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2
6887285|NCT00570492|10901308|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0
6887286|NCT00570492|10901309|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0
6887287|NCT00570492|10901307|FG000|16-week Single-blind Baseline Period|Adverse Event|1
6887288|NCT00570492|10901308|FG001|16-week Single-blind Baseline Period|Adverse Event|0
6887289|NCT00570492|10901309|FG002|16-week Single-blind Baseline Period|Adverse Event|0
6887290|NCT00570492|10901307|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1
6887291|NCT00570492|10901308|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
6887292|NCT00570492|10901309|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
6887293|NCT00570492|10901307|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0
6887294|NCT00570492|10901308|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20
6887295|NCT00570492|10901309|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20
6887296|NCT00570492|10901307|FG000|52-week Double-blind Treatment Period|Protocol Violation|0
6887297|NCT00570492|10901308|FG001|52-week Double-blind Treatment Period|Protocol Violation|12
6887298|NCT00570492|10901309|FG002|52-week Double-blind Treatment Period|Protocol Violation|15
6887299|NCT00570492|10901307|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0
6887300|NCT00570492|10901308|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5
6887301|NCT00570492|10901309|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7
6887302|NCT00570492|10901307|FG000|52-week Double-blind Treatment Period|Adverse Event|0
6887303|NCT00570492|10901308|FG001|52-week Double-blind Treatment Period|Adverse Event|5
6887304|NCT00570492|10901309|FG002|52-week Double-blind Treatment Period|Adverse Event|5
6887305|NCT00570492|10901307|FG000|52-week Double-blind Treatment Period|Physician Decision|0
6887306|NCT00570492|10901308|FG001|52-week Double-blind Treatment Period|Physician Decision|2
6887307|NCT00570492|10901309|FG002|52-week Double-blind Treatment Period|Physician Decision|4
6887308|NCT00570492|10901307|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0
6887309|NCT00570492|10901308|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3
6887310|NCT00570492|10901309|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0
6887311|NCT00570492|10901307|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
6887312|NCT00570492|10901308|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3
6887313|NCT00570492|10901309|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
6887314|NCT00570505|10901315|FG000|Overall Study|Adverse Event|7
6887315|NCT00570505|10901315|FG000|Overall Study|Withdrawal by Subject|7
6887316|NCT00570505|10901315|FG000|Overall Study|Lost to Follow-up|23
6887317|NCT00570505|10901315|FG000|Overall Study|Other loss to follow-up|4
6887318|NCT00570661|10901319|FG000|Overall Study|Disease worsening|5
6887319|NCT00570661|10901319|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1
6887320|NCT00570661|10901319|FG000|Overall Study|Adverse Event|1
6887321|NCT00570674|10901324|FG000|Overall Study|Withdrawal by Subject|0
6887322|NCT00570674|10901325|FG001|Overall Study|Withdrawal by Subject|0
6887323|NCT00570674|10901326|FG002|Overall Study|Withdrawal by Subject|1
6887324|NCT00570674|10901327|FG003|Overall Study|Withdrawal by Subject|0
6887325|NCT00570674|10901328|FG004|Overall Study|Withdrawal by Subject|0
6887326|NCT00570674|10901329|FG005|Overall Study|Withdrawal by Subject|0
6887327|NCT00570674|10901330|FG006|Overall Study|Withdrawal by Subject|0
6887328|NCT00570687|10901343|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6887329|NCT00570687|10901344|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6887330|NCT00570687|10901345|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6970116|NCT01153347|11020052|FG001|Overall Study|Study-specific withdrawal criteria|3
6887331|NCT00570687|10901346|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6887332|NCT00570687|10901347|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
6887333|NCT00570687|10901348|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
6887334|NCT00570687|10901349|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
6887335|NCT00570687|10901350|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
6887336|NCT00570687|10901351|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
6887337|NCT00570687|10901352|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
6887338|NCT00570687|10901343|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6887339|NCT00570687|10901344|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6887340|NCT00570687|10901345|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6887341|NCT00570687|10901346|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6887342|NCT00570687|10901347|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6887343|NCT00570687|10901348|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6887344|NCT00570687|10901349|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6887345|NCT00570687|10901350|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6887346|NCT00570687|10901351|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1
6887347|NCT00570687|10901352|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6887348|NCT00570687|10901343|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6887349|NCT00570687|10901344|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6887350|NCT00570687|10901345|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6887351|NCT00570687|10901346|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6887352|NCT00570687|10901347|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6887353|NCT00570687|10901348|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6887354|NCT00570687|10901349|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1
6887355|NCT00570687|10901350|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6887356|NCT00570687|10901351|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6887357|NCT00570687|10901352|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6887358|NCT00570713|10901372|FG000|Overall Study|Adverse Event|16
6887359|NCT00570713|10901373|FG001|Overall Study|Adverse Event|9
6887360|NCT00570713|10901372|FG000|Overall Study|Death|7
6887361|NCT00570713|10901373|FG001|Overall Study|Death|7
6887362|NCT00570713|10901372|FG000|Overall Study|Lack of Efficacy|40
6887363|NCT00570713|10901373|FG001|Overall Study|Lack of Efficacy|49
6887364|NCT00570713|10901372|FG000|Overall Study|Physician Decision|2
6887365|NCT00570713|10901373|FG001|Overall Study|Physician Decision|2
6887366|NCT00570713|10901372|FG000|Overall Study|Withdrawal by Subject|3
6970117|NCT01153347|11020053|FG002|Overall Study|Study-specific withdrawal criteria|1
6970118|NCT01153347|11020054|FG003|Overall Study|Study-specific withdrawal criteria|2
6970119|NCT01153347|11020051|FG000|Overall Study|Lost to Follow-up|4
6970120|NCT01153347|11020052|FG001|Overall Study|Lost to Follow-up|9
6970121|NCT01153347|11020053|FG002|Overall Study|Lost to Follow-up|11
6970122|NCT01153347|11020054|FG003|Overall Study|Lost to Follow-up|8
6970123|NCT01153347|11020051|FG000|Overall Study|Other|5
6970124|NCT01153347|11020052|FG001|Overall Study|Other|5
6970125|NCT01153347|11020053|FG002|Overall Study|Other|4
6970126|NCT01153347|11020054|FG003|Overall Study|Other|0
6970127|NCT01153347|11020051|FG000|Overall Study|Death|1
6970128|NCT01153347|11020052|FG001|Overall Study|Death|0
6970129|NCT01153347|11020053|FG002|Overall Study|Death|0
6970130|NCT01153347|11020054|FG003|Overall Study|Death|0
6970131|NCT01153425|11020066|FG000|Overall Study|Withdrawal by Subject|3
6970132|NCT01153425|11020067|FG001|Overall Study|Withdrawal by Subject|3
6970133|NCT01153516|11020089|FG000|Overall Study|Both subjects refused surgery|2
6970134|NCT01153516|11020090|FG001|Overall Study|Both subjects refused surgery|0
6970135|NCT01153633|11020117|FG000|Overall Study|Protocol Violation|1
6970136|NCT01153633|11020118|FG001|Overall Study|Protocol Violation|1
6970137|NCT01153633|11020117|FG000|Overall Study|Therapeutic failure|3
6970138|NCT01153633|11020118|FG001|Overall Study|Therapeutic failure|3
6970139|NCT01153698|11020139|FG000|Overall Study|Adverse Event|12
6970140|NCT01153698|11020139|FG000|Overall Study|Lost to Follow-up|4
6970141|NCT01153698|11020139|FG000|Overall Study|Withdrawal by Subject|2
6970142|NCT01153698|11020139|FG000|Overall Study|Switch to other anticoagulants|4
6970143|NCT01153698|11020139|FG000|Overall Study|Other|2
6970144|NCT01153698|11020139|FG000|Overall Study|Not treated with Pradaxa|5
6970145|NCT01153724|11020150|FG000|Treatment Period 1|Withdrawal by Subject|1
6970146|NCT01153724|11020150|FG000|Treatment Period 2|Adverse Event|1
6970147|NCT01153724|11020150|FG000|Treatment Period 2|Other reason not defined above|1
6970148|NCT01153763|11020156|FG000|Overall Study|Study Closed|16
6970149|NCT01153763|11020156|FG000|Overall Study|Lost to Follow-up|1
6970150|NCT01153763|11020156|FG000|Overall Study|Physician Decision|2
6970151|NCT01153763|11020156|FG000|Overall Study|Withdrawal by Subject|2
6970152|NCT01153815|11020162|FG000|Overall Study|Adverse Event|3
6970153|NCT01153815|11020163|FG001|Overall Study|Adverse Event|1
6970154|NCT01153815|11020162|FG000|Overall Study|Withdrawal by Subject|6
6970155|NCT01153815|11020163|FG001|Overall Study|Withdrawal by Subject|4
6970156|NCT01153841|11020171|FG000|Overall Study|Adverse Event|1
6970157|NCT01153841|11020172|FG001|Overall Study|Adverse Event|0
6970158|NCT01153841|11020171|FG000|Overall Study|Withdrawal by Subject|1
6970159|NCT01153841|11020172|FG001|Overall Study|Withdrawal by Subject|0
6887367|NCT00570713|10901373|FG001|Overall Study|Withdrawal by Subject|3
6970160|NCT01153841|11020171|FG000|Overall Study|Protocol Violation|2
7155681|NCT03345472|11323743|FG000|3 Months to 12 Months|Withdrawal by Subject|1
7155682|NCT03345472|11323743|FG000|3 Months to 12 Months|Adverse Event|1
7155683|NCT03345472|11323743|FG000|3 Months to 12 Months|Death|1
7155684|NCT03345914|11323750|FG000|Overall Study|Transition to another study at week 16|80
7155685|NCT03345914|11323751|FG001|Overall Study|Transition to another study at week 16|86
6887368|NCT00570713|10901372|FG000|Overall Study|Discontinuation of Study by the Sponsor|10
6887369|NCT00570713|10901373|FG001|Overall Study|Discontinuation of Study by the Sponsor|7
6887370|NCT00570739|10901383|FG000|Overall Study|Adverse Event|8
6887371|NCT00570739|10901384|FG001|Overall Study|Adverse Event|6
6887372|NCT00570739|10901385|FG002|Overall Study|Adverse Event|2
6887373|NCT00570739|10901386|FG003|Overall Study|Adverse Event|2
6887374|NCT00570739|10901383|FG000|Overall Study|Lost to Follow-up|4
6887375|NCT00570739|10901384|FG001|Overall Study|Lost to Follow-up|5
6887376|NCT00570739|10901385|FG002|Overall Study|Lost to Follow-up|4
6887377|NCT00570739|10901386|FG003|Overall Study|Lost to Follow-up|1
6887378|NCT00570739|10901383|FG000|Overall Study|Physician Decision|1
6887379|NCT00570739|10901384|FG001|Overall Study|Physician Decision|1
6887380|NCT00570739|10901385|FG002|Overall Study|Physician Decision|0
6887381|NCT00570739|10901386|FG003|Overall Study|Physician Decision|0
6887382|NCT00570739|10901383|FG000|Overall Study|Withdrawal by Subject|7
6887383|NCT00570739|10901384|FG001|Overall Study|Withdrawal by Subject|7
6887384|NCT00570739|10901385|FG002|Overall Study|Withdrawal by Subject|3
6887385|NCT00570739|10901386|FG003|Overall Study|Withdrawal by Subject|5
6887386|NCT00570739|10901383|FG000|Overall Study|Required restricted medication|0
6887387|NCT00570739|10901384|FG001|Overall Study|Required restricted medication|0
6887388|NCT00570739|10901385|FG002|Overall Study|Required restricted medication|1
6887389|NCT00570739|10901386|FG003|Overall Study|Required restricted medication|0
6887390|NCT00570739|10901383|FG000|Overall Study|Met discontinuation criteria|1
6887391|NCT00570739|10901384|FG001|Overall Study|Met discontinuation criteria|0
6887392|NCT00570739|10901385|FG002|Overall Study|Met discontinuation criteria|1
6887393|NCT00570739|10901386|FG003|Overall Study|Met discontinuation criteria|1
6887394|NCT00570739|10901383|FG000|Overall Study|Other|0
6887395|NCT00570739|10901384|FG001|Overall Study|Other|2
6887396|NCT00570739|10901385|FG002|Overall Study|Other|5
6887397|NCT00570739|10901386|FG003|Overall Study|Other|3
6970161|NCT01153841|11020172|FG001|Overall Study|Protocol Violation|0
6970162|NCT01153841|11020171|FG000|Overall Study|Lost to Follow-up|2
6970163|NCT01153841|11020172|FG001|Overall Study|Lost to Follow-up|0
6970164|NCT01153893|11020180|FG000|Overall Study|Adverse Event|1
6970165|NCT01153893|11020181|FG001|Overall Study|Adverse Event|0
6970166|NCT01153958|11020189|FG000|Overall Study|Study Terminated|36
6970167|NCT01153958|11020190|FG001|Overall Study|Study Terminated|32
6970168|NCT01153971|11020196|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2
6970169|NCT01153971|11020196|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1
6970170|NCT01153971|11020196|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2
6970171|NCT01153971|11020196|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1
6970172|NCT01153971|11020196|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1
6970173|NCT01153971|11020196|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1
6970174|NCT01153971|11020196|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2
6970175|NCT01153984|11020200|FG000|Overall Study|Withdrawal by Subject|1
6970176|NCT01153984|11020200|FG000|Overall Study|Adverse Event|1
6970177|NCT01154010|11020206|FG000|Overall Study|Lost to Follow-up|0
6970178|NCT01154010|11020207|FG001|Overall Study|Lost to Follow-up|1
6970179|NCT01154088|11020216|FG000|Overall Study|Lost to Follow-up|4
6970180|NCT01154088|11020217|FG001|Overall Study|Lost to Follow-up|6
6970181|NCT01154088|11020218|FG002|Overall Study|Lost to Follow-up|7
6970182|NCT01154101|11020232|FG000|Overall Study|Adverse Event|0
6970183|NCT01154101|11020233|FG001|Overall Study|Adverse Event|2
6970184|NCT01154101|11020234|FG002|Overall Study|Adverse Event|1
6970185|NCT01154101|11020235|FG003|Overall Study|Adverse Event|1
6970186|NCT01154101|11020236|FG004|Overall Study|Adverse Event|0
6970187|NCT01154101|11020232|FG000|Overall Study|Lost to Follow-up|0
6970188|NCT01154101|11020233|FG001|Overall Study|Lost to Follow-up|1
6970189|NCT01154101|11020234|FG002|Overall Study|Lost to Follow-up|0
6970190|NCT01154101|11020235|FG003|Overall Study|Lost to Follow-up|1
6970191|NCT01154101|11020236|FG004|Overall Study|Lost to Follow-up|0
6970192|NCT01154101|11020232|FG000|Overall Study|Withdrawal by Subject|0
6970193|NCT01154101|11020233|FG001|Overall Study|Withdrawal by Subject|1
6970194|NCT01154101|11020234|FG002|Overall Study|Withdrawal by Subject|2
6970195|NCT01154101|11020235|FG003|Overall Study|Withdrawal by Subject|0
6970196|NCT01154101|11020236|FG004|Overall Study|Withdrawal by Subject|1
6970197|NCT01154127|11020255|FG000|Period 1 (21 Days)|Adverse Event|3
6970198|NCT01154127|11020256|FG001|Period 1 (21 Days)|Adverse Event|4
6970199|NCT01154127|11020255|FG000|Period 1 (21 Days)|Withdrawal by Subject|0
7155686|NCT03345914|11323752|FG002|Overall Study|Transition to another study at week 16|78
6970200|NCT01154127|11020256|FG001|Period 1 (21 Days)|Withdrawal by Subject|2
6970201|NCT01154127|11020255|FG000|Washout (14 - 28 Days)|Adverse Event|2
6970202|NCT01154127|11020256|FG001|Washout (14 - 28 Days)|Adverse Event|0
6970203|NCT01154127|11020255|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1
6970204|NCT01154127|11020256|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0
6970205|NCT01154127|11020255|FG000|Period 2 (21 Days)|Protocol Deviation|0
6970206|NCT01154127|11020256|FG001|Period 2 (21 Days)|Protocol Deviation|1
6887398|NCT00570765|10901419|FG000|DB Phase|Withdrawal by Subject|1
6887399|NCT00570765|10901420|FG001|DB Phase|Withdrawal by Subject|0
6887400|NCT00570765|10901421|FG002|DB Phase|Withdrawal by Subject|0
6887401|NCT00570765|10901422|FG003|DB Phase|Withdrawal by Subject|0
6887402|NCT00570765|10901419|FG000|DB Phase|Protocol Violation|0
6887403|NCT00570765|10901420|FG001|DB Phase|Protocol Violation|1
6887404|NCT00570765|10901421|FG002|DB Phase|Protocol Violation|0
6887405|NCT00570765|10901422|FG003|DB Phase|Protocol Violation|0
6887406|NCT00570765|10901419|FG000|DB Phase|Adverse Event|3
6887407|NCT00570765|10901420|FG001|DB Phase|Adverse Event|6
6887408|NCT00570765|10901421|FG002|DB Phase|Adverse Event|0
6887409|NCT00570765|10901422|FG003|DB Phase|Adverse Event|0
6887410|NCT00570765|10901419|FG000|DB Phase|Did Not Receive Study Drug|0
6887411|NCT00570765|10901420|FG001|DB Phase|Did Not Receive Study Drug|0
6887412|NCT00570765|10901421|FG002|DB Phase|Did Not Receive Study Drug|1
6887413|NCT00570765|10901422|FG003|DB Phase|Did Not Receive Study Drug|0
6887414|NCT00570765|10901419|FG000|LTSE Phase|Withdrawal by Subject|0
6887415|NCT00570765|10901420|FG001|LTSE Phase|Withdrawal by Subject|0
6887416|NCT00570765|10901421|FG002|LTSE Phase|Withdrawal by Subject|0
6887417|NCT00570765|10901422|FG003|LTSE Phase|Withdrawal by Subject|1
6887418|NCT00570765|10901419|FG000|LTSE Phase|Adverse Event|0
6887419|NCT00570765|10901420|FG001|LTSE Phase|Adverse Event|0
6887420|NCT00570765|10901421|FG002|LTSE Phase|Adverse Event|0
6887421|NCT00570765|10901422|FG003|LTSE Phase|Adverse Event|7
6887422|NCT00570765|10901419|FG000|LTSE Phase|Physician Decision|0
6887423|NCT00570765|10901420|FG001|LTSE Phase|Physician Decision|0
6887424|NCT00570765|10901421|FG002|LTSE Phase|Physician Decision|0
6887425|NCT00570765|10901422|FG003|LTSE Phase|Physician Decision|4
6887426|NCT00570778|10901433|FG000|Overall Study|Protocol deviation|2
6887427|NCT00570778|10901434|FG001|Overall Study|Protocol deviation|1
6887428|NCT00570778|10901435|FG002|Overall Study|Protocol deviation|2
6887429|NCT00570778|10901436|FG003|Overall Study|Protocol deviation|2
6887430|NCT00570778|10901433|FG000|Overall Study|Adverse Event|0
6887431|NCT00570778|10901434|FG001|Overall Study|Adverse Event|1
6887432|NCT00570778|10901435|FG002|Overall Study|Adverse Event|4
6887433|NCT00570778|10901436|FG003|Overall Study|Adverse Event|1
6887434|NCT00570778|10901433|FG000|Overall Study|Subject withdrew consent|0
6887435|NCT00570778|10901434|FG001|Overall Study|Subject withdrew consent|1
6887436|NCT00570778|10901435|FG002|Overall Study|Subject withdrew consent|0
6887437|NCT00570778|10901436|FG003|Overall Study|Subject withdrew consent|1
6887438|NCT00570778|10901433|FG000|Overall Study|Abnormal test procedure|1
6887439|NCT00570778|10901434|FG001|Overall Study|Abnormal test procedure|0
6887440|NCT00570778|10901435|FG002|Overall Study|Abnormal test procedure|0
6887441|NCT00570778|10901436|FG003|Overall Study|Abnormal test procedure|0
6887442|NCT00570778|10901433|FG000|Overall Study|Unsatisfactory therapeutic effect|1
6887443|NCT00570778|10901434|FG001|Overall Study|Unsatisfactory therapeutic effect|0
6887444|NCT00570778|10901435|FG002|Overall Study|Unsatisfactory therapeutic effect|0
6887445|NCT00570778|10901436|FG003|Overall Study|Unsatisfactory therapeutic effect|0
6887446|NCT00570778|10901433|FG000|Overall Study|Lost to Follow-up|0
6887447|NCT00570778|10901434|FG001|Overall Study|Lost to Follow-up|0
6887448|NCT00570778|10901435|FG002|Overall Study|Lost to Follow-up|1
6887449|NCT00570778|10901436|FG003|Overall Study|Lost to Follow-up|0
6887450|NCT00570778|10901433|FG000|Overall Study|Subject no longer requires study drug|0
6887451|NCT00570778|10901434|FG001|Overall Study|Subject no longer requires study drug|1
6887452|NCT00570778|10901435|FG002|Overall Study|Subject no longer requires study drug|0
6887453|NCT00570778|10901436|FG003|Overall Study|Subject no longer requires study drug|0
6887454|NCT00570908|10901446|FG000|Overall Study|Adverse Event|5
6887455|NCT00570908|10901446|FG000|Overall Study|Withdrawal by Subject|2
6887456|NCT00570921|10901450|FG000|Overall Study|Protocol Violation|1
6887457|NCT00570921|10901450|FG000|Overall Study|Physician Decision|1
6887458|NCT00571038|10901465|FG000|Overall Study|Lost to Follow-up|1
6887459|NCT00571038|10901466|FG001|Overall Study|Lost to Follow-up|4
6887460|NCT00571038|10901465|FG000|Overall Study|Death|7
6887461|NCT00571038|10901466|FG001|Overall Study|Death|5
6887462|NCT00571038|10901465|FG000|Overall Study|Withdrawal by Subject|1
6887463|NCT00571038|10901466|FG001|Overall Study|Withdrawal by Subject|3
6887464|NCT00571038|10901465|FG000|Overall Study|Moved out of state|2
6887465|NCT00571038|10901466|FG001|Overall Study|Moved out of state|2
6887466|NCT00571064|10901472|FG000|Overall Study|Adverse Event|13
6887467|NCT00571064|10901472|FG000|Overall Study|Protocol Violation|4
6887468|NCT00571064|10901472|FG000|Overall Study|Withdrawal by Subject|2
6887469|NCT00571064|10901472|FG000|Overall Study|Other|2
6887470|NCT00571103|10901477|FG000|Overall Study|Withdrawal by Subject|1
6887471|NCT00571103|10901477|FG000|Overall Study|Lost to Follow-up|1
6887472|NCT00571519|10901529|FG000|Overall Study|Subject withdrew consent|0
6887473|NCT00571519|10901530|FG001|Overall Study|Subject withdrew consent|1
6887474|NCT00571519|10901531|FG002|Overall Study|Subject withdrew consent|0
6887475|NCT00571519|10901532|FG003|Overall Study|Subject withdrew consent|2
6887476|NCT00571519|10901533|FG004|Overall Study|Subject withdrew consent|1
6887477|NCT00571519|10901534|FG005|Overall Study|Subject withdrew consent|1
6887478|NCT00571519|10901535|FG006|Overall Study|Subject withdrew consent|2
6887479|NCT00571519|10901529|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1
6887480|NCT00571519|10901530|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0
6887481|NCT00571519|10901531|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1
6887482|NCT00571519|10901532|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1
6887483|NCT00571519|10901533|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0
6887484|NCT00571519|10901534|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0
6887485|NCT00571519|10901535|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0
6887486|NCT00571519|10901529|FG000|Overall Study|Therapeutic failure/lack of efficacy|0
6887487|NCT00571519|10901530|FG001|Overall Study|Therapeutic failure/lack of efficacy|1
6887488|NCT00571519|10901531|FG002|Overall Study|Therapeutic failure/lack of efficacy|0
6887489|NCT00571519|10901532|FG003|Overall Study|Therapeutic failure/lack of efficacy|0
6887490|NCT00571519|10901533|FG004|Overall Study|Therapeutic failure/lack of efficacy|0
6887491|NCT00571519|10901534|FG005|Overall Study|Therapeutic failure/lack of efficacy|0
6887492|NCT00571519|10901535|FG006|Overall Study|Therapeutic failure/lack of efficacy|0
6887493|NCT00571519|10901529|FG000|Overall Study|Termination of study by Sponsor|2
6887494|NCT00571519|10901530|FG001|Overall Study|Termination of study by Sponsor|7
6887495|NCT00571519|10901531|FG002|Overall Study|Termination of study by Sponsor|10
6887496|NCT00571519|10901532|FG003|Overall Study|Termination of study by Sponsor|24
6887497|NCT00571519|10901533|FG004|Overall Study|Termination of study by Sponsor|8
6887498|NCT00571519|10901534|FG005|Overall Study|Termination of study by Sponsor|9
6887499|NCT00571519|10901535|FG006|Overall Study|Termination of study by Sponsor|22
6887500|NCT00571519|10901529|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
6887501|NCT00571519|10901530|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
6887502|NCT00571519|10901531|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1
6887503|NCT00571519|10901532|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
6887504|NCT00571519|10901533|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
6887505|NCT00571519|10901534|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
6887506|NCT00571519|10901535|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
6887507|NCT00571649|10901553|FG000|Treatment Period|Adverse Event|438
6887508|NCT00571649|10901554|FG001|Treatment Period|Adverse Event|385
6887509|NCT00571649|10901553|FG000|Treatment Period|Clinical endpoint reached|50
6887510|NCT00571649|10901554|FG001|Treatment Period|Clinical endpoint reached|56
6887511|NCT00571649|10901553|FG000|Treatment Period|Withdrawal by Subject|285
6887512|NCT00571649|10901554|FG001|Treatment Period|Withdrawal by Subject|255
6887513|NCT00571649|10901553|FG000|Treatment Period|Death|76
6887514|NCT00571649|10901554|FG001|Treatment Period|Death|59
6887515|NCT00571649|10901553|FG000|Treatment Period|Physician Decision|8
6887516|NCT00571649|10901554|FG001|Treatment Period|Physician Decision|9
6887517|NCT00571649|10901553|FG000|Treatment Period|Lost to Follow-up|43
6887518|NCT00571649|10901554|FG001|Treatment Period|Lost to Follow-up|41
6887519|NCT00571649|10901553|FG000|Treatment Period|Non-compliant with study medication|88
6887520|NCT00571649|10901554|FG001|Treatment Period|Non-compliant with study medication|89
6887521|NCT00571649|10901553|FG000|Treatment Period|Patient convenience|11
6887522|NCT00571649|10901554|FG001|Treatment Period|Patient convenience|13
6887523|NCT00571649|10901553|FG000|Treatment Period|Protocol Violation|90
6887524|NCT00571649|10901554|FG001|Treatment Period|Protocol Violation|92
6887525|NCT00571649|10901553|FG000|Treatment Period|Technical problems|3
6887526|NCT00571649|10901554|FG001|Treatment Period|Technical problems|5
6887527|NCT00571649|10901553|FG000|Follow-up Period|Adverse Event|46
6887528|NCT00571649|10901554|FG001|Follow-up Period|Adverse Event|40
6887529|NCT00571649|10901553|FG000|Follow-up Period|Clinical endpoint reached|5
6887530|NCT00571649|10901554|FG001|Follow-up Period|Clinical endpoint reached|2
6887531|NCT00571649|10901553|FG000|Follow-up Period|Withdrawal by Subject|119
6887532|NCT00571649|10901554|FG001|Follow-up Period|Withdrawal by Subject|115
6887533|NCT00571649|10901553|FG000|Follow-up Period|Death|132
6887534|NCT00571649|10901554|FG001|Follow-up Period|Death|133
6887535|NCT00571649|10901553|FG000|Follow-up Period|Physician Decision|7
6887536|NCT00571649|10901554|FG001|Follow-up Period|Physician Decision|13
6887537|NCT00571649|10901553|FG000|Follow-up Period|Lost to Follow-up|95
6887538|NCT00571649|10901554|FG001|Follow-up Period|Lost to Follow-up|92
6887539|NCT00571649|10901553|FG000|Follow-up Period|Patient convenience|136
6887540|NCT00571649|10901554|FG001|Follow-up Period|Patient convenience|121
6887541|NCT00571649|10901553|FG000|Follow-up Period|Protocol Violation|5
6887542|NCT00571649|10901554|FG001|Follow-up Period|Protocol Violation|12
6887543|NCT00571662|10901560|FG000|Overall Study|Withdrawal by Subject|2
6887544|NCT00571662|10901560|FG000|Overall Study|psychiatric instability|1
6887545|NCT00571662|10901560|FG000|Overall Study|Adverse Event|5
6887546|NCT00571688|10901568|FG000|Overall Study|Lost to Follow-up|3
6887547|NCT00571688|10901569|FG001|Overall Study|Lost to Follow-up|6
7079177|NCT02110225|11187982|FG001|Overall Study|Lost to Follow-up|1
6887548|NCT00571688|10901568|FG000|Overall Study|subject did not tolerate Consta|1
6887549|NCT00571688|10901569|FG001|Overall Study|subject did not tolerate Consta|0
6887550|NCT00571688|10901568|FG000|Overall Study|subject moved out of the area|1
6887551|NCT00571688|10901569|FG001|Overall Study|subject moved out of the area|0
6887552|NCT00571701|10901577|FG000|First Intervention 12 Months|Withdrawal by Subject|2
6887553|NCT00571701|10901578|FG001|First Intervention 12 Months|Withdrawal by Subject|1
6887554|NCT00571701|10901577|FG000|First Intervention 12 Months|Death|1
6887555|NCT00571701|10901578|FG001|First Intervention 12 Months|Death|0
6887556|NCT00571701|10901577|FG000|Second Intervention 12 Months|Adverse Event|0
6887557|NCT00571701|10901578|FG001|Second Intervention 12 Months|Adverse Event|1
6887558|NCT00571701|10901577|FG000|Second Intervention 12 Months|Withdrawal by Subject|3
6887559|NCT00571701|10901578|FG001|Second Intervention 12 Months|Withdrawal by Subject|0
6887560|NCT00571948|10901604|FG000|Overall Study|Lost to Follow-up|2
6887561|NCT00571948|10901605|FG001|Overall Study|Lost to Follow-up|0
6887562|NCT00571948|10901604|FG000|Overall Study|Withdrawal by Subject|1
6887563|NCT00571948|10901605|FG001|Overall Study|Withdrawal by Subject|2
6887564|NCT00571948|10901604|FG000|Overall Study|Protocol Violation|3
6887565|NCT00571948|10901605|FG001|Overall Study|Protocol Violation|3
6887566|NCT00571948|10901604|FG000|Overall Study|infant refused study meal|3
6887567|NCT00571948|10901605|FG001|Overall Study|infant refused study meal|4
6887568|NCT00571948|10901604|FG000|Overall Study|Parent were afraid of blood colection|2
6887569|NCT00571948|10901605|FG001|Overall Study|Parent were afraid of blood colection|5
6887570|NCT00572039|10901631|FG000|Overall Study|Withdrawal by Subject|9
6887571|NCT00572039|10901632|FG001|Overall Study|Withdrawal by Subject|6
6887572|NCT00572039|10901631|FG000|Overall Study|Death|2
6887573|NCT00572039|10901632|FG001|Overall Study|Death|3
6887574|NCT00572039|10901631|FG000|Overall Study|Ill|5
6887575|NCT00572039|10901632|FG001|Overall Study|Ill|1
6887576|NCT00572156|10901655|FG000|Overall Study|Adverse Event|3
6887577|NCT00572156|10901656|FG001|Overall Study|Adverse Event|1
6887578|NCT00572156|10901657|FG002|Overall Study|Adverse Event|5
6887579|NCT00572156|10901658|FG003|Overall Study|Adverse Event|1
6887580|NCT00572156|10901655|FG000|Overall Study|Lost to Follow-up|1
6887581|NCT00572156|10901656|FG001|Overall Study|Lost to Follow-up|1
6887582|NCT00572156|10901657|FG002|Overall Study|Lost to Follow-up|1
6887583|NCT00572156|10901658|FG003|Overall Study|Lost to Follow-up|0
6887584|NCT00572156|10901655|FG000|Overall Study|Protocol Violation|1
6887585|NCT00572156|10901656|FG001|Overall Study|Protocol Violation|2
6887586|NCT00572156|10901657|FG002|Overall Study|Protocol Violation|0
6887587|NCT00572156|10901658|FG003|Overall Study|Protocol Violation|2
6887588|NCT00572156|10901655|FG000|Overall Study|Patient/Parent Decision|1
6887589|NCT00572156|10901656|FG001|Overall Study|Patient/Parent Decision|6
6887590|NCT00572156|10901657|FG002|Overall Study|Patient/Parent Decision|4
6887591|NCT00572156|10901658|FG003|Overall Study|Patient/Parent Decision|3
6887592|NCT00572156|10901655|FG000|Overall Study|Sponsor Decision|20
6887593|NCT00572156|10901656|FG001|Overall Study|Sponsor Decision|16
6887594|NCT00572156|10901657|FG002|Overall Study|Sponsor Decision|17
6887595|NCT00572156|10901658|FG003|Overall Study|Sponsor Decision|19
6887596|NCT00572195|10901668|FG000|Overall Study|Withdrawal by Subject|50
6887597|NCT00572195|10901668|FG000|Overall Study|Death|9
6887598|NCT00572195|10901668|FG000|Overall Study|Adverse Event|4
6887599|NCT00572195|10901668|FG000|Overall Study|Lost to Follow-up|5
6887600|NCT00572455|10901695|FG000|Stage I (14 Days)|Adverse Event|0
6887601|NCT00572455|10901696|FG001|Stage I (14 Days)|Adverse Event|0
6887602|NCT00572455|10901697|FG002|Stage I (14 Days)|Adverse Event|0
6887603|NCT00572455|10901698|FG003|Stage I (14 Days)|Adverse Event|0
6887604|NCT00572455|10901699|FG004|Stage I (14 Days)|Adverse Event|0
6887605|NCT00572455|10901700|FG005|Stage I (14 Days)|Adverse Event|3
6887606|NCT00572455|10901701|FG006|Stage I (14 Days)|Adverse Event|0
6887607|NCT00572455|10901702|FG007|Stage I (14 Days)|Adverse Event|0
6887608|NCT00572455|10901703|FG008|Stage I (14 Days)|Adverse Event|0
6887609|NCT00572455|10901704|FG009|Stage I (14 Days)|Adverse Event|0
6887610|NCT00572455|10901705|FG010|Stage I (14 Days)|Adverse Event|0
6887611|NCT00572455|10901706|FG011|Stage I (14 Days)|Adverse Event|0
6887612|NCT00572455|10901707|FG012|Stage I (14 Days)|Adverse Event|0
6887613|NCT00572455|10901708|FG013|Stage I (14 Days)|Adverse Event|0
6887614|NCT00572455|10901695|FG000|Stage I (14 Days)|Other|0
6887615|NCT00572455|10901696|FG001|Stage I (14 Days)|Other|0
6887616|NCT00572455|10901697|FG002|Stage I (14 Days)|Other|0
6887617|NCT00572455|10901698|FG003|Stage I (14 Days)|Other|0
6887618|NCT00572455|10901699|FG004|Stage I (14 Days)|Other|1
6887619|NCT00572455|10901700|FG005|Stage I (14 Days)|Other|0
6887620|NCT00572455|10901701|FG006|Stage I (14 Days)|Other|0
6887621|NCT00572455|10901702|FG007|Stage I (14 Days)|Other|0
6887622|NCT00572455|10901703|FG008|Stage I (14 Days)|Other|0
6887623|NCT00572455|10901704|FG009|Stage I (14 Days)|Other|0
6887624|NCT00572455|10901705|FG010|Stage I (14 Days)|Other|0
6887625|NCT00572455|10901706|FG011|Stage I (14 Days)|Other|0
6887626|NCT00572455|10901707|FG012|Stage I (14 Days)|Other|0
6887627|NCT00572455|10901708|FG013|Stage I (14 Days)|Other|0
6887628|NCT00572455|10901695|FG000|Stage II (28 Days)|Adverse Event|0
6887629|NCT00572455|10901696|FG001|Stage II (28 Days)|Adverse Event|0
6887630|NCT00572455|10901697|FG002|Stage II (28 Days)|Adverse Event|0
6887631|NCT00572455|10901698|FG003|Stage II (28 Days)|Adverse Event|0
6887632|NCT00572455|10901699|FG004|Stage II (28 Days)|Adverse Event|0
6887633|NCT00572455|10901700|FG005|Stage II (28 Days)|Adverse Event|0
6887634|NCT00572455|10901701|FG006|Stage II (28 Days)|Adverse Event|0
6887635|NCT00572455|10901702|FG007|Stage II (28 Days)|Adverse Event|0
6887636|NCT00572455|10901703|FG008|Stage II (28 Days)|Adverse Event|1
6887637|NCT00572455|10901704|FG009|Stage II (28 Days)|Adverse Event|3
6887638|NCT00572455|10901705|FG010|Stage II (28 Days)|Adverse Event|3
6887639|NCT00572455|10901706|FG011|Stage II (28 Days)|Adverse Event|4
6887640|NCT00572455|10901707|FG012|Stage II (28 Days)|Adverse Event|5
6887641|NCT00572455|10901708|FG013|Stage II (28 Days)|Adverse Event|1
6887642|NCT00572455|10901695|FG000|Stage II (28 Days)|Death|0
6887643|NCT00572455|10901696|FG001|Stage II (28 Days)|Death|0
6887644|NCT00572455|10901697|FG002|Stage II (28 Days)|Death|0
6887645|NCT00572455|10901698|FG003|Stage II (28 Days)|Death|0
6887646|NCT00572455|10901699|FG004|Stage II (28 Days)|Death|0
6887647|NCT00572455|10901700|FG005|Stage II (28 Days)|Death|0
6887648|NCT00572455|10901701|FG006|Stage II (28 Days)|Death|0
6887649|NCT00572455|10901702|FG007|Stage II (28 Days)|Death|0
6887650|NCT00572455|10901703|FG008|Stage II (28 Days)|Death|1
6887651|NCT00572455|10901704|FG009|Stage II (28 Days)|Death|0
6887652|NCT00572455|10901705|FG010|Stage II (28 Days)|Death|0
6887653|NCT00572455|10901706|FG011|Stage II (28 Days)|Death|0
6887654|NCT00572455|10901707|FG012|Stage II (28 Days)|Death|0
6887655|NCT00572455|10901708|FG013|Stage II (28 Days)|Death|0
6887656|NCT00572455|10901695|FG000|Stage II (28 Days)|Withdrawal by Subject|0
6887657|NCT00572455|10901696|FG001|Stage II (28 Days)|Withdrawal by Subject|0
6887658|NCT00572455|10901697|FG002|Stage II (28 Days)|Withdrawal by Subject|0
6887659|NCT00572455|10901698|FG003|Stage II (28 Days)|Withdrawal by Subject|0
6887660|NCT00572455|10901699|FG004|Stage II (28 Days)|Withdrawal by Subject|0
6887661|NCT00572455|10901700|FG005|Stage II (28 Days)|Withdrawal by Subject|0
6887662|NCT00572455|10901701|FG006|Stage II (28 Days)|Withdrawal by Subject|0
6887663|NCT00572455|10901702|FG007|Stage II (28 Days)|Withdrawal by Subject|1
6887664|NCT00572455|10901703|FG008|Stage II (28 Days)|Withdrawal by Subject|0
6887665|NCT00572455|10901704|FG009|Stage II (28 Days)|Withdrawal by Subject|0
6887666|NCT00572455|10901705|FG010|Stage II (28 Days)|Withdrawal by Subject|2
6887667|NCT00572455|10901706|FG011|Stage II (28 Days)|Withdrawal by Subject|0
6887668|NCT00572455|10901707|FG012|Stage II (28 Days)|Withdrawal by Subject|0
6887669|NCT00572455|10901708|FG013|Stage II (28 Days)|Withdrawal by Subject|0
6887670|NCT00572455|10901695|FG000|Stage II (28 Days)|Other|0
6887671|NCT00572455|10901696|FG001|Stage II (28 Days)|Other|0
6887672|NCT00572455|10901697|FG002|Stage II (28 Days)|Other|0
6887673|NCT00572455|10901698|FG003|Stage II (28 Days)|Other|0
6887674|NCT00572455|10901699|FG004|Stage II (28 Days)|Other|0
6887675|NCT00572455|10901700|FG005|Stage II (28 Days)|Other|0
6887676|NCT00572455|10901701|FG006|Stage II (28 Days)|Other|0
6887677|NCT00572455|10901702|FG007|Stage II (28 Days)|Other|0
6887678|NCT00572455|10901703|FG008|Stage II (28 Days)|Other|1
6887679|NCT00572455|10901704|FG009|Stage II (28 Days)|Other|0
6887680|NCT00572455|10901705|FG010|Stage II (28 Days)|Other|0
6887681|NCT00572455|10901706|FG011|Stage II (28 Days)|Other|0
6887682|NCT00572455|10901707|FG012|Stage II (28 Days)|Other|0
6887683|NCT00572455|10901708|FG013|Stage II (28 Days)|Other|0
6887684|NCT00572455|10901695|FG000|Stage II (28 Days)|Randomized, but not treated|0
6887685|NCT00572455|10901696|FG001|Stage II (28 Days)|Randomized, but not treated|0
6887686|NCT00572455|10901697|FG002|Stage II (28 Days)|Randomized, but not treated|0
6887687|NCT00572455|10901698|FG003|Stage II (28 Days)|Randomized, but not treated|0
6887688|NCT00572455|10901699|FG004|Stage II (28 Days)|Randomized, but not treated|0
6887689|NCT00572455|10901700|FG005|Stage II (28 Days)|Randomized, but not treated|0
6887690|NCT00572455|10901701|FG006|Stage II (28 Days)|Randomized, but not treated|0
6887691|NCT00572455|10901702|FG007|Stage II (28 Days)|Randomized, but not treated|0
6887692|NCT00572455|10901703|FG008|Stage II (28 Days)|Randomized, but not treated|0
6887693|NCT00572455|10901704|FG009|Stage II (28 Days)|Randomized, but not treated|0
6887694|NCT00572455|10901705|FG010|Stage II (28 Days)|Randomized, but not treated|0
6887695|NCT00572455|10901706|FG011|Stage II (28 Days)|Randomized, but not treated|0
6887696|NCT00572455|10901707|FG012|Stage II (28 Days)|Randomized, but not treated|0
6887697|NCT00572455|10901708|FG013|Stage II (28 Days)|Randomized, but not treated|1
6887698|NCT00572533|10901749|FG000|Overall Study|Death|4
6887699|NCT00572533|10901750|FG001|Overall Study|Death|1
6887700|NCT00572533|10901749|FG000|Overall Study|Received Kidney Transplant|2
6887701|NCT00572533|10901750|FG001|Overall Study|Received Kidney Transplant|1
6887702|NCT00572533|10901749|FG000|Overall Study|Social Issues|1
6887703|NCT00572533|10901750|FG001|Overall Study|Social Issues|0
6887704|NCT00572533|10901749|FG000|Overall Study|Transfer out of Facility|0
6887705|NCT00572533|10901750|FG001|Overall Study|Transfer out of Facility|1
6887706|NCT00572572|10901758|FG000|Overall Study|Withdrawal by Subject|3
6887707|NCT00572572|10901759|FG001|Overall Study|Withdrawal by Subject|6
6887708|NCT00572624|10901767|FG000|Overall Study|Lost to Follow-up|10
6887709|NCT00572624|10901768|FG001|Overall Study|Lost to Follow-up|4
6887710|NCT00572624|10901767|FG000|Overall Study|Wanted to do a different diet program|1
6887711|NCT00572624|10901768|FG001|Overall Study|Wanted to do a different diet program|0
6887712|NCT00572624|10901767|FG000|Overall Study|Medication change|1
6887713|NCT00572624|10901768|FG001|Overall Study|Medication change|0
6887714|NCT00572624|10901767|FG000|Overall Study|Started a new job-- no time for study|1
6887715|NCT00572624|10901768|FG001|Overall Study|Started a new job-- no time for study|0
6887716|NCT00572624|10901767|FG000|Overall Study|Admitted to being a smoker|1
6887717|NCT00572624|10901768|FG001|Overall Study|Admitted to being a smoker|0
6887718|NCT00572624|10901767|FG000|Overall Study|Refused to do the stress test|1
6887719|NCT00572624|10901768|FG001|Overall Study|Refused to do the stress test|0
6887720|NCT00572624|10901767|FG000|Overall Study|Problem with vascular access|1
6887721|NCT00572624|10901768|FG001|Overall Study|Problem with vascular access|0
6887722|NCT00572624|10901767|FG000|Overall Study|Health issues unrelated to the study|1
6887723|NCT00572624|10901768|FG001|Overall Study|Health issues unrelated to the study|0
6887724|NCT00572728|10901774|FG000|Overall Study|Withdrawal by Subject|10
6887725|NCT00572728|10901774|FG000|Overall Study|Ineligible|3
6887726|NCT00572728|10901774|FG000|Overall Study|Enrolled under Amendment 4|5
6887727|NCT00572728|10901774|FG000|Overall Study|Offstudy due to complicating disease|1
6887728|NCT00572728|10901774|FG000|Overall Study|FLT1 not completed|4
6887729|NCT00572728|10901774|FG000|Overall Study|First Chemotherapy not initiated|2
6887730|NCT00572728|10901774|FG000|Overall Study|FLT2 not completed|5
6887731|NCT00572728|10901774|FG000|Overall Study|Second chemotherapy not initiated|1
6887732|NCT00572728|10901774|FG000|Overall Study|FLT2 after second chemotherapy initiated|7
6887733|NCT00572728|10901774|FG000|Overall Study|Pathology missing|1
6887734|NCT00572832|10901782|FG000|Overall Study|Lost to Follow-up|0
6887735|NCT00572832|10901783|FG001|Overall Study|Lost to Follow-up|11
6887736|NCT00572832|10901782|FG000|Overall Study|Pregnancy|0
6887737|NCT00572832|10901783|FG001|Overall Study|Pregnancy|1
6887738|NCT00572910|10901804|FG000|Overall Study|Adverse Event|1
6887739|NCT00572910|10901805|FG001|Overall Study|Adverse Event|2
6887740|NCT00572910|10901806|FG002|Overall Study|Adverse Event|0
6887741|NCT00572910|10901807|FG003|Overall Study|Adverse Event|2
6887742|NCT00572910|10901808|FG004|Overall Study|Adverse Event|0
6887743|NCT00572910|10901809|FG005|Overall Study|Adverse Event|0
6887744|NCT00572910|10901810|FG006|Overall Study|Adverse Event|4
6887745|NCT00572910|10901811|FG007|Overall Study|Adverse Event|2
6887746|NCT00572910|10901812|FG008|Overall Study|Adverse Event|1
6887747|NCT00572910|10901813|FG009|Overall Study|Adverse Event|3
6887748|NCT00572910|10901814|FG010|Overall Study|Adverse Event|2
6887749|NCT00572910|10901804|FG000|Overall Study|Lost to Follow-up|0
6887750|NCT00572910|10901805|FG001|Overall Study|Lost to Follow-up|1
6887751|NCT00572910|10901806|FG002|Overall Study|Lost to Follow-up|1
6887752|NCT00572910|10901807|FG003|Overall Study|Lost to Follow-up|2
6887753|NCT00572910|10901808|FG004|Overall Study|Lost to Follow-up|1
6887754|NCT00572910|10901809|FG005|Overall Study|Lost to Follow-up|0
6887755|NCT00572910|10901810|FG006|Overall Study|Lost to Follow-up|0
6887756|NCT00572910|10901811|FG007|Overall Study|Lost to Follow-up|0
6887757|NCT00572910|10901812|FG008|Overall Study|Lost to Follow-up|0
6887758|NCT00572910|10901813|FG009|Overall Study|Lost to Follow-up|1
6887759|NCT00572910|10901814|FG010|Overall Study|Lost to Follow-up|0
6887760|NCT00572910|10901804|FG000|Overall Study|Withdrawal by Subject|3
6887761|NCT00572910|10901805|FG001|Overall Study|Withdrawal by Subject|0
6887762|NCT00572910|10901806|FG002|Overall Study|Withdrawal by Subject|1
6887763|NCT00572910|10901807|FG003|Overall Study|Withdrawal by Subject|0
6887764|NCT00572910|10901808|FG004|Overall Study|Withdrawal by Subject|1
6887765|NCT00572910|10901809|FG005|Overall Study|Withdrawal by Subject|3
6887766|NCT00572910|10901810|FG006|Overall Study|Withdrawal by Subject|0
6887767|NCT00572910|10901811|FG007|Overall Study|Withdrawal by Subject|2
6887768|NCT00572910|10901812|FG008|Overall Study|Withdrawal by Subject|2
6887769|NCT00572910|10901813|FG009|Overall Study|Withdrawal by Subject|2
6887770|NCT00572910|10901814|FG010|Overall Study|Withdrawal by Subject|1
6887771|NCT00573066|10901862|FG000|Overall Study|Exclusion criteria|18
6887772|NCT00573066|10901862|FG000|Overall Study|IV malfunction|1
6887773|NCT00573066|10901862|FG000|Overall Study|Postoperative bleeding|1
6887774|NCT00573144|10901868|FG000|Overall Study|Withdrawal by Subject|2
6887775|NCT00573144|10901869|FG001|Overall Study|Withdrawal by Subject|3
6887776|NCT00573170|10901875|FG000|First Treatment Period|Did Not Treat Attack 1|0
6887777|NCT00573170|10901876|FG001|First Treatment Period|Did Not Treat Attack 1|0
6887778|NCT00573170|10901877|FG002|First Treatment Period|Did Not Treat Attack 1|0
6887779|NCT00573170|10901878|FG003|First Treatment Period|Did Not Treat Attack 1|0
6887780|NCT00573170|10901879|FG004|First Treatment Period|Did Not Treat Attack 1|1
6887781|NCT00573170|10901880|FG005|First Treatment Period|Did Not Treat Attack 1|0
6887782|NCT00573170|10901875|FG000|First Washout Period|Adverse Event|1
6887783|NCT00573170|10901876|FG001|First Washout Period|Adverse Event|1
6887784|NCT00573170|10901877|FG002|First Washout Period|Adverse Event|0
6887785|NCT00573170|10901878|FG003|First Washout Period|Adverse Event|0
6887786|NCT00573170|10901879|FG004|First Washout Period|Adverse Event|0
6887787|NCT00573170|10901880|FG005|First Washout Period|Adverse Event|1
6887788|NCT00573170|10901875|FG000|First Washout Period|Lack of Efficacy|0
6887789|NCT00573170|10901876|FG001|First Washout Period|Lack of Efficacy|0
6887790|NCT00573170|10901877|FG002|First Washout Period|Lack of Efficacy|0
6887791|NCT00573170|10901878|FG003|First Washout Period|Lack of Efficacy|0
6887792|NCT00573170|10901879|FG004|First Washout Period|Lack of Efficacy|0
6887793|NCT00573170|10901880|FG005|First Washout Period|Lack of Efficacy|1
6887794|NCT00573170|10901875|FG000|First Washout Period|Lost to Follow-up|1
6887795|NCT00573170|10901876|FG001|First Washout Period|Lost to Follow-up|1
6887796|NCT00573170|10901877|FG002|First Washout Period|Lost to Follow-up|0
6887797|NCT00573170|10901878|FG003|First Washout Period|Lost to Follow-up|2
6887798|NCT00573170|10901879|FG004|First Washout Period|Lost to Follow-up|0
6887799|NCT00573170|10901880|FG005|First Washout Period|Lost to Follow-up|2
6887800|NCT00573170|10901875|FG000|First Washout Period|Withdrawal by Subject|2
6887801|NCT00573170|10901876|FG001|First Washout Period|Withdrawal by Subject|0
6887802|NCT00573170|10901877|FG002|First Washout Period|Withdrawal by Subject|0
6887803|NCT00573170|10901878|FG003|First Washout Period|Withdrawal by Subject|2
6887804|NCT00573170|10901879|FG004|First Washout Period|Withdrawal by Subject|3
6887805|NCT00573170|10901880|FG005|First Washout Period|Withdrawal by Subject|3
6887806|NCT00573170|10901875|FG000|First Washout Period|Other|4
6887807|NCT00573170|10901876|FG001|First Washout Period|Other|0
6887808|NCT00573170|10901877|FG002|First Washout Period|Other|1
6887809|NCT00573170|10901878|FG003|First Washout Period|Other|1
6887810|NCT00573170|10901879|FG004|First Washout Period|Other|0
6887811|NCT00573170|10901880|FG005|First Washout Period|Other|0
6887812|NCT00573170|10901875|FG000|Second Washout Period|Adverse Event|1
6887813|NCT00573170|10901876|FG001|Second Washout Period|Adverse Event|0
6887814|NCT00573170|10901877|FG002|Second Washout Period|Adverse Event|0
6887815|NCT00573170|10901878|FG003|Second Washout Period|Adverse Event|0
6887816|NCT00573170|10901879|FG004|Second Washout Period|Adverse Event|1
6887817|NCT00573170|10901880|FG005|Second Washout Period|Adverse Event|0
6887818|NCT00573170|10901875|FG000|Second Washout Period|Protocol Violation|2
6887819|NCT00573170|10901876|FG001|Second Washout Period|Protocol Violation|1
6887820|NCT00573170|10901877|FG002|Second Washout Period|Protocol Violation|1
6887821|NCT00573170|10901878|FG003|Second Washout Period|Protocol Violation|0
6887822|NCT00573170|10901879|FG004|Second Washout Period|Protocol Violation|0
6887823|NCT00573170|10901880|FG005|Second Washout Period|Protocol Violation|0
6887824|NCT00573170|10901875|FG000|Second Washout Period|Withdrawal by Subject|1
6887825|NCT00573170|10901876|FG001|Second Washout Period|Withdrawal by Subject|1
6887826|NCT00573170|10901877|FG002|Second Washout Period|Withdrawal by Subject|2
6887827|NCT00573170|10901878|FG003|Second Washout Period|Withdrawal by Subject|0
6887828|NCT00573170|10901879|FG004|Second Washout Period|Withdrawal by Subject|1
6887829|NCT00573170|10901880|FG005|Second Washout Period|Withdrawal by Subject|0
6887830|NCT00573170|10901875|FG000|Second Washout Period|Lost to Follow-up|0
6887831|NCT00573170|10901876|FG001|Second Washout Period|Lost to Follow-up|0
6887832|NCT00573170|10901877|FG002|Second Washout Period|Lost to Follow-up|0
6887833|NCT00573170|10901878|FG003|Second Washout Period|Lost to Follow-up|1
6887834|NCT00573170|10901879|FG004|Second Washout Period|Lost to Follow-up|0
6887835|NCT00573170|10901880|FG005|Second Washout Period|Lost to Follow-up|0
6887836|NCT00573170|10901875|FG000|Second Washout Period|Other|1
6887837|NCT00573170|10901876|FG001|Second Washout Period|Other|2
6887838|NCT00573170|10901877|FG002|Second Washout Period|Other|1
6887839|NCT00573170|10901878|FG003|Second Washout Period|Other|4
6887840|NCT00573170|10901879|FG004|Second Washout Period|Other|6
6887841|NCT00573170|10901880|FG005|Second Washout Period|Other|2
6887842|NCT00573170|10901875|FG000|Third Treatment Period|Withdrawal by Subject|1
6887843|NCT00573170|10901876|FG001|Third Treatment Period|Withdrawal by Subject|0
6887844|NCT00573170|10901877|FG002|Third Treatment Period|Withdrawal by Subject|0
6887845|NCT00573170|10901878|FG003|Third Treatment Period|Withdrawal by Subject|0
6887846|NCT00573170|10901879|FG004|Third Treatment Period|Withdrawal by Subject|0
6887847|NCT00573170|10901880|FG005|Third Treatment Period|Withdrawal by Subject|0
6887848|NCT00573170|10901875|FG000|Third Treatment Period|Lost to Follow-up|0
6887849|NCT00573170|10901876|FG001|Third Treatment Period|Lost to Follow-up|0
6887850|NCT00573170|10901877|FG002|Third Treatment Period|Lost to Follow-up|0
6887851|NCT00573170|10901878|FG003|Third Treatment Period|Lost to Follow-up|0
6887852|NCT00573170|10901879|FG004|Third Treatment Period|Lost to Follow-up|0
6887853|NCT00573170|10901880|FG005|Third Treatment Period|Lost to Follow-up|2
6887854|NCT00573183|10901899|FG000|Overall Study|Lost to Follow-up|52
6887855|NCT00573183|10901900|FG001|Overall Study|Lost to Follow-up|50
6887856|NCT00573183|10901899|FG000|Overall Study|Withdrawal by Subject|8
6887857|NCT00573183|10901900|FG001|Overall Study|Withdrawal by Subject|2
6887858|NCT00573183|10901899|FG000|Overall Study|Death|0
6887859|NCT00573183|10901900|FG001|Overall Study|Death|1
6887860|NCT00573183|10901899|FG000|Overall Study|Adverse Event|2
6887861|NCT00573183|10901900|FG001|Overall Study|Adverse Event|0
6887862|NCT00573183|10901899|FG000|Overall Study|Incarceration|5
6887863|NCT00573183|10901900|FG001|Overall Study|Incarceration|8
6887864|NCT00573183|10901899|FG000|Overall Study|Other|5
6887865|NCT00573183|10901900|FG001|Overall Study|Other|2
6887866|NCT00573248|10901910|FG000|Overall Study|scheduling conflicts|15
6887867|NCT00573248|10901911|FG001|Overall Study|scheduling conflicts|11
6887868|NCT00573313|10901941|FG000|Overall Study|Protocol Violation|5
6887869|NCT00573313|10901942|FG001|Overall Study|Protocol Violation|0
6887870|NCT00573313|10901943|FG002|Overall Study|Protocol Violation|6
6887871|NCT00573313|10901944|FG003|Overall Study|Protocol Violation|0
6887872|NCT00573430|10901954|FG000|Overall Study|Incorrect enrollment of randomization|0
6887873|NCT00573430|10901955|FG001|Overall Study|Incorrect enrollment of randomization|4
6887874|NCT00573430|10901956|FG002|Overall Study|Incorrect enrollment of randomization|3
6887875|NCT00573430|10901954|FG000|Overall Study|Adverse Event|0
6887876|NCT00573430|10901955|FG001|Overall Study|Adverse Event|0
6887877|NCT00573430|10901956|FG002|Overall Study|Adverse Event|2
6887878|NCT00573430|10901954|FG000|Overall Study|Withdrawal by Subject|1
6887879|NCT00573430|10901955|FG001|Overall Study|Withdrawal by Subject|0
6887880|NCT00573430|10901956|FG002|Overall Study|Withdrawal by Subject|1
6887881|NCT00573430|10901954|FG000|Overall Study|Protocol Violation|0
6887882|NCT00573430|10901955|FG001|Overall Study|Protocol Violation|1
6887883|NCT00573430|10901956|FG002|Overall Study|Protocol Violation|1
6887884|NCT00573430|10901954|FG000|Overall Study|Eligibility criteria not fulfilled|0
6887885|NCT00573430|10901955|FG001|Overall Study|Eligibility criteria not fulfilled|0
6887886|NCT00573430|10901956|FG002|Overall Study|Eligibility criteria not fulfilled|3
6887887|NCT00573443|10901967|FG000|Double-Blind Phase|Lost to Follow-up|1
6887888|NCT00573443|10901968|FG001|Double-Blind Phase|Lost to Follow-up|3
6887889|NCT00573443|10901969|FG002|Double-Blind Phase|Lost to Follow-up|2
6887890|NCT00573443|10901967|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1
6887891|NCT00573443|10901968|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0
6887892|NCT00573443|10901969|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1
7155687|NCT03345914|11323750|FG000|Overall Study|Transition to OLE during follow-up|37
7155688|NCT03345914|11323751|FG001|Overall Study|Transition to OLE during follow-up|33
6887893|NCT00573443|10901967|FG000|Double-Blind Phase|Adverse Event|1
6887894|NCT00573443|10901968|FG001|Double-Blind Phase|Adverse Event|5
6887895|NCT00573443|10901969|FG002|Double-Blind Phase|Adverse Event|0
6887896|NCT00573443|10901967|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2
6887897|NCT00573443|10901968|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3
6887898|NCT00573443|10901969|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1
6887899|NCT00573443|10901967|FG000|Double-Blind Phase|Medication refusal due to AE|2
6887900|NCT00573443|10901968|FG001|Double-Blind Phase|Medication refusal due to AE|2
6887901|NCT00573443|10901969|FG002|Double-Blind Phase|Medication refusal due to AE|0
6887902|NCT00573443|10901967|FG000|Double-Blind Phase|Withdrawal by Subject|2
6887903|NCT00573443|10901968|FG001|Double-Blind Phase|Withdrawal by Subject|2
6887904|NCT00573443|10901969|FG002|Double-Blind Phase|Withdrawal by Subject|7
6887905|NCT00573443|10901967|FG000|Double-Blind Phase|Protocol Violation|0
6887906|NCT00573443|10901968|FG001|Double-Blind Phase|Protocol Violation|2
6887907|NCT00573443|10901969|FG002|Double-Blind Phase|Protocol Violation|1
6887908|NCT00573443|10901967|FG000|Double-Blind Phase|Other|0
6887909|NCT00573443|10901968|FG001|Double-Blind Phase|Other|2
6887910|NCT00573443|10901969|FG002|Double-Blind Phase|Other|3
6887911|NCT00573443|10901967|FG000|Open-Label Extension Phase|Lost to Follow-up|1
6887912|NCT00573443|10901968|FG001|Open-Label Extension Phase|Lost to Follow-up|0
6887913|NCT00573443|10901969|FG002|Open-Label Extension Phase|Lost to Follow-up|0
6887914|NCT00573443|10901967|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2
6887915|NCT00573443|10901968|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0
6887916|NCT00573443|10901969|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0
6887917|NCT00573443|10901967|FG000|Open-Label Extension Phase|Adverse Event|3
6887918|NCT00573443|10901968|FG001|Open-Label Extension Phase|Adverse Event|0
6887919|NCT00573443|10901969|FG002|Open-Label Extension Phase|Adverse Event|0
6887920|NCT00573443|10901967|FG000|Open-Label Extension Phase|Serious Adverse Event|5
6887921|NCT00573443|10901968|FG001|Open-Label Extension Phase|Serious Adverse Event|0
6887922|NCT00573443|10901969|FG002|Open-Label Extension Phase|Serious Adverse Event|0
6887923|NCT00573443|10901967|FG000|Open-Label Extension Phase|Withdrawal by Subject|3
6887924|NCT00573443|10901968|FG001|Open-Label Extension Phase|Withdrawal by Subject|0
6887925|NCT00573443|10901969|FG002|Open-Label Extension Phase|Withdrawal by Subject|0
6887926|NCT00573443|10901967|FG000|Open-Label Extension Phase|Protocol Violation|2
6887927|NCT00573443|10901968|FG001|Open-Label Extension Phase|Protocol Violation|0
6887928|NCT00573443|10901969|FG002|Open-Label Extension Phase|Protocol Violation|0
6887929|NCT00573443|10901967|FG000|Open-Label Extension Phase|Other|2
6887930|NCT00573443|10901968|FG001|Open-Label Extension Phase|Other|0
6887931|NCT00573443|10901969|FG002|Open-Label Extension Phase|Other|0
6887932|NCT00573469|10901981|FG000|Overall Study|Adverse Event|1
6887933|NCT00573469|10901982|FG001|Overall Study|Adverse Event|1
6887934|NCT00573469|10901983|FG002|Overall Study|Adverse Event|1
6887935|NCT00573469|10901981|FG000|Overall Study|Withdrawal by Subject|0
6887936|NCT00573469|10901982|FG001|Overall Study|Withdrawal by Subject|2
6887937|NCT00573469|10901983|FG002|Overall Study|Withdrawal by Subject|0
6887938|NCT00573469|10901981|FG000|Overall Study|Other|5
6887939|NCT00573469|10901982|FG001|Overall Study|Other|1
6887940|NCT00573469|10901983|FG002|Overall Study|Other|3
6887941|NCT00573534|10902000|FG000|Overall Study|oppositional behavior|3
6887942|NCT00573755|10902007|FG000|Overall Study|Still receiving treatment|1
6887943|NCT00573755|10902008|FG001|Overall Study|Still receiving treatment|0
6887944|NCT00573768|10902017|FG000|Overall Study|Adverse Event|1
6887945|NCT00573768|10902018|FG001|Overall Study|Adverse Event|1
6887946|NCT00573768|10902019|FG002|Overall Study|Adverse Event|2
6887947|NCT00573768|10902017|FG000|Overall Study|Protocol Violation|1
6887948|NCT00573768|10902018|FG001|Overall Study|Protocol Violation|0
6887949|NCT00573768|10902019|FG002|Overall Study|Protocol Violation|1
6887950|NCT00573768|10902017|FG000|Overall Study|Withdrawal by Subject|0
6887951|NCT00573768|10902018|FG001|Overall Study|Withdrawal by Subject|1
6887952|NCT00573768|10902019|FG002|Overall Study|Withdrawal by Subject|0
6887953|NCT00573768|10902017|FG000|Overall Study|Lost to Follow-up|0
6887954|NCT00573768|10902018|FG001|Overall Study|Lost to Follow-up|0
6887955|NCT00573768|10902019|FG002|Overall Study|Lost to Follow-up|1
6887956|NCT00573794|10902027|FG000|Overall Study|Adverse Event|81
6887957|NCT00573794|10902027|FG000|Overall Study|Withdrew Consent|90
6887958|NCT00573794|10902027|FG000|Overall Study|Lost to Follow-up|13
6887959|NCT00573794|10902027|FG000|Overall Study|Protocol Violation|6
6887960|NCT00573794|10902027|FG000|Overall Study|Lack of Efficacy|94
6887961|NCT00573794|10902027|FG000|Overall Study|Other|46
6887962|NCT00573833|10902031|FG000|Overall Study|Not Treated|2
6887963|NCT00573859|10902035|FG000|Medication Versus Placebo|Scheduling conflicts|12
6887964|NCT00573859|10902035|FG000|Smoking Versus Abstinence|Scheduling conflicts|12
6887965|NCT00574119|10902074|FG000|Overall Study|Adverse Event|1
6887966|NCT00574119|10902074|FG000|Overall Study|Protocol Violation|1
6887967|NCT00574119|10902074|FG000|Overall Study|Withdrawal by Subject|1
6887968|NCT00574119|10902074|FG000|Overall Study|Physician Decision|1
6887969|NCT00574145|10902080|FG000|Overall Study|Withdrawal by Subject|2
6887970|NCT00574145|10902081|FG001|Overall Study|Withdrawal by Subject|1
7155689|NCT03345914|11323752|FG002|Overall Study|Transition to OLE during follow-up|39
6887971|NCT00574249|10902101|FG000|Overall Study|Adverse Event|6
6887972|NCT00574249|10902102|FG001|Overall Study|Adverse Event|18
6887973|NCT00574249|10902101|FG000|Overall Study|Lack of Efficacy|5
6887974|NCT00574249|10902102|FG001|Overall Study|Lack of Efficacy|3
6887975|NCT00574249|10902101|FG000|Overall Study|Lost to Follow-up|4
6887976|NCT00574249|10902102|FG001|Overall Study|Lost to Follow-up|3
6887977|NCT00574249|10902101|FG000|Overall Study|Protocol Violation|5
6887978|NCT00574249|10902102|FG001|Overall Study|Protocol Violation|2
6887979|NCT00574249|10902101|FG000|Overall Study|History of carcinoma|1
6887980|NCT00574249|10902102|FG001|Overall Study|History of carcinoma|0
6887981|NCT00574249|10902101|FG000|Overall Study|Withdrawal by Subject|3
6887982|NCT00574249|10902102|FG001|Overall Study|Withdrawal by Subject|0
6887983|NCT00574249|10902101|FG000|Overall Study|Physician Decision|1
6887984|NCT00574249|10902102|FG001|Overall Study|Physician Decision|0
6887985|NCT00574249|10902101|FG000|Overall Study|Pregnancy|1
6887986|NCT00574249|10902102|FG001|Overall Study|Pregnancy|0
6887987|NCT00574249|10902101|FG000|Overall Study|Excluded by company|0
6887988|NCT00574249|10902102|FG001|Overall Study|Excluded by company|1
6887989|NCT00574249|10902101|FG000|Overall Study|PPD test taken twice|0
6887990|NCT00574249|10902102|FG001|Overall Study|PPD test taken twice|1
6887991|NCT00574275|10902110|FG000|Overall Study|Randomized but not treated|2
6887992|NCT00574275|10902111|FG001|Overall Study|Randomized but not treated|3
6887993|NCT00574275|10902110|FG000|Overall Study|Adverse Event|32
6887994|NCT00574275|10902111|FG001|Overall Study|Adverse Event|76
6887995|NCT00574275|10902110|FG000|Overall Study|Disease progression|160
6887996|NCT00574275|10902111|FG001|Overall Study|Disease progression|146
6887997|NCT00574275|10902110|FG000|Overall Study|Lost to Follow-up|2
6887998|NCT00574275|10902111|FG001|Overall Study|Lost to Follow-up|1
6887999|NCT00574275|10902110|FG000|Overall Study|Study stopped based on DMC decision|62
6888000|NCT00574275|10902111|FG001|Overall Study|Study stopped based on DMC decision|23
6888001|NCT00574275|10902110|FG000|Overall Study|Withdrawal by Subject|15
6888002|NCT00574275|10902111|FG001|Overall Study|Withdrawal by Subject|17
6888003|NCT00574275|10902110|FG000|Overall Study|Error calculating tumor measurement|1
6888004|NCT00574275|10902111|FG001|Overall Study|Error calculating tumor measurement|0
6888005|NCT00574275|10902110|FG000|Overall Study|Physician Decision|1
6888006|NCT00574275|10902111|FG001|Overall Study|Physician Decision|1
6888007|NCT00574275|10902110|FG000|Overall Study|Protocol Violation|0
6888008|NCT00574275|10902111|FG001|Overall Study|Protocol Violation|1
6888009|NCT00574275|10902110|FG000|Overall Study|Patient and Investigator decision|0
6888010|NCT00574275|10902111|FG001|Overall Study|Patient and Investigator decision|1
6888011|NCT00574275|10902110|FG000|Overall Study|Insurance change|0
6888012|NCT00574275|10902111|FG001|Overall Study|Insurance change|1
6888013|NCT00574275|10902110|FG000|Overall Study|Operation for curative intent|0
6888014|NCT00574275|10902111|FG001|Overall Study|Operation for curative intent|1
6888015|NCT00574288|10902124|FG000|Overall Study|Adverse Event|2
6888016|NCT00574288|10902125|FG001|Overall Study|Adverse Event|0
6888017|NCT00574288|10902126|FG002|Overall Study|Adverse Event|0
6888018|NCT00574288|10902127|FG003|Overall Study|Adverse Event|0
6888019|NCT00574288|10902128|FG004|Overall Study|Adverse Event|1
6888020|NCT00574288|10902129|FG005|Overall Study|Adverse Event|0
6888021|NCT00574288|10902130|FG006|Overall Study|Adverse Event|0
6888022|NCT00574288|10902124|FG000|Overall Study|Death|0
6888023|NCT00574288|10902125|FG001|Overall Study|Death|0
6888024|NCT00574288|10902126|FG002|Overall Study|Death|0
6888025|NCT00574288|10902127|FG003|Overall Study|Death|0
6888026|NCT00574288|10902128|FG004|Overall Study|Death|0
6888027|NCT00574288|10902129|FG005|Overall Study|Death|25
6888028|NCT00574288|10902130|FG006|Overall Study|Death|21
6888029|NCT00574288|10902124|FG000|Overall Study|Lost to Follow-up|0
6888030|NCT00574288|10902125|FG001|Overall Study|Lost to Follow-up|0
6888031|NCT00574288|10902126|FG002|Overall Study|Lost to Follow-up|0
6888032|NCT00574288|10902127|FG003|Overall Study|Lost to Follow-up|0
6888033|NCT00574288|10902128|FG004|Overall Study|Lost to Follow-up|0
6888034|NCT00574288|10902129|FG005|Overall Study|Lost to Follow-up|1
6888035|NCT00574288|10902130|FG006|Overall Study|Lost to Follow-up|2
6888036|NCT00574288|10902124|FG000|Overall Study|Study Terminated By Sponsor|0
6888037|NCT00574288|10902125|FG001|Overall Study|Study Terminated By Sponsor|0
6888038|NCT00574288|10902126|FG002|Overall Study|Study Terminated By Sponsor|0
6888039|NCT00574288|10902127|FG003|Overall Study|Study Terminated By Sponsor|0
6888040|NCT00574288|10902128|FG004|Overall Study|Study Terminated By Sponsor|0
6888041|NCT00574288|10902129|FG005|Overall Study|Study Terminated By Sponsor|0
6888042|NCT00574288|10902130|FG006|Overall Study|Study Terminated By Sponsor|5
6888043|NCT00574288|10902124|FG000|Overall Study|Progressive Disease|17
6888044|NCT00574288|10902125|FG001|Overall Study|Progressive Disease|2
6888045|NCT00574288|10902126|FG002|Overall Study|Progressive Disease|3
6888046|NCT00574288|10902127|FG003|Overall Study|Progressive Disease|2
6888047|NCT00574288|10902128|FG004|Overall Study|Progressive Disease|1
6888048|NCT00574288|10902129|FG005|Overall Study|Progressive Disease|0
6888049|NCT00574288|10902130|FG006|Overall Study|Progressive Disease|0
6888050|NCT00574288|10902124|FG000|Overall Study|Other|1
6888051|NCT00574288|10902125|FG001|Overall Study|Other|1
6888052|NCT00574288|10902126|FG002|Overall Study|Other|0
6888053|NCT00574288|10902127|FG003|Overall Study|Other|0
6888054|NCT00574288|10902128|FG004|Overall Study|Other|0
6888055|NCT00574288|10902129|FG005|Overall Study|Other|0
6888056|NCT00574288|10902130|FG006|Overall Study|Other|0
6888057|NCT00574405|10902165|FG000|Overall Study|Withdrawal by Subject|3
6888058|NCT00574405|10902166|FG001|Overall Study|Withdrawal by Subject|2
6888059|NCT00574795|10902234|FG000|Infant Series|Withdrawal by Subject|2
6888060|NCT00574795|10902234|FG000|Infant Series|Protocol Violation|2
6888061|NCT00574795|10902234|FG000|Infant Series|Adverse Event|1
6888062|NCT00574795|10902234|FG000|After Infant Series|Withdrawal by Subject|1
6888063|NCT00574795|10902234|FG000|After Infant Series|Adverse Event|2
6888064|NCT00574795|10902234|FG000|Toddler Dose|Withdrawal by Subject|1
6888065|NCT00574847|10902264|FG000|Overall Study|Adverse Event|2
6888066|NCT00574847|10902265|FG001|Overall Study|Adverse Event|0
6888067|NCT00574847|10902264|FG000|Overall Study|Death|1
6888068|NCT00574847|10902265|FG001|Overall Study|Death|0
6888069|NCT00574847|10902264|FG000|Overall Study|Withdrawal by Subject|2
6888070|NCT00574847|10902265|FG001|Overall Study|Withdrawal by Subject|2
6888071|NCT00574847|10902264|FG000|Overall Study|Physician Decision|1
6888072|NCT00574847|10902265|FG001|Overall Study|Physician Decision|0
6888073|NCT00574847|10902264|FG000|Overall Study|Did not receive medication (declined)|2
6888074|NCT00574847|10902265|FG001|Overall Study|Did not receive medication (declined)|5
6888075|NCT00574873|10902273|FG000|Overall Study|Withdrawal by Subject|18
6888076|NCT00574873|10902274|FG001|Overall Study|Withdrawal by Subject|19
6888077|NCT00574873|10902273|FG000|Overall Study|Investigator request|18
6888078|NCT00574873|10902274|FG001|Overall Study|Investigator request|8
6888079|NCT00574873|10902273|FG000|Overall Study|Death|15
6888080|NCT00574873|10902274|FG001|Overall Study|Death|14
6888081|NCT00574873|10902273|FG000|Overall Study|Lost to Follow-up|14
6888082|NCT00574873|10902274|FG001|Overall Study|Lost to Follow-up|5
6888083|NCT00574873|10902273|FG000|Overall Study|Other|40
6888084|NCT00574873|10902274|FG001|Overall Study|Other|4
6888085|NCT00574873|10902273|FG000|Overall Study|Discontinuation of study by sponsor|5
6888086|NCT00574873|10902274|FG001|Overall Study|Discontinuation of study by sponsor|199
6888087|NCT00574873|10902273|FG000|Overall Study|Blank, site closed per local regulations|2
6888088|NCT00574873|10902274|FG001|Overall Study|Blank, site closed per local regulations|2
6888089|NCT00574873|10902273|FG000|Overall Study|Extension Study|126
6888090|NCT00574873|10902274|FG001|Overall Study|Extension Study|0
6888091|NCT00574912|10902280|FG000|Overall Study|Could not place IV lines.|3
6888092|NCT00574912|10902280|FG000|Overall Study|scheduling conflicts|3
6888093|NCT00574912|10902280|FG000|Overall Study|Physician Decision|2
6888094|NCT00574951|10902292|FG000|Overall Study|Ineligible - improper prior treatment|1
6888095|NCT00575042|10902333|FG000|Overall Study|Adverse Event|2
6888096|NCT00575042|10902333|FG000|Overall Study|Lost to Follow-up|1
6888097|NCT00575094|10902338|FG000|Overall Study|Adverse Event|2
6888098|NCT00575094|10902338|FG000|Overall Study|Withdrawal by Subject|1
6888099|NCT00575328|10902375|FG000|Overall Study|Adverse Event|1
6888100|NCT00575328|10902376|FG001|Overall Study|Adverse Event|1
6888101|NCT00575328|10902375|FG000|Overall Study|Lost to Follow-up|2
6888102|NCT00575328|10902376|FG001|Overall Study|Lost to Follow-up|1
6888103|NCT00575380|10902393|FG000|Overall Study|Withdrawal by Subject|1
6888104|NCT00575380|10902394|FG001|Overall Study|Withdrawal by Subject|0
6888105|NCT00575380|10902393|FG000|Overall Study|Adverse Event|0
6888106|NCT00575380|10902394|FG001|Overall Study|Adverse Event|1
6888107|NCT00575380|10902393|FG000|Overall Study|Various|0
6888108|NCT00575380|10902394|FG001|Overall Study|Various|2
6888109|NCT00575510|10902403|FG000|Overall Study|Lost to Follow-up|4
6888110|NCT00575510|10902404|FG001|Overall Study|Lost to Follow-up|6
6888111|NCT00575510|10902405|FG002|Overall Study|Lost to Follow-up|9
6888112|NCT00575510|10902403|FG000|Overall Study|Withdrawal by Subject|1
6888113|NCT00575510|10902404|FG001|Overall Study|Withdrawal by Subject|0
6888114|NCT00575510|10902405|FG002|Overall Study|Withdrawal by Subject|0
6888115|NCT00575510|10902403|FG000|Overall Study|Clinic Called Patient|7
6888116|NCT00575510|10902404|FG001|Overall Study|Clinic Called Patient|7
6888117|NCT00575510|10902405|FG002|Overall Study|Clinic Called Patient|7
6888118|NCT00575510|10902403|FG000|Overall Study|Pregnancy|0
6888119|NCT00575510|10902404|FG001|Overall Study|Pregnancy|0
6888120|NCT00575510|10902405|FG002|Overall Study|Pregnancy|1
6888121|NCT00575588|10902416|FG000|Overall Study|Adverse Event|11
6888122|NCT00575588|10902417|FG001|Overall Study|Adverse Event|13
6888123|NCT00575588|10902416|FG000|Overall Study|Withdrawal by Subject|27
6888124|NCT00575588|10902417|FG001|Overall Study|Withdrawal by Subject|31
6888125|NCT00575588|10902416|FG000|Overall Study|Lost to Follow-up|1
6888126|NCT00575588|10902417|FG001|Overall Study|Lost to Follow-up|3
6888127|NCT00575588|10902416|FG000|Overall Study|Death|4
6888128|NCT00575588|10902417|FG001|Overall Study|Death|2
6888129|NCT00575588|10902416|FG000|Overall Study|Incorrect enrollment|8
6888130|NCT00575588|10902417|FG001|Overall Study|Incorrect enrollment|4
6888131|NCT00575588|10902416|FG000|Overall Study|Study specific discontinuation criteria|203
6888132|NCT00575588|10902417|FG001|Overall Study|Study specific discontinuation criteria|218
6888133|NCT00575588|10902416|FG000|Overall Study|Severe non-compliance to protocol|5
6888134|NCT00575588|10902417|FG001|Overall Study|Severe non-compliance to protocol|7
6888135|NCT00575588|10902416|FG000|Overall Study|Safety reasons|2
6888136|NCT00575588|10902417|FG001|Overall Study|Safety reasons|1
6888137|NCT00575588|10902416|FG000|Overall Study|Elevated triglyceride|1
6888138|NCT00575588|10902417|FG001|Overall Study|Elevated triglyceride|0
6888139|NCT00575588|10902416|FG000|Overall Study|Patient moved|1
6888140|NCT00575588|10902417|FG001|Overall Study|Patient moved|3
6888141|NCT00575588|10902416|FG000|Overall Study|Impossible to determine HbA1c|0
6888142|NCT00575588|10902417|FG001|Overall Study|Impossible to determine HbA1c|1
6888143|NCT00575666|10902425|FG000|Overall Study|Withdrawal by Subject|3
6888144|NCT00575666|10902426|FG001|Overall Study|Withdrawal by Subject|2
6888145|NCT00575666|10902425|FG000|Overall Study|Physician Decision|1
6888146|NCT00575666|10902426|FG001|Overall Study|Physician Decision|1
6888147|NCT00576056|10902440|FG000|Overall Study|Adverse Event|1
6888148|NCT00576056|10902440|FG000|Overall Study|Death|1
6888149|NCT00576056|10902440|FG000|Overall Study|Lack of Efficacy|1
6888150|NCT00576056|10902440|FG000|Overall Study|Withdrawal by Subject|2
6888151|NCT00576056|10902440|FG000|Overall Study|did not meet eligibility criteria|8
6888152|NCT00576056|10902440|FG000|Overall Study|Physician Decision|1
6888153|NCT00576199|10902448|FG000|Overall Study|Adverse Event|12
6888154|NCT00576199|10902448|FG000|Overall Study|Insufficient Therapeutic Response|14
6888155|NCT00576199|10902448|FG000|Overall Study|Refused Treatment|2
6888156|NCT00576199|10902448|FG000|Overall Study|Reason Unspecified|2
6888157|NCT00576303|10902461|FG000|Dose Titration Period|Early withdrawal|17
6888158|NCT00576303|10902461|FG000|Efficacy Evaluation Period|Early withdrawal|5
6888159|NCT00576303|10902461|FG000|Long Term Safety Period|Early withdrawal|16
6888160|NCT00576316|10902465|FG000|Overall Study|Adverse Event|9
6888161|NCT00576316|10902465|FG000|Overall Study|Withdrawal by Subject|2
6888162|NCT00576316|10902465|FG000|Overall Study|Protocol Violation|9
6888163|NCT00576381|10902469|FG000|Overall Study|Reoperation|3
6888164|NCT00576381|10902469|FG000|Overall Study|Adverse Event|4
6888165|NCT00576420|10902476|FG000|Overall Study|Death|0
6888166|NCT00576420|10902477|FG001|Overall Study|Death|0
6888167|NCT00576420|10902478|FG002|Overall Study|Death|1
6970207|NCT01154140|11020264|FG000|Overall Study|Death|71
6970208|NCT01154140|11020265|FG001|Overall Study|Death|81
6970209|NCT01154140|11020264|FG000|Overall Study|Lost to Follow-up|4
6970210|NCT01154140|11020265|FG001|Overall Study|Lost to Follow-up|5
6970211|NCT01154140|11020264|FG000|Overall Study|Withdrawal by Subject|12
6970212|NCT01154140|11020265|FG001|Overall Study|Withdrawal by Subject|13
6970213|NCT01154140|11020264|FG000|Overall Study|Other|3
6970214|NCT01154140|11020265|FG001|Overall Study|Other|1
6970215|NCT01154140|11020264|FG000|Overall Study|Randomized but not treated|1
6970216|NCT01154140|11020265|FG001|Overall Study|Randomized but not treated|2
6970217|NCT01154153|11020273|FG000|Overall Study|Poor compliance to protocol|2
6970218|NCT01154153|11020274|FG001|Overall Study|Poor compliance to protocol|0
6970219|NCT01154153|11020273|FG000|Overall Study|Unable to use labs|2
6970220|NCT01154153|11020274|FG001|Overall Study|Unable to use labs|3
6970221|NCT01154153|11020273|FG000|Overall Study|Withdrew consent|1
6970222|NCT01154153|11020274|FG001|Overall Study|Withdrew consent|0
6970223|NCT01154166|11020282|FG000|Overall Study|Adverse Event|14
6970224|NCT01154166|11020283|FG001|Overall Study|Adverse Event|9
6970225|NCT01154166|11020282|FG000|Overall Study|Lost to Follow-up|1
6970226|NCT01154166|11020283|FG001|Overall Study|Lost to Follow-up|1
6970227|NCT01154166|11020282|FG000|Overall Study|Protocol Violation|4
6970228|NCT01154166|11020283|FG001|Overall Study|Protocol Violation|1
6970229|NCT01154166|11020282|FG000|Overall Study|Withdrawal by Subject|10
6970230|NCT01154166|11020283|FG001|Overall Study|Withdrawal by Subject|1
6970231|NCT01154166|11020282|FG000|Overall Study|Lack of Efficacy|3
6970232|NCT01154166|11020283|FG001|Overall Study|Lack of Efficacy|0
6970233|NCT01154166|11020282|FG000|Overall Study|Disease Progression|1
6970234|NCT01154166|11020283|FG001|Overall Study|Disease Progression|0
6970235|NCT01154166|11020282|FG000|Overall Study|Poor Compliance|1
6970236|NCT01154166|11020283|FG001|Overall Study|Poor Compliance|0
6970237|NCT01154218|11020303|FG000|Third Intervention Period|Adverse Event|0
6970238|NCT01154218|11020304|FG001|Third Intervention Period|Adverse Event|1
6970239|NCT01154218|11020305|FG002|Third Intervention Period|Adverse Event|0
6970240|NCT01154218|11020306|FG003|Third Intervention Period|Adverse Event|0
6970241|NCT01154218|11020303|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
6970242|NCT01154218|11020304|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
6970243|NCT01154218|11020305|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
6970244|NCT01154218|11020306|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1
6970245|NCT01154218|11020303|FG000|Fourth Intervention Period|Withdrawal by Subject|1
6970246|NCT01154218|11020304|FG001|Fourth Intervention Period|Withdrawal by Subject|0
6970247|NCT01154218|11020305|FG002|Fourth Intervention Period|Withdrawal by Subject|0
6970248|NCT01154218|11020306|FG003|Fourth Intervention Period|Withdrawal by Subject|0
6970249|NCT01154231|11020316|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1
6970250|NCT01154231|11020316|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1
6970251|NCT01154283|11020322|FG000|0-6 Weeks|Withdrawal by Subject|7
6970252|NCT01154283|11020323|FG001|0-6 Weeks|Withdrawal by Subject|2
6970253|NCT01154283|11020322|FG000|0-6 Weeks|Death|0
6970254|NCT01154283|11020323|FG001|0-6 Weeks|Death|1
6970255|NCT01154283|11020322|FG000|7-12 Weeks|Death|1
6970256|NCT01154283|11020323|FG001|7-12 Weeks|Death|0
6970257|NCT01154283|11020322|FG000|7-12 Weeks|Withdrawal by Subject|0
6970258|NCT01154283|11020323|FG001|7-12 Weeks|Withdrawal by Subject|1
6970259|NCT01154296|11020331|FG000|Randomization and Intervention|Decided to decline|1
6970260|NCT01154296|11020332|FG001|Randomization and Intervention|Decided to decline|1
6970261|NCT01154296|11020331|FG000|Randomization and Intervention|Declined by staff|1
6970262|NCT01154296|11020332|FG001|Randomization and Intervention|Declined by staff|0
6970263|NCT01154296|11020331|FG000|Randomization and Intervention|Did not return|1
6970264|NCT01154296|11020332|FG001|Randomization and Intervention|Did not return|0
6888168|NCT00576472|10902542|FG000|MPH In-Lab Phase|Declined participation in medication pha|0
6888169|NCT00576472|10902543|FG001|MPH In-Lab Phase|Declined participation in medication pha|0
6888170|NCT00576472|10902544|FG002|MPH In-Lab Phase|Declined participation in medication pha|0
6888171|NCT00576472|10902545|FG003|MPH In-Lab Phase|Declined participation in medication pha|75
6888172|NCT00576472|10902546|FG004|MPH In-Lab Phase|Declined participation in medication pha|0
6888173|NCT00576472|10902547|FG005|MPH In-Lab Phase|Declined participation in medication pha|0
6888174|NCT00576472|10902548|FG006|MPH In-Lab Phase|Declined participation in medication pha|0
6888175|NCT00576472|10902549|FG007|MPH In-Lab Phase|Declined participation in medication pha|0
6888176|NCT00576472|10902550|FG008|MPH In-Lab Phase|Declined participation in medication pha|0
6888177|NCT00576472|10902551|FG009|MPH In-Lab Phase|Declined participation in medication pha|0
6888178|NCT00576472|10902552|FG010|MPH In-Lab Phase|Declined participation in medication pha|0
6888179|NCT00576472|10902553|FG011|MPH In-Lab Phase|Declined participation in medication pha|0
6888180|NCT00576472|10902554|FG012|MPH In-Lab Phase|Declined participation in medication pha|0
6888181|NCT00576472|10902555|FG013|MPH In-Lab Phase|Declined participation in medication pha|0
6888182|NCT00576472|10902556|FG014|MPH In-Lab Phase|Declined participation in medication pha|0
6888183|NCT00576472|10902542|FG000|MPH In-Lab Phase|Lost to Follow-up|0
6888184|NCT00576472|10902543|FG001|MPH In-Lab Phase|Lost to Follow-up|0
6888185|NCT00576472|10902544|FG002|MPH In-Lab Phase|Lost to Follow-up|0
6888186|NCT00576472|10902545|FG003|MPH In-Lab Phase|Lost to Follow-up|1
6888187|NCT00576472|10902546|FG004|MPH In-Lab Phase|Lost to Follow-up|0
6888188|NCT00576472|10902547|FG005|MPH In-Lab Phase|Lost to Follow-up|0
6888189|NCT00576472|10902548|FG006|MPH In-Lab Phase|Lost to Follow-up|0
6888190|NCT00576472|10902549|FG007|MPH In-Lab Phase|Lost to Follow-up|0
6888191|NCT00576472|10902550|FG008|MPH In-Lab Phase|Lost to Follow-up|0
6888192|NCT00576472|10902551|FG009|MPH In-Lab Phase|Lost to Follow-up|0
6888193|NCT00576472|10902552|FG010|MPH In-Lab Phase|Lost to Follow-up|0
6888194|NCT00576472|10902553|FG011|MPH In-Lab Phase|Lost to Follow-up|0
6888195|NCT00576472|10902554|FG012|MPH In-Lab Phase|Lost to Follow-up|0
6888196|NCT00576472|10902555|FG013|MPH In-Lab Phase|Lost to Follow-up|0
6888197|NCT00576472|10902556|FG014|MPH In-Lab Phase|Lost to Follow-up|0
6888198|NCT00576472|10902542|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
6888199|NCT00576472|10902543|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
6888200|NCT00576472|10902544|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
6888201|NCT00576472|10902545|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4
6888202|NCT00576472|10902546|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
6888203|NCT00576472|10902547|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
6888204|NCT00576472|10902548|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
6888205|NCT00576472|10902549|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
6888206|NCT00576472|10902550|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
6888207|NCT00576472|10902551|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
6888208|NCT00576472|10902552|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
6888209|NCT00576472|10902553|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
6888210|NCT00576472|10902554|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
6888211|NCT00576472|10902555|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
6888212|NCT00576472|10902556|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
6888213|NCT00576472|10902542|FG000|MPH In-Lab Phase|No attention/academic problems|0
6888214|NCT00576472|10902543|FG001|MPH In-Lab Phase|No attention/academic problems|0
6888215|NCT00576472|10902544|FG002|MPH In-Lab Phase|No attention/academic problems|0
6888216|NCT00576472|10902545|FG003|MPH In-Lab Phase|No attention/academic problems|245
6888217|NCT00576472|10902546|FG004|MPH In-Lab Phase|No attention/academic problems|0
6888218|NCT00576472|10902547|FG005|MPH In-Lab Phase|No attention/academic problems|0
6888219|NCT00576472|10902548|FG006|MPH In-Lab Phase|No attention/academic problems|0
6888220|NCT00576472|10902549|FG007|MPH In-Lab Phase|No attention/academic problems|0
6888221|NCT00576472|10902550|FG008|MPH In-Lab Phase|No attention/academic problems|0
6888222|NCT00576472|10902551|FG009|MPH In-Lab Phase|No attention/academic problems|0
6888223|NCT00576472|10902552|FG010|MPH In-Lab Phase|No attention/academic problems|0
6888224|NCT00576472|10902553|FG011|MPH In-Lab Phase|No attention/academic problems|0
6888225|NCT00576472|10902554|FG012|MPH In-Lab Phase|No attention/academic problems|0
6888226|NCT00576472|10902555|FG013|MPH In-Lab Phase|No attention/academic problems|0
6888227|NCT00576472|10902556|FG014|MPH In-Lab Phase|No attention/academic problems|0
6888228|NCT00576472|10902542|FG000|MPH In-Lab Phase|Psychiatric exclusion|0
6888229|NCT00576472|10902543|FG001|MPH In-Lab Phase|Psychiatric exclusion|0
6888230|NCT00576472|10902544|FG002|MPH In-Lab Phase|Psychiatric exclusion|0
6888231|NCT00576472|10902545|FG003|MPH In-Lab Phase|Psychiatric exclusion|10
6888232|NCT00576472|10902546|FG004|MPH In-Lab Phase|Psychiatric exclusion|0
6888233|NCT00576472|10902547|FG005|MPH In-Lab Phase|Psychiatric exclusion|0
6888234|NCT00576472|10902548|FG006|MPH In-Lab Phase|Psychiatric exclusion|0
6888235|NCT00576472|10902549|FG007|MPH In-Lab Phase|Psychiatric exclusion|0
6888236|NCT00576472|10902550|FG008|MPH In-Lab Phase|Psychiatric exclusion|0
6888237|NCT00576472|10902551|FG009|MPH In-Lab Phase|Psychiatric exclusion|0
6888238|NCT00576472|10902552|FG010|MPH In-Lab Phase|Psychiatric exclusion|0
6888239|NCT00576472|10902553|FG011|MPH In-Lab Phase|Psychiatric exclusion|0
6888240|NCT00576472|10902554|FG012|MPH In-Lab Phase|Psychiatric exclusion|0
6888241|NCT00576472|10902555|FG013|MPH In-Lab Phase|Psychiatric exclusion|0
6888242|NCT00576472|10902556|FG014|MPH In-Lab Phase|Psychiatric exclusion|0
6888243|NCT00576472|10902542|FG000|MPH Cross Over Phase|Withdrawal by Subject|0
6888244|NCT00576472|10902543|FG001|MPH Cross Over Phase|Withdrawal by Subject|0
6888245|NCT00576472|10902544|FG002|MPH Cross Over Phase|Withdrawal by Subject|0
6888246|NCT00576472|10902545|FG003|MPH Cross Over Phase|Withdrawal by Subject|0
6888247|NCT00576472|10902546|FG004|MPH Cross Over Phase|Withdrawal by Subject|0
6888248|NCT00576472|10902547|FG005|MPH Cross Over Phase|Withdrawal by Subject|0
6888249|NCT00576472|10902548|FG006|MPH Cross Over Phase|Withdrawal by Subject|6
6888250|NCT00576472|10902549|FG007|MPH Cross Over Phase|Withdrawal by Subject|0
6888251|NCT00576472|10902550|FG008|MPH Cross Over Phase|Withdrawal by Subject|0
6888252|NCT00576472|10902551|FG009|MPH Cross Over Phase|Withdrawal by Subject|0
6888253|NCT00576472|10902552|FG010|MPH Cross Over Phase|Withdrawal by Subject|0
6888254|NCT00576472|10902553|FG011|MPH Cross Over Phase|Withdrawal by Subject|0
6888255|NCT00576472|10902554|FG012|MPH Cross Over Phase|Withdrawal by Subject|0
6888256|NCT00576472|10902555|FG013|MPH Cross Over Phase|Withdrawal by Subject|0
6888257|NCT00576472|10902556|FG014|MPH Cross Over Phase|Withdrawal by Subject|0
6888258|NCT00576472|10902542|FG000|MPH Cross Over Phase|Ineligible due to disease|0
6888259|NCT00576472|10902543|FG001|MPH Cross Over Phase|Ineligible due to disease|0
6888260|NCT00576472|10902544|FG002|MPH Cross Over Phase|Ineligible due to disease|0
6888261|NCT00576472|10902545|FG003|MPH Cross Over Phase|Ineligible due to disease|0
6888262|NCT00576472|10902546|FG004|MPH Cross Over Phase|Ineligible due to disease|0
6888263|NCT00576472|10902547|FG005|MPH Cross Over Phase|Ineligible due to disease|0
6888264|NCT00576472|10902548|FG006|MPH Cross Over Phase|Ineligible due to disease|2
6888265|NCT00576472|10902549|FG007|MPH Cross Over Phase|Ineligible due to disease|0
6888266|NCT00576472|10902550|FG008|MPH Cross Over Phase|Ineligible due to disease|0
6888267|NCT00576472|10902551|FG009|MPH Cross Over Phase|Ineligible due to disease|0
6888268|NCT00576472|10902552|FG010|MPH Cross Over Phase|Ineligible due to disease|0
6888269|NCT00576472|10902553|FG011|MPH Cross Over Phase|Ineligible due to disease|0
6888270|NCT00576472|10902554|FG012|MPH Cross Over Phase|Ineligible due to disease|0
6888271|NCT00576472|10902555|FG013|MPH Cross Over Phase|Ineligible due to disease|0
6888272|NCT00576472|10902556|FG014|MPH Cross Over Phase|Ineligible due to disease|0
6888273|NCT00576472|10902542|FG000|MPH Cross Over Phase|Physician Decision|0
6888274|NCT00576472|10902543|FG001|MPH Cross Over Phase|Physician Decision|0
6888275|NCT00576472|10902544|FG002|MPH Cross Over Phase|Physician Decision|0
6888276|NCT00576472|10902545|FG003|MPH Cross Over Phase|Physician Decision|0
6888277|NCT00576472|10902546|FG004|MPH Cross Over Phase|Physician Decision|0
6888278|NCT00576472|10902547|FG005|MPH Cross Over Phase|Physician Decision|0
6888279|NCT00576472|10902548|FG006|MPH Cross Over Phase|Physician Decision|4
6888280|NCT00576472|10902549|FG007|MPH Cross Over Phase|Physician Decision|0
6888281|NCT00576472|10902550|FG008|MPH Cross Over Phase|Physician Decision|0
6888282|NCT00576472|10902551|FG009|MPH Cross Over Phase|Physician Decision|0
7155690|NCT03345914|11323750|FG000|Overall Study|Physician Decision|0
7155691|NCT03345914|11323751|FG001|Overall Study|Physician Decision|1
7155692|NCT03345914|11323752|FG002|Overall Study|Physician Decision|1
7155693|NCT03345914|11323750|FG000|Overall Study|Withdrawal by Subject|5
7155694|NCT03345914|11323751|FG001|Overall Study|Withdrawal by Subject|1
6888283|NCT00576472|10902552|FG010|MPH Cross Over Phase|Physician Decision|0
6888284|NCT00576472|10902553|FG011|MPH Cross Over Phase|Physician Decision|0
6888285|NCT00576472|10902554|FG012|MPH Cross Over Phase|Physician Decision|0
6888286|NCT00576472|10902555|FG013|MPH Cross Over Phase|Physician Decision|0
6888287|NCT00576472|10902556|FG014|MPH Cross Over Phase|Physician Decision|0
6888288|NCT00576472|10902542|FG000|MPH Cross Over Phase|Did not complete cross over phase|0
6888289|NCT00576472|10902543|FG001|MPH Cross Over Phase|Did not complete cross over phase|0
6888290|NCT00576472|10902544|FG002|MPH Cross Over Phase|Did not complete cross over phase|0
6888291|NCT00576472|10902545|FG003|MPH Cross Over Phase|Did not complete cross over phase|0
6888292|NCT00576472|10902546|FG004|MPH Cross Over Phase|Did not complete cross over phase|0
6888293|NCT00576472|10902547|FG005|MPH Cross Over Phase|Did not complete cross over phase|0
6888294|NCT00576472|10902548|FG006|MPH Cross Over Phase|Did not complete cross over phase|0
6888295|NCT00576472|10902549|FG007|MPH Cross Over Phase|Did not complete cross over phase|0
6888296|NCT00576472|10902550|FG008|MPH Cross Over Phase|Did not complete cross over phase|2
6888297|NCT00576472|10902551|FG009|MPH Cross Over Phase|Did not complete cross over phase|0
6888298|NCT00576472|10902552|FG010|MPH Cross Over Phase|Did not complete cross over phase|1
6888299|NCT00576472|10902553|FG011|MPH Cross Over Phase|Did not complete cross over phase|1
6888300|NCT00576472|10902554|FG012|MPH Cross Over Phase|Did not complete cross over phase|0
6888301|NCT00576472|10902555|FG013|MPH Cross Over Phase|Did not complete cross over phase|0
6888302|NCT00576472|10902556|FG014|MPH Cross Over Phase|Did not complete cross over phase|0
6888303|NCT00576472|10902542|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0
6888304|NCT00576472|10902543|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0
6888305|NCT00576472|10902544|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0
6888306|NCT00576472|10902545|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0
7155695|NCT03345914|11323752|FG002|Overall Study|Withdrawal by Subject|2
7155696|NCT03345914|11323750|FG000|Overall Study|Other|1
6888307|NCT00576472|10902546|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0
6888308|NCT00576472|10902547|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0
6888309|NCT00576472|10902548|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0
6888310|NCT00576472|10902549|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0
6888311|NCT00576472|10902550|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0
6888312|NCT00576472|10902551|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0
6888313|NCT00576472|10902552|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0
6888314|NCT00576472|10902553|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0
6888315|NCT00576472|10902554|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0
6888316|NCT00576472|10902555|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16
6888317|NCT00576472|10902556|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0
6888318|NCT00576472|10902542|FG000|MPH Home Maintenance Phase|Declined to participate|0
6888319|NCT00576472|10902543|FG001|MPH Home Maintenance Phase|Declined to participate|0
6888320|NCT00576472|10902544|FG002|MPH Home Maintenance Phase|Declined to participate|0
6888321|NCT00576472|10902545|FG003|MPH Home Maintenance Phase|Declined to participate|0
6888322|NCT00576472|10902546|FG004|MPH Home Maintenance Phase|Declined to participate|0
6888323|NCT00576472|10902547|FG005|MPH Home Maintenance Phase|Declined to participate|0
6888324|NCT00576472|10902548|FG006|MPH Home Maintenance Phase|Declined to participate|0
6888325|NCT00576472|10902549|FG007|MPH Home Maintenance Phase|Declined to participate|0
6888326|NCT00576472|10902550|FG008|MPH Home Maintenance Phase|Declined to participate|0
6888327|NCT00576472|10902551|FG009|MPH Home Maintenance Phase|Declined to participate|0
6888328|NCT00576472|10902552|FG010|MPH Home Maintenance Phase|Declined to participate|0
6888329|NCT00576472|10902553|FG011|MPH Home Maintenance Phase|Declined to participate|0
7079178|NCT02110225|11187983|FG002|Overall Study|Lost to Follow-up|0
7079179|NCT02110238|11187994|FG000|12 Week Pivotal Phase|Adverse Event|3
7079180|NCT02110238|11187995|FG001|12 Week Pivotal Phase|Adverse Event|0
7079181|NCT02110238|11187994|FG000|12 Week Pivotal Phase|Lack of Efficacy|2
7079182|NCT02110238|11187995|FG001|12 Week Pivotal Phase|Lack of Efficacy|3
7079183|NCT02110238|11187994|FG000|12 Week Pivotal Phase|Lost to Follow-up|2
7079184|NCT02110238|11187995|FG001|12 Week Pivotal Phase|Lost to Follow-up|0
6888330|NCT00576472|10902554|FG012|MPH Home Maintenance Phase|Declined to participate|0
6888331|NCT00576472|10902555|FG013|MPH Home Maintenance Phase|Declined to participate|7
6888332|NCT00576472|10902556|FG014|MPH Home Maintenance Phase|Declined to participate|0
6888333|NCT00576472|10902542|FG000|MPH Home Maintenance Phase|Insufficient data|0
6888334|NCT00576472|10902543|FG001|MPH Home Maintenance Phase|Insufficient data|0
6888335|NCT00576472|10902544|FG002|MPH Home Maintenance Phase|Insufficient data|0
6888336|NCT00576472|10902545|FG003|MPH Home Maintenance Phase|Insufficient data|0
6888337|NCT00576472|10902546|FG004|MPH Home Maintenance Phase|Insufficient data|0
6888338|NCT00576472|10902547|FG005|MPH Home Maintenance Phase|Insufficient data|0
6888339|NCT00576472|10902548|FG006|MPH Home Maintenance Phase|Insufficient data|0
6888340|NCT00576472|10902549|FG007|MPH Home Maintenance Phase|Insufficient data|0
6888341|NCT00576472|10902550|FG008|MPH Home Maintenance Phase|Insufficient data|0
6888342|NCT00576472|10902551|FG009|MPH Home Maintenance Phase|Insufficient data|0
6888343|NCT00576472|10902552|FG010|MPH Home Maintenance Phase|Insufficient data|0
6888344|NCT00576472|10902553|FG011|MPH Home Maintenance Phase|Insufficient data|0
6888345|NCT00576472|10902554|FG012|MPH Home Maintenance Phase|Insufficient data|0
6888346|NCT00576472|10902555|FG013|MPH Home Maintenance Phase|Insufficient data|4
6888347|NCT00576472|10902556|FG014|MPH Home Maintenance Phase|Insufficient data|0
6888348|NCT00576472|10902542|FG000|MPH Home Maintenance Phase|Side effects|0
6888349|NCT00576472|10902543|FG001|MPH Home Maintenance Phase|Side effects|0
6888350|NCT00576472|10902544|FG002|MPH Home Maintenance Phase|Side effects|0
6888351|NCT00576472|10902545|FG003|MPH Home Maintenance Phase|Side effects|0
6888352|NCT00576472|10902546|FG004|MPH Home Maintenance Phase|Side effects|0
6888353|NCT00576472|10902547|FG005|MPH Home Maintenance Phase|Side effects|0
6888354|NCT00576472|10902548|FG006|MPH Home Maintenance Phase|Side effects|0
6888355|NCT00576472|10902549|FG007|MPH Home Maintenance Phase|Side effects|0
6888356|NCT00576472|10902550|FG008|MPH Home Maintenance Phase|Side effects|0
6888357|NCT00576472|10902551|FG009|MPH Home Maintenance Phase|Side effects|0
6888358|NCT00576472|10902552|FG010|MPH Home Maintenance Phase|Side effects|0
6888359|NCT00576472|10902553|FG011|MPH Home Maintenance Phase|Side effects|0
6888360|NCT00576472|10902554|FG012|MPH Home Maintenance Phase|Side effects|0
6888361|NCT00576472|10902555|FG013|MPH Home Maintenance Phase|Side effects|0
6888362|NCT00576472|10902556|FG014|MPH Home Maintenance Phase|Side effects|8
6970265|NCT01154296|11020331|FG000|Randomization and Intervention|Left before test|0
6970266|NCT01154296|11020332|FG001|Randomization and Intervention|Left before test|1
6970267|NCT01154296|11020331|FG000|Randomization and Intervention|Left clinic early|2
6970268|NCT01154296|11020332|FG001|Randomization and Intervention|Left clinic early|0
6970269|NCT01154296|11020331|FG000|6-month Follow-up|Lost contact|269
6970270|NCT01154296|11020332|FG001|6-month Follow-up|Lost contact|275
6970271|NCT01154296|11020331|FG000|6-month Follow-up|Incarcerated|37
6970272|NCT01154296|11020332|FG001|6-month Follow-up|Incarcerated|32
6970273|NCT01154296|11020331|FG000|6-month Follow-up|Withdrew consent|14
6970274|NCT01154296|11020332|FG001|6-month Follow-up|Withdrew consent|15
6970275|NCT01154296|11020331|FG000|6-month Follow-up|Death|3
6970276|NCT01154296|11020332|FG001|6-month Follow-up|Death|2
6970277|NCT01154296|11020331|FG000|6-month Follow-up|Declined by Study Coordinator|5
6970278|NCT01154296|11020332|FG001|6-month Follow-up|Declined by Study Coordinator|4
6970279|NCT01154452|11020347|FG000|Phase Ib|Not Treated|1
7079185|NCT02110238|11187994|FG000|12 Week Pivotal Phase|Physician Decision|0
6888363|NCT00576472|10902542|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0
6888364|NCT00576472|10902543|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0
6888365|NCT00576472|10902544|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0
6888366|NCT00576472|10902545|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0
6888367|NCT00576472|10902546|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0
6888368|NCT00576472|10902547|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0
6888369|NCT00576472|10902548|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0
6888370|NCT00576472|10902549|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0
6888371|NCT00576472|10902550|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0
6888372|NCT00576472|10902551|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0
6888373|NCT00576472|10902552|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0
6888374|NCT00576472|10902553|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0
6888375|NCT00576472|10902554|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0
6888376|NCT00576472|10902555|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0
6888377|NCT00576472|10902556|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6
6888378|NCT00576472|10902542|FG000|MPH Home Maintenance Phase|Medical reasons|0
6888379|NCT00576472|10902543|FG001|MPH Home Maintenance Phase|Medical reasons|0
6888380|NCT00576472|10902544|FG002|MPH Home Maintenance Phase|Medical reasons|0
6888381|NCT00576472|10902545|FG003|MPH Home Maintenance Phase|Medical reasons|0
6888382|NCT00576472|10902546|FG004|MPH Home Maintenance Phase|Medical reasons|0
6888383|NCT00576472|10902547|FG005|MPH Home Maintenance Phase|Medical reasons|0
6888384|NCT00576472|10902548|FG006|MPH Home Maintenance Phase|Medical reasons|0
6888385|NCT00576472|10902549|FG007|MPH Home Maintenance Phase|Medical reasons|0
6888386|NCT00576472|10902550|FG008|MPH Home Maintenance Phase|Medical reasons|0
6888387|NCT00576472|10902551|FG009|MPH Home Maintenance Phase|Medical reasons|0
6888388|NCT00576472|10902552|FG010|MPH Home Maintenance Phase|Medical reasons|0
6888389|NCT00576472|10902553|FG011|MPH Home Maintenance Phase|Medical reasons|0
6888390|NCT00576472|10902554|FG012|MPH Home Maintenance Phase|Medical reasons|0
6888391|NCT00576472|10902555|FG013|MPH Home Maintenance Phase|Medical reasons|0
6888392|NCT00576472|10902556|FG014|MPH Home Maintenance Phase|Medical reasons|6
6888393|NCT00576472|10902542|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0
6888394|NCT00576472|10902543|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0
6888395|NCT00576472|10902544|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0
6888396|NCT00576472|10902545|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0
6888397|NCT00576472|10902546|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0
6888398|NCT00576472|10902547|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0
6888399|NCT00576472|10902548|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0
6888400|NCT00576472|10902549|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0
6888401|NCT00576472|10902550|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0
6888402|NCT00576472|10902551|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0
6888403|NCT00576472|10902552|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0
6888404|NCT00576472|10902553|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0
6888405|NCT00576472|10902554|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0
6888406|NCT00576472|10902555|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0
6888407|NCT00576472|10902556|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3
6888408|NCT00576576|10902587|FG000|Overall Study|Lost to Follow-up|6
6888409|NCT00576576|10902587|FG000|Overall Study|Protocol Violation|1
6888410|NCT00576628|10902591|FG000|Overall Study|Adverse Event|11
6888411|NCT00576628|10902591|FG000|Overall Study|Death|2
6888412|NCT00576628|10902591|FG000|Overall Study|Failure to return|1
6888413|NCT00576628|10902591|FG000|Overall Study|Refused Treatment|8
6888414|NCT00576628|10902591|FG000|Overall Study|Pregnancy|1
6888415|NCT00576628|10902591|FG000|Overall Study|RBC transfusion|1
6888416|NCT00576628|10902591|FG000|Overall Study|Progression of Kidney Disease|1
6888417|NCT00576628|10902591|FG000|Overall Study|Progression of Renal Failure|1
6888418|NCT00576628|10902591|FG000|Overall Study|The patient move into other town|1
6888419|NCT00576628|10902591|FG000|Overall Study|Transplantation|1
6888420|NCT00576628|10902591|FG000|Overall Study|Dialysis|15
6888421|NCT00576693|10902602|FG000|Overall Study|Lost to Follow-up|7
6888422|NCT00576693|10902603|FG001|Overall Study|Lost to Follow-up|11
6888423|NCT00576693|10902602|FG000|Overall Study|Withdrawal by Subject|3
6970280|NCT01154452|11020348|FG001|Phase Ib|Not Treated|0
6970281|NCT01154452|11020349|FG002|Phase Ib|Not Treated|0
6970282|NCT01154452|11020350|FG003|Phase Ib|Not Treated|0
6970283|NCT01154452|11020347|FG000|Phase Ib|Adverse Event|2
6970284|NCT01154452|11020348|FG001|Phase Ib|Adverse Event|1
6970285|NCT01154452|11020349|FG002|Phase Ib|Adverse Event|0
6970286|NCT01154452|11020350|FG003|Phase Ib|Adverse Event|0
6970287|NCT01154452|11020347|FG000|Phase II|Withdrawal by Subject|0
6888424|NCT00576693|10902603|FG001|Overall Study|Withdrawal by Subject|13
6888425|NCT00576732|10902612|FG000|DOUBLE BLIND|Adverse Event|0
6888426|NCT00576732|10902613|FG001|DOUBLE BLIND|Adverse Event|0
6888427|NCT00576732|10902614|FG002|DOUBLE BLIND|Adverse Event|1
6888428|NCT00576732|10902615|FG003|DOUBLE BLIND|Adverse Event|0
6888429|NCT00576732|10902616|FG004|DOUBLE BLIND|Adverse Event|0
6888430|NCT00576732|10902617|FG005|DOUBLE BLIND|Adverse Event|0
6888431|NCT00576732|10902612|FG000|DOUBLE BLIND|Lost to Follow-up|0
6888432|NCT00576732|10902613|FG001|DOUBLE BLIND|Lost to Follow-up|1
6970288|NCT01154452|11020348|FG001|Phase II|Withdrawal by Subject|0
6970289|NCT01154452|11020349|FG002|Phase II|Withdrawal by Subject|1
6888433|NCT00576732|10902614|FG002|DOUBLE BLIND|Lost to Follow-up|1
6888434|NCT00576732|10902615|FG003|DOUBLE BLIND|Lost to Follow-up|0
6888435|NCT00576732|10902616|FG004|DOUBLE BLIND|Lost to Follow-up|0
6888436|NCT00576732|10902617|FG005|DOUBLE BLIND|Lost to Follow-up|0
6888437|NCT00576732|10902612|FG000|DOUBLE BLIND|Withdrawal by Subject|1
6888438|NCT00576732|10902613|FG001|DOUBLE BLIND|Withdrawal by Subject|1
6888439|NCT00576732|10902614|FG002|DOUBLE BLIND|Withdrawal by Subject|3
6888440|NCT00576732|10902615|FG003|DOUBLE BLIND|Withdrawal by Subject|0
6888441|NCT00576732|10902616|FG004|DOUBLE BLIND|Withdrawal by Subject|0
6888442|NCT00576732|10902617|FG005|DOUBLE BLIND|Withdrawal by Subject|0
6888443|NCT00576732|10902612|FG000|DOUBLE BLIND|OTHER|0
6888444|NCT00576732|10902613|FG001|DOUBLE BLIND|OTHER|2
6888445|NCT00576732|10902614|FG002|DOUBLE BLIND|OTHER|1
6888446|NCT00576732|10902615|FG003|DOUBLE BLIND|OTHER|0
6888447|NCT00576732|10902616|FG004|DOUBLE BLIND|OTHER|0
6888448|NCT00576732|10902617|FG005|DOUBLE BLIND|OTHER|0
6888449|NCT00576732|10902612|FG000|DOUBLE BLIND|Lack of Efficacy|6
6888450|NCT00576732|10902613|FG001|DOUBLE BLIND|Lack of Efficacy|1
6888451|NCT00576732|10902614|FG002|DOUBLE BLIND|Lack of Efficacy|0
6888452|NCT00576732|10902615|FG003|DOUBLE BLIND|Lack of Efficacy|0
6888453|NCT00576732|10902616|FG004|DOUBLE BLIND|Lack of Efficacy|0
6888454|NCT00576732|10902617|FG005|DOUBLE BLIND|Lack of Efficacy|0
6888455|NCT00576732|10902612|FG000|DOUBLE BLIND|Protocol Violation|1
6888456|NCT00576732|10902613|FG001|DOUBLE BLIND|Protocol Violation|0
6888457|NCT00576732|10902614|FG002|DOUBLE BLIND|Protocol Violation|0
6888458|NCT00576732|10902615|FG003|DOUBLE BLIND|Protocol Violation|0
6888459|NCT00576732|10902616|FG004|DOUBLE BLIND|Protocol Violation|0
6888460|NCT00576732|10902617|FG005|DOUBLE BLIND|Protocol Violation|0
6888461|NCT00576732|10902612|FG000|OPEN LABEL|Adverse Event|0
6888462|NCT00576732|10902613|FG001|OPEN LABEL|Adverse Event|0
6888463|NCT00576732|10902614|FG002|OPEN LABEL|Adverse Event|0
6888464|NCT00576732|10902615|FG003|OPEN LABEL|Adverse Event|4
6888465|NCT00576732|10902616|FG004|OPEN LABEL|Adverse Event|0
6888466|NCT00576732|10902617|FG005|OPEN LABEL|Adverse Event|1
6888467|NCT00576732|10902612|FG000|OPEN LABEL|Lost to Follow-up|0
6888468|NCT00576732|10902613|FG001|OPEN LABEL|Lost to Follow-up|0
6888469|NCT00576732|10902614|FG002|OPEN LABEL|Lost to Follow-up|0
6888470|NCT00576732|10902615|FG003|OPEN LABEL|Lost to Follow-up|2
6888471|NCT00576732|10902616|FG004|OPEN LABEL|Lost to Follow-up|1
6888472|NCT00576732|10902617|FG005|OPEN LABEL|Lost to Follow-up|1
6888473|NCT00576732|10902612|FG000|OPEN LABEL|Withdrawal by Subject|0
6888474|NCT00576732|10902613|FG001|OPEN LABEL|Withdrawal by Subject|0
6888475|NCT00576732|10902614|FG002|OPEN LABEL|Withdrawal by Subject|0
6888476|NCT00576732|10902615|FG003|OPEN LABEL|Withdrawal by Subject|1
6888477|NCT00576732|10902616|FG004|OPEN LABEL|Withdrawal by Subject|0
6888478|NCT00576732|10902617|FG005|OPEN LABEL|Withdrawal by Subject|1
6888479|NCT00576732|10902612|FG000|OPEN LABEL|OTHER|0
6888480|NCT00576732|10902613|FG001|OPEN LABEL|OTHER|0
6888481|NCT00576732|10902614|FG002|OPEN LABEL|OTHER|0
6888482|NCT00576732|10902615|FG003|OPEN LABEL|OTHER|0
6888483|NCT00576732|10902616|FG004|OPEN LABEL|OTHER|0
6888484|NCT00576732|10902617|FG005|OPEN LABEL|OTHER|2
6888485|NCT00576732|10902612|FG000|OPEN LABEL|Lack of Efficacy|0
6888486|NCT00576732|10902613|FG001|OPEN LABEL|Lack of Efficacy|0
6888487|NCT00576732|10902614|FG002|OPEN LABEL|Lack of Efficacy|0
6888488|NCT00576732|10902615|FG003|OPEN LABEL|Lack of Efficacy|2
6888489|NCT00576732|10902616|FG004|OPEN LABEL|Lack of Efficacy|2
6888490|NCT00576732|10902617|FG005|OPEN LABEL|Lack of Efficacy|3
6888491|NCT00576732|10902612|FG000|OPEN LABEL|Protocol Violation|0
6888492|NCT00576732|10902613|FG001|OPEN LABEL|Protocol Violation|0
6888493|NCT00576732|10902614|FG002|OPEN LABEL|Protocol Violation|0
6888494|NCT00576732|10902615|FG003|OPEN LABEL|Protocol Violation|2
6888495|NCT00576732|10902616|FG004|OPEN LABEL|Protocol Violation|1
6888496|NCT00576732|10902617|FG005|OPEN LABEL|Protocol Violation|0
6888497|NCT00576758|10902631|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3
6888498|NCT00576758|10902632|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3
6888499|NCT00576758|10902631|FG000|Induction Treatment Period|Insufficient therapeutic response|2
6888500|NCT00576758|10902632|FG001|Induction Treatment Period|Insufficient therapeutic response|0
6888501|NCT00576758|10902631|FG000|Induction Treatment Period|Violation of selection criteria at entry|1
6888502|NCT00576758|10902632|FG001|Induction Treatment Period|Violation of selection criteria at entry|1
6888503|NCT00576758|10902631|FG000|Induction Treatment Period|Death|1
6888504|NCT00576758|10902632|FG001|Induction Treatment Period|Death|0
6888505|NCT00576758|10902631|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0
6888506|NCT00576758|10902632|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1
6888507|NCT00576758|10902631|FG000|Induction Treatment Period|Withdrew consent|1
6888508|NCT00576758|10902632|FG001|Induction Treatment Period|Withdrew consent|0
6888509|NCT00576758|10902631|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6
6888510|NCT00576758|10902632|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7
6888511|NCT00576758|10902631|FG000|Extension Treatment Period|Death|1
6888512|NCT00576758|10902632|FG001|Extension Treatment Period|Death|1
6888513|NCT00576758|10902631|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2
6888514|NCT00576758|10902632|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1
6888515|NCT00576758|10902631|FG000|Extension Treatment Period|Insufficient therapeutic response|30
6888516|NCT00576758|10902632|FG001|Extension Treatment Period|Insufficient therapeutic response|33
6888517|NCT00576758|10902631|FG000|Extension Treatment Period|Administrative/Other|3
6888518|NCT00576758|10902632|FG001|Extension Treatment Period|Administrative/Other|1
6888519|NCT00576758|10902631|FG000|Follow-up Period|Administrative/Other|6
6888520|NCT00576758|10902632|FG001|Follow-up Period|Administrative/Other|8
6888521|NCT00576758|10902631|FG000|Follow-up Period|Death|3
6888522|NCT00576758|10902632|FG001|Follow-up Period|Death|3
6888523|NCT00576758|10902631|FG000|Follow-up Period|Insufficient therapeutic response|16
6888524|NCT00576758|10902632|FG001|Follow-up Period|Insufficient therapeutic response|5
6888525|NCT00576758|10902631|FG000|Follow-up Period|Withdrew consent|2
6888526|NCT00576758|10902632|FG001|Follow-up Period|Withdrew consent|1
6888527|NCT00576823|10902642|FG000|12-week Efficacy Phase|Parent's schedule issue|1
6888528|NCT00576823|10902643|FG001|12-week Efficacy Phase|Parent's schedule issue|0
6888529|NCT00576823|10902644|FG002|12-week Efficacy Phase|Parent's schedule issue|0
6888530|NCT00576823|10902642|FG000|40-week Safety Extension Phase|Lack of Efficacy|1
6888531|NCT00576823|10902643|FG001|40-week Safety Extension Phase|Lack of Efficacy|0
6888532|NCT00576823|10902644|FG002|40-week Safety Extension Phase|Lack of Efficacy|0
6888533|NCT00576901|10902655|FG000|Overall Study|Withdrawal by Subject|1
6888534|NCT00576901|10902655|FG000|Overall Study|Disease course|1
6888535|NCT00576901|10902655|FG000|Overall Study|Protocol Violation|1
6888536|NCT00576927|10902661|FG000|Clinical Assessment|Lack of Efficacy|24
6888537|NCT00576927|10902661|FG000|Clinical Assessment|Death|1
6888538|NCT00576927|10902661|FG000|Clinical Assessment|Withdrawal by Subject|10
6888539|NCT00576927|10902661|FG000|Clinical Assessment|Physician Decision|1
6888540|NCT00576927|10902661|FG000|Baseline|Physician Decision|9
6888541|NCT00576927|10902661|FG000|Baseline|Medication Change by PCP of subject|1
6888542|NCT00576927|10902661|FG000|Baseline|Withdrawal by Subject|3
6888543|NCT00576927|10902661|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4
6888544|NCT00576927|10902661|FG000|Sleep Hygiene Behavioral Intervention|Death|1
6888545|NCT00576927|10902661|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1
6888546|NCT00576927|10902661|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1
6888547|NCT00576927|10902661|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1
6888548|NCT00577005|10902669|FG000|Overall Study|Lost to Follow-up|3
6888549|NCT00577005|10902670|FG001|Overall Study|Lost to Follow-up|2
6888550|NCT00577005|10902669|FG000|Overall Study|Withdrawal by Subject|2
6888551|NCT00577005|10902670|FG001|Overall Study|Withdrawal by Subject|1
6888552|NCT00577031|10902679|FG000|Overall Study|Adverse Event|52
6888553|NCT00577031|10902679|FG000|Overall Study|Progression of disease|93
6888554|NCT00577031|10902679|FG000|Overall Study|Protocol Violation|5
6888555|NCT00577031|10902679|FG000|Overall Study|Participant withdrew consent|13
6888556|NCT00577031|10902679|FG000|Overall Study|Participant non-compliance|5
6888557|NCT00577031|10902679|FG000|Overall Study|Need for surgery|17
6888558|NCT00577031|10902679|FG000|Overall Study|Medical decision|14
6888559|NCT00577031|10902679|FG000|Overall Study|Death|6
6888560|NCT00577096|10902703|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3
6888561|NCT00577096|10902704|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2
6888562|NCT00577096|10902703|FG000|Short Term Participation|Withdrawal by Subject|3
6888563|NCT00577096|10902704|FG001|Short Term Participation|Withdrawal by Subject|5
6888564|NCT00577096|10902703|FG000|Short Term Participation|Death|1
7079186|NCT02110238|11187995|FG001|12 Week Pivotal Phase|Physician Decision|2
6888565|NCT00577096|10902704|FG001|Short Term Participation|Death|1
6888566|NCT00577122|10902712|FG000|Overall Study|Adverse Event|0
6888567|NCT00577122|10902713|FG001|Overall Study|Adverse Event|2
6888568|NCT00577122|10902712|FG000|Overall Study|Progression, relapse during active trt|6
6888569|NCT00577122|10902713|FG001|Overall Study|Progression, relapse during active trt|8
6888570|NCT00577122|10902712|FG000|Overall Study|Prog, refract disease during active trt|8
6888571|NCT00577122|10902713|FG001|Overall Study|Prog, refract disease during active trt|5
6888572|NCT00577122|10902712|FG000|Overall Study|Alternative Therapy|0
6888573|NCT00577122|10902713|FG001|Overall Study|Alternative Therapy|1
6888574|NCT00577382|10902739|FG000|Overall Study|Adverse Event|0
6888575|NCT00577382|10902740|FG001|Overall Study|Adverse Event|6
6888576|NCT00577382|10902739|FG000|Overall Study|Withdrawal by Subject|0
6888577|NCT00577382|10902740|FG001|Overall Study|Withdrawal by Subject|1
6888578|NCT00577382|10902739|FG000|Overall Study|Progressive Disease|17
6888579|NCT00577382|10902740|FG001|Overall Study|Progressive Disease|19
6888580|NCT00577382|10902739|FG000|Overall Study|Intercurrent Illness|1
6888581|NCT00577382|10902740|FG001|Overall Study|Intercurrent Illness|2
6888582|NCT00577382|10902739|FG000|Overall Study|Death|1
6888583|NCT00577382|10902740|FG001|Overall Study|Death|1
6888584|NCT00577382|10902739|FG000|Overall Study|Lost to Follow-up|2
6888585|NCT00577382|10902740|FG001|Overall Study|Lost to Follow-up|2
6888586|NCT00577408|10902748|FG000|Overall Study|Stopped attending study visits|9
6888587|NCT00577408|10902749|FG001|Overall Study|Stopped attending study visits|11
6888588|NCT00577408|10902748|FG000|Overall Study|Continued opioid use|3
6888589|NCT00577408|10902749|FG001|Overall Study|Continued opioid use|2
6888590|NCT00577408|10902748|FG000|Overall Study|Non-compliance with study meds|0
6888591|NCT00577408|10902749|FG001|Overall Study|Non-compliance with study meds|3
6888592|NCT00577408|10902748|FG000|Overall Study|Refused Oral Naltrexone|0
6888593|NCT00577408|10902749|FG001|Overall Study|Refused Oral Naltrexone|1
6888594|NCT00577408|10902748|FG000|Overall Study|Moved out of state|0
6888595|NCT00577408|10902749|FG001|Overall Study|Moved out of state|1
6888596|NCT00577408|10902748|FG000|Overall Study|Scheduling Issues|0
6888597|NCT00577408|10902749|FG001|Overall Study|Scheduling Issues|3
6888598|NCT00577408|10902748|FG000|Overall Study|Death|0
6888599|NCT00577408|10902749|FG001|Overall Study|Death|1
6888600|NCT00577408|10902748|FG000|Overall Study|Psychiatric hospitalization|0
6888601|NCT00577408|10902749|FG001|Overall Study|Psychiatric hospitalization|1
6888602|NCT00577460|10902758|FG000|Overall Study|Adverse Event|11
6888603|NCT00577460|10902759|FG001|Overall Study|Adverse Event|7
6888604|NCT00577460|10902760|FG002|Overall Study|Adverse Event|14
6888605|NCT00577460|10902758|FG000|Overall Study|Protocol Violation|0
6888606|NCT00577460|10902759|FG001|Overall Study|Protocol Violation|1
6888607|NCT00577460|10902760|FG002|Overall Study|Protocol Violation|1
6888608|NCT00577460|10902758|FG000|Overall Study|Lost to Follow-up|0
6888609|NCT00577460|10902759|FG001|Overall Study|Lost to Follow-up|3
6888610|NCT00577460|10902760|FG002|Overall Study|Lost to Follow-up|4
6888611|NCT00577460|10902758|FG000|Overall Study|Withdrawal by Subject|5
6888612|NCT00577460|10902759|FG001|Overall Study|Withdrawal by Subject|5
6888613|NCT00577460|10902760|FG002|Overall Study|Withdrawal by Subject|6
6888614|NCT00577460|10902758|FG000|Overall Study|Other|0
6888615|NCT00577460|10902759|FG001|Overall Study|Other|3
6888616|NCT00577460|10902760|FG002|Overall Study|Other|2
6888617|NCT00577473|10902777|FG000|Overall Study|Protocol Violation|1
6888618|NCT00577473|10902778|FG001|Overall Study|Protocol Violation|4
6888619|NCT00577473|10902777|FG000|Overall Study|Adverse Event|8
6888620|NCT00577473|10902778|FG001|Overall Study|Adverse Event|5
6888621|NCT00577473|10902777|FG000|Overall Study|Withdrawal by Subject|2
6888622|NCT00577473|10902778|FG001|Overall Study|Withdrawal by Subject|6
6888623|NCT00577473|10902777|FG000|Overall Study|Physician Decision|2
6888624|NCT00577473|10902778|FG001|Overall Study|Physician Decision|2
6888625|NCT00577473|10902777|FG000|Overall Study|Lack of Efficacy|8
6888626|NCT00577473|10902778|FG001|Overall Study|Lack of Efficacy|7
6888627|NCT00577629|10902801|FG000|Treatment Period|Death|1
6888628|NCT00577629|10902801|FG000|Long Term Follow-Up|Death|15
6888629|NCT00577629|10902801|FG000|Long Term Follow-Up|Lost to Follow-up|5
6888630|NCT00577629|10902801|FG000|Long Term Follow-Up|Withdrawal by Subject|4
6888631|NCT00577629|10902801|FG000|Long Term Follow-Up|Physician Decision|1
6888632|NCT00577642|10902807|FG000|Overall Study|Clinical Disease Progression|1
6888633|NCT00577655|10902813|FG000|Overall Study|Patient Request|0
6888634|NCT00577655|10902814|FG001|Overall Study|Patient Request|2
6888635|NCT00577655|10902813|FG000|Overall Study|Protocol Violation|0
6888636|NCT00577655|10902814|FG001|Overall Study|Protocol Violation|1
6888637|NCT00577655|10902813|FG000|Overall Study|Lost to Follow-up|1
6888638|NCT00577655|10902814|FG001|Overall Study|Lost to Follow-up|1
6888639|NCT00577707|10902821|FG000|Overall Study|Withdrawal by Subject|3
6888640|NCT00577720|10902829|FG000|Overall Study|Adverse Event|2
6888641|NCT00577720|10902830|FG001|Overall Study|Adverse Event|1
6888642|NCT00577720|10902831|FG002|Overall Study|Adverse Event|0
7155697|NCT03345914|11323751|FG001|Overall Study|Other|1
7155698|NCT03345914|11323752|FG002|Overall Study|Other|1
7155699|NCT03345914|11323750|FG000|Overall Study|Ongoing|0
7155700|NCT03345914|11323751|FG001|Overall Study|Ongoing|0
7155701|NCT03345914|11323752|FG002|Overall Study|Ongoing|1
7155702|NCT03345979|11323762|FG000|Overall Study|Withdrawal by Subject|20
7155703|NCT03345979|11323763|FG001|Overall Study|Withdrawal by Subject|31
7155704|NCT03345979|11323762|FG000|Overall Study|Adverse Event|10
7155705|NCT03345979|11323763|FG001|Overall Study|Adverse Event|11
7155706|NCT03345979|11323762|FG000|Overall Study|Lost to Follow-up|8
7155707|NCT03345979|11323763|FG001|Overall Study|Lost to Follow-up|9
7155708|NCT03345979|11323762|FG000|Overall Study|Lack of Efficacy|4
7155709|NCT03345979|11323763|FG001|Overall Study|Lack of Efficacy|2
7155710|NCT03345979|11323762|FG000|Overall Study|Protocol Violation|1
7155711|NCT03345979|11323763|FG001|Overall Study|Protocol Violation|3
7155712|NCT03345979|11323762|FG000|Overall Study|Physician Decision|0
7155713|NCT03345979|11323763|FG001|Overall Study|Physician Decision|2
7155714|NCT03346057|11323773|FG000|Overall Study|Death|1
7155715|NCT03346057|11323774|FG001|Overall Study|Death|2
7155716|NCT03346057|11323775|FG002|Overall Study|Death|0
7155717|NCT03346057|11323776|FG003|Overall Study|Death|0
7155718|NCT03346057|11323773|FG000|Overall Study|Lost to Follow-up|0
7155719|NCT03346057|11323774|FG001|Overall Study|Lost to Follow-up|2
7155720|NCT03346057|11323775|FG002|Overall Study|Lost to Follow-up|1
7155721|NCT03346057|11323776|FG003|Overall Study|Lost to Follow-up|0
6888643|NCT00577720|10902832|FG003|Overall Study|Adverse Event|4
6888644|NCT00577720|10902829|FG000|Overall Study|Lost to Follow-up|0
6888645|NCT00577720|10902830|FG001|Overall Study|Lost to Follow-up|0
6888646|NCT00577720|10902831|FG002|Overall Study|Lost to Follow-up|1
6888647|NCT00577720|10902832|FG003|Overall Study|Lost to Follow-up|0
6888648|NCT00577720|10902829|FG000|Overall Study|Protocol Violation|0
6888649|NCT00577720|10902830|FG001|Overall Study|Protocol Violation|0
6888650|NCT00577720|10902831|FG002|Overall Study|Protocol Violation|0
6888651|NCT00577720|10902832|FG003|Overall Study|Protocol Violation|1
6888652|NCT00577720|10902829|FG000|Overall Study|Withdrawal by Subject|2
6888653|NCT00577720|10902830|FG001|Overall Study|Withdrawal by Subject|0
6888654|NCT00577720|10902831|FG002|Overall Study|Withdrawal by Subject|0
6888655|NCT00577720|10902832|FG003|Overall Study|Withdrawal by Subject|2
6888656|NCT00577824|10902845|FG000|Overall Study|Adverse Event|6
7155722|NCT03346057|11323773|FG000|Overall Study|Ineligible For Study - Not Treated|0
7155723|NCT03346057|11323774|FG001|Overall Study|Ineligible For Study - Not Treated|1
6888657|NCT00577824|10902846|FG001|Overall Study|Adverse Event|18
6888658|NCT00577824|10902847|FG002|Overall Study|Adverse Event|1
6888659|NCT00577824|10902845|FG000|Overall Study|Patient decision|0
6888660|NCT00577824|10902846|FG001|Overall Study|Patient decision|1
6888661|NCT00577824|10902847|FG002|Overall Study|Patient decision|1
6888662|NCT00577824|10902845|FG000|Overall Study|Protocol Violation|1
6888663|NCT00577824|10902846|FG001|Overall Study|Protocol Violation|1
6888664|NCT00577824|10902847|FG002|Overall Study|Protocol Violation|0
6888665|NCT00577863|10902857|FG000|Overall Study|Adverse Event|4
6888666|NCT00577863|10902858|FG001|Overall Study|Adverse Event|2
6888667|NCT00577863|10902857|FG000|Overall Study|Death|1
6888668|NCT00577863|10902858|FG001|Overall Study|Death|0
6888669|NCT00577863|10902857|FG000|Overall Study|Lost to Follow-up|2
6888670|NCT00577863|10902858|FG001|Overall Study|Lost to Follow-up|2
6888671|NCT00577863|10902857|FG000|Overall Study|Entry Criteria Exclusion|1
6888672|NCT00577863|10902858|FG001|Overall Study|Entry Criteria Exclusion|0
6888673|NCT00577863|10902857|FG000|Overall Study|Withdrawal by Subject|0
6888674|NCT00577863|10902858|FG001|Overall Study|Withdrawal by Subject|2
6888675|NCT00577863|10902857|FG000|Overall Study|Sponsor Decision|2
6888676|NCT00577863|10902858|FG001|Overall Study|Sponsor Decision|7
6888677|NCT00577863|10902857|FG000|Overall Study|Did Not Receive at Least One Injection|0
6888678|NCT00577863|10902858|FG001|Overall Study|Did Not Receive at Least One Injection|1
6888679|NCT00577889|10902867|FG000|Overall Study|Withdrawal by Subject|1
6888680|NCT00577889|10902868|FG001|Overall Study|Withdrawal by Subject|0
6888681|NCT00577889|10902869|FG002|Overall Study|Withdrawal by Subject|0
6888682|NCT00577993|10902880|FG000|Overall Study|Adverse Event|1
6888683|NCT00577993|10902881|FG001|Overall Study|Adverse Event|0
6888684|NCT00577993|10902882|FG002|Overall Study|Adverse Event|0
6888685|NCT00577993|10902880|FG000|Overall Study|Death|0
6888686|NCT00577993|10902881|FG001|Overall Study|Death|1
6888687|NCT00577993|10902882|FG002|Overall Study|Death|1
6888688|NCT00577993|10902880|FG000|Overall Study|Lack of Efficacy|0
6888689|NCT00577993|10902881|FG001|Overall Study|Lack of Efficacy|1
6888690|NCT00577993|10902882|FG002|Overall Study|Lack of Efficacy|0
6888691|NCT00577993|10902880|FG000|Overall Study|Protocol Violation|2
6888692|NCT00577993|10902881|FG001|Overall Study|Protocol Violation|3
6888693|NCT00577993|10902882|FG002|Overall Study|Protocol Violation|0
6888694|NCT00577993|10902880|FG000|Overall Study|Withdrawal by Subject|1
6888695|NCT00577993|10902881|FG001|Overall Study|Withdrawal by Subject|0
6888696|NCT00577993|10902882|FG002|Overall Study|Withdrawal by Subject|2
7041307|NCT01725529|11124825|FG001|Overall Study|Adverse Event|0
7041308|NCT01725529|11124826|FG002|Overall Study|Adverse Event|0
7041309|NCT01725529|11124824|FG000|Overall Study|Lost to Follow-up|2
7041310|NCT01725529|11124825|FG001|Overall Study|Lost to Follow-up|1
7041311|NCT01725529|11124826|FG002|Overall Study|Lost to Follow-up|1
7041312|NCT01725529|11124824|FG000|Overall Study|Protocol Violation|0
7041313|NCT01725529|11124825|FG001|Overall Study|Protocol Violation|1
7041314|NCT01725529|11124826|FG002|Overall Study|Protocol Violation|1
7041315|NCT01725529|11124824|FG000|Overall Study|Withdrawal by Subject|12
7041316|NCT01725529|11124825|FG001|Overall Study|Withdrawal by Subject|14
7041317|NCT01725529|11124826|FG002|Overall Study|Withdrawal by Subject|8
7041318|NCT01725750|11124836|FG000|Overall Study|Adverse Event|1
7041319|NCT01725750|11124837|FG001|Overall Study|Adverse Event|0
7041320|NCT01725750|11124836|FG000|Overall Study|Lost to Follow-up|1
7041321|NCT01725750|11124837|FG001|Overall Study|Lost to Follow-up|1
7041322|NCT01725750|11124836|FG000|Overall Study|Withdrawal by Subject|0
7041323|NCT01725750|11124837|FG001|Overall Study|Withdrawal by Subject|9
7041324|NCT01726023|11124865|FG000|Overall Study|Death|1
6888697|NCT00577993|10902880|FG000|Overall Study|Conversion|2
6888698|NCT00577993|10902881|FG001|Overall Study|Conversion|5
6888699|NCT00577993|10902882|FG002|Overall Study|Conversion|0
6888700|NCT00577993|10902880|FG000|Overall Study|Uninsured|1
6888701|NCT00577993|10902881|FG001|Overall Study|Uninsured|0
6970290|NCT01154452|11020350|FG003|Phase II|Withdrawal by Subject|2
6970291|NCT01154452|11020347|FG000|Phase II|Adverse Event|0
6970292|NCT01154452|11020348|FG001|Phase II|Adverse Event|0
6970293|NCT01154452|11020349|FG002|Phase II|Adverse Event|4
6970294|NCT01154452|11020350|FG003|Phase II|Adverse Event|4
6970295|NCT01154673|11020382|FG000|Overall Study|Lost to Follow-up|1
6970296|NCT01154673|11020383|FG001|Overall Study|Lost to Follow-up|0
6970297|NCT01154673|11020382|FG000|Overall Study|moved out of province|1
6970298|NCT01154673|11020383|FG001|Overall Study|moved out of province|0
6970299|NCT01154816|11020416|FG000|Overall Study|Withdrawal by Subject|1
6970300|NCT01154816|11020417|FG001|Overall Study|Withdrawal by Subject|0
6970301|NCT01154816|11020418|FG002|Overall Study|Withdrawal by Subject|0
6970302|NCT01154816|11020419|FG003|Overall Study|Withdrawal by Subject|1
6970303|NCT01154816|11020420|FG004|Overall Study|Withdrawal by Subject|0
6970304|NCT01154816|11020421|FG005|Overall Study|Withdrawal by Subject|0
6970305|NCT01154816|11020422|FG006|Overall Study|Withdrawal by Subject|0
6970306|NCT01154816|11020423|FG007|Overall Study|Withdrawal by Subject|0
6970307|NCT01154816|11020424|FG008|Overall Study|Withdrawal by Subject|1
6970308|NCT01154816|11020425|FG009|Overall Study|Withdrawal by Subject|3
7041325|NCT01726023|11124866|FG001|Overall Study|Death|1
7041326|NCT01726023|11124865|FG000|Overall Study|Lost to Follow-up|5
7041327|NCT01726023|11124866|FG001|Overall Study|Lost to Follow-up|10
6888702|NCT00577993|10902882|FG002|Overall Study|Uninsured|0
6888703|NCT00578136|10902895|FG000|Overall Study|Not given intervention|1
6970309|NCT01154816|11020426|FG010|Overall Study|Withdrawal by Subject|0
6970310|NCT01154816|11020427|FG011|Overall Study|Withdrawal by Subject|0
6970311|NCT01154816|11020416|FG000|Overall Study|Progressive Disease|13
6970312|NCT01154816|11020417|FG001|Overall Study|Progressive Disease|8
6888704|NCT00578136|10902896|FG001|Overall Study|Not given intervention|1
6888705|NCT00578175|10902905|FG000|Overall Study|Adverse Event|0
6888706|NCT00578175|10902906|FG001|Overall Study|Adverse Event|1
6888707|NCT00578175|10902907|FG002|Overall Study|Adverse Event|1
6888708|NCT00578175|10902905|FG000|Overall Study|Other reasons|70
6888709|NCT00578175|10902906|FG001|Overall Study|Other reasons|42
6888710|NCT00578175|10902907|FG002|Overall Study|Other reasons|23
6888711|NCT00578227|10902933|FG000|Overall Study|Lost to Follow-up|0
6888712|NCT00578227|10902934|FG001|Overall Study|Lost to Follow-up|1
6888713|NCT00578227|10902935|FG002|Overall Study|Lost to Follow-up|1
6888714|NCT00578227|10902933|FG000|Overall Study|Withdrawal by Subject|5
6888715|NCT00578227|10902934|FG001|Overall Study|Withdrawal by Subject|1
6888716|NCT00578227|10902935|FG002|Overall Study|Withdrawal by Subject|3
6888717|NCT00578292|10902954|FG000|Overall Study|Death|1
6888718|NCT00578292|10902954|FG000|Overall Study|Graft failure|2
6888719|NCT00578318|10902979|FG000|Overall Study|Lost to Follow-up|2
6888720|NCT00578318|10902980|FG001|Overall Study|Lost to Follow-up|0
6888721|NCT00578318|10902979|FG000|Overall Study|Physician Decision|1
6888722|NCT00578318|10902980|FG001|Overall Study|Physician Decision|0
6888723|NCT00578344|10902995|FG000|Overall Study|Insurance problems|1
6888724|NCT00578344|10902995|FG000|Overall Study|Graft failure|1
6888725|NCT00578448|10903020|FG000|Day 1 up to 3 Years of Planned Study|Death|1
6888726|NCT00578448|10903020|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1
6888727|NCT00578448|10903020|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1
6888728|NCT00578448|10903020|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1
6888729|NCT00578565|10903047|FG000|Overall Study|Adverse Event|3
6888730|NCT00578643|10903061|FG000|Overall Study|Death|1
6888731|NCT00578643|10903061|FG000|Overall Study|Lost to Follow-up|1
6888732|NCT00578786|10903086|FG000|Overall Study|Adverse Event|27
6888733|NCT00578786|10903087|FG001|Overall Study|Adverse Event|37
6888734|NCT00578786|10903088|FG002|Overall Study|Adverse Event|17
6888735|NCT00578786|10903086|FG000|Overall Study|Lack of Efficacy|2
6888736|NCT00578786|10903087|FG001|Overall Study|Lack of Efficacy|5
6888737|NCT00578786|10903088|FG002|Overall Study|Lack of Efficacy|2
6888738|NCT00578786|10903086|FG000|Overall Study|Early Escape from Prior Study|2
6888739|NCT00578786|10903087|FG001|Overall Study|Early Escape from Prior Study|1
6888740|NCT00578786|10903088|FG002|Overall Study|Early Escape from Prior Study|2
6888741|NCT00578786|10903086|FG000|Overall Study|Withdrawal by Subject|7
6888742|NCT00578786|10903087|FG001|Overall Study|Withdrawal by Subject|8
6888743|NCT00578786|10903088|FG002|Overall Study|Withdrawal by Subject|5
6888744|NCT00578786|10903086|FG000|Overall Study|Protocol Violation|0
6888745|NCT00578786|10903087|FG001|Overall Study|Protocol Violation|3
6888746|NCT00578786|10903088|FG002|Overall Study|Protocol Violation|1
6888747|NCT00578786|10903086|FG000|Overall Study|Physician Decision|1
6888748|NCT00578786|10903087|FG001|Overall Study|Physician Decision|0
6888749|NCT00578786|10903088|FG002|Overall Study|Physician Decision|1
6888750|NCT00578786|10903086|FG000|Overall Study|Sponsor Decision|0
6888751|NCT00578786|10903087|FG001|Overall Study|Sponsor Decision|0
6888752|NCT00578786|10903088|FG002|Overall Study|Sponsor Decision|1
6888753|NCT00578786|10903086|FG000|Overall Study|Lost to Follow-up|0
6888754|NCT00578786|10903087|FG001|Overall Study|Lost to Follow-up|4
6888755|NCT00578786|10903088|FG002|Overall Study|Lost to Follow-up|0
6888756|NCT00578786|10903086|FG000|Overall Study|Pregnancy|0
6888757|NCT00578786|10903087|FG001|Overall Study|Pregnancy|1
6888758|NCT00578786|10903088|FG002|Overall Study|Pregnancy|0
6888759|NCT00578786|10903086|FG000|Overall Study|Not Otherwise Specified|0
6888760|NCT00578786|10903087|FG001|Overall Study|Not Otherwise Specified|4
6888761|NCT00578786|10903088|FG002|Overall Study|Not Otherwise Specified|1
6888762|NCT00578786|10903086|FG000|Overall Study|Qualified but Not Enrolled in Extension|0
6888763|NCT00578786|10903087|FG001|Overall Study|Qualified but Not Enrolled in Extension|3
6888764|NCT00578786|10903088|FG002|Overall Study|Qualified but Not Enrolled in Extension|0
6888765|NCT00578812|10903108|FG000|Overall Study|Not treated|6
6888766|NCT00578812|10903109|FG001|Overall Study|Not treated|7
6888767|NCT00578864|10903118|FG000|Overall Study|Death|1
6888768|NCT00578864|10903119|FG001|Overall Study|Death|0
6888769|NCT00578877|10903127|FG000|Overall Study|Lost to Follow-up|8
6888770|NCT00578877|10903128|FG001|Overall Study|Lost to Follow-up|10
6888771|NCT00578877|10903127|FG000|Overall Study|early discontinue|61
6888772|NCT00578877|10903128|FG001|Overall Study|early discontinue|101
6888773|NCT00578877|10903127|FG000|Overall Study|did not provide follow-up data|12
6888774|NCT00578877|10903128|FG001|Overall Study|did not provide follow-up data|17
6888775|NCT00578942|10903156|FG000|Overall Study|Lost to Follow-up|1
6888776|NCT00579059|10903176|FG000|Overall Study|Study Canceled at 1 Year|21
6888777|NCT00579059|10903177|FG001|Overall Study|Study Canceled at 1 Year|10
6888778|NCT00579098|10903185|FG000|Overall Study|Lost to Follow-up|2
6888779|NCT00579098|10903186|FG001|Overall Study|Lost to Follow-up|0
6888780|NCT00579098|10903185|FG000|Overall Study|Adverse Event|2
6888781|NCT00579098|10903186|FG001|Overall Study|Adverse Event|3
6888782|NCT00579098|10903185|FG000|Overall Study|Withdrawal by Subject|2
6888783|NCT00579098|10903186|FG001|Overall Study|Withdrawal by Subject|3
6888784|NCT00579098|10903185|FG000|Overall Study|AF returned after ablation|3
6888785|NCT00579098|10903186|FG001|Overall Study|AF returned after ablation|2
6888786|NCT00579345|10903226|FG000|Overall Study|Withdrawal by Subject|2
6888787|NCT00579345|10903227|FG001|Overall Study|Withdrawal by Subject|0
6888788|NCT00579345|10903228|FG002|Overall Study|Withdrawal by Subject|0
6888789|NCT00579345|10903229|FG003|Overall Study|Withdrawal by Subject|0
6888790|NCT00579345|10903230|FG004|Overall Study|Withdrawal by Subject|0
6888791|NCT00579345|10903231|FG005|Overall Study|Withdrawal by Subject|0
6888792|NCT00579345|10903232|FG006|Overall Study|Withdrawal by Subject|0
6888793|NCT00579345|10903233|FG007|Overall Study|Withdrawal by Subject|1
6888794|NCT00579345|10903226|FG000|Overall Study|Lost to Follow-up|1
6888795|NCT00579345|10903227|FG001|Overall Study|Lost to Follow-up|0
6888796|NCT00579345|10903228|FG002|Overall Study|Lost to Follow-up|0
6888797|NCT00579345|10903229|FG003|Overall Study|Lost to Follow-up|0
6888798|NCT00579345|10903230|FG004|Overall Study|Lost to Follow-up|0
6888799|NCT00579345|10903231|FG005|Overall Study|Lost to Follow-up|0
6888800|NCT00579345|10903232|FG006|Overall Study|Lost to Follow-up|0
6888801|NCT00579345|10903233|FG007|Overall Study|Lost to Follow-up|0
6888802|NCT00579345|10903226|FG000|Overall Study|Adverse Event|0
6888803|NCT00579345|10903227|FG001|Overall Study|Adverse Event|0
6888804|NCT00579345|10903228|FG002|Overall Study|Adverse Event|1
6888805|NCT00579345|10903229|FG003|Overall Study|Adverse Event|0
6888806|NCT00579345|10903230|FG004|Overall Study|Adverse Event|0
6888807|NCT00579345|10903231|FG005|Overall Study|Adverse Event|0
6888808|NCT00579345|10903232|FG006|Overall Study|Adverse Event|0
6888809|NCT00579345|10903233|FG007|Overall Study|Adverse Event|0
6888810|NCT00579345|10903226|FG000|Overall Study|Protocol Violation|1
6888811|NCT00579345|10903227|FG001|Overall Study|Protocol Violation|0
6888812|NCT00579345|10903228|FG002|Overall Study|Protocol Violation|0
6888813|NCT00579345|10903229|FG003|Overall Study|Protocol Violation|0
6888814|NCT00579345|10903230|FG004|Overall Study|Protocol Violation|0
6888815|NCT00579345|10903231|FG005|Overall Study|Protocol Violation|0
6888816|NCT00579345|10903232|FG006|Overall Study|Protocol Violation|0
6888817|NCT00579345|10903233|FG007|Overall Study|Protocol Violation|1
6888818|NCT00579345|10903226|FG000|Overall Study|Death|1
6888819|NCT00579345|10903227|FG001|Overall Study|Death|1
6888820|NCT00579345|10903228|FG002|Overall Study|Death|1
6888821|NCT00579345|10903229|FG003|Overall Study|Death|1
6888822|NCT00579345|10903230|FG004|Overall Study|Death|0
6888823|NCT00579345|10903231|FG005|Overall Study|Death|0
6888824|NCT00579345|10903232|FG006|Overall Study|Death|0
6888825|NCT00579345|10903233|FG007|Overall Study|Death|0
6888826|NCT00579501|10903270|FG000|Overall Study|Death|1
6888827|NCT00579501|10903270|FG000|Overall Study|End of neoadjuvant therapy|25
6888828|NCT00579501|10903270|FG000|Overall Study|toxicity|1
6888829|NCT00579501|10903270|FG000|Overall Study|Secondary lesion|1
6888830|NCT00579501|10903270|FG000|Overall Study|Radiation therapy before surgery|1
6888831|NCT00579553|10903276|FG000|Overall Study|Lost to Follow-up|16
6888832|NCT00579553|10903277|FG001|Overall Study|Lost to Follow-up|13
6888833|NCT00579670|10903288|FG000|Overall Study|Death|1
6888834|NCT00579670|10903289|FG001|Overall Study|Death|0
6888835|NCT00579670|10903290|FG002|Overall Study|Death|0
6888836|NCT00579670|10903291|FG003|Overall Study|Death|0
6888837|NCT00579670|10903292|FG004|Overall Study|Death|0
6888838|NCT00579670|10903288|FG000|Overall Study|Adverse Event|1
6888839|NCT00579670|10903289|FG001|Overall Study|Adverse Event|0
6888840|NCT00579670|10903290|FG002|Overall Study|Adverse Event|1
6888841|NCT00579670|10903291|FG003|Overall Study|Adverse Event|2
6888842|NCT00579670|10903292|FG004|Overall Study|Adverse Event|0
7155724|NCT03346057|11323775|FG002|Overall Study|Ineligible For Study - Not Treated|0
7155725|NCT03346057|11323776|FG003|Overall Study|Ineligible For Study - Not Treated|0
7155726|NCT03346057|11323773|FG000|Overall Study|Renal Insufficiency - Not Treated|1
7155727|NCT03346057|11323774|FG001|Overall Study|Renal Insufficiency - Not Treated|0
7155728|NCT03346057|11323775|FG002|Overall Study|Renal Insufficiency - Not Treated|0
7155729|NCT03346057|11323776|FG003|Overall Study|Renal Insufficiency - Not Treated|0
7155730|NCT03346057|11323773|FG000|Overall Study|Physician Decision|3
7155731|NCT03346057|11323774|FG001|Overall Study|Physician Decision|2
6888843|NCT00579670|10903288|FG000|Overall Study|Lack of Efficacy|0
6888844|NCT00579670|10903289|FG001|Overall Study|Lack of Efficacy|0
6888845|NCT00579670|10903290|FG002|Overall Study|Lack of Efficacy|1
6888846|NCT00579670|10903291|FG003|Overall Study|Lack of Efficacy|14
6888847|NCT00579670|10903292|FG004|Overall Study|Lack of Efficacy|0
6888848|NCT00579670|10903288|FG000|Overall Study|Lost to Follow-up|0
6888849|NCT00579670|10903289|FG001|Overall Study|Lost to Follow-up|1
6888850|NCT00579670|10903290|FG002|Overall Study|Lost to Follow-up|0
6888851|NCT00579670|10903291|FG003|Overall Study|Lost to Follow-up|4
6888852|NCT00579670|10903292|FG004|Overall Study|Lost to Follow-up|0
6888853|NCT00579670|10903288|FG000|Overall Study|Other|0
6888854|NCT00579670|10903289|FG001|Overall Study|Other|0
6888855|NCT00579670|10903290|FG002|Overall Study|Other|1
6888856|NCT00579670|10903291|FG003|Overall Study|Other|2
6888857|NCT00579670|10903292|FG004|Overall Study|Other|0
6888858|NCT00579670|10903288|FG000|Overall Study|Withdrawal by Subject|0
6888859|NCT00579670|10903289|FG001|Overall Study|Withdrawal by Subject|0
6888860|NCT00579670|10903290|FG002|Overall Study|Withdrawal by Subject|1
6888861|NCT00579670|10903291|FG003|Overall Study|Withdrawal by Subject|0
6888862|NCT00579670|10903292|FG004|Overall Study|Withdrawal by Subject|0
6888863|NCT00579982|10903339|FG000|Overall Study|Adverse Event|4
7155732|NCT03346057|11323775|FG002|Overall Study|Physician Decision|0
7155733|NCT03346057|11323776|FG003|Overall Study|Physician Decision|2
7155734|NCT03346057|11323773|FG000|Overall Study|Randomization Mistake - Not Treated|1
6888864|NCT00579982|10903339|FG000|Overall Study|Protocol Violation|4
6888865|NCT00580034|10903343|FG000|Overall Study|Toxicity|10
6888866|NCT00580034|10903344|FG001|Overall Study|Toxicity|0
6888867|NCT00580047|10903351|FG000|Overall Study|Lost to Follow-up|1
6888868|NCT00580047|10903352|FG001|Overall Study|Lost to Follow-up|1
6888869|NCT00580047|10903353|FG002|Overall Study|Lost to Follow-up|0
6888870|NCT00580047|10903351|FG000|Overall Study|Withdrawal by Subject|1
6888871|NCT00580047|10903352|FG001|Overall Study|Withdrawal by Subject|1
6888872|NCT00580047|10903353|FG002|Overall Study|Withdrawal by Subject|2
6888873|NCT00580047|10903351|FG000|Overall Study|Withdrawal by Subject|1
6888874|NCT00580047|10903352|FG001|Overall Study|Withdrawal by Subject|0
6888875|NCT00580047|10903353|FG002|Overall Study|Withdrawal by Subject|0
6888876|NCT00580606|10903413|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2
6888877|NCT00580606|10903414|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1
6888878|NCT00580606|10903413|FG000|Open Label (OL)|Withdrawal by Subject|4
6888879|NCT00580606|10903414|FG001|Open Label (OL)|Withdrawal by Subject|6
6888880|NCT00580606|10903413|FG000|Open Label (OL)|Dosing Symptoms|0
6888881|NCT00580606|10903414|FG001|Open Label (OL)|Dosing Symptoms|1
6888882|NCT00580606|10903413|FG000|Open Label (OL)|Lost to Follow-up|0
6888883|NCT00580606|10903414|FG001|Open Label (OL)|Lost to Follow-up|1
6888884|NCT00580606|10903413|FG000|Open Label (OL)|Pregnancy|0
6888885|NCT00580606|10903414|FG001|Open Label (OL)|Pregnancy|1
6888886|NCT00580606|10903413|FG000|Open Label (OL)|Non-compliance|2
6888887|NCT00580606|10903414|FG001|Open Label (OL)|Non-compliance|0
6888888|NCT00580606|10903413|FG000|Open Label (OL)|Physician Decision|1
6888889|NCT00580606|10903414|FG001|Open Label (OL)|Physician Decision|1
6888890|NCT00580606|10903413|FG000|Open Label (OL)|Needed Prohibited Medication|0
6888891|NCT00580606|10903414|FG001|Open Label (OL)|Needed Prohibited Medication|1
6888892|NCT00580723|10903454|FG000|Overall Study|Did not want to participate in extension|3
6888893|NCT00580723|10903454|FG000|Overall Study|Lost to Follow-up|5
6888894|NCT00580788|10903462|FG000|Overall Study|Adverse Event|0
6888895|NCT00580788|10903463|FG001|Overall Study|Adverse Event|0
6888896|NCT00580788|10903464|FG002|Overall Study|Adverse Event|0
6888897|NCT00580788|10903465|FG003|Overall Study|Adverse Event|1
6888898|NCT00580801|10903485|FG000|Overall Study|Physician Decision|1
6888899|NCT00580801|10903486|FG001|Overall Study|Physician Decision|0
6888900|NCT00580801|10903487|FG002|Overall Study|Physician Decision|0
6888901|NCT00580801|10903485|FG000|Overall Study|Adverse Event|2
6888902|NCT00580801|10903486|FG001|Overall Study|Adverse Event|0
6888903|NCT00580801|10903487|FG002|Overall Study|Adverse Event|0
6888904|NCT00580801|10903485|FG000|Overall Study|Lost to Follow-up|2
6888905|NCT00580801|10903486|FG001|Overall Study|Lost to Follow-up|0
6888906|NCT00580801|10903487|FG002|Overall Study|Lost to Follow-up|0
6888907|NCT00580801|10903485|FG000|Overall Study|Reached a virologic endpoint|0
6888908|NCT00580801|10903486|FG001|Overall Study|Reached a virologic endpoint|1
6888909|NCT00580801|10903487|FG002|Overall Study|Reached a virologic endpoint|2
6888910|NCT00580801|10903485|FG000|Overall Study|Participant non-compliant|0
6888911|NCT00580801|10903486|FG001|Overall Study|Participant non-compliant|0
6888912|NCT00580801|10903487|FG002|Overall Study|Participant non-compliant|1
6888913|NCT00580801|10903485|FG000|Overall Study|Travel|1
6888914|NCT00580801|10903486|FG001|Overall Study|Travel|0
6888915|NCT00580801|10903487|FG002|Overall Study|Travel|0
6888916|NCT00580840|10903495|FG000|Run-in|Adverse Event|17
6888917|NCT00580840|10903496|FG001|Run-in|Adverse Event|0
6888918|NCT00580840|10903497|FG002|Run-in|Adverse Event|0
6888919|NCT00580840|10903498|FG003|Run-in|Adverse Event|0
6888920|NCT00580840|10903495|FG000|Run-in|Lack of Efficacy|93
6888921|NCT00580840|10903496|FG001|Run-in|Lack of Efficacy|0
6888922|NCT00580840|10903497|FG002|Run-in|Lack of Efficacy|0
6888923|NCT00580840|10903498|FG003|Run-in|Lack of Efficacy|0
6888924|NCT00580840|10903495|FG000|Run-in|Loss of Efficacy|1
6888925|NCT00580840|10903496|FG001|Run-in|Loss of Efficacy|0
6888926|NCT00580840|10903497|FG002|Run-in|Loss of Efficacy|0
6888927|NCT00580840|10903498|FG003|Run-in|Loss of Efficacy|0
6888928|NCT00580840|10903495|FG000|Run-in|Lost to Follow-up|4
6888929|NCT00580840|10903496|FG001|Run-in|Lost to Follow-up|0
6888930|NCT00580840|10903497|FG002|Run-in|Lost to Follow-up|0
6888931|NCT00580840|10903498|FG003|Run-in|Lost to Follow-up|0
6888932|NCT00580840|10903495|FG000|Run-in|Withdrawal by Subject|5
6888933|NCT00580840|10903496|FG001|Run-in|Withdrawal by Subject|0
6888934|NCT00580840|10903497|FG002|Run-in|Withdrawal by Subject|0
6888935|NCT00580840|10903498|FG003|Run-in|Withdrawal by Subject|0
6888936|NCT00580840|10903495|FG000|Run-in|Other: Per Sponsor Request|2
6888937|NCT00580840|10903496|FG001|Run-in|Other: Per Sponsor Request|0
6888938|NCT00580840|10903497|FG002|Run-in|Other: Per Sponsor Request|0
6888939|NCT00580840|10903498|FG003|Run-in|Other: Per Sponsor Request|0
6888940|NCT00580840|10903495|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1
6888941|NCT00580840|10903496|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0
6888942|NCT00580840|10903497|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0
6888943|NCT00580840|10903498|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0
6888944|NCT00580840|10903495|FG000|Run-in|Other: Exclusionary Lab Value|1
6888945|NCT00580840|10903496|FG001|Run-in|Other: Exclusionary Lab Value|0
6888946|NCT00580840|10903497|FG002|Run-in|Other: Exclusionary Lab Value|0
6888947|NCT00580840|10903498|FG003|Run-in|Other: Exclusionary Lab Value|0
6888948|NCT00580840|10903495|FG000|Double-Blind|Adverse Event|0
6888949|NCT00580840|10903496|FG001|Double-Blind|Adverse Event|3
6888950|NCT00580840|10903497|FG002|Double-Blind|Adverse Event|4
6888951|NCT00580840|10903498|FG003|Double-Blind|Adverse Event|1
6888952|NCT00580840|10903495|FG000|Double-Blind|Loss of Efficacy|0
6888953|NCT00580840|10903496|FG001|Double-Blind|Loss of Efficacy|1
6888954|NCT00580840|10903497|FG002|Double-Blind|Loss of Efficacy|2
6888955|NCT00580840|10903498|FG003|Double-Blind|Loss of Efficacy|10
6888956|NCT00580840|10903495|FG000|Double-Blind|Lost to Follow-up|0
6888957|NCT00580840|10903496|FG001|Double-Blind|Lost to Follow-up|1
6888958|NCT00580840|10903497|FG002|Double-Blind|Lost to Follow-up|0
6888959|NCT00580840|10903498|FG003|Double-Blind|Lost to Follow-up|2
6888960|NCT00580840|10903495|FG000|Double-Blind|Withdrawal by Subject|0
6888961|NCT00580840|10903496|FG001|Double-Blind|Withdrawal by Subject|1
6888962|NCT00580840|10903497|FG002|Double-Blind|Withdrawal by Subject|2
6888963|NCT00580840|10903498|FG003|Double-Blind|Withdrawal by Subject|2
6888964|NCT00580840|10903495|FG000|Double-Blind|Other: Discontinued Methotrexate|0
6888965|NCT00580840|10903496|FG001|Double-Blind|Other: Discontinued Methotrexate|1
6888966|NCT00580840|10903497|FG002|Double-Blind|Other: Discontinued Methotrexate|0
6888967|NCT00580840|10903498|FG003|Double-Blind|Other: Discontinued Methotrexate|0
6888968|NCT00580840|10903495|FG000|Double-Blind|Other: Forbidden Medication|0
6888969|NCT00580840|10903496|FG001|Double-Blind|Other: Forbidden Medication|0
6888970|NCT00580840|10903497|FG002|Double-Blind|Other: Forbidden Medication|1
6888971|NCT00580840|10903498|FG003|Double-Blind|Other: Forbidden Medication|0
6888972|NCT00580866|10903523|FG000|Overall Study|Lost to Follow-up|2
6888973|NCT00580866|10903524|FG001|Overall Study|Lost to Follow-up|2
6888974|NCT00580970|10903541|FG000|Pre-treatment|Non-compliance|1
6888975|NCT00580970|10903541|FG000|Treatment (Lovastatin)|Non-compliance|6
6888976|NCT00580970|10903541|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7
6888977|NCT00580970|10903541|FG000|Treatment (Lovastatin)|Physician Decision|4
6888978|NCT00580970|10903541|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1
6888979|NCT00580970|10903541|FG000|Treatment (Lovastatin)|Death|1
6888980|NCT00580983|10903545|FG000|Overall Study|Did not complete 12 mon post RT studies|7
6888981|NCT00581100|10903562|FG000|Overall Study|Death|1
6888982|NCT00581100|10903563|FG001|Overall Study|Death|0
6888983|NCT00581100|10903562|FG000|Overall Study|Adverse Event|2
6888984|NCT00581100|10903563|FG001|Overall Study|Adverse Event|1
6888985|NCT00581100|10903562|FG000|Overall Study|Withdrawal by Subject|1
6888986|NCT00581100|10903563|FG001|Overall Study|Withdrawal by Subject|4
6888987|NCT00581100|10903562|FG000|Overall Study|Other|3
6888988|NCT00581100|10903563|FG001|Overall Study|Other|0
6970313|NCT01154816|11020418|FG002|Overall Study|Progressive Disease|9
6970314|NCT01154816|11020419|FG003|Overall Study|Progressive Disease|9
6970315|NCT01154816|11020420|FG004|Overall Study|Progressive Disease|8
6970316|NCT01154816|11020421|FG005|Overall Study|Progressive Disease|8
6970317|NCT01154816|11020422|FG006|Overall Study|Progressive Disease|5
6970318|NCT01154816|11020423|FG007|Overall Study|Progressive Disease|6
6970319|NCT01154816|11020424|FG008|Overall Study|Progressive Disease|8
6970320|NCT01154816|11020425|FG009|Overall Study|Progressive Disease|6
6970321|NCT01154816|11020426|FG010|Overall Study|Progressive Disease|10
6970322|NCT01154816|11020427|FG011|Overall Study|Progressive Disease|3
6970323|NCT01154816|11020416|FG000|Overall Study|Physician Decision|1
6970324|NCT01154816|11020417|FG001|Overall Study|Physician Decision|0
6970325|NCT01154816|11020418|FG002|Overall Study|Physician Decision|1
6970326|NCT01154816|11020419|FG003|Overall Study|Physician Decision|0
6970327|NCT01154816|11020420|FG004|Overall Study|Physician Decision|2
6970328|NCT01154816|11020421|FG005|Overall Study|Physician Decision|0
6970329|NCT01154816|11020422|FG006|Overall Study|Physician Decision|0
6970330|NCT01154816|11020423|FG007|Overall Study|Physician Decision|0
6970331|NCT01154816|11020424|FG008|Overall Study|Physician Decision|0
6970332|NCT01154816|11020425|FG009|Overall Study|Physician Decision|1
6970333|NCT01154816|11020426|FG010|Overall Study|Physician Decision|1
6970334|NCT01154816|11020427|FG011|Overall Study|Physician Decision|1
6970335|NCT01154816|11020416|FG000|Overall Study|Adverse Event|5
6970336|NCT01154816|11020417|FG001|Overall Study|Adverse Event|2
6970337|NCT01154816|11020418|FG002|Overall Study|Adverse Event|0
6970338|NCT01154816|11020419|FG003|Overall Study|Adverse Event|0
6970339|NCT01154816|11020420|FG004|Overall Study|Adverse Event|0
6970340|NCT01154816|11020421|FG005|Overall Study|Adverse Event|0
6970341|NCT01154816|11020422|FG006|Overall Study|Adverse Event|1
6970342|NCT01154816|11020423|FG007|Overall Study|Adverse Event|1
6970343|NCT01154816|11020424|FG008|Overall Study|Adverse Event|0
6970344|NCT01154816|11020425|FG009|Overall Study|Adverse Event|0
6970345|NCT01154816|11020426|FG010|Overall Study|Adverse Event|0
6970346|NCT01154816|11020427|FG011|Overall Study|Adverse Event|0
6970347|NCT01155011|11020470|FG000|Baseline to 6 Months|Withdrawal by Subject|18
6970348|NCT01155011|11020471|FG001|Baseline to 6 Months|Withdrawal by Subject|19
6970349|NCT01155011|11020470|FG000|Baseline to 6 Months|investigator decision, moved|4
6970350|NCT01155011|11020471|FG001|Baseline to 6 Months|investigator decision, moved|5
6970351|NCT01155011|11020470|FG000|Baseline to 6 Months|Death|0
6970352|NCT01155011|11020471|FG001|Baseline to 6 Months|Death|1
6970353|NCT01155011|11020470|FG000|6 to 12 Months|Withdrawal by Subject|8
6970354|NCT01155011|11020471|FG001|6 to 12 Months|Withdrawal by Subject|5
6970355|NCT01155011|11020470|FG000|6 to 12 Months|Death|1
6888989|NCT00581308|10903585|FG000|Pre Discharge|Lost to Follow-up|1
6888990|NCT00581308|10903585|FG000|Pre Discharge|Device Removed|1
6888991|NCT00581308|10903585|FG000|Month 1|Lost to Follow-up|3
6888992|NCT00581308|10903585|FG000|Month 1|Withdrawal by Subject|2
6888993|NCT00581308|10903585|FG000|Month 1|Device Removed|2
6888994|NCT00581308|10903585|FG000|Month 1|Uknown|1
6888995|NCT00581308|10903585|FG000|Month 6|Lost to Follow-up|1
6888996|NCT00581308|10903585|FG000|Month 6|Withdrawal by Subject|2
6888997|NCT00581308|10903585|FG000|Month 12|Death|1
6888998|NCT00581308|10903585|FG000|Month 12|Lost to Follow-up|14
6888999|NCT00581308|10903585|FG000|Month 12|Withdrawal by Subject|3
6889000|NCT00581308|10903585|FG000|Month 12|Device Removed|1
6889001|NCT00581308|10903585|FG000|Month 12|Other|1
6889002|NCT00581360|10903601|FG000|Overall Study|Withdrawal by Subject|1
6889003|NCT00581542|10903633|FG000|Overall Study|they met an exclusion criteria|2
6889004|NCT00581542|10903634|FG001|Overall Study|they met an exclusion criteria|2
6889005|NCT00581542|10903633|FG000|Overall Study|Lost to Follow-up|9
6889006|NCT00581542|10903634|FG001|Overall Study|Lost to Follow-up|21
6889007|NCT00581555|10903644|FG000|Overall Study|Adverse Event|4
6889008|NCT00581555|10903645|FG001|Overall Study|Adverse Event|3
6889009|NCT00581555|10903644|FG000|Overall Study|Physician Decision|3
6889010|NCT00581555|10903645|FG001|Overall Study|Physician Decision|2
6889011|NCT00581555|10903644|FG000|Overall Study|Withdrawal by Subject|18
6889012|NCT00581555|10903645|FG001|Overall Study|Withdrawal by Subject|9
6889013|NCT00581555|10903644|FG000|Overall Study|Lost to Follow-up|2
6889014|NCT00581555|10903645|FG001|Overall Study|Lost to Follow-up|2
6889015|NCT00581555|10903644|FG000|Overall Study|Other reasons|16
6889016|NCT00581555|10903645|FG001|Overall Study|Other reasons|4
6889017|NCT00581776|10903660|FG000|Overall Study|Disease progression or no response|3
6889018|NCT00581828|10903664|FG000|Overall Study|Protocol Violation|1
6889019|NCT00581893|10903679|FG000|Second Intervention (1 Month)|Lost to Follow-up|3
6889020|NCT00581893|10903680|FG001|Second Intervention (1 Month)|Lost to Follow-up|2
6889021|NCT00581919|10903686|FG000|Overall Study|Adverse Event|8
6889022|NCT00581919|10903686|FG000|Overall Study|Death|1
6889023|NCT00581919|10903686|FG000|Overall Study|Disease Progression|10
6889024|NCT00581919|10903686|FG000|Overall Study|Physician Decision|1
6889025|NCT00581919|10903686|FG000|Overall Study|Other Complicating Disease|1
6889026|NCT00581919|10903686|FG000|Overall Study|Started Non-Protocol Therapy|2
6889027|NCT00581919|10903686|FG000|Overall Study|Withdrawal by Subject|1
6889028|NCT00581945|10903693|FG000|Overall Study|Adverse Event|4
7079187|NCT02110238|11187994|FG000|12 Week Pivotal Phase|Protocol Violation|0
7079188|NCT02110238|11187995|FG001|12 Week Pivotal Phase|Protocol Violation|1
7079189|NCT02110238|11187994|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3
7079190|NCT02110238|11187995|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3
7079191|NCT02110238|11187994|FG000|14 Week Blinded Extension Phase|Adverse Event|1
7079192|NCT02110238|11187995|FG001|14 Week Blinded Extension Phase|Adverse Event|1
6889029|NCT00581945|10903694|FG001|Overall Study|Adverse Event|4
6889030|NCT00581945|10903693|FG000|Overall Study|Unsatisfactory therapeutic effect|2
6889031|NCT00581945|10903694|FG001|Overall Study|Unsatisfactory therapeutic effect|0
6889032|NCT00581945|10903693|FG000|Overall Study|Withdrawal by Subject|2
6889033|NCT00581945|10903694|FG001|Overall Study|Withdrawal by Subject|6
6889034|NCT00581945|10903693|FG000|Overall Study|Death|1
6889035|NCT00581945|10903694|FG001|Overall Study|Death|0
6889036|NCT00582010|10903707|FG000|Overall Study|Death|0
6889037|NCT00582010|10903708|FG001|Overall Study|Death|1
6889038|NCT00582114|10903720|FG000|Overall Study|Death|4
6889039|NCT00582114|10903721|FG001|Overall Study|Death|4
6889040|NCT00582114|10903720|FG000|Overall Study|Kidney Transplant|3
6889041|NCT00582114|10903721|FG001|Overall Study|Kidney Transplant|1
6889042|NCT00582114|10903720|FG000|Overall Study|Lost to Follow-up|7
6889043|NCT00582114|10903721|FG001|Overall Study|Lost to Follow-up|6
6889044|NCT00582114|10903720|FG000|Overall Study|Withdrawal by Subject|8
6889045|NCT00582114|10903721|FG001|Overall Study|Withdrawal by Subject|16
6889046|NCT00582114|10903720|FG000|Overall Study|Adverse Event|1
6889047|NCT00582114|10903721|FG001|Overall Study|Adverse Event|1
6889048|NCT00582114|10903720|FG000|Overall Study|Physician Decision|0
6889049|NCT00582114|10903721|FG001|Overall Study|Physician Decision|6
6889050|NCT00582114|10903720|FG000|Overall Study|Stopped by data safety monitoring board|19
7079193|NCT02110238|11187994|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2
7079194|NCT02110238|11187995|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4
7079195|NCT02110238|11187994|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3
7079196|NCT02110238|11187995|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1
7079197|NCT02110238|11187994|FG000|14 Week Blinded Extension Phase|Protocol Violation|2
6889051|NCT00582114|10903721|FG001|Overall Study|Stopped by data safety monitoring board|20
7079198|NCT02110238|11187995|FG001|14 Week Blinded Extension Phase|Protocol Violation|3
6889052|NCT00582166|10903727|FG000|Overall Study|Death|1
6889053|NCT00582166|10903727|FG000|Overall Study|Ineligible pathology|1
6889054|NCT00582309|10903738|FG000|Overall Study|Protocol Violation|0
7079199|NCT02110238|11187994|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4
6889055|NCT00582309|10903739|FG001|Overall Study|Protocol Violation|0
6889056|NCT00582309|10903740|FG002|Overall Study|Protocol Violation|2
6889057|NCT00582426|10903763|FG000|Overall Study|Lost to Follow-up|0
6889058|NCT00582426|10903764|FG001|Overall Study|Lost to Follow-up|2
6889059|NCT00582426|10903763|FG000|Overall Study|Adverse Event|4
6889060|NCT00582426|10903764|FG001|Overall Study|Adverse Event|2
6889061|NCT00582426|10903763|FG000|Overall Study|Protocol Violation|6
6889062|NCT00582426|10903764|FG001|Overall Study|Protocol Violation|2
6889063|NCT00582426|10903763|FG000|Overall Study|Death|4
6889064|NCT00582426|10903764|FG001|Overall Study|Death|3
6889065|NCT00582426|10903763|FG000|Overall Study|Withdrawal by Subject|3
6889066|NCT00582426|10903764|FG001|Overall Study|Withdrawal by Subject|2
6889067|NCT00582426|10903763|FG000|Overall Study|Disease Progression|2
6889068|NCT00582426|10903764|FG001|Overall Study|Disease Progression|2
6889069|NCT00582426|10903763|FG000|Overall Study|Use of illicit drugs|1
6889070|NCT00582426|10903764|FG001|Overall Study|Use of illicit drugs|0
6889071|NCT00582491|10903772|FG000|Overall Study|Withdrawal by Subject|1
6889072|NCT00582491|10903773|FG001|Overall Study|Withdrawal by Subject|0
6889073|NCT00582556|10903791|FG000|Overall Study|Withdrawal by Subject|0
6889074|NCT00582556|10903792|FG001|Overall Study|Withdrawal by Subject|1
6889075|NCT00582556|10903793|FG002|Overall Study|Withdrawal by Subject|1
6889076|NCT00582556|10903791|FG000|Overall Study|Physician Decision|0
6889077|NCT00582556|10903792|FG001|Overall Study|Physician Decision|0
6889078|NCT00582556|10903793|FG002|Overall Study|Physician Decision|1
6889079|NCT00582608|10903802|FG000|Overall Study|Not Treated|7
6889080|NCT00582608|10903802|FG000|Overall Study|Patient Ineligible|1
6889081|NCT00582608|10903802|FG000|Overall Study|Lack of accrual|4
6889082|NCT00582738|10903817|FG000|Overall Study|Administrative Problems|7
6889083|NCT00582738|10903818|FG001|Overall Study|Administrative Problems|8
6889084|NCT00582738|10903817|FG000|Overall Study|Adverse Event|0
6889085|NCT00582738|10903818|FG001|Overall Study|Adverse Event|5
6889086|NCT00582738|10903817|FG000|Overall Study|Graft Lost|0
6889087|NCT00582738|10903818|FG001|Overall Study|Graft Lost|1
6889088|NCT00582738|10903817|FG000|Overall Study|Other|1
6889089|NCT00582738|10903818|FG001|Overall Study|Other|0
6889090|NCT00582738|10903817|FG000|Overall Study|Protocol Violation|1
6889091|NCT00582738|10903818|FG001|Overall Study|Protocol Violation|1
6889092|NCT00582738|10903817|FG000|Overall Study|Withdrawal by Subject|0
6889093|NCT00582738|10903818|FG001|Overall Study|Withdrawal by Subject|3
6889094|NCT00582790|10903830|FG000|Overall Study|Rapid progression of disease|1
6889095|NCT00582816|10903835|FG000|Overall Study|Engraftment Failure|3
6889096|NCT00582907|10903843|FG000|1st Course|Withdrawal by Subject|1
6889097|NCT00582907|10903844|FG001|1st Course|Withdrawal by Subject|0
6889098|NCT00582907|10903845|FG002|1st Course|Withdrawal by Subject|0
6889099|NCT00582907|10903846|FG003|1st Course|Withdrawal by Subject|0
6889100|NCT00582907|10903843|FG000|1st Course|Lost to Follow-up|0
6889101|NCT00582907|10903844|FG001|1st Course|Lost to Follow-up|0
6889102|NCT00582907|10903845|FG002|1st Course|Lost to Follow-up|0
6889103|NCT00582907|10903846|FG003|1st Course|Lost to Follow-up|1
6889104|NCT00582907|10903843|FG000|2nd Course|Lack of Efficacy|1
6889105|NCT00582907|10903844|FG001|2nd Course|Lack of Efficacy|0
6889106|NCT00582907|10903845|FG002|2nd Course|Lack of Efficacy|0
6889107|NCT00582907|10903846|FG003|2nd Course|Lack of Efficacy|0
6889108|NCT00582933|10903852|FG000|Overall Study|Physician Decision|3
6889109|NCT00582972|10903860|FG000|Overall Study|Protocol Violation|2
6889110|NCT00583102|10903888|FG000|Overall Study|Adverse Event|3
6889111|NCT00583219|10903892|FG000|Phase 2|Withdrawal by Subject|1
6889112|NCT00583362|10903896|FG000|Overall Study|Adverse Event|44
6889113|NCT00583362|10903896|FG000|Overall Study|Lack of Efficacy|22
6889114|NCT00583362|10903896|FG000|Overall Study|Lost to Follow-up|4
6889115|NCT00583362|10903896|FG000|Overall Study|Non-compliance with study drug|28
6889116|NCT00583362|10903896|FG000|Overall Study|Pregnancy|7
6889117|NCT00583362|10903896|FG000|Overall Study|Miscommunication of visit window|5
6889118|NCT00583362|10903896|FG000|Overall Study|Current site closed|7
6889119|NCT00583362|10903896|FG000|Overall Study|Subject not dosed in LBSL99|1
6889120|NCT00583362|10903896|FG000|Overall Study|Subject moved out of the country/state|2
6889121|NCT00583362|10903896|FG000|Overall Study|Missed visits due to staff changes|1
6889122|NCT00583362|10903896|FG000|Overall Study|Misunderstanding of protocol|1
6889123|NCT00583362|10903896|FG000|Overall Study|Behavioral problems and non-compliance|1
6889124|NCT00583362|10903896|FG000|Overall Study|Sponsor request due to missed doses|1
6889125|NCT00583362|10903896|FG000|Overall Study|Physician Decision|19
6889126|NCT00583362|10903896|FG000|Overall Study|Protocol Violation|2
6889127|NCT00583362|10903896|FG000|Overall Study|Withdrawal by Subject|57
6889128|NCT00583453|10903915|FG000|Overall Study|discontinued intervention|0
6889129|NCT00583453|10903916|FG001|Overall Study|discontinued intervention|2
6889130|NCT00583557|10903933|FG000|Overall Study|Withdrawal by Subject|18
6889131|NCT00583557|10903933|FG000|Overall Study|Adverse Event|9
6889132|NCT00583557|10903933|FG000|Overall Study|Lack of Efficacy|31
6889133|NCT00583557|10903933|FG000|Overall Study|Lack of Compliance|5
6889134|NCT00583557|10903933|FG000|Overall Study|Other|5
6889135|NCT00583557|10903933|FG000|Overall Study|Did not receive belimumab in LBRA99|2
6889136|NCT00583596|10903937|FG000|Overall Study|Lost to Follow-up|110
6889137|NCT00583596|10903937|FG000|Overall Study|Excluded due to Hurricane Katrina|30
6889138|NCT00583596|10903937|FG000|Overall Study|Death|2
6889139|NCT00583596|10903937|FG000|Overall Study|Withdrawal by Subject|6
6889140|NCT00583596|10903937|FG000|Overall Study|Lost to Follow-up|94
6889141|NCT00583596|10903937|FG000|Overall Study|Data not complete|1
6889142|NCT00583596|10903937|FG000|Overall Study|Not consented|15
6889143|NCT00583596|10903937|FG000|Overall Study|Outside f-up window|26
6889144|NCT00583791|10903973|FG000|Overall Study|Other|67
6889145|NCT00583791|10903973|FG000|Overall Study|Death|6
6889146|NCT00583947|10904008|FG000|Cross-over Period|Adverse Event|2
6889147|NCT00583947|10904009|FG001|Cross-over Period|Adverse Event|0
6889148|NCT00583947|10904008|FG000|Cross-over Period|Withdrawal by Subject|2
6889149|NCT00583947|10904009|FG001|Cross-over Period|Withdrawal by Subject|0
6889150|NCT00583947|10904008|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0
6889151|NCT00583947|10904009|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1
6889152|NCT00583947|10904008|FG000|Cross-over Period|Other|1
6889153|NCT00583947|10904009|FG001|Cross-over Period|Other|1
6889154|NCT00584194|10904022|FG000|Overall Study|Other|135
6889155|NCT00584415|10904041|FG000|Overall Study|Adverse Event|7
6889156|NCT00584454|10904046|FG000|Overall Study|Adverse Event|1
6889157|NCT00584454|10904046|FG000|Overall Study|Relocation|1
6889158|NCT00584454|10904046|FG000|Overall Study|Clinical Hold|2
6889159|NCT00584727|10904064|FG000|First Intervention|Discontinuation|0
6889160|NCT00584727|10904065|FG001|First Intervention|Discontinuation|0
6889161|NCT00584727|10904066|FG002|First Intervention|Discontinuation|1
6889162|NCT00584727|10904067|FG003|First Intervention|Discontinuation|0
6889163|NCT00584727|10904068|FG004|First Intervention|Discontinuation|0
6889164|NCT00584727|10904069|FG005|First Intervention|Discontinuation|0
6889165|NCT00584727|10904064|FG000|Third Intervention|Protocol Violation|0
6889166|NCT00584727|10904065|FG001|Third Intervention|Protocol Violation|0
6889167|NCT00584727|10904066|FG002|Third Intervention|Protocol Violation|1
6889168|NCT00584727|10904067|FG003|Third Intervention|Protocol Violation|0
6889169|NCT00584727|10904068|FG004|Third Intervention|Protocol Violation|4
6889170|NCT00584727|10904069|FG005|Third Intervention|Protocol Violation|2
7155735|NCT03346057|11323774|FG001|Overall Study|Randomization Mistake - Not Treated|1
7155736|NCT03346057|11323775|FG002|Overall Study|Randomization Mistake - Not Treated|0
6889171|NCT00584740|10904082|FG000|Overall Study|Adverse Event|1
6889172|NCT00584740|10904083|FG001|Overall Study|Adverse Event|1
6889173|NCT00584740|10904082|FG000|Overall Study|Lack of Efficacy|8
6889174|NCT00584740|10904083|FG001|Overall Study|Lack of Efficacy|2
6889175|NCT00584740|10904082|FG000|Overall Study|Withdrawal by Subject|3
6889176|NCT00584740|10904083|FG001|Overall Study|Withdrawal by Subject|2
6889177|NCT00584740|10904082|FG000|Overall Study|Lost to Follow-up|0
6889178|NCT00584740|10904083|FG001|Overall Study|Lost to Follow-up|1
6889179|NCT00584805|10904089|FG000|Overall Study|No longer at risk of exposure|39
6889180|NCT00584805|10904089|FG000|Overall Study|Relocation|36
6889181|NCT00584805|10904089|FG000|Overall Study|Withdrawal by Subject|18
6889182|NCT00584805|10904089|FG000|Overall Study|Non-compliance|1
6889183|NCT00584805|10904089|FG000|Overall Study|Lost to follow up|3
6889184|NCT00584805|10904089|FG000|Overall Study|Screen failures|2
6889185|NCT00584844|10904123|FG000|Overall Study|Withdrawal by Subject|59
6889186|NCT00584844|10904123|FG000|Overall Study|Screen Failure|20
6889187|NCT00584870|10904138|FG000|Overall Study|Adverse Event|4
6889188|NCT00584870|10904139|FG001|Overall Study|Adverse Event|3
6889189|NCT00584870|10904140|FG002|Overall Study|Adverse Event|2
6889190|NCT00584870|10904138|FG000|Overall Study|Lost to Follow-up|4
6889191|NCT00584870|10904139|FG001|Overall Study|Lost to Follow-up|1
6889192|NCT00584870|10904140|FG002|Overall Study|Lost to Follow-up|1
6889193|NCT00584870|10904138|FG000|Overall Study|Lack of Efficacy|7
6889194|NCT00584870|10904139|FG001|Overall Study|Lack of Efficacy|14
6889195|NCT00584870|10904140|FG002|Overall Study|Lack of Efficacy|8
6889196|NCT00584870|10904138|FG000|Overall Study|Withdrawal by Subject|10
6889197|NCT00584870|10904139|FG001|Overall Study|Withdrawal by Subject|5
6889198|NCT00584870|10904140|FG002|Overall Study|Withdrawal by Subject|3
6889199|NCT00584870|10904138|FG000|Overall Study|Protocol Violation|1
6889200|NCT00584870|10904139|FG001|Overall Study|Protocol Violation|1
6889201|NCT00584870|10904140|FG002|Overall Study|Protocol Violation|2
6889202|NCT00584870|10904138|FG000|Overall Study|Did not met entrance criteria|1
6889203|NCT00584870|10904139|FG001|Overall Study|Did not met entrance criteria|0
6889204|NCT00584870|10904140|FG002|Overall Study|Did not met entrance criteria|0
6889205|NCT00584870|10904138|FG000|Overall Study|Other|2
6889206|NCT00584870|10904139|FG001|Overall Study|Other|0
6889207|NCT00584870|10904140|FG002|Overall Study|Other|0
6889208|NCT00584870|10904138|FG000|Overall Study|Randomized but not treated|0
6889209|NCT00584870|10904139|FG001|Overall Study|Randomized but not treated|1
6889210|NCT00584870|10904140|FG002|Overall Study|Randomized but not treated|2
6889211|NCT00584909|10904148|FG000|Overall Study|Adverse Event|4
6889212|NCT00584987|10904169|FG000|Overall Study|Protocol Violation|1
6889213|NCT00584987|10904170|FG001|Overall Study|Protocol Violation|1
6889214|NCT00584987|10904171|FG002|Overall Study|Protocol Violation|1
6889215|NCT00584987|10904172|FG003|Overall Study|Protocol Violation|0
6889216|NCT00584987|10904169|FG000|Overall Study|Adverse Event|0
7155737|NCT03346057|11323776|FG003|Overall Study|Randomization Mistake - Not Treated|0
6889217|NCT00584987|10904170|FG001|Overall Study|Adverse Event|0
6889218|NCT00584987|10904171|FG002|Overall Study|Adverse Event|0
6889219|NCT00584987|10904172|FG003|Overall Study|Adverse Event|1
6889220|NCT00585039|10904195|FG000|Overall Study|medication spilled|2
6889221|NCT00585039|10904196|FG001|Overall Study|medication spilled|0
6889222|NCT00585052|10904204|FG000|Overall Study|Withdrawal by Subject|1
6889223|NCT00585078|10904208|FG000|Overall Study|Withdrawal by Subject|4
6889224|NCT00585078|10904208|FG000|Overall Study|Poor performance status|1
6889225|NCT00585078|10904208|FG000|Overall Study|Disease Progression|24
6889226|NCT00585078|10904208|FG000|Overall Study|Adverse Event|10
6889227|NCT00585078|10904208|FG000|Overall Study|Death|1
6889228|NCT00585169|10904216|FG000|Overall Study|Withdrawal by Subject|1
6889229|NCT00585286|10904235|FG000|Overall Study|Lost to Follow-up|1
6889230|NCT00585312|10904241|FG000|Overall Study|Adverse Event|3
6889231|NCT00585312|10904242|FG001|Overall Study|Adverse Event|0
6889232|NCT00585312|10904241|FG000|Overall Study|Lack of Efficacy|6
6889233|NCT00585312|10904242|FG001|Overall Study|Lack of Efficacy|11
6889234|NCT00585312|10904241|FG000|Overall Study|Lost to Follow-up|1
6889235|NCT00585312|10904242|FG001|Overall Study|Lost to Follow-up|1
6889236|NCT00585312|10904241|FG000|Overall Study|Reason not specified|2
6889237|NCT00585312|10904242|FG001|Overall Study|Reason not specified|0
6889238|NCT00585312|10904241|FG000|Overall Study|Withdrawal by Subject|5
6889239|NCT00585312|10904242|FG001|Overall Study|Withdrawal by Subject|1
6889240|NCT00585312|10904241|FG000|Overall Study|Study terminated by the sponsor|34
6889241|NCT00585312|10904242|FG001|Overall Study|Study terminated by the sponsor|31
6889242|NCT00585325|10904250|FG000|Overall Study|Withdrawal by Subject|1
6889243|NCT00585325|10904251|FG001|Overall Study|Withdrawal by Subject|1
6889244|NCT00585351|10904263|FG000|Notification Period (Informed Consent)|Physician Decision|0
6889245|NCT00585351|10904264|FG001|Notification Period (Informed Consent)|Physician Decision|2
7079200|NCT02110238|11187995|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3
7079201|NCT02110693|11188033|FG000|Overall Study|Withdrawal by Subject|6
7079202|NCT02110693|11188034|FG001|Overall Study|Withdrawal by Subject|7
7079203|NCT02110693|11188033|FG000|Overall Study|skipped assessment|15
7079204|NCT02110693|11188034|FG001|Overall Study|skipped assessment|18
7079205|NCT02110693|11188033|FG000|Overall Study|technical difficulties|6
7079206|NCT02110693|11188034|FG001|Overall Study|technical difficulties|4
7079207|NCT02110693|11188033|FG000|Overall Study|Other|1
7079208|NCT02110693|11188034|FG001|Overall Study|Other|0
7079209|NCT02110706|11188056|FG000|Overall Study|Adverse Event|2
7079210|NCT02110706|11188057|FG001|Overall Study|Adverse Event|3
7079211|NCT02110706|11188056|FG000|Overall Study|Patients who didn't receive 2nd infusion|3
7079212|NCT02110706|11188057|FG001|Overall Study|Patients who didn't receive 2nd infusion|1
7079213|NCT02110732|11188067|FG000|Overall Study|Physician Decision|5
7079214|NCT02110732|11188068|FG001|Overall Study|Physician Decision|2
7079215|NCT02110732|11188067|FG000|Overall Study|Lost to Follow-up|1
7079216|NCT02110732|11188068|FG001|Overall Study|Lost to Follow-up|1
7079217|NCT02110901|11188097|FG000|Overall Study|Death|6
7079218|NCT02110901|11188098|FG001|Overall Study|Death|3
7079219|NCT02110901|11188097|FG000|Overall Study|Lost to Follow-up|12
7079220|NCT02110901|11188098|FG001|Overall Study|Lost to Follow-up|8
7079221|NCT02110901|11188097|FG000|Overall Study|Withdrawal by Subject|7
7079222|NCT02110901|11188098|FG001|Overall Study|Withdrawal by Subject|3
7079223|NCT02110901|11188097|FG000|Overall Study|received a kidney transplant|5
6889246|NCT00585351|10904265|FG002|Notification Period (Informed Consent)|Physician Decision|0
6889247|NCT00585351|10904266|FG003|Notification Period (Informed Consent)|Physician Decision|0
6889248|NCT00585351|10904267|FG004|Notification Period (Informed Consent)|Physician Decision|0
6889249|NCT00585351|10904268|FG005|Notification Period (Informed Consent)|Physician Decision|0
6889250|NCT00585351|10904269|FG006|Notification Period (Informed Consent)|Physician Decision|0
6889251|NCT00585351|10904270|FG007|Notification Period (Informed Consent)|Physician Decision|0
6889252|NCT00585351|10904263|FG000|Notification Period (Informed Consent)|Flight aborted|2
6889253|NCT00585351|10904264|FG001|Notification Period (Informed Consent)|Flight aborted|1
6889254|NCT00585351|10904265|FG002|Notification Period (Informed Consent)|Flight aborted|0
6889255|NCT00585351|10904266|FG003|Notification Period (Informed Consent)|Flight aborted|0
6889256|NCT00585351|10904267|FG004|Notification Period (Informed Consent)|Flight aborted|0
6889257|NCT00585351|10904268|FG005|Notification Period (Informed Consent)|Flight aborted|0
6889258|NCT00585351|10904269|FG006|Notification Period (Informed Consent)|Flight aborted|0
6889259|NCT00585351|10904270|FG007|Notification Period (Informed Consent)|Flight aborted|0
6889260|NCT00585351|10904263|FG000|Notification Period (Informed Consent)|No study medication on flight|0
6889261|NCT00585351|10904264|FG001|Notification Period (Informed Consent)|No study medication on flight|1
6889262|NCT00585351|10904265|FG002|Notification Period (Informed Consent)|No study medication on flight|0
6889263|NCT00585351|10904266|FG003|Notification Period (Informed Consent)|No study medication on flight|0
6889264|NCT00585351|10904267|FG004|Notification Period (Informed Consent)|No study medication on flight|0
6889265|NCT00585351|10904268|FG005|Notification Period (Informed Consent)|No study medication on flight|0
6889266|NCT00585351|10904269|FG006|Notification Period (Informed Consent)|No study medication on flight|0
6889267|NCT00585351|10904270|FG007|Notification Period (Informed Consent)|No study medication on flight|0
6889268|NCT00585351|10904263|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
6889269|NCT00585351|10904264|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
6889270|NCT00585351|10904265|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
6889271|NCT00585351|10904266|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
6889272|NCT00585351|10904267|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
6889273|NCT00585351|10904268|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
6889274|NCT00585351|10904269|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
7079224|NCT02110901|11188098|FG001|Overall Study|received a kidney transplant|0
6889275|NCT00585351|10904270|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
7079225|NCT02111083|11188107|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1
6889276|NCT00585351|10904263|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0
6889277|NCT00585351|10904264|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0
6889278|NCT00585351|10904265|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0
6889279|NCT00585351|10904266|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0
6889280|NCT00585351|10904267|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0
6889281|NCT00585351|10904268|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0
6889282|NCT00585351|10904269|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1
6889283|NCT00585351|10904270|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1
6889284|NCT00585351|10904263|FG000|Enrollment Period (Intervention)|Death|0
6889285|NCT00585351|10904264|FG001|Enrollment Period (Intervention)|Death|0
6889286|NCT00585351|10904265|FG002|Enrollment Period (Intervention)|Death|0
6889287|NCT00585351|10904266|FG003|Enrollment Period (Intervention)|Death|0
6889288|NCT00585351|10904267|FG004|Enrollment Period (Intervention)|Death|1
6889289|NCT00585351|10904268|FG005|Enrollment Period (Intervention)|Death|0
6889290|NCT00585351|10904269|FG006|Enrollment Period (Intervention)|Death|1
6889291|NCT00585351|10904270|FG007|Enrollment Period (Intervention)|Death|0
6889292|NCT00585351|10904263|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0
6889293|NCT00585351|10904264|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0
6889294|NCT00585351|10904265|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0
6889295|NCT00585351|10904266|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0
6889296|NCT00585351|10904267|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1
6889297|NCT00585351|10904268|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2
6889298|NCT00585351|10904269|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0
6889299|NCT00585351|10904270|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0
6889300|NCT00585468|10904288|FG000|First Intervention|Withdrawal by Subject|1
6889301|NCT00585468|10904289|FG001|First Intervention|Withdrawal by Subject|1
6889302|NCT00585533|10904301|FG000|Overall Study|objective or symptomatic progression|9
6889303|NCT00585546|10904305|FG000|Clenbuterol Treatment - up to 12 Months|Death|1
6889304|NCT00585546|10904305|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3
6889305|NCT00585689|10904335|FG000|Overall Study|Received different ABI-007 schedule|3
6889306|NCT00585689|10904335|FG000|Overall Study|Adverse Event|1
6889307|NCT00585689|10904335|FG000|Overall Study|Patient Declined Surgery|1
6889308|NCT00585689|10904335|FG000|Overall Study|Patient had unresectable disease|1
6889309|NCT00585689|10904335|FG000|Overall Study|Death|1
6970356|NCT01155011|11020471|FG001|6 to 12 Months|Death|5
6970357|NCT01155024|11020481|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0
6970358|NCT01155024|11020482|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2
6970359|NCT01155024|11020481|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0
6970360|NCT01155024|11020482|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2
6970361|NCT01155024|11020481|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0
6970362|NCT01155024|11020482|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2
6970363|NCT01155050|11020493|FG000|Overall Study|Lost to Follow-up|15
6970364|NCT01155050|11020494|FG001|Overall Study|Lost to Follow-up|20
6970365|NCT01155050|11020495|FG002|Overall Study|Lost to Follow-up|19
6970366|NCT01155050|11020496|FG003|Overall Study|Lost to Follow-up|22
6970367|NCT01155063|11020506|FG000|Overall Study|Adverse Event|1
6970368|NCT01155063|11020506|FG000|Overall Study|Withdrawal by Subject|1
6970369|NCT01155063|11020506|FG000|Overall Study|Study terminated by sponsor|87
6970370|NCT01155141|11020510|FG000|Overall Study|Withdrawal by Subject|1
6970371|NCT01155141|11020510|FG000|Overall Study|Screen Failure|1
6970372|NCT01155167|11020529|FG000|Overall Study|Insufficient ultrasound data|2
6970373|NCT01155167|11020530|FG001|Overall Study|Insufficient ultrasound data|0
6970374|NCT01155167|11020529|FG000|Overall Study|Access site changed to femoral artery|1
6970375|NCT01155167|11020530|FG001|Overall Study|Access site changed to femoral artery|0
6970376|NCT01155219|11020569|FG000|Overall Study|Adverse Event|3
6970377|NCT01155219|11020570|FG001|Overall Study|Adverse Event|1
6970378|NCT01155219|11020569|FG000|Overall Study|non-medical reason|1
6970379|NCT01155219|11020570|FG001|Overall Study|non-medical reason|2
6970380|NCT01155284|11020578|FG000|Overall Study|Withdrawal by Subject|4
6970381|NCT01155284|11020579|FG001|Overall Study|Withdrawal by Subject|3
6970382|NCT01155284|11020578|FG000|Overall Study|Lost to Follow-up|1
6970383|NCT01155284|11020579|FG001|Overall Study|Lost to Follow-up|2
6970384|NCT01155284|11020578|FG000|Overall Study|Physician Decision|1
6970385|NCT01155284|11020579|FG001|Overall Study|Physician Decision|0
6970386|NCT01155284|11020578|FG000|Overall Study|Adverse Event|1
6970387|NCT01155284|11020579|FG001|Overall Study|Adverse Event|0
6970388|NCT01155323|11020587|FG000|First Intervention|exclusion criteria|1
6970389|NCT01155323|11020588|FG001|First Intervention|exclusion criteria|1
6970390|NCT01155323|11020587|FG000|Second Intervention|Lost to Follow-up|1
6970391|NCT01155323|11020588|FG001|Second Intervention|Lost to Follow-up|1
6970392|NCT01155466|11020608|FG000|Overall Study|Adverse Event|13
6970393|NCT01155466|11020609|FG001|Overall Study|Adverse Event|15
6970394|NCT01155466|11020610|FG002|Overall Study|Adverse Event|6
6970395|NCT01155466|11020611|FG003|Overall Study|Adverse Event|17
6970396|NCT01155466|11020612|FG004|Overall Study|Adverse Event|18
6970397|NCT01155466|11020608|FG000|Overall Study|Lost to Follow-up|0
6970398|NCT01155466|11020609|FG001|Overall Study|Lost to Follow-up|0
6889310|NCT00585923|10904376|FG000|Overall Study|Physician decided not to continue|31
6889311|NCT00585923|10904377|FG001|Overall Study|Physician decided not to continue|33
6889312|NCT00585975|10904385|FG000|Overall Study|Withdrawal by Subject|3
6889313|NCT00585975|10904386|FG001|Overall Study|Withdrawal by Subject|3
6889314|NCT00585975|10904385|FG000|Overall Study|Lost to Follow-up|2
6889315|NCT00585975|10904386|FG001|Overall Study|Lost to Follow-up|1
6889316|NCT00585975|10904385|FG000|Overall Study|Enrollment met/over-enrolled|10
6889317|NCT00585975|10904386|FG001|Overall Study|Enrollment met/over-enrolled|9
6889318|NCT00586066|10904404|FG000|Overall Study|Lost to Follow-up|6
6889319|NCT00586066|10904405|FG001|Overall Study|Lost to Follow-up|3
6889320|NCT00586066|10904404|FG000|Overall Study|Lack of Efficacy|5
6889321|NCT00586066|10904405|FG001|Overall Study|Lack of Efficacy|3
6889322|NCT00586066|10904404|FG000|Overall Study|Adverse Event|2
6889323|NCT00586066|10904405|FG001|Overall Study|Adverse Event|2
6889324|NCT00586066|10904404|FG000|Overall Study|Physician Decision|1
6889325|NCT00586066|10904405|FG001|Overall Study|Physician Decision|0
6889326|NCT00586066|10904404|FG000|Overall Study|Withdrawal of consent|4
6889327|NCT00586066|10904405|FG001|Overall Study|Withdrawal of consent|2
6889328|NCT00586105|10904411|FG000|Overall Study|Adverse Event|4
6889329|NCT00586105|10904411|FG000|Overall Study|Death|2
6889330|NCT00586105|10904411|FG000|Overall Study|Protocol Violation|1
6889331|NCT00586105|10904411|FG000|Overall Study|Withdrawal by Subject|3
6889332|NCT00586105|10904411|FG000|Overall Study|Disease progression|19
6889333|NCT00586105|10904411|FG000|Overall Study|Switched to commercial drug|9
6889334|NCT00586105|10904411|FG000|Overall Study|Reason not reported|1
6889335|NCT00586157|10904415|FG000|First Intervention|Worsening behavior|1
6889336|NCT00586157|10904416|FG001|First Intervention|Worsening behavior|0
6889337|NCT00586157|10904415|FG000|Second Intervention|Withdrawal by Subject|1
6889338|NCT00586157|10904416|FG001|Second Intervention|Withdrawal by Subject|0
6889339|NCT00586157|10904415|FG000|Second Intervention|Worsening behavior|1
6889340|NCT00586157|10904416|FG001|Second Intervention|Worsening behavior|0
6889341|NCT00586157|10904415|FG000|Second Intervention|Adverse Event|0
6889342|NCT00586157|10904416|FG001|Second Intervention|Adverse Event|1
6889343|NCT00586313|10904449|FG000|Overall Study|Lack of Efficacy|2
6889344|NCT00586326|10904453|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6
6889345|NCT00586326|10904453|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4
6889346|NCT00586326|10904453|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2
6889347|NCT00586326|10904453|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1
6889348|NCT00586326|10904453|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1
6889349|NCT00586326|10904453|FG000|Enrollment to Device Placement-Enrolled|Other|1
6889350|NCT00586326|10904453|FG000|Device Placed toTreatment-ITT|Skin Distance|7
6889351|NCT00586326|10904453|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6
6889352|NCT00586326|10904453|FG000|Device Placed toTreatment-ITT|Microinvasion|1
6889353|NCT00586326|10904453|FG000|Device Placed toTreatment-ITT|Positive Margins|3
6889354|NCT00586326|10904453|FG000|Device Placed toTreatment-ITT|Physician Decision|1
6889355|NCT00586326|10904453|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1
6889356|NCT00586326|10904453|FG000|Treated Through 5-yr Follow Up-Treated|Death|2
6889357|NCT00586326|10904453|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2
6889358|NCT00586326|10904453|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5
6889359|NCT00586326|10904453|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14
6889360|NCT00586326|10904453|FG000|Treated Through 5-yr Follow Up-Treated|Other|2
6889361|NCT00586339|10904464|FG000|Overall Study|Withdrawal by Subject|1
6889362|NCT00586339|10904465|FG001|Overall Study|Withdrawal by Subject|3
6889363|NCT00586339|10904466|FG002|Overall Study|Withdrawal by Subject|1
6889364|NCT00586339|10904464|FG000|Overall Study|Migrated/moved from study area|3
6889365|NCT00586339|10904465|FG001|Overall Study|Migrated/moved from study area|2
6889366|NCT00586339|10904466|FG002|Overall Study|Migrated/moved from study area|4
6889367|NCT00586339|10904464|FG000|Overall Study|Lost to Follow-up|3
6889368|NCT00586339|10904465|FG001|Overall Study|Lost to Follow-up|2
6889369|NCT00586339|10904466|FG002|Overall Study|Lost to Follow-up|1
6889370|NCT00586469|10904476|FG000|Overall Study|Adverse Event|0
6889371|NCT00586469|10904477|FG001|Overall Study|Adverse Event|1
6889372|NCT00586495|10904492|FG000|Treatment Period|Adverse Event|11
6889373|NCT00586495|10904492|FG000|Treatment Period|Death|1
6889374|NCT00586495|10904492|FG000|Treatment Period|Protocol Violation|1
6889375|NCT00586495|10904492|FG000|Treatment Period|Withdrawal by Subject|1
6889376|NCT00586495|10904492|FG000|Treatment Period|Disease progression, recurrence/relapse|71
6889377|NCT00586495|10904492|FG000|Treatment Period|Switch to commercial drug|10
6889378|NCT00586495|10904492|FG000|Follow-up|Death|40
6889379|NCT00586495|10904492|FG000|Follow-up|Lost to Follow-up|1
6889380|NCT00586495|10904492|FG000|Follow-up|Withdrawal by Subject|4
7079226|NCT02111083|11188108|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1
7079227|NCT02111096|11188117|FG000|Overall Study|Adverse Event|4
7079228|NCT02111096|11188118|FG001|Overall Study|Adverse Event|1
7079229|NCT02111096|11188119|FG002|Overall Study|Adverse Event|2
7079230|NCT02111096|11188117|FG000|Overall Study|Non-Compliance with Study Drug|1
7079231|NCT02111096|11188118|FG001|Overall Study|Non-Compliance with Study Drug|1
7079232|NCT02111096|11188119|FG002|Overall Study|Non-Compliance with Study Drug|0
6889381|NCT00586495|10904492|FG000|Follow-up|Protocol driven decision point|37
6889382|NCT00586495|10904492|FG000|Follow-up|Switch to commercial drug|10
7079233|NCT02111096|11188117|FG000|Overall Study|Lost to Follow Up|1
7079234|NCT02111096|11188118|FG001|Overall Study|Lost to Follow Up|1
7079235|NCT02111096|11188119|FG002|Overall Study|Lost to Follow Up|1
7079236|NCT02111096|11188117|FG000|Overall Study|Physician Decision|0
6889383|NCT00586508|10904498|FG000|Overall Study|Progressive disease|52
6889384|NCT00586508|10904499|FG001|Overall Study|Progressive disease|8
6889385|NCT00586508|10904498|FG000|Overall Study|Death|0
6889386|NCT00586508|10904499|FG001|Overall Study|Death|1
6889387|NCT00586508|10904498|FG000|Overall Study|Adverse Event|12
6889388|NCT00586508|10904499|FG001|Overall Study|Adverse Event|4
6889389|NCT00586508|10904498|FG000|Overall Study|Withdrawal by Subject|4
6889390|NCT00586508|10904499|FG001|Overall Study|Withdrawal by Subject|0
6889391|NCT00586521|10904505|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1
6889392|NCT00586612|10904515|FG000|Primary Phase|Protocol Violation|1
6889393|NCT00586612|10904516|FG001|Primary Phase|Protocol Violation|0
6889394|NCT00586612|10904515|FG000|Primary Phase|Lost to Follow-up|0
6889395|NCT00586612|10904516|FG001|Primary Phase|Lost to Follow-up|1
6889396|NCT00586612|10904515|FG000|Primary Phase|Withdrawal by Subject|0
6889397|NCT00586612|10904516|FG001|Primary Phase|Withdrawal by Subject|2
6889398|NCT00586612|10904515|FG000|Booster Phase|Lost to Follow-up|3
6889399|NCT00586612|10904516|FG001|Booster Phase|Lost to Follow-up|1
6889400|NCT00586625|10904524|FG000|Overall Study|Adverse Event|6
6889401|NCT00586625|10904525|FG001|Overall Study|Adverse Event|6
6889402|NCT00586625|10904524|FG000|Overall Study|Protocol Violation|3
6889403|NCT00586625|10904525|FG001|Overall Study|Protocol Violation|0
6889404|NCT00586625|10904524|FG000|Overall Study|Withdrawal by Subject|32
6889405|NCT00586625|10904525|FG001|Overall Study|Withdrawal by Subject|10
6889406|NCT00586625|10904524|FG000|Overall Study|Subject non-compliance|0
6889407|NCT00586625|10904525|FG001|Overall Study|Subject non-compliance|1
6889408|NCT00586625|10904524|FG000|Overall Study|Subject unable to return for visit|2
6889409|NCT00586625|10904525|FG001|Overall Study|Subject unable to return for visit|0
6889410|NCT00586664|10904534|FG000|Overall Study|Withdrawal by Subject|3
6889411|NCT00586664|10904535|FG001|Overall Study|Withdrawal by Subject|7
6889412|NCT00586664|10904536|FG002|Overall Study|Withdrawal by Subject|1
6889413|NCT00586664|10904534|FG000|Overall Study|Exclusion criteria met|2
6889414|NCT00586664|10904535|FG001|Overall Study|Exclusion criteria met|0
6889415|NCT00586664|10904536|FG002|Overall Study|Exclusion criteria met|0
6889416|NCT00586690|10904546|FG000|Overall Study|Death|2
6889417|NCT00586690|10904547|FG001|Overall Study|Death|0
6889418|NCT00586690|10904546|FG000|Overall Study|Disease Progression|10
6889419|NCT00586690|10904547|FG001|Overall Study|Disease Progression|0
6889420|NCT00586690|10904546|FG000|Overall Study|Adverse Event|1
6889421|NCT00586690|10904547|FG001|Overall Study|Adverse Event|0
6889422|NCT00586690|10904546|FG000|Overall Study|Lack of Efficacy|2
6889423|NCT00586690|10904547|FG001|Overall Study|Lack of Efficacy|0
6889424|NCT00586690|10904546|FG000|Overall Study|Lab can't accommodate|1
6889425|NCT00586690|10904547|FG001|Overall Study|Lab can't accommodate|0
6889426|NCT00586703|10904552|FG000|Overall Study|Death|12
6889427|NCT00586820|10904567|FG000|Overall Study|Unsuccessful PCI|1
6889428|NCT00586820|10904568|FG001|Overall Study|Unsuccessful PCI|0
6889429|NCT00586846|10904574|FG000|Overall Study|Physician Decision|1
6889430|NCT00586846|10904574|FG000|Overall Study|Death|1
6889431|NCT00586846|10904574|FG000|Overall Study|Evaluable for Toxicity Only|4
6889432|NCT00586898|10904578|FG000|Overall Study|Adverse Event|1
6889433|NCT00586898|10904578|FG000|Overall Study|Patiemt Non-compliance|1
6889434|NCT00586898|10904578|FG000|Overall Study|Evaluable for Toxicity Only|5
6889435|NCT00587054|10904595|FG000|Overall Study|Patient not treated|9
6889436|NCT00587158|10904622|FG000|Overall Study|Did not want to do 24 hr urine collect.|4
6889437|NCT00587158|10904623|FG001|Overall Study|Did not want to do 24 hr urine collect.|3
6889438|NCT00587158|10904622|FG000|Overall Study|Physician Decision|0
6889439|NCT00587158|10904623|FG001|Overall Study|Physician Decision|1
6889440|NCT00587158|10904622|FG000|Overall Study|Lost to Follow-up|1
6889441|NCT00587158|10904623|FG001|Overall Study|Lost to Follow-up|2
6889442|NCT00587158|10904622|FG000|Overall Study|Death|0
6889443|NCT00587158|10904623|FG001|Overall Study|Death|1
6889444|NCT00587158|10904622|FG000|Overall Study|Subject did not want to take study med|0
6889445|NCT00587158|10904623|FG001|Overall Study|Subject did not want to take study med|1
6889446|NCT00587171|10904631|FG000|Overall Study|Lost to Follow-up|1
6889447|NCT00587171|10904632|FG001|Overall Study|Lost to Follow-up|1
6889448|NCT00587288|10904640|FG000|Overall Study|Adverse Event|0
6889449|NCT00587288|10904641|FG001|Overall Study|Adverse Event|1
6889450|NCT00587288|10904640|FG000|Overall Study|Lack of Efficacy|2
6889451|NCT00587288|10904641|FG001|Overall Study|Lack of Efficacy|8
6889452|NCT00587288|10904640|FG000|Overall Study|Protocol Violation|1
6889453|NCT00587288|10904641|FG001|Overall Study|Protocol Violation|0
6889454|NCT00587431|10904651|FG000|Overall Study|Adverse Event|1
6889455|NCT00587431|10904652|FG001|Overall Study|Adverse Event|0
6889456|NCT00587431|10904651|FG000|Overall Study|Withdrawal by Subject|0
6889457|NCT00587431|10904652|FG001|Overall Study|Withdrawal by Subject|1
6889458|NCT00587457|10904664|FG000|Overall Study|Adverse Event|1
6889459|NCT00587457|10904665|FG001|Overall Study|Adverse Event|2
6889460|NCT00587457|10904666|FG002|Overall Study|Adverse Event|1
6889461|NCT00587457|10904664|FG000|Overall Study|Disease progression|2
6889462|NCT00587457|10904665|FG001|Overall Study|Disease progression|0
6889463|NCT00587457|10904666|FG002|Overall Study|Disease progression|2
6889464|NCT00587457|10904664|FG000|Overall Study|Initiation of alternative therapy|0
6889465|NCT00587457|10904665|FG001|Overall Study|Initiation of alternative therapy|1
6889466|NCT00587457|10904666|FG002|Overall Study|Initiation of alternative therapy|0
6889467|NCT00587457|10904664|FG000|Overall Study|Undefined|0
6889468|NCT00587457|10904665|FG001|Overall Study|Undefined|0
6889469|NCT00587457|10904666|FG002|Overall Study|Undefined|1
6889470|NCT00587457|10904664|FG000|Overall Study|Development of neutralizing Abs|0
6889471|NCT00587457|10904665|FG001|Overall Study|Development of neutralizing Abs|0
6889472|NCT00587457|10904666|FG002|Overall Study|Development of neutralizing Abs|1
6889473|NCT00587587|10904689|FG000|Overall Study|Lost to Follow-up|6
6889474|NCT00587587|10904690|FG001|Overall Study|Lost to Follow-up|1
6889475|NCT00587639|10904698|FG000|Overall Study|Withdrawal by Subject|1
6889476|NCT00587847|10904734|FG000|Overall Study|Lack of Efficacy|5
6889477|NCT00587847|10904734|FG000|Overall Study|Adverse Event|2
6970399|NCT01155466|11020610|FG002|Overall Study|Lost to Follow-up|0
6970400|NCT01155466|11020611|FG003|Overall Study|Lost to Follow-up|0
6970401|NCT01155466|11020612|FG004|Overall Study|Lost to Follow-up|2
6970402|NCT01155466|11020608|FG000|Overall Study|Withdrawal by Subject|7
6970403|NCT01155466|11020609|FG001|Overall Study|Withdrawal by Subject|5
6970404|NCT01155466|11020610|FG002|Overall Study|Withdrawal by Subject|9
6970405|NCT01155466|11020611|FG003|Overall Study|Withdrawal by Subject|4
6970406|NCT01155466|11020612|FG004|Overall Study|Withdrawal by Subject|4
6970407|NCT01155466|11020608|FG000|Overall Study|Protocol Violation|0
6970408|NCT01155466|11020609|FG001|Overall Study|Protocol Violation|0
6970409|NCT01155466|11020610|FG002|Overall Study|Protocol Violation|2
6970410|NCT01155466|11020611|FG003|Overall Study|Protocol Violation|0
6970411|NCT01155466|11020612|FG004|Overall Study|Protocol Violation|1
6970412|NCT01155466|11020608|FG000|Overall Study|Administrative|0
6970413|NCT01155466|11020609|FG001|Overall Study|Administrative|3
6970414|NCT01155466|11020610|FG002|Overall Study|Administrative|0
6970415|NCT01155466|11020611|FG003|Overall Study|Administrative|0
6970416|NCT01155466|11020612|FG004|Overall Study|Administrative|0
6970417|NCT01155466|11020608|FG000|Overall Study|Randomized not treated|2
6970418|NCT01155466|11020609|FG001|Overall Study|Randomized not treated|2
6970419|NCT01155466|11020610|FG002|Overall Study|Randomized not treated|3
6970420|NCT01155466|11020611|FG003|Overall Study|Randomized not treated|0
6970421|NCT01155466|11020612|FG004|Overall Study|Randomized not treated|2
6970422|NCT01155479|11020629|FG000|Part I|Adverse Event|13
6970423|NCT01155479|11020630|FG001|Part I|Adverse Event|8
6970424|NCT01155479|11020631|FG002|Part I|Adverse Event|18
6970425|NCT01155479|11020632|FG003|Part I|Adverse Event|7
6970426|NCT01155479|11020633|FG004|Part I|Adverse Event|6
6970427|NCT01155479|11020629|FG000|Part I|Administrative|2
6970428|NCT01155479|11020630|FG001|Part I|Administrative|2
6970429|NCT01155479|11020631|FG002|Part I|Administrative|2
6970430|NCT01155479|11020632|FG003|Part I|Administrative|0
6970431|NCT01155479|11020633|FG004|Part I|Administrative|0
6970432|NCT01155479|11020629|FG000|Part I|Did Not Meet Protocol Eligibility|3
6970433|NCT01155479|11020630|FG001|Part I|Did Not Meet Protocol Eligibility|1
6970434|NCT01155479|11020631|FG002|Part I|Did Not Meet Protocol Eligibility|2
6970435|NCT01155479|11020632|FG003|Part I|Did Not Meet Protocol Eligibility|1
6970436|NCT01155479|11020633|FG004|Part I|Did Not Meet Protocol Eligibility|3
6970437|NCT01155479|11020629|FG000|Part I|Withdrawal by Subject|11
6970438|NCT01155479|11020630|FG001|Part I|Withdrawal by Subject|13
6970439|NCT01155479|11020631|FG002|Part I|Withdrawal by Subject|8
6970440|NCT01155479|11020632|FG003|Part I|Withdrawal by Subject|8
6970441|NCT01155479|11020633|FG004|Part I|Withdrawal by Subject|9
6970442|NCT01155479|11020629|FG000|Part I|Lost to Follow-up|0
6970443|NCT01155479|11020630|FG001|Part I|Lost to Follow-up|0
6970444|NCT01155479|11020631|FG002|Part I|Lost to Follow-up|1
6970445|NCT01155479|11020632|FG003|Part I|Lost to Follow-up|1
6970446|NCT01155479|11020633|FG004|Part I|Lost to Follow-up|0
6970447|NCT01155479|11020629|FG000|Part I|Treatment Failure|3
6970448|NCT01155479|11020630|FG001|Part I|Treatment Failure|0
6970449|NCT01155479|11020631|FG002|Part I|Treatment Failure|3
6970450|NCT01155479|11020632|FG003|Part I|Treatment Failure|1
6970451|NCT01155479|11020633|FG004|Part I|Treatment Failure|2
6970452|NCT01155479|11020629|FG000|Part I|Did Not Receive Treatment|4
6970453|NCT01155479|11020630|FG001|Part I|Did Not Receive Treatment|2
6970454|NCT01155479|11020631|FG002|Part I|Did Not Receive Treatment|2
6970455|NCT01155479|11020632|FG003|Part I|Did Not Receive Treatment|6
6970456|NCT01155479|11020633|FG004|Part I|Did Not Receive Treatment|1
6970457|NCT01155479|11020629|FG000|Part I|Non-Compliance with Protocol|2
6970458|NCT01155479|11020630|FG001|Part I|Non-Compliance with Protocol|1
6970459|NCT01155479|11020631|FG002|Part I|Non-Compliance with Protocol|3
6970460|NCT01155479|11020632|FG003|Part I|Non-Compliance with Protocol|3
6970461|NCT01155479|11020633|FG004|Part I|Non-Compliance with Protocol|2
6970462|NCT01155479|11020629|FG000|Part II|Adverse Event|7
6970463|NCT01155479|11020630|FG001|Part II|Adverse Event|6
6970464|NCT01155479|11020631|FG002|Part II|Adverse Event|8
6970465|NCT01155479|11020632|FG003|Part II|Adverse Event|3
6970466|NCT01155479|11020633|FG004|Part II|Adverse Event|4
6970467|NCT01155479|11020629|FG000|Part II|Administrative|43
6970468|NCT01155479|11020630|FG001|Part II|Administrative|49
6970469|NCT01155479|11020631|FG002|Part II|Administrative|36
6970470|NCT01155479|11020632|FG003|Part II|Administrative|38
6970471|NCT01155479|11020633|FG004|Part II|Administrative|46
6970472|NCT01155479|11020629|FG000|Part II|Withdrawal by Subject|8
6889478|NCT04411680|10904745|FG000|Treatment Period|Adverse Event|3
6889479|NCT04411680|10904746|FG001|Treatment Period|Adverse Event|0
6889480|NCT04411680|10904745|FG000|Treatment Period|Discharged from hospital|18
6889481|NCT04411680|10904746|FG001|Treatment Period|Discharged from hospital|7
6889482|NCT04411680|10904745|FG000|Treatment Period|Missed 1 or more doses|8
6889483|NCT04411680|10904746|FG001|Treatment Period|Missed 1 or more doses|0
6889484|NCT04411680|10904745|FG000|Treatment Period|Transferred to another hospital|0
6889485|NCT04411680|10904746|FG001|Treatment Period|Transferred to another hospital|1
6889486|NCT04411680|10904745|FG000|Follow up Period|Withdrawal by Subject|2
6889487|NCT04411680|10904746|FG001|Follow up Period|Withdrawal by Subject|0
6889488|NCT04411680|10904745|FG000|Follow up Period|Lost to Follow-up|5
6889489|NCT04411680|10904746|FG001|Follow up Period|Lost to Follow-up|6
6889490|NCT04411680|10904745|FG000|Follow up Period|Death|11
6889491|NCT04411680|10904746|FG001|Follow up Period|Death|8
6889492|NCT04364984|10904755|FG000|Overall Study|Death|2
6889493|NCT04364984|10904756|FG001|Overall Study|Death|2
6889494|NCT04364984|10904757|FG002|Overall Study|Death|0
6889495|NCT03711266|10904801|FG000|Overall Study|Lost to Follow-up|10
6889496|NCT03630393|10904807|FG000|Overall Study|Death|1
6889497|NCT03630393|10904808|FG001|Overall Study|Death|0
6889498|NCT03359811|10904825|FG000|Overall Study|Protocol Violation|2
6889499|NCT03359811|10904826|FG001|Overall Study|Protocol Violation|0
6889500|NCT02954406|10904868|FG000|Overall Study|Adverse Event|0
6889501|NCT02954406|10904869|FG001|Overall Study|Adverse Event|1
6889502|NCT02954406|10904870|FG002|Overall Study|Adverse Event|0
6889503|NCT02954406|10904871|FG003|Overall Study|Adverse Event|0
6889504|NCT02954406|10904872|FG004|Overall Study|Adverse Event|1
6889505|NCT02954406|10904873|FG005|Overall Study|Adverse Event|0
6889506|NCT02954406|10904874|FG006|Overall Study|Adverse Event|0
6889507|NCT02954406|10904875|FG007|Overall Study|Adverse Event|0
6889508|NCT02954406|10904876|FG008|Overall Study|Adverse Event|1
6889509|NCT02954406|10904877|FG009|Overall Study|Adverse Event|1
6889510|NCT02954406|10904878|FG010|Overall Study|Adverse Event|0
6889511|NCT02954406|10904868|FG000|Overall Study|Progressive Disease|3
6889512|NCT02954406|10904869|FG001|Overall Study|Progressive Disease|4
6889513|NCT02954406|10904870|FG002|Overall Study|Progressive Disease|3
6889514|NCT02954406|10904871|FG003|Overall Study|Progressive Disease|4
6889515|NCT02954406|10904872|FG004|Overall Study|Progressive Disease|3
6889516|NCT02954406|10904873|FG005|Overall Study|Progressive Disease|3
6889517|NCT02954406|10904874|FG006|Overall Study|Progressive Disease|2
6889518|NCT02954406|10904875|FG007|Overall Study|Progressive Disease|2
6889519|NCT02954406|10904876|FG008|Overall Study|Progressive Disease|1
6889520|NCT02954406|10904877|FG009|Overall Study|Progressive Disease|1
6889521|NCT02954406|10904878|FG010|Overall Study|Progressive Disease|0
6889522|NCT02954406|10904868|FG000|Overall Study|Symptomatic Deterioration|0
6889523|NCT02954406|10904869|FG001|Overall Study|Symptomatic Deterioration|1
6889524|NCT02954406|10904870|FG002|Overall Study|Symptomatic Deterioration|0
6889525|NCT02954406|10904871|FG003|Overall Study|Symptomatic Deterioration|0
6889526|NCT02954406|10904872|FG004|Overall Study|Symptomatic Deterioration|0
6889527|NCT02954406|10904873|FG005|Overall Study|Symptomatic Deterioration|0
6889528|NCT02954406|10904874|FG006|Overall Study|Symptomatic Deterioration|0
6889529|NCT02954406|10904875|FG007|Overall Study|Symptomatic Deterioration|0
6889530|NCT02954406|10904876|FG008|Overall Study|Symptomatic Deterioration|0
6889531|NCT02954406|10904877|FG009|Overall Study|Symptomatic Deterioration|0
6889532|NCT02954406|10904878|FG010|Overall Study|Symptomatic Deterioration|0
6889533|NCT02954406|10904868|FG000|Overall Study|Death|0
6889534|NCT02954406|10904869|FG001|Overall Study|Death|0
6889535|NCT02954406|10904870|FG002|Overall Study|Death|0
6889536|NCT02954406|10904871|FG003|Overall Study|Death|0
6889537|NCT02954406|10904872|FG004|Overall Study|Death|1
6889538|NCT02954406|10904873|FG005|Overall Study|Death|0
6889539|NCT02954406|10904874|FG006|Overall Study|Death|0
6889540|NCT02954406|10904875|FG007|Overall Study|Death|0
6889541|NCT02954406|10904876|FG008|Overall Study|Death|1
6889542|NCT02954406|10904877|FG009|Overall Study|Death|1
6889543|NCT02954406|10904878|FG010|Overall Study|Death|0
6889544|NCT02954406|10904868|FG000|Overall Study|Reason Not Specified|0
6889545|NCT02954406|10904869|FG001|Overall Study|Reason Not Specified|0
6889546|NCT02954406|10904870|FG002|Overall Study|Reason Not Specified|3
6889547|NCT02954406|10904871|FG003|Overall Study|Reason Not Specified|2
6889548|NCT02954406|10904872|FG004|Overall Study|Reason Not Specified|2
6889549|NCT02954406|10904873|FG005|Overall Study|Reason Not Specified|0
6889550|NCT02954406|10904874|FG006|Overall Study|Reason Not Specified|1
6889551|NCT02954406|10904875|FG007|Overall Study|Reason Not Specified|0
6889552|NCT02954406|10904876|FG008|Overall Study|Reason Not Specified|1
6889553|NCT02954406|10904877|FG009|Overall Study|Reason Not Specified|0
6889554|NCT02954406|10904878|FG010|Overall Study|Reason Not Specified|0
6889555|NCT02927145|10904913|FG000|Initial Recruitment|Withdrawal by Subject|0
6889556|NCT02927145|10904914|FG001|Initial Recruitment|Withdrawal by Subject|1
6889557|NCT02927145|10904915|FG002|Initial Recruitment|Withdrawal by Subject|1
6889558|NCT02927145|10904916|FG003|Initial Recruitment|Withdrawal by Subject|4
6889559|NCT02927145|10904917|FG004|Initial Recruitment|Withdrawal by Subject|1
6889560|NCT02927145|10904918|FG005|Initial Recruitment|Withdrawal by Subject|1
6889561|NCT02927145|10904919|FG006|Initial Recruitment|Withdrawal by Subject|0
6889562|NCT02927145|10904920|FG007|Initial Recruitment|Withdrawal by Subject|0
6889563|NCT02927145|10904921|FG008|Initial Recruitment|Withdrawal by Subject|2
6889564|NCT02927145|10904913|FG000|Initial Recruitment|Adverse Event|0
6889565|NCT02927145|10904914|FG001|Initial Recruitment|Adverse Event|0
6889566|NCT02927145|10904915|FG002|Initial Recruitment|Adverse Event|0
6889567|NCT02927145|10904916|FG003|Initial Recruitment|Adverse Event|0
6889568|NCT02927145|10904917|FG004|Initial Recruitment|Adverse Event|2
6889569|NCT02927145|10904918|FG005|Initial Recruitment|Adverse Event|0
6889570|NCT02927145|10904919|FG006|Initial Recruitment|Adverse Event|0
6889571|NCT02927145|10904920|FG007|Initial Recruitment|Adverse Event|0
6889572|NCT02927145|10904921|FG008|Initial Recruitment|Adverse Event|0
6889573|NCT02927145|10904913|FG000|Invitation for Additional Challenge|Pregnancy|0
6889574|NCT02927145|10904914|FG001|Invitation for Additional Challenge|Pregnancy|0
6889575|NCT02927145|10904915|FG002|Invitation for Additional Challenge|Pregnancy|0
6889576|NCT02927145|10904916|FG003|Invitation for Additional Challenge|Pregnancy|0
6889577|NCT02927145|10904917|FG004|Invitation for Additional Challenge|Pregnancy|0
6889578|NCT02927145|10904918|FG005|Invitation for Additional Challenge|Pregnancy|0
6889579|NCT02927145|10904919|FG006|Invitation for Additional Challenge|Pregnancy|1
6889580|NCT02927145|10904920|FG007|Invitation for Additional Challenge|Pregnancy|0
6889581|NCT02927145|10904921|FG008|Invitation for Additional Challenge|Pregnancy|0
6889582|NCT02910583|10904944|FG000|Overall Study|Withdrawal by Subject|6
6889583|NCT02910583|10904945|FG001|Overall Study|Withdrawal by Subject|7
6889584|NCT02910583|10904944|FG000|Overall Study|Other, Not Specified|1
6889585|NCT02910583|10904945|FG001|Overall Study|Other, Not Specified|0
6889586|NCT02598388|10905002|FG000|Overall Study|Lost to Follow-up|1
6889587|NCT02598388|10905003|FG001|Overall Study|Lost to Follow-up|0
6889588|NCT02598388|10905004|FG002|Overall Study|Lost to Follow-up|1
6889589|NCT02598388|10905005|FG003|Overall Study|Lost to Follow-up|0
6889590|NCT02598388|10905006|FG004|Overall Study|Lost to Follow-up|5
6889591|NCT02598388|10905007|FG005|Overall Study|Lost to Follow-up|1
6889592|NCT02598388|10905008|FG006|Overall Study|Lost to Follow-up|2
6889593|NCT02598388|10905009|FG007|Overall Study|Lost to Follow-up|1
6889594|NCT02598388|10905010|FG008|Overall Study|Lost to Follow-up|0
6889595|NCT02598388|10905011|FG009|Overall Study|Lost to Follow-up|0
6889596|NCT02598388|10905012|FG010|Overall Study|Lost to Follow-up|1
6889597|NCT02598388|10905013|FG011|Overall Study|Lost to Follow-up|0
6889598|NCT02598388|10905002|FG000|Overall Study|Withdrawal by Subject|0
6889599|NCT02598388|10905003|FG001|Overall Study|Withdrawal by Subject|0
6889600|NCT02598388|10905004|FG002|Overall Study|Withdrawal by Subject|0
6889601|NCT02598388|10905005|FG003|Overall Study|Withdrawal by Subject|0
6889602|NCT02598388|10905006|FG004|Overall Study|Withdrawal by Subject|2
6889603|NCT02598388|10905007|FG005|Overall Study|Withdrawal by Subject|0
6889604|NCT02598388|10905008|FG006|Overall Study|Withdrawal by Subject|2
6889605|NCT02598388|10905009|FG007|Overall Study|Withdrawal by Subject|0
6889606|NCT02598388|10905010|FG008|Overall Study|Withdrawal by Subject|0
6889607|NCT02598388|10905011|FG009|Overall Study|Withdrawal by Subject|1
6889608|NCT02598388|10905012|FG010|Overall Study|Withdrawal by Subject|0
6889609|NCT02598388|10905013|FG011|Overall Study|Withdrawal by Subject|0
6889610|NCT02598388|10905002|FG000|Overall Study|Other|0
6889611|NCT02598388|10905003|FG001|Overall Study|Other|0
6889612|NCT02598388|10905004|FG002|Overall Study|Other|1
6889613|NCT02598388|10905005|FG003|Overall Study|Other|0
6889614|NCT02598388|10905006|FG004|Overall Study|Other|3
6889615|NCT02598388|10905007|FG005|Overall Study|Other|0
6889616|NCT02598388|10905008|FG006|Overall Study|Other|1
6889617|NCT02598388|10905009|FG007|Overall Study|Other|0
6889618|NCT02598388|10905010|FG008|Overall Study|Other|0
6889619|NCT02598388|10905011|FG009|Overall Study|Other|0
6889620|NCT02598388|10905012|FG010|Overall Study|Other|0
6889621|NCT02598388|10905013|FG011|Overall Study|Other|0
6889622|NCT02493751|10905046|FG000|Overall Study|Withdrawal by Subject|2
6889623|NCT02493751|10905047|FG001|Overall Study|Withdrawal by Subject|8
6889624|NCT02493751|10905046|FG000|Overall Study|Death|6
6889625|NCT02493751|10905047|FG001|Overall Study|Death|13
6889626|NCT02493751|10905046|FG000|Overall Study|Lost to Follow-up|2
6889627|NCT02493751|10905047|FG001|Overall Study|Lost to Follow-up|3
6889628|NCT02493751|10905046|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6
6889629|NCT02493751|10905047|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15
6889630|NCT02285166|10905054|FG000|Overall Study|Case Report Forms Uncollected|564
6889631|NCT02285166|10905054|FG000|Overall Study|Protocol Deviation|402
6889632|NCT02075593|10905060|FG000|Overall Study|Withdrawal by Subject|1
6889633|NCT02075593|10905060|FG000|Overall Study|Treatment ongoing at the time of analysis|2
6889634|NCT00587860|10905068|FG000|Overall Study|Lost to Follow-up|2
6889635|NCT00587860|10905069|FG001|Overall Study|Lost to Follow-up|2
6889636|NCT00587860|10905068|FG000|Overall Study|Withdrawal by Subject|3
6889637|NCT00587860|10905069|FG001|Overall Study|Withdrawal by Subject|3
6970473|NCT01155479|11020630|FG001|Part II|Withdrawal by Subject|4
6970474|NCT01155479|11020631|FG002|Part II|Withdrawal by Subject|12
6970475|NCT01155479|11020632|FG003|Part II|Withdrawal by Subject|7
6970476|NCT01155479|11020633|FG004|Part II|Withdrawal by Subject|3
6970477|NCT01155479|11020629|FG000|Part II|Lost to Follow-up|1
6970478|NCT01155479|11020630|FG001|Part II|Lost to Follow-up|0
6970479|NCT01155479|11020631|FG002|Part II|Lost to Follow-up|0
6970480|NCT01155479|11020632|FG003|Part II|Lost to Follow-up|0
6970481|NCT01155479|11020633|FG004|Part II|Lost to Follow-up|1
6970482|NCT01155479|11020629|FG000|Part II|Treatment Failure|0
6970483|NCT01155479|11020630|FG001|Part II|Treatment Failure|1
6889638|NCT00587964|10905075|FG000|Overall Study|Withdrawal by Subject|1
6889639|NCT00587964|10905075|FG000|Overall Study|Lost to Follow-up|1
6889640|NCT00587964|10905075|FG000|Overall Study|Patient found to be ineligible|1
6889641|NCT00587964|10905075|FG000|Overall Study|Patient did not receive intervention|5
6889642|NCT00587964|10905075|FG000|Overall Study|Progression of Disease|4
6889643|NCT00587990|10905082|FG000|Overall Study|Death|0
6889644|NCT00587990|10905083|FG001|Overall Study|Death|0
6889645|NCT00587990|10905084|FG002|Overall Study|Death|1
6889646|NCT00588094|10905092|FG000|Overall Study|Adverse Event|3
6889647|NCT00588094|10905092|FG000|Overall Study|Progression of Disease|2
6889648|NCT00588237|10905105|FG000|Overall Study|Evaluable for toxicity only|3
6889649|NCT00588237|10905105|FG000|Overall Study|Patien not treated|1
6889650|NCT00588341|10905109|FG000|Overall Study|Withdrawal by Subject|3
6889651|NCT00588341|10905109|FG000|Overall Study|Not treated due to metastatic disease|1
6889652|NCT00588341|10905109|FG000|Overall Study|Patient ineligible|1
6889653|NCT00588354|10905115|FG000|Baseline to 2 Weeks|Adverse Event|1
6889654|NCT00588354|10905116|FG001|Baseline to 2 Weeks|Adverse Event|0
6889655|NCT00588354|10905115|FG000|Baseline to 2 Weeks|Lack of Efficacy|1
6889656|NCT00588354|10905116|FG001|Baseline to 2 Weeks|Lack of Efficacy|0
6889657|NCT00588354|10905115|FG000|Baseline to 4 Weeks|Lost to Follow-up|0
6889658|NCT00588354|10905116|FG001|Baseline to 4 Weeks|Lost to Follow-up|1
6889659|NCT00588445|10905137|FG000|Overall Study|Protocol Violation|1
6889660|NCT00588445|10905137|FG000|Overall Study|Withdrawal by Subject|3
6889661|NCT00588445|10905137|FG000|Overall Study|Disease Progression|1
6889662|NCT00588445|10905137|FG000|Overall Study|Not Treated|10
6889663|NCT00588640|10905147|FG000|Overall Study|Physician Decision|1
6889664|NCT00588640|10905147|FG000|Overall Study|Ineligible Patient|1
6889665|NCT00588666|10905151|FG000|Overall Study|Adverse Event|4
6889666|NCT00588692|10905157|FG000|Overall Study|Withdrawal by Subject|4
6889667|NCT00588692|10905158|FG001|Overall Study|Withdrawal by Subject|2
6889668|NCT00588692|10905157|FG000|Overall Study|Hip Surgery|0
6889669|NCT00588692|10905158|FG001|Overall Study|Hip Surgery|1
6889670|NCT00588692|10905157|FG000|Overall Study|Severe Peptic Ulcer Disease|1
6889671|NCT00588692|10905158|FG001|Overall Study|Severe Peptic Ulcer Disease|0
6889672|NCT00588692|10905157|FG000|Overall Study|Cancer|1
6889673|NCT00588692|10905158|FG001|Overall Study|Cancer|0
6889674|NCT00588692|10905157|FG000|Overall Study|Death|1
6889675|NCT00588692|10905158|FG001|Overall Study|Death|0
6889676|NCT00588731|10905168|FG000|Overall Study|Withdrawal by Subject|3
7155738|NCT03346057|11323773|FG000|Overall Study|Withdrawal by Subject|1
7155739|NCT03346057|11323774|FG001|Overall Study|Withdrawal by Subject|0
7155740|NCT03346057|11323775|FG002|Overall Study|Withdrawal by Subject|0
7155741|NCT03346057|11323776|FG003|Overall Study|Withdrawal by Subject|0
7155742|NCT03346070|11323791|FG000|Overall Study|Death|0
6889677|NCT00588731|10905169|FG001|Overall Study|Withdrawal by Subject|2
6889678|NCT00588822|10905179|FG000|Overall Study|progression of disease|8
6889679|NCT00588848|10905185|FG000|Overall Study|Physician Decision|0
6889680|NCT00588848|10905186|FG001|Overall Study|Physician Decision|3
6889681|NCT00588952|10905200|FG000|Overall Study|Adverse Event|0
6889682|NCT00588952|10905201|FG001|Overall Study|Adverse Event|2
6889683|NCT00588952|10905200|FG000|Overall Study|Withdrawal by Subject|3
6889684|NCT00588952|10905201|FG001|Overall Study|Withdrawal by Subject|5
6889685|NCT00589108|10905220|FG000|Overall Study|Lost to Follow-up|1
6889686|NCT00589108|10905221|FG001|Overall Study|Lost to Follow-up|1
6889687|NCT00589108|10905222|FG002|Overall Study|Lost to Follow-up|1
6889688|NCT00589108|10905220|FG000|Overall Study|Death|3
6889689|NCT00589108|10905221|FG001|Overall Study|Death|3
6889690|NCT00589108|10905222|FG002|Overall Study|Death|4
6889691|NCT00589121|10905232|FG000|Overall Study|Protocol Violation|2
6889692|NCT00589121|10905233|FG001|Overall Study|Protocol Violation|6
6889693|NCT00589121|10905232|FG000|Overall Study|No protocol treatment received|0
6889694|NCT00589121|10905233|FG001|Overall Study|No protocol treatment received|1
6889695|NCT00589290|10905251|FG000|Overall Study|Withdrawal by Subject|1
7155743|NCT03346070|11323792|FG001|Overall Study|Death|0
6889696|NCT00589303|10905259|FG000|Overall Study|Withdrawal by Subject|2
6889697|NCT00589303|10905260|FG001|Overall Study|Withdrawal by Subject|1
6889698|NCT00589472|10905276|FG000|Overall Study|Adverse Event|1
7155744|NCT03346070|11323793|FG002|Overall Study|Death|0
7155745|NCT03346070|11323794|FG003|Overall Study|Death|0
7155746|NCT03346070|11323795|FG004|Overall Study|Death|1
7155747|NCT03346070|11323791|FG000|Overall Study|Lost to Follow-up|0
7155748|NCT03346070|11323792|FG001|Overall Study|Lost to Follow-up|1
7155749|NCT03346070|11323793|FG002|Overall Study|Lost to Follow-up|2
7155750|NCT03346070|11323794|FG003|Overall Study|Lost to Follow-up|0
7155751|NCT03346070|11323795|FG004|Overall Study|Lost to Follow-up|0
7155752|NCT03346070|11323791|FG000|Overall Study|Physician Decision|0
7155753|NCT03346070|11323792|FG001|Overall Study|Physician Decision|0
7155754|NCT03346070|11323793|FG002|Overall Study|Physician Decision|0
7155755|NCT03346070|11323794|FG003|Overall Study|Physician Decision|1
7155756|NCT03346070|11323795|FG004|Overall Study|Physician Decision|1
6889699|NCT00589602|10905284|FG000|Overall Study|Did not collect enough CD34+ cells|1
6889700|NCT00589628|10905292|FG000|Overall Study|Lost to Follow-up|0
6889701|NCT00589628|10905293|FG001|Overall Study|Lost to Follow-up|1
6889702|NCT00589667|10905299|FG000|Overall Study|Adverse Event|2
6889703|NCT00589667|10905299|FG000|Overall Study|Withdrawal by Subject|1
7155757|NCT03346070|11323791|FG000|Overall Study|Withdrawal by Subject|1
6889704|NCT00589693|10905305|FG000|Overall Study|randomized in error|12
6889705|NCT00589693|10905306|FG001|Overall Study|randomized in error|6
6889706|NCT00589693|10905305|FG000|Overall Study|Adverse Event|4
6889707|NCT00589693|10905306|FG001|Overall Study|Adverse Event|4
6889708|NCT00589693|10905305|FG000|Overall Study|Death|26
6889709|NCT00589693|10905306|FG001|Overall Study|Death|16
6889710|NCT00589693|10905305|FG000|Overall Study|Lack of Efficacy|0
6889711|NCT00589693|10905306|FG001|Overall Study|Lack of Efficacy|1
6889712|NCT00589693|10905305|FG000|Overall Study|Lost to Follow-up|1
6889713|NCT00589693|10905306|FG001|Overall Study|Lost to Follow-up|0
6889714|NCT00589693|10905305|FG000|Overall Study|Physician Decision|0
6889715|NCT00589693|10905306|FG001|Overall Study|Physician Decision|1
6889716|NCT00589693|10905305|FG000|Overall Study|Protocol Violation|1
6889717|NCT00589693|10905306|FG001|Overall Study|Protocol Violation|1
6889718|NCT00589784|10905314|FG000|Overall Study|Withdrawal by Subject|0
6889719|NCT00589784|10905315|FG001|Overall Study|Withdrawal by Subject|6
6889720|NCT00589784|10905314|FG000|Overall Study|Patient inevaluable|1
6889721|NCT00589784|10905315|FG001|Overall Study|Patient inevaluable|0
6889722|NCT00589784|10905314|FG000|Overall Study|Adverse Event|0
6889723|NCT00589784|10905315|FG001|Overall Study|Adverse Event|4
6889724|NCT00589797|10905322|FG000|Overall Study|Death|1
6889725|NCT00589797|10905323|FG001|Overall Study|Death|0
6889726|NCT00589797|10905322|FG000|Overall Study|Lost to Follow-up|12
6889727|NCT00589797|10905323|FG001|Overall Study|Lost to Follow-up|9
6889728|NCT00589797|10905322|FG000|Overall Study|Physician Decision|8
6889729|NCT00589797|10905323|FG001|Overall Study|Physician Decision|3
6889730|NCT00589797|10905322|FG000|Overall Study|Withdrawal by Subject|6
6889731|NCT00589797|10905323|FG001|Overall Study|Withdrawal by Subject|5
6889732|NCT00589797|10905322|FG000|Overall Study|Non-Randomized Training Subjects|46
6889733|NCT00589797|10905323|FG001|Overall Study|Non-Randomized Training Subjects|6
6889734|NCT00589914|10905360|FG000|Overall Study|Adverse Event|19
6889735|NCT00589914|10905361|FG001|Overall Study|Adverse Event|10
6889736|NCT00589914|10905360|FG000|Overall Study|Death|2
6889737|NCT00589914|10905361|FG001|Overall Study|Death|0
6889738|NCT00589914|10905360|FG000|Overall Study|Lack of Efficacy|40
6889739|NCT00589914|10905361|FG001|Overall Study|Lack of Efficacy|43
6889740|NCT00589914|10905360|FG000|Overall Study|Lost to Follow-up|11
6889741|NCT00589914|10905361|FG001|Overall Study|Lost to Follow-up|18
6889742|NCT00589914|10905360|FG000|Overall Study|Pregnancy|1
6889743|NCT00589914|10905361|FG001|Overall Study|Pregnancy|0
6889744|NCT00589914|10905360|FG000|Overall Study|Withdrawal by Subject|55
6889745|NCT00589914|10905361|FG001|Overall Study|Withdrawal by Subject|49
6889746|NCT00589914|10905360|FG000|Overall Study|Other|22
6889747|NCT00589914|10905361|FG001|Overall Study|Other|17
6889748|NCT00589979|10905369|FG000|Run-In Period|Adverse Event|5
6889749|NCT00589979|10905370|FG001|Run-In Period|Adverse Event|0
6889750|NCT00589979|10905371|FG002|Run-In Period|Adverse Event|0
6889751|NCT00589979|10905369|FG000|Run-In Period|Protocol Violation|3
6889752|NCT00589979|10905370|FG001|Run-In Period|Protocol Violation|0
6889753|NCT00589979|10905371|FG002|Run-In Period|Protocol Violation|0
6889754|NCT00589979|10905369|FG000|Run-In Period|Did not qualify for randomization|54
6889755|NCT00589979|10905370|FG001|Run-In Period|Did not qualify for randomization|0
6889756|NCT00589979|10905371|FG002|Run-In Period|Did not qualify for randomization|0
6889757|NCT00589979|10905369|FG000|Run-In Period|Withdrawal by Subject|10
6889758|NCT00589979|10905370|FG001|Run-In Period|Withdrawal by Subject|0
6889759|NCT00589979|10905371|FG002|Run-In Period|Withdrawal by Subject|0
6889760|NCT00589979|10905369|FG000|Run-In Period|Informed Consent Withdrawn|4
6889761|NCT00589979|10905370|FG001|Run-In Period|Informed Consent Withdrawn|0
6889762|NCT00589979|10905371|FG002|Run-In Period|Informed Consent Withdrawn|0
6889763|NCT00589979|10905369|FG000|Double-Blind Treatment Period 1|Adverse Event|0
6889764|NCT00589979|10905370|FG001|Double-Blind Treatment Period 1|Adverse Event|1
6889765|NCT00589979|10905371|FG002|Double-Blind Treatment Period 1|Adverse Event|0
6889766|NCT00589979|10905369|FG000|Double-Blind Treatment Period 1|Protocol Violation|0
6889767|NCT00589979|10905370|FG001|Double-Blind Treatment Period 1|Protocol Violation|1
6889768|NCT00589979|10905371|FG002|Double-Blind Treatment Period 1|Protocol Violation|1
6889769|NCT00589979|10905369|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0
6889770|NCT00589979|10905370|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0
6889771|NCT00589979|10905371|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1
6889772|NCT00589979|10905369|FG000|Double-Blind Treatment Period 2|Adverse Event|0
6889773|NCT00589979|10905370|FG001|Double-Blind Treatment Period 2|Adverse Event|1
6889774|NCT00589979|10905371|FG002|Double-Blind Treatment Period 2|Adverse Event|0
6889775|NCT00589979|10905369|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0
6889776|NCT00589979|10905370|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0
6889777|NCT00589979|10905371|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1
6889778|NCT00589979|10905369|FG000|Double-Blind Treatment Period 2|Other|0
6889779|NCT00589979|10905370|FG001|Double-Blind Treatment Period 2|Other|0
6889780|NCT00589979|10905371|FG002|Double-Blind Treatment Period 2|Other|1
6889781|NCT00589979|10905369|FG000|Double-Blind Treatment Period 3|Protocol Violation|0
6889782|NCT00589979|10905370|FG001|Double-Blind Treatment Period 3|Protocol Violation|1
6889783|NCT00589979|10905371|FG002|Double-Blind Treatment Period 3|Protocol Violation|0
6889784|NCT00589979|10905369|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0
6889785|NCT00589979|10905370|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0
6889786|NCT00589979|10905371|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1
6889787|NCT00590031|10905399|FG000|Overall Study|Adverse Event|3
6889788|NCT00590031|10905399|FG000|Overall Study|Withdrawal by Subject|1
6889789|NCT00590031|10905399|FG000|Overall Study|Metastatic Disease|1
6889790|NCT00590031|10905399|FG000|Overall Study|Admin Hold|1
6889791|NCT00590044|10905405|FG000|Overall Study|Withdrawal by Subject|2
6889792|NCT00590044|10905406|FG001|Overall Study|Withdrawal by Subject|2
6889793|NCT00590044|10905405|FG000|Overall Study|wrong insulin arm assigned|1
6889794|NCT00590044|10905406|FG001|Overall Study|wrong insulin arm assigned|0
6889795|NCT00590044|10905405|FG000|Overall Study|Protocol Violation|1
6889796|NCT00590044|10905406|FG001|Overall Study|Protocol Violation|0
6889797|NCT00590317|10905435|FG000|Overall Study|Lack of Efficacy|1
6889798|NCT00590317|10905436|FG001|Overall Study|Lack of Efficacy|5
6889799|NCT00590564|10905464|FG000|Overall Study|Withdrawal by Subject|4
6889800|NCT00590564|10905464|FG000|Overall Study|Lost to Follow-up|6
6889801|NCT00590564|10905464|FG000|Overall Study|Protocol Violation|1
6889802|NCT00590564|10905464|FG000|Overall Study|Patient Found to be Ineligible|1
6889803|NCT00590564|10905464|FG000|Overall Study|Patient Non-compliance|6
6889804|NCT00590577|10905472|FG000|Overall Study|Lack of Efficacy|31
6889805|NCT00590577|10905473|FG001|Overall Study|Lack of Efficacy|28
6889806|NCT00590577|10905474|FG002|Overall Study|Lack of Efficacy|23
6889807|NCT00590577|10905475|FG003|Overall Study|Lack of Efficacy|45
6889808|NCT00590577|10905472|FG000|Overall Study|Withdrawal by Subject|23
6889809|NCT00590577|10905473|FG001|Overall Study|Withdrawal by Subject|28
6889810|NCT00590577|10905474|FG002|Overall Study|Withdrawal by Subject|30
6889811|NCT00590577|10905475|FG003|Overall Study|Withdrawal by Subject|26
6889812|NCT00590577|10905472|FG000|Overall Study|Adverse Event|10
6889813|NCT00590577|10905473|FG001|Overall Study|Adverse Event|10
6889814|NCT00590577|10905474|FG002|Overall Study|Adverse Event|13
6889815|NCT00590577|10905475|FG003|Overall Study|Adverse Event|11
6889816|NCT00590577|10905472|FG000|Overall Study|Lost to Follow-up|12
6889817|NCT00590577|10905473|FG001|Overall Study|Lost to Follow-up|6
6889818|NCT00590577|10905474|FG002|Overall Study|Lost to Follow-up|6
6889819|NCT00590577|10905475|FG003|Overall Study|Lost to Follow-up|9
6889820|NCT00590577|10905472|FG000|Overall Study|Pregnancy|0
6889821|NCT00590577|10905473|FG001|Overall Study|Pregnancy|1
6889822|NCT00590577|10905474|FG002|Overall Study|Pregnancy|0
6889823|NCT00590577|10905475|FG003|Overall Study|Pregnancy|0
6889824|NCT00590577|10905472|FG000|Overall Study|Various reasons|1
6889825|NCT00590577|10905473|FG001|Overall Study|Various reasons|3
6889826|NCT00590577|10905474|FG002|Overall Study|Various reasons|1
6889827|NCT00590577|10905475|FG003|Overall Study|Various reasons|2
6889828|NCT00590590|10905488|FG000|Overall Study|Lack of Efficacy|1
6889829|NCT00590590|10905489|FG001|Overall Study|Lack of Efficacy|2
6889830|NCT00590590|10905490|FG002|Overall Study|Lack of Efficacy|0
6889831|NCT00590590|10905488|FG000|Overall Study|Adverse Event|1
6889832|NCT00590590|10905489|FG001|Overall Study|Adverse Event|0
6889833|NCT00590590|10905490|FG002|Overall Study|Adverse Event|0
6889834|NCT00590590|10905488|FG000|Overall Study|Protocol Violation|0
6889835|NCT00590590|10905489|FG001|Overall Study|Protocol Violation|0
6889836|NCT00590590|10905490|FG002|Overall Study|Protocol Violation|2
6889837|NCT00590590|10905488|FG000|Overall Study|Lost to Follow-up|4
6889838|NCT00590590|10905489|FG001|Overall Study|Lost to Follow-up|1
6889839|NCT00590590|10905490|FG002|Overall Study|Lost to Follow-up|2
6889840|NCT00590590|10905488|FG000|Overall Study|Withdrawal by Subject|0
6889841|NCT00590590|10905489|FG001|Overall Study|Withdrawal by Subject|1
6889842|NCT00590590|10905490|FG002|Overall Study|Withdrawal by Subject|1
6889843|NCT00590590|10905488|FG000|Overall Study|Did not complete due to study closure|1
6889844|NCT00590590|10905489|FG001|Overall Study|Did not complete due to study closure|1
6889845|NCT00590590|10905490|FG002|Overall Study|Did not complete due to study closure|1
6889846|NCT00590590|10905488|FG000|Overall Study|Did not complete study|0
6889847|NCT00590590|10905489|FG001|Overall Study|Did not complete study|1
6889848|NCT00590590|10905490|FG002|Overall Study|Did not complete study|0
6889849|NCT00590681|10905498|FG000|Overall Study|Withdrawal by Subject|7
6889850|NCT00590681|10905498|FG000|Overall Study|Adverse Event|8
6889851|NCT00590681|10905498|FG000|Overall Study|Death|3
6889852|NCT00590681|10905498|FG000|Overall Study|Lost to Follow-up|1
6889853|NCT00590681|10905498|FG000|Overall Study|disease progression|1
6889854|NCT00590720|10905513|FG000|Overall Study|Lost to Follow-up|1
6889855|NCT00590720|10905514|FG001|Overall Study|Lost to Follow-up|0
6889856|NCT00590720|10905513|FG000|Overall Study|Withdrawal by Subject|0
6889857|NCT00590720|10905514|FG001|Overall Study|Withdrawal by Subject|1
6889858|NCT00590759|10905520|FG000|Overall Study|Death|52
6889859|NCT00590759|10905520|FG000|Overall Study|Lost to Follow-up|28
6889860|NCT00590824|10905534|FG000|Overall Study|Disease could not be resected|0
6889861|NCT00590824|10905535|FG001|Overall Study|Disease could not be resected|2
6889862|NCT00590824|10905536|FG002|Overall Study|Disease could not be resected|1
6889863|NCT00590824|10905537|FG003|Overall Study|Disease could not be resected|0
6889864|NCT00590824|10905534|FG000|Overall Study|Adverse Event|0
6889865|NCT00590824|10905535|FG001|Overall Study|Adverse Event|0
6889866|NCT00590824|10905536|FG002|Overall Study|Adverse Event|0
6889867|NCT00590824|10905537|FG003|Overall Study|Adverse Event|1
6889868|NCT00590902|10905570|FG000|Overall Study|Death|1
6889869|NCT00590954|10905574|FG000|Overall Study|Inevaluable|2
6889870|NCT00590967|10905582|FG000|Overall Study|Withdrawal by Subject|1
6889871|NCT00590967|10905583|FG001|Overall Study|Withdrawal by Subject|1
6889872|NCT00590967|10905582|FG000|Overall Study|Ineligible|1
6889873|NCT00590967|10905583|FG001|Overall Study|Ineligible|0
6889874|NCT00590967|10905582|FG000|Overall Study|Poor performance status|0
6889875|NCT00590967|10905583|FG001|Overall Study|Poor performance status|1
6889876|NCT00590967|10905582|FG000|Overall Study|Non-compliant|0
6889877|NCT00590967|10905583|FG001|Overall Study|Non-compliant|2
6889878|NCT00590967|10905582|FG000|Overall Study|Did not sign consent form|0
6889879|NCT00590967|10905583|FG001|Overall Study|Did not sign consent form|1
6889880|NCT00590967|10905582|FG000|Overall Study|Did not receive chemo per protocol|1
6889881|NCT00590967|10905583|FG001|Overall Study|Did not receive chemo per protocol|0
6889882|NCT00590980|10905589|FG000|Overall Study|Did not meet all inclusion criteria|10
6889883|NCT00591006|10905593|FG000|Overall Study|Withdrawal by Subject|0
6889884|NCT00591006|10905594|FG001|Overall Study|Withdrawal by Subject|0
6889885|NCT00591006|10905595|FG002|Overall Study|Withdrawal by Subject|0
6889886|NCT00591006|10905596|FG003|Overall Study|Withdrawal by Subject|0
6889887|NCT00591006|10905597|FG004|Overall Study|Withdrawal by Subject|0
6889888|NCT00591006|10905598|FG005|Overall Study|Withdrawal by Subject|0
6889889|NCT00591006|10905599|FG006|Overall Study|Withdrawal by Subject|0
6889890|NCT00591006|10905600|FG007|Overall Study|Withdrawal by Subject|0
6889891|NCT00591006|10905601|FG008|Overall Study|Withdrawal by Subject|0
6889892|NCT00591006|10905602|FG009|Overall Study|Withdrawal by Subject|0
6889893|NCT00591006|10905603|FG010|Overall Study|Withdrawal by Subject|0
6889894|NCT00591006|10905604|FG011|Overall Study|Withdrawal by Subject|0
6889895|NCT00591006|10905605|FG012|Overall Study|Withdrawal by Subject|0
6889896|NCT00591006|10905606|FG013|Overall Study|Withdrawal by Subject|0
6889897|NCT00591006|10905607|FG014|Overall Study|Withdrawal by Subject|0
6889898|NCT00591006|10905608|FG015|Overall Study|Withdrawal by Subject|1
6889899|NCT00591006|10905609|FG016|Overall Study|Withdrawal by Subject|0
6889900|NCT00591006|10905610|FG017|Overall Study|Withdrawal by Subject|0
6889901|NCT00591006|10905611|FG018|Overall Study|Withdrawal by Subject|0
6889902|NCT00591006|10905612|FG019|Overall Study|Withdrawal by Subject|0
6889903|NCT00591006|10905613|FG020|Overall Study|Withdrawal by Subject|0
6889904|NCT00591006|10905614|FG021|Overall Study|Withdrawal by Subject|0
6889905|NCT00591006|10905615|FG022|Overall Study|Withdrawal by Subject|0
6889906|NCT00591006|10905616|FG023|Overall Study|Withdrawal by Subject|1
6889907|NCT00591006|10905593|FG000|Overall Study|Adverse Event|0
6889908|NCT00591006|10905594|FG001|Overall Study|Adverse Event|0
6889909|NCT00591006|10905595|FG002|Overall Study|Adverse Event|0
6889910|NCT00591006|10905596|FG003|Overall Study|Adverse Event|0
6889911|NCT00591006|10905597|FG004|Overall Study|Adverse Event|0
6889912|NCT00591006|10905598|FG005|Overall Study|Adverse Event|0
6889913|NCT00591006|10905599|FG006|Overall Study|Adverse Event|0
6889914|NCT00591006|10905600|FG007|Overall Study|Adverse Event|0
6889915|NCT00591006|10905601|FG008|Overall Study|Adverse Event|0
6889916|NCT00591006|10905602|FG009|Overall Study|Adverse Event|0
6889917|NCT00591006|10905603|FG010|Overall Study|Adverse Event|0
6889918|NCT00591006|10905604|FG011|Overall Study|Adverse Event|0
6889919|NCT00591006|10905605|FG012|Overall Study|Adverse Event|0
6889920|NCT00591006|10905606|FG013|Overall Study|Adverse Event|0
6889921|NCT00591006|10905607|FG014|Overall Study|Adverse Event|0
6889922|NCT00591006|10905608|FG015|Overall Study|Adverse Event|0
6889923|NCT00591006|10905609|FG016|Overall Study|Adverse Event|0
6889924|NCT00591006|10905610|FG017|Overall Study|Adverse Event|0
6889925|NCT00591006|10905611|FG018|Overall Study|Adverse Event|0
6889926|NCT00591006|10905612|FG019|Overall Study|Adverse Event|0
6889927|NCT00591006|10905613|FG020|Overall Study|Adverse Event|0
6889928|NCT00591006|10905614|FG021|Overall Study|Adverse Event|0
6889929|NCT00591006|10905615|FG022|Overall Study|Adverse Event|1
6889930|NCT00591006|10905616|FG023|Overall Study|Adverse Event|0
7079237|NCT02111096|11188118|FG001|Overall Study|Physician Decision|1
7079238|NCT02111096|11188119|FG002|Overall Study|Physician Decision|0
7079239|NCT02111096|11188117|FG000|Overall Study|Protocol Violation|1
7079240|NCT02111096|11188118|FG001|Overall Study|Protocol Violation|0
7079241|NCT02111096|11188119|FG002|Overall Study|Protocol Violation|1
7079242|NCT02111096|11188117|FG000|Overall Study|Terminated by Sponsor|53
7079243|NCT02111096|11188118|FG001|Overall Study|Terminated by Sponsor|35
7079244|NCT02111096|11188119|FG002|Overall Study|Terminated by Sponsor|54
7155758|NCT03346070|11323792|FG001|Overall Study|Withdrawal by Subject|0
6889931|NCT00591149|10905646|FG000|Overall Study|Adverse Event|4
6889932|NCT00591149|10905646|FG000|Overall Study|Withdrawal by Subject|1
6889933|NCT00591214|10905650|FG000|Overall Study|Physician Decision|7
6889934|NCT00591214|10905650|FG000|Overall Study|Withdrawal by Subject|1
6889935|NCT00591253|10905666|FG000|Overall Study|Adverse Event|3
6889936|NCT00591253|10905667|FG001|Overall Study|Adverse Event|3
6889937|NCT00591253|10905668|FG002|Overall Study|Adverse Event|1
6889938|NCT00591253|10905666|FG000|Overall Study|Protocol Violation|2
6889939|NCT00591253|10905667|FG001|Overall Study|Protocol Violation|2
6889940|NCT00591253|10905668|FG002|Overall Study|Protocol Violation|2
6889941|NCT00591253|10905666|FG000|Overall Study|Lost to Follow-up|2
6889942|NCT00591253|10905667|FG001|Overall Study|Lost to Follow-up|4
6889943|NCT00591253|10905668|FG002|Overall Study|Lost to Follow-up|0
6889944|NCT00591253|10905666|FG000|Overall Study|Withdrawal by Subject|1
6889945|NCT00591253|10905667|FG001|Overall Study|Withdrawal by Subject|7
7155759|NCT03346070|11323793|FG002|Overall Study|Withdrawal by Subject|0
7155760|NCT03346070|11323794|FG003|Overall Study|Withdrawal by Subject|1
7155761|NCT03346070|11323795|FG004|Overall Study|Withdrawal by Subject|0
7155762|NCT03346070|11323791|FG000|Overall Study|Study medication not received as planned|2
7155763|NCT03346070|11323792|FG001|Overall Study|Study medication not received as planned|3
7155764|NCT03346070|11323793|FG002|Overall Study|Study medication not received as planned|2
7155765|NCT03346070|11323794|FG003|Overall Study|Study medication not received as planned|3
7155766|NCT03346070|11323795|FG004|Overall Study|Study medication not received as planned|2
7155767|NCT03346070|11323791|FG000|Overall Study|Screen Failure|0
7155768|NCT03346070|11323792|FG001|Overall Study|Screen Failure|0
7155769|NCT03346070|11323793|FG002|Overall Study|Screen Failure|0
7155770|NCT03346070|11323794|FG003|Overall Study|Screen Failure|1
7155771|NCT03346070|11323795|FG004|Overall Study|Screen Failure|1
7155772|NCT03346759|11323820|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2
7155773|NCT03346759|11323821|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3
7155774|NCT03346759|11323820|FG000|First Menstrual Cycle|Withdrawal by Subject|1
7155775|NCT03346759|11323821|FG001|First Menstrual Cycle|Withdrawal by Subject|0
7155776|NCT03346759|11323820|FG000|Second Menstrual Cycle|Lost to Follow-up|1
7155777|NCT03346759|11323821|FG001|Second Menstrual Cycle|Lost to Follow-up|0
7155778|NCT03347188|11323848|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2
7155779|NCT03347188|11323849|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2
7155780|NCT03347188|11323848|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4
7155781|NCT03347188|11323849|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8
7155782|NCT03347188|11323848|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7
7155783|NCT03347188|11323849|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4
7155784|NCT03347188|11323848|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1
7155785|NCT03347188|11323849|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1
7155786|NCT03347188|11323848|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1
7155787|NCT03347188|11323849|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2
7155788|NCT03347188|11323848|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26
7184162|NCT01777295|11384168|FG000|Overall Study|Pregnancy|0
6889946|NCT00591253|10905668|FG002|Overall Study|Withdrawal by Subject|6
6889947|NCT00591253|10905666|FG000|Overall Study|Lack of Efficacy|1
6889948|NCT00591253|10905667|FG001|Overall Study|Lack of Efficacy|0
6889949|NCT00591253|10905668|FG002|Overall Study|Lack of Efficacy|3
6889950|NCT00591253|10905666|FG000|Overall Study|Other|5
6889951|NCT00591253|10905667|FG001|Overall Study|Other|5
6889952|NCT00591253|10905668|FG002|Overall Study|Other|3
6889953|NCT00591266|10905679|FG000|Overall Study|Adverse Event|2
6889954|NCT00591266|10905680|FG001|Overall Study|Adverse Event|2
6889955|NCT00591266|10905681|FG002|Overall Study|Adverse Event|3
6889956|NCT00591266|10905679|FG000|Overall Study|Lost to Follow-up|0
6889957|NCT00591266|10905680|FG001|Overall Study|Lost to Follow-up|1
6889958|NCT00591266|10905681|FG002|Overall Study|Lost to Follow-up|0
6889959|NCT00591266|10905679|FG000|Overall Study|Protocol Violation|0
6889960|NCT00591266|10905680|FG001|Overall Study|Protocol Violation|0
6889961|NCT00591266|10905681|FG002|Overall Study|Protocol Violation|1
6889962|NCT00591266|10905679|FG000|Overall Study|Withdrawal by Subject|6
6889963|NCT00591266|10905680|FG001|Overall Study|Withdrawal by Subject|2
6889964|NCT00591266|10905681|FG002|Overall Study|Withdrawal by Subject|5
6889965|NCT00591266|10905679|FG000|Overall Study|Lack of Efficacy|0
6889966|NCT00591266|10905680|FG001|Overall Study|Lack of Efficacy|2
6889967|NCT00591266|10905681|FG002|Overall Study|Lack of Efficacy|0
6889968|NCT00591266|10905679|FG000|Overall Study|Other|1
6889969|NCT00591266|10905680|FG001|Overall Study|Other|4
6889970|NCT00591266|10905681|FG002|Overall Study|Other|5
6889971|NCT00591344|10905701|FG000|Overall Study|Transportation issues|1
6889972|NCT00591344|10905702|FG001|Overall Study|Transportation issues|0
6889973|NCT00591344|10905701|FG000|Overall Study|Moved out of state|1
6889974|NCT00591344|10905702|FG001|Overall Study|Moved out of state|0
6889975|NCT00591344|10905701|FG000|Overall Study|Medical complications|1
6889976|NCT00591344|10905702|FG001|Overall Study|Medical complications|3
6889977|NCT00591344|10905701|FG000|Overall Study|Underwent DBS|2
6889978|NCT00591344|10905702|FG001|Overall Study|Underwent DBS|2
6889979|NCT00591344|10905701|FG000|Overall Study|Death|0
6889980|NCT00591344|10905702|FG001|Overall Study|Death|1
6889981|NCT00591344|10905701|FG000|Overall Study|Lost to Follow-up|0
6889982|NCT00591344|10905702|FG001|Overall Study|Lost to Follow-up|1
6889983|NCT00591344|10905701|FG000|Overall Study|Did not want to come off medication|0
6889984|NCT00591344|10905702|FG001|Overall Study|Did not want to come off medication|1
6889985|NCT00591370|10905712|FG000|Overall Study|Not Treated|2
6889986|NCT00591409|10905726|FG000|Overall Study|Not Treated|0
6889987|NCT00591409|10905727|FG001|Overall Study|Not Treated|0
6889988|NCT00591409|10905728|FG002|Overall Study|Not Treated|0
6889989|NCT00591409|10905729|FG003|Overall Study|Not Treated|0
6889990|NCT00591409|10905730|FG004|Overall Study|Not Treated|1
6889991|NCT00591409|10905731|FG005|Overall Study|Not Treated|0
6889992|NCT00591409|10905732|FG006|Overall Study|Not Treated|0
6889993|NCT00591409|10905733|FG007|Overall Study|Not Treated|0
6889994|NCT00591409|10905734|FG008|Overall Study|Not Treated|0
6889995|NCT00591409|10905735|FG009|Overall Study|Not Treated|1
6889996|NCT00591565|10905757|FG000|Overall Study|lost follow up, withdrawn|5
6889997|NCT00591578|10905764|FG000|Double-Blind Treatment Phase|Adverse Event|20
6889998|NCT00591578|10905765|FG001|Double-Blind Treatment Phase|Adverse Event|26
6889999|NCT00591578|10905766|FG002|Double-Blind Treatment Phase|Adverse Event|19
6890000|NCT00591578|10905764|FG000|Double-Blind Treatment Phase|Protocol Violation|3
6890001|NCT00591578|10905765|FG001|Double-Blind Treatment Phase|Protocol Violation|2
6890002|NCT00591578|10905766|FG002|Double-Blind Treatment Phase|Protocol Violation|3
6890003|NCT00591578|10905764|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12
6890004|NCT00591578|10905765|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12
6890005|NCT00591578|10905766|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11
6890006|NCT00591578|10905764|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22
6890007|NCT00591578|10905765|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22
6890008|NCT00591578|10905766|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22
6890009|NCT00591578|10905764|FG000|Double-Blind Treatment Phase|Pregnancy|1
6890010|NCT00591578|10905765|FG001|Double-Blind Treatment Phase|Pregnancy|0
6890011|NCT00591578|10905766|FG002|Double-Blind Treatment Phase|Pregnancy|0
6890012|NCT00591578|10905764|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16
6890013|NCT00591578|10905765|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9
6890014|NCT00591578|10905766|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25
6890015|NCT00591578|10905764|FG000|Double-Blind Treatment Phase|Other|4
6890016|NCT00591578|10905765|FG001|Double-Blind Treatment Phase|Other|9
6890017|NCT00591578|10905766|FG002|Double-Blind Treatment Phase|Other|4
6890018|NCT00591578|10905764|FG000|Open-Label Extension Phase|Adverse Event|3
6890019|NCT00591578|10905765|FG001|Open-Label Extension Phase|Adverse Event|5
6890020|NCT00591578|10905766|FG002|Open-Label Extension Phase|Adverse Event|0
6890021|NCT00591578|10905764|FG000|Open-Label Extension Phase|Lost to Follow-up|1
6890022|NCT00591578|10905765|FG001|Open-Label Extension Phase|Lost to Follow-up|4
6890023|NCT00591578|10905766|FG002|Open-Label Extension Phase|Lost to Follow-up|0
6890024|NCT00591578|10905764|FG000|Open-Label Extension Phase|Withdrawal by Subject|1
6890025|NCT00591578|10905765|FG001|Open-Label Extension Phase|Withdrawal by Subject|1
6890026|NCT00591578|10905766|FG002|Open-Label Extension Phase|Withdrawal by Subject|0
6890027|NCT00591578|10905764|FG000|Open-Label Extension Phase|Other|1
6890028|NCT00591578|10905765|FG001|Open-Label Extension Phase|Other|0
6890029|NCT00591578|10905766|FG002|Open-Label Extension Phase|Other|0
6890030|NCT00591591|10905777|FG000|Overall Study|Withdrawal by Subject|1
6890031|NCT00591591|10905778|FG001|Overall Study|Withdrawal by Subject|37
6890032|NCT00591591|10905777|FG000|Overall Study|Lack of Efficacy|10
6890033|NCT00591591|10905778|FG001|Overall Study|Lack of Efficacy|2
6890034|NCT00591630|10905788|FG000|Overall Study|Death|0
6890035|NCT00591630|10905789|FG001|Overall Study|Death|0
6890036|NCT00591630|10905790|FG002|Overall Study|Death|1
6890037|NCT00591630|10905791|FG003|Overall Study|Death|0
6890038|NCT00591721|10905803|FG000|Overall Study|Withdrawal by Subject|10
6890039|NCT00591721|10905804|FG001|Overall Study|Withdrawal by Subject|10
6890040|NCT00591721|10905803|FG000|Overall Study|Lost to Follow-up|1
6890041|NCT00591721|10905804|FG001|Overall Study|Lost to Follow-up|4
6890042|NCT00591721|10905803|FG000|Overall Study|Intervention not received|10
6890043|NCT00591721|10905804|FG001|Overall Study|Intervention not received|8
6890044|NCT00591734|10905810|FG000|Overall Study|Lack of Efficacy|35
6890045|NCT00591734|10905810|FG000|Overall Study|Adverse Event|5
6890046|NCT00591734|10905810|FG000|Overall Study|Physician Decision|5
6890047|NCT00591734|10905810|FG000|Overall Study|Intercurrent Illness|8
6890048|NCT00591773|10905826|FG000|Overall Study|Adverse Event|9
6890049|NCT00591773|10905827|FG001|Overall Study|Adverse Event|9
6890050|NCT00591773|10905828|FG002|Overall Study|Adverse Event|6
6890051|NCT00591773|10905826|FG000|Overall Study|Protocol Violation|2
6890052|NCT00591773|10905827|FG001|Overall Study|Protocol Violation|3
6890053|NCT00591773|10905828|FG002|Overall Study|Protocol Violation|0
6890054|NCT00591773|10905826|FG000|Overall Study|Lost to Follow-up|1
6890055|NCT00591773|10905827|FG001|Overall Study|Lost to Follow-up|4
6890056|NCT00591773|10905828|FG002|Overall Study|Lost to Follow-up|1
6890057|NCT00591773|10905826|FG000|Overall Study|Withdrawal by Subject|2
6890058|NCT00591773|10905827|FG001|Overall Study|Withdrawal by Subject|5
6890059|NCT00591773|10905828|FG002|Overall Study|Withdrawal by Subject|3
6890060|NCT00591773|10905826|FG000|Overall Study|Lack of Efficacy|1
6890061|NCT00591773|10905827|FG001|Overall Study|Lack of Efficacy|2
6890062|NCT00591773|10905828|FG002|Overall Study|Lack of Efficacy|2
6890063|NCT00591773|10905826|FG000|Overall Study|Other|1
7079245|NCT02111096|11188117|FG000|Overall Study|Withdrawal by Subject|4
7079246|NCT02111096|11188118|FG001|Overall Study|Withdrawal by Subject|2
7079247|NCT02111096|11188119|FG002|Overall Study|Withdrawal by Subject|8
7079248|NCT02111174|11188132|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1
6890064|NCT00591773|10905827|FG001|Overall Study|Other|1
6890065|NCT00591773|10905828|FG002|Overall Study|Other|4
6890066|NCT00591786|10905846|FG000|Overall Study|Withdrawal of Informed Consent|0
6890067|NCT00591786|10905847|FG001|Overall Study|Withdrawal of Informed Consent|0
6890068|NCT00591786|10905848|FG002|Overall Study|Withdrawal of Informed Consent|1
6890069|NCT00591786|10905849|FG003|Overall Study|Withdrawal of Informed Consent|0
6890070|NCT00591786|10905850|FG004|Overall Study|Withdrawal of Informed Consent|0
6890071|NCT00591786|10905851|FG005|Overall Study|Withdrawal of Informed Consent|0
6890072|NCT00591786|10905852|FG006|Overall Study|Withdrawal of Informed Consent|0
6890073|NCT00591786|10905853|FG007|Overall Study|Withdrawal of Informed Consent|0
6970484|NCT01155479|11020631|FG002|Part II|Treatment Failure|2
6890074|NCT00591786|10905854|FG008|Overall Study|Withdrawal of Informed Consent|0
6890075|NCT00591786|10905855|FG009|Overall Study|Withdrawal of Informed Consent|0
6890076|NCT00591838|10905909|FG000|Overall Study|Withdrawal by Subject|0
6890077|NCT00591838|10905910|FG001|Overall Study|Withdrawal by Subject|0
6890078|NCT00591838|10905911|FG002|Overall Study|Withdrawal by Subject|0
6890079|NCT00591838|10905912|FG003|Overall Study|Withdrawal by Subject|1
6890080|NCT00591838|10905913|FG004|Overall Study|Withdrawal by Subject|0
6890081|NCT00591851|10905926|FG000|Overall Study|Withdrawal by Subject|3
6890082|NCT00591851|10905926|FG000|Overall Study|Adverse Event|2
6890083|NCT00591851|10905926|FG000|Overall Study|Progressive Disease|1
6890084|NCT00591864|10905930|FG000|Overall Study|Incomplete Imaging|5
6890085|NCT00592072|10905942|FG000|Wash Out Period|Lost to Follow-up|1
6890086|NCT00592072|10905943|FG001|Wash Out Period|Lost to Follow-up|1
6970485|NCT01155479|11020632|FG003|Part II|Treatment Failure|0
6970486|NCT01155479|11020633|FG004|Part II|Treatment Failure|1
6970487|NCT01155479|11020629|FG000|Part II|Non-Compliance with Protocol|0
6970488|NCT01155479|11020630|FG001|Part II|Non-Compliance with Protocol|1
6970489|NCT01155479|11020631|FG002|Part II|Non-Compliance with Protocol|0
6970490|NCT01155479|11020632|FG003|Part II|Non-Compliance with Protocol|2
6970491|NCT01155479|11020633|FG004|Part II|Non-Compliance with Protocol|0
6970492|NCT01155531|11020665|FG000|Overall Study|Adverse Event|0
6970493|NCT01155531|11020666|FG001|Overall Study|Adverse Event|0
6970494|NCT01155531|11020667|FG002|Overall Study|Adverse Event|1
6970495|NCT01155531|11020668|FG003|Overall Study|Adverse Event|0
6970496|NCT01155531|11020665|FG000|Overall Study|Lost to Follow-up|0
7079249|NCT02111174|11188133|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0
7079250|NCT02111174|11188132|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2
7079251|NCT02111174|11188133|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2
7079252|NCT02111174|11188132|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8
6970497|NCT01155531|11020666|FG001|Overall Study|Lost to Follow-up|0
6970498|NCT01155531|11020667|FG002|Overall Study|Lost to Follow-up|0
6970499|NCT01155531|11020668|FG003|Overall Study|Lost to Follow-up|1
6970500|NCT01155531|11020665|FG000|Overall Study|Withdrawal by Subject|1
6970501|NCT01155531|11020666|FG001|Overall Study|Withdrawal by Subject|0
6970502|NCT01155531|11020667|FG002|Overall Study|Withdrawal by Subject|1
6970503|NCT01155531|11020668|FG003|Overall Study|Withdrawal by Subject|0
6970504|NCT01155570|11020678|FG000|Overall Study|Adverse Event|39
6970505|NCT01155570|11020678|FG000|Overall Study|Lack of Efficacy|46
6970506|NCT01155570|11020678|FG000|Overall Study|Participant's Economic Reasons|17
6970507|NCT01155570|11020678|FG000|Overall Study|No Hospital Visits|7
6970508|NCT01155570|11020678|FG000|Overall Study|Adverse Event + Lack of Efficacy|2
6970509|NCT01155570|11020678|FG000|Overall Study|Adverse Event + Other Reasons|7
6970510|NCT01155570|11020678|FG000|Overall Study|Participant's Economic Reasons + Other|1
6970511|NCT01155570|11020678|FG000|Overall Study|Other Reasons|23
6970512|NCT01155583|11020693|FG000|Phase I|Screen failure - did not start treatment|0
6970513|NCT01155583|11020694|FG001|Phase I|Screen failure - did not start treatment|0
6970514|NCT01155583|11020695|FG002|Phase I|Screen failure - did not start treatment|0
6970515|NCT01155583|11020696|FG003|Phase I|Screen failure - did not start treatment|0
6970516|NCT01155583|11020697|FG004|Phase I|Screen failure - did not start treatment|1
6970517|NCT01155583|11020698|FG005|Phase I|Screen failure - did not start treatment|0
6970518|NCT01155583|11020699|FG006|Phase I|Screen failure - did not start treatment|0
6970519|NCT01155583|11020700|FG007|Phase I|Screen failure - did not start treatment|2
6970520|NCT01155583|11020701|FG008|Phase I|Screen failure - did not start treatment|0
6970521|NCT01155583|11020693|FG000|Phase I|Withdrawal by Subject|0
6970522|NCT01155583|11020694|FG001|Phase I|Withdrawal by Subject|0
6970523|NCT01155583|11020695|FG002|Phase I|Withdrawal by Subject|0
6970524|NCT01155583|11020696|FG003|Phase I|Withdrawal by Subject|0
6970525|NCT01155583|11020697|FG004|Phase I|Withdrawal by Subject|0
6970526|NCT01155583|11020698|FG005|Phase I|Withdrawal by Subject|0
6970527|NCT01155583|11020699|FG006|Phase I|Withdrawal by Subject|0
6970528|NCT01155583|11020700|FG007|Phase I|Withdrawal by Subject|1
6970529|NCT01155583|11020701|FG008|Phase I|Withdrawal by Subject|0
6970530|NCT01155661|11020717|FG000|Overall Study|Adverse Event|101
6970531|NCT01155661|11020717|FG000|Overall Study|Death|1
6970532|NCT01155661|11020717|FG000|Overall Study|Lack of Efficacy|32
6970533|NCT01155661|11020717|FG000|Overall Study|Lost to Follow-up|22
6970534|NCT01155661|11020717|FG000|Overall Study|Physician Decision|3
6970535|NCT01155661|11020717|FG000|Overall Study|Protocol Violation|35
6970536|NCT01155661|11020717|FG000|Overall Study|Withdrawal by Subject|73
6970537|NCT01155661|11020717|FG000|Overall Study|Sponsor Decision|13
6970538|NCT01155726|11020723|FG000|Period 1, 3 Days (Masked)|Inconvenience|1
6970539|NCT01155726|11020724|FG001|Period 1, 3 Days (Masked)|Inconvenience|0
6970540|NCT01155726|11020725|FG002|Period 1, 3 Days (Masked)|Inconvenience|2
6970541|NCT01155726|11020726|FG003|Period 1, 3 Days (Masked)|Inconvenience|0
6970542|NCT01155869|11020776|FG000|Overall Study|Lost to Follow-up|3
6970543|NCT01155869|11020777|FG001|Overall Study|Lost to Follow-up|1
6970544|NCT01156012|11020794|FG000|Overall Study|Adverse Event|3
6970545|NCT01156012|11020795|FG001|Overall Study|Adverse Event|1
6970546|NCT01156012|11020794|FG000|Overall Study|Lost to Follow-up|1
6970547|NCT01156012|11020795|FG001|Overall Study|Lost to Follow-up|0
6970548|NCT01156012|11020794|FG000|Overall Study|Withdrawal by Subject|1
6890087|NCT00592319|10905976|FG000|Overall Study|Lost to Follow-up|0
6890088|NCT00592319|10905977|FG001|Overall Study|Lost to Follow-up|3
6890089|NCT00592358|10905985|FG000|Overall Study|Withdrawal by Subject|2
6890090|NCT00592358|10905985|FG000|Overall Study|Adverse Event|1
6890091|NCT00592358|10905985|FG000|Overall Study|Lack of Efficacy|2
6890092|NCT00592358|10905985|FG000|Overall Study|Inability to swallow pills|1
6890093|NCT00592384|10905991|FG000|Overall Study|Withdrawal by Subject|5
6890094|NCT00592384|10905992|FG001|Overall Study|Withdrawal by Subject|6
6890095|NCT00592501|10906022|FG000|Overall Study|Withdrawal by Subject|1
6890096|NCT00592501|10906022|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1
6890097|NCT00592553|10906029|FG000|Overall Study|Protocol Noncompliance|1
6890098|NCT00592553|10906030|FG001|Overall Study|Protocol Noncompliance|0
6890099|NCT00592553|10906031|FG002|Overall Study|Protocol Noncompliance|0
6890100|NCT00592631|10906041|FG000|Overall Study|Lost to Follow-up|0
6890101|NCT00592631|10906042|FG001|Overall Study|Lost to Follow-up|2
6890102|NCT00592683|10906050|FG000|Overall Study|Found ineligible|0
6890103|NCT00592683|10906051|FG001|Overall Study|Found ineligible|1
6890104|NCT00592683|10906050|FG000|Overall Study|Withdrawal by Subject|1
6890105|NCT00592683|10906051|FG001|Overall Study|Withdrawal by Subject|0
6890106|NCT00592683|10906050|FG000|Overall Study|Adverse Event|0
6890107|NCT00592683|10906051|FG001|Overall Study|Adverse Event|2
6890108|NCT00592683|10906050|FG000|Overall Study|Protocol Violation|1
6890109|NCT00592683|10906051|FG001|Overall Study|Protocol Violation|0
6890110|NCT00592683|10906050|FG000|Overall Study|Study drug expired|1
6890111|NCT00592683|10906051|FG001|Overall Study|Study drug expired|0
6890112|NCT00592683|10906050|FG000|Overall Study|Other|1
6890113|NCT00592683|10906051|FG001|Overall Study|Other|0
6890114|NCT00592683|10906050|FG000|Overall Study|Lost to Follow-up|0
6890115|NCT00592683|10906051|FG001|Overall Study|Lost to Follow-up|1
6890116|NCT00592774|10906069|FG000|Overall Study|Adverse Event|5
6890117|NCT00592774|10906070|FG001|Overall Study|Adverse Event|19
6890118|NCT00592774|10906071|FG002|Overall Study|Adverse Event|2
6890119|NCT00592774|10906072|FG003|Overall Study|Adverse Event|14
6890120|NCT00592774|10906073|FG004|Overall Study|Adverse Event|8
6890121|NCT00592774|10906069|FG000|Overall Study|Protocol Violation|0
6890122|NCT00592774|10906070|FG001|Overall Study|Protocol Violation|1
6890123|NCT00592774|10906071|FG002|Overall Study|Protocol Violation|0
6890124|NCT00592774|10906072|FG003|Overall Study|Protocol Violation|0
6890125|NCT00592774|10906073|FG004|Overall Study|Protocol Violation|1
6890126|NCT00592774|10906069|FG000|Overall Study|Withdrawal by Subject|3
6890127|NCT00592774|10906070|FG001|Overall Study|Withdrawal by Subject|7
6890128|NCT00592774|10906071|FG002|Overall Study|Withdrawal by Subject|0
6890129|NCT00592774|10906072|FG003|Overall Study|Withdrawal by Subject|0
6890130|NCT00592774|10906073|FG004|Overall Study|Withdrawal by Subject|0
6890131|NCT00592774|10906069|FG000|Overall Study|Lack of Efficacy|3
6890132|NCT00592774|10906070|FG001|Overall Study|Lack of Efficacy|3
6890133|NCT00592774|10906071|FG002|Overall Study|Lack of Efficacy|0
6890134|NCT00592774|10906072|FG003|Overall Study|Lack of Efficacy|0
6890135|NCT00592774|10906073|FG004|Overall Study|Lack of Efficacy|2
6890136|NCT00592774|10906069|FG000|Overall Study|Physician Decision|0
6890137|NCT00592774|10906070|FG001|Overall Study|Physician Decision|1
6890138|NCT00592774|10906071|FG002|Overall Study|Physician Decision|1
6890139|NCT00592774|10906072|FG003|Overall Study|Physician Decision|0
6890140|NCT00592774|10906073|FG004|Overall Study|Physician Decision|1
6890141|NCT00592774|10906069|FG000|Overall Study|Other|0
6890142|NCT00592774|10906070|FG001|Overall Study|Other|1
6890143|NCT00592774|10906071|FG002|Overall Study|Other|1
6890144|NCT00592774|10906072|FG003|Overall Study|Other|0
6890145|NCT00592774|10906073|FG004|Overall Study|Other|2
6890146|NCT00592839|10906088|FG000|Overall Study|Withdrawal by Subject|1
6890147|NCT00592839|10906089|FG001|Overall Study|Withdrawal by Subject|1
6890148|NCT00592839|10906090|FG002|Overall Study|Withdrawal by Subject|3
6890149|NCT00592839|10906088|FG000|Overall Study|Protocol Violation|1
6890150|NCT00592839|10906089|FG001|Overall Study|Protocol Violation|1
6890151|NCT00592839|10906090|FG002|Overall Study|Protocol Violation|2
6890152|NCT00592839|10906088|FG000|Overall Study|Adverse Event|0
6890153|NCT00592839|10906089|FG001|Overall Study|Adverse Event|1
6890154|NCT00592839|10906090|FG002|Overall Study|Adverse Event|0
6890155|NCT00592839|10906088|FG000|Overall Study|Lost to Follow-up|0
6890156|NCT00592839|10906089|FG001|Overall Study|Lost to Follow-up|1
6890157|NCT00592839|10906090|FG002|Overall Study|Lost to Follow-up|1
6890158|NCT00592852|10906098|FG000|Overall Study|Non-compliance|1
6890159|NCT00592852|10906098|FG000|Overall Study|Adverse Event|3
6890160|NCT00592852|10906098|FG000|Overall Study|Found ineligible|1
6890161|NCT00592852|10906098|FG000|Overall Study|Withdrawal by Subject|1
6890162|NCT00592904|10906106|FG000|Overall Study|Adverse Event|15
6890163|NCT00592904|10906107|FG001|Overall Study|Adverse Event|25
6890164|NCT00592904|10906108|FG002|Overall Study|Adverse Event|13
6890165|NCT00592904|10906109|FG003|Overall Study|Adverse Event|5
6890166|NCT00592904|10906106|FG000|Overall Study|Protocol Violation|1
6890167|NCT00592904|10906107|FG001|Overall Study|Protocol Violation|1
6890168|NCT00592904|10906108|FG002|Overall Study|Protocol Violation|0
6890169|NCT00592904|10906109|FG003|Overall Study|Protocol Violation|1
6890170|NCT00592904|10906106|FG000|Overall Study|Withdrawal by Subject|4
6890171|NCT00592904|10906107|FG001|Overall Study|Withdrawal by Subject|16
6890172|NCT00592904|10906108|FG002|Overall Study|Withdrawal by Subject|1
6890173|NCT00592904|10906109|FG003|Overall Study|Withdrawal by Subject|2
6890174|NCT00592904|10906106|FG000|Overall Study|Lack of Efficacy|2
6890175|NCT00592904|10906107|FG001|Overall Study|Lack of Efficacy|7
6890176|NCT00592904|10906108|FG002|Overall Study|Lack of Efficacy|2
6890177|NCT00592904|10906109|FG003|Overall Study|Lack of Efficacy|3
6890178|NCT00592904|10906106|FG000|Overall Study|Physician Decision|0
6890179|NCT00592904|10906107|FG001|Overall Study|Physician Decision|3
6890180|NCT00592904|10906108|FG002|Overall Study|Physician Decision|1
6890181|NCT00592904|10906109|FG003|Overall Study|Physician Decision|0
6890182|NCT00592904|10906106|FG000|Overall Study|Other|3
6890183|NCT00592904|10906107|FG001|Overall Study|Other|3
6890184|NCT00592904|10906108|FG002|Overall Study|Other|0
6890185|NCT00592904|10906109|FG003|Overall Study|Other|0
6890186|NCT00593112|10906130|FG000|Overall Study|Scan Anxiety|3
6890187|NCT00593112|10906131|FG001|Overall Study|Scan Anxiety|0
6890188|NCT00593112|10906130|FG000|Overall Study|Abnormal Scan|1
6890189|NCT00593112|10906131|FG001|Overall Study|Abnormal Scan|0
6890190|NCT00593112|10906130|FG000|Overall Study|Unreadable Scan|1
6890191|NCT00593112|10906131|FG001|Overall Study|Unreadable Scan|0
6890192|NCT00593112|10906130|FG000|Overall Study|Withdrawal by Subject|5
6890193|NCT00593112|10906131|FG001|Overall Study|Withdrawal by Subject|0
6890194|NCT00593333|10906139|FG000|Overall Study|Lost to Follow-up|10
6890195|NCT00593333|10906140|FG001|Overall Study|Lost to Follow-up|11
6890196|NCT00593385|10906160|FG000|Overall Study|Death|14
6890197|NCT00593385|10906160|FG000|Overall Study|Lost to Follow-up|17
6890198|NCT00593385|10906160|FG000|Overall Study|Withdrawal by Subject|9
6890199|NCT00593489|10906185|FG000|Allocation|did not attend workshop; allocation not|2
6890200|NCT00593489|10906186|FG001|Allocation|did not attend workshop; allocation not|1
6890201|NCT00593554|10906196|FG000|Overall Study|Death|1
6890202|NCT00593554|10906197|FG001|Overall Study|Death|2
6890203|NCT00593554|10906196|FG000|Overall Study|Physician Decision|0
6890204|NCT00593554|10906197|FG001|Overall Study|Physician Decision|1
6890205|NCT00593554|10906196|FG000|Overall Study|Withdrawal by Subject|1
6890206|NCT00593554|10906197|FG001|Overall Study|Withdrawal by Subject|0
6890207|NCT00593554|10906196|FG000|Overall Study|Disease Progression|1
6890208|NCT00593554|10906197|FG001|Overall Study|Disease Progression|2
6890209|NCT00593606|10906203|FG000|Overall Study|Adverse Event|13
6890210|NCT00593606|10906203|FG000|Overall Study|Withdrawal by Subject|1
6890211|NCT00593606|10906203|FG000|Overall Study|Protocol Violation|3
6890212|NCT00593606|10906203|FG000|Overall Study|Lost to Follow-up|2
6890213|NCT00593606|10906203|FG000|Overall Study|Run-In Failure|5
6890214|NCT00593606|10906203|FG000|Overall Study|Screen Failure|3
6890215|NCT00593684|10906213|FG000|Overall Study|Death|2
6890216|NCT00593684|10906214|FG001|Overall Study|Death|1
6890217|NCT00593736|10906224|FG000|Screening Period and Placebo Run-in|Adverse Event|0
6890218|NCT00593736|10906225|FG001|Screening Period and Placebo Run-in|Adverse Event|0
6890219|NCT00593736|10906226|FG002|Screening Period and Placebo Run-in|Adverse Event|0
6890220|NCT00593736|10906227|FG003|Screening Period and Placebo Run-in|Adverse Event|3
6890221|NCT00593736|10906224|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0
6890222|NCT00593736|10906225|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0
6890223|NCT00593736|10906226|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0
6890224|NCT00593736|10906227|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9
6890225|NCT00593736|10906224|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0
6890226|NCT00593736|10906225|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0
6890227|NCT00593736|10906226|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0
6890228|NCT00593736|10906227|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43
6890229|NCT00593736|10906224|FG000|Screening Period and Placebo Run-in|Study Termination|0
6890230|NCT00593736|10906225|FG001|Screening Period and Placebo Run-in|Study Termination|0
6890231|NCT00593736|10906226|FG002|Screening Period and Placebo Run-in|Study Termination|0
6890232|NCT00593736|10906227|FG003|Screening Period and Placebo Run-in|Study Termination|15
6890233|NCT00593736|10906224|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
6890234|NCT00593736|10906225|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
6890235|NCT00593736|10906226|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
6890236|NCT00593736|10906227|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322
6890237|NCT00593736|10906224|FG000|Screening Period and Placebo Run-in|Various|0
6890238|NCT00593736|10906225|FG001|Screening Period and Placebo Run-in|Various|0
6890239|NCT00593736|10906226|FG002|Screening Period and Placebo Run-in|Various|0
6890240|NCT00593736|10906227|FG003|Screening Period and Placebo Run-in|Various|25
6890241|NCT00593736|10906224|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2
6890242|NCT00593736|10906225|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1
6890243|NCT00593736|10906226|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2
6890244|NCT00593736|10906227|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0
6890245|NCT00593736|10906224|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0
6890246|NCT00593736|10906225|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0
6890247|NCT00593736|10906226|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1
6890248|NCT00593736|10906227|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1
6890249|NCT00593736|10906224|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
6890250|NCT00593736|10906225|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
6890251|NCT00593736|10906226|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1
6890252|NCT00593736|10906227|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3
6890253|NCT00593736|10906224|FG000|Treatment Period and Placebo Run-out|Various|1
6890254|NCT00593736|10906225|FG001|Treatment Period and Placebo Run-out|Various|1
6890255|NCT00593736|10906226|FG002|Treatment Period and Placebo Run-out|Various|1
6890256|NCT00593736|10906227|FG003|Treatment Period and Placebo Run-out|Various|0
6890257|NCT00593814|10906239|FG000|Overall Study|Death|7
6890258|NCT00593814|10906240|FG001|Overall Study|Death|0
6890259|NCT00593814|10906239|FG000|Overall Study|Withdrawal by Subject|7
6890260|NCT00593814|10906240|FG001|Overall Study|Withdrawal by Subject|0
6890261|NCT00593814|10906239|FG000|Overall Study|Lost to Follow-up|7
6890262|NCT00593814|10906240|FG001|Overall Study|Lost to Follow-up|0
6890263|NCT00593814|10906239|FG000|Overall Study|Physician Decision|3
6890264|NCT00593814|10906240|FG001|Overall Study|Physician Decision|0
6890265|NCT00593827|10906248|FG000|Overall Study|On Active Treatment/Pending|0
6890266|NCT00593827|10906249|FG001|Overall Study|On Active Treatment/Pending|2
6890268|NCT00593918|10906265|FG000|Overall Study|Withdrawal by Subject|5
6890269|NCT00593918|10906266|FG001|Overall Study|Withdrawal by Subject|24
6890270|NCT00593957|10906275|FG000|Overall Study|Physician Decision|0
6890271|NCT00593957|10906276|FG001|Overall Study|Physician Decision|1
6890272|NCT00593957|10906277|FG002|Overall Study|Physician Decision|2
6890273|NCT00594035|10906314|FG000|Overall Study|Lost to Follow-up|1
6890274|NCT00594035|10906315|FG001|Overall Study|Lost to Follow-up|1
6890275|NCT00594035|10906314|FG000|Overall Study|Withdrawal by Subject|1
6890276|NCT00594035|10906315|FG001|Overall Study|Withdrawal by Subject|0
6890277|NCT00594035|10906314|FG000|Overall Study|Subject transferred to nursing home|0
6890278|NCT00594035|10906315|FG001|Overall Study|Subject transferred to nursing home|1
6890279|NCT00594035|10906314|FG000|Overall Study|Subject couldn't return due to job|0
6890280|NCT00594035|10906315|FG001|Overall Study|Subject couldn't return due to job|1
6890281|NCT00594100|10906325|FG000|Procedure|Technical Failure|9
6890282|NCT00594100|10906325|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2
6890283|NCT00594100|10906325|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6
6890284|NCT00594100|10906325|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4
6890285|NCT00594165|10906329|FG000|Overall Study|Major protocol violation|1
7079253|NCT02111174|11188133|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6
6890286|NCT00594165|10906329|FG000|Overall Study|Lack of Efficacy|12
6890287|NCT00594165|10906329|FG000|Overall Study|Adverse Event|52
6890288|NCT00594165|10906329|FG000|Overall Study|Unsatisfactory compliance of subject|6
7155789|NCT03347188|11323849|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28
7155790|NCT03347188|11323848|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1
7155791|NCT03347188|11323849|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0
7155792|NCT03347188|11323848|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0
7155793|NCT03347188|11323849|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1
7155794|NCT03347279|11323857|FG000|Overall Study|Withdrawal by Subject|8
7155795|NCT03347279|11323858|FG001|Overall Study|Withdrawal by Subject|15
7155796|NCT03347279|11323857|FG000|Overall Study|Death|0
7155797|NCT03347279|11323858|FG001|Overall Study|Death|2
7155798|NCT03347279|11323857|FG000|Overall Study|Lost to Follow-up|5
7155799|NCT03347279|11323858|FG001|Overall Study|Lost to Follow-up|2
7155800|NCT03347279|11323857|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3
7155801|NCT03347279|11323858|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4
7155802|NCT03347695|11323866|FG000|Overall Study|Death|0
7155803|NCT03347695|11323867|FG001|Overall Study|Death|4
7155804|NCT03347695|11323866|FG000|Overall Study|Lost to Follow-up|0
7155805|NCT03347695|11323867|FG001|Overall Study|Lost to Follow-up|1
7155806|NCT03349034|11323886|FG000|Overall Study|catheters dislodged during transport|2
7155807|NCT03349034|11323887|FG001|Overall Study|catheters dislodged during transport|0
7155808|NCT03349034|11323886|FG000|Overall Study|intubated for >48 hrs following surgery|1
7155809|NCT03349034|11323887|FG001|Overall Study|intubated for >48 hrs following surgery|1
6890289|NCT00594165|10906329|FG000|Overall Study|Subject withdrew consent|27
6890290|NCT00594165|10906329|FG000|Overall Study|Study ended per sponsor|102
6890291|NCT00594165|10906329|FG000|Overall Study|Lost to Follow-up|4
6890292|NCT00594165|10906329|FG000|Overall Study|Other: PI discretion|5
6890293|NCT00594165|10906329|FG000|Overall Study|Other: Subject moving|3
6890294|NCT00594165|10906329|FG000|Overall Study|Other: Brain surgery controlled symptoms|1
6890295|NCT00594165|10906329|FG000|Overall Study|Other: House bound; can't get to clinic|1
6890296|NCT00594165|10906329|FG000|Overall Study|Other: Subject enrolled in other trial|1
6890297|NCT00594165|10906329|FG000|Overall Study|Other: Site terminated participation|2
6890298|NCT00594178|10906333|FG000|Overall Study|Physician Decision|5
6890299|NCT00594204|10906339|FG000|Overall Study|Adverse Event|15
6890300|NCT00594204|10906340|FG001|Overall Study|Adverse Event|3
6890301|NCT00594204|10906339|FG000|Overall Study|Lost to Follow-up|9
6890302|NCT00594204|10906340|FG001|Overall Study|Lost to Follow-up|5
6890303|NCT00594204|10906339|FG000|Overall Study|Withdrawal by Subject|23
6890304|NCT00594204|10906340|FG001|Overall Study|Withdrawal by Subject|29
7155810|NCT03349034|11323886|FG000|Overall Study|soft tissue flap used|1
6890305|NCT00594204|10906339|FG000|Overall Study|Other|4
6890306|NCT00594204|10906340|FG001|Overall Study|Other|3
7155811|NCT03349034|11323887|FG001|Overall Study|soft tissue flap used|0
7155812|NCT03349034|11323886|FG000|Overall Study|Other|0
7155813|NCT03349034|11323887|FG001|Overall Study|Other|1
7155814|NCT03349060|11323898|FG000|Overall Study|Adverse Event|9
7155815|NCT03349060|11323899|FG001|Overall Study|Adverse Event|9
7155816|NCT03349060|11323900|FG002|Overall Study|Adverse Event|7
7155817|NCT03349060|11323898|FG000|Overall Study|Lack of Efficacy|1
7155818|NCT03349060|11323899|FG001|Overall Study|Lack of Efficacy|0
7155819|NCT03349060|11323900|FG002|Overall Study|Lack of Efficacy|2
7155820|NCT03349060|11323898|FG000|Overall Study|Lost to Follow-up|2
7155821|NCT03349060|11323899|FG001|Overall Study|Lost to Follow-up|1
7155822|NCT03349060|11323900|FG002|Overall Study|Lost to Follow-up|1
7155823|NCT03349060|11323898|FG000|Overall Study|Protocol Violation|2
7155824|NCT03349060|11323899|FG001|Overall Study|Protocol Violation|2
7155825|NCT03349060|11323900|FG002|Overall Study|Protocol Violation|1
7155826|NCT03349060|11323898|FG000|Overall Study|Withdrawal by Subject|5
7155827|NCT03349060|11323899|FG001|Overall Study|Withdrawal by Subject|3
7155828|NCT03349060|11323900|FG002|Overall Study|Withdrawal by Subject|4
7155829|NCT03349060|11323898|FG000|Overall Study|Medication error,no linked adverse event|0
7155830|NCT03349060|11323899|FG001|Overall Study|Medication error,no linked adverse event|0
7155831|NCT03349060|11323900|FG002|Overall Study|Medication error,no linked adverse event|1
7155832|NCT03349060|11323898|FG000|Overall Study|Withdrawal By Parent/Guardian|0
7155833|NCT03349060|11323899|FG001|Overall Study|Withdrawal By Parent/Guardian|1
7155834|NCT03349060|11323900|FG002|Overall Study|Withdrawal By Parent/Guardian|0
7155835|NCT03349060|11323898|FG000|Overall Study|Other|2
7155836|NCT03349060|11323899|FG001|Overall Study|Other|1
7155837|NCT03349060|11323900|FG002|Overall Study|Other|0
7155838|NCT03349099|11323910|FG000|Overall Study|Physician Decision|3
7155839|NCT03349099|11323911|FG001|Overall Study|Physician Decision|4
7155840|NCT03349099|11323910|FG000|Overall Study|Stone migrated from the kidney|1
7155841|NCT03349099|11323911|FG001|Overall Study|Stone migrated from the kidney|0
7155842|NCT03349333|11323917|FG000|Overall Study|Progression of Disease|36
7155843|NCT03349333|11323917|FG000|Overall Study|Adverse Event|11
6890307|NCT00594204|10906339|FG000|Overall Study|Lack of Efficacy|3
6890308|NCT00594204|10906340|FG001|Overall Study|Lack of Efficacy|4
6890309|NCT00594204|10906339|FG000|Overall Study|Randomized but not treated|4
6890310|NCT00594204|10906340|FG001|Overall Study|Randomized but not treated|1
6890311|NCT00594399|10906366|FG000|Initial 3 Month Counseling|Not ready to exercise|1
6890312|NCT00594399|10906367|FG001|Initial 3 Month Counseling|Not ready to exercise|0
6890313|NCT00594399|10906368|FG002|Initial 3 Month Counseling|Not ready to exercise|0
6890314|NCT00594399|10906366|FG000|Initial 3 Month Counseling|Lack of Interest|3
6890315|NCT00594399|10906367|FG001|Initial 3 Month Counseling|Lack of Interest|3
6890316|NCT00594399|10906368|FG002|Initial 3 Month Counseling|Lack of Interest|0
6890317|NCT00594399|10906366|FG000|Initial 3 Month Counseling|Personal issues|2
6890318|NCT00594399|10906367|FG001|Initial 3 Month Counseling|Personal issues|0
6890319|NCT00594399|10906368|FG002|Initial 3 Month Counseling|Personal issues|0
6890320|NCT00594399|10906366|FG000|Initial 3 Month Counseling|Too busy|7
6890321|NCT00594399|10906367|FG001|Initial 3 Month Counseling|Too busy|1
6890322|NCT00594399|10906368|FG002|Initial 3 Month Counseling|Too busy|0
6890323|NCT00594399|10906366|FG000|Initial 3 Month Counseling|Pain|2
6890324|NCT00594399|10906367|FG001|Initial 3 Month Counseling|Pain|0
6890325|NCT00594399|10906368|FG002|Initial 3 Month Counseling|Pain|0
6890326|NCT00594399|10906366|FG000|Initial 3 Month Counseling|Moved|1
6890327|NCT00594399|10906367|FG001|Initial 3 Month Counseling|Moved|0
6890328|NCT00594399|10906368|FG002|Initial 3 Month Counseling|Moved|0
6890329|NCT00594399|10906366|FG000|Initial 3 Month Counseling|Family illness|1
6890330|NCT00594399|10906367|FG001|Initial 3 Month Counseling|Family illness|0
6890331|NCT00594399|10906368|FG002|Initial 3 Month Counseling|Family illness|0
6890332|NCT00594399|10906366|FG000|Rerandomization Arm 1 Only|Death|2
6890333|NCT00594399|10906367|FG001|Rerandomization Arm 1 Only|Death|1
6890334|NCT00594399|10906368|FG002|Rerandomization Arm 1 Only|Death|0
6890335|NCT00594399|10906366|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0
6890336|NCT00594399|10906367|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3
6890337|NCT00594399|10906368|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0
6890338|NCT00594464|10906387|FG000|Overall Study|Withdrawal by Subject|1
6890339|NCT00594464|10906387|FG000|Overall Study|Delay in operation|2
6890340|NCT00594516|10906397|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4
7155844|NCT03349333|11323917|FG000|Overall Study|Other|6
7155845|NCT03349333|11323917|FG000|Overall Study|Withdrawal by Subject|5
7155846|NCT03349333|11323917|FG000|Overall Study|Conditions interfere with participation|2
7155847|NCT03349333|11323917|FG000|Overall Study|Physician Decision|2
7155848|NCT03349333|11323917|FG000|Overall Study|3-week lapse between pralatrexate doses|1
7155849|NCT03349333|11323917|FG000|Overall Study|Patients in treatment less than 24 month|8
6890341|NCT00594516|10906398|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
6890342|NCT00594516|10906399|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
6890343|NCT00594516|10906397|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2
6890344|NCT00594516|10906398|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
6890345|NCT00594516|10906399|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
6890346|NCT00594516|10906397|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16
7155850|NCT03349437|11323921|FG000|Screening|Screen Fail|4
7155851|NCT03349437|11323922|FG001|Screening|Screen Fail|0
6890347|NCT00594516|10906398|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0
6890348|NCT00594516|10906399|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0
6890349|NCT00594516|10906397|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1
6890350|NCT00594516|10906398|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
6890351|NCT00594516|10906399|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
6890352|NCT00594516|10906397|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6
6890353|NCT00594516|10906398|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
6890354|NCT00594516|10906399|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
6890355|NCT00594516|10906397|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0
6890356|NCT00594516|10906398|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
6890357|NCT00594516|10906399|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
6890358|NCT00594516|10906397|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0
6890359|NCT00594516|10906398|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3
6890360|NCT00594516|10906399|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2
6890361|NCT00594516|10906397|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0
6890362|NCT00594516|10906398|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
6890363|NCT00594516|10906399|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
6890364|NCT00594516|10906397|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
6890365|NCT00594516|10906398|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
6890366|NCT00594516|10906399|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2
6890367|NCT00594568|10906406|FG000|Initial Treatment|Adverse Event|51
6890368|NCT00594568|10906407|FG001|Initial Treatment|Adverse Event|121
6890369|NCT00594568|10906408|FG002|Initial Treatment|Adverse Event|144
6890370|NCT00594568|10906406|FG000|Initial Treatment|Death|6
6890371|NCT00594568|10906407|FG001|Initial Treatment|Death|11
6890372|NCT00594568|10906408|FG002|Initial Treatment|Death|15
6890373|NCT00594568|10906406|FG000|Initial Treatment|Lost to Follow-up|4
6890374|NCT00594568|10906407|FG001|Initial Treatment|Lost to Follow-up|1
6890375|NCT00594568|10906408|FG002|Initial Treatment|Lost to Follow-up|4
6890376|NCT00594568|10906406|FG000|Initial Treatment|Physician Decision|3
6890377|NCT00594568|10906407|FG001|Initial Treatment|Physician Decision|2
6890378|NCT00594568|10906408|FG002|Initial Treatment|Physician Decision|4
6890379|NCT00594568|10906406|FG000|Initial Treatment|Protocol Violation|2
6890380|NCT00594568|10906407|FG001|Initial Treatment|Protocol Violation|2
6890381|NCT00594568|10906408|FG002|Initial Treatment|Protocol Violation|5
6890382|NCT00594568|10906406|FG000|Initial Treatment|Withdrawal by Subject|25
6890383|NCT00594568|10906407|FG001|Initial Treatment|Withdrawal by Subject|31
6890384|NCT00594568|10906408|FG002|Initial Treatment|Withdrawal by Subject|46
6890385|NCT00594568|10906406|FG000|Initial Treatment|Sponsor decision|193
6890386|NCT00594568|10906407|FG001|Initial Treatment|Sponsor decision|142
6890387|NCT00594568|10906408|FG002|Initial Treatment|Sponsor decision|147
6890388|NCT00594568|10906406|FG000|Initial Treatment|Caregiver decision|21
6890389|NCT00594568|10906407|FG001|Initial Treatment|Caregiver decision|36
6890390|NCT00594568|10906408|FG002|Initial Treatment|Caregiver decision|36
6890391|NCT00594568|10906406|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
6890392|NCT00594568|10906407|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
6890393|NCT00594568|10906408|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6
6890394|NCT00594568|10906406|FG000|Initial Treatment|Entry criteria exclusion|0
6890395|NCT00594568|10906407|FG001|Initial Treatment|Entry criteria exclusion|1
6890396|NCT00594568|10906408|FG002|Initial Treatment|Entry criteria exclusion|1
6890397|NCT00594568|10906406|FG000|Delayed Start|Death|0
6890398|NCT00594568|10906407|FG001|Delayed Start|Death|0
6890399|NCT00594568|10906408|FG002|Delayed Start|Death|1
6890400|NCT00594568|10906406|FG000|Delayed Start|Adverse Event|12
6890401|NCT00594568|10906407|FG001|Delayed Start|Adverse Event|2
6890402|NCT00594568|10906408|FG002|Delayed Start|Adverse Event|2
6890403|NCT00594568|10906406|FG000|Delayed Start|Withdrawal by Subject|4
6890404|NCT00594568|10906407|FG001|Delayed Start|Withdrawal by Subject|3
6890405|NCT00594568|10906408|FG002|Delayed Start|Withdrawal by Subject|0
6890406|NCT00594568|10906406|FG000|Delayed Start|Physician Decision|0
6890407|NCT00594568|10906407|FG001|Delayed Start|Physician Decision|0
6890408|NCT00594568|10906408|FG002|Delayed Start|Physician Decision|1
6890409|NCT00594568|10906406|FG000|Delayed Start|Lost to Follow-up|0
6890410|NCT00594568|10906407|FG001|Delayed Start|Lost to Follow-up|0
6890411|NCT00594568|10906408|FG002|Delayed Start|Lost to Follow-up|1
6890412|NCT00594568|10906406|FG000|Delayed Start|Caregiver Decision|5
6890413|NCT00594568|10906407|FG001|Delayed Start|Caregiver Decision|6
6890414|NCT00594568|10906408|FG002|Delayed Start|Caregiver Decision|2
6890415|NCT00594568|10906406|FG000|Delayed Start|Sponsor Decision|77
6890416|NCT00594568|10906407|FG001|Delayed Start|Sponsor Decision|66
6890417|NCT00594568|10906408|FG002|Delayed Start|Sponsor Decision|59
6890418|NCT00594568|10906406|FG000|Safety Follow Up (SFU)-Optional|Death|0
6890419|NCT00594568|10906407|FG001|Safety Follow Up (SFU)-Optional|Death|1
6890420|NCT00594568|10906408|FG002|Safety Follow Up (SFU)-Optional|Death|0
6890421|NCT00594568|10906406|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5
6890422|NCT00594568|10906407|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0
6890423|NCT00594568|10906408|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0
6890424|NCT00594568|10906406|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12
6890425|NCT00594568|10906407|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15
6890426|NCT00594568|10906408|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13
6890427|NCT00594568|10906406|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
6890428|NCT00594568|10906407|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
6890429|NCT00594568|10906408|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
6890430|NCT00594568|10906406|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17
6890431|NCT00594568|10906407|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16
6890432|NCT00594568|10906408|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9
6890433|NCT00594568|10906406|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25
6890434|NCT00594568|10906407|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22
6890435|NCT00594568|10906408|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18
6890436|NCT00594646|10906424|FG000|Overall Study|Withdrawal by Subject|1
6890437|NCT00594646|10906424|FG000|Overall Study|Lost to Follow-up|15
6890438|NCT00594659|10906432|FG000|Overall Study|Lost to Follow-up|13
6890439|NCT00594659|10906433|FG001|Overall Study|Lost to Follow-up|9
6890440|NCT00594659|10906434|FG002|Overall Study|Lost to Follow-up|7
6890441|NCT00594815|10906446|FG000|Overall Study|Never Treated|3
6890442|NCT00594815|10906446|FG000|Overall Study|Withdrawal by Subject|2
6890443|NCT00594815|10906446|FG000|Overall Study|Toxicity|4
6890444|NCT00594854|10906452|FG000|Overall Study|Study terminated|7
6890445|NCT00594854|10906453|FG001|Overall Study|Study terminated|10
6890446|NCT00594880|10906461|FG000|Overall Study|Withdrawal by Subject|1
6890447|NCT00594880|10906462|FG001|Overall Study|Withdrawal by Subject|1
6890448|NCT00594880|10906461|FG000|Overall Study|Lost to Follow-up|1
6890449|NCT00594880|10906462|FG001|Overall Study|Lost to Follow-up|0
6890450|NCT00594906|10906474|FG000|Overall Study|Physician Decision|1
6890451|NCT00594906|10906475|FG001|Overall Study|Physician Decision|0
6890452|NCT00594906|10906474|FG000|Overall Study|Physician Decision|0
6890453|NCT00594906|10906475|FG001|Overall Study|Physician Decision|1
6890454|NCT00594906|10906474|FG000|Overall Study|Death|0
6890455|NCT00594906|10906475|FG001|Overall Study|Death|1
6890456|NCT00594932|10906483|FG000|First 3 Months|Withdrawal by Subject|1
6890457|NCT00594932|10906484|FG001|First 3 Months|Withdrawal by Subject|3
6890458|NCT00594932|10906483|FG000|Final 3 Months|Withdrawal by Subject|4
6890459|NCT00594932|10906484|FG001|Final 3 Months|Withdrawal by Subject|3
6890460|NCT00594958|10906504|FG000|Overall Study|Withdrawal by Subject|1
6890461|NCT00594958|10906505|FG001|Overall Study|Withdrawal by Subject|0
6890462|NCT00594958|10906506|FG002|Overall Study|Withdrawal by Subject|1
6890463|NCT00594958|10906504|FG000|Overall Study|Adverse Event|4
6890464|NCT00594958|10906505|FG001|Overall Study|Adverse Event|1
6890465|NCT00594958|10906506|FG002|Overall Study|Adverse Event|2
6890466|NCT00594958|10906504|FG000|Overall Study|Pregnancy|0
6890467|NCT00594958|10906505|FG001|Overall Study|Pregnancy|2
6890468|NCT00594958|10906506|FG002|Overall Study|Pregnancy|0
6890469|NCT00594958|10906504|FG000|Overall Study|Protocol Violation|1
6890470|NCT00594958|10906505|FG001|Overall Study|Protocol Violation|0
6890471|NCT00594958|10906506|FG002|Overall Study|Protocol Violation|2
6890472|NCT00594958|10906504|FG000|Overall Study|Lost to Follow-up|5
6890473|NCT00594958|10906505|FG001|Overall Study|Lost to Follow-up|0
6890474|NCT00594958|10906506|FG002|Overall Study|Lost to Follow-up|3
6890475|NCT00594958|10906504|FG000|Overall Study|administrative|3
6890476|NCT00594958|10906505|FG001|Overall Study|administrative|0
6890477|NCT00594958|10906506|FG002|Overall Study|administrative|2
6890478|NCT00595075|10906527|FG000|Overall Study|Withdrawal by Subject|1
6890479|NCT00595075|10906528|FG001|Overall Study|Withdrawal by Subject|0
6890480|NCT00595127|10906564|FG000|Overall Study|Death|6
6890481|NCT00595127|10906564|FG000|Overall Study|Relapsed|3
6890482|NCT00595127|10906564|FG000|Overall Study|joined another trial|1
6890483|NCT00595309|10906603|FG000|Overall Study|Lost to Follow-up|1
6890484|NCT00595309|10906603|FG000|Overall Study|planned vaccination against yellow fever|1
6890485|NCT00595309|10906603|FG000|Overall Study|acute infection after V0|1
6890486|NCT00595309|10906603|FG000|Overall Study|personal reason|1
6890487|NCT00595335|10906609|FG000|Baseline to Six Months|Withdrawal by Subject|0
6890488|NCT00595335|10906610|FG001|Baseline to Six Months|Withdrawal by Subject|1
6890489|NCT00595335|10906609|FG000|Baseline to Six Months|Disease Progression|1
6890490|NCT00595335|10906610|FG001|Baseline to Six Months|Disease Progression|1
6890491|NCT00595335|10906609|FG000|Baseline to Six Months|Adverse Event|1
6890492|NCT00595335|10906610|FG001|Baseline to Six Months|Adverse Event|0
6890493|NCT00595335|10906609|FG000|Six Months to Twelve Months|Withdrawal by Subject|0
6890494|NCT00595335|10906610|FG001|Six Months to Twelve Months|Withdrawal by Subject|1
6890495|NCT00595335|10906609|FG000|Six Months to Twelve Months|Disease Progression|1
6890496|NCT00595335|10906610|FG001|Six Months to Twelve Months|Disease Progression|0
6890497|NCT00595413|10906633|FG000|Overall Study|Adverse Event|0
6890498|NCT00595413|10906634|FG001|Overall Study|Adverse Event|2
6890499|NCT00595413|10906635|FG002|Overall Study|Adverse Event|1
6890500|NCT00595413|10906636|FG003|Overall Study|Adverse Event|1
6890501|NCT00595413|10906633|FG000|Overall Study|Lost to Follow-up|2
6890502|NCT00595413|10906634|FG001|Overall Study|Lost to Follow-up|2
6890503|NCT00595413|10906635|FG002|Overall Study|Lost to Follow-up|1
6890504|NCT00595413|10906636|FG003|Overall Study|Lost to Follow-up|3
6890505|NCT00595413|10906633|FG000|Overall Study|Death|0
6890506|NCT00595413|10906634|FG001|Overall Study|Death|0
6890507|NCT00595413|10906635|FG002|Overall Study|Death|1
6890508|NCT00595413|10906636|FG003|Overall Study|Death|0
6890509|NCT00595413|10906633|FG000|Overall Study|Other|5
6890510|NCT00595413|10906634|FG001|Overall Study|Other|1
6890511|NCT00595413|10906635|FG002|Overall Study|Other|5
6890512|NCT00595413|10906636|FG003|Overall Study|Other|0
6890513|NCT00595465|10906649|FG000|Overall Study|Adverse Event|4
6890514|NCT00595465|10906650|FG001|Overall Study|Adverse Event|3
6890515|NCT00595465|10906651|FG002|Overall Study|Adverse Event|3
6890516|NCT00595465|10906649|FG000|Overall Study|Pregnancy|0
6890517|NCT00595465|10906650|FG001|Overall Study|Pregnancy|0
6890518|NCT00595465|10906651|FG002|Overall Study|Pregnancy|1
6890519|NCT00595465|10906649|FG000|Overall Study|Protocol Violation|2
6890520|NCT00595465|10906650|FG001|Overall Study|Protocol Violation|1
6890521|NCT00595465|10906651|FG002|Overall Study|Protocol Violation|0
6890522|NCT00595465|10906649|FG000|Overall Study|Lost to Follow-up|0
6890523|NCT00595465|10906650|FG001|Overall Study|Lost to Follow-up|0
6890524|NCT00595465|10906651|FG002|Overall Study|Lost to Follow-up|2
6890525|NCT00595465|10906649|FG000|Overall Study|administrative reason|0
6890526|NCT00595465|10906650|FG001|Overall Study|administrative reason|0
6890527|NCT00595465|10906651|FG002|Overall Study|administrative reason|1
6890528|NCT00595478|10906661|FG000|36-week Follow-up Period|Lost to Follow-up|5
6890529|NCT00595478|10906662|FG001|36-week Follow-up Period|Lost to Follow-up|4
6890530|NCT00595478|10906661|FG000|36-week Follow-up Period|Withdrawal by Subject|4
6890531|NCT00595478|10906662|FG001|36-week Follow-up Period|Withdrawal by Subject|4
6890532|NCT00595504|10906670|FG000|Overall Study|Withdrawal by Subject|1
6890533|NCT00595504|10906671|FG001|Overall Study|Withdrawal by Subject|3
6890534|NCT00595504|10906670|FG000|Overall Study|Physician Decision|1
6890535|NCT00595504|10906671|FG001|Overall Study|Physician Decision|0
6890536|NCT00595517|10906677|FG000|Overall Study|Adverse Event|6
6890537|NCT00595517|10906677|FG000|Overall Study|Withdrawal by Subject|4
6890538|NCT00595517|10906677|FG000|Overall Study|Protocol Violation|2
6890539|NCT00595517|10906677|FG000|Overall Study|Recurrence of ulcer|5
6890540|NCT00595517|10906677|FG000|Overall Study|usage of prohibited treatment|1
6890541|NCT00595517|10906677|FG000|Overall Study|No intention to attend regularly|1
6890542|NCT00595621|10906697|FG000|Open Label Run in|Adverse Event|1
6890543|NCT00595621|10906698|FG001|Open Label Run in|Adverse Event|0
6890544|NCT00595621|10906697|FG000|Open Label Run in|Physician Decision|1
6890545|NCT00595621|10906698|FG001|Open Label Run in|Physician Decision|0
6890546|NCT00595621|10906697|FG000|Open Label Run in|Withdrawal by Subject|1
6890547|NCT00595621|10906698|FG001|Open Label Run in|Withdrawal by Subject|0
6890548|NCT00595621|10906697|FG000|Randomization and Study|Adverse Event|2
6890549|NCT00595621|10906698|FG001|Randomization and Study|Adverse Event|0
6890550|NCT00595621|10906697|FG000|Randomization and Study|Withdrawal by Subject|0
6890551|NCT00595621|10906698|FG001|Randomization and Study|Withdrawal by Subject|1
6890552|NCT00595764|10906707|FG000|Overall Study|Protocol Violation|24
6890553|NCT00595764|10906708|FG001|Overall Study|Protocol Violation|19
6890554|NCT00595764|10906707|FG000|Overall Study|Missed Medication >1 week|10
6890555|NCT00595764|10906708|FG001|Overall Study|Missed Medication >1 week|17
6890556|NCT00595764|10906707|FG000|Overall Study|Missed 3 PM visits|1
6890557|NCT00595764|10906708|FG001|Overall Study|Missed 3 PM visits|7
6890558|NCT00595764|10906707|FG000|Overall Study|Withdrawal by Subject|4
6890559|NCT00595764|10906708|FG001|Overall Study|Withdrawal by Subject|0
6890560|NCT00595868|10906729|FG000|Overall Study|Lost to Follow-up|45
6890561|NCT00595868|10906730|FG001|Overall Study|Lost to Follow-up|50
6890562|NCT00595959|10906750|FG000|Overall Study|Withdrawal by Subject|1
6890563|NCT00595959|10906750|FG000|Overall Study|Lost to Follow-up|1
6890564|NCT00596011|10906756|FG000|Overall Study|Withdrawal by Subject|2
6890565|NCT00596011|10906757|FG001|Overall Study|Withdrawal by Subject|3
6890566|NCT00596011|10906756|FG000|Overall Study|Adverse Event|11
6890567|NCT00596011|10906757|FG001|Overall Study|Adverse Event|7
6890568|NCT00596362|10906793|FG000|Overall Study|Progressive Disease|1
6890569|NCT00596427|10906799|FG000|Overall Study|Withdrawal by Subject|2
6890570|NCT00596427|10906800|FG001|Overall Study|Withdrawal by Subject|2
6890571|NCT00596427|10906799|FG000|Overall Study|Increased Fasting Triacylglycerol level|1
6890572|NCT00596427|10906800|FG001|Overall Study|Increased Fasting Triacylglycerol level|0
6890573|NCT00596427|10906799|FG000|Overall Study|Protocol Violation|1
6890574|NCT00596427|10906800|FG001|Overall Study|Protocol Violation|0
6890575|NCT00596466|10906825|FG000|Overall Study|Lack of Efficacy|5
6890576|NCT00596466|10906825|FG000|Overall Study|Adverse Event|4
6890577|NCT00596466|10906825|FG000|Overall Study|Withdrawal by Subject|2
6890578|NCT00596466|10906825|FG000|Overall Study|Protocol Violation|2
6890579|NCT00596466|10906825|FG000|Overall Study|Unpecified|2
6890580|NCT00596466|10906825|FG000|Overall Study|Enrolled, not treated|2
6890581|NCT00596635|10906844|FG000|Overall Study|Lost to Follow-up|0
6890582|NCT00596635|10906845|FG001|Overall Study|Lost to Follow-up|2
6890583|NCT00596635|10906846|FG002|Overall Study|Lost to Follow-up|0
6970549|NCT01156012|11020795|FG001|Overall Study|Withdrawal by Subject|0
6890584|NCT00596635|10906844|FG000|Overall Study|Treatment for symptomatic UTI|4
6970550|NCT01156012|11020794|FG000|Overall Study|use of commercial drug instead of study|0
6890585|NCT00596635|10906845|FG001|Overall Study|Treatment for symptomatic UTI|6
6890586|NCT00596635|10906846|FG002|Overall Study|Treatment for symptomatic UTI|3
6890587|NCT00596635|10906844|FG000|Overall Study|Hip fracture|2
6890588|NCT00596635|10906845|FG001|Overall Study|Hip fracture|3
6890589|NCT00596635|10906846|FG002|Overall Study|Hip fracture|3
6890590|NCT00596635|10906844|FG000|Overall Study|Could not provide urine specimen|1
6890591|NCT00596635|10906845|FG001|Overall Study|Could not provide urine specimen|2
6890592|NCT00596635|10906846|FG002|Overall Study|Could not provide urine specimen|2
6890593|NCT00596687|10906856|FG000|Overall Study|< 24 hours of insulin treatment|8
6890594|NCT00596687|10906857|FG001|Overall Study|< 24 hours of insulin treatment|6
6890595|NCT00596687|10906856|FG000|Overall Study|continuous insulin infusion during TPN|2
6890596|NCT00596687|10906857|FG001|Overall Study|continuous insulin infusion during TPN|1
6890597|NCT00596687|10906856|FG000|Overall Study|Withdrawal by Subject|3
6890598|NCT00596687|10906857|FG001|Overall Study|Withdrawal by Subject|1
6890599|NCT00596687|10906856|FG000|Overall Study|cancelled surgery|1
6890600|NCT00596687|10906857|FG001|Overall Study|cancelled surgery|1
6890601|NCT00596752|10906865|FG000|Overall Study|Other Reason|44
6890602|NCT00596752|10906866|FG001|Overall Study|Other Reason|49
6890603|NCT00596752|10906865|FG000|Overall Study|Adverse Event|34
6890604|NCT00596752|10906866|FG001|Overall Study|Adverse Event|34
6890605|NCT00596752|10906865|FG000|Overall Study|Lost to Follow-up|22
6890606|NCT00596752|10906866|FG001|Overall Study|Lost to Follow-up|38
6890607|NCT00596752|10906865|FG000|Overall Study|Withdrawal by Subject|12
6890608|NCT00596752|10906866|FG001|Overall Study|Withdrawal by Subject|9
6890609|NCT00596752|10906865|FG000|Overall Study|Unsatisfactory Compliance|9
6890610|NCT00596752|10906866|FG001|Overall Study|Unsatisfactory Compliance|6
6890611|NCT00596752|10906865|FG000|Overall Study|Lack of Efficacy|4
6890612|NCT00596752|10906866|FG001|Overall Study|Lack of Efficacy|7
6890613|NCT00596752|10906865|FG000|Overall Study|Protocol Violation|1
6890614|NCT00596752|10906866|FG001|Overall Study|Protocol Violation|0
6970551|NCT01156012|11020795|FG001|Overall Study|use of commercial drug instead of study|1
6970552|NCT01156012|11020794|FG000|Overall Study|Non respect of one of inclusion criteria|2
6970553|NCT01156012|11020795|FG001|Overall Study|Non respect of one of inclusion criteria|1
6970554|NCT01156051|11020803|FG000|Overall Study|Lost to Follow-up|1
6970555|NCT01156051|11020804|FG001|Overall Study|Lost to Follow-up|0
6970556|NCT01156051|11020803|FG000|Overall Study|patient not compliant with protocol|0
6970557|NCT01156051|11020804|FG001|Overall Study|patient not compliant with protocol|1
6970558|NCT01156116|11020812|FG000|Overall Study|Withdrawal by Subject|3
6970559|NCT01156116|11020813|FG001|Overall Study|Withdrawal by Subject|1
6970560|NCT01156116|11020812|FG000|Overall Study|CPAP intolerance|2
6970561|NCT01156116|11020813|FG001|Overall Study|CPAP intolerance|0
6970562|NCT01156142|11020821|FG000|Overall Study|Withdrawal by Subject|8
6970563|NCT01156142|11020822|FG001|Overall Study|Withdrawal by Subject|6
6970564|NCT01156142|11020821|FG000|Overall Study|Ineligible|0
6970565|NCT01156142|11020822|FG001|Overall Study|Ineligible|1
6970566|NCT01156311|11020830|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1
6970567|NCT01156311|11020831|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1
6970568|NCT01156311|11020832|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0
6970569|NCT01156311|11020833|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0
6970570|NCT01156311|11020830|FG000|2-Month Monotherapy Period|Physician Decision|0
6970571|NCT01156311|11020831|FG001|2-Month Monotherapy Period|Physician Decision|1
6970572|NCT01156311|11020832|FG002|2-Month Monotherapy Period|Physician Decision|0
6970573|NCT01156311|11020833|FG003|2-Month Monotherapy Period|Physician Decision|0
6970574|NCT01156311|11020830|FG000|2-Month Monotherapy Period|Other|1
6970575|NCT01156311|11020831|FG001|2-Month Monotherapy Period|Other|0
6970576|NCT01156311|11020832|FG002|2-Month Monotherapy Period|Other|0
6970577|NCT01156311|11020833|FG003|2-Month Monotherapy Period|Other|0
6970578|NCT01156311|11020830|FG000|6-month Add-on Therapy Period|Adverse Event|0
6970579|NCT01156311|11020831|FG001|6-month Add-on Therapy Period|Adverse Event|0
6970580|NCT01156311|11020832|FG002|6-month Add-on Therapy Period|Adverse Event|7
6970581|NCT01156311|11020833|FG003|6-month Add-on Therapy Period|Adverse Event|6
6970582|NCT01156311|11020830|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0
6970583|NCT01156311|11020831|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0
6970584|NCT01156311|11020832|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2
6970585|NCT01156311|11020833|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0
6970586|NCT01156311|11020830|FG000|6-month Add-on Therapy Period|Disease Activity|0
6970587|NCT01156311|11020831|FG001|6-month Add-on Therapy Period|Disease Activity|0
6970588|NCT01156311|11020832|FG002|6-month Add-on Therapy Period|Disease Activity|1
6970589|NCT01156311|11020833|FG003|6-month Add-on Therapy Period|Disease Activity|2
6970590|NCT01156311|11020830|FG000|6-month Add-on Therapy Period|Physician Decision|0
6970591|NCT01156311|11020831|FG001|6-month Add-on Therapy Period|Physician Decision|0
6970592|NCT01156311|11020832|FG002|6-month Add-on Therapy Period|Physician Decision|1
6970593|NCT01156311|11020833|FG003|6-month Add-on Therapy Period|Physician Decision|0
6970594|NCT01156311|11020830|FG000|6-month Add-on Therapy Period|Other|0
6970595|NCT01156311|11020831|FG001|6-month Add-on Therapy Period|Other|0
6970596|NCT01156311|11020832|FG002|6-month Add-on Therapy Period|Other|1
6970597|NCT01156311|11020833|FG003|6-month Add-on Therapy Period|Other|2
6970598|NCT01156363|11020844|FG000|Overall Study|Adverse Event|6
6970599|NCT01156363|11020844|FG000|Overall Study|Insufficient Therapeutic Response|5
6970600|NCT01156363|11020844|FG000|Overall Study|Failure to Return|1
6970601|NCT01156363|11020844|FG000|Overall Study|Refused Treatment|4
6970602|NCT01156363|11020844|FG000|Overall Study|Other|6
6970603|NCT01156376|11020858|FG000|Overall Study|Adverse Event|1
6970604|NCT01156376|11020859|FG001|Overall Study|Adverse Event|0
6970605|NCT01156376|11020860|FG002|Overall Study|Adverse Event|1
6970606|NCT01156376|11020858|FG000|Overall Study|Withdrawal by Subject|0
6970607|NCT01156376|11020859|FG001|Overall Study|Withdrawal by Subject|0
6890615|NCT00594386|10906872|FG000|Overall Study|Major protocol violation|2
6890616|NCT00594386|10906872|FG000|Overall Study|Lack of Efficacy|12
6890617|NCT00594386|10906872|FG000|Overall Study|Adverse Event|68
6890618|NCT00594386|10906872|FG000|Overall Study|Unsatisfactory compliance of subject|11
6890619|NCT00594386|10906872|FG000|Overall Study|Subject withdrew consent|35
6890620|NCT00594386|10906872|FG000|Overall Study|Study ended per sponsor|115
6890621|NCT00594386|10906872|FG000|Overall Study|Lost to Follow-up|6
6890622|NCT00594386|10906872|FG000|Overall Study|Other: Patient went off patch (hospital)|1
6890623|NCT00594386|10906872|FG000|Overall Study|Other: Subject moved to Seattle|1
6890624|NCT00594386|10906872|FG000|Overall Study|Other: Subject admitted to nursing home|1
6890625|NCT00594386|10906872|FG000|Overall Study|Other: Study terminated per investigator|2
6890626|NCT00594386|10906872|FG000|Overall Study|Other: Sponsor closure of study|1
6890627|NCT00594386|10906872|FG000|Overall Study|Other: Site terminated participation|1
6890628|NCT00594386|10906872|FG000|Overall Study|Other: Patient wants prescription Neupro|1
6890629|NCT00594386|10906872|FG000|Overall Study|Other: Loss of drivers license|1
6890630|NCT00596817|10906879|FG000|Open-label Period|Adverse Event|0
6890631|NCT00596817|10906880|FG001|Open-label Period|Adverse Event|49
6890632|NCT00596817|10906879|FG000|Open-label Period|Lack of Efficacy|0
6890633|NCT00596817|10906880|FG001|Open-label Period|Lack of Efficacy|33
6890634|NCT00596817|10906879|FG000|Open-label Period|Other Reasons|0
6890635|NCT00596817|10906880|FG001|Open-label Period|Other Reasons|65
6890636|NCT00596817|10906879|FG000|Open-label Period to Double-blind Period|Adverse Event|0
6890637|NCT00596817|10906880|FG001|Open-label Period to Double-blind Period|Adverse Event|5
6890638|NCT00596817|10906879|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0
6890639|NCT00596817|10906880|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24
6890640|NCT00596817|10906879|FG000|Open-label Period to Double-blind Period|Not Eligible|0
6890641|NCT00596817|10906880|FG001|Open-label Period to Double-blind Period|Not Eligible|49
6890642|NCT00596817|10906879|FG000|Open-label Period to Double-blind Period|Other Reasons|0
6890643|NCT00596817|10906880|FG001|Open-label Period to Double-blind Period|Other Reasons|14
6890644|NCT00596817|10906879|FG000|Double-blind Period|Adverse Event|5
6890645|NCT00596817|10906880|FG001|Double-blind Period|Adverse Event|16
6890646|NCT00596817|10906879|FG000|Double-blind Period|Lack of Efficacy|52
6890647|NCT00596817|10906880|FG001|Double-blind Period|Lack of Efficacy|28
6890648|NCT00596817|10906879|FG000|Double-blind Period|Non-compliance With Study Product|3
6890649|NCT00596817|10906880|FG001|Double-blind Period|Non-compliance With Study Product|4
6890650|NCT00596817|10906879|FG000|Double-blind Period|Protocol Violation|11
6890651|NCT00596817|10906880|FG001|Double-blind Period|Protocol Violation|8
6890652|NCT00596817|10906879|FG000|Double-blind Period|Withdrawal of Consent|7
6890653|NCT00596817|10906880|FG001|Double-blind Period|Withdrawal of Consent|3
6890654|NCT00596817|10906879|FG000|Double-blind Period|Lost to Follow-up|0
6890655|NCT00596817|10906880|FG001|Double-blind Period|Lost to Follow-up|2
6890656|NCT00596817|10906879|FG000|Double-blind Period|Other Reasons|10
6890657|NCT00596817|10906880|FG001|Double-blind Period|Other Reasons|18
6890658|NCT00596830|10906889|FG000|Overall Study|Death|258
6890659|NCT00596830|10906890|FG001|Overall Study|Death|247
6890660|NCT00596830|10906889|FG000|Overall Study|Lost to Follow-up|7
6890661|NCT00596830|10906890|FG001|Overall Study|Lost to Follow-up|11
6890662|NCT00596830|10906889|FG000|Overall Study|Withdrawal by Subject|22
6890663|NCT00596830|10906890|FG001|Overall Study|Withdrawal by Subject|12
6890664|NCT00596830|10906889|FG000|Overall Study|Study terminated by sponsor|51
6890665|NCT00596830|10906890|FG001|Overall Study|Study terminated by sponsor|62
6890666|NCT00596830|10906889|FG000|Overall Study|Follow-up was discontinued|1
6890667|NCT00596830|10906890|FG001|Overall Study|Follow-up was discontinued|0
6890668|NCT00596830|10906889|FG000|Overall Study|Randomized but not treated|3
6890669|NCT00596830|10906890|FG001|Overall Study|Randomized but not treated|7
6890670|NCT00596934|10906896|FG000|Overall Study|Protocol Violation|1
6890671|NCT00596934|10906896|FG000|Overall Study|Withdrawal by Subject|1
6890672|NCT00596960|10906904|FG000|Overall Study|Death|1
6890673|NCT00596960|10906905|FG001|Overall Study|Death|2
6890674|NCT00596960|10906904|FG000|Overall Study|Lost to Follow-up|6
6890675|NCT00596960|10906905|FG001|Overall Study|Lost to Follow-up|5
6890676|NCT00596960|10906904|FG000|Overall Study|Withdrawal by Subject|1
6890677|NCT00596960|10906905|FG001|Overall Study|Withdrawal by Subject|0
6890678|NCT00596960|10906904|FG000|Overall Study|Incarcerated|2
6890679|NCT00596960|10906905|FG001|Overall Study|Incarcerated|0
6890680|NCT00596960|10906904|FG000|Overall Study|Physician Decision|1
6890681|NCT00596960|10906905|FG001|Overall Study|Physician Decision|0
6890682|NCT00596960|10906904|FG000|Overall Study|Protocol Violation|0
6890683|NCT00596960|10906905|FG001|Overall Study|Protocol Violation|1
6890684|NCT00596960|10906904|FG000|Overall Study|No alcohol use data|0
6890685|NCT00596960|10906905|FG001|Overall Study|No alcohol use data|1
6890686|NCT00597012|10906913|FG000|Overall Study|Death|1
6890687|NCT00597012|10906914|FG001|Overall Study|Death|1
6890688|NCT00597012|10906913|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3
6890689|NCT00597012|10906914|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1
6890690|NCT00597012|10906913|FG000|Overall Study|Withdrawal by Subject|7
6890691|NCT00597012|10906914|FG001|Overall Study|Withdrawal by Subject|4
6890692|NCT00597012|10906913|FG000|Overall Study|Ineligible|2
6890693|NCT00597012|10906914|FG001|Overall Study|Ineligible|0
6890694|NCT00597012|10906913|FG000|Overall Study|Lost to Follow-up|0
6890695|NCT00597012|10906914|FG001|Overall Study|Lost to Follow-up|2
6890696|NCT00597116|10906935|FG000|Overall Study|Adverse Event|2
6890697|NCT00597116|10906936|FG001|Overall Study|Adverse Event|1
6890698|NCT00597116|10906935|FG000|Overall Study|Withdrawal by Subject|0
6890699|NCT00597116|10906936|FG001|Overall Study|Withdrawal by Subject|2
6890700|NCT00597116|10906935|FG000|Overall Study|Physician Decision|0
6890701|NCT00597116|10906936|FG001|Overall Study|Physician Decision|1
6890702|NCT00597116|10906935|FG000|Overall Study|Death|0
6890703|NCT00597116|10906936|FG001|Overall Study|Death|1
6890704|NCT00597116|10906935|FG000|Overall Study|Lost to Follow-up|1
6890705|NCT00597116|10906936|FG001|Overall Study|Lost to Follow-up|0
6890706|NCT00597116|10906935|FG000|Overall Study|Progressive disease|11
6890707|NCT00597116|10906936|FG001|Overall Study|Progressive disease|6
6890708|NCT00597207|10906944|FG000|Overall Study|Lost to Follow-up|5
6890709|NCT00597207|10906945|FG001|Overall Study|Lost to Follow-up|7
6890710|NCT00597376|10906986|FG000|Overall Study|Withdrawal by Subject|4
6890711|NCT00597376|10906987|FG001|Overall Study|Withdrawal by Subject|3
6890712|NCT00597376|10906986|FG000|Overall Study|Adverse Event|4
6890713|NCT00597376|10906987|FG001|Overall Study|Adverse Event|1
6890714|NCT00597506|10907014|FG000|Overall Study|Subject is being followed for survival|1
6890715|NCT00597519|10907018|FG000|Overall Study|Death|1
6890716|NCT00597584|10907037|FG000|Overall Study|Adverse Event|4
6890717|NCT00597584|10907038|FG001|Overall Study|Adverse Event|2
6890718|NCT00597584|10907037|FG000|Overall Study|Death|53
6890719|NCT00597584|10907038|FG001|Overall Study|Death|30
6890720|NCT00597584|10907037|FG000|Overall Study|Lack of Efficacy|1
6890721|NCT00597584|10907038|FG001|Overall Study|Lack of Efficacy|0
6890722|NCT00597584|10907037|FG000|Overall Study|Lost to Follow-up|2
6890723|NCT00597584|10907038|FG001|Overall Study|Lost to Follow-up|4
6890724|NCT00597584|10907037|FG000|Overall Study|Physician Decision|3
6890725|NCT00597584|10907038|FG001|Overall Study|Physician Decision|0
6890726|NCT00597584|10907037|FG000|Overall Study|Pregnancy|2
6890727|NCT00597584|10907038|FG001|Overall Study|Pregnancy|0
6890728|NCT00597584|10907037|FG000|Overall Study|Withdrawal by Subject|44
6890729|NCT00597584|10907038|FG001|Overall Study|Withdrawal by Subject|12
6890730|NCT00597584|10907037|FG000|Overall Study|Discontinued Dialysis|0
6890731|NCT00597584|10907038|FG001|Overall Study|Discontinued Dialysis|1
6890732|NCT00597584|10907037|FG000|Overall Study|Lost ability to consent|1
6890733|NCT00597584|10907038|FG001|Overall Study|Lost ability to consent|1
6890734|NCT00597584|10907037|FG000|Overall Study|Never dosed|1
6890735|NCT00597584|10907038|FG001|Overall Study|Never dosed|0
6890736|NCT00597584|10907037|FG000|Overall Study|Relocation|8
6890737|NCT00597584|10907038|FG001|Overall Study|Relocation|6
6890738|NCT00597584|10907037|FG000|Overall Study|Renal transplant|9
6890739|NCT00597584|10907038|FG001|Overall Study|Renal transplant|7
6890740|NCT00597701|10907057|FG000|Overall Study|Withdrawal by Subject|5
6890741|NCT00597701|10907058|FG001|Overall Study|Withdrawal by Subject|5
6890742|NCT00597701|10907057|FG000|Overall Study|Death|0
6890743|NCT00597701|10907058|FG001|Overall Study|Death|1
6890744|NCT00597701|10907057|FG000|Overall Study|Physician Decision|2
6890745|NCT00597701|10907058|FG001|Overall Study|Physician Decision|0
6890746|NCT00597701|10907057|FG000|Overall Study|Did not start intervention (pharmacy er)|0
6890747|NCT00597701|10907058|FG001|Overall Study|Did not start intervention (pharmacy er)|2
6890748|NCT00597714|10907066|FG000|Overall Study|Death|56
6890749|NCT00597714|10907067|FG001|Overall Study|Death|46
7079254|NCT02111174|11188132|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0
6890750|NCT00597714|10907068|FG002|Overall Study|Death|0
6890751|NCT00597714|10907066|FG000|Overall Study|Recipient death|0
6890752|NCT00597714|10907067|FG001|Overall Study|Recipient death|0
6890753|NCT00597714|10907068|FG002|Overall Study|Recipient death|10
6890754|NCT00597753|10907101|FG000|Overall Study|Adverse Event|6
6890755|NCT00597753|10907102|FG001|Overall Study|Adverse Event|2
6890756|NCT00597753|10907101|FG000|Overall Study|Death|55
6890757|NCT00597753|10907102|FG001|Overall Study|Death|29
6890758|NCT00597753|10907101|FG000|Overall Study|Lack of Efficacy|2
6890759|NCT00597753|10907102|FG001|Overall Study|Lack of Efficacy|0
6890760|NCT00597753|10907101|FG000|Overall Study|Lost to Follow-up|10
6890761|NCT00597753|10907102|FG001|Overall Study|Lost to Follow-up|3
6890762|NCT00597753|10907101|FG000|Overall Study|Physician Decision|5
6890763|NCT00597753|10907102|FG001|Overall Study|Physician Decision|1
6890764|NCT00597753|10907101|FG000|Overall Study|Pregnancy|1
6890765|NCT00597753|10907102|FG001|Overall Study|Pregnancy|0
6890766|NCT00597753|10907101|FG000|Overall Study|Withdrawal by Subject|35
6890767|NCT00597753|10907102|FG001|Overall Study|Withdrawal by Subject|12
7079255|NCT02111174|11188133|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1
7079256|NCT02111213|11188165|FG000|Overall Study|Withdrawal by Subject|3
6890768|NCT00597753|10907101|FG000|Overall Study|Discontinued Dialysis|0
6890769|NCT00597753|10907102|FG001|Overall Study|Discontinued Dialysis|1
6890770|NCT00597753|10907101|FG000|Overall Study|Never dosed|2
6890771|NCT00597753|10907102|FG001|Overall Study|Never dosed|0
6890772|NCT00597753|10907101|FG000|Overall Study|Noncompliance|2
6890773|NCT00597753|10907102|FG001|Overall Study|Noncompliance|1
6890774|NCT00597753|10907101|FG000|Overall Study|Relocation|17
6890775|NCT00597753|10907102|FG001|Overall Study|Relocation|6
6890776|NCT00597753|10907101|FG000|Overall Study|Renal transplant|10
6890777|NCT00597753|10907102|FG001|Overall Study|Renal transplant|3
6890778|NCT00597753|10907101|FG000|Overall Study|Site closed by sponsor|19
6890779|NCT00597753|10907102|FG001|Overall Study|Site closed by sponsor|7
6890780|NCT00597753|10907101|FG000|Overall Study|Site elected to close|2
6890781|NCT00597753|10907102|FG001|Overall Study|Site elected to close|4
6890782|NCT00597766|10907111|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1
6890783|NCT00597766|10907112|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0
6890784|NCT00597766|10907113|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0
6890785|NCT00597766|10907111|FG000|Follow-up 2, Week 8|Lost to Follow-up|0
6890786|NCT00597766|10907112|FG001|Follow-up 2, Week 8|Lost to Follow-up|0
6890787|NCT00597766|10907113|FG002|Follow-up 2, Week 8|Lost to Follow-up|1
6890788|NCT00598078|10907165|FG000|Period 2 (Day 2)|Adverse Event|1
6890789|NCT00598078|10907166|FG001|Period 2 (Day 2)|Adverse Event|0
6890790|NCT00598273|10907177|FG000|Overall Study|Adverse Event|4
6890791|NCT00598273|10907178|FG001|Overall Study|Adverse Event|5
6890792|NCT00598273|10907179|FG002|Overall Study|Adverse Event|2
6890793|NCT00598273|10907177|FG000|Overall Study|Death|6
6890794|NCT00598273|10907178|FG001|Overall Study|Death|12
6890795|NCT00598273|10907179|FG002|Overall Study|Death|8
6890796|NCT00598273|10907177|FG000|Overall Study|Lost to Follow-up|8
6890797|NCT00598273|10907178|FG001|Overall Study|Lost to Follow-up|3
6890798|NCT00598273|10907179|FG002|Overall Study|Lost to Follow-up|5
6890799|NCT00598273|10907177|FG000|Overall Study|Physician Decision|0
6890800|NCT00598273|10907178|FG001|Overall Study|Physician Decision|0
6890801|NCT00598273|10907179|FG002|Overall Study|Physician Decision|1
6890802|NCT00598273|10907177|FG000|Overall Study|Withdrawal by Subject|12
6890803|NCT00598273|10907178|FG001|Overall Study|Withdrawal by Subject|10
6890804|NCT00598273|10907179|FG002|Overall Study|Withdrawal by Subject|10
6890805|NCT00598273|10907177|FG000|Overall Study|Noncompliance|3
6890806|NCT00598273|10907178|FG001|Overall Study|Noncompliance|2
6890807|NCT00598273|10907179|FG002|Overall Study|Noncompliance|3
6890808|NCT00598273|10907177|FG000|Overall Study|Relocation|0
6890809|NCT00598273|10907178|FG001|Overall Study|Relocation|2
6890810|NCT00598273|10907179|FG002|Overall Study|Relocation|4
6890811|NCT00598273|10907177|FG000|Overall Study|Renal transplant|1
6890812|NCT00598273|10907178|FG001|Overall Study|Renal transplant|0
6890813|NCT00598273|10907179|FG002|Overall Study|Renal transplant|1
6890814|NCT00598273|10907177|FG000|Overall Study|Site elected to close|1
6890815|NCT00598273|10907178|FG001|Overall Study|Site elected to close|0
6890816|NCT00598273|10907179|FG002|Overall Study|Site elected to close|0
6890817|NCT00598273|10907177|FG000|Overall Study|Started dialysis|6
6890818|NCT00598273|10907178|FG001|Overall Study|Started dialysis|4
6890819|NCT00598273|10907179|FG002|Overall Study|Started dialysis|5
6890820|NCT00598442|10907190|FG000|Overall Study|Adverse Event|3
6890821|NCT00598442|10907191|FG001|Overall Study|Adverse Event|0
6890822|NCT00598442|10907192|FG002|Overall Study|Adverse Event|0
6890823|NCT00598442|10907190|FG000|Overall Study|Death|19
6890824|NCT00598442|10907191|FG001|Overall Study|Death|11
6890825|NCT00598442|10907192|FG002|Overall Study|Death|11
6890826|NCT00598442|10907190|FG000|Overall Study|Lost to Follow-up|4
6890827|NCT00598442|10907191|FG001|Overall Study|Lost to Follow-up|3
6890828|NCT00598442|10907192|FG002|Overall Study|Lost to Follow-up|3
6890829|NCT00598442|10907190|FG000|Overall Study|Physician Decision|2
6890830|NCT00598442|10907191|FG001|Overall Study|Physician Decision|1
6890831|NCT00598442|10907192|FG002|Overall Study|Physician Decision|1
6890832|NCT00598442|10907190|FG000|Overall Study|Withdrawal by Subject|8
6890833|NCT00598442|10907191|FG001|Overall Study|Withdrawal by Subject|16
6890834|NCT00598442|10907192|FG002|Overall Study|Withdrawal by Subject|6
6890835|NCT00598442|10907190|FG000|Overall Study|Noncompliance|0
6890836|NCT00598442|10907191|FG001|Overall Study|Noncompliance|2
6890837|NCT00598442|10907192|FG002|Overall Study|Noncompliance|1
6890838|NCT00598442|10907190|FG000|Overall Study|Relocation|1
6890839|NCT00598442|10907191|FG001|Overall Study|Relocation|4
6890840|NCT00598442|10907192|FG002|Overall Study|Relocation|0
6890841|NCT00598442|10907190|FG000|Overall Study|Renal transplant|0
6890842|NCT00598442|10907191|FG001|Overall Study|Renal transplant|0
6890843|NCT00598442|10907192|FG002|Overall Study|Renal transplant|1
6890844|NCT00598442|10907190|FG000|Overall Study|Site closed by sponsor|5
6890845|NCT00598442|10907191|FG001|Overall Study|Site closed by sponsor|2
6890846|NCT00598442|10907192|FG002|Overall Study|Site closed by sponsor|1
6890847|NCT00598442|10907190|FG000|Overall Study|Started dialysis|1
6890848|NCT00598442|10907191|FG001|Overall Study|Started dialysis|0
6890849|NCT00598442|10907192|FG002|Overall Study|Started dialysis|0
6890850|NCT00598481|10907200|FG000|Treatment|Physician Decision|1
6890851|NCT00598559|10907214|FG000|Overall Study|Adverse Event|11
6890852|NCT00598559|10907215|FG001|Overall Study|Adverse Event|7
6890853|NCT00598559|10907216|FG002|Overall Study|Adverse Event|0
6890854|NCT00598559|10907214|FG000|Overall Study|Withdrawal by Subject|2
6890855|NCT00598559|10907215|FG001|Overall Study|Withdrawal by Subject|2
6890856|NCT00598559|10907216|FG002|Overall Study|Withdrawal by Subject|0
6890857|NCT00598559|10907214|FG000|Overall Study|Protocol Non-compliance|1
6890858|NCT00598559|10907215|FG001|Overall Study|Protocol Non-compliance|0
6890859|NCT00598559|10907216|FG002|Overall Study|Protocol Non-compliance|0
6890860|NCT00598559|10907214|FG000|Overall Study|Early discharge from hospital|9
6890861|NCT00598559|10907215|FG001|Overall Study|Early discharge from hospital|12
6890862|NCT00598559|10907216|FG002|Overall Study|Early discharge from hospital|3
6890863|NCT00598559|10907214|FG000|Overall Study|Subject unable/unwilling to attend visit|4
6890864|NCT00598559|10907215|FG001|Overall Study|Subject unable/unwilling to attend visit|7
6890865|NCT00598559|10907216|FG002|Overall Study|Subject unable/unwilling to attend visit|0
6890866|NCT00598585|10907226|FG000|Overall Study|Lost to Follow-up|1
6890867|NCT00598585|10907227|FG001|Overall Study|Lost to Follow-up|0
6890868|NCT00598650|10907233|FG000|Overall Study|Withdrawal by Subject|3
6890869|NCT00598650|10907233|FG000|Overall Study|Adverse Event|18
6890870|NCT00598650|10907233|FG000|Overall Study|No treatment for 3 weeks|1
6890871|NCT00598650|10907233|FG000|Overall Study|Not eligible|1
6890872|NCT00598650|10907233|FG000|Overall Study|Prohibited Concomitant Medication|2
6890873|NCT00598650|10907233|FG000|Overall Study|Physician Decision|2
6890874|NCT00598702|10907267|FG000|Overall Study|Other|0
6890875|NCT00598702|10907268|FG001|Overall Study|Other|2
6890876|NCT00598702|10907269|FG002|Overall Study|Other|0
6890877|NCT00598702|10907270|FG003|Overall Study|Other|0
6890878|NCT00598702|10907271|FG004|Overall Study|Other|0
6890879|NCT00598702|10907272|FG005|Overall Study|Other|1
6970608|NCT01156376|11020860|FG002|Overall Study|Withdrawal by Subject|3
6970609|NCT01156480|11020870|FG000|Overall Study|change in diagnosis|0
6970610|NCT01156480|11020871|FG001|Overall Study|change in diagnosis|1
6970611|NCT01156532|11020879|FG000|Overall Study|Family Reasons|1
6970612|NCT01156532|11020879|FG000|Overall Study|Lost to Follow-up|1
6970613|NCT01156675|11020905|FG000|Overall Study|Death|5
6970614|NCT01156675|11020906|FG001|Overall Study|Death|3
6970615|NCT01156675|11020907|FG002|Overall Study|Death|0
6970616|NCT01156675|11020905|FG000|Overall Study|No data|29
6970617|NCT01156675|11020906|FG001|Overall Study|No data|22
6970618|NCT01156675|11020907|FG002|Overall Study|No data|2
6970619|NCT01156714|11020932|FG000|Overall Study|Withdrawal by Subject|9
6970620|NCT01156714|11020933|FG001|Overall Study|Withdrawal by Subject|4
6970621|NCT01156714|11020934|FG002|Overall Study|Withdrawal by Subject|3
6970622|NCT01156792|11020945|FG000|Overall Study|Adverse Event|1
6970623|NCT01156792|11020945|FG000|Overall Study|Lack of Efficacy|36
6970624|NCT01156792|11020945|FG000|Overall Study|Protocol Violation|6
6970625|NCT01156792|11020945|FG000|Overall Study|Lost to Follow-up|3
6970626|NCT01156792|11020945|FG000|Overall Study|Physician Decision|3
6970627|NCT01156792|11020945|FG000|Overall Study|Withdrawal by Subject|9
6970628|NCT01156792|11020945|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11
6970629|NCT01156844|11020973|FG000|Overall Study|Adverse Event|0
6970630|NCT01156844|11020974|FG001|Overall Study|Adverse Event|0
6970631|NCT01156844|11020975|FG002|Overall Study|Adverse Event|1
6970632|NCT01156844|11020976|FG003|Overall Study|Adverse Event|1
6970633|NCT01156844|11020973|FG000|Overall Study|Abnormal test procedure result(s)|0
6970634|NCT01156844|11020974|FG001|Overall Study|Abnormal test procedure result(s)|1
6970635|NCT01156844|11020975|FG002|Overall Study|Abnormal test procedure result(s)|2
6970636|NCT01156844|11020976|FG003|Overall Study|Abnormal test procedure result(s)|2
6970637|NCT01156844|11020973|FG000|Overall Study|Withdrawal by Subject|0
6970638|NCT01156844|11020974|FG001|Overall Study|Withdrawal by Subject|0
6970639|NCT01156844|11020975|FG002|Overall Study|Withdrawal by Subject|2
6970640|NCT01156844|11020976|FG003|Overall Study|Withdrawal by Subject|2
6970641|NCT01156844|11020973|FG000|Overall Study|Lost to Follow-up|0
6970642|NCT01156844|11020974|FG001|Overall Study|Lost to Follow-up|0
6970643|NCT01156844|11020975|FG002|Overall Study|Lost to Follow-up|1
6970644|NCT01156844|11020976|FG003|Overall Study|Lost to Follow-up|0
6970645|NCT01156844|11020973|FG000|Overall Study|Administrative problems|0
6970646|NCT01156844|11020974|FG001|Overall Study|Administrative problems|1
6970647|NCT01156844|11020975|FG002|Overall Study|Administrative problems|0
6970648|NCT01156844|11020976|FG003|Overall Study|Administrative problems|1
6970649|NCT01156844|11020973|FG000|Overall Study|Protocol deviation|2
6970650|NCT01156844|11020974|FG001|Overall Study|Protocol deviation|0
6970651|NCT01156844|11020975|FG002|Overall Study|Protocol deviation|0
6970652|NCT01156844|11020976|FG003|Overall Study|Protocol deviation|0
6970653|NCT01157065|11021000|FG000|Overall Study|Death|0
6970654|NCT01157065|11021001|FG001|Overall Study|Death|1
6970655|NCT01157078|11021009|FG000|Overall Study|Withdrawal by Subject|12
6970656|NCT01157078|11021010|FG001|Overall Study|Withdrawal by Subject|14
6970657|NCT01157078|11021009|FG000|Overall Study|Eligibility criteria not fulfilled|2
6970658|NCT01157078|11021010|FG001|Overall Study|Eligibility criteria not fulfilled|0
6970659|NCT01157078|11021009|FG000|Overall Study|Adverse Event|6
6970660|NCT01157078|11021010|FG001|Overall Study|Adverse Event|6
6970661|NCT01157078|11021009|FG000|Overall Study|Severe non-compliance to protocol|2
6970662|NCT01157078|11021010|FG001|Overall Study|Severe non-compliance to protocol|4
6970663|NCT01157078|11021009|FG000|Overall Study|Condition under investigation worsened|0
6970664|NCT01157078|11021010|FG001|Overall Study|Condition under investigation worsened|1
6970665|NCT01157078|11021009|FG000|Overall Study|Lack of Efficacy|2
6970666|NCT01157078|11021010|FG001|Overall Study|Lack of Efficacy|0
6970667|NCT01157078|11021009|FG000|Overall Study|Study-specific withdrawal criteria|2
6970668|NCT01157078|11021010|FG001|Overall Study|Study-specific withdrawal criteria|2
6970669|NCT01157078|11021009|FG000|Overall Study|Lost to Follow-up|7
6970670|NCT01157078|11021010|FG001|Overall Study|Lost to Follow-up|5
6970671|NCT01157078|11021009|FG000|Overall Study|Other|2
6970672|NCT01157078|11021010|FG001|Overall Study|Other|4
6970673|NCT01157117|11021019|FG000|Overall Study|Dosing Symptoms|0
6970674|NCT01157117|11021020|FG001|Overall Study|Dosing Symptoms|4
6970675|NCT01157117|11021021|FG002|Overall Study|Dosing Symptoms|0
6890880|NCT00598702|10907273|FG006|Overall Study|Other|0
6890881|NCT00598702|10907274|FG007|Overall Study|Other|0
6970676|NCT01157117|11021019|FG000|Overall Study|Withdrawal by Subject|4
6890882|NCT00598702|10907267|FG000|Overall Study|Early discharge from hospital|0
6890883|NCT00598702|10907268|FG001|Overall Study|Early discharge from hospital|0
6890884|NCT00598702|10907269|FG002|Overall Study|Early discharge from hospital|2
6890885|NCT00598702|10907270|FG003|Overall Study|Early discharge from hospital|5
6890886|NCT00598702|10907271|FG004|Overall Study|Early discharge from hospital|0
6890887|NCT00598702|10907272|FG005|Overall Study|Early discharge from hospital|10
6890888|NCT00598702|10907273|FG006|Overall Study|Early discharge from hospital|1
6890889|NCT00598702|10907274|FG007|Overall Study|Early discharge from hospital|0
6890890|NCT00598702|10907267|FG000|Overall Study|Adverse Event|0
6890891|NCT00598702|10907268|FG001|Overall Study|Adverse Event|0
6890892|NCT00598702|10907269|FG002|Overall Study|Adverse Event|0
6890893|NCT00598702|10907270|FG003|Overall Study|Adverse Event|1
6890894|NCT00598702|10907271|FG004|Overall Study|Adverse Event|0
6890895|NCT00598702|10907272|FG005|Overall Study|Adverse Event|0
6890896|NCT00598702|10907273|FG006|Overall Study|Adverse Event|0
6890897|NCT00598702|10907274|FG007|Overall Study|Adverse Event|0
6890898|NCT00598702|10907267|FG000|Overall Study|Withdrawal by Subject|0
6890899|NCT00598702|10907268|FG001|Overall Study|Withdrawal by Subject|0
6890900|NCT00598702|10907269|FG002|Overall Study|Withdrawal by Subject|0
6890901|NCT00598702|10907270|FG003|Overall Study|Withdrawal by Subject|1
6890902|NCT00598702|10907271|FG004|Overall Study|Withdrawal by Subject|1
6890903|NCT00598702|10907272|FG005|Overall Study|Withdrawal by Subject|0
6890904|NCT00598702|10907273|FG006|Overall Study|Withdrawal by Subject|0
6890905|NCT00598702|10907274|FG007|Overall Study|Withdrawal by Subject|0
6890906|NCT00598702|10907267|FG000|Overall Study|Physician Decision|0
6890907|NCT00598702|10907268|FG001|Overall Study|Physician Decision|0
6890908|NCT00598702|10907269|FG002|Overall Study|Physician Decision|0
6890909|NCT00598702|10907270|FG003|Overall Study|Physician Decision|0
6890910|NCT00598702|10907271|FG004|Overall Study|Physician Decision|1
6890911|NCT00598702|10907272|FG005|Overall Study|Physician Decision|0
6890912|NCT00598702|10907273|FG006|Overall Study|Physician Decision|0
6890913|NCT00598702|10907274|FG007|Overall Study|Physician Decision|0
6890914|NCT00598702|10907267|FG000|Overall Study|Dose limiting toxicity|0
6890915|NCT00598702|10907268|FG001|Overall Study|Dose limiting toxicity|0
6890916|NCT00598702|10907269|FG002|Overall Study|Dose limiting toxicity|0
6890917|NCT00598702|10907270|FG003|Overall Study|Dose limiting toxicity|1
6890918|NCT00598702|10907271|FG004|Overall Study|Dose limiting toxicity|1
6890919|NCT00598702|10907272|FG005|Overall Study|Dose limiting toxicity|1
6890920|NCT00598702|10907273|FG006|Overall Study|Dose limiting toxicity|0
6890921|NCT00598702|10907274|FG007|Overall Study|Dose limiting toxicity|0
6890922|NCT00598832|10907307|FG000|Overall Study|Lack of Efficacy|3
6890923|NCT00598832|10907308|FG001|Overall Study|Lack of Efficacy|7
6890924|NCT00598832|10907307|FG000|Overall Study|Adverse Event|6
6890925|NCT00598832|10907308|FG001|Overall Study|Adverse Event|2
6890926|NCT00598832|10907307|FG000|Overall Study|Withdrawal by Subject|25
6890927|NCT00598832|10907308|FG001|Overall Study|Withdrawal by Subject|36
6890928|NCT00598832|10907307|FG000|Overall Study|Protocol Violation|0
6890929|NCT00598832|10907308|FG001|Overall Study|Protocol Violation|2
6890930|NCT00598832|10907307|FG000|Overall Study|Lost to Follow-up|24
6890931|NCT00598832|10907308|FG001|Overall Study|Lost to Follow-up|29
6890932|NCT00598832|10907307|FG000|Overall Study|Pregnancy|2
6890933|NCT00598832|10907308|FG001|Overall Study|Pregnancy|2
6890934|NCT00598832|10907307|FG000|Overall Study|Physician Decision|1
6890935|NCT00598832|10907308|FG001|Overall Study|Physician Decision|4
6890936|NCT00598832|10907307|FG000|Overall Study|Non compliance|1
6890937|NCT00598832|10907308|FG001|Overall Study|Non compliance|0
6890938|NCT00598871|10907316|FG000|Overall Study|Adverse Event|0
6890939|NCT00598871|10907317|FG001|Overall Study|Adverse Event|1
6890940|NCT00598975|10907325|FG000|Overall Study|Adverse Event|1
6890941|NCT00598975|10907326|FG001|Overall Study|Adverse Event|1
6890942|NCT00598975|10907325|FG000|Overall Study|Brain metastases|1
6890943|NCT00598975|10907326|FG001|Overall Study|Brain metastases|0
6890944|NCT00598975|10907325|FG000|Overall Study|Withdrawal by Subject|1
6890945|NCT00598975|10907326|FG001|Overall Study|Withdrawal by Subject|1
6890946|NCT00598975|10907325|FG000|Overall Study|Withdrawal of consent|0
6890947|NCT00598975|10907326|FG001|Overall Study|Withdrawal of consent|1
6890948|NCT00598975|10907325|FG000|Overall Study|Disease progression|8
6890949|NCT00598975|10907326|FG001|Overall Study|Disease progression|3
6890950|NCT00598975|10907325|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1
6890951|NCT00598975|10907326|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0
6890952|NCT00599196|10907347|FG000|Overall Study|Lack of Efficacy|22
6890953|NCT00599196|10907347|FG000|Overall Study|Adverse Event|93
6890954|NCT00599196|10907347|FG000|Overall Study|Unsatisfactory compliance of subject|3
6890955|NCT00599196|10907347|FG000|Overall Study|Subject withdrew consent|43
6890956|NCT00599196|10907347|FG000|Overall Study|Study ended per sponsor|197
6890957|NCT00599196|10907347|FG000|Overall Study|Lost to Follow-up|17
6890958|NCT00599196|10907347|FG000|Overall Study|Other: Patient Leaving For Israel|1
6890959|NCT00599196|10907347|FG000|Overall Study|Other: Spouse Withdrew Consent|1
6890960|NCT00599196|10907347|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1
6890961|NCT00599196|10907347|FG000|Overall Study|Other: Pt Moved To Australia|1
6890962|NCT00599196|10907347|FG000|Overall Study|Other: Patient Stopped Due To Moving|1
6890963|NCT00599196|10907347|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1
6890964|NCT00599313|10907365|FG000|Overall Study|Adverse Event|19
6890965|NCT00599313|10907365|FG000|Overall Study|Disease Progression|12
6890966|NCT00599313|10907365|FG000|Overall Study|Patient Request|4
6890967|NCT00599313|10907365|FG000|Overall Study|Ineligible|1
6890968|NCT00599326|10907369|FG000|Overall Study|Lost to Follow-up|1
6890969|NCT00599326|10907369|FG000|Overall Study|Noncompliant|1
6890970|NCT00599339|10907373|FG000|Overall Study|Adverse Event|79
6890971|NCT00599339|10907373|FG000|Overall Study|Withdrawal by Subject|137
6890972|NCT00599339|10907373|FG000|Overall Study|Other Reason|179
6890973|NCT00599339|10907373|FG000|Overall Study|Lost to Follow-up|221
6890974|NCT00599339|10907373|FG000|Overall Study|No valid data consent|36
6890975|NCT00599339|10907373|FG000|Overall Study|Study Termination Status Unknown|12
6890976|NCT00599521|10907397|FG000|Overall Study|Lack of Efficacy|4
6890977|NCT00599521|10907398|FG001|Overall Study|Lack of Efficacy|8
6890978|NCT00599521|10907397|FG000|Overall Study|Adverse Event|4
6890979|NCT00599521|10907398|FG001|Overall Study|Adverse Event|1
6890980|NCT00599521|10907397|FG000|Overall Study|Withdrawal by Subject|28
6890981|NCT00599521|10907398|FG001|Overall Study|Withdrawal by Subject|34
6890982|NCT00599521|10907397|FG000|Overall Study|Protocol Violation|1
6890983|NCT00599521|10907398|FG001|Overall Study|Protocol Violation|1
6890984|NCT00599521|10907397|FG000|Overall Study|Lost to Follow-up|23
6890985|NCT00599521|10907398|FG001|Overall Study|Lost to Follow-up|23
6890986|NCT00599521|10907397|FG000|Overall Study|Pregnancy|0
6890987|NCT00599521|10907398|FG001|Overall Study|Pregnancy|2
6890988|NCT00599638|10907408|FG000|First Intervention Period (2 Weeks)|Adverse Event|1
6890989|NCT00599638|10907409|FG001|First Intervention Period (2 Weeks)|Adverse Event|0
6890990|NCT00599638|10907410|FG002|First Intervention Period (2 Weeks)|Adverse Event|3
6890991|NCT00599638|10907411|FG003|First Intervention Period (2 Weeks)|Adverse Event|2
6890992|NCT00599638|10907408|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1
6890993|NCT00599638|10907409|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0
6890994|NCT00599638|10907410|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0
6890995|NCT00599638|10907411|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1
6890996|NCT00599638|10907408|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0
6890997|NCT00599638|10907409|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1
6890998|NCT00599638|10907410|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0
6890999|NCT00599638|10907411|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1
6891000|NCT00599638|10907408|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0
6891001|NCT00599638|10907409|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1
6891002|NCT00599638|10907410|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0
6891003|NCT00599638|10907411|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1
6891004|NCT00599638|10907408|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1
6891005|NCT00599638|10907409|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0
6891006|NCT00599638|10907410|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0
6891007|NCT00599638|10907411|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1
6891008|NCT00599638|10907408|FG000|Washout Period (2 Weeks)|Adverse Event|0
6891009|NCT00599638|10907409|FG001|Washout Period (2 Weeks)|Adverse Event|0
6891010|NCT00599638|10907410|FG002|Washout Period (2 Weeks)|Adverse Event|0
6891011|NCT00599638|10907411|FG003|Washout Period (2 Weeks)|Adverse Event|1
6891012|NCT00599638|10907408|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0
6891013|NCT00599638|10907409|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0
6891014|NCT00599638|10907410|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0
6891015|NCT00599638|10907411|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1
6891016|NCT00599638|10907408|FG000|Washout Period (2 Weeks)|Protocol Violation|0
6891017|NCT00599638|10907409|FG001|Washout Period (2 Weeks)|Protocol Violation|1
6891018|NCT00599638|10907410|FG002|Washout Period (2 Weeks)|Protocol Violation|0
6891019|NCT00599638|10907411|FG003|Washout Period (2 Weeks)|Protocol Violation|0
6891020|NCT00599638|10907408|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1
6891021|NCT00599638|10907409|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0
6891022|NCT00599638|10907410|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0
6891023|NCT00599638|10907411|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0
6891024|NCT00599755|10907419|FG000|Overall Study|Adverse Event|11
6891025|NCT00599755|10907419|FG000|Overall Study|Withdrawal by Subject|2
6891026|NCT00599755|10907419|FG000|Overall Study|Progression of Disease|3
6891027|NCT00599755|10907419|FG000|Overall Study|Other Reason|2
6891028|NCT00599755|10907419|FG000|Overall Study|No data available|1
6891029|NCT00599924|10907443|FG000|Overall Study|Lack of Efficacy|3
6891030|NCT00599924|10907444|FG001|Overall Study|Lack of Efficacy|5
6891031|NCT00599924|10907445|FG002|Overall Study|Lack of Efficacy|1
6891032|NCT00599924|10907446|FG003|Overall Study|Lack of Efficacy|2
6891033|NCT00599924|10907447|FG004|Overall Study|Lack of Efficacy|3
6891034|NCT00599924|10907448|FG005|Overall Study|Lack of Efficacy|2
6891035|NCT00599924|10907449|FG006|Overall Study|Lack of Efficacy|0
6891036|NCT00599924|10907443|FG000|Overall Study|Adverse Event|0
6891037|NCT00599924|10907444|FG001|Overall Study|Adverse Event|0
6891038|NCT00599924|10907445|FG002|Overall Study|Adverse Event|0
6891039|NCT00599924|10907446|FG003|Overall Study|Adverse Event|2
6891040|NCT00599924|10907447|FG004|Overall Study|Adverse Event|0
6891041|NCT00599924|10907448|FG005|Overall Study|Adverse Event|0
6891042|NCT00599924|10907449|FG006|Overall Study|Adverse Event|2
6891043|NCT00599924|10907443|FG000|Overall Study|Death|0
6891044|NCT00599924|10907444|FG001|Overall Study|Death|0
6891045|NCT00599924|10907445|FG002|Overall Study|Death|0
6891046|NCT00599924|10907446|FG003|Overall Study|Death|2
6891047|NCT00599924|10907447|FG004|Overall Study|Death|0
6891048|NCT00599924|10907448|FG005|Overall Study|Death|2
6891049|NCT00599924|10907449|FG006|Overall Study|Death|1
6891050|NCT00599924|10907443|FG000|Overall Study|Protocol Violation|0
6891051|NCT00599924|10907444|FG001|Overall Study|Protocol Violation|0
6891052|NCT00599924|10907445|FG002|Overall Study|Protocol Violation|0
6891053|NCT00599924|10907446|FG003|Overall Study|Protocol Violation|1
6891054|NCT00599924|10907447|FG004|Overall Study|Protocol Violation|0
6891055|NCT00599924|10907448|FG005|Overall Study|Protocol Violation|0
6891056|NCT00599924|10907449|FG006|Overall Study|Protocol Violation|0
6891057|NCT00599924|10907443|FG000|Overall Study|Withdrawal by Subject|0
6891058|NCT00599924|10907444|FG001|Overall Study|Withdrawal by Subject|0
6891059|NCT00599924|10907445|FG002|Overall Study|Withdrawal by Subject|1
6891060|NCT00599924|10907446|FG003|Overall Study|Withdrawal by Subject|0
6891061|NCT00599924|10907447|FG004|Overall Study|Withdrawal by Subject|1
6891062|NCT00599924|10907448|FG005|Overall Study|Withdrawal by Subject|0
6891063|NCT00599924|10907449|FG006|Overall Study|Withdrawal by Subject|0
6891064|NCT00599924|10907443|FG000|Overall Study|Other|0
6891065|NCT00599924|10907444|FG001|Overall Study|Other|0
6891066|NCT00599924|10907445|FG002|Overall Study|Other|0
6891067|NCT00599924|10907446|FG003|Overall Study|Other|1
6891068|NCT00599924|10907447|FG004|Overall Study|Other|2
6891069|NCT00599924|10907448|FG005|Overall Study|Other|0
6891070|NCT00599924|10907449|FG006|Overall Study|Other|2
6891071|NCT00600028|10907472|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1
6891072|NCT00600028|10907473|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0
6891073|NCT00600028|10907472|FG000|First Intervention (12 Weeks)|Adverse Event|0
6891074|NCT00600028|10907473|FG001|First Intervention (12 Weeks)|Adverse Event|1
6891075|NCT00600028|10907472|FG000|Second Intervention (12 Weeks)|Adverse Event|0
6891076|NCT00600028|10907473|FG001|Second Intervention (12 Weeks)|Adverse Event|2
6891077|NCT00600067|10907484|FG000|Overall Study|Adverse Event|0
6891078|NCT00600067|10907485|FG001|Overall Study|Adverse Event|1
6891079|NCT00600067|10907484|FG000|Overall Study|Lost to Follow-up|2
6891080|NCT00600067|10907485|FG001|Overall Study|Lost to Follow-up|3
6891081|NCT00600067|10907484|FG000|Overall Study|protocol non-compliance|0
6891082|NCT00600067|10907485|FG001|Overall Study|protocol non-compliance|3
6891083|NCT00600067|10907484|FG000|Overall Study|Lack of Efficacy|1
6891084|NCT00600067|10907485|FG001|Overall Study|Lack of Efficacy|0
6891085|NCT00600106|10907501|FG000|Overall Study|Withdrawal by Subject|1
6891086|NCT00600106|10907502|FG001|Overall Study|Withdrawal by Subject|1
6891087|NCT00600119|10907514|FG000|Single-blind Placebo run-in Period|Other - Not specified|1
6891088|NCT00600119|10907515|FG001|Single-blind Placebo run-in Period|Other - Not specified|0
6891089|NCT00600119|10907516|FG002|Single-blind Placebo run-in Period|Other - Not specified|0
6891090|NCT00600119|10907517|FG003|Single-blind Placebo run-in Period|Other - Not specified|0
6891091|NCT00600119|10907518|FG004|Single-blind Placebo run-in Period|Other - Not specified|1
6891092|NCT00600119|10907519|FG005|Single-blind Placebo run-in Period|Other - Not specified|1
6891093|NCT00600119|10907514|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
6891094|NCT00600119|10907515|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
6891095|NCT00600119|10907516|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
6891096|NCT00600119|10907517|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
6891097|NCT00600119|10907518|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
6891098|NCT00600119|10907519|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
6891099|NCT00600119|10907514|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0
6891100|NCT00600119|10907515|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0
6891101|NCT00600119|10907516|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1
6891102|NCT00600119|10907517|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0
6891103|NCT00600119|10907518|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1
6891104|NCT00600119|10907519|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0
6891105|NCT00600119|10907514|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1
6891106|NCT00600119|10907515|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0
6891107|NCT00600119|10907516|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0
6891108|NCT00600119|10907517|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0
6891109|NCT00600119|10907518|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0
6891110|NCT00600119|10907519|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0
6891111|NCT00600119|10907514|FG000|Single-blind Placebo run-in Period|Adverse Event|0
6891112|NCT00600119|10907515|FG001|Single-blind Placebo run-in Period|Adverse Event|0
6891113|NCT00600119|10907516|FG002|Single-blind Placebo run-in Period|Adverse Event|0
6891114|NCT00600119|10907517|FG003|Single-blind Placebo run-in Period|Adverse Event|1
6891115|NCT00600119|10907518|FG004|Single-blind Placebo run-in Period|Adverse Event|0
6891116|NCT00600119|10907519|FG005|Single-blind Placebo run-in Period|Adverse Event|1
6891117|NCT00600119|10907514|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2
6891118|NCT00600119|10907515|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1
6891119|NCT00600119|10907516|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0
6891120|NCT00600119|10907517|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0
6891121|NCT00600119|10907518|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0
6891122|NCT00600119|10907519|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0
6891123|NCT00600119|10907514|FG000|Double-blind Treatment Period|Withdrawal by Subject|2
6891124|NCT00600119|10907515|FG001|Double-blind Treatment Period|Withdrawal by Subject|0
6891125|NCT00600119|10907516|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
6891126|NCT00600119|10907517|FG003|Double-blind Treatment Period|Withdrawal by Subject|1
6891127|NCT00600119|10907518|FG004|Double-blind Treatment Period|Withdrawal by Subject|0
6891128|NCT00600119|10907519|FG005|Double-blind Treatment Period|Withdrawal by Subject|3
6891129|NCT00600119|10907514|FG000|Double-blind Treatment Period|Other|0
6891130|NCT00600119|10907515|FG001|Double-blind Treatment Period|Other|0
6891131|NCT00600119|10907516|FG002|Double-blind Treatment Period|Other|0
6891132|NCT00600119|10907517|FG003|Double-blind Treatment Period|Other|0
6891133|NCT00600119|10907518|FG004|Double-blind Treatment Period|Other|2
6891134|NCT00600119|10907519|FG005|Double-blind Treatment Period|Other|1
6891135|NCT00600119|10907514|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
6891136|NCT00600119|10907515|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
6891137|NCT00600119|10907516|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
6891138|NCT00600119|10907517|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
6891139|NCT00600119|10907518|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
6891140|NCT00600119|10907519|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
6891141|NCT00600119|10907514|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
6891142|NCT00600119|10907515|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1
6891143|NCT00600119|10907516|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
6891144|NCT00600119|10907517|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
6891145|NCT00600119|10907518|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
6891146|NCT00600119|10907519|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
6891147|NCT00600119|10907514|FG000|Double-blind Treatment Period|Sponsor Decision|0
6891148|NCT00600119|10907515|FG001|Double-blind Treatment Period|Sponsor Decision|1
6891149|NCT00600119|10907516|FG002|Double-blind Treatment Period|Sponsor Decision|0
6891150|NCT00600119|10907517|FG003|Double-blind Treatment Period|Sponsor Decision|0
6891151|NCT00600119|10907518|FG004|Double-blind Treatment Period|Sponsor Decision|1
6891152|NCT00600119|10907519|FG005|Double-blind Treatment Period|Sponsor Decision|0
6891153|NCT00600119|10907514|FG000|Double-blind Treatment Period|Physician Decision|2
6891154|NCT00600119|10907515|FG001|Double-blind Treatment Period|Physician Decision|0
6891155|NCT00600119|10907516|FG002|Double-blind Treatment Period|Physician Decision|0
6891156|NCT00600119|10907517|FG003|Double-blind Treatment Period|Physician Decision|0
6891157|NCT00600119|10907518|FG004|Double-blind Treatment Period|Physician Decision|0
6891158|NCT00600119|10907519|FG005|Double-blind Treatment Period|Physician Decision|0
6891159|NCT00600119|10907514|FG000|Double-blind Treatment Period|Lost to Follow-up|0
6891160|NCT00600119|10907515|FG001|Double-blind Treatment Period|Lost to Follow-up|1
6891161|NCT00600119|10907516|FG002|Double-blind Treatment Period|Lost to Follow-up|0
6891162|NCT00600119|10907517|FG003|Double-blind Treatment Period|Lost to Follow-up|0
6891163|NCT00600119|10907518|FG004|Double-blind Treatment Period|Lost to Follow-up|0
6891164|NCT00600119|10907519|FG005|Double-blind Treatment Period|Lost to Follow-up|0
6891165|NCT00600119|10907514|FG000|Double-blind Treatment Period|Adverse Event|1
6891166|NCT00600119|10907515|FG001|Double-blind Treatment Period|Adverse Event|1
6891167|NCT00600119|10907516|FG002|Double-blind Treatment Period|Adverse Event|0
6891168|NCT00600119|10907517|FG003|Double-blind Treatment Period|Adverse Event|1
6891169|NCT00600119|10907518|FG004|Double-blind Treatment Period|Adverse Event|2
6891170|NCT00600119|10907519|FG005|Double-blind Treatment Period|Adverse Event|10
6891171|NCT00600119|10907514|FG000|Follow-up Period|Adverse Event|0
6891172|NCT00600119|10907515|FG001|Follow-up Period|Adverse Event|0
6891173|NCT00600119|10907516|FG002|Follow-up Period|Adverse Event|0
6891174|NCT00600119|10907517|FG003|Follow-up Period|Adverse Event|0
6891175|NCT00600119|10907518|FG004|Follow-up Period|Adverse Event|0
6891176|NCT00600119|10907519|FG005|Follow-up Period|Adverse Event|1
6891177|NCT00600119|10907514|FG000|Follow-up Period|Other|1
6891178|NCT00600119|10907515|FG001|Follow-up Period|Other|0
6891179|NCT00600119|10907516|FG002|Follow-up Period|Other|0
6891180|NCT00600119|10907517|FG003|Follow-up Period|Other|0
6891181|NCT00600119|10907518|FG004|Follow-up Period|Other|0
6891182|NCT00600119|10907519|FG005|Follow-up Period|Other|0
6891183|NCT00600171|10907539|FG000|Overall Study|Adverse Event|0
6891184|NCT00600171|10907540|FG001|Overall Study|Adverse Event|1
6891185|NCT00600171|10907541|FG002|Overall Study|Adverse Event|0
6891186|NCT00600171|10907542|FG003|Overall Study|Adverse Event|0
6891187|NCT00600171|10907543|FG004|Overall Study|Adverse Event|1
6891188|NCT00600171|10907544|FG005|Overall Study|Adverse Event|0
6891189|NCT00600171|10907539|FG000|Overall Study|Lack of Efficacy|9
6891190|NCT00600171|10907540|FG001|Overall Study|Lack of Efficacy|12
6891191|NCT00600171|10907541|FG002|Overall Study|Lack of Efficacy|3
6891192|NCT00600171|10907542|FG003|Overall Study|Lack of Efficacy|5
6891193|NCT00600171|10907543|FG004|Overall Study|Lack of Efficacy|4
6891194|NCT00600171|10907544|FG005|Overall Study|Lack of Efficacy|0
6891195|NCT00600171|10907539|FG000|Overall Study|Protocol Violation|1
6891196|NCT00600171|10907540|FG001|Overall Study|Protocol Violation|2
6891197|NCT00600171|10907541|FG002|Overall Study|Protocol Violation|0
6891198|NCT00600171|10907542|FG003|Overall Study|Protocol Violation|1
6891199|NCT00600171|10907543|FG004|Overall Study|Protocol Violation|0
6891200|NCT00600171|10907544|FG005|Overall Study|Protocol Violation|0
6891201|NCT00600171|10907539|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3
6891202|NCT00600171|10907540|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1
6891203|NCT00600171|10907541|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7
6891204|NCT00600171|10907542|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3
6891205|NCT00600171|10907543|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2
6891206|NCT00600171|10907544|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2
6891207|NCT00600171|10907539|FG000|Overall Study|Withdrawal by Subject|3
6891208|NCT00600171|10907540|FG001|Overall Study|Withdrawal by Subject|0
6891209|NCT00600171|10907541|FG002|Overall Study|Withdrawal by Subject|0
6891210|NCT00600171|10907542|FG003|Overall Study|Withdrawal by Subject|1
6891211|NCT00600171|10907543|FG004|Overall Study|Withdrawal by Subject|1
6891212|NCT00600171|10907544|FG005|Overall Study|Withdrawal by Subject|1
6891213|NCT00600171|10907539|FG000|Overall Study|Physician Decision|0
6891214|NCT00600171|10907540|FG001|Overall Study|Physician Decision|1
6891215|NCT00600171|10907541|FG002|Overall Study|Physician Decision|0
6891216|NCT00600171|10907542|FG003|Overall Study|Physician Decision|1
6891217|NCT00600171|10907543|FG004|Overall Study|Physician Decision|0
6891218|NCT00600171|10907544|FG005|Overall Study|Physician Decision|2
6891219|NCT00600171|10907539|FG000|Overall Study|Lost to Follow-up|0
6891220|NCT00600171|10907540|FG001|Overall Study|Lost to Follow-up|0
6891221|NCT00600171|10907541|FG002|Overall Study|Lost to Follow-up|0
6891222|NCT00600171|10907542|FG003|Overall Study|Lost to Follow-up|1
6891223|NCT00600171|10907543|FG004|Overall Study|Lost to Follow-up|0
6891224|NCT00600171|10907544|FG005|Overall Study|Lost to Follow-up|0
6891225|NCT00600353|10907571|FG000|Overall Study|history of malignancy within 5 years|1
6891226|NCT00600353|10907572|FG001|Overall Study|history of malignancy within 5 years|0
6891227|NCT00600353|10907571|FG000|Overall Study|History of prepartive regimen|0
6891228|NCT00600353|10907572|FG001|Overall Study|History of prepartive regimen|1
6891229|NCT00600613|10907578|FG000|Overall Study|Protocol Deviation|1
6891230|NCT00600756|10907619|FG000|Analysis After 6 Months|Adverse Event|43
6891231|NCT00600756|10907620|FG001|Analysis After 6 Months|Adverse Event|33
6891232|NCT00600756|10907619|FG000|Analysis After 6 Months|Withdrawal by Subject|38
6891233|NCT00600756|10907620|FG001|Analysis After 6 Months|Withdrawal by Subject|30
6891234|NCT00600756|10907619|FG000|Analysis After 6 Months|Incorrect Enrollment|12
6891235|NCT00600756|10907620|FG001|Analysis After 6 Months|Incorrect Enrollment|21
6891236|NCT00600756|10907619|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11
6891237|NCT00600756|10907620|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14
6891238|NCT00600756|10907619|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11
6891239|NCT00600756|10907620|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11
6891240|NCT00600756|10907619|FG000|Analysis After 6 Months|Lost to Follow-up|10
6891241|NCT00600756|10907620|FG001|Analysis After 6 Months|Lost to Follow-up|8
6891242|NCT00600756|10907619|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6
6891243|NCT00600756|10907620|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3
6891244|NCT00600756|10907619|FG000|Overall Study Analysis After 12 Months|Adverse Event|53
6891245|NCT00600756|10907620|FG001|Overall Study Analysis After 12 Months|Adverse Event|44
6891246|NCT00600756|10907619|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51
6891247|NCT00600756|10907620|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41
6891248|NCT00600756|10907619|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21
6891249|NCT00600756|10907620|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29
6891250|NCT00600756|10907619|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17
6891251|NCT00600756|10907620|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20
6891252|NCT00600756|10907619|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16
6891253|NCT00600756|10907620|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20
6891254|NCT00600756|10907619|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16
6891255|NCT00600756|10907620|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13
6891256|NCT00600756|10907619|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
6891257|NCT00600756|10907620|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
6891258|NCT00600821|10907628|FG000|Overall Study|Death|45
6891259|NCT00600821|10907629|FG001|Overall Study|Death|46
6891260|NCT00600821|10907628|FG000|Overall Study|Lost to Follow-up|2
6891261|NCT00600821|10907629|FG001|Overall Study|Lost to Follow-up|2
6891262|NCT00600821|10907628|FG000|Overall Study|Withdrawal by Subject|1
6891263|NCT00600821|10907629|FG001|Overall Study|Withdrawal by Subject|1
6891264|NCT00600821|10907628|FG000|Overall Study|Terminated by sponsor|8
6891265|NCT00600821|10907629|FG001|Overall Study|Terminated by sponsor|6
6891266|NCT00600821|10907628|FG000|Overall Study|Objective progression or relapse|0
6891267|NCT00600821|10907629|FG001|Overall Study|Objective progression or relapse|1
6891268|NCT00600821|10907628|FG000|Overall Study|Randomized but not treated|0
6970677|NCT01157117|11021020|FG001|Overall Study|Withdrawal by Subject|1
6970678|NCT01157117|11021021|FG002|Overall Study|Withdrawal by Subject|1
6970679|NCT01157117|11021019|FG000|Overall Study|Lack of Efficacy|1
6970680|NCT01157117|11021020|FG001|Overall Study|Lack of Efficacy|1
6970681|NCT01157117|11021021|FG002|Overall Study|Lack of Efficacy|0
6970682|NCT01157117|11021019|FG000|Overall Study|Lost to Follow-up|0
6970683|NCT01157117|11021020|FG001|Overall Study|Lost to Follow-up|0
6970684|NCT01157117|11021021|FG002|Overall Study|Lost to Follow-up|1
6970685|NCT01157117|11021019|FG000|Overall Study|Unknown (Pending Final Form Submission)|4
6970686|NCT01157117|11021020|FG001|Overall Study|Unknown (Pending Final Form Submission)|5
6970687|NCT01157117|11021021|FG002|Overall Study|Unknown (Pending Final Form Submission)|13
6891269|NCT00600821|10907629|FG001|Overall Study|Randomized but not treated|1
6891270|NCT00600821|10907628|FG000|Overall Study|Other|2
6891271|NCT00600821|10907629|FG001|Overall Study|Other|3
6891272|NCT00600886|10907639|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14
6891273|NCT00600886|10907640|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6
6891274|NCT00600886|10907639|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7
6891275|NCT00600886|10907640|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8
6891276|NCT00600886|10907639|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5
6891277|NCT00600886|10907640|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8
6891278|NCT00600886|10907639|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5
6891279|NCT00600886|10907640|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3
6891280|NCT00600886|10907639|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2
6891281|NCT00600886|10907640|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0
6891282|NCT00600886|10907639|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1
6891283|NCT00600886|10907640|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0
6891284|NCT00600886|10907639|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1
6891285|NCT00600886|10907640|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0
6891286|NCT00600886|10907639|FG000|Core Phase - Full Analysis Set (FAS)|Death|0
6891287|NCT00600886|10907640|FG001|Core Phase - Full Analysis Set (FAS)|Death|1
6891288|NCT00600886|10907639|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16
6891289|NCT00600886|10907640|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2
6891290|NCT00600886|10907639|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3
6891291|NCT00600886|10907640|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3
6891292|NCT00600886|10907639|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9
6891293|NCT00600886|10907640|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3
6891294|NCT00600886|10907639|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3
6891295|NCT00600886|10907640|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1
6891296|NCT00600886|10907639|FG000|Extension - Same Treatment (FAS)|Adverse Event|4
6891297|NCT00600886|10907640|FG001|Extension - Same Treatment (FAS)|Adverse Event|1
6891298|NCT00600886|10907639|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4
6891299|NCT00600886|10907640|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0
6891300|NCT00600886|10907639|FG000|Extension - Same Treatment (FAS)|Death|1
6891301|NCT00600886|10907640|FG001|Extension - Same Treatment (FAS)|Death|1
6891302|NCT00600886|10907639|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6
6891303|NCT00600886|10907640|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0
6891304|NCT00600886|10907639|FG000|Extension - After Crossover (CAS)|Adverse Event|19
6891305|NCT00600886|10907640|FG001|Extension - After Crossover (CAS)|Adverse Event|1
6891306|NCT00600886|10907639|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19
6891307|NCT00600886|10907640|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4
6891308|NCT00600886|10907639|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13
6891309|NCT00600886|10907640|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4
6891310|NCT00600886|10907639|FG000|Extension - After Crossover (CAS)|Administrative Problems|4
6891311|NCT00600886|10907640|FG001|Extension - After Crossover (CAS)|Administrative Problems|4
6891312|NCT00600886|10907639|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3
6891313|NCT00600886|10907640|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0
6891314|NCT00600886|10907639|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3
6891315|NCT00600886|10907640|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0
6891316|NCT00600886|10907639|FG000|Extension - After Crossover (CAS)|Death|1
6891317|NCT00600886|10907640|FG001|Extension - After Crossover (CAS)|Death|0
6891318|NCT00600938|10907671|FG000|Core Study|Abnormal test procedure result(s)|3
6891319|NCT00600938|10907672|FG001|Core Study|Abnormal test procedure result(s)|2
6891320|NCT00600938|10907673|FG002|Core Study|Abnormal test procedure result(s)|0
6891321|NCT00600938|10907674|FG003|Core Study|Abnormal test procedure result(s)|0
6891322|NCT00600938|10907671|FG000|Core Study|Unsatisfactory therapeutic effect|1
6891323|NCT00600938|10907672|FG001|Core Study|Unsatisfactory therapeutic effect|2
6891324|NCT00600938|10907673|FG002|Core Study|Unsatisfactory therapeutic effect|0
6891325|NCT00600938|10907674|FG003|Core Study|Unsatisfactory therapeutic effect|0
6891326|NCT00600938|10907671|FG000|Core Study|Patient withdrew consent|7
6891327|NCT00600938|10907672|FG001|Core Study|Patient withdrew consent|12
6891328|NCT00600938|10907673|FG002|Core Study|Patient withdrew consent|0
6891329|NCT00600938|10907674|FG003|Core Study|Patient withdrew consent|0
6891330|NCT00600938|10907671|FG000|Core Study|Lost to Follow-up|3
6891331|NCT00600938|10907672|FG001|Core Study|Lost to Follow-up|2
6891332|NCT00600938|10907673|FG002|Core Study|Lost to Follow-up|0
6891333|NCT00600938|10907674|FG003|Core Study|Lost to Follow-up|0
6891334|NCT00600938|10907671|FG000|Core Study|Death|1
6891335|NCT00600938|10907672|FG001|Core Study|Death|1
6891336|NCT00600938|10907673|FG002|Core Study|Death|0
6891337|NCT00600938|10907674|FG003|Core Study|Death|0
6891338|NCT00600938|10907671|FG000|Core Study|Protocol Violation|1
6891339|NCT00600938|10907672|FG001|Core Study|Protocol Violation|2
6891340|NCT00600938|10907673|FG002|Core Study|Protocol Violation|0
6891341|NCT00600938|10907674|FG003|Core Study|Protocol Violation|0
6891342|NCT00600938|10907671|FG000|Extension Study|Adverse Event|1
6891343|NCT00600938|10907672|FG001|Extension Study|Adverse Event|0
6891344|NCT00600938|10907673|FG002|Extension Study|Adverse Event|2
6891345|NCT00600938|10907674|FG003|Extension Study|Adverse Event|0
6891346|NCT00600938|10907671|FG000|Extension Study|Abnormal test procedure results|0
6891347|NCT00600938|10907672|FG001|Extension Study|Abnormal test procedure results|1
6891348|NCT00600938|10907673|FG002|Extension Study|Abnormal test procedure results|1
6891349|NCT00600938|10907674|FG003|Extension Study|Abnormal test procedure results|1
6891350|NCT00600938|10907671|FG000|Extension Study|Unsatisfactory therapeutic effect|4
6891351|NCT00600938|10907672|FG001|Extension Study|Unsatisfactory therapeutic effect|1
6891352|NCT00600938|10907673|FG002|Extension Study|Unsatisfactory therapeutic effect|1
6891353|NCT00600938|10907674|FG003|Extension Study|Unsatisfactory therapeutic effect|0
6891354|NCT00600938|10907671|FG000|Extension Study|Withdrawal by Subject|2
6891355|NCT00600938|10907672|FG001|Extension Study|Withdrawal by Subject|2
6891356|NCT00600938|10907673|FG002|Extension Study|Withdrawal by Subject|3
6891357|NCT00600938|10907674|FG003|Extension Study|Withdrawal by Subject|0
6891358|NCT00600938|10907671|FG000|Extension Study|Lost to Follow-up|1
6891359|NCT00600938|10907672|FG001|Extension Study|Lost to Follow-up|1
6891360|NCT00600938|10907673|FG002|Extension Study|Lost to Follow-up|2
6891361|NCT00600938|10907674|FG003|Extension Study|Lost to Follow-up|0
6891362|NCT00600938|10907671|FG000|Extension Study|Death|1
6891363|NCT00600938|10907672|FG001|Extension Study|Death|0
6891364|NCT00600938|10907673|FG002|Extension Study|Death|0
6891365|NCT00600938|10907674|FG003|Extension Study|Death|0
6891366|NCT00601107|10907703|FG000|Overall Study|Adverse Event|0
6891367|NCT00601107|10907704|FG001|Overall Study|Adverse Event|1
6891368|NCT00601107|10907705|FG002|Overall Study|Adverse Event|3
6891369|NCT00601107|10907706|FG003|Overall Study|Adverse Event|0
6891370|NCT00601107|10907703|FG000|Overall Study|Withdrawal by Subject|5
6891371|NCT00601107|10907704|FG001|Overall Study|Withdrawal by Subject|4
6891372|NCT00601107|10907705|FG002|Overall Study|Withdrawal by Subject|7
6891373|NCT00601107|10907706|FG003|Overall Study|Withdrawal by Subject|4
6891374|NCT00601107|10907703|FG000|Overall Study|Lost to Follow-up|3
6891375|NCT00601107|10907704|FG001|Overall Study|Lost to Follow-up|3
6891376|NCT00601107|10907705|FG002|Overall Study|Lost to Follow-up|0
6891377|NCT00601107|10907706|FG003|Overall Study|Lost to Follow-up|3
6891378|NCT00601107|10907703|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
6891379|NCT00601107|10907704|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
6891380|NCT00601107|10907705|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
6891381|NCT00601107|10907706|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1
6891382|NCT00601107|10907703|FG000|Overall Study|Worsening of Psoriasis|4
6891383|NCT00601107|10907704|FG001|Overall Study|Worsening of Psoriasis|1
6891384|NCT00601107|10907705|FG002|Overall Study|Worsening of Psoriasis|1
6891385|NCT00601107|10907706|FG003|Overall Study|Worsening of Psoriasis|4
6891386|NCT00601107|10907703|FG000|Overall Study|Undefined|1
6891387|NCT00601107|10907704|FG001|Overall Study|Undefined|0
6891388|NCT00601107|10907705|FG002|Overall Study|Undefined|1
6891389|NCT00601107|10907706|FG003|Overall Study|Undefined|0
6891390|NCT00601172|10907722|FG000|Overall Study|Adverse Event|43
6891391|NCT00601172|10907723|FG001|Overall Study|Adverse Event|32
6891392|NCT00601172|10907722|FG000|Overall Study|Lack of Efficacy|11
6891393|NCT00601172|10907723|FG001|Overall Study|Lack of Efficacy|12
6891394|NCT00601172|10907722|FG000|Overall Study|Protocol Violation|2
6891395|NCT00601172|10907723|FG001|Overall Study|Protocol Violation|5
6891396|NCT00601172|10907722|FG000|Overall Study|Lost to Follow-up|4
6891397|NCT00601172|10907723|FG001|Overall Study|Lost to Follow-up|3
6891398|NCT00601172|10907722|FG000|Overall Study|Physician Decision|27
6891399|NCT00601172|10907723|FG001|Overall Study|Physician Decision|28
6891400|NCT00601172|10907722|FG000|Overall Study|Withdrawal by Subject|35
6891401|NCT00601172|10907723|FG001|Overall Study|Withdrawal by Subject|27
6891402|NCT00601172|10907722|FG000|Overall Study|Did not meet continuation criteria|19
6891403|NCT00601172|10907723|FG001|Overall Study|Did not meet continuation criteria|20
6891404|NCT00601250|10907732|FG000|Overall Study|Adverse Event|3
6891405|NCT00601250|10907733|FG001|Overall Study|Adverse Event|9
6891406|NCT00601250|10907732|FG000|Overall Study|Protocol Violation|3
6891407|NCT00601250|10907733|FG001|Overall Study|Protocol Violation|2
6891408|NCT00601250|10907732|FG000|Overall Study|Lost to Follow-up|2
6891409|NCT00601250|10907733|FG001|Overall Study|Lost to Follow-up|6
6891410|NCT00601250|10907732|FG000|Overall Study|Withdrawal by Subject|4
6977002|NCT01203930|11029959|FG000|Overall Study|Investigator Request|0
6891411|NCT00601250|10907733|FG001|Overall Study|Withdrawal by Subject|13
6891412|NCT00601250|10907732|FG000|Overall Study|Other incl. lack of efficacy|2
6891413|NCT00601250|10907733|FG001|Overall Study|Other incl. lack of efficacy|9
6891414|NCT00601354|10907741|FG000|Overall Study|Lost to Follow-up|4
6891415|NCT00601354|10907742|FG001|Overall Study|Lost to Follow-up|5
6891416|NCT00601419|10907752|FG000|Overall Study|Lost to Follow-up|3
6891417|NCT00601419|10907752|FG000|Overall Study|Missed Visits|1
6891418|NCT00601458|10907775|FG000|Overall Study|Dosing Error|1
6891419|NCT00601458|10907776|FG001|Overall Study|Dosing Error|0
6891420|NCT00601458|10907777|FG002|Overall Study|Dosing Error|0
6891421|NCT00601458|10907775|FG000|Overall Study|Incomplete Data|0
6891422|NCT00601458|10907776|FG001|Overall Study|Incomplete Data|2
6891423|NCT00601458|10907777|FG002|Overall Study|Incomplete Data|0
6891424|NCT00601458|10907775|FG000|Overall Study|Protocol Violation|3
6891425|NCT00601458|10907776|FG001|Overall Study|Protocol Violation|2
6891426|NCT00601458|10907777|FG002|Overall Study|Protocol Violation|1
6891427|NCT00601458|10907775|FG000|Overall Study|Early Termination|0
6891428|NCT00601458|10907776|FG001|Overall Study|Early Termination|1
6891429|NCT00601458|10907777|FG002|Overall Study|Early Termination|1
6891430|NCT00601484|10907787|FG000|Overall Study|Adverse Event|0
6891431|NCT00601484|10907788|FG001|Overall Study|Adverse Event|1
6891432|NCT00601484|10907787|FG000|Overall Study|Lost to Follow-up|4
6891433|NCT00601484|10907788|FG001|Overall Study|Lost to Follow-up|3
6891434|NCT00601484|10907787|FG000|Overall Study|Lack of Efficacy|0
6891435|NCT00601484|10907788|FG001|Overall Study|Lack of Efficacy|2
6891436|NCT00601484|10907787|FG000|Overall Study|Withdrawal by Subject|1
6891437|NCT00601484|10907788|FG001|Overall Study|Withdrawal by Subject|1
6891438|NCT00601484|10907787|FG000|Overall Study|Randomized, but not treated|0
6891439|NCT00601484|10907788|FG001|Overall Study|Randomized, but not treated|1
6891440|NCT00601523|10907796|FG000|Overall Study|Adverse Event|42
6891441|NCT00601523|10907797|FG001|Overall Study|Adverse Event|14
6891442|NCT00601523|10907796|FG000|Overall Study|Lack of Efficacy|3
6891443|NCT00601523|10907797|FG001|Overall Study|Lack of Efficacy|0
6891444|NCT00601523|10907796|FG000|Overall Study|Protocol Violation|5
6891445|NCT00601523|10907797|FG001|Overall Study|Protocol Violation|1
6891446|NCT00601523|10907796|FG000|Overall Study|Lost to Follow-up|0
6891447|NCT00601523|10907797|FG001|Overall Study|Lost to Follow-up|1
6891448|NCT00601523|10907796|FG000|Overall Study|Withdrawal by Subject|18
6891449|NCT00601523|10907797|FG001|Overall Study|Withdrawal by Subject|9
6891450|NCT00601523|10907796|FG000|Overall Study|Other|9
6891451|NCT00601523|10907797|FG001|Overall Study|Other|1
6891452|NCT00601640|10907810|FG000|Overall Study|Withdrawal by Subject|3
6891453|NCT00601640|10907811|FG001|Overall Study|Withdrawal by Subject|0
6891454|NCT00601640|10907812|FG002|Overall Study|Withdrawal by Subject|7
6891455|NCT00601640|10907810|FG000|Overall Study|Death|1
6891456|NCT00601640|10907811|FG001|Overall Study|Death|0
6891457|NCT00601640|10907812|FG002|Overall Study|Death|0
6891458|NCT00601640|10907810|FG000|Overall Study|Adverse Event|0
6891459|NCT00601640|10907811|FG001|Overall Study|Adverse Event|4
6891460|NCT00601640|10907812|FG002|Overall Study|Adverse Event|2
6891461|NCT00601640|10907810|FG000|Overall Study|intercurrent illness|1
6891462|NCT00601640|10907811|FG001|Overall Study|intercurrent illness|0
6891463|NCT00601640|10907812|FG002|Overall Study|intercurrent illness|0
6891464|NCT00601640|10907810|FG000|Overall Study|change in eligibility status|0
6891465|NCT00601640|10907811|FG001|Overall Study|change in eligibility status|1
6891466|NCT00601640|10907812|FG002|Overall Study|change in eligibility status|1
6891467|NCT00601705|10907822|FG000|Overall Study|Withdrawal by Subject|1
6891468|NCT00601835|10907878|FG000|Overall Study|Withdrawal by Subject|9
6891469|NCT00601835|10907879|FG001|Overall Study|Withdrawal by Subject|6
6891470|NCT00601835|10907878|FG000|Overall Study|Physician Decision|1
6891471|NCT00601835|10907879|FG001|Overall Study|Physician Decision|0
6891472|NCT00601835|10907878|FG000|Overall Study|Lost to Follow-up|37
6891473|NCT00601835|10907879|FG001|Overall Study|Lost to Follow-up|5
7041328|NCT01726023|11124865|FG000|Overall Study|Other Eligibility criteria|7
7041329|NCT01726023|11124866|FG001|Overall Study|Other Eligibility criteria|7
7041330|NCT01726023|11124865|FG000|Overall Study|Withdrawal by Subject|16
7041331|NCT01726023|11124866|FG001|Overall Study|Withdrawal by Subject|8
6891474|NCT00601835|10907878|FG000|Overall Study|Adverse Event|1
6891475|NCT00601835|10907879|FG001|Overall Study|Adverse Event|1
6891476|NCT00601835|10907878|FG000|Overall Study|Relocate|12
6891477|NCT00601835|10907879|FG001|Overall Study|Relocate|2
6891478|NCT00602420|10907955|FG000|Overall Study|Death|1
6891479|NCT00602420|10907956|FG001|Overall Study|Death|4
6891480|NCT00602420|10907955|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5
6891481|NCT00602420|10907956|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3
6891482|NCT00602420|10907955|FG000|Overall Study|Withdrawal by Subject|18
6891483|NCT00602420|10907956|FG001|Overall Study|Withdrawal by Subject|17
6891484|NCT00602420|10907955|FG000|Overall Study|Adverse Event|1
6891485|NCT00602420|10907956|FG001|Overall Study|Adverse Event|0
6891486|NCT00602472|10907968|FG000|Overall Study|Adverse Event|5
6891487|NCT00602472|10907969|FG001|Overall Study|Adverse Event|23
6891488|NCT00602472|10907968|FG000|Overall Study|Protocol Violation|4
6891489|NCT00602472|10907969|FG001|Overall Study|Protocol Violation|19
7041332|NCT01726049|11124890|FG000|Overall Study|Death|1
7041333|NCT01726049|11124891|FG001|Overall Study|Death|1
6891490|NCT00602472|10907968|FG000|Overall Study|Withdrawal by Subject|8
6891491|NCT00602472|10907969|FG001|Overall Study|Withdrawal by Subject|14
6891492|NCT00602472|10907968|FG000|Overall Study|Other incl. lack of efficacy|4
6891493|NCT00602472|10907969|FG001|Overall Study|Other incl. lack of efficacy|2
6970688|NCT01157169|11021031|FG000|First Intervention|Emesis Within 4 hrs of Administration|4
6970689|NCT01157169|11021032|FG001|First Intervention|Emesis Within 4 hrs of Administration|2
6970690|NCT01157169|11021031|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0
6970691|NCT01157169|11021032|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1
6970692|NCT01157182|11021040|FG000|Washout of 28 Days|Adverse Event|2
6891494|NCT00602537|10907977|FG000|12 Week Double Blind Comparison|Adverse Event|2
6891495|NCT00602537|10907978|FG001|12 Week Double Blind Comparison|Adverse Event|5
6891496|NCT00602537|10907977|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13
6891497|NCT00602537|10907978|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23
6891498|NCT00602537|10907977|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5
6891499|NCT00602537|10907978|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6
6891500|NCT00602537|10907977|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3
6891501|NCT00602537|10907978|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13
6891502|NCT00602537|10907977|FG000|Follow Up Study Comparison|Adverse Event|1
6891503|NCT00602537|10907978|FG001|Follow Up Study Comparison|Adverse Event|0
6891504|NCT00602537|10907977|FG000|Follow Up Study Comparison|Lost to Follow-up|8
6891505|NCT00602537|10907978|FG001|Follow Up Study Comparison|Lost to Follow-up|1
6891506|NCT00602537|10907977|FG000|Follow Up Study Comparison|Withdrawal by Subject|2
6891507|NCT00602537|10907978|FG001|Follow Up Study Comparison|Withdrawal by Subject|2
6891508|NCT00602797|10907993|FG000|Overall Study|Adverse Event|1
6891509|NCT00602927|10908004|FG000|Period 1: 13 Days|Protocol Violation|2
6891510|NCT00602927|10908005|FG001|Period 1: 13 Days|Protocol Violation|4
6891511|NCT00602927|10908004|FG000|Period 1: 13 Days|MRI scanner technical issue|1
6891512|NCT00602927|10908005|FG001|Period 1: 13 Days|MRI scanner technical issue|0
6891513|NCT00602927|10908004|FG000|Period 1: 13 Days|Time|1
6891514|NCT00602927|10908005|FG001|Period 1: 13 Days|Time|0
6891515|NCT00602927|10908004|FG000|Period 1: 13 Days|Claustrophobia|0
6891516|NCT00602927|10908005|FG001|Period 1: 13 Days|Claustrophobia|1
6891517|NCT00602927|10908004|FG000|Period 2: 14 Days|Protocol Violation|0
6891518|NCT00602927|10908005|FG001|Period 2: 14 Days|Protocol Violation|2
6891519|NCT00602927|10908004|FG000|Period 3: 13 Days|Protocol Violation|0
6891520|NCT00602927|10908005|FG001|Period 3: 13 Days|Protocol Violation|1
6891521|NCT00602927|10908004|FG000|Period 3: 13 Days|MRI data quality|2
6891522|NCT00602927|10908005|FG001|Period 3: 13 Days|MRI data quality|2
6891523|NCT00602979|10908037|FG000|Overall Study|Lost to Follow-up|3
6891524|NCT00602979|10908038|FG001|Overall Study|Lost to Follow-up|2
6891525|NCT00602979|10908039|FG002|Overall Study|Lost to Follow-up|3
6891526|NCT00602979|10908040|FG003|Overall Study|Lost to Follow-up|2
6891527|NCT00602979|10908041|FG004|Overall Study|Lost to Follow-up|3
6891528|NCT00602979|10908037|FG000|Overall Study|Failed Intubation|0
6891529|NCT00602979|10908038|FG001|Overall Study|Failed Intubation|1
6891530|NCT00602979|10908039|FG002|Overall Study|Failed Intubation|0
6891531|NCT00602979|10908040|FG003|Overall Study|Failed Intubation|1
6891532|NCT00602979|10908041|FG004|Overall Study|Failed Intubation|0
6891533|NCT00603239|10908073|FG000|Overall Study|Adverse Event|4
6891534|NCT00603239|10908074|FG001|Overall Study|Adverse Event|1
6891535|NCT00603239|10908073|FG000|Overall Study|Entry criteria not met|0
6891536|NCT00603239|10908074|FG001|Overall Study|Entry criteria not met|1
6891537|NCT00603239|10908073|FG000|Overall Study|Loss of glucose control|3
6891538|NCT00603239|10908074|FG001|Overall Study|Loss of glucose control|0
6891539|NCT00603239|10908073|FG000|Overall Study|Lost to Follow-up|2
6891540|NCT00603239|10908074|FG001|Overall Study|Lost to Follow-up|1
6891541|NCT00603239|10908073|FG000|Overall Study|Physician Decision|2
6891542|NCT00603239|10908074|FG001|Overall Study|Physician Decision|0
6891543|NCT00603239|10908073|FG000|Overall Study|Protocol Violation|2
6891544|NCT00603239|10908074|FG001|Overall Study|Protocol Violation|0
6891545|NCT00603239|10908073|FG000|Overall Study|Subject decision|2
6891546|NCT00603239|10908074|FG001|Overall Study|Subject decision|1
6891547|NCT00603265|10908083|FG000|Overall Study|Adverse Event|2
6891548|NCT00603265|10908084|FG001|Overall Study|Adverse Event|11
6891549|NCT00603265|10908085|FG002|Overall Study|Adverse Event|1
6891550|NCT00603265|10908083|FG000|Overall Study|Withdrawal by Subject|1
6891551|NCT00603265|10908084|FG001|Overall Study|Withdrawal by Subject|2
6891552|NCT00603265|10908085|FG002|Overall Study|Withdrawal by Subject|1
6891553|NCT00603265|10908083|FG000|Overall Study|Lack of Efficacy|3
6891554|NCT00603265|10908084|FG001|Overall Study|Lack of Efficacy|0
6891555|NCT00603265|10908085|FG002|Overall Study|Lack of Efficacy|3
6891556|NCT00603265|10908083|FG000|Overall Study|Lost to Follow-up|0
6891557|NCT00603265|10908084|FG001|Overall Study|Lost to Follow-up|1
6891558|NCT00603265|10908085|FG002|Overall Study|Lost to Follow-up|0
6891559|NCT00603265|10908083|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0
6891560|NCT00603265|10908084|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1
6891561|NCT00603265|10908085|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0
6891562|NCT00603265|10908083|FG000|Overall Study|Participant Left Country, No Responses|0
6891563|NCT00603265|10908084|FG001|Overall Study|Participant Left Country, No Responses|1
6891564|NCT00603265|10908085|FG002|Overall Study|Participant Left Country, No Responses|0
6891565|NCT00603265|10908083|FG000|Overall Study|Protocol Violation|1
6891566|NCT00603265|10908084|FG001|Overall Study|Protocol Violation|0
6891567|NCT00603265|10908085|FG002|Overall Study|Protocol Violation|0
6891568|NCT00603278|10908099|FG000|Overall Study|Lack of Efficacy|35
6891569|NCT00603278|10908100|FG001|Overall Study|Lack of Efficacy|10
6891570|NCT00603278|10908101|FG002|Overall Study|Lack of Efficacy|11
6891571|NCT00603278|10908102|FG003|Overall Study|Lack of Efficacy|8
6891572|NCT00603278|10908103|FG004|Overall Study|Lack of Efficacy|7
6891573|NCT00603278|10908104|FG005|Overall Study|Lack of Efficacy|14
6891574|NCT00603278|10908099|FG000|Overall Study|Adverse Event|0
6891575|NCT00603278|10908100|FG001|Overall Study|Adverse Event|3
6891576|NCT00603278|10908101|FG002|Overall Study|Adverse Event|1
6891577|NCT00603278|10908102|FG003|Overall Study|Adverse Event|0
6891578|NCT00603278|10908103|FG004|Overall Study|Adverse Event|2
6891579|NCT00603278|10908104|FG005|Overall Study|Adverse Event|1
6891580|NCT00603278|10908099|FG000|Overall Study|Withdrawal by Subject|2
6891581|NCT00603278|10908100|FG001|Overall Study|Withdrawal by Subject|3
6891582|NCT00603278|10908101|FG002|Overall Study|Withdrawal by Subject|1
6891583|NCT00603278|10908102|FG003|Overall Study|Withdrawal by Subject|2
6891584|NCT00603278|10908103|FG004|Overall Study|Withdrawal by Subject|1
6891585|NCT00603278|10908104|FG005|Overall Study|Withdrawal by Subject|2
6891586|NCT00603278|10908099|FG000|Overall Study|Protocol Violation|3
6891587|NCT00603278|10908100|FG001|Overall Study|Protocol Violation|0
6891588|NCT00603278|10908101|FG002|Overall Study|Protocol Violation|1
6891589|NCT00603278|10908102|FG003|Overall Study|Protocol Violation|1
6891590|NCT00603278|10908103|FG004|Overall Study|Protocol Violation|0
6891591|NCT00603278|10908104|FG005|Overall Study|Protocol Violation|1
6891592|NCT00603278|10908099|FG000|Overall Study|Physician Decision|0
6891593|NCT00603278|10908100|FG001|Overall Study|Physician Decision|1
6891594|NCT00603278|10908101|FG002|Overall Study|Physician Decision|0
6891595|NCT00603278|10908102|FG003|Overall Study|Physician Decision|0
6891596|NCT00603278|10908103|FG004|Overall Study|Physician Decision|2
6891597|NCT00603278|10908104|FG005|Overall Study|Physician Decision|1
6891598|NCT00603278|10908099|FG000|Overall Study|Lost to Follow-up|1
6891599|NCT00603278|10908100|FG001|Overall Study|Lost to Follow-up|0
6891600|NCT00603278|10908101|FG002|Overall Study|Lost to Follow-up|0
6891601|NCT00603278|10908102|FG003|Overall Study|Lost to Follow-up|0
6891602|NCT00603278|10908103|FG004|Overall Study|Lost to Follow-up|1
6891603|NCT00603278|10908104|FG005|Overall Study|Lost to Follow-up|0
6891604|NCT00603304|10908133|FG000|Overall Study|Lost to Follow-up|5
6891605|NCT00603304|10908134|FG001|Overall Study|Lost to Follow-up|7
6891606|NCT00603304|10908133|FG000|Overall Study|Withdrawal by Subject|8
6891607|NCT00603304|10908134|FG001|Overall Study|Withdrawal by Subject|5
6891608|NCT00603304|10908133|FG000|Overall Study|Protocol Violation|1
6891609|NCT00603304|10908134|FG001|Overall Study|Protocol Violation|0
6891610|NCT00603304|10908133|FG000|Overall Study|Adverse Event|4
6891611|NCT00603304|10908134|FG001|Overall Study|Adverse Event|2
6891612|NCT00603304|10908133|FG000|Overall Study|Unacceptable Treatment Toxicity|5
6891613|NCT00603304|10908134|FG001|Overall Study|Unacceptable Treatment Toxicity|8
6891614|NCT00603304|10908133|FG000|Overall Study|Crossed Over to Open Label Therapy|3
6891615|NCT00603304|10908134|FG001|Overall Study|Crossed Over to Open Label Therapy|3
6891616|NCT00603304|10908133|FG000|Overall Study|Exclusionary Medication|2
6891617|NCT00603304|10908134|FG001|Overall Study|Exclusionary Medication|3
6891618|NCT00603304|10908133|FG000|Overall Study|Non-Compliant|0
6891619|NCT00603304|10908134|FG001|Overall Study|Non-Compliant|1
6891620|NCT00603304|10908133|FG000|Overall Study|Moved Away|0
6891621|NCT00603304|10908134|FG001|Overall Study|Moved Away|2
6891622|NCT00603304|10908133|FG000|Overall Study|Other|2
6891623|NCT00603304|10908134|FG001|Overall Study|Other|0
6891624|NCT00603304|10908133|FG000|Overall Study|Patient Decision|2
6891625|NCT00603304|10908134|FG001|Overall Study|Patient Decision|0
6891626|NCT00603382|10908148|FG000|Overall Study|Adverse Event|0
6891627|NCT00603382|10908149|FG001|Overall Study|Adverse Event|1
6891628|NCT00603382|10908150|FG002|Overall Study|Adverse Event|1
6891629|NCT00603382|10908151|FG003|Overall Study|Adverse Event|2
6891630|NCT00603382|10908152|FG004|Overall Study|Adverse Event|1
6891631|NCT00603382|10908153|FG005|Overall Study|Adverse Event|2
6891632|NCT00603382|10908148|FG000|Overall Study|Lack of Efficacy|14
6891633|NCT00603382|10908149|FG001|Overall Study|Lack of Efficacy|9
6891634|NCT00603382|10908150|FG002|Overall Study|Lack of Efficacy|3
6891635|NCT00603382|10908151|FG003|Overall Study|Lack of Efficacy|6
6891636|NCT00603382|10908152|FG004|Overall Study|Lack of Efficacy|6
6891637|NCT00603382|10908153|FG005|Overall Study|Lack of Efficacy|11
6891638|NCT00603382|10908148|FG000|Overall Study|Protocol Violation|1
6891639|NCT00603382|10908149|FG001|Overall Study|Protocol Violation|0
6891640|NCT00603382|10908150|FG002|Overall Study|Protocol Violation|1
6891641|NCT00603382|10908151|FG003|Overall Study|Protocol Violation|2
6891642|NCT00603382|10908152|FG004|Overall Study|Protocol Violation|1
6891643|NCT00603382|10908153|FG005|Overall Study|Protocol Violation|0
6891644|NCT00603382|10908148|FG000|Overall Study|Lost to Follow-up|0
6891645|NCT00603382|10908149|FG001|Overall Study|Lost to Follow-up|1
6891646|NCT00603382|10908150|FG002|Overall Study|Lost to Follow-up|1
6891647|NCT00603382|10908151|FG003|Overall Study|Lost to Follow-up|1
6891648|NCT00603382|10908152|FG004|Overall Study|Lost to Follow-up|0
6891649|NCT00603382|10908153|FG005|Overall Study|Lost to Follow-up|1
6891650|NCT00603382|10908148|FG000|Overall Study|Physician Decision|0
6891651|NCT00603382|10908149|FG001|Overall Study|Physician Decision|0
6891652|NCT00603382|10908150|FG002|Overall Study|Physician Decision|2
6891653|NCT00603382|10908151|FG003|Overall Study|Physician Decision|0
6891654|NCT00603382|10908152|FG004|Overall Study|Physician Decision|1
6891655|NCT00603382|10908153|FG005|Overall Study|Physician Decision|3
6891656|NCT00603382|10908148|FG000|Overall Study|Withdrawal by Subject|3
6891657|NCT00603382|10908149|FG001|Overall Study|Withdrawal by Subject|3
6891658|NCT00603382|10908150|FG002|Overall Study|Withdrawal by Subject|1
6891659|NCT00603382|10908151|FG003|Overall Study|Withdrawal by Subject|1
6891660|NCT00603382|10908152|FG004|Overall Study|Withdrawal by Subject|0
6891661|NCT00603382|10908153|FG005|Overall Study|Withdrawal by Subject|1
6891662|NCT00603447|10908179|FG000|Overall Study|Adverse Event|0
6891663|NCT00603447|10908180|FG001|Overall Study|Adverse Event|1
6891664|NCT00603447|10908181|FG002|Overall Study|Adverse Event|1
6891665|NCT00603447|10908182|FG003|Overall Study|Adverse Event|2
7079257|NCT02111213|11188166|FG001|Overall Study|Withdrawal by Subject|2
7079258|NCT02111213|11188165|FG000|Overall Study|Lost to Follow-up|3
7079259|NCT02111213|11188166|FG001|Overall Study|Lost to Follow-up|4
7079260|NCT02111369|11188176|FG000|Overall Study|Lost to Follow-up|2
6891666|NCT00603447|10908183|FG004|Overall Study|Adverse Event|1
6891667|NCT00603447|10908184|FG005|Overall Study|Adverse Event|2
6891668|NCT00603447|10908185|FG006|Overall Study|Adverse Event|10
6891669|NCT00603447|10908179|FG000|Overall Study|Other|0
6891670|NCT00603447|10908180|FG001|Overall Study|Other|0
6891671|NCT00603447|10908181|FG002|Overall Study|Other|1
6891672|NCT00603447|10908182|FG003|Overall Study|Other|0
6891673|NCT00603447|10908183|FG004|Overall Study|Other|3
6891674|NCT00603447|10908184|FG005|Overall Study|Other|0
6891675|NCT00603447|10908185|FG006|Overall Study|Other|13
6891676|NCT00603447|10908179|FG000|Overall Study|Withdrew Consent|0
6891677|NCT00603447|10908180|FG001|Overall Study|Withdrew Consent|2
6891678|NCT00603447|10908181|FG002|Overall Study|Withdrew Consent|0
6891679|NCT00603447|10908182|FG003|Overall Study|Withdrew Consent|0
6891680|NCT00603447|10908183|FG004|Overall Study|Withdrew Consent|1
6891681|NCT00603447|10908184|FG005|Overall Study|Withdrew Consent|0
6891682|NCT00603447|10908185|FG006|Overall Study|Withdrew Consent|1
6891683|NCT00603473|10908201|FG000|Overall Study|Adverse Event|4
6891684|NCT00603473|10908201|FG000|Overall Study|Lack of Efficacy|4
6891685|NCT00603473|10908201|FG000|Overall Study|Protocol Violation|1
6891686|NCT00603512|10908210|FG000|Overall Study|Adverse Event|0
6891687|NCT00603512|10908211|FG001|Overall Study|Adverse Event|2
6891688|NCT00603512|10908212|FG002|Overall Study|Adverse Event|4
6891689|NCT00603512|10908213|FG003|Overall Study|Adverse Event|4
6891690|NCT00603512|10908214|FG004|Overall Study|Adverse Event|2
6891691|NCT00603512|10908210|FG000|Overall Study|Lack of Efficacy|0
6891692|NCT00603512|10908211|FG001|Overall Study|Lack of Efficacy|1
6891693|NCT00603512|10908212|FG002|Overall Study|Lack of Efficacy|0
6891694|NCT00603512|10908213|FG003|Overall Study|Lack of Efficacy|0
6891695|NCT00603512|10908214|FG004|Overall Study|Lack of Efficacy|1
6891696|NCT00603512|10908210|FG000|Overall Study|Other|2
6891697|NCT00603512|10908211|FG001|Overall Study|Other|1
6891698|NCT00603512|10908212|FG002|Overall Study|Other|0
6891699|NCT00603512|10908213|FG003|Overall Study|Other|1
6891700|NCT00603512|10908214|FG004|Overall Study|Other|1
6891701|NCT00603512|10908210|FG000|Overall Study|Withdrawal by Subject|0
6891702|NCT00603512|10908211|FG001|Overall Study|Withdrawal by Subject|0
6891703|NCT00603512|10908212|FG002|Overall Study|Withdrawal by Subject|0
6891704|NCT00603512|10908213|FG003|Overall Study|Withdrawal by Subject|0
6891705|NCT00603512|10908214|FG004|Overall Study|Withdrawal by Subject|1
6891706|NCT00603512|10908210|FG000|Overall Study|Randomized but not treated|0
6891707|NCT00603512|10908211|FG001|Overall Study|Randomized but not treated|1
6891708|NCT00603512|10908212|FG002|Overall Study|Randomized but not treated|1
6891709|NCT00603512|10908213|FG003|Overall Study|Randomized but not treated|2
6891710|NCT00603512|10908214|FG004|Overall Study|Randomized but not treated|0
6891711|NCT00603525|10908228|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3
6891712|NCT00603525|10908229|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9
6891713|NCT00603525|10908230|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0
6891714|NCT00603525|10908228|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7
6891715|NCT00603525|10908229|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
6891716|NCT00603525|10908230|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
6891717|NCT00603525|10908228|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1
6891718|NCT00603525|10908229|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2
6891719|NCT00603525|10908230|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0
6891720|NCT00603525|10908228|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1
6891721|NCT00603525|10908229|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3
6891722|NCT00603525|10908230|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0
6970693|NCT01157182|11021041|FG001|Washout of 28 Days|Adverse Event|0
6970694|NCT01157234|11021049|FG000|Overall Study|Withdrawal by Subject|1
6970695|NCT01157234|11021050|FG001|Overall Study|Withdrawal by Subject|0
6970696|NCT01157351|11021065|FG000|Overall Study|Adverse Event|5
6970697|NCT01157351|11021066|FG001|Overall Study|Adverse Event|4
6970698|NCT01157351|11021065|FG000|Overall Study|Death|1
6891723|NCT00603525|10908228|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5
6891724|NCT00603525|10908229|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6
6970699|NCT01157351|11021066|FG001|Overall Study|Death|0
6891725|NCT00603525|10908230|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
6891726|NCT00603525|10908228|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0
6891727|NCT00603525|10908229|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1
6891728|NCT00603525|10908230|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0
6891729|NCT00603525|10908228|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
6891730|NCT00603525|10908229|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1
6891731|NCT00603525|10908230|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
6891732|NCT00603525|10908228|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0
6891733|NCT00603525|10908229|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12
6970700|NCT01157351|11021065|FG000|Overall Study|Lost to Follow-up|53
6891734|NCT00603525|10908230|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0
6891735|NCT00603525|10908228|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
6891736|NCT00603525|10908229|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13
6891737|NCT00603525|10908230|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
6891738|NCT00603525|10908228|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0
6891739|NCT00603525|10908229|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1
6891740|NCT00603525|10908230|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0
6891741|NCT00603525|10908228|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
6891742|NCT00603525|10908229|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5
6891743|NCT00603525|10908230|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
6891744|NCT00603525|10908228|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
6891745|NCT00603525|10908229|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71
6891746|NCT00603525|10908230|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
6891747|NCT00603525|10908228|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0
6891748|NCT00603525|10908229|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2
6891749|NCT00603525|10908230|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0
6891750|NCT00603525|10908228|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
6891751|NCT00603525|10908229|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8
6891752|NCT00603525|10908230|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
6891753|NCT00603525|10908228|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
6891754|NCT00603525|10908229|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
6891755|NCT00603525|10908230|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111
6891756|NCT00603538|10908244|FG000|Overall Study|Adverse Event|0
6891757|NCT00603538|10908245|FG001|Overall Study|Adverse Event|4
6891758|NCT00603538|10908246|FG002|Overall Study|Adverse Event|2
6891759|NCT00603538|10908244|FG000|Overall Study|Objective progression or relapse|3
6891760|NCT00603538|10908245|FG001|Overall Study|Objective progression or relapse|0
6891761|NCT00603538|10908246|FG002|Overall Study|Objective progression or relapse|0
6891762|NCT00603590|10908268|FG000|Overall Study|Did not attend study clinic|39
6891763|NCT00603590|10908269|FG001|Overall Study|Did not attend study clinic|30
6891764|NCT00603590|10908268|FG000|Overall Study|Refused blood test|5
6891765|NCT00603590|10908269|FG001|Overall Study|Refused blood test|1
6891766|NCT00603590|10908268|FG000|Overall Study|Patient discontinued study drug|22
6891767|NCT00603590|10908269|FG001|Overall Study|Patient discontinued study drug|15
6891768|NCT00603590|10908268|FG000|Overall Study|Adverse Event|2
6891769|NCT00603590|10908269|FG001|Overall Study|Adverse Event|0
6891770|NCT00603590|10908268|FG000|Overall Study|Lost to Follow-up|8
6891771|NCT00603590|10908269|FG001|Overall Study|Lost to Follow-up|4
6891772|NCT00603590|10908268|FG000|Overall Study|Cardiovascular event|0
6891773|NCT00603590|10908269|FG001|Overall Study|Cardiovascular event|1
6891774|NCT00603733|10908307|FG000|Active Phase ITT|Adverse Event|8
6891775|NCT00603733|10908308|FG001|Active Phase ITT|Adverse Event|7
6891776|NCT00603733|10908307|FG000|Active Phase ITT|Withdrawal by Subject|0
6891777|NCT00603733|10908308|FG001|Active Phase ITT|Withdrawal by Subject|3
6891778|NCT00603733|10908307|FG000|Active Phase ITT|Lost to Follow-up|0
6891779|NCT00603733|10908308|FG001|Active Phase ITT|Lost to Follow-up|1
6891780|NCT00603733|10908307|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1
6891781|NCT00603733|10908308|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3
6891782|NCT00603733|10908307|FG000|Active Phase ITT|Lack of Efficacy|1
6891783|NCT00603733|10908308|FG001|Active Phase ITT|Lack of Efficacy|2
6891784|NCT00603733|10908307|FG000|Active Phase ITT|Subject moved, site closed|1
6891785|NCT00603733|10908308|FG001|Active Phase ITT|Subject moved, site closed|1
6891786|NCT00603733|10908307|FG000|Run-In Phase - 4 Weeks|Adverse Event|2
6891787|NCT00603733|10908308|FG001|Run-In Phase - 4 Weeks|Adverse Event|1
6891788|NCT00603733|10908307|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4
6891789|NCT00603733|10908308|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1
6891790|NCT00603733|10908307|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1
6891791|NCT00603733|10908308|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0
6891792|NCT00603733|10908307|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5
6891793|NCT00603733|10908308|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10
6891794|NCT00603733|10908307|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2
6891795|NCT00603733|10908308|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1
6891796|NCT00603733|10908307|FG000|Maintenance Phase ITT|Adverse Event|3
6891797|NCT00603733|10908308|FG001|Maintenance Phase ITT|Adverse Event|6
6891798|NCT00603733|10908307|FG000|Maintenance Phase ITT|Withdrawal by Subject|1
6891799|NCT00603733|10908308|FG001|Maintenance Phase ITT|Withdrawal by Subject|0
6891800|NCT00603733|10908307|FG000|Maintenance Phase ITT|Protocol Violation|1
6891801|NCT00603733|10908308|FG001|Maintenance Phase ITT|Protocol Violation|1
6891802|NCT00603733|10908307|FG000|Maintenance Phase ITT|Lost to Follow-up|0
6891803|NCT00603733|10908308|FG001|Maintenance Phase ITT|Lost to Follow-up|1
6891804|NCT00603733|10908307|FG000|Maintenance Phase ITT|Lack of Efficacy|2
6891805|NCT00603733|10908308|FG001|Maintenance Phase ITT|Lack of Efficacy|2
6891806|NCT00603733|10908307|FG000|Maintenance Phase ITT|Physician Decision|0
6891807|NCT00603733|10908308|FG001|Maintenance Phase ITT|Physician Decision|1
6891808|NCT00603733|10908307|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3
6891809|NCT00603733|10908308|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5
6891810|NCT00603746|10908320|FG000|Overall Study|Adverse Event|2
6891811|NCT00603746|10908321|FG001|Overall Study|Adverse Event|3
6891812|NCT00603746|10908322|FG002|Overall Study|Adverse Event|0
6891813|NCT00603746|10908323|FG003|Overall Study|Adverse Event|1
6891814|NCT00603746|10908324|FG004|Overall Study|Adverse Event|0
6891815|NCT00603746|10908325|FG005|Overall Study|Adverse Event|4
6891816|NCT00603746|10908320|FG000|Overall Study|Lack of Efficacy|34
7079261|NCT02111369|11188176|FG000|Overall Study|Withdrawal by Subject|1
7079262|NCT02111564|11188199|FG000|Overall Study|Death|109
7079263|NCT02111564|11188200|FG001|Overall Study|Death|120
7079264|NCT02111564|11188199|FG000|Overall Study|Lost to Follow-up|2
7079265|NCT02111564|11188200|FG001|Overall Study|Lost to Follow-up|3
6891817|NCT00603746|10908321|FG001|Overall Study|Lack of Efficacy|11
6891818|NCT00603746|10908322|FG002|Overall Study|Lack of Efficacy|6
6891819|NCT00603746|10908323|FG003|Overall Study|Lack of Efficacy|11
6891820|NCT00603746|10908324|FG004|Overall Study|Lack of Efficacy|12
6891821|NCT00603746|10908325|FG005|Overall Study|Lack of Efficacy|8
6891822|NCT00603746|10908320|FG000|Overall Study|Protocol Violation|0
6891823|NCT00603746|10908321|FG001|Overall Study|Protocol Violation|3
6891824|NCT00603746|10908322|FG002|Overall Study|Protocol Violation|1
6891825|NCT00603746|10908323|FG003|Overall Study|Protocol Violation|0
6891826|NCT00603746|10908324|FG004|Overall Study|Protocol Violation|1
6891827|NCT00603746|10908325|FG005|Overall Study|Protocol Violation|0
6891828|NCT00603746|10908320|FG000|Overall Study|Lost to Follow-up|0
6891829|NCT00603746|10908321|FG001|Overall Study|Lost to Follow-up|1
6891830|NCT00603746|10908322|FG002|Overall Study|Lost to Follow-up|1
6891831|NCT00603746|10908323|FG003|Overall Study|Lost to Follow-up|0
6891832|NCT00603746|10908324|FG004|Overall Study|Lost to Follow-up|0
6891833|NCT00603746|10908325|FG005|Overall Study|Lost to Follow-up|0
6891834|NCT00603746|10908320|FG000|Overall Study|Physician Decision|1
6891835|NCT00603746|10908321|FG001|Overall Study|Physician Decision|0
6891836|NCT00603746|10908322|FG002|Overall Study|Physician Decision|0
6891837|NCT00603746|10908323|FG003|Overall Study|Physician Decision|0
6891838|NCT00603746|10908324|FG004|Overall Study|Physician Decision|1
6891839|NCT00603746|10908325|FG005|Overall Study|Physician Decision|0
6891840|NCT00603746|10908320|FG000|Overall Study|Withdrawal by Subject|1
6891841|NCT00603746|10908321|FG001|Overall Study|Withdrawal by Subject|0
6891842|NCT00603746|10908322|FG002|Overall Study|Withdrawal by Subject|0
6891843|NCT00603746|10908323|FG003|Overall Study|Withdrawal by Subject|1
6891844|NCT00603746|10908324|FG004|Overall Study|Withdrawal by Subject|3
6891845|NCT00603746|10908325|FG005|Overall Study|Withdrawal by Subject|1
6891846|NCT00603798|10908342|FG000|Overall Study|Adverse Event|4
6891847|NCT00603798|10908343|FG001|Overall Study|Adverse Event|2
6891848|NCT00603798|10908344|FG002|Overall Study|Adverse Event|1
6891849|NCT00603798|10908342|FG000|Overall Study|Withdrawal by Subject|4
6891850|NCT00603798|10908343|FG001|Overall Study|Withdrawal by Subject|3
6891851|NCT00603798|10908344|FG002|Overall Study|Withdrawal by Subject|4
6891852|NCT00603798|10908342|FG000|Overall Study|Lost to Follow-up|1
6891853|NCT00603798|10908343|FG001|Overall Study|Lost to Follow-up|0
6891854|NCT00603798|10908344|FG002|Overall Study|Lost to Follow-up|1
6891855|NCT00603798|10908342|FG000|Overall Study|Non-compliance with study procedures|0
6891856|NCT00603798|10908343|FG001|Overall Study|Non-compliance with study procedures|1
6891857|NCT00603798|10908344|FG002|Overall Study|Non-compliance with study procedures|0
6891858|NCT00603798|10908342|FG000|Overall Study|Not due to AE|1
6891859|NCT00603798|10908343|FG001|Overall Study|Not due to AE|1
6891860|NCT00603798|10908344|FG002|Overall Study|Not due to AE|4
6891861|NCT00603837|10908354|FG000|Overall Study|Physician Decision|3
6891862|NCT00603837|10908355|FG001|Overall Study|Physician Decision|0
6891863|NCT00603915|10908378|FG000|Overall Study|Physician Decision|1
6891864|NCT00603941|10908385|FG000|Overall Study|Disease progression|6
6891865|NCT00603941|10908386|FG001|Overall Study|Disease progression|7
6891866|NCT00603941|10908387|FG002|Overall Study|Disease progression|1
6891867|NCT00603941|10908385|FG000|Overall Study|Adverse Event|1
6891868|NCT00603941|10908386|FG001|Overall Study|Adverse Event|0
6891869|NCT00603941|10908387|FG002|Overall Study|Adverse Event|1
6891870|NCT00603941|10908385|FG000|Overall Study|Physician Decision|0
6891871|NCT00603941|10908386|FG001|Overall Study|Physician Decision|1
6891872|NCT00603941|10908387|FG002|Overall Study|Physician Decision|0
6891873|NCT00603941|10908385|FG000|Overall Study|Withdrawal by Subject|0
6891874|NCT00603941|10908386|FG001|Overall Study|Withdrawal by Subject|2
6891875|NCT00603941|10908387|FG002|Overall Study|Withdrawal by Subject|0
6891876|NCT00603980|10908396|FG000|Study Qualification|Protocol Violation|3
7079266|NCT02111564|11188199|FG000|Overall Study|Withdrawal by Subject|20
7079267|NCT02111564|11188200|FG001|Overall Study|Withdrawal by Subject|20
6891877|NCT00603980|10908396|FG000|Study Qualification|Inconsistent data reporting|13
6891878|NCT00603980|10908396|FG000|Main Study|14th subject completed trial|1
6891879|NCT00604162|10908438|FG000|Overall Study|Physician Decision|3
6891880|NCT00604162|10908438|FG000|Overall Study|Withdrawal by Subject|1
6891881|NCT00604175|10908448|FG000|Entry Through Week 28|Death|2
6891882|NCT00604175|10908449|FG001|Entry Through Week 28|Death|0
6891883|NCT00604175|10908450|FG002|Entry Through Week 28|Death|0
6891884|NCT00604175|10908448|FG000|Entry Through Week 28|Withdrawal by Subject|1
7079268|NCT02111577|11188208|FG000|Overall Study|Protocol Violation|2
6891885|NCT00604175|10908449|FG001|Entry Through Week 28|Withdrawal by Subject|0
6891886|NCT00604175|10908450|FG002|Entry Through Week 28|Withdrawal by Subject|0
6891887|NCT00604175|10908448|FG000|Entry Through Week 28|Lost to Follow-up|4
6891888|NCT00604175|10908449|FG001|Entry Through Week 28|Lost to Follow-up|3
6891889|NCT00604175|10908450|FG002|Entry Through Week 28|Lost to Follow-up|0
6891890|NCT00604175|10908448|FG000|Entry Through Week 28|Ineligible|1
6891891|NCT00604175|10908449|FG001|Entry Through Week 28|Ineligible|0
6891892|NCT00604175|10908450|FG002|Entry Through Week 28|Ineligible|0
6891893|NCT00604175|10908448|FG000|Entry Through Week 28|Did not start intervention|2
6891894|NCT00604175|10908449|FG001|Entry Through Week 28|Did not start intervention|0
6891895|NCT00604175|10908450|FG002|Entry Through Week 28|Did not start intervention|1
6891896|NCT00604175|10908448|FG000|Week 29 Through Week 72|Death|0
6891897|NCT00604175|10908449|FG001|Week 29 Through Week 72|Death|0
6891898|NCT00604175|10908450|FG002|Week 29 Through Week 72|Death|1
6891899|NCT00604175|10908448|FG000|Week 29 Through Week 72|Lost to Follow-up|12
6891900|NCT00604175|10908449|FG001|Week 29 Through Week 72|Lost to Follow-up|6
6891901|NCT00604175|10908450|FG002|Week 29 Through Week 72|Lost to Follow-up|2
6891902|NCT00604175|10908448|FG000|Week 29 Through Week 72|Site closure|0
6891903|NCT00604175|10908449|FG001|Week 29 Through Week 72|Site closure|1
6891904|NCT00604175|10908450|FG002|Week 29 Through Week 72|Site closure|0
6891905|NCT00604175|10908448|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0
6891906|NCT00604175|10908449|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0
6891907|NCT00604175|10908450|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1
6891908|NCT00604188|10908484|FG000|Overall Study|Adverse Event|1
6891909|NCT00604188|10908485|FG001|Overall Study|Adverse Event|4
6891910|NCT00604188|10908484|FG000|Overall Study|Lost to Follow-up|17
6891911|NCT00604188|10908485|FG001|Overall Study|Lost to Follow-up|15
6891912|NCT00604188|10908484|FG000|Overall Study|Withdrawal by Subject|5
6891913|NCT00604188|10908485|FG001|Overall Study|Withdrawal by Subject|1
6891914|NCT00604188|10908484|FG000|Overall Study|Non-compliance with protocol|4
6891915|NCT00604188|10908485|FG001|Overall Study|Non-compliance with protocol|4
6891916|NCT00604188|10908484|FG000|Overall Study|Did not receive study drug|0
6891917|NCT00604188|10908485|FG001|Overall Study|Did not receive study drug|1
6891918|NCT00604214|10908493|FG000|Baseline to Day 28|Death|223
6891919|NCT00604214|10908494|FG001|Baseline to Day 28|Death|202
6891920|NCT00604214|10908493|FG000|Baseline to Day 28|Lost to Follow-up|2
6891921|NCT00604214|10908494|FG001|Baseline to Day 28|Lost to Follow-up|4
6891922|NCT00604214|10908493|FG000|Baseline to Day 28|Withdrawal by Subject|3
6891923|NCT00604214|10908494|FG001|Baseline to Day 28|Withdrawal by Subject|7
6891924|NCT00604214|10908493|FG000|Day 29 to Day 90|Death|64
6891925|NCT00604214|10908494|FG001|Day 29 to Day 90|Death|67
6891926|NCT00604214|10908493|FG000|Day 29 to Day 90|Lost to Follow-up|4
6891927|NCT00604214|10908494|FG001|Day 29 to Day 90|Lost to Follow-up|6
6891928|NCT00604214|10908493|FG000|Day 29 to Day 90|Withdrawal by Subject|0
6891929|NCT00604214|10908494|FG001|Day 29 to Day 90|Withdrawal by Subject|6
6891930|NCT00604214|10908493|FG000|Day 91 to Day 180|Death|19
6891931|NCT00604214|10908494|FG001|Day 91 to Day 180|Death|23
6891932|NCT00604214|10908493|FG000|Day 91 to Day 180|Lost to Follow-up|6
6891933|NCT00604214|10908494|FG001|Day 91 to Day 180|Lost to Follow-up|8
6891934|NCT00604214|10908493|FG000|Day 91 to Day 180|Withdrawal by Subject|1
6891935|NCT00604214|10908494|FG001|Day 91 to Day 180|Withdrawal by Subject|1
6891936|NCT00604279|10908502|FG000|Overall Study|Lack of Efficacy|22
6891937|NCT00604279|10908503|FG001|Overall Study|Lack of Efficacy|9
6891938|NCT00604279|10908502|FG000|Overall Study|Lost to Follow-up|9
6891939|NCT00604279|10908503|FG001|Overall Study|Lost to Follow-up|14
6891940|NCT00604279|10908502|FG000|Overall Study|Pregnancy|2
6891941|NCT00604279|10908503|FG001|Overall Study|Pregnancy|0
6891942|NCT00604279|10908502|FG000|Overall Study|Protocol Violation|3
6891943|NCT00604279|10908503|FG001|Overall Study|Protocol Violation|1
6891944|NCT00604279|10908502|FG000|Overall Study|Withdrawal by Subject|16
6891945|NCT00604279|10908503|FG001|Overall Study|Withdrawal by Subject|5
6891946|NCT00604279|10908502|FG000|Overall Study|Adverse Event|4
6891947|NCT00604279|10908503|FG001|Overall Study|Adverse Event|5
6891948|NCT00604279|10908502|FG000|Overall Study|Other|8
6891949|NCT00604279|10908503|FG001|Overall Study|Other|4
6891950|NCT00604383|10908511|FG000|Overall Study|Withdrawal by Subject|33
6891951|NCT00604383|10908512|FG001|Overall Study|Withdrawal by Subject|31
6891952|NCT00604383|10908511|FG000|Overall Study|Lost to Follow-up|24
6891953|NCT00604383|10908512|FG001|Overall Study|Lost to Follow-up|19
6891954|NCT00604383|10908511|FG000|Overall Study|Death|14
6891955|NCT00604383|10908512|FG001|Overall Study|Death|22
6891956|NCT00604383|10908511|FG000|Overall Study|Adverse Event|16
6891957|NCT00604383|10908512|FG001|Overall Study|Adverse Event|9
6891958|NCT00604383|10908511|FG000|Overall Study|Physician Decision|0
6891959|NCT00604383|10908512|FG001|Overall Study|Physician Decision|3
6891960|NCT00604565|10908535|FG000|Overall Study|Study terminated|0
6891961|NCT00604565|10908536|FG001|Overall Study|Study terminated|3
6891962|NCT00604669|10908542|FG000|Overall Study|lack of information in chart|7
6891963|NCT00604695|10908548|FG000|Overall Study|Did not receive first bolus.|0
6891964|NCT00604695|10908549|FG001|Overall Study|Did not receive first bolus.|4
6891965|NCT00604708|10908557|FG000|Overall Study|Withdrawal by Subject|9
6891966|NCT00604708|10908558|FG001|Overall Study|Withdrawal by Subject|10
6891967|NCT00604708|10908557|FG000|Overall Study|Protocol Violation|2
6891968|NCT00604708|10908558|FG001|Overall Study|Protocol Violation|8
6891969|NCT00604708|10908557|FG000|Overall Study|Lost to Follow-up|5
6891970|NCT00604708|10908558|FG001|Overall Study|Lost to Follow-up|5
6891971|NCT00604708|10908557|FG000|Overall Study|administrative reasons|9
6891972|NCT00604708|10908558|FG001|Overall Study|administrative reasons|11
6891973|NCT00604708|10908557|FG000|Overall Study|Adverse Event|6
6891974|NCT00604708|10908558|FG001|Overall Study|Adverse Event|6
6891975|NCT00604721|10908564|FG000|Overall Study|Physician Decision|1
6891976|NCT00604721|10908564|FG000|Overall Study|Withdrawal by Subject|1
6891977|NCT00604786|10908571|FG000|Overall Study|Lost to Follow-up|2
6891978|NCT00604786|10908572|FG001|Overall Study|Lost to Follow-up|0
6891979|NCT00604825|10908582|FG000|Overall Study|Adverse Event|2
6891980|NCT00604825|10908583|FG001|Overall Study|Adverse Event|6
6891981|NCT00604825|10908584|FG002|Overall Study|Adverse Event|7
6891982|NCT00604825|10908585|FG003|Overall Study|Adverse Event|4
6891983|NCT00604825|10908582|FG000|Overall Study|Lost to Follow-up|0
6891984|NCT00604825|10908583|FG001|Overall Study|Lost to Follow-up|3
6891985|NCT00604825|10908584|FG002|Overall Study|Lost to Follow-up|1
6891986|NCT00604825|10908585|FG003|Overall Study|Lost to Follow-up|0
6891987|NCT00604825|10908582|FG000|Overall Study|Protocol Violation|0
6891988|NCT00604825|10908583|FG001|Overall Study|Protocol Violation|1
6891989|NCT00604825|10908584|FG002|Overall Study|Protocol Violation|0
6891990|NCT00604825|10908585|FG003|Overall Study|Protocol Violation|0
6891991|NCT00604825|10908582|FG000|Overall Study|Withdrawal by Subject|4
6891992|NCT00604825|10908583|FG001|Overall Study|Withdrawal by Subject|3
6891993|NCT00604825|10908584|FG002|Overall Study|Withdrawal by Subject|5
6891994|NCT00604825|10908585|FG003|Overall Study|Withdrawal by Subject|5
6891995|NCT00604825|10908582|FG000|Overall Study|Lack of Efficacy|3
6891996|NCT00604825|10908583|FG001|Overall Study|Lack of Efficacy|2
6891997|NCT00604825|10908584|FG002|Overall Study|Lack of Efficacy|1
6891998|NCT00604825|10908585|FG003|Overall Study|Lack of Efficacy|0
6891999|NCT00604825|10908582|FG000|Overall Study|Did not meet eligibility criteria|0
6892000|NCT00604825|10908583|FG001|Overall Study|Did not meet eligibility criteria|0
6892001|NCT00604825|10908584|FG002|Overall Study|Did not meet eligibility criteria|2
6892002|NCT00604825|10908585|FG003|Overall Study|Did not meet eligibility criteria|0
6892003|NCT00604825|10908582|FG000|Overall Study|Physician Decision|0
6892004|NCT00604825|10908583|FG001|Overall Study|Physician Decision|0
6892005|NCT00604825|10908584|FG002|Overall Study|Physician Decision|0
6892006|NCT00604825|10908585|FG003|Overall Study|Physician Decision|1
6892007|NCT00604825|10908582|FG000|Overall Study|Exclusion criterion met|0
6892008|NCT00604825|10908583|FG001|Overall Study|Exclusion criterion met|0
6892009|NCT00604825|10908584|FG002|Overall Study|Exclusion criterion met|0
6892010|NCT00604825|10908585|FG003|Overall Study|Exclusion criterion met|1
6892011|NCT00605033|10908619|FG000|Overall Study|Adverse Event|2
6892012|NCT00605033|10908620|FG001|Overall Study|Adverse Event|2
6892013|NCT00605033|10908619|FG000|Overall Study|Lost to Follow-up|1
6892014|NCT00605033|10908620|FG001|Overall Study|Lost to Follow-up|1
6892015|NCT00605033|10908619|FG000|Overall Study|Withdrawal by Subject|3
6892016|NCT00605033|10908620|FG001|Overall Study|Withdrawal by Subject|4
6892017|NCT00605033|10908619|FG000|Overall Study|Protocol Violation|1
6892018|NCT00605033|10908620|FG001|Overall Study|Protocol Violation|1
6892019|NCT00605085|10908641|FG000|Overall Study|Withdrawal by Subject|8
6892020|NCT00605085|10908642|FG001|Overall Study|Withdrawal by Subject|5
6892021|NCT00605085|10908641|FG000|Overall Study|Adverse Event|9
6892022|NCT00605085|10908642|FG001|Overall Study|Adverse Event|5
6892023|NCT00605085|10908641|FG000|Overall Study|Pregnancy|2
6892024|NCT00605085|10908642|FG001|Overall Study|Pregnancy|0
6892025|NCT00605085|10908641|FG000|Overall Study|Protocol Violation|3
6892026|NCT00605085|10908642|FG001|Overall Study|Protocol Violation|2
6892027|NCT00605085|10908641|FG000|Overall Study|Lost to Follow-up|10
6892028|NCT00605085|10908642|FG001|Overall Study|Lost to Follow-up|5
6892029|NCT00605085|10908641|FG000|Overall Study|administrative reasons|18
6892030|NCT00605085|10908642|FG001|Overall Study|administrative reasons|8
6892031|NCT00605176|10908651|FG000|Overall Study|Adverse Event|2
6892032|NCT00605176|10908652|FG001|Overall Study|Adverse Event|1
6892033|NCT00605176|10908653|FG002|Overall Study|Adverse Event|3
6892034|NCT00605176|10908651|FG000|Overall Study|Withdrawal by Subject|4
6892035|NCT00605176|10908652|FG001|Overall Study|Withdrawal by Subject|2
6892036|NCT00605176|10908653|FG002|Overall Study|Withdrawal by Subject|4
6892037|NCT00605176|10908651|FG000|Overall Study|Lost to Follow-up|2
6892038|NCT00605176|10908652|FG001|Overall Study|Lost to Follow-up|2
6892039|NCT00605176|10908653|FG002|Overall Study|Lost to Follow-up|1
7079269|NCT02111577|11188209|FG001|Overall Study|Protocol Violation|0
6892040|NCT00605176|10908651|FG000|Overall Study|Non-complicance with study procedures|1
6892041|NCT00605176|10908652|FG001|Overall Study|Non-complicance with study procedures|0
6892042|NCT00605176|10908653|FG002|Overall Study|Non-complicance with study procedures|0
6892043|NCT00605176|10908651|FG000|Overall Study|Use of concomitant therapy|1
6892044|NCT00605176|10908652|FG001|Overall Study|Use of concomitant therapy|0
6892045|NCT00605176|10908653|FG002|Overall Study|Use of concomitant therapy|1
6892046|NCT00605176|10908651|FG000|Overall Study|Other (not due to AE)|1
6892047|NCT00605176|10908652|FG001|Overall Study|Other (not due to AE)|1
6892048|NCT00605176|10908653|FG002|Overall Study|Other (not due to AE)|0
6892049|NCT00605189|10908664|FG000|Overall Study|Adverse Event|1
6892050|NCT00605189|10908665|FG001|Overall Study|Adverse Event|0
6892051|NCT00605189|10908666|FG002|Overall Study|Adverse Event|0
6892052|NCT00605189|10908664|FG000|Overall Study|Other|2
6892053|NCT00605189|10908665|FG001|Overall Study|Other|2
6892054|NCT00605189|10908666|FG002|Overall Study|Other|0
6892055|NCT00605267|10908683|FG000|Overall Study|Adverse Event|0
6892056|NCT00605267|10908684|FG001|Overall Study|Adverse Event|1
6892057|NCT00605267|10908683|FG000|Overall Study|Lack of Efficacy|1
6892058|NCT00605267|10908684|FG001|Overall Study|Lack of Efficacy|5
6892059|NCT00605267|10908683|FG000|Overall Study|Withdrawal by Subject|2
6892060|NCT00605267|10908684|FG001|Overall Study|Withdrawal by Subject|3
6892061|NCT00605280|10908694|FG000|Year 1|Protocol Violation|0
6892062|NCT00605280|10908695|FG001|Year 1|Protocol Violation|0
6892063|NCT00605280|10908696|FG002|Year 1|Protocol Violation|0
6892064|NCT00605280|10908697|FG003|Year 1|Protocol Violation|1
6892065|NCT00605280|10908694|FG000|Year 1|Adverse Event|3
6892066|NCT00605280|10908695|FG001|Year 1|Adverse Event|1
6892067|NCT00605280|10908696|FG002|Year 1|Adverse Event|1
6892068|NCT00605280|10908697|FG003|Year 1|Adverse Event|5
6892069|NCT00605280|10908694|FG000|Year 1|Physician Decision|7
6892070|NCT00605280|10908695|FG001|Year 1|Physician Decision|4
6892071|NCT00605280|10908696|FG002|Year 1|Physician Decision|0
6892072|NCT00605280|10908697|FG003|Year 1|Physician Decision|6
6892073|NCT00605280|10908694|FG000|Year 1|Withdrawal by Subject|2
6892074|NCT00605280|10908695|FG001|Year 1|Withdrawal by Subject|4
6892075|NCT00605280|10908696|FG002|Year 1|Withdrawal by Subject|0
6892076|NCT00605280|10908697|FG003|Year 1|Withdrawal by Subject|4
6892077|NCT00605280|10908694|FG000|Year 1|Other|2
6892078|NCT00605280|10908695|FG001|Year 1|Other|1
6892079|NCT00605280|10908696|FG002|Year 1|Other|0
6892080|NCT00605280|10908697|FG003|Year 1|Other|1
6892081|NCT00605280|10908694|FG000|Year 1|Lost to Follow-up or Patient non-comply|5
6892082|NCT00605280|10908695|FG001|Year 1|Lost to Follow-up or Patient non-comply|1
6892083|NCT00605280|10908696|FG002|Year 1|Lost to Follow-up or Patient non-comply|0
6892084|NCT00605280|10908697|FG003|Year 1|Lost to Follow-up or Patient non-comply|2
6892085|NCT00605280|10908694|FG000|Year 2|Adverse Event|4
6892086|NCT00605280|10908695|FG001|Year 2|Adverse Event|0
6892087|NCT00605280|10908696|FG002|Year 2|Adverse Event|2
6892088|NCT00605280|10908697|FG003|Year 2|Adverse Event|4
6892089|NCT00605280|10908694|FG000|Year 2|Physician Decision|11
6892090|NCT00605280|10908695|FG001|Year 2|Physician Decision|6
6892091|NCT00605280|10908696|FG002|Year 2|Physician Decision|4
6892092|NCT00605280|10908697|FG003|Year 2|Physician Decision|11
6892093|NCT00605280|10908694|FG000|Year 2|Withdrawal by Subject|4
6892094|NCT00605280|10908695|FG001|Year 2|Withdrawal by Subject|0
6892095|NCT00605280|10908696|FG002|Year 2|Withdrawal by Subject|0
6892096|NCT00605280|10908697|FG003|Year 2|Withdrawal by Subject|4
6892097|NCT00605280|10908694|FG000|Year 2|Other|1
6892098|NCT00605280|10908695|FG001|Year 2|Other|0
6892099|NCT00605280|10908696|FG002|Year 2|Other|0
6892100|NCT00605280|10908697|FG003|Year 2|Other|1
6892101|NCT00605280|10908694|FG000|Year 2|Lost to Follow-up or Patient non-comply|4
6892102|NCT00605280|10908695|FG001|Year 2|Lost to Follow-up or Patient non-comply|0
6892103|NCT00605280|10908696|FG002|Year 2|Lost to Follow-up or Patient non-comply|0
6892104|NCT00605280|10908697|FG003|Year 2|Lost to Follow-up or Patient non-comply|2
6892105|NCT00605280|10908694|FG000|Year 3 Extension|Adverse Event|2
6892106|NCT00605280|10908695|FG001|Year 3 Extension|Adverse Event|0
6892107|NCT00605280|10908696|FG002|Year 3 Extension|Adverse Event|0
6892108|NCT00605280|10908697|FG003|Year 3 Extension|Adverse Event|2
6892109|NCT00605280|10908694|FG000|Year 3 Extension|Physician Decision|0
6892110|NCT00605280|10908695|FG001|Year 3 Extension|Physician Decision|0
6892111|NCT00605280|10908696|FG002|Year 3 Extension|Physician Decision|0
6892112|NCT00605280|10908697|FG003|Year 3 Extension|Physician Decision|2
6892113|NCT00605280|10908694|FG000|Year 3 Extension|Withdrawal by Subject|2
6892114|NCT00605280|10908695|FG001|Year 3 Extension|Withdrawal by Subject|0
6892115|NCT00605280|10908696|FG002|Year 3 Extension|Withdrawal by Subject|0
6892116|NCT00605280|10908697|FG003|Year 3 Extension|Withdrawal by Subject|5
6892117|NCT00605280|10908694|FG000|Year 3 Extension|Other|2
6892118|NCT00605280|10908695|FG001|Year 3 Extension|Other|0
6892119|NCT00605280|10908696|FG002|Year 3 Extension|Other|0
6892120|NCT00605280|10908697|FG003|Year 3 Extension|Other|0
6892121|NCT00605280|10908694|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2
6892122|NCT00605280|10908695|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
6892123|NCT00605280|10908696|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
6892124|NCT00605280|10908697|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
6892125|NCT00605293|10908709|FG000|Overall Study|Death|2
6892126|NCT00605293|10908710|FG001|Overall Study|Death|1
6892127|NCT00605293|10908709|FG000|Overall Study|Insufficient Therapeutic Response|2
6892128|NCT00605293|10908710|FG001|Overall Study|Insufficient Therapeutic Response|0
6892129|NCT00605293|10908709|FG000|Overall Study|Adverse Event|1
6892130|NCT00605293|10908710|FG001|Overall Study|Adverse Event|0
6892131|NCT00605293|10908709|FG000|Overall Study|Holidays Dialysis Out|1
6892132|NCT00605293|10908710|FG001|Overall Study|Holidays Dialysis Out|0
6892133|NCT00605293|10908709|FG000|Overall Study|Blood Transfusion|7
6892134|NCT00605293|10908710|FG001|Overall Study|Blood Transfusion|1
6892135|NCT00605293|10908709|FG000|Overall Study|Renal Transplantation|3
6892136|NCT00605293|10908710|FG001|Overall Study|Renal Transplantation|1
6892137|NCT00605293|10908709|FG000|Overall Study|Incorrect Epoetin Beta Administration|1
6892138|NCT00605293|10908710|FG001|Overall Study|Incorrect Epoetin Beta Administration|0
6892139|NCT00605293|10908709|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0
6892140|NCT00605293|10908710|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1
6892141|NCT00605293|10908709|FG000|Overall Study|Principal Investigator Decision|0
6892142|NCT00605293|10908710|FG001|Overall Study|Principal Investigator Decision|1
6892143|NCT00605306|10908718|FG000|Overall Study|Adverse Event|0
6892144|NCT00605306|10908719|FG001|Overall Study|Adverse Event|1
6892145|NCT00605319|10908725|FG000|Overall Study|Adverse Event|6
6892146|NCT00605345|10908737|FG000|Overall Study|Withdrawal by Subject|1
6892147|NCT00605345|10908738|FG001|Overall Study|Withdrawal by Subject|0
6892148|NCT00605345|10908737|FG000|Overall Study|Adverse Event|0
6892149|NCT00605345|10908738|FG001|Overall Study|Adverse Event|1
6892150|NCT00605345|10908737|FG000|Overall Study|Protocol Violation|0
6892151|NCT00605345|10908738|FG001|Overall Study|Protocol Violation|2
6892152|NCT00605475|10908781|FG000|Overall Study|Abnormal Laboratory Values|0
6892153|NCT00605475|10908782|FG001|Overall Study|Abnormal Laboratory Values|0
6892154|NCT00605475|10908783|FG002|Overall Study|Abnormal Laboratory Values|0
6892155|NCT00605475|10908784|FG003|Overall Study|Abnormal Laboratory Values|0
6892156|NCT00605475|10908785|FG004|Overall Study|Abnormal Laboratory Values|0
6892157|NCT00605475|10908786|FG005|Overall Study|Abnormal Laboratory Values|0
6892158|NCT00605475|10908787|FG006|Overall Study|Abnormal Laboratory Values|0
6892159|NCT00605475|10908788|FG007|Overall Study|Abnormal Laboratory Values|0
6892160|NCT00605475|10908789|FG008|Overall Study|Abnormal Laboratory Values|1
6892161|NCT00605475|10908790|FG009|Overall Study|Abnormal Laboratory Values|0
6892162|NCT00605475|10908781|FG000|Overall Study|Administrative problems|0
6892163|NCT00605475|10908782|FG001|Overall Study|Administrative problems|0
6892164|NCT00605475|10908783|FG002|Overall Study|Administrative problems|0
6892165|NCT00605475|10908784|FG003|Overall Study|Administrative problems|0
6892166|NCT00605475|10908785|FG004|Overall Study|Administrative problems|0
6892167|NCT00605475|10908786|FG005|Overall Study|Administrative problems|0
6892168|NCT00605475|10908787|FG006|Overall Study|Administrative problems|1
6892169|NCT00605475|10908788|FG007|Overall Study|Administrative problems|0
6892170|NCT00605475|10908789|FG008|Overall Study|Administrative problems|0
6892171|NCT00605475|10908790|FG009|Overall Study|Administrative problems|0
6892172|NCT00605475|10908781|FG000|Overall Study|Lost to Follow-up|0
6892173|NCT00605475|10908782|FG001|Overall Study|Lost to Follow-up|0
6892174|NCT00605475|10908783|FG002|Overall Study|Lost to Follow-up|0
6892175|NCT00605475|10908784|FG003|Overall Study|Lost to Follow-up|0
6892176|NCT00605475|10908785|FG004|Overall Study|Lost to Follow-up|0
6892177|NCT00605475|10908786|FG005|Overall Study|Lost to Follow-up|0
6892178|NCT00605475|10908787|FG006|Overall Study|Lost to Follow-up|0
6892179|NCT00605475|10908788|FG007|Overall Study|Lost to Follow-up|0
6892180|NCT00605475|10908789|FG008|Overall Study|Lost to Follow-up|1
6892181|NCT00605475|10908790|FG009|Overall Study|Lost to Follow-up|1
6892182|NCT00605475|10908781|FG000|Overall Study|Protocol Violation|0
7155852|NCT03349437|11323923|FG002|Screening|Screen Fail|0
7155853|NCT03349437|11323921|FG000|Screening|Withdrawn|1
7155854|NCT03349437|11323922|FG001|Screening|Withdrawn|0
7155855|NCT03349437|11323923|FG002|Screening|Withdrawn|0
7155856|NCT03349515|11323932|FG000|Overall Study|Lack of Efficacy|2
7155857|NCT03349515|11323933|FG001|Overall Study|Lack of Efficacy|0
7155858|NCT03349515|11323932|FG000|Overall Study|Physician Decision|3
7155859|NCT03349515|11323933|FG001|Overall Study|Physician Decision|1
7155860|NCT03349710|11323975|FG000|Treatment Period|Death|0
7155861|NCT03349710|11323976|FG001|Treatment Period|Death|0
7155862|NCT03349710|11323977|FG002|Treatment Period|Death|1
7155863|NCT03349710|11323978|FG003|Treatment Period|Death|0
7155864|NCT03349710|11323975|FG000|Treatment Period|Disease Progression|0
7155865|NCT03349710|11323976|FG001|Treatment Period|Disease Progression|2
6892183|NCT00605475|10908782|FG001|Overall Study|Protocol Violation|0
6892184|NCT00605475|10908783|FG002|Overall Study|Protocol Violation|0
6892185|NCT00605475|10908784|FG003|Overall Study|Protocol Violation|0
6892186|NCT00605475|10908785|FG004|Overall Study|Protocol Violation|1
6892187|NCT00605475|10908786|FG005|Overall Study|Protocol Violation|0
6892188|NCT00605475|10908787|FG006|Overall Study|Protocol Violation|0
6892189|NCT00605475|10908788|FG007|Overall Study|Protocol Violation|0
6892190|NCT00605475|10908789|FG008|Overall Study|Protocol Violation|0
6892191|NCT00605475|10908790|FG009|Overall Study|Protocol Violation|0
6892192|NCT00605475|10908781|FG000|Overall Study|Withdrawal by Subject|0
6892193|NCT00605475|10908782|FG001|Overall Study|Withdrawal by Subject|0
6892194|NCT00605475|10908783|FG002|Overall Study|Withdrawal by Subject|0
6892195|NCT00605475|10908784|FG003|Overall Study|Withdrawal by Subject|0
6892196|NCT00605475|10908785|FG004|Overall Study|Withdrawal by Subject|0
6892197|NCT00605475|10908786|FG005|Overall Study|Withdrawal by Subject|2
6892198|NCT00605475|10908787|FG006|Overall Study|Withdrawal by Subject|0
6892199|NCT00605475|10908788|FG007|Overall Study|Withdrawal by Subject|0
7155866|NCT03349710|11323977|FG002|Treatment Period|Disease Progression|0
7155867|NCT03349710|11323978|FG003|Treatment Period|Disease Progression|1
7155868|NCT03349710|11323975|FG000|Treatment Period|Study Drug Toxicity|1
7155869|NCT03349710|11323976|FG001|Treatment Period|Study Drug Toxicity|0
6892200|NCT00605475|10908789|FG008|Overall Study|Withdrawal by Subject|0
6892201|NCT00605475|10908790|FG009|Overall Study|Withdrawal by Subject|1
6892202|NCT00605540|10908833|FG000|Overall Study|Death|15
6892203|NCT00605540|10908833|FG000|Overall Study|Lost to Follow-up|23
6892204|NCT00605566|10908837|FG000|Overall Study|Adverse Event|1
6892205|NCT00605566|10908837|FG000|Overall Study|Clinical deterioration|1
6892206|NCT00605566|10908837|FG000|Overall Study|Poor compliance in run-in period|1
6892207|NCT00605657|10908862|FG000|Overall Study|Adverse Event|1
7155870|NCT03349710|11323977|FG002|Treatment Period|Study Drug Toxicity|1
6892208|NCT00605657|10908862|FG000|Overall Study|Protocol Violation|1
6892209|NCT00605722|10908875|FG000|Overall Study|Adverse Event|6
6892210|NCT00605722|10908875|FG000|Overall Study|Insufficient therapeutic response|44
6892211|NCT00605722|10908875|FG000|Overall Study|Failure to return|1
6892212|NCT00605813|10908879|FG000|Overall Study|Protocol Violation|25
6892213|NCT00605839|10908904|FG000|Overall Study|Protocol Violation|1
6892214|NCT00605839|10908905|FG001|Overall Study|Protocol Violation|0
6892215|NCT00605839|10908906|FG002|Overall Study|Protocol Violation|0
6892216|NCT00605865|10908914|FG000|Overall Study|Protocol Violation|115
6892217|NCT00605917|10908955|FG000|Overall Study|Protocol Violation|79
6892218|NCT00606008|10908990|FG000|Overall Study|Adverse Event|1
6892219|NCT00606008|10908990|FG000|Overall Study|Withdrawal by Subject|4
6892220|NCT00606021|10909000|FG000|Induction Phase|Death|73
6892221|NCT00606021|10909001|FG001|Induction Phase|Death|0
6892222|NCT00606021|10909002|FG002|Induction Phase|Death|0
6892223|NCT00606021|10909000|FG000|Induction Phase|Physician Decision|2
6892224|NCT00606021|10909001|FG001|Induction Phase|Physician Decision|0
6892225|NCT00606021|10909002|FG002|Induction Phase|Physician Decision|0
6892226|NCT00606021|10909000|FG000|Induction Phase|Withdrawal by Subject|2
6892227|NCT00606021|10909001|FG001|Induction Phase|Withdrawal by Subject|0
6892228|NCT00606021|10909002|FG002|Induction Phase|Withdrawal by Subject|0
6892229|NCT00606021|10909000|FG000|Induction Phase|Lost to Follow-up|10
6892230|NCT00606021|10909001|FG001|Induction Phase|Lost to Follow-up|0
6892231|NCT00606021|10909002|FG002|Induction Phase|Lost to Follow-up|0
6892232|NCT00606021|10909000|FG000|Maintenance Phase|Death|0
6892233|NCT00606021|10909001|FG001|Maintenance Phase|Death|17
6892234|NCT00606021|10909002|FG002|Maintenance Phase|Death|15
6892235|NCT00606021|10909000|FG000|Maintenance Phase|Physician Decision|0
6892236|NCT00606021|10909001|FG001|Maintenance Phase|Physician Decision|1
6892237|NCT00606021|10909002|FG002|Maintenance Phase|Physician Decision|0
6892238|NCT00606021|10909000|FG000|Maintenance Phase|Lost to Follow-up|0
6892239|NCT00606021|10909001|FG001|Maintenance Phase|Lost to Follow-up|5
6892240|NCT00606021|10909002|FG002|Maintenance Phase|Lost to Follow-up|2
6892241|NCT00606034|10909010|FG000|Overall Study|incarceration|1
6892242|NCT00606086|10909022|FG000|Overall Study|Adverse Event|1
6892243|NCT00606086|10909023|FG001|Overall Study|Adverse Event|1
6892244|NCT00606086|10909022|FG000|Overall Study|Lost to Follow-up|4
7079270|NCT02111577|11188208|FG000|Overall Study|Unable to tolerate leukapheresis|1
7079271|NCT02111577|11188209|FG001|Overall Study|Unable to tolerate leukapheresis|0
7079272|NCT02111577|11188208|FG000|Overall Study|Failure to produce study treatment|6
7079273|NCT02111577|11188209|FG001|Overall Study|Failure to produce study treatment|0
7079274|NCT02111577|11188208|FG000|Overall Study|Death|518
7079275|NCT02111577|11188209|FG001|Overall Study|Death|254
7079276|NCT02111577|11188208|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1
7079277|NCT02111577|11188209|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0
7155871|NCT03349710|11323978|FG003|Treatment Period|Study Drug Toxicity|1
7155872|NCT03349710|11323975|FG000|Treatment Period|Adverse event unrelated to Study Drug|2
7079278|NCT02111577|11188208|FG000|Overall Study|Adverse Event|1
7079279|NCT02111577|11188209|FG001|Overall Study|Adverse Event|1
7079280|NCT02111577|11188208|FG000|Overall Study|Withdrawal by Subject|51
7079281|NCT02111577|11188209|FG001|Overall Study|Withdrawal by Subject|23
7079282|NCT02111577|11188208|FG000|Overall Study|Disease progression|0
7079283|NCT02111577|11188209|FG001|Overall Study|Disease progression|1
7079284|NCT02111577|11188208|FG000|Overall Study|Lost to Follow-up|19
7079285|NCT02111577|11188209|FG001|Overall Study|Lost to Follow-up|10
7079286|NCT02111603|11188217|FG000|Overall Study|Withdrawal by Subject|1
7079287|NCT02111785|11188243|FG000|Overall Study|Death|0
7079288|NCT02111785|11188244|FG001|Overall Study|Death|1
7079289|NCT02111785|11188245|FG002|Overall Study|Death|0
7079290|NCT02111785|11188246|FG003|Overall Study|Death|0
7079291|NCT02111811|11188280|FG000|Treatment Phase|Lost to Follow-up|22
7079292|NCT02111811|11188281|FG001|Treatment Phase|Lost to Follow-up|18
7079293|NCT02111811|11188280|FG000|Treatment Phase|Death|2
7079294|NCT02111811|11188281|FG001|Treatment Phase|Death|0
7079295|NCT02111811|11188280|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26
7079296|NCT02111811|11188281|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17
7079297|NCT02111811|11188280|FG000|Follow up Period (Aim 2)|Death|2
7079298|NCT02111811|11188281|FG001|Follow up Period (Aim 2)|Death|0
7079299|NCT02111993|11188300|FG000|Overall Study|Physician Decision|5
7155873|NCT03349710|11323976|FG001|Treatment Period|Adverse event unrelated to Study Drug|1
7155874|NCT03349710|11323977|FG002|Treatment Period|Adverse event unrelated to Study Drug|1
7155875|NCT03349710|11323978|FG003|Treatment Period|Adverse event unrelated to Study Drug|1
7155876|NCT03349710|11323975|FG000|Treatment Period|admin reason by sponsor|0
7155877|NCT03349710|11323976|FG001|Treatment Period|admin reason by sponsor|7
6892245|NCT00606086|10909023|FG001|Overall Study|Lost to Follow-up|8
6892246|NCT00606086|10909022|FG000|Overall Study|Protocol Violation|1
6892247|NCT00606086|10909023|FG001|Overall Study|Protocol Violation|0
6892248|NCT00606086|10909022|FG000|Overall Study|Withdrawal by Subject|5
6892249|NCT00606086|10909023|FG001|Overall Study|Withdrawal by Subject|3
6892250|NCT00606086|10909022|FG000|Overall Study|Non-compliance|0
6892251|NCT00606086|10909023|FG001|Overall Study|Non-compliance|1
6892252|NCT00606086|10909022|FG000|Overall Study|Randomized, not treated|1
7079300|NCT02111993|11188301|FG001|Overall Study|Physician Decision|4
7079301|NCT02112045|11188311|FG000|Overall Study|Withdrawal by Subject|1
6892253|NCT00606086|10909023|FG001|Overall Study|Randomized, not treated|2
6892254|NCT00606177|10909040|FG000|Overall Study|Adverse Event|9
6892255|NCT00606177|10909041|FG001|Overall Study|Adverse Event|5
6892256|NCT00606177|10909040|FG000|Overall Study|Lack of Efficacy|3
6892257|NCT00606177|10909041|FG001|Overall Study|Lack of Efficacy|7
6892258|NCT00606177|10909040|FG000|Overall Study|Physician Decision|1
6892259|NCT00606177|10909041|FG001|Overall Study|Physician Decision|0
6892260|NCT00606177|10909040|FG000|Overall Study|Protocol Violation|1
6892261|NCT00606177|10909041|FG001|Overall Study|Protocol Violation|4
6892262|NCT00606177|10909040|FG000|Overall Study|Withdrawal by Subject|5
6892263|NCT00606177|10909041|FG001|Overall Study|Withdrawal by Subject|6
6892264|NCT00606177|10909040|FG000|Overall Study|Progression to depressive phase|6
6892265|NCT00606177|10909041|FG001|Overall Study|Progression to depressive phase|1
6892266|NCT00606177|10909040|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1
6892267|NCT00606177|10909041|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1
6892268|NCT00606177|10909040|FG000|Overall Study|Change of residence or other commitments|1
6892269|NCT00606177|10909041|FG001|Overall Study|Change of residence or other commitments|1
6892270|NCT00606229|10909047|FG000|Overall Study|Adverse Event|11
6892271|NCT00606229|10909047|FG000|Overall Study|Lack of Efficacy|1
6892272|NCT00606229|10909047|FG000|Overall Study|Withdrawal by Subject|4
6892273|NCT00606229|10909047|FG000|Overall Study|does not meet inclusion criterion 1-3|4
6892274|NCT00606229|10909047|FG000|Overall Study|change of residence or other commitments|2
6892275|NCT00606281|10909053|FG000|Overall Study|Adverse Event|11
6892276|NCT00606281|10909054|FG001|Overall Study|Adverse Event|12
6892277|NCT00606281|10909053|FG000|Overall Study|Death|1
6892278|NCT00606281|10909054|FG001|Overall Study|Death|0
6892279|NCT00606281|10909053|FG000|Overall Study|Lack of Efficacy|28
6892280|NCT00606281|10909054|FG001|Overall Study|Lack of Efficacy|35
6892281|NCT00606281|10909053|FG000|Overall Study|Physician Decision|0
6892282|NCT00606281|10909054|FG001|Overall Study|Physician Decision|1
6892283|NCT00606281|10909053|FG000|Overall Study|Protocol Violation|3
6892284|NCT00606281|10909054|FG001|Overall Study|Protocol Violation|3
6892285|NCT00606281|10909053|FG000|Overall Study|Withdrawal by Subject|11
6892286|NCT00606281|10909054|FG001|Overall Study|Withdrawal by Subject|13
6892287|NCT00606281|10909053|FG000|Overall Study|Progression to depressive phase|1
6892288|NCT00606281|10909054|FG001|Overall Study|Progression to depressive phase|1
6892289|NCT00606281|10909053|FG000|Overall Study|Change of residence or other commitments|1
6892290|NCT00606281|10909054|FG001|Overall Study|Change of residence or other commitments|1
6892291|NCT00606294|10909062|FG000|Overall Study|Withdrawal by Subject|36
6892292|NCT00606294|10909063|FG001|Overall Study|Withdrawal by Subject|0
6892293|NCT00606307|10909069|FG000|Overall Study|Adverse Event|2
6892294|NCT00606307|10909069|FG000|Overall Study|Withdrawal by Subject|2
6892295|NCT00606307|10909069|FG000|Overall Study|Disease progression|6
6892296|NCT00606307|10909069|FG000|Overall Study|QTc prolongation|1
6892297|NCT00606320|10909073|FG000|Overall Study|Adverse Event|3
6892298|NCT00606320|10909073|FG000|Overall Study|Lack of Efficacy|5
6892299|NCT00606320|10909073|FG000|Overall Study|Physician Decision|7
6892300|NCT00606320|10909073|FG000|Overall Study|Protocol Violation|8
6892301|NCT00606320|10909073|FG000|Overall Study|Withdrawal by Subject|10
6892302|NCT00606320|10909073|FG000|Overall Study|Progression to depressive phase|4
6892303|NCT00606502|10909088|FG000|Randomization|Randomized but not treated|3
6892304|NCT00606502|10909089|FG001|Randomization|Randomized but not treated|0
6892305|NCT00606502|10909088|FG000|Treatment|Treatment ongoing at time of data cutoff|0
6892306|NCT00606502|10909089|FG001|Treatment|Treatment ongoing at time of data cutoff|3
6892307|NCT00606580|10909111|FG000|Overall Study|Lost to Follow-up|1
6892308|NCT00606580|10909112|FG001|Overall Study|Lost to Follow-up|1
6892309|NCT00606580|10909113|FG002|Overall Study|Lost to Follow-up|4
6892310|NCT00606580|10909111|FG000|Overall Study|Clinical failures|1
6892311|NCT00606580|10909112|FG001|Overall Study|Clinical failures|0
6892312|NCT00606580|10909113|FG002|Overall Study|Clinical failures|12
6892313|NCT00606580|10909111|FG000|Overall Study|Withdrawal by investigator|0
6892314|NCT00606580|10909112|FG001|Overall Study|Withdrawal by investigator|1
6892315|NCT00606580|10909113|FG002|Overall Study|Withdrawal by investigator|6
6892316|NCT00606580|10909111|FG000|Overall Study|Withdrawal by Subject|0
6892317|NCT00606580|10909112|FG001|Overall Study|Withdrawal by Subject|1
6892318|NCT00606580|10909113|FG002|Overall Study|Withdrawal by Subject|0
6892319|NCT00606593|10909121|FG000|Overall Study|Adverse Event|0
6892320|NCT00606593|10909122|FG001|Overall Study|Adverse Event|0
6892321|NCT00606593|10909123|FG002|Overall Study|Adverse Event|0
6892322|NCT00606593|10909124|FG003|Overall Study|Adverse Event|1
6892323|NCT00606593|10909125|FG004|Overall Study|Adverse Event|1
6892324|NCT00606593|10909126|FG005|Overall Study|Adverse Event|0
6892325|NCT00606593|10909127|FG006|Overall Study|Adverse Event|1
6892326|NCT00606593|10909128|FG007|Overall Study|Adverse Event|2
6892327|NCT00606593|10909129|FG008|Overall Study|Adverse Event|1
6892328|NCT00606593|10909130|FG009|Overall Study|Adverse Event|0
6892329|NCT00606593|10909121|FG000|Overall Study|Withdrawal of consent|1
6892330|NCT00606593|10909122|FG001|Overall Study|Withdrawal of consent|0
6892331|NCT00606593|10909123|FG002|Overall Study|Withdrawal of consent|1
6892332|NCT00606593|10909124|FG003|Overall Study|Withdrawal of consent|0
6892333|NCT00606593|10909125|FG004|Overall Study|Withdrawal of consent|0
6892334|NCT00606593|10909126|FG005|Overall Study|Withdrawal of consent|0
6892335|NCT00606593|10909127|FG006|Overall Study|Withdrawal of consent|0
6892336|NCT00606593|10909128|FG007|Overall Study|Withdrawal of consent|0
6892337|NCT00606593|10909129|FG008|Overall Study|Withdrawal of consent|0
6892338|NCT00606593|10909130|FG009|Overall Study|Withdrawal of consent|0
6892339|NCT00606593|10909121|FG000|Overall Study|Administrative/Other|0
6892340|NCT00606593|10909122|FG001|Overall Study|Administrative/Other|0
6892341|NCT00606593|10909123|FG002|Overall Study|Administrative/Other|1
6892342|NCT00606593|10909124|FG003|Overall Study|Administrative/Other|0
6892343|NCT00606593|10909125|FG004|Overall Study|Administrative/Other|0
6892344|NCT00606593|10909126|FG005|Overall Study|Administrative/Other|0
6892345|NCT00606593|10909127|FG006|Overall Study|Administrative/Other|0
6892346|NCT00606593|10909128|FG007|Overall Study|Administrative/Other|0
6892347|NCT00606593|10909129|FG008|Overall Study|Administrative/Other|0
6892348|NCT00606593|10909130|FG009|Overall Study|Administrative/Other|0
6970701|NCT01157351|11021066|FG001|Overall Study|Lost to Follow-up|55
6970702|NCT01157351|11021065|FG000|Overall Study|Withdrawal by Subject|37
6970703|NCT01157351|11021066|FG001|Overall Study|Withdrawal by Subject|27
6970704|NCT01157351|11021065|FG000|Overall Study|Physician Decision|5
6970705|NCT01157351|11021066|FG001|Overall Study|Physician Decision|4
6970706|NCT01157351|11021065|FG000|Overall Study|Protocol Violation|0
6970707|NCT01157351|11021066|FG001|Overall Study|Protocol Violation|1
6970708|NCT01157351|11021065|FG000|Overall Study|Other|32
6970709|NCT01157351|11021066|FG001|Overall Study|Other|36
6970710|NCT01157351|11021065|FG000|Overall Study|Noncompliance with Study Drug|0
6970711|NCT01157351|11021066|FG001|Overall Study|Noncompliance with Study Drug|3
6970712|NCT01157351|11021065|FG000|Overall Study|Randomized but not Treated|4
6970713|NCT01157351|11021066|FG001|Overall Study|Randomized but not Treated|2
6970714|NCT01157364|11021078|FG000|Overall Study|Other Reasons|1
6970715|NCT01157364|11021079|FG001|Overall Study|Other Reasons|1
6970716|NCT01157364|11021080|FG002|Overall Study|Other Reasons|2
6970717|NCT01157364|11021081|FG003|Overall Study|Other Reasons|1
6970718|NCT01157364|11021082|FG004|Overall Study|Other Reasons|0
6970719|NCT01157364|11021083|FG005|Overall Study|Other Reasons|0
6970720|NCT01157364|11021078|FG000|Overall Study|Personal Reasons|0
6970721|NCT01157364|11021079|FG001|Overall Study|Personal Reasons|2
6970722|NCT01157364|11021080|FG002|Overall Study|Personal Reasons|0
6970723|NCT01157364|11021081|FG003|Overall Study|Personal Reasons|0
6970724|NCT01157364|11021082|FG004|Overall Study|Personal Reasons|1
6970725|NCT01157364|11021083|FG005|Overall Study|Personal Reasons|1
6970726|NCT01157364|11021078|FG000|Overall Study|Lost to Follow-up|1
6970727|NCT01157364|11021079|FG001|Overall Study|Lost to Follow-up|0
6970728|NCT01157364|11021080|FG002|Overall Study|Lost to Follow-up|1
6970729|NCT01157364|11021081|FG003|Overall Study|Lost to Follow-up|0
6970730|NCT01157364|11021082|FG004|Overall Study|Lost to Follow-up|0
6970731|NCT01157364|11021083|FG005|Overall Study|Lost to Follow-up|0
6970732|NCT01157364|11021078|FG000|Overall Study|Lack of Efficacy|0
6970733|NCT01157364|11021079|FG001|Overall Study|Lack of Efficacy|0
6970734|NCT01157364|11021080|FG002|Overall Study|Lack of Efficacy|0
6970735|NCT01157364|11021081|FG003|Overall Study|Lack of Efficacy|1
6970736|NCT01157364|11021082|FG004|Overall Study|Lack of Efficacy|0
6970737|NCT01157364|11021083|FG005|Overall Study|Lack of Efficacy|0
6970738|NCT01157364|11021078|FG000|Overall Study|Adverse Event|0
6970739|NCT01157364|11021079|FG001|Overall Study|Adverse Event|1
6970740|NCT01157364|11021080|FG002|Overall Study|Adverse Event|1
6970741|NCT01157364|11021081|FG003|Overall Study|Adverse Event|0
6970742|NCT01157364|11021082|FG004|Overall Study|Adverse Event|1
6970743|NCT01157364|11021083|FG005|Overall Study|Adverse Event|0
6970744|NCT01157377|11021104|FG000|Overall Study|Lost to Follow-up|0
6970745|NCT01157377|11021105|FG001|Overall Study|Lost to Follow-up|0
6970746|NCT01157377|11021106|FG002|Overall Study|Lost to Follow-up|1
6970747|NCT01157377|11021107|FG003|Overall Study|Lost to Follow-up|0
6970748|NCT01157377|11021108|FG004|Overall Study|Lost to Follow-up|1
6970749|NCT01157377|11021109|FG005|Overall Study|Lost to Follow-up|1
6970750|NCT01157377|11021110|FG006|Overall Study|Lost to Follow-up|0
6970751|NCT01157377|11021104|FG000|Overall Study|Personal Reasons|2
6970752|NCT01157377|11021105|FG001|Overall Study|Personal Reasons|1
6970753|NCT01157377|11021106|FG002|Overall Study|Personal Reasons|0
6970754|NCT01157377|11021107|FG003|Overall Study|Personal Reasons|1
6970755|NCT01157377|11021108|FG004|Overall Study|Personal Reasons|0
6970756|NCT01157377|11021109|FG005|Overall Study|Personal Reasons|0
6970757|NCT01157377|11021110|FG006|Overall Study|Personal Reasons|0
6970758|NCT01157377|11021104|FG000|Overall Study|Protocol Violation|0
6970759|NCT01157377|11021105|FG001|Overall Study|Protocol Violation|0
6970760|NCT01157377|11021106|FG002|Overall Study|Protocol Violation|0
6970761|NCT01157377|11021107|FG003|Overall Study|Protocol Violation|0
6970762|NCT01157377|11021108|FG004|Overall Study|Protocol Violation|0
6970763|NCT01157377|11021109|FG005|Overall Study|Protocol Violation|1
6970764|NCT01157377|11021110|FG006|Overall Study|Protocol Violation|0
6970765|NCT01157377|11021104|FG000|Overall Study|Lack of Efficacy|0
6970766|NCT01157377|11021105|FG001|Overall Study|Lack of Efficacy|0
6970767|NCT01157377|11021106|FG002|Overall Study|Lack of Efficacy|0
6970768|NCT01157377|11021107|FG003|Overall Study|Lack of Efficacy|0
6970769|NCT01157377|11021108|FG004|Overall Study|Lack of Efficacy|0
6970770|NCT01157377|11021109|FG005|Overall Study|Lack of Efficacy|0
6970771|NCT01157377|11021110|FG006|Overall Study|Lack of Efficacy|1
6970772|NCT01157377|11021104|FG000|Overall Study|Other Miscellaneous Reasons|0
6892349|NCT00606632|10909143|FG000|Overall Study|Withdrawal by Subject|13
6892350|NCT00606632|10909143|FG000|Overall Study|Miscellaneous reasons|9
6892351|NCT00606684|10909158|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173
6892352|NCT00606684|10909159|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
6892353|NCT00606684|10909160|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
6892354|NCT00606684|10909161|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
6892355|NCT00606684|10909162|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
6892356|NCT00606684|10909163|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
6892357|NCT00606684|10909164|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
6892358|NCT00606684|10909158|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32
6892359|NCT00606684|10909159|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
6892360|NCT00606684|10909160|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
6892361|NCT00606684|10909161|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
6892362|NCT00606684|10909162|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
6892363|NCT00606684|10909163|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
6892364|NCT00606684|10909164|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
6892365|NCT00606684|10909158|FG000|2-week Single-Blind Run-in Period|Physician Decision|18
6892366|NCT00606684|10909159|FG001|2-week Single-Blind Run-in Period|Physician Decision|0
6892367|NCT00606684|10909160|FG002|2-week Single-Blind Run-in Period|Physician Decision|0
6892368|NCT00606684|10909161|FG003|2-week Single-Blind Run-in Period|Physician Decision|0
6892369|NCT00606684|10909162|FG004|2-week Single-Blind Run-in Period|Physician Decision|0
6892370|NCT00606684|10909163|FG005|2-week Single-Blind Run-in Period|Physician Decision|0
6892371|NCT00606684|10909164|FG006|2-week Single-Blind Run-in Period|Physician Decision|0
6892372|NCT00606684|10909158|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15
6892373|NCT00606684|10909159|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
6892374|NCT00606684|10909160|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
6892375|NCT00606684|10909161|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
6892376|NCT00606684|10909162|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
6892377|NCT00606684|10909163|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
7079302|NCT02112045|11188312|FG001|Overall Study|Withdrawal by Subject|0
6892378|NCT00606684|10909164|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
6892379|NCT00606684|10909158|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5
6892380|NCT00606684|10909159|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0
6892381|NCT00606684|10909160|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0
6892382|NCT00606684|10909161|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0
6892383|NCT00606684|10909162|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0
6892384|NCT00606684|10909163|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0
6892385|NCT00606684|10909164|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0
6892386|NCT00606684|10909158|FG000|2-week Single-Blind Run-in Period|Adverse Event|2
6892387|NCT00606684|10909159|FG001|2-week Single-Blind Run-in Period|Adverse Event|0
6892388|NCT00606684|10909160|FG002|2-week Single-Blind Run-in Period|Adverse Event|0
6892389|NCT00606684|10909161|FG003|2-week Single-Blind Run-in Period|Adverse Event|0
6892390|NCT00606684|10909162|FG004|2-week Single-Blind Run-in Period|Adverse Event|0
6892391|NCT00606684|10909163|FG005|2-week Single-Blind Run-in Period|Adverse Event|0
6892392|NCT00606684|10909164|FG006|2-week Single-Blind Run-in Period|Adverse Event|0
6892393|NCT00606684|10909158|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1
6892394|NCT00606684|10909159|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
6892395|NCT00606684|10909160|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
6892396|NCT00606684|10909161|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
6892397|NCT00606684|10909162|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
6892398|NCT00606684|10909163|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
6892399|NCT00606684|10909164|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
6892400|NCT00606684|10909158|FG000|Double-Blind Treatment Period|Adverse Event|0
6892401|NCT00606684|10909159|FG001|Double-Blind Treatment Period|Adverse Event|3
6892402|NCT00606684|10909160|FG002|Double-Blind Treatment Period|Adverse Event|2
6892403|NCT00606684|10909161|FG003|Double-Blind Treatment Period|Adverse Event|4
6892404|NCT00606684|10909162|FG004|Double-Blind Treatment Period|Adverse Event|2
6892405|NCT00606684|10909163|FG005|Double-Blind Treatment Period|Adverse Event|0
6892406|NCT00606684|10909164|FG006|Double-Blind Treatment Period|Adverse Event|1
6892407|NCT00606684|10909158|FG000|Double-Blind Treatment Period|Lack of Efficacy|0
6892408|NCT00606684|10909159|FG001|Double-Blind Treatment Period|Lack of Efficacy|1
6892409|NCT00606684|10909160|FG002|Double-Blind Treatment Period|Lack of Efficacy|0
6892410|NCT00606684|10909161|FG003|Double-Blind Treatment Period|Lack of Efficacy|0
6892411|NCT00606684|10909162|FG004|Double-Blind Treatment Period|Lack of Efficacy|1
6892412|NCT00606684|10909163|FG005|Double-Blind Treatment Period|Lack of Efficacy|0
6892413|NCT00606684|10909164|FG006|Double-Blind Treatment Period|Lack of Efficacy|0
6892414|NCT00606684|10909158|FG000|Double-Blind Treatment Period|Protocol Violation|0
6892415|NCT00606684|10909159|FG001|Double-Blind Treatment Period|Protocol Violation|5
6892416|NCT00606684|10909160|FG002|Double-Blind Treatment Period|Protocol Violation|5
7155878|NCT03349710|11323977|FG002|Treatment Period|admin reason by sponsor|0
6892417|NCT00606684|10909161|FG003|Double-Blind Treatment Period|Protocol Violation|3
6892418|NCT00606684|10909162|FG004|Double-Blind Treatment Period|Protocol Violation|0
6892419|NCT00606684|10909163|FG005|Double-Blind Treatment Period|Protocol Violation|3
6892420|NCT00606684|10909164|FG006|Double-Blind Treatment Period|Protocol Violation|4
6892421|NCT00606684|10909158|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0
6892422|NCT00606684|10909159|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
6892423|NCT00606684|10909160|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
6892424|NCT00606684|10909161|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
6892425|NCT00606684|10909162|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
6892426|NCT00606684|10909163|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3
6892427|NCT00606684|10909164|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
6892428|NCT00606684|10909158|FG000|Double-Blind Treatment Period|Physician Decision|0
6892429|NCT00606684|10909159|FG001|Double-Blind Treatment Period|Physician Decision|5
6892430|NCT00606684|10909160|FG002|Double-Blind Treatment Period|Physician Decision|1
6892431|NCT00606684|10909161|FG003|Double-Blind Treatment Period|Physician Decision|0
6892432|NCT00606684|10909162|FG004|Double-Blind Treatment Period|Physician Decision|3
6892433|NCT00606684|10909163|FG005|Double-Blind Treatment Period|Physician Decision|1
6892434|NCT00606684|10909164|FG006|Double-Blind Treatment Period|Physician Decision|2
6892435|NCT00606684|10909158|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
6892436|NCT00606684|10909159|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1
6892437|NCT00606684|10909160|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1
6892438|NCT00606684|10909161|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2
6892439|NCT00606684|10909162|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1
6892440|NCT00606684|10909163|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2
6892441|NCT00606684|10909164|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0
6892442|NCT00606801|10909180|FG000|Intervention|Protocol Violation|3
6892443|NCT00606801|10909181|FG001|Intervention|Protocol Violation|3
6892444|NCT00606892|10909191|FG000|First Intervention|Protocol Violation|1
6892445|NCT00606892|10909192|FG001|First Intervention|Protocol Violation|4
6892446|NCT00606905|10909226|FG000|Overall Study|No Pregnancy|9
6892447|NCT00606905|10909227|FG001|Overall Study|No Pregnancy|6
6892448|NCT00606905|10909226|FG000|Overall Study|Non-Index Pregnancy|1
6892449|NCT00606905|10909227|FG001|Overall Study|Non-Index Pregnancy|4
6892450|NCT00606905|10909226|FG000|Overall Study|Withdrew|5
6892451|NCT00606905|10909227|FG001|Overall Study|Withdrew|5
6892452|NCT00606931|10909233|FG000|Overall Study|Withdrawal by Subject|3
6892453|NCT00607022|10909249|FG000|Overall Study|Withdrawal by Subject|1
6892454|NCT00607022|10909250|FG001|Overall Study|Withdrawal by Subject|0
6892455|NCT00607022|10909251|FG002|Overall Study|Withdrawal by Subject|0
6892456|NCT00607048|10909261|FG000|Overall Study|Adverse Event|0
6892457|NCT00607048|10909262|FG001|Overall Study|Adverse Event|1
6892458|NCT00607048|10909263|FG002|Overall Study|Adverse Event|0
6892459|NCT00607048|10909264|FG003|Overall Study|Adverse Event|0
6892460|NCT00607048|10909265|FG004|Overall Study|Adverse Event|4
6892461|NCT00607048|10909266|FG005|Overall Study|Adverse Event|0
6892462|NCT00607048|10909261|FG000|Overall Study|Global deterioration of health|1
6892463|NCT00607048|10909262|FG001|Overall Study|Global deterioration of health|0
6892464|NCT00607048|10909263|FG002|Overall Study|Global deterioration of health|0
6892465|NCT00607048|10909264|FG003|Overall Study|Global deterioration of health|0
7079303|NCT02112448|11188329|FG000|Overall Study|lab values precluding use of ketorolac|2
7079304|NCT02112448|11188330|FG001|Overall Study|lab values precluding use of ketorolac|2
7079305|NCT02112448|11188329|FG000|Overall Study|Protocol Violation|1
6892466|NCT00607048|10909265|FG004|Overall Study|Global deterioration of health|0
6892467|NCT00607048|10909266|FG005|Overall Study|Global deterioration of health|0
6892468|NCT00607048|10909261|FG000|Overall Study|Objective disease progression - relapse|1
6892469|NCT00607048|10909262|FG001|Overall Study|Objective disease progression - relapse|2
6892470|NCT00607048|10909263|FG002|Overall Study|Objective disease progression - relapse|4
6892471|NCT00607048|10909264|FG003|Overall Study|Objective disease progression - relapse|2
6892472|NCT00607048|10909265|FG004|Overall Study|Objective disease progression - relapse|2
6892473|NCT00607048|10909266|FG005|Overall Study|Objective disease progression - relapse|2
6892474|NCT00607048|10909261|FG000|Overall Study|Withdrawal by Subject|0
6892475|NCT00607048|10909262|FG001|Overall Study|Withdrawal by Subject|0
6970773|NCT01157377|11021105|FG001|Overall Study|Other Miscellaneous Reasons|2
7079306|NCT02112448|11188330|FG001|Overall Study|Protocol Violation|2
7079307|NCT02112448|11188329|FG000|Overall Study|Physician Decision|4
7079308|NCT02112448|11188330|FG001|Overall Study|Physician Decision|6
7079309|NCT02112448|11188329|FG000|Overall Study|required heparin so could not use ketoro|1
6892476|NCT00607048|10909263|FG002|Overall Study|Withdrawal by Subject|0
6892477|NCT00607048|10909264|FG003|Overall Study|Withdrawal by Subject|1
6892478|NCT00607048|10909265|FG004|Overall Study|Withdrawal by Subject|0
6892479|NCT00607048|10909266|FG005|Overall Study|Withdrawal by Subject|2
6892480|NCT00607048|10909261|FG000|Overall Study|Other|1
6892481|NCT00607048|10909262|FG001|Overall Study|Other|1
6892482|NCT00607048|10909263|FG002|Overall Study|Other|0
6892483|NCT00607048|10909264|FG003|Overall Study|Other|0
6892484|NCT00607048|10909265|FG004|Overall Study|Other|0
6892485|NCT00607048|10909266|FG005|Overall Study|Other|1
6892486|NCT00607087|10909285|FG000|Overall Study|Withdrawal by Subject|9
6892487|NCT00607087|10909286|FG001|Overall Study|Withdrawal by Subject|4
6892488|NCT00607087|10909287|FG002|Overall Study|Withdrawal by Subject|4
6892489|NCT00607087|10909285|FG000|Overall Study|Adverse Event|3
6892490|NCT00607087|10909286|FG001|Overall Study|Adverse Event|2
6892491|NCT00607087|10909287|FG002|Overall Study|Adverse Event|3
6892492|NCT00607087|10909285|FG000|Overall Study|Other reason|1
6892493|NCT00607087|10909286|FG001|Overall Study|Other reason|5
6892494|NCT00607087|10909287|FG002|Overall Study|Other reason|2
6892495|NCT00607087|10909285|FG000|Overall Study|Poor compliance to protocol|1
6892496|NCT00607087|10909286|FG001|Overall Study|Poor compliance to protocol|0
6892497|NCT00607087|10909287|FG002|Overall Study|Poor compliance to protocol|1
6892498|NCT00607087|10909285|FG000|Overall Study|Lost to Follow-up|1
6892499|NCT00607087|10909286|FG001|Overall Study|Lost to Follow-up|0
6892500|NCT00607087|10909287|FG002|Overall Study|Lost to Follow-up|0
6892501|NCT00607087|10909285|FG000|Period 1|Withdrawal by Subject|7
6892502|NCT00607087|10909286|FG001|Period 1|Withdrawal by Subject|2
6892503|NCT00607087|10909287|FG002|Period 1|Withdrawal by Subject|3
6892504|NCT00607087|10909285|FG000|Period 1|Adverse Event|3
6892505|NCT00607087|10909286|FG001|Period 1|Adverse Event|0
6892506|NCT00607087|10909287|FG002|Period 1|Adverse Event|0
6892507|NCT00607087|10909285|FG000|Period 1|Poor compliance to protocol|1
6892508|NCT00607087|10909286|FG001|Period 1|Poor compliance to protocol|0
6892509|NCT00607087|10909287|FG002|Period 1|Poor compliance to protocol|0
6892510|NCT00607087|10909285|FG000|Period 1|Lost to Follow-up|1
6892511|NCT00607087|10909286|FG001|Period 1|Lost to Follow-up|0
6892512|NCT00607087|10909287|FG002|Period 1|Lost to Follow-up|0
6892513|NCT00607087|10909285|FG000|Period 1|Other reason|0
6892514|NCT00607087|10909286|FG001|Period 1|Other reason|4
6892515|NCT00607087|10909287|FG002|Period 1|Other reason|2
6892516|NCT00607087|10909285|FG000|Period 2|Withdrawal by Subject|0
6892517|NCT00607087|10909286|FG001|Period 2|Withdrawal by Subject|1
6892518|NCT00607087|10909287|FG002|Period 2|Withdrawal by Subject|1
6892519|NCT00607087|10909285|FG000|Period 2|Other reason|1
6892520|NCT00607087|10909286|FG001|Period 2|Other reason|1
6892521|NCT00607087|10909287|FG002|Period 2|Other reason|0
6892522|NCT00607087|10909285|FG000|Period 2|Adverse Event|0
6892523|NCT00607087|10909286|FG001|Period 2|Adverse Event|1
6892524|NCT00607087|10909287|FG002|Period 2|Adverse Event|3
6892525|NCT00607087|10909285|FG000|Period 2|Poor compliance to protocol|0
6892526|NCT00607087|10909286|FG001|Period 2|Poor compliance to protocol|0
6892527|NCT00607087|10909287|FG002|Period 2|Poor compliance to protocol|1
6892528|NCT00607087|10909285|FG000|Period 3|Withdrawal by Subject|2
6892529|NCT00607087|10909286|FG001|Period 3|Withdrawal by Subject|1
6892530|NCT00607087|10909287|FG002|Period 3|Withdrawal by Subject|0
6892531|NCT00607087|10909285|FG000|Period 3|Adverse Event|0
6892532|NCT00607087|10909286|FG001|Period 3|Adverse Event|1
6892533|NCT00607087|10909287|FG002|Period 3|Adverse Event|0
6892534|NCT00607373|10909338|FG000|Treatment Period|Adverse Event|0
6892535|NCT00607373|10909339|FG001|Treatment Period|Adverse Event|4
6892536|NCT00607373|10909338|FG000|Treatment Period|Physician Decision|0
6892537|NCT00607373|10909339|FG001|Treatment Period|Physician Decision|1
6892538|NCT00607373|10909338|FG000|Treatment Period|Withdrawal by Subject|0
6892539|NCT00607373|10909339|FG001|Treatment Period|Withdrawal by Subject|1
6892540|NCT00607373|10909338|FG000|Follow-up Period|Other|0
6892541|NCT00607373|10909339|FG001|Follow-up Period|Other|1
6892542|NCT00607373|10909338|FG000|Follow-up Period|Protocol Violation|0
6892543|NCT00607373|10909339|FG001|Follow-up Period|Protocol Violation|1
6892544|NCT00607373|10909338|FG000|Follow-up Period|Withdrawal by Subject|1
6892545|NCT00607373|10909339|FG001|Follow-up Period|Withdrawal by Subject|3
6892546|NCT00607386|10909345|FG000|Overall Study|Physician Decision|1
6892547|NCT00607724|10909387|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7
6892548|NCT00607724|10909388|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8
6892549|NCT00607724|10909389|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4
6892550|NCT00607724|10909390|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
6892551|NCT00607724|10909391|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
6892552|NCT00607724|10909392|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
6892553|NCT00607724|10909393|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
6892554|NCT00607724|10909387|FG000|Stage 2: Expanded Cohort|Adverse Event|0
6892555|NCT00607724|10909388|FG001|Stage 2: Expanded Cohort|Adverse Event|0
6892556|NCT00607724|10909389|FG002|Stage 2: Expanded Cohort|Adverse Event|0
6892557|NCT00607724|10909390|FG003|Stage 2: Expanded Cohort|Adverse Event|0
6892558|NCT00607724|10909391|FG004|Stage 2: Expanded Cohort|Adverse Event|0
6892559|NCT00607724|10909392|FG005|Stage 2: Expanded Cohort|Adverse Event|0
6892560|NCT00607724|10909393|FG006|Stage 2: Expanded Cohort|Adverse Event|1
6892561|NCT00607724|10909387|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0
6892562|NCT00607724|10909388|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0
6892563|NCT00607724|10909389|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0
6892564|NCT00607724|10909390|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4
6892565|NCT00607724|10909391|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8
6892566|NCT00607724|10909392|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11
6892567|NCT00607724|10909393|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10
6892568|NCT00607724|10909387|FG000|Stage 2: Expanded Cohort|Physician Decision|0
6892569|NCT00607724|10909388|FG001|Stage 2: Expanded Cohort|Physician Decision|0
6892570|NCT00607724|10909389|FG002|Stage 2: Expanded Cohort|Physician Decision|0
6892571|NCT00607724|10909390|FG003|Stage 2: Expanded Cohort|Physician Decision|0
6892572|NCT00607724|10909391|FG004|Stage 2: Expanded Cohort|Physician Decision|1
6892573|NCT00607724|10909392|FG005|Stage 2: Expanded Cohort|Physician Decision|1
6892574|NCT00607724|10909393|FG006|Stage 2: Expanded Cohort|Physician Decision|0
6892575|NCT00607724|10909387|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0
6892576|NCT00607724|10909388|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0
6892577|NCT00607724|10909389|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0
6892578|NCT00607724|10909390|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1
6892579|NCT00607724|10909391|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0
6892580|NCT00607724|10909392|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0
6892581|NCT00607724|10909393|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0
6892582|NCT00607789|10909419|FG000|Overall Study|Adverse Event|3
6892583|NCT00607789|10909420|FG001|Overall Study|Adverse Event|0
6892584|NCT00607789|10909419|FG000|Overall Study|Lack of Efficacy|0
6892585|NCT00607789|10909420|FG001|Overall Study|Lack of Efficacy|1
6892586|NCT00607789|10909419|FG000|Overall Study|Inadequate adherence|3
6892587|NCT00607789|10909420|FG001|Overall Study|Inadequate adherence|0
6892588|NCT00607789|10909419|FG000|Overall Study|Lost to Follow-up|0
6892589|NCT00607789|10909420|FG001|Overall Study|Lost to Follow-up|5
6892590|NCT00607789|10909419|FG000|Overall Study|Withdrawal by Subject|1
6892591|NCT00607789|10909420|FG001|Overall Study|Withdrawal by Subject|0
6892592|NCT00607880|10909448|FG000|Overall Study|Unable to place port due to occlusion|1
6892593|NCT00607880|10909449|FG001|Overall Study|Unable to place port due to occlusion|0
6892594|NCT00607893|10909457|FG000|Overall Study|Lost to Follow-up|4
6892595|NCT00607893|10909458|FG001|Overall Study|Lost to Follow-up|0
6892596|NCT00607893|10909457|FG000|Overall Study|withdrew due to loss of interest|0
6892597|NCT00607893|10909458|FG001|Overall Study|withdrew due to loss of interest|1
6892598|NCT00607893|10909457|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0
6892599|NCT00607893|10909458|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1
6892600|NCT00607893|10909457|FG000|Overall Study|withdrew could not tolerate CPAP|0
6892601|NCT00607893|10909458|FG001|Overall Study|withdrew could not tolerate CPAP|1
6892602|NCT00607893|10909457|FG000|Overall Study|Declined to be treated|1
6892603|NCT00607893|10909458|FG001|Overall Study|Declined to be treated|0
6892604|NCT00607893|10909457|FG000|Overall Study|Withdrew due to hypertensive urgency|1
6892605|NCT00607893|10909458|FG001|Overall Study|Withdrew due to hypertensive urgency|1
6892606|NCT00607919|10909468|FG000|Acute Phase|Adverse Event|9
6892607|NCT00607919|10909469|FG001|Acute Phase|Adverse Event|2
6892608|NCT00607919|10909468|FG000|Acute Phase|Entry Criteria Not Met|1
6892609|NCT00607919|10909469|FG001|Acute Phase|Entry Criteria Not Met|1
6892610|NCT00607919|10909468|FG000|Acute Phase|Lack of Efficacy|1
6892611|NCT00607919|10909469|FG001|Acute Phase|Lack of Efficacy|2
6892612|NCT00607919|10909468|FG000|Acute Phase|Lost to Follow-up|9
6892613|NCT00607919|10909469|FG001|Acute Phase|Lost to Follow-up|3
6892614|NCT00607919|10909468|FG000|Acute Phase|Parent/Caregiver Decision|6
6892615|NCT00607919|10909469|FG001|Acute Phase|Parent/Caregiver Decision|4
6892616|NCT00607919|10909468|FG000|Acute Phase|Protocol Violation|5
6892617|NCT00607919|10909469|FG001|Acute Phase|Protocol Violation|1
6892618|NCT00607919|10909468|FG000|Acute Phase|Withdrawal by Subject|3
6892619|NCT00607919|10909469|FG001|Acute Phase|Withdrawal by Subject|3
6892620|NCT00607919|10909468|FG000|Open-Label Phase|Adverse Event|1
6892621|NCT00607919|10909469|FG001|Open-Label Phase|Adverse Event|5
6892622|NCT00607919|10909468|FG000|Open-Label Phase|Lost to Follow-up|4
6892623|NCT00607919|10909469|FG001|Open-Label Phase|Lost to Follow-up|1
6892624|NCT00607919|10909468|FG000|Open-Label Phase|Protocol Violation|2
6892625|NCT00607919|10909469|FG001|Open-Label Phase|Protocol Violation|2
6892626|NCT00607919|10909468|FG000|Open-Label Phase|Withdrawal by Subject|2
6892627|NCT00607919|10909469|FG001|Open-Label Phase|Withdrawal by Subject|2
6892628|NCT00607919|10909468|FG000|Open-Label Phase|Parent/Caregiver Decision|1
6970774|NCT01157377|11021106|FG002|Overall Study|Other Miscellaneous Reasons|0
6970775|NCT01157377|11021107|FG003|Overall Study|Other Miscellaneous Reasons|0
6970776|NCT01157377|11021108|FG004|Overall Study|Other Miscellaneous Reasons|1
6970777|NCT01157377|11021109|FG005|Overall Study|Other Miscellaneous Reasons|1
6970778|NCT01157377|11021110|FG006|Overall Study|Other Miscellaneous Reasons|1
6970779|NCT01157676|11021146|FG000|Randomization|Death|1
6970780|NCT01157676|11021147|FG001|Randomization|Death|1
6970781|NCT01157676|11021146|FG000|Randomization|unresectable|2
6892629|NCT00607919|10909469|FG001|Open-Label Phase|Parent/Caregiver Decision|2
6892630|NCT00607997|10909481|FG000|Overall Study|Lack of Efficacy|6
6892631|NCT00607997|10909482|FG001|Overall Study|Lack of Efficacy|20
6892632|NCT00607997|10909483|FG002|Overall Study|Lack of Efficacy|14
6892633|NCT00607997|10909484|FG003|Overall Study|Lack of Efficacy|10
6892634|NCT00607997|10909481|FG000|Overall Study|Death|8
6892635|NCT00607997|10909482|FG001|Overall Study|Death|5
6892636|NCT00607997|10909483|FG002|Overall Study|Death|2
6892637|NCT00607997|10909484|FG003|Overall Study|Death|5
6892638|NCT00607997|10909481|FG000|Overall Study|Adverse Event|3
6892639|NCT00607997|10909482|FG001|Overall Study|Adverse Event|1
6892640|NCT00607997|10909483|FG002|Overall Study|Adverse Event|2
6892641|NCT00607997|10909484|FG003|Overall Study|Adverse Event|0
6892642|NCT00607997|10909481|FG000|Overall Study|Physician Decision|4
6892643|NCT00607997|10909482|FG001|Overall Study|Physician Decision|1
6892644|NCT00607997|10909483|FG002|Overall Study|Physician Decision|0
6892645|NCT00607997|10909484|FG003|Overall Study|Physician Decision|0
6892646|NCT00607997|10909481|FG000|Overall Study|Relapse, recurrent illness|4
6892647|NCT00607997|10909482|FG001|Overall Study|Relapse, recurrent illness|0
6892648|NCT00607997|10909483|FG002|Overall Study|Relapse, recurrent illness|2
6892649|NCT00607997|10909484|FG003|Overall Study|Relapse, recurrent illness|0
6892650|NCT00607997|10909481|FG000|Overall Study|Other without explanation|2
6892651|NCT00607997|10909482|FG001|Overall Study|Other without explanation|0
6892652|NCT00607997|10909483|FG002|Overall Study|Other without explanation|4
6892653|NCT00607997|10909484|FG003|Overall Study|Other without explanation|1
6892654|NCT00608205|10909546|FG000|Overall Study|Adverse Event|3
6892655|NCT00608205|10909547|FG001|Overall Study|Adverse Event|2
6892656|NCT00608205|10909546|FG000|Overall Study|Patient non-compliant|0
6892657|NCT00608205|10909547|FG001|Overall Study|Patient non-compliant|1
6892658|NCT00608244|10909555|FG000|Overall Study|Adverse Event|1
6892659|NCT00608244|10909555|FG000|Overall Study|Low trough levels|1
6892660|NCT00608322|10909563|FG000|Overall Study|Death|2
6892661|NCT00608322|10909564|FG001|Overall Study|Death|1
6892662|NCT00608426|10909572|FG000|Overall Study|Death|32
6892663|NCT00608426|10909573|FG001|Overall Study|Death|36
6892664|NCT00608426|10909572|FG000|Overall Study|Lost to Follow-up|485
7079310|NCT02112448|11188330|FG001|Overall Study|required heparin so could not use ketoro|0
7079311|NCT02112877|11188353|FG000|Overall Study|Withdrawal by Subject|1
7079312|NCT02112877|11188354|FG001|Overall Study|Withdrawal by Subject|7
6892665|NCT00608426|10909573|FG001|Overall Study|Lost to Follow-up|521
6892666|NCT00608426|10909572|FG000|Overall Study|refused, health issues, wrong address|319
6892667|NCT00608426|10909573|FG001|Overall Study|refused, health issues, wrong address|348
6892668|NCT00608517|10909591|FG000|Overall Study|Death|1
6892669|NCT00608517|10909592|FG001|Overall Study|Death|0
6892670|NCT00608517|10909593|FG002|Overall Study|Death|0
7155879|NCT03349710|11323978|FG003|Treatment Period|admin reason by sponsor|19
7155880|NCT03349710|11323975|FG000|Treatment Period|Other Reason|2
6892671|NCT00608530|10909606|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11
6892672|NCT00608530|10909607|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5
6892673|NCT00608530|10909608|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
6892674|NCT00608530|10909609|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
6892675|NCT00608530|10909606|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
6892676|NCT00608530|10909607|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
6892677|NCT00608530|10909608|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
6892678|NCT00608530|10909609|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
6892679|NCT00608530|10909606|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
6892680|NCT00608530|10909607|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
6892681|NCT00608530|10909608|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2
6892682|NCT00608530|10909609|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3
6892683|NCT00608530|10909606|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0
6892684|NCT00608530|10909607|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0
6892685|NCT00608530|10909608|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2
6892686|NCT00608530|10909609|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0
6892687|NCT00608530|10909606|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0
6892688|NCT00608530|10909607|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0
6892689|NCT00608530|10909608|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4
6892690|NCT00608530|10909609|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1
6892691|NCT00608530|10909606|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
6892692|NCT00608530|10909607|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
6892693|NCT00608530|10909608|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1
6892694|NCT00608530|10909609|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
6892695|NCT00608543|10909624|FG000|Overall Study|Adverse Event|4
6892696|NCT00608569|10909631|FG000|Overall Study|Death|4
6892697|NCT00608569|10909632|FG001|Overall Study|Death|3
6892698|NCT00608569|10909631|FG000|Overall Study|Lost to Follow-up|4
6892699|NCT00608569|10909632|FG001|Overall Study|Lost to Follow-up|5
6892700|NCT00608569|10909631|FG000|Overall Study|Withdrawal by Subject|1
6892701|NCT00608569|10909632|FG001|Overall Study|Withdrawal by Subject|0
6892702|NCT00608569|10909631|FG000|Overall Study|Adverse Event|1
6892703|NCT00608569|10909632|FG001|Overall Study|Adverse Event|0
6892704|NCT00608569|10909631|FG000|Overall Study|Unable to adhere with study requirements|0
7155881|NCT03349710|11323976|FG001|Treatment Period|Other Reason|0
6892705|NCT00608569|10909632|FG001|Overall Study|Unable to adhere with study requirements|1
6892706|NCT00608582|10909640|FG000|Overall Study|Lost to Follow-up|2
6892707|NCT00608582|10909641|FG001|Overall Study|Lost to Follow-up|0
6892708|NCT00608582|10909640|FG000|Overall Study|No Best Response in Phase 1 located|1
6892709|NCT00608582|10909641|FG001|Overall Study|No Best Response in Phase 1 located|1
6892710|NCT00608582|10909640|FG000|Overall Study|Illicit Drug Use|1
6892711|NCT00608582|10909641|FG001|Overall Study|Illicit Drug Use|0
6892712|NCT00608582|10909640|FG000|Overall Study|Early stage Design Change|0
6892713|NCT00608582|10909641|FG001|Overall Study|Early stage Design Change|3
6892714|NCT00608829|10909664|FG000|Overall Study|Death|6
6892715|NCT00608829|10909664|FG000|Overall Study|Withdrawal by Subject|4
6892716|NCT00608829|10909664|FG000|Overall Study|Subject refuses to follow up or return.|5
6892717|NCT00608842|10909672|FG000|Overall Study|Participant's Request|0
6892718|NCT00608842|10909673|FG001|Overall Study|Participant's Request|1
6892719|NCT00608842|10909674|FG002|Overall Study|Participant's Request|2
6892720|NCT00608842|10909675|FG003|Overall Study|Participant's Request|1
6892721|NCT00608842|10909672|FG000|Overall Study|Lost to Follow-up|1
6892722|NCT00608842|10909673|FG001|Overall Study|Lost to Follow-up|0
7079313|NCT02112877|11188353|FG000|Overall Study|Visit Missed|1
7079314|NCT02112877|11188354|FG001|Overall Study|Visit Missed|6
7079315|NCT02112994|11188362|FG000|Overall Study|Progressive Disease|0
7079316|NCT02112994|11188363|FG001|Overall Study|Progressive Disease|0
7079317|NCT02112994|11188364|FG002|Overall Study|Progressive Disease|1
7079318|NCT02112994|11188362|FG000|Overall Study|Pregnancy|0
7079319|NCT02112994|11188363|FG001|Overall Study|Pregnancy|1
7079320|NCT02112994|11188364|FG002|Overall Study|Pregnancy|1
7079321|NCT02112994|11188362|FG000|Overall Study|Liver Transplant|0
7079322|NCT02112994|11188363|FG001|Overall Study|Liver Transplant|1
7079323|NCT02112994|11188364|FG002|Overall Study|Liver Transplant|0
7079324|NCT02112994|11188362|FG000|Overall Study|Withdrawal by Subject|0
6892723|NCT00608842|10909674|FG002|Overall Study|Lost to Follow-up|0
6892724|NCT00608842|10909675|FG003|Overall Study|Lost to Follow-up|0
6892725|NCT00608868|10909685|FG000|Overall Study|Withdrawal by Subject|7
6892726|NCT00608868|10909685|FG000|Overall Study|Protocol Violation|3
6892727|NCT00608868|10909685|FG000|Overall Study|Lost to Follow-up|2
6892728|NCT00608868|10909685|FG000|Overall Study|Adverse Event|1
6892729|NCT00608868|10909685|FG000|Overall Study|Physician Decision|2
6892730|NCT00608881|10909691|FG000|Overall Study|Death|22
6892731|NCT00608881|10909692|FG001|Overall Study|Death|13
6892732|NCT00608881|10909691|FG000|Overall Study|Adverse Event|5
6892733|NCT00608881|10909692|FG001|Overall Study|Adverse Event|3
6892734|NCT00608881|10909691|FG000|Overall Study|Lost to Follow-up|28
6892735|NCT00608881|10909692|FG001|Overall Study|Lost to Follow-up|14
6892736|NCT00608881|10909691|FG000|Overall Study|Withdrawal by Subject|18
6892737|NCT00608881|10909692|FG001|Overall Study|Withdrawal by Subject|29
6892738|NCT00608881|10909691|FG000|Overall Study|Physician Decision|5
6892739|NCT00608881|10909692|FG001|Overall Study|Physician Decision|5
6892740|NCT00608881|10909691|FG000|Overall Study|Institutionalized|1
6892741|NCT00608881|10909692|FG001|Overall Study|Institutionalized|2
6892742|NCT00608894|10909700|FG000|Overall Study|Withdrawal by Subject|0
6892743|NCT00608894|10909701|FG001|Overall Study|Withdrawal by Subject|2
6892744|NCT00608907|10909712|FG000|Overall Study|Adverse Event|6
6892745|NCT00608907|10909713|FG001|Overall Study|Adverse Event|0
6892746|NCT00608907|10909714|FG002|Overall Study|Adverse Event|1
6892747|NCT00608907|10909712|FG000|Overall Study|Death|1
6892748|NCT00608907|10909713|FG001|Overall Study|Death|0
6892749|NCT00608907|10909714|FG002|Overall Study|Death|0
6892750|NCT00608907|10909712|FG000|Overall Study|Withdrawal by Subject|4
6892751|NCT00608907|10909713|FG001|Overall Study|Withdrawal by Subject|0
6892752|NCT00608907|10909714|FG002|Overall Study|Withdrawal by Subject|0
6892753|NCT00608907|10909712|FG000|Overall Study|Progressive Disease|1
6892754|NCT00608907|10909713|FG001|Overall Study|Progressive Disease|0
6892755|NCT00608907|10909714|FG002|Overall Study|Progressive Disease|0
6892756|NCT00608959|10909724|FG000|Part 1|Did not meet eligibility criteria|1
6892757|NCT00608985|10909738|FG000|Overall Study|Adverse Event|2
6892758|NCT00608985|10909739|FG001|Overall Study|Adverse Event|7
6892759|NCT00608985|10909740|FG002|Overall Study|Adverse Event|4
6892760|NCT00608985|10909741|FG003|Overall Study|Adverse Event|6
6892761|NCT00608985|10909738|FG000|Overall Study|Administrative/Other|7
6892762|NCT00608985|10909739|FG001|Overall Study|Administrative/Other|4
6892763|NCT00608985|10909740|FG002|Overall Study|Administrative/Other|1
6892764|NCT00608985|10909741|FG003|Overall Study|Administrative/Other|2
6892765|NCT00608985|10909738|FG000|Overall Study|Withdrawal of Consent|5
6892766|NCT00608985|10909739|FG001|Overall Study|Withdrawal of Consent|1
6892767|NCT00608985|10909740|FG002|Overall Study|Withdrawal of Consent|1
6892768|NCT00608985|10909741|FG003|Overall Study|Withdrawal of Consent|1
6892769|NCT00608985|10909738|FG000|Overall Study|Lost to Follow-up|2
6892770|NCT00608985|10909739|FG001|Overall Study|Lost to Follow-up|1
6892771|NCT00608985|10909740|FG002|Overall Study|Lost to Follow-up|0
6892772|NCT00608985|10909741|FG003|Overall Study|Lost to Follow-up|0
6892773|NCT00609167|10909758|FG000|Overall Study|Withdrawal by Subject|1
6892774|NCT00609167|10909759|FG001|Overall Study|Withdrawal by Subject|0
6892775|NCT00609167|10909758|FG000|Overall Study|Lack of Efficacy|1
6892776|NCT00609167|10909759|FG001|Overall Study|Lack of Efficacy|0
7079325|NCT02112994|11188363|FG001|Overall Study|Withdrawal by Subject|0
6892777|NCT00609167|10909758|FG000|Overall Study|Adverse Event|5
6892778|NCT00609167|10909759|FG001|Overall Study|Adverse Event|1
6892779|NCT00609167|10909758|FG000|Overall Study|Disease Progression|1
6892780|NCT00609167|10909759|FG001|Overall Study|Disease Progression|0
6892781|NCT00609167|10909758|FG000|Overall Study|Stem Cell Transplant|0
6892782|NCT00609167|10909759|FG001|Overall Study|Stem Cell Transplant|6
6892783|NCT00609245|10909765|FG000|Overall Study|Adverse Event|1
6892784|NCT00609336|10909780|FG000|Overall Study|Protocol Violation|3
6892785|NCT00609336|10909780|FG000|Overall Study|Death|1
7079326|NCT02112994|11188364|FG002|Overall Study|Withdrawal by Subject|1
7079327|NCT02113007|11188376|FG000|Overall Study|Progressive disease|2
6892786|NCT00609336|10909780|FG000|Overall Study|LA or Met at Surgery|9
6892787|NCT00609362|10909787|FG000|Overall Study|Withdrawal by Subject|2
6892788|NCT00609362|10909788|FG001|Overall Study|Withdrawal by Subject|1
6892789|NCT00609362|10909787|FG000|Overall Study|Adverse Event|1
6892790|NCT00609362|10909788|FG001|Overall Study|Adverse Event|0
6892791|NCT00609466|10909797|FG000|Overall Study|Withdrawal by Subject|0
6892792|NCT00609466|10909798|FG001|Overall Study|Withdrawal by Subject|1
6892793|NCT00609466|10909799|FG002|Overall Study|Withdrawal by Subject|1
6892794|NCT00609466|10909797|FG000|Overall Study|Adverse Event|2
6892795|NCT00609466|10909798|FG001|Overall Study|Adverse Event|3
6892796|NCT00609466|10909799|FG002|Overall Study|Adverse Event|1
6892797|NCT00609466|10909797|FG000|Overall Study|Lack of Efficacy|0
6892798|NCT00609466|10909798|FG001|Overall Study|Lack of Efficacy|2
6892799|NCT00609466|10909799|FG002|Overall Study|Lack of Efficacy|2
6892800|NCT00609492|10909810|FG000|Overall Study|Withdrawal by Subject|0
6892801|NCT00609492|10909811|FG001|Overall Study|Withdrawal by Subject|2
6892802|NCT00609492|10909812|FG002|Overall Study|Withdrawal by Subject|3
6892803|NCT00609492|10909810|FG000|Overall Study|Lost to Follow-up|1
6892804|NCT00609492|10909811|FG001|Overall Study|Lost to Follow-up|1
6892805|NCT00609492|10909812|FG002|Overall Study|Lost to Follow-up|4
6892806|NCT00609518|10909824|FG000|Overall Study|Death from Study Disease|32
6892807|NCT00609518|10909825|FG001|Overall Study|Death from Study Disease|32
6892808|NCT00609518|10909824|FG000|Overall Study|Withdrawal by Subject|5
6892809|NCT00609518|10909825|FG001|Overall Study|Withdrawal by Subject|3
6892810|NCT00609518|10909824|FG000|Overall Study|Lost to Follow-up|3
6892811|NCT00609518|10909825|FG001|Overall Study|Lost to Follow-up|0
6892812|NCT00609518|10909824|FG000|Overall Study|Physician Decision|1
6892813|NCT00609518|10909825|FG001|Overall Study|Physician Decision|3
6892814|NCT00609518|10909824|FG000|Overall Study|Death from Adverse Event|2
6892815|NCT00609518|10909825|FG001|Overall Study|Death from Adverse Event|2
6892816|NCT00609609|10909833|FG000|Overall Study|Withdrawal by Subject|2
6892817|NCT00609609|10909834|FG001|Overall Study|Withdrawal by Subject|0
6892818|NCT00609609|10909833|FG000|Overall Study|Progression|4
6892819|NCT00609609|10909834|FG001|Overall Study|Progression|2
6892820|NCT00609622|10909842|FG000|Overall Study|Adverse Event|14
6892821|NCT00609622|10909843|FG001|Overall Study|Adverse Event|10
6892822|NCT00609622|10909842|FG000|Overall Study|Withdrawal by Subject|4
6892823|NCT00609622|10909843|FG001|Overall Study|Withdrawal by Subject|20
6892824|NCT00609622|10909842|FG000|Overall Study|Death|1
6892825|NCT00609622|10909843|FG001|Overall Study|Death|4
6892826|NCT00609622|10909842|FG000|Overall Study|Protocol Violation|1
6892827|NCT00609622|10909843|FG001|Overall Study|Protocol Violation|1
6892828|NCT00609622|10909842|FG000|Overall Study|Objective progression or relapse|47
6892829|NCT00609622|10909843|FG001|Overall Study|Objective progression or relapse|41
6892830|NCT00609622|10909842|FG000|Overall Study|Study terminated by sponsor|16
6892831|NCT00609622|10909843|FG001|Overall Study|Study terminated by sponsor|3
6892832|NCT00609622|10909842|FG000|Overall Study|Other|7
6892833|NCT00609622|10909843|FG001|Overall Study|Other|14
6892834|NCT00609622|10909842|FG000|Overall Study|Global deterioration of health status|6
6892835|NCT00609622|10909843|FG001|Overall Study|Global deterioration of health status|2
6892836|NCT00609674|10909851|FG000|Overall Study|Adverse Event|1
6892837|NCT00609674|10909852|FG001|Overall Study|Adverse Event|1
6892838|NCT00609674|10909851|FG000|Overall Study|Protocol Violation|3
6892839|NCT00609674|10909852|FG001|Overall Study|Protocol Violation|5
6892840|NCT00609674|10909851|FG000|Overall Study|Lost to Follow-up|1
6892841|NCT00609674|10909852|FG001|Overall Study|Lost to Follow-up|0
6892842|NCT00609674|10909851|FG000|Overall Study|Withdrew consent|2
6892843|NCT00609674|10909852|FG001|Overall Study|Withdrew consent|1
6892844|NCT00609869|10909874|FG000|Overall Study|Withdrawn, ischemic stroke|1
6892845|NCT00609869|10909874|FG000|Overall Study|Severe hematologic toxicity|1
6892846|NCT00609869|10909874|FG000|Overall Study|Withdrawal by Subject|1
6892847|NCT00609869|10909874|FG000|Overall Study|Seizures|1
6892848|NCT00609869|10909874|FG000|Overall Study|Severe tumor flare reaction|1
6892849|NCT00609869|10909874|FG000|Overall Study|Hepatitis B infection|1
6892850|NCT00609869|10909874|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1
6892851|NCT00609869|10909874|FG000|Overall Study|Mantle cell: not evaluable|4
6892852|NCT00609947|10909878|FG000|Overall Study|Death|1
6892853|NCT00609973|10909885|FG000|Overall Study|Adverse Event|2
6892854|NCT00609973|10909886|FG001|Overall Study|Adverse Event|1
6892855|NCT00609973|10909885|FG000|Overall Study|Protocol Violation|4
6892856|NCT00609973|10909886|FG001|Overall Study|Protocol Violation|3
6892857|NCT00609973|10909885|FG000|Overall Study|Lost to Follow-up|2
6892858|NCT00609973|10909886|FG001|Overall Study|Lost to Follow-up|1
6892859|NCT00609973|10909885|FG000|Overall Study|Withdrawal by Subject|0
6892860|NCT00609973|10909886|FG001|Overall Study|Withdrawal by Subject|1
6892861|NCT00609986|10909894|FG000|Overall Study|Did not receive transplant or treatment|8
6892862|NCT00609986|10909895|FG001|Overall Study|Did not receive transplant or treatment|3
6892863|NCT00610129|10909905|FG000|Overall Study|Not treated since patients ineligible|3
6892864|NCT00610155|10909909|FG000|Period 1|Withdrawal by Subject|0
6892865|NCT00610155|10909910|FG001|Period 1|Withdrawal by Subject|0
6892866|NCT00610155|10909911|FG002|Period 1|Withdrawal by Subject|1
6892867|NCT00610155|10909912|FG003|Period 1|Withdrawal by Subject|0
6892868|NCT00610155|10909913|FG004|Period 1|Withdrawal by Subject|0
6892869|NCT00610155|10909914|FG005|Period 1|Withdrawal by Subject|0
6892870|NCT00610155|10909909|FG000|Period 3|Adverse Event|1
6892871|NCT00610155|10909910|FG001|Period 3|Adverse Event|0
6892872|NCT00610155|10909911|FG002|Period 3|Adverse Event|0
6892873|NCT00610155|10909912|FG003|Period 3|Adverse Event|0
6892874|NCT00610155|10909913|FG004|Period 3|Adverse Event|0
6892875|NCT00610155|10909914|FG005|Period 3|Adverse Event|0
6892876|NCT00610168|10909924|FG000|Overall Study|Withdrawal by Subject|2
6892877|NCT00610168|10909925|FG001|Overall Study|Withdrawal by Subject|0
6892878|NCT00610207|10909931|FG000|Overall Study|Lost to Follow-up|3
6892879|NCT00610363|10909941|FG000|Overall Study|Non-compliance with protocol|0
6892880|NCT00610363|10909942|FG001|Overall Study|Non-compliance with protocol|1
6892881|NCT00610363|10909941|FG000|Overall Study|Adverse Event|3
6892882|NCT00610363|10909942|FG001|Overall Study|Adverse Event|1
6892883|NCT00610363|10909941|FG000|Overall Study|Lack of Efficacy|2
6892884|NCT00610363|10909942|FG001|Overall Study|Lack of Efficacy|0
6892885|NCT00610363|10909941|FG000|Overall Study|Lost to Follow-up|4
6892886|NCT00610363|10909942|FG001|Overall Study|Lost to Follow-up|0
6892887|NCT00610363|10909941|FG000|Overall Study|Withdrawal by Subject|1
6892888|NCT00610363|10909942|FG001|Overall Study|Withdrawal by Subject|0
6892889|NCT00610363|10909941|FG000|Overall Study|Other than specified above|1
6892890|NCT00610363|10909942|FG001|Overall Study|Other than specified above|1
6892891|NCT00610441|10909966|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1
6892892|NCT00610441|10909967|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1
6892893|NCT00610441|10909968|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4
6892894|NCT00610441|10909969|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1
6892895|NCT00610441|10909966|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
6892896|NCT00610441|10909967|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
6892897|NCT00610441|10909968|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1
6892898|NCT00610441|10909969|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
6892899|NCT00610441|10909966|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
6892900|NCT00610441|10909967|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
6892901|NCT00610441|10909968|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
6892902|NCT00610441|10909969|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0
6892903|NCT00610441|10909966|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
6892904|NCT00610441|10909967|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0
6892905|NCT00610441|10909968|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
6892906|NCT00610441|10909969|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
6892907|NCT00610441|10909966|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0
6892908|NCT00610441|10909967|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0
6892909|NCT00610441|10909968|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2
6892910|NCT00610441|10909969|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0
6892911|NCT00610441|10909966|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
6892912|NCT00610441|10909967|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1
6892913|NCT00610441|10909968|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
6892914|NCT00610441|10909969|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
6892915|NCT00610441|10909966|FG000|Treatment Period 2 - 3 Weeks|Other|1
6892916|NCT00610441|10909967|FG001|Treatment Period 2 - 3 Weeks|Other|1
6892917|NCT00610441|10909968|FG002|Treatment Period 2 - 3 Weeks|Other|0
6892918|NCT00610441|10909969|FG003|Treatment Period 2 - 3 Weeks|Other|1
6892919|NCT00610441|10909966|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0
6892920|NCT00610441|10909967|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0
6892921|NCT00610441|10909968|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0
6892922|NCT00610441|10909969|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1
6892923|NCT00610441|10909966|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1
6892924|NCT00610441|10909967|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
6892925|NCT00610441|10909968|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
6892926|NCT00610441|10909969|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
6892927|NCT00610649|10910001|FG000|Overall Study|Adverse Event|1
6892928|NCT00610649|10910002|FG001|Overall Study|Adverse Event|0
6892929|NCT00610649|10910003|FG002|Overall Study|Adverse Event|0
6892930|NCT00610649|10910004|FG003|Overall Study|Adverse Event|0
6892931|NCT00610649|10910005|FG004|Overall Study|Adverse Event|0
6892932|NCT00610649|10910006|FG005|Overall Study|Adverse Event|0
6892933|NCT00610649|10910007|FG006|Overall Study|Adverse Event|0
6892934|NCT00610649|10910008|FG007|Overall Study|Adverse Event|0
6892935|NCT00610649|10910009|FG008|Overall Study|Adverse Event|0
6892936|NCT00610649|10910010|FG009|Overall Study|Adverse Event|0
6892937|NCT00610649|10910011|FG010|Overall Study|Adverse Event|1
6892938|NCT00610649|10910001|FG000|Overall Study|Family Emergency|0
6892939|NCT00610649|10910002|FG001|Overall Study|Family Emergency|1
6892940|NCT00610649|10910003|FG002|Overall Study|Family Emergency|0
6892941|NCT00610649|10910004|FG003|Overall Study|Family Emergency|0
6892942|NCT00610649|10910005|FG004|Overall Study|Family Emergency|0
6892943|NCT00610649|10910006|FG005|Overall Study|Family Emergency|0
7041334|NCT01726049|11124890|FG000|Overall Study|Adverse Event|4
6892944|NCT00610649|10910007|FG006|Overall Study|Family Emergency|0
7041335|NCT01726049|11124891|FG001|Overall Study|Adverse Event|1
6892945|NCT00610649|10910008|FG007|Overall Study|Family Emergency|0
6892946|NCT00610649|10910009|FG008|Overall Study|Family Emergency|0
6892947|NCT00610649|10910010|FG009|Overall Study|Family Emergency|0
7041336|NCT01726049|11124890|FG000|Overall Study|refused second HC|0
6892948|NCT00610649|10910011|FG010|Overall Study|Family Emergency|0
6892949|NCT00610649|10910001|FG000|Overall Study|Withdrawal by Subject|0
6892950|NCT00610649|10910002|FG001|Overall Study|Withdrawal by Subject|0
6892951|NCT00610649|10910003|FG002|Overall Study|Withdrawal by Subject|0
6892952|NCT00610649|10910004|FG003|Overall Study|Withdrawal by Subject|0
6892953|NCT00610649|10910005|FG004|Overall Study|Withdrawal by Subject|0
6892954|NCT00610649|10910006|FG005|Overall Study|Withdrawal by Subject|0
6892955|NCT00610649|10910007|FG006|Overall Study|Withdrawal by Subject|0
6892956|NCT00610649|10910008|FG007|Overall Study|Withdrawal by Subject|0
6892957|NCT00610649|10910009|FG008|Overall Study|Withdrawal by Subject|0
6892958|NCT00610649|10910010|FG009|Overall Study|Withdrawal by Subject|1
6892959|NCT00610649|10910011|FG010|Overall Study|Withdrawal by Subject|0
6892960|NCT00610675|10910035|FG000|Overall Study|Untreated|4
6892961|NCT00610675|10910035|FG000|Overall Study|Adverse Event|67
6892962|NCT00610675|10910035|FG000|Overall Study|Insufficient Effect|31
6892963|NCT00610675|10910035|FG000|Overall Study|Withdrawal by Subject|28
6892964|NCT00610675|10910035|FG000|Overall Study|Reasons unrelated to trial|27
6892965|NCT00610675|10910035|FG000|Overall Study|Lack of Compliance|7
6892966|NCT00610675|10910035|FG000|Overall Study|Lost to Follow-up|31
6892967|NCT00610675|10910035|FG000|Overall Study|Other reason (not specified)|25
6892968|NCT00610714|10910063|FG000|Overall Study|Adverse Event|3
6892969|NCT00610714|10910064|FG001|Overall Study|Adverse Event|1
6892970|NCT00610714|10910063|FG000|Overall Study|Death|12
6892971|NCT00610714|10910064|FG001|Overall Study|Death|18
6892972|NCT00610714|10910063|FG000|Overall Study|Withdrawal by Subject|9
6892973|NCT00610714|10910064|FG001|Overall Study|Withdrawal by Subject|3
6892974|NCT00610714|10910063|FG000|Overall Study|Study completion at 120 PFS events|2
6892975|NCT00610714|10910064|FG001|Overall Study|Study completion at 120 PFS events|2
6892976|NCT00610857|10910103|FG000|Overall Study|Not evaluable for response|2
6892977|NCT00610935|10910113|FG000|Overall Study|Lost to Follow-up|0
6892978|NCT00610935|10910114|FG001|Overall Study|Lost to Follow-up|1
6892979|NCT00610935|10910113|FG000|Overall Study|Withdrawal by Subject|0
6892980|NCT00610935|10910114|FG001|Overall Study|Withdrawal by Subject|2
6892981|NCT00610935|10910113|FG000|Overall Study|Sponsor Discontinuation|1
6892982|NCT00610935|10910114|FG001|Overall Study|Sponsor Discontinuation|0
6892983|NCT00611026|10910132|FG000|Randomized to Double-blind Treatment|Not treated|2
6892984|NCT00611026|10910133|FG001|Randomized to Double-blind Treatment|Not treated|1
6892985|NCT00611026|10910134|FG002|Randomized to Double-blind Treatment|Not treated|3
6892986|NCT00611026|10910132|FG000|Double-blind Treatment Period|Death|1
6892987|NCT00611026|10910133|FG001|Double-blind Treatment Period|Death|0
6892988|NCT00611026|10910134|FG002|Double-blind Treatment Period|Death|0
6892989|NCT00611026|10910132|FG000|Double-blind Treatment Period|Adverse Event|9
6892990|NCT00611026|10910133|FG001|Double-blind Treatment Period|Adverse Event|28
6892991|NCT00611026|10910134|FG002|Double-blind Treatment Period|Adverse Event|46
6892992|NCT00611026|10910132|FG000|Double-blind Treatment Period|Lack of Efficacy|11
6892993|NCT00611026|10910133|FG001|Double-blind Treatment Period|Lack of Efficacy|10
6892994|NCT00611026|10910134|FG002|Double-blind Treatment Period|Lack of Efficacy|4
6892995|NCT00611026|10910132|FG000|Double-blind Treatment Period|Lost to Follow-up|6
6892996|NCT00611026|10910133|FG001|Double-blind Treatment Period|Lost to Follow-up|11
6892997|NCT00611026|10910134|FG002|Double-blind Treatment Period|Lost to Follow-up|14
6892998|NCT00611026|10910132|FG000|Double-blind Treatment Period|Withdrawal by Subject|7
6892999|NCT00611026|10910133|FG001|Double-blind Treatment Period|Withdrawal by Subject|19
6893000|NCT00611026|10910134|FG002|Double-blind Treatment Period|Withdrawal by Subject|16
6893001|NCT00611026|10910132|FG000|Double-blind Treatment Period|Other|13
6893002|NCT00611026|10910133|FG001|Double-blind Treatment Period|Other|20
6893003|NCT00611026|10910134|FG002|Double-blind Treatment Period|Other|18
6893004|NCT00611130|10910146|FG000|Overall Study|Lost to Follow-up|25
6893005|NCT00611130|10910147|FG001|Overall Study|Lost to Follow-up|29
6893006|NCT00611130|10910146|FG000|Overall Study|Protocol noncompliance|7
7079328|NCT02113124|11188382|FG000|Overall Study|Unable to retrieve blood sample|1
7079329|NCT02113124|11188383|FG001|Overall Study|Unable to retrieve blood sample|1
7079330|NCT02113189|11188392|FG000|Overall Study|Lost to follow up|2
7079331|NCT02113189|11188393|FG001|Overall Study|Lost to follow up|1
7079332|NCT02113189|11188394|FG002|Overall Study|Lost to follow up|3
7079333|NCT02113436|11188427|FG000|Period 1: 8 Weeks|Adverse Event|1
7079334|NCT02113436|11188428|FG001|Period 1: 8 Weeks|Adverse Event|0
7079335|NCT02113436|11188429|FG002|Period 1: 8 Weeks|Adverse Event|0
7079336|NCT02113436|11188430|FG003|Period 1: 8 Weeks|Adverse Event|0
7079337|NCT02113436|11188427|FG000|Period 1: 8 Weeks|Protocol Violation|1
7079338|NCT02113436|11188428|FG001|Period 1: 8 Weeks|Protocol Violation|0
7079339|NCT02113436|11188429|FG002|Period 1: 8 Weeks|Protocol Violation|0
7079340|NCT02113436|11188430|FG003|Period 1: 8 Weeks|Protocol Violation|0
7079341|NCT02113436|11188427|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5
7079342|NCT02113436|11188428|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2
7079343|NCT02113436|11188429|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
7079344|NCT02113436|11188430|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
6893007|NCT00611130|10910147|FG001|Overall Study|Protocol noncompliance|6
6893008|NCT00611130|10910146|FG000|Overall Study|Withdrawal by Subject|6
7079345|NCT02113436|11188427|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1
7079346|NCT02113436|11188428|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0
7079347|NCT02113436|11188429|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0
7079348|NCT02113436|11188430|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0
7079349|NCT02113436|11188427|FG000|Period 2: 16 Weeks|Adverse Event|0
7079350|NCT02113436|11188428|FG001|Period 2: 16 Weeks|Adverse Event|0
7079351|NCT02113436|11188429|FG002|Period 2: 16 Weeks|Adverse Event|4
7079352|NCT02113436|11188430|FG003|Period 2: 16 Weeks|Adverse Event|5
7079353|NCT02113436|11188427|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
7079354|NCT02113436|11188428|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
7079355|NCT02113436|11188429|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2
7079356|NCT02113436|11188430|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5
7079357|NCT02113436|11188427|FG000|Period 2: 16 Weeks|Physician Decision|0
7079358|NCT02113436|11188428|FG001|Period 2: 16 Weeks|Physician Decision|0
7079359|NCT02113436|11188429|FG002|Period 2: 16 Weeks|Physician Decision|2
7079360|NCT02113436|11188430|FG003|Period 2: 16 Weeks|Physician Decision|0
7079361|NCT02113436|11188427|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0
7079362|NCT02113436|11188428|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0
7079363|NCT02113436|11188429|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1
7079364|NCT02113436|11188430|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1
7079365|NCT02113449|11188439|FG000|Overall Study|Adverse Event|4
6893009|NCT00611130|10910147|FG001|Overall Study|Withdrawal by Subject|5
6893010|NCT00611130|10910146|FG000|Overall Study|Other|5
6893011|NCT00611130|10910147|FG001|Overall Study|Other|4
6893012|NCT00611130|10910146|FG000|Overall Study|Incarceration|3
6893013|NCT00611130|10910147|FG001|Overall Study|Incarceration|2
6893014|NCT00611130|10910146|FG000|Overall Study|Administrative|1
6893015|NCT00611130|10910147|FG001|Overall Study|Administrative|1
6893016|NCT00611130|10910146|FG000|Overall Study|Adverse Event|1
6893017|NCT00611130|10910147|FG001|Overall Study|Adverse Event|0
6893018|NCT00611130|10910146|FG000|Overall Study|Death|1
6893019|NCT00611130|10910147|FG001|Overall Study|Death|0
6893020|NCT00611247|10910156|FG000|Overall Study|Death|1
6893021|NCT00611247|10910157|FG001|Overall Study|Death|5
6893022|NCT00611247|10910156|FG000|Overall Study|Lack of Efficacy|1
6893023|NCT00611247|10910157|FG001|Overall Study|Lack of Efficacy|16
6893024|NCT00611455|10910197|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2
6893025|NCT00611455|10910198|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8
6893026|NCT00611455|10910199|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0
6893027|NCT00611455|10910197|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2
6893028|NCT00611455|10910198|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
6893029|NCT00611455|10910199|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
6893030|NCT00611455|10910197|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4
6893031|NCT00611455|10910198|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1
6893032|NCT00611455|10910199|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0
6893033|NCT00611455|10910197|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2
6893034|NCT00611455|10910198|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3
6893035|NCT00611455|10910199|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
6893036|NCT00611455|10910197|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
6893037|NCT00611455|10910198|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
6893038|NCT00611455|10910199|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0
6893039|NCT00611455|10910197|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1
6893040|NCT00611455|10910198|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
6893041|NCT00611455|10910199|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
6893042|NCT00611455|10910197|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0
6893043|NCT00611455|10910198|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17
6893044|NCT00611455|10910199|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0
6893045|NCT00611455|10910197|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
6893046|NCT00611455|10910198|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9
6893047|NCT00611455|10910199|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
6893048|NCT00611455|10910197|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0
6893049|NCT00611455|10910198|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3
6893050|NCT00611455|10910199|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0
6893051|NCT00611455|10910197|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
6893052|NCT00611455|10910198|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12
6893053|NCT00611455|10910199|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
6893054|NCT00611455|10910197|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
6893055|NCT00611455|10910198|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110
6893056|NCT00611455|10910199|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
6893057|NCT00611455|10910197|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
6893058|NCT00611455|10910198|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5
6893059|NCT00611455|10910199|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
6893060|NCT00611455|10910197|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0
6893061|NCT00611455|10910198|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5
6893062|NCT00611455|10910199|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0
6893063|NCT00611455|10910197|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
7079366|NCT02113579|11188449|FG000|Overall Study|Adverse Event|1
7079367|NCT02113579|11188450|FG001|Overall Study|Adverse Event|0
7079368|NCT02113579|11188449|FG000|Overall Study|Withdrawal by Subject|3
7079369|NCT02113579|11188450|FG001|Overall Study|Withdrawal by Subject|2
6893064|NCT00611455|10910198|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18
6893065|NCT00611455|10910199|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
6893066|NCT00611455|10910197|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0
6893067|NCT00611455|10910198|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0
6893068|NCT00611455|10910199|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30
6893069|NCT00611455|10910197|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
6893070|NCT00611455|10910198|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
6893071|NCT00611455|10910199|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12
6893072|NCT00611455|10910197|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
6893073|NCT00611455|10910198|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
6893074|NCT00611455|10910199|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4
6893075|NCT00611455|10910197|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
6893076|NCT00611455|10910198|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
6893077|NCT00611455|10910199|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23
6893078|NCT00611455|10910197|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
6893079|NCT00611455|10910198|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
6893080|NCT00611455|10910199|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80
6893081|NCT00611455|10910197|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
6893082|NCT00611455|10910198|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
6893083|NCT00611455|10910199|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13
7079370|NCT02113579|11188449|FG000|Overall Study|Lost to Follow-up|6
7079371|NCT02113579|11188450|FG001|Overall Study|Lost to Follow-up|2
7079372|NCT02113956|11188458|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5
7079373|NCT02113956|11188459|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1
7079374|NCT02113956|11188458|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4
7079375|NCT02113956|11188459|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3
7079376|NCT02113956|11188458|FG000|3 Month Post-intervention|Lost to Follow-up|4
7079377|NCT02113956|11188459|FG001|3 Month Post-intervention|Lost to Follow-up|2
7079378|NCT02114151|11188465|FG000|Overall Study|Death|1
6893084|NCT00611455|10910197|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
6893085|NCT00611455|10910198|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
6893086|NCT00611455|10910199|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49
6893087|NCT00611533|10910216|FG000|First Intervention (6 Weeks)|Never started study|0
6893088|NCT00611533|10910217|FG001|First Intervention (6 Weeks)|Never started study|1
6893089|NCT00611533|10910216|FG000|First Intervention (6 Weeks)|Adverse Event|0
6893090|NCT00611533|10910217|FG001|First Intervention (6 Weeks)|Adverse Event|1
6893091|NCT00611533|10910216|FG000|Second Intervention (6 Weeks)|Adverse Event|0
6893092|NCT00611533|10910217|FG001|Second Intervention (6 Weeks)|Adverse Event|2
6893093|NCT00611559|10910227|FG000|Overall Study|Lost to Follow-up|0
6893094|NCT00611559|10910228|FG001|Overall Study|Lost to Follow-up|1
6893095|NCT00611559|10910229|FG002|Overall Study|Lost to Follow-up|0
6893096|NCT00611559|10910227|FG000|Overall Study|Protocol Violation|1
6893097|NCT00611559|10910228|FG001|Overall Study|Protocol Violation|0
6893098|NCT00611559|10910229|FG002|Overall Study|Protocol Violation|1
6970782|NCT01157676|11021147|FG001|Randomization|unresectable|3
6970783|NCT01157676|11021146|FG000|Randomization|Withdrawal by Subject|17
6970784|NCT01157676|11021147|FG001|Randomization|Withdrawal by Subject|13
6970785|NCT01157676|11021146|FG000|Randomization|Physician Decision|1
6970786|NCT01157676|11021147|FG001|Randomization|Physician Decision|0
6970787|NCT01157676|11021146|FG000|Surgery|underwent open cystectomy|0
6970788|NCT01157676|11021147|FG001|Surgery|underwent open cystectomy|4
6970789|NCT01157676|11021146|FG000|Surgery|converted to open procedure|0
6970790|NCT01157676|11021147|FG001|Surgery|converted to open procedure|5
6970791|NCT01157676|11021146|FG000|Surgery|underwent robotic cystectomy|1
6970792|NCT01157676|11021147|FG001|Surgery|underwent robotic cystectomy|0
6970793|NCT01157845|11021159|FG000|Overall Study|Lost to Follow-up|5
6970794|NCT01157845|11021159|FG000|Overall Study|Withdrawal by Subject|12
6970795|NCT01157845|11021159|FG000|Overall Study|Physician Decision|3
6970796|NCT01157845|11021159|FG000|Overall Study|Protocol Violation|13
6970797|NCT01157845|11021159|FG000|Overall Study|Study was ended|1
6970798|NCT01157845|11021159|FG000|Overall Study|Device malfunction|1
6970799|NCT01157897|11021167|FG000|Overall Study|Lost to Follow-up|2
6970800|NCT01157897|11021168|FG001|Overall Study|Lost to Follow-up|0
6970801|NCT01157897|11021169|FG002|Overall Study|Lost to Follow-up|0
6970802|NCT01157897|11021170|FG003|Overall Study|Lost to Follow-up|1
6970803|NCT01157897|11021167|FG000|Overall Study|Relocated|0
6970804|NCT01157897|11021168|FG001|Overall Study|Relocated|2
6970805|NCT01157897|11021169|FG002|Overall Study|Relocated|0
6970806|NCT01157897|11021170|FG003|Overall Study|Relocated|0
6970807|NCT01158118|11021182|FG000|Overall Study|Screen failure|1
6970808|NCT01158118|11021183|FG001|Overall Study|Screen failure|0
6970809|NCT01158118|11021182|FG000|Overall Study|Donor match was a screen failure|0
6970810|NCT01158118|11021183|FG001|Overall Study|Donor match was a screen failure|1
6970811|NCT01158118|11021182|FG000|Overall Study|Suffered stroke prior to transplant|0
6970812|NCT01158118|11021183|FG001|Overall Study|Suffered stroke prior to transplant|1
6970813|NCT01158118|11021182|FG000|Overall Study|Death|0
6893099|NCT00611715|10910244|FG000|Overall Study|Disease Progression|24
6893100|NCT00611715|10910245|FG001|Overall Study|Disease Progression|4
6893101|NCT00611715|10910244|FG000|Overall Study|Withdrawal by Subject|5
6893102|NCT00611715|10910245|FG001|Overall Study|Withdrawal by Subject|1
6893103|NCT00611715|10910244|FG000|Overall Study|Adverse Event|9
6893104|NCT00611715|10910245|FG001|Overall Study|Adverse Event|1
6893105|NCT00611715|10910244|FG000|Overall Study|Death|1
6893106|NCT00611715|10910245|FG001|Overall Study|Death|0
6893107|NCT00611715|10910244|FG000|Overall Study|two patients are still on treatment|2
6893108|NCT00611715|10910245|FG001|Overall Study|two patients are still on treatment|0
6893109|NCT00611767|10910259|FG000|Overall Study|Withdrawal by Subject|4
6893110|NCT00611767|10910260|FG001|Overall Study|Withdrawal by Subject|1
6893111|NCT00611767|10910259|FG000|Overall Study|Thiopental not available|3
6893112|NCT00611767|10910260|FG001|Overall Study|Thiopental not available|0
6893113|NCT00611767|10910259|FG000|Overall Study|didn't like the medication|1
6893114|NCT00611767|10910260|FG001|Overall Study|didn't like the medication|1
6893115|NCT00611767|10910259|FG000|Overall Study|Physician Decision|1
6893116|NCT00611767|10910260|FG001|Overall Study|Physician Decision|0
6893117|NCT00611806|10910268|FG000|Overall Study|Withdrawal by Subject|8
6893118|NCT00611806|10910269|FG001|Overall Study|Withdrawal by Subject|2
6893119|NCT00611806|10910268|FG000|Overall Study|Adverse Event|2
6893120|NCT00611806|10910269|FG001|Overall Study|Adverse Event|1
6893121|NCT00611806|10910268|FG000|Overall Study|Lost to Follow-up|6
6893122|NCT00611806|10910269|FG001|Overall Study|Lost to Follow-up|0
6893123|NCT00611858|10910275|FG000|Overall Study|Adverse Event|2
6893124|NCT00611858|10910275|FG000|Overall Study|Withdrawal by Subject|2
6893125|NCT00611884|10910285|FG000|Overall Study|Adverse Event|1
6893126|NCT00611884|10910286|FG001|Overall Study|Adverse Event|0
6893127|NCT00611884|10910287|FG002|Overall Study|Adverse Event|0
6893128|NCT00611884|10910288|FG003|Overall Study|Adverse Event|1
6893129|NCT00611884|10910285|FG000|Overall Study|Non-Compliance|1
6893130|NCT00611884|10910286|FG001|Overall Study|Non-Compliance|4
6893131|NCT00611884|10910287|FG002|Overall Study|Non-Compliance|2
6893132|NCT00611884|10910288|FG003|Overall Study|Non-Compliance|2
6893133|NCT00611884|10910285|FG000|Overall Study|Lack of Efficacy|0
6893134|NCT00611884|10910286|FG001|Overall Study|Lack of Efficacy|1
6893135|NCT00611884|10910287|FG002|Overall Study|Lack of Efficacy|0
6893136|NCT00611884|10910288|FG003|Overall Study|Lack of Efficacy|0
6893137|NCT00611884|10910285|FG000|Overall Study|Unclassified|7
6893138|NCT00611884|10910286|FG001|Overall Study|Unclassified|4
6893139|NCT00611884|10910287|FG002|Overall Study|Unclassified|2
6893140|NCT00611884|10910288|FG003|Overall Study|Unclassified|3
6893141|NCT00611923|10910309|FG000|Overall Study|Withdrawal by Subject|2
6893142|NCT00611923|10910310|FG001|Overall Study|Withdrawal by Subject|2
6893143|NCT00611975|10910320|FG000|Overall Study|Withdrawal by Subject|3
6893144|NCT00611975|10910321|FG001|Overall Study|Withdrawal by Subject|7
6893145|NCT00611975|10910320|FG000|Overall Study|Pregnancy|2
6893146|NCT00611975|10910321|FG001|Overall Study|Pregnancy|1
6893147|NCT00612040|10910330|FG000|Overall Study|Adverse Event|0
6893148|NCT00612040|10910331|FG001|Overall Study|Adverse Event|2
6893149|NCT00612040|10910332|FG002|Overall Study|Adverse Event|1
6893150|NCT00612040|10910330|FG000|Overall Study|Protocol Violation|1
6893151|NCT00612040|10910331|FG001|Overall Study|Protocol Violation|2
6893152|NCT00612040|10910332|FG002|Overall Study|Protocol Violation|1
6893153|NCT00612040|10910330|FG000|Overall Study|Lack of Efficacy|2
6893154|NCT00612040|10910331|FG001|Overall Study|Lack of Efficacy|1
6893155|NCT00612040|10910332|FG002|Overall Study|Lack of Efficacy|0
6893156|NCT00612040|10910330|FG000|Overall Study|Unclassified|2
6893157|NCT00612040|10910331|FG001|Overall Study|Unclassified|2
6893158|NCT00612040|10910332|FG002|Overall Study|Unclassified|5
6893159|NCT00612066|10910340|FG000|Overall Study|Adverse Event|1
6893160|NCT00612105|10910346|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18
6893161|NCT00612105|10910347|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1
6893162|NCT00612105|10910346|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6
6893163|NCT00612105|10910347|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1
6893164|NCT00612105|10910346|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2
6893165|NCT00612105|10910347|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0
6893166|NCT00612105|10910346|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1
6893167|NCT00612105|10910347|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1
6893168|NCT00612105|10910346|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1
6893169|NCT00612105|10910347|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0
6893170|NCT00612105|10910346|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3
6893171|NCT00612105|10910347|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1
6893172|NCT00612105|10910346|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5
6893173|NCT00612105|10910347|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0
6893174|NCT00612105|10910346|FG000|Period Title 1: 6-Week Titration Phase|Other|0
6893175|NCT00612105|10910347|FG001|Period Title 1: 6-Week Titration Phase|Other|1
6893176|NCT00612105|10910346|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9
6893177|NCT00612105|10910347|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1
6893178|NCT00612105|10910346|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
6970814|NCT01158118|11021183|FG001|Overall Study|Death|1
6893179|NCT00612105|10910347|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
6893180|NCT00612105|10910346|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1
6893181|NCT00612105|10910347|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0
6893182|NCT00612105|10910346|FG000|Period Title 3: 3-Week Taper Phase|Other|1
6893183|NCT00612105|10910347|FG001|Period Title 3: 3-Week Taper Phase|Other|0
6893184|NCT00612313|10910377|FG000|Overall Study|Withdrawal by Subject|6
6893185|NCT00612313|10910378|FG001|Overall Study|Withdrawal by Subject|9
6893186|NCT00612313|10910377|FG000|Overall Study|Lost to Follow-up|11
6893187|NCT00612313|10910378|FG001|Overall Study|Lost to Follow-up|4
6893188|NCT00612352|10910396|FG000|Overall Study|Adverse Event|1
6893189|NCT00612352|10910397|FG001|Overall Study|Adverse Event|0
6893190|NCT00612352|10910396|FG000|Overall Study|Withdrawal by Subject|3
6893191|NCT00612352|10910397|FG001|Overall Study|Withdrawal by Subject|5
6893192|NCT00612352|10910396|FG000|Overall Study|moved out of state|1
7079379|NCT02114151|11188465|FG000|Overall Study|Lost to Follow-up|1
7079380|NCT02114151|11188465|FG000|Overall Study|Withdrawal by Subject|5
7079381|NCT02114177|11188480|FG000|Overall Study|Lost to Follow-up|1
7079382|NCT02114177|11188481|FG001|Overall Study|Lost to Follow-up|2
7079383|NCT02114177|11188480|FG000|Overall Study|Withdrawal by Subject|6
7079384|NCT02114177|11188481|FG001|Overall Study|Withdrawal by Subject|1
7079385|NCT02114177|11188480|FG000|Overall Study|Other|2
7079386|NCT02114177|11188481|FG001|Overall Study|Other|1
7079387|NCT02114203|11188490|FG000|Overall Study|Adverse Event|0
7079388|NCT02114203|11188491|FG001|Overall Study|Adverse Event|1
7079389|NCT02114203|11188492|FG002|Overall Study|Adverse Event|0
7079390|NCT02114203|11188490|FG000|Overall Study|Withdrawal by Subject|0
7079391|NCT02114203|11188491|FG001|Overall Study|Withdrawal by Subject|1
7079392|NCT02114203|11188492|FG002|Overall Study|Withdrawal by Subject|0
7079393|NCT02114268|11188522|FG000|Overall Study|Lost to Follow-up|4
7079394|NCT02114268|11188523|FG001|Overall Study|Lost to Follow-up|1
7079395|NCT02114268|11188524|FG002|Overall Study|Lost to Follow-up|1
7079396|NCT02114268|11188525|FG003|Overall Study|Lost to Follow-up|0
7079397|NCT02114268|11188526|FG004|Overall Study|Lost to Follow-up|0
7079398|NCT02114268|11188527|FG005|Overall Study|Lost to Follow-up|2
7079399|NCT02114268|11188522|FG000|Overall Study|Withdrawal by Subject|1
7155882|NCT03349710|11323977|FG002|Treatment Period|Other Reason|2
6893193|NCT00612352|10910397|FG001|Overall Study|moved out of state|0
6893194|NCT00612352|10910396|FG000|Overall Study|didn't return calls/show up on test date|4
6893195|NCT00612352|10910397|FG001|Overall Study|didn't return calls/show up on test date|1
6893196|NCT00612456|10910417|FG000|Overall Study|Adverse Event|1
6893197|NCT00612456|10910418|FG001|Overall Study|Adverse Event|0
6893198|NCT00612456|10910419|FG002|Overall Study|Adverse Event|0
6893199|NCT00612456|10910417|FG000|Overall Study|Lack of Efficacy|1
6893200|NCT00612456|10910418|FG001|Overall Study|Lack of Efficacy|1
6893201|NCT00612456|10910419|FG002|Overall Study|Lack of Efficacy|0
6893202|NCT00612456|10910417|FG000|Overall Study|Withdrawal by Subject|0
6893203|NCT00612456|10910418|FG001|Overall Study|Withdrawal by Subject|1
6893204|NCT00612456|10910419|FG002|Overall Study|Withdrawal by Subject|0
6893205|NCT00612508|10910431|FG000|Overall Study|Withdrawal by Subject|3
6893206|NCT00612508|10910432|FG001|Overall Study|Withdrawal by Subject|4
6893207|NCT00612534|10910444|FG000|Overall Study|Adverse Event|0
6893208|NCT00612534|10910445|FG001|Overall Study|Adverse Event|4
6893209|NCT00612534|10910446|FG002|Overall Study|Adverse Event|2
6893210|NCT00612534|10910447|FG003|Overall Study|Adverse Event|1
6893211|NCT00612534|10910444|FG000|Overall Study|Lack of Efficacy|13
6893212|NCT00612534|10910445|FG001|Overall Study|Lack of Efficacy|12
6893213|NCT00612534|10910446|FG002|Overall Study|Lack of Efficacy|5
6893214|NCT00612534|10910447|FG003|Overall Study|Lack of Efficacy|16
6893215|NCT00612534|10910444|FG000|Overall Study|Other Reason|0
6893216|NCT00612534|10910445|FG001|Overall Study|Other Reason|1
6893217|NCT00612534|10910446|FG002|Overall Study|Other Reason|0
6893218|NCT00612534|10910447|FG003|Overall Study|Other Reason|0
6893219|NCT00612586|10910493|FG000|Overall Study|Adverse Event|6
6893220|NCT00612586|10910494|FG001|Overall Study|Adverse Event|2
6893221|NCT00612586|10910493|FG000|Overall Study|Death|1
6893222|NCT00612586|10910494|FG001|Overall Study|Death|0
6893223|NCT00612586|10910493|FG000|Overall Study|Entry Criteria Not Met|0
6893224|NCT00612586|10910494|FG001|Overall Study|Entry Criteria Not Met|2
6893225|NCT00612586|10910493|FG000|Overall Study|Withdrawal by Subject|7
6893226|NCT00612586|10910494|FG001|Overall Study|Withdrawal by Subject|9
6893227|NCT00612586|10910493|FG000|Overall Study|Physician Decision|1
6893228|NCT00612586|10910494|FG001|Overall Study|Physician Decision|2
6893229|NCT00612586|10910493|FG000|Overall Study|Sponsor Decision|1
6893230|NCT00612586|10910494|FG001|Overall Study|Sponsor Decision|1
6893231|NCT00612586|10910493|FG000|Overall Study|Progressive Disease|26
6893232|NCT00612586|10910494|FG001|Overall Study|Progressive Disease|24
6893233|NCT00612586|10910493|FG000|Overall Study|Randomized and Not Treated|1
6893234|NCT00612586|10910494|FG001|Overall Study|Randomized and Not Treated|1
6893235|NCT00612690|10910503|FG000|Overall Study|Lost to Follow-up|72
6893236|NCT00612690|10910504|FG001|Overall Study|Lost to Follow-up|98
6893237|NCT00612690|10910503|FG000|Overall Study|Withdrawal by Subject|32
7079400|NCT02114268|11188523|FG001|Overall Study|Withdrawal by Subject|0
7079401|NCT02114268|11188524|FG002|Overall Study|Withdrawal by Subject|0
7079402|NCT02114268|11188525|FG003|Overall Study|Withdrawal by Subject|0
6893238|NCT00612690|10910504|FG001|Overall Study|Withdrawal by Subject|20
6893239|NCT00612690|10910503|FG000|Overall Study|Withdrawal by Site|11
6893240|NCT00612690|10910504|FG001|Overall Study|Withdrawal by Site|0
6893241|NCT00612807|10910543|FG000|Overall Study|Withdrawal by Subject|2
6893242|NCT00612807|10910544|FG001|Overall Study|Withdrawal by Subject|0
6893243|NCT00613015|10910566|FG000|Overall Study|Lost to Follow-up|0
6893244|NCT00613015|10910567|FG001|Overall Study|Lost to Follow-up|1
6893245|NCT00613015|10910568|FG002|Overall Study|Lost to Follow-up|3
6893246|NCT00613015|10910569|FG003|Overall Study|Lost to Follow-up|3
6893247|NCT00613015|10910570|FG004|Overall Study|Lost to Follow-up|2
6893248|NCT00613015|10910571|FG005|Overall Study|Lost to Follow-up|3
6893249|NCT00613080|10910594|FG000|Overall Study|Ineligible / no protocol treatment|11
6893250|NCT00613106|10910600|FG000|Overall Study|Adverse Event|3
6893251|NCT00613106|10910601|FG001|Overall Study|Adverse Event|1
6893252|NCT00613106|10910600|FG000|Overall Study|Withdrawal by Subject|6
6893253|NCT00613106|10910601|FG001|Overall Study|Withdrawal by Subject|3
6893254|NCT00613106|10910600|FG000|Overall Study|Lost to Follow-up|7
6893255|NCT00613106|10910601|FG001|Overall Study|Lost to Follow-up|2
6893256|NCT00613106|10910600|FG000|Overall Study|misc|4
6893257|NCT00613106|10910601|FG001|Overall Study|misc|3
6893258|NCT00613171|10910607|FG000|Overall Study|Adverse Event|7
6893259|NCT00613171|10910607|FG000|Overall Study|Withdrawal by Subject|3
6893260|NCT00613171|10910607|FG000|Overall Study|Reason not Specified|4
6893261|NCT00613301|10910612|FG000|Overall Study|Adverse Event|49
6893262|NCT00613301|10910612|FG000|Overall Study|Lost to Follow-up|88
6893263|NCT00613301|10910612|FG000|Overall Study|Withdrawal by Subject|5
6893264|NCT00613301|10910612|FG000|Overall Study|Death|6
6893265|NCT00613301|10910612|FG000|Overall Study|Lack of Efficacy|13
6893266|NCT00613301|10910612|FG000|Overall Study|Physician Decision|2
6893267|NCT00613301|10910612|FG000|Overall Study|No data was collected|53
6893268|NCT00613301|10910612|FG000|Overall Study|Irregularly enrolled patients|12
6893269|NCT00613314|10910617|FG000|Overall Study|Adverse Event|5
6893270|NCT00613314|10910617|FG000|Overall Study|Protocol Violation|14
6893271|NCT00613314|10910617|FG000|Overall Study|Lost to Follow-up|46
6893272|NCT00613314|10910617|FG000|Overall Study|Other reason not defined above|90
6893273|NCT00613327|10910621|FG000|Overall Study|Adverse Event|38
6893274|NCT00613327|10910621|FG000|Overall Study|Lost to Follow-up|8
6893275|NCT00613327|10910621|FG000|Overall Study|Withdrawal by Subject|6
6893276|NCT00613327|10910621|FG000|Overall Study|Protocol Violation|2
6893277|NCT00613327|10910621|FG000|Overall Study|Other|47
6893278|NCT00613366|10910627|FG000|Overall Study|Withdrawal by Subject|3
6893279|NCT00613366|10910628|FG001|Overall Study|Withdrawal by Subject|2
6893280|NCT00613509|10910658|FG000|Cycle 1|Adverse Event|2
6893281|NCT00613509|10910659|FG001|Cycle 1|Adverse Event|1
6893282|NCT00613509|10910658|FG000|Cycle 1|Disease Progression|2
6893283|NCT00613509|10910659|FG001|Cycle 1|Disease Progression|6
6893284|NCT00613509|10910658|FG000|Cycle 1|Unacceptable Toxicity|1
6893285|NCT00613509|10910659|FG001|Cycle 1|Unacceptable Toxicity|0
6893286|NCT00613509|10910658|FG000|Cycle 1|Other administrative reason|0
6893287|NCT00613509|10910659|FG001|Cycle 1|Other administrative reason|1
6893288|NCT00613574|10910665|FG000|Overall Study|Adverse Event|3
6893289|NCT00613574|10910665|FG000|Overall Study|Lost to Follow-up|2
6893290|NCT00613574|10910665|FG000|Overall Study|Other|1
6893291|NCT00613626|10910672|FG000|Overall Study|Ineligible|0
6893292|NCT00613626|10910673|FG001|Overall Study|Ineligible|1
6893293|NCT00613626|10910674|FG002|Overall Study|Ineligible|0
6893294|NCT00613821|10910683|FG000|Overall Study|Withdrawal by Subject|1
6893295|NCT00613821|10910684|FG001|Overall Study|Withdrawal by Subject|0
6893296|NCT00613821|10910683|FG000|Overall Study|Physician Decision|1
6893297|NCT00613821|10910684|FG001|Overall Study|Physician Decision|1
6893298|NCT00613834|10910692|FG000|Overall Study|Withdrawal by Subject|0
6893299|NCT00613834|10910693|FG001|Overall Study|Withdrawal by Subject|3
6893300|NCT00613925|10910703|FG000|Overall Study|1 did not tolerate outpatient biopsy|0
6893301|NCT00613925|10910704|FG001|Overall Study|1 did not tolerate outpatient biopsy|1
6893302|NCT00613938|10910714|FG000|Overall Study|Withdrawal by Subject|2
6893303|NCT00613938|10910715|FG001|Overall Study|Withdrawal by Subject|4
6893304|NCT00613938|10910716|FG002|Overall Study|Withdrawal by Subject|9
6893305|NCT00613938|10910717|FG003|Overall Study|Withdrawal by Subject|9
6893306|NCT00613938|10910714|FG000|Overall Study|Adverse Event|1
6893307|NCT00613938|10910715|FG001|Overall Study|Adverse Event|4
6893308|NCT00613938|10910716|FG002|Overall Study|Adverse Event|8
6893309|NCT00613938|10910717|FG003|Overall Study|Adverse Event|5
6893310|NCT00613938|10910714|FG000|Overall Study|Lack of Efficacy|16
6893311|NCT00613938|10910715|FG001|Overall Study|Lack of Efficacy|18
6893312|NCT00613938|10910716|FG002|Overall Study|Lack of Efficacy|5
6893313|NCT00613938|10910717|FG003|Overall Study|Lack of Efficacy|9
6893314|NCT00613938|10910714|FG000|Overall Study|Other|1
6893315|NCT00613938|10910715|FG001|Overall Study|Other|2
6893316|NCT00613938|10910716|FG002|Overall Study|Other|1
6893317|NCT00613938|10910717|FG003|Overall Study|Other|3
6893318|NCT00613951|10910730|FG000|Overall Study|Adverse Event|1
6893319|NCT00613951|10910731|FG001|Overall Study|Adverse Event|0
6893320|NCT00613951|10910732|FG002|Overall Study|Adverse Event|1
6893321|NCT00613951|10910730|FG000|Overall Study|Lack of Efficacy|0
6893322|NCT00613951|10910731|FG001|Overall Study|Lack of Efficacy|1
6893323|NCT00613951|10910732|FG002|Overall Study|Lack of Efficacy|1
6893324|NCT00613951|10910730|FG000|Overall Study|Protocol Violation|1
6893325|NCT00613951|10910731|FG001|Overall Study|Protocol Violation|1
6893326|NCT00613951|10910732|FG002|Overall Study|Protocol Violation|1
6893327|NCT00613951|10910730|FG000|Overall Study|Unclassified|5
6893328|NCT00613951|10910731|FG001|Overall Study|Unclassified|3
6893329|NCT00613951|10910732|FG002|Overall Study|Unclassified|2
6893330|NCT00614055|10910746|FG000|Overall Study|Adverse Event|1
6893331|NCT00614055|10910747|FG001|Overall Study|Adverse Event|0
6893332|NCT00614055|10910748|FG002|Overall Study|Adverse Event|0
6893333|NCT00614055|10910746|FG000|Overall Study|Protocol Violation|2
6893334|NCT00614055|10910747|FG001|Overall Study|Protocol Violation|2
6893335|NCT00614055|10910748|FG002|Overall Study|Protocol Violation|1
6893336|NCT00614055|10910746|FG000|Overall Study|Lack of Efficacy|0
6893337|NCT00614055|10910747|FG001|Overall Study|Lack of Efficacy|0
6893338|NCT00614055|10910748|FG002|Overall Study|Lack of Efficacy|2
6893339|NCT00614055|10910746|FG000|Overall Study|Unclassified|1
6893340|NCT00614055|10910747|FG001|Overall Study|Unclassified|4
6893341|NCT00614055|10910748|FG002|Overall Study|Unclassified|2
6893342|NCT00614120|10910763|FG000|Overall Study|Adverse Event|9
6893343|NCT00614120|10910764|FG001|Overall Study|Adverse Event|22
6893344|NCT00614120|10910765|FG002|Overall Study|Adverse Event|30
6893345|NCT00614120|10910766|FG003|Overall Study|Adverse Event|3
6893346|NCT00614120|10910763|FG000|Overall Study|Lack of Efficacy|3
6893347|NCT00614120|10910764|FG001|Overall Study|Lack of Efficacy|3
6893348|NCT00614120|10910765|FG002|Overall Study|Lack of Efficacy|2
6893349|NCT00614120|10910766|FG003|Overall Study|Lack of Efficacy|2
6893350|NCT00614120|10910763|FG000|Overall Study|Protocol Violation|2
6893351|NCT00614120|10910764|FG001|Overall Study|Protocol Violation|5
6893352|NCT00614120|10910765|FG002|Overall Study|Protocol Violation|3
6893353|NCT00614120|10910766|FG003|Overall Study|Protocol Violation|1
6893354|NCT00614120|10910763|FG000|Overall Study|Withdrawal criteria|1
6893355|NCT00614120|10910764|FG001|Overall Study|Withdrawal criteria|0
6893356|NCT00614120|10910765|FG002|Overall Study|Withdrawal criteria|0
6893357|NCT00614120|10910766|FG003|Overall Study|Withdrawal criteria|0
6893358|NCT00614120|10910763|FG000|Overall Study|Withdrawal by Subject|9
6893359|NCT00614120|10910764|FG001|Overall Study|Withdrawal by Subject|10
6893360|NCT00614120|10910765|FG002|Overall Study|Withdrawal by Subject|16
6893361|NCT00614120|10910766|FG003|Overall Study|Withdrawal by Subject|3
6893362|NCT00614120|10910763|FG000|Overall Study|Did not meet trial criteria|0
6893363|NCT00614120|10910764|FG001|Overall Study|Did not meet trial criteria|1
6893364|NCT00614120|10910765|FG002|Overall Study|Did not meet trial criteria|1
6893365|NCT00614120|10910766|FG003|Overall Study|Did not meet trial criteria|1
6893366|NCT00614120|10910763|FG000|Overall Study|hCG positive (not pregnant)|0
6893367|NCT00614120|10910764|FG001|Overall Study|hCG positive (not pregnant)|0
6893368|NCT00614120|10910765|FG002|Overall Study|hCG positive (not pregnant)|1
6893369|NCT00614120|10910766|FG003|Overall Study|hCG positive (not pregnant)|0
6893370|NCT00614120|10910763|FG000|Overall Study|Hypoglycaemia|0
6893371|NCT00614120|10910764|FG001|Overall Study|Hypoglycaemia|0
6893372|NCT00614120|10910765|FG002|Overall Study|Hypoglycaemia|0
6893373|NCT00614120|10910766|FG003|Overall Study|Hypoglycaemia|1
6893374|NCT00614120|10910763|FG000|Overall Study|Lack of trial product|3
6893375|NCT00614120|10910764|FG001|Overall Study|Lack of trial product|3
6893376|NCT00614120|10910765|FG002|Overall Study|Lack of trial product|2
6893377|NCT00614120|10910766|FG003|Overall Study|Lack of trial product|0
6893378|NCT00614120|10910763|FG000|Overall Study|Late syphilis, latent|1
6893379|NCT00614120|10910764|FG001|Overall Study|Late syphilis, latent|0
6893380|NCT00614120|10910765|FG002|Overall Study|Late syphilis, latent|0
6893381|NCT00614120|10910766|FG003|Overall Study|Late syphilis, latent|0
6893382|NCT00614120|10910763|FG000|Overall Study|Taken inhibition medication eg Prandin|0
6893383|NCT00614120|10910764|FG001|Overall Study|Taken inhibition medication eg Prandin|0
6893384|NCT00614120|10910765|FG002|Overall Study|Taken inhibition medication eg Prandin|1
6893385|NCT00614120|10910766|FG003|Overall Study|Taken inhibition medication eg Prandin|1
6893386|NCT00614120|10910763|FG000|Overall Study|Lost to Follow-up|1
6893387|NCT00614120|10910764|FG001|Overall Study|Lost to Follow-up|2
6893388|NCT00614120|10910765|FG002|Overall Study|Lost to Follow-up|3
6893389|NCT00614120|10910766|FG003|Overall Study|Lost to Follow-up|4
6893390|NCT00614380|10910793|FG000|Overall Study|Adverse Event|14
6893391|NCT00614380|10910794|FG001|Overall Study|Adverse Event|4
6893392|NCT00614380|10910795|FG002|Overall Study|Adverse Event|0
6893393|NCT00614380|10910796|FG003|Overall Study|Adverse Event|0
6893394|NCT00614380|10910793|FG000|Overall Study|Lost to Follow-up|6
6893395|NCT00614380|10910794|FG001|Overall Study|Lost to Follow-up|1
6893396|NCT00614380|10910795|FG002|Overall Study|Lost to Follow-up|0
6893397|NCT00614380|10910796|FG003|Overall Study|Lost to Follow-up|0
6893398|NCT00614380|10910793|FG000|Overall Study|Non compliant with the protocol|12
6893399|NCT00614380|10910794|FG001|Overall Study|Non compliant with the protocol|2
6893400|NCT00614380|10910795|FG002|Overall Study|Non compliant with the protocol|1
6893401|NCT00614380|10910796|FG003|Overall Study|Non compliant with the protocol|2
6893402|NCT00614380|10910793|FG000|Overall Study|Consent withdrawn|3
6893403|NCT00614380|10910794|FG001|Overall Study|Consent withdrawn|1
6893404|NCT00614380|10910795|FG002|Overall Study|Consent withdrawn|0
6893405|NCT00614380|10910796|FG003|Overall Study|Consent withdrawn|0
6893406|NCT00614393|10910816|FG000|Overall Study|Adverse Event|20
6893407|NCT00614393|10910817|FG001|Overall Study|Adverse Event|2
6893408|NCT00614393|10910818|FG002|Overall Study|Adverse Event|3
6893409|NCT00614393|10910819|FG003|Overall Study|Adverse Event|13
6893410|NCT00614393|10910820|FG004|Overall Study|Adverse Event|21
6893411|NCT00614393|10910816|FG000|Overall Study|Lost to Follow-up|0
6893412|NCT00614393|10910817|FG001|Overall Study|Lost to Follow-up|0
6893413|NCT00614393|10910818|FG002|Overall Study|Lost to Follow-up|0
6893414|NCT00614393|10910819|FG003|Overall Study|Lost to Follow-up|1
6893415|NCT00614393|10910820|FG004|Overall Study|Lost to Follow-up|2
6893416|NCT00614393|10910816|FG000|Overall Study|Physician Decision|17
6893417|NCT00614393|10910817|FG001|Overall Study|Physician Decision|0
6893418|NCT00614393|10910818|FG002|Overall Study|Physician Decision|1
6893419|NCT00614393|10910819|FG003|Overall Study|Physician Decision|8
6893420|NCT00614393|10910820|FG004|Overall Study|Physician Decision|9
6893421|NCT00614393|10910816|FG000|Overall Study|Progressive Disease|118
6893422|NCT00614393|10910817|FG001|Overall Study|Progressive Disease|5
6893423|NCT00614393|10910818|FG002|Overall Study|Progressive Disease|5
6893424|NCT00614393|10910819|FG003|Overall Study|Progressive Disease|138
6893425|NCT00614393|10910820|FG004|Overall Study|Progressive Disease|130
6893426|NCT00614393|10910816|FG000|Overall Study|Protocol Violation|1
6893427|NCT00614393|10910817|FG001|Overall Study|Protocol Violation|0
6893428|NCT00614393|10910818|FG002|Overall Study|Protocol Violation|0
6893429|NCT00614393|10910819|FG003|Overall Study|Protocol Violation|0
6893430|NCT00614393|10910820|FG004|Overall Study|Protocol Violation|0
6893431|NCT00614393|10910816|FG000|Overall Study|Terminated by Sponsor|0
6893432|NCT00614393|10910817|FG001|Overall Study|Terminated by Sponsor|0
6893433|NCT00614393|10910818|FG002|Overall Study|Terminated by Sponsor|0
6893434|NCT00614393|10910819|FG003|Overall Study|Terminated by Sponsor|0
6893435|NCT00614393|10910820|FG004|Overall Study|Terminated by Sponsor|1
6893436|NCT00614393|10910816|FG000|Overall Study|Withdrawal by Subject|20
6893437|NCT00614393|10910817|FG001|Overall Study|Withdrawal by Subject|1
6893438|NCT00614393|10910818|FG002|Overall Study|Withdrawal by Subject|1
6893439|NCT00614393|10910819|FG003|Overall Study|Withdrawal by Subject|16
6893440|NCT00614393|10910820|FG004|Overall Study|Withdrawal by Subject|13
6893441|NCT00614393|10910816|FG000|Overall Study|Other|4
6893442|NCT00614393|10910817|FG001|Overall Study|Other|0
6893443|NCT00614393|10910818|FG002|Overall Study|Other|0
6893444|NCT00614393|10910819|FG003|Overall Study|Other|4
6893445|NCT00614393|10910820|FG004|Overall Study|Other|2
6893446|NCT00614393|10910816|FG000|Overall Study|Not Treated|0
6893447|NCT00614393|10910817|FG001|Overall Study|Not Treated|0
6893448|NCT00614393|10910818|FG002|Overall Study|Not Treated|0
6893449|NCT00614393|10910819|FG003|Overall Study|Not Treated|0
6893450|NCT00614393|10910820|FG004|Overall Study|Not Treated|2
6893451|NCT00614523|10910870|FG000|Overall Study|Adverse Event|4
6893452|NCT00614523|10910871|FG001|Overall Study|Adverse Event|20
6893453|NCT00614523|10910870|FG000|Overall Study|Death|5
6893454|NCT00614523|10910871|FG001|Overall Study|Death|8
6893455|NCT00614523|10910870|FG000|Overall Study|Lack of Efficacy|9
6893456|NCT00614523|10910871|FG001|Overall Study|Lack of Efficacy|11
6893457|NCT00614523|10910870|FG000|Overall Study|Lost to Follow-up|0
6893458|NCT00614523|10910871|FG001|Overall Study|Lost to Follow-up|1
6893459|NCT00614523|10910870|FG000|Overall Study|Protocol Violation|3
6893460|NCT00614523|10910871|FG001|Overall Study|Protocol Violation|2
6893461|NCT00614523|10910870|FG000|Overall Study|Withdrawal by Subject|12
6893462|NCT00614523|10910871|FG001|Overall Study|Withdrawal by Subject|22
6893463|NCT00614523|10910870|FG000|Overall Study|Other|6
6893464|NCT00614523|10910871|FG001|Overall Study|Other|11
6893465|NCT00614523|10910870|FG000|Overall Study|Ineligibility Determined|1
6893466|NCT00614523|10910871|FG001|Overall Study|Ineligibility Determined|2
6893467|NCT00614523|10910870|FG000|Overall Study|Disease Progression|0
6893468|NCT00614523|10910871|FG001|Overall Study|Disease Progression|8
6893469|NCT00614523|10910870|FG000|Overall Study|Administrative Decision|23
6893470|NCT00614523|10910871|FG001|Overall Study|Administrative Decision|46
6893471|NCT00614575|10910877|FG000|Overall Study|Adverse Event|106
6893472|NCT00614575|10910877|FG000|Overall Study|Lost to Follow-up|55
6893473|NCT00614575|10910877|FG000|Overall Study|Lack of Efficacy|14
6893474|NCT00614575|10910877|FG000|Overall Study|Withdrawal by Subject|6
6893475|NCT00614575|10910877|FG000|Overall Study|Death|3
6893476|NCT00614575|10910877|FG000|Overall Study|Physician Decision|2
6893477|NCT00614575|10910877|FG000|Overall Study|No data were collected.|18
6893478|NCT00614575|10910877|FG000|Overall Study|Irregularly enrolled patients|23
6893479|NCT00614575|10910877|FG000|Overall Study|No treatment|1
6893480|NCT00614614|10910883|FG000|Primary Vaccination Phase|Adverse Event|6
7079403|NCT02114268|11188526|FG004|Overall Study|Withdrawal by Subject|0
7079404|NCT02114268|11188527|FG005|Overall Study|Withdrawal by Subject|1
6893481|NCT00614614|10910884|FG001|Primary Vaccination Phase|Adverse Event|0
6893482|NCT00614614|10910885|FG002|Primary Vaccination Phase|Adverse Event|0
6893483|NCT00614614|10910886|FG003|Primary Vaccination Phase|Adverse Event|0
6893484|NCT00614614|10910887|FG004|Primary Vaccination Phase|Adverse Event|0
6893485|NCT00614614|10910883|FG000|Primary Vaccination Phase|Withdrawal by Subject|45
6893486|NCT00614614|10910884|FG001|Primary Vaccination Phase|Withdrawal by Subject|6
6893487|NCT00614614|10910885|FG002|Primary Vaccination Phase|Withdrawal by Subject|0
6893488|NCT00614614|10910886|FG003|Primary Vaccination Phase|Withdrawal by Subject|0
6893489|NCT00614614|10910887|FG004|Primary Vaccination Phase|Withdrawal by Subject|0
6893490|NCT00614614|10910883|FG000|Primary Vaccination Phase|Lost to Follow-up|26
6893491|NCT00614614|10910884|FG001|Primary Vaccination Phase|Lost to Follow-up|8
6893492|NCT00614614|10910885|FG002|Primary Vaccination Phase|Lost to Follow-up|0
6893493|NCT00614614|10910886|FG003|Primary Vaccination Phase|Lost to Follow-up|0
6893494|NCT00614614|10910887|FG004|Primary Vaccination Phase|Lost to Follow-up|0
6893495|NCT00614614|10910883|FG000|Primary Vaccination Phase|Protocol Violation|9
6893496|NCT00614614|10910884|FG001|Primary Vaccination Phase|Protocol Violation|3
6893497|NCT00614614|10910885|FG002|Primary Vaccination Phase|Protocol Violation|0
6893498|NCT00614614|10910886|FG003|Primary Vaccination Phase|Protocol Violation|0
6893499|NCT00614614|10910887|FG004|Primary Vaccination Phase|Protocol Violation|0
6893500|NCT00614614|10910883|FG000|Primary Vaccination Phase|Other|4
6893501|NCT00614614|10910884|FG001|Primary Vaccination Phase|Other|0
6893502|NCT00614614|10910885|FG002|Primary Vaccination Phase|Other|0
6893503|NCT00614614|10910886|FG003|Primary Vaccination Phase|Other|0
6893504|NCT00614614|10910887|FG004|Primary Vaccination Phase|Other|0
6893505|NCT00614614|10910883|FG000|Booster Vaccination Phase|Adverse Event|0
6893506|NCT00614614|10910884|FG001|Booster Vaccination Phase|Adverse Event|0
6893507|NCT00614614|10910885|FG002|Booster Vaccination Phase|Adverse Event|1
6893508|NCT00614614|10910886|FG003|Booster Vaccination Phase|Adverse Event|1
6893509|NCT00614614|10910887|FG004|Booster Vaccination Phase|Adverse Event|0
6893510|NCT00614614|10910883|FG000|Booster Vaccination Phase|Withdrawal by Subject|0
6893511|NCT00614614|10910884|FG001|Booster Vaccination Phase|Withdrawal by Subject|0
6893512|NCT00614614|10910885|FG002|Booster Vaccination Phase|Withdrawal by Subject|4
6893513|NCT00614614|10910886|FG003|Booster Vaccination Phase|Withdrawal by Subject|3
6893514|NCT00614614|10910887|FG004|Booster Vaccination Phase|Withdrawal by Subject|4
6893515|NCT00614614|10910883|FG000|Booster Vaccination Phase|Lost to Follow-up|0
6893516|NCT00614614|10910884|FG001|Booster Vaccination Phase|Lost to Follow-up|5
6893517|NCT00614614|10910885|FG002|Booster Vaccination Phase|Lost to Follow-up|17
6893518|NCT00614614|10910886|FG003|Booster Vaccination Phase|Lost to Follow-up|10
6893519|NCT00614614|10910887|FG004|Booster Vaccination Phase|Lost to Follow-up|8
6893520|NCT00614614|10910883|FG000|Booster Vaccination Phase|Protocol Violation|0
6893521|NCT00614614|10910884|FG001|Booster Vaccination Phase|Protocol Violation|0
6893522|NCT00614614|10910885|FG002|Booster Vaccination Phase|Protocol Violation|2
6893523|NCT00614614|10910886|FG003|Booster Vaccination Phase|Protocol Violation|3
6893524|NCT00614614|10910887|FG004|Booster Vaccination Phase|Protocol Violation|0
6893525|NCT00614614|10910883|FG000|Booster Vaccination Phase|Other|0
6893526|NCT00614614|10910884|FG001|Booster Vaccination Phase|Other|1
6893527|NCT00614614|10910885|FG002|Booster Vaccination Phase|Other|3
6893528|NCT00614614|10910886|FG003|Booster Vaccination Phase|Other|2
6893529|NCT00614614|10910887|FG004|Booster Vaccination Phase|Other|1
6893530|NCT00614744|10910904|FG000|Overall Study|Lost to Follow-up|5
6893531|NCT00614744|10910905|FG001|Overall Study|Lost to Follow-up|4
6893532|NCT00614744|10910904|FG000|Overall Study|Incomplete for Behavior Issues|0
6893533|NCT00614744|10910905|FG001|Overall Study|Incomplete for Behavior Issues|2
6893534|NCT00614822|10910911|FG000|Overall Study|Adverse Event|3
6893535|NCT00614874|10910916|FG000|Overall Study|Protocol Violation|1
6893536|NCT00614874|10910916|FG000|Overall Study|Withdrawal by Subject|1
6893537|NCT00614926|10910926|FG000|Overall Study|Burden of travel|1
6893538|NCT00614926|10910927|FG001|Overall Study|Burden of travel|0
6893539|NCT00614926|10910926|FG000|Overall Study|Adverse Event|3
6893540|NCT00614926|10910927|FG001|Overall Study|Adverse Event|0
6893541|NCT00614939|10910935|FG000|Overall Study|Withdrawal by Subject|10
6893542|NCT00614939|10910936|FG001|Overall Study|Withdrawal by Subject|17
6893543|NCT00614939|10910935|FG000|Overall Study|Study specific discontinuation criteris|13
6893544|NCT00614939|10910936|FG001|Overall Study|Study specific discontinuation criteris|16
6893545|NCT00614939|10910935|FG000|Overall Study|Adverse Event|2
6893546|NCT00614939|10910936|FG001|Overall Study|Adverse Event|5
6893547|NCT00614939|10910935|FG000|Overall Study|Incorrect enrollment|1
6893548|NCT00614939|10910936|FG001|Overall Study|Incorrect enrollment|2
6893549|NCT00614939|10910935|FG000|Overall Study|Death|4
6893550|NCT00614939|10910936|FG001|Overall Study|Death|3
6893551|NCT00614939|10910935|FG000|Overall Study|Poor/non-compliance|4
6893552|NCT00614939|10910936|FG001|Overall Study|Poor/non-compliance|0
6893553|NCT00614939|10910935|FG000|Overall Study|Hospitalized due to kidney transplant|1
6893554|NCT00614939|10910936|FG001|Overall Study|Hospitalized due to kidney transplant|0
6893555|NCT00614991|10910948|FG000|Overall Study|Adverse Event|3
6893556|NCT00614991|10910949|FG001|Overall Study|Adverse Event|3
6893557|NCT00614991|10910950|FG002|Overall Study|Adverse Event|0
6893558|NCT00614991|10910951|FG003|Overall Study|Adverse Event|0
6893559|NCT00614991|10910952|FG004|Overall Study|Adverse Event|1
6893560|NCT00614991|10910953|FG005|Overall Study|Adverse Event|0
6893561|NCT00615017|10910978|FG000|Overall Study|Adverse Event|0
6893562|NCT00615017|10910979|FG001|Overall Study|Adverse Event|1
6893563|NCT00615017|10910980|FG002|Overall Study|Adverse Event|2
6893564|NCT00615017|10910981|FG003|Overall Study|Adverse Event|0
6893565|NCT00615017|10910982|FG004|Overall Study|Adverse Event|0
6893566|NCT00615017|10910983|FG005|Overall Study|Adverse Event|1
6893567|NCT00615017|10910978|FG000|Overall Study|Death|0
6893568|NCT00615017|10910979|FG001|Overall Study|Death|0
6893569|NCT00615017|10910980|FG002|Overall Study|Death|2
6893570|NCT00615017|10910981|FG003|Overall Study|Death|0
6893571|NCT00615017|10910982|FG004|Overall Study|Death|1
6893572|NCT00615017|10910983|FG005|Overall Study|Death|1
6893573|NCT00615017|10910978|FG000|Overall Study|Sepsis resolved|0
6893574|NCT00615017|10910979|FG001|Overall Study|Sepsis resolved|0
6893575|NCT00615017|10910980|FG002|Overall Study|Sepsis resolved|1
6893576|NCT00615017|10910981|FG003|Overall Study|Sepsis resolved|0
6893577|NCT00615017|10910982|FG004|Overall Study|Sepsis resolved|0
6893578|NCT00615017|10910983|FG005|Overall Study|Sepsis resolved|0
6893579|NCT00615017|10910978|FG000|Overall Study|Transferred out of Intensive Care Unit|0
6893580|NCT00615017|10910979|FG001|Overall Study|Transferred out of Intensive Care Unit|0
6893581|NCT00615017|10910980|FG002|Overall Study|Transferred out of Intensive Care Unit|0
6893582|NCT00615017|10910981|FG003|Overall Study|Transferred out of Intensive Care Unit|1
6893583|NCT00615017|10910982|FG004|Overall Study|Transferred out of Intensive Care Unit|0
6893584|NCT00615017|10910983|FG005|Overall Study|Transferred out of Intensive Care Unit|0
6893585|NCT00615017|10910978|FG000|Overall Study|Physician discontinued drug|0
6893586|NCT00615017|10910979|FG001|Overall Study|Physician discontinued drug|0
6893587|NCT00615017|10910980|FG002|Overall Study|Physician discontinued drug|0
6893588|NCT00615017|10910981|FG003|Overall Study|Physician discontinued drug|0
6893589|NCT00615017|10910982|FG004|Overall Study|Physician discontinued drug|0
6893590|NCT00615017|10910983|FG005|Overall Study|Physician discontinued drug|1
6893591|NCT00615030|10910997|FG000|Period I|Administrative problem|0
6893592|NCT00615030|10910998|FG001|Period I|Administrative problem|0
6893593|NCT00615030|10910999|FG002|Period I|Administrative problem|0
6893594|NCT00615030|10911000|FG003|Period I|Administrative problem|0
6893595|NCT00615030|10911001|FG004|Period I|Administrative problem|1
6893596|NCT00615030|10911002|FG005|Period I|Administrative problem|0
6893597|NCT00615030|10911003|FG006|Period I|Administrative problem|0
6893598|NCT00615030|10911004|FG007|Period I|Administrative problem|0
6893599|NCT00615030|10911005|FG008|Period I|Administrative problem|0
6893600|NCT00615030|10911006|FG009|Period I|Administrative problem|0
6893601|NCT00615030|10911007|FG010|Period I|Administrative problem|0
6893602|NCT00615030|10911008|FG011|Period I|Administrative problem|0
6893603|NCT00615030|10910997|FG000|Period I|Protocol deviation|1
6893604|NCT00615030|10910998|FG001|Period I|Protocol deviation|0
6893605|NCT00615030|10910999|FG002|Period I|Protocol deviation|0
6893606|NCT00615030|10911000|FG003|Period I|Protocol deviation|0
6893607|NCT00615030|10911001|FG004|Period I|Protocol deviation|0
6893608|NCT00615030|10911002|FG005|Period I|Protocol deviation|0
6893609|NCT00615030|10911003|FG006|Period I|Protocol deviation|0
6893610|NCT00615030|10911004|FG007|Period I|Protocol deviation|0
6893611|NCT00615030|10911005|FG008|Period I|Protocol deviation|0
6893612|NCT00615030|10911006|FG009|Period I|Protocol deviation|0
6893613|NCT00615030|10911007|FG010|Period I|Protocol deviation|0
6893614|NCT00615030|10911008|FG011|Period I|Protocol deviation|0
6893615|NCT00615030|10910997|FG000|Period I|Subject withdrew consent|0
6893616|NCT00615030|10910998|FG001|Period I|Subject withdrew consent|0
6893617|NCT00615030|10910999|FG002|Period I|Subject withdrew consent|0
6893618|NCT00615030|10911000|FG003|Period I|Subject withdrew consent|0
6893619|NCT00615030|10911001|FG004|Period I|Subject withdrew consent|0
6893620|NCT00615030|10911002|FG005|Period I|Subject withdrew consent|0
6893621|NCT00615030|10911003|FG006|Period I|Subject withdrew consent|0
6893622|NCT00615030|10911004|FG007|Period I|Subject withdrew consent|0
6893623|NCT00615030|10911005|FG008|Period I|Subject withdrew consent|1
6893624|NCT00615030|10911006|FG009|Period I|Subject withdrew consent|0
6893625|NCT00615030|10911007|FG010|Period I|Subject withdrew consent|1
6893626|NCT00615030|10911008|FG011|Period I|Subject withdrew consent|1
6893627|NCT00615030|10910997|FG000|Period I|Abnormal laboratory value(s)|0
6893628|NCT00615030|10910998|FG001|Period I|Abnormal laboratory value(s)|0
6893629|NCT00615030|10910999|FG002|Period I|Abnormal laboratory value(s)|0
6893630|NCT00615030|10911000|FG003|Period I|Abnormal laboratory value(s)|0
6893631|NCT00615030|10911001|FG004|Period I|Abnormal laboratory value(s)|0
6893632|NCT00615030|10911002|FG005|Period I|Abnormal laboratory value(s)|1
6893633|NCT00615030|10911003|FG006|Period I|Abnormal laboratory value(s)|0
6893634|NCT00615030|10911004|FG007|Period I|Abnormal laboratory value(s)|0
6893635|NCT00615030|10911005|FG008|Period I|Abnormal laboratory value(s)|0
6893636|NCT00615030|10911006|FG009|Period I|Abnormal laboratory value(s)|0
6893637|NCT00615030|10911007|FG010|Period I|Abnormal laboratory value(s)|0
6893638|NCT00615030|10911008|FG011|Period I|Abnormal laboratory value(s)|0
6893639|NCT00615030|10910997|FG000|Period II|Adverse Event|0
6893640|NCT00615030|10910998|FG001|Period II|Adverse Event|0
6893641|NCT00615030|10910999|FG002|Period II|Adverse Event|1
6893642|NCT00615030|10911000|FG003|Period II|Adverse Event|0
6893643|NCT00615030|10911001|FG004|Period II|Adverse Event|0
6893644|NCT00615030|10911002|FG005|Period II|Adverse Event|0
6893645|NCT00615030|10911003|FG006|Period II|Adverse Event|0
6893646|NCT00615030|10911004|FG007|Period II|Adverse Event|0
6893647|NCT00615030|10911005|FG008|Period II|Adverse Event|1
6893648|NCT00615030|10911006|FG009|Period II|Adverse Event|0
6893649|NCT00615030|10911007|FG010|Period II|Adverse Event|0
6893650|NCT00615030|10911008|FG011|Period II|Adverse Event|0
6893651|NCT00615030|10910997|FG000|Period II|Subject withdrew consent|0
6893652|NCT00615030|10910998|FG001|Period II|Subject withdrew consent|0
6893653|NCT00615030|10910999|FG002|Period II|Subject withdrew consent|0
6893654|NCT00615030|10911000|FG003|Period II|Subject withdrew consent|1
6893655|NCT00615030|10911001|FG004|Period II|Subject withdrew consent|0
6893656|NCT00615030|10911002|FG005|Period II|Subject withdrew consent|0
6970815|NCT01158222|11021193|FG000|Overall Study|Not eligible for intermediate phase|17
6893657|NCT00615030|10911003|FG006|Period II|Subject withdrew consent|1
6893658|NCT00615030|10911004|FG007|Period II|Subject withdrew consent|0
6893659|NCT00615030|10911005|FG008|Period II|Subject withdrew consent|0
6893660|NCT00615030|10911006|FG009|Period II|Subject withdrew consent|0
6893661|NCT00615030|10911007|FG010|Period II|Subject withdrew consent|0
6893662|NCT00615030|10911008|FG011|Period II|Subject withdrew consent|0
6893663|NCT00615030|10910997|FG000|Period III|Administrative problems|1
6893664|NCT00615030|10910998|FG001|Period III|Administrative problems|0
6893665|NCT00615030|10910999|FG002|Period III|Administrative problems|0
6893666|NCT00615030|10911000|FG003|Period III|Administrative problems|1
6893667|NCT00615030|10911001|FG004|Period III|Administrative problems|0
6893668|NCT00615030|10911002|FG005|Period III|Administrative problems|0
6893669|NCT00615030|10911003|FG006|Period III|Administrative problems|0
6893670|NCT00615030|10911004|FG007|Period III|Administrative problems|0
6893671|NCT00615030|10911005|FG008|Period III|Administrative problems|0
6893672|NCT00615030|10911006|FG009|Period III|Administrative problems|0
6893673|NCT00615030|10911007|FG010|Period III|Administrative problems|0
6893674|NCT00615030|10911008|FG011|Period III|Administrative problems|0
6893675|NCT00615056|10911026|FG000|Overall Study|Death|31
6893676|NCT00615056|10911027|FG001|Overall Study|Death|31
6893677|NCT00615056|10911028|FG002|Overall Study|Death|21
6893678|NCT00615056|10911029|FG003|Overall Study|Death|23
6893679|NCT00615056|10911026|FG000|Overall Study|Lost to Follow-up|1
6893680|NCT00615056|10911027|FG001|Overall Study|Lost to Follow-up|2
6893681|NCT00615056|10911028|FG002|Overall Study|Lost to Follow-up|4
6893682|NCT00615056|10911029|FG003|Overall Study|Lost to Follow-up|5
6893683|NCT00615056|10911026|FG000|Overall Study|Other|13
6893684|NCT00615056|10911027|FG001|Overall Study|Other|15
6893685|NCT00615056|10911028|FG002|Overall Study|Other|10
6893686|NCT00615056|10911029|FG003|Overall Study|Other|7
6893687|NCT00615056|10911026|FG000|Overall Study|Objective progression or relapse|0
6893688|NCT00615056|10911027|FG001|Overall Study|Objective progression or relapse|2
6893689|NCT00615056|10911028|FG002|Overall Study|Objective progression or relapse|0
6893690|NCT00615056|10911029|FG003|Overall Study|Objective progression or relapse|0
6893691|NCT00615056|10911026|FG000|Overall Study|Withdrawal by Subject|0
6893692|NCT00615056|10911027|FG001|Overall Study|Withdrawal by Subject|1
6893693|NCT00615056|10911028|FG002|Overall Study|Withdrawal by Subject|1
6893694|NCT00615056|10911029|FG003|Overall Study|Withdrawal by Subject|0
6893695|NCT00615056|10911026|FG000|Overall Study|Discontinued by Sponsor|1
6893696|NCT00615056|10911027|FG001|Overall Study|Discontinued by Sponsor|0
6893697|NCT00615056|10911028|FG002|Overall Study|Discontinued by Sponsor|0
6893698|NCT00615056|10911029|FG003|Overall Study|Discontinued by Sponsor|0
6893699|NCT00615056|10911026|FG000|Overall Study|Randomized but not treated|3
6893700|NCT00615056|10911027|FG001|Overall Study|Randomized but not treated|0
6893701|NCT00615056|10911028|FG002|Overall Study|Randomized but not treated|0
6893702|NCT00615056|10911029|FG003|Overall Study|Randomized but not treated|0
6893703|NCT00615069|10911039|FG000|Overall Study|Death|10
6893704|NCT00615069|10911039|FG000|Overall Study|Physician Decision|2
6893705|NCT00615069|10911039|FG000|Overall Study|Withdrawal by Subject|4
6893706|NCT00615108|10911043|FG000|Overall Study|Adverse Event|122
6893707|NCT00615108|10911043|FG000|Overall Study|Other|370
6893708|NCT00615108|10911043|FG000|Overall Study|Lost to Follow-up|15
6893709|NCT00615199|10911053|FG000|Overall Study|Adverse Event|3
6893710|NCT00615199|10911054|FG001|Overall Study|Adverse Event|1
6893711|NCT00615199|10911055|FG002|Overall Study|Adverse Event|1
6893712|NCT00615199|10911056|FG003|Overall Study|Adverse Event|0
6893713|NCT00615199|10911053|FG000|Overall Study|Lack of Efficacy|2
6893714|NCT00615199|10911054|FG001|Overall Study|Lack of Efficacy|0
6893715|NCT00615199|10911055|FG002|Overall Study|Lack of Efficacy|0
6893716|NCT00615199|10911056|FG003|Overall Study|Lack of Efficacy|1
6893717|NCT00615199|10911053|FG000|Overall Study|Lost to Follow-up|1
6893718|NCT00615199|10911054|FG001|Overall Study|Lost to Follow-up|0
6893719|NCT00615199|10911055|FG002|Overall Study|Lost to Follow-up|0
6893720|NCT00615199|10911056|FG003|Overall Study|Lost to Follow-up|0
6893721|NCT00615199|10911053|FG000|Overall Study|Other|0
6893722|NCT00615199|10911054|FG001|Overall Study|Other|0
6893723|NCT00615199|10911055|FG002|Overall Study|Other|0
6893724|NCT00615199|10911056|FG003|Overall Study|Other|1
6893725|NCT00615199|10911053|FG000|Overall Study|Withdrawal by Subject|2
6893726|NCT00615199|10911054|FG001|Overall Study|Withdrawal by Subject|1
6893727|NCT00615199|10911055|FG002|Overall Study|Withdrawal by Subject|0
6893728|NCT00615199|10911056|FG003|Overall Study|Withdrawal by Subject|0
6893729|NCT00615264|10911068|FG000|Overall Study|Withdrawal by Subject|17
6893730|NCT00615264|10911069|FG001|Overall Study|Withdrawal by Subject|19
6893731|NCT00615264|10911068|FG000|Overall Study|Lost to Follow-up|6
6893732|NCT00615264|10911069|FG001|Overall Study|Lost to Follow-up|13
6893733|NCT00615264|10911068|FG000|Overall Study|Adverse Event|8
6893734|NCT00615264|10911069|FG001|Overall Study|Adverse Event|5
6893735|NCT00615264|10911068|FG000|Overall Study|Death|1
6893736|NCT00615264|10911069|FG001|Overall Study|Death|1
6893737|NCT00615264|10911068|FG000|Overall Study|Protocol Violation|11
6893738|NCT00615264|10911069|FG001|Overall Study|Protocol Violation|7
6893739|NCT00615264|10911068|FG000|Overall Study|Not defined|7
6893740|NCT00615264|10911069|FG001|Overall Study|Not defined|4
6893741|NCT00615264|10911068|FG000|Overall Study|Dermal Hypersensitivity|0
6970816|NCT01158261|11021197|FG000|Overall Study|Lost to Follow-up|9
6893742|NCT00615264|10911069|FG001|Overall Study|Dermal Hypersensitivity|3
6893743|NCT00615290|10911075|FG000|Overall Study|Adverse Event|2
6893744|NCT00615290|10911075|FG000|Overall Study|Lost to Follow-up|3
6893745|NCT00615290|10911075|FG000|Overall Study|Withdrawal by Subject|1
6893746|NCT00615290|10911075|FG000|Overall Study|Other|2
6893747|NCT00615459|10911106|FG000|Period I|Adverse Event|2
6893748|NCT00615459|10911107|FG001|Period I|Adverse Event|0
6893749|NCT00615459|10911108|FG002|Period I|Adverse Event|1
6893750|NCT00615459|10911109|FG003|Period I|Adverse Event|0
6893751|NCT00615459|10911106|FG000|Period I|Subject withdrew consent|1
6893752|NCT00615459|10911107|FG001|Period I|Subject withdrew consent|0
6893753|NCT00615459|10911108|FG002|Period I|Subject withdrew consent|0
6893754|NCT00615459|10911109|FG003|Period I|Subject withdrew consent|1
6893755|NCT00615459|10911106|FG000|Period I|Abnormal test procedure results|1
6893756|NCT00615459|10911107|FG001|Period I|Abnormal test procedure results|1
6893757|NCT00615459|10911108|FG002|Period I|Abnormal test procedure results|1
6893758|NCT00615459|10911109|FG003|Period I|Abnormal test procedure results|0
6893759|NCT00615459|10911106|FG000|Period II|Adverse Event|1
6893760|NCT00615459|10911107|FG001|Period II|Adverse Event|0
6893761|NCT00615459|10911108|FG002|Period II|Adverse Event|0
6893762|NCT00615459|10911109|FG003|Period II|Adverse Event|0
6893763|NCT00615459|10911106|FG000|Period II|Lost to Follow-up|0
6893764|NCT00615459|10911107|FG001|Period II|Lost to Follow-up|0
6893765|NCT00615459|10911108|FG002|Period II|Lost to Follow-up|0
6893766|NCT00615459|10911109|FG003|Period II|Lost to Follow-up|1
6970817|NCT01158261|11021197|FG000|Overall Study|Death|7
6970818|NCT01158261|11021197|FG000|Overall Study|Withdrawal by Subject|1
6970819|NCT01158378|11021203|FG000|Overall Study|Death|4
6970820|NCT01158378|11021204|FG001|Overall Study|Death|5
6970821|NCT01158378|11021203|FG000|Overall Study|Lost to Follow-up|2
6970822|NCT01158378|11021204|FG001|Overall Study|Lost to Follow-up|4
6970823|NCT01158378|11021203|FG000|Overall Study|Withdrawal by Subject|4
6970824|NCT01158378|11021204|FG001|Overall Study|Withdrawal by Subject|0
6977003|NCT01203930|11029960|FG001|Overall Study|Investigator Request|8
6977004|NCT01203930|11029959|FG000|Overall Study|Study Terminated by Sponsor|0
6977005|NCT01203930|11029960|FG001|Overall Study|Study Terminated by Sponsor|12
6977006|NCT01203930|11029959|FG000|Overall Study|Poor tolerance of study drug|0
6977007|NCT01203930|11029960|FG001|Overall Study|Poor tolerance of study drug|1
6977008|NCT01203930|11029959|FG000|Overall Study|Adverse Event|17
6977009|NCT01203930|11029960|FG001|Overall Study|Adverse Event|5
6977010|NCT01203956|11029968|FG000|Second Two-week Period|Non-compliant: no evaluable results|5
6977011|NCT01203956|11029969|FG001|Second Two-week Period|Non-compliant: no evaluable results|6
6977012|NCT01204294|11029991|FG000|Overall Study|Adverse Event|2
6977013|NCT01204294|11029992|FG001|Overall Study|Adverse Event|6
6977014|NCT01204294|11029993|FG002|Overall Study|Adverse Event|0
6977015|NCT01204294|11029994|FG003|Overall Study|Adverse Event|7
6977016|NCT01204294|11029995|FG004|Overall Study|Adverse Event|1
6977017|NCT01204294|11029996|FG005|Overall Study|Adverse Event|4
6977018|NCT01204294|11029997|FG006|Overall Study|Adverse Event|0
6977019|NCT01204294|11029991|FG000|Overall Study|Protocol Violation|1
6977020|NCT01204294|11029992|FG001|Overall Study|Protocol Violation|0
6977021|NCT01204294|11029993|FG002|Overall Study|Protocol Violation|2
6977022|NCT01204294|11029994|FG003|Overall Study|Protocol Violation|1
6977023|NCT01204294|11029995|FG004|Overall Study|Protocol Violation|0
6977024|NCT01204294|11029996|FG005|Overall Study|Protocol Violation|0
6977025|NCT01204294|11029997|FG006|Overall Study|Protocol Violation|0
6977026|NCT01204294|11029991|FG000|Overall Study|Withdrawal by Subject|0
6977027|NCT01204294|11029992|FG001|Overall Study|Withdrawal by Subject|2
6977028|NCT01204294|11029993|FG002|Overall Study|Withdrawal by Subject|2
7155883|NCT03349710|11323978|FG003|Treatment Period|Other Reason|1
7155884|NCT03349710|11323975|FG000|Treatment Period|completed|6
7155885|NCT03349710|11323976|FG001|Treatment Period|completed|0
7155886|NCT03349710|11323977|FG002|Treatment Period|completed|18
7155887|NCT03349710|11323978|FG003|Treatment Period|completed|1
7155888|NCT03349710|11323975|FG000|Treatment Period|participant request to discontinue|0
7155889|NCT03349710|11323976|FG001|Treatment Period|participant request to discontinue|0
7155890|NCT03349710|11323977|FG002|Treatment Period|participant request to discontinue|4
7155891|NCT03349710|11323978|FG003|Treatment Period|participant request to discontinue|0
7155892|NCT03349710|11323975|FG000|Treatment Period|participant withdrew consent|1
7155893|NCT03349710|11323976|FG001|Treatment Period|participant withdrew consent|0
7155894|NCT03349710|11323977|FG002|Treatment Period|participant withdrew consent|0
7155895|NCT03349710|11323978|FG003|Treatment Period|participant withdrew consent|0
6977029|NCT01204294|11029994|FG003|Overall Study|Withdrawal by Subject|1
6977030|NCT01204294|11029995|FG004|Overall Study|Withdrawal by Subject|1
6977031|NCT01204294|11029996|FG005|Overall Study|Withdrawal by Subject|1
6977032|NCT01204294|11029997|FG006|Overall Study|Withdrawal by Subject|2
6977033|NCT01204294|11029991|FG000|Overall Study|Lack of Efficacy|0
6977034|NCT01204294|11029992|FG001|Overall Study|Lack of Efficacy|0
6977035|NCT01204294|11029993|FG002|Overall Study|Lack of Efficacy|0
7155896|NCT03350256|11324001|FG000|Overall Study|Inclusion/exclusion violation|4
6893767|NCT00615459|10911106|FG000|Period III|Adverse Event|0
6977036|NCT01204294|11029994|FG003|Overall Study|Lack of Efficacy|2
6977037|NCT01204294|11029995|FG004|Overall Study|Lack of Efficacy|0
6977038|NCT01204294|11029996|FG005|Overall Study|Lack of Efficacy|0
6977039|NCT01204294|11029997|FG006|Overall Study|Lack of Efficacy|0
6893768|NCT00615459|10911107|FG001|Period III|Adverse Event|1
6893769|NCT00615459|10911108|FG002|Period III|Adverse Event|0
6893770|NCT00615459|10911109|FG003|Period III|Adverse Event|0
6893771|NCT00615459|10911106|FG000|Period III|Administrative problems|0
6893772|NCT00615459|10911107|FG001|Period III|Administrative problems|1
6893773|NCT00615459|10911108|FG002|Period III|Administrative problems|1
6893774|NCT00615459|10911109|FG003|Period III|Administrative problems|0
6893775|NCT00615459|10911106|FG000|Period III|Unsatisfactory therapeutic effect|0
6893776|NCT00615459|10911107|FG001|Period III|Unsatisfactory therapeutic effect|1
6893777|NCT00615459|10911108|FG002|Period III|Unsatisfactory therapeutic effect|0
6893778|NCT00615459|10911109|FG003|Period III|Unsatisfactory therapeutic effect|0
6893779|NCT00615550|10911130|FG000|Overall Study|Lost to Follow-up|6
6893780|NCT00615550|10911131|FG001|Overall Study|Lost to Follow-up|1
6893781|NCT00615719|10911142|FG000|Overall Study|Physician Decision|5
6893782|NCT00615836|10911154|FG000|Extension Study (FE992026 CS31)|Adverse Event|7
6893783|NCT00615836|10911155|FG001|Extension Study (FE992026 CS31)|Adverse Event|12
6893784|NCT00615836|10911156|FG002|Extension Study (FE992026 CS31)|Adverse Event|15
6893785|NCT00615836|10911157|FG003|Extension Study (FE992026 CS31)|Adverse Event|13
6893786|NCT00615836|10911158|FG004|Extension Study (FE992026 CS31)|Adverse Event|0
6893787|NCT00615836|10911154|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1
6893788|NCT00615836|10911155|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
6893789|NCT00615836|10911156|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
6893790|NCT00615836|10911157|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
6893791|NCT00615836|10911158|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
6893792|NCT00615836|10911154|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
6893793|NCT00615836|10911155|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2
6893794|NCT00615836|10911156|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
6893795|NCT00615836|10911157|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
6893796|NCT00615836|10911158|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
6893797|NCT00615836|10911154|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4
6893798|NCT00615836|10911155|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5
6893799|NCT00615836|10911156|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2
6893800|NCT00615836|10911157|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3
6893801|NCT00615836|10911158|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0
6893802|NCT00615836|10911154|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37
6893803|NCT00615836|10911155|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42
6893804|NCT00615836|10911156|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38
6893805|NCT00615836|10911157|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43
6893806|NCT00615836|10911158|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0
6893807|NCT00615836|10911154|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10
6893808|NCT00615836|10911155|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14
6893809|NCT00615836|10911156|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5
6893810|NCT00615836|10911157|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10
6893811|NCT00615836|10911158|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0
6893812|NCT00615836|10911154|FG000|Extension Study (FE992026 CS31)|Other|10
6893813|NCT00615836|10911155|FG001|Extension Study (FE992026 CS31)|Other|7
6893814|NCT00615836|10911156|FG002|Extension Study (FE992026 CS31)|Other|8
6893815|NCT00615836|10911157|FG003|Extension Study (FE992026 CS31)|Other|8
6893816|NCT00615836|10911158|FG004|Extension Study (FE992026 CS31)|Other|0
6893817|NCT00615836|10911154|FG000|Extension Study (FE992026 CS31)|Not reported|6
6893818|NCT00615836|10911155|FG001|Extension Study (FE992026 CS31)|Not reported|4
6893819|NCT00615836|10911156|FG002|Extension Study (FE992026 CS31)|Not reported|1
6893820|NCT00615836|10911157|FG003|Extension Study (FE992026 CS31)|Not reported|4
6893821|NCT00615836|10911158|FG004|Extension Study (FE992026 CS31)|Not reported|0
6893822|NCT00615836|10911154|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65
6893823|NCT00615836|10911155|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
6893824|NCT00615836|10911156|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
6893825|NCT00615836|10911157|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
6893826|NCT00615836|10911158|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
6893827|NCT00615901|10911174|FG000|Overall Study|Withdrawal by Subject|2
6893828|NCT00615901|10911174|FG000|Overall Study|Adverse Event|7
6893829|NCT00615914|10911178|FG000|Overall Study|Adverse Event|274
6893830|NCT00615914|10911178|FG000|Overall Study|Death|20
6893831|NCT00615914|10911178|FG000|Overall Study|Lack of Efficacy|59
6893832|NCT00615914|10911178|FG000|Overall Study|Lost to Follow-up|187
6893833|NCT00615914|10911178|FG000|Overall Study|Withdrawal by Subject|16
6893834|NCT00615914|10911178|FG000|Overall Study|Physician Decision|4
6893835|NCT00615914|10911178|FG000|Overall Study|No data was collected.|65
6893836|NCT00615914|10911178|FG000|Overall Study|No treatment|2
6893837|NCT00615914|10911178|FG000|Overall Study|Irregularly enrolled patients|10
6893838|NCT00615992|10911192|FG000|Overall Study|Protocol Violation|67
6893839|NCT00616018|10911196|FG000|Overall Study|Protocol Violation|3
6893840|NCT00616239|10911220|FG000|Overall Study|Withdrawal by Subject|2
6893841|NCT00616421|10911227|FG000|Overall Study|Withdrawal by Subject|9
6893842|NCT00616421|10911228|FG001|Overall Study|Withdrawal by Subject|11
6893843|NCT00616421|10911229|FG002|Overall Study|Withdrawal by Subject|8
6970825|NCT01158404|11021219|FG000|Overall Study|Withdrawal by Subject|0
6893844|NCT00616421|10911227|FG000|Overall Study|Lost to Follow-up|12
6893845|NCT00616421|10911228|FG001|Overall Study|Lost to Follow-up|26
6893846|NCT00616421|10911229|FG002|Overall Study|Lost to Follow-up|30
6893847|NCT00616421|10911227|FG000|Overall Study|Inappropriate enrollment|3
6893848|NCT00616421|10911228|FG001|Overall Study|Inappropriate enrollment|0
6893849|NCT00616421|10911229|FG002|Overall Study|Inappropriate enrollment|1
6893850|NCT00616421|10911227|FG000|Overall Study|Administrative reason|1
6893851|NCT00616421|10911228|FG001|Overall Study|Administrative reason|0
6893852|NCT00616421|10911229|FG002|Overall Study|Administrative reason|0
6893853|NCT00616421|10911227|FG000|Overall Study|Protocol Violation|0
6893854|NCT00616421|10911228|FG001|Overall Study|Protocol Violation|1
6893855|NCT00616421|10911229|FG002|Overall Study|Protocol Violation|2
6893856|NCT00616421|10911227|FG000|Overall Study|Unable to classify|1
6893857|NCT00616421|10911228|FG001|Overall Study|Unable to classify|0
6893858|NCT00616421|10911229|FG002|Overall Study|Unable to classify|0
6893859|NCT00616434|10911253|FG000|Overall Study|Adverse Event|5
6893860|NCT00616434|10911254|FG001|Overall Study|Adverse Event|2
6893861|NCT00616434|10911253|FG000|Overall Study|Physician Decision|0
6893862|NCT00616434|10911254|FG001|Overall Study|Physician Decision|4
6893863|NCT00616434|10911253|FG000|Overall Study|Withdrawal by Subject|1
6893864|NCT00616434|10911254|FG001|Overall Study|Withdrawal by Subject|1
6893865|NCT00616434|10911253|FG000|Overall Study|Protocol deviation|0
6893866|NCT00616434|10911254|FG001|Overall Study|Protocol deviation|1
6893867|NCT00616629|10911265|FG000|Overall Study|Protocol Violation|1
6893868|NCT00616629|10911266|FG001|Overall Study|Protocol Violation|2
6893869|NCT00616629|10911267|FG002|Overall Study|Protocol Violation|1
6893870|NCT00616629|10911268|FG003|Overall Study|Protocol Violation|0
6893871|NCT00616629|10911269|FG004|Overall Study|Protocol Violation|0
6893872|NCT00616629|10911265|FG000|Overall Study|AV-block|1
6893873|NCT00616629|10911266|FG001|Overall Study|AV-block|0
6893874|NCT00616629|10911267|FG002|Overall Study|AV-block|0
6893875|NCT00616629|10911268|FG003|Overall Study|AV-block|0
6893876|NCT00616629|10911269|FG004|Overall Study|AV-block|0
6893877|NCT00616655|10911284|FG000|Overall Study|Adverse Event|10
6893878|NCT00616655|10911285|FG001|Overall Study|Adverse Event|7
6893879|NCT00616655|10911286|FG002|Overall Study|Adverse Event|12
6893880|NCT00616655|10911284|FG000|Overall Study|Lack of Efficacy|5
6893881|NCT00616655|10911285|FG001|Overall Study|Lack of Efficacy|5
6893882|NCT00616655|10911286|FG002|Overall Study|Lack of Efficacy|5
6893883|NCT00616655|10911284|FG000|Overall Study|Lost to Follow-up|3
6893884|NCT00616655|10911285|FG001|Overall Study|Lost to Follow-up|12
6893885|NCT00616655|10911286|FG002|Overall Study|Lost to Follow-up|10
6893886|NCT00616655|10911284|FG000|Overall Study|Protocol Violation|2
6893887|NCT00616655|10911285|FG001|Overall Study|Protocol Violation|4
6893888|NCT00616655|10911286|FG002|Overall Study|Protocol Violation|3
6893889|NCT00616655|10911284|FG000|Overall Study|Withdrawal by Subject|9
6893890|NCT00616655|10911285|FG001|Overall Study|Withdrawal by Subject|7
6893891|NCT00616655|10911286|FG002|Overall Study|Withdrawal by Subject|11
6893892|NCT00616655|10911284|FG000|Overall Study|Does not meet in/ex criteria|0
6893893|NCT00616655|10911285|FG001|Overall Study|Does not meet in/ex criteria|0
6893894|NCT00616655|10911286|FG002|Overall Study|Does not meet in/ex criteria|2
6893895|NCT00616655|10911284|FG000|Overall Study|Other|6
6893896|NCT00616655|10911285|FG001|Overall Study|Other|6
6893897|NCT00616655|10911286|FG002|Overall Study|Other|5
6893898|NCT00616902|10911305|FG000|Overall Study|Termination of study|6
6893899|NCT00616902|10911306|FG001|Overall Study|Termination of study|6
6970826|NCT01158404|11021220|FG001|Overall Study|Withdrawal by Subject|1
6970827|NCT01158404|11021221|FG002|Overall Study|Withdrawal by Subject|0
6970828|NCT01158404|11021222|FG003|Overall Study|Withdrawal by Subject|0
6970829|NCT01158404|11021223|FG004|Overall Study|Withdrawal by Subject|3
6970830|NCT01158404|11021224|FG005|Overall Study|Withdrawal by Subject|1
6970831|NCT01158404|11021225|FG006|Overall Study|Withdrawal by Subject|0
6970832|NCT01158404|11021226|FG007|Overall Study|Withdrawal by Subject|1
6970833|NCT01158404|11021219|FG000|Overall Study|Physician Decision|0
6970834|NCT01158404|11021220|FG001|Overall Study|Physician Decision|0
6970835|NCT01158404|11021221|FG002|Overall Study|Physician Decision|0
6970836|NCT01158404|11021222|FG003|Overall Study|Physician Decision|0
6970837|NCT01158404|11021223|FG004|Overall Study|Physician Decision|0
6970838|NCT01158404|11021224|FG005|Overall Study|Physician Decision|0
6970839|NCT01158404|11021225|FG006|Overall Study|Physician Decision|0
6970840|NCT01158404|11021226|FG007|Overall Study|Physician Decision|1
6970841|NCT01158404|11021219|FG000|Overall Study|Progressive Disease|0
6970842|NCT01158404|11021220|FG001|Overall Study|Progressive Disease|0
6970843|NCT01158404|11021221|FG002|Overall Study|Progressive Disease|0
6970844|NCT01158404|11021222|FG003|Overall Study|Progressive Disease|0
6970845|NCT01158404|11021223|FG004|Overall Study|Progressive Disease|0
6970846|NCT01158404|11021224|FG005|Overall Study|Progressive Disease|0
6970847|NCT01158404|11021225|FG006|Overall Study|Progressive Disease|1
6970848|NCT01158404|11021226|FG007|Overall Study|Progressive Disease|0
6970849|NCT01158534|11021252|FG000|Overall Study|Withdrawal by Subject|1
6970850|NCT01158534|11021252|FG000|Overall Study|Death|1
6970851|NCT01158534|11021252|FG000|Overall Study|Other|1
6970852|NCT01158924|11021311|FG000|Overall Study|Withdrawal by Subject|1
6970853|NCT01158924|11021312|FG001|Overall Study|Withdrawal by Subject|2
6970854|NCT01158924|11021311|FG000|Overall Study|Lost to Follow-up|0
6970855|NCT01158924|11021312|FG001|Overall Study|Lost to Follow-up|1
6970856|NCT01158950|11021318|FG000|1st Intervention (1 Day)|Physician Decision|1
6970857|NCT01158950|11021319|FG001|1st Intervention (1 Day)|Physician Decision|2
6893900|NCT00616928|10911316|FG000|Overall Study|Adverse Event|6
6893901|NCT00616928|10911317|FG001|Overall Study|Adverse Event|3
6893902|NCT00616928|10911318|FG002|Overall Study|Adverse Event|2
6893903|NCT00616928|10911319|FG003|Overall Study|Adverse Event|2
6893904|NCT00616928|10911316|FG000|Overall Study|Other|51
6893905|NCT00616928|10911317|FG001|Overall Study|Other|8
6893906|NCT00616928|10911318|FG002|Overall Study|Other|15
6893907|NCT00616928|10911319|FG003|Overall Study|Other|5
6893908|NCT00616928|10911316|FG000|Overall Study|Lost to Follow-up|5
6893909|NCT00616928|10911317|FG001|Overall Study|Lost to Follow-up|7
6893910|NCT00616928|10911318|FG002|Overall Study|Lost to Follow-up|0
6893911|NCT00616928|10911319|FG003|Overall Study|Lost to Follow-up|0
6893912|NCT00616941|10911344|FG000|Overall Study|Progressive Disease|1
6893913|NCT00616941|10911345|FG001|Overall Study|Progressive Disease|2
6893914|NCT00616941|10911346|FG002|Overall Study|Progressive Disease|1
6893915|NCT00616941|10911344|FG000|Overall Study|Adverse Event|0
6893916|NCT00616941|10911345|FG001|Overall Study|Adverse Event|1
6893917|NCT00616941|10911346|FG002|Overall Study|Adverse Event|1
6893918|NCT00616941|10911344|FG000|Overall Study|Subject Non-compliance|0
6893919|NCT00616941|10911345|FG001|Overall Study|Subject Non-compliance|0
6893920|NCT00616941|10911346|FG002|Overall Study|Subject Non-compliance|1
6893921|NCT00616941|10911344|FG000|Overall Study|Unrelated Medical Illness/Complication|0
6893922|NCT00616941|10911345|FG001|Overall Study|Unrelated Medical Illness/Complication|2
6893923|NCT00616941|10911346|FG002|Overall Study|Unrelated Medical Illness/Complication|0
6893924|NCT00616941|10911344|FG000|Overall Study|Vaccination Suspended|0
6893925|NCT00616941|10911345|FG001|Overall Study|Vaccination Suspended|0
6893926|NCT00616941|10911346|FG002|Overall Study|Vaccination Suspended|3
6893927|NCT00617084|10911369|FG000|Overall Study|Withdrawal by Subject|5
6893928|NCT00617084|10911370|FG001|Overall Study|Withdrawal by Subject|7
6893929|NCT00617084|10911369|FG000|Overall Study|Missed 12 Months visit|16
6893930|NCT00617084|10911370|FG001|Overall Study|Missed 12 Months visit|19
6893931|NCT00617123|10911389|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36
6893932|NCT00617123|10911390|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24
6893933|NCT00617123|10911389|FG000|Referral Screening Period|Did Not Wish To Continue|3
6893934|NCT00617123|10911390|FG001|Referral Screening Period|Did Not Wish To Continue|1
6893935|NCT00617123|10911389|FG000|Referral Screening Period|Adverse Event|0
6893936|NCT00617123|10911390|FG001|Referral Screening Period|Adverse Event|1
6893937|NCT00617123|10911389|FG000|Study Treatment Period|Withdrawal by Subject|8
6893938|NCT00617123|10911390|FG001|Study Treatment Period|Withdrawal by Subject|12
6893939|NCT00617123|10911389|FG000|Study Treatment Period|Adverse Event|7
6893940|NCT00617123|10911390|FG001|Study Treatment Period|Adverse Event|3
6893941|NCT00617123|10911389|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2
6893942|NCT00617123|10911390|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0
6893943|NCT00617123|10911389|FG000|Study Treatment Period|Noncompliance with Protocol|0
6893944|NCT00617123|10911390|FG001|Study Treatment Period|Noncompliance with Protocol|1
6893945|NCT00617201|10911411|FG000|Overall Study|Lost to Follow-up|9
6893946|NCT00617201|10911412|FG001|Overall Study|Lost to Follow-up|13
6893947|NCT00617240|10911422|FG000|Overall Study|Lack of Efficacy|1
6893948|NCT00617240|10911423|FG001|Overall Study|Lack of Efficacy|0
6893949|NCT00617279|10911431|FG000|Overall Study|Study terminated by Sponsor|10
6893950|NCT00617279|10911432|FG001|Overall Study|Study terminated by Sponsor|15
6893951|NCT00617279|10911431|FG000|Overall Study|Graft abandonment|2
6893952|NCT00617279|10911432|FG001|Overall Study|Graft abandonment|0
6893953|NCT00617279|10911431|FG000|Overall Study|Lost to Follow-up|1
7155897|NCT03350256|11324001|FG000|Overall Study|Recommended for other therapies|2
7155898|NCT03350256|11324001|FG000|Overall Study|Protocol Violation|3
7155899|NCT03350256|11324001|FG000|Overall Study|Non compliance|2
7155900|NCT03350256|11324001|FG000|Overall Study|Denial by insurance|1
7155901|NCT03350256|11324001|FG000|Overall Study|Adverse Event|2
7155902|NCT03350256|11324001|FG000|Overall Study|Trial failure|12
7155903|NCT03350256|11324001|FG000|Overall Study|Did not proceed to permanent implant|3
7155904|NCT03350256|11324001|FG000|Overall Study|Withdrawal by Subject|3
7155905|NCT03350256|11324001|FG000|Overall Study|Subject moving out of state|1
6893954|NCT00617279|10911432|FG001|Overall Study|Lost to Follow-up|0
6893955|NCT00617279|10911431|FG000|Overall Study|Death|1
6893956|NCT00617279|10911432|FG001|Overall Study|Death|2
6893957|NCT00617305|10911441|FG000|Overall Study|Adverse Event|4
7155906|NCT03350256|11324001|FG000|Overall Study|Lost to Follow-up|1
7155907|NCT03350256|11324001|FG000|Overall Study|Lack of Efficacy|2
7155908|NCT03350672|11324012|FG000|Overall Study|Withdrawal by Subject|7
7155909|NCT03350672|11324013|FG001|Overall Study|Withdrawal by Subject|0
7155910|NCT03350672|11324014|FG002|Overall Study|Withdrawal by Subject|0
7155911|NCT03351114|11324051|FG000|Overall Study|Withdrawal by Subject|1
7155912|NCT03351231|11324055|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1
7155913|NCT03351231|11324055|FG000|Combination Therapy Period|Disease progression|2
6893958|NCT00617305|10911442|FG001|Overall Study|Adverse Event|0
6893959|NCT00617305|10911443|FG002|Overall Study|Adverse Event|0
6893960|NCT00617305|10911441|FG000|Overall Study|Death|1
6893961|NCT00617305|10911442|FG001|Overall Study|Death|0
6893962|NCT00617305|10911443|FG002|Overall Study|Death|0
6893963|NCT00617305|10911441|FG000|Overall Study|Physician Decision|1
6893964|NCT00617305|10911442|FG001|Overall Study|Physician Decision|0
6893965|NCT00617305|10911443|FG002|Overall Study|Physician Decision|0
6893966|NCT00617305|10911441|FG000|Overall Study|Protocol Violation|1
6893967|NCT00617305|10911442|FG001|Overall Study|Protocol Violation|0
6893968|NCT00617305|10911443|FG002|Overall Study|Protocol Violation|1
6893969|NCT00617305|10911441|FG000|Overall Study|Withdrawal by Subject|1
6893970|NCT00617305|10911442|FG001|Overall Study|Withdrawal by Subject|0
6893971|NCT00617305|10911443|FG002|Overall Study|Withdrawal by Subject|0
6893972|NCT00617344|10911457|FG000|Overall Study|Serious adverse event|1
6893973|NCT00617344|10911458|FG001|Overall Study|Serious adverse event|0
6893974|NCT00617344|10911459|FG002|Overall Study|Serious adverse event|0
6893975|NCT00617344|10911457|FG000|Overall Study|Other Adverse Event|1
6893976|NCT00617344|10911458|FG001|Overall Study|Other Adverse Event|1
6893977|NCT00617344|10911459|FG002|Overall Study|Other Adverse Event|0
6893978|NCT00617344|10911457|FG000|Overall Study|Protocol Violation|10
6893979|NCT00617344|10911458|FG001|Overall Study|Protocol Violation|8
6893980|NCT00617344|10911459|FG002|Overall Study|Protocol Violation|5
6893981|NCT00617344|10911457|FG000|Overall Study|Lost to Follow-up|5
6893982|NCT00617344|10911458|FG001|Overall Study|Lost to Follow-up|4
6893983|NCT00617344|10911459|FG002|Overall Study|Lost to Follow-up|1
6893984|NCT00617344|10911457|FG000|Overall Study|Withdrawal by Subject|8
6893985|NCT00617344|10911458|FG001|Overall Study|Withdrawal by Subject|9
6893986|NCT00617344|10911459|FG002|Overall Study|Withdrawal by Subject|2
6893987|NCT00617357|10911467|FG000|Overall Study|Lost to Follow-up|7
6893988|NCT00617357|10911467|FG000|Overall Study|Death|5
6893989|NCT00617357|10911467|FG000|Overall Study|insurance concerns|2
6893990|NCT00617357|10911467|FG000|Overall Study|Withdrawal by Subject|1
6893991|NCT00617357|10911467|FG000|Overall Study|Physician Decision|1
6893992|NCT00617409|10911479|FG000|Overall Study|Withdrawal by Subject|4
7155914|NCT03351231|11324055|FG000|Combination Therapy Period|Study drug toxicity|1
7155915|NCT03351231|11324055|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1
7155916|NCT03351231|11324055|FG000|Safety Follow-Up Period|Participant withdrew consent|1
7155917|NCT03351231|11324055|FG000|Safety Follow-Up Period|Other reason|2
6893993|NCT00617409|10911480|FG001|Overall Study|Withdrawal by Subject|1
6893994|NCT00617409|10911481|FG002|Overall Study|Withdrawal by Subject|2
6893995|NCT00617409|10911479|FG000|Overall Study|Adverse Event|0
6893996|NCT00617409|10911480|FG001|Overall Study|Adverse Event|2
6893997|NCT00617409|10911481|FG002|Overall Study|Adverse Event|3
6893998|NCT00617409|10911479|FG000|Overall Study|Disease Progression|8
6893999|NCT00617409|10911480|FG001|Overall Study|Disease Progression|8
6894000|NCT00617409|10911481|FG002|Overall Study|Disease Progression|18
6894001|NCT00617409|10911479|FG000|Overall Study|Death|3
6894002|NCT00617409|10911480|FG001|Overall Study|Death|5
6894003|NCT00617409|10911481|FG002|Overall Study|Death|4
6894004|NCT00617409|10911479|FG000|Overall Study|Alternative Therapy|1
7041337|NCT01726049|11124891|FG001|Overall Study|refused second HC|2
7079405|NCT02114268|11188522|FG000|Overall Study|Withdrawn by site due to noncompliance|1
7079406|NCT02114268|11188523|FG001|Overall Study|Withdrawn by site due to noncompliance|0
7079407|NCT02114268|11188524|FG002|Overall Study|Withdrawn by site due to noncompliance|0
7079408|NCT02114268|11188525|FG003|Overall Study|Withdrawn by site due to noncompliance|0
7079409|NCT02114268|11188526|FG004|Overall Study|Withdrawn by site due to noncompliance|0
7079410|NCT02114268|11188527|FG005|Overall Study|Withdrawn by site due to noncompliance|0
7079411|NCT02114385|11188559|FG000|Overall Study|Withdrawal by Subject|3
7079412|NCT02114385|11188560|FG001|Overall Study|Withdrawal by Subject|2
7155918|NCT03351335|11324062|FG000|Overall Study|Failure to maintain inclusion/exclusion|0
7155919|NCT03351335|11324063|FG001|Overall Study|Failure to maintain inclusion/exclusion|0
7155920|NCT03351335|11324064|FG002|Overall Study|Failure to maintain inclusion/exclusion|4
7155921|NCT03351478|11324075|FG000|Overall Study|At the subject's own request|11
7155922|NCT03351478|11324076|FG001|Overall Study|At the subject's own request|12
7184163|NCT01777295|11384169|FG001|Overall Study|Pregnancy|1
6894005|NCT00617409|10911480|FG001|Overall Study|Alternative Therapy|2
6894006|NCT00617409|10911481|FG002|Overall Study|Alternative Therapy|0
6894007|NCT00617461|10911490|FG000|First Treatment Intervention Period|Adverse Event|2
6894008|NCT00617461|10911491|FG001|First Treatment Intervention Period|Adverse Event|0
6894009|NCT00617461|10911490|FG000|First Treatment Intervention Period|Lack of Efficacy|1
6894010|NCT00617461|10911491|FG001|First Treatment Intervention Period|Lack of Efficacy|0
7041338|NCT01726270|11124897|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10
7041339|NCT01726270|11124897|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20
7041340|NCT01726270|11124897|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21
7041341|NCT01726270|11124897|FG000|Part 2, Actual-Use Phase|Adverse Event|6
7041342|NCT01726270|11124897|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5
7041343|NCT01726270|11124897|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7
7041344|NCT01726335|11124903|FG000|Overall Study|Lost to Follow-up|2
7041345|NCT01726335|11124903|FG000|Overall Study|Withdrawal by Subject|15
6894011|NCT00617461|10911490|FG000|First Treatment Intervention Period|Protocol Violation|2
6894012|NCT00617461|10911491|FG001|First Treatment Intervention Period|Protocol Violation|1
6894013|NCT00617461|10911490|FG000|First Treatment Intervention Period|Lost to Follow-up|0
6894014|NCT00617461|10911491|FG001|First Treatment Intervention Period|Lost to Follow-up|1
6894015|NCT00617461|10911490|FG000|First Treatment Intervention Period|Investigator Discretion|1
7041346|NCT01726335|11124903|FG000|Overall Study|Adverse Event|4
7079413|NCT02114385|11188559|FG000|Overall Study|Lost to Follow-up|0
6894016|NCT00617461|10911491|FG001|First Treatment Intervention Period|Investigator Discretion|1
6894017|NCT00617461|10911490|FG000|First Treatment Intervention Period|Withdrawal by Subject|4
6894018|NCT00617461|10911491|FG001|First Treatment Intervention Period|Withdrawal by Subject|0
6894019|NCT00617461|10911490|FG000|4-Day Crossover Period|Withdrawal by Subject|1
6894020|NCT00617461|10911491|FG001|4-Day Crossover Period|Withdrawal by Subject|0
6894021|NCT00617461|10911490|FG000|Second Treatment Intervention Period|Adverse Event|0
6894022|NCT00617461|10911491|FG001|Second Treatment Intervention Period|Adverse Event|1
6894023|NCT00617461|10911490|FG000|Second Treatment Intervention Period|Lack of Efficacy|0
6894024|NCT00617461|10911491|FG001|Second Treatment Intervention Period|Lack of Efficacy|3
6894025|NCT00617461|10911490|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1
6894026|NCT00617461|10911491|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0
6894027|NCT00617461|10911490|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1
6894028|NCT00617461|10911491|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2
6894029|NCT00617591|10911518|FG000|Overall Study|Withdrew consent during Induction|4
6894030|NCT00617591|10911518|FG000|Overall Study|Withdrew consent during Maintenance|6
6894031|NCT00617604|10911525|FG000|Overall Study|Death|2
6894032|NCT00617604|10911526|FG001|Overall Study|Death|1
6894033|NCT00617604|10911525|FG000|Overall Study|Lost to Follow-up|1
6894034|NCT00617604|10911526|FG001|Overall Study|Lost to Follow-up|0
6894035|NCT00617604|10911525|FG000|Overall Study|Miscellaneous Reasons|8
6894036|NCT00617604|10911526|FG001|Overall Study|Miscellaneous Reasons|10
6894037|NCT00617604|10911525|FG000|Overall Study|Withdrawal by Subject|4
6894038|NCT00617604|10911526|FG001|Overall Study|Withdrawal by Subject|6
6894039|NCT00617604|10911525|FG000|Overall Study|Randomized but Never Received Study Drug|3
6894040|NCT00617604|10911526|FG001|Overall Study|Randomized but Never Received Study Drug|3
6894041|NCT00617669|10911534|FG000|Overall Study|Withdrawal by Subject|71
6894042|NCT00617669|10911535|FG001|Overall Study|Withdrawal by Subject|77
6894043|NCT00617669|10911534|FG000|Overall Study|Lost to Follow-up|3
6894044|NCT00617669|10911535|FG001|Overall Study|Lost to Follow-up|2
6894045|NCT00617669|10911534|FG000|Overall Study|Adverse Event|87
6894046|NCT00617669|10911535|FG001|Overall Study|Adverse Event|76
6894047|NCT00617669|10911534|FG000|Overall Study|Protocol Violation|2
6894048|NCT00617669|10911535|FG001|Overall Study|Protocol Violation|3
6894049|NCT00617669|10911534|FG000|Overall Study|Reason not otherwise captured, eg; death|265
6894050|NCT00617669|10911535|FG001|Overall Study|Reason not otherwise captured, eg; death|290
6894051|NCT00617669|10911534|FG000|Overall Study|Patients randomized but not treated|2
6894052|NCT00617669|10911535|FG001|Overall Study|Patients randomized but not treated|3
6894053|NCT00617734|10911543|FG000|Overall Study|Withdrew Consent|2
6894054|NCT00617734|10911544|FG001|Overall Study|Withdrew Consent|0
6894055|NCT00617734|10911543|FG000|Overall Study|Adverse Event|4
6894056|NCT00617734|10911544|FG001|Overall Study|Adverse Event|1
6894057|NCT00617734|10911543|FG000|Overall Study|Protocol Violation|1
6894058|NCT00617734|10911544|FG001|Overall Study|Protocol Violation|0
6894059|NCT00617734|10911543|FG000|Overall Study|Found Ineligible After Randomization|1
6894060|NCT00617734|10911544|FG001|Overall Study|Found Ineligible After Randomization|4
6894061|NCT00617734|10911543|FG000|Overall Study|Lost to Follow-up|0
6894062|NCT00617734|10911544|FG001|Overall Study|Lost to Follow-up|1
6894063|NCT00617773|10911550|FG000|Overall Study|Physician Decision|1
6894064|NCT00617773|10911550|FG000|Overall Study|Lack of compliance with the protocol|1
6894065|NCT00617773|10911550|FG000|Overall Study|Withdrawal by Subject|1
6894066|NCT00617773|10911550|FG000|Overall Study|Death|1
6894067|NCT00617773|10911550|FG000|Overall Study|Progressive disease|19
6894068|NCT00617773|10911550|FG000|Overall Study|Protocol Violation|1
6894069|NCT00617851|10911558|FG000|Overall Study|Death|0
6894070|NCT00617851|10911559|FG001|Overall Study|Death|0
6894071|NCT00617851|10911560|FG002|Overall Study|Death|0
6894072|NCT00617851|10911561|FG003|Overall Study|Death|1
6894073|NCT00617851|10911558|FG000|Overall Study|Withdrawal by Subject|14
6894074|NCT00617851|10911559|FG001|Overall Study|Withdrawal by Subject|7
6894075|NCT00617851|10911560|FG002|Overall Study|Withdrawal by Subject|12
6894076|NCT00617851|10911561|FG003|Overall Study|Withdrawal by Subject|4
6894077|NCT00617851|10911558|FG000|Overall Study|Lost to Follow-up|27
6894078|NCT00617851|10911559|FG001|Overall Study|Lost to Follow-up|29
6894079|NCT00617851|10911560|FG002|Overall Study|Lost to Follow-up|31
6894080|NCT00617851|10911561|FG003|Overall Study|Lost to Follow-up|19
6894081|NCT00617851|10911558|FG000|Overall Study|Inappropriate Enrollment|5
6894082|NCT00617851|10911559|FG001|Overall Study|Inappropriate Enrollment|4
6894083|NCT00617851|10911560|FG002|Overall Study|Inappropriate Enrollment|1
6894084|NCT00617851|10911561|FG003|Overall Study|Inappropriate Enrollment|1
6894085|NCT00617851|10911558|FG000|Overall Study|Unable to classify|1
6894086|NCT00617851|10911559|FG001|Overall Study|Unable to classify|0
6894087|NCT00617851|10911560|FG002|Overall Study|Unable to classify|1
6894088|NCT00617851|10911561|FG003|Overall Study|Unable to classify|0
6894089|NCT00617890|10911585|FG000|Overall Study|Treatment ongoing at data cut-off|0
6894090|NCT00617890|10911586|FG001|Overall Study|Treatment ongoing at data cut-off|0
6894091|NCT00617890|10911587|FG002|Overall Study|Treatment ongoing at data cut-off|0
6894092|NCT00617890|10911588|FG003|Overall Study|Treatment ongoing at data cut-off|5
6894093|NCT00617890|10911585|FG000|Overall Study|Lack of Efficacy|23
6894094|NCT00617890|10911586|FG001|Overall Study|Lack of Efficacy|26
6894095|NCT00617890|10911587|FG002|Overall Study|Lack of Efficacy|30
6894096|NCT00617890|10911588|FG003|Overall Study|Lack of Efficacy|97
6894097|NCT00617890|10911585|FG000|Overall Study|Lost to Follow-up|0
6894098|NCT00617890|10911586|FG001|Overall Study|Lost to Follow-up|0
6894099|NCT00617890|10911587|FG002|Overall Study|Lost to Follow-up|1
6894100|NCT00617890|10911588|FG003|Overall Study|Lost to Follow-up|2
6894101|NCT00617890|10911585|FG000|Overall Study|Withdrawal by Subject|4
6894102|NCT00617890|10911586|FG001|Overall Study|Withdrawal by Subject|1
6894103|NCT00617890|10911587|FG002|Overall Study|Withdrawal by Subject|0
6894104|NCT00617890|10911588|FG003|Overall Study|Withdrawal by Subject|2
6894105|NCT00617890|10911585|FG000|Overall Study|Protocol Violation|2
6894106|NCT00617890|10911586|FG001|Overall Study|Protocol Violation|1
6894107|NCT00617890|10911587|FG002|Overall Study|Protocol Violation|0
6894108|NCT00617890|10911588|FG003|Overall Study|Protocol Violation|0
6894109|NCT00617890|10911585|FG000|Overall Study|Adverse Event|1
6894110|NCT00617890|10911586|FG001|Overall Study|Adverse Event|0
6894111|NCT00617890|10911587|FG002|Overall Study|Adverse Event|3
6894112|NCT00617890|10911588|FG003|Overall Study|Adverse Event|8
6894113|NCT00617890|10911585|FG000|Overall Study|Not treated|1
6894114|NCT00617890|10911586|FG001|Overall Study|Not treated|0
6894115|NCT00617890|10911587|FG002|Overall Study|Not treated|1
6894116|NCT00617890|10911588|FG003|Overall Study|Not treated|1
6894117|NCT00617903|10911603|FG000|Overall Study|Withdrawal by Subject|2
6894118|NCT00617903|10911604|FG001|Overall Study|Withdrawal by Subject|3
6894119|NCT00617903|10911603|FG000|Overall Study|Lost to Follow-up|1
6894120|NCT00617903|10911604|FG001|Overall Study|Lost to Follow-up|1
6894121|NCT00617903|10911603|FG000|Overall Study|Lack of Efficacy|0
6894122|NCT00617903|10911604|FG001|Overall Study|Lack of Efficacy|1
6894123|NCT00617903|10911603|FG000|Overall Study|Adverse Event|0
6894124|NCT00617903|10911604|FG001|Overall Study|Adverse Event|1
6894125|NCT00617903|10911603|FG000|Overall Study|noncompliance|0
6894126|NCT00617903|10911604|FG001|Overall Study|noncompliance|1
6894127|NCT00617929|10911610|FG000|Overall Study|Physician Decision|1
6894128|NCT00618072|10911641|FG000|Overall Study|Lost to Follow-up|2
6894129|NCT00618072|10911642|FG001|Overall Study|Lost to Follow-up|0
6894130|NCT00618072|10911643|FG002|Overall Study|Lost to Follow-up|3
6894131|NCT00618072|10911641|FG000|Overall Study|Physician Decision|0
6894132|NCT00618072|10911642|FG001|Overall Study|Physician Decision|1
6894133|NCT00618072|10911643|FG002|Overall Study|Physician Decision|1
6894134|NCT00618371|10911660|FG000|Overall Study|Withdrawal by Subject|2
6894135|NCT00618410|10911665|FG000|Washout Period (2 Weeks)|Physician Decision|0
6894136|NCT00618410|10911666|FG001|Washout Period (2 Weeks)|Physician Decision|1
6894137|NCT00618449|10911683|FG000|Overall Study|Lost to Follow-up|98
6894138|NCT00618449|10911684|FG001|Overall Study|Lost to Follow-up|110
6894139|NCT00618514|10911692|FG000|Overall Study|Lost to Follow-up|11
6894140|NCT00618514|10911693|FG001|Overall Study|Lost to Follow-up|12
6894141|NCT00618514|10911694|FG002|Overall Study|Lost to Follow-up|4
6894142|NCT00618618|10911709|FG000|Overall Study|Patient Request|0
6894143|NCT00618618|10911710|FG001|Overall Study|Patient Request|0
6894144|NCT00618618|10911711|FG002|Overall Study|Patient Request|2
6894145|NCT00618618|10911712|FG003|Overall Study|Patient Request|0
6894146|NCT00618618|10911709|FG000|Overall Study|Inability to Complete Study Procedures|0
6894147|NCT00618618|10911710|FG001|Overall Study|Inability to Complete Study Procedures|1
6894148|NCT00618618|10911711|FG002|Overall Study|Inability to Complete Study Procedures|0
6894149|NCT00618618|10911712|FG003|Overall Study|Inability to Complete Study Procedures|0
6894150|NCT00618618|10911709|FG000|Overall Study|Lost to Follow-up|3
6894151|NCT00618618|10911710|FG001|Overall Study|Lost to Follow-up|0
6894152|NCT00618618|10911711|FG002|Overall Study|Lost to Follow-up|0
6894153|NCT00618618|10911712|FG003|Overall Study|Lost to Follow-up|1
6894154|NCT00618618|10911709|FG000|Overall Study|Non-compliance|1
6894155|NCT00618618|10911710|FG001|Overall Study|Non-compliance|1
6894156|NCT00618618|10911711|FG002|Overall Study|Non-compliance|0
6894157|NCT00618618|10911712|FG003|Overall Study|Non-compliance|0
6894158|NCT00618618|10911709|FG000|Overall Study|Did Not Meet Entry Criteria|0
6894159|NCT00618618|10911710|FG001|Overall Study|Did Not Meet Entry Criteria|0
6894160|NCT00618618|10911711|FG002|Overall Study|Did Not Meet Entry Criteria|1
6894161|NCT00618618|10911712|FG003|Overall Study|Did Not Meet Entry Criteria|0
6894162|NCT00618618|10911709|FG000|Overall Study|Death|0
6894163|NCT00618618|10911710|FG001|Overall Study|Death|1
6894164|NCT00618618|10911711|FG002|Overall Study|Death|0
6894165|NCT00618618|10911712|FG003|Overall Study|Death|0
6894166|NCT00618722|10911727|FG000|Overall Study|Refusal of Treatment|0
6894167|NCT00618722|10911728|FG001|Overall Study|Refusal of Treatment|0
6894168|NCT00618722|10911729|FG002|Overall Study|Refusal of Treatment|1
6894169|NCT00618722|10911730|FG003|Overall Study|Refusal of Treatment|0
6894170|NCT00618722|10911727|FG000|Overall Study|Patient Request|1
6894171|NCT00618722|10911728|FG001|Overall Study|Patient Request|1
6894172|NCT00618722|10911729|FG002|Overall Study|Patient Request|1
6894173|NCT00618722|10911730|FG003|Overall Study|Patient Request|1
6894174|NCT00618722|10911727|FG000|Overall Study|Inability to Complete Study Procedure|0
6894175|NCT00618722|10911728|FG001|Overall Study|Inability to Complete Study Procedure|1
6894176|NCT00618722|10911729|FG002|Overall Study|Inability to Complete Study Procedure|0
6894177|NCT00618722|10911730|FG003|Overall Study|Inability to Complete Study Procedure|0
6894178|NCT00618722|10911727|FG000|Overall Study|Lost to Follow-up|2
6894179|NCT00618722|10911728|FG001|Overall Study|Lost to Follow-up|0
6894180|NCT00618722|10911729|FG002|Overall Study|Lost to Follow-up|0
6894181|NCT00618722|10911730|FG003|Overall Study|Lost to Follow-up|2
6894182|NCT00618722|10911727|FG000|Overall Study|Miscellaneous Reasons|0
6894183|NCT00618722|10911728|FG001|Overall Study|Miscellaneous Reasons|0
6894184|NCT00618722|10911729|FG002|Overall Study|Miscellaneous Reasons|1
6894185|NCT00618722|10911730|FG003|Overall Study|Miscellaneous Reasons|1
6894186|NCT00618748|10911743|FG000|Overall Study|Adverse Event|4
6894187|NCT00618748|10911744|FG001|Overall Study|Adverse Event|3
6894188|NCT00618748|10911745|FG002|Overall Study|Adverse Event|8
6894189|NCT00618748|10911743|FG000|Overall Study|Physician Decision|3
6894190|NCT00618748|10911744|FG001|Overall Study|Physician Decision|1
6894191|NCT00618748|10911745|FG002|Overall Study|Physician Decision|1
6894192|NCT00618748|10911743|FG000|Overall Study|Withdrawal by Subject|4
6894193|NCT00618748|10911744|FG001|Overall Study|Withdrawal by Subject|1
6894194|NCT00618748|10911745|FG002|Overall Study|Withdrawal by Subject|5
6894195|NCT00618774|10911755|FG000|Overall Study|Adverse Event|5
6894196|NCT00618774|10911756|FG001|Overall Study|Adverse Event|3
6894197|NCT00618774|10911755|FG000|Overall Study|Withdrawal by Subject|1
6894198|NCT00618774|10911756|FG001|Overall Study|Withdrawal by Subject|0
6894199|NCT00618787|10911764|FG000|Overall Study|Adverse Event|0
6894200|NCT00618787|10911765|FG001|Overall Study|Adverse Event|1
6894201|NCT00618787|10911764|FG000|Overall Study|Withdrawal by Subject|2
6894202|NCT00618787|10911765|FG001|Overall Study|Withdrawal by Subject|1
6894203|NCT00618787|10911764|FG000|Overall Study|Lost to Follow-up|1
6894204|NCT00618787|10911765|FG001|Overall Study|Lost to Follow-up|0
6894205|NCT00618813|10911771|FG000|Overall Study|Lack of Efficacy|1
6894206|NCT00618813|10911771|FG000|Overall Study|Physician Decision|2
6894207|NCT00618813|10911771|FG000|Overall Study|Withdrawal by Subject|1
6894208|NCT00618826|10911775|FG000|Overall Study|Adverse Event|1
6894209|NCT00618956|10911802|FG000|Overall Study|Adverse Event|10
6894210|NCT00618956|10911803|FG001|Overall Study|Adverse Event|34
6894211|NCT00618956|10911802|FG000|Overall Study|Lack of Efficacy|2
6894212|NCT00618956|10911803|FG001|Overall Study|Lack of Efficacy|1
6894213|NCT00618956|10911802|FG000|Overall Study|Withdrawal by Subject|5
6894214|NCT00618956|10911803|FG001|Overall Study|Withdrawal by Subject|7
6894215|NCT00618956|10911802|FG000|Overall Study|Lost to Follow-up|4
6894216|NCT00618956|10911803|FG001|Overall Study|Lost to Follow-up|5
6894217|NCT00618956|10911802|FG000|Overall Study|Protocol Violation|2
6894218|NCT00618956|10911803|FG001|Overall Study|Protocol Violation|2
6894219|NCT00618956|10911802|FG000|Overall Study|did not meet criteria, non-compliance|2
6894220|NCT00618956|10911803|FG001|Overall Study|did not meet criteria, non-compliance|1
6894221|NCT00618982|10911815|FG000|Overall Study|Adverse Event|23
6894222|NCT00618982|10911815|FG000|Overall Study|Withdrawal by Subject|1
6894223|NCT00618982|10911815|FG000|Overall Study|Protocol Violation|1
6894224|NCT00618982|10911815|FG000|Overall Study|ongoing, still treated with study med.|25
6894225|NCT00618995|10911822|FG000|Period 1|Adverse Event|0
6894226|NCT00618995|10911823|FG001|Period 1|Adverse Event|0
6894227|NCT00618995|10911824|FG002|Period 1|Adverse Event|1
6894228|NCT00618995|10911825|FG003|Period 1|Adverse Event|0
6894229|NCT00618995|10911822|FG000|Period 1|Protocol Violation|0
6894230|NCT00618995|10911823|FG001|Period 1|Protocol Violation|1
6894231|NCT00618995|10911824|FG002|Period 1|Protocol Violation|1
6894232|NCT00618995|10911825|FG003|Period 1|Protocol Violation|0
6894233|NCT00618995|10911822|FG000|Period 2|Protocol Violation|0
6894234|NCT00618995|10911823|FG001|Period 2|Protocol Violation|0
6894235|NCT00618995|10911824|FG002|Period 2|Protocol Violation|1
6894236|NCT00618995|10911825|FG003|Period 2|Protocol Violation|0
6894237|NCT00618995|10911822|FG000|Period 4|Adverse Event|1
6894238|NCT00618995|10911823|FG001|Period 4|Adverse Event|0
6894239|NCT00618995|10911824|FG002|Period 4|Adverse Event|0
6894240|NCT00618995|10911825|FG003|Period 4|Adverse Event|0
6894241|NCT00619099|10911853|FG000|Overall Study|Progressive Disease|7
6894242|NCT00619099|10911854|FG001|Overall Study|Progressive Disease|5
6894243|NCT00619099|10911853|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2
6894244|NCT00619099|10911854|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1
6894245|NCT00619099|10911853|FG000|Overall Study|Adverse Event|4
6894246|NCT00619099|10911854|FG001|Overall Study|Adverse Event|3
6894247|NCT00619099|10911853|FG000|Overall Study|Emergence of Clinically Significant Lab|1
6894248|NCT00619099|10911854|FG001|Overall Study|Emergence of Clinically Significant Lab|2
6894249|NCT00619099|10911853|FG000|Overall Study|Withdrawal by Subject|10
6894250|NCT00619099|10911854|FG001|Overall Study|Withdrawal by Subject|2
6894251|NCT00619099|10911853|FG000|Overall Study|Physician Decision|9
6894252|NCT00619099|10911854|FG001|Overall Study|Physician Decision|6
6894253|NCT00619112|10911862|FG000|Overall Study|Adverse Event|1
6894254|NCT00619112|10911863|FG001|Overall Study|Adverse Event|2
6894255|NCT00619177|10911872|FG000|Overall Study|Adverse Event|18
6894256|NCT00619177|10911872|FG000|Overall Study|Lost to Follow-up|2
6894257|NCT00619177|10911872|FG000|Overall Study|Lack of Efficacy|1
6894258|NCT00619177|10911872|FG000|Overall Study|Missing termination information|481
6894259|NCT00619177|10911872|FG000|Overall Study|Not specified reasons|6
6894260|NCT00619229|10911887|FG000|Overall Study|Withdrawal by Subject|1
6894261|NCT00619229|10911888|FG001|Overall Study|Withdrawal by Subject|1
6894262|NCT00619229|10911887|FG000|Overall Study|Lost to Follow-up|1
6894263|NCT00619229|10911888|FG001|Overall Study|Lost to Follow-up|0
6894264|NCT00619229|10911887|FG000|Overall Study|Termination of the Study by the Sponsor|1
6894265|NCT00619229|10911888|FG001|Overall Study|Termination of the Study by the Sponsor|1
6894266|NCT00619229|10911887|FG000|Overall Study|Investigator planned Cataract Operation|1
6894267|NCT00619229|10911888|FG001|Overall Study|Investigator planned Cataract Operation|0
6894268|NCT00619307|10911905|FG000|Overall Study|Adverse Event|0
6894269|NCT00619307|10911906|FG001|Overall Study|Adverse Event|1
6894270|NCT00619307|10911905|FG000|Overall Study|Lost to Follow-up|0
6894271|NCT00619307|10911906|FG001|Overall Study|Lost to Follow-up|1
6894272|NCT00619307|10911905|FG000|Overall Study|Protocol Violation|3
6894273|NCT00619307|10911906|FG001|Overall Study|Protocol Violation|0
6894274|NCT00619307|10911905|FG000|Overall Study|Withdrew consent|1
6894275|NCT00619307|10911906|FG001|Overall Study|Withdrew consent|0
6894276|NCT00619307|10911905|FG000|Overall Study|Severe migraine|0
6894277|NCT00619307|10911906|FG001|Overall Study|Severe migraine|1
6894278|NCT00619307|10911905|FG000|Overall Study|MS attack plus steroids|0
6894279|NCT00619307|10911906|FG001|Overall Study|MS attack plus steroids|1
6894280|NCT00619359|10911914|FG000|Overall Study|Adverse Event|32
6894281|NCT00619359|10911915|FG001|Overall Study|Adverse Event|36
6894282|NCT00619359|10911914|FG000|Overall Study|Lost to Follow-up|12
6894283|NCT00619359|10911915|FG001|Overall Study|Lost to Follow-up|16
6894284|NCT00619359|10911914|FG000|Overall Study|Physician Decision|0
6894285|NCT00619359|10911915|FG001|Overall Study|Physician Decision|7
6894286|NCT00619359|10911914|FG000|Overall Study|Protocol Violation|1
6894287|NCT00619359|10911915|FG001|Overall Study|Protocol Violation|1
6894288|NCT00619359|10911914|FG000|Overall Study|Withdrawal by Subject|19
6894289|NCT00619359|10911915|FG001|Overall Study|Withdrawal by Subject|20
6894290|NCT00619359|10911914|FG000|Overall Study|Progressive Disease|3
6894291|NCT00619359|10911915|FG001|Overall Study|Progressive Disease|1
6894292|NCT00619385|10911924|FG000|Overall Study|Adverse Event|0
6894293|NCT00619385|10911925|FG001|Overall Study|Adverse Event|0
6894294|NCT00619385|10911926|FG002|Overall Study|Adverse Event|3
6894295|NCT00619385|10911924|FG000|Overall Study|Other|1
6894296|NCT00619385|10911925|FG001|Overall Study|Other|2
6894297|NCT00619385|10911926|FG002|Overall Study|Other|1
6894298|NCT00619476|10911941|FG000|Overall Study|Adverse Event|12
6894299|NCT00619476|10911942|FG001|Overall Study|Adverse Event|6
6894300|NCT00619476|10911943|FG002|Overall Study|Adverse Event|12
6894301|NCT00619476|10911944|FG003|Overall Study|Adverse Event|16
6894302|NCT00619476|10911941|FG000|Overall Study|Lack of Efficacy|6
6894303|NCT00619476|10911942|FG001|Overall Study|Lack of Efficacy|1
6894304|NCT00619476|10911943|FG002|Overall Study|Lack of Efficacy|1
6894305|NCT00619476|10911944|FG003|Overall Study|Lack of Efficacy|4
6894306|NCT00619476|10911941|FG000|Overall Study|Protocol Violation|5
6894307|NCT00619476|10911942|FG001|Overall Study|Protocol Violation|4
6894308|NCT00619476|10911943|FG002|Overall Study|Protocol Violation|4
6894309|NCT00619476|10911944|FG003|Overall Study|Protocol Violation|9
6894310|NCT00619476|10911941|FG000|Overall Study|Lost to Follow-up|1
6894311|NCT00619476|10911942|FG001|Overall Study|Lost to Follow-up|2
6894312|NCT00619476|10911943|FG002|Overall Study|Lost to Follow-up|0
6894313|NCT00619476|10911944|FG003|Overall Study|Lost to Follow-up|1
6894314|NCT00619476|10911941|FG000|Overall Study|Investigator Discretion|2
6894315|NCT00619476|10911942|FG001|Overall Study|Investigator Discretion|2
6894316|NCT00619476|10911943|FG002|Overall Study|Investigator Discretion|2
6894317|NCT00619476|10911944|FG003|Overall Study|Investigator Discretion|0
6894318|NCT00619476|10911941|FG000|Overall Study|Withdrawal by Subject|5
6894319|NCT00619476|10911942|FG001|Overall Study|Withdrawal by Subject|7
6894320|NCT00619476|10911943|FG002|Overall Study|Withdrawal by Subject|5
6894321|NCT00619476|10911944|FG003|Overall Study|Withdrawal by Subject|4
6894322|NCT00619489|10911956|FG000|Overall Study|Adverse Event|0
6894323|NCT00619489|10911957|FG001|Overall Study|Adverse Event|7
6894324|NCT00619489|10911956|FG000|Overall Study|Withdrawal by Subject|1
6894325|NCT00619489|10911957|FG001|Overall Study|Withdrawal by Subject|1
6894326|NCT00619489|10911956|FG000|Overall Study|Lack of Efficacy|0
6894327|NCT00619489|10911957|FG001|Overall Study|Lack of Efficacy|11
6894328|NCT00619489|10911956|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22
6894329|NCT00619489|10911957|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15
6894330|NCT00619502|10911965|FG000|Overall Study|Lost to Follow-up|8
6894331|NCT00619502|10911966|FG001|Overall Study|Lost to Follow-up|10
6894332|NCT00619619|10911982|FG000|Overall Study|Physician Decision|0
6894333|NCT00619619|10911983|FG001|Overall Study|Physician Decision|0
6894334|NCT00619619|10911984|FG002|Overall Study|Physician Decision|1
6894335|NCT00619619|10911985|FG003|Overall Study|Physician Decision|0
6894336|NCT00619619|10911986|FG004|Overall Study|Physician Decision|0
6894337|NCT00619619|10911987|FG005|Overall Study|Physician Decision|0
6894338|NCT00619619|10911988|FG006|Overall Study|Physician Decision|0
6894339|NCT00619619|10911989|FG007|Overall Study|Physician Decision|0
6894340|NCT00619619|10911982|FG000|Overall Study|Protocol Violation|0
6894341|NCT00619619|10911983|FG001|Overall Study|Protocol Violation|0
6894342|NCT00619619|10911984|FG002|Overall Study|Protocol Violation|0
6894343|NCT00619619|10911985|FG003|Overall Study|Protocol Violation|1
6894344|NCT00619619|10911986|FG004|Overall Study|Protocol Violation|0
6894345|NCT00619619|10911987|FG005|Overall Study|Protocol Violation|0
6894346|NCT00619619|10911988|FG006|Overall Study|Protocol Violation|1
6894347|NCT00619619|10911989|FG007|Overall Study|Protocol Violation|1
6894348|NCT00619619|10911982|FG000|Overall Study|Adverse Event|0
6894349|NCT00619619|10911983|FG001|Overall Study|Adverse Event|0
6894350|NCT00619619|10911984|FG002|Overall Study|Adverse Event|0
6894351|NCT00619619|10911985|FG003|Overall Study|Adverse Event|0
6894352|NCT00619619|10911986|FG004|Overall Study|Adverse Event|2
6894353|NCT00619619|10911987|FG005|Overall Study|Adverse Event|0
6894354|NCT00619619|10911988|FG006|Overall Study|Adverse Event|0
6894355|NCT00619619|10911989|FG007|Overall Study|Adverse Event|2
6894356|NCT00619645|10912010|FG000|Overall Study|Adverse Event|1
6894357|NCT00619801|10912034|FG000|Overall Study|Lack of Efficacy|0
6894358|NCT00619801|10912035|FG001|Overall Study|Lack of Efficacy|1
6894359|NCT00619801|10912034|FG000|Overall Study|Withdrawal by Subject|1
6894360|NCT00619801|10912035|FG001|Overall Study|Withdrawal by Subject|1
6894361|NCT00619801|10912034|FG000|Overall Study|Loss of efficacy|0
6894362|NCT00619801|10912035|FG001|Overall Study|Loss of efficacy|1
6894363|NCT00619827|10912043|FG000|Overall Study|Adverse Event|1
6894364|NCT00619827|10912044|FG001|Overall Study|Adverse Event|2
6894365|NCT00619827|10912043|FG000|Overall Study|Withdrawal by Subject|2
6894366|NCT00619827|10912044|FG001|Overall Study|Withdrawal by Subject|2
6894367|NCT00619866|10912053|FG000|Weeks 1 - 12|Adverse Event|0
6894368|NCT00619866|10912054|FG001|Weeks 1 - 12|Adverse Event|1
6894369|NCT00619866|10912055|FG002|Weeks 1 - 12|Adverse Event|2
6894370|NCT00619866|10912056|FG003|Weeks 1 - 12|Adverse Event|0
6970858|NCT01159171|11021350|FG000|Overall Study|Adverse Event|11
6970859|NCT01159171|11021350|FG000|Overall Study|Progression of Disease|28
6970860|NCT01159171|11021350|FG000|Overall Study|Protocol Violation|1
6970861|NCT01159171|11021350|FG000|Overall Study|Need for Surgery|5
6970862|NCT01159171|11021350|FG000|Overall Study|Medical Decision|4
6970863|NCT01159171|11021350|FG000|Overall Study|Death|1
6970864|NCT01159431|11021370|FG000|Overall Study|Adverse Event|1
6970865|NCT01159431|11021371|FG001|Overall Study|Adverse Event|2
6894371|NCT00619866|10912057|FG004|Weeks 1 - 12|Adverse Event|0
6894372|NCT00619866|10912053|FG000|Weeks 1 - 12|Non-compliance|0
6894373|NCT00619866|10912054|FG001|Weeks 1 - 12|Non-compliance|0
6894374|NCT00619866|10912055|FG002|Weeks 1 - 12|Non-compliance|1
6894375|NCT00619866|10912056|FG003|Weeks 1 - 12|Non-compliance|0
6894376|NCT00619866|10912057|FG004|Weeks 1 - 12|Non-compliance|0
6894377|NCT00619866|10912053|FG000|Weeks 1 - 12|Withdrawal by Subject|7
6894378|NCT00619866|10912054|FG001|Weeks 1 - 12|Withdrawal by Subject|2
6894379|NCT00619866|10912055|FG002|Weeks 1 - 12|Withdrawal by Subject|4
6894380|NCT00619866|10912056|FG003|Weeks 1 - 12|Withdrawal by Subject|0
6894381|NCT00619866|10912057|FG004|Weeks 1 - 12|Withdrawal by Subject|0
6894382|NCT00619866|10912053|FG000|Weeks 1 - 12|Lack of Efficacy|3
6894383|NCT00619866|10912054|FG001|Weeks 1 - 12|Lack of Efficacy|2
6894384|NCT00619866|10912055|FG002|Weeks 1 - 12|Lack of Efficacy|1
6894385|NCT00619866|10912056|FG003|Weeks 1 - 12|Lack of Efficacy|0
6894386|NCT00619866|10912057|FG004|Weeks 1 - 12|Lack of Efficacy|0
6894387|NCT00619866|10912053|FG000|Weeks 1 - 12|Lost to Follow-up|4
6894388|NCT00619866|10912054|FG001|Weeks 1 - 12|Lost to Follow-up|0
6894389|NCT00619866|10912055|FG002|Weeks 1 - 12|Lost to Follow-up|2
6894390|NCT00619866|10912056|FG003|Weeks 1 - 12|Lost to Follow-up|0
6894391|NCT00619866|10912057|FG004|Weeks 1 - 12|Lost to Follow-up|0
6894392|NCT00619866|10912053|FG000|Weeks 1 - 12|Sponsor Decision|0
6894393|NCT00619866|10912054|FG001|Weeks 1 - 12|Sponsor Decision|1
6894394|NCT00619866|10912055|FG002|Weeks 1 - 12|Sponsor Decision|0
6894395|NCT00619866|10912056|FG003|Weeks 1 - 12|Sponsor Decision|0
6894396|NCT00619866|10912057|FG004|Weeks 1 - 12|Sponsor Decision|0
6894397|NCT00619866|10912053|FG000|Weeks 13 - 24|Adverse Event|0
6894398|NCT00619866|10912054|FG001|Weeks 13 - 24|Adverse Event|0
6894399|NCT00619866|10912055|FG002|Weeks 13 - 24|Adverse Event|2
6894400|NCT00619866|10912056|FG003|Weeks 13 - 24|Adverse Event|1
6894401|NCT00619866|10912057|FG004|Weeks 13 - 24|Adverse Event|0
6894402|NCT00619866|10912053|FG000|Weeks 13 - 24|Protocol Deviation|0
6894403|NCT00619866|10912054|FG001|Weeks 13 - 24|Protocol Deviation|0
6894404|NCT00619866|10912055|FG002|Weeks 13 - 24|Protocol Deviation|0
6894405|NCT00619866|10912056|FG003|Weeks 13 - 24|Protocol Deviation|1
6894406|NCT00619866|10912057|FG004|Weeks 13 - 24|Protocol Deviation|0
6894407|NCT00619866|10912053|FG000|Weeks 13 - 24|Withdrawal by Subject|0
6894408|NCT00619866|10912054|FG001|Weeks 13 - 24|Withdrawal by Subject|3
6894409|NCT00619866|10912055|FG002|Weeks 13 - 24|Withdrawal by Subject|2
6894410|NCT00619866|10912056|FG003|Weeks 13 - 24|Withdrawal by Subject|2
6894411|NCT00619866|10912057|FG004|Weeks 13 - 24|Withdrawal by Subject|2
6894412|NCT00619866|10912053|FG000|Weeks 13 - 24|Non-compliance|0
6894413|NCT00619866|10912054|FG001|Weeks 13 - 24|Non-compliance|1
6894414|NCT00619866|10912055|FG002|Weeks 13 - 24|Non-compliance|1
6894415|NCT00619866|10912056|FG003|Weeks 13 - 24|Non-compliance|0
6894416|NCT00619866|10912057|FG004|Weeks 13 - 24|Non-compliance|0
6894417|NCT00619866|10912053|FG000|Weeks 13 - 24|Lost to Follow-up|0
6894418|NCT00619866|10912054|FG001|Weeks 13 - 24|Lost to Follow-up|3
6894419|NCT00619866|10912055|FG002|Weeks 13 - 24|Lost to Follow-up|0
6894420|NCT00619866|10912056|FG003|Weeks 13 - 24|Lost to Follow-up|0
6894421|NCT00619866|10912057|FG004|Weeks 13 - 24|Lost to Follow-up|0
6894422|NCT00619892|10912071|FG000|Overall Study|Adverse Event|3
6894423|NCT00619892|10912072|FG001|Overall Study|Adverse Event|0
6894424|NCT00619892|10912071|FG000|Overall Study|Lost to Follow-up|0
6894425|NCT00619892|10912072|FG001|Overall Study|Lost to Follow-up|1
6894426|NCT00619892|10912071|FG000|Overall Study|Intercurrent illness|0
6894427|NCT00619892|10912072|FG001|Overall Study|Intercurrent illness|1
6894428|NCT00619918|10912082|FG000|Overall Study|Withdrawal by Subject|4
6894429|NCT00619918|10912083|FG001|Overall Study|Withdrawal by Subject|3
6894430|NCT00619918|10912082|FG000|Overall Study|Physician Decision|8
6894431|NCT00619918|10912083|FG001|Overall Study|Physician Decision|8
6894432|NCT00619918|10912082|FG000|Overall Study|Transfer to outside facility|3
6894433|NCT00619918|10912083|FG001|Overall Study|Transfer to outside facility|3
6894434|NCT00619918|10912082|FG000|Overall Study|Left before receiving first dose|5
6894435|NCT00619918|10912083|FG001|Overall Study|Left before receiving first dose|8
6894436|NCT00619957|10912091|FG000|Month 24 Double-Blind|Adverse Event|9
6894437|NCT00619957|10912092|FG001|Month 24 Double-Blind|Adverse Event|7
6894438|NCT00619957|10912091|FG000|Month 24 Double-Blind|Protocol Violation|1
6894439|NCT00619957|10912092|FG001|Month 24 Double-Blind|Protocol Violation|0
6894440|NCT00619957|10912091|FG000|Month 24 Double-Blind|Withdrawal by Subject|7
6894441|NCT00619957|10912092|FG001|Month 24 Double-Blind|Withdrawal by Subject|9
6894442|NCT00619957|10912091|FG000|Month 24 Double-Blind|Lost to Follow-up|1
6894443|NCT00619957|10912092|FG001|Month 24 Double-Blind|Lost to Follow-up|0
6894444|NCT00619957|10912091|FG000|Month 24 Double-Blind|Did not take any study medication|0
6894445|NCT00619957|10912092|FG001|Month 24 Double-Blind|Did not take any study medication|1
6894446|NCT00619957|10912091|FG000|Month 48 Open-Label|Adverse Event|4
6894447|NCT00619957|10912092|FG001|Month 48 Open-Label|Adverse Event|4
6894448|NCT00619957|10912091|FG000|Month 48 Open-Label|Lost to Follow-up|2
6894449|NCT00619957|10912092|FG001|Month 48 Open-Label|Lost to Follow-up|4
6894450|NCT00619957|10912091|FG000|Month 48 Open-Label|Withdrawal by Subject|6
6894451|NCT00619957|10912092|FG001|Month 48 Open-Label|Withdrawal by Subject|9
6894452|NCT00619983|10912119|FG000|Test Drug Alone|Withdrawal by Subject|1
6894453|NCT00619983|10912120|FG001|Test Drug Alone|Withdrawal by Subject|0
6894454|NCT00619983|10912121|FG002|Test Drug Alone|Withdrawal by Subject|0
6894455|NCT00619983|10912122|FG003|Test Drug Alone|Withdrawal by Subject|1
6894456|NCT00619983|10912119|FG000|Test Drug Alone|Failure of daily diary device|1
6894457|NCT00619983|10912120|FG001|Test Drug Alone|Failure of daily diary device|1
6894458|NCT00619983|10912121|FG002|Test Drug Alone|Failure of daily diary device|2
6894459|NCT00619983|10912122|FG003|Test Drug Alone|Failure of daily diary device|2
6894460|NCT00620022|10912132|FG000|Treatment Period 1|Adverse Event|4
6894461|NCT00620022|10912133|FG001|Treatment Period 1|Adverse Event|6
6894462|NCT00620022|10912132|FG000|Treatment Period 1|Subject withdrew consent|1
6894463|NCT00620022|10912133|FG001|Treatment Period 1|Subject withdrew consent|0
6894464|NCT00620022|10912132|FG000|Treatment Period 2|Adverse Event|2
6894465|NCT00620022|10912133|FG001|Treatment Period 2|Adverse Event|2
6894466|NCT00620074|10912144|FG000|Overall Study|Adverse Event|1
6894467|NCT00620113|10912152|FG000|Overall Study|Adverse Event|3
6894468|NCT00620113|10912153|FG001|Overall Study|Adverse Event|2
6894469|NCT00620113|10912154|FG002|Overall Study|Adverse Event|2
6894470|NCT00620113|10912155|FG003|Overall Study|Adverse Event|1
6894471|NCT00620113|10912152|FG000|Overall Study|Lack of Efficacy|2
6894472|NCT00620113|10912153|FG001|Overall Study|Lack of Efficacy|3
6894473|NCT00620113|10912154|FG002|Overall Study|Lack of Efficacy|0
6894474|NCT00620113|10912155|FG003|Overall Study|Lack of Efficacy|2
6894475|NCT00620113|10912152|FG000|Overall Study|Physician Decision|1
6894476|NCT00620113|10912153|FG001|Overall Study|Physician Decision|0
6894477|NCT00620113|10912154|FG002|Overall Study|Physician Decision|0
6894478|NCT00620113|10912155|FG003|Overall Study|Physician Decision|2
6894479|NCT00620113|10912152|FG000|Overall Study|Protocol Violation|2
6894480|NCT00620113|10912153|FG001|Overall Study|Protocol Violation|1
6894481|NCT00620113|10912154|FG002|Overall Study|Protocol Violation|0
6894482|NCT00620113|10912155|FG003|Overall Study|Protocol Violation|0
6894483|NCT00620113|10912152|FG000|Overall Study|Withdrawal by Subject|5
6894484|NCT00620113|10912153|FG001|Overall Study|Withdrawal by Subject|1
6894485|NCT00620113|10912154|FG002|Overall Study|Withdrawal by Subject|3
6894486|NCT00620113|10912155|FG003|Overall Study|Withdrawal by Subject|5
6894487|NCT00620282|10912191|FG000|Overall Study|Adverse Event|0
6894488|NCT00620282|10912192|FG001|Overall Study|Adverse Event|1
6894489|NCT00620282|10912193|FG002|Overall Study|Adverse Event|0
6894490|NCT00620282|10912191|FG000|Overall Study|Arterial line unable to be placed|0
6894491|NCT00620282|10912192|FG001|Overall Study|Arterial line unable to be placed|0
6894492|NCT00620282|10912193|FG002|Overall Study|Arterial line unable to be placed|1
6894493|NCT00620282|10912191|FG000|Overall Study|Withdrawal by Subject|0
6894494|NCT00620282|10912192|FG001|Overall Study|Withdrawal by Subject|1
6894495|NCT00620282|10912193|FG002|Overall Study|Withdrawal by Subject|0
6894496|NCT00620321|10912203|FG000|Overall Study|Adverse Event|1
6894497|NCT00620321|10912204|FG001|Overall Study|Adverse Event|1
6894498|NCT00620321|10912203|FG000|Overall Study|Death|1
6894499|NCT00620321|10912204|FG001|Overall Study|Death|1
6894500|NCT00620321|10912203|FG000|Overall Study|Physician Decision|0
6894501|NCT00620321|10912204|FG001|Overall Study|Physician Decision|7
6894502|NCT00620321|10912203|FG000|Overall Study|Progressive Disease|5
6894503|NCT00620321|10912204|FG001|Overall Study|Progressive Disease|5
6894504|NCT00620321|10912203|FG000|Overall Study|Sponsor Decision|0
6894505|NCT00620321|10912204|FG001|Overall Study|Sponsor Decision|1
6894506|NCT00620321|10912203|FG000|Overall Study|Withdrawal by Subject|1
6894507|NCT00620321|10912204|FG001|Overall Study|Withdrawal by Subject|1
6894508|NCT00620373|10912210|FG000|Overall Study|Unverified cancer status|33
6894509|NCT00620542|10912243|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12
6894510|NCT00620542|10912244|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15
6894511|NCT00620542|10912245|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0
6894512|NCT00620542|10912246|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0
6970866|NCT01159431|11021370|FG000|Overall Study|non-compliance|1
6894513|NCT00620542|10912243|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406
6894514|NCT00620542|10912244|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409
6894515|NCT00620542|10912245|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0
6894516|NCT00620542|10912246|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0
6894517|NCT00620542|10912243|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43
6894518|NCT00620542|10912244|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40
6894519|NCT00620542|10912245|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
6894520|NCT00620542|10912246|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
6894521|NCT00620542|10912243|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7
6894522|NCT00620542|10912244|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6
6894523|NCT00620542|10912245|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
6894524|NCT00620542|10912246|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
6894525|NCT00620542|10912243|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0
6894526|NCT00620542|10912244|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1
6894527|NCT00620542|10912245|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0
6894528|NCT00620542|10912246|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0
6894529|NCT00620542|10912243|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0
6894530|NCT00620542|10912244|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1
6894531|NCT00620542|10912245|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0
6894532|NCT00620542|10912246|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0
6894533|NCT00620542|10912243|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4
6894534|NCT00620542|10912244|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4
6894535|NCT00620542|10912245|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0
6894536|NCT00620542|10912246|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0
6894537|NCT00620542|10912243|FG000|Part B (2 Year Core Study)|Adverse Event|0
6894538|NCT00620542|10912244|FG001|Part B (2 Year Core Study)|Adverse Event|0
6894539|NCT00620542|10912245|FG002|Part B (2 Year Core Study)|Adverse Event|46
6894540|NCT00620542|10912246|FG003|Part B (2 Year Core Study)|Adverse Event|49
6894541|NCT00620542|10912243|FG000|Part B (2 Year Core Study)|Protocol Violation|0
6894542|NCT00620542|10912244|FG001|Part B (2 Year Core Study)|Protocol Violation|0
6894543|NCT00620542|10912245|FG002|Part B (2 Year Core Study)|Protocol Violation|3
6894544|NCT00620542|10912246|FG003|Part B (2 Year Core Study)|Protocol Violation|5
6894545|NCT00620542|10912243|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0
6894546|NCT00620542|10912244|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0
6894547|NCT00620542|10912245|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55
6894548|NCT00620542|10912246|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54
6894549|NCT00620542|10912243|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0
6894550|NCT00620542|10912244|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0
6894551|NCT00620542|10912245|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20
7079414|NCT02114385|11188560|FG001|Overall Study|Lost to Follow-up|6
7079415|NCT02114515|11188568|FG000|Overall Study|Lost to Follow-up|52
7079416|NCT02114515|11188569|FG001|Overall Study|Lost to Follow-up|55
7079417|NCT02114515|11188568|FG000|Overall Study|Death|12
7079418|NCT02114515|11188569|FG001|Overall Study|Death|12
7079419|NCT02114515|11188568|FG000|Overall Study|Withdrawal by Subject|4
7079420|NCT02114515|11188569|FG001|Overall Study|Withdrawal by Subject|22
6894552|NCT00620542|10912246|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9
6894553|NCT00620542|10912243|FG000|Part B (2 Year Core Study)|Protocol Violation|0
6894554|NCT00620542|10912244|FG001|Part B (2 Year Core Study)|Protocol Violation|0
6894555|NCT00620542|10912245|FG002|Part B (2 Year Core Study)|Protocol Violation|13
6894556|NCT00620542|10912246|FG003|Part B (2 Year Core Study)|Protocol Violation|16
6894557|NCT00620542|10912243|FG000|Part B (2 Year Core Study)|Safety reasons|0
6894558|NCT00620542|10912244|FG001|Part B (2 Year Core Study)|Safety reasons|0
6894559|NCT00620542|10912245|FG002|Part B (2 Year Core Study)|Safety reasons|2
6894560|NCT00620542|10912246|FG003|Part B (2 Year Core Study)|Safety reasons|3
6894561|NCT00620542|10912243|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
6894562|NCT00620542|10912244|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
6894563|NCT00620542|10912245|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
6894564|NCT00620542|10912246|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
6894565|NCT00620542|10912243|FG000|Part B (2 Year Core Study)|IVUS not available|0
6894566|NCT00620542|10912244|FG001|Part B (2 Year Core Study)|IVUS not available|0
6894567|NCT00620542|10912245|FG002|Part B (2 Year Core Study)|IVUS not available|3
6894568|NCT00620542|10912246|FG003|Part B (2 Year Core Study)|IVUS not available|2
6894569|NCT00620555|10912254|FG000|Overall Study|Adverse Event|4
6894570|NCT00620555|10912254|FG000|Overall Study|Protocol Violation|2
6894571|NCT00620555|10912254|FG000|Overall Study|Lack of Efficacy|12
6894572|NCT00620555|10912254|FG000|Overall Study|Withdrawal by Subject|1
6894573|NCT00620555|10912254|FG000|Overall Study|Choice of other treatment|1
6970867|NCT01159431|11021371|FG001|Overall Study|non-compliance|1
7079421|NCT02114515|11188568|FG000|Overall Study|Other|65
6894574|NCT00620555|10912254|FG000|Overall Study|Visit failure against planned|1
7079422|NCT02114515|11188569|FG001|Overall Study|Other|61
7079423|NCT02114606|11188575|FG000|Overall Study|Unable to swallow Cytosponge|6
6894575|NCT00620659|10912258|FG000|Treatment Period 1|Adverse Event|1
6894576|NCT00620659|10912259|FG001|Treatment Period 1|Adverse Event|0
6894577|NCT00620659|10912260|FG002|Treatment Period 1|Adverse Event|0
6894578|NCT00620659|10912261|FG003|Treatment Period 1|Adverse Event|3
6894579|NCT00620659|10912262|FG004|Treatment Period 1|Adverse Event|0
6894580|NCT00620659|10912263|FG005|Treatment Period 1|Adverse Event|0
6894581|NCT00620659|10912258|FG000|Treatment Period 1|Protocol Violation|1
6894582|NCT00620659|10912259|FG001|Treatment Period 1|Protocol Violation|0
6894583|NCT00620659|10912260|FG002|Treatment Period 1|Protocol Violation|0
6894584|NCT00620659|10912261|FG003|Treatment Period 1|Protocol Violation|0
6894585|NCT00620659|10912262|FG004|Treatment Period 1|Protocol Violation|0
6894586|NCT00620659|10912263|FG005|Treatment Period 1|Protocol Violation|0
6894587|NCT00620659|10912258|FG000|Treatment Period 1|Withdrawal by Subject|1
6894588|NCT00620659|10912259|FG001|Treatment Period 1|Withdrawal by Subject|0
6894589|NCT00620659|10912260|FG002|Treatment Period 1|Withdrawal by Subject|1
6894590|NCT00620659|10912261|FG003|Treatment Period 1|Withdrawal by Subject|0
6894591|NCT00620659|10912262|FG004|Treatment Period 1|Withdrawal by Subject|1
6894592|NCT00620659|10912263|FG005|Treatment Period 1|Withdrawal by Subject|0
6894593|NCT00620659|10912258|FG000|Placebo Washout Period 1|Withdrawal by Subject|0
6894594|NCT00620659|10912259|FG001|Placebo Washout Period 1|Withdrawal by Subject|0
6894595|NCT00620659|10912260|FG002|Placebo Washout Period 1|Withdrawal by Subject|0
6894596|NCT00620659|10912261|FG003|Placebo Washout Period 1|Withdrawal by Subject|1
6894597|NCT00620659|10912262|FG004|Placebo Washout Period 1|Withdrawal by Subject|0
6894598|NCT00620659|10912263|FG005|Placebo Washout Period 1|Withdrawal by Subject|0
6894599|NCT00620659|10912258|FG000|Treatment Period 2|Adverse Event|0
6894600|NCT00620659|10912259|FG001|Treatment Period 2|Adverse Event|3
6894601|NCT00620659|10912260|FG002|Treatment Period 2|Adverse Event|0
6894602|NCT00620659|10912261|FG003|Treatment Period 2|Adverse Event|0
6894603|NCT00620659|10912262|FG004|Treatment Period 2|Adverse Event|2
6894604|NCT00620659|10912263|FG005|Treatment Period 2|Adverse Event|0
6894605|NCT00620659|10912258|FG000|Treatment Period 2|Withdrawal by Subject|0
6894606|NCT00620659|10912259|FG001|Treatment Period 2|Withdrawal by Subject|0
6894607|NCT00620659|10912260|FG002|Treatment Period 2|Withdrawal by Subject|1
6894608|NCT00620659|10912261|FG003|Treatment Period 2|Withdrawal by Subject|0
6894609|NCT00620659|10912262|FG004|Treatment Period 2|Withdrawal by Subject|3
6894610|NCT00620659|10912263|FG005|Treatment Period 2|Withdrawal by Subject|0
6894611|NCT00620659|10912258|FG000|Placebo Washout Period 2|Adverse Event|2
6894612|NCT00620659|10912259|FG001|Placebo Washout Period 2|Adverse Event|0
6894613|NCT00620659|10912260|FG002|Placebo Washout Period 2|Adverse Event|0
6894614|NCT00620659|10912261|FG003|Placebo Washout Period 2|Adverse Event|0
6894615|NCT00620659|10912262|FG004|Placebo Washout Period 2|Adverse Event|0
6894616|NCT00620659|10912263|FG005|Placebo Washout Period 2|Adverse Event|0
6894617|NCT00620659|10912258|FG000|Treatment Period 3|Adverse Event|0
6894618|NCT00620659|10912259|FG001|Treatment Period 3|Adverse Event|2
6894619|NCT00620659|10912260|FG002|Treatment Period 3|Adverse Event|0
6894620|NCT00620659|10912261|FG003|Treatment Period 3|Adverse Event|0
6894621|NCT00620659|10912262|FG004|Treatment Period 3|Adverse Event|0
6894622|NCT00620659|10912263|FG005|Treatment Period 3|Adverse Event|0
6894623|NCT00620659|10912258|FG000|Treatment Period 3|Withdrawal by Subject|0
6894624|NCT00620659|10912259|FG001|Treatment Period 3|Withdrawal by Subject|0
6894625|NCT00620659|10912260|FG002|Treatment Period 3|Withdrawal by Subject|0
6894626|NCT00620659|10912261|FG003|Treatment Period 3|Withdrawal by Subject|1
6894627|NCT00620659|10912262|FG004|Treatment Period 3|Withdrawal by Subject|0
6894628|NCT00620659|10912263|FG005|Treatment Period 3|Withdrawal by Subject|0
6894629|NCT00620750|10912284|FG000|Overall Study|Lost to Follow-up|25
6894630|NCT00620763|10912288|FG000|Period: First Intervention|Withdrawal by Subject|0
6894631|NCT00620763|10912289|FG001|Period: First Intervention|Withdrawal by Subject|2
6894632|NCT00620763|10912288|FG000|Period: First Intervention|Protocol Violation|0
6894633|NCT00620763|10912289|FG001|Period: First Intervention|Protocol Violation|3
6894634|NCT00620763|10912288|FG000|Period: Second Intervention|Withdrawal by Subject|1
6894635|NCT00620763|10912289|FG001|Period: Second Intervention|Withdrawal by Subject|0
6894636|NCT00620776|10912297|FG000|Overall Study|Did not receive treatment|3
6894637|NCT00620776|10912298|FG001|Overall Study|Did not receive treatment|5
6894638|NCT00620776|10912297|FG000|Overall Study|Adverse Event|2
6894639|NCT00620776|10912298|FG001|Overall Study|Adverse Event|3
6894640|NCT00620776|10912297|FG000|Overall Study|Lack of Efficacy|2
6894641|NCT00620776|10912298|FG001|Overall Study|Lack of Efficacy|1
6894642|NCT00620776|10912297|FG000|Overall Study|Lost to Follow-up|2
6894643|NCT00620776|10912298|FG001|Overall Study|Lost to Follow-up|5
6894644|NCT00620776|10912297|FG000|Overall Study|Withdrawal by Subject|3
6894645|NCT00620776|10912298|FG001|Overall Study|Withdrawal by Subject|2
6894646|NCT00620815|10912307|FG000|Overall Study|Adverse Event|1
6894647|NCT00620815|10912308|FG001|Overall Study|Adverse Event|1
6894648|NCT00620815|10912309|FG002|Overall Study|Adverse Event|2
6894649|NCT00620815|10912307|FG000|Overall Study|Withdrawal by Subject|1
6894650|NCT00620815|10912308|FG001|Overall Study|Withdrawal by Subject|2
6894651|NCT00620815|10912309|FG002|Overall Study|Withdrawal by Subject|0
6894652|NCT00620815|10912307|FG000|Overall Study|Lost to Follow-up|1
6894653|NCT00620815|10912308|FG001|Overall Study|Lost to Follow-up|6
6894654|NCT00620815|10912309|FG002|Overall Study|Lost to Follow-up|3
6894655|NCT00620815|10912307|FG000|Overall Study|Inappropriate enrolment|0
6894656|NCT00620815|10912308|FG001|Overall Study|Inappropriate enrolment|0
6894657|NCT00620815|10912309|FG002|Overall Study|Inappropriate enrolment|1
6894658|NCT00620815|10912307|FG000|Overall Study|Protocol Violation|1
6894659|NCT00620815|10912308|FG001|Overall Study|Protocol Violation|2
6894660|NCT00620815|10912309|FG002|Overall Study|Protocol Violation|1
6894661|NCT00620854|10912348|FG000|Washout 1|Withdrawal by Subject|0
6894662|NCT00620854|10912349|FG001|Washout 1|Withdrawal by Subject|0
6894663|NCT00620854|10912350|FG002|Washout 1|Withdrawal by Subject|1
6894664|NCT00620854|10912351|FG003|Washout 1|Withdrawal by Subject|1
6894665|NCT00620854|10912352|FG004|Washout 1|Withdrawal by Subject|0
6894666|NCT00620854|10912353|FG005|Washout 1|Withdrawal by Subject|0
6894667|NCT00621023|10912368|FG000|Overall Study|Death|5
6894668|NCT00621023|10912368|FG000|Overall Study|Follow up discontinued|1
6970868|NCT01159431|11021370|FG000|Overall Study|Lack of Efficacy|0
6970869|NCT01159431|11021371|FG001|Overall Study|Lack of Efficacy|3
6970870|NCT01159574|11021397|FG000|Treatment Phase|non-evaluable/not included in analysis|1
6970871|NCT01159574|11021397|FG000|Treatment Phase|Adverse Event|3
6970872|NCT01159574|11021397|FG000|Treatment Phase|Death|6
6970873|NCT01159574|11021397|FG000|Treatment Phase|Physician Decision|2
6970874|NCT01159574|11021397|FG000|Treatment Phase|Withdrawal by Subject|7
6970875|NCT01159574|11021397|FG000|Treatment Phase|still on treatment|2
6970876|NCT01159574|11021397|FG000|Follow Up Phase|Lost to Follow-up|2
6970877|NCT01159574|11021397|FG000|Follow Up Phase|still being followed for overall surviva|18
6970878|NCT01159600|11021409|FG000|Overall Study|Not treated|0
6970879|NCT01159600|11021410|FG001|Overall Study|Not treated|0
6970880|NCT01159600|11021411|FG002|Overall Study|Not treated|1
6970881|NCT01159600|11021412|FG003|Overall Study|Not treated|0
6970882|NCT01159600|11021413|FG004|Overall Study|Not treated|0
6970883|NCT01159600|11021414|FG005|Overall Study|Not treated|1
6970884|NCT01159600|11021415|FG006|Overall Study|Not treated|2
6970885|NCT01159600|11021416|FG007|Overall Study|Not treated|2
6970886|NCT01159600|11021409|FG000|Overall Study|Adverse Event|7
6970887|NCT01159600|11021410|FG001|Overall Study|Adverse Event|2
6970888|NCT01159600|11021411|FG002|Overall Study|Adverse Event|5
6970889|NCT01159600|11021412|FG003|Overall Study|Adverse Event|1
6970890|NCT01159600|11021413|FG004|Overall Study|Adverse Event|8
6970891|NCT01159600|11021414|FG005|Overall Study|Adverse Event|6
6970892|NCT01159600|11021415|FG006|Overall Study|Adverse Event|7
6970893|NCT01159600|11021416|FG007|Overall Study|Adverse Event|5
6970894|NCT01159600|11021409|FG000|Overall Study|Lack of Efficacy|0
6970895|NCT01159600|11021410|FG001|Overall Study|Lack of Efficacy|0
6970896|NCT01159600|11021411|FG002|Overall Study|Lack of Efficacy|0
6970897|NCT01159600|11021412|FG003|Overall Study|Lack of Efficacy|0
6970898|NCT01159600|11021413|FG004|Overall Study|Lack of Efficacy|2
6970899|NCT01159600|11021414|FG005|Overall Study|Lack of Efficacy|0
6970900|NCT01159600|11021415|FG006|Overall Study|Lack of Efficacy|0
6970901|NCT01159600|11021416|FG007|Overall Study|Lack of Efficacy|1
6970902|NCT01159600|11021409|FG000|Overall Study|Non compliant with protocol|2
6970903|NCT01159600|11021410|FG001|Overall Study|Non compliant with protocol|1
6970904|NCT01159600|11021411|FG002|Overall Study|Non compliant with protocol|0
6970905|NCT01159600|11021412|FG003|Overall Study|Non compliant with protocol|0
6970906|NCT01159600|11021413|FG004|Overall Study|Non compliant with protocol|2
6970907|NCT01159600|11021414|FG005|Overall Study|Non compliant with protocol|0
6970908|NCT01159600|11021415|FG006|Overall Study|Non compliant with protocol|2
6970909|NCT01159600|11021416|FG007|Overall Study|Non compliant with protocol|0
6970910|NCT01159600|11021409|FG000|Overall Study|Lost to Follow-up|2
6970911|NCT01159600|11021410|FG001|Overall Study|Lost to Follow-up|3
6970912|NCT01159600|11021411|FG002|Overall Study|Lost to Follow-up|4
6970913|NCT01159600|11021412|FG003|Overall Study|Lost to Follow-up|3
6970914|NCT01159600|11021413|FG004|Overall Study|Lost to Follow-up|3
6970915|NCT01159600|11021414|FG005|Overall Study|Lost to Follow-up|0
6970916|NCT01159600|11021415|FG006|Overall Study|Lost to Follow-up|3
6970917|NCT01159600|11021416|FG007|Overall Study|Lost to Follow-up|2
6970918|NCT01159600|11021409|FG000|Overall Study|Patient refusal to continue,not due toAE|7
6970919|NCT01159600|11021410|FG001|Overall Study|Patient refusal to continue,not due toAE|2
6970920|NCT01159600|11021411|FG002|Overall Study|Patient refusal to continue,not due toAE|4
6970921|NCT01159600|11021412|FG003|Overall Study|Patient refusal to continue,not due toAE|5
6970922|NCT01159600|11021413|FG004|Overall Study|Patient refusal to continue,not due toAE|4
6970923|NCT01159600|11021414|FG005|Overall Study|Patient refusal to continue,not due toAE|4
6970924|NCT01159600|11021415|FG006|Overall Study|Patient refusal to continue,not due toAE|2
6970925|NCT01159600|11021416|FG007|Overall Study|Patient refusal to continue,not due toAE|5
6970926|NCT01159600|11021409|FG000|Overall Study|Other reason not defined above|3
6970927|NCT01159600|11021410|FG001|Overall Study|Other reason not defined above|0
6970928|NCT01159600|11021411|FG002|Overall Study|Other reason not defined above|4
6970929|NCT01159600|11021412|FG003|Overall Study|Other reason not defined above|2
6970930|NCT01159600|11021413|FG004|Overall Study|Other reason not defined above|5
6970931|NCT01159600|11021414|FG005|Overall Study|Other reason not defined above|7
6970932|NCT01159600|11021415|FG006|Overall Study|Other reason not defined above|3
6970933|NCT01159600|11021416|FG007|Overall Study|Other reason not defined above|3
6970934|NCT01159665|11021441|FG000|Overall Study|Withdrawal by Subject|0
6970935|NCT01159665|11021442|FG001|Overall Study|Withdrawal by Subject|1
6970936|NCT01159665|11021443|FG002|Overall Study|Withdrawal by Subject|0
6970937|NCT01159665|11021444|FG003|Overall Study|Withdrawal by Subject|0
6970938|NCT01159665|11021445|FG004|Overall Study|Withdrawal by Subject|0
6970939|NCT01159665|11021446|FG005|Overall Study|Withdrawal by Subject|0
6970940|NCT01159691|11021460|FG000|Overall Study|Lost to Follow-up|2
6970941|NCT01159691|11021460|FG000|Overall Study|Unknown reasons|1
6970942|NCT01159691|11021460|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6
6970943|NCT01159691|11021460|FG000|Overall Study|Discontinued Neupro due to other reasons|1
6970944|NCT01159691|11021460|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2
6970945|NCT01159691|11021460|FG000|Overall Study|Disc. Neupro other & unknown reasons|7
6970946|NCT01159691|11021460|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2
6970947|NCT01159691|11021460|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1
6970948|NCT01159769|11021473|FG000|Overall Study|Adverse Event|1
6970949|NCT01159912|11021480|FG000|Overall Study|Adverse Event|2
6970950|NCT01159912|11021481|FG001|Overall Study|Adverse Event|2
6970951|NCT01159912|11021482|FG002|Overall Study|Adverse Event|3
6970952|NCT01159912|11021480|FG000|Overall Study|Lack of Efficacy|23
6970953|NCT01159912|11021481|FG001|Overall Study|Lack of Efficacy|15
6970954|NCT01159912|11021482|FG002|Overall Study|Lack of Efficacy|14
6970955|NCT01159912|11021480|FG000|Overall Study|Protocol Violation|1
6970956|NCT01159912|11021481|FG001|Overall Study|Protocol Violation|2
6970957|NCT01159912|11021482|FG002|Overall Study|Protocol Violation|3
6970958|NCT01159912|11021480|FG000|Overall Study|Lost to Follow-up|4
6970959|NCT01159912|11021481|FG001|Overall Study|Lost to Follow-up|0
6970960|NCT01159912|11021482|FG002|Overall Study|Lost to Follow-up|0
6970961|NCT01159912|11021480|FG000|Overall Study|Physician Decision|0
6970962|NCT01159912|11021481|FG001|Overall Study|Physician Decision|0
6970963|NCT01159912|11021482|FG002|Overall Study|Physician Decision|3
6970964|NCT01159912|11021480|FG000|Overall Study|Withdrawal by Subject|10
6970965|NCT01159912|11021481|FG001|Overall Study|Withdrawal by Subject|3
6970966|NCT01159912|11021482|FG002|Overall Study|Withdrawal by Subject|3
6970967|NCT01159938|11021493|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0
6970968|NCT01159938|11021494|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0
6970969|NCT01159938|11021495|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1
6970970|NCT01159938|11021496|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0
6970971|NCT01159938|11021497|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0
6970972|NCT01160198|11021521|FG000|Overall Study|Withdrawal by Subject|2
6970973|NCT01160198|11021522|FG001|Overall Study|Withdrawal by Subject|1
6970974|NCT01160198|11021523|FG002|Overall Study|Withdrawal by Subject|0
6970975|NCT01160198|11021521|FG000|Overall Study|Adverse Event|0
6970976|NCT01160198|11021522|FG001|Overall Study|Adverse Event|1
6970977|NCT01160198|11021523|FG002|Overall Study|Adverse Event|0
6970978|NCT01160198|11021521|FG000|Overall Study|Lost to Follow-up|0
6970979|NCT01160198|11021522|FG001|Overall Study|Lost to Follow-up|1
6970980|NCT01160198|11021523|FG002|Overall Study|Lost to Follow-up|0
6970981|NCT01160198|11021521|FG000|Overall Study|Participant lost drug; withdrew consent|0
6970982|NCT01160198|11021522|FG001|Overall Study|Participant lost drug; withdrew consent|0
6970983|NCT01160198|11021523|FG002|Overall Study|Participant lost drug; withdrew consent|1
7079424|NCT02114684|11188581|FG000|Overall Study|Death|6
6970996|NCT01160289|11021563|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8
6970997|NCT01160289|11021564|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0
6970998|NCT01160289|11021565|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0
7079425|NCT02114684|11188582|FG001|Overall Study|Death|4
7079426|NCT02114684|11188581|FG000|Overall Study|Lost to Follow-up|1
7079427|NCT02114684|11188582|FG001|Overall Study|Lost to Follow-up|2
7079428|NCT02114684|11188581|FG000|Overall Study|Withdrawal by Subject|1
7079429|NCT02114684|11188582|FG001|Overall Study|Withdrawal by Subject|2
7079430|NCT02114684|11188581|FG000|Overall Study|Relocation|3
7079431|NCT02114684|11188582|FG001|Overall Study|Relocation|1
7079432|NCT02114684|11188581|FG000|Overall Study|Rifampicin resistant on culture|0
7079433|NCT02114684|11188582|FG001|Overall Study|Rifampicin resistant on culture|1
7079434|NCT02114684|11188581|FG000|Overall Study|Patient Incarcerated|1
7079435|NCT02114684|11188582|FG001|Overall Study|Patient Incarcerated|0
7079436|NCT02114879|11188594|FG000|Overall Study|Withdrawal by Subject|9
6970999|NCT01160289|11021566|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0
6971000|NCT01160289|11021567|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0
7079437|NCT02114879|11188595|FG001|Overall Study|Withdrawal by Subject|5
7079438|NCT02114879|11188594|FG000|Overall Study|Death|6
7079439|NCT02114879|11188595|FG001|Overall Study|Death|11
7079440|NCT02114879|11188594|FG000|Overall Study|Lost to Follow-up|4
7079441|NCT02114879|11188595|FG001|Overall Study|Lost to Follow-up|6
7079442|NCT02114879|11188594|FG000|Overall Study|Physician Decision|0
7079443|NCT02114879|11188595|FG001|Overall Study|Physician Decision|2
6971001|NCT01160289|11021568|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0
6971002|NCT01160289|11021563|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308
6971003|NCT01160289|11021564|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
6971004|NCT01160289|11021565|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
6971005|NCT01160289|11021566|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
6971006|NCT01160289|11021567|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
6971007|NCT01160289|11021568|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
6971008|NCT01160289|11021563|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1
6971009|NCT01160289|11021564|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
6971010|NCT01160289|11021565|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
6971011|NCT01160289|11021566|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
6971012|NCT01160289|11021567|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
6971013|NCT01160289|11021568|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
6971014|NCT01160289|11021563|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9
6971015|NCT01160289|11021564|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
6971016|NCT01160289|11021565|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
6971017|NCT01160289|11021566|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
6971018|NCT01160289|11021567|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
6971019|NCT01160289|11021568|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
6971020|NCT01160289|11021563|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26
6971021|NCT01160289|11021564|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0
6971022|NCT01160289|11021565|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0
6971023|NCT01160289|11021566|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0
6971024|NCT01160289|11021567|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0
6971025|NCT01160289|11021568|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0
6971026|NCT01160289|11021563|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1
6971027|NCT01160289|11021564|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0
6971028|NCT01160289|11021565|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0
6971029|NCT01160289|11021566|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0
6971030|NCT01160289|11021567|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0
6971031|NCT01160289|11021568|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0
6971032|NCT01160289|11021563|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67
6971033|NCT01160289|11021564|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
6971034|NCT01160289|11021565|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
6971035|NCT01160289|11021566|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
6971036|NCT01160289|11021567|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
6971037|NCT01160289|11021568|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
6971038|NCT01160289|11021563|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64
6971039|NCT01160289|11021564|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
6971040|NCT01160289|11021565|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
6971041|NCT01160289|11021566|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
6971042|NCT01160289|11021567|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
6971043|NCT01160289|11021568|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
6971044|NCT01160289|11021563|FG000|Post-Randomization Period|Adverse Event|0
6971045|NCT01160289|11021564|FG001|Post-Randomization Period|Adverse Event|4
6971046|NCT01160289|11021565|FG002|Post-Randomization Period|Adverse Event|4
6971047|NCT01160289|11021566|FG003|Post-Randomization Period|Adverse Event|2
6971048|NCT01160289|11021567|FG004|Post-Randomization Period|Adverse Event|0
6971049|NCT01160289|11021568|FG005|Post-Randomization Period|Adverse Event|0
6971050|NCT01160289|11021563|FG000|Post-Randomization Period|Death|0
6971051|NCT01160289|11021564|FG001|Post-Randomization Period|Death|0
6971052|NCT01160289|11021565|FG002|Post-Randomization Period|Death|0
6971053|NCT01160289|11021566|FG003|Post-Randomization Period|Death|1
6971054|NCT01160289|11021567|FG004|Post-Randomization Period|Death|0
6971055|NCT01160289|11021568|FG005|Post-Randomization Period|Death|0
6971056|NCT01160289|11021563|FG000|Post-Randomization Period|Lack of Efficacy|0
6971057|NCT01160289|11021564|FG001|Post-Randomization Period|Lack of Efficacy|1
6971058|NCT01160289|11021565|FG002|Post-Randomization Period|Lack of Efficacy|0
6971059|NCT01160289|11021566|FG003|Post-Randomization Period|Lack of Efficacy|3
6971060|NCT01160289|11021567|FG004|Post-Randomization Period|Lack of Efficacy|0
6971061|NCT01160289|11021568|FG005|Post-Randomization Period|Lack of Efficacy|0
6971062|NCT01160289|11021563|FG000|Post-Randomization Period|Lost to Follow-up|0
6971063|NCT01160289|11021564|FG001|Post-Randomization Period|Lost to Follow-up|3
6971064|NCT01160289|11021565|FG002|Post-Randomization Period|Lost to Follow-up|2
6971065|NCT01160289|11021566|FG003|Post-Randomization Period|Lost to Follow-up|5
6971066|NCT01160289|11021567|FG004|Post-Randomization Period|Lost to Follow-up|3
6971067|NCT01160289|11021568|FG005|Post-Randomization Period|Lost to Follow-up|4
6971068|NCT01160289|11021563|FG000|Post-Randomization Period|Physician Decision|0
6971069|NCT01160289|11021564|FG001|Post-Randomization Period|Physician Decision|0
6971070|NCT01160289|11021565|FG002|Post-Randomization Period|Physician Decision|1
6971071|NCT01160289|11021566|FG003|Post-Randomization Period|Physician Decision|0
6971072|NCT01160289|11021567|FG004|Post-Randomization Period|Physician Decision|0
6971073|NCT01160289|11021568|FG005|Post-Randomization Period|Physician Decision|0
6971074|NCT01160289|11021563|FG000|Post-Randomization Period|Protocol Violation|0
6971075|NCT01160289|11021564|FG001|Post-Randomization Period|Protocol Violation|4
6977040|NCT01204294|11029991|FG000|Overall Study|Other (house moving)|0
6971076|NCT01160289|11021565|FG002|Post-Randomization Period|Protocol Violation|2
6971077|NCT01160289|11021566|FG003|Post-Randomization Period|Protocol Violation|0
6971078|NCT01160289|11021567|FG004|Post-Randomization Period|Protocol Violation|1
6971079|NCT01160289|11021568|FG005|Post-Randomization Period|Protocol Violation|3
6971080|NCT01160289|11021563|FG000|Post-Randomization Period|Withdrawal by Subject|0
6971081|NCT01160289|11021564|FG001|Post-Randomization Period|Withdrawal by Subject|5
6971082|NCT01160289|11021565|FG002|Post-Randomization Period|Withdrawal by Subject|13
6971083|NCT01160289|11021566|FG003|Post-Randomization Period|Withdrawal by Subject|8
6971084|NCT01160289|11021567|FG004|Post-Randomization Period|Withdrawal by Subject|5
6971085|NCT01160289|11021568|FG005|Post-Randomization Period|Withdrawal by Subject|7
6971086|NCT01160289|11021563|FG000|Post-Randomization Period|Entry Criteria Not Met|0
6971087|NCT01160289|11021564|FG001|Post-Randomization Period|Entry Criteria Not Met|2
6971088|NCT01160289|11021565|FG002|Post-Randomization Period|Entry Criteria Not Met|2
6971089|NCT01160289|11021566|FG003|Post-Randomization Period|Entry Criteria Not Met|2
6971090|NCT01160289|11021567|FG004|Post-Randomization Period|Entry Criteria Not Met|0
6971091|NCT01160289|11021568|FG005|Post-Randomization Period|Entry Criteria Not Met|0
6971092|NCT01160289|11021563|FG000|Post-Randomization Period|Sponsor Decision|0
6971093|NCT01160289|11021564|FG001|Post-Randomization Period|Sponsor Decision|1
6971094|NCT01160289|11021565|FG002|Post-Randomization Period|Sponsor Decision|0
6971095|NCT01160289|11021566|FG003|Post-Randomization Period|Sponsor Decision|0
6971096|NCT01160289|11021567|FG004|Post-Randomization Period|Sponsor Decision|0
6971097|NCT01160289|11021568|FG005|Post-Randomization Period|Sponsor Decision|0
6971098|NCT01160354|11021584|FG000|Overall Study|Death|0
6971099|NCT01160354|11021585|FG001|Overall Study|Death|1
6971100|NCT01160354|11021586|FG002|Overall Study|Death|1
6971101|NCT01160484|11021616|FG000|Overall Study|Lack of Efficacy|9
6971102|NCT01160484|11021616|FG000|Overall Study|Adverse Event|6
6971103|NCT01160484|11021616|FG000|Overall Study|Withdrawal by Subject|2
6971104|NCT01160484|11021616|FG000|Overall Study|inclusion/exclusion criteria failure|1
6971105|NCT01160614|11021622|FG000|Overall Study|Withdrawal by Subject|0
6971106|NCT01160614|11021623|FG001|Overall Study|Withdrawal by Subject|2
6971107|NCT01160640|11021649|FG000|Overall Study|Physician Decision|3
6971108|NCT01160640|11021650|FG001|Overall Study|Physician Decision|3
6971109|NCT01160640|11021649|FG000|Overall Study|Incarceration|1
6971110|NCT01160640|11021650|FG001|Overall Study|Incarceration|0
6971111|NCT01160640|11021649|FG000|Overall Study|Withdrawal by Subject|0
6971112|NCT01160640|11021650|FG001|Overall Study|Withdrawal by Subject|3
6971113|NCT01160744|11021662|FG000|Overall Study|Withdrawal by Subject|11
6971114|NCT01160744|11021663|FG001|Overall Study|Withdrawal by Subject|5
6971115|NCT01160744|11021664|FG002|Overall Study|Withdrawal by Subject|6
6971116|NCT01160744|11021665|FG003|Overall Study|Withdrawal by Subject|4
6971117|NCT01160744|11021662|FG000|Overall Study|Not meet inclusion/exclusion criteria|0
6971118|NCT01160744|11021663|FG001|Overall Study|Not meet inclusion/exclusion criteria|0
7041347|NCT01726335|11124903|FG000|Overall Study|Lost to Follow-up|2
7041348|NCT01726335|11124903|FG000|Overall Study|Exacerbation of psychotic symptoms|1
7041349|NCT01726517|11124921|FG000|Overall Study|Withdrawal by Subject|0
7041350|NCT01726517|11124922|FG001|Overall Study|Withdrawal by Subject|0
7041351|NCT01726517|11124923|FG002|Overall Study|Withdrawal by Subject|1
7041352|NCT01726517|11124924|FG003|Overall Study|Withdrawal by Subject|0
7041353|NCT01726517|11124925|FG004|Overall Study|Withdrawal by Subject|0
7041354|NCT01726803|11124956|FG000|Overall Study|Lost to Follow-up|6
7041355|NCT01726803|11124957|FG001|Overall Study|Lost to Follow-up|1
7041356|NCT01726803|11124956|FG000|Overall Study|Withdrawal by Subject|1
7041357|NCT01726803|11124957|FG001|Overall Study|Withdrawal by Subject|0
7041358|NCT01727024|11124963|FG000|Period 1|Lost to Follow-up|1
7041359|NCT01727024|11124964|FG001|Period 1|Lost to Follow-up|1
7041360|NCT01727024|11124963|FG000|Period 1|Withdrawal by Subject|2
7041361|NCT01727024|11124964|FG001|Period 1|Withdrawal by Subject|3
7041362|NCT01727141|11124983|FG000|Overall Study|Physician Decision|0
7041363|NCT01727141|11124984|FG001|Overall Study|Physician Decision|1
7041364|NCT01727141|11124985|FG002|Overall Study|Physician Decision|0
7041365|NCT01727141|11124986|FG003|Overall Study|Physician Decision|2
7041366|NCT01727141|11124983|FG000|Overall Study|Lost to Follow-up|0
7041367|NCT01727141|11124984|FG001|Overall Study|Lost to Follow-up|2
7041368|NCT01727141|11124985|FG002|Overall Study|Lost to Follow-up|0
7041369|NCT01727141|11124986|FG003|Overall Study|Lost to Follow-up|0
7041370|NCT01727141|11124983|FG000|Overall Study|Death|0
7041371|NCT01727141|11124984|FG001|Overall Study|Death|1
7041372|NCT01727141|11124985|FG002|Overall Study|Death|1
7041373|NCT01727141|11124986|FG003|Overall Study|Death|1
7041374|NCT01727141|11124983|FG000|Overall Study|Protocol deviation|1
7041375|NCT01727141|11124984|FG001|Overall Study|Protocol deviation|1
7041376|NCT01727141|11124985|FG002|Overall Study|Protocol deviation|0
6971119|NCT01160744|11021664|FG002|Overall Study|Not meet inclusion/exclusion criteria|1
6971120|NCT01160744|11021665|FG003|Overall Study|Not meet inclusion/exclusion criteria|0
6971121|NCT01160770|11021677|FG000|Overall Study|Adverse Event|10
6971122|NCT01160770|11021677|FG000|Overall Study|Protocol Violation|2
6971123|NCT01160770|11021677|FG000|Overall Study|Subject/parent/caregiver request|33
6971124|NCT01160770|11021677|FG000|Overall Study|Physician Decision|1
6971125|NCT01160770|11021677|FG000|Overall Study|Lost to Follow-up|7
7041377|NCT01727141|11124986|FG003|Overall Study|Protocol deviation|1
6971126|NCT01160770|11021677|FG000|Overall Study|Study termination or sponsor request|1
6971127|NCT01160770|11021677|FG000|Overall Study|Death|9
6971128|NCT01160770|11021677|FG000|Overall Study|Lack of Efficacy|15
6971129|NCT01160770|11021677|FG000|Overall Study|Other Reasons|1
6971130|NCT01160822|11021688|FG000|Overall Study|Adverse Event|0
6971131|NCT01160822|11021689|FG001|Overall Study|Adverse Event|0
6971132|NCT01160822|11021690|FG002|Overall Study|Adverse Event|0
6971133|NCT01160822|11021691|FG003|Overall Study|Adverse Event|0
6971134|NCT01160822|11021692|FG004|Overall Study|Adverse Event|1
6971135|NCT01160822|11021693|FG005|Overall Study|Adverse Event|2
6971136|NCT01160822|11021694|FG006|Overall Study|Adverse Event|5
6971137|NCT01160822|11021688|FG000|Overall Study|Unsatisfactory therapeutic effect|0
6971138|NCT01160822|11021689|FG001|Overall Study|Unsatisfactory therapeutic effect|0
6971139|NCT01160822|11021690|FG002|Overall Study|Unsatisfactory therapeutic effect|0
6971140|NCT01160822|11021691|FG003|Overall Study|Unsatisfactory therapeutic effect|0
6971141|NCT01160822|11021692|FG004|Overall Study|Unsatisfactory therapeutic effect|4
6971142|NCT01160822|11021693|FG005|Overall Study|Unsatisfactory therapeutic effect|5
6971143|NCT01160822|11021694|FG006|Overall Study|Unsatisfactory therapeutic effect|3
6971144|NCT01160822|11021688|FG000|Overall Study|Withdrawal by Subject|0
6971145|NCT01160822|11021689|FG001|Overall Study|Withdrawal by Subject|0
6971146|NCT01160822|11021690|FG002|Overall Study|Withdrawal by Subject|0
6971147|NCT01160822|11021691|FG003|Overall Study|Withdrawal by Subject|0
6971148|NCT01160822|11021692|FG004|Overall Study|Withdrawal by Subject|0
6971149|NCT01160822|11021693|FG005|Overall Study|Withdrawal by Subject|0
6971150|NCT01160822|11021694|FG006|Overall Study|Withdrawal by Subject|1
6971151|NCT01160822|11021688|FG000|Overall Study|Lost to Follow-up|0
6971152|NCT01160822|11021689|FG001|Overall Study|Lost to Follow-up|0
6971153|NCT01160822|11021690|FG002|Overall Study|Lost to Follow-up|0
6971154|NCT01160822|11021691|FG003|Overall Study|Lost to Follow-up|0
6971155|NCT01160822|11021692|FG004|Overall Study|Lost to Follow-up|1
6971156|NCT01160822|11021693|FG005|Overall Study|Lost to Follow-up|0
6971157|NCT01160822|11021694|FG006|Overall Study|Lost to Follow-up|0
6971158|NCT01160822|11021688|FG000|Overall Study|Administrative problems|0
6971159|NCT01160822|11021689|FG001|Overall Study|Administrative problems|0
6971160|NCT01160822|11021690|FG002|Overall Study|Administrative problems|0
6971161|NCT01160822|11021691|FG003|Overall Study|Administrative problems|0
6971162|NCT01160822|11021692|FG004|Overall Study|Administrative problems|1
6971163|NCT01160822|11021693|FG005|Overall Study|Administrative problems|0
6971164|NCT01160822|11021694|FG006|Overall Study|Administrative problems|0
6971165|NCT01160822|11021688|FG000|Overall Study|Protocol deviation|0
6971166|NCT01160822|11021689|FG001|Overall Study|Protocol deviation|0
6971167|NCT01160822|11021690|FG002|Overall Study|Protocol deviation|0
6971168|NCT01160822|11021691|FG003|Overall Study|Protocol deviation|0
6971169|NCT01160822|11021692|FG004|Overall Study|Protocol deviation|2
6971170|NCT01160822|11021693|FG005|Overall Study|Protocol deviation|0
6971171|NCT01160822|11021694|FG006|Overall Study|Protocol deviation|0
6971172|NCT01161043|11021724|FG000|Overall Study|Withdrawal by Subject|3
6971173|NCT01161173|11021749|FG000|Overall Study|Protocol Violation|13
6971174|NCT01161173|11021749|FG000|Overall Study|Lost to Follow-up|7
6971175|NCT01161173|11021749|FG000|Overall Study|Progressive Disease|82
6971176|NCT01161173|11021749|FG000|Overall Study|Withdrawal of Consent|5
7079444|NCT02114892|11188603|FG000|Overall Study|Lost to Follow-up|1
7079445|NCT02114892|11188604|FG001|Overall Study|Lost to Follow-up|2
7082946|NCT02147158|11193690|FG004|Off-Treatment Interval 2|Lost to Follow-up|2
7082947|NCT02147158|11193691|FG005|Off-Treatment Interval 2|Lost to Follow-up|2
7082948|NCT02147158|11193686|FG000|Off-Treatment Interval 2|Protocol Violation|0
7082949|NCT02147158|11193687|FG001|Off-Treatment Interval 2|Protocol Violation|0
7082950|NCT02147158|11193688|FG002|Off-Treatment Interval 2|Protocol Violation|0
7082951|NCT02147158|11193689|FG003|Off-Treatment Interval 2|Protocol Violation|1
6971177|NCT01161173|11021749|FG000|Overall Study|Unacceptable Toxicity|21
6971178|NCT01161173|11021749|FG000|Overall Study|Death|194
6971179|NCT01161173|11021749|FG000|Overall Study|End of Study|2
6971180|NCT01161173|11021749|FG000|Overall Study|Reasons Not Specified|23
6971181|NCT01161407|11021782|FG000|Overall Study|Protocol Violation|3
6971182|NCT01161407|11021783|FG001|Overall Study|Protocol Violation|1
6971183|NCT01161446|11021801|FG000|Overall Study|Lost to Follow-up|18
6971184|NCT01161446|11021802|FG001|Overall Study|Lost to Follow-up|14
6971185|NCT01161446|11021801|FG000|Overall Study|Withdrawal by Subject|0
6971186|NCT01161446|11021802|FG001|Overall Study|Withdrawal by Subject|1
6971187|NCT01161472|11021808|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1
6971188|NCT01161472|11021809|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
6971189|NCT01161472|11021810|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
6971190|NCT01161472|11021811|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
6971191|NCT01161498|11021823|FG000|Overall Study|Disease Progression|0
6971192|NCT01161498|11021824|FG001|Overall Study|Disease Progression|1
6971193|NCT01161524|11021832|FG000|Core Study (23 Weeks)|Adverse Event|3
6971194|NCT01161524|11021833|FG001|Core Study (23 Weeks)|Adverse Event|0
6971195|NCT01161524|11021834|FG002|Core Study (23 Weeks)|Adverse Event|0
6971196|NCT01161524|11021832|FG000|Core Study (23 Weeks)|Other|1
6971197|NCT01161524|11021833|FG001|Core Study (23 Weeks)|Other|0
6971198|NCT01161524|11021834|FG002|Core Study (23 Weeks)|Other|0
6977041|NCT01204294|11029992|FG001|Overall Study|Other (house moving)|0
6971199|NCT01161524|11021832|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1
6971200|NCT01161524|11021833|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1
6971201|NCT01161524|11021834|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0
6971202|NCT01161524|11021832|FG000|Core Study (23 Weeks)|Lost to Follow-up|1
6971203|NCT01161524|11021833|FG001|Core Study (23 Weeks)|Lost to Follow-up|2
6971204|NCT01161524|11021834|FG002|Core Study (23 Weeks)|Lost to Follow-up|0
6971205|NCT01161524|11021832|FG000|Core Study (23 Weeks)|Subject Choice|3
6971206|NCT01161524|11021833|FG001|Core Study (23 Weeks)|Subject Choice|2
6971207|NCT01161524|11021834|FG002|Core Study (23 Weeks)|Subject Choice|0
6971208|NCT01161524|11021832|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0
6971209|NCT01161524|11021833|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0
6971210|NCT01161524|11021834|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8
6971211|NCT01161524|11021832|FG000|Extension Phase (Approximately 83 Weeks)|Other|0
6971212|NCT01161524|11021833|FG001|Extension Phase (Approximately 83 Weeks)|Other|0
6971213|NCT01161524|11021834|FG002|Extension Phase (Approximately 83 Weeks)|Other|6
6971214|NCT01161524|11021832|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0
6971215|NCT01161524|11021833|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0
6971216|NCT01161524|11021834|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1
6971217|NCT01161524|11021832|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0
6971218|NCT01161524|11021833|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0
6971219|NCT01161524|11021834|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5
6971220|NCT01161524|11021832|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0
6971221|NCT01161524|11021833|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0
6971222|NCT01161524|11021834|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4
6971223|NCT01161537|11021843|FG000|Part B|Withdrawal by Subject|2
6971224|NCT01161628|11021861|FG000|Overall Study|Death|6
6971225|NCT01161628|11021861|FG000|Overall Study|Lack of Efficacy|2
6971226|NCT01162122|11021899|FG000|Overall Study|Withdrawal by Subject|52
6971227|NCT01162122|11021900|FG001|Overall Study|Withdrawal by Subject|43
6971228|NCT01162122|11021899|FG000|Overall Study|Lost to Follow-up|73
6971229|NCT01162122|11021900|FG001|Overall Study|Lost to Follow-up|91
6971230|NCT01162122|11021899|FG000|Overall Study|Adverse Event|3
6971231|NCT01162122|11021900|FG001|Overall Study|Adverse Event|2
6971232|NCT01162122|11021899|FG000|Overall Study|Death|51
6971233|NCT01162122|11021900|FG001|Overall Study|Death|46
6971234|NCT01162122|11021899|FG000|Overall Study|Protocol Violation|2
6971235|NCT01162122|11021900|FG001|Overall Study|Protocol Violation|2
6971236|NCT01162122|11021899|FG000|Overall Study|Inappropriate enrollment|5
6971237|NCT01162122|11021900|FG001|Overall Study|Inappropriate enrollment|4
6971238|NCT01162122|11021899|FG000|Overall Study|Administrative reason|1
6971239|NCT01162122|11021900|FG001|Overall Study|Administrative reason|1
6971240|NCT01162122|11021899|FG000|Overall Study|Unable to classify|3
6971241|NCT01162122|11021900|FG001|Overall Study|Unable to classify|7
6971242|NCT01162122|11021899|FG000|Overall Study|Missing primary reason|1
6971243|NCT01162122|11021900|FG001|Overall Study|Missing primary reason|0
6971244|NCT01162135|11021909|FG000|Overall Study|Withdrawal by Subject|1
6971245|NCT01162135|11021909|FG000|Overall Study|Severe back pain|1
6971246|NCT01162135|11021909|FG000|Overall Study|Ineligible|1
6971247|NCT01162239|11021917|FG000|Treatment Phase|Withdrawal by Subject|1
6971248|NCT01162239|11021918|FG001|Treatment Phase|Withdrawal by Subject|3
6971249|NCT01162239|11021919|FG002|Treatment Phase|Withdrawal by Subject|2
6971250|NCT01162239|11021920|FG003|Treatment Phase|Withdrawal by Subject|3
6971251|NCT01162239|11021917|FG000|Treatment Phase|Death|0
6971252|NCT01162239|11021918|FG001|Treatment Phase|Death|0
6971253|NCT01162239|11021919|FG002|Treatment Phase|Death|0
6971254|NCT01162239|11021920|FG003|Treatment Phase|Death|1
6971255|NCT01162239|11021917|FG000|Treatment Phase|Lost to Follow-up|5
6971256|NCT01162239|11021918|FG001|Treatment Phase|Lost to Follow-up|4
6971257|NCT01162239|11021919|FG002|Treatment Phase|Lost to Follow-up|2
6971258|NCT01162239|11021920|FG003|Treatment Phase|Lost to Follow-up|1
6971259|NCT01162239|11021917|FG000|Extended Follow-up|Lost to Follow-up|8
6971260|NCT01162239|11021918|FG001|Extended Follow-up|Lost to Follow-up|13
6971261|NCT01162239|11021919|FG002|Extended Follow-up|Lost to Follow-up|8
6971262|NCT01162239|11021920|FG003|Extended Follow-up|Lost to Follow-up|6
6971263|NCT01162343|11021940|FG000|Overall Study|Left ED prior to psychiatrist assessment|80
6971264|NCT01162343|11021940|FG000|Overall Study|Refused psychiatrist assessment|12
6971265|NCT01162421|11021946|FG000|Overall Study|Did not receive study drug|2
6971266|NCT01162421|11021947|FG001|Overall Study|Did not receive study drug|1
6971267|NCT01162421|11021946|FG000|Overall Study|Adverse Event|2
6971268|NCT01162421|11021947|FG001|Overall Study|Adverse Event|5
6971269|NCT01162421|11021946|FG000|Overall Study|Lost to Follow-up|0
6971270|NCT01162421|11021947|FG001|Overall Study|Lost to Follow-up|2
6971271|NCT01162421|11021946|FG000|Overall Study|Lack of Efficacy|2
6971272|NCT01162421|11021947|FG001|Overall Study|Lack of Efficacy|2
6971273|NCT01162421|11021946|FG000|Overall Study|Other|2
6971274|NCT01162421|11021947|FG001|Overall Study|Other|3
6971275|NCT01162473|11021955|FG000|Overall Study|Adverse Event|2
6971276|NCT01162473|11021956|FG001|Overall Study|Adverse Event|1
6971277|NCT01162473|11021955|FG000|Overall Study|Withdrawal by Subject|0
6971278|NCT01162473|11021956|FG001|Overall Study|Withdrawal by Subject|4
6971279|NCT01162486|11021967|FG000|Overall Study|low ANC|1
6971280|NCT01162486|11021968|FG001|Overall Study|low ANC|0
6971281|NCT01162486|11021969|FG002|Overall Study|low ANC|0
6971282|NCT01162486|11021970|FG003|Overall Study|low ANC|0
6971283|NCT01162486|11021971|FG004|Overall Study|low ANC|0
6971284|NCT01162486|11021967|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1
6971285|NCT01162486|11021968|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0
6971286|NCT01162486|11021969|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0
6971287|NCT01162486|11021970|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0
6971288|NCT01162486|11021971|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0
6971289|NCT01162486|11021967|FG000|Overall Study|elevated LFTs|0
6971290|NCT01162486|11021968|FG001|Overall Study|elevated LFTs|0
6971291|NCT01162486|11021969|FG002|Overall Study|elevated LFTs|1
6971292|NCT01162486|11021970|FG003|Overall Study|elevated LFTs|0
6971293|NCT01162486|11021971|FG004|Overall Study|elevated LFTs|0
6971294|NCT01162486|11021967|FG000|Overall Study|Pregnancy|0
6971295|NCT01162486|11021968|FG001|Overall Study|Pregnancy|0
6971296|NCT01162486|11021969|FG002|Overall Study|Pregnancy|0
6971297|NCT01162486|11021970|FG003|Overall Study|Pregnancy|1
6971298|NCT01162486|11021971|FG004|Overall Study|Pregnancy|0
6971299|NCT01162499|11021987|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0
6971300|NCT01162499|11021988|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1
6971301|NCT01162863|11022012|FG000|Overall Study|Lack of Efficacy|1
6971302|NCT01162863|11022013|FG001|Overall Study|Lack of Efficacy|0
6971303|NCT01162863|11022014|FG002|Overall Study|Lack of Efficacy|0
6971304|NCT01162863|11022012|FG000|Overall Study|Adverse Event|0
6971305|NCT01162863|11022013|FG001|Overall Study|Adverse Event|1
6971306|NCT01162863|11022014|FG002|Overall Study|Adverse Event|0
6971307|NCT01163032|11022025|FG000|Randomization Phase|Withdrawal by Subject|2
6971308|NCT01163032|11022026|FG001|Randomization Phase|Withdrawal by Subject|3
6971309|NCT01163032|11022027|FG002|Randomization Phase|Withdrawal by Subject|0
6971310|NCT01163032|11022025|FG000|Randomization Phase|Adverse Event|3
6971311|NCT01163032|11022026|FG001|Randomization Phase|Adverse Event|3
6971312|NCT01163032|11022027|FG002|Randomization Phase|Adverse Event|0
6971313|NCT01163032|11022025|FG000|Randomization Phase|Protocol Violation|0
6971314|NCT01163032|11022026|FG001|Randomization Phase|Protocol Violation|1
6971315|NCT01163032|11022027|FG002|Randomization Phase|Protocol Violation|0
6971316|NCT01163032|11022025|FG000|Randomization Phase|Various*|5
6971317|NCT01163032|11022026|FG001|Randomization Phase|Various*|4
6971318|NCT01163032|11022027|FG002|Randomization Phase|Various*|0
6971319|NCT01163032|11022025|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0
6971320|NCT01163032|11022026|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1
6971321|NCT01163032|11022027|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0
6971322|NCT01163032|11022025|FG000|Open Label Extension Phase|Adverse Event|0
6971323|NCT01163032|11022026|FG001|Open Label Extension Phase|Adverse Event|0
6971324|NCT01163032|11022027|FG002|Open Label Extension Phase|Adverse Event|3
6971325|NCT01163032|11022025|FG000|Open Label Extension Phase|Withdrawal by Subject|0
6971326|NCT01163032|11022026|FG001|Open Label Extension Phase|Withdrawal by Subject|0
6971327|NCT01163032|11022027|FG002|Open Label Extension Phase|Withdrawal by Subject|3
6971328|NCT01163032|11022025|FG000|Open Label Extension Phase|Protocol Violation|0
6971329|NCT01163032|11022026|FG001|Open Label Extension Phase|Protocol Violation|0
6971330|NCT01163032|11022027|FG002|Open Label Extension Phase|Protocol Violation|1
6971331|NCT01163032|11022025|FG000|Open Label Extension Phase|Study Termination|0
6971332|NCT01163032|11022026|FG001|Open Label Extension Phase|Study Termination|0
6971333|NCT01163032|11022027|FG002|Open Label Extension Phase|Study Termination|7
6971334|NCT01163032|11022025|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
6971335|NCT01163032|11022026|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
6971336|NCT01163032|11022027|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2
6971337|NCT01163149|11022053|FG000|Extension Treatment Period|Withdrawal by Subject|2
6971338|NCT01163149|11022054|FG001|Extension Treatment Period|Withdrawal by Subject|0
6971339|NCT01163149|11022055|FG002|Extension Treatment Period|Withdrawal by Subject|1
6971340|NCT01163149|11022053|FG000|Extension Treatment Period|Adverse Event|0
6971341|NCT01163149|11022054|FG001|Extension Treatment Period|Adverse Event|1
6971342|NCT01163149|11022055|FG002|Extension Treatment Period|Adverse Event|0
6971343|NCT01163149|11022053|FG000|Extension Treatment Period|Noncompliance|0
6971344|NCT01163149|11022054|FG001|Extension Treatment Period|Noncompliance|0
6971345|NCT01163149|11022055|FG002|Extension Treatment Period|Noncompliance|1
6971346|NCT01163253|11022092|FG000|Overall Study|Withdrawn Due to Pregnancy|12
6971347|NCT01163253|11022093|FG001|Overall Study|Withdrawn Due to Pregnancy|2
6971348|NCT01163253|11022092|FG000|Overall Study|Study Terminated by Sponsor|978
6971349|NCT01163253|11022093|FG001|Overall Study|Study Terminated by Sponsor|349
6971350|NCT01163253|11022092|FG000|Overall Study|Protocol Violation|43
6971351|NCT01163253|11022093|FG001|Overall Study|Protocol Violation|12
6971352|NCT01163253|11022092|FG000|Overall Study|Withdrawal by Subject|199
6971353|NCT01163253|11022093|FG001|Overall Study|Withdrawal by Subject|50
6971354|NCT01163253|11022092|FG000|Overall Study|Medication Error|1
6971355|NCT01163253|11022093|FG001|Overall Study|Medication Error|0
6971356|NCT01163253|11022092|FG000|Overall Study|Lost to Follow-up|125
6971357|NCT01163253|11022093|FG001|Overall Study|Lost to Follow-up|23
6971358|NCT01163253|11022092|FG000|Overall Study|Insufficient Clinical Response|423
6971359|NCT01163253|11022093|FG001|Overall Study|Insufficient Clinical Response|29
6971360|NCT01163253|11022092|FG000|Overall Study|Adverse Event|300
6971361|NCT01163253|11022093|FG001|Overall Study|Adverse Event|78
6971362|NCT01163253|11022092|FG000|Overall Study|Death|17
6971363|NCT01163253|11022093|FG001|Overall Study|Death|5
6971364|NCT01163253|11022092|FG000|Overall Study|Ongoing|13
6971365|NCT01163253|11022093|FG001|Overall Study|Ongoing|4
6971366|NCT01163253|11022092|FG000|Overall Study|Other Unspecified|170
6971367|NCT01163253|11022093|FG001|Overall Study|Other Unspecified|34
6971368|NCT01163266|11022102|FG000|Overall Study|Pretreatment Event or Adverse Event|2
6971369|NCT01163266|11022103|FG001|Overall Study|Pretreatment Event or Adverse Event|9
6971370|NCT01163266|11022104|FG002|Overall Study|Pretreatment Event or Adverse Event|7
6971371|NCT01163266|11022102|FG000|Overall Study|Lack of Efficacy|1
6971372|NCT01163266|11022103|FG001|Overall Study|Lack of Efficacy|3
6971373|NCT01163266|11022104|FG002|Overall Study|Lack of Efficacy|1
6971374|NCT01163266|11022102|FG000|Overall Study|Noncompliance with Study Drug|0
6971375|NCT01163266|11022103|FG001|Overall Study|Noncompliance with Study Drug|2
6971376|NCT01163266|11022104|FG002|Overall Study|Noncompliance with Study Drug|0
6971377|NCT01163266|11022102|FG000|Overall Study|Protocol Deviations|2
6971378|NCT01163266|11022103|FG001|Overall Study|Protocol Deviations|2
6971379|NCT01163266|11022104|FG002|Overall Study|Protocol Deviations|5
6971380|NCT01163266|11022102|FG000|Overall Study|Withdrawal of Consent|5
6971381|NCT01163266|11022103|FG001|Overall Study|Withdrawal of Consent|7
6971382|NCT01163266|11022104|FG002|Overall Study|Withdrawal of Consent|3
6971383|NCT01163266|11022102|FG000|Overall Study|Lost to Follow-up|7
6971384|NCT01163266|11022103|FG001|Overall Study|Lost to Follow-up|7
6971385|NCT01163266|11022104|FG002|Overall Study|Lost to Follow-up|10
6971386|NCT01163266|11022102|FG000|Overall Study|Other|1
6971387|NCT01163266|11022103|FG001|Overall Study|Other|1
6971388|NCT01163266|11022104|FG002|Overall Study|Other|2
6971389|NCT01163279|11022114|FG000|Overall Study|Withdrawal by Subject|2
6971390|NCT01163279|11022115|FG001|Overall Study|Withdrawal by Subject|0
6971391|NCT01163292|11022124|FG000|Overall Study|Lack of Efficacy|9
6971392|NCT01163292|11022125|FG001|Overall Study|Lack of Efficacy|0
6971393|NCT01163292|11022124|FG000|Overall Study|Adverse Event|6
6971394|NCT01163292|11022125|FG001|Overall Study|Adverse Event|0
6971395|NCT01163292|11022124|FG000|Overall Study|Initiation of biological therapy|0
6971396|NCT01163292|11022125|FG001|Overall Study|Initiation of biological therapy|15
6971397|NCT01163292|11022124|FG000|Overall Study|Sufficient response to adalimumab|8
6971398|NCT01163292|11022125|FG001|Overall Study|Sufficient response to adalimumab|0
6971399|NCT01163292|11022124|FG000|Overall Study|Refusal to receive adalimumab|7
6971400|NCT01163292|11022125|FG001|Overall Study|Refusal to receive adalimumab|0
6971401|NCT01163292|11022124|FG000|Overall Study|Economic reasons|6
6971402|NCT01163292|11022125|FG001|Overall Study|Economic reasons|0
6971403|NCT01163292|11022124|FG000|Overall Study|No further visits|5
6971404|NCT01163292|11022125|FG001|Overall Study|No further visits|7
6971405|NCT01163318|11022131|FG000|Overall Study|Off-Label Use of Adalimumab|8
6971406|NCT01163318|11022131|FG000|Overall Study|Did Not Continue Use of Adalimumab|26
6971407|NCT01163318|11022131|FG000|Overall Study|History/comorbidity of malignant tumor|3
6971408|NCT01163318|11022131|FG000|Overall Study|Participants Without Case Report Form|7
6971409|NCT01163318|11022131|FG000|Overall Study|Multiple Reasons Per Participant|224
7041378|NCT01727141|11124983|FG000|Overall Study|Withdrawal by Subject|4
7041379|NCT01727141|11124984|FG001|Overall Study|Withdrawal by Subject|4
7041380|NCT01727141|11124985|FG002|Overall Study|Withdrawal by Subject|2
7041381|NCT01727141|11124986|FG003|Overall Study|Withdrawal by Subject|11
7079446|NCT02114931|11188612|FG000|Overall Study|Withdrawal by Subject|15
7079447|NCT02114931|11188613|FG001|Overall Study|Withdrawal by Subject|18
7079448|NCT02114931|11188612|FG000|Overall Study|Adverse Event|4
7079449|NCT02114931|11188613|FG001|Overall Study|Adverse Event|6
7079450|NCT02114931|11188612|FG000|Overall Study|Lost to Follow-up|3
7079451|NCT02114931|11188613|FG001|Overall Study|Lost to Follow-up|3
7079452|NCT02114931|11188612|FG000|Overall Study|Physician Decision|1
7079453|NCT02114931|11188613|FG001|Overall Study|Physician Decision|2
7079454|NCT02114931|11188612|FG000|Overall Study|Other|2
7079455|NCT02114931|11188613|FG001|Overall Study|Other|1
7041382|NCT01727154|11124996|FG000|Overall Study|Death|17
7041383|NCT01727154|11124996|FG000|Overall Study|Withdrawal by Subject|14
7155923|NCT03351478|11324077|FG002|Overall Study|At the subject's own request|5
7155924|NCT03351478|11324075|FG000|Overall Study|Adverse Event|1
7155925|NCT03351478|11324076|FG001|Overall Study|Adverse Event|2
6971410|NCT01163474|11022140|FG000|Overall Study|Withdrawal by Subject|1
7041384|NCT01727154|11124996|FG000|Overall Study|Subject Withdrew Consent|18
7079456|NCT02115113|11188628|FG000|Participants in Run-in Period|Death|0
7079457|NCT02115113|11188629|FG001|Participants in Run-in Period|Death|0
7079458|NCT02115113|11188630|FG002|Participants in Run-in Period|Death|1
7155926|NCT03351478|11324077|FG002|Overall Study|Adverse Event|1
7155927|NCT03351478|11324075|FG000|Overall Study|Poor compliance to protocol|1
6971411|NCT01163474|11022140|FG000|Overall Study|Tech barriers to videoteleconference vis|12
7041385|NCT01727154|11124996|FG000|Overall Study|Study Terminated|6
7079459|NCT02115113|11188628|FG000|Participants in Run-in Period|Administrative problems|0
7079460|NCT02115113|11188629|FG001|Participants in Run-in Period|Administrative problems|0
7155928|NCT03351478|11324076|FG001|Overall Study|Poor compliance to protocol|0
7041386|NCT01727154|11124996|FG000|Overall Study|No Discontinuation Documentation|4
7041387|NCT01727258|11125007|FG000|Overall Study|Adverse Event|0
7079461|NCT02115113|11188630|FG002|Participants in Run-in Period|Administrative problems|1
6971412|NCT01163474|11022140|FG000|Overall Study|Lost to Follow-up|3
6971413|NCT01163617|11022156|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
6971414|NCT01163617|11022157|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1
6971415|NCT01163617|11022158|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
6971416|NCT01163617|11022159|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
6971417|NCT01163617|11022160|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
6971418|NCT01163617|11022161|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
6971419|NCT01163617|11022162|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
6971420|NCT01163617|11022163|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
6971421|NCT01163617|11022156|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
6971422|NCT01163617|11022157|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1
6971423|NCT01163617|11022158|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
6971424|NCT01163617|11022159|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
6971425|NCT01163617|11022160|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
6971426|NCT01163617|11022161|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
6971427|NCT01163617|11022162|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
6971428|NCT01163617|11022163|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
6971429|NCT01163617|11022156|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
6971430|NCT01163617|11022157|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
6971431|NCT01163617|11022158|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1
6971432|NCT01163617|11022159|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
6971433|NCT01163617|11022160|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
6971434|NCT01163617|11022161|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
6971435|NCT01163617|11022162|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
6971436|NCT01163617|11022163|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
6971437|NCT01163721|11022219|FG000|Overall Study|Adverse Event|5
6971438|NCT01163721|11022220|FG001|Overall Study|Adverse Event|6
6971439|NCT01163721|11022219|FG000|Overall Study|Withdrawal by Subject|3
6971440|NCT01163721|11022220|FG001|Overall Study|Withdrawal by Subject|4
6971441|NCT01163721|11022219|FG000|Overall Study|Lost to Follow-up|0
6971442|NCT01163721|11022220|FG001|Overall Study|Lost to Follow-up|1
6971443|NCT01163721|11022219|FG000|Overall Study|Physician Decision|0
6971444|NCT01163721|11022220|FG001|Overall Study|Physician Decision|1
6971445|NCT01163747|11022228|FG000|Overall Study|Adverse Event|0
6971446|NCT01163747|11022229|FG001|Overall Study|Adverse Event|5
6971447|NCT01163747|11022228|FG000|Overall Study|Insufficient Therapeutic Response|0
6971448|NCT01163747|11022229|FG001|Overall Study|Insufficient Therapeutic Response|1
6971449|NCT01163747|11022228|FG000|Overall Study|Protocol Violation|0
6971450|NCT01163747|11022229|FG001|Overall Study|Protocol Violation|1
6971451|NCT01163747|11022228|FG000|Overall Study|Refused Treatment|6
6971452|NCT01163747|11022229|FG001|Overall Study|Refused Treatment|4
6971453|NCT01163786|11022246|FG000|Treatment With Bortezomib|Withdrawal by Subject|1
6971454|NCT01163786|11022246|FG000|Treatment With Bortezomib|Adverse Event|2
6971455|NCT01163786|11022246|FG000|Completed Follow up (Visit 9 and 10)|Other|1
6971456|NCT01163851|11022252|FG000|Overall Study|Site Closure|0
6971457|NCT01163851|11022253|FG001|Overall Study|Site Closure|1
6971458|NCT01163851|11022252|FG000|Overall Study|Enrolled but not treated|1
6971459|NCT01163851|11022253|FG001|Overall Study|Enrolled but not treated|0
6971460|NCT01163916|11022262|FG000|Overall Study|Withdrawal by Subject|2
6971461|NCT01163916|11022263|FG001|Overall Study|Withdrawal by Subject|0
6971462|NCT01163916|11022264|FG002|Overall Study|Withdrawal by Subject|2
6971463|NCT01163916|11022262|FG000|Overall Study|Adverse Event|2
6971464|NCT01163916|11022263|FG001|Overall Study|Adverse Event|0
6971465|NCT01163916|11022264|FG002|Overall Study|Adverse Event|1
6971466|NCT01163916|11022262|FG000|Overall Study|Lack of Efficacy|2
6971467|NCT01163916|11022263|FG001|Overall Study|Lack of Efficacy|0
6971468|NCT01163916|11022264|FG002|Overall Study|Lack of Efficacy|1
6971469|NCT01163916|11022262|FG000|Overall Study|Other|24
6971470|NCT01163916|11022263|FG001|Overall Study|Other|4
6971471|NCT01163916|11022264|FG002|Overall Study|Other|16
6971472|NCT01164007|11022286|FG000|Overall Study|Adverse Event|5
6971473|NCT01164007|11022286|FG000|Overall Study|Progression of Disease|30
6971474|NCT01164007|11022286|FG000|Overall Study|Protocol Violation|1
6971475|NCT01164007|11022286|FG000|Overall Study|Withdrawal by Subject|1
6971476|NCT01164007|11022286|FG000|Overall Study|Medical Decision|3
6971477|NCT01164475|11022310|FG000|Overall Study|Lack of Efficacy|1
6971478|NCT01164475|11022311|FG001|Overall Study|Lack of Efficacy|0
6971479|NCT01164475|11022310|FG000|Overall Study|Other|0
6971480|NCT01164475|11022311|FG001|Overall Study|Other|1
6971481|NCT01164475|11022310|FG000|Overall Study|Progressive disease|0
6971482|NCT01164475|11022311|FG001|Overall Study|Progressive disease|1
6971483|NCT01164475|11022310|FG000|Overall Study|Protocol Violation|1
6971484|NCT01164475|11022311|FG001|Overall Study|Protocol Violation|0
6977042|NCT01204294|11029993|FG002|Overall Study|Other (house moving)|1
6977043|NCT01204294|11029994|FG003|Overall Study|Other (house moving)|0
6977044|NCT01204294|11029995|FG004|Overall Study|Other (house moving)|0
6971485|NCT01164501|11022320|FG000|Overall Study|Not treated|2
6971486|NCT01164501|11022321|FG001|Overall Study|Not treated|0
6971487|NCT01164501|11022322|FG002|Overall Study|Not treated|1
6971488|NCT01164501|11022320|FG000|Overall Study|Adverse Event|18
6971489|NCT01164501|11022321|FG001|Overall Study|Adverse Event|4
6971490|NCT01164501|11022322|FG002|Overall Study|Adverse Event|21
6971491|NCT01164501|11022320|FG000|Overall Study|Lack of Efficacy|0
6971492|NCT01164501|11022321|FG001|Overall Study|Lack of Efficacy|0
6971493|NCT01164501|11022322|FG002|Overall Study|Lack of Efficacy|1
6971494|NCT01164501|11022320|FG000|Overall Study|Non compliant with protocol|1
6971495|NCT01164501|11022321|FG001|Overall Study|Non compliant with protocol|1
6971496|NCT01164501|11022322|FG002|Overall Study|Non compliant with protocol|4
6971497|NCT01164501|11022320|FG000|Overall Study|Lost to Follow-up|3
6971498|NCT01164501|11022321|FG001|Overall Study|Lost to Follow-up|0
6971499|NCT01164501|11022322|FG002|Overall Study|Lost to Follow-up|3
6971500|NCT01164501|11022320|FG000|Overall Study|Patient refusal to continue,not due toAE|10
6971501|NCT01164501|11022321|FG001|Overall Study|Patient refusal to continue,not due toAE|4
6971502|NCT01164501|11022322|FG002|Overall Study|Patient refusal to continue,not due toAE|8
6971503|NCT01164501|11022320|FG000|Overall Study|Other reason not defined above|9
6971504|NCT01164501|11022321|FG001|Overall Study|Other reason not defined above|1
6971505|NCT01164501|11022322|FG002|Overall Study|Other reason not defined above|4
6971506|NCT01164579|11022335|FG000|Overall Study|Lack of Efficacy|0
6971507|NCT01164579|11022336|FG001|Overall Study|Lack of Efficacy|0
6971508|NCT01164579|11022337|FG002|Overall Study|Lack of Efficacy|6
6971509|NCT01164579|11022335|FG000|Overall Study|Lost to Follow-up|1
6971510|NCT01164579|11022336|FG001|Overall Study|Lost to Follow-up|1
6971511|NCT01164579|11022337|FG002|Overall Study|Lost to Follow-up|0
6971512|NCT01164579|11022335|FG000|Overall Study|Withdrawal by Subject|2
6971513|NCT01164579|11022336|FG001|Overall Study|Withdrawal by Subject|5
6971514|NCT01164579|11022337|FG002|Overall Study|Withdrawal by Subject|3
6971515|NCT01164579|11022335|FG000|Overall Study|Protocol Violation|0
6971516|NCT01164579|11022336|FG001|Overall Study|Protocol Violation|1
6971517|NCT01164579|11022337|FG002|Overall Study|Protocol Violation|2
6971518|NCT01164579|11022335|FG000|Overall Study|Adverse Event|4
6971519|NCT01164579|11022336|FG001|Overall Study|Adverse Event|2
6971520|NCT01164579|11022337|FG002|Overall Study|Adverse Event|5
6971521|NCT01164579|11022335|FG000|Overall Study|Reason not specified|1
6971522|NCT01164579|11022336|FG001|Overall Study|Reason not specified|0
6971523|NCT01164579|11022337|FG002|Overall Study|Reason not specified|0
7079462|NCT02115113|11188628|FG000|Participants in Run-in Period|Lost to Follow-up|0
7079463|NCT02115113|11188629|FG001|Participants in Run-in Period|Lost to Follow-up|0
7079464|NCT02115113|11188630|FG002|Participants in Run-in Period|Lost to Follow-up|5
7079465|NCT02115113|11188628|FG000|Participants in Run-in Period|Withdrawal by Subject|0
7079466|NCT02115113|11188629|FG001|Participants in Run-in Period|Withdrawal by Subject|0
7079467|NCT02115113|11188630|FG002|Participants in Run-in Period|Withdrawal by Subject|3
7079468|NCT02115113|11188628|FG000|Participants Randomized|Lost to Follow-up|1
7079469|NCT02115113|11188629|FG001|Participants Randomized|Lost to Follow-up|0
7079470|NCT02115113|11188630|FG002|Participants Randomized|Lost to Follow-up|0
7079471|NCT02115113|11188628|FG000|Participants Randomized|Death|1
7079472|NCT02115113|11188629|FG001|Participants Randomized|Death|0
7079473|NCT02115113|11188630|FG002|Participants Randomized|Death|0
7079474|NCT02115139|11188639|FG000|Overall Study|Protocol Violation|1
7079475|NCT02115139|11188639|FG000|Overall Study|treatment discontinuation|6
7079476|NCT02115256|11188645|FG000|Overall Study|Withdrawal by Subject|0
7079477|NCT02115256|11188646|FG001|Overall Study|Withdrawal by Subject|1
7079478|NCT02115269|11188652|FG000|Overall Study|Lost to Follow-up|43
7079479|NCT02115269|11188652|FG000|Overall Study|Did not complete patient diary|3
7079480|NCT02115269|11188652|FG000|Overall Study|Moved to another city|7
7079481|NCT02115269|11188652|FG000|Overall Study|Withdrawal by Subject|2
7079482|NCT02115269|11188652|FG000|Overall Study|Didn't take study drug|2
7155929|NCT03351478|11324077|FG002|Overall Study|Poor compliance to protocol|0
7155930|NCT03351478|11324075|FG000|Overall Study|Reason not Specified|1
7155931|NCT03351478|11324076|FG001|Overall Study|Reason not Specified|3
7155932|NCT03351478|11324077|FG002|Overall Study|Reason not Specified|0
7155933|NCT03351478|11324075|FG000|Overall Study|Lost to Follow-up|0
7155934|NCT03351478|11324076|FG001|Overall Study|Lost to Follow-up|0
7155935|NCT03351478|11324077|FG002|Overall Study|Lost to Follow-up|1
7155936|NCT03351608|11324090|FG000|Overall Study|Lost to Follow-up|0
7155937|NCT03351608|11324091|FG001|Overall Study|Lost to Follow-up|1
7155938|NCT03351608|11324092|FG002|Overall Study|Lost to Follow-up|1
7155939|NCT03351608|11324093|FG003|Overall Study|Lost to Follow-up|1
7155940|NCT03351608|11324094|FG004|Overall Study|Lost to Follow-up|1
7155941|NCT03351608|11324090|FG000|Overall Study|Physician Decision|1
7155942|NCT03351608|11324091|FG001|Overall Study|Physician Decision|0
6971524|NCT01164722|11022357|FG000|Overall Study|Adverse Event|0
6971525|NCT01164722|11022358|FG001|Overall Study|Adverse Event|1
6971526|NCT01164722|11022357|FG000|Overall Study|Withdrawal by Subject|3
6971527|NCT01164722|11022358|FG001|Overall Study|Withdrawal by Subject|4
7079483|NCT02115282|11188669|FG000|Overall Study|Disease progression during treatment|216
7079484|NCT02115282|11188670|FG001|Overall Study|Disease progression during treatment|229
7079485|NCT02115282|11188669|FG000|Overall Study|Adverse Event|49
6971528|NCT01164722|11022357|FG000|Overall Study|Lost to Follow-up|3
6971529|NCT01164722|11022358|FG001|Overall Study|Lost to Follow-up|6
6971530|NCT01164722|11022357|FG000|Overall Study|met protocol criteria for non-treatment|11
6971531|NCT01164722|11022358|FG001|Overall Study|met protocol criteria for non-treatment|1
6971532|NCT01164722|11022357|FG000|Overall Study|enrolled on other study, concomitant med|1
6971533|NCT01164722|11022358|FG001|Overall Study|enrolled on other study, concomitant med|3
6971534|NCT01164865|11022366|FG000|Overall Study|Lost to Follow-up|2
6971535|NCT01164865|11022367|FG001|Overall Study|Lost to Follow-up|1
6971536|NCT01164891|11022373|FG000|Overall Study|Disease Progression|5
6971537|NCT01164891|11022373|FG000|Overall Study|Adverse Event|1
6971538|NCT01164956|11022378|FG000|Overall Study|Side Effects|1
6971539|NCT01164956|11022379|FG001|Overall Study|Side Effects|0
6971540|NCT01164956|11022380|FG002|Overall Study|Side Effects|1
6971541|NCT01165021|11022388|FG000|Overall Study|Death|1
6971542|NCT01165138|11022403|FG000|Overall Study|Adverse Event|0
6971543|NCT01165138|11022404|FG001|Overall Study|Adverse Event|1
6971544|NCT01165138|11022405|FG002|Overall Study|Adverse Event|0
6971545|NCT01165138|11022406|FG003|Overall Study|Adverse Event|2
6971546|NCT01165138|11022403|FG000|Overall Study|Lack of Efficacy|0
6971547|NCT01165138|11022404|FG001|Overall Study|Lack of Efficacy|32
6971548|NCT01165138|11022405|FG002|Overall Study|Lack of Efficacy|6
6971549|NCT01165138|11022406|FG003|Overall Study|Lack of Efficacy|7
6971550|NCT01165138|11022403|FG000|Overall Study|Protocol Violation|0
6971551|NCT01165138|11022404|FG001|Overall Study|Protocol Violation|7
6971552|NCT01165138|11022405|FG002|Overall Study|Protocol Violation|0
6971553|NCT01165138|11022406|FG003|Overall Study|Protocol Violation|2
6971554|NCT01165138|11022403|FG000|Overall Study|Lost to Follow-up|0
6971555|NCT01165138|11022404|FG001|Overall Study|Lost to Follow-up|0
6971556|NCT01165138|11022405|FG002|Overall Study|Lost to Follow-up|1
6971557|NCT01165138|11022406|FG003|Overall Study|Lost to Follow-up|2
6971558|NCT01165138|11022403|FG000|Overall Study|Physician Decision|0
6971559|NCT01165138|11022404|FG001|Overall Study|Physician Decision|6
6971560|NCT01165138|11022405|FG002|Overall Study|Physician Decision|7
6971561|NCT01165138|11022406|FG003|Overall Study|Physician Decision|6
6971562|NCT01165138|11022403|FG000|Overall Study|Withdrawal by Subject|0
6971563|NCT01165138|11022404|FG001|Overall Study|Withdrawal by Subject|6
6971564|NCT01165138|11022405|FG002|Overall Study|Withdrawal by Subject|6
6971565|NCT01165138|11022406|FG003|Overall Study|Withdrawal by Subject|3
6971566|NCT01165177|11022416|FG000|Overall Study|Serious Adverse Event|227
6971567|NCT01165177|11022417|FG001|Overall Study|Serious Adverse Event|235
6971568|NCT01165177|11022416|FG000|Overall Study|Withdrawal by Subject|368
6971569|NCT01165177|11022417|FG001|Overall Study|Withdrawal by Subject|354
6971570|NCT01165177|11022416|FG000|Overall Study|Protocol Violation|19
6971571|NCT01165177|11022417|FG001|Overall Study|Protocol Violation|21
6971572|NCT01165177|11022416|FG000|Overall Study|Non-serious adverse event|30
6971573|NCT01165177|11022417|FG001|Overall Study|Non-serious adverse event|18
6971574|NCT01165177|11022416|FG000|Overall Study|Other unspecified reasons|47
6971575|NCT01165177|11022417|FG001|Overall Study|Other unspecified reasons|35
6971576|NCT01165177|11022416|FG000|Overall Study|Suspected HZ episode|0
6971577|NCT01165177|11022417|FG001|Overall Study|Suspected HZ episode|2
6971578|NCT01165177|11022416|FG000|Overall Study|Lost to Follow-up|183
7079486|NCT02115282|11188670|FG001|Overall Study|Adverse Event|23
7079487|NCT02115282|11188669|FG000|Overall Study|Death|1
7155943|NCT03351608|11324092|FG002|Overall Study|Physician Decision|0
7155944|NCT03351608|11324093|FG003|Overall Study|Physician Decision|2
7155945|NCT03351608|11324094|FG004|Overall Study|Physician Decision|1
7155946|NCT03351608|11324090|FG000|Overall Study|Randomized by mistake, no treatment given|0
7155947|NCT03351608|11324091|FG001|Overall Study|Randomized by mistake, no treatment given|0
7155948|NCT03351608|11324092|FG002|Overall Study|Randomized by mistake, no treatment given|0
7155949|NCT03351608|11324093|FG003|Overall Study|Randomized by mistake, no treatment given|1
6971579|NCT01165177|11022417|FG001|Overall Study|Lost to Follow-up|194
6971580|NCT01165177|11022416|FG000|Overall Study|Migrated/ moved from study area|48
6971581|NCT01165177|11022417|FG001|Overall Study|Migrated/ moved from study area|43
6971582|NCT01165203|11022433|FG000|Active Phase|Serious Adverse Event|1
6971583|NCT01165203|11022434|FG001|Active Phase|Serious Adverse Event|0
6971584|NCT01165203|11022433|FG000|Active Phase|Withdrawal by Subject|2
6971585|NCT01165203|11022434|FG001|Active Phase|Withdrawal by Subject|1
7079488|NCT02115282|11188670|FG001|Overall Study|Death|3
7079489|NCT02115282|11188669|FG000|Overall Study|Alternative therapy|1
7079490|NCT02115282|11188670|FG001|Overall Study|Alternative therapy|1
7079491|NCT02115282|11188669|FG000|Overall Study|Complicating disease|0
7079492|NCT02115282|11188670|FG001|Overall Study|Complicating disease|3
7079493|NCT02115282|11188669|FG000|Overall Study|Withdrawal by Subject|12
7079494|NCT02115282|11188670|FG001|Overall Study|Withdrawal by Subject|10
7079495|NCT02115282|11188669|FG000|Overall Study|Symptomatic progression/deterioration|7
7079496|NCT02115282|11188670|FG001|Overall Study|Symptomatic progression/deterioration|18
7079497|NCT02115282|11188669|FG000|Overall Study|Non-compliance|5
7079498|NCT02115282|11188670|FG001|Overall Study|Non-compliance|1
7079499|NCT02115282|11188669|FG000|Overall Study|Protocol Violation|2
7079500|NCT02115282|11188670|FG001|Overall Study|Protocol Violation|2
7079501|NCT02115282|11188669|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3
7079502|NCT02115282|11188670|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3
6971586|NCT01165203|11022433|FG000|Active Phase|Migrated/moved from study area|0
6971587|NCT01165203|11022434|FG001|Active Phase|Migrated/moved from study area|1
6971588|NCT01165203|11022433|FG000|Active Phase|Lost to Follow-up|2
6971589|NCT01165203|11022434|FG001|Active Phase|Lost to Follow-up|0
6971590|NCT01165203|11022433|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1
6971591|NCT01165203|11022434|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0
6971592|NCT01165203|11022433|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2
6971593|NCT01165203|11022434|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2
6971594|NCT01165203|11022433|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2
6971595|NCT01165203|11022434|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1
6971596|NCT01165203|11022433|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2
6971597|NCT01165203|11022434|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0
6971598|NCT01165203|11022433|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0
6971599|NCT01165203|11022434|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1
6971600|NCT01165216|11022449|FG000|Overall Study|Adverse Event|6
6971601|NCT01165216|11022450|FG001|Overall Study|Adverse Event|3
6971602|NCT01165216|11022449|FG000|Overall Study|Withdrawal by Subject|1
6971603|NCT01165216|11022450|FG001|Overall Study|Withdrawal by Subject|1
6971604|NCT01165216|11022449|FG000|Overall Study|Disease progression|1
6971605|NCT01165216|11022450|FG001|Overall Study|Disease progression|3
7079503|NCT02115282|11188669|FG000|Overall Study|Not start protocol therapy|9
7079504|NCT02115282|11188670|FG001|Overall Study|Not start protocol therapy|10
7079505|NCT02115308|11188680|FG000|Overall Study|Safety Screening|2
7079506|NCT02115308|11188681|FG001|Overall Study|Safety Screening|2
7079507|NCT02115321|11188693|FG000|Overall Study|Death|1
7079508|NCT02115321|11188694|FG001|Overall Study|Death|0
7155950|NCT03351608|11324094|FG004|Overall Study|Randomized by mistake, no treatment given|0
7155951|NCT03351608|11324090|FG000|Overall Study|Withdrawal by parent/guardian|0
7155952|NCT03351608|11324091|FG001|Overall Study|Withdrawal by parent/guardian|0
7155953|NCT03351608|11324092|FG002|Overall Study|Withdrawal by parent/guardian|1
7155954|NCT03351608|11324093|FG003|Overall Study|Withdrawal by parent/guardian|1
7155955|NCT03351608|11324094|FG004|Overall Study|Withdrawal by parent/guardian|0
7155956|NCT03351608|11324090|FG000|Overall Study|Other|0
7155957|NCT03351608|11324091|FG001|Overall Study|Other|1
7155958|NCT03351608|11324092|FG002|Overall Study|Other|1
7155959|NCT03351608|11324093|FG003|Overall Study|Other|3
7155960|NCT03351608|11324094|FG004|Overall Study|Other|0
7155961|NCT03351738|11324150|FG000|Overall Study|Withdrawal by Subject|0
7155962|NCT03351738|11324151|FG001|Overall Study|Withdrawal by Subject|1
7155963|NCT03351738|11324152|FG002|Overall Study|Withdrawal by Subject|0
6971606|NCT01165229|11022460|FG000|Overall Study|Serious Adverse Event|456
6971607|NCT01165229|11022461|FG001|Overall Study|Serious Adverse Event|487
6971608|NCT01165229|11022460|FG000|Overall Study|Non-Serious Adverse Event|47
6971609|NCT01165229|11022461|FG001|Overall Study|Non-Serious Adverse Event|15
6971610|NCT01165229|11022460|FG000|Overall Study|Protocol Violation|6
6971611|NCT01165229|11022461|FG001|Overall Study|Protocol Violation|8
6971612|NCT01165229|11022460|FG000|Overall Study|Withdrawal by Subject|387
6971613|NCT01165229|11022461|FG001|Overall Study|Withdrawal by Subject|396
6971614|NCT01165229|11022460|FG000|Overall Study|Migrated/moved from study area|51
6971615|NCT01165229|11022461|FG001|Overall Study|Migrated/moved from study area|46
6971616|NCT01165229|11022460|FG000|Overall Study|Lost to Follow-up|123
6971617|NCT01165229|11022461|FG001|Overall Study|Lost to Follow-up|133
6971618|NCT01165229|11022460|FG000|Overall Study|Suspected HZ Episode|2
6971619|NCT01165229|11022461|FG001|Overall Study|Suspected HZ Episode|2
6971620|NCT01165229|11022460|FG000|Overall Study|No reason from the subject|108
6971621|NCT01165229|11022461|FG001|Overall Study|No reason from the subject|102
6971622|NCT01165229|11022460|FG000|Overall Study|Unknown completion status|0
6971623|NCT01165229|11022461|FG001|Overall Study|Unknown completion status|1
6971624|NCT01165242|11022500|FG000|Overall Study|Unreachable Subjects|1
6971625|NCT01165242|11022501|FG001|Overall Study|Unreachable Subjects|0
6971626|NCT01165242|11022502|FG002|Overall Study|Unreachable Subjects|0
6971627|NCT01165242|11022500|FG000|Overall Study|Incarcerated Subjects|0
6971628|NCT01165242|11022501|FG001|Overall Study|Incarcerated Subjects|1
7155964|NCT03351738|11324153|FG003|Overall Study|Withdrawal by Subject|1
7155965|NCT03351738|11324154|FG004|Overall Study|Withdrawal by Subject|0
7155966|NCT03351738|11324155|FG005|Overall Study|Withdrawal by Subject|0
7155967|NCT03352414|11324193|FG000|Overall Study|Ineligible by operative criteria|12
7155968|NCT03352414|11324194|FG001|Overall Study|Ineligible by operative criteria|10
7155969|NCT03352453|11324204|FG000|Overall Study|Miscellaneous Reasons|1
7155970|NCT03352453|11324205|FG001|Overall Study|Miscellaneous Reasons|2
7155971|NCT03352453|11324204|FG000|Overall Study|Lack of Efficacy|1
7155972|NCT03352453|11324205|FG001|Overall Study|Lack of Efficacy|0
7155973|NCT03352453|11324204|FG000|Overall Study|Withdrawal by Subject|8
7155974|NCT03352453|11324205|FG001|Overall Study|Withdrawal by Subject|14
6971629|NCT01165242|11022502|FG002|Overall Study|Incarcerated Subjects|0
6971630|NCT01165242|11022500|FG000|Overall Study|Visit 2 Declined by Subject|0
6971631|NCT01165242|11022501|FG001|Overall Study|Visit 2 Declined by Subject|0
6971632|NCT01165242|11022502|FG002|Overall Study|Visit 2 Declined by Subject|1
6971633|NCT01165242|11022500|FG000|Overall Study|Withdrawal by Subject|0
7079509|NCT02115386|11188730|FG000|Overall Study|Protocol Violation|1
6971634|NCT01165242|11022501|FG001|Overall Study|Withdrawal by Subject|2
6971635|NCT01165242|11022502|FG002|Overall Study|Withdrawal by Subject|2
6971636|NCT01165242|11022500|FG000|Overall Study|Extended Holiday|0
6971637|NCT01165242|11022501|FG001|Overall Study|Extended Holiday|0
6971638|NCT01165242|11022502|FG002|Overall Study|Extended Holiday|1
6971639|NCT01165242|11022500|FG000|Overall Study|Lost to Follow-up|9
6971640|NCT01165242|11022501|FG001|Overall Study|Lost to Follow-up|7
6971641|NCT01165242|11022502|FG002|Overall Study|Lost to Follow-up|10
6971642|NCT01165281|11022514|FG000|Overall Study|Adverse Event|12
6971643|NCT01165281|11022515|FG001|Overall Study|Adverse Event|14
6971644|NCT01165281|11022514|FG000|Overall Study|Death|3
6971645|NCT01165281|11022515|FG001|Overall Study|Death|4
6971646|NCT01165281|11022514|FG000|Overall Study|Lack of Efficacy|4
6971647|NCT01165281|11022515|FG001|Overall Study|Lack of Efficacy|1
6971648|NCT01165281|11022514|FG000|Overall Study|Lost to Follow-up|0
6971649|NCT01165281|11022515|FG001|Overall Study|Lost to Follow-up|1
7155975|NCT03352453|11324204|FG000|Overall Study|Study Terminated by Sponsor|2
7155976|NCT03352453|11324205|FG001|Overall Study|Study Terminated by Sponsor|1
7155977|NCT03352453|11324204|FG000|Overall Study|Protocol Deviation|1
7155978|NCT03352453|11324205|FG001|Overall Study|Protocol Deviation|0
7155979|NCT03352453|11324204|FG000|Overall Study|Lost to Follow-up|7
7155980|NCT03352453|11324205|FG001|Overall Study|Lost to Follow-up|6
7155981|NCT03352453|11324204|FG000|Overall Study|Adverse Event|2
7155982|NCT03352453|11324205|FG001|Overall Study|Adverse Event|9
7155983|NCT03352713|11324220|FG000|Overall Study|Lost to Follow-up|8
7155984|NCT03352713|11324220|FG000|Overall Study|Withdrawn by investigator|5
7155985|NCT03352713|11324220|FG000|Overall Study|Completed 0 EMAs|8
7155986|NCT03352713|11324220|FG000|Overall Study|Device incompatible/stolen|5
7155987|NCT03353220|11324224|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4
6894669|NCT00621140|10912383|FG000|Overall Study|Adverse Event|4
6894670|NCT00621140|10912384|FG001|Overall Study|Adverse Event|5
6894671|NCT00621140|10912383|FG000|Overall Study|Lost to Follow-up|1
6894672|NCT00621140|10912384|FG001|Overall Study|Lost to Follow-up|2
6894673|NCT00621140|10912383|FG000|Overall Study|Withdrawal by Subject|4
6894674|NCT00621140|10912384|FG001|Overall Study|Withdrawal by Subject|6
6894675|NCT00621140|10912383|FG000|Overall Study|Other incl. lack of efficacy|6
6894676|NCT00621140|10912384|FG001|Overall Study|Other incl. lack of efficacy|5
6894677|NCT00621153|10912392|FG000|Overall Study|Safety Reason|8
6894678|NCT00621153|10912393|FG001|Overall Study|Safety Reason|7
6894679|NCT00621153|10912392|FG000|Overall Study|Adverse Event|3
6894680|NCT00621153|10912393|FG001|Overall Study|Adverse Event|2
6894681|NCT00621153|10912392|FG000|Overall Study|Lost to Follow-up|5
6894682|NCT00621153|10912393|FG001|Overall Study|Lost to Follow-up|1
6894683|NCT00621153|10912392|FG000|Overall Study|Withdrawal by Subject|4
6894684|NCT00621153|10912393|FG001|Overall Study|Withdrawal by Subject|5
6894685|NCT00621192|10912420|FG000|Overall Study|Withdrawal by Subject|0
6894686|NCT00621192|10912421|FG001|Overall Study|Withdrawal by Subject|0
6894687|NCT00621192|10912422|FG002|Overall Study|Withdrawal by Subject|2
6894688|NCT00621192|10912423|FG003|Overall Study|Withdrawal by Subject|0
6894689|NCT00621192|10912420|FG000|Overall Study|Physician Decision|1
6894690|NCT00621192|10912421|FG001|Overall Study|Physician Decision|3
6894691|NCT00621192|10912422|FG002|Overall Study|Physician Decision|0
6894692|NCT00621192|10912423|FG003|Overall Study|Physician Decision|0
6894693|NCT00621192|10912420|FG000|Overall Study|Protocol Violation|1
6894694|NCT00621192|10912421|FG001|Overall Study|Protocol Violation|0
6894695|NCT00621192|10912422|FG002|Overall Study|Protocol Violation|0
6894696|NCT00621192|10912423|FG003|Overall Study|Protocol Violation|1
6894697|NCT00621192|10912420|FG000|Overall Study|Adverse Event|0
6894698|NCT00621192|10912421|FG001|Overall Study|Adverse Event|1
6894699|NCT00621192|10912422|FG002|Overall Study|Adverse Event|0
6894700|NCT00621192|10912423|FG003|Overall Study|Adverse Event|1
6894701|NCT00621192|10912420|FG000|Overall Study|Death|2
6894702|NCT00621192|10912421|FG001|Overall Study|Death|5
6894703|NCT00621192|10912422|FG002|Overall Study|Death|0
6894704|NCT00621192|10912423|FG003|Overall Study|Death|0
6894705|NCT00621192|10912420|FG000|Overall Study|Final Assessments not Completed|0
6894706|NCT00621192|10912421|FG001|Overall Study|Final Assessments not Completed|0
6894707|NCT00621192|10912422|FG002|Overall Study|Final Assessments not Completed|3
6971650|NCT01165281|11022514|FG000|Overall Study|Physician Decision|8
6971651|NCT01165281|11022515|FG001|Overall Study|Physician Decision|1
6971652|NCT01165281|11022514|FG000|Overall Study|Protocol Violation|6
6971653|NCT01165281|11022515|FG001|Overall Study|Protocol Violation|5
6894708|NCT00621192|10912423|FG003|Overall Study|Final Assessments not Completed|1
6894709|NCT00621244|10912437|FG000|Overall Study|Withdrawal by Subject|7
6894710|NCT00621244|10912438|FG001|Overall Study|Withdrawal by Subject|3
6894711|NCT00621244|10912439|FG002|Overall Study|Withdrawal by Subject|3
6894712|NCT00621244|10912440|FG003|Overall Study|Withdrawal by Subject|3
6894713|NCT00621244|10912437|FG000|Overall Study|Disease progression|44
6894714|NCT00621244|10912438|FG001|Overall Study|Disease progression|20
6894715|NCT00621244|10912439|FG002|Overall Study|Disease progression|20
6894716|NCT00621244|10912440|FG003|Overall Study|Disease progression|15
6894717|NCT00621244|10912437|FG000|Overall Study|Death|3
6894718|NCT00621244|10912438|FG001|Overall Study|Death|3
6971654|NCT01165281|11022514|FG000|Overall Study|Withdrawal by Subject|8
6971655|NCT01165281|11022515|FG001|Overall Study|Withdrawal by Subject|7
6971656|NCT01165281|11022514|FG000|Overall Study|Noncompliance with Study Drug|1
6971657|NCT01165281|11022515|FG001|Overall Study|Noncompliance with Study Drug|4
6971658|NCT01165281|11022514|FG000|Overall Study|Progressive Disease|10
6971659|NCT01165281|11022515|FG001|Overall Study|Progressive Disease|14
6971660|NCT01165281|11022514|FG000|Overall Study|Other|6
6971661|NCT01165281|11022515|FG001|Overall Study|Other|0
6971662|NCT01165307|11022523|FG000|Overall Study|Lost to Follow-up|11
6971663|NCT01165307|11022524|FG001|Overall Study|Lost to Follow-up|3
6971664|NCT01165307|11022523|FG000|Overall Study|Withdrawal by Subject|2
6971665|NCT01165307|11022524|FG001|Overall Study|Withdrawal by Subject|0
6971666|NCT01165307|11022523|FG000|Overall Study|Subject not available for contact|1
6971667|NCT01165307|11022524|FG001|Overall Study|Subject not available for contact|0
6971668|NCT01165320|11022532|FG000|Overall Study|Clinical adverse experience|2
6971669|NCT01165320|11022533|FG001|Overall Study|Clinical adverse experience|1
6971670|NCT01165320|11022534|FG002|Overall Study|Clinical adverse experience|0
6971671|NCT01165320|11022532|FG000|Overall Study|Laboratory adverse experience|1
6971672|NCT01165320|11022533|FG001|Overall Study|Laboratory adverse experience|0
6971673|NCT01165320|11022534|FG002|Overall Study|Laboratory adverse experience|0
7155988|NCT03353220|11324225|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7
7155989|NCT03353740|11324235|FG000|Overall Study|Images for these participants not viable|52
7155990|NCT03354429|11324259|FG000|Overall Study|Withdrawal by Subject|8
7155991|NCT03354429|11324260|FG001|Overall Study|Withdrawal by Subject|7
6971674|NCT01165320|11022532|FG000|Overall Study|Lack of Efficacy|0
6971675|NCT01165320|11022533|FG001|Overall Study|Lack of Efficacy|2
6971676|NCT01165320|11022534|FG002|Overall Study|Lack of Efficacy|0
6971677|NCT01165320|11022532|FG000|Overall Study|Reason unknown|0
6971678|NCT01165320|11022533|FG001|Overall Study|Reason unknown|1
6971679|NCT01165320|11022534|FG002|Overall Study|Reason unknown|0
6971680|NCT01165554|11022546|FG000|Overall Study|Withdrawal by Subject|23
6971681|NCT01165684|11022555|FG000|Overall Study|Adverse Event|1
6971682|NCT01165684|11022556|FG001|Overall Study|Adverse Event|1
6971683|NCT01165684|11022555|FG000|Overall Study|Lack of Efficacy|2
6971684|NCT01165684|11022556|FG001|Overall Study|Lack of Efficacy|1
6971685|NCT01165684|11022555|FG000|Overall Study|Protocol Violation|7
6971686|NCT01165684|11022556|FG001|Overall Study|Protocol Violation|15
6971687|NCT01165684|11022555|FG000|Overall Study|Withdrawal Criteria|2
6971688|NCT01165684|11022556|FG001|Overall Study|Withdrawal Criteria|13
6971689|NCT01165684|11022555|FG000|Overall Study|Unclassified|16
6971690|NCT01165684|11022556|FG001|Overall Study|Unclassified|22
6971691|NCT01165996|11022585|FG000|Overall Study|Death|1
6971692|NCT01165996|11022585|FG000|Overall Study|Physician Decision|1
6971693|NCT01166282|11022609|FG000|Open-label Period|Adverse Event|0
6971694|NCT01166282|11022610|FG001|Open-label Period|Adverse Event|0
6971695|NCT01166282|11022611|FG002|Open-label Period|Adverse Event|6
6971696|NCT01166282|11022609|FG000|Open-label Period|Withdrawal by Subject|0
6971697|NCT01166282|11022610|FG001|Open-label Period|Withdrawal by Subject|0
6971698|NCT01166282|11022611|FG002|Open-label Period|Withdrawal by Subject|4
6971699|NCT01166282|11022609|FG000|Open-label Period|Lack of Efficacy|0
6971700|NCT01166282|11022610|FG001|Open-label Period|Lack of Efficacy|0
6971701|NCT01166282|11022611|FG002|Open-label Period|Lack of Efficacy|2
6971702|NCT01166282|11022609|FG000|Open-label Period|Remission|0
6971703|NCT01166282|11022610|FG001|Open-label Period|Remission|0
6971704|NCT01166282|11022611|FG002|Open-label Period|Remission|4
6971705|NCT01166282|11022609|FG000|Open-label Period|Irregular Compliance|0
6971706|NCT01166282|11022610|FG001|Open-label Period|Irregular Compliance|0
7155992|NCT03354429|11324259|FG000|Overall Study|Lost to Follow-up|1
7155993|NCT03354429|11324260|FG001|Overall Study|Lost to Follow-up|0
7155994|NCT03354637|11324278|FG000|Double-blind Period|Protocol Violation|2
7155995|NCT03354637|11324279|FG001|Double-blind Period|Protocol Violation|0
7155996|NCT03354637|11324280|FG002|Double-blind Period|Protocol Violation|0
7155997|NCT03354637|11324278|FG000|Double-blind Period|Adverse Event|1
7155998|NCT03354637|11324279|FG001|Double-blind Period|Adverse Event|2
7155999|NCT03354637|11324280|FG002|Double-blind Period|Adverse Event|0
7156000|NCT03354637|11324278|FG000|Double-blind Period|Lost to Follow-up|3
7156001|NCT03354637|11324279|FG001|Double-blind Period|Lost to Follow-up|4
7156002|NCT03354637|11324280|FG002|Double-blind Period|Lost to Follow-up|3
7156003|NCT03354637|11324278|FG000|Double-blind Period|Withdrawal by Subject|10
7156004|NCT03354637|11324279|FG001|Double-blind Period|Withdrawal by Subject|6
7156005|NCT03354637|11324280|FG002|Double-blind Period|Withdrawal by Subject|4
7156006|NCT03354637|11324278|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1
7156007|NCT03354637|11324279|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1
7156008|NCT03354637|11324280|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0
7156009|NCT03354637|11324278|FG000|Open Label Extension|Adverse Event|0
6971707|NCT01166282|11022611|FG002|Open-label Period|Irregular Compliance|1
6971708|NCT01166373|11022632|FG000|Overall Study|Lost to Follow-up|3
6971709|NCT01166373|11022633|FG001|Overall Study|Lost to Follow-up|2
6971710|NCT01166373|11022634|FG002|Overall Study|Lost to Follow-up|2
6971711|NCT01166373|11022635|FG003|Overall Study|Lost to Follow-up|2
6971712|NCT01166373|11022632|FG000|Overall Study|Withdrawal by Subject|1
6971713|NCT01166373|11022633|FG001|Overall Study|Withdrawal by Subject|2
6971714|NCT01166373|11022634|FG002|Overall Study|Withdrawal by Subject|2
6971715|NCT01166373|11022635|FG003|Overall Study|Withdrawal by Subject|3
6971716|NCT01166373|11022632|FG000|Overall Study|Physician Decision|1
6971717|NCT01166373|11022633|FG001|Overall Study|Physician Decision|0
6971718|NCT01166373|11022634|FG002|Overall Study|Physician Decision|0
6971719|NCT01166373|11022635|FG003|Overall Study|Physician Decision|0
6971720|NCT01166438|11022649|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8
6971721|NCT01166438|11022650|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4
6971722|NCT01166438|11022649|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0
6971723|NCT01166438|11022650|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4
6971724|NCT01166438|11022649|FG000|Double-blind Phase: 1st 6 Months|Not treated|1
6971725|NCT01166438|11022650|FG001|Double-blind Phase: 1st 6 Months|Not treated|1
6971726|NCT01166438|11022649|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1
6971727|NCT01166438|11022650|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2
6971728|NCT01166438|11022649|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4
6971729|NCT01166438|11022650|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2
6971730|NCT01166438|11022649|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29
6971731|NCT01166438|11022650|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52
6971732|NCT01166568|11022660|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0
6971733|NCT01166568|11022661|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0
6971734|NCT01166568|11022662|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1
6971735|NCT01166568|11022660|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7
6971736|NCT01166568|11022661|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1
6971737|NCT01166568|11022662|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0
6971738|NCT01166568|11022660|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7
7156010|NCT03354637|11324279|FG001|Open Label Extension|Adverse Event|0
7156011|NCT03354637|11324280|FG002|Open Label Extension|Adverse Event|1
7156012|NCT03354637|11324278|FG000|Open Label Extension|Lost to Follow-up|0
7156013|NCT03354637|11324279|FG001|Open Label Extension|Lost to Follow-up|0
7156014|NCT03354637|11324280|FG002|Open Label Extension|Lost to Follow-up|2
7156015|NCT03354637|11324278|FG000|Open Label Extension|Withdrawal by Subject|0
7156016|NCT03354637|11324279|FG001|Open Label Extension|Withdrawal by Subject|0
7156017|NCT03354637|11324280|FG002|Open Label Extension|Withdrawal by Subject|5
7156018|NCT03354637|11324278|FG000|Open Label Extension|Study Terminated by Sponsor|0
7156019|NCT03354637|11324279|FG001|Open Label Extension|Study Terminated by Sponsor|0
7156020|NCT03354637|11324280|FG002|Open Label Extension|Study Terminated by Sponsor|17
7156021|NCT03354637|11324278|FG000|Open Label Extension|Subject Noncompliance|0
7156022|NCT03354637|11324279|FG001|Open Label Extension|Subject Noncompliance|0
7156023|NCT03354637|11324280|FG002|Open Label Extension|Subject Noncompliance|1
7156024|NCT03354637|11324278|FG000|Open Label Extension|Lack of Efficacy|0
7156025|NCT03354637|11324279|FG001|Open Label Extension|Lack of Efficacy|0
7156026|NCT03354637|11324280|FG002|Open Label Extension|Lack of Efficacy|1
7156027|NCT03354637|11324278|FG000|Open Label Extension|Physician Decision|0
7156028|NCT03354637|11324279|FG001|Open Label Extension|Physician Decision|0
7156029|NCT03354637|11324280|FG002|Open Label Extension|Physician Decision|1
7156030|NCT03354663|11324289|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4
7156031|NCT03354663|11324289|FG000|Enrollment to Catheter Insertion|Adverse Event|1
7156032|NCT03354663|11324289|FG000|Completed 30-day Visit|Withdrawal by Subject|1
7156033|NCT03354663|11324289|FG000|Completed 30-day Visit|Missed Visit|1
7156034|NCT03355326|11324308|FG000|Overall Study|Protocol Violation|3
7156035|NCT03355326|11324309|FG001|Overall Study|Protocol Violation|3
7156036|NCT03355742|11324315|FG000|Overall Study|Lost to Follow-up|4
7156037|NCT03355742|11324315|FG000|Overall Study|Withdrawal by Subject|29
7156038|NCT03355742|11324315|FG000|Overall Study|Physician Decision|6
7156039|NCT03355742|11324315|FG000|Overall Study|Death|55
7156040|NCT03355742|11324315|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5
7156041|NCT03356145|11324325|FG000|Overall Study|Withdrawal by Subject|2
7156042|NCT03356145|11324326|FG001|Overall Study|Withdrawal by Subject|1
7156043|NCT03356145|11324325|FG000|Overall Study|Did not meet inclusion criteria|1
7156044|NCT03356145|11324326|FG001|Overall Study|Did not meet inclusion criteria|0
7156045|NCT03356977|11324332|FG000|Overall Study|Lost to Follow-up|3
7156046|NCT03356977|11324332|FG000|Overall Study|Withdrawal by parent/guardian|2
7156047|NCT03357341|11324338|FG000|Overall Study|Withdrawal by Subject|3
7156048|NCT03357341|11324339|FG001|Overall Study|Withdrawal by Subject|6
7156049|NCT03357341|11324338|FG000|Overall Study|Lost to Follow-up|4
7156050|NCT03357341|11324339|FG001|Overall Study|Lost to Follow-up|5
7156051|NCT03357341|11324338|FG000|Overall Study|Death|0
7156052|NCT03357341|11324339|FG001|Overall Study|Death|1
7156053|NCT03357471|11324361|FG000|Overall Study|Adverse Event|1
7156054|NCT03357471|11324362|FG001|Overall Study|Adverse Event|0
6971739|NCT01166568|11022661|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
6971740|NCT01166568|11022662|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1
6971741|NCT01166646|11022670|FG000|Overall Study|Protocol Violation|0
6971742|NCT01166646|11022671|FG001|Overall Study|Protocol Violation|1
6971743|NCT01166646|11022670|FG000|Overall Study|Adverse Event|1
7156055|NCT03357471|11324361|FG000|Overall Study|Lost to Follow-up|1
7156056|NCT03357471|11324362|FG001|Overall Study|Lost to Follow-up|0
6971744|NCT01166646|11022671|FG001|Overall Study|Adverse Event|0
6971745|NCT01166659|11022677|FG000|Overall Study|Subject Decision|8
6971746|NCT01166659|11022677|FG000|Overall Study|Investigator Decision|2
6971747|NCT01166659|11022677|FG000|Overall Study|Death|1
6971748|NCT01166659|11022677|FG000|Overall Study|Lost to Follow-up|1
6971749|NCT01166659|11022677|FG000|Overall Study|Study Closed at Site|1
6971750|NCT01166750|11022684|FG000|Overall Study|Lost to Follow-up|1
6971751|NCT01166750|11022685|FG001|Overall Study|Lost to Follow-up|0
6971752|NCT01166763|11022691|FG000|Overall Study|Withdrawal by Subject|3
6971753|NCT01166945|11022697|FG000|Randomized|diagnosed with Group A strep|4
6971754|NCT01166945|11022698|FG001|Randomized|diagnosed with Group A strep|4
6971755|NCT01166945|11022697|FG000|Day 10|NonCompliance/Lost to Follow Up|3
6971756|NCT01166945|11022698|FG001|Day 10|NonCompliance/Lost to Follow Up|2
6971757|NCT01166945|11022697|FG000|Day 15|NonCompliance/Lost to Follow Up|2
6971758|NCT01166945|11022698|FG001|Day 15|NonCompliance/Lost to Follow Up|1
6971759|NCT01166945|11022697|FG000|Day 30|Lost to Follow-up|4
6971760|NCT01166945|11022698|FG001|Day 30|Lost to Follow-up|3
6971761|NCT01166958|11022708|FG000|Overall Study|Withdrawal by Subject|1
6971762|NCT01166958|11022709|FG001|Overall Study|Withdrawal by Subject|0
6971763|NCT01167023|11022768|FG000|Overall Study|Lost to Follow-up|0
6971764|NCT01167023|11022769|FG001|Overall Study|Lost to Follow-up|1
6971765|NCT01167023|11022770|FG002|Overall Study|Lost to Follow-up|1
6971766|NCT01167023|11022768|FG000|Overall Study|Screen Failure|0
6971767|NCT01167023|11022769|FG001|Overall Study|Screen Failure|1
6971768|NCT01167023|11022770|FG002|Overall Study|Screen Failure|0
6971769|NCT01167023|11022768|FG000|Overall Study|Sponsor Decision|0
6971770|NCT01167023|11022769|FG001|Overall Study|Sponsor Decision|1
6971771|NCT01167023|11022770|FG002|Overall Study|Sponsor Decision|0
6971772|NCT01167023|11022768|FG000|Overall Study|Withdrawal by Subject|0
6971773|NCT01167023|11022769|FG001|Overall Study|Withdrawal by Subject|0
6971774|NCT01167023|11022770|FG002|Overall Study|Withdrawal by Subject|1
6971775|NCT01167140|11022776|FG000|Overall Study|Withdrawal by Subject|1
6971776|NCT01167153|11022782|FG000|Overall Study|Non-effective therapy|1
6971777|NCT01167153|11022783|FG001|Overall Study|Non-effective therapy|4
6971778|NCT01167153|11022782|FG000|Overall Study|AE including clinical laboratory AE|2
6971779|NCT01167153|11022783|FG001|Overall Study|AE including clinical laboratory AE|8
6971780|NCT01167153|11022782|FG000|Overall Study|Hypotension|1
6971781|NCT01167153|11022783|FG001|Overall Study|Hypotension|0
6971782|NCT01167153|11022782|FG000|Overall Study|Lost to Follow-up|7
6971783|NCT01167153|11022783|FG001|Overall Study|Lost to Follow-up|9
6971784|NCT01167153|11022782|FG000|Overall Study|Non-compliance to concomitant medication|0
6971785|NCT01167153|11022783|FG001|Overall Study|Non-compliance to concomitant medication|2
6971786|NCT01167153|11022782|FG000|Overall Study|Investigator initiation withdrawal,Other|1
6971787|NCT01167153|11022783|FG001|Overall Study|Investigator initiation withdrawal,Other|1
6971788|NCT01167153|11022782|FG000|Overall Study|Withdrawal consent|1
6971789|NCT01167153|11022783|FG001|Overall Study|Withdrawal consent|1
6971790|NCT01167153|11022782|FG000|Overall Study|Subject initiation withdrawal, Other|5
6971791|NCT01167153|11022783|FG001|Overall Study|Subject initiation withdrawal, Other|8
6971792|NCT01167179|11022791|FG000|Overall Study|disease recurrence|4
6971793|NCT01167179|11022792|FG001|Overall Study|disease recurrence|4
6971794|NCT01167179|11022791|FG000|Overall Study|Death|4
6971795|NCT01167179|11022792|FG001|Overall Study|Death|10
6971796|NCT01167179|11022791|FG000|Overall Study|Withdrawal by Subject|1
6971797|NCT01167179|11022792|FG001|Overall Study|Withdrawal by Subject|2
6971798|NCT01167179|11022791|FG000|Overall Study|diverse|6
6971799|NCT01167179|11022792|FG001|Overall Study|diverse|5
6971800|NCT01167192|11022798|FG000|Overall Study|Adverse Event|1
6971801|NCT01167192|11022798|FG000|Overall Study|Death|1
6971802|NCT01167192|11022798|FG000|Overall Study|Withdrawal by Subject|1
6971803|NCT01167192|11022798|FG000|Overall Study|Insurance denial|1
6971804|NCT01167257|11022804|FG000|Overall Study|Lost to Follow-up|2
6971805|NCT01167257|11022805|FG001|Overall Study|Lost to Follow-up|2
6971806|NCT01167257|11022804|FG000|Overall Study|Withdrew consent|1
6971807|NCT01167257|11022805|FG001|Overall Study|Withdrew consent|1
6971808|NCT01167426|11022815|FG000|Overall Study|Lost to Follow-up|6
6971809|NCT01167426|11022815|FG000|Overall Study|Protocol Violation|1
6971810|NCT01167426|11022815|FG000|Overall Study|Withdrawal by Subject|2
6971811|NCT01167426|11022815|FG000|Overall Study|Sponsor Decision|1
6971812|NCT01167582|11022842|FG000|Overall Study|Lost to Follow-up|0
6971813|NCT01167582|11022843|FG001|Overall Study|Lost to Follow-up|1
6971814|NCT01167634|11022867|FG000|Overall Study|Lost to Follow-up|1
6971815|NCT01167634|11022868|FG001|Overall Study|Lost to Follow-up|3
6971816|NCT01167634|11022869|FG002|Overall Study|Lost to Follow-up|3
6971817|NCT01167634|11022870|FG003|Overall Study|Lost to Follow-up|4
7079510|NCT02115386|11188730|FG000|Overall Study|Administrative - trial was terminated|6
7079511|NCT02115607|11188747|FG000|Overall Study|Withdrawal by Subject|1
6971818|NCT01167634|11022867|FG000|Overall Study|Withdrawal by Subject|1
6971819|NCT01167634|11022868|FG001|Overall Study|Withdrawal by Subject|1
6971820|NCT01167634|11022869|FG002|Overall Study|Withdrawal by Subject|0
6971821|NCT01167634|11022870|FG003|Overall Study|Withdrawal by Subject|0
6971822|NCT01167881|11022897|FG000|Overall Study|Adverse Event|47
6971823|NCT01167881|11022898|FG001|Overall Study|Adverse Event|51
6971824|NCT01167881|11022897|FG000|Overall Study|Lack of Efficacy|4
6971825|NCT01167881|11022898|FG001|Overall Study|Lack of Efficacy|7
6971826|NCT01167881|11022897|FG000|Overall Study|Non compliant with protocol|9
6971827|NCT01167881|11022898|FG001|Overall Study|Non compliant with protocol|18
6971828|NCT01167881|11022897|FG000|Overall Study|Lost to Follow-up|19
6971829|NCT01167881|11022898|FG001|Overall Study|Lost to Follow-up|20
6971830|NCT01167881|11022897|FG000|Overall Study|Patient refusal to cont., not due to AE|45
6971831|NCT01167881|11022898|FG001|Overall Study|Patient refusal to cont., not due to AE|40
6971832|NCT01167881|11022897|FG000|Overall Study|Not treated|4
6971833|NCT01167881|11022898|FG001|Overall Study|Not treated|0
6971834|NCT01167881|11022897|FG000|Overall Study|Other not defined above|31
6971835|NCT01167881|11022898|FG001|Overall Study|Other not defined above|55
6971836|NCT01167907|11022906|FG000|Overall Study|Protocol Violation|1
6971837|NCT01167907|11022907|FG001|Overall Study|Protocol Violation|0
6971838|NCT01167907|11022906|FG000|Overall Study|saphenous catheter dislodged before comp|1
6971839|NCT01167907|11022907|FG001|Overall Study|saphenous catheter dislodged before comp|1
7156057|NCT03357731|11324377|FG000|Overall Study|Withdrew consent due to personal reasons|0
7156058|NCT03357731|11324378|FG001|Overall Study|Withdrew consent due to personal reasons|0
7156059|NCT03357731|11324379|FG002|Overall Study|Withdrew consent due to personal reasons|0
7156060|NCT03357731|11324380|FG003|Overall Study|Withdrew consent due to personal reasons|0
7156061|NCT03357731|11324381|FG004|Overall Study|Withdrew consent due to personal reasons|1
7156062|NCT03357731|11324382|FG005|Overall Study|Withdrew consent due to personal reasons|0
7156063|NCT03357731|11324377|FG000|Overall Study|Acute bradycardia and hypotension|0
7156064|NCT03357731|11324378|FG001|Overall Study|Acute bradycardia and hypotension|0
7156065|NCT03357731|11324379|FG002|Overall Study|Acute bradycardia and hypotension|0
7156066|NCT03357731|11324380|FG003|Overall Study|Acute bradycardia and hypotension|1
7156067|NCT03357731|11324381|FG004|Overall Study|Acute bradycardia and hypotension|0
7156068|NCT03357731|11324382|FG005|Overall Study|Acute bradycardia and hypotension|0
7156069|NCT03357731|11324377|FG000|Overall Study|Adverse Event|0
7156070|NCT03357731|11324378|FG001|Overall Study|Adverse Event|0
7156071|NCT03357731|11324379|FG002|Overall Study|Adverse Event|0
7156072|NCT03357731|11324380|FG003|Overall Study|Adverse Event|0
7156073|NCT03357731|11324381|FG004|Overall Study|Adverse Event|0
7156074|NCT03357731|11324382|FG005|Overall Study|Adverse Event|1
7156075|NCT03357731|11324377|FG000|Overall Study|Hypotension|0
7156076|NCT03357731|11324378|FG001|Overall Study|Hypotension|0
7156077|NCT03357731|11324379|FG002|Overall Study|Hypotension|1
7156078|NCT03357731|11324380|FG003|Overall Study|Hypotension|1
6894719|NCT00621244|10912439|FG002|Overall Study|Death|1
6894720|NCT00621244|10912440|FG003|Overall Study|Death|1
6894721|NCT00621244|10912437|FG000|Overall Study|Adverse Event|27
6894722|NCT00621244|10912438|FG001|Overall Study|Adverse Event|7
6894723|NCT00621244|10912439|FG002|Overall Study|Adverse Event|9
6894724|NCT00621244|10912440|FG003|Overall Study|Adverse Event|2
7156079|NCT03357731|11324381|FG004|Overall Study|Hypotension|0
7156080|NCT03357731|11324382|FG005|Overall Study|Hypotension|0
7156081|NCT03357731|11324377|FG000|Overall Study|Lost to Follow-up|0
7156082|NCT03357731|11324378|FG001|Overall Study|Lost to Follow-up|0
7156083|NCT03357731|11324379|FG002|Overall Study|Lost to Follow-up|0
7156084|NCT03357731|11324380|FG003|Overall Study|Lost to Follow-up|1
7156085|NCT03357731|11324381|FG004|Overall Study|Lost to Follow-up|0
7156086|NCT03357731|11324382|FG005|Overall Study|Lost to Follow-up|0
7156087|NCT03358147|11324395|FG000|Overall Study|Withdrawal by Subject|13
7156088|NCT03358147|11324396|FG001|Overall Study|Withdrawal by Subject|19
7156089|NCT03358147|11324397|FG002|Overall Study|Withdrawal by Subject|16
7156090|NCT03358147|11324398|FG003|Overall Study|Withdrawal by Subject|10
7156091|NCT03358147|11324399|FG004|Overall Study|Withdrawal by Subject|5
7156092|NCT03358147|11324395|FG000|Overall Study|Adverse Event|3
7156093|NCT03358147|11324396|FG001|Overall Study|Adverse Event|9
7156094|NCT03358147|11324397|FG002|Overall Study|Adverse Event|7
7156095|NCT03358147|11324398|FG003|Overall Study|Adverse Event|5
7156096|NCT03358147|11324399|FG004|Overall Study|Adverse Event|2
7156097|NCT03358147|11324395|FG000|Overall Study|Lost to Follow-up|4
7156098|NCT03358147|11324396|FG001|Overall Study|Lost to Follow-up|3
7156099|NCT03358147|11324397|FG002|Overall Study|Lost to Follow-up|7
7156100|NCT03358147|11324398|FG003|Overall Study|Lost to Follow-up|6
7156101|NCT03358147|11324399|FG004|Overall Study|Lost to Follow-up|4
7156102|NCT03358147|11324395|FG000|Overall Study|Major Protocol Deviation|11
7156103|NCT03358147|11324396|FG001|Overall Study|Major Protocol Deviation|3
7156104|NCT03358147|11324397|FG002|Overall Study|Major Protocol Deviation|2
7156105|NCT03358147|11324398|FG003|Overall Study|Major Protocol Deviation|3
7156106|NCT03358147|11324399|FG004|Overall Study|Major Protocol Deviation|1
7156107|NCT03358147|11324395|FG000|Overall Study|Protocol specified criteria|2
7156108|NCT03358147|11324396|FG001|Overall Study|Protocol specified criteria|3
7156109|NCT03358147|11324397|FG002|Overall Study|Protocol specified criteria|0
7156110|NCT03358147|11324398|FG003|Overall Study|Protocol specified criteria|3
7156111|NCT03358147|11324399|FG004|Overall Study|Protocol specified criteria|1
7156112|NCT03358147|11324395|FG000|Overall Study|Physician Decision|1
6894725|NCT00621244|10912437|FG000|Overall Study|Administrative problems|5
6894726|NCT00621244|10912438|FG001|Overall Study|Administrative problems|1
6894727|NCT00621244|10912439|FG002|Overall Study|Administrative problems|0
6894728|NCT00621244|10912440|FG003|Overall Study|Administrative problems|2
6971840|NCT01168232|11022922|FG000|Overall Study|Ineligible-Second primary cancer site|1
7156113|NCT03358147|11324396|FG001|Overall Study|Physician Decision|0
7156114|NCT03358147|11324397|FG002|Overall Study|Physician Decision|1
6971841|NCT01168232|11022922|FG000|Overall Study|Ineligible- Wrong cell type|6
6971842|NCT01168232|11022922|FG000|Overall Study|Ineligible-Inadequate pathology|1
6971843|NCT01168349|11022926|FG000|Overall Study|Death|157
6971844|NCT01168349|11022926|FG000|Overall Study|Lost to Follow-up|34
6971845|NCT01168349|11022926|FG000|Overall Study|Withdrawal by Subject|9
6971846|NCT01168349|11022926|FG000|Overall Study|Kidney transplantation|3
6971847|NCT01168349|11022926|FG000|Overall Study|Other|22
6971848|NCT01168349|11022926|FG000|Overall Study|Protocol Violation|76
6971849|NCT01168401|11022957|FG000|Overall Study|Lost to Follow-up|1
6971850|NCT01168401|11022958|FG001|Overall Study|Lost to Follow-up|1
6971851|NCT01168401|11022959|FG002|Overall Study|Lost to Follow-up|2
6971852|NCT01168401|11022960|FG003|Overall Study|Lost to Follow-up|1
6971853|NCT01168401|11022961|FG004|Overall Study|Lost to Follow-up|0
6971854|NCT01168401|11022962|FG005|Overall Study|Lost to Follow-up|0
6971855|NCT01168401|11022963|FG006|Overall Study|Lost to Follow-up|0
6971856|NCT01168401|11022964|FG007|Overall Study|Lost to Follow-up|0
6971857|NCT01168401|11022965|FG008|Overall Study|Lost to Follow-up|0
6971858|NCT01168401|11022966|FG009|Overall Study|Lost to Follow-up|0
6971859|NCT01168401|11022967|FG010|Overall Study|Lost to Follow-up|0
6971860|NCT01168401|11022957|FG000|Overall Study|Withdrawal by Subject|0
6971861|NCT01168401|11022958|FG001|Overall Study|Withdrawal by Subject|0
6971862|NCT01168401|11022959|FG002|Overall Study|Withdrawal by Subject|0
6971863|NCT01168401|11022960|FG003|Overall Study|Withdrawal by Subject|1
6971864|NCT01168401|11022961|FG004|Overall Study|Withdrawal by Subject|0
6971865|NCT01168401|11022962|FG005|Overall Study|Withdrawal by Subject|0
6971866|NCT01168401|11022963|FG006|Overall Study|Withdrawal by Subject|0
6971867|NCT01168401|11022964|FG007|Overall Study|Withdrawal by Subject|0
6971868|NCT01168401|11022965|FG008|Overall Study|Withdrawal by Subject|0
6971869|NCT01168401|11022966|FG009|Overall Study|Withdrawal by Subject|0
6971870|NCT01168401|11022967|FG010|Overall Study|Withdrawal by Subject|0
6971871|NCT01168427|11022991|FG000|Overall Study|Patient exited prior to implant|1
6971872|NCT01168596|11022997|FG000|Overall Study|Withdrawal by Subject|3
6971873|NCT01168596|11022998|FG001|Overall Study|Withdrawal by Subject|1
6971874|NCT01168856|11023036|FG000|Overall Study|Lost to Follow-up|4
6971875|NCT01168856|11023037|FG001|Overall Study|Lost to Follow-up|34
6971876|NCT01168856|11023036|FG000|Overall Study|Withdrawal by Subject|6
6971877|NCT01168856|11023037|FG001|Overall Study|Withdrawal by Subject|8
6971878|NCT01168856|11023036|FG000|Overall Study|Physician Decision|2
6971879|NCT01168856|11023037|FG001|Overall Study|Physician Decision|1
6971880|NCT01168856|11023036|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0
6971881|NCT01168856|11023037|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1
6971882|NCT01168856|11023036|FG000|Overall Study|Participant received anti-HCV treatment|1
6971883|NCT01168856|11023037|FG001|Overall Study|Participant received anti-HCV treatment|0
6971884|NCT01168856|11023036|FG000|Overall Study|Death|0
6971885|NCT01168856|11023037|FG001|Overall Study|Death|2
6971886|NCT01168856|11023036|FG000|Overall Study|Other|1
6971887|NCT01168856|11023037|FG001|Overall Study|Other|291
6971888|NCT01168856|11023036|FG000|Overall Study|Protocol Violation|4
6971889|NCT01168856|11023037|FG001|Overall Study|Protocol Violation|6
6971890|NCT01168973|11023067|FG000|Overall Study|Progressive Disease|341
6971891|NCT01168973|11023068|FG001|Overall Study|Progressive Disease|429
6971892|NCT01168973|11023067|FG000|Overall Study|Adverse Event|94
6971893|NCT01168973|11023068|FG001|Overall Study|Adverse Event|55
6971894|NCT01168973|11023067|FG000|Overall Study|Withdrawal by Subject|90
6971895|NCT01168973|11023068|FG001|Overall Study|Withdrawal by Subject|53
6971896|NCT01168973|11023067|FG000|Overall Study|Death|42
6971897|NCT01168973|11023068|FG001|Overall Study|Death|45
6971898|NCT01168973|11023067|FG000|Overall Study|Physician Decision|37
6971899|NCT01168973|11023068|FG001|Overall Study|Physician Decision|19
6971900|NCT01168973|11023067|FG000|Overall Study|Sponsor Decision|2
6971901|NCT01168973|11023068|FG001|Overall Study|Sponsor Decision|1
6971902|NCT01168973|11023067|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7
6971903|NCT01168973|11023068|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9
6971904|NCT01168999|11023091|FG000|Overall Study|Lost to Follow-up|2
6971905|NCT01168999|11023092|FG001|Overall Study|Lost to Follow-up|1
6971906|NCT01168999|11023093|FG002|Overall Study|Lost to Follow-up|0
6971907|NCT01168999|11023094|FG003|Overall Study|Lost to Follow-up|0
6971908|NCT01169038|11023104|FG000|Overall Study|Death|1
6971909|NCT01169038|11023104|FG000|Overall Study|Adverse Event|5
7156115|NCT03358147|11324398|FG003|Overall Study|Physician Decision|6
7156116|NCT03358147|11324399|FG004|Overall Study|Physician Decision|1
7156117|NCT03358147|11324395|FG000|Overall Study|Administrative reasons|0
7156118|NCT03358147|11324396|FG001|Overall Study|Administrative reasons|1
7156119|NCT03358147|11324397|FG002|Overall Study|Administrative reasons|0
6971910|NCT01169038|11023104|FG000|Overall Study|Required antibiotic administration|1
6971911|NCT01169103|11023121|FG000|Overall Study|Lost to Follow-up|3
6971912|NCT01169103|11023122|FG001|Overall Study|Lost to Follow-up|3
6971913|NCT01169103|11023121|FG000|Overall Study|Withdrawal by Subject|3
6971914|NCT01169103|11023122|FG001|Overall Study|Withdrawal by Subject|1
6971915|NCT01169337|11023136|FG000|Overall Study|Lack of Efficacy|5
6971916|NCT01169337|11023137|FG001|Overall Study|Lack of Efficacy|7
6971917|NCT01169337|11023138|FG002|Overall Study|Lack of Efficacy|0
6971918|NCT01169337|11023136|FG000|Overall Study|Adverse Event|12
6971919|NCT01169337|11023137|FG001|Overall Study|Adverse Event|18
7156120|NCT03358147|11324398|FG003|Overall Study|Administrative reasons|3
6971920|NCT01169337|11023138|FG002|Overall Study|Adverse Event|0
6971921|NCT01169337|11023136|FG000|Overall Study|Death|2
6971922|NCT01169337|11023137|FG001|Overall Study|Death|0
6971923|NCT01169337|11023138|FG002|Overall Study|Death|0
6971924|NCT01169337|11023136|FG000|Overall Study|Withdrawal by Subject|11
6971925|NCT01169337|11023137|FG001|Overall Study|Withdrawal by Subject|11
6971926|NCT01169337|11023138|FG002|Overall Study|Withdrawal by Subject|6
6971927|NCT01169337|11023136|FG000|Overall Study|Noncompliance|2
6971928|NCT01169337|11023137|FG001|Overall Study|Noncompliance|0
6971929|NCT01169337|11023138|FG002|Overall Study|Noncompliance|0
6971930|NCT01169337|11023136|FG000|Overall Study|Other complicating disease|1
6971931|NCT01169337|11023137|FG001|Overall Study|Other complicating disease|1
6971932|NCT01169337|11023138|FG002|Overall Study|Other complicating disease|0
6971933|NCT01169337|11023136|FG000|Overall Study|Physician Decision|1
6971934|NCT01169337|11023137|FG001|Overall Study|Physician Decision|5
6971935|NCT01169337|11023138|FG002|Overall Study|Physician Decision|0
6971936|NCT01169337|11023136|FG000|Overall Study|Alternative therapy|0
6971937|NCT01169337|11023137|FG001|Overall Study|Alternative therapy|2
6971938|NCT01169337|11023138|FG002|Overall Study|Alternative therapy|0
6971939|NCT01169337|11023136|FG000|Overall Study|Changed hospital|0
6971940|NCT01169337|11023137|FG001|Overall Study|Changed hospital|1
6971941|NCT01169337|11023138|FG002|Overall Study|Changed hospital|0
6971942|NCT01169337|11023136|FG000|Overall Study|Never started treatment|0
6971943|NCT01169337|11023137|FG001|Overall Study|Never started treatment|2
6971944|NCT01169337|11023138|FG002|Overall Study|Never started treatment|0
6971945|NCT01169337|11023136|FG000|Overall Study|Reason not reported|1
6971946|NCT01169337|11023137|FG001|Overall Study|Reason not reported|0
6971947|NCT01169337|11023138|FG002|Overall Study|Reason not reported|0
6971948|NCT01169337|11023136|FG000|Overall Study|Continuing lenalidomide|9
6971949|NCT01169337|11023137|FG001|Overall Study|Continuing lenalidomide|43
6971950|NCT01169337|11023138|FG002|Overall Study|Continuing lenalidomide|0
6971951|NCT01169350|11023146|FG000|Overall Study|Physician Decision|3
6971952|NCT01169350|11023146|FG000|Overall Study|Lost to Follow-up|2
6971953|NCT01169493|11023165|FG000|Period 1 (6 Months)|Withdrawal by Subject|0
6971954|NCT01169493|11023166|FG001|Period 1 (6 Months)|Withdrawal by Subject|1
6971955|NCT01169493|11023167|FG002|Period 1 (6 Months)|Withdrawal by Subject|2
6971956|NCT01169493|11023168|FG003|Period 1 (6 Months)|Withdrawal by Subject|0
6971957|NCT01169493|11023169|FG004|Period 1 (6 Months)|Withdrawal by Subject|0
6971958|NCT01169493|11023170|FG005|Period 1 (6 Months)|Withdrawal by Subject|3
6971959|NCT01169493|11023165|FG000|Period 3 (6 Months)|Adverse Event|0
6971960|NCT01169493|11023166|FG001|Period 3 (6 Months)|Adverse Event|1
6971961|NCT01169493|11023167|FG002|Period 3 (6 Months)|Adverse Event|0
6971962|NCT01169493|11023168|FG003|Period 3 (6 Months)|Adverse Event|0
6971963|NCT01169493|11023169|FG004|Period 3 (6 Months)|Adverse Event|0
6971964|NCT01169493|11023170|FG005|Period 3 (6 Months)|Adverse Event|0
6971965|NCT01169493|11023165|FG000|Period 3 (6 Months)|Physician Decision|0
6971966|NCT01169493|11023166|FG001|Period 3 (6 Months)|Physician Decision|1
6971967|NCT01169493|11023167|FG002|Period 3 (6 Months)|Physician Decision|1
6971968|NCT01169493|11023168|FG003|Period 3 (6 Months)|Physician Decision|0
6971969|NCT01169493|11023169|FG004|Period 3 (6 Months)|Physician Decision|0
6971970|NCT01169493|11023170|FG005|Period 3 (6 Months)|Physician Decision|0
6971971|NCT01169532|11023190|FG000|Overall Study|Withdrawal by Subject|1
6971972|NCT01169558|11023194|FG000|Overall Study|Disease progression|98
6971973|NCT01169558|11023194|FG000|Overall Study|Adverse Event|25
6971974|NCT01169558|11023194|FG000|Overall Study|Withdrawal of Consent|8
6971975|NCT01169558|11023194|FG000|Overall Study|Medical Decision|7
6971976|NCT01169558|11023194|FG000|Overall Study|Stable Disease|4
6971977|NCT01169558|11023194|FG000|Overall Study|Lost to Follow-up|4
6971978|NCT01169558|11023194|FG000|Overall Study|Need for Surgery|4
6971979|NCT01169558|11023194|FG000|Overall Study|Non-compliance|2
6971980|NCT01169558|11023194|FG000|Overall Study|Protocol Violation|2
6971981|NCT01169558|11023194|FG000|Overall Study|Partial response|2
6971982|NCT01169636|11023203|FG000|Overall Study|Adverse Event|0
6971983|NCT01169636|11023204|FG001|Overall Study|Adverse Event|0
6971984|NCT01169636|11023205|FG002|Overall Study|Adverse Event|1
6971985|NCT01169636|11023206|FG003|Overall Study|Adverse Event|1
6971986|NCT01169636|11023207|FG004|Overall Study|Adverse Event|0
6971987|NCT01169636|11023203|FG000|Overall Study|Screen failure|0
6971988|NCT01169636|11023204|FG001|Overall Study|Screen failure|0
6971989|NCT01169636|11023205|FG002|Overall Study|Screen failure|2
6971990|NCT01169636|11023206|FG003|Overall Study|Screen failure|0
6971991|NCT01169636|11023207|FG004|Overall Study|Screen failure|0
6971992|NCT01169636|11023203|FG000|Overall Study|Withdrawal by Subject|0
6971993|NCT01169636|11023204|FG001|Overall Study|Withdrawal by Subject|0
6971994|NCT01169636|11023205|FG002|Overall Study|Withdrawal by Subject|0
6971995|NCT01169636|11023206|FG003|Overall Study|Withdrawal by Subject|0
6971996|NCT01169636|11023207|FG004|Overall Study|Withdrawal by Subject|3
6971997|NCT01169649|11023217|FG000|Overall Study|Patient Not Treated|3
6971998|NCT01169675|11023226|FG000|Overall Study|Progressive disease|13
6971999|NCT01169675|11023227|FG001|Overall Study|Progressive disease|2
6972000|NCT01169675|11023228|FG002|Overall Study|Progressive disease|5
6972001|NCT01169675|11023229|FG003|Overall Study|Progressive disease|15
6972002|NCT01169675|11023230|FG004|Overall Study|Progressive disease|1
6972003|NCT01169675|11023226|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1
6972004|NCT01169675|11023227|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0
6972005|NCT01169675|11023228|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0
6972006|NCT01169675|11023229|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0
6972007|NCT01169675|11023230|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2
6972008|NCT01169675|11023226|FG000|Overall Study|Adverse Event|5
6972009|NCT01169675|11023227|FG001|Overall Study|Adverse Event|1
6972010|NCT01169675|11023228|FG002|Overall Study|Adverse Event|2
6972011|NCT01169675|11023229|FG003|Overall Study|Adverse Event|0
6972012|NCT01169675|11023230|FG004|Overall Study|Adverse Event|0
6972013|NCT01169675|11023226|FG000|Overall Study|Withdrawal by Subject|1
6972014|NCT01169675|11023227|FG001|Overall Study|Withdrawal by Subject|0
6972015|NCT01169675|11023228|FG002|Overall Study|Withdrawal by Subject|0
6972016|NCT01169675|11023229|FG003|Overall Study|Withdrawal by Subject|1
6972017|NCT01169675|11023230|FG004|Overall Study|Withdrawal by Subject|2
6972018|NCT01169675|11023226|FG000|Overall Study|Other Reason Not Defined Above|0
6972019|NCT01169675|11023227|FG001|Overall Study|Other Reason Not Defined Above|0
6972020|NCT01169675|11023228|FG002|Overall Study|Other Reason Not Defined Above|0
6972021|NCT01169675|11023229|FG003|Overall Study|Other Reason Not Defined Above|1
6972022|NCT01169675|11023230|FG004|Overall Study|Other Reason Not Defined Above|1
6972023|NCT01169701|11023244|FG000|Overall Study|Lost to Follow-up|1
6972024|NCT01169701|11023245|FG001|Overall Study|Lost to Follow-up|1
6972025|NCT01169701|11023244|FG000|Overall Study|Withdrawal by Subject|1
6972026|NCT01169701|11023245|FG001|Overall Study|Withdrawal by Subject|3
6972027|NCT01169701|11023244|FG000|Overall Study|Adverse Event|1
6972028|NCT01169701|11023245|FG001|Overall Study|Adverse Event|2
6972029|NCT01169701|11023244|FG000|Overall Study|Exclusion criteria|2
6972030|NCT01169701|11023245|FG001|Overall Study|Exclusion criteria|0
6972031|NCT01169701|11023244|FG000|Overall Study|Death|0
6972032|NCT01169701|11023245|FG001|Overall Study|Death|1
6972033|NCT01169701|11023244|FG000|Overall Study|Administrative problems|0
6972034|NCT01169701|11023245|FG001|Overall Study|Administrative problems|1
6972035|NCT01169701|11023244|FG000|Overall Study|Serious adverse event|0
6972036|NCT01169701|11023245|FG001|Overall Study|Serious adverse event|1
6972037|NCT01169701|11023244|FG000|Overall Study|Sponsor decision|0
6972038|NCT01169701|11023245|FG001|Overall Study|Sponsor decision|1
6972039|NCT01169779|11023253|FG000|Overall Study|Adverse Event|3
6972040|NCT01169779|11023254|FG001|Overall Study|Adverse Event|11
6972041|NCT01169779|11023253|FG000|Overall Study|Lack of Efficacy|1
6972042|NCT01169779|11023254|FG001|Overall Study|Lack of Efficacy|0
6972043|NCT01169779|11023253|FG000|Overall Study|Protocol Violation|1
6972044|NCT01169779|11023254|FG001|Overall Study|Protocol Violation|1
6972045|NCT01169779|11023253|FG000|Overall Study|Withdrawal by Subject|3
6972046|NCT01169779|11023254|FG001|Overall Study|Withdrawal by Subject|2
6972047|NCT01169779|11023253|FG000|Overall Study|Familial and personal reasons|3
6972048|NCT01169779|11023254|FG001|Overall Study|Familial and personal reasons|3
6972049|NCT01169844|11023262|FG000|Overall Study|Adverse Event|0
6972050|NCT01169844|11023263|FG001|Overall Study|Adverse Event|1
6972051|NCT01169844|11023262|FG000|Overall Study|Patient withdrew consent|4
6972052|NCT01169844|11023263|FG001|Overall Study|Patient withdrew consent|0
6972053|NCT01169844|11023262|FG000|Overall Study|Unsatisfactory therapeutic effect|1
6972054|NCT01169844|11023263|FG001|Overall Study|Unsatisfactory therapeutic effect|0
6972055|NCT01169987|11023269|FG000|Overall Study|Withdrawal by Subject|3
6972056|NCT01169987|11023269|FG000|Overall Study|Lost to Follow-up|24
6972057|NCT01169987|11023269|FG000|Overall Study|Other|4
6972058|NCT01170039|11023281|FG000|Overall Study|Withdrawal by Subject|5
6972059|NCT01170039|11023282|FG001|Overall Study|Withdrawal by Subject|3
6972060|NCT01170039|11023281|FG000|Overall Study|Lack of funding, drug not available|3
6972061|NCT01170039|11023282|FG001|Overall Study|Lack of funding, drug not available|3
6972062|NCT01170065|11023291|FG000|Overall Study|Adverse Event|17
6972063|NCT01170065|11023292|FG001|Overall Study|Adverse Event|50
6972064|NCT01170065|11023293|FG002|Overall Study|Adverse Event|10
6972065|NCT01170065|11023291|FG000|Overall Study|Lost to Follow-up|1
6972066|NCT01170065|11023292|FG001|Overall Study|Lost to Follow-up|4
6972067|NCT01170065|11023293|FG002|Overall Study|Lost to Follow-up|1
6972068|NCT01170065|11023291|FG000|Overall Study|Consent withdrawn, not due to AE|2
6972069|NCT01170065|11023292|FG001|Overall Study|Consent withdrawn, not due to AE|4
6972070|NCT01170065|11023293|FG002|Overall Study|Consent withdrawn, not due to AE|2
6972071|NCT01170065|11023291|FG000|Overall Study|Reason other than specified|3
6972072|NCT01170065|11023292|FG001|Overall Study|Reason other than specified|8
6972073|NCT01170065|11023293|FG002|Overall Study|Reason other than specified|3
6972074|NCT01170065|11023291|FG000|Overall Study|Ongoing after planned observation time|5
6972075|NCT01170065|11023292|FG001|Overall Study|Ongoing after planned observation time|26
6972076|NCT01170065|11023293|FG002|Overall Study|Ongoing after planned observation time|10
6972077|NCT01170091|11023301|FG000|Overall Study|Missing efficacy evaluation|3
6972078|NCT01170091|11023301|FG000|Overall Study|Treatment duration is less than 4 weeks|21
6972079|NCT01170208|11023317|FG000|Overall Study|Withdrawal by Subject|5
6972080|NCT01170208|11023318|FG001|Overall Study|Withdrawal by Subject|0
6972081|NCT01170208|11023319|FG002|Overall Study|Withdrawal by Subject|1
6972082|NCT01170208|11023317|FG000|Overall Study|Protocol Violation|1
6972083|NCT01170208|11023318|FG001|Overall Study|Protocol Violation|0
6972084|NCT01170208|11023319|FG002|Overall Study|Protocol Violation|1
6972085|NCT01170221|11023332|FG000|Overall Study|Lost to Follow-up|22
6972086|NCT01170221|11023333|FG001|Overall Study|Lost to Follow-up|21
6972087|NCT01170221|11023332|FG000|Overall Study|Withdrawal by Subject|9
6972088|NCT01170221|11023333|FG001|Overall Study|Withdrawal by Subject|7
6972089|NCT01170221|11023332|FG000|Overall Study|Subject completed only screening and LFU|1
6972090|NCT01170221|11023333|FG001|Overall Study|Subject completed only screening and LFU|0
6972091|NCT01170221|11023332|FG000|Overall Study|Randomized but not treated|1
6972092|NCT01170221|11023333|FG001|Overall Study|Randomized but not treated|0
6977045|NCT01204294|11029996|FG005|Overall Study|Other (house moving)|0
6977046|NCT01204294|11029997|FG006|Overall Study|Other (house moving)|0
6977047|NCT01204398|11030013|FG000|Overall Study|Adverse Event|1
6977048|NCT01204658|11030021|FG000|Primary Phase|Adverse Event|0
6977049|NCT01204658|11030022|FG001|Primary Phase|Adverse Event|0
6977050|NCT01204658|11030023|FG002|Primary Phase|Adverse Event|1
6977051|NCT01204658|11030024|FG003|Primary Phase|Adverse Event|0
6977052|NCT01204671|11030042|FG000|Overall Study|Adverse Event|4
6977053|NCT01204671|11030043|FG001|Overall Study|Adverse Event|3
6977054|NCT01204671|11030044|FG002|Overall Study|Adverse Event|3
6977055|NCT01204671|11030045|FG003|Overall Study|Adverse Event|3
6977056|NCT01204671|11030046|FG004|Overall Study|Adverse Event|1
6977057|NCT01204671|11030042|FG000|Overall Study|Withdrawal by Subject|2
6977058|NCT01204671|11030043|FG001|Overall Study|Withdrawal by Subject|3
6977059|NCT01204671|11030044|FG002|Overall Study|Withdrawal by Subject|4
6977060|NCT01204671|11030045|FG003|Overall Study|Withdrawal by Subject|5
6977061|NCT01204671|11030046|FG004|Overall Study|Withdrawal by Subject|3
6977062|NCT01204671|11030042|FG000|Overall Study|Lost to Follow-up|7
6977063|NCT01204671|11030043|FG001|Overall Study|Lost to Follow-up|8
6977064|NCT01204671|11030044|FG002|Overall Study|Lost to Follow-up|6
6977065|NCT01204671|11030045|FG003|Overall Study|Lost to Follow-up|4
6977066|NCT01204671|11030046|FG004|Overall Study|Lost to Follow-up|0
6977067|NCT01204671|11030042|FG000|Overall Study|Unknown Completion Status|1
6977068|NCT01204671|11030043|FG001|Overall Study|Unknown Completion Status|1
6977069|NCT01204671|11030044|FG002|Overall Study|Unknown Completion Status|0
6977070|NCT01204671|11030045|FG003|Overall Study|Unknown Completion Status|0
6977071|NCT01204671|11030046|FG004|Overall Study|Unknown Completion Status|0
7156121|NCT03358147|11324399|FG004|Overall Study|Administrative reasons|0
7156122|NCT03358147|11324395|FG000|Overall Study|Lack of Efficacy|0
7156123|NCT03358147|11324396|FG001|Overall Study|Lack of Efficacy|1
7156124|NCT03358147|11324397|FG002|Overall Study|Lack of Efficacy|1
7156125|NCT03358147|11324398|FG003|Overall Study|Lack of Efficacy|0
7156126|NCT03358147|11324399|FG004|Overall Study|Lack of Efficacy|0
7156127|NCT03358238|11324413|FG000|Overall Study|Withdrawal by Subject|0
7156128|NCT03358238|11324414|FG001|Overall Study|Withdrawal by Subject|1
7156129|NCT03358290|11324436|FG000|Overall Study|Study discontinued by Sponsor|0
7156130|NCT03358290|11324437|FG001|Overall Study|Study discontinued by Sponsor|1
7156131|NCT03358290|11324438|FG002|Overall Study|Study discontinued by Sponsor|1
7156132|NCT03358290|11324439|FG003|Overall Study|Study discontinued by Sponsor|0
7156133|NCT03358290|11324440|FG004|Overall Study|Study discontinued by Sponsor|0
7156134|NCT03358290|11324436|FG000|Overall Study|Adverse Event|0
7156135|NCT03358290|11324437|FG001|Overall Study|Adverse Event|0
7156136|NCT03358290|11324438|FG002|Overall Study|Adverse Event|1
7156137|NCT03358290|11324439|FG003|Overall Study|Adverse Event|2
7156138|NCT03358290|11324440|FG004|Overall Study|Adverse Event|0
7156139|NCT03358290|11324436|FG000|Overall Study|Withdrawal by Subject|0
7156140|NCT03358290|11324437|FG001|Overall Study|Withdrawal by Subject|0
7156141|NCT03358290|11324438|FG002|Overall Study|Withdrawal by Subject|0
7156142|NCT03358290|11324439|FG003|Overall Study|Withdrawal by Subject|0
7156143|NCT03358290|11324440|FG004|Overall Study|Withdrawal by Subject|1
7156144|NCT03358329|11324452|FG000|Overall Study|Lost to Follow-up|2
7156145|NCT03358329|11324452|FG000|Overall Study|Withdrawal by Subject|2
7156146|NCT03358407|11324477|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
7156147|NCT03358407|11324478|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
7156148|NCT03358407|11324479|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1
7156149|NCT03358407|11324480|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
7156150|NCT03358407|11324481|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
7156151|NCT03358407|11324482|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
7156152|NCT03358407|11324483|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
7156153|NCT03358407|11324484|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
6977072|NCT01204671|11030042|FG000|Overall Study|Physician Decision|0
6977073|NCT01204671|11030043|FG001|Overall Study|Physician Decision|0
6977074|NCT01204671|11030044|FG002|Overall Study|Physician Decision|0
6977075|NCT01204671|11030045|FG003|Overall Study|Physician Decision|1
6977076|NCT01204671|11030046|FG004|Overall Study|Physician Decision|0
6977077|NCT01204697|11030064|FG000|Overall Study|Death|26
6977078|NCT01204697|11030065|FG001|Overall Study|Death|27
6977079|NCT01204697|11030064|FG000|Overall Study|Lost to Follow-up|3
6977080|NCT01204697|11030065|FG001|Overall Study|Lost to Follow-up|4
6977081|NCT01204697|11030064|FG000|Overall Study|Withdrawal by Subject|2
7156154|NCT03358407|11324485|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
7156155|NCT03358407|11324486|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
6977082|NCT01204697|11030065|FG001|Overall Study|Withdrawal by Subject|4
6977083|NCT01204697|11030064|FG000|Overall Study|Randomized, but not treated|0
6977084|NCT01204697|11030065|FG001|Overall Study|Randomized, but not treated|1
6977085|NCT01204710|11030073|FG000|Randomization Treatment|Lost to Follow-up|1
6972093|NCT01170273|11023350|FG000|Overall Study|Lost to Follow-up|6
6972094|NCT01170273|11023351|FG001|Overall Study|Lost to Follow-up|8
7156156|NCT03358407|11324477|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
7156157|NCT03358407|11324478|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
7156158|NCT03358407|11324479|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
7156159|NCT03358407|11324480|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
7156160|NCT03358407|11324481|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1
7156161|NCT03358407|11324482|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
7156162|NCT03358407|11324483|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
7079512|NCT02115815|11188790|FG000|Overall Study|Withdrawal by Subject|2
7079513|NCT02115815|11188791|FG001|Overall Study|Withdrawal by Subject|0
7079514|NCT02115815|11188792|FG002|Overall Study|Withdrawal by Subject|0
7156163|NCT03358407|11324484|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
7156164|NCT03358407|11324485|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
7156165|NCT03358407|11324486|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
7156166|NCT03358407|11324477|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
7156167|NCT03358407|11324478|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
7156168|NCT03358407|11324479|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
7156169|NCT03358407|11324480|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
7156170|NCT03358407|11324481|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
7156171|NCT03358407|11324482|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1
7156172|NCT03358407|11324483|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
7156173|NCT03358407|11324484|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2
7156174|NCT03358407|11324485|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
7156175|NCT03358407|11324486|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
7156176|NCT03358407|11324477|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
7156177|NCT03358407|11324478|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
7156178|NCT03358407|11324479|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
7156179|NCT03358407|11324480|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
7156180|NCT03358407|11324481|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
7156181|NCT03358407|11324482|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1
7156182|NCT03358407|11324483|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
7156183|NCT03358407|11324484|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1
7156184|NCT03358407|11324485|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
7156185|NCT03358407|11324486|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
7156186|NCT03358407|11324477|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
7156187|NCT03358407|11324478|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
7156188|NCT03358407|11324479|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
7156189|NCT03358407|11324480|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
7156190|NCT03358407|11324481|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
7156191|NCT03358407|11324482|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1
7156192|NCT03358407|11324483|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1
7156193|NCT03358407|11324484|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
7156194|NCT03358407|11324485|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
7156195|NCT03358407|11324486|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
7156196|NCT03358407|11324477|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
7156197|NCT03358407|11324478|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
7156198|NCT03358407|11324479|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
7156199|NCT03358407|11324480|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
7156200|NCT03358407|11324481|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
7156201|NCT03358407|11324482|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3
7156202|NCT03358407|11324483|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3
7156203|NCT03358407|11324484|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6
7156204|NCT03358407|11324485|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
7156205|NCT03358407|11324486|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
7156206|NCT03359395|11324525|FG000|First Intervention A / B|Withdrawal by Subject|1
7156207|NCT03359395|11324526|FG001|First Intervention A / B|Withdrawal by Subject|0
7156208|NCT03359395|11324525|FG000|First Intervention A / B|Lost to Follow-up|2
7156209|NCT03359395|11324526|FG001|First Intervention A / B|Lost to Follow-up|3
7156210|NCT03359395|11324525|FG000|Second Intervention B/A|Exclusion criteria|0
7156211|NCT03359395|11324526|FG001|Second Intervention B/A|Exclusion criteria|1
7156212|NCT03359395|11324525|FG000|Second Intervention B/A|Lost to Follow-up|3
6972095|NCT01170273|11023350|FG000|Overall Study|Protocol Violation|1
7079515|NCT02115815|11188793|FG003|Overall Study|Withdrawal by Subject|0
7079516|NCT02115815|11188794|FG004|Overall Study|Withdrawal by Subject|0
7079517|NCT02115815|11188795|FG005|Overall Study|Withdrawal by Subject|0
7079518|NCT02115815|11188796|FG006|Overall Study|Withdrawal by Subject|0
7079519|NCT02115815|11188790|FG000|Overall Study|Not enough drug to dose participant|0
6972096|NCT01170273|11023351|FG001|Overall Study|Protocol Violation|0
6972097|NCT01170273|11023350|FG000|Overall Study|Death|1
6972098|NCT01170273|11023351|FG001|Overall Study|Death|0
6972099|NCT01170273|11023350|FG000|Overall Study|Adverse Event|0
6972100|NCT01170273|11023351|FG001|Overall Study|Adverse Event|1
6972101|NCT01170364|11023359|FG000|Overall Study|Protocol Violation|4
6972102|NCT01170364|11023360|FG001|Overall Study|Protocol Violation|1
6972103|NCT01170598|11023406|FG000|Overall Study|Withdrawal by Subject|1
6972104|NCT01170598|11023406|FG000|Overall Study|Death|3
6972105|NCT01170598|11023406|FG000|Overall Study|Lost to Follow-up|1
6972106|NCT01170598|11023406|FG000|Overall Study|Refused|1
6972107|NCT01170663|11023412|FG000|Overall Study|Lost to Follow-up|3
6972108|NCT01170663|11023413|FG001|Overall Study|Lost to Follow-up|9
6972109|NCT01170663|11023412|FG000|Overall Study|Withdrawal of consent without follow-up|11
6972110|NCT01170663|11023413|FG001|Overall Study|Withdrawal of consent without follow-up|11
6972111|NCT01170962|11023455|FG000|Treatment Period|Lack of Efficacy|96
6972112|NCT01170962|11023456|FG001|Treatment Period|Lack of Efficacy|91
6972113|NCT01170962|11023457|FG002|Treatment Period|Lack of Efficacy|7
6972114|NCT01170962|11023455|FG000|Treatment Period|Adverse Event|11
6972115|NCT01170962|11023456|FG001|Treatment Period|Adverse Event|12
6972116|NCT01170962|11023457|FG002|Treatment Period|Adverse Event|3
6972117|NCT01170962|11023455|FG000|Treatment Period|Withdrawal by Subject|2
6972118|NCT01170962|11023456|FG001|Treatment Period|Withdrawal by Subject|1
6972119|NCT01170962|11023457|FG002|Treatment Period|Withdrawal by Subject|0
6972120|NCT01170962|11023455|FG000|Treatment Period|Lost to Follow-up|1
6972121|NCT01170962|11023456|FG001|Treatment Period|Lost to Follow-up|1
6972122|NCT01170962|11023457|FG002|Treatment Period|Lost to Follow-up|1
6972123|NCT01170962|11023455|FG000|Treatment Period|Participant no longer meets criteria|0
6972124|NCT01170962|11023456|FG001|Treatment Period|Participant no longer meets criteria|1
6972125|NCT01170962|11023457|FG002|Treatment Period|Participant no longer meets criteria|0
6972126|NCT01170962|11023455|FG000|Treatment Period|Request to discontinue treatment|7
6972127|NCT01170962|11023456|FG001|Treatment Period|Request to discontinue treatment|3
6972128|NCT01170962|11023457|FG002|Treatment Period|Request to discontinue treatment|1
6972129|NCT01170962|11023455|FG000|Treatment Period|Completed 24 Week treatment period only|10
6972130|NCT01170962|11023456|FG001|Treatment Period|Completed 24 Week treatment period only|2
6972131|NCT01170962|11023457|FG002|Treatment Period|Completed 24 Week treatment period only|0
6972132|NCT01170962|11023455|FG000|Follow up Period|Withdrawal by Subject|14
6972133|NCT01170962|11023456|FG001|Follow up Period|Withdrawal by Subject|10
6972134|NCT01170962|11023457|FG002|Follow up Period|Withdrawal by Subject|2
6972135|NCT01170962|11023455|FG000|Follow up Period|Lost to Follow-up|13
6972136|NCT01170962|11023456|FG001|Follow up Period|Lost to Follow-up|8
6972137|NCT01170962|11023457|FG002|Follow up Period|Lost to Follow-up|1
6972138|NCT01170962|11023455|FG000|Follow up Period|Death|2
6972139|NCT01170962|11023456|FG001|Follow up Period|Death|2
6972140|NCT01170962|11023457|FG002|Follow up Period|Death|0
6972141|NCT01170962|11023455|FG000|Follow up Period|Others|10
6972142|NCT01170962|11023456|FG001|Follow up Period|Others|7
6972143|NCT01170962|11023457|FG002|Follow up Period|Others|3
6972144|NCT01171183|11023486|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
6972145|NCT01171183|11023487|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
6972146|NCT01171183|11023486|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0
6972147|NCT01171183|11023487|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1
6972148|NCT01171183|11023486|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0
7156213|NCT03359395|11324526|FG001|Second Intervention B/A|Lost to Follow-up|2
7156214|NCT03359473|11324536|FG000|Overall Study|Adverse Event|0
7156215|NCT03359473|11324537|FG001|Overall Study|Adverse Event|2
7156216|NCT03359473|11324538|FG002|Overall Study|Adverse Event|5
7156217|NCT03359473|11324539|FG003|Overall Study|Adverse Event|3
7156218|NCT03359473|11324536|FG000|Overall Study|Lost to Follow-up|0
7156219|NCT03359473|11324537|FG001|Overall Study|Lost to Follow-up|1
7156220|NCT03359473|11324538|FG002|Overall Study|Lost to Follow-up|0
7156221|NCT03359473|11324539|FG003|Overall Study|Lost to Follow-up|0
7156222|NCT03359473|11324536|FG000|Overall Study|Physician Decision|0
7156223|NCT03359473|11324537|FG001|Overall Study|Physician Decision|1
7156224|NCT03359473|11324538|FG002|Overall Study|Physician Decision|0
7156225|NCT03359473|11324539|FG003|Overall Study|Physician Decision|1
7156226|NCT03359473|11324536|FG000|Overall Study|Withdrawal by Subject|1
7156227|NCT03359473|11324537|FG001|Overall Study|Withdrawal by Subject|2
7156228|NCT03359473|11324538|FG002|Overall Study|Withdrawal by Subject|1
7156229|NCT03359473|11324539|FG003|Overall Study|Withdrawal by Subject|0
6972149|NCT01171183|11023487|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3
6972150|NCT01171183|11023486|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
6972151|NCT01171183|11023487|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
6972152|NCT01171183|11023486|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7
6972153|NCT01171183|11023487|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3
6972154|NCT01171183|11023486|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1
6977086|NCT01204710|11030074|FG001|Randomization Treatment|Lost to Follow-up|0
7156230|NCT03359473|11324536|FG000|Overall Study|Protocol-defined stopping criteria|1
7156231|NCT03359473|11324537|FG001|Overall Study|Protocol-defined stopping criteria|0
7156232|NCT03359473|11324538|FG002|Overall Study|Protocol-defined stopping criteria|0
7184164|NCT01777295|11384168|FG000|Overall Study|Personal problem|1
6972155|NCT01171183|11023487|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0
6972156|NCT01171521|11023493|FG000|Overall Study|Lost to Follow-up|5
6972157|NCT01171521|11023493|FG000|Overall Study|screen failure|1
6972158|NCT01171612|11023497|FG000|Overall Study|Lost to Follow-up|51
6972159|NCT01171625|11023504|FG000|Overall Study|On-Protocol|67
6972160|NCT01171625|11023504|FG000|Overall Study|Death|38
6972161|NCT01171625|11023504|FG000|Overall Study|Withdrawal by Subject|31
6972162|NCT01171625|11023504|FG000|Overall Study|Explanted|10
6972163|NCT01171625|11023504|FG000|Overall Study|Lost to Follow-up|5
6972164|NCT01171625|11023504|FG000|Overall Study|Patient received valve-in-valve|3
6972165|NCT01171625|11023504|FG000|Overall Study|Other|1
6972166|NCT01171625|11023504|FG000|Overall Study|Consented but did not receive device|25
6972167|NCT01171677|11023518|FG000|Overall Study|Withdrawal by Subject|0
6972168|NCT01171677|11023519|FG001|Overall Study|Withdrawal by Subject|3
6972169|NCT01171677|11023518|FG000|Overall Study|Adverse Event|1
6972170|NCT01171677|11023519|FG001|Overall Study|Adverse Event|0
6972171|NCT01171677|11023518|FG000|Overall Study|completed <70% IntenSati classes|5
6972172|NCT01171677|11023519|FG001|Overall Study|completed <70% IntenSati classes|0
6972173|NCT01171820|11023545|FG000|Overall Study|Death|3
6972174|NCT01171820|11023546|FG001|Overall Study|Death|3
6972175|NCT01171820|11023545|FG000|Overall Study|Lost to Follow-up|0
6972176|NCT01171820|11023546|FG001|Overall Study|Lost to Follow-up|1
6972177|NCT01171820|11023545|FG000|Overall Study|Withdrawal by Subject|2
6972178|NCT01171820|11023546|FG001|Overall Study|Withdrawal by Subject|0
6972179|NCT01171820|11023545|FG000|Overall Study|Physician Decision|0
7156233|NCT03359473|11324539|FG003|Overall Study|Protocol-defined stopping criteria|1
7156234|NCT03359590|11324552|FG000|First Intervention|Withdrawal by Subject|1
7156235|NCT03359590|11324553|FG001|First Intervention|Withdrawal by Subject|1
7156236|NCT03359590|11324552|FG000|First Intervention|Protocol Violation|0
7156237|NCT03359590|11324553|FG001|First Intervention|Protocol Violation|1
7156238|NCT03359850|11324570|FG000|PK Phase (Up to Day 8)|Physician Decision|0
7156239|NCT03359850|11324571|FG001|PK Phase (Up to Day 8)|Physician Decision|1
7156240|NCT03359850|11324570|FG000|PK Phase (Up to Day 8)|Adverse Event|1
7156241|NCT03359850|11324571|FG001|PK Phase (Up to Day 8)|Adverse Event|0
7156242|NCT03359850|11324570|FG000|Extension Phase (Up to 28 Months)|Death|2
7156243|NCT03359850|11324571|FG001|Extension Phase (Up to 28 Months)|Death|4
7156244|NCT03359850|11324570|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1
7156245|NCT03359850|11324571|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2
7156246|NCT03359850|11324570|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5
7156247|NCT03359850|11324571|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0
7156248|NCT03360071|11324585|FG000|Overall Study|Lost to Follow-up|1
7156249|NCT03360071|11324586|FG001|Overall Study|Lost to Follow-up|0
7156250|NCT03360344|11324614|FG000|Overall Study|Withdrawal by Subject|0
7156251|NCT03360344|11324615|FG001|Overall Study|Withdrawal by Subject|1
7156252|NCT03360344|11324616|FG002|Overall Study|Withdrawal by Subject|1
7156253|NCT03360747|11324624|FG000|Overall Study|Voluntary Withdrawal|1
7156254|NCT03361137|11324633|FG000|Overall Study|Reason not specified|1
7156255|NCT03361137|11324634|FG001|Overall Study|Reason not specified|0
7156256|NCT03361137|11324635|FG002|Overall Study|Reason not specified|0
7156257|NCT03361137|11324636|FG003|Overall Study|Reason not specified|0
7156258|NCT03361137|11324637|FG004|Overall Study|Reason not specified|0
7156259|NCT03361176|11324653|FG000|Overall Study|Lost to Follow-up|1
7156260|NCT03361176|11324654|FG001|Overall Study|Lost to Follow-up|2
7156261|NCT03361176|11324653|FG000|Overall Study|Adverse Event|0
7156262|NCT03361176|11324654|FG001|Overall Study|Adverse Event|2
7156263|NCT03361176|11324653|FG000|Overall Study|Withdrawal by Subject|0
7156264|NCT03361176|11324654|FG001|Overall Study|Withdrawal by Subject|1
7156265|NCT03361293|11324662|FG000|Overall Study|Lost to Follow-up|0
7156266|NCT03361293|11324663|FG001|Overall Study|Lost to Follow-up|2
7156267|NCT03361293|11324662|FG000|Overall Study|Withdrawal by Subject|1
7156268|NCT03361293|11324663|FG001|Overall Study|Withdrawal by Subject|3
7156269|NCT03361423|11324671|FG000|Overall Study|Withdrawal by Subject|4
7156270|NCT03361423|11324672|FG001|Overall Study|Withdrawal by Subject|3
7156271|NCT03361423|11324671|FG000|Overall Study|Did not treat|19
7156272|NCT03361423|11324672|FG001|Overall Study|Did not treat|18
7156273|NCT03361423|11324671|FG000|Overall Study|Started >60 minutes from migraine onset|0
7156274|NCT03361423|11324672|FG001|Overall Study|Started >60 minutes from migraine onset|1
7156275|NCT03361423|11324671|FG000|Overall Study|Missing data|4
7156276|NCT03361423|11324672|FG001|Overall Study|Missing data|1
7156277|NCT03361605|11324678|FG000|Overall Study|Analyzable data not available|3
7156278|NCT03363321|11324719|FG000|Overall Study|Withdrawal by Subject|0
7156279|NCT03363321|11324720|FG001|Overall Study|Withdrawal by Subject|1
6972180|NCT01171820|11023546|FG001|Overall Study|Physician Decision|1
6972181|NCT01171820|11023545|FG000|Overall Study|1-Year Missed Visit|1
6972182|NCT01171820|11023546|FG001|Overall Study|1-Year Missed Visit|1
7156280|NCT03363321|11324721|FG002|Overall Study|Withdrawal by Subject|0
7156281|NCT03363321|11324722|FG003|Overall Study|Withdrawal by Subject|1
7156282|NCT03363321|11324723|FG004|Overall Study|Withdrawal by Subject|0
7156283|NCT03363776|11324739|FG000|Overall Study|Progressive disease|2
7156284|NCT03363776|11324740|FG001|Overall Study|Progressive disease|3
7156285|NCT03363776|11324741|FG002|Overall Study|Progressive disease|1
7156286|NCT03363776|11324739|FG000|Overall Study|Study drug toxicity|0
6972183|NCT01171963|11023563|FG000|Overall Study|Adverse Event|10
6972184|NCT01171963|11023564|FG001|Overall Study|Adverse Event|15
6972185|NCT01171963|11023563|FG000|Overall Study|Lost to Follow-up|23
6972186|NCT01171963|11023564|FG001|Overall Study|Lost to Follow-up|24
6972187|NCT01171963|11023563|FG000|Overall Study|Other - diarrhoea|1
7079520|NCT02115815|11188791|FG001|Overall Study|Not enough drug to dose participant|0
6972188|NCT01171963|11023564|FG001|Overall Study|Other - diarrhoea|0
6972189|NCT01171963|11023563|FG000|Overall Study|Withdrawal by Subject|114
7156287|NCT03363776|11324740|FG001|Overall Study|Study drug toxicity|0
7156288|NCT03363776|11324741|FG002|Overall Study|Study drug toxicity|1
7156289|NCT03363776|11324739|FG000|Overall Study|Death|1
7156290|NCT03363776|11324740|FG001|Overall Study|Death|0
7156291|NCT03363776|11324741|FG002|Overall Study|Death|0
7156292|NCT03363906|11324781|FG000|Period 1 (Reference or Test)|Adverse Event|1
7156293|NCT03363906|11324782|FG001|Period 1 (Reference or Test)|Adverse Event|2
7156294|NCT03363906|11324781|FG000|Period 2 (Test or Reference)|Adverse Event|2
7156295|NCT03363906|11324782|FG001|Period 2 (Test or Reference)|Adverse Event|0
7156296|NCT03363906|11324781|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1
7156297|NCT03363906|11324782|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1
7156298|NCT03363906|11324781|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1
7156299|NCT03363906|11324782|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0
7184165|NCT01777295|11384169|FG001|Overall Study|Personal problem|0
7184166|NCT01777295|11384168|FG000|Overall Study|Investigator call for AEs check|1
7184167|NCT01777295|11384169|FG001|Overall Study|Investigator call for AEs check|0
7187380|NCT02536339|11388011|FG000|Overall Study|Withdrawal by Subject|3
7187381|NCT02536339|11388011|FG000|Overall Study|Lost to Follow-up|2
7187382|NCT02536339|11388011|FG000|Overall Study|Treatment discontinued|2
7187383|NCT02536339|11388011|FG000|Overall Study|Physician Decision|1
7187384|NCT02323295|11388017|FG000|Overall Study|Adverse Event|0
7187385|NCT02323295|11388018|FG001|Overall Study|Adverse Event|1
7187386|NCT02323295|11388017|FG000|Overall Study|Withdrawal by Subject|0
7187387|NCT02323295|11388018|FG001|Overall Study|Withdrawal by Subject|1
7187388|NCT02323295|11388017|FG000|Overall Study|Patient did not have surgery as planned.|0
7187389|NCT02323295|11388018|FG001|Overall Study|Patient did not have surgery as planned.|1
7187390|NCT02036970|11388048|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0
7187391|NCT02036970|11388049|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0
7187392|NCT02036970|11388050|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3
7187393|NCT02036970|11388051|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2
7187394|NCT02036970|11388052|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0
7187395|NCT02036970|11388053|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1
7187396|NCT02036970|11388054|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0
7187397|NCT02036970|11388055|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1
7187398|NCT02036970|11388056|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3
7187399|NCT02036970|11388057|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1
7187400|NCT02036970|11388048|FG000|Part 1: Day 1 Through Week 16|Death|0
7187401|NCT02036970|11388049|FG001|Part 1: Day 1 Through Week 16|Death|0
7187402|NCT02036970|11388050|FG002|Part 1: Day 1 Through Week 16|Death|0
7187403|NCT02036970|11388051|FG003|Part 1: Day 1 Through Week 16|Death|0
7187404|NCT02036970|11388052|FG004|Part 1: Day 1 Through Week 16|Death|0
7187405|NCT02036970|11388053|FG005|Part 1: Day 1 Through Week 16|Death|0
7187406|NCT02036970|11388054|FG006|Part 1: Day 1 Through Week 16|Death|0
7187407|NCT02036970|11388055|FG007|Part 1: Day 1 Through Week 16|Death|0
7187408|NCT02036970|11388056|FG008|Part 1: Day 1 Through Week 16|Death|1
7187409|NCT02036970|11388057|FG009|Part 1: Day 1 Through Week 16|Death|0
7187410|NCT02036970|11388048|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1
7187411|NCT02036970|11388049|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0
7187412|NCT02036970|11388050|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1
7187413|NCT02036970|11388051|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0
6972190|NCT01171963|11023564|FG001|Overall Study|Withdrawal by Subject|129
6972191|NCT01171976|11023576|FG000|Overall Study|Protocol Violation|0
7079521|NCT02115815|11188792|FG002|Overall Study|Not enough drug to dose participant|0
7079522|NCT02115815|11188793|FG003|Overall Study|Not enough drug to dose participant|0
7079523|NCT02115815|11188794|FG004|Overall Study|Not enough drug to dose participant|0
7079524|NCT02115815|11188795|FG005|Overall Study|Not enough drug to dose participant|1
7079525|NCT02115815|11188796|FG006|Overall Study|Not enough drug to dose participant|0
7079526|NCT02115815|11188790|FG000|Overall Study|Missed appointment, randomized in error|0
7079527|NCT02115815|11188791|FG001|Overall Study|Missed appointment, randomized in error|0
7079528|NCT02115815|11188792|FG002|Overall Study|Missed appointment, randomized in error|0
7079529|NCT02115815|11188793|FG003|Overall Study|Missed appointment, randomized in error|0
7079530|NCT02115815|11188794|FG004|Overall Study|Missed appointment, randomized in error|0
7079531|NCT02115815|11188795|FG005|Overall Study|Missed appointment, randomized in error|1
7079532|NCT02115815|11188796|FG006|Overall Study|Missed appointment, randomized in error|0
7079533|NCT02116205|11188829|FG000|Overall Study|Withdrawal by Subject|2
7079534|NCT02116205|11188830|FG001|Overall Study|Withdrawal by Subject|4
7079535|NCT02116205|11188831|FG002|Overall Study|Withdrawal by Subject|1
7079536|NCT02116205|11188832|FG003|Overall Study|Withdrawal by Subject|3
7079537|NCT02116205|11188829|FG000|Overall Study|Lost to Follow-up|0
7079538|NCT02116205|11188830|FG001|Overall Study|Lost to Follow-up|2
6972192|NCT01171976|11023577|FG001|Overall Study|Protocol Violation|0
6972193|NCT01171976|11023578|FG002|Overall Study|Protocol Violation|1
6972194|NCT01171976|11023576|FG000|Overall Study|Death|2
6972195|NCT01171976|11023577|FG001|Overall Study|Death|4
6972196|NCT01171976|11023578|FG002|Overall Study|Death|1
6972197|NCT01171976|11023576|FG000|Overall Study|Lost to Follow-up|4
6972198|NCT01171976|11023577|FG001|Overall Study|Lost to Follow-up|0
6972199|NCT01171976|11023578|FG002|Overall Study|Lost to Follow-up|2
6972200|NCT01171976|11023576|FG000|Overall Study|Withdrawal by Subject|1
6972201|NCT01171976|11023577|FG001|Overall Study|Withdrawal by Subject|5
6972202|NCT01171976|11023578|FG002|Overall Study|Withdrawal by Subject|6
6972203|NCT01171976|11023576|FG000|Overall Study|Abnormal test result|1
6972204|NCT01171976|11023577|FG001|Overall Study|Abnormal test result|0
6972205|NCT01171976|11023578|FG002|Overall Study|Abnormal test result|0
6972206|NCT01171976|11023576|FG000|Overall Study|Adverse Event|6
6972207|NCT01171976|11023577|FG001|Overall Study|Adverse Event|2
6972208|NCT01171976|11023578|FG002|Overall Study|Adverse Event|5
6972209|NCT01171989|11023589|FG000|Overall Study|Lost to Follow-up|0
6972210|NCT01171989|11023590|FG001|Overall Study|Lost to Follow-up|0
6972211|NCT01171989|11023591|FG002|Overall Study|Lost to Follow-up|1
6972212|NCT01172275|11023632|FG000|Overall Study|Lost to Follow-up|1
6972213|NCT01172275|11023633|FG001|Overall Study|Lost to Follow-up|0
6972214|NCT01172275|11023632|FG000|Overall Study|Protocol Violation|1
6972215|NCT01172275|11023633|FG001|Overall Study|Protocol Violation|0
6972216|NCT01172288|11023641|FG000|Overall Study|Adverse Event|1
6972217|NCT01172288|11023642|FG001|Overall Study|Adverse Event|0
6972218|NCT01172288|11023641|FG000|Overall Study|Protocol Violation|0
6972219|NCT01172288|11023642|FG001|Overall Study|Protocol Violation|1
6972220|NCT01172535|11023676|FG000|Overall Study|Death|3
6972221|NCT01172535|11023676|FG000|Overall Study|Withdrawal by Subject|2
6972222|NCT01172535|11023676|FG000|Overall Study|Lost to Follow-up|1
6972223|NCT01172535|11023676|FG000|Overall Study|Ineligible at study entry|1
6972224|NCT01172535|11023676|FG000|Overall Study|Unwilling to adhere to study requirement|1
6972225|NCT01172639|11023697|FG000|Overall Study|Death|1
6972226|NCT01172639|11023698|FG001|Overall Study|Death|1
6972227|NCT01172639|11023699|FG002|Overall Study|Death|0
6972228|NCT01172639|11023700|FG003|Overall Study|Death|0
6972229|NCT01172639|11023701|FG004|Overall Study|Death|0
6972230|NCT01172639|11023697|FG000|Overall Study|Lost to Follow-up|9
6972231|NCT01172639|11023698|FG001|Overall Study|Lost to Follow-up|7
6972232|NCT01172639|11023699|FG002|Overall Study|Lost to Follow-up|11
6972233|NCT01172639|11023700|FG003|Overall Study|Lost to Follow-up|6
6972234|NCT01172639|11023701|FG004|Overall Study|Lost to Follow-up|6
6972235|NCT01172639|11023697|FG000|Overall Study|Withdrawal by Subject|3
6972236|NCT01172639|11023698|FG001|Overall Study|Withdrawal by Subject|3
6972237|NCT01172639|11023699|FG002|Overall Study|Withdrawal by Subject|5
6972238|NCT01172639|11023700|FG003|Overall Study|Withdrawal by Subject|5
6972239|NCT01172639|11023701|FG004|Overall Study|Withdrawal by Subject|0
6972240|NCT01172808|11023717|FG000|Overall Study|Adverse Event|8
6972241|NCT01172808|11023718|FG001|Overall Study|Adverse Event|4
6972242|NCT01172808|11023719|FG002|Overall Study|Adverse Event|8
6972243|NCT01172808|11023720|FG003|Overall Study|Adverse Event|3
6972244|NCT01172808|11023717|FG000|Overall Study|Lack of Efficacy|1
6972245|NCT01172808|11023718|FG001|Overall Study|Lack of Efficacy|0
6972246|NCT01172808|11023719|FG002|Overall Study|Lack of Efficacy|0
6972247|NCT01172808|11023720|FG003|Overall Study|Lack of Efficacy|0
6972248|NCT01172808|11023717|FG000|Overall Study|Protocol Violation|2
6972249|NCT01172808|11023718|FG001|Overall Study|Protocol Violation|2
6972250|NCT01172808|11023719|FG002|Overall Study|Protocol Violation|2
6972251|NCT01172808|11023720|FG003|Overall Study|Protocol Violation|0
6972252|NCT01172808|11023717|FG000|Overall Study|Lost to Follow-up|0
6972253|NCT01172808|11023718|FG001|Overall Study|Lost to Follow-up|1
6972254|NCT01172808|11023719|FG002|Overall Study|Lost to Follow-up|1
6972255|NCT01172808|11023720|FG003|Overall Study|Lost to Follow-up|3
6972256|NCT01172808|11023717|FG000|Overall Study|Withdrawal by Subject|4
6972257|NCT01172808|11023718|FG001|Overall Study|Withdrawal by Subject|1
6972258|NCT01172808|11023719|FG002|Overall Study|Withdrawal by Subject|3
6972259|NCT01172808|11023720|FG003|Overall Study|Withdrawal by Subject|2
7041388|NCT01727258|11125008|FG001|Overall Study|Adverse Event|2
6972260|NCT01172808|11023717|FG000|Overall Study|Other|6
6972261|NCT01172808|11023718|FG001|Overall Study|Other|5
6972262|NCT01172808|11023719|FG002|Overall Study|Other|9
6972263|NCT01172808|11023720|FG003|Overall Study|Other|7
6972264|NCT01172821|11023734|FG000|Overall Study|Adverse Event|5
6972265|NCT01172821|11023735|FG001|Overall Study|Adverse Event|2
6972266|NCT01172821|11023736|FG002|Overall Study|Adverse Event|2
6972267|NCT01172821|11023737|FG003|Overall Study|Adverse Event|7
6972268|NCT01172821|11023734|FG000|Overall Study|Protocol Violation|0
6972269|NCT01172821|11023735|FG001|Overall Study|Protocol Violation|2
6972270|NCT01172821|11023736|FG002|Overall Study|Protocol Violation|1
6972271|NCT01172821|11023737|FG003|Overall Study|Protocol Violation|2
6972272|NCT01172821|11023734|FG000|Overall Study|Lost to Follow-up|4
6972273|NCT01172821|11023735|FG001|Overall Study|Lost to Follow-up|1
6972274|NCT01172821|11023736|FG002|Overall Study|Lost to Follow-up|2
6972275|NCT01172821|11023737|FG003|Overall Study|Lost to Follow-up|2
6972276|NCT01172821|11023734|FG000|Overall Study|Withdrawal by Subject|2
6972277|NCT01172821|11023735|FG001|Overall Study|Withdrawal by Subject|3
6972278|NCT01172821|11023736|FG002|Overall Study|Withdrawal by Subject|3
6972279|NCT01172821|11023737|FG003|Overall Study|Withdrawal by Subject|3
6972280|NCT01172821|11023734|FG000|Overall Study|Other|3
6972281|NCT01172821|11023735|FG001|Overall Study|Other|4
6972282|NCT01172821|11023736|FG002|Overall Study|Other|5
6972283|NCT01172821|11023737|FG003|Overall Study|Other|3
6972284|NCT01172847|11023747|FG000|Overall Study|Withdrawal by Subject|3
6972285|NCT01172873|11023759|FG000|Overall Study|Withdrawal by Subject|3
6972286|NCT01172873|11023760|FG001|Overall Study|Withdrawal by Subject|2
6972287|NCT01172938|11023769|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11
6972288|NCT01172938|11023770|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8
6972289|NCT01172938|11023771|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10
6972290|NCT01172938|11023772|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
6972291|NCT01172938|11023773|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
6972292|NCT01172938|11023774|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
6972293|NCT01172938|11023775|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
6972294|NCT01172938|11023776|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
6972295|NCT01172938|11023777|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
6972296|NCT01172938|11023769|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
6972297|NCT01172938|11023770|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5
6972298|NCT01172938|11023771|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
6972299|NCT01172938|11023772|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
6972300|NCT01172938|11023773|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
6972301|NCT01172938|11023774|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
6972302|NCT01172938|11023775|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
6972303|NCT01172938|11023776|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
6972304|NCT01172938|11023777|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
6972305|NCT01172938|11023769|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
6972306|NCT01172938|11023770|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
6972307|NCT01172938|11023771|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2
6972308|NCT01172938|11023772|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
6972309|NCT01172938|11023773|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
6972310|NCT01172938|11023774|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
6972311|NCT01172938|11023775|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
6972312|NCT01172938|11023776|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
6972313|NCT01172938|11023777|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
6972314|NCT01172938|11023769|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2
6972315|NCT01172938|11023770|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5
6972316|NCT01172938|11023771|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3
6972317|NCT01172938|11023772|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
6972318|NCT01172938|11023773|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
6972319|NCT01172938|11023774|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
6972320|NCT01172938|11023775|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
6972321|NCT01172938|11023776|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
6972322|NCT01172938|11023777|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7156300|NCT03364023|11324788|FG000|Overall Study|Lost to Follow-up|3
7156301|NCT03364023|11324788|FG000|Overall Study|Death|14
7156302|NCT03364049|11324796|FG000|Overall Study|Death|6
7156303|NCT03364049|11324797|FG001|Overall Study|Death|4
7156304|NCT03364049|11324798|FG002|Overall Study|Death|5
7156305|NCT03364049|11324799|FG003|Overall Study|Death|14
7156306|NCT03364049|11324796|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0
7156307|NCT03364049|11324797|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1
7156308|NCT03364049|11324798|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0
7156309|NCT03364049|11324799|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0
7156310|NCT03364049|11324796|FG000|Overall Study|Withdrawal by Subject|0
7156311|NCT03364049|11324797|FG001|Overall Study|Withdrawal by Subject|1
7156312|NCT03364049|11324798|FG002|Overall Study|Withdrawal by Subject|1
7156313|NCT03364049|11324799|FG003|Overall Study|Withdrawal by Subject|1
7156314|NCT03364192|11324809|FG000|Overall Study|Ineligible|10
7156315|NCT03364192|11324809|FG000|Overall Study|Withdrawal by Subject|5
7156316|NCT03364192|11324809|FG000|Overall Study|Lost to Follow-up|1
7156317|NCT03364309|11324817|FG000|Induction Period|Adverse Event|4
7156318|NCT03364309|11324818|FG001|Induction Period|Adverse Event|0
7156319|NCT03364309|11324819|FG002|Induction Period|Adverse Event|1
7156320|NCT03364309|11324820|FG003|Induction Period|Adverse Event|0
7156321|NCT03364309|11324821|FG004|Induction Period|Adverse Event|0
7156322|NCT03364309|11324822|FG005|Induction Period|Adverse Event|0
7156323|NCT03364309|11324823|FG006|Induction Period|Adverse Event|0
7156324|NCT03364309|11324824|FG007|Induction Period|Adverse Event|0
7156325|NCT03364309|11324825|FG008|Induction Period|Adverse Event|0
7156326|NCT03364309|11324826|FG009|Induction Period|Adverse Event|0
6972323|NCT01172938|11023769|FG000|Placebo-controlled Phase (Week 0-24)|Death|0
6972324|NCT01172938|11023770|FG001|Placebo-controlled Phase (Week 0-24)|Death|1
6972325|NCT01172938|11023771|FG002|Placebo-controlled Phase (Week 0-24)|Death|0
6972326|NCT01172938|11023772|FG003|Placebo-controlled Phase (Week 0-24)|Death|0
6972327|NCT01172938|11023773|FG004|Placebo-controlled Phase (Week 0-24)|Death|0
6972328|NCT01172938|11023774|FG005|Placebo-controlled Phase (Week 0-24)|Death|0
6972329|NCT01172938|11023775|FG006|Placebo-controlled Phase (Week 0-24)|Death|0
6972330|NCT01172938|11023776|FG007|Placebo-controlled Phase (Week 0-24)|Death|0
6972331|NCT01172938|11023777|FG008|Placebo-controlled Phase (Week 0-24)|Death|0
6972332|NCT01172938|11023769|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1
6972333|NCT01172938|11023770|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
6972334|NCT01172938|11023771|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
6972335|NCT01172938|11023772|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
6972336|NCT01172938|11023773|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
6972337|NCT01172938|11023774|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
6972338|NCT01172938|11023775|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
6972339|NCT01172938|11023776|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
6972340|NCT01172938|11023777|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
6972341|NCT01172938|11023769|FG000|Placebo-controlled Phase (Week 0-24)|Other|0
6972342|NCT01172938|11023770|FG001|Placebo-controlled Phase (Week 0-24)|Other|2
6972343|NCT01172938|11023771|FG002|Placebo-controlled Phase (Week 0-24)|Other|1
6972344|NCT01172938|11023772|FG003|Placebo-controlled Phase (Week 0-24)|Other|0
6972345|NCT01172938|11023773|FG004|Placebo-controlled Phase (Week 0-24)|Other|0
6972346|NCT01172938|11023774|FG005|Placebo-controlled Phase (Week 0-24)|Other|0
6972347|NCT01172938|11023775|FG006|Placebo-controlled Phase (Week 0-24)|Other|0
6972348|NCT01172938|11023776|FG007|Placebo-controlled Phase (Week 0-24)|Other|0
6972349|NCT01172938|11023777|FG008|Placebo-controlled Phase (Week 0-24)|Other|0
6972350|NCT01172938|11023769|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
6972351|NCT01172938|11023770|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
6972352|NCT01172938|11023771|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5
6972353|NCT01172938|11023772|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
6972354|NCT01172938|11023773|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
6972355|NCT01172938|11023774|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
6972356|NCT01172938|11023775|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
6972357|NCT01172938|11023776|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
6972358|NCT01172938|11023777|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
6972359|NCT01172938|11023769|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
6972360|NCT01172938|11023770|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4
6972361|NCT01172938|11023771|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7
7041389|NCT01727258|11125009|FG002|Overall Study|Adverse Event|0
7041390|NCT01727258|11125007|FG000|Overall Study|Noncompliance with Study Drug|0
7156327|NCT03364309|11324827|FG010|Induction Period|Adverse Event|0
7156328|NCT03364309|11324828|FG011|Induction Period|Adverse Event|0
7156329|NCT03364309|11324829|FG012|Induction Period|Adverse Event|0
7156330|NCT03364309|11324830|FG013|Induction Period|Adverse Event|0
7156331|NCT03364309|11324831|FG014|Induction Period|Adverse Event|0
7156332|NCT03364309|11324832|FG015|Induction Period|Adverse Event|0
7156333|NCT03364309|11324833|FG016|Induction Period|Adverse Event|0
7156334|NCT03364309|11324834|FG017|Induction Period|Adverse Event|0
7156335|NCT03364309|11324835|FG018|Induction Period|Adverse Event|0
7156336|NCT03364309|11324817|FG000|Induction Period|Withdrawal by Subject|1
7156337|NCT03364309|11324818|FG001|Induction Period|Withdrawal by Subject|3
7156338|NCT03364309|11324819|FG002|Induction Period|Withdrawal by Subject|0
7156339|NCT03364309|11324820|FG003|Induction Period|Withdrawal by Subject|0
7156340|NCT03364309|11324821|FG004|Induction Period|Withdrawal by Subject|0
7156341|NCT03364309|11324822|FG005|Induction Period|Withdrawal by Subject|0
7156342|NCT03364309|11324823|FG006|Induction Period|Withdrawal by Subject|0
7156343|NCT03364309|11324824|FG007|Induction Period|Withdrawal by Subject|0
7156344|NCT03364309|11324825|FG008|Induction Period|Withdrawal by Subject|0
7156345|NCT03364309|11324826|FG009|Induction Period|Withdrawal by Subject|0
7156346|NCT03364309|11324827|FG010|Induction Period|Withdrawal by Subject|0
7156347|NCT03364309|11324828|FG011|Induction Period|Withdrawal by Subject|0
7156348|NCT03364309|11324829|FG012|Induction Period|Withdrawal by Subject|0
7156349|NCT03364309|11324830|FG013|Induction Period|Withdrawal by Subject|0
7156350|NCT03364309|11324831|FG014|Induction Period|Withdrawal by Subject|0
7156351|NCT03364309|11324832|FG015|Induction Period|Withdrawal by Subject|0
7156352|NCT03364309|11324833|FG016|Induction Period|Withdrawal by Subject|0
7156353|NCT03364309|11324834|FG017|Induction Period|Withdrawal by Subject|0
7156354|NCT03364309|11324835|FG018|Induction Period|Withdrawal by Subject|0
7156355|NCT03364309|11324817|FG000|Induction Period|Lost to Follow-up|1
7156356|NCT03364309|11324818|FG001|Induction Period|Lost to Follow-up|0
7156357|NCT03364309|11324819|FG002|Induction Period|Lost to Follow-up|0
6972362|NCT01172938|11023772|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
6972363|NCT01172938|11023773|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1
6972364|NCT01172938|11023774|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
6972365|NCT01172938|11023775|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
6972366|NCT01172938|11023776|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
6972367|NCT01172938|11023777|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
6972368|NCT01172938|11023769|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
6972369|NCT01172938|11023770|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
6972370|NCT01172938|11023771|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1
6972371|NCT01172938|11023772|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
6972372|NCT01172938|11023773|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
6972373|NCT01172938|11023774|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
6972374|NCT01172938|11023775|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
6972375|NCT01172938|11023776|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
6972376|NCT01172938|11023777|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
6972377|NCT01172938|11023769|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
6972378|NCT01172938|11023770|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5
6972379|NCT01172938|11023771|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
6972380|NCT01172938|11023772|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
6972381|NCT01172938|11023773|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
6972382|NCT01172938|11023774|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9
6972383|NCT01172938|11023775|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
6972384|NCT01172938|11023776|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
6972385|NCT01172938|11023777|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
6972386|NCT01172938|11023769|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
6972387|NCT01172938|11023770|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
6972388|NCT01172938|11023771|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
6972389|NCT01172938|11023772|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
6972390|NCT01172938|11023773|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
6972391|NCT01172938|11023774|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
6972392|NCT01172938|11023775|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
6972393|NCT01172938|11023776|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
6972394|NCT01172938|11023777|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
6972395|NCT01172938|11023769|FG000|Active Treatment Phase (Weeks 25-52)|Other|0
6972396|NCT01172938|11023770|FG001|Active Treatment Phase (Weeks 25-52)|Other|0
6972397|NCT01172938|11023771|FG002|Active Treatment Phase (Weeks 25-52)|Other|0
6972398|NCT01172938|11023772|FG003|Active Treatment Phase (Weeks 25-52)|Other|0
6972399|NCT01172938|11023773|FG004|Active Treatment Phase (Weeks 25-52)|Other|0
6972400|NCT01172938|11023774|FG005|Active Treatment Phase (Weeks 25-52)|Other|1
6972401|NCT01172938|11023775|FG006|Active Treatment Phase (Weeks 25-52)|Other|1
6972402|NCT01172938|11023776|FG007|Active Treatment Phase (Weeks 25-52)|Other|0
6972403|NCT01172938|11023777|FG008|Active Treatment Phase (Weeks 25-52)|Other|0
6972404|NCT01172938|11023769|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
6972405|NCT01172938|11023770|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2
6972406|NCT01172938|11023771|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
6972407|NCT01172938|11023772|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
6972408|NCT01172938|11023773|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
6972409|NCT01172938|11023774|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
6972410|NCT01172938|11023775|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
6972411|NCT01172938|11023776|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3
6972412|NCT01172938|11023777|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
6972413|NCT01172938|11023769|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
6972414|NCT01172938|11023770|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7
6972415|NCT01172938|11023771|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8
6972416|NCT01172938|11023772|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
6972417|NCT01172938|11023773|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
6972418|NCT01172938|11023774|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
7041391|NCT01727258|11125008|FG001|Overall Study|Noncompliance with Study Drug|0
7041392|NCT01727258|11125009|FG002|Overall Study|Noncompliance with Study Drug|1
7156358|NCT03364309|11324820|FG003|Induction Period|Lost to Follow-up|0
7156359|NCT03364309|11324821|FG004|Induction Period|Lost to Follow-up|0
7156360|NCT03364309|11324822|FG005|Induction Period|Lost to Follow-up|0
7156361|NCT03364309|11324823|FG006|Induction Period|Lost to Follow-up|0
7156362|NCT03364309|11324824|FG007|Induction Period|Lost to Follow-up|0
7156363|NCT03364309|11324825|FG008|Induction Period|Lost to Follow-up|0
7156364|NCT03364309|11324826|FG009|Induction Period|Lost to Follow-up|0
7156365|NCT03364309|11324827|FG010|Induction Period|Lost to Follow-up|0
7156366|NCT03364309|11324828|FG011|Induction Period|Lost to Follow-up|0
7156367|NCT03364309|11324829|FG012|Induction Period|Lost to Follow-up|0
7156368|NCT03364309|11324830|FG013|Induction Period|Lost to Follow-up|0
7156369|NCT03364309|11324831|FG014|Induction Period|Lost to Follow-up|0
7156370|NCT03364309|11324832|FG015|Induction Period|Lost to Follow-up|0
7156371|NCT03364309|11324833|FG016|Induction Period|Lost to Follow-up|0
7156372|NCT03364309|11324834|FG017|Induction Period|Lost to Follow-up|0
6972419|NCT01172938|11023775|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
6972420|NCT01172938|11023776|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4
6972421|NCT01172938|11023777|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
6972422|NCT01172938|11023769|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
6972423|NCT01172938|11023770|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
6972424|NCT01172938|11023771|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2
6972425|NCT01172938|11023772|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
6972426|NCT01172938|11023773|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
6972427|NCT01172938|11023774|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
6972428|NCT01172938|11023775|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
6972429|NCT01172938|11023776|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
6972430|NCT01172938|11023777|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
7156373|NCT03364309|11324835|FG018|Induction Period|Lost to Follow-up|0
7156374|NCT03364309|11324817|FG000|Induction Period|Physician Decision|0
7156375|NCT03364309|11324818|FG001|Induction Period|Physician Decision|1
7156376|NCT03364309|11324819|FG002|Induction Period|Physician Decision|0
7156377|NCT03364309|11324820|FG003|Induction Period|Physician Decision|0
7156378|NCT03364309|11324821|FG004|Induction Period|Physician Decision|0
7156379|NCT03364309|11324822|FG005|Induction Period|Physician Decision|0
7156380|NCT03364309|11324823|FG006|Induction Period|Physician Decision|0
7156381|NCT03364309|11324824|FG007|Induction Period|Physician Decision|0
7156382|NCT03364309|11324825|FG008|Induction Period|Physician Decision|0
7156383|NCT03364309|11324826|FG009|Induction Period|Physician Decision|0
7156384|NCT03364309|11324827|FG010|Induction Period|Physician Decision|0
7156385|NCT03364309|11324828|FG011|Induction Period|Physician Decision|0
7156386|NCT03364309|11324829|FG012|Induction Period|Physician Decision|0
7156387|NCT03364309|11324830|FG013|Induction Period|Physician Decision|0
7156388|NCT03364309|11324831|FG014|Induction Period|Physician Decision|0
7156389|NCT03364309|11324832|FG015|Induction Period|Physician Decision|0
7156390|NCT03364309|11324833|FG016|Induction Period|Physician Decision|0
7156391|NCT03364309|11324834|FG017|Induction Period|Physician Decision|0
7156392|NCT03364309|11324835|FG018|Induction Period|Physician Decision|0
7156393|NCT03364309|11324817|FG000|Maintenance Period|Withdrawal by Subject|0
7156394|NCT03364309|11324818|FG001|Maintenance Period|Withdrawal by Subject|0
7156395|NCT03364309|11324819|FG002|Maintenance Period|Withdrawal by Subject|0
7156396|NCT03364309|11324820|FG003|Maintenance Period|Withdrawal by Subject|1
7156397|NCT03364309|11324821|FG004|Maintenance Period|Withdrawal by Subject|3
7156398|NCT03364309|11324822|FG005|Maintenance Period|Withdrawal by Subject|1
7156399|NCT03364309|11324823|FG006|Maintenance Period|Withdrawal by Subject|3
7156400|NCT03364309|11324824|FG007|Maintenance Period|Withdrawal by Subject|0
7156401|NCT03364309|11324825|FG008|Maintenance Period|Withdrawal by Subject|1
7156402|NCT03364309|11324826|FG009|Maintenance Period|Withdrawal by Subject|1
7156403|NCT03364309|11324827|FG010|Maintenance Period|Withdrawal by Subject|2
7156404|NCT03364309|11324828|FG011|Maintenance Period|Withdrawal by Subject|0
7156405|NCT03364309|11324829|FG012|Maintenance Period|Withdrawal by Subject|0
7156406|NCT03364309|11324830|FG013|Maintenance Period|Withdrawal by Subject|0
7156407|NCT03364309|11324831|FG014|Maintenance Period|Withdrawal by Subject|0
7156408|NCT03364309|11324832|FG015|Maintenance Period|Withdrawal by Subject|0
7156409|NCT03364309|11324833|FG016|Maintenance Period|Withdrawal by Subject|0
7156410|NCT03364309|11324834|FG017|Maintenance Period|Withdrawal by Subject|0
7156411|NCT03364309|11324835|FG018|Maintenance Period|Withdrawal by Subject|0
7156412|NCT03364309|11324817|FG000|Maintenance Period|Adverse Event|0
7156413|NCT03364309|11324818|FG001|Maintenance Period|Adverse Event|0
7156414|NCT03364309|11324819|FG002|Maintenance Period|Adverse Event|0
7156415|NCT03364309|11324820|FG003|Maintenance Period|Adverse Event|0
7156416|NCT03364309|11324821|FG004|Maintenance Period|Adverse Event|2
7156417|NCT03364309|11324822|FG005|Maintenance Period|Adverse Event|0
7156418|NCT03364309|11324823|FG006|Maintenance Period|Adverse Event|3
7156419|NCT03364309|11324824|FG007|Maintenance Period|Adverse Event|0
7156420|NCT03364309|11324825|FG008|Maintenance Period|Adverse Event|1
7156421|NCT03364309|11324826|FG009|Maintenance Period|Adverse Event|0
7156422|NCT03364309|11324827|FG010|Maintenance Period|Adverse Event|2
7156423|NCT03364309|11324828|FG011|Maintenance Period|Adverse Event|0
7156424|NCT03364309|11324829|FG012|Maintenance Period|Adverse Event|0
7156425|NCT03364309|11324830|FG013|Maintenance Period|Adverse Event|0
7156426|NCT03364309|11324831|FG014|Maintenance Period|Adverse Event|0
7156427|NCT03364309|11324832|FG015|Maintenance Period|Adverse Event|0
7156428|NCT03364309|11324833|FG016|Maintenance Period|Adverse Event|0
7156429|NCT03364309|11324834|FG017|Maintenance Period|Adverse Event|0
7156430|NCT03364309|11324835|FG018|Maintenance Period|Adverse Event|0
7156431|NCT03364309|11324817|FG000|Maintenance Period|Relapsed|0
7156432|NCT03364309|11324818|FG001|Maintenance Period|Relapsed|0
7156433|NCT03364309|11324819|FG002|Maintenance Period|Relapsed|0
7156434|NCT03364309|11324820|FG003|Maintenance Period|Relapsed|43
7156435|NCT03364309|11324821|FG004|Maintenance Period|Relapsed|7
7156436|NCT03364309|11324822|FG005|Maintenance Period|Relapsed|45
7156437|NCT03364309|11324823|FG006|Maintenance Period|Relapsed|10
7156438|NCT03364309|11324824|FG007|Maintenance Period|Relapsed|2
7156439|NCT03364309|11324825|FG008|Maintenance Period|Relapsed|0
7156440|NCT03364309|11324826|FG009|Maintenance Period|Relapsed|0
6972431|NCT01172938|11023769|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
6972432|NCT01172938|11023770|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10
6972433|NCT01172938|11023771|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8
6972434|NCT01172938|11023772|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
6972435|NCT01172938|11023773|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
6972436|NCT01172938|11023774|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
6972437|NCT01172938|11023775|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
6972438|NCT01172938|11023776|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5
6972439|NCT01172938|11023777|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2
6972440|NCT01172938|11023769|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0
6972441|NCT01172938|11023770|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0
6972442|NCT01172938|11023771|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1
6972443|NCT01172938|11023772|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0
6972444|NCT01172938|11023773|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0
6972445|NCT01172938|11023774|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0
6972446|NCT01172938|11023775|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0
6972447|NCT01172938|11023776|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0
6972448|NCT01172938|11023777|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0
6972449|NCT01172938|11023769|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
6972450|NCT01172938|11023770|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
6972451|NCT01172938|11023771|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
6972452|NCT01172938|11023772|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
6972453|NCT01172938|11023773|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
6972454|NCT01172938|11023774|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
6972455|NCT01172938|11023775|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
6972456|NCT01172938|11023776|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3
6972457|NCT01172938|11023777|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
6972458|NCT01172938|11023769|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
6972459|NCT01172938|11023770|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2
6972460|NCT01172938|11023771|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
6972461|NCT01172938|11023772|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
6972462|NCT01172938|11023773|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
6972463|NCT01172938|11023774|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
6972464|NCT01172938|11023775|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
6972465|NCT01172938|11023776|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
6972466|NCT01172938|11023777|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1
6972467|NCT01172938|11023769|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0
6972468|NCT01172938|11023770|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1
6972469|NCT01172938|11023771|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0
6972470|NCT01172938|11023772|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0
6972471|NCT01172938|11023773|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0
6972472|NCT01172938|11023774|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0
6972473|NCT01172938|11023775|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0
6972474|NCT01172938|11023776|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0
6972475|NCT01172938|11023777|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0
6972476|NCT01172938|11023769|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
6972477|NCT01172938|11023770|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
6972478|NCT01172938|11023771|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
6972479|NCT01172938|11023772|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
6972480|NCT01172938|11023773|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
6972481|NCT01172938|11023774|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
6972482|NCT01172938|11023775|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
6972483|NCT01172938|11023776|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
6972484|NCT01172938|11023777|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1
6972485|NCT01172938|11023769|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
6972486|NCT01172938|11023770|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4
6972487|NCT01172938|11023771|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
6972488|NCT01172938|11023772|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
6972489|NCT01172938|11023773|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
6972490|NCT01172938|11023774|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
6972491|NCT01172938|11023775|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
6972492|NCT01172938|11023776|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
6972493|NCT01172938|11023777|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
6972494|NCT01172938|11023769|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
6972495|NCT01172938|11023770|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6
6972496|NCT01172938|11023771|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3
6972497|NCT01172938|11023772|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
6972498|NCT01172938|11023773|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
6972499|NCT01172938|11023774|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
7041393|NCT01727258|11125007|FG000|Overall Study|Withdrawal by Subject|1
6972500|NCT01172938|11023775|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
6972501|NCT01172938|11023776|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2
6972502|NCT01172938|11023777|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1
6972503|NCT01172938|11023769|FG000|Active-Treatment Phase Weeks (104-156)|Death|0
6972504|NCT01172938|11023770|FG001|Active-Treatment Phase Weeks (104-156)|Death|0
6972505|NCT01172938|11023771|FG002|Active-Treatment Phase Weeks (104-156)|Death|0
6972506|NCT01172938|11023772|FG003|Active-Treatment Phase Weeks (104-156)|Death|0
6972507|NCT01172938|11023773|FG004|Active-Treatment Phase Weeks (104-156)|Death|0
6972508|NCT01172938|11023774|FG005|Active-Treatment Phase Weeks (104-156)|Death|0
6972509|NCT01172938|11023775|FG006|Active-Treatment Phase Weeks (104-156)|Death|0
6972510|NCT01172938|11023776|FG007|Active-Treatment Phase Weeks (104-156)|Death|1
6972511|NCT01172938|11023777|FG008|Active-Treatment Phase Weeks (104-156)|Death|0
6972512|NCT01172938|11023769|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
6972513|NCT01172938|11023770|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1
6972514|NCT01172938|11023771|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
6972515|NCT01172938|11023772|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
6972516|NCT01172938|11023773|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
6972517|NCT01172938|11023774|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
6972518|NCT01172938|11023775|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
6972519|NCT01172938|11023776|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
6972520|NCT01172938|11023777|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
6972521|NCT01172938|11023769|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
6972522|NCT01172938|11023770|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
6972523|NCT01172938|11023771|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2
6972524|NCT01172938|11023772|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
6972525|NCT01172938|11023773|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
6972526|NCT01172938|11023774|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
6972527|NCT01172938|11023775|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
6972528|NCT01172938|11023776|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
6972529|NCT01172938|11023777|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
6972530|NCT01172938|11023769|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
6972531|NCT01172938|11023770|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4
6972532|NCT01172938|11023771|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1
6972533|NCT01172938|11023772|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
6972534|NCT01172938|11023773|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
6972535|NCT01172938|11023774|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
6972536|NCT01172938|11023775|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
6972537|NCT01172938|11023776|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3
6972538|NCT01172938|11023777|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
7156441|NCT03364309|11324827|FG010|Maintenance Period|Relapsed|0
7156442|NCT03364309|11324828|FG011|Maintenance Period|Relapsed|0
7156443|NCT03364309|11324829|FG012|Maintenance Period|Relapsed|0
7156444|NCT03364309|11324830|FG013|Maintenance Period|Relapsed|0
7156445|NCT03364309|11324831|FG014|Maintenance Period|Relapsed|0
7156446|NCT03364309|11324832|FG015|Maintenance Period|Relapsed|0
7156447|NCT03364309|11324833|FG016|Maintenance Period|Relapsed|0
7156448|NCT03364309|11324834|FG017|Maintenance Period|Relapsed|0
7156449|NCT03364309|11324835|FG018|Maintenance Period|Relapsed|0
7156450|NCT03364309|11324817|FG000|Maintenance Period|Lack of Efficacy|0
7156451|NCT03364309|11324818|FG001|Maintenance Period|Lack of Efficacy|0
7156452|NCT03364309|11324819|FG002|Maintenance Period|Lack of Efficacy|0
7156453|NCT03364309|11324820|FG003|Maintenance Period|Lack of Efficacy|0
7156454|NCT03364309|11324821|FG004|Maintenance Period|Lack of Efficacy|0
7156455|NCT03364309|11324822|FG005|Maintenance Period|Lack of Efficacy|0
7156456|NCT03364309|11324823|FG006|Maintenance Period|Lack of Efficacy|0
7156457|NCT03364309|11324824|FG007|Maintenance Period|Lack of Efficacy|0
7156458|NCT03364309|11324825|FG008|Maintenance Period|Lack of Efficacy|1
7156459|NCT03364309|11324826|FG009|Maintenance Period|Lack of Efficacy|3
7156460|NCT03364309|11324827|FG010|Maintenance Period|Lack of Efficacy|2
7156461|NCT03364309|11324828|FG011|Maintenance Period|Lack of Efficacy|0
7156462|NCT03364309|11324829|FG012|Maintenance Period|Lack of Efficacy|0
7156463|NCT03364309|11324830|FG013|Maintenance Period|Lack of Efficacy|0
7156464|NCT03364309|11324831|FG014|Maintenance Period|Lack of Efficacy|0
7156465|NCT03364309|11324832|FG015|Maintenance Period|Lack of Efficacy|0
7156466|NCT03364309|11324833|FG016|Maintenance Period|Lack of Efficacy|0
7156467|NCT03364309|11324834|FG017|Maintenance Period|Lack of Efficacy|0
7156468|NCT03364309|11324835|FG018|Maintenance Period|Lack of Efficacy|0
7156469|NCT03364309|11324817|FG000|Maintenance Period|Death|0
7156470|NCT03364309|11324818|FG001|Maintenance Period|Death|0
7156471|NCT03364309|11324819|FG002|Maintenance Period|Death|0
7156472|NCT03364309|11324820|FG003|Maintenance Period|Death|0
7156473|NCT03364309|11324821|FG004|Maintenance Period|Death|0
7156474|NCT03364309|11324822|FG005|Maintenance Period|Death|0
7156475|NCT03364309|11324823|FG006|Maintenance Period|Death|0
7156476|NCT03364309|11324824|FG007|Maintenance Period|Death|0
7156477|NCT03364309|11324825|FG008|Maintenance Period|Death|1
7156478|NCT03364309|11324826|FG009|Maintenance Period|Death|0
6972539|NCT01172938|11023769|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
6972540|NCT01172938|11023770|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
6972541|NCT01172938|11023771|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
6972542|NCT01172938|11023772|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
6972543|NCT01172938|11023773|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
6972544|NCT01172938|11023774|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
6972545|NCT01172938|11023775|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
6972546|NCT01172938|11023776|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3
7041394|NCT01727258|11125008|FG001|Overall Study|Withdrawal by Subject|1
7156479|NCT03364309|11324827|FG010|Maintenance Period|Death|0
7156480|NCT03364309|11324828|FG011|Maintenance Period|Death|0
7156481|NCT03364309|11324829|FG012|Maintenance Period|Death|0
7156482|NCT03364309|11324830|FG013|Maintenance Period|Death|0
7156483|NCT03364309|11324831|FG014|Maintenance Period|Death|0
7156484|NCT03364309|11324832|FG015|Maintenance Period|Death|0
7156485|NCT03364309|11324833|FG016|Maintenance Period|Death|0
7156486|NCT03364309|11324834|FG017|Maintenance Period|Death|0
7156487|NCT03364309|11324835|FG018|Maintenance Period|Death|0
7156488|NCT03364309|11324817|FG000|Maintenance Period|Lost to Follow-up|0
7156489|NCT03364309|11324818|FG001|Maintenance Period|Lost to Follow-up|0
7156490|NCT03364309|11324819|FG002|Maintenance Period|Lost to Follow-up|0
7156491|NCT03364309|11324820|FG003|Maintenance Period|Lost to Follow-up|0
7156492|NCT03364309|11324821|FG004|Maintenance Period|Lost to Follow-up|0
7156493|NCT03364309|11324822|FG005|Maintenance Period|Lost to Follow-up|0
7156494|NCT03364309|11324823|FG006|Maintenance Period|Lost to Follow-up|0
7156495|NCT03364309|11324824|FG007|Maintenance Period|Lost to Follow-up|0
7156496|NCT03364309|11324825|FG008|Maintenance Period|Lost to Follow-up|1
7156497|NCT03364309|11324826|FG009|Maintenance Period|Lost to Follow-up|0
7156498|NCT03364309|11324827|FG010|Maintenance Period|Lost to Follow-up|0
7156499|NCT03364309|11324828|FG011|Maintenance Period|Lost to Follow-up|0
7156500|NCT03364309|11324829|FG012|Maintenance Period|Lost to Follow-up|0
7156501|NCT03364309|11324830|FG013|Maintenance Period|Lost to Follow-up|0
7156502|NCT03364309|11324831|FG014|Maintenance Period|Lost to Follow-up|0
7156503|NCT03364309|11324832|FG015|Maintenance Period|Lost to Follow-up|0
7156504|NCT03364309|11324833|FG016|Maintenance Period|Lost to Follow-up|0
7156505|NCT03364309|11324834|FG017|Maintenance Period|Lost to Follow-up|0
7156506|NCT03364309|11324835|FG018|Maintenance Period|Lost to Follow-up|0
7156507|NCT03364309|11324817|FG000|Maintenance Period|Miscellaneous|0
7156508|NCT03364309|11324818|FG001|Maintenance Period|Miscellaneous|0
7156509|NCT03364309|11324819|FG002|Maintenance Period|Miscellaneous|0
7156510|NCT03364309|11324820|FG003|Maintenance Period|Miscellaneous|0
7156511|NCT03364309|11324821|FG004|Maintenance Period|Miscellaneous|0
7156512|NCT03364309|11324822|FG005|Maintenance Period|Miscellaneous|0
7156513|NCT03364309|11324823|FG006|Maintenance Period|Miscellaneous|0
7156514|NCT03364309|11324824|FG007|Maintenance Period|Miscellaneous|0
7156515|NCT03364309|11324825|FG008|Maintenance Period|Miscellaneous|1
7156516|NCT03364309|11324826|FG009|Maintenance Period|Miscellaneous|0
7156517|NCT03364309|11324827|FG010|Maintenance Period|Miscellaneous|0
7156518|NCT03364309|11324828|FG011|Maintenance Period|Miscellaneous|0
7156519|NCT03364309|11324829|FG012|Maintenance Period|Miscellaneous|0
7156520|NCT03364309|11324830|FG013|Maintenance Period|Miscellaneous|0
7156521|NCT03364309|11324831|FG014|Maintenance Period|Miscellaneous|0
7156522|NCT03364309|11324832|FG015|Maintenance Period|Miscellaneous|0
7156523|NCT03364309|11324833|FG016|Maintenance Period|Miscellaneous|0
7156524|NCT03364309|11324834|FG017|Maintenance Period|Miscellaneous|0
7156525|NCT03364309|11324835|FG018|Maintenance Period|Miscellaneous|0
7156526|NCT03364309|11324817|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7156527|NCT03364309|11324818|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7156528|NCT03364309|11324819|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7156529|NCT03364309|11324820|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7156530|NCT03364309|11324821|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7156531|NCT03364309|11324822|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7156532|NCT03364309|11324823|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7156533|NCT03364309|11324824|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7156534|NCT03364309|11324825|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7156535|NCT03364309|11324826|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7156536|NCT03364309|11324827|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7156537|NCT03364309|11324828|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7156538|NCT03364309|11324829|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7156539|NCT03364309|11324830|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1
7156540|NCT03364309|11324831|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1
7156541|NCT03364309|11324832|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1
7156542|NCT03364309|11324833|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7156543|NCT03364309|11324834|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7156544|NCT03364309|11324835|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7156545|NCT03364309|11324817|FG000|Re-treatment (Maintenance) Period|Adverse Event|0
7156546|NCT03364309|11324818|FG001|Re-treatment (Maintenance) Period|Adverse Event|0
7156547|NCT03364309|11324819|FG002|Re-treatment (Maintenance) Period|Adverse Event|0
7156548|NCT03364309|11324820|FG003|Re-treatment (Maintenance) Period|Adverse Event|0
6972547|NCT01172938|11023777|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2
6972548|NCT01172938|11023769|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
6972549|NCT01172938|11023770|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
6972550|NCT01172938|11023771|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
6972551|NCT01172938|11023772|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
6972552|NCT01172938|11023773|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
7156549|NCT03364309|11324821|FG004|Re-treatment (Maintenance) Period|Adverse Event|0
7156550|NCT03364309|11324822|FG005|Re-treatment (Maintenance) Period|Adverse Event|0
7156551|NCT03364309|11324823|FG006|Re-treatment (Maintenance) Period|Adverse Event|0
7156552|NCT03364309|11324824|FG007|Re-treatment (Maintenance) Period|Adverse Event|0
7156553|NCT03364309|11324825|FG008|Re-treatment (Maintenance) Period|Adverse Event|0
7156554|NCT03364309|11324826|FG009|Re-treatment (Maintenance) Period|Adverse Event|0
7156555|NCT03364309|11324827|FG010|Re-treatment (Maintenance) Period|Adverse Event|0
7156556|NCT03364309|11324828|FG011|Re-treatment (Maintenance) Period|Adverse Event|0
7156557|NCT03364309|11324829|FG012|Re-treatment (Maintenance) Period|Adverse Event|0
7156558|NCT03364309|11324830|FG013|Re-treatment (Maintenance) Period|Adverse Event|0
7156559|NCT03364309|11324831|FG014|Re-treatment (Maintenance) Period|Adverse Event|1
7156560|NCT03364309|11324832|FG015|Re-treatment (Maintenance) Period|Adverse Event|0
7156561|NCT03364309|11324833|FG016|Re-treatment (Maintenance) Period|Adverse Event|0
7156562|NCT03364309|11324834|FG017|Re-treatment (Maintenance) Period|Adverse Event|0
7156563|NCT03364309|11324835|FG018|Re-treatment (Maintenance) Period|Adverse Event|0
7156564|NCT03364309|11324817|FG000|Re-treatment (Maintenance) Period|Relapse|0
7156565|NCT03364309|11324818|FG001|Re-treatment (Maintenance) Period|Relapse|0
7156566|NCT03364309|11324819|FG002|Re-treatment (Maintenance) Period|Relapse|0
7156567|NCT03364309|11324820|FG003|Re-treatment (Maintenance) Period|Relapse|0
7156568|NCT03364309|11324821|FG004|Re-treatment (Maintenance) Period|Relapse|0
7156569|NCT03364309|11324822|FG005|Re-treatment (Maintenance) Period|Relapse|0
7156570|NCT03364309|11324823|FG006|Re-treatment (Maintenance) Period|Relapse|0
7156571|NCT03364309|11324824|FG007|Re-treatment (Maintenance) Period|Relapse|0
7156572|NCT03364309|11324825|FG008|Re-treatment (Maintenance) Period|Relapse|0
7156573|NCT03364309|11324826|FG009|Re-treatment (Maintenance) Period|Relapse|0
7156574|NCT03364309|11324827|FG010|Re-treatment (Maintenance) Period|Relapse|0
7156575|NCT03364309|11324828|FG011|Re-treatment (Maintenance) Period|Relapse|0
7156576|NCT03364309|11324829|FG012|Re-treatment (Maintenance) Period|Relapse|1
7156577|NCT03364309|11324830|FG013|Re-treatment (Maintenance) Period|Relapse|0
7156578|NCT03364309|11324831|FG014|Re-treatment (Maintenance) Period|Relapse|0
7156579|NCT03364309|11324832|FG015|Re-treatment (Maintenance) Period|Relapse|1
7156580|NCT03364309|11324833|FG016|Re-treatment (Maintenance) Period|Relapse|0
7156581|NCT03364309|11324834|FG017|Re-treatment (Maintenance) Period|Relapse|0
7156582|NCT03364309|11324835|FG018|Re-treatment (Maintenance) Period|Relapse|0
7156583|NCT03364309|11324817|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0
7156584|NCT03364309|11324818|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0
7156585|NCT03364309|11324819|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0
7156586|NCT03364309|11324820|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0
7156587|NCT03364309|11324821|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0
7156588|NCT03364309|11324822|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0
7156589|NCT03364309|11324823|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0
7156590|NCT03364309|11324824|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0
7156591|NCT03364309|11324825|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0
7156592|NCT03364309|11324826|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0
7156593|NCT03364309|11324827|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0
7156594|NCT03364309|11324828|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0
7156595|NCT03364309|11324829|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0
7156596|NCT03364309|11324830|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0
7156597|NCT03364309|11324831|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0
7156598|NCT03364309|11324832|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0
7156599|NCT03364309|11324833|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3
7156600|NCT03364309|11324834|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19
7156601|NCT03364309|11324835|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1
7156602|NCT03364309|11324817|FG000|Post-Treatment Followup Period|Adverse Event|0
7156603|NCT03364309|11324818|FG001|Post-Treatment Followup Period|Adverse Event|0
7156604|NCT03364309|11324819|FG002|Post-Treatment Followup Period|Adverse Event|0
7156605|NCT03364309|11324820|FG003|Post-Treatment Followup Period|Adverse Event|0
7156606|NCT03364309|11324821|FG004|Post-Treatment Followup Period|Adverse Event|0
7156607|NCT03364309|11324822|FG005|Post-Treatment Followup Period|Adverse Event|0
7156608|NCT03364309|11324823|FG006|Post-Treatment Followup Period|Adverse Event|0
7156609|NCT03364309|11324824|FG007|Post-Treatment Followup Period|Adverse Event|0
7156610|NCT03364309|11324825|FG008|Post-Treatment Followup Period|Adverse Event|0
7156611|NCT03364309|11324826|FG009|Post-Treatment Followup Period|Adverse Event|0
7156612|NCT03364309|11324827|FG010|Post-Treatment Followup Period|Adverse Event|0
7156613|NCT03364309|11324828|FG011|Post-Treatment Followup Period|Adverse Event|0
7156614|NCT03364309|11324829|FG012|Post-Treatment Followup Period|Adverse Event|0
7156615|NCT03364309|11324830|FG013|Post-Treatment Followup Period|Adverse Event|0
7156616|NCT03364309|11324831|FG014|Post-Treatment Followup Period|Adverse Event|0
6972553|NCT01172938|11023774|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
6972554|NCT01172938|11023775|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
6972555|NCT01172938|11023776|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
6972556|NCT01172938|11023777|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
6972557|NCT01172938|11023769|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
6972558|NCT01172938|11023770|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
6972559|NCT01172938|11023771|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
6972560|NCT01172938|11023772|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
6972561|NCT01172938|11023773|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
6972562|NCT01172938|11023774|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
6972563|NCT01172938|11023775|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
6972564|NCT01172938|11023776|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
6972565|NCT01172938|11023777|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
6972566|NCT01172938|11023769|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
6972567|NCT01172938|11023770|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
6972568|NCT01172938|11023771|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
6972569|NCT01172938|11023772|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
6972570|NCT01172938|11023773|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
6972571|NCT01172938|11023774|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
6972572|NCT01172938|11023775|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
6972573|NCT01172938|11023776|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1
6972574|NCT01172938|11023777|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
6972575|NCT01172938|11023769|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
6972576|NCT01172938|11023770|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
7079539|NCT02116205|11188831|FG002|Overall Study|Lost to Follow-up|1
7079540|NCT02116205|11188832|FG003|Overall Study|Lost to Follow-up|2
7079541|NCT02116205|11188829|FG000|Overall Study|Physician Decision|0
7079542|NCT02116205|11188830|FG001|Overall Study|Physician Decision|1
7079543|NCT02116205|11188831|FG002|Overall Study|Physician Decision|1
7079544|NCT02116205|11188832|FG003|Overall Study|Physician Decision|1
7156617|NCT03364309|11324832|FG015|Post-Treatment Followup Period|Adverse Event|0
7156618|NCT03364309|11324833|FG016|Post-Treatment Followup Period|Adverse Event|2
7156619|NCT03364309|11324834|FG017|Post-Treatment Followup Period|Adverse Event|6
7156620|NCT03364309|11324835|FG018|Post-Treatment Followup Period|Adverse Event|1
7156621|NCT03364309|11324817|FG000|Post-Treatment Followup Period|Lost to Follow-up|0
7156622|NCT03364309|11324818|FG001|Post-Treatment Followup Period|Lost to Follow-up|0
7156623|NCT03364309|11324819|FG002|Post-Treatment Followup Period|Lost to Follow-up|0
7156624|NCT03364309|11324820|FG003|Post-Treatment Followup Period|Lost to Follow-up|0
7156625|NCT03364309|11324821|FG004|Post-Treatment Followup Period|Lost to Follow-up|0
7156626|NCT03364309|11324822|FG005|Post-Treatment Followup Period|Lost to Follow-up|0
7156627|NCT03364309|11324823|FG006|Post-Treatment Followup Period|Lost to Follow-up|0
7156628|NCT03364309|11324824|FG007|Post-Treatment Followup Period|Lost to Follow-up|0
7156629|NCT03364309|11324825|FG008|Post-Treatment Followup Period|Lost to Follow-up|0
7156630|NCT03364309|11324826|FG009|Post-Treatment Followup Period|Lost to Follow-up|0
7156631|NCT03364309|11324827|FG010|Post-Treatment Followup Period|Lost to Follow-up|0
7156632|NCT03364309|11324828|FG011|Post-Treatment Followup Period|Lost to Follow-up|0
7079545|NCT02116205|11188829|FG000|Overall Study|Exclusion criteria|0
7079546|NCT02116205|11188830|FG001|Overall Study|Exclusion criteria|0
7079547|NCT02116205|11188831|FG002|Overall Study|Exclusion criteria|1
7079548|NCT02116205|11188832|FG003|Overall Study|Exclusion criteria|0
7079549|NCT02116309|11188844|FG000|Overall Study|Lost to Follow-up|0
7079550|NCT02116309|11188845|FG001|Overall Study|Lost to Follow-up|1
7079551|NCT02116361|11188859|FG000|Overall Study|Pregnancy|0
7079552|NCT02116361|11188860|FG001|Overall Study|Pregnancy|0
7079553|NCT02116361|11188861|FG002|Overall Study|Pregnancy|0
7079554|NCT02116361|11188862|FG003|Overall Study|Pregnancy|1
7079555|NCT02116361|11188859|FG000|Overall Study|Protocol Violation|1
7079556|NCT02116361|11188860|FG001|Overall Study|Protocol Violation|0
7079557|NCT02116361|11188861|FG002|Overall Study|Protocol Violation|0
7079558|NCT02116361|11188862|FG003|Overall Study|Protocol Violation|2
7079559|NCT02116361|11188859|FG000|Overall Study|Physician Decision|2
7079560|NCT02116361|11188860|FG001|Overall Study|Physician Decision|3
7079561|NCT02116361|11188861|FG002|Overall Study|Physician Decision|0
7079562|NCT02116361|11188862|FG003|Overall Study|Physician Decision|0
7079563|NCT02116361|11188859|FG000|Overall Study|Adverse Event|1
7079564|NCT02116361|11188860|FG001|Overall Study|Adverse Event|0
7079565|NCT02116361|11188861|FG002|Overall Study|Adverse Event|0
7079566|NCT02116361|11188862|FG003|Overall Study|Adverse Event|3
7079567|NCT02116361|11188859|FG000|Overall Study|Other Reasons|3
7079568|NCT02116361|11188860|FG001|Overall Study|Other Reasons|3
7079569|NCT02116361|11188861|FG002|Overall Study|Other Reasons|3
7079570|NCT02116361|11188862|FG003|Overall Study|Other Reasons|3
7079571|NCT02116361|11188859|FG000|Overall Study|Lack of Efficacy|5
7079572|NCT02116361|11188860|FG001|Overall Study|Lack of Efficacy|7
7079573|NCT02116361|11188861|FG002|Overall Study|Lack of Efficacy|4
7079574|NCT02116361|11188862|FG003|Overall Study|Lack of Efficacy|3
7079575|NCT02116361|11188859|FG000|Overall Study|Lost to Follow-up|4
7079576|NCT02116361|11188860|FG001|Overall Study|Lost to Follow-up|5
6972577|NCT01172938|11023771|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
6972578|NCT01172938|11023772|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
6972579|NCT01172938|11023773|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
6972580|NCT01172938|11023774|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
6972581|NCT01172938|11023775|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
6972582|NCT01172938|11023776|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
6972583|NCT01172938|11023777|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
6972584|NCT01172938|11023769|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
7156633|NCT03364309|11324829|FG012|Post-Treatment Followup Period|Lost to Follow-up|0
7156634|NCT03364309|11324830|FG013|Post-Treatment Followup Period|Lost to Follow-up|0
7156635|NCT03364309|11324831|FG014|Post-Treatment Followup Period|Lost to Follow-up|0
7156636|NCT03364309|11324832|FG015|Post-Treatment Followup Period|Lost to Follow-up|0
7156637|NCT03364309|11324833|FG016|Post-Treatment Followup Period|Lost to Follow-up|0
7156638|NCT03364309|11324834|FG017|Post-Treatment Followup Period|Lost to Follow-up|2
7156639|NCT03364309|11324835|FG018|Post-Treatment Followup Period|Lost to Follow-up|0
7156640|NCT03364309|11324817|FG000|Post-Treatment Followup Period|Miscellaneous|0
7156641|NCT03364309|11324818|FG001|Post-Treatment Followup Period|Miscellaneous|0
7156642|NCT03364309|11324819|FG002|Post-Treatment Followup Period|Miscellaneous|0
7156643|NCT03364309|11324820|FG003|Post-Treatment Followup Period|Miscellaneous|0
7156644|NCT03364309|11324821|FG004|Post-Treatment Followup Period|Miscellaneous|0
7156645|NCT03364309|11324822|FG005|Post-Treatment Followup Period|Miscellaneous|0
7156646|NCT03364309|11324823|FG006|Post-Treatment Followup Period|Miscellaneous|0
7156647|NCT03364309|11324824|FG007|Post-Treatment Followup Period|Miscellaneous|0
7156648|NCT03364309|11324825|FG008|Post-Treatment Followup Period|Miscellaneous|0
7156649|NCT03364309|11324826|FG009|Post-Treatment Followup Period|Miscellaneous|0
7156650|NCT03364309|11324827|FG010|Post-Treatment Followup Period|Miscellaneous|0
7156651|NCT03364309|11324828|FG011|Post-Treatment Followup Period|Miscellaneous|0
7156652|NCT03364309|11324829|FG012|Post-Treatment Followup Period|Miscellaneous|0
7156653|NCT03364309|11324830|FG013|Post-Treatment Followup Period|Miscellaneous|0
7156654|NCT03364309|11324831|FG014|Post-Treatment Followup Period|Miscellaneous|0
7156655|NCT03364309|11324832|FG015|Post-Treatment Followup Period|Miscellaneous|0
7156656|NCT03364309|11324833|FG016|Post-Treatment Followup Period|Miscellaneous|0
7156657|NCT03364309|11324834|FG017|Post-Treatment Followup Period|Miscellaneous|4
7156658|NCT03364309|11324835|FG018|Post-Treatment Followup Period|Miscellaneous|0
7156659|NCT03364335|11324864|FG000|Overall Study|Adverse Event|3
7156660|NCT03364335|11324865|FG001|Overall Study|Adverse Event|4
7156661|NCT03364335|11324866|FG002|Overall Study|Adverse Event|1
7156662|NCT03364335|11324867|FG003|Overall Study|Adverse Event|2
7156663|NCT03364335|11324868|FG004|Overall Study|Adverse Event|0
7156664|NCT03364335|11324864|FG000|Overall Study|Lost to Follow-up|7
7156665|NCT03364335|11324865|FG001|Overall Study|Lost to Follow-up|7
7156666|NCT03364335|11324866|FG002|Overall Study|Lost to Follow-up|10
7156667|NCT03364335|11324867|FG003|Overall Study|Lost to Follow-up|11
7156668|NCT03364335|11324868|FG004|Overall Study|Lost to Follow-up|11
7156669|NCT03364608|11324880|FG000|Overall Study|Withdrawal by Subject|4
7156670|NCT03364608|11324880|FG000|Overall Study|Protocol Violation|2
7156671|NCT03364608|11324880|FG000|Overall Study|Lost to Follow-up|2
7156672|NCT03364738|11324892|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6
7156673|NCT03364738|11324892|FG000|Overall Study|Withdrawal by Subject|1
7156674|NCT03364738|11324892|FG000|Overall Study|Adverse Event|1
7156675|NCT03364751|11324901|FG000|Overall Study|Withdrawal by Subject|1
7156676|NCT03364751|11324902|FG001|Overall Study|Withdrawal by Subject|0
7156677|NCT03364751|11324903|FG002|Overall Study|Withdrawal by Subject|0
7156678|NCT03364751|11324904|FG003|Overall Study|Withdrawal by Subject|0
7156679|NCT03364751|11324901|FG000|Overall Study|Lost to Follow-up|0
7156680|NCT03364751|11324902|FG001|Overall Study|Lost to Follow-up|1
7156681|NCT03364751|11324903|FG002|Overall Study|Lost to Follow-up|0
7156682|NCT03364751|11324904|FG003|Overall Study|Lost to Follow-up|0
7156683|NCT03365011|11324920|FG000|Overall Study|Withdrawal by Subject|1
7156684|NCT03365011|11324921|FG001|Overall Study|Withdrawal by Subject|2
7156685|NCT03365934|11324944|FG000|Overall Study|Adverse Event|1
7156686|NCT03365934|11324944|FG000|Overall Study|Withdrawal by Subject|1
7156687|NCT03367793|11324974|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0
7156688|NCT03367793|11324975|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0
7156689|NCT03367793|11324976|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1
7156690|NCT03367793|11324977|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0
7156691|NCT03367793|11324978|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0
7156692|NCT03367793|11324979|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0
7156693|NCT03368807|11325003|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3
7156694|NCT03368807|11325003|FG000|Period 1 (Blinded CGM)|Protocol Violation|1
7156695|NCT03368807|11325003|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1
7156696|NCT03368807|11325003|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1
7156697|NCT03368859|11325011|FG000|Overall Study|Withdrew Consent|5
7156698|NCT03368859|11325012|FG001|Overall Study|Withdrew Consent|4
7156699|NCT03368859|11325011|FG000|Overall Study|Death|12
7156700|NCT03368859|11325012|FG001|Overall Study|Death|6
6972585|NCT01172938|11023770|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
6972586|NCT01172938|11023771|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2
6972587|NCT01172938|11023772|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
6972588|NCT01172938|11023773|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
6972589|NCT01172938|11023774|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
6972590|NCT01172938|11023775|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
6972591|NCT01172938|11023776|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
6972592|NCT01172938|11023777|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
6972593|NCT01172938|11023769|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
6972594|NCT01172938|11023770|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
6972595|NCT01172938|11023771|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
6972596|NCT01172938|11023772|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
6972597|NCT01172938|11023773|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
6972598|NCT01172938|11023774|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
6972599|NCT01172938|11023775|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
6972600|NCT01172938|11023776|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
6972601|NCT01172938|11023777|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
6972602|NCT01172938|11023769|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
6972603|NCT01172938|11023770|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2
6972604|NCT01172938|11023771|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3
6972605|NCT01172938|11023772|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
6972606|NCT01172938|11023773|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
6972607|NCT01172938|11023774|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
6972608|NCT01172938|11023775|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
6972609|NCT01172938|11023776|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1
6972610|NCT01172938|11023777|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
6972611|NCT01172938|11023769|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0
6972612|NCT01172938|11023770|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0
6972613|NCT01172938|11023771|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1
6972614|NCT01172938|11023772|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0
6972615|NCT01172938|11023773|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0
6972616|NCT01172938|11023774|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0
6972617|NCT01172938|11023775|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0
6972618|NCT01172938|11023776|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0
6972619|NCT01172938|11023777|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0
6972620|NCT01172938|11023769|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
6972621|NCT01172938|11023770|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
6972622|NCT01172938|11023771|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1
6972623|NCT01172938|11023772|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
6972624|NCT01172938|11023773|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
6972625|NCT01172938|11023774|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
6972626|NCT01172938|11023775|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
6972627|NCT01172938|11023776|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
6972628|NCT01172938|11023777|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
6972629|NCT01172938|11023769|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
6972630|NCT01172938|11023770|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
6972631|NCT01172938|11023771|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
6972632|NCT01172938|11023772|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
6972633|NCT01172938|11023773|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
6972634|NCT01172938|11023774|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
6972635|NCT01172938|11023775|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
6972636|NCT01172938|11023776|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
6972637|NCT01172938|11023777|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1
6972638|NCT01173055|11023819|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2
6972639|NCT01173055|11023820|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2
6972640|NCT01173055|11023819|FG000|Period 2 - Day 64 to 112|Adverse Event|0
6972641|NCT01173055|11023820|FG001|Period 2 - Day 64 to 112|Adverse Event|1
6972642|NCT01173120|11023826|FG000|Overall Study|Lack of Efficacy|2
6972643|NCT01173120|11023826|FG000|Overall Study|Lost to Follow-up|1
6972644|NCT01173120|11023826|FG000|Overall Study|Participant Decision|2
6972645|NCT01173120|11023826|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33
6972646|NCT01173120|11023826|FG000|Overall Study|Switch-Participant Decision|12
6972647|NCT01173120|11023826|FG000|Overall Study|Switch-Difficulty With Device|12
6972648|NCT01173471|11023865|FG000|Overall Study|Eligibility criteria not fulfilled|0
6972649|NCT01173471|11023866|FG001|Overall Study|Eligibility criteria not fulfilled|0
6972650|NCT01173471|11023867|FG002|Overall Study|Eligibility criteria not fulfilled|1
6972651|NCT01173471|11023868|FG003|Overall Study|Eligibility criteria not fulfilled|1
6972652|NCT01173471|11023865|FG000|Overall Study|Condition under investigation worsened|2
6972653|NCT01173471|11023866|FG001|Overall Study|Condition under investigation worsened|0
6972654|NCT01173471|11023867|FG002|Overall Study|Condition under investigation worsened|0
6972655|NCT01173471|11023868|FG003|Overall Study|Condition under investigation worsened|0
6972656|NCT01173471|11023865|FG000|Overall Study|Lost to Follow-up|0
6972657|NCT01173471|11023866|FG001|Overall Study|Lost to Follow-up|0
6972658|NCT01173471|11023867|FG002|Overall Study|Lost to Follow-up|1
6972659|NCT01173471|11023868|FG003|Overall Study|Lost to Follow-up|0
6972660|NCT01173471|11023865|FG000|Overall Study|Reason given as Other|0
6972661|NCT01173471|11023866|FG001|Overall Study|Reason given as Other|0
6972662|NCT01173471|11023867|FG002|Overall Study|Reason given as Other|1
6972663|NCT01173471|11023868|FG003|Overall Study|Reason given as Other|0
6972664|NCT01173523|11023880|FG000|Overall Study|Clinical Progression|1
6972665|NCT01173523|11023881|FG001|Overall Study|Clinical Progression|1
6972666|NCT01173523|11023880|FG000|Overall Study|Progressive Disease|10
7156701|NCT03368859|11325011|FG000|Overall Study|Study terminated by Sponsor|18
7156702|NCT03368859|11325012|FG001|Overall Study|Study terminated by Sponsor|23
7156703|NCT03368859|11325011|FG000|Overall Study|Other|1
7156704|NCT03368859|11325012|FG001|Overall Study|Other|1
7156705|NCT03369236|11325042|FG000|Double-blind Treatment Period|Accidental unblinding|0
7156706|NCT03369236|11325043|FG001|Double-blind Treatment Period|Accidental unblinding|1
7156707|NCT03369236|11325042|FG000|Open-label Extension Period|Lack of Efficacy|2
7156708|NCT03369236|11325043|FG001|Open-label Extension Period|Lack of Efficacy|1
7156709|NCT03369236|11325042|FG000|Open-label Extension Period|Adverse Event|0
7156710|NCT03369236|11325043|FG001|Open-label Extension Period|Adverse Event|1
7156711|NCT03369236|11325042|FG000|Open-label Extension Period|Sponsor decision to close study|3
7156712|NCT03369236|11325043|FG001|Open-label Extension Period|Sponsor decision to close study|4
7156713|NCT03369418|11325072|FG000|Overall Study|Withdrawal by Subject|3
7156714|NCT03369418|11325073|FG001|Overall Study|Withdrawal by Subject|3
7156715|NCT03369704|11325081|FG000|Treatment Epoch|technical problems|1
7156716|NCT03369704|11325082|FG001|Treatment Epoch|technical problems|0
7156717|NCT03369704|11325081|FG000|Treatment Epoch|Protocol Violation|1
7156718|NCT03369704|11325082|FG001|Treatment Epoch|Protocol Violation|0
7156719|NCT03369704|11325081|FG000|Treatment Epoch|Lost to Follow-up|0
7156720|NCT03369704|11325082|FG001|Treatment Epoch|Lost to Follow-up|1
7156721|NCT03369704|11325081|FG000|Treatment Epoch|Lack of Efficacy|0
7156722|NCT03369704|11325082|FG001|Treatment Epoch|Lack of Efficacy|2
7156723|NCT03369704|11325081|FG000|Treatment Epoch|Adverse Event|2
7156724|NCT03369704|11325082|FG001|Treatment Epoch|Adverse Event|0
7156725|NCT03369704|11325081|FG000|Follow-up Epoch|Lost to Follow-up|1
7156726|NCT03369704|11325082|FG001|Follow-up Epoch|Lost to Follow-up|0
7156727|NCT03369951|11325092|FG000|Overall Study|Withdrawal by Subject|3
7156728|NCT03369951|11325092|FG000|Overall Study|Death|1
7156729|NCT03369951|11325092|FG000|Overall Study|Lost to Follow-up|1
7156730|NCT03369951|11325092|FG000|Overall Study|Protocol Violation|1
7156731|NCT03370289|11325109|FG000|Overall Study|Screen Failure|1
7156732|NCT03370289|11325109|FG000|Overall Study|Sample Size Sufficient|4
7156733|NCT03370302|11325119|FG000|Dose Escalation Phase|Other|0
7156734|NCT03370302|11325120|FG001|Dose Escalation Phase|Other|1
7156735|NCT03370302|11325121|FG002|Dose Escalation Phase|Other|1
7156736|NCT03370302|11325122|FG003|Dose Escalation Phase|Other|0
7156737|NCT03370302|11325123|FG004|Dose Escalation Phase|Other|0
7156738|NCT03370302|11325124|FG005|Dose Escalation Phase|Other|0
7156739|NCT03370302|11325119|FG000|Dose Escalation Phase|Withdrawal by Subject|0
7156740|NCT03370302|11325120|FG001|Dose Escalation Phase|Withdrawal by Subject|1
7156741|NCT03370302|11325121|FG002|Dose Escalation Phase|Withdrawal by Subject|2
7156742|NCT03370302|11325122|FG003|Dose Escalation Phase|Withdrawal by Subject|0
7156743|NCT03370302|11325123|FG004|Dose Escalation Phase|Withdrawal by Subject|0
7156744|NCT03370302|11325124|FG005|Dose Escalation Phase|Withdrawal by Subject|2
7156745|NCT03370302|11325119|FG000|Dose Escalation Phase|Adverse Event|1
7156746|NCT03370302|11325120|FG001|Dose Escalation Phase|Adverse Event|0
7156747|NCT03370302|11325121|FG002|Dose Escalation Phase|Adverse Event|2
7156748|NCT03370302|11325122|FG003|Dose Escalation Phase|Adverse Event|0
7156749|NCT03370302|11325123|FG004|Dose Escalation Phase|Adverse Event|0
7156750|NCT03370302|11325124|FG005|Dose Escalation Phase|Adverse Event|0
7156751|NCT03370302|11325119|FG000|Dose Escalation Phase|Progressive Disease|2
7156752|NCT03370302|11325120|FG001|Dose Escalation Phase|Progressive Disease|4
7156753|NCT03370302|11325121|FG002|Dose Escalation Phase|Progressive Disease|2
7156754|NCT03370302|11325122|FG003|Dose Escalation Phase|Progressive Disease|0
7156755|NCT03370302|11325123|FG004|Dose Escalation Phase|Progressive Disease|3
7156756|NCT03370302|11325124|FG005|Dose Escalation Phase|Progressive Disease|1
7156757|NCT03370302|11325119|FG000|Dose Expansion Phase|Progressive Disease|0
7156758|NCT03370302|11325120|FG001|Dose Expansion Phase|Progressive Disease|0
7156759|NCT03370302|11325121|FG002|Dose Expansion Phase|Progressive Disease|0
7156760|NCT03370302|11325122|FG003|Dose Expansion Phase|Progressive Disease|6
7156761|NCT03370302|11325123|FG004|Dose Expansion Phase|Progressive Disease|0
7156762|NCT03370302|11325124|FG005|Dose Expansion Phase|Progressive Disease|0
7156763|NCT03370419|11325142|FG000|Overall Study|Lost to Follow-up|16
7156764|NCT03370471|11325148|FG000|Overall Study|Withdrawal by Subject|6
7156765|NCT03370471|11325149|FG001|Overall Study|Withdrawal by Subject|1
6972667|NCT01173523|11023881|FG001|Overall Study|Progressive Disease|8
6972668|NCT01173523|11023880|FG000|Overall Study|Other|2
6972669|NCT01173523|11023881|FG001|Overall Study|Other|3
6972670|NCT01173601|11023891|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23
6972671|NCT01173601|11023892|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
6972672|NCT01173601|11023893|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
7156766|NCT03370471|11325148|FG000|Overall Study|Unable to access veins for blood draw|0
7156767|NCT03370471|11325149|FG001|Overall Study|Unable to access veins for blood draw|1
7156768|NCT03370471|11325148|FG000|Overall Study|Screen fail|1
7156769|NCT03370471|11325149|FG001|Overall Study|Screen fail|0
7156770|NCT03370770|11325157|FG000|Overall Study|Patient was followed in another hospital center|1
7156771|NCT03370770|11325157|FG000|Overall Study|Progressive Disease|98
7156772|NCT03370770|11325157|FG000|Overall Study|Adverse Event|2
7156773|NCT03370770|11325157|FG000|Overall Study|Death|5
7156774|NCT03371355|11325165|FG000|Overall Study|Investigator judgment|0
7156775|NCT03371355|11325166|FG001|Overall Study|Investigator judgment|0
7156776|NCT03371355|11325167|FG002|Overall Study|Investigator judgment|1
7156777|NCT03371355|11325168|FG003|Overall Study|Investigator judgment|1
7156778|NCT03371355|11325165|FG000|Overall Study|Voluntary withdrawal|1
7156779|NCT03371355|11325166|FG001|Overall Study|Voluntary withdrawal|0
7156780|NCT03371355|11325167|FG002|Overall Study|Voluntary withdrawal|1
7156781|NCT03371355|11325168|FG003|Overall Study|Voluntary withdrawal|2
7156782|NCT03371355|11325165|FG000|Overall Study|Adverse Event|0
7156783|NCT03371355|11325166|FG001|Overall Study|Adverse Event|1
7156784|NCT03371355|11325167|FG002|Overall Study|Adverse Event|2
7156785|NCT03371355|11325168|FG003|Overall Study|Adverse Event|3
7156786|NCT03371355|11325165|FG000|Overall Study|Reason not Specified|0
7156787|NCT03371355|11325166|FG001|Overall Study|Reason not Specified|1
7156788|NCT03371355|11325167|FG002|Overall Study|Reason not Specified|0
7156789|NCT03371355|11325168|FG003|Overall Study|Reason not Specified|1
7156790|NCT03371381|11325182|FG000|Overall Study|Death|5
7156791|NCT03371381|11325182|FG000|Overall Study|Study terminated by sponsor|3
7156792|NCT03371381|11325182|FG000|Overall Study|Other|4
7156793|NCT03371459|11325186|FG000|Washout|Lost to Follow-up|0
7156794|NCT03371459|11325187|FG001|Washout|Lost to Follow-up|1
7156795|NCT03371732|11325195|FG000|Overall Study|Withdrawal by Subject|9
7156796|NCT03371732|11325196|FG001|Overall Study|Withdrawal by Subject|3
7156797|NCT03371732|11325195|FG000|Overall Study|Refusal to continue|3
7156798|NCT03371732|11325196|FG001|Overall Study|Refusal to continue|4
7156799|NCT03372083|11325208|FG000|Overall Study|Adverse Event|3
7156800|NCT03372083|11325208|FG000|Overall Study|Physician Decision|1
7156801|NCT03372083|11325208|FG000|Overall Study|Withdrawal by Subject|1
7156802|NCT03372096|11325212|FG000|Overall Study|Study Closed|8
7156803|NCT03372369|11325221|FG000|Qualification Period|Withdrawal by Subject|16
7156804|NCT03372369|11325222|FG001|Qualification Period|Withdrawal by Subject|13
7156805|NCT03372369|11325221|FG000|Qualification Period|Inconsistent Eligibility Results|10
7156806|NCT03372369|11325222|FG001|Qualification Period|Inconsistent Eligibility Results|9
7156807|NCT03372369|11325221|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3
7156808|NCT03372369|11325222|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3
7156809|NCT03372551|11325252|FG000|First Intervention (1 Week)|Withdrawal by Subject|1
7156810|NCT03372551|11325253|FG001|First Intervention (1 Week)|Withdrawal by Subject|0
7156811|NCT03372603|11325266|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1
7156812|NCT03372603|11325267|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0
7156813|NCT03372603|11325266|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1
7156814|NCT03372603|11325267|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0
7156815|NCT03373383|11325304|FG000|Treatment Period: Wk0-16|Adverse Event|7
7156816|NCT03373383|11325305|FG001|Treatment Period: Wk0-16|Adverse Event|6
7156817|NCT03373383|11325306|FG002|Treatment Period: Wk0-16|Adverse Event|11
7156818|NCT03373383|11325307|FG003|Treatment Period: Wk0-16|Adverse Event|15
7156819|NCT03373383|11325308|FG004|Treatment Period: Wk0-16|Adverse Event|21
7156820|NCT03373383|11325304|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2
7156821|NCT03373383|11325305|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1
7156822|NCT03373383|11325306|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0
7156823|NCT03373383|11325307|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0
7156824|NCT03373383|11325308|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0
7156825|NCT03373383|11325304|FG000|Treatment Period: Wk0-16|Protocol Violation|0
7156826|NCT03373383|11325305|FG001|Treatment Period: Wk0-16|Protocol Violation|4
7156827|NCT03373383|11325306|FG002|Treatment Period: Wk0-16|Protocol Violation|2
7156828|NCT03373383|11325307|FG003|Treatment Period: Wk0-16|Protocol Violation|1
7156829|NCT03373383|11325308|FG004|Treatment Period: Wk0-16|Protocol Violation|0
7156830|NCT03373383|11325304|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2
7156831|NCT03373383|11325305|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0
7156832|NCT03373383|11325306|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0
7156833|NCT03373383|11325307|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0
7156834|NCT03373383|11325308|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0
7156835|NCT03373383|11325304|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2
6972673|NCT01173601|11023894|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
7156836|NCT03373383|11325305|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3
7156837|NCT03373383|11325306|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2
7156838|NCT03373383|11325307|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3
7156839|NCT03373383|11325308|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3
6972674|NCT01173601|11023895|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
6972675|NCT01173601|11023891|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9
7156840|NCT03373383|11325304|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0
7156841|NCT03373383|11325305|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1
7156842|NCT03373383|11325306|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0
7156843|NCT03373383|11325307|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0
7156844|NCT03373383|11325308|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0
7156845|NCT03373383|11325304|FG000|Treatment Period: Wk0-16|By opinion of investigator|0
7156846|NCT03373383|11325305|FG001|Treatment Period: Wk0-16|By opinion of investigator|0
7156847|NCT03373383|11325306|FG002|Treatment Period: Wk0-16|By opinion of investigator|0
7156848|NCT03373383|11325307|FG003|Treatment Period: Wk0-16|By opinion of investigator|1
7156849|NCT03373383|11325308|FG004|Treatment Period: Wk0-16|By opinion of investigator|0
7156850|NCT03373383|11325304|FG000|Treatment Period: Wk0-16|Sponsor decision|0
7156851|NCT03373383|11325305|FG001|Treatment Period: Wk0-16|Sponsor decision|0
7156852|NCT03373383|11325306|FG002|Treatment Period: Wk0-16|Sponsor decision|0
7156853|NCT03373383|11325307|FG003|Treatment Period: Wk0-16|Sponsor decision|1
7156854|NCT03373383|11325308|FG004|Treatment Period: Wk0-16|Sponsor decision|0
7156855|NCT03373383|11325304|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1
7156856|NCT03373383|11325305|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0
7156857|NCT03373383|11325306|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0
7156858|NCT03373383|11325307|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0
7156859|NCT03373383|11325308|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0
7156860|NCT03374189|11325370|FG000|Overall Study|Lost to Follow-up|1
7156861|NCT03374189|11325371|FG001|Overall Study|Lost to Follow-up|0
7156862|NCT03374358|11325379|FG000|Overall Study|Withdrawal by Subject|0
7156863|NCT03374358|11325380|FG001|Overall Study|Withdrawal by Subject|2
7156864|NCT03374488|11325388|FG000|Overall Study|Death|13
7156865|NCT03374488|11325389|FG001|Overall Study|Death|13
7156866|NCT03374488|11325388|FG000|Overall Study|Withdrawal by Subject|3
7156867|NCT03374488|11325389|FG001|Overall Study|Withdrawal by Subject|1
7156868|NCT03374488|11325388|FG000|Overall Study|Physician Decision|3
7156869|NCT03374488|11325389|FG001|Overall Study|Physician Decision|0
7156870|NCT03374995|11325411|FG000|Overall Study|Withdrawal by Subject|0
7156871|NCT03374995|11325412|FG001|Overall Study|Withdrawal by Subject|1
7156872|NCT03376321|11325452|FG000|Overall Study|Other|5
7156873|NCT03376321|11325453|FG001|Overall Study|Other|1
7156874|NCT03376321|11325452|FG000|Overall Study|Withdrawal by Subject|8
7156875|NCT03376321|11325453|FG001|Overall Study|Withdrawal by Subject|14
7156876|NCT03376321|11325452|FG000|Overall Study|Lost to Follow-up|1
7156877|NCT03376321|11325453|FG001|Overall Study|Lost to Follow-up|7
7156878|NCT03376321|11325452|FG000|Overall Study|Death|4
7156879|NCT03376321|11325453|FG001|Overall Study|Death|0
7156880|NCT03376321|11325452|FG000|Overall Study|Randomized, not treated|5
7156881|NCT03376321|11325453|FG001|Overall Study|Randomized, not treated|3
7156882|NCT03376516|11325459|FG000|Overall Study|Not treated|1
7156883|NCT03376516|11325459|FG000|Overall Study|Consent withdrawn|1
7156884|NCT03377556|11325496|FG000|Overall Study|Adverse Event|5
7156885|NCT03377556|11325496|FG000|Overall Study|Refusal unrelated to adverse events|1
7156886|NCT03377556|11325496|FG000|Overall Study|Progression/relapse|38
7156887|NCT03377556|11325496|FG000|Overall Study|Death|3
7156888|NCT03377634|11325502|FG000|Study Period|Adverse Event|1
7156889|NCT03377634|11325503|FG001|Study Period|Adverse Event|0
7156890|NCT03377634|11325502|FG000|Study Period|Withdrawal by Subject|1
7156891|NCT03377634|11325503|FG001|Study Period|Withdrawal by Subject|0
7156892|NCT03378635|11325521|FG000|Overall Study|Adverse Event|1
7156893|NCT03378635|11325522|FG001|Overall Study|Adverse Event|0
7156894|NCT03378635|11325523|FG002|Overall Study|Adverse Event|0
7156895|NCT03378635|11325521|FG000|Overall Study|Withdrawal by Subject|1
7156896|NCT03378635|11325522|FG001|Overall Study|Withdrawal by Subject|0
7156897|NCT03378635|11325523|FG002|Overall Study|Withdrawal by Subject|0
7156898|NCT03379259|11325556|FG000|Overall Study|Commenced new anti-cancer therapy|1
7156899|NCT03379259|11325557|FG001|Overall Study|Commenced new anti-cancer therapy|0
7156900|NCT03379259|11325558|FG002|Overall Study|Commenced new anti-cancer therapy|0
7156901|NCT03379259|11325559|FG003|Overall Study|Commenced new anti-cancer therapy|0
7156902|NCT03379259|11325560|FG004|Overall Study|Commenced new anti-cancer therapy|0
7156903|NCT03379259|11325561|FG005|Overall Study|Commenced new anti-cancer therapy|0
7156904|NCT03379259|11325556|FG000|Overall Study|Death|0
7156905|NCT03379259|11325557|FG001|Overall Study|Death|1
7156906|NCT03379259|11325558|FG002|Overall Study|Death|2
7156907|NCT03379259|11325559|FG003|Overall Study|Death|1
7156908|NCT03379259|11325560|FG004|Overall Study|Death|4
7156909|NCT03379259|11325561|FG005|Overall Study|Death|2
7156910|NCT03379259|11325556|FG000|Overall Study|Withdrawal by Subject|0
7156911|NCT03379259|11325557|FG001|Overall Study|Withdrawal by Subject|0
7156912|NCT03379259|11325558|FG002|Overall Study|Withdrawal by Subject|1
7156913|NCT03379259|11325559|FG003|Overall Study|Withdrawal by Subject|0
7156914|NCT03379259|11325560|FG004|Overall Study|Withdrawal by Subject|2
7156915|NCT03379259|11325561|FG005|Overall Study|Withdrawal by Subject|0
7156916|NCT03379259|11325556|FG000|Overall Study|Study terminated by sponsor|0
7156917|NCT03379259|11325557|FG001|Overall Study|Study terminated by sponsor|0
7156918|NCT03379259|11325558|FG002|Overall Study|Study terminated by sponsor|0
7156919|NCT03379259|11325559|FG003|Overall Study|Study terminated by sponsor|1
7156920|NCT03379259|11325560|FG004|Overall Study|Study terminated by sponsor|1
6972676|NCT01173601|11023892|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
6972677|NCT01173601|11023893|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
6972678|NCT01173601|11023894|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
6972679|NCT01173601|11023895|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
6972680|NCT01173601|11023891|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7
6972681|NCT01173601|11023892|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
6972682|NCT01173601|11023893|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
6972683|NCT01173601|11023894|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
6972684|NCT01173601|11023895|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
6972685|NCT01173601|11023891|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3
6972686|NCT01173601|11023892|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
6972687|NCT01173601|11023893|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
6972688|NCT01173601|11023894|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
6972689|NCT01173601|11023895|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
6972690|NCT01173601|11023891|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15
6972691|NCT01173601|11023892|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
7156921|NCT03379259|11325561|FG005|Overall Study|Study terminated by sponsor|4
7156922|NCT03379259|11325556|FG000|Overall Study|Disease progression|0
7156923|NCT03379259|11325557|FG001|Overall Study|Disease progression|0
7156924|NCT03379259|11325558|FG002|Overall Study|Disease progression|0
7156925|NCT03379259|11325559|FG003|Overall Study|Disease progression|1
7156926|NCT03379259|11325560|FG004|Overall Study|Disease progression|0
7156927|NCT03379259|11325561|FG005|Overall Study|Disease progression|1
7156928|NCT03379259|11325556|FG000|Overall Study|Lost to Follow-up|0
7156929|NCT03379259|11325557|FG001|Overall Study|Lost to Follow-up|0
7156930|NCT03379259|11325558|FG002|Overall Study|Lost to Follow-up|0
7156931|NCT03379259|11325559|FG003|Overall Study|Lost to Follow-up|0
7156932|NCT03379259|11325560|FG004|Overall Study|Lost to Follow-up|1
7156933|NCT03379259|11325561|FG005|Overall Study|Lost to Follow-up|0
7156934|NCT03379259|11325556|FG000|Overall Study|Deteriorating condition|0
7156935|NCT03379259|11325557|FG001|Overall Study|Deteriorating condition|0
7156936|NCT03379259|11325558|FG002|Overall Study|Deteriorating condition|0
7156937|NCT03379259|11325559|FG003|Overall Study|Deteriorating condition|0
7156938|NCT03379259|11325560|FG004|Overall Study|Deteriorating condition|1
7156939|NCT03379259|11325561|FG005|Overall Study|Deteriorating condition|0
7156940|NCT03379376|11325578|FG000|Overall Study|Lost to Follow-up|2
7156941|NCT03379376|11325578|FG000|Overall Study|Did not wish to complete follow up|1
7156942|NCT03379376|11325578|FG000|Overall Study|Overwhelmed, didn't want to continue|1
7156943|NCT03379376|11325578|FG000|Overall Study|Death|1
7156944|NCT03379753|11325631|FG000|Overall Study|Withdrawal by Subject|2
7156945|NCT03379753|11325632|FG001|Overall Study|Withdrawal by Subject|1
7156946|NCT03379753|11325631|FG000|Overall Study|not having correct procedure|1
7156947|NCT03379753|11325632|FG001|Overall Study|not having correct procedure|2
7156948|NCT03379753|11325631|FG000|Overall Study|No primary outcome|12
7156949|NCT03379753|11325632|FG001|Overall Study|No primary outcome|22
7156950|NCT03380091|11325654|FG000|Overall Study|Withdrawal by Subject|2
7156951|NCT03380091|11325655|FG001|Overall Study|Withdrawal by Subject|1
7156952|NCT03380390|11325663|FG000|Overall Study|Adverse Event|3
7156953|NCT03380429|11325672|FG000|Overall Study|Physician Decision|0
7156954|NCT03380429|11325673|FG001|Overall Study|Physician Decision|1
7156955|NCT03380429|11325674|FG002|Overall Study|Physician Decision|0
7156956|NCT03380429|11325675|FG003|Overall Study|Physician Decision|1
7156957|NCT03380429|11325676|FG004|Overall Study|Physician Decision|1
7156958|NCT03380429|11325672|FG000|Overall Study|Withdrawal by Subject|3
7156959|NCT03380429|11325673|FG001|Overall Study|Withdrawal by Subject|3
7156960|NCT03380429|11325674|FG002|Overall Study|Withdrawal by Subject|5
7156961|NCT03380429|11325675|FG003|Overall Study|Withdrawal by Subject|2
7156962|NCT03380429|11325676|FG004|Overall Study|Withdrawal by Subject|1
7156963|NCT03380429|11325672|FG000|Overall Study|Lost to Follow-up|0
7156964|NCT03380429|11325673|FG001|Overall Study|Lost to Follow-up|2
7156965|NCT03380429|11325674|FG002|Overall Study|Lost to Follow-up|4
7156966|NCT03380429|11325675|FG003|Overall Study|Lost to Follow-up|3
7156967|NCT03380429|11325676|FG004|Overall Study|Lost to Follow-up|1
7156968|NCT03380429|11325672|FG000|Overall Study|Protocol Violation|1
7156969|NCT03380429|11325673|FG001|Overall Study|Protocol Violation|0
7156970|NCT03380429|11325674|FG002|Overall Study|Protocol Violation|1
7156971|NCT03380429|11325675|FG003|Overall Study|Protocol Violation|0
7156972|NCT03380429|11325676|FG004|Overall Study|Protocol Violation|1
7156973|NCT03380429|11325672|FG000|Overall Study|Lack of Efficacy|0
7156974|NCT03380429|11325673|FG001|Overall Study|Lack of Efficacy|0
7156975|NCT03380429|11325674|FG002|Overall Study|Lack of Efficacy|0
7156976|NCT03380429|11325675|FG003|Overall Study|Lack of Efficacy|2
7156977|NCT03380429|11325676|FG004|Overall Study|Lack of Efficacy|1
7156978|NCT03380429|11325672|FG000|Overall Study|Adverse Event|1
7156979|NCT03380429|11325673|FG001|Overall Study|Adverse Event|1
7156980|NCT03380429|11325674|FG002|Overall Study|Adverse Event|1
7156981|NCT03380429|11325675|FG003|Overall Study|Adverse Event|2
7156982|NCT03380429|11325676|FG004|Overall Study|Adverse Event|0
7156983|NCT03381196|11325721|FG000|Overall Study|Withdrawal by Subject|7
7156984|NCT03381196|11325722|FG001|Overall Study|Withdrawal by Subject|7
7156985|NCT03381196|11325721|FG000|Overall Study|Other|0
7156986|NCT03381196|11325722|FG001|Overall Study|Other|1
6972692|NCT01173601|11023893|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
6972693|NCT01173601|11023894|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
6972694|NCT01173601|11023895|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
6972695|NCT01173601|11023891|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25
6972696|NCT01173601|11023892|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
6972697|NCT01173601|11023893|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
6972698|NCT01173601|11023894|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
6972699|NCT01173601|11023895|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
7156987|NCT03381196|11325721|FG000|Overall Study|Lost to Follow-up|5
7156988|NCT03381196|11325722|FG001|Overall Study|Lost to Follow-up|4
7156989|NCT03381196|11325721|FG000|Overall Study|Death|0
7156990|NCT03381196|11325722|FG001|Overall Study|Death|1
7156991|NCT03381196|11325721|FG000|Overall Study|Adverse Event|1
7156992|NCT03381196|11325722|FG001|Overall Study|Adverse Event|0
7156993|NCT03381196|11325721|FG000|Overall Study|Randomized, not treated|3
7156994|NCT03381196|11325722|FG001|Overall Study|Randomized, not treated|6
7156995|NCT03381248|11325730|FG000|Overall Study|Withdrawal by Subject|5
7156996|NCT03381248|11325731|FG001|Overall Study|Withdrawal by Subject|3
7156997|NCT03381248|11325730|FG000|Overall Study|Lost to Follow-up|3
7156998|NCT03381248|11325731|FG001|Overall Study|Lost to Follow-up|2
7156999|NCT03381248|11325730|FG000|Overall Study|Lack of Efficacy|1
7157000|NCT03381248|11325731|FG001|Overall Study|Lack of Efficacy|0
7157001|NCT03381248|11325730|FG000|Overall Study|Adverse Event|2
7157002|NCT03381248|11325731|FG001|Overall Study|Adverse Event|0
7157003|NCT03381248|11325730|FG000|Overall Study|Protocol Violation|2
7157004|NCT03381248|11325731|FG001|Overall Study|Protocol Violation|1
7157005|NCT03381339|11325739|FG000|Overall Study|Protocol Violation|4
7157006|NCT03381339|11325740|FG001|Overall Study|Protocol Violation|3
7157007|NCT03381339|11325739|FG000|Overall Study|Lost to Follow-up|0
7157008|NCT03381339|11325740|FG001|Overall Study|Lost to Follow-up|1
7157009|NCT03382262|11325772|FG000|Overall Study|Physician Decision|0
7157010|NCT03382262|11325773|FG001|Overall Study|Physician Decision|0
7157011|NCT03382262|11325774|FG002|Overall Study|Physician Decision|1
7157012|NCT03382262|11325775|FG003|Overall Study|Physician Decision|0
6972700|NCT01173601|11023891|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6
6972701|NCT01173601|11023892|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
6972702|NCT01173601|11023893|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
6972703|NCT01173601|11023894|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
6972704|NCT01173601|11023895|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
6972705|NCT01173601|11023891|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
6972706|NCT01173601|11023892|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10
6972707|NCT01173601|11023893|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15
6972708|NCT01173601|11023894|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7
6972709|NCT01173601|11023895|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14
7041395|NCT01727258|11125009|FG002|Overall Study|Withdrawal by Subject|0
7041396|NCT01727258|11125007|FG000|Overall Study|Lost to Follow-up|1
7157013|NCT03382262|11325772|FG000|Overall Study|Withdrawal by Subject|0
7157014|NCT03382262|11325773|FG001|Overall Study|Withdrawal by Subject|0
7041397|NCT01727258|11125008|FG001|Overall Study|Lost to Follow-up|0
7041398|NCT01727258|11125009|FG002|Overall Study|Lost to Follow-up|0
7041399|NCT01727297|11125017|FG000|Overall Study|Death|13
7041400|NCT01727297|11125018|FG001|Overall Study|Death|0
7041401|NCT01727297|11125017|FG000|Overall Study|Protocol Violation|1
7041402|NCT01727297|11125018|FG001|Overall Study|Protocol Violation|10
7041403|NCT01727297|11125017|FG000|Overall Study|Adverse Event|3
7041404|NCT01727297|11125018|FG001|Overall Study|Adverse Event|1
7041405|NCT01727297|11125017|FG000|Overall Study|Lost to Follow-up|11
7041406|NCT01727297|11125018|FG001|Overall Study|Lost to Follow-up|0
7041407|NCT01727297|11125017|FG000|Overall Study|Withdrawal by Subject|26
7041408|NCT01727297|11125018|FG001|Overall Study|Withdrawal by Subject|27
7041409|NCT01727297|11125017|FG000|Overall Study|Physician Decision|19
7041410|NCT01727297|11125018|FG001|Overall Study|Physician Decision|5
7041411|NCT01727297|11125017|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29
7041412|NCT01727297|11125018|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8
7041413|NCT01727336|11125037|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0
7041414|NCT01727336|11125038|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1
7041415|NCT01727336|11125039|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5
7041416|NCT01727336|11125040|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0
7041417|NCT01727336|11125041|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0
7041418|NCT01727336|11125042|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0
7041419|NCT01727336|11125037|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3
7041420|NCT01727336|11125038|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1
7041421|NCT01727336|11125039|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3
7041422|NCT01727336|11125040|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0
7041423|NCT01727336|11125041|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0
7157015|NCT03382262|11325774|FG002|Overall Study|Withdrawal by Subject|0
7157016|NCT03382262|11325775|FG003|Overall Study|Withdrawal by Subject|1
7157017|NCT03382418|11325788|FG000|Overall Study|Withdrawal by Subject|1
7157018|NCT03382418|11325789|FG001|Overall Study|Withdrawal by Subject|0
6972710|NCT01173601|11023891|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
6972711|NCT01173601|11023892|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10
6972712|NCT01173601|11023893|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6
6972713|NCT01173601|11023894|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
6972714|NCT01173601|11023895|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9
6972715|NCT01173601|11023891|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
6972716|NCT01173601|11023892|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
6972717|NCT01173601|11023893|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
6972718|NCT01173601|11023894|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
6972719|NCT01173601|11023895|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
6972720|NCT01173601|11023891|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
6972721|NCT01173601|11023892|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
6972722|NCT01173601|11023893|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
6972723|NCT01173601|11023894|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
6972724|NCT01173601|11023895|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
6972725|NCT01173601|11023891|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
7041424|NCT01727336|11125042|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0
7041425|NCT01727336|11125037|FG000|Part 2 Blinded|Death|0
7041426|NCT01727336|11125038|FG001|Part 2 Blinded|Death|0
7041427|NCT01727336|11125039|FG002|Part 2 Blinded|Death|0
7041428|NCT01727336|11125040|FG003|Part 2 Blinded|Death|0
7041429|NCT01727336|11125041|FG004|Part 2 Blinded|Death|20
7041430|NCT01727336|11125042|FG005|Part 2 Blinded|Death|16
7041431|NCT01727336|11125037|FG000|Part 2 Blinded|Lack of Efficacy|0
7041432|NCT01727336|11125038|FG001|Part 2 Blinded|Lack of Efficacy|0
7041433|NCT01727336|11125039|FG002|Part 2 Blinded|Lack of Efficacy|0
7041434|NCT01727336|11125040|FG003|Part 2 Blinded|Lack of Efficacy|0
7041435|NCT01727336|11125041|FG004|Part 2 Blinded|Lack of Efficacy|42
7041436|NCT01727336|11125042|FG005|Part 2 Blinded|Lack of Efficacy|44
7041437|NCT01727336|11125037|FG000|Part 2 Blinded|Lost to Follow-up|0
7041438|NCT01727336|11125038|FG001|Part 2 Blinded|Lost to Follow-up|0
7041439|NCT01727336|11125039|FG002|Part 2 Blinded|Lost to Follow-up|0
7041440|NCT01727336|11125040|FG003|Part 2 Blinded|Lost to Follow-up|0
7041441|NCT01727336|11125041|FG004|Part 2 Blinded|Lost to Follow-up|0
7041442|NCT01727336|11125042|FG005|Part 2 Blinded|Lost to Follow-up|1
7041443|NCT01727336|11125037|FG000|Part 2 Blinded|Withdrawal by Subject|0
7041444|NCT01727336|11125038|FG001|Part 2 Blinded|Withdrawal by Subject|0
7041445|NCT01727336|11125039|FG002|Part 2 Blinded|Withdrawal by Subject|0
7041446|NCT01727336|11125040|FG003|Part 2 Blinded|Withdrawal by Subject|0
7041447|NCT01727336|11125041|FG004|Part 2 Blinded|Withdrawal by Subject|0
7041448|NCT01727336|11125042|FG005|Part 2 Blinded|Withdrawal by Subject|4
7041449|NCT01727336|11125037|FG000|Part 2 Blinded|use of prohibited medications|0
7041450|NCT01727336|11125038|FG001|Part 2 Blinded|use of prohibited medications|0
7041451|NCT01727336|11125039|FG002|Part 2 Blinded|use of prohibited medications|0
7041452|NCT01727336|11125040|FG003|Part 2 Blinded|use of prohibited medications|0
7041453|NCT01727336|11125041|FG004|Part 2 Blinded|use of prohibited medications|1
7041454|NCT01727336|11125042|FG005|Part 2 Blinded|use of prohibited medications|3
7044835|NCT01757821|11130871|FG000|Overall Study|Adverse Event|1
7044836|NCT01757847|11130881|FG000|Overall Study|Withdrawal by Subject|3
7044837|NCT01757847|11130882|FG001|Overall Study|Withdrawal by Subject|4
7044838|NCT01758289|11130895|FG000|Overall Study|Premature Study Termination|44
7044839|NCT01758289|11130895|FG000|Overall Study|Adverse Event|9
7044840|NCT01758523|11130934|FG000|Overall Study|Adverse Event|2
7044841|NCT01758523|11130935|FG001|Overall Study|Adverse Event|1
7044842|NCT01758523|11130934|FG000|Overall Study|Lack of Efficacy|4
7044843|NCT01758523|11130935|FG001|Overall Study|Lack of Efficacy|2
7044844|NCT01758523|11130934|FG000|Overall Study|Lost to Follow-up|3
7044845|NCT01758523|11130935|FG001|Overall Study|Lost to Follow-up|4
7044846|NCT01758523|11130934|FG000|Overall Study|Withdrawal by Subject|12
7044847|NCT01758523|11130935|FG001|Overall Study|Withdrawal by Subject|7
7044848|NCT01758731|11130956|FG000|Overall Study|Physician Decision|1
7044849|NCT01758900|11130962|FG000|Overall Study|difficulty for further intubation|7
7044850|NCT01758900|11130963|FG001|Overall Study|difficulty for further intubation|8
7044851|NCT01759264|11130982|FG000|Overall Study|Serious Adverse Events (SAEs)|1
7044852|NCT01759264|11130982|FG000|Overall Study|Adverse Event|1
7044853|NCT01759264|11130982|FG000|Overall Study|Other|2
7044854|NCT01759264|11130982|FG000|Overall Study|Lost to Follow-up|2
7044855|NCT01759264|11130982|FG000|Overall Study|Withdrawal by Subject|3
7044856|NCT01759264|11130982|FG000|Overall Study|Discontinued Humira Due to Business Trip|1
7044857|NCT01759290|11130998|FG000|Overall Study|Subjects withdrawn consent|5
7044858|NCT01759290|11130998|FG000|Overall Study|Physician Decision|2
7044859|NCT01759290|11130998|FG000|Overall Study|Death|17
7044860|NCT01759290|11130998|FG000|Overall Study|Lost to Follow-up|53
7044861|NCT01759290|11130998|FG000|Overall Study|Unknown reason|4
7044862|NCT01759368|11131004|FG000|Overall Study|Lost to Follow-up|1
7044863|NCT01759368|11131005|FG001|Overall Study|Lost to Follow-up|0
7044864|NCT01759381|11131015|FG000|Overall Study|Death|1
7044865|NCT01759381|11131016|FG001|Overall Study|Death|0
6972726|NCT01173601|11023892|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1
6972727|NCT01173601|11023893|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
7041455|NCT01727505|11125071|FG000|First 24 Hours|Adverse Event|0
7041456|NCT01727505|11125072|FG001|First 24 Hours|Adverse Event|1
7079577|NCT02116361|11188861|FG002|Overall Study|Lost to Follow-up|7
7079578|NCT02116361|11188862|FG003|Overall Study|Lost to Follow-up|5
7079579|NCT02116361|11188859|FG000|Overall Study|Personal Reasons|6
7079580|NCT02116361|11188860|FG001|Overall Study|Personal Reasons|6
7079581|NCT02116361|11188861|FG002|Overall Study|Personal Reasons|4
7079582|NCT02116361|11188862|FG003|Overall Study|Personal Reasons|9
7079583|NCT02116361|11188859|FG000|Overall Study|Investigator Decision - Relapse|9
7079584|NCT02116361|11188860|FG001|Overall Study|Investigator Decision - Relapse|7
7079585|NCT02116361|11188861|FG002|Overall Study|Investigator Decision - Relapse|8
7079586|NCT02116361|11188862|FG003|Overall Study|Investigator Decision - Relapse|5
7079587|NCT02116530|11188874|FG000|Overall Study|Withdrawal by Subject|1
7079588|NCT02116530|11188875|FG001|Overall Study|Withdrawal by Subject|2
7079589|NCT02116530|11188874|FG000|Overall Study|Adverse Event|4
7079590|NCT02116530|11188875|FG001|Overall Study|Adverse Event|0
7079591|NCT02116530|11188874|FG000|Overall Study|Physician Decision|1
7079592|NCT02116530|11188875|FG001|Overall Study|Physician Decision|0
7079593|NCT02116530|11188874|FG000|Overall Study|Lost to Follow-up|1
7079594|NCT02116530|11188875|FG001|Overall Study|Lost to Follow-up|0
7079595|NCT02116530|11188874|FG000|Overall Study|Other Medical Problems|2
7079596|NCT02116530|11188875|FG001|Overall Study|Other Medical Problems|2
7079597|NCT02116582|11188881|FG000|Overall Study|Enrolled but Never Received Study Drug|1
7079598|NCT02116582|11188881|FG000|Overall Study|Adverse Event|22
7079599|NCT02116582|11188881|FG000|Overall Study|Death|9
7079600|NCT02116582|11188881|FG000|Overall Study|Progressive Disease|148
7079601|NCT02116582|11188881|FG000|Overall Study|Protocol Violation|3
7079602|NCT02116582|11188881|FG000|Overall Study|Withdrawal by Subject|8
7079603|NCT02116582|11188881|FG000|Overall Study|Other: Miscellaneous|11
7079604|NCT02116582|11188881|FG000|Overall Study|Lost to Follow-up|1
7079605|NCT02116582|11188881|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12
7079606|NCT02116608|11188888|FG000|Overall Study|Lost to Follow-up|0
7079607|NCT02116608|11188889|FG001|Overall Study|Lost to Follow-up|0
7079608|NCT02116608|11188890|FG002|Overall Study|Lost to Follow-up|1
7079609|NCT02116608|11188888|FG000|Overall Study|Physician Decision|0
7079610|NCT02116608|11188889|FG001|Overall Study|Physician Decision|1
7079611|NCT02116608|11188890|FG002|Overall Study|Physician Decision|0
7079612|NCT02116608|11188888|FG000|Overall Study|Death|0
7079613|NCT02116608|11188889|FG001|Overall Study|Death|1
7079614|NCT02116608|11188890|FG002|Overall Study|Death|0
7079615|NCT02116621|11188900|FG000|Baseline|Withdrawal by Subject|0
7079616|NCT02116621|11188901|FG001|Baseline|Withdrawal by Subject|4
7079617|NCT02116621|11188900|FG000|Three Month Follow-up|Death|1
7079618|NCT02116621|11188901|FG001|Three Month Follow-up|Death|1
7079619|NCT02116621|11188900|FG000|Three Month Follow-up|Withdrawal by Subject|4
7079620|NCT02116621|11188901|FG001|Three Month Follow-up|Withdrawal by Subject|1
7079621|NCT02116621|11188900|FG000|Three Month Follow-up|Lost to Follow-up|0
7079622|NCT02116621|11188901|FG001|Three Month Follow-up|Lost to Follow-up|1
7079623|NCT02116621|11188900|FG000|Three Month Follow-up|Did not complete follow-up survey|14
7079624|NCT02116621|11188901|FG001|Three Month Follow-up|Did not complete follow-up survey|4
7079625|NCT02116621|11188900|FG000|Six Month Follow-up|Withdrawal by Subject|1
7079626|NCT02116621|11188901|FG001|Six Month Follow-up|Withdrawal by Subject|1
7079627|NCT02116621|11188900|FG000|Six Month Follow-up|Lost to Follow-up|2
7079628|NCT02116621|11188901|FG001|Six Month Follow-up|Lost to Follow-up|1
7079629|NCT02116621|11188900|FG000|Six Month Follow-up|Did not complete follow-up survey|1
7079630|NCT02116621|11188901|FG001|Six Month Follow-up|Did not complete follow-up survey|1
7079631|NCT02116621|11188900|FG000|Twelve Month Follow-up|Withdrawal by Subject|1
7079632|NCT02116621|11188901|FG001|Twelve Month Follow-up|Withdrawal by Subject|0
7079633|NCT02116621|11188900|FG000|Twelve Month Follow-up|Lost to Follow-up|0
7079634|NCT02116621|11188901|FG001|Twelve Month Follow-up|Lost to Follow-up|1
7079635|NCT02116621|11188900|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1
7079636|NCT02116621|11188901|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3
7079637|NCT02116621|11188900|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14
7079638|NCT02116621|11188901|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8
7079639|NCT02116660|11188909|FG000|Overall Study|Deteriorating renal function|0
7079640|NCT02116660|11188910|FG001|Overall Study|Deteriorating renal function|1
7079641|NCT02116660|11188909|FG000|Overall Study|Adverse Event|1
7079642|NCT02116660|11188910|FG001|Overall Study|Adverse Event|1
7079643|NCT02116660|11188909|FG000|Overall Study|Withdrawal by Subject|0
7079644|NCT02116660|11188910|FG001|Overall Study|Withdrawal by Subject|2
7041457|NCT01727505|11125071|FG000|Second 24 Hours|Missing data|0
7041458|NCT01727505|11125072|FG001|Second 24 Hours|Missing data|1
7041459|NCT01727700|11125081|FG000|Overall Study|Adverse Event|0
7041460|NCT01727700|11125082|FG001|Overall Study|Adverse Event|7
7041461|NCT01727700|11125083|FG002|Overall Study|Adverse Event|1
7041462|NCT01727700|11125081|FG000|Overall Study|Particpant withdrew consent|0
7041463|NCT01727700|11125082|FG001|Overall Study|Particpant withdrew consent|3
7041464|NCT01727700|11125083|FG002|Overall Study|Particpant withdrew consent|1
7041465|NCT01727700|11125081|FG000|Overall Study|Protocol Violation|2
7041466|NCT01727700|11125082|FG001|Overall Study|Protocol Violation|0
7041467|NCT01727700|11125083|FG002|Overall Study|Protocol Violation|0
7041468|NCT01727713|11125091|FG000|Overall Study|Lost to Follow-up|5
7041469|NCT01727713|11125091|FG000|Overall Study|Adverse Event|10
7041470|NCT01727713|11125091|FG000|Overall Study|Participant Met Withdrawal Criteria|5
7041471|NCT01727713|11125091|FG000|Overall Study|Withdrawal by Subject|13
7041472|NCT01727713|11125091|FG000|Overall Study|Protocol Deviation|2
7041473|NCT01728077|11125132|FG000|Overall Study|Lack of Efficacy|3
7041474|NCT01728077|11125133|FG001|Overall Study|Lack of Efficacy|1
7041475|NCT01728077|11125132|FG000|Overall Study|Lost to Follow-up|1
7041476|NCT01728077|11125133|FG001|Overall Study|Lost to Follow-up|0
7041477|NCT01728077|11125132|FG000|Overall Study|Subject choice|2
7041478|NCT01728077|11125133|FG001|Overall Study|Subject choice|3
7041479|NCT01728077|11125132|FG000|Overall Study|Death|0
7041480|NCT01728077|11125133|FG001|Overall Study|Death|1
7041481|NCT01728077|11125132|FG000|Overall Study|Patient moving|1
7041482|NCT01728077|11125133|FG001|Overall Study|Patient moving|0
7041483|NCT01728077|11125132|FG000|Overall Study|Non compliance|1
7041484|NCT01728077|11125133|FG001|Overall Study|Non compliance|0
7041485|NCT01728116|11125142|FG000|Overall Study|Sponsor Terminated Study|106
7041486|NCT01728116|11125143|FG001|Overall Study|Sponsor Terminated Study|35
7041487|NCT01728116|11125142|FG000|Overall Study|Withdrawal by Subject|16
7041488|NCT01728116|11125143|FG001|Overall Study|Withdrawal by Subject|9
7041489|NCT01728116|11125142|FG000|Overall Study|Adverse Event|13
7041490|NCT01728116|11125143|FG001|Overall Study|Adverse Event|0
7041491|NCT01728116|11125142|FG000|Overall Study|Procedure/device failure|7
7041492|NCT01728116|11125143|FG001|Overall Study|Procedure/device failure|0
7041493|NCT01728116|11125142|FG000|Overall Study|Lost to Follow-up|9
7041494|NCT01728116|11125143|FG001|Overall Study|Lost to Follow-up|2
7041495|NCT01728116|11125142|FG000|Overall Study|Physician Decision|2
7041496|NCT01728116|11125143|FG001|Overall Study|Physician Decision|0
7041497|NCT01728116|11125142|FG000|Overall Study|Subject Non-Compliance|2
7041498|NCT01728116|11125143|FG001|Overall Study|Subject Non-Compliance|0
7041499|NCT01728116|11125142|FG000|Overall Study|Inter-current finding at procedure|1
7041500|NCT01728116|11125143|FG001|Overall Study|Inter-current finding at procedure|0
7041501|NCT01728116|11125142|FG000|Overall Study|Incorrectly enrolled in Study|0
7041502|NCT01728116|11125143|FG001|Overall Study|Incorrectly enrolled in Study|1
7041503|NCT01728116|11125142|FG000|Overall Study|various not noted previously|5
7041504|NCT01728116|11125143|FG001|Overall Study|various not noted previously|0
7041505|NCT01728194|11125152|FG000|Overall Study|Lost to Follow-up|4
7041506|NCT01728194|11125153|FG001|Overall Study|Lost to Follow-up|3
7041507|NCT01728194|11125152|FG000|Overall Study|Physician Decision|4
7041508|NCT01728194|11125153|FG001|Overall Study|Physician Decision|0
7041509|NCT01728194|11125152|FG000|Overall Study|Withdrawal by Subject|7
7041510|NCT01728194|11125153|FG001|Overall Study|Withdrawal by Subject|3
7041511|NCT01728194|11125152|FG000|Overall Study|Perceived Medication Side Effects|4
7041512|NCT01728194|11125153|FG001|Overall Study|Perceived Medication Side Effects|0
7041513|NCT01728194|11125152|FG000|Overall Study|Family Member Request|1
7041514|NCT01728194|11125153|FG001|Overall Study|Family Member Request|0
7041515|NCT01728246|11125161|FG000|Overall Study|Participant needed rescue medication|1
7041516|NCT01728246|11125162|FG001|Overall Study|Participant needed rescue medication|5
7041517|NCT01728246|11125161|FG000|Overall Study|Protocol Violation|1
7041518|NCT01728246|11125162|FG001|Overall Study|Protocol Violation|0
7041519|NCT01728246|11125161|FG000|Overall Study|Withdrawal by Subject|2
7041520|NCT01728246|11125162|FG001|Overall Study|Withdrawal by Subject|3
7041521|NCT01728246|11125161|FG000|Overall Study|Lost to Follow-up|23
7041522|NCT01728246|11125162|FG001|Overall Study|Lost to Follow-up|22
7041523|NCT01728246|11125161|FG000|Overall Study|Lack of Efficacy|1
7041524|NCT01728246|11125162|FG001|Overall Study|Lack of Efficacy|1
7041525|NCT01728246|11125161|FG000|Overall Study|Adverse Event|8
7041526|NCT01728246|11125162|FG001|Overall Study|Adverse Event|5
7041527|NCT01728324|11125171|FG000|Termination of DBV|Adverse Event|14
7041528|NCT01728324|11125172|FG001|Termination of DBV|Adverse Event|13
7041529|NCT01728324|11125173|FG002|Termination of DBV|Adverse Event|4
7041530|NCT01728324|11125171|FG000|Termination of DBV|Lack of Efficacy|14
7041531|NCT01728324|11125172|FG001|Termination of DBV|Lack of Efficacy|12
7041532|NCT01728324|11125173|FG002|Termination of DBV|Lack of Efficacy|8
7041533|NCT01728324|11125171|FG000|Termination of DBV|Withdrawal by Subject|9
7041534|NCT01728324|11125172|FG001|Termination of DBV|Withdrawal by Subject|6
7041535|NCT01728324|11125173|FG002|Termination of DBV|Withdrawal by Subject|2
7041536|NCT01728324|11125171|FG000|Termination of DBV|Other than stated|1
7041537|NCT01728324|11125172|FG001|Termination of DBV|Other than stated|3
7041538|NCT01728324|11125173|FG002|Termination of DBV|Other than stated|0
7041539|NCT01728324|11125171|FG000|Termination of DBV|Adverse Event (Placebo Period)|0
7041540|NCT01728324|11125172|FG001|Termination of DBV|Adverse Event (Placebo Period)|1
7041541|NCT01728324|11125173|FG002|Termination of DBV|Adverse Event (Placebo Period)|0
7041542|NCT01728324|11125171|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0
7041543|NCT01728324|11125172|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1
7041544|NCT01728324|11125173|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0
7041545|NCT01728324|11125171|FG000|Termination of FDV|Adverse Event|14
7079645|NCT02116660|11188909|FG000|Overall Study|Organization reason|1
7079646|NCT02116660|11188910|FG001|Overall Study|Organization reason|0
7079647|NCT02116777|11188925|FG000|Overall Study|Adverse Event|0
7079648|NCT02116777|11188926|FG001|Overall Study|Adverse Event|0
7079649|NCT02116777|11188927|FG002|Overall Study|Adverse Event|0
7157019|NCT03382418|11325790|FG002|Overall Study|Withdrawal by Subject|0
7157020|NCT03382418|11325788|FG000|Overall Study|Lost to Follow-up|2
7157021|NCT03382418|11325789|FG001|Overall Study|Lost to Follow-up|3
7157022|NCT03382418|11325790|FG002|Overall Study|Lost to Follow-up|0
7157023|NCT03382821|11325819|FG000|Overall Study|Did not receive allocated intervention.|0
7157024|NCT03382821|11325820|FG001|Overall Study|Did not receive allocated intervention.|3
7157025|NCT03382899|11325833|FG000|Overall Study|Ineligibility Determined|0
7157026|NCT03382899|11325834|FG001|Overall Study|Ineligibility Determined|1
7157027|NCT03382899|11325833|FG000|Overall Study|Lost to Follow-up|0
7157028|NCT03382899|11325834|FG001|Overall Study|Lost to Follow-up|1
7157029|NCT03382899|11325833|FG000|Overall Study|Sponsor's decision|31
7157030|NCT03382899|11325834|FG001|Overall Study|Sponsor's decision|28
7157031|NCT03382899|11325833|FG000|Overall Study|Withdrawal by Subject|0
7157032|NCT03382899|11325834|FG001|Overall Study|Withdrawal by Subject|5
7157033|NCT03382912|11325842|FG000|Overall Study|Physician Decision|0
7157034|NCT03382912|11325843|FG001|Overall Study|Physician Decision|1
7157035|NCT03382912|11325842|FG000|Overall Study|Sponsor Decision|6
7157036|NCT03382912|11325843|FG001|Overall Study|Sponsor Decision|6
7157037|NCT03382912|11325842|FG000|Overall Study|Withdrawal by Subject|0
7157038|NCT03382912|11325843|FG001|Overall Study|Withdrawal by Subject|5
7184168|NCT01787552|11384189|FG000|Overall Study|Withdrawal by Subject|2
7184169|NCT01787552|11384190|FG001|Overall Study|Withdrawal by Subject|0
7184170|NCT01787552|11384191|FG002|Overall Study|Withdrawal by Subject|0
7184171|NCT01787552|11384192|FG003|Overall Study|Withdrawal by Subject|4
7184172|NCT01787552|11384189|FG000|Overall Study|Physician Decision|2
7184173|NCT01787552|11384190|FG001|Overall Study|Physician Decision|2
7184174|NCT01787552|11384191|FG002|Overall Study|Physician Decision|1
7184175|NCT01787552|11384192|FG003|Overall Study|Physician Decision|2
7184176|NCT01787552|11384189|FG000|Overall Study|Death|0
7184177|NCT01787552|11384190|FG001|Overall Study|Death|0
7184178|NCT01787552|11384191|FG002|Overall Study|Death|0
7184179|NCT01787552|11384192|FG003|Overall Study|Death|1
7184180|NCT01787552|11384189|FG000|Overall Study|Adverse Event|2
7184181|NCT01787552|11384190|FG001|Overall Study|Adverse Event|5
7184182|NCT01787552|11384191|FG002|Overall Study|Adverse Event|2
7184183|NCT01787552|11384192|FG003|Overall Study|Adverse Event|16
7184184|NCT01787552|11384189|FG000|Overall Study|Study terminated by Sponsor|0
7184185|NCT01787552|11384190|FG001|Overall Study|Study terminated by Sponsor|0
7184186|NCT01787552|11384191|FG002|Overall Study|Study terminated by Sponsor|1
7184187|NCT01787552|11384192|FG003|Overall Study|Study terminated by Sponsor|3
7184188|NCT01787552|11384189|FG000|Overall Study|Progressive Disease|2
7184189|NCT01787552|11384190|FG001|Overall Study|Progressive Disease|2
7184190|NCT01787552|11384191|FG002|Overall Study|Progressive Disease|1
7184191|NCT01787552|11384192|FG003|Overall Study|Progressive Disease|1
7184192|NCT01807117|11384207|FG000|Overall Study|Physician Decision|2
7184193|NCT01807117|11384207|FG000|Overall Study|Disease diagnosis not a study disease|1
7184194|NCT01808261|11384215|FG000|Overall Study|Physician Decision|0
7184195|NCT01808261|11384216|FG001|Overall Study|Physician Decision|2
7184196|NCT01808261|11384215|FG000|Overall Study|Study Closed/Terminated|25
7184197|NCT01808261|11384216|FG001|Overall Study|Study Closed/Terminated|23
7184198|NCT01808261|11384215|FG000|Overall Study|Adverse event, non-fatal|2
7184199|NCT01808261|11384216|FG001|Overall Study|Adverse event, non-fatal|0
7184200|NCT01808261|11384215|FG000|Overall Study|Consent withdrawn by subject|6
7184201|NCT01808261|11384216|FG001|Overall Study|Consent withdrawn by subject|7
7184202|NCT01808261|11384215|FG000|Overall Study|Lost to Follow-up|3
7184203|NCT01808261|11384216|FG001|Overall Study|Lost to Follow-up|1
6894729|NCT00621257|10912519|FG000|Overall Study|Lost to Follow-up|4
6894730|NCT00621257|10912520|FG001|Overall Study|Lost to Follow-up|0
6894731|NCT00621257|10912521|FG002|Overall Study|Lost to Follow-up|2
6894732|NCT00621257|10912522|FG003|Overall Study|Lost to Follow-up|4
6894733|NCT00621257|10912523|FG004|Overall Study|Lost to Follow-up|7
6894734|NCT00621257|10912519|FG000|Overall Study|Adverse Event|0
7079650|NCT02116777|11188928|FG003|Overall Study|Adverse Event|0
7184204|NCT01814826|11384235|FG000|Overall Study|Other|3
7184205|NCT01814826|11384236|FG001|Overall Study|Other|5
6894735|NCT00621257|10912520|FG001|Overall Study|Adverse Event|1
6894736|NCT00621257|10912521|FG002|Overall Study|Adverse Event|1
7079651|NCT02116777|11188929|FG004|Overall Study|Adverse Event|2
7079652|NCT02116777|11188930|FG005|Overall Study|Adverse Event|2
7079653|NCT02116777|11188931|FG006|Overall Study|Adverse Event|0
7079654|NCT02116777|11188925|FG000|Overall Study|Death|0
7079655|NCT02116777|11188926|FG001|Overall Study|Death|0
7079656|NCT02116777|11188927|FG002|Overall Study|Death|0
7079657|NCT02116777|11188928|FG003|Overall Study|Death|1
7079658|NCT02116777|11188929|FG004|Overall Study|Death|0
7079659|NCT02116777|11188930|FG005|Overall Study|Death|0
7079660|NCT02116777|11188931|FG006|Overall Study|Death|0
7079661|NCT02116777|11188925|FG000|Overall Study|Lack of Efficacy|3
7079662|NCT02116777|11188926|FG001|Overall Study|Lack of Efficacy|3
7079663|NCT02116777|11188927|FG002|Overall Study|Lack of Efficacy|3
7079664|NCT02116777|11188928|FG003|Overall Study|Lack of Efficacy|8
7157039|NCT03383146|11325851|FG000|Overall Study|Screen Failure|1
7157040|NCT03383146|11325852|FG001|Overall Study|Screen Failure|0
7157041|NCT03383146|11325851|FG000|Overall Study|Adverse Event|6
7157042|NCT03383146|11325852|FG001|Overall Study|Adverse Event|18
7157043|NCT03383146|11325851|FG000|Overall Study|Lack of Efficacy|0
7157044|NCT03383146|11325852|FG001|Overall Study|Lack of Efficacy|3
7157045|NCT03383146|11325851|FG000|Overall Study|Withdrawal by Subject|20
7157046|NCT03383146|11325852|FG001|Overall Study|Withdrawal by Subject|36
7157047|NCT03383146|11325851|FG000|Overall Study|Lost to Follow-up|5
7157048|NCT03383146|11325852|FG001|Overall Study|Lost to Follow-up|15
7157049|NCT03383146|11325851|FG000|Overall Study|Death|0
7157050|NCT03383146|11325852|FG001|Overall Study|Death|2
7157051|NCT03383146|11325851|FG000|Overall Study|Physician Decision|0
7157052|NCT03383146|11325852|FG001|Overall Study|Physician Decision|1
7157053|NCT03383146|11325851|FG000|Overall Study|Protocol Deviation|1
7157054|NCT03383146|11325852|FG001|Overall Study|Protocol Deviation|8
7157055|NCT03383146|11325851|FG000|Overall Study|Study Terminated by the Sponsor|48
7157056|NCT03383146|11325852|FG001|Overall Study|Study Terminated by the Sponsor|95
7157057|NCT03383146|11325851|FG000|Overall Study|Reason not Specified|4
7157058|NCT03383146|11325852|FG001|Overall Study|Reason not Specified|6
7157059|NCT03383614|11325914|FG000|Overall Study|Withdrawal by Subject|0
7157060|NCT03383614|11325915|FG001|Overall Study|Withdrawal by Subject|1
7157061|NCT03383614|11325916|FG002|Overall Study|Withdrawal by Subject|0
7157062|NCT03383614|11325917|FG003|Overall Study|Withdrawal by Subject|0
7157063|NCT03383783|11325940|FG000|Overall Study|Withdrawal by Subject|2
7157064|NCT03383887|11325956|FG000|Overall Study|Lost to Follow-up|0
7157065|NCT03383887|11325957|FG001|Overall Study|Lost to Follow-up|1
7157066|NCT03384316|11325977|FG000|Overall Study|Screen failure|0
7157067|NCT03384316|11325978|FG001|Overall Study|Screen failure|1
7157068|NCT03384693|11325995|FG000|Overall Study|Adverse Event|3
7157069|NCT03384745|11326005|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0
6894737|NCT00621257|10912522|FG003|Overall Study|Adverse Event|0
6894738|NCT00621257|10912523|FG004|Overall Study|Adverse Event|0
6894739|NCT00621257|10912519|FG000|Overall Study|Physician Decision|0
6894740|NCT00621257|10912520|FG001|Overall Study|Physician Decision|2
6894741|NCT00621257|10912521|FG002|Overall Study|Physician Decision|0
6894742|NCT00621257|10912522|FG003|Overall Study|Physician Decision|1
6894743|NCT00621257|10912523|FG004|Overall Study|Physician Decision|1
6894744|NCT00621257|10912519|FG000|Overall Study|Withdrawal by Subject|0
6894745|NCT00621257|10912520|FG001|Overall Study|Withdrawal by Subject|0
6894746|NCT00621257|10912521|FG002|Overall Study|Withdrawal by Subject|0
6894747|NCT00621257|10912522|FG003|Overall Study|Withdrawal by Subject|1
6894748|NCT00621257|10912523|FG004|Overall Study|Withdrawal by Subject|1
6894749|NCT00621296|10912535|FG000|Overall Study|Adverse Event|2
6894750|NCT00621296|10912535|FG000|Overall Study|Lack of Efficacy|1
6894751|NCT00621296|10912535|FG000|Overall Study|Physician Decision|7
6894752|NCT00621296|10912535|FG000|Overall Study|Unmatch Criteria|1
6894753|NCT00621296|10912535|FG000|Overall Study|Stopping Criteria|3
7079665|NCT02116777|11188929|FG004|Overall Study|Lack of Efficacy|4
7079666|NCT02116777|11188930|FG005|Overall Study|Lack of Efficacy|1
7079667|NCT02116777|11188931|FG006|Overall Study|Lack of Efficacy|9
7079668|NCT02116777|11188925|FG000|Overall Study|Physician Decision|0
7079669|NCT02116777|11188926|FG001|Overall Study|Physician Decision|0
7157070|NCT03384745|11326006|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0
7157071|NCT03384745|11326007|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1
7157072|NCT03384745|11326008|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2
7157073|NCT03384745|11326009|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0
7157074|NCT03384745|11326010|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0
7157075|NCT03384745|11326005|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0
7157076|NCT03384745|11326006|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0
7157077|NCT03384745|11326007|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0
7157078|NCT03384745|11326008|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0
7157079|NCT03384745|11326009|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3
7157080|NCT03384745|11326010|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1
7157081|NCT03384745|11326005|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0
7157082|NCT03384745|11326006|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1
7157083|NCT03384745|11326007|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1
7157084|NCT03384745|11326008|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0
7157085|NCT03384745|11326009|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0
7079670|NCT02116777|11188927|FG002|Overall Study|Physician Decision|0
7079671|NCT02116777|11188928|FG003|Overall Study|Physician Decision|2
7157086|NCT03384745|11326010|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1
7157087|NCT03384745|11326005|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0
7157088|NCT03384745|11326006|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0
6894754|NCT00621309|10912539|FG000|Overall Study|Withdrawal by Subject|2
6894755|NCT00621309|10912540|FG001|Overall Study|Withdrawal by Subject|0
6894756|NCT00621309|10912541|FG002|Overall Study|Withdrawal by Subject|1
6894757|NCT00621309|10912542|FG003|Overall Study|Withdrawal by Subject|1
7079672|NCT02116777|11188929|FG004|Overall Study|Physician Decision|0
7079673|NCT02116777|11188930|FG005|Overall Study|Physician Decision|0
7157089|NCT03384745|11326007|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1
7157090|NCT03384745|11326008|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0
7157091|NCT03384745|11326009|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0
7157092|NCT03384745|11326010|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0
7157093|NCT03384745|11326005|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0
7157094|NCT03384745|11326006|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0
7157095|NCT03384745|11326007|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0
7157096|NCT03384745|11326008|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1
7157097|NCT03384745|11326009|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1
7157098|NCT03384745|11326010|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0
7157099|NCT03384745|11326005|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0
7157100|NCT03384745|11326006|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0
7157101|NCT03384745|11326007|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0
7157102|NCT03384745|11326008|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0
7157103|NCT03384745|11326009|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1
7157104|NCT03384745|11326010|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0
7157105|NCT03384745|11326005|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0
7157106|NCT03384745|11326006|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0
7157107|NCT03384745|11326007|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1
7157108|NCT03384745|11326008|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1
7157109|NCT03384745|11326009|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0
7157110|NCT03384745|11326010|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0
7157111|NCT03384745|11326005|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1
7157112|NCT03384745|11326006|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1
7157113|NCT03384745|11326007|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3
7157114|NCT03384745|11326008|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0
7157115|NCT03384745|11326009|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1
7157116|NCT03384745|11326010|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0
7157117|NCT03384745|11326005|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0
7157118|NCT03384745|11326006|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1
7157119|NCT03384745|11326007|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1
7157120|NCT03384745|11326008|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2
7157121|NCT03384745|11326009|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0
7157122|NCT03384745|11326010|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2
7157123|NCT03384745|11326005|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0
7157124|NCT03384745|11326006|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0
7157125|NCT03384745|11326007|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0
7157126|NCT03384745|11326008|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2
7157127|NCT03384745|11326009|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0
7157128|NCT03384745|11326010|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0
7157129|NCT03384745|11326005|FG000|Response Assess/Dose Hold (W24-W48)|Death|0
7157130|NCT03384745|11326006|FG001|Response Assess/Dose Hold (W24-W48)|Death|1
7157131|NCT03384745|11326007|FG002|Response Assess/Dose Hold (W24-W48)|Death|0
7157132|NCT03384745|11326008|FG003|Response Assess/Dose Hold (W24-W48)|Death|0
7157133|NCT03384745|11326009|FG004|Response Assess/Dose Hold (W24-W48)|Death|0
7157134|NCT03384745|11326010|FG005|Response Assess/Dose Hold (W24-W48)|Death|0
7157135|NCT03384940|11326033|FG000|Overall Study|Progressive disease|36
7157136|NCT03384940|11326034|FG001|Overall Study|Progressive disease|11
7157137|NCT03384940|11326035|FG002|Overall Study|Progressive disease|13
7157138|NCT03384940|11326033|FG000|Overall Study|Clinical progression|4
7157139|NCT03384940|11326034|FG001|Overall Study|Clinical progression|0
7157140|NCT03384940|11326035|FG002|Overall Study|Clinical progression|3
7157141|NCT03384940|11326033|FG000|Overall Study|Adverse Event|7
7157142|NCT03384940|11326034|FG001|Overall Study|Adverse Event|1
7157143|NCT03384940|11326035|FG002|Overall Study|Adverse Event|1
7157144|NCT03384940|11326033|FG000|Overall Study|Withdrawal by Subject|3
7157145|NCT03384940|11326034|FG001|Overall Study|Withdrawal by Subject|1
7157146|NCT03384940|11326035|FG002|Overall Study|Withdrawal by Subject|0
7157147|NCT03384940|11326033|FG000|Overall Study|Physician Decision|1
7157148|NCT03384940|11326034|FG001|Overall Study|Physician Decision|1
7157149|NCT03384940|11326035|FG002|Overall Study|Physician Decision|0
7157150|NCT03384940|11326033|FG000|Overall Study|Death|2
7157151|NCT03384940|11326034|FG001|Overall Study|Death|1
7157152|NCT03384940|11326035|FG002|Overall Study|Death|0
7157153|NCT03384940|11326033|FG000|Overall Study|Other|0
7157154|NCT03384940|11326034|FG001|Overall Study|Other|0
7157155|NCT03384940|11326035|FG002|Overall Study|Other|1
7157156|NCT03384966|11326055|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1
7157157|NCT03384966|11326056|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0
7157158|NCT03384966|11326057|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0
7157159|NCT03384966|11326055|FG000|Follow-up Period|Adverse Event|1
7157160|NCT03384966|11326056|FG001|Follow-up Period|Adverse Event|0
7157161|NCT03384966|11326057|FG002|Follow-up Period|Adverse Event|0
7157162|NCT03386032|11326077|FG000|Overall Study|Lack of Efficacy|6
7157163|NCT03386032|11326078|FG001|Overall Study|Lack of Efficacy|2
7157164|NCT03386032|11326079|FG002|Overall Study|Lack of Efficacy|0
7157165|NCT03386032|11326077|FG000|Overall Study|Adverse Event|2
7157166|NCT03386032|11326078|FG001|Overall Study|Adverse Event|2
7157167|NCT03386032|11326079|FG002|Overall Study|Adverse Event|0
7157168|NCT03386032|11326077|FG000|Overall Study|Withdrawal by Subject|1
7157169|NCT03386032|11326078|FG001|Overall Study|Withdrawal by Subject|0
7157170|NCT03386032|11326079|FG002|Overall Study|Withdrawal by Subject|0
7157171|NCT03386032|11326077|FG000|Overall Study|Lost to Follow-up|9
7157172|NCT03386032|11326078|FG001|Overall Study|Lost to Follow-up|3
7157173|NCT03386032|11326079|FG002|Overall Study|Lost to Follow-up|0
7157174|NCT03386344|11326099|FG000|Overall Study|Adverse Event|6
7157175|NCT03386344|11326100|FG001|Overall Study|Adverse Event|3
7157176|NCT03386344|11326101|FG002|Overall Study|Adverse Event|1
7157177|NCT03386344|11326099|FG000|Overall Study|Poor Compliance to Protocol|0
7157178|NCT03386344|11326100|FG001|Overall Study|Poor Compliance to Protocol|1
7157179|NCT03386344|11326101|FG002|Overall Study|Poor Compliance to Protocol|0
7157180|NCT03386344|11326099|FG000|Overall Study|Study Terminated by Sponsor|101
7157181|NCT03386344|11326100|FG001|Overall Study|Study Terminated by Sponsor|102
7157182|NCT03386344|11326101|FG002|Overall Study|Study Terminated by Sponsor|106
7157183|NCT03386344|11326099|FG000|Overall Study|Lost to Follow-up|3
7157184|NCT03386344|11326100|FG001|Overall Study|Lost to Follow-up|2
7157185|NCT03386344|11326101|FG002|Overall Study|Lost to Follow-up|1
7157186|NCT03386344|11326099|FG000|Overall Study|At the Participant's own Request|7
7157187|NCT03386344|11326100|FG001|Overall Study|At the Participant's own Request|7
7157188|NCT03386344|11326101|FG002|Overall Study|At the Participant's own Request|8
7157189|NCT03386344|11326099|FG000|Overall Study|Reason not Specified|0
7157190|NCT03386344|11326100|FG001|Overall Study|Reason not Specified|1
7157191|NCT03386344|11326101|FG002|Overall Study|Reason not Specified|0
7157192|NCT03386435|11326111|FG000|Overall Study|Protocol Violation|5
7157193|NCT03386435|11326112|FG001|Overall Study|Protocol Violation|7
7157194|NCT03386448|11326120|FG000|Overall Study|Adverse Event|0
7157195|NCT03386448|11326121|FG001|Overall Study|Adverse Event|2
7157196|NCT03386474|11326129|FG000|Overall Study|Death|1
7157197|NCT03386474|11326130|FG001|Overall Study|Death|0
7157198|NCT03386474|11326129|FG000|Overall Study|Adverse Event|0
7157199|NCT03386474|11326130|FG001|Overall Study|Adverse Event|1
7157200|NCT03386994|11326144|FG000|Overall Study|Lung transplant|1
7157201|NCT03386994|11326144|FG000|Overall Study|Adverse Event|14
7157202|NCT03386994|11326144|FG000|Overall Study|Lost to Follow-up|4
7157203|NCT03386994|11326144|FG000|Overall Study|Withdrawal by Subject|3
7157204|NCT03386994|11326144|FG000|Overall Study|Death|16
7157205|NCT03387020|11326162|FG000|Overall Study|Adverse Event|0
7157206|NCT03387020|11326163|FG001|Overall Study|Adverse Event|2
7157207|NCT03387020|11326164|FG002|Overall Study|Adverse Event|0
7157208|NCT03387020|11326162|FG000|Overall Study|Withdrawal by Subject|2
7157209|NCT03387020|11326163|FG001|Overall Study|Withdrawal by Subject|0
7157210|NCT03387020|11326164|FG002|Overall Study|Withdrawal by Subject|0
7157211|NCT03387046|11326188|FG000|Overall Study|Adverse Event|1
7157212|NCT03387046|11326189|FG001|Overall Study|Adverse Event|1
7157213|NCT03387462|11326209|FG000|Overall Study|Lost to Follow-up|1
7157214|NCT03387683|11326215|FG000|Overall Study|In receipt of disallowed medication|1
7157215|NCT03387683|11326216|FG001|Overall Study|In receipt of disallowed medication|0
7157216|NCT03387683|11326215|FG000|Overall Study|Did not receive treatment|1
7157217|NCT03387683|11326216|FG001|Overall Study|Did not receive treatment|0
7157218|NCT03388164|11326233|FG000|Overall Study|Withdrawal by Subject|3
7157219|NCT03388164|11326234|FG001|Overall Study|Withdrawal by Subject|1
7157220|NCT03389308|11326267|FG000|Overall Study|Withdrawal by Subject|5
7157221|NCT03389308|11326267|FG000|Overall Study|Lost to Follow-up|3
7157222|NCT03389308|11326267|FG000|Overall Study|Adverse Event|2
7157223|NCT03389308|11326267|FG000|Overall Study|Sponsor Request|2
7157224|NCT03389555|11326273|FG000|Overall Study|Protocol Violation|1
7157225|NCT03389555|11326274|FG001|Overall Study|Protocol Violation|3
7157226|NCT03389555|11326273|FG000|Overall Study|Death|1
7157227|NCT03389555|11326274|FG001|Overall Study|Death|0
7157228|NCT03389893|11326303|FG000|Randomized Double Blind Period|Withdrawal by Subject|1
7157229|NCT03389893|11326304|FG001|Randomized Double Blind Period|Withdrawal by Subject|0
7157230|NCT03389893|11326305|FG002|Randomized Double Blind Period|Withdrawal by Subject|0
7157231|NCT03389893|11326306|FG003|Randomized Double Blind Period|Withdrawal by Subject|0
7157232|NCT03389893|11326303|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0
7157233|NCT03389893|11326304|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0
7157234|NCT03389893|11326305|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2
7157235|NCT03389893|11326306|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1
7157236|NCT03389893|11326303|FG000|Open Label Extension and Follow-Up|Physician Decision|0
7157237|NCT03389893|11326304|FG001|Open Label Extension and Follow-Up|Physician Decision|0
7157238|NCT03389893|11326305|FG002|Open Label Extension and Follow-Up|Physician Decision|1
7157239|NCT03389893|11326306|FG003|Open Label Extension and Follow-Up|Physician Decision|0
7157240|NCT03389893|11326303|FG000|Open Label Extension and Follow-Up|Participant Moved|0
7157241|NCT03389893|11326304|FG001|Open Label Extension and Follow-Up|Participant Moved|0
7157242|NCT03389893|11326305|FG002|Open Label Extension and Follow-Up|Participant Moved|1
7157243|NCT03389893|11326306|FG003|Open Label Extension and Follow-Up|Participant Moved|0
7157244|NCT03390166|11326323|FG000|Overall Study|Death|0
7157245|NCT03390166|11326324|FG001|Overall Study|Death|1
7157246|NCT03390166|11326323|FG000|Overall Study|Lost to Follow-up|6
7157247|NCT03390166|11326324|FG001|Overall Study|Lost to Follow-up|4
7157248|NCT03390166|11326323|FG000|Overall Study|Physician Decision|2
7157249|NCT03390166|11326324|FG001|Overall Study|Physician Decision|1
7157250|NCT03390166|11326323|FG000|Overall Study|Move from study area|3
7157251|NCT03390166|11326324|FG001|Overall Study|Move from study area|2
7157252|NCT03390166|11326323|FG000|Overall Study|To militarycamp for conscript|1
7157253|NCT03390166|11326324|FG001|Overall Study|To militarycamp for conscript|0
7157254|NCT03390166|11326323|FG000|Overall Study|To drug therapy course|0
7157255|NCT03390166|11326324|FG001|Overall Study|To drug therapy course|1
7157256|NCT03390166|11326323|FG000|Overall Study|Move to work oversea|0
7157257|NCT03390166|11326324|FG001|Overall Study|Move to work oversea|1
7157258|NCT03390426|11326338|FG000|Overall Study|Protocol Violation|0
7157259|NCT03390426|11326339|FG001|Overall Study|Protocol Violation|1
7157260|NCT03391765|11326372|FG000|Overall Study|Adverse Event|2
7157261|NCT03391765|11326373|FG001|Overall Study|Adverse Event|0
7157262|NCT03391765|11326374|FG002|Overall Study|Adverse Event|0
7157263|NCT03391765|11326375|FG003|Overall Study|Adverse Event|2
7157264|NCT03391765|11326372|FG000|Overall Study|Withdrew consent|5
7157265|NCT03391765|11326373|FG001|Overall Study|Withdrew consent|7
7157266|NCT03391765|11326374|FG002|Overall Study|Withdrew consent|2
7157267|NCT03391765|11326375|FG003|Overall Study|Withdrew consent|5
7157268|NCT03391765|11326372|FG000|Overall Study|Other, not specified|44
7157269|NCT03391765|11326373|FG001|Overall Study|Other, not specified|38
7157270|NCT03391765|11326374|FG002|Overall Study|Other, not specified|21
7157271|NCT03391765|11326375|FG003|Overall Study|Other, not specified|16
7157272|NCT03392168|11326402|FG000|Period 2: Cohort 2|Lost to Follow-up|0
7157273|NCT03392168|11326403|FG001|Period 2: Cohort 2|Lost to Follow-up|1
7157274|NCT03392168|11326404|FG002|Period 2: Cohort 2|Lost to Follow-up|1
7157275|NCT03392168|11326405|FG003|Period 2: Cohort 2|Lost to Follow-up|1
7157276|NCT03392168|11326402|FG000|Period 2: Cohort 2|Other|0
7157277|NCT03392168|11326403|FG001|Period 2: Cohort 2|Other|1
7157278|NCT03392168|11326404|FG002|Period 2: Cohort 2|Other|0
7157279|NCT03392168|11326405|FG003|Period 2: Cohort 2|Other|0
7157280|NCT03392194|11326416|FG000|Overall Study|Withdrawal by Subject|1
7157281|NCT03392194|11326417|FG001|Overall Study|Withdrawal by Subject|2
7157282|NCT03392194|11326416|FG000|Overall Study|Conflicts with personal schedule|1
7157283|NCT03392194|11326417|FG001|Overall Study|Conflicts with personal schedule|0
7157284|NCT03393000|11326439|FG000|Overall Study|Death|11
7157285|NCT03393000|11326439|FG000|Overall Study|Withdrawal by Subject|2
7157286|NCT03393000|11326439|FG000|Overall Study|Physician Decision|1
7157287|NCT03393806|11326486|FG000|Overall Study|Physician Decision|1
7157288|NCT03393806|11326487|FG001|Overall Study|Physician Decision|0
7157289|NCT03394391|11326496|FG000|Overall Study|Lost to Follow-up|1
7157290|NCT03394391|11326497|FG001|Overall Study|Lost to Follow-up|2
7157291|NCT03394508|11326505|FG000|Overall Study|Protocol Violation|0
7157292|NCT03394508|11326506|FG001|Overall Study|Protocol Violation|3
7157293|NCT03394508|11326505|FG000|Overall Study|Lost to Follow-up|1
7157294|NCT03394508|11326506|FG001|Overall Study|Lost to Follow-up|0
7157295|NCT03394885|11326520|FG000|Overall Study|Adverse Event|4
7157296|NCT03394885|11326520|FG000|Overall Study|Lack of Efficacy|1
7157297|NCT03394885|11326520|FG000|Overall Study|Physician Decision|1
7157298|NCT03394885|11326520|FG000|Overall Study|Withdrawal by Subject|8
7157299|NCT03394885|11326520|FG000|Overall Study|Alternative Therapy|1
7157300|NCT03394924|11326527|FG000|Overall Study|Adverse Event|0
7157301|NCT03394924|11326528|FG001|Overall Study|Adverse Event|5
7157302|NCT03394924|11326529|FG002|Overall Study|Adverse Event|0
7157303|NCT03394924|11326527|FG000|Overall Study|Withdrawal by Subject|2
7157304|NCT03394924|11326528|FG001|Overall Study|Withdrawal by Subject|0
7157305|NCT03394924|11326529|FG002|Overall Study|Withdrawal by Subject|0
7157306|NCT03394924|11326527|FG000|Overall Study|Lost to Follow-up|0
7157307|NCT03394924|11326528|FG001|Overall Study|Lost to Follow-up|1
7157308|NCT03394924|11326529|FG002|Overall Study|Lost to Follow-up|0
7157309|NCT03394924|11326527|FG000|Overall Study|Did not meet all inclusion criteria|1
7157310|NCT03394924|11326528|FG001|Overall Study|Did not meet all inclusion criteria|0
7157311|NCT03394924|11326529|FG002|Overall Study|Did not meet all inclusion criteria|0
7157312|NCT03395353|11326539|FG000|Overall Study|Adverse Event|20
7157313|NCT03395353|11326539|FG000|Overall Study|Protocol Violation|1
7157314|NCT03395353|11326539|FG000|Overall Study|Lack of Efficacy|3
7157315|NCT03395353|11326539|FG000|Overall Study|Withdrawal by Subject|24
7157316|NCT03395353|11326539|FG000|Overall Study|Discontinued visit|1
7157317|NCT03395353|11326539|FG000|Overall Study|Refrain from visit due to COVID-19|1
7157318|NCT03395353|11326539|FG000|Overall Study|Physician Decision|4
7157319|NCT03395353|11326539|FG000|Overall Study|Early termination of overall study|33
7157320|NCT03396835|11326580|FG000|Overall Study|Withdrawn prior to completion|1
7157321|NCT03396835|11326580|FG000|Overall Study|Did not meet criteria for data analysis|1
7157322|NCT03396913|11326586|FG000|Overall Study|Lost to Follow-up|0
7157323|NCT03396913|11326587|FG001|Overall Study|Lost to Follow-up|6
7157324|NCT03397771|11326620|FG000|Overall Study|2 erroneously randomized, never treated|3
7157325|NCT03397771|11326621|FG001|Overall Study|2 erroneously randomized, never treated|1
7157326|NCT03397771|11326620|FG000|Overall Study|Withdrawal by Subject|1
7157327|NCT03397771|11326621|FG001|Overall Study|Withdrawal by Subject|3
7157328|NCT03397771|11326620|FG000|Overall Study|Protocol Violation|2
7157329|NCT03397771|11326621|FG001|Overall Study|Protocol Violation|2
7157330|NCT03397771|11326620|FG000|Overall Study|Adverse Event|2
7157331|NCT03397771|11326621|FG001|Overall Study|Adverse Event|1
7157332|NCT03399786|11326743|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1
7157333|NCT03399786|11326744|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0
7157334|NCT03399786|11326745|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0
7157335|NCT03399786|11326746|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0
7157336|NCT03399786|11326743|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0
7157337|NCT03399786|11326744|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0
7157338|NCT03399786|11326745|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1
7157339|NCT03399786|11326746|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0
7157340|NCT03399786|11326743|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0
7157341|NCT03399786|11326744|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0
7157342|NCT03399786|11326745|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0
7157343|NCT03399786|11326746|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1
7157344|NCT03400033|11326756|FG000|Overall Study|Withdrawal by Subject|1
7157345|NCT03400033|11326757|FG001|Overall Study|Withdrawal by Subject|2
7157346|NCT03400787|11326812|FG000|Overall Study|Lost to Follow-up|1
7157347|NCT03400787|11326813|FG001|Overall Study|Lost to Follow-up|0
7157348|NCT03400787|11326812|FG000|Overall Study|Death|1
7157349|NCT03400787|11326813|FG001|Overall Study|Death|0
7157350|NCT03400787|11326812|FG000|Overall Study|Protocol Violation|0
7157351|NCT03400787|11326813|FG001|Overall Study|Protocol Violation|2
7157352|NCT03400787|11326812|FG000|Overall Study|Unblinded before 3-month follow-upa-|0
7157353|NCT03400787|11326813|FG001|Overall Study|Unblinded before 3-month follow-upa-|6
7157354|NCT03400852|11326830|FG000|Blinded Treatment Period|Physician Decision|0
7157355|NCT03400852|11326831|FG001|Blinded Treatment Period|Physician Decision|1
7041546|NCT01728324|11125172|FG001|Termination of FDV|Adverse Event|13
7157356|NCT03400852|11326832|FG002|Blinded Treatment Period|Physician Decision|0
7157357|NCT03400852|11326830|FG000|Blinded Treatment Period|Adverse Event|1
7157358|NCT03400852|11326831|FG001|Blinded Treatment Period|Adverse Event|1
7157359|NCT03400852|11326832|FG002|Blinded Treatment Period|Adverse Event|0
7157360|NCT03400852|11326830|FG000|Blinded Treatment Period|Study terminated by sponsor|8
7157361|NCT03400852|11326831|FG001|Blinded Treatment Period|Study terminated by sponsor|4
7157362|NCT03400852|11326832|FG002|Blinded Treatment Period|Study terminated by sponsor|0
7157363|NCT03400852|11326830|FG000|Open Label Period|Physician Decision|0
7157364|NCT03400852|11326831|FG001|Open Label Period|Physician Decision|0
7157365|NCT03400852|11326832|FG002|Open Label Period|Physician Decision|1
7157366|NCT03400852|11326830|FG000|Open Label Period|Study terminated by sponsor|0
7157367|NCT03400852|11326831|FG001|Open Label Period|Study terminated by sponsor|0
7157368|NCT03400852|11326832|FG002|Open Label Period|Study terminated by sponsor|21
7157420|NCT03401229|11326858|FG000|Overall Study|Lost to Follow-up|2
7157421|NCT03401229|11326859|FG001|Overall Study|Lost to Follow-up|1
7157422|NCT03401229|11326858|FG000|Overall Study|Other|1
7157423|NCT03401229|11326859|FG001|Overall Study|Other|3
7157424|NCT03401229|11326858|FG000|Overall Study|Adverse Event|8
7157425|NCT03401229|11326859|FG001|Overall Study|Adverse Event|6
7157426|NCT03401229|11326858|FG000|Overall Study|Withdrawal by Subject|29
7157427|NCT03401229|11326859|FG001|Overall Study|Withdrawal by Subject|26
7157428|NCT03401229|11326858|FG000|Overall Study|COVID-19|0
7157429|NCT03401229|11326859|FG001|Overall Study|COVID-19|1
7157430|NCT03401450|11326867|FG000|Overall Study|Lost to Follow-up|4
7157431|NCT03401450|11326868|FG001|Overall Study|Lost to Follow-up|6
7157432|NCT03401450|11326867|FG000|Overall Study|Anesthesia plan changed|2
7157433|NCT03401450|11326868|FG001|Overall Study|Anesthesia plan changed|2
7157434|NCT03401450|11326867|FG000|Overall Study|Did not complete medication diary|4
7157435|NCT03401450|11326868|FG001|Overall Study|Did not complete medication diary|2
7157436|NCT03401450|11326867|FG000|Overall Study|post surgery medication change|2
7157437|NCT03401450|11326868|FG001|Overall Study|post surgery medication change|1
7157438|NCT03401450|11326867|FG000|Overall Study|Cancelled surgery|0
7157439|NCT03401450|11326868|FG001|Overall Study|Cancelled surgery|2
7157440|NCT03402126|11326883|FG000|Overall Study|Lost to Follow-up|6
7157441|NCT03402126|11326883|FG000|Overall Study|Protocol Violation|10
7157442|NCT03402126|11326883|FG000|Overall Study|Sponsor request/Study termination|29
7157443|NCT03402126|11326883|FG000|Overall Study|Study product no longer in use|1
7157444|NCT03402126|11326883|FG000|Overall Study|Technical problems|1
7157445|NCT03402126|11326883|FG000|Overall Study|Withdrawal by Subject|6
7157446|NCT03402126|11326883|FG000|Overall Study|Physician Decision|2
7157447|NCT03402126|11326883|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3
7157448|NCT03402126|11326883|FG000|Overall Study|Death|4
7157449|NCT03402386|11326900|FG000|Overall Study|Adverse Event|3
7157450|NCT03402386|11326900|FG000|Overall Study|Physician Decision|1
7157451|NCT03402386|11326900|FG000|Overall Study|Difficult to control Hb|2
7184206|NCT01814826|11384237|FG002|Overall Study|Other|0
7184207|NCT01814826|11384235|FG000|Overall Study|Death|29
7184208|NCT01814826|11384236|FG001|Overall Study|Death|24
7184209|NCT01814826|11384237|FG002|Overall Study|Death|3
7187414|NCT02036970|11388052|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0
7187415|NCT02036970|11388053|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0
7187416|NCT02036970|11388054|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0
7187417|NCT02036970|11388055|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0
7187418|NCT02036970|11388056|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2
7187419|NCT02036970|11388057|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0
7187420|NCT02036970|11388048|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
7187421|NCT02036970|11388049|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
7187422|NCT02036970|11388050|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
7187423|NCT02036970|11388051|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
7187424|NCT02036970|11388052|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1
7187425|NCT02036970|11388053|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
7187426|NCT02036970|11388054|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
7187427|NCT02036970|11388055|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
7187428|NCT02036970|11388056|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2
7187429|NCT02036970|11388057|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4
7187430|NCT02036970|11388048|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0
7187431|NCT02036970|11388049|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0
7187432|NCT02036970|11388050|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0
7187433|NCT02036970|11388051|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1
7187434|NCT02036970|11388052|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0
7187435|NCT02036970|11388053|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0
7187436|NCT02036970|11388054|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0
7187437|NCT02036970|11388055|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0
7187438|NCT02036970|11388056|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0
7187439|NCT02036970|11388057|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0
7187440|NCT02036970|11388048|FG000|Part 2: Week 16 Onwards|Adverse Event|0
7187441|NCT02036970|11388049|FG001|Part 2: Week 16 Onwards|Adverse Event|2
7187442|NCT02036970|11388050|FG002|Part 2: Week 16 Onwards|Adverse Event|1
7187443|NCT02036970|11388051|FG003|Part 2: Week 16 Onwards|Adverse Event|1
7187444|NCT02036970|11388052|FG004|Part 2: Week 16 Onwards|Adverse Event|1
7187445|NCT02036970|11388053|FG005|Part 2: Week 16 Onwards|Adverse Event|0
7187446|NCT02036970|11388054|FG006|Part 2: Week 16 Onwards|Adverse Event|1
7157452|NCT03402750|11326919|FG000|Overall Study|Lost to Follow-up|2
7157453|NCT03402750|11326920|FG001|Overall Study|Lost to Follow-up|1
7157454|NCT03402893|11326926|FG000|Overall Study|Withdrawal by Subject|1
7157455|NCT03403036|11326952|FG000|Overall Study|Lack of Efficacy|5
7157456|NCT03403192|11326960|FG000|Overall Study|Lost to Follow-up|1
7157457|NCT03403192|11326961|FG001|Overall Study|Lost to Follow-up|2
7157458|NCT03403192|11326962|FG002|Overall Study|Lost to Follow-up|0
7157459|NCT03403192|11326963|FG003|Overall Study|Lost to Follow-up|0
7157460|NCT03403192|11326960|FG000|Overall Study|Unable to respond|0
7157461|NCT03403192|11326961|FG001|Overall Study|Unable to respond|1
7157462|NCT03403192|11326962|FG002|Overall Study|Unable to respond|0
7157463|NCT03403192|11326963|FG003|Overall Study|Unable to respond|0
7157464|NCT03403192|11326960|FG000|Overall Study|Incomplete|3
7157465|NCT03403192|11326961|FG001|Overall Study|Incomplete|1
7157466|NCT03403192|11326962|FG002|Overall Study|Incomplete|3
7157467|NCT03403192|11326963|FG003|Overall Study|Incomplete|6
7157468|NCT03403374|11327038|FG000|Overall Study|Lost to Follow-up|1
7157469|NCT03403400|11327045|FG000|Overall Study|Lost to Follow-up|1
7157470|NCT03403400|11327046|FG001|Overall Study|Lost to Follow-up|0
7157471|NCT03403400|11327047|FG002|Overall Study|Lost to Follow-up|1
7157472|NCT03403400|11327045|FG000|Overall Study|Hospitalization|1
7157473|NCT03403400|11327046|FG001|Overall Study|Hospitalization|0
7157474|NCT03403400|11327047|FG002|Overall Study|Hospitalization|0
7157475|NCT03403400|11327045|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0
7157476|NCT03403400|11327046|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0
7157477|NCT03403400|11327047|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1
7157478|NCT03403413|11327070|FG000|Overall Study|Lack of Efficacy|2
7157479|NCT03403426|11327076|FG000|Overall Study|Death|1
7157480|NCT03403426|11327076|FG000|Overall Study|Lost to Follow-up|2
7157481|NCT03403751|11327178|FG000|Overall Study|Death|5
7157482|NCT03403751|11327179|FG001|Overall Study|Death|6
7157483|NCT03403751|11327178|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2
7157484|NCT03403751|11327179|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2
7157485|NCT03404206|11327196|FG000|Overall Study|Withdrawal by Subject|1
7157486|NCT03404206|11327197|FG001|Overall Study|Withdrawal by Subject|1
7157487|NCT03404206|11327198|FG002|Overall Study|Withdrawal by Subject|0
7157488|NCT03404206|11327196|FG000|Overall Study|Lost to Follow-up|3
7157489|NCT03404206|11327197|FG001|Overall Study|Lost to Follow-up|1
7157490|NCT03404206|11327198|FG002|Overall Study|Lost to Follow-up|0
7157491|NCT03404674|11327243|FG000|Overall Study|Inability to Attend Future Visits|0
7157492|NCT03404674|11327244|FG001|Overall Study|Inability to Attend Future Visits|1
7157493|NCT03404674|11327245|FG002|Overall Study|Inability to Attend Future Visits|1
7157494|NCT03404674|11327246|FG003|Overall Study|Inability to Attend Future Visits|0
7157495|NCT03404674|11327247|FG004|Overall Study|Inability to Attend Future Visits|0
7157496|NCT03404674|11327248|FG005|Overall Study|Inability to Attend Future Visits|0
7157497|NCT03404674|11327243|FG000|Overall Study|Behavioral Problems|0
7157498|NCT03404674|11327244|FG001|Overall Study|Behavioral Problems|0
7157499|NCT03404674|11327245|FG002|Overall Study|Behavioral Problems|1
7157500|NCT03404674|11327246|FG003|Overall Study|Behavioral Problems|0
7157501|NCT03404674|11327247|FG004|Overall Study|Behavioral Problems|0
7157502|NCT03404674|11327248|FG005|Overall Study|Behavioral Problems|0
7157503|NCT03404674|11327243|FG000|Overall Study|Started a Medication that Precluded Eligibility|0
7157504|NCT03404674|11327244|FG001|Overall Study|Started a Medication that Precluded Eligibility|0
7157505|NCT03404674|11327245|FG002|Overall Study|Started a Medication that Precluded Eligibility|0
7157506|NCT03404674|11327246|FG003|Overall Study|Started a Medication that Precluded Eligibility|1
7157507|NCT03404674|11327247|FG004|Overall Study|Started a Medication that Precluded Eligibility|0
7157508|NCT03404674|11327248|FG005|Overall Study|Started a Medication that Precluded Eligibility|1
7157509|NCT03404843|11327265|FG000|Overall Study|Study difficulties unrelated to Tx|4
7157510|NCT03404843|11327266|FG001|Overall Study|Study difficulties unrelated to Tx|1
7157511|NCT03405818|11327294|FG000|Overall Study|Withdrawal by Subject|4
7157512|NCT03405818|11327294|FG000|Overall Study|Lost to Follow-up|4
7157513|NCT03405935|11327298|FG000|Overall Study|Adverse Event|3
7157514|NCT03405935|11327298|FG000|Overall Study|Death|2
7157515|NCT03405935|11327298|FG000|Overall Study|Withdrawal by Subject|1
7157516|NCT03405935|11327298|FG000|Overall Study|Lost to Follow-up|2
7157517|NCT03406260|11327308|FG000|Period 1|Adverse Event|0
7157518|NCT03406260|11327309|FG001|Period 1|Adverse Event|0
7157519|NCT03406260|11327310|FG002|Period 1|Adverse Event|0
7157520|NCT03406260|11327311|FG003|Period 1|Adverse Event|0
7157521|NCT03406260|11327312|FG004|Period 1|Adverse Event|1
7157522|NCT03406260|11327313|FG005|Period 1|Adverse Event|0
7157523|NCT03406962|11327379|FG000|Overall Study|Death|2
7157524|NCT03406962|11327379|FG000|Overall Study|Adverse Event|1
7157525|NCT03407118|11327393|FG000|Period 2|Withdrawal by Subject|1
7157526|NCT03407118|11327394|FG001|Period 2|Withdrawal by Subject|0
7157527|NCT03407170|11327400|FG000|Overall Study|Adverse Event|1
7157528|NCT03407430|11327410|FG000|Washout|Protocol Violation|1
7157529|NCT03407430|11327411|FG001|Washout|Protocol Violation|0
7157530|NCT03407482|11327424|FG000|Overall Study|Adverse Event|12
7157531|NCT03407482|11327424|FG000|Overall Study|Disease Relapse|1
7157532|NCT03407482|11327424|FG000|Overall Study|Lost to Follow-up|1
7157533|NCT03407482|11327424|FG000|Overall Study|Non-Compliance With Study Drug|1
7157534|NCT03407482|11327424|FG000|Overall Study|Pregnancy|2
7157535|NCT03407482|11327424|FG000|Overall Study|Protocol Violation|1
7157536|NCT03407482|11327424|FG000|Overall Study|Study Terminated By Sponsor|106
7157537|NCT03407482|11327424|FG000|Overall Study|Withdrawal by Subject|6
7157538|NCT03407482|11327424|FG000|Overall Study|Data Entry Error|1
7157539|NCT03408483|11327484|FG000|Overall Study|Physician Decision|3
7157540|NCT03408483|11327485|FG001|Overall Study|Physician Decision|3
7079674|NCT02116777|11188931|FG006|Overall Study|Physician Decision|0
7079675|NCT02116777|11188925|FG000|Overall Study|Protocol Violation|0
7079676|NCT02116777|11188926|FG001|Overall Study|Protocol Violation|0
7079677|NCT02116777|11188927|FG002|Overall Study|Protocol Violation|0
7079678|NCT02116777|11188928|FG003|Overall Study|Protocol Violation|1
7079679|NCT02116777|11188929|FG004|Overall Study|Protocol Violation|0
7079680|NCT02116777|11188930|FG005|Overall Study|Protocol Violation|0
7079681|NCT02116777|11188931|FG006|Overall Study|Protocol Violation|0
7079682|NCT02116777|11188925|FG000|Overall Study|Withdrawal by Subject|0
7079683|NCT02116777|11188926|FG001|Overall Study|Withdrawal by Subject|0
7079684|NCT02116777|11188927|FG002|Overall Study|Withdrawal by Subject|0
7079685|NCT02116777|11188928|FG003|Overall Study|Withdrawal by Subject|1
7079686|NCT02116777|11188929|FG004|Overall Study|Withdrawal by Subject|0
7079687|NCT02116777|11188930|FG005|Overall Study|Withdrawal by Subject|0
7157541|NCT03408483|11327484|FG000|Overall Study|Lost to Follow-up|3
7157542|NCT03408483|11327485|FG001|Overall Study|Lost to Follow-up|0
7157543|NCT03408639|11327493|FG000|Overall Study|Death|5
7157544|NCT03408639|11327494|FG001|Overall Study|Death|5
7157545|NCT03408639|11327493|FG000|Overall Study|Lost to Follow-up|1
7157546|NCT03408639|11327494|FG001|Overall Study|Lost to Follow-up|4
7157547|NCT03408639|11327493|FG000|Overall Study|Withdrawal by Subject|2
7157548|NCT03408639|11327494|FG001|Overall Study|Withdrawal by Subject|7
7157549|NCT03408639|11327493|FG000|Overall Study|Physician Decision|3
7157550|NCT03408639|11327494|FG001|Overall Study|Physician Decision|6
7157551|NCT03409107|11327532|FG000|Overall Study|Withdrawal by Subject|4
7157552|NCT03409107|11327533|FG001|Overall Study|Withdrawal by Subject|2
7157553|NCT03409107|11327532|FG000|Overall Study|Physician Decision|1
7157554|NCT03409107|11327533|FG001|Overall Study|Physician Decision|0
7157555|NCT03409107|11327532|FG000|Overall Study|Lost to Follow-up|7
7157556|NCT03409107|11327533|FG001|Overall Study|Lost to Follow-up|2
7157557|NCT03409107|11327532|FG000|Overall Study|Adverse Event|5
7157558|NCT03409107|11327533|FG001|Overall Study|Adverse Event|3
7157559|NCT03410056|11327543|FG000|Overall Study|Decision by Sponsor|0
7157560|NCT03410056|11327544|FG001|Overall Study|Decision by Sponsor|0
7157561|NCT03410056|11327545|FG002|Overall Study|Decision by Sponsor|3
7157562|NCT03410056|11327546|FG003|Overall Study|Decision by Sponsor|0
7157563|NCT03410056|11327547|FG004|Overall Study|Decision by Sponsor|0
7157564|NCT03410056|11327548|FG005|Overall Study|Decision by Sponsor|0
7157565|NCT03410056|11327549|FG006|Overall Study|Decision by Sponsor|0
7157566|NCT03410056|11327543|FG000|Overall Study|Withdrawal by Subject|0
7157567|NCT03410056|11327544|FG001|Overall Study|Withdrawal by Subject|2
7157568|NCT03410056|11327545|FG002|Overall Study|Withdrawal by Subject|5
7157569|NCT03410056|11327546|FG003|Overall Study|Withdrawal by Subject|5
7157570|NCT03410056|11327547|FG004|Overall Study|Withdrawal by Subject|0
7157571|NCT03410056|11327548|FG005|Overall Study|Withdrawal by Subject|0
7157572|NCT03410056|11327549|FG006|Overall Study|Withdrawal by Subject|0
7157573|NCT03411902|11327593|FG000|Overall Study|Lost to Follow-up|3
7157574|NCT03411902|11327594|FG001|Overall Study|Lost to Follow-up|0
7157575|NCT03412019|11327602|FG000|Overall Study|Withdrawal by Subject|1
7157576|NCT03412019|11327603|FG001|Overall Study|Withdrawal by Subject|1
7157577|NCT03412084|11327611|FG000|Overall Study|Withdrawal by Subject|2
7157578|NCT03412084|11327612|FG001|Overall Study|Withdrawal by Subject|0
7157579|NCT03412084|11327611|FG000|Overall Study|Participant moved|1
7157580|NCT03412084|11327612|FG001|Overall Study|Participant moved|0
7157581|NCT03412084|11327611|FG000|Overall Study|Lost to Follow-up|1
7157582|NCT03412084|11327612|FG001|Overall Study|Lost to Follow-up|1
7157583|NCT03412734|11327620|FG000|Overall Study|Incorrect labeling of samples|2
7157584|NCT03412734|11327621|FG001|Overall Study|Incorrect labeling of samples|0
7157585|NCT03412734|11327620|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1
7157586|NCT03412734|11327621|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0
7157587|NCT03412929|11327627|FG000|Overall Study|Protocol Violation|3
7157588|NCT03414047|11327644|FG000|Overall Study|Adverse Event|0
7157589|NCT03414047|11327645|FG001|Overall Study|Adverse Event|0
7157590|NCT03414047|11327646|FG002|Overall Study|Adverse Event|1
7157591|NCT03414047|11327647|FG003|Overall Study|Adverse Event|1
7157592|NCT03414047|11327644|FG000|Overall Study|Physician Decision|1
7157593|NCT03414047|11327645|FG001|Overall Study|Physician Decision|0
7157594|NCT03414047|11327646|FG002|Overall Study|Physician Decision|0
7157595|NCT03414047|11327647|FG003|Overall Study|Physician Decision|1
7157596|NCT03414047|11327644|FG000|Overall Study|Withdrawal by Subject|1
7157597|NCT03414047|11327645|FG001|Overall Study|Withdrawal by Subject|0
7157598|NCT03414047|11327646|FG002|Overall Study|Withdrawal by Subject|2
7157599|NCT03414047|11327647|FG003|Overall Study|Withdrawal by Subject|0
7157600|NCT03414359|11327660|FG000|Overall Study|Lack of Efficacy|1
7157601|NCT03414359|11327661|FG001|Overall Study|Lack of Efficacy|1
7157602|NCT03414359|11327660|FG000|Overall Study|Protocol Violation|0
7157603|NCT03414359|11327661|FG001|Overall Study|Protocol Violation|1
7079688|NCT02116777|11188931|FG006|Overall Study|Withdrawal by Subject|0
7079689|NCT02116803|11188952|FG000|Overall Study|Adverse Event|2
7079690|NCT02116803|11188953|FG001|Overall Study|Adverse Event|1
7157604|NCT03415178|11327676|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0
7157605|NCT03415178|11327677|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2
7157606|NCT03415178|11327676|FG000|Single Arm Period (up to Week 16)|Adverse Event|0
7157607|NCT03415178|11327677|FG001|Single Arm Period (up to Week 16)|Adverse Event|1
7157608|NCT03416127|11327710|FG000|Overall Study|Withdrawal by Subject|0
7157609|NCT03416127|11327711|FG001|Overall Study|Withdrawal by Subject|1
7157610|NCT03416127|11327712|FG002|Overall Study|Withdrawal by Subject|1
7157611|NCT03417024|11327761|FG000|Overall Study|Study Termination prior to follow-up|11
7157612|NCT03417024|11327761|FG000|Overall Study|Physician Decision|2
7157613|NCT03417141|11327765|FG000|Overall Study|Withdrawal by Subject|1
7157614|NCT03417141|11327765|FG000|Overall Study|Protocol Violation|3
7157615|NCT03417219|11327771|FG000|Overall Study|Lost to Follow-up|0
7157616|NCT03417219|11327772|FG001|Overall Study|Lost to Follow-up|3
7157617|NCT03417505|11327782|FG000|First Lens Type (30 Days)|Lost to Follow-up|1
7157618|NCT03417505|11327783|FG001|First Lens Type (30 Days)|Lost to Follow-up|1
7157619|NCT03417830|11327833|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1
7157620|NCT03417830|11327834|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0
7157621|NCT03418324|11327871|FG000|Overall Study|Death|0
7157622|NCT03418324|11327872|FG001|Overall Study|Death|1
7157623|NCT03418324|11327871|FG000|Overall Study|Physician Decision|1
7157624|NCT03418324|11327872|FG001|Overall Study|Physician Decision|1
7157625|NCT03418376|11327882|FG000|Overall Study|Musculoskeletal injury|1
7157626|NCT03418376|11327883|FG001|Overall Study|Musculoskeletal injury|2
7157627|NCT03418376|11327884|FG002|Overall Study|Musculoskeletal injury|1
7157628|NCT03418376|11327885|FG003|Overall Study|Musculoskeletal injury|0
7157629|NCT03418376|11327882|FG000|Overall Study|Personal reasons|0
7157630|NCT03418376|11327883|FG001|Overall Study|Personal reasons|2
7157631|NCT03418376|11327884|FG002|Overall Study|Personal reasons|2
7157632|NCT03418376|11327885|FG003|Overall Study|Personal reasons|1
7157633|NCT03418376|11327882|FG000|Overall Study|Exacerbation|0
7157634|NCT03418376|11327883|FG001|Overall Study|Exacerbation|1
7157635|NCT03418376|11327884|FG002|Overall Study|Exacerbation|0
7157636|NCT03418376|11327885|FG003|Overall Study|Exacerbation|0
7157637|NCT03418545|11327897|FG000|Overall Study|Withdrawal by Participant|2
7157638|NCT03418545|11327898|FG001|Overall Study|Withdrawal by Participant|4
7157639|NCT03418545|11327897|FG000|Overall Study|Lost to Follow-up|3
7157640|NCT03418545|11327898|FG001|Overall Study|Lost to Follow-up|5
7157641|NCT03418545|11327897|FG000|Overall Study|Reason Not Specified|0
7157642|NCT03418545|11327898|FG001|Overall Study|Reason Not Specified|1
7157643|NCT03418545|11327897|FG000|Overall Study|Missing Completion Status|0
7157644|NCT03418545|11327898|FG001|Overall Study|Missing Completion Status|1
7157645|NCT03418571|11327909|FG000|Overall Study|Consent withdrawn by legal guardian|1
7157646|NCT03418571|11327910|FG001|Overall Study|Consent withdrawn by legal guardian|0
7157647|NCT03419403|11327945|FG000|Overall Study|Withdrawal by Subject|5
7157648|NCT03419403|11327946|FG001|Overall Study|Withdrawal by Subject|2
7157649|NCT03419403|11327947|FG002|Overall Study|Withdrawal by Subject|5
7157650|NCT03419403|11327948|FG003|Overall Study|Withdrawal by Subject|1
7157651|NCT03419403|11327945|FG000|Overall Study|Progressive disease (per protocol)|0
7157652|NCT03419403|11327946|FG001|Overall Study|Progressive disease (per protocol)|2
7157653|NCT03419403|11327947|FG002|Overall Study|Progressive disease (per protocol)|2
7157654|NCT03419403|11327948|FG003|Overall Study|Progressive disease (per protocol)|0
7157655|NCT03419403|11327945|FG000|Overall Study|Other, not specified|6
7157656|NCT03419403|11327946|FG001|Overall Study|Other, not specified|4
7157657|NCT03419403|11327947|FG002|Overall Study|Other, not specified|5
7157658|NCT03419403|11327948|FG003|Overall Study|Other, not specified|1
7157659|NCT03419403|11327945|FG000|Overall Study|Left study due to COVID-19 restrictions|1
7157660|NCT03419403|11327946|FG001|Overall Study|Left study due to COVID-19 restrictions|1
7157661|NCT03419403|11327947|FG002|Overall Study|Left study due to COVID-19 restrictions|0
7157662|NCT03419403|11327948|FG003|Overall Study|Left study due to COVID-19 restrictions|0
7157663|NCT03419598|11327973|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2
7157664|NCT03419962|11327988|FG000|Overall Study|Change to other medication|1
7157665|NCT03419962|11327988|FG000|Overall Study|Refusal of continuing with trial drug|1
7157666|NCT03419962|11327988|FG000|Overall Study|Lost to Follow-up|3
7157667|NCT03419962|11327988|FG000|Overall Study|Difficulty in inhaling the doses|1
7157668|NCT03419962|11327988|FG000|Overall Study|Missing completion data|31
7157669|NCT03420300|11327992|FG000|Overall Study|Death|2
7184210|NCT01829711|11384246|FG000|Overall Study|Lost to Follow-up|2
7184211|NCT01829711|11384246|FG000|Overall Study|Withdrawal by Subject|3
7184212|NCT01829711|11384246|FG000|Overall Study|Death|4
7079691|NCT02116803|11188952|FG000|Overall Study|Physician Decision|1
7079692|NCT02116803|11188953|FG001|Overall Study|Physician Decision|0
7079693|NCT02116803|11188952|FG000|Overall Study|Progressive disease|4
7079694|NCT02116803|11188953|FG001|Overall Study|Progressive disease|0
7079695|NCT02116803|11188952|FG000|Overall Study|Study terminated by sponsor|2
7079696|NCT02116803|11188953|FG001|Overall Study|Study terminated by sponsor|1
7079697|NCT02116803|11188952|FG000|Overall Study|Death|1
7079698|NCT02116803|11188953|FG001|Overall Study|Death|0
7079699|NCT02116972|11188962|FG000|Overall Study|Adverse Event|4
7079700|NCT02116972|11188963|FG001|Overall Study|Adverse Event|4
7079701|NCT02116972|11188964|FG002|Overall Study|Adverse Event|1
7184213|NCT01829711|11384246|FG000|Overall Study|Started new therapies|17
7157670|NCT03421379|11328018|FG000|Period 1|Withdrawal by Subject|0
7157671|NCT03421379|11328019|FG001|Period 1|Withdrawal by Subject|1
7157672|NCT03421379|11328018|FG000|Period 1|Physician Decision|1
7157673|NCT03421379|11328019|FG001|Period 1|Physician Decision|1
7157674|NCT03421379|11328018|FG000|Period 1|Did not receive treatment|1
7157675|NCT03421379|11328019|FG001|Period 1|Did not receive treatment|2
7157676|NCT03421431|11328028|FG000|Overall Study|Adverse Event|2
7157677|NCT03421431|11328029|FG001|Overall Study|Adverse Event|1
7157678|NCT03421431|11328030|FG002|Overall Study|Adverse Event|12
7157679|NCT03421431|11328028|FG000|Overall Study|Lost to Follow-up|1
7157680|NCT03421431|11328029|FG001|Overall Study|Lost to Follow-up|1
7157681|NCT03421431|11328030|FG002|Overall Study|Lost to Follow-up|1
7157682|NCT03421431|11328028|FG000|Overall Study|Withdrawal by Subject|3
7157683|NCT03421431|11328029|FG001|Overall Study|Withdrawal by Subject|2
7157684|NCT03421431|11328030|FG002|Overall Study|Withdrawal by Subject|1
7157685|NCT03421431|11328028|FG000|Overall Study|Protocol Violation|0
7157686|NCT03421431|11328029|FG001|Overall Study|Protocol Violation|1
7157687|NCT03421431|11328030|FG002|Overall Study|Protocol Violation|0
7157688|NCT03421431|11328028|FG000|Overall Study|Participant met Stopping Rules|0
7157689|NCT03421431|11328029|FG001|Overall Study|Participant met Stopping Rules|1
7157690|NCT03421431|11328030|FG002|Overall Study|Participant met Stopping Rules|0
7157691|NCT03421730|11328040|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7157692|NCT03421730|11328041|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2
7157693|NCT03421730|11328042|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7157694|NCT03421730|11328043|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7157695|NCT03421730|11328044|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7157696|NCT03421730|11328045|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7157697|NCT03421730|11328046|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7157698|NCT03421730|11328047|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7157699|NCT03421730|11328048|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7157700|NCT03421730|11328049|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7157701|NCT03421730|11328050|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7157702|NCT03421730|11328051|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7157703|NCT03421730|11328040|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7157704|NCT03421730|11328041|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7157705|NCT03421730|11328042|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7157706|NCT03421730|11328043|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7157707|NCT03421730|11328044|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2
7157708|NCT03421730|11328045|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7157709|NCT03421730|11328046|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7157710|NCT03421730|11328047|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7157711|NCT03421730|11328048|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7157712|NCT03421730|11328049|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7157713|NCT03421730|11328050|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7157714|NCT03421730|11328051|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7157715|NCT03422159|11328076|FG000|Overall Study|Exclusion due to terminal disease|2
7157716|NCT03422159|11328077|FG001|Overall Study|Exclusion due to terminal disease|1
7157717|NCT03422172|11328085|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1
7157718|NCT03422172|11328085|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1
7157719|NCT03422172|11328085|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3
7157720|NCT03422250|11328098|FG000|Intervention|Adverse Event|0
7157721|NCT03422250|11328099|FG001|Intervention|Adverse Event|1
7157722|NCT03422250|11328100|FG002|Intervention|Adverse Event|0
7157723|NCT03422250|11328101|FG003|Intervention|Adverse Event|1
7157724|NCT03422250|11328098|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1
7157725|NCT03422250|11328099|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0
7157726|NCT03422250|11328100|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2
7157727|NCT03422250|11328101|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0
7157728|NCT03422250|11328098|FG000|Follow-up|Withdrawal by Subject|0
7157729|NCT03422250|11328099|FG001|Follow-up|Withdrawal by Subject|0
7157730|NCT03422250|11328100|FG002|Follow-up|Withdrawal by Subject|0
7157731|NCT03422250|11328101|FG003|Follow-up|Withdrawal by Subject|1
7157732|NCT03422250|11328098|FG000|Follow-up|Adverse Event|0
7157733|NCT03422250|11328099|FG001|Follow-up|Adverse Event|0
7157734|NCT03422250|11328100|FG002|Follow-up|Adverse Event|0
7157735|NCT03422250|11328101|FG003|Follow-up|Adverse Event|1
7157736|NCT03423173|11328121|FG000|Overall Study|Randomized but not vaccinated|1
7157737|NCT03423173|11328122|FG001|Overall Study|Randomized but not vaccinated|0
7157738|NCT03423173|11328123|FG002|Overall Study|Randomized but not vaccinated|2
7157739|NCT03423173|11328124|FG003|Overall Study|Randomized but not vaccinated|1
7157740|NCT03423173|11328121|FG000|Overall Study|Adverse Event|1
7157741|NCT03423173|11328122|FG001|Overall Study|Adverse Event|1
7157742|NCT03423173|11328123|FG002|Overall Study|Adverse Event|1
7157743|NCT03423173|11328124|FG003|Overall Study|Adverse Event|1
7157744|NCT03423173|11328121|FG000|Overall Study|Lost to Follow-up|10
7157745|NCT03423173|11328122|FG001|Overall Study|Lost to Follow-up|19
7157746|NCT03423173|11328123|FG002|Overall Study|Lost to Follow-up|17
7157747|NCT03423173|11328124|FG003|Overall Study|Lost to Follow-up|22
7157748|NCT03423173|11328121|FG000|Overall Study|Withdrawal of consent|4
7157749|NCT03423173|11328122|FG001|Overall Study|Withdrawal of consent|10
7157750|NCT03423173|11328123|FG002|Overall Study|Withdrawal of consent|4
7157751|NCT03423173|11328124|FG003|Overall Study|Withdrawal of consent|5
7157752|NCT03423173|11328121|FG000|Overall Study|Death|1
7157753|NCT03423173|11328122|FG001|Overall Study|Death|0
7157754|NCT03423173|11328123|FG002|Overall Study|Death|0
7157755|NCT03423173|11328124|FG003|Overall Study|Death|0
7157756|NCT03423173|11328121|FG000|Overall Study|Reason not Specified|2
7157757|NCT03423173|11328122|FG001|Overall Study|Reason not Specified|5
7157758|NCT03423173|11328123|FG002|Overall Study|Reason not Specified|3
7157759|NCT03423173|11328124|FG003|Overall Study|Reason not Specified|1
6894758|NCT00621309|10912543|FG004|Overall Study|Withdrawal by Subject|1
6894759|NCT00621309|10912544|FG005|Overall Study|Withdrawal by Subject|1
7157760|NCT03423238|11328145|FG000|Overall Study|Lost to Follow-up|1
7157761|NCT03423238|11328146|FG001|Overall Study|Lost to Follow-up|0
7157762|NCT03423238|11328145|FG000|Overall Study|Withdrawal by Subject|1
7157763|NCT03423238|11328146|FG001|Overall Study|Withdrawal by Subject|0
7157764|NCT03424044|11328162|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
7157765|NCT03424044|11328163|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
7157766|NCT03424044|11328164|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1
7157767|NCT03424044|11328165|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
7157768|NCT03424044|11328166|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
7157769|NCT03424044|11328167|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
7157770|NCT03424044|11328168|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
7157771|NCT03424044|11328169|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
7157772|NCT03424044|11328170|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
7157773|NCT03424044|11328162|FG000|First Intervention (76 Hours)|Adverse Event|0
7157774|NCT03424044|11328163|FG001|First Intervention (76 Hours)|Adverse Event|0
7157775|NCT03424044|11328164|FG002|First Intervention (76 Hours)|Adverse Event|0
7157776|NCT03424044|11328165|FG003|First Intervention (76 Hours)|Adverse Event|0
7157777|NCT03424044|11328166|FG004|First Intervention (76 Hours)|Adverse Event|1
7157778|NCT03424044|11328167|FG005|First Intervention (76 Hours)|Adverse Event|0
7157779|NCT03424044|11328168|FG006|First Intervention (76 Hours)|Adverse Event|0
7157780|NCT03424044|11328169|FG007|First Intervention (76 Hours)|Adverse Event|0
7157781|NCT03424044|11328170|FG008|First Intervention (76 Hours)|Adverse Event|0
7157782|NCT03424044|11328162|FG000|First Intervention (76 Hours)|device issues|0
7157783|NCT03424044|11328163|FG001|First Intervention (76 Hours)|device issues|0
7157784|NCT03424044|11328164|FG002|First Intervention (76 Hours)|device issues|0
7157785|NCT03424044|11328165|FG003|First Intervention (76 Hours)|device issues|0
7157786|NCT03424044|11328166|FG004|First Intervention (76 Hours)|device issues|0
7157787|NCT03424044|11328167|FG005|First Intervention (76 Hours)|device issues|0
7157788|NCT03424044|11328168|FG006|First Intervention (76 Hours)|device issues|1
7157789|NCT03424044|11328169|FG007|First Intervention (76 Hours)|device issues|1
7157790|NCT03424044|11328170|FG008|First Intervention (76 Hours)|device issues|1
7157791|NCT03424044|11328162|FG000|Third Intervention (76 Hours)|Adverse Event|1
7157792|NCT03424044|11328163|FG001|Third Intervention (76 Hours)|Adverse Event|0
7157793|NCT03424044|11328164|FG002|Third Intervention (76 Hours)|Adverse Event|0
7157794|NCT03424044|11328165|FG003|Third Intervention (76 Hours)|Adverse Event|0
7157795|NCT03424044|11328166|FG004|Third Intervention (76 Hours)|Adverse Event|0
7157796|NCT03424044|11328167|FG005|Third Intervention (76 Hours)|Adverse Event|0
7157797|NCT03424044|11328168|FG006|Third Intervention (76 Hours)|Adverse Event|1
7157798|NCT03424044|11328169|FG007|Third Intervention (76 Hours)|Adverse Event|0
7157799|NCT03424044|11328170|FG008|Third Intervention (76 Hours)|Adverse Event|0
7157800|NCT03424044|11328162|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0
7157801|NCT03424044|11328163|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0
7157802|NCT03424044|11328164|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0
7157803|NCT03424044|11328165|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1
7157804|NCT03424044|11328166|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0
7157805|NCT03424044|11328167|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0
7157806|NCT03424044|11328168|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0
7157807|NCT03424044|11328169|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0
7157808|NCT03424044|11328170|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0
7157809|NCT03424239|11328204|FG000|Overall Study|Withdrawal by Subject|2
7157810|NCT03424265|11328210|FG000|Overall Study|screening failure|1
7157811|NCT03424265|11328211|FG001|Overall Study|screening failure|0
7157812|NCT03424265|11328210|FG000|Overall Study|Withdrawal by Subject|0
7157813|NCT03424265|11328211|FG001|Overall Study|Withdrawal by Subject|2
7157814|NCT03425188|11328241|FG000|Overall Study|Withdrawal by Subject|1
7157815|NCT03425253|11328246|FG000|Overall Study|Adverse Event|2
6894760|NCT00621322|10912556|FG000|Overall Study|Lost to Follow-up|0
6894761|NCT00621322|10912557|FG001|Overall Study|Lost to Follow-up|0
7157816|NCT03425253|11328246|FG000|Overall Study|Lost to Follow-up|3
7157817|NCT03425253|11328246|FG000|Overall Study|Withdrew Consent|6
7157818|NCT03425253|11328246|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5
7157819|NCT03425396|11328256|FG000|Overall Study|Lost to Follow-up|2
7157820|NCT03425396|11328257|FG001|Overall Study|Lost to Follow-up|5
7157821|NCT03425396|11328258|FG002|Overall Study|Lost to Follow-up|2
7157822|NCT03425396|11328259|FG003|Overall Study|Lost to Follow-up|0
7157823|NCT03425396|11328260|FG004|Overall Study|Lost to Follow-up|0
7157824|NCT03425396|11328256|FG000|Overall Study|Withdrawal by Subject|0
7157825|NCT03425396|11328257|FG001|Overall Study|Withdrawal by Subject|1
7157826|NCT03425396|11328258|FG002|Overall Study|Withdrawal by Subject|0
7157827|NCT03425396|11328259|FG003|Overall Study|Withdrawal by Subject|1
7157828|NCT03425396|11328260|FG004|Overall Study|Withdrawal by Subject|0
7157829|NCT03425396|11328256|FG000|Overall Study|Other|0
7157830|NCT03425396|11328257|FG001|Overall Study|Other|1
7157831|NCT03425396|11328258|FG002|Overall Study|Other|1
7157832|NCT03425396|11328259|FG003|Overall Study|Other|0
7157833|NCT03425396|11328260|FG004|Overall Study|Other|1
7157834|NCT03426267|11328285|FG000|Overall Study|Physician Decision|1
7157835|NCT03426267|11328286|FG001|Overall Study|Physician Decision|4
7157836|NCT03426267|11328285|FG000|Overall Study|Lost to Follow-up|1
7157837|NCT03426267|11328286|FG001|Overall Study|Lost to Follow-up|0
7157838|NCT03426267|11328285|FG000|Overall Study|Withdrawal by Subject|4
7157839|NCT03426267|11328286|FG001|Overall Study|Withdrawal by Subject|10
7157840|NCT03426267|11328285|FG000|Overall Study|Protocol Violation|1
7157841|NCT03426267|11328286|FG001|Overall Study|Protocol Violation|3
7157842|NCT03426267|11328285|FG000|Overall Study|Adverse Event|9
7157843|NCT03426267|11328286|FG001|Overall Study|Adverse Event|27
7157844|NCT03426267|11328285|FG000|Overall Study|Prohibited Treatment Intake|2
7157845|NCT03426267|11328286|FG001|Overall Study|Prohibited Treatment Intake|3
7157846|NCT03426267|11328285|FG000|Overall Study|Lack of Efficacy|0
7157847|NCT03426267|11328286|FG001|Overall Study|Lack of Efficacy|25
7157848|NCT03426267|11328285|FG000|Overall Study|other|3
7157849|NCT03426267|11328286|FG001|Overall Study|other|0
7157850|NCT03426345|11328294|FG000|Overall Study|Adverse Event|4
7157851|NCT03426345|11328295|FG001|Overall Study|Adverse Event|4
7157852|NCT03426345|11328294|FG000|Overall Study|Lack of Efficacy|1
7157853|NCT03426345|11328295|FG001|Overall Study|Lack of Efficacy|0
7157854|NCT03426345|11328294|FG000|Overall Study|Withdrawal by Subject|5
7157855|NCT03426345|11328295|FG001|Overall Study|Withdrawal by Subject|6
7157856|NCT03426345|11328294|FG000|Overall Study|Lost to Follow-up|3
7157857|NCT03426345|11328295|FG001|Overall Study|Lost to Follow-up|1
7157858|NCT03426345|11328294|FG000|Overall Study|Protocol Deviation|3
7157859|NCT03426345|11328295|FG001|Overall Study|Protocol Deviation|4
7157860|NCT03426345|11328294|FG000|Overall Study|Reason Not Specified|1
7157861|NCT03426345|11328295|FG001|Overall Study|Reason Not Specified|2
7157862|NCT03426345|11328294|FG000|Overall Study|Missing Completion Status|1
7157863|NCT03426345|11328295|FG001|Overall Study|Missing Completion Status|0
7157864|NCT03426436|11328302|FG000|Overall Study|Incorrect lead placement|12
7157865|NCT03426436|11328302|FG000|Overall Study|Withdrawal by Subject|2
7157866|NCT03426436|11328302|FG000|Overall Study|Consent issue|1
7157867|NCT03426436|11328302|FG000|Overall Study|ECGs not saved|4
7157868|NCT03426631|11328306|FG000|Overall Study|Lost to Follow-up|0
7157869|NCT03426631|11328307|FG001|Overall Study|Lost to Follow-up|1
7157870|NCT03426787|11328313|FG000|Overall Study|Withdrawal by Subject|6
7157871|NCT03426787|11328313|FG000|Overall Study|Lost to Follow-up|7
7157872|NCT03426787|11328313|FG000|Overall Study|Unrelated to intervention death|1
7157873|NCT03426995|11328342|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7157874|NCT03426995|11328343|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7157875|NCT03426995|11328344|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1
7157876|NCT03426995|11328345|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7157877|NCT03426995|11328346|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7157878|NCT03426995|11328347|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7157879|NCT03426995|11328348|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7157880|NCT03426995|11328349|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7157881|NCT03426995|11328350|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7157882|NCT03426995|11328351|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7157883|NCT03426995|11328352|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7157884|NCT03426995|11328353|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7157885|NCT03426995|11328354|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7157886|NCT03426995|11328355|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7157887|NCT03426995|11328356|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7157888|NCT03426995|11328357|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7157889|NCT03426995|11328358|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7157890|NCT03426995|11328359|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7157891|NCT03426995|11328360|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7157892|NCT03426995|11328342|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
6894762|NCT00621322|10912558|FG002|Overall Study|Lost to Follow-up|0
7157893|NCT03426995|11328343|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7157894|NCT03426995|11328344|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7157895|NCT03426995|11328345|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7157896|NCT03426995|11328346|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7157897|NCT03426995|11328347|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1
7157898|NCT03426995|11328348|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7157899|NCT03426995|11328349|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7157900|NCT03426995|11328350|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7157901|NCT03426995|11328351|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7157902|NCT03426995|11328352|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7157903|NCT03426995|11328353|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7157904|NCT03426995|11328354|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7157905|NCT03426995|11328355|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7157906|NCT03426995|11328356|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7157907|NCT03426995|11328357|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7157908|NCT03426995|11328358|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7157909|NCT03426995|11328359|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7157910|NCT03426995|11328360|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7157911|NCT03426995|11328342|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7157912|NCT03426995|11328343|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7157913|NCT03426995|11328344|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7157914|NCT03426995|11328345|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7157915|NCT03426995|11328346|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1
7157916|NCT03426995|11328347|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1
7157917|NCT03426995|11328348|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7157918|NCT03426995|11328349|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7157919|NCT03426995|11328350|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7157920|NCT03426995|11328351|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7157921|NCT03426995|11328352|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7157922|NCT03426995|11328353|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7157923|NCT03426995|11328354|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7157924|NCT03426995|11328355|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7157925|NCT03426995|11328356|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7157926|NCT03426995|11328357|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7157927|NCT03426995|11328358|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7157928|NCT03426995|11328359|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7157929|NCT03426995|11328360|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7157930|NCT03426995|11328342|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7157931|NCT03426995|11328343|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7157932|NCT03426995|11328344|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7157933|NCT03426995|11328345|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7157934|NCT03426995|11328346|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7157935|NCT03426995|11328347|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7157936|NCT03426995|11328348|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7157937|NCT03426995|11328349|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7157938|NCT03426995|11328350|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7157939|NCT03426995|11328351|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7157940|NCT03426995|11328352|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1
7157941|NCT03426995|11328353|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7157942|NCT03426995|11328354|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7157943|NCT03426995|11328355|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7157944|NCT03426995|11328356|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7157945|NCT03426995|11328357|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7157946|NCT03426995|11328358|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7157947|NCT03426995|11328359|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7157948|NCT03426995|11328360|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7157949|NCT03426995|11328342|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7157950|NCT03426995|11328343|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7157951|NCT03426995|11328344|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7157952|NCT03426995|11328345|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7157953|NCT03426995|11328346|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7157954|NCT03426995|11328347|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7157955|NCT03426995|11328348|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7157956|NCT03426995|11328349|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1
7157957|NCT03426995|11328350|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7157958|NCT03426995|11328351|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7157959|NCT03426995|11328352|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7157960|NCT03426995|11328353|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7157961|NCT03426995|11328354|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7157962|NCT03426995|11328355|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7157963|NCT03426995|11328356|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7157964|NCT03426995|11328357|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7157965|NCT03426995|11328358|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7157966|NCT03426995|11328359|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7157967|NCT03426995|11328360|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7157968|NCT03426995|11328342|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7157969|NCT03426995|11328343|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7157970|NCT03426995|11328344|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7157971|NCT03426995|11328345|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7157972|NCT03426995|11328346|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7157973|NCT03426995|11328347|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7157974|NCT03426995|11328348|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7157975|NCT03426995|11328349|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7157976|NCT03426995|11328350|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7157977|NCT03426995|11328351|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7157978|NCT03426995|11328352|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7157979|NCT03426995|11328353|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7157980|NCT03426995|11328354|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7157981|NCT03426995|11328355|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7157982|NCT03426995|11328356|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8
7157983|NCT03426995|11328357|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9
7157984|NCT03426995|11328358|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7157985|NCT03426995|11328359|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7157986|NCT03426995|11328360|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7157987|NCT03426995|11328342|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7157988|NCT03426995|11328343|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7157989|NCT03426995|11328344|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7157990|NCT03426995|11328345|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7157991|NCT03426995|11328346|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7157992|NCT03426995|11328347|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7157993|NCT03426995|11328348|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7157994|NCT03426995|11328349|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7157995|NCT03426995|11328350|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7157996|NCT03426995|11328351|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7157997|NCT03426995|11328352|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7157998|NCT03426995|11328353|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7157999|NCT03426995|11328354|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7158000|NCT03426995|11328355|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7158001|NCT03426995|11328356|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1
7158002|NCT03426995|11328357|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3
7158003|NCT03426995|11328358|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7158004|NCT03426995|11328359|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7158005|NCT03426995|11328360|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7158006|NCT03427073|11328415|FG000|Overall Study|Disease Progression|1
7158007|NCT03427073|11328416|FG001|Overall Study|Disease Progression|1
7158008|NCT03427073|11328417|FG002|Overall Study|Disease Progression|1
7158009|NCT03427073|11328418|FG003|Overall Study|Disease Progression|3
7158010|NCT03427073|11328419|FG004|Overall Study|Disease Progression|3
7158011|NCT03427073|11328420|FG005|Overall Study|Disease Progression|4
7158012|NCT03427073|11328421|FG006|Overall Study|Disease Progression|2
7158013|NCT03427073|11328422|FG007|Overall Study|Disease Progression|3
7158014|NCT03427073|11328415|FG000|Overall Study|Physician Decision|0
7158015|NCT03427073|11328416|FG001|Overall Study|Physician Decision|0
7158016|NCT03427073|11328417|FG002|Overall Study|Physician Decision|0
7158017|NCT03427073|11328418|FG003|Overall Study|Physician Decision|0
7158018|NCT03427073|11328419|FG004|Overall Study|Physician Decision|0
7158019|NCT03427073|11328420|FG005|Overall Study|Physician Decision|0
7158020|NCT03427073|11328421|FG006|Overall Study|Physician Decision|1
7158021|NCT03427073|11328422|FG007|Overall Study|Physician Decision|1
7158022|NCT03427268|11328449|FG000|Overall Study|Progressive disease|25
7158023|NCT03427268|11328449|FG000|Overall Study|Never treated|2
7158024|NCT03427268|11328449|FG000|Overall Study|Compassionate use|1
7158025|NCT03427268|11328449|FG000|Overall Study|Withdrawal by Subject|1
7158026|NCT03427268|11328449|FG000|Overall Study|Adverse Event|3
7158027|NCT03427619|11328453|FG000|Overall Study|Physician Decision|3
7158028|NCT03427619|11328453|FG000|Overall Study|Withdrawal by Subject|4
7158029|NCT03427619|11328453|FG000|Overall Study|Lost to Follow-up|5
7158030|NCT03427619|11328453|FG000|Overall Study|Administrative|4
7158031|NCT03427619|11328453|FG000|Overall Study|Other|2
7158032|NCT03427619|11328453|FG000|Overall Study|Unknown or Missing Completion Status|48
7158033|NCT03427892|11328457|FG000|Overall Study|Lost to Follow-up|2
7158034|NCT03428152|11328467|FG000|Overall Study|Physician Decision|4
7158035|NCT03428152|11328468|FG001|Overall Study|Physician Decision|2
7158036|NCT03428152|11328467|FG000|Overall Study|Protocol Violation|3
7158037|NCT03428152|11328468|FG001|Overall Study|Protocol Violation|5
7158038|NCT03428152|11328467|FG000|Overall Study|Lack of Efficacy|0
7158039|NCT03428152|11328468|FG001|Overall Study|Lack of Efficacy|4
7158040|NCT03428360|11328491|FG000|Overall Study|Informed consent withdrawn|5
7158041|NCT03428360|11328491|FG000|Overall Study|Withdrawal by Subject|4
7158042|NCT03428360|11328491|FG000|Overall Study|Lost to Follow-up|5
7158043|NCT03428360|11328491|FG000|Overall Study|Physician Decision|2
7158044|NCT03428360|11328491|FG000|Overall Study|Informed consent withdrawn|5
7158045|NCT03428360|11328491|FG000|Overall Study|Study terminated by sponsor|10
7158046|NCT03428360|11328491|FG000|Overall Study|Non-compliant with study|1
7158047|NCT03428360|11328491|FG000|Overall Study|Non-compliant with study drug|3
7158048|NCT03428360|11328491|FG000|Overall Study|Death|3
7158049|NCT03428360|11328491|FG000|Overall Study|Adverse Event|1
7158050|NCT03428360|11328491|FG000|Overall Study|Not on antiepileptic drug|1
7158051|NCT03428750|11328501|FG000|Overall Study|Withdrawal by Subject|11
7158052|NCT03428750|11328502|FG001|Overall Study|Withdrawal by Subject|10
7041547|NCT01728324|11125173|FG002|Termination of FDV|Adverse Event|4
7041548|NCT01728324|11125171|FG000|Termination of FDV|Lack of Efficacy|14
7158053|NCT03428750|11328501|FG000|Overall Study|Lost to Follow-up|3
7158054|NCT03428750|11328502|FG001|Overall Study|Lost to Follow-up|9
7158055|NCT03428750|11328501|FG000|Overall Study|Adverse Event|9
7158056|NCT03428750|11328502|FG001|Overall Study|Adverse Event|1
7158057|NCT03428750|11328501|FG000|Overall Study|Protocol Violation|1
7158058|NCT03428750|11328502|FG001|Overall Study|Protocol Violation|0
7158059|NCT03428750|11328501|FG000|Overall Study|Administrative|0
7158060|NCT03428750|11328502|FG001|Overall Study|Administrative|1
7158061|NCT03428815|11328533|FG000|Overall Study|Lost to Follow-up|2
7158062|NCT03428815|11328534|FG001|Overall Study|Lost to Follow-up|2
7158063|NCT03428815|11328533|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5
7158064|NCT03428815|11328534|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2
7158065|NCT03428815|11328533|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3
7158066|NCT03428815|11328534|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1
7158067|NCT03428997|11328540|FG000|Overall Study|Sponsor decision.|1
7158068|NCT03428997|11328540|FG000|Overall Study|Withdrawal by Subject|3
7158069|NCT03428997|11328540|FG000|Overall Study|Lost to Follow-up|4
7158070|NCT03429556|11328565|FG000|Overall Study|Lost to Follow-up|0
7158071|NCT03429556|11328566|FG001|Overall Study|Lost to Follow-up|1
7158072|NCT03429556|11328567|FG002|Overall Study|Lost to Follow-up|0
7158073|NCT03429556|11328568|FG003|Overall Study|Lost to Follow-up|0
7158074|NCT03430245|11328596|FG000|Overall Study|Withdrawal by Subject|6
7158075|NCT03430245|11328596|FG000|Overall Study|Lost to Follow-up|1
7158076|NCT03430856|11328613|FG000|Overall Study|Adverse Event|0
7158077|NCT03430856|11328614|FG001|Overall Study|Adverse Event|1
7158078|NCT03430856|11328615|FG002|Overall Study|Adverse Event|0
7158079|NCT03430856|11328613|FG000|Overall Study|Rescue criteria|1
7158080|NCT03430856|11328614|FG001|Overall Study|Rescue criteria|1
7158081|NCT03430856|11328615|FG002|Overall Study|Rescue criteria|0
7158082|NCT03430856|11328613|FG000|Overall Study|Voluntary withdrawal of consent|1
7158083|NCT03430856|11328614|FG001|Overall Study|Voluntary withdrawal of consent|1
7158084|NCT03430856|11328615|FG002|Overall Study|Voluntary withdrawal of consent|1
7158085|NCT03430986|11328628|FG000|24-week Control Period|Adverse Event|1
7158086|NCT03430986|11328629|FG001|24-week Control Period|Adverse Event|0
7158087|NCT03430986|11328628|FG000|24-week Control Period|Lost to Follow-up|2
7158088|NCT03430986|11328629|FG001|24-week Control Period|Lost to Follow-up|2
7158089|NCT03430986|11328628|FG000|24-week Control Period|Withdrawal by Participant|5
7158090|NCT03430986|11328629|FG001|24-week Control Period|Withdrawal by Participant|0
7158091|NCT03430986|11328628|FG000|24-week Control Period|Protocol Deviation|0
7158092|NCT03430986|11328629|FG001|24-week Control Period|Protocol Deviation|2
7158093|NCT03430986|11328628|FG000|24-week Post-Control Period|Lost to Follow-up|1
7158094|NCT03430986|11328629|FG001|24-week Post-Control Period|Lost to Follow-up|1
7158095|NCT03430986|11328628|FG000|24-week Post-Control Period|Withdrawal by Participant|0
7158096|NCT03430986|11328629|FG001|24-week Post-Control Period|Withdrawal by Participant|1
7158097|NCT03431337|11328661|FG000|Overall Study|Lost to Follow-up|21
7158098|NCT03431337|11328662|FG001|Overall Study|Lost to Follow-up|19
7158099|NCT03431337|11328661|FG000|Overall Study|Withdrawal by Subject|8
7158100|NCT03431337|11328662|FG001|Overall Study|Withdrawal by Subject|3
7158101|NCT03431441|11328672|FG000|Overall Study|Withdrawal by Subject|2
7158102|NCT03431441|11328672|FG000|Overall Study|Adverse Event|2
7158103|NCT03431441|11328672|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1
7158104|NCT03431857|11328676|FG000|Overall Study|Death|6
7158105|NCT03431857|11328676|FG000|Overall Study|Lost to Follow-up|41
7158106|NCT03431857|11328676|FG000|Overall Study|Adverse Event|6
7158107|NCT03431857|11328676|FG000|Overall Study|Withdrawal by Subject|1
7158108|NCT03432390|11328682|FG000|Apnea Period|Protocol Violation|2
7041549|NCT01728324|11125172|FG001|Termination of FDV|Lack of Efficacy|12
7041550|NCT01728324|11125173|FG002|Termination of FDV|Lack of Efficacy|8
7041551|NCT01728324|11125171|FG000|Termination of FDV|Withdrawal by Subject|9
7041552|NCT01728324|11125172|FG001|Termination of FDV|Withdrawal by Subject|6
7041553|NCT01728324|11125173|FG002|Termination of FDV|Withdrawal by Subject|2
7158109|NCT03432390|11328683|FG001|Apnea Period|Protocol Violation|2
7158110|NCT03432533|11328691|FG000|Overall Study|Lost to Follow-up|1
7158111|NCT03432533|11328692|FG001|Overall Study|Lost to Follow-up|2
7158112|NCT03432533|11328691|FG000|Overall Study|Withdrawal by Subject|14
7158113|NCT03432533|11328692|FG001|Overall Study|Withdrawal by Subject|9
7158114|NCT03432858|11328701|FG000|Overall Study|Protocol Violation|2
7158115|NCT03432858|11328702|FG001|Overall Study|Protocol Violation|1
7158116|NCT03432858|11328703|FG002|Overall Study|Protocol Violation|9
7158117|NCT03432858|11328701|FG000|Overall Study|Withdrawal by Subject|0
7158118|NCT03432858|11328702|FG001|Overall Study|Withdrawal by Subject|1
7158119|NCT03432858|11328703|FG002|Overall Study|Withdrawal by Subject|1
7158120|NCT03432858|11328701|FG000|Overall Study|Procedure canceled/rescheduled|0
7158121|NCT03432858|11328702|FG001|Overall Study|Procedure canceled/rescheduled|9
7158122|NCT03432858|11328703|FG002|Overall Study|Procedure canceled/rescheduled|6
7158123|NCT03432858|11328701|FG000|Overall Study|Required postop mobilization with splinting|0
7158124|NCT03432858|11328702|FG001|Overall Study|Required postop mobilization with splinting|0
7158125|NCT03432858|11328703|FG002|Overall Study|Required postop mobilization with splinting|1
7158126|NCT03433482|11328715|FG000|Overall Study|Lost to Follow-up|1
7158127|NCT03433482|11328716|FG001|Overall Study|Lost to Follow-up|0
7158128|NCT03433482|11328717|FG002|Overall Study|Lost to Follow-up|1
7158129|NCT03433482|11328718|FG003|Overall Study|Lost to Follow-up|1
7158130|NCT03433482|11328715|FG000|Overall Study|Withdrawal by Subject|0
7158131|NCT03433482|11328716|FG001|Overall Study|Withdrawal by Subject|0
7158132|NCT03433482|11328717|FG002|Overall Study|Withdrawal by Subject|1
7158133|NCT03433482|11328718|FG003|Overall Study|Withdrawal by Subject|0
7158134|NCT03433482|11328715|FG000|Overall Study|Unknown reason|0
7158135|NCT03433482|11328716|FG001|Overall Study|Unknown reason|0
7158136|NCT03433482|11328717|FG002|Overall Study|Unknown reason|2
7158137|NCT03433482|11328718|FG003|Overall Study|Unknown reason|0
7158138|NCT03433677|11328730|FG000|Period 1|Protocol Violation|1
7158139|NCT03433677|11328731|FG001|Period 1|Protocol Violation|0
7158140|NCT03433677|11328730|FG000|Period 2|Withdrawal by Subject|1
7158141|NCT03433677|11328731|FG001|Period 2|Withdrawal by Subject|1
7158142|NCT03433703|11328738|FG000|Overall Study|Study terminated by Sponsor|2
7158143|NCT03433755|11328746|FG000|Overall Study|Lost to Follow-up|1
7158144|NCT03433755|11328747|FG001|Overall Study|Lost to Follow-up|0
7158145|NCT03433755|11328748|FG002|Overall Study|Lost to Follow-up|0
7158146|NCT03433755|11328749|FG003|Overall Study|Lost to Follow-up|0
7158147|NCT03433755|11328746|FG000|Overall Study|Decision by Sponsor|1
7158148|NCT03433755|11328747|FG001|Overall Study|Decision by Sponsor|0
7158149|NCT03433755|11328748|FG002|Overall Study|Decision by Sponsor|0
7158150|NCT03433755|11328749|FG003|Overall Study|Decision by Sponsor|0
7158151|NCT03434249|11328776|FG000|Overall Study|Adverse Event|1
7158152|NCT03434249|11328777|FG001|Overall Study|Adverse Event|0
7158153|NCT03434249|11328776|FG000|Overall Study|Lost to Follow-up|0
7158154|NCT03434249|11328777|FG001|Overall Study|Lost to Follow-up|1
7158155|NCT03434249|11328776|FG000|Overall Study|Non-compliance of family|2
7158156|NCT03434249|11328777|FG001|Overall Study|Non-compliance of family|1
7158157|NCT03434249|11328776|FG000|Overall Study|Difficulties in completing daily diary|2
7158158|NCT03434249|11328777|FG001|Overall Study|Difficulties in completing daily diary|1
7158159|NCT03434834|11328787|FG000|Overall Study|unable to swallow OCT probe|16
7158160|NCT03434977|11328793|FG000|Washout Period (at Least 6 Days)|Adverse Event|0
7158161|NCT03434977|11328794|FG001|Washout Period (at Least 6 Days)|Adverse Event|1
7158162|NCT03435055|11328800|FG000|Screening|Physician Decision|2
7158163|NCT03435055|11328800|FG000|Received Intervention|Did not complete nitrous administration|3
7158164|NCT03435081|11328814|FG000|Overall Study|Lack of Efficacy|6
7158165|NCT03435081|11328815|FG001|Overall Study|Lack of Efficacy|5
7158166|NCT03435081|11328816|FG002|Overall Study|Lack of Efficacy|0
7158167|NCT03435081|11328814|FG000|Overall Study|Adverse Event|2
7158168|NCT03435081|11328815|FG001|Overall Study|Adverse Event|2
7158169|NCT03435081|11328816|FG002|Overall Study|Adverse Event|2
7158170|NCT03435081|11328814|FG000|Overall Study|Withdrawal by Subject|8
7158171|NCT03435081|11328815|FG001|Overall Study|Withdrawal by Subject|7
7158172|NCT03435081|11328816|FG002|Overall Study|Withdrawal by Subject|10
7158173|NCT03435081|11328814|FG000|Overall Study|Lost to Follow-up|3
7158174|NCT03435081|11328815|FG001|Overall Study|Lost to Follow-up|1
7158175|NCT03435081|11328816|FG002|Overall Study|Lost to Follow-up|4
7158176|NCT03435081|11328814|FG000|Overall Study|Pregnancy|1
7158177|NCT03435081|11328815|FG001|Overall Study|Pregnancy|0
7158178|NCT03435081|11328816|FG002|Overall Study|Pregnancy|0
7158179|NCT03435081|11328814|FG000|Overall Study|Non-compliance|1
7158180|NCT03435081|11328815|FG001|Overall Study|Non-compliance|0
7158181|NCT03435081|11328816|FG002|Overall Study|Non-compliance|2
7158182|NCT03435081|11328814|FG000|Overall Study|Inadequate Response|0
7158183|NCT03435081|11328815|FG001|Overall Study|Inadequate Response|1
7158184|NCT03435081|11328816|FG002|Overall Study|Inadequate Response|0
7158185|NCT03435081|11328814|FG000|Overall Study|Withdrawal Due to Caregiver Circumstance|0
7158186|NCT03435081|11328815|FG001|Overall Study|Withdrawal Due to Caregiver Circumstance|0
7158187|NCT03435081|11328816|FG002|Overall Study|Withdrawal Due to Caregiver Circumstance|1
7158188|NCT03435211|11328825|FG000|Overall Study|Unable to achieve minimum desaturation level|1
7158189|NCT03435224|11328829|FG000|Overall Study|Unable to achieve a minimum desaturation level|4
7158190|NCT03435497|11328835|FG000|Overall Study|Lost to Follow-up|1
7158191|NCT03435497|11328836|FG001|Overall Study|Lost to Follow-up|0
7158192|NCT03435497|11328835|FG000|Overall Study|Death|1
7158193|NCT03435497|11328836|FG001|Overall Study|Death|0
7158194|NCT03435497|11328835|FG000|Overall Study|Withdrawal by Subject|0
7158195|NCT03435497|11328836|FG001|Overall Study|Withdrawal by Subject|4
7158196|NCT03435497|11328835|FG000|Overall Study|Wrong survey administered|0
7158197|NCT03435497|11328836|FG001|Overall Study|Wrong survey administered|2
7158198|NCT03435692|11328866|FG000|Overall Study|Lack of Efficacy|2
7158199|NCT03435692|11328867|FG001|Overall Study|Lack of Efficacy|2
7158200|NCT03435692|11328868|FG002|Overall Study|Lack of Efficacy|0
7158201|NCT03436082|11328891|FG000|Overall Study|Did not undergo procedure|1
7158202|NCT03436082|11328892|FG001|Overall Study|Did not undergo procedure|0
7158203|NCT03436420|11328909|FG000|Overall Study|Lack of Efficacy|3
7158204|NCT03436732|11328915|FG000|Overall Study|Not treated-enrolled in different study|1
7158205|NCT03436732|11328916|FG001|Overall Study|Not treated-enrolled in different study|0
7158206|NCT03436732|11328915|FG000|Overall Study|Off study after cycle 1|1
7158207|NCT03436732|11328916|FG001|Overall Study|Off study after cycle 1|0
7158208|NCT03436732|11328915|FG000|Overall Study|Adverse Event|2
7158209|NCT03436732|11328916|FG001|Overall Study|Adverse Event|0
7158210|NCT03436732|11328915|FG000|Overall Study|Death|0
7158211|NCT03436732|11328916|FG001|Overall Study|Death|1
7158212|NCT03437265|11328952|FG000|Overall Study|Protocol Violation|6
7158213|NCT03437447|11328959|FG000|Treatment Period 1|Withdrawal by Subject|0
7158214|NCT03437447|11328960|FG001|Treatment Period 1|Withdrawal by Subject|0
7158215|NCT03437447|11328961|FG002|Treatment Period 1|Withdrawal by Subject|1
7158216|NCT03437512|11328971|FG000|Randomized|Withdrawal by Subject|0
7158217|NCT03437512|11328972|FG001|Randomized|Withdrawal by Subject|2
7158218|NCT03437512|11328971|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2
7158219|NCT03437512|11328972|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1
7158220|NCT03437577|11328990|FG000|Pre-Randomization|Withdrawal by Subject|0
7158221|NCT03437577|11328991|FG001|Pre-Randomization|Withdrawal by Subject|0
7158222|NCT03437577|11328992|FG002|Pre-Randomization|Withdrawal by Subject|10
7158223|NCT03437577|11328990|FG000|Post-Randomization|Physician Decision|0
7158224|NCT03437577|11328991|FG001|Post-Randomization|Physician Decision|2
7158225|NCT03437577|11328992|FG002|Post-Randomization|Physician Decision|0
7158226|NCT03437733|11329000|FG000|Overall Study|Eligibility criteria not met|0
7158227|NCT03437733|11329001|FG001|Overall Study|Eligibility criteria not met|3
7158228|NCT03438006|11329010|FG000|Overall Study|Adverse Event|1
7158229|NCT03438006|11329010|FG000|Overall Study|Lost to Follow-up|67
7158230|NCT03438006|11329010|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47
7158231|NCT03438006|11329010|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3
7158232|NCT03438383|11329026|FG000|Overall Study|Protocol Violation|9
7158233|NCT03438383|11329027|FG001|Overall Study|Protocol Violation|3
7158234|NCT03438396|11329033|FG000|Overall Study|Ongoing on study treatment|4
7158235|NCT03438396|11329033|FG000|Overall Study|Ongoing in survival follow-up|33
7158236|NCT03438396|11329033|FG000|Overall Study|Withdrawal by Subject|4
7158237|NCT03438396|11329033|FG000|Overall Study|Lost to Follow-up|2
7158238|NCT03438396|11329033|FG000|Overall Study|Death|58
7158239|NCT03438396|11329033|FG000|Overall Study|Not treated|1
7158240|NCT03438539|11329043|FG000|Overall Study|Lost to Follow-up|8
7158241|NCT03438539|11329044|FG001|Overall Study|Lost to Follow-up|4
7158242|NCT03438539|11329045|FG002|Overall Study|Lost to Follow-up|10
7158243|NCT03438539|11329046|FG003|Overall Study|Lost to Follow-up|9
7158244|NCT03438539|11329047|FG004|Overall Study|Lost to Follow-up|3
7158245|NCT03438539|11329048|FG005|Overall Study|Lost to Follow-up|8
7158246|NCT03439072|11329071|FG000|Overall Study|Withdrawal by Subject|2
7158247|NCT03439072|11329072|FG001|Overall Study|Withdrawal by Subject|3
7158248|NCT03439072|11329071|FG000|Overall Study|Physician Decision|0
7158249|NCT03439072|11329072|FG001|Overall Study|Physician Decision|1
7158250|NCT03439137|11329080|FG000|Overall Study|Adverse Event|16
7158251|NCT03439137|11329081|FG001|Overall Study|Adverse Event|12
7158252|NCT03439137|11329080|FG000|Overall Study|Physician Decision|0
7158253|NCT03439137|11329081|FG001|Overall Study|Physician Decision|5
7158254|NCT03439137|11329080|FG000|Overall Study|Withdrawal by Subject|14
7158255|NCT03439137|11329081|FG001|Overall Study|Withdrawal by Subject|4
7158256|NCT03439137|11329080|FG000|Overall Study|Conducting rescue therapy|2
7158257|NCT03439137|11329081|FG001|Overall Study|Conducting rescue therapy|1
7158258|NCT03439137|11329080|FG000|Overall Study|Difficult to control Hb|10
7158259|NCT03439137|11329081|FG001|Overall Study|Difficult to control Hb|2
7158260|NCT03439137|11329080|FG000|Overall Study|Initiation of a renal transplant|0
7158261|NCT03439137|11329081|FG001|Overall Study|Initiation of a renal transplant|2
7158262|NCT03439189|11329087|FG000|Overall Study|Protocol Violation|19
7158263|NCT03439189|11329087|FG000|Overall Study|Lack of Efficacy|63
7184214|NCT01829711|11384246|FG000|Overall Study|Adverse Event|3
7184215|NCT01829711|11384246|FG000|Overall Study|Due to progression of disease|13
7184216|NCT01829711|11384246|FG000|Overall Study|Due to lack of response|1
7187447|NCT02036970|11388055|FG007|Part 2: Week 16 Onwards|Adverse Event|0
7187448|NCT02036970|11388056|FG008|Part 2: Week 16 Onwards|Adverse Event|6
7187449|NCT02036970|11388057|FG009|Part 2: Week 16 Onwards|Adverse Event|3
7187450|NCT02036970|11388048|FG000|Part 2: Week 16 Onwards|Protocol Violation|0
7187451|NCT02036970|11388049|FG001|Part 2: Week 16 Onwards|Protocol Violation|0
7187452|NCT02036970|11388050|FG002|Part 2: Week 16 Onwards|Protocol Violation|0
7187453|NCT02036970|11388051|FG003|Part 2: Week 16 Onwards|Protocol Violation|0
7187454|NCT02036970|11388052|FG004|Part 2: Week 16 Onwards|Protocol Violation|0
7187455|NCT02036970|11388053|FG005|Part 2: Week 16 Onwards|Protocol Violation|0
7187456|NCT02036970|11388054|FG006|Part 2: Week 16 Onwards|Protocol Violation|0
7187457|NCT02036970|11388055|FG007|Part 2: Week 16 Onwards|Protocol Violation|1
7187458|NCT02036970|11388056|FG008|Part 2: Week 16 Onwards|Protocol Violation|0
7158264|NCT03440320|11329105|FG000|Overall Study|Withdrawal by Subject|0
7158265|NCT03440320|11329106|FG001|Overall Study|Withdrawal by Subject|1
7158266|NCT03440411|11329118|FG000|Overall Study|Adverse Event|0
7158267|NCT03440411|11329119|FG001|Overall Study|Adverse Event|0
7158268|NCT03440411|11329120|FG002|Overall Study|Adverse Event|1
7158269|NCT03440411|11329121|FG003|Overall Study|Adverse Event|0
7158270|NCT03440411|11329118|FG000|Overall Study|PD|2
7158271|NCT03440411|11329119|FG001|Overall Study|PD|1
7158272|NCT03440411|11329120|FG002|Overall Study|PD|1
7158273|NCT03440411|11329121|FG003|Overall Study|PD|1
7158274|NCT03440411|11329118|FG000|Overall Study|Withdrawal by Subject|1
7158275|NCT03440411|11329119|FG001|Overall Study|Withdrawal by Subject|0
7158276|NCT03440411|11329120|FG002|Overall Study|Withdrawal by Subject|0
7158277|NCT03440411|11329121|FG003|Overall Study|Withdrawal by Subject|0
7158278|NCT03440411|11329118|FG000|Overall Study|Closed study by sponsor|0
7158279|NCT03440411|11329119|FG001|Overall Study|Closed study by sponsor|0
7158280|NCT03440411|11329120|FG002|Overall Study|Closed study by sponsor|0
7158281|NCT03440411|11329121|FG003|Overall Study|Closed study by sponsor|1
7158282|NCT03440918|11329165|FG000|Overall Study|Protocol Violation|0
7158283|NCT03440918|11329166|FG001|Overall Study|Protocol Violation|16
7158284|NCT03440944|11329174|FG000|Overall Study|Physician Decision|1
7158285|NCT03440944|11329175|FG001|Overall Study|Physician Decision|0
7158286|NCT03440944|11329174|FG000|Overall Study|No Acceptable Vasculature|0
7158287|NCT03440944|11329175|FG001|Overall Study|No Acceptable Vasculature|1
7158288|NCT03441789|11329267|FG000|Overall Study|Withdrawal by Subject|1
7158289|NCT03441789|11329268|FG001|Overall Study|Withdrawal by Subject|1
7158290|NCT03441789|11329267|FG000|Overall Study|Adverse Event|0
7158291|NCT03441789|11329268|FG001|Overall Study|Adverse Event|1
7158292|NCT03441789|11329267|FG000|Overall Study|Protocol Violation|0
7158293|NCT03441789|11329268|FG001|Overall Study|Protocol Violation|1
7158294|NCT03441789|11329267|FG000|Overall Study|Lost to Follow-up|0
7158295|NCT03441789|11329268|FG001|Overall Study|Lost to Follow-up|1
7158296|NCT03441984|11329276|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7158297|NCT03441984|11329277|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7158298|NCT03441984|11329278|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1
7158299|NCT03441984|11329279|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7158300|NCT03441984|11329280|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7158301|NCT03441984|11329281|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7158302|NCT03441984|11329282|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7158303|NCT03441984|11329283|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7158304|NCT03441984|11329284|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7158305|NCT03441984|11329285|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7158306|NCT03441984|11329286|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7158307|NCT03441984|11329287|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7158308|NCT03442296|11329315|FG000|3 Month Follow-up|Death|3
7158309|NCT03442296|11329316|FG001|3 Month Follow-up|Death|1
7158310|NCT03442296|11329315|FG000|3 Month Follow-up|Lost to Follow-up|1
7158311|NCT03442296|11329316|FG001|3 Month Follow-up|Lost to Follow-up|1
7158312|NCT03442296|11329315|FG000|3 Month Follow-up|Withdrawal by Subject|1
7158313|NCT03442296|11329316|FG001|3 Month Follow-up|Withdrawal by Subject|0
7158314|NCT03442296|11329315|FG000|3 Month Follow-up|Obtained Hearing Aids|0
7158315|NCT03442296|11329316|FG001|3 Month Follow-up|Obtained Hearing Aids|1
7158316|NCT03442296|11329315|FG000|12 Month Follow-up|Incomplete measurement|1
7158317|NCT03442296|11329316|FG001|12 Month Follow-up|Incomplete measurement|1
7158318|NCT03442569|11329322|FG000|Overall Study|Subject was ineligible after enrollment|1
7158319|NCT03442595|11329328|FG000|Overall Study|Lost to Follow-up|94
7158320|NCT03442595|11329329|FG001|Overall Study|Lost to Follow-up|0
7158321|NCT03442777|11329352|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8
7158322|NCT03442777|11329353|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13
7158323|NCT03442777|11329354|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7
7158324|NCT03442829|11329362|FG000|Overall Study|Scheduling clash|3
7158325|NCT03442829|11329363|FG001|Overall Study|Scheduling clash|1
7158326|NCT03442829|11329362|FG000|Overall Study|Illness unrelated to study|1
7158327|NCT03442829|11329363|FG001|Overall Study|Illness unrelated to study|1
7158328|NCT03443024|11329387|FG000|Overall Study|Adverse Event|2
7158329|NCT03443024|11329388|FG001|Overall Study|Adverse Event|4
7158330|NCT03443024|11329389|FG002|Overall Study|Adverse Event|3
7158331|NCT03443024|11329390|FG003|Overall Study|Adverse Event|1
7158332|NCT03443024|11329387|FG000|Overall Study|Lost to Follow-up|9
7158333|NCT03443024|11329388|FG001|Overall Study|Lost to Follow-up|9
7158334|NCT03443024|11329389|FG002|Overall Study|Lost to Follow-up|7
7158335|NCT03443024|11329390|FG003|Overall Study|Lost to Follow-up|5
7158336|NCT03443024|11329387|FG000|Overall Study|Withdrawal by Subject|8
7158337|NCT03443024|11329388|FG001|Overall Study|Withdrawal by Subject|15
7158338|NCT03443024|11329389|FG002|Overall Study|Withdrawal by Subject|9
7158339|NCT03443024|11329390|FG003|Overall Study|Withdrawal by Subject|23
7158340|NCT03443024|11329387|FG000|Overall Study|Physician Decision|1
7158341|NCT03443024|11329388|FG001|Overall Study|Physician Decision|2
7158342|NCT03443024|11329389|FG002|Overall Study|Physician Decision|0
7158343|NCT03443024|11329390|FG003|Overall Study|Physician Decision|1
7158344|NCT03443024|11329387|FG000|Overall Study|Sponsor Decision|1
7158345|NCT03443024|11329388|FG001|Overall Study|Sponsor Decision|1
7158346|NCT03443024|11329389|FG002|Overall Study|Sponsor Decision|0
7158347|NCT03443024|11329390|FG003|Overall Study|Sponsor Decision|0
7158348|NCT03443024|11329387|FG000|Overall Study|Protocol Deviation|0
7158349|NCT03443024|11329388|FG001|Overall Study|Protocol Deviation|0
7158350|NCT03443024|11329389|FG002|Overall Study|Protocol Deviation|0
7158351|NCT03443024|11329390|FG003|Overall Study|Protocol Deviation|2
7158352|NCT03443414|11329416|FG000|Overall Study|Adverse Event|6
7158353|NCT03443414|11329417|FG001|Overall Study|Adverse Event|0
7158354|NCT03443414|11329418|FG002|Overall Study|Adverse Event|4
7158355|NCT03443414|11329419|FG003|Overall Study|Adverse Event|2
7158356|NCT03443414|11329420|FG004|Overall Study|Adverse Event|3
7158357|NCT03443414|11329416|FG000|Overall Study|Withdrawal by Subject|3
7158358|NCT03443414|11329417|FG001|Overall Study|Withdrawal by Subject|2
7158359|NCT03443414|11329418|FG002|Overall Study|Withdrawal by Subject|2
7158360|NCT03443414|11329419|FG003|Overall Study|Withdrawal by Subject|2
7158361|NCT03443414|11329420|FG004|Overall Study|Withdrawal by Subject|1
7158362|NCT03443414|11329416|FG000|Overall Study|Death|0
7158363|NCT03443414|11329417|FG001|Overall Study|Death|1
7079702|NCT02116972|11188962|FG000|Overall Study|Withdrawal by Subject|1
7079703|NCT02116972|11188963|FG001|Overall Study|Withdrawal by Subject|1
7158364|NCT03443414|11329418|FG002|Overall Study|Death|0
7158365|NCT03443414|11329419|FG003|Overall Study|Death|1
7158366|NCT03443414|11329420|FG004|Overall Study|Death|0
7158367|NCT03443414|11329416|FG000|Overall Study|Reason not specified|2
7158368|NCT03443414|11329417|FG001|Overall Study|Reason not specified|0
7158369|NCT03443414|11329418|FG002|Overall Study|Reason not specified|0
7158370|NCT03443414|11329419|FG003|Overall Study|Reason not specified|0
7158371|NCT03443414|11329420|FG004|Overall Study|Reason not specified|1
7158372|NCT03443427|11329434|FG000|Overall Study|Adverse Event|2
7158373|NCT03443427|11329435|FG001|Overall Study|Adverse Event|3
7158374|NCT03443427|11329434|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6
7158375|NCT03443427|11329435|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2
7158376|NCT03443427|11329434|FG000|Overall Study|Other|4
7158377|NCT03443427|11329435|FG001|Overall Study|Other|6
7158378|NCT03443713|11329444|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0
7158379|NCT03443713|11329445|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0
7158380|NCT03443713|11329446|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1
7158381|NCT03444155|11329469|FG000|First Intervention (6 Weeks)|Adverse Event|1
7158382|NCT03444155|11329470|FG001|First Intervention (6 Weeks)|Adverse Event|0
7158383|NCT03444584|11329478|FG000|Overall Study|Withdrawal by Subject|0
7158384|NCT03444584|11329479|FG001|Overall Study|Withdrawal by Subject|1
7158385|NCT03444584|11329478|FG000|Overall Study|Other|0
7158386|NCT03444584|11329479|FG001|Overall Study|Other|1
7158387|NCT03444766|11329486|FG000|Overall Study|Other Reasons|2
7158388|NCT03444766|11329486|FG000|Overall Study|Participant Withdrew Consent|5
7158389|NCT03444766|11329486|FG000|Overall Study|Lost to Follow-up|2
7158390|NCT03444766|11329486|FG000|Overall Study|Death|2
7158391|NCT03444766|11329486|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6
7158392|NCT03444766|11329486|FG000|Overall Study|Disease Progression|49
7158393|NCT03445065|11329502|FG000|Overall Study|Withdrawal by Subject|3
7158394|NCT03445065|11329503|FG001|Overall Study|Withdrawal by Subject|6
7158395|NCT03445065|11329504|FG002|Overall Study|Withdrawal by Subject|2
7158396|NCT03445065|11329505|FG003|Overall Study|Withdrawal by Subject|2
7158397|NCT03445065|11329502|FG000|Overall Study|Other|4
7158398|NCT03445065|11329503|FG001|Overall Study|Other|3
7158399|NCT03445065|11329504|FG002|Overall Study|Other|3
7158400|NCT03445065|11329505|FG003|Overall Study|Other|1
7158401|NCT03446781|11329612|FG000|Overall Study|Lost to Follow-up|11
7158402|NCT03446781|11329613|FG001|Overall Study|Lost to Follow-up|5
7158403|NCT03446781|11329612|FG000|Overall Study|Withdrawal by Subject|9
7158404|NCT03446781|11329613|FG001|Overall Study|Withdrawal by Subject|7
7158405|NCT03446781|11329612|FG000|Overall Study|Adverse Event|8
7158406|NCT03446781|11329613|FG001|Overall Study|Adverse Event|2
7158407|NCT03446781|11329612|FG000|Overall Study|Protocol Violation|0
7158408|NCT03446781|11329613|FG001|Overall Study|Protocol Violation|3
7158409|NCT03446885|11329654|FG000|Overall Study|Lost to Follow-up|1
7158410|NCT03446885|11329655|FG001|Overall Study|Lost to Follow-up|0
7158411|NCT03446885|11329654|FG000|Overall Study|Did not complete entire visit|1
7158412|NCT03446885|11329655|FG001|Overall Study|Did not complete entire visit|0
7158413|NCT03447249|11329674|FG000|Overall Study|Adverse Event|1
7079704|NCT02116972|11188964|FG002|Overall Study|Withdrawal by Subject|5
7079705|NCT02116972|11188962|FG000|Overall Study|Protocol Violation|1
7079706|NCT02116972|11188963|FG001|Overall Study|Protocol Violation|0
7079707|NCT02116972|11188964|FG002|Overall Study|Protocol Violation|1
7079708|NCT02116972|11188962|FG000|Overall Study|Lost to Follow-up|4
7079709|NCT02116972|11188963|FG001|Overall Study|Lost to Follow-up|3
7079710|NCT02116972|11188964|FG002|Overall Study|Lost to Follow-up|1
7079711|NCT02116972|11188962|FG000|Overall Study|Lack of Efficacy|6
7079712|NCT02116972|11188963|FG001|Overall Study|Lack of Efficacy|6
7079713|NCT02116972|11188964|FG002|Overall Study|Lack of Efficacy|5
7079714|NCT02116972|11188962|FG000|Overall Study|scheduling conflicts and relocation|3
7158414|NCT03447249|11329675|FG001|Overall Study|Adverse Event|0
7158415|NCT03447249|11329674|FG000|Overall Study|Withdrawal of consent (not due to AE)|1
7158416|NCT03447249|11329675|FG001|Overall Study|Withdrawal of consent (not due to AE)|0
7158417|NCT03447249|11329674|FG000|Overall Study|Other|3
7158418|NCT03447249|11329675|FG001|Overall Study|Other|0
7158419|NCT03447353|11329683|FG000|Overall Study|Failure at Screening Visit|2
7158420|NCT03447353|11329683|FG000|Overall Study|Lost to Follow-up|4
7158421|NCT03447353|11329683|FG000|Overall Study|Scheduling Conflicts|3
7158422|NCT03447353|11329683|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1
7158423|NCT03447730|11329696|FG000|Overall Study|Adverse Event|0
7158424|NCT03447730|11329697|FG001|Overall Study|Adverse Event|2
7158425|NCT03447730|11329698|FG002|Overall Study|Adverse Event|0
7158426|NCT03447821|11329709|FG000|Overall Study|Withdrawal by Subject|1
7158427|NCT03447821|11329710|FG001|Overall Study|Withdrawal by Subject|1
7158428|NCT03447821|11329711|FG002|Overall Study|Withdrawal by Subject|0
7158429|NCT03447821|11329709|FG000|Overall Study|Lost to Follow-up|0
7158430|NCT03447821|11329710|FG001|Overall Study|Lost to Follow-up|0
7158431|NCT03447821|11329711|FG002|Overall Study|Lost to Follow-up|1
7158432|NCT03448224|11329730|FG000|Overall Study|Provided same answer to every question|1
7158433|NCT03448224|11329731|FG001|Overall Study|Provided same answer to every question|0
7158434|NCT03448406|11329739|FG000|Overall Study|Noncompliance of scheduled visits|1
7158435|NCT03448406|11329740|FG001|Overall Study|Noncompliance of scheduled visits|2
7158436|NCT03448406|11329739|FG000|Overall Study|Withdrawal by Subject|1
7158437|NCT03448406|11329740|FG001|Overall Study|Withdrawal by Subject|2
7158438|NCT03448406|11329739|FG000|Overall Study|Protocol Violation|1
7158439|NCT03448406|11329740|FG001|Overall Study|Protocol Violation|0
7158440|NCT03448406|11329739|FG000|Overall Study|Adverse Event|8
7158441|NCT03448406|11329740|FG001|Overall Study|Adverse Event|9
7158442|NCT03448419|11329748|FG000|Overall Study|Adverse Event|10
7158443|NCT03448419|11329749|FG001|Overall Study|Adverse Event|9
7158444|NCT03448419|11329748|FG000|Overall Study|Lost to Follow-up|0
7158445|NCT03448419|11329749|FG001|Overall Study|Lost to Follow-up|2
7158446|NCT03448419|11329748|FG000|Overall Study|Withdrawal by Subject|3
7158447|NCT03448419|11329749|FG001|Overall Study|Withdrawal by Subject|1
7158448|NCT03448419|11329748|FG000|Overall Study|Not treated|0
7158449|NCT03448419|11329749|FG001|Overall Study|Not treated|1
7158450|NCT03448419|11329748|FG000|Overall Study|Patient did not attend all visits|0
7158451|NCT03448419|11329749|FG001|Overall Study|Patient did not attend all visits|2
7158452|NCT03448419|11329748|FG000|Overall Study|Withdrawn by Sponsor|0
7158453|NCT03448419|11329749|FG001|Overall Study|Withdrawn by Sponsor|1
7158454|NCT03448536|11329759|FG000|Overall Study|Protocol Violation|2
7158455|NCT03448536|11329760|FG001|Overall Study|Protocol Violation|0
7158456|NCT03448536|11329759|FG000|Overall Study|Pregnancy|1
7158457|NCT03448536|11329760|FG001|Overall Study|Pregnancy|0
7158458|NCT03448536|11329759|FG000|Overall Study|Withdrawal by Subject|1
7158459|NCT03448536|11329760|FG001|Overall Study|Withdrawal by Subject|2
7158460|NCT03448536|11329759|FG000|Overall Study|Lost to Follow-up|3
7158461|NCT03448536|11329760|FG001|Overall Study|Lost to Follow-up|2
7158462|NCT03448536|11329759|FG000|Overall Study|Inadequate pain reporter|1
7158463|NCT03448536|11329760|FG001|Overall Study|Inadequate pain reporter|0
7158464|NCT03448536|11329759|FG000|Overall Study|Other|3
7158465|NCT03448536|11329760|FG001|Overall Study|Other|0
7158466|NCT03448536|11329759|FG000|Overall Study|Physician Decision|1
7158467|NCT03448536|11329760|FG001|Overall Study|Physician Decision|0
7158468|NCT03449030|11329776|FG000|Overall Study|Withdrawal by Subject|0
7158469|NCT03449030|11329777|FG001|Overall Study|Withdrawal by Subject|0
7158470|NCT03449030|11329778|FG002|Overall Study|Withdrawal by Subject|0
7158471|NCT03449030|11329779|FG003|Overall Study|Withdrawal by Subject|1
7158472|NCT03449030|11329780|FG004|Overall Study|Withdrawal by Subject|1
7158473|NCT03449030|11329781|FG005|Overall Study|Withdrawal by Subject|1
7158474|NCT03449030|11329782|FG006|Overall Study|Withdrawal by Subject|1
7158475|NCT03449030|11329783|FG007|Overall Study|Withdrawal by Subject|2
7158476|NCT03449030|11329784|FG008|Overall Study|Withdrawal by Subject|0
7158477|NCT03449030|11329785|FG009|Overall Study|Withdrawal by Subject|0
7158478|NCT03449030|11329776|FG000|Overall Study|Symptomatic Deterioration|0
7158479|NCT03449030|11329777|FG001|Overall Study|Symptomatic Deterioration|1
7158480|NCT03449030|11329778|FG002|Overall Study|Symptomatic Deterioration|0
7158481|NCT03449030|11329779|FG003|Overall Study|Symptomatic Deterioration|0
7158482|NCT03449030|11329780|FG004|Overall Study|Symptomatic Deterioration|0
7158483|NCT03449030|11329781|FG005|Overall Study|Symptomatic Deterioration|1
7158484|NCT03449030|11329782|FG006|Overall Study|Symptomatic Deterioration|1
7158485|NCT03449030|11329783|FG007|Overall Study|Symptomatic Deterioration|0
7158486|NCT03449030|11329784|FG008|Overall Study|Symptomatic Deterioration|2
7158487|NCT03449030|11329785|FG009|Overall Study|Symptomatic Deterioration|0
7158488|NCT03449030|11329776|FG000|Overall Study|Progressive Disease|1
7158489|NCT03449030|11329777|FG001|Overall Study|Progressive Disease|0
7158490|NCT03449030|11329778|FG002|Overall Study|Progressive Disease|1
7158491|NCT03449030|11329779|FG003|Overall Study|Progressive Disease|4
7158492|NCT03449030|11329780|FG004|Overall Study|Progressive Disease|5
7158493|NCT03449030|11329781|FG005|Overall Study|Progressive Disease|3
7158494|NCT03449030|11329782|FG006|Overall Study|Progressive Disease|0
7158495|NCT03449030|11329783|FG007|Overall Study|Progressive Disease|1
7158496|NCT03449030|11329784|FG008|Overall Study|Progressive Disease|1
7158497|NCT03449030|11329785|FG009|Overall Study|Progressive Disease|1
7158498|NCT03449030|11329776|FG000|Overall Study|Adverse Event|0
7158499|NCT03449030|11329777|FG001|Overall Study|Adverse Event|0
7158500|NCT03449030|11329778|FG002|Overall Study|Adverse Event|0
7158501|NCT03449030|11329779|FG003|Overall Study|Adverse Event|0
7158502|NCT03449030|11329780|FG004|Overall Study|Adverse Event|0
7158503|NCT03449030|11329781|FG005|Overall Study|Adverse Event|2
7158504|NCT03449030|11329782|FG006|Overall Study|Adverse Event|0
7158505|NCT03449030|11329783|FG007|Overall Study|Adverse Event|0
7158506|NCT03449030|11329784|FG008|Overall Study|Adverse Event|0
7158507|NCT03449030|11329785|FG009|Overall Study|Adverse Event|0
7158508|NCT03449030|11329776|FG000|Overall Study|Death|0
7158509|NCT03449030|11329777|FG001|Overall Study|Death|0
7158510|NCT03449030|11329778|FG002|Overall Study|Death|0
7158511|NCT03449030|11329779|FG003|Overall Study|Death|0
7158512|NCT03449030|11329780|FG004|Overall Study|Death|1
7079715|NCT02116972|11188963|FG001|Overall Study|scheduling conflicts and relocation|3
7079716|NCT02116972|11188964|FG002|Overall Study|scheduling conflicts and relocation|6
7158513|NCT03449030|11329781|FG005|Overall Study|Death|0
7158514|NCT03449030|11329782|FG006|Overall Study|Death|0
7158515|NCT03449030|11329783|FG007|Overall Study|Death|0
7158516|NCT03449030|11329784|FG008|Overall Study|Death|0
7158517|NCT03449030|11329785|FG009|Overall Study|Death|0
7158518|NCT03449134|11329811|FG000|52-Week Treatment Period|Death|2
7158519|NCT03449134|11329812|FG001|52-Week Treatment Period|Death|1
7158520|NCT03449134|11329813|FG002|52-Week Treatment Period|Death|0
7158521|NCT03449134|11329811|FG000|52-Week Treatment Period|Lost to Follow-up|2
7158522|NCT03449134|11329812|FG001|52-Week Treatment Period|Lost to Follow-up|1
7158523|NCT03449134|11329813|FG002|52-Week Treatment Period|Lost to Follow-up|1
7158524|NCT03449134|11329811|FG000|52-Week Treatment Period|Physician Decision|2
7158525|NCT03449134|11329812|FG001|52-Week Treatment Period|Physician Decision|3
7158526|NCT03449134|11329813|FG002|52-Week Treatment Period|Physician Decision|3
7158527|NCT03449134|11329811|FG000|52-Week Treatment Period|Screen Failure|1
7158528|NCT03449134|11329812|FG001|52-Week Treatment Period|Screen Failure|0
7158529|NCT03449134|11329813|FG002|52-Week Treatment Period|Screen Failure|1
7158530|NCT03449134|11329811|FG000|52-Week Treatment Period|Withdrawal by Subject|37
7158531|NCT03449134|11329812|FG001|52-Week Treatment Period|Withdrawal by Subject|39
7158532|NCT03449134|11329813|FG002|52-Week Treatment Period|Withdrawal by Subject|55
7158533|NCT03449134|11329811|FG000|52-Week Treatment Period|Site Closure|1
7158534|NCT03449134|11329812|FG001|52-Week Treatment Period|Site Closure|0
7158535|NCT03449134|11329813|FG002|52-Week Treatment Period|Site Closure|0
7158536|NCT03449147|11329827|FG000|52-week Treatment Period|Death|0
7158537|NCT03449147|11329828|FG001|52-week Treatment Period|Death|1
7158538|NCT03449147|11329829|FG002|52-week Treatment Period|Death|0
7158539|NCT03449147|11329827|FG000|52-week Treatment Period|Lost to Follow-up|6
7158540|NCT03449147|11329828|FG001|52-week Treatment Period|Lost to Follow-up|2
7158541|NCT03449147|11329829|FG002|52-week Treatment Period|Lost to Follow-up|5
7158542|NCT03449147|11329827|FG000|52-week Treatment Period|Other|0
7158543|NCT03449147|11329828|FG001|52-week Treatment Period|Other|1
7158544|NCT03449147|11329829|FG002|52-week Treatment Period|Other|2
7158545|NCT03449147|11329827|FG000|52-week Treatment Period|Physician Decision|1
7158546|NCT03449147|11329828|FG001|52-week Treatment Period|Physician Decision|0
7158547|NCT03449147|11329829|FG002|52-week Treatment Period|Physician Decision|3
7158548|NCT03449147|11329827|FG000|52-week Treatment Period|Screen Failure|1
7158549|NCT03449147|11329828|FG001|52-week Treatment Period|Screen Failure|2
7158550|NCT03449147|11329829|FG002|52-week Treatment Period|Screen Failure|0
7158551|NCT03449147|11329827|FG000|52-week Treatment Period|Withdrawal by Subject|46
7158552|NCT03449147|11329828|FG001|52-week Treatment Period|Withdrawal by Subject|68
7158553|NCT03449147|11329829|FG002|52-week Treatment Period|Withdrawal by Subject|74
7158554|NCT03449147|11329827|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1
7158555|NCT03449147|11329828|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0
7158556|NCT03449147|11329829|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0
7079717|NCT02117024|11188976|FG000|Overall Study|Progressive Disease|26
7079718|NCT02117024|11188977|FG001|Overall Study|Progressive Disease|9
7079719|NCT02117024|11188976|FG000|Overall Study|Significant Clinical Progression|7
7079720|NCT02117024|11188977|FG001|Overall Study|Significant Clinical Progression|4
7079721|NCT02117024|11188976|FG000|Overall Study|Death|5
7079722|NCT02117024|11188977|FG001|Overall Study|Death|0
7079723|NCT02117024|11188976|FG000|Overall Study|Withdrawal by Subject|3
7079724|NCT02117024|11188977|FG001|Overall Study|Withdrawal by Subject|1
7079725|NCT02117024|11188976|FG000|Overall Study|Protocol Violation|1
7079726|NCT02117024|11188977|FG001|Overall Study|Protocol Violation|0
7079727|NCT02117024|11188976|FG000|Overall Study|Adverse Event|1
7079728|NCT02117024|11188977|FG001|Overall Study|Adverse Event|2
7158557|NCT03449147|11329827|FG000|12-Week Off-Treatment Durability Period|Other|0
7158558|NCT03449147|11329828|FG001|12-Week Off-Treatment Durability Period|Other|1
7158559|NCT03449147|11329829|FG002|12-Week Off-Treatment Durability Period|Other|0
7158560|NCT03449446|11329877|FG000|Overall Study|Randomized but Never Treated|0
7158561|NCT03449446|11329878|FG001|Overall Study|Randomized but Never Treated|0
7158562|NCT03449446|11329879|FG002|Overall Study|Randomized but Never Treated|1
7158563|NCT03449446|11329880|FG003|Overall Study|Randomized but Never Treated|1
7158564|NCT03449446|11329881|FG004|Overall Study|Randomized but Never Treated|1
7079729|NCT02117024|11188976|FG000|Overall Study|Randomized in Error|1
7158565|NCT03449446|11329882|FG005|Overall Study|Randomized but Never Treated|0
7158566|NCT03449446|11329883|FG006|Overall Study|Randomized but Never Treated|0
7158567|NCT03449446|11329877|FG000|Overall Study|Unknown Reason|33
7158568|NCT03449446|11329878|FG001|Overall Study|Unknown Reason|1
7158569|NCT03449446|11329879|FG002|Overall Study|Unknown Reason|1
7158570|NCT03449446|11329880|FG003|Overall Study|Unknown Reason|1
7158571|NCT03449446|11329881|FG004|Overall Study|Unknown Reason|2
7158572|NCT03449446|11329882|FG005|Overall Study|Unknown Reason|2
7158573|NCT03449446|11329883|FG006|Overall Study|Unknown Reason|0
7158574|NCT03449446|11329877|FG000|Overall Study|Withdrew Consent|1
7158575|NCT03449446|11329878|FG001|Overall Study|Withdrew Consent|3
7158576|NCT03449446|11329879|FG002|Overall Study|Withdrew Consent|1
7158577|NCT03449446|11329880|FG003|Overall Study|Withdrew Consent|4
7158578|NCT03449446|11329881|FG004|Overall Study|Withdrew Consent|4
7158579|NCT03449446|11329882|FG005|Overall Study|Withdrew Consent|4
7158580|NCT03449446|11329883|FG006|Overall Study|Withdrew Consent|1
7158581|NCT03449446|11329877|FG000|Overall Study|Adverse Event|1
7158582|NCT03449446|11329878|FG001|Overall Study|Adverse Event|2
7158583|NCT03449446|11329879|FG002|Overall Study|Adverse Event|1
7158584|NCT03449446|11329880|FG003|Overall Study|Adverse Event|0
7158585|NCT03449446|11329881|FG004|Overall Study|Adverse Event|0
7158586|NCT03449446|11329882|FG005|Overall Study|Adverse Event|2
7158587|NCT03449446|11329883|FG006|Overall Study|Adverse Event|0
7158588|NCT03449446|11329877|FG000|Overall Study|Lost to Follow-up|0
7158589|NCT03449446|11329878|FG001|Overall Study|Lost to Follow-up|0
7158590|NCT03449446|11329879|FG002|Overall Study|Lost to Follow-up|2
7158591|NCT03449446|11329880|FG003|Overall Study|Lost to Follow-up|1
7158592|NCT03449446|11329881|FG004|Overall Study|Lost to Follow-up|3
7158593|NCT03449446|11329882|FG005|Overall Study|Lost to Follow-up|0
7158594|NCT03449446|11329883|FG006|Overall Study|Lost to Follow-up|0
7158595|NCT03449446|11329877|FG000|Overall Study|Investigator's Discretion|0
7158596|NCT03449446|11329878|FG001|Overall Study|Investigator's Discretion|1
7158597|NCT03449446|11329879|FG002|Overall Study|Investigator's Discretion|1
7158598|NCT03449446|11329880|FG003|Overall Study|Investigator's Discretion|2
7158599|NCT03449446|11329881|FG004|Overall Study|Investigator's Discretion|0
7158600|NCT03449446|11329882|FG005|Overall Study|Investigator's Discretion|0
7158601|NCT03449446|11329883|FG006|Overall Study|Investigator's Discretion|0
7158602|NCT03449446|11329877|FG000|Overall Study|Non Compliance with Study Drug|1
7158603|NCT03449446|11329878|FG001|Overall Study|Non Compliance with Study Drug|0
7158604|NCT03449446|11329879|FG002|Overall Study|Non Compliance with Study Drug|0
7158605|NCT03449446|11329880|FG003|Overall Study|Non Compliance with Study Drug|0
7158606|NCT03449446|11329881|FG004|Overall Study|Non Compliance with Study Drug|0
7158607|NCT03449446|11329882|FG005|Overall Study|Non Compliance with Study Drug|0
7158608|NCT03449446|11329883|FG006|Overall Study|Non Compliance with Study Drug|0
7158609|NCT03449446|11329877|FG000|Overall Study|Protocol Violation|0
7158610|NCT03449446|11329878|FG001|Overall Study|Protocol Violation|0
7158611|NCT03449446|11329879|FG002|Overall Study|Protocol Violation|0
7158612|NCT03449446|11329880|FG003|Overall Study|Protocol Violation|0
7158613|NCT03449446|11329881|FG004|Overall Study|Protocol Violation|1
7158614|NCT03449446|11329882|FG005|Overall Study|Protocol Violation|1
7158615|NCT03449446|11329883|FG006|Overall Study|Protocol Violation|0
7158616|NCT03449446|11329877|FG000|Overall Study|Death|0
7158617|NCT03449446|11329878|FG001|Overall Study|Death|0
7158618|NCT03449446|11329879|FG002|Overall Study|Death|0
7158619|NCT03449446|11329880|FG003|Overall Study|Death|0
7158620|NCT03449446|11329881|FG004|Overall Study|Death|1
7158621|NCT03449446|11329882|FG005|Overall Study|Death|0
7158622|NCT03449446|11329883|FG006|Overall Study|Death|0
7158623|NCT03449979|11329903|FG000|Overall Study|Technical difficulty|0
7158624|NCT03449979|11329904|FG001|Overall Study|Technical difficulty|0
7158625|NCT03449979|11329905|FG002|Overall Study|Technical difficulty|0
7158626|NCT03449979|11329906|FG003|Overall Study|Technical difficulty|1
7158627|NCT03450070|11329916|FG000|Overall Study|Withdrawal by Subject|8
7158628|NCT03451071|11329947|FG000|First Vaccine|Withdrawal by Subject|1
7158629|NCT03451071|11329947|FG000|Second Vaccine|Lost to Follow-up|19
7158630|NCT03451071|11329947|FG000|Third Vaccine|Lost to Follow-up|22
7158631|NCT03451071|11329947|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4
7158632|NCT03451084|11329955|FG000|Overall Study|Withdrawal by Subject|2
7158633|NCT03451084|11329956|FG001|Overall Study|Withdrawal by Subject|1
7158634|NCT03451084|11329957|FG002|Overall Study|Withdrawal by Subject|2
7158635|NCT03451084|11329958|FG003|Overall Study|Withdrawal by Subject|1
7158636|NCT03451084|11329955|FG000|Overall Study|Disease recurrence|0
7158637|NCT03451084|11329956|FG001|Overall Study|Disease recurrence|2
7158638|NCT03451084|11329957|FG002|Overall Study|Disease recurrence|0
7158639|NCT03451084|11329958|FG003|Overall Study|Disease recurrence|0
7158640|NCT03451084|11329955|FG000|Overall Study|Lack of Efficacy|0
7158641|NCT03451084|11329956|FG001|Overall Study|Lack of Efficacy|3
7158642|NCT03451084|11329957|FG002|Overall Study|Lack of Efficacy|0
7158643|NCT03451084|11329958|FG003|Overall Study|Lack of Efficacy|1
7158644|NCT03451084|11329955|FG000|Overall Study|Death|1
7158645|NCT03451084|11329956|FG001|Overall Study|Death|0
7158646|NCT03451084|11329957|FG002|Overall Study|Death|2
7158647|NCT03451084|11329958|FG003|Overall Study|Death|0
7158648|NCT03451084|11329955|FG000|Overall Study|Physician Decision|0
7158649|NCT03451084|11329956|FG001|Overall Study|Physician Decision|0
7158650|NCT03451084|11329957|FG002|Overall Study|Physician Decision|2
7158651|NCT03451084|11329958|FG003|Overall Study|Physician Decision|2
7158652|NCT03451084|11329955|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3
7158653|NCT03451084|11329956|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0
7158654|NCT03451084|11329957|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0
7158655|NCT03451084|11329958|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2
7158656|NCT03451721|11329968|FG000|Overall Study|Death|1
7158657|NCT03451773|11329974|FG000|Overall Study|Death on study|1
7158658|NCT03451773|11329975|FG001|Overall Study|Death on study|5
7158659|NCT03451773|11329974|FG000|Overall Study|Death during follow-up period|0
7158660|NCT03451773|11329975|FG001|Overall Study|Death during follow-up period|1
7158661|NCT03452189|11330019|FG000|First Intervention (3 Months)|Adverse Event|1
7158662|NCT03452189|11330020|FG001|First Intervention (3 Months)|Adverse Event|0
7158663|NCT03452189|11330019|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4
7158664|NCT03452189|11330020|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0
7158665|NCT03452527|11330037|FG000|Overall Study|Withdrawal by Subject|1
7158666|NCT03452527|11330038|FG001|Overall Study|Withdrawal by Subject|1
7158667|NCT03452527|11330037|FG000|Overall Study|Study Terminated|2
7158668|NCT03452527|11330038|FG001|Overall Study|Study Terminated|3
7158669|NCT03452943|11330046|FG000|Titration Period (7 Weeks)|Adverse Event|1
7158670|NCT03452943|11330047|FG001|Titration Period (7 Weeks)|Adverse Event|1
7158671|NCT03452943|11330046|FG000|Titration Period (7 Weeks)|Protocol Violation|0
7158672|NCT03452943|11330047|FG001|Titration Period (7 Weeks)|Protocol Violation|1
7158673|NCT03452943|11330046|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3
7158674|NCT03452943|11330047|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2
7158675|NCT03452943|11330046|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1
7158676|NCT03452943|11330047|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0
7158677|NCT03452943|11330046|FG000|Maintenance Period (5 Weeks)|Adverse Event|1
7158678|NCT03452943|11330047|FG001|Maintenance Period (5 Weeks)|Adverse Event|0
7158679|NCT03452943|11330046|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2
7158680|NCT03452943|11330047|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0
7158681|NCT03453151|11330074|FG000|Overall Study|Withdrawal by Subject|1
7158682|NCT03453151|11330074|FG000|Overall Study|Physician Decision|3
7158683|NCT03454412|11330106|FG000|Baseline Assesment|Physician Decision|12
7158684|NCT03455543|11330148|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2
7158685|NCT03455543|11330149|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5
7158686|NCT03455543|11330150|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0
7158687|NCT03455543|11330148|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7
7158688|NCT03455543|11330149|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2
7158689|NCT03455543|11330150|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0
7158690|NCT03455543|11330148|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2
7158691|NCT03455543|11330149|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0
7158692|NCT03455543|11330150|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0
7158693|NCT03455543|11330148|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0
7158694|NCT03455543|11330149|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0
7158695|NCT03455543|11330150|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3
7158696|NCT03455543|11330148|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0
7158697|NCT03455543|11330149|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0
7158698|NCT03455543|11330150|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20
7158699|NCT03455543|11330148|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0
7158700|NCT03455543|11330149|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0
7158701|NCT03455543|11330150|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7
7158702|NCT03455543|11330148|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0
7158703|NCT03455543|11330149|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0
7158704|NCT03455543|11330150|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4
7158705|NCT03455543|11330148|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0
7158706|NCT03455543|11330149|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0
7158707|NCT03455543|11330150|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2
7158708|NCT03455543|11330148|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0
7158709|NCT03455543|11330149|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0
7158710|NCT03455543|11330150|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1
7158711|NCT03456856|11330167|FG000|Overall Study|Lost to Follow-up|2
7158712|NCT03456856|11330167|FG000|Overall Study|Withdrawal by Subject|1
7158713|NCT03456960|11330177|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
7158714|NCT03456960|11330178|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
7158715|NCT03456960|11330179|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1
7158716|NCT03456960|11330180|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2
7158717|NCT03456960|11330181|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
7158718|NCT03456960|11330182|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
7158719|NCT03456960|11330177|FG000|Period 2 (1 Day)|Adverse Event|1
7158720|NCT03456960|11330178|FG001|Period 2 (1 Day)|Adverse Event|0
7158721|NCT03456960|11330179|FG002|Period 2 (1 Day)|Adverse Event|0
7079730|NCT02117024|11188977|FG001|Overall Study|Randomized in Error|0
7158722|NCT03456960|11330180|FG003|Period 2 (1 Day)|Adverse Event|1
7158723|NCT03456960|11330181|FG004|Period 2 (1 Day)|Adverse Event|0
7158724|NCT03456960|11330182|FG005|Period 2 (1 Day)|Adverse Event|0
7158725|NCT03457103|11330200|FG000|Overall Study|illness/hospitalization|4
7158726|NCT03457103|11330201|FG001|Overall Study|illness/hospitalization|2
7158727|NCT03457103|11330200|FG000|Overall Study|Lost to Follow-up|2
7158728|NCT03457103|11330201|FG001|Overall Study|Lost to Follow-up|1
7158729|NCT03457103|11330200|FG000|Overall Study|Withdrawal by Subject|1
7158730|NCT03457103|11330201|FG001|Overall Study|Withdrawal by Subject|2
7158731|NCT03457103|11330200|FG000|Overall Study|financial/ insurance issues|1
7158732|NCT03457103|11330201|FG001|Overall Study|financial/ insurance issues|1
7158733|NCT03457636|11330216|FG000|Overall Study|Lost to Follow-up|2
7158734|NCT03457727|11330224|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
7158735|NCT03457727|11330225|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
7158736|NCT03457727|11330226|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
7158737|NCT03457727|11330227|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1
7158738|NCT03458702|11330263|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4
7158739|NCT03458702|11330264|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6
7158740|NCT03458702|11330263|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4
7158741|NCT03458702|11330264|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2
7158742|NCT03459040|11330274|FG000|Overall Study|Death|8
7158743|NCT03459040|11330274|FG000|Overall Study|Withdrawal by Subject|1
7158744|NCT03459196|11330286|FG000|Overall Study|Subject didn't receive study catheter|2
7184217|NCT01846273|11384253|FG000|Overall Study|Adverse Event|9
7184218|NCT01846273|11384254|FG001|Overall Study|Adverse Event|7
7184219|NCT01846273|11384255|FG002|Overall Study|Adverse Event|0
7184220|NCT01846273|11384253|FG000|Overall Study|Subject withdrew consent|5
7184221|NCT01846273|11384254|FG001|Overall Study|Subject withdrew consent|8
7184222|NCT01846273|11384255|FG002|Overall Study|Subject withdrew consent|0
7184223|NCT01846273|11384253|FG000|Overall Study|Lost to Follow-up|2
7184224|NCT01846273|11384254|FG001|Overall Study|Lost to Follow-up|1
7184225|NCT01846273|11384255|FG002|Overall Study|Lost to Follow-up|0
7184226|NCT01846273|11384253|FG000|Overall Study|Administrative problems|1
7184227|NCT01846273|11384254|FG001|Overall Study|Administrative problems|0
7184228|NCT01846273|11384255|FG002|Overall Study|Administrative problems|0
7184229|NCT01846273|11384253|FG000|Overall Study|Death|2
7184230|NCT01846273|11384254|FG001|Overall Study|Death|1
7184231|NCT01846273|11384255|FG002|Overall Study|Death|0
7184232|NCT01846273|11384253|FG000|Overall Study|Disease Progression|0
7184233|NCT01846273|11384254|FG001|Overall Study|Disease Progression|4
7184234|NCT01846273|11384255|FG002|Overall Study|Disease Progression|0
7184235|NCT01846273|11384253|FG000|Overall Study|Protocol Deviation|2
7184236|NCT01846273|11384254|FG001|Overall Study|Protocol Deviation|3
7184237|NCT01846273|11384255|FG002|Overall Study|Protocol Deviation|0
7184238|NCT01846273|11384253|FG000|Overall Study|Physician Decision|1
7184239|NCT01846273|11384254|FG001|Overall Study|Physician Decision|2
7184240|NCT01846273|11384255|FG002|Overall Study|Physician Decision|0
7184241|NCT01875185|11384265|FG000|Overall Study|study was terminated|52
7184242|NCT01875185|11384266|FG001|Overall Study|study was terminated|48
7184243|NCT01891643|11384292|FG000|Overall Study|Adverse event unrelated to study drug|2
7184244|NCT01891643|11384293|FG001|Overall Study|Adverse event unrelated to study drug|5
7184245|NCT01891643|11384292|FG000|Overall Study|Disease Progression|4
7184246|NCT01891643|11384293|FG001|Overall Study|Disease Progression|3
7184247|NCT01891643|11384292|FG000|Overall Study|Study Drug Toxicity|3
7184248|NCT01891643|11384293|FG001|Overall Study|Study Drug Toxicity|0
7184249|NCT01891643|11384292|FG000|Overall Study|Maximum Clinical Benefit|0
7184250|NCT01891643|11384293|FG001|Overall Study|Maximum Clinical Benefit|1
7184251|NCT01891643|11384292|FG000|Overall Study|Poor/Non-compliance|0
7184252|NCT01891643|11384293|FG001|Overall Study|Poor/Non-compliance|1
7184253|NCT01891643|11384292|FG000|Overall Study|Participant request to discontinue|1
7184254|NCT01891643|11384293|FG001|Overall Study|Participant request to discontinue|0
7184255|NCT01900691|11384299|FG000|Overall Study|Death|7
7184256|NCT01900691|11384299|FG000|Overall Study|Lost to Follow-up|4
7184257|NCT01900691|11384299|FG000|Overall Study|Study Device Not Placed|3
7184258|NCT01900691|11384299|FG000|Overall Study|Non Study stent inside study stent|1
7184259|NCT01900691|11384299|FG000|Overall Study|Six month Follow up completed, stent not removed|2
7184260|NCT01900691|11384299|FG000|Overall Study|Miscellaneous|2
7187459|NCT02036970|11388057|FG009|Part 2: Week 16 Onwards|Protocol Violation|0
7187460|NCT02036970|11388048|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0
7187461|NCT02036970|11388049|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1
7187462|NCT02036970|11388050|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1
7187463|NCT02036970|11388051|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0
7079731|NCT02117024|11188976|FG000|Overall Study|Patient returned to primary oncologist|0
7079732|NCT02117024|11188977|FG001|Overall Study|Patient returned to primary oncologist|1
7079733|NCT02117024|11188976|FG000|Overall Study|Patient took treatment break|0
7079734|NCT02117024|11188977|FG001|Overall Study|Patient took treatment break|1
7079735|NCT02117024|11188976|FG000|Overall Study|Physician Decision|0
7079736|NCT02117024|11188977|FG001|Overall Study|Physician Decision|2
7079737|NCT02117349|11189008|FG000|Overall Study|Withdrawal by Subject|1
7079738|NCT02117349|11189009|FG001|Overall Study|Withdrawal by Subject|0
7158745|NCT03461146|11330347|FG000|Overall Study|Adverse Event|2
7158746|NCT03461146|11330347|FG000|Overall Study|Physician Decision|1
7158747|NCT03461757|11330353|FG000|Overall Study|Adverse Event|1
7158748|NCT03461757|11330354|FG001|Overall Study|Adverse Event|0
7158749|NCT03461757|11330353|FG000|Overall Study|Lost to Follow-up|13
7158750|NCT03461757|11330354|FG001|Overall Study|Lost to Follow-up|7
7158751|NCT03461757|11330353|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28
7158752|NCT03461757|11330354|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25
7158753|NCT03461757|11330353|FG000|Overall Study|Non-compliance with study treatment|0
7158754|NCT03461757|11330354|FG001|Overall Study|Non-compliance with study treatment|1
7158755|NCT03461757|11330353|FG000|Overall Study|Pregnancy|2
7158756|NCT03461757|11330354|FG001|Overall Study|Pregnancy|0
7158757|NCT03461757|11330353|FG000|Overall Study|Protocol Violation|1
7158758|NCT03461757|11330354|FG001|Overall Study|Protocol Violation|1
7158759|NCT03461757|11330353|FG000|Overall Study|Withdrawal by Subject|7
7158760|NCT03461757|11330354|FG001|Overall Study|Withdrawal by Subject|7
7158761|NCT03461757|11330353|FG000|Overall Study|Other Reasons|1
7158762|NCT03461757|11330354|FG001|Overall Study|Other Reasons|4
7158763|NCT03462082|11330369|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0
7158764|NCT03462082|11330370|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0
7158765|NCT03462082|11330371|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0
7158766|NCT03462082|11330372|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0
7158767|NCT03462082|11330373|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0
7158768|NCT03462082|11330374|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0
7158769|NCT03462082|11330375|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1
7158770|NCT03462082|11330376|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2
7158771|NCT03462576|11330389|FG000|Overall Study|Protocol Violation|5
7158772|NCT03462576|11330390|FG001|Overall Study|Protocol Violation|11
7158773|NCT03462576|11330391|FG002|Overall Study|Protocol Violation|7
7158774|NCT03462576|11330389|FG000|Overall Study|Device Malfunction|0
7158775|NCT03462576|11330390|FG001|Overall Study|Device Malfunction|0
7158776|NCT03462576|11330391|FG002|Overall Study|Device Malfunction|1
7158777|NCT03462680|11330401|FG000|Overall Study|Withdrawal by Subject|3
7158778|NCT03462680|11330402|FG001|Overall Study|Withdrawal by Subject|5
7158779|NCT03463031|11330430|FG000|Overall Study|Withdrawal by Subject|4
7158780|NCT03463031|11330431|FG001|Overall Study|Withdrawal by Subject|2
7158781|NCT03463031|11330430|FG000|Overall Study|Investigator/Sponsor Decision|0
7158782|NCT03463031|11330431|FG001|Overall Study|Investigator/Sponsor Decision|1
7158783|NCT03463031|11330430|FG000|Overall Study|Lost to Follow-up|1
7158784|NCT03463031|11330431|FG001|Overall Study|Lost to Follow-up|1
7158785|NCT03463031|11330430|FG000|Overall Study|Adverse Event|4
7158786|NCT03463031|11330431|FG001|Overall Study|Adverse Event|1
7158787|NCT03463031|11330430|FG000|Overall Study|Use of prohibited medication by subject|1
7158788|NCT03463031|11330431|FG001|Overall Study|Use of prohibited medication by subject|0
7158789|NCT03464383|11330473|FG000|Overall Study|Lost to Follow-up|1
7158790|NCT03464383|11330474|FG001|Overall Study|Lost to Follow-up|0
7158791|NCT03464383|11330475|FG002|Overall Study|Lost to Follow-up|0
7158792|NCT03464383|11330473|FG000|Overall Study|Withdrawal by Subject|0
7158793|NCT03464383|11330474|FG001|Overall Study|Withdrawal by Subject|1
7158794|NCT03464383|11330475|FG002|Overall Study|Withdrawal by Subject|0
7158795|NCT03464422|11330484|FG000|Overall Study|Lost to Follow-up|2
7158796|NCT03464422|11330484|FG000|Overall Study|Withdrawal by Subject|2
7158797|NCT03465436|11330494|FG000|Period 1|Protocol Violation|0
7158798|NCT03465436|11330495|FG001|Period 1|Protocol Violation|0
7158799|NCT03465436|11330496|FG002|Period 1|Protocol Violation|1
7158800|NCT03465436|11330497|FG003|Period 1|Protocol Violation|0
7158801|NCT03465436|11330494|FG000|Period 2|Protocol Violation|0
7158802|NCT03465436|11330495|FG001|Period 2|Protocol Violation|1
7158803|NCT03465436|11330496|FG002|Period 2|Protocol Violation|0
7158804|NCT03465436|11330497|FG003|Period 2|Protocol Violation|0
7158805|NCT03465436|11330494|FG000|Period 3|Protocol Violation|1
7158806|NCT03465436|11330495|FG001|Period 3|Protocol Violation|1
7158807|NCT03465436|11330496|FG002|Period 3|Protocol Violation|0
7158808|NCT03465436|11330497|FG003|Period 3|Protocol Violation|0
7158809|NCT03465436|11330494|FG000|Period 4|Protocol Violation|0
7158810|NCT03465436|11330495|FG001|Period 4|Protocol Violation|0
7158811|NCT03465436|11330496|FG002|Period 4|Protocol Violation|1
7158812|NCT03465436|11330497|FG003|Period 4|Protocol Violation|0
7158813|NCT03465709|11330509|FG000|Overall Study|Study/Site Terminated by Sponsor|14
7158814|NCT03465709|11330509|FG000|Overall Study|Withdrawal by Subject|3
7158815|NCT03465722|11330517|FG000|End of Treatment|Patient Refused Treatment|3
7158816|NCT03465722|11330518|FG001|End of Treatment|Patient Refused Treatment|1
7158817|NCT03465722|11330517|FG000|End of Treatment|Withdrawal by Subject|6
7158818|NCT03465722|11330518|FG001|End of Treatment|Withdrawal by Subject|1
7158819|NCT03465722|11330517|FG000|End of Treatment|Adverse Event|30
7158820|NCT03465722|11330518|FG001|End of Treatment|Adverse Event|23
7158821|NCT03465722|11330517|FG000|End of Treatment|Disease Progression (Confirmed by Central Review)|102
7158822|NCT03465722|11330518|FG001|End of Treatment|Disease Progression (Confirmed by Central Review)|101
7158823|NCT03465722|11330517|FG000|End of Treatment|Clinical Progression|17
7158824|NCT03465722|11330518|FG001|End of Treatment|Clinical Progression|5
7158825|NCT03465722|11330517|FG000|End of Treatment|Physician Decision|4
7158826|NCT03465722|11330518|FG001|End of Treatment|Physician Decision|5
7158827|NCT03465722|11330517|FG000|End of Treatment|Lost to Follow-up|3
7158828|NCT03465722|11330518|FG001|End of Treatment|Lost to Follow-up|1
7158829|NCT03465722|11330517|FG000|End of Treatment|Administrative/Other|6
7158830|NCT03465722|11330518|FG001|End of Treatment|Administrative/Other|3
7158831|NCT03465722|11330517|FG000|End of Treatment|Treatment Ongoing|68
7158832|NCT03465722|11330518|FG001|End of Treatment|Treatment Ongoing|94
7158833|NCT03465722|11330517|FG000|End of Treatment|Randomized But Not Treated|1
7158834|NCT03465722|11330518|FG001|End of Treatment|Randomized But Not Treated|2
7158835|NCT03465722|11330517|FG000|End of Study|Withdrawal by Subject|17
7158836|NCT03465722|11330518|FG001|End of Study|Withdrawal by Subject|7
7158837|NCT03465722|11330517|FG000|End of Study|Death|57
7158838|NCT03465722|11330518|FG001|End of Study|Death|57
7158839|NCT03465722|11330517|FG000|End of Study|Lost to Follow-up|5
7158840|NCT03465722|11330518|FG001|End of Study|Lost to Follow-up|2
7158841|NCT03465722|11330517|FG000|End of Study|Administrative/Other|4
7158842|NCT03465722|11330518|FG001|End of Study|Administrative/Other|2
7158843|NCT03465722|11330517|FG000|End of Study|On Treatment or in Follow Up|157
7158844|NCT03465722|11330518|FG001|End of Study|On Treatment or in Follow Up|168
7158845|NCT03465878|11330526|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0
7158846|NCT03465878|11330527|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1
7158847|NCT03465878|11330528|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0
7158848|NCT03465878|11330529|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0
7158849|NCT03465878|11330526|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0
7158850|NCT03465878|11330527|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0
7158851|NCT03465878|11330528|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0
7158852|NCT03465878|11330529|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1
7158853|NCT03465878|11330526|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0
7158854|NCT03465878|11330527|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0
7158855|NCT03465878|11330528|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0
7158856|NCT03465878|11330529|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1
7158857|NCT03465904|11330557|FG000|Overall Study|Withdrawal by Subject|9
7158858|NCT03465904|11330558|FG001|Overall Study|Withdrawal by Subject|5
7158859|NCT03465904|11330557|FG000|Overall Study|Lost to Follow-up|10
7158860|NCT03465904|11330558|FG001|Overall Study|Lost to Follow-up|9
7158861|NCT03465904|11330557|FG000|Overall Study|Protocol Violation|8
7158862|NCT03465904|11330558|FG001|Overall Study|Protocol Violation|5
7158863|NCT03465904|11330557|FG000|Overall Study|Ineligible for mITT analysis|62
7158864|NCT03465904|11330558|FG001|Overall Study|Ineligible for mITT analysis|47
7158865|NCT03466060|11330593|FG000|Period 1|Test Lens Damage|0
7158866|NCT03466060|11330594|FG001|Period 1|Test Lens Damage|2
7158867|NCT03466060|11330595|FG002|Period 1|Test Lens Damage|0
7158868|NCT03466060|11330596|FG003|Period 1|Test Lens Damage|0
7158869|NCT03466060|11330597|FG004|Period 1|Test Lens Damage|0
7158870|NCT03466060|11330598|FG005|Period 1|Test Lens Damage|0
7158871|NCT03466060|11330593|FG000|Period 1|Withdrawal by Subject|0
7158872|NCT03466060|11330594|FG001|Period 1|Withdrawal by Subject|0
7158873|NCT03466060|11330595|FG002|Period 1|Withdrawal by Subject|2
7158874|NCT03466060|11330596|FG003|Period 1|Withdrawal by Subject|0
7158875|NCT03466060|11330597|FG004|Period 1|Withdrawal by Subject|0
7158876|NCT03466060|11330598|FG005|Period 1|Withdrawal by Subject|0
7158877|NCT03466060|11330593|FG000|Period 1|Lost to Follow-up|0
7158878|NCT03466060|11330594|FG001|Period 1|Lost to Follow-up|0
7158879|NCT03466060|11330595|FG002|Period 1|Lost to Follow-up|0
7158880|NCT03466060|11330596|FG003|Period 1|Lost to Follow-up|1
7158881|NCT03466060|11330597|FG004|Period 1|Lost to Follow-up|0
7158882|NCT03466060|11330598|FG005|Period 1|Lost to Follow-up|0
7158883|NCT03466060|11330593|FG000|Period 1|Grade 2 Conjunctivitis|0
7158884|NCT03466060|11330594|FG001|Period 1|Grade 2 Conjunctivitis|0
7158885|NCT03466060|11330595|FG002|Period 1|Grade 2 Conjunctivitis|1
7158886|NCT03466060|11330596|FG003|Period 1|Grade 2 Conjunctivitis|0
7158887|NCT03466060|11330597|FG004|Period 1|Grade 2 Conjunctivitis|0
7158888|NCT03466060|11330598|FG005|Period 1|Grade 2 Conjunctivitis|0
7158889|NCT03466060|11330593|FG000|Period 2|Lens Handling Difficulties|0
7158890|NCT03466060|11330594|FG001|Period 2|Lens Handling Difficulties|0
7158891|NCT03466060|11330595|FG002|Period 2|Lens Handling Difficulties|1
7158892|NCT03466060|11330596|FG003|Period 2|Lens Handling Difficulties|0
7158893|NCT03466060|11330597|FG004|Period 2|Lens Handling Difficulties|0
7158894|NCT03466060|11330598|FG005|Period 2|Lens Handling Difficulties|0
7158895|NCT03466073|11330618|FG000|Overall Study|Death|1
7158896|NCT03466073|11330619|FG001|Overall Study|Death|0
7158897|NCT03466073|11330620|FG002|Overall Study|Death|0
7158898|NCT03466073|11330621|FG003|Overall Study|Death|0
7158899|NCT03466073|11330622|FG004|Overall Study|Death|0
7158900|NCT03466073|11330623|FG005|Overall Study|Death|1
7158901|NCT03466086|11330644|FG000|Period 1|Sponsor decision due to study timeline|1
7158902|NCT03466086|11330645|FG001|Period 1|Sponsor decision due to study timeline|0
7158903|NCT03466086|11330644|FG000|Period 1|Withdrawal by Subject|1
7158904|NCT03466086|11330645|FG001|Period 1|Withdrawal by Subject|0
7158905|NCT03466099|11330654|FG000|Overall Study|Adverse Event|1
7158906|NCT03466099|11330655|FG001|Overall Study|Adverse Event|1
7158907|NCT03466099|11330656|FG002|Overall Study|Adverse Event|1
7158908|NCT03466099|11330654|FG000|Overall Study|Withdrawal by Subject|2
7158909|NCT03466099|11330655|FG001|Overall Study|Withdrawal by Subject|3
7158910|NCT03466099|11330656|FG002|Overall Study|Withdrawal by Subject|1
7158911|NCT03466099|11330654|FG000|Overall Study|Use of rescue medication|8
7158912|NCT03466099|11330655|FG001|Overall Study|Use of rescue medication|9
7158913|NCT03466099|11330656|FG002|Overall Study|Use of rescue medication|13
7158914|NCT03466099|11330654|FG000|Overall Study|Rescued without meeting criteria|4
7158915|NCT03466099|11330655|FG001|Overall Study|Rescued without meeting criteria|1
7158916|NCT03466099|11330656|FG002|Overall Study|Rescued without meeting criteria|1
7158917|NCT03466099|11330654|FG000|Overall Study|Subject compliance|2
7158918|NCT03466099|11330655|FG001|Overall Study|Subject compliance|0
7158919|NCT03466099|11330656|FG002|Overall Study|Subject compliance|0
7158920|NCT03466099|11330654|FG000|Overall Study|Worsening disease|0
7158921|NCT03466099|11330655|FG001|Overall Study|Worsening disease|0
7158922|NCT03466099|11330656|FG002|Overall Study|Worsening disease|1
7158923|NCT03467217|11330680|FG000|Overall Study|Trial stopped early|5
7158924|NCT03467217|11330681|FG001|Overall Study|Trial stopped early|2
7158925|NCT03467217|11330680|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5
7158926|NCT03467217|11330681|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2
7158927|NCT03467217|11330680|FG000|Overall Study|Lost to Follow-up|0
7158928|NCT03467217|11330681|FG001|Overall Study|Lost to Follow-up|2
7158929|NCT03467425|11330712|FG000|Overall Study|Adverse Event|9
7158930|NCT03467425|11330713|FG001|Overall Study|Adverse Event|9
7158931|NCT03467425|11330712|FG000|Overall Study|Lack of Efficacy|3
7158932|NCT03467425|11330713|FG001|Overall Study|Lack of Efficacy|1
7158933|NCT03467425|11330712|FG000|Overall Study|Protocol Violation|0
7158934|NCT03467425|11330713|FG001|Overall Study|Protocol Violation|1
7158935|NCT03467425|11330712|FG000|Overall Study|Lost to Follow-up|18
7158936|NCT03467425|11330713|FG001|Overall Study|Lost to Follow-up|25
7158937|NCT03467425|11330712|FG000|Overall Study|Physician Decision|2
7158938|NCT03467425|11330713|FG001|Overall Study|Physician Decision|1
7158939|NCT03467425|11330712|FG000|Overall Study|Withdrawal by Subject|15
7158940|NCT03467425|11330713|FG001|Overall Study|Withdrawal by Subject|17
7158941|NCT03467763|11330735|FG000|Overall Study|Lost to Follow-up|1
7158942|NCT03467763|11330735|FG000|Overall Study|Protocol Violation|2
7158943|NCT03467945|11330745|FG000|Treatment Period 2|Withdrawal by Subject|0
7158944|NCT03467945|11330746|FG001|Treatment Period 2|Withdrawal by Subject|1
7158945|NCT03467945|11330747|FG002|Treatment Period 2|Withdrawal by Subject|0
7158946|NCT03467945|11330748|FG003|Treatment Period 2|Withdrawal by Subject|0
7158947|NCT03467945|11330745|FG000|Treatment Period 3|Withdrawal by Subject|1
7158948|NCT03467945|11330746|FG001|Treatment Period 3|Withdrawal by Subject|0
7158949|NCT03467945|11330747|FG002|Treatment Period 3|Withdrawal by Subject|2
7158950|NCT03467945|11330748|FG003|Treatment Period 3|Withdrawal by Subject|1
7158951|NCT03467971|11330761|FG000|Treatment Period 2|Withdrawal by Subject|0
7158952|NCT03467971|11330762|FG001|Treatment Period 2|Withdrawal by Subject|1
7158953|NCT03468543|11330780|FG000|Overall Study|Protocol stopping rules met|3
7158954|NCT03468855|11330795|FG000|Overall Study|Adverse Event|2
7158955|NCT03468855|11330795|FG000|Overall Study|Lost to Follow-up|5
7158956|NCT03468855|11330795|FG000|Overall Study|Withdrawal by Subject|3
7158957|NCT03468855|11330795|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1
7158958|NCT03469336|11330817|FG000|Overall Study|Adverse Event|1
7158959|NCT03469349|11330829|FG000|Overall Study|Withdrawal by Subject|1
7158960|NCT03469349|11330830|FG001|Overall Study|Withdrawal by Subject|3
7158961|NCT03469349|11330829|FG000|Overall Study|Progressive Disease|0
7158962|NCT03469349|11330830|FG001|Overall Study|Progressive Disease|1
7158963|NCT03469349|11330829|FG000|Overall Study|Lost to Follow-up|2
7158964|NCT03469349|11330830|FG001|Overall Study|Lost to Follow-up|2
7158965|NCT03469349|11330829|FG000|Overall Study|Adverse Event|2
7158966|NCT03469349|11330830|FG001|Overall Study|Adverse Event|4
7158967|NCT03470194|11330842|FG000|Overall Study|Lost to Follow-up|11
7158968|NCT03470194|11330843|FG001|Overall Study|Lost to Follow-up|17
7158969|NCT03470545|11330855|FG000|Overall Study|Death|0
7158970|NCT03470545|11330856|FG001|Overall Study|Death|1
7158971|NCT03470545|11330855|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1
7158972|NCT03470545|11330856|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0
7158973|NCT03470545|11330855|FG000|Overall Study|Adverse Event|2
7158974|NCT03470545|11330856|FG001|Overall Study|Adverse Event|0
7158975|NCT03470545|11330855|FG000|Overall Study|Withdrawal by Subject|1
7158976|NCT03470545|11330856|FG001|Overall Study|Withdrawal by Subject|1
7158977|NCT03470545|11330855|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0
7158978|NCT03470545|11330856|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1
7158979|NCT03471078|11330879|FG000|Overall Study|Withdrawal by Subject|9
7158980|NCT03471078|11330880|FG001|Overall Study|Withdrawal by Subject|1
7158981|NCT03471078|11330879|FG000|Overall Study|Adverse Event|4
7158982|NCT03471078|11330880|FG001|Overall Study|Adverse Event|1
7158983|NCT03471078|11330879|FG000|Overall Study|Physician Decision|3
7158984|NCT03471078|11330880|FG001|Overall Study|Physician Decision|2
7158985|NCT03471078|11330879|FG000|Overall Study|Death|2
7158986|NCT03471078|11330880|FG001|Overall Study|Death|0
7158987|NCT03471078|11330879|FG000|Overall Study|Other|3
7158988|NCT03471078|11330880|FG001|Overall Study|Other|2
7158989|NCT03471871|11330897|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
7158990|NCT03471871|11330898|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
7158991|NCT03471871|11330899|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1
7158992|NCT03471871|11330900|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
7158993|NCT03471871|11330901|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
7158994|NCT03471871|11330897|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
7158995|NCT03471871|11330898|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
7158996|NCT03471871|11330899|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
7158997|NCT03471871|11330900|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1
7158998|NCT03471871|11330901|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1
7158999|NCT03471871|11330897|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
7159000|NCT03471871|11330898|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
7159001|NCT03471871|11330899|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
7159002|NCT03471871|11330900|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
7159003|NCT03471871|11330901|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1
7159004|NCT03471871|11330897|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
7159005|NCT03471871|11330898|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
7159006|NCT03471871|11330899|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
7159007|NCT03471871|11330900|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
7159008|NCT03471871|11330901|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1
7159009|NCT03471871|11330897|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
7159010|NCT03471871|11330898|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
7159011|NCT03471871|11330899|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
7159012|NCT03471871|11330900|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1
7159013|NCT03471871|11330901|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
7159014|NCT03472014|11330922|FG000|Overall Study|Lost to Follow-up|4
7159015|NCT03472326|11330937|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0
7159016|NCT03472326|11330938|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0
7159017|NCT03472326|11330939|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1
7159018|NCT03472326|11330940|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2
7159019|NCT03472326|11330937|FG000|Part 2: Combination Therapy|Pregnancy|0
7159020|NCT03472326|11330938|FG001|Part 2: Combination Therapy|Pregnancy|0
7159021|NCT03472326|11330939|FG002|Part 2: Combination Therapy|Pregnancy|0
7159022|NCT03472326|11330940|FG003|Part 2: Combination Therapy|Pregnancy|1
7159023|NCT03472534|11330958|FG000|Overall Study|Withdrawal by Subject|9
7159024|NCT03472534|11330958|FG000|Overall Study|Adverse Event|2
7159025|NCT03472547|11330962|FG000|Overall Study|Withdrawal by Subject|30
7159026|NCT03473197|11330974|FG000|Overall Study|Adverse Event|4
7159027|NCT03473197|11330974|FG000|Overall Study|Lost to Follow-up|1
7159028|NCT03473197|11330974|FG000|Overall Study|Withdrawal by Subject|5
7159029|NCT03473236|11330988|FG000|Overall Study|Withdrawal by Subject|0
7159030|NCT03473236|11330989|FG001|Overall Study|Withdrawal by Subject|0
7159031|NCT03473236|11330990|FG002|Overall Study|Withdrawal by Subject|0
7159032|NCT03473236|11330991|FG003|Overall Study|Withdrawal by Subject|0
7159033|NCT03473236|11330992|FG004|Overall Study|Withdrawal by Subject|0
7159034|NCT03473236|11330993|FG005|Overall Study|Withdrawal by Subject|1
7159035|NCT03473236|11330994|FG006|Overall Study|Withdrawal by Subject|0
7159036|NCT03473236|11330995|FG007|Overall Study|Withdrawal by Subject|0
7159037|NCT03473236|11330996|FG008|Overall Study|Withdrawal by Subject|1
7159038|NCT03473236|11330997|FG009|Overall Study|Withdrawal by Subject|0
7159039|NCT03473301|11331030|FG000|Overall Study|Protocol Violation|4
7159040|NCT03473301|11331031|FG001|Overall Study|Protocol Violation|0
7159041|NCT03473301|11331032|FG002|Overall Study|Protocol Violation|0
7159042|NCT03473301|11331030|FG000|Overall Study|Withdrawal by Subject|0
7159043|NCT03473301|11331031|FG001|Overall Study|Withdrawal by Subject|1
7159044|NCT03473301|11331032|FG002|Overall Study|Withdrawal by Subject|0
7159045|NCT03473301|11331030|FG000|Overall Study|Missed study visit due to pandemic restrictions|7
7159046|NCT03473301|11331031|FG001|Overall Study|Missed study visit due to pandemic restrictions|5
7159047|NCT03473301|11331032|FG002|Overall Study|Missed study visit due to pandemic restrictions|6
7159048|NCT03473808|11331051|FG000|Overall Study|Withdrawal by Subject|1
7159049|NCT03474081|11331061|FG000|Overall Study|Adverse Event|6
7159050|NCT03474081|11331062|FG001|Overall Study|Adverse Event|3
7159051|NCT03474081|11331061|FG000|Overall Study|Lost to Follow-up|2
7159052|NCT03474081|11331062|FG001|Overall Study|Lost to Follow-up|1
7159053|NCT03474081|11331061|FG000|Overall Study|Physician Decision|3
7159054|NCT03474081|11331062|FG001|Overall Study|Physician Decision|2
7159055|NCT03474081|11331061|FG000|Overall Study|Withdrawal by Subject|5
7159056|NCT03474081|11331062|FG001|Overall Study|Withdrawal by Subject|7
7159057|NCT03474081|11331061|FG000|Overall Study|Investigator site closed|1
7159058|NCT03474081|11331062|FG001|Overall Study|Investigator site closed|0
7159059|NCT03475056|11331092|FG000|Overall Study|Lost to Follow-up|0
7159060|NCT03475056|11331093|FG001|Overall Study|Lost to Follow-up|1
7159061|NCT03475056|11331092|FG000|Overall Study|Moved from Area|0
7159062|NCT03475056|11331093|FG001|Overall Study|Moved from Area|2
7159063|NCT03475316|11331102|FG000|6 Month Intervention|Adverse Event|2
7159064|NCT03475316|11331103|FG001|6 Month Intervention|Adverse Event|1
7159065|NCT03475316|11331102|FG000|6 Month Intervention|Withdrawal by Subject|2
7159066|NCT03475316|11331103|FG001|6 Month Intervention|Withdrawal by Subject|0
7159067|NCT03475316|11331102|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1
7159068|NCT03475316|11331103|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3
7159069|NCT03475316|11331102|FG000|9 Months|Study stopped due to COVID pandemic|3
7159070|NCT03475316|11331103|FG001|9 Months|Study stopped due to COVID pandemic|4
7159071|NCT03475875|11331109|FG000|Period 1|Lost to Follow-up|1
7159072|NCT03475875|11331110|FG001|Period 1|Lost to Follow-up|0
7159073|NCT03475875|11331109|FG000|Period 1|Adverse Event|2
7159074|NCT03475875|11331110|FG001|Period 1|Adverse Event|1
7159075|NCT03475875|11331109|FG000|Period 2|Adverse Event|3
7159076|NCT03475875|11331110|FG001|Period 2|Adverse Event|0
7159077|NCT03475875|11331109|FG000|Period 2|Protocol Violation|0
7159078|NCT03475875|11331110|FG001|Period 2|Protocol Violation|1
7159079|NCT03476798|11331143|FG000|Overall Study|Death|1
7159080|NCT03476798|11331143|FG000|Overall Study|Withdrawal by Subject|2
7159081|NCT03476798|11331143|FG000|Overall Study|Protocol Violation|2
7159082|NCT03477838|11331187|FG000|Overall Study|Lost to Follow-up|14
7159083|NCT03478371|11331205|FG000|Overall Study|non-compliance|1
7159084|NCT03478371|11331205|FG000|Overall Study|Lost to Follow-up|4
7159085|NCT03478644|11331217|FG000|Phase 2|Withdrawal by Subject|2
7159086|NCT03478644|11331218|FG001|Phase 2|Withdrawal by Subject|1
7159087|NCT03478644|11331217|FG000|Phase 2|Lost to Follow-up|1
7159088|NCT03478644|11331218|FG001|Phase 2|Lost to Follow-up|0
7159089|NCT03478657|11331226|FG000|Overall Study|Withdrawal by Subject|0
7159090|NCT03478657|11331227|FG001|Overall Study|Withdrawal by Subject|1
7159091|NCT03478683|11331235|FG000|Overall Study|Adverse Event|5
7159092|NCT03478683|11331236|FG001|Overall Study|Adverse Event|3
7159093|NCT03478683|11331235|FG000|Overall Study|Lost to Follow-up|0
7159094|NCT03478683|11331236|FG001|Overall Study|Lost to Follow-up|5
7159095|NCT03478683|11331235|FG000|Overall Study|Physician Decision|1
7159096|NCT03478683|11331236|FG001|Overall Study|Physician Decision|3
7159097|NCT03478683|11331235|FG000|Overall Study|Withdrawal by Subject|7
7159098|NCT03478683|11331236|FG001|Overall Study|Withdrawal by Subject|7
7159099|NCT03478696|11331244|FG000|Overall Study|Adverse Event|1
7159100|NCT03478696|11331245|FG001|Overall Study|Adverse Event|5
7159101|NCT03478696|11331244|FG000|Overall Study|Lost to Follow-up|1
7159102|NCT03478696|11331245|FG001|Overall Study|Lost to Follow-up|0
7159103|NCT03478696|11331244|FG000|Overall Study|Physician Decision|6
7159104|NCT03478696|11331245|FG001|Overall Study|Physician Decision|3
7159105|NCT03478696|11331244|FG000|Overall Study|Withdrawal by Subject|9
7159106|NCT03478696|11331245|FG001|Overall Study|Withdrawal by Subject|4
7159107|NCT03478787|11331253|FG000|Overall Study|Adverse Event|5
7159108|NCT03478787|11331254|FG001|Overall Study|Adverse Event|1
7159109|NCT03478787|11331253|FG000|Overall Study|Protocol Violation|3
7159110|NCT03478787|11331254|FG001|Overall Study|Protocol Violation|0
7159111|NCT03478787|11331253|FG000|Overall Study|Lack of Efficacy|7
7159112|NCT03478787|11331254|FG001|Overall Study|Lack of Efficacy|1
7159113|NCT03478787|11331253|FG000|Overall Study|Lost to Follow-up|9
7159114|NCT03478787|11331254|FG001|Overall Study|Lost to Follow-up|5
7159115|NCT03478787|11331253|FG000|Overall Study|Withdrawal by Subject|2
7159116|NCT03478787|11331254|FG001|Overall Study|Withdrawal by Subject|6
7159117|NCT03478787|11331253|FG000|Overall Study|Other, Not Specified|3
7159118|NCT03478787|11331254|FG001|Overall Study|Other, Not Specified|0
7159119|NCT03478891|11331263|FG000|Overall Study|Enrolled, but product never administered|0
7159120|NCT03478891|11331264|FG001|Overall Study|Enrolled, but product never administered|0
7159121|NCT03478891|11331265|FG002|Overall Study|Enrolled, but product never administered|1
7159122|NCT03478891|11331263|FG000|Overall Study|Moved from area|0
7159123|NCT03478891|11331264|FG001|Overall Study|Moved from area|0
7159124|NCT03478891|11331265|FG002|Overall Study|Moved from area|1
7159125|NCT03478891|11331263|FG000|Overall Study|Lost to Follow-up|1
7159126|NCT03478891|11331264|FG001|Overall Study|Lost to Follow-up|0
7159127|NCT03478891|11331265|FG002|Overall Study|Lost to Follow-up|1
7159128|NCT03478969|11331291|FG000|Overall Study|Withdrawal by Subject|4
7159129|NCT03478969|11331292|FG001|Overall Study|Withdrawal by Subject|7
7159130|NCT03478969|11331293|FG002|Overall Study|Withdrawal by Subject|6
7159131|NCT03478969|11331291|FG000|Overall Study|Adverse Event|2
7159132|NCT03478969|11331292|FG001|Overall Study|Adverse Event|0
7159133|NCT03478969|11331293|FG002|Overall Study|Adverse Event|1
7159134|NCT03478969|11331291|FG000|Overall Study|Pregnancy|1
7159135|NCT03478969|11331292|FG001|Overall Study|Pregnancy|0
7159136|NCT03478969|11331293|FG002|Overall Study|Pregnancy|0
7159137|NCT03478969|11331291|FG000|Overall Study|Personal Reasons|1
7159138|NCT03478969|11331292|FG001|Overall Study|Personal Reasons|0
7159139|NCT03478969|11331293|FG002|Overall Study|Personal Reasons|1
7159140|NCT03478969|11331291|FG000|Overall Study|Covid-19|1
7159141|NCT03478969|11331292|FG001|Overall Study|Covid-19|4
7159142|NCT03478969|11331293|FG002|Overall Study|Covid-19|3
7159143|NCT03478969|11331291|FG000|Overall Study|Multiple Reasons|0
7159144|NCT03478969|11331292|FG001|Overall Study|Multiple Reasons|1
7159145|NCT03478969|11331293|FG002|Overall Study|Multiple Reasons|1
7159146|NCT03478969|11331291|FG000|Overall Study|Eligibility Criteria|0
7159147|NCT03478969|11331292|FG001|Overall Study|Eligibility Criteria|0
7159148|NCT03478969|11331293|FG002|Overall Study|Eligibility Criteria|5
7159149|NCT03478969|11331291|FG000|Overall Study|Lost to Follow-up|0
7159150|NCT03478969|11331292|FG001|Overall Study|Lost to Follow-up|0
7159151|NCT03478969|11331293|FG002|Overall Study|Lost to Follow-up|1
7184261|NCT01901432|11384309|FG000|Overall Study|Adverse Event|0
7159152|NCT03479216|11331322|FG000|Overall Study|Withdrawal by Subject|3
7159153|NCT03479216|11331323|FG001|Overall Study|Withdrawal by Subject|2
7159154|NCT03479216|11331322|FG000|Overall Study|Physician Decision|2
7159155|NCT03479216|11331323|FG001|Overall Study|Physician Decision|3
7159156|NCT03480009|11331341|FG000|Overall Study|Lost to Follow-up|4
7159157|NCT03480009|11331342|FG001|Overall Study|Lost to Follow-up|5
7159158|NCT03480009|11331343|FG002|Overall Study|Lost to Follow-up|4
7159159|NCT03480009|11331344|FG003|Overall Study|Lost to Follow-up|0
7159160|NCT03480022|11331359|FG000|Overall Study|Pregnancy|2
7159161|NCT03480022|11331360|FG001|Overall Study|Pregnancy|0
7159162|NCT03480022|11331359|FG000|Overall Study|Adverse Event|6
7159163|NCT03480022|11331360|FG001|Overall Study|Adverse Event|0
7159164|NCT03480022|11331359|FG000|Overall Study|Lack of Efficacy|0
7159165|NCT03480022|11331360|FG001|Overall Study|Lack of Efficacy|2
7159166|NCT03480022|11331359|FG000|Overall Study|Physician Decision|0
7159167|NCT03480022|11331360|FG001|Overall Study|Physician Decision|1
7159168|NCT03480022|11331359|FG000|Overall Study|Withdrawal by Subject|2
7159169|NCT03480022|11331360|FG001|Overall Study|Withdrawal by Subject|0
7159170|NCT03480022|11331359|FG000|Overall Study|Medication concerns|1
7159171|NCT03480022|11331360|FG001|Overall Study|Medication concerns|0
7159172|NCT03480022|11331359|FG000|Overall Study|Family member COVID exposure|0
7159173|NCT03480022|11331360|FG001|Overall Study|Family member COVID exposure|1
7159174|NCT03480152|11331377|FG000|Phase I|Signed consent. Died before treatment.|1
7159175|NCT03480152|11331378|FG001|Phase I|Signed consent. Died before treatment.|0
7159176|NCT03480152|11331379|FG002|Phase I|Signed consent. Died before treatment.|0
7159177|NCT03480243|11331387|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1
7159178|NCT03480243|11331387|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1
7159179|NCT03480425|11331400|FG000|Overall Study|Force transducer technical failure|1
7159180|NCT03480750|11331416|FG000|Overall Study|Withdrawal by Subject|0
7159181|NCT03480750|11331417|FG001|Overall Study|Withdrawal by Subject|1
7159182|NCT03480750|11331418|FG002|Overall Study|Withdrawal by Subject|0
7159183|NCT03480750|11331419|FG003|Overall Study|Withdrawal by Subject|0
7159184|NCT03480750|11331420|FG004|Overall Study|Withdrawal by Subject|0
7159185|NCT03480750|11331421|FG005|Overall Study|Withdrawal by Subject|0
7159186|NCT03480750|11331416|FG000|Overall Study|The interruption in Trientine shippment|0
7159187|NCT03480750|11331417|FG001|Overall Study|The interruption in Trientine shippment|0
7159188|NCT03480750|11331418|FG002|Overall Study|The interruption in Trientine shippment|0
7159189|NCT03480750|11331419|FG003|Overall Study|The interruption in Trientine shippment|0
7159190|NCT03480750|11331420|FG004|Overall Study|The interruption in Trientine shippment|0
7159191|NCT03480750|11331421|FG005|Overall Study|The interruption in Trientine shippment|1
7159192|NCT03480763|11331446|FG000|Overall Study|Withdrawal by Subject|18
7159193|NCT03480763|11331447|FG001|Overall Study|Withdrawal by Subject|10
7159194|NCT03480763|11331446|FG000|Overall Study|Lost to Follow-up|4
7159195|NCT03480763|11331447|FG001|Overall Study|Lost to Follow-up|7
7159196|NCT03480763|11331446|FG000|Overall Study|non-study pneumococcal vaccine|1
7159197|NCT03480763|11331447|FG001|Overall Study|non-study pneumococcal vaccine|0
7159198|NCT03480763|11331446|FG000|Overall Study|oncological treatment|0
7159199|NCT03480763|11331447|FG001|Overall Study|oncological treatment|2
7159200|NCT03480763|11331446|FG000|Overall Study|pain with vaccination|1
7159201|NCT03480763|11331447|FG001|Overall Study|pain with vaccination|0
7159202|NCT03480841|11331459|FG000|Overall Study|Lost to Follow-up|2
7159203|NCT03480932|11331479|FG000|Overall Study|Death|1
7159204|NCT03480932|11331480|FG001|Overall Study|Death|1
7159205|NCT03480932|11331481|FG002|Overall Study|Death|0
7159206|NCT03480932|11331479|FG000|Overall Study|Lost to Follow-up|0
7159207|NCT03480932|11331480|FG001|Overall Study|Lost to Follow-up|2
7159208|NCT03480932|11331481|FG002|Overall Study|Lost to Follow-up|3
7159209|NCT03480932|11331479|FG000|Overall Study|Incarcerated|2
7159210|NCT03480932|11331480|FG001|Overall Study|Incarcerated|2
7159211|NCT03480932|11331481|FG002|Overall Study|Incarcerated|2
7159212|NCT03481309|11331504|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1
7159213|NCT03481309|11331505|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0
7159214|NCT03481309|11331506|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0
7159215|NCT03481309|11331507|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0
7159216|NCT03481309|11331508|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0
7159217|NCT03481309|11331509|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0
7159218|NCT03481725|11331528|FG000|Overall Study|Withdrawal by Subject|1
7159219|NCT03481725|11331529|FG001|Overall Study|Withdrawal by Subject|0
7159220|NCT03481816|11331539|FG000|Starting Dose|Refused further vaccines after 1 dose|1
7159221|NCT03481816|11331540|FG001|Starting Dose|Refused further vaccines after 1 dose|0
7159222|NCT03481816|11331539|FG000|Dose Expansion|Off treatment due to progressive disease|0
7159223|NCT03481816|11331540|FG001|Dose Expansion|Off treatment due to progressive disease|5
7159224|NCT03481816|11331539|FG000|Dose Expansion|Withdrawal by Subject|0
7159225|NCT03481816|11331540|FG001|Dose Expansion|Withdrawal by Subject|2
7159226|NCT03481816|11331539|FG000|Dose Expansion|Physician Decision|0
7159227|NCT03481816|11331540|FG001|Dose Expansion|Physician Decision|5
7159228|NCT03482011|11331550|FG000|Induction Period (16 Weeks)|Adverse Event|1
7159229|NCT03482011|11331551|FG001|Induction Period (16 Weeks)|Adverse Event|3
7159230|NCT03482011|11331552|FG002|Induction Period (16 Weeks)|Adverse Event|0
7159231|NCT03482011|11331553|FG003|Induction Period (16 Weeks)|Adverse Event|0
7159232|NCT03482011|11331554|FG004|Induction Period (16 Weeks)|Adverse Event|0
7159233|NCT03482011|11331555|FG005|Induction Period (16 Weeks)|Adverse Event|0
7159234|NCT03482011|11331556|FG006|Induction Period (16 Weeks)|Adverse Event|0
7159235|NCT03482011|11331557|FG007|Induction Period (16 Weeks)|Adverse Event|0
7159236|NCT03482011|11331550|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3
7159237|NCT03482011|11331551|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1
7159238|NCT03482011|11331552|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0
7159239|NCT03482011|11331553|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0
7159240|NCT03482011|11331554|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0
7159241|NCT03482011|11331555|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0
7159242|NCT03482011|11331556|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0
7159243|NCT03482011|11331557|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0
7159244|NCT03482011|11331550|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0
7159245|NCT03482011|11331551|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1
7159246|NCT03482011|11331552|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0
7159247|NCT03482011|11331553|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0
7159248|NCT03482011|11331554|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0
7159249|NCT03482011|11331555|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0
7159250|NCT03482011|11331556|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0
7159251|NCT03482011|11331557|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0
7159252|NCT03482011|11331550|FG000|Induction Period (16 Weeks)|Screen Failure|0
7159253|NCT03482011|11331551|FG001|Induction Period (16 Weeks)|Screen Failure|1
7159254|NCT03482011|11331552|FG002|Induction Period (16 Weeks)|Screen Failure|0
7159255|NCT03482011|11331553|FG003|Induction Period (16 Weeks)|Screen Failure|0
7159256|NCT03482011|11331554|FG004|Induction Period (16 Weeks)|Screen Failure|0
7159257|NCT03482011|11331555|FG005|Induction Period (16 Weeks)|Screen Failure|0
7159258|NCT03482011|11331556|FG006|Induction Period (16 Weeks)|Screen Failure|0
7159259|NCT03482011|11331557|FG007|Induction Period (16 Weeks)|Screen Failure|0
7159260|NCT03482011|11331550|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2
7159261|NCT03482011|11331551|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5
7159262|NCT03482011|11331552|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0
7159263|NCT03482011|11331553|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0
7159264|NCT03482011|11331554|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0
7159265|NCT03482011|11331555|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0
7159266|NCT03482011|11331556|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0
7159267|NCT03482011|11331557|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0
7159268|NCT03482011|11331550|FG000|Maintenance Period (36 Weeks)|Adverse Event|0
7159269|NCT03482011|11331551|FG001|Maintenance Period (36 Weeks)|Adverse Event|0
7159270|NCT03482011|11331552|FG002|Maintenance Period (36 Weeks)|Adverse Event|0
7159271|NCT03482011|11331553|FG003|Maintenance Period (36 Weeks)|Adverse Event|0
7159272|NCT03482011|11331554|FG004|Maintenance Period (36 Weeks)|Adverse Event|0
7159273|NCT03482011|11331555|FG005|Maintenance Period (36 Weeks)|Adverse Event|1
7159274|NCT03482011|11331556|FG006|Maintenance Period (36 Weeks)|Adverse Event|1
7159275|NCT03482011|11331557|FG007|Maintenance Period (36 Weeks)|Adverse Event|4
7159276|NCT03482011|11331550|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0
7159277|NCT03482011|11331551|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0
7159278|NCT03482011|11331552|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1
7159279|NCT03482011|11331553|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2
7159280|NCT03482011|11331554|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1
7159281|NCT03482011|11331555|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1
7159282|NCT03482011|11331556|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0
7159283|NCT03482011|11331557|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9
7159284|NCT03482011|11331550|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7159285|NCT03482011|11331551|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7159286|NCT03482011|11331552|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7159287|NCT03482011|11331553|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7159288|NCT03482011|11331554|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2
7159289|NCT03482011|11331555|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7159290|NCT03482011|11331556|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7159291|NCT03482011|11331557|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1
7159292|NCT03482011|11331550|FG000|Maintenance Period (36 Weeks)|Physician Decision|0
7159293|NCT03482011|11331551|FG001|Maintenance Period (36 Weeks)|Physician Decision|0
7159294|NCT03482011|11331552|FG002|Maintenance Period (36 Weeks)|Physician Decision|0
7159295|NCT03482011|11331553|FG003|Maintenance Period (36 Weeks)|Physician Decision|1
7159296|NCT03482011|11331554|FG004|Maintenance Period (36 Weeks)|Physician Decision|0
7159297|NCT03482011|11331555|FG005|Maintenance Period (36 Weeks)|Physician Decision|1
7159298|NCT03482011|11331556|FG006|Maintenance Period (36 Weeks)|Physician Decision|1
7159299|NCT03482011|11331557|FG007|Maintenance Period (36 Weeks)|Physician Decision|1
7159300|NCT03482011|11331550|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7159301|NCT03482011|11331551|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7159302|NCT03482011|11331552|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7159303|NCT03482011|11331553|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1
7159304|NCT03482011|11331554|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
7159305|NCT03482011|11331555|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1
7159306|NCT03482011|11331556|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
7159307|NCT03482011|11331557|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
7159308|NCT03482011|11331550|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
7159309|NCT03482011|11331551|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
7159310|NCT03482011|11331552|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
7159311|NCT03482011|11331553|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2
7159312|NCT03482011|11331554|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
7159313|NCT03482011|11331555|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1
7159314|NCT03482011|11331556|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1
7159315|NCT03482011|11331557|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5
7159316|NCT03482011|11331550|FG000|Follow-up Period (12 Weeks)|Adverse Event|0
7159317|NCT03482011|11331551|FG001|Follow-up Period (12 Weeks)|Adverse Event|0
7159318|NCT03482011|11331552|FG002|Follow-up Period (12 Weeks)|Adverse Event|0
7159319|NCT03482011|11331553|FG003|Follow-up Period (12 Weeks)|Adverse Event|0
7159320|NCT03482011|11331554|FG004|Follow-up Period (12 Weeks)|Adverse Event|0
7159321|NCT03482011|11331555|FG005|Follow-up Period (12 Weeks)|Adverse Event|0
7159322|NCT03482011|11331556|FG006|Follow-up Period (12 Weeks)|Adverse Event|1
7159323|NCT03482011|11331557|FG007|Follow-up Period (12 Weeks)|Adverse Event|4
7159324|NCT03482011|11331550|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0
7159325|NCT03482011|11331551|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0
7159326|NCT03482011|11331552|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1
7159327|NCT03482011|11331553|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3
7159328|NCT03482011|11331554|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0
7159329|NCT03482011|11331555|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0
7159330|NCT03482011|11331556|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0
7159331|NCT03482011|11331557|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6
7159332|NCT03482011|11331550|FG000|Follow-up Period (12 Weeks)|Physician Decision|0
7159333|NCT03482011|11331551|FG001|Follow-up Period (12 Weeks)|Physician Decision|0
7159334|NCT03482011|11331552|FG002|Follow-up Period (12 Weeks)|Physician Decision|0
7159335|NCT03482011|11331553|FG003|Follow-up Period (12 Weeks)|Physician Decision|0
7159336|NCT03482011|11331554|FG004|Follow-up Period (12 Weeks)|Physician Decision|0
7159337|NCT03482011|11331555|FG005|Follow-up Period (12 Weeks)|Physician Decision|0
7159338|NCT03482011|11331556|FG006|Follow-up Period (12 Weeks)|Physician Decision|0
7159339|NCT03482011|11331557|FG007|Follow-up Period (12 Weeks)|Physician Decision|1
7159340|NCT03482011|11331550|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0
7159341|NCT03482011|11331551|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0
7159342|NCT03482011|11331552|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0
7159343|NCT03482011|11331553|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0
7159344|NCT03482011|11331554|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0
7159345|NCT03482011|11331555|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0
7159346|NCT03482011|11331556|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0
7159347|NCT03482011|11331557|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1
7159348|NCT03482453|11331594|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7159349|NCT03482453|11331595|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7159350|NCT03482453|11331596|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7159351|NCT03482453|11331597|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7159352|NCT03482453|11331598|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7159353|NCT03482453|11331599|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7159354|NCT03482453|11331600|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7159355|NCT03482453|11331601|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7159356|NCT03482453|11331602|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7159357|NCT03482453|11331603|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7159358|NCT03482453|11331604|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1
7159359|NCT03482453|11331605|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7159360|NCT03482635|11331659|FG000|Overall Study|Lack of Efficacy|0
7159361|NCT03482635|11331660|FG001|Overall Study|Lack of Efficacy|0
7159362|NCT03482635|11331661|FG002|Overall Study|Lack of Efficacy|1
7159363|NCT03482635|11331662|FG003|Overall Study|Lack of Efficacy|3
7159364|NCT03482635|11331659|FG000|Overall Study|Adverse Event|2
7159365|NCT03482635|11331660|FG001|Overall Study|Adverse Event|2
7159366|NCT03482635|11331661|FG002|Overall Study|Adverse Event|0
7159367|NCT03482635|11331662|FG003|Overall Study|Adverse Event|3
7159368|NCT03482635|11331659|FG000|Overall Study|Withdrawal by Subject|2
7159369|NCT03482635|11331660|FG001|Overall Study|Withdrawal by Subject|1
7159370|NCT03482635|11331661|FG002|Overall Study|Withdrawal by Subject|0
7159371|NCT03482635|11331662|FG003|Overall Study|Withdrawal by Subject|1
7159372|NCT03482635|11331659|FG000|Overall Study|Withdrawn by Principle Investigator|1
7159373|NCT03482635|11331660|FG001|Overall Study|Withdrawn by Principle Investigator|0
7159374|NCT03482635|11331661|FG002|Overall Study|Withdrawn by Principle Investigator|0
7159375|NCT03482635|11331662|FG003|Overall Study|Withdrawn by Principle Investigator|0
7159376|NCT03482635|11331659|FG000|Overall Study|Not treated|0
7159377|NCT03482635|11331660|FG001|Overall Study|Not treated|0
7159378|NCT03482635|11331661|FG002|Overall Study|Not treated|0
7159379|NCT03482635|11331662|FG003|Overall Study|Not treated|1
7159380|NCT03482882|11331681|FG000|Overall Study|Adverse Event|3
7159381|NCT03482882|11331681|FG000|Overall Study|Lost to Follow-up|1
7159382|NCT03482882|11331681|FG000|Overall Study|Protocol Violation|2
7159383|NCT03482882|11331681|FG000|Overall Study|Not further specified|1
7159384|NCT03483623|11331700|FG000|Overall Study|43 complete sets achieved|1
7159385|NCT03483961|11331743|FG000|Overall Study|Lost to Follow-up|7
7159386|NCT03483961|11331744|FG001|Overall Study|Lost to Follow-up|6
7159387|NCT03483961|11331745|FG002|Overall Study|Lost to Follow-up|6
7159388|NCT03483961|11331746|FG003|Overall Study|Lost to Follow-up|6
7159389|NCT03483961|11331747|FG004|Overall Study|Lost to Follow-up|6
7159390|NCT03483961|11331748|FG005|Overall Study|Lost to Follow-up|4
7159391|NCT03483961|11331749|FG006|Overall Study|Lost to Follow-up|4
7159392|NCT03483961|11331750|FG007|Overall Study|Lost to Follow-up|11
7159393|NCT03483961|11331751|FG008|Overall Study|Lost to Follow-up|1
7159394|NCT03483961|11331752|FG009|Overall Study|Lost to Follow-up|0
7159395|NCT03483961|11331743|FG000|Overall Study|Withdrawal by Subject|3
7159396|NCT03483961|11331744|FG001|Overall Study|Withdrawal by Subject|4
7159397|NCT03483961|11331745|FG002|Overall Study|Withdrawal by Subject|5
7159398|NCT03483961|11331746|FG003|Overall Study|Withdrawal by Subject|3
7159399|NCT03483961|11331747|FG004|Overall Study|Withdrawal by Subject|4
7159400|NCT03483961|11331748|FG005|Overall Study|Withdrawal by Subject|2
7159401|NCT03483961|11331749|FG006|Overall Study|Withdrawal by Subject|1
7159402|NCT03483961|11331750|FG007|Overall Study|Withdrawal by Subject|2
7159403|NCT03483961|11331751|FG008|Overall Study|Withdrawal by Subject|1
7159404|NCT03483961|11331752|FG009|Overall Study|Withdrawal by Subject|0
7159405|NCT03483961|11331743|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1
7159406|NCT03483961|11331744|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
7159407|NCT03483961|11331745|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
7159408|NCT03483961|11331746|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
7159409|NCT03483961|11331747|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
7159410|NCT03483961|11331748|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
7159411|NCT03483961|11331749|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
7159412|NCT03483961|11331750|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
7159413|NCT03483961|11331751|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
7159414|NCT03483961|11331752|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
7159415|NCT03483961|11331743|FG000|Overall Study|Adverse Event|0
7159416|NCT03483961|11331744|FG001|Overall Study|Adverse Event|0
7159417|NCT03483961|11331745|FG002|Overall Study|Adverse Event|1
7159418|NCT03483961|11331746|FG003|Overall Study|Adverse Event|0
7159419|NCT03483961|11331747|FG004|Overall Study|Adverse Event|0
7159420|NCT03483961|11331748|FG005|Overall Study|Adverse Event|0
7159421|NCT03483961|11331749|FG006|Overall Study|Adverse Event|0
7159422|NCT03483961|11331750|FG007|Overall Study|Adverse Event|0
7159423|NCT03483961|11331751|FG008|Overall Study|Adverse Event|0
7159424|NCT03483961|11331752|FG009|Overall Study|Adverse Event|0
7159425|NCT03484273|11331773|FG000|Overall Study|Equipment Malfunction|1
7159426|NCT03484273|11331773|FG000|Overall Study|Data excluded from analysis|1
7159427|NCT03484429|11331787|FG000|Overall Study|Withdrawal by Subject|1
7159428|NCT03484429|11331788|FG001|Overall Study|Withdrawal by Subject|0
7159429|NCT03484429|11331787|FG000|Overall Study|Adverse Event|2
7159430|NCT03484429|11331788|FG001|Overall Study|Adverse Event|0
7159431|NCT03485222|11331796|FG000|Overall Study|Death|0
7159432|NCT03485222|11331797|FG001|Overall Study|Death|1
7159433|NCT03485222|11331796|FG000|Overall Study|Lost to Follow-up|2
7159434|NCT03485222|11331797|FG001|Overall Study|Lost to Follow-up|1
7159435|NCT03485495|11331805|FG000|Overall Study|Non-compliance with inclusion criteria|1
7159436|NCT03485495|11331806|FG001|Overall Study|Non-compliance with inclusion criteria|0
7159437|NCT03486392|11331821|FG000|Overall Study|Lost to Follow-up|0
7159438|NCT03486392|11331822|FG001|Overall Study|Lost to Follow-up|0
7159439|NCT03486392|11331823|FG002|Overall Study|Lost to Follow-up|8
7159440|NCT03486392|11331824|FG003|Overall Study|Lost to Follow-up|5
7159441|NCT03486392|11331825|FG004|Overall Study|Lost to Follow-up|2
7159442|NCT03486392|11331821|FG000|Overall Study|Withdrawal by Subject|3
7159443|NCT03486392|11331822|FG001|Overall Study|Withdrawal by Subject|0
7159444|NCT03486392|11331823|FG002|Overall Study|Withdrawal by Subject|6
7159445|NCT03486392|11331824|FG003|Overall Study|Withdrawal by Subject|4
7159446|NCT03486392|11331825|FG004|Overall Study|Withdrawal by Subject|1
7159447|NCT03486392|11331821|FG000|Overall Study|Death|0
7159448|NCT03486392|11331822|FG001|Overall Study|Death|0
7159449|NCT03486392|11331823|FG002|Overall Study|Death|0
7159450|NCT03486392|11331824|FG003|Overall Study|Death|0
7159451|NCT03486392|11331825|FG004|Overall Study|Death|1
7159452|NCT03486834|11331840|FG000|Overall Study|Withdrawal by Subject|46
7159453|NCT03486834|11331841|FG001|Overall Study|Withdrawal by Subject|46
7159454|NCT03486834|11331842|FG002|Overall Study|Withdrawal by Subject|52
7159455|NCT03486834|11331840|FG000|Overall Study|Adverse Event|8
7159456|NCT03486834|11331841|FG001|Overall Study|Adverse Event|7
7159457|NCT03486834|11331842|FG002|Overall Study|Adverse Event|0
7159458|NCT03486834|11331840|FG000|Overall Study|Lost to Follow-up|41
7159459|NCT03486834|11331841|FG001|Overall Study|Lost to Follow-up|24
7159460|NCT03486834|11331842|FG002|Overall Study|Lost to Follow-up|39
7159461|NCT03486834|11331840|FG000|Overall Study|Non-compliance with Study Drug|2
7159462|NCT03486834|11331841|FG001|Overall Study|Non-compliance with Study Drug|2
7159463|NCT03486834|11331842|FG002|Overall Study|Non-compliance with Study Drug|0
7159464|NCT03486834|11331840|FG000|Overall Study|Physician Decision|5
7159465|NCT03486834|11331841|FG001|Overall Study|Physician Decision|2
7159466|NCT03486834|11331842|FG002|Overall Study|Physician Decision|3
7159467|NCT03486834|11331840|FG000|Overall Study|Pregnancy|10
7159468|NCT03486834|11331841|FG001|Overall Study|Pregnancy|12
7159469|NCT03486834|11331842|FG002|Overall Study|Pregnancy|12
7159470|NCT03486834|11331840|FG000|Overall Study|Protocol Deviation|2
7159471|NCT03486834|11331841|FG001|Overall Study|Protocol Deviation|3
7159472|NCT03486834|11331842|FG002|Overall Study|Protocol Deviation|3
7159473|NCT03486834|11331840|FG000|Overall Study|Withdrawal by Parent/Guardian|1
7159474|NCT03486834|11331841|FG001|Overall Study|Withdrawal by Parent/Guardian|2
7159475|NCT03486834|11331842|FG002|Overall Study|Withdrawal by Parent/Guardian|2
7159476|NCT03486834|11331840|FG000|Overall Study|Randomized but not treated|4
7159477|NCT03486834|11331841|FG001|Overall Study|Randomized but not treated|4
7159478|NCT03486834|11331842|FG002|Overall Study|Randomized but not treated|1
7159479|NCT03487445|11331937|FG000|Randomization|Not treated for administrative reasons|1
7159480|NCT03487445|11331938|FG001|Randomization|Not treated for administrative reasons|0
7159481|NCT03487549|11331946|FG000|Overall Study|Protocol Violation|0
7159482|NCT03487549|11331947|FG001|Overall Study|Protocol Violation|1
7159483|NCT03487549|11331946|FG000|Overall Study|Lost to Follow-up|2
7159484|NCT03487549|11331947|FG001|Overall Study|Lost to Follow-up|1
7159485|NCT03487549|11331946|FG000|Overall Study|Withdrawal by Subject|2
7159486|NCT03487549|11331947|FG001|Overall Study|Withdrawal by Subject|0
7159487|NCT03487848|11331966|FG000|Overall Study|Lost to Follow-up|1
7159488|NCT03488108|11331972|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0
7159489|NCT03488108|11331973|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1
7159490|NCT03488108|11331972|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1
7159491|NCT03488108|11331973|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0
7159492|NCT03488225|11331981|FG000|Overall Study|Off Protocol Therapy|2
7159493|NCT03488225|11331981|FG000|Overall Study|Stem Cell Transplant|2
7159494|NCT03488238|11331985|FG000|Overall Study|Equipment malfunction|1
7159495|NCT03488238|11331985|FG000|Overall Study|Adverse Event|1
7159496|NCT03488927|11332005|FG000|Overall Study|Withdrawal by Subject|44
7159497|NCT03488927|11332006|FG001|Overall Study|Withdrawal by Subject|118
7159498|NCT03488927|11332007|FG002|Overall Study|Withdrawal by Subject|217
7079739|NCT02117349|11189008|FG000|Overall Study|Lost to Follow-up|1
7079740|NCT02117349|11189009|FG001|Overall Study|Lost to Follow-up|1
7079741|NCT02117349|11189008|FG000|Overall Study|Death|1
7079742|NCT02117349|11189009|FG001|Overall Study|Death|0
7079743|NCT02117414|11189017|FG000|Overall Study|Death|5
7079744|NCT02117414|11189018|FG001|Overall Study|Death|2
7079745|NCT02117414|11189017|FG000|Overall Study|Withdrawal by Subject|10
7079746|NCT02117414|11189018|FG001|Overall Study|Withdrawal by Subject|4
7079747|NCT02117427|11189029|FG000|Overall Study|Permanent need for exogenous EPO Tx|2
7159499|NCT03489304|11332015|FG000|Overall Study|Lost to Follow-up|4
7159500|NCT03489343|11332026|FG000|Overall Study|Documented progressive disease|1
7159501|NCT03489343|11332027|FG001|Overall Study|Documented progressive disease|0
7159502|NCT03489343|11332028|FG002|Overall Study|Documented progressive disease|3
7159503|NCT03489343|11332029|FG003|Overall Study|Documented progressive disease|1
7159504|NCT03489343|11332030|FG004|Overall Study|Documented progressive disease|3
7159505|NCT03489343|11332031|FG005|Overall Study|Documented progressive disease|5
7159506|NCT03489343|11332032|FG006|Overall Study|Documented progressive disease|4
7159507|NCT03489343|11332026|FG000|Overall Study|Adverse Event|0
7159508|NCT03489343|11332027|FG001|Overall Study|Adverse Event|1
7159509|NCT03489343|11332028|FG002|Overall Study|Adverse Event|0
7159510|NCT03489343|11332029|FG003|Overall Study|Adverse Event|0
7159511|NCT03489343|11332030|FG004|Overall Study|Adverse Event|0
7159512|NCT03489343|11332031|FG005|Overall Study|Adverse Event|1
7159513|NCT03489343|11332032|FG006|Overall Study|Adverse Event|0
7159514|NCT03489343|11332026|FG000|Overall Study|Withdrawal by Subject|0
7159515|NCT03489343|11332027|FG001|Overall Study|Withdrawal by Subject|0
7159516|NCT03489343|11332028|FG002|Overall Study|Withdrawal by Subject|0
7159517|NCT03489343|11332029|FG003|Overall Study|Withdrawal by Subject|1
7159518|NCT03489343|11332030|FG004|Overall Study|Withdrawal by Subject|0
7159519|NCT03489343|11332031|FG005|Overall Study|Withdrawal by Subject|1
7159520|NCT03489343|11332032|FG006|Overall Study|Withdrawal by Subject|1
7159521|NCT03489343|11332026|FG000|Overall Study|Clinical progression|0
7159522|NCT03489343|11332027|FG001|Overall Study|Clinical progression|0
7159523|NCT03489343|11332028|FG002|Overall Study|Clinical progression|0
7159524|NCT03489343|11332029|FG003|Overall Study|Clinical progression|1
7159525|NCT03489343|11332030|FG004|Overall Study|Clinical progression|0
7159526|NCT03489343|11332031|FG005|Overall Study|Clinical progression|0
7159527|NCT03489343|11332032|FG006|Overall Study|Clinical progression|1
7159528|NCT03489369|11332052|FG000|Overall Study|Documented Progressive Disease|3
7159529|NCT03489369|11332053|FG001|Overall Study|Documented Progressive Disease|2
7079748|NCT02117427|11189030|FG001|Overall Study|Permanent need for exogenous EPO Tx|0
7079749|NCT02117427|11189031|FG002|Overall Study|Permanent need for exogenous EPO Tx|0
7079750|NCT02117427|11189029|FG000|Overall Study|Permanent need for exogenous ESA Tx|3
7159530|NCT03489369|11332054|FG002|Overall Study|Documented Progressive Disease|3
7159531|NCT03489369|11332055|FG003|Overall Study|Documented Progressive Disease|6
7159532|NCT03489369|11332052|FG000|Overall Study|Clinical Progression (Worsening of Clini|0
7159533|NCT03489369|11332053|FG001|Overall Study|Clinical Progression (Worsening of Clini|1
7159534|NCT03489369|11332054|FG002|Overall Study|Clinical Progression (Worsening of Clini|0
7159535|NCT03489369|11332055|FG003|Overall Study|Clinical Progression (Worsening of Clini|0
7159536|NCT03489551|11332065|FG000|Overall Study|Withdrawal by Subject|2
7159537|NCT03489720|11332071|FG000|Overall Study|Withdrawal by Subject|2
7159538|NCT03489720|11332072|FG001|Overall Study|Withdrawal by Subject|0
7159539|NCT03489863|11332093|FG000|Overall Study|Withdrawal by Subject|0
7159540|NCT03489863|11332094|FG001|Overall Study|Withdrawal by Subject|1
7159541|NCT03490032|11332111|FG000|Overall Study|family issue (child custody)|1
7159542|NCT03490032|11332112|FG001|Overall Study|family issue (child custody)|0
7159543|NCT03490032|11332113|FG002|Overall Study|family issue (child custody)|0
7159544|NCT03490981|11332146|FG000|Overall Study|Lost to Follow-up|1
7159545|NCT03490981|11332147|FG001|Overall Study|Lost to Follow-up|2
7159546|NCT03491150|11332155|FG000|Overall Study|Adverse Event|1
7159547|NCT03491150|11332156|FG001|Overall Study|Adverse Event|0
7159548|NCT03491150|11332155|FG000|Overall Study|Study Terminated by Sponsor|74
7159549|NCT03491150|11332156|FG001|Overall Study|Study Terminated by Sponsor|70
7159550|NCT03491150|11332155|FG000|Overall Study|Other|0
7159551|NCT03491150|11332156|FG001|Overall Study|Other|1
7159552|NCT03491150|11332155|FG000|Overall Study|Withdrawal by Subject|1
7159553|NCT03491150|11332156|FG001|Overall Study|Withdrawal by Subject|2
7159554|NCT03491553|11332172|FG000|Main Study (Up to Week 48)|Adverse Event|0
7159555|NCT03491553|11332173|FG001|Main Study (Up to Week 48)|Adverse Event|0
7159556|NCT03491553|11332174|FG002|Main Study (Up to Week 48)|Adverse Event|0
7159557|NCT03491553|11332175|FG003|Main Study (Up to Week 48)|Adverse Event|1
7159558|NCT03491553|11332176|FG004|Main Study (Up to Week 48)|Adverse Event|0
7159559|NCT03491553|11332177|FG005|Main Study (Up to Week 48)|Adverse Event|0
7159560|NCT03491553|11332172|FG000|Main Study (Up to Week 48)|Withdrew Consent|1
7159561|NCT03491553|11332173|FG001|Main Study (Up to Week 48)|Withdrew Consent|1
7159562|NCT03491553|11332174|FG002|Main Study (Up to Week 48)|Withdrew Consent|0
7159563|NCT03491553|11332175|FG003|Main Study (Up to Week 48)|Withdrew Consent|0
7159564|NCT03491553|11332176|FG004|Main Study (Up to Week 48)|Withdrew Consent|0
7159565|NCT03491553|11332177|FG005|Main Study (Up to Week 48)|Withdrew Consent|0
7159566|NCT03492281|11332226|FG000|Overall Study|Withdrawal by Subject|21
7159567|NCT03492281|11332227|FG001|Overall Study|Withdrawal by Subject|14
7159568|NCT03492281|11332228|FG002|Overall Study|Withdrawal by Subject|13
7159569|NCT03492281|11332226|FG000|Overall Study|Lost to Follow-up|14
7159570|NCT03492281|11332227|FG001|Overall Study|Lost to Follow-up|15
7159571|NCT03492281|11332228|FG002|Overall Study|Lost to Follow-up|10
7159572|NCT03492281|11332226|FG000|Overall Study|Adverse Event|6
7159573|NCT03492281|11332227|FG001|Overall Study|Adverse Event|8
7159574|NCT03492281|11332228|FG002|Overall Study|Adverse Event|13
7159575|NCT03492281|11332226|FG000|Overall Study|Lack of Efficacy|3
7159576|NCT03492281|11332227|FG001|Overall Study|Lack of Efficacy|0
7159577|NCT03492281|11332228|FG002|Overall Study|Lack of Efficacy|1
7159578|NCT03492281|11332226|FG000|Overall Study|Physician Decision|1
7159579|NCT03492281|11332227|FG001|Overall Study|Physician Decision|0
7159580|NCT03492281|11332228|FG002|Overall Study|Physician Decision|3
7159581|NCT03492281|11332226|FG000|Overall Study|Protocol Violation|0
7159582|NCT03492281|11332227|FG001|Overall Study|Protocol Violation|2
7159583|NCT03492281|11332228|FG002|Overall Study|Protocol Violation|1
7159584|NCT03492281|11332226|FG000|Overall Study|Withdrawn Due to Sponsor|1
7159585|NCT03492281|11332227|FG001|Overall Study|Withdrawn Due to Sponsor|0
7159586|NCT03492281|11332228|FG002|Overall Study|Withdrawn Due to Sponsor|1
7159587|NCT03492281|11332226|FG000|Overall Study|Death|0
7159588|NCT03492281|11332227|FG001|Overall Study|Death|0
7159589|NCT03492281|11332228|FG002|Overall Study|Death|1
7159590|NCT03492281|11332226|FG000|Overall Study|Captured as Other in Database|8
7159591|NCT03492281|11332227|FG001|Overall Study|Captured as Other in Database|6
7159592|NCT03492281|11332228|FG002|Overall Study|Captured as Other in Database|3
7159593|NCT03492554|11332278|FG000|Overall Study|Protocol Violation|0
7159594|NCT03492554|11332279|FG001|Overall Study|Protocol Violation|14
7159595|NCT03493386|11332288|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7159596|NCT03493386|11332289|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1
7159597|NCT03493386|11332290|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7159598|NCT03493386|11332291|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7159599|NCT03493542|11332310|FG000|Overall Study|Ongoing|2
7159600|NCT03493542|11332311|FG001|Overall Study|Ongoing|3
7159601|NCT03493542|11332310|FG000|Overall Study|Withdrawal by parent or guardian|3
7159602|NCT03493542|11332311|FG001|Overall Study|Withdrawal by parent or guardian|0
7159603|NCT03493542|11332310|FG000|Overall Study|Withdrawal by Subject|2
7159604|NCT03493542|11332311|FG001|Overall Study|Withdrawal by Subject|6
7159605|NCT03493698|11332321|FG000|Treatment Period C|Adverse Event|1
7159606|NCT03493698|11332321|FG000|Treatment Period C|Withdrawal by Subject|1
7159607|NCT03494725|11332359|FG000|Overall Study|Withdrawal by Subject|0
7159608|NCT03494725|11332360|FG001|Overall Study|Withdrawal by Subject|2
7159609|NCT03494725|11332359|FG000|Overall Study|Antibiotic use|1
7159610|NCT03494725|11332360|FG001|Overall Study|Antibiotic use|0
7159611|NCT03494816|11332372|FG000|Overall Study|Protocol Violation|2
7159612|NCT03494816|11332372|FG000|Overall Study|Physician Decision|2
7159613|NCT03494816|11332372|FG000|Overall Study|Did not start trial treatment|1
7159614|NCT03494816|11332372|FG000|Overall Study|Adverse Event|1
7159615|NCT03494985|11332384|FG000|Overall Study|Adverse Event|3
7159616|NCT03494985|11332385|FG001|Overall Study|Adverse Event|2
7079751|NCT02117427|11189030|FG001|Overall Study|Permanent need for exogenous ESA Tx|1
7079752|NCT02117427|11189031|FG002|Overall Study|Permanent need for exogenous ESA Tx|0
7079753|NCT02117427|11189029|FG000|Overall Study|Physician Decision|0
7079754|NCT02117427|11189030|FG001|Overall Study|Physician Decision|2
7079755|NCT02117427|11189031|FG002|Overall Study|Physician Decision|0
7079756|NCT02117427|11189029|FG000|Overall Study|No longer meets inclusion criteria|0
7079757|NCT02117427|11189030|FG001|Overall Study|No longer meets inclusion criteria|1
7079758|NCT02117427|11189031|FG002|Overall Study|No longer meets inclusion criteria|0
7079759|NCT02117427|11189029|FG000|Overall Study|Death|0
7079760|NCT02117427|11189030|FG001|Overall Study|Death|1
7079761|NCT02117427|11189031|FG002|Overall Study|Death|0
7079762|NCT02117479|11189039|FG000|Overall Study|Death|13
7079763|NCT02117479|11189040|FG001|Overall Study|Death|8
7079764|NCT02117479|11189039|FG000|Overall Study|Adverse Event|8
7079765|NCT02117479|11189040|FG001|Overall Study|Adverse Event|16
7079766|NCT02117479|11189039|FG000|Overall Study|Subject decision|8
7079767|NCT02117479|11189040|FG001|Overall Study|Subject decision|9
7079768|NCT02117479|11189039|FG000|Overall Study|Disease progression|104
7079769|NCT02117479|11189040|FG001|Overall Study|Disease progression|108
7079770|NCT02117479|11189039|FG000|Overall Study|Noncompliance with study treatment|1
7079771|NCT02117479|11189040|FG001|Overall Study|Noncompliance with study treatment|0
7159617|NCT03494985|11332386|FG002|Overall Study|Adverse Event|3
7159618|NCT03494985|11332387|FG003|Overall Study|Adverse Event|0
7159619|NCT03494985|11332384|FG000|Overall Study|Other (Withdrawal of consent)|2
7159620|NCT03494985|11332385|FG001|Overall Study|Other (Withdrawal of consent)|3
7159621|NCT03494985|11332386|FG002|Overall Study|Other (Withdrawal of consent)|2
7159622|NCT03494985|11332387|FG003|Overall Study|Other (Withdrawal of consent)|5
7159623|NCT03494985|11332384|FG000|Overall Study|Other (Not specified)|0
7159624|NCT03494985|11332385|FG001|Overall Study|Other (Not specified)|1
7159625|NCT03494985|11332386|FG002|Overall Study|Other (Not specified)|1
7159626|NCT03494985|11332387|FG003|Overall Study|Other (Not specified)|0
7159627|NCT03495102|11332400|FG000|Overall Study|Adverse Event|5
7159628|NCT03495102|11332401|FG001|Overall Study|Adverse Event|7
7159629|NCT03495102|11332402|FG002|Overall Study|Adverse Event|10
7159630|NCT03495102|11332400|FG000|Overall Study|Death|3
7159631|NCT03495102|11332401|FG001|Overall Study|Death|4
7159632|NCT03495102|11332402|FG002|Overall Study|Death|4
7159633|NCT03495102|11332400|FG000|Overall Study|Lost to Follow-up|15
7159634|NCT03495102|11332401|FG001|Overall Study|Lost to Follow-up|16
7159635|NCT03495102|11332402|FG002|Overall Study|Lost to Follow-up|17
7159636|NCT03495102|11332400|FG000|Overall Study|Physician Decision|2
7159637|NCT03495102|11332401|FG001|Overall Study|Physician Decision|0
7159638|NCT03495102|11332402|FG002|Overall Study|Physician Decision|2
7159639|NCT03495102|11332400|FG000|Overall Study|Withdrawal by Subject|25
7159640|NCT03495102|11332401|FG001|Overall Study|Withdrawal by Subject|36
7159641|NCT03495102|11332402|FG002|Overall Study|Withdrawal by Subject|18
7159642|NCT03495102|11332400|FG000|Overall Study|Protocol Violation|1
7159643|NCT03495102|11332401|FG001|Overall Study|Protocol Violation|1
7159644|NCT03495102|11332402|FG002|Overall Study|Protocol Violation|0
7159645|NCT03495102|11332400|FG000|Overall Study|Site Closure|3
7159646|NCT03495102|11332401|FG001|Overall Study|Site Closure|1
7159647|NCT03495102|11332402|FG002|Overall Study|Site Closure|2
7159648|NCT03495102|11332400|FG000|Overall Study|Non-compliance|1
7159649|NCT03495102|11332401|FG001|Overall Study|Non-compliance|0
7159650|NCT03495102|11332402|FG002|Overall Study|Non-compliance|0
7159651|NCT03495102|11332400|FG000|Overall Study|Participant Duplicated at Another Site|0
7159652|NCT03495102|11332401|FG001|Overall Study|Participant Duplicated at Another Site|0
7159653|NCT03495102|11332402|FG002|Overall Study|Participant Duplicated at Another Site|1
7159654|NCT03495102|11332400|FG000|Overall Study|Primary Care Physician Recommendation|0
7159655|NCT03495102|11332401|FG001|Overall Study|Primary Care Physician Recommendation|1
7159656|NCT03495102|11332402|FG002|Overall Study|Primary Care Physician Recommendation|0
7159657|NCT03495102|11332400|FG000|Overall Study|Relocated to Another Country|0
7159658|NCT03495102|11332401|FG001|Overall Study|Relocated to Another Country|1
7159659|NCT03495102|11332402|FG002|Overall Study|Relocated to Another Country|0
7079772|NCT02117479|11189039|FG000|Overall Study|Study terminated by the sponsor|4
7079773|NCT02117479|11189040|FG001|Overall Study|Study terminated by the sponsor|6
7079774|NCT02117479|11189039|FG000|Overall Study|Physician Decision|7
7079775|NCT02117479|11189040|FG001|Overall Study|Physician Decision|2
7079776|NCT02117479|11189039|FG000|Overall Study|Other unspecified|11
7079777|NCT02117479|11189040|FG001|Overall Study|Other unspecified|7
7159660|NCT03495102|11332400|FG000|Overall Study|Participant was in Rehabilitation|1
7159661|NCT03495102|11332401|FG001|Overall Study|Participant was in Rehabilitation|0
7079778|NCT02117544|11189046|FG000|Period 1|Lost to follow-up (prior to treatment)|2
7159662|NCT03495102|11332402|FG002|Overall Study|Participant was in Rehabilitation|0
7159663|NCT03495817|11332419|FG000|26 Week Open Label|Adverse Event|3
7159664|NCT03495817|11332419|FG000|26 Week Open Label|Withdrawal by Subject|4
7159665|NCT03495817|11332419|FG000|26 Week Open Label|Lost to Follow-up|1
7159666|NCT03495817|11332419|FG000|26 Week Extension|Lost to Follow-up|2
7159667|NCT03495869|11332431|FG000|Overall Study|Lost to Follow-up|4
7159668|NCT03495869|11332432|FG001|Overall Study|Lost to Follow-up|17
7159669|NCT03495869|11332433|FG002|Overall Study|Lost to Follow-up|8
7159670|NCT03495869|11332434|FG003|Overall Study|Lost to Follow-up|14
7159671|NCT03495869|11332431|FG000|Overall Study|Withdrawal by Subject|0
7159672|NCT03495869|11332432|FG001|Overall Study|Withdrawal by Subject|3
7159673|NCT03495869|11332433|FG002|Overall Study|Withdrawal by Subject|0
7159674|NCT03495869|11332434|FG003|Overall Study|Withdrawal by Subject|3
7159675|NCT03495869|11332431|FG000|Overall Study|Dropped from study|0
7159676|NCT03495869|11332432|FG001|Overall Study|Dropped from study|7
7159677|NCT03495869|11332433|FG002|Overall Study|Dropped from study|2
7159678|NCT03495869|11332434|FG003|Overall Study|Dropped from study|4
7159679|NCT03495908|11332446|FG000|Overall Study|Withdrawal by Subject|3
7159680|NCT03495908|11332447|FG001|Overall Study|Withdrawal by Subject|1
7159681|NCT03495908|11332446|FG000|Overall Study|Lost to Follow-up|1
7159682|NCT03495908|11332447|FG001|Overall Study|Lost to Follow-up|4
7159683|NCT03495908|11332446|FG000|Overall Study|Adverse Event|0
7159684|NCT03495908|11332447|FG001|Overall Study|Adverse Event|2
7159685|NCT03495908|11332446|FG000|Overall Study|Death|1
7159686|NCT03495908|11332447|FG001|Overall Study|Death|0
7159687|NCT03495908|11332446|FG000|Overall Study|Physician Decision|5
7159688|NCT03495908|11332447|FG001|Overall Study|Physician Decision|4
7159689|NCT03495908|11332446|FG000|Overall Study|No documented reason|0
7159690|NCT03495908|11332447|FG001|Overall Study|No documented reason|2
7159691|NCT03496298|11332466|FG000|Overall Study|Adverse Event|49
7159692|NCT03496298|11332467|FG001|Overall Study|Adverse Event|68
7159693|NCT03496298|11332468|FG002|Overall Study|Adverse Event|79
7159694|NCT03496298|11332466|FG000|Overall Study|Study terminated by Sponsor|1050
7159695|NCT03496298|11332467|FG001|Overall Study|Study terminated by Sponsor|1063
7159696|NCT03496298|11332468|FG002|Overall Study|Study terminated by Sponsor|1071
7159697|NCT03496298|11332466|FG000|Overall Study|Physician decision (other than Adverse event)|12
7159698|NCT03496298|11332467|FG001|Overall Study|Physician decision (other than Adverse event)|17
7159699|NCT03496298|11332468|FG002|Overall Study|Physician decision (other than Adverse event)|10
7159700|NCT03496298|11332466|FG000|Overall Study|Withdrawal by Subject|176
7159701|NCT03496298|11332467|FG001|Overall Study|Withdrawal by Subject|154
7159702|NCT03496298|11332468|FG002|Overall Study|Withdrawal by Subject|151
7159703|NCT03496298|11332466|FG000|Overall Study|Other|29
7159704|NCT03496298|11332467|FG001|Overall Study|Other|20
7159705|NCT03496298|11332468|FG002|Overall Study|Other|23
7159706|NCT03496298|11332466|FG000|Overall Study|Randomized and not treated|1
7159707|NCT03496298|11332467|FG001|Overall Study|Randomized and not treated|1
7159708|NCT03496298|11332468|FG002|Overall Study|Randomized and not treated|1
7159709|NCT03497039|11332540|FG000|Overall Study|Withdrawal by Subject|1
7159710|NCT03497039|11332541|FG001|Overall Study|Withdrawal by Subject|0
7159711|NCT03497039|11332540|FG000|Overall Study|Protocol Violation|0
7159712|NCT03497039|11332541|FG001|Overall Study|Protocol Violation|1
7159713|NCT03497130|11332549|FG000|Overall Study|Lost to Follow-up|1
7159714|NCT03497130|11332550|FG001|Overall Study|Lost to Follow-up|1
7159715|NCT03497429|11332558|FG000|Overall Study|Progressive disease|3
7159716|NCT03497429|11332559|FG001|Overall Study|Progressive disease|4
7159717|NCT03497429|11332558|FG000|Overall Study|Adverse Event|0
7159718|NCT03497429|11332559|FG001|Overall Study|Adverse Event|2
7184262|NCT01901432|11384310|FG001|Overall Study|Adverse Event|1
7184263|NCT01901432|11384311|FG002|Overall Study|Adverse Event|1
7184264|NCT01901432|11384312|FG003|Overall Study|Adverse Event|0
7184265|NCT01901432|11384313|FG004|Overall Study|Adverse Event|1
7184266|NCT01901432|11384309|FG000|Overall Study|Withdrawal by Subject|0
7184267|NCT01901432|11384310|FG001|Overall Study|Withdrawal by Subject|0
7184268|NCT01901432|11384311|FG002|Overall Study|Withdrawal by Subject|1
7184269|NCT01901432|11384312|FG003|Overall Study|Withdrawal by Subject|0
7184270|NCT01901432|11384313|FG004|Overall Study|Withdrawal by Subject|5
7184271|NCT01901432|11384309|FG000|Overall Study|Physician Decision|0
7184272|NCT01901432|11384310|FG001|Overall Study|Physician Decision|0
7184273|NCT01901432|11384311|FG002|Overall Study|Physician Decision|0
7184274|NCT01901432|11384312|FG003|Overall Study|Physician Decision|0
7184275|NCT01901432|11384313|FG004|Overall Study|Physician Decision|2
7184276|NCT01901432|11384309|FG000|Overall Study|Patient decision to stop study drug|0
7184277|NCT01901432|11384310|FG001|Overall Study|Patient decision to stop study drug|0
7184278|NCT01901432|11384311|FG002|Overall Study|Patient decision to stop study drug|0
7184279|NCT01901432|11384312|FG003|Overall Study|Patient decision to stop study drug|0
7184280|NCT01901432|11384313|FG004|Overall Study|Patient decision to stop study drug|1
7187464|NCT02036970|11388052|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0
7187465|NCT02036970|11388053|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0
7187466|NCT02036970|11388054|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0
7187467|NCT02036970|11388055|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0
7187468|NCT02036970|11388056|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3
7187469|NCT02036970|11388057|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0
7187470|NCT02036970|11388048|FG000|Part 2: Week 16 Onwards|Progressive Disease|0
7187471|NCT02036970|11388049|FG001|Part 2: Week 16 Onwards|Progressive Disease|2
7187472|NCT02036970|11388050|FG002|Part 2: Week 16 Onwards|Progressive Disease|1
7187473|NCT02036970|11388051|FG003|Part 2: Week 16 Onwards|Progressive Disease|1
7159719|NCT03498287|11332630|FG000|Overall Study|Withdrawal by Subject|3
7159720|NCT03498287|11332631|FG001|Overall Study|Withdrawal by Subject|0
7159721|NCT03498287|11332630|FG000|Overall Study|Protocol Violation|0
7159722|NCT03498287|11332631|FG001|Overall Study|Protocol Violation|4
7159723|NCT03498287|11332630|FG000|Overall Study|Adverse Event|0
7159724|NCT03498287|11332631|FG001|Overall Study|Adverse Event|1
7159725|NCT03499028|11332649|FG000|Overall Study|Lost to Follow-up|12
7159726|NCT03499028|11332650|FG001|Overall Study|Lost to Follow-up|9
7159727|NCT03499028|11332649|FG000|Overall Study|Withdrawal by Subject|5
7159728|NCT03499028|11332650|FG001|Overall Study|Withdrawal by Subject|8
7159729|NCT03499028|11332649|FG000|Overall Study|Unplanned SNF discharge|5
7159730|NCT03499028|11332650|FG001|Overall Study|Unplanned SNF discharge|8
7159731|NCT03499067|11332658|FG000|First Intervention|Physician Decision|2
7159732|NCT03499067|11332659|FG001|First Intervention|Physician Decision|1
7159733|NCT03499067|11332658|FG000|First Intervention|Withdrawal by Subject|3
7159734|NCT03499067|11332659|FG001|First Intervention|Withdrawal by Subject|6
7159735|NCT03499353|11332665|FG000|Treatment|Adverse Event|3
7159736|NCT03499353|11332665|FG000|Treatment|Progressive Disease|10
7159737|NCT03499353|11332665|FG000|Treatment|Other|1
7159738|NCT03499353|11332665|FG000|Treatment|Withdrawal by Subject|2
7159739|NCT03499353|11332665|FG000|Long-Term Follow-up|Death|2
7159740|NCT03499353|11332665|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55
7159741|NCT03499353|11332665|FG000|Long-Term Follow-up|Withdrawal by Subject|1
7159742|NCT03499873|11332672|FG000|Overall Study|Withdrawal by Subject|4
7159743|NCT03499873|11332673|FG001|Overall Study|Withdrawal by Subject|6
7159744|NCT03499873|11332674|FG002|Overall Study|Withdrawal by Subject|1
7159745|NCT03499873|11332672|FG000|Overall Study|Subjects condition worsened|0
7159746|NCT03499873|11332673|FG001|Overall Study|Subjects condition worsened|3
7159747|NCT03499873|11332674|FG002|Overall Study|Subjects condition worsened|11
7159748|NCT03499873|11332672|FG000|Overall Study|Adverse Event|8
7159749|NCT03499873|11332673|FG001|Overall Study|Adverse Event|3
7159750|NCT03499873|11332674|FG002|Overall Study|Adverse Event|6
7159751|NCT03499873|11332672|FG000|Overall Study|Physician Decision|1
7159752|NCT03499873|11332673|FG001|Overall Study|Physician Decision|0
7159753|NCT03499873|11332674|FG002|Overall Study|Physician Decision|0
7159754|NCT03499873|11332672|FG000|Overall Study|Administrative reasons|0
7159755|NCT03499873|11332673|FG001|Overall Study|Administrative reasons|1
7159756|NCT03499873|11332674|FG002|Overall Study|Administrative reasons|0
7159757|NCT03499873|11332672|FG000|Overall Study|Concomitant therapy|5
7159758|NCT03499873|11332673|FG001|Overall Study|Concomitant therapy|4
7159759|NCT03499873|11332674|FG002|Overall Study|Concomitant therapy|7
7159760|NCT03499873|11332672|FG000|Overall Study|Miscellaneous|1
7159761|NCT03499873|11332673|FG001|Overall Study|Miscellaneous|2
7159762|NCT03499873|11332674|FG002|Overall Study|Miscellaneous|2
7159763|NCT03499873|11332672|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1
7159764|NCT03499873|11332673|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1
7159765|NCT03499873|11332674|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0
7159766|NCT03500094|11332682|FG000|Overall Study|Withdrawal by Subject|1
7159767|NCT03500094|11332682|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1
7159768|NCT03500094|11332682|FG000|Overall Study|Lost to Follow-up|1
7159769|NCT03500198|11332690|FG000|Overall Study|Lost to Follow-up|0
7159770|NCT03500198|11332691|FG001|Overall Study|Lost to Follow-up|1
7159771|NCT03500211|11332701|FG000|Overall Study|Withdrawal by Subject|1
7159772|NCT03500211|11332702|FG001|Overall Study|Withdrawal by Subject|1
7159773|NCT03500224|11332708|FG000|Overall Study|Withdrawal by Subject|2
7159774|NCT03500419|11332727|FG000|Overall Study|Withdrawal by Subject|2
7159775|NCT03500419|11332728|FG001|Overall Study|Withdrawal by Subject|25
7159776|NCT03500679|11332736|FG000|Overall Study|Lost to Follow-up|6
7159777|NCT03500679|11332737|FG001|Overall Study|Lost to Follow-up|3
7159778|NCT03500679|11332736|FG000|Overall Study|Withdrawal by Subject|3
7159779|NCT03500679|11332737|FG001|Overall Study|Withdrawal by Subject|0
7159780|NCT03501277|11332816|FG000|Intervention Period 1 (4 Days)|Other|0
7159781|NCT03501277|11332817|FG001|Intervention Period 1 (4 Days)|Other|0
7159782|NCT03501277|11332818|FG002|Intervention Period 1 (4 Days)|Other|1
7159783|NCT03501277|11332819|FG003|Intervention Period 1 (4 Days)|Other|0
7159784|NCT03501277|11332816|FG000|Intervention Period 1 (4 Days)|Adverse Event|0
7159785|NCT03501277|11332817|FG001|Intervention Period 1 (4 Days)|Adverse Event|0
7159786|NCT03501277|11332818|FG002|Intervention Period 1 (4 Days)|Adverse Event|0
7159787|NCT03501277|11332819|FG003|Intervention Period 1 (4 Days)|Adverse Event|1
7159788|NCT03501277|11332816|FG000|Intervention Period 2 (4 Days)|Adverse Event|0
7159789|NCT03501277|11332817|FG001|Intervention Period 2 (4 Days)|Adverse Event|0
7159790|NCT03501277|11332818|FG002|Intervention Period 2 (4 Days)|Adverse Event|0
7159791|NCT03501277|11332819|FG003|Intervention Period 2 (4 Days)|Adverse Event|1
7159792|NCT03501277|11332816|FG000|Intervention Period 3 (4 Days)|Adverse Event|0
7159793|NCT03501277|11332817|FG001|Intervention Period 3 (4 Days)|Adverse Event|0
7159794|NCT03501277|11332818|FG002|Intervention Period 3 (4 Days)|Adverse Event|0
7159795|NCT03501277|11332819|FG003|Intervention Period 3 (4 Days)|Adverse Event|1
7159796|NCT03502616|11332846|FG000|Up to Week 16|Withdrawal by Subject|1
7159797|NCT03502616|11332847|FG001|Up to Week 16|Withdrawal by Subject|2
7159798|NCT03502616|11332846|FG000|Up to Week 16|Lost to Follow-up|0
7159799|NCT03502616|11332847|FG001|Up to Week 16|Lost to Follow-up|1
7159800|NCT03502616|11332846|FG000|Up to Week 16|Randomized, but not treated|1
7159801|NCT03502616|11332847|FG001|Up to Week 16|Randomized, but not treated|0
7159802|NCT03502616|11332846|FG000|Week 16 to Week 48|Withdrawal by Subject|6
7159803|NCT03502616|11332847|FG001|Week 16 to Week 48|Withdrawal by Subject|6
7159804|NCT03502616|11332846|FG000|Week 16 to Week 48|Lost to Follow-up|1
7159805|NCT03502616|11332847|FG001|Week 16 to Week 48|Lost to Follow-up|0
7159806|NCT03502681|11332857|FG000|Overall Study|Adverse Event|1
7159807|NCT03502681|11332858|FG001|Overall Study|Adverse Event|1
7159808|NCT03502681|11332857|FG000|Overall Study|Disease Progression|2
7159809|NCT03502681|11332858|FG001|Overall Study|Disease Progression|1
7159810|NCT03502798|11332865|FG000|Overall Study|equipment failure|0
7159811|NCT03502798|11332866|FG001|Overall Study|equipment failure|7
7079779|NCT02117544|11189047|FG001|Period 1|Lost to follow-up (prior to treatment)|0
7159812|NCT03503162|11332894|FG000|Overall Study|did not meet eligibility|1
7159813|NCT03503188|11332900|FG000|Overall Study|Non eligible in the sub study|0
7159814|NCT03503188|11332901|FG001|Overall Study|Non eligible in the sub study|1
7159815|NCT03504189|11332929|FG000|Overall Study|Withdrawal by Subject|1
7159816|NCT03504189|11332929|FG000|Overall Study|Screening Failure|1
7159817|NCT03504189|11332929|FG000|Overall Study|Device Failure|2
7159818|NCT03504852|11332945|FG000|Overall Study|Withdrawal of informed consent|2
7159819|NCT03504852|11332946|FG001|Overall Study|Withdrawal of informed consent|1
7159820|NCT03504852|11332947|FG002|Overall Study|Withdrawal of informed consent|0
7159821|NCT03504852|11332945|FG000|Overall Study|Withdrawal by Subject|5
7159822|NCT03504852|11332946|FG001|Overall Study|Withdrawal by Subject|5
7159823|NCT03504852|11332947|FG002|Overall Study|Withdrawal by Subject|1
7159824|NCT03504852|11332945|FG000|Overall Study|Lost to Follow-up|4
7159825|NCT03504852|11332946|FG001|Overall Study|Lost to Follow-up|1
7159826|NCT03504852|11332947|FG002|Overall Study|Lost to Follow-up|0
7159827|NCT03504852|11332945|FG000|Overall Study|New therapy for study indication|1
7159828|NCT03504852|11332946|FG001|Overall Study|New therapy for study indication|0
7159829|NCT03504852|11332947|FG002|Overall Study|New therapy for study indication|0
7159830|NCT03504852|11332945|FG000|Overall Study|Lack of Efficacy|1
7159831|NCT03504852|11332946|FG001|Overall Study|Lack of Efficacy|2
7159832|NCT03504852|11332947|FG002|Overall Study|Lack of Efficacy|0
7159833|NCT03504852|11332945|FG000|Overall Study|Death|0
7159834|NCT03504852|11332946|FG001|Overall Study|Death|1
7159835|NCT03504852|11332947|FG002|Overall Study|Death|0
7159836|NCT03504852|11332945|FG000|Overall Study|Adverse Event|4
7159837|NCT03504852|11332946|FG001|Overall Study|Adverse Event|8
7159838|NCT03504852|11332947|FG002|Overall Study|Adverse Event|2
7159839|NCT03504917|11332959|FG000|Blinded Treatment Period|Protocol Violation|1
7159840|NCT03504917|11332960|FG001|Blinded Treatment Period|Protocol Violation|0
7159841|NCT03504917|11332959|FG000|Blinded Treatment Period|Withdrawal by Subject|12
7159842|NCT03504917|11332960|FG001|Blinded Treatment Period|Withdrawal by Subject|9
7159843|NCT03504917|11332959|FG000|Blinded Treatment Period|Lack of Efficacy|1
7159844|NCT03504917|11332960|FG001|Blinded Treatment Period|Lack of Efficacy|1
7159845|NCT03504917|11332959|FG000|Blinded Treatment Period|Lost to Follow-up|1
7159846|NCT03504917|11332960|FG001|Blinded Treatment Period|Lost to Follow-up|4
7159847|NCT03504917|11332959|FG000|Blinded Treatment Period|Adverse Event|4
7159848|NCT03504917|11332960|FG001|Blinded Treatment Period|Adverse Event|4
7159849|NCT03504917|11332959|FG000|Blinded Treatment Period|Physician Decision|1
7159850|NCT03504917|11332960|FG001|Blinded Treatment Period|Physician Decision|0
7159851|NCT03504917|11332959|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1
7159852|NCT03504917|11332960|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3
7159853|NCT03504917|11332959|FG000|Blinded Treatment Period|Study terminated by sponsor|39
7159854|NCT03504917|11332960|FG001|Blinded Treatment Period|Study terminated by sponsor|34
7159855|NCT03504917|11332959|FG000|Blinded Treatment Period|Non-compliance with study drug|0
7159856|NCT03504917|11332960|FG001|Blinded Treatment Period|Non-compliance with study drug|1
7159857|NCT03504917|11332959|FG000|Open Label Extension Treatment Period|The participant left the study site|0
7159858|NCT03504917|11332960|FG001|Open Label Extension Treatment Period|The participant left the study site|1
7159859|NCT03504917|11332959|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8
7159860|NCT03504917|11332960|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2
7159861|NCT03504917|11332959|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1
7079780|NCT02117570|11189057|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0
7079781|NCT02117570|11189058|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2
7079782|NCT02117570|11189059|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1
7079783|NCT02117570|11189057|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
7079784|NCT02117570|11189058|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
7079785|NCT02117570|11189059|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0
7079786|NCT02117570|11189057|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
7079787|NCT02117570|11189058|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
7079788|NCT02117570|11189059|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2
7079789|NCT02117570|11189057|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0
7079790|NCT02117570|11189058|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0
7079791|NCT02117570|11189059|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1
7079792|NCT02117570|11189057|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
7159862|NCT03504917|11332960|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4
7159863|NCT03504917|11332959|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3
7159864|NCT03504917|11332960|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1
7159865|NCT03504917|11332959|FG000|Open Label Extension Treatment Period|Adverse Event|7
7159866|NCT03504917|11332960|FG001|Open Label Extension Treatment Period|Adverse Event|0
7159867|NCT03504917|11332959|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0
7159868|NCT03504917|11332960|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1
7159869|NCT03504917|11332959|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81
7159870|NCT03504917|11332960|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88
7159871|NCT03505593|11332993|FG000|Overall Study|Withdrawal by Subject|1
7159872|NCT03505593|11332993|FG000|Overall Study|Died before procedure|1
7159873|NCT03505593|11332993|FG000|Overall Study|Anatomical abnormality|1
7159874|NCT03505593|11332993|FG000|Overall Study|Unable to pass through esophagus|1
7159875|NCT03505593|11332993|FG000|Overall Study|Obstruction by Endotracheal tube|1
7159876|NCT03506425|11333019|FG000|Overall Study|Adverse Event|1
7159877|NCT03506425|11333020|FG001|Overall Study|Adverse Event|3
7159878|NCT03506425|11333021|FG002|Overall Study|Adverse Event|0
7159879|NCT03506425|11333019|FG000|Overall Study|Death|1
7159880|NCT03506425|11333020|FG001|Overall Study|Death|0
7159881|NCT03506425|11333021|FG002|Overall Study|Death|0
7159882|NCT03506425|11333019|FG000|Overall Study|Withdrawal by Subject|0
7159883|NCT03506425|11333020|FG001|Overall Study|Withdrawal by Subject|0
7159884|NCT03506425|11333021|FG002|Overall Study|Withdrawal by Subject|1
7159885|NCT03506477|11333032|FG000|Overall Study|Withdrawal by Subject|1
7159886|NCT03506477|11333033|FG001|Overall Study|Withdrawal by Subject|0
7159887|NCT03508050|11333074|FG000|Overall Study|Pleural adhesions|1
7159888|NCT03508050|11333075|FG001|Overall Study|Pleural adhesions|0
7159889|NCT03508050|11333074|FG000|Overall Study|Mucus plug|1
7159890|NCT03508050|11333075|FG001|Overall Study|Mucus plug|0
7159891|NCT03508050|11333074|FG000|Overall Study|Negative biopsy, surgery cancelled|3
7159892|NCT03508050|11333075|FG001|Overall Study|Negative biopsy, surgery cancelled|1
7159893|NCT03508050|11333074|FG000|Overall Study|Sustained desaturation|0
7159894|NCT03508050|11333075|FG001|Overall Study|Sustained desaturation|1
7159895|NCT03508609|11333082|FG000|Overall Study|Withdrawal by Subject|1
7159896|NCT03508830|11333103|FG000|Overall Study|Withdrawal by Subject|3
7159897|NCT03508830|11333104|FG001|Overall Study|Withdrawal by Subject|4
7159898|NCT03508830|11333103|FG000|Overall Study|Physician Decision|2
7159899|NCT03508830|11333104|FG001|Overall Study|Physician Decision|2
7159900|NCT03508843|11333110|FG000|Overall Study|Withdrawal by Subject|1
7159901|NCT03508843|11333110|FG000|Overall Study|technical difficulties|2
7159902|NCT03509350|11333116|FG000|Overall Study|Withdrawal by Subject|0
7159903|NCT03509350|11333117|FG001|Overall Study|Withdrawal by Subject|2
7159904|NCT03509675|11333125|FG000|First Intervention (7 Days)|Lost to Follow-up|3
7159905|NCT03509675|11333126|FG001|First Intervention (7 Days)|Lost to Follow-up|3
7159906|NCT03509675|11333125|FG000|First Intervention (7 Days)|Lack of Efficacy|2
7159907|NCT03509675|11333126|FG001|First Intervention (7 Days)|Lack of Efficacy|1
7159908|NCT03509675|11333125|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1
7159909|NCT03509675|11333126|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0
7159910|NCT03509675|11333125|FG000|Second Intervention )7 Days)|Lost Rinse B|1
7159911|NCT03509675|11333126|FG001|Second Intervention )7 Days)|Lost Rinse B|0
7159912|NCT03509948|11333147|FG000|Overall Study|Protocol Violation|0
7159913|NCT03509948|11333148|FG001|Overall Study|Protocol Violation|1
7159914|NCT03510182|11333158|FG000|Overall Study|Withdrawal by Subject|2
7159915|NCT03510273|11333176|FG000|Overall Study|Withdrawal by Subject|2
7159916|NCT03510273|11333176|FG000|Overall Study|Care outside study, ineligible to cont.|3
7159917|NCT03510273|11333176|FG000|Overall Study|Moved away from study area|4
7159918|NCT03510455|11333184|FG000|Overall Study|Physician Decision|1
7159919|NCT03510663|11333217|FG000|Overall Study|Withdrawal by Subject|0
7159920|NCT03510663|11333218|FG001|Overall Study|Withdrawal by Subject|1
7159921|NCT03510663|11333219|FG002|Overall Study|Withdrawal by Subject|0
7079793|NCT02117570|11189058|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
7079794|NCT02117570|11189059|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1
7079795|NCT02117570|11189057|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1
7159922|NCT03510663|11333220|FG003|Overall Study|Withdrawal by Subject|0
7159923|NCT03510663|11333221|FG004|Overall Study|Withdrawal by Subject|0
7079796|NCT02117570|11189058|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
7079797|NCT02117570|11189059|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
7079798|NCT02117570|11189057|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
7079799|NCT02117570|11189058|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1
7079800|NCT02117570|11189059|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
7079801|NCT02117648|11189070|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1
7079802|NCT02117648|11189070|FG000|Abemaciclib Alone Period 1|Adverse Event|1
7079803|NCT02117648|11189070|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1
7079804|NCT02117648|11189070|FG000|Abemaciclib + Clarithromycin Period 2|Death|1
7079805|NCT02117648|11189070|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1
7079806|NCT02117648|11189070|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1
7159924|NCT03510663|11333222|FG005|Overall Study|Withdrawal by Subject|0
7159925|NCT03510663|11333223|FG006|Overall Study|Withdrawal by Subject|0
7159926|NCT03510663|11333224|FG007|Overall Study|Withdrawal by Subject|0
7159927|NCT03510715|11333236|FG000|Overall Study|Adverse Event|1
7159928|NCT03510715|11333237|FG001|Overall Study|Adverse Event|0
7159929|NCT03510910|11333246|FG000|Overall Study|Incomplete Survey|2
7159930|NCT03510910|11333247|FG001|Overall Study|Incomplete Survey|3
7159931|NCT03511053|11333262|FG000|Overall Study|Withdrawal by Subject|1
7159932|NCT03511105|11333268|FG000|Overall Study|Adverse Event|1
7159933|NCT03511105|11333269|FG001|Overall Study|Adverse Event|0
7159934|NCT03511105|11333268|FG000|Overall Study|Withdrew consent|1
7159935|NCT03511105|11333269|FG001|Overall Study|Withdrew consent|0
7159936|NCT03511326|11333276|FG000|Overall Study|Withdrawal by Subject|1
7159937|NCT03511378|11333282|FG000|Overall Study|Withdrawal by Subject|2
7159938|NCT03511378|11333283|FG001|Overall Study|Withdrawal by Subject|2
7159939|NCT03511378|11333282|FG000|Overall Study|Patient not coming or schedule visit|1
7159940|NCT03511378|11333283|FG001|Overall Study|Patient not coming or schedule visit|0
7159941|NCT03512028|11333320|FG000|Overall Study|Withdrawal by Subject|2
7159942|NCT03512028|11333321|FG001|Overall Study|Withdrawal by Subject|0
7159943|NCT03512028|11333320|FG000|Overall Study|Protocol Violation|2
7159944|NCT03512028|11333321|FG001|Overall Study|Protocol Violation|0
7159945|NCT03512288|11333350|FG000|Overall Study|Adverse Event|1
7159946|NCT03512288|11333351|FG001|Overall Study|Adverse Event|0
7159947|NCT03512288|11333350|FG000|Overall Study|Lost to Follow-up|12
7159948|NCT03512288|11333351|FG001|Overall Study|Lost to Follow-up|15
7159949|NCT03512288|11333350|FG000|Overall Study|Physician Decision|0
7159950|NCT03512288|11333351|FG001|Overall Study|Physician Decision|2
7159951|NCT03512288|11333350|FG000|Overall Study|Protocol Violation|6
7159952|NCT03512288|11333351|FG001|Overall Study|Protocol Violation|4
7159953|NCT03512288|11333350|FG000|Overall Study|Medication error without associated adverse event|1
7159954|NCT03512288|11333351|FG001|Overall Study|Medication error without associated adverse event|0
7159955|NCT03512288|11333350|FG000|Overall Study|No longer met eligibility criteria|5
7159956|NCT03512288|11333351|FG001|Overall Study|No longer met eligibility criteria|2
7159957|NCT03512288|11333350|FG000|Overall Study|Withdrawal by parent/guardian|14
7159958|NCT03512288|11333351|FG001|Overall Study|Withdrawal by parent/guardian|18
7159959|NCT03512288|11333350|FG000|Overall Study|Other|1
7159960|NCT03512288|11333351|FG001|Overall Study|Other|1
7159961|NCT03512288|11333350|FG000|Overall Study|Randomized but not treated|1
7159962|NCT03512288|11333351|FG001|Overall Study|Randomized but not treated|1
7159963|NCT03512353|11333357|FG000|Overall Study|Sponsor Decision|3
7159964|NCT03512353|11333357|FG000|Overall Study|Death|1
7159965|NCT03513588|11333377|FG000|Overall Study|Lost to Follow-up|0
7159966|NCT03513588|11333378|FG001|Overall Study|Lost to Follow-up|1
7159967|NCT03513588|11333379|FG002|Overall Study|Lost to Follow-up|1
7159968|NCT03513588|11333377|FG000|Overall Study|Study dosing paused by sponsor|1
7159969|NCT03513588|11333378|FG001|Overall Study|Study dosing paused by sponsor|1
7159970|NCT03513588|11333379|FG002|Overall Study|Study dosing paused by sponsor|0
7159971|NCT03513588|11333377|FG000|Overall Study|Death|0
7159972|NCT03513588|11333378|FG001|Overall Study|Death|0
7159973|NCT03513588|11333379|FG002|Overall Study|Death|1
7159974|NCT03514641|11333431|FG000|603A: 0-12 Week Study Period|Protocol Violation|3
7159975|NCT03514641|11333432|FG001|603A: 0-12 Week Study Period|Protocol Violation|3
7159976|NCT03514641|11333433|FG002|603A: 0-12 Week Study Period|Protocol Violation|0
7159977|NCT03514641|11333434|FG003|603A: 0-12 Week Study Period|Protocol Violation|0
7159978|NCT03514641|11333431|FG000|603A: 0-12 Week Study Period|Adverse Event|5
7159979|NCT03514641|11333432|FG001|603A: 0-12 Week Study Period|Adverse Event|2
7159980|NCT03514641|11333433|FG002|603A: 0-12 Week Study Period|Adverse Event|0
7159981|NCT03514641|11333434|FG003|603A: 0-12 Week Study Period|Adverse Event|0
7159982|NCT03514641|11333431|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7
7159983|NCT03514641|11333432|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5
7159984|NCT03514641|11333433|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0
7159985|NCT03514641|11333434|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0
7159986|NCT03514641|11333431|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10
7159987|NCT03514641|11333432|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9
7159988|NCT03514641|11333433|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0
7159989|NCT03514641|11333434|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0
7159990|NCT03514641|11333431|FG000|603A: 0-12 Week Study Period|Physician Decision|1
7159991|NCT03514641|11333432|FG001|603A: 0-12 Week Study Period|Physician Decision|0
7159992|NCT03514641|11333433|FG002|603A: 0-12 Week Study Period|Physician Decision|0
7159993|NCT03514641|11333434|FG003|603A: 0-12 Week Study Period|Physician Decision|0
7159994|NCT03514641|11333431|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1
7159995|NCT03514641|11333432|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0
7159996|NCT03514641|11333433|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0
7159997|NCT03514641|11333434|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0
7159998|NCT03514641|11333431|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0
7159999|NCT03514641|11333432|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1
7160000|NCT03514641|11333433|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0
7160001|NCT03514641|11333434|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0
7160002|NCT03514641|11333431|FG000|603B: 24-36 Week Study Period|Protocol Violation|0
7160003|NCT03514641|11333432|FG001|603B: 24-36 Week Study Period|Protocol Violation|0
7160004|NCT03514641|11333433|FG002|603B: 24-36 Week Study Period|Protocol Violation|0
7160005|NCT03514641|11333434|FG003|603B: 24-36 Week Study Period|Protocol Violation|2
7160006|NCT03514641|11333431|FG000|603B: 24-36 Week Study Period|Adverse Event|0
7160007|NCT03514641|11333432|FG001|603B: 24-36 Week Study Period|Adverse Event|0
7160008|NCT03514641|11333433|FG002|603B: 24-36 Week Study Period|Adverse Event|3
7160009|NCT03514641|11333434|FG003|603B: 24-36 Week Study Period|Adverse Event|1
7160010|NCT03514641|11333431|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0
7160011|NCT03514641|11333432|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0
7160012|NCT03514641|11333433|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2
7160013|NCT03514641|11333434|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3
7160014|NCT03514641|11333431|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0
7160015|NCT03514641|11333432|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0
7160016|NCT03514641|11333433|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6
7160017|NCT03514641|11333434|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6
7160018|NCT03514641|11333431|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0
7160019|NCT03514641|11333432|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0
7160020|NCT03514641|11333433|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3
7160021|NCT03514641|11333434|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3
7160022|NCT03515824|11333467|FG000|Overall Study|Death|3
7160023|NCT03515824|11333468|FG001|Overall Study|Death|2
7160024|NCT03515824|11333469|FG002|Overall Study|Death|6
7160025|NCT03515824|11333470|FG003|Overall Study|Death|0
7160026|NCT03515824|11333467|FG000|Overall Study|Lost to Follow-up|0
7160027|NCT03515824|11333468|FG001|Overall Study|Lost to Follow-up|1
7160028|NCT03515824|11333469|FG002|Overall Study|Lost to Follow-up|1
7160029|NCT03515824|11333470|FG003|Overall Study|Lost to Follow-up|0
7160030|NCT03515824|11333467|FG000|Overall Study|Study terminated by sponsor|0
7160031|NCT03515824|11333468|FG001|Overall Study|Study terminated by sponsor|1
7160032|NCT03515824|11333469|FG002|Overall Study|Study terminated by sponsor|6
7160033|NCT03515824|11333470|FG003|Overall Study|Study terminated by sponsor|0
7160034|NCT03515824|11333467|FG000|Overall Study|Status not recorded|0
7160035|NCT03515824|11333468|FG001|Overall Study|Status not recorded|0
7160036|NCT03515824|11333469|FG002|Overall Study|Status not recorded|2
7160037|NCT03515824|11333470|FG003|Overall Study|Status not recorded|0
7160038|NCT03515941|11333480|FG000|Overall Study|Adverse Event|1
7160039|NCT03515941|11333481|FG001|Overall Study|Adverse Event|0
7160040|NCT03517436|11333497|FG000|Overall Study|Death|3
7160041|NCT03517436|11333497|FG000|Overall Study|Withdrawal by Subject|4
7160042|NCT03517436|11333497|FG000|Overall Study|Did not receive study valve.|1
7160043|NCT03517566|11333506|FG000|Overall Study|Adverse Event|5
7160044|NCT03517566|11333507|FG001|Overall Study|Adverse Event|2
7160045|NCT03517566|11333508|FG002|Overall Study|Adverse Event|2
7160046|NCT03517566|11333509|FG003|Overall Study|Adverse Event|8
7160047|NCT03517566|11333510|FG004|Overall Study|Adverse Event|7
7160048|NCT03517566|11333506|FG000|Overall Study|Lack of Efficacy|3
7160049|NCT03517566|11333507|FG001|Overall Study|Lack of Efficacy|2
7160050|NCT03517566|11333508|FG002|Overall Study|Lack of Efficacy|1
7160051|NCT03517566|11333509|FG003|Overall Study|Lack of Efficacy|1
7160052|NCT03517566|11333510|FG004|Overall Study|Lack of Efficacy|4
7160053|NCT03517566|11333506|FG000|Overall Study|Lost to Follow-up|3
7160054|NCT03517566|11333507|FG001|Overall Study|Lost to Follow-up|1
7160055|NCT03517566|11333508|FG002|Overall Study|Lost to Follow-up|1
7160056|NCT03517566|11333509|FG003|Overall Study|Lost to Follow-up|1
7160057|NCT03517566|11333510|FG004|Overall Study|Lost to Follow-up|0
7160058|NCT03517566|11333506|FG000|Overall Study|Physician Decision|1
7160059|NCT03517566|11333507|FG001|Overall Study|Physician Decision|1
7160060|NCT03517566|11333508|FG002|Overall Study|Physician Decision|0
7160061|NCT03517566|11333509|FG003|Overall Study|Physician Decision|1
7160062|NCT03517566|11333510|FG004|Overall Study|Physician Decision|0
7160063|NCT03517566|11333506|FG000|Overall Study|Pregnancy|0
7160064|NCT03517566|11333507|FG001|Overall Study|Pregnancy|1
7160065|NCT03517566|11333508|FG002|Overall Study|Pregnancy|0
7160066|NCT03517566|11333509|FG003|Overall Study|Pregnancy|0
7160067|NCT03517566|11333510|FG004|Overall Study|Pregnancy|0
7160068|NCT03517566|11333506|FG000|Overall Study|Protocol Deviation|0
7160069|NCT03517566|11333507|FG001|Overall Study|Protocol Deviation|1
7160070|NCT03517566|11333508|FG002|Overall Study|Protocol Deviation|0
7160071|NCT03517566|11333509|FG003|Overall Study|Protocol Deviation|1
7160072|NCT03517566|11333510|FG004|Overall Study|Protocol Deviation|1
7160073|NCT03517566|11333506|FG000|Overall Study|Study terminated by Sponsor|11
7160074|NCT03517566|11333507|FG001|Overall Study|Study terminated by Sponsor|5
7160075|NCT03517566|11333508|FG002|Overall Study|Study terminated by Sponsor|6
7160076|NCT03517566|11333509|FG003|Overall Study|Study terminated by Sponsor|14
7160077|NCT03517566|11333510|FG004|Overall Study|Study terminated by Sponsor|12
7160078|NCT03517566|11333506|FG000|Overall Study|Subject Decision /Guardian Decision|9
7160079|NCT03517566|11333507|FG001|Overall Study|Subject Decision /Guardian Decision|8
7160080|NCT03517566|11333508|FG002|Overall Study|Subject Decision /Guardian Decision|5
7160081|NCT03517566|11333509|FG003|Overall Study|Subject Decision /Guardian Decision|8
7160082|NCT03517566|11333510|FG004|Overall Study|Subject Decision /Guardian Decision|8
7160083|NCT03518008|11333523|FG000|Period 2, Second Week of Wear|Family emergency|0
7160084|NCT03518008|11333524|FG001|Period 2, Second Week of Wear|Family emergency|1
7160085|NCT03518125|11333536|FG000|Overall Study|Lost to Follow-up|0
7160086|NCT03518125|11333537|FG001|Overall Study|Lost to Follow-up|2
7160087|NCT03518125|11333538|FG002|Overall Study|Lost to Follow-up|0
7160088|NCT03518125|11333539|FG003|Overall Study|Lost to Follow-up|0
7160089|NCT03518125|11333540|FG004|Overall Study|Lost to Follow-up|3
7160090|NCT03518125|11333541|FG005|Overall Study|Lost to Follow-up|5
7160091|NCT03518125|11333536|FG000|Overall Study|Physician Decision|0
7160092|NCT03518125|11333537|FG001|Overall Study|Physician Decision|1
7160093|NCT03518125|11333538|FG002|Overall Study|Physician Decision|0
7160094|NCT03518125|11333539|FG003|Overall Study|Physician Decision|0
7160095|NCT03518125|11333540|FG004|Overall Study|Physician Decision|0
7160096|NCT03518125|11333541|FG005|Overall Study|Physician Decision|0
7160097|NCT03518125|11333536|FG000|Overall Study|Withdrawal by Subject|1
7160098|NCT03518125|11333537|FG001|Overall Study|Withdrawal by Subject|1
7160099|NCT03518125|11333538|FG002|Overall Study|Withdrawal by Subject|0
7160100|NCT03518125|11333539|FG003|Overall Study|Withdrawal by Subject|1
7160101|NCT03518125|11333540|FG004|Overall Study|Withdrawal by Subject|1
7160102|NCT03518125|11333541|FG005|Overall Study|Withdrawal by Subject|3
7160103|NCT03518125|11333536|FG000|Overall Study|Missed Day 394 Visit|1
7160104|NCT03518125|11333537|FG001|Overall Study|Missed Day 394 Visit|0
7160105|NCT03518125|11333538|FG002|Overall Study|Missed Day 394 Visit|0
7160106|NCT03518125|11333539|FG003|Overall Study|Missed Day 394 Visit|0
7160107|NCT03518125|11333540|FG004|Overall Study|Missed Day 394 Visit|0
7160108|NCT03518125|11333541|FG005|Overall Study|Missed Day 394 Visit|0
7160109|NCT03518658|11333558|FG000|Overall Study|Other|51
7160110|NCT03518658|11333559|FG001|Overall Study|Other|0
7160111|NCT03518840|11333567|FG000|Overall Study|Lost to Follow-up|6
7160112|NCT03519087|11333576|FG000|Clinic Evaluation|Physician Decision|15
7160113|NCT03519087|11333577|FG001|Clinic Evaluation|Physician Decision|18
7160114|NCT03519087|11333578|FG002|Clinic Evaluation|Physician Decision|0
7160115|NCT03519087|11333579|FG003|Clinic Evaluation|Physician Decision|0
7160116|NCT03519087|11333580|FG004|Clinic Evaluation|Physician Decision|0
7160117|NCT03519087|11333576|FG000|Clinic Evaluation|Protocol Violation|1
7160118|NCT03519087|11333577|FG001|Clinic Evaluation|Protocol Violation|0
7160119|NCT03519087|11333578|FG002|Clinic Evaluation|Protocol Violation|0
7160120|NCT03519087|11333579|FG003|Clinic Evaluation|Protocol Violation|0
7160121|NCT03519087|11333580|FG004|Clinic Evaluation|Protocol Violation|0
7160122|NCT03519087|11333576|FG000|Re-randomization for Treatment|Withdrawal by Subject|25
7160123|NCT03519087|11333577|FG001|Re-randomization for Treatment|Withdrawal by Subject|29
7160124|NCT03519087|11333578|FG002|Re-randomization for Treatment|Withdrawal by Subject|0
7160125|NCT03519087|11333579|FG003|Re-randomization for Treatment|Withdrawal by Subject|0
7160126|NCT03519087|11333580|FG004|Re-randomization for Treatment|Withdrawal by Subject|0
7160127|NCT03519087|11333576|FG000|Re-randomization for Treatment|Not appropriate|2
7160128|NCT03519087|11333577|FG001|Re-randomization for Treatment|Not appropriate|3
7160129|NCT03519087|11333578|FG002|Re-randomization for Treatment|Not appropriate|0
7079807|NCT02117648|11189070|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12
7079808|NCT02117648|11189070|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1
7160130|NCT03519087|11333579|FG003|Re-randomization for Treatment|Not appropriate|0
7160131|NCT03519087|11333580|FG004|Re-randomization for Treatment|Not appropriate|0
7160132|NCT03519087|11333576|FG000|Laboratory Testing|Lost to Follow-up|0
7160133|NCT03519087|11333577|FG001|Laboratory Testing|Lost to Follow-up|0
7160134|NCT03519087|11333578|FG002|Laboratory Testing|Lost to Follow-up|2
7160135|NCT03519087|11333579|FG003|Laboratory Testing|Lost to Follow-up|3
7160136|NCT03519087|11333580|FG004|Laboratory Testing|Lost to Follow-up|6
7160137|NCT03519087|11333576|FG000|Laboratory Testing|Protocol Violation|0
7160138|NCT03519087|11333577|FG001|Laboratory Testing|Protocol Violation|0
7160139|NCT03519087|11333578|FG002|Laboratory Testing|Protocol Violation|0
7160140|NCT03519087|11333579|FG003|Laboratory Testing|Protocol Violation|1
7160141|NCT03519087|11333580|FG004|Laboratory Testing|Protocol Violation|0
7184281|NCT01904279|11384334|FG000|Overall Study|Lack of Efficacy|2
7184282|NCT01904279|11384335|FG001|Overall Study|Lack of Efficacy|3
7184283|NCT01904279|11384334|FG000|Overall Study|Withdrawal by Subject|1
7184284|NCT01904279|11384335|FG001|Overall Study|Withdrawal by Subject|0
7187474|NCT02036970|11388052|FG004|Part 2: Week 16 Onwards|Progressive Disease|0
7187475|NCT02036970|11388053|FG005|Part 2: Week 16 Onwards|Progressive Disease|0
7187476|NCT02036970|11388054|FG006|Part 2: Week 16 Onwards|Progressive Disease|0
7187477|NCT02036970|11388055|FG007|Part 2: Week 16 Onwards|Progressive Disease|0
7187478|NCT02036970|11388056|FG008|Part 2: Week 16 Onwards|Progressive Disease|0
7079809|NCT02117648|11189070|FG000|Abemaciclib Safety-Extension Phase|Death|3
7079810|NCT02117648|11189070|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2
7079811|NCT02117648|11189070|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2
7079812|NCT02117687|11189080|FG000|Overall Study|Lost to Follow-up|0
7079813|NCT02117687|11189081|FG001|Overall Study|Lost to Follow-up|1
7079814|NCT02117687|11189080|FG000|Overall Study|Adverse Event|0
7079815|NCT02117687|11189081|FG001|Overall Study|Adverse Event|2
7079816|NCT02117687|11189080|FG000|Overall Study|Other Reasons|1
7079817|NCT02117687|11189081|FG001|Overall Study|Other Reasons|1
7079818|NCT02117713|11189087|FG000|Week 48|Adverse Event|4
7079819|NCT02117713|11189087|FG000|Week 48|Withdrawal by caregiver|2
7079820|NCT02117713|11189087|FG000|Week 48|Did not consent to Protocol Amendment 4|2
7160142|NCT03519204|11333598|FG000|Overall Study|Lost to Follow-up|3
7160143|NCT03519204|11333599|FG001|Overall Study|Lost to Follow-up|8
7160144|NCT03519204|11333598|FG000|Overall Study|Withdrawal by Subject|9
7160145|NCT03519204|11333599|FG001|Overall Study|Withdrawal by Subject|7
7160146|NCT03519204|11333598|FG000|Overall Study|Other Miscellaneous Reasons|1
7160147|NCT03519204|11333599|FG001|Overall Study|Other Miscellaneous Reasons|0
7160148|NCT03519516|11333632|FG000|Overall Study|Adverse Event|0
7160149|NCT03519516|11333633|FG001|Overall Study|Adverse Event|1
7160150|NCT03519854|11333657|FG000|Overall Study|Technical Error|0
7160151|NCT03519854|11333658|FG001|Overall Study|Technical Error|0
7160152|NCT03519854|11333659|FG002|Overall Study|Technical Error|1
7160153|NCT03519854|11333660|FG003|Overall Study|Technical Error|0
7160154|NCT03519854|11333661|FG004|Overall Study|Technical Error|0
7160155|NCT03519854|11333662|FG005|Overall Study|Technical Error|0
7160156|NCT03519854|11333663|FG006|Overall Study|Technical Error|0
7160157|NCT03519854|11333664|FG007|Overall Study|Technical Error|0
7160158|NCT03519854|11333665|FG008|Overall Study|Technical Error|0
7160159|NCT03519854|11333666|FG009|Overall Study|Technical Error|0
7079821|NCT02117713|11189087|FG000|Long Term Follow-up Treatment|Adverse Event|3
6894763|NCT00621322|10912559|FG003|Overall Study|Lost to Follow-up|0
6894764|NCT00621322|10912560|FG004|Overall Study|Lost to Follow-up|1
6894765|NCT00621322|10912561|FG005|Overall Study|Lost to Follow-up|0
6894766|NCT00621322|10912556|FG000|Overall Study|Physician Decision|0
6894767|NCT00621322|10912557|FG001|Overall Study|Physician Decision|0
6894768|NCT00621322|10912558|FG002|Overall Study|Physician Decision|1
6894769|NCT00621322|10912559|FG003|Overall Study|Physician Decision|1
7079822|NCT02117713|11189087|FG000|Long Term Follow-up Treatment|Progressive Disease|2
7079823|NCT02117713|11189087|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1
7079824|NCT02118012|11189121|FG000|Overall Study|Adverse Event|0
7079825|NCT02118012|11189122|FG001|Overall Study|Adverse Event|1
7079826|NCT02118012|11189121|FG000|Overall Study|Physician Decision|0
7079827|NCT02118012|11189122|FG001|Overall Study|Physician Decision|1
7079828|NCT02118337|11189137|FG000|Overall Study|Other|1
7079829|NCT02118337|11189138|FG001|Overall Study|Other|0
7079830|NCT02118337|11189139|FG002|Overall Study|Other|0
7079831|NCT02118337|11189140|FG003|Overall Study|Other|0
7079832|NCT02118337|11189141|FG004|Overall Study|Other|2
7079833|NCT02118337|11189142|FG005|Overall Study|Other|3
7079834|NCT02118337|11189143|FG006|Overall Study|Other|1
7079835|NCT02118337|11189144|FG007|Overall Study|Other|28
7079836|NCT02118337|11189145|FG008|Overall Study|Other|15
7079837|NCT02118337|11189137|FG000|Overall Study|Lost to Follow-up|0
7079838|NCT02118337|11189138|FG001|Overall Study|Lost to Follow-up|0
7079839|NCT02118337|11189139|FG002|Overall Study|Lost to Follow-up|0
7079840|NCT02118337|11189140|FG003|Overall Study|Lost to Follow-up|0
7079841|NCT02118337|11189141|FG004|Overall Study|Lost to Follow-up|0
7079842|NCT02118337|11189142|FG005|Overall Study|Lost to Follow-up|0
7079843|NCT02118337|11189143|FG006|Overall Study|Lost to Follow-up|0
7079844|NCT02118337|11189144|FG007|Overall Study|Lost to Follow-up|1
7079845|NCT02118337|11189145|FG008|Overall Study|Lost to Follow-up|0
7079846|NCT02118337|11189137|FG000|Overall Study|Withdrawal by Subject|1
7079847|NCT02118337|11189138|FG001|Overall Study|Withdrawal by Subject|3
7079848|NCT02118337|11189139|FG002|Overall Study|Withdrawal by Subject|2
7079849|NCT02118337|11189140|FG003|Overall Study|Withdrawal by Subject|1
7079850|NCT02118337|11189141|FG004|Overall Study|Withdrawal by Subject|2
7079851|NCT02118337|11189142|FG005|Overall Study|Withdrawal by Subject|2
7079852|NCT02118337|11189143|FG006|Overall Study|Withdrawal by Subject|1
7079853|NCT02118337|11189144|FG007|Overall Study|Withdrawal by Subject|4
7079854|NCT02118337|11189145|FG008|Overall Study|Withdrawal by Subject|2
7079855|NCT02118337|11189137|FG000|Overall Study|Death|2
7079856|NCT02118337|11189138|FG001|Overall Study|Death|2
7079857|NCT02118337|11189139|FG002|Overall Study|Death|1
7079858|NCT02118337|11189140|FG003|Overall Study|Death|2
7079859|NCT02118337|11189141|FG004|Overall Study|Death|5
7079860|NCT02118337|11189142|FG005|Overall Study|Death|1
7079861|NCT02118337|11189143|FG006|Overall Study|Death|2
7079862|NCT02118337|11189144|FG007|Overall Study|Death|9
7079863|NCT02118337|11189145|FG008|Overall Study|Death|4
7079864|NCT02118428|11189171|FG000|Overall Study|Physician Decision|0
7079865|NCT02118428|11189172|FG001|Overall Study|Physician Decision|1
7079866|NCT02118428|11189173|FG002|Overall Study|Physician Decision|0
7079867|NCT02118428|11189171|FG000|Overall Study|Withdrawal by Subject|2
7079868|NCT02118428|11189172|FG001|Overall Study|Withdrawal by Subject|2
7079869|NCT02118428|11189173|FG002|Overall Study|Withdrawal by Subject|0
7079870|NCT02118428|11189171|FG000|Overall Study|Death|7
7079871|NCT02118428|11189172|FG001|Overall Study|Death|5
7079872|NCT02118428|11189173|FG002|Overall Study|Death|0
7079873|NCT02118428|11189171|FG000|Overall Study|Lost to Follow-up|3
7079874|NCT02118428|11189172|FG001|Overall Study|Lost to Follow-up|1
7079875|NCT02118428|11189173|FG002|Overall Study|Lost to Follow-up|0
7079876|NCT02118428|11189171|FG000|Overall Study|Screen Failure or Became Inelegible|1
7079877|NCT02118428|11189172|FG001|Overall Study|Screen Failure or Became Inelegible|0
7079878|NCT02118428|11189173|FG002|Overall Study|Screen Failure or Became Inelegible|1
7079879|NCT02118597|11189189|FG000|Overall Study|Sponsor terminated the study|14
7079880|NCT02118597|11189189|FG000|Overall Study|Serious Adverse Event|1
7160160|NCT03519854|11333667|FG010|Overall Study|Technical Error|0
7160161|NCT03519854|11333668|FG011|Overall Study|Technical Error|0
7160162|NCT03519854|11333669|FG012|Overall Study|Technical Error|0
7160163|NCT03519854|11333670|FG013|Overall Study|Technical Error|0
7160164|NCT03519854|11333671|FG014|Overall Study|Technical Error|0
7160165|NCT03519854|11333672|FG015|Overall Study|Technical Error|0
7160166|NCT03519854|11333673|FG016|Overall Study|Technical Error|0
7160167|NCT03519854|11333674|FG017|Overall Study|Technical Error|0
7160168|NCT03519867|11333722|FG000|Overall Study|Adverse Event|1
7160169|NCT03519867|11333723|FG001|Overall Study|Adverse Event|1
7160170|NCT03519867|11333724|FG002|Overall Study|Adverse Event|0
7160171|NCT03519867|11333725|FG003|Overall Study|Adverse Event|0
7160172|NCT03519867|11333726|FG004|Overall Study|Adverse Event|0
7160173|NCT03519867|11333727|FG005|Overall Study|Adverse Event|0
7160174|NCT03519867|11333728|FG006|Overall Study|Adverse Event|0
7160175|NCT03519867|11333729|FG007|Overall Study|Adverse Event|0
7160176|NCT03519867|11333730|FG008|Overall Study|Adverse Event|0
7160177|NCT03519867|11333731|FG009|Overall Study|Adverse Event|0
7160178|NCT03519867|11333722|FG000|Overall Study|Protocol Violation|0
7160179|NCT03519867|11333723|FG001|Overall Study|Protocol Violation|0
7160180|NCT03519867|11333724|FG002|Overall Study|Protocol Violation|0
7160181|NCT03519867|11333725|FG003|Overall Study|Protocol Violation|0
7160182|NCT03519867|11333726|FG004|Overall Study|Protocol Violation|0
7160183|NCT03519867|11333727|FG005|Overall Study|Protocol Violation|1
7160184|NCT03519867|11333728|FG006|Overall Study|Protocol Violation|0
7160185|NCT03519867|11333729|FG007|Overall Study|Protocol Violation|0
7160186|NCT03519867|11333730|FG008|Overall Study|Protocol Violation|0
7160187|NCT03519867|11333731|FG009|Overall Study|Protocol Violation|0
7160188|NCT03519867|11333722|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0
7160189|NCT03519867|11333723|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0
7160190|NCT03519867|11333724|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0
7160191|NCT03519867|11333725|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0
7160192|NCT03519867|11333726|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0
7160193|NCT03519867|11333727|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0
7160194|NCT03519867|11333728|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1
7160195|NCT03519867|11333729|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0
7160196|NCT03519867|11333730|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0
7160197|NCT03519867|11333731|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0
7160198|NCT03519867|11333722|FG000|Overall Study|Admin. of other reversal agent|1
7160199|NCT03519867|11333723|FG001|Overall Study|Admin. of other reversal agent|1
7160200|NCT03519867|11333724|FG002|Overall Study|Admin. of other reversal agent|0
7160201|NCT03519867|11333725|FG003|Overall Study|Admin. of other reversal agent|0
7160202|NCT03519867|11333726|FG004|Overall Study|Admin. of other reversal agent|0
7160203|NCT03519867|11333727|FG005|Overall Study|Admin. of other reversal agent|1
7160204|NCT03519867|11333728|FG006|Overall Study|Admin. of other reversal agent|0
7160205|NCT03519867|11333729|FG007|Overall Study|Admin. of other reversal agent|0
7160206|NCT03519867|11333730|FG008|Overall Study|Admin. of other reversal agent|0
7160207|NCT03519867|11333731|FG009|Overall Study|Admin. of other reversal agent|0
7160208|NCT03519867|11333722|FG000|Overall Study|Reason not provided|1
7160209|NCT03519867|11333723|FG001|Overall Study|Reason not provided|1
7160210|NCT03519867|11333724|FG002|Overall Study|Reason not provided|1
7160211|NCT03519867|11333725|FG003|Overall Study|Reason not provided|1
7160212|NCT03519867|11333726|FG004|Overall Study|Reason not provided|0
7160213|NCT03519867|11333727|FG005|Overall Study|Reason not provided|1
7160214|NCT03519867|11333728|FG006|Overall Study|Reason not provided|0
7160215|NCT03519867|11333729|FG007|Overall Study|Reason not provided|1
7160216|NCT03519867|11333730|FG008|Overall Study|Reason not provided|1
7160217|NCT03519867|11333731|FG009|Overall Study|Reason not provided|0
7160218|NCT03519919|11333753|FG000|Overall Study|Withdrawal by Subject|1
7160219|NCT03519919|11333753|FG000|Overall Study|Lack of Efficacy|1
7160220|NCT03519919|11333753|FG000|Overall Study|Screen Failure|1
7160221|NCT03519932|11333783|FG000|First Intervention|Adverse Event|1
7160222|NCT03519932|11333784|FG001|First Intervention|Adverse Event|3
7160223|NCT03520387|11333827|FG000|Pre-Randomization|Withdrawal by Subject|1
7160224|NCT03520387|11333828|FG001|Pre-Randomization|Withdrawal by Subject|0
7160225|NCT03520387|11333829|FG002|Pre-Randomization|Withdrawal by Subject|0
7160226|NCT03520387|11333830|FG003|Pre-Randomization|Withdrawal by Subject|0
7160227|NCT03520387|11333831|FG004|Pre-Randomization|Withdrawal by Subject|0
7160228|NCT03520387|11333827|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2
7160229|NCT03520387|11333828|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0
7160230|NCT03520387|11333829|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0
7160231|NCT03520387|11333830|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0
7160232|NCT03520387|11333831|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0
7160233|NCT03520400|11333844|FG000|Overall Study|Physician Decision|15
7160234|NCT03520400|11333845|FG001|Overall Study|Physician Decision|7
7160235|NCT03520920|11333854|FG000|Overall Study|Death|13
7160236|NCT03520920|11333855|FG001|Overall Study|Death|1
7160237|NCT03520920|11333856|FG002|Overall Study|Death|0
7160238|NCT03520920|11333854|FG000|Overall Study|Withdrawal by Subject|2
7160239|NCT03520920|11333855|FG001|Overall Study|Withdrawal by Subject|1
7160240|NCT03520920|11333856|FG002|Overall Study|Withdrawal by Subject|0
7160241|NCT03520920|11333854|FG000|Overall Study|Study Terminated by the Sponsor|5
7160242|NCT03520920|11333855|FG001|Overall Study|Study Terminated by the Sponsor|14
7160243|NCT03520920|11333856|FG002|Overall Study|Study Terminated by the Sponsor|5
7160244|NCT03520959|11333872|FG000|Overall Study|Study terminated by Sponsor|0
7160245|NCT03520959|11333873|FG001|Overall Study|Study terminated by Sponsor|1
7160246|NCT03521115|11333899|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56
7160247|NCT03521115|11333900|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40
7160248|NCT03521115|11333899|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3
7160249|NCT03521115|11333900|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1
7160250|NCT03521141|11333915|FG000|Overall Study|Death|1
7160251|NCT03521141|11333916|FG001|Overall Study|Death|0
7160252|NCT03521141|11333917|FG002|Overall Study|Death|1
7160253|NCT03521193|11333927|FG000|Overall Study|Withdrawal by Subject|8
7160254|NCT03521193|11333928|FG001|Overall Study|Withdrawal by Subject|0
7160255|NCT03521193|11333927|FG000|Overall Study|non compliant to ASA treatment|8
7160256|NCT03521193|11333928|FG001|Overall Study|non compliant to ASA treatment|0
7160257|NCT03521635|11333963|FG000|Overall Study|Adverse Event|1
7160258|NCT03521635|11333964|FG001|Overall Study|Adverse Event|1
7160259|NCT03521635|11333963|FG000|Overall Study|Refused to complete study visit|1
7160260|NCT03521635|11333964|FG001|Overall Study|Refused to complete study visit|0
7160261|NCT03521635|11333963|FG000|Overall Study|Refused to continue trial medication|2
7160262|NCT03521635|11333964|FG001|Overall Study|Refused to continue trial medication|2
7160263|NCT03521635|11333963|FG000|Overall Study|Lost to Follow-up|0
7160264|NCT03521635|11333964|FG001|Overall Study|Lost to Follow-up|1
7160265|NCT03521635|11333963|FG000|Overall Study|Meet exclusion criteria|0
7160266|NCT03521635|11333964|FG001|Overall Study|Meet exclusion criteria|1
7160267|NCT03521635|11333963|FG000|Overall Study|Patient not taken study medicine|0
7160268|NCT03521635|11333964|FG001|Overall Study|Patient not taken study medicine|1
7160269|NCT03521791|11333972|FG000|Overall Study|Protocol Violation|7
7160270|NCT03521791|11333973|FG001|Overall Study|Protocol Violation|17
7160271|NCT03521817|11333981|FG000|Overall Study|Protocol Violation|0
7160272|NCT03521817|11333982|FG001|Overall Study|Protocol Violation|1
7160273|NCT03522506|11334011|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7160274|NCT03522506|11334012|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7160275|NCT03522506|11334013|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7160276|NCT03522506|11334014|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1
7160277|NCT03522506|11334011|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0
7160278|NCT03522506|11334012|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0
7160279|NCT03522506|11334013|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0
7160280|NCT03522506|11334014|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1
7160281|NCT03522675|11334028|FG000|Overall Study|Screen fail|1
7160282|NCT03522675|11334028|FG000|Overall Study|Non-reactive to histamine|1
7160283|NCT03522948|11334036|FG000|Overall Study|Lost to Follow-up|1
7160284|NCT03523715|11334042|FG000|Overall Study|Lost to Follow-up|11
7160285|NCT03523715|11334043|FG001|Overall Study|Lost to Follow-up|14
7160286|NCT03523715|11334042|FG000|Overall Study|Did not meet inclusion criteria|1
7160287|NCT03523715|11334043|FG001|Overall Study|Did not meet inclusion criteria|0
7160288|NCT03523715|11334042|FG000|Overall Study|Internally inconsistent reporting|0
7160289|NCT03523715|11334043|FG001|Overall Study|Internally inconsistent reporting|2
7160290|NCT03523871|11334049|FG000|Overall Study|Death|1
7160291|NCT03524157|11334069|FG000|Overall Study|cytology not readable|0
7160292|NCT03524157|11334070|FG001|Overall Study|cytology not readable|0
7160293|NCT03524157|11334071|FG002|Overall Study|cytology not readable|1
7160294|NCT03525119|11334091|FG000|Overall Study|Adverse Event|0
7160295|NCT03525119|11334092|FG001|Overall Study|Adverse Event|1
7079881|NCT02118597|11189189|FG000|Overall Study|Investigator's decision|1
7079882|NCT02118714|11189193|FG000|Overall Study|Lost to Follow-up|2
7079883|NCT02118714|11189193|FG000|Overall Study|Protocol Violation|1
7079884|NCT02118766|11189199|FG000|Overall Study|Adverse Event|7
7079885|NCT02118766|11189200|FG001|Overall Study|Adverse Event|2
7079886|NCT02118766|11189199|FG000|Overall Study|Withdrawal by Subject|3
7079887|NCT02118766|11189200|FG001|Overall Study|Withdrawal by Subject|6
7079888|NCT02118766|11189199|FG000|Overall Study|Lost to Follow-up|5
7079889|NCT02118766|11189200|FG001|Overall Study|Lost to Follow-up|4
7079890|NCT02118766|11189199|FG000|Overall Study|Withdrawal by parent/guardian|12
7079891|NCT02118766|11189200|FG001|Overall Study|Withdrawal by parent/guardian|18
7079892|NCT02118766|11189199|FG000|Overall Study|Other|3
7079893|NCT02118766|11189200|FG001|Overall Study|Other|1
7079894|NCT02118792|11189208|FG000|Overall Study|Withdrawal by Subject|6
7079895|NCT02118792|11189209|FG001|Overall Study|Withdrawal by Subject|3
7079896|NCT02118792|11189208|FG000|Overall Study|Lost to Follow-up|4
7079897|NCT02118792|11189209|FG001|Overall Study|Lost to Follow-up|4
7079898|NCT02118792|11189208|FG000|Overall Study|Adverse Event|5
7079899|NCT02118792|11189209|FG001|Overall Study|Adverse Event|4
7079900|NCT02118792|11189208|FG000|Overall Study|Withdrawal by parent/guardian|14
7079901|NCT02118792|11189209|FG001|Overall Study|Withdrawal by parent/guardian|20
7079902|NCT02118792|11189208|FG000|Overall Study|Other|1
7079903|NCT02118792|11189209|FG001|Overall Study|Other|6
7079904|NCT02118792|11189208|FG000|Overall Study|Randomised but not treated|1
7079905|NCT02118792|11189209|FG001|Overall Study|Randomised but not treated|0
7079906|NCT02118896|11189240|FG000|Overall Study|Death|4
7160296|NCT03525119|11334093|FG002|Overall Study|Adverse Event|0
7160297|NCT03525119|11334091|FG000|Overall Study|Lost to Follow-up|32
7160298|NCT03525119|11334092|FG001|Overall Study|Lost to Follow-up|33
7160299|NCT03525119|11334093|FG002|Overall Study|Lost to Follow-up|37
7160300|NCT03525119|11334091|FG000|Overall Study|Withdrawal by Subject|5
7160301|NCT03525119|11334092|FG001|Overall Study|Withdrawal by Subject|4
7160302|NCT03525119|11334093|FG002|Overall Study|Withdrawal by Subject|2
7160303|NCT03525119|11334091|FG000|Overall Study|Reason not Specified|2
7160304|NCT03525119|11334092|FG001|Overall Study|Reason not Specified|1
7160305|NCT03525119|11334093|FG002|Overall Study|Reason not Specified|2
7160306|NCT03525119|11334091|FG000|Overall Study|Randomized but not Vaccinated|1
7160307|NCT03525119|11334092|FG001|Overall Study|Randomized but not Vaccinated|0
7160308|NCT03525119|11334093|FG002|Overall Study|Randomized but not Vaccinated|2
7160309|NCT03525444|11334114|FG000|Overall Study|Adverse Event|0
7160310|NCT03525444|11334115|FG001|Overall Study|Adverse Event|1
7160311|NCT03525444|11334114|FG000|Overall Study|Withdrawal of consent (not due to AE)|0
7160312|NCT03525444|11334115|FG001|Overall Study|Withdrawal of consent (not due to AE)|1
7160313|NCT03525444|11334114|FG000|Overall Study|Other|0
7160314|NCT03525444|11334115|FG001|Overall Study|Other|1
7160315|NCT03525834|11334131|FG000|Overall Study|Progressive disease|1
7160316|NCT03526458|11334145|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2
7160317|NCT03526458|11334146|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2
7160318|NCT03526458|11334145|FG000|Overall Study|Stone passed, surgery cancelled|2
7160319|NCT03526458|11334146|FG001|Overall Study|Stone passed, surgery cancelled|1
7160320|NCT03526458|11334145|FG000|Overall Study|Withdrawal by Subject|1
7160321|NCT03526458|11334146|FG001|Overall Study|Withdrawal by Subject|0
7160322|NCT03526458|11334145|FG000|Overall Study|Physician Decision|2
7160323|NCT03526458|11334146|FG001|Overall Study|Physician Decision|1
7160324|NCT03526458|11334145|FG000|Overall Study|Lack of equipment|1
7160325|NCT03526458|11334146|FG001|Overall Study|Lack of equipment|1
7160326|NCT03526861|11334155|FG000|Initial Treatment Period|Not dosed|1
7160327|NCT03526861|11334156|FG001|Initial Treatment Period|Not dosed|1
7160328|NCT03526861|11334157|FG002|Initial Treatment Period|Not dosed|1
7160329|NCT03526861|11334158|FG003|Initial Treatment Period|Not dosed|0
7160330|NCT03526861|11334159|FG004|Initial Treatment Period|Not dosed|0
7160331|NCT03526861|11334160|FG005|Initial Treatment Period|Not dosed|0
7160332|NCT03526861|11334161|FG006|Initial Treatment Period|Not dosed|0
7160333|NCT03526861|11334162|FG007|Initial Treatment Period|Not dosed|0
7160334|NCT03526861|11334163|FG008|Initial Treatment Period|Not dosed|0
7160335|NCT03526861|11334155|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3
7160336|NCT03526861|11334156|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1
7160337|NCT03526861|11334157|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5
7160338|NCT03526861|11334158|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7160339|NCT03526861|11334159|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7160340|NCT03526861|11334160|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7160341|NCT03526861|11334161|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7160342|NCT03526861|11334162|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7160343|NCT03526861|11334163|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7160344|NCT03526861|11334155|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3
7160345|NCT03526861|11334156|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5
7160346|NCT03526861|11334157|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8
7160347|NCT03526861|11334158|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0
7160348|NCT03526861|11334159|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0
7160349|NCT03526861|11334160|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0
7160350|NCT03526861|11334161|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0
7160351|NCT03526861|11334162|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0
7160352|NCT03526861|11334163|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0
7160353|NCT03526861|11334155|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7160354|NCT03526861|11334156|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7160355|NCT03526861|11334157|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7160356|NCT03526861|11334158|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1
7160357|NCT03526861|11334159|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1
7160358|NCT03526861|11334160|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7160359|NCT03526861|11334161|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1
7160360|NCT03526861|11334162|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7160361|NCT03526861|11334163|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7160362|NCT03526861|11334155|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0
7184285|NCT01917318|11384344|FG000|First Treatment|Withdrawal by Subject|0
7160363|NCT03526861|11334156|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0
7160364|NCT03526861|11334157|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0
7160365|NCT03526861|11334158|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6
7160366|NCT03526861|11334159|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5
7160367|NCT03526861|11334160|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4
7160368|NCT03526861|11334161|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5
7160369|NCT03526861|11334162|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2
7160370|NCT03526861|11334163|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0
7160371|NCT03526861|11334155|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7160372|NCT03526861|11334156|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7160373|NCT03526861|11334157|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7160374|NCT03526861|11334158|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1
7160375|NCT03526861|11334159|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7160376|NCT03526861|11334160|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7160377|NCT03526861|11334161|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7160378|NCT03526861|11334162|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7160379|NCT03526861|11334163|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7160380|NCT03526861|11334155|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7160381|NCT03526861|11334156|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7160382|NCT03526861|11334157|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7079907|NCT02118896|11189241|FG001|Overall Study|Death|0
7079908|NCT02118896|11189242|FG002|Overall Study|Death|4
7079909|NCT02118896|11189243|FG003|Overall Study|Death|6
7079910|NCT02118896|11189244|FG004|Overall Study|Death|3
7079911|NCT02118896|11189245|FG005|Overall Study|Death|1
7160383|NCT03526861|11334158|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7160384|NCT03526861|11334159|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7160385|NCT03526861|11334160|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7160386|NCT03526861|11334161|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7160387|NCT03526861|11334162|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7160388|NCT03526861|11334163|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19
7160389|NCT03526861|11334155|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
7160390|NCT03526861|11334156|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
7160391|NCT03526861|11334157|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
7160392|NCT03526861|11334158|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
7160393|NCT03526861|11334159|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
7160394|NCT03526861|11334160|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
7160395|NCT03526861|11334161|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
7160396|NCT03526861|11334162|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
7160397|NCT03526861|11334163|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1
7160398|NCT03526861|11334155|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7079912|NCT02118896|11189246|FG006|Overall Study|Death|0
7079913|NCT02118896|11189247|FG007|Overall Study|Death|0
7079914|NCT02118896|11189248|FG008|Overall Study|Death|0
7079915|NCT02118896|11189249|FG009|Overall Study|Death|0
7079916|NCT02118896|11189240|FG000|Overall Study|Adverse Event|5
7079917|NCT02118896|11189241|FG001|Overall Study|Adverse Event|4
7079918|NCT02118896|11189242|FG002|Overall Study|Adverse Event|4
7079919|NCT02118896|11189243|FG003|Overall Study|Adverse Event|5
7079920|NCT02118896|11189244|FG004|Overall Study|Adverse Event|5
7079921|NCT02118896|11189245|FG005|Overall Study|Adverse Event|9
7079922|NCT02118896|11189246|FG006|Overall Study|Adverse Event|1
7079923|NCT02118896|11189247|FG007|Overall Study|Adverse Event|1
7079924|NCT02118896|11189248|FG008|Overall Study|Adverse Event|4
7079925|NCT02118896|11189249|FG009|Overall Study|Adverse Event|0
7079926|NCT02118896|11189240|FG000|Overall Study|Consent withdrawn|2
7079927|NCT02118896|11189241|FG001|Overall Study|Consent withdrawn|0
7079928|NCT02118896|11189242|FG002|Overall Study|Consent withdrawn|3
7079929|NCT02118896|11189243|FG003|Overall Study|Consent withdrawn|4
7160399|NCT03526861|11334156|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7160400|NCT03526861|11334157|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7160401|NCT03526861|11334158|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7160402|NCT03526861|11334159|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7160403|NCT03526861|11334160|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7160404|NCT03526861|11334161|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7160405|NCT03526861|11334162|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7160406|NCT03526861|11334163|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8
7160407|NCT03527160|11334185|FG000|Overall Study|No urine collected|13
7160408|NCT03527160|11334185|FG000|Overall Study|No clinical serum creatinine collected|6
7160409|NCT03527160|11334185|FG000|Overall Study|Did not meet inclusion|2
7160410|NCT03527173|11334194|FG000|Overall Study|Lost to Follow-up|4
7160411|NCT03527173|11334195|FG001|Overall Study|Lost to Follow-up|2
7160412|NCT03527173|11334194|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1
7160413|NCT03527173|11334195|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0
7160414|NCT03527173|11334194|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1
7160415|NCT03527173|11334195|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5
7160416|NCT03527173|11334194|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1
7160417|NCT03527173|11334195|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
7160418|NCT03527550|11334203|FG000|Overall Study|Lost to Follow-up|4
7160419|NCT03527550|11334204|FG001|Overall Study|Lost to Follow-up|2
7160420|NCT03527550|11334203|FG000|Overall Study|Withdrawal by Subject|4
7160421|NCT03527550|11334204|FG001|Overall Study|Withdrawal by Subject|1
7160422|NCT03527550|11334203|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1
7160423|NCT03527550|11334204|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0
7160424|NCT03527745|11334238|FG000|Overall Study|Lost to Follow-up|3
7160425|NCT03527745|11334239|FG001|Overall Study|Lost to Follow-up|6
7160426|NCT03527745|11334240|FG002|Overall Study|Lost to Follow-up|7
7160427|NCT03527745|11334241|FG003|Overall Study|Lost to Follow-up|9
7160428|NCT03527745|11334242|FG004|Overall Study|Lost to Follow-up|0
7160429|NCT03527745|11334243|FG005|Overall Study|Lost to Follow-up|2
7160430|NCT03527745|11334244|FG006|Overall Study|Lost to Follow-up|3
7160431|NCT03527745|11334245|FG007|Overall Study|Lost to Follow-up|2
7160432|NCT03527745|11334246|FG008|Overall Study|Lost to Follow-up|3
7160433|NCT03527745|11334247|FG009|Overall Study|Lost to Follow-up|2
7160434|NCT03527745|11334248|FG010|Overall Study|Lost to Follow-up|1
7160435|NCT03527745|11334249|FG011|Overall Study|Lost to Follow-up|1
7160436|NCT03527745|11334250|FG012|Overall Study|Lost to Follow-up|0
7160437|NCT03527745|11334251|FG013|Overall Study|Lost to Follow-up|0
7160438|NCT03527745|11334252|FG014|Overall Study|Lost to Follow-up|0
7160439|NCT03527745|11334253|FG015|Overall Study|Lost to Follow-up|0
7160440|NCT03527745|11334254|FG016|Overall Study|Lost to Follow-up|1
7160441|NCT03527745|11334255|FG017|Overall Study|Lost to Follow-up|0
7160442|NCT03527745|11334256|FG018|Overall Study|Lost to Follow-up|0
7160443|NCT03527745|11334257|FG019|Overall Study|Lost to Follow-up|1
7160444|NCT03527745|11334258|FG020|Overall Study|Lost to Follow-up|1
7160445|NCT03527745|11334259|FG021|Overall Study|Lost to Follow-up|5
7160446|NCT03527745|11334260|FG022|Overall Study|Lost to Follow-up|6
7160447|NCT03527745|11334261|FG023|Overall Study|Lost to Follow-up|8
7160448|NCT03527745|11334262|FG024|Overall Study|Lost to Follow-up|1
7160449|NCT03527745|11334263|FG025|Overall Study|Lost to Follow-up|3
7160450|NCT03527966|11334321|FG000|Overall Study|Lost to Follow-up|3
7160451|NCT03527966|11334322|FG001|Overall Study|Lost to Follow-up|0
7160452|NCT03528174|11334328|FG000|Overall Study|Adverse Event|1
7160453|NCT03528174|11334328|FG000|Overall Study|sensors dislodged|1
7160454|NCT03528369|11334335|FG000|Overall Study|Withdrawal by Subject|2
7160455|NCT03528369|11334336|FG001|Overall Study|Withdrawal by Subject|0
7160456|NCT03528369|11334337|FG002|Overall Study|Withdrawal by Subject|0
7160457|NCT03528369|11334335|FG000|Overall Study|Lost to Follow-up|1
7160458|NCT03528369|11334336|FG001|Overall Study|Lost to Follow-up|0
7160459|NCT03528369|11334337|FG002|Overall Study|Lost to Follow-up|0
7160460|NCT03528369|11334335|FG000|Overall Study|Adverse Event|0
7160461|NCT03528369|11334336|FG001|Overall Study|Adverse Event|1
7160462|NCT03528369|11334337|FG002|Overall Study|Adverse Event|0
7160463|NCT03528551|11334357|FG000|Overall Study|Lost to Follow-up|0
7160464|NCT03528551|11334358|FG001|Overall Study|Lost to Follow-up|1
7160465|NCT03528551|11334359|FG002|Overall Study|Lost to Follow-up|0
7160466|NCT03528551|11334357|FG000|Overall Study|Transferred to other arm/group|2
7160467|NCT03528551|11334358|FG001|Overall Study|Transferred to other arm/group|3
7160468|NCT03528551|11334359|FG002|Overall Study|Transferred to other arm/group|0
7160469|NCT03528551|11334357|FG000|Overall Study|Withdrawal by parent/guardian|0
7160470|NCT03528551|11334358|FG001|Overall Study|Withdrawal by parent/guardian|5
7160471|NCT03528551|11334359|FG002|Overall Study|Withdrawal by parent/guardian|0
7160472|NCT03528551|11334357|FG000|Overall Study|Protocol Violation|0
7160473|NCT03528551|11334358|FG001|Overall Study|Protocol Violation|3
7160474|NCT03528551|11334359|FG002|Overall Study|Protocol Violation|0
7160475|NCT03528551|11334357|FG000|Overall Study|Withdrawal by Subject|0
7160476|NCT03528551|11334358|FG001|Overall Study|Withdrawal by Subject|7
7160477|NCT03528551|11334359|FG002|Overall Study|Withdrawal by Subject|0
7160478|NCT03528577|11334368|FG000|Sequence 1|Failed Spirometry|1
7160479|NCT03528577|11334368|FG000|Sequence 1|Restricted medication|1
7160480|NCT03528577|11334368|FG000|Sequence 2|Adverse Event|1
7160481|NCT03528577|11334368|FG000|Sequence 2|Withdrawal by Subject|1
7160482|NCT03528577|11334368|FG000|Sequence 2|Failed Spirometry|1
7160483|NCT03528577|11334368|FG000|Sequence 3|Failed Spirometry|1
7160484|NCT03528577|11334368|FG000|Sequence 4|Failed Spirometry|2
7160485|NCT03528577|11334368|FG000|Sequence 4|Adverse Event|1
7160486|NCT03529162|11334377|FG000|Overall Study|Lost to Follow-up|2
7160487|NCT03529162|11334378|FG001|Overall Study|Lost to Follow-up|2
7160488|NCT03530345|11334408|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1
7160489|NCT03530345|11334409|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0
7160490|NCT03530345|11334408|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3
7160491|NCT03530345|11334409|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1
7160492|NCT03530345|11334408|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17
7160493|NCT03530345|11334409|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21
7160494|NCT03530345|11334408|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5
7160495|NCT03530345|11334409|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7
7160496|NCT03531840|11334499|FG000|Overall Study|Death on study|3
7160497|NCT03531840|11334500|FG001|Overall Study|Death on study|2
7160498|NCT03531840|11334501|FG002|Overall Study|Death on study|1
7160499|NCT03531840|11334502|FG003|Overall Study|Death on study|2
7160500|NCT03531840|11334499|FG000|Overall Study|Death during follow up|2
7160501|NCT03531840|11334500|FG001|Overall Study|Death during follow up|3
7160502|NCT03531840|11334501|FG002|Overall Study|Death during follow up|4
7160503|NCT03531840|11334502|FG003|Overall Study|Death during follow up|1
7160504|NCT03531905|11334520|FG000|Overall Study|Withdrawal by Subject|3
7160505|NCT03531905|11334521|FG001|Overall Study|Withdrawal by Subject|3
7160506|NCT03531905|11334522|FG002|Overall Study|Withdrawal by Subject|2
7160507|NCT03531905|11334520|FG000|Overall Study|Lost to Follow-up|2
7160508|NCT03531905|11334521|FG001|Overall Study|Lost to Follow-up|2
7160509|NCT03531905|11334522|FG002|Overall Study|Lost to Follow-up|1
7160510|NCT03531905|11334520|FG000|Overall Study|Participant was out of town|1
7160511|NCT03531905|11334521|FG001|Overall Study|Participant was out of town|0
7160512|NCT03531905|11334522|FG002|Overall Study|Participant was out of town|0
7160513|NCT03531905|11334520|FG000|Overall Study|Could not speak with the participant|1
7160514|NCT03531905|11334521|FG001|Overall Study|Could not speak with the participant|0
7160515|NCT03531905|11334522|FG002|Overall Study|Could not speak with the participant|0
7160516|NCT03532009|11334534|FG000|Overall Study|Other|1
7160517|NCT03532009|11334535|FG001|Overall Study|Other|1
7160518|NCT03532009|11334534|FG000|Overall Study|Death|1
7160519|NCT03532009|11334535|FG001|Overall Study|Death|1
7160520|NCT03532009|11334534|FG000|Overall Study|Withdrawal by Patient|0
7160521|NCT03532009|11334535|FG001|Overall Study|Withdrawal by Patient|2
7160522|NCT03532048|11334543|FG000|Overall Study|Lost to Follow-up|12
7160523|NCT03532048|11334544|FG001|Overall Study|Lost to Follow-up|17
7160524|NCT03532048|11334543|FG000|Overall Study|Withdrawal by Subject|7
7160525|NCT03532048|11334544|FG001|Overall Study|Withdrawal by Subject|0
7160526|NCT03533114|11334584|FG000|Overall|Adverse Event|16
7160527|NCT03533114|11334585|FG001|Overall|Adverse Event|11
7160528|NCT03533114|11334584|FG000|Overall|Consent Withdrawal by Participant|7
7160529|NCT03533114|11334585|FG001|Overall|Consent Withdrawal by Participant|6
7160530|NCT03533114|11334584|FG000|Overall|Lack of Efficacy|5
7160531|NCT03533114|11334585|FG001|Overall|Lack of Efficacy|3
7160532|NCT03533114|11334584|FG000|Overall|Lost to Follow-up|1
7160533|NCT03533114|11334585|FG001|Overall|Lost to Follow-up|1
7160534|NCT03533114|11334584|FG000|Overall|Physician Decision|0
7160535|NCT03533114|11334585|FG001|Overall|Physician Decision|2
7160536|NCT03533114|11334584|FG000|Overall|Protocol deviation|1
7160537|NCT03533114|11334585|FG001|Overall|Protocol deviation|1
7160538|NCT03533114|11334584|FG000|Overall|Failure to meet randomization criteria|1
7160539|NCT03533114|11334585|FG001|Overall|Failure to meet randomization criteria|2
7160540|NCT03533114|11334584|FG000|Overall|Non-Compliance with study drug|0
7160541|NCT03533114|11334585|FG001|Overall|Non-Compliance with study drug|1
7160542|NCT03533114|11334584|FG000|Overall|Other|0
7160543|NCT03533114|11334585|FG001|Overall|Other|1
7160544|NCT03533114|11334584|FG000|Open Label Titration and Optimization|Adverse Event|11
7160545|NCT03533114|11334585|FG001|Open Label Titration and Optimization|Adverse Event|8
7160546|NCT03533114|11334584|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2
7160547|NCT03533114|11334585|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1
7160548|NCT03533114|11334584|FG000|Open Label Titration and Optimization|Lack of Efficacy|3
7160549|NCT03533114|11334585|FG001|Open Label Titration and Optimization|Lack of Efficacy|1
7160550|NCT03533114|11334584|FG000|Open Label Titration and Optimization|Lost to Follow-up|0
7160551|NCT03533114|11334585|FG001|Open Label Titration and Optimization|Lost to Follow-up|1
7160552|NCT03533114|11334584|FG000|Open Label Titration and Optimization|Protocol Deviation|0
7160553|NCT03533114|11334585|FG001|Open Label Titration and Optimization|Protocol Deviation|1
7160554|NCT03533114|11334584|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0
7160555|NCT03533114|11334585|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1
7160556|NCT03533114|11334584|FG000|Stable Dose|Adverse Event|0
7160557|NCT03533114|11334585|FG001|Stable Dose|Adverse Event|2
7160558|NCT03533114|11334584|FG000|Stable Dose|Consent Withdrawal by Participant|1
7160559|NCT03533114|11334585|FG001|Stable Dose|Consent Withdrawal by Participant|0
7160560|NCT03533114|11334584|FG000|Stable Dose|Lack of Efficacy|1
7160561|NCT03533114|11334585|FG001|Stable Dose|Lack of Efficacy|0
7160562|NCT03533114|11334584|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1
6894770|NCT00621322|10912560|FG004|Overall Study|Physician Decision|0
6894771|NCT00621322|10912561|FG005|Overall Study|Physician Decision|0
6894772|NCT00621322|10912556|FG000|Overall Study|Withdrawal by Subject|0
6894773|NCT00621322|10912557|FG001|Overall Study|Withdrawal by Subject|0
6894774|NCT00621322|10912558|FG002|Overall Study|Withdrawal by Subject|0
6894775|NCT00621322|10912559|FG003|Overall Study|Withdrawal by Subject|1
6894776|NCT00621322|10912560|FG004|Overall Study|Withdrawal by Subject|0
6894777|NCT00621322|10912561|FG005|Overall Study|Withdrawal by Subject|2
6894778|NCT00621322|10912556|FG000|Overall Study|Migrated/moved from study area|1
6894779|NCT00621322|10912557|FG001|Overall Study|Migrated/moved from study area|0
6894780|NCT00621322|10912558|FG002|Overall Study|Migrated/moved from study area|1
6894781|NCT00621322|10912559|FG003|Overall Study|Migrated/moved from study area|1
6894782|NCT00621322|10912560|FG004|Overall Study|Migrated/moved from study area|0
6894783|NCT00621322|10912561|FG005|Overall Study|Migrated/moved from study area|2
6894784|NCT00621504|10912590|FG000|Overall Study|Adverse Event|1
6894785|NCT00621504|10912591|FG001|Overall Study|Adverse Event|3
6894786|NCT00621504|10912590|FG000|Overall Study|At the request of sponsor/investigator|1
6894787|NCT00621504|10912591|FG001|Overall Study|At the request of sponsor/investigator|0
6894788|NCT00621504|10912590|FG000|Overall Study|Withdrew consent|9
6894789|NCT00621504|10912591|FG001|Overall Study|Withdrew consent|6
6894790|NCT00621504|10912590|FG000|Overall Study|Lost to Follow-up|8
6894791|NCT00621504|10912591|FG001|Overall Study|Lost to Follow-up|10
6894792|NCT00621504|10912590|FG000|Overall Study|Other|1
6894793|NCT00621504|10912591|FG001|Overall Study|Other|0
6894794|NCT00621504|10912590|FG000|Overall Study|Death|6
6894795|NCT00621504|10912591|FG001|Overall Study|Death|6
6894796|NCT00621517|10912599|FG000|Overall Study|Lost to Follow-up|3
6894797|NCT00621517|10912600|FG001|Overall Study|Lost to Follow-up|3
6894798|NCT00621517|10912599|FG000|Overall Study|Withdrawal by Subject|3
6894799|NCT00621517|10912600|FG001|Overall Study|Withdrawal by Subject|4
6894800|NCT00621517|10912599|FG000|Overall Study|Adverse Event|1
6894801|NCT00621517|10912600|FG001|Overall Study|Adverse Event|0
6894802|NCT00621543|10912618|FG000|Overall Study|Lost to Follow-up|23
6894803|NCT00621582|10912622|FG000|Overall Study|Adverse Event|7
6894804|NCT00621582|10912622|FG000|Overall Study|Protocol Violation|57
6894805|NCT00621582|10912622|FG000|Overall Study|Lost to Follow-up|24
6894806|NCT00621582|10912622|FG000|Overall Study|issues not identified by investigators|18
6894807|NCT00621621|10912629|FG000|Overall Study|Subjects were exited at EP study|30
6894808|NCT00621621|10912630|FG001|Overall Study|Subjects were exited at EP study|0
6894809|NCT00621764|10912652|FG000|Overall Study|Protocol Violation|0
6894810|NCT00621764|10912653|FG001|Overall Study|Protocol Violation|0
6894811|NCT00621764|10912654|FG002|Overall Study|Protocol Violation|0
6894812|NCT00621764|10912655|FG003|Overall Study|Protocol Violation|1
6894813|NCT00621777|10912668|FG000|Open Phase|Adverse Event|20
6894814|NCT00621777|10912669|FG001|Open Phase|Adverse Event|0
6894815|NCT00621777|10912668|FG000|Open Phase|Did not abstain during open phase|56
6894816|NCT00621777|10912669|FG001|Open Phase|Did not abstain during open phase|0
6894817|NCT00621777|10912668|FG000|Open Phase|Withdrawal by Subject|17
6894818|NCT00621777|10912669|FG001|Open Phase|Withdrawal by Subject|0
6894819|NCT00621777|10912668|FG000|Open Phase|administrative|13
6894820|NCT00621777|10912669|FG001|Open Phase|administrative|0
6894821|NCT00621777|10912668|FG000|Open Phase|Lost to Follow-up|10
6894822|NCT00621777|10912669|FG001|Open Phase|Lost to Follow-up|0
6894823|NCT00621777|10912668|FG000|Randomized Phase|Adverse Event|3
6894824|NCT00621777|10912669|FG001|Randomized Phase|Adverse Event|3
6894825|NCT00621777|10912668|FG000|Randomized Phase|Lost to Follow-up|3
6894826|NCT00621777|10912669|FG001|Randomized Phase|Lost to Follow-up|3
6894827|NCT00621777|10912668|FG000|Randomized Phase|Withdrawal by Subject|1
6894828|NCT00621777|10912669|FG001|Randomized Phase|Withdrawal by Subject|9
7160563|NCT03533114|11334585|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1
6894829|NCT00621777|10912668|FG000|Randomized Phase|administrative|0
6894830|NCT00621777|10912669|FG001|Randomized Phase|administrative|3
6894831|NCT00621777|10912668|FG000|Randomized Phase|Death|0
6894832|NCT00621777|10912669|FG001|Randomized Phase|Death|1
6894833|NCT00621842|10912677|FG000|Overall Study|Adverse Event|6
6894834|NCT00621842|10912677|FG000|Overall Study|Withdrawal by Subject|7
6894835|NCT00621842|10912677|FG000|Overall Study|Protocol Violation|4
6894836|NCT00621842|10912677|FG000|Overall Study|Lack of Efficacy|2
6894837|NCT00621855|10912686|FG000|Overall Study|Adverse Event|32
6894838|NCT00621855|10912687|FG001|Overall Study|Adverse Event|31
6894839|NCT00621855|10912688|FG002|Overall Study|Adverse Event|48
6894840|NCT00621855|10912689|FG003|Overall Study|Adverse Event|34
6894841|NCT00621855|10912690|FG004|Overall Study|Adverse Event|31
6894842|NCT00621855|10912686|FG000|Overall Study|Lost to Follow-up|0
6894843|NCT00621855|10912687|FG001|Overall Study|Lost to Follow-up|1
6894844|NCT00621855|10912688|FG002|Overall Study|Lost to Follow-up|3
6894845|NCT00621855|10912689|FG003|Overall Study|Lost to Follow-up|4
6894846|NCT00621855|10912690|FG004|Overall Study|Lost to Follow-up|1
6894847|NCT00621855|10912686|FG000|Overall Study|Protocol Violation|16
6894848|NCT00621855|10912687|FG001|Overall Study|Protocol Violation|8
6894849|NCT00621855|10912688|FG002|Overall Study|Protocol Violation|6
6894850|NCT00621855|10912689|FG003|Overall Study|Protocol Violation|7
6894851|NCT00621855|10912690|FG004|Overall Study|Protocol Violation|8
6894852|NCT00621855|10912686|FG000|Overall Study|Withdrawal by Subject|16
6894853|NCT00621855|10912687|FG001|Overall Study|Withdrawal by Subject|11
6894854|NCT00621855|10912688|FG002|Overall Study|Withdrawal by Subject|13
6894855|NCT00621855|10912689|FG003|Overall Study|Withdrawal by Subject|13
6894856|NCT00621855|10912690|FG004|Overall Study|Withdrawal by Subject|9
6894857|NCT00621855|10912686|FG000|Overall Study|Other|9
6894858|NCT00621855|10912687|FG001|Overall Study|Other|7
6894859|NCT00621855|10912688|FG002|Overall Study|Other|6
6894860|NCT00621855|10912689|FG003|Overall Study|Other|5
6894861|NCT00621855|10912690|FG004|Overall Study|Other|4
6894862|NCT00621855|10912686|FG000|Overall Study|Patients did not receive study drug|3
6894863|NCT00621855|10912687|FG001|Overall Study|Patients did not receive study drug|3
6894864|NCT00621855|10912688|FG002|Overall Study|Patients did not receive study drug|5
6894865|NCT00621855|10912689|FG003|Overall Study|Patients did not receive study drug|4
6894866|NCT00621855|10912690|FG004|Overall Study|Patients did not receive study drug|2
6894867|NCT00621959|10912718|FG000|Overall Study|Adverse Event|4
6894868|NCT00621959|10912719|FG001|Overall Study|Adverse Event|2
6894869|NCT00621959|10912718|FG000|Overall Study|Lack of Efficacy|1
6894870|NCT00621959|10912719|FG001|Overall Study|Lack of Efficacy|1
6894871|NCT00621959|10912718|FG000|Overall Study|Lost to Follow-up|0
6894872|NCT00621959|10912719|FG001|Overall Study|Lost to Follow-up|2
6894873|NCT00621959|10912718|FG000|Overall Study|Withdrawal by Subject|1
6894874|NCT00621959|10912719|FG001|Overall Study|Withdrawal by Subject|1
6894875|NCT00621959|10912718|FG000|Overall Study|Other|1
6894876|NCT00621959|10912719|FG001|Overall Study|Other|3
6894877|NCT00621985|10912725|FG000|Dexamethasone Admission|Adverse Event|1
6894878|NCT00622180|10912731|FG000|Overall Study|Lost to Follow-up|1
7079930|NCT02118896|11189244|FG004|Overall Study|Consent withdrawn|1
7079931|NCT02118896|11189245|FG005|Overall Study|Consent withdrawn|4
7079932|NCT02118896|11189246|FG006|Overall Study|Consent withdrawn|0
7079933|NCT02118896|11189247|FG007|Overall Study|Consent withdrawn|0
7079934|NCT02118896|11189248|FG008|Overall Study|Consent withdrawn|0
7079935|NCT02118896|11189249|FG009|Overall Study|Consent withdrawn|0
7160564|NCT03533114|11334584|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1
6894879|NCT00622180|10912732|FG001|Overall Study|Lost to Follow-up|2
6894880|NCT00622284|10912740|FG000|Overall Study|Lack of Efficacy|45
6894881|NCT00622284|10912741|FG001|Overall Study|Lack of Efficacy|15
6894882|NCT00622284|10912740|FG000|Overall Study|Adverse Event|61
6894883|NCT00622284|10912741|FG001|Overall Study|Adverse Event|90
6894884|NCT00622284|10912740|FG000|Overall Study|Protocol Violation|12
6894885|NCT00622284|10912741|FG001|Overall Study|Protocol Violation|5
6894886|NCT00622284|10912740|FG000|Overall Study|Lost to Follow-up|11
6894887|NCT00622284|10912741|FG001|Overall Study|Lost to Follow-up|13
6894888|NCT00622284|10912740|FG000|Overall Study|Withdrawal by Subject|27
6894889|NCT00622284|10912741|FG001|Overall Study|Withdrawal by Subject|24
7160565|NCT03533114|11334585|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0
7160566|NCT03533114|11334584|FG000|Open-Label Safety Extension|Adverse Event|3
7160567|NCT03533114|11334585|FG001|Open-Label Safety Extension|Adverse Event|0
7160568|NCT03533114|11334584|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2
7160569|NCT03533114|11334585|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3
7160570|NCT03533114|11334584|FG000|Open-Label Safety Extension|Lack of Efficacy|1
7160571|NCT03533114|11334585|FG001|Open-Label Safety Extension|Lack of Efficacy|0
7160572|NCT03533114|11334584|FG000|Open-Label Safety Extension|Lost to Follow-up|1
7160573|NCT03533114|11334585|FG001|Open-Label Safety Extension|Lost to Follow-up|0
7160574|NCT03533114|11334584|FG000|Open-Label Safety Extension|Protocol Deviation|1
7160575|NCT03533114|11334585|FG001|Open-Label Safety Extension|Protocol Deviation|0
7160576|NCT03533608|11334615|FG000|Overall Study|Withdrawal by Subject|3
7160577|NCT03533608|11334615|FG000|Overall Study|Physician Decision|2
7160578|NCT03535194|11334660|FG000|Induction Period|Adverse Event|2
7160579|NCT03535194|11334661|FG001|Induction Period|Adverse Event|2
6894890|NCT00622284|10912740|FG000|Overall Study|Other reason (not specified)|33
6894891|NCT00622284|10912741|FG001|Overall Study|Other reason (not specified)|24
6894892|NCT00622336|10912747|FG000|Treatment Phase|Progression of Disease|181
6894893|NCT00622336|10912747|FG000|Treatment Phase|Adverse Event|46
6894894|NCT00622336|10912747|FG000|Treatment Phase|Other|40
6894895|NCT00622336|10912747|FG000|Treatment Phase|Death|14
6894896|NCT00622336|10912747|FG000|Treatment Phase|Lack of therapeutic effect|13
6894897|NCT00622336|10912747|FG000|Treatment Phase|Withdrawal by Subject|13
6894898|NCT00622336|10912747|FG000|Treatment Phase|Lost to Follow-up|2
6894899|NCT00622336|10912747|FG000|Extension Phase|Adverse Event|2
6894900|NCT00622336|10912747|FG000|Extension Phase|Progressive Disease|6
6894901|NCT00622336|10912747|FG000|Extension Phase|Lack of therapeutic effect|2
7160580|NCT03535194|11334662|FG002|Induction Period|Adverse Event|1
7160581|NCT03535194|11334663|FG003|Induction Period|Adverse Event|3
7079936|NCT02118896|11189240|FG000|Overall Study|Non-compliance|2
6894902|NCT00622336|10912747|FG000|Extension Phase|Withdrawal by Subject|1
6894903|NCT00622336|10912747|FG000|Extension Phase|Lost to Follow-up|1
6894904|NCT00622336|10912747|FG000|Extension Phase|Other|9
6894905|NCT00622388|10912753|FG000|Overall Study|Disease Progression|47
6894906|NCT00622388|10912753|FG000|Overall Study|Adverse Event|6
6894907|NCT00622388|10912753|FG000|Overall Study|Protocol Violation|3
6894908|NCT00622388|10912753|FG000|Overall Study|Participant Refusal|1
6894909|NCT00622388|10912753|FG000|Overall Study|Death|3
6894910|NCT00622388|10912753|FG000|Overall Study|Received Alternate Anticancer Therapy|8
6894911|NCT00622388|10912753|FG000|Overall Study|Took Prohibited Medication|2
6894912|NCT00622388|10912753|FG000|Overall Study|Withdrew Consent|1
6894913|NCT00622388|10912753|FG000|Overall Study|Insurance Expired|1
6894914|NCT00622401|10912761|FG000|Overall Study|Disease progression prior to treatment|3
6894915|NCT00622401|10912762|FG001|Overall Study|Disease progression prior to treatment|2
6894916|NCT00622401|10912763|FG002|Overall Study|Disease progression prior to treatment|0
6894917|NCT00622440|10912783|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4
6894918|NCT00622440|10912784|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1
6894919|NCT00622440|10912783|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3
6894920|NCT00622440|10912784|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5
6894921|NCT00622440|10912783|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0
6894922|NCT00622440|10912784|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1
6894923|NCT00622440|10912783|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0
6894924|NCT00622440|10912784|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1
6894925|NCT00622466|10912790|FG000|Overall Study|Death|1
6894926|NCT00622466|10912790|FG000|Overall Study|Adverse Event|1
6894927|NCT00622466|10912790|FG000|Overall Study|Withdrawal by Subject|2
6894928|NCT00622505|10912796|FG000|Overall Study|Adverse Event|9
6894929|NCT00622505|10912797|FG001|Overall Study|Adverse Event|7
6894930|NCT00622505|10912796|FG000|Overall Study|Abnormal Laboratory Value(s)|3
6894931|NCT00622505|10912797|FG001|Overall Study|Abnormal Laboratory Value(s)|5
6894932|NCT00622505|10912796|FG000|Overall Study|Abnormal Test Procedure Result(s)|1
6894933|NCT00622505|10912797|FG001|Overall Study|Abnormal Test Procedure Result(s)|0
6894934|NCT00622505|10912796|FG000|Overall Study|Withdrawal by Subject|12
6894935|NCT00622505|10912797|FG001|Overall Study|Withdrawal by Subject|5
6894936|NCT00622505|10912796|FG000|Overall Study|Administrative Problems|2
6894937|NCT00622505|10912797|FG001|Overall Study|Administrative Problems|4
6894938|NCT00622505|10912796|FG000|Overall Study|Death|2
6894939|NCT00622505|10912797|FG001|Overall Study|Death|2
6894940|NCT00622635|10912816|FG000|Treatment Period 1|Adverse Event|0
6894941|NCT00622635|10912817|FG001|Treatment Period 1|Adverse Event|0
6894942|NCT00622635|10912818|FG002|Treatment Period 1|Adverse Event|1
6894943|NCT00622635|10912819|FG003|Treatment Period 1|Adverse Event|0
6894944|NCT00622635|10912820|FG004|Treatment Period 1|Adverse Event|0
6894945|NCT00622635|10912821|FG005|Treatment Period 1|Adverse Event|0
6894946|NCT00622635|10912816|FG000|Treatment Period 1|Withdrawal by Subject|0
6894947|NCT00622635|10912817|FG001|Treatment Period 1|Withdrawal by Subject|1
6894948|NCT00622635|10912818|FG002|Treatment Period 1|Withdrawal by Subject|0
6894949|NCT00622635|10912819|FG003|Treatment Period 1|Withdrawal by Subject|0
6894950|NCT00622635|10912820|FG004|Treatment Period 1|Withdrawal by Subject|0
6894951|NCT00622635|10912821|FG005|Treatment Period 1|Withdrawal by Subject|0
6894952|NCT00622635|10912816|FG000|Treatment Period 1|Abnormal test procedure result(s)|0
6894953|NCT00622635|10912817|FG001|Treatment Period 1|Abnormal test procedure result(s)|0
6894954|NCT00622635|10912818|FG002|Treatment Period 1|Abnormal test procedure result(s)|0
6894955|NCT00622635|10912819|FG003|Treatment Period 1|Abnormal test procedure result(s)|0
6894956|NCT00622635|10912820|FG004|Treatment Period 1|Abnormal test procedure result(s)|1
6894957|NCT00622635|10912821|FG005|Treatment Period 1|Abnormal test procedure result(s)|0
6894958|NCT00622635|10912816|FG000|Treatment Period 2|Adverse Event|1
6894959|NCT00622635|10912817|FG001|Treatment Period 2|Adverse Event|0
6894960|NCT00622635|10912818|FG002|Treatment Period 2|Adverse Event|0
6894961|NCT00622635|10912819|FG003|Treatment Period 2|Adverse Event|0
6894962|NCT00622635|10912820|FG004|Treatment Period 2|Adverse Event|0
6894963|NCT00622635|10912821|FG005|Treatment Period 2|Adverse Event|0
6894964|NCT00622635|10912816|FG000|Treatment Period 3|Adverse Event|0
6894965|NCT00622635|10912817|FG001|Treatment Period 3|Adverse Event|0
6894966|NCT00622635|10912818|FG002|Treatment Period 3|Adverse Event|0
6894967|NCT00622635|10912819|FG003|Treatment Period 3|Adverse Event|2
6894968|NCT00622635|10912820|FG004|Treatment Period 3|Adverse Event|0
6894969|NCT00622635|10912821|FG005|Treatment Period 3|Adverse Event|0
6894970|NCT00622635|10912816|FG000|Treatment Period 3|Withdrawal by Subject|0
6894971|NCT00622635|10912817|FG001|Treatment Period 3|Withdrawal by Subject|0
6894972|NCT00622635|10912818|FG002|Treatment Period 3|Withdrawal by Subject|0
6894973|NCT00622635|10912819|FG003|Treatment Period 3|Withdrawal by Subject|1
6894974|NCT00622635|10912820|FG004|Treatment Period 3|Withdrawal by Subject|0
6894975|NCT00622635|10912821|FG005|Treatment Period 3|Withdrawal by Subject|0
6894976|NCT00622700|10912832|FG000|Core Treatment Period|Randomized but Not Treated|0
6894977|NCT00622700|10912833|FG001|Core Treatment Period|Randomized but Not Treated|2
6894978|NCT00622700|10912834|FG002|Core Treatment Period|Randomized but Not Treated|2
6894979|NCT00622700|10912835|FG003|Core Treatment Period|Randomized but Not Treated|0
6894980|NCT00622700|10912836|FG004|Core Treatment Period|Randomized but Not Treated|0
7041554|NCT01728324|11125171|FG000|Termination of FDV|Other than stated|1
6894981|NCT00622700|10912837|FG005|Core Treatment Period|Randomized but Not Treated|0
6894982|NCT00622700|10912838|FG006|Core Treatment Period|Randomized but Not Treated|0
6894983|NCT00622700|10912832|FG000|Core Treatment Period|Adverse Event|18
6894984|NCT00622700|10912833|FG001|Core Treatment Period|Adverse Event|25
6894985|NCT00622700|10912834|FG002|Core Treatment Period|Adverse Event|18
7160582|NCT03535194|11334664|FG004|Induction Period|Adverse Event|0
7160583|NCT03535194|11334660|FG000|Induction Period|Death|0
7160584|NCT03535194|11334661|FG001|Induction Period|Death|1
7160585|NCT03535194|11334662|FG002|Induction Period|Death|0
7160586|NCT03535194|11334663|FG003|Induction Period|Death|0
7079937|NCT02118896|11189241|FG001|Overall Study|Non-compliance|1
7079938|NCT02118896|11189242|FG002|Overall Study|Non-compliance|1
6894986|NCT00622700|10912835|FG003|Core Treatment Period|Adverse Event|0
6972728|NCT01173601|11023894|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4
7160587|NCT03535194|11334664|FG004|Induction Period|Death|0
7160588|NCT03535194|11334660|FG000|Induction Period|Lack of Efficacy|1
7160589|NCT03535194|11334661|FG001|Induction Period|Lack of Efficacy|3
7160590|NCT03535194|11334662|FG002|Induction Period|Lack of Efficacy|2
7160591|NCT03535194|11334663|FG003|Induction Period|Lack of Efficacy|2
7160592|NCT03535194|11334664|FG004|Induction Period|Lack of Efficacy|0
7160593|NCT03535194|11334660|FG000|Induction Period|Lost to Follow-up|3
7160594|NCT03535194|11334661|FG001|Induction Period|Lost to Follow-up|5
7160595|NCT03535194|11334662|FG002|Induction Period|Lost to Follow-up|2
7160596|NCT03535194|11334663|FG003|Induction Period|Lost to Follow-up|3
7160597|NCT03535194|11334664|FG004|Induction Period|Lost to Follow-up|0
7160598|NCT03535194|11334660|FG000|Induction Period|Physician Decision|1
7160599|NCT03535194|11334661|FG001|Induction Period|Physician Decision|1
7160600|NCT03535194|11334662|FG002|Induction Period|Physician Decision|0
7160601|NCT03535194|11334663|FG003|Induction Period|Physician Decision|0
7160602|NCT03535194|11334664|FG004|Induction Period|Physician Decision|0
7160603|NCT03535194|11334660|FG000|Induction Period|Protocol Violation|1
7160604|NCT03535194|11334661|FG001|Induction Period|Protocol Violation|0
7160605|NCT03535194|11334662|FG002|Induction Period|Protocol Violation|0
7160606|NCT03535194|11334663|FG003|Induction Period|Protocol Violation|1
7160607|NCT03535194|11334664|FG004|Induction Period|Protocol Violation|0
7160608|NCT03535194|11334660|FG000|Induction Period|Screen Failure|0
7160609|NCT03535194|11334661|FG001|Induction Period|Screen Failure|1
7160610|NCT03535194|11334662|FG002|Induction Period|Screen Failure|0
7160611|NCT03535194|11334663|FG003|Induction Period|Screen Failure|0
7160612|NCT03535194|11334664|FG004|Induction Period|Screen Failure|0
7160613|NCT03535194|11334660|FG000|Induction Period|Withdrawal by Subject|3
7160614|NCT03535194|11334661|FG001|Induction Period|Withdrawal by Subject|4
7160615|NCT03535194|11334662|FG002|Induction Period|Withdrawal by Subject|3
7160616|NCT03535194|11334663|FG003|Induction Period|Withdrawal by Subject|2
7160617|NCT03535194|11334664|FG004|Induction Period|Withdrawal by Subject|0
7160618|NCT03535194|11334660|FG000|Maintenance Period|Adverse Event|6
7160619|NCT03535194|11334661|FG001|Maintenance Period|Adverse Event|5
7160620|NCT03535194|11334662|FG002|Maintenance Period|Adverse Event|1
7160621|NCT03535194|11334663|FG003|Maintenance Period|Adverse Event|11
7160622|NCT03535194|11334664|FG004|Maintenance Period|Adverse Event|4
7160623|NCT03535194|11334660|FG000|Maintenance Period|Lack of Efficacy|3
7160624|NCT03535194|11334661|FG001|Maintenance Period|Lack of Efficacy|2
7160625|NCT03535194|11334662|FG002|Maintenance Period|Lack of Efficacy|5
7160626|NCT03535194|11334663|FG003|Maintenance Period|Lack of Efficacy|9
7160627|NCT03535194|11334664|FG004|Maintenance Period|Lack of Efficacy|0
6894987|NCT00622700|10912836|FG004|Core Treatment Period|Adverse Event|0
6894988|NCT00622700|10912837|FG005|Core Treatment Period|Adverse Event|0
7079939|NCT02118896|11189243|FG003|Overall Study|Non-compliance|5
7079940|NCT02118896|11189244|FG004|Overall Study|Non-compliance|0
7079941|NCT02118896|11189245|FG005|Overall Study|Non-compliance|1
7079942|NCT02118896|11189246|FG006|Overall Study|Non-compliance|0
7079943|NCT02118896|11189247|FG007|Overall Study|Non-compliance|1
7079944|NCT02118896|11189248|FG008|Overall Study|Non-compliance|0
7079945|NCT02118896|11189249|FG009|Overall Study|Non-compliance|0
7079946|NCT02118896|11189240|FG000|Overall Study|Pregnancy|1
7079947|NCT02118896|11189241|FG001|Overall Study|Pregnancy|1
7079948|NCT02118896|11189242|FG002|Overall Study|Pregnancy|0
7079949|NCT02118896|11189243|FG003|Overall Study|Pregnancy|0
7079950|NCT02118896|11189244|FG004|Overall Study|Pregnancy|1
7079951|NCT02118896|11189245|FG005|Overall Study|Pregnancy|3
7079952|NCT02118896|11189246|FG006|Overall Study|Pregnancy|1
7079953|NCT02118896|11189247|FG007|Overall Study|Pregnancy|0
7079954|NCT02118896|11189248|FG008|Overall Study|Pregnancy|0
7079955|NCT02118896|11189249|FG009|Overall Study|Pregnancy|0
7079956|NCT02118896|11189240|FG000|Overall Study|Lost to Follow-up|1
7079957|NCT02118896|11189241|FG001|Overall Study|Lost to Follow-up|2
7079958|NCT02118896|11189242|FG002|Overall Study|Lost to Follow-up|1
7079959|NCT02118896|11189243|FG003|Overall Study|Lost to Follow-up|0
7079960|NCT02118896|11189244|FG004|Overall Study|Lost to Follow-up|2
7079961|NCT02118896|11189245|FG005|Overall Study|Lost to Follow-up|1
7079962|NCT02118896|11189246|FG006|Overall Study|Lost to Follow-up|0
7079963|NCT02118896|11189247|FG007|Overall Study|Lost to Follow-up|0
7079964|NCT02118896|11189248|FG008|Overall Study|Lost to Follow-up|0
7079965|NCT02118896|11189249|FG009|Overall Study|Lost to Follow-up|0
7160628|NCT03535194|11334660|FG000|Maintenance Period|Lost to Follow-up|4
7160629|NCT03535194|11334661|FG001|Maintenance Period|Lost to Follow-up|2
7160630|NCT03535194|11334662|FG002|Maintenance Period|Lost to Follow-up|1
7160631|NCT03535194|11334663|FG003|Maintenance Period|Lost to Follow-up|5
7160632|NCT03535194|11334664|FG004|Maintenance Period|Lost to Follow-up|2
7160633|NCT03535194|11334660|FG000|Maintenance Period|Other|1
7160634|NCT03535194|11334661|FG001|Maintenance Period|Other|2
7160635|NCT03535194|11334662|FG002|Maintenance Period|Other|0
7160636|NCT03535194|11334663|FG003|Maintenance Period|Other|0
7160637|NCT03535194|11334664|FG004|Maintenance Period|Other|0
7160638|NCT03535194|11334660|FG000|Maintenance Period|Physician Decision|1
7160639|NCT03535194|11334661|FG001|Maintenance Period|Physician Decision|2
7160640|NCT03535194|11334662|FG002|Maintenance Period|Physician Decision|0
7160641|NCT03535194|11334663|FG003|Maintenance Period|Physician Decision|2
7160642|NCT03535194|11334664|FG004|Maintenance Period|Physician Decision|0
7160643|NCT03535194|11334660|FG000|Maintenance Period|Pregnancy|0
7160644|NCT03535194|11334661|FG001|Maintenance Period|Pregnancy|0
7160645|NCT03535194|11334662|FG002|Maintenance Period|Pregnancy|0
7160646|NCT03535194|11334663|FG003|Maintenance Period|Pregnancy|2
7160647|NCT03535194|11334664|FG004|Maintenance Period|Pregnancy|0
7160648|NCT03535194|11334660|FG000|Maintenance Period|Protocol Violation|0
7160649|NCT03535194|11334661|FG001|Maintenance Period|Protocol Violation|1
7160650|NCT03535194|11334662|FG002|Maintenance Period|Protocol Violation|0
7160651|NCT03535194|11334663|FG003|Maintenance Period|Protocol Violation|0
7160652|NCT03535194|11334664|FG004|Maintenance Period|Protocol Violation|0
7160653|NCT03535194|11334660|FG000|Maintenance Period|Withdrawal by Subject|7
7160654|NCT03535194|11334661|FG001|Maintenance Period|Withdrawal by Subject|2
7160655|NCT03535194|11334662|FG002|Maintenance Period|Withdrawal by Subject|1
7160656|NCT03535194|11334663|FG003|Maintenance Period|Withdrawal by Subject|8
7160657|NCT03535194|11334664|FG004|Maintenance Period|Withdrawal by Subject|0
7160658|NCT03535194|11334660|FG000|Post-Treatment Followup Period|Adverse Event|4
7160659|NCT03535194|11334661|FG001|Post-Treatment Followup Period|Adverse Event|5
7160660|NCT03535194|11334662|FG002|Post-Treatment Followup Period|Adverse Event|1
7160661|NCT03535194|11334663|FG003|Post-Treatment Followup Period|Adverse Event|8
7160662|NCT03535194|11334664|FG004|Post-Treatment Followup Period|Adverse Event|0
7160663|NCT03535194|11334660|FG000|Post-Treatment Followup Period|Lack of Efficacy|3
7160664|NCT03535194|11334661|FG001|Post-Treatment Followup Period|Lack of Efficacy|4
7160665|NCT03535194|11334662|FG002|Post-Treatment Followup Period|Lack of Efficacy|5
7160666|NCT03535194|11334663|FG003|Post-Treatment Followup Period|Lack of Efficacy|4
7160667|NCT03535194|11334664|FG004|Post-Treatment Followup Period|Lack of Efficacy|0
7160668|NCT03535194|11334660|FG000|Post-Treatment Followup Period|Lost to Follow-up|1
7160669|NCT03535194|11334661|FG001|Post-Treatment Followup Period|Lost to Follow-up|1
7160670|NCT03535194|11334662|FG002|Post-Treatment Followup Period|Lost to Follow-up|1
7160671|NCT03535194|11334663|FG003|Post-Treatment Followup Period|Lost to Follow-up|0
7160672|NCT03535194|11334664|FG004|Post-Treatment Followup Period|Lost to Follow-up|0
7160673|NCT03535194|11334660|FG000|Post-Treatment Followup Period|Other|1
7160674|NCT03535194|11334661|FG001|Post-Treatment Followup Period|Other|0
7160675|NCT03535194|11334662|FG002|Post-Treatment Followup Period|Other|0
7160676|NCT03535194|11334663|FG003|Post-Treatment Followup Period|Other|5
7160677|NCT03535194|11334664|FG004|Post-Treatment Followup Period|Other|0
7160678|NCT03535194|11334660|FG000|Post-Treatment Followup Period|Physician Decision|0
7160679|NCT03535194|11334661|FG001|Post-Treatment Followup Period|Physician Decision|2
7160680|NCT03535194|11334662|FG002|Post-Treatment Followup Period|Physician Decision|1
7160681|NCT03535194|11334663|FG003|Post-Treatment Followup Period|Physician Decision|1
7160682|NCT03535194|11334664|FG004|Post-Treatment Followup Period|Physician Decision|0
7160683|NCT03535194|11334660|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2
7160684|NCT03535194|11334661|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2
7160685|NCT03535194|11334662|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3
7160686|NCT03535194|11334663|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6
7160687|NCT03535194|11334664|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0
7160688|NCT03535844|11334700|FG000|Overall Study|Withdrawal by Subject|0
7160689|NCT03535844|11334701|FG001|Overall Study|Withdrawal by Subject|1
7160690|NCT03535974|11334710|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0
7160691|NCT03535974|11334711|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1
7160692|NCT03535974|11334712|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0
7160693|NCT03535974|11334710|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2
7160694|NCT03535974|11334711|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1
7160695|NCT03535974|11334712|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0
7160696|NCT03536663|11334720|FG000|Endexo|Protocol Violation|1
7160697|NCT03536949|11334748|FG000|Overall Study|Adverse Event|4
7160698|NCT03536949|11334749|FG001|Overall Study|Adverse Event|0
7160699|NCT03536949|11334748|FG000|Overall Study|Lost to Follow-up|2
7160700|NCT03536949|11334749|FG001|Overall Study|Lost to Follow-up|1
7160701|NCT03536949|11334748|FG000|Overall Study|Withdrawal by Subject|6
7160702|NCT03536949|11334749|FG001|Overall Study|Withdrawal by Subject|0
7160703|NCT03536949|11334748|FG000|Overall Study|Non-compliance|2
7160704|NCT03536949|11334749|FG001|Overall Study|Non-compliance|1
7160705|NCT03537261|11334761|FG000|Overall Study|Lost to Follow-up|4
7160706|NCT03537261|11334762|FG001|Overall Study|Lost to Follow-up|5
7160707|NCT03537261|11334761|FG000|Overall Study|Withdrawal by Subject|4
7160708|NCT03537261|11334762|FG001|Overall Study|Withdrawal by Subject|6
7160709|NCT03537261|11334761|FG000|Overall Study|Did not return study questionnaires|0
7160710|NCT03537261|11334762|FG001|Overall Study|Did not return study questionnaires|1
7160711|NCT03537651|11334813|FG000|Overall Study|Adverse Event|2
7160712|NCT03537651|11334813|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2
7160713|NCT03537651|11334813|FG000|Overall Study|Commercial Drug is Available for Participant|56
7160714|NCT03537651|11334813|FG000|Overall Study|Other|1
7160715|NCT03538431|11334832|FG000|Overall Study|Physician Decision|0
7160716|NCT03538431|11334833|FG001|Overall Study|Physician Decision|1
7160717|NCT03538431|11334832|FG000|Overall Study|Withdrawal by Subject|1
7160718|NCT03538431|11334833|FG001|Overall Study|Withdrawal by Subject|0
7160719|NCT03538743|11334859|FG000|Overall Study|Adverse Event|0
7160720|NCT03538743|11334860|FG001|Overall Study|Adverse Event|0
7160721|NCT03538743|11334861|FG002|Overall Study|Adverse Event|1
7160722|NCT03538743|11334862|FG003|Overall Study|Adverse Event|1
7160723|NCT03538743|11334863|FG004|Overall Study|Adverse Event|0
7160724|NCT03538743|11334864|FG005|Overall Study|Adverse Event|0
7160725|NCT03538743|11334865|FG006|Overall Study|Adverse Event|0
7160726|NCT03538743|11334866|FG007|Overall Study|Adverse Event|0
7160727|NCT03538743|11334867|FG008|Overall Study|Adverse Event|0
7160728|NCT03538743|11334859|FG000|Overall Study|Non-Treatment-Related Reasons|0
7160729|NCT03538743|11334860|FG001|Overall Study|Non-Treatment-Related Reasons|0
7160730|NCT03538743|11334861|FG002|Overall Study|Non-Treatment-Related Reasons|0
7160731|NCT03538743|11334862|FG003|Overall Study|Non-Treatment-Related Reasons|0
7160732|NCT03538743|11334863|FG004|Overall Study|Non-Treatment-Related Reasons|0
7160733|NCT03538743|11334864|FG005|Overall Study|Non-Treatment-Related Reasons|0
7160734|NCT03538743|11334865|FG006|Overall Study|Non-Treatment-Related Reasons|0
7160735|NCT03538743|11334866|FG007|Overall Study|Non-Treatment-Related Reasons|0
7160736|NCT03538743|11334867|FG008|Overall Study|Non-Treatment-Related Reasons|3
7160737|NCT03538743|11334859|FG000|Overall Study|Withdrawal by Subject|0
7160738|NCT03538743|11334860|FG001|Overall Study|Withdrawal by Subject|0
7160739|NCT03538743|11334861|FG002|Overall Study|Withdrawal by Subject|0
7160740|NCT03538743|11334862|FG003|Overall Study|Withdrawal by Subject|1
7160741|NCT03538743|11334863|FG004|Overall Study|Withdrawal by Subject|0
7160742|NCT03538743|11334864|FG005|Overall Study|Withdrawal by Subject|0
7160743|NCT03538743|11334865|FG006|Overall Study|Withdrawal by Subject|0
7160744|NCT03538743|11334866|FG007|Overall Study|Withdrawal by Subject|0
7160745|NCT03538743|11334867|FG008|Overall Study|Withdrawal by Subject|0
7160746|NCT03539432|11334927|FG000|Overall Study|Lost to Follow-up|0
7160747|NCT03539432|11334928|FG001|Overall Study|Lost to Follow-up|1
7160748|NCT03539484|11334941|FG000|Overall Study|Death|1
7160749|NCT03539484|11334942|FG001|Overall Study|Death|0
7160750|NCT03539484|11334943|FG002|Overall Study|Death|0
7160751|NCT03539484|11334944|FG003|Overall Study|Death|2
7160752|NCT03539484|11334945|FG004|Overall Study|Death|8
7160753|NCT03539484|11334946|FG005|Overall Study|Death|3
7160754|NCT03539484|11334947|FG006|Overall Study|Death|0
7160755|NCT03539484|11334941|FG000|Overall Study|Lost to Follow-up|0
7160756|NCT03539484|11334942|FG001|Overall Study|Lost to Follow-up|1
7160757|NCT03539484|11334943|FG002|Overall Study|Lost to Follow-up|0
7160758|NCT03539484|11334944|FG003|Overall Study|Lost to Follow-up|0
7160759|NCT03539484|11334945|FG004|Overall Study|Lost to Follow-up|1
7160760|NCT03539484|11334946|FG005|Overall Study|Lost to Follow-up|0
7160761|NCT03539484|11334947|FG006|Overall Study|Lost to Follow-up|0
7160762|NCT03539484|11334941|FG000|Overall Study|Withdrawal by Subject|0
7160763|NCT03539484|11334942|FG001|Overall Study|Withdrawal by Subject|0
7160764|NCT03539484|11334943|FG002|Overall Study|Withdrawal by Subject|0
7160765|NCT03539484|11334944|FG003|Overall Study|Withdrawal by Subject|0
7160766|NCT03539484|11334945|FG004|Overall Study|Withdrawal by Subject|2
7160767|NCT03539484|11334946|FG005|Overall Study|Withdrawal by Subject|0
7160768|NCT03539484|11334947|FG006|Overall Study|Withdrawal by Subject|1
7160769|NCT03539484|11334941|FG000|Overall Study|Study Terminated by Sponsor|0
7160770|NCT03539484|11334942|FG001|Overall Study|Study Terminated by Sponsor|0
7160771|NCT03539484|11334943|FG002|Overall Study|Study Terminated by Sponsor|1
7160772|NCT03539484|11334944|FG003|Overall Study|Study Terminated by Sponsor|1
7160773|NCT03539484|11334945|FG004|Overall Study|Study Terminated by Sponsor|2
7160774|NCT03539484|11334946|FG005|Overall Study|Study Terminated by Sponsor|2
7160775|NCT03539484|11334947|FG006|Overall Study|Study Terminated by Sponsor|1
7160776|NCT03539549|11334968|FG000|Overall Study|Adverse Event|12
7160777|NCT03539549|11334968|FG000|Overall Study|Lost to Follow-up|1
7160778|NCT03539549|11334968|FG000|Overall Study|Death|2
7160779|NCT03539549|11334968|FG000|Overall Study|Progressive Disease|1
7160780|NCT03539549|11334968|FG000|Overall Study|Reason not Specified|1
7160781|NCT03540030|11334974|FG000|Overall Study|Withdrawal by Subject|2
7160782|NCT03540030|11334975|FG001|Overall Study|Withdrawal by Subject|1
7160783|NCT03540030|11334974|FG000|Overall Study|screen fail|7
7160784|NCT03540030|11334975|FG001|Overall Study|screen fail|1
7160785|NCT03540030|11334974|FG000|Overall Study|never had surgery after signing consent|9
7160786|NCT03540030|11334975|FG001|Overall Study|never had surgery after signing consent|1
7184286|NCT01917318|11384345|FG001|First Treatment|Withdrawal by Subject|1
7187479|NCT02036970|11388057|FG009|Part 2: Week 16 Onwards|Progressive Disease|2
7187480|NCT01941719|11388091|FG000|Overall Study|Lost to Follow-up|20
6894989|NCT00622700|10912838|FG006|Core Treatment Period|Adverse Event|0
6894990|NCT00622700|10912832|FG000|Core Treatment Period|Lack of Efficacy|19
6894991|NCT00622700|10912833|FG001|Core Treatment Period|Lack of Efficacy|6
6894992|NCT00622700|10912834|FG002|Core Treatment Period|Lack of Efficacy|12
6894993|NCT00622700|10912835|FG003|Core Treatment Period|Lack of Efficacy|0
6894994|NCT00622700|10912836|FG004|Core Treatment Period|Lack of Efficacy|0
6894995|NCT00622700|10912837|FG005|Core Treatment Period|Lack of Efficacy|0
6894996|NCT00622700|10912838|FG006|Core Treatment Period|Lack of Efficacy|0
6894997|NCT00622700|10912832|FG000|Core Treatment Period|Lost to Follow-up|1
6894998|NCT00622700|10912833|FG001|Core Treatment Period|Lost to Follow-up|1
6894999|NCT00622700|10912834|FG002|Core Treatment Period|Lost to Follow-up|1
6895000|NCT00622700|10912835|FG003|Core Treatment Period|Lost to Follow-up|0
6895001|NCT00622700|10912836|FG004|Core Treatment Period|Lost to Follow-up|0
6895002|NCT00622700|10912837|FG005|Core Treatment Period|Lost to Follow-up|0
6895003|NCT00622700|10912838|FG006|Core Treatment Period|Lost to Follow-up|0
6895004|NCT00622700|10912832|FG000|Core Treatment Period|Death|1
6895005|NCT00622700|10912833|FG001|Core Treatment Period|Death|0
6895006|NCT00622700|10912834|FG002|Core Treatment Period|Death|0
6895007|NCT00622700|10912835|FG003|Core Treatment Period|Death|0
6895008|NCT00622700|10912836|FG004|Core Treatment Period|Death|0
6895009|NCT00622700|10912837|FG005|Core Treatment Period|Death|0
6895010|NCT00622700|10912838|FG006|Core Treatment Period|Death|0
6895011|NCT00622700|10912832|FG000|Core Treatment Period|Progressive Disease|3
6895012|NCT00622700|10912833|FG001|Core Treatment Period|Progressive Disease|1
6895013|NCT00622700|10912834|FG002|Core Treatment Period|Progressive Disease|0
6895014|NCT00622700|10912835|FG003|Core Treatment Period|Progressive Disease|0
6895015|NCT00622700|10912836|FG004|Core Treatment Period|Progressive Disease|0
6895016|NCT00622700|10912837|FG005|Core Treatment Period|Progressive Disease|0
6895017|NCT00622700|10912838|FG006|Core Treatment Period|Progressive Disease|0
6895018|NCT00622700|10912832|FG000|Core Treatment Period|Withdrawal by Subject|12
6895019|NCT00622700|10912833|FG001|Core Treatment Period|Withdrawal by Subject|18
6895020|NCT00622700|10912834|FG002|Core Treatment Period|Withdrawal by Subject|15
6895021|NCT00622700|10912835|FG003|Core Treatment Period|Withdrawal by Subject|0
6895022|NCT00622700|10912836|FG004|Core Treatment Period|Withdrawal by Subject|0
6895023|NCT00622700|10912837|FG005|Core Treatment Period|Withdrawal by Subject|0
6895024|NCT00622700|10912838|FG006|Core Treatment Period|Withdrawal by Subject|0
6895025|NCT00622700|10912832|FG000|Core Treatment Period|Other than specified above|2
6895026|NCT00622700|10912833|FG001|Core Treatment Period|Other than specified above|2
6895027|NCT00622700|10912834|FG002|Core Treatment Period|Other than specified above|5
6895028|NCT00622700|10912835|FG003|Core Treatment Period|Other than specified above|0
6895029|NCT00622700|10912836|FG004|Core Treatment Period|Other than specified above|0
6895030|NCT00622700|10912837|FG005|Core Treatment Period|Other than specified above|0
6895031|NCT00622700|10912838|FG006|Core Treatment Period|Other than specified above|0
6895032|NCT00622700|10912832|FG000|Extension Treatment Period|Adverse Event|0
6895033|NCT00622700|10912833|FG001|Extension Treatment Period|Adverse Event|0
6895034|NCT00622700|10912834|FG002|Extension Treatment Period|Adverse Event|0
6895035|NCT00622700|10912835|FG003|Extension Treatment Period|Adverse Event|5
6895036|NCT00622700|10912836|FG004|Extension Treatment Period|Adverse Event|9
6895037|NCT00622700|10912837|FG005|Extension Treatment Period|Adverse Event|6
6895038|NCT00622700|10912838|FG006|Extension Treatment Period|Adverse Event|8
6895039|NCT00622700|10912832|FG000|Extension Treatment Period|Lack of Efficacy|0
6895040|NCT00622700|10912833|FG001|Extension Treatment Period|Lack of Efficacy|0
6895041|NCT00622700|10912834|FG002|Extension Treatment Period|Lack of Efficacy|0
6895042|NCT00622700|10912835|FG003|Extension Treatment Period|Lack of Efficacy|2
6895043|NCT00622700|10912836|FG004|Extension Treatment Period|Lack of Efficacy|8
6895044|NCT00622700|10912837|FG005|Extension Treatment Period|Lack of Efficacy|1
6895045|NCT00622700|10912838|FG006|Extension Treatment Period|Lack of Efficacy|9
6895046|NCT00622700|10912832|FG000|Extension Treatment Period|Protocol Violation|0
6895047|NCT00622700|10912833|FG001|Extension Treatment Period|Protocol Violation|0
6895048|NCT00622700|10912834|FG002|Extension Treatment Period|Protocol Violation|0
6895049|NCT00622700|10912835|FG003|Extension Treatment Period|Protocol Violation|0
6895050|NCT00622700|10912836|FG004|Extension Treatment Period|Protocol Violation|0
6895051|NCT00622700|10912837|FG005|Extension Treatment Period|Protocol Violation|2
6895052|NCT00622700|10912838|FG006|Extension Treatment Period|Protocol Violation|0
7079966|NCT02118896|11189240|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1
7079967|NCT02118896|11189241|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5
6895053|NCT00622700|10912832|FG000|Extension Treatment Period|Lost to Follow-up|0
6895054|NCT00622700|10912833|FG001|Extension Treatment Period|Lost to Follow-up|0
6895055|NCT00622700|10912834|FG002|Extension Treatment Period|Lost to Follow-up|0
6895056|NCT00622700|10912835|FG003|Extension Treatment Period|Lost to Follow-up|0
6895057|NCT00622700|10912836|FG004|Extension Treatment Period|Lost to Follow-up|1
6895058|NCT00622700|10912837|FG005|Extension Treatment Period|Lost to Follow-up|0
6895059|NCT00622700|10912838|FG006|Extension Treatment Period|Lost to Follow-up|0
6895060|NCT00622700|10912832|FG000|Extension Treatment Period|Progressive Disease|0
6972729|NCT01173601|11023895|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
7160787|NCT03540160|11334997|FG000|Overall Study|Protocol Violation|1
7160788|NCT03540160|11334997|FG000|Overall Study|Physician Decision|8
7160789|NCT03540160|11334997|FG000|Overall Study|Lack of Efficacy|60
7160790|NCT03540160|11334997|FG000|Overall Study|Pregnancy|1
7160791|NCT03540160|11334997|FG000|Overall Study|Adverse Event|20
7160792|NCT03540160|11334997|FG000|Overall Study|Withdrawal by Subject|68
7160793|NCT03540160|11334997|FG000|Overall Study|COVID-19|2
7160794|NCT03540160|11334997|FG000|Overall Study|Study Closure|10
7160795|NCT03540160|11334997|FG000|Overall Study|Lost to Follow-up|18
7160796|NCT03540160|11334997|FG000|Overall Study|Sponsor decision|191
7160797|NCT03541044|11335001|FG000|Study Period 2: Up to Day 8|Protocol Violation|1
7160798|NCT03541044|11335002|FG001|Study Period 2: Up to Day 8|Protocol Violation|0
7160799|NCT03541044|11335001|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1
7160800|NCT03541044|11335002|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0
7160801|NCT03543137|11335102|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1
7160802|NCT03543137|11335103|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0
7160803|NCT03543137|11335102|FG000|Study Period 2: Up to Day 8|Protocol Violation|1
7160804|NCT03543137|11335103|FG001|Study Period 2: Up to Day 8|Protocol Violation|0
7160805|NCT03543137|11335102|FG000|Study Period 2: Up to Day 8|Adverse Event|0
7160806|NCT03543137|11335103|FG001|Study Period 2: Up to Day 8|Adverse Event|1
7160807|NCT03544333|11335151|FG000|Overall Study|Withdrawal by Subject|1
7160808|NCT03544333|11335152|FG001|Overall Study|Withdrawal by Subject|0
7160809|NCT03545503|11335179|FG000|Overall Study|Protocol Violation|14
7160810|NCT03545503|11335180|FG001|Overall Study|Protocol Violation|16
7160811|NCT03545984|11335197|FG000|Overall Study|CSF cases not present during rotation|11
7160812|NCT03545984|11335198|FG001|Overall Study|CSF cases not present during rotation|9
7160813|NCT03546621|11335227|FG000|Overall Study|Withdrawal by Subject|0
7160814|NCT03546621|11335228|FG001|Overall Study|Withdrawal by Subject|1
7160815|NCT03546621|11335229|FG002|Overall Study|Withdrawal by Subject|2
7160816|NCT03546621|11335230|FG003|Overall Study|Withdrawal by Subject|1
7160817|NCT03546621|11335227|FG000|Overall Study|Lost to Follow-up|0
7160818|NCT03546621|11335228|FG001|Overall Study|Lost to Follow-up|1
7160819|NCT03546621|11335229|FG002|Overall Study|Lost to Follow-up|0
7160820|NCT03546621|11335230|FG003|Overall Study|Lost to Follow-up|0
7160821|NCT03546621|11335227|FG000|Overall Study|Adverse Event|0
7160822|NCT03546621|11335228|FG001|Overall Study|Adverse Event|1
7160823|NCT03546621|11335229|FG002|Overall Study|Adverse Event|0
7160824|NCT03546621|11335230|FG003|Overall Study|Adverse Event|1
7160825|NCT03546621|11335227|FG000|Overall Study|Progressive disease|0
7160826|NCT03546621|11335228|FG001|Overall Study|Progressive disease|0
7160827|NCT03546621|11335229|FG002|Overall Study|Progressive disease|0
7160828|NCT03546621|11335230|FG003|Overall Study|Progressive disease|1
7160829|NCT03546647|11335240|FG000|Overall Study|Adverse Event|1
7160830|NCT03546647|11335241|FG001|Overall Study|Adverse Event|0
7160831|NCT03546816|11335249|FG000|Overall Study|Adverse Event|5
7160832|NCT03546816|11335250|FG001|Overall Study|Adverse Event|3
7160833|NCT03546816|11335249|FG000|Overall Study|Lack of Efficacy|2
7160834|NCT03546816|11335250|FG001|Overall Study|Lack of Efficacy|4
7160835|NCT03546816|11335249|FG000|Overall Study|Pregnancy|1
7160836|NCT03546816|11335250|FG001|Overall Study|Pregnancy|0
7160837|NCT03546816|11335249|FG000|Overall Study|Physician Decision|2
7160838|NCT03546816|11335250|FG001|Overall Study|Physician Decision|0
7160839|NCT03546816|11335249|FG000|Overall Study|Withdrawal by Subject|8
7160840|NCT03546816|11335250|FG001|Overall Study|Withdrawal by Subject|10
7160841|NCT03546816|11335249|FG000|Overall Study|Lost to Follow-up|3
7160842|NCT03546816|11335250|FG001|Overall Study|Lost to Follow-up|2
7160843|NCT03546842|11335258|FG000|Overall Study|Protocol Violation|1
7160844|NCT03546842|11335258|FG000|Overall Study|Withdrawal by Subject|2
7160845|NCT03547154|11335264|FG000|Overall Study|Disease Progression/Recurrence|6
7160846|NCT03547154|11335265|FG001|Overall Study|Disease Progression/Recurrence|14
7160847|NCT03547154|11335264|FG000|Overall Study|Adverse Event|26
7160848|NCT03547154|11335265|FG001|Overall Study|Adverse Event|31
7160849|NCT03547154|11335264|FG000|Overall Study|Protocol Violation|6
7160850|NCT03547154|11335265|FG001|Overall Study|Protocol Violation|1
7160851|NCT03547154|11335264|FG000|Overall Study|Physician Decision|4
7160852|NCT03547154|11335265|FG001|Overall Study|Physician Decision|3
7160853|NCT03547154|11335264|FG000|Overall Study|Insufficient Therapeutic Response|13
7160854|NCT03547154|11335265|FG001|Overall Study|Insufficient Therapeutic Response|10
7160855|NCT03547154|11335264|FG000|Overall Study|Withdrawal by Subject|10
7160856|NCT03547154|11335265|FG001|Overall Study|Withdrawal by Subject|6
7160857|NCT03547154|11335264|FG000|Overall Study|Not Selected|0
7160858|NCT03547154|11335265|FG001|Overall Study|Not Selected|1
7160859|NCT03547154|11335264|FG000|Overall Study|Continued treatment beyond 12 mo.|58
7160860|NCT03547154|11335265|FG001|Overall Study|Continued treatment beyond 12 mo.|50
7160861|NCT03547167|11335273|FG000|Overall Study|Withdrawal by Subject|34
7160862|NCT03547167|11335274|FG001|Overall Study|Withdrawal by Subject|12
7160863|NCT03547167|11335273|FG000|Overall Study|Screen Failure|0
7160864|NCT03547167|11335274|FG001|Overall Study|Screen Failure|1
7160865|NCT03547167|11335273|FG000|Overall Study|Lost to Follow-up|59
7160866|NCT03547167|11335274|FG001|Overall Study|Lost to Follow-up|15
7160867|NCT03547167|11335273|FG000|Overall Study|Death|4
7160868|NCT03547167|11335274|FG001|Overall Study|Death|2
7160869|NCT03547531|11335286|FG000|Overall Study|not coming in data collection : sick|2
7160870|NCT03547531|11335287|FG001|Overall Study|not coming in data collection : sick|2
7160871|NCT03547531|11335286|FG000|Overall Study|having family occasion|0
7160872|NCT03547531|11335287|FG001|Overall Study|having family occasion|2
7160873|NCT03547583|11335296|FG000|Overall Study|Adverse Event|16
7160874|NCT03547583|11335297|FG001|Overall Study|Adverse Event|11
7160875|NCT03547583|11335298|FG002|Overall Study|Adverse Event|10
7160876|NCT03547583|11335296|FG000|Overall Study|Death|11
7160877|NCT03547583|11335297|FG001|Overall Study|Death|7
7160878|NCT03547583|11335298|FG002|Overall Study|Death|4
7160879|NCT03547583|11335296|FG000|Overall Study|Lost to Follow-up|1
7160880|NCT03547583|11335297|FG001|Overall Study|Lost to Follow-up|0
7160881|NCT03547583|11335298|FG002|Overall Study|Lost to Follow-up|0
7160882|NCT03547583|11335296|FG000|Overall Study|Non-compliance with study drug|0
7160883|NCT03547583|11335297|FG001|Overall Study|Non-compliance with study drug|0
7160884|NCT03547583|11335298|FG002|Overall Study|Non-compliance with study drug|1
7160885|NCT03547583|11335296|FG000|Overall Study|Physician Decision|1
7160886|NCT03547583|11335297|FG001|Overall Study|Physician Decision|0
7160887|NCT03547583|11335298|FG002|Overall Study|Physician Decision|3
7160888|NCT03547583|11335296|FG000|Overall Study|Protocol Violation|2
7160889|NCT03547583|11335297|FG001|Overall Study|Protocol Violation|1
7160890|NCT03547583|11335298|FG002|Overall Study|Protocol Violation|1
7160891|NCT03547583|11335296|FG000|Overall Study|Withdrawal by Subject|12
7160892|NCT03547583|11335297|FG001|Overall Study|Withdrawal by Subject|19
7160893|NCT03547583|11335298|FG002|Overall Study|Withdrawal by Subject|10
7160894|NCT03547583|11335296|FG000|Overall Study|Other|2
7160895|NCT03547583|11335297|FG001|Overall Study|Other|2
7160896|NCT03547583|11335298|FG002|Overall Study|Other|3
7160897|NCT03547635|11335312|FG000|Overall Study|Adverse Event|5
7160898|NCT03547635|11335313|FG001|Overall Study|Adverse Event|2
7160899|NCT03547635|11335314|FG002|Overall Study|Adverse Event|3
7160900|NCT03547635|11335312|FG000|Overall Study|Lost to Follow-up|1
7160901|NCT03547635|11335313|FG001|Overall Study|Lost to Follow-up|3
7160902|NCT03547635|11335314|FG002|Overall Study|Lost to Follow-up|4
7160903|NCT03547635|11335312|FG000|Overall Study|Withdrawal by Subject|1
7160904|NCT03547635|11335313|FG001|Overall Study|Withdrawal by Subject|0
7160905|NCT03547635|11335314|FG002|Overall Study|Withdrawal by Subject|0
7160906|NCT03547635|11335312|FG000|Overall Study|Withdrawal By PI|0
7160907|NCT03547635|11335313|FG001|Overall Study|Withdrawal By PI|1
7160908|NCT03547635|11335314|FG002|Overall Study|Withdrawal By PI|0
7160909|NCT03547635|11335312|FG000|Overall Study|Withdrawal by Sponsor|0
7160910|NCT03547635|11335313|FG001|Overall Study|Withdrawal by Sponsor|0
7160911|NCT03547635|11335314|FG002|Overall Study|Withdrawal by Sponsor|1
7160912|NCT03547635|11335312|FG000|Overall Study|Errant Randomization before Treatment|0
7160913|NCT03547635|11335313|FG001|Overall Study|Errant Randomization before Treatment|1
7160914|NCT03547635|11335314|FG002|Overall Study|Errant Randomization before Treatment|0
7160915|NCT03547635|11335312|FG000|Overall Study|Withdrawal by Subject|1
7160916|NCT03547635|11335313|FG001|Overall Study|Withdrawal by Subject|0
7160917|NCT03547635|11335314|FG002|Overall Study|Withdrawal by Subject|0
7160918|NCT03547687|11335322|FG000|Overall Study|Withdrawal by Subject|1
7160919|NCT03547687|11335322|FG000|Overall Study|Death|1
7160920|NCT03548337|11335328|FG000|Infant Series|Withdrawal by Parent/Guardian|8
7160921|NCT03548337|11335329|FG001|Infant Series|Withdrawal by Parent/Guardian|8
7160922|NCT03548337|11335328|FG000|Infant Series|No Longer Met Eligibility Criteria|1
7160923|NCT03548337|11335329|FG001|Infant Series|No Longer Met Eligibility Criteria|0
7160924|NCT03548337|11335328|FG000|Infant Series|Lost to Follow-up|2
7160925|NCT03548337|11335329|FG001|Infant Series|Lost to Follow-up|1
7160926|NCT03548337|11335328|FG000|Infant Series|Adverse Event|0
7160927|NCT03548337|11335329|FG001|Infant Series|Adverse Event|2
7160928|NCT03548337|11335328|FG000|Infant Series|Randomized but Not Vaccinated|1
7160929|NCT03548337|11335329|FG001|Infant Series|Randomized but Not Vaccinated|0
7160930|NCT03548337|11335328|FG000|Toddler Dose|Withdrawal by parent/guardian|1
7160931|NCT03548337|11335329|FG001|Toddler Dose|Withdrawal by parent/guardian|1
7160932|NCT03548935|11335343|FG000|Overall Study|Withdrawal by Subject|26
7160933|NCT03548935|11335344|FG001|Overall Study|Withdrawal by Subject|17
7160934|NCT03548935|11335343|FG000|Overall Study|Lost to Follow-up|39
7160935|NCT03548935|11335344|FG001|Overall Study|Lost to Follow-up|28
7160936|NCT03548935|11335343|FG000|Overall Study|Death|1
7160937|NCT03548935|11335344|FG001|Overall Study|Death|1
7160938|NCT03549117|11335352|FG000|Overall Study|Withdrawal by Subject|1
7160939|NCT03549117|11335353|FG001|Overall Study|Withdrawal by Subject|0
7160940|NCT03549130|11335361|FG000|Overall Study|Adverse Event|0
7160941|NCT03549130|11335362|FG001|Overall Study|Adverse Event|1
7160942|NCT03549130|11335361|FG000|Overall Study|Lost to Follow-up|0
7160943|NCT03549130|11335362|FG001|Overall Study|Lost to Follow-up|1
7160944|NCT03549338|11335382|FG000|Overall Study|Progressive Disease|1
7160945|NCT03549338|11335383|FG001|Overall Study|Progressive Disease|0
7160946|NCT03549338|11335384|FG002|Overall Study|Progressive Disease|0
7160947|NCT03549338|11335382|FG000|Overall Study|Clinical Progression|0
7160948|NCT03549338|11335383|FG001|Overall Study|Clinical Progression|1
7160949|NCT03549338|11335384|FG002|Overall Study|Clinical Progression|0
7160950|NCT03549429|11335392|FG000|Overall Study|Protocol Violation|5
7160951|NCT03549429|11335393|FG001|Overall Study|Protocol Violation|3
7160952|NCT03550209|11335420|FG000|Overall Study|Lost to Follow-up|1
7160953|NCT03550209|11335421|FG001|Overall Study|Lost to Follow-up|0
7160954|NCT03550209|11335422|FG002|Overall Study|Lost to Follow-up|1
7160955|NCT03550209|11335423|FG003|Overall Study|Lost to Follow-up|0
7160956|NCT03550209|11335420|FG000|Overall Study|Withdrawal by Subject|0
7160957|NCT03550209|11335421|FG001|Overall Study|Withdrawal by Subject|3
7160958|NCT03550209|11335422|FG002|Overall Study|Withdrawal by Subject|1
7160959|NCT03550209|11335423|FG003|Overall Study|Withdrawal by Subject|2
7160960|NCT03550209|11335420|FG000|Overall Study|Excluded due to ineligibility after randomization|0
7160961|NCT03550209|11335421|FG001|Overall Study|Excluded due to ineligibility after randomization|0
7160962|NCT03550209|11335422|FG002|Overall Study|Excluded due to ineligibility after randomization|0
7160963|NCT03550209|11335423|FG003|Overall Study|Excluded due to ineligibility after randomization|2
7160964|NCT03550313|11335436|FG000|Overall Study|Adverse Event|0
7160965|NCT03550313|11335437|FG001|Overall Study|Adverse Event|1
7160966|NCT03550313|11335438|FG002|Overall Study|Adverse Event|0
7160967|NCT03550313|11335436|FG000|Overall Study|Lost to Follow-up|5
7160968|NCT03550313|11335437|FG001|Overall Study|Lost to Follow-up|7
7160969|NCT03550313|11335438|FG002|Overall Study|Lost to Follow-up|12
7160970|NCT03550313|11335436|FG000|Overall Study|Study terminated by sponsor|44
7160971|NCT03550313|11335437|FG001|Overall Study|Study terminated by sponsor|37
7160972|NCT03550313|11335438|FG002|Overall Study|Study terminated by sponsor|48
7160973|NCT03550313|11335436|FG000|Overall Study|No longer met eligibility criteria|3
7160974|NCT03550313|11335437|FG001|Overall Study|No longer met eligibility criteria|5
7160975|NCT03550313|11335438|FG002|Overall Study|No longer met eligibility criteria|6
7160976|NCT03550313|11335436|FG000|Overall Study|Withdrawal by parent/guardian|20
7160977|NCT03550313|11335437|FG001|Overall Study|Withdrawal by parent/guardian|18
7160978|NCT03550313|11335438|FG002|Overall Study|Withdrawal by parent/guardian|26
7160979|NCT03550313|11335436|FG000|Overall Study|Other|4
7160980|NCT03550313|11335437|FG001|Overall Study|Other|2
7160981|NCT03550313|11335438|FG002|Overall Study|Other|2
7160982|NCT03550313|11335436|FG000|Overall Study|Randomized but not vaccinated|3
7160983|NCT03550313|11335437|FG001|Overall Study|Randomized but not vaccinated|23
7160984|NCT03550313|11335438|FG002|Overall Study|Randomized but not vaccinated|2
7160985|NCT03550313|11335436|FG000|Overall Study|Sites terminated due to quality issues|18
7160986|NCT03550313|11335437|FG001|Overall Study|Sites terminated due to quality issues|17
7160987|NCT03550313|11335438|FG002|Overall Study|Sites terminated due to quality issues|18
7160988|NCT03550378|11335449|FG000|Overall Study|Death|0
7160989|NCT03550378|11335450|FG001|Overall Study|Death|1
7079968|NCT02118896|11189242|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1
7079969|NCT02118896|11189243|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2
7160990|NCT03551730|11335482|FG000|Overall Study|Adverse Event|1
7160991|NCT03551730|11335483|FG001|Overall Study|Adverse Event|0
7160992|NCT03551730|11335484|FG002|Overall Study|Adverse Event|0
7160993|NCT03551730|11335485|FG003|Overall Study|Adverse Event|0
7160994|NCT03551743|11335499|FG000|Overall Study|Adverse Event|1
7160995|NCT03551743|11335500|FG001|Overall Study|Adverse Event|0
7160996|NCT03551743|11335501|FG002|Overall Study|Adverse Event|0
7160997|NCT03551743|11335502|FG003|Overall Study|Adverse Event|0
7160998|NCT03551743|11335499|FG000|Overall Study|Withdrawal by Subject|1
7160999|NCT03551743|11335500|FG001|Overall Study|Withdrawal by Subject|0
7161000|NCT03551743|11335501|FG002|Overall Study|Withdrawal by Subject|0
7161001|NCT03551743|11335502|FG003|Overall Study|Withdrawal by Subject|0
7161002|NCT03552198|11335520|FG000|Overall Study|Lost to Follow-up|42
7161003|NCT03552198|11335521|FG001|Overall Study|Lost to Follow-up|48
7161004|NCT03552198|11335522|FG002|Overall Study|Lost to Follow-up|15
7161005|NCT03552198|11335523|FG003|Overall Study|Lost to Follow-up|19
7161006|NCT03552198|11335520|FG000|Overall Study|Incomplete/unmatched questionnaire|6
7161007|NCT03552198|11335521|FG001|Overall Study|Incomplete/unmatched questionnaire|7
7161008|NCT03552198|11335522|FG002|Overall Study|Incomplete/unmatched questionnaire|2
7161009|NCT03552198|11335523|FG003|Overall Study|Incomplete/unmatched questionnaire|2
7161010|NCT03552198|11335520|FG000|Overall Study|Did not receive air alerts|1
7161011|NCT03552198|11335521|FG001|Overall Study|Did not receive air alerts|0
7161012|NCT03552198|11335522|FG002|Overall Study|Did not receive air alerts|0
7161013|NCT03552198|11335523|FG003|Overall Study|Did not receive air alerts|1
7161014|NCT03552523|11335542|FG000|Overall Study|Withdrawal by Subject|1
7161015|NCT03552523|11335543|FG001|Overall Study|Withdrawal by Subject|1
7161016|NCT03552549|11335562|FG000|Overall Study|Disease progression|25
7161017|NCT03552549|11335563|FG001|Overall Study|Disease progression|17
7161018|NCT03552549|11335562|FG000|Overall Study|Adverse event in first 12 months|12
7161019|NCT03552549|11335563|FG001|Overall Study|Adverse event in first 12 months|8
7079970|NCT02118896|11189244|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4
7079971|NCT02118896|11189245|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2
7161020|NCT03552549|11335562|FG000|Overall Study|Withdrawal by Subject|7
7161021|NCT03552549|11335563|FG001|Overall Study|Withdrawal by Subject|7
7161022|NCT03552549|11335562|FG000|Overall Study|Unknown (no reason provided)|4
7161023|NCT03552549|11335563|FG001|Overall Study|Unknown (no reason provided)|2
7161024|NCT03552549|11335562|FG000|Overall Study|Not in participant's best interest|2
7161025|NCT03552549|11335563|FG001|Overall Study|Not in participant's best interest|1
7161026|NCT03552549|11335562|FG000|Overall Study|Did not complete study treatment|2
7161027|NCT03552549|11335563|FG001|Overall Study|Did not complete study treatment|3
7161028|NCT03552549|11335562|FG000|Overall Study|Did not meet eligibility criteria|1
7161029|NCT03552549|11335563|FG001|Overall Study|Did not meet eligibility criteria|0
7161030|NCT03552549|11335562|FG000|Overall Study|Administrative|0
7161031|NCT03552549|11335563|FG001|Overall Study|Administrative|14
7161032|NCT03552757|11335572|FG000|Overall Study|Withdrawal by Subject|10
7161033|NCT03552757|11335573|FG001|Overall Study|Withdrawal by Subject|5
7161034|NCT03552757|11335574|FG002|Overall Study|Withdrawal by Subject|12
7161035|NCT03552757|11335572|FG000|Overall Study|Lost to Follow-up|2
7161036|NCT03552757|11335573|FG001|Overall Study|Lost to Follow-up|7
7161037|NCT03552757|11335574|FG002|Overall Study|Lost to Follow-up|7
7161038|NCT03552757|11335572|FG000|Overall Study|Death|1
7161039|NCT03552757|11335573|FG001|Overall Study|Death|1
7161040|NCT03552757|11335574|FG002|Overall Study|Death|1
7161041|NCT03553758|11335585|FG000|Overall Study|Lost to Follow-up|1
7161042|NCT03553823|11335593|FG000|Overall Study|Physician Decision|0
7161043|NCT03553823|11335594|FG001|Overall Study|Physician Decision|1
7161044|NCT03554005|11335615|FG000|Overall Study|Not in participant's best interest|0
7161045|NCT03554005|11335616|FG001|Overall Study|Not in participant's best interest|0
7161046|NCT03554005|11335617|FG002|Overall Study|Not in participant's best interest|0
7161047|NCT03554005|11335618|FG003|Overall Study|Not in participant's best interest|0
7161048|NCT03554005|11335619|FG004|Overall Study|Not in participant's best interest|0
7161049|NCT03554005|11335620|FG005|Overall Study|Not in participant's best interest|1
7161050|NCT03554005|11335615|FG000|Overall Study|Disease Progression|1
7161051|NCT03554005|11335616|FG001|Overall Study|Disease Progression|1
7161052|NCT03554005|11335617|FG002|Overall Study|Disease Progression|1
7161053|NCT03554005|11335618|FG003|Overall Study|Disease Progression|1
7161054|NCT03554005|11335619|FG004|Overall Study|Disease Progression|5
7161055|NCT03554005|11335620|FG005|Overall Study|Disease Progression|6
7161056|NCT03554005|11335615|FG000|Overall Study|Adverse Event|0
7161057|NCT03554005|11335616|FG001|Overall Study|Adverse Event|0
7161058|NCT03554005|11335617|FG002|Overall Study|Adverse Event|0
7161059|NCT03554005|11335618|FG003|Overall Study|Adverse Event|0
7161060|NCT03554005|11335619|FG004|Overall Study|Adverse Event|0
7161061|NCT03554005|11335620|FG005|Overall Study|Adverse Event|3
7161062|NCT03554005|11335615|FG000|Overall Study|Physician Decision|0
7161063|NCT03554005|11335616|FG001|Overall Study|Physician Decision|0
7161064|NCT03554005|11335617|FG002|Overall Study|Physician Decision|0
7161065|NCT03554005|11335618|FG003|Overall Study|Physician Decision|0
7161066|NCT03554005|11335619|FG004|Overall Study|Physician Decision|1
7161067|NCT03554005|11335620|FG005|Overall Study|Physician Decision|0
7161068|NCT03554005|11335615|FG000|Overall Study|Other|0
7161069|NCT03554005|11335616|FG001|Overall Study|Other|0
7161070|NCT03554005|11335617|FG002|Overall Study|Other|0
7161071|NCT03554005|11335618|FG003|Overall Study|Other|0
7161072|NCT03554005|11335619|FG004|Overall Study|Other|0
7161073|NCT03554005|11335620|FG005|Overall Study|Other|1
7161074|NCT03554018|11335636|FG000|Overall Study|Lost to Follow-up|3
7161075|NCT03554018|11335637|FG001|Overall Study|Lost to Follow-up|7
7161076|NCT03554486|11335645|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1
7161077|NCT03554486|11335646|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0
7161078|NCT03554486|11335647|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0
7161079|NCT03554486|11335645|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2
7161080|NCT03554486|11335646|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0
7161081|NCT03554486|11335647|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0
7161082|NCT03554486|11335645|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0
7161083|NCT03554486|11335646|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1
7161084|NCT03554486|11335647|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1
7161085|NCT03554629|11335654|FG000|Overall Study|Inadequate data|6
7161086|NCT03554772|11335695|FG000|Overall Study|Lost to Follow-up|0
7161087|NCT03554772|11335696|FG001|Overall Study|Lost to Follow-up|0
7161088|NCT03554772|11335697|FG002|Overall Study|Lost to Follow-up|0
7161089|NCT03554772|11335698|FG003|Overall Study|Lost to Follow-up|2
7161090|NCT03555266|11335718|FG000|Overall Study|Protocol Violation|6
7161091|NCT03555266|11335719|FG001|Overall Study|Protocol Violation|4
7161092|NCT03555305|11335725|FG000|Period 1|Physician Decision|0
7161093|NCT03555305|11335726|FG001|Period 1|Physician Decision|1
7161094|NCT03555305|11335725|FG000|Period 1|Adverse Event|0
7161095|NCT03555305|11335726|FG001|Period 1|Adverse Event|1
7161096|NCT03555435|11335735|FG000|Overall Study|Lost to Follow-up|17
7161097|NCT03555435|11335736|FG001|Overall Study|Lost to Follow-up|19
7161098|NCT03555435|11335737|FG002|Overall Study|Lost to Follow-up|8
7161099|NCT03555565|11335745|FG000|Overall Study|Case Report Forms Uncollected|2
7161100|NCT03555565|11335745|FG000|Overall Study|Protocol Deviation|13
7161101|NCT03555890|11335753|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7161102|NCT03555890|11335754|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7161103|NCT03555890|11335755|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7161104|NCT03555890|11335756|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1
7161105|NCT03556891|11335788|FG000|Overall Study|Adverse Event|4
7161106|NCT03556891|11335788|FG000|Overall Study|MRI Need|3
7161107|NCT03556891|11335788|FG000|Overall Study|Device Failure|1
7161108|NCT03556891|11335788|FG000|Overall Study|Death|1
7161109|NCT03556891|11335788|FG000|Overall Study|Lost to Follow-up|1
7161110|NCT03556891|11335788|FG000|Overall Study|Missing at random|1
7161111|NCT03556891|11335788|FG000|Overall Study|Missing due to COVID|1
7161112|NCT03556891|11335788|FG000|Overall Study|Protocol Violation|1
7161113|NCT03557034|11335794|FG000|Overall Study|Withdrawal by Subject|1
7161114|NCT03557034|11335795|FG001|Overall Study|Withdrawal by Subject|0
7161115|NCT03557775|11335852|FG000|Overall Study|Withdrawal by Subject|1
7161116|NCT03557775|11335853|FG001|Overall Study|Withdrawal by Subject|2
7161117|NCT03557775|11335854|FG002|Overall Study|Withdrawal by Subject|4
7161118|NCT03557775|11335852|FG000|Overall Study|Physician Decision|0
7161119|NCT03557775|11335853|FG001|Overall Study|Physician Decision|1
7161120|NCT03557775|11335854|FG002|Overall Study|Physician Decision|0
7161121|NCT03557801|11335865|FG000|Overall Study|Protocol Violation|1
7161122|NCT03557801|11335866|FG001|Overall Study|Protocol Violation|0
7161123|NCT03557801|11335867|FG002|Overall Study|Protocol Violation|0
7161124|NCT03557801|11335865|FG000|Overall Study|Withdrawal by Subject|1
7161125|NCT03557801|11335866|FG001|Overall Study|Withdrawal by Subject|0
7161126|NCT03557801|11335867|FG002|Overall Study|Withdrawal by Subject|3
7161127|NCT03557801|11335865|FG000|Overall Study|Lost to Follow-up|0
7161128|NCT03557801|11335866|FG001|Overall Study|Lost to Follow-up|1
7161129|NCT03557801|11335867|FG002|Overall Study|Lost to Follow-up|0
7079972|NCT02118896|11189246|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0
7161130|NCT03558516|11335895|FG000|Overall Study|Protocol Violation|2
7079973|NCT02118896|11189247|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0
7079974|NCT02118896|11189248|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0
7079975|NCT02118896|11189249|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2
7079976|NCT02118896|11189240|FG000|Overall Study|Prohibited medication|0
7079977|NCT02118896|11189241|FG001|Overall Study|Prohibited medication|0
7079978|NCT02118896|11189242|FG002|Overall Study|Prohibited medication|0
7079979|NCT02118896|11189243|FG003|Overall Study|Prohibited medication|0
7079980|NCT02118896|11189244|FG004|Overall Study|Prohibited medication|1
7079981|NCT02118896|11189245|FG005|Overall Study|Prohibited medication|3
7079982|NCT02118896|11189246|FG006|Overall Study|Prohibited medication|0
7079983|NCT02118896|11189247|FG007|Overall Study|Prohibited medication|0
7079984|NCT02118896|11189248|FG008|Overall Study|Prohibited medication|0
7079985|NCT02118896|11189249|FG009|Overall Study|Prohibited medication|0
7079986|NCT02118896|11189240|FG000|Overall Study|Miscellaneous|1
7079987|NCT02118896|11189241|FG001|Overall Study|Miscellaneous|2
7079988|NCT02118896|11189242|FG002|Overall Study|Miscellaneous|0
7079989|NCT02118896|11189243|FG003|Overall Study|Miscellaneous|2
7079990|NCT02118896|11189244|FG004|Overall Study|Miscellaneous|0
7079991|NCT02118896|11189245|FG005|Overall Study|Miscellaneous|4
7079992|NCT02118896|11189246|FG006|Overall Study|Miscellaneous|0
7079993|NCT02118896|11189247|FG007|Overall Study|Miscellaneous|0
7079994|NCT02118896|11189248|FG008|Overall Study|Miscellaneous|0
7079995|NCT02118896|11189249|FG009|Overall Study|Miscellaneous|0
7079996|NCT02118961|11189274|FG000|Overall Study|Withdrawal by Subject|1
7079997|NCT02118961|11189275|FG001|Overall Study|Withdrawal by Subject|0
7079998|NCT02119026|11189283|FG000|1st-line Treatment|Adverse Event|9
7079999|NCT02119026|11189284|FG001|1st-line Treatment|Adverse Event|14
7080000|NCT02119026|11189283|FG000|1st-line Treatment|Physician Decision|3
7080001|NCT02119026|11189284|FG001|1st-line Treatment|Physician Decision|8
7080002|NCT02119026|11189283|FG000|1st-line Treatment|Withdrawal by Subject|4
7080003|NCT02119026|11189284|FG001|1st-line Treatment|Withdrawal by Subject|10
7080004|NCT02119026|11189283|FG000|1st-line Treatment|Patient condition or compliance|6
7080005|NCT02119026|11189284|FG001|1st-line Treatment|Patient condition or compliance|4
7080006|NCT02119026|11189283|FG000|1st-line Treatment|Surgery of metastases|2
7080007|NCT02119026|11189284|FG001|1st-line Treatment|Surgery of metastases|1
7080008|NCT02119026|11189283|FG000|1st-line Treatment|Death|2
7080009|NCT02119026|11189284|FG001|1st-line Treatment|Death|1
7080010|NCT02119026|11189283|FG000|2nd-line Treatment|Lost to Follow-up|2
7080011|NCT02119026|11189284|FG001|2nd-line Treatment|Lost to Follow-up|0
7080012|NCT02119026|11189283|FG000|2nd-line Treatment|Withdrawal by Subject|3
7080013|NCT02119026|11189284|FG001|2nd-line Treatment|Withdrawal by Subject|1
7080014|NCT02119026|11189283|FG000|2nd-line Treatment|Adverse Event|4
7080015|NCT02119026|11189284|FG001|2nd-line Treatment|Adverse Event|1
7080016|NCT02119104|11189290|FG000|Overall Study|Protocol Violation|16
7080017|NCT02119156|11189297|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0
7080018|NCT02119156|11189298|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0
7080019|NCT02119156|11189299|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1
7080020|NCT02119156|11189297|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4
7080021|NCT02119156|11189298|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0
7080022|NCT02119156|11189299|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0
7080023|NCT02119156|11189297|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1
7080024|NCT02119156|11189298|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2
7080025|NCT02119156|11189299|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0
7080026|NCT02119156|11189297|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1
7080027|NCT02119156|11189298|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0
7080028|NCT02119156|11189299|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0
7080029|NCT02119156|11189297|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0
7080030|NCT02119156|11189298|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10
7080031|NCT02119156|11189299|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7
7080032|NCT02119260|11189321|FG000|Overall Study|Adverse Event|1
7080033|NCT02119260|11189322|FG001|Overall Study|Adverse Event|0
7161131|NCT03558516|11335896|FG001|Overall Study|Protocol Violation|2
7161132|NCT03558555|11335904|FG000|Overall Study|Lost to Follow-up|2
7161133|NCT03558555|11335905|FG001|Overall Study|Lost to Follow-up|1
7161134|NCT03558672|11335911|FG000|Overall Study|Study Early Termination|10
7161135|NCT03558997|11335919|FG000|Overall Study|Adverse Event|0
7161136|NCT03558997|11335920|FG001|Overall Study|Adverse Event|2
7161137|NCT03558997|11335921|FG002|Overall Study|Adverse Event|5
7161138|NCT03558997|11335922|FG003|Overall Study|Adverse Event|1
7161139|NCT03558997|11335919|FG000|Overall Study|Physician Decision|0
7161140|NCT03558997|11335920|FG001|Overall Study|Physician Decision|0
7161141|NCT03558997|11335921|FG002|Overall Study|Physician Decision|1
7161142|NCT03558997|11335922|FG003|Overall Study|Physician Decision|0
7161143|NCT03558997|11335919|FG000|Overall Study|Withdrawal by Subject|1
7161144|NCT03558997|11335920|FG001|Overall Study|Withdrawal by Subject|0
7161145|NCT03558997|11335921|FG002|Overall Study|Withdrawal by Subject|1
7161146|NCT03558997|11335922|FG003|Overall Study|Withdrawal by Subject|1
7161147|NCT03558997|11335919|FG000|Overall Study|Lost to Follow-up|0
7161148|NCT03558997|11335920|FG001|Overall Study|Lost to Follow-up|0
7161149|NCT03558997|11335921|FG002|Overall Study|Lost to Follow-up|1
7161150|NCT03558997|11335922|FG003|Overall Study|Lost to Follow-up|0
7161151|NCT03559062|11335938|FG000|Overall Study|Other|0
7161152|NCT03559062|11335939|FG001|Overall Study|Other|1
7161153|NCT03559062|11335940|FG002|Overall Study|Other|0
7161154|NCT03559218|11335982|FG000|Overall Study|Withdrawal by Subject|1
7161155|NCT03559218|11335983|FG001|Overall Study|Withdrawal by Subject|0
7161156|NCT03559257|11335991|FG000|Double Blind Treatment Period|Withdrawal by Subject|2
7161157|NCT03559257|11335992|FG001|Double Blind Treatment Period|Withdrawal by Subject|1
7161158|NCT03559257|11335991|FG000|Double Blind Treatment Period|Protocol Violation|1
7161159|NCT03559257|11335992|FG001|Double Blind Treatment Period|Protocol Violation|4
7161160|NCT03559257|11335991|FG000|Double Blind Treatment Period|Lack of Efficacy|1
7161161|NCT03559257|11335992|FG001|Double Blind Treatment Period|Lack of Efficacy|1
7161162|NCT03559257|11335991|FG000|Double Blind Treatment Period|Adverse Event|0
7161163|NCT03559257|11335992|FG001|Double Blind Treatment Period|Adverse Event|1
7161164|NCT03559257|11335991|FG000|Double Blind Treatment Period|Screen Failure|0
7161165|NCT03559257|11335992|FG001|Double Blind Treatment Period|Screen Failure|1
7161166|NCT03559257|11335991|FG000|Open-label Treatment Period|Adverse Event|1
7161167|NCT03559257|11335992|FG001|Open-label Treatment Period|Adverse Event|4
7161168|NCT03559257|11335991|FG000|Open-label Treatment Period|Lack of Efficacy|3
7161169|NCT03559257|11335992|FG001|Open-label Treatment Period|Lack of Efficacy|2
7161170|NCT03559257|11335991|FG000|Open-label Treatment Period|Withdrawal by Subject|3
7161171|NCT03559257|11335992|FG001|Open-label Treatment Period|Withdrawal by Subject|0
7161172|NCT03559257|11335991|FG000|Open-label Treatment Period|Protocol Violation|2
7161173|NCT03559257|11335992|FG001|Open-label Treatment Period|Protocol Violation|0
7080034|NCT02119260|11189323|FG002|Overall Study|Adverse Event|0
7080035|NCT02119260|11189324|FG003|Overall Study|Adverse Event|0
7080036|NCT02119260|11189325|FG004|Overall Study|Adverse Event|0
7080037|NCT02119260|11189326|FG005|Overall Study|Adverse Event|0
7080038|NCT02119260|11189327|FG006|Overall Study|Adverse Event|0
7080039|NCT02119260|11189321|FG000|Overall Study|Withdrew consent|0
7080040|NCT02119260|11189322|FG001|Overall Study|Withdrew consent|1
7080041|NCT02119260|11189323|FG002|Overall Study|Withdrew consent|1
7080042|NCT02119260|11189324|FG003|Overall Study|Withdrew consent|0
7080043|NCT02119260|11189325|FG004|Overall Study|Withdrew consent|0
7080044|NCT02119260|11189326|FG005|Overall Study|Withdrew consent|0
7080045|NCT02119260|11189327|FG006|Overall Study|Withdrew consent|0
7080046|NCT02119286|11189355|FG000|Overall Study|Adverse Event|9
7080047|NCT02119286|11189356|FG001|Overall Study|Adverse Event|7
7080048|NCT02119286|11189357|FG002|Overall Study|Adverse Event|2
7080049|NCT02119286|11189355|FG000|Overall Study|Lack of Efficacy|11
7080050|NCT02119286|11189356|FG001|Overall Study|Lack of Efficacy|3
7080051|NCT02119286|11189357|FG002|Overall Study|Lack of Efficacy|4
7080052|NCT02119286|11189355|FG000|Overall Study|Lost to Follow-up|2
7080053|NCT02119286|11189356|FG001|Overall Study|Lost to Follow-up|0
7080054|NCT02119286|11189357|FG002|Overall Study|Lost to Follow-up|1
7080055|NCT02119286|11189355|FG000|Overall Study|Withdrawal by Subject|4
7080056|NCT02119286|11189356|FG001|Overall Study|Withdrawal by Subject|1
7080057|NCT02119286|11189357|FG002|Overall Study|Withdrawal by Subject|0
7080058|NCT02119299|11189365|FG000|Overall Study|Withdrawal by Subject|7
7080059|NCT02119299|11189365|FG000|Overall Study|Lack of Efficacy|1
7080060|NCT02119299|11189365|FG000|Overall Study|Pregnancy|1
7161174|NCT03559257|11335991|FG000|Open-label Treatment Period|Lost to Follow-up|1
7161175|NCT03559257|11335992|FG001|Open-label Treatment Period|Lost to Follow-up|0
7161176|NCT03559257|11335991|FG000|Open-label Treatment Period|Physician Decision|0
7161177|NCT03559257|11335992|FG001|Open-label Treatment Period|Physician Decision|1
7161178|NCT03559517|11336004|FG000|Overall Study|Withdrawal by Subject|1
7161179|NCT03559517|11336005|FG001|Overall Study|Withdrawal by Subject|0
7161180|NCT03559517|11336006|FG002|Overall Study|Withdrawal by Subject|0
7161181|NCT03559530|11336014|FG000|Overall Study|non-location of medical records|44
7080061|NCT02119325|11189369|FG000|Washout Period 1|Adverse Event|0
7080062|NCT02119325|11189370|FG001|Washout Period 1|Adverse Event|1
7080063|NCT02119650|11189393|FG000|Overall Study|Adverse Event|3
7080064|NCT02119650|11189394|FG001|Overall Study|Adverse Event|4
7080065|NCT02119650|11189393|FG000|Overall Study|Subject decision|2
7161182|NCT03559530|11336015|FG001|Overall Study|non-location of medical records|0
7161183|NCT03559530|11336014|FG000|Overall Study|culture results not considered for treat|29
7161184|NCT03559530|11336015|FG001|Overall Study|culture results not considered for treat|0
7161185|NCT03559530|11336014|FG000|Overall Study|duplicate cases|8
7161186|NCT03559530|11336015|FG001|Overall Study|duplicate cases|0
7161187|NCT03559530|11336014|FG000|Overall Study|other species of Acinetobacte|7
7161188|NCT03559530|11336015|FG001|Overall Study|other species of Acinetobacte|0
7161189|NCT03559530|11336014|FG000|Overall Study|contamination / colonization|3
7161190|NCT03559530|11336015|FG001|Overall Study|contamination / colonization|0
7184287|NCT01921218|11384353|FG000|Overall Study|Death|2
7184288|NCT01921218|11384354|FG001|Overall Study|Death|1
7184289|NCT01921218|11384353|FG000|Overall Study|Withdrawal by Subject|0
7184290|NCT01921218|11384354|FG001|Overall Study|Withdrawal by Subject|2
7184291|NCT01921218|11384353|FG000|Overall Study|Kidney transplant|1
7184292|NCT01921218|11384354|FG001|Overall Study|Kidney transplant|1
7184293|NCT01923168|11384363|FG000|Overall Study|Protocol Violation|1
7184294|NCT01923168|11384364|FG001|Overall Study|Protocol Violation|1
7184295|NCT01923168|11384365|FG002|Overall Study|Protocol Violation|0
7184296|NCT01923168|11384363|FG000|Overall Study|Subject/guardian decision|14
7184297|NCT01923168|11384364|FG001|Overall Study|Subject/guardian decision|14
7184298|NCT01923168|11384365|FG002|Overall Study|Subject/guardian decision|4
7184299|NCT01923168|11384363|FG000|Overall Study|Adverse Event|12
7184300|NCT01923168|11384364|FG001|Overall Study|Adverse Event|12
7184301|NCT01923168|11384365|FG002|Overall Study|Adverse Event|0
7184302|NCT01923168|11384363|FG000|Overall Study|Physician Decision|6
7184303|NCT01923168|11384364|FG001|Overall Study|Physician Decision|9
7184304|NCT01923168|11384365|FG002|Overall Study|Physician Decision|5
7184305|NCT01923168|11384363|FG000|Overall Study|Progressive disease|4
7184306|NCT01923168|11384364|FG001|Overall Study|Progressive disease|3
7184307|NCT01923168|11384365|FG002|Overall Study|Progressive disease|7
7184308|NCT01923168|11384363|FG000|Overall Study|Death|0
7184309|NCT01923168|11384364|FG001|Overall Study|Death|0
7184310|NCT01923168|11384365|FG002|Overall Study|Death|1
7184311|NCT01931098|11384395|FG000|Overall Study|Withdrawal by Subject|0
7184312|NCT01931098|11384396|FG001|Overall Study|Withdrawal by Subject|1
7184313|NCT01931098|11384395|FG000|Overall Study|Enrolled in different protocol|0
7184314|NCT01931098|11384396|FG001|Overall Study|Enrolled in different protocol|1
7184315|NCT01931098|11384395|FG000|Overall Study|Unable to begin trmt:active infection|0
7184316|NCT01931098|11384396|FG001|Overall Study|Unable to begin trmt:active infection|1
7184317|NCT01931098|11384395|FG000|Overall Study|Refused further treatment|0
7184318|NCT01931098|11384396|FG001|Overall Study|Refused further treatment|1
7184319|NCT01945021|11384404|FG000|Overall Study|Adverse Event|1
7184320|NCT01945021|11384404|FG000|Overall Study|Withdrawal of consent|12
7184321|NCT01945021|11384404|FG000|Overall Study|Lost to Follow-up|5
7184322|NCT01945021|11384404|FG000|Overall Study|Death|65
7184323|NCT04466384|11384412|FG000|First Phase|Protocol Violation|1
7184324|NCT04466384|11384413|FG001|First Phase|Protocol Violation|0
7184325|NCT04466384|11384412|FG000|First Phase|Missing data|1
7184326|NCT04466384|11384413|FG001|First Phase|Missing data|0
7184327|NCT04466384|11384412|FG000|Cross Over Phase|Physician Decision|1
7184328|NCT04466384|11384413|FG001|Cross Over Phase|Physician Decision|0
7184329|NCT04466384|11384412|FG000|Cross Over Phase|Withdrawal by Subject|0
7184330|NCT04466384|11384413|FG001|Cross Over Phase|Withdrawal by Subject|1
7184331|NCT03951077|11384463|FG000|Overall Study|Adverse Event|1
7184332|NCT03951077|11384464|FG001|Overall Study|Adverse Event|0
7184333|NCT03951077|11384465|FG002|Overall Study|Adverse Event|0
7184334|NCT03951077|11384466|FG003|Overall Study|Adverse Event|0
7184335|NCT03951077|11384467|FG004|Overall Study|Adverse Event|0
7184336|NCT03951077|11384468|FG005|Overall Study|Adverse Event|0
7184337|NCT03951077|11384463|FG000|Overall Study|Withdrawal by Subject|3
7184338|NCT03951077|11384464|FG001|Overall Study|Withdrawal by Subject|3
7184339|NCT03951077|11384465|FG002|Overall Study|Withdrawal by Subject|0
7184340|NCT03951077|11384466|FG003|Overall Study|Withdrawal by Subject|3
7184341|NCT03951077|11384467|FG004|Overall Study|Withdrawal by Subject|3
7184342|NCT03951077|11384468|FG005|Overall Study|Withdrawal by Subject|2
7184343|NCT03951077|11384463|FG000|Overall Study|Lost to Follow-up|1
7184344|NCT03951077|11384464|FG001|Overall Study|Lost to Follow-up|1
7184345|NCT03951077|11384465|FG002|Overall Study|Lost to Follow-up|2
7184346|NCT03951077|11384466|FG003|Overall Study|Lost to Follow-up|3
7184347|NCT03951077|11384467|FG004|Overall Study|Lost to Follow-up|2
7184348|NCT03951077|11384468|FG005|Overall Study|Lost to Follow-up|3
7184349|NCT03951077|11384463|FG000|Overall Study|Non-Compliance With Study Procedures|0
7184350|NCT03951077|11384464|FG001|Overall Study|Non-Compliance With Study Procedures|0
7184351|NCT03951077|11384465|FG002|Overall Study|Non-Compliance With Study Procedures|0
7184352|NCT03951077|11384466|FG003|Overall Study|Non-Compliance With Study Procedures|0
7184353|NCT03951077|11384467|FG004|Overall Study|Non-Compliance With Study Procedures|1
7184354|NCT03951077|11384468|FG005|Overall Study|Non-Compliance With Study Procedures|0
7184355|NCT03951077|11384463|FG000|Overall Study|Other, Not Specified|12
7184356|NCT03951077|11384464|FG001|Overall Study|Other, Not Specified|10
7184357|NCT03951077|11384465|FG002|Overall Study|Other, Not Specified|10
7184358|NCT03951077|11384466|FG003|Overall Study|Other, Not Specified|5
7184359|NCT03951077|11384467|FG004|Overall Study|Other, Not Specified|9
7161191|NCT03560245|11336055|FG000|Overall Study|Withdrawal by Subject|3
7161192|NCT03560245|11336056|FG001|Overall Study|Withdrawal by Subject|2
7161193|NCT03560245|11336055|FG000|Overall Study|Adverse Event|1
7161194|NCT03560245|11336056|FG001|Overall Study|Adverse Event|1
7161195|NCT03560245|11336055|FG000|Overall Study|Protocol Violation|1
7161196|NCT03560245|11336056|FG001|Overall Study|Protocol Violation|0
7161197|NCT03560245|11336055|FG000|Overall Study|Death|0
7161198|NCT03560245|11336056|FG001|Overall Study|Death|1
7161199|NCT03560245|11336055|FG000|Overall Study|Lost to Follow-up|0
7161200|NCT03560245|11336056|FG001|Overall Study|Lost to Follow-up|1
7161201|NCT03560245|11336055|FG000|Overall Study|Physician Decision|0
7161202|NCT03560245|11336056|FG001|Overall Study|Physician Decision|1
7161203|NCT03560245|11336055|FG000|Overall Study|Other|0
7161204|NCT03560245|11336056|FG001|Overall Study|Other|1
7161205|NCT03560518|11336067|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1
7161206|NCT03560518|11336068|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0
7161207|NCT03560518|11336069|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0
7161208|NCT03560518|11336067|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6
7161209|NCT03560518|11336068|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9
7161210|NCT03560518|11336069|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10
7161211|NCT03560518|11336067|FG000|Double Blind Treatment Period|Protocol Violation|1
7161212|NCT03560518|11336068|FG001|Double Blind Treatment Period|Protocol Violation|2
7161213|NCT03560518|11336069|FG002|Double Blind Treatment Period|Protocol Violation|0
7161214|NCT03560518|11336067|FG000|Double Blind Treatment Period|Pregnancy|0
7161215|NCT03560518|11336068|FG001|Double Blind Treatment Period|Pregnancy|2
7161216|NCT03560518|11336069|FG002|Double Blind Treatment Period|Pregnancy|0
7161217|NCT03560518|11336067|FG000|Double Blind Treatment Period|Lost to Follow-up|5
7161218|NCT03560518|11336068|FG001|Double Blind Treatment Period|Lost to Follow-up|6
7161219|NCT03560518|11336069|FG002|Double Blind Treatment Period|Lost to Follow-up|6
7161220|NCT03560518|11336067|FG000|Double Blind Treatment Period|Withdrawal by Subject|10
7161221|NCT03560518|11336068|FG001|Double Blind Treatment Period|Withdrawal by Subject|6
7161222|NCT03560518|11336069|FG002|Double Blind Treatment Period|Withdrawal by Subject|5
7161223|NCT03560518|11336067|FG000|Double Blind Treatment Period|Lack of Efficacy|2
7161224|NCT03560518|11336068|FG001|Double Blind Treatment Period|Lack of Efficacy|1
7161225|NCT03560518|11336069|FG002|Double Blind Treatment Period|Lack of Efficacy|1
7161226|NCT03560518|11336067|FG000|Double Blind Treatment Period|Adverse Event|0
7161227|NCT03560518|11336068|FG001|Double Blind Treatment Period|Adverse Event|3
7161228|NCT03560518|11336069|FG002|Double Blind Treatment Period|Adverse Event|1
7161229|NCT03560739|11336081|FG000|Overall Study|Adverse Event|0
7161230|NCT03560739|11336082|FG001|Overall Study|Adverse Event|1
7161231|NCT03560739|11336083|FG002|Overall Study|Adverse Event|0
7161232|NCT03560739|11336084|FG003|Overall Study|Adverse Event|0
7161233|NCT03560869|11336094|FG000|Overall Study|Withdrawal by Subject|3
7161234|NCT03560869|11336095|FG001|Overall Study|Withdrawal by Subject|4
7161235|NCT03560869|11336094|FG000|Overall Study|Screening failure|4
7161236|NCT03560869|11336095|FG001|Overall Study|Screening failure|4
7161237|NCT03560869|11336094|FG000|Overall Study|Withdrawal by PI|0
7161238|NCT03560869|11336095|FG001|Overall Study|Withdrawal by PI|1
7161239|NCT03560986|11336103|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3
7161240|NCT03560986|11336104|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1
7161241|NCT03560986|11336103|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1
7161242|NCT03560986|11336104|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1
7161243|NCT03560986|11336103|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0
7161244|NCT03560986|11336104|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1
7161245|NCT03560986|11336103|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32
7161246|NCT03560986|11336104|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35
7161247|NCT03560986|11336103|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1
7161248|NCT03560986|11336104|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0
7161249|NCT03560986|11336103|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0
7161250|NCT03560986|11336104|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1
7161251|NCT03560986|11336103|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7
7161252|NCT03560986|11336104|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7
7161253|NCT03561090|11336118|FG000|Overall Study|Adverse Event|11
7161254|NCT03561090|11336119|FG001|Overall Study|Adverse Event|7
7161255|NCT03561090|11336118|FG000|Overall Study|Non-Compliance With Study Drug|2
7161256|NCT03561090|11336119|FG001|Overall Study|Non-Compliance With Study Drug|0
7161257|NCT03561090|11336118|FG000|Overall Study|Protocol Violation|2
7161258|NCT03561090|11336119|FG001|Overall Study|Protocol Violation|2
7161259|NCT03561090|11336118|FG000|Overall Study|Withdrawal by Subject|7
7161260|NCT03561090|11336119|FG001|Overall Study|Withdrawal by Subject|7
7161261|NCT03561090|11336118|FG000|Overall Study|Lost to Follow-up|7
7161262|NCT03561090|11336119|FG001|Overall Study|Lost to Follow-up|2
7161263|NCT03561090|11336118|FG000|Overall Study|Study Terminated by Sponsor|10
7161264|NCT03561090|11336119|FG001|Overall Study|Study Terminated by Sponsor|15
7161265|NCT03561090|11336118|FG000|Overall Study|Randomized by Mistake|1
7161266|NCT03561090|11336119|FG001|Overall Study|Randomized by Mistake|1
7161267|NCT03561090|11336118|FG000|Overall Study|Other Not Specified|0
7161268|NCT03561090|11336119|FG001|Overall Study|Other Not Specified|2
7161269|NCT03561883|11336129|FG000|Overall Study|Adverse Event|10
7161270|NCT03561883|11336130|FG001|Overall Study|Adverse Event|13
7161271|NCT03561883|11336129|FG000|Overall Study|Non-Compliance With Study Drug|1
7161272|NCT03561883|11336130|FG001|Overall Study|Non-Compliance With Study Drug|2
7161273|NCT03561883|11336129|FG000|Overall Study|Protocol Violation|2
7161274|NCT03561883|11336130|FG001|Overall Study|Protocol Violation|3
7161275|NCT03561883|11336129|FG000|Overall Study|Withdrawal by Subject|14
7161276|NCT03561883|11336130|FG001|Overall Study|Withdrawal by Subject|6
7161277|NCT03561883|11336129|FG000|Overall Study|Lost to Follow-up|2
7161278|NCT03561883|11336130|FG001|Overall Study|Lost to Follow-up|6
7161279|NCT03561883|11336129|FG000|Overall Study|Study Terminated by Sponsor|12
7161280|NCT03561883|11336130|FG001|Overall Study|Study Terminated by Sponsor|11
7161281|NCT03561883|11336129|FG000|Overall Study|Physician Decision|1
7161282|NCT03561883|11336130|FG001|Overall Study|Physician Decision|0
7161283|NCT03561883|11336129|FG000|Overall Study|Randomized by Mistake|1
7161284|NCT03561883|11336130|FG001|Overall Study|Randomized by Mistake|0
7161285|NCT03561883|11336129|FG000|Overall Study|Other, Not Specified|3
7161286|NCT03561883|11336130|FG001|Overall Study|Other, Not Specified|2
7161287|NCT03562117|11336139|FG000|Part 1, Up to 3 Days|Adverse Event|1
7161288|NCT03562117|11336140|FG001|Part 1, Up to 3 Days|Adverse Event|0
7161289|NCT03562117|11336141|FG002|Part 1, Up to 3 Days|Adverse Event|0
7161290|NCT03562481|11336160|FG000|First Intervention|Lost to Follow-up|1
7161291|NCT03562481|11336161|FG001|First Intervention|Lost to Follow-up|0
7161292|NCT03565068|11336275|FG000|Overall Study|Protocol Violation|0
7161293|NCT03565068|11336276|FG001|Overall Study|Protocol Violation|0
7161294|NCT03565068|11336277|FG002|Overall Study|Protocol Violation|0
7161295|NCT03565068|11336278|FG003|Overall Study|Protocol Violation|0
7161296|NCT03565068|11336279|FG004|Overall Study|Protocol Violation|1
7161297|NCT03565068|11336280|FG005|Overall Study|Protocol Violation|0
7161298|NCT03565068|11336281|FG006|Overall Study|Protocol Violation|0
7161299|NCT03565068|11336282|FG007|Overall Study|Protocol Violation|1
7161300|NCT03565068|11336283|FG008|Overall Study|Protocol Violation|0
7161301|NCT03565068|11336275|FG000|Overall Study|Sponsor decision|0
7161302|NCT03565068|11336276|FG001|Overall Study|Sponsor decision|0
7161303|NCT03565068|11336277|FG002|Overall Study|Sponsor decision|0
7161304|NCT03565068|11336278|FG003|Overall Study|Sponsor decision|0
7161305|NCT03565068|11336279|FG004|Overall Study|Sponsor decision|1
7161306|NCT03565068|11336280|FG005|Overall Study|Sponsor decision|1
7161307|NCT03565068|11336281|FG006|Overall Study|Sponsor decision|0
7161308|NCT03565068|11336282|FG007|Overall Study|Sponsor decision|0
7161309|NCT03565068|11336283|FG008|Overall Study|Sponsor decision|0
7161310|NCT03565068|11336275|FG000|Overall Study|Withdrawal by Subject|0
7161311|NCT03565068|11336276|FG001|Overall Study|Withdrawal by Subject|0
7161312|NCT03565068|11336277|FG002|Overall Study|Withdrawal by Subject|1
7161313|NCT03565068|11336278|FG003|Overall Study|Withdrawal by Subject|0
7161314|NCT03565068|11336279|FG004|Overall Study|Withdrawal by Subject|2
7161315|NCT03565068|11336280|FG005|Overall Study|Withdrawal by Subject|0
7161316|NCT03565068|11336281|FG006|Overall Study|Withdrawal by Subject|1
7161317|NCT03565068|11336282|FG007|Overall Study|Withdrawal by Subject|5
7161318|NCT03565068|11336283|FG008|Overall Study|Withdrawal by Subject|1
7161319|NCT03565068|11336275|FG000|Overall Study|Physician Decision|0
7161320|NCT03565068|11336276|FG001|Overall Study|Physician Decision|0
7161321|NCT03565068|11336277|FG002|Overall Study|Physician Decision|0
7161322|NCT03565068|11336278|FG003|Overall Study|Physician Decision|0
7161323|NCT03565068|11336279|FG004|Overall Study|Physician Decision|0
7161324|NCT03565068|11336280|FG005|Overall Study|Physician Decision|0
7161325|NCT03565068|11336281|FG006|Overall Study|Physician Decision|0
7161326|NCT03565068|11336282|FG007|Overall Study|Physician Decision|1
7161327|NCT03565068|11336283|FG008|Overall Study|Physician Decision|0
7161328|NCT03565068|11336275|FG000|Overall Study|Lost to Follow-up|0
7161329|NCT03565068|11336276|FG001|Overall Study|Lost to Follow-up|0
7080066|NCT02119650|11189394|FG001|Overall Study|Subject decision|3
7080067|NCT02119650|11189393|FG000|Overall Study|Disease progression|11
6895061|NCT00622700|10912833|FG001|Extension Treatment Period|Progressive Disease|0
6895062|NCT00622700|10912834|FG002|Extension Treatment Period|Progressive Disease|0
6895063|NCT00622700|10912835|FG003|Extension Treatment Period|Progressive Disease|1
6895064|NCT00622700|10912836|FG004|Extension Treatment Period|Progressive Disease|2
6895065|NCT00622700|10912837|FG005|Extension Treatment Period|Progressive Disease|0
6895066|NCT00622700|10912838|FG006|Extension Treatment Period|Progressive Disease|2
6895067|NCT00622700|10912832|FG000|Extension Treatment Period|Withdrawal by Subject|0
6895068|NCT00622700|10912833|FG001|Extension Treatment Period|Withdrawal by Subject|0
6895069|NCT00622700|10912834|FG002|Extension Treatment Period|Withdrawal by Subject|0
6895070|NCT00622700|10912835|FG003|Extension Treatment Period|Withdrawal by Subject|11
7080068|NCT02119650|11189394|FG001|Overall Study|Disease progression|14
7080069|NCT02119650|11189393|FG000|Overall Study|Death|5
7080070|NCT02119650|11189394|FG001|Overall Study|Death|1
7080071|NCT02119650|11189393|FG000|Overall Study|Noncompliance with study treatment|1
7080072|NCT02119650|11189394|FG001|Overall Study|Noncompliance with study treatment|1
7080073|NCT02119650|11189393|FG000|Overall Study|Study terminated by the sponsor|1
7080074|NCT02119650|11189394|FG001|Overall Study|Study terminated by the sponsor|0
7080075|NCT02119650|11189393|FG000|Overall Study|Physician Decision|0
7080076|NCT02119650|11189394|FG001|Overall Study|Physician Decision|2
7161330|NCT03565068|11336277|FG002|Overall Study|Lost to Follow-up|0
7161331|NCT03565068|11336278|FG003|Overall Study|Lost to Follow-up|0
7161332|NCT03565068|11336279|FG004|Overall Study|Lost to Follow-up|0
7161333|NCT03565068|11336280|FG005|Overall Study|Lost to Follow-up|0
7161334|NCT03565068|11336281|FG006|Overall Study|Lost to Follow-up|0
7161335|NCT03565068|11336282|FG007|Overall Study|Lost to Follow-up|1
7161336|NCT03565068|11336283|FG008|Overall Study|Lost to Follow-up|0
7161337|NCT03565211|11336340|FG000|Overall Study|Withdrawal by Subject|2
7161338|NCT03565211|11336340|FG000|Overall Study|Lost to Follow-up|1
7161339|NCT03565211|11336340|FG000|Overall Study|Adverse Event|44
7161340|NCT03565211|11336340|FG000|Overall Study|Personal issues|1
7161341|NCT03565315|11336348|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0
7161342|NCT03565315|11336349|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0
7161343|NCT03565315|11336350|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0
7161344|NCT03565315|11336351|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1
7161345|NCT03565887|11336400|FG000|Overall Study|Adverse Event|1
7161346|NCT03565887|11336401|FG001|Overall Study|Adverse Event|0
7161347|NCT03565887|11336400|FG000|Overall Study|Withdrawal by Subject|0
7161348|NCT03565887|11336401|FG001|Overall Study|Withdrawal by Subject|2
7161349|NCT03566238|11336410|FG000|Overall Study|Adverse Event|0
7161350|NCT03566238|11336411|FG001|Overall Study|Adverse Event|1
7161351|NCT03566238|11336412|FG002|Overall Study|Adverse Event|0
7161352|NCT03566238|11336410|FG000|Overall Study|Lack of Efficacy|4
7161353|NCT03566238|11336411|FG001|Overall Study|Lack of Efficacy|2
7161354|NCT03566238|11336412|FG002|Overall Study|Lack of Efficacy|5
7161355|NCT03566238|11336410|FG000|Overall Study|Other|1
7161356|NCT03566238|11336411|FG001|Overall Study|Other|0
7161357|NCT03566238|11336412|FG002|Overall Study|Other|0
7161358|NCT03566485|11336422|FG000|Overall Study|Disease progression|5
7161359|NCT03566485|11336423|FG001|Overall Study|Disease progression|4
7161360|NCT03566485|11336422|FG000|Overall Study|Clinical progression|0
7161361|NCT03566485|11336423|FG001|Overall Study|Clinical progression|1
7161362|NCT03566485|11336422|FG000|Overall Study|Toxicity|0
7161363|NCT03566485|11336423|FG001|Overall Study|Toxicity|2
7161364|NCT03566550|11336431|FG000|Overall Study|Withdrawal by Subject|0
7161365|NCT03566550|11336432|FG001|Overall Study|Withdrawal by Subject|1
7161366|NCT03566680|11336438|FG000|Overall Study|Pregnancy|1
7161367|NCT03566680|11336438|FG000|Overall Study|Lost to Follow-up|13
7161368|NCT03566680|11336438|FG000|Overall Study|Withdrawal by Subject|3
7161369|NCT03566810|11336446|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
7161370|NCT03566810|11336447|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1
7161371|NCT03566810|11336448|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
7161372|NCT03566810|11336449|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
7161373|NCT03566823|11336462|FG000|Overall Study|Lack of Efficacy|0
7161374|NCT03566823|11336463|FG001|Overall Study|Lack of Efficacy|1
7161375|NCT03566823|11336464|FG002|Overall Study|Lack of Efficacy|0
7161376|NCT03566823|11336462|FG000|Overall Study|Withdrawal by Subject|1
7161377|NCT03566823|11336463|FG001|Overall Study|Withdrawal by Subject|2
7161378|NCT03566823|11336464|FG002|Overall Study|Withdrawal by Subject|0
7161379|NCT03566823|11336462|FG000|Overall Study|Adverse Event|1
7161380|NCT03566823|11336463|FG001|Overall Study|Adverse Event|0
7161381|NCT03566823|11336464|FG002|Overall Study|Adverse Event|2
7161382|NCT03566979|11336476|FG000|Overall Study|Withdrawal by Subject|2
7161383|NCT03566979|11336477|FG001|Overall Study|Withdrawal by Subject|0
7161384|NCT03566979|11336478|FG002|Overall Study|Withdrawal by Subject|1
7161385|NCT03566979|11336479|FG003|Overall Study|Withdrawal by Subject|1
7161386|NCT03566979|11336476|FG000|Overall Study|Lost to Follow-up|2
7161387|NCT03566979|11336477|FG001|Overall Study|Lost to Follow-up|7
7161388|NCT03566979|11336478|FG002|Overall Study|Lost to Follow-up|9
7161389|NCT03566979|11336479|FG003|Overall Study|Lost to Follow-up|5
7161390|NCT03566979|11336476|FG000|Overall Study|Adverse Event|1
7161391|NCT03566979|11336477|FG001|Overall Study|Adverse Event|0
7161392|NCT03566979|11336478|FG002|Overall Study|Adverse Event|0
7161393|NCT03566979|11336479|FG003|Overall Study|Adverse Event|0
7161394|NCT03567291|11336505|FG000|Period I|Adverse Event|14
7161395|NCT03567291|11336506|FG001|Period I|Adverse Event|0
7161396|NCT03567291|11336507|FG002|Period I|Adverse Event|0
7161397|NCT03567291|11336508|FG003|Period I|Adverse Event|0
7161398|NCT03567291|11336505|FG000|Period I|Protocol Violation|1
7161399|NCT03567291|11336506|FG001|Period I|Protocol Violation|0
7161400|NCT03567291|11336507|FG002|Period I|Protocol Violation|0
7161401|NCT03567291|11336508|FG003|Period I|Protocol Violation|0
7161402|NCT03567291|11336505|FG000|Period I|Withdrawal by Subject|23
7161403|NCT03567291|11336506|FG001|Period I|Withdrawal by Subject|0
7161404|NCT03567291|11336507|FG002|Period I|Withdrawal by Subject|0
7161405|NCT03567291|11336508|FG003|Period I|Withdrawal by Subject|0
7161406|NCT03567291|11336505|FG000|Period I|Lost to Follow-up|2
7161407|NCT03567291|11336506|FG001|Period I|Lost to Follow-up|0
7161408|NCT03567291|11336507|FG002|Period I|Lost to Follow-up|0
7161409|NCT03567291|11336508|FG003|Period I|Lost to Follow-up|0
7161410|NCT03567291|11336505|FG000|Period I|Terminated by sponsor|44
7161411|NCT03567291|11336506|FG001|Period I|Terminated by sponsor|0
7161412|NCT03567291|11336507|FG002|Period I|Terminated by sponsor|0
7161413|NCT03567291|11336508|FG003|Period I|Terminated by sponsor|0
7161414|NCT03567291|11336505|FG000|Period I|Missing or unknown|7
7161415|NCT03567291|11336506|FG001|Period I|Missing or unknown|0
7161416|NCT03567291|11336507|FG002|Period I|Missing or unknown|0
7161417|NCT03567291|11336508|FG003|Period I|Missing or unknown|0
7161418|NCT03567291|11336505|FG000|Period II|Adverse Event|0
7161419|NCT03567291|11336506|FG001|Period II|Adverse Event|1
7161420|NCT03567291|11336507|FG002|Period II|Adverse Event|0
7161421|NCT03567291|11336508|FG003|Period II|Adverse Event|0
7161422|NCT03567291|11336505|FG000|Period II|Missing or unknown|0
7161423|NCT03567291|11336506|FG001|Period II|Missing or unknown|2
7161424|NCT03567291|11336507|FG002|Period II|Missing or unknown|1
7161425|NCT03567291|11336508|FG003|Period II|Missing or unknown|0
7161426|NCT03567291|11336505|FG000|Period III|Adverse Event|0
7161427|NCT03567291|11336506|FG001|Period III|Adverse Event|0
7161428|NCT03567291|11336507|FG002|Period III|Adverse Event|0
7161429|NCT03567291|11336508|FG003|Period III|Adverse Event|4
7161430|NCT03567291|11336505|FG000|Period III|Withdrawal by Subject|0
7161431|NCT03567291|11336506|FG001|Period III|Withdrawal by Subject|0
7161432|NCT03567291|11336507|FG002|Period III|Withdrawal by Subject|0
7161433|NCT03567291|11336508|FG003|Period III|Withdrawal by Subject|4
7161434|NCT03567291|11336505|FG000|Period III|Lost to Follow-up|0
7161435|NCT03567291|11336506|FG001|Period III|Lost to Follow-up|0
7161436|NCT03567291|11336507|FG002|Period III|Lost to Follow-up|0
7161437|NCT03567291|11336508|FG003|Period III|Lost to Follow-up|1
7161438|NCT03567291|11336505|FG000|Period III|Terminated by sponsor|0
7161439|NCT03567291|11336506|FG001|Period III|Terminated by sponsor|0
7161440|NCT03567291|11336507|FG002|Period III|Terminated by sponsor|0
7161441|NCT03567291|11336508|FG003|Period III|Terminated by sponsor|68
7161442|NCT03567291|11336505|FG000|Period III|Missing or unknown|0
7161443|NCT03567291|11336506|FG001|Period III|Missing or unknown|0
7161444|NCT03567291|11336507|FG002|Period III|Missing or unknown|0
7161445|NCT03567291|11336508|FG003|Period III|Missing or unknown|8
7161446|NCT03567382|11336516|FG000|Overall Study|Lost to Follow-up|1
7161447|NCT03567382|11336517|FG001|Overall Study|Lost to Follow-up|21
7161448|NCT03567382|11336518|FG002|Overall Study|Lost to Follow-up|1
7161449|NCT03567382|11336519|FG003|Overall Study|Lost to Follow-up|21
7161450|NCT03567382|11336516|FG000|Overall Study|Withdrawal by Subject|2
7161451|NCT03567382|11336517|FG001|Overall Study|Withdrawal by Subject|14
7161452|NCT03567382|11336518|FG002|Overall Study|Withdrawal by Subject|1
7161453|NCT03567382|11336519|FG003|Overall Study|Withdrawal by Subject|12
7161454|NCT03567616|11336532|FG000|Overall Study|Disease progression|4
7161455|NCT03567616|11336532|FG000|Overall Study|Withdrawal by Subject|1
7161456|NCT03567616|11336532|FG000|Overall Study|Physician Decision|1
7161457|NCT03567616|11336532|FG000|Overall Study|Death|1
7161458|NCT03567616|11336532|FG000|Overall Study|Adverse Event|1
7161459|NCT03567980|11336539|FG000|Overall Study|Adverse Event|1
7161460|NCT03568500|11336546|FG000|Overall Study|Lost to Follow-up|1
7161461|NCT03568500|11336547|FG001|Overall Study|Lost to Follow-up|1
7161462|NCT03568500|11336548|FG002|Overall Study|Lost to Follow-up|2
7161463|NCT03568500|11336546|FG000|Overall Study|Adverse Event|1
7161464|NCT03568500|11336547|FG001|Overall Study|Adverse Event|1
7161465|NCT03568500|11336548|FG002|Overall Study|Adverse Event|2
7161466|NCT03568500|11336546|FG000|Overall Study|Physician Decision|1
7161467|NCT03568500|11336547|FG001|Overall Study|Physician Decision|0
7161468|NCT03568500|11336548|FG002|Overall Study|Physician Decision|0
7161469|NCT03568500|11336546|FG000|Overall Study|Withdrawal by Subject|4
7161470|NCT03568500|11336547|FG001|Overall Study|Withdrawal by Subject|2
7161471|NCT03568500|11336548|FG002|Overall Study|Withdrawal by Subject|0
7161472|NCT03568500|11336546|FG000|Overall Study|Technical Problems|2
7161473|NCT03568500|11336547|FG001|Overall Study|Technical Problems|1
7161474|NCT03568500|11336548|FG002|Overall Study|Technical Problems|0
7161475|NCT03568500|11336546|FG000|Overall Study|Participant Noncompliance|1
7161476|NCT03568500|11336547|FG001|Overall Study|Participant Noncompliance|1
7161477|NCT03568500|11336548|FG002|Overall Study|Participant Noncompliance|0
7161478|NCT03568942|11336571|FG000|Overall Study|Family emergency|1
7161479|NCT03568942|11336571|FG000|Overall Study|Lost to Follow-up|1
7161480|NCT03569098|11336600|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5
7161481|NCT03569098|11336601|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2
7161482|NCT03569098|11336602|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5
7161483|NCT03569098|11336600|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0
7161484|NCT03569098|11336601|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6
7161485|NCT03569098|11336602|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3
7161486|NCT03569098|11336600|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1
7161487|NCT03569098|11336601|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1
7161488|NCT03569098|11336602|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0
7161489|NCT03569098|11336600|FG000|Double-Blind Treatment Cycle 1|Technical problems|0
7161490|NCT03569098|11336601|FG001|Double-Blind Treatment Cycle 1|Technical problems|0
7161491|NCT03569098|11336602|FG002|Double-Blind Treatment Cycle 1|Technical problems|2
7161492|NCT03569098|11336600|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1
7161493|NCT03569098|11336601|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0
7161494|NCT03569098|11336602|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0
7161495|NCT03569098|11336600|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0
7161496|NCT03569098|11336601|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1
7161497|NCT03569098|11336602|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0
7161498|NCT03569098|11336600|FG000|Double-Blind Treatment Cycle 1|Other|1
7161499|NCT03569098|11336601|FG001|Double-Blind Treatment Cycle 1|Other|0
7161500|NCT03569098|11336602|FG002|Double-Blind Treatment Cycle 1|Other|1
7161501|NCT03569098|11336600|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0
7161502|NCT03569098|11336601|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21
7161503|NCT03569098|11336602|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0
7161504|NCT03569098|11336600|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0
7161505|NCT03569098|11336601|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11
7161506|NCT03569098|11336602|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0
7161507|NCT03569098|11336600|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0
7161508|NCT03569098|11336601|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3
7161509|NCT03569098|11336602|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0
7161510|NCT03569098|11336600|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0
7161511|NCT03569098|11336601|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0
7161512|NCT03569098|11336602|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4
7161513|NCT03569098|11336600|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0
7161514|NCT03569098|11336601|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1
7161515|NCT03569098|11336602|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1
7161516|NCT03569098|11336600|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0
7161517|NCT03569098|11336601|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0
7161518|NCT03569098|11336602|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1
7161519|NCT03569202|11336615|FG000|Part 3|Physician Decision|1
7161520|NCT03569202|11336616|FG001|Part 3|Physician Decision|0
7161521|NCT03569202|11336615|FG000|Part 3|Other|1
7161522|NCT03569202|11336616|FG001|Part 3|Other|1
7161523|NCT03569371|11336622|FG000|Overall Study|Lack of Efficacy|1
7161524|NCT03569371|11336622|FG000|Overall Study|Lost to Follow-up|1
7161525|NCT03569371|11336622|FG000|Overall Study|Adverse Event|1
7161526|NCT03570554|11336693|FG000|Overall Study|Non-compliance with study drug|0
7161527|NCT03570554|11336694|FG001|Overall Study|Non-compliance with study drug|0
7161528|NCT03570554|11336695|FG002|Overall Study|Non-compliance with study drug|1
7161529|NCT03570554|11336696|FG003|Overall Study|Non-compliance with study drug|0
7161530|NCT03570554|11336693|FG000|Overall Study|Adverse Event|0
7161531|NCT03570554|11336694|FG001|Overall Study|Adverse Event|0
7161532|NCT03570554|11336695|FG002|Overall Study|Adverse Event|0
7161533|NCT03570554|11336696|FG003|Overall Study|Adverse Event|1
7161534|NCT03571256|11336740|FG000|Overall Study|Adverse Event|3
7161535|NCT03571256|11336741|FG001|Overall Study|Adverse Event|0
7161536|NCT03571256|11336742|FG002|Overall Study|Adverse Event|1
7161537|NCT03571256|11336740|FG000|Overall Study|Withdrawal by Subject|3
7161538|NCT03571256|11336741|FG001|Overall Study|Withdrawal by Subject|1
7161539|NCT03571256|11336742|FG002|Overall Study|Withdrawal by Subject|1
7161540|NCT03571256|11336740|FG000|Overall Study|Other than specified|0
7161541|NCT03571256|11336741|FG001|Overall Study|Other than specified|1
7161542|NCT03571256|11336742|FG002|Overall Study|Other than specified|1
7161543|NCT03571256|11336740|FG000|Overall Study|Protocol Violation|0
7161544|NCT03571256|11336741|FG001|Overall Study|Protocol Violation|1
7161545|NCT03571256|11336742|FG002|Overall Study|Protocol Violation|1
7161546|NCT03571516|11336754|FG000|Overall Study|Severe diarrhea|1
7161547|NCT03571516|11336755|FG001|Overall Study|Severe diarrhea|0
7161548|NCT03571516|11336754|FG000|Overall Study|Withdrawal by Subject|0
7161549|NCT03571516|11336755|FG001|Overall Study|Withdrawal by Subject|1
7161550|NCT03572062|11336825|FG000|Overall Study|Adverse Event|0
7161551|NCT03572062|11336826|FG001|Overall Study|Adverse Event|0
7161552|NCT03572062|11336827|FG002|Overall Study|Adverse Event|0
7161553|NCT03572062|11336828|FG003|Overall Study|Adverse Event|0
7161554|NCT03572062|11336829|FG004|Overall Study|Adverse Event|0
7161555|NCT03572062|11336830|FG005|Overall Study|Adverse Event|0
7161556|NCT03572062|11336831|FG006|Overall Study|Adverse Event|0
7161557|NCT03572062|11336832|FG007|Overall Study|Adverse Event|0
7161558|NCT03572062|11336833|FG008|Overall Study|Adverse Event|1
7161559|NCT03572062|11336834|FG009|Overall Study|Adverse Event|3
7161560|NCT03572062|11336825|FG000|Overall Study|Death|0
7161561|NCT03572062|11336826|FG001|Overall Study|Death|0
7161562|NCT03572062|11336827|FG002|Overall Study|Death|0
7161563|NCT03572062|11336828|FG003|Overall Study|Death|0
7161564|NCT03572062|11336829|FG004|Overall Study|Death|0
7161565|NCT03572062|11336830|FG005|Overall Study|Death|1
7161566|NCT03572062|11336831|FG006|Overall Study|Death|0
7161567|NCT03572062|11336832|FG007|Overall Study|Death|0
7161568|NCT03572062|11336833|FG008|Overall Study|Death|0
7161569|NCT03572062|11336834|FG009|Overall Study|Death|0
7161570|NCT03572062|11336825|FG000|Overall Study|Lost to Follow-up|0
7161571|NCT03572062|11336826|FG001|Overall Study|Lost to Follow-up|0
7161572|NCT03572062|11336827|FG002|Overall Study|Lost to Follow-up|0
7161573|NCT03572062|11336828|FG003|Overall Study|Lost to Follow-up|0
7161574|NCT03572062|11336829|FG004|Overall Study|Lost to Follow-up|0
7161575|NCT03572062|11336830|FG005|Overall Study|Lost to Follow-up|1
7041555|NCT01728324|11125172|FG001|Termination of FDV|Other than stated|3
7161576|NCT03572062|11336831|FG006|Overall Study|Lost to Follow-up|1
7161577|NCT03572062|11336832|FG007|Overall Study|Lost to Follow-up|0
7161578|NCT03572062|11336833|FG008|Overall Study|Lost to Follow-up|0
7161579|NCT03572062|11336834|FG009|Overall Study|Lost to Follow-up|0
7161580|NCT03572062|11336825|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
7161581|NCT03572062|11336826|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
7161582|NCT03572062|11336827|FG002|Overall Study|No Longer Meets Eligibility Criteria|0
7161583|NCT03572062|11336828|FG003|Overall Study|No Longer Meets Eligibility Criteria|0
7161584|NCT03572062|11336829|FG004|Overall Study|No Longer Meets Eligibility Criteria|0
7161585|NCT03572062|11336830|FG005|Overall Study|No Longer Meets Eligibility Criteria|0
7161586|NCT03572062|11336831|FG006|Overall Study|No Longer Meets Eligibility Criteria|0
7161587|NCT03572062|11336832|FG007|Overall Study|No Longer Meets Eligibility Criteria|0
7161588|NCT03572062|11336833|FG008|Overall Study|No Longer Meets Eligibility Criteria|1
7161589|NCT03572062|11336834|FG009|Overall Study|No Longer Meets Eligibility Criteria|0
7161590|NCT03572062|11336825|FG000|Overall Study|Study Terminated By Sponsor|0
7161591|NCT03572062|11336826|FG001|Overall Study|Study Terminated By Sponsor|0
7161592|NCT03572062|11336827|FG002|Overall Study|Study Terminated By Sponsor|0
7161593|NCT03572062|11336828|FG003|Overall Study|Study Terminated By Sponsor|0
7161594|NCT03572062|11336829|FG004|Overall Study|Study Terminated By Sponsor|0
7161595|NCT03572062|11336830|FG005|Overall Study|Study Terminated By Sponsor|0
7161596|NCT03572062|11336831|FG006|Overall Study|Study Terminated By Sponsor|0
7161597|NCT03572062|11336832|FG007|Overall Study|Study Terminated By Sponsor|0
7161598|NCT03572062|11336833|FG008|Overall Study|Study Terminated By Sponsor|29
7161599|NCT03572062|11336834|FG009|Overall Study|Study Terminated By Sponsor|27
7161600|NCT03572062|11336825|FG000|Overall Study|Physician Decision|0
7161601|NCT03572062|11336826|FG001|Overall Study|Physician Decision|0
7161602|NCT03572062|11336827|FG002|Overall Study|Physician Decision|0
7161603|NCT03572062|11336828|FG003|Overall Study|Physician Decision|0
7161604|NCT03572062|11336829|FG004|Overall Study|Physician Decision|0
7161605|NCT03572062|11336830|FG005|Overall Study|Physician Decision|0
7161606|NCT03572062|11336831|FG006|Overall Study|Physician Decision|0
7161607|NCT03572062|11336832|FG007|Overall Study|Physician Decision|0
7161608|NCT03572062|11336833|FG008|Overall Study|Physician Decision|1
7161609|NCT03572062|11336834|FG009|Overall Study|Physician Decision|0
7161610|NCT03572062|11336825|FG000|Overall Study|Withdrawal by Subject|0
7161611|NCT03572062|11336826|FG001|Overall Study|Withdrawal by Subject|0
7161612|NCT03572062|11336827|FG002|Overall Study|Withdrawal by Subject|0
7161613|NCT03572062|11336828|FG003|Overall Study|Withdrawal by Subject|0
7161614|NCT03572062|11336829|FG004|Overall Study|Withdrawal by Subject|0
7161615|NCT03572062|11336830|FG005|Overall Study|Withdrawal by Subject|0
7161616|NCT03572062|11336831|FG006|Overall Study|Withdrawal by Subject|0
7161617|NCT03572062|11336832|FG007|Overall Study|Withdrawal by Subject|0
7161618|NCT03572062|11336833|FG008|Overall Study|Withdrawal by Subject|0
7161619|NCT03572062|11336834|FG009|Overall Study|Withdrawal by Subject|1
7161620|NCT03572062|11336825|FG000|Overall Study|Randomized But Not Treated|0
7161621|NCT03572062|11336826|FG001|Overall Study|Randomized But Not Treated|0
7161622|NCT03572062|11336827|FG002|Overall Study|Randomized But Not Treated|0
7161623|NCT03572062|11336828|FG003|Overall Study|Randomized But Not Treated|0
7161624|NCT03572062|11336829|FG004|Overall Study|Randomized But Not Treated|1
7161625|NCT03572062|11336830|FG005|Overall Study|Randomized But Not Treated|2
7161626|NCT03572062|11336831|FG006|Overall Study|Randomized But Not Treated|0
7161627|NCT03572062|11336832|FG007|Overall Study|Randomized But Not Treated|1
7161628|NCT03572062|11336833|FG008|Overall Study|Randomized But Not Treated|0
7161629|NCT03572062|11336834|FG009|Overall Study|Randomized But Not Treated|0
7161630|NCT03572218|11336856|FG000|Overall Study|Lost to Follow-up|3
7161631|NCT03572218|11336857|FG001|Overall Study|Lost to Follow-up|2
7161632|NCT03572218|11336856|FG000|Overall Study|No longer available for study visits|2
7161633|NCT03572218|11336857|FG001|Overall Study|No longer available for study visits|1
7161634|NCT03572218|11336856|FG000|Overall Study|No longer interested|1
7161635|NCT03572218|11336857|FG001|Overall Study|No longer interested|2
7161636|NCT03573323|11336902|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1
7161637|NCT03573323|11336903|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1
7161638|NCT03573323|11336902|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15
7161639|NCT03573323|11336903|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8
7161640|NCT03573323|11336902|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3
7161641|NCT03573323|11336903|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8
7161642|NCT03573323|11336902|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17
7161643|NCT03573323|11336903|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9
7161644|NCT03573323|11336902|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2
7161645|NCT03573323|11336903|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3
7161646|NCT03573323|11336902|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1
7161647|NCT03573323|11336903|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2
7161648|NCT03573323|11336902|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1
7161649|NCT03573323|11336903|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0
7161650|NCT03573323|11336902|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14
7161651|NCT03573323|11336903|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13
7161652|NCT03573323|11336902|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0
7161653|NCT03573323|11336903|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1
7161654|NCT03573323|11336902|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0
7161655|NCT03573323|11336903|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1
7161656|NCT03573323|11336902|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1
7161657|NCT03573323|11336903|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2
7161658|NCT03573323|11336902|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22
7161659|NCT03573323|11336903|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12
7161660|NCT03573323|11336902|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8
7161661|NCT03573323|11336903|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19
7161662|NCT03573323|11336902|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4
7161663|NCT03573323|11336903|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3
7161664|NCT03573323|11336902|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3
7161665|NCT03573323|11336903|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2
7161666|NCT03573323|11336902|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14
7161667|NCT03573323|11336903|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8
7161668|NCT03573323|11336902|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8
7161669|NCT03573323|11336903|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11
7161670|NCT03573323|11336902|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0
7161671|NCT03573323|11336903|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1
7161672|NCT03573323|11336902|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0
7161673|NCT03573323|11336903|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1
7161674|NCT03573505|11336915|FG000|Overall Study|Adverse Event|1
7161675|NCT03573505|11336916|FG001|Overall Study|Adverse Event|1
7161676|NCT03573505|11336915|FG000|Overall Study|Consent withdrawn|0
7161677|NCT03573505|11336916|FG001|Overall Study|Consent withdrawn|1
7161678|NCT03573505|11336915|FG000|Overall Study|Disease progression|0
7161679|NCT03573505|11336916|FG001|Overall Study|Disease progression|1
7161680|NCT03573505|11336915|FG000|Overall Study|Site Terminated by Sponsor|1
7161681|NCT03573505|11336916|FG001|Overall Study|Site Terminated by Sponsor|1
7161682|NCT03573505|11336915|FG000|Overall Study|Study terminated by sponsor|50
7161683|NCT03573505|11336916|FG001|Overall Study|Study terminated by sponsor|45
7161684|NCT03573505|11336915|FG000|Overall Study|Reason not specified|0
7161685|NCT03573505|11336916|FG001|Overall Study|Reason not specified|1
7161686|NCT03573505|11336915|FG000|Overall Study|Death|0
7161687|NCT03573505|11336916|FG001|Overall Study|Death|4
7161688|NCT03573804|11336923|FG000|Overall Study|claustrophobia or MRI table problems|10
7161689|NCT03573830|11336935|FG000|Overall Study|Dropped without completing treatment|0
7161690|NCT03573830|11336936|FG001|Overall Study|Dropped without completing treatment|7
7161691|NCT03573830|11336935|FG000|Overall Study|Lost to Follow-up|4
7161692|NCT03573830|11336936|FG001|Overall Study|Lost to Follow-up|0
7161693|NCT03573908|11336943|FG000|Treatment Period|Adverse Event|4
7161694|NCT03573908|11336944|FG001|Treatment Period|Adverse Event|9
7161695|NCT03573908|11336945|FG002|Treatment Period|Adverse Event|0
7161696|NCT03573908|11336946|FG003|Treatment Period|Adverse Event|0
7161697|NCT03573908|11336947|FG004|Treatment Period|Adverse Event|0
7161698|NCT03573908|11336943|FG000|Treatment Period|Protocol Violation|1
7161699|NCT03573908|11336944|FG001|Treatment Period|Protocol Violation|0
7161700|NCT03573908|11336945|FG002|Treatment Period|Protocol Violation|0
7161701|NCT03573908|11336946|FG003|Treatment Period|Protocol Violation|0
7161702|NCT03573908|11336947|FG004|Treatment Period|Protocol Violation|0
7161703|NCT03573908|11336943|FG000|Treatment Period|Withdrawal by Subject|7
7161704|NCT03573908|11336944|FG001|Treatment Period|Withdrawal by Subject|5
7161705|NCT03573908|11336945|FG002|Treatment Period|Withdrawal by Subject|0
7161706|NCT03573908|11336946|FG003|Treatment Period|Withdrawal by Subject|0
7161707|NCT03573908|11336947|FG004|Treatment Period|Withdrawal by Subject|0
7161708|NCT03573908|11336943|FG000|Treatment Period|Lost to Follow-up|7
7161709|NCT03573908|11336944|FG001|Treatment Period|Lost to Follow-up|6
7161710|NCT03573908|11336945|FG002|Treatment Period|Lost to Follow-up|0
7161711|NCT03573908|11336946|FG003|Treatment Period|Lost to Follow-up|0
7161712|NCT03573908|11336947|FG004|Treatment Period|Lost to Follow-up|0
7161713|NCT03573908|11336943|FG000|Treatment Period|Pregnancy|1
7161714|NCT03573908|11336944|FG001|Treatment Period|Pregnancy|0
7161715|NCT03573908|11336945|FG002|Treatment Period|Pregnancy|0
7161716|NCT03573908|11336946|FG003|Treatment Period|Pregnancy|0
7161717|NCT03573908|11336947|FG004|Treatment Period|Pregnancy|0
7161718|NCT03573908|11336943|FG000|Treatment Period|Other, Not Specified|4
7161719|NCT03573908|11336944|FG001|Treatment Period|Other, Not Specified|6
7161720|NCT03573908|11336945|FG002|Treatment Period|Other, Not Specified|0
7161721|NCT03573908|11336946|FG003|Treatment Period|Other, Not Specified|0
7161722|NCT03573908|11336947|FG004|Treatment Period|Other, Not Specified|0
7161723|NCT03573908|11336943|FG000|Randomized Withdrawal Period|Adverse Event|0
7161724|NCT03573908|11336944|FG001|Randomized Withdrawal Period|Adverse Event|0
7161725|NCT03573908|11336945|FG002|Randomized Withdrawal Period|Adverse Event|3
7161726|NCT03573908|11336946|FG003|Randomized Withdrawal Period|Adverse Event|0
7161727|NCT03573908|11336947|FG004|Randomized Withdrawal Period|Adverse Event|0
7161728|NCT03573908|11336943|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0
7161729|NCT03573908|11336944|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0
7161730|NCT03573908|11336945|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0
7161731|NCT03573908|11336946|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0
7161732|NCT03573908|11336947|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2
7161733|NCT03573908|11336943|FG000|Randomized Withdrawal Period|Lost to Follow-up|0
7161734|NCT03573908|11336944|FG001|Randomized Withdrawal Period|Lost to Follow-up|0
7161735|NCT03573908|11336945|FG002|Randomized Withdrawal Period|Lost to Follow-up|1
7161736|NCT03573908|11336946|FG003|Randomized Withdrawal Period|Lost to Follow-up|0
7161737|NCT03573908|11336947|FG004|Randomized Withdrawal Period|Lost to Follow-up|0
7161738|NCT03573908|11336943|FG000|Randomized Withdrawal Period|Other, Not Specified|0
7161739|NCT03573908|11336944|FG001|Randomized Withdrawal Period|Other, Not Specified|0
7161740|NCT03573908|11336945|FG002|Randomized Withdrawal Period|Other, Not Specified|4
7161741|NCT03573908|11336946|FG003|Randomized Withdrawal Period|Other, Not Specified|2
7161742|NCT03573908|11336947|FG004|Randomized Withdrawal Period|Other, Not Specified|0
7161743|NCT03574753|11336973|FG000|Overall Study|Adverse Event|3
7161744|NCT03574753|11336973|FG000|Overall Study|Progression/relapse|19
7161745|NCT03574753|11336973|FG000|Overall Study|Death|1
7161746|NCT03575702|11336984|FG000|Overall Study|Withdrawal by Subject|1
7161747|NCT03575702|11336985|FG001|Overall Study|Withdrawal by Subject|1
7161748|NCT03575702|11336984|FG000|Overall Study|Lost to Follow-up|1
7161749|NCT03575702|11336985|FG001|Overall Study|Lost to Follow-up|2
7161750|NCT03575702|11336984|FG000|Overall Study|Protocol Violation|0
7161751|NCT03575702|11336985|FG001|Overall Study|Protocol Violation|1
7161752|NCT03575702|11336984|FG000|Overall Study|Patient non compliance|4
7161753|NCT03575702|11336985|FG001|Overall Study|Patient non compliance|0
7161754|NCT03575806|11337002|FG000|Overall Study|Withdrawal by Subject|0
7161755|NCT03575806|11337003|FG001|Overall Study|Withdrawal by Subject|2
7161756|NCT03575806|11337002|FG000|Overall Study|Protocol Violation|0
7161757|NCT03575806|11337003|FG001|Overall Study|Protocol Violation|2
7161758|NCT03575871|11337012|FG000|Overall Study|Adverse Event|5
7161759|NCT03575871|11337013|FG001|Overall Study|Adverse Event|5
7161760|NCT03575871|11337014|FG002|Overall Study|Adverse Event|8
7161761|NCT03575871|11337012|FG000|Overall Study|Death|1
7161762|NCT03575871|11337013|FG001|Overall Study|Death|0
7161763|NCT03575871|11337014|FG002|Overall Study|Death|0
7161764|NCT03575871|11337012|FG000|Overall Study|Lack of Efficacy|5
7161765|NCT03575871|11337013|FG001|Overall Study|Lack of Efficacy|4
7161766|NCT03575871|11337014|FG002|Overall Study|Lack of Efficacy|7
7161767|NCT03575871|11337012|FG000|Overall Study|Lost to Follow-up|1
7161768|NCT03575871|11337013|FG001|Overall Study|Lost to Follow-up|1
7161769|NCT03575871|11337014|FG002|Overall Study|Lost to Follow-up|1
7161770|NCT03575871|11337012|FG000|Overall Study|Protocol Deviation|1
7161771|NCT03575871|11337013|FG001|Overall Study|Protocol Deviation|1
7161772|NCT03575871|11337014|FG002|Overall Study|Protocol Deviation|1
7161773|NCT03575871|11337012|FG000|Overall Study|Withdrawal by Subject|6
7161774|NCT03575871|11337013|FG001|Overall Study|Withdrawal by Subject|1
7161775|NCT03575871|11337014|FG002|Overall Study|Withdrawal by Subject|9
7161776|NCT03575871|11337012|FG000|Overall Study|Other than specified|2
7161777|NCT03575871|11337013|FG001|Overall Study|Other than specified|2
7161778|NCT03575871|11337014|FG002|Overall Study|Other than specified|0
7161779|NCT03575975|11337032|FG000|Overall Study|Lost to Follow-up|1
7161780|NCT03575975|11337033|FG001|Overall Study|Lost to Follow-up|0
7161781|NCT03575975|11337034|FG002|Overall Study|Lost to Follow-up|0
7161782|NCT03576066|11337042|FG000|Overall Study|Noncompliance with study drug|0
7161783|NCT03576066|11337043|FG001|Overall Study|Noncompliance with study drug|1
7161784|NCT03576768|11337075|FG000|Overall Study|Lost to Follow-up|3
7161785|NCT03576768|11337076|FG001|Overall Study|Lost to Follow-up|3
7161786|NCT03576768|11337077|FG002|Overall Study|Lost to Follow-up|0
7161787|NCT03576768|11337078|FG003|Overall Study|Lost to Follow-up|0
7161788|NCT03577730|11337113|FG000|Overall Study|Physician Decision|3
7161789|NCT03577730|11337114|FG001|Overall Study|Physician Decision|1
7161790|NCT03577730|11337113|FG000|Overall Study|Did not receive allocated intervention|1
7161791|NCT03577730|11337114|FG001|Overall Study|Did not receive allocated intervention|0
7161792|NCT03578146|11337126|FG000|Overall Study|Did Not Receive Treatment|1
7161793|NCT03578146|11337127|FG001|Overall Study|Did Not Receive Treatment|0
7161794|NCT03578146|11337128|FG002|Overall Study|Did Not Receive Treatment|0
7161795|NCT03578146|11337129|FG003|Overall Study|Did Not Receive Treatment|0
7161796|NCT03578146|11337130|FG004|Overall Study|Did Not Receive Treatment|0
6895071|NCT00622700|10912836|FG004|Extension Treatment Period|Withdrawal by Subject|16
6895072|NCT00622700|10912837|FG005|Extension Treatment Period|Withdrawal by Subject|6
7161797|NCT03578146|11337131|FG005|Overall Study|Did Not Receive Treatment|2
7161798|NCT03578146|11337126|FG000|Overall Study|Lost to Follow-up|0
7161799|NCT03578146|11337127|FG001|Overall Study|Lost to Follow-up|1
7161800|NCT03578146|11337128|FG002|Overall Study|Lost to Follow-up|1
7161801|NCT03578146|11337129|FG003|Overall Study|Lost to Follow-up|0
7161802|NCT03578146|11337130|FG004|Overall Study|Lost to Follow-up|0
6895073|NCT00622700|10912838|FG006|Extension Treatment Period|Withdrawal by Subject|10
7161803|NCT03578146|11337131|FG005|Overall Study|Lost to Follow-up|1
7161804|NCT03579290|11337158|FG000|Overall Study|Lost to Follow-up|9
7161805|NCT03579719|11337170|FG000|Overall Study|Protocol deviation, pre-existent disease|1
7161806|NCT03579940|11337185|FG000|Period 2|Withdrawal by Subject|0
7161807|NCT03579940|11337186|FG001|Period 2|Withdrawal by Subject|0
7161808|NCT03579940|11337187|FG002|Period 2|Withdrawal by Subject|1
7161809|NCT03579940|11337188|FG003|Period 2|Withdrawal by Subject|0
7161810|NCT03579940|11337189|FG004|Period 2|Withdrawal by Subject|0
7161811|NCT03579940|11337190|FG005|Period 2|Withdrawal by Subject|0
7161812|NCT03579940|11337191|FG006|Period 2|Withdrawal by Subject|0
7161813|NCT03579940|11337192|FG007|Period 2|Withdrawal by Subject|0
7161814|NCT03579940|11337193|FG008|Period 2|Withdrawal by Subject|0
7161815|NCT03579940|11337194|FG009|Period 2|Withdrawal by Subject|0
7161816|NCT03579940|11337195|FG010|Period 2|Withdrawal by Subject|0
7184360|NCT03951077|11384468|FG005|Overall Study|Other, Not Specified|6
7184361|NCT03951077|11384463|FG000|Overall Study|Did Not Receive Any Study Drug|1
7184362|NCT03951077|11384464|FG001|Overall Study|Did Not Receive Any Study Drug|0
7184363|NCT03951077|11384465|FG002|Overall Study|Did Not Receive Any Study Drug|1
7184364|NCT03951077|11384466|FG003|Overall Study|Did Not Receive Any Study Drug|1
7184365|NCT03951077|11384467|FG004|Overall Study|Did Not Receive Any Study Drug|1
7184366|NCT03951077|11384468|FG005|Overall Study|Did Not Receive Any Study Drug|0
7184367|NCT03873246|11384485|FG000|Overall Study|Adverse Event|1
7184368|NCT03873246|11384486|FG001|Overall Study|Adverse Event|3
7184369|NCT03873246|11384487|FG002|Overall Study|Adverse Event|3
7184370|NCT03873246|11384485|FG000|Overall Study|Lost to Follow-up|4
7184371|NCT03873246|11384486|FG001|Overall Study|Lost to Follow-up|4
7184372|NCT03873246|11384487|FG002|Overall Study|Lost to Follow-up|5
7184373|NCT03873246|11384485|FG000|Overall Study|Protocol Violation|0
7184374|NCT03873246|11384486|FG001|Overall Study|Protocol Violation|1
7184375|NCT03873246|11384487|FG002|Overall Study|Protocol Violation|0
7184376|NCT03873246|11384485|FG000|Overall Study|Withdrawal by Subject|0
7184377|NCT03873246|11384486|FG001|Overall Study|Withdrawal by Subject|4
7184378|NCT03873246|11384487|FG002|Overall Study|Withdrawal by Subject|1
7184379|NCT03807349|11384496|FG000|Overall Study|Early Study Termination|9
7184380|NCT03769649|11384500|FG000|Overall Study|Lost to Follow-up|4
7184381|NCT03408444|11384565|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1
7184382|NCT03408444|11384566|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0
7184383|NCT03408444|11384567|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0
7184384|NCT03408444|11384568|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0
7184385|NCT03408444|11384565|FG000|Overall Study|Lens Discomfort|0
7184386|NCT03408444|11384566|FG001|Overall Study|Lens Discomfort|1
7184387|NCT03408444|11384567|FG002|Overall Study|Lens Discomfort|0
7184388|NCT03408444|11384568|FG003|Overall Study|Lens Discomfort|0
6895074|NCT00622700|10912832|FG000|Extension Treatment Period|Missing|0
6895075|NCT00622700|10912833|FG001|Extension Treatment Period|Missing|0
6895076|NCT00622700|10912834|FG002|Extension Treatment Period|Missing|0
6895077|NCT00622700|10912835|FG003|Extension Treatment Period|Missing|2
6895078|NCT00622700|10912836|FG004|Extension Treatment Period|Missing|3
6895079|NCT00622700|10912837|FG005|Extension Treatment Period|Missing|1
6895080|NCT00622700|10912838|FG006|Extension Treatment Period|Missing|0
6895081|NCT00622700|10912832|FG000|Extension Treatment Period|Other than specified above|0
6895082|NCT00622700|10912833|FG001|Extension Treatment Period|Other than specified above|0
6895083|NCT00622700|10912834|FG002|Extension Treatment Period|Other than specified above|0
6895084|NCT00622700|10912835|FG003|Extension Treatment Period|Other than specified above|0
6895085|NCT00622700|10912836|FG004|Extension Treatment Period|Other than specified above|0
6895086|NCT00622700|10912837|FG005|Extension Treatment Period|Other than specified above|1
6895087|NCT00622700|10912838|FG006|Extension Treatment Period|Other than specified above|1
6895088|NCT00622713|10912855|FG000|Overall Study|Adverse Event|35
7080077|NCT02119650|11189393|FG000|Overall Study|Multiple reasons for termination|2
7080078|NCT02119650|11189394|FG001|Overall Study|Multiple reasons for termination|1
7080079|NCT02119663|11189402|FG000|Overall Study|Disease progression|26
7080080|NCT02119663|11189403|FG001|Overall Study|Disease progression|27
7080081|NCT02119663|11189402|FG000|Overall Study|Adverse Event|5
7080082|NCT02119663|11189403|FG001|Overall Study|Adverse Event|5
7080083|NCT02119663|11189402|FG000|Overall Study|Death|3
7080084|NCT02119663|11189403|FG001|Overall Study|Death|2
6895089|NCT00622713|10912855|FG000|Overall Study|Administrative problems|4
6895090|NCT00622713|10912855|FG000|Overall Study|Withdrawal by Subject|11
6895091|NCT00622713|10912855|FG000|Overall Study|Lost to Follow-up|5
6895092|NCT00622713|10912855|FG000|Overall Study|Death|2
6895093|NCT00622713|10912855|FG000|Overall Study|Subject no longer required study drug|1
6895094|NCT00622713|10912855|FG000|Overall Study|Did not meet eligibility criteria|1
6895095|NCT00622726|10912861|FG000|March, 2008 to August, 2010|Death|5
6895096|NCT00622726|10912862|FG001|March, 2008 to August, 2010|Death|2
6895097|NCT00622726|10912861|FG000|August, 2010 to April, 2013|Death|1
6895098|NCT00622726|10912862|FG001|August, 2010 to April, 2013|Death|5
6895099|NCT00622739|10912874|FG000|Overall Study|Physician Decision|1
6895100|NCT00622739|10912875|FG001|Overall Study|Physician Decision|0
6895101|NCT00622739|10912874|FG000|Overall Study|Adverse Event|1
6895102|NCT00622739|10912875|FG001|Overall Study|Adverse Event|2
6895103|NCT00622739|10912874|FG000|Overall Study|Lack of Efficacy|0
7080085|NCT02119663|11189402|FG000|Overall Study|Physician Decision|1
7184389|NCT03408444|11384565|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0
7184390|NCT03408444|11384566|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0
7184391|NCT03408444|11384567|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1
6895104|NCT00622739|10912875|FG001|Overall Study|Lack of Efficacy|2
7080086|NCT02119663|11189403|FG001|Overall Study|Physician Decision|2
7080087|NCT02119663|11189402|FG000|Overall Study|Other unspecified|2
7184392|NCT03408444|11384568|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0
7184393|NCT03408444|11384565|FG000|Overall Study|Withdrawal by Subject|0
7161817|NCT03581825|11337250|FG000|Period 1|Lens Discomfort|1
7161818|NCT03581825|11337251|FG001|Period 1|Lens Discomfort|0
7161819|NCT03581825|11337250|FG000|Period 2|Unsatisfactory Vision to Test|0
7161820|NCT03581825|11337251|FG001|Period 2|Unsatisfactory Vision to Test|1
7161821|NCT03582215|11337265|FG000|Overall Study|Adverse Event|1
7161822|NCT03582215|11337266|FG001|Overall Study|Adverse Event|0
7161823|NCT03582215|11337267|FG002|Overall Study|Adverse Event|0
7161824|NCT03582215|11337268|FG003|Overall Study|Adverse Event|0
7161825|NCT03582215|11337269|FG004|Overall Study|Adverse Event|0
7161826|NCT03582215|11337270|FG005|Overall Study|Adverse Event|0
7161827|NCT03582215|11337271|FG006|Overall Study|Adverse Event|2
7161828|NCT03582215|11337272|FG007|Overall Study|Adverse Event|2
7161829|NCT03582813|11337332|FG000|Overall Study|Lost to Follow-up|18
7161830|NCT03582813|11337333|FG001|Overall Study|Lost to Follow-up|21
7161831|NCT03582813|11337332|FG000|Overall Study|Withdrawal by Subject|1
7161832|NCT03582813|11337333|FG001|Overall Study|Withdrawal by Subject|0
7161833|NCT03582826|11337341|FG000|Overall Study|Lost to Follow-up|39
7161834|NCT03582826|11337342|FG001|Overall Study|Lost to Follow-up|0
7161835|NCT03582826|11337341|FG000|Overall Study|Withdrawal by Subject|2
7161836|NCT03582826|11337342|FG001|Overall Study|Withdrawal by Subject|0
7161837|NCT03582943|11337359|FG000|Allocated to Groups|Withdrawal by Subject|1
7161838|NCT03582943|11337360|FG001|Allocated to Groups|Withdrawal by Subject|1
7161839|NCT03582943|11337359|FG000|Intervention and Follow up|Withdrawal by Subject|4
7161840|NCT03582943|11337360|FG001|Intervention and Follow up|Withdrawal by Subject|2
7161841|NCT03582943|11337359|FG000|Analyzed|Protocol Violation|4
7161842|NCT03582943|11337360|FG001|Analyzed|Protocol Violation|1
7161843|NCT03583372|11337370|FG000|Overall Study|Withdrawal by Subject|6
7161844|NCT03583372|11337371|FG001|Overall Study|Withdrawal by Subject|11
7161845|NCT03583372|11337372|FG002|Overall Study|Withdrawal by Subject|7
7161846|NCT03583372|11337373|FG003|Overall Study|Withdrawal by Subject|8
7161847|NCT03583372|11337370|FG000|Overall Study|Lost to Follow-up|4
7161848|NCT03583372|11337371|FG001|Overall Study|Lost to Follow-up|6
7161849|NCT03583372|11337372|FG002|Overall Study|Lost to Follow-up|3
7161850|NCT03583372|11337373|FG003|Overall Study|Lost to Follow-up|2
7161851|NCT03583372|11337370|FG000|Overall Study|Adverse Event|1
7161852|NCT03583372|11337371|FG001|Overall Study|Adverse Event|3
7161853|NCT03583372|11337372|FG002|Overall Study|Adverse Event|4
7161854|NCT03583372|11337373|FG003|Overall Study|Adverse Event|4
7161855|NCT03583372|11337370|FG000|Overall Study|Physician Decision|0
7161856|NCT03583372|11337371|FG001|Overall Study|Physician Decision|1
7161857|NCT03583372|11337372|FG002|Overall Study|Physician Decision|1
7161858|NCT03583372|11337373|FG003|Overall Study|Physician Decision|1
7161859|NCT03583372|11337370|FG000|Overall Study|Lack of Efficacy|0
7161860|NCT03583372|11337371|FG001|Overall Study|Lack of Efficacy|1
7161861|NCT03583372|11337372|FG002|Overall Study|Lack of Efficacy|0
7161862|NCT03583372|11337373|FG003|Overall Study|Lack of Efficacy|1
7161863|NCT03583372|11337370|FG000|Overall Study|Death|1
7161864|NCT03583372|11337371|FG001|Overall Study|Death|0
7161865|NCT03583372|11337372|FG002|Overall Study|Death|0
7161866|NCT03583372|11337373|FG003|Overall Study|Death|0
7161867|NCT03583372|11337370|FG000|Overall Study|Protocol Violation|0
7161868|NCT03583372|11337371|FG001|Overall Study|Protocol Violation|1
7161869|NCT03583372|11337372|FG002|Overall Study|Protocol Violation|0
7161870|NCT03583372|11337373|FG003|Overall Study|Protocol Violation|0
7161871|NCT03583372|11337370|FG000|Overall Study|Subject Withdrawn due to Sponsor|0
7161872|NCT03583372|11337371|FG001|Overall Study|Subject Withdrawn due to Sponsor|0
7161873|NCT03583372|11337372|FG002|Overall Study|Subject Withdrawn due to Sponsor|0
7161874|NCT03583372|11337373|FG003|Overall Study|Subject Withdrawn due to Sponsor|1
7161875|NCT03583372|11337370|FG000|Overall Study|Did Not Receive Study Drug|0
7161876|NCT03583372|11337371|FG001|Overall Study|Did Not Receive Study Drug|1
7161877|NCT03583372|11337372|FG002|Overall Study|Did Not Receive Study Drug|0
7161878|NCT03583372|11337373|FG003|Overall Study|Did Not Receive Study Drug|0
7161879|NCT03583372|11337370|FG000|Overall Study|Captured as Other in the Database|1
7161880|NCT03583372|11337371|FG001|Overall Study|Captured as Other in the Database|2
7161881|NCT03583372|11337372|FG002|Overall Study|Captured as Other in the Database|4
7161882|NCT03583372|11337373|FG003|Overall Study|Captured as Other in the Database|1
7161883|NCT03583385|11337383|FG000|Treatment Period 1|Withdrawal by Subject|1
7161884|NCT03583385|11337384|FG001|Treatment Period 1|Withdrawal by Subject|1
7161885|NCT03583385|11337383|FG000|Treatment Period 2|Adverse Event|1
7161886|NCT03583385|11337384|FG001|Treatment Period 2|Adverse Event|0
7161887|NCT03583450|11337392|FG000|Overall Study|hardware malfunction (battery depletion)|1
7161888|NCT03583450|11337393|FG001|Overall Study|hardware malfunction (battery depletion)|0
7161889|NCT03583606|11337404|FG000|Overall Study|Lost to Follow-up|0
7161890|NCT03583606|11337405|FG001|Overall Study|Lost to Follow-up|1
7161891|NCT03583606|11337406|FG002|Overall Study|Lost to Follow-up|0
7161892|NCT03583606|11337404|FG000|Overall Study|Ineligible at baseline|1
7161893|NCT03583606|11337405|FG001|Overall Study|Ineligible at baseline|0
7041556|NCT01728324|11125173|FG002|Termination of FDV|Other than stated|0
7041557|NCT01728324|11125171|FG000|Termination of FDV|Adverse Event (Placebo Period)|0
7161894|NCT03583606|11337406|FG002|Overall Study|Ineligible at baseline|0
7161905|NCT03585244|11337431|FG000|Overall Study|Withdrawal by Subject|15
7161906|NCT03585296|11337435|FG000|Overall Study|Adverse Event|1
7161907|NCT03585296|11337435|FG000|Overall Study|Lost to Follow-up|2
7161908|NCT03585296|11337435|FG000|Overall Study|Withdrawal by Subject|2
7161909|NCT03585504|11337441|FG000|Overall Study|Lost to Follow-up|26
7161910|NCT03585504|11337442|FG001|Overall Study|Lost to Follow-up|29
7161911|NCT03585712|11337453|FG000|Treatment Period 1|Protocol Violation|1
7161912|NCT03585712|11337454|FG001|Treatment Period 1|Protocol Violation|0
7161913|NCT03585712|11337455|FG002|Treatment Period 1|Protocol Violation|0
7161914|NCT03585712|11337453|FG000|Treatment Periods 2 and 3|Protocol Violation|0
7161915|NCT03585712|11337454|FG001|Treatment Periods 2 and 3|Protocol Violation|1
7161916|NCT03585712|11337455|FG002|Treatment Periods 2 and 3|Protocol Violation|1
7161917|NCT03585712|11337453|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0
7161918|NCT03585712|11337454|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2
7161919|NCT03585712|11337455|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0
7161920|NCT03585712|11337453|FG000|Treatment Periods 2 and 3|Physician Decision|0
7161921|NCT03585712|11337454|FG001|Treatment Periods 2 and 3|Physician Decision|0
7161922|NCT03585712|11337455|FG002|Treatment Periods 2 and 3|Physician Decision|2
7161923|NCT03585959|11337482|FG000|Overall Study|Physician Decision|1
7161924|NCT03585959|11337482|FG000|Overall Study|Unsuccessful Procedure|2
7161925|NCT03586167|11337490|FG000|Overall Study|Other|1
7161926|NCT03586167|11337491|FG001|Overall Study|Other|0
7161927|NCT03586544|11337499|FG000|First Intervention|Adverse Event|0
7161928|NCT03586544|11337500|FG001|First Intervention|Adverse Event|1
7161929|NCT03586544|11337499|FG000|Second Intervention|Withdrawal by Subject|0
7161930|NCT03586544|11337500|FG001|Second Intervention|Withdrawal by Subject|1
7161931|NCT03586648|11337511|FG000|Period 1|Withdrawal by Subject|0
7161932|NCT03586648|11337512|FG001|Period 1|Withdrawal by Subject|1
7161933|NCT03586648|11337511|FG000|Period 1|Lost to Follow-up|1
7161934|NCT03586648|11337512|FG001|Period 1|Lost to Follow-up|1
7161935|NCT03586648|11337511|FG000|Period 1|Adverse Event|1
7161936|NCT03586648|11337512|FG001|Period 1|Adverse Event|0
7161937|NCT03586648|11337511|FG000|Period 1|Study related symptoms or complaints|2
7161938|NCT03586648|11337512|FG001|Period 1|Study related symptoms or complaints|1
7161939|NCT03586648|11337511|FG000|Period 1|Physician Decision|0
7161940|NCT03586648|11337512|FG001|Period 1|Physician Decision|1
7161941|NCT03586648|11337511|FG000|Period 2|Adverse Event|1
7161942|NCT03586648|11337512|FG001|Period 2|Adverse Event|0
7161943|NCT03586726|11337518|FG000|Overall Study|Withdrawal by Subject|1
7161944|NCT03586830|11337526|FG000|Overall Study|Site terminated by Sponsor|1
7161945|NCT03586830|11337527|FG001|Overall Study|Site terminated by Sponsor|4
7161946|NCT03586830|11337528|FG002|Overall Study|Site terminated by Sponsor|3
7161947|NCT03586830|11337529|FG003|Overall Study|Site terminated by Sponsor|3
7161948|NCT03586830|11337526|FG000|Overall Study|Lost to Follow-up|0
7161949|NCT03586830|11337527|FG001|Overall Study|Lost to Follow-up|2
7161950|NCT03586830|11337528|FG002|Overall Study|Lost to Follow-up|2
7161951|NCT03586830|11337529|FG003|Overall Study|Lost to Follow-up|1
7161952|NCT03586830|11337526|FG000|Overall Study|Withdrawal by Subject|1
7161953|NCT03586830|11337527|FG001|Overall Study|Withdrawal by Subject|0
7161954|NCT03586830|11337528|FG002|Overall Study|Withdrawal by Subject|3
7161955|NCT03586830|11337529|FG003|Overall Study|Withdrawal by Subject|1
7161956|NCT03587974|11337575|FG000|Overall Study|caregiver demented, care recipient died|3
7161957|NCT03587974|11337576|FG001|Overall Study|caregiver demented, care recipient died|3
7161958|NCT03587974|11337575|FG000|Overall Study|Withdrawal by Subject|2
7161959|NCT03587974|11337576|FG001|Overall Study|Withdrawal by Subject|1
7161960|NCT03588572|11337584|FG000|Visitation 1|Lack of Efficacy|1
7161961|NCT03588572|11337585|FG001|Visitation 1|Lack of Efficacy|1
7161962|NCT03588572|11337584|FG000|Visitation 2|Lost to Follow-up|1
7161963|NCT03588572|11337585|FG001|Visitation 2|Lost to Follow-up|1
7161964|NCT03588572|11337584|FG000|Visitation 2|Lack of Efficacy|0
7161965|NCT03588572|11337585|FG001|Visitation 2|Lack of Efficacy|1
7161966|NCT03588572|11337584|FG000|Visitation 2|Withdrawal by Subject|1
7161967|NCT03588572|11337585|FG001|Visitation 2|Withdrawal by Subject|0
7161968|NCT03588572|11337584|FG000|Visitation 3|Lost to Follow-up|1
7161969|NCT03588572|11337585|FG001|Visitation 3|Lost to Follow-up|1
7161970|NCT03588572|11337584|FG000|Visitation 3|Physician Decision|1
7161971|NCT03588572|11337585|FG001|Visitation 3|Physician Decision|1
7161972|NCT03588572|11337584|FG000|Visitation 3|Withdrawal by Subject|1
7161973|NCT03588572|11337585|FG001|Visitation 3|Withdrawal by Subject|0
7161974|NCT03588741|11337591|FG000|Overall Study|Withdrawal by Subject|1
7161975|NCT03588910|11337601|FG000|Overall Study|Withdrawal by Subject|1
7161976|NCT03588910|11337602|FG001|Overall Study|Withdrawal by Subject|0
7161977|NCT03588910|11337601|FG000|Overall Study|Allergy|2
7161978|NCT03588910|11337602|FG001|Overall Study|Allergy|0
7161979|NCT03588910|11337601|FG000|Overall Study|Protocol Violation|0
7161980|NCT03588910|11337602|FG001|Overall Study|Protocol Violation|3
7161981|NCT03588910|11337601|FG000|Overall Study|Did not complete Day 1 Survey|5
7161982|NCT03588910|11337602|FG001|Overall Study|Did not complete Day 1 Survey|10
7184394|NCT03408444|11384566|FG001|Overall Study|Withdrawal by Subject|2
7184395|NCT03408444|11384567|FG002|Overall Study|Withdrawal by Subject|3
7184396|NCT03408444|11384568|FG003|Overall Study|Withdrawal by Subject|0
7184397|NCT03408444|11384565|FG000|Overall Study|Lost to Follow-up|0
7184398|NCT03408444|11384566|FG001|Overall Study|Lost to Follow-up|0
7161983|NCT03588910|11337601|FG000|Overall Study|Did not complete Day 7 Survey|5
7161984|NCT03588910|11337602|FG001|Overall Study|Did not complete Day 7 Survey|2
7161985|NCT03589807|11337614|FG000|Overall Study|Lost to Follow-up|0
7161986|NCT03589807|11337615|FG001|Overall Study|Lost to Follow-up|2
7161987|NCT03589807|11337616|FG002|Overall Study|Lost to Follow-up|2
7161988|NCT03589807|11337617|FG003|Overall Study|Lost to Follow-up|3
7161989|NCT03589807|11337618|FG004|Overall Study|Lost to Follow-up|1
7161990|NCT03589807|11337619|FG005|Overall Study|Lost to Follow-up|1
7161991|NCT03589807|11337614|FG000|Overall Study|Withdrawal by Subject|0
7161992|NCT03589807|11337615|FG001|Overall Study|Withdrawal by Subject|5
7161993|NCT03589807|11337616|FG002|Overall Study|Withdrawal by Subject|0
7161994|NCT03589807|11337617|FG003|Overall Study|Withdrawal by Subject|0
7161995|NCT03589807|11337618|FG004|Overall Study|Withdrawal by Subject|0
7161996|NCT03589807|11337619|FG005|Overall Study|Withdrawal by Subject|0
7161997|NCT03589807|11337614|FG000|Overall Study|Protocol Violation|0
7161998|NCT03589807|11337615|FG001|Overall Study|Protocol Violation|0
7161999|NCT03589807|11337616|FG002|Overall Study|Protocol Violation|0
7162000|NCT03589807|11337617|FG003|Overall Study|Protocol Violation|1
7162001|NCT03589807|11337618|FG004|Overall Study|Protocol Violation|0
7162002|NCT03589807|11337619|FG005|Overall Study|Protocol Violation|0
7162003|NCT03589807|11337614|FG000|Overall Study|Enrolled but treatment not administered|0
7162004|NCT03589807|11337615|FG001|Overall Study|Enrolled but treatment not administered|0
7162005|NCT03589807|11337616|FG002|Overall Study|Enrolled but treatment not administered|0
7162006|NCT03589807|11337617|FG003|Overall Study|Enrolled but treatment not administered|0
7162007|NCT03589807|11337618|FG004|Overall Study|Enrolled but treatment not administered|1
7162008|NCT03589807|11337619|FG005|Overall Study|Enrolled but treatment not administered|0
7162009|NCT03589885|11337639|FG000|Treatment Period 1-Randomized Set|Adverse Event|0
7162010|NCT03589885|11337640|FG001|Treatment Period 1-Randomized Set|Adverse Event|1
7162011|NCT03589885|11337641|FG002|Treatment Period 1-Randomized Set|Adverse Event|0
7162012|NCT03589885|11337642|FG003|Treatment Period 1-Randomized Set|Adverse Event|0
7162013|NCT03589885|11337643|FG004|Treatment Period 1-Randomized Set|Adverse Event|0
7162014|NCT03589885|11337639|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0
7162015|NCT03589885|11337640|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0
7162016|NCT03589885|11337641|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2
7162017|NCT03589885|11337642|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0
7162018|NCT03589885|11337643|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0
7162019|NCT03589885|11337639|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0
7162020|NCT03589885|11337640|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1
7162021|NCT03589885|11337641|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0
7162022|NCT03589885|11337642|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0
7162023|NCT03589885|11337643|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0
7162024|NCT03589885|11337639|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0
7162025|NCT03589885|11337640|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0
7162026|NCT03589885|11337641|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1
7162027|NCT03589885|11337642|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0
7162028|NCT03589885|11337643|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0
7162029|NCT03589885|11337639|FG000|Treatment Period 2-Randomized Set|Adverse Event|0
7162030|NCT03589885|11337640|FG001|Treatment Period 2-Randomized Set|Adverse Event|1
7162031|NCT03589885|11337641|FG002|Treatment Period 2-Randomized Set|Adverse Event|0
7162032|NCT03589885|11337642|FG003|Treatment Period 2-Randomized Set|Adverse Event|0
7162033|NCT03589885|11337643|FG004|Treatment Period 2-Randomized Set|Adverse Event|0
7162034|NCT03589885|11337639|FG000|Treatment Period 2-Randomized Set|Pregnancy|1
7162035|NCT03589885|11337640|FG001|Treatment Period 2-Randomized Set|Pregnancy|0
7162036|NCT03589885|11337641|FG002|Treatment Period 2-Randomized Set|Pregnancy|0
7162037|NCT03589885|11337642|FG003|Treatment Period 2-Randomized Set|Pregnancy|0
7162038|NCT03589885|11337643|FG004|Treatment Period 2-Randomized Set|Pregnancy|0
7162039|NCT03589885|11337639|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0
7162040|NCT03589885|11337640|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3
7162041|NCT03589885|11337641|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1
7162042|NCT03589885|11337642|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0
7162043|NCT03589885|11337643|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1
7162044|NCT03589885|11337639|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0
7162045|NCT03589885|11337640|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1
7162046|NCT03589885|11337641|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0
7162047|NCT03589885|11337642|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0
7162048|NCT03589885|11337643|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0
7162049|NCT03590613|11337661|FG000|Period 2, 4 Days|Physician Decision|0
7162050|NCT03590613|11337662|FG001|Period 2, 4 Days|Physician Decision|0
7162051|NCT03590613|11337663|FG002|Period 2, 4 Days|Physician Decision|0
7162052|NCT03590613|11337664|FG003|Period 2, 4 Days|Physician Decision|1
7162053|NCT03591146|11337688|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0
7162054|NCT03591146|11337689|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0
7162055|NCT03591146|11337690|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0
7162056|NCT03591146|11337691|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0
7162057|NCT03591146|11337692|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1
7162058|NCT03591146|11337688|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0
7162059|NCT03591146|11337689|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1
7162060|NCT03591146|11337690|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0
7162061|NCT03591146|11337691|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0
7162062|NCT03591146|11337692|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0
7162063|NCT03591146|11337688|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0
7162064|NCT03591146|11337689|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0
7162065|NCT03591146|11337690|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0
7162066|NCT03591146|11337691|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0
7162067|NCT03591146|11337692|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1
7162068|NCT03591146|11337688|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0
7162069|NCT03591146|11337689|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0
7162070|NCT03591146|11337690|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1
7162071|NCT03591146|11337691|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0
7162072|NCT03591146|11337692|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1
7162073|NCT03591406|11337706|FG000|Overall Study|Adverse Event|5
7162074|NCT03591406|11337707|FG001|Overall Study|Adverse Event|3
7162075|NCT03591406|11337706|FG000|Overall Study|Protocol Violation|2
7162076|NCT03591406|11337707|FG001|Overall Study|Protocol Violation|1
7162077|NCT03591406|11337706|FG000|Overall Study|Withdrawal by Subject|0
7162078|NCT03591406|11337707|FG001|Overall Study|Withdrawal by Subject|5
7162079|NCT03592745|11337724|FG000|Overall Study|Adverse Event|0
7162080|NCT03592745|11337725|FG001|Overall Study|Adverse Event|2
7162081|NCT03592745|11337724|FG000|Overall Study|Lost to Follow-up|2
7162082|NCT03592745|11337725|FG001|Overall Study|Lost to Follow-up|0
7162083|NCT03592745|11337724|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1
7162084|NCT03592745|11337725|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1
7162085|NCT03593681|11337748|FG000|Overall Study|Inadequate sample collected|12
7162086|NCT03593681|11337748|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11
7162087|NCT03593681|11337748|FG000|Overall Study|Protocol Violation|3
7162088|NCT03593681|11337748|FG000|Overall Study|Withdrawal by Subject|3
7162089|NCT03593681|11337748|FG000|Overall Study|Procedure not attempted|3
7162090|NCT03593681|11337748|FG000|Overall Study|Adverse Event|2
7162091|NCT03593681|11337748|FG000|Overall Study|Physician Decision|1
7162092|NCT03593876|11337769|FG000|Overall Study|Withdrawal by Subject|1
7162093|NCT03593876|11337769|FG000|Overall Study|Discharged home before intervention completion|2
7162094|NCT03594071|11337786|FG000|Overall Study|Re-operation|3
7162095|NCT03594071|11337786|FG000|Overall Study|Missed visit|2
7162096|NCT03594227|11337794|FG000|Overall Study|Adverse Event|2
7162097|NCT03594227|11337795|FG001|Overall Study|Adverse Event|1
7162098|NCT03594227|11337796|FG002|Overall Study|Adverse Event|0
7162099|NCT03594227|11337797|FG003|Overall Study|Adverse Event|2
7162100|NCT03594227|11337794|FG000|Overall Study|Lost to Follow-up|1
7162101|NCT03594227|11337795|FG001|Overall Study|Lost to Follow-up|1
7162102|NCT03594227|11337796|FG002|Overall Study|Lost to Follow-up|1
7162103|NCT03594227|11337797|FG003|Overall Study|Lost to Follow-up|0
7162104|NCT03594227|11337794|FG000|Overall Study|Withdrawal by Subject|1
7162105|NCT03594227|11337795|FG001|Overall Study|Withdrawal by Subject|1
7162106|NCT03594227|11337796|FG002|Overall Study|Withdrawal by Subject|1
7162107|NCT03594227|11337797|FG003|Overall Study|Withdrawal by Subject|1
7080088|NCT02119663|11189403|FG001|Overall Study|Other unspecified|0
7080089|NCT02119663|11189402|FG000|Overall Study|Subject decision|0
7080090|NCT02119663|11189403|FG001|Overall Study|Subject decision|1
7080091|NCT02119663|11189402|FG000|Overall Study|Study Terminated by the Sponsor|3
7080092|NCT02119663|11189403|FG001|Overall Study|Study Terminated by the Sponsor|4
7080093|NCT02119676|11189413|FG000|Overall Study|Adverse Event|9
7162108|NCT03594227|11337794|FG000|Overall Study|Pregnancy|0
7162109|NCT03594227|11337795|FG001|Overall Study|Pregnancy|1
7162110|NCT03594227|11337796|FG002|Overall Study|Pregnancy|0
7162111|NCT03594227|11337797|FG003|Overall Study|Pregnancy|0
7162112|NCT03594227|11337794|FG000|Overall Study|Sponsor Decision|0
7162113|NCT03594227|11337795|FG001|Overall Study|Sponsor Decision|0
7162114|NCT03594227|11337796|FG002|Overall Study|Sponsor Decision|0
7162115|NCT03594227|11337797|FG003|Overall Study|Sponsor Decision|1
7162116|NCT03594227|11337794|FG000|Overall Study|Programmatic Analysis Non-completer|1
7162117|NCT03594227|11337795|FG001|Overall Study|Programmatic Analysis Non-completer|0
7162118|NCT03594227|11337796|FG002|Overall Study|Programmatic Analysis Non-completer|1
7162119|NCT03594227|11337797|FG003|Overall Study|Programmatic Analysis Non-completer|1
7162120|NCT03595280|11337837|FG000|Overall Study|Lost to Follow-up|6
7162121|NCT03595280|11337838|FG001|Overall Study|Lost to Follow-up|9
7162122|NCT03595280|11337839|FG002|Overall Study|Lost to Follow-up|15
7080094|NCT02119676|11189414|FG001|Overall Study|Adverse Event|17
7162123|NCT03595618|11337869|FG000|Overall Study|Adverse Event|16
7162124|NCT03595618|11337870|FG001|Overall Study|Adverse Event|17
7162125|NCT03595618|11337871|FG002|Overall Study|Adverse Event|20
7162126|NCT03595618|11337872|FG003|Overall Study|Adverse Event|8
7162127|NCT03595618|11337869|FG000|Overall Study|Withdrawal by Subject|12
7162128|NCT03595618|11337870|FG001|Overall Study|Withdrawal by Subject|14
7162129|NCT03595618|11337871|FG002|Overall Study|Withdrawal by Subject|14
7162130|NCT03595618|11337872|FG003|Overall Study|Withdrawal by Subject|10
7080095|NCT02119676|11189415|FG002|Overall Study|Adverse Event|10
7080096|NCT02119676|11189416|FG003|Overall Study|Adverse Event|10
7162131|NCT03595618|11337869|FG000|Overall Study|Lost to Follow-up|6
7162132|NCT03595618|11337870|FG001|Overall Study|Lost to Follow-up|4
7162133|NCT03595618|11337871|FG002|Overall Study|Lost to Follow-up|5
7162134|NCT03595618|11337872|FG003|Overall Study|Lost to Follow-up|6
7162135|NCT03595618|11337869|FG000|Overall Study|Protocol Violation|2
7162136|NCT03595618|11337870|FG001|Overall Study|Protocol Violation|0
7162137|NCT03595618|11337871|FG002|Overall Study|Protocol Violation|6
7162138|NCT03595618|11337872|FG003|Overall Study|Protocol Violation|2
7162139|NCT03595618|11337869|FG000|Overall Study|Physician Decision|0
7162140|NCT03595618|11337870|FG001|Overall Study|Physician Decision|0
7162141|NCT03595618|11337871|FG002|Overall Study|Physician Decision|1
7162142|NCT03595618|11337872|FG003|Overall Study|Physician Decision|2
7162143|NCT03595618|11337869|FG000|Overall Study|Miscellaneous|7
7162144|NCT03595618|11337870|FG001|Overall Study|Miscellaneous|5
7162145|NCT03595618|11337871|FG002|Overall Study|Miscellaneous|10
7162146|NCT03595618|11337872|FG003|Overall Study|Miscellaneous|6
7162147|NCT03595904|11337884|FG000|Overall Study|Protocol Violation|3
7162148|NCT03595904|11337885|FG001|Overall Study|Protocol Violation|1
7162149|NCT03595904|11337884|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4
7162150|NCT03595904|11337885|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3
7162151|NCT03595904|11337884|FG000|Overall Study|Insurance complications|1
7162152|NCT03595904|11337885|FG001|Overall Study|Insurance complications|0
7162153|NCT03595904|11337884|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2
7162154|NCT03595904|11337885|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1
7162155|NCT03596151|11337891|FG000|Overall Study|Withdrawal by Subject|1
7162156|NCT03596177|11337897|FG000|Single Blind Period|Withdrawal by Subject|1
7162157|NCT03596177|11337898|FG001|Single Blind Period|Withdrawal by Subject|1
7162158|NCT03596177|11337897|FG000|Single Blind Period|Other|1
7162159|NCT03596177|11337898|FG001|Single Blind Period|Other|0
7162160|NCT03596177|11337897|FG000|Double Blind Period|Withdrawal by Subject|0
7162161|NCT03596177|11337898|FG001|Double Blind Period|Withdrawal by Subject|1
7162162|NCT03596177|11337897|FG000|Double Blind Period|Other|0
7162163|NCT03596177|11337898|FG001|Double Blind Period|Other|4
7162164|NCT03596177|11337897|FG000|Double Blind Period|Death during safety follow-up|0
7162165|NCT03596177|11337898|FG001|Double Blind Period|Death during safety follow-up|1
7162166|NCT03597022|11337920|FG000|Overall Study|Premature termination of the study|7
7162167|NCT03597022|11337921|FG001|Overall Study|Premature termination of the study|7
7162168|NCT03597022|11337922|FG002|Overall Study|Premature termination of the study|8
7162169|NCT03597022|11337920|FG000|Overall Study|Serious adverse event|1
7162170|NCT03597022|11337921|FG001|Overall Study|Serious adverse event|1
7162171|NCT03597022|11337922|FG002|Overall Study|Serious adverse event|0
7162172|NCT03597061|11337932|FG000|Overall Study|Lost to Follow-up|1
7162173|NCT03597061|11337933|FG001|Overall Study|Lost to Follow-up|0
7162174|NCT03597061|11337932|FG000|Overall Study|Protocol Violation|0
7162175|NCT03597061|11337933|FG001|Overall Study|Protocol Violation|1
7162176|NCT03597139|11337941|FG000|Overall Study|Adverse Event|3
7162177|NCT03597139|11337942|FG001|Overall Study|Adverse Event|0
7162178|NCT03597139|11337941|FG000|Overall Study|Protocol Non-compliance|1
7162179|NCT03597139|11337942|FG001|Overall Study|Protocol Non-compliance|0
7162180|NCT03597347|11337955|FG000|Overall Study|Withdrawal by Subject|1
7162181|NCT03597347|11337956|FG001|Overall Study|Withdrawal by Subject|1
7162182|NCT03597347|11337957|FG002|Overall Study|Withdrawal by Subject|0
7162183|NCT03597347|11337955|FG000|Overall Study|Withdrawal due to Covid-19|3
7162184|NCT03597347|11337956|FG001|Overall Study|Withdrawal due to Covid-19|0
7162185|NCT03597347|11337957|FG002|Overall Study|Withdrawal due to Covid-19|0
7162186|NCT03597347|11337955|FG000|Overall Study|Sponsor decision to terminate study|3
7162187|NCT03597347|11337956|FG001|Overall Study|Sponsor decision to terminate study|2
7162188|NCT03597347|11337957|FG002|Overall Study|Sponsor decision to terminate study|4
7162189|NCT03597529|11337967|FG000|Overall Study|Lost to Follow-up|10
7162190|NCT03597529|11337968|FG001|Overall Study|Lost to Follow-up|12
7162191|NCT03597529|11337967|FG000|Overall Study|Physician Decision|3
7162192|NCT03597529|11337968|FG001|Overall Study|Physician Decision|1
7162193|NCT03597529|11337967|FG000|Overall Study|Withdrawal by Subject|6
7162194|NCT03597529|11337968|FG001|Overall Study|Withdrawal by Subject|3
7162195|NCT03597529|11337967|FG000|Overall Study|Non-compliant with study activities|1
7162196|NCT03597529|11337968|FG001|Overall Study|Non-compliant with study activities|2
7162197|NCT03599089|11337997|FG000|Overall Study|Lost to Follow-up|1
7162198|NCT03599089|11337998|FG001|Overall Study|Lost to Follow-up|0
7162199|NCT03599089|11337999|FG002|Overall Study|Lost to Follow-up|0
7162200|NCT03599089|11338000|FG003|Overall Study|Lost to Follow-up|0
7162201|NCT03599089|11337997|FG000|Overall Study|Withdrawal by Subject|2
7162202|NCT03599089|11337998|FG001|Overall Study|Withdrawal by Subject|1
7162203|NCT03599089|11337999|FG002|Overall Study|Withdrawal by Subject|0
7162204|NCT03599089|11338000|FG003|Overall Study|Withdrawal by Subject|0
7162205|NCT03599089|11337997|FG000|Overall Study|Lack of Efficacy|0
7162206|NCT03599089|11337998|FG001|Overall Study|Lack of Efficacy|0
7162207|NCT03599089|11337999|FG002|Overall Study|Lack of Efficacy|1
7162208|NCT03599089|11338000|FG003|Overall Study|Lack of Efficacy|2
7162209|NCT03599193|11338012|FG000|Overall Study|Adverse Event|0
7162210|NCT03599193|11338013|FG001|Overall Study|Adverse Event|2
7162211|NCT03599193|11338012|FG000|Overall Study|Withdrawal by Subject|1
7162212|NCT03599193|11338013|FG001|Overall Study|Withdrawal by Subject|0
7162213|NCT03599193|11338012|FG000|Overall Study|Protocol Violation|1
7162214|NCT03599193|11338013|FG001|Overall Study|Protocol Violation|0
7162215|NCT03599193|11338012|FG000|Overall Study|Lost to Follow-up|0
7162216|NCT03599193|11338013|FG001|Overall Study|Lost to Follow-up|1
7162217|NCT03599349|11338031|FG000|Overall Study|Lost to Follow-up|1
7162218|NCT03599362|11338035|FG000|Overall Study|Screen Failure|3
7162219|NCT03600376|11338068|FG000|Overall Study|Adverse Event|1
7162220|NCT03600376|11338069|FG001|Overall Study|Adverse Event|1
7162221|NCT03600376|11338068|FG000|Overall Study|Transferred to other facility|1
7162222|NCT03600376|11338069|FG001|Overall Study|Transferred to other facility|0
7162223|NCT03600376|11338068|FG000|Overall Study|Investigator Decision|0
7162224|NCT03600376|11338069|FG001|Overall Study|Investigator Decision|4
7162225|NCT03600376|11338068|FG000|Overall Study|Determined to be ineligible for study|0
7162226|NCT03600376|11338069|FG001|Overall Study|Determined to be ineligible for study|1
7162227|NCT03600428|11338077|FG000|Overall Study|Not eligible|0
7162228|NCT03600428|11338078|FG001|Overall Study|Not eligible|1
7162229|NCT03600428|11338077|FG000|Overall Study|Lost to Follow-up|5
7162230|NCT03600428|11338078|FG001|Overall Study|Lost to Follow-up|4
7162231|NCT03601052|11338084|FG000|Overall Study|Lost to Follow-up|2
7162232|NCT03601715|11338096|FG000|Second Intervention|Lost to Follow-up|1
7162233|NCT03601715|11338097|FG001|Second Intervention|Lost to Follow-up|1
7162234|NCT03601715|11338098|FG002|Second Intervention|Lost to Follow-up|0
7162235|NCT03602053|11338109|FG000|Overall Study|Withdrawal by Subject|7
7162236|NCT03602053|11338110|FG001|Overall Study|Withdrawal by Subject|9
7162237|NCT03602053|11338111|FG002|Overall Study|Withdrawal by Subject|7
7162238|NCT03602053|11338109|FG000|Overall Study|Lost to Follow-up|5
7162239|NCT03602053|11338110|FG001|Overall Study|Lost to Follow-up|6
7162240|NCT03602053|11338111|FG002|Overall Study|Lost to Follow-up|0
7162241|NCT03602053|11338109|FG000|Overall Study|Protocol Violation|3
7162242|NCT03602053|11338110|FG001|Overall Study|Protocol Violation|0
7162243|NCT03602053|11338111|FG002|Overall Study|Protocol Violation|4
7162244|NCT03602053|11338109|FG000|Overall Study|Physician Decision|1
7162245|NCT03602053|11338110|FG001|Overall Study|Physician Decision|0
7162246|NCT03602053|11338111|FG002|Overall Study|Physician Decision|0
7162247|NCT03602053|11338109|FG000|Overall Study|migration|2
7162248|NCT03602053|11338110|FG001|Overall Study|migration|3
7162249|NCT03602053|11338111|FG002|Overall Study|migration|0
7162250|NCT03602053|11338109|FG000|Overall Study|Other|1
7162251|NCT03602053|11338110|FG001|Overall Study|Other|0
7162252|NCT03602053|11338111|FG002|Overall Study|Other|0
7162253|NCT03602339|11338123|FG000|Overall Study|Withdrawal by Subject|9
7162254|NCT03602339|11338123|FG000|Overall Study|Physician Decision|2
7162255|NCT03602339|11338123|FG000|Overall Study|Other reason|4
7162256|NCT03602482|11338132|FG000|Overall Study|Withdrawal by Subject|6
7162257|NCT03602482|11338133|FG001|Overall Study|Withdrawal by Subject|7
7162258|NCT03602482|11338134|FG002|Overall Study|Withdrawal by Subject|0
7162259|NCT03602482|11338135|FG003|Overall Study|Withdrawal by Subject|0
7162260|NCT03603028|11338148|FG000|Overall Study|Withdrawal by Subject|1
7162261|NCT03603652|11338206|FG000|Overall Study|Death|2
7162262|NCT03604341|11338216|FG000|Overall Study|Withdrawal by Subject|1
7162263|NCT03604341|11338217|FG001|Overall Study|Withdrawal by Subject|1
7162264|NCT03604341|11338216|FG000|Overall Study|Adverse Event|1
7162265|NCT03604341|11338217|FG001|Overall Study|Adverse Event|0
7162266|NCT03604341|11338216|FG000|Overall Study|Protocol Violation|0
7162267|NCT03604341|11338217|FG001|Overall Study|Protocol Violation|1
7162268|NCT03604497|11338223|FG000|Overall Study|Protocol Violation|52
7162269|NCT03604523|11338233|FG000|Overall Study|Physician Decision|1
7162270|NCT03604523|11338234|FG001|Overall Study|Physician Decision|0
7162271|NCT03605212|11338257|FG000|Treatment Period|Adverse Event|1
7162272|NCT03605212|11338258|FG001|Treatment Period|Adverse Event|0
7162273|NCT03605212|11338259|FG002|Treatment Period|Adverse Event|0
7162274|NCT03605212|11338260|FG003|Treatment Period|Adverse Event|0
7162275|NCT03605212|11338261|FG004|Treatment Period|Adverse Event|0
7162276|NCT03605212|11338257|FG000|Treatment Period|Physician Decision|0
7162277|NCT03605212|11338258|FG001|Treatment Period|Physician Decision|0
7162278|NCT03605212|11338259|FG002|Treatment Period|Physician Decision|0
7162279|NCT03605212|11338260|FG003|Treatment Period|Physician Decision|0
7162280|NCT03605212|11338261|FG004|Treatment Period|Physician Decision|1
7162281|NCT03605693|11338276|FG000|Overall Study|Lost to Follow-up|4
7162282|NCT03605693|11338277|FG001|Overall Study|Lost to Follow-up|0
7162283|NCT03605693|11338276|FG000|Overall Study|Physician Decision|1
7162284|NCT03605693|11338277|FG001|Overall Study|Physician Decision|0
7162285|NCT03605745|11338283|FG000|Overall Study|Study was terminated for business reasons|47
7162286|NCT03605836|11338291|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2
7162287|NCT03605836|11338292|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0
7162288|NCT03605836|11338293|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0
7162289|NCT03605836|11338294|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0
7162290|NCT03605836|11338291|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2
7162291|NCT03605836|11338292|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0
7162292|NCT03605836|11338293|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0
7162293|NCT03605836|11338294|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0
7162294|NCT03605836|11338291|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8
7162295|NCT03605836|11338292|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0
7162296|NCT03605836|11338293|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0
7162297|NCT03605836|11338294|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0
7162298|NCT03605836|11338291|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4
7162299|NCT03605836|11338292|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0
7162300|NCT03605836|11338293|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0
7162301|NCT03605836|11338294|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0
7162302|NCT03605836|11338291|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4
7162303|NCT03605836|11338292|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0
7162304|NCT03605836|11338293|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0
7162305|NCT03605836|11338294|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0
7162306|NCT03605836|11338291|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17
7162307|NCT03605836|11338292|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0
7162308|NCT03605836|11338293|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0
7162309|NCT03605836|11338294|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0
7162310|NCT03605836|11338291|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5
7162311|NCT03605836|11338292|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0
7162312|NCT03605836|11338293|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0
7162313|NCT03605836|11338294|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0
7162314|NCT03605836|11338291|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7
7162315|NCT03605836|11338292|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0
7162316|NCT03605836|11338293|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0
7162317|NCT03605836|11338294|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0
7162318|NCT03605836|11338291|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85
7162319|NCT03605836|11338292|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0
7162320|NCT03605836|11338293|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0
7162321|NCT03605836|11338294|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0
7162322|NCT03605836|11338291|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15
7162323|NCT03605836|11338292|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0
7162324|NCT03605836|11338293|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0
7162325|NCT03605836|11338294|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0
7162326|NCT03605836|11338291|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1
7162327|NCT03605836|11338292|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0
7162328|NCT03605836|11338293|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0
7162329|NCT03605836|11338294|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0
7162330|NCT03605836|11338291|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0
7162331|NCT03605836|11338292|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2
7162332|NCT03605836|11338293|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4
7162333|NCT03605836|11338294|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4
7162334|NCT03605836|11338291|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0
7162335|NCT03605836|11338292|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5
7162336|NCT03605836|11338293|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8
7162337|NCT03605836|11338294|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0
7162338|NCT03605836|11338291|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0
7162339|NCT03605836|11338292|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0
7162340|NCT03605836|11338293|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2
7162341|NCT03605836|11338294|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1
7162342|NCT03605836|11338291|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0
7162343|NCT03605836|11338292|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3
7162344|NCT03605836|11338293|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5
7162345|NCT03605836|11338294|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1
7162346|NCT03605836|11338291|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0
7162347|NCT03605836|11338292|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1
7162348|NCT03605836|11338293|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0
7162349|NCT03605836|11338294|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4
7162350|NCT03605836|11338291|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0
7162351|NCT03605836|11338292|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1
7162352|NCT03605836|11338293|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0
7162353|NCT03605836|11338294|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0
7162354|NCT03605836|11338291|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0
7162355|NCT03605836|11338292|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5
7162356|NCT03605836|11338293|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1
7162357|NCT03605836|11338294|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1
7162358|NCT03605836|11338291|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0
7162359|NCT03605836|11338292|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10
7162360|NCT03605836|11338293|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6
7162361|NCT03605836|11338294|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4
7162362|NCT03605836|11338291|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0
7162363|NCT03605836|11338292|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3
7162364|NCT03605836|11338293|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1
7162365|NCT03605836|11338294|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0
7162366|NCT03605836|11338291|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0
7162367|NCT03605836|11338292|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6
7162368|NCT03605836|11338293|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16
7162369|NCT03605836|11338294|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7
7162370|NCT03605836|11338291|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0
7162371|NCT03605836|11338292|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0
7162372|NCT03605836|11338293|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2
7162373|NCT03605836|11338294|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1
7162374|NCT03606460|11338327|FG000|Overall Study|Lost to Follow-up|1
7162375|NCT03606460|11338328|FG001|Overall Study|Lost to Follow-up|8
7184399|NCT03408444|11384567|FG002|Overall Study|Lost to Follow-up|1
7184400|NCT03408444|11384568|FG003|Overall Study|Lost to Follow-up|0
7184401|NCT03408444|11384565|FG000|Overall Study|Adverse Event|0
7184402|NCT03408444|11384566|FG001|Overall Study|Adverse Event|0
7184403|NCT03408444|11384567|FG002|Overall Study|Adverse Event|0
7184404|NCT03408444|11384568|FG003|Overall Study|Adverse Event|1
7184405|NCT03408444|11384565|FG000|Overall Study|Lens Handling Difficulties|0
7184406|NCT03408444|11384566|FG001|Overall Study|Lens Handling Difficulties|0
7184407|NCT03408444|11384567|FG002|Overall Study|Lens Handling Difficulties|1
7184408|NCT03408444|11384568|FG003|Overall Study|Lens Handling Difficulties|0
7184409|NCT03408444|11384565|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0
7184410|NCT03408444|11384566|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0
6895105|NCT00622739|10912874|FG000|Overall Study|Withdrawal by Subject|0
6895106|NCT00622739|10912875|FG001|Overall Study|Withdrawal by Subject|1
6895107|NCT00622739|10912874|FG000|Overall Study|Lost to Follow-up|0
6895108|NCT00622739|10912875|FG001|Overall Study|Lost to Follow-up|1
6895109|NCT00622869|10912886|FG000|Overall Study|Subject Withdrew Consent|13
6895110|NCT00622869|10912887|FG001|Overall Study|Subject Withdrew Consent|17
6895111|NCT00622869|10912888|FG002|Overall Study|Subject Withdrew Consent|11
6895112|NCT00622869|10912886|FG000|Overall Study|Administrative Problems|11
6895113|NCT00622869|10912887|FG001|Overall Study|Administrative Problems|17
6895114|NCT00622869|10912888|FG002|Overall Study|Administrative Problems|13
7184411|NCT03408444|11384567|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0
7184412|NCT03408444|11384568|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3
7187481|NCT01941719|11388092|FG001|Overall Study|Lost to Follow-up|19
7187482|NCT00943618|11388118|FG000|Overall Study|Lost to Follow-up|38
7187483|NCT00943618|11388119|FG001|Overall Study|Lost to Follow-up|48
7187484|NCT00943618|11388120|FG002|Overall Study|Lost to Follow-up|20
7187485|NCT00943618|11388118|FG000|Overall Study|Discontinued Medication|17
7187486|NCT00943618|11388119|FG001|Overall Study|Discontinued Medication|29
7187487|NCT00943618|11388120|FG002|Overall Study|Discontinued Medication|11
7188276|NCT02906020|11388819|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7188277|NCT02906020|11388820|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7188278|NCT02906020|11388821|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7188279|NCT02906020|11388822|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7188280|NCT02906020|11388823|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1
7188281|NCT02906020|11388824|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1
7188282|NCT02906020|11388825|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7188283|NCT02906020|11388826|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7188284|NCT02906020|11388811|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7188285|NCT02906020|11388812|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7188286|NCT02906020|11388813|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7188287|NCT02906020|11388814|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7188288|NCT02906020|11388815|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7188289|NCT02906020|11388816|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7188290|NCT02906020|11388817|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7188291|NCT02906020|11388818|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7188292|NCT02906020|11388819|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7188293|NCT02906020|11388820|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7188294|NCT02906020|11388821|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7188295|NCT02906020|11388822|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7188296|NCT02906020|11388823|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1
7188297|NCT02906020|11388824|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4
7188298|NCT02906020|11388825|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7188299|NCT02906020|11388826|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
6895115|NCT00622869|10912886|FG000|Overall Study|Death|12
7162376|NCT03607682|11338344|FG000|Overall Study|Withdrawal by Subject|1
7162377|NCT03607682|11338344|FG000|Overall Study|Disease progression|1
7162378|NCT03607695|11338348|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1
7162379|NCT03607695|11338348|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2
7162380|NCT03608774|11338371|FG000|Overall Study|Lost to Follow-up|5
7162381|NCT03608774|11338372|FG001|Overall Study|Lost to Follow-up|5
7162382|NCT03608774|11338371|FG000|Overall Study|Withdrawal by Subject|1
7162383|NCT03608774|11338372|FG001|Overall Study|Withdrawal by Subject|0
7162384|NCT03608774|11338371|FG000|Overall Study|Protocol Violation|1
7162385|NCT03608774|11338372|FG001|Overall Study|Protocol Violation|0
7162386|NCT03608774|11338371|FG000|Overall Study|Not eligible at enrollment|0
7162387|NCT03608774|11338372|FG001|Overall Study|Not eligible at enrollment|1
7162388|NCT03608774|11338371|FG000|Overall Study|Health related event|0
7162389|NCT03608774|11338372|FG001|Overall Study|Health related event|1
7162390|NCT03609619|11338393|FG000|Overall Study|Adverse Event|1
7162391|NCT03609619|11338394|FG001|Overall Study|Adverse Event|0
7162392|NCT03609619|11338393|FG000|Overall Study|Lack of Efficacy|1
7162393|NCT03609619|11338394|FG001|Overall Study|Lack of Efficacy|2
7162394|NCT03609619|11338393|FG000|Overall Study|Protocol Violation|5
7162395|NCT03609619|11338394|FG001|Overall Study|Protocol Violation|0
7162396|NCT03609619|11338393|FG000|Overall Study|Withdrawal by Subject|2
7162397|NCT03609619|11338394|FG001|Overall Study|Withdrawal by Subject|3
7162398|NCT03609619|11338393|FG000|Overall Study|Lost to Follow-up|1
7162399|NCT03609619|11338394|FG001|Overall Study|Lost to Follow-up|1
7162400|NCT03610048|11338409|FG000|Overall Study|Study terminated by sponsor|84
7162401|NCT03610048|11338409|FG000|Overall Study|Adverse Event|32
7162402|NCT03610048|11338409|FG000|Overall Study|Withdrawal by Subject|31
7162403|NCT03610048|11338409|FG000|Overall Study|Lost to Follow-up|8
6895116|NCT00622869|10912887|FG001|Overall Study|Death|15
6895117|NCT00622869|10912888|FG002|Overall Study|Death|10
6895118|NCT00622869|10912886|FG000|Overall Study|Lost to Follow-up|2
6895119|NCT00622869|10912887|FG001|Overall Study|Lost to Follow-up|4
6895120|NCT00622869|10912888|FG002|Overall Study|Lost to Follow-up|2
6895121|NCT00622869|10912886|FG000|Overall Study|Graft Loss|5
6895122|NCT00622869|10912887|FG001|Overall Study|Graft Loss|3
7080097|NCT02119676|11189413|FG000|Overall Study|Disease progression|53
7162404|NCT03610048|11338409|FG000|Overall Study|Other|4
7162405|NCT03610048|11338409|FG000|Overall Study|Physician Decision|1
7162406|NCT03610048|11338409|FG000|Overall Study|Pregnancy|1
7162407|NCT03610165|11338415|FG000|Overall Study|Device didn't work|0
7162408|NCT03610165|11338416|FG001|Overall Study|Device didn't work|1
7162409|NCT03610269|11338422|FG000|Overall Study|Physician Decision|10
7162410|NCT03610269|11338422|FG000|Overall Study|Protocol Violation|1
7162411|NCT03610269|11338422|FG000|Overall Study|Unable to draw blood|1
7162412|NCT03610269|11338422|FG000|Overall Study|Screen fail|4
7162413|NCT03610581|11338446|FG000|Overall Study|Study terminated by sponsor|2
7162414|NCT03610581|11338447|FG001|Overall Study|Study terminated by sponsor|0
7162415|NCT03610581|11338446|FG000|Overall Study|Other|0
7162416|NCT03610581|11338447|FG001|Overall Study|Other|1
7162417|NCT03610581|11338446|FG000|Overall Study|Withdrawal by Subject|1
7162418|NCT03610581|11338447|FG001|Overall Study|Withdrawal by Subject|0
7162419|NCT03611582|11338473|FG000|Overall Study|Adverse Event|26
7162420|NCT03611582|11338474|FG001|Overall Study|Adverse Event|6
7162421|NCT03611582|11338473|FG000|Overall Study|Protocol Violation|0
7162422|NCT03611582|11338474|FG001|Overall Study|Protocol Violation|1
7162423|NCT03611582|11338473|FG000|Overall Study|Pregnancy|1
7162424|NCT03611582|11338474|FG001|Overall Study|Pregnancy|2
7162425|NCT03611582|11338473|FG000|Overall Study|Lack of Efficacy|0
7162426|NCT03611582|11338474|FG001|Overall Study|Lack of Efficacy|1
7162427|NCT03611582|11338473|FG000|Overall Study|At the discretion of the investigator|1
7162428|NCT03611582|11338474|FG001|Overall Study|At the discretion of the investigator|0
7162429|NCT03611582|11338473|FG000|Overall Study|Safety concern as judged by the investigator|1
7162430|NCT03611582|11338474|FG001|Overall Study|Safety concern as judged by the investigator|2
7162431|NCT03611582|11338473|FG000|Overall Study|Withdrawal by Subject|4
7162432|NCT03611582|11338474|FG001|Overall Study|Withdrawal by Subject|3
7162433|NCT03611582|11338473|FG000|Overall Study|Lost to Follow-up|18
7162434|NCT03611582|11338474|FG001|Overall Study|Lost to Follow-up|7
7162435|NCT03611582|11338473|FG000|Overall Study|other|17
7162436|NCT03611582|11338474|FG001|Overall Study|other|16
7162437|NCT03613129|11338506|FG000|Pre-treatment Assessment|Protocol Violation|2
7162438|NCT03613129|11338507|FG001|Pre-treatment Assessment|Protocol Violation|0
7162439|NCT03613129|11338508|FG002|Pre-treatment Assessment|Protocol Violation|0
7162440|NCT03613129|11338509|FG003|Pre-treatment Assessment|Protocol Violation|0
7080098|NCT02119676|11189414|FG001|Overall Study|Disease progression|55
7162441|NCT03613129|11338510|FG004|Pre-treatment Assessment|Protocol Violation|0
7162442|NCT03613129|11338506|FG000|Pre-treatment Assessment|Withdrawal by Subject|1
7162443|NCT03613129|11338507|FG001|Pre-treatment Assessment|Withdrawal by Subject|0
7162444|NCT03613129|11338508|FG002|Pre-treatment Assessment|Withdrawal by Subject|0
7162445|NCT03613129|11338509|FG003|Pre-treatment Assessment|Withdrawal by Subject|0
7162446|NCT03613129|11338510|FG004|Pre-treatment Assessment|Withdrawal by Subject|0
7162447|NCT03613454|11338524|FG000|Overall Study|Protocol Violation|1
7162448|NCT03613454|11338525|FG001|Overall Study|Protocol Violation|0
7162449|NCT03613454|11338524|FG000|Overall Study|Protocol Violation|0
6895123|NCT00622869|10912888|FG002|Overall Study|Graft Loss|2
7162450|NCT03613454|11338525|FG001|Overall Study|Protocol Violation|1
7162451|NCT03613649|11338559|FG000|Second Treatment|Lost to Follow-up|0
7162452|NCT03613649|11338560|FG001|Second Treatment|Lost to Follow-up|0
7162453|NCT03613649|11338561|FG002|Second Treatment|Lost to Follow-up|1
7162454|NCT03613649|11338562|FG003|Second Treatment|Lost to Follow-up|0
7162455|NCT03613649|11338563|FG004|Second Treatment|Lost to Follow-up|0
7162456|NCT03613649|11338564|FG005|Second Treatment|Lost to Follow-up|0
7162457|NCT03613649|11338565|FG006|Second Treatment|Lost to Follow-up|0
7162458|NCT03613649|11338566|FG007|Second Treatment|Lost to Follow-up|0
7162459|NCT03613649|11338567|FG008|Second Treatment|Lost to Follow-up|0
7162460|NCT03613649|11338568|FG009|Second Treatment|Lost to Follow-up|0
7162461|NCT03613649|11338569|FG010|Second Treatment|Lost to Follow-up|0
7162462|NCT03613649|11338570|FG011|Second Treatment|Lost to Follow-up|0
7162463|NCT03613649|11338559|FG000|Second Treatment|Withdrawal by Subject|0
7162464|NCT03613649|11338560|FG001|Second Treatment|Withdrawal by Subject|0
7162465|NCT03613649|11338561|FG002|Second Treatment|Withdrawal by Subject|0
7162466|NCT03613649|11338562|FG003|Second Treatment|Withdrawal by Subject|0
7162467|NCT03613649|11338563|FG004|Second Treatment|Withdrawal by Subject|1
7162468|NCT03613649|11338564|FG005|Second Treatment|Withdrawal by Subject|0
7162469|NCT03613649|11338565|FG006|Second Treatment|Withdrawal by Subject|0
7162470|NCT03613649|11338566|FG007|Second Treatment|Withdrawal by Subject|0
7162471|NCT03613649|11338567|FG008|Second Treatment|Withdrawal by Subject|0
7162472|NCT03613649|11338568|FG009|Second Treatment|Withdrawal by Subject|0
7162473|NCT03613649|11338569|FG010|Second Treatment|Withdrawal by Subject|0
7162474|NCT03613649|11338570|FG011|Second Treatment|Withdrawal by Subject|0
7162475|NCT03613649|11338559|FG000|Third Treatment|Lost to Follow-up|0
7162476|NCT03613649|11338560|FG001|Third Treatment|Lost to Follow-up|0
7162477|NCT03613649|11338561|FG002|Third Treatment|Lost to Follow-up|0
7162478|NCT03613649|11338562|FG003|Third Treatment|Lost to Follow-up|0
7080099|NCT02119676|11189415|FG002|Overall Study|Disease progression|68
7080100|NCT02119676|11189416|FG003|Overall Study|Disease progression|73
7162479|NCT03613649|11338563|FG004|Third Treatment|Lost to Follow-up|1
7162480|NCT03613649|11338564|FG005|Third Treatment|Lost to Follow-up|0
7162481|NCT03613649|11338565|FG006|Third Treatment|Lost to Follow-up|0
7162482|NCT03613649|11338566|FG007|Third Treatment|Lost to Follow-up|0
7162483|NCT03613649|11338567|FG008|Third Treatment|Lost to Follow-up|0
7162484|NCT03613649|11338568|FG009|Third Treatment|Lost to Follow-up|0
7162485|NCT03613649|11338569|FG010|Third Treatment|Lost to Follow-up|0
7162486|NCT03613649|11338570|FG011|Third Treatment|Lost to Follow-up|1
7162487|NCT03613649|11338559|FG000|Third Treatment|Protocol Violation|0
7162488|NCT03613649|11338560|FG001|Third Treatment|Protocol Violation|0
7162489|NCT03613649|11338561|FG002|Third Treatment|Protocol Violation|0
7162490|NCT03613649|11338562|FG003|Third Treatment|Protocol Violation|0
7162491|NCT03613649|11338563|FG004|Third Treatment|Protocol Violation|0
7162492|NCT03613649|11338564|FG005|Third Treatment|Protocol Violation|0
7162493|NCT03613649|11338565|FG006|Third Treatment|Protocol Violation|1
7162494|NCT03613649|11338566|FG007|Third Treatment|Protocol Violation|0
7162495|NCT03613649|11338567|FG008|Third Treatment|Protocol Violation|0
7162496|NCT03613649|11338568|FG009|Third Treatment|Protocol Violation|0
7162497|NCT03613649|11338569|FG010|Third Treatment|Protocol Violation|0
7162498|NCT03613649|11338570|FG011|Third Treatment|Protocol Violation|1
7162499|NCT03613649|11338559|FG000|Fourth Treatment|Protocol Violation|1
7162500|NCT03613649|11338560|FG001|Fourth Treatment|Protocol Violation|0
7162501|NCT03613649|11338561|FG002|Fourth Treatment|Protocol Violation|0
7162502|NCT03613649|11338562|FG003|Fourth Treatment|Protocol Violation|0
7162503|NCT03613649|11338563|FG004|Fourth Treatment|Protocol Violation|1
7162504|NCT03613649|11338564|FG005|Fourth Treatment|Protocol Violation|0
7162505|NCT03613649|11338565|FG006|Fourth Treatment|Protocol Violation|0
7162506|NCT03613649|11338566|FG007|Fourth Treatment|Protocol Violation|0
7162507|NCT03613649|11338567|FG008|Fourth Treatment|Protocol Violation|0
7162508|NCT03613649|11338568|FG009|Fourth Treatment|Protocol Violation|0
7162509|NCT03613649|11338569|FG010|Fourth Treatment|Protocol Violation|0
7162510|NCT03613649|11338570|FG011|Fourth Treatment|Protocol Violation|0
7162511|NCT03613649|11338559|FG000|Fourth Treatment|Physician Decision|0
7162512|NCT03613649|11338560|FG001|Fourth Treatment|Physician Decision|0
7162513|NCT03613649|11338561|FG002|Fourth Treatment|Physician Decision|0
7162514|NCT03613649|11338562|FG003|Fourth Treatment|Physician Decision|0
7162515|NCT03613649|11338563|FG004|Fourth Treatment|Physician Decision|0
7162516|NCT03613649|11338564|FG005|Fourth Treatment|Physician Decision|0
7162517|NCT03613649|11338565|FG006|Fourth Treatment|Physician Decision|1
7162518|NCT03613649|11338566|FG007|Fourth Treatment|Physician Decision|0
7162519|NCT03613649|11338567|FG008|Fourth Treatment|Physician Decision|0
7162520|NCT03613649|11338568|FG009|Fourth Treatment|Physician Decision|0
7080101|NCT02119676|11189413|FG000|Overall Study|Patient decision, inc. consent withdrawn|4
7080102|NCT02119676|11189414|FG001|Overall Study|Patient decision, inc. consent withdrawn|5
7080103|NCT02119676|11189415|FG002|Overall Study|Patient decision, inc. consent withdrawn|5
7080104|NCT02119676|11189416|FG003|Overall Study|Patient decision, inc. consent withdrawn|6
7080105|NCT02119676|11189413|FG000|Overall Study|Physician Decision|4
7080106|NCT02119676|11189414|FG001|Overall Study|Physician Decision|2
7080107|NCT02119676|11189415|FG002|Overall Study|Physician Decision|3
7080108|NCT02119676|11189416|FG003|Overall Study|Physician Decision|2
7080109|NCT02119676|11189413|FG000|Overall Study|Death|9
7162521|NCT03613649|11338569|FG010|Fourth Treatment|Physician Decision|0
7162522|NCT03613649|11338570|FG011|Fourth Treatment|Physician Decision|0
7162523|NCT03614078|11338600|FG000|Overall Study|Withdrawal by Subject|2
7162524|NCT03614078|11338601|FG001|Overall Study|Withdrawal by Subject|2
7162525|NCT03614078|11338602|FG002|Overall Study|Withdrawal by Subject|3
7162526|NCT03614078|11338600|FG000|Overall Study|Participant Did Not Return for Visit|0
6895124|NCT00622869|10912886|FG000|Overall Study|Missing|0
6895125|NCT00622869|10912887|FG001|Overall Study|Missing|1
6895126|NCT00622869|10912888|FG002|Overall Study|Missing|1
6895127|NCT00622908|10912905|FG000|Overall Study|Protocol Violation|1
6895128|NCT00622908|10912906|FG001|Overall Study|Protocol Violation|0
6895129|NCT00622908|10912905|FG000|Overall Study|Adverse Event|0
6895130|NCT00622908|10912906|FG001|Overall Study|Adverse Event|1
6895131|NCT00622908|10912905|FG000|Overall Study|Lack of Efficacy|1
6895132|NCT00622908|10912906|FG001|Overall Study|Lack of Efficacy|7
6895133|NCT00622908|10912905|FG000|Overall Study|Lost to Follow-up|1
6895134|NCT00622908|10912906|FG001|Overall Study|Lost to Follow-up|0
6895135|NCT00622908|10912905|FG000|Overall Study|Refusal|0
7162527|NCT03614078|11338601|FG001|Overall Study|Participant Did Not Return for Visit|1
7162528|NCT03614078|11338602|FG002|Overall Study|Participant Did Not Return for Visit|0
7162529|NCT03614078|11338600|FG000|Overall Study|High Neutrophils|0
7162530|NCT03614078|11338601|FG001|Overall Study|High Neutrophils|0
7162531|NCT03614078|11338602|FG002|Overall Study|High Neutrophils|2
7162532|NCT03614078|11338600|FG000|Overall Study|Patient Did Not Meet Eligibility|1
7162533|NCT03614078|11338601|FG001|Overall Study|Patient Did Not Meet Eligibility|0
7162534|NCT03614078|11338602|FG002|Overall Study|Patient Did Not Meet Eligibility|0
7162535|NCT03614078|11338600|FG000|Overall Study|Exacerbation of Psoriasis|0
7162536|NCT03614078|11338601|FG001|Overall Study|Exacerbation of Psoriasis|1
7162537|NCT03614078|11338602|FG002|Overall Study|Exacerbation of Psoriasis|0
7162538|NCT03614078|11338600|FG000|Overall Study|Adverse Event|0
7162539|NCT03614078|11338601|FG001|Overall Study|Adverse Event|2
7162540|NCT03614078|11338602|FG002|Overall Study|Adverse Event|0
7162541|NCT03614078|11338600|FG000|Overall Study|Dizziness and Rash|0
7162542|NCT03614078|11338601|FG001|Overall Study|Dizziness and Rash|1
7162543|NCT03614078|11338602|FG002|Overall Study|Dizziness and Rash|0
7162544|NCT03614156|11338624|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6
7162545|NCT03614156|11338625|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0
7162546|NCT03614156|11338626|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0
7162547|NCT03614156|11338627|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0
7162548|NCT03614156|11338624|FG000|Open-Label Treatment Period|Adverse Event|7
7162549|NCT03614156|11338625|FG001|Open-Label Treatment Period|Adverse Event|0
7162550|NCT03614156|11338626|FG002|Open-Label Treatment Period|Adverse Event|0
7162551|NCT03614156|11338627|FG003|Open-Label Treatment Period|Adverse Event|0
7162552|NCT03614156|11338624|FG000|Open-Label Treatment Period|Lack of Efficacy|18
7162553|NCT03614156|11338625|FG001|Open-Label Treatment Period|Lack of Efficacy|0
7162554|NCT03614156|11338626|FG002|Open-Label Treatment Period|Lack of Efficacy|0
7162555|NCT03614156|11338627|FG003|Open-Label Treatment Period|Lack of Efficacy|0
7162556|NCT03614156|11338624|FG000|Open-Label Treatment Period|Withdrawal by Subject|36
7162557|NCT03614156|11338625|FG001|Open-Label Treatment Period|Withdrawal by Subject|0
7162558|NCT03614156|11338626|FG002|Open-Label Treatment Period|Withdrawal by Subject|0
7162559|NCT03614156|11338627|FG003|Open-Label Treatment Period|Withdrawal by Subject|0
7162560|NCT03614156|11338624|FG000|Open-Label Treatment Period|Lost to Follow-up|10
7162561|NCT03614156|11338625|FG001|Open-Label Treatment Period|Lost to Follow-up|0
7162562|NCT03614156|11338626|FG002|Open-Label Treatment Period|Lost to Follow-up|0
7162563|NCT03614156|11338627|FG003|Open-Label Treatment Period|Lost to Follow-up|0
7162564|NCT03614156|11338624|FG000|Open-Label Treatment Period|Protocol Violation|2
7162565|NCT03614156|11338625|FG001|Open-Label Treatment Period|Protocol Violation|0
7162566|NCT03614156|11338626|FG002|Open-Label Treatment Period|Protocol Violation|0
7162567|NCT03614156|11338627|FG003|Open-Label Treatment Period|Protocol Violation|0
7162568|NCT03614156|11338624|FG000|Open-Label Treatment Period|Non-compliance with study drug|1
7162569|NCT03614156|11338625|FG001|Open-Label Treatment Period|Non-compliance with study drug|0
7162570|NCT03614156|11338626|FG002|Open-Label Treatment Period|Non-compliance with study drug|0
7162571|NCT03614156|11338627|FG003|Open-Label Treatment Period|Non-compliance with study drug|0
7162572|NCT03614156|11338624|FG000|Open-Label Treatment Period|Study terminated by sponsor|74
7162573|NCT03614156|11338625|FG001|Open-Label Treatment Period|Study terminated by sponsor|0
7162574|NCT03614156|11338626|FG002|Open-Label Treatment Period|Study terminated by sponsor|0
7162575|NCT03614156|11338627|FG003|Open-Label Treatment Period|Study terminated by sponsor|0
7162576|NCT03614156|11338624|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0
7162577|NCT03614156|11338625|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2
7162578|NCT03614156|11338626|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0
7162579|NCT03614156|11338627|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1
7162580|NCT03614156|11338624|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0
6895136|NCT00622908|10912906|FG001|Overall Study|Refusal|1
6895137|NCT00622908|10912905|FG000|Overall Study|Termination by study sponser|0
6895138|NCT00622908|10912906|FG001|Overall Study|Termination by study sponser|1
6895139|NCT00623103|10912918|FG000|Overall Study|Adverse Event|70
6895140|NCT00623103|10912919|FG001|Overall Study|Adverse Event|60
7044866|NCT01759407|11131024|FG000|Overall Study|Protocol Violation|0
7162581|NCT03614156|11338625|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4
7162582|NCT03614156|11338626|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1
7162583|NCT03614156|11338627|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1
7162584|NCT03614156|11338624|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0
7162585|NCT03614156|11338625|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0
7162586|NCT03614156|11338626|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3
7162587|NCT03614156|11338627|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4
7162588|NCT03614156|11338624|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0
7162589|NCT03614156|11338625|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1
7162590|NCT03614156|11338626|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1
7162591|NCT03614156|11338627|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1
7162592|NCT03614156|11338624|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0
7162593|NCT03614156|11338625|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22
7162594|NCT03614156|11338626|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26
7162595|NCT03614156|11338627|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38
7162596|NCT03614156|11338624|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0
7162597|NCT03614156|11338625|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1
7162598|NCT03614156|11338626|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0
7162599|NCT03614156|11338627|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0
7162600|NCT03614156|11338624|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2
7162601|NCT03614156|11338625|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0
7162602|NCT03614156|11338626|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0
7162603|NCT03614156|11338627|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0
7162604|NCT03614156|11338624|FG000|Safety Follow-Up Period|Withdrawal by Subject|0
7162605|NCT03614156|11338625|FG001|Safety Follow-Up Period|Withdrawal by Subject|0
7162606|NCT03614156|11338626|FG002|Safety Follow-Up Period|Withdrawal by Subject|1
7162607|NCT03614156|11338627|FG003|Safety Follow-Up Period|Withdrawal by Subject|0
7162608|NCT03614156|11338624|FG000|Safety Follow-Up Period|Lost to Follow-up|1
7162609|NCT03614156|11338625|FG001|Safety Follow-Up Period|Lost to Follow-up|0
7162610|NCT03614156|11338626|FG002|Safety Follow-Up Period|Lost to Follow-up|0
7162611|NCT03614156|11338627|FG003|Safety Follow-Up Period|Lost to Follow-up|1
7162612|NCT03614975|11338644|FG000|Overall Study|Physician Decision|7
7162613|NCT03614975|11338645|FG001|Overall Study|Physician Decision|5
7162614|NCT03614975|11338644|FG000|Overall Study|Withdrawal by Subject|2
7162615|NCT03614975|11338645|FG001|Overall Study|Withdrawal by Subject|2
7162616|NCT03614975|11338644|FG000|Overall Study|Specimens not in lab batch shipment|1
7162617|NCT03614975|11338645|FG001|Overall Study|Specimens not in lab batch shipment|1
7162618|NCT03615404|11338676|FG000|Overall Study|Death|1
7162619|NCT03615404|11338676|FG000|Overall Study|vaccine did not pass quality assurance|1
7162620|NCT03615482|11338682|FG000|Overall Study|Death|1
7162621|NCT03615482|11338683|FG001|Overall Study|Death|0
7162622|NCT03615482|11338682|FG000|Overall Study|Lost to Follow-up|7
7162623|NCT03615482|11338683|FG001|Overall Study|Lost to Follow-up|7
7162624|NCT03615482|11338682|FG000|Overall Study|Physician Decision|2
7162625|NCT03615482|11338683|FG001|Overall Study|Physician Decision|3
7162626|NCT03615482|11338682|FG000|Overall Study|Withdrawal by Subject|7
7162627|NCT03615482|11338683|FG001|Overall Study|Withdrawal by Subject|7
7162628|NCT03615924|11338728|FG000|Overall Study|Withdrawal by Subject|2
7162629|NCT03615924|11338729|FG001|Overall Study|Withdrawal by Subject|5
7162630|NCT03615924|11338728|FG000|Overall Study|Death|3
7162631|NCT03615924|11338729|FG001|Overall Study|Death|1
7162632|NCT03615924|11338728|FG000|Overall Study|Lost to Follow-up|1
7162633|NCT03615924|11338729|FG001|Overall Study|Lost to Follow-up|0
7162634|NCT03615924|11338728|FG000|Overall Study|Randomized in error|1
7162635|NCT03615924|11338729|FG001|Overall Study|Randomized in error|0
7162636|NCT03615924|11338728|FG000|Overall Study|Study termination by Sponsor|94
7162637|NCT03615924|11338729|FG001|Overall Study|Study termination by Sponsor|86
7162638|NCT03616106|11338737|FG000|Overall Study|Removed by PI|6
7162639|NCT03616106|11338738|FG001|Overall Study|Removed by PI|0
7162640|NCT03616106|11338737|FG000|Overall Study|Withdrawal by Subject|1
7162641|NCT03616106|11338738|FG001|Overall Study|Withdrawal by Subject|1
7162642|NCT03616106|11338737|FG000|Overall Study|Lost to Follow-up|7
7162643|NCT03616106|11338738|FG001|Overall Study|Lost to Follow-up|0
7162644|NCT03616600|11338755|FG000|Overall Study|Withdrawal by Subject|1
7162645|NCT03616600|11338756|FG001|Overall Study|Withdrawal by Subject|0
7162646|NCT03616977|11338772|FG000|Period 1|Physician Decision|0
7162647|NCT03616977|11338773|FG001|Period 1|Physician Decision|1
7162648|NCT03616977|11338772|FG000|Period 3|Adverse Event|1
7162649|NCT03616977|11338773|FG001|Period 3|Adverse Event|1
7162650|NCT03617588|11338786|FG000|Overall Study|Withdrawal by Subject|1
7162651|NCT03617588|11338787|FG001|Overall Study|Withdrawal by Subject|0
7162652|NCT03617770|11338799|FG000|Overall Study|Lost to Follow-up|1
7162653|NCT03617770|11338800|FG001|Overall Study|Lost to Follow-up|0
7162654|NCT03617861|11338808|FG000|Second Intervention (1 Day)|Adverse Event|0
7162655|NCT03617861|11338809|FG001|Second Intervention (1 Day)|Adverse Event|0
7162656|NCT03617861|11338810|FG002|Second Intervention (1 Day)|Adverse Event|1
7162657|NCT03617861|11338811|FG003|Second Intervention (1 Day)|Adverse Event|0
7162658|NCT03618628|11338863|FG000|Overall Study|Death|1
7162659|NCT03618628|11338863|FG000|Overall Study|Lost to Follow-up|1
7162660|NCT03618823|11338869|FG000|Overall Study|Lost to Follow-up|63
7162661|NCT03618823|11338870|FG001|Overall Study|Lost to Follow-up|61
7162662|NCT03619837|11338896|FG000|Screening|received organs from HCV-negative donors|47
7162663|NCT03619837|11338896|FG000|Screening|died on the wait-list|2
7162664|NCT03619837|11338896|FG000|Screening|remained on the wait list|40
7162665|NCT03619837|11338896|FG000|Screening|didn't meet eligibility criteria|3
7162666|NCT03619837|11338896|FG000|Screening|withdrew consent|2
7162667|NCT03619837|11338896|FG000|Screening|never listed for HCV-viremic donor|1
7162668|NCT03619837|11338896|FG000|Screening|developed exclusion criteria|2
7162669|NCT03619837|11338896|FG000|Screening|excluded by the investigator due to non-compliance|1
7162670|NCT03620162|11338914|FG000|Overall Study|Physician Decision|4
7162671|NCT03620162|11338915|FG001|Overall Study|Physician Decision|0
7162672|NCT03620162|11338916|FG002|Overall Study|Physician Decision|1
7162673|NCT03620162|11338917|FG003|Overall Study|Physician Decision|0
7162674|NCT03620162|11338918|FG004|Overall Study|Physician Decision|2
7162675|NCT03620162|11338914|FG000|Overall Study|Lost to Follow-up|2
7162676|NCT03620162|11338915|FG001|Overall Study|Lost to Follow-up|6
7162677|NCT03620162|11338916|FG002|Overall Study|Lost to Follow-up|7
7162678|NCT03620162|11338917|FG003|Overall Study|Lost to Follow-up|3
7162679|NCT03620162|11338918|FG004|Overall Study|Lost to Follow-up|2
7162680|NCT03620162|11338914|FG000|Overall Study|Consent withdrawn by parent/guardian|9
7162681|NCT03620162|11338915|FG001|Overall Study|Consent withdrawn by parent/guardian|8
7162682|NCT03620162|11338916|FG002|Overall Study|Consent withdrawn by parent/guardian|25
7162683|NCT03620162|11338917|FG003|Overall Study|Consent withdrawn by parent/guardian|17
7162684|NCT03620162|11338918|FG004|Overall Study|Consent withdrawn by parent/guardian|9
7162685|NCT03620708|11338944|FG000|Overall Study|Lost to Follow-up|1
7162686|NCT03620708|11338945|FG001|Overall Study|Lost to Follow-up|1
7162687|NCT03620708|11338946|FG002|Overall Study|Lost to Follow-up|2
7162688|NCT03620708|11338944|FG000|Overall Study|Withdrawal by Subject|0
7162689|NCT03620708|11338945|FG001|Overall Study|Withdrawal by Subject|0
7162690|NCT03620708|11338946|FG002|Overall Study|Withdrawal by Subject|1
7162691|NCT03621189|11338972|FG000|Overall Study|Withdrawal by Subject|0
7162692|NCT03621189|11338973|FG001|Overall Study|Withdrawal by Subject|3
7162693|NCT03621189|11338972|FG000|Overall Study|Physician Decision|0
7162694|NCT03621189|11338973|FG001|Overall Study|Physician Decision|2
7162695|NCT03622112|11339008|FG000|Overall Study|Withdrawal by Subject|6
7162696|NCT03622112|11339009|FG001|Overall Study|Withdrawal by Subject|2
7162697|NCT03622112|11339010|FG002|Overall Study|Withdrawal by Subject|4
7162698|NCT03622112|11339011|FG003|Overall Study|Withdrawal by Subject|2
7162699|NCT03622112|11339012|FG004|Overall Study|Withdrawal by Subject|1
7080110|NCT02119676|11189414|FG001|Overall Study|Death|3
7080111|NCT02119676|11189415|FG002|Overall Study|Death|2
7080112|NCT02119676|11189416|FG003|Overall Study|Death|1
7080113|NCT02119676|11189413|FG000|Overall Study|Noncompliance|0
7080114|NCT02119676|11189414|FG001|Overall Study|Noncompliance|1
7162700|NCT03622112|11339013|FG005|Overall Study|Withdrawal by Subject|2
7162701|NCT03622112|11339014|FG006|Overall Study|Withdrawal by Subject|2
7162702|NCT03622112|11339008|FG000|Overall Study|Death|0
7162703|NCT03622112|11339009|FG001|Overall Study|Death|0
7162704|NCT03622112|11339010|FG002|Overall Study|Death|0
7162705|NCT03622112|11339011|FG003|Overall Study|Death|1
7162706|NCT03622112|11339012|FG004|Overall Study|Death|0
7162707|NCT03622112|11339013|FG005|Overall Study|Death|0
7080115|NCT02119676|11189415|FG002|Overall Study|Noncompliance|0
7162708|NCT03622112|11339014|FG006|Overall Study|Death|0
7162709|NCT03622112|11339008|FG000|Overall Study|Lost to Follow-up|1
7162710|NCT03622112|11339009|FG001|Overall Study|Lost to Follow-up|1
7162711|NCT03622112|11339010|FG002|Overall Study|Lost to Follow-up|0
7162712|NCT03622112|11339011|FG003|Overall Study|Lost to Follow-up|0
7162713|NCT03622112|11339012|FG004|Overall Study|Lost to Follow-up|0
7162714|NCT03622112|11339013|FG005|Overall Study|Lost to Follow-up|0
7080116|NCT02119676|11189416|FG003|Overall Study|Noncompliance|0
7162715|NCT03622112|11339014|FG006|Overall Study|Lost to Follow-up|0
7162716|NCT03622112|11339008|FG000|Overall Study|Study-specific withdrawal criteria|10
7162717|NCT03622112|11339009|FG001|Overall Study|Study-specific withdrawal criteria|8
7162718|NCT03622112|11339010|FG002|Overall Study|Study-specific withdrawal criteria|7
7162719|NCT03622112|11339011|FG003|Overall Study|Study-specific withdrawal criteria|6
7162720|NCT03622112|11339012|FG004|Overall Study|Study-specific withdrawal criteria|4
7162721|NCT03622112|11339013|FG005|Overall Study|Study-specific withdrawal criteria|18
7162722|NCT03622112|11339014|FG006|Overall Study|Study-specific withdrawal criteria|4
7162723|NCT03622112|11339008|FG000|Overall Study|Protocol Violation|2
7162724|NCT03622112|11339009|FG001|Overall Study|Protocol Violation|0
7162725|NCT03622112|11339010|FG002|Overall Study|Protocol Violation|1
7162726|NCT03622112|11339011|FG003|Overall Study|Protocol Violation|1
7162727|NCT03622112|11339012|FG004|Overall Study|Protocol Violation|0
7080117|NCT02119676|11189413|FG000|Overall Study|Lost to Follow-up|0
7162728|NCT03622112|11339013|FG005|Overall Study|Protocol Violation|0
7162729|NCT03622112|11339014|FG006|Overall Study|Protocol Violation|0
7162730|NCT03622112|11339008|FG000|Overall Study|Adverse Event|6
7162731|NCT03622112|11339009|FG001|Overall Study|Adverse Event|8
7162732|NCT03622112|11339010|FG002|Overall Study|Adverse Event|4
7162733|NCT03622112|11339011|FG003|Overall Study|Adverse Event|11
7080118|NCT02119676|11189414|FG001|Overall Study|Lost to Follow-up|0
7162734|NCT03622112|11339012|FG004|Overall Study|Adverse Event|4
7162735|NCT03622112|11339013|FG005|Overall Study|Adverse Event|20
7162736|NCT03622112|11339014|FG006|Overall Study|Adverse Event|2
7162737|NCT03622112|11339008|FG000|Overall Study|Reason not specified|0
7162738|NCT03622112|11339009|FG001|Overall Study|Reason not specified|1
7162739|NCT03622112|11339010|FG002|Overall Study|Reason not specified|0
7162740|NCT03622112|11339011|FG003|Overall Study|Reason not specified|1
7162741|NCT03622112|11339012|FG004|Overall Study|Reason not specified|1
7162742|NCT03622112|11339013|FG005|Overall Study|Reason not specified|2
7162743|NCT03622112|11339014|FG006|Overall Study|Reason not specified|1
7162744|NCT03624192|11339067|FG000|Overall Study|Lost to Follow-up|1
7162745|NCT03624192|11339068|FG001|Overall Study|Lost to Follow-up|1
7162746|NCT03624504|11339076|FG000|Overall Study|Unsuccessful Implant|1
7162747|NCT03624946|11339101|FG000|Overall Study|Lost to Follow-up|0
7162748|NCT03624946|11339102|FG001|Overall Study|Lost to Follow-up|1
7162749|NCT03624972|11339115|FG000|Overall Study|Lost to Follow-up|2
7162750|NCT03624972|11339116|FG001|Overall Study|Lost to Follow-up|0
7162751|NCT03624972|11339117|FG002|Overall Study|Lost to Follow-up|0
7162752|NCT03624972|11339115|FG000|Overall Study|Withdrawal by Subject|0
7162753|NCT03624972|11339116|FG001|Overall Study|Withdrawal by Subject|2
7162754|NCT03624972|11339117|FG002|Overall Study|Withdrawal by Subject|0
7162755|NCT03627065|11339152|FG000|Overall Study|Study Terminated by sponsor|1
7162756|NCT03627065|11339152|FG000|Overall Study|Withdrawal by Subject|2
7162757|NCT03627195|11339162|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1
7162758|NCT03627195|11339163|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0
7162759|NCT03627195|11339164|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0
7162760|NCT03627195|11339165|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0
7162761|NCT03627195|11339166|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0
7162762|NCT03627195|11339167|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0
7162763|NCT03627416|11339187|FG000|Overall Study|Adverse Event|0
7162764|NCT03627416|11339188|FG001|Overall Study|Adverse Event|1
7162765|NCT03627494|11339206|FG000|Part A Washout 2 (7 Days)|Adverse Event|1
7162766|NCT03627494|11339207|FG001|Part A Washout 2 (7 Days)|Adverse Event|0
7162767|NCT03627494|11339208|FG002|Part A Washout 2 (7 Days)|Adverse Event|1
7162768|NCT03627494|11339209|FG003|Part A Washout 2 (7 Days)|Adverse Event|0
7162769|NCT03627494|11339210|FG004|Part A Washout 2 (7 Days)|Adverse Event|0
7162770|NCT03627494|11339211|FG005|Part A Washout 2 (7 Days)|Adverse Event|0
7162771|NCT03627494|11339212|FG006|Part A Washout 2 (7 Days)|Adverse Event|0
7162772|NCT03627494|11339213|FG007|Part A Washout 2 (7 Days)|Adverse Event|0
7162773|NCT03627494|11339214|FG008|Part A Washout 2 (7 Days)|Adverse Event|0
7162774|NCT03627494|11339215|FG009|Part A Washout 2 (7 Days)|Adverse Event|0
7162775|NCT03627494|11339216|FG010|Part A Washout 2 (7 Days)|Adverse Event|0
7162776|NCT03627494|11339217|FG011|Part A Washout 2 (7 Days)|Adverse Event|0
7162777|NCT03627494|11339206|FG000|Part B (Maximum of 34 Days)|Adverse Event|0
7162778|NCT03627494|11339207|FG001|Part B (Maximum of 34 Days)|Adverse Event|0
7162779|NCT03627494|11339208|FG002|Part B (Maximum of 34 Days)|Adverse Event|0
7162780|NCT03627494|11339209|FG003|Part B (Maximum of 34 Days)|Adverse Event|0
7162781|NCT03627494|11339210|FG004|Part B (Maximum of 34 Days)|Adverse Event|0
7162782|NCT03627494|11339211|FG005|Part B (Maximum of 34 Days)|Adverse Event|0
7162783|NCT03627494|11339212|FG006|Part B (Maximum of 34 Days)|Adverse Event|0
7162784|NCT03627494|11339213|FG007|Part B (Maximum of 34 Days)|Adverse Event|0
7162785|NCT03627494|11339214|FG008|Part B (Maximum of 34 Days)|Adverse Event|2
7162786|NCT03627494|11339215|FG009|Part B (Maximum of 34 Days)|Adverse Event|0
6895141|NCT00623103|10912918|FG000|Overall Study|Unsatisfactory therapeutic effect|4
6895142|NCT00623103|10912919|FG001|Overall Study|Unsatisfactory therapeutic effect|12
6895143|NCT00623103|10912918|FG000|Overall Study|Withdrawal by Subject|18
6895144|NCT00623103|10912919|FG001|Overall Study|Withdrawal by Subject|24
7162787|NCT03627494|11339216|FG010|Part B (Maximum of 34 Days)|Adverse Event|0
7162788|NCT03627494|11339217|FG011|Part B (Maximum of 34 Days)|Adverse Event|0
7162789|NCT03627494|11339206|FG000|Part C Washout 1 (7 Days)|Adverse Event|0
7162790|NCT03627494|11339207|FG001|Part C Washout 1 (7 Days)|Adverse Event|0
7162791|NCT03627494|11339208|FG002|Part C Washout 1 (7 Days)|Adverse Event|0
7162792|NCT03627494|11339209|FG003|Part C Washout 1 (7 Days)|Adverse Event|0
7162793|NCT03627494|11339210|FG004|Part C Washout 1 (7 Days)|Adverse Event|0
7162794|NCT03627494|11339211|FG005|Part C Washout 1 (7 Days)|Adverse Event|0
7162795|NCT03627494|11339212|FG006|Part C Washout 1 (7 Days)|Adverse Event|0
7162796|NCT03627494|11339213|FG007|Part C Washout 1 (7 Days)|Adverse Event|0
7162797|NCT03627494|11339214|FG008|Part C Washout 1 (7 Days)|Adverse Event|0
7162798|NCT03627494|11339215|FG009|Part C Washout 1 (7 Days)|Adverse Event|0
7162799|NCT03627494|11339216|FG010|Part C Washout 1 (7 Days)|Adverse Event|1
7162800|NCT03627494|11339217|FG011|Part C Washout 1 (7 Days)|Adverse Event|1
7162801|NCT03627767|11339259|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48
7162802|NCT03627767|11339260|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0
7162803|NCT03627767|11339261|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0
7162804|NCT03627767|11339262|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0
7162805|NCT03627767|11339263|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0
7162806|NCT03627767|11339259|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1
7162807|NCT03627767|11339260|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0
6895145|NCT00623103|10912918|FG000|Overall Study|Lost to Follow-up|4
7162808|NCT03627767|11339261|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0
6895146|NCT00623103|10912919|FG001|Overall Study|Lost to Follow-up|1
7162809|NCT03627767|11339262|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0
7162810|NCT03627767|11339263|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0
6895147|NCT00623103|10912918|FG000|Overall Study|Administrative problems|2
6895148|NCT00623103|10912919|FG001|Overall Study|Administrative problems|4
7162811|NCT03627767|11339259|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315
7162812|NCT03627767|11339260|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0
7162813|NCT03627767|11339261|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0
7162814|NCT03627767|11339262|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0
7162815|NCT03627767|11339263|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0
7162816|NCT03627767|11339259|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13
7162817|NCT03627767|11339260|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0
7162818|NCT03627767|11339261|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0
7162819|NCT03627767|11339262|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0
7162820|NCT03627767|11339263|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0
7162821|NCT03627767|11339259|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11
7162822|NCT03627767|11339260|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0
7162823|NCT03627767|11339261|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0
7162824|NCT03627767|11339262|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0
7162825|NCT03627767|11339263|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0
7162826|NCT03627767|11339259|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40
7162827|NCT03627767|11339260|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0
7162828|NCT03627767|11339261|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0
7162829|NCT03627767|11339262|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0
7162830|NCT03627767|11339263|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0
7162831|NCT03627767|11339259|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1
7162832|NCT03627767|11339260|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0
7162833|NCT03627767|11339261|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0
7162834|NCT03627767|11339262|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0
7162835|NCT03627767|11339263|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0
7162836|NCT03627767|11339259|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2
7162837|NCT03627767|11339260|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0
7162838|NCT03627767|11339261|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0
7162839|NCT03627767|11339262|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0
7162840|NCT03627767|11339263|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0
7162841|NCT03627767|11339259|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4
7162842|NCT03627767|11339260|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0
7162843|NCT03627767|11339261|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0
7162844|NCT03627767|11339262|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0
7162845|NCT03627767|11339263|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0
7162846|NCT03627767|11339259|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2
7162847|NCT03627767|11339260|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0
7162848|NCT03627767|11339261|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0
7162849|NCT03627767|11339262|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0
7162850|NCT03627767|11339263|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0
7162851|NCT03627767|11339259|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0
7162852|NCT03627767|11339260|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6
7162853|NCT03627767|11339261|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7
7162854|NCT03627767|11339262|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19
7162855|NCT03627767|11339263|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0
7162856|NCT03627767|11339259|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0
7162857|NCT03627767|11339260|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0
7162858|NCT03627767|11339261|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2
7162859|NCT03627767|11339262|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3
7162860|NCT03627767|11339263|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0
7162861|NCT03627767|11339259|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0
7162862|NCT03627767|11339260|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1
7162863|NCT03627767|11339261|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5
7162864|NCT03627767|11339262|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2
7162865|NCT03627767|11339263|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0
7162866|NCT03627767|11339259|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0
7162867|NCT03627767|11339260|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9
7162868|NCT03627767|11339261|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6
7162869|NCT03627767|11339262|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10
7162870|NCT03627767|11339263|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0
6895149|NCT00623103|10912918|FG000|Overall Study|Death|11
7162871|NCT03627767|11339259|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0
7162872|NCT03627767|11339260|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0
7162873|NCT03627767|11339261|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1
7162874|NCT03627767|11339262|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0
7162875|NCT03627767|11339263|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0
7162876|NCT03627767|11339259|FG000|Double-blind Treatment Period (40 Weeks)|Other|0
7162877|NCT03627767|11339260|FG001|Double-blind Treatment Period (40 Weeks)|Other|0
7162878|NCT03627767|11339261|FG002|Double-blind Treatment Period (40 Weeks)|Other|1
7162879|NCT03627767|11339262|FG003|Double-blind Treatment Period (40 Weeks)|Other|1
7162880|NCT03627767|11339263|FG004|Double-blind Treatment Period (40 Weeks)|Other|0
7162881|NCT03627767|11339259|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0
7162882|NCT03627767|11339260|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0
7162883|NCT03627767|11339261|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0
7162884|NCT03627767|11339262|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0
7162885|NCT03627767|11339263|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9
7162886|NCT03627767|11339259|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0
7162887|NCT03627767|11339260|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0
7162888|NCT03627767|11339261|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0
7162889|NCT03627767|11339262|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0
7162890|NCT03627767|11339263|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1
7162891|NCT03627767|11339259|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0
7162892|NCT03627767|11339260|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0
7162893|NCT03627767|11339261|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0
7162894|NCT03627767|11339262|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0
7162895|NCT03627767|11339263|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9
7080119|NCT02119676|11189415|FG002|Overall Study|Lost to Follow-up|1
7080120|NCT02119676|11189416|FG003|Overall Study|Lost to Follow-up|0
7080121|NCT02119676|11189413|FG000|Overall Study|Protocol deviation|0
7080122|NCT02119676|11189414|FG001|Overall Study|Protocol deviation|0
7080123|NCT02119676|11189415|FG002|Overall Study|Protocol deviation|1
7080124|NCT02119676|11189416|FG003|Overall Study|Protocol deviation|0
7080125|NCT02119676|11189413|FG000|Overall Study|Other, unspecified|2
7080126|NCT02119676|11189414|FG001|Overall Study|Other, unspecified|1
7080127|NCT02119676|11189415|FG002|Overall Study|Other, unspecified|3
7080128|NCT02119676|11189416|FG003|Overall Study|Other, unspecified|4
7080129|NCT02119676|11189413|FG000|Overall Study|Did not receive study med|2
7080130|NCT02119676|11189414|FG001|Overall Study|Did not receive study med|2
7080131|NCT02119676|11189415|FG002|Overall Study|Did not receive study med|4
7080132|NCT02119676|11189416|FG003|Overall Study|Did not receive study med|5
7080133|NCT02119819|11189432|FG000|Overall Study|Adverse Event|3
7080134|NCT02119819|11189433|FG001|Overall Study|Adverse Event|1
7080135|NCT02119819|11189434|FG002|Overall Study|Adverse Event|2
7080136|NCT02119819|11189435|FG003|Overall Study|Adverse Event|3
7080137|NCT02119819|11189436|FG004|Overall Study|Adverse Event|0
7080138|NCT02119819|11189437|FG005|Overall Study|Adverse Event|1
7080139|NCT02119819|11189432|FG000|Overall Study|Lack of Efficacy|0
7080140|NCT02119819|11189433|FG001|Overall Study|Lack of Efficacy|0
7080141|NCT02119819|11189434|FG002|Overall Study|Lack of Efficacy|0
7080142|NCT02119819|11189435|FG003|Overall Study|Lack of Efficacy|0
7080143|NCT02119819|11189436|FG004|Overall Study|Lack of Efficacy|0
7080144|NCT02119819|11189437|FG005|Overall Study|Lack of Efficacy|1
7080145|NCT02119819|11189432|FG000|Overall Study|Lost to Follow-up|0
7080146|NCT02119819|11189433|FG001|Overall Study|Lost to Follow-up|0
7080147|NCT02119819|11189434|FG002|Overall Study|Lost to Follow-up|1
7080148|NCT02119819|11189435|FG003|Overall Study|Lost to Follow-up|2
7080149|NCT02119819|11189436|FG004|Overall Study|Lost to Follow-up|1
7080150|NCT02119819|11189437|FG005|Overall Study|Lost to Follow-up|2
7080151|NCT02119819|11189432|FG000|Overall Study|Physician Decision|1
7080152|NCT02119819|11189433|FG001|Overall Study|Physician Decision|1
7080153|NCT02119819|11189434|FG002|Overall Study|Physician Decision|0
7080154|NCT02119819|11189435|FG003|Overall Study|Physician Decision|0
7080155|NCT02119819|11189436|FG004|Overall Study|Physician Decision|0
7080156|NCT02119819|11189437|FG005|Overall Study|Physician Decision|1
7080157|NCT02119819|11189432|FG000|Overall Study|Withdrawal by Subject|5
7080158|NCT02119819|11189433|FG001|Overall Study|Withdrawal by Subject|3
7080159|NCT02119819|11189434|FG002|Overall Study|Withdrawal by Subject|0
7080160|NCT02119819|11189435|FG003|Overall Study|Withdrawal by Subject|0
7080161|NCT02119819|11189436|FG004|Overall Study|Withdrawal by Subject|6
7080162|NCT02119819|11189437|FG005|Overall Study|Withdrawal by Subject|10
7080163|NCT02119819|11189432|FG000|Overall Study|Jury Duty|0
7080164|NCT02119819|11189433|FG001|Overall Study|Jury Duty|0
7080165|NCT02119819|11189434|FG002|Overall Study|Jury Duty|1
7080166|NCT02119819|11189435|FG003|Overall Study|Jury Duty|0
7080167|NCT02119819|11189436|FG004|Overall Study|Jury Duty|0
7080168|NCT02119819|11189437|FG005|Overall Study|Jury Duty|0
7080169|NCT02119819|11189432|FG000|Overall Study|Protocol Violation|0
7080170|NCT02119819|11189433|FG001|Overall Study|Protocol Violation|0
7080171|NCT02119819|11189434|FG002|Overall Study|Protocol Violation|0
7080172|NCT02119819|11189435|FG003|Overall Study|Protocol Violation|1
6895150|NCT00623103|10912919|FG001|Overall Study|Death|11
6895151|NCT00623103|10912918|FG000|Overall Study|Protocol deviation|2
6895152|NCT00623103|10912919|FG001|Overall Study|Protocol deviation|1
6895153|NCT00623194|10912938|FG000|Overall Study|Lack of Efficacy|1
6895154|NCT00623194|10912938|FG000|Overall Study|Protocol Violation|3
6895155|NCT00623194|10912938|FG000|Overall Study|Unclassified|1
6895156|NCT00623233|10912942|FG000|Overall Study|Adverse Event|10
6895157|NCT00623233|10912942|FG000|Overall Study|Physician Decision|10
6895158|NCT00623233|10912942|FG000|Overall Study|Lost to Follow-up|1
6895159|NCT00623233|10912942|FG000|Overall Study|Withdrawal by Subject|3
6895160|NCT00623363|10912948|FG000|Overall Study|Adverse Event|2
6895161|NCT00623363|10912949|FG001|Overall Study|Adverse Event|2
6895162|NCT00623428|10912958|FG000|Treatment Period|Adverse event/intercurrent illness|0
6895163|NCT00623428|10912959|FG001|Treatment Period|Adverse event/intercurrent illness|9
6895164|NCT00623428|10912958|FG000|Treatment Period|Death|0
6895165|NCT00623428|10912959|FG001|Treatment Period|Death|1
6895166|NCT00623428|10912958|FG000|Treatment Period|Did not cooperate / refused treatment|0
6895167|NCT00623428|10912959|FG001|Treatment Period|Did not cooperate / refused treatment|13
6895168|NCT00623428|10912958|FG000|Treatment Period|Insufficient therapeutic response|0
6895169|NCT00623428|10912959|FG001|Treatment Period|Insufficient therapeutic response|2
6895170|NCT00623428|10912958|FG000|Treatment Period|Other|0
6895171|NCT00623428|10912959|FG001|Treatment Period|Other|1
6895172|NCT00623428|10912958|FG000|Treatment Period|Withdrawal by Subject|0
6895173|NCT00623428|10912959|FG001|Treatment Period|Withdrawal by Subject|1
6895174|NCT00623428|10912958|FG000|Follow-up Period|Relapse post-treatment|11
6895175|NCT00623428|10912959|FG001|Follow-up Period|Relapse post-treatment|3
6895176|NCT00623428|10912958|FG000|Follow-up Period|Failure to return|10
6895177|NCT00623428|10912959|FG001|Follow-up Period|Failure to return|2
7162896|NCT03627767|11339259|FG000|Open-label Rescue Period (12 Weeks)|Other|0
7162897|NCT03627767|11339260|FG001|Open-label Rescue Period (12 Weeks)|Other|0
7162898|NCT03627767|11339261|FG002|Open-label Rescue Period (12 Weeks)|Other|0
7162899|NCT03627767|11339262|FG003|Open-label Rescue Period (12 Weeks)|Other|0
7162900|NCT03627767|11339263|FG004|Open-label Rescue Period (12 Weeks)|Other|1
7162901|NCT03627832|11339276|FG000|Overall Study|Withdrawal by Subject|10
7162902|NCT03627832|11339277|FG001|Overall Study|Withdrawal by Subject|1
7162903|NCT03628417|11339283|FG000|Overall Study|Death|1
7162904|NCT03628417|11339284|FG001|Overall Study|Death|1
7162905|NCT03628508|11339302|FG000|Overall Study|Lost to Follow-up|1
7162906|NCT03628599|11339308|FG000|Overall Study|Adverse Event|0
7162907|NCT03628599|11339309|FG001|Overall Study|Adverse Event|1
7162908|NCT03628898|11339332|FG000|Overall Study|Device deficiency|1
7162909|NCT03628924|11339339|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2
7162910|NCT03628924|11339340|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
7162911|NCT03628924|11339341|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
7162912|NCT03628924|11339342|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
7162913|NCT03628924|11339343|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
7162914|NCT03628924|11339344|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
7162915|NCT03628924|11339345|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
7162916|NCT03628924|11339339|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
7162917|NCT03628924|11339340|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
7162918|NCT03628924|11339341|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1
7162919|NCT03628924|11339342|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
7162920|NCT03628924|11339343|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
7162921|NCT03628924|11339344|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
7162922|NCT03628924|11339345|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
7162923|NCT03628924|11339339|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1
7162924|NCT03628924|11339340|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2
7162925|NCT03628924|11339341|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1
7162926|NCT03628924|11339342|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0
7162927|NCT03628924|11339343|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0
7162928|NCT03628924|11339344|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0
7162929|NCT03628924|11339345|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0
7162930|NCT03628924|11339339|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
7162931|NCT03628924|11339340|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1
7162932|NCT03628924|11339341|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
7162933|NCT03628924|11339342|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
7162934|NCT03628924|11339343|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
7162935|NCT03628924|11339344|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
7162936|NCT03628924|11339345|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
6895178|NCT00623428|10912958|FG000|Follow-up Period|Patient withdrew consent|5
6895179|NCT00623428|10912959|FG001|Follow-up Period|Patient withdrew consent|4
6895180|NCT00623428|10912958|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2
6895181|NCT00623428|10912959|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1
6895182|NCT00623428|10912958|FG000|Follow-up Period|Did not cooperate|0
6895183|NCT00623428|10912959|FG001|Follow-up Period|Did not cooperate|3
6895184|NCT00623428|10912958|FG000|Follow-up Period|Reason not specified|1
7162937|NCT03628924|11339339|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3
7162938|NCT03628924|11339340|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0
7162939|NCT03628924|11339341|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1
7162940|NCT03628924|11339342|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0
7162941|NCT03628924|11339343|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0
7162942|NCT03628924|11339344|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0
7162943|NCT03628924|11339345|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0
7162944|NCT03628924|11339339|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0
7162945|NCT03628924|11339340|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0
7162946|NCT03628924|11339341|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0
7162947|NCT03628924|11339342|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1
7162948|NCT03628924|11339343|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1
7162949|NCT03628924|11339344|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2
7162950|NCT03628924|11339345|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1
7162951|NCT03628924|11339339|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0
7162952|NCT03628924|11339340|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0
7162953|NCT03628924|11339341|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0
7162954|NCT03628924|11339342|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1
7162955|NCT03628924|11339343|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0
7162956|NCT03628924|11339344|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2
7162957|NCT03628924|11339345|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4
7162958|NCT03628924|11339339|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0
7162959|NCT03628924|11339340|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0
7162960|NCT03628924|11339341|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0
7162961|NCT03628924|11339342|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1
7162962|NCT03628924|11339343|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1
7162963|NCT03628924|11339344|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0
7162964|NCT03628924|11339345|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1
7162965|NCT03628924|11339339|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0
7162966|NCT03628924|11339340|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0
7162967|NCT03628924|11339341|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0
7162968|NCT03628924|11339342|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5
7162969|NCT03628924|11339343|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1
7162970|NCT03628924|11339344|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4
7162971|NCT03628924|11339345|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2
7162972|NCT03628924|11339339|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0
7162973|NCT03628924|11339340|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0
7162974|NCT03628924|11339341|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0
7162975|NCT03628924|11339342|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0
7162976|NCT03628924|11339343|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1
7162977|NCT03628924|11339344|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5
7162978|NCT03628924|11339345|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3
7162979|NCT03629028|11339359|FG000|Overall Study|Lost to Follow-up|26
7162980|NCT03629028|11339360|FG001|Overall Study|Lost to Follow-up|23
7162981|NCT03629028|11339359|FG000|Overall Study|Pregnancy|4
7162982|NCT03629028|11339360|FG001|Overall Study|Pregnancy|2
7162983|NCT03629028|11339359|FG000|Overall Study|intolerance to examination|2
7162984|NCT03629028|11339360|FG001|Overall Study|intolerance to examination|0
7162985|NCT03629041|11339376|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
7162986|NCT03629041|11339377|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1
7162987|NCT03629041|11339378|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
7162988|NCT03629041|11339379|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
7162989|NCT03629054|11339399|FG000|Period 2 (4 Days)|Not treated|0
7162990|NCT03629054|11339400|FG001|Period 2 (4 Days)|Not treated|1
7162991|NCT03629184|11339408|FG000|Overall Study|Withdrawal by Subject|2
7162992|NCT03629184|11339409|FG001|Overall Study|Withdrawal by Subject|1
7162993|NCT03629184|11339408|FG000|Overall Study|Physician Decision|1
7162994|NCT03629184|11339409|FG001|Overall Study|Physician Decision|0
7162995|NCT03629249|11339418|FG000|Overall Study|Study terminated by sponsor|197
7162996|NCT03629249|11339419|FG001|Overall Study|Study terminated by sponsor|197
7162997|NCT03629249|11339420|FG002|Overall Study|Study terminated by sponsor|194
7162998|NCT03629249|11339418|FG000|Overall Study|Protocol deviation|0
7162999|NCT03629249|11339419|FG001|Overall Study|Protocol deviation|2
7163000|NCT03629249|11339420|FG002|Overall Study|Protocol deviation|5
7163001|NCT03629249|11339418|FG000|Overall Study|Subject decision|1
7163002|NCT03629249|11339419|FG001|Overall Study|Subject decision|1
7163003|NCT03629249|11339420|FG002|Overall Study|Subject decision|3
7163004|NCT03629249|11339418|FG000|Overall Study|Adverse Event|1
7163005|NCT03629249|11339419|FG001|Overall Study|Adverse Event|1
7163006|NCT03629249|11339420|FG002|Overall Study|Adverse Event|0
7163007|NCT03629249|11339418|FG000|Overall Study|Death|1
7163008|NCT03629249|11339419|FG001|Overall Study|Death|0
7163009|NCT03629249|11339420|FG002|Overall Study|Death|0
7163010|NCT03629249|11339418|FG000|Overall Study|Physician Decision|1
7163011|NCT03629249|11339419|FG001|Overall Study|Physician Decision|0
7163012|NCT03629249|11339420|FG002|Overall Study|Physician Decision|0
7163013|NCT03629886|11339434|FG000|Overall Study|Migrated / moved from the study area|0
7163014|NCT03629886|11339435|FG001|Overall Study|Migrated / moved from the study area|55
7163015|NCT03629886|11339434|FG000|Overall Study|Consent withdrawal, not due to an AE|0
7163016|NCT03629886|11339435|FG001|Overall Study|Consent withdrawal, not due to an AE|50
7163017|NCT03629886|11339434|FG000|Overall Study|Study vaccine not administrated|0
7163018|NCT03629886|11339435|FG001|Overall Study|Study vaccine not administrated|3
7163019|NCT03629886|11339434|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0
7163020|NCT03629886|11339435|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28
7163021|NCT03629886|11339434|FG000|Overall Study|Refused vaccination step of the study|0
7163022|NCT03629886|11339435|FG001|Overall Study|Refused vaccination step of the study|44
7184413|NCT03282123|11384578|FG000|Overall Study|Withdrawal by Subject|5
7184414|NCT03112590|11384586|FG000|Overall Study|Adverse Event|0
7184415|NCT03112590|11384587|FG001|Overall Study|Adverse Event|1
7184416|NCT03112590|11384588|FG002|Overall Study|Adverse Event|0
7184417|NCT02862548|11384627|FG000|Randomized Phase (Up to Week 48)|Death|0
7184418|NCT02862548|11384628|FG001|Randomized Phase (Up to Week 48)|Death|1
7184419|NCT02862548|11384627|FG000|OLE Phase (Week 49 to Week 192)|Death|2
7184420|NCT02862548|11384628|FG001|OLE Phase (Week 49 to Week 192)|Death|0
7184421|NCT02862548|11384627|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1
7184422|NCT02862548|11384628|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0
7184423|NCT02862548|11384627|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0
7184424|NCT02862548|11384628|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1
7187488|NCT03938272|11388130|FG000|Overall Study|Withdrawal by Subject|1
7187489|NCT03938272|11388131|FG001|Overall Study|Withdrawal by Subject|0
7187490|NCT03938272|11388130|FG000|Overall Study|Physician Decision|0
7187491|NCT03938272|11388131|FG001|Overall Study|Physician Decision|2
7187492|NCT03938272|11388130|FG000|Overall Study|Study termination by sponsor|10
7187493|NCT03938272|11388131|FG001|Overall Study|Study termination by sponsor|8
7188300|NCT02906020|11388811|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
7188301|NCT02906020|11388812|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
7188302|NCT02906020|11388813|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
7188303|NCT02906020|11388814|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
7188304|NCT02906020|11388815|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
7188305|NCT02906020|11388816|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
7188306|NCT02906020|11388817|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
7188307|NCT02906020|11388818|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
7188308|NCT02906020|11388819|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
7188309|NCT02906020|11388820|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
7188310|NCT02906020|11388821|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
7188311|NCT02906020|11388822|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
7188312|NCT02906020|11388823|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67
7188313|NCT02906020|11388824|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64
7188314|NCT02906020|11388825|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7
7188315|NCT02906020|11388826|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8
7188316|NCT02906020|11388811|FG000|Part 2: Long-term Follow-up Period|Other|0
7188317|NCT02906020|11388812|FG001|Part 2: Long-term Follow-up Period|Other|0
7188318|NCT02906020|11388813|FG002|Part 2: Long-term Follow-up Period|Other|0
7188319|NCT02906020|11388814|FG003|Part 2: Long-term Follow-up Period|Other|0
7188320|NCT02906020|11388815|FG004|Part 2: Long-term Follow-up Period|Other|0
7188321|NCT02906020|11388816|FG005|Part 2: Long-term Follow-up Period|Other|0
7188322|NCT02906020|11388817|FG006|Part 2: Long-term Follow-up Period|Other|0
7188323|NCT02906020|11388818|FG007|Part 2: Long-term Follow-up Period|Other|0
7188324|NCT02906020|11388819|FG008|Part 2: Long-term Follow-up Period|Other|0
7188325|NCT02906020|11388820|FG009|Part 2: Long-term Follow-up Period|Other|0
7188326|NCT02906020|11388821|FG010|Part 2: Long-term Follow-up Period|Other|0
7188327|NCT02906020|11388822|FG011|Part 2: Long-term Follow-up Period|Other|0
7188328|NCT02906020|11388823|FG012|Part 2: Long-term Follow-up Period|Other|13
7188329|NCT02906020|11388824|FG013|Part 2: Long-term Follow-up Period|Other|8
7188330|NCT02906020|11388825|FG014|Part 2: Long-term Follow-up Period|Other|3
7080173|NCT02119819|11189436|FG004|Overall Study|Protocol Violation|0
7080174|NCT02119819|11189437|FG005|Overall Study|Protocol Violation|0
7080175|NCT02119819|11189432|FG000|Overall Study|Left the city to get a job|0
7188331|NCT02906020|11388826|FG015|Part 2: Long-term Follow-up Period|Other|2
7188379|NCT02891226|11388873|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7080176|NCT02119819|11189433|FG001|Overall Study|Left the city to get a job|0
7080177|NCT02119819|11189434|FG002|Overall Study|Left the city to get a job|0
7080178|NCT02119819|11189435|FG003|Overall Study|Left the city to get a job|1
7080179|NCT02119819|11189436|FG004|Overall Study|Left the city to get a job|0
7080180|NCT02119819|11189437|FG005|Overall Study|Left the city to get a job|0
7080181|NCT02119936|11189460|FG000|Overall Study|Lost to Follow-up|10
7080182|NCT02120027|11189475|FG000|Overall Study|Adverse Event|4
7080183|NCT02120027|11189476|FG001|Overall Study|Adverse Event|5
7080184|NCT02120027|11189475|FG000|Overall Study|Lack of Efficacy|3
7080185|NCT02120027|11189476|FG001|Overall Study|Lack of Efficacy|5
7163023|NCT03630016|11339451|FG000|Overall Study|Poor Sensor Placement|1
7163024|NCT03630302|11339473|FG000|Surgery|hardware issue prevented LFP recordings|1
7163025|NCT03630302|11339473|FG000|3 Month Visit|Adverse Event|2
7163026|NCT03630302|11339473|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2
7163027|NCT03631355|11339488|FG000|Overall Study|Lost to Follow-up|1
7163028|NCT03631355|11339489|FG001|Overall Study|Lost to Follow-up|2
7163029|NCT03631732|11339506|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3
7163030|NCT03631732|11339507|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0
7163031|NCT03631732|11339506|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1
7163032|NCT03631732|11339507|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2
7163033|NCT03631732|11339506|FG000|Randomized Phase Up to Week 24|Adverse Event|2
7163034|NCT03631732|11339507|FG001|Randomized Phase Up to Week 24|Adverse Event|0
7163035|NCT03631732|11339506|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1
7163036|NCT03631732|11339507|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0
7163037|NCT03631732|11339506|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6
7163038|NCT03631732|11339507|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1
7163039|NCT03631732|11339506|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3
7163040|NCT03631732|11339507|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3
7163041|NCT03631732|11339506|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4
7163042|NCT03631732|11339507|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1
7163043|NCT03631732|11339506|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1
7163044|NCT03631732|11339507|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0
7163045|NCT03631732|11339506|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1
7163046|NCT03631732|11339507|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0
7163047|NCT03631732|11339506|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1
7163048|NCT03631732|11339507|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0
7163049|NCT03633331|11339564|FG000|Overall Study|Withdrawal by Subject|1
7163050|NCT03633825|11339602|FG000|Enrollment|Did not post on network|5066
7163051|NCT03633825|11339603|FG001|Enrollment|Did not post on network|5080
7163052|NCT03633825|11339602|FG000|Enrollment|Post not classified as crisis|13967
7163053|NCT03633825|11339603|FG001|Enrollment|Post not classified as crisis|13757
7163054|NCT03633825|11339602|FG000|Follow up|Lost to Follow-up|478
7163055|NCT03633825|11339603|FG001|Follow up|Lost to Follow-up|450
7163056|NCT03633903|11339611|FG000|Overall Study|Withdrawal by Subject|1
7163057|NCT03633903|11339612|FG001|Overall Study|Withdrawal by Subject|2
7163058|NCT03633903|11339611|FG000|Overall Study|Lost to Follow-up|5
7163059|NCT03633903|11339612|FG001|Overall Study|Lost to Follow-up|5
7163060|NCT03633929|11339618|FG000|Overall Study|Lost to Follow-up|1
7163061|NCT03633929|11339618|FG000|Overall Study|Did not login to software. Did not participate|3
7163062|NCT03634085|11339624|FG000|Overall Study|Adverse Event|1
7163063|NCT03634085|11339625|FG001|Overall Study|Adverse Event|0
7163064|NCT03634085|11339624|FG000|Overall Study|Withdrawal by Subject|0
7163065|NCT03634085|11339625|FG001|Overall Study|Withdrawal by Subject|2
7163066|NCT03634579|11339651|FG000|Overall Study|study termination|9
7163067|NCT03634800|11339655|FG000|Overall Study|Adverse Event|1
7163068|NCT03634800|11339655|FG000|Overall Study|Disease Progression|4
7163069|NCT03634800|11339655|FG000|Overall Study|Withdrawal by Subject|1
7163070|NCT03635086|11339674|FG000|Overall Study|Withdrawal of consent|0
7163071|NCT03635086|11339675|FG001|Overall Study|Withdrawal of consent|0
7163072|NCT03635086|11339676|FG002|Overall Study|Withdrawal of consent|1
7163073|NCT03635086|11339677|FG003|Overall Study|Withdrawal of consent|0
7163074|NCT03635086|11339678|FG004|Overall Study|Withdrawal of consent|0
7163075|NCT03635086|11339674|FG000|Overall Study|Adverse Event|0
7163076|NCT03635086|11339675|FG001|Overall Study|Adverse Event|1
7163077|NCT03635086|11339676|FG002|Overall Study|Adverse Event|0
7163078|NCT03635086|11339677|FG003|Overall Study|Adverse Event|0
7163079|NCT03635086|11339678|FG004|Overall Study|Adverse Event|0
7163080|NCT03635086|11339674|FG000|Overall Study|Lost to Follow-up|1
7163081|NCT03635086|11339675|FG001|Overall Study|Lost to Follow-up|0
7163082|NCT03635086|11339676|FG002|Overall Study|Lost to Follow-up|0
7080186|NCT02120027|11189475|FG000|Overall Study|Lost to Follow-up|5
7080187|NCT02120027|11189476|FG001|Overall Study|Lost to Follow-up|13
7080188|NCT02120027|11189475|FG000|Overall Study|Other|4
7080189|NCT02120027|11189476|FG001|Overall Study|Other|0
7080190|NCT02120027|11189475|FG000|Overall Study|Physician Decision|4
7163083|NCT03635086|11339677|FG003|Overall Study|Lost to Follow-up|0
7163084|NCT03635086|11339678|FG004|Overall Study|Lost to Follow-up|0
7163085|NCT03635320|11339693|FG000|Overall Study|not implanted the device|1
7163086|NCT03635320|11339694|FG001|Overall Study|not implanted the device|2
7163087|NCT03635320|11339693|FG000|Overall Study|Withdrawal by Subject|11
7163088|NCT03635320|11339694|FG001|Overall Study|Withdrawal by Subject|6
7163089|NCT03635775|11339704|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0
7163090|NCT03635775|11339705|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0
7163091|NCT03635775|11339706|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0
7163092|NCT03635775|11339707|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1
7163093|NCT03635957|11339717|FG000|Run-In Period|Lost to Follow-up|1
7163094|NCT03635957|11339717|FG000|Pegloticase + IMM Period|Lack of Efficacy|3
7163095|NCT03636893|11339753|FG000|Overall Study|Death|0
7163096|NCT03636893|11339754|FG001|Overall Study|Death|1
7163097|NCT03636893|11339753|FG000|Overall Study|Protocol Violation|0
7163098|NCT03636893|11339754|FG001|Overall Study|Protocol Violation|3
7163099|NCT03636893|11339753|FG000|Overall Study|Withdrawal by Subject|1
7163100|NCT03636893|11339754|FG001|Overall Study|Withdrawal by Subject|2
7163101|NCT03636893|11339753|FG000|Overall Study|Refusal to surgery|4
7163102|NCT03636893|11339754|FG001|Overall Study|Refusal to surgery|3
7163103|NCT03636893|11339753|FG000|Overall Study|Early surgery (for acute bleeding)|3
7163104|NCT03636893|11339754|FG001|Overall Study|Early surgery (for acute bleeding)|0
7163105|NCT03636893|11339753|FG000|Overall Study|Adverse Event|1
7163106|NCT03636893|11339754|FG001|Overall Study|Adverse Event|1
7163107|NCT03638635|11339821|FG000|Initial Hospitalization|Study terminated prematurely|0
7163108|NCT03638635|11339822|FG001|Initial Hospitalization|Study terminated prematurely|1
7163109|NCT03638635|11339821|FG000|Initial Hospitalization|Withdrawal by study personnel|0
7163110|NCT03638635|11339822|FG001|Initial Hospitalization|Withdrawal by study personnel|1
7163111|NCT03638635|11339821|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39
7163112|NCT03638635|11339822|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22
7163113|NCT03639675|11339836|FG000|Overall Study|Withdrawal by Subject|1
7163114|NCT03639779|11339846|FG000|Overall Study|Lost to Follow-up|1
7163115|NCT03639987|11339864|FG000|Overall Study|Study terminated by sponsor|26
7163116|NCT03639987|11339865|FG001|Overall Study|Study terminated by sponsor|25
7163117|NCT03639987|11339864|FG000|Overall Study|Lost to Follow-up|0
7163118|NCT03639987|11339865|FG001|Overall Study|Lost to Follow-up|1
7163119|NCT03640052|11339871|FG000|Overall Study|Lost to Follow-up|0
7163120|NCT03640052|11339872|FG001|Overall Study|Lost to Follow-up|1
7163121|NCT03640052|11339873|FG002|Overall Study|Lost to Follow-up|0
7163122|NCT03640052|11339874|FG003|Overall Study|Lost to Follow-up|0
7163123|NCT03640052|11339875|FG004|Overall Study|Lost to Follow-up|0
7163124|NCT03640507|11339890|FG000|Overall Study|Withdrawal by Subject|0
7163125|NCT03640507|11339891|FG001|Overall Study|Withdrawal by Subject|0
7163126|NCT03640507|11339892|FG002|Overall Study|Withdrawal by Subject|1
7163127|NCT03640559|11339902|FG000|Overall Study|Physician Decision|1
7163128|NCT03640559|11339903|FG001|Overall Study|Physician Decision|1
7163129|NCT03640559|11339902|FG000|Overall Study|Withdrawal by Subject|1
7163130|NCT03640559|11339903|FG001|Overall Study|Withdrawal by Subject|0
7163131|NCT03641508|11339920|FG000|First Injection|Lost to Follow-up|2
7163132|NCT03641508|11339921|FG001|First Injection|Lost to Follow-up|0
7163133|NCT03642262|11339931|FG000|Period 1|Withdrawal by Subject|1
7163134|NCT03642262|11339932|FG001|Period 1|Withdrawal by Subject|1
7163135|NCT03642262|11339931|FG000|Period 1|Adverse Event|0
7163136|NCT03642262|11339932|FG001|Period 1|Adverse Event|1
7163137|NCT03642717|11339948|FG000|Overall Study|Lost to Follow-up|2
7163138|NCT03642717|11339948|FG000|Overall Study|Inclusion/exclusion criteria violation|33
7163139|NCT03642717|11339948|FG000|Overall Study|Taken study drug prior to contract date|3
7163140|NCT03642873|11339953|FG000|Third Intervention (1 Day)|Screen failure|0
7163141|NCT03642873|11339954|FG001|Third Intervention (1 Day)|Screen failure|0
7163142|NCT03642873|11339955|FG002|Third Intervention (1 Day)|Screen failure|0
7163143|NCT03642873|11339956|FG003|Third Intervention (1 Day)|Screen failure|0
7163144|NCT03642873|11339957|FG004|Third Intervention (1 Day)|Screen failure|1
7163145|NCT03642873|11339958|FG005|Third Intervention (1 Day)|Screen failure|0
7163146|NCT03643432|11339972|FG000|Overall Study|Lost to Follow-up|1
7163147|NCT03643432|11339973|FG001|Overall Study|Lost to Follow-up|0
7163148|NCT03643575|11339979|FG000|Washout: 7 Days|Withdrew consent due to illness|0
7163149|NCT03643575|11339980|FG001|Washout: 7 Days|Withdrew consent due to illness|0
7163150|NCT03643575|11339981|FG002|Washout: 7 Days|Withdrew consent due to illness|0
7163151|NCT03643575|11339982|FG003|Washout: 7 Days|Withdrew consent due to illness|1
7163152|NCT03643575|11339983|FG004|Washout: 7 Days|Withdrew consent due to illness|0
7163153|NCT03643575|11339984|FG005|Washout: 7 Days|Withdrew consent due to illness|0
7163154|NCT03643575|11339979|FG000|Washout: 7 Days|Adverse Event|1
7163155|NCT03643575|11339980|FG001|Washout: 7 Days|Adverse Event|0
7163156|NCT03643575|11339981|FG002|Washout: 7 Days|Adverse Event|0
7163157|NCT03643575|11339982|FG003|Washout: 7 Days|Adverse Event|0
7163158|NCT03643575|11339983|FG004|Washout: 7 Days|Adverse Event|0
7163159|NCT03643575|11339984|FG005|Washout: 7 Days|Adverse Event|0
7163160|NCT03643575|11339979|FG000|Washout: 7 Days|Non compliance check in|0
7163161|NCT03643575|11339980|FG001|Washout: 7 Days|Non compliance check in|1
7163162|NCT03643575|11339981|FG002|Washout: 7 Days|Non compliance check in|0
7163163|NCT03643575|11339982|FG003|Washout: 7 Days|Non compliance check in|0
7163164|NCT03643575|11339983|FG004|Washout: 7 Days|Non compliance check in|0
7163165|NCT03643575|11339984|FG005|Washout: 7 Days|Non compliance check in|0
7163166|NCT03643952|11339996|FG000|Overall Study|Lack of Efficacy|1
7163167|NCT03644173|11340019|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21
7163168|NCT03644173|11340019|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2
7163169|NCT03644173|11340019|FG000|Participants at the 1-month Follow up|Death|2
7163170|NCT03644173|11340019|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2
7163171|NCT03645421|11340037|FG000|Overall Study|Adverse Event|0
7163172|NCT03645421|11340038|FG001|Overall Study|Adverse Event|0
7163173|NCT03645421|11340039|FG002|Overall Study|Adverse Event|4
7163174|NCT03645421|11340040|FG003|Overall Study|Adverse Event|1
7163175|NCT03645421|11340037|FG000|Overall Study|Withdrawal by patient|0
7163176|NCT03645421|11340038|FG001|Overall Study|Withdrawal by patient|0
7163177|NCT03645421|11340039|FG002|Overall Study|Withdrawal by patient|0
7163178|NCT03645421|11340040|FG003|Overall Study|Withdrawal by patient|3
7163179|NCT03645421|11340037|FG000|Overall Study|Study specific withdrawal criteria|0
7163180|NCT03645421|11340038|FG001|Overall Study|Study specific withdrawal criteria|0
7163181|NCT03645421|11340039|FG002|Overall Study|Study specific withdrawal criteria|1
7163182|NCT03645421|11340040|FG003|Overall Study|Study specific withdrawal criteria|0
7163183|NCT03645434|11340053|FG000|Period 1|Adverse Event|0
7163184|NCT03645434|11340054|FG001|Period 1|Adverse Event|0
7163185|NCT03645434|11340055|FG002|Period 1|Adverse Event|0
7163186|NCT03645434|11340056|FG003|Period 1|Adverse Event|1
7163187|NCT03645434|11340057|FG004|Period 1|Adverse Event|0
7163188|NCT03645434|11340058|FG005|Period 1|Adverse Event|0
7163189|NCT03645434|11340053|FG000|Period 1|COPD exacerbation|0
7163190|NCT03645434|11340054|FG001|Period 1|COPD exacerbation|0
7163191|NCT03645434|11340055|FG002|Period 1|COPD exacerbation|0
7163192|NCT03645434|11340056|FG003|Period 1|COPD exacerbation|0
7163193|NCT03645434|11340057|FG004|Period 1|COPD exacerbation|1
7163194|NCT03645434|11340058|FG005|Period 1|COPD exacerbation|0
7163195|NCT03646305|11340108|FG000|Overall Study|Lost to Follow-up|4
7163196|NCT03646305|11340109|FG001|Overall Study|Lost to Follow-up|2
7163197|NCT03646305|11340110|FG002|Overall Study|Lost to Follow-up|2
7163198|NCT03646305|11340111|FG003|Overall Study|Lost to Follow-up|1
7163199|NCT03646305|11340108|FG000|Overall Study|Withdrawal by Subject|1
7163200|NCT03646305|11340109|FG001|Overall Study|Withdrawal by Subject|0
7163201|NCT03646305|11340110|FG002|Overall Study|Withdrawal by Subject|0
7163202|NCT03646305|11340111|FG003|Overall Study|Withdrawal by Subject|1
7163203|NCT03646656|11340127|FG000|Overall Study|Lost to Follow-up|1
7163204|NCT03646656|11340128|FG001|Overall Study|Lost to Follow-up|0
7163205|NCT03646656|11340127|FG000|Overall Study|Withdrawal by Subject|2
7163206|NCT03646656|11340128|FG001|Overall Study|Withdrawal by Subject|0
7163207|NCT03647267|11340153|FG000|Overall Study|Lost to Follow-up|1
7163208|NCT03647267|11340154|FG001|Overall Study|Lost to Follow-up|0
7163209|NCT03647709|11340166|FG000|Overall Study|Lost to Follow-up|5
7163210|NCT03647709|11340166|FG000|Overall Study|Physician Decision|6
7163211|NCT03647709|11340166|FG000|Overall Study|Withdrawal by Subject|3
7163212|NCT03648879|11340176|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1
7163213|NCT03649412|11340182|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1
7163214|NCT03649412|11340183|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0
7163215|NCT03649412|11340182|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1
7080191|NCT02120027|11189476|FG001|Overall Study|Physician Decision|3
7080192|NCT02120027|11189475|FG000|Overall Study|Protocol Violation|18
6972730|NCT01173601|11023891|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
6972731|NCT01173601|11023892|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
6972732|NCT01173601|11023893|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7
6972733|NCT01173601|11023894|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5
7080193|NCT02120027|11189476|FG001|Overall Study|Protocol Violation|21
7080194|NCT02120027|11189475|FG000|Overall Study|Study terminated by Sponsor|45
7080195|NCT02120027|11189476|FG001|Overall Study|Study terminated by Sponsor|47
7080196|NCT02120027|11189475|FG000|Overall Study|Withdrawal by Subject|33
7080197|NCT02120027|11189476|FG001|Overall Study|Withdrawal by Subject|25
7080198|NCT02120157|11189482|FG000|Overall Study|Death|8
7080199|NCT02120300|11189505|FG000|Overall Study|Enrolled but Never Treated|2
7080200|NCT02120300|11189506|FG001|Overall Study|Enrolled but Never Treated|0
7080201|NCT02120300|11189507|FG002|Overall Study|Enrolled but Never Treated|0
7080202|NCT02120300|11189508|FG003|Overall Study|Enrolled but Never Treated|0
7080203|NCT02120300|11189505|FG000|Overall Study|Lack of Efficacy|0
7080204|NCT02120300|11189506|FG001|Overall Study|Lack of Efficacy|0
7080205|NCT02120300|11189507|FG002|Overall Study|Lack of Efficacy|0
7080206|NCT02120300|11189508|FG003|Overall Study|Lack of Efficacy|1
7080207|NCT02120300|11189505|FG000|Overall Study|Lost to Follow-up|1
7080208|NCT02120300|11189506|FG001|Overall Study|Lost to Follow-up|0
7080209|NCT02120300|11189507|FG002|Overall Study|Lost to Follow-up|0
7080210|NCT02120300|11189508|FG003|Overall Study|Lost to Follow-up|0
7080211|NCT02120417|11189522|FG000|Overall Study|Death|5
7080212|NCT02120417|11189523|FG001|Overall Study|Death|1
7080213|NCT02120417|11189522|FG000|Overall Study|Adverse Event|3
7080214|NCT02120417|11189523|FG001|Overall Study|Adverse Event|9
7080215|NCT02120417|11189522|FG000|Overall Study|Participant decision|4
7080216|NCT02120417|11189523|FG001|Overall Study|Participant decision|4
7080217|NCT02120417|11189522|FG000|Overall Study|Disease progression|41
7080218|NCT02120417|11189523|FG001|Overall Study|Disease progression|45
7080219|NCT02120417|11189522|FG000|Overall Study|Noncompliance with study treatment|0
7080220|NCT02120417|11189523|FG001|Overall Study|Noncompliance with study treatment|2
7080221|NCT02120417|11189522|FG000|Overall Study|Physician Decision|2
7080222|NCT02120417|11189523|FG001|Overall Study|Physician Decision|3
7080223|NCT02120417|11189522|FG000|Overall Study|Other unspecified|5
7080224|NCT02120417|11189523|FG001|Overall Study|Other unspecified|4
7080225|NCT02120456|11189542|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0
7080226|NCT02120456|11189543|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0
7080227|NCT02120456|11189544|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0
7080228|NCT02120456|11189545|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0
7163216|NCT03649412|11340183|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0
7163217|NCT03649412|11340182|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1
7163218|NCT03649412|11340183|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0
7163219|NCT03649412|11340182|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1
7080229|NCT02120456|11189546|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0
7080230|NCT02120456|11189547|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0
7080231|NCT02120456|11189548|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1
7080232|NCT02120456|11189549|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0
7080233|NCT02120456|11189550|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0
7080234|NCT02120456|11189542|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0
7080235|NCT02120456|11189543|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0
7080236|NCT02120456|11189544|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0
7080237|NCT02120456|11189545|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0
7080238|NCT02120456|11189546|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0
7080239|NCT02120456|11189547|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0
7080240|NCT02120456|11189548|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1
7080241|NCT02120456|11189549|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0
7080242|NCT02120456|11189550|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0
7080243|NCT02120456|11189542|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0
7080244|NCT02120456|11189543|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0
7080245|NCT02120456|11189544|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0
7080246|NCT02120456|11189545|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0
7080247|NCT02120456|11189546|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0
7080248|NCT02120456|11189547|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0
7080249|NCT02120456|11189548|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0
7080250|NCT02120456|11189549|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0
7080251|NCT02120456|11189550|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1
7080252|NCT02120625|11189570|FG000|Overall Study|Physician Decision|2
7080253|NCT02120664|11189579|FG000|Overall Study|Withdrawal by Subject|0
7080254|NCT02120664|11189580|FG001|Overall Study|Withdrawal by Subject|0
7080255|NCT02120664|11189581|FG002|Overall Study|Withdrawal by Subject|0
7080256|NCT02120664|11189582|FG003|Overall Study|Withdrawal by Subject|1
7080257|NCT02120664|11189583|FG004|Overall Study|Withdrawal by Subject|0
7080258|NCT02120781|11189607|FG000|Overall Study|Physician Decision|2
7080259|NCT02120781|11189608|FG001|Overall Study|Physician Decision|0
7080260|NCT02120781|11189607|FG000|Overall Study|Completion not documented|2
7080261|NCT02120781|11189608|FG001|Overall Study|Completion not documented|1
7080262|NCT02120794|11189614|FG000|Overall Study|Withdrawal by Subject|43
7080263|NCT02120794|11189614|FG000|Overall Study|Adverse Event|10
7080264|NCT02120794|11189614|FG000|Overall Study|Physician Decision|4
7080265|NCT02120794|11189614|FG000|Overall Study|Due to insurance coverage|1
7080266|NCT02120833|11189620|FG000|Overall Study|Adverse Event|1
7080267|NCT02120833|11189621|FG001|Overall Study|Adverse Event|0
7080268|NCT02120833|11189620|FG000|Overall Study|Withdrawal by Subject|2
7080269|NCT02120833|11189621|FG001|Overall Study|Withdrawal by Subject|0
7080270|NCT02120833|11189620|FG000|Overall Study|Lost to Follow-up|1
7080271|NCT02120833|11189621|FG001|Overall Study|Lost to Follow-up|1
7080272|NCT02120898|11189630|FG000|Overall Study|Withdrawal by Subject|4
7080273|NCT02120898|11189631|FG001|Overall Study|Withdrawal by Subject|2
7080274|NCT02120898|11189632|FG002|Overall Study|Withdrawal by Subject|2
7163220|NCT03649412|11340183|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0
7163221|NCT03649412|11340182|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0
7163222|NCT03649412|11340183|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1
7163223|NCT03649412|11340182|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0
7163224|NCT03649412|11340183|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1
7163225|NCT03649477|11340229|FG000|Overall Study|Adverse Event|2
7163226|NCT03649477|11340230|FG001|Overall Study|Adverse Event|0
7163227|NCT03649477|11340231|FG002|Overall Study|Adverse Event|0
7163228|NCT03650387|11340276|FG000|Overall Study|Withdrawal by Subject|13
7163229|NCT03650387|11340276|FG000|Overall Study|Lost to Follow-up|12
7163230|NCT03650387|11340276|FG000|Overall Study|Adverse Event (Not related)|1
7163231|NCT03650387|11340276|FG000|Overall Study|Due to COVID-19 Pandemic|8
7163232|NCT03650400|11340291|FG000|Overall Study|Study terminated by sponsor|0
7163233|NCT03650400|11340292|FG001|Overall Study|Study terminated by sponsor|5
7163234|NCT03650452|11340300|FG000|Overall Study|Physician Decision|1
7163235|NCT03650452|11340301|FG001|Overall Study|Physician Decision|0
7163236|NCT03650452|11340300|FG000|Overall Study|Withdrawal by Parent/Guardian|3
7163237|NCT03650452|11340301|FG001|Overall Study|Withdrawal by Parent/Guardian|1
7163238|NCT03650452|11340300|FG000|Overall Study|Adverse Event|3
7163239|NCT03650452|11340301|FG001|Overall Study|Adverse Event|4
7163240|NCT03650452|11340300|FG000|Overall Study|Early Withdrawal from Study Treatment|3
7163241|NCT03650452|11340301|FG001|Overall Study|Early Withdrawal from Study Treatment|0
7163242|NCT03652610|11340326|FG000|Overall Study|Lost to Follow-up|1
7163243|NCT03652610|11340327|FG001|Overall Study|Lost to Follow-up|0
7163244|NCT03652610|11340326|FG000|Overall Study|Withdrawal by Subject|3
7163245|NCT03652610|11340327|FG001|Overall Study|Withdrawal by Subject|5
7163246|NCT03652662|11340335|FG000|Overall Study|Withdrawal by Subject|2
7080275|NCT02120898|11189630|FG000|Overall Study|Non-compliance with study drug|3
7080276|NCT02120898|11189631|FG001|Overall Study|Non-compliance with study drug|0
7080277|NCT02120898|11189632|FG002|Overall Study|Non-compliance with study drug|0
7080278|NCT02120898|11189630|FG000|Overall Study|Adverse Event|1
7080279|NCT02120898|11189631|FG001|Overall Study|Adverse Event|2
7080280|NCT02120898|11189632|FG002|Overall Study|Adverse Event|1
7080281|NCT02120898|11189630|FG000|Overall Study|Protocol Violation|1
7080282|NCT02120898|11189631|FG001|Overall Study|Protocol Violation|2
7080283|NCT02120898|11189632|FG002|Overall Study|Protocol Violation|0
7080284|NCT02120898|11189630|FG000|Overall Study|Lost to Follow-up|0
7080285|NCT02120898|11189631|FG001|Overall Study|Lost to Follow-up|0
7080286|NCT02120898|11189632|FG002|Overall Study|Lost to Follow-up|1
7080287|NCT02120924|11189643|FG000|Overall Study|Lack of Efficacy|1
7080288|NCT02120924|11189644|FG001|Overall Study|Lack of Efficacy|2
7080289|NCT02120924|11189645|FG002|Overall Study|Lack of Efficacy|3
7080290|NCT02120924|11189643|FG000|Overall Study|Adverse Event|0
7080291|NCT02120924|11189644|FG001|Overall Study|Adverse Event|1
7080292|NCT02120924|11189645|FG002|Overall Study|Adverse Event|3
7080293|NCT02120924|11189643|FG000|Overall Study|Withdrawal by Subject|16
7080294|NCT02120924|11189644|FG001|Overall Study|Withdrawal by Subject|20
7080295|NCT02120924|11189645|FG002|Overall Study|Withdrawal by Subject|8
7080296|NCT02120924|11189643|FG000|Overall Study|Lost to Follow-up|14
7080297|NCT02120924|11189644|FG001|Overall Study|Lost to Follow-up|14
7080298|NCT02120924|11189645|FG002|Overall Study|Lost to Follow-up|11
7080299|NCT02120924|11189643|FG000|Overall Study|Pregnancy|2
7080300|NCT02120924|11189644|FG001|Overall Study|Pregnancy|0
7080301|NCT02120924|11189645|FG002|Overall Study|Pregnancy|0
7080302|NCT02120924|11189643|FG000|Overall Study|Protocol Violation|3
7080303|NCT02120924|11189644|FG001|Overall Study|Protocol Violation|7
7080304|NCT02120924|11189645|FG002|Overall Study|Protocol Violation|2
7080305|NCT02120924|11189643|FG000|Overall Study|Physician Decision|0
7080306|NCT02120924|11189644|FG001|Overall Study|Physician Decision|1
7080307|NCT02120924|11189645|FG002|Overall Study|Physician Decision|1
7080308|NCT02120924|11189643|FG000|Overall Study|Death|1
7080309|NCT02120924|11189644|FG001|Overall Study|Death|0
7080310|NCT02120924|11189645|FG002|Overall Study|Death|0
7163247|NCT03652662|11340336|FG001|Overall Study|Withdrawal by Subject|1
7163248|NCT03652662|11340335|FG000|Overall Study|Lost to Follow-up|1
7163249|NCT03652662|11340336|FG001|Overall Study|Lost to Follow-up|0
7163250|NCT03652675|11340344|FG000|Overall Study|Lost to Follow-up|4
7163251|NCT03652675|11340345|FG001|Overall Study|Lost to Follow-up|4
7163252|NCT03652818|11340356|FG000|Overall Study|Adverse Event|1
7163253|NCT03652818|11340357|FG001|Overall Study|Adverse Event|0
7163254|NCT03652818|11340358|FG002|Overall Study|Adverse Event|0
7163255|NCT03652818|11340359|FG003|Overall Study|Adverse Event|0
7163256|NCT03652818|11340360|FG004|Overall Study|Adverse Event|0
7163257|NCT03652818|11340356|FG000|Overall Study|Physician Decision|1
7163258|NCT03652818|11340357|FG001|Overall Study|Physician Decision|0
7163259|NCT03652818|11340358|FG002|Overall Study|Physician Decision|0
7163260|NCT03652818|11340359|FG003|Overall Study|Physician Decision|0
7163261|NCT03652818|11340360|FG004|Overall Study|Physician Decision|0
7163262|NCT03652818|11340356|FG000|Overall Study|Lost to Follow-up|0
7163263|NCT03652818|11340357|FG001|Overall Study|Lost to Follow-up|1
7163264|NCT03652818|11340358|FG002|Overall Study|Lost to Follow-up|2
7163265|NCT03652818|11340359|FG003|Overall Study|Lost to Follow-up|1
7163266|NCT03652818|11340360|FG004|Overall Study|Lost to Follow-up|1
7163267|NCT03653208|11340381|FG000|Overall Study|Withdrawal by Subject|0
7163268|NCT03653208|11340382|FG001|Overall Study|Withdrawal by Subject|0
7163269|NCT03653208|11340383|FG002|Overall Study|Withdrawal by Subject|0
7163270|NCT03653208|11340384|FG003|Overall Study|Withdrawal by Subject|0
7163271|NCT03653208|11340385|FG004|Overall Study|Withdrawal by Subject|1
7163272|NCT03653208|11340386|FG005|Overall Study|Withdrawal by Subject|0
7163273|NCT03653208|11340387|FG006|Overall Study|Withdrawal by Subject|0
7163274|NCT03653208|11340388|FG007|Overall Study|Withdrawal by Subject|1
7163275|NCT03653208|11340389|FG008|Overall Study|Withdrawal by Subject|1
7184425|NCT02335099|11384647|FG000|Treatment|Withdrawal by Subject|1
7184426|NCT02335099|11384648|FG001|Treatment|Withdrawal by Subject|3
7184427|NCT02335099|11384647|FG000|Treatment|Lost to Follow-up|2
7184428|NCT02335099|11384648|FG001|Treatment|Lost to Follow-up|0
7184429|NCT02335099|11384647|FG000|Treatment|Death|1
7184430|NCT02335099|11384648|FG001|Treatment|Death|0
7184431|NCT02335099|11384647|FG000|Treatment|Adverse Event|1
7184432|NCT02335099|11384648|FG001|Treatment|Adverse Event|2
7184433|NCT02335099|11384647|FG000|Follow-up|Death|0
7184434|NCT02335099|11384648|FG001|Follow-up|Death|1
7184435|NCT02330562|11384665|FG000|Overall Study|Adverse Event|0
7184436|NCT02330562|11384666|FG001|Overall Study|Adverse Event|0
7080311|NCT02120924|11189643|FG000|Overall Study|Compliance with IP|5
7080312|NCT02120924|11189644|FG001|Overall Study|Compliance with IP|1
7080313|NCT02120924|11189645|FG002|Overall Study|Compliance with IP|1
7080314|NCT02120950|11189656|FG000|Overall Study|Adverse Event|5
7080315|NCT02120950|11189657|FG001|Overall Study|Adverse Event|4
7080316|NCT02120950|11189658|FG002|Overall Study|Adverse Event|3
7080317|NCT02120950|11189656|FG000|Overall Study|Death|3
7184437|NCT02330562|11384667|FG002|Overall Study|Adverse Event|3
7184438|NCT02330562|11384668|FG003|Overall Study|Adverse Event|0
7184439|NCT02330562|11384669|FG004|Overall Study|Adverse Event|3
7184440|NCT02330562|11384670|FG005|Overall Study|Adverse Event|1
7080318|NCT02120950|11189657|FG001|Overall Study|Death|0
7080319|NCT02120950|11189658|FG002|Overall Study|Death|1
7080320|NCT02120950|11189656|FG000|Overall Study|Withdrawal by Subject|6
7163276|NCT03653416|11340420|FG000|Overall Study|Protocol Violation|6
7163277|NCT03653416|11340421|FG001|Overall Study|Protocol Violation|1
7163278|NCT03653429|11340429|FG000|Overall Study|Physician Decision|4
7163279|NCT03653429|11340430|FG001|Overall Study|Physician Decision|10
7080321|NCT02120950|11189657|FG001|Overall Study|Withdrawal by Subject|3
7080322|NCT02120950|11189658|FG002|Overall Study|Withdrawal by Subject|2
7080323|NCT02120950|11189656|FG000|Overall Study|Protocol Violation|1
7080324|NCT02120950|11189657|FG001|Overall Study|Protocol Violation|1
7080325|NCT02120950|11189658|FG002|Overall Study|Protocol Violation|7
7163280|NCT03654326|11340438|FG000|Overall Study|Withdrawal by Subject|5
7163281|NCT03654326|11340439|FG001|Overall Study|Withdrawal by Subject|3
7163282|NCT03654326|11340438|FG000|Overall Study|Physician Decision|0
7163283|NCT03654326|11340439|FG001|Overall Study|Physician Decision|1
7163284|NCT03654326|11340438|FG000|Overall Study|Unable to adhere to study schedule|0
7163285|NCT03654326|11340439|FG001|Overall Study|Unable to adhere to study schedule|1
7163286|NCT03654326|11340438|FG000|Overall Study|Lost to Follow-up|1
7163287|NCT03654326|11340439|FG001|Overall Study|Lost to Follow-up|1
7163288|NCT03654560|11340456|FG000|Overall Study|Death|3
7163289|NCT03654560|11340457|FG001|Overall Study|Death|1
7163290|NCT03654560|11340456|FG000|Overall Study|Lost to Follow-up|1
7163291|NCT03654560|11340457|FG001|Overall Study|Lost to Follow-up|0
7163292|NCT03655106|11340469|FG000|Overall Study|Withdrawal by Subject|3
7163293|NCT03655106|11340470|FG001|Overall Study|Withdrawal by Subject|2
7163294|NCT03655106|11340469|FG000|Overall Study|Lost to Follow-up|2
7163295|NCT03655106|11340470|FG001|Overall Study|Lost to Follow-up|1
7163296|NCT03655106|11340469|FG000|Overall Study|Duplicate Enrollment|1
7163297|NCT03655106|11340470|FG001|Overall Study|Duplicate Enrollment|1
7163298|NCT03655106|11340469|FG000|Overall Study|Protocol Violation|3
7163299|NCT03655106|11340470|FG001|Overall Study|Protocol Violation|0
7163300|NCT03655405|11340482|FG000|Overall Study|Death after initial data collection|4
7163301|NCT03655405|11340483|FG001|Overall Study|Death after initial data collection|2
7163302|NCT03655405|11340482|FG000|Overall Study|Died before initial data collection|1
7163303|NCT03655405|11340483|FG001|Overall Study|Died before initial data collection|2
7163304|NCT03655405|11340482|FG000|Overall Study|Protocol Violation|0
7163305|NCT03655405|11340483|FG001|Overall Study|Protocol Violation|1
7163306|NCT03655951|11340500|FG000|Overall Study|Lost to Follow-up|39
7163307|NCT03655951|11340501|FG001|Overall Study|Lost to Follow-up|20
7163308|NCT03655951|11340500|FG000|Overall Study|Withdrawal by Subject|0
7163309|NCT03655951|11340501|FG001|Overall Study|Withdrawal by Subject|1
7163310|NCT03657095|11340515|FG000|Overall Study|Withdrawal by Subject|1
7163311|NCT03657095|11340516|FG001|Overall Study|Withdrawal by Subject|1
7163312|NCT03657095|11340515|FG000|Overall Study|Adverse Event|0
7163313|NCT03657095|11340516|FG001|Overall Study|Adverse Event|3
7163314|NCT03657095|11340515|FG000|Overall Study|Study Terminated by Sponsor|58
7163315|NCT03657095|11340516|FG001|Overall Study|Study Terminated by Sponsor|49
7163316|NCT03657277|11340545|FG000|Overall Study|Physician Decision|2
7163317|NCT03657277|11340545|FG000|Overall Study|Lost to Follow-up|1
7163318|NCT03657277|11340545|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8
7163319|NCT03658811|11340558|FG000|Overall Study|Lost to Follow-up|3
7163320|NCT03658876|11340564|FG000|Overall Study|Protocol Violation|3
7163321|NCT03658876|11340565|FG001|Overall Study|Protocol Violation|2
7163322|NCT03658876|11340564|FG000|Overall Study|Withdrawal by Subject|2
7163323|NCT03658876|11340565|FG001|Overall Study|Withdrawal by Subject|0
7163324|NCT03658876|11340564|FG000|Overall Study|Death|0
7163325|NCT03658876|11340565|FG001|Overall Study|Death|1
7163326|NCT03658876|11340564|FG000|Overall Study|Intercurrent illness|6
7163327|NCT03658876|11340565|FG001|Overall Study|Intercurrent illness|4
7163328|NCT03658876|11340564|FG000|Overall Study|Transplantation/other operation|1
7163329|NCT03658876|11340565|FG001|Overall Study|Transplantation/other operation|5
7163330|NCT03658889|11340573|FG000|Overall Study|Protocol Violation|2
7163331|NCT03658889|11340574|FG001|Overall Study|Protocol Violation|0
7163332|NCT03661983|11340645|FG000|Open Label Stabilization Phase|Adverse Event|5
7163333|NCT03661983|11340646|FG001|Open Label Stabilization Phase|Adverse Event|0
7163334|NCT03661983|11340647|FG002|Open Label Stabilization Phase|Adverse Event|0
7163335|NCT03661983|11340648|FG003|Open Label Stabilization Phase|Adverse Event|0
7163336|NCT03661983|11340645|FG000|Open Label Stabilization Phase|Lack of Efficacy|1
7163337|NCT03661983|11340646|FG001|Open Label Stabilization Phase|Lack of Efficacy|0
7163338|NCT03661983|11340647|FG002|Open Label Stabilization Phase|Lack of Efficacy|0
7163339|NCT03661983|11340648|FG003|Open Label Stabilization Phase|Lack of Efficacy|0
7163340|NCT03661983|11340645|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2
7163341|NCT03661983|11340646|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0
7163342|NCT03661983|11340647|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0
7163343|NCT03661983|11340648|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0
7163344|NCT03661983|11340645|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3
7080326|NCT02120950|11189656|FG000|Overall Study|Other reasons|5
7163345|NCT03661983|11340646|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0
7163346|NCT03661983|11340647|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0
7080327|NCT02120950|11189657|FG001|Overall Study|Other reasons|4
7163347|NCT03661983|11340648|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0
7163348|NCT03661983|11340645|FG000|Double-blind Randomized Phase|Adverse Event|0
7163349|NCT03661983|11340646|FG001|Double-blind Randomized Phase|Adverse Event|1
7163350|NCT03661983|11340647|FG002|Double-blind Randomized Phase|Adverse Event|0
7163351|NCT03661983|11340648|FG003|Double-blind Randomized Phase|Adverse Event|0
7163352|NCT03661983|11340645|FG000|Double-blind Randomized Phase|Disease Relapse|0
7163353|NCT03661983|11340646|FG001|Double-blind Randomized Phase|Disease Relapse|0
7163354|NCT03661983|11340647|FG002|Double-blind Randomized Phase|Disease Relapse|0
7163355|NCT03661983|11340648|FG003|Double-blind Randomized Phase|Disease Relapse|6
7163356|NCT03661983|11340645|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0
7163357|NCT03661983|11340646|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0
7163358|NCT03661983|11340647|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0
7163359|NCT03661983|11340648|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1
7163360|NCT03661983|11340645|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0
7163361|NCT03661983|11340646|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1
7163362|NCT03661983|11340647|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1
7163363|NCT03661983|11340648|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1
7163364|NCT03662334|11340678|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1
7163365|NCT03662334|11340679|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0
7163366|NCT03662750|11340695|FG000|Overall Study|Withdrawal by Subject|1
7163367|NCT03662789|11340701|FG000|Overall Study|Lost to Follow-up|1
7163368|NCT03662789|11340702|FG001|Overall Study|Lost to Follow-up|2
7163369|NCT03662789|11340701|FG000|Overall Study|Could not perform treadmill test|4
7163370|NCT03662789|11340702|FG001|Overall Study|Could not perform treadmill test|4
7163371|NCT03662789|11340701|FG000|Overall Study|Death|0
7163372|NCT03662789|11340702|FG001|Overall Study|Death|1
7163373|NCT03662997|11340712|FG000|Overall Study|Adverse Event|0
7163374|NCT03662997|11340713|FG001|Overall Study|Adverse Event|2
7163375|NCT03662997|11340714|FG002|Overall Study|Adverse Event|0
7163376|NCT03662997|11340715|FG003|Overall Study|Adverse Event|0
7163377|NCT03663179|11340746|FG000|Overall Study|Withdrawal by Subject|2
7163378|NCT03663179|11340747|FG001|Overall Study|Withdrawal by Subject|0
7163379|NCT03663179|11340746|FG000|Overall Study|Lost to Follow-up|1
7163380|NCT03663179|11340747|FG001|Overall Study|Lost to Follow-up|1
7163381|NCT03663179|11340746|FG000|Overall Study|Revealed exclusionary condition|1
7163382|NCT03663179|11340747|FG001|Overall Study|Revealed exclusionary condition|0
7163383|NCT03663569|11340771|FG000|Overall Study|Discontinuation of study|11
7163384|NCT03663569|11340771|FG000|Overall Study|Never taken Spiolto® Respimat®|1
7163385|NCT03663569|11340771|FG000|Overall Study|Deceased patient|6
7163386|NCT03663569|11340771|FG000|Overall Study|Lost to Follow-up|18
7163387|NCT03663569|11340771|FG000|Overall Study|Withdrawal of consent|5
7163388|NCT03663569|11340771|FG000|Overall Study|Patient's request|11
7163389|NCT03663569|11340771|FG000|Overall Study|Adverse Event|4
7163390|NCT03663569|11340771|FG000|Overall Study|Not come to second visit|3
7163391|NCT03663569|11340771|FG000|Overall Study|Not meet inclusion / exclusion criterion|3
7163392|NCT03663569|11340771|FG000|Overall Study|Serious adverse event|1
7163393|NCT03663582|11340775|FG000|Overall Study|Physician Decision|1
7163394|NCT03666858|11340841|FG000|Cohort 1|Adverse Event|1
7163395|NCT03666858|11340842|FG001|Cohort 1|Adverse Event|0
7163396|NCT03666858|11340841|FG000|Cohort 2|Adverse Event|0
7163397|NCT03666858|11340842|FG001|Cohort 2|Adverse Event|1
7163398|NCT03667053|11340851|FG000|Overall Study|Withdrawal by Subject|1
7163399|NCT03667053|11340852|FG001|Overall Study|Withdrawal by Subject|0
7163400|NCT03667053|11340853|FG002|Overall Study|Withdrawal by Subject|0
7163401|NCT03668600|11340872|FG000|Overall Study|Study Terminated by the Sponsor|157
7163402|NCT03668600|11340872|FG000|Overall Study|Protocol Violation|1
7163403|NCT03668600|11340872|FG000|Overall Study|Pregnancy|1
7163404|NCT03668600|11340872|FG000|Overall Study|Lost to Follow-up|7
7163405|NCT03668600|11340872|FG000|Overall Study|Withdrawal by Subject|56
7163406|NCT03668600|11340872|FG000|Overall Study|Lack of Efficacy|7
7163407|NCT03668600|11340872|FG000|Overall Study|Adverse Event|1
7163408|NCT03668613|11340878|FG000|Overall Study|Adverse Event|0
7163409|NCT03668613|11340879|FG001|Overall Study|Adverse Event|2
7163410|NCT03668613|11340878|FG000|Overall Study|Lack of Efficacy|0
7163411|NCT03668613|11340879|FG001|Overall Study|Lack of Efficacy|1
7163412|NCT03669081|11340888|FG000|Overall Study|Data could not be validated|1
7163413|NCT03669081|11340889|FG001|Overall Study|Data could not be validated|1
7163414|NCT03669549|11340913|FG000|Overall Study|Adverse Event|4
7163415|NCT03669549|11340913|FG000|Overall Study|Withdrawal by Subject|1
7163416|NCT03669549|11340913|FG000|Overall Study|Study terminated by the Sponsor|1
7163417|NCT03669861|11340921|FG000|Overall Study|Disease Flare|5
7163418|NCT03669861|11340921|FG000|Overall Study|Lack of Efficacy|2
7163419|NCT03670537|11340955|FG000|Overall Study|Protocol Violation|1
7163420|NCT03670641|11340959|FG000|Overall Study|Lost to Follow-up|3
7163421|NCT03670810|11340969|FG000|Overall Study|Adverse Event|36
7163422|NCT03670810|11340970|FG001|Overall Study|Adverse Event|38
7163423|NCT03670810|11340971|FG002|Overall Study|Adverse Event|2
7163424|NCT03670810|11340972|FG003|Overall Study|Adverse Event|4
7163425|NCT03670810|11340969|FG000|Overall Study|Lack of Efficacy|8
7163426|NCT03670810|11340970|FG001|Overall Study|Lack of Efficacy|8
7163427|NCT03670810|11340971|FG002|Overall Study|Lack of Efficacy|3
7163428|NCT03670810|11340972|FG003|Overall Study|Lack of Efficacy|4
7163429|NCT03670810|11340969|FG000|Overall Study|Lost to Follow-up|6
7163430|NCT03670810|11340970|FG001|Overall Study|Lost to Follow-up|6
7163431|NCT03670810|11340971|FG002|Overall Study|Lost to Follow-up|4
7163432|NCT03670810|11340972|FG003|Overall Study|Lost to Follow-up|6
7163433|NCT03670810|11340969|FG000|Overall Study|Non-compliance with Study Drug|0
7163434|NCT03670810|11340970|FG001|Overall Study|Non-compliance with Study Drug|2
7163435|NCT03670810|11340971|FG002|Overall Study|Non-compliance with Study Drug|3
7163436|NCT03670810|11340972|FG003|Overall Study|Non-compliance with Study Drug|0
7163437|NCT03670810|11340969|FG000|Overall Study|Missing|1
7163438|NCT03670810|11340970|FG001|Overall Study|Missing|1
7163439|NCT03670810|11340971|FG002|Overall Study|Missing|0
7163440|NCT03670810|11340972|FG003|Overall Study|Missing|1
7163441|NCT03670810|11340969|FG000|Overall Study|Physician Decision|3
7163442|NCT03670810|11340970|FG001|Overall Study|Physician Decision|0
7163443|NCT03670810|11340971|FG002|Overall Study|Physician Decision|1
7163444|NCT03670810|11340972|FG003|Overall Study|Physician Decision|0
7163445|NCT03670810|11340969|FG000|Overall Study|Pregnancy|1
7163446|NCT03670810|11340970|FG001|Overall Study|Pregnancy|1
7163447|NCT03670810|11340971|FG002|Overall Study|Pregnancy|0
7163448|NCT03670810|11340972|FG003|Overall Study|Pregnancy|0
7163449|NCT03670810|11340969|FG000|Overall Study|Protocol Violation|2
7163450|NCT03670810|11340970|FG001|Overall Study|Protocol Violation|12
7163451|NCT03670810|11340971|FG002|Overall Study|Protocol Violation|8
7163452|NCT03670810|11340972|FG003|Overall Study|Protocol Violation|4
7163453|NCT03670810|11340969|FG000|Overall Study|Withdrawal by Subject|20
7163454|NCT03670810|11340970|FG001|Overall Study|Withdrawal by Subject|20
7163455|NCT03670810|11340971|FG002|Overall Study|Withdrawal by Subject|8
7163456|NCT03670810|11340972|FG003|Overall Study|Withdrawal by Subject|9
7163457|NCT03670810|11340969|FG000|Overall Study|Continuing Study|27
7163458|NCT03670810|11340970|FG001|Overall Study|Continuing Study|29
7163459|NCT03670810|11340971|FG002|Overall Study|Continuing Study|12
7163460|NCT03670810|11340972|FG003|Overall Study|Continuing Study|10
7163461|NCT03672006|11340984|FG000|Overall Study|exclusion criteria met|0
7163462|NCT03672006|11340985|FG001|Overall Study|exclusion criteria met|1
7163463|NCT03672097|11341002|FG000|Period 1|Withdrawal by Subject|2
7163464|NCT03672097|11341002|FG000|Period 1|Adverse Event|1
7163465|NCT03672097|11341002|FG000|Period 1|Did not receive treatment|1
7163466|NCT03672097|11341002|FG000|Period 2|Withdrawal by Subject|3
7163467|NCT03672097|11341002|FG000|Period 2|Other|1
7163468|NCT03672396|11341010|FG000|Overall Study|Withdrawal by Subject|4
7163469|NCT03672396|11341010|FG000|Overall Study|Physician Decision|1
7163470|NCT03672396|11341010|FG000|Overall Study|Adverse Event|1
7163471|NCT03673670|11341020|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1
7163472|NCT03673670|11341021|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
7163473|NCT03673670|11341022|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
7163474|NCT03673670|11341023|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
7163475|NCT03673670|11341024|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
7163476|NCT03673670|11341025|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
7163477|NCT03673670|11341020|FG000|Treatment Period 1 (3 Days)|Physician Decision|0
7163478|NCT03673670|11341021|FG001|Treatment Period 1 (3 Days)|Physician Decision|0
7163479|NCT03673670|11341022|FG002|Treatment Period 1 (3 Days)|Physician Decision|1
7163480|NCT03673670|11341023|FG003|Treatment Period 1 (3 Days)|Physician Decision|0
7163481|NCT03673670|11341024|FG004|Treatment Period 1 (3 Days)|Physician Decision|0
7163482|NCT03673670|11341025|FG005|Treatment Period 1 (3 Days)|Physician Decision|0
7163483|NCT03673670|11341020|FG000|Treatment Period 1 (3 Days)|Adverse Event|0
7163484|NCT03673670|11341021|FG001|Treatment Period 1 (3 Days)|Adverse Event|0
7163485|NCT03673670|11341022|FG002|Treatment Period 1 (3 Days)|Adverse Event|0
7163486|NCT03673670|11341023|FG003|Treatment Period 1 (3 Days)|Adverse Event|0
7163487|NCT03673670|11341024|FG004|Treatment Period 1 (3 Days)|Adverse Event|0
7163488|NCT03673670|11341025|FG005|Treatment Period 1 (3 Days)|Adverse Event|1
7163489|NCT03673670|11341020|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
7163490|NCT03673670|11341021|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
7163491|NCT03673670|11341022|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
7163492|NCT03673670|11341023|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
7163493|NCT03673670|11341024|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
7163494|NCT03673670|11341025|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1
7163495|NCT03673670|11341020|FG000|Treatment Period 2 (3 Days)|Adverse Event|0
7163496|NCT03673670|11341021|FG001|Treatment Period 2 (3 Days)|Adverse Event|0
7163497|NCT03673670|11341022|FG002|Treatment Period 2 (3 Days)|Adverse Event|1
7163498|NCT03673670|11341023|FG003|Treatment Period 2 (3 Days)|Adverse Event|0
7163499|NCT03673670|11341024|FG004|Treatment Period 2 (3 Days)|Adverse Event|1
7163500|NCT03673670|11341025|FG005|Treatment Period 2 (3 Days)|Adverse Event|0
7163501|NCT03673670|11341020|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
7163502|NCT03673670|11341021|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
7163503|NCT03673670|11341022|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
7163504|NCT03673670|11341023|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
7163505|NCT03673670|11341024|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1
7163506|NCT03673670|11341025|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
7163507|NCT03673670|11341020|FG000|Treatment Period 3 (3 Days)|Adverse Event|0
7163508|NCT03673670|11341021|FG001|Treatment Period 3 (3 Days)|Adverse Event|0
7163509|NCT03673670|11341022|FG002|Treatment Period 3 (3 Days)|Adverse Event|0
7163510|NCT03673670|11341023|FG003|Treatment Period 3 (3 Days)|Adverse Event|0
7163511|NCT03673670|11341024|FG004|Treatment Period 3 (3 Days)|Adverse Event|1
7163512|NCT03673670|11341025|FG005|Treatment Period 3 (3 Days)|Adverse Event|0
7163513|NCT03674177|11341046|FG000|Overall Study|Lost to Follow-up|2
7163514|NCT03674177|11341047|FG001|Overall Study|Lost to Follow-up|1
7163515|NCT03674177|11341048|FG002|Overall Study|Lost to Follow-up|0
7163516|NCT03674177|11341049|FG003|Overall Study|Lost to Follow-up|2
7163517|NCT03674281|11341062|FG000|Overall Study|screen failure|2
7163518|NCT03674281|11341063|FG001|Overall Study|screen failure|0
7163519|NCT03674281|11341064|FG002|Overall Study|screen failure|0
7163520|NCT03674281|11341062|FG000|Overall Study|Withdrawal by Subject|1
7163521|NCT03674281|11341063|FG001|Overall Study|Withdrawal by Subject|3
7163522|NCT03674281|11341064|FG002|Overall Study|Withdrawal by Subject|3
7163523|NCT03675776|11341123|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5
7163524|NCT03675776|11341124|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6
7163525|NCT03675776|11341125|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8
7163526|NCT03675776|11341123|FG000|Double Blind Treatment Period|Lack of Efficacy|1
7163527|NCT03675776|11341124|FG001|Double Blind Treatment Period|Lack of Efficacy|0
7163528|NCT03675776|11341125|FG002|Double Blind Treatment Period|Lack of Efficacy|0
7163529|NCT03676634|11341137|FG000|Overall Study|Red blood cell loss|1
7163530|NCT03676634|11341137|FG000|Overall Study|Out-of-limit pulse|2
7163531|NCT03677375|11341189|FG000|Overall Study|Incomplete procedure|8
7163532|NCT03677375|11341189|FG000|Overall Study|Adverse Event|3
7163533|NCT03677375|11341189|FG000|Overall Study|Physician Decision|1
7163534|NCT03677401|11341195|FG000|Overall Study|Adverse Event|4
7163535|NCT03677401|11341196|FG001|Overall Study|Adverse Event|14
7163536|NCT03677401|11341195|FG000|Overall Study|Lack of Efficacy|3
7163537|NCT03677401|11341196|FG001|Overall Study|Lack of Efficacy|1
7163538|NCT03677401|11341195|FG000|Overall Study|Withdrawal by Subject|2
7163539|NCT03677401|11341196|FG001|Overall Study|Withdrawal by Subject|2
7163540|NCT03677401|11341195|FG000|Overall Study|Sponsor decision|0
7163541|NCT03677401|11341196|FG001|Overall Study|Sponsor decision|1
7163542|NCT03677401|11341195|FG000|Overall Study|Reason Unspecified|1
7163543|NCT03677401|11341196|FG001|Overall Study|Reason Unspecified|0
7080328|NCT02120950|11189658|FG002|Overall Study|Other reasons|1
7080329|NCT02120950|11189656|FG000|Overall Study|Lost to Follow-up|0
7080330|NCT02120950|11189657|FG001|Overall Study|Lost to Follow-up|2
7080331|NCT02120950|11189658|FG002|Overall Study|Lost to Follow-up|1
7163544|NCT03677869|11341202|FG000|Overall Study|Withdrawal by Subject|1
7163545|NCT03678103|11341206|FG000|Overall Study|Withdrawn prior to completion|4
7163546|NCT03678285|11341210|FG000|Overall Study|Adverse Event|2
7163547|NCT03678285|11341210|FG000|Overall Study|Withdrawal by subject prior to start of workout|1
7163548|NCT03678285|11341210|FG000|Overall Study|Dehydrated prior to start of workout|1
7163549|NCT03678870|11341220|FG000|Overall Study|prescribed non- protocol medications|10
7163550|NCT03678870|11341221|FG001|Overall Study|prescribed non- protocol medications|6
7163551|NCT03678870|11341220|FG000|Overall Study|Lost to Follow-up|3
7163552|NCT03678870|11341221|FG001|Overall Study|Lost to Follow-up|2
7163553|NCT03679741|11341236|FG000|Period 1|No longer meet eligibility criteria|1
7163554|NCT03679741|11341237|FG001|Period 1|No longer meet eligibility criteria|0
7163555|NCT03679741|11341236|FG000|Period 1|Lost to Follow-up|0
7163556|NCT03679741|11341237|FG001|Period 1|Lost to Follow-up|1
7163557|NCT03679741|11341236|FG000|Period 1|Adverse Event|1
7163558|NCT03679741|11341237|FG001|Period 1|Adverse Event|1
7163559|NCT03679741|11341236|FG000|Period 1|Withdrawal by Subject|0
7163560|NCT03679741|11341237|FG001|Period 1|Withdrawal by Subject|1
7163561|NCT03679741|11341236|FG000|Period 2|Adverse Event|2
7163562|NCT03679741|11341237|FG001|Period 2|Adverse Event|1
7163563|NCT03679741|11341236|FG000|Period 2|Withdrawal by Subject|1
7163564|NCT03679741|11341237|FG001|Period 2|Withdrawal by Subject|1
7184441|NCT02330562|11384671|FG006|Overall Study|Adverse Event|0
7184442|NCT02330562|11384672|FG007|Overall Study|Adverse Event|0
7184443|NCT02330562|11384673|FG008|Overall Study|Adverse Event|0
7184444|NCT02330562|11384674|FG009|Overall Study|Adverse Event|1
7184445|NCT02330562|11384675|FG010|Overall Study|Adverse Event|1
7184446|NCT02330562|11384665|FG000|Overall Study|Participant decision|1
7184447|NCT02330562|11384666|FG001|Overall Study|Participant decision|0
7184448|NCT02330562|11384667|FG002|Overall Study|Participant decision|4
7184449|NCT02330562|11384668|FG003|Overall Study|Participant decision|1
7184450|NCT02330562|11384669|FG004|Overall Study|Participant decision|5
7184451|NCT02330562|11384670|FG005|Overall Study|Participant decision|2
7080332|NCT02121002|11189668|FG000|Overall Study|Physician Decision|2
7184452|NCT02330562|11384671|FG006|Overall Study|Participant decision|0
7184453|NCT02330562|11384672|FG007|Overall Study|Participant decision|0
7184454|NCT02330562|11384673|FG008|Overall Study|Participant decision|0
7184455|NCT02330562|11384674|FG009|Overall Study|Participant decision|3
7080333|NCT02121002|11189669|FG001|Overall Study|Physician Decision|0
7080334|NCT02121002|11189670|FG002|Overall Study|Physician Decision|0
7080335|NCT02121002|11189668|FG000|Overall Study|Withdrawal by Subject|3
7080336|NCT02121002|11189669|FG001|Overall Study|Withdrawal by Subject|1
7080337|NCT02121002|11189670|FG002|Overall Study|Withdrawal by Subject|4
7080338|NCT02121002|11189668|FG000|Overall Study|Protocol Violation|1
7080339|NCT02121002|11189669|FG001|Overall Study|Protocol Violation|2
7080340|NCT02121002|11189670|FG002|Overall Study|Protocol Violation|4
7080341|NCT02121002|11189668|FG000|Overall Study|Concomitant therapy|0
7080342|NCT02121002|11189669|FG001|Overall Study|Concomitant therapy|1
7080343|NCT02121002|11189670|FG002|Overall Study|Concomitant therapy|1
7080344|NCT02121002|11189668|FG000|Overall Study|Others|1
7080345|NCT02121002|11189669|FG001|Overall Study|Others|0
7080346|NCT02121002|11189670|FG002|Overall Study|Others|1
7080347|NCT02121210|11189694|FG000|Overall Study|Adverse Event|5
7080348|NCT02121210|11189695|FG001|Overall Study|Adverse Event|7
7080349|NCT02121210|11189694|FG000|Overall Study|Lack of Efficacy|2
7080350|NCT02121210|11189695|FG001|Overall Study|Lack of Efficacy|0
7080351|NCT02121210|11189694|FG000|Overall Study|Other than specified above|0
7080352|NCT02121210|11189695|FG001|Overall Study|Other than specified above|2
7080353|NCT02121262|11189703|FG000|Overall Study|Adverse Event|6
7080354|NCT02121262|11189704|FG001|Overall Study|Adverse Event|3
7080355|NCT02121262|11189703|FG000|Overall Study|Lack of Efficacy|3
7080356|NCT02121262|11189704|FG001|Overall Study|Lack of Efficacy|0
7080357|NCT02121262|11189703|FG000|Overall Study|Personal Reasons|19
7080358|NCT02121262|11189704|FG001|Overall Study|Personal Reasons|5
7080359|NCT02121262|11189703|FG000|Overall Study|Protocol Violation|1
7080360|NCT02121262|11189704|FG001|Overall Study|Protocol Violation|1
7080361|NCT02121262|11189703|FG000|Overall Study|Participant Dropped-out|0
7080362|NCT02121262|11189704|FG001|Overall Study|Participant Dropped-out|1
7080363|NCT02121262|11189703|FG000|Overall Study|Participant was Deemed Unsuitable|1
7080364|NCT02121262|11189704|FG001|Overall Study|Participant was Deemed Unsuitable|0
7080365|NCT02121262|11189703|FG000|Overall Study|Consent Withdrawn|1
7080366|NCT02121262|11189704|FG001|Overall Study|Consent Withdrawn|0
7080367|NCT02121301|11189713|FG000|Overall Study|Protocol Violation|1
7080368|NCT02121301|11189714|FG001|Overall Study|Protocol Violation|4
7080369|NCT02121301|11189715|FG002|Overall Study|Protocol Violation|1
7080370|NCT02121392|11189725|FG000|Prior to Intervention|Protocol Violation|40
7080371|NCT02121392|11189726|FG001|Prior to Intervention|Protocol Violation|35
7163565|NCT03680521|11341290|FG000|Overall Study|Ongoing in long-term follow up|7
7163566|NCT03680521|11341291|FG001|Overall Study|Ongoing in long-term follow up|11
7163567|NCT03680742|11341300|FG000|Overall Study|Unsuccessful Implant Attempt|2
7163568|NCT03681093|11341307|FG000|Overall Study|Subject decision|0
7163569|NCT03681093|11341308|FG001|Overall Study|Subject decision|2
7163570|NCT03681093|11341309|FG002|Overall Study|Subject decision|1
7163571|NCT03681119|11341319|FG000|Overall Study|No specific reason|4
7163572|NCT03681119|11341320|FG001|Overall Study|No specific reason|0
7163573|NCT03681119|11341319|FG000|Overall Study|Sickness|2
7163574|NCT03681119|11341320|FG001|Overall Study|Sickness|0
7163575|NCT03681353|11341324|FG000|Overall Study|Lost to Follow-up|2
7163576|NCT03681353|11341324|FG000|Overall Study|Withdrawal by Subject|3
7163577|NCT03681353|11341324|FG000|Overall Study|withdrawn by PI|2
7163578|NCT03681405|11341330|FG000|Overall Study|Found to be ineligible after randomized|1
7163579|NCT03681405|11341331|FG001|Overall Study|Found to be ineligible after randomized|0
7184456|NCT02330562|11384675|FG010|Overall Study|Participant decision|0
7184457|NCT02330562|11384665|FG000|Overall Study|Disease progression|5
7184458|NCT02330562|11384666|FG001|Overall Study|Disease progression|3
7184459|NCT02330562|11384667|FG002|Overall Study|Disease progression|20
7184460|NCT02330562|11384668|FG003|Overall Study|Disease progression|28
7184461|NCT02330562|11384669|FG004|Overall Study|Disease progression|23
7184462|NCT02330562|11384670|FG005|Overall Study|Disease progression|7
7184463|NCT02330562|11384671|FG006|Overall Study|Disease progression|1
7184464|NCT02330562|11384672|FG007|Overall Study|Disease progression|1
7184465|NCT02330562|11384673|FG008|Overall Study|Disease progression|1
7184466|NCT02330562|11384674|FG009|Overall Study|Disease progression|0
7184467|NCT02330562|11384675|FG010|Overall Study|Disease progression|5
7184468|NCT02330562|11384665|FG000|Overall Study|Other reasons|0
7184469|NCT02330562|11384666|FG001|Overall Study|Other reasons|0
7184470|NCT02330562|11384667|FG002|Overall Study|Other reasons|0
7184471|NCT02330562|11384668|FG003|Overall Study|Other reasons|1
7184472|NCT02330562|11384669|FG004|Overall Study|Other reasons|0
7184473|NCT02330562|11384670|FG005|Overall Study|Other reasons|0
7184474|NCT02330562|11384671|FG006|Overall Study|Other reasons|0
7184475|NCT02330562|11384672|FG007|Overall Study|Other reasons|0
7184476|NCT02330562|11384673|FG008|Overall Study|Other reasons|0
7184477|NCT02330562|11384674|FG009|Overall Study|Other reasons|0
7184478|NCT02330562|11384675|FG010|Overall Study|Other reasons|0
7080372|NCT02121392|11189725|FG000|Prior to Intervention|Withdrawal by Subject|8
7080373|NCT02121392|11189726|FG001|Prior to Intervention|Withdrawal by Subject|6
7080374|NCT02121392|11189725|FG000|After Placement of AC Block vs Sham|Protocol Violation|3
7080375|NCT02121392|11189726|FG001|After Placement of AC Block vs Sham|Protocol Violation|2
7080376|NCT02121392|11189725|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0
7080377|NCT02121392|11189726|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1
7184479|NCT02330562|11384665|FG000|Overall Study|Withdrawal by Subject|0
7184480|NCT02330562|11384666|FG001|Overall Study|Withdrawal by Subject|0
7184481|NCT02330562|11384667|FG002|Overall Study|Withdrawal by Subject|0
7184482|NCT02330562|11384668|FG003|Overall Study|Withdrawal by Subject|0
7184483|NCT02330562|11384669|FG004|Overall Study|Withdrawal by Subject|0
7184484|NCT02330562|11384670|FG005|Overall Study|Withdrawal by Subject|0
7184485|NCT02330562|11384671|FG006|Overall Study|Withdrawal by Subject|0
7163580|NCT03681951|11341377|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1
7163581|NCT03681951|11341378|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
7163582|NCT03681951|11341379|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
7163583|NCT03681951|11341380|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
7163584|NCT03681951|11341381|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
7163585|NCT03681951|11341382|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
7163586|NCT03681951|11341383|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
7163587|NCT03681951|11341384|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
7163588|NCT03681951|11341377|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4
7163589|NCT03681951|11341378|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
7163590|NCT03681951|11341379|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
7163591|NCT03681951|11341380|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
7163592|NCT03681951|11341381|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
7163593|NCT03681951|11341382|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
7163594|NCT03681951|11341383|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
7163595|NCT03681951|11341384|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
7163596|NCT03681951|11341377|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3
7163597|NCT03681951|11341378|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
7163598|NCT03681951|11341379|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
7163599|NCT03681951|11341380|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
7163600|NCT03681951|11341381|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
7163601|NCT03681951|11341382|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
7163602|NCT03681951|11341383|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
7163603|NCT03681951|11341384|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
7163604|NCT03682107|11341412|FG000|Overall Study|Withdrawal by Subject|0
7163605|NCT03682107|11341413|FG001|Overall Study|Withdrawal by Subject|1
7163606|NCT03682107|11341414|FG002|Overall Study|Withdrawal by Subject|0
7163607|NCT03682107|11341415|FG003|Overall Study|Withdrawal by Subject|0
7163608|NCT03682107|11341416|FG004|Overall Study|Withdrawal by Subject|0
7163609|NCT03682120|11341432|FG000|Overall Study|Lost to Follow-up|11
7163610|NCT03682120|11341433|FG001|Overall Study|Lost to Follow-up|4
7163611|NCT03682120|11341434|FG002|Overall Study|Lost to Follow-up|5
7163612|NCT03682120|11341435|FG003|Overall Study|Lost to Follow-up|2
7163613|NCT03682120|11341432|FG000|Overall Study|Physician Decision|1
7163614|NCT03682120|11341433|FG001|Overall Study|Physician Decision|0
7163615|NCT03682120|11341434|FG002|Overall Study|Physician Decision|0
7163616|NCT03682120|11341435|FG003|Overall Study|Physician Decision|0
7163617|NCT03682120|11341432|FG000|Overall Study|Withdrawal by Subject|1
7163618|NCT03682120|11341433|FG001|Overall Study|Withdrawal by Subject|2
7163619|NCT03682120|11341434|FG002|Overall Study|Withdrawal by Subject|3
7163620|NCT03682120|11341435|FG003|Overall Study|Withdrawal by Subject|0
7163621|NCT03682120|11341432|FG000|Overall Study|Death|0
7163622|NCT03682120|11341433|FG001|Overall Study|Death|1
7163623|NCT03682120|11341434|FG002|Overall Study|Death|0
7163624|NCT03682120|11341435|FG003|Overall Study|Death|0
7163625|NCT03682120|11341432|FG000|Overall Study|Enrolled but Treatment Not Administered|0
7163626|NCT03682120|11341433|FG001|Overall Study|Enrolled but Treatment Not Administered|1
7163627|NCT03682120|11341434|FG002|Overall Study|Enrolled but Treatment Not Administered|0
7163628|NCT03682120|11341435|FG003|Overall Study|Enrolled but Treatment Not Administered|0
7163629|NCT03682302|11341451|FG000|Overall Study|Lost to Follow-up|1
7163630|NCT03682302|11341452|FG001|Overall Study|Lost to Follow-up|2
7163631|NCT03682302|11341453|FG002|Overall Study|Lost to Follow-up|0
7163632|NCT03682302|11341454|FG003|Overall Study|Lost to Follow-up|1
7163633|NCT03682302|11341451|FG000|Overall Study|Study drug was not administered|0
7163634|NCT03682302|11341452|FG001|Overall Study|Study drug was not administered|0
7163635|NCT03682302|11341453|FG002|Overall Study|Study drug was not administered|1
7163636|NCT03682302|11341454|FG003|Overall Study|Study drug was not administered|1
7163637|NCT03682705|11341470|FG000|Overall Study|Adverse Event|1
7163638|NCT03682705|11341471|FG001|Overall Study|Adverse Event|1
7163639|NCT03682705|11341472|FG002|Overall Study|Adverse Event|1
7163640|NCT03682705|11341473|FG003|Overall Study|Adverse Event|0
7163641|NCT03682705|11341474|FG004|Overall Study|Adverse Event|1
7163642|NCT03682705|11341475|FG005|Overall Study|Adverse Event|1
7163643|NCT03682705|11341470|FG000|Overall Study|Withdrawal by Subject|1
7163644|NCT03682705|11341471|FG001|Overall Study|Withdrawal by Subject|3
7163645|NCT03682705|11341472|FG002|Overall Study|Withdrawal by Subject|2
7163646|NCT03682705|11341473|FG003|Overall Study|Withdrawal by Subject|4
7163647|NCT03682705|11341474|FG004|Overall Study|Withdrawal by Subject|0
7163648|NCT03682705|11341475|FG005|Overall Study|Withdrawal by Subject|1
7163649|NCT03682705|11341470|FG000|Overall Study|Other, not specified|0
7163650|NCT03682705|11341471|FG001|Overall Study|Other, not specified|0
7163651|NCT03682705|11341472|FG002|Overall Study|Other, not specified|0
7163652|NCT03682705|11341473|FG003|Overall Study|Other, not specified|1
7163653|NCT03682705|11341474|FG004|Overall Study|Other, not specified|2
7163654|NCT03682705|11341475|FG005|Overall Study|Other, not specified|0
7163655|NCT03682705|11341470|FG000|Overall Study|Lost to Follow-up|0
7163656|NCT03682705|11341471|FG001|Overall Study|Lost to Follow-up|0
7163657|NCT03682705|11341472|FG002|Overall Study|Lost to Follow-up|0
7163658|NCT03682705|11341473|FG003|Overall Study|Lost to Follow-up|0
7163659|NCT03682705|11341474|FG004|Overall Study|Lost to Follow-up|3
7163660|NCT03682705|11341475|FG005|Overall Study|Lost to Follow-up|0
7163661|NCT03683576|11341511|FG000|Overall Study|Withdrawal by Subject|2
7163662|NCT03683576|11341512|FG001|Overall Study|Withdrawal by Subject|0
7163663|NCT03683576|11341513|FG002|Overall Study|Withdrawal by Subject|8
7163664|NCT03683576|11341514|FG003|Overall Study|Withdrawal by Subject|3
7163665|NCT03683576|11341511|FG000|Overall Study|Adverse Event|3
7163666|NCT03683576|11341512|FG001|Overall Study|Adverse Event|0
7163667|NCT03683576|11341513|FG002|Overall Study|Adverse Event|0
7163668|NCT03683576|11341514|FG003|Overall Study|Adverse Event|4
7163669|NCT03683576|11341511|FG000|Overall Study|Lack of Efficacy|1
7163670|NCT03683576|11341512|FG001|Overall Study|Lack of Efficacy|0
7163671|NCT03683576|11341513|FG002|Overall Study|Lack of Efficacy|1
7163672|NCT03683576|11341514|FG003|Overall Study|Lack of Efficacy|1
7163673|NCT03683576|11341511|FG000|Overall Study|Lost to Follow-up|0
7163674|NCT03683576|11341512|FG001|Overall Study|Lost to Follow-up|1
7163675|NCT03683576|11341513|FG002|Overall Study|Lost to Follow-up|2
7163676|NCT03683576|11341514|FG003|Overall Study|Lost to Follow-up|0
7163677|NCT03683576|11341511|FG000|Overall Study|Other, Not Specified|0
7163678|NCT03683576|11341512|FG001|Overall Study|Other, Not Specified|2
7163679|NCT03683576|11341513|FG002|Overall Study|Other, Not Specified|0
7163680|NCT03683576|11341514|FG003|Overall Study|Other, Not Specified|0
7163681|NCT03683576|11341511|FG000|Overall Study|Protocol Violation|0
7163682|NCT03683576|11341512|FG001|Overall Study|Protocol Violation|1
7163683|NCT03683576|11341513|FG002|Overall Study|Protocol Violation|1
7163684|NCT03683576|11341514|FG003|Overall Study|Protocol Violation|0
7163685|NCT03683719|11341529|FG000|Overall Study|Lack of Efficacy|1
7163686|NCT03683719|11341530|FG001|Overall Study|Lack of Efficacy|3
7163687|NCT03683719|11341531|FG002|Overall Study|Lack of Efficacy|4
7163688|NCT03683719|11341532|FG003|Overall Study|Lack of Efficacy|0
7163689|NCT03683719|11341533|FG004|Overall Study|Lack of Efficacy|4
7163690|NCT03683719|11341529|FG000|Overall Study|Adverse Event|6
7163691|NCT03683719|11341530|FG001|Overall Study|Adverse Event|6
7163692|NCT03683719|11341531|FG002|Overall Study|Adverse Event|0
7163693|NCT03683719|11341532|FG003|Overall Study|Adverse Event|1
7163694|NCT03683719|11341533|FG004|Overall Study|Adverse Event|3
7163695|NCT03683719|11341529|FG000|Overall Study|Withdrawal by Subject|4
7163696|NCT03683719|11341530|FG001|Overall Study|Withdrawal by Subject|4
7163697|NCT03683719|11341531|FG002|Overall Study|Withdrawal by Subject|3
7163698|NCT03683719|11341532|FG003|Overall Study|Withdrawal by Subject|5
7163699|NCT03683719|11341533|FG004|Overall Study|Withdrawal by Subject|5
7163700|NCT03683719|11341529|FG000|Overall Study|Lost to Follow-up|1
7163701|NCT03683719|11341530|FG001|Overall Study|Lost to Follow-up|0
7163702|NCT03683719|11341531|FG002|Overall Study|Lost to Follow-up|0
7163703|NCT03683719|11341532|FG003|Overall Study|Lost to Follow-up|1
7163704|NCT03683719|11341533|FG004|Overall Study|Lost to Follow-up|1
7163705|NCT03683719|11341529|FG000|Overall Study|Other personal reasons|0
7163706|NCT03683719|11341530|FG001|Overall Study|Other personal reasons|0
7163707|NCT03683719|11341531|FG002|Overall Study|Other personal reasons|1
7163708|NCT03683719|11341532|FG003|Overall Study|Other personal reasons|0
7163709|NCT03683719|11341533|FG004|Overall Study|Other personal reasons|1
7163710|NCT03683758|11341547|FG000|Overall Study|Non-study commitment conflict|1
7163711|NCT03683758|11341548|FG001|Overall Study|Non-study commitment conflict|3
7163712|NCT03683758|11341547|FG000|Overall Study|Illness preventing participation|1
7163713|NCT03683758|11341548|FG001|Overall Study|Illness preventing participation|0
7163714|NCT03683758|11341547|FG000|Overall Study|Adverse Event|1
7163715|NCT03683758|11341548|FG001|Overall Study|Adverse Event|0
7163716|NCT03684044|11341562|FG000|Overall Study|Adverse Event|3
7163717|NCT03684044|11341563|FG001|Overall Study|Adverse Event|0
7163718|NCT03684044|11341562|FG000|Overall Study|Death|4
7163719|NCT03684044|11341563|FG001|Overall Study|Death|7
7163720|NCT03684044|11341562|FG000|Overall Study|Lost to Follow-up|3
7163721|NCT03684044|11341563|FG001|Overall Study|Lost to Follow-up|2
7163722|NCT03684044|11341562|FG000|Overall Study|Patient Not Available|0
7163723|NCT03684044|11341563|FG001|Overall Study|Patient Not Available|2
7163724|NCT03684044|11341562|FG000|Overall Study|Physician Decision|1
7163725|NCT03684044|11341563|FG001|Overall Study|Physician Decision|0
7163726|NCT03684044|11341562|FG000|Overall Study|Withdrawal by Subject|11
7163727|NCT03684044|11341563|FG001|Overall Study|Withdrawal by Subject|9
7163728|NCT03684642|11341581|FG000|Overall Study|Adverse Event|6
7163729|NCT03684642|11341582|FG001|Overall Study|Adverse Event|15
7163730|NCT03684642|11341583|FG002|Overall Study|Adverse Event|11
7163731|NCT03684642|11341581|FG000|Overall Study|Withdrawal by Subject|35
7163732|NCT03684642|11341582|FG001|Overall Study|Withdrawal by Subject|53
7163733|NCT03684642|11341583|FG002|Overall Study|Withdrawal by Subject|23
7163734|NCT03684642|11341581|FG000|Overall Study|Lack of Efficacy|0
7163735|NCT03684642|11341582|FG001|Overall Study|Lack of Efficacy|0
7163736|NCT03684642|11341583|FG002|Overall Study|Lack of Efficacy|1
7163737|NCT03684642|11341581|FG000|Overall Study|Poor compliance to protocol|0
7163738|NCT03684642|11341582|FG001|Overall Study|Poor compliance to protocol|4
7163739|NCT03684642|11341583|FG002|Overall Study|Poor compliance to protocol|1
7163740|NCT03684642|11341581|FG000|Overall Study|Other than specified|62
7163741|NCT03684642|11341582|FG001|Overall Study|Other than specified|60
7163742|NCT03684642|11341583|FG002|Overall Study|Other than specified|67
7080378|NCT02121509|11189751|FG000|Washout Period (35 Days)|Adverse Event|1
7080379|NCT02121509|11189752|FG001|Washout Period (35 Days)|Adverse Event|1
7163743|NCT03684642|11341581|FG000|Overall Study|Randomized and not treated|0
7163744|NCT03684642|11341582|FG001|Overall Study|Randomized and not treated|0
7163745|NCT03684642|11341583|FG002|Overall Study|Randomized and not treated|1
7163746|NCT03684642|11341581|FG000|Overall Study|Missing completion status but alive at last contact|0
7163747|NCT03684642|11341582|FG001|Overall Study|Missing completion status but alive at last contact|1
7163748|NCT03684642|11341583|FG002|Overall Study|Missing completion status but alive at last contact|2
7163749|NCT03684928|11341591|FG000|First Intervention|Lost to Follow-up|0
7163750|NCT03684928|11341592|FG001|First Intervention|Lost to Follow-up|1
7163751|NCT03684928|11341591|FG000|First Intervention|Withdrawal by Subject|0
7163752|NCT03684928|11341592|FG001|First Intervention|Withdrawal by Subject|2
7163753|NCT03684928|11341591|FG000|Second Intervention|Soft Tissue Injury|1
7163754|NCT03684928|11341592|FG001|Second Intervention|Soft Tissue Injury|0
7163755|NCT03685344|11341602|FG000|Overall Study|Withdrawal by Subject|1
7163756|NCT03685344|11341603|FG001|Overall Study|Withdrawal by Subject|1
7163757|NCT03685344|11341604|FG002|Overall Study|Withdrawal by Subject|2
7163758|NCT03685344|11341605|FG003|Overall Study|Withdrawal by Subject|0
7163759|NCT03685344|11341602|FG000|Overall Study|Physician Decision|1
7163760|NCT03685344|11341603|FG001|Overall Study|Physician Decision|1
7163761|NCT03685344|11341604|FG002|Overall Study|Physician Decision|5
7163762|NCT03685344|11341605|FG003|Overall Study|Physician Decision|0
7163763|NCT03685344|11341602|FG000|Overall Study|Death|1
7163764|NCT03685344|11341603|FG001|Overall Study|Death|1
7163765|NCT03685344|11341604|FG002|Overall Study|Death|0
7163766|NCT03685344|11341605|FG003|Overall Study|Death|0
7163767|NCT03685643|11341626|FG000|Overall Study|Lost to Follow-up|14
7163768|NCT03685643|11341627|FG001|Overall Study|Lost to Follow-up|22
7163769|NCT03686033|11341646|FG000|Treatment Period 2 (1 Day)|Adverse Event|0
7163770|NCT03686033|11341647|FG001|Treatment Period 2 (1 Day)|Adverse Event|0
7163771|NCT03686033|11341648|FG002|Treatment Period 2 (1 Day)|Adverse Event|0
7163772|NCT03686033|11341649|FG003|Treatment Period 2 (1 Day)|Adverse Event|0
7163773|NCT03686033|11341650|FG004|Treatment Period 2 (1 Day)|Adverse Event|1
7163774|NCT03686033|11341651|FG005|Treatment Period 2 (1 Day)|Adverse Event|0
7163775|NCT03686176|11341668|FG000|Overall Study|Procedure cancelled|1
7163776|NCT03686176|11341669|FG001|Overall Study|Procedure cancelled|0
7163777|NCT03686176|11341670|FG002|Overall Study|Procedure cancelled|0
7163778|NCT03686176|11341668|FG000|Overall Study|VR Malfunction|1
7163779|NCT03686176|11341669|FG001|Overall Study|VR Malfunction|0
7163780|NCT03686176|11341670|FG002|Overall Study|VR Malfunction|0
7163781|NCT03687125|11341680|FG000|Overall Study|Progressive Disease|2
7163782|NCT03687125|11341681|FG001|Overall Study|Progressive Disease|1
7163783|NCT03687125|11341680|FG000|Overall Study|Protocol Violation|1
7163784|NCT03687125|11341681|FG001|Overall Study|Protocol Violation|0
7163785|NCT03687372|11341691|FG000|Overall Study|Lost to Follow-up|12
7163786|NCT03687372|11341692|FG001|Overall Study|Lost to Follow-up|21
7163787|NCT03687372|11341691|FG000|Overall Study|Withdrawal by Subject|4
7163788|NCT03687372|11341692|FG001|Overall Study|Withdrawal by Subject|17
7163789|NCT03687372|11341691|FG000|Overall Study|Investigator Decision|1
7163790|NCT03687372|11341692|FG001|Overall Study|Investigator Decision|1
7163791|NCT03687736|11341756|FG000|Overall Study|Lost to Follow-up|7
7163792|NCT03687736|11341756|FG000|Overall Study|Withdrawal by Subject|3
7163793|NCT03687827|11341762|FG000|Treatment Period 1|Death|0
7163794|NCT03687827|11341763|FG001|Treatment Period 1|Death|1
6895185|NCT00623428|10912959|FG001|Follow-up Period|Reason not specified|1
6895186|NCT00623428|10912958|FG000|Follow-up Period|Death|0
7163795|NCT03687827|11341762|FG000|Treatment Period 1|Lost to Follow-up|2
7163796|NCT03687827|11341763|FG001|Treatment Period 1|Lost to Follow-up|2
7163797|NCT03687827|11341762|FG000|Treatment Period 1|Physician Decision|5
7080380|NCT02121509|11189753|FG002|Washout Period (35 Days)|Adverse Event|0
7080381|NCT02121509|11189754|FG003|Washout Period (35 Days)|Adverse Event|0
7080382|NCT02121509|11189751|FG000|Washout Period (35 Days)|Withdrawal by Subject|0
7080383|NCT02121509|11189752|FG001|Washout Period (35 Days)|Withdrawal by Subject|3
7080384|NCT02121509|11189753|FG002|Washout Period (35 Days)|Withdrawal by Subject|0
7080385|NCT02121509|11189754|FG003|Washout Period (35 Days)|Withdrawal by Subject|0
7080386|NCT02121509|11189751|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1
7080387|NCT02121509|11189752|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0
7080388|NCT02121509|11189753|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0
7163798|NCT03687827|11341763|FG001|Treatment Period 1|Physician Decision|2
7163799|NCT03687827|11341762|FG000|Treatment Period 1|Withdrawal by Subject|7
7163800|NCT03687827|11341763|FG001|Treatment Period 1|Withdrawal by Subject|3
7163801|NCT03687827|11341762|FG000|Treatment Period 2|Physician Decision|4
7163802|NCT03687827|11341763|FG001|Treatment Period 2|Physician Decision|1
7163803|NCT03687827|11341762|FG000|Treatment Period 2|Withdrawal by Subject|1
7163804|NCT03687827|11341763|FG001|Treatment Period 2|Withdrawal by Subject|2
7163805|NCT03687970|11341771|FG000|Overall Study|visit scheduling conflicts|2
7163806|NCT03687970|11341772|FG001|Overall Study|visit scheduling conflicts|0
7163807|NCT03688620|11341798|FG000|Overall Study|Other|0
7163808|NCT03688620|11341799|FG001|Overall Study|Other|0
7163809|NCT03688620|11341800|FG002|Overall Study|Other|1
7163810|NCT03688620|11341798|FG000|Overall Study|Unwilling to attend the scheduled visit|0
7163811|NCT03688620|11341799|FG001|Overall Study|Unwilling to attend the scheduled visit|1
7163812|NCT03688620|11341800|FG002|Overall Study|Unwilling to attend the scheduled visit|0
7163813|NCT03688620|11341798|FG000|Overall Study|Lost to Follow-up|16
7163814|NCT03688620|11341799|FG001|Overall Study|Lost to Follow-up|0
7163815|NCT03688620|11341800|FG002|Overall Study|Lost to Follow-up|1
7163816|NCT03688620|11341798|FG000|Overall Study|Withdrawal by Subject|0
7163817|NCT03688620|11341799|FG001|Overall Study|Withdrawal by Subject|0
7163818|NCT03688620|11341800|FG002|Overall Study|Withdrawal by Subject|6
7163819|NCT03688711|11341816|FG000|Overall Study|Withdrawal by Subject|0
7163820|NCT03688711|11341817|FG001|Overall Study|Withdrawal by Subject|1
7163821|NCT03688880|11341825|FG000|Overall Study|Withdrawal by Subject|0
7163822|NCT03688880|11341826|FG001|Overall Study|Withdrawal by Subject|2
7163823|NCT03688880|11341825|FG000|Overall Study|Use of non-permitted concurrent therapy|0
7163824|NCT03688880|11341826|FG001|Overall Study|Use of non-permitted concurrent therapy|2
7163825|NCT03688880|11341825|FG000|Overall Study|Lost to Follow-up|4
7163826|NCT03688880|11341826|FG001|Overall Study|Lost to Follow-up|7
7163827|NCT03688880|11341825|FG000|Overall Study|Adverse Event|0
7163828|NCT03688880|11341826|FG001|Overall Study|Adverse Event|2
7163829|NCT03688880|11341825|FG000|Overall Study|Device deficiencies|0
7163830|NCT03688880|11341826|FG001|Overall Study|Device deficiencies|2
7163831|NCT03688880|11341825|FG000|Overall Study|Other|10
7163832|NCT03688880|11341826|FG001|Overall Study|Other|16
7163833|NCT03689452|11341834|FG000|Overall Study|Lost to Follow-up|1
7163834|NCT03689452|11341835|FG001|Overall Study|Lost to Follow-up|1
7163835|NCT03691779|11341862|FG000|Part B (24 Weeks)|Adverse Event|0
7163836|NCT03691779|11341863|FG001|Part B (24 Weeks)|Adverse Event|1
7163837|NCT03691779|11341862|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0
7163838|NCT03691779|11341863|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1
7163839|NCT03691831|11341872|FG000|Overall Study|Lost to Follow-up|16
7163840|NCT03691831|11341873|FG001|Overall Study|Lost to Follow-up|12
7163841|NCT03691831|11341872|FG000|Overall Study|Withdrawal by Subject|9
7163842|NCT03691831|11341873|FG001|Overall Study|Withdrawal by Subject|17
7163843|NCT03691831|11341872|FG000|Overall Study|Investigator Decision|2
7163844|NCT03691831|11341873|FG001|Overall Study|Investigator Decision|2
7163845|NCT03691948|11341900|FG000|Overall Study|Lost to Follow-up|1
7163846|NCT03691948|11341901|FG001|Overall Study|Lost to Follow-up|3
7163847|NCT03692676|11341912|FG000|Overall Study|exclude patients with prior use|4424
7163848|NCT03692676|11341913|FG001|Overall Study|exclude patients with prior use|24726
7163849|NCT03692676|11341914|FG002|Overall Study|exclude patients with prior use|0
7163850|NCT03692676|11341915|FG003|Overall Study|exclude patients with prior use|0
7163851|NCT03692676|11341912|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480
7163852|NCT03692676|11341913|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037
7163853|NCT03692676|11341914|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0
7163854|NCT03692676|11341915|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0
7163855|NCT03692676|11341912|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881
7163856|NCT03692676|11341913|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563
7163857|NCT03692676|11341914|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281
7163858|NCT03692676|11341915|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558
7163859|NCT03692676|11341912|FG000|Overall Study|exclude patients less than 18 years of age on index date|8
7163860|NCT03692676|11341913|FG001|Overall Study|exclude patients less than 18 years of age on index date|613
7163861|NCT03692676|11341914|FG002|Overall Study|exclude patients less than 18 years of age on index date|836
7163862|NCT03692676|11341915|FG003|Overall Study|exclude patients less than 18 years of age on index date|193
7163863|NCT03692676|11341912|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149
7163864|NCT03692676|11341913|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717
7163865|NCT03692676|11341914|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723
7163866|NCT03692676|11341915|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273
7163867|NCT03692676|11341912|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208
7163868|NCT03692676|11341913|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759
7163869|NCT03692676|11341914|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419
7163870|NCT03692676|11341915|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684
7163871|NCT03692676|11341912|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275
7163872|NCT03692676|11341913|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218
7163873|NCT03692676|11341914|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515
7163874|NCT03692676|11341915|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173
7163875|NCT03692676|11341912|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0
7163876|NCT03692676|11341913|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0
7163877|NCT03692676|11341914|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147
7163878|NCT03692676|11341915|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4
7163879|NCT03692676|11341912|FG000|Overall Study|exclude patients with prior use of same substances and device|0
7163880|NCT03692676|11341913|FG001|Overall Study|exclude patients with prior use of same substances and device|0
7163881|NCT03692676|11341914|FG002|Overall Study|exclude patients with prior use of same substances and device|3700
7163882|NCT03692676|11341915|FG003|Overall Study|exclude patients with prior use of same substances and device|0
7163883|NCT03692676|11341912|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0
7163884|NCT03692676|11341913|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0
7163885|NCT03692676|11341914|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965
7163886|NCT03692676|11341915|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198
7163887|NCT03692676|11341912|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0
7163888|NCT03692676|11341913|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0
7163889|NCT03692676|11341914|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0
7163890|NCT03692676|11341915|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223
7163891|NCT03692676|11341912|FG000|Overall Study|Other|0
7163892|NCT03692676|11341913|FG001|Overall Study|Other|805
7163893|NCT03692676|11341914|FG002|Overall Study|Other|758
7163894|NCT03692676|11341915|FG003|Overall Study|Other|277
7163895|NCT03692676|11341912|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0
7163896|NCT03692676|11341913|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0
7163897|NCT03692676|11341914|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0
7163898|NCT03692676|11341915|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3
7163899|NCT03693625|11341927|FG000|Overall Study|Adverse Event|2
7163900|NCT03693625|11341928|FG001|Overall Study|Adverse Event|0
7163901|NCT03693625|11341927|FG000|Overall Study|Study Terminated By Sponsor|20
7163902|NCT03693625|11341928|FG001|Overall Study|Study Terminated By Sponsor|7
7163903|NCT03693625|11341927|FG000|Overall Study|Withdrawal by Subject|1
7163904|NCT03693625|11341928|FG001|Overall Study|Withdrawal by Subject|1
7163905|NCT03693950|11341951|FG000|Overall Study|Withdrawal by Subject|1
7163906|NCT03693950|11341952|FG001|Overall Study|Withdrawal by Subject|0
7163907|NCT03693989|11341960|FG000|Overall Study|Protocol Violation|3
7163908|NCT03693989|11341961|FG001|Overall Study|Protocol Violation|4
7163909|NCT03694197|11341967|FG000|Overall Study|Adverse Event|9
7163910|NCT03694197|11341967|FG000|Overall Study|Protocol became inconvenient to participate|1
7163911|NCT03694197|11341967|FG000|Overall Study|Physician Decision|4
7163912|NCT03694197|11341967|FG000|Overall Study|Study terminated by sponsor|1350
7163913|NCT03694197|11341967|FG000|Overall Study|Participant moved|5
7163914|NCT03694197|11341967|FG000|Overall Study|Participant withdrew consent|10
7163915|NCT03694197|11341967|FG000|Overall Study|Related to IMP administration|1
7163916|NCT03694197|11341967|FG000|Overall Study|Not disclosed|5
7163917|NCT03694210|11341971|FG000|Overall Study|Death|1
7163918|NCT03694210|11341971|FG000|Overall Study|Screen Failure|7
7163919|NCT03694548|11341979|FG000|Part A Survey|Protocol Violation|3
7163920|NCT03694548|11341980|FG001|Part A Survey|Protocol Violation|3
7163921|NCT03694548|11341981|FG002|Part A Survey|Protocol Violation|0
7163922|NCT03694548|11341979|FG000|Part B Yoga Program|Protocol Violation|0
7163923|NCT03694548|11341980|FG001|Part B Yoga Program|Protocol Violation|0
7163924|NCT03694548|11341981|FG002|Part B Yoga Program|Protocol Violation|3
7163925|NCT03694548|11341979|FG000|Part B Yoga Program|Did not attend intervention|0
7184486|NCT02330562|11384672|FG007|Overall Study|Withdrawal by Subject|0
7041558|NCT01728324|11125172|FG001|Termination of FDV|Adverse Event (Placebo Period)|1
7041559|NCT01728324|11125173|FG002|Termination of FDV|Adverse Event (Placebo Period)|0
7041560|NCT01728324|11125171|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0
7041561|NCT01728324|11125172|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1
7041562|NCT01728324|11125173|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0
7041563|NCT01728324|11125171|FG000|Termination of RBV|Adverse Event|15
7080389|NCT02121509|11189754|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0
7080390|NCT02121522|11189764|FG000|Overall Study|Adverse Event|1
7041564|NCT01728324|11125172|FG001|Termination of RBV|Adverse Event|16
7041565|NCT01728324|11125173|FG002|Termination of RBV|Adverse Event|5
7041566|NCT01728324|11125171|FG000|Termination of RBV|Lack of Efficacy|14
7041567|NCT01728324|11125172|FG001|Termination of RBV|Lack of Efficacy|11
7041568|NCT01728324|11125173|FG002|Termination of RBV|Lack of Efficacy|7
7041569|NCT01728324|11125171|FG000|Termination of RBV|Withdrawal by Subject|9
7041570|NCT01728324|11125172|FG001|Termination of RBV|Withdrawal by Subject|5
7080391|NCT02121535|11189770|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0
7041571|NCT01728324|11125173|FG002|Termination of RBV|Withdrawal by Subject|2
7041572|NCT01728324|11125171|FG000|Termination of RBV|Other than stated|1
7041573|NCT01728324|11125172|FG001|Termination of RBV|Other than stated|3
7080392|NCT02121535|11189771|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1
7080393|NCT02121535|11189770|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1
7080394|NCT02121535|11189771|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0
7080395|NCT02121756|11189780|FG000|Overall Study|Adverse Event|3
7080396|NCT02121756|11189781|FG001|Overall Study|Adverse Event|0
7080397|NCT02121756|11189780|FG000|Overall Study|Protocol Violation|1
7080398|NCT02121756|11189781|FG001|Overall Study|Protocol Violation|1
7080399|NCT02121756|11189780|FG000|Overall Study|Physician Decision|2
7080400|NCT02121756|11189781|FG001|Overall Study|Physician Decision|1
7080401|NCT02121795|11189792|FG000|Double-Blind Phase|Randomized but Never Treated|1
7080402|NCT02121795|11189793|FG001|Double-Blind Phase|Randomized but Never Treated|4
7163926|NCT03694548|11341980|FG001|Part B Yoga Program|Did not attend intervention|0
7163927|NCT03694548|11341981|FG002|Part B Yoga Program|Did not attend intervention|8
7163928|NCT03694925|11342007|FG000|Overall Study|Inadequate laboratory testing|0
7163929|NCT03694925|11342008|FG001|Overall Study|Inadequate laboratory testing|3
7163930|NCT03694925|11342009|FG002|Overall Study|Inadequate laboratory testing|0
7163931|NCT03695094|11342021|FG000|Overall Study|Adverse Event|1
7163932|NCT03695094|11342022|FG001|Overall Study|Adverse Event|1
7163933|NCT03695094|11342021|FG000|Overall Study|Withdrawal by Subject|1
7163934|NCT03695094|11342022|FG001|Overall Study|Withdrawal by Subject|0
7163935|NCT03695367|11342032|FG000|Overall Study|Missed the Day 28 visit.|1
7163936|NCT03695367|11342033|FG001|Overall Study|Missed the Day 28 visit.|0
7163937|NCT03695367|11342032|FG000|Overall Study|Lost to Follow-up|0
7163938|NCT03695367|11342033|FG001|Overall Study|Lost to Follow-up|1
7163939|NCT03695367|11342032|FG000|Overall Study|Withdrawal by Subject|0
7163940|NCT03695367|11342033|FG001|Overall Study|Withdrawal by Subject|1
7163941|NCT03695367|11342032|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0
7163942|NCT03695367|11342033|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2
7163943|NCT03695393|11342041|FG000|Overall Study|Death|3
7163944|NCT03695393|11342042|FG001|Overall Study|Death|1
7163945|NCT03695393|11342041|FG000|Overall Study|Lost to Follow-up|0
7163946|NCT03695393|11342042|FG001|Overall Study|Lost to Follow-up|1
7163947|NCT03696108|11342054|FG000|Overall Study|Physician Decision|1
7163948|NCT03696108|11342055|FG001|Overall Study|Physician Decision|0
7163949|NCT03696108|11342054|FG000|Overall Study|Withdrawal by Subject|3
7163950|NCT03696108|11342055|FG001|Overall Study|Withdrawal by Subject|6
7163951|NCT03696342|11342063|FG000|Overall Study|Lost to Follow-up|1
7163952|NCT03696342|11342064|FG001|Overall Study|Lost to Follow-up|0
7163953|NCT03696576|11342072|FG000|Overall Study|Soreness of throat after therapy|1
7163954|NCT03696576|11342073|FG001|Overall Study|Soreness of throat after therapy|1
7163955|NCT03696576|11342072|FG000|Overall Study|Lost to Follow-up|2
7163956|NCT03696576|11342073|FG001|Overall Study|Lost to Follow-up|4
7163957|NCT03697252|11342118|FG000|Overall Study|Adverse Event|3
7163958|NCT03697252|11342119|FG001|Overall Study|Adverse Event|2
7163959|NCT03697252|11342118|FG000|Overall Study|Withdrawal by Subject|14
7163960|NCT03697252|11342119|FG001|Overall Study|Withdrawal by Subject|14
7163961|NCT03697252|11342118|FG000|Overall Study|Lost to Follow-up|0
7163962|NCT03697252|11342119|FG001|Overall Study|Lost to Follow-up|1
7163963|NCT03697252|11342118|FG000|Overall Study|Physician Decision|1
7163964|NCT03697252|11342119|FG001|Overall Study|Physician Decision|1
7163965|NCT03697252|11342118|FG000|Overall Study|Other|0
7163966|NCT03697252|11342119|FG001|Overall Study|Other|1
7163967|NCT03697460|11342125|FG000|Overall Study|Withdrawal by Subject|3
7163968|NCT03697993|11342131|FG000|Overall Study|Became Ineligible after Enrollment|1
7163969|NCT03697993|11342132|FG001|Overall Study|Became Ineligible after Enrollment|3
7163970|NCT03697993|11342131|FG000|Overall Study|Enrolled but Treatment not Administered|2
7163971|NCT03697993|11342132|FG001|Overall Study|Enrolled but Treatment not Administered|1
7163972|NCT03697993|11342131|FG000|Overall Study|Lost to Follow-up|3
7163973|NCT03697993|11342132|FG001|Overall Study|Lost to Follow-up|0
7163974|NCT03697993|11342131|FG000|Overall Study|Physician Decision|4
7163975|NCT03697993|11342132|FG001|Overall Study|Physician Decision|0
7163976|NCT03697993|11342131|FG000|Overall Study|Initial Urine Culture Negative|0
7163977|NCT03697993|11342132|FG001|Overall Study|Initial Urine Culture Negative|1
7163978|NCT03698331|11342141|FG000|Overall Study|Adverse Event|2
7163979|NCT03698331|11342142|FG001|Overall Study|Adverse Event|3
7163980|NCT03698331|11342141|FG000|Overall Study|Withdrawal by Subject|1
7163981|NCT03698331|11342142|FG001|Overall Study|Withdrawal by Subject|1
7163982|NCT03698331|11342141|FG000|Overall Study|Lost to Follow-up|0
7163983|NCT03698331|11342142|FG001|Overall Study|Lost to Follow-up|2
7163984|NCT03698331|11342141|FG000|Overall Study|Non-compliance with study drug|1
7163985|NCT03698331|11342142|FG001|Overall Study|Non-compliance with study drug|0
7163986|NCT03698591|11342150|FG000|Overall Study|Withdrawal by Subject|2
7163987|NCT03698591|11342151|FG001|Overall Study|Withdrawal by Subject|2
7163988|NCT03698591|11342150|FG000|Overall Study|Failed drug screen|1
7163989|NCT03698591|11342151|FG001|Overall Study|Failed drug screen|1
7163990|NCT03698591|11342150|FG000|Overall Study|Failed health screen|0
7163991|NCT03698591|11342151|FG001|Overall Study|Failed health screen|1
7163992|NCT03698591|11342150|FG000|Overall Study|Ineligible for financial compensation|1
7163993|NCT03698591|11342151|FG001|Overall Study|Ineligible for financial compensation|0
7163994|NCT03698591|11342150|FG000|Overall Study|Equipment Error|1
7163995|NCT03698591|11342151|FG001|Overall Study|Equipment Error|0
7163996|NCT03698591|11342150|FG000|Overall Study|Could not establish TMS dosage|0
7163997|NCT03698591|11342151|FG001|Overall Study|Could not establish TMS dosage|1
7080403|NCT02121795|11189792|FG000|Double-Blind Phase|Withdrawal by Subject|19
7080404|NCT02121795|11189793|FG001|Double-Blind Phase|Withdrawal by Subject|16
7080405|NCT02121795|11189792|FG000|Double-Blind Phase|Lost to Follow-up|7
7080406|NCT02121795|11189793|FG001|Double-Blind Phase|Lost to Follow-up|4
7080407|NCT02121795|11189792|FG000|Double-Blind Phase|Physician Decision|2
7080408|NCT02121795|11189793|FG001|Double-Blind Phase|Physician Decision|5
7080409|NCT02121795|11189792|FG000|Double-Blind Phase|Adverse Event|5
7080410|NCT02121795|11189793|FG001|Double-Blind Phase|Adverse Event|0
7163998|NCT03699124|11342160|FG000|Overall Study|Adverse Event|6
7163999|NCT03699124|11342161|FG001|Overall Study|Adverse Event|5
7164000|NCT03699124|11342162|FG002|Overall Study|Adverse Event|2
7164001|NCT03699124|11342160|FG000|Overall Study|Death|0
7164002|NCT03699124|11342161|FG001|Overall Study|Death|2
7164003|NCT03699124|11342162|FG002|Overall Study|Death|0
7164004|NCT03699124|11342160|FG000|Overall Study|Lost to Follow-up|20
7164005|NCT03699124|11342161|FG001|Overall Study|Lost to Follow-up|16
7164006|NCT03699124|11342162|FG002|Overall Study|Lost to Follow-up|15
7164007|NCT03699124|11342160|FG000|Overall Study|Protocol Violation|1
7164008|NCT03699124|11342161|FG001|Overall Study|Protocol Violation|0
7164009|NCT03699124|11342162|FG002|Overall Study|Protocol Violation|0
7164010|NCT03699124|11342160|FG000|Overall Study|Withdrawal by Subject|13
7164011|NCT03699124|11342161|FG001|Overall Study|Withdrawal by Subject|14
7164012|NCT03699124|11342162|FG002|Overall Study|Withdrawal by Subject|13
7164013|NCT03699124|11342160|FG000|Overall Study|Other reasons|5
7164014|NCT03699124|11342161|FG001|Overall Study|Other reasons|3
7164015|NCT03699124|11342162|FG002|Overall Study|Other reasons|10
7164016|NCT03700320|11342172|FG000|Overall Study|Adverse Event|5
7164017|NCT03700320|11342173|FG001|Overall Study|Adverse Event|31
7164018|NCT03700320|11342172|FG000|Overall Study|Lack of Efficacy|2
7164019|NCT03700320|11342173|FG001|Overall Study|Lack of Efficacy|5
7164020|NCT03700320|11342172|FG000|Overall Study|Withdrawal by Subject|29
7164021|NCT03700320|11342173|FG001|Overall Study|Withdrawal by Subject|75
7164022|NCT03700320|11342172|FG000|Overall Study|Lost to Follow-up|16
7164023|NCT03700320|11342173|FG001|Overall Study|Lost to Follow-up|23
7164024|NCT03700320|11342172|FG000|Overall Study|Pregnancy|2
7164025|NCT03700320|11342173|FG001|Overall Study|Pregnancy|4
7164026|NCT03700320|11342172|FG000|Overall Study|Protocol Deviation|7
7164027|NCT03700320|11342173|FG001|Overall Study|Protocol Deviation|31
7164028|NCT03700320|11342172|FG000|Overall Study|Non-compliance with Study Drug|1
7164029|NCT03700320|11342173|FG001|Overall Study|Non-compliance with Study Drug|3
7164030|NCT03700320|11342172|FG000|Overall Study|Reason not Specified|0
7164031|NCT03700320|11342173|FG001|Overall Study|Reason not Specified|1
7164032|NCT03700385|11342183|FG000|Overall Study|Lost to Follow-up|1
7164033|NCT03700671|11342189|FG000|Overall Study|Lack of Efficacy|1
7164034|NCT03700671|11342190|FG001|Overall Study|Lack of Efficacy|2
7164035|NCT03700736|11342200|FG000|Overall Study|Pregnancy|1
7164036|NCT03700736|11342201|FG001|Overall Study|Pregnancy|1
7164037|NCT03700736|11342200|FG000|Overall Study|Withdrawal by Subject|2
7164038|NCT03700736|11342201|FG001|Overall Study|Withdrawal by Subject|6
7164039|NCT03700892|11342212|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0
7164040|NCT03700892|11342213|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1
7164041|NCT03700892|11342214|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0
7164042|NCT03701074|11342234|FG000|Overall Study|Physician Decision|1
7164043|NCT03701074|11342235|FG001|Overall Study|Physician Decision|0
7164044|NCT03702010|11342243|FG000|Follow-up (30days)|Lack of Efficacy|2
7164045|NCT03702010|11342244|FG001|Follow-up (30days)|Lack of Efficacy|2
7164046|NCT03702166|11342256|FG000|Overall Study|Lost to Follow-up|1
7164047|NCT03702166|11342256|FG000|Overall Study|Withdrawal by Subject|1
7164048|NCT03703336|11342267|FG000|Overall Study|Parent withdrew consent|29
7164049|NCT03703336|11342268|FG001|Overall Study|Parent withdrew consent|8
7164050|NCT03703336|11342267|FG000|Overall Study|Migration|3
7164051|NCT03703336|11342268|FG001|Overall Study|Migration|3
7164052|NCT03703336|11342267|FG000|Overall Study|Protocol Violation|3
7164053|NCT03703336|11342268|FG001|Overall Study|Protocol Violation|1
7164054|NCT03703336|11342267|FG000|Overall Study|Physician Decision|2
7164055|NCT03703336|11342268|FG001|Overall Study|Physician Decision|0
7164056|NCT03703336|11342267|FG000|Overall Study|Adverse Event|0
7164057|NCT03703336|11342268|FG001|Overall Study|Adverse Event|2
7164058|NCT03703336|11342267|FG000|Overall Study|Lost to Follow-up|1
7164059|NCT03703336|11342268|FG001|Overall Study|Lost to Follow-up|0
7164060|NCT03703817|11342276|FG000|Overall Study|Not meeting eligibility criteria|7
7164061|NCT03703817|11342277|FG001|Overall Study|Not meeting eligibility criteria|4
7164062|NCT03704194|11342285|FG000|Overall Study|Withdrawal by Subject|0
7164063|NCT03704194|11342286|FG001|Overall Study|Withdrawal by Subject|1
7164064|NCT03705494|11342325|FG000|Overall Study|Lost to Follow-up|2
7164065|NCT03705494|11342326|FG001|Overall Study|Lost to Follow-up|1
7164066|NCT03705494|11342325|FG000|Overall Study|Withdrawal by Subject|5
7164067|NCT03705494|11342326|FG001|Overall Study|Withdrawal by Subject|2
7164068|NCT03705793|11342334|FG000|Overall Study|Lost to Follow-up|3
7164069|NCT03705793|11342335|FG001|Overall Study|Lost to Follow-up|4
7164070|NCT03705793|11342334|FG000|Overall Study|Withdrawal by Subject|2
7164071|NCT03705793|11342335|FG001|Overall Study|Withdrawal by Subject|1
7164072|NCT03706040|11342344|FG000|Period A (Week 0 to Week 16)|Adverse Event|3
7164073|NCT03706040|11342345|FG001|Period A (Week 0 to Week 16)|Adverse Event|2
7164074|NCT03706040|11342346|FG002|Period A (Week 0 to Week 16)|Adverse Event|1
7164075|NCT03706040|11342347|FG003|Period A (Week 0 to Week 16)|Adverse Event|0
7164076|NCT03706040|11342348|FG004|Period A (Week 0 to Week 16)|Adverse Event|0
7164077|NCT03706040|11342349|FG005|Period A (Week 0 to Week 16)|Adverse Event|0
7164078|NCT03706040|11342350|FG006|Period A (Week 0 to Week 16)|Adverse Event|0
7164079|NCT03706040|11342344|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3
7164080|NCT03706040|11342345|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5
7164081|NCT03706040|11342346|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4
7164082|NCT03706040|11342347|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0
7164083|NCT03706040|11342348|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0
7164084|NCT03706040|11342349|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0
7164085|NCT03706040|11342350|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0
7164086|NCT03706040|11342344|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1
7164087|NCT03706040|11342345|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1
7164088|NCT03706040|11342346|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4
7164089|NCT03706040|11342347|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0
7164090|NCT03706040|11342348|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0
7164091|NCT03706040|11342349|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0
7164092|NCT03706040|11342350|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0
7164093|NCT03706040|11342344|FG000|Period A (Week 0 to Week 16)|Other|2
7164094|NCT03706040|11342345|FG001|Period A (Week 0 to Week 16)|Other|0
7164095|NCT03706040|11342346|FG002|Period A (Week 0 to Week 16)|Other|2
7164096|NCT03706040|11342347|FG003|Period A (Week 0 to Week 16)|Other|0
7164097|NCT03706040|11342348|FG004|Period A (Week 0 to Week 16)|Other|0
7164098|NCT03706040|11342349|FG005|Period A (Week 0 to Week 16)|Other|0
7164099|NCT03706040|11342350|FG006|Period A (Week 0 to Week 16)|Other|0
7164100|NCT03706040|11342344|FG000|Period B (Week 16 to Week 52)|Adverse Event|0
7164101|NCT03706040|11342345|FG001|Period B (Week 16 to Week 52)|Adverse Event|0
7164102|NCT03706040|11342346|FG002|Period B (Week 16 to Week 52)|Adverse Event|0
7164103|NCT03706040|11342347|FG003|Period B (Week 16 to Week 52)|Adverse Event|1
7164104|NCT03706040|11342348|FG004|Period B (Week 16 to Week 52)|Adverse Event|2
7164105|NCT03706040|11342349|FG005|Period B (Week 16 to Week 52)|Adverse Event|3
7164106|NCT03706040|11342350|FG006|Period B (Week 16 to Week 52)|Adverse Event|0
7164107|NCT03706040|11342344|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0
7164108|NCT03706040|11342345|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0
7164109|NCT03706040|11342346|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0
7164110|NCT03706040|11342347|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3
7164111|NCT03706040|11342348|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2
7164112|NCT03706040|11342349|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1
7164113|NCT03706040|11342350|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10
7164114|NCT03706040|11342344|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0
7164115|NCT03706040|11342345|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0
7164116|NCT03706040|11342346|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0
7164117|NCT03706040|11342347|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0
7164118|NCT03706040|11342348|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0
7164119|NCT03706040|11342349|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1
7164120|NCT03706040|11342350|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1
7164121|NCT03706040|11342344|FG000|Period B (Week 16 to Week 52)|Other|0
7164122|NCT03706040|11342345|FG001|Period B (Week 16 to Week 52)|Other|0
7164123|NCT03706040|11342346|FG002|Period B (Week 16 to Week 52)|Other|0
7164124|NCT03706040|11342347|FG003|Period B (Week 16 to Week 52)|Other|4
7164125|NCT03706040|11342348|FG004|Period B (Week 16 to Week 52)|Other|5
7164126|NCT03706040|11342349|FG005|Period B (Week 16 to Week 52)|Other|23
7164127|NCT03706040|11342350|FG006|Period B (Week 16 to Week 52)|Other|17
7164128|NCT03706456|11342375|FG000|Overall Study|Lack of Efficacy|1
7164129|NCT03706456|11342375|FG000|Overall Study|Ongoing|21
7164130|NCT03707522|11342427|FG000|Overall Study|Lost to Follow-up|24
7164131|NCT03707522|11342428|FG001|Overall Study|Lost to Follow-up|27
7164132|NCT03707522|11342429|FG002|Overall Study|Lost to Follow-up|41
7164133|NCT03707522|11342430|FG003|Overall Study|Lost to Follow-up|36
7164134|NCT03707587|11342442|FG000|Overall Study|Death|0
7164135|NCT03707587|11342443|FG001|Overall Study|Death|1
7164136|NCT03707821|11342451|FG000|Overall Study|Protocol Violation|0
7164137|NCT03707821|11342452|FG001|Overall Study|Protocol Violation|1
7164138|NCT03707821|11342451|FG000|Overall Study|Unsatisfactory Visual Response|1
7164139|NCT03707821|11342452|FG001|Overall Study|Unsatisfactory Visual Response|0
7164140|NCT03707821|11342451|FG000|Overall Study|Unsatisfactory Lens Fitting|1
7164141|NCT03707821|11342452|FG001|Overall Study|Unsatisfactory Lens Fitting|0
7164142|NCT03707912|11342460|FG000|Overall Study|Violation of inclusion criteria|1
7164143|NCT03707912|11342461|FG001|Overall Study|Violation of inclusion criteria|0
7184487|NCT02330562|11384673|FG008|Overall Study|Withdrawal by Subject|0
7184488|NCT02330562|11384674|FG009|Overall Study|Withdrawal by Subject|1
7184489|NCT02330562|11384675|FG010|Overall Study|Withdrawal by Subject|0
7187494|NCT03641339|11388143|FG000|Overall Study|Physician Decision|1
7187495|NCT03641339|11388144|FG001|Overall Study|Physician Decision|0
7187496|NCT03641339|11388145|FG002|Overall Study|Physician Decision|0
7187497|NCT03641339|11388146|FG003|Overall Study|Physician Decision|0
7187498|NCT03641339|11388147|FG004|Overall Study|Physician Decision|0
7187499|NCT03641339|11388148|FG005|Overall Study|Physician Decision|0
7187500|NCT03641339|11388143|FG000|Overall Study|Withdrawal by Subject|0
7187501|NCT03641339|11388144|FG001|Overall Study|Withdrawal by Subject|2
7187502|NCT03641339|11388145|FG002|Overall Study|Withdrawal by Subject|0
7187503|NCT03641339|11388146|FG003|Overall Study|Withdrawal by Subject|2
7187504|NCT03641339|11388147|FG004|Overall Study|Withdrawal by Subject|0
7187505|NCT03641339|11388148|FG005|Overall Study|Withdrawal by Subject|1
7187506|NCT03625466|11388164|FG000|Overall Study|Adverse Event|0
7187507|NCT03625466|11388165|FG001|Overall Study|Adverse Event|1
7164144|NCT03708211|11342469|FG000|Overall Study|Progressive Disease|10
7164145|NCT03708211|11342470|FG001|Overall Study|Progressive Disease|7
7164146|NCT03708211|11342469|FG000|Overall Study|Withdrawal by Subject|0
7164147|NCT03708211|11342470|FG001|Overall Study|Withdrawal by Subject|1
7164148|NCT03708211|11342469|FG000|Overall Study|Other|2
7164149|NCT03708211|11342470|FG001|Overall Study|Other|0
7164150|NCT03708744|11342501|FG000|Overall Study|Withdrawal by Subject|0
7164151|NCT03708744|11342502|FG001|Overall Study|Withdrawal by Subject|0
7164152|NCT03708744|11342503|FG002|Overall Study|Withdrawal by Subject|1
7164153|NCT03708744|11342504|FG003|Overall Study|Withdrawal by Subject|0
7164154|NCT03709654|11342531|FG000|Overall Study|Lost to Follow-up|1
7164155|NCT03709654|11342532|FG001|Overall Study|Lost to Follow-up|1
7164156|NCT03709654|11342531|FG000|Overall Study|Withdrawal by Subject|1
7164157|NCT03709654|11342532|FG001|Overall Study|Withdrawal by Subject|1
7164158|NCT03709654|11342531|FG000|Overall Study|Adverse Event|1
7164159|NCT03709654|11342532|FG001|Overall Study|Adverse Event|0
7164160|NCT03709823|11342551|FG000|Overall Study|Adverse Event|0
7164161|NCT03709823|11342552|FG001|Overall Study|Adverse Event|0
7164162|NCT03709823|11342553|FG002|Overall Study|Adverse Event|1
7164163|NCT03709823|11342554|FG003|Overall Study|Adverse Event|0
7164164|NCT03709823|11342555|FG004|Overall Study|Adverse Event|0
7164165|NCT03709823|11342556|FG005|Overall Study|Adverse Event|0
7164166|NCT03709823|11342551|FG000|Overall Study|Lost to Follow-up|2
7164167|NCT03709823|11342552|FG001|Overall Study|Lost to Follow-up|2
7164168|NCT03709823|11342553|FG002|Overall Study|Lost to Follow-up|2
7164169|NCT03709823|11342554|FG003|Overall Study|Lost to Follow-up|1
7164170|NCT03709823|11342555|FG004|Overall Study|Lost to Follow-up|1
7164171|NCT03709823|11342556|FG005|Overall Study|Lost to Follow-up|0
7164172|NCT03709823|11342551|FG000|Overall Study|Withdrawal by Subject|1
7164173|NCT03709823|11342552|FG001|Overall Study|Withdrawal by Subject|3
7164174|NCT03709823|11342553|FG002|Overall Study|Withdrawal by Subject|0
7164175|NCT03709823|11342554|FG003|Overall Study|Withdrawal by Subject|0
7164176|NCT03709823|11342555|FG004|Overall Study|Withdrawal by Subject|0
7164177|NCT03709823|11342556|FG005|Overall Study|Withdrawal by Subject|0
7164178|NCT03709823|11342551|FG000|Overall Study|Other, Not Specified|0
7164179|NCT03709823|11342552|FG001|Overall Study|Other, Not Specified|0
7164180|NCT03709823|11342553|FG002|Overall Study|Other, Not Specified|0
7164181|NCT03709823|11342554|FG003|Overall Study|Other, Not Specified|1
7164182|NCT03709823|11342555|FG004|Overall Study|Other, Not Specified|0
7164183|NCT03709823|11342556|FG005|Overall Study|Other, Not Specified|0
7164184|NCT03710083|11342573|FG000|Overall Study|Withdrawal by Subject|2
7164185|NCT03710083|11342573|FG000|Overall Study|Unsuccessful Procedure|1
7164186|NCT03710161|11342579|FG000|Overall Study|Study halted due to COVID pandemic|3
7164187|NCT03710161|11342580|FG001|Overall Study|Study halted due to COVID pandemic|2
7164188|NCT03710590|11342606|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10
7164189|NCT03710590|11342607|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8
7164190|NCT03710889|11342613|FG000|Overall Study|Adverse Event|2
7164191|NCT03710889|11342613|FG000|Overall Study|Protocol Deviation|1
7164192|NCT03712280|11342642|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0
7164193|NCT03712280|11342643|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1
7164194|NCT03712280|11342644|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0
7164195|NCT03712280|11342645|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1
7164196|NCT03712280|11342642|FG000|Overall Study|Withdrawal by Participant or Caregiver|1
7164197|NCT03712280|11342643|FG001|Overall Study|Withdrawal by Participant or Caregiver|0
7164198|NCT03712280|11342644|FG002|Overall Study|Withdrawal by Participant or Caregiver|0
7164199|NCT03712280|11342645|FG003|Overall Study|Withdrawal by Participant or Caregiver|0
7164200|NCT03712280|11342642|FG000|Overall Study|Adverse Event|0
7164201|NCT03712280|11342643|FG001|Overall Study|Adverse Event|0
7164202|NCT03712280|11342644|FG002|Overall Study|Adverse Event|1
7164203|NCT03712280|11342645|FG003|Overall Study|Adverse Event|0
7164204|NCT03712449|11342657|FG000|Overall Study|Withdraw Consent|0
7164205|NCT03712449|11342658|FG001|Overall Study|Withdraw Consent|1
7164206|NCT03712917|11342680|FG000|Overall Study|Pregnancy|0
7164207|NCT03712917|11342681|FG001|Overall Study|Pregnancy|0
7164208|NCT03712917|11342682|FG002|Overall Study|Pregnancy|1
7164209|NCT03712917|11342680|FG000|Overall Study|Adverse Event|0
7164210|NCT03712917|11342681|FG001|Overall Study|Adverse Event|4
7164211|NCT03712917|11342682|FG002|Overall Study|Adverse Event|3
7164212|NCT03712917|11342680|FG000|Overall Study|Lost to Follow-up|9
7164213|NCT03712917|11342681|FG001|Overall Study|Lost to Follow-up|4
7164214|NCT03712917|11342682|FG002|Overall Study|Lost to Follow-up|5
7164215|NCT03712930|11342690|FG000|Overall Study|Death|7
7164216|NCT03712930|11342690|FG000|Overall Study|Physician Decision|1
7164217|NCT03712930|11342690|FG000|Overall Study|Study Terminated by Sponsor|3
7164218|NCT03712930|11342690|FG000|Overall Study|Progressive Disease|2
7164219|NCT03714022|11342705|FG000|Overall Study|Adverse Event|1
7164220|NCT03714022|11342706|FG001|Overall Study|Adverse Event|0
7164221|NCT03714022|11342705|FG000|Overall Study|Consent withdrawal|0
7164222|NCT03714022|11342706|FG001|Overall Study|Consent withdrawal|1
7164223|NCT03714022|11342705|FG000|Overall Study|Lost to Follow-up|3
7164224|NCT03714022|11342706|FG001|Overall Study|Lost to Follow-up|2
7164225|NCT03714672|11342729|FG000|Overall Study|Adverse Event|0
7164226|NCT03714672|11342730|FG001|Overall Study|Adverse Event|0
7164227|NCT03714672|11342731|FG002|Overall Study|Adverse Event|3
7164228|NCT03714672|11342732|FG003|Overall Study|Adverse Event|0
7164229|NCT03714672|11342729|FG000|Overall Study|Physician Decision|0
7164230|NCT03714672|11342730|FG001|Overall Study|Physician Decision|1
7164231|NCT03714672|11342731|FG002|Overall Study|Physician Decision|0
7164232|NCT03714672|11342732|FG003|Overall Study|Physician Decision|0
7164233|NCT03714672|11342729|FG000|Overall Study|Other Reason|1
7164234|NCT03714672|11342730|FG001|Overall Study|Other Reason|2
7164235|NCT03714672|11342731|FG002|Overall Study|Other Reason|1
7164236|NCT03714672|11342732|FG003|Overall Study|Other Reason|1
7164237|NCT03714672|11342729|FG000|Overall Study|Lost to Follow-up|1
7164238|NCT03714672|11342730|FG001|Overall Study|Lost to Follow-up|1
7164239|NCT03714672|11342731|FG002|Overall Study|Lost to Follow-up|0
7164240|NCT03714672|11342732|FG003|Overall Study|Lost to Follow-up|0
7164241|NCT03715530|11342763|FG000|Overall Study|Lost to Follow-up|3
7164242|NCT03715530|11342764|FG001|Overall Study|Lost to Follow-up|1
7164243|NCT03715530|11342765|FG002|Overall Study|Lost to Follow-up|2
7164244|NCT03716024|11342784|FG000|Overall Study|Randomized, not Treated|7
7164245|NCT03716024|11342785|FG001|Overall Study|Randomized, not Treated|8
7164246|NCT03716024|11342784|FG000|Overall Study|Adverse Event|1
7164247|NCT03716024|11342785|FG001|Overall Study|Adverse Event|2
7164248|NCT03716024|11342784|FG000|Overall Study|Treatment Failure|1
7164249|NCT03716024|11342785|FG001|Overall Study|Treatment Failure|0
7164250|NCT03716024|11342784|FG000|Overall Study|Lost to Follow-up|2
7164251|NCT03716024|11342785|FG001|Overall Study|Lost to Follow-up|6
7164252|NCT03716024|11342784|FG000|Overall Study|Withdrawal by Subject|0
7164253|NCT03716024|11342785|FG001|Overall Study|Withdrawal by Subject|1
7164254|NCT03716024|11342784|FG000|Overall Study|Missing Reason|0
7164255|NCT03716024|11342785|FG001|Overall Study|Missing Reason|1
7164256|NCT03716050|11342799|FG000|Overall Study|Lost to Follow-up|0
7164257|NCT03716050|11342800|FG001|Overall Study|Lost to Follow-up|0
7164258|NCT03716050|11342801|FG002|Overall Study|Lost to Follow-up|1
7164259|NCT03716050|11342802|FG003|Overall Study|Lost to Follow-up|0
7164260|NCT03716050|11342803|FG004|Overall Study|Lost to Follow-up|0
7164261|NCT03716050|11342804|FG005|Overall Study|Lost to Follow-up|0
7164262|NCT03716050|11342805|FG006|Overall Study|Lost to Follow-up|0
7164263|NCT03716050|11342806|FG007|Overall Study|Lost to Follow-up|0
7164264|NCT03716050|11342799|FG000|Overall Study|Physician Decision|0
7164265|NCT03716050|11342800|FG001|Overall Study|Physician Decision|0
7164266|NCT03716050|11342801|FG002|Overall Study|Physician Decision|0
7164267|NCT03716050|11342802|FG003|Overall Study|Physician Decision|1
7164268|NCT03716050|11342803|FG004|Overall Study|Physician Decision|0
7164269|NCT03716050|11342804|FG005|Overall Study|Physician Decision|0
7164270|NCT03716050|11342805|FG006|Overall Study|Physician Decision|0
7164271|NCT03716050|11342806|FG007|Overall Study|Physician Decision|0
7164272|NCT03716050|11342799|FG000|Overall Study|Protocol Violation|0
7164273|NCT03716050|11342800|FG001|Overall Study|Protocol Violation|0
7164274|NCT03716050|11342801|FG002|Overall Study|Protocol Violation|0
7164275|NCT03716050|11342802|FG003|Overall Study|Protocol Violation|1
7164276|NCT03716050|11342803|FG004|Overall Study|Protocol Violation|0
7080411|NCT02121795|11189792|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3
7164277|NCT03716050|11342804|FG005|Overall Study|Protocol Violation|0
7164278|NCT03716050|11342805|FG006|Overall Study|Protocol Violation|0
7164279|NCT03716050|11342806|FG007|Overall Study|Protocol Violation|2
7164280|NCT03717012|11342834|FG000|Overall Study|Due to trial termination|1
7164281|NCT03717012|11342835|FG001|Overall Study|Due to trial termination|2
7080412|NCT02121795|11189793|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1
7080413|NCT02121795|11189792|FG000|Double-Blind Phase|Protocol Violation|0
7080414|NCT02121795|11189793|FG001|Double-Blind Phase|Protocol Violation|3
7080415|NCT02121795|11189792|FG000|Double-Blind Phase|Death|1
7080416|NCT02121795|11189793|FG001|Double-Blind Phase|Death|1
7080417|NCT02121795|11189792|FG000|Open-Label Phase|Physician Decision|8
7080418|NCT02121795|11189793|FG001|Open-Label Phase|Physician Decision|8
7080419|NCT02121795|11189792|FG000|Open-Label Phase|Withdrawal by Subject|3
7080420|NCT02121795|11189793|FG001|Open-Label Phase|Withdrawal by Subject|2
7080421|NCT02121795|11189792|FG000|Open-Label Phase|Lost to Follow-up|1
7080422|NCT02121795|11189793|FG001|Open-Label Phase|Lost to Follow-up|0
7080423|NCT02121808|11189801|FG000|Overall Study|Technical problem|3
7080424|NCT02121834|11189817|FG000|Overall Study|Protocol Violation|0
7080425|NCT02121834|11189818|FG001|Overall Study|Protocol Violation|1
7080426|NCT02121834|11189819|FG002|Overall Study|Protocol Violation|0
7080427|NCT02121834|11189820|FG003|Overall Study|Protocol Violation|0
7080428|NCT02121834|11189821|FG004|Overall Study|Protocol Violation|0
7080429|NCT02121834|11189822|FG005|Overall Study|Protocol Violation|0
7080430|NCT02121834|11189823|FG006|Overall Study|Protocol Violation|0
7080431|NCT02121834|11189817|FG000|Overall Study|Withdrawal by Subject|0
7080432|NCT02121834|11189818|FG001|Overall Study|Withdrawal by Subject|1
7080433|NCT02121834|11189819|FG002|Overall Study|Withdrawal by Subject|1
7080434|NCT02121834|11189820|FG003|Overall Study|Withdrawal by Subject|0
7080435|NCT02121834|11189821|FG004|Overall Study|Withdrawal by Subject|0
7080436|NCT02121834|11189822|FG005|Overall Study|Withdrawal by Subject|0
7080437|NCT02121834|11189823|FG006|Overall Study|Withdrawal by Subject|0
7080438|NCT02121834|11189817|FG000|Overall Study|Lost to Follow-up|0
7080439|NCT02121834|11189818|FG001|Overall Study|Lost to Follow-up|0
7080440|NCT02121834|11189819|FG002|Overall Study|Lost to Follow-up|1
7164282|NCT03717012|11342834|FG000|Overall Study|Protocol Violation|0
7164283|NCT03717012|11342835|FG001|Overall Study|Protocol Violation|2
7164284|NCT03717012|11342834|FG000|Overall Study|Adverse Event|0
7164285|NCT03717012|11342835|FG001|Overall Study|Adverse Event|1
7164286|NCT03717012|11342834|FG000|Overall Study|Lung transplant|0
7164287|NCT03717012|11342835|FG001|Overall Study|Lung transplant|1
7164288|NCT03717064|11342850|FG000|Period 2|Adverse Event|1
7164289|NCT03719586|11342894|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8
7164290|NCT03719586|11342895|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7
7164291|NCT03719586|11342896|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4
7164292|NCT03719586|11342897|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0
7164293|NCT03720470|11342931|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5
7164294|NCT03720470|11342932|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0
7164295|NCT03720470|11342933|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0
7164296|NCT03720470|11342934|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5
7164297|NCT03720470|11342935|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8
7164298|NCT03720470|11342936|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6
7164299|NCT03720470|11342931|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0
7164300|NCT03720470|11342932|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0
7164301|NCT03720470|11342933|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0
7164302|NCT03720470|11342934|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1
7164303|NCT03720470|11342935|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0
7164304|NCT03720470|11342936|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1
7164305|NCT03720470|11342931|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1
7164306|NCT03720470|11342932|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0
7164307|NCT03720470|11342933|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0
7164308|NCT03720470|11342934|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2
7164309|NCT03720470|11342935|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1
7164310|NCT03720470|11342936|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2
7164311|NCT03720470|11342931|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0
7164312|NCT03720470|11342932|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0
7164313|NCT03720470|11342933|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0
7164314|NCT03720470|11342934|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0
7164315|NCT03720470|11342935|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1
7164316|NCT03720470|11342936|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1
7164317|NCT03720470|11342931|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2
7164318|NCT03720470|11342932|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0
7164319|NCT03720470|11342933|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0
7164320|NCT03720470|11342934|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2
7164321|NCT03720470|11342935|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2
7164322|NCT03720470|11342936|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1
7164323|NCT03720470|11342931|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5
7164324|NCT03720470|11342932|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0
7164325|NCT03720470|11342933|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0
7164326|NCT03720470|11342934|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9
7164327|NCT03720470|11342935|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3
7164328|NCT03720470|11342936|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6
7164329|NCT03720470|11342931|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0
7164330|NCT03720470|11342932|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0
7164331|NCT03720470|11342933|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0
7164332|NCT03720470|11342934|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1
7164333|NCT03720470|11342935|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1
7164334|NCT03720470|11342936|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0
7164335|NCT03720470|11342931|FG000|Treatment Period: First Part 16 Weeks|Other|1
7164336|NCT03720470|11342932|FG001|Treatment Period: First Part 16 Weeks|Other|0
7164337|NCT03720470|11342933|FG002|Treatment Period: First Part 16 Weeks|Other|0
7164338|NCT03720470|11342934|FG003|Treatment Period: First Part 16 Weeks|Other|1
7164339|NCT03720470|11342935|FG004|Treatment Period: First Part 16 Weeks|Other|2
7164340|NCT03720470|11342936|FG005|Treatment Period: First Part 16 Weeks|Other|2
7164341|NCT03720470|11342931|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
7164342|NCT03720470|11342932|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
7164343|NCT03720470|11342933|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
7164344|NCT03720470|11342934|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
7164345|NCT03720470|11342935|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
7164346|NCT03720470|11342936|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1
7164347|NCT03720470|11342931|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0
7164348|NCT03720470|11342932|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0
7164349|NCT03720470|11342933|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0
7164350|NCT03720470|11342934|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2
7164351|NCT03720470|11342935|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1
7164352|NCT03720470|11342936|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1
7164353|NCT03720470|11342931|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
7164354|NCT03720470|11342932|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
7164355|NCT03720470|11342933|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1
7164356|NCT03720470|11342934|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
7164357|NCT03720470|11342935|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
7164358|NCT03720470|11342936|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
7164359|NCT03720470|11342931|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0
7164360|NCT03720470|11342932|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0
7164361|NCT03720470|11342933|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0
7164362|NCT03720470|11342934|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1
7164363|NCT03720470|11342935|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0
7164364|NCT03720470|11342936|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1
7164365|NCT03720470|11342931|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0
7164366|NCT03720470|11342932|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0
7164367|NCT03720470|11342933|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0
7164368|NCT03720470|11342934|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0
7164369|NCT03720470|11342935|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0
7164370|NCT03720470|11342936|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1
7164371|NCT03720470|11342931|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0
7164372|NCT03720470|11342932|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0
7164373|NCT03720470|11342933|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1
7164374|NCT03720470|11342934|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0
7164375|NCT03720470|11342935|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0
7164376|NCT03720470|11342936|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0
7164377|NCT03720470|11342931|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0
7164378|NCT03720470|11342932|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1
7164379|NCT03720470|11342933|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0
7164380|NCT03720470|11342934|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2
7164381|NCT03720470|11342935|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2
7164382|NCT03720470|11342936|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2
7164383|NCT03720470|11342931|FG000|Treatment Period: Final 4 Weeks|Other|0
7164384|NCT03720470|11342932|FG001|Treatment Period: Final 4 Weeks|Other|1
7164385|NCT03720470|11342933|FG002|Treatment Period: Final 4 Weeks|Other|0
7164386|NCT03720470|11342934|FG003|Treatment Period: Final 4 Weeks|Other|2
7164387|NCT03720470|11342935|FG004|Treatment Period: Final 4 Weeks|Other|1
7164388|NCT03720470|11342936|FG005|Treatment Period: Final 4 Weeks|Other|0
7164389|NCT03720652|11342958|FG000|Overall Study|Withdrawal by Subject|2
7164390|NCT03720652|11342959|FG001|Overall Study|Withdrawal by Subject|7
7164391|NCT03720652|11342958|FG000|Overall Study|Lost to Follow-up|0
7164392|NCT03720652|11342959|FG001|Overall Study|Lost to Follow-up|4
7164393|NCT03720847|11342967|FG000|Washout|Physician Decision|1
7164394|NCT03720847|11342968|FG001|Washout|Physician Decision|2
7164395|NCT03721172|11342997|FG000|Placebo-controlled Phase|Adverse Event|7
7164396|NCT03721172|11342998|FG001|Placebo-controlled Phase|Adverse Event|7
7164397|NCT03721172|11342999|FG002|Placebo-controlled Phase|Adverse Event|0
7164398|NCT03721172|11342997|FG000|Placebo-controlled Phase|Lack of Efficacy|4
7164399|NCT03721172|11342998|FG001|Placebo-controlled Phase|Lack of Efficacy|0
7164400|NCT03721172|11342999|FG002|Placebo-controlled Phase|Lack of Efficacy|0
7164401|NCT03721172|11342997|FG000|Placebo-controlled Phase|Non-compliance with study drug|0
7164402|NCT03721172|11342998|FG001|Placebo-controlled Phase|Non-compliance with study drug|1
7164403|NCT03721172|11342999|FG002|Placebo-controlled Phase|Non-compliance with study drug|0
7164404|NCT03721172|11342997|FG000|Placebo-controlled Phase|Lost to Follow-up|15
7164405|NCT03721172|11342998|FG001|Placebo-controlled Phase|Lost to Follow-up|13
7164406|NCT03721172|11342999|FG002|Placebo-controlled Phase|Lost to Follow-up|0
7164407|NCT03721172|11342997|FG000|Placebo-controlled Phase|Withdrawal by Subject|23
7164408|NCT03721172|11342998|FG001|Placebo-controlled Phase|Withdrawal by Subject|18
7164409|NCT03721172|11342999|FG002|Placebo-controlled Phase|Withdrawal by Subject|0
7164410|NCT03721172|11342997|FG000|Placebo-controlled Phase|Other|3
7164411|NCT03721172|11342998|FG001|Placebo-controlled Phase|Other|0
7164412|NCT03721172|11342999|FG002|Placebo-controlled Phase|Other|0
7164413|NCT03721172|11342997|FG000|Apremilast Extension Phase|Adverse Event|0
7164414|NCT03721172|11342998|FG001|Apremilast Extension Phase|Adverse Event|0
7164415|NCT03721172|11342999|FG002|Apremilast Extension Phase|Adverse Event|10
7164416|NCT03721172|11342997|FG000|Apremilast Extension Phase|Lack of Efficacy|0
7164417|NCT03721172|11342998|FG001|Apremilast Extension Phase|Lack of Efficacy|0
7164418|NCT03721172|11342999|FG002|Apremilast Extension Phase|Lack of Efficacy|2
7164419|NCT03721172|11342997|FG000|Apremilast Extension Phase|Non-compliance with study drug|0
7164420|NCT03721172|11342998|FG001|Apremilast Extension Phase|Non-compliance with study drug|0
7164421|NCT03721172|11342999|FG002|Apremilast Extension Phase|Non-compliance with study drug|1
7164422|NCT03721172|11342997|FG000|Apremilast Extension Phase|Lost to Follow-up|0
7164423|NCT03721172|11342998|FG001|Apremilast Extension Phase|Lost to Follow-up|0
7164424|NCT03721172|11342999|FG002|Apremilast Extension Phase|Lost to Follow-up|20
7164425|NCT03721172|11342997|FG000|Apremilast Extension Phase|Protocol Violation|0
7164426|NCT03721172|11342998|FG001|Apremilast Extension Phase|Protocol Violation|0
7164427|NCT03721172|11342999|FG002|Apremilast Extension Phase|Protocol Violation|1
7164428|NCT03721172|11342997|FG000|Apremilast Extension Phase|Physician Decision|0
7164429|NCT03721172|11342998|FG001|Apremilast Extension Phase|Physician Decision|0
7164430|NCT03721172|11342999|FG002|Apremilast Extension Phase|Physician Decision|1
7164431|NCT03721172|11342997|FG000|Apremilast Extension Phase|Withdrawal by Subject|0
7164432|NCT03721172|11342998|FG001|Apremilast Extension Phase|Withdrawal by Subject|0
7164433|NCT03721172|11342999|FG002|Apremilast Extension Phase|Withdrawal by Subject|21
7164434|NCT03721172|11342997|FG000|Apremilast Extension Phase|Other|0
7164435|NCT03721172|11342998|FG001|Apremilast Extension Phase|Other|0
7164436|NCT03721172|11342999|FG002|Apremilast Extension Phase|Other|3
7164437|NCT03721172|11342997|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0
7164438|NCT03721172|11342998|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0
7164439|NCT03721172|11342999|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7
7164440|NCT03722030|11343018|FG000|Overall Study|Withdrawal by Subject|1
7164441|NCT03722030|11343019|FG001|Overall Study|Withdrawal by Subject|0
7164442|NCT03722238|11343028|FG000|Overall Study|Protocol Violation|1
7164443|NCT03722238|11343029|FG001|Overall Study|Protocol Violation|0
7164444|NCT03722238|11343028|FG000|Overall Study|Physician Decision|1
7164445|NCT03722238|11343029|FG001|Overall Study|Physician Decision|0
7164446|NCT03722238|11343028|FG000|Overall Study|Death|1
7164447|NCT03722238|11343029|FG001|Overall Study|Death|0
7164448|NCT03722238|11343028|FG000|Overall Study|Lost to Follow-up|6
7164449|NCT03722238|11343029|FG001|Overall Study|Lost to Follow-up|0
7164450|NCT03722238|11343028|FG000|Overall Study|Partial missing data|44
7164451|NCT03722238|11343029|FG001|Overall Study|Partial missing data|1
7164452|NCT03722238|11343028|FG000|Overall Study|Withdrawal by Subject|2
7164453|NCT03722238|11343029|FG001|Overall Study|Withdrawal by Subject|0
7164454|NCT03722238|11343028|FG000|Overall Study|Other|4
7164455|NCT03722238|11343029|FG001|Overall Study|Other|0
7164456|NCT03722238|11343028|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2
7164457|NCT03722238|11343029|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0
7164458|NCT03722238|11343028|FG000|Overall Study|Did not meet risk classification group criteria|90
7164459|NCT03722238|11343029|FG001|Overall Study|Did not meet risk classification group criteria|0
7164460|NCT03722238|11343028|FG000|Overall Study|Did not sign consent|17
7164461|NCT03722238|11343029|FG001|Overall Study|Did not sign consent|0
7164462|NCT03722238|11343028|FG000|Overall Study|Other eligibility criteria not met pre-consent|22
7164463|NCT03722238|11343029|FG001|Overall Study|Other eligibility criteria not met pre-consent|0
7164464|NCT03722238|11343028|FG000|Overall Study|Not willing to purchase study medication|142
7164465|NCT03722238|11343029|FG001|Overall Study|Not willing to purchase study medication|0
7164466|NCT03722238|11343028|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133
7164467|NCT03722238|11343029|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0
7164468|NCT03722264|11343035|FG000|Overall Study|Physician Decision|3
7164469|NCT03722446|11343043|FG000|Overall Study|Protocol Violation|15
7164470|NCT03722446|11343044|FG001|Overall Study|Protocol Violation|2
7164471|NCT03722524|11343050|FG000|Overall Study|Protocol Violation|86
7164472|NCT03722524|11343050|FG000|Overall Study|Adverse Event|7
7164473|NCT03722524|11343050|FG000|Overall Study|Lost to Follow-up|1
7164474|NCT03722524|11343050|FG000|Overall Study|Reason is not stated|1
7164475|NCT03722524|11343050|FG000|Overall Study|Physician Decision|1
7164476|NCT03722524|11343050|FG000|Overall Study|Patient's decision (refusal to continue participation)|3
7164477|NCT03722576|11343054|FG000|Overall Study|Withdrawal by Subject|3
7164478|NCT03722576|11343054|FG000|Overall Study|Adverse Event|2
7164479|NCT03722576|11343054|FG000|Overall Study|Physician Decision|1
7164480|NCT03722576|11343054|FG000|Overall Study|Lost to Follow-up|1
7164481|NCT03722784|11343060|FG000|Overall Study|Withdrawal by Subject|1
7164482|NCT03722784|11343061|FG001|Overall Study|Withdrawal by Subject|0
7164483|NCT03722784|11343060|FG000|Overall Study|Physician Decision|1
7164484|NCT03722784|11343061|FG001|Overall Study|Physician Decision|1
7164485|NCT03722784|11343060|FG000|Overall Study|Protocol Violation|0
7164486|NCT03722784|11343061|FG001|Overall Study|Protocol Violation|1
7164487|NCT03723915|11343068|FG000|Screening|Failed to meet screening requirements.|2
7164488|NCT03723915|11343068|FG000|On Treatment|Failed to meet treatment requirements|2
7164489|NCT03724812|11343072|FG000|Overall Study|Missed Visit|1
7164490|NCT03724812|11343072|FG000|Overall Study|Death|2
7164491|NCT03724812|11343072|FG000|Overall Study|Withdrawal by Subject|1
7164492|NCT03725982|11343079|FG000|First Intervention|Withdrawal by Subject|0
7164493|NCT03725982|11343080|FG001|First Intervention|Withdrawal by Subject|1
7164494|NCT03725982|11343079|FG000|First Intervention|Physician Decision|1
7164495|NCT03725982|11343080|FG001|First Intervention|Physician Decision|1
7164496|NCT03727841|11343094|FG000|Overall Study|Physician Decision|2
7164497|NCT03727841|11343095|FG001|Overall Study|Physician Decision|1
7164498|NCT03736967|11343105|FG000|Overall Study|Withdrawal by Subject|26
7164499|NCT03736967|11343106|FG001|Overall Study|Withdrawal by Subject|25
7164500|NCT03736967|11343107|FG002|Overall Study|Withdrawal by Subject|23
7164501|NCT03736967|11343108|FG003|Overall Study|Withdrawal by Subject|26
7164502|NCT03736967|11343105|FG000|Overall Study|Lost to Follow-up|3
7164503|NCT03736967|11343106|FG001|Overall Study|Lost to Follow-up|2
7164504|NCT03736967|11343107|FG002|Overall Study|Lost to Follow-up|1
7164505|NCT03736967|11343108|FG003|Overall Study|Lost to Follow-up|1
7164506|NCT03736967|11343105|FG000|Overall Study|Physician Decision|1
7164507|NCT03736967|11343106|FG001|Overall Study|Physician Decision|0
7164508|NCT03736967|11343107|FG002|Overall Study|Physician Decision|0
7164509|NCT03736967|11343108|FG003|Overall Study|Physician Decision|1
7164510|NCT03736967|11343105|FG000|Overall Study|Adverse Event|0
7164511|NCT03736967|11343106|FG001|Overall Study|Adverse Event|1
7164512|NCT03736967|11343107|FG002|Overall Study|Adverse Event|0
7164513|NCT03736967|11343108|FG003|Overall Study|Adverse Event|1
7164514|NCT03736967|11343105|FG000|Overall Study|Death|0
7164515|NCT03736967|11343106|FG001|Overall Study|Death|0
7164516|NCT03736967|11343107|FG002|Overall Study|Death|0
7164517|NCT03736967|11343108|FG003|Overall Study|Death|1
7164518|NCT03736967|11343105|FG000|Overall Study|Randomized but never treated|1
7164519|NCT03736967|11343106|FG001|Overall Study|Randomized but never treated|0
7164520|NCT03736967|11343107|FG002|Overall Study|Randomized but never treated|0
7164521|NCT03736967|11343108|FG003|Overall Study|Randomized but never treated|0
7164522|NCT03739840|11343125|FG000|Treatment Period: Wk0-16|Adverse Event|2
7164523|NCT03739840|11343126|FG001|Treatment Period: Wk0-16|Adverse Event|6
7164524|NCT03739840|11343127|FG002|Treatment Period: Wk0-16|Adverse Event|6
7164525|NCT03739840|11343128|FG003|Treatment Period: Wk0-16|Adverse Event|12
7164526|NCT03739840|11343125|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0
7164527|NCT03739840|11343126|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1
7164528|NCT03739840|11343127|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0
7164529|NCT03739840|11343128|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3
7164530|NCT03739840|11343125|FG000|Treatment Period: Wk0-16|Protocol Violation|0
7164531|NCT03739840|11343126|FG001|Treatment Period: Wk0-16|Protocol Violation|0
7164532|NCT03739840|11343127|FG002|Treatment Period: Wk0-16|Protocol Violation|1
7164533|NCT03739840|11343128|FG003|Treatment Period: Wk0-16|Protocol Violation|0
7164534|NCT03739840|11343125|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1
7164535|NCT03739840|11343126|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3
7164536|NCT03739840|11343127|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1
7164537|NCT03739840|11343128|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1
7164538|NCT03739840|11343125|FG000|Treatment Period: Wk0-16|Program Termination|3
7164539|NCT03739840|11343126|FG001|Treatment Period: Wk0-16|Program Termination|0
7164540|NCT03739840|11343127|FG002|Treatment Period: Wk0-16|Program Termination|1
7164541|NCT03739840|11343128|FG003|Treatment Period: Wk0-16|Program Termination|1
7164542|NCT03739840|11343125|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1
7164543|NCT03739840|11343126|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0
7164544|NCT03739840|11343127|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0
7164545|NCT03739840|11343128|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0
7164546|NCT03739840|11343125|FG000|Treatment Period: Wk0-16|Sponsors Decision|3
7164547|NCT03739840|11343126|FG001|Treatment Period: Wk0-16|Sponsors Decision|2
7164548|NCT03739840|11343127|FG002|Treatment Period: Wk0-16|Sponsors Decision|1
7164549|NCT03739840|11343128|FG003|Treatment Period: Wk0-16|Sponsors Decision|3
7164550|NCT03739840|11343125|FG000|Treatment Period: Wk0-16|Promotor Decision|0
7164551|NCT03739840|11343126|FG001|Treatment Period: Wk0-16|Promotor Decision|1
7164552|NCT03739840|11343127|FG002|Treatment Period: Wk0-16|Promotor Decision|0
7164553|NCT03739840|11343128|FG003|Treatment Period: Wk0-16|Promotor Decision|0
7164554|NCT03739840|11343125|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0
7164555|NCT03739840|11343126|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1
7164556|NCT03739840|11343127|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0
7164557|NCT03739840|11343128|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0
7164558|NCT03739840|11343125|FG000|Treatment Period: Wk0-16|Premature Program Termination|0
7164559|NCT03739840|11343126|FG001|Treatment Period: Wk0-16|Premature Program Termination|1
7164560|NCT03739840|11343127|FG002|Treatment Period: Wk0-16|Premature Program Termination|0
7164561|NCT03739840|11343128|FG003|Treatment Period: Wk0-16|Premature Program Termination|0
7164562|NCT03739840|11343125|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0
7164563|NCT03739840|11343126|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1
7164564|NCT03739840|11343127|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0
7164565|NCT03739840|11343128|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0
7164566|NCT03739840|11343125|FG000|Treatment Period: Wk0-16|Study Early Closure|0
7164567|NCT03739840|11343126|FG001|Treatment Period: Wk0-16|Study Early Closure|0
7164568|NCT03739840|11343127|FG002|Treatment Period: Wk0-16|Study Early Closure|1
7164569|NCT03739840|11343128|FG003|Treatment Period: Wk0-16|Study Early Closure|0
7164570|NCT03739840|11343125|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0
7164571|NCT03739840|11343126|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0
7164572|NCT03739840|11343127|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1
7164573|NCT03739840|11343128|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0
7164574|NCT03739840|11343125|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0
7164575|NCT03739840|11343126|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0
7164576|NCT03739840|11343127|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1
7164577|NCT03739840|11343128|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0
7164578|NCT03739840|11343125|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0
7164579|NCT03739840|11343126|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0
7164580|NCT03739840|11343127|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0
7164581|NCT03739840|11343128|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1
7164582|NCT03739840|11343125|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0
7164583|NCT03739840|11343126|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0
7164584|NCT03739840|11343127|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0
7164585|NCT03739840|11343128|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1
7164586|NCT03739840|11343125|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0
7164587|NCT03739840|11343126|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0
7164588|NCT03739840|11343127|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0
7164589|NCT03739840|11343128|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1
7164590|NCT03739840|11343125|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3
7164591|NCT03739840|11343126|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0
7164592|NCT03739840|11343127|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0
7164593|NCT03739840|11343128|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0
7164594|NCT03739840|11343125|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0
7164595|NCT03739840|11343126|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0
7164596|NCT03739840|11343127|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0
7164597|NCT03739840|11343128|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1
7164598|NCT03739840|11343125|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1
7164599|NCT03739840|11343126|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0
7164600|NCT03739840|11343127|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0
7164601|NCT03739840|11343128|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0
7164602|NCT03739840|11343125|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0
7164603|NCT03739840|11343126|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1
7164604|NCT03739840|11343127|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0
7164605|NCT03739840|11343128|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0
7164606|NCT03739840|11343125|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0
7164607|NCT03739840|11343126|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1
7164608|NCT03739840|11343127|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0
7164609|NCT03739840|11343128|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0
7164610|NCT03739840|11343125|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0
7164611|NCT03739840|11343126|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0
7164612|NCT03739840|11343127|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1
7164613|NCT03739840|11343128|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0
7164614|NCT03739840|11343125|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0
7164615|NCT03739840|11343126|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0
7164616|NCT03739840|11343127|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1
7164617|NCT03739840|11343128|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0
7164618|NCT03739840|11343125|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0
7164619|NCT03739840|11343126|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0
7164620|NCT03739840|11343127|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1
7164621|NCT03739840|11343128|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0
7164622|NCT03753763|11343187|FG000|Overall Study|Adverse Event|2
7164623|NCT03753763|11343188|FG001|Overall Study|Adverse Event|0
7164624|NCT03753763|11343187|FG000|Overall Study|Withdrawal by Subject|3
7164625|NCT03753763|11343188|FG001|Overall Study|Withdrawal by Subject|1
7164626|NCT03753763|11343187|FG000|Overall Study|clinical deterioration|1
7164627|NCT03753763|11343188|FG001|Overall Study|clinical deterioration|0
7164628|NCT03756571|11343196|FG000|Overall Study|Lost to Follow-up|1
7164629|NCT03756571|11343197|FG001|Overall Study|Lost to Follow-up|1
7164630|NCT03763877|11343224|FG000|Overall Study|Withdrawal by Subject|3
7164631|NCT03763877|11343225|FG001|Overall Study|Withdrawal by Subject|1
7164632|NCT03763877|11343226|FG002|Overall Study|Withdrawal by Subject|3
7164633|NCT03763877|11343227|FG003|Overall Study|Withdrawal by Subject|4
7164634|NCT03763877|11343224|FG000|Overall Study|Adverse Event|1
7164635|NCT03763877|11343225|FG001|Overall Study|Adverse Event|1
7164636|NCT03763877|11343226|FG002|Overall Study|Adverse Event|3
7164637|NCT03763877|11343227|FG003|Overall Study|Adverse Event|1
7164638|NCT03763877|11343224|FG000|Overall Study|Protocol Violation|1
7164639|NCT03763877|11343225|FG001|Overall Study|Protocol Violation|1
7164640|NCT03763877|11343226|FG002|Overall Study|Protocol Violation|0
7164641|NCT03763877|11343227|FG003|Overall Study|Protocol Violation|0
7164642|NCT03763877|11343224|FG000|Overall Study|Lost to Follow-up|0
7164643|NCT03763877|11343225|FG001|Overall Study|Lost to Follow-up|1
7164644|NCT03763877|11343226|FG002|Overall Study|Lost to Follow-up|1
7164645|NCT03763877|11343227|FG003|Overall Study|Lost to Follow-up|0
7164646|NCT03772587|11343250|FG000|Overall Study|COVID-19|0
7164647|NCT03772587|11343251|FG001|Overall Study|COVID-19|0
7164648|NCT03772587|11343252|FG002|Overall Study|COVID-19|1
7164649|NCT03772587|11343253|FG003|Overall Study|COVID-19|1
7164650|NCT03772587|11343254|FG004|Overall Study|COVID-19|0
7164651|NCT03772587|11343250|FG000|Overall Study|Withdrawal by Subject|1
7164652|NCT03772587|11343251|FG001|Overall Study|Withdrawal by Subject|0
7164653|NCT03772587|11343252|FG002|Overall Study|Withdrawal by Subject|0
7164654|NCT03772587|11343253|FG003|Overall Study|Withdrawal by Subject|0
7164655|NCT03772587|11343254|FG004|Overall Study|Withdrawal by Subject|0
7164656|NCT03789292|11343278|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7
7164657|NCT03789292|11343279|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8
7164658|NCT03789292|11343280|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0
7164659|NCT03789292|11343278|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2
7164660|NCT03789292|11343279|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0
7164661|NCT03789292|11343280|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0
7164662|NCT03789292|11343278|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1
7164663|NCT03789292|11343279|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0
7164664|NCT03789292|11343280|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0
7164665|NCT03789292|11343278|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1
7164666|NCT03789292|11343279|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1
7164667|NCT03789292|11343280|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0
7164668|NCT03789292|11343278|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9
7164669|NCT03789292|11343279|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8
7164670|NCT03789292|11343280|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0
7164671|NCT03789292|11343278|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1
7164672|NCT03789292|11343279|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0
7164673|NCT03789292|11343280|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0
7164674|NCT03789292|11343278|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0
7164675|NCT03789292|11343279|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2
7164676|NCT03789292|11343280|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0
7164677|NCT03789292|11343278|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3
7164678|NCT03789292|11343279|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3
7164679|NCT03789292|11343280|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6
7164680|NCT03789292|11343278|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0
7164681|NCT03789292|11343279|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0
7164682|NCT03789292|11343280|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1
7164683|NCT03789292|11343278|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1
7164684|NCT03789292|11343279|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0
7164685|NCT03789292|11343280|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0
7164686|NCT03789292|11343278|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9
7164687|NCT03789292|11343279|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2
7164688|NCT03789292|11343280|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2
7164689|NCT03789292|11343278|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1
7164690|NCT03789292|11343279|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0
7164691|NCT03789292|11343280|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0
7164692|NCT03789292|11343278|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2
7164693|NCT03789292|11343279|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1
7164694|NCT03789292|11343280|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0
7164695|NCT03805438|11343307|FG000|Overall Study|Lack of Efficacy|1
6895187|NCT00623428|10912959|FG001|Follow-up Period|Death|1
6895188|NCT00623467|10912969|FG000|Overall Study|Lost to Follow-up|1
7164696|NCT03805438|11343307|FG000|Overall Study|Protocol Violation|1
7164697|NCT03817528|11343319|FG000|Overall Study|Withdrawal by Subject|1
7164698|NCT03817528|11343319|FG000|Overall Study|Adverse Event|2
7164699|NCT03829228|11343346|FG000|Overall Study|Protocol Violation|1
7164700|NCT03830333|11343365|FG000|Overall Study|Death|0
7164701|NCT03830333|11343366|FG001|Overall Study|Death|1
7164702|NCT03830333|11343365|FG000|Overall Study|Withdrawal by Subject|5
7164703|NCT03830333|11343366|FG001|Overall Study|Withdrawal by Subject|1
7164704|NCT03830333|11343365|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3
7164705|NCT03830333|11343366|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2
7164706|NCT03831880|11343374|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0
7164707|NCT03831880|11343375|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1
7164708|NCT03831880|11343374|FG000|Period 2 (12 Weeks)|Protocol Deviation|0
7164709|NCT03831880|11343375|FG001|Period 2 (12 Weeks)|Protocol Deviation|1
7164710|NCT03831945|11343385|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4
7164711|NCT03831945|11343386|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4
7164712|NCT03831945|11343385|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1
7164713|NCT03831945|11343386|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1
7164714|NCT03831945|11343385|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2
7164715|NCT03831945|11343386|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1
7164716|NCT03840174|11343405|FG000|Overall Study|Withdrawal by Subject|1
7164717|NCT03840174|11343406|FG001|Overall Study|Withdrawal by Subject|0
7164718|NCT03840174|11343407|FG002|Overall Study|Withdrawal by Subject|0
7164719|NCT03840174|11343408|FG003|Overall Study|Withdrawal by Subject|0
7164720|NCT03857841|11343437|FG000|Overall Study|Death|1
7164721|NCT03857841|11343438|FG001|Overall Study|Death|0
7164722|NCT03857841|11343439|FG002|Overall Study|Death|0
7164723|NCT03857841|11343440|FG003|Overall Study|Death|0
7164724|NCT03857841|11343437|FG000|Overall Study|Study Terminated by Sponsor|1
7164725|NCT03857841|11343438|FG001|Overall Study|Study Terminated by Sponsor|0
7164726|NCT03857841|11343439|FG002|Overall Study|Study Terminated by Sponsor|0
7164727|NCT03857841|11343440|FG003|Overall Study|Study Terminated by Sponsor|0
7164728|NCT03862625|11343465|FG000|Overall Study|Lost to Follow-up|0
7164729|NCT03862625|11343466|FG001|Overall Study|Lost to Follow-up|1
7184490|NCT02035137|11384732|FG000|Overall Study|Physician Decision|0
7184491|NCT02035137|11384733|FG001|Overall Study|Physician Decision|0
7184492|NCT02035137|11384734|FG002|Overall Study|Physician Decision|1
7184493|NCT02035137|11384732|FG000|Overall Study|Withdrawal by Subject|0
7184494|NCT02035137|11384733|FG001|Overall Study|Withdrawal by Subject|1
7184495|NCT02035137|11384734|FG002|Overall Study|Withdrawal by Subject|2
7184496|NCT02035137|11384732|FG000|Overall Study|Ineligible|0
7184497|NCT02035137|11384733|FG001|Overall Study|Ineligible|1
7184498|NCT02035137|11384734|FG002|Overall Study|Ineligible|2
7184499|NCT02035137|11384732|FG000|Overall Study|Disease progression prior to treatment start|2
7184500|NCT02035137|11384733|FG001|Overall Study|Disease progression prior to treatment start|0
7184501|NCT02035137|11384734|FG002|Overall Study|Disease progression prior to treatment start|0
7184502|NCT01660451|11384758|FG000|Overall Study|Protocol Violation|0
7184503|NCT01660451|11384759|FG001|Overall Study|Protocol Violation|1
7184504|NCT01660451|11384760|FG002|Overall Study|Protocol Violation|1
7184505|NCT01660451|11384758|FG000|Overall Study|Adverse Event (AE) without Clinical PD|11
7184506|NCT01660451|11384759|FG001|Overall Study|Adverse Event (AE) without Clinical PD|8
7184507|NCT01660451|11384760|FG002|Overall Study|Adverse Event (AE) without Clinical PD|26
7184508|NCT01660451|11384758|FG000|Overall Study|AE with Clinical PD|1
7184509|NCT01660451|11384759|FG001|Overall Study|AE with Clinical PD|3
7184510|NCT01660451|11384760|FG002|Overall Study|AE with Clinical PD|9
7184511|NCT01660451|11384758|FG000|Overall Study|Sponsor Decision|0
7184512|NCT01660451|11384759|FG001|Overall Study|Sponsor Decision|0
7184513|NCT01660451|11384760|FG002|Overall Study|Sponsor Decision|1
7184514|NCT01660451|11384758|FG000|Overall Study|Protocol Deviation|0
7184515|NCT01660451|11384759|FG001|Overall Study|Protocol Deviation|0
7184516|NCT01660451|11384760|FG002|Overall Study|Protocol Deviation|1
7184517|NCT01660451|11384758|FG000|Overall Study|Physician Decision|1
7184518|NCT01660451|11384759|FG001|Overall Study|Physician Decision|2
7184519|NCT01660451|11384760|FG002|Overall Study|Physician Decision|5
7184520|NCT01660451|11384758|FG000|Overall Study|Withdrawal by Subject|1
7184521|NCT01660451|11384759|FG001|Overall Study|Withdrawal by Subject|0
7184522|NCT01660451|11384760|FG002|Overall Study|Withdrawal by Subject|16
7184523|NCT01660451|11384758|FG000|Overall Study|Ongoing with treatment|3
7184524|NCT01660451|11384759|FG001|Overall Study|Ongoing with treatment|3
7184525|NCT01660451|11384760|FG002|Overall Study|Ongoing with treatment|46
7184526|NCT01589523|11384769|FG000|Overall Study|Withdrawal by Subject|1
7184527|NCT01566695|11384777|FG000|Overall Study|Lack of Efficacy|18
7184528|NCT01566695|11384778|FG001|Overall Study|Lack of Efficacy|45
7184529|NCT01566695|11384777|FG000|Overall Study|Adverse Event|28
7184530|NCT01566695|11384778|FG001|Overall Study|Adverse Event|27
7184531|NCT01566695|11384777|FG000|Overall Study|Death|20
7184532|NCT01566695|11384778|FG001|Overall Study|Death|8
7184533|NCT01566695|11384777|FG000|Overall Study|Withdrawal by Subject|14
7184534|NCT01566695|11384778|FG001|Overall Study|Withdrawal by Subject|7
7184535|NCT01566695|11384777|FG000|Overall Study|Progressive Disease|11
7184536|NCT01566695|11384778|FG001|Overall Study|Progressive Disease|6
7184537|NCT01566695|11384777|FG000|Overall Study|Miscellaneous|4
7184538|NCT01566695|11384778|FG001|Overall Study|Miscellaneous|6
7187508|NCT03625466|11388164|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0
7187509|NCT03625466|11388165|FG001|Overall Study|Withdrawal of Consent (not due to AE)|1
7187510|NCT03317795|11388173|FG000|Overall Study|IUD Expulsion|1
7187511|NCT03317795|11388174|FG001|Overall Study|IUD Expulsion|0
7187512|NCT03317795|11388173|FG000|Overall Study|Lost to Follow-up|1
7187513|NCT03317795|11388174|FG001|Overall Study|Lost to Follow-up|3
7187514|NCT03317795|11388173|FG000|Overall Study|Treatment change|0
7187515|NCT03317795|11388174|FG001|Overall Study|Treatment change|3
7187516|NCT03317795|11388173|FG000|Overall Study|Intolerance of medication|0
7187517|NCT03317795|11388174|FG001|Overall Study|Intolerance of medication|1
7187518|NCT03287245|11388184|FG000|Overall Study|Study terminated by sponsor|3
7187519|NCT03287245|11388185|FG001|Overall Study|Study terminated by sponsor|0
7187520|NCT03287245|11388186|FG002|Overall Study|Study terminated by sponsor|3
7187521|NCT03287245|11388187|FG003|Overall Study|Study terminated by sponsor|1
7187522|NCT03287245|11388184|FG000|Overall Study|Adverse Event|1
7187523|NCT03287245|11388185|FG001|Overall Study|Adverse Event|0
7187524|NCT03287245|11388186|FG002|Overall Study|Adverse Event|0
7187525|NCT03287245|11388187|FG003|Overall Study|Adverse Event|0
7187526|NCT03287245|11388184|FG000|Overall Study|Withdrawal by Subject|8
7187527|NCT03287245|11388185|FG001|Overall Study|Withdrawal by Subject|3
7187528|NCT03287245|11388186|FG002|Overall Study|Withdrawal by Subject|3
7187529|NCT03287245|11388187|FG003|Overall Study|Withdrawal by Subject|0
7164730|NCT03877224|11343494|FG000|Overall Study|Death|3
7164731|NCT03877224|11343495|FG001|Overall Study|Death|2
7164732|NCT03877224|11343494|FG000|Overall Study|Withdrawal by Subject|1
7164733|NCT03877224|11343495|FG001|Overall Study|Withdrawal by Subject|6
7164734|NCT03877224|11343494|FG000|Overall Study|Participant is alive, just unable to come for visits|1
7164735|NCT03877224|11343495|FG001|Overall Study|Participant is alive, just unable to come for visits|0
7164736|NCT03885596|11343514|FG000|Overall Study|Withdrawal by Subject|2
7164737|NCT03885596|11343515|FG001|Overall Study|Withdrawal by Subject|1
7164738|NCT03885596|11343516|FG002|Overall Study|Withdrawal by Subject|0
7164739|NCT03885596|11343517|FG003|Overall Study|Withdrawal by Subject|0
7164740|NCT03885661|11343532|FG000|Overall Study|Withdrawal by Subject|0
7164741|NCT03885661|11343533|FG001|Overall Study|Withdrawal by Subject|1
7164742|NCT03885661|11343532|FG000|Overall Study|Unwilling to undergo required study procedure|1
7164743|NCT03885661|11343533|FG001|Overall Study|Unwilling to undergo required study procedure|0
7164744|NCT03886493|11343539|FG000|Overall Study|Adverse Event|1
7164745|NCT03888235|11343546|FG000|Overall Study|Lost to Follow-up|1
7164746|NCT03888235|11343547|FG001|Overall Study|Lost to Follow-up|1
7164747|NCT03888235|11343548|FG002|Overall Study|Lost to Follow-up|0
7164748|NCT03900416|11343620|FG000|Six Week Follow-up|Lost to Follow-up|1
7164749|NCT03900416|11343621|FG001|Six Week Follow-up|Lost to Follow-up|0
7164750|NCT03900416|11343620|FG000|Six Week Follow-up|Withdrawal by Subject|1
7164751|NCT03900416|11343621|FG001|Six Week Follow-up|Withdrawal by Subject|0
7164752|NCT03900416|11343620|FG000|Twelve Week Follow-up|Lost to Follow-up|0
7164753|NCT03900416|11343621|FG001|Twelve Week Follow-up|Lost to Follow-up|2
7164754|NCT03900416|11343620|FG000|Twelve Week Follow-up|Withdrawal by Subject|0
7164755|NCT03900416|11343621|FG001|Twelve Week Follow-up|Withdrawal by Subject|1
7164756|NCT03900416|11343620|FG000|Twelve Week Follow-up|Adverse Event|1
7164757|NCT03900416|11343621|FG001|Twelve Week Follow-up|Adverse Event|1
7164758|NCT03900416|11343620|FG000|Six Month Follow-up|Lost to Follow-up|4
7164759|NCT03900416|11343621|FG001|Six Month Follow-up|Lost to Follow-up|3
7164760|NCT03900416|11343620|FG000|Six Month Follow-up|Withdrawal by Subject|1
7164761|NCT03900416|11343621|FG001|Six Month Follow-up|Withdrawal by Subject|1
7164762|NCT03905863|11343629|FG000|Overall Study|Adverse Event|2
7164763|NCT03905863|11343630|FG001|Overall Study|Adverse Event|4
7164764|NCT03905863|11343629|FG000|Overall Study|Withdrawal by Subject|2
7164765|NCT03905863|11343630|FG001|Overall Study|Withdrawal by Subject|2
7164766|NCT03905863|11343629|FG000|Overall Study|Physician Decision|0
7164767|NCT03905863|11343630|FG001|Overall Study|Physician Decision|3
7164768|NCT03905863|11343629|FG000|Overall Study|Lost to Follow-up|1
7164769|NCT03905863|11343630|FG001|Overall Study|Lost to Follow-up|0
7164770|NCT03905863|11343629|FG000|Overall Study|Protocol Violation|0
7164771|NCT03905863|11343630|FG001|Overall Study|Protocol Violation|2
7164772|NCT03905863|11343629|FG000|Overall Study|Death|0
7164773|NCT03905863|11343630|FG001|Overall Study|Death|1
7164774|NCT03909971|11343647|FG000|Overall Study|Other Reasons Not Specified|0
7164775|NCT03909971|11343648|FG001|Overall Study|Other Reasons Not Specified|1
7164776|NCT03909971|11343647|FG000|Overall Study|Global Deterioration of Health Status|2
7164777|NCT03909971|11343648|FG001|Overall Study|Global Deterioration of Health Status|1
7164778|NCT03909971|11343647|FG000|Overall Study|Progressive Disease|6
7164779|NCT03909971|11343648|FG001|Overall Study|Progressive Disease|14
7164780|NCT03909971|11343647|FG000|Overall Study|Death|2
7164781|NCT03909971|11343648|FG001|Overall Study|Death|6
7164782|NCT03920215|11343659|FG000|Overall Study|Lost to Follow-up|1
7164783|NCT03920215|11343660|FG001|Overall Study|Lost to Follow-up|2
7164784|NCT03920215|11343661|FG002|Overall Study|Lost to Follow-up|0
7164785|NCT03920215|11343662|FG003|Overall Study|Lost to Follow-up|0
7164786|NCT03920215|11343659|FG000|Overall Study|Death|0
7164787|NCT03920215|11343660|FG001|Overall Study|Death|0
7164788|NCT03920215|11343661|FG002|Overall Study|Death|0
7164789|NCT03920215|11343662|FG003|Overall Study|Death|1
7164790|NCT03921151|11343674|FG000|Overall Study|Withdrawal by Subject|11
7164791|NCT03921151|11343675|FG001|Overall Study|Withdrawal by Subject|16
7164792|NCT03927911|11343696|FG000|Overall Study|problems with eDiary|0
7164793|NCT03927911|11343697|FG001|Overall Study|problems with eDiary|1
7164794|NCT03927911|11343698|FG002|Overall Study|problems with eDiary|0
7164795|NCT03927911|11343699|FG003|Overall Study|problems with eDiary|1
7164796|NCT03927911|11343700|FG004|Overall Study|problems with eDiary|0
7164797|NCT03927911|11343701|FG005|Overall Study|problems with eDiary|4
7164798|NCT03927911|11343696|FG000|Overall Study|Adverse Event|0
7164799|NCT03927911|11343697|FG001|Overall Study|Adverse Event|0
7164800|NCT03927911|11343698|FG002|Overall Study|Adverse Event|0
7164801|NCT03927911|11343699|FG003|Overall Study|Adverse Event|0
7164802|NCT03927911|11343700|FG004|Overall Study|Adverse Event|0
7164803|NCT03927911|11343701|FG005|Overall Study|Adverse Event|1
7164804|NCT03927911|11343696|FG000|Overall Study|not treated -study terminated by sponsor|0
7164805|NCT03927911|11343697|FG001|Overall Study|not treated -study terminated by sponsor|1
7164806|NCT03927911|11343698|FG002|Overall Study|not treated -study terminated by sponsor|0
7164807|NCT03927911|11343699|FG003|Overall Study|not treated -study terminated by sponsor|0
7164808|NCT03927911|11343700|FG004|Overall Study|not treated -study terminated by sponsor|0
7164809|NCT03927911|11343701|FG005|Overall Study|not treated -study terminated by sponsor|0
7164810|NCT03927911|11343696|FG000|Overall Study|Surgery cancelled|0
7164811|NCT03927911|11343697|FG001|Overall Study|Surgery cancelled|0
7164812|NCT03927911|11343698|FG002|Overall Study|Surgery cancelled|0
7164813|NCT03927911|11343699|FG003|Overall Study|Surgery cancelled|1
7164814|NCT03927911|11343700|FG004|Overall Study|Surgery cancelled|0
7164815|NCT03927911|11343701|FG005|Overall Study|Surgery cancelled|1
7164816|NCT03927911|11343696|FG000|Overall Study|Protocol Violation|0
7164817|NCT03927911|11343697|FG001|Overall Study|Protocol Violation|0
7164818|NCT03927911|11343698|FG002|Overall Study|Protocol Violation|0
7164819|NCT03927911|11343699|FG003|Overall Study|Protocol Violation|0
7164820|NCT03927911|11343700|FG004|Overall Study|Protocol Violation|0
7164821|NCT03927911|11343701|FG005|Overall Study|Protocol Violation|1
7164822|NCT03938857|11343728|FG000|Overall Study|Physician Decision|1
7164823|NCT03938857|11343729|FG001|Overall Study|Physician Decision|0
7164824|NCT03938857|11343730|FG002|Overall Study|Physician Decision|0
7164825|NCT03938857|11343731|FG003|Overall Study|Physician Decision|0
7164826|NCT03945981|11343745|FG000|Overall Study|Lost to Follow-up|12
7164827|NCT03945981|11343745|FG000|Overall Study|Physician Decision|4
7164828|NCT03945981|11343745|FG000|Overall Study|Withdrawal by Subject|6
7164829|NCT03945981|11343745|FG000|Overall Study|Protocol Violation|1
7164830|NCT03954834|11343762|FG000|Overall Study|Adverse Event|1
7164831|NCT03954834|11343763|FG001|Overall Study|Adverse Event|3
7164832|NCT03954834|11343764|FG002|Overall Study|Adverse Event|1
7164833|NCT03954834|11343765|FG003|Overall Study|Adverse Event|1
7164834|NCT03954834|11343762|FG000|Overall Study|Death|0
7164835|NCT03954834|11343763|FG001|Overall Study|Death|0
7164836|NCT03954834|11343764|FG002|Overall Study|Death|0
7164837|NCT03954834|11343765|FG003|Overall Study|Death|1
7164838|NCT03954834|11343762|FG000|Overall Study|Physician Decision|0
7164839|NCT03954834|11343763|FG001|Overall Study|Physician Decision|1
7164840|NCT03954834|11343764|FG002|Overall Study|Physician Decision|0
7164841|NCT03954834|11343765|FG003|Overall Study|Physician Decision|2
7164842|NCT03954834|11343762|FG000|Overall Study|Protocol Violation|1
7164843|NCT03954834|11343763|FG001|Overall Study|Protocol Violation|0
7164844|NCT03954834|11343764|FG002|Overall Study|Protocol Violation|0
7164845|NCT03954834|11343765|FG003|Overall Study|Protocol Violation|1
7164846|NCT03954834|11343762|FG000|Overall Study|Withdrawal by Subject|2
7164847|NCT03954834|11343763|FG001|Overall Study|Withdrawal by Subject|3
7164848|NCT03954834|11343764|FG002|Overall Study|Withdrawal by Subject|13
7164849|NCT03954834|11343765|FG003|Overall Study|Withdrawal by Subject|6
7164850|NCT03954834|11343762|FG000|Overall Study|Participant left the country|0
7164851|NCT03954834|11343763|FG001|Overall Study|Participant left the country|0
7164852|NCT03954834|11343764|FG002|Overall Study|Participant left the country|1
7164853|NCT03954834|11343765|FG003|Overall Study|Participant left the country|0
7164854|NCT03954834|11343762|FG000|Overall Study|Lost to Follow-up|3
7164855|NCT03954834|11343763|FG001|Overall Study|Lost to Follow-up|2
7164856|NCT03954834|11343764|FG002|Overall Study|Lost to Follow-up|3
7164857|NCT03954834|11343765|FG003|Overall Study|Lost to Follow-up|5
7164858|NCT03961529|11343792|FG000|Overall Study|Adverse Event|13
7164859|NCT03961529|11343793|FG001|Overall Study|Adverse Event|5
7164860|NCT03961529|11343794|FG002|Overall Study|Adverse Event|2
7164861|NCT03961529|11343792|FG000|Overall Study|Withdrawal by Subject|17
7164862|NCT03961529|11343793|FG001|Overall Study|Withdrawal by Subject|2
7164863|NCT03961529|11343794|FG002|Overall Study|Withdrawal by Subject|1
7164864|NCT03961529|11343792|FG000|Overall Study|Withdrawal by parent/guardian|0
7164865|NCT03961529|11343793|FG001|Overall Study|Withdrawal by parent/guardian|7
7164866|NCT03961529|11343794|FG002|Overall Study|Withdrawal by parent/guardian|0
7164867|NCT03961529|11343792|FG000|Overall Study|Physician Decision|2
7164868|NCT03961529|11343793|FG001|Overall Study|Physician Decision|1
7164869|NCT03961529|11343794|FG002|Overall Study|Physician Decision|1
7164870|NCT03961529|11343792|FG000|Overall Study|Lost to Follow-up|2
7164871|NCT03961529|11343793|FG001|Overall Study|Lost to Follow-up|1
7164872|NCT03961529|11343794|FG002|Overall Study|Lost to Follow-up|0
7164873|NCT03961529|11343792|FG000|Overall Study|Lack of Efficacy|2
7164874|NCT03961529|11343793|FG001|Overall Study|Lack of Efficacy|0
7164875|NCT03961529|11343794|FG002|Overall Study|Lack of Efficacy|1
7164876|NCT03961529|11343792|FG000|Overall Study|Other|6
7164877|NCT03961529|11343793|FG001|Overall Study|Other|1
7164878|NCT03961529|11343794|FG002|Overall Study|Other|0
7164879|NCT03968159|11343804|FG000|Overall Study|Adverse Event|4
7164880|NCT03968159|11343805|FG001|Overall Study|Adverse Event|4
7164881|NCT03968159|11343804|FG000|Overall Study|Lost to Follow-up|1
7164882|NCT03968159|11343805|FG001|Overall Study|Lost to Follow-up|1
7164883|NCT03968159|11343804|FG000|Overall Study|Use of prohibited medication|0
7164884|NCT03968159|11343805|FG001|Overall Study|Use of prohibited medication|1
7164885|NCT03968159|11343804|FG000|Overall Study|Protocol Violation|2
7164886|NCT03968159|11343805|FG001|Overall Study|Protocol Violation|2
7164887|NCT03968159|11343804|FG000|Overall Study|Withdrawal by Subject|4
7164888|NCT03968159|11343805|FG001|Overall Study|Withdrawal by Subject|6
7164889|NCT03968159|11343804|FG000|Overall Study|Lack of Efficacy|0
7164890|NCT03968159|11343805|FG001|Overall Study|Lack of Efficacy|1
7164891|NCT03968159|11343804|FG000|Overall Study|Not further specified|2
7164892|NCT03968159|11343805|FG001|Overall Study|Not further specified|0
7164893|NCT03970824|11343823|FG000|Overall Study|Withdrawal by Subject|1
7164894|NCT03970824|11343824|FG001|Overall Study|Withdrawal by Subject|1
7164895|NCT03970824|11343825|FG002|Overall Study|Withdrawal by Subject|3
7164896|NCT03970824|11343823|FG000|Overall Study|Lost to Follow-up|0
7164897|NCT03970824|11343824|FG001|Overall Study|Lost to Follow-up|2
7164898|NCT03970824|11343825|FG002|Overall Study|Lost to Follow-up|1
7164899|NCT03970824|11343823|FG000|Overall Study|Adverse Event|1
7164900|NCT03970824|11343824|FG001|Overall Study|Adverse Event|0
7164901|NCT03970824|11343825|FG002|Overall Study|Adverse Event|0
7164902|NCT03982069|11343871|FG000|Overall Study|Lost to Follow-up|5
7164903|NCT03982069|11343872|FG001|Overall Study|Lost to Follow-up|5
7164904|NCT03982069|11343873|FG002|Overall Study|Lost to Follow-up|3
7164905|NCT03982069|11343874|FG003|Overall Study|Lost to Follow-up|5
7164906|NCT03982069|11343871|FG000|Overall Study|Physician Decision|0
7164907|NCT03982069|11343872|FG001|Overall Study|Physician Decision|1
7164908|NCT03982069|11343873|FG002|Overall Study|Physician Decision|0
7164909|NCT03982069|11343874|FG003|Overall Study|Physician Decision|0
7164910|NCT03982069|11343871|FG000|Overall Study|Withdrawal by Subject|2
7164911|NCT03982069|11343872|FG001|Overall Study|Withdrawal by Subject|1
7164912|NCT03982069|11343873|FG002|Overall Study|Withdrawal by Subject|5
7164913|NCT03982069|11343874|FG003|Overall Study|Withdrawal by Subject|2
7164914|NCT03982069|11343871|FG000|Overall Study|Specimen loss|3
7164915|NCT03982069|11343872|FG001|Overall Study|Specimen loss|3
7164916|NCT03982069|11343873|FG002|Overall Study|Specimen loss|1
7164917|NCT03982069|11343874|FG003|Overall Study|Specimen loss|1
7164918|NCT03984812|11343893|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0
7164919|NCT03984812|11343894|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0
7164920|NCT03984812|11343895|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1
7164921|NCT03984812|11343896|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0
7164922|NCT03984812|11343897|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0
7164923|NCT03984812|11343898|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0
7164924|NCT03984812|11343899|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0
7164925|NCT03984812|11343900|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0
7164926|NCT03984812|11343901|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0
7164927|NCT03984812|11343902|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0
7164928|NCT03984812|11343903|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0
7164929|NCT04006171|11343966|FG000|Overall Study|Withdrawal by Subject|8
7164930|NCT04006171|11343967|FG001|Overall Study|Withdrawal by Subject|7
7164931|NCT04006171|11343966|FG000|Overall Study|missing serum samples|2
7164932|NCT04006171|11343967|FG001|Overall Study|missing serum samples|2
7164933|NCT04006171|11343966|FG000|Overall Study|insufficient sample volume|2
7164934|NCT04006171|11343967|FG001|Overall Study|insufficient sample volume|3
7164935|NCT04013529|11343994|FG000|Overall Study|Withdrawal by Subject|1
7164936|NCT04013529|11343995|FG001|Overall Study|Withdrawal by Subject|1
7164937|NCT04018066|11344010|FG000|Overall Study|participants started taking medications during the study period|3
7164938|NCT04018066|11344010|FG000|Overall Study|participant dropped out due to schedule conflicts.|1
7164939|NCT04041440|11344055|FG000|Overall Study|Withdrawal by Subject|0
7164940|NCT04041440|11344056|FG001|Overall Study|Withdrawal by Subject|1
7164941|NCT04041440|11344055|FG000|Overall Study|Lost to Follow-up|0
7164942|NCT04041440|11344056|FG001|Overall Study|Lost to Follow-up|1
7164943|NCT04041570|11344065|FG000|Overall Study|Moved from Area|0
7164944|NCT04041570|11344066|FG001|Overall Study|Moved from Area|2
7164945|NCT04043143|11344075|FG000|Overall Study|Lost to Follow-up|5
7164946|NCT04043143|11344076|FG001|Overall Study|Lost to Follow-up|5
7164947|NCT04043143|11344075|FG000|Overall Study|screen failure|1
7164948|NCT04043143|11344076|FG001|Overall Study|screen failure|0
7164949|NCT04052204|11344101|FG000|Overall Study|Death|1
7164950|NCT04052204|11344102|FG001|Overall Study|Death|0
7164951|NCT04052204|11344103|FG002|Overall Study|Death|0
7164952|NCT04052204|11344101|FG000|Overall Study|Progressive disease|1
7164953|NCT04052204|11344102|FG001|Overall Study|Progressive disease|0
7164954|NCT04052204|11344103|FG002|Overall Study|Progressive disease|0
7164955|NCT04052204|11344101|FG000|Overall Study|Other|1
7164956|NCT04052204|11344102|FG001|Overall Study|Other|0
7164957|NCT04052204|11344103|FG002|Overall Study|Other|0
7164958|NCT04067011|11344123|FG000|Overall Study|Not Treated|8
7164959|NCT04067011|11344124|FG001|Overall Study|Not Treated|7
7164960|NCT04067011|11344125|FG002|Overall Study|Not Treated|5
7164961|NCT04067011|11344123|FG000|Overall Study|Adverse Event|2
7164962|NCT04067011|11344124|FG001|Overall Study|Adverse Event|1
7164963|NCT04067011|11344125|FG002|Overall Study|Adverse Event|0
7164964|NCT04067011|11344123|FG000|Overall Study|Withdrawal by Subject|6
7164965|NCT04067011|11344124|FG001|Overall Study|Withdrawal by Subject|2
7164966|NCT04067011|11344125|FG002|Overall Study|Withdrawal by Subject|1
7164967|NCT04067011|11344123|FG000|Overall Study|Lost to Follow-up|0
7164968|NCT04067011|11344124|FG001|Overall Study|Lost to Follow-up|0
7164969|NCT04067011|11344125|FG002|Overall Study|Lost to Follow-up|1
7164970|NCT04067011|11344123|FG000|Overall Study|Physician Decision|1
7164971|NCT04067011|11344124|FG001|Overall Study|Physician Decision|1
7164972|NCT04067011|11344125|FG002|Overall Study|Physician Decision|0
7164973|NCT04067011|11344123|FG000|Overall Study|Other Reasons|2
7164974|NCT04067011|11344124|FG001|Overall Study|Other Reasons|0
7164975|NCT04067011|11344125|FG002|Overall Study|Other Reasons|1
7164976|NCT04067011|11344123|FG000|Overall Study|Missing|0
7164977|NCT04067011|11344124|FG001|Overall Study|Missing|2
7164978|NCT04067011|11344125|FG002|Overall Study|Missing|0
7164979|NCT04072159|11344137|FG000|Overall Study|Lost to Follow-up|6
7164980|NCT04072159|11344138|FG001|Overall Study|Lost to Follow-up|6
7164981|NCT04072159|11344137|FG000|Overall Study|Withdrawal by Subject|2
7164982|NCT04072159|11344138|FG001|Overall Study|Withdrawal by Subject|0
7164983|NCT04094870|11344157|FG000|Overall Study|Lost to Follow-up|1
7164984|NCT04094870|11344158|FG001|Overall Study|Lost to Follow-up|1
7164985|NCT04123405|11344199|FG000|Overall Study|Adverse Event|1
7164986|NCT04123405|11344200|FG001|Overall Study|Adverse Event|2
7164987|NCT04123405|11344201|FG002|Overall Study|Adverse Event|3
7164988|NCT04123405|11344202|FG003|Overall Study|Adverse Event|3
7164989|NCT04123405|11344199|FG000|Overall Study|Exclusion criteria met|1
7164990|NCT04123405|11344200|FG001|Overall Study|Exclusion criteria met|2
7164991|NCT04123405|11344201|FG002|Overall Study|Exclusion criteria met|0
7164992|NCT04123405|11344202|FG003|Overall Study|Exclusion criteria met|2
7164993|NCT04123405|11344199|FG000|Overall Study|Withdrawal by Subject|1
7164994|NCT04123405|11344200|FG001|Overall Study|Withdrawal by Subject|3
7164995|NCT04123405|11344201|FG002|Overall Study|Withdrawal by Subject|0
7164996|NCT04123405|11344202|FG003|Overall Study|Withdrawal by Subject|2
7164997|NCT04123405|11344199|FG000|Overall Study|Contact to subject lost|0
7164998|NCT04123405|11344200|FG001|Overall Study|Contact to subject lost|0
7164999|NCT04123405|11344201|FG002|Overall Study|Contact to subject lost|0
7165000|NCT04123405|11344202|FG003|Overall Study|Contact to subject lost|1
7165001|NCT04123405|11344199|FG000|Overall Study|screening failure|1
7165002|NCT04123405|11344200|FG001|Overall Study|screening failure|0
7165003|NCT04123405|11344201|FG002|Overall Study|screening failure|0
7165004|NCT04123405|11344202|FG003|Overall Study|screening failure|0
7165005|NCT04147715|11344245|FG000|Overall Study|Adverse Event|0
7165006|NCT04147715|11344246|FG001|Overall Study|Adverse Event|0
7165007|NCT04147715|11344247|FG002|Overall Study|Adverse Event|0
7165008|NCT04147715|11344248|FG003|Overall Study|Adverse Event|0
7165009|NCT04147715|11344249|FG004|Overall Study|Adverse Event|0
7165010|NCT04147715|11344250|FG005|Overall Study|Adverse Event|0
7165011|NCT04147715|11344251|FG006|Overall Study|Adverse Event|0
7165012|NCT04147715|11344252|FG007|Overall Study|Adverse Event|2
7165013|NCT04147715|11344253|FG008|Overall Study|Adverse Event|1
7165014|NCT04147715|11344254|FG009|Overall Study|Adverse Event|0
7165015|NCT04147715|11344255|FG010|Overall Study|Adverse Event|0
7165016|NCT04147715|11344256|FG011|Overall Study|Adverse Event|0
7165017|NCT04154605|11344330|FG000|Overall Study|Procedure Canceled|1
7165018|NCT04154605|11344331|FG001|Overall Study|Procedure Canceled|1
7165019|NCT04154605|11344330|FG000|Overall Study|Missed follow up|1
7165020|NCT04154605|11344331|FG001|Overall Study|Missed follow up|1
7165021|NCT04154605|11344330|FG000|Overall Study|Withdrawal by Subject|1
7165022|NCT04154605|11344331|FG001|Overall Study|Withdrawal by Subject|0
7165023|NCT04160091|11344341|FG000|Overall Study|Terminated by Sponsor|7
7165024|NCT04160091|11344342|FG001|Overall Study|Terminated by Sponsor|3
7080441|NCT02121834|11189820|FG003|Overall Study|Lost to Follow-up|0
7080442|NCT02121834|11189821|FG004|Overall Study|Lost to Follow-up|0
7165025|NCT04160091|11344343|FG002|Overall Study|Terminated by Sponsor|5
7165026|NCT04160091|11344344|FG003|Overall Study|Terminated by Sponsor|2
7165027|NCT04160091|11344341|FG000|Overall Study|Noncompliance|0
7165028|NCT04160091|11344342|FG001|Overall Study|Noncompliance|0
7165029|NCT04160091|11344343|FG002|Overall Study|Noncompliance|0
7165030|NCT04160091|11344344|FG003|Overall Study|Noncompliance|1
7165031|NCT04160091|11344341|FG000|Overall Study|Withdrawal by Subject|0
7165032|NCT04160091|11344342|FG001|Overall Study|Withdrawal by Subject|0
7165033|NCT04160091|11344343|FG002|Overall Study|Withdrawal by Subject|0
7165034|NCT04160091|11344344|FG003|Overall Study|Withdrawal by Subject|1
7165035|NCT04164758|11344361|FG000|Overall Study|COVID-19 withdrawal of consent|1
7165036|NCT04164758|11344362|FG001|Overall Study|COVID-19 withdrawal of consent|0
7165037|NCT04164758|11344363|FG002|Overall Study|COVID-19 withdrawal of consent|0
7165038|NCT04164758|11344361|FG000|Overall Study|Adverse Event|0
7165039|NCT04164758|11344362|FG001|Overall Study|Adverse Event|1
7165040|NCT04164758|11344363|FG002|Overall Study|Adverse Event|0
7165041|NCT04165031|11344377|FG000|Overall Study|Adverse Event|1
7165042|NCT04165031|11344378|FG001|Overall Study|Adverse Event|1
7165043|NCT04165031|11344379|FG002|Overall Study|Adverse Event|0
7080443|NCT02121834|11189822|FG005|Overall Study|Lost to Follow-up|0
7080444|NCT02121834|11189823|FG006|Overall Study|Lost to Follow-up|0
7080445|NCT02121847|11189849|FG000|Overall Study|Administrative Reasons|1
7080446|NCT02121847|11189849|FG000|Overall Study|Adverse Event|2
7080447|NCT02122146|11189884|FG000|Part 1: Dose Escalation|Death|0
7080448|NCT02122146|11189885|FG001|Part 1: Dose Escalation|Death|1
7080449|NCT02122146|11189886|FG002|Part 1: Dose Escalation|Death|1
7080450|NCT02122146|11189887|FG003|Part 1: Dose Escalation|Death|0
7080451|NCT02122146|11189888|FG004|Part 1: Dose Escalation|Death|0
7080452|NCT02122146|11189889|FG005|Part 1: Dose Escalation|Death|0
7080453|NCT02122146|11189890|FG006|Part 1: Dose Escalation|Death|0
7080454|NCT02122146|11189891|FG007|Part 1: Dose Escalation|Death|0
7080455|NCT02122146|11189884|FG000|Part 1: Dose Escalation|Lost to Follow-up|0
7080456|NCT02122146|11189885|FG001|Part 1: Dose Escalation|Lost to Follow-up|0
7080457|NCT02122146|11189886|FG002|Part 1: Dose Escalation|Lost to Follow-up|1
7080458|NCT02122146|11189887|FG003|Part 1: Dose Escalation|Lost to Follow-up|0
7080459|NCT02122146|11189888|FG004|Part 1: Dose Escalation|Lost to Follow-up|1
7080460|NCT02122146|11189889|FG005|Part 1: Dose Escalation|Lost to Follow-up|0
7080461|NCT02122146|11189890|FG006|Part 1: Dose Escalation|Lost to Follow-up|0
7080462|NCT02122146|11189891|FG007|Part 1: Dose Escalation|Lost to Follow-up|0
7080463|NCT02122146|11189884|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0
7165044|NCT04165031|11344380|FG003|Overall Study|Adverse Event|0
7165045|NCT04165031|11344381|FG004|Overall Study|Adverse Event|0
7165046|NCT04165031|11344382|FG005|Overall Study|Adverse Event|0
7165047|NCT04165031|11344377|FG000|Overall Study|Withdrawal by Subject|0
7165048|NCT04165031|11344378|FG001|Overall Study|Withdrawal by Subject|0
7165049|NCT04165031|11344379|FG002|Overall Study|Withdrawal by Subject|1
7165050|NCT04165031|11344380|FG003|Overall Study|Withdrawal by Subject|0
7165051|NCT04165031|11344381|FG004|Overall Study|Withdrawal by Subject|0
7165052|NCT04165031|11344382|FG005|Overall Study|Withdrawal by Subject|0
7165053|NCT04171414|11344401|FG000|Overall Study|Death|1
7165054|NCT04171414|11344401|FG000|Overall Study|Withdrawal by Subject|1
7165055|NCT04175808|11344405|FG000|Part A|Miscellaneous|2
7165056|NCT04175808|11344406|FG001|Part A|Miscellaneous|0
7165057|NCT04175808|11344407|FG002|Part A|Miscellaneous|0
7165058|NCT04175808|11344408|FG003|Part A|Miscellaneous|0
7165059|NCT04175808|11344409|FG004|Part A|Miscellaneous|0
7165060|NCT04175808|11344410|FG005|Part A|Miscellaneous|0
7165061|NCT04175808|11344411|FG006|Part A|Miscellaneous|0
7165062|NCT04178720|11344429|FG000|Overall Study|Withdrawal by Subject|2
7165063|NCT04178720|11344430|FG001|Overall Study|Withdrawal by Subject|0
7165064|NCT04178720|11344429|FG000|Overall Study|Relocation|0
7165065|NCT04178720|11344430|FG001|Overall Study|Relocation|1
7165066|NCT04218110|11344473|FG000|Overall Study|Withdrawal by Subject|0
7165067|NCT04218110|11344474|FG001|Overall Study|Withdrawal by Subject|0
7165068|NCT04218110|11344475|FG002|Overall Study|Withdrawal by Subject|0
7165069|NCT04218110|11344476|FG003|Overall Study|Withdrawal by Subject|1
7165070|NCT04222725|11344490|FG000|Overall Study|Adverse Event|0
7165071|NCT04222725|11344491|FG001|Overall Study|Adverse Event|1
7165072|NCT04222725|11344492|FG002|Overall Study|Adverse Event|0
7165073|NCT04222725|11344493|FG003|Overall Study|Adverse Event|0
7165074|NCT04258995|11344579|FG000|Overall Study|Lost to Follow-up|1
7165075|NCT04258995|11344580|FG001|Overall Study|Lost to Follow-up|1
7165076|NCT04317040|11344619|FG000|Overall Study|Lost to Follow-up|2
7165077|NCT04317040|11344620|FG001|Overall Study|Lost to Follow-up|0
7165078|NCT04317040|11344619|FG000|Overall Study|Death|16
7165079|NCT04317040|11344620|FG001|Overall Study|Death|18
7165080|NCT04317040|11344619|FG000|Overall Study|Withdrawal by Subject|0
7165081|NCT04317040|11344620|FG001|Overall Study|Withdrawal by Subject|1
7165082|NCT04317040|11344619|FG000|Overall Study|Incomplete assessments|0
7165083|NCT04317040|11344620|FG001|Overall Study|Incomplete assessments|1
7165084|NCT04319159|11344637|FG000|Overall Study|Screening failure|13
7165085|NCT04319159|11344637|FG000|Overall Study|Re-screening due to COVID-19 implications|2
7165086|NCT04319159|11344637|FG000|Overall Study|Withdrawal by Subject|1
7184539|NCT01256398|11384784|FG000|Overall Study|Withdrawal by Subject|1
7184540|NCT00777036|11384802|FG000|On Treatment|Reason Not Specified|4
7184541|NCT00777036|11384803|FG001|On Treatment|Reason Not Specified|7
7184542|NCT00777036|11384804|FG002|On Treatment|Reason Not Specified|12
7184543|NCT00777036|11384802|FG000|On Treatment|Failure to Meet Study Criteria|0
7184544|NCT00777036|11384803|FG001|On Treatment|Failure to Meet Study Criteria|1
7184545|NCT00777036|11384804|FG002|On Treatment|Failure to Meet Study Criteria|0
7184546|NCT00777036|11384802|FG000|On Treatment|Non-compliance with Study Drug|1
7184547|NCT00777036|11384803|FG001|On Treatment|Non-compliance with Study Drug|0
7184548|NCT00777036|11384804|FG002|On Treatment|Non-compliance with Study Drug|0
7184549|NCT00777036|11384802|FG000|On Treatment|Maximum Clinical Benefit|2
7184550|NCT00777036|11384803|FG001|On Treatment|Maximum Clinical Benefit|0
7184551|NCT00777036|11384804|FG002|On Treatment|Maximum Clinical Benefit|1
7184552|NCT00777036|11384802|FG000|On Treatment|Withdrawal by Subject|3
7184553|NCT00777036|11384803|FG001|On Treatment|Withdrawal by Subject|2
7184554|NCT00777036|11384804|FG002|On Treatment|Withdrawal by Subject|3
7184555|NCT00777036|11384802|FG000|On Treatment|Death|0
7184556|NCT00777036|11384803|FG001|On Treatment|Death|2
7184557|NCT00777036|11384804|FG002|On Treatment|Death|0
7184558|NCT00777036|11384802|FG000|On Treatment|Study Drug Toxicity|0
7184559|NCT00777036|11384803|FG001|On Treatment|Study Drug Toxicity|0
7184560|NCT00777036|11384804|FG002|On Treatment|Study Drug Toxicity|1
7184561|NCT00777036|11384802|FG000|On Treatment|Progressive Disease|5
7184562|NCT00777036|11384803|FG001|On Treatment|Progressive Disease|4
7184563|NCT00777036|11384804|FG002|On Treatment|Progressive Disease|6
7184564|NCT00777036|11384802|FG000|Follow-Up|Lost to Follow-up|1
7184565|NCT00777036|11384803|FG001|Follow-Up|Lost to Follow-up|0
7184566|NCT00777036|11384804|FG002|Follow-Up|Lost to Follow-up|0
7184567|NCT00777036|11384802|FG000|Follow-Up|Reason Not Specified|2
7184568|NCT00777036|11384803|FG001|Follow-Up|Reason Not Specified|0
7184569|NCT00777036|11384804|FG002|Follow-Up|Reason Not Specified|0
7184570|NCT00777036|11384802|FG000|Follow-Up|Withdrawal by Subject|1
7184571|NCT00777036|11384803|FG001|Follow-Up|Withdrawal by Subject|0
7184572|NCT00777036|11384804|FG002|Follow-Up|Withdrawal by Subject|4
7184573|NCT00777036|11384802|FG000|Follow-Up|Death|1
7184574|NCT00777036|11384803|FG001|Follow-Up|Death|8
7184575|NCT00777036|11384804|FG002|Follow-Up|Death|0
7187530|NCT03287245|11388184|FG000|Overall Study|Physician Decision|3
7187531|NCT03287245|11388185|FG001|Overall Study|Physician Decision|2
7187532|NCT03287245|11388186|FG002|Overall Study|Physician Decision|0
7187533|NCT03287245|11388187|FG003|Overall Study|Physician Decision|0
7187534|NCT03092219|11388228|FG000|Overall Study|Protocol Violation|7
7187535|NCT03092219|11388229|FG001|Overall Study|Protocol Violation|4
7165087|NCT04331899|11344667|FG000|Trial Period (28 Days)|Withdrawal by Subject|2
7165088|NCT04331899|11344668|FG001|Trial Period (28 Days)|Withdrawal by Subject|2
7165089|NCT04334148|11344676|FG000|Overall Study|positive nasal swab at baseline|0
7165090|NCT04334148|11344677|FG001|Overall Study|positive nasal swab at baseline|1
7165091|NCT04347954|11344697|FG000|Overall Study|Did not present to study site for allocated intervention|3
7165092|NCT04347954|11344698|FG001|Overall Study|Did not present to study site for allocated intervention|0
7165093|NCT04347954|11344699|FG002|Overall Study|Did not present to study site for allocated intervention|3
7165094|NCT04347954|11344697|FG000|Overall Study|Lost to Follow-up|0
7165095|NCT04347954|11344698|FG001|Overall Study|Lost to Follow-up|1
7165096|NCT04347954|11344699|FG002|Overall Study|Lost to Follow-up|0
7165097|NCT04349098|11344709|FG000|Overall Study|Death|16
7165098|NCT04349098|11344710|FG001|Overall Study|Death|8
7165099|NCT04349098|11344709|FG000|Overall Study|Lost to Follow-up|11
7165100|NCT04349098|11344710|FG001|Overall Study|Lost to Follow-up|8
7165101|NCT04349098|11344709|FG000|Overall Study|Withdrawal by Subject|8
7165102|NCT04349098|11344710|FG001|Overall Study|Withdrawal by Subject|5
7165103|NCT04349098|11344709|FG000|Overall Study|Other|3
7165104|NCT04349098|11344710|FG001|Overall Study|Other|5
7165105|NCT04353037|11344720|FG000|Overall Study|Lost to Follow-up|0
7165106|NCT04353037|11344721|FG001|Overall Study|Lost to Follow-up|1
7165107|NCT04353037|11344722|FG002|Overall Study|Lost to Follow-up|2
7165108|NCT04353037|11344723|FG003|Overall Study|Lost to Follow-up|3
7165109|NCT04353037|11344720|FG000|Overall Study|Withdrawal by Subject|0
7165110|NCT04353037|11344721|FG001|Overall Study|Withdrawal by Subject|2
7165111|NCT04353037|11344722|FG002|Overall Study|Withdrawal by Subject|3
7165112|NCT04353037|11344723|FG003|Overall Study|Withdrawal by Subject|5
7165113|NCT04353037|11344720|FG000|Overall Study|Adverse Event|0
7165114|NCT04353037|11344721|FG001|Overall Study|Adverse Event|0
7165115|NCT04353037|11344722|FG002|Overall Study|Adverse Event|2
7165116|NCT04353037|11344723|FG003|Overall Study|Adverse Event|0
7165117|NCT04353037|11344720|FG000|Overall Study|Exposure Change|0
7165118|NCT04353037|11344721|FG001|Overall Study|Exposure Change|0
7165119|NCT04353037|11344722|FG002|Overall Study|Exposure Change|0
7165120|NCT04353037|11344723|FG003|Overall Study|Exposure Change|2
7165121|NCT04355767|11344743|FG000|Overall Study|Withdrawal by Subject|2
7165122|NCT04355767|11344744|FG001|Overall Study|Withdrawal by Subject|2
7165123|NCT04355767|11344743|FG000|Overall Study|Death|5
7165124|NCT04355767|11344744|FG001|Overall Study|Death|1
7165125|NCT04356573|11344752|FG000|Overall Study|Didn't Qualify|1
7165126|NCT04356573|11344753|FG001|Overall Study|Didn't Qualify|0
7165127|NCT04358068|11344765|FG000|Overall Study|Did not initiate study treatment|2
7165128|NCT04358068|11344766|FG001|Overall Study|Did not initiate study treatment|2
7165129|NCT04366349|11344778|FG000|Overall Study|Withdrawal by Subject|1
7165130|NCT04366349|11344779|FG001|Overall Study|Withdrawal by Subject|0
7165131|NCT04366349|11344780|FG002|Overall Study|Withdrawal by Subject|0
7165132|NCT04366349|11344781|FG003|Overall Study|Withdrawal by Subject|0
7165133|NCT04366349|11344782|FG004|Overall Study|Withdrawal by Subject|0
7165134|NCT04366349|11344783|FG005|Overall Study|Withdrawal by Subject|0
7165135|NCT04388826|11344827|FG000|Overall Study|Lost to Follow-up|3
7165136|NCT04388826|11344828|FG001|Overall Study|Lost to Follow-up|2
7165137|NCT04388826|11344827|FG000|Overall Study|Adverse Event|1
7165138|NCT04388826|11344828|FG001|Overall Study|Adverse Event|0
7165139|NCT04398732|11344840|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50
7165140|NCT04401293|11344848|FG000|Overall Study|Withdrawal by Subject|1
7165141|NCT04401293|11344849|FG001|Overall Study|Withdrawal by Subject|3
7165142|NCT04411628|11344859|FG000|Overall Study|Withdrawal by Subject|1
7165143|NCT04411628|11344860|FG001|Overall Study|Withdrawal by Subject|1
7165144|NCT04411628|11344861|FG002|Overall Study|Withdrawal by Subject|2
7165145|NCT04411628|11344862|FG003|Overall Study|Withdrawal by Subject|0
7165146|NCT04411628|11344859|FG000|Overall Study|Lost to Follow-up|0
7165147|NCT04411628|11344860|FG001|Overall Study|Lost to Follow-up|1
7165148|NCT04411628|11344861|FG002|Overall Study|Lost to Follow-up|0
7165149|NCT04411628|11344862|FG003|Overall Study|Lost to Follow-up|0
7165150|NCT04428411|11344914|FG000|Overall Study|Lost to Follow-up|114
7165151|NCT04435184|11344923|FG000|Overall Study|follow-up blood draws missing|3
7165152|NCT04435184|11344924|FG001|Overall Study|follow-up blood draws missing|5
7165153|NCT04476784|11344932|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1
7165154|NCT04476784|11344933|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0
7165155|NCT04495283|11344965|FG000|Overall Study|Physician Decision|0
7165156|NCT04495283|11344966|FG001|Overall Study|Physician Decision|0
7165157|NCT04495283|11344967|FG002|Overall Study|Physician Decision|1
7165158|NCT04495283|11344965|FG000|Overall Study|Withdrawal by Subject|0
7165159|NCT04495283|11344966|FG001|Overall Study|Withdrawal by Subject|1
7165160|NCT04495283|11344967|FG002|Overall Study|Withdrawal by Subject|1
7165161|NCT04495283|11344965|FG000|Overall Study|Other|1
7165162|NCT04495283|11344966|FG001|Overall Study|Other|0
7165163|NCT04495283|11344967|FG002|Overall Study|Other|1
7165164|NCT04497948|11344978|FG000|Overall Study|Death|2
7165165|NCT04501952|11345005|FG000|Overall Study|Adverse Event|0
7165166|NCT04501952|11345006|FG001|Overall Study|Adverse Event|3
7165167|NCT04501952|11345005|FG000|Overall Study|Investigator's Discretion|0
7165168|NCT04501952|11345006|FG001|Overall Study|Investigator's Discretion|1
7165169|NCT04501952|11345005|FG000|Overall Study|Protocol Violation|1
7165170|NCT04501952|11345006|FG001|Overall Study|Protocol Violation|1
7165171|NCT04501952|11345005|FG000|Overall Study|Withdrew Consent|5
7165172|NCT04501952|11345006|FG001|Overall Study|Withdrew Consent|4
7165173|NCT04501952|11345005|FG000|Overall Study|Lost to Follow-up|7
7165174|NCT04501952|11345006|FG001|Overall Study|Lost to Follow-up|2
7165175|NCT04501952|11345005|FG000|Overall Study|Randomized and Never Treated|13
7165176|NCT04501952|11345006|FG001|Overall Study|Randomized and Never Treated|9
7165177|NCT04504032|11345015|FG000|Overall Study|Adverse Event|1
7165178|NCT04504032|11345016|FG001|Overall Study|Adverse Event|2
7165179|NCT04504032|11345015|FG000|Overall Study|Lost to Follow-up|6
7165180|NCT04504032|11345016|FG001|Overall Study|Lost to Follow-up|9
7165181|NCT04504032|11345015|FG000|Overall Study|Protocol Violation|2
7165182|NCT04504032|11345016|FG001|Overall Study|Protocol Violation|0
7165183|NCT04504032|11345015|FG000|Overall Study|Study terminated by sponsor|1
7165184|NCT04504032|11345016|FG001|Overall Study|Study terminated by sponsor|2
7165185|NCT04504032|11345015|FG000|Overall Study|Withdrawal by Subject|9
7165186|NCT04504032|11345016|FG001|Overall Study|Withdrawal by Subject|11
7165187|NCT04504032|11345015|FG000|Overall Study|Disease progression prior to dosing|15
7165188|NCT04504032|11345016|FG001|Overall Study|Disease progression prior to dosing|3
7165189|NCT04504032|11345015|FG000|Overall Study|Drug supply issues|1
7165190|NCT04504032|11345016|FG001|Overall Study|Drug supply issues|1
7165191|NCT04504032|11345015|FG000|Overall Study|Progressed to moderate/severe COVID-19|1
7165192|NCT04504032|11345016|FG001|Overall Study|Progressed to moderate/severe COVID-19|0
7165193|NCT04507763|11345022|FG000|Overall Study|Participants did not meet entrance criteria|201
7165194|NCT04507867|11345031|FG000|Overall Study|Death|7
7165195|NCT04507867|11345032|FG001|Overall Study|Death|1
7165196|NCT04527978|11345077|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1
7165197|NCT04527978|11345078|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0
7165198|NCT04529109|11345099|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0
7165199|NCT04529109|11345100|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1
7165200|NCT04601103|11345215|FG000|Overall Study|Needed crown & cleaning|0
7165201|NCT04601103|11345216|FG001|Overall Study|Needed crown & cleaning|0
7165202|NCT04601103|11345217|FG002|Overall Study|Needed crown & cleaning|1
7165203|NCT04601103|11345215|FG000|Overall Study|study was terminated|18
7165204|NCT04601103|11345216|FG001|Overall Study|study was terminated|18
7165205|NCT04601103|11345217|FG002|Overall Study|study was terminated|16
7165206|NCT04664855|11345245|FG000|Overall Study|Withdrawal by Subject|0
7165207|NCT04664855|11345246|FG001|Overall Study|Withdrawal by Subject|2
7165208|NCT04701658|11345252|FG000|Overall Study|Lost to Follow-up|6
7165209|NCT04706416|11345258|FG000|Overall Study|Lost to Follow-up|2
7165210|NCT04706416|11345259|FG001|Overall Study|Lost to Follow-up|0
7165211|NCT04727749|11345279|FG000|Overall Study|Lost to Follow-up|10
7165212|NCT04727749|11345280|FG001|Overall Study|Lost to Follow-up|3
7165213|NCT04854707|11345302|FG000|Overall Study|Lack of Efficacy|78
7165214|NCT04854707|11345303|FG001|Overall Study|Lack of Efficacy|59
7165215|NCT04854707|11345304|FG002|Overall Study|Lack of Efficacy|30
7165216|NCT04947436|11345399|FG000|Overall Study|Lost to Follow-up|3
7165217|NCT04947436|11345400|FG001|Overall Study|Lost to Follow-up|7
7165218|NCT04947436|11345401|FG002|Overall Study|Lost to Follow-up|5
7165219|NCT04947436|11345399|FG000|Overall Study|Death|1
7165220|NCT04947436|11345400|FG001|Overall Study|Death|1
7165221|NCT04947436|11345401|FG002|Overall Study|Death|1
7165222|NCT05002972|11345409|FG000|Overall Study|Withdrawal by Subject|2
7165223|NCT05002985|11345413|FG000|Overall Study|Withdrawal by Subject|1
7165224|NCT04512482|11345419|FG000|Second Intervention (1 Day)|Protocol Violation|2
7165225|NCT04512482|11345420|FG001|Second Intervention (1 Day)|Protocol Violation|1
7165226|NCT04523831|11345445|FG000|Overall Study|Lost to Follow-up|15
7165227|NCT04523831|11345446|FG001|Overall Study|Lost to Follow-up|17
7165228|NCT04523831|11345445|FG000|Overall Study|Death|0
7165229|NCT04523831|11345446|FG001|Overall Study|Death|3
7165230|NCT04523831|11345445|FG000|Overall Study|Adverse Event|2
7165231|NCT04523831|11345446|FG001|Overall Study|Adverse Event|0
7165232|NCT04521777|11345455|FG000|Overall Study|Death|2
7165233|NCT04521777|11345455|FG000|Overall Study|Withdrawal by Subject|2
7165234|NCT04507776|11345485|FG000|Overall Study|Participants did not meet the entrance criteria|201
7165235|NCT04502979|11345496|FG000|Overall Study|Lost to Follow-up|1
7165236|NCT04502979|11345497|FG001|Overall Study|Lost to Follow-up|3
7165237|NCT04502979|11345496|FG000|Overall Study|Withdrawal by Subject|2
7165238|NCT04502979|11345497|FG001|Overall Study|Withdrawal by Subject|1
7165239|NCT04498403|11345540|FG000|Overall Study|Adverse Event|1
7165240|NCT04498403|11345541|FG001|Overall Study|Adverse Event|0
7165241|NCT04498403|11345540|FG000|Overall Study|Study Terminated By Sponsor|29
7165242|NCT04498403|11345541|FG001|Overall Study|Study Terminated By Sponsor|10
7165243|NCT04495374|11345549|FG000|Overall Study|Protocol Violation|2
7165244|NCT04495374|11345550|FG001|Overall Study|Protocol Violation|1
7165245|NCT04491994|11345574|FG000|Overall Study|Withdrawal by Subject|10
7165246|NCT04491994|11345575|FG001|Overall Study|Withdrawal by Subject|5
7165247|NCT04491994|11345574|FG000|Overall Study|developed fever > 3 days|4
7165248|NCT04491994|11345575|FG001|Overall Study|developed fever > 3 days|1
7165249|NCT04491994|11345574|FG000|Overall Study|Protocol Violation|11
7165250|NCT04491994|11345575|FG001|Overall Study|Protocol Violation|2
7165251|NCT04491994|11345574|FG000|Overall Study|Lost to Follow-up|4
7165252|NCT04491994|11345575|FG001|Overall Study|Lost to Follow-up|3
7165253|NCT04490499|11345598|FG000|Overall Study|Withdrawal by Subject|2
7165254|NCT04486235|11345608|FG000|Overall Study|Pregnancy|1
7165255|NCT04486235|11345609|FG001|Overall Study|Pregnancy|0
7165256|NCT04486235|11345608|FG000|Overall Study|Lost to Follow-up|1
7165257|NCT04486235|11345609|FG001|Overall Study|Lost to Follow-up|0
7165258|NCT04483011|11345618|FG000|Washout (7 Days)|Withdrawal by Subject|0
7165259|NCT04483011|11345619|FG001|Washout (7 Days)|Withdrawal by Subject|1
7165260|NCT04475588|11345629|FG000|Overall Study|Adverse Event|2
7165261|NCT04475588|11345630|FG001|Overall Study|Adverse Event|0
7165262|NCT04474405|11345656|FG000|Overall Study|Withdrawal by Subject|0
7165263|NCT04474405|11345657|FG001|Overall Study|Withdrawal by Subject|0
7165264|NCT04474405|11345658|FG002|Overall Study|Withdrawal by Subject|1
7165265|NCT04474405|11345659|FG003|Overall Study|Withdrawal by Subject|0
7165266|NCT04474405|11345660|FG004|Overall Study|Withdrawal by Subject|1
7165267|NCT04474405|11345661|FG005|Overall Study|Withdrawal by Subject|0
7165268|NCT04474405|11345656|FG000|Overall Study|Other|0
7165269|NCT04474405|11345657|FG001|Overall Study|Other|0
7165270|NCT04474405|11345658|FG002|Overall Study|Other|0
7165271|NCT04474405|11345659|FG003|Overall Study|Other|0
7165272|NCT04474405|11345660|FG004|Overall Study|Other|3
7165273|NCT04474405|11345661|FG005|Overall Study|Other|0
7165274|NCT04468347|11345683|FG000|Overall Study|Withdrawal by Subject|0
7165275|NCT04468347|11345684|FG001|Overall Study|Withdrawal by Subject|1
7165276|NCT04468347|11345685|FG002|Overall Study|Withdrawal by Subject|3
7165277|NCT04468347|11345686|FG003|Overall Study|Withdrawal by Subject|3
7165278|NCT04468347|11345683|FG000|Overall Study|Lost to Follow-up|0
7165279|NCT04468347|11345684|FG001|Overall Study|Lost to Follow-up|0
7165280|NCT04468347|11345685|FG002|Overall Study|Lost to Follow-up|1
7165281|NCT04468347|11345686|FG003|Overall Study|Lost to Follow-up|1
7165282|NCT04468347|11345683|FG000|Overall Study|Physician Decision|1
7165283|NCT04468347|11345684|FG001|Overall Study|Physician Decision|0
7165284|NCT04468347|11345685|FG002|Overall Study|Physician Decision|2
7165285|NCT04468347|11345686|FG003|Overall Study|Physician Decision|0
7165286|NCT04468347|11345683|FG000|Overall Study|Protocol Violation|1
7165287|NCT04468347|11345684|FG001|Overall Study|Protocol Violation|0
7165288|NCT04468347|11345685|FG002|Overall Study|Protocol Violation|0
7165289|NCT04468347|11345686|FG003|Overall Study|Protocol Violation|0
7165290|NCT04465422|11345711|FG000|Overall Study|Lost to Follow-up|0
7165291|NCT04465422|11345712|FG001|Overall Study|Lost to Follow-up|2
7165292|NCT04448561|11345731|FG000|Overall Study|Noncompliance|1
7165293|NCT04448561|11345732|FG001|Overall Study|Noncompliance|0
7184576|NCT03703102|11384865|FG000|Overall Study|Adverse Event|4
7184577|NCT03703102|11384866|FG001|Overall Study|Adverse Event|3
7184578|NCT03703102|11384867|FG002|Overall Study|Adverse Event|7
7184579|NCT03703102|11384868|FG003|Overall Study|Adverse Event|3
7184580|NCT03703102|11384869|FG004|Overall Study|Adverse Event|13
7184581|NCT03703102|11384865|FG000|Overall Study|Lack of Efficacy|4
7184582|NCT03703102|11384866|FG001|Overall Study|Lack of Efficacy|0
7184583|NCT03703102|11384867|FG002|Overall Study|Lack of Efficacy|1
7184584|NCT03703102|11384868|FG003|Overall Study|Lack of Efficacy|4
7184585|NCT03703102|11384869|FG004|Overall Study|Lack of Efficacy|1
7184586|NCT03703102|11384865|FG000|Overall Study|Lost to Follow-up|0
7184587|NCT03703102|11384866|FG001|Overall Study|Lost to Follow-up|0
7184588|NCT03703102|11384867|FG002|Overall Study|Lost to Follow-up|1
7184589|NCT03703102|11384868|FG003|Overall Study|Lost to Follow-up|2
7184590|NCT03703102|11384869|FG004|Overall Study|Lost to Follow-up|2
7184591|NCT03703102|11384865|FG000|Overall Study|Physician Decision|2
7184592|NCT03703102|11384866|FG001|Overall Study|Physician Decision|2
7184593|NCT03703102|11384867|FG002|Overall Study|Physician Decision|2
7184594|NCT03703102|11384868|FG003|Overall Study|Physician Decision|2
7184595|NCT03703102|11384869|FG004|Overall Study|Physician Decision|4
7184596|NCT03703102|11384865|FG000|Overall Study|Withdrawal by Subject|7
7184597|NCT03703102|11384866|FG001|Overall Study|Withdrawal by Subject|5
7184598|NCT03703102|11384867|FG002|Overall Study|Withdrawal by Subject|5
7184599|NCT03703102|11384868|FG003|Overall Study|Withdrawal by Subject|5
7184600|NCT03703102|11384869|FG004|Overall Study|Withdrawal by Subject|9
7184601|NCT03703102|11384865|FG000|Overall Study|Ineligibility|0
7184602|NCT03703102|11384866|FG001|Overall Study|Ineligibility|0
7184603|NCT03703102|11384867|FG002|Overall Study|Ineligibility|1
7184604|NCT03703102|11384868|FG003|Overall Study|Ineligibility|0
7184605|NCT03703102|11384869|FG004|Overall Study|Ineligibility|0
7184606|NCT03703102|11384865|FG000|Overall Study|Protocol Deviation|4
7184607|NCT03703102|11384866|FG001|Overall Study|Protocol Deviation|4
7184608|NCT03703102|11384867|FG002|Overall Study|Protocol Deviation|3
7184609|NCT03703102|11384868|FG003|Overall Study|Protocol Deviation|0
7184610|NCT03703102|11384869|FG004|Overall Study|Protocol Deviation|0
7184611|NCT03703102|11384865|FG000|Overall Study|Non-Compliance with Study Drug|1
7184612|NCT03703102|11384866|FG001|Overall Study|Non-Compliance with Study Drug|1
7184613|NCT03703102|11384867|FG002|Overall Study|Non-Compliance with Study Drug|2
7184614|NCT03703102|11384868|FG003|Overall Study|Non-Compliance with Study Drug|1
7184615|NCT03703102|11384869|FG004|Overall Study|Non-Compliance with Study Drug|4
7184616|NCT03395704|11384888|FG000|Overall Study|Adverse Event|2
7184617|NCT03395704|11384889|FG001|Overall Study|Adverse Event|1
7184618|NCT03395704|11384888|FG000|Overall Study|Withdrawal by Subject|2
7184619|NCT03395704|11384889|FG001|Overall Study|Withdrawal by Subject|1
7184620|NCT03395704|11384888|FG000|Overall Study|Physician Decision|0
7184621|NCT03395704|11384889|FG001|Overall Study|Physician Decision|1
7165294|NCT04450381|11345807|FG000|Overall Study|Protocol Violation|4
7165295|NCT04450381|11345807|FG000|Overall Study|Wrong device setting|2
7165296|NCT04449341|11345813|FG000|Overall Study|Protocol Violation|1
7165297|NCT04449341|11345814|FG001|Overall Study|Protocol Violation|0
7165298|NCT04439214|11345829|FG000|Overall Study|Adverse Event|13
7165299|NCT04439214|11345829|FG000|Overall Study|Disease progression|16
7165300|NCT04439214|11345829|FG000|Overall Study|Death|1
7165301|NCT04439214|11345829|FG000|Overall Study|Withdrawal by Subject|2
7165302|NCT04439214|11345829|FG000|Overall Study|Declining health|1
7165303|NCT04439214|11345829|FG000|Overall Study|Still receiving treatment at the time of the analysis|9
7165304|NCT04439214|11345829|FG000|Overall Study|Ineligible|5
7165305|NCT04439240|11345833|FG000|Overall Study|Ineligible|2
7165306|NCT04439240|11345833|FG000|Overall Study|Never started treatment|2
7165307|NCT04439240|11345833|FG000|Overall Study|Adverse Event|12
7165308|NCT04439240|11345833|FG000|Overall Study|Death|2
7165309|NCT04439240|11345833|FG000|Overall Study|Disease progression|25
7165310|NCT04439240|11345833|FG000|Overall Study|Other diseases|2
7165311|NCT04439240|11345833|FG000|Overall Study|Withdrawal by Subject|3
7165312|NCT04439240|11345833|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1
7165313|NCT04439240|11345833|FG000|Overall Study|Symptomatic decline|1
7165314|NCT04439240|11345833|FG000|Overall Study|Pogression of the lymphadenopathy|1
7165315|NCT04439240|11345833|FG000|Overall Study|Clinical progression|1
7165316|NCT04438785|11345839|FG000|Overall Study|change of weight, give up intervention|2
7165317|NCT04438785|11345840|FG001|Overall Study|change of weight, give up intervention|10
7165318|NCT04428502|11345929|FG000|Overall Study|Did not meet entrance criteria|14
7165319|NCT04428424|11345934|FG000|Overall Study|Does not meet entrance criteria|132
7165320|NCT04428424|11345934|FG000|Overall Study|Lost to Follow-up|115
7165321|NCT04425863|11345978|FG000|Overall Study|Death|0
7165322|NCT04425863|11345979|FG001|Overall Study|Death|0
7165323|NCT04425863|11345980|FG002|Overall Study|Death|1
7165324|NCT04422561|11346013|FG000|Overall Study|Lost to Follow-up|25
7165325|NCT04422561|11346014|FG001|Overall Study|Lost to Follow-up|11
7165326|NCT04419311|11346031|FG000|Overall Study|Lost to Follow-up|1
7165327|NCT04419311|11346032|FG001|Overall Study|Lost to Follow-up|0
7165328|NCT04411667|11346052|FG000|Overall Study|Physician Decision|1
7165329|NCT04411667|11346053|FG001|Overall Study|Physician Decision|0
7165330|NCT04407507|11346065|FG000|Overall Study|Withdrawal by Subject|0
7165331|NCT04407507|11346066|FG001|Overall Study|Withdrawal by Subject|1
7165332|NCT04406194|11346074|FG000|Period 1|Withdrawal by Subject|0
7165333|NCT04406194|11346075|FG001|Period 1|Withdrawal by Subject|1
7165334|NCT04404010|11346095|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1
7165335|NCT04404010|11346096|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0
7165336|NCT04403399|11346106|FG000|Period 2|Physician Decision|0
7165337|NCT04403399|11346107|FG001|Period 2|Physician Decision|1
7165338|NCT04401202|11346137|FG000|Overall Study|Lost to Follow-up|2
7165339|NCT04401202|11346138|FG001|Overall Study|Lost to Follow-up|2
7165340|NCT04401202|11346137|FG000|Overall Study|Adverse Event|0
7165341|NCT04401202|11346138|FG001|Overall Study|Adverse Event|1
7165342|NCT04401202|11346137|FG000|Overall Study|Hospitalized|4
7165343|NCT04401202|11346138|FG001|Overall Study|Hospitalized|1
7165344|NCT04400682|11346147|FG000|Period 1|Withdrawal by Subject|1
7165345|NCT04400682|11346148|FG001|Period 1|Withdrawal by Subject|4
7165346|NCT04399161|11346157|FG000|Overall Study|Withdrawal by Subject|1
7165347|NCT04399161|11346158|FG001|Overall Study|Withdrawal by Subject|0
7165348|NCT04399161|11346159|FG002|Overall Study|Withdrawal by Subject|2
7165349|NCT04399161|11346157|FG000|Overall Study|Protocol Violation|1
7165350|NCT04399161|11346158|FG001|Overall Study|Protocol Violation|2
7165351|NCT04399161|11346159|FG002|Overall Study|Protocol Violation|0
7165352|NCT04399122|11346178|FG000|Overall Study|Lost to Follow-up|2
7165353|NCT04399122|11346179|FG001|Overall Study|Lost to Follow-up|0
7165354|NCT04399122|11346178|FG000|Overall Study|Withdrawal by Subject|1
7165355|NCT04399122|11346179|FG001|Overall Study|Withdrawal by Subject|0
7165356|NCT04397445|11346185|FG000|Overall Study|Withdrawal by Subject|1
7165357|NCT04397445|11346186|FG001|Overall Study|Withdrawal by Subject|0
7165358|NCT04397445|11346187|FG002|Overall Study|Withdrawal by Subject|0
7165359|NCT04397445|11346188|FG003|Overall Study|Withdrawal by Subject|0
7165360|NCT04396639|11346214|FG000|Overall Study|Withdrawal by Subject|1
7165361|NCT04396639|11346214|FG000|Overall Study|Other|1
7165362|NCT04393493|11346233|FG000|First 4 Days of Intervention|Early improvement|5
7165363|NCT04393493|11346234|FG001|First 4 Days of Intervention|Early improvement|7
7165364|NCT04391842|11346333|FG000|Overall Study|Withdrawal by Subject|2
7165365|NCT04386902|11346346|FG000|Overall Study|Withdrawal by Subject|5
7165366|NCT04386902|11346346|FG000|Overall Study|Technical problems in the recording|5
7165367|NCT04384523|11346365|FG000|Overall Study|Lost to Follow-up|0
7165368|NCT04384523|11346366|FG001|Overall Study|Lost to Follow-up|0
7165369|NCT04384523|11346367|FG002|Overall Study|Lost to Follow-up|0
7165370|NCT04384523|11346368|FG003|Overall Study|Lost to Follow-up|0
7165371|NCT04384523|11346369|FG004|Overall Study|Lost to Follow-up|0
7165372|NCT04384523|11346370|FG005|Overall Study|Lost to Follow-up|1
7165373|NCT04384523|11346365|FG000|Overall Study|Protocol Violation|0
7165374|NCT04384523|11346366|FG001|Overall Study|Protocol Violation|1
7165375|NCT04384523|11346367|FG002|Overall Study|Protocol Violation|0
7165376|NCT04384523|11346368|FG003|Overall Study|Protocol Violation|0
7165377|NCT04384523|11346369|FG004|Overall Study|Protocol Violation|0
7165378|NCT04384523|11346370|FG005|Overall Study|Protocol Violation|0
7165379|NCT04384523|11346365|FG000|Overall Study|Withdrawal by Subject|1
7165380|NCT04384523|11346366|FG001|Overall Study|Withdrawal by Subject|0
7165381|NCT04384523|11346367|FG002|Overall Study|Withdrawal by Subject|0
7165382|NCT04384523|11346368|FG003|Overall Study|Withdrawal by Subject|0
7165383|NCT04384523|11346369|FG004|Overall Study|Withdrawal by Subject|0
7165384|NCT04384523|11346370|FG005|Overall Study|Withdrawal by Subject|0
7165385|NCT04382066|11346415|FG000|Overall Study|Adverse Event|1
7165386|NCT04382066|11346416|FG001|Overall Study|Adverse Event|0
7165387|NCT04382066|11346417|FG002|Overall Study|Adverse Event|0
7165388|NCT04382066|11346415|FG000|Overall Study|Death|1
7165389|NCT04382066|11346416|FG001|Overall Study|Death|0
7165390|NCT04382066|11346417|FG002|Overall Study|Death|1
7165391|NCT04380688|11346478|FG000|Overall Study|Death|2
7165392|NCT04380688|11346479|FG001|Overall Study|Death|2
7165393|NCT04380688|11346478|FG000|Overall Study|Lost to Follow-up|2
7165394|NCT04380688|11346479|FG001|Overall Study|Lost to Follow-up|4
7165395|NCT04380688|11346478|FG000|Overall Study|Withdrawal by Subject|3
7165396|NCT04380688|11346479|FG001|Overall Study|Withdrawal by Subject|3
7165397|NCT04376060|11346485|FG000|Overall Study|Physician Decision|1
7165398|NCT04372186|11346504|FG000|Overall Study|Death|24
7165399|NCT04372186|11346505|FG001|Overall Study|Death|11
7165400|NCT04372186|11346504|FG000|Overall Study|Transferred to a different facility for care|0
7165401|NCT04372186|11346505|FG001|Overall Study|Transferred to a different facility for care|2
7165402|NCT04370028|11346579|FG000|Overall Study|Withdrawal by Subject|695
7165403|NCT04370028|11346579|FG000|Overall Study|Protocol Violation|9
7165404|NCT04370028|11346579|FG000|Overall Study|Adverse Event|3
7165405|NCT04363736|11346592|FG000|Overall Study|Withdrawal by Subject|1
7165406|NCT04363736|11346593|FG001|Overall Study|Withdrawal by Subject|0
7165407|NCT04363736|11346592|FG000|Overall Study|Lost to Follow-up|10
7165408|NCT04363736|11346593|FG001|Overall Study|Lost to Follow-up|7
7165409|NCT04363736|11346592|FG000|Overall Study|Death|8
7165410|NCT04363736|11346593|FG001|Overall Study|Death|6
7165411|NCT04365699|11346611|FG000|Overall Study|Death|2
7165412|NCT04365699|11346612|FG001|Overall Study|Death|5
7165413|NCT04365699|11346613|FG002|Overall Study|Death|15
7165414|NCT04362137|11346646|FG000|Overall Study|Death|9
7165415|NCT04362137|11346647|FG001|Overall Study|Death|3
7165416|NCT04362137|11346646|FG000|Overall Study|Patient decision|6
7165417|NCT04362137|11346647|FG001|Overall Study|Patient decision|3
7165418|NCT04362137|11346646|FG000|Overall Study|Adverse Event|1
7165419|NCT04362137|11346647|FG001|Overall Study|Adverse Event|0
7165420|NCT04362137|11346646|FG000|Overall Study|Lost to Follow-up|1
7165421|NCT04362137|11346647|FG001|Overall Study|Lost to Follow-up|0
7165422|NCT04362137|11346646|FG000|Overall Study|Protocol deviation|1
7165423|NCT04362137|11346647|FG001|Overall Study|Protocol deviation|0
7165424|NCT04359771|11346655|FG000|Overall Study|Lack of Efficacy|2
7165425|NCT04359771|11346656|FG001|Overall Study|Lack of Efficacy|2
7165426|NCT04358081|11346669|FG000|Treatment Phase of Study|Withdrawal by Subject|0
7165427|NCT04358081|11346670|FG001|Treatment Phase of Study|Withdrawal by Subject|1
7165428|NCT04358081|11346671|FG002|Treatment Phase of Study|Withdrawal by Subject|1
7165429|NCT04358081|11346669|FG000|Treatment Phase of Study|Adverse Event|1
7165430|NCT04358081|11346670|FG001|Treatment Phase of Study|Adverse Event|0
7165431|NCT04358081|11346671|FG002|Treatment Phase of Study|Adverse Event|1
7165432|NCT04358081|11346669|FG000|Treatment Phase of Study|Physician Decision|2
7165433|NCT04358081|11346670|FG001|Treatment Phase of Study|Physician Decision|0
7165434|NCT04358081|11346671|FG002|Treatment Phase of Study|Physician Decision|1
7165435|NCT04358081|11346669|FG000|Treatment Phase of Study|Protocol Violation|1
7165436|NCT04358081|11346670|FG001|Treatment Phase of Study|Protocol Violation|0
7165437|NCT04358081|11346671|FG002|Treatment Phase of Study|Protocol Violation|0
6895189|NCT00623467|10912969|FG000|Overall Study|Protocol Violation|4
6895190|NCT00623467|10912969|FG000|Overall Study|Withdrawal by Subject|2
6895191|NCT00623480|10912977|FG000|Overall Study|Lost to Follow-up|0
6895192|NCT00623480|10912978|FG001|Overall Study|Lost to Follow-up|1
7165438|NCT04358081|11346669|FG000|Study Completion Phase|Death|0
7165439|NCT04358081|11346670|FG001|Study Completion Phase|Death|0
7165440|NCT04358081|11346671|FG002|Study Completion Phase|Death|1
7165441|NCT04358081|11346669|FG000|Study Completion Phase|Lost to Follow-up|1
7165442|NCT04358081|11346670|FG001|Study Completion Phase|Lost to Follow-up|0
7165443|NCT04358081|11346671|FG002|Study Completion Phase|Lost to Follow-up|1
7165444|NCT04356937|11346683|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0
7165445|NCT04356937|11346684|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1
7165446|NCT04355663|11346693|FG000|Overall Study|Physician Decision|2
7165447|NCT04355663|11346694|FG001|Overall Study|Physician Decision|7
7165448|NCT04355663|11346695|FG002|Overall Study|Physician Decision|0
7165449|NCT04355663|11346693|FG000|Overall Study|Adverse Event|0
7165450|NCT04355663|11346694|FG001|Overall Study|Adverse Event|0
7165451|NCT04355663|11346695|FG002|Overall Study|Adverse Event|1
7165452|NCT04355663|11346693|FG000|Overall Study|Withdrawal by Subject|0
7165453|NCT04355663|11346694|FG001|Overall Study|Withdrawal by Subject|8
7165454|NCT04355663|11346695|FG002|Overall Study|Withdrawal by Subject|3
7165455|NCT04354870|11346705|FG000|Overall Study|Lost to Follow-up|32
7165456|NCT04354870|11346706|FG001|Overall Study|Lost to Follow-up|12
7165457|NCT04354870|11346705|FG000|Overall Study|Withdrawal by Subject|10
7165458|NCT04354870|11346706|FG001|Overall Study|Withdrawal by Subject|16
7165459|NCT04354870|11346705|FG000|Overall Study|Did not complete all study visits|6
7165460|NCT04354870|11346706|FG001|Overall Study|Did not complete all study visits|5
7165461|NCT04350788|11346732|FG000|Overall Study|Lost to Follow-up|6
7165462|NCT04350788|11346733|FG001|Overall Study|Lost to Follow-up|2
7165463|NCT04350788|11346732|FG000|Overall Study|Withdrawal by Subject|2
7165464|NCT04350788|11346733|FG001|Overall Study|Withdrawal by Subject|4
7165465|NCT04350788|11346732|FG000|Overall Study|Protocol Violation|4
7165466|NCT04350788|11346733|FG001|Overall Study|Protocol Violation|0
7165467|NCT04349917|11346746|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0
7165468|NCT04349917|11346747|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1
7165469|NCT04349917|11346746|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0
7165470|NCT04349917|11346747|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1
7165471|NCT04348851|11346758|FG000|Post-Test 1|Withdrawal by Subject|0
7165472|NCT04348851|11346759|FG001|Post-Test 1|Withdrawal by Subject|1
7165473|NCT04348851|11346760|FG002|Post-Test 1|Withdrawal by Subject|0
7165474|NCT04348851|11346761|FG003|Post-Test 1|Withdrawal by Subject|0
7165475|NCT04348851|11346758|FG000|Post-Test 1|Lost to Follow-up|0
7165476|NCT04348851|11346759|FG001|Post-Test 1|Lost to Follow-up|1
7165477|NCT04348851|11346760|FG002|Post-Test 1|Lost to Follow-up|0
7165478|NCT04348851|11346761|FG003|Post-Test 1|Lost to Follow-up|0
7165479|NCT04348851|11346758|FG000|Post-Test 2|Stroke survivor death|0
7165480|NCT04348851|11346759|FG001|Post-Test 2|Stroke survivor death|1
7165481|NCT04348851|11346760|FG002|Post-Test 2|Stroke survivor death|0
7165482|NCT04348851|11346761|FG003|Post-Test 2|Stroke survivor death|1
7165483|NCT04346199|11346782|FG000|Overall Study|Death|8
7165484|NCT04346199|11346783|FG001|Overall Study|Death|9
7165485|NCT04346199|11346782|FG000|Overall Study|Lost to Follow-up|0
7165486|NCT04346199|11346783|FG001|Overall Study|Lost to Follow-up|1
7165487|NCT04346199|11346782|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2
7165488|NCT04346199|11346783|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0
7165489|NCT04346199|11346782|FG000|Overall Study|Withdrawal by Subject|5
7165490|NCT04346199|11346783|FG001|Overall Study|Withdrawal by Subject|1
7165491|NCT04345653|11346789|FG000|Overall Study|Withdrawal by Subject|2
7165492|NCT04343261|11346794|FG000|Overall Study|Adverse Event|1
7165493|NCT04343261|11346794|FG000|Overall Study|received inadequate amount of antibodies|7
7165494|NCT04342897|11346826|FG000|Overall Study|Death|7
7165495|NCT04342897|11346827|FG001|Overall Study|Death|4
7165496|NCT04342897|11346826|FG000|Overall Study|Lost to Follow-up|6
7165497|NCT04342897|11346827|FG001|Overall Study|Lost to Follow-up|6
7165498|NCT04342897|11346826|FG000|Overall Study|Withdrawal by Subject|1
7165499|NCT04342897|11346827|FG001|Overall Study|Withdrawal by Subject|2
7165500|NCT04340557|11346839|FG000|Overall Study|Transferred to ICU and/or death|1
7165501|NCT04340557|11346840|FG001|Overall Study|Transferred to ICU and/or death|2
7165502|NCT04339972|11346848|FG000|Overall Study|Scheduling Issues|3
7165503|NCT04339972|11346849|FG001|Overall Study|Scheduling Issues|3
7165504|NCT04339972|11346848|FG000|Overall Study|dropout|1
7165505|NCT04339972|11346849|FG001|Overall Study|dropout|1
7165506|NCT04339972|11346848|FG000|Overall Study|Technical issues|1
7165507|NCT04339972|11346849|FG001|Overall Study|Technical issues|0
7165508|NCT04339972|11346848|FG000|Overall Study|Claustraphobia|0
7165509|NCT04339972|11346849|FG001|Overall Study|Claustraphobia|1
7165510|NCT04339296|11346857|FG000|Overall Study|Refuse to participate after allocation|1
7165511|NCT04339296|11346858|FG001|Overall Study|Refuse to participate after allocation|1
7165512|NCT04339296|11346857|FG000|Overall Study|Withdrew after completion of baseline|2
7165513|NCT04339296|11346858|FG001|Overall Study|Withdrew after completion of baseline|1
7165514|NCT04339296|11346857|FG000|Overall Study|Lost to Follow-up|0
7165515|NCT04339296|11346858|FG001|Overall Study|Lost to Follow-up|4
7165516|NCT04339296|11346857|FG000|Overall Study|Discontinued intervention|5
7165517|NCT04339296|11346858|FG001|Overall Study|Discontinued intervention|3
7165518|NCT04336475|11346888|FG000|Overall Study|pain|1
7165519|NCT04336475|11346889|FG001|Overall Study|pain|0
7165520|NCT04336475|11346888|FG000|Overall Study|upper respiratory infection|1
7165521|NCT04336475|11346889|FG001|Overall Study|upper respiratory infection|0
7080464|NCT02122146|11189885|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0
7080465|NCT02122146|11189886|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0
7080466|NCT02122146|11189887|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1
7080467|NCT02122146|11189888|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0
7080468|NCT02122146|11189889|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0
7080469|NCT02122146|11189890|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0
7080470|NCT02122146|11189891|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0
7080471|NCT02122146|11189884|FG000|Part 1: Dose Escalation|Other|1
7080472|NCT02122146|11189885|FG001|Part 1: Dose Escalation|Other|0
7080473|NCT02122146|11189886|FG002|Part 1: Dose Escalation|Other|0
7080474|NCT02122146|11189887|FG003|Part 1: Dose Escalation|Other|0
7080475|NCT02122146|11189888|FG004|Part 1: Dose Escalation|Other|0
7080476|NCT02122146|11189889|FG005|Part 1: Dose Escalation|Other|1
7080477|NCT02122146|11189890|FG006|Part 1: Dose Escalation|Other|1
7080478|NCT02122146|11189891|FG007|Part 1: Dose Escalation|Other|2
7080479|NCT02122380|11189921|FG000|First Intervention (30 Days)|Adverse Event|1
7165522|NCT04336475|11346888|FG000|Overall Study|Lost to Follow-up|0
7165523|NCT04336475|11346889|FG001|Overall Study|Lost to Follow-up|2
7165524|NCT04335929|11346895|FG000|Overall Study|Lost to Follow-up|10
7165525|NCT04335812|11346901|FG000|Overall Study|Withdrawal by Subject|1
7165526|NCT04335812|11346902|FG001|Overall Study|Withdrawal by Subject|3
7165527|NCT04335812|11346901|FG000|Overall Study|Lost to Follow-up|12
7165528|NCT04335812|11346902|FG001|Overall Study|Lost to Follow-up|12
7165529|NCT04335812|11346901|FG000|Overall Study|Did not engage in the intervention|22
7165530|NCT04335812|11346902|FG001|Overall Study|Did not engage in the intervention|18
7165531|NCT04335136|11346910|FG000|Overall Study|Death|8
7165532|NCT04335136|11346911|FG001|Overall Study|Death|4
7165533|NCT04335136|11346910|FG000|Overall Study|Lost to Follow-up|2
7165534|NCT04335136|11346911|FG001|Overall Study|Lost to Follow-up|0
7165535|NCT04335136|11346910|FG000|Overall Study|Protocol Violation|1
7165536|NCT04335136|11346911|FG001|Overall Study|Protocol Violation|0
7165537|NCT04335136|11346910|FG000|Overall Study|Withdrawal by Subject|1
7165538|NCT04335136|11346911|FG001|Overall Study|Withdrawal by Subject|1
7165539|NCT04335136|11346910|FG000|Overall Study|Health-threatening condition|0
7165540|NCT04335136|11346911|FG001|Overall Study|Health-threatening condition|1
7165541|NCT04335136|11346910|FG000|Overall Study|Adverse Event|0
7165542|NCT04335136|11346911|FG001|Overall Study|Adverse Event|1
7165543|NCT04335136|11346910|FG000|Overall Study|Erroneously randomized|2
7165544|NCT04335136|11346911|FG001|Overall Study|Erroneously randomized|0
7184622|NCT03335813|11384895|FG000|Overall Study|Withdrawal by Subject|1
7184623|NCT03246503|11384899|FG000|Overall Study|Lost to Follow-up|23
7184624|NCT03246503|11384899|FG000|Overall Study|Withdrawal by Subject|20
7184625|NCT03246503|11384899|FG000|Overall Study|Physician Decision|5
7184626|NCT03246503|11384899|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5
7187536|NCT03033069|11388242|FG000|Overall Study|Adverse Event|6
7187537|NCT03033069|11388243|FG001|Overall Study|Adverse Event|7
7187538|NCT03033069|11388244|FG002|Overall Study|Adverse Event|4
7187539|NCT03033069|11388245|FG003|Overall Study|Adverse Event|6
7187540|NCT03033069|11388242|FG000|Overall Study|Lack of Efficacy|0
7187541|NCT03033069|11388243|FG001|Overall Study|Lack of Efficacy|0
7187542|NCT03033069|11388244|FG002|Overall Study|Lack of Efficacy|1
7187543|NCT03033069|11388245|FG003|Overall Study|Lack of Efficacy|0
7187544|NCT03033069|11388242|FG000|Overall Study|Lost to Follow-up|6
7187545|NCT03033069|11388243|FG001|Overall Study|Lost to Follow-up|5
7187546|NCT03033069|11388244|FG002|Overall Study|Lost to Follow-up|5
7187547|NCT03033069|11388245|FG003|Overall Study|Lost to Follow-up|6
7187548|NCT03033069|11388242|FG000|Overall Study|Non-Compliance With Study Drug|1
7187549|NCT03033069|11388243|FG001|Overall Study|Non-Compliance With Study Drug|1
7187550|NCT03033069|11388244|FG002|Overall Study|Non-Compliance With Study Drug|1
7187551|NCT03033069|11388245|FG003|Overall Study|Non-Compliance With Study Drug|0
7187552|NCT03033069|11388242|FG000|Overall Study|Protocol Deviation|0
7187553|NCT03033069|11388243|FG001|Overall Study|Protocol Deviation|1
7187554|NCT03033069|11388244|FG002|Overall Study|Protocol Deviation|0
7187555|NCT03033069|11388245|FG003|Overall Study|Protocol Deviation|0
7187556|NCT03033069|11388242|FG000|Overall Study|Withdrawal by Subject|10
7187557|NCT03033069|11388243|FG001|Overall Study|Withdrawal by Subject|10
7187558|NCT03033069|11388244|FG002|Overall Study|Withdrawal by Subject|11
7187559|NCT03033069|11388245|FG003|Overall Study|Withdrawal by Subject|6
7187560|NCT03033069|11388242|FG000|Overall Study|Withdrawal By Caregiver|1
7187561|NCT03033069|11388243|FG001|Overall Study|Withdrawal By Caregiver|0
7187562|NCT03033069|11388244|FG002|Overall Study|Withdrawal By Caregiver|0
7187563|NCT03033069|11388245|FG003|Overall Study|Withdrawal By Caregiver|0
7187564|NCT03033069|11388242|FG000|Overall Study|Reason not Specified|0
7187565|NCT03033069|11388243|FG001|Overall Study|Reason not Specified|1
7187566|NCT03033069|11388244|FG002|Overall Study|Reason not Specified|0
7187567|NCT03033069|11388245|FG003|Overall Study|Reason not Specified|1
7187568|NCT02609503|11388270|FG000|Overall Study|Adverse Event|1
7187569|NCT02609503|11388270|FG000|Overall Study|Death|1
7187570|NCT02609503|11388270|FG000|Overall Study|Withdrawal by Subject|1
7187571|NCT02609503|11388270|FG000|Overall Study|Disease progression|1
7187572|NCT02587598|11388288|FG000|Overall Study|Death|4
7187573|NCT02587598|11388289|FG001|Overall Study|Death|8
7187574|NCT02587598|11388290|FG002|Overall Study|Death|4
7187575|NCT02587598|11388291|FG003|Overall Study|Death|16
7187576|NCT02587598|11388292|FG004|Overall Study|Death|9
7187577|NCT02587598|11388293|FG005|Overall Study|Death|4
7187578|NCT02587598|11388294|FG006|Overall Study|Death|6
7187579|NCT02587598|11388295|FG007|Overall Study|Death|7
7187580|NCT02587598|11388296|FG008|Overall Study|Death|9
7187581|NCT02587598|11388297|FG009|Overall Study|Death|1
7187582|NCT02587598|11388298|FG010|Overall Study|Death|3
7187583|NCT02587598|11388288|FG000|Overall Study|Study Terminated by the Sponsor|0
7187584|NCT02587598|11388289|FG001|Overall Study|Study Terminated by the Sponsor|1
7187585|NCT02587598|11388290|FG002|Overall Study|Study Terminated by the Sponsor|0
7187586|NCT02587598|11388291|FG003|Overall Study|Study Terminated by the Sponsor|3
7187587|NCT02587598|11388292|FG004|Overall Study|Study Terminated by the Sponsor|0
7187588|NCT02587598|11388293|FG005|Overall Study|Study Terminated by the Sponsor|1
7187589|NCT02587598|11388294|FG006|Overall Study|Study Terminated by the Sponsor|0
7187590|NCT02587598|11388295|FG007|Overall Study|Study Terminated by the Sponsor|0
7187591|NCT02587598|11388296|FG008|Overall Study|Study Terminated by the Sponsor|0
7165545|NCT04333199|11346961|FG000|Evaluated Patients|Lost to Follow-up|0
7165546|NCT04333199|11346962|FG001|Evaluated Patients|Lost to Follow-up|1
7165547|NCT04333199|11346963|FG002|Evaluated Patients|Lost to Follow-up|2
7165548|NCT04332107|11347035|FG000|Day 3|Lost to Follow-up|23
7165549|NCT04332107|11347036|FG001|Day 3|Lost to Follow-up|14
7165550|NCT04332107|11347035|FG000|Day 3|Missing outcome data|3
7165551|NCT04332107|11347036|FG001|Day 3|Missing outcome data|6
7165552|NCT04332107|11347035|FG000|Day 14|Lost to Follow-up|13
7165553|NCT04332107|11347036|FG001|Day 14|Lost to Follow-up|4
7165554|NCT04332107|11347035|FG000|Day 14|Missing outcome data|4
7165555|NCT04332107|11347036|FG001|Day 14|Missing outcome data|4
7165556|NCT04332107|11347035|FG000|Day 21|Lost to Follow-up|10
7165557|NCT04332107|11347036|FG001|Day 21|Lost to Follow-up|2
7165558|NCT04329923|11347070|FG000|Overall Study|Withdrawal by Subject|1
7165559|NCT04329923|11347071|FG001|Overall Study|Withdrawal by Subject|4
7165560|NCT04329923|11347072|FG002|Overall Study|Withdrawal by Subject|1
7165561|NCT04329923|11347073|FG003|Overall Study|Withdrawal by Subject|1
7165562|NCT04329923|11347074|FG004|Overall Study|Withdrawal by Subject|1
7165563|NCT04329923|11347075|FG005|Overall Study|Withdrawal by Subject|1
7165564|NCT04329923|11347070|FG000|Overall Study|early termination of study|0
7165565|NCT04329923|11347071|FG001|Overall Study|early termination of study|0
7165566|NCT04329923|11347072|FG002|Overall Study|early termination of study|0
7165567|NCT04329923|11347073|FG003|Overall Study|early termination of study|0
7165568|NCT04329923|11347074|FG004|Overall Study|early termination of study|1
7165569|NCT04329923|11347075|FG005|Overall Study|early termination of study|2
7165570|NCT04329923|11347070|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0
7165571|NCT04329923|11347071|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0
7165572|NCT04329923|11347072|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0
7165573|NCT04329923|11347073|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0
7165574|NCT04329923|11347074|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0
7165575|NCT04329923|11347075|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2
7165576|NCT04328467|11347092|FG000|Overall Study|Did not meet inclusion criteria after randomization|4
7165577|NCT04328467|11347093|FG001|Overall Study|Did not meet inclusion criteria after randomization|2
7165578|NCT04328467|11347094|FG002|Overall Study|Did not meet inclusion criteria after randomization|1
7165579|NCT04322526|11347104|FG000|First Intervention (1 Day)|Withdrawal by Subject|1
7165580|NCT04322526|11347105|FG001|First Intervention (1 Day)|Withdrawal by Subject|1
7165581|NCT04322526|11347104|FG000|Washout (1 Week)|Lost to Follow-up|1
7165582|NCT04322526|11347105|FG001|Washout (1 Week)|Lost to Follow-up|2
7165583|NCT04322682|11347122|FG000|Overall Study|Withdrawal by Subject|33
7165584|NCT04322682|11347123|FG001|Overall Study|Withdrawal by Subject|47
7165585|NCT04322682|11347122|FG000|Overall Study|Death|5
7165586|NCT04322682|11347123|FG001|Overall Study|Death|9
7165587|NCT04322682|11347122|FG000|Overall Study|Lost to Follow-up|4
7165588|NCT04322682|11347123|FG001|Overall Study|Lost to Follow-up|8
7165589|NCT04322682|11347122|FG000|Overall Study|Admitted to Hospital and Intubated|1
7165590|NCT04322682|11347123|FG001|Overall Study|Admitted to Hospital and Intubated|0
7165591|NCT04320615|11347174|FG000|Overall Study|Withdrawal by Subject|4
7165592|NCT04320615|11347175|FG001|Overall Study|Withdrawal by Subject|10
7165593|NCT04320615|11347174|FG000|Overall Study|Physician Decision|2
7165594|NCT04320615|11347175|FG001|Overall Study|Physician Decision|0
7165595|NCT04320615|11347174|FG000|Overall Study|Other|2
7165596|NCT04320615|11347175|FG001|Overall Study|Other|0
7165597|NCT04320615|11347174|FG000|Overall Study|Lost to Follow-up|5
7165598|NCT04320615|11347175|FG001|Overall Study|Lost to Follow-up|23
7165599|NCT04320615|11347174|FG000|Overall Study|Death|35
7165600|NCT04320615|11347175|FG001|Overall Study|Death|71
7165601|NCT04318535|11347185|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0
7165602|NCT04318535|11347186|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1
7165603|NCT04318535|11347187|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0
7165604|NCT04314037|11347208|FG000|Treatment Period 2|Adverse Event|1
7165605|NCT04314037|11347209|FG001|Treatment Period 2|Adverse Event|0
7165606|NCT04314037|11347208|FG000|Treatment Period 3|Protocol Violation|1
7165607|NCT04314037|11347209|FG001|Treatment Period 3|Protocol Violation|0
7165608|NCT04314037|11347208|FG000|Treatment Period 3|Adverse Event|0
7165609|NCT04314037|11347209|FG001|Treatment Period 3|Adverse Event|1
7165610|NCT04315298|11347240|FG000|Overall Study|Withdrawal by Subject|0
7165611|NCT04315298|11347241|FG001|Overall Study|Withdrawal by Subject|0
7165612|NCT04315298|11347242|FG002|Overall Study|Withdrawal by Subject|0
7165613|NCT04315298|11347243|FG003|Overall Study|Withdrawal by Subject|2
7165614|NCT04315298|11347244|FG004|Overall Study|Withdrawal by Subject|2
7165615|NCT04315298|11347245|FG005|Overall Study|Withdrawal by Subject|2
7165616|NCT04315298|11347246|FG006|Overall Study|Withdrawal by Subject|0
7165617|NCT04315298|11347247|FG007|Overall Study|Withdrawal by Subject|1
7165618|NCT04315298|11347248|FG008|Overall Study|Withdrawal by Subject|1
7165619|NCT04315298|11347249|FG009|Overall Study|Withdrawal by Subject|1
7165620|NCT04315298|11347250|FG010|Overall Study|Withdrawal by Subject|0
7165621|NCT04315298|11347251|FG011|Overall Study|Withdrawal by Subject|0
7165622|NCT04315298|11347252|FG012|Overall Study|Withdrawal by Subject|0
7165623|NCT04315298|11347253|FG013|Overall Study|Withdrawal by Subject|0
7165624|NCT04315298|11347254|FG014|Overall Study|Withdrawal by Subject|0
7165625|NCT04315298|11347255|FG015|Overall Study|Withdrawal by Subject|0
7165626|NCT04315298|11347256|FG016|Overall Study|Withdrawal by Subject|0
7165627|NCT04315298|11347257|FG017|Overall Study|Withdrawal by Subject|0
7165628|NCT04315298|11347258|FG018|Overall Study|Withdrawal by Subject|0
7165629|NCT04315298|11347240|FG000|Overall Study|Physician Decision|0
7165630|NCT04315298|11347241|FG001|Overall Study|Physician Decision|0
7165631|NCT04315298|11347242|FG002|Overall Study|Physician Decision|0
7165632|NCT04315298|11347243|FG003|Overall Study|Physician Decision|0
7165633|NCT04315298|11347244|FG004|Overall Study|Physician Decision|1
7165634|NCT04315298|11347245|FG005|Overall Study|Physician Decision|0
7165635|NCT04315298|11347246|FG006|Overall Study|Physician Decision|0
7165636|NCT04315298|11347247|FG007|Overall Study|Physician Decision|0
7165637|NCT04315298|11347248|FG008|Overall Study|Physician Decision|0
7165638|NCT04315298|11347249|FG009|Overall Study|Physician Decision|0
7165639|NCT04315298|11347250|FG010|Overall Study|Physician Decision|0
7165640|NCT04315298|11347251|FG011|Overall Study|Physician Decision|0
7165641|NCT04315298|11347252|FG012|Overall Study|Physician Decision|0
7165642|NCT04315298|11347253|FG013|Overall Study|Physician Decision|0
7165643|NCT04315298|11347254|FG014|Overall Study|Physician Decision|0
7165644|NCT04315298|11347255|FG015|Overall Study|Physician Decision|0
7165645|NCT04315298|11347256|FG016|Overall Study|Physician Decision|0
7165646|NCT04315298|11347257|FG017|Overall Study|Physician Decision|0
7165647|NCT04315298|11347258|FG018|Overall Study|Physician Decision|0
7165648|NCT04315298|11347240|FG000|Overall Study|Lost to Follow-up|5
7165649|NCT04315298|11347241|FG001|Overall Study|Lost to Follow-up|10
7165650|NCT04315298|11347242|FG002|Overall Study|Lost to Follow-up|6
7165651|NCT04315298|11347243|FG003|Overall Study|Lost to Follow-up|8
7165652|NCT04315298|11347244|FG004|Overall Study|Lost to Follow-up|12
7165653|NCT04315298|11347245|FG005|Overall Study|Lost to Follow-up|13
7165654|NCT04315298|11347246|FG006|Overall Study|Lost to Follow-up|9
7165655|NCT04315298|11347247|FG007|Overall Study|Lost to Follow-up|16
7165656|NCT04315298|11347248|FG008|Overall Study|Lost to Follow-up|14
7165657|NCT04315298|11347249|FG009|Overall Study|Lost to Follow-up|0
7165658|NCT04315298|11347250|FG010|Overall Study|Lost to Follow-up|2
7165659|NCT04315298|11347251|FG011|Overall Study|Lost to Follow-up|1
7165660|NCT04315298|11347252|FG012|Overall Study|Lost to Follow-up|0
7165661|NCT04315298|11347253|FG013|Overall Study|Lost to Follow-up|0
7165662|NCT04315298|11347254|FG014|Overall Study|Lost to Follow-up|0
7165663|NCT04315298|11347255|FG015|Overall Study|Lost to Follow-up|2
7165664|NCT04315298|11347256|FG016|Overall Study|Lost to Follow-up|0
7165665|NCT04315298|11347257|FG017|Overall Study|Lost to Follow-up|0
7165666|NCT04315298|11347258|FG018|Overall Study|Lost to Follow-up|0
7165667|NCT04315298|11347240|FG000|Overall Study|Death|24
7165668|NCT04315298|11347241|FG001|Overall Study|Death|60
7165669|NCT04315298|11347242|FG002|Overall Study|Death|49
7165670|NCT04315298|11347243|FG003|Overall Study|Death|59
7165671|NCT04315298|11347244|FG004|Overall Study|Death|70
7165672|NCT04315298|11347245|FG005|Overall Study|Death|114
7165673|NCT04315298|11347246|FG006|Overall Study|Death|9
7165674|NCT04315298|11347247|FG007|Overall Study|Death|12
7165675|NCT04315298|11347248|FG008|Overall Study|Death|21
7165676|NCT04315298|11347249|FG009|Overall Study|Death|16
7165677|NCT04315298|11347250|FG010|Overall Study|Death|40
7165678|NCT04315298|11347251|FG011|Overall Study|Death|40
7165679|NCT04315298|11347252|FG012|Overall Study|Death|3
7165680|NCT04315298|11347253|FG013|Overall Study|Death|4
7165681|NCT04315298|11347254|FG014|Overall Study|Death|6
7165682|NCT04315298|11347255|FG015|Overall Study|Death|4
7165683|NCT04315298|11347256|FG016|Overall Study|Death|3
7165684|NCT04315298|11347257|FG017|Overall Study|Death|1
7165685|NCT04315298|11347258|FG018|Overall Study|Death|0
7165686|NCT04308239|11347368|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2
7165687|NCT04308239|11347369|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1
7165688|NCT04308239|11347368|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1
7165689|NCT04308239|11347369|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2
7165690|NCT04308239|11347368|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1
7165691|NCT04308239|11347369|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2
7165692|NCT04308239|11347368|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0
7165693|NCT04308239|11347369|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2
7165694|NCT04308668|11347381|FG000|Overall Study|Lost to Follow-up|32
7165695|NCT04308668|11347382|FG001|Overall Study|Lost to Follow-up|38
7165696|NCT04308668|11347381|FG000|Overall Study|Withdrawal by Subject|4
7165697|NCT04308668|11347382|FG001|Overall Study|Withdrawal by Subject|4
7165698|NCT04307940|11347391|FG000|Overall Study|Adverse Event|1
7165699|NCT04307940|11347392|FG001|Overall Study|Adverse Event|0
7165700|NCT04307940|11347393|FG002|Overall Study|Adverse Event|0
7165701|NCT04307940|11347391|FG000|Overall Study|Withdrawal by Subject|2
7165702|NCT04307940|11347392|FG001|Overall Study|Withdrawal by Subject|3
7165703|NCT04307940|11347393|FG002|Overall Study|Withdrawal by Subject|1
7165704|NCT04307940|11347391|FG000|Overall Study|Lost to Follow-up|2
7165705|NCT04307940|11347392|FG001|Overall Study|Lost to Follow-up|0
7165706|NCT04307940|11347393|FG002|Overall Study|Lost to Follow-up|1
7165707|NCT04302545|11347403|FG000|Overall Study|Lost to Follow-up|3
7165708|NCT04302545|11347404|FG001|Overall Study|Lost to Follow-up|4
7165709|NCT04297241|11347426|FG000|Overall Study|Withdrawal by Subject|1
7165710|NCT04297241|11347426|FG000|Overall Study|Adverse Event|1
7165711|NCT04297241|11347426|FG000|Overall Study|Physician Decision|3
7165712|NCT04295356|11347455|FG000|Overall Study|Physician Decision|1
7041574|NCT01728324|11125173|FG002|Termination of RBV|Other than stated|1
7041575|NCT01728324|11125171|FG000|Termination of RBV|Adverse Event (Placebo Period)|0
7041576|NCT01728324|11125172|FG001|Termination of RBV|Adverse Event (Placebo Period)|1
7041577|NCT01728324|11125173|FG002|Termination of RBV|Adverse Event (Placebo Period)|0
7041578|NCT01728324|11125171|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0
7041579|NCT01728324|11125172|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1
7165713|NCT04295356|11347456|FG001|Overall Study|Physician Decision|0
7165714|NCT04295356|11347455|FG000|Overall Study|Lost to Follow-up|0
7165715|NCT04295356|11347456|FG001|Overall Study|Lost to Follow-up|3
7165716|NCT04295356|11347455|FG000|Overall Study|Protocol Violation|0
7165717|NCT04295356|11347456|FG001|Overall Study|Protocol Violation|1
7165718|NCT04292535|11347480|FG000|Overall Study|Withdrawal by Subject|0
7165719|NCT04292535|11347481|FG001|Overall Study|Withdrawal by Subject|0
7165720|NCT04292535|11347482|FG002|Overall Study|Withdrawal by Subject|0
7165721|NCT04292535|11347483|FG003|Overall Study|Withdrawal by Subject|0
7165722|NCT04292535|11347484|FG004|Overall Study|Withdrawal by Subject|0
7165723|NCT04292535|11347485|FG005|Overall Study|Withdrawal by Subject|0
7165724|NCT04292535|11347486|FG006|Overall Study|Withdrawal by Subject|0
7165725|NCT04292535|11347487|FG007|Overall Study|Withdrawal by Subject|1
7165726|NCT04292535|11347488|FG008|Overall Study|Withdrawal by Subject|0
7165727|NCT04292535|11347489|FG009|Overall Study|Withdrawal by Subject|0
7165728|NCT04292535|11347490|FG010|Overall Study|Withdrawal by Subject|0
7165729|NCT04292535|11347491|FG011|Overall Study|Withdrawal by Subject|0
7165730|NCT04292535|11347492|FG012|Overall Study|Withdrawal by Subject|0
7165731|NCT04292535|11347493|FG013|Overall Study|Withdrawal by Subject|0
7165732|NCT04292535|11347480|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
7165733|NCT04292535|11347481|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
7165734|NCT04292535|11347482|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
7165735|NCT04292535|11347483|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
7165736|NCT04292535|11347484|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
7165737|NCT04292535|11347485|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
7165738|NCT04292535|11347486|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
7165739|NCT04292535|11347487|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1
7165740|NCT04292535|11347488|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
7165741|NCT04292535|11347489|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
7165742|NCT04292535|11347490|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
7165743|NCT04292535|11347491|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
7165744|NCT04292535|11347492|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1
7165745|NCT04292535|11347493|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1
7165746|NCT04292535|11347480|FG000|Overall Study|Report of Dizziness|0
7165747|NCT04292535|11347481|FG001|Overall Study|Report of Dizziness|0
7165748|NCT04292535|11347482|FG002|Overall Study|Report of Dizziness|0
7165749|NCT04292535|11347483|FG003|Overall Study|Report of Dizziness|0
7165750|NCT04292535|11347484|FG004|Overall Study|Report of Dizziness|0
7165751|NCT04292535|11347485|FG005|Overall Study|Report of Dizziness|0
7165752|NCT04292535|11347486|FG006|Overall Study|Report of Dizziness|0
7165753|NCT04292535|11347487|FG007|Overall Study|Report of Dizziness|0
7165754|NCT04292535|11347488|FG008|Overall Study|Report of Dizziness|0
7165755|NCT04292535|11347489|FG009|Overall Study|Report of Dizziness|0
7165756|NCT04292535|11347490|FG010|Overall Study|Report of Dizziness|0
7165757|NCT04292535|11347491|FG011|Overall Study|Report of Dizziness|0
7165758|NCT04292535|11347492|FG012|Overall Study|Report of Dizziness|0
7165759|NCT04292535|11347493|FG013|Overall Study|Report of Dizziness|1
7165760|NCT04292535|11347480|FG000|Overall Study|Equipment Failure|0
7165761|NCT04292535|11347481|FG001|Overall Study|Equipment Failure|0
7165762|NCT04292535|11347482|FG002|Overall Study|Equipment Failure|0
7165763|NCT04292535|11347483|FG003|Overall Study|Equipment Failure|0
7165764|NCT04292535|11347484|FG004|Overall Study|Equipment Failure|0
7165765|NCT04292535|11347485|FG005|Overall Study|Equipment Failure|0
7165766|NCT04292535|11347486|FG006|Overall Study|Equipment Failure|0
7165767|NCT04292535|11347487|FG007|Overall Study|Equipment Failure|0
7165768|NCT04292535|11347488|FG008|Overall Study|Equipment Failure|0
7165769|NCT04292535|11347489|FG009|Overall Study|Equipment Failure|0
7165770|NCT04292535|11347490|FG010|Overall Study|Equipment Failure|0
7165771|NCT04292535|11347491|FG011|Overall Study|Equipment Failure|1
7165772|NCT04292535|11347492|FG012|Overall Study|Equipment Failure|0
7165773|NCT04292535|11347493|FG013|Overall Study|Equipment Failure|0
7165774|NCT04292171|11347525|FG000|Overall Study|Pharmacy error|2
7165775|NCT04292171|11347526|FG001|Overall Study|Pharmacy error|0
7165776|NCT04292171|11347525|FG000|Overall Study|Delivered prior to procedure|0
7165777|NCT04292171|11347526|FG001|Overall Study|Delivered prior to procedure|1
7165778|NCT04292899|11347536|FG000|Overall Study|Death|21
7165779|NCT04292899|11347537|FG001|Overall Study|Death|28
7165780|NCT04292899|11347538|FG002|Overall Study|Death|188
7165781|NCT04292899|11347539|FG003|Overall Study|Death|371
7165782|NCT04292899|11347536|FG000|Overall Study|Lost to Follow-up|8
7165783|NCT04292899|11347537|FG001|Overall Study|Lost to Follow-up|4
7165784|NCT04292899|11347538|FG002|Overall Study|Lost to Follow-up|22
7165785|NCT04292899|11347539|FG003|Overall Study|Lost to Follow-up|235
7165786|NCT04292899|11347536|FG000|Overall Study|Withdrew consent|1
7165787|NCT04292899|11347537|FG001|Overall Study|Withdrew consent|0
7165788|NCT04292899|11347538|FG002|Overall Study|Withdrew consent|11
7080480|NCT02122380|11189922|FG001|First Intervention (30 Days)|Adverse Event|0
7080481|NCT02122380|11189921|FG000|First Intervention (30 Days)|Physician Decision|0
7165789|NCT04292899|11347539|FG003|Overall Study|Withdrew consent|32
7165790|NCT04292899|11347536|FG000|Overall Study|Adverse Event|2
7165791|NCT04292899|11347537|FG001|Overall Study|Adverse Event|1
7165792|NCT04292899|11347538|FG002|Overall Study|Adverse Event|2
7165793|NCT04292899|11347539|FG003|Overall Study|Adverse Event|2
7165794|NCT04292899|11347536|FG000|Overall Study|Investigator's Discretion|0
7165795|NCT04292899|11347537|FG001|Overall Study|Investigator's Discretion|0
7165796|NCT04292899|11347538|FG002|Overall Study|Investigator's Discretion|0
6972734|NCT01173601|11023895|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
6972735|NCT01173601|11023891|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
7080482|NCT02122380|11189922|FG001|First Intervention (30 Days)|Physician Decision|1
7080483|NCT02122380|11189921|FG000|Washout (8 Weeks)|Lost to Follow-up|1
7165797|NCT04292899|11347539|FG003|Overall Study|Investigator's Discretion|3
7165798|NCT04292899|11347536|FG000|Overall Study|Non-compliance With Study Drug|0
7165799|NCT04292899|11347537|FG001|Overall Study|Non-compliance With Study Drug|0
7165800|NCT04292899|11347538|FG002|Overall Study|Non-compliance With Study Drug|0
7165801|NCT04292899|11347539|FG003|Overall Study|Non-compliance With Study Drug|1
7165802|NCT04292899|11347536|FG000|Overall Study|Protocol Violation|0
7165803|NCT04292899|11347537|FG001|Overall Study|Protocol Violation|0
7165804|NCT04292899|11347538|FG002|Overall Study|Protocol Violation|0
7165805|NCT04292899|11347539|FG003|Overall Study|Protocol Violation|1
7165806|NCT04292730|11347551|FG000|Overall Study|Lost to Follow-up|8
7165807|NCT04292730|11347552|FG001|Overall Study|Lost to Follow-up|12
7165808|NCT04292730|11347553|FG002|Overall Study|Lost to Follow-up|12
7165809|NCT04292730|11347554|FG003|Overall Study|Lost to Follow-up|48
7165810|NCT04292730|11347551|FG000|Overall Study|Death|2
7165811|NCT04292730|11347552|FG001|Overall Study|Death|2
7165812|NCT04292730|11347553|FG002|Overall Study|Death|4
7165813|NCT04292730|11347554|FG003|Overall Study|Death|12
7165814|NCT04292730|11347551|FG000|Overall Study|Withdrew Consent|2
7165815|NCT04292730|11347552|FG001|Overall Study|Withdrew Consent|2
7165816|NCT04292730|11347553|FG002|Overall Study|Withdrew Consent|5
7165817|NCT04292730|11347554|FG003|Overall Study|Withdrew Consent|6
7165818|NCT04292730|11347551|FG000|Overall Study|Non-Compliance with Study Drug|0
7165819|NCT04292730|11347552|FG001|Overall Study|Non-Compliance with Study Drug|1
7165820|NCT04292730|11347553|FG002|Overall Study|Non-Compliance with Study Drug|0
7165821|NCT04292730|11347554|FG003|Overall Study|Non-Compliance with Study Drug|0
7165822|NCT04292730|11347551|FG000|Overall Study|Protocol Violation|0
7165823|NCT04292730|11347552|FG001|Overall Study|Protocol Violation|0
7080484|NCT02122380|11189922|FG001|Washout (8 Weeks)|Lost to Follow-up|0
7165824|NCT04292730|11347553|FG002|Overall Study|Protocol Violation|1
7165825|NCT04292730|11347554|FG003|Overall Study|Protocol Violation|0
7165826|NCT04292730|11347551|FG000|Overall Study|Randomized but not Treated|8
7165827|NCT04292730|11347552|FG001|Overall Study|Randomized but not Treated|4
7165828|NCT04292730|11347553|FG002|Overall Study|Randomized but not Treated|0
7165829|NCT04292730|11347554|FG003|Overall Study|Randomized but not Treated|14
7165830|NCT04289623|11347587|FG000|Wave 1 Emails|Email was not delivered|268
7165831|NCT04289623|11347588|FG001|Wave 1 Emails|Email was not delivered|257
7165832|NCT04289623|11347589|FG002|Wave 1 Emails|Email was not delivered|0
7165833|NCT04289623|11347590|FG003|Wave 1 Emails|Email was not delivered|0
7165834|NCT04289623|11347591|FG004|Wave 1 Emails|Email was not delivered|0
7165835|NCT04289623|11347592|FG005|Wave 1 Emails|Email was not delivered|0
7165836|NCT04276207|11347606|FG000|Period 1|Withdrawal by Subject|0
7165837|NCT04276207|11347607|FG001|Period 1|Withdrawal by Subject|1
7165838|NCT04287517|11347637|FG000|Overall Study|Withdrawal by Subject|1
7165839|NCT04287517|11347638|FG001|Overall Study|Withdrawal by Subject|1
7165840|NCT04275336|11347708|FG000|Overall Study|First venipuncture failed|4
7165841|NCT04275336|11347709|FG001|Overall Study|First venipuncture failed|6
7165842|NCT04275336|11347710|FG002|Overall Study|First venipuncture failed|5
7165843|NCT04275336|11347708|FG000|Overall Study|Unscheduled venipuncture|9
7165844|NCT04275336|11347709|FG001|Overall Study|Unscheduled venipuncture|13
7165845|NCT04275336|11347710|FG002|Overall Study|Unscheduled venipuncture|7
7165846|NCT04275336|11347708|FG000|Overall Study|Failed specimen of saliva|4
7165847|NCT04275336|11347709|FG001|Overall Study|Failed specimen of saliva|3
7165848|NCT04275336|11347710|FG002|Overall Study|Failed specimen of saliva|4
7165849|NCT04272775|11347723|FG000|Overall Study|Study Terminated by Sponsor|1
7165850|NCT04272775|11347724|FG001|Overall Study|Study Terminated by Sponsor|0
7165851|NCT04272775|11347723|FG000|Overall Study|Protocol Violation|0
7165852|NCT04272775|11347724|FG001|Overall Study|Protocol Violation|1
7165853|NCT04272775|11347723|FG000|Overall Study|Symptomatic Deterioration|1
7165854|NCT04272775|11347724|FG001|Overall Study|Symptomatic Deterioration|1
7165855|NCT04272775|11347723|FG000|Overall Study|Withdrawal by Subject|1
7165856|NCT04272775|11347724|FG001|Overall Study|Withdrawal by Subject|2
7165857|NCT04272775|11347723|FG000|Overall Study|Adverse Event|1
7165858|NCT04272775|11347724|FG001|Overall Study|Adverse Event|2
7080485|NCT02122380|11189921|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0
7080486|NCT02122380|11189922|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2
7080487|NCT02122380|11189921|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0
7165859|NCT04272775|11347723|FG000|Overall Study|Progressive Disease|3
7165860|NCT04272775|11347724|FG001|Overall Study|Progressive Disease|1
7165861|NCT04271605|11347756|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5
7165862|NCT04268316|11347767|FG000|Overall Study|Withdrawal by Subject|2
7165863|NCT04268316|11347768|FG001|Overall Study|Withdrawal by Subject|1
7165864|NCT04268316|11347769|FG002|Overall Study|Withdrawal by Subject|0
7165865|NCT04263142|11347812|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0
7165866|NCT04263142|11347813|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0
7165867|NCT04263142|11347814|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0
7165868|NCT04263142|11347815|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0
7165869|NCT04263142|11347816|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1
7165870|NCT04263142|11347812|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0
7165871|NCT04263142|11347813|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0
7165872|NCT04263142|11347814|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0
7165873|NCT04263142|11347815|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0
7165874|NCT04263142|11347816|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1
7165875|NCT04256785|11347831|FG000|Overall Study|Adverse Event|8
7165876|NCT04256785|11347832|FG001|Overall Study|Adverse Event|6
7165877|NCT04256785|11347831|FG000|Overall Study|Lack of Efficacy|3
7165878|NCT04256785|11347832|FG001|Overall Study|Lack of Efficacy|4
7165879|NCT04256785|11347831|FG000|Overall Study|Lost to Follow-up|7
7165880|NCT04256785|11347832|FG001|Overall Study|Lost to Follow-up|7
7165881|NCT04256785|11347831|FG000|Overall Study|Protocol Violation|1
7165882|NCT04256785|11347832|FG001|Overall Study|Protocol Violation|0
7165883|NCT04256785|11347831|FG000|Overall Study|Withdrawal by Subject|4
7165884|NCT04256785|11347832|FG001|Overall Study|Withdrawal by Subject|1
7165885|NCT04256785|11347831|FG000|Overall Study|Surgery or quarantined due to Covid-19|5
7165886|NCT04256785|11347832|FG001|Overall Study|Surgery or quarantined due to Covid-19|7
7165887|NCT04249336|11347857|FG000|Overall Study|Lost to Follow-up|3
7165888|NCT04249336|11347858|FG001|Overall Study|Lost to Follow-up|3
7165889|NCT04249336|11347859|FG002|Overall Study|Lost to Follow-up|3
7165890|NCT04249336|11347860|FG003|Overall Study|Lost to Follow-up|3
7165891|NCT04247061|11347879|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6
7165892|NCT04247061|11347879|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2
7165893|NCT04247061|11347879|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1
7165894|NCT04245202|11347885|FG000|Overall Study|Lack of Efficacy|10
7165895|NCT04245202|11347886|FG001|Overall Study|Lack of Efficacy|1
7165896|NCT04238650|11347917|FG000|Overall Study|Withdrawal by Subject|0
7165897|NCT04238650|11347918|FG001|Overall Study|Withdrawal by Subject|1
7165898|NCT04238663|11347927|FG000|Overall Study|Lost to Follow-up|0
7165899|NCT04238663|11347928|FG001|Overall Study|Lost to Follow-up|1
7165900|NCT04238663|11347929|FG002|Overall Study|Lost to Follow-up|0
7165901|NCT04222699|11348003|FG000|Overall Study|Lost to Follow-up|2
7165902|NCT04206293|11348026|FG000|Overall Study|Consent withdrawal|1
7165903|NCT04228302|11348037|FG000|Overall Study|Adverse Event|0
7165904|NCT04228302|11348038|FG001|Overall Study|Adverse Event|0
7165905|NCT04228302|11348039|FG002|Overall Study|Adverse Event|0
7165906|NCT04228302|11348040|FG003|Overall Study|Adverse Event|0
7165907|NCT04228302|11348041|FG004|Overall Study|Adverse Event|1
7165908|NCT04228302|11348042|FG005|Overall Study|Adverse Event|0
7165909|NCT04223687|11348080|FG000|Overall Study|Missing primary outcome|1
7165910|NCT04223687|11348081|FG001|Overall Study|Missing primary outcome|0
7165911|NCT04223232|11348087|FG000|Overall Study|Withdrawal by Subject|1
7165912|NCT04189224|11348091|FG000|Period 2|Adverse Event|0
7165913|NCT04189224|11348092|FG001|Period 2|Adverse Event|1
7165914|NCT04214600|11348100|FG000|Overall Study|Lost to Follow-up|9
7165915|NCT04214600|11348101|FG001|Overall Study|Lost to Follow-up|14
7165916|NCT04202497|11348108|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1
7165917|NCT04202497|11348109|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0
7165918|NCT04202497|11348110|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0
7165919|NCT04202497|11348111|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0
7184627|NCT02514447|11384960|FG000|Overall Study|Withdrawal by Subject|3
7184628|NCT02514447|11384961|FG001|Overall Study|Withdrawal by Subject|1
7184629|NCT02514447|11384962|FG002|Overall Study|Withdrawal by Subject|1
7184630|NCT02514447|11384963|FG003|Overall Study|Withdrawal by Subject|0
7184631|NCT02514447|11384964|FG004|Overall Study|Withdrawal by Subject|0
7184632|NCT02514447|11384965|FG005|Overall Study|Withdrawal by Subject|0
7184633|NCT02514447|11384966|FG006|Overall Study|Withdrawal by Subject|0
7184634|NCT02514447|11384967|FG007|Overall Study|Withdrawal by Subject|1
7184635|NCT02514447|11384968|FG008|Overall Study|Withdrawal by Subject|1
7184636|NCT02514447|11384960|FG000|Overall Study|Death|24
7184637|NCT02514447|11384961|FG001|Overall Study|Death|28
7184638|NCT02514447|11384962|FG002|Overall Study|Death|29
7184639|NCT02514447|11384963|FG003|Overall Study|Death|0
7184640|NCT02514447|11384964|FG004|Overall Study|Death|3
7184641|NCT02514447|11384965|FG005|Overall Study|Death|4
7184642|NCT02514447|11384966|FG006|Overall Study|Death|8
7184643|NCT02514447|11384967|FG007|Overall Study|Death|6
7184644|NCT02514447|11384968|FG008|Overall Study|Death|5
7184645|NCT02514447|11384960|FG000|Overall Study|Lost to Follow-up|1
7184646|NCT02514447|11384961|FG001|Overall Study|Lost to Follow-up|0
7165920|NCT04209530|11348138|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4
7165921|NCT04209530|11348139|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2
7165922|NCT04209530|11348138|FG000|Overall Study|Withdrawal by Subject|0
7165923|NCT04209530|11348139|FG001|Overall Study|Withdrawal by Subject|1
7165924|NCT04207840|11348159|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0
7165925|NCT04207840|11348160|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0
7165926|NCT04207840|11348161|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1
7165927|NCT04207840|11348159|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0
7165928|NCT04207840|11348160|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0
7165929|NCT04207840|11348161|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1
7165930|NCT04206384|11348196|FG000|Overall Study|Withdrawal by Subject|8
7165931|NCT04206384|11348196|FG000|Overall Study|Adverse Event|2
7165932|NCT04195893|11348217|FG000|Second Intervention|Withdrawal by Subject|1
7165933|NCT04195893|11348218|FG001|Second Intervention|Withdrawal by Subject|0
7165934|NCT04195581|11348233|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4
7165935|NCT04195581|11348233|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5
7165936|NCT04195581|11348233|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1
7165937|NCT04195581|11348233|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1
7165938|NCT04195581|11348233|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3
7165939|NCT04195581|11348233|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2
7165940|NCT04194151|11348257|FG000|Overall Study|Physician Decision|1
7165941|NCT04194151|11348258|FG001|Overall Study|Physician Decision|1
7165942|NCT04194151|11348259|FG002|Overall Study|Physician Decision|1
7165943|NCT04194151|11348260|FG003|Overall Study|Physician Decision|1
7165944|NCT04194151|11348261|FG004|Overall Study|Physician Decision|0
7165945|NCT04194151|11348262|FG005|Overall Study|Physician Decision|1
7165946|NCT04194151|11348257|FG000|Overall Study|Monitorization problem|0
7165947|NCT04194151|11348258|FG001|Overall Study|Monitorization problem|1
7165948|NCT04194151|11348259|FG002|Overall Study|Monitorization problem|0
7165949|NCT04194151|11348260|FG003|Overall Study|Monitorization problem|0
7165950|NCT04194151|11348261|FG004|Overall Study|Monitorization problem|0
7165951|NCT04194151|11348262|FG005|Overall Study|Monitorization problem|0
7165952|NCT04194008|11348276|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19
7165953|NCT04194008|11348276|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6
7165954|NCT04194008|11348276|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2
7165955|NCT04194008|11348276|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3
7165956|NCT04194008|11348276|FG000|Treatment Phase With Nerivio|Missing data|4
7165957|NCT04194008|11348276|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1
7165958|NCT04189081|11348287|FG000|Overall Study|Lost to Follow-up|1
7165959|NCT04189081|11348288|FG001|Overall Study|Lost to Follow-up|0
7165960|NCT04189081|11348289|FG002|Overall Study|Lost to Follow-up|0
7165961|NCT04189081|11348287|FG000|Overall Study|Withdrawal by Subject|0
7165962|NCT04189081|11348288|FG001|Overall Study|Withdrawal by Subject|0
7165963|NCT04189081|11348289|FG002|Overall Study|Withdrawal by Subject|1
7165964|NCT04186806|11348310|FG000|Period 1: 7 Days|Adverse Event|1
7165965|NCT04186806|11348311|FG001|Period 1: 7 Days|Adverse Event|0
7165966|NCT04179838|11348345|FG000|First Intervention (1 Day)|Withdrawal by Subject|0
7165967|NCT04179838|11348346|FG001|First Intervention (1 Day)|Withdrawal by Subject|3
7165968|NCT04179838|11348345|FG000|Second Intervention (1 Day)|Protocol Violation|0
7165969|NCT04179838|11348346|FG001|Second Intervention (1 Day)|Protocol Violation|1
7165970|NCT04179461|11348352|FG000|Overall Study|Lost to Follow-up|4
7165971|NCT04178590|11348380|FG000|Overall Study|Pregnancy|1
7165972|NCT04178590|11348380|FG000|Overall Study|Lost to Follow-up|1
7165973|NCT04177862|11348408|FG000|Overall Study|Protocol Violation|2
7165974|NCT04177862|11348409|FG001|Overall Study|Protocol Violation|7
7165975|NCT04173741|11348484|FG000|Overall Study|IVC measurement cannot be done|1
7165976|NCT04173741|11348485|FG001|Overall Study|IVC measurement cannot be done|1
7165977|NCT04169061|11348491|FG000|Overall Study|Adverse Event|2
7165978|NCT04169061|11348491|FG000|Overall Study|Death|1
7165979|NCT04169061|11348491|FG000|Overall Study|Withdrawal by Subject|1
7165980|NCT04169061|11348491|FG000|Overall Study|Protocol Violation|1
7165981|NCT04157738|11348497|FG000|Overall Study|Moved out of state|0
7165982|NCT04157738|11348498|FG001|Overall Study|Moved out of state|2
7165983|NCT04157738|11348497|FG000|Overall Study|Did not show up to the Follow-up appointment|1
7165984|NCT04157738|11348498|FG001|Overall Study|Did not show up to the Follow-up appointment|0
7165985|NCT04156646|11348506|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0
7165986|NCT04156646|11348507|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1
7165987|NCT04170686|11348518|FG000|Screening|Physician Decision|12
7165988|NCT04170686|11348519|FG001|Screening|Physician Decision|13
7165989|NCT04170686|11348518|FG000|Randomization and Treatment|Lost to Follow-up|26
7165990|NCT04170686|11348519|FG001|Randomization and Treatment|Lost to Follow-up|15
7165991|NCT04162795|11348571|FG000|Overall Study|Other|16
7165992|NCT04162795|11348571|FG000|Overall Study|Screen failures|10
7165993|NCT04161807|11348575|FG000|Overall Study|Withdrawal by Subject|2
7165994|NCT04161807|11348575|FG000|Overall Study|Performed only 1 treatment|2
7165995|NCT04161144|11348581|FG000|Overall Study|Withdrawal by Subject|0
7165996|NCT04161144|11348582|FG001|Overall Study|Withdrawal by Subject|1
7165997|NCT04161144|11348581|FG000|Overall Study|Protocol Violation|1
7165998|NCT04161144|11348582|FG001|Overall Study|Protocol Violation|0
7165999|NCT04161079|11348588|FG000|Clinical Investigation 2010-040|Adverse Event|1
7166000|NCT04152083|11348607|FG000|Overall Study|Lost to Follow-up|2
7166001|NCT04152083|11348608|FG001|Overall Study|Lost to Follow-up|1
7166002|NCT04152083|11348607|FG000|Overall Study|Adverse Event|1
7166003|NCT04152083|11348608|FG001|Overall Study|Adverse Event|0
7166004|NCT04152083|11348607|FG000|Overall Study|Randomized but not treated|3
7166005|NCT04152083|11348608|FG001|Overall Study|Randomized but not treated|2
7166006|NCT04155047|11348620|FG000|Overall Study|Adverse Event|1
7166007|NCT04155047|11348621|FG001|Overall Study|Adverse Event|0
7166008|NCT04155047|11348620|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1
7166009|NCT04155047|11348621|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0
7166010|NCT04150250|11348650|FG000|Overall Study|Lost to Follow-up|0
7166011|NCT04150250|11348651|FG001|Overall Study|Lost to Follow-up|2
7166012|NCT04149353|11348736|FG000|Overall Study|Study terminated|1
7166013|NCT04136444|11348756|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0
7166014|NCT04136444|11348757|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1
7166015|NCT04147611|11348791|FG000|Overall Study|Physician Decision|0
7166016|NCT04147611|11348792|FG001|Overall Study|Physician Decision|1
7166017|NCT04142216|11348861|FG000|Overall Study|Hospitalization|0
7166018|NCT04142216|11348862|FG001|Overall Study|Hospitalization|2
7166019|NCT04142216|11348861|FG000|Overall Study|Death|3
7166020|NCT04142216|11348862|FG001|Overall Study|Death|1
7166021|NCT04142216|11348861|FG000|Overall Study|Referral to another hemodialysis unit|3
7166022|NCT04142216|11348862|FG001|Overall Study|Referral to another hemodialysis unit|2
7166023|NCT04142216|11348861|FG000|Overall Study|Use of clove|0
7166024|NCT04142216|11348862|FG001|Overall Study|Use of clove|1
7166025|NCT04142450|11348873|FG000|Overall Study|Screen Failure|1
7166026|NCT04142450|11348873|FG000|Overall Study|Lost to Follow-up|1
7166027|NCT04140890|11348879|FG000|Overall Study|Withdrawal by Subject|0
7166028|NCT04140890|11348880|FG001|Overall Study|Withdrawal by Subject|1
7166029|NCT04139018|11348891|FG000|Overall Study|Screen fail|1
7166030|NCT04139018|11348892|FG001|Overall Study|Screen fail|0
7166031|NCT04139018|11348891|FG000|Overall Study|Withdrawal by Subject|2
7166032|NCT04139018|11348892|FG001|Overall Study|Withdrawal by Subject|0
7166033|NCT04139018|11348891|FG000|Overall Study|Lost to Follow-up|0
7166034|NCT04139018|11348892|FG001|Overall Study|Lost to Follow-up|1
7166035|NCT04138810|11348900|FG000|Overall Study|Withdrawal by Subject|0
7166036|NCT04138810|11348901|FG001|Overall Study|Withdrawal by Subject|1
7166037|NCT04138810|11348900|FG000|Overall Study|Subject cancelled surgery|1
7166038|NCT04138810|11348901|FG001|Overall Study|Subject cancelled surgery|0
7166039|NCT04131556|11348907|FG000|Overall Study|Adverse Event|1
7166040|NCT04131556|11348907|FG000|Overall Study|Withdrawal by Subject|1
7166041|NCT04126174|11348914|FG000|Overall Study|Lost to Follow-up|3
7166042|NCT04126174|11348915|FG001|Overall Study|Lost to Follow-up|3
7166043|NCT04138043|11348959|FG000|Overall Study|Withdrawal by Subject|0
7166044|NCT04138043|11348960|FG001|Overall Study|Withdrawal by Subject|1
7166045|NCT04132336|11348993|FG000|Overall Study|Investigator Decision|0
7166046|NCT04132336|11348994|FG001|Overall Study|Investigator Decision|1
7166047|NCT04132336|11348995|FG002|Overall Study|Investigator Decision|0
7166048|NCT04132336|11348996|FG003|Overall Study|Investigator Decision|0
7166049|NCT04132336|11348997|FG004|Overall Study|Investigator Decision|0
7166050|NCT04132336|11348998|FG005|Overall Study|Investigator Decision|0
7166051|NCT04132336|11348999|FG006|Overall Study|Investigator Decision|0
7166052|NCT04128293|11349039|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
7166053|NCT04128293|11349040|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
7166054|NCT04128293|11349041|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
7166055|NCT04128293|11349042|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
7166056|NCT04126343|11349063|FG000|Overall Study|Adverse Event|0
7166057|NCT04126343|11349064|FG001|Overall Study|Adverse Event|0
7166058|NCT04126343|11349065|FG002|Overall Study|Adverse Event|0
7166059|NCT04126343|11349066|FG003|Overall Study|Adverse Event|0
7080488|NCT02122380|11189922|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2
7080489|NCT02122770|11189959|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3
7080490|NCT02122770|11189960|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0
7080491|NCT02122770|11189961|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1
7080492|NCT02122770|11189962|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2
7080493|NCT02122770|11189963|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0
7080494|NCT02122770|11189964|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0
7080495|NCT02122770|11189959|FG000|Part A: Drug-drug Interaction 2|Other|0
7080496|NCT02122770|11189960|FG001|Part A: Drug-drug Interaction 2|Other|0
7080497|NCT02122770|11189961|FG002|Part A: Drug-drug Interaction 2|Other|1
7080498|NCT02122770|11189962|FG003|Part A: Drug-drug Interaction 2|Other|0
7080499|NCT02122770|11189963|FG004|Part A: Drug-drug Interaction 2|Other|0
7080500|NCT02122770|11189964|FG005|Part A: Drug-drug Interaction 2|Other|0
7080501|NCT02122770|11189959|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
7080502|NCT02122770|11189960|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1
7080503|NCT02122770|11189961|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
7080504|NCT02122770|11189962|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
7080505|NCT02122770|11189963|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
7166060|NCT04126343|11349067|FG004|Overall Study|Adverse Event|0
7166061|NCT04126343|11349068|FG005|Overall Study|Adverse Event|1
7166062|NCT04126343|11349063|FG000|Overall Study|Withdrawal by Subject|0
7166063|NCT04126343|11349064|FG001|Overall Study|Withdrawal by Subject|0
7166064|NCT04126343|11349065|FG002|Overall Study|Withdrawal by Subject|0
7166065|NCT04126343|11349066|FG003|Overall Study|Withdrawal by Subject|1
7166066|NCT04126343|11349067|FG004|Overall Study|Withdrawal by Subject|0
7166067|NCT04126343|11349068|FG005|Overall Study|Withdrawal by Subject|0
7166068|NCT04126343|11349063|FG000|Overall Study|Related to COVID-19 pandemic|3
7166069|NCT04126343|11349064|FG001|Overall Study|Related to COVID-19 pandemic|4
7166070|NCT04126343|11349065|FG002|Overall Study|Related to COVID-19 pandemic|3
7166071|NCT04126343|11349066|FG003|Overall Study|Related to COVID-19 pandemic|3
7166072|NCT04126343|11349067|FG004|Overall Study|Related to COVID-19 pandemic|3
7166073|NCT04126343|11349068|FG005|Overall Study|Related to COVID-19 pandemic|3
7166074|NCT04124952|11349087|FG000|Overall Study|Lost to Follow-up|1
7166075|NCT04123665|11349093|FG000|Overall Study|Withdrawal by Subject|7
7166076|NCT04123665|11349094|FG001|Overall Study|Withdrawal by Subject|0
7166077|NCT04123665|11349093|FG000|Overall Study|Lost to Follow-up|1
7166078|NCT04123665|11349094|FG001|Overall Study|Lost to Follow-up|0
7166079|NCT04122534|11349100|FG000|Overall Study|Lost to Follow-up|4
7166080|NCT04117607|11349116|FG000|Overall Study|Early Termination|0
7166081|NCT04117607|11349117|FG001|Overall Study|Early Termination|1
7166082|NCT04117607|11349118|FG002|Overall Study|Early Termination|0
7166083|NCT04117607|11349119|FG003|Overall Study|Early Termination|0
7166084|NCT04117607|11349120|FG004|Overall Study|Early Termination|0
7166085|NCT04117607|11349121|FG005|Overall Study|Early Termination|0
7166086|NCT04117607|11349122|FG006|Overall Study|Early Termination|1
7166087|NCT04117607|11349123|FG007|Overall Study|Early Termination|0
7166088|NCT04117607|11349124|FG008|Overall Study|Early Termination|0
7166089|NCT04117607|11349125|FG009|Overall Study|Early Termination|0
7166090|NCT04117607|11349126|FG010|Overall Study|Early Termination|0
7166091|NCT04117607|11349127|FG011|Overall Study|Early Termination|0
7166092|NCT04117607|11349128|FG012|Overall Study|Early Termination|0
7166093|NCT04117607|11349129|FG013|Overall Study|Early Termination|0
7166094|NCT04096365|11349154|FG000|Overall Study|Adverse Event|1
7166095|NCT04080297|11349160|FG000|Overall Study|Adverse Event|1
7166096|NCT04080297|11349161|FG001|Overall Study|Adverse Event|3
7166097|NCT04080297|11349160|FG000|Overall Study|concurrent illness|1
7166098|NCT04080297|11349161|FG001|Overall Study|concurrent illness|0
7166099|NCT04115358|11349170|FG000|Overall Study|exfoliation|0
7166100|NCT04115358|11349171|FG001|Overall Study|exfoliation|0
7166101|NCT04115358|11349172|FG002|Overall Study|exfoliation|1
7166102|NCT04113694|11349196|FG000|Overall Study|Adverse Event|2
7166103|NCT04113694|11349196|FG000|Overall Study|Lost to Follow-up|2
7166104|NCT04113694|11349196|FG000|Overall Study|Withdrawal by Subject|6
7166105|NCT04113694|11349196|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1
7184647|NCT02514447|11384962|FG002|Overall Study|Lost to Follow-up|0
7184648|NCT02514447|11384963|FG003|Overall Study|Lost to Follow-up|0
7184649|NCT02514447|11384964|FG004|Overall Study|Lost to Follow-up|0
7184650|NCT02514447|11384965|FG005|Overall Study|Lost to Follow-up|0
7184651|NCT02514447|11384966|FG006|Overall Study|Lost to Follow-up|0
7184652|NCT02514447|11384967|FG007|Overall Study|Lost to Follow-up|0
7184653|NCT02514447|11384968|FG008|Overall Study|Lost to Follow-up|1
7184654|NCT02514447|11384960|FG000|Overall Study|Sponsor Termination of Study|0
7184655|NCT02514447|11384961|FG001|Overall Study|Sponsor Termination of Study|1
7184656|NCT02514447|11384962|FG002|Overall Study|Sponsor Termination of Study|1
7184657|NCT02514447|11384963|FG003|Overall Study|Sponsor Termination of Study|0
7184658|NCT02514447|11384964|FG004|Overall Study|Sponsor Termination of Study|0
7184659|NCT02514447|11384965|FG005|Overall Study|Sponsor Termination of Study|0
7184660|NCT02514447|11384966|FG006|Overall Study|Sponsor Termination of Study|0
7184661|NCT02514447|11384967|FG007|Overall Study|Sponsor Termination of Study|0
7184662|NCT02514447|11384968|FG008|Overall Study|Sponsor Termination of Study|0
7184663|NCT02514447|11384960|FG000|Overall Study|Study completion per Investigator|1
7184664|NCT02514447|11384961|FG001|Overall Study|Study completion per Investigator|0
7184665|NCT02514447|11384962|FG002|Overall Study|Study completion per Investigator|1
7184666|NCT02514447|11384963|FG003|Overall Study|Study completion per Investigator|2
7184667|NCT02514447|11384964|FG004|Overall Study|Study completion per Investigator|0
7184668|NCT02514447|11384965|FG005|Overall Study|Study completion per Investigator|0
7184669|NCT02514447|11384966|FG006|Overall Study|Study completion per Investigator|0
7184670|NCT02514447|11384967|FG007|Overall Study|Study completion per Investigator|0
7184671|NCT02514447|11384968|FG008|Overall Study|Study completion per Investigator|1
7184672|NCT02288247|11385008|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|52
7184673|NCT02288247|11385009|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|0
7184674|NCT02288247|11385008|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Death|35
7184675|NCT02288247|11385009|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Death|0
7184676|NCT02288247|11385008|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|1
7184677|NCT02288247|11385009|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|0
7184678|NCT02288247|11385008|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|392
7184679|NCT02288247|11385009|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|0
7184680|NCT02288247|11385008|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|9
6895193|NCT00623480|10912977|FG000|Overall Study|Withdrawal by Subject|2
6895194|NCT00623480|10912978|FG001|Overall Study|Withdrawal by Subject|4
7166106|NCT04106817|11349252|FG000|Overall Study|Lost to Follow-up|1
7166107|NCT04106817|11349253|FG001|Overall Study|Lost to Follow-up|0
7166108|NCT04106817|11349254|FG002|Overall Study|Lost to Follow-up|0
7166109|NCT04105972|11349264|FG000|Overall Study|Adverse Event|2
7166110|NCT04105972|11349265|FG001|Overall Study|Adverse Event|1
7166111|NCT04105218|11349273|FG000|Overall Study|Withdrawal by Subject|3
7166112|NCT04105218|11349274|FG001|Overall Study|Withdrawal by Subject|2
7166113|NCT04105218|11349273|FG000|Overall Study|Study was terminated; unable to complete study visits|1
7166114|NCT04105218|11349274|FG001|Overall Study|Study was terminated; unable to complete study visits|3
7166115|NCT04105218|11349273|FG000|Overall Study|Failed screening tests|2
7166116|NCT04105218|11349274|FG001|Overall Study|Failed screening tests|1
7166117|NCT04102540|11349289|FG000|Overall Study|Withdrawn by PI|2
7166118|NCT04102540|11349289|FG000|Overall Study|Lost to Follow-up|6
7166119|NCT04102345|11349295|FG000|Overall Study|Withdrawal by Subject|1
7166120|NCT04102345|11349296|FG001|Overall Study|Withdrawal by Subject|0
7166121|NCT04099277|11349336|FG000|Overall Study|Physician Decision|1
7166122|NCT04099277|11349336|FG000|Overall Study|Withdrawal by Subject|1
7166123|NCT04098809|11349342|FG000|Overall Study|Withdrawal by Subject|1
7166124|NCT04098809|11349343|FG001|Overall Study|Withdrawal by Subject|3
7166125|NCT04098809|11349342|FG000|Overall Study|Physician Decision|2
7166126|NCT04098809|11349343|FG001|Overall Study|Physician Decision|1
7166127|NCT04098458|11349362|FG000|Overall Study|Death|1
7166128|NCT04098458|11349362|FG000|Overall Study|did not meet study inclusion criteria|3
7166129|NCT04095286|11349367|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
7166130|NCT04095286|11349368|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1
7166131|NCT04095286|11349369|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
7166132|NCT04095286|11349370|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
7166133|NCT04095286|11349371|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
7166134|NCT04095286|11349372|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
7166135|NCT04095286|11349367|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1
7166136|NCT04095286|11349368|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
7166137|NCT04095286|11349369|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
7166138|NCT04095286|11349370|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
7166139|NCT04095286|11349371|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
7166140|NCT04095286|11349372|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
7166141|NCT04095286|11349367|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
7166142|NCT04095286|11349368|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
7166143|NCT04095286|11349369|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1
7166144|NCT04095286|11349370|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
7166145|NCT04095286|11349371|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
7166146|NCT04095286|11349372|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
7166147|NCT04095286|11349367|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
7166148|NCT04095286|11349368|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
7166149|NCT04095286|11349369|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2
7166150|NCT04095286|11349370|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
7166151|NCT04095286|11349371|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
7166152|NCT04095286|11349372|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
7166153|NCT04095286|11349367|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
7166154|NCT04095286|11349368|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
7166155|NCT04095286|11349369|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
7166156|NCT04095286|11349370|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
7166157|NCT04095286|11349371|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1
7166158|NCT04095286|11349372|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
7166159|NCT04094883|11349380|FG000|Overall Study|Withdrawal by Subject|1
7166160|NCT04091659|11349386|FG000|Overall Study|Protocol Violation|3
7166161|NCT04091659|11349387|FG001|Overall Study|Protocol Violation|0
7166162|NCT04091659|11349386|FG000|Overall Study|Lost to Follow-up|0
7166163|NCT04091659|11349387|FG001|Overall Study|Lost to Follow-up|1
7166164|NCT04090242|11349412|FG000|Overall Study|Withdrawal by Subject|1
7166165|NCT04090242|11349413|FG001|Overall Study|Withdrawal by Subject|0
7166166|NCT04089761|11349420|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14
7166167|NCT04089761|11349420|FG000|"Run In Phase"|Lost to Follow-up|1
7166168|NCT04089761|11349420|FG000|"Treatment Phase"|No evaluable data|5
7166169|NCT04089761|11349420|FG000|"Treatment Phase"|Lost to Follow-up|1
7166170|NCT04079803|11349427|FG000|Overall Study|Withdrawal by Subject|0
7166171|NCT04079803|11349428|FG001|Overall Study|Withdrawal by Subject|0
7166172|NCT04079803|11349429|FG002|Overall Study|Withdrawal by Subject|1
7166173|NCT04086641|11349472|FG000|Foot 1 (Two Week Utilization)|COVID-19|1
7166174|NCT04086641|11349473|FG001|Foot 1 (Two Week Utilization)|COVID-19|2
7166175|NCT04085289|11349491|FG000|Overall Study|Withdrawal by Subject|0
6895195|NCT00623480|10912977|FG000|Overall Study|Lack of Efficacy|1
7166176|NCT04085289|11349492|FG001|Overall Study|Withdrawal by Subject|0
7166177|NCT04085289|11349493|FG002|Overall Study|Withdrawal by Subject|1
7166178|NCT04082663|11349504|FG000|Overall Study|Adverse Event|6
7166179|NCT04082663|11349504|FG000|Overall Study|Lost to Follow-up|1
7166180|NCT04079790|11349585|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1
7166181|NCT04079790|11349586|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0
7166182|NCT04079790|11349587|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0
7166183|NCT04079790|11349588|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0
7166184|NCT04079790|11349585|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0
7166185|NCT04079790|11349586|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0
7166186|NCT04079790|11349587|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1
7166187|NCT04079790|11349588|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0
7166188|NCT04079790|11349585|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0
7166189|NCT04079790|11349586|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0
7166190|NCT04079790|11349587|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2
7166191|NCT04079790|11349588|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0
7166192|NCT04073407|11349679|FG000|Part 1|Withdrawal by Subject|1
7166193|NCT04073407|11349680|FG001|Part 1|Withdrawal by Subject|0
7166194|NCT04073407|11349679|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4
7166195|NCT04073407|11349680|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1
7166196|NCT04073407|11349679|FG000|Part 2|Withdrawal by Subject|0
7166197|NCT04073407|11349680|FG001|Part 2|Withdrawal by Subject|1
7166198|NCT04073368|11349690|FG000|Overall Study|Adverse Event|2
7166199|NCT04073368|11349691|FG001|Overall Study|Adverse Event|0
7166200|NCT04073368|11349692|FG002|Overall Study|Adverse Event|1
7166201|NCT04073368|11349693|FG003|Overall Study|Adverse Event|1
7166202|NCT04073368|11349690|FG000|Overall Study|Withdrawal by Subject|2
7166203|NCT04073368|11349691|FG001|Overall Study|Withdrawal by Subject|2
7166204|NCT04073368|11349692|FG002|Overall Study|Withdrawal by Subject|1
7166205|NCT04073368|11349693|FG003|Overall Study|Withdrawal by Subject|1
7166206|NCT04073368|11349690|FG000|Overall Study|Lost to Follow-up|1
7166207|NCT04073368|11349691|FG001|Overall Study|Lost to Follow-up|1
7166208|NCT04073368|11349692|FG002|Overall Study|Lost to Follow-up|1
7166209|NCT04073368|11349693|FG003|Overall Study|Lost to Follow-up|0
7166210|NCT04073368|11349690|FG000|Overall Study|Protocol Violation|0
7166211|NCT04073368|11349691|FG001|Overall Study|Protocol Violation|1
7166212|NCT04073368|11349692|FG002|Overall Study|Protocol Violation|0
7166213|NCT04073368|11349693|FG003|Overall Study|Protocol Violation|0
7166214|NCT04073368|11349690|FG000|Overall Study|Subject noncompliance|7
7166215|NCT04073368|11349691|FG001|Overall Study|Subject noncompliance|4
7166216|NCT04073368|11349692|FG002|Overall Study|Subject noncompliance|0
7166217|NCT04073368|11349693|FG003|Overall Study|Subject noncompliance|0
7166218|NCT04073186|11349703|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1
7166219|NCT04073186|11349703|FG000|First Wearing Cycle|Withdrawal by Subject|1
7166220|NCT04073186|11349703|FG000|First Wearing Cycle|Protocol Violation|1
7166221|NCT04073186|11349703|FG000|First Wearing Cycle|Lens Discomfort|2
7166222|NCT04073186|11349703|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1
7166223|NCT04073186|11349703|FG000|Second Wearing Cycle|Adverse Event|1
7166224|NCT04071301|11349771|FG000|Overall Study|Withdrawal by Subject|6
7166225|NCT04071301|11349771|FG000|Overall Study|Death|1
7166226|NCT04071158|11349780|FG000|Overall Study|Lost to Follow-up|1
7166227|NCT04071158|11349781|FG001|Overall Study|Lost to Follow-up|2
7166228|NCT04071158|11349782|FG002|Overall Study|Lost to Follow-up|3
7166229|NCT04071158|11349783|FG003|Overall Study|Lost to Follow-up|3
7166230|NCT04071158|11349784|FG004|Overall Study|Lost to Follow-up|5
7166231|NCT04071158|11349780|FG000|Overall Study|Randomized but not treated|2
7166232|NCT04071158|11349781|FG001|Overall Study|Randomized but not treated|2
7166233|NCT04071158|11349782|FG002|Overall Study|Randomized but not treated|0
7166234|NCT04071158|11349783|FG003|Overall Study|Randomized but not treated|0
7166235|NCT04071158|11349784|FG004|Overall Study|Randomized but not treated|0
7166236|NCT04069715|11349825|FG000|Overall Study|Lost to Follow-up|1
7166237|NCT04069715|11349826|FG001|Overall Study|Lost to Follow-up|1
7166238|NCT04069715|11349825|FG000|Overall Study|Physician Decision|1
7166239|NCT04069715|11349826|FG001|Overall Study|Physician Decision|1
7166240|NCT04069715|11349825|FG000|Overall Study|Withdrawal by Subject|3
7166241|NCT04069715|11349826|FG001|Overall Study|Withdrawal by Subject|3
7166242|NCT04050722|11349834|FG000|Overall Study|Withdrawal by Subject|1
7166243|NCT04050722|11349835|FG001|Overall Study|Withdrawal by Subject|0
7166244|NCT04067141|11349856|FG000|First Intervention|Withdrawal by Subject|0
7166245|NCT04067141|11349857|FG001|First Intervention|Withdrawal by Subject|1
7166246|NCT04067141|11349856|FG000|Second Intervention|Adverse Event|0
7166247|NCT04067141|11349857|FG001|Second Intervention|Adverse Event|2
7166248|NCT04049578|11349863|FG000|Overall Study|Physician Decision|1
7166249|NCT04067401|11349869|FG000|Overall Study|Withdrawal by Subject|7
7166250|NCT04067401|11349870|FG001|Overall Study|Withdrawal by Subject|0
7166251|NCT04067401|11349869|FG000|Overall Study|no data provided|1
7166252|NCT04067401|11349870|FG001|Overall Study|no data provided|0
7166253|NCT04067050|11349878|FG000|One Month|Lost to Follow-up|4
7166254|NCT04067050|11349879|FG001|One Month|Lost to Follow-up|0
7166255|NCT04067050|11349878|FG000|Two Month|Lost to Follow-up|1
7166256|NCT04067050|11349879|FG001|Two Month|Lost to Follow-up|0
7166257|NCT04067050|11349878|FG000|Two Month|Adverse Event|1
7166258|NCT04067050|11349879|FG001|Two Month|Adverse Event|0
7166259|NCT04060654|11349915|FG000|Overall Study|Withdrawal by Subject|1
7166260|NCT04060654|11349915|FG000|Overall Study|Lost to Follow-up|5
7166261|NCT04058353|11349928|FG000|Overall Study|Adverse Event|2
7166262|NCT04058353|11349929|FG001|Overall Study|Adverse Event|1
7166263|NCT04058353|11349928|FG000|Overall Study|Physician Decision|1
7166264|NCT04058353|11349929|FG001|Overall Study|Physician Decision|0
7166265|NCT04058353|11349928|FG000|Overall Study|Other|1
7166266|NCT04058353|11349929|FG001|Overall Study|Other|0
7166267|NCT04054765|11349961|FG000|Baseline|Withdrawal by Subject|5
7166268|NCT04054765|11349962|FG001|Baseline|Withdrawal by Subject|3
7166269|NCT04054765|11349961|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8
7166270|NCT04054765|11349962|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3
7166271|NCT04054765|11349961|FG000|3-month Follow up|Withdrawal by Subject|0
7166272|NCT04054765|11349962|FG001|3-month Follow up|Withdrawal by Subject|3
7166273|NCT04054765|11349961|FG000|6-month Follow up|Lost to Follow-up|32
7166274|NCT04054765|11349962|FG001|6-month Follow up|Lost to Follow-up|32
7166275|NCT04054011|11349968|FG000|Overall Study|COVID|3
7166276|NCT04059094|11349979|FG000|Overall Study|Adverse Event|0
7166277|NCT04059094|11349980|FG001|Overall Study|Adverse Event|0
7166278|NCT04059094|11349981|FG002|Overall Study|Adverse Event|0
7166279|NCT04059094|11349982|FG003|Overall Study|Adverse Event|0
7166280|NCT04059094|11349983|FG004|Overall Study|Adverse Event|1
7166281|NCT04059094|11349979|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0
7166282|NCT04059094|11349980|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2
7166283|NCT04059094|11349981|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0
7166284|NCT04059094|11349982|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0
7166285|NCT04059094|11349983|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0
7166286|NCT04046341|11350008|FG000|Overall Study|Lost to Follow-up|2
7166287|NCT04046341|11350008|FG000|Overall Study|Withdrawal by Subject|1
7166288|NCT04043416|11350023|FG000|Washout|Change in health condition|0
7166289|NCT04043416|11350024|FG001|Washout|Change in health condition|1
7166290|NCT04054193|11350086|FG000|Cycle 1|Physician Decision|1
7166291|NCT04054193|11350086|FG000|Cycle 1|Consent withdrawn by parent/guardian|1
7166292|NCT04054193|11350086|FG000|Cycle 1|Allocated but not treated|3
7166293|NCT04054193|11350086|FG000|Cycles 2-3|Physician Decision|2
7166294|NCT04054193|11350086|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2
7166295|NCT04054193|11350086|FG000|Cycles 2-3|Various reasons|17
7166296|NCT04050618|11350093|FG000|First Intervention|Withdrawal by Subject|2
7166297|NCT04050618|11350094|FG001|First Intervention|Withdrawal by Subject|0
7166298|NCT04050618|11350093|FG000|Second Intervention|Withdrawal by Subject|1
7166299|NCT04050618|11350094|FG001|Second Intervention|Withdrawal by Subject|0
7166300|NCT04053465|11350107|FG000|Overall Study|Withdrawal by Subject|4
7166301|NCT04053465|11350108|FG001|Overall Study|Withdrawal by Subject|4
7166302|NCT04049552|11350127|FG000|Overall Study|Lost to Follow-up|1
7166303|NCT04053023|11350135|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1
7166304|NCT04053023|11350136|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0
7166305|NCT04050865|11350161|FG000|Overall Study|Adverse Event|1
7166306|NCT04050865|11350162|FG001|Overall Study|Adverse Event|0
7166307|NCT04050865|11350161|FG000|Overall Study|no insert|1
7166308|NCT04050865|11350162|FG001|Overall Study|no insert|0
7166309|NCT04050865|11350161|FG000|Overall Study|Only 1 insert|2
7166310|NCT04050865|11350162|FG001|Overall Study|Only 1 insert|3
7166311|NCT04050865|11350161|FG000|Overall Study|Physician Decision|0
7166312|NCT04050865|11350162|FG001|Overall Study|Physician Decision|1
7166313|NCT04050865|11350161|FG000|Overall Study|Withdrawal by Subject|0
7166314|NCT04050865|11350162|FG001|Overall Study|Withdrawal by Subject|1
7166315|NCT04050371|11350180|FG000|Overall Study|Withdrawal by Subject|1
7166316|NCT04050371|11350181|FG001|Overall Study|Withdrawal by Subject|0
7166317|NCT04048681|11350191|FG000|Overall Study|family emergency|0
7166318|NCT04048681|11350192|FG001|Overall Study|family emergency|0
7166319|NCT04048681|11350193|FG002|Overall Study|family emergency|0
7166320|NCT04048681|11350194|FG003|Overall Study|family emergency|1
7166321|NCT04048681|11350195|FG004|Overall Study|family emergency|0
7166322|NCT04046250|11350205|FG000|Overall Study|Death|0
7166323|NCT04046250|11350206|FG001|Overall Study|Death|1
7166324|NCT04046250|11350205|FG000|Overall Study|Withdrawal by Subject|3
7166325|NCT04046250|11350206|FG001|Overall Study|Withdrawal by Subject|3
7166326|NCT04044352|11350221|FG000|Overall Study|Lost to Follow-up|9
7166327|NCT04044352|11350221|FG000|Overall Study|Withdrawal by Subject|2
7166328|NCT04043728|11350229|FG000|Overall Study|Lost to Follow-up|1
7166329|NCT04043728|11350230|FG001|Overall Study|Lost to Follow-up|2
7166330|NCT04043728|11350231|FG002|Overall Study|Lost to Follow-up|0
7166331|NCT04041414|11350260|FG000|Overall Study|Lost to Follow-up|1
7166332|NCT04041414|11350261|FG001|Overall Study|Lost to Follow-up|2
7166333|NCT04041700|11350274|FG000|Overall Study|Pregnancy|1
7166334|NCT04041700|11350274|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1
7166335|NCT04040933|11350278|FG000|Overall Study|Protocol Violation|1
7166336|NCT04040933|11350278|FG000|Overall Study|Withdrawal by Subject|2
7184681|NCT02288247|11385009|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|0
7184682|NCT02288247|11385008|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|52
7188332|NCT02891226|11388858|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4
7166337|NCT04029519|11350319|FG000|Overall Study|Protocol Violation|1
7166338|NCT04029519|11350319|FG000|Overall Study|Withdrawal by Subject|3
7166339|NCT04029519|11350319|FG000|Overall Study|Lost to Follow-up|1
7166340|NCT04039919|11350328|FG000|Treatment Period 1|Withdrawal by Subject|1
7166341|NCT04039919|11350329|FG001|Treatment Period 1|Withdrawal by Subject|0
7166342|NCT04039919|11350330|FG002|Treatment Period 1|Withdrawal by Subject|0
7166343|NCT04039919|11350331|FG003|Treatment Period 1|Withdrawal by Subject|0
7166344|NCT04039919|11350332|FG004|Treatment Period 1|Withdrawal by Subject|0
7166345|NCT04039919|11350328|FG000|Treatment Period 1|Sponsor's decision|0
7166346|NCT04039919|11350329|FG001|Treatment Period 1|Sponsor's decision|0
7166347|NCT04039919|11350330|FG002|Treatment Period 1|Sponsor's decision|0
7166348|NCT04039919|11350331|FG003|Treatment Period 1|Sponsor's decision|0
7166349|NCT04039919|11350332|FG004|Treatment Period 1|Sponsor's decision|16
7166350|NCT04039919|11350328|FG000|Treatment Period 5|Withdrawal by Subject|1
7166351|NCT04039919|11350329|FG001|Treatment Period 5|Withdrawal by Subject|0
7166352|NCT04039919|11350330|FG002|Treatment Period 5|Withdrawal by Subject|0
7166353|NCT04039919|11350331|FG003|Treatment Period 5|Withdrawal by Subject|0
7166354|NCT04039919|11350332|FG004|Treatment Period 5|Withdrawal by Subject|0
7166355|NCT04037748|11350381|FG000|Treatment Period 1|Withdrawal by Subject|3
7166356|NCT04037748|11350382|FG001|Treatment Period 1|Withdrawal by Subject|0
7166357|NCT04037748|11350381|FG000|Treatment Period 1|Adverse Event|1
7166358|NCT04037748|11350382|FG001|Treatment Period 1|Adverse Event|1
7166359|NCT04037748|11350381|FG000|Treatment Period 1|Protocol Violation|4
7166360|NCT04037748|11350382|FG001|Treatment Period 1|Protocol Violation|5
7166361|NCT04037748|11350381|FG000|Treatment Period 2|Adverse Event|0
7166362|NCT04037748|11350382|FG001|Treatment Period 2|Adverse Event|1
7166363|NCT04037748|11350381|FG000|Treatment Period 2|Protocol Violation|2
7166364|NCT04037748|11350382|FG001|Treatment Period 2|Protocol Violation|0
7166365|NCT04027686|11350399|FG000|Overall Study|Lost to Follow-up|2
7166366|NCT04027686|11350400|FG001|Overall Study|Lost to Follow-up|0
7166367|NCT04027686|11350399|FG000|Overall Study|Withdrawal by Subject|0
7166368|NCT04027686|11350400|FG001|Overall Study|Withdrawal by Subject|1
7166369|NCT04036110|11350430|FG000|Overall Study|Lost to Follow-up|3
7166370|NCT04036110|11350431|FG001|Overall Study|Lost to Follow-up|2
7166371|NCT04036110|11350432|FG002|Overall Study|Lost to Follow-up|1
7166372|NCT04036110|11350430|FG000|Overall Study|Study Suspended|4
7166373|NCT04036110|11350431|FG001|Overall Study|Study Suspended|5
7166374|NCT04036110|11350432|FG002|Overall Study|Study Suspended|1
7166375|NCT04035577|11350449|FG000|Overall Study|Lost to Follow-up|1
7166376|NCT04035577|11350449|FG000|Overall Study|Withdrawal by Subject|1
7166377|NCT04035564|11350457|FG000|Overall Study|Protocol Violation|1
7166378|NCT04035564|11350458|FG001|Overall Study|Protocol Violation|2
7166379|NCT04035564|11350457|FG000|Overall Study|No laboratory available|2
7166380|NCT04035564|11350458|FG001|Overall Study|No laboratory available|2
7166381|NCT04035564|11350457|FG000|Overall Study|Guardian declined consent|1
7166382|NCT04035564|11350458|FG001|Overall Study|Guardian declined consent|2
7166383|NCT04032977|11350466|FG000|Overall Study|Withdrawal by Subject|6
7166384|NCT04032977|11350467|FG001|Overall Study|Withdrawal by Subject|1
7166385|NCT04032977|11350466|FG000|Overall Study|Lost to Follow-up|2
7166386|NCT04032977|11350467|FG001|Overall Study|Lost to Follow-up|7
7166387|NCT04032977|11350466|FG000|Overall Study|Pregnancy|1
7166388|NCT04032977|11350467|FG001|Overall Study|Pregnancy|0
7166389|NCT04032652|11350475|FG000|Overall Study|The study was terminated and the PI has|1
7166390|NCT04032652|11350476|FG001|Overall Study|The study was terminated and the PI has|1
7166391|NCT04032613|11350496|FG000|Overall Study|Did not complete post-program assessment|5
7166392|NCT04032613|11350497|FG001|Overall Study|Did not complete post-program assessment|2
7166393|NCT04032171|11350505|FG000|Overall Study|Study Termination|1
7166394|NCT04032171|11350506|FG001|Overall Study|Study Termination|0
7166395|NCT04032158|11350514|FG000|Overall Study|Study Termination|2
7166396|NCT04032158|11350515|FG001|Overall Study|Study Termination|1
7166397|NCT04031404|11350521|FG000|Baseline|Lost to Follow-up|0
7166398|NCT04031404|11350522|FG001|Baseline|Lost to Follow-up|1
7166399|NCT04031404|11350521|FG000|Baseline|Did not meet full inclusion/exclusion.|2
7166400|NCT04031404|11350522|FG001|Baseline|Did not meet full inclusion/exclusion.|4
7166401|NCT04031404|11350521|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1
7166402|NCT04031404|11350522|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3
7166403|NCT04031404|11350521|FG000|Pre-randomization|Disqualified by TMS safety screening|1
7166404|NCT04031404|11350522|FG001|Pre-randomization|Disqualified by TMS safety screening|0
7166405|NCT04031404|11350521|FG000|Washout (5 Day Min)|Lost to Follow-up|1
7166406|NCT04031404|11350522|FG001|Washout (5 Day Min)|Lost to Follow-up|0
7166407|NCT04029961|11350567|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1
7166408|NCT04029961|11350568|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0
7166409|NCT04029961|11350567|FG000|Overall Study|Change in Treatment Course|0
7166410|NCT04029961|11350568|FG001|Overall Study|Change in Treatment Course|1
7166411|NCT04025684|11350578|FG000|Overall Study|Withdrawal by Subject|1
7166412|NCT04025684|11350579|FG001|Overall Study|Withdrawal by Subject|1
7166413|NCT04025684|11350580|FG002|Overall Study|Withdrawal by Subject|0
7166414|NCT04025684|11350581|FG003|Overall Study|Withdrawal by Subject|0
7166415|NCT04025684|11350578|FG000|Overall Study|Multiple reasons|1
7166416|NCT04025684|11350579|FG001|Overall Study|Multiple reasons|3
7166417|NCT04025684|11350580|FG002|Overall Study|Multiple reasons|0
7166418|NCT04025684|11350581|FG003|Overall Study|Multiple reasons|1
7166419|NCT04019054|11350593|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0
7166420|NCT04019054|11350594|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1
7166421|NCT04019054|11350593|FG000|Overall Study|Withdrawal by Subject|3
7166422|NCT04019054|11350594|FG001|Overall Study|Withdrawal by Subject|1
7166423|NCT04016311|11350727|FG000|Overall Study|Withdrawal by Subject|1
7166424|NCT04016311|11350728|FG001|Overall Study|Withdrawal by Subject|0
7166425|NCT04023682|11350821|FG000|Overall Study|Clinical schedules did not allow continued participation|6
7166426|NCT04023994|11350868|FG000|Overall Study|Lost to Follow-up|0
7166427|NCT04023994|11350869|FG001|Overall Study|Lost to Follow-up|1
7166428|NCT04023994|11350870|FG002|Overall Study|Lost to Follow-up|2
7166429|NCT04023994|11350871|FG003|Overall Study|Lost to Follow-up|0
7166430|NCT04023994|11350872|FG004|Overall Study|Lost to Follow-up|0
7166431|NCT04023994|11350873|FG005|Overall Study|Lost to Follow-up|0
7166432|NCT04023994|11350868|FG000|Overall Study|Withdrawal by Subject|0
7166433|NCT04023994|11350869|FG001|Overall Study|Withdrawal by Subject|0
7166434|NCT04023994|11350870|FG002|Overall Study|Withdrawal by Subject|0
7166435|NCT04023994|11350871|FG003|Overall Study|Withdrawal by Subject|1
7166436|NCT04023994|11350872|FG004|Overall Study|Withdrawal by Subject|0
7166437|NCT04023994|11350873|FG005|Overall Study|Withdrawal by Subject|0
7166438|NCT04017611|11350916|FG000|Overall Study|Withdrawn prior to completion|1
7166439|NCT04015232|11350922|FG000|Overall Study|Withdrawal by Subject|7
7166440|NCT04015232|11350923|FG001|Overall Study|Withdrawal by Subject|4
7166441|NCT04015232|11350922|FG000|Overall Study|Protocol Violation|1
7166442|NCT04015232|11350923|FG001|Overall Study|Protocol Violation|0
7166443|NCT04015232|11350922|FG000|Overall Study|Medical Grounds|3
7166444|NCT04015232|11350923|FG001|Overall Study|Medical Grounds|3
7166445|NCT04014062|11350963|FG000|Period I: Dosing|Medical Grounds|4
7166446|NCT04014062|11350964|FG001|Period I: Dosing|Medical Grounds|5
7166447|NCT04014062|11350963|FG000|Period I: Dosing|Withdrawal by Subject|3
7166448|NCT04014062|11350964|FG001|Period I: Dosing|Withdrawal by Subject|1
7166449|NCT04013191|11351001|FG000|Overall Study|Adverse Event|1
7166450|NCT04013191|11351002|FG001|Overall Study|Adverse Event|0
7166451|NCT04011735|11351019|FG000|Overall Study|Withdrawal by Subject|1
7166452|NCT04011735|11351020|FG001|Overall Study|Withdrawal by Subject|0
7166453|NCT04011735|11351021|FG002|Overall Study|Withdrawal by Subject|1
7166454|NCT04011735|11351019|FG000|Overall Study|Met exclusion criteria after study entry|0
7166455|NCT04011735|11351020|FG001|Overall Study|Met exclusion criteria after study entry|1
7166456|NCT04011735|11351021|FG002|Overall Study|Met exclusion criteria after study entry|0
7166457|NCT04009577|11351035|FG000|Core Study|Adverse Event|1
7166458|NCT04009577|11351036|FG001|Core Study|Adverse Event|0
7166459|NCT04009577|11351037|FG002|Core Study|Adverse Event|2
7166460|NCT04009577|11351038|FG003|Core Study|Adverse Event|4
7166461|NCT04009577|11351035|FG000|Core Study|Withdrawal by Subject|0
7166462|NCT04009577|11351036|FG001|Core Study|Withdrawal by Subject|0
7166463|NCT04009577|11351037|FG002|Core Study|Withdrawal by Subject|2
7166464|NCT04009577|11351038|FG003|Core Study|Withdrawal by Subject|0
7166465|NCT04009577|11351035|FG000|Core Study|Other|0
7166466|NCT04009577|11351036|FG001|Core Study|Other|0
7166467|NCT04009577|11351037|FG002|Core Study|Other|0
7166468|NCT04009577|11351038|FG003|Core Study|Other|1
7166469|NCT04009577|11351035|FG000|Extension Phase|Adverse Event|0
7166470|NCT04009577|11351036|FG001|Extension Phase|Adverse Event|0
7166471|NCT04009577|11351037|FG002|Extension Phase|Adverse Event|0
7166472|NCT04009577|11351038|FG003|Extension Phase|Adverse Event|1
7166473|NCT04009577|11351035|FG000|Extension Phase|Inadequate therapeutic effect|0
7166474|NCT04009577|11351036|FG001|Extension Phase|Inadequate therapeutic effect|0
7166475|NCT04009577|11351037|FG002|Extension Phase|Inadequate therapeutic effect|1
7166476|NCT04009577|11351038|FG003|Extension Phase|Inadequate therapeutic effect|0
7166477|NCT04009577|11351035|FG000|Extension Phase|Withdrawal by Subject|0
7166478|NCT04009577|11351036|FG001|Extension Phase|Withdrawal by Subject|0
7166479|NCT04009577|11351037|FG002|Extension Phase|Withdrawal by Subject|1
7166480|NCT04009577|11351038|FG003|Extension Phase|Withdrawal by Subject|0
7166481|NCT04009577|11351035|FG000|Extension Phase|Not Treated|0
7166482|NCT04009577|11351036|FG001|Extension Phase|Not Treated|0
7166483|NCT04009577|11351037|FG002|Extension Phase|Not Treated|2
7166484|NCT04009577|11351038|FG003|Extension Phase|Not Treated|0
7166485|NCT04007159|11351064|FG000|Induction Phase|(missed study visits)|16
7166486|NCT04007159|11351064|FG000|Induction Phase|Withdrawal by Subject|4
7166487|NCT04007159|11351064|FG000|Induction Phase|Adverse Event|2
7166488|NCT04007159|11351064|FG000|Challenge Phase|missed study visits|3
7166489|NCT04007107|11351075|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0
7166490|NCT04007107|11351076|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1
7166491|NCT04007107|11351077|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0
7166492|NCT04007107|11351078|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0
7166493|NCT04005885|11351094|FG000|First Intervention|Withdrawal by Subject|1
7166494|NCT04005885|11351095|FG001|First Intervention|Withdrawal by Subject|1
7166495|NCT04005885|11351094|FG000|Second Intervention|Withdrawal by Subject|0
7166496|NCT04005885|11351095|FG001|Second Intervention|Withdrawal by Subject|2
7166497|NCT04000815|11351109|FG000|Overall Study|Lost to Follow-up|9
7166498|NCT04000815|11351110|FG001|Overall Study|Lost to Follow-up|2
7166499|NCT04000815|11351111|FG002|Overall Study|Lost to Follow-up|3
7166500|NCT04000815|11351109|FG000|Overall Study|Withdrawal by Subject|4
7166501|NCT04000815|11351110|FG001|Overall Study|Withdrawal by Subject|3
7166502|NCT04000815|11351111|FG002|Overall Study|Withdrawal by Subject|2
7166503|NCT04000815|11351109|FG000|Overall Study|Right ovarian cyst occured|1
7166504|NCT04000815|11351110|FG001|Overall Study|Right ovarian cyst occured|0
7166505|NCT04000815|11351111|FG002|Overall Study|Right ovarian cyst occured|0
7166506|NCT04000815|11351109|FG000|Overall Study|Hypertension occured on follow up|0
7166507|NCT04000815|11351110|FG001|Overall Study|Hypertension occured on follow up|0
7166508|NCT04000815|11351111|FG002|Overall Study|Hypertension occured on follow up|2
7166509|NCT04006366|11351136|FG000|Overall Study|Withdrawal by Subject|1
7166510|NCT04006145|11351142|FG000|Overall Study|Lost to Follow-up|0
7166511|NCT04006145|11351143|FG001|Overall Study|Lost to Follow-up|1
7166512|NCT04006145|11351142|FG000|Overall Study|Other|1
7166513|NCT04006145|11351143|FG001|Overall Study|Other|2
7166514|NCT04005755|11351149|FG000|Overall Study|Adverse Event|6
7166515|NCT04005755|11351149|FG000|Overall Study|Physician Decision|3
7166516|NCT04005755|11351149|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4
7166517|NCT04005755|11351149|FG000|Overall Study|Withdrawal by Subject|3
7166518|NCT04005755|11351149|FG000|Overall Study|Lost to Follow-up|1
7166519|NCT03993288|11351172|FG000|Overall Study|Lost to Follow-up|2
7166520|NCT03993288|11351173|FG001|Overall Study|Lost to Follow-up|1
7166521|NCT03993288|11351172|FG000|Overall Study|non-compliance to the inclusion criteria|0
7166522|NCT03993288|11351173|FG001|Overall Study|non-compliance to the inclusion criteria|1
7166523|NCT03993288|11351172|FG000|Overall Study|wrong randomization|0
7166524|NCT03993288|11351173|FG001|Overall Study|wrong randomization|1
7166525|NCT03993288|11351172|FG000|Overall Study|improper enrollment|0
7166526|NCT03993288|11351173|FG001|Overall Study|improper enrollment|1
7166527|NCT03993288|11351172|FG000|Overall Study|prescribed with prohibited concomitant therapy|1
7166528|NCT03993288|11351173|FG001|Overall Study|prescribed with prohibited concomitant therapy|0
7166529|NCT03993288|11351172|FG000|Overall Study|developed SAE|2
7166530|NCT03993288|11351173|FG001|Overall Study|developed SAE|0
7166531|NCT03993288|11351172|FG000|Overall Study|consent withdrawal|1
7166532|NCT03993288|11351173|FG001|Overall Study|consent withdrawal|0
7166533|NCT03993288|11351172|FG000|Overall Study|did not follow the treatment schedule|1
7166534|NCT03993288|11351173|FG001|Overall Study|did not follow the treatment schedule|0
7166535|NCT03993288|11351172|FG000|Overall Study|did not follow the treatment regimen|1
7166536|NCT03993288|11351173|FG001|Overall Study|did not follow the treatment regimen|0
7166537|NCT03993288|11351172|FG000|Overall Study|Adverse Event|1
7166538|NCT03993288|11351173|FG001|Overall Study|Adverse Event|0
7166539|NCT03993288|11351172|FG000|Overall Study|Withdrawal by Subject|1
7166540|NCT03993288|11351173|FG001|Overall Study|Withdrawal by Subject|1
7166541|NCT03978832|11351204|FG000|Overall Study|Adverse Event|1
7166542|NCT03978832|11351204|FG000|Overall Study|Lost to Follow-up|1
7166543|NCT03978832|11351204|FG000|Overall Study|Withdrawal by Subject|6
7166544|NCT03978832|11351204|FG000|Overall Study|Physician Decision|2
7166545|NCT03978832|11351204|FG000|Overall Study|did not pass screening criteria|44
7166546|NCT04004260|11351245|FG000|Overall Study|Withdrawal by Subject|7
6895196|NCT00623480|10912978|FG001|Overall Study|Lack of Efficacy|0
6895197|NCT00623480|10912977|FG000|Overall Study|Non-compliant with study medication|4
6895198|NCT00623480|10912978|FG001|Overall Study|Non-compliant with study medication|0
6895199|NCT00623480|10912977|FG000|Overall Study|Protocol Violation|0
6895200|NCT00623480|10912978|FG001|Overall Study|Protocol Violation|1
6895201|NCT00623480|10912977|FG000|Overall Study|Site closed by sponsor|0
6895202|NCT00623480|10912978|FG001|Overall Study|Site closed by sponsor|1
6895203|NCT00623545|10912993|FG000|Overall Study|Adverse Event|6
6895204|NCT00623545|10912993|FG000|Overall Study|Withdrawal by Subject|4
6895205|NCT00623597|10913000|FG000|Overall Study|Failed to return|1
6895206|NCT00623597|10913001|FG001|Overall Study|Failed to return|0
6895207|NCT00623623|10913011|FG000|Overall Study|Previous enrolment into this study|1
6895208|NCT00623623|10913012|FG001|Overall Study|Previous enrolment into this study|1
6895209|NCT00623727|10913037|FG000|Double Blind (DB)|Adverse Event|1
6895210|NCT00623727|10913038|FG001|Double Blind (DB)|Adverse Event|3
7166547|NCT04004260|11351246|FG001|Overall Study|Withdrawal by Subject|3
7166548|NCT04004260|11351245|FG000|Overall Study|Lost to Follow-up|22
7166549|NCT04004260|11351246|FG001|Overall Study|Lost to Follow-up|12
7166550|NCT04004260|11351245|FG000|Overall Study|Did not engage in intervention|13
7166551|NCT04004260|11351246|FG001|Overall Study|Did not engage in intervention|17
7166552|NCT04002960|11351279|FG000|Overall Study|Withdrawn prior to Completion|2
7166553|NCT04002648|11351289|FG000|Overall Study|Lost to Follow-up|2
7166554|NCT04002648|11351290|FG001|Overall Study|Lost to Follow-up|0
7166555|NCT03990649|11351319|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0
7166556|NCT03990649|11351320|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1
7166557|NCT03990649|11351321|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0
7166558|NCT03990649|11351319|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0
7166559|NCT03990649|11351320|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1
7166560|NCT03990649|11351321|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0
6895211|NCT00623727|10913037|FG000|Double Blind (DB)|Physician Decision|0
6895212|NCT00623727|10913038|FG001|Double Blind (DB)|Physician Decision|1
6895213|NCT00623727|10913037|FG000|Double Blind (DB)|Withdrawal by Subject|8
6895214|NCT00623727|10913038|FG001|Double Blind (DB)|Withdrawal by Subject|2
7166561|NCT03990649|11351319|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2
7166562|NCT03990649|11351320|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0
7166563|NCT03990649|11351321|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0
7166564|NCT03990649|11351319|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1
7166565|NCT03990649|11351320|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1
7166566|NCT03990649|11351321|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0
7166567|NCT03990649|11351319|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0
7166568|NCT03990649|11351320|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0
7166569|NCT03990649|11351321|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1
7166570|NCT03990649|11351319|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0
7166571|NCT03990649|11351320|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0
7166572|NCT03990649|11351321|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2
7166573|NCT03990649|11351319|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0
7166574|NCT03990649|11351320|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0
7166575|NCT03990649|11351321|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1
7166576|NCT04000581|11351339|FG000|Overall Study|Withdrawal by Subject|0
7166577|NCT04000581|11351340|FG001|Overall Study|Withdrawal by Subject|1
7166578|NCT03996694|11351346|FG000|First Washout (7 Days)|positive urine drug screen|0
7166579|NCT03996694|11351347|FG001|First Washout (7 Days)|positive urine drug screen|0
7166580|NCT03996694|11351348|FG002|First Washout (7 Days)|positive urine drug screen|1
7166581|NCT03996694|11351349|FG003|First Washout (7 Days)|positive urine drug screen|0
7166582|NCT03996694|11351350|FG004|First Washout (7 Days)|positive urine drug screen|0
7166583|NCT03996694|11351351|FG005|First Washout (7 Days)|positive urine drug screen|0
7166584|NCT03996694|11351346|FG000|First Washout (7 Days)|Adverse Event|0
7166585|NCT03996694|11351347|FG001|First Washout (7 Days)|Adverse Event|1
7166586|NCT03996694|11351348|FG002|First Washout (7 Days)|Adverse Event|0
7166587|NCT03996694|11351349|FG003|First Washout (7 Days)|Adverse Event|0
7166588|NCT03996694|11351350|FG004|First Washout (7 Days)|Adverse Event|0
7166589|NCT03996694|11351351|FG005|First Washout (7 Days)|Adverse Event|0
7166590|NCT03996694|11351346|FG000|First Washout (7 Days)|Lost to Follow-up|0
7166591|NCT03996694|11351347|FG001|First Washout (7 Days)|Lost to Follow-up|0
7166592|NCT03996694|11351348|FG002|First Washout (7 Days)|Lost to Follow-up|1
7166593|NCT03996694|11351349|FG003|First Washout (7 Days)|Lost to Follow-up|0
7166594|NCT03996694|11351350|FG004|First Washout (7 Days)|Lost to Follow-up|0
7166595|NCT03996694|11351351|FG005|First Washout (7 Days)|Lost to Follow-up|0
7166596|NCT03996694|11351346|FG000|Third Washout (7 Days)|Withdrawal by Subject|0
7166597|NCT03996694|11351347|FG001|Third Washout (7 Days)|Withdrawal by Subject|0
7166598|NCT03996694|11351348|FG002|Third Washout (7 Days)|Withdrawal by Subject|0
7166599|NCT03996694|11351349|FG003|Third Washout (7 Days)|Withdrawal by Subject|0
7166600|NCT03996694|11351350|FG004|Third Washout (7 Days)|Withdrawal by Subject|1
7166601|NCT03996694|11351351|FG005|Third Washout (7 Days)|Withdrawal by Subject|0
7166602|NCT03988907|11351367|FG000|Overall Study|Unable to complete visit|0
7166603|NCT03988907|11351368|FG001|Overall Study|Unable to complete visit|1
7166604|NCT03988088|11351382|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0
7166605|NCT03988088|11351383|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1
7166606|NCT03988088|11351384|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0
7166607|NCT03988088|11351385|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0
7166608|NCT03988088|11351382|FG000|Open-Label Addendum|Lost to Follow-up|0
7166609|NCT03988088|11351383|FG001|Open-Label Addendum|Lost to Follow-up|0
7166610|NCT03988088|11351384|FG002|Open-Label Addendum|Lost to Follow-up|1
7166611|NCT03988088|11351385|FG003|Open-Label Addendum|Lost to Follow-up|0
7166612|NCT03980522|11351398|FG000|Treatment Period|Adverse Event|1
7166613|NCT03980522|11351399|FG001|Treatment Period|Adverse Event|0
7166614|NCT03980522|11351400|FG002|Treatment Period|Adverse Event|0
7166615|NCT03980522|11351401|FG003|Treatment Period|Adverse Event|0
7166616|NCT03980522|11351402|FG004|Treatment Period|Adverse Event|0
7184683|NCT02288247|11385009|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|0
7184684|NCT02288247|11385008|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Other|106
7184685|NCT02288247|11385009|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Other|0
7184686|NCT02288247|11385008|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10
7184687|NCT02288247|11385009|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8
7184688|NCT02288247|11385008|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8
7184689|NCT02288247|11385009|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4
7184690|NCT02288247|11385008|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1
7184691|NCT02288247|11385009|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0
7184692|NCT02288247|11385008|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87
7184693|NCT02288247|11385009|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94
7184694|NCT02288247|11385008|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2
7184695|NCT02288247|11385009|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1
7184696|NCT02288247|11385008|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7
7184697|NCT02288247|11385009|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7
7184698|NCT02288247|11385008|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|20
7184699|NCT02288247|11385009|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21
7188333|NCT02891226|11388859|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1
7166617|NCT03995784|11351418|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1
7166618|NCT03993392|11351429|FG000|Overall Study|Withdrawal by Subject|3
7166619|NCT03993392|11351429|FG000|Overall Study|Lost to Follow-up|2
7166620|NCT03993392|11351429|FG000|Overall Study|Did not meet Day 1 check-in criteria|1
7166621|NCT03981822|11351452|FG000|Overall Study|Lost to Follow-up|0
7166622|NCT03981822|11351453|FG001|Overall Study|Lost to Follow-up|1
7166623|NCT03981822|11351454|FG002|Overall Study|Lost to Follow-up|1
7166624|NCT03981822|11351455|FG003|Overall Study|Lost to Follow-up|0
7166625|NCT03981822|11351456|FG004|Overall Study|Lost to Follow-up|6
7166626|NCT03981822|11351457|FG005|Overall Study|Lost to Follow-up|4
7166627|NCT03981822|11351458|FG006|Overall Study|Lost to Follow-up|4
7166628|NCT03981822|11351459|FG007|Overall Study|Lost to Follow-up|2
7166629|NCT03981822|11351452|FG000|Overall Study|Withdrawal by Subject|0
6895215|NCT00623727|10913037|FG000|Double Blind (DB)|Lack of Efficacy|2
6895216|NCT00623727|10913038|FG001|Double Blind (DB)|Lack of Efficacy|2
6895217|NCT00623727|10913037|FG000|Double Blind (DB)|Termination of the double-blind period|22
6895218|NCT00623727|10913038|FG001|Double Blind (DB)|Termination of the double-blind period|21
6895219|NCT00623727|10913037|FG000|Double Blind (DB)|Lost to Follow-up|1
6895220|NCT00623727|10913038|FG001|Double Blind (DB)|Lost to Follow-up|1
7166630|NCT03981822|11351453|FG001|Overall Study|Withdrawal by Subject|1
7166631|NCT03981822|11351454|FG002|Overall Study|Withdrawal by Subject|0
7166632|NCT03981822|11351455|FG003|Overall Study|Withdrawal by Subject|0
7166633|NCT03981822|11351456|FG004|Overall Study|Withdrawal by Subject|0
7166634|NCT03981822|11351457|FG005|Overall Study|Withdrawal by Subject|1
7166635|NCT03981822|11351458|FG006|Overall Study|Withdrawal by Subject|0
7166636|NCT03981822|11351459|FG007|Overall Study|Withdrawal by Subject|2
7166637|NCT03981822|11351452|FG000|Overall Study|COVID-19 Related|0
7166638|NCT03981822|11351453|FG001|Overall Study|COVID-19 Related|0
7166639|NCT03981822|11351454|FG002|Overall Study|COVID-19 Related|0
7166640|NCT03981822|11351455|FG003|Overall Study|COVID-19 Related|0
7166641|NCT03981822|11351456|FG004|Overall Study|COVID-19 Related|2
7166642|NCT03981822|11351457|FG005|Overall Study|COVID-19 Related|1
7166643|NCT03981822|11351458|FG006|Overall Study|COVID-19 Related|2
7166644|NCT03981822|11351459|FG007|Overall Study|COVID-19 Related|1
7166645|NCT03991494|11351512|FG000|Overall Study|Progressive Disease|4
7166646|NCT03988803|11351531|FG000|Period 2|Prematurely discontinued from medication|2
7166647|NCT03988803|11351531|FG000|Period 2|Adverse Event|1
7166648|NCT03987932|11351542|FG000|Overall Study|Lost to Follow-up|2
7166649|NCT03987932|11351543|FG001|Overall Study|Lost to Follow-up|1
7166650|NCT03987932|11351544|FG002|Overall Study|Lost to Follow-up|1
7166651|NCT03987932|11351542|FG000|Overall Study|Non-study related elective surgery|0
7166652|NCT03987932|11351543|FG001|Overall Study|Non-study related elective surgery|0
7166653|NCT03987932|11351544|FG002|Overall Study|Non-study related elective surgery|1
7166654|NCT03987191|11351554|FG000|Overall Study|COVID-19 related research disruption|0
7166655|NCT03987191|11351555|FG001|Overall Study|COVID-19 related research disruption|2
7166656|NCT03988842|11351561|FG000|Overall Study|Death|1
7166657|NCT03981861|11351566|FG000|Overall Study|Withdrawal by Subject|3
7166658|NCT03974334|11351570|FG000|Overall Study|Lost to Follow-up|1
7166659|NCT03987074|11351598|FG000|Overall Study|Withdrew Consent|1
7166660|NCT03987074|11351599|FG001|Overall Study|Withdrew Consent|1
7166661|NCT03987074|11351600|FG002|Overall Study|Withdrew Consent|0
7166662|NCT03987074|11351601|FG003|Overall Study|Withdrew Consent|2
7166663|NCT03987074|11351602|FG004|Overall Study|Withdrew Consent|1
7166664|NCT03987074|11351598|FG000|Overall Study|Adverse Event|2
7166665|NCT03987074|11351599|FG001|Overall Study|Adverse Event|1
7166666|NCT03987074|11351600|FG002|Overall Study|Adverse Event|0
7166667|NCT03987074|11351601|FG003|Overall Study|Adverse Event|0
7166668|NCT03987074|11351602|FG004|Overall Study|Adverse Event|1
7166669|NCT03987074|11351598|FG000|Overall Study|Lost to Follow-up|0
7166670|NCT03987074|11351599|FG001|Overall Study|Lost to Follow-up|0
7166671|NCT03987074|11351600|FG002|Overall Study|Lost to Follow-up|1
7166672|NCT03987074|11351601|FG003|Overall Study|Lost to Follow-up|1
7166673|NCT03987074|11351602|FG004|Overall Study|Lost to Follow-up|0
7166674|NCT03987074|11351598|FG000|Overall Study|Investigator's Discretion|0
7166675|NCT03987074|11351599|FG001|Overall Study|Investigator's Discretion|0
7166676|NCT03987074|11351600|FG002|Overall Study|Investigator's Discretion|0
7166677|NCT03987074|11351601|FG003|Overall Study|Investigator's Discretion|1
7166678|NCT03987074|11351602|FG004|Overall Study|Investigator's Discretion|0
7166679|NCT03979820|11351636|FG000|Overall Study|Protocol Violation|1
7166680|NCT03979820|11351637|FG001|Overall Study|Protocol Violation|0
7166681|NCT03979820|11351638|FG002|Overall Study|Protocol Violation|0
7166682|NCT03979820|11351639|FG003|Overall Study|Protocol Violation|0
7166683|NCT03979820|11351636|FG000|Overall Study|Withdrawal by Subject|0
7166684|NCT03979820|11351637|FG001|Overall Study|Withdrawal by Subject|0
7166685|NCT03979820|11351638|FG002|Overall Study|Withdrawal by Subject|1
7166686|NCT03979820|11351639|FG003|Overall Study|Withdrawal by Subject|0
7166687|NCT03979820|11351636|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5
7166688|NCT03979820|11351637|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0
7166689|NCT03979820|11351638|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0
7166690|NCT03979820|11351639|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10
6895221|NCT00623727|10913037|FG000|Double Blind (DB)|Protocol Violation|2
7166691|NCT03972137|11351653|FG000|Overall Study|Lost to Follow-up|2
7166692|NCT03972137|11351653|FG000|Overall Study|Withdrawal by Subject|4
7166693|NCT03970395|11351671|FG000|Overall Study|Withdrawal by Subject|3
7166694|NCT03970395|11351672|FG001|Overall Study|Withdrawal by Subject|4
7166695|NCT03970395|11351671|FG000|Overall Study|Lost to Follow-up|4
7166696|NCT03970395|11351672|FG001|Overall Study|Lost to Follow-up|8
7166697|NCT03987620|11351684|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43
7166698|NCT03987620|11351685|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41
7166699|NCT03987620|11351684|FG000|Overall Study|Adverse Event|3
7166700|NCT03987620|11351685|FG001|Overall Study|Adverse Event|0
7166701|NCT03987620|11351684|FG000|Overall Study|Lost to Follow-up|1
7166702|NCT03987620|11351685|FG001|Overall Study|Lost to Follow-up|2
7166703|NCT03987620|11351684|FG000|Overall Study|Physician Decision|0
7166704|NCT03987620|11351685|FG001|Overall Study|Physician Decision|1
7166705|NCT03987620|11351684|FG000|Overall Study|Pregnancy|1
7166706|NCT03987620|11351685|FG001|Overall Study|Pregnancy|0
7166707|NCT03987620|11351684|FG000|Overall Study|Withdrawal by Subject|7
7166708|NCT03987620|11351685|FG001|Overall Study|Withdrawal by Subject|1
7166709|NCT03987620|11351684|FG000|Overall Study|Other|2
7166710|NCT03987620|11351685|FG001|Overall Study|Other|5
7166711|NCT03983317|11351691|FG000|Overall Study|Physician Decision|5
7166712|NCT03984825|11351754|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2
7166713|NCT03984825|11351754|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1
7166714|NCT03984825|11351754|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3
7166715|NCT03982433|11351767|FG000|Overall Study|Lost to Follow-up|1
7166716|NCT03976466|11351777|FG000|Overall Study|Lost to Follow-up|1
7166717|NCT03976466|11351778|FG001|Overall Study|Lost to Follow-up|3
7166718|NCT03979638|11351788|FG000|Period 1|Physician Decision|1
7166719|NCT03979638|11351789|FG001|Period 1|Physician Decision|1
7166720|NCT03979638|11351788|FG000|Period 1|Withdrawal by Subject|4
7166721|NCT03979638|11351789|FG001|Period 1|Withdrawal by Subject|3
7166722|NCT03979638|11351788|FG000|Period 1|Study terminated by Sponsor|1
7166723|NCT03979638|11351789|FG001|Period 1|Study terminated by Sponsor|3
7166724|NCT03979638|11351788|FG000|Period 1|Protocol Violation|1
7166725|NCT03979638|11351789|FG001|Period 1|Protocol Violation|0
7166726|NCT03979638|11351788|FG000|Period 2|Study terminated by Sponsor|1
7166727|NCT03979638|11351789|FG001|Period 2|Study terminated by Sponsor|1
7166728|NCT03979274|11351804|FG000|Treatment Period 2|Withdrawal by Subject|0
7166729|NCT03979274|11351805|FG001|Treatment Period 2|Withdrawal by Subject|1
7166730|NCT03977727|11351822|FG000|Second Treatment|Lost to Follow-up|0
7166731|NCT03977727|11351823|FG001|Second Treatment|Lost to Follow-up|3
7166732|NCT03977155|11351832|FG000|Overall Study|Adverse Event|3
7166733|NCT03977155|11351833|FG001|Overall Study|Adverse Event|0
7166734|NCT03977155|11351834|FG002|Overall Study|Adverse Event|0
7166735|NCT03977155|11351832|FG000|Overall Study|Lost to Follow-up|0
7166736|NCT03977155|11351833|FG001|Overall Study|Lost to Follow-up|1
7166737|NCT03977155|11351834|FG002|Overall Study|Lost to Follow-up|0
7166738|NCT03977155|11351832|FG000|Overall Study|Withdrawal by Subject|1
7166739|NCT03977155|11351833|FG001|Overall Study|Withdrawal by Subject|1
7166740|NCT03977155|11351834|FG002|Overall Study|Withdrawal by Subject|2
7166741|NCT03977155|11351832|FG000|Overall Study|Participant was unable to come in for the Visit|1
7166742|NCT03977155|11351833|FG001|Overall Study|Participant was unable to come in for the Visit|0
7166743|NCT03977155|11351834|FG002|Overall Study|Participant was unable to come in for the Visit|0
7166744|NCT03970733|11351856|FG000|Overall Study|Withdrawal by Subject|0
7166745|NCT03970733|11351857|FG001|Overall Study|Withdrawal by Subject|5
7166746|NCT03970733|11351858|FG002|Overall Study|Withdrawal by Subject|1
7166747|NCT03970733|11351856|FG000|Overall Study|e.g.: moved from study area|1
7166748|NCT03970733|11351857|FG001|Overall Study|e.g.: moved from study area|0
7166749|NCT03970733|11351858|FG002|Overall Study|e.g.: moved from study area|0
7166750|NCT03970733|11351856|FG000|Overall Study|Lost to Follow-up|2
7166751|NCT03970733|11351857|FG001|Overall Study|Lost to Follow-up|1
7166752|NCT03970733|11351858|FG002|Overall Study|Lost to Follow-up|1
7166753|NCT03970733|11351856|FG000|Overall Study|Other|1
7166754|NCT03970733|11351857|FG001|Overall Study|Other|0
7166755|NCT03970733|11351858|FG002|Overall Study|Other|0
7166756|NCT03968978|11351868|FG000|Overall Study|Adverse Event|1
7166757|NCT03968978|11351869|FG001|Overall Study|Adverse Event|0
7166758|NCT03967444|11351886|FG000|Overall Study|Lost to Follow-up|1
7166759|NCT03967444|11351887|FG001|Overall Study|Lost to Follow-up|2
7166760|NCT03966911|11351899|FG000|Overall Study|Adverse Event|1
7166761|NCT03966911|11351900|FG001|Overall Study|Adverse Event|1
7166762|NCT03966911|11351899|FG000|Overall Study|Withdrawal by Subject|8
7166763|NCT03966911|11351900|FG001|Overall Study|Withdrawal by Subject|2
7166764|NCT03966911|11351899|FG000|Overall Study|Unable to complete study visits due to COVID-19|0
7166765|NCT03966911|11351900|FG001|Overall Study|Unable to complete study visits due to COVID-19|13
7166766|NCT03966365|11351910|FG000|Overall Study|Protocol Violation|1
7166767|NCT03966365|11351911|FG001|Overall Study|Protocol Violation|0
7166768|NCT03965403|11351917|FG000|Overall Study|Subject not meeting eligibility criteria|1
7166769|NCT03965351|11351974|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0
7166770|NCT03965351|11351975|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1
7166771|NCT03965351|11351974|FG000|Second Intervention (4 Weeks)|Adverse Event|0
7166772|NCT03965351|11351975|FG001|Second Intervention (4 Weeks)|Adverse Event|1
7166773|NCT03958955|11351990|FG000|Overall Study|Adverse Event|1
7166774|NCT03965052|11351998|FG000|Overall Study|Protocol Violation|1
7166775|NCT03965052|11351999|FG001|Overall Study|Protocol Violation|0
7166776|NCT03963401|11352028|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1
7166777|NCT03963401|11352029|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2
7166778|NCT03963401|11352030|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0
7166779|NCT03963401|11352031|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0
7166780|NCT03963401|11352032|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1
7166781|NCT03963401|11352033|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2
7166782|NCT03963401|11352028|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0
7166783|NCT03963401|11352029|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0
7166784|NCT03963401|11352030|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1
7166785|NCT03963401|11352031|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1
7166786|NCT03963401|11352032|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0
7166787|NCT03963401|11352033|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0
7166788|NCT03963401|11352028|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2
7166789|NCT03963401|11352029|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1
7166790|NCT03963401|11352030|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1
7166791|NCT03963401|11352031|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1
7166792|NCT03963401|11352032|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2
7166793|NCT03963401|11352033|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0
7166794|NCT03963401|11352028|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0
7166795|NCT03963401|11352029|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1
7166796|NCT03963401|11352030|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0
7166797|NCT03963401|11352031|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0
7166798|NCT03963401|11352032|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0
7166799|NCT03963401|11352033|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0
7166800|NCT03963401|11352028|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6
7166801|NCT03963401|11352029|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3
7166802|NCT03963401|11352030|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2
7166803|NCT03963401|11352031|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0
7166804|NCT03963401|11352032|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4
7166805|NCT03963401|11352033|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3
7166806|NCT03963401|11352028|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1
7166807|NCT03963401|11352029|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0
7166808|NCT03963401|11352030|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1
7166809|NCT03963401|11352031|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0
7166810|NCT03963401|11352032|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0
7166811|NCT03963401|11352033|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0
7166812|NCT03963401|11352028|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0
7166813|NCT03963401|11352029|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0
7166814|NCT03963401|11352030|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1
7166815|NCT03963401|11352031|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0
7166816|NCT03963401|11352032|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0
7166817|NCT03963401|11352033|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0
7166818|NCT03963401|11352028|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1
7166819|NCT03963401|11352029|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0
7166820|NCT03963401|11352030|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0
7166821|NCT03963401|11352031|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0
7166822|NCT03963401|11352032|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0
7166823|NCT03963401|11352033|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0
7166824|NCT03963401|11352028|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4
7166825|NCT03963401|11352029|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1
7166826|NCT03963401|11352030|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0
7166827|NCT03963401|11352031|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0
7166828|NCT03963401|11352032|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1
7166829|NCT03963401|11352033|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1
7166830|NCT03963401|11352028|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1
7166831|NCT03963401|11352029|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0
7166832|NCT03963401|11352030|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0
7166833|NCT03963401|11352031|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0
7166834|NCT03963401|11352032|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0
7166835|NCT03963401|11352033|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0
7166836|NCT03963401|11352028|FG000|Extension Period (Week 17 - Week 52)|Other|1
7166837|NCT03963401|11352029|FG001|Extension Period (Week 17 - Week 52)|Other|1
7166838|NCT03963401|11352030|FG002|Extension Period (Week 17 - Week 52)|Other|0
7166839|NCT03963401|11352031|FG003|Extension Period (Week 17 - Week 52)|Other|1
7166840|NCT03963401|11352032|FG004|Extension Period (Week 17 - Week 52)|Other|1
7166841|NCT03963401|11352033|FG005|Extension Period (Week 17 - Week 52)|Other|1
7166842|NCT03962790|11352060|FG000|Period 1|Adverse Event|0
7166843|NCT03962790|11352061|FG001|Period 1|Adverse Event|1
7166844|NCT03962790|11352060|FG000|Period 1|Failed to meet all eligibility criteria|1
7166845|NCT03962790|11352061|FG001|Period 1|Failed to meet all eligibility criteria|1
7166846|NCT03962790|11352060|FG000|Period 1|No Longer Meets Eligibility Criteria|1
7166847|NCT03962790|11352061|FG001|Period 1|No Longer Meets Eligibility Criteria|0
7166848|NCT03962790|11352060|FG000|Period 1|Withdrawal by Subject|1
7166849|NCT03962790|11352061|FG001|Period 1|Withdrawal by Subject|0
7166850|NCT03956225|11352069|FG000|Overall Study|Lack of Efficacy|1
7166851|NCT03956225|11352070|FG001|Overall Study|Lack of Efficacy|1
7166852|NCT03956225|11352069|FG000|Overall Study|Lost to Follow-up|0
7166853|NCT03956225|11352070|FG001|Overall Study|Lost to Follow-up|1
7166854|NCT03956225|11352069|FG000|Overall Study|Withdrawal by Subject|2
7166855|NCT03956225|11352070|FG001|Overall Study|Withdrawal by Subject|1
7166856|NCT03956225|11352069|FG000|Overall Study|Other Reasons|2
7166857|NCT03956225|11352070|FG001|Overall Study|Other Reasons|1
7166858|NCT03958149|11352088|FG000|Overall Study|Withdrawal by Subject|0
7166859|NCT03958149|11352089|FG001|Overall Study|Withdrawal by Subject|1
7166860|NCT03953183|11352101|FG000|Overall Study|Physician Decision|0
7166861|NCT03953183|11352102|FG001|Overall Study|Physician Decision|1
7166862|NCT03953183|11352101|FG000|Overall Study|Withdrawal by Subject|0
7166863|NCT03953183|11352102|FG001|Overall Study|Withdrawal by Subject|1
7166864|NCT03962738|11352123|FG000|Overall Study|Protocol Deviation|3
7166865|NCT03962738|11352124|FG001|Overall Study|Protocol Deviation|0
7166866|NCT03962738|11352125|FG002|Overall Study|Protocol Deviation|1
7166867|NCT03962738|11352126|FG003|Overall Study|Protocol Deviation|1
7166868|NCT03962738|11352123|FG000|Overall Study|Withdrawal by Subject|4
7166869|NCT03962738|11352124|FG001|Overall Study|Withdrawal by Subject|0
7166870|NCT03962738|11352125|FG002|Overall Study|Withdrawal by Subject|0
7166871|NCT03962738|11352126|FG003|Overall Study|Withdrawal by Subject|0
7166872|NCT03962738|11352123|FG000|Overall Study|Lost to Follow-up|0
7166873|NCT03962738|11352124|FG001|Overall Study|Lost to Follow-up|0
7166874|NCT03962738|11352125|FG002|Overall Study|Lost to Follow-up|1
7166875|NCT03962738|11352126|FG003|Overall Study|Lost to Follow-up|0
7166876|NCT03962101|11352144|FG000|Overall Study|Adverse Event|1
7166877|NCT03962101|11352144|FG000|Overall Study|Physician Decision|2
7166878|NCT03962101|11352144|FG000|Overall Study|Not related to medical events|1
7166879|NCT03959137|11352149|FG000|Overall Study|Protocol Violation|6
7166880|NCT03946124|11352153|FG000|Overall Study|Withdrawal by Subject|19
7166881|NCT03961308|11352159|FG000|Overall Study|Withdrawal by Subject|1
7166882|NCT03961308|11352160|FG001|Overall Study|Withdrawal by Subject|0
7166883|NCT03961308|11352159|FG000|Overall Study|Other|1
7166884|NCT03961308|11352160|FG001|Overall Study|Other|0
7166885|NCT03961308|11352159|FG000|Overall Study|Lost to Follow-up|0
7166886|NCT03961308|11352160|FG001|Overall Study|Lost to Follow-up|1
7166887|NCT03961308|11352159|FG000|Overall Study|Adverse Event|0
7166888|NCT03961308|11352160|FG001|Overall Study|Adverse Event|1
7166889|NCT03956862|11352186|FG000|Overall Study|Lost to Follow-up|1
7166890|NCT03956862|11352187|FG001|Overall Study|Lost to Follow-up|1
7166891|NCT03956862|11352186|FG000|Overall Study|Withdrawal by Subject|1
7166892|NCT03956862|11352187|FG001|Overall Study|Withdrawal by Subject|1
7166893|NCT03954444|11352196|FG000|Overall Study|Withdrawal by Subject|5
7166894|NCT03954444|11352197|FG001|Overall Study|Withdrawal by Subject|5
7166895|NCT03954444|11352198|FG002|Overall Study|Withdrawal by Subject|5
7166896|NCT03954444|11352196|FG000|Overall Study|Adverse Event|1
7166897|NCT03954444|11352197|FG001|Overall Study|Adverse Event|3
7166898|NCT03954444|11352198|FG002|Overall Study|Adverse Event|2
7166899|NCT03954444|11352196|FG000|Overall Study|Protocol Violation|0
7166900|NCT03954444|11352197|FG001|Overall Study|Protocol Violation|3
7166901|NCT03954444|11352198|FG002|Overall Study|Protocol Violation|5
7166902|NCT03954444|11352196|FG000|Overall Study|Use of prohibited therapy|1
7166903|NCT03954444|11352197|FG001|Overall Study|Use of prohibited therapy|1
7166904|NCT03954444|11352198|FG002|Overall Study|Use of prohibited therapy|2
7166905|NCT03954444|11352196|FG000|Overall Study|Lost to Follow-up|1
7166906|NCT03954444|11352197|FG001|Overall Study|Lost to Follow-up|0
7166907|NCT03954444|11352198|FG002|Overall Study|Lost to Follow-up|1
7166908|NCT03954444|11352196|FG000|Overall Study|Non-compliant with study drug application|2
7166909|NCT03954444|11352197|FG001|Overall Study|Non-compliant with study drug application|2
7166910|NCT03954444|11352198|FG002|Overall Study|Non-compliant with study drug application|0
7166911|NCT03954444|11352196|FG000|Overall Study|Administrative reasons|0
7166912|NCT03954444|11352197|FG001|Overall Study|Administrative reasons|0
7166913|NCT03954444|11352198|FG002|Overall Study|Administrative reasons|1
7166914|NCT03954444|11352196|FG000|Overall Study|Miscellaneous|3
7166915|NCT03954444|11352197|FG001|Overall Study|Miscellaneous|2
7166916|NCT03954444|11352198|FG002|Overall Study|Miscellaneous|1
7166917|NCT03953820|11352206|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1
7166918|NCT03953820|11352207|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0
7166919|NCT03953820|11352208|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0
7166920|NCT03953820|11352206|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1
7166921|NCT03953820|11352207|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0
7166922|NCT03953820|11352208|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0
7166923|NCT03951766|11352221|FG000|Treatment Phase|Lost to Follow-up|1
7166924|NCT03951766|11352221|FG000|Follow-up Phase|Lost to Follow-up|10
7166925|NCT03950856|11352251|FG000|Overall Study|Death|1
7166926|NCT03950856|11352252|FG001|Overall Study|Death|2
7166927|NCT03950856|11352253|FG002|Overall Study|Death|0
7166928|NCT03950856|11352254|FG003|Overall Study|Death|0
7166929|NCT03950856|11352251|FG000|Overall Study|Lost to Follow-up|5
7166930|NCT03950856|11352252|FG001|Overall Study|Lost to Follow-up|6
7166931|NCT03950856|11352253|FG002|Overall Study|Lost to Follow-up|8
7166932|NCT03950856|11352254|FG003|Overall Study|Lost to Follow-up|2
7166933|NCT03950856|11352251|FG000|Overall Study|Protocol Violation|2
7166934|NCT03950856|11352252|FG001|Overall Study|Protocol Violation|0
7166935|NCT03950856|11352253|FG002|Overall Study|Protocol Violation|0
7166936|NCT03950856|11352254|FG003|Overall Study|Protocol Violation|1
7166937|NCT03950856|11352251|FG000|Overall Study|Withdrawal by Subject|4
7166938|NCT03950856|11352252|FG001|Overall Study|Withdrawal by Subject|1
7166939|NCT03950856|11352253|FG002|Overall Study|Withdrawal by Subject|3
7166940|NCT03950856|11352254|FG003|Overall Study|Withdrawal by Subject|1
7166941|NCT03950856|11352251|FG000|Overall Study|Unable to phone|7
7166942|NCT03950856|11352252|FG001|Overall Study|Unable to phone|6
7166943|NCT03950856|11352253|FG002|Overall Study|Unable to phone|7
7166944|NCT03950856|11352254|FG003|Overall Study|Unable to phone|2
7166945|NCT03956550|11352307|FG000|Overall Study|Sponsor decision|65
7166946|NCT03956550|11352308|FG001|Overall Study|Sponsor decision|66
7166947|NCT03956550|11352309|FG002|Overall Study|Sponsor decision|64
7166948|NCT03956550|11352307|FG000|Overall Study|Adverse Event|0
7166949|NCT03956550|11352308|FG001|Overall Study|Adverse Event|1
7166950|NCT03956550|11352309|FG002|Overall Study|Adverse Event|0
7166951|NCT03956550|11352307|FG000|Overall Study|Withdrawal by Subject|5
7166952|NCT03956550|11352308|FG001|Overall Study|Withdrawal by Subject|5
7166953|NCT03956550|11352309|FG002|Overall Study|Withdrawal by Subject|6
7166954|NCT03958656|11352361|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0
7166955|NCT03958656|11352362|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1
7166956|NCT03958656|11352363|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0
7166957|NCT03958656|11352364|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0
7166958|NCT03958656|11352361|FG000|Overall Study|No longer meets eligibility criteria|0
7166959|NCT03958656|11352362|FG001|Overall Study|No longer meets eligibility criteria|0
7166960|NCT03958656|11352363|FG002|Overall Study|No longer meets eligibility criteria|1
7166961|NCT03958656|11352364|FG003|Overall Study|No longer meets eligibility criteria|0
7166962|NCT03958656|11352361|FG000|Overall Study|Started anti-cancer treatment|0
7166963|NCT03958656|11352362|FG001|Overall Study|Started anti-cancer treatment|0
7166964|NCT03958656|11352363|FG002|Overall Study|Started anti-cancer treatment|1
7166965|NCT03958656|11352364|FG003|Overall Study|Started anti-cancer treatment|0
7166966|NCT03951805|11352387|FG000|Overall Study|Adverse Event|1
7166967|NCT03951805|11352388|FG001|Overall Study|Adverse Event|0
7166968|NCT03951805|11352389|FG002|Overall Study|Adverse Event|0
7166969|NCT03951805|11352390|FG003|Overall Study|Adverse Event|0
7166970|NCT03950622|11352415|FG000|Overall Study|Withdrawal by Subject|1
7166971|NCT03950622|11352416|FG001|Overall Study|Withdrawal by Subject|0
7166972|NCT03950622|11352415|FG000|Overall Study|Protocol Deviation|0
7166973|NCT03950622|11352416|FG001|Overall Study|Protocol Deviation|1
7166974|NCT03950622|11352415|FG000|Overall Study|Physician Decision|1
7166975|NCT03950622|11352416|FG001|Overall Study|Physician Decision|0
7166976|NCT03950622|11352415|FG000|Overall Study|Lost to Follow-up|5
7166977|NCT03950622|11352416|FG001|Overall Study|Lost to Follow-up|5
7166978|NCT03950622|11352415|FG000|Overall Study|Death|1
7166979|NCT03950622|11352416|FG001|Overall Study|Death|1
7166980|NCT03948581|11352446|FG000|Overall Study|Lost to Follow-up|0
7166981|NCT03948581|11352447|FG001|Overall Study|Lost to Follow-up|1
7166982|NCT03948334|11352468|FG000|Overall Study|Adverse Event|1
7166983|NCT03948334|11352469|FG001|Overall Study|Adverse Event|4
7166984|NCT03948334|11352468|FG000|Overall Study|Lack of Efficacy|2
7166985|NCT03948334|11352469|FG001|Overall Study|Lack of Efficacy|0
7166986|NCT03948334|11352468|FG000|Overall Study|Lost to Follow-up|1
7166987|NCT03948334|11352469|FG001|Overall Study|Lost to Follow-up|0
7166988|NCT03948334|11352468|FG000|Overall Study|Physician Decision|1
7166989|NCT03948334|11352469|FG001|Overall Study|Physician Decision|0
7166990|NCT03948334|11352468|FG000|Overall Study|Pregnancy|0
7166991|NCT03948334|11352469|FG001|Overall Study|Pregnancy|1
7166992|NCT03948334|11352468|FG000|Overall Study|Protocol Deviation|1
7166993|NCT03948334|11352469|FG001|Overall Study|Protocol Deviation|0
7166994|NCT03948334|11352468|FG000|Overall Study|Study terminated by Sponsor|50
7166995|NCT03948334|11352469|FG001|Overall Study|Study terminated by Sponsor|51
7166996|NCT03948334|11352468|FG000|Overall Study|Subject Decision /Guardian Decision|4
7166997|NCT03948334|11352469|FG001|Overall Study|Subject Decision /Guardian Decision|7
7166998|NCT03944707|11352496|FG000|Overall Study|Adverse Event|0
7166999|NCT03944707|11352497|FG001|Overall Study|Adverse Event|2
7167000|NCT03944707|11352496|FG000|Overall Study|Study terminated by sponsor|12
7167001|NCT03944707|11352497|FG001|Overall Study|Study terminated by sponsor|7
7167002|NCT03944707|11352496|FG000|Overall Study|Subject decision|0
7167003|NCT03944707|11352497|FG001|Overall Study|Subject decision|1
7167004|NCT03943095|11352514|FG000|Overall Study|Incorrectly dispensed wrong box kit|0
7167005|NCT03943095|11352515|FG001|Overall Study|Incorrectly dispensed wrong box kit|1
7167006|NCT03943095|11352514|FG000|Overall Study|Withdrawal by Subject|1
7167007|NCT03943095|11352515|FG001|Overall Study|Withdrawal by Subject|0
7167008|NCT03943290|11352531|FG000|Overall Study|Sponsor Terminated Study|6
7167009|NCT03943290|11352532|FG001|Overall Study|Sponsor Terminated Study|1
7167010|NCT03943290|11352533|FG002|Overall Study|Sponsor Terminated Study|11
7167011|NCT03943290|11352534|FG003|Overall Study|Sponsor Terminated Study|6
7167012|NCT03943290|11352535|FG004|Overall Study|Sponsor Terminated Study|7
7167013|NCT03943290|11352536|FG005|Overall Study|Sponsor Terminated Study|6
7167014|NCT03943290|11352537|FG006|Overall Study|Sponsor Terminated Study|6
7167015|NCT03943290|11352538|FG007|Overall Study|Sponsor Terminated Study|7
7167016|NCT03943290|11352539|FG008|Overall Study|Sponsor Terminated Study|8
7167017|NCT03943290|11352531|FG000|Overall Study|Lost to Follow-up|1
7167018|NCT03943290|11352532|FG001|Overall Study|Lost to Follow-up|0
7167019|NCT03943290|11352533|FG002|Overall Study|Lost to Follow-up|1
7167020|NCT03943290|11352534|FG003|Overall Study|Lost to Follow-up|0
7167021|NCT03943290|11352535|FG004|Overall Study|Lost to Follow-up|0
7167022|NCT03943290|11352536|FG005|Overall Study|Lost to Follow-up|0
7167023|NCT03943290|11352537|FG006|Overall Study|Lost to Follow-up|0
7167024|NCT03943290|11352538|FG007|Overall Study|Lost to Follow-up|1
7167025|NCT03943290|11352539|FG008|Overall Study|Lost to Follow-up|0
7167026|NCT03943290|11352531|FG000|Overall Study|Withdrawal by Subject|0
7167027|NCT03943290|11352532|FG001|Overall Study|Withdrawal by Subject|0
7167028|NCT03943290|11352533|FG002|Overall Study|Withdrawal by Subject|1
7167029|NCT03943290|11352534|FG003|Overall Study|Withdrawal by Subject|0
7167030|NCT03943290|11352535|FG004|Overall Study|Withdrawal by Subject|0
7167031|NCT03943290|11352536|FG005|Overall Study|Withdrawal by Subject|0
7167032|NCT03943290|11352537|FG006|Overall Study|Withdrawal by Subject|0
7167033|NCT03943290|11352538|FG007|Overall Study|Withdrawal by Subject|0
7167034|NCT03943290|11352539|FG008|Overall Study|Withdrawal by Subject|0
7184700|NCT02288247|11385008|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1
7184701|NCT02288247|11385009|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0
7184702|NCT01785563|11385021|FG000|Overall Study|Physician Decision|10
7184703|NCT01785563|11385021|FG000|Overall Study|Withdrawal by Subject|1
7184704|NCT01785563|11385021|FG000|Overall Study|Protocol Violation|2
7184705|NCT01434290|11385036|FG000|Overall Study|Protocol Violation|6
7184706|NCT01434290|11385037|FG001|Overall Study|Protocol Violation|3
7184707|NCT01434290|11385036|FG000|Overall Study|No protocol treatment|2
7184708|NCT01434290|11385037|FG001|Overall Study|No protocol treatment|4
7184709|NCT01062399|11385049|FG000|Overall Study|Protocol Violation|0
7184710|NCT01062399|11385050|FG001|Overall Study|Protocol Violation|1
7184711|NCT01062399|11385051|FG002|Overall Study|Protocol Violation|0
7184712|NCT01062399|11385052|FG003|Overall Study|Protocol Violation|6
7184713|NCT01062399|11385053|FG004|Overall Study|Protocol Violation|4
7184714|NCT00750269|11385070|FG000|Overall Study|Protocol Violation|0
7184715|NCT00750269|11385071|FG001|Overall Study|Protocol Violation|1
7184716|NCT00750269|11385072|FG002|Overall Study|Protocol Violation|1
7184717|NCT00750269|11385073|FG003|Overall Study|Protocol Violation|2
7184718|NCT00750269|11385074|FG004|Overall Study|Protocol Violation|4
7184719|NCT00750269|11385070|FG000|Overall Study|Withdrawal by Subject|0
7184720|NCT00750269|11385071|FG001|Overall Study|Withdrawal by Subject|0
7184721|NCT00750269|11385072|FG002|Overall Study|Withdrawal by Subject|2
7184722|NCT00750269|11385073|FG003|Overall Study|Withdrawal by Subject|2
7184723|NCT00750269|11385074|FG004|Overall Study|Withdrawal by Subject|2
7184724|NCT00750269|11385070|FG000|Overall Study|Physician Decision|0
7184725|NCT00750269|11385071|FG001|Overall Study|Physician Decision|0
7184726|NCT00750269|11385072|FG002|Overall Study|Physician Decision|0
7184727|NCT00750269|11385073|FG003|Overall Study|Physician Decision|0
7184728|NCT00750269|11385074|FG004|Overall Study|Physician Decision|2
7184729|NCT00750269|11385070|FG000|Overall Study|Patient too large for positioning|0
7184730|NCT00750269|11385071|FG001|Overall Study|Patient too large for positioning|0
7184731|NCT00750269|11385072|FG002|Overall Study|Patient too large for positioning|1
7184732|NCT00750269|11385073|FG003|Overall Study|Patient too large for positioning|0
7184733|NCT00750269|11385074|FG004|Overall Study|Patient too large for positioning|0
7184734|NCT00750269|11385070|FG000|Overall Study|Site error|0
7184735|NCT00750269|11385071|FG001|Overall Study|Site error|0
7184736|NCT00750269|11385072|FG002|Overall Study|Site error|0
7184737|NCT00750269|11385073|FG003|Overall Study|Site error|1
7184738|NCT00750269|11385074|FG004|Overall Study|Site error|0
7184739|NCT00750269|11385070|FG000|Overall Study|SBRT plan could not be drawn|0
7184740|NCT00750269|11385071|FG001|Overall Study|SBRT plan could not be drawn|0
7184741|NCT00750269|11385072|FG002|Overall Study|SBRT plan could not be drawn|0
7184742|NCT00750269|11385073|FG003|Overall Study|SBRT plan could not be drawn|0
7184743|NCT00750269|11385074|FG004|Overall Study|SBRT plan could not be drawn|1
7184744|NCT00750269|11385070|FG000|Overall Study|Fiducials could not be placed|0
7184745|NCT00750269|11385071|FG001|Overall Study|Fiducials could not be placed|0
7184746|NCT00750269|11385072|FG002|Overall Study|Fiducials could not be placed|0
7184747|NCT00750269|11385073|FG003|Overall Study|Fiducials could not be placed|0
7184748|NCT00750269|11385074|FG004|Overall Study|Fiducials could not be placed|1
7184749|NCT00712322|11385096|FG000|Overall Study|Protocol deviation|0
7184750|NCT00712322|11385097|FG001|Overall Study|Protocol deviation|1
7184751|NCT00712322|11385098|FG002|Overall Study|Protocol deviation|0
7184752|NCT00323856|11385106|FG000|Overall Study|Withdrawal by Subject|1
7184753|NCT00323856|11385106|FG000|Overall Study|Was uncooperative and noncompliant|1
7184754|NCT00323856|11385106|FG000|Overall Study|Reason not specified|1
7184755|NCT00323856|11385106|FG000|Overall Study|Missing|2
7167035|NCT03942042|11352574|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0
7167036|NCT03942042|11352575|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1
7167037|NCT03942042|11352574|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1
7167038|NCT03942042|11352575|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0
7167039|NCT03923530|11352594|FG000|Overall Study|Withdrawal by Subject|1
7167040|NCT03923530|11352594|FG000|Overall Study|screen failure|3
7167041|NCT03914417|11352598|FG000|Overall Study|Withdrawal by Subject|2
7167042|NCT03913377|11352604|FG000|Period 1|Test Article no longer available|0
7167043|NCT03913377|11352605|FG001|Period 1|Test Article no longer available|1
7167044|NCT03913377|11352606|FG002|Period 1|Test Article no longer available|0
7167045|NCT03913377|11352604|FG000|Period 1|No Longer Meets Eligibility Criteria|0
7167046|NCT03913377|11352605|FG001|Period 1|No Longer Meets Eligibility Criteria|0
7167047|NCT03913377|11352606|FG002|Period 1|No Longer Meets Eligibility Criteria|1
7167048|NCT03937778|11352617|FG000|Overall Study|Withdrawal by Subject|1
7167049|NCT03937778|11352617|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1
7167050|NCT03937479|11352626|FG000|Overall Study|Adverse Event|2
7167051|NCT03937479|11352627|FG001|Overall Study|Adverse Event|3
7167052|NCT03937479|11352628|FG002|Overall Study|Adverse Event|0
7167053|NCT03937479|11352629|FG003|Overall Study|Adverse Event|0
7167054|NCT03937479|11352630|FG004|Overall Study|Adverse Event|1
7167055|NCT03937479|11352626|FG000|Overall Study|Withdrawal by Subject|3
7167056|NCT03937479|11352627|FG001|Overall Study|Withdrawal by Subject|5
7167057|NCT03937479|11352628|FG002|Overall Study|Withdrawal by Subject|2
7167058|NCT03937479|11352629|FG003|Overall Study|Withdrawal by Subject|2
7167059|NCT03937479|11352630|FG004|Overall Study|Withdrawal by Subject|1
7167060|NCT03937479|11352626|FG000|Overall Study|Protocol Violation|5
7167061|NCT03937479|11352627|FG001|Overall Study|Protocol Violation|6
7167062|NCT03937479|11352628|FG002|Overall Study|Protocol Violation|4
7167063|NCT03937479|11352629|FG003|Overall Study|Protocol Violation|3
7167064|NCT03937479|11352630|FG004|Overall Study|Protocol Violation|2
7167065|NCT03937479|11352626|FG000|Overall Study|Lost to Follow-up|0
7167066|NCT03937479|11352627|FG001|Overall Study|Lost to Follow-up|1
7167067|NCT03937479|11352628|FG002|Overall Study|Lost to Follow-up|0
7167068|NCT03937479|11352629|FG003|Overall Study|Lost to Follow-up|1
7167069|NCT03937479|11352630|FG004|Overall Study|Lost to Follow-up|0
7167070|NCT03937479|11352626|FG000|Overall Study|Physician Decision|0
7167071|NCT03937479|11352627|FG001|Overall Study|Physician Decision|0
7167072|NCT03937479|11352628|FG002|Overall Study|Physician Decision|1
7167073|NCT03937479|11352629|FG003|Overall Study|Physician Decision|0
7167074|NCT03937479|11352630|FG004|Overall Study|Physician Decision|1
7167075|NCT03936244|11352666|FG000|Overall Study|Lost to Follow-up|5
7167076|NCT03936244|11352667|FG001|Overall Study|Lost to Follow-up|1
7167077|NCT03936244|11352666|FG000|Overall Study|Physician Decision|7
7167078|NCT03936244|11352667|FG001|Overall Study|Physician Decision|3
7167079|NCT03935126|11352674|FG000|Overall Study|Study termination by sponsor|3
7167080|NCT03933462|11352693|FG000|Overall Study|Adverse Event|2
7167081|NCT03933462|11352694|FG001|Overall Study|Adverse Event|0
7167082|NCT03931330|11352709|FG000|Overall Study|Physician Decision|1
7167083|NCT03931785|11352752|FG000|Overall Study|Lost to Follow-up|4
7167084|NCT03931785|11352753|FG001|Overall Study|Lost to Follow-up|1
7167085|NCT03931785|11352754|FG002|Overall Study|Lost to Follow-up|4
7167086|NCT03931785|11352755|FG003|Overall Study|Lost to Follow-up|3
7167087|NCT03931785|11352752|FG000|Overall Study|Adverse Event|1
7167088|NCT03931785|11352753|FG001|Overall Study|Adverse Event|0
7167089|NCT03931785|11352754|FG002|Overall Study|Adverse Event|3
7167090|NCT03931785|11352755|FG003|Overall Study|Adverse Event|4
7167091|NCT03931785|11352752|FG000|Overall Study|Protocol Violation|0
7167092|NCT03931785|11352753|FG001|Overall Study|Protocol Violation|1
7167093|NCT03931785|11352754|FG002|Overall Study|Protocol Violation|0
7167094|NCT03931785|11352755|FG003|Overall Study|Protocol Violation|0
7167095|NCT03931785|11352752|FG000|Overall Study|Noncompliance With Study drug|0
7167096|NCT03931785|11352753|FG001|Overall Study|Noncompliance With Study drug|1
7167097|NCT03931785|11352754|FG002|Overall Study|Noncompliance With Study drug|0
7167098|NCT03931785|11352755|FG003|Overall Study|Noncompliance With Study drug|0
7167099|NCT03931785|11352752|FG000|Overall Study|Other Not specified|0
7167100|NCT03931785|11352753|FG001|Overall Study|Other Not specified|2
7167101|NCT03931785|11352754|FG002|Overall Study|Other Not specified|2
7167102|NCT03931785|11352755|FG003|Overall Study|Other Not specified|2
7167103|NCT03931785|11352752|FG000|Overall Study|Withdrawal by Subject|0
7167104|NCT03931785|11352753|FG001|Overall Study|Withdrawal by Subject|2
7167105|NCT03931785|11352754|FG002|Overall Study|Withdrawal by Subject|4
7167106|NCT03931785|11352755|FG003|Overall Study|Withdrawal by Subject|1
7167107|NCT03931785|11352752|FG000|Overall Study|Pregnancy|0
7167108|NCT03931785|11352753|FG001|Overall Study|Pregnancy|0
7167109|NCT03931785|11352754|FG002|Overall Study|Pregnancy|0
7167110|NCT03931785|11352755|FG003|Overall Study|Pregnancy|1
7167111|NCT03927846|11352771|FG000|Overall Study|Lost to Follow-up|10
7167112|NCT03927846|11352772|FG001|Overall Study|Lost to Follow-up|11
7167113|NCT03927105|11352778|FG000|Overall Study|Death|1
7167114|NCT03927105|11352778|FG000|Overall Study|In observation for potential re-treatment|2
7167115|NCT03927105|11352778|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1
7167116|NCT03923933|11352784|FG000|Overall Study|Lost to Follow-up|1
7167117|NCT03923933|11352785|FG001|Overall Study|Lost to Follow-up|0
7167118|NCT03923933|11352784|FG000|Overall Study|Withdrawal by Subject|0
7167119|NCT03923933|11352785|FG001|Overall Study|Withdrawal by Subject|1
7167120|NCT03909295|11352791|FG000|Overall Study|Adverse Event|2
7167121|NCT03909295|11352791|FG000|Overall Study|Study terminated by sponsor|50
7167122|NCT03908970|11352797|FG000|Overall Study|Adverse Event|7
7167123|NCT03908970|11352798|FG001|Overall Study|Adverse Event|21
7167124|NCT03908970|11352797|FG000|Overall Study|Physician Decision|1
7167125|NCT03908970|11352798|FG001|Overall Study|Physician Decision|4
7167126|NCT03908970|11352797|FG000|Overall Study|Withdrawal by Subject|9
7167127|NCT03908970|11352798|FG001|Overall Study|Withdrawal by Subject|22
7167128|NCT03897179|11352804|FG000|Overall Study|Withdrawal by Subject|1
7167129|NCT03927950|11352868|FG000|Overall Study|Adverse Event|9
7167130|NCT03920670|11352890|FG000|Overall Study|Protocol Violation|2
7167131|NCT03920670|11352891|FG001|Overall Study|Protocol Violation|2
7167132|NCT03920670|11352890|FG000|Overall Study|Adverse Event|1
7167133|NCT03920670|11352891|FG001|Overall Study|Adverse Event|0
7167134|NCT03898063|11352912|FG000|Overall Study|Withdrawal by Subject|10
7167135|NCT03898063|11352913|FG001|Overall Study|Withdrawal by Subject|8
7167136|NCT03909100|11352959|FG000|Overall Study|Protocol Deviation|2
7167137|NCT03909100|11352959|FG000|Overall Study|Technical Problems|4
7167138|NCT03909100|11352959|FG000|Overall Study|Withdrawal by Subject|4
7167139|NCT03909100|11352959|FG000|Overall Study|Lost to Follow-up|1
7167140|NCT03909100|11352959|FG000|Overall Study|Reason not Specified|4
7167141|NCT03905642|11352966|FG000|Overall Study|Withdrawal by Subject|3
7167142|NCT03905642|11352966|FG000|Overall Study|Pregnancy|1
7167143|NCT03905642|11352966|FG000|Overall Study|Adverse Event|1
7167144|NCT03905642|11352966|FG000|Overall Study|Lack of Efficacy|1
7167145|NCT03905642|11352966|FG000|Overall Study|Completed study but not 24 of 28 days|2
7167146|NCT03892889|11352970|FG000|Overall Study|Adverse Event|17
7167147|NCT03892889|11352970|FG000|Overall Study|Lack of Efficacy|1
7167148|NCT03892889|11352970|FG000|Overall Study|Lost to Follow-up|46
7167149|NCT03892889|11352970|FG000|Overall Study|Non-compliance with study drug|22
7167150|NCT03892889|11352970|FG000|Overall Study|Pregnancy|1
7167151|NCT03892889|11352970|FG000|Overall Study|Protocol Deviation|3
7167152|NCT03892889|11352970|FG000|Overall Study|Withdrawal by Subject|50
7167153|NCT03892889|11352970|FG000|Overall Study|Withdrawal by Caregiver|1
7167154|NCT03892889|11352970|FG000|Overall Study|Study Terminated by Sponsor|50
7167155|NCT03892889|11352970|FG000|Overall Study|Physician Decision|8
7167156|NCT03892889|11352970|FG000|Overall Study|Reason not Specified|5
7167157|NCT03921723|11352974|FG000|Period 2 (4 Days)|Withdrawal by Subject|3
7167158|NCT03921723|11352974|FG000|Period 3 (4 Days)|Withdrawal by Subject|1
7167159|NCT03918239|11353018|FG000|Overall Study|Lost to Follow-up|3
7167160|NCT03918239|11353019|FG001|Overall Study|Lost to Follow-up|1
7167161|NCT03918239|11353018|FG000|Overall Study|Pregnancy|0
7167162|NCT03918239|11353019|FG001|Overall Study|Pregnancy|2
7167163|NCT03918239|11353018|FG000|Overall Study|Withdrawal by Subject|3
7167164|NCT03918239|11353019|FG001|Overall Study|Withdrawal by Subject|3
7167165|NCT03918239|11353018|FG000|Overall Study|positive urine drug screening results|4
7167166|NCT03918239|11353019|FG001|Overall Study|positive urine drug screening results|1
7167167|NCT03917823|11353027|FG000|Overall Study|Lost to Follow-up|1
7167168|NCT03917823|11353028|FG001|Overall Study|Lost to Follow-up|1
7167169|NCT03917823|11353027|FG000|Overall Study|Withdrawal by Subject|0
7167170|NCT03917823|11353028|FG001|Overall Study|Withdrawal by Subject|1
7167171|NCT03902613|11353049|FG000|Overall Study|Physician Decision|1
7167172|NCT03902574|11353056|FG000|Overall Study|Urinary drug test was positive on Day 20|0
7167173|NCT03902574|11353057|FG001|Overall Study|Urinary drug test was positive on Day 20|0
7167174|NCT03902574|11353058|FG002|Overall Study|Urinary drug test was positive on Day 20|1
7167175|NCT03914950|11353066|FG000|Overall Study|Physician Decision|54
7167176|NCT03911843|11353078|FG000|Overall Study|Adverse Event|2
7167177|NCT03911843|11353079|FG001|Overall Study|Adverse Event|0
7167178|NCT03911843|11353078|FG000|Overall Study|Protocol Violation|2
7167179|NCT03911843|11353079|FG001|Overall Study|Protocol Violation|0
7167180|NCT03911843|11353078|FG000|Overall Study|Lost to Follow-up|0
7167181|NCT03911843|11353079|FG001|Overall Study|Lost to Follow-up|1
7167182|NCT03894813|11353096|FG000|Overall Study|Adverse Event|1
7167183|NCT03894813|11353097|FG001|Overall Study|Adverse Event|1
7167184|NCT03894813|11353096|FG000|Overall Study|Lack of Efficacy|3
7167185|NCT03894813|11353097|FG001|Overall Study|Lack of Efficacy|3
7167186|NCT03894813|11353096|FG000|Overall Study|Lost to Follow-up|1
7167187|NCT03894813|11353097|FG001|Overall Study|Lost to Follow-up|0
7167188|NCT03894813|11353096|FG000|Overall Study|Pregnancy|2
7167189|NCT03894813|11353097|FG001|Overall Study|Pregnancy|1
7167190|NCT03894813|11353096|FG000|Overall Study|Protocol Violation|3
7167191|NCT03894813|11353097|FG001|Overall Study|Protocol Violation|7
7167192|NCT03894813|11353096|FG000|Overall Study|Withdrawal by Subject|1
7167193|NCT03894813|11353097|FG001|Overall Study|Withdrawal by Subject|3
7167194|NCT03894813|11353096|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0
7167195|NCT03894813|11353097|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1
7167196|NCT03911960|11353105|FG000|Overall Study|Lost to Follow-up|5
7167197|NCT03911960|11353106|FG001|Overall Study|Lost to Follow-up|3
7167198|NCT03907072|11353116|FG000|Overall Study|Study Terminated by Sponsor|2
7167199|NCT03907072|11353117|FG001|Overall Study|Study Terminated by Sponsor|2
7167200|NCT03907072|11353118|FG002|Overall Study|Study Terminated by Sponsor|2
7167201|NCT03911401|11353138|FG000|Overall Study|Adverse Event|1
7167202|NCT03911401|11353139|FG001|Overall Study|Adverse Event|2
7167203|NCT03911401|11353140|FG002|Overall Study|Adverse Event|5
7167204|NCT03911401|11353138|FG000|Overall Study|Lack of Efficacy|1
7167205|NCT03911401|11353139|FG001|Overall Study|Lack of Efficacy|1
7167206|NCT03911401|11353140|FG002|Overall Study|Lack of Efficacy|8
7167207|NCT03911401|11353138|FG000|Overall Study|Physician Decision|0
7167208|NCT03911401|11353139|FG001|Overall Study|Physician Decision|0
7167209|NCT03911401|11353140|FG002|Overall Study|Physician Decision|1
7167210|NCT03911401|11353138|FG000|Overall Study|Withdrawal by Subject|1
7167211|NCT03911401|11353139|FG001|Overall Study|Withdrawal by Subject|2
7167212|NCT03911401|11353140|FG002|Overall Study|Withdrawal by Subject|0
7167213|NCT03911401|11353138|FG000|Overall Study|Withdrawal by parent/guardian|4
7167214|NCT03911401|11353139|FG001|Overall Study|Withdrawal by parent/guardian|4
7167215|NCT03911401|11353140|FG002|Overall Study|Withdrawal by parent/guardian|11
7167216|NCT03904420|11353167|FG000|Overall Study|Study terminated|2
7167217|NCT03904420|11353168|FG001|Overall Study|Study terminated|2
7167218|NCT03903822|11353182|FG000|Treatment Phase (6 Weeks)|Adverse Event|3
7167219|NCT03903822|11353183|FG001|Treatment Phase (6 Weeks)|Adverse Event|3
7167220|NCT03903822|11353184|FG002|Treatment Phase (6 Weeks)|Adverse Event|1
7167221|NCT03903822|11353185|FG003|Treatment Phase (6 Weeks)|Adverse Event|1
7167222|NCT03903822|11353186|FG004|Treatment Phase (6 Weeks)|Adverse Event|1
7167223|NCT03903822|11353187|FG005|Treatment Phase (6 Weeks)|Adverse Event|6
7167224|NCT03903822|11353188|FG006|Treatment Phase (6 Weeks)|Adverse Event|1
7167225|NCT03903822|11353189|FG007|Treatment Phase (6 Weeks)|Adverse Event|0
7167226|NCT03903822|11353182|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0
7167227|NCT03903822|11353183|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0
7167228|NCT03903822|11353184|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0
7167229|NCT03903822|11353185|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0
7167230|NCT03903822|11353186|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1
7167231|NCT03903822|11353187|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1
7167232|NCT03903822|11353188|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0
7167233|NCT03903822|11353189|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0
7167234|NCT03903822|11353182|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0
7167235|NCT03903822|11353183|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0
7167236|NCT03903822|11353184|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0
7167237|NCT03903822|11353185|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0
7167238|NCT03903822|11353186|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0
7167239|NCT03903822|11353187|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0
7167240|NCT03903822|11353188|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1
7167241|NCT03903822|11353189|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1
7167242|NCT03903822|11353182|FG000|Treatment Phase (6 Weeks)|Physician Decision|0
7167243|NCT03903822|11353183|FG001|Treatment Phase (6 Weeks)|Physician Decision|2
7167244|NCT03903822|11353184|FG002|Treatment Phase (6 Weeks)|Physician Decision|0
7167245|NCT03903822|11353185|FG003|Treatment Phase (6 Weeks)|Physician Decision|0
7167246|NCT03903822|11353186|FG004|Treatment Phase (6 Weeks)|Physician Decision|0
7167247|NCT03903822|11353187|FG005|Treatment Phase (6 Weeks)|Physician Decision|0
7167248|NCT03903822|11353188|FG006|Treatment Phase (6 Weeks)|Physician Decision|0
7167249|NCT03903822|11353189|FG007|Treatment Phase (6 Weeks)|Physician Decision|0
7167250|NCT03903822|11353182|FG000|Treatment Phase (6 Weeks)|Pregnancy|0
7167251|NCT03903822|11353183|FG001|Treatment Phase (6 Weeks)|Pregnancy|0
7167252|NCT03903822|11353184|FG002|Treatment Phase (6 Weeks)|Pregnancy|0
7167253|NCT03903822|11353185|FG003|Treatment Phase (6 Weeks)|Pregnancy|1
7167254|NCT03903822|11353186|FG004|Treatment Phase (6 Weeks)|Pregnancy|1
7167255|NCT03903822|11353187|FG005|Treatment Phase (6 Weeks)|Pregnancy|0
7167256|NCT03903822|11353188|FG006|Treatment Phase (6 Weeks)|Pregnancy|0
7167257|NCT03903822|11353189|FG007|Treatment Phase (6 Weeks)|Pregnancy|0
7167258|NCT03903822|11353182|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0
7167259|NCT03903822|11353183|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0
7167260|NCT03903822|11353184|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0
7167261|NCT03903822|11353185|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1
7167262|NCT03903822|11353186|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0
7167263|NCT03903822|11353187|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0
7167264|NCT03903822|11353188|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0
7167265|NCT03903822|11353189|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0
7167266|NCT03903822|11353182|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2
7167267|NCT03903822|11353183|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4
7167268|NCT03903822|11353184|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2
7167269|NCT03903822|11353185|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2
7167270|NCT03903822|11353186|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1
7167271|NCT03903822|11353187|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2
7167272|NCT03903822|11353188|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3
7167273|NCT03903822|11353189|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3
7167274|NCT03903822|11353182|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2
7167275|NCT03903822|11353183|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0
7167276|NCT03903822|11353184|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0
7167277|NCT03903822|11353185|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0
7167278|NCT03903822|11353186|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0
7167279|NCT03903822|11353187|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1
7167280|NCT03903822|11353188|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0
7167281|NCT03903822|11353189|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0
7167282|NCT03903822|11353182|FG000|Treatment Phase (6 Weeks)|Other|2
7167283|NCT03903822|11353183|FG001|Treatment Phase (6 Weeks)|Other|1
7167284|NCT03903822|11353184|FG002|Treatment Phase (6 Weeks)|Other|0
7167285|NCT03903822|11353185|FG003|Treatment Phase (6 Weeks)|Other|0
7167286|NCT03903822|11353186|FG004|Treatment Phase (6 Weeks)|Other|1
7167287|NCT03903822|11353187|FG005|Treatment Phase (6 Weeks)|Other|1
7167288|NCT03903822|11353188|FG006|Treatment Phase (6 Weeks)|Other|0
7167289|NCT03903822|11353189|FG007|Treatment Phase (6 Weeks)|Other|0
7167290|NCT03903822|11353182|FG000|Follow up Phase (4 Weeks)|Adverse Event|3
7167291|NCT03903822|11353183|FG001|Follow up Phase (4 Weeks)|Adverse Event|2
7167292|NCT03903822|11353184|FG002|Follow up Phase (4 Weeks)|Adverse Event|1
7167293|NCT03903822|11353185|FG003|Follow up Phase (4 Weeks)|Adverse Event|1
7167294|NCT03903822|11353186|FG004|Follow up Phase (4 Weeks)|Adverse Event|0
7167295|NCT03903822|11353187|FG005|Follow up Phase (4 Weeks)|Adverse Event|5
7167296|NCT03903822|11353188|FG006|Follow up Phase (4 Weeks)|Adverse Event|1
7167297|NCT03903822|11353189|FG007|Follow up Phase (4 Weeks)|Adverse Event|0
7167298|NCT03903822|11353182|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0
7167299|NCT03903822|11353183|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0
7167300|NCT03903822|11353184|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0
7167301|NCT03903822|11353185|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0
7167302|NCT03903822|11353186|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1
7167303|NCT03903822|11353187|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0
7167304|NCT03903822|11353188|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0
7167305|NCT03903822|11353189|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0
7167306|NCT03903822|11353182|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2
7167307|NCT03903822|11353183|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0
7167308|NCT03903822|11353184|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0
7167309|NCT03903822|11353185|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0
7167310|NCT03903822|11353186|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0
7167311|NCT03903822|11353187|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0
7167312|NCT03903822|11353188|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1
7167313|NCT03903822|11353189|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3
7167314|NCT03903822|11353182|FG000|Follow up Phase (4 Weeks)|Pregnancy|0
7167315|NCT03903822|11353183|FG001|Follow up Phase (4 Weeks)|Pregnancy|0
7167316|NCT03903822|11353184|FG002|Follow up Phase (4 Weeks)|Pregnancy|0
7167317|NCT03903822|11353185|FG003|Follow up Phase (4 Weeks)|Pregnancy|1
7167318|NCT03903822|11353186|FG004|Follow up Phase (4 Weeks)|Pregnancy|1
7167319|NCT03903822|11353187|FG005|Follow up Phase (4 Weeks)|Pregnancy|0
7167320|NCT03903822|11353188|FG006|Follow up Phase (4 Weeks)|Pregnancy|0
7167321|NCT03903822|11353189|FG007|Follow up Phase (4 Weeks)|Pregnancy|0
7167322|NCT03903822|11353182|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2
7167323|NCT03903822|11353183|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5
7167324|NCT03903822|11353184|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3
7167325|NCT03903822|11353185|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2
7167326|NCT03903822|11353186|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2
7167327|NCT03903822|11353187|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2
7167328|NCT03903822|11353188|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3
7167329|NCT03903822|11353189|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3
7167330|NCT03903822|11353182|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
7167331|NCT03903822|11353183|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
7167332|NCT03903822|11353184|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
7167333|NCT03903822|11353185|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
7167334|NCT03903822|11353186|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
7167335|NCT03903822|11353187|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1
7167336|NCT03903822|11353188|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
7167337|NCT03903822|11353189|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
7167338|NCT03903822|11353182|FG000|Follow up Phase (4 Weeks)|Other|1
7167339|NCT03903822|11353183|FG001|Follow up Phase (4 Weeks)|Other|1
7167340|NCT03903822|11353184|FG002|Follow up Phase (4 Weeks)|Other|0
7167341|NCT03903822|11353185|FG003|Follow up Phase (4 Weeks)|Other|0
7167342|NCT03903822|11353186|FG004|Follow up Phase (4 Weeks)|Other|0
7167343|NCT03903822|11353187|FG005|Follow up Phase (4 Weeks)|Other|0
7167344|NCT03903822|11353188|FG006|Follow up Phase (4 Weeks)|Other|0
7167345|NCT03903822|11353189|FG007|Follow up Phase (4 Weeks)|Other|0
7167346|NCT03905096|11353209|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1
7167347|NCT03905096|11353210|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0
7167348|NCT03899064|11353223|FG000|Overall Study|Lost to Follow-up|1
7167349|NCT03899064|11353223|FG000|Overall Study|Protocol Violation|2
7167350|NCT03899064|11353223|FG000|Overall Study|Withdrawal by Subject|2
7167351|NCT03899064|11353223|FG000|Overall Study|Other|2
7167352|NCT03903159|11353227|FG000|Overall Study|Discharged with Staff Approval|2
7167353|NCT03903159|11353227|FG000|Overall Study|Discharged at Staff Request|2
7167354|NCT03903159|11353227|FG000|Overall Study|Discharged Against Staff Advice|1
7167355|NCT03902392|11353233|FG000|Overall Study|Lost to Follow-up|7
7167356|NCT03902392|11353234|FG001|Overall Study|Lost to Follow-up|7
7167357|NCT03900728|11353290|FG000|Overall Study|No text responses|0
7167358|NCT03900728|11353291|FG001|Overall Study|No text responses|0
7167359|NCT03900728|11353292|FG002|Overall Study|No text responses|4
7167360|NCT03895372|11353331|FG000|Investigational Treatment Period|Adverse Event|1
7167361|NCT03895372|11353332|FG001|Investigational Treatment Period|Adverse Event|0
7167362|NCT03895372|11353333|FG002|Investigational Treatment Period|Adverse Event|0
7167363|NCT03895372|11353334|FG003|Investigational Treatment Period|Adverse Event|0
7167364|NCT03895372|11353335|FG004|Investigational Treatment Period|Adverse Event|0
7167365|NCT03895372|11353336|FG005|Investigational Treatment Period|Adverse Event|0
7167366|NCT03895372|11353337|FG006|Investigational Treatment Period|Adverse Event|4
7167367|NCT03895372|11353338|FG007|Investigational Treatment Period|Adverse Event|3
7167368|NCT03895372|11353331|FG000|Investigational Treatment Period|Lack of Efficacy|1
7167369|NCT03895372|11353332|FG001|Investigational Treatment Period|Lack of Efficacy|0
7167370|NCT03895372|11353333|FG002|Investigational Treatment Period|Lack of Efficacy|0
7167371|NCT03895372|11353334|FG003|Investigational Treatment Period|Lack of Efficacy|0
7167372|NCT03895372|11353335|FG004|Investigational Treatment Period|Lack of Efficacy|0
7167373|NCT03895372|11353336|FG005|Investigational Treatment Period|Lack of Efficacy|0
7167374|NCT03895372|11353337|FG006|Investigational Treatment Period|Lack of Efficacy|0
7167375|NCT03895372|11353338|FG007|Investigational Treatment Period|Lack of Efficacy|0
7167376|NCT03895372|11353331|FG000|Investigational Treatment Period|Lost to Follow-up|0
7167377|NCT03895372|11353332|FG001|Investigational Treatment Period|Lost to Follow-up|0
7167378|NCT03895372|11353333|FG002|Investigational Treatment Period|Lost to Follow-up|0
7167379|NCT03895372|11353334|FG003|Investigational Treatment Period|Lost to Follow-up|0
7167380|NCT03895372|11353335|FG004|Investigational Treatment Period|Lost to Follow-up|0
7167381|NCT03895372|11353336|FG005|Investigational Treatment Period|Lost to Follow-up|0
7167382|NCT03895372|11353337|FG006|Investigational Treatment Period|Lost to Follow-up|1
7167383|NCT03895372|11353338|FG007|Investigational Treatment Period|Lost to Follow-up|0
7167384|NCT03895372|11353331|FG000|Investigational Treatment Period|Other|0
7167385|NCT03895372|11353332|FG001|Investigational Treatment Period|Other|0
7167386|NCT03895372|11353333|FG002|Investigational Treatment Period|Other|0
7167387|NCT03895372|11353334|FG003|Investigational Treatment Period|Other|0
7167388|NCT03895372|11353335|FG004|Investigational Treatment Period|Other|0
7167389|NCT03895372|11353336|FG005|Investigational Treatment Period|Other|1
7167390|NCT03895372|11353337|FG006|Investigational Treatment Period|Other|0
7167391|NCT03895372|11353338|FG007|Investigational Treatment Period|Other|2
7167392|NCT03895372|11353331|FG000|Investigational Treatment Period|Protocol Violation|0
7167393|NCT03895372|11353332|FG001|Investigational Treatment Period|Protocol Violation|0
7167394|NCT03895372|11353333|FG002|Investigational Treatment Period|Protocol Violation|0
7167395|NCT03895372|11353334|FG003|Investigational Treatment Period|Protocol Violation|1
7167396|NCT03895372|11353335|FG004|Investigational Treatment Period|Protocol Violation|0
7167397|NCT03895372|11353336|FG005|Investigational Treatment Period|Protocol Violation|0
7167398|NCT03895372|11353337|FG006|Investigational Treatment Period|Protocol Violation|0
7167399|NCT03895372|11353338|FG007|Investigational Treatment Period|Protocol Violation|0
7167400|NCT03895372|11353331|FG000|Investigational Treatment Period|Withdrawal by Subject|2
7167401|NCT03895372|11353332|FG001|Investigational Treatment Period|Withdrawal by Subject|3
7167402|NCT03895372|11353333|FG002|Investigational Treatment Period|Withdrawal by Subject|1
7167403|NCT03895372|11353334|FG003|Investigational Treatment Period|Withdrawal by Subject|1
7167404|NCT03895372|11353335|FG004|Investigational Treatment Period|Withdrawal by Subject|0
7167405|NCT03895372|11353336|FG005|Investigational Treatment Period|Withdrawal by Subject|1
7167406|NCT03895372|11353337|FG006|Investigational Treatment Period|Withdrawal by Subject|3
7167407|NCT03895372|11353338|FG007|Investigational Treatment Period|Withdrawal by Subject|0
7167408|NCT03895372|11353331|FG000|Extension Treatment Period|Adverse Event|0
7167409|NCT03895372|11353332|FG001|Extension Treatment Period|Adverse Event|1
7167410|NCT03895372|11353333|FG002|Extension Treatment Period|Adverse Event|0
7167411|NCT03895372|11353334|FG003|Extension Treatment Period|Adverse Event|1
7167412|NCT03895372|11353335|FG004|Extension Treatment Period|Adverse Event|0
7167413|NCT03895372|11353336|FG005|Extension Treatment Period|Adverse Event|0
7167414|NCT03895372|11353337|FG006|Extension Treatment Period|Adverse Event|3
7167415|NCT03895372|11353338|FG007|Extension Treatment Period|Adverse Event|3
7167416|NCT03895372|11353331|FG000|Extension Treatment Period|Other|1
7167417|NCT03895372|11353332|FG001|Extension Treatment Period|Other|3
7167418|NCT03895372|11353333|FG002|Extension Treatment Period|Other|0
7167419|NCT03895372|11353334|FG003|Extension Treatment Period|Other|0
7167420|NCT03895372|11353335|FG004|Extension Treatment Period|Other|1
7167421|NCT03895372|11353336|FG005|Extension Treatment Period|Other|0
7167422|NCT03895372|11353337|FG006|Extension Treatment Period|Other|0
7167423|NCT03895372|11353338|FG007|Extension Treatment Period|Other|2
7167424|NCT03895372|11353331|FG000|Extension Treatment Period|Pregnancy|0
7167425|NCT03895372|11353332|FG001|Extension Treatment Period|Pregnancy|0
7167426|NCT03895372|11353333|FG002|Extension Treatment Period|Pregnancy|0
7167427|NCT03895372|11353334|FG003|Extension Treatment Period|Pregnancy|0
7167428|NCT03895372|11353335|FG004|Extension Treatment Period|Pregnancy|1
7167429|NCT03895372|11353336|FG005|Extension Treatment Period|Pregnancy|0
7167430|NCT03895372|11353337|FG006|Extension Treatment Period|Pregnancy|0
7167431|NCT03895372|11353338|FG007|Extension Treatment Period|Pregnancy|0
7167432|NCT03895372|11353331|FG000|Extension Treatment Period|Withdrawal by Subject|2
7167433|NCT03895372|11353332|FG001|Extension Treatment Period|Withdrawal by Subject|1
7167434|NCT03895372|11353333|FG002|Extension Treatment Period|Withdrawal by Subject|0
7167435|NCT03895372|11353334|FG003|Extension Treatment Period|Withdrawal by Subject|0
7167436|NCT03895372|11353335|FG004|Extension Treatment Period|Withdrawal by Subject|1
7167437|NCT03895372|11353336|FG005|Extension Treatment Period|Withdrawal by Subject|1
7167438|NCT03895372|11353337|FG006|Extension Treatment Period|Withdrawal by Subject|1
7167439|NCT03895372|11353338|FG007|Extension Treatment Period|Withdrawal by Subject|1
7167440|NCT03896022|11353364|FG000|Overall Study|Withdrawal by Subject|1
7167441|NCT03896022|11353365|FG001|Overall Study|Withdrawal by Subject|0
7167442|NCT03896022|11353366|FG002|Overall Study|Withdrawal by Subject|0
7167443|NCT03896022|11353364|FG000|Overall Study|Did not have procedure|3
7167444|NCT03896022|11353365|FG001|Overall Study|Did not have procedure|0
7167445|NCT03896022|11353366|FG002|Overall Study|Did not have procedure|0
7167446|NCT03891862|11353378|FG000|Open-label Period|Adverse Event|2
7167447|NCT03891862|11353379|FG001|Open-label Period|Adverse Event|0
7167448|NCT03891862|11353380|FG002|Open-label Period|Adverse Event|0
7167449|NCT03891862|11353378|FG000|Open-label Period|Protocol Violation|5
7167450|NCT03891862|11353379|FG001|Open-label Period|Protocol Violation|0
7167451|NCT03891862|11353380|FG002|Open-label Period|Protocol Violation|0
7167452|NCT03891862|11353378|FG000|Open-label Period|Withdrawal by Subject|6
7167453|NCT03891862|11353379|FG001|Open-label Period|Withdrawal by Subject|0
7167454|NCT03891862|11353380|FG002|Open-label Period|Withdrawal by Subject|0
7167455|NCT03891862|11353378|FG000|Open-label Period|Death|1
7167456|NCT03891862|11353379|FG001|Open-label Period|Death|0
7167457|NCT03891862|11353380|FG002|Open-label Period|Death|0
7167458|NCT03891862|11353378|FG000|Open-label Period|Lost to Follow-up|2
7167459|NCT03891862|11353379|FG001|Open-label Period|Lost to Follow-up|0
7167460|NCT03891862|11353380|FG002|Open-label Period|Lost to Follow-up|0
7167461|NCT03891862|11353378|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0
7167462|NCT03891862|11353379|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1
7167463|NCT03891862|11353380|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1
7167464|NCT03891862|11353378|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0
7167465|NCT03891862|11353379|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2
7167466|NCT03891862|11353380|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1
7167467|NCT03891862|11353378|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0
7167468|NCT03891862|11353379|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1
7167469|NCT03891862|11353380|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2
7167470|NCT03891862|11353378|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0
7167471|NCT03891862|11353379|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2
7167472|NCT03891862|11353380|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0
7167473|NCT03892564|11353408|FG000|Overall Study|Withdrawal by Subject|2
7167474|NCT03892707|11353415|FG000|Overall Study|Screen failure|6
7167475|NCT03892707|11353416|FG001|Overall Study|Screen failure|0
7167476|NCT03892707|11353415|FG000|Overall Study|Pain resolution|0
7167477|NCT03892707|11353416|FG001|Overall Study|Pain resolution|4
7167478|NCT03892707|11353415|FG000|Overall Study|Withdrawal by Subject|0
7167479|NCT03892707|11353416|FG001|Overall Study|Withdrawal by Subject|1
7167480|NCT03892707|11353415|FG000|Overall Study|Other (long business trip)|0
7167481|NCT03892707|11353416|FG001|Overall Study|Other (long business trip)|1
7167482|NCT03891641|11353435|FG000|Overall Study|Study Stoppage Due to COVID-19|2
7167483|NCT03891641|11353436|FG001|Overall Study|Study Stoppage Due to COVID-19|2
7167484|NCT03889704|11353442|FG000|Overall Study|Study terminated due to pandemic|1
7167485|NCT03888391|11353456|FG000|Overall Study|Lost to Follow-up|15
7167486|NCT03888482|11353462|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0
7167487|NCT03888482|11353463|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1
7167488|NCT03888482|11353462|FG000|Second Wear (8 -1/+2 Days)|Other|1
7167489|NCT03888482|11353463|FG001|Second Wear (8 -1/+2 Days)|Other|0
7167490|NCT03887442|11353498|FG000|Overall Study|Adverse Event|1
7167491|NCT03887442|11353499|FG001|Overall Study|Adverse Event|0
7167492|NCT03878602|11353523|FG000|Overall Study|cord blood donation|7
7167493|NCT03878602|11353524|FG001|Overall Study|cord blood donation|1
7167494|NCT03878602|11353523|FG000|Overall Study|incomplete data collection|2
7167495|NCT03878602|11353524|FG001|Overall Study|incomplete data collection|0
7167496|NCT03875118|11353534|FG000|Overall Study|Withdrawal by Subject|4
7167497|NCT03875118|11353535|FG001|Overall Study|Withdrawal by Subject|4
7167498|NCT03873987|11353543|FG000|Overall Study|Adverse Event|1
7167499|NCT03873987|11353544|FG001|Overall Study|Adverse Event|0
7167500|NCT03873987|11353543|FG000|Overall Study|staff was unable to start a new IV line|1
7167501|NCT03873987|11353544|FG001|Overall Study|staff was unable to start a new IV line|0
7080506|NCT02122770|11189964|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
7167502|NCT03873987|11353543|FG000|Overall Study|Lost to Follow-up|0
7167503|NCT03873987|11353544|FG001|Overall Study|Lost to Follow-up|1
7184756|NCT00103038|11385110|FG000|Overall Study|Withdrawal by Subject|8
7184757|NCT00103038|11385110|FG000|Overall Study|Screen failure|3
7184758|NCT00103038|11385110|FG000|Overall Study|Death|1
7184759|NCT00103038|11385110|FG000|Overall Study|Physician Decision|1
7187592|NCT02587598|11388297|FG009|Overall Study|Study Terminated by the Sponsor|1
7187593|NCT02587598|11388298|FG010|Overall Study|Study Terminated by the Sponsor|6
7187594|NCT02587598|11388288|FG000|Overall Study|Reason for study withdrawal not specified|0
7167504|NCT03878758|11353570|FG000|Overall Study|Withdrawal by Subject|1
7167505|NCT03878758|11353570|FG000|Overall Study|Protocol defined|2
7167506|NCT03878758|11353570|FG000|Overall Study|Improper consent documentation|1
7167507|NCT03849300|11353587|FG000|Overall Study|move out to different area|1
7167508|NCT03849300|11353588|FG001|Overall Study|move out to different area|3
7167509|NCT03849300|11353589|FG002|Overall Study|move out to different area|1
7167510|NCT03849300|11353590|FG003|Overall Study|move out to different area|4
7167511|NCT03849300|11353587|FG000|Overall Study|scheduling/transportation conflict|4
7167512|NCT03849300|11353588|FG001|Overall Study|scheduling/transportation conflict|4
7167513|NCT03849300|11353589|FG002|Overall Study|scheduling/transportation conflict|3
7167514|NCT03849300|11353590|FG003|Overall Study|scheduling/transportation conflict|2
7167515|NCT03883113|11353632|FG000|Overall Study|Physician Decision|4
7167516|NCT03883113|11353633|FG001|Overall Study|Physician Decision|2
7167517|NCT03883113|11353632|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9
7167518|NCT03883113|11353633|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7
7167519|NCT03883113|11353632|FG000|Overall Study|Pregnancy|1
7167520|NCT03883113|11353633|FG001|Overall Study|Pregnancy|0
7167521|NCT03883113|11353632|FG000|Overall Study|Adverse Event|0
7167522|NCT03883113|11353633|FG001|Overall Study|Adverse Event|1
7167523|NCT03883113|11353632|FG000|Overall Study|Withdrawal by Subject|1
7167524|NCT03883113|11353633|FG001|Overall Study|Withdrawal by Subject|2
7167525|NCT03883113|11353632|FG000|Overall Study|Lost to Follow-up|1
7167526|NCT03883113|11353633|FG001|Overall Study|Lost to Follow-up|0
7167527|NCT03880227|11353655|FG000|First Visit|Withdrawal by Subject|1
7167528|NCT03880227|11353656|FG001|First Visit|Withdrawal by Subject|0
7167529|NCT03880227|11353657|FG002|First Visit|Withdrawal by Subject|0
7167530|NCT03880227|11353658|FG003|First Visit|Withdrawal by Subject|0
7167531|NCT03880227|11353655|FG000|1 Week Washout/ Delay|Lost to Follow-up|0
7167532|NCT03880227|11353656|FG001|1 Week Washout/ Delay|Lost to Follow-up|1
7167533|NCT03880227|11353657|FG002|1 Week Washout/ Delay|Lost to Follow-up|0
7167534|NCT03880227|11353658|FG003|1 Week Washout/ Delay|Lost to Follow-up|0
7167535|NCT03880227|11353655|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0
7167536|NCT03880227|11353656|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0
7167537|NCT03880227|11353657|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2
7167538|NCT03880227|11353658|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0
7167539|NCT03880227|11353655|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0
7167540|NCT03880227|11353656|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0
7167541|NCT03880227|11353657|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1
7167542|NCT03880227|11353658|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0
7167543|NCT03876743|11353672|FG000|Overall Study|Lost to Follow-up|6
7167544|NCT03876743|11353673|FG001|Overall Study|Lost to Follow-up|4
7167545|NCT03876743|11353674|FG002|Overall Study|Lost to Follow-up|4
7167546|NCT03876743|11353675|FG003|Overall Study|Lost to Follow-up|7
7167547|NCT03885934|11353695|FG000|Overall Study|Withdrawn by Parent/Guardian|1
7167548|NCT03885934|11353696|FG001|Overall Study|Withdrawn by Parent/Guardian|0
7167549|NCT03885934|11353697|FG002|Overall Study|Withdrawn by Parent/Guardian|0
7167550|NCT03885934|11353698|FG003|Overall Study|Withdrawn by Parent/Guardian|0
7167551|NCT03885934|11353699|FG004|Overall Study|Withdrawn by Parent/Guardian|0
7167552|NCT03885934|11353700|FG005|Overall Study|Withdrawn by Parent/Guardian|0
7167553|NCT03885726|11353714|FG000|Overall Study|Staffing issues/lost interest|1
7167554|NCT03885726|11353714|FG000|Overall Study|Early discharge from hospital|3
7167555|NCT03883386|11353739|FG000|First Assignment|Lost to Follow-up|1
7167556|NCT03883386|11353740|FG001|First Assignment|Lost to Follow-up|0
7167557|NCT03883386|11353739|FG000|First Assignment|Withdrawal by Subject|1
7167558|NCT03883386|11353740|FG001|First Assignment|Withdrawal by Subject|1
7167559|NCT03882801|11353752|FG000|Period 1|Adverse Event|0
7167560|NCT03882801|11353753|FG001|Period 1|Adverse Event|1
7167561|NCT03882801|11353752|FG000|Period 1|Non-compliance with study drug|1
7167562|NCT03882801|11353753|FG001|Period 1|Non-compliance with study drug|1
7167563|NCT03882801|11353752|FG000|Period 1|Never treated with study drug|1
7167564|NCT03882801|11353753|FG001|Period 1|Never treated with study drug|0
7167565|NCT03882801|11353752|FG000|Washout Period|Physician Decision|0
7167566|NCT03882801|11353753|FG001|Washout Period|Physician Decision|1
7167567|NCT03882801|11353752|FG000|Period 2|Non-compliance with study drug|0
7167568|NCT03882801|11353753|FG001|Period 2|Non-compliance with study drug|1
7167569|NCT03882424|11353764|FG000|Overall Study|Lost to Follow-up|3
7167570|NCT03882424|11353765|FG001|Overall Study|Lost to Follow-up|0
7167571|NCT03882424|11353766|FG002|Overall Study|Lost to Follow-up|0
7167572|NCT03882424|11353764|FG000|Overall Study|schedule conflict|1
7167573|NCT03882424|11353765|FG001|Overall Study|schedule conflict|0
7167574|NCT03882424|11353766|FG002|Overall Study|schedule conflict|0
7167575|NCT03880266|11353799|FG000|Overall Study|Withdrawal by Subject|0
7167576|NCT03880266|11353800|FG001|Overall Study|Withdrawal by Subject|1
7167577|NCT03880266|11353801|FG002|Overall Study|Withdrawal by Subject|1
7167578|NCT03880266|11353802|FG003|Overall Study|Withdrawal by Subject|0
7167579|NCT03880266|11353803|FG004|Overall Study|Withdrawal by Subject|0
7167580|NCT03880266|11353804|FG005|Overall Study|Withdrawal by Subject|0
7167581|NCT03880266|11353805|FG006|Overall Study|Withdrawal by Subject|0
7167582|NCT03880266|11353806|FG007|Overall Study|Withdrawal by Subject|0
7167583|NCT03878160|11353849|FG000|Overall Study|Lost to Follow-up|1
7167584|NCT03878160|11353850|FG001|Overall Study|Lost to Follow-up|1
7167585|NCT03878160|11353851|FG002|Overall Study|Lost to Follow-up|1
7167586|NCT03878160|11353849|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1
7167587|NCT03878160|11353850|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0
7167588|NCT03878160|11353851|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0
7167589|NCT03864627|11353861|FG000|Overall Study|Adverse Event|0
7167590|NCT03864627|11353862|FG001|Overall Study|Adverse Event|1
7167591|NCT03864627|11353861|FG000|Overall Study|Lack of Efficacy|0
7167592|NCT03864627|11353862|FG001|Overall Study|Lack of Efficacy|1
7167593|NCT03864627|11353861|FG000|Overall Study|Lost to Follow-up|0
7167594|NCT03864627|11353862|FG001|Overall Study|Lost to Follow-up|1
7167595|NCT03864627|11353861|FG000|Overall Study|Withdrawal by Subject|4
7167596|NCT03864627|11353862|FG001|Overall Study|Withdrawal by Subject|8
7167597|NCT03864627|11353861|FG000|Overall Study|Study terminated by sponsor|0
7167598|NCT03864627|11353862|FG001|Overall Study|Study terminated by sponsor|1
7167599|NCT03848403|11353877|FG000|Period 2 (Day 8)|Adverse Event|1
7167600|NCT03848403|11353878|FG001|Period 2 (Day 8)|Adverse Event|2
7167601|NCT03848403|11353879|FG002|Period 2 (Day 8)|Adverse Event|2
7167602|NCT03848403|11353877|FG000|Period 2 (Day 8)|Physician Decision|0
7167603|NCT03848403|11353878|FG001|Period 2 (Day 8)|Physician Decision|1
7167604|NCT03848403|11353879|FG002|Period 2 (Day 8)|Physician Decision|0
7167605|NCT03848403|11353877|FG000|Period 2 (Day 8)|Sponsor Decision|8
7167606|NCT03848403|11353878|FG001|Period 2 (Day 8)|Sponsor Decision|6
7167607|NCT03848403|11353879|FG002|Period 2 (Day 8)|Sponsor Decision|5
7167608|NCT03878108|11353946|FG000|Overall Study|Adverse Event|1
7167609|NCT03878108|11353947|FG001|Overall Study|Adverse Event|0
7167610|NCT03877237|11353963|FG000|Overall Study|Adverse Event|1
7167611|NCT03877237|11353964|FG001|Overall Study|Adverse Event|2
7167612|NCT03877237|11353963|FG000|Overall Study|Death|3
7167613|NCT03877237|11353964|FG001|Overall Study|Death|2
7167614|NCT03877237|11353963|FG000|Overall Study|Physician Decision|1
7167615|NCT03877237|11353964|FG001|Overall Study|Physician Decision|0
7167616|NCT03877237|11353963|FG000|Overall Study|Withdrawal by Subject|0
7167617|NCT03877237|11353964|FG001|Overall Study|Withdrawal by Subject|2
7167618|NCT03859323|11353993|FG000|Overall Study|Lost to Follow-up|0
7167619|NCT03859323|11353994|FG001|Overall Study|Lost to Follow-up|0
7167620|NCT03859323|11353995|FG002|Overall Study|Lost to Follow-up|0
7167621|NCT03859323|11353996|FG003|Overall Study|Lost to Follow-up|0
7167622|NCT03859323|11353997|FG004|Overall Study|Lost to Follow-up|0
7167623|NCT03859323|11353998|FG005|Overall Study|Lost to Follow-up|0
7167624|NCT03859323|11353999|FG006|Overall Study|Lost to Follow-up|1
7167625|NCT03859323|11354000|FG007|Overall Study|Lost to Follow-up|0
7167626|NCT03859323|11354001|FG008|Overall Study|Lost to Follow-up|0
7167627|NCT03859323|11354002|FG009|Overall Study|Lost to Follow-up|0
7167628|NCT03859323|11354003|FG010|Overall Study|Lost to Follow-up|0
7167629|NCT03859323|11354004|FG011|Overall Study|Lost to Follow-up|0
7167630|NCT03859323|11354005|FG012|Overall Study|Lost to Follow-up|0
7167631|NCT03859323|11353993|FG000|Overall Study|Withdrawal by Subject|0
7167632|NCT03859323|11353994|FG001|Overall Study|Withdrawal by Subject|0
7167633|NCT03859323|11353995|FG002|Overall Study|Withdrawal by Subject|1
7167634|NCT03859323|11353996|FG003|Overall Study|Withdrawal by Subject|0
7167635|NCT03859323|11353997|FG004|Overall Study|Withdrawal by Subject|0
7167636|NCT03859323|11353998|FG005|Overall Study|Withdrawal by Subject|1
7167637|NCT03859323|11353999|FG006|Overall Study|Withdrawal by Subject|0
7167638|NCT03859323|11354000|FG007|Overall Study|Withdrawal by Subject|0
7167639|NCT03859323|11354001|FG008|Overall Study|Withdrawal by Subject|0
7167640|NCT03859323|11354002|FG009|Overall Study|Withdrawal by Subject|1
7167641|NCT03859323|11354003|FG010|Overall Study|Withdrawal by Subject|1
7167642|NCT03859323|11354004|FG011|Overall Study|Withdrawal by Subject|2
7167643|NCT03859323|11354005|FG012|Overall Study|Withdrawal by Subject|1
7167644|NCT03859323|11353993|FG000|Overall Study|Pregnancy|0
7167645|NCT03859323|11353994|FG001|Overall Study|Pregnancy|0
7167646|NCT03859323|11353995|FG002|Overall Study|Pregnancy|0
7167647|NCT03859323|11353996|FG003|Overall Study|Pregnancy|0
7167648|NCT03859323|11353997|FG004|Overall Study|Pregnancy|0
7167649|NCT03859323|11353998|FG005|Overall Study|Pregnancy|0
7167650|NCT03859323|11353999|FG006|Overall Study|Pregnancy|0
7167651|NCT03859323|11354000|FG007|Overall Study|Pregnancy|0
7167652|NCT03859323|11354001|FG008|Overall Study|Pregnancy|0
7167653|NCT03859323|11354002|FG009|Overall Study|Pregnancy|1
7167654|NCT03859323|11354003|FG010|Overall Study|Pregnancy|0
6972736|NCT01173601|11023892|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
7167655|NCT03859323|11354004|FG011|Overall Study|Pregnancy|0
7167656|NCT03859323|11354005|FG012|Overall Study|Pregnancy|0
7167657|NCT03875508|11354070|FG000|Overall Study|Adverse Event|1
7167658|NCT03875508|11354070|FG000|Overall Study|Lost to Follow-up|8
7167659|NCT03875508|11354070|FG000|Overall Study|Lack of Efficacy|1
7167660|NCT03875508|11354070|FG000|Overall Study|Other, not specified|2
7167661|NCT03869333|11354078|FG000|Overall Study|Lost to Follow-up|1
7167662|NCT03869333|11354079|FG001|Overall Study|Lost to Follow-up|0
7167663|NCT03869333|11354080|FG002|Overall Study|Lost to Follow-up|0
7167664|NCT03869333|11354081|FG003|Overall Study|Lost to Follow-up|0
7167665|NCT03869333|11354078|FG000|Overall Study|Pregnancy|1
7167666|NCT03869333|11354079|FG001|Overall Study|Pregnancy|0
7167667|NCT03869333|11354080|FG002|Overall Study|Pregnancy|0
7167668|NCT03869333|11354081|FG003|Overall Study|Pregnancy|0
7167669|NCT03869333|11354078|FG000|Overall Study|Physician Decision|0
7167670|NCT03869333|11354079|FG001|Overall Study|Physician Decision|1
7167671|NCT03869333|11354080|FG002|Overall Study|Physician Decision|0
7167672|NCT03869333|11354081|FG003|Overall Study|Physician Decision|0
7167673|NCT03864900|11354093|FG000|Overall Study|Withdrawal by Subject|1
7167674|NCT03864900|11354094|FG001|Overall Study|Withdrawal by Subject|1
7167675|NCT03864900|11354093|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2
7167676|NCT03864900|11354094|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5
7167677|NCT03875482|11354119|FG000|Overall Study|Adverse Event|0
7167678|NCT03875482|11354120|FG001|Overall Study|Adverse Event|1
7167679|NCT03875482|11354119|FG000|Overall Study|Withdrew consent|5
7167680|NCT03875482|11354120|FG001|Overall Study|Withdrew consent|6
7167681|NCT03875482|11354119|FG000|Overall Study|Lost to Follow-up|8
7167682|NCT03875482|11354120|FG001|Overall Study|Lost to Follow-up|2
7167683|NCT03875482|11354119|FG000|Overall Study|Lack of Efficacy|0
7167684|NCT03875482|11354120|FG001|Overall Study|Lack of Efficacy|11
7167685|NCT03874013|11354138|FG000|Overall Study|Adverse Event|0
7167686|NCT03874013|11354139|FG001|Overall Study|Adverse Event|1
7167687|NCT03873116|11354148|FG000|Overall Study|Study drug discontinuation due to rash|0
7167688|NCT03873116|11354149|FG001|Overall Study|Study drug discontinuation due to rash|0
7167689|NCT03873116|11354150|FG002|Overall Study|Study drug discontinuation due to rash|1
7167690|NCT03872843|11354160|FG000|Overall Study|Lost to Follow-up|5
7167691|NCT03872843|11354161|FG001|Overall Study|Lost to Follow-up|7
7167692|NCT03870997|11354173|FG000|Overall Study|Did not complete mid-study/final survey|10544
7167693|NCT03870997|11354174|FG001|Overall Study|Did not complete mid-study/final survey|10431
7167694|NCT03870997|11354175|FG002|Overall Study|Did not complete mid-study/final survey|10978
7167695|NCT03870997|11354176|FG003|Overall Study|Did not complete mid-study/final survey|10947
7167696|NCT03870997|11354177|FG004|Overall Study|Did not complete mid-study/final survey|10588
7167697|NCT03870997|11354178|FG005|Overall Study|Did not complete mid-study/final survey|10531
7167698|NCT03869684|11354190|FG000|Overall Study|Adverse Event|0
7167699|NCT03869684|11354191|FG001|Overall Study|Adverse Event|3
7167700|NCT03869684|11354192|FG002|Overall Study|Adverse Event|1
7167701|NCT03869684|11354190|FG000|Overall Study|Withdrawal by Subject|1
7167702|NCT03869684|11354191|FG001|Overall Study|Withdrawal by Subject|0
7167703|NCT03869684|11354192|FG002|Overall Study|Withdrawal by Subject|0
7167704|NCT03869684|11354190|FG000|Overall Study|Lost to Follow-up|1
7167705|NCT03869684|11354191|FG001|Overall Study|Lost to Follow-up|0
7167706|NCT03869684|11354192|FG002|Overall Study|Lost to Follow-up|0
7167707|NCT03869684|11354190|FG000|Overall Study|Study prematurely terminated by sponsor|0
7167708|NCT03869684|11354191|FG001|Overall Study|Study prematurely terminated by sponsor|0
7167709|NCT03869684|11354192|FG002|Overall Study|Study prematurely terminated by sponsor|2
7167710|NCT03848416|11354246|FG000|Overall Study|Withdrawal by Subject|1
7167711|NCT03848416|11354247|FG001|Overall Study|Withdrawal by Subject|0
7167712|NCT03848416|11354248|FG002|Overall Study|Withdrawal by Subject|0
7167713|NCT03848416|11354246|FG000|Overall Study|Death|0
7167714|NCT03848416|11354247|FG001|Overall Study|Death|0
7167715|NCT03848416|11354248|FG002|Overall Study|Death|1
7167716|NCT03847987|11354258|FG000|Overall Study|Lost to Follow-up|1
7167717|NCT03847987|11354259|FG001|Overall Study|Lost to Follow-up|0
7167718|NCT03847987|11354258|FG000|Overall Study|Adverse Event|2
7167719|NCT03847987|11354259|FG001|Overall Study|Adverse Event|0
7167720|NCT03853551|11354321|FG000|Overall Study|Death|2
7167721|NCT03853551|11354321|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7
7167722|NCT03870555|11354328|FG000|Period 3 (2 Days)|Adverse Event|1
7167723|NCT03870555|11354329|FG001|Period 3 (2 Days)|Adverse Event|0
7167724|NCT03870555|11354330|FG002|Period 3 (2 Days)|Adverse Event|0
7167725|NCT03851094|11354356|FG000|Overall Study|Withdrawal by Subject|0
7167726|NCT03851094|11354357|FG001|Overall Study|Withdrawal by Subject|1
7167727|NCT03851094|11354356|FG000|Overall Study|Participant lost device|0
7167728|NCT03851094|11354357|FG001|Overall Study|Participant lost device|1
7167729|NCT03851094|11354356|FG000|Overall Study|Participant returned device|0
7167730|NCT03851094|11354357|FG001|Overall Study|Participant returned device|2
7167731|NCT03868631|11354380|FG000|Baseline to Week 6|Adverse Event|0
7167732|NCT03868631|11354381|FG001|Baseline to Week 6|Adverse Event|3
7167733|NCT03868631|11354380|FG000|Baseline to Week 6|Protocol Violation|1
7167734|NCT03868631|11354381|FG001|Baseline to Week 6|Protocol Violation|1
7167735|NCT03868631|11354380|FG000|Baseline to Week 6|Withdrawal by Subject|3
7167736|NCT03868631|11354381|FG001|Baseline to Week 6|Withdrawal by Subject|0
7167737|NCT03868631|11354380|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2
7167738|NCT03868631|11354381|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0
7167739|NCT03868631|11354380|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1
7167740|NCT03868631|11354381|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0
7167741|NCT03868631|11354380|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1
7167742|NCT03868631|11354381|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1
7167743|NCT03865953|11354389|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2
7167744|NCT03865953|11354390|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0
7167745|NCT03865953|11354389|FG000|First Intervention (4 Weeks)|Protocol Violation|0
7167746|NCT03865953|11354390|FG001|First Intervention (4 Weeks)|Protocol Violation|1
7167747|NCT03865953|11354389|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0
7167748|NCT03865953|11354390|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2
7167749|NCT03865381|11354396|FG000|Overall Study|Protocol Violation/Non-Compliance|3
7167750|NCT03865381|11354396|FG000|Overall Study|Withdrawal by Subject|2
7167751|NCT03868059|11354424|FG000|Overall Study|Adverse Event|3
7167752|NCT03868059|11354424|FG000|Overall Study|Lost to Follow-up|3
7167753|NCT03868059|11354424|FG000|Overall Study|Withdrawal by Subject|6
7167754|NCT03865407|11354439|FG000|Overall Study|Adverse Event|1
7167755|NCT03865407|11354440|FG001|Overall Study|Adverse Event|0
7167756|NCT03865407|11354439|FG000|Overall Study|Withdrawal by Subject|1
7167757|NCT03865407|11354440|FG001|Overall Study|Withdrawal by Subject|0
7167758|NCT03865407|11354439|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1
7167759|NCT03865407|11354440|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0
7167760|NCT03864653|11354459|FG000|Overall Study|Withdrawal by Subject|1
7167761|NCT03853213|11354476|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1
7167762|NCT03853213|11354477|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0
7167763|NCT03853213|11354476|FG000|Overall Study|Other (e.g., too busy)|0
7167764|NCT03853213|11354477|FG001|Overall Study|Other (e.g., too busy)|2
7167765|NCT03847610|11354483|FG000|Overall Study|Withdrawal by Subject|1
7167766|NCT03850093|11354490|FG000|Overall Study|Withdrawal by Subject|1
7167767|NCT03850093|11354491|FG001|Overall Study|Withdrawal by Subject|0
7167768|NCT03850093|11354492|FG002|Overall Study|Withdrawal by Subject|2
7167769|NCT03861936|11354573|FG000|Overall Study|Withdrawal by Subject|4
7167770|NCT03861936|11354574|FG001|Overall Study|Withdrawal by Subject|1
7167771|NCT03861936|11354575|FG002|Overall Study|Withdrawal by Subject|3
7167772|NCT03861936|11354573|FG000|Overall Study|Lost to Follow-up|5
7167773|NCT03861936|11354574|FG001|Overall Study|Lost to Follow-up|3
7167774|NCT03861936|11354575|FG002|Overall Study|Lost to Follow-up|3
7167775|NCT03861936|11354573|FG000|Overall Study|Physician Decision|0
7167776|NCT03861936|11354574|FG001|Overall Study|Physician Decision|1
7167777|NCT03861936|11354575|FG002|Overall Study|Physician Decision|0
7167778|NCT03861936|11354573|FG000|Overall Study|Protocol Deviation|0
7167779|NCT03861936|11354574|FG001|Overall Study|Protocol Deviation|0
7167780|NCT03861936|11354575|FG002|Overall Study|Protocol Deviation|1
7167781|NCT03861936|11354573|FG000|Overall Study|Reason not Specified|5
7167782|NCT03861936|11354574|FG001|Overall Study|Reason not Specified|5
7167783|NCT03861936|11354575|FG002|Overall Study|Reason not Specified|3
7167784|NCT03850509|11354615|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2
7167785|NCT03850509|11354616|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1
7167786|NCT03851016|11354701|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1
7167787|NCT03851016|11354702|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2
7167788|NCT03850496|11354711|FG000|Overall Study|Withdrawal by Subject|1
7167789|NCT03850496|11354712|FG001|Overall Study|Withdrawal by Subject|0
7167790|NCT03850496|11354713|FG002|Overall Study|Withdrawal by Subject|0
7167791|NCT03850496|11354711|FG000|Overall Study|Lost to Follow-up|0
7167792|NCT03850496|11354712|FG001|Overall Study|Lost to Follow-up|1
7167793|NCT03850496|11354713|FG002|Overall Study|Lost to Follow-up|4
7167794|NCT03848949|11354723|FG000|Overall Study|Lost to Follow-up|5
7167795|NCT03848949|11354724|FG001|Overall Study|Lost to Follow-up|7
7184760|NCT04524663|11385126|FG000|Overall Study|Withdrawal by Subject|0
7184761|NCT04524663|11385127|FG001|Overall Study|Withdrawal by Subject|2
7184762|NCT04067518|11385157|FG000|Overall Study|Screen Failures|0
7184763|NCT04067518|11385158|FG001|Overall Study|Screen Failures|1
7184764|NCT04067518|11385157|FG000|Overall Study|Enrolled but not Treated|0
7184765|NCT04067518|11385158|FG001|Overall Study|Enrolled but not Treated|1
7184766|NCT04067518|11385157|FG000|Overall Study|Adverse Events|0
7184767|NCT04067518|11385158|FG001|Overall Study|Adverse Events|2
7184768|NCT04067518|11385157|FG000|Overall Study|Ongoing|3
7184769|NCT04067518|11385158|FG001|Overall Study|Ongoing|21
7184770|NCT03866473|11385167|FG000|Phase 1|Death|1
7184771|NCT03866473|11385168|FG001|Phase 1|Death|0
7184772|NCT03866473|11385167|FG000|Phase 2|Death|0
7184773|NCT03866473|11385168|FG001|Phase 2|Death|2
7184774|NCT03866473|11385167|FG000|Phase 2|Dropped|1
7184775|NCT03866473|11385168|FG001|Phase 2|Dropped|1
7184776|NCT03866473|11385167|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1
7184777|NCT03866473|11385168|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0
7184778|NCT03738423|11385183|FG000|Overall Study|Withdrawal by Subject|9
7184779|NCT03738423|11385184|FG001|Overall Study|Withdrawal by Subject|12
7184780|NCT03738423|11385185|FG002|Overall Study|Withdrawal by Subject|9
7184781|NCT03738423|11385186|FG003|Overall Study|Withdrawal by Subject|12
7184782|NCT03738423|11385187|FG004|Overall Study|Withdrawal by Subject|10
7184783|NCT03738423|11385183|FG000|Overall Study|Lack of Efficacy|3
7184784|NCT03738423|11385184|FG001|Overall Study|Lack of Efficacy|1
7184785|NCT03738423|11385185|FG002|Overall Study|Lack of Efficacy|1
7184786|NCT03738423|11385186|FG003|Overall Study|Lack of Efficacy|1
7184787|NCT03738423|11385187|FG004|Overall Study|Lack of Efficacy|2
7184788|NCT03738423|11385183|FG000|Overall Study|Lost to Follow-up|1
7184789|NCT03738423|11385184|FG001|Overall Study|Lost to Follow-up|0
7184790|NCT03738423|11385185|FG002|Overall Study|Lost to Follow-up|1
7184791|NCT03738423|11385186|FG003|Overall Study|Lost to Follow-up|1
7184792|NCT03738423|11385187|FG004|Overall Study|Lost to Follow-up|0
7184793|NCT03738423|11385183|FG000|Overall Study|Protocol Violation|1
7184794|NCT03738423|11385184|FG001|Overall Study|Protocol Violation|0
7167796|NCT03844945|11354752|FG000|Overall Study|Adverse Event|1
7167797|NCT03844945|11354753|FG001|Overall Study|Adverse Event|1
7167798|NCT03844945|11354754|FG002|Overall Study|Adverse Event|4
7167799|NCT03844945|11354755|FG003|Overall Study|Adverse Event|0
7167800|NCT03844945|11354752|FG000|Overall Study|Withdrawal by Subject|0
7167801|NCT03844945|11354753|FG001|Overall Study|Withdrawal by Subject|0
7167802|NCT03844945|11354754|FG002|Overall Study|Withdrawal by Subject|1
7167803|NCT03844945|11354755|FG003|Overall Study|Withdrawal by Subject|0
7167804|NCT03844945|11354752|FG000|Overall Study|Lack of Efficacy|0
7167805|NCT03844945|11354753|FG001|Overall Study|Lack of Efficacy|0
7167806|NCT03844945|11354754|FG002|Overall Study|Lack of Efficacy|0
7167807|NCT03844945|11354755|FG003|Overall Study|Lack of Efficacy|1
7167808|NCT03843632|11354778|FG000|Overall Study|Withdrawal by Subject|1
7167809|NCT03843632|11354779|FG001|Overall Study|Withdrawal by Subject|0
7167810|NCT03843632|11354780|FG002|Overall Study|Withdrawal by Subject|0
7167811|NCT03843632|11354781|FG003|Overall Study|Withdrawal by Subject|0
7167812|NCT03840811|11354794|FG000|Overall Study|Lost to Follow-up|0
7167813|NCT03840811|11354795|FG001|Overall Study|Lost to Follow-up|0
7167814|NCT03840811|11354796|FG002|Overall Study|Lost to Follow-up|1
7167815|NCT03837028|11354808|FG000|Overall Study|Lost to Follow-up|4
7167816|NCT03837028|11354809|FG001|Overall Study|Lost to Follow-up|0
7167817|NCT03837028|11354810|FG002|Overall Study|Lost to Follow-up|2
7167818|NCT03837028|11354811|FG003|Overall Study|Lost to Follow-up|0
7167819|NCT03837028|11354808|FG000|Overall Study|Withdrawal by Subject|12
7167820|NCT03837028|11354809|FG001|Overall Study|Withdrawal by Subject|11
7167821|NCT03837028|11354810|FG002|Overall Study|Withdrawal by Subject|11
7167822|NCT03837028|11354811|FG003|Overall Study|Withdrawal by Subject|7
7167823|NCT03841331|11354854|FG000|Overall Study|Withdrawal by Subject|4
7167824|NCT03841331|11354855|FG001|Overall Study|Withdrawal by Subject|9
7167825|NCT03841331|11354854|FG000|Overall Study|Lost to Follow-up|5
7167826|NCT03841331|11354855|FG001|Overall Study|Lost to Follow-up|1
7167827|NCT03840135|11354870|FG000|Overall Study|Protocol Violation|6
7167828|NCT03840135|11354871|FG001|Overall Study|Protocol Violation|1
7167829|NCT03840135|11354870|FG000|Overall Study|Withdrawal by Subject|1
7167830|NCT03840135|11354871|FG001|Overall Study|Withdrawal by Subject|0
7167831|NCT03839641|11354883|FG000|Overall Study|Withdrawal by Subject|1
7167832|NCT03839641|11354884|FG001|Overall Study|Withdrawal by Subject|1
7167833|NCT03839212|11354892|FG000|Overall Study|COVID-19 related suspension of research activities.|4
7167834|NCT03839355|11354898|FG000|Overall Study|Withdrawal by Subject|1
7167835|NCT03839355|11354899|FG001|Overall Study|Withdrawal by Subject|0
7167836|NCT03838731|11354916|FG000|Overall Study|Pregnancy|0
7167837|NCT03838731|11354917|FG001|Overall Study|Pregnancy|1
7167838|NCT03838731|11354916|FG000|Overall Study|Withdrawal of consent|1
7167839|NCT03838731|11354917|FG001|Overall Study|Withdrawal of consent|0
7167840|NCT03838198|11354925|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0
7167841|NCT03838198|11354926|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0
7167842|NCT03838198|11354927|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1
7167843|NCT03838198|11354928|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0
7167844|NCT03838198|11354925|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0
7167845|NCT03838198|11354926|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22
7167846|NCT03838198|11354927|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0
7167847|NCT03838198|11354928|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22
7167848|NCT03836677|11355047|FG000|Period 1|Adverse Event|0
7167849|NCT03836677|11355048|FG001|Period 1|Adverse Event|1
7167850|NCT03836677|11355047|FG000|Period 2|Severe non-compliance to protocol|1
7167851|NCT03836677|11355048|FG001|Period 2|Severe non-compliance to protocol|0
7167852|NCT03827564|11355068|FG000|Overall Study|Discontinued due to Study Termination|1
7167853|NCT03827564|11355069|FG001|Overall Study|Discontinued due to Study Termination|0
7167854|NCT03824236|11355078|FG000|Overall Study|Lost to Follow-up|0
7167855|NCT03824236|11355079|FG001|Overall Study|Lost to Follow-up|0
7167856|NCT03824236|11355080|FG002|Overall Study|Lost to Follow-up|1
7167857|NCT03810235|11355101|FG000|Overall Study|Withdrawal by Subject|2
7167858|NCT03810235|11355102|FG001|Overall Study|Withdrawal by Subject|0
7167859|NCT03836664|11355121|FG000|Overall Study|Didn't complete forms and lost drug|3
7167860|NCT03836664|11355122|FG001|Overall Study|Didn't complete forms and lost drug|3
7167861|NCT03832738|11355135|FG000|Overall Study|Withdrawal by Subject|6
7167862|NCT03832738|11355136|FG001|Overall Study|Withdrawal by Subject|7
7167863|NCT03832738|11355137|FG002|Overall Study|Withdrawal by Subject|16
7167864|NCT03832738|11355135|FG000|Overall Study|Physician Decision|0
7167865|NCT03832738|11355136|FG001|Overall Study|Physician Decision|1
7167866|NCT03832738|11355137|FG002|Overall Study|Physician Decision|2
7167867|NCT03832738|11355135|FG000|Overall Study|Adverse Event|2
7167868|NCT03832738|11355136|FG001|Overall Study|Adverse Event|3
7167869|NCT03832738|11355137|FG002|Overall Study|Adverse Event|1
7167870|NCT03832738|11355135|FG000|Overall Study|Pregnancy|0
7167871|NCT03832738|11355136|FG001|Overall Study|Pregnancy|1
7167872|NCT03832738|11355137|FG002|Overall Study|Pregnancy|0
7167873|NCT03823391|11355147|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1
7167874|NCT03823391|11355148|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1
7167875|NCT03823391|11355147|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1
7167876|NCT03823391|11355148|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0
7167877|NCT03808298|11355170|FG000|Overall Study|Adverse Event|3
7167878|NCT03808298|11355170|FG000|Overall Study|Physician Decision|1
7167879|NCT03808298|11355170|FG000|Overall Study|Withdrawal by Subject|1
7167880|NCT03808298|11355170|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3
7167881|NCT03836729|11355199|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1
7167882|NCT03835975|11355212|FG000|Overall Study|Lost to Follow-up|1
7167883|NCT03835975|11355213|FG001|Overall Study|Lost to Follow-up|1
7167884|NCT03835975|11355214|FG002|Overall Study|Lost to Follow-up|0
7167885|NCT03835975|11355215|FG003|Overall Study|Lost to Follow-up|0
7167886|NCT03835975|11355216|FG004|Overall Study|Lost to Follow-up|0
7167887|NCT03835975|11355212|FG000|Overall Study|No longer met eligibility criteria|0
7167888|NCT03835975|11355213|FG001|Overall Study|No longer met eligibility criteria|1
7167889|NCT03835975|11355214|FG002|Overall Study|No longer met eligibility criteria|0
7167890|NCT03835975|11355215|FG003|Overall Study|No longer met eligibility criteria|0
7167891|NCT03835975|11355216|FG004|Overall Study|No longer met eligibility criteria|0
7167892|NCT03835975|11355212|FG000|Overall Study|Protocol Violation|1
7167893|NCT03835975|11355213|FG001|Overall Study|Protocol Violation|1
7167894|NCT03835975|11355214|FG002|Overall Study|Protocol Violation|2
7167895|NCT03835975|11355215|FG003|Overall Study|Protocol Violation|0
7167896|NCT03835975|11355216|FG004|Overall Study|Protocol Violation|0
7167897|NCT03835975|11355212|FG000|Overall Study|Withdrawal by Subject|1
7167898|NCT03835975|11355213|FG001|Overall Study|Withdrawal by Subject|0
7167899|NCT03835975|11355214|FG002|Overall Study|Withdrawal by Subject|1
7167900|NCT03835975|11355215|FG003|Overall Study|Withdrawal by Subject|1
7167901|NCT03835975|11355216|FG004|Overall Study|Withdrawal by Subject|0
7167902|NCT03835221|11355271|FG000|Methafilcon A|Withdrawal by Subject|1
7167903|NCT03819634|11355277|FG000|Overall Study|Physician Decision|2
7167904|NCT03812679|11355281|FG000|Overall Study|Adverse Event|2
7167905|NCT03812679|11355281|FG000|Overall Study|Missed >4 consecutive therapy days|1
7167906|NCT03812679|11355281|FG000|Overall Study|Renal transplant|1
7167907|NCT03812679|11355281|FG000|Overall Study|Withdrawal by Subject|1
7167908|NCT03812679|11355281|FG000|Overall Study|Termination of study|2
7167909|NCT03812679|11355281|FG000|Overall Study|Water device replacement|1
7167910|NCT03801148|11355336|FG000|Period 1 (2 Days)|Adverse Event|1
7167911|NCT03801148|11355337|FG001|Period 1 (2 Days)|Adverse Event|1
7167912|NCT03801148|11355338|FG002|Period 1 (2 Days)|Adverse Event|0
7167913|NCT03801148|11355339|FG003|Period 1 (2 Days)|Adverse Event|0
7167914|NCT03801148|11355336|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0
7167915|NCT03801148|11355337|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0
7167916|NCT03801148|11355338|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0
7167917|NCT03801148|11355339|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1
7167918|NCT03801148|11355336|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7167919|NCT03801148|11355337|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7167920|NCT03801148|11355338|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1
7167921|NCT03801148|11355339|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7167922|NCT03801148|11355336|FG000|Follow-Up (12 Days)|Lost to Follow-up|0
7167923|NCT03801148|11355337|FG001|Follow-Up (12 Days)|Lost to Follow-up|1
7167924|NCT03801148|11355338|FG002|Follow-Up (12 Days)|Lost to Follow-up|1
7167925|NCT03801148|11355339|FG003|Follow-Up (12 Days)|Lost to Follow-up|0
7167926|NCT03832322|11355355|FG000|Overall Study|Failed cecal intubation in 2nd exam|3
7167927|NCT03832322|11355356|FG001|Overall Study|Failed cecal intubation in 2nd exam|1
7167928|NCT03832387|11355366|FG000|Overall Study|Protocol Violation|2
7167929|NCT03832387|11355367|FG001|Overall Study|Protocol Violation|6
7167930|NCT03832387|11355366|FG000|Overall Study|EXCLUSION CRITERIA|3
7167931|NCT03832387|11355367|FG001|Overall Study|EXCLUSION CRITERIA|1
7167932|NCT03807739|11355390|FG000|Overall Study|Adverse Event|1
7167933|NCT03807739|11355391|FG001|Overall Study|Adverse Event|0
7167934|NCT03807739|11355392|FG002|Overall Study|Adverse Event|0
7167935|NCT03807739|11355393|FG003|Overall Study|Adverse Event|0
7167936|NCT03807739|11355390|FG000|Overall Study|Withdrawal by Subject|1
7167937|NCT03807739|11355391|FG001|Overall Study|Withdrawal by Subject|0
7167938|NCT03807739|11355392|FG002|Overall Study|Withdrawal by Subject|0
7167939|NCT03807739|11355393|FG003|Overall Study|Withdrawal by Subject|0
7167940|NCT03831282|11355403|FG000|Overall Study|Could not place sensor|1
7167941|NCT03824912|11355410|FG000|Overall Study|Lost to Follow-up|18
7167942|NCT03824912|11355411|FG001|Overall Study|Lost to Follow-up|15
7167943|NCT03824912|11355412|FG002|Overall Study|Lost to Follow-up|8
7167944|NCT03824912|11355410|FG000|Overall Study|Negative Baseline Culture Result|118
7167945|NCT03824912|11355411|FG001|Overall Study|Negative Baseline Culture Result|112
7167946|NCT03824912|11355412|FG002|Overall Study|Negative Baseline Culture Result|57
7167947|NCT03824912|11355410|FG000|Overall Study|Non-Compliance with Study Drug|0
7167948|NCT03824912|11355411|FG001|Overall Study|Non-Compliance with Study Drug|0
7167949|NCT03824912|11355412|FG002|Overall Study|Non-Compliance with Study Drug|1
7167950|NCT03824912|11355410|FG000|Overall Study|Protocol Violation|1
7167951|NCT03824912|11355411|FG001|Overall Study|Protocol Violation|4
7167952|NCT03824912|11355412|FG002|Overall Study|Protocol Violation|1
7167953|NCT03824912|11355410|FG000|Overall Study|Withdrawal by Subject|3
7167954|NCT03824912|11355411|FG001|Overall Study|Withdrawal by Subject|2
7167955|NCT03824912|11355412|FG002|Overall Study|Withdrawal by Subject|1
7167956|NCT03824912|11355410|FG000|Overall Study|Participation in another study|0
7167957|NCT03824912|11355411|FG001|Overall Study|Participation in another study|1
7167958|NCT03824912|11355412|FG002|Overall Study|Participation in another study|0
7167959|NCT03822884|11355426|FG000|Overall Study|Withdrawal by Subject|0
7167960|NCT03822884|11355427|FG001|Overall Study|Withdrawal by Subject|0
7167961|NCT03822884|11355428|FG002|Overall Study|Withdrawal by Subject|0
7167962|NCT03822884|11355429|FG003|Overall Study|Withdrawal by Subject|0
7167963|NCT03822884|11355430|FG004|Overall Study|Withdrawal by Subject|1
7167964|NCT03822884|11355431|FG005|Overall Study|Withdrawal by Subject|0
7167965|NCT03810014|11355447|FG000|Overall Study|Pregnancy|2
7167966|NCT03810014|11355448|FG001|Overall Study|Pregnancy|2
7167967|NCT03810014|11355449|FG002|Overall Study|Pregnancy|0
7167968|NCT03810014|11355450|FG003|Overall Study|Pregnancy|2
7167969|NCT03830892|11355475|FG000|Overall Study|Physician Decision|2
7167970|NCT03830892|11355476|FG001|Overall Study|Physician Decision|3
7167971|NCT03830892|11355475|FG000|Overall Study|Study terminated due to COVID|4
7167972|NCT03830892|11355476|FG001|Overall Study|Study terminated due to COVID|0
7167973|NCT03830892|11355475|FG000|Overall Study|Protocol Violation|0
7167974|NCT03830892|11355476|FG001|Overall Study|Protocol Violation|1
7167975|NCT03830892|11355475|FG000|Overall Study|Withdrawal by Subject|0
7167976|NCT03830892|11355476|FG001|Overall Study|Withdrawal by Subject|2
7167977|NCT03825042|11355488|FG000|Overall Study|Adverse Event|1
7167978|NCT03825042|11355489|FG001|Overall Study|Adverse Event|0
7167979|NCT03825042|11355488|FG000|Overall Study|Withdrawal by Subject|1
7167980|NCT03825042|11355489|FG001|Overall Study|Withdrawal by Subject|0
7167981|NCT03823378|11355501|FG000|Overall Study|Adverse Event|2
7167982|NCT03823378|11355502|FG001|Overall Study|Adverse Event|2
7167983|NCT03823378|11355503|FG002|Overall Study|Adverse Event|0
7167984|NCT03823378|11355504|FG003|Overall Study|Adverse Event|0
7167985|NCT03823378|11355505|FG004|Overall Study|Adverse Event|0
7167986|NCT03823378|11355506|FG005|Overall Study|Adverse Event|0
7167987|NCT03823378|11355501|FG000|Overall Study|Lost to Follow-up|0
7167988|NCT03823378|11355502|FG001|Overall Study|Lost to Follow-up|1
7167989|NCT03823378|11355503|FG002|Overall Study|Lost to Follow-up|0
7167990|NCT03823378|11355504|FG003|Overall Study|Lost to Follow-up|0
7167991|NCT03823378|11355505|FG004|Overall Study|Lost to Follow-up|1
7167992|NCT03823378|11355506|FG005|Overall Study|Lost to Follow-up|0
7167993|NCT03823378|11355501|FG000|Overall Study|Withdrawal by Subject|0
7167994|NCT03823378|11355502|FG001|Overall Study|Withdrawal by Subject|1
7167995|NCT03823378|11355503|FG002|Overall Study|Withdrawal by Subject|4
7167996|NCT03823378|11355504|FG003|Overall Study|Withdrawal by Subject|2
7080507|NCT02122770|11189959|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1
7080508|NCT02122770|11189960|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5
7167997|NCT03823378|11355505|FG004|Overall Study|Withdrawal by Subject|0
7167998|NCT03823378|11355506|FG005|Overall Study|Withdrawal by Subject|1
7167999|NCT03823378|11355501|FG000|Overall Study|Other, not specified|19
7168000|NCT03823378|11355502|FG001|Overall Study|Other, not specified|12
7080509|NCT02122770|11189961|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
7080510|NCT02122770|11189962|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1
7080511|NCT02122770|11189963|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
7080512|NCT02122770|11189964|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
7080513|NCT02122770|11189959|FG000|Part B: Standard of Care|Adverse Event|0
7080514|NCT02122770|11189960|FG001|Part B: Standard of Care|Adverse Event|0
7080515|NCT02122770|11189961|FG002|Part B: Standard of Care|Adverse Event|0
7080516|NCT02122770|11189962|FG003|Part B: Standard of Care|Adverse Event|0
7080517|NCT02122770|11189963|FG004|Part B: Standard of Care|Adverse Event|4
7080518|NCT02122770|11189964|FG005|Part B: Standard of Care|Adverse Event|1
7080519|NCT02122770|11189959|FG000|Part B: Standard of Care|Other|0
7168001|NCT03823378|11355503|FG002|Overall Study|Other, not specified|6
7168002|NCT03823378|11355504|FG003|Overall Study|Other, not specified|8
7168003|NCT03823378|11355505|FG004|Overall Study|Other, not specified|17
7168004|NCT03823378|11355506|FG005|Overall Study|Other, not specified|7
7168005|NCT03831191|11355524|FG000|Induction Period (16 Weeks)|Adverse Event|2
7168006|NCT03831191|11355525|FG001|Induction Period (16 Weeks)|Adverse Event|1
7168007|NCT03831191|11355526|FG002|Induction Period (16 Weeks)|Adverse Event|3
7168008|NCT03831191|11355527|FG003|Induction Period (16 Weeks)|Adverse Event|4
7168009|NCT03831191|11355528|FG004|Induction Period (16 Weeks)|Adverse Event|0
7168010|NCT03831191|11355529|FG005|Induction Period (16 Weeks)|Adverse Event|0
7168011|NCT03831191|11355530|FG006|Induction Period (16 Weeks)|Adverse Event|0
7168012|NCT03831191|11355531|FG007|Induction Period (16 Weeks)|Adverse Event|0
7168013|NCT03831191|11355532|FG008|Induction Period (16 Weeks)|Adverse Event|0
7168014|NCT03831191|11355533|FG009|Induction Period (16 Weeks)|Adverse Event|0
7168015|NCT03831191|11355534|FG010|Induction Period (16 Weeks)|Adverse Event|0
7168016|NCT03831191|11355535|FG011|Induction Period (16 Weeks)|Adverse Event|0
7168017|NCT03831191|11355536|FG012|Induction Period (16 Weeks)|Adverse Event|0
7168018|NCT03831191|11355537|FG013|Induction Period (16 Weeks)|Adverse Event|0
7080520|NCT02122770|11189960|FG001|Part B: Standard of Care|Other|0
7168019|NCT03831191|11355538|FG014|Induction Period (16 Weeks)|Adverse Event|0
7168020|NCT03831191|11355524|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2
7168021|NCT03831191|11355525|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3
7168022|NCT03831191|11355526|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0
7168023|NCT03831191|11355527|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0
7168024|NCT03831191|11355528|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0
7168025|NCT03831191|11355529|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0
7168026|NCT03831191|11355530|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0
7168027|NCT03831191|11355531|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0
7168028|NCT03831191|11355532|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0
7168029|NCT03831191|11355533|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0
7168030|NCT03831191|11355534|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0
7168031|NCT03831191|11355535|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0
7168032|NCT03831191|11355536|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0
7168033|NCT03831191|11355537|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0
7168034|NCT03831191|11355538|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0
7168035|NCT03831191|11355524|FG000|Induction Period (16 Weeks)|Pregnancy|0
7168036|NCT03831191|11355525|FG001|Induction Period (16 Weeks)|Pregnancy|0
7168037|NCT03831191|11355526|FG002|Induction Period (16 Weeks)|Pregnancy|1
7168038|NCT03831191|11355527|FG003|Induction Period (16 Weeks)|Pregnancy|0
7168039|NCT03831191|11355528|FG004|Induction Period (16 Weeks)|Pregnancy|0
7168040|NCT03831191|11355529|FG005|Induction Period (16 Weeks)|Pregnancy|0
7168041|NCT03831191|11355530|FG006|Induction Period (16 Weeks)|Pregnancy|0
7168042|NCT03831191|11355531|FG007|Induction Period (16 Weeks)|Pregnancy|0
7168043|NCT03831191|11355532|FG008|Induction Period (16 Weeks)|Pregnancy|0
7168044|NCT03831191|11355533|FG009|Induction Period (16 Weeks)|Pregnancy|0
7168045|NCT03831191|11355534|FG010|Induction Period (16 Weeks)|Pregnancy|0
7168046|NCT03831191|11355535|FG011|Induction Period (16 Weeks)|Pregnancy|0
7168047|NCT03831191|11355536|FG012|Induction Period (16 Weeks)|Pregnancy|0
7168048|NCT03831191|11355537|FG013|Induction Period (16 Weeks)|Pregnancy|0
7168049|NCT03831191|11355538|FG014|Induction Period (16 Weeks)|Pregnancy|0
7168050|NCT03831191|11355524|FG000|Induction Period (16 Weeks)|Protocol Violation|0
7168051|NCT03831191|11355525|FG001|Induction Period (16 Weeks)|Protocol Violation|0
7168052|NCT03831191|11355526|FG002|Induction Period (16 Weeks)|Protocol Violation|0
7168053|NCT03831191|11355527|FG003|Induction Period (16 Weeks)|Protocol Violation|2
7168054|NCT03831191|11355528|FG004|Induction Period (16 Weeks)|Protocol Violation|0
7168055|NCT03831191|11355529|FG005|Induction Period (16 Weeks)|Protocol Violation|0
7168056|NCT03831191|11355530|FG006|Induction Period (16 Weeks)|Protocol Violation|0
7168057|NCT03831191|11355531|FG007|Induction Period (16 Weeks)|Protocol Violation|0
7168058|NCT03831191|11355532|FG008|Induction Period (16 Weeks)|Protocol Violation|0
7168059|NCT03831191|11355533|FG009|Induction Period (16 Weeks)|Protocol Violation|0
7168060|NCT03831191|11355534|FG010|Induction Period (16 Weeks)|Protocol Violation|0
7168061|NCT03831191|11355535|FG011|Induction Period (16 Weeks)|Protocol Violation|0
7168062|NCT03831191|11355536|FG012|Induction Period (16 Weeks)|Protocol Violation|0
7168063|NCT03831191|11355537|FG013|Induction Period (16 Weeks)|Protocol Violation|0
7168064|NCT03831191|11355538|FG014|Induction Period (16 Weeks)|Protocol Violation|0
7168065|NCT03831191|11355524|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7
7168066|NCT03831191|11355525|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2
7168067|NCT03831191|11355526|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1
7168068|NCT03831191|11355527|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3
7168069|NCT03831191|11355528|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0
7080521|NCT02122770|11189961|FG002|Part B: Standard of Care|Other|0
7080522|NCT02122770|11189962|FG003|Part B: Standard of Care|Other|0
7080523|NCT02122770|11189963|FG004|Part B: Standard of Care|Other|0
7080524|NCT02122770|11189964|FG005|Part B: Standard of Care|Other|2
7080525|NCT02122770|11189959|FG000|Part B: Standard of Care|Withdrawal by Subject|0
7168070|NCT03831191|11355529|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0
7168071|NCT03831191|11355530|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0
7168072|NCT03831191|11355531|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0
7168073|NCT03831191|11355532|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0
7168074|NCT03831191|11355533|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0
7168075|NCT03831191|11355534|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0
7168076|NCT03831191|11355535|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0
7168077|NCT03831191|11355536|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0
7168078|NCT03831191|11355537|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0
7168079|NCT03831191|11355538|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0
7168080|NCT03831191|11355524|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12
7168081|NCT03831191|11355525|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15
7168082|NCT03831191|11355526|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16
7168083|NCT03831191|11355527|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13
7168084|NCT03831191|11355528|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
7168085|NCT03831191|11355529|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
7168086|NCT03831191|11355530|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
7168087|NCT03831191|11355531|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
7168088|NCT03831191|11355532|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
7168089|NCT03831191|11355533|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
7168090|NCT03831191|11355534|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
7168091|NCT03831191|11355535|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
7168092|NCT03831191|11355536|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
7168093|NCT03831191|11355537|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
7168094|NCT03831191|11355538|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
7168095|NCT03831191|11355524|FG000|Induction Period (16 Weeks)|Sponsor Decision|0
7168096|NCT03831191|11355525|FG001|Induction Period (16 Weeks)|Sponsor Decision|0
7168097|NCT03831191|11355526|FG002|Induction Period (16 Weeks)|Sponsor Decision|0
7168098|NCT03831191|11355527|FG003|Induction Period (16 Weeks)|Sponsor Decision|1
7168099|NCT03831191|11355528|FG004|Induction Period (16 Weeks)|Sponsor Decision|0
7168100|NCT03831191|11355529|FG005|Induction Period (16 Weeks)|Sponsor Decision|0
7168101|NCT03831191|11355530|FG006|Induction Period (16 Weeks)|Sponsor Decision|0
7168102|NCT03831191|11355531|FG007|Induction Period (16 Weeks)|Sponsor Decision|0
7168103|NCT03831191|11355532|FG008|Induction Period (16 Weeks)|Sponsor Decision|0
7168104|NCT03831191|11355533|FG009|Induction Period (16 Weeks)|Sponsor Decision|0
7168105|NCT03831191|11355534|FG010|Induction Period (16 Weeks)|Sponsor Decision|0
7168106|NCT03831191|11355535|FG011|Induction Period (16 Weeks)|Sponsor Decision|0
7168107|NCT03831191|11355536|FG012|Induction Period (16 Weeks)|Sponsor Decision|0
7168108|NCT03831191|11355537|FG013|Induction Period (16 Weeks)|Sponsor Decision|0
7168109|NCT03831191|11355538|FG014|Induction Period (16 Weeks)|Sponsor Decision|0
7168110|NCT03831191|11355524|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0
7168111|NCT03831191|11355525|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0
7168112|NCT03831191|11355526|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0
7168113|NCT03831191|11355527|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0
7168114|NCT03831191|11355528|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4
7168115|NCT03831191|11355529|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5
7168116|NCT03831191|11355530|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2
7168117|NCT03831191|11355531|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4
7168118|NCT03831191|11355532|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8
7168119|NCT03831191|11355533|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1
7168120|NCT03831191|11355534|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4
7168121|NCT03831191|11355535|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7
7168122|NCT03831191|11355536|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1
7168123|NCT03831191|11355537|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1
7168124|NCT03831191|11355538|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6
7168125|NCT03831191|11355524|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7168126|NCT03831191|11355525|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7168127|NCT03831191|11355526|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7168128|NCT03831191|11355527|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7168129|NCT03831191|11355528|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7168130|NCT03831191|11355529|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7168131|NCT03831191|11355530|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7168132|NCT03831191|11355531|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7168133|NCT03831191|11355532|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7168134|NCT03831191|11355533|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7168135|NCT03831191|11355534|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7168136|NCT03831191|11355535|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7168137|NCT03831191|11355536|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7168138|NCT03831191|11355537|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7168139|NCT03831191|11355538|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
7168140|NCT03831191|11355524|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7168141|NCT03831191|11355525|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7168142|NCT03831191|11355526|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7168143|NCT03831191|11355527|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7168144|NCT03831191|11355528|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7168145|NCT03831191|11355529|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7168146|NCT03831191|11355530|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7168147|NCT03831191|11355531|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7168148|NCT03831191|11355532|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7168149|NCT03831191|11355533|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7168150|NCT03831191|11355534|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7168151|NCT03831191|11355535|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7168152|NCT03831191|11355536|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7168153|NCT03831191|11355537|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7168154|NCT03831191|11355538|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1
7168155|NCT03830281|11355573|FG000|Lead-in Period (2 Weeks)|Adverse Event|2
7168156|NCT03830281|11355574|FG001|Lead-in Period (2 Weeks)|Adverse Event|0
7168157|NCT03830281|11355573|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6
7168158|NCT03830281|11355574|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0
7168159|NCT03830281|11355573|FG000|Lead-in Period (2 Weeks)|Physician Decision|2
7168160|NCT03830281|11355574|FG001|Lead-in Period (2 Weeks)|Physician Decision|0
7168161|NCT03830281|11355573|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29
7168162|NCT03830281|11355574|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0
7168163|NCT03830281|11355573|FG000|Treatment Period (16 Weeks)|Adverse Event|1
7168164|NCT03830281|11355574|FG001|Treatment Period (16 Weeks)|Adverse Event|7
7168165|NCT03830281|11355573|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4
7168166|NCT03830281|11355574|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3
7168167|NCT03830281|11355573|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1
7168168|NCT03830281|11355574|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1
7168169|NCT03830281|11355573|FG000|Treatment Period (16 Weeks)|Physician Decision|1
7168170|NCT03830281|11355574|FG001|Treatment Period (16 Weeks)|Physician Decision|0
7168171|NCT03830281|11355573|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5
7168172|NCT03830281|11355574|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6
7168173|NCT03827395|11355590|FG000|Overall Study|Lost to Follow-up|1
7080526|NCT02122770|11189960|FG001|Part B: Standard of Care|Withdrawal by Subject|0
7080527|NCT02122770|11189961|FG002|Part B: Standard of Care|Withdrawal by Subject|0
7080528|NCT02122770|11189962|FG003|Part B: Standard of Care|Withdrawal by Subject|0
7080529|NCT02122770|11189963|FG004|Part B: Standard of Care|Withdrawal by Subject|4
7080530|NCT02122770|11189964|FG005|Part B: Standard of Care|Withdrawal by Subject|2
7080531|NCT02122770|11189959|FG000|Part B: Standard of Care|Symptomatic Deterioration|0
7080532|NCT02122770|11189960|FG001|Part B: Standard of Care|Symptomatic Deterioration|0
7080533|NCT02122770|11189961|FG002|Part B: Standard of Care|Symptomatic Deterioration|0
7168174|NCT03827395|11355591|FG001|Overall Study|Lost to Follow-up|0
7168175|NCT03827395|11355590|FG000|Overall Study|Protocol Violation|1
7168176|NCT03827395|11355591|FG001|Overall Study|Protocol Violation|0
7168177|NCT03827395|11355590|FG000|Overall Study|Became ineligible after enrollment|1
7168178|NCT03827395|11355591|FG001|Overall Study|Became ineligible after enrollment|2
7168179|NCT03819218|11355597|FG000|Overall Study|Protocol Violation|1
7168180|NCT03828487|11355610|FG000|Overall Study|Physician Decision|1
7168181|NCT03828617|11355618|FG000|Overall Study|Lost to Follow-up|22
7168182|NCT03828617|11355619|FG001|Overall Study|Lost to Follow-up|12
7168183|NCT03828617|11355620|FG002|Overall Study|Lost to Follow-up|23
7168184|NCT03828617|11355621|FG003|Overall Study|Lost to Follow-up|7
7168185|NCT03828617|11355618|FG000|Overall Study|No longer met eligibility criteria|0
7168186|NCT03828617|11355619|FG001|Overall Study|No longer met eligibility criteria|1
7168187|NCT03828617|11355620|FG002|Overall Study|No longer met eligibility criteria|1
7168188|NCT03828617|11355621|FG003|Overall Study|No longer met eligibility criteria|3
7168189|NCT03828617|11355618|FG000|Overall Study|Protocol Violation|0
7168190|NCT03828617|11355619|FG001|Overall Study|Protocol Violation|2
7168191|NCT03828617|11355620|FG002|Overall Study|Protocol Violation|0
7168192|NCT03828617|11355621|FG003|Overall Study|Protocol Violation|0
7168193|NCT03828617|11355618|FG000|Overall Study|Withdrawal by Subject|2
7168194|NCT03828617|11355619|FG001|Overall Study|Withdrawal by Subject|0
7168195|NCT03828617|11355620|FG002|Overall Study|Withdrawal by Subject|2
7168196|NCT03828617|11355621|FG003|Overall Study|Withdrawal by Subject|0
7168197|NCT03828539|11355632|FG000|Overall Study|Adverse Event|3
7168198|NCT03828539|11355633|FG001|Overall Study|Adverse Event|12
7168199|NCT03828539|11355632|FG000|Overall Study|Patient's/guardian's decision|3
7168200|NCT03828539|11355633|FG001|Overall Study|Patient's/guardian's decision|5
7168201|NCT03828539|11355632|FG000|Overall Study|Lost to Follow-up|4
7168202|NCT03828539|11355633|FG001|Overall Study|Lost to Follow-up|2
7168203|NCT03828539|11355632|FG000|Overall Study|Protocol Violation|3
7168204|NCT03828539|11355633|FG001|Overall Study|Protocol Violation|2
7168205|NCT03828539|11355632|FG000|Overall Study|Withdrawal of informed consent|2
7168206|NCT03828539|11355633|FG001|Overall Study|Withdrawal of informed consent|1
7168207|NCT03828539|11355632|FG000|Overall Study|New therapy for study indication|1
7168208|NCT03828539|11355633|FG001|Overall Study|New therapy for study indication|0
7168209|NCT03824704|11355639|FG000|Overall Study|Study Terminated by Sponsor|1
7168210|NCT03817879|11355654|FG000|Overall Study|Drop out|5
7168211|NCT03817879|11355655|FG001|Overall Study|Drop out|12
7168212|NCT03817879|11355654|FG000|Overall Study|Withdrawal by Subject|0
7168213|NCT03817879|11355655|FG001|Overall Study|Withdrawal by Subject|1
7168214|NCT03811834|11355661|FG000|Period 1 ( 7 Days)|Adverse Event|1
7168215|NCT03806127|11355676|FG000|Overall Study|Withdrawal by Subject|4
7168216|NCT03806127|11355677|FG001|Overall Study|Withdrawal by Subject|5
7168217|NCT03806127|11355676|FG000|Overall Study|Protocol Violation|3
7168218|NCT03806127|11355677|FG001|Overall Study|Protocol Violation|1
7168219|NCT03806127|11355676|FG000|Overall Study|Adverse Event|3
7168220|NCT03806127|11355677|FG001|Overall Study|Adverse Event|0
7168221|NCT03806127|11355676|FG000|Overall Study|Unable to Complete Procedures|0
7168222|NCT03806127|11355677|FG001|Overall Study|Unable to Complete Procedures|1
7168223|NCT03806127|11355676|FG000|Overall Study|Pregnancy|0
7080534|NCT02122770|11189962|FG003|Part B: Standard of Care|Symptomatic Deterioration|0
7080535|NCT02122770|11189963|FG004|Part B: Standard of Care|Symptomatic Deterioration|5
7080536|NCT02122770|11189964|FG005|Part B: Standard of Care|Symptomatic Deterioration|0
7168224|NCT03806127|11355677|FG001|Overall Study|Pregnancy|1
7168225|NCT03806127|11355676|FG000|Overall Study|Lost to Follow-up|5
7168226|NCT03806127|11355677|FG001|Overall Study|Lost to Follow-up|1
7168227|NCT03806127|11355676|FG000|Overall Study|Physician Decision|1
7168228|NCT03806127|11355677|FG001|Overall Study|Physician Decision|1
7168229|NCT03806127|11355676|FG000|Overall Study|Could Not Come Due to Covid|1
7168230|NCT03806127|11355677|FG001|Overall Study|Could Not Come Due to Covid|0
7168231|NCT03806127|11355676|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1
7168232|NCT03806127|11355677|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0
7168233|NCT03806127|11355676|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1
6972737|NCT01173601|11023893|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
6972738|NCT01173601|11023894|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
6972739|NCT01173601|11023895|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6
6972740|NCT01173653|11023915|FG000|Overall Study|Pts unwilling to provide follow-up|53
6972741|NCT01173653|11023916|FG001|Overall Study|Pts unwilling to provide follow-up|41
6972742|NCT01173679|11023922|FG000|Overall Study|Death|1
6972743|NCT01173692|11023929|FG000|Overall Study|Adverse Event|1
6972744|NCT01173692|11023930|FG001|Overall Study|Adverse Event|2
7168234|NCT03806127|11355677|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0
7168235|NCT03806127|11355676|FG000|Overall Study|Covid 19 Restrictions|2
7168236|NCT03806127|11355677|FG001|Overall Study|Covid 19 Restrictions|0
7168237|NCT03806127|11355676|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0
7168238|NCT03806127|11355677|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1
7168239|NCT03806127|11355676|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0
7168240|NCT03806127|11355677|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1
7168241|NCT03827473|11355685|FG000|Overall Study|Withdrawal by Subject|1
7168242|NCT03827473|11355686|FG001|Overall Study|Withdrawal by Subject|0
7168243|NCT03826914|11355694|FG000|Overall Study|Withdrawal by Subject|1
7168244|NCT03826914|11355695|FG001|Overall Study|Withdrawal by Subject|1
7168245|NCT03808688|11355718|FG000|Overall Study|Adverse Event|13
7080537|NCT02122770|11189959|FG000|Part B: Standard of Care|Progressive Disease|0
7080538|NCT02122770|11189960|FG001|Part B: Standard of Care|Progressive Disease|0
7080539|NCT02122770|11189961|FG002|Part B: Standard of Care|Progressive Disease|0
7080540|NCT02122770|11189962|FG003|Part B: Standard of Care|Progressive Disease|0
7080541|NCT02122770|11189963|FG004|Part B: Standard of Care|Progressive Disease|10
7168246|NCT03808688|11355719|FG001|Overall Study|Adverse Event|17
7168247|NCT03808688|11355718|FG000|Overall Study|Lack of Efficacy|2
7168248|NCT03808688|11355719|FG001|Overall Study|Lack of Efficacy|0
7168249|NCT03808688|11355718|FG000|Overall Study|Lost to Follow-up|0
7168250|NCT03808688|11355719|FG001|Overall Study|Lost to Follow-up|2
7168251|NCT03808688|11355718|FG000|Overall Study|Withdrawal by Subject|1
7168252|NCT03808688|11355719|FG001|Overall Study|Withdrawal by Subject|0
7168253|NCT03808688|11355718|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1
7168254|NCT03808688|11355719|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0
7168255|NCT03808688|11355718|FG000|Overall Study|IOP Too High|1
7168256|NCT03808688|11355719|FG001|Overall Study|IOP Too High|1
7168257|NCT03808688|11355718|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0
7168258|NCT03808688|11355719|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1
7168259|NCT03808688|11355718|FG000|Overall Study|Visit Out of Window|0
7168260|NCT03808688|11355719|FG001|Overall Study|Visit Out of Window|1
7168261|NCT03808688|11355718|FG000|Overall Study|Medication Non-Compliance|0
7168262|NCT03808688|11355719|FG001|Overall Study|Medication Non-Compliance|1
7168263|NCT03811093|11355729|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0
7168264|NCT03811093|11355730|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4
7168265|NCT03811093|11355729|FG000|Overall Study|Unable to measure body fat percentage|2
7168266|NCT03811093|11355730|FG001|Overall Study|Unable to measure body fat percentage|0
7168267|NCT03822182|11355742|FG000|Overall Study|Protocol Violation|0
7168268|NCT03822182|11355743|FG001|Overall Study|Protocol Violation|1
7168269|NCT03822182|11355744|FG002|Overall Study|Protocol Violation|1
7168270|NCT03822416|11355755|FG000|Overall Study|Lost to Follow-up|1
7168271|NCT03822416|11355756|FG001|Overall Study|Lost to Follow-up|0
7168272|NCT03822416|11355755|FG000|Overall Study|Withdrawal by Subject|0
7168273|NCT03822416|11355756|FG001|Overall Study|Withdrawal by Subject|1
7168274|NCT03809104|11355762|FG000|Overall Study|Withdrawal by Subject|3
7168275|NCT03806231|11355777|FG000|Overall Study|Physician Decision|1
7168276|NCT03806231|11355778|FG001|Overall Study|Physician Decision|0
7168277|NCT03806231|11355777|FG000|Overall Study|Withdrawal by Subject|1
7168278|NCT03806231|11355778|FG001|Overall Study|Withdrawal by Subject|0
7168279|NCT03804710|11355786|FG000|Overall Study|Adverse Event|0
7168280|NCT03804710|11355787|FG001|Overall Study|Adverse Event|3
7168281|NCT03804710|11355786|FG000|Overall Study|Withdrawal by Subject|2
7168282|NCT03804710|11355787|FG001|Overall Study|Withdrawal by Subject|1
6972745|NCT01173692|11023929|FG000|Overall Study|Withdrawal by Subject|1
7168283|NCT03804710|11355786|FG000|Overall Study|Other|0
7168284|NCT03804710|11355787|FG001|Overall Study|Other|1
7168285|NCT03821064|11355831|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1
7168286|NCT03820024|11355846|FG000|Overall Study|Physician Decision|1
7168287|NCT03820024|11355847|FG001|Overall Study|Physician Decision|2
7168288|NCT03816761|11355872|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0
7168289|NCT03816761|11355873|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0
7168290|NCT03816761|11355874|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0
7168291|NCT03816761|11355875|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0
7168292|NCT03816761|11355876|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0
7168293|NCT03816761|11355877|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1
7168294|NCT03816761|11355872|FG000|Second Treatment Period (7 Days)|Unclassified|0
7168295|NCT03816761|11355873|FG001|Second Treatment Period (7 Days)|Unclassified|0
7168296|NCT03816761|11355874|FG002|Second Treatment Period (7 Days)|Unclassified|0
7080542|NCT02122770|11189964|FG005|Part B: Standard of Care|Progressive Disease|8
7168297|NCT03816761|11355875|FG003|Second Treatment Period (7 Days)|Unclassified|1
7168298|NCT03816761|11355876|FG004|Second Treatment Period (7 Days)|Unclassified|0
7168299|NCT03816761|11355877|FG005|Second Treatment Period (7 Days)|Unclassified|0
7184795|NCT03738423|11385185|FG002|Overall Study|Protocol Violation|0
7184796|NCT03738423|11385186|FG003|Overall Study|Protocol Violation|0
7184797|NCT03738423|11385187|FG004|Overall Study|Protocol Violation|1
7184798|NCT03738423|11385183|FG000|Overall Study|Physician Decision|0
7184799|NCT03738423|11385184|FG001|Overall Study|Physician Decision|0
7184800|NCT03738423|11385185|FG002|Overall Study|Physician Decision|1
7184801|NCT03738423|11385186|FG003|Overall Study|Physician Decision|0
7184802|NCT03738423|11385187|FG004|Overall Study|Physician Decision|1
7184803|NCT03738423|11385183|FG000|Overall Study|Death|0
7184804|NCT03738423|11385184|FG001|Overall Study|Death|0
7184805|NCT03738423|11385185|FG002|Overall Study|Death|0
7184806|NCT03738423|11385186|FG003|Overall Study|Death|0
7184807|NCT03738423|11385187|FG004|Overall Study|Death|1
7184808|NCT03738423|11385183|FG000|Overall Study|Randomized but never treated|0
7184809|NCT03738423|11385184|FG001|Overall Study|Randomized but never treated|0
7184810|NCT03738423|11385185|FG002|Overall Study|Randomized but never treated|1
7184811|NCT03738423|11385186|FG003|Overall Study|Randomized but never treated|1
7184812|NCT03738423|11385187|FG004|Overall Study|Randomized but never treated|0
7184813|NCT03600818|11385201|FG000|Overall Study|Adverse Event|4
7184814|NCT03600818|11385202|FG001|Overall Study|Adverse Event|7
7184815|NCT03600818|11385201|FG000|Overall Study|Lack of Efficacy|9
7184816|NCT03600818|11385202|FG001|Overall Study|Lack of Efficacy|4
7184817|NCT03600818|11385201|FG000|Overall Study|Withdrawal by Subject|4
7184818|NCT03600818|11385202|FG001|Overall Study|Withdrawal by Subject|3
7184819|NCT03600818|11385201|FG000|Overall Study|Other-unspecified|5
7184820|NCT03600818|11385202|FG001|Overall Study|Other-unspecified|3
7184821|NCT03600818|11385201|FG000|Overall Study|Randomized and not treated|0
7184822|NCT03600818|11385202|FG001|Overall Study|Randomized and not treated|1
7187595|NCT02587598|11388289|FG001|Overall Study|Reason for study withdrawal not specified|1
7187596|NCT02587598|11388290|FG002|Overall Study|Reason for study withdrawal not specified|0
7187597|NCT02587598|11388291|FG003|Overall Study|Reason for study withdrawal not specified|0
7187598|NCT02587598|11388292|FG004|Overall Study|Reason for study withdrawal not specified|0
7187599|NCT02587598|11388293|FG005|Overall Study|Reason for study withdrawal not specified|0
7187600|NCT02587598|11388294|FG006|Overall Study|Reason for study withdrawal not specified|0
7187601|NCT02587598|11388295|FG007|Overall Study|Reason for study withdrawal not specified|0
7187602|NCT02587598|11388296|FG008|Overall Study|Reason for study withdrawal not specified|0
7187603|NCT02587598|11388297|FG009|Overall Study|Reason for study withdrawal not specified|0
7187604|NCT02587598|11388298|FG010|Overall Study|Reason for study withdrawal not specified|0
7187605|NCT02587598|11388288|FG000|Overall Study|Withdrawal by Subject|0
7187606|NCT02587598|11388289|FG001|Overall Study|Withdrawal by Subject|1
7187607|NCT02587598|11388290|FG002|Overall Study|Withdrawal by Subject|0
7187608|NCT02587598|11388291|FG003|Overall Study|Withdrawal by Subject|2
7187609|NCT02587598|11388292|FG004|Overall Study|Withdrawal by Subject|3
7187610|NCT02587598|11388293|FG005|Overall Study|Withdrawal by Subject|1
7187611|NCT02587598|11388294|FG006|Overall Study|Withdrawal by Subject|0
7187612|NCT02587598|11388295|FG007|Overall Study|Withdrawal by Subject|0
7187613|NCT02587598|11388296|FG008|Overall Study|Withdrawal by Subject|0
7187614|NCT02587598|11388297|FG009|Overall Study|Withdrawal by Subject|1
7187615|NCT02587598|11388298|FG010|Overall Study|Withdrawal by Subject|2
7187616|NCT02587598|11388288|FG000|Overall Study|Physician Decision|0
7187617|NCT02587598|11388289|FG001|Overall Study|Physician Decision|0
7187618|NCT02587598|11388290|FG002|Overall Study|Physician Decision|0
7187619|NCT02587598|11388291|FG003|Overall Study|Physician Decision|0
7187620|NCT02587598|11388292|FG004|Overall Study|Physician Decision|0
7187621|NCT02587598|11388293|FG005|Overall Study|Physician Decision|0
7187622|NCT02587598|11388294|FG006|Overall Study|Physician Decision|0
7187623|NCT02587598|11388295|FG007|Overall Study|Physician Decision|0
7187624|NCT02587598|11388296|FG008|Overall Study|Physician Decision|0
7187625|NCT02587598|11388297|FG009|Overall Study|Physician Decision|0
7187626|NCT02587598|11388298|FG010|Overall Study|Physician Decision|3
7187627|NCT02485574|11388334|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4
7187628|NCT02214160|11388346|FG000|Overall Study|Withdrawal by Subject|1
7187629|NCT02214160|11388347|FG001|Overall Study|Withdrawal by Subject|0
7187630|NCT02214160|11388348|FG002|Overall Study|Withdrawal by Subject|6
7187631|NCT02214160|11388346|FG000|Overall Study|Death|2
7187632|NCT02214160|11388347|FG001|Overall Study|Death|2
7187633|NCT02214160|11388348|FG002|Overall Study|Death|1
7187634|NCT02214160|11388346|FG000|Overall Study|Subject Non-Compliance|0
7187635|NCT02214160|11388347|FG001|Overall Study|Subject Non-Compliance|3
7187636|NCT02214160|11388348|FG002|Overall Study|Subject Non-Compliance|1
7187637|NCT02214160|11388346|FG000|Overall Study|Adverse Event|0
7187638|NCT02214160|11388347|FG001|Overall Study|Adverse Event|1
7187639|NCT02214160|11388348|FG002|Overall Study|Adverse Event|1
7187640|NCT02214160|11388346|FG000|Overall Study|Sponsor Decision|0
7187641|NCT02214160|11388347|FG001|Overall Study|Sponsor Decision|2
7187642|NCT02214160|11388348|FG002|Overall Study|Sponsor Decision|0
7187643|NCT02214160|11388346|FG000|Overall Study|Protocol Violation|1
7187644|NCT02214160|11388347|FG001|Overall Study|Protocol Violation|0
7187645|NCT02214160|11388348|FG002|Overall Study|Protocol Violation|0
7168300|NCT03812510|11355942|FG000|Overall Study|Lost to Follow-up|39
7168301|NCT03812510|11355942|FG000|Overall Study|Withdrawal by Subject|42
7168302|NCT03812510|11355942|FG000|Overall Study|Physician Decision|2
7168303|NCT03812510|11355942|FG000|Overall Study|Study Terminated by Sponsor|9
7168304|NCT03812510|11355942|FG000|Overall Study|Did Not Start Study Medication|55
7168305|NCT03812510|11355942|FG000|Overall Study|Adverse Event|5
7168306|NCT03802994|11355952|FG000|Overall Study|Lost to Follow-up|0
7168307|NCT03802994|11355953|FG001|Overall Study|Lost to Follow-up|2
7168308|NCT03802994|11355954|FG002|Overall Study|Lost to Follow-up|3
7168309|NCT03802994|11355955|FG003|Overall Study|Lost to Follow-up|2
7168310|NCT03802994|11355956|FG004|Overall Study|Lost to Follow-up|2
7168311|NCT03810183|11355981|FG000|Overall Study|Study terminated by Sponsor|2
7168312|NCT03810183|11355982|FG001|Overall Study|Study terminated by Sponsor|1
7168313|NCT03805971|11356022|FG000|Overall Study|Withdrawal by Subject|1
7168314|NCT03805971|11356022|FG000|Overall Study|Protocol Violation|2
7168315|NCT03802916|11356029|FG000|Overall Study|Adverse Event|0
7168316|NCT03802916|11356030|FG001|Overall Study|Adverse Event|1
7168317|NCT03802916|11356029|FG000|Overall Study|Withdrawal by Subject|0
7168318|NCT03802916|11356030|FG001|Overall Study|Withdrawal by Subject|1
7168319|NCT03809039|11356047|FG000|Part 1|Withdrawal by Subject|1
7168320|NCT03809039|11356048|FG001|Part 1|Withdrawal by Subject|0
7168321|NCT03809039|11356049|FG002|Part 1|Withdrawal by Subject|0
7168322|NCT03809039|11356050|FG003|Part 1|Withdrawal by Subject|1
7168323|NCT03809039|11356051|FG004|Part 1|Withdrawal by Subject|0
7168324|NCT03809039|11356052|FG005|Part 1|Withdrawal by Subject|0
7168325|NCT03809039|11356053|FG006|Part 1|Withdrawal by Subject|0
7168326|NCT03809039|11356054|FG007|Part 1|Withdrawal by Subject|0
7168327|NCT03809039|11356055|FG008|Part 1|Withdrawal by Subject|0
7168328|NCT03809039|11356047|FG000|Part 3|Withdrawn by study termination|0
7168329|NCT03809039|11356048|FG001|Part 3|Withdrawn by study termination|0
7168330|NCT03809039|11356049|FG002|Part 3|Withdrawn by study termination|0
7168331|NCT03809039|11356050|FG003|Part 3|Withdrawn by study termination|0
7168332|NCT03809039|11356051|FG004|Part 3|Withdrawn by study termination|0
7168333|NCT03809039|11356052|FG005|Part 3|Withdrawn by study termination|0
7168334|NCT03809039|11356053|FG006|Part 3|Withdrawn by study termination|0
7168335|NCT03809039|11356054|FG007|Part 3|Withdrawn by study termination|2
7168336|NCT03809039|11356055|FG008|Part 3|Withdrawn by study termination|6
7168337|NCT03807700|11356090|FG000|Overall Study|Withdrawal by Subject|2
7168338|NCT03807700|11356091|FG001|Overall Study|Withdrawal by Subject|1
7168339|NCT03804918|11356098|FG000|Overall Study|Participant did not use the app|1
7168340|NCT03803475|11356114|FG000|Overall Study|Physician Decision|1
7168341|NCT03801928|11356167|FG000|Overall Study|Adverse Event|1
7168342|NCT03801928|11356168|FG001|Overall Study|Adverse Event|0
7168343|NCT03801928|11356169|FG002|Overall Study|Adverse Event|1
7168344|NCT03801928|11356170|FG003|Overall Study|Adverse Event|2
7168345|NCT03801928|11356171|FG004|Overall Study|Adverse Event|0
7168346|NCT03801928|11356172|FG005|Overall Study|Adverse Event|2
7168347|NCT03801928|11356167|FG000|Overall Study|Lack of Efficacy|0
7168348|NCT03801928|11356168|FG001|Overall Study|Lack of Efficacy|0
7168349|NCT03801928|11356169|FG002|Overall Study|Lack of Efficacy|1
7168350|NCT03801928|11356170|FG003|Overall Study|Lack of Efficacy|0
7168351|NCT03801928|11356171|FG004|Overall Study|Lack of Efficacy|0
7168352|NCT03801928|11356172|FG005|Overall Study|Lack of Efficacy|0
7168353|NCT03801928|11356167|FG000|Overall Study|Lost to Follow-up|5
7168354|NCT03801928|11356168|FG001|Overall Study|Lost to Follow-up|1
7168355|NCT03801928|11356169|FG002|Overall Study|Lost to Follow-up|1
7168356|NCT03801928|11356170|FG003|Overall Study|Lost to Follow-up|4
7168357|NCT03801928|11356171|FG004|Overall Study|Lost to Follow-up|4
7168358|NCT03801928|11356172|FG005|Overall Study|Lost to Follow-up|2
7168359|NCT03801928|11356167|FG000|Overall Study|Withdrawal by Subject|0
7168360|NCT03801928|11356168|FG001|Overall Study|Withdrawal by Subject|0
7168361|NCT03801928|11356169|FG002|Overall Study|Withdrawal by Subject|2
7168362|NCT03801928|11356170|FG003|Overall Study|Withdrawal by Subject|1
7168363|NCT03801928|11356171|FG004|Overall Study|Withdrawal by Subject|0
7168364|NCT03801928|11356172|FG005|Overall Study|Withdrawal by Subject|0
7168365|NCT03801928|11356167|FG000|Overall Study|Other|0
7168366|NCT03801928|11356168|FG001|Overall Study|Other|2
7168367|NCT03801928|11356169|FG002|Overall Study|Other|0
7168368|NCT03801928|11356170|FG003|Overall Study|Other|1
7168369|NCT03801928|11356171|FG004|Overall Study|Other|0
7168370|NCT03801928|11356172|FG005|Overall Study|Other|1
7168371|NCT03800173|11356194|FG000|Overall Study|Lost to Follow-up|0
7168372|NCT03800173|11356195|FG001|Overall Study|Lost to Follow-up|0
7168373|NCT03800173|11356196|FG002|Overall Study|Lost to Follow-up|0
7168374|NCT03800173|11356197|FG003|Overall Study|Lost to Follow-up|0
7168375|NCT03800173|11356198|FG004|Overall Study|Lost to Follow-up|1
7168376|NCT03799211|11356233|FG000|Overall Study|Lost to Follow-up|2
7168377|NCT03799211|11356234|FG001|Overall Study|Lost to Follow-up|13
7168378|NCT03799211|11356233|FG000|Overall Study|Withdrawal by Subject|2
7168379|NCT03799211|11356234|FG001|Overall Study|Withdrawal by Subject|0
7168380|NCT03798717|11356248|FG000|Overall Study|Failed Screening|0
7168381|NCT03798717|11356249|FG001|Overall Study|Failed Screening|0
7168382|NCT03798717|11356250|FG002|Overall Study|Failed Screening|0
7168383|NCT03798717|11356251|FG003|Overall Study|Failed Screening|0
7168384|NCT03798717|11356252|FG004|Overall Study|Failed Screening|0
7168385|NCT03798717|11356253|FG005|Overall Study|Failed Screening|1
7168386|NCT03798717|11356248|FG000|Overall Study|Physician Decision|1
7168387|NCT03798717|11356249|FG001|Overall Study|Physician Decision|0
7168388|NCT03798717|11356250|FG002|Overall Study|Physician Decision|1
7168389|NCT03798717|11356251|FG003|Overall Study|Physician Decision|0
7168390|NCT03798717|11356252|FG004|Overall Study|Physician Decision|0
7168391|NCT03798717|11356253|FG005|Overall Study|Physician Decision|0
7168392|NCT03798717|11356248|FG000|Overall Study|Withdrawal by Subject|0
7168393|NCT03798717|11356249|FG001|Overall Study|Withdrawal by Subject|0
7168394|NCT03798717|11356250|FG002|Overall Study|Withdrawal by Subject|0
7168395|NCT03798717|11356251|FG003|Overall Study|Withdrawal by Subject|1
7168396|NCT03798717|11356252|FG004|Overall Study|Withdrawal by Subject|0
7168397|NCT03798717|11356253|FG005|Overall Study|Withdrawal by Subject|0
7168398|NCT03798717|11356248|FG000|Overall Study|Lost to Follow-up|1
7168399|NCT03798717|11356249|FG001|Overall Study|Lost to Follow-up|0
7168400|NCT03798717|11356250|FG002|Overall Study|Lost to Follow-up|0
7168401|NCT03798717|11356251|FG003|Overall Study|Lost to Follow-up|1
7168402|NCT03798717|11356252|FG004|Overall Study|Lost to Follow-up|0
7168403|NCT03798717|11356253|FG005|Overall Study|Lost to Follow-up|0
7168404|NCT03798717|11356248|FG000|Overall Study|Adverse Event|0
7168405|NCT03798717|11356249|FG001|Overall Study|Adverse Event|1
7168406|NCT03798717|11356250|FG002|Overall Study|Adverse Event|0
7168407|NCT03798717|11356251|FG003|Overall Study|Adverse Event|0
7168408|NCT03798717|11356252|FG004|Overall Study|Adverse Event|0
7168409|NCT03798717|11356253|FG005|Overall Study|Adverse Event|0
7168410|NCT03798717|11356248|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0
7168411|NCT03798717|11356249|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0
7168412|NCT03798717|11356250|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0
7168413|NCT03798717|11356251|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0
7168414|NCT03798717|11356252|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1
7168415|NCT03798717|11356253|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0
7168416|NCT03798483|11356262|FG000|Overall Study|Lost to Follow-up|2
7168417|NCT03798366|11356272|FG000|Overall Study|Lost to Follow-up|0
7168418|NCT03798366|11356273|FG001|Overall Study|Lost to Follow-up|1
7168419|NCT03799952|11356281|FG000|Overall Study|Program was too easy, discontinued|1
7168420|NCT03799952|11356282|FG001|Overall Study|Program was too easy, discontinued|0
7168421|NCT03799952|11356281|FG000|Overall Study|Lost to Follow-up|0
7168422|NCT03799952|11356282|FG001|Overall Study|Lost to Follow-up|2
7168423|NCT03796728|11356316|FG000|Overall Study|Lost to Follow-up|8
7168424|NCT03796728|11356316|FG000|Overall Study|Reason not Specified|16
7168425|NCT03797144|11356322|FG000|Enrollment|Protocol Violation|4
7168426|NCT03797144|11356323|FG001|Enrollment|Protocol Violation|1
7168427|NCT03797144|11356322|FG000|Surgery|Protocol Violation|1
7168428|NCT03797144|11356323|FG001|Surgery|Protocol Violation|0
7168429|NCT03797144|11356322|FG000|3 Month|Early termination cut-off date|2
7168430|NCT03797144|11356323|FG001|3 Month|Early termination cut-off date|0
7168431|NCT03797144|11356322|FG000|12 Month|Early termination cut-off date|8
7168432|NCT03797144|11356323|FG001|12 Month|Early termination cut-off date|9
7168433|NCT03797144|11356322|FG000|24 Month|Early termination cut-off date|1
7168434|NCT03797144|11356323|FG001|24 Month|Early termination cut-off date|1
7168435|NCT03782571|11356330|FG000|Period 1|Withdrawal by Subject|1
7168436|NCT03782571|11356331|FG001|Period 1|Withdrawal by Subject|0
7168437|NCT03782571|11356332|FG002|Period 1|Withdrawal by Subject|0
7168438|NCT03782571|11356333|FG003|Period 1|Withdrawal by Subject|0
7168439|NCT03782571|11356330|FG000|Period 3|Subject Unable to Attend V5|1
7168440|NCT03782571|11356331|FG001|Period 3|Subject Unable to Attend V5|0
7168441|NCT03782571|11356332|FG002|Period 3|Subject Unable to Attend V5|0
7168442|NCT03782571|11356333|FG003|Period 3|Subject Unable to Attend V5|0
7168443|NCT03782571|11356330|FG000|Period 3|Adverse Event|1
7168444|NCT03782571|11356331|FG001|Period 3|Adverse Event|0
7168445|NCT03782571|11356332|FG002|Period 3|Adverse Event|0
7168446|NCT03782571|11356333|FG003|Period 3|Adverse Event|0
7168447|NCT03796039|11356356|FG000|Overall Study|Death|2
7168448|NCT03796039|11356357|FG001|Overall Study|Death|1
7168449|NCT03796039|11356356|FG000|Overall Study|Withdrawal by Subject|7
7168450|NCT03796039|11356357|FG001|Overall Study|Withdrawal by Subject|4
7168451|NCT03783780|11356363|FG000|Overall Study|Withdrawn prior to completion|1
7168452|NCT03780959|11356371|FG000|Part 1|Adverse Event|1
7168453|NCT03780959|11356372|FG001|Part 1|Adverse Event|0
7168454|NCT03780959|11356373|FG002|Part 1|Adverse Event|0
7168455|NCT03780959|11356371|FG000|Part 1|Withdrawal by Subject|1
7168456|NCT03780959|11356372|FG001|Part 1|Withdrawal by Subject|0
7168457|NCT03780959|11356373|FG002|Part 1|Withdrawal by Subject|0
7168458|NCT03780959|11356371|FG000|Part 1|Withdrawal by Parent/Guardian|1
7168459|NCT03780959|11356372|FG001|Part 1|Withdrawal by Parent/Guardian|0
7168460|NCT03780959|11356373|FG002|Part 1|Withdrawal by Parent/Guardian|0
7168461|NCT03780959|11356371|FG000|Part 1|Response Status|2
7168462|NCT03780959|11356372|FG001|Part 1|Response Status|0
7168463|NCT03780959|11356373|FG002|Part 1|Response Status|0
7168464|NCT03780959|11356371|FG000|Part 2|Withdrawal by Parent/Guardian|0
7168465|NCT03780959|11356372|FG001|Part 2|Withdrawal by Parent/Guardian|1
7168466|NCT03780959|11356373|FG002|Part 2|Withdrawal by Parent/Guardian|0
7168467|NCT03780959|11356371|FG000|Part 2|Response Status|0
7168468|NCT03780959|11356372|FG001|Part 2|Response Status|18
7168469|NCT03780959|11356373|FG002|Part 2|Response Status|6
7168470|NCT03792477|11356413|FG000|Overall Study|Adverse Event|0
7168471|NCT03792477|11356414|FG001|Overall Study|Adverse Event|0
7168472|NCT03792477|11356415|FG002|Overall Study|Adverse Event|0
7168473|NCT03792477|11356416|FG003|Overall Study|Adverse Event|1
7168474|NCT03792477|11356417|FG004|Overall Study|Adverse Event|0
7168475|NCT03792477|11356413|FG000|Overall Study|Lost to Follow-up|0
7168476|NCT03792477|11356414|FG001|Overall Study|Lost to Follow-up|0
7168477|NCT03792477|11356415|FG002|Overall Study|Lost to Follow-up|2
7168478|NCT03792477|11356416|FG003|Overall Study|Lost to Follow-up|0
7168479|NCT03792477|11356417|FG004|Overall Study|Lost to Follow-up|0
7168480|NCT03792477|11356413|FG000|Overall Study|Other|0
7168481|NCT03792477|11356414|FG001|Overall Study|Other|0
7168482|NCT03792477|11356415|FG002|Overall Study|Other|0
7168483|NCT03792477|11356416|FG003|Overall Study|Other|0
7168484|NCT03792477|11356417|FG004|Overall Study|Other|1
7168485|NCT03783962|11356425|FG000|Overall Study|Lost to Follow-up|3
7168486|NCT03783962|11356426|FG001|Overall Study|Lost to Follow-up|6
7168487|NCT03783962|11356425|FG000|Overall Study|Protocol Violation|0
7168488|NCT03783962|11356426|FG001|Overall Study|Protocol Violation|1
7168489|NCT03793556|11356481|FG000|Overall Study|Withdrawal by Subject|12
7168490|NCT03793556|11356482|FG001|Overall Study|Withdrawal by Subject|1
7168491|NCT03793556|11356481|FG000|Overall Study|Lost to Follow-up|1
7168492|NCT03793556|11356482|FG001|Overall Study|Lost to Follow-up|1
7168493|NCT03785548|11356493|FG000|Overall Study|age > 80|1
7168494|NCT03785548|11356494|FG001|Overall Study|age > 80|0
7168495|NCT03785548|11356493|FG000|Overall Study|no Postop queries|1
7168496|NCT03785548|11356494|FG001|Overall Study|no Postop queries|0
7168497|NCT03773133|11356506|FG000|Overall Study|Screen Failure|8
7168498|NCT03792672|11356511|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1
7168499|NCT03792672|11356512|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0
7168500|NCT03792672|11356513|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0
7168501|NCT03792672|11356514|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2
7168502|NCT03792672|11356515|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0
7168503|NCT03792672|11356516|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0
7168504|NCT03792672|11356511|FG000|Washout Period 3 (10 Days)|Physician Decision|0
7168505|NCT03792672|11356512|FG001|Washout Period 3 (10 Days)|Physician Decision|0
7168506|NCT03792672|11356513|FG002|Washout Period 3 (10 Days)|Physician Decision|1
7168507|NCT03792672|11356514|FG003|Washout Period 3 (10 Days)|Physician Decision|0
7168508|NCT03792672|11356515|FG004|Washout Period 3 (10 Days)|Physician Decision|0
7168509|NCT03792672|11356516|FG005|Washout Period 3 (10 Days)|Physician Decision|0
7168510|NCT03792672|11356511|FG000|Treatment Period 4 (2 Days)|Other|1
7168511|NCT03792672|11356512|FG001|Treatment Period 4 (2 Days)|Other|0
7168512|NCT03792672|11356513|FG002|Treatment Period 4 (2 Days)|Other|0
7168513|NCT03792672|11356514|FG003|Treatment Period 4 (2 Days)|Other|0
7168514|NCT03792672|11356515|FG004|Treatment Period 4 (2 Days)|Other|0
7168515|NCT03792672|11356516|FG005|Treatment Period 4 (2 Days)|Other|0
7168516|NCT03787615|11356625|FG000|Overall Study|Withdrawal by Subject|2
7168517|NCT03787615|11356625|FG000|Overall Study|Lost to Follow-up|2
7168518|NCT03786718|11356630|FG000|Overall Study|Lost to Follow-up|3
7168519|NCT03786718|11356630|FG000|Overall Study|Withdrawal by Subject|1
7168520|NCT03786718|11356630|FG000|Overall Study|Did not use the intervention|2
7168521|NCT03786718|11356630|FG000|Overall Study|diagnosis changed from type 2 to type 1|1
7168522|NCT03784963|11356639|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12
7168523|NCT03784963|11356640|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10
7168524|NCT03784963|11356641|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1
7168525|NCT03784963|11356642|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0
7168526|NCT03787212|11356663|FG000|Period 1|Study Termination|2
7168527|NCT03787212|11356664|FG001|Period 1|Study Termination|2
7168528|NCT03783702|11356685|FG000|Overall Study|Lost to Follow-up|6
7168529|NCT03783702|11356686|FG001|Overall Study|Lost to Follow-up|8
7168530|NCT03783702|11356685|FG000|Overall Study|Protocol Violation|1
7168531|NCT03783702|11356686|FG001|Overall Study|Protocol Violation|3
7168532|NCT03783039|11356744|FG000|Overall Study|Death|2
7168533|NCT03783039|11356745|FG001|Overall Study|Death|1
7168534|NCT03776175|11356773|FG000|Treatment Period (42 Days)|Adverse Event|0
7168535|NCT03776175|11356774|FG001|Treatment Period (42 Days)|Adverse Event|1
7168536|NCT03776175|11356775|FG002|Treatment Period (42 Days)|Adverse Event|1
7168537|NCT03776175|11356776|FG003|Treatment Period (42 Days)|Adverse Event|0
7168538|NCT03776175|11356773|FG000|Treatment Period (42 Days)|Lost to Follow-up|0
7168539|NCT03776175|11356774|FG001|Treatment Period (42 Days)|Lost to Follow-up|0
7168540|NCT03776175|11356775|FG002|Treatment Period (42 Days)|Lost to Follow-up|0
7168541|NCT03776175|11356776|FG003|Treatment Period (42 Days)|Lost to Follow-up|2
7168542|NCT03776175|11356773|FG000|Treatment Period (42 Days)|Participants screened at other site|0
7168543|NCT03776175|11356774|FG001|Treatment Period (42 Days)|Participants screened at other site|2
7168544|NCT03776175|11356775|FG002|Treatment Period (42 Days)|Participants screened at other site|0
7168545|NCT03776175|11356776|FG003|Treatment Period (42 Days)|Participants screened at other site|0
7168546|NCT03776175|11356773|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1
7168547|NCT03776175|11356774|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2
7168548|NCT03776175|11356775|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3
7168549|NCT03776175|11356776|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0
7168550|NCT03776175|11356773|FG000|Treatment Period (42 Days)|Unable to attend study visits|0
7168551|NCT03776175|11356774|FG001|Treatment Period (42 Days)|Unable to attend study visits|2
7168552|NCT03776175|11356775|FG002|Treatment Period (42 Days)|Unable to attend study visits|0
7168553|NCT03776175|11356776|FG003|Treatment Period (42 Days)|Unable to attend study visits|0
7168554|NCT03776175|11356773|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0
7168555|NCT03776175|11356774|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0
7168556|NCT03776175|11356775|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0
7168557|NCT03776175|11356776|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2
7168558|NCT03771963|11356786|FG000|Overall Study|Lost to Follow-up|22
7168559|NCT03771963|11356786|FG000|Overall Study|Withdrawal of Consent|10
7168560|NCT03771352|11356790|FG000|Overall Study|Screen failure|2
7168561|NCT03771352|11356790|FG000|Overall Study|Withdrawal by Subject|2
7168562|NCT03773796|11356794|FG000|Overall Study|Adverse Event|1
7168563|NCT03773796|11356794|FG000|Overall Study|Withdrawal by Subject|1
7168564|NCT03773796|11356794|FG000|Overall Study|Lack of Efficacy|1
7168565|NCT03781375|11356811|FG000|Double-blind Phase|Adverse Event|0
7168566|NCT03781375|11356812|FG001|Double-blind Phase|Adverse Event|1
7168567|NCT03781375|11356811|FG000|Double-blind Phase|Lack of Response|6
7168568|NCT03781375|11356812|FG001|Double-blind Phase|Lack of Response|2
7168569|NCT03781375|11356811|FG000|Double-blind Phase|Other|1
7168570|NCT03781375|11356812|FG001|Double-blind Phase|Other|3
7168571|NCT03781375|11356811|FG000|Open-label Phase|Protocol Issues|0
7168572|NCT03781375|11356812|FG001|Open-label Phase|Protocol Issues|1
7168573|NCT03781375|11356811|FG000|Open-label Phase|Suboptimal Clinical Response|1
7168574|NCT03781375|11356812|FG001|Open-label Phase|Suboptimal Clinical Response|0
7168575|NCT03781375|11356811|FG000|Open-label Phase|Other|2
7168576|NCT03781375|11356812|FG001|Open-label Phase|Other|2
7168577|NCT03781336|11356821|FG000|Overall Study|Withdrawal by Subject|2
7168578|NCT03781336|11356822|FG001|Overall Study|Withdrawal by Subject|2
7168579|NCT03780400|11356828|FG000|Overall Study|Lost to Follow-up|5
7168580|NCT03780400|11356828|FG000|Overall Study|Withdrawal by Subject|2
7168581|NCT03779503|11356841|FG000|First Intervention|Adverse Event|0
7168582|NCT03779503|11356842|FG001|First Intervention|Adverse Event|1
7168583|NCT03779503|11356841|FG000|First Intervention|Withdrawal by Subject|1
7168584|NCT03779503|11356842|FG001|First Intervention|Withdrawal by Subject|0
7168585|NCT03777059|11356876|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6
7168586|NCT03777059|11356877|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9
7168587|NCT03777059|11356878|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4
7168588|NCT03777059|11356879|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6
7168589|NCT03777059|11356876|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1
7168590|NCT03777059|11356877|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0
7168591|NCT03777059|11356878|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0
7168592|NCT03777059|11356879|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1
7168593|NCT03777059|11356876|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8
7168594|NCT03777059|11356877|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9
7168595|NCT03777059|11356878|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8
7168596|NCT03777059|11356879|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10
7168597|NCT03777059|11356876|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3
7168598|NCT03777059|11356877|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3
7168599|NCT03777059|11356878|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4
7168600|NCT03777059|11356879|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5
7168601|NCT03777059|11356876|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0
7168602|NCT03777059|11356877|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1
7168603|NCT03777059|11356878|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0
7168604|NCT03777059|11356879|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0
7168605|NCT03777059|11356876|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4
7168606|NCT03777059|11356877|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5
7168607|NCT03777059|11356878|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7
7168608|NCT03777059|11356879|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8
7168609|NCT03777059|11356876|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0
7168610|NCT03777059|11356877|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2
7168611|NCT03777059|11356878|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0
7168612|NCT03777059|11356879|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1
7168613|NCT03777059|11356876|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5
7168614|NCT03777059|11356877|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3
7168615|NCT03777059|11356878|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4
7168616|NCT03777059|11356879|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5
7168617|NCT03777059|11356876|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0
7168618|NCT03777059|11356877|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1
7168619|NCT03777059|11356878|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0
7168620|NCT03777059|11356879|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3
7168621|NCT03777059|11356876|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0
7168622|NCT03777059|11356877|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1
7168623|NCT03777059|11356878|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1
7168624|NCT03777059|11356879|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0
7168625|NCT03777059|11356876|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0
7168626|NCT03777059|11356877|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0
7168627|NCT03777059|11356878|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1
7168628|NCT03777059|11356879|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1
7168629|NCT03772522|11356891|FG000|Pre-intervention|Withdrawal by Subject|3
7168630|NCT03772522|11356892|FG001|Pre-intervention|Withdrawal by Subject|4
7168631|NCT03772522|11356891|FG000|Intervention|Withdrawal by Subject|1
7168632|NCT03772522|11356892|FG001|Intervention|Withdrawal by Subject|0
7168633|NCT03772522|11356891|FG000|Post-intervention Follow-up|Lost to Follow-up|1
7168634|NCT03772522|11356892|FG001|Post-intervention Follow-up|Lost to Follow-up|0
7168635|NCT03772327|11356904|FG000|Overall Study|Lost to Follow-up|3
7168636|NCT03772327|11356905|FG001|Overall Study|Lost to Follow-up|4
7168637|NCT03772327|11356904|FG000|Overall Study|Withdrawal by Subject|2
7168638|NCT03772327|11356905|FG001|Overall Study|Withdrawal by Subject|3
7168639|NCT03774576|11356915|FG000|Period 2|Adverse Event|1
7168640|NCT03772041|11356943|FG000|Overall Study|Adverse Event|8
7168641|NCT03772041|11356944|FG001|Overall Study|Adverse Event|3
7168642|NCT03772041|11356943|FG000|Overall Study|Withdrawal by Subject|0
7168643|NCT03772041|11356944|FG001|Overall Study|Withdrawal by Subject|2
7168644|NCT03772041|11356943|FG000|Overall Study|Protocol Violation|4
7168645|NCT03772041|11356944|FG001|Overall Study|Protocol Violation|2
7168646|NCT03772041|11356943|FG000|Overall Study|Physician Decision|2
7168647|NCT03772041|11356944|FG001|Overall Study|Physician Decision|3
7168648|NCT03775681|11356950|FG000|Overall Study|Physician Decision|3
7168649|NCT03774823|11356956|FG000|Overall Study|Withdrawal by Subject|1
7168650|NCT03774823|11356957|FG001|Overall Study|Withdrawal by Subject|1
7168651|NCT03774433|11356972|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14
7184823|NCT03578276|11385211|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2
7184824|NCT03578276|11385212|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2
7184825|NCT03035409|11385227|FG000|Overall Study|Adverse Event|5
7184826|NCT03035409|11385227|FG000|Overall Study|Death|2
7184827|NCT03035409|11385227|FG000|Overall Study|Withdrawal by Subject|2
7184828|NCT03035409|11385227|FG000|Overall Study|Non compliance|4
7184829|NCT03035409|11385227|FG000|Overall Study|Patient was jittery|1
7184830|NCT03035409|11385227|FG000|Overall Study|Did not like Questionnaire|1
7184831|NCT03035409|11385227|FG000|Overall Study|Aspartate Aminotransferase increased|1
7184832|NCT03035409|11385227|FG000|Overall Study|Did not like taking drugs|1
7184833|NCT02971761|11385231|FG000|Overall Study|GTx-024 drug supply was withdrawn|2
7184834|NCT02220894|11385263|FG000|Overall Study|Adverse Event|118
7184835|NCT02220894|11385264|FG001|Overall Study|Adverse Event|70
7184836|NCT02220894|11385263|FG000|Overall Study|Death|252
7184837|NCT02220894|11385264|FG001|Overall Study|Death|368
7184838|NCT02220894|11385263|FG000|Overall Study|Lost to Follow-up|0
7184839|NCT02220894|11385264|FG001|Overall Study|Lost to Follow-up|2
7184840|NCT02220894|11385263|FG000|Overall Study|Withdrawal by Parent/Guardian|0
7184841|NCT02220894|11385264|FG001|Overall Study|Withdrawal by Parent/Guardian|1
7184842|NCT02220894|11385263|FG000|Overall Study|Withdrawal by Subject|2
7184843|NCT02220894|11385264|FG001|Overall Study|Withdrawal by Subject|13
7184844|NCT02220894|11385263|FG000|Overall Study|Ongoing in Study|265
7184845|NCT02220894|11385264|FG001|Overall Study|Ongoing in Study|183
7184846|NCT01968213|11385281|FG000|Overall Study|Ongoing|90
7184847|NCT01968213|11385282|FG001|Overall Study|Ongoing|9
7184848|NCT01843374|11385290|FG000|Overall Study|Death|155
7184849|NCT01843374|11385291|FG001|Overall Study|Death|313
7184850|NCT01843374|11385290|FG000|Overall Study|Withdrawal by Subject|14
7184851|NCT01843374|11385291|FG001|Overall Study|Withdrawal by Subject|20
7184852|NCT01843374|11385290|FG000|Overall Study|Withdrawing due to Other reason|20
7184853|NCT01843374|11385291|FG001|Overall Study|Withdrawing due to Other reason|46
7184854|NCT01627574|11385306|FG000|Overall Study|Withdrawal by Subject|8
7184855|NCT01627574|11385307|FG001|Overall Study|Withdrawal by Subject|5
7184856|NCT01627574|11385306|FG000|Overall Study|Lost to Follow-up|13
7184857|NCT01627574|11385307|FG001|Overall Study|Lost to Follow-up|13
7184858|NCT01498458|11385313|FG000|Overall Study|Adverse Event|4
7184859|NCT01498458|11385313|FG000|Overall Study|Physician Decision|3
7184860|NCT01427712|11385322|FG000|Overall Study|Transfer to a different hospital|2
7184861|NCT01427712|11385322|FG000|Overall Study|Lost to Follow-up|1
7184862|NCT01427712|11385322|FG000|Overall Study|Aggravation of cystic fibrosis|3
7184863|NCT01427712|11385322|FG000|Overall Study|Failure to visit|1
7184864|NCT01369147|11385329|FG000|Overall Study|All collected data were unintentionally destroyed|0
7184865|NCT01369147|11385330|FG001|Overall Study|All collected data were unintentionally destroyed|1
7184866|NCT01369147|11385331|FG002|Overall Study|All collected data were unintentionally destroyed|0
7184867|NCT01097746|11385339|FG000|Overall Study|Adverse Event|4
7184868|NCT01097746|11385339|FG000|Overall Study|taken off study before any treatment given|1
7184869|NCT01079780|11385346|FG000|Overall Study|Disease progression|43
7184870|NCT01079780|11385347|FG001|Overall Study|Disease progression|7
7184871|NCT01079780|11385348|FG002|Overall Study|Disease progression|31
7184872|NCT01079780|11385346|FG000|Overall Study|Adverse Event|13
7184873|NCT01079780|11385347|FG001|Overall Study|Adverse Event|5
7184874|NCT01079780|11385348|FG002|Overall Study|Adverse Event|7
7184875|NCT01079780|11385346|FG000|Overall Study|Death|2
7184876|NCT01079780|11385347|FG001|Overall Study|Death|0
7168652|NCT03769896|11356995|FG000|Open-label Phase|Lack of Efficacy|5
7168653|NCT03769896|11356996|FG001|Open-label Phase|Lack of Efficacy|0
7168654|NCT03769896|11356995|FG000|Open-label Phase|Adverse Event|3
7168655|NCT03769896|11356996|FG001|Open-label Phase|Adverse Event|0
7168656|NCT03769896|11356995|FG000|Open-label Phase|Withdrawal by Subject|1
7168657|NCT03769896|11356996|FG001|Open-label Phase|Withdrawal by Subject|0
7168658|NCT03768726|11357013|FG000|Treatment Phase|Adverse Event|2
7168659|NCT03768726|11357014|FG001|Treatment Phase|Adverse Event|2
7168660|NCT03768726|11357013|FG000|Treatment Phase|Lost to Follow-up|1
7168661|NCT03768726|11357014|FG001|Treatment Phase|Lost to Follow-up|0
7168662|NCT03768726|11357013|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2
7168663|NCT03768726|11357014|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0
7168664|NCT03768726|11357013|FG000|Treatment Phase|Withdrawal by Subject|3
7168665|NCT03768726|11357014|FG001|Treatment Phase|Withdrawal by Subject|1
7168666|NCT03768726|11357013|FG000|Follow-Up|Adverse Event|2
7168667|NCT03768726|11357014|FG001|Follow-Up|Adverse Event|2
7168668|NCT03768726|11357013|FG000|Follow-Up|Withdrawal By Parent/Guardian|1
7168669|NCT03768726|11357014|FG001|Follow-Up|Withdrawal By Parent/Guardian|1
7168670|NCT03768726|11357013|FG000|Follow-Up|Withdrawal by Subject|2
7168671|NCT03768726|11357014|FG001|Follow-Up|Withdrawal by Subject|0
7168672|NCT03768726|11357013|FG000|Follow-Up|Other|1
7168673|NCT03768726|11357014|FG001|Follow-Up|Other|0
7168674|NCT03768206|11357022|FG000|Overall Study|Lost to Follow-up|2
7168675|NCT03768206|11357023|FG001|Overall Study|Lost to Follow-up|1
7168676|NCT03768206|11357022|FG000|Overall Study|Withdrawal by Subject|0
7168677|NCT03768206|11357023|FG001|Overall Study|Withdrawal by Subject|1
7168678|NCT03767894|11357030|FG000|Overall Study|Withdrawal by Subject|1
7168679|NCT03766646|11357063|FG000|Overall Study|Withdrawal by Subject|1
7168680|NCT03766646|11357064|FG001|Overall Study|Withdrawal by Subject|0
7168681|NCT03766646|11357063|FG000|Overall Study|Protocol Violation|0
7168682|NCT03766646|11357064|FG001|Overall Study|Protocol Violation|3
7168683|NCT03765164|11357136|FG000|Pre-intervention|Withdrawal by Subject|5
7168684|NCT03765164|11357137|FG001|Pre-intervention|Withdrawal by Subject|6
7168685|NCT03765138|11357143|FG000|Overall Study|Lost to Follow-up|1
7168686|NCT03762681|11357211|FG000|Part 1|Withdrawal by Subject|0
7168687|NCT03762681|11357212|FG001|Part 1|Withdrawal by Subject|0
7168688|NCT03762681|11357213|FG002|Part 1|Withdrawal by Subject|0
7168689|NCT03762681|11357214|FG003|Part 1|Withdrawal by Subject|1
7168690|NCT03762681|11357215|FG004|Part 1|Withdrawal by Subject|0
7168691|NCT03762681|11357216|FG005|Part 1|Withdrawal by Subject|0
7168692|NCT03762681|11357217|FG006|Part 1|Withdrawal by Subject|0
7168693|NCT03762681|11357218|FG007|Part 1|Withdrawal by Subject|0
7168694|NCT03762681|11357211|FG000|Part 2a|Pandemic Travel Restrictions|0
7168695|NCT03762681|11357212|FG001|Part 2a|Pandemic Travel Restrictions|0
7168696|NCT03762681|11357213|FG002|Part 2a|Pandemic Travel Restrictions|0
7168697|NCT03762681|11357214|FG003|Part 2a|Pandemic Travel Restrictions|0
7168698|NCT03762681|11357215|FG004|Part 2a|Pandemic Travel Restrictions|0
7168699|NCT03762681|11357216|FG005|Part 2a|Pandemic Travel Restrictions|0
7168700|NCT03762681|11357217|FG006|Part 2a|Pandemic Travel Restrictions|0
7168701|NCT03762681|11357218|FG007|Part 2a|Pandemic Travel Restrictions|1
7168702|NCT03762668|11357247|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0
7168703|NCT03762668|11357248|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1
7168704|NCT03762616|11357254|FG000|Overall Study|Protocol Violation|2
7168705|NCT03762200|11357269|FG000|Overall Study|Death|2
7168706|NCT03761147|11357284|FG000|Overall Study|Withdrawal by Subject|6
7168707|NCT03761147|11357285|FG001|Overall Study|Withdrawal by Subject|1
7168708|NCT03761147|11357284|FG000|Overall Study|Adverse Event|1
7168709|NCT03761147|11357285|FG001|Overall Study|Adverse Event|3
7168710|NCT03760510|11357399|FG000|Overall Study|Not ventilated for 24 hours|105
7168711|NCT03760510|11357400|FG001|Overall Study|Not ventilated for 24 hours|97
7168712|NCT03760250|11357406|FG000|Overall Study|Withdrawal by Subject|1
7168713|NCT03760250|11357406|FG000|Overall Study|Physician Decision|1
7168714|NCT03759600|11357410|FG000|Overall Study|Ongoing at Data Cut-off|16
7168715|NCT03759600|11357410|FG000|Overall Study|Adverse Event|1
7168716|NCT03759600|11357410|FG000|Overall Study|Progressive Disease|3
7168717|NCT03759340|11357414|FG000|Overall Study|Adverse Event|2
7168718|NCT03759340|11357414|FG000|Overall Study|Lost to Follow-up|1
7168719|NCT03759340|11357414|FG000|Overall Study|Withdrawal by Subject|15
7168720|NCT03759340|11357414|FG000|Overall Study|Study Terminated by Sponsor|38
7168721|NCT03757988|11357437|FG000|Overall Study|Withdrawal by Subject|1
7168722|NCT03757234|11357458|FG000|Overall Study|Adverse Event|0
7168723|NCT03757234|11357459|FG001|Overall Study|Adverse Event|0
7168724|NCT03757234|11357460|FG002|Overall Study|Adverse Event|0
7168725|NCT03757234|11357461|FG003|Overall Study|Adverse Event|0
7168726|NCT03757234|11357462|FG004|Overall Study|Adverse Event|1
6972746|NCT01173692|11023930|FG001|Overall Study|Withdrawal by Subject|3
7168727|NCT03757234|11357458|FG000|Overall Study|Lost to Follow-up|1
7168728|NCT03757234|11357459|FG001|Overall Study|Lost to Follow-up|0
7168729|NCT03757234|11357460|FG002|Overall Study|Lost to Follow-up|0
7168730|NCT03757234|11357461|FG003|Overall Study|Lost to Follow-up|0
7168731|NCT03757234|11357462|FG004|Overall Study|Lost to Follow-up|1
7168732|NCT03757234|11357458|FG000|Overall Study|Withdrawal by Subject|1
7168733|NCT03757234|11357459|FG001|Overall Study|Withdrawal by Subject|1
7168734|NCT03757234|11357460|FG002|Overall Study|Withdrawal by Subject|0
7168735|NCT03757234|11357461|FG003|Overall Study|Withdrawal by Subject|1
7168736|NCT03757234|11357462|FG004|Overall Study|Withdrawal by Subject|2
7168737|NCT03757234|11357458|FG000|Overall Study|Other|1
7168738|NCT03757234|11357459|FG001|Overall Study|Other|1
7168739|NCT03757234|11357460|FG002|Overall Study|Other|0
7168740|NCT03757234|11357461|FG003|Overall Study|Other|0
7168741|NCT03757234|11357462|FG004|Overall Study|Other|0
7168742|NCT03756883|11357490|FG000|Overall Study|Adverse Event|2
7168743|NCT03756883|11357491|FG001|Overall Study|Adverse Event|2
7168744|NCT03756883|11357492|FG002|Overall Study|Adverse Event|2
7168745|NCT03756883|11357490|FG000|Overall Study|Lack of Efficacy|0
7168746|NCT03756883|11357491|FG001|Overall Study|Lack of Efficacy|1
7168747|NCT03756883|11357492|FG002|Overall Study|Lack of Efficacy|2
7168748|NCT03756883|11357490|FG000|Overall Study|Lost to Follow-up|3
7168749|NCT03756883|11357491|FG001|Overall Study|Lost to Follow-up|3
7168750|NCT03756883|11357492|FG002|Overall Study|Lost to Follow-up|0
7168751|NCT03756883|11357490|FG000|Overall Study|Protocol Violation|2
7168752|NCT03756883|11357491|FG001|Overall Study|Protocol Violation|0
7168753|NCT03756883|11357492|FG002|Overall Study|Protocol Violation|1
7168754|NCT03756883|11357490|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0
7168755|NCT03756883|11357491|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0
7168756|NCT03756883|11357492|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2
7168757|NCT03756883|11357490|FG000|Overall Study|Withdrawal by Subject|4
7168758|NCT03756883|11357491|FG001|Overall Study|Withdrawal by Subject|1
7168759|NCT03756883|11357492|FG002|Overall Study|Withdrawal by Subject|0
7168760|NCT03756883|11357490|FG000|Overall Study|Other Reasons|2
7168761|NCT03756883|11357491|FG001|Overall Study|Other Reasons|4
7168762|NCT03756883|11357492|FG002|Overall Study|Other Reasons|0
7168763|NCT03756285|11357511|FG000|Overall Study|Lost to Follow-up|0
7168764|NCT03756285|11357512|FG001|Overall Study|Lost to Follow-up|1
7168765|NCT03756285|11357511|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0
7168766|NCT03756285|11357512|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1
7168767|NCT03756285|11357511|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3
7168768|NCT03756285|11357512|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3
7168769|NCT03756129|11357525|FG000|Overall Study|Adverse Event|1
7168770|NCT03756129|11357526|FG001|Overall Study|Adverse Event|1
7168771|NCT03756129|11357527|FG002|Overall Study|Adverse Event|0
7168772|NCT03756129|11357528|FG003|Overall Study|Adverse Event|2
7168773|NCT03756129|11357529|FG004|Overall Study|Adverse Event|0
7168774|NCT03756129|11357530|FG005|Overall Study|Adverse Event|0
7168775|NCT03756129|11357525|FG000|Overall Study|Withdrawal by Subject|2
7168776|NCT03756129|11357526|FG001|Overall Study|Withdrawal by Subject|1
7168777|NCT03756129|11357527|FG002|Overall Study|Withdrawal by Subject|3
7168778|NCT03756129|11357528|FG003|Overall Study|Withdrawal by Subject|1
7168779|NCT03756129|11357529|FG004|Overall Study|Withdrawal by Subject|1
7168780|NCT03756129|11357530|FG005|Overall Study|Withdrawal by Subject|3
7168781|NCT03756129|11357525|FG000|Overall Study|Lost to Follow-up|0
7168782|NCT03756129|11357526|FG001|Overall Study|Lost to Follow-up|0
7168783|NCT03756129|11357527|FG002|Overall Study|Lost to Follow-up|0
7168784|NCT03756129|11357528|FG003|Overall Study|Lost to Follow-up|0
7168785|NCT03756129|11357529|FG004|Overall Study|Lost to Follow-up|0
7168786|NCT03756129|11357530|FG005|Overall Study|Lost to Follow-up|1
7168787|NCT03756129|11357525|FG000|Overall Study|Physician Decision|0
7168788|NCT03756129|11357526|FG001|Overall Study|Physician Decision|0
7168789|NCT03756129|11357527|FG002|Overall Study|Physician Decision|0
7168790|NCT03756129|11357528|FG003|Overall Study|Physician Decision|0
7168791|NCT03756129|11357529|FG004|Overall Study|Physician Decision|0
7168792|NCT03756129|11357530|FG005|Overall Study|Physician Decision|1
7168793|NCT03755882|11357566|FG000|Period 1|Protocol Violation|1
7168794|NCT03755882|11357567|FG001|Period 1|Protocol Violation|0
7168795|NCT03755882|11357566|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3
7168796|NCT03755882|11357567|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0
7168797|NCT03755661|11357575|FG000|Overall Study|Lost to Follow-up|1
7168798|NCT03755661|11357576|FG001|Overall Study|Lost to Follow-up|0
7168799|NCT03754582|11357582|FG000|Treatment Phase|Adverse Event|0
7168800|NCT03754582|11357583|FG001|Treatment Phase|Adverse Event|1
7168801|NCT03754582|11357584|FG002|Treatment Phase|Adverse Event|0
7168802|NCT03754582|11357582|FG000|Follow-up Phase|Other|0
7168803|NCT03754582|11357583|FG001|Follow-up Phase|Other|0
7168804|NCT03754582|11357584|FG002|Follow-up Phase|Other|1
7168805|NCT03752528|11357617|FG000|Part A|Lost to Follow-up|1
7168806|NCT03752528|11357617|FG000|Part A|Protocol Violation|1
7168807|NCT03752528|11357617|FG000|Part B|Protocol Violation|1
7168808|NCT03752528|11357617|FG000|Part B|Study terminated by sponsor|3
7168809|NCT03752151|11357624|FG000|Overall Study|Withdrawal by Subject|1
7168810|NCT03752151|11357624|FG000|Overall Study|Protocol Violation|1
7168811|NCT03751657|11357631|FG000|Overall Study|Physician Decision|0
7168812|NCT03751657|11357632|FG001|Overall Study|Physician Decision|1
7168813|NCT03751657|11357631|FG000|Overall Study|Withdrawal by Subject|1
7168814|NCT03751657|11357632|FG001|Overall Study|Withdrawal by Subject|1
7168815|NCT03751657|11357631|FG000|Overall Study|Lost to Follow-up|2
7168816|NCT03751657|11357632|FG001|Overall Study|Lost to Follow-up|1
7168817|NCT03751280|11357640|FG000|Overall Study|Adverse Event|0
7168818|NCT03751280|11357641|FG001|Overall Study|Adverse Event|1
7168819|NCT03751280|11357640|FG000|Overall Study|Lost to Follow-up|3
7168820|NCT03751280|11357641|FG001|Overall Study|Lost to Follow-up|5
7168821|NCT03751280|11357640|FG000|Overall Study|Physician Decision|0
7168822|NCT03751280|11357641|FG001|Overall Study|Physician Decision|2
7168823|NCT03751280|11357640|FG000|Overall Study|Protocol Violation|0
7168824|NCT03751280|11357641|FG001|Overall Study|Protocol Violation|2
7168825|NCT03751280|11357640|FG000|Overall Study|Withdrawal by Subject|5
7168826|NCT03751280|11357641|FG001|Overall Study|Withdrawal by Subject|2
7168827|NCT03751020|11357651|FG000|Overall Study|Withdrawal by Subject|2
7168828|NCT03751020|11357652|FG001|Overall Study|Withdrawal by Subject|0
7168829|NCT03751020|11357653|FG002|Overall Study|Withdrawal by Subject|0
7168830|NCT03751020|11357651|FG000|Overall Study|Lost to Follow-up|7
7168831|NCT03751020|11357652|FG001|Overall Study|Lost to Follow-up|4
7168832|NCT03751020|11357653|FG002|Overall Study|Lost to Follow-up|10
7168833|NCT03750955|11357663|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2
7168834|NCT03750955|11357664|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2
7168835|NCT03750955|11357663|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1
7168836|NCT03750955|11357664|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1
7168837|NCT03750695|11357672|FG000|Overall Study|Lost to Follow-up|0
7168838|NCT03750695|11357673|FG001|Overall Study|Lost to Follow-up|1
7168839|NCT03748706|11357781|FG000|Overall Study|Lost to Follow-up|1
7168840|NCT03746405|11357809|FG000|Overall Study|Withdrawal by Subject|3
7168841|NCT03746405|11357810|FG001|Overall Study|Withdrawal by Subject|0
7168842|NCT03746405|11357809|FG000|Overall Study|technical difficulties|0
7168843|NCT03746405|11357810|FG001|Overall Study|technical difficulties|2
7168844|NCT03745937|11357820|FG000|Overall Study|Withdrawal by Subject|0
7168845|NCT03745937|11357821|FG001|Overall Study|Withdrawal by Subject|0
7168846|NCT03745937|11357822|FG002|Overall Study|Withdrawal by Subject|0
7168847|NCT03745937|11357823|FG003|Overall Study|Withdrawal by Subject|1
7168848|NCT03745937|11357820|FG000|Overall Study|Not-specifed|0
7168849|NCT03745937|11357821|FG001|Overall Study|Not-specifed|1
7168850|NCT03745937|11357822|FG002|Overall Study|Not-specifed|0
7168851|NCT03745937|11357823|FG003|Overall Study|Not-specifed|1
7168852|NCT03745222|11357837|FG000|Overall Study|Withdrawal by Subject|0
7168853|NCT03745222|11357838|FG001|Overall Study|Withdrawal by Subject|1
7168854|NCT03745222|11357839|FG002|Overall Study|Withdrawal by Subject|0
7168855|NCT03743038|11357874|FG000|Overall Study|Physician Decision|1
7168856|NCT03742271|11357897|FG000|Overall Study|Unsatisfactory Visual Response|1
7168857|NCT03742271|11357897|FG000|Overall Study|Withdrawal by Subject|3
7168858|NCT03742271|11357897|FG000|Overall Study|Lost to Follow-up|4
7168859|NCT03742271|11357897|FG000|Overall Study|Failed Insertion & removal|3
7168860|NCT03742271|11357897|FG000|Overall Study|Protocol Violation|1
7168861|NCT03741062|11357932|FG000|Overall Study|Protocol Violation|1
7168862|NCT03741062|11357933|FG001|Overall Study|Protocol Violation|0
7168863|NCT03739866|11357964|FG000|Overall Study|Lost to Follow-up|0
7168864|NCT03739866|11357965|FG001|Overall Study|Lost to Follow-up|0
7168865|NCT03739866|11357966|FG002|Overall Study|Lost to Follow-up|0
7168866|NCT03739866|11357967|FG003|Overall Study|Lost to Follow-up|1
7168867|NCT03739866|11357968|FG004|Overall Study|Lost to Follow-up|0
7168868|NCT03739866|11357969|FG005|Overall Study|Lost to Follow-up|0
7168869|NCT03739866|11357970|FG006|Overall Study|Lost to Follow-up|0
7168870|NCT03739866|11357971|FG007|Overall Study|Lost to Follow-up|0
7168871|NCT03739866|11357964|FG000|Overall Study|Enrolled but not treated|0
7168872|NCT03739866|11357965|FG001|Overall Study|Enrolled but not treated|0
7168873|NCT03739866|11357966|FG002|Overall Study|Enrolled but not treated|1
7168874|NCT03739866|11357967|FG003|Overall Study|Enrolled but not treated|0
7168875|NCT03739866|11357968|FG004|Overall Study|Enrolled but not treated|1
7168876|NCT03739866|11357969|FG005|Overall Study|Enrolled but not treated|0
7168877|NCT03739866|11357970|FG006|Overall Study|Enrolled but not treated|0
7168878|NCT03739866|11357971|FG007|Overall Study|Enrolled but not treated|0
7168879|NCT03739528|11357999|FG000|Overall Study|Not treated|8
7168880|NCT03739528|11358000|FG001|Overall Study|Not treated|12
7168881|NCT03739528|11357999|FG000|Overall Study|Treatment and study discontinued|6
7168882|NCT03739528|11358000|FG001|Overall Study|Treatment and study discontinued|2
7168883|NCT03739528|11357999|FG000|Overall Study|Treatment discontinued + study completed|1
7168884|NCT03739528|11358000|FG001|Overall Study|Treatment discontinued + study completed|3
7168885|NCT03739242|11358011|FG000|Overall Study|Withdrawal by Subject|1
7168886|NCT03739242|11358012|FG001|Overall Study|Withdrawal by Subject|1
7168887|NCT03739242|11358011|FG000|Overall Study|Protocol Violation|0
7168888|NCT03739242|11358012|FG001|Overall Study|Protocol Violation|1
7168889|NCT03738865|11358020|FG000|Overall Study|Withdrawal by Subject|3
7168890|NCT03738865|11358021|FG001|Overall Study|Withdrawal by Subject|3
7168891|NCT03738865|11358020|FG000|Overall Study|Adverse Event|2
7168892|NCT03738865|11358021|FG001|Overall Study|Adverse Event|0
7168893|NCT03738865|11358020|FG000|Overall Study|Physician Decision|0
7168894|NCT03738865|11358021|FG001|Overall Study|Physician Decision|1
7168895|NCT03738475|11358038|FG000|Overall Study|Participant Non-Compliance|1
7168896|NCT03738475|11358039|FG001|Overall Study|Participant Non-Compliance|0
7168897|NCT03738241|11358055|FG000|Overall Study|Withdrawal by Subject|0
7168898|NCT03738241|11358056|FG001|Overall Study|Withdrawal by Subject|0
7168899|NCT03738241|11358057|FG002|Overall Study|Withdrawal by Subject|0
7168900|NCT03738241|11358058|FG003|Overall Study|Withdrawal by Subject|0
7168901|NCT03738241|11358059|FG004|Overall Study|Withdrawal by Subject|0
7168902|NCT03738241|11358060|FG005|Overall Study|Withdrawal by Subject|0
7168903|NCT03738241|11358061|FG006|Overall Study|Withdrawal by Subject|0
7168904|NCT03738241|11358062|FG007|Overall Study|Withdrawal by Subject|0
7168905|NCT03738241|11358063|FG008|Overall Study|Withdrawal by Subject|0
7168906|NCT03738241|11358064|FG009|Overall Study|Withdrawal by Subject|1
7168907|NCT03738241|11358055|FG000|Overall Study|Physician Decision|0
7168908|NCT03738241|11358056|FG001|Overall Study|Physician Decision|0
7168909|NCT03738241|11358057|FG002|Overall Study|Physician Decision|0
7168910|NCT03738241|11358058|FG003|Overall Study|Physician Decision|0
7168911|NCT03738241|11358059|FG004|Overall Study|Physician Decision|0
7168912|NCT03738241|11358060|FG005|Overall Study|Physician Decision|0
7168913|NCT03738241|11358061|FG006|Overall Study|Physician Decision|0
7041580|NCT01728324|11125173|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0
7041581|NCT01728376|11125195|FG000|Overall Study|Adverse Event|1
7041582|NCT01728376|11125196|FG001|Overall Study|Adverse Event|1
7168914|NCT03738241|11358062|FG007|Overall Study|Physician Decision|0
7168915|NCT03738241|11358063|FG008|Overall Study|Physician Decision|1
7168916|NCT03738241|11358064|FG009|Overall Study|Physician Decision|0
7168917|NCT03738241|11358055|FG000|Overall Study|Adverse Event|1
7168918|NCT03738241|11358056|FG001|Overall Study|Adverse Event|0
7168919|NCT03738241|11358057|FG002|Overall Study|Adverse Event|0
7168920|NCT03738241|11358058|FG003|Overall Study|Adverse Event|0
7168921|NCT03738241|11358059|FG004|Overall Study|Adverse Event|0
7168922|NCT03738241|11358060|FG005|Overall Study|Adverse Event|0
7168923|NCT03738241|11358061|FG006|Overall Study|Adverse Event|0
7168924|NCT03738241|11358062|FG007|Overall Study|Adverse Event|0
7168925|NCT03738241|11358063|FG008|Overall Study|Adverse Event|0
7168926|NCT03738241|11358064|FG009|Overall Study|Adverse Event|0
7168927|NCT03736785|11358121|FG000|Overall Study|Adverse Event|1
7168928|NCT03736785|11358122|FG001|Overall Study|Adverse Event|1
7168929|NCT03736785|11358123|FG002|Overall Study|Adverse Event|1
7168930|NCT03736785|11358121|FG000|Overall Study|Death|1
7168931|NCT03736785|11358122|FG001|Overall Study|Death|0
7168932|NCT03736785|11358123|FG002|Overall Study|Death|1
7168933|NCT03736785|11358121|FG000|Overall Study|Lost to Follow-up|0
7168934|NCT03736785|11358122|FG001|Overall Study|Lost to Follow-up|2
7168935|NCT03736785|11358123|FG002|Overall Study|Lost to Follow-up|3
7168936|NCT03736785|11358121|FG000|Overall Study|Non compliance with study drug|1
7168937|NCT03736785|11358122|FG001|Overall Study|Non compliance with study drug|1
7168938|NCT03736785|11358123|FG002|Overall Study|Non compliance with study drug|0
7168939|NCT03736785|11358121|FG000|Overall Study|Physician Decision|0
7168940|NCT03736785|11358122|FG001|Overall Study|Physician Decision|1
7168941|NCT03736785|11358123|FG002|Overall Study|Physician Decision|1
7168942|NCT03736785|11358121|FG000|Overall Study|Protocol Violation|1
7168943|NCT03736785|11358122|FG001|Overall Study|Protocol Violation|4
7168944|NCT03736785|11358123|FG002|Overall Study|Protocol Violation|3
7168945|NCT03736785|11358121|FG000|Overall Study|Sponsor Decision|1
7168946|NCT03736785|11358122|FG001|Overall Study|Sponsor Decision|0
7168947|NCT03736785|11358123|FG002|Overall Study|Sponsor Decision|0
7168948|NCT03736785|11358121|FG000|Overall Study|Unknown/Missing data|3
7168949|NCT03736785|11358122|FG001|Overall Study|Unknown/Missing data|2
7168950|NCT03736785|11358123|FG002|Overall Study|Unknown/Missing data|1
7168951|NCT03736785|11358121|FG000|Overall Study|Withdrawal by Subject|9
7168952|NCT03736785|11358122|FG001|Overall Study|Withdrawal by Subject|6
7168953|NCT03736785|11358123|FG002|Overall Study|Withdrawal by Subject|4
7184877|NCT01079780|11385348|FG002|Overall Study|Death|2
7184878|NCT01079780|11385346|FG000|Overall Study|Withdrawal by Subject|6
7184879|NCT01079780|11385347|FG001|Overall Study|Withdrawal by Subject|4
7184880|NCT01079780|11385348|FG002|Overall Study|Withdrawal by Subject|4
7184881|NCT01079780|11385346|FG000|Overall Study|Alternative therapy|2
7184882|NCT01079780|11385347|FG001|Overall Study|Alternative therapy|0
7184883|NCT01079780|11385348|FG002|Overall Study|Alternative therapy|2
7184884|NCT01079780|11385346|FG000|Overall Study|Physician Decision|1
7184885|NCT01079780|11385347|FG001|Overall Study|Physician Decision|0
7184886|NCT01079780|11385348|FG002|Overall Study|Physician Decision|1
7184887|NCT01079780|11385346|FG000|Overall Study|Error made in lesion measurement|1
7184888|NCT01079780|11385347|FG001|Overall Study|Error made in lesion measurement|0
7184889|NCT01079780|11385348|FG002|Overall Study|Error made in lesion measurement|0
7184890|NCT01079780|11385346|FG000|Overall Study|Patient had surgery|1
7184891|NCT01079780|11385347|FG001|Overall Study|Patient had surgery|0
7184892|NCT01079780|11385348|FG002|Overall Study|Patient had surgery|0
7184893|NCT01079780|11385346|FG000|Overall Study|Treatment cycle delay|0
7184894|NCT01079780|11385347|FG001|Overall Study|Treatment cycle delay|0
7184895|NCT01079780|11385348|FG002|Overall Study|Treatment cycle delay|1
7184896|NCT01079780|11385346|FG000|Overall Study|Never started treatment|1
7184897|NCT01079780|11385347|FG001|Overall Study|Never started treatment|0
7184898|NCT01079780|11385348|FG002|Overall Study|Never started treatment|2
7184899|NCT00075946|11385360|FG000|Overall Study|Path ineligible: undetermined histology|0
7041583|NCT01728376|11125197|FG002|Overall Study|Adverse Event|1
7184900|NCT00075946|11385361|FG001|Overall Study|Path ineligible: undetermined histology|0
7184901|NCT00075946|11385362|FG002|Overall Study|Path ineligible: undetermined histology|0
7184902|NCT00075946|11385363|FG003|Overall Study|Path ineligible: undetermined histology|0
7184903|NCT00075946|11385364|FG004|Overall Study|Path ineligible: undetermined histology|6
7168954|NCT03736031|11358134|FG000|Overall Study|Death|2
7168955|NCT03736031|11358135|FG001|Overall Study|Death|4
7168956|NCT03736031|11358134|FG000|Overall Study|Lost to Follow-up|21
7168957|NCT03736031|11358135|FG001|Overall Study|Lost to Follow-up|2
7168958|NCT03736031|11358134|FG000|Overall Study|Withdrawal by Subject|9
7168959|NCT03736031|11358135|FG001|Overall Study|Withdrawal by Subject|0
7168960|NCT03734991|11358147|FG000|Overall Study|Adverse Event|4
7168961|NCT03734991|11358148|FG001|Overall Study|Adverse Event|0
7168962|NCT03734991|11358147|FG000|Overall Study|Lost to Follow-up|4
7168963|NCT03734991|11358148|FG001|Overall Study|Lost to Follow-up|0
7168964|NCT03734991|11358147|FG000|Overall Study|Physician Decision|0
7168965|NCT03734991|11358148|FG001|Overall Study|Physician Decision|1
7168966|NCT03734991|11358147|FG000|Overall Study|Pregnancy|1
7168967|NCT03734991|11358148|FG001|Overall Study|Pregnancy|0
7168968|NCT03734991|11358147|FG000|Overall Study|Withdrawal by Subject|6
7168969|NCT03734991|11358148|FG001|Overall Study|Withdrawal by Subject|3
7168970|NCT03734991|11358147|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49
7168971|NCT03734991|11358148|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41
7168972|NCT03734991|11358147|FG000|Overall Study|Other|2
7168973|NCT03734991|11358148|FG001|Overall Study|Other|2
7168974|NCT03733899|11358162|FG000|Period 1|Protocol Violation|0
7168975|NCT03733899|11358163|FG001|Period 1|Protocol Violation|0
7168976|NCT03733899|11358164|FG002|Period 1|Protocol Violation|0
7168977|NCT03733899|11358165|FG003|Period 1|Protocol Violation|0
7168978|NCT03733899|11358166|FG004|Period 1|Protocol Violation|0
7168979|NCT03733899|11358167|FG005|Period 1|Protocol Violation|1
7168980|NCT03733899|11358162|FG000|Period 2|Unscuccessful Treatment|0
7168981|NCT03733899|11358163|FG001|Period 2|Unscuccessful Treatment|1
7168982|NCT03733899|11358164|FG002|Period 2|Unscuccessful Treatment|0
7168983|NCT03733899|11358165|FG003|Period 2|Unscuccessful Treatment|0
7168984|NCT03733899|11358166|FG004|Period 2|Unscuccessful Treatment|0
7168985|NCT03733899|11358167|FG005|Period 2|Unscuccessful Treatment|0
7168986|NCT03733899|11358162|FG000|Period 3|Withdrawal by Subject|1
7168987|NCT03733899|11358163|FG001|Period 3|Withdrawal by Subject|0
7168988|NCT03733899|11358164|FG002|Period 3|Withdrawal by Subject|0
7168989|NCT03733899|11358165|FG003|Period 3|Withdrawal by Subject|0
7168990|NCT03733899|11358166|FG004|Period 3|Withdrawal by Subject|0
7168991|NCT03733899|11358167|FG005|Period 3|Withdrawal by Subject|0
7168992|NCT03733470|11358186|FG000|Overall Study|PI Decision|1
7168993|NCT03733470|11358187|FG001|Overall Study|PI Decision|1
7168994|NCT03733301|11358196|FG000|Overall Study|Screen Fail|1
7168995|NCT03733301|11358197|FG001|Overall Study|Screen Fail|0
7168996|NCT03733301|11358198|FG002|Overall Study|Screen Fail|0
7168997|NCT03733301|11358196|FG000|Overall Study|Non-compliance|1
7168998|NCT03733301|11358197|FG001|Overall Study|Non-compliance|0
7168999|NCT03733301|11358198|FG002|Overall Study|Non-compliance|0
7169000|NCT03733301|11358196|FG000|Overall Study|Lack of Efficacy|2
7169001|NCT03733301|11358197|FG001|Overall Study|Lack of Efficacy|3
7169002|NCT03733301|11358198|FG002|Overall Study|Lack of Efficacy|0
7169003|NCT03733301|11358196|FG000|Overall Study|Adverse Event|0
7169004|NCT03733301|11358197|FG001|Overall Study|Adverse Event|1
7169005|NCT03733301|11358198|FG002|Overall Study|Adverse Event|3
7169006|NCT03733301|11358196|FG000|Overall Study|Withdrawal by Subject|3
7169007|NCT03733301|11358197|FG001|Overall Study|Withdrawal by Subject|5
7169008|NCT03733301|11358198|FG002|Overall Study|Withdrawal by Subject|1
7169009|NCT03732638|11358209|FG000|Overall Study|Adverse Event|5
7169010|NCT03732638|11358210|FG001|Overall Study|Adverse Event|2
7169011|NCT03732638|11358209|FG000|Overall Study|Eligibility failure due to baseline laboratory values|8
7169012|NCT03732638|11358210|FG001|Overall Study|Eligibility failure due to baseline laboratory values|13
7169013|NCT03732638|11358209|FG000|Overall Study|Lack of Efficacy|1
7169014|NCT03732638|11358210|FG001|Overall Study|Lack of Efficacy|1
7169015|NCT03732638|11358209|FG000|Overall Study|Lost to Follow-up|19
7169016|NCT03732638|11358210|FG001|Overall Study|Lost to Follow-up|12
7169017|NCT03732638|11358209|FG000|Overall Study|Non-compliance|6
7169018|NCT03732638|11358210|FG001|Overall Study|Non-compliance|5
7169019|NCT03732638|11358209|FG000|Overall Study|Physician Decision|0
7169020|NCT03732638|11358210|FG001|Overall Study|Physician Decision|1
7169021|NCT03732638|11358209|FG000|Overall Study|Protocol deviation|4
7169022|NCT03732638|11358210|FG001|Overall Study|Protocol deviation|5
7169023|NCT03732638|11358209|FG000|Overall Study|Withdrawal by Subject|11
7169024|NCT03732638|11358210|FG001|Overall Study|Withdrawal by Subject|22
7169025|NCT03732248|11358219|FG000|Overall Study|Withdrawal by Subject|1
7169026|NCT03732248|11358220|FG001|Overall Study|Withdrawal by Subject|0
7169027|NCT03731182|11358228|FG000|Overall Study|Lost to Follow-up|2
7169028|NCT03731182|11358229|FG001|Overall Study|Lost to Follow-up|0
7169029|NCT03731182|11358228|FG000|Overall Study|Physician Decision|1
7169030|NCT03731182|11358229|FG001|Overall Study|Physician Decision|0
7169031|NCT03731182|11358228|FG000|Overall Study|Withdrawal By Parent/Guardian|2
7169032|NCT03731182|11358229|FG001|Overall Study|Withdrawal By Parent/Guardian|0
7169033|NCT03730961|11358238|FG000|Overall Study|Adverse Event|0
7169034|NCT03730961|11358239|FG001|Overall Study|Adverse Event|1
7169035|NCT03730103|11358255|FG000|Overall Study|Did not meet inclusion criteria|0
7169036|NCT03730103|11358256|FG001|Overall Study|Did not meet inclusion criteria|5
7169037|NCT03728140|11358286|FG000|Overall Study|Abnormal embryo transfer operation|10
7169038|NCT03728140|11358287|FG001|Overall Study|Abnormal embryo transfer operation|7
7169039|NCT03727347|11358306|FG000|Overall Study|Withdrawal by Subject|2
7169040|NCT03727347|11358306|FG000|Overall Study|Lost to Follow-up|1
7169041|NCT03726996|11358319|FG000|Overall Study|Parent's decision|2
7169042|NCT03726996|11358319|FG000|Overall Study|Study early termination|2
7169043|NCT03725852|11358334|FG000|Overall Study|Death|1
7169044|NCT03725852|11358335|FG001|Overall Study|Death|0
7169045|NCT03725852|11358334|FG000|Overall Study|Withdrawal by Subject|1
7169046|NCT03725852|11358335|FG001|Overall Study|Withdrawal by Subject|0
7169047|NCT03725852|11358334|FG000|Overall Study|Travel restrictions due to COVID-19|2
7169048|NCT03725852|11358335|FG001|Overall Study|Travel restrictions due to COVID-19|0
7169049|NCT03725722|11358346|FG000|Overall Study|Lack of Efficacy|2
7169050|NCT03725722|11358347|FG001|Overall Study|Lack of Efficacy|1
7169051|NCT03725722|11358348|FG002|Overall Study|Lack of Efficacy|2
7169052|NCT03725722|11358349|FG003|Overall Study|Lack of Efficacy|0
7169053|NCT03725722|11358350|FG004|Overall Study|Lack of Efficacy|2
7169054|NCT03725722|11358346|FG000|Overall Study|Adverse Event|2
7169055|NCT03725722|11358347|FG001|Overall Study|Adverse Event|2
7169056|NCT03725722|11358348|FG002|Overall Study|Adverse Event|1
7169057|NCT03725722|11358349|FG003|Overall Study|Adverse Event|0
7169058|NCT03725722|11358350|FG004|Overall Study|Adverse Event|6
7169059|NCT03725722|11358346|FG000|Overall Study|Withdrawal by Subject|4
7169060|NCT03725722|11358347|FG001|Overall Study|Withdrawal by Subject|1
7169061|NCT03725722|11358348|FG002|Overall Study|Withdrawal by Subject|0
7169062|NCT03725722|11358349|FG003|Overall Study|Withdrawal by Subject|4
7169063|NCT03725722|11358350|FG004|Overall Study|Withdrawal by Subject|4
7169064|NCT03725722|11358346|FG000|Overall Study|Lost to Follow-up|3
7169065|NCT03725722|11358347|FG001|Overall Study|Lost to Follow-up|1
7169066|NCT03725722|11358348|FG002|Overall Study|Lost to Follow-up|2
7169067|NCT03725722|11358349|FG003|Overall Study|Lost to Follow-up|2
7169068|NCT03725722|11358350|FG004|Overall Study|Lost to Follow-up|1
7169069|NCT03725722|11358346|FG000|Overall Study|Personal reasons|0
7169070|NCT03725722|11358347|FG001|Overall Study|Personal reasons|0
7169071|NCT03725722|11358348|FG002|Overall Study|Personal reasons|1
7169072|NCT03725722|11358349|FG003|Overall Study|Personal reasons|0
7169073|NCT03725722|11358350|FG004|Overall Study|Personal reasons|1
7169074|NCT03725722|11358346|FG000|Overall Study|COVID-19 situation|0
7169075|NCT03725722|11358347|FG001|Overall Study|COVID-19 situation|1
7169076|NCT03725722|11358348|FG002|Overall Study|COVID-19 situation|0
7169077|NCT03725722|11358349|FG003|Overall Study|COVID-19 situation|0
7169078|NCT03725722|11358350|FG004|Overall Study|COVID-19 situation|0
7169079|NCT03725085|11358371|FG000|Overall Study|Lost to Follow-up|2
7169080|NCT03724981|11358387|FG000|First Device|Protocol Violation|1
7169081|NCT03724981|11358388|FG001|First Device|Protocol Violation|1
7169082|NCT03724968|11358398|FG000|Overall Study|Insurance issues|0
7169083|NCT03724968|11358399|FG001|Overall Study|Insurance issues|1
7169084|NCT03724968|11358398|FG000|Overall Study|Study closed|0
7169085|NCT03724968|11358399|FG001|Overall Study|Study closed|1
7169086|NCT03723070|11358463|FG000|Overall Study|Lost to Follow-up|2
7169087|NCT03723070|11358463|FG000|Overall Study|Physician Decision|1
7169088|NCT03723070|11358463|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6
7169089|NCT03720210|11358467|FG000|Overall Study|Lost to Follow-up|1
7169090|NCT03718143|11358475|FG000|Overall Study|Death|1
7169091|NCT03718143|11358476|FG001|Overall Study|Death|0
7169092|NCT03718143|11358477|FG002|Overall Study|Death|0
7169093|NCT03718143|11358475|FG000|Overall Study|Progression of Disease|1
7169094|NCT03718143|11358476|FG001|Overall Study|Progression of Disease|0
7169095|NCT03718143|11358477|FG002|Overall Study|Progression of Disease|0
7169096|NCT03718143|11358475|FG000|Overall Study|Withdrawal of Informed Consent|1
7169097|NCT03718143|11358476|FG001|Overall Study|Withdrawal of Informed Consent|2
7169098|NCT03718143|11358477|FG002|Overall Study|Withdrawal of Informed Consent|1
7169099|NCT03709576|11358485|FG000|Overall Study|progression prior to enrollment|1
7169100|NCT03704636|11358490|FG000|Overall Study|Inadequate Venous Flow|3
7169101|NCT03694821|11358514|FG000|Overall Study|Study terminated|4
7169102|NCT03694821|11358515|FG001|Overall Study|Study terminated|8
7169103|NCT03694821|11358516|FG002|Overall Study|Study terminated|4
7169104|NCT03686969|11358526|FG000|Overall Study|Study terminated|1
7169105|NCT03686969|11358527|FG001|Overall Study|Study terminated|0
7169106|NCT03682367|11358535|FG000|Overall Study|Protocol Violation|2
7169107|NCT03682367|11358536|FG001|Overall Study|Protocol Violation|1
7169108|NCT03682367|11358535|FG000|Overall Study|Closed Study Early|0
7169109|NCT03682367|11358536|FG001|Overall Study|Closed Study Early|3
7169110|NCT03680911|11358544|FG000|At Home Treatment|Study Termination|3
7169111|NCT03680911|11358545|FG001|At Home Treatment|Study Termination|0
7169112|NCT03680911|11358544|FG000|At Home Treatment|Lost to Follow-up|0
7169113|NCT03680911|11358545|FG001|At Home Treatment|Lost to Follow-up|1
7169114|NCT03680911|11358544|FG000|At Home Treatment|Withdrawal by Subject|0
7169115|NCT03680911|11358545|FG001|At Home Treatment|Withdrawal by Subject|2
7169116|NCT03680911|11358544|FG000|Visit 3 (4 Month Follow up)|Study Termination|0
7169117|NCT03680911|11358545|FG001|Visit 3 (4 Month Follow up)|Study Termination|1
7169118|NCT03656692|11358551|FG000|Overall Study|Worsening of disease activity|2
7169119|NCT03656692|11358551|FG000|Overall Study|Physician Decision|1
7169120|NCT03648983|11358555|FG000|Overall Study|Study was terminated due to PI departure|95
7169121|NCT03643159|11358562|FG000|Overall Study|Adverse Event|1
7169122|NCT03643159|11358562|FG000|Overall Study|Withdrawal by Subject|1
7169123|NCT03630120|11358580|FG000|Overall Study|Disease progression|0
7169124|NCT03630120|11358581|FG001|Overall Study|Disease progression|1
7169125|NCT03630120|11358582|FG002|Overall Study|Disease progression|1
7169126|NCT03630120|11358583|FG003|Overall Study|Disease progression|1
7169127|NCT03615144|11358610|FG000|Overall Study|Participant no longer eligible for this protocol|1
7169128|NCT03615144|11358611|FG001|Overall Study|Participant no longer eligible for this protocol|0
7169129|NCT03605303|11358617|FG000|Period 1|Study Terminated|2
7169130|NCT03605303|11358618|FG001|Period 1|Study Terminated|1
7169131|NCT03600740|11358624|FG000|Overall Study|Surgical plan was altered-subject not eligible|1
7169132|NCT03598140|11358630|FG000|Overall Study|enrolled but didn't start|1
7169133|NCT03598140|11358631|FG001|Overall Study|enrolled but didn't start|0
7169134|NCT03598036|11358639|FG000|Overall Study|Withdrawal by Subject|1
7169135|NCT03598036|11358640|FG001|Overall Study|Withdrawal by Subject|0
7169136|NCT03590743|11358659|FG000|Overall Study|Withdrawal by Subject|0
7169137|NCT03590743|11358660|FG001|Overall Study|Withdrawal by Subject|1
7169138|NCT03580382|11358668|FG000|Overall Study|Early Termination of Study|0
7169139|NCT03580382|11358669|FG001|Overall Study|Early Termination of Study|3
7169140|NCT03571646|11358676|FG000|Overall Study|Adverse Event|1
7169141|NCT03571646|11358677|FG001|Overall Study|Adverse Event|0
7169142|NCT03571646|11358676|FG000|Overall Study|Withdrawal by Subject|1
7169143|NCT03571646|11358677|FG001|Overall Study|Withdrawal by Subject|1
7169144|NCT03543358|11358700|FG000|Overall Study|Death|1
7169145|NCT03543358|11358701|FG001|Overall Study|Death|0
7169146|NCT03543358|11358700|FG000|Overall Study|Disease Progression|1
7169147|NCT03543358|11358701|FG001|Overall Study|Disease Progression|0
7169148|NCT03543358|11358700|FG000|Overall Study|Parent Study Closure|1
7169149|NCT03543358|11358701|FG001|Overall Study|Parent Study Closure|0
7169150|NCT03509207|11358729|FG000|Overall Study|Death|2
7169151|NCT03500341|11358746|FG000|Overall Study|Withdrawn prior to Completion|2
6895222|NCT00623727|10913038|FG001|Double Blind (DB)|Protocol Violation|2
6895223|NCT00623727|10913037|FG000|Open Label Follow-up|Withdrawal by Subject|0
6895224|NCT00623727|10913038|FG001|Open Label Follow-up|Withdrawal by Subject|1
6895225|NCT00623727|10913037|FG000|Open Label Follow-up|Study termination|0
6895226|NCT00623727|10913038|FG001|Open Label Follow-up|Study termination|6
6895227|NCT00623727|10913037|FG000|Open Label Follow-up|Participant convenience|0
7169152|NCT03500159|11358752|FG000|Overall Study|Study Terminated|2
7169153|NCT03500159|11358753|FG001|Overall Study|Study Terminated|1
7169154|NCT03477903|11358779|FG000|Overall Study|Study Terminated by Sponsor|1
7169155|NCT03469258|11358783|FG000|Overall Study|Upon surgery, did not meet criteria|4
7169156|NCT03466658|11358787|FG000|Overall Study|Withdrawal by Subject|3
7169157|NCT03465891|11358795|FG000|Overall Study|Withdrawal by Subject|0
7169158|NCT03465891|11358796|FG001|Overall Study|Withdrawal by Subject|1
7169159|NCT03465891|11358795|FG000|Overall Study|Disease progression|1
7169160|NCT03465891|11358796|FG001|Overall Study|Disease progression|0
7169161|NCT03387059|11358874|FG000|Overall Study|Study termination|5
7169162|NCT03387059|11358875|FG001|Overall Study|Study termination|4
7169163|NCT03379233|11358892|FG000|Overall Study|Technical issues with Concept 2 inhalers|1
7169164|NCT03379233|11358893|FG001|Overall Study|Technical issues with Concept 2 inhalers|6
7169165|NCT03361228|11358909|FG000|Overall Study|Other|1
7169166|NCT03361228|11358910|FG001|Overall Study|Other|1
7169167|NCT03361228|11358909|FG000|Overall Study|Death|3
7169168|NCT03361228|11358910|FG001|Overall Study|Death|0
7169169|NCT03359174|11358925|FG000|Overall Study|Adverse Event|1
7169170|NCT03348904|11358936|FG000|Overall Study|Administrative reason by the sponsor|0
7169171|NCT03348904|11358937|FG001|Overall Study|Administrative reason by the sponsor|1
7169172|NCT03348904|11358938|FG002|Overall Study|Administrative reason by the sponsor|0
7184904|NCT00075946|11385360|FG000|Overall Study|Did not achieve response after induction|0
7184905|NCT00075946|11385361|FG001|Overall Study|Did not achieve response after induction|0
7184906|NCT00075946|11385362|FG002|Overall Study|Did not achieve response after induction|0
7184907|NCT00075946|11385363|FG003|Overall Study|Did not achieve response after induction|0
7184908|NCT00075946|11385364|FG004|Overall Study|Did not achieve response after induction|182
7184909|NCT00075946|11385360|FG000|Overall Study|Incorrectly randomized (no response)|5
7184910|NCT00075946|11385361|FG001|Overall Study|Incorrectly randomized (no response)|5
7184911|NCT00075946|11385362|FG002|Overall Study|Incorrectly randomized (no response)|5
7184912|NCT00075946|11385363|FG003|Overall Study|Incorrectly randomized (no response)|1
7184913|NCT00075946|11385364|FG004|Overall Study|Incorrectly randomized (no response)|0
7184914|NCT00075946|11385360|FG000|Overall Study|Still on treatment at time of analysis|52
7184915|NCT00075946|11385361|FG001|Overall Study|Still on treatment at time of analysis|19
7184916|NCT00075946|11385362|FG002|Overall Study|Still on treatment at time of analysis|3
7184917|NCT00075946|11385363|FG003|Overall Study|Still on treatment at time of analysis|9
7184918|NCT00075946|11385364|FG004|Overall Study|Still on treatment at time of analysis|0
7184919|NCT00075946|11385360|FG000|Overall Study|Adverse Event|2
7184920|NCT00075946|11385361|FG001|Overall Study|Adverse Event|10
7184921|NCT00075946|11385362|FG002|Overall Study|Adverse Event|0
7184922|NCT00075946|11385363|FG003|Overall Study|Adverse Event|2
7184923|NCT00075946|11385364|FG004|Overall Study|Adverse Event|0
7184924|NCT00075946|11385360|FG000|Overall Study|Death|0
7184925|NCT00075946|11385361|FG001|Overall Study|Death|1
7184926|NCT00075946|11385362|FG002|Overall Study|Death|0
7184927|NCT00075946|11385363|FG003|Overall Study|Death|0
7184928|NCT00075946|11385364|FG004|Overall Study|Death|0
7169173|NCT03345901|11358946|FG000|Overall Study|The study was terminated|18
7169174|NCT03344562|11358953|FG000|Overall Study|Withdrawal by Subject|2
7169175|NCT03344562|11358954|FG001|Overall Study|Withdrawal by Subject|0
7169176|NCT03342638|11358962|FG000|Overall Study|Withdrawal by Subject|1
7169177|NCT03342638|11358963|FG001|Overall Study|Withdrawal by Subject|0
7169178|NCT03342638|11358962|FG000|Overall Study|Physician Decision|0
7169179|NCT03342638|11358963|FG001|Overall Study|Physician Decision|1
7169180|NCT03339401|11358980|FG000|Overall Study|Death|2
7169181|NCT03339401|11358981|FG001|Overall Study|Death|1
7169182|NCT03339401|11358980|FG000|Overall Study|Withdrawal by Subject|2
7169183|NCT03339401|11358981|FG001|Overall Study|Withdrawal by Subject|0
7169184|NCT03339401|11358980|FG000|Overall Study|Study terminated|4
7169185|NCT03339401|11358981|FG001|Overall Study|Study terminated|3
7169186|NCT03339401|11358980|FG000|Overall Study|Investigator Decision|1
7169187|NCT03339401|11358981|FG001|Overall Study|Investigator Decision|0
7169188|NCT03339245|11358989|FG000|Overall Study|Adverse Event|1
7169189|NCT03339245|11358990|FG001|Overall Study|Adverse Event|1
7169190|NCT03339245|11358989|FG000|Overall Study|Withdrawal by Subject|1
7169191|NCT03339245|11358990|FG001|Overall Study|Withdrawal by Subject|0
7169192|NCT03329404|11359002|FG000|Overall Study|The study was suspended.|1
7169193|NCT03329404|11359003|FG001|Overall Study|The study was suspended.|4
7169194|NCT03326869|11359011|FG000|Overall Study|Study data has been lost to natural disa|1
7169195|NCT03326869|11359012|FG001|Overall Study|Study data has been lost to natural disa|1
7169196|NCT03305055|11359037|FG000|Overall Study|Withdrawal by Subject|0
7169197|NCT03305055|11359038|FG001|Overall Study|Withdrawal by Subject|1
7169198|NCT03305055|11359037|FG000|Overall Study|Adverse Event|1
7169199|NCT03305055|11359038|FG001|Overall Study|Adverse Event|1
7169200|NCT03303469|11359044|FG000|Overall Study|Lost to Follow-up|2
7169201|NCT03302247|11359048|FG000|Overall Study|the study has closed prematurely|2
7169202|NCT03302247|11359048|FG000|Overall Study|Death|1
7169203|NCT03300024|11359054|FG000|Overall Study|Physician Decision|4
7169204|NCT03300024|11359055|FG001|Overall Study|Physician Decision|6
7169205|NCT03283709|11359065|FG000|Overall Study|trial terminated|0
7169206|NCT03283709|11359066|FG001|Overall Study|trial terminated|1
7169207|NCT03263806|11359101|FG000|Overall Study|Elevated Troponin (failed screen)|1
7169208|NCT03263806|11359102|FG001|Overall Study|Elevated Troponin (failed screen)|0
7169209|NCT03263806|11359101|FG000|Overall Study|Withdrawal by Subject|0
7169210|NCT03263806|11359102|FG001|Overall Study|Withdrawal by Subject|1
7169211|NCT03263806|11359101|FG000|Overall Study|Study Termination|5
7169212|NCT03263806|11359102|FG001|Overall Study|Study Termination|6
7169213|NCT03261531|11359108|FG000|Overall Study|Withdrawal by Subject|4
7169214|NCT03219372|11359114|FG000|Overall Study|Withdrawal by Subject|1
7169215|NCT03219372|11359115|FG001|Overall Study|Withdrawal by Subject|0
7169216|NCT03217175|11359121|FG000|Overall Study|Physician Decision|4
7169217|NCT03217175|11359122|FG001|Overall Study|Physician Decision|1
7169218|NCT03223662|11359149|FG000|Overall Study|Physician Decision|1
7169219|NCT03223662|11359149|FG000|Overall Study|Study closure|1
7169220|NCT03212144|11359155|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1
7169221|NCT03212144|11359156|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0
7169222|NCT03212144|11359155|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1
7169223|NCT03212144|11359156|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1
7169224|NCT03204539|11359172|FG000|Overall Study|Loss of funding|0
7169225|NCT03204539|11359173|FG001|Overall Study|Loss of funding|1
7169226|NCT03206216|11359181|FG000|Overall Study|Withdrawal by Subject|0
7169227|NCT03206216|11359182|FG001|Overall Study|Withdrawal by Subject|1
7169228|NCT03195660|11359188|FG000|Overall Study|The study was terminated|2
7169229|NCT03166618|11359198|FG000|Overall Study|Study was Terminated|0
7169230|NCT03166618|11359199|FG001|Overall Study|Study was Terminated|1
7169231|NCT03169530|11359207|FG000|Overall Study|Study ended by NIH|15
7169232|NCT03169530|11359208|FG001|Overall Study|Study ended by NIH|17
7169233|NCT03151226|11359223|FG000|Overall Study|Withdrawal by Subject|2
7169234|NCT03151226|11359223|FG000|Overall Study|not wear device correctly|1
7169235|NCT03168906|11359238|FG000|Overall Study|Lack of Efficacy|6
7169236|NCT03168906|11359239|FG001|Overall Study|Lack of Efficacy|6
7169237|NCT03178201|11359246|FG000|Overall Study|Off study|5
7169238|NCT03172026|11359252|FG000|Overall Study|Withdrawal by Subject|1
7169239|NCT03172026|11359253|FG001|Overall Study|Withdrawal by Subject|0
7169240|NCT03172026|11359252|FG000|Overall Study|COVID restrictions|1
7169241|NCT03172026|11359253|FG001|Overall Study|COVID restrictions|0
7169242|NCT03152526|11359262|FG000|Overall Study|Withdrawal by Subject|0
7169243|NCT03152526|11359263|FG001|Overall Study|Withdrawal by Subject|1
7169244|NCT03123393|11359298|FG000|Overall Study|Study Terminated by Sponsor|6
7169245|NCT03123393|11359299|FG001|Overall Study|Study Terminated by Sponsor|9
7169246|NCT03123393|11359298|FG000|Overall Study|Withdrawal by Subject|2
7169247|NCT03123393|11359299|FG001|Overall Study|Withdrawal by Subject|1
7169248|NCT03123393|11359298|FG000|Overall Study|Reason not Specified|13
7169249|NCT03123393|11359299|FG001|Overall Study|Reason not Specified|13
7169250|NCT03119662|11359311|FG000|Overall Study|Withdrawal by Subject|0
7169251|NCT03119662|11359312|FG001|Overall Study|Withdrawal by Subject|1
7169252|NCT03120676|11359327|FG000|Overall Study|Not treated|1
7169253|NCT03113071|11359352|FG000|Overall Study|Withdrawal by Subject|1
7169254|NCT03113071|11359353|FG001|Overall Study|Withdrawal by Subject|0
7169255|NCT03110900|11359361|FG000|Overall Study|Sponsor withdrew|1
7169256|NCT03110900|11359362|FG001|Overall Study|Sponsor withdrew|1
7169257|NCT03078868|11359368|FG000|Overall Study|Physician Decision|3
7169258|NCT03065933|11359381|FG000|Overall Study|study terminated|5
7169259|NCT03070002|11359385|FG000|Follow up for 2 Years|Death|1
7169260|NCT03058705|11359389|FG000|Overall Study|Withdrawal by Subject|2
7169261|NCT03058705|11359389|FG000|Overall Study|Physician Decision|2
7169262|NCT03053518|11359411|FG000|Overall Study|Withdrawal by Subject|3
7169263|NCT03053518|11359411|FG000|Overall Study|Lost to Follow-up|2
7169264|NCT03053518|11359411|FG000|Overall Study|Ineligible|5
7169265|NCT03050398|11359415|FG000|Overall Study|Study terminated by sponsor|8
7169266|NCT03029832|11359433|FG000|Overall Study|Safety Follow-Up Completed|2
7169267|NCT03029832|11359434|FG001|Overall Study|Safety Follow-Up Completed|0
7169268|NCT03029832|11359433|FG000|Overall Study|Death due to Disease Progression|1
7169269|NCT03029832|11359434|FG001|Overall Study|Death due to Disease Progression|0
7169270|NCT03029832|11359433|FG000|Overall Study|Study Terminated By Sponsor|1
7169271|NCT03029832|11359434|FG001|Overall Study|Study Terminated By Sponsor|1
7169272|NCT03010423|11359469|FG000|Overall Study|Study termination|8
7169273|NCT02991430|11359485|FG000|Treatment Period 1|Adverse Event|1
7169274|NCT02991430|11359486|FG001|Treatment Period 1|Adverse Event|0
7169275|NCT02991430|11359487|FG002|Treatment Period 1|Adverse Event|2
7169276|NCT02991430|11359485|FG000|Treatment Period 1|Withdrawal by Subject|0
7169277|NCT02991430|11359486|FG001|Treatment Period 1|Withdrawal by Subject|4
7169278|NCT02991430|11359487|FG002|Treatment Period 1|Withdrawal by Subject|0
7169279|NCT02991430|11359485|FG000|Treatment Period 2|Study Termination|6
7169280|NCT02991430|11359486|FG001|Treatment Period 2|Study Termination|3
7169281|NCT02991430|11359487|FG002|Treatment Period 2|Study Termination|3
7169282|NCT02991430|11359485|FG000|Treatment Period 2|Lost to Follow-up|0
7169283|NCT02991430|11359486|FG001|Treatment Period 2|Lost to Follow-up|0
7169284|NCT02991430|11359487|FG002|Treatment Period 2|Lost to Follow-up|1
7169285|NCT02991430|11359485|FG000|Post-treatment Observation Period|Study Termination|3
7169286|NCT02991430|11359486|FG001|Post-treatment Observation Period|Study Termination|6
7169287|NCT02991430|11359487|FG002|Post-treatment Observation Period|Study Termination|5
7169288|NCT02978833|11359520|FG000|Overall Study|Study terminated|1
7169289|NCT02978833|11359521|FG001|Overall Study|Study terminated|1
7169290|NCT02966223|11359558|FG000|Overall Study|Physician Decision|3
7169291|NCT02966223|11359558|FG000|Overall Study|Withdrawal by Subject|11
7169292|NCT02966223|11359558|FG000|Overall Study|Lost to Follow-up|1
7169293|NCT02965846|11359565|FG000|Overall Study|Lost to Follow-up|1
7169294|NCT02965846|11359566|FG001|Overall Study|Lost to Follow-up|0
7169295|NCT02965846|11359567|FG002|Overall Study|Lost to Follow-up|0
7169296|NCT02965846|11359565|FG000|Overall Study|Withdrawal by Subject|0
7169297|NCT02965846|11359566|FG001|Overall Study|Withdrawal by Subject|1
7169298|NCT02965846|11359567|FG002|Overall Study|Withdrawal by Subject|0
7169299|NCT02965846|11359565|FG000|Overall Study|Study Terminated By Sponsor|4
7169300|NCT02965846|11359566|FG001|Overall Study|Study Terminated By Sponsor|4
7169301|NCT02965846|11359567|FG002|Overall Study|Study Terminated By Sponsor|0
7169302|NCT02965846|11359565|FG000|Overall Study|Participants not randomized|0
7169303|NCT02965846|11359566|FG001|Overall Study|Participants not randomized|0
7169304|NCT02965846|11359567|FG002|Overall Study|Participants not randomized|33
7169305|NCT02956005|11359588|FG000|Overall Study|Not eligible|1
7169306|NCT02956005|11359588|FG000|Overall Study|Withdrawal by Subject|3
7169307|NCT02956005|11359588|FG000|Overall Study|Physician Decision|12
7169308|NCT02940223|11359603|FG000|Overall Study|Failed Requirement|2
7169309|NCT02940223|11359604|FG001|Overall Study|Failed Requirement|0
7169310|NCT02954159|11359612|FG000|Overall Study|Study ended prematurely due to low enrol|1
7169311|NCT02954159|11359613|FG001|Overall Study|Study ended prematurely due to low enrol|0
7169312|NCT02954159|11359612|FG000|Overall Study|Withdrawal by Subject|0
7169313|NCT02954159|11359613|FG001|Overall Study|Withdrawal by Subject|1
7169314|NCT02954952|11359622|FG000|Overall Study|Withdrawal by Subject|1
7169315|NCT02954952|11359623|FG001|Overall Study|Withdrawal by Subject|0
7169316|NCT02954952|11359624|FG002|Overall Study|Withdrawal by Subject|0
7169317|NCT02954952|11359622|FG000|Overall Study|No data collected|0
7169318|NCT02954952|11359623|FG001|Overall Study|No data collected|1
7169319|NCT02954952|11359624|FG002|Overall Study|No data collected|0
7169320|NCT02947022|11359636|FG000|Overall Study|Study Stopped|1
7169321|NCT02950480|11359651|FG000|Overall Study|Withdrawal by Subject|1
7169322|NCT02950480|11359652|FG001|Overall Study|Withdrawal by Subject|0
7169323|NCT02949947|11359660|FG000|Overall Study|Non Compliance|0
7169324|NCT02949947|11359661|FG001|Overall Study|Non Compliance|1
7169325|NCT02949947|11359660|FG000|Overall Study|Insurance change|1
7169326|NCT02949947|11359661|FG001|Overall Study|Insurance change|0
7169327|NCT02947100|11359667|FG000|Overall Study|study terminated early|3
7169328|NCT02947100|11359667|FG000|Overall Study|did not meet inclusion criteria|1
7169329|NCT02908516|11359688|FG000|Overall Study|Study Terminated|3
7169330|NCT02908516|11359689|FG001|Overall Study|Study Terminated|3
7184929|NCT00075946|11385360|FG000|Overall Study|Withdrawal by Subject|23
7184930|NCT00075946|11385361|FG001|Overall Study|Withdrawal by Subject|58
7184931|NCT00075946|11385362|FG002|Overall Study|Withdrawal by Subject|4
7184932|NCT00075946|11385363|FG003|Overall Study|Withdrawal by Subject|9
7184933|NCT00075946|11385364|FG004|Overall Study|Withdrawal by Subject|0
7184934|NCT00075946|11385360|FG000|Overall Study|Alternative therapy|16
7184935|NCT00075946|11385361|FG001|Overall Study|Alternative therapy|2
7184936|NCT00075946|11385362|FG002|Overall Study|Alternative therapy|5
7169331|NCT02923830|11359697|FG000|Overall Study|Physician Decision|13
7169332|NCT02923830|11359698|FG001|Overall Study|Physician Decision|15
7169333|NCT02920450|11359704|FG000|Overall Study|Death|1
7169334|NCT02920450|11359705|FG001|Overall Study|Death|0
7169335|NCT02920450|11359706|FG002|Overall Study|Death|0
7169336|NCT02920450|11359707|FG003|Overall Study|Death|0
7169337|NCT02920450|11359704|FG000|Overall Study|Withdrawal by Subject|1
7169338|NCT02920450|11359705|FG001|Overall Study|Withdrawal by Subject|0
7169339|NCT02920450|11359706|FG002|Overall Study|Withdrawal by Subject|0
7169340|NCT02920450|11359707|FG003|Overall Study|Withdrawal by Subject|0
7169341|NCT02920177|11359716|FG000|Overall Study|Withdrawal by Subject|1
7169342|NCT02920177|11359717|FG001|Overall Study|Withdrawal by Subject|1
7169343|NCT02920177|11359716|FG000|Overall Study|Physician Decision|1
7169344|NCT02920177|11359717|FG001|Overall Study|Physician Decision|0
7169345|NCT02920177|11359716|FG000|Overall Study|Lost to Follow-up|0
7169346|NCT02920177|11359717|FG001|Overall Study|Lost to Follow-up|1
7169347|NCT02926638|11359725|FG000|Overall Study|Progression|2
7169348|NCT02926638|11359726|FG001|Overall Study|Progression|5
7169349|NCT02926638|11359725|FG000|Overall Study|Ineligible|1
7169350|NCT02926638|11359726|FG001|Overall Study|Ineligible|0
7169351|NCT02926638|11359725|FG000|Overall Study|Not protocol specified|1
7169352|NCT02926638|11359726|FG001|Overall Study|Not protocol specified|0
7169353|NCT02920242|11359735|FG000|Overall Study|Withdrawal by Subject|1
7169354|NCT02920242|11359736|FG001|Overall Study|Withdrawal by Subject|0
7169355|NCT02920242|11359737|FG002|Overall Study|Withdrawal by Subject|1
7169356|NCT02920242|11359735|FG000|Overall Study|Did not meet inc./exc. criteria|1
7169357|NCT02920242|11359736|FG001|Overall Study|Did not meet inc./exc. criteria|0
7169358|NCT02920242|11359737|FG002|Overall Study|Did not meet inc./exc. criteria|0
7169359|NCT02899728|11359769|FG000|Overall Study|Withdrawal by Subject|1
7169360|NCT02899728|11359770|FG001|Overall Study|Withdrawal by Subject|1
7169361|NCT02875067|11359776|FG000|Overall Study|Withdrawal by Subject|1
7169362|NCT02875067|11359776|FG000|Overall Study|Withdrawal by Termination of Study|5
7169363|NCT02860169|11359791|FG000|Part A|Withdrawal by Subject|1
7169364|NCT02860169|11359791|FG000|Part A|Other (Screening failure)|6
7169365|NCT02860169|11359791|FG000|Part A|Other (Survey not completed)|3
7169366|NCT02860169|11359791|FG000|Part A|Other (did not completed consent)|1
7169367|NCT02860169|11359791|FG000|Part B|Other (Screening failure)|10
7169368|NCT02860169|11359791|FG000|Part B|Withdrawal by Subject|1
7169369|NCT02860169|11359791|FG000|Part C|Other (Screening failure)|1
7169370|NCT02865395|11359800|FG000|Overall Study|Physician Decision|6
7169371|NCT02865395|11359801|FG001|Overall Study|Physician Decision|10
7169372|NCT02865395|11359802|FG002|Overall Study|Physician Decision|7
7169373|NCT02868892|11359810|FG000|Overall Study|Investigator left site and no follow-up|6
7169374|NCT02865083|11359816|FG000|Overall Study|Early Termination|3
7169375|NCT02865083|11359817|FG001|Overall Study|Early Termination|1
7169376|NCT02865122|11359826|FG000|Overall Study|Adverse Event|1
7169377|NCT02865122|11359827|FG001|Overall Study|Adverse Event|0
7169378|NCT02865122|11359828|FG002|Overall Study|Adverse Event|0
7169379|NCT02865915|11359838|FG000|Overall Study|Pregnancy|1
7169380|NCT02865915|11359839|FG001|Overall Study|Pregnancy|0
7169381|NCT02865915|11359838|FG000|Overall Study|Withdrawal by Subject|1
7169382|NCT02865915|11359839|FG001|Overall Study|Withdrawal by Subject|1
7169383|NCT02865915|11359838|FG000|Overall Study|Adverse Event|0
7169384|NCT02865915|11359839|FG001|Overall Study|Adverse Event|4
7169385|NCT02865915|11359838|FG000|Overall Study|Lost to Follow-up|0
7169386|NCT02865915|11359839|FG001|Overall Study|Lost to Follow-up|1
7169387|NCT02865915|11359838|FG000|Overall Study|Protocol Violation|0
7169388|NCT02865915|11359839|FG001|Overall Study|Protocol Violation|1
7169389|NCT02865915|11359838|FG000|Overall Study|Study terminated by sponsor|23
7169390|NCT02865915|11359839|FG001|Overall Study|Study terminated by sponsor|18
7169391|NCT02865915|11359838|FG000|Overall Study|Dosing group discontinued|0
7169392|NCT02865915|11359839|FG001|Overall Study|Dosing group discontinued|5
7169393|NCT02855411|11359845|FG000|Overall Study|Study terminated by sponsor|21
7169394|NCT02855411|11359845|FG000|Overall Study|Does not meet entrance criteria|14
7169395|NCT02828124|11359853|FG000|Overall Study|Disease Progression|1
7169396|NCT02828124|11359854|FG001|Overall Study|Disease Progression|2
7169397|NCT02828124|11359855|FG002|Overall Study|Disease Progression|1
7169398|NCT02828124|11359856|FG003|Overall Study|Disease Progression|4
7169399|NCT02828124|11359853|FG000|Overall Study|AE Unrelated to Study Drug|0
7169400|NCT02828124|11359854|FG001|Overall Study|AE Unrelated to Study Drug|0
7169401|NCT02828124|11359855|FG002|Overall Study|AE Unrelated to Study Drug|0
7169402|NCT02828124|11359856|FG003|Overall Study|AE Unrelated to Study Drug|1
7169403|NCT02828124|11359853|FG000|Overall Study|Subject Withdrew Consent|0
7169404|NCT02828124|11359854|FG001|Overall Study|Subject Withdrew Consent|0
7169405|NCT02828124|11359855|FG002|Overall Study|Subject Withdrew Consent|0
7169406|NCT02828124|11359856|FG003|Overall Study|Subject Withdrew Consent|1
7169407|NCT02825043|11359875|FG000|Overall Study|Lost to Follow-up|4
7169408|NCT02819804|11359879|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1
7169409|NCT02809118|11359886|FG000|Overall Study|Withdrawal by Subject|0
7169410|NCT02809118|11359887|FG001|Overall Study|Withdrawal by Subject|1
7169411|NCT02809118|11359888|FG002|Overall Study|Withdrawal by Subject|1
7169412|NCT02806960|11359924|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3
7169413|NCT02806960|11359925|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3
7169414|NCT02806960|11359926|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3
7169415|NCT02806960|11359927|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3
7169416|NCT02815397|11359937|FG000|Overall Study|Physician Decision|2
7169417|NCT02802592|11359941|FG000|Overall Study|Study terminated due to loss of funding|4
7169418|NCT02730793|11359966|FG000|Overall Study|Physician Decision|0
7169419|NCT02730793|11359967|FG001|Overall Study|Physician Decision|1
7169420|NCT02730793|11359966|FG000|Overall Study|Withdrawal by Subject|0
7169421|NCT02730793|11359967|FG001|Overall Study|Withdrawal by Subject|1
7169422|NCT02760602|11359984|FG000|Overall Study|Withdrawal by Subject|1
7169423|NCT02760602|11359985|FG001|Overall Study|Withdrawal by Subject|0
7169424|NCT02760602|11359984|FG000|Overall Study|Terminated by sponsor|12
7169425|NCT02760602|11359985|FG001|Overall Study|Terminated by sponsor|13
7169426|NCT02757521|11359993|FG000|Overall Study|Adverse Event|1
7169427|NCT02757521|11359994|FG001|Overall Study|Adverse Event|0
7169428|NCT02725671|11360047|FG000|Overall Study|Lost to Follow-up|1
7169429|NCT02732327|11360068|FG000|Overall Study|Protocol Violation|0
7169430|NCT02732327|11360069|FG001|Overall Study|Protocol Violation|1
7169431|NCT02726399|11360075|FG000|Overall Study|Participant Non-Compliance|1
7169432|NCT02726399|11360075|FG000|Overall Study|Adverse Event|2
7169433|NCT02726399|11360075|FG000|Overall Study|Progression of disease|4
7169434|NCT02720510|11360081|FG000|Overall Study|Study Terminated by the sponsor|2
7169435|NCT02720510|11360082|FG001|Overall Study|Study Terminated by the sponsor|0
7169436|NCT02720510|11360081|FG000|Overall Study|Adverse Event|0
7169437|NCT02720510|11360082|FG001|Overall Study|Adverse Event|1
7169438|NCT02720510|11360081|FG000|Overall Study|Physician Decision|1
7169439|NCT02720510|11360082|FG001|Overall Study|Physician Decision|2
7169440|NCT02715765|11360091|FG000|Overall Study|Study Termination|3
7169441|NCT02715765|11360092|FG001|Overall Study|Study Termination|0
7169442|NCT02715765|11360093|FG002|Overall Study|Study Termination|0
7169443|NCT02717130|11360112|FG000|Overall Study|Withdrawal by Subject|1
7169444|NCT02717130|11360112|FG000|Overall Study|Adverse Event|1
7169445|NCT02717130|11360112|FG000|Overall Study|Physician Decision|1
7169446|NCT02717130|11360112|FG000|Overall Study|Study Closure|4
7169447|NCT02685202|11360116|FG000|Overall Study|Lost to Follow-up|9
7169448|NCT02709083|11360120|FG000|Overall Study|Original PI left institution|7
7169449|NCT02693171|11360124|FG000|Overall Study|Adverse Event|1
7169450|NCT02693171|11360124|FG000|Overall Study|Discontinuation of Study by Sponsor|8
7169451|NCT02696226|11360132|FG000|Overall Study|Study terminated - lack of enrollment|1
7169452|NCT02696226|11360133|FG001|Overall Study|Study terminated - lack of enrollment|0
7169453|NCT02696226|11360134|FG002|Overall Study|Study terminated - lack of enrollment|2
7169454|NCT02696226|11360135|FG003|Overall Study|Study terminated - lack of enrollment|0
7169455|NCT02693743|11360147|FG000|Overall Study|Physician Decision|1
7169456|NCT02693743|11360148|FG001|Overall Study|Physician Decision|0
7169457|NCT02706691|11360154|FG000|Overall Study|Adverse Event|1
7169458|NCT02694757|11360172|FG000|Overall Study|Lack of Efficacy|3
7169459|NCT02693002|11360178|FG000|Overall Study|Withdrawal by Subject|1
7169460|NCT02693002|11360179|FG001|Overall Study|Withdrawal by Subject|0
7169461|NCT02689518|11360185|FG000|Overall Study|Withdrawal by Subject|3
7169462|NCT02673684|11360216|FG000|Overall Study|Study not completed d/t loss of funding|9
7169463|NCT02673684|11360217|FG001|Overall Study|Study not completed d/t loss of funding|8
7169464|NCT02674204|11360227|FG000|Overall Study|Adverse Event|1
7169465|NCT02674204|11360228|FG001|Overall Study|Adverse Event|0
7169466|NCT02671461|11360250|FG000|Treatment|Adverse Event|0
7169467|NCT02671461|11360251|FG001|Treatment|Adverse Event|0
7169468|NCT02671461|11360252|FG002|Treatment|Adverse Event|1
7169469|NCT02671461|11360250|FG000|Treatment|Administrative Reason by Sponsor|1
7169470|NCT02671461|11360251|FG001|Treatment|Administrative Reason by Sponsor|3
7169471|NCT02671461|11360252|FG002|Treatment|Administrative Reason by Sponsor|4
7169472|NCT02671461|11360250|FG000|Treatment|Randomized, not treated|1
7169473|NCT02671461|11360251|FG001|Treatment|Randomized, not treated|0
7169474|NCT02671461|11360252|FG002|Treatment|Randomized, not treated|0
7169475|NCT02671461|11360250|FG000|Follow-up|Withdrawal by Subject|1
7169476|NCT02671461|11360251|FG001|Follow-up|Withdrawal by Subject|0
7169477|NCT02671461|11360252|FG002|Follow-up|Withdrawal by Subject|0
7169478|NCT02671461|11360250|FG000|Follow-up|Lost to Follow-up|0
7169479|NCT02671461|11360251|FG001|Follow-up|Lost to Follow-up|0
7169480|NCT02671461|11360252|FG002|Follow-up|Lost to Follow-up|1
7169481|NCT02671461|11360250|FG000|Follow-up|Administrative Reason by Sponsor|0
7169482|NCT02671461|11360251|FG001|Follow-up|Administrative Reason by Sponsor|1
7169483|NCT02671461|11360252|FG002|Follow-up|Administrative Reason by Sponsor|0
7169484|NCT02653495|11360323|FG000|Overall Study|Lost to Follow-up|2
7169485|NCT02653495|11360324|FG001|Overall Study|Lost to Follow-up|0
7169486|NCT02653495|11360323|FG000|Overall Study|Screening Failure|10
7169487|NCT02653495|11360324|FG001|Overall Study|Screening Failure|0
7169488|NCT02639390|11360336|FG000|Overall Study|Subject unable to comply with treatment schedule.|0
7169489|NCT02639390|11360337|FG001|Overall Study|Subject unable to comply with treatment schedule.|2
7169490|NCT02634606|11360343|FG000|Overall Study|unable to obtain the drug at start|13
7169491|NCT02636283|11360357|FG000|Overall Study|Adverse Event|2
7169492|NCT02636283|11360358|FG001|Overall Study|Adverse Event|0
7169493|NCT02636283|11360357|FG000|Overall Study|Trial Terminated Prematurely|0
7169494|NCT02636283|11360358|FG001|Overall Study|Trial Terminated Prematurely|3
7169495|NCT02638129|11360366|FG000|Overall Study|Study terminated|28
7169496|NCT02638129|11360367|FG001|Overall Study|Study terminated|30
7169497|NCT02615990|11360375|FG000|Overall Study|study terminated|1
7169498|NCT02615990|11360376|FG001|Overall Study|study terminated|1
7169499|NCT02640677|11360382|FG000|Overall Study|Lost to Follow-up|1
7169500|NCT02640677|11360382|FG000|Overall Study|Withdrawal by Subject|1
7169501|NCT02623959|11360392|FG000|Overall Study|Progression|0
7169502|NCT02623959|11360393|FG001|Overall Study|Progression|1
7169503|NCT02631148|11360403|FG000|Overall Study|8 were ineligible|8
7169504|NCT02631148|11360404|FG001|Overall Study|8 were ineligible|0
7169505|NCT02631148|11360403|FG000|Overall Study|Withdrawal by Subject|1
7169506|NCT02631148|11360404|FG001|Overall Study|Withdrawal by Subject|0
7169507|NCT02631148|11360403|FG000|Overall Study|PAH not available to study participant|1
7169508|NCT02631148|11360404|FG001|Overall Study|PAH not available to study participant|0
7169509|NCT02630472|11360412|FG000|Overall Study|Physician Decision|10
7169510|NCT02630472|11360413|FG001|Overall Study|Physician Decision|0
7169511|NCT02626520|11360422|FG000|Overall Study|Physician Decision|1
7169512|NCT02626520|11360423|FG001|Overall Study|Physician Decision|1
7169513|NCT02626520|11360422|FG000|Overall Study|Adverse Event|0
7169514|NCT02626520|11360423|FG001|Overall Study|Adverse Event|4
7169515|NCT02626520|11360422|FG000|Overall Study|Lack of Efficacy|0
6895228|NCT00623727|10913038|FG001|Open Label Follow-up|Participant convenience|1
6895229|NCT00623766|10913048|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36
6895230|NCT00623766|10913049|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16
6895231|NCT00623766|10913048|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4
7169516|NCT02626520|11360423|FG001|Overall Study|Lack of Efficacy|2
7169517|NCT02626520|11360422|FG000|Overall Study|Did not start protocol therapy|0
7169518|NCT02626520|11360423|FG001|Overall Study|Did not start protocol therapy|2
7169519|NCT02626520|11360422|FG000|Overall Study|Study terminated|0
7169520|NCT02626520|11360423|FG001|Overall Study|Study terminated|1
7169521|NCT02614898|11360431|FG000|Overall Study|Participated until study termination|10
7169522|NCT02614898|11360432|FG001|Overall Study|Participated until study termination|26
7169523|NCT02614898|11360431|FG000|Overall Study|Lost to Follow-up|0
7169524|NCT02614898|11360432|FG001|Overall Study|Lost to Follow-up|2
7169525|NCT02614898|11360431|FG000|Overall Study|Physician Decision|1
7169526|NCT02614898|11360432|FG001|Overall Study|Physician Decision|8
7169527|NCT02614898|11360431|FG000|Overall Study|Study Terminated by Sponsor|3
7169528|NCT02614898|11360432|FG001|Overall Study|Study Terminated by Sponsor|0
7169529|NCT02614898|11360431|FG000|Overall Study|Withdrawal by Subject|0
7169530|NCT02614898|11360432|FG001|Overall Study|Withdrawal by Subject|2
7169531|NCT02614898|11360431|FG000|Overall Study|Withdrawal by Parent/Guardian|1
7169532|NCT02614898|11360432|FG001|Overall Study|Withdrawal by Parent/Guardian|1
7169533|NCT02614898|11360431|FG000|Overall Study|Other-Additional Information Unavailable|0
7169534|NCT02614898|11360432|FG001|Overall Study|Other-Additional Information Unavailable|11
7169535|NCT02614898|11360431|FG000|Overall Study|Missing|0
7169536|NCT02614898|11360432|FG001|Overall Study|Missing|1
7169537|NCT02622828|11360439|FG000|Overall Study|participant withdrew|3
7169538|NCT02619812|11360465|FG000|Overall Study|Withdrawal by Subject|0
7169539|NCT02619812|11360466|FG001|Overall Study|Withdrawal by Subject|0
7169540|NCT02619812|11360467|FG002|Overall Study|Withdrawal by Subject|1
7169541|NCT02619812|11360468|FG003|Overall Study|Withdrawal by Subject|2
7169542|NCT02612285|11360478|FG000|Overall Study|Withdrawal by Subject|1
7184937|NCT00075946|11385363|FG003|Overall Study|Alternative therapy|0
7184938|NCT00075946|11385364|FG004|Overall Study|Alternative therapy|0
7184939|NCT00075946|11385360|FG000|Overall Study|Other complicating disease|7
7184940|NCT00075946|11385361|FG001|Overall Study|Other complicating disease|13
7184941|NCT00075946|11385362|FG002|Overall Study|Other complicating disease|1
7184942|NCT00075946|11385363|FG003|Overall Study|Other complicating disease|4
7184943|NCT00075946|11385364|FG004|Overall Study|Other complicating disease|0
7184944|NCT00075946|11385360|FG000|Overall Study|No response to retreatment|23
7184945|NCT00075946|11385361|FG001|Overall Study|No response to retreatment|0
7184946|NCT00075946|11385362|FG002|Overall Study|No response to retreatment|2
7184947|NCT00075946|11385363|FG003|Overall Study|No response to retreatment|0
7184948|NCT00075946|11385364|FG004|Overall Study|No response to retreatment|0
7184949|NCT00075946|11385360|FG000|Overall Study|Time to progression less than 6 months|15
7184950|NCT00075946|11385361|FG001|Overall Study|Time to progression less than 6 months|30
7184951|NCT00075946|11385362|FG002|Overall Study|Time to progression less than 6 months|8
7184952|NCT00075946|11385363|FG003|Overall Study|Time to progression less than 6 months|3
7184953|NCT00075946|11385364|FG004|Overall Study|Time to progression less than 6 months|0
7184954|NCT00075946|11385360|FG000|Overall Study|Other|5
7184955|NCT00075946|11385361|FG001|Overall Study|Other|13
7184956|NCT00075946|11385362|FG002|Overall Study|Other|0
7184957|NCT00075946|11385363|FG003|Overall Study|Other|2
7184958|NCT00075946|11385364|FG004|Overall Study|Other|0
7184959|NCT00003641|11385377|FG000|Overall Study|Withdrawal by Subject|0
7184960|NCT00003641|11385378|FG001|Overall Study|Withdrawal by Subject|100
7184961|NCT00003641|11385377|FG000|Overall Study|Adverse Event|0
7184962|NCT00003641|11385378|FG001|Overall Study|Adverse Event|38
7184963|NCT00003641|11385377|FG000|Overall Study|Disease progression|0
7184964|NCT00003641|11385378|FG001|Overall Study|Disease progression|2
7184965|NCT00003641|11385377|FG000|Overall Study|Unknown/missing|0
7184966|NCT00003641|11385378|FG001|Overall Study|Unknown/missing|22
7184967|NCT00003641|11385377|FG000|Overall Study|Should not receive interferon therapy|2
7184968|NCT00003641|11385378|FG001|Overall Study|Should not receive interferon therapy|0
7169543|NCT02606279|11360488|FG000|Overall Study|Lost to Follow-up|0
7169544|NCT02606279|11360489|FG001|Overall Study|Lost to Follow-up|1
7169545|NCT02605824|11360497|FG000|Overall Study|Physician Decision|1
7169546|NCT02605824|11360498|FG001|Overall Study|Physician Decision|0
7169547|NCT02598622|11360506|FG000|Overall Study|Withdrawal by Subject|3
7169548|NCT02598622|11360507|FG001|Overall Study|Withdrawal by Subject|0
7169549|NCT02598622|11360506|FG000|Overall Study|Physician Decision|3
7169550|NCT02598622|11360507|FG001|Overall Study|Physician Decision|0
7169551|NCT02582749|11360528|FG000|Overall Study|Study terminated by funder|5
7169552|NCT02582749|11360529|FG001|Overall Study|Study terminated by funder|10
7169553|NCT02582749|11360528|FG000|Overall Study|Withdrawal by Subject|0
7169554|NCT02582749|11360529|FG001|Overall Study|Withdrawal by Subject|1
7169555|NCT02569957|11360562|FG000|Overall Study|Withdrawal by Subject|0
7169556|NCT02569957|11360563|FG001|Overall Study|Withdrawal by Subject|1
7169557|NCT02575365|11360582|FG000|Overall Study|Lost to Follow-up|4
7169558|NCT02547129|11360592|FG000|Overall Study|Difficulty with ongoing infection|1
7169559|NCT02547129|11360593|FG001|Overall Study|Difficulty with ongoing infection|0
7169560|NCT02533531|11360632|FG000|Overall Study|Device did not turn on|1
7169561|NCT02520726|11360648|FG000|Overall Study|Lost to Follow-up|3
7169562|NCT02520726|11360649|FG001|Overall Study|Lost to Follow-up|2
7169563|NCT02519712|11360659|FG000|Overall Study|Disease Relapse|1
7169564|NCT02519712|11360659|FG000|Overall Study|Disease Progression|1
7169565|NCT02519712|11360659|FG000|Overall Study|Accruals are donors|2
7169566|NCT02516228|11360667|FG000|Overall Study|Lost to Follow-up|1
7169567|NCT02516228|11360667|FG000|Overall Study|Withdrawal by Subject|1
7169568|NCT02516228|11360667|FG000|Overall Study|Physician Decision|1
7169569|NCT02506101|11360707|FG000|Overall Study|Transportation issues|1
7169570|NCT02506101|11360708|FG001|Overall Study|Transportation issues|0
7169571|NCT02506101|11360707|FG000|Overall Study|No enrollment and staff unavailability|1
7169572|NCT02506101|11360708|FG001|Overall Study|No enrollment and staff unavailability|0
7169573|NCT02500901|11360727|FG000|Overall Study|Disease ProgressionDD|2
7169574|NCT02483533|11360733|FG000|Overall Study|Lack of Efficacy|50
7169575|NCT02483533|11360734|FG001|Overall Study|Lack of Efficacy|50
7169576|NCT02496039|11360740|FG000|Overall Study|Adverse Event|3
7169577|NCT02496039|11360740|FG000|Overall Study|Protocol Violation|1
7169578|NCT02494206|11360749|FG000|Overall Study|Adverse Event|1
7169579|NCT02494206|11360749|FG000|Overall Study|Disease Progression|1
7169580|NCT02473445|11360753|FG000|Overall Study|Withdrawal by Subject|2
7169581|NCT02473445|11360753|FG000|Overall Study|Sponsor Decision|20
7169582|NCT02491411|11360757|FG000|Overall Study|Physician Decision|4
7169583|NCT02476994|11360763|FG000|Overall Study|Based on feedback from FDA|1
7169584|NCT02476994|11360764|FG001|Overall Study|Based on feedback from FDA|0
7169585|NCT02473523|11360770|FG000|Overall Study|Death|1
7169586|NCT02473523|11360770|FG000|Overall Study|Lost to Follow-up|1
7169587|NCT02472639|11360789|FG000|Overall Study|Physician Decision|4
7169588|NCT02472639|11360790|FG001|Overall Study|Physician Decision|3
7169589|NCT02469415|11360796|FG000|Overall Study|Withdrawal by Subject|1
7169590|NCT02469415|11360796|FG000|Overall Study|Investigational agent placed on hold|2
7169591|NCT02452359|11360808|FG000|Overall Study|Adverse Event|1
7169592|NCT02452359|11360808|FG000|Overall Study|Lost to Follow-up|15
7169593|NCT02452359|11360808|FG000|Overall Study|Pregnancy|1
7169594|NCT02452359|11360808|FG000|Overall Study|Withdrawal by Subject|4
7169595|NCT02452398|11360816|FG000|Overall Study|Adverse Event|1
7169596|NCT02452398|11360816|FG000|Overall Study|Lost to Follow-up|28
7169597|NCT02452398|11360816|FG000|Overall Study|Physician Decision|2
7169598|NCT02452398|11360816|FG000|Overall Study|Withdrawal by Subject|6
7169599|NCT02452398|11360816|FG000|Overall Study|Moved away|4
7169600|NCT02447887|11360820|FG000|Overall Study|Study was terminated|3
7169601|NCT02439970|11360841|FG000|Overall Study|Study Terminated|2
7169602|NCT02439970|11360842|FG001|Overall Study|Study Terminated|3
7169603|NCT02439957|11360850|FG000|Overall Study|Study Terminated|3
7169604|NCT02439957|11360851|FG001|Overall Study|Study Terminated|3
7169605|NCT02441036|11360862|FG000|Overall Study|No tissue resected|0
7169606|NCT02441036|11360863|FG001|Overall Study|No tissue resected|1
7169607|NCT02441036|11360864|FG002|Overall Study|No tissue resected|0
7169608|NCT02441036|11360865|FG003|Overall Study|No tissue resected|1
7169609|NCT02441036|11360866|FG004|Overall Study|No tissue resected|0
7169610|NCT02430532|11360903|FG000|Overall Study|Sponsor Decision to Stop Study Early|30
7169611|NCT02430532|11360904|FG001|Overall Study|Sponsor Decision to Stop Study Early|25
7169612|NCT02430532|11360903|FG000|Overall Study|Consent Withdrawn|0
7169613|NCT02430532|11360904|FG001|Overall Study|Consent Withdrawn|2
7169614|NCT02430532|11360903|FG000|Overall Study|Adverse Event|0
7169615|NCT02430532|11360904|FG001|Overall Study|Adverse Event|1
7169616|NCT02428231|11360914|FG000|Overall Study|Other|10
7169617|NCT02428231|11360915|FG001|Overall Study|Other|16
7169618|NCT02428231|11360914|FG000|Overall Study|Required Symptomatic Therapy|0
7169619|NCT02428231|11360915|FG001|Overall Study|Required Symptomatic Therapy|1
7169620|NCT02428231|11360914|FG000|Overall Study|Adverse Event|3
7169621|NCT02428231|11360915|FG001|Overall Study|Adverse Event|0
7169622|NCT02424565|11360921|FG000|Period 1 (D0)|Protocol Violation|0
7169623|NCT02424565|11360922|FG001|Period 1 (D0)|Protocol Violation|1
7169624|NCT02422303|11360943|FG000|Overall Study|Lost to Follow-up|1
7169625|NCT02422303|11360944|FG001|Overall Study|Lost to Follow-up|1
7169626|NCT02414152|11360967|FG000|Overall Study|Withdrawal by Subject|1
7169627|NCT02414152|11360967|FG000|Overall Study|Lack of Efficacy|1
7169628|NCT02410551|11360971|FG000|Overall Study|Adverse Event|1
7169629|NCT02410551|11360971|FG000|Overall Study|Withdrawal by Subject|1
7169630|NCT02410551|11360971|FG000|Overall Study|FDA Clinical hold-patients taken off|2
7169631|NCT02410954|11360982|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6
7169632|NCT02410954|11360983|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0
7169633|NCT02410954|11360982|FG000|Overall Study|Instrument malfunction generated unusable data|8
7169634|NCT02410954|11360983|FG001|Overall Study|Instrument malfunction generated unusable data|0
7169635|NCT02409355|11360995|FG000|Overall Study|Withdrawal by Subject|1
7169636|NCT02409355|11360996|FG001|Overall Study|Withdrawal by Subject|0
7169637|NCT02409355|11360995|FG000|Overall Study|Death|1
7169638|NCT02409355|11360996|FG001|Overall Study|Death|1
7169639|NCT02409355|11360995|FG000|Overall Study|Study terminated by Sponsor|2
7169640|NCT02409355|11360996|FG001|Overall Study|Study terminated by Sponsor|3
7169641|NCT02404545|11361021|FG000|Overall Study|Sponsor Termination|6
7169642|NCT02404545|11361022|FG001|Overall Study|Sponsor Termination|6
7169643|NCT02392377|11361031|FG000|Overall Study|Withdrawal by Subject|0
7169644|NCT02392377|11361032|FG001|Overall Study|Withdrawal by Subject|1
7169645|NCT02394665|11361066|FG000|Overall Study|Physician Decision|1
7169646|NCT02394665|11361067|FG001|Overall Study|Physician Decision|0
7169647|NCT02394665|11361068|FG002|Overall Study|Physician Decision|0
7169648|NCT02390362|11361087|FG000|Overall Study|Withdrawal by Subject|0
7169649|NCT02390362|11361088|FG001|Overall Study|Withdrawal by Subject|1
7169650|NCT02388776|11361094|FG000|Overall Study|Death|1
7169651|NCT02388776|11361094|FG000|Overall Study|Lost to Follow-up|1
7169652|NCT02383433|11361099|FG000|Overall Study|Disease progression|2
7169653|NCT02379390|11361127|FG000|Overall Study|Adverse Event|1
7169654|NCT02379390|11361128|FG001|Overall Study|Adverse Event|1
7169655|NCT02379390|11361127|FG000|Overall Study|Investigator's decision|1
7169656|NCT02379390|11361128|FG001|Overall Study|Investigator's decision|0
7169657|NCT02379390|11361127|FG000|Overall Study|Study Termination|0
7169658|NCT02379390|11361128|FG001|Overall Study|Study Termination|1
7169659|NCT02361580|11361152|FG000|Overall Study|Lost to Follow-up|6
7169660|NCT02361580|11361153|FG001|Overall Study|Lost to Follow-up|3
7169661|NCT02370888|11361184|FG000|Overall Study|disease progression|2
7169662|NCT02370888|11361184|FG000|Overall Study|did not meet chimerism criteria|6
7169663|NCT02365233|11361208|FG000|Overall Study|IRB withheld the data|1
7169664|NCT02365233|11361209|FG001|Overall Study|IRB withheld the data|2
7169665|NCT02365233|11361210|FG002|Overall Study|IRB withheld the data|2
7169666|NCT02347943|11361221|FG000|Overall Study|Study was cancelled|140
7169667|NCT02347943|11361222|FG001|Overall Study|Study was cancelled|67
7169668|NCT02347943|11361223|FG002|Overall Study|Study was cancelled|45
7169669|NCT02365207|11361231|FG000|Overall Study|Withdrawal by Subject|1
7169670|NCT02365207|11361231|FG000|Overall Study|Physician Decision|1
7169671|NCT02360111|11361235|FG000|Overall Study|Death|2
7169672|NCT02353468|11361239|FG000|Overall Study|Study terminated|3
7184969|NCT00003641|11385377|FG000|Overall Study|Never started interferon|567
7184970|NCT00003641|11385378|FG001|Overall Study|Never started interferon|12
7187646|NCT02214160|11388346|FG000|Overall Study|Physician Decision|0
7187647|NCT02214160|11388347|FG001|Overall Study|Physician Decision|0
7187648|NCT02214160|11388348|FG002|Overall Study|Physician Decision|1
7187649|NCT01460160|11388368|FG000|Treatment Phase|Lack of Efficacy|3
7187650|NCT01460160|11388368|FG000|Treatment Phase|Study Drug Toxicity|2
7187651|NCT01460160|11388368|FG000|Treatment Phase|Adverse Event|8
7187652|NCT01460160|11388368|FG000|Treatment Phase|Withdrawal by Subject|4
7187653|NCT01460160|11388368|FG000|Treatment Phase|Death|2
7187654|NCT01460160|11388368|FG000|Treatment Phase|Other reasons|9
7187655|NCT01460160|11388368|FG000|Follow-up Phase|Withdrawal by Subject|4
7187656|NCT01460160|11388368|FG000|Follow-up Phase|Death|14
7187657|NCT01460160|11388368|FG000|Follow-up Phase|Lost to Follow-up|7
7187658|NCT01460160|11388368|FG000|Follow-up Phase|Follow-up no longer required per protocol|70
7187659|NCT01460160|11388368|FG000|Follow-up Phase|Other and not reported reasons|5
7187660|NCT01170702|11388376|FG000|Overall Study|Exclusion criteria met after consent|1
7187661|NCT01170702|11388377|FG001|Overall Study|Exclusion criteria met after consent|2
7187662|NCT01170702|11388378|FG002|Overall Study|Exclusion criteria met after consent|0
7187663|NCT01170702|11388379|FG003|Overall Study|Exclusion criteria met after consent|2
7187664|NCT01018563|11388389|FG000|Overall Study|Termination of the study by Sponsor|2
7187665|NCT01018563|11388390|FG001|Overall Study|Termination of the study by Sponsor|1
7187666|NCT00805961|11388400|FG000|Modality Therapy|Withdrawal by Subject|1
7187667|NCT00805961|11388400|FG000|Modality Therapy|Adverse Event|1
7187668|NCT00805961|11388400|FG000|Modality Therapy|Disease Progression|2
7187669|NCT00805961|11388400|FG000|Treatment-Free Interval|Adverse Event|3
7187670|NCT00805961|11388400|FG000|Treatment-Free Interval|Intercurrent Illness|2
7187671|NCT00805961|11388400|FG000|Treatment-Free Interval|Physician Decision|1
7187672|NCT00805961|11388400|FG000|Treatment-Free Interval|Lack of Efficacy|1
7187673|NCT00805961|11388400|FG000|Maintenance Treatment|Lack of Efficacy|13
7187674|NCT00805961|11388400|FG000|Maintenance Treatment|Intercurrent Illness|7
7187675|NCT00805961|11388400|FG000|Maintenance Treatment|Adverse Event|6
7187676|NCT00805961|11388400|FG000|Maintenance Treatment|Withdrawal by Subject|5
7187677|NCT00805961|11388400|FG000|Maintenance Treatment|Symptomatic Deterioration|2
7187678|NCT00805961|11388400|FG000|Maintenance Treatment|Withdrawn Consent|1
7188334|NCT02891226|11388860|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3
7169673|NCT02346877|11361267|FG000|Overall Study|Adverse Event|1
7169674|NCT02346877|11361268|FG001|Overall Study|Adverse Event|0
7169675|NCT02346877|11361267|FG000|Overall Study|Administrative Decision|1
7169676|NCT02346877|11361268|FG001|Overall Study|Administrative Decision|0
7169677|NCT02346877|11361267|FG000|Overall Study|Sponsor Decision|12
7169678|NCT02346877|11361268|FG001|Overall Study|Sponsor Decision|0
7169679|NCT02346877|11361267|FG000|Overall Study|Missing|5
7169680|NCT02346877|11361268|FG001|Overall Study|Missing|0
7169681|NCT02353572|11361291|FG000|Overall Study|Withdrawal by Subject|1
7169682|NCT02353572|11361291|FG000|Overall Study|Study terminated|2
7169683|NCT02343263|11361307|FG000|Overall Study|Physician Decision|5
7169684|NCT02343263|11361308|FG001|Overall Study|Physician Decision|3
7169685|NCT02343263|11361309|FG002|Overall Study|Physician Decision|1
7169686|NCT02343159|11361324|FG000|Overall Study|Early Study Termination|16
7169687|NCT02343159|11361325|FG001|Overall Study|Early Study Termination|19
7169688|NCT02343159|11361326|FG002|Overall Study|Early Study Termination|23
7169689|NCT02343159|11361324|FG000|Overall Study|Physician Decision|2
7169690|NCT02343159|11361325|FG001|Overall Study|Physician Decision|0
7169691|NCT02343159|11361326|FG002|Overall Study|Physician Decision|1
7169692|NCT02343159|11361324|FG000|Overall Study|Withdrawal by Subject|3
7169693|NCT02343159|11361325|FG001|Overall Study|Withdrawal by Subject|0
7169694|NCT02343159|11361326|FG002|Overall Study|Withdrawal by Subject|2
7169695|NCT02343159|11361324|FG000|Overall Study|Lost to Follow-up|0
7169696|NCT02343159|11361325|FG001|Overall Study|Lost to Follow-up|2
7169697|NCT02343159|11361326|FG002|Overall Study|Lost to Follow-up|2
7169698|NCT02343159|11361324|FG000|Overall Study|Adverse Event|4
7169699|NCT02343159|11361325|FG001|Overall Study|Adverse Event|4
7169700|NCT02343159|11361326|FG002|Overall Study|Adverse Event|2
7169701|NCT02343159|11361324|FG000|Overall Study|Sponsor Decision|0
7169702|NCT02343159|11361325|FG001|Overall Study|Sponsor Decision|1
7169703|NCT02343159|11361326|FG002|Overall Study|Sponsor Decision|0
7169704|NCT02343159|11361324|FG000|Overall Study|Enrollment Error|1
7169705|NCT02343159|11361325|FG001|Overall Study|Enrollment Error|0
7169706|NCT02343159|11361326|FG002|Overall Study|Enrollment Error|0
7169707|NCT02336425|11361343|FG000|Overall Study|Study terminated.|2
7169708|NCT02336425|11361344|FG001|Overall Study|Study terminated.|2
7169709|NCT02336425|11361345|FG002|Overall Study|Study terminated.|3
7169710|NCT02336425|11361346|FG003|Overall Study|Study terminated.|3
7169711|NCT02308735|11361407|FG000|Overall Study|Physician Decision|2
7169712|NCT02308735|11361408|FG001|Overall Study|Physician Decision|0
7169713|NCT02308735|11361409|FG002|Overall Study|Physician Decision|0
7169714|NCT02308735|11361410|FG003|Overall Study|Physician Decision|2
7169715|NCT02299206|11361420|FG000|Overall Study|Lost to Follow-up|1
7169716|NCT02299206|11361420|FG000|Overall Study|Withdrawal by Subject|1
7169717|NCT02302859|11361426|FG000|Overall Study|Lost Phone|1
7169718|NCT02302859|11361427|FG001|Overall Study|Lost Phone|1
7169719|NCT02302859|11361426|FG000|Overall Study|Withdrawal by Subject|0
7169720|NCT02302859|11361427|FG001|Overall Study|Withdrawal by Subject|1
7169721|NCT02299934|11361433|FG000|Overall Study|Termination of study|13
7169722|NCT02294981|11361460|FG000|Overall Study|Lost to Follow-up|1
7169723|NCT02284906|11361467|FG000|Overall Study|Pretreatment Event/Adverse Event|0
7169724|NCT02284906|11361468|FG001|Overall Study|Pretreatment Event/Adverse Event|1
7169725|NCT02284906|11361469|FG002|Overall Study|Pretreatment Event/Adverse Event|0
7169726|NCT02284906|11361467|FG000|Overall Study|Major Protocol Deviation|0
7169727|NCT02284906|11361468|FG001|Overall Study|Major Protocol Deviation|1
7169728|NCT02284906|11361469|FG002|Overall Study|Major Protocol Deviation|0
7169729|NCT02284906|11361467|FG000|Overall Study|Voluntary Withdrawal|2
7169730|NCT02284906|11361468|FG001|Overall Study|Voluntary Withdrawal|4
7169731|NCT02284906|11361469|FG002|Overall Study|Voluntary Withdrawal|5
7169732|NCT02284906|11361467|FG000|Overall Study|Study Termination|0
7169733|NCT02284906|11361468|FG001|Overall Study|Study Termination|11
7169734|NCT02284906|11361469|FG002|Overall Study|Study Termination|14
7169735|NCT02284906|11361467|FG000|Overall Study|Reason not Specified|1
7169736|NCT02284906|11361468|FG001|Overall Study|Reason not Specified|1
7169737|NCT02284906|11361469|FG002|Overall Study|Reason not Specified|0
7169738|NCT02287025|11361479|FG000|Overall Study|Not treated|2
7169739|NCT02287025|11361480|FG001|Overall Study|Not treated|0
7169740|NCT02287025|11361479|FG000|Overall Study|Progression of disease|3
7169741|NCT02287025|11361480|FG001|Overall Study|Progression of disease|2
7169742|NCT02287025|11361479|FG000|Overall Study|Adverse Event|2
7169743|NCT02287025|11361480|FG001|Overall Study|Adverse Event|4
7169744|NCT02287025|11361479|FG000|Overall Study|Withdrawal by Subject|2
7169745|NCT02287025|11361480|FG001|Overall Study|Withdrawal by Subject|2
7169746|NCT02287025|11361479|FG000|Overall Study|Screening failed|1
7169747|NCT02287025|11361480|FG001|Overall Study|Screening failed|1
7169748|NCT02276560|11361495|FG000|Overall Study|Adverse Event|1
7169749|NCT02276560|11361496|FG001|Overall Study|Adverse Event|0
7169750|NCT02276560|11361497|FG002|Overall Study|Adverse Event|0
7169751|NCT02284373|11361512|FG000|Overall Study|Withdrawal by Subject|0
7169752|NCT02284373|11361513|FG001|Overall Study|Withdrawal by Subject|1
7169753|NCT02284373|11361514|FG002|Overall Study|Withdrawal by Subject|0
7169754|NCT02284373|11361512|FG000|Overall Study|Other|0
7169755|NCT02284373|11361513|FG001|Overall Study|Other|1
7169756|NCT02284373|11361514|FG002|Overall Study|Other|0
7169757|NCT02284373|11361512|FG000|Overall Study|Lost to Follow-up|0
7169758|NCT02284373|11361513|FG001|Overall Study|Lost to Follow-up|1
7169759|NCT02284373|11361514|FG002|Overall Study|Lost to Follow-up|0
7169760|NCT02285270|11361522|FG000|Overall Study|Lost to Follow-up|1
7169761|NCT02285270|11361522|FG000|Overall Study|Physician Decision|3
7169762|NCT02285270|11361522|FG000|Overall Study|Determined to be ineligible|1
7169763|NCT02275481|11361528|FG000|Overall Study|Death|2
7169764|NCT02275481|11361529|FG001|Overall Study|Death|1
7169765|NCT02275481|11361528|FG000|Overall Study|Lost to Follow-up|2
7169766|NCT02275481|11361529|FG001|Overall Study|Lost to Follow-up|0
7169767|NCT02275481|11361528|FG000|Overall Study|Withdrawal by Subject|3
7169768|NCT02275481|11361529|FG001|Overall Study|Withdrawal by Subject|0
7169769|NCT02275481|11361528|FG000|Overall Study|all other reasons combined|2
7169770|NCT02275481|11361529|FG001|Overall Study|all other reasons combined|1
7169771|NCT02275481|11361528|FG000|Overall Study|Physician Decision|0
7169772|NCT02275481|11361529|FG001|Overall Study|Physician Decision|1
7169773|NCT02273752|11361539|FG000|Overall Study|Trial was terminated early|2
7169774|NCT02270684|11361545|FG000|Overall Study|Lost to Follow-up|0
7169775|NCT02270684|11361546|FG001|Overall Study|Lost to Follow-up|3
7169776|NCT02270684|11361545|FG000|Overall Study|Study terminated|1
7169777|NCT02270684|11361546|FG001|Overall Study|Study terminated|0
7169778|NCT02271594|11361563|FG000|Overall Study|Study closed; recruiting failure|19
7169779|NCT02271594|11361564|FG001|Overall Study|Study closed; recruiting failure|12
7169780|NCT02263365|11361574|FG000|Overall Study|Physician Decision|22
7169781|NCT02263365|11361575|FG001|Overall Study|Physician Decision|18
7169782|NCT02241551|11361609|FG000|Overall Study|Adverse Event|1
7169783|NCT02241551|11361610|FG001|Overall Study|Adverse Event|0
7169784|NCT02246114|11361620|FG000|Overall Study|miscarriage|1
7169785|NCT02246114|11361621|FG001|Overall Study|miscarriage|0
7169786|NCT02232880|11361627|FG000|Overall Study|study stopped prior to randomization|1
7169787|NCT02244944|11361649|FG000|Overall Study|Withdrawal by Subject|1
7169788|NCT02244944|11361649|FG000|Overall Study|Study Terminated|1
7169789|NCT02241187|11361653|FG000|Overall Study|Protocol closed due to lack of accrual.|2
7169790|NCT02239926|11361659|FG000|Overall Study|Withdrawal by Subject|0
7169791|NCT02239926|11361660|FG001|Overall Study|Withdrawal by Subject|1
7169792|NCT02231892|11361669|FG000|Overall Study|Lost to Follow-up|1
7169793|NCT02231892|11361670|FG001|Overall Study|Lost to Follow-up|0
7169794|NCT02231892|11361671|FG002|Overall Study|Lost to Follow-up|3
7169795|NCT02231892|11361669|FG000|Overall Study|Withdrawal by Subject|4
6895232|NCT00623766|10913049|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0
6895233|NCT00623766|10913048|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4
6895234|NCT00623766|10913049|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0
6895235|NCT00623766|10913048|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1
6895236|NCT00623766|10913049|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2
6895237|NCT00623766|10913048|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1
6895238|NCT00623766|10913049|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0
7169796|NCT02231892|11361670|FG001|Overall Study|Withdrawal by Subject|3
7169797|NCT02231892|11361671|FG002|Overall Study|Withdrawal by Subject|15
7169798|NCT02231892|11361669|FG000|Overall Study|Physician Decision|0
7169799|NCT02231892|11361670|FG001|Overall Study|Physician Decision|2
7169800|NCT02231892|11361671|FG002|Overall Study|Physician Decision|4
7169801|NCT02231892|11361669|FG000|Overall Study|Motor activity when stimulating ante ACC|4
7169802|NCT02231892|11361670|FG001|Overall Study|Motor activity when stimulating ante ACC|7
7169803|NCT02231892|11361671|FG002|Overall Study|Motor activity when stimulating ante ACC|12
7169804|NCT02231892|11361669|FG000|Overall Study|Participant motor threshold was >83%|0
7169805|NCT02231892|11361670|FG001|Overall Study|Participant motor threshold was >83%|0
7169806|NCT02231892|11361671|FG002|Overall Study|Participant motor threshold was >83%|9
7169807|NCT02231892|11361669|FG000|Overall Study|Could not find motor threshold|2
7169808|NCT02231892|11361670|FG001|Overall Study|Could not find motor threshold|0
7169809|NCT02231892|11361671|FG002|Overall Study|Could not find motor threshold|1
7169810|NCT02231892|11361669|FG000|Overall Study|Could not find reliable motor hotspot|0
7169811|NCT02231892|11361670|FG001|Overall Study|Could not find reliable motor hotspot|0
7169812|NCT02231892|11361671|FG002|Overall Study|Could not find reliable motor hotspot|1
7169813|NCT02241343|11361685|FG000|Overall Study|Adverse Event|1
7169814|NCT02224599|11361720|FG000|Overall Study|Physician Decision|1
7169815|NCT02224599|11361720|FG000|Overall Study|Progression of Disease|1
7169816|NCT02201472|11361724|FG000|Overall Study|Lack of Efficacy|2
7169817|NCT02200042|11361747|FG000|Overall Study|Withdrawal by Subject|0
7169818|NCT02200042|11361748|FG001|Overall Study|Withdrawal by Subject|1
7169819|NCT02181790|11361756|FG000|Overall Study|study terminated|2
7169820|NCT02181790|11361757|FG001|Overall Study|study terminated|0
7169821|NCT02177266|11361785|FG000|Overall Study|Adverse Event|0
7169822|NCT02177266|11361786|FG001|Overall Study|Adverse Event|1
7169823|NCT02177266|11361785|FG000|Overall Study|Withdrawal by Subject|1
7169824|NCT02177266|11361786|FG001|Overall Study|Withdrawal by Subject|0
7169825|NCT02170298|11361803|FG000|Overall Study|Withdrawal by Subject|0
7169826|NCT02170298|11361804|FG001|Overall Study|Withdrawal by Subject|1
7169827|NCT02170298|11361803|FG000|Overall Study|unblinded, rerandomized to intervention|1
7169828|NCT02170298|11361804|FG001|Overall Study|unblinded, rerandomized to intervention|0
7169829|NCT02169830|11361826|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0
7169830|NCT02169830|11361827|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0
7184971|NCT01956669|11385391|FG000|Overall Study|Disease Progression|12
7169831|NCT02169830|11361828|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1
7169832|NCT02169830|11361826|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1
7169833|NCT02169830|11361827|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0
7169834|NCT02169830|11361828|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0
7169835|NCT02169830|11361826|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2
7169836|NCT02169830|11361827|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5
7169837|NCT02169830|11361828|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0
7169838|NCT02169830|11361826|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0
7169839|NCT02169830|11361827|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1
7169840|NCT02169830|11361828|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0
7169841|NCT02169830|11361826|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0
7169842|NCT02169830|11361827|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1
7169843|NCT02169830|11361828|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0
7169844|NCT02163187|11361838|FG000|Overall Study|Device removed|1
7169845|NCT02163187|11361839|FG001|Overall Study|Device removed|0
7169846|NCT02163187|11361838|FG000|Overall Study|Progressive disease|1
7169847|NCT02163187|11361839|FG001|Overall Study|Progressive disease|0
7169848|NCT02161016|11361845|FG000|Overall Study|withdrawn by IRB|1
7169849|NCT02159040|11361849|FG000|Overall Study|Death|1
7169850|NCT02168270|11361853|FG000|Overall Study|Lack of Efficacy|4
7169851|NCT02157116|11361857|FG000|Overall Study|Withdrawal by Subject|4
7169852|NCT02157116|11361857|FG000|Overall Study|Physician Decision|3
7169853|NCT02157116|11361857|FG000|Overall Study|Failed Screening|2
7169854|NCT02154087|11361861|FG000|Overall Study|Study Termination|1
7169855|NCT02152566|11361869|FG000|Overall Study|Lost to Follow-up|1
7169856|NCT02152566|11361869|FG000|Overall Study|Withdrawal by Subject|2
7169857|NCT02145390|11361886|FG000|Overall Study|Withdrawal by Subject|1
7169858|NCT02150863|11361919|FG000|Overall Study|Lost to Follow-up|0
7169859|NCT02150863|11361920|FG001|Overall Study|Lost to Follow-up|1
7169860|NCT02150863|11361921|FG002|Overall Study|Lost to Follow-up|0
7169861|NCT02131155|11361957|FG000|Overall Study|Adverse Event|1
7169862|NCT02131155|11361958|FG001|Overall Study|Adverse Event|0
7169863|NCT02131155|11361957|FG000|Overall Study|Treatment completed|1
7169864|NCT02131155|11361958|FG001|Overall Study|Treatment completed|0
7169865|NCT02131155|11361957|FG000|Overall Study|Primary tumour recurrence|2
7169866|NCT02131155|11361958|FG001|Overall Study|Primary tumour recurrence|1
7169867|NCT02131155|11361957|FG000|Overall Study|Refused to continue study medication|1
7169868|NCT02131155|11361958|FG001|Overall Study|Refused to continue study medication|0
7169869|NCT02131155|11361957|FG000|Overall Study|Study early termination|20
7169870|NCT02131155|11361958|FG001|Overall Study|Study early termination|10
7169871|NCT02117050|11361964|FG000|Overall Study|Subject Enrolled but not Dosed|1
7169872|NCT02105116|11361986|FG000|Overall Study|not eligible for step 2 of trial|5
7169873|NCT02105116|11361986|FG000|Overall Study|Death|1
7169874|NCT02099344|11362003|FG000|Overall Study|Physician Decision|1
7169875|NCT02099344|11362004|FG001|Overall Study|Physician Decision|0
7169876|NCT02096042|11362021|FG000|Overall Study|Disease Progression|1
7169877|NCT02096042|11362022|FG001|Overall Study|Disease Progression|0
7169878|NCT02096042|11362023|FG002|Overall Study|Disease Progression|0
7169879|NCT02088957|11362030|FG000|Overall Study|Lack of Efficacy|1
7169880|NCT02088957|11362031|FG001|Overall Study|Lack of Efficacy|0
7184972|NCT01956669|11385392|FG001|Overall Study|Disease Progression|7
7184973|NCT01956669|11385393|FG002|Overall Study|Disease Progression|7
7184974|NCT01956669|11385394|FG003|Overall Study|Disease Progression|8
7184975|NCT01956669|11385395|FG004|Overall Study|Disease Progression|4
7184976|NCT01956669|11385396|FG005|Overall Study|Disease Progression|3
7184977|NCT01956669|11385397|FG006|Overall Study|Disease Progression|5
7184978|NCT01956669|11385391|FG000|Overall Study|Adverse Event|0
7184979|NCT01956669|11385392|FG001|Overall Study|Adverse Event|2
7184980|NCT01956669|11385393|FG002|Overall Study|Adverse Event|2
7184981|NCT01956669|11385394|FG003|Overall Study|Adverse Event|1
7184982|NCT01956669|11385395|FG004|Overall Study|Adverse Event|0
7184983|NCT01956669|11385396|FG005|Overall Study|Adverse Event|0
7184984|NCT01956669|11385397|FG006|Overall Study|Adverse Event|0
7184985|NCT01956669|11385391|FG000|Overall Study|Physician Decision|0
7184986|NCT01956669|11385392|FG001|Overall Study|Physician Decision|2
7184987|NCT01956669|11385393|FG002|Overall Study|Physician Decision|0
7184988|NCT01956669|11385394|FG003|Overall Study|Physician Decision|0
7184989|NCT01956669|11385395|FG004|Overall Study|Physician Decision|0
7184990|NCT01956669|11385396|FG005|Overall Study|Physician Decision|1
7184991|NCT01956669|11385397|FG006|Overall Study|Physician Decision|0
7184992|NCT01956669|11385391|FG000|Overall Study|Withdrawal by Subject|0
7184993|NCT01956669|11385392|FG001|Overall Study|Withdrawal by Subject|0
7184994|NCT01956669|11385393|FG002|Overall Study|Withdrawal by Subject|1
7184995|NCT01956669|11385394|FG003|Overall Study|Withdrawal by Subject|1
7184996|NCT01956669|11385395|FG004|Overall Study|Withdrawal by Subject|0
7184997|NCT01956669|11385396|FG005|Overall Study|Withdrawal by Subject|0
7184998|NCT01956669|11385397|FG006|Overall Study|Withdrawal by Subject|1
7187679|NCT03921424|11388421|FG000|Overall Study|Lost to Follow-up|0
7187680|NCT03921424|11388422|FG001|Overall Study|Lost to Follow-up|1
7187681|NCT03921424|11388421|FG000|Overall Study|Withdrawal By Parent/Guardian|0
7187682|NCT03921424|11388422|FG001|Overall Study|Withdrawal By Parent/Guardian|2
7187683|NCT03598777|11388435|FG000|Overall Study|Study Terminated by Sponsor|3
7187684|NCT03598777|11388436|FG001|Overall Study|Study Terminated by Sponsor|0
7169881|NCT02093689|11362040|FG000|Overall Study|Physician Decision|4
7169882|NCT02093689|11362041|FG001|Overall Study|Physician Decision|0
7169883|NCT02093689|11362042|FG002|Overall Study|Physician Decision|0
7169884|NCT02091752|11362048|FG000|Overall Study|Study terminated by Sponsor|2
7169885|NCT02091752|11362048|FG000|Overall Study|Adverse Event|1
7169886|NCT02068547|11362054|FG000|Overall Study|Lost to Follow-up|3
7169887|NCT02068547|11362055|FG001|Overall Study|Lost to Follow-up|3
7169888|NCT02068547|11362054|FG000|Overall Study|Physician Decision|1
7169889|NCT02068547|11362055|FG001|Overall Study|Physician Decision|0
7169890|NCT02081183|11362093|FG000|Overall Study|Lost to Follow-up|0
7169891|NCT02081183|11362094|FG001|Overall Study|Lost to Follow-up|1
7169892|NCT02081183|11362093|FG000|Overall Study|Protocol Violation|1
7169893|NCT02081183|11362094|FG001|Overall Study|Protocol Violation|0
7169894|NCT02081183|11362093|FG000|Overall Study|Other|3
7169895|NCT02081183|11362094|FG001|Overall Study|Other|3
7169896|NCT02067104|11362114|FG000|Overall Study|Study termination due to low accrual|4
7169897|NCT02067104|11362115|FG001|Overall Study|Study termination due to low accrual|5
7169898|NCT02057874|11362125|FG000|Overall Study|participant did not return for scan|1
7169899|NCT02058537|11362139|FG000|Overall Study|Withdrawal by Subject|1
7169900|NCT02038153|11362152|FG000|Overall Study|Withdrawal by Subject|1
7169901|NCT02054910|11362158|FG000|Overall Study|Lost to Follow-up|4
7169902|NCT02054910|11362159|FG001|Overall Study|Lost to Follow-up|1
7169903|NCT02044302|11362169|FG000|Overall Study|study terminated|2
7169904|NCT02044302|11362170|FG001|Overall Study|study terminated|0
7169905|NCT02046226|11362174|FG000|Overall Study|Lost to Follow-up|7
7169906|NCT02044848|11362181|FG000|Overall Study|Administrative Problems|2
7169907|NCT02044848|11362182|FG001|Overall Study|Administrative Problems|3
7169908|NCT02042950|11362188|FG000|Overall Study|Progressive Disease|4
7169909|NCT02048904|11362192|FG000|Overall Study|Withdrawal by Subject|7
7169910|NCT02048904|11362192|FG000|Overall Study|Physician Decision|70
7169911|NCT02044822|11362196|FG000|Overall Study|Study Terminated by Sponsor|77
7169912|NCT02044822|11362196|FG000|Overall Study|Investigator's Discretion|10
7169913|NCT02044822|11362196|FG000|Overall Study|Withdrew Consent|3
7169914|NCT02044822|11362196|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2
7169915|NCT02044822|11362196|FG000|Overall Study|Lost to Follow-up|1
7169916|NCT02042924|11362200|FG000|Overall Study|Early Death|1
7169917|NCT02017522|11362208|FG000|Overall Study|Withdrawal by Subject|1
7169918|NCT02030015|11362213|FG000|Overall Study|Withdrawal by Subject|3
7169919|NCT02030015|11362213|FG000|Overall Study|Death|13
7169920|NCT02015663|11362219|FG000|Overall Study|unsatisfactory therapeutic effect|1
7169921|NCT02015663|11362220|FG001|Overall Study|unsatisfactory therapeutic effect|0
7169922|NCT02015663|11362219|FG000|Overall Study|Withdrawal by Subject|1
7169923|NCT02015663|11362220|FG001|Overall Study|Withdrawal by Subject|0
7169924|NCT02015663|11362219|FG000|Overall Study|Protocol Violation|0
7169925|NCT02015663|11362220|FG001|Overall Study|Protocol Violation|1
7169926|NCT02015663|11362219|FG000|Overall Study|Adverse Event|3
7169927|NCT02015663|11362220|FG001|Overall Study|Adverse Event|0
7169928|NCT02015663|11362219|FG000|Overall Study|Administrative problems|10
7169929|NCT02015663|11362220|FG001|Overall Study|Administrative problems|11
7169930|NCT02029846|11362229|FG000|Overall Study|n=1 each arm|1
7169931|NCT02029846|11362230|FG001|Overall Study|n=1 each arm|1
7169932|NCT02011542|11362267|FG000|Overall Study|Physician Decision|1
7169933|NCT02008370|11362271|FG000|Overall Study|Lost to Follow-up|7
7169934|NCT02005445|11362292|FG000|Overall Study|Dual study enrollment|0
7169935|NCT02005445|11362293|FG001|Overall Study|Dual study enrollment|1
7169936|NCT02006927|11362312|FG000|Overall Study|Adverse Event|2
7169937|NCT02006927|11362312|FG000|Overall Study|Withdrawal by Subject|1
7169938|NCT01996982|11362316|FG000|Overall Study|PI/team left institution|7
7169939|NCT01986751|11362326|FG000|Overall Study|improperly consented|10
7169940|NCT01986751|11362327|FG001|Overall Study|improperly consented|2
7169941|NCT01977729|11362386|FG000|Overall Study|Study terminated|1
7169942|NCT01982253|11362399|FG000|Overall Study|Withdrawal by Subject|1
7169943|NCT01982253|11362400|FG001|Overall Study|Withdrawal by Subject|0
7169944|NCT01982253|11362401|FG002|Overall Study|Withdrawal by Subject|0
7169945|NCT01982253|11362399|FG000|Overall Study|Study terminated by sponsor|1
7169946|NCT01982253|11362400|FG001|Overall Study|Study terminated by sponsor|4
7169947|NCT01982253|11362401|FG002|Overall Study|Study terminated by sponsor|4
7169948|NCT01984268|11362409|FG000|Overall Study|Study Terminated|15
7169949|NCT01980875|11362429|FG000|Overall Study|Withdrew Consent|1
7169950|NCT01980875|11362430|FG001|Overall Study|Withdrew Consent|1
7169951|NCT01980875|11362431|FG002|Overall Study|Withdrew Consent|1
7169952|NCT01980875|11362429|FG000|Overall Study|Study Terminated by Sponsor|7
7169953|NCT01980875|11362430|FG001|Overall Study|Study Terminated by Sponsor|24
7169954|NCT01980875|11362431|FG002|Overall Study|Study Terminated by Sponsor|22
7169955|NCT01980875|11362429|FG000|Overall Study|Lost to Follow-up|0
7169956|NCT01980875|11362430|FG001|Overall Study|Lost to Follow-up|0
7169957|NCT01980875|11362431|FG002|Overall Study|Lost to Follow-up|1
7169958|NCT01970462|11362477|FG000|Overall Study|Lost to Follow-up|0
7169959|NCT01970462|11362478|FG001|Overall Study|Lost to Follow-up|2
7169960|NCT01969565|11362484|FG000|Overall Study|Withdrawal by Subject|1
7169961|NCT01968226|11362489|FG000|Overall Study|[F-18] RDG-K5 was not available|2
7169962|NCT01962974|11362508|FG000|Overall Study|Study termination|7
7169963|NCT01951378|11362525|FG000|Overall Study|Study Terminated-Not completed|23
7169964|NCT01951378|11362526|FG001|Overall Study|Study Terminated-Not completed|17
7169965|NCT01944059|11362549|FG000|Overall Study|Lost to Follow-up|1
7169966|NCT01944059|11362549|FG000|Overall Study|Physician Decision|3
7169967|NCT01944059|11362549|FG000|Overall Study|Withdrawal by Subject|1
7169968|NCT01944059|11362549|FG000|Overall Study|Adverse Event|2
7169969|NCT01935947|11362557|FG000|Overall Study|Adverse Event|0
7169970|NCT01935947|11362558|FG001|Overall Study|Adverse Event|2
7169971|NCT01935947|11362559|FG002|Overall Study|Adverse Event|0
7169972|NCT01935947|11362557|FG000|Overall Study|Diease Progression|2
7169973|NCT01935947|11362558|FG001|Overall Study|Diease Progression|2
7169974|NCT01935947|11362559|FG002|Overall Study|Diease Progression|2
7169975|NCT01935947|11362557|FG000|Overall Study|Death|1
7169976|NCT01935947|11362558|FG001|Overall Study|Death|0
7169977|NCT01935947|11362559|FG002|Overall Study|Death|0
7169978|NCT01939223|11362572|FG000|Overall Study|AE not assoc. with disease recurrence|1
7169979|NCT01939223|11362573|FG001|Overall Study|AE not assoc. with disease recurrence|1
7169980|NCT01939223|11362572|FG000|Overall Study|Disease recurrence (radiological)|1
7169981|NCT01939223|11362573|FG001|Overall Study|Disease recurrence (radiological)|3
7169982|NCT01939223|11362572|FG000|Overall Study|Study stopped by Sponsor|5
7169983|NCT01939223|11362573|FG001|Overall Study|Study stopped by Sponsor|7
7169984|NCT01939223|11362572|FG000|Overall Study|Withdrawal by Subject|6
7169985|NCT01939223|11362573|FG001|Overall Study|Withdrawal by Subject|0
7169986|NCT01938716|11362579|FG000|Overall Study|Physician Decision|2
7169987|NCT01938716|11362579|FG000|Overall Study|Withdrawal by Subject|2
7169988|NCT01936974|11362585|FG000|Overall Study|Physician Decision|2
7169989|NCT01936974|11362586|FG001|Overall Study|Physician Decision|5
7169990|NCT01934504|11362613|FG000|Overall Study|Protocol Deviation|0
7169991|NCT01934504|11362614|FG001|Overall Study|Protocol Deviation|0
7169992|NCT01934504|11362615|FG002|Overall Study|Protocol Deviation|0
7169993|NCT01934504|11362616|FG003|Overall Study|Protocol Deviation|2
7169994|NCT01934504|11362613|FG000|Overall Study|Study Terminated by Sponsor|1
7169995|NCT01934504|11362614|FG001|Overall Study|Study Terminated by Sponsor|0
7169996|NCT01934504|11362615|FG002|Overall Study|Study Terminated by Sponsor|5
7169997|NCT01934504|11362616|FG003|Overall Study|Study Terminated by Sponsor|5
7169998|NCT01928082|11362626|FG000|Overall Study|Study terminated.|1
7169999|NCT01928615|11362630|FG000|Overall Study|Study Terminated by Sponsor|2
7170000|NCT01911793|11362637|FG000|Overall Study|Physician Decision|1
7170001|NCT01911793|11362638|FG001|Overall Study|Physician Decision|5
7170002|NCT01912404|11362646|FG000|Overall Study|Due to personal reasons|1
7170003|NCT01912404|11362647|FG001|Overall Study|Due to personal reasons|0
7170004|NCT01910389|11362655|FG000|Overall Study|Withdrawal by Subject|2
7170005|NCT01910389|11362656|FG001|Overall Study|Withdrawal by Subject|0
7170006|NCT01910389|11362655|FG000|Overall Study|Study Closed|13
7170007|NCT01910389|11362656|FG001|Overall Study|Study Closed|8
7170008|NCT01913327|11362682|FG000|Overall Study|Withdrawal by Subject|0
7170009|NCT01913327|11362683|FG001|Overall Study|Withdrawal by Subject|1
7170010|NCT01902888|11362689|FG000|Overall Study|Study Terminated|3
7170011|NCT01901224|11362693|FG000|Overall Study|study was not funded and terminated|2
7170012|NCT01910441|11362699|FG000|Overall Study|Sponsor decision|0
7170013|NCT01910441|11362700|FG001|Overall Study|Sponsor decision|2
7170014|NCT01910441|11362699|FG000|Overall Study|Lost to Follow-up|6
7170015|NCT01910441|11362700|FG001|Overall Study|Lost to Follow-up|5
7170016|NCT01910441|11362699|FG000|Overall Study|Withdrawal by Subject|0
7170017|NCT01910441|11362700|FG001|Overall Study|Withdrawal by Subject|1
7170018|NCT01910441|11362699|FG000|Overall Study|Non-compliance|0
7170019|NCT01910441|11362700|FG001|Overall Study|Non-compliance|1
7170020|NCT01910441|11362699|FG000|Overall Study|Adverse Event|1
7170021|NCT01910441|11362700|FG001|Overall Study|Adverse Event|0
7170022|NCT01910441|11362699|FG000|Overall Study|Physician Decision|0
7170023|NCT01910441|11362700|FG001|Overall Study|Physician Decision|1
7170024|NCT01902966|11362706|FG000|Overall Study|Death|1
7170025|NCT01902966|11362706|FG000|Overall Study|Physician Decision|1
7170026|NCT01902966|11362706|FG000|Overall Study|Withdrawal by Subject|1
7170027|NCT01900730|11362721|FG000|Overall Study|Withdrawal by Subject|1
7170028|NCT01900730|11362722|FG001|Overall Study|Withdrawal by Subject|0
7170029|NCT01900730|11362721|FG000|Overall Study|Screen Failure|1
7170030|NCT01900730|11362722|FG001|Overall Study|Screen Failure|0
7170031|NCT01900626|11362750|FG000|Overall Study|study was closed due to low enrollment|1
7170032|NCT01900626|11362751|FG001|Overall Study|study was closed due to low enrollment|1
7170033|NCT01884077|11362773|FG000|Overall Study|screen fail|0
7170034|NCT01884077|11362774|FG001|Overall Study|screen fail|2
7170035|NCT01884077|11362773|FG000|Overall Study|canceled surgery|2
7170036|NCT01884077|11362774|FG001|Overall Study|canceled surgery|0
7170037|NCT01884077|11362773|FG000|Overall Study|Lost to Follow-up|0
7170038|NCT01884077|11362774|FG001|Overall Study|Lost to Follow-up|4
7170039|NCT01884077|11362773|FG000|Overall Study|study closed|6
7170040|NCT01884077|11362774|FG001|Overall Study|study closed|4
7184999|NCT01967823|11385422|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1
7185000|NCT01989676|11385432|FG000|Overall Study|Death|52
7185001|NCT01989676|11385433|FG001|Overall Study|Death|60
7185002|NCT01989676|11385432|FG000|Overall Study|Protocol Violation|2
6895239|NCT00623779|10913062|FG000|Overall Study|Adverse Event|1
7185003|NCT01989676|11385433|FG001|Overall Study|Protocol Violation|1
7185004|NCT01989676|11385432|FG000|Overall Study|Lost to Follow-up|8
6895240|NCT00623779|10913063|FG001|Overall Study|Adverse Event|3
7185005|NCT01989676|11385433|FG001|Overall Study|Lost to Follow-up|18
7170041|NCT01887288|11362806|FG000|Overall Study|The study was terminated and the PI has|16
7170042|NCT01861717|11362849|FG000|Overall Study|Lost to Follow-up|1
7170043|NCT01861717|11362849|FG000|Overall Study|Withdrawal by Subject|1
7170044|NCT01866709|11362856|FG000|Overall Study|Adverse Event|1
7170045|NCT01866709|11362857|FG001|Overall Study|Adverse Event|0
7170046|NCT01860040|11362865|FG000|Overall Study|Withdrawal by Subject|1
7170047|NCT01860040|11362866|FG001|Overall Study|Withdrawal by Subject|0
7170048|NCT01856322|11362911|FG000|Overall Study|off study due to lack of accrual|0
7170049|NCT01856322|11362912|FG001|Overall Study|off study due to lack of accrual|0
7170050|NCT01856322|11362913|FG002|Overall Study|off study due to lack of accrual|3
7170051|NCT01853176|11362922|FG000|Overall Study|Study terminated|4
7170052|NCT01853176|11362923|FG001|Overall Study|Study terminated|0
7170053|NCT01857271|11362929|FG000|Overall Study|Lost to Follow-up|1
7170054|NCT01853982|11362944|FG000|Overall Study|Withdrawal by Subject|1
7170055|NCT01853982|11362945|FG001|Overall Study|Withdrawal by Subject|0
7170056|NCT01853982|11362944|FG000|Overall Study|Death|1
7170057|NCT01853982|11362945|FG001|Overall Study|Death|0
7170058|NCT01853982|11362944|FG000|Overall Study|Lost to Follow-up|0
7170059|NCT01853982|11362945|FG001|Overall Study|Lost to Follow-up|1
7170060|NCT01831596|11362976|FG000|Overall Study|Other|8
7170061|NCT01821963|11362989|FG000|Overall Study|Adverse Event|1
7170062|NCT01821898|11362995|FG000|Overall Study|Withdrawal by Subject|2
7170063|NCT01821898|11362996|FG001|Overall Study|Withdrawal by Subject|1
7170064|NCT01829477|11363027|FG000|Overall Study|Study Terminated by Sponsor|15
7170065|NCT01829477|11363028|FG001|Overall Study|Study Terminated by Sponsor|15
7170066|NCT01829477|11363027|FG000|Overall Study|Withdrawal by Subject|1
7170067|NCT01829477|11363028|FG001|Overall Study|Withdrawal by Subject|0
7170068|NCT01803711|11363036|FG000|Overall Study|Adverse Event|1
7170069|NCT01803711|11363037|FG001|Overall Study|Adverse Event|1
7170070|NCT01806051|11363065|FG000|Overall Study|Withdrawal by Subject|6
7170071|NCT01810302|11363092|FG000|Overall Study|Death|1
7170072|NCT01810302|11363093|FG001|Overall Study|Death|0
7170073|NCT01810302|11363092|FG000|Overall Study|Physician Decision|0
7170074|NCT01810302|11363093|FG001|Overall Study|Physician Decision|1
7170075|NCT01806961|11363099|FG000|Overall Study|sponsor decision|16
7170076|NCT01783015|11363109|FG000|Blinded Treatment|Adverse Event|0
7170077|NCT01783015|11363110|FG001|Blinded Treatment|Adverse Event|1
7170078|NCT01783015|11363111|FG002|Blinded Treatment|Adverse Event|0
7170079|NCT01783015|11363109|FG000|Blinded Treatment|Protocol Violation|0
7170080|NCT01783015|11363110|FG001|Blinded Treatment|Protocol Violation|1
7170081|NCT01783015|11363111|FG002|Blinded Treatment|Protocol Violation|0
7170082|NCT01783015|11363109|FG000|Blinded Treatment|Withdrawal by Subject|0
7170083|NCT01783015|11363110|FG001|Blinded Treatment|Withdrawal by Subject|1
7170084|NCT01783015|11363111|FG002|Blinded Treatment|Withdrawal by Subject|0
7170085|NCT01783015|11363109|FG000|Blinded Treatment|Study Terminated by Sponsor|2
7170086|NCT01783015|11363110|FG001|Blinded Treatment|Study Terminated by Sponsor|0
7170087|NCT01783015|11363111|FG002|Blinded Treatment|Study Terminated by Sponsor|0
7170088|NCT01783015|11363109|FG000|Open Label Treatment|Study Terminated by Sponsor|0
7170089|NCT01783015|11363110|FG001|Open Label Treatment|Study Terminated by Sponsor|0
7170090|NCT01783015|11363111|FG002|Open Label Treatment|Study Terminated by Sponsor|6
7170091|NCT01781026|11363145|FG000|Overall Study|Lack of Efficacy|2
7170092|NCT01777854|11363171|FG000|Overall Study|Physician Decision|3
7170093|NCT01777854|11363172|FG001|Overall Study|Physician Decision|3
7170094|NCT01772719|11363180|FG000|Overall Study|Withdrawal by Subject|3
7170095|NCT01772719|11363180|FG000|Overall Study|Adverse Event|2
7170096|NCT01772719|11363180|FG000|Overall Study|Protocol Violation|1
7170097|NCT01772719|11363180|FG000|Overall Study|Lost to Follow-up|1
7170098|NCT01764997|11363192|FG000|Run-in Period|Adverse Event|15
7170099|NCT01764997|11363193|FG001|Run-in Period|Adverse Event|0
7170100|NCT01764997|11363194|FG002|Run-in Period|Adverse Event|0
7170101|NCT01764997|11363195|FG003|Run-in Period|Adverse Event|0
7170102|NCT01764997|11363196|FG004|Run-in Period|Adverse Event|0
7170103|NCT01764997|11363192|FG000|Run-in Period|Lack of Efficacy|5
7170104|NCT01764997|11363193|FG001|Run-in Period|Lack of Efficacy|0
7170105|NCT01764997|11363194|FG002|Run-in Period|Lack of Efficacy|0
7170106|NCT01764997|11363195|FG003|Run-in Period|Lack of Efficacy|0
7170107|NCT01764997|11363196|FG004|Run-in Period|Lack of Efficacy|0
7170108|NCT01764997|11363192|FG000|Run-in Period|Poor compliance to protocol|1
7170109|NCT01764997|11363193|FG001|Run-in Period|Poor compliance to protocol|0
7170110|NCT01764997|11363194|FG002|Run-in Period|Poor compliance to protocol|0
7170111|NCT01764997|11363195|FG003|Run-in Period|Poor compliance to protocol|0
7170112|NCT01764997|11363196|FG004|Run-in Period|Poor compliance to protocol|0
7170113|NCT01764997|11363192|FG000|Run-in Period|Other than specified above|17
7170114|NCT01764997|11363193|FG001|Run-in Period|Other than specified above|0
7170115|NCT01764997|11363194|FG002|Run-in Period|Other than specified above|0
7170116|NCT01764997|11363195|FG003|Run-in Period|Other than specified above|0
7170117|NCT01764997|11363196|FG004|Run-in Period|Other than specified above|0
7170118|NCT01764997|11363192|FG000|Study Drug Treatment Period|Adverse Event|0
7170119|NCT01764997|11363193|FG001|Study Drug Treatment Period|Adverse Event|1
7170120|NCT01764997|11363194|FG002|Study Drug Treatment Period|Adverse Event|0
7170121|NCT01764997|11363195|FG003|Study Drug Treatment Period|Adverse Event|0
7170122|NCT01764997|11363196|FG004|Study Drug Treatment Period|Adverse Event|24
7170123|NCT01764997|11363192|FG000|Study Drug Treatment Period|Lack of Efficacy|0
7170124|NCT01764997|11363193|FG001|Study Drug Treatment Period|Lack of Efficacy|0
7170125|NCT01764997|11363194|FG002|Study Drug Treatment Period|Lack of Efficacy|0
7170126|NCT01764997|11363195|FG003|Study Drug Treatment Period|Lack of Efficacy|0
7170127|NCT01764997|11363196|FG004|Study Drug Treatment Period|Lack of Efficacy|2
7170128|NCT01764997|11363192|FG000|Study Drug Treatment Period|Other than specified above|0
7170129|NCT01764997|11363193|FG001|Study Drug Treatment Period|Other than specified above|0
7170130|NCT01764997|11363194|FG002|Study Drug Treatment Period|Other than specified above|0
7170131|NCT01764997|11363195|FG003|Study Drug Treatment Period|Other than specified above|0
7170132|NCT01764997|11363196|FG004|Study Drug Treatment Period|Other than specified above|10
7170133|NCT01769443|11363212|FG000|Overall Study|Study closure|1
7170134|NCT01769443|11363213|FG001|Overall Study|Study closure|0
7170135|NCT01749826|11363235|FG000|Overall Study|Study Terminated|20
7170136|NCT01749826|11363236|FG001|Overall Study|Study Terminated|0
7170137|NCT01752023|11363297|FG000|Overall Study|Physician Decision|2
7170138|NCT01752023|11363298|FG001|Overall Study|Physician Decision|1
7170139|NCT01740154|11363308|FG000|Overall Study|Adverse Event|1
7170140|NCT01748890|11363312|FG000|Overall Study|Insufficient recruitment for analysis|4
7170141|NCT01748162|11363318|FG000|Overall Study|no additional croup episodes to evaluate|2
7170142|NCT01748162|11363319|FG001|Overall Study|no additional croup episodes to evaluate|2
7170143|NCT01748162|11363318|FG000|Overall Study|participant consented but did not begin|0
7170144|NCT01748162|11363319|FG001|Overall Study|participant consented but did not begin|1
7170145|NCT01748162|11363318|FG000|Overall Study|reasons not available|3
7170146|NCT01748162|11363319|FG001|Overall Study|reasons not available|2
7170147|NCT01732926|11363344|FG000|Overall Study|Study Terminated by Sponsor|168
7170148|NCT01732926|11363345|FG001|Overall Study|Study Terminated by Sponsor|80
7170149|NCT01732926|11363344|FG000|Overall Study|Withdrawal by Subject|46
7170150|NCT01732926|11363345|FG001|Overall Study|Withdrawal by Subject|8
7170151|NCT01732926|11363344|FG000|Overall Study|Physician Decision|24
7170152|NCT01732926|11363345|FG001|Overall Study|Physician Decision|11
7170153|NCT01732926|11363344|FG000|Overall Study|Other Reason|21
7170154|NCT01732926|11363345|FG001|Overall Study|Other Reason|4
7170155|NCT01732926|11363344|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7
7170156|NCT01732926|11363345|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6
7170157|NCT01732926|11363344|FG000|Overall Study|Blind Broken by Subject or Study Site|1
7170158|NCT01732926|11363345|FG001|Overall Study|Blind Broken by Subject or Study Site|1
7080543|NCT02122783|11189989|FG000|Overall Study|Adverse Event|0
7080544|NCT02122783|11189990|FG001|Overall Study|Adverse Event|1
7080545|NCT02122887|11190011|FG000|Overall Study|Withdrawal by Subject|20
7080546|NCT02122887|11190012|FG001|Overall Study|Withdrawal by Subject|2
7080547|NCT02123134|11190042|FG000|Overall Study|Withdrawal of consent|3
7080548|NCT02123134|11190043|FG001|Overall Study|Withdrawal of consent|2
7080549|NCT02123134|11190042|FG000|Overall Study|Administrative decision|0
7080550|NCT02123134|11190043|FG001|Overall Study|Administrative decision|1
7080551|NCT02123251|11190051|FG000|Overall Study|Death|1
7080552|NCT02123251|11190052|FG001|Overall Study|Death|1
7080553|NCT02123251|11190051|FG000|Overall Study|Withdrawal by Subject|0
7080554|NCT02123251|11190052|FG001|Overall Study|Withdrawal by Subject|3
7170159|NCT01732913|11363362|FG000|Overall Study|Study Terminated by Sponsor|105
7170160|NCT01732913|11363363|FG001|Overall Study|Study Terminated by Sponsor|55
7170161|NCT01732913|11363362|FG000|Overall Study|Withdrawal by Subject|27
7170162|NCT01732913|11363363|FG001|Overall Study|Withdrawal by Subject|4
7170163|NCT01732913|11363362|FG000|Overall Study|Physician Decision|14
7170164|NCT01732913|11363363|FG001|Overall Study|Physician Decision|7
7170165|NCT01732913|11363362|FG000|Overall Study|Other|7
7170166|NCT01732913|11363363|FG001|Overall Study|Other|1
7170167|NCT01732913|11363362|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3
7170168|NCT01732913|11363363|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2
7170169|NCT01716052|11363375|FG000|Overall Study|Withdrawal of funding|1
7170170|NCT01716052|11363376|FG001|Overall Study|Withdrawal of funding|1
7170171|NCT01712854|11363391|FG000|Overall Study|Physician Decision|1
7170172|NCT01708057|11363418|FG000|Overall Study|Withdrawal due to study termination.|1
7170173|NCT01708057|11363419|FG001|Overall Study|Withdrawal due to study termination.|1
7170174|NCT01708057|11363420|FG002|Overall Study|Withdrawal due to study termination.|1
7170175|NCT01693367|11363440|FG000|Overall Study|Withdrawal by Subject|1
7170176|NCT01693367|11363441|FG001|Overall Study|Withdrawal by Subject|1
7170177|NCT01693367|11363440|FG000|Overall Study|Physician Decision|0
7170178|NCT01693367|11363441|FG001|Overall Study|Physician Decision|1
7170179|NCT01697800|11363462|FG000|Overall Study|Death|0
7170180|NCT01697800|11363463|FG001|Overall Study|Death|1
7170181|NCT01700348|11363469|FG000|Overall Study|Withdrawal by Subject|22
7170182|NCT01700348|11363469|FG000|Overall Study|Lost to Follow-up|1
7170183|NCT01689974|11363514|FG000|Overall Study|Termination of Study|5
7170184|NCT01689974|11363515|FG001|Overall Study|Termination of Study|5
7080555|NCT02123251|11190051|FG000|Overall Study|Lost Medicaid eligibility|29
7170185|NCT01676961|11363521|FG000|Overall Study|Death|3
7170186|NCT01676961|11363521|FG000|Overall Study|Lost to Follow-up|1
7080556|NCT02123251|11190052|FG001|Overall Study|Lost Medicaid eligibility|22
7080557|NCT02123251|11190051|FG000|Overall Study|Switched Managed Care Organization (MCO)|4
7170187|NCT01676961|11363521|FG000|Overall Study|Withdrawal by Subject|1
7170188|NCT01675011|11363589|FG000|Overall Study|Trial terminated by Sponsor|3
7170189|NCT01675011|11363590|FG001|Overall Study|Trial terminated by Sponsor|1
7170190|NCT01668147|11363618|FG000|Overall Study|Withdrawal by Subject|6
7170191|NCT01676701|11363628|FG000|Overall Study|Protocol Violation|1
7170192|NCT01676701|11363629|FG001|Overall Study|Protocol Violation|0
7170193|NCT01676701|11363628|FG000|Overall Study|Sponsor Decision|3
7170194|NCT01676701|11363629|FG001|Overall Study|Sponsor Decision|4
7170195|NCT01662102|11363644|FG000|Overall Study|Sponsor's decision|1
7170196|NCT01662102|11363645|FG001|Overall Study|Sponsor's decision|0
7170197|NCT01659554|11363652|FG000|Overall Study|Study Termination|4
7185006|NCT01989676|11385432|FG000|Overall Study|No longer willing to participate in study|26
7185007|NCT01989676|11385433|FG001|Overall Study|No longer willing to participate in study|26
7185008|NCT01989676|11385432|FG000|Overall Study|Participants terminated from study by Sponsor|26
7185009|NCT01989676|11385433|FG001|Overall Study|Participants terminated from study by Sponsor|30
7185010|NCT01989676|11385432|FG000|Overall Study|Other|4
7185011|NCT01989676|11385433|FG001|Overall Study|Other|3
7187685|NCT03598777|11388437|FG002|Overall Study|Study Terminated by Sponsor|0
7187686|NCT03598777|11388438|FG003|Overall Study|Study Terminated by Sponsor|0
7187687|NCT03598777|11388439|FG004|Overall Study|Study Terminated by Sponsor|15
7187688|NCT03598777|11388435|FG000|Overall Study|Withdrawal by Subject|1
7187689|NCT03598777|11388436|FG001|Overall Study|Withdrawal by Subject|1
7187690|NCT03598777|11388437|FG002|Overall Study|Withdrawal by Subject|0
7187691|NCT03598777|11388438|FG003|Overall Study|Withdrawal by Subject|0
7187692|NCT03598777|11388439|FG004|Overall Study|Withdrawal by Subject|0
7187693|NCT03598777|11388435|FG000|Overall Study|Adverse Event|1
7187694|NCT03598777|11388436|FG001|Overall Study|Adverse Event|0
7187695|NCT03598777|11388437|FG002|Overall Study|Adverse Event|0
7187696|NCT03598777|11388438|FG003|Overall Study|Adverse Event|0
7187697|NCT03598777|11388439|FG004|Overall Study|Adverse Event|0
7187698|NCT03598777|11388435|FG000|Overall Study|Lost to Follow-up|1
7187699|NCT03598777|11388436|FG001|Overall Study|Lost to Follow-up|0
7187700|NCT03598777|11388437|FG002|Overall Study|Lost to Follow-up|0
7187701|NCT03598777|11388438|FG003|Overall Study|Lost to Follow-up|0
7187702|NCT03598777|11388439|FG004|Overall Study|Lost to Follow-up|0
7187703|NCT03406078|11388456|FG000|Overall Study|Death|1
7187704|NCT03406078|11388457|FG001|Overall Study|Death|0
7187705|NCT03406078|11388456|FG000|Overall Study|Lost to Follow-up|0
7187706|NCT03406078|11388457|FG001|Overall Study|Lost to Follow-up|1
7187707|NCT03406078|11388456|FG000|Overall Study|Withdrawal by Subject|5
7187708|NCT03406078|11388457|FG001|Overall Study|Withdrawal by Subject|2
7187709|NCT03345342|11388479|FG000|Open-Label Phase|Adverse Event|30
7187710|NCT03345342|11388480|FG001|Open-Label Phase|Adverse Event|0
7187711|NCT03345342|11388481|FG002|Open-Label Phase|Adverse Event|0
7187712|NCT03345342|11388482|FG003|Open-Label Phase|Adverse Event|0
7187713|NCT03345342|11388483|FG004|Open-Label Phase|Adverse Event|0
7187714|NCT03345342|11388479|FG000|Open-Label Phase|Death|1
7187715|NCT03345342|11388480|FG001|Open-Label Phase|Death|0
7187716|NCT03345342|11388481|FG002|Open-Label Phase|Death|0
7187717|NCT03345342|11388482|FG003|Open-Label Phase|Death|0
7187718|NCT03345342|11388483|FG004|Open-Label Phase|Death|0
7187719|NCT03345342|11388479|FG000|Open-Label Phase|Initiated Prohibited Medication|2
7187720|NCT03345342|11388480|FG001|Open-Label Phase|Initiated Prohibited Medication|0
7187721|NCT03345342|11388481|FG002|Open-Label Phase|Initiated Prohibited Medication|0
7187722|NCT03345342|11388482|FG003|Open-Label Phase|Initiated Prohibited Medication|0
7187723|NCT03345342|11388483|FG004|Open-Label Phase|Initiated Prohibited Medication|0
7187724|NCT03345342|11388479|FG000|Open-Label Phase|Lack of Efficacy|6
7187725|NCT03345342|11388480|FG001|Open-Label Phase|Lack of Efficacy|0
7187726|NCT03345342|11388481|FG002|Open-Label Phase|Lack of Efficacy|0
7187727|NCT03345342|11388482|FG003|Open-Label Phase|Lack of Efficacy|0
7187728|NCT03345342|11388483|FG004|Open-Label Phase|Lack of Efficacy|0
7187729|NCT03345342|11388479|FG000|Open-Label Phase|Lost to Follow-up|9
7187730|NCT03345342|11388480|FG001|Open-Label Phase|Lost to Follow-up|0
7187731|NCT03345342|11388481|FG002|Open-Label Phase|Lost to Follow-up|0
7187732|NCT03345342|11388482|FG003|Open-Label Phase|Lost to Follow-up|0
7187733|NCT03345342|11388483|FG004|Open-Label Phase|Lost to Follow-up|0
7187734|NCT03345342|11388479|FG000|Open-Label Phase|Non-Compliance with Study Drug|4
7187735|NCT03345342|11388480|FG001|Open-Label Phase|Non-Compliance with Study Drug|0
7187736|NCT03345342|11388481|FG002|Open-Label Phase|Non-Compliance with Study Drug|0
7187737|NCT03345342|11388482|FG003|Open-Label Phase|Non-Compliance with Study Drug|0
7187738|NCT03345342|11388483|FG004|Open-Label Phase|Non-Compliance with Study Drug|0
7187739|NCT03345342|11388479|FG000|Open-Label Phase|Physician Decision|4
7187740|NCT03345342|11388480|FG001|Open-Label Phase|Physician Decision|0
7187741|NCT03345342|11388481|FG002|Open-Label Phase|Physician Decision|0
7187742|NCT03345342|11388482|FG003|Open-Label Phase|Physician Decision|0
7187743|NCT03345342|11388483|FG004|Open-Label Phase|Physician Decision|0
7187744|NCT03345342|11388479|FG000|Open-Label Phase|Protocol Violation|8
7187745|NCT03345342|11388480|FG001|Open-Label Phase|Protocol Violation|0
7187746|NCT03345342|11388481|FG002|Open-Label Phase|Protocol Violation|0
7187747|NCT03345342|11388482|FG003|Open-Label Phase|Protocol Violation|0
7187748|NCT03345342|11388483|FG004|Open-Label Phase|Protocol Violation|0
7187749|NCT03345342|11388479|FG000|Open-Label Phase|Withdrawal by Subject|57
7187750|NCT03345342|11388480|FG001|Open-Label Phase|Withdrawal by Subject|0
7187751|NCT03345342|11388481|FG002|Open-Label Phase|Withdrawal by Subject|0
7187752|NCT03345342|11388482|FG003|Open-Label Phase|Withdrawal by Subject|0
7170198|NCT01658813|11363656|FG000|Overall Study|Disease progression|3
7170199|NCT01642732|11363684|FG000|Overall Study|Withdrawal by Subject|1
7170200|NCT01648270|11363697|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12
7170201|NCT01641601|11363713|FG000|Overall Study|Study discontinued.|3
7170202|NCT01641601|11363714|FG001|Overall Study|Study discontinued.|5
7170203|NCT01627899|11363742|FG000|Overall Study|Study terminated early by sponsor.|5
7170204|NCT01632020|11363748|FG000|Overall Study|Withdrawal by Subject|1
7170205|NCT01632020|11363749|FG001|Overall Study|Withdrawal by Subject|0
7170206|NCT01632020|11363748|FG000|Overall Study|Adverse Event|1
7170207|NCT01632020|11363749|FG001|Overall Study|Adverse Event|0
7170208|NCT01619800|11363761|FG000|Overall Study|study terminated|2
7170209|NCT01619800|11363762|FG001|Overall Study|study terminated|0
7170210|NCT01614067|11363779|FG000|Overall Study|Pregnancy|1
7170211|NCT01614067|11363780|FG001|Overall Study|Pregnancy|0
7170212|NCT01614067|11363779|FG000|Overall Study|Physician Decision|6
7170213|NCT01614067|11363780|FG001|Overall Study|Physician Decision|5
7170214|NCT01614067|11363779|FG000|Overall Study|Withdrawal by Subject|0
7170215|NCT01614067|11363780|FG001|Overall Study|Withdrawal by Subject|1
7170216|NCT01614067|11363779|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8
7170217|NCT01614067|11363780|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9
7170218|NCT01605019|11363793|FG000|Overall Study|pt did not meet transplant endpoint|3
7170219|NCT01605019|11363794|FG001|Overall Study|pt did not meet transplant endpoint|0
7170220|NCT01609231|11363802|FG000|Overall Study|Adverse Event|1
7170221|NCT01609231|11363803|FG001|Overall Study|Adverse Event|3
7170222|NCT01609231|11363802|FG000|Overall Study|Physician Decision|1
7170223|NCT01609231|11363803|FG001|Overall Study|Physician Decision|0
7170224|NCT01609231|11363802|FG000|Overall Study|Withdrawal by Subject|1
7170225|NCT01609231|11363803|FG001|Overall Study|Withdrawal by Subject|0
7170226|NCT01603043|11363829|FG000|Overall Study|Study Futility|7
7170227|NCT01603043|11363830|FG001|Overall Study|Study Futility|3
7170228|NCT01605370|11363838|FG000|Overall Study|Adverse Event|1
7170229|NCT01605370|11363839|FG001|Overall Study|Adverse Event|0
7170230|NCT01605617|11363847|FG000|First Intervention|Adverse Event|0
7170231|NCT01605617|11363848|FG001|First Intervention|Adverse Event|1
7170232|NCT01605617|11363847|FG000|Washout Period of 4 Weeks|Study Terminated|2
7170233|NCT01605617|11363848|FG001|Washout Period of 4 Weeks|Study Terminated|1
7170234|NCT01603121|11363865|FG000|Second Intervention, 10 Hours|Adverse Event|1
7170235|NCT01603121|11363866|FG001|Second Intervention, 10 Hours|Adverse Event|0
7170236|NCT01603394|11363879|FG000|Overall Study|Adverse Event|1
7170237|NCT01592383|11363883|FG000|Overall Study|Adverse Event|1
7170238|NCT01591096|11363905|FG000|Overall Study|Adverse Event|1
7170239|NCT01576575|11363922|FG000|Buprenorphine Control|Withdrawal by Subject|3
7170240|NCT01576575|11363922|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3
7170241|NCT01576575|11363922|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1
7170242|NCT01582100|11363946|FG000|Overall Study|Adverse Event|1
7170243|NCT01582100|11363946|FG000|Overall Study|Withdrawal by Subject|1
7170244|NCT01575028|11363959|FG000|Overall Study|Physician Decision|0
7170245|NCT01575028|11363960|FG001|Overall Study|Physician Decision|1
7170246|NCT01578785|11363968|FG000|Overall Study|Withdrawal by Subject|0
7170247|NCT01578785|11363969|FG001|Overall Study|Withdrawal by Subject|1
7170248|NCT01578785|11363968|FG000|Overall Study|Study terminated by sponsor|59
7170249|NCT01578785|11363969|FG001|Overall Study|Study terminated by sponsor|118
7170250|NCT01576549|11363975|FG000|Overall Study|Sponsor Decision|2
7170251|NCT01561989|11363995|FG000|Overall Study|accural target not met.|5
7170252|NCT01561989|11363996|FG001|Overall Study|accural target not met.|6
7170253|NCT01564732|11364004|FG000|Overall Study|Early termination by the study sponsor|6
7170254|NCT01564732|11364005|FG001|Overall Study|Early termination by the study sponsor|5
7170255|NCT01560507|11364014|FG000|Overall Study|Lost to Follow-up|3
7170256|NCT01560507|11364015|FG001|Overall Study|Lost to Follow-up|1
7170257|NCT01560507|11364016|FG002|Overall Study|Lost to Follow-up|2
7170258|NCT01560507|11364014|FG000|Overall Study|Withdrawal by Subject|1
7170259|NCT01560507|11364015|FG001|Overall Study|Withdrawal by Subject|1
7170260|NCT01560507|11364016|FG002|Overall Study|Withdrawal by Subject|0
7170261|NCT01555073|11364060|FG000|Overall Study|Lost to Follow-up|1
7170262|NCT01555073|11364061|FG001|Overall Study|Lost to Follow-up|2
7170263|NCT01555073|11364062|FG002|Overall Study|Lost to Follow-up|0
7170264|NCT01555073|11364063|FG003|Overall Study|Lost to Follow-up|5
7170265|NCT01541397|11364098|FG000|Overall Study|Study ended prior to data collection|4
7170266|NCT01541397|11364099|FG001|Overall Study|Study ended prior to data collection|2
7170267|NCT01546207|11364105|FG000|Overall Study|Death|1
7170268|NCT01547728|11364113|FG000|Overall Study|Change in procedure and equipment|1
7170269|NCT01547728|11364113|FG000|Overall Study|Drug not ready for subject|1
7170270|NCT01547728|11364113|FG000|Overall Study|Screen failure|39
7170271|NCT01546883|11364130|FG000|Overall Study|Withdrawal by Subject|3
7170272|NCT01546883|11364130|FG000|Overall Study|Adverse Event|4
7170273|NCT01546883|11364130|FG000|Overall Study|Lost to Follow-up|2
7170274|NCT01546883|11364130|FG000|Overall Study|early closure of study|2
7170275|NCT01546883|11364130|FG000|Overall Study|other unrelated illness|1
7170276|NCT01536015|11364140|FG000|Overall Study|Adverse Event|1
7170277|NCT01536015|11364141|FG001|Overall Study|Adverse Event|4
7170278|NCT01536015|11364140|FG000|Overall Study|Lost to Follow-up|0
7170279|NCT01536015|11364141|FG001|Overall Study|Lost to Follow-up|1
7170280|NCT01536015|11364140|FG000|Overall Study|Inclusion Criterion not met|2
7170281|NCT01536015|11364141|FG001|Overall Study|Inclusion Criterion not met|0
7170282|NCT01536015|11364140|FG000|Overall Study|Study closure|5
7170283|NCT01536015|11364141|FG001|Overall Study|Study closure|5
7170284|NCT01534676|11364167|FG000|Overall Study|Study closed due to poor enrollment|2
7170285|NCT01534676|11364168|FG001|Overall Study|Study closed due to poor enrollment|1
7170286|NCT01530087|11364192|FG000|Overall Study|Physician Decision|2
7170287|NCT01531387|11364229|FG000|Overall Study|Early termination of study|11
7170288|NCT01531387|11364230|FG001|Overall Study|Early termination of study|11
7170289|NCT01527292|11364249|FG000|Overall Study|Physician Decision|0
7170290|NCT01527292|11364250|FG001|Overall Study|Physician Decision|3
7170291|NCT01528696|11364269|FG000|Overall Study|See detailed description|18
7170292|NCT01528696|11364270|FG001|Overall Study|See detailed description|19
7170293|NCT01520714|11364304|FG000|Overall Study|Protocol Violation|0
7170294|NCT01520714|11364305|FG001|Overall Study|Protocol Violation|3
7170295|NCT01520714|11364304|FG000|Overall Study|Adverse Event|0
7170296|NCT01520714|11364305|FG001|Overall Study|Adverse Event|2
7170297|NCT01520714|11364304|FG000|Overall Study|Lack of Efficacy|0
7170298|NCT01520714|11364305|FG001|Overall Study|Lack of Efficacy|1
7170299|NCT01516034|11364320|FG000|Overall Study|Physician Decision|1
7170300|NCT01516034|11364320|FG000|Overall Study|Lack of Efficacy|7
7170301|NCT01510756|11364345|FG000|Overall Study|Death|1
7170302|NCT01510756|11364345|FG000|Overall Study|Lack of Efficacy|2
7170303|NCT01510756|11364345|FG000|Overall Study|Physician Decision|1
7170304|NCT01509053|11364371|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11
7170305|NCT01509053|11364371|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1
7170306|NCT01509053|11364371|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13
7170307|NCT01509053|11364371|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1
7170308|NCT01509053|11364371|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1
7170309|NCT01509053|11364371|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3
7185012|NCT01992653|11385448|FG000|Overall Study|Death|0
7185013|NCT01992653|11385449|FG001|Overall Study|Death|0
7185014|NCT01992653|11385450|FG002|Overall Study|Death|1
7185015|NCT01992653|11385451|FG003|Overall Study|Death|0
7185016|NCT01992653|11385452|FG004|Overall Study|Death|1
7185017|NCT01992653|11385453|FG005|Overall Study|Death|0
7185018|NCT01992653|11385454|FG006|Overall Study|Death|4
7185019|NCT01992653|11385455|FG007|Overall Study|Death|2
7185020|NCT01992653|11385448|FG000|Overall Study|Lost to Follow-up|0
7185021|NCT01992653|11385449|FG001|Overall Study|Lost to Follow-up|0
7185022|NCT01992653|11385450|FG002|Overall Study|Lost to Follow-up|0
7185023|NCT01992653|11385451|FG003|Overall Study|Lost to Follow-up|0
7185024|NCT01992653|11385452|FG004|Overall Study|Lost to Follow-up|0
7185025|NCT01992653|11385453|FG005|Overall Study|Lost to Follow-up|0
7185026|NCT01992653|11385454|FG006|Overall Study|Lost to Follow-up|0
7185027|NCT01992653|11385455|FG007|Overall Study|Lost to Follow-up|1
7185028|NCT01992653|11385448|FG000|Overall Study|Study Completed|0
7185029|NCT01992653|11385449|FG001|Overall Study|Study Completed|0
7185030|NCT01992653|11385450|FG002|Overall Study|Study Completed|0
7185031|NCT01992653|11385451|FG003|Overall Study|Study Completed|0
7185032|NCT01992653|11385452|FG004|Overall Study|Study Completed|0
7185033|NCT01992653|11385453|FG005|Overall Study|Study Completed|0
7185034|NCT01992653|11385454|FG006|Overall Study|Study Completed|0
7185035|NCT01992653|11385455|FG007|Overall Study|Study Completed|1
7185036|NCT01992653|11385448|FG000|Overall Study|Disease Progression|0
7185037|NCT01992653|11385449|FG001|Overall Study|Disease Progression|0
7185038|NCT01992653|11385450|FG002|Overall Study|Disease Progression|0
7185039|NCT01992653|11385451|FG003|Overall Study|Disease Progression|0
7185040|NCT01992653|11385452|FG004|Overall Study|Disease Progression|0
7185041|NCT01992653|11385453|FG005|Overall Study|Disease Progression|0
7185042|NCT01992653|11385454|FG006|Overall Study|Disease Progression|4
7185043|NCT01992653|11385455|FG007|Overall Study|Disease Progression|0
7187753|NCT03345342|11388483|FG004|Open-Label Phase|Withdrawal by Subject|0
7187754|NCT03345342|11388479|FG000|Open-Label Phase|Other|15
7187755|NCT03345342|11388480|FG001|Open-Label Phase|Other|0
7187756|NCT03345342|11388481|FG002|Open-Label Phase|Other|0
7187757|NCT03345342|11388482|FG003|Open-Label Phase|Other|0
7187758|NCT03345342|11388483|FG004|Open-Label Phase|Other|0
7187759|NCT03345342|11388479|FG000|Double-Blind Phase|Adverse Event|0
7187760|NCT03345342|11388480|FG001|Double-Blind Phase|Adverse Event|1
7187761|NCT03345342|11388481|FG002|Double-Blind Phase|Adverse Event|6
7187762|NCT03345342|11388482|FG003|Double-Blind Phase|Adverse Event|0
7187763|NCT03345342|11388483|FG004|Double-Blind Phase|Adverse Event|0
7187764|NCT03345342|11388479|FG000|Double-Blind Phase|Death|0
7187765|NCT03345342|11388480|FG001|Double-Blind Phase|Death|2
7187766|NCT03345342|11388481|FG002|Double-Blind Phase|Death|1
7187767|NCT03345342|11388482|FG003|Double-Blind Phase|Death|0
7187768|NCT03345342|11388483|FG004|Double-Blind Phase|Death|0
7187769|NCT03345342|11388479|FG000|Double-Blind Phase|Initiated Prohibited Medication|0
7187770|NCT03345342|11388480|FG001|Double-Blind Phase|Initiated Prohibited Medication|0
7187771|NCT03345342|11388481|FG002|Double-Blind Phase|Initiated Prohibited Medication|2
7187772|NCT03345342|11388482|FG003|Double-Blind Phase|Initiated Prohibited Medication|0
7187773|NCT03345342|11388483|FG004|Double-Blind Phase|Initiated Prohibited Medication|0
7187774|NCT03345342|11388479|FG000|Double-Blind Phase|Lost to Follow-up|0
7187775|NCT03345342|11388480|FG001|Double-Blind Phase|Lost to Follow-up|1
7170310|NCT01478113|11364420|FG000|Overall Study|Withdrawal by Subject|0
7170311|NCT01478113|11364421|FG001|Overall Study|Withdrawal by Subject|1
7170312|NCT01478113|11364420|FG000|Overall Study|Physician Decision|1
7170313|NCT01478113|11364421|FG001|Overall Study|Physician Decision|0
7170314|NCT01482598|11364439|FG000|Overall Study|Death|7
7170315|NCT01482598|11364440|FG001|Overall Study|Death|10
7170316|NCT01482598|11364439|FG000|Overall Study|Physician Decision|0
7170317|NCT01482598|11364440|FG001|Overall Study|Physician Decision|3
7170318|NCT01482598|11364439|FG000|Overall Study|Withdrawal by Subject|4
7170319|NCT01482598|11364440|FG001|Overall Study|Withdrawal by Subject|5
7170320|NCT01482598|11364439|FG000|Overall Study|Lost to Follow-up|5
7170321|NCT01482598|11364440|FG001|Overall Study|Lost to Follow-up|4
7170322|NCT01473732|11364460|FG000|Overall Study|Adverse Event|1
7170323|NCT01473732|11364461|FG001|Overall Study|Adverse Event|0
7170324|NCT01473732|11364460|FG000|Overall Study|Death|1
7170325|NCT01473732|11364461|FG001|Overall Study|Death|0
7170326|NCT01465230|11364476|FG000|Overall Study|Withdrawal by Subject|2
7170327|NCT01463293|11364498|FG000|Overall Study|Lost to Follow-up|1
7170328|NCT01463293|11364499|FG001|Overall Study|Lost to Follow-up|4
7170329|NCT01463293|11364500|FG002|Overall Study|Lost to Follow-up|5
7170330|NCT01463293|11364498|FG000|Overall Study|Adverse Event|1
7170331|NCT01463293|11364499|FG001|Overall Study|Adverse Event|2
7170332|NCT01463293|11364500|FG002|Overall Study|Adverse Event|0
7170333|NCT01463293|11364498|FG000|Overall Study|Withdrawal by Subject|4
7170334|NCT01463293|11364499|FG001|Overall Study|Withdrawal by Subject|10
7170335|NCT01463293|11364500|FG002|Overall Study|Withdrawal by Subject|5
7170336|NCT01463293|11364498|FG000|Overall Study|Other|0
7170337|NCT01463293|11364499|FG001|Overall Study|Other|0
7170338|NCT01463293|11364500|FG002|Overall Study|Other|2
7170339|NCT01457053|11364508|FG000|Overall Study|Unable to undergo selected treatment|1
7170340|NCT01457053|11364509|FG001|Overall Study|Unable to undergo selected treatment|1
7170341|NCT01451723|11364517|FG000|Overall Study|study halted|6
7170342|NCT01451723|11364518|FG001|Overall Study|study halted|5
7170343|NCT01440517|11364528|FG000|Overall Study|Subject withdrawn prior to dosing|1
7170344|NCT01440595|11364534|FG000|Overall Study|Lost to Follow-up|0
7170345|NCT01440595|11364535|FG001|Overall Study|Lost to Follow-up|1
7170346|NCT01440595|11364536|FG002|Overall Study|Lost to Follow-up|0
7170347|NCT01440595|11364534|FG000|Overall Study|Study terminated by sponsor.|1
7170348|NCT01440595|11364535|FG001|Overall Study|Study terminated by sponsor.|2
7170349|NCT01440595|11364536|FG002|Overall Study|Study terminated by sponsor.|1
7170350|NCT01446796|11364542|FG000|Overall Study|Withdrawal by Subject|1
7170351|NCT01446796|11364543|FG001|Overall Study|Withdrawal by Subject|0
7170352|NCT01443923|11364553|FG000|Overall Study|Adverse Event|1
7170353|NCT01443923|11364554|FG001|Overall Study|Adverse Event|0
7170354|NCT01439347|11364562|FG000|Overall Study|Death|10
7170355|NCT01439347|11364563|FG001|Overall Study|Death|9
7170356|NCT01439347|11364562|FG000|Overall Study|Withdrawal by Subject|0
7170357|NCT01439347|11364563|FG001|Overall Study|Withdrawal by Subject|1
7170358|NCT01439347|11364562|FG000|Overall Study|Physician Decision|1
7170359|NCT01439347|11364563|FG001|Overall Study|Physician Decision|0
7170360|NCT01439347|11364562|FG000|Overall Study|Sponsor Terminated Study|2
7170361|NCT01439347|11364563|FG001|Overall Study|Sponsor Terminated Study|3
7170362|NCT01433471|11364588|FG000|Overall Study|Withdrawal by Subject|0
7170363|NCT01433471|11364589|FG001|Overall Study|Withdrawal by Subject|1
7170364|NCT01436084|11364597|FG000|Overall Study|Disease Progression|2
7170365|NCT01436084|11364597|FG000|Overall Study|Withdrawal by Subject|1
7170366|NCT01436084|11364597|FG000|Overall Study|Early Closure of Study|1
7170367|NCT01415986|11364625|FG000|Overall Study|Lost to Follow-up|1
7170368|NCT01410799|11364630|FG000|Overall Study|PI decision|13
7170369|NCT01426113|11364636|FG000|Overall Study|Study Discontinued|1
7170370|NCT01426113|11364637|FG001|Overall Study|Study Discontinued|1
7170371|NCT01426113|11364636|FG000|Overall Study|Adverse Event|0
7170372|NCT01426113|11364637|FG001|Overall Study|Adverse Event|1
7170373|NCT01420965|11364655|FG000|Overall Study|Withdrawal by Subject|1
7170374|NCT01420965|11364656|FG001|Overall Study|Withdrawal by Subject|0
7170375|NCT01420965|11364657|FG002|Overall Study|Withdrawal by Subject|0
7170376|NCT01420965|11364655|FG000|Overall Study|Adverse Event|0
7170377|NCT01420965|11364656|FG001|Overall Study|Adverse Event|1
7170378|NCT01420965|11364657|FG002|Overall Study|Adverse Event|0
7170379|NCT01417377|11364665|FG000|Overall Study|Lost to Follow-up|12
7170380|NCT01417377|11364665|FG000|Overall Study|Enrolled, but not treated|1
7170381|NCT01416272|11364669|FG000|Overall Study|Unacceptable distance visual acuity|2
7170382|NCT01416272|11364669|FG000|Overall Study|Lost to Follow-up|1
7170383|NCT01416272|11364669|FG000|Overall Study|Study related complaints|1
7170384|NCT01414166|11364675|FG000|Overall Study|Adverse Event|10
7170385|NCT01414166|11364676|FG001|Overall Study|Adverse Event|2
7170386|NCT01414166|11364675|FG000|Overall Study|Lost to Follow-up|4
7170387|NCT01414166|11364676|FG001|Overall Study|Lost to Follow-up|1
7170388|NCT01414166|11364675|FG000|Overall Study|Non-compliance with study drug|2
7170389|NCT01414166|11364676|FG001|Overall Study|Non-compliance with study drug|0
7170390|NCT01414166|11364675|FG000|Overall Study|Physician Decision|2
7170391|NCT01414166|11364676|FG001|Overall Study|Physician Decision|0
7170392|NCT01414166|11364675|FG000|Overall Study|Protocol Violation|2
7170393|NCT01414166|11364676|FG001|Overall Study|Protocol Violation|0
7170394|NCT01414166|11364675|FG000|Overall Study|Study terminated by Sponsor|68
7170395|NCT01414166|11364676|FG001|Overall Study|Study terminated by Sponsor|75
7170396|NCT01414166|11364675|FG000|Overall Study|Withdrawal by Subject|3
7170397|NCT01414166|11364676|FG001|Overall Study|Withdrawal by Subject|5
7170398|NCT01409031|11364703|FG000|Overall Study|transferred to other hosp|1
7170399|NCT01409031|11364704|FG001|Overall Study|transferred to other hosp|0
7170400|NCT01403194|11364727|FG000|Overall Study|Screen Failure|2
7170401|NCT01403194|11364727|FG000|Overall Study|Lost to Follow-up|8
7170402|NCT01397552|11364733|FG000|Overall Study|Adverse Event|1
7170403|NCT01397552|11364734|FG001|Overall Study|Adverse Event|0
7170404|NCT01397552|11364733|FG000|Overall Study|Withdrawal by Subject|2
7170405|NCT01397552|11364734|FG001|Overall Study|Withdrawal by Subject|1
7170406|NCT01392170|11364740|FG000|Overall Study|Withdrawal by Subject|1
7170407|NCT01392170|11364740|FG000|Overall Study|Ineligible|1
7170408|NCT01389817|11364746|FG000|Overall Study|Physician Decision|1
7170409|NCT01389817|11364747|FG001|Overall Study|Physician Decision|0
7170410|NCT01389817|11364746|FG000|Overall Study|Lost to Follow-up|1
7170411|NCT01389817|11364747|FG001|Overall Study|Lost to Follow-up|0
7170412|NCT01389817|11364746|FG000|Overall Study|Withdrawal by Subject|2
7170413|NCT01389817|11364747|FG001|Overall Study|Withdrawal by Subject|0
7170414|NCT01390181|11364757|FG000|Overall Study|Lost to Follow-up|1
7170415|NCT01390181|11364757|FG000|Overall Study|Study Terminated due to Low Accrual|3
7170416|NCT01372618|11364792|FG000|Overall Study|PI Died. Study Terminated|9
7170417|NCT01379274|11364800|FG000|Overall Study|funding withdrawn|1
7170418|NCT01369641|11364813|FG000|Overall Study|Withdrawal by Subject|1
7170419|NCT01359254|11364828|FG000|Overall Study|Death|1
7170420|NCT01359254|11364829|FG001|Overall Study|Death|0
7170421|NCT01352416|11364866|FG000|Overall Study|Physician Decision|1
7170422|NCT01352416|11364867|FG001|Overall Study|Physician Decision|2
7170423|NCT01352416|11364868|FG002|Overall Study|Physician Decision|2
7170424|NCT01352416|11364869|FG003|Overall Study|Physician Decision|1
7170425|NCT01349595|11364885|FG000|Overall Study|Lack of funding|2
7170426|NCT01349595|11364886|FG001|Overall Study|Lack of funding|2
7170427|NCT01347840|11364905|FG000|Overall Study|Withdrawal by Subject|1
7170428|NCT01335997|11364916|FG000|Period I and II|Adverse Event|63
7170429|NCT01335997|11364917|FG001|Period I and II|Adverse Event|43
7170430|NCT01335997|11364916|FG000|Period I and II|Noncompliance with Study Drug|1
7170431|NCT01335997|11364917|FG001|Period I and II|Noncompliance with Study Drug|1
7170432|NCT01335997|11364916|FG000|Period I and II|Lost to Follow-up|3
7170433|NCT01335997|11364917|FG001|Period I and II|Lost to Follow-up|5
7170434|NCT01335997|11364916|FG000|Period I and II|Withdrawal by Subject|9
7170435|NCT01335997|11364917|FG001|Period I and II|Withdrawal by Subject|4
7170436|NCT01335997|11364916|FG000|Period I and II|Study Terminated by Sponsor|406
7170437|NCT01335997|11364917|FG001|Period I and II|Study Terminated by Sponsor|415
7170438|NCT01335997|11364916|FG000|Period I and II|Protocol Violation|9
7170439|NCT01335997|11364917|FG001|Period I and II|Protocol Violation|10
7170440|NCT01335997|11364916|FG000|Period I and II|Physician Decision|2
7170441|NCT01335997|11364917|FG001|Period I and II|Physician Decision|1
7170442|NCT01335997|11364916|FG000|Period III|Adverse Event|0
7170443|NCT01335997|11364917|FG001|Period III|Adverse Event|2
7170444|NCT01335997|11364916|FG000|Period III|Study Terminated by Sponsor|77
7170445|NCT01335997|11364917|FG001|Period III|Study Terminated by Sponsor|76
7170446|NCT01335997|11364916|FG000|Period III|Protocol Violation|0
7170447|NCT01335997|11364917|FG001|Period III|Protocol Violation|1
7170448|NCT01335997|11364916|FG000|Period III|Lost to Follow-up|1
7170449|NCT01335997|11364917|FG001|Period III|Lost to Follow-up|0
7170450|NCT01341587|11364940|FG000|Overall Study|Lost to Follow-up|2
7170451|NCT01341587|11364941|FG001|Overall Study|Lost to Follow-up|0
7170452|NCT01341587|11364940|FG000|Overall Study|stopped using the meters|2
7170453|NCT01341587|11364941|FG001|Overall Study|stopped using the meters|10
7170454|NCT01332799|11364953|FG000|Overall Study|Insufficient funding|10
7170455|NCT01332799|11364954|FG001|Overall Study|Insufficient funding|10
7170456|NCT01329549|11364960|FG000|Overall Study|Withdrawal by Subject|1
7170457|NCT01329549|11364960|FG000|Overall Study|Adverse Event|1
7170458|NCT01326845|11364966|FG000|Overall Study|Administrative Problems|5
7170459|NCT01326845|11364967|FG001|Overall Study|Administrative Problems|2
7170460|NCT01326845|11364966|FG000|Overall Study|Adverse Event|1
7170461|NCT01326845|11364967|FG001|Overall Study|Adverse Event|0
7170462|NCT01326845|11364966|FG000|Overall Study|Misisng|1
7170463|NCT01326845|11364967|FG001|Overall Study|Misisng|3
7170464|NCT01329341|11364973|FG000|Overall Study|Withdrawal by Subject|44
7170465|NCT01320683|11364986|FG000|Overall Study|Positive antibody response|1
7170466|NCT01313273|11364992|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1
7170467|NCT01313273|11364993|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0
7170468|NCT01313273|11364992|FG000|Overall Study|Withdrawal by Subject|1
7170469|NCT01313273|11364993|FG001|Overall Study|Withdrawal by Subject|0
7170470|NCT01313273|11364992|FG000|Overall Study|Screening Chromogranin A-in normal range|0
7170471|NCT01313273|11364993|FG001|Overall Study|Screening Chromogranin A-in normal range|1
7170472|NCT01321008|11364999|FG000|Overall Study|Early Study Termination|1
7170473|NCT01310803|11365005|FG000|Overall Study|Subject terminated by Sponsor|1
7170474|NCT01310803|11365006|FG001|Overall Study|Subject terminated by Sponsor|0
7170475|NCT01313923|11365025|FG000|Overall Study|Physician Decision|3
7170476|NCT01321697|11365029|FG000|Overall Study|Study Terminated|7
7170477|NCT01312428|11365035|FG000|Overall Study|Study Termination|3
7170478|NCT01312428|11365036|FG001|Overall Study|Study Termination|4
7170479|NCT01290822|11365094|FG000|Overall Study|Withdrawal by Subject|1
7170480|NCT01290822|11365094|FG000|Overall Study|Physician Decision|10
7170481|NCT01290718|11365098|FG000|Overall Study|Early termination of the study|4
7170482|NCT01293123|11365104|FG000|Overall Study|Lost to Follow-up|0
7170483|NCT01293123|11365105|FG001|Overall Study|Lost to Follow-up|1
7170484|NCT01294046|11365111|FG000|Overall Study|Infection and surgical explant|1
7170485|NCT01294046|11365111|FG000|Overall Study|Eligibility criteria expanded|1
7170486|NCT01294046|11365111|FG000|Overall Study|Stimulation response inadqequate|1
7185044|NCT02001974|11385476|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2
7185045|NCT02001974|11385477|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3
7185046|NCT02001974|11385478|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14
7185047|NCT02001974|11385476|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1
7185048|NCT02001974|11385477|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0
7185049|NCT02001974|11385478|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4
7185050|NCT02001974|11385476|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1
7185051|NCT02001974|11385477|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0
7185052|NCT02001974|11385478|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6
7185053|NCT02001974|11385476|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0
7185054|NCT02001974|11385477|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0
7185055|NCT02001974|11385478|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2
7185056|NCT02014558|11385499|FG000|Overall Study|Never Received Study Drug|0
7185057|NCT02014558|11385500|FG001|Overall Study|Never Received Study Drug|0
7185058|NCT02014558|11385501|FG002|Overall Study|Never Received Study Drug|0
7185059|NCT02014558|11385502|FG003|Overall Study|Never Received Study Drug|0
7185060|NCT02014558|11385503|FG004|Overall Study|Never Received Study Drug|1
7185061|NCT02014558|11385504|FG005|Overall Study|Never Received Study Drug|0
7185062|NCT02014558|11385505|FG006|Overall Study|Never Received Study Drug|1
7185063|NCT02014558|11385506|FG007|Overall Study|Never Received Study Drug|0
7185064|NCT02014558|11385507|FG008|Overall Study|Never Received Study Drug|2
7185065|NCT02014558|11385508|FG009|Overall Study|Never Received Study Drug|0
7185066|NCT02014558|11385509|FG010|Overall Study|Never Received Study Drug|2
7185067|NCT02014558|11385510|FG011|Overall Study|Never Received Study Drug|2
7185068|NCT02014558|11385511|FG012|Overall Study|Never Received Study Drug|0
7185069|NCT02014558|11385499|FG000|Overall Study|Adverse Event|0
7185070|NCT02014558|11385500|FG001|Overall Study|Adverse Event|0
7185071|NCT02014558|11385501|FG002|Overall Study|Adverse Event|0
7185072|NCT02014558|11385502|FG003|Overall Study|Adverse Event|0
7185073|NCT02014558|11385503|FG004|Overall Study|Adverse Event|1
7185074|NCT02014558|11385504|FG005|Overall Study|Adverse Event|0
7185075|NCT02014558|11385505|FG006|Overall Study|Adverse Event|0
7185076|NCT02014558|11385506|FG007|Overall Study|Adverse Event|0
7185077|NCT02014558|11385507|FG008|Overall Study|Adverse Event|2
7185078|NCT02014558|11385508|FG009|Overall Study|Adverse Event|2
7185079|NCT02014558|11385509|FG010|Overall Study|Adverse Event|5
7185080|NCT02014558|11385510|FG011|Overall Study|Adverse Event|21
7185081|NCT02014558|11385511|FG012|Overall Study|Adverse Event|3
7185082|NCT02014558|11385499|FG000|Overall Study|Death|1
7185083|NCT02014558|11385500|FG001|Overall Study|Death|0
7185084|NCT02014558|11385501|FG002|Overall Study|Death|0
7185085|NCT02014558|11385502|FG003|Overall Study|Death|0
7185086|NCT02014558|11385503|FG004|Overall Study|Death|0
7185087|NCT02014558|11385504|FG005|Overall Study|Death|0
7185088|NCT02014558|11385505|FG006|Overall Study|Death|1
7185089|NCT02014558|11385506|FG007|Overall Study|Death|1
7185090|NCT02014558|11385507|FG008|Overall Study|Death|2
7185091|NCT02014558|11385508|FG009|Overall Study|Death|5
7185092|NCT02014558|11385509|FG010|Overall Study|Death|5
7185093|NCT02014558|11385510|FG011|Overall Study|Death|19
7185094|NCT02014558|11385511|FG012|Overall Study|Death|2
7185095|NCT02014558|11385499|FG000|Overall Study|Lack of Efficacy|1
7185096|NCT02014558|11385500|FG001|Overall Study|Lack of Efficacy|2
7185097|NCT02014558|11385501|FG002|Overall Study|Lack of Efficacy|1
7185098|NCT02014558|11385502|FG003|Overall Study|Lack of Efficacy|1
7185099|NCT02014558|11385503|FG004|Overall Study|Lack of Efficacy|0
7185100|NCT02014558|11385504|FG005|Overall Study|Lack of Efficacy|0
7185101|NCT02014558|11385505|FG006|Overall Study|Lack of Efficacy|1
7185102|NCT02014558|11385506|FG007|Overall Study|Lack of Efficacy|3
7185103|NCT02014558|11385507|FG008|Overall Study|Lack of Efficacy|3
7185104|NCT02014558|11385508|FG009|Overall Study|Lack of Efficacy|3
7185105|NCT02014558|11385509|FG010|Overall Study|Lack of Efficacy|16
7185106|NCT02014558|11385510|FG011|Overall Study|Lack of Efficacy|8
7185107|NCT02014558|11385511|FG012|Overall Study|Lack of Efficacy|5
7185108|NCT02014558|11385499|FG000|Overall Study|Lost to Follow-up|0
7185109|NCT02014558|11385500|FG001|Overall Study|Lost to Follow-up|0
7185110|NCT02014558|11385501|FG002|Overall Study|Lost to Follow-up|0
7185111|NCT02014558|11385502|FG003|Overall Study|Lost to Follow-up|0
7185112|NCT02014558|11385503|FG004|Overall Study|Lost to Follow-up|0
7185113|NCT02014558|11385504|FG005|Overall Study|Lost to Follow-up|0
7185114|NCT02014558|11385505|FG006|Overall Study|Lost to Follow-up|0
7185115|NCT02014558|11385506|FG007|Overall Study|Lost to Follow-up|0
7185116|NCT02014558|11385507|FG008|Overall Study|Lost to Follow-up|0
7185117|NCT02014558|11385508|FG009|Overall Study|Lost to Follow-up|0
7185118|NCT02014558|11385509|FG010|Overall Study|Lost to Follow-up|1
7185119|NCT02014558|11385510|FG011|Overall Study|Lost to Follow-up|0
7170487|NCT01281124|11365155|FG000|Overall Study|Death|1
7170488|NCT01282216|11365167|FG000|Overall Study|Graft failure|0
7170489|NCT01282216|11365168|FG001|Overall Study|Graft failure|0
7170490|NCT01282216|11365169|FG002|Overall Study|Graft failure|3
7170491|NCT01282216|11365170|FG003|Overall Study|Graft failure|2
7170492|NCT01282216|11365167|FG000|Overall Study|Physician Decision|0
7170493|NCT01282216|11365168|FG001|Overall Study|Physician Decision|0
7170494|NCT01282216|11365169|FG002|Overall Study|Physician Decision|11
7170495|NCT01282216|11365170|FG003|Overall Study|Physician Decision|0
7170496|NCT01282216|11365167|FG000|Overall Study|Relapse|0
7170497|NCT01282216|11365168|FG001|Overall Study|Relapse|0
7170498|NCT01282216|11365169|FG002|Overall Study|Relapse|17
7170499|NCT01282216|11365170|FG003|Overall Study|Relapse|6
7170500|NCT01282216|11365167|FG000|Overall Study|Death|0
7170501|NCT01282216|11365168|FG001|Overall Study|Death|0
7170502|NCT01282216|11365169|FG002|Overall Study|Death|2
7170503|NCT01282216|11365170|FG003|Overall Study|Death|0
7170504|NCT01284491|11365176|FG000|Overall Study|Study termination|13
7170505|NCT01274533|11365208|FG000|Overall Study|Withdrawal by Subject|1
7170506|NCT01274533|11365208|FG000|Overall Study|Non-compliance|1
7170507|NCT01274533|11365208|FG000|Overall Study|Disease progression|2
7170508|NCT01279616|11365212|FG000|Overall Study|donor could not be located|5
7170509|NCT01279616|11365212|FG000|Overall Study|no signs of sickle cell disease|2
7170510|NCT01276054|11365218|FG000|Overall Study|No one to oversee trial after P.I. left|2
7170511|NCT01276054|11365219|FG001|Overall Study|No one to oversee trial after P.I. left|2
7170512|NCT01264965|11365225|FG000|Overall Study|Withdrawal by Subject|10
7170513|NCT01266824|11365231|FG000|Overall Study|Study terminated prior to completion|2
7170514|NCT01266824|11365232|FG001|Overall Study|Study terminated prior to completion|3
7170515|NCT01264835|11365238|FG000|Overall Study|Lost to Follow-up|1
7170516|NCT01274429|11365242|FG000|Overall Study|Study closed do to lack of funding|5
6895241|NCT00623779|10913064|FG002|Overall Study|Adverse Event|0
6895242|NCT00623779|10913062|FG000|Overall Study|Criteria from CSR|2
6895243|NCT00623779|10913063|FG001|Overall Study|Criteria from CSR|0
6895244|NCT00623779|10913064|FG002|Overall Study|Criteria from CSR|1
6895245|NCT00623805|10913074|FG000|Overall Study|Adverse Event|9
6895246|NCT00623805|10913075|FG001|Overall Study|Adverse Event|6
6895247|NCT00623805|10913074|FG000|Overall Study|Death|2
6895248|NCT00623805|10913075|FG001|Overall Study|Death|0
6895249|NCT00623805|10913074|FG000|Overall Study|Lack of Efficacy|3
6895250|NCT00623805|10913075|FG001|Overall Study|Lack of Efficacy|7
6895251|NCT00623805|10913074|FG000|Overall Study|Lost to Follow-up|2
6895252|NCT00623805|10913075|FG001|Overall Study|Lost to Follow-up|2
7170517|NCT01273064|11365251|FG000|Overall Study|Adverse Event|5
7170518|NCT01273064|11365252|FG001|Overall Study|Adverse Event|1
7170519|NCT01273064|11365253|FG002|Overall Study|Adverse Event|3
7170520|NCT01273064|11365254|FG003|Overall Study|Adverse Event|2
7170521|NCT01273064|11365255|FG004|Overall Study|Adverse Event|1
7170522|NCT01273064|11365251|FG000|Overall Study|Withdrawal by Subject|4
7170523|NCT01273064|11365252|FG001|Overall Study|Withdrawal by Subject|2
7170524|NCT01273064|11365253|FG002|Overall Study|Withdrawal by Subject|2
7170525|NCT01273064|11365254|FG003|Overall Study|Withdrawal by Subject|2
7170526|NCT01273064|11365255|FG004|Overall Study|Withdrawal by Subject|0
7170527|NCT01273064|11365251|FG000|Overall Study|Study Termination|13
7170528|NCT01273064|11365252|FG001|Overall Study|Study Termination|27
7170529|NCT01273064|11365253|FG002|Overall Study|Study Termination|26
7170530|NCT01273064|11365254|FG003|Overall Study|Study Termination|16
7170531|NCT01273064|11365255|FG004|Overall Study|Study Termination|8
7170532|NCT01273064|11365251|FG000|Overall Study|Lost to Follow-up|1
7170533|NCT01273064|11365252|FG001|Overall Study|Lost to Follow-up|0
7170534|NCT01273064|11365253|FG002|Overall Study|Lost to Follow-up|0
7170535|NCT01273064|11365254|FG003|Overall Study|Lost to Follow-up|0
7170536|NCT01273064|11365255|FG004|Overall Study|Lost to Follow-up|0
7170537|NCT01273064|11365251|FG000|Overall Study|Physician Decision|0
7170538|NCT01273064|11365252|FG001|Overall Study|Physician Decision|0
7170539|NCT01273064|11365253|FG002|Overall Study|Physician Decision|0
7170540|NCT01273064|11365254|FG003|Overall Study|Physician Decision|0
7170541|NCT01273064|11365255|FG004|Overall Study|Physician Decision|1
7170542|NCT01274559|11365269|FG000|Overall Study|Adverse Event|57
7170543|NCT01274559|11365270|FG001|Overall Study|Adverse Event|13
7170544|NCT01274559|11365269|FG000|Overall Study|Death|1
7170545|NCT01274559|11365270|FG001|Overall Study|Death|1
7170546|NCT01274559|11365269|FG000|Overall Study|Lost to Follow-up|3
7170547|NCT01274559|11365270|FG001|Overall Study|Lost to Follow-up|3
7170548|NCT01274559|11365269|FG000|Overall Study|Non-compliance with Study Drug|2
7170549|NCT01274559|11365270|FG001|Overall Study|Non-compliance with Study Drug|4
7170550|NCT01274559|11365269|FG000|Overall Study|Physician Decision|2
6895253|NCT00623805|10913074|FG000|Overall Study|Protocol Violation|1
6895254|NCT00623805|10913075|FG001|Overall Study|Protocol Violation|1
6895255|NCT00623805|10913074|FG000|Overall Study|Reason not Specified|3
7170551|NCT01274559|11365270|FG001|Overall Study|Physician Decision|1
7170552|NCT01274559|11365269|FG000|Overall Study|Protocol Violation|28
7170553|NCT01274559|11365270|FG001|Overall Study|Protocol Violation|23
7170554|NCT01274559|11365269|FG000|Overall Study|Study Terminated by Sponsor|79
7170555|NCT01274559|11365270|FG001|Overall Study|Study Terminated by Sponsor|87
7170556|NCT01274559|11365269|FG000|Overall Study|Withdrawal by Subject|25
7170557|NCT01274559|11365270|FG001|Overall Study|Withdrawal by Subject|13
6895256|NCT00623805|10913075|FG001|Overall Study|Reason not Specified|6
6895257|NCT00623831|10913083|FG000|Overall Study|Withdrawal by Subject|1
6895258|NCT00623831|10913084|FG001|Overall Study|Withdrawal by Subject|0
6895259|NCT00623831|10913083|FG000|Overall Study|Progressive Disease|0
6895260|NCT00623831|10913084|FG001|Overall Study|Progressive Disease|1
6895261|NCT00623935|10913093|FG000|Overall Study|Death|1
6895262|NCT00623935|10913093|FG000|Overall Study|Patient Declined Transplant|1
6895263|NCT00624052|10913112|FG000|Overall Study|Adverse Event|7
6895264|NCT00624052|10913113|FG001|Overall Study|Adverse Event|6
6895265|NCT00624052|10913114|FG002|Overall Study|Adverse Event|0
6895266|NCT00624052|10913115|FG003|Overall Study|Adverse Event|3
6895267|NCT00624052|10913112|FG000|Overall Study|Lack of Efficacy|1
6895268|NCT00624052|10913113|FG001|Overall Study|Lack of Efficacy|1
6895269|NCT00624052|10913114|FG002|Overall Study|Lack of Efficacy|0
6895270|NCT00624052|10913115|FG003|Overall Study|Lack of Efficacy|0
6895271|NCT00624052|10913112|FG000|Overall Study|Lost to Follow-up|2
6895272|NCT00624052|10913113|FG001|Overall Study|Lost to Follow-up|3
6895273|NCT00624052|10913114|FG002|Overall Study|Lost to Follow-up|1
6895274|NCT00624052|10913115|FG003|Overall Study|Lost to Follow-up|0
6895275|NCT00624052|10913112|FG000|Overall Study|Non compliant with the protocol|2
6895276|NCT00624052|10913113|FG001|Overall Study|Non compliant with the protocol|1
6895277|NCT00624052|10913114|FG002|Overall Study|Non compliant with the protocol|1
6895278|NCT00624052|10913115|FG003|Overall Study|Non compliant with the protocol|1
6895279|NCT00624052|10913112|FG000|Overall Study|Consent withdrawn|3
6895280|NCT00624052|10913113|FG001|Overall Study|Consent withdrawn|1
6895281|NCT00624052|10913114|FG002|Overall Study|Consent withdrawn|1
6895282|NCT00624052|10913115|FG003|Overall Study|Consent withdrawn|0
6895283|NCT00624052|10913112|FG000|Overall Study|Changed job/ran out if meds|0
6895284|NCT00624052|10913113|FG001|Overall Study|Changed job/ran out if meds|2
7170558|NCT01267825|11365304|FG000|Overall Study|study terminated. no data collected.|1
7170559|NCT01267825|11365305|FG001|Overall Study|study terminated. no data collected.|0
7170560|NCT01259284|11365314|FG000|Overall Study|Study Termination|2
7170561|NCT01259284|11365315|FG001|Overall Study|Study Termination|0
7170562|NCT01259284|11365316|FG002|Overall Study|Study Termination|0
7170563|NCT01249157|11365324|FG000|Overall Study|Withdrawal by Subject|1
7170564|NCT01263028|11365328|FG000|Overall Study|Withdrawal by Subject|1
7170565|NCT01263028|11365328|FG000|Overall Study|Adverse Event|1
7170566|NCT01263028|11365328|FG000|Overall Study|Study terminated due to low enrollment.|4
7170567|NCT01259024|11365340|FG000|Overall Study|Physician Decision|1
7170568|NCT01251952|11365344|FG000|Overall Study|Adverse Event|1
7170569|NCT01251120|11365350|FG000|Overall Study|Lack of Efficacy|0
7170570|NCT01251120|11365351|FG001|Overall Study|Lack of Efficacy|1
7170571|NCT01248130|11365359|FG000|Overall Study|Protocol Violation|1
7170572|NCT01248130|11365360|FG001|Overall Study|Protocol Violation|0
7170573|NCT01248130|11365359|FG000|Overall Study|Ineligible|1
7170574|NCT01248130|11365360|FG001|Overall Study|Ineligible|0
7170575|NCT01243892|11365368|FG000|Overall Study|Did not meet eligibility criteria|2
7170576|NCT01243892|11365369|FG001|Overall Study|Did not meet eligibility criteria|0
7170577|NCT01246011|11365378|FG000|Overall Study|If needed warfarin clinically, withdrawn|0
7170578|NCT01246011|11365379|FG001|Overall Study|If needed warfarin clinically, withdrawn|0
7170579|NCT01246011|11365380|FG002|Overall Study|If needed warfarin clinically, withdrawn|3
7170580|NCT01246011|11365378|FG000|Overall Study|Withdrawal by Subject|0
7170581|NCT01246011|11365379|FG001|Overall Study|Withdrawal by Subject|0
7170582|NCT01246011|11365380|FG002|Overall Study|Withdrawal by Subject|1
7170583|NCT01242020|11365391|FG000|Overall Study|Withdrawal by Subject|2
7170584|NCT01242020|11365392|FG001|Overall Study|Withdrawal by Subject|0
7170585|NCT01242020|11365391|FG000|Overall Study|Failed screening|1
7170586|NCT01242020|11365392|FG001|Overall Study|Failed screening|0
7170587|NCT01244620|11365398|FG000|Overall Study|Study terminated|4
7170588|NCT01244620|11365399|FG001|Overall Study|Study terminated|4
7170589|NCT01244620|11365400|FG002|Overall Study|Study terminated|4
7170590|NCT01244620|11365401|FG003|Overall Study|Study terminated|4
7170591|NCT01241279|11365417|FG000|Overall Study|Lost to Follow-up|0
7170592|NCT01241279|11365418|FG001|Overall Study|Lost to Follow-up|1
7170593|NCT01230788|11365424|FG000|Overall Study|Prescribed exclusion drug|1
7170594|NCT01239680|11365430|FG000|Overall Study|Withdrawal by Subject|2
7170595|NCT01239680|11365431|FG001|Overall Study|Withdrawal by Subject|0
7170596|NCT01230307|11365462|FG000|Overall Study|LVAD Placement|0
7170597|NCT01230307|11365463|FG001|Overall Study|LVAD Placement|2
7170598|NCT01230489|11365469|FG000|Overall Study|Death|2
7170599|NCT01230489|11365469|FG000|Overall Study|Adverse Event|2
7170600|NCT01230489|11365469|FG000|Overall Study|Treatment modality changed|1
7170601|NCT01217060|11365525|FG000|Overall Study|Withdrawal by Subject|1
7170602|NCT01217047|11365533|FG000|Overall Study|Lost to Follow-up|0
7170603|NCT01217047|11365534|FG001|Overall Study|Lost to Follow-up|1
7170604|NCT01217047|11365535|FG002|Overall Study|Lost to Follow-up|0
7170605|NCT01206101|11365546|FG000|Overall Study|Adverse Event|1
7170606|NCT01206101|11365547|FG001|Overall Study|Adverse Event|0
7170607|NCT01206101|11365546|FG000|Overall Study|Physician Decision|0
6895285|NCT00624052|10913114|FG002|Overall Study|Changed job/ran out if meds|0
6895286|NCT00624052|10913115|FG003|Overall Study|Changed job/ran out if meds|0
6895287|NCT00624065|10913131|FG000|Overall Study|Adverse Event|5
6895288|NCT00624065|10913132|FG001|Overall Study|Adverse Event|6
6895289|NCT00624065|10913131|FG000|Overall Study|Lost to Follow-up|4
7170608|NCT01206101|11365547|FG001|Overall Study|Physician Decision|1
7170609|NCT01206101|11365546|FG000|Overall Study|Unclassified|1
7170610|NCT01206101|11365547|FG001|Overall Study|Unclassified|0
7170611|NCT01209520|11365570|FG000|Overall Study|Withdrawal by Subject|3
7170612|NCT01207102|11365591|FG000|Overall Study|Withdrawal by Subject|5
7170613|NCT01207102|11365591|FG000|Overall Study|Adverse Event|2
7170614|NCT01207102|11365591|FG000|Overall Study|progression|2
7170615|NCT01207102|11365591|FG000|Overall Study|Withdrawal by Treating Physician|1
7170616|NCT01206439|11365609|FG000|Overall Study|subject did not meet inclusion criteria|1
7170617|NCT01198548|11365631|FG000|Overall Study|Disease Progression|9
7170618|NCT01198548|11365631|FG000|Overall Study|Administrative Decision|1
7170619|NCT01193556|11365654|FG000|Overall Study|Study termination|26
7170620|NCT01193556|11365655|FG001|Overall Study|Study termination|25
7170621|NCT01189435|11365661|FG000|Overall Study|Withdrawal by Subject|1
7170622|NCT01189435|11365661|FG000|Overall Study|Physician Decision|1
7170623|NCT01193530|11365667|FG000|Overall Study|Withdrawal by Subject|2
7170624|NCT01193530|11365668|FG001|Overall Study|Withdrawal by Subject|2
7170625|NCT01193530|11365667|FG000|Overall Study|Began Contraindicated Therapy|1
7170626|NCT01193530|11365668|FG001|Overall Study|Began Contraindicated Therapy|0
7170627|NCT01193530|11365667|FG000|Overall Study|Lost Light Box|0
7170628|NCT01193530|11365668|FG001|Overall Study|Lost Light Box|1
7170629|NCT01193530|11365667|FG000|Overall Study|Returned home - out of state|0
7170630|NCT01193530|11365668|FG001|Overall Study|Returned home - out of state|1
7170631|NCT01193530|11365667|FG000|Overall Study|Non-Compliance|0
7170632|NCT01193530|11365668|FG001|Overall Study|Non-Compliance|1
7170633|NCT01183221|11365702|FG000|3 Weeks Wash Out|Lost to Follow-up|1
7170634|NCT01183221|11365703|FG001|3 Weeks Wash Out|Lost to Follow-up|1
7170635|NCT01189227|11365711|FG000|Overall Study|Study terminated due to low accrual|6
7170636|NCT01189227|11365712|FG001|Overall Study|Study terminated due to low accrual|3
7170637|NCT01179737|11365731|FG000|Cohort 1 & Cohort 2|Adverse Event|3
7170638|NCT01179737|11365732|FG001|Cohort 1 & Cohort 2|Adverse Event|1
7170639|NCT01179737|11365733|FG002|Cohort 1 & Cohort 2|Adverse Event|1
7170640|NCT01179737|11365734|FG003|Cohort 1 & Cohort 2|Adverse Event|0
7170641|NCT01179737|11365731|FG000|Cohort 1 & Cohort 2|Withdrew consent|2
7170642|NCT01179737|11365732|FG001|Cohort 1 & Cohort 2|Withdrew consent|0
7170643|NCT01179737|11365733|FG002|Cohort 1 & Cohort 2|Withdrew consent|0
7170644|NCT01179737|11365734|FG003|Cohort 1 & Cohort 2|Withdrew consent|0
7170645|NCT01179737|11365731|FG000|Cohort 1 & Cohort 2|Administrative problems|0
7170646|NCT01179737|11365732|FG001|Cohort 1 & Cohort 2|Administrative problems|0
7170647|NCT01179737|11365733|FG002|Cohort 1 & Cohort 2|Administrative problems|2
7170648|NCT01179737|11365734|FG003|Cohort 1 & Cohort 2|Administrative problems|4
7170649|NCT01179737|11365731|FG000|Cohort 1 & Cohort 2|Death|0
7170650|NCT01179737|11365732|FG001|Cohort 1 & Cohort 2|Death|0
7170651|NCT01179737|11365733|FG002|Cohort 1 & Cohort 2|Death|1
7170652|NCT01179737|11365734|FG003|Cohort 1 & Cohort 2|Death|0
7170653|NCT01179737|11365731|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
7170654|NCT01179737|11365732|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1
7170655|NCT01179737|11365733|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
7170656|NCT01179737|11365734|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
7170657|NCT01179737|11365731|FG000|Cohort 1 & Cohort 2 Expansion|Death|1
7170658|NCT01179737|11365732|FG001|Cohort 1 & Cohort 2 Expansion|Death|0
7170659|NCT01179737|11365733|FG002|Cohort 1 & Cohort 2 Expansion|Death|0
7170660|NCT01179737|11365734|FG003|Cohort 1 & Cohort 2 Expansion|Death|0
7170661|NCT01179737|11365731|FG000|Extension|The study was terminated|3
7170662|NCT01179737|11365732|FG001|Extension|The study was terminated|0
7170663|NCT01179737|11365733|FG002|Extension|The study was terminated|0
7170664|NCT01179737|11365734|FG003|Extension|The study was terminated|0
7170665|NCT01183468|11365747|FG000|Overall Study|Lost to Follow-up|2
7170666|NCT01183468|11365748|FG001|Overall Study|Lost to Follow-up|1
7170667|NCT01183468|11365749|FG002|Overall Study|Lost to Follow-up|0
7170668|NCT01183468|11365750|FG003|Overall Study|Lost to Follow-up|0
7170669|NCT01183468|11365747|FG000|Overall Study|Physician Decision|1
7170670|NCT01183468|11365748|FG001|Overall Study|Physician Decision|0
7170671|NCT01183468|11365749|FG002|Overall Study|Physician Decision|0
7170672|NCT01183468|11365750|FG003|Overall Study|Physician Decision|0
7170673|NCT01183468|11365747|FG000|Overall Study|Withdrawal by Subject|0
7170674|NCT01183468|11365748|FG001|Overall Study|Withdrawal by Subject|1
7170675|NCT01183468|11365749|FG002|Overall Study|Withdrawal by Subject|0
7170676|NCT01183468|11365750|FG003|Overall Study|Withdrawal by Subject|0
7170677|NCT01181921|11365758|FG000|Overall Study|Lost to Follow-up|1
7170678|NCT01188798|11365764|FG000|Overall Study|Death|0
7170679|NCT01188798|11365765|FG001|Overall Study|Death|1
7170680|NCT01188798|11365764|FG000|Overall Study|Required additional transplant|1
7170681|NCT01188798|11365765|FG001|Overall Study|Required additional transplant|1
7170682|NCT01188798|11365764|FG000|Overall Study|Protocol closure|1
7170683|NCT01188798|11365765|FG001|Overall Study|Protocol closure|1
7170684|NCT01174368|11365772|FG000|Overall Study|Withdrawal by Subject|1
7170685|NCT01183884|11365780|FG000|Overall Study|Progressive Disease|26
7170686|NCT01183884|11365780|FG000|Overall Study|Adverse Event|3
7170687|NCT01183884|11365780|FG000|Overall Study|Withdrawal by Subject|1
7170688|NCT01183884|11365780|FG000|Overall Study|Other Complicating Disease|3
7170689|NCT01183884|11365780|FG000|Overall Study|Not Treated|1
7170690|NCT01183884|11365780|FG000|Overall Study|Other|4
7170691|NCT01166178|11365790|FG000|Overall Study|Withdrawal by Subject|1
7170692|NCT01166178|11365791|FG001|Overall Study|Withdrawal by Subject|0
7170693|NCT01166178|11365790|FG000|Overall Study|Study was terminated|20
7170694|NCT01166178|11365791|FG001|Overall Study|Study was terminated|8
7170695|NCT01176513|11365797|FG000|Overall Study|Withdrew subjects prior to dosing|3
7170696|NCT01179399|11365805|FG000|Overall Study|Adverse Event|1
7170697|NCT01179399|11365805|FG000|Overall Study|Lack of Efficacy|30
7170698|NCT01179399|11365805|FG000|Overall Study|Withdrawal by Subject|1
7170699|NCT01171534|11365820|FG000|Overall Study|Lost to Follow-up|0
7170700|NCT01171534|11365821|FG001|Overall Study|Lost to Follow-up|2
7170701|NCT01171534|11365820|FG000|Overall Study|screen failure|0
7170702|NCT01171534|11365821|FG001|Overall Study|screen failure|1
7170703|NCT01162304|11365857|FG000|Overall Study|Beck scale to high|11
7170704|NCT01147393|11365909|FG000|Dose Level 1|Dose limiting Toxicity|2
7170705|NCT01147393|11365909|FG000|Dose Level -1|Dose Limited Toxicity|1
7185120|NCT02014558|11385511|FG012|Overall Study|Lost to Follow-up|0
7185121|NCT02014558|11385499|FG000|Overall Study|Progressive Disease|1
7185122|NCT02014558|11385500|FG001|Overall Study|Progressive Disease|0
7185123|NCT02014558|11385501|FG002|Overall Study|Progressive Disease|1
7185124|NCT02014558|11385502|FG003|Overall Study|Progressive Disease|1
7185125|NCT02014558|11385503|FG004|Overall Study|Progressive Disease|1
7185126|NCT02014558|11385504|FG005|Overall Study|Progressive Disease|2
7185127|NCT02014558|11385505|FG006|Overall Study|Progressive Disease|1
7185128|NCT02014558|11385506|FG007|Overall Study|Progressive Disease|6
7185129|NCT02014558|11385507|FG008|Overall Study|Progressive Disease|5
7185130|NCT02014558|11385508|FG009|Overall Study|Progressive Disease|6
7185131|NCT02014558|11385509|FG010|Overall Study|Progressive Disease|22
7185132|NCT02014558|11385510|FG011|Overall Study|Progressive Disease|31
6972747|NCT01173718|11023936|FG000|Overall Study|Death|17
6972748|NCT01173718|11023936|FG000|Overall Study|Abandonment of study graft|27
6972749|NCT01174004|11023959|FG000|Overall Study|Adverse Event|2
6972750|NCT01174004|11023960|FG001|Overall Study|Adverse Event|10
6972751|NCT01174004|11023959|FG000|Overall Study|Withdrawal by Subject|2
6972752|NCT01174004|11023960|FG001|Overall Study|Withdrawal by Subject|3
6972753|NCT01174004|11023959|FG000|Overall Study|At Discretion of Sponsor|2
6972754|NCT01174004|11023960|FG001|Overall Study|At Discretion of Sponsor|2
6972755|NCT01174004|11023959|FG000|Overall Study|Protocol Violation|0
6972756|NCT01174004|11023960|FG001|Overall Study|Protocol Violation|1
6972757|NCT01174004|11023959|FG000|Overall Study|Physician Decision|1
6972758|NCT01174004|11023960|FG001|Overall Study|Physician Decision|0
6972759|NCT01174043|11023987|FG000|Overall Study|Disease progression|5
6972760|NCT01174043|11023987|FG000|Overall Study|Adverse Event|3
6972761|NCT01174043|11023987|FG000|Overall Study|Death|1
6972762|NCT01174043|11023987|FG000|Overall Study|Withdrawal by Subject|2
6972763|NCT01174160|11024002|FG000|Overall Study|Adverse Event|1
6972764|NCT01174160|11024003|FG001|Overall Study|Adverse Event|0
6972765|NCT01174160|11024002|FG000|Overall Study|Lost to Follow-up|1
6972766|NCT01174160|11024003|FG001|Overall Study|Lost to Follow-up|0
6972767|NCT01174160|11024002|FG000|Overall Study|Physician Decision|1
6972768|NCT01174160|11024003|FG001|Overall Study|Physician Decision|0
6972769|NCT01174160|11024002|FG000|Overall Study|Protocol Violation|4
6972770|NCT01174160|11024003|FG001|Overall Study|Protocol Violation|6
6972771|NCT01174160|11024002|FG000|Overall Study|Withdrawal by Subject|1
6972772|NCT01174160|11024003|FG001|Overall Study|Withdrawal by Subject|0
6972773|NCT01174173|11024009|FG000|Overall Study|drug-drug interaction|1
6972774|NCT01174186|11024016|FG000|Overall Study|Lost to Follow-up|0
6972775|NCT01174186|11024017|FG001|Overall Study|Lost to Follow-up|1
6972776|NCT01174186|11024016|FG000|Overall Study|Withdrawal by Subject|0
6972777|NCT01174186|11024017|FG001|Overall Study|Withdrawal by Subject|2
6972778|NCT01174238|11024023|FG000|Overall Study|Lost to Follow-up|2
6972779|NCT01174264|11024033|FG000|Single Dose Pharmacokinetics|Early progressive disease|1
6972780|NCT01174264|11024034|FG001|Single Dose Pharmacokinetics|Early progressive disease|0
6972781|NCT01174264|11024035|FG002|Single Dose Pharmacokinetics|Early progressive disease|1
6972782|NCT01174264|11024033|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0
6972783|NCT01174264|11024034|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0
6972784|NCT01174264|11024035|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1
6972785|NCT01174264|11024033|FG000|Steady-state Pharmacokinetics|Not evaluable|6
6972786|NCT01174264|11024034|FG001|Steady-state Pharmacokinetics|Not evaluable|0
6972787|NCT01174264|11024035|FG002|Steady-state Pharmacokinetics|Not evaluable|2
6972788|NCT01174342|11024043|FG000|Overall Study|Conversion to cesarean section|4
6972789|NCT01174446|11024047|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
6972790|NCT01174446|11024048|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
6972791|NCT01174446|11024049|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1
7185133|NCT02014558|11385511|FG012|Overall Study|Progressive Disease|6
7185134|NCT02014558|11385499|FG000|Overall Study|Withdrawal by Subject|0
7185135|NCT02014558|11385500|FG001|Overall Study|Withdrawal by Subject|0
7185136|NCT02014558|11385501|FG002|Overall Study|Withdrawal by Subject|0
7185137|NCT02014558|11385502|FG003|Overall Study|Withdrawal by Subject|0
7185138|NCT02014558|11385503|FG004|Overall Study|Withdrawal by Subject|1
6972792|NCT01174446|11024050|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
6972793|NCT01174446|11024047|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
6972794|NCT01174446|11024048|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
7041584|NCT01728376|11125198|FG003|Overall Study|Adverse Event|1
7170706|NCT01147536|11365922|FG000|Overall Study|Administrative study close|2
7170707|NCT01147536|11365922|FG000|Overall Study|Death|1
7170708|NCT01133288|11365935|FG000|Eligibility Assessment|met exclusion criteria|5
7170709|NCT01133288|11365935|FG000|Intervention Allocation|study terminated|2
7170710|NCT01142128|11365943|FG000|Overall Study|Physician Decision|1
7170711|NCT01142128|11365943|FG000|Overall Study|Lost to Follow-up|1
7170712|NCT01142128|11365943|FG000|Overall Study|Withdrawal by Subject|2
7170713|NCT01128114|11365962|FG000|Overall Study|Treatment Withdrawn|6
7170714|NCT01128114|11365962|FG000|Overall Study|Screening Failed|2
7170715|NCT01126879|11365968|FG000|Overall Study|Progressive Disease|3
7170716|NCT01126879|11365969|FG001|Overall Study|Progressive Disease|1
7170717|NCT01126879|11365968|FG000|Overall Study|Withdrawal by Subject|1
7170718|NCT01126879|11365969|FG001|Overall Study|Withdrawal by Subject|0
7170719|NCT01126879|11365968|FG000|Overall Study|Adverse Event|0
7170720|NCT01126879|11365969|FG001|Overall Study|Adverse Event|1
7170721|NCT01126879|11365968|FG000|Overall Study|Physician Decision|1
7170722|NCT01126879|11365969|FG001|Overall Study|Physician Decision|0
7170723|NCT01136811|11365975|FG000|Overall Study|Physician Decision|11
7170724|NCT01139125|11365988|FG000|Overall Study|Withdrawal by Subject|1
7170725|NCT01131455|11366012|FG000|Overall Study|Death of PI|6
7170726|NCT01131455|11366013|FG001|Overall Study|Death of PI|4
7170727|NCT01131455|11366014|FG002|Overall Study|Death of PI|0
7170728|NCT01123850|11366031|FG000|Overall Study|Slow enrollment|45
7170729|NCT01122381|11366064|FG000|Overall Study|study terminated early|0
7170730|NCT01122381|11366065|FG001|Overall Study|study terminated early|1
7170731|NCT01116232|11366071|FG000|Overall Study|Progressive diease|4
7170732|NCT01108523|11366099|FG000|Overall Study|Protocol Violation|4
7170733|NCT01106534|11366107|FG000|Overall Study|Withdrawal by Subject|18
7170734|NCT01106534|11366107|FG000|Overall Study|Lost to Follow-up|2
7170735|NCT01106534|11366107|FG000|Overall Study|Death|16
7170736|NCT01106534|11366107|FG000|Overall Study|Physician Decision|1
7170737|NCT01100658|11366116|FG000|Overall Study|Withdrawal by Subject|1
7170738|NCT01103180|11366122|FG000|Overall Study|Withdrawal by Subject|8
7170739|NCT01103180|11366123|FG001|Overall Study|Withdrawal by Subject|13
7170740|NCT01103180|11366122|FG000|Overall Study|Lost to Follow-up|13
7170741|NCT01103180|11366123|FG001|Overall Study|Lost to Follow-up|7
7170742|NCT01103180|11366122|FG000|Overall Study|Physician Decision|1
7170743|NCT01103180|11366123|FG001|Overall Study|Physician Decision|0
7170744|NCT01103180|11366122|FG000|Overall Study|Protocol Violation|0
7170745|NCT01103180|11366123|FG001|Overall Study|Protocol Violation|1
7170746|NCT01102140|11366140|FG000|Overall Study|Lost to Follow-up|1
7170747|NCT01102140|11366141|FG001|Overall Study|Lost to Follow-up|0
7170748|NCT01102140|11366140|FG000|Overall Study|Investigator terminated study|2
7170749|NCT01102140|11366141|FG001|Overall Study|Investigator terminated study|2
7170750|NCT01095250|11366153|FG000|Overall Study|administrative reasons|8
7170751|NCT01095250|11366154|FG001|Overall Study|administrative reasons|10
7170752|NCT01095250|11366155|FG002|Overall Study|administrative reasons|7
7170753|NCT01095250|11366156|FG003|Overall Study|administrative reasons|5
7170754|NCT01095250|11366153|FG000|Overall Study|Withdrawal by Subject|0
7170755|NCT01095250|11366154|FG001|Overall Study|Withdrawal by Subject|0
7170756|NCT01095250|11366155|FG002|Overall Study|Withdrawal by Subject|1
7170757|NCT01095250|11366156|FG003|Overall Study|Withdrawal by Subject|0
7170758|NCT01093846|11366173|FG000|Overall Study|Adverse Event|0
7170759|NCT01093846|11366174|FG001|Overall Study|Adverse Event|0
7170760|NCT01093846|11366175|FG002|Overall Study|Adverse Event|1
7170761|NCT01093846|11366173|FG000|Overall Study|Lack of Efficacy|0
7170762|NCT01093846|11366174|FG001|Overall Study|Lack of Efficacy|0
7170763|NCT01093846|11366175|FG002|Overall Study|Lack of Efficacy|4
7170764|NCT01093846|11366173|FG000|Overall Study|Condition no longer required study drug|1
7170765|NCT01093846|11366174|FG001|Overall Study|Condition no longer required study drug|1
7170766|NCT01093846|11366175|FG002|Overall Study|Condition no longer required study drug|1
7170767|NCT01093846|11366173|FG000|Overall Study|Administrative Problems|18
7170768|NCT01093846|11366174|FG001|Overall Study|Administrative Problems|17
7170769|NCT01093846|11366175|FG002|Overall Study|Administrative Problems|15
7170770|NCT01081886|11366188|FG000|Overall Study|Study termination|11
7170771|NCT01081886|11366189|FG001|Overall Study|Study termination|13
7170772|NCT01080768|11366210|FG000|Overall Study|Protocol Deviation|2
7170773|NCT01080768|11366211|FG001|Overall Study|Protocol Deviation|1
7170774|NCT01074502|11366221|FG000|Overall Study|Withdrawal by Subject|1
7170775|NCT01069861|11366234|FG000|Overall Study|Death|1
7170776|NCT01069861|11366234|FG000|Overall Study|Adverse Event|1
7170777|NCT01069861|11366234|FG000|Overall Study|Did not meet entrance criteria|1
7170778|NCT01069120|11366267|FG000|Overall Study|Study prematurely terminated|27
7170779|NCT01058642|11366286|FG000|Treatment Period 1|Adverse Event|0
7170780|NCT01058642|11366287|FG001|Treatment Period 1|Adverse Event|1
7170781|NCT01058642|11366288|FG002|Treatment Period 1|Adverse Event|1
7170782|NCT01058642|11366289|FG003|Treatment Period 1|Adverse Event|0
7170783|NCT01058642|11366286|FG000|Treatment Period 1|Physician Decision|0
7170784|NCT01058642|11366287|FG001|Treatment Period 1|Physician Decision|0
7170785|NCT01058642|11366288|FG002|Treatment Period 1|Physician Decision|1
7170786|NCT01058642|11366289|FG003|Treatment Period 1|Physician Decision|0
7170787|NCT01058642|11366286|FG000|Treatment Period 1|Withdrawal by Subject|1
7170788|NCT01058642|11366287|FG001|Treatment Period 1|Withdrawal by Subject|0
7170789|NCT01058642|11366288|FG002|Treatment Period 1|Withdrawal by Subject|0
7170790|NCT01058642|11366289|FG003|Treatment Period 1|Withdrawal by Subject|0
7170791|NCT01058642|11366286|FG000|Treatment Period 1|Lack of Efficacy|0
7170792|NCT01058642|11366287|FG001|Treatment Period 1|Lack of Efficacy|0
7170793|NCT01058642|11366288|FG002|Treatment Period 1|Lack of Efficacy|0
7170794|NCT01058642|11366289|FG003|Treatment Period 1|Lack of Efficacy|1
7170795|NCT01058642|11366286|FG000|Treatment Period 1|Protocol Violation|0
7170796|NCT01058642|11366287|FG001|Treatment Period 1|Protocol Violation|0
7170797|NCT01058642|11366288|FG002|Treatment Period 1|Protocol Violation|0
7170798|NCT01058642|11366289|FG003|Treatment Period 1|Protocol Violation|1
7170799|NCT01058642|11366286|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1
7170800|NCT01058642|11366287|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0
7170801|NCT01058642|11366288|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0
7170802|NCT01058642|11366289|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0
7170803|NCT01065818|11366297|FG000|Overall Study|Withdrawal by Subject|1
7170804|NCT01065818|11366297|FG000|Overall Study|Not a candidate for surgery|1
7170805|NCT01051921|11366301|FG000|Overall Study|Physician Decision|9
7170806|NCT01051921|11366301|FG000|Overall Study|Adverse Event|8
7170807|NCT01051921|11366301|FG000|Overall Study|Withdrawal by Subject|7
7170808|NCT01051921|11366301|FG000|Overall Study|Lost to Follow-up|4
7170809|NCT01051921|11366301|FG000|Overall Study|virological failure|1
7170810|NCT01051921|11366301|FG000|Overall Study|patient moved|1
7170811|NCT01058369|11366323|FG000|Overall Study|Adverse Event|1
7170812|NCT01058369|11366323|FG000|Overall Study|Early termination study|1
7170813|NCT01053221|11366333|FG000|Overall Study|The study was closed prematurely|5
7170814|NCT01053221|11366334|FG001|Overall Study|The study was closed prematurely|9
7170815|NCT01038752|11366342|FG000|Overall Study|Tumor Progression|2
7170816|NCT01038752|11366343|FG001|Overall Study|Tumor Progression|2
7170817|NCT01038752|11366342|FG000|Overall Study|Lost to Follow-up|3
7170818|NCT01038752|11366343|FG001|Overall Study|Lost to Follow-up|3
7170819|NCT01050218|11366349|FG000|Overall Study|Adverse Event|37
7170820|NCT01050218|11366349|FG000|Overall Study|Lack of Efficacy|8
7170821|NCT01050218|11366349|FG000|Overall Study|Protocol Violation|3
7170822|NCT01050218|11366349|FG000|Overall Study|Withdrawal by Subject|18
7170823|NCT01050218|11366349|FG000|Overall Study|Discontinued by sponsor|18
7170824|NCT01050218|11366349|FG000|Overall Study|Compliance|2
7170825|NCT01050218|11366349|FG000|Overall Study|Failed to return|7
7170826|NCT01050218|11366349|FG000|Overall Study|Serious Adverse Event|1
7170827|NCT01050218|11366349|FG000|Overall Study|Family emergency|1
7170828|NCT01045694|11366353|FG000|Overall Study|Withdrawal by Subject|2
7170829|NCT01031628|11366378|FG000|Overall Study|Study terminated early|0
7170830|NCT01031628|11366379|FG001|Overall Study|Study terminated early|1
7170831|NCT01031628|11366380|FG002|Overall Study|Study terminated early|3
7170832|NCT01031628|11366381|FG003|Overall Study|Study terminated early|0
7170833|NCT01030198|11366412|FG000|Overall Study|Could not measure efficacy accurately|0
7170834|NCT01030198|11366413|FG001|Overall Study|Could not measure efficacy accurately|7
7170835|NCT01028300|11366419|FG000|Overall Study|Study Terminated|4
7170836|NCT01022398|11366430|FG000|Overall Study|Study terminated|2
7170837|NCT01022398|11366431|FG001|Overall Study|Study terminated|2
7170838|NCT01019980|11366438|FG000|Overall Study|Drug not available.|2
7170839|NCT01019980|11366439|FG001|Overall Study|Drug not available.|0
7170840|NCT01017263|11366449|FG000|Overall Study|not eligible|12
7170841|NCT01018810|11366476|FG000|Overall Study|Withdrawal by Subject|0
7170842|NCT01018810|11366477|FG001|Overall Study|Withdrawal by Subject|1
7170843|NCT01018810|11366478|FG002|Overall Study|Withdrawal by Subject|0
7170844|NCT01018810|11366479|FG003|Overall Study|Withdrawal by Subject|0
7170845|NCT01018810|11366480|FG004|Overall Study|Withdrawal by Subject|0
7170846|NCT01018810|11366476|FG000|Overall Study|Sponsor Decision|2
7170847|NCT01018810|11366477|FG001|Overall Study|Sponsor Decision|0
7170848|NCT01018810|11366478|FG002|Overall Study|Sponsor Decision|1
7170849|NCT01018810|11366479|FG003|Overall Study|Sponsor Decision|1
7170850|NCT01018810|11366480|FG004|Overall Study|Sponsor Decision|1
7170851|NCT01014767|11366509|FG000|Overall Study|PI left institution, data unavailable|12
7170852|NCT01014767|11366510|FG001|Overall Study|PI left institution, data unavailable|1
7170853|NCT01014767|11366511|FG002|Overall Study|PI left institution, data unavailable|4
7170854|NCT01014767|11366512|FG003|Overall Study|PI left institution, data unavailable|1
7170855|NCT01013701|11366522|FG000|Overall Study|study prematurely terminated|7
7170856|NCT01012414|11366527|FG000|Overall Study|Withdrawal by Subject|2
7170857|NCT01012414|11366527|FG000|Overall Study|Lost to Follow-up|1
7170858|NCT01012414|11366527|FG000|Overall Study|Trial was stopped before completed|7
7170859|NCT01001390|11366546|FG000|Overall Study|Failure to wear AFO device|2
7170860|NCT01001390|11366547|FG001|Overall Study|Failure to wear AFO device|0
7170861|NCT01004510|11366565|FG000|Overall Study|Adverse Event|1
7170862|NCT01005914|11366569|FG000|Overall Study|Adverse Event|4
7170863|NCT01005914|11366569|FG000|Overall Study|Death|4
7170864|NCT01005914|11366569|FG000|Overall Study|Lack of Efficacy|1
7170865|NCT01005914|11366569|FG000|Overall Study|Withdrawal by Subject|1
7170866|NCT00996333|11366573|FG000|Overall Study|Screen failure|1
7170867|NCT00996333|11366573|FG000|Overall Study|Withdrawal by Subject|1
7170868|NCT00996333|11366573|FG000|Overall Study|Death|4
7170869|NCT00996333|11366573|FG000|Overall Study|Adverse Event|1
7170870|NCT00996333|11366573|FG000|Overall Study|Physician Decision|1
7080558|NCT02123251|11190052|FG001|Overall Study|Switched Managed Care Organization (MCO)|4
7080559|NCT02123446|11190068|FG000|Washout Period (1 Day)|Physician Decision|1
7170871|NCT00996333|11366573|FG000|Overall Study|Other|5
7170872|NCT00998738|11366577|FG000|Overall Study|Uknown|1
7170873|NCT00997386|11366585|FG000|Overall Study|Death|7
7170874|NCT00985738|11366591|FG000|Overall Study|Study closed prematurely|8
7170875|NCT00985738|11366592|FG001|Overall Study|Study closed prematurely|8
7185139|NCT02014558|11385504|FG005|Overall Study|Withdrawal by Subject|0
7185140|NCT02014558|11385505|FG006|Overall Study|Withdrawal by Subject|0
7185141|NCT02014558|11385506|FG007|Overall Study|Withdrawal by Subject|0
7185142|NCT02014558|11385507|FG008|Overall Study|Withdrawal by Subject|0
7185143|NCT02014558|11385508|FG009|Overall Study|Withdrawal by Subject|2
7185144|NCT02014558|11385509|FG010|Overall Study|Withdrawal by Subject|6
7185145|NCT02014558|11385510|FG011|Overall Study|Withdrawal by Subject|10
7185146|NCT02014558|11385511|FG012|Overall Study|Withdrawal by Subject|0
7185147|NCT02014558|11385499|FG000|Overall Study|Miscellaneous|2
7185148|NCT02014558|11385500|FG001|Overall Study|Miscellaneous|1
7185149|NCT02014558|11385501|FG002|Overall Study|Miscellaneous|1
7185150|NCT02014558|11385502|FG003|Overall Study|Miscellaneous|1
7185151|NCT02014558|11385503|FG004|Overall Study|Miscellaneous|0
7185152|NCT02014558|11385504|FG005|Overall Study|Miscellaneous|1
7185153|NCT02014558|11385505|FG006|Overall Study|Miscellaneous|0
7185154|NCT02014558|11385506|FG007|Overall Study|Miscellaneous|1
7185155|NCT02014558|11385507|FG008|Overall Study|Miscellaneous|1
7185156|NCT02014558|11385508|FG009|Overall Study|Miscellaneous|3
7185157|NCT02014558|11385509|FG010|Overall Study|Miscellaneous|12
7185158|NCT02014558|11385510|FG011|Overall Study|Miscellaneous|11
7185159|NCT02014558|11385511|FG012|Overall Study|Miscellaneous|1
7187776|NCT03345342|11388481|FG002|Double-Blind Phase|Lost to Follow-up|7
7187777|NCT03345342|11388482|FG003|Double-Blind Phase|Lost to Follow-up|0
7187778|NCT03345342|11388483|FG004|Double-Blind Phase|Lost to Follow-up|0
7187779|NCT03345342|11388479|FG000|Double-Blind Phase|Physician Decision|0
7187780|NCT03345342|11388480|FG001|Double-Blind Phase|Physician Decision|1
7187781|NCT03345342|11388481|FG002|Double-Blind Phase|Physician Decision|4
7187782|NCT03345342|11388482|FG003|Double-Blind Phase|Physician Decision|0
7187783|NCT03345342|11388483|FG004|Double-Blind Phase|Physician Decision|0
7187784|NCT03345342|11388479|FG000|Double-Blind Phase|Protocol Violation|0
7187785|NCT03345342|11388480|FG001|Double-Blind Phase|Protocol Violation|0
7187786|NCT03345342|11388481|FG002|Double-Blind Phase|Protocol Violation|1
7187787|NCT03345342|11388482|FG003|Double-Blind Phase|Protocol Violation|0
7187788|NCT03345342|11388483|FG004|Double-Blind Phase|Protocol Violation|0
7187789|NCT03345342|11388479|FG000|Double-Blind Phase|Withdrawal by Subject|0
7187790|NCT03345342|11388480|FG001|Double-Blind Phase|Withdrawal by Subject|16
7187791|NCT03345342|11388481|FG002|Double-Blind Phase|Withdrawal by Subject|38
7187792|NCT03345342|11388482|FG003|Double-Blind Phase|Withdrawal by Subject|0
7187793|NCT03345342|11388483|FG004|Double-Blind Phase|Withdrawal by Subject|0
7187794|NCT03345342|11388479|FG000|Double-Blind Phase|Other|0
7187795|NCT03345342|11388480|FG001|Double-Blind Phase|Other|1
7187796|NCT03345342|11388481|FG002|Double-Blind Phase|Other|3
7187797|NCT03345342|11388482|FG003|Double-Blind Phase|Other|0
7187798|NCT03345342|11388483|FG004|Double-Blind Phase|Other|0
7187799|NCT03345342|11388479|FG000|Follow-Up Phase|Adverse Event|0
7187800|NCT03345342|11388480|FG001|Follow-Up Phase|Adverse Event|0
7187801|NCT03345342|11388481|FG002|Follow-Up Phase|Adverse Event|0
7187802|NCT03345342|11388482|FG003|Follow-Up Phase|Adverse Event|0
7187803|NCT03345342|11388483|FG004|Follow-Up Phase|Adverse Event|4
7187804|NCT03345342|11388479|FG000|Follow-Up Phase|Lost to Follow-up|0
7187805|NCT03345342|11388480|FG001|Follow-Up Phase|Lost to Follow-up|0
7187806|NCT03345342|11388481|FG002|Follow-Up Phase|Lost to Follow-up|0
7187807|NCT03345342|11388482|FG003|Follow-Up Phase|Lost to Follow-up|0
7187808|NCT03345342|11388483|FG004|Follow-Up Phase|Lost to Follow-up|6
7187809|NCT03345342|11388479|FG000|Follow-Up Phase|Physician Decision|0
7187810|NCT03345342|11388480|FG001|Follow-Up Phase|Physician Decision|0
7187811|NCT03345342|11388481|FG002|Follow-Up Phase|Physician Decision|0
7187812|NCT03345342|11388482|FG003|Follow-Up Phase|Physician Decision|0
7187813|NCT03345342|11388483|FG004|Follow-Up Phase|Physician Decision|5
7187814|NCT03345342|11388479|FG000|Follow-Up Phase|Withdrawal by Subject|0
7187815|NCT03345342|11388480|FG001|Follow-Up Phase|Withdrawal by Subject|0
7080560|NCT02123446|11190069|FG001|Washout Period (1 Day)|Physician Decision|0
7187816|NCT03345342|11388481|FG002|Follow-Up Phase|Withdrawal by Subject|0
7187817|NCT03345342|11388482|FG003|Follow-Up Phase|Withdrawal by Subject|5
7187818|NCT03345342|11388483|FG004|Follow-Up Phase|Withdrawal by Subject|15
7187819|NCT03345342|11388479|FG000|Follow-Up Phase|Other|0
7187820|NCT03345342|11388480|FG001|Follow-Up Phase|Other|0
7080561|NCT02123459|11190075|FG000|Washout Period (1 Day)|Adverse Event|1
7187821|NCT03345342|11388481|FG002|Follow-Up Phase|Other|0
7187822|NCT03345342|11388482|FG003|Follow-Up Phase|Other|3
7187823|NCT03345342|11388483|FG004|Follow-Up Phase|Other|1
7187824|NCT02880241|11388516|FG000|Overall Study|Lack of Efficacy|1
7187825|NCT02880241|11388517|FG001|Overall Study|Lack of Efficacy|0
7187826|NCT02880241|11388518|FG002|Overall Study|Lack of Efficacy|0
7187827|NCT02880241|11388519|FG003|Overall Study|Lack of Efficacy|0
7170876|NCT00975611|11366685|FG000|Overall Study|Screen Fail|16
7170877|NCT00975611|11366685|FG000|Overall Study|Physician Decision|1
7170878|NCT00974922|11366710|FG000|Overall Study|study terminated|24
7170879|NCT00965146|11366725|FG000|Overall Study|Death|7
7170880|NCT00965146|11366725|FG000|Overall Study|Lost to Follow-up|22
7170881|NCT00965146|11366725|FG000|Overall Study|Withdrawal by Subject|17
7170882|NCT00965146|11366725|FG000|Overall Study|Unable to return|1
7170883|NCT00965146|11366725|FG000|Overall Study|Unwilling to return|11
7170884|NCT00965146|11366725|FG000|Overall Study|Intercurrent illness|1
7170885|NCT00965146|11366725|FG000|Overall Study|Revision / Removal of Study Implant|6
7170886|NCT00965146|11366725|FG000|Overall Study|Overall Study Termination|145
7170887|NCT00972023|11366729|FG000|Overall Study|Withdrawal by Subject|1
7170888|NCT00953329|11366748|FG000|Overall Study|Lack of Efficacy|1
7170889|NCT00958893|11366765|FG000|Overall Study|Study prematurely terminated|4
7170890|NCT00966654|11366769|FG000|Overall Study|Study was terminated,PI left institution|12
7170891|NCT00960154|11366777|FG000|Overall Study|Study termination|25
7170892|NCT00960154|11366778|FG001|Overall Study|Study termination|25
7170893|NCT00960752|11366787|FG000|Overall Study|Adverse Event|0
7170894|NCT00960752|11366788|FG001|Overall Study|Adverse Event|0
7170895|NCT00960752|11366789|FG002|Overall Study|Adverse Event|1
7170896|NCT00960752|11366787|FG000|Overall Study|Progression|0
7170897|NCT00960752|11366788|FG001|Overall Study|Progression|0
7170898|NCT00960752|11366789|FG002|Overall Study|Progression|1
7170899|NCT00958347|11366797|FG000|Overall Study|Death|43
7170900|NCT00958347|11366797|FG000|Overall Study|Withdrawal by Subject|23
7170901|NCT00958347|11366797|FG000|Overall Study|Lost to Follow-up|15
7170902|NCT00958347|11366797|FG000|Overall Study|revision/removal|10
7170903|NCT00958347|11366797|FG000|Overall Study|study termination|135
7170904|NCT00953615|11366810|FG000|Overall Study|Adverse Event|1
7170905|NCT00957034|11366822|FG000|Overall Study|Adverse Event|0
7170906|NCT00957034|11366823|FG001|Overall Study|Adverse Event|1
7170907|NCT00957034|11366824|FG002|Overall Study|Adverse Event|1
7170908|NCT00957034|11366822|FG000|Overall Study|Sponsor Terminated Study|6
7170909|NCT00957034|11366823|FG001|Overall Study|Sponsor Terminated Study|1
7170910|NCT00957034|11366824|FG002|Overall Study|Sponsor Terminated Study|5
7170911|NCT00957034|11366822|FG000|Overall Study|Withdrawal by Subject|0
7170912|NCT00957034|11366823|FG001|Overall Study|Withdrawal by Subject|2
7170913|NCT00957034|11366824|FG002|Overall Study|Withdrawal by Subject|0
7170914|NCT00949988|11366832|FG000|Overall Study|Withdrawal by Subject|3
7170915|NCT00948194|11366838|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1
7170916|NCT00948194|11366839|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0
7170917|NCT00946985|11366845|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4
7170918|NCT00946985|11366845|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3
7170919|NCT00946985|11366845|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5
7170920|NCT00946985|11366845|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4
7170921|NCT00946985|11366845|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139
7170922|NCT00946985|11366845|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2
7170923|NCT00946985|11366845|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1
7170924|NCT00946985|11366845|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2
7170925|NCT00946985|11366845|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2
7170926|NCT00950690|11366853|FG000|Overall Study|Death|4
7170927|NCT00950690|11366853|FG000|Overall Study|Adverse Event|15
7170928|NCT00950690|11366853|FG000|Overall Study|Lack of Efficacy|22
7170929|NCT00950690|11366853|FG000|Overall Study|Lost to Follow-up|40
7170930|NCT00950690|11366853|FG000|Overall Study|Other|163
7170931|NCT00944229|11366857|FG000|Overall Study|Withdrawal by Subject|11
7170932|NCT00944229|11366857|FG000|Overall Study|Physician Decision|14
7170933|NCT00941928|11366861|FG000|Overall Study|Withdrawal by Subject|1
7170934|NCT00941928|11366861|FG000|Overall Study|Disease Progression|1
7170935|NCT00947011|11366878|FG000|Overall Study|Study was terminated,PI left institution|12
7170936|NCT00943605|11366886|FG000|Overall Study|Study termination|30
7170937|NCT00943605|11366887|FG001|Overall Study|Study termination|30
7170938|NCT00942409|11366893|FG000|Overall Study|Lack of Efficacy|1
7170939|NCT00942409|11366893|FG000|Overall Study|study drug unavailable|2
7170940|NCT00936598|11366903|FG000|Overall Study|Withdrawal by Subject|1
7170941|NCT00936598|11366904|FG001|Overall Study|Withdrawal by Subject|0
7170942|NCT00936598|11366903|FG000|Overall Study|Ineligible after consent|1
7170943|NCT00936598|11366904|FG001|Overall Study|Ineligible after consent|0
7170944|NCT00934791|11366928|FG000|Overall Study|Withdrawal by Subject|1
7170945|NCT00934791|11366929|FG001|Overall Study|Withdrawal by Subject|0
7170946|NCT00925548|11366977|FG000|Overall Study|Discontinuation of trial by sponsor|10
7170947|NCT00925548|11366978|FG001|Overall Study|Discontinuation of trial by sponsor|5
7170948|NCT00926575|11366987|FG000|Overall Study|Adverse Event|1
7170949|NCT00926575|11366988|FG001|Overall Study|Adverse Event|1
7170950|NCT00926575|11366987|FG000|Overall Study|Death|4
7170951|NCT00926575|11366988|FG001|Overall Study|Death|4
7170952|NCT00926575|11366987|FG000|Overall Study|Lost to Follow-up|1
7170953|NCT00926575|11366988|FG001|Overall Study|Lost to Follow-up|1
7170954|NCT00926575|11366987|FG000|Overall Study|Physician Decision|1
7170955|NCT00926575|11366988|FG001|Overall Study|Physician Decision|2
7170956|NCT00926575|11366987|FG000|Overall Study|Protocol Violation|1
7170957|NCT00926575|11366988|FG001|Overall Study|Protocol Violation|0
7170958|NCT00926575|11366987|FG000|Overall Study|Withdrawal by Subject|8
7170959|NCT00926575|11366988|FG001|Overall Study|Withdrawal by Subject|9
7170960|NCT00918463|11367015|FG000|Overall Study|Death|1
7170961|NCT00918463|11367015|FG000|Overall Study|Lack of Efficacy|1
7170962|NCT00913692|11367019|FG000|Screening (4 Months)|Physician Decision|3
7170963|NCT00913692|11367019|FG000|Screening (4 Months)|Not eligible after screening phase.|6
7170964|NCT00913692|11367019|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1
7170965|NCT00918645|11367026|FG000|Overall Study|Withdrawal by Subject|1
7170966|NCT00906035|11367059|FG000|Overall Study|Withdrawal by Subject|2
7170967|NCT00906035|11367060|FG001|Overall Study|Withdrawal by Subject|3
7170968|NCT00906035|11367061|FG002|Overall Study|Withdrawal by Subject|0
7170969|NCT00894790|11367092|FG000|Overall Study|Protocol Violation|0
7170970|NCT00894790|11367093|FG001|Overall Study|Protocol Violation|1
7170971|NCT00894790|11367092|FG000|Overall Study|Lost to Follow-up|0
7170972|NCT00894790|11367093|FG001|Overall Study|Lost to Follow-up|1
7170973|NCT00894790|11367092|FG000|Overall Study|Did not meet entrance criteria|1
7170974|NCT00894790|11367093|FG001|Overall Study|Did not meet entrance criteria|0
7170975|NCT00902668|11367099|FG000|Overall Study|Protocol stopped due to slow accrual.|3
7170976|NCT00881205|11367105|FG000|Overall Study|Adverse Event|8
7170977|NCT00881205|11367106|FG001|Overall Study|Adverse Event|3
7170978|NCT00881205|11367105|FG000|Overall Study|Withdrawal by Subject|1
7170979|NCT00881205|11367106|FG001|Overall Study|Withdrawal by Subject|2
7170980|NCT00881205|11367105|FG000|Overall Study|Lost to Follow-up|0
7170981|NCT00881205|11367106|FG001|Overall Study|Lost to Follow-up|1
7170982|NCT00881205|11367105|FG000|Overall Study|Administrative problems|1
7170983|NCT00881205|11367106|FG001|Overall Study|Administrative problems|1
7170984|NCT00881205|11367105|FG000|Overall Study|Condition no longer requires drug|1
7170985|NCT00881205|11367106|FG001|Overall Study|Condition no longer requires drug|0
7170986|NCT00903006|11367123|FG000|Overall Study|Withdrawal by Subject|2
7170987|NCT00903006|11367124|FG001|Overall Study|Withdrawal by Subject|0
7170988|NCT00903006|11367125|FG002|Overall Study|Withdrawal by Subject|0
7170989|NCT00903006|11367126|FG003|Overall Study|Withdrawal by Subject|0
7170990|NCT00903006|11367123|FG000|Overall Study|Progressive Disease|0
7170991|NCT00903006|11367124|FG001|Overall Study|Progressive Disease|3
7170992|NCT00903006|11367125|FG002|Overall Study|Progressive Disease|1
7170993|NCT00903006|11367126|FG003|Overall Study|Progressive Disease|0
7170994|NCT00887315|11367143|FG000|Overall Study|Study termination|7
7170995|NCT00887315|11367144|FG001|Overall Study|Study termination|4
7170996|NCT00891904|11367150|FG000|Overall Study|Death|1
7170997|NCT00891904|11367150|FG000|Overall Study|Adverse Event|1
7170998|NCT00881608|11367159|FG000|Overall Study|Study prematurely terminated|11
7170999|NCT00889421|11367171|FG000|Overall Study|Lack of Efficacy|3
7171000|NCT00882310|11367188|FG000|Overall Study|Screen Failure|10
7171001|NCT00882310|11367188|FG000|Overall Study|Never received treatment|1
7171002|NCT00882310|11367188|FG000|Overall Study|Death|6
7171003|NCT00882310|11367188|FG000|Overall Study|Progression of disease|4
7171004|NCT00882310|11367188|FG000|Overall Study|Adverse Event|1
7171005|NCT00880542|11367192|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1
7171006|NCT00880542|11367192|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2
7171007|NCT00880542|11367192|FG000|REP: Surgical Resection|progressive disease|1
7171008|NCT00874939|11367200|FG000|Overall Study|Study terminated|4
7171009|NCT00877071|11367227|FG000|Overall Study|disease progression|2
7171010|NCT00878969|11367234|FG000|Overall Study|Physician Decision|5
7171011|NCT00878969|11367235|FG001|Overall Study|Physician Decision|3
7171012|NCT00878969|11367236|FG002|Overall Study|Physician Decision|2
7171013|NCT00878969|11367234|FG000|Overall Study|Withdrawal by Subject|1
7171014|NCT00878969|11367235|FG001|Overall Study|Withdrawal by Subject|6
7171015|NCT00878969|11367236|FG002|Overall Study|Withdrawal by Subject|3
7171016|NCT00878969|11367234|FG000|Overall Study|kidney transplant|2
7171017|NCT00878969|11367235|FG001|Overall Study|kidney transplant|3
7171018|NCT00878969|11367236|FG002|Overall Study|kidney transplant|2
7171019|NCT00878969|11367234|FG000|Overall Study|Adverse Event|3
7171020|NCT00878969|11367235|FG001|Overall Study|Adverse Event|1
7171021|NCT00878969|11367236|FG002|Overall Study|Adverse Event|2
7171022|NCT00878969|11367234|FG000|Overall Study|Lost to Follow-up|2
7171023|NCT00878969|11367235|FG001|Overall Study|Lost to Follow-up|1
7171024|NCT00878969|11367236|FG002|Overall Study|Lost to Follow-up|0
7171025|NCT00878969|11367234|FG000|Overall Study|Protocol Violation|2
7171026|NCT00878969|11367235|FG001|Overall Study|Protocol Violation|0
7171027|NCT00878969|11367236|FG002|Overall Study|Protocol Violation|0
7171028|NCT00878969|11367234|FG000|Overall Study|Death|0
7171029|NCT00878969|11367235|FG001|Overall Study|Death|0
7171030|NCT00878969|11367236|FG002|Overall Study|Death|2
7171031|NCT00878969|11367234|FG000|Overall Study|Pregnancy|0
7171032|NCT00878969|11367235|FG001|Overall Study|Pregnancy|1
7171033|NCT00878969|11367236|FG002|Overall Study|Pregnancy|0
7171034|NCT00865514|11367244|FG000|Overall Study|Infusion cost exceeded funding|2
7171035|NCT00863512|11367261|FG000|Overall Study|Adverse Event|2
7171036|NCT00863512|11367262|FG001|Overall Study|Adverse Event|0
7171037|NCT00863512|11367261|FG000|Overall Study|Withdrawal by Subject|11
7171038|NCT00863512|11367262|FG001|Overall Study|Withdrawal by Subject|0
7171039|NCT00863512|11367261|FG000|Overall Study|Physician Decision|1
7171040|NCT00863512|11367262|FG001|Overall Study|Physician Decision|0
7171041|NCT00868998|11367268|FG000|Overall Study|Screen Failure|1
7171042|NCT00868998|11367268|FG000|Overall Study|Withdrawal by Subject|1
7171043|NCT00868998|11367268|FG000|Overall Study|Progression of disease|2
7171044|NCT00868998|11367268|FG000|Overall Study|Death|1
7171045|NCT00869258|11367272|FG000|Overall Study|Physician Decision|1
7171046|NCT00863330|11367276|FG000|Overall Study|study terminated early due to administra|6
7171047|NCT00853229|11367282|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
7171048|NCT00853229|11367283|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
7171049|NCT00860249|11367294|FG000|Overall Study|trial was terminated prior to completion|21
7171050|NCT00860249|11367295|FG001|Overall Study|trial was terminated prior to completion|18
7171051|NCT00860249|11367296|FG002|Overall Study|trial was terminated prior to completion|21
7171052|NCT00860158|11367304|FG000|Overall Study|Study Terminated|1
7171053|NCT00853567|11367311|FG000|Overall Study|Study prematurely terminated|71
7171054|NCT00849524|11367319|FG000|Overall Study|Lack of Efficacy|3
7171055|NCT00851682|11367334|FG000|Overall Study|screen failure|5
7171056|NCT00851682|11367335|FG001|Overall Study|screen failure|0
7171057|NCT00851747|11367357|FG000|Overall Study|Physician Decision|6
7171058|NCT00851747|11367358|FG001|Overall Study|Physician Decision|6
7171059|NCT00851747|11367359|FG002|Overall Study|Physician Decision|6
7171060|NCT00852241|11367366|FG000|Overall Study|Physician Decision|18
7171061|NCT00851552|11367370|FG000|Overall Study|Death|2
7171062|NCT00851552|11367370|FG000|Overall Study|Adverse Event|1
7171063|NCT00851552|11367370|FG000|Overall Study|Disease Progression|4
7185160|NCT02024555|11385566|FG000|Overall Study|Lost to Follow-up|1
7185161|NCT02024555|11385567|FG001|Overall Study|Lost to Follow-up|1
7185162|NCT02024555|11385566|FG000|Overall Study|Withdrawal by Subject|5
7185163|NCT02024555|11385567|FG001|Overall Study|Withdrawal by Subject|1
7185164|NCT02034123|11385591|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7185165|NCT02034123|11385592|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7185166|NCT02034123|11385593|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7185167|NCT02034123|11385594|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7185168|NCT02034123|11385595|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
7185169|NCT02034123|11385596|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7185170|NCT02034123|11385597|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7185171|NCT02034123|11385598|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
7185172|NCT02034123|11385599|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
7185173|NCT02034123|11385600|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7185174|NCT02034123|11385601|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7185175|NCT02034123|11385602|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7185176|NCT02034123|11385603|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7185177|NCT02034123|11385604|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7185178|NCT02034123|11385605|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7185179|NCT02034123|11385606|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7185180|NCT02034123|11385607|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7185181|NCT02034123|11385608|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7185182|NCT02034123|11385591|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7185183|NCT02034123|11385592|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7185184|NCT02034123|11385593|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7185185|NCT02034123|11385594|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1
7185186|NCT02034123|11385595|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7185187|NCT02034123|11385596|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7185188|NCT02034123|11385597|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7185189|NCT02034123|11385598|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7185190|NCT02034123|11385599|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7185191|NCT02034123|11385600|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7185192|NCT02034123|11385601|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7185193|NCT02034123|11385602|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7185194|NCT02034123|11385603|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7185195|NCT02034123|11385604|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7185196|NCT02034123|11385605|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7185197|NCT02034123|11385606|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7185198|NCT02034123|11385607|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7185199|NCT02034123|11385608|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7185200|NCT02034123|11385591|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7185201|NCT02034123|11385592|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7185202|NCT02034123|11385593|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7185203|NCT02034123|11385594|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7185204|NCT02034123|11385595|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7185205|NCT02034123|11385596|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7185206|NCT02034123|11385597|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7185207|NCT02034123|11385598|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7185208|NCT02034123|11385599|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1
7185209|NCT02034123|11385600|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7187828|NCT02880241|11388520|FG004|Overall Study|Lack of Efficacy|0
7171064|NCT00845845|11367380|FG000|Overall Study|Lost to Follow-up|0
7171065|NCT00845845|11367381|FG001|Overall Study|Lost to Follow-up|4
7171066|NCT00851591|11367389|FG000|Overall Study|Withdrawal by Subject|2
7171067|NCT00851591|11367390|FG001|Overall Study|Withdrawal by Subject|0
7171068|NCT00835679|11367427|FG000|Overall Study|Withdrawal by Subject|1
7171069|NCT00835679|11367428|FG001|Overall Study|Withdrawal by Subject|0
7171070|NCT00835679|11367429|FG002|Overall Study|Withdrawal by Subject|0
7171071|NCT00835679|11367430|FG003|Overall Study|Withdrawal by Subject|0
7171072|NCT00841035|11367444|FG000|Phase 1 Overall Study|Physician Decision|13
7171073|NCT00840827|11367462|FG000|Overall Study|Adverse Event|1
7171074|NCT00840827|11367462|FG000|Overall Study|Lack of Efficacy|4
7171075|NCT00840827|11367462|FG000|Overall Study|Physician Decision|1
7171076|NCT00832624|11367496|FG000|Overall Study|Study Terminated|10
7171077|NCT00827567|11367539|FG000|Overall Study|Progression of Disease/Screen Failure|4
7171078|NCT00815633|11367543|FG000|Overall Study|study terminated|1
7171079|NCT00814983|11367549|FG000|Overall Study|Screen failure|1
7171080|NCT00814983|11367550|FG001|Overall Study|Screen failure|0
7171081|NCT00814983|11367549|FG000|Overall Study|Withdrawal by Subject|1
7171082|NCT00814983|11367550|FG001|Overall Study|Withdrawal by Subject|0
7171083|NCT00814983|11367549|FG000|Overall Study|Graft failure|1
7171084|NCT00814983|11367550|FG001|Overall Study|Graft failure|0
7171085|NCT00819832|11367573|FG000|Overall Study|Sponsor Termination of Study|3
7171086|NCT00819832|11367574|FG001|Overall Study|Sponsor Termination of Study|0
7171087|NCT00819832|11367575|FG002|Overall Study|Sponsor Termination of Study|0
7171088|NCT00819832|11367576|FG003|Overall Study|Sponsor Termination of Study|0
7171089|NCT00819832|11367577|FG004|Overall Study|Sponsor Termination of Study|0
7171090|NCT00819832|11367578|FG005|Overall Study|Sponsor Termination of Study|0
7171091|NCT00814892|11367601|FG000|Overall Study|Disease Progression|1
7171092|NCT00814892|11367601|FG000|Overall Study|Study Termination|1
7171093|NCT00802659|11367618|FG000|Overall Study|Physician Decision|0
7171094|NCT00802659|11367619|FG001|Overall Study|Physician Decision|1
7171095|NCT00802659|11367620|FG002|Overall Study|Physician Decision|0
7171096|NCT00802659|11367621|FG003|Overall Study|Physician Decision|0
7171097|NCT00807365|11367631|FG000|Overall Study|Study Terminated|5
7171098|NCT00814333|11367637|FG000|Enrollment|Lost to Follow-up|1
7171099|NCT00814333|11367638|FG001|Enrollment|Lost to Follow-up|0
7171100|NCT00808080|11367644|FG000|Overall Study|Patients Became Ineligible for infusion|6
7171101|NCT00802893|11367649|FG000|Overall Study|study terminated|3
7171102|NCT00809341|11367655|FG000|Overall Study|Physician Decision|0
7171103|NCT00809341|11367656|FG001|Overall Study|Physician Decision|1
7171104|NCT00808899|11367684|FG000|Overall Study|Death|1
7171105|NCT00808899|11367684|FG000|Overall Study|Physician Decision|3
7171106|NCT00803179|11367695|FG000|Overall Study|Lost to Follow-up|3
7171107|NCT00790452|11367734|FG000|Overall Study|Drug supply issue|1
7171108|NCT00790452|11367735|FG001|Overall Study|Drug supply issue|0
7080562|NCT02123459|11190076|FG001|Washout Period (1 Day)|Adverse Event|0
7080563|NCT02123472|11190082|FG000|Period 2 (7 Days)|Withdrawal by Subject|0
7080564|NCT02123472|11190083|FG001|Period 2 (7 Days)|Withdrawal by Subject|1
7080565|NCT02123511|11190100|FG000|Overall Study|Cancelled treatment|1
7080566|NCT02123511|11190101|FG001|Overall Study|Cancelled treatment|0
7080567|NCT02123511|11190100|FG000|Overall Study|Incomplete data|1
7080568|NCT02123511|11190101|FG001|Overall Study|Incomplete data|3
7171109|NCT00787917|11367747|FG000|Blinded Treatment|Adverse Event|1
7171110|NCT00787917|11367748|FG001|Blinded Treatment|Adverse Event|0
7171111|NCT00787917|11367747|FG000|Blinded Treatment|Lack of Efficacy|1
7171112|NCT00787917|11367748|FG001|Blinded Treatment|Lack of Efficacy|0
7171113|NCT00787917|11367747|FG000|Blinded Treatment|Administrative problems|3
7171114|NCT00787917|11367748|FG001|Blinded Treatment|Administrative problems|2
7171115|NCT00787917|11367747|FG000|Open Label|Unsatisfactory therapeutic effect|1
7171116|NCT00787917|11367748|FG001|Open Label|Unsatisfactory therapeutic effect|0
7171117|NCT00787917|11367747|FG000|Open Label|Administrative problems|3
7171118|NCT00787917|11367748|FG001|Open Label|Administrative problems|0
7171119|NCT00798590|11367758|FG000|Overall Study|P.I, Left institution. Study terminated|11
7171120|NCT00798590|11367759|FG001|Overall Study|P.I, Left institution. Study terminated|8
7171121|NCT00796510|11367767|FG000|Overall Study|Death|1
7171122|NCT00796510|11367768|FG001|Overall Study|Death|0
7171123|NCT00796510|11367767|FG000|Overall Study|Study Terminated|2
7080569|NCT02123511|11190100|FG000|Overall Study|Ineligible|0
7171124|NCT00796510|11367768|FG001|Overall Study|Study Terminated|0
7171125|NCT00796861|11367774|FG000|Overall Study|Withdrawal by Subject|2
7171126|NCT00796861|11367774|FG000|Overall Study|Death|2
7171127|NCT00791076|11367778|FG000|Overall Study|Study was terminated,PI left institution|8
7171128|NCT00796107|11367793|FG000|Overall Study|Lack of Efficacy|1
7171129|NCT00796107|11367793|FG000|Overall Study|Progressive Disease|5
7171130|NCT00785356|11367817|FG000|Overall Study|Study prematurely terminated|8
7171131|NCT00782483|11367825|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6
7171132|NCT00784043|11367835|FG000|Overall Study|Withdrawal by Subject|8
7171133|NCT00784043|11367836|FG001|Overall Study|Withdrawal by Subject|5
7171134|NCT00784043|11367835|FG000|Overall Study|Protocol Terminated|23
7171135|NCT00784043|11367836|FG001|Overall Study|Protocol Terminated|1
7171136|NCT00774306|11367859|FG000|Overall Study|Adverse Event|3
7171137|NCT00774306|11367860|FG001|Overall Study|Adverse Event|0
7171138|NCT00774306|11367861|FG002|Overall Study|Adverse Event|0
7171139|NCT00774306|11367862|FG003|Overall Study|Adverse Event|0
7171140|NCT00774306|11367859|FG000|Overall Study|Protocol Violation|2
7171141|NCT00774306|11367860|FG001|Overall Study|Protocol Violation|0
7171142|NCT00774306|11367861|FG002|Overall Study|Protocol Violation|3
7171143|NCT00774306|11367862|FG003|Overall Study|Protocol Violation|0
7171144|NCT00774306|11367859|FG000|Overall Study|Withdrawal by Subject|6
7171145|NCT00774306|11367860|FG001|Overall Study|Withdrawal by Subject|1
7171146|NCT00774306|11367861|FG002|Overall Study|Withdrawal by Subject|1
7171147|NCT00774306|11367862|FG003|Overall Study|Withdrawal by Subject|0
7171148|NCT00774306|11367859|FG000|Overall Study|Lost to Follow-up|6
7171149|NCT00774306|11367860|FG001|Overall Study|Lost to Follow-up|0
7171150|NCT00774306|11367861|FG002|Overall Study|Lost to Follow-up|4
7171151|NCT00774306|11367862|FG003|Overall Study|Lost to Follow-up|5
7171152|NCT00774306|11367859|FG000|Overall Study|Death|1
7171153|NCT00774306|11367860|FG001|Overall Study|Death|1
7171154|NCT00774306|11367861|FG002|Overall Study|Death|0
7171155|NCT00774306|11367862|FG003|Overall Study|Death|0
7171156|NCT00779038|11367885|FG000|Overall Study|Study Prematurely Terminated|13
7171157|NCT00776100|11367900|FG000|Overall Study|Disease Progression|1
7171158|NCT00776100|11367901|FG001|Overall Study|Disease Progression|0
7171159|NCT00771316|11367909|FG000|Overall Study|Adverse Event|0
7171160|NCT00771316|11367910|FG001|Overall Study|Adverse Event|1
7171161|NCT00771316|11367909|FG000|Overall Study|Patient withdrew consent|1
7171162|NCT00771316|11367910|FG001|Overall Study|Patient withdrew consent|0
7171163|NCT00771316|11367909|FG000|Overall Study|Discontinued due to early termination|1
7171164|NCT00771316|11367910|FG001|Overall Study|Discontinued due to early termination|0
7171165|NCT00768040|11367931|FG000|Overall Study|Adverse Event|3
7171166|NCT00768040|11367932|FG001|Overall Study|Adverse Event|2
7171167|NCT00768040|11367931|FG000|Overall Study|Abnormal laboratory value|1
7171168|NCT00768040|11367932|FG001|Overall Study|Abnormal laboratory value|1
7171169|NCT00776555|11367940|FG000|Overall Study|Study terminated|3
7171170|NCT00776555|11367941|FG001|Overall Study|Study terminated|0
7171171|NCT00775190|11367949|FG000|Overall Study|Lost to Follow-up|2
7171172|NCT00775190|11367950|FG001|Overall Study|Lost to Follow-up|3
7171173|NCT00775190|11367949|FG000|Overall Study|Withdrawal by Subject|1
7171174|NCT00775190|11367950|FG001|Overall Study|Withdrawal by Subject|2
7171175|NCT00775190|11367949|FG000|Overall Study|Protocol Violation|1
7171176|NCT00775190|11367950|FG001|Overall Study|Protocol Violation|0
7171177|NCT00762723|11367963|FG000|Overall Study|Study Terminated slow enrollement|5
7171178|NCT00762723|11367964|FG001|Overall Study|Study Terminated slow enrollement|5
7171179|NCT00762723|11367965|FG002|Overall Study|Study Terminated slow enrollement|3
7171180|NCT00770965|11367977|FG000|Safety Set|Withdrawal by Subject|0
7171181|NCT00770965|11367978|FG001|Safety Set|Withdrawal by Subject|0
7171182|NCT00770965|11367979|FG002|Safety Set|Withdrawal by Subject|0
7171183|NCT00770965|11367980|FG003|Safety Set|Withdrawal by Subject|1
7171184|NCT00770965|11367977|FG000|Safety Set|Protocol deviation|0
7171185|NCT00770965|11367978|FG001|Safety Set|Protocol deviation|0
7171186|NCT00770965|11367979|FG002|Safety Set|Protocol deviation|1
7171187|NCT00770965|11367980|FG003|Safety Set|Protocol deviation|0
7171188|NCT00770965|11367977|FG000|Excluded Set|Administrative problems|14
7171189|NCT00770965|11367978|FG001|Excluded Set|Administrative problems|12
7171190|NCT00770965|11367979|FG002|Excluded Set|Administrative problems|12
7171191|NCT00770965|11367980|FG003|Excluded Set|Administrative problems|10
7171192|NCT00770965|11367977|FG000|Excluded Set|Withdrawal by Subject|1
7171193|NCT00770965|11367978|FG001|Excluded Set|Withdrawal by Subject|1
7171194|NCT00770965|11367979|FG002|Excluded Set|Withdrawal by Subject|2
7171195|NCT00770965|11367980|FG003|Excluded Set|Withdrawal by Subject|3
7171196|NCT00769002|11367994|FG000|Overall Study|Study was not completed, no data|9
7171197|NCT00769002|11367995|FG001|Overall Study|Study was not completed, no data|9
7171198|NCT00766636|11368002|FG000|Overall Study|Withdrawal by Subject|1
7171199|NCT00766636|11368003|FG001|Overall Study|Withdrawal by Subject|1
7171200|NCT00766636|11368002|FG000|Overall Study|Incomplete Treatment|0
7171201|NCT00766636|11368003|FG001|Overall Study|Incomplete Treatment|1
7171202|NCT00766636|11368002|FG000|Overall Study|Adverse Event|1
7171203|NCT00766636|11368003|FG001|Overall Study|Adverse Event|0
7171204|NCT00766636|11368002|FG000|Overall Study|Disease Progression|1
7171205|NCT00766636|11368003|FG001|Overall Study|Disease Progression|0
7171206|NCT00768248|11368011|FG000|Overall Study|Research coordinator didn't collect data|1
7171207|NCT00768248|11368012|FG001|Overall Study|Research coordinator didn't collect data|1
7171208|NCT00764699|11368022|FG000|Overall Study|PI left and study terminated|3
7171209|NCT00763009|11368030|FG000|Overall Study|Coronary Anatomy unsuitable|1
7171210|NCT00761176|11368037|FG000|Overall Study|Death|1
7171211|NCT00761176|11368038|FG001|Overall Study|Death|0
7171212|NCT00761176|11368037|FG000|Overall Study|Withdrawal by Subject|1
7171213|NCT00761176|11368038|FG001|Overall Study|Withdrawal by Subject|1
7171214|NCT00754793|11368063|FG000|Overall Study|voluntary withdrawn from study|0
7171215|NCT00754793|11368064|FG001|Overall Study|voluntary withdrawn from study|1
7171216|NCT00754052|11368072|FG000|Overall Study|Study terminated by Sponsor|5
7171217|NCT00754052|11368073|FG001|Overall Study|Study terminated by Sponsor|3
7171218|NCT00750204|11368095|FG000|Overall Study|study halted prematurely|1
7171219|NCT00750204|11368096|FG001|Overall Study|study halted prematurely|1
7171220|NCT00752986|11368118|FG000|Overall Study|Withdrawal by Subject|2
7171221|NCT00752986|11368119|FG001|Overall Study|Withdrawal by Subject|1
7171222|NCT00752986|11368120|FG002|Overall Study|Withdrawal by Subject|2
7171223|NCT00752986|11368118|FG000|Overall Study|Protocol Violation|3
7171224|NCT00752986|11368119|FG001|Overall Study|Protocol Violation|0
7171225|NCT00752986|11368120|FG002|Overall Study|Protocol Violation|0
7171226|NCT00754013|11368143|FG000|Overall Study|Lost to Follow-up|1
7171227|NCT00754013|11368144|FG001|Overall Study|Lost to Follow-up|1
7171228|NCT00754013|11368143|FG000|Overall Study|didn't return after study termed|3
7171229|NCT00754013|11368144|FG001|Overall Study|didn't return after study termed|4
7171230|NCT00735553|11368153|FG000|Overall Study|Study prematurely terminated|77
7171231|NCT00751933|11368161|FG000|Overall Study|Withdrawal by Subject|0
7171232|NCT00751933|11368162|FG001|Overall Study|Withdrawal by Subject|1
7171233|NCT00751933|11368163|FG002|Overall Study|Withdrawal by Subject|0
7171234|NCT00751933|11368164|FG003|Overall Study|Withdrawal by Subject|0
7171235|NCT00751933|11368161|FG000|Overall Study|Physician Decision|0
7171236|NCT00751933|11368162|FG001|Overall Study|Physician Decision|0
7171237|NCT00751933|11368163|FG002|Overall Study|Physician Decision|1
7171238|NCT00751933|11368164|FG003|Overall Study|Physician Decision|1
7185210|NCT02034123|11385601|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7185211|NCT02034123|11385602|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7185212|NCT02034123|11385603|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7185213|NCT02034123|11385604|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7185214|NCT02034123|11385605|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7185215|NCT02034123|11385606|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7185216|NCT02034123|11385607|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7185217|NCT02034123|11385608|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7185218|NCT02034123|11385591|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7185219|NCT02034123|11385592|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7185220|NCT02034123|11385593|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7185221|NCT02034123|11385594|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1
7185222|NCT02034123|11385595|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1
7185223|NCT02034123|11385596|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7185224|NCT02034123|11385597|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7185225|NCT02034123|11385598|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7185226|NCT02034123|11385599|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7185227|NCT02034123|11385600|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7185228|NCT02034123|11385601|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7185229|NCT02034123|11385602|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7185230|NCT02034123|11385603|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7185231|NCT02034123|11385604|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7185232|NCT02034123|11385605|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7185233|NCT02034123|11385606|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7185234|NCT02034123|11385607|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7185235|NCT02034123|11385608|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7187829|NCT02880241|11388521|FG005|Overall Study|Lack of Efficacy|0
7188335|NCT02891226|11388861|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0
7188336|NCT02891226|11388862|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0
7188337|NCT02891226|11388863|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0
7188338|NCT02891226|11388864|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0
7188339|NCT02891226|11388865|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0
7188340|NCT02891226|11388866|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0
7188341|NCT02891226|11388867|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0
7188342|NCT02891226|11388868|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0
7188343|NCT02891226|11388869|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0
7188344|NCT02891226|11388870|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0
7188345|NCT02891226|11388871|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0
7188346|NCT02891226|11388872|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0
7188347|NCT02891226|11388873|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0
7188348|NCT02891226|11388858|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1
7188349|NCT02891226|11388859|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1
7188350|NCT02891226|11388860|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7188351|NCT02891226|11388861|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7188352|NCT02891226|11388862|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7188353|NCT02891226|11388863|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7188354|NCT02891226|11388864|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7188355|NCT02891226|11388865|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7188356|NCT02891226|11388866|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7188357|NCT02891226|11388867|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7188358|NCT02891226|11388868|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7188359|NCT02891226|11388869|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7188360|NCT02891226|11388870|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7188361|NCT02891226|11388871|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7188362|NCT02891226|11388872|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7188363|NCT02891226|11388873|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7171239|NCT00747461|11368181|FG000|Overall Study|study terminated by sponsor|5
7171240|NCT00736385|11368196|FG000|Overall Study|Withdrawal by Subject|2
7171241|NCT00736385|11368197|FG001|Overall Study|Withdrawal by Subject|2
7171242|NCT00736385|11368196|FG000|Overall Study|Adverse Event|0
7171243|NCT00736385|11368197|FG001|Overall Study|Adverse Event|1
7171244|NCT00739063|11368220|FG000|Overall Study|Screen failures|8
7171245|NCT00740597|11368224|FG000|Overall Study|insurance would not cover treatment|1
7171246|NCT00737282|11368243|FG000|Overall Study|Study prematurely terminated|175
7171247|NCT00739882|11368251|FG000|Double-blind Period|Adverse Event|1
7171248|NCT00739882|11368252|FG001|Double-blind Period|Adverse Event|2
7171249|NCT00739882|11368251|FG000|Double-blind Period|Protocol Violation|1
7171250|NCT00739882|11368252|FG001|Double-blind Period|Protocol Violation|0
7171251|NCT00739882|11368251|FG000|Double-blind Period|Lack of Efficacy|1
7171252|NCT00739882|11368252|FG001|Double-blind Period|Lack of Efficacy|1
7171253|NCT00739882|11368251|FG000|Double-blind Period|Other|16
7171254|NCT00739882|11368252|FG001|Double-blind Period|Other|8
7171255|NCT00739882|11368251|FG000|Open-label Period|Adverse Event|1
7171256|NCT00739882|11368252|FG001|Open-label Period|Adverse Event|0
7171257|NCT00739882|11368251|FG000|Open-label Period|Other|9
7171258|NCT00739882|11368252|FG001|Open-label Period|Other|5
7171259|NCT00735254|11368284|FG000|Overall Study|Protocol Violation|1
7171260|NCT00735254|11368285|FG001|Overall Study|Protocol Violation|1
7171261|NCT00735254|11368286|FG002|Overall Study|Protocol Violation|1
7171262|NCT00735254|11368287|FG003|Overall Study|Protocol Violation|0
7171263|NCT00729365|11368300|FG000|Overall Study|Physician Decision|33
6972795|NCT01174446|11024049|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1
6972796|NCT01174446|11024050|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
6972797|NCT01174446|11024047|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1
7171264|NCT00729365|11368301|FG001|Overall Study|Physician Decision|6
7171265|NCT00729365|11368302|FG002|Overall Study|Physician Decision|7
7171266|NCT00724282|11368320|FG000|Overall Study|Withdrawal by Subject|3
7171267|NCT00724282|11368320|FG000|Overall Study|Physician Decision|1
7171268|NCT00730886|11368326|FG000|Overall Study|Lost to Follow-up|1
7171269|NCT00730886|11368327|FG001|Overall Study|Lost to Follow-up|0
7171270|NCT00730886|11368326|FG000|Overall Study|Physician Decision|1
7171271|NCT00730886|11368327|FG001|Overall Study|Physician Decision|0
7171272|NCT00729560|11368355|FG000|Overall Study|Withdrawal by Subject|3
7171273|NCT00714948|11368376|FG000|Overall Study|Adverse Event|2
7171274|NCT00720343|11368380|FG000|Overall Study|Physician Decision|3
7171275|NCT00720343|11368380|FG000|Overall Study|No data|3
7171276|NCT00718640|11368395|FG000|Overall Study|Adverse Event|4
7171277|NCT00718640|11368395|FG000|Overall Study|Death|1
7171278|NCT00718640|11368395|FG000|Overall Study|Unresolved toxicity after 2 weeks|2
7171279|NCT00720083|11368401|FG000|Overall Study|Ineligible|1
7171280|NCT00720083|11368402|FG001|Overall Study|Ineligible|2
7171281|NCT00717275|11368408|FG000|Overall Study|Premature study termination.|3
7171282|NCT00708734|11368412|FG000|Overall Study|scheduling conflict|2
7171283|NCT00708734|11368412|FG000|Overall Study|moved|1
7171284|NCT00708734|11368412|FG000|Overall Study|leg injury|1
7171285|NCT00708734|11368412|FG000|Overall Study|knee replacement|1
7171286|NCT00708734|11368412|FG000|Overall Study|vertigo|1
7171287|NCT00708734|11368412|FG000|Overall Study|leg fracture|1
7171288|NCT00711087|11368418|FG000|Overall Study|Lost to Follow-up|1
7171289|NCT00711087|11368419|FG001|Overall Study|Lost to Follow-up|0
7171290|NCT00706797|11368427|FG000|Overall Study|Lack of Efficacy|3
7171291|NCT00706797|11368428|FG001|Overall Study|Lack of Efficacy|0
7171292|NCT00706797|11368427|FG000|Overall Study|Adverse Event|0
7171293|NCT00706797|11368428|FG001|Overall Study|Adverse Event|3
7171294|NCT00706797|11368427|FG000|Overall Study|Withdrawal by Subject|8
7171295|NCT00706797|11368428|FG001|Overall Study|Withdrawal by Subject|1
7171296|NCT00706797|11368427|FG000|Overall Study|Death|1
7171297|NCT00706797|11368428|FG001|Overall Study|Death|0
7171298|NCT00706797|11368427|FG000|Overall Study|Discontinuation of study by sponsor|52
7171299|NCT00706797|11368428|FG001|Overall Study|Discontinuation of study by sponsor|63
7171300|NCT00706797|11368427|FG000|Overall Study|Protocol Violation|3
7171301|NCT00706797|11368428|FG001|Overall Study|Protocol Violation|2
7171302|NCT00706797|11368427|FG000|Overall Study|Lost to Follow-up|1
7171303|NCT00706797|11368428|FG001|Overall Study|Lost to Follow-up|2
7171304|NCT00706797|11368427|FG000|Overall Study|Other|1
7171305|NCT00706797|11368428|FG001|Overall Study|Other|0
7171306|NCT00713596|11368437|FG000|Overall Study|Study was terminated|2
7171307|NCT00713596|11368438|FG001|Overall Study|Study was terminated|3
7171308|NCT00713596|11368439|FG002|Overall Study|Study was terminated|2
7171309|NCT00703092|11368452|FG000|Overall Study|Withdrawal by Subject|2
7171310|NCT00713258|11368458|FG000|Overall Study|Adverse Event|2
7171311|NCT00713258|11368459|FG001|Overall Study|Adverse Event|4
7171312|NCT00713258|11368458|FG000|Overall Study|Non-Compliance|2
7171313|NCT00713258|11368459|FG001|Overall Study|Non-Compliance|1
7171314|NCT00713258|11368458|FG000|Overall Study|Other|1
7171315|NCT00713258|11368459|FG001|Overall Study|Other|1
7171316|NCT00707434|11368469|FG000|Overall Study|Adverse Event|1
7171317|NCT00707161|11368473|FG000|Overall Study|Physician Decision|6
7171318|NCT00708916|11368486|FG000|Overall Study|Subject Noncompliance|2
7171319|NCT00708916|11368486|FG000|Overall Study|Adverse Event|2
7171320|NCT00700778|11368491|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2
7171321|NCT00699842|11368498|FG000|Overall Study|Death|0
7171322|NCT00699842|11368499|FG001|Overall Study|Death|1
7171323|NCT00699842|11368500|FG002|Overall Study|Death|0
7171324|NCT00702962|11368510|FG000|Overall Study|Progressive disease|0
7171325|NCT00702962|11368511|FG001|Overall Study|Progressive disease|1
7171326|NCT00702962|11368510|FG000|Overall Study|Hospitalized for other health disorder|1
7171327|NCT00702962|11368511|FG001|Overall Study|Hospitalized for other health disorder|0
7171328|NCT00703534|11368521|FG000|Overall Study|Adverse Event|14
7171329|NCT00703534|11368522|FG001|Overall Study|Adverse Event|3
7171330|NCT00703534|11368521|FG000|Overall Study|Withdrawal by Subject|8
6895290|NCT00624065|10913132|FG001|Overall Study|Lost to Follow-up|1
6895291|NCT00624065|10913131|FG000|Overall Study|Consent withdrawn|6
6895292|NCT00624065|10913132|FG001|Overall Study|Consent withdrawn|5
7171331|NCT00703534|11368522|FG001|Overall Study|Withdrawal by Subject|7
7171332|NCT00703534|11368521|FG000|Overall Study|Incorrect Enrollment|6
7171333|NCT00703534|11368522|FG001|Overall Study|Incorrect Enrollment|6
7171334|NCT00703534|11368521|FG000|Overall Study|Lost to Follow-up|1
7171335|NCT00703534|11368522|FG001|Overall Study|Lost to Follow-up|4
7171336|NCT00703534|11368521|FG000|Overall Study|Severe Non Compliance|1
7171337|NCT00703534|11368522|FG001|Overall Study|Severe Non Compliance|5
7171338|NCT00698009|11368528|FG000|Overall Study|Withdrawal by Subject|1
7171339|NCT00702702|11368552|FG000|Overall Study|Study prematurely terminated|56
7171340|NCT00699413|11368571|FG000|Overall Study|Withdrawal by Subject|0
7171341|NCT00699413|11368572|FG001|Overall Study|Withdrawal by Subject|2
7171342|NCT00699413|11368571|FG000|Overall Study|Study terminated by sponsor|4
7171343|NCT00699413|11368572|FG001|Overall Study|Study terminated by sponsor|2
7171344|NCT00686972|11368582|FG000|Overall Study|P.I, Left institution. Study terminated|51
7171345|NCT00693017|11368588|FG000|Overall Study|Sponsor Decision|2
7171346|NCT00693017|11368589|FG001|Overall Study|Sponsor Decision|1
7171347|NCT00693017|11368588|FG000|Overall Study|Death|0
7171348|NCT00693017|11368589|FG001|Overall Study|Death|1
7171349|NCT00692003|11368628|FG000|Overall Study|Sponsor Decision|5
7171350|NCT00692003|11368629|FG001|Overall Study|Sponsor Decision|1
7171351|NCT00678288|11368637|FG000|Overall Study|Adverse Event|0
7171352|NCT00678288|11368638|FG001|Overall Study|Adverse Event|2
7171353|NCT00678288|11368637|FG000|Overall Study|Withdrawal by Subject|1
7171354|NCT00678288|11368638|FG001|Overall Study|Withdrawal by Subject|1
7171355|NCT00678288|11368637|FG000|Overall Study|Study terminated by the sponsor|2
7171356|NCT00678288|11368638|FG001|Overall Study|Study terminated by the sponsor|0
7171357|NCT00678288|11368637|FG000|Overall Study|Not compliant with study medication|0
7171358|NCT00678288|11368638|FG001|Overall Study|Not compliant with study medication|1
7171359|NCT00678288|11368637|FG000|Overall Study|Switch to commercial drug|0
7171360|NCT00678288|11368638|FG001|Overall Study|Switch to commercial drug|1
7171361|NCT00678288|11368637|FG000|Overall Study|Reason not reported|1
7171362|NCT00678288|11368638|FG001|Overall Study|Reason not reported|0
7171363|NCT00678288|11368637|FG000|Overall Study|Disease progression/recurrence/relapse|6
7171364|NCT00678288|11368638|FG001|Overall Study|Disease progression/recurrence/relapse|1
7171365|NCT00689052|11368650|FG000|Overall Study|Adverse Event|4
7171366|NCT00689052|11368651|FG001|Overall Study|Adverse Event|6
7171367|NCT00689052|11368650|FG000|Overall Study|Protocol Violation|1
7171368|NCT00689052|11368651|FG001|Overall Study|Protocol Violation|0
7171369|NCT00689052|11368650|FG000|Overall Study|Lost to Follow-up|2
7171370|NCT00689052|11368651|FG001|Overall Study|Lost to Follow-up|0
7171371|NCT00689052|11368650|FG000|Overall Study|Withdrawal by Subject|2
7171372|NCT00689052|11368651|FG001|Overall Study|Withdrawal by Subject|0
7171373|NCT00689052|11368650|FG000|Overall Study|Early termination of the trial|22
7171374|NCT00689052|11368651|FG001|Overall Study|Early termination of the trial|24
7171375|NCT00683917|11368671|FG000|Overall Study|Study prematurely terminated|10
7171376|NCT00686036|11368694|FG000|Overall Study|Adverse Event|3
7171377|NCT00686036|11368695|FG001|Overall Study|Adverse Event|0
7171378|NCT00686036|11368694|FG000|Overall Study|Withdrawal by Subject|3
7171379|NCT00686036|11368695|FG001|Overall Study|Withdrawal by Subject|1
7171380|NCT00686036|11368694|FG000|Overall Study|Study terminated by AstraZeneca|2
7171381|NCT00686036|11368695|FG001|Overall Study|Study terminated by AstraZeneca|1
7171382|NCT00686036|11368694|FG000|Overall Study|PSA ≥ 10ng/mL|1
7171383|NCT00686036|11368695|FG001|Overall Study|PSA ≥ 10ng/mL|0
7171384|NCT00686036|11368694|FG000|Overall Study|Other reasons not identified|0
7171385|NCT00686036|11368695|FG001|Overall Study|Other reasons not identified|4
7171386|NCT00683787|11368717|FG000|Overall Study|Progression|3
7171387|NCT00683787|11368718|FG001|Overall Study|Progression|3
7171388|NCT00683787|11368719|FG002|Overall Study|Progression|0
7171389|NCT00683787|11368717|FG000|Overall Study|Adverse Event|0
7171390|NCT00683787|11368718|FG001|Overall Study|Adverse Event|0
7171391|NCT00683787|11368719|FG002|Overall Study|Adverse Event|2
7171392|NCT00678041|11368734|FG000|Overall Study|Physician Decision|5
7171393|NCT00678041|11368735|FG001|Overall Study|Physician Decision|5
7171394|NCT00681629|11368753|FG000|Overall Study|Study termination|4
7171395|NCT00681629|11368754|FG001|Overall Study|Study termination|2
7171396|NCT00681629|11368753|FG000|Overall Study|Adverse Event|1
7171397|NCT00681629|11368754|FG001|Overall Study|Adverse Event|0
7171398|NCT00673361|11368814|FG000|Overall Study|Screen Failure|2
7171399|NCT00673179|11368831|FG000|Overall Study|Toxicity/Complications|3
7171400|NCT00673179|11368832|FG001|Overall Study|Toxicity/Complications|0
7171401|NCT00660348|11368851|FG000|Overall Study|Withdrawal by Subject|1
7171402|NCT00660348|11368852|FG001|Overall Study|Withdrawal by Subject|0
7171403|NCT00664066|11368858|FG000|Overall Study|Study terminated|3
7171404|NCT00667017|11368862|FG000|Overall Study|Withdrawal by Subject|1
7171405|NCT00665444|11368866|FG000|Overall Study|Physician Decision|1
7171406|NCT00665444|11368866|FG000|Overall Study|Study Terminated by Study Sponsor|1
7171407|NCT00660595|11368881|FG000|Overall Study|Lost to Follow-up|0
7171408|NCT00660595|11368882|FG001|Overall Study|Lost to Follow-up|1
7171409|NCT00660595|11368881|FG000|Overall Study|Did not consent to participate in study|12
7171410|NCT00660595|11368882|FG001|Overall Study|Did not consent to participate in study|8
7171411|NCT00660595|11368881|FG000|Overall Study|Participant left hospital|1
7171412|NCT00660595|11368882|FG001|Overall Study|Participant left hospital|0
7171413|NCT00660595|11368881|FG000|Overall Study|Non Specified reasons|5
7171414|NCT00660595|11368882|FG001|Overall Study|Non Specified reasons|0
7171415|NCT00646282|11368899|FG000|Overall Study|Protocol terminated|4
7171416|NCT00646282|11368900|FG001|Overall Study|Protocol terminated|4
7171417|NCT00657553|11368908|FG000|Overall Study|low accrual, no analysis run|5
7171418|NCT00657553|11368909|FG001|Overall Study|low accrual, no analysis run|5
7171419|NCT00648895|11368930|FG000|Overall Study|Lack of Efficacy|0
7171420|NCT00648895|11368931|FG001|Overall Study|Lack of Efficacy|1
7171421|NCT00647426|11368937|FG000|Overall Study|Withdrawal by Subject|2
7171422|NCT00645567|11368942|FG000|Overall Study|Adverse Event|1
7171423|NCT00637806|11368953|FG000|Double-blind Phase|Study Discontinued|2
7171424|NCT00637806|11368954|FG001|Double-blind Phase|Study Discontinued|0
7171425|NCT00637806|11368955|FG002|Double-blind Phase|Study Discontinued|1
7171426|NCT00637806|11368956|FG003|Double-blind Phase|Study Discontinued|0
7171427|NCT00637806|11368953|FG000|Extension Phase|Study Discontinued|0
7171428|NCT00637806|11368954|FG001|Extension Phase|Study Discontinued|0
7171429|NCT00637806|11368955|FG002|Extension Phase|Study Discontinued|0
7171430|NCT00637806|11368956|FG003|Extension Phase|Study Discontinued|1
7185236|NCT02040584|11385653|FG000|Overall Study|Adverse Event|13
7185237|NCT02040584|11385654|FG001|Overall Study|Adverse Event|6
7185238|NCT02040584|11385653|FG000|Overall Study|Protocol Violation|9
7185239|NCT02040584|11385654|FG001|Overall Study|Protocol Violation|11
7185240|NCT02040584|11385653|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7185241|NCT02040584|11385654|FG001|Overall Study|Unsatisfactory therapeutic effect|1
7185242|NCT02040584|11385653|FG000|Overall Study|Death|6
7185243|NCT02040584|11385654|FG001|Overall Study|Death|3
7185244|NCT02040584|11385653|FG000|Overall Study|Transplant rejection/retransplant|0
7185245|NCT02040584|11385654|FG001|Overall Study|Transplant rejection/retransplant|1
7185246|NCT02040584|11385653|FG000|Overall Study|Immunosuppressant/prohibited med use|7
7185247|NCT02040584|11385654|FG001|Overall Study|Immunosuppressant/prohibited med use|10
7185248|NCT02045797|11385673|FG000|Overall Study|Adverse Event|3
7185249|NCT02045797|11385674|FG001|Overall Study|Adverse Event|1
7185250|NCT02045797|11385675|FG002|Overall Study|Adverse Event|0
7185251|NCT02045797|11385673|FG000|Overall Study|Lack of Efficacy|1
7185252|NCT02045797|11385674|FG001|Overall Study|Lack of Efficacy|0
7185253|NCT02045797|11385675|FG002|Overall Study|Lack of Efficacy|0
7185254|NCT02045797|11385673|FG000|Overall Study|Lost to Follow-up|2
7185255|NCT02045797|11385674|FG001|Overall Study|Lost to Follow-up|3
7185256|NCT02045797|11385675|FG002|Overall Study|Lost to Follow-up|1
7185257|NCT02045797|11385673|FG000|Overall Study|Physician Decision|0
7185258|NCT02045797|11385674|FG001|Overall Study|Physician Decision|1
7185259|NCT02045797|11385675|FG002|Overall Study|Physician Decision|0
7185260|NCT02045797|11385673|FG000|Overall Study|Withdrawal by Subject|1
7185261|NCT02045797|11385674|FG001|Overall Study|Withdrawal by Subject|2
7185262|NCT02045797|11385675|FG002|Overall Study|Withdrawal by Subject|0
7185263|NCT02049710|11385685|FG000|Overall Study|Lost to Follow-up|319
7185264|NCT02049710|11385686|FG001|Overall Study|Lost to Follow-up|324
7185265|NCT02055547|11385692|FG000|Overall Study|Protocol Violation|0
7185266|NCT02055547|11385693|FG001|Overall Study|Protocol Violation|0
7185267|NCT02055547|11385694|FG002|Overall Study|Protocol Violation|1
7185268|NCT02055547|11385695|FG003|Overall Study|Protocol Violation|0
7185269|NCT02055547|11385696|FG004|Overall Study|Protocol Violation|0
7185270|NCT02055547|11385697|FG005|Overall Study|Protocol Violation|0
7185271|NCT02055547|11385698|FG006|Overall Study|Protocol Violation|1
7185272|NCT02055547|11385699|FG007|Overall Study|Protocol Violation|0
7185273|NCT02055547|11385700|FG008|Overall Study|Protocol Violation|0
7185274|NCT02055547|11385701|FG009|Overall Study|Protocol Violation|0
7185275|NCT02055547|11385702|FG010|Overall Study|Protocol Violation|0
7185276|NCT02055547|11385703|FG011|Overall Study|Protocol Violation|0
7185277|NCT02055547|11385704|FG012|Overall Study|Protocol Violation|0
7185278|NCT02055547|11385705|FG013|Overall Study|Protocol Violation|0
7185279|NCT02055547|11385706|FG014|Overall Study|Protocol Violation|0
7185280|NCT02055547|11385707|FG015|Overall Study|Protocol Violation|0
7185281|NCT02055547|11385708|FG016|Overall Study|Protocol Violation|0
7185282|NCT02055547|11385709|FG017|Overall Study|Protocol Violation|0
7185283|NCT02055547|11385710|FG018|Overall Study|Protocol Violation|0
7185284|NCT02055547|11385692|FG000|Overall Study|Physician Decision|0
7185285|NCT02055547|11385693|FG001|Overall Study|Physician Decision|1
7185286|NCT02055547|11385694|FG002|Overall Study|Physician Decision|1
7185287|NCT02055547|11385695|FG003|Overall Study|Physician Decision|0
7185288|NCT02055547|11385696|FG004|Overall Study|Physician Decision|1
7185289|NCT02055547|11385697|FG005|Overall Study|Physician Decision|0
7185290|NCT02055547|11385698|FG006|Overall Study|Physician Decision|0
7171431|NCT00629798|11368981|FG000|Overall Study|Not Treated|4
7171432|NCT00637728|11368991|FG000|Double-blind Phase|Adverse Event|1
7171433|NCT00637728|11368992|FG001|Double-blind Phase|Adverse Event|0
7080570|NCT02123511|11190101|FG001|Overall Study|Ineligible|1
7080571|NCT02123576|11190109|FG000|Overall Study|Adverse Event|1
7080572|NCT02123576|11190110|FG001|Overall Study|Adverse Event|0
7080573|NCT02123797|11190122|FG000|Baseline Intervention|Death|9
7080574|NCT02123797|11190123|FG001|Baseline Intervention|Death|16
7080575|NCT02123797|11190124|FG002|Baseline Intervention|Death|0
7080576|NCT02123797|11190125|FG003|Baseline Intervention|Death|0
7080577|NCT02123797|11190126|FG004|Baseline Intervention|Death|0
7080578|NCT02123797|11190122|FG000|Baseline Intervention|Withdrawal by Subject|2
7080579|NCT02123797|11190123|FG001|Baseline Intervention|Withdrawal by Subject|8
7080580|NCT02123797|11190124|FG002|Baseline Intervention|Withdrawal by Subject|0
7080581|NCT02123797|11190125|FG003|Baseline Intervention|Withdrawal by Subject|0
7080582|NCT02123797|11190126|FG004|Baseline Intervention|Withdrawal by Subject|0
7080583|NCT02123797|11190122|FG000|Baseline Intervention|Relocation|2
7080584|NCT02123797|11190123|FG001|Baseline Intervention|Relocation|0
7080585|NCT02123797|11190124|FG002|Baseline Intervention|Relocation|0
7080586|NCT02123797|11190125|FG003|Baseline Intervention|Relocation|0
7080587|NCT02123797|11190126|FG004|Baseline Intervention|Relocation|0
7080588|NCT02123797|11190122|FG000|Baseline Intervention|Out of window for initial survey|6
7171434|NCT00637728|11368993|FG002|Double-blind Phase|Adverse Event|0
7171435|NCT00637728|11368991|FG000|Double-blind Phase|Non-compliance|2
7171436|NCT00637728|11368992|FG001|Double-blind Phase|Non-compliance|0
7171437|NCT00637728|11368993|FG002|Double-blind Phase|Non-compliance|0
7171438|NCT00637728|11368991|FG000|Double-blind Phase|Study Discontinued|1
7171439|NCT00637728|11368992|FG001|Double-blind Phase|Study Discontinued|1
7171440|NCT00637728|11368993|FG002|Double-blind Phase|Study Discontinued|0
7171441|NCT00637416|11369028|FG000|Overall Study|Lost to Follow-up|1
7171442|NCT00637416|11369029|FG001|Overall Study|Lost to Follow-up|1
7171443|NCT00637416|11369028|FG000|Overall Study|Unable to take study drug|0
7171444|NCT00637416|11369029|FG001|Overall Study|Unable to take study drug|1
7171445|NCT00631137|11369079|FG000|Overall Study|Withdrawal by Subject|1
7171446|NCT00631137|11369080|FG001|Overall Study|Withdrawal by Subject|0
7171447|NCT00633061|11369097|FG000|Overall Study|Study closed|86
7171448|NCT00633061|11369098|FG001|Overall Study|Study closed|0
7171449|NCT00630292|11369110|FG000|Overall Study|Withdrawal by Subject|1
7171450|NCT00634010|11369116|FG000|Overall Study|Adverse Event|2
7171451|NCT00634010|11369117|FG001|Overall Study|Adverse Event|5
6972798|NCT01174446|11024048|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
6972799|NCT01174446|11024049|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
6972800|NCT01174446|11024050|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
6972801|NCT01174446|11024047|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
6972802|NCT01174446|11024048|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1
6972803|NCT01174446|11024049|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
6972804|NCT01174446|11024050|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
6972805|NCT01174459|11024097|FG000|Overall Study|case report form (CRF) not collected|5
6972806|NCT01174550|11024103|FG000|Overall Study|Death|75
6972807|NCT01174550|11024104|FG001|Overall Study|Death|74
6972808|NCT01174550|11024103|FG000|Overall Study|Lost to Follow-up|652
6972809|NCT01174550|11024104|FG001|Overall Study|Lost to Follow-up|510
6972810|NCT01174550|11024103|FG000|Overall Study|Withdrawal by Subject|543
6972811|NCT01174550|11024104|FG001|Overall Study|Withdrawal by Subject|289
6972812|NCT01174784|11024123|FG000|Overall Study|Screen fails|4
6972813|NCT01175018|11024144|FG000|Overall Study|Adverse Event|3
6972814|NCT01175018|11024145|FG001|Overall Study|Adverse Event|1
6972815|NCT01175083|11024167|FG000|Primary Epoch|Withdrawal by Subject|0
6972816|NCT01175083|11024168|FG001|Primary Epoch|Withdrawal by Subject|0
6972817|NCT01175083|11024169|FG002|Primary Epoch|Withdrawal by Subject|0
6972818|NCT01175083|11024170|FG003|Primary Epoch|Withdrawal by Subject|0
6972819|NCT01175083|11024171|FG004|Primary Epoch|Withdrawal by Subject|0
6972820|NCT01175083|11024172|FG005|Primary Epoch|Withdrawal by Subject|2
6972821|NCT01175083|11024167|FG000|Primary Epoch|Lost to Follow-up|0
6972822|NCT01175083|11024168|FG001|Primary Epoch|Lost to Follow-up|0
6972823|NCT01175083|11024169|FG002|Primary Epoch|Lost to Follow-up|0
6972824|NCT01175083|11024170|FG003|Primary Epoch|Lost to Follow-up|0
6972825|NCT01175083|11024171|FG004|Primary Epoch|Lost to Follow-up|0
6972826|NCT01175083|11024172|FG005|Primary Epoch|Lost to Follow-up|1
6972827|NCT01175083|11024167|FG000|Booster Epoch|Death|0
6972828|NCT01175083|11024168|FG001|Booster Epoch|Death|0
6972829|NCT01175083|11024169|FG002|Booster Epoch|Death|1
6972830|NCT01175083|11024170|FG003|Booster Epoch|Death|0
6972831|NCT01175083|11024171|FG004|Booster Epoch|Death|0
7080589|NCT02123797|11190123|FG001|Baseline Intervention|Out of window for initial survey|13
7080590|NCT02123797|11190124|FG002|Baseline Intervention|Out of window for initial survey|0
7080591|NCT02123797|11190125|FG003|Baseline Intervention|Out of window for initial survey|0
7080592|NCT02123797|11190126|FG004|Baseline Intervention|Out of window for initial survey|0
7171452|NCT00634010|11369116|FG000|Overall Study|Withdrawal by Subject|5
6972832|NCT01175083|11024172|FG005|Booster Epoch|Death|0
7171453|NCT00634010|11369117|FG001|Overall Study|Withdrawal by Subject|6
7171454|NCT00634010|11369116|FG000|Overall Study|Physician Decision|1
7171455|NCT00634010|11369117|FG001|Overall Study|Physician Decision|1
6972833|NCT01175083|11024167|FG000|Booster Epoch|Withdrawal by Subject|0
6972834|NCT01175083|11024168|FG001|Booster Epoch|Withdrawal by Subject|0
6972835|NCT01175083|11024169|FG002|Booster Epoch|Withdrawal by Subject|0
7171456|NCT00634010|11369116|FG000|Overall Study|Disease Progression|1
7171457|NCT00634010|11369117|FG001|Overall Study|Disease Progression|1
7171458|NCT00634010|11369116|FG000|Overall Study|Non-Compliant|1
7171459|NCT00634010|11369117|FG001|Overall Study|Non-Compliant|1
7171460|NCT00626561|11369167|FG000|Overall Study|Withdrawal by Subject|2
7171461|NCT00626561|11369167|FG000|Overall Study|Disease Progression|2
7171462|NCT00613730|11369171|FG000|Overall Study|Disease progression|2
7171463|NCT00613730|11369171|FG000|Overall Study|Administrative decision|1
7171464|NCT00625586|11369175|FG000|Overall Study|Adverse Event|1
7171465|NCT00625742|11369183|FG000|Overall Study|Disease Progression|2
7171466|NCT00625742|11369183|FG000|Overall Study|Withdrawal by Subject|1
7171467|NCT00625742|11369183|FG000|Overall Study|Adverse Event|4
7171468|NCT00625742|11369183|FG000|Overall Study|Lost to Follow-up|4
7171469|NCT00625742|11369183|FG000|Overall Study|Ineligible|1
7171470|NCT00619151|11369193|FG000|Overall Study|Study terminated prior to followup|1
7171471|NCT00619151|11369194|FG001|Overall Study|Study terminated prior to followup|0
7171472|NCT00622167|11369200|FG000|Overall Study|Did not meet angiographic criteria|20
7171473|NCT00616759|11369219|FG000|Overall Study|Physician Decision|2
7171474|NCT00616759|11369220|FG001|Overall Study|Physician Decision|0
7171475|NCT00616759|11369219|FG000|Overall Study|Withdrawal by Subject|1
7171476|NCT00616759|11369220|FG001|Overall Study|Withdrawal by Subject|2
7171477|NCT00616642|11369228|FG000|Overall Study|Withdrawal by Subject|0
7171478|NCT00616642|11369229|FG001|Overall Study|Withdrawal by Subject|1
7171479|NCT00619515|11369235|FG000|Overall Study|Study Termination by IRB|73
7171480|NCT00612677|11369243|FG000|Overall Study|study closed before treatment started|1
7171481|NCT00616603|11369250|FG000|Overall Study|Physician Decision|2
7171482|NCT00616603|11369251|FG001|Overall Study|Physician Decision|0
7171483|NCT00616603|11369252|FG002|Overall Study|Physician Decision|2
7171484|NCT00609765|11369293|FG000|Overall Study|Study ended prior to 12 months|1
7171485|NCT00595920|11369318|FG000|Overall Study|The OLTERMS study was discontinued by th|116
7171486|NCT00596947|11369324|FG000|Overall Study|study halted due to low enrollment|5
7171487|NCT00596947|11369325|FG001|Overall Study|study halted due to low enrollment|3
7171488|NCT00596947|11369324|FG000|Overall Study|Lost to Follow-up|1
7171489|NCT00596947|11369325|FG001|Overall Study|Lost to Follow-up|0
7171490|NCT00584012|11369331|FG000|Overall Study|Withdrawal by Subject|1
7171491|NCT00577772|11369367|FG000|Overall Study|Lost to Follow-up|0
7171492|NCT00577772|11369368|FG001|Overall Study|Lost to Follow-up|1
7171493|NCT00592007|11369374|FG000|Overall Study|Withdrawal by Subject|1
7171494|NCT00592007|11369374|FG000|Overall Study|patient ineligible (out of lab range)|1
7171495|NCT00595582|11369378|FG000|Overall Study|Pilot study that PI terminated|2
7171496|NCT00595582|11369378|FG000|Overall Study|Lost to Follow-up|1
7171497|NCT00595582|11369378|FG000|Overall Study|Adverse Event|2
7171498|NCT00595582|11369378|FG000|Overall Study|Physician Decision|5
7171499|NCT00588146|11369382|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4
7171500|NCT00588146|11369383|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3
7171501|NCT00590538|11369398|FG000|Overall Study|Study terminated before completed|2
7171502|NCT00583115|11369402|FG000|Overall Study|Death|1
7171503|NCT00582712|11369406|FG000|Overall Study|Adverse Event|1
7171504|NCT00582712|11369406|FG000|Overall Study|Lack of Efficacy|1
7171505|NCT00582712|11369406|FG000|Overall Study|Withdrawal by Subject|1
7171506|NCT00582712|11369406|FG000|Overall Study|Complicating disease requiring treatment|1
7171507|NCT00587795|11369437|FG000|Overall Study|Withdrawal by Subject|1
7171508|NCT00587795|11369438|FG001|Overall Study|Withdrawal by Subject|0
7171509|NCT00590135|11369444|FG000|Overall Study|Primary endpoint measure not obtainable|59
7171510|NCT00582036|11369451|FG000|Overall Study|Withdrawal by Subject|0
7171511|NCT00582036|11369452|FG001|Overall Study|Withdrawal by Subject|1
7171512|NCT00585585|11369458|FG000|Overall Study|Adverse Event|1
7171513|NCT00585221|11369462|FG000|Overall Study|Protocol Violation|8
7171514|NCT00581113|11369468|FG000|Overall Study|Withdrawal by Subject|0
7171515|NCT00581113|11369469|FG001|Overall Study|Withdrawal by Subject|1
7171516|NCT00579254|11369475|FG000|Overall Study|Lost to Follow-up|39
7171517|NCT00579254|11369475|FG000|Overall Study|Discontinued when study terminated|73
7171518|NCT00587223|11369479|FG000|Overall Study|Adverse Event|1
7171519|NCT00577395|11369510|FG000|Overall Study|Study was terminated early by Sponsor|7
6972836|NCT01175083|11024170|FG003|Booster Epoch|Withdrawal by Subject|1
6972837|NCT01175083|11024171|FG004|Booster Epoch|Withdrawal by Subject|0
6972838|NCT01175083|11024172|FG005|Booster Epoch|Withdrawal by Subject|0
6972839|NCT01175135|11024194|FG000|Overall Study|Adverse Event|2
6972840|NCT01175135|11024195|FG001|Overall Study|Adverse Event|5
6972841|NCT01175135|11024196|FG002|Overall Study|Adverse Event|3
6972842|NCT01175135|11024197|FG003|Overall Study|Adverse Event|4
6972843|NCT01175135|11024194|FG000|Overall Study|Death|1
6972844|NCT01175135|11024195|FG001|Overall Study|Death|0
6972845|NCT01175135|11024196|FG002|Overall Study|Death|0
7171520|NCT00577395|11369511|FG001|Overall Study|Study was terminated early by Sponsor|6
7171521|NCT00573391|11369519|FG000|Overall Study|study stopped|2
6972846|NCT01175135|11024197|FG003|Overall Study|Death|0
6972847|NCT01175135|11024194|FG000|Overall Study|Lack of Efficacy|4
6972848|NCT01175135|11024195|FG001|Overall Study|Lack of Efficacy|5
7171522|NCT00573391|11369520|FG001|Overall Study|study stopped|2
7171523|NCT00573391|11369519|FG000|Overall Study|Death|1
7171524|NCT00573391|11369520|FG001|Overall Study|Death|0
7171525|NCT00574080|11369564|FG000|Overall Study|Death|10
7171526|NCT00574080|11369565|FG001|Overall Study|Death|10
7171527|NCT00558558|11369571|FG000|Overall Study|Unable to swallow|1
7171528|NCT00558558|11369571|FG000|Overall Study|Withdrawal by Subject|1
7171529|NCT00558558|11369571|FG000|Overall Study|Lack of Efficacy|4
7171530|NCT00573937|11369581|FG000|Overall Study|Study Terminated|0
7171531|NCT00573937|11369582|FG001|Overall Study|Study Terminated|1
7171532|NCT00577317|11369590|FG000|Overall Study|Study Terminated|0
7171533|NCT00577317|11369591|FG001|Overall Study|Study Terminated|2
7171534|NCT00571922|11369599|FG000|Overall Study|Completion unknown|36
7171535|NCT00571922|11369600|FG001|Overall Study|Completion unknown|36
7171536|NCT00573157|11369612|FG000|Overall Study|Adverse Event|3
7171537|NCT00573157|11369613|FG001|Overall Study|Adverse Event|1
7171538|NCT00573157|11369612|FG000|Overall Study|Other|1
7171539|NCT00573157|11369613|FG001|Overall Study|Other|1
7171540|NCT00561912|11369632|FG000|Overall Study|ineligible|1
7171541|NCT00561795|11369638|FG000|Overall Study|Adverse Event|3
7171542|NCT00561795|11369639|FG001|Overall Study|Adverse Event|3
7171543|NCT00561795|11369640|FG002|Overall Study|Adverse Event|0
7171544|NCT00561795|11369641|FG003|Overall Study|Adverse Event|0
7171545|NCT00561795|11369638|FG000|Overall Study|Study Closed/Terminated|0
7171546|NCT00561795|11369639|FG001|Overall Study|Study Closed/Terminated|3
7171547|NCT00561795|11369640|FG002|Overall Study|Study Closed/Terminated|0
7171548|NCT00561795|11369641|FG003|Overall Study|Study Closed/Terminated|0
7171549|NCT00561795|11369638|FG000|Overall Study|Physician Decision|1
7171550|NCT00561795|11369639|FG001|Overall Study|Physician Decision|0
7171551|NCT00561795|11369640|FG002|Overall Study|Physician Decision|0
7171552|NCT00561795|11369641|FG003|Overall Study|Physician Decision|0
7185291|NCT02055547|11385699|FG007|Overall Study|Physician Decision|0
7185292|NCT02055547|11385700|FG008|Overall Study|Physician Decision|0
7185293|NCT02055547|11385701|FG009|Overall Study|Physician Decision|1
7185294|NCT02055547|11385702|FG010|Overall Study|Physician Decision|1
7185295|NCT02055547|11385703|FG011|Overall Study|Physician Decision|0
7185296|NCT02055547|11385704|FG012|Overall Study|Physician Decision|0
7185297|NCT02055547|11385705|FG013|Overall Study|Physician Decision|0
7185298|NCT02055547|11385706|FG014|Overall Study|Physician Decision|0
7185299|NCT02055547|11385707|FG015|Overall Study|Physician Decision|0
7185300|NCT02055547|11385708|FG016|Overall Study|Physician Decision|0
7185301|NCT02055547|11385709|FG017|Overall Study|Physician Decision|0
7185302|NCT02055547|11385710|FG018|Overall Study|Physician Decision|0
7185303|NCT02055547|11385692|FG000|Overall Study|Adverse Event|0
7185304|NCT02055547|11385693|FG001|Overall Study|Adverse Event|0
7185305|NCT02055547|11385694|FG002|Overall Study|Adverse Event|0
7185306|NCT02055547|11385695|FG003|Overall Study|Adverse Event|0
7185307|NCT02055547|11385696|FG004|Overall Study|Adverse Event|0
7185308|NCT02055547|11385697|FG005|Overall Study|Adverse Event|0
7185309|NCT02055547|11385698|FG006|Overall Study|Adverse Event|1
7185310|NCT02055547|11385699|FG007|Overall Study|Adverse Event|0
7185311|NCT02055547|11385700|FG008|Overall Study|Adverse Event|1
7185312|NCT02055547|11385701|FG009|Overall Study|Adverse Event|0
7185313|NCT02055547|11385702|FG010|Overall Study|Adverse Event|0
7185314|NCT02055547|11385703|FG011|Overall Study|Adverse Event|0
7185315|NCT02055547|11385704|FG012|Overall Study|Adverse Event|0
7185316|NCT02055547|11385705|FG013|Overall Study|Adverse Event|0
7185317|NCT02055547|11385706|FG014|Overall Study|Adverse Event|0
7185318|NCT02055547|11385707|FG015|Overall Study|Adverse Event|0
7185319|NCT02055547|11385708|FG016|Overall Study|Adverse Event|0
7185320|NCT02055547|11385709|FG017|Overall Study|Adverse Event|0
7185321|NCT02055547|11385710|FG018|Overall Study|Adverse Event|0
7185322|NCT02055547|11385692|FG000|Overall Study|Withdrawal by Subject|0
7185323|NCT02055547|11385693|FG001|Overall Study|Withdrawal by Subject|0
7185324|NCT02055547|11385694|FG002|Overall Study|Withdrawal by Subject|0
7185325|NCT02055547|11385695|FG003|Overall Study|Withdrawal by Subject|0
7185326|NCT02055547|11385696|FG004|Overall Study|Withdrawal by Subject|0
7185327|NCT02055547|11385697|FG005|Overall Study|Withdrawal by Subject|1
7185328|NCT02055547|11385698|FG006|Overall Study|Withdrawal by Subject|0
7185329|NCT02055547|11385699|FG007|Overall Study|Withdrawal by Subject|0
7185330|NCT02055547|11385700|FG008|Overall Study|Withdrawal by Subject|1
7185331|NCT02055547|11385701|FG009|Overall Study|Withdrawal by Subject|0
7185332|NCT02055547|11385702|FG010|Overall Study|Withdrawal by Subject|0
7185333|NCT02055547|11385703|FG011|Overall Study|Withdrawal by Subject|0
7185334|NCT02055547|11385704|FG012|Overall Study|Withdrawal by Subject|0
7185335|NCT02055547|11385705|FG013|Overall Study|Withdrawal by Subject|1
7185336|NCT02055547|11385706|FG014|Overall Study|Withdrawal by Subject|0
6895293|NCT00624065|10913131|FG000|Overall Study|Lack of Efficacy|0
7185337|NCT02055547|11385707|FG015|Overall Study|Withdrawal by Subject|1
7185338|NCT02055547|11385708|FG016|Overall Study|Withdrawal by Subject|0
7185339|NCT02055547|11385709|FG017|Overall Study|Withdrawal by Subject|0
7185340|NCT02055547|11385710|FG018|Overall Study|Withdrawal by Subject|0
7185341|NCT02055547|11385692|FG000|Overall Study|Lost to Follow-up|0
7185342|NCT02055547|11385693|FG001|Overall Study|Lost to Follow-up|0
7185343|NCT02055547|11385694|FG002|Overall Study|Lost to Follow-up|1
7185344|NCT02055547|11385695|FG003|Overall Study|Lost to Follow-up|0
7171553|NCT00556075|11369677|FG000|Overall Study|Lost to Follow-up|3
7171554|NCT00556075|11369678|FG001|Overall Study|Lost to Follow-up|0
7171555|NCT00556075|11369679|FG002|Overall Study|Lost to Follow-up|3
7171556|NCT00556075|11369677|FG000|Overall Study|Withdrawal by Subject|3
7171557|NCT00556075|11369678|FG001|Overall Study|Withdrawal by Subject|3
7171558|NCT00556075|11369679|FG002|Overall Study|Withdrawal by Subject|0
7171559|NCT00556075|11369677|FG000|Overall Study|Protocol Violation|1
7171560|NCT00556075|11369678|FG001|Overall Study|Protocol Violation|1
7171561|NCT00556075|11369679|FG002|Overall Study|Protocol Violation|3
7171562|NCT00556075|11369677|FG000|Overall Study|Not eligible|1
7171563|NCT00556075|11369678|FG001|Overall Study|Not eligible|1
7171564|NCT00556075|11369679|FG002|Overall Study|Not eligible|2
7171565|NCT00556075|11369677|FG000|Overall Study|Adverse Event|1
7171566|NCT00556075|11369678|FG001|Overall Study|Adverse Event|2
7171567|NCT00556075|11369679|FG002|Overall Study|Adverse Event|0
7171568|NCT00556075|11369677|FG000|Overall Study|Personal issues|4
7171569|NCT00556075|11369678|FG001|Overall Study|Personal issues|1
7171570|NCT00556075|11369679|FG002|Overall Study|Personal issues|0
7171571|NCT00556075|11369677|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0
7171572|NCT00556075|11369678|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1
7171573|NCT00556075|11369679|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0
7171574|NCT00556166|11369691|FG000|Overall Study|Withdrawal by Subject|1
7171575|NCT00539838|11369715|FG000|Overall Study|Fail to return|2
7171576|NCT00539838|11369716|FG001|Overall Study|Fail to return|0
7171577|NCT00539838|11369717|FG002|Overall Study|Fail to return|0
7171578|NCT00539838|11369715|FG000|Overall Study|Withdrawal by Subject|0
7171579|NCT00539838|11369716|FG001|Overall Study|Withdrawal by Subject|4
7171580|NCT00539838|11369717|FG002|Overall Study|Withdrawal by Subject|0
7171581|NCT00539838|11369715|FG000|Overall Study|Death|0
7171582|NCT00539838|11369716|FG001|Overall Study|Death|2
7171583|NCT00539838|11369717|FG002|Overall Study|Death|0
7171584|NCT00539838|11369715|FG000|Overall Study|Did not cooperate|1
7171585|NCT00539838|11369716|FG001|Overall Study|Did not cooperate|0
7171586|NCT00539838|11369717|FG002|Overall Study|Did not cooperate|1
7171587|NCT00539838|11369715|FG000|Overall Study|Administrative|4
7171588|NCT00539838|11369716|FG001|Overall Study|Administrative|0
7171589|NCT00539838|11369717|FG002|Overall Study|Administrative|8
7171590|NCT00549328|11369727|FG000|Overall Study|Adverse Event|2
7171591|NCT00549328|11369727|FG000|Overall Study|Disease Progression|10
7171592|NCT00549328|11369727|FG000|Overall Study|Death|1
7171593|NCT00549328|11369727|FG000|Overall Study|Use of Prohibited Medication|1
7171594|NCT00548327|11369733|FG000|Overall Study|Adverse Event|0
7171595|NCT00548327|11369734|FG001|Overall Study|Adverse Event|1
7171596|NCT00547300|11369765|FG000|Overall Study|Study was Administratively Terminated|25
7171597|NCT00547300|11369766|FG001|Overall Study|Study was Administratively Terminated|24
7171598|NCT00547300|11369765|FG000|Overall Study|Did not Meet Entry Criteria|0
7171599|NCT00547300|11369766|FG001|Overall Study|Did not Meet Entry Criteria|2
7171600|NCT00535262|11369798|FG000|Overall Study|No funding|3
7171601|NCT00537199|11369815|FG000|Overall Study|Study Terminated|1
7171602|NCT00536978|11369825|FG000|Overall Study|Not eligible for Adback Infusion|22
7171603|NCT00524485|11369829|FG000|Overall Study|Withdrawal by Subject|5
7171604|NCT00524134|11369851|FG000|Overall Study|Withdrawal by Subject|1
7171605|NCT00524134|11369851|FG000|Overall Study|Physician Decision|1
7171606|NCT00527748|11369855|FG000|Overall Study|Other|3
7171607|NCT00517699|11369859|FG000|Overall Study|Withdrawal by Subject|1
7171608|NCT00517699|11369859|FG000|Overall Study|Lack of Efficacy|1
7171609|NCT00517699|11369859|FG000|Overall Study|Administrative error|1
7171610|NCT00517699|11369859|FG000|Overall Study|Study terminated by Sponsor|2
7171611|NCT00528775|11369863|FG000|Overall Study|Other not specified|1
7171612|NCT00527982|11369899|FG000|Overall Study|Physician Decision|1
7171613|NCT00527982|11369900|FG001|Overall Study|Physician Decision|0
7171614|NCT00524459|11369906|FG000|Overall Study|Withdrawal by Subject|1
7171615|NCT00524459|11369906|FG000|Overall Study|Other|1
7171616|NCT00517361|11369910|FG000|Overall Study|Death|6
7171617|NCT00517361|11369910|FG000|Overall Study|The study was terminated|5
7171618|NCT00522457|11369922|FG000|Overall Study|Due to disease progression|16
7171619|NCT00522457|11369922|FG000|Overall Study|Adverse Event|2
7171620|NCT00526331|11369926|FG000|Overall Study|Sponsor Termination|55
7171621|NCT00522301|11369947|FG000|Overall Study|Withdrawal by Subject|1
7171622|NCT00522301|11369947|FG000|Overall Study|Adverse Event|5
7171623|NCT00517192|11369953|FG000|Overall Study|Adverse Event|1
7171624|NCT00517192|11369954|FG001|Overall Study|Adverse Event|1
7171625|NCT00517192|11369953|FG000|Overall Study|Lost to Follow-up|1
7171626|NCT00517192|11369954|FG001|Overall Study|Lost to Follow-up|1
7171627|NCT00517192|11369953|FG000|Overall Study|Withdrawal by Subject|1
7171628|NCT00517192|11369954|FG001|Overall Study|Withdrawal by Subject|0
7171629|NCT00517192|11369953|FG000|Overall Study|Early termination of the trial|16
7171630|NCT00517192|11369954|FG001|Overall Study|Early termination of the trial|18
7171631|NCT00503581|11369967|FG000|Overall Study|Study closed|3
7171632|NCT00503581|11369968|FG001|Overall Study|Study closed|4
7171633|NCT00503581|11369969|FG002|Overall Study|Study closed|2
7171634|NCT00509600|11369977|FG000|Overall Study|Adverse Event|1
7171635|NCT00515112|11369983|FG000|Overall Study|Death|0
7171636|NCT00515112|11369984|FG001|Overall Study|Death|1
7171637|NCT00515112|11369983|FG000|Overall Study|The study was terminated|3
7171638|NCT00515112|11369984|FG001|Overall Study|The study was terminated|2
7171639|NCT00508872|11369990|FG000|Overall Study|Lost to Follow-up|1
7171640|NCT00508872|11369990|FG000|Overall Study|Physician Decision|1
7171641|NCT00514813|11369998|FG000|Overall Study|Study terminated|14
7171642|NCT00514813|11369999|FG001|Overall Study|Study terminated|74
7171643|NCT00514813|11370000|FG002|Overall Study|Study terminated|40
7171644|NCT00514813|11370001|FG003|Overall Study|Study terminated|2
7171645|NCT00514813|11369998|FG000|Overall Study|Adverse Event|0
7171646|NCT00514813|11369999|FG001|Overall Study|Adverse Event|2
7171647|NCT00514813|11370000|FG002|Overall Study|Adverse Event|2
7171648|NCT00514813|11370001|FG003|Overall Study|Adverse Event|0
7171649|NCT00514813|11369998|FG000|Overall Study|Protocol Violation|1
7171650|NCT00514813|11369999|FG001|Overall Study|Protocol Violation|0
7171651|NCT00514813|11370000|FG002|Overall Study|Protocol Violation|0
7171652|NCT00514813|11370001|FG003|Overall Study|Protocol Violation|0
7171653|NCT00514813|11369998|FG000|Overall Study|Withdrawal by Subject|0
7171654|NCT00514813|11369999|FG001|Overall Study|Withdrawal by Subject|1
7171655|NCT00514813|11370000|FG002|Overall Study|Withdrawal by Subject|0
7171656|NCT00514813|11370001|FG003|Overall Study|Withdrawal by Subject|0
7171657|NCT00514813|11369998|FG000|Overall Study|Lack of Efficacy|0
7171658|NCT00514813|11369999|FG001|Overall Study|Lack of Efficacy|1
7171659|NCT00514813|11370000|FG002|Overall Study|Lack of Efficacy|0
7171660|NCT00514813|11370001|FG003|Overall Study|Lack of Efficacy|0
7171661|NCT00514813|11369998|FG000|Overall Study|Kidney transplant|0
7171662|NCT00514813|11369999|FG001|Overall Study|Kidney transplant|6
7171663|NCT00514813|11370000|FG002|Overall Study|Kidney transplant|2
7171664|NCT00514813|11370001|FG003|Overall Study|Kidney transplant|0
7171665|NCT00514813|11369998|FG000|Overall Study|Death|0
7171666|NCT00514813|11369999|FG001|Overall Study|Death|2
7171667|NCT00514813|11370000|FG002|Overall Study|Death|3
7171668|NCT00514813|11370001|FG003|Overall Study|Death|2
7171669|NCT00501228|11370034|FG000|Overall Study|Withdrawal by Subject|1
7171670|NCT00496782|11370040|FG000|Overall Study|Protocol Violation|1
7171671|NCT00496782|11370041|FG001|Overall Study|Protocol Violation|2
7171672|NCT00487578|11370053|FG000|Overall Study|Adverse Event|1
7171673|NCT00487578|11370054|FG001|Overall Study|Adverse Event|2
7171674|NCT00487578|11370053|FG000|Overall Study|Lack of Efficacy|0
7171675|NCT00487578|11370054|FG001|Overall Study|Lack of Efficacy|1
7171676|NCT00487578|11370053|FG000|Overall Study|Lost to Follow-up|0
7171677|NCT00487578|11370054|FG001|Overall Study|Lost to Follow-up|1
7171678|NCT00503009|11370063|FG000|Overall Study|Protocol Violation|1
7171679|NCT00503009|11370064|FG001|Overall Study|Protocol Violation|0
7171680|NCT00503009|11370065|FG002|Overall Study|Protocol Violation|1
7171681|NCT00503009|11370063|FG000|Overall Study|Withdrawal by Subject|0
7171682|NCT00503009|11370064|FG001|Overall Study|Withdrawal by Subject|1
7171683|NCT00503009|11370065|FG002|Overall Study|Withdrawal by Subject|1
7171684|NCT00503009|11370063|FG000|Overall Study|Physician Decision|0
7171685|NCT00503009|11370064|FG001|Overall Study|Physician Decision|1
7171686|NCT00503009|11370065|FG002|Overall Study|Physician Decision|1
7171687|NCT00499590|11370080|FG000|Overall Study|Study Terminated|112
7171688|NCT00499590|11370081|FG001|Overall Study|Study Terminated|112
7171689|NCT00499590|11370082|FG002|Overall Study|Study Terminated|112
7171690|NCT00499590|11370080|FG000|Overall Study|Not treated|1
7171691|NCT00499590|11370081|FG001|Overall Study|Not treated|0
7171692|NCT00499590|11370082|FG002|Overall Study|Not treated|1
7171693|NCT00503841|11370117|FG000|Overall Study|All screen failures|44
7171694|NCT00493025|11370123|FG000|Overall Study|Physician Decision|19
7171695|NCT00491400|11370130|FG000|Overall Study|Withdrawal by Subject|5
7171696|NCT00491400|11370131|FG001|Overall Study|Withdrawal by Subject|4
7171697|NCT00490776|11370139|FG000|Overall Study|Withdrawal by Subject|1
7171698|NCT00490776|11370139|FG000|Overall Study|Administrative Problems|1
7171699|NCT00490776|11370139|FG000|Overall Study|Death|1
7171700|NCT00490776|11370139|FG000|Overall Study|New Cancer Therapy|1
7171701|NCT00490776|11370139|FG000|Overall Study|Disease Progression|5
7171702|NCT00487162|11370145|FG000|Overall Study|Adverse Event|0
7171703|NCT00487162|11370146|FG001|Overall Study|Adverse Event|1
7171704|NCT00487162|11370145|FG000|Overall Study|Physician Decision|0
7171705|NCT00487162|11370146|FG001|Overall Study|Physician Decision|1
7171706|NCT00487162|11370145|FG000|Overall Study|Withdrawal by Subject|2
7171707|NCT00487162|11370146|FG001|Overall Study|Withdrawal by Subject|3
7171708|NCT00487981|11370152|FG000|Overall Study|Hypothyroidism diagnosis|1
7171709|NCT00491387|11370156|FG000|Overall Study|study terminated|20
7171710|NCT00483119|11370167|FG000|Overall Study|Adverse Event|0
7171711|NCT00483119|11370168|FG001|Overall Study|Adverse Event|1
7171712|NCT00483119|11370167|FG000|Overall Study|Physician Decision|1
7171713|NCT00483119|11370168|FG001|Overall Study|Physician Decision|0
7171714|NCT00470067|11370209|FG000|Overall Study|Death|1
7171715|NCT00470067|11370209|FG000|Overall Study|Disease Progression|6
7171716|NCT00475657|11370236|FG000|Overall Study|Death|1
7171717|NCT00475657|11370236|FG000|Overall Study|Sponsor's Decision|3
7171718|NCT00472082|11370240|FG000|Overall Study|Study prematurely terminated|5
7171719|NCT00467753|11370254|FG000|Overall Study|Lost to Follow-up|1
7171720|NCT00467753|11370255|FG001|Overall Study|Lost to Follow-up|2
7171721|NCT00467753|11370254|FG000|Overall Study|Adverse Event|2
7171722|NCT00467753|11370255|FG001|Overall Study|Adverse Event|0
7171723|NCT00456612|11370265|FG000|Overall Study|Withdrawal by Subject|3
7171724|NCT00469612|11370272|FG000|Overall Study|Study terminated before data collected|2
7171725|NCT00469612|11370273|FG001|Overall Study|Study terminated before data collected|0
7171726|NCT00461812|11370279|FG000|Overall Study|study terminated|10
7171727|NCT00461682|11370289|FG000|Overall Study|Protocol Violation|1
7171728|NCT00462904|11370295|FG000|Overall Study|Lost to Follow-up|1
7171729|NCT00450333|11370303|FG000|Overall Study|Study terminated|47
7171730|NCT00450333|11370304|FG001|Overall Study|Study terminated|54
7171731|NCT00450333|11370305|FG002|Overall Study|Study terminated|16
7171732|NCT00450333|11370306|FG003|Overall Study|Study terminated|21
7171733|NCT00450333|11370303|FG000|Overall Study|Adverse Event|1
7171734|NCT00450333|11370304|FG001|Overall Study|Adverse Event|7
7171735|NCT00450333|11370305|FG002|Overall Study|Adverse Event|2
7171736|NCT00450333|11370306|FG003|Overall Study|Adverse Event|2
7171737|NCT00450333|11370303|FG000|Overall Study|Protocol Violation|1
7171738|NCT00450333|11370304|FG001|Overall Study|Protocol Violation|0
7171739|NCT00450333|11370305|FG002|Overall Study|Protocol Violation|1
7171740|NCT00450333|11370306|FG003|Overall Study|Protocol Violation|0
7171741|NCT00450333|11370303|FG000|Overall Study|Withdrawal by Subject|1
7171742|NCT00450333|11370304|FG001|Overall Study|Withdrawal by Subject|0
7171743|NCT00450333|11370305|FG002|Overall Study|Withdrawal by Subject|3
7171744|NCT00450333|11370306|FG003|Overall Study|Withdrawal by Subject|0
7171745|NCT00450333|11370303|FG000|Overall Study|Kidney transplant|1
7171746|NCT00450333|11370304|FG001|Overall Study|Kidney transplant|0
7171747|NCT00450333|11370305|FG002|Overall Study|Kidney transplant|1
7171748|NCT00450333|11370306|FG003|Overall Study|Kidney transplant|3
7171749|NCT00450333|11370303|FG000|Overall Study|Death|3
7171750|NCT00450333|11370304|FG001|Overall Study|Death|2
7171751|NCT00450333|11370305|FG002|Overall Study|Death|2
7171752|NCT00450333|11370306|FG003|Overall Study|Death|2
7171753|NCT00455143|11370316|FG000|Overall Study|Physician Decision|1
7171754|NCT00455143|11370316|FG000|Overall Study|Withdrawal by Subject|1
7171755|NCT00455143|11370316|FG000|Overall Study|Staff was not avail to follow patient|2
7171756|NCT00455143|11370316|FG000|Overall Study|No longer met Inclusion Criteria|1
7171757|NCT00455143|11370316|FG000|Overall Study|Surgical time, staff not available|1
7171758|NCT00454571|11370332|FG000|Overall Study|Adverse Event|2
7171759|NCT00454571|11370333|FG001|Overall Study|Adverse Event|0
7171760|NCT00454571|11370332|FG000|Overall Study|Physician Decision|0
7171761|NCT00454571|11370333|FG001|Overall Study|Physician Decision|1
7171762|NCT00454571|11370332|FG000|Overall Study|Protocol Violation|1
7171763|NCT00454571|11370333|FG001|Overall Study|Protocol Violation|0
7171764|NCT00454571|11370332|FG000|Overall Study|Withdrawal by Subject|10
7171765|NCT00454571|11370333|FG001|Overall Study|Withdrawal by Subject|5
7171766|NCT00452361|11370341|FG000|Overall Study|Adverse Event|8
7171767|NCT00452361|11370342|FG001|Overall Study|Adverse Event|0
7171768|NCT00452361|11370341|FG000|Overall Study|Withdrawal by Subject|0
7171769|NCT00452361|11370342|FG001|Overall Study|Withdrawal by Subject|1
7171770|NCT00452361|11370341|FG000|Overall Study|Premature termination|13
7171771|NCT00452361|11370342|FG001|Overall Study|Premature termination|9
7171772|NCT00443040|11370351|FG000|Overall Study|Withdrawal by Subject|1
7171773|NCT00443040|11370352|FG001|Overall Study|Withdrawal by Subject|0
7171774|NCT00443040|11370353|FG002|Overall Study|Withdrawal by Subject|0
7171775|NCT00443040|11370351|FG000|Overall Study|Converted to an open laparotomy|3
7171776|NCT00443040|11370352|FG001|Overall Study|Converted to an open laparotomy|0
7171777|NCT00443040|11370353|FG002|Overall Study|Converted to an open laparotomy|1
7171778|NCT00447421|11370361|FG000|Overall Study|Lack of Efficacy|1
7171779|NCT00447421|11370361|FG000|Overall Study|Adverse Event|3
7171780|NCT00447421|11370361|FG000|Overall Study|Sponsor Decision|2
7171781|NCT00441272|11370367|FG000|Overall Study|Study terminated prior to enrollment|25
7171782|NCT00441272|11370368|FG001|Overall Study|Study terminated prior to enrollment|25
7171783|NCT00440271|11370380|FG000|Overall Study|Protocol Violation|1
7171784|NCT00440271|11370381|FG001|Overall Study|Protocol Violation|1
7171785|NCT00440271|11370380|FG000|Overall Study|Adverse Event|0
7171786|NCT00440271|11370381|FG001|Overall Study|Adverse Event|1
6972849|NCT01175135|11024196|FG002|Overall Study|Lack of Efficacy|0
6972850|NCT01175135|11024197|FG003|Overall Study|Lack of Efficacy|5
6972851|NCT01175135|11024194|FG000|Overall Study|Lost to Follow-up|1
6972852|NCT01175135|11024195|FG001|Overall Study|Lost to Follow-up|2
6972853|NCT01175135|11024196|FG002|Overall Study|Lost to Follow-up|0
6972854|NCT01175135|11024197|FG003|Overall Study|Lost to Follow-up|0
6972855|NCT01175135|11024194|FG000|Overall Study|Protocol Violation|1
6972856|NCT01175135|11024195|FG001|Overall Study|Protocol Violation|1
6972857|NCT01175135|11024196|FG002|Overall Study|Protocol Violation|0
6972858|NCT01175135|11024197|FG003|Overall Study|Protocol Violation|0
6972859|NCT01175135|11024194|FG000|Overall Study|Withdrawal by Subject|4
6972860|NCT01175135|11024195|FG001|Overall Study|Withdrawal by Subject|8
6972861|NCT01175135|11024196|FG002|Overall Study|Withdrawal by Subject|5
6972862|NCT01175135|11024197|FG003|Overall Study|Withdrawal by Subject|5
7171787|NCT00440271|11370380|FG000|Overall Study|Lost to Follow-up|1
7171788|NCT00440271|11370381|FG001|Overall Study|Lost to Follow-up|0
7171789|NCT00440271|11370380|FG000|Overall Study|Withdrawal by Subject|0
7171790|NCT00440271|11370381|FG001|Overall Study|Withdrawal by Subject|2
7171791|NCT00440271|11370380|FG000|Overall Study|Lack of Efficacy|0
7171792|NCT00440271|11370381|FG001|Overall Study|Lack of Efficacy|1
7171793|NCT00440271|11370380|FG000|Overall Study|Due to closure of trial|8
7171794|NCT00440271|11370381|FG001|Overall Study|Due to closure of trial|10
7171795|NCT00440271|11370380|FG000|Overall Study|Other|2
6972863|NCT01175135|11024194|FG000|Overall Study|Other|3
6972864|NCT01175135|11024195|FG001|Overall Study|Other|1
6972865|NCT01175135|11024196|FG002|Overall Study|Other|3
6972866|NCT01175135|11024197|FG003|Overall Study|Other|0
6972867|NCT01175135|11024194|FG000|Overall Study|Randomized But Not Treated|0
6972868|NCT01175135|11024195|FG001|Overall Study|Randomized But Not Treated|0
7171796|NCT00440271|11370381|FG001|Overall Study|Other|0
7171797|NCT00429026|11370391|FG000|Overall Study|Inevaluable for response.|40
7185345|NCT02055547|11385696|FG004|Overall Study|Lost to Follow-up|0
7185346|NCT02055547|11385697|FG005|Overall Study|Lost to Follow-up|0
7185347|NCT02055547|11385698|FG006|Overall Study|Lost to Follow-up|0
7185348|NCT02055547|11385699|FG007|Overall Study|Lost to Follow-up|0
7185349|NCT02055547|11385700|FG008|Overall Study|Lost to Follow-up|0
7185350|NCT02055547|11385701|FG009|Overall Study|Lost to Follow-up|0
7185351|NCT02055547|11385702|FG010|Overall Study|Lost to Follow-up|0
7185352|NCT02055547|11385703|FG011|Overall Study|Lost to Follow-up|0
7185353|NCT02055547|11385704|FG012|Overall Study|Lost to Follow-up|0
7185354|NCT02055547|11385705|FG013|Overall Study|Lost to Follow-up|0
7185355|NCT02055547|11385706|FG014|Overall Study|Lost to Follow-up|0
7185356|NCT02055547|11385707|FG015|Overall Study|Lost to Follow-up|0
7185357|NCT02055547|11385708|FG016|Overall Study|Lost to Follow-up|0
7185358|NCT02055547|11385709|FG017|Overall Study|Lost to Follow-up|0
7185359|NCT02055547|11385710|FG018|Overall Study|Lost to Follow-up|0
7187830|NCT02832687|11388539|FG000|Overall Study|Adverse Event|0
7187831|NCT02832687|11388540|FG001|Overall Study|Adverse Event|2
7187832|NCT02499900|11388552|FG000|Core Study Period|Other|1
7187833|NCT02499900|11388553|FG001|Core Study Period|Other|4
7187834|NCT02499900|11388552|FG000|Core Study Period|Lost to Follow-up|1
7187835|NCT02499900|11388553|FG001|Core Study Period|Lost to Follow-up|2
7187836|NCT02499900|11388552|FG000|Core Study Period|Per sponsor request|0
7187837|NCT02499900|11388553|FG001|Core Study Period|Per sponsor request|1
7187838|NCT02499900|11388552|FG000|Core Study Period|Pregnancy|1
7187839|NCT02499900|11388553|FG001|Core Study Period|Pregnancy|0
7187840|NCT02499900|11388552|FG000|Core Study Period|Protocol Violation|3
7187841|NCT02499900|11388553|FG001|Core Study Period|Protocol Violation|0
7187842|NCT02499900|11388552|FG000|Core Study Period|Withdrawal by Subject|11
7187843|NCT02499900|11388553|FG001|Core Study Period|Withdrawal by Subject|10
7187844|NCT02499900|11388552|FG000|Core Study Period|Adverse Event|18
7187845|NCT02499900|11388553|FG001|Core Study Period|Adverse Event|14
7187846|NCT02499900|11388552|FG000|Core Study Period|Death|0
7187847|NCT02499900|11388553|FG001|Core Study Period|Death|1
7187848|NCT02499900|11388552|FG000|Completed Core, Continued Into Extension|Physician Decision|1
7187849|NCT02499900|11388553|FG001|Completed Core, Continued Into Extension|Physician Decision|0
7187850|NCT02499900|11388552|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0
7187851|NCT02499900|11388553|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2
7187852|NCT02499900|11388552|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1
7187853|NCT02499900|11388553|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0
7187854|NCT02499900|11388552|FG000|Completed Core, Continued Into Extension|Personal motivation|1
7187855|NCT02499900|11388553|FG001|Completed Core, Continued Into Extension|Personal motivation|0
7187856|NCT02499900|11388552|FG000|Extension Study Period|Adverse Event|2
7187857|NCT02499900|11388553|FG001|Extension Study Period|Adverse Event|4
7187858|NCT02499900|11388552|FG000|Extension Study Period|Withdrawal by Subject|5
7187859|NCT02499900|11388553|FG001|Extension Study Period|Withdrawal by Subject|2
7187860|NCT02499900|11388552|FG000|Extension Study Period|Physician Decision|2
7187861|NCT02499900|11388553|FG001|Extension Study Period|Physician Decision|5
7187862|NCT02499900|11388552|FG000|Extension Study Period|Pregnancy|1
7187863|NCT02499900|11388553|FG001|Extension Study Period|Pregnancy|2
7187864|NCT02499900|11388552|FG000|Extension Study Period|Lost to Follow-up|2
7187865|NCT02499900|11388553|FG001|Extension Study Period|Lost to Follow-up|5
7187866|NCT02499900|11388552|FG000|Extension Study Period|Other|0
7187867|NCT02499900|11388553|FG001|Extension Study Period|Other|2
7187868|NCT02269917|11388580|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25
7187869|NCT02269917|11388581|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7
7187870|NCT02269917|11388582|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0
7187871|NCT02269917|11388580|FG000|BL to EOE-Test and BL to Switch-Control|Other|19
7187872|NCT02269917|11388581|FG001|BL to EOE-Test and BL to Switch-Control|Other|4
7187873|NCT02269917|11388582|FG002|BL to EOE-Test and BL to Switch-Control|Other|0
7187874|NCT02269917|11388580|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32
7187875|NCT02269917|11388581|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10
7187876|NCT02269917|11388582|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0
7187877|NCT02269917|11388580|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24
7187878|NCT02269917|11388581|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4
7187879|NCT02269917|11388582|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0
7187880|NCT02269917|11388580|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4
7187881|NCT02269917|11388581|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0
7187882|NCT02269917|11388582|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0
6972869|NCT01175135|11024196|FG002|Overall Study|Randomized But Not Treated|1
6972870|NCT01175135|11024197|FG003|Overall Study|Randomized But Not Treated|0
6972871|NCT01175213|11024219|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4
7171798|NCT00439569|11370402|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1
7171799|NCT00439569|11370402|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3
7171800|NCT00439569|11370402|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1
7171801|NCT00422669|11370409|FG000|Overall Study|The study was terminated early.|98
7171802|NCT00422669|11370410|FG001|Overall Study|The study was terminated early.|100
7171803|NCT00422669|11370411|FG002|Overall Study|The study was terminated early.|7
7171804|NCT00434590|11370423|FG000|Overall Study|Administrative problems|5
7171805|NCT00434590|11370424|FG001|Overall Study|Administrative problems|5
7171806|NCT00424645|11370432|FG000|Overall Study|Death|1
7171807|NCT00424645|11370433|FG001|Overall Study|Death|0
7171808|NCT00430027|11370439|FG000|Overall Study|Study terminated|8
7171809|NCT00429858|11370443|FG000|Overall Study|Withdrawal by Subject|1
7171810|NCT00429858|11370443|FG000|Overall Study|Study Termination|1
7171811|NCT00425438|11370450|FG000|Overall Study|Termination by Sponsor|25
7171812|NCT00425438|11370451|FG001|Overall Study|Termination by Sponsor|27
7171813|NCT00422942|11370461|FG000|Overall Study|Study terminated by Sponsor|3
7171814|NCT00409344|11370467|FG000|Overall Study|no enrollment|0
7171815|NCT00409344|11370468|FG001|Overall Study|no enrollment|0
7171816|NCT00414453|11370474|FG000|Overall Study|Abnormal lab work|16
7171817|NCT00417248|11370484|FG000|Overall Study|Study Terminated|6
7171818|NCT00417248|11370484|FG000|Overall Study|Death|1
7171819|NCT00417248|11370484|FG000|Overall Study|Lack of Efficacy|1
7171820|NCT00418145|11370489|FG000|Overall Study|study terminated|6
7171821|NCT00409331|11370495|FG000|Overall Study|Physician Decision|1
7171822|NCT00391430|11370512|FG000|Overall Study|Withdrawal by Subject|3
7171823|NCT00391430|11370513|FG001|Overall Study|Withdrawal by Subject|0
7171824|NCT00391430|11370514|FG002|Overall Study|Withdrawal by Subject|12
7171825|NCT00384293|11370547|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120
7171826|NCT00384293|11370548|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
7171827|NCT00384293|11370549|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
7171828|NCT00384293|11370547|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1
7171829|NCT00384293|11370548|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
7171830|NCT00384293|11370549|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
7171831|NCT00384293|11370547|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24
7171832|NCT00384293|11370548|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
7171833|NCT00384293|11370549|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
7171834|NCT00384293|11370547|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340
7171835|NCT00384293|11370548|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
7171836|NCT00384293|11370549|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
7171837|NCT00384293|11370547|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16
7171838|NCT00384293|11370548|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
7171839|NCT00384293|11370549|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
7171840|NCT00384293|11370547|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2
7171841|NCT00384293|11370548|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
7171842|NCT00384293|11370549|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
7171843|NCT00384293|11370547|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1
7171844|NCT00384293|11370548|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
7171845|NCT00384293|11370549|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
7171846|NCT00384293|11370547|FG000|Post-randomization Period|Adverse Event|0
7171847|NCT00384293|11370548|FG001|Post-randomization Period|Adverse Event|23
7171848|NCT00384293|11370549|FG002|Post-randomization Period|Adverse Event|7
7171849|NCT00384293|11370547|FG000|Post-randomization Period|Lost to Follow-up|0
7171850|NCT00384293|11370548|FG001|Post-randomization Period|Lost to Follow-up|2
7171851|NCT00384293|11370549|FG002|Post-randomization Period|Lost to Follow-up|1
7171852|NCT00384293|11370547|FG000|Post-randomization Period|Protocol Violation|0
7171853|NCT00384293|11370548|FG001|Post-randomization Period|Protocol Violation|1
7171854|NCT00384293|11370549|FG002|Post-randomization Period|Protocol Violation|0
7171855|NCT00384293|11370547|FG000|Post-randomization Period|Withdrawal by Subject|0
7171856|NCT00384293|11370548|FG001|Post-randomization Period|Withdrawal by Subject|8
7171857|NCT00384293|11370549|FG002|Post-randomization Period|Withdrawal by Subject|6
7171858|NCT00384293|11370547|FG000|Post-randomization Period|Trial Termination|0
7171859|NCT00384293|11370548|FG001|Post-randomization Period|Trial Termination|180
7171860|NCT00384293|11370549|FG002|Post-randomization Period|Trial Termination|204
7171861|NCT00384293|11370547|FG000|Post-randomization Period|Patient Randomized in Error|0
7171862|NCT00384293|11370548|FG001|Post-randomization Period|Patient Randomized in Error|0
7171863|NCT00384293|11370549|FG002|Post-randomization Period|Patient Randomized in Error|1
7171864|NCT00377455|11370570|FG000|Overall Study|Withdrawal by Subject|1
7171865|NCT00371462|11370576|FG000|Overall Study|Withdrawal by Subject|1
7171866|NCT00371462|11370577|FG001|Overall Study|Withdrawal by Subject|0
7171867|NCT00371462|11370576|FG000|Overall Study|Other|7
7171868|NCT00371462|11370577|FG001|Overall Study|Other|8
7171869|NCT00369265|11370585|FG000|Overall Study|Study terminated|4
7171870|NCT00369265|11370586|FG001|Overall Study|Study terminated|7
6972872|NCT01175213|11024220|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0
7171871|NCT00364689|11370599|FG000|Overall Study|Lost to Follow-up|1
7171872|NCT00352118|11370605|FG000|Overall Study|Physician Decision|4
7171873|NCT00356421|11370628|FG000|Overall Study|Lack of Efficacy|3
7171874|NCT00356421|11370629|FG001|Overall Study|Lack of Efficacy|0
7171875|NCT00356421|11370628|FG000|Overall Study|Withdrawal by Subject|9
7171876|NCT00356421|11370629|FG001|Overall Study|Withdrawal by Subject|2
7171877|NCT00356421|11370628|FG000|Overall Study|Related to study drug|15
7171878|NCT00356421|11370629|FG001|Overall Study|Related to study drug|12
7171879|NCT00356421|11370628|FG000|Overall Study|Not related to study drug|5
7171880|NCT00356421|11370629|FG001|Overall Study|Not related to study drug|3
7171881|NCT00350623|11370638|FG000|Overall Study|Lost to Follow-up|8
7171882|NCT00350623|11370639|FG001|Overall Study|Lost to Follow-up|3
7171883|NCT00350623|11370640|FG002|Overall Study|Lost to Follow-up|4
7171884|NCT00350623|11370638|FG000|Overall Study|Withdrawal by Subject|0
7171885|NCT00350623|11370639|FG001|Overall Study|Withdrawal by Subject|1
7171886|NCT00350623|11370640|FG002|Overall Study|Withdrawal by Subject|1
7171887|NCT00350623|11370638|FG000|Overall Study|patient traveling outside the country|0
7171888|NCT00350623|11370639|FG001|Overall Study|patient traveling outside the country|0
7171889|NCT00350623|11370640|FG002|Overall Study|patient traveling outside the country|1
7171890|NCT00350844|11370668|FG000|Overall Study|Lost to Follow-up|1
7171891|NCT00348556|11370672|FG000|Overall Study|Adverse Event|1
7171892|NCT00319839|11370676|FG000|Overall Study|Adverse Event|5
7171893|NCT00319839|11370676|FG000|Overall Study|Withdrawal by Subject|1
7171894|NCT00344019|11370683|FG000|Overall Study|did not meet final inclusion criteria|0
7171895|NCT00344019|11370684|FG001|Overall Study|did not meet final inclusion criteria|0
7171896|NCT00344019|11370685|FG002|Overall Study|did not meet final inclusion criteria|74
7171897|NCT00338455|11370698|FG000|Overall Study|Death|2
7171898|NCT00338455|11370699|FG001|Overall Study|Death|1
7080593|NCT02123797|11190122|FG000|Baseline Intervention|Lost to Follow-up|0
7080594|NCT02123797|11190123|FG001|Baseline Intervention|Lost to Follow-up|5
7080595|NCT02123797|11190124|FG002|Baseline Intervention|Lost to Follow-up|0
7171899|NCT00338455|11370698|FG000|Overall Study|Physician Decision|1
7171900|NCT00338455|11370699|FG001|Overall Study|Physician Decision|0
7171901|NCT00329108|11370707|FG000|Overall Study|Adverse Event|2
7171902|NCT00329108|11370708|FG001|Overall Study|Adverse Event|2
7171903|NCT00329108|11370707|FG000|Overall Study|Lack of Efficacy|3
7171904|NCT00329108|11370708|FG001|Overall Study|Lack of Efficacy|3
7171905|NCT00329108|11370707|FG000|Overall Study|Withdrawal by Subject|0
7171906|NCT00329108|11370708|FG001|Overall Study|Withdrawal by Subject|2
7171907|NCT00329108|11370707|FG000|Overall Study|symptomatic deterioration|1
7171908|NCT00329108|11370708|FG001|Overall Study|symptomatic deterioration|1
7171909|NCT00329108|11370707|FG000|Overall Study|Subject no longer willing to participate|2
7171910|NCT00329108|11370708|FG001|Overall Study|Subject no longer willing to participate|2
7171911|NCT00329108|11370707|FG000|Overall Study|study terminated by sponsor|1
7171912|NCT00329108|11370708|FG001|Overall Study|study terminated by sponsor|0
7171913|NCT00329108|11370707|FG000|Overall Study|withdrew patient after SAE resolved|1
7171914|NCT00329108|11370708|FG001|Overall Study|withdrew patient after SAE resolved|0
7171915|NCT00329108|11370707|FG000|Overall Study|Protocol Violation|0
7171916|NCT00329108|11370708|FG001|Overall Study|Protocol Violation|2
7171917|NCT00333229|11370729|FG000|Overall Study|Lack of Efficacy|0
7171918|NCT00333229|11370730|FG001|Overall Study|Lack of Efficacy|1
7171919|NCT00314327|11370776|FG000|Overall Study|Withdrawal by Subject|1
7171920|NCT00308113|11370784|FG000|Overall Study|Protocol closure|0
7171921|NCT00308113|11370785|FG001|Overall Study|Protocol closure|0
7171922|NCT00308113|11370786|FG002|Overall Study|Protocol closure|0
7171923|NCT00308113|11370787|FG003|Overall Study|Protocol closure|1
7171924|NCT00298740|11370807|FG000|Overall Study|Lack of Efficacy|6
7171925|NCT00298740|11370807|FG000|Overall Study|Withdrawal by Subject|3
7171926|NCT00301080|11370811|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1
7171927|NCT00301080|11370812|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0
7171928|NCT00301080|11370813|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0
7171929|NCT00301080|11370814|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0
7171930|NCT00301080|11370815|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0
7171931|NCT00290407|11370833|FG000|Overall Study|Physician Decision|2
7171932|NCT00295490|11370841|FG000|Overall Study|Protocol Violation|0
7171933|NCT00295490|11370842|FG001|Overall Study|Protocol Violation|0
7171934|NCT00295490|11370843|FG002|Overall Study|Protocol Violation|3
7171935|NCT00295490|11370844|FG003|Overall Study|Protocol Violation|3
7171936|NCT00295490|11370841|FG000|Overall Study|Withdrawal by Subject|0
7171937|NCT00295490|11370842|FG001|Overall Study|Withdrawal by Subject|2
7171938|NCT00295490|11370843|FG002|Overall Study|Withdrawal by Subject|0
7171939|NCT00295490|11370844|FG003|Overall Study|Withdrawal by Subject|1
7171940|NCT00295490|11370841|FG000|Overall Study|Lost to Follow-up|0
7171941|NCT00295490|11370842|FG001|Overall Study|Lost to Follow-up|0
7171942|NCT00295490|11370843|FG002|Overall Study|Lost to Follow-up|1
7080596|NCT02123797|11190125|FG003|Baseline Intervention|Lost to Follow-up|0
7171943|NCT00295490|11370844|FG003|Overall Study|Lost to Follow-up|0
7171944|NCT00295490|11370841|FG000|Overall Study|Adverse Event|1
7080597|NCT02123797|11190126|FG004|Baseline Intervention|Lost to Follow-up|0
7171945|NCT00295490|11370842|FG001|Overall Study|Adverse Event|0
7171946|NCT00295490|11370843|FG002|Overall Study|Adverse Event|0
7080598|NCT02123797|11190122|FG000|Baseline Intervention|Other Disease|3
7171947|NCT00295490|11370844|FG003|Overall Study|Adverse Event|0
7171948|NCT00295490|11370841|FG000|Overall Study|Other|0
7171949|NCT00295490|11370842|FG001|Overall Study|Other|2
7171950|NCT00295490|11370843|FG002|Overall Study|Other|0
7171951|NCT00295490|11370844|FG003|Overall Study|Other|1
7171952|NCT00268463|11370856|FG000|Overall Study|study terminated due to low accrual|10
7171953|NCT00268463|11370857|FG001|Overall Study|study terminated due to low accrual|12
7171954|NCT00276419|11370874|FG000|First Intervention|Adverse Event|1
7171955|NCT00276419|11370875|FG001|First Intervention|Adverse Event|0
7171956|NCT00276419|11370874|FG000|First Intervention|Withdrawal by Subject|0
7171957|NCT00276419|11370875|FG001|First Intervention|Withdrawal by Subject|2
7171958|NCT00271947|11370923|FG000|Overall Study|Lost to Follow-up|1
7171959|NCT00252174|11370943|FG000|Overall Study|Withdrawal by Subject|0
7171960|NCT00252174|11370944|FG001|Overall Study|Withdrawal by Subject|1
7171961|NCT00252174|11370945|FG002|Overall Study|Withdrawal by Subject|0
7171962|NCT00256295|11370953|FG000|Overall Study|Withdrawal by Subject|3
7171963|NCT00256295|11370953|FG000|Overall Study|Death|1
7171964|NCT00239720|11370967|FG000|Overall Study|Adverse Event|1
7171965|NCT00239720|11370968|FG001|Overall Study|Adverse Event|0
7171966|NCT00239720|11370967|FG000|Overall Study|Lost to Follow-up|0
7171967|NCT00239720|11370968|FG001|Overall Study|Lost to Follow-up|1
7171968|NCT00250718|11370974|FG000|Overall Study|Death|1
7171969|NCT00250718|11370974|FG000|Overall Study|Adverse Event|1
7171970|NCT00250718|11370974|FG000|Overall Study|Withdrawal by Subject|1
7171971|NCT00206375|11371022|FG000|Overall Study|Lost to Follow-up|1
7171972|NCT00206375|11371023|FG001|Overall Study|Lost to Follow-up|0
7171973|NCT00206375|11371024|FG002|Overall Study|Lost to Follow-up|0
7171974|NCT00206375|11371022|FG000|Overall Study|Withdrawal by Subject|2
7171975|NCT00206375|11371023|FG001|Overall Study|Withdrawal by Subject|1
7171976|NCT00206375|11371024|FG002|Overall Study|Withdrawal by Subject|3
7171977|NCT00206375|11371022|FG000|Overall Study|Study terminated due to lack of funds|0
7171978|NCT00206375|11371023|FG001|Overall Study|Study terminated due to lack of funds|1
7171979|NCT00206375|11371024|FG002|Overall Study|Study terminated due to lack of funds|1
7171980|NCT00229931|11371034|FG000|Overall Study|Death|1
7171981|NCT00229931|11371035|FG001|Overall Study|Death|0
7171982|NCT00229931|11371034|FG000|Overall Study|Lost to Follow-up|3
7171983|NCT00229931|11371035|FG001|Overall Study|Lost to Follow-up|2
7171984|NCT00209131|11371043|FG000|Overall Study|Lack of personnel due to turnovers.|15
7171985|NCT00209131|11371044|FG001|Overall Study|Lack of personnel due to turnovers.|11
7171986|NCT00209027|11371074|FG000|Overall Study|study terminated|10
7171987|NCT00209027|11371075|FG001|Overall Study|study terminated|0
7171988|NCT00182637|11371081|FG000|Overall Study|Adverse Event|2
7171989|NCT00182637|11371081|FG000|Overall Study|Disease Progression|1
7171990|NCT00176488|11371086|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1
7171991|NCT00162773|11371123|FG000|Overall Study|P.I, Left institution. Study terminated|22
7171992|NCT00147238|11371153|FG000|Overall Study|Inevaluable|8
7171993|NCT00165503|11371157|FG000|Overall Study|Death|1
7171994|NCT00165503|11371157|FG000|Overall Study|Lost to Follow-up|12
7171995|NCT00165503|11371157|FG000|Overall Study|Unresectable|3
7171996|NCT00160563|11371164|FG000|Overall Study|Adverse Event|1
7171997|NCT00160563|11371165|FG001|Overall Study|Adverse Event|1
7171998|NCT00160563|11371166|FG002|Overall Study|Adverse Event|1
7171999|NCT00160563|11371164|FG000|Overall Study|Lost to Follow-up|1
7172000|NCT00160563|11371165|FG001|Overall Study|Lost to Follow-up|1
7172001|NCT00160563|11371166|FG002|Overall Study|Lost to Follow-up|2
7172002|NCT00160563|11371164|FG000|Overall Study|Protocol Violation|0
7172003|NCT00160563|11371165|FG001|Overall Study|Protocol Violation|0
7172004|NCT00160563|11371166|FG002|Overall Study|Protocol Violation|3
7172005|NCT00160563|11371164|FG000|Overall Study|Withdrawal by Subject|1
7172006|NCT00160563|11371165|FG001|Overall Study|Withdrawal by Subject|2
7172007|NCT00160563|11371166|FG002|Overall Study|Withdrawal by Subject|3
7172008|NCT00160563|11371164|FG000|Overall Study|Other (listed in the study report)|48
7172009|NCT00160563|11371165|FG001|Overall Study|Other (listed in the study report)|40
7172010|NCT00160563|11371166|FG002|Overall Study|Other (listed in the study report)|81
7172011|NCT00160563|11371164|FG000|Overall Study|Missing reason|0
7172012|NCT00160563|11371165|FG001|Overall Study|Missing reason|1
7172013|NCT00160563|11371166|FG002|Overall Study|Missing reason|0
7172014|NCT00142519|11371177|FG000|Overall Study|Not Treated|7
7172015|NCT00142519|11371178|FG001|Overall Study|Not Treated|9
7172016|NCT00142519|11371177|FG000|Overall Study|Protocol Violation|1
7172017|NCT00142519|11371178|FG001|Overall Study|Protocol Violation|0
7172018|NCT00142519|11371177|FG000|Overall Study|Withdrawal by Subject|10
7172019|NCT00142519|11371178|FG001|Overall Study|Withdrawal by Subject|7
7172020|NCT00138073|11371193|FG000|Overall Study|lack of resources|55
7185360|NCT02064387|11385756|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0
7185361|NCT02064387|11385757|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0
7185362|NCT02064387|11385758|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0
7185363|NCT02064387|11385759|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0
7185364|NCT02064387|11385760|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0
7185365|NCT02064387|11385761|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0
7185366|NCT02064387|11385762|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0
7185367|NCT02064387|11385763|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1
7185368|NCT02064387|11385764|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0
7185369|NCT02064387|11385765|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1
7172021|NCT00113386|11371199|FG000|Overall Study|Withdrawal by Subject|1
7172022|NCT00113386|11371200|FG001|Overall Study|Withdrawal by Subject|0
7172023|NCT00113386|11371199|FG000|Overall Study|Physician Decision|0
7172024|NCT00113386|11371200|FG001|Overall Study|Physician Decision|1
7172025|NCT00113386|11371199|FG000|Overall Study|Toxicity|3
7172026|NCT00113386|11371200|FG001|Overall Study|Toxicity|0
7172027|NCT00113386|11371199|FG000|Overall Study|Ineligible|1
7172028|NCT00113386|11371200|FG001|Overall Study|Ineligible|2
7172029|NCT00113386|11371199|FG000|Overall Study|Unknown - Lost to Follow-Up|2
7172030|NCT00113386|11371200|FG001|Overall Study|Unknown - Lost to Follow-Up|1
7172031|NCT00138151|11371206|FG000|Overall Study|Withdrawal by Subject|3
7172032|NCT00138151|11371206|FG000|Overall Study|Physician Decision|1
7172033|NCT00129974|11371210|FG000|Overall Study|Other|1
7172034|NCT00126659|11371217|FG000|Overall Study|Adverse Event|0
7172035|NCT00126659|11371218|FG001|Overall Study|Adverse Event|0
7172036|NCT00126659|11371219|FG002|Overall Study|Adverse Event|2
7172037|NCT00125268|11371236|FG000|Overall Study|Withdrawal by Subject|1
7172038|NCT00125268|11371237|FG001|Overall Study|Withdrawal by Subject|1
7172039|NCT00113399|11371245|FG000|Overall Study|Death|1
7172040|NCT00113399|11371246|FG001|Overall Study|Death|1
7172041|NCT00113399|11371245|FG000|Overall Study|Withdrawal by Subject|1
7172042|NCT00113399|11371246|FG001|Overall Study|Withdrawal by Subject|2
7172043|NCT00113399|11371245|FG000|Overall Study|Complete Response|0
7172044|NCT00113399|11371246|FG001|Overall Study|Complete Response|1
7172045|NCT00113399|11371245|FG000|Overall Study|Other|0
7172046|NCT00113399|11371246|FG001|Overall Study|Other|1
7172047|NCT00107614|11371256|FG000|Overall Study|Physician Decision|10
7172048|NCT00107614|11371256|FG000|Overall Study|Death|2
7172049|NCT00107315|11371260|FG000|Overall Study|Disease Progression|9
7172050|NCT00107315|11371260|FG000|Overall Study|Adverse Event|4
7172051|NCT00107315|11371260|FG000|Overall Study|Withdrawal by Subject|2
7172052|NCT00108433|11371266|FG000|Overall Study|Lack of Efficacy|1
7172053|NCT00108433|11371267|FG001|Overall Study|Lack of Efficacy|2
7172054|NCT00108433|11371266|FG000|Overall Study|Death|3
7172055|NCT00108433|11371267|FG001|Overall Study|Death|0
7172056|NCT00108433|11371266|FG000|Overall Study|Adverse Event|3
7172057|NCT00108433|11371267|FG001|Overall Study|Adverse Event|1
7172058|NCT00108433|11371266|FG000|Overall Study|Other|14
7172059|NCT00108433|11371267|FG001|Overall Study|Other|14
7172060|NCT00113919|11371273|FG000|Overall Study|Physician Decision|8
7172061|NCT00113919|11371273|FG000|Overall Study|Death|6
7172062|NCT00100828|11371286|FG000|Overall Study|Physician Decision|6
7172063|NCT00104728|11371290|FG000|Overall Study|screen failures|19
7172064|NCT00083915|11371309|FG000|Overall Study|Death|6
7172065|NCT00083915|11371310|FG001|Overall Study|Death|3
7172066|NCT00083915|11371309|FG000|Overall Study|Physician Decision|11
7172067|NCT00083915|11371310|FG001|Overall Study|Physician Decision|6
7172068|NCT00083915|11371309|FG000|Overall Study|Withdrawal by Subject|8
7172069|NCT00083915|11371310|FG001|Overall Study|Withdrawal by Subject|3
7172070|NCT00083915|11371309|FG000|Overall Study|disease progression|18
7172071|NCT00083915|11371310|FG001|Overall Study|disease progression|23
7172072|NCT00083915|11371309|FG000|Overall Study|Failure to collect|3
7172073|NCT00083915|11371310|FG001|Overall Study|Failure to collect|0
7172074|NCT00083915|11371309|FG000|Overall Study|No response|3
7172075|NCT00083915|11371310|FG001|Overall Study|No response|1
7172076|NCT00083915|11371309|FG000|Overall Study|Insurance issues|1
7172077|NCT00083915|11371310|FG001|Overall Study|Insurance issues|1
7172078|NCT00088829|11371329|FG000|Overall Study|PI left institution and study was close|22
7172079|NCT00085631|11371352|FG000|Overall Study|Missing Data|4
7172080|NCT00085631|11371353|FG001|Overall Study|Missing Data|11
7172081|NCT00085631|11371354|FG002|Overall Study|Missing Data|7
7172082|NCT00062751|11371366|FG000|Overall Study|Disease progression|24
7172083|NCT00062751|11371367|FG001|Overall Study|Disease progression|17
7172084|NCT00062751|11371368|FG002|Overall Study|Disease progression|24
7172085|NCT00062751|11371369|FG003|Overall Study|Disease progression|2
7172086|NCT00062751|11371370|FG004|Overall Study|Disease progression|2
7172087|NCT00062751|11371366|FG000|Overall Study|Adverse Event|4
7172088|NCT00062751|11371367|FG001|Overall Study|Adverse Event|7
7172089|NCT00062751|11371368|FG002|Overall Study|Adverse Event|2
7172090|NCT00062751|11371369|FG003|Overall Study|Adverse Event|2
7172091|NCT00062751|11371370|FG004|Overall Study|Adverse Event|2
7172092|NCT00062751|11371366|FG000|Overall Study|Other|2
7172093|NCT00062751|11371367|FG001|Overall Study|Other|3
7172094|NCT00062751|11371368|FG002|Overall Study|Other|1
7172095|NCT00062751|11371369|FG003|Overall Study|Other|0
7172096|NCT00062751|11371370|FG004|Overall Study|Other|1
7172097|NCT00062751|11371366|FG000|Overall Study|Withdrawal by Subject|1
7172098|NCT00062751|11371367|FG001|Overall Study|Withdrawal by Subject|2
7172099|NCT00062751|11371368|FG002|Overall Study|Withdrawal by Subject|2
7172100|NCT00062751|11371369|FG003|Overall Study|Withdrawal by Subject|1
7172101|NCT00062751|11371370|FG004|Overall Study|Withdrawal by Subject|0
7172102|NCT00062751|11371366|FG000|Overall Study|Symptomatic deterioration|1
7172103|NCT00062751|11371367|FG001|Overall Study|Symptomatic deterioration|1
7172104|NCT00062751|11371368|FG002|Overall Study|Symptomatic deterioration|0
7172105|NCT00062751|11371369|FG003|Overall Study|Symptomatic deterioration|0
7172106|NCT00062751|11371370|FG004|Overall Study|Symptomatic deterioration|1
7172107|NCT00062751|11371366|FG000|Overall Study|Death|1
7172108|NCT00062751|11371367|FG001|Overall Study|Death|0
7172109|NCT00062751|11371368|FG002|Overall Study|Death|1
7172110|NCT00062751|11371369|FG003|Overall Study|Death|0
7172111|NCT00062751|11371370|FG004|Overall Study|Death|0
7172112|NCT00066807|11371385|FG000|Overall Study|Study was terminated early|14
7172113|NCT00066807|11371386|FG001|Overall Study|Study was terminated early|15
7172114|NCT00038142|11371407|FG000|Overall Study|Ineligible|1
7172115|NCT00038142|11371408|FG001|Overall Study|Ineligible|0
7172116|NCT00038142|11371407|FG000|Overall Study|Progressive Disease|11
7172117|NCT00038142|11371408|FG001|Overall Study|Progressive Disease|7
7172118|NCT00038142|11371407|FG000|Overall Study|Death|1
7172119|NCT00038142|11371408|FG001|Overall Study|Death|0
7172120|NCT00038142|11371407|FG000|Overall Study|Adverse Event|1
7172121|NCT00038142|11371408|FG001|Overall Study|Adverse Event|0
7172122|NCT00038142|11371407|FG000|Overall Study|Unknown Reason|8
7172123|NCT00038142|11371408|FG001|Overall Study|Unknown Reason|0
7172124|NCT00006478|11371423|FG000|Overall Study|Vaccine could not be produced|1
7172125|NCT00006478|11371423|FG000|Overall Study|Physician Decision|6
7172126|NCT00006916|11371436|FG000|Overall Study|Device not inserted|4
7172127|NCT00006916|11371436|FG000|Overall Study|Complication of device insertion|1
7172128|NCT02009384|11371510|FG000|Overall Study|Death|2
7172129|NCT04558125|11371514|FG000|Overall Study|Death|1
7172130|NCT02401308|11371520|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0
7172131|NCT02401308|11371521|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1
7172132|NCT04381988|11371529|FG000|Overall Study|The study was terminated|4
7172133|NCT04381988|11371530|FG001|Overall Study|The study was terminated|0
7172134|NCT00479167|11371558|FG000|Overall Study|Withdrawal by Subject|1
7172135|NCT03998189|11371565|FG000|Overall Study|Lack of Efficacy|0
7172136|NCT03998189|11371566|FG001|Overall Study|Lack of Efficacy|1
7172137|NCT02934503|11371680|FG000|Overall Study|progression of disease|3
7172138|NCT02934503|11371680|FG000|Overall Study|Withdrawal by Subject|1
7172139|NCT02137252|11371686|FG000|Overall Study|trial terminated early|2
7172140|NCT02137252|11371687|FG001|Overall Study|trial terminated early|1
7172141|NCT01294670|11371702|FG000|Overall Study|Not treated|1
7172142|NCT01294670|11371703|FG001|Overall Study|Not treated|0
7172143|NCT01294670|11371704|FG002|Overall Study|Not treated|0
7172144|NCT01294670|11371705|FG003|Overall Study|Not treated|0
7172145|NCT01294670|11371706|FG004|Overall Study|Not treated|0
7172146|NCT03095287|11371718|FG000|Overall Study|Treatment Failure|1
7172147|NCT03095287|11371718|FG000|Overall Study|Adverse Event|1
7172148|NCT02930122|11371728|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3
7172149|NCT02930122|11371729|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3
7172150|NCT04144166|11371749|FG000|Overall Study|Discharged before study start|1
7172151|NCT04144166|11371749|FG000|Overall Study|Pregnancy|1
7172152|NCT04144166|11371749|FG000|Overall Study|Nail polish could not be removed from finger|1
7172153|NCT04090164|11371760|FG000|Overall Study|incomplete data on file|245
7080599|NCT02123797|11190123|FG001|Baseline Intervention|Other Disease|0
7080600|NCT02123797|11190124|FG002|Baseline Intervention|Other Disease|0
7080601|NCT02123797|11190125|FG003|Baseline Intervention|Other Disease|0
7080602|NCT02123797|11190126|FG004|Baseline Intervention|Other Disease|0
7080603|NCT02123797|11190122|FG000|3-month Follow up (Cumulative Counts)|Death|33
7080604|NCT02123797|11190123|FG001|3-month Follow up (Cumulative Counts)|Death|57
7080605|NCT02123797|11190124|FG002|3-month Follow up (Cumulative Counts)|Death|0
7080606|NCT02123797|11190125|FG003|3-month Follow up (Cumulative Counts)|Death|0
7080607|NCT02123797|11190126|FG004|3-month Follow up (Cumulative Counts)|Death|0
7080608|NCT02123797|11190122|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2
7080609|NCT02123797|11190123|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7
7080610|NCT02123797|11190124|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50
7080611|NCT02123797|11190125|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82
7080612|NCT02123797|11190126|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3
7080613|NCT02123797|11190122|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6
7080614|NCT02123797|11190123|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16
7080615|NCT02123797|11190124|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
7080616|NCT02123797|11190125|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
7080617|NCT02123797|11190126|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
7080618|NCT02123797|11190122|FG000|3-month Follow up (Cumulative Counts)|Relocation|0
7080619|NCT02123797|11190123|FG001|3-month Follow up (Cumulative Counts)|Relocation|1
7080620|NCT02123797|11190124|FG002|3-month Follow up (Cumulative Counts)|Relocation|0
7080621|NCT02123797|11190125|FG003|3-month Follow up (Cumulative Counts)|Relocation|0
7080622|NCT02123797|11190126|FG004|3-month Follow up (Cumulative Counts)|Relocation|0
7080623|NCT02123797|11190122|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16
7172154|NCT04090164|11371761|FG001|Overall Study|incomplete data on file|0
7172155|NCT03997825|11371850|FG000|Overall Study|Death|3
7172156|NCT03997825|11371850|FG000|Overall Study|Lost to Follow-up|10
7172157|NCT03997825|11371850|FG000|Overall Study|Withdrawal by Subject|3
7172158|NCT03997825|11371850|FG000|Overall Study|Refused participation|1
7172159|NCT03764813|11371887|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0
7172160|NCT03764813|11371888|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1
7172161|NCT03764813|11371889|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1
7172162|NCT03764813|11371890|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0
7185370|NCT02064387|11385766|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0
7185371|NCT02064387|11385767|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0
7185372|NCT02064387|11385756|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7185373|NCT02064387|11385757|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7185374|NCT02064387|11385758|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7185375|NCT02064387|11385759|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7185376|NCT02064387|11385760|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7185377|NCT02064387|11385761|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7185378|NCT02064387|11385762|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7185379|NCT02064387|11385763|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1
7185380|NCT02064387|11385764|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7185381|NCT02064387|11385765|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7185382|NCT02064387|11385766|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7185383|NCT02064387|11385767|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7185384|NCT02064387|11385756|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7185385|NCT02064387|11385757|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7185386|NCT02064387|11385758|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7185387|NCT02064387|11385759|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7185388|NCT02064387|11385760|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7185389|NCT02064387|11385761|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7185390|NCT02064387|11385762|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7185391|NCT02064387|11385763|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7185392|NCT02064387|11385764|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1
7185393|NCT02064387|11385765|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7185394|NCT02064387|11385766|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7185395|NCT02064387|11385767|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7185396|NCT02064387|11385756|FG000|Part 2 Max 35 Months Followup Duration|Death|0
7185397|NCT02064387|11385757|FG001|Part 2 Max 35 Months Followup Duration|Death|0
7185398|NCT02064387|11385758|FG002|Part 2 Max 35 Months Followup Duration|Death|0
7185399|NCT02064387|11385759|FG003|Part 2 Max 35 Months Followup Duration|Death|0
7185400|NCT02064387|11385760|FG004|Part 2 Max 35 Months Followup Duration|Death|0
7185401|NCT02064387|11385761|FG005|Part 2 Max 35 Months Followup Duration|Death|0
7185402|NCT02064387|11385762|FG006|Part 2 Max 35 Months Followup Duration|Death|0
7185403|NCT02064387|11385763|FG007|Part 2 Max 35 Months Followup Duration|Death|0
7185404|NCT02064387|11385764|FG008|Part 2 Max 35 Months Followup Duration|Death|0
7185405|NCT02064387|11385765|FG009|Part 2 Max 35 Months Followup Duration|Death|0
7185406|NCT02064387|11385766|FG010|Part 2 Max 35 Months Followup Duration|Death|5
7185407|NCT02064387|11385767|FG011|Part 2 Max 35 Months Followup Duration|Death|3
7185408|NCT02064387|11385756|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7185409|NCT02064387|11385757|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7185410|NCT02064387|11385758|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7185411|NCT02064387|11385759|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7185412|NCT02064387|11385760|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7185413|NCT02064387|11385761|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7185414|NCT02064387|11385762|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7185415|NCT02064387|11385763|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7185416|NCT02064387|11385764|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7185417|NCT02064387|11385765|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7185418|NCT02064387|11385766|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1
7185419|NCT02064387|11385767|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7187883|NCT02269917|11388580|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4
7187884|NCT02269917|11388581|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0
7187885|NCT02269917|11388582|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0
7187886|NCT02269917|11388580|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2
7187887|NCT02269917|11388581|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1
7187888|NCT02269917|11388582|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0
7187889|NCT02269917|11388580|FG000|BL to EOE-Test and BL to Switch-Control|Death|4
7187890|NCT02269917|11388581|FG001|BL to EOE-Test and BL to Switch-Control|Death|0
7187891|NCT02269917|11388582|FG002|BL to EOE-Test and BL to Switch-Control|Death|0
7187892|NCT02269917|11388580|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3
7187893|NCT02269917|11388581|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5
7187894|NCT02269917|11388582|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0
7187895|NCT02269917|11388580|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0
7187896|NCT02269917|11388581|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0
7187897|NCT02269917|11388582|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1
7172163|NCT04584788|11371910|FG000|Overall Study|Physician Decision|8
7172164|NCT04584788|11371910|FG000|Overall Study|Withdrawal by Subject|1
7172165|NCT04584788|11371910|FG000|Overall Study|Adverse Event|3
7172166|NCT03783923|11371925|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3
7172167|NCT03783923|11371926|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2
7172168|NCT03783923|11371925|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1
7172169|NCT03783923|11371926|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0
7172170|NCT03783923|11371925|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0
7172171|NCT03783923|11371926|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2
7172172|NCT03783923|11371925|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1
7172173|NCT03783923|11371926|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1
7172174|NCT03783923|11371925|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0
7172175|NCT03783923|11371926|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1
7172176|NCT03718429|11371934|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0
7172177|NCT03718429|11371935|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1
7172178|NCT03718429|11371936|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1
7172179|NCT03718429|11371937|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0
7172180|NCT03315130|11371960|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0
7172181|NCT03315130|11371961|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1
7172182|NCT03315130|11371962|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0
7172183|NCT03315130|11371963|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0
7172184|NCT03315130|11371960|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0
7172185|NCT03315130|11371961|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1
7172186|NCT03315130|11371962|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0
7172187|NCT03315130|11371963|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0
7172188|NCT03315130|11371960|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1
7172189|NCT03315130|11371961|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0
7172190|NCT03315130|11371962|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0
7172191|NCT03315130|11371963|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0
7172192|NCT03315130|11371960|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0
7172193|NCT03315130|11371961|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1
7172194|NCT03315130|11371962|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0
7172195|NCT03315130|11371963|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0
7172196|NCT03315130|11371960|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0
7172197|NCT03315130|11371961|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1
7172198|NCT03315130|11371962|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0
7172199|NCT03315130|11371963|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0
7172200|NCT03315130|11371960|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0
7172201|NCT03315130|11371961|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2
7172202|NCT03315130|11371962|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0
7172203|NCT03315130|11371963|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1
7172204|NCT03022461|11372001|FG000|Overall Study|Death|3
7172205|NCT02927262|11372008|FG000|Overall Study|Adverse Event|7
7172206|NCT02927262|11372009|FG001|Overall Study|Adverse Event|1
7172207|NCT02927262|11372008|FG000|Overall Study|Death|1
7172208|NCT02927262|11372009|FG001|Overall Study|Death|0
7172209|NCT02927262|11372008|FG000|Overall Study|Withdrawal by Subject|3
7172210|NCT02927262|11372009|FG001|Overall Study|Withdrawal by Subject|0
7172211|NCT02927262|11372008|FG000|Overall Study|Disease Relapse|23
7172212|NCT02927262|11372009|FG001|Overall Study|Disease Relapse|18
7172213|NCT02927262|11372008|FG000|Overall Study|Miscellaneous|5
7172214|NCT02927262|11372009|FG001|Overall Study|Miscellaneous|4
7172215|NCT02927262|11372008|FG000|Overall Study|Ongoing|4
7172216|NCT02927262|11372009|FG001|Overall Study|Ongoing|0
7172217|NCT02689349|11372021|FG000|Overall Study|Not implanted|4
7172218|NCT02689349|11372022|FG001|Overall Study|Not implanted|0
7172219|NCT02689349|11372021|FG000|Overall Study|Withdrawal by Subject|9
7172220|NCT02689349|11372022|FG001|Overall Study|Withdrawal by Subject|0
7172221|NCT02680574|11372033|FG000|Overall Study|Death|137
7172222|NCT02680574|11372034|FG001|Overall Study|Death|137
7172223|NCT02680574|11372033|FG000|Overall Study|Withdrawal by Subject|17
7172224|NCT02680574|11372034|FG001|Overall Study|Withdrawal by Subject|9
7172225|NCT02680574|11372033|FG000|Overall Study|Lost to Follow-up|4
7172226|NCT02680574|11372034|FG001|Overall Study|Lost to Follow-up|6
7172227|NCT02648347|11372042|FG000|Overall Study|Death|174
7172228|NCT02648347|11372043|FG001|Overall Study|Death|167
7172229|NCT02648347|11372042|FG000|Overall Study|Withdrawal by Subject|16
7172230|NCT02648347|11372043|FG001|Overall Study|Withdrawal by Subject|9
7172231|NCT02648347|11372042|FG000|Overall Study|Lost to Follow-up|18
7172232|NCT02648347|11372043|FG001|Overall Study|Lost to Follow-up|21
7172233|NCT02648347|11372042|FG000|Overall Study|Missing|1
7172234|NCT02648347|11372043|FG001|Overall Study|Missing|0
7172235|NCT02224755|11372064|FG000|Randomization to Device Implant|Withdrawn prior to implant|7
7172236|NCT02224755|11372065|FG001|Randomization to Device Implant|Withdrawn prior to implant|1
7172237|NCT02224755|11372064|FG000|Two Year Follow up Post-implant|Death|103
7172238|NCT02224755|11372065|FG001|Two Year Follow up Post-implant|Death|98
7172239|NCT02224755|11372064|FG000|Two Year Follow up Post-implant|Heart transplant|137
7172240|NCT02224755|11372065|FG001|Two Year Follow up Post-implant|Heart transplant|119
7172241|NCT02224755|11372064|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3
7172242|NCT02224755|11372065|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3
7172243|NCT02224755|11372064|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15
7172244|NCT02224755|11372065|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6
7172245|NCT02090114|11372085|FG000|Overall Study|Withdrawal by Subject|3
7172246|NCT02090114|11372086|FG001|Overall Study|Withdrawal by Subject|6
7172247|NCT02090114|11372087|FG002|Overall Study|Withdrawal by Subject|2
7172248|NCT02090114|11372088|FG003|Overall Study|Withdrawal by Subject|1
7172249|NCT02090114|11372085|FG000|Overall Study|Physician Decision|5
7172250|NCT02090114|11372086|FG001|Overall Study|Physician Decision|0
7172251|NCT02090114|11372087|FG002|Overall Study|Physician Decision|1
7172252|NCT02090114|11372088|FG003|Overall Study|Physician Decision|1
7172253|NCT02090114|11372085|FG000|Overall Study|Adverse Event|1
7172254|NCT02090114|11372086|FG001|Overall Study|Adverse Event|2
7172255|NCT02090114|11372087|FG002|Overall Study|Adverse Event|2
7172256|NCT02090114|11372088|FG003|Overall Study|Adverse Event|0
7172257|NCT02090114|11372085|FG000|Overall Study|Progressive Disease|20
7172258|NCT02090114|11372086|FG001|Overall Study|Progressive Disease|21
7172259|NCT02090114|11372087|FG002|Overall Study|Progressive Disease|23
7172260|NCT02090114|11372088|FG003|Overall Study|Progressive Disease|6
7172261|NCT02090114|11372085|FG000|Overall Study|Death|1
7172262|NCT02090114|11372086|FG001|Overall Study|Death|0
7172263|NCT02090114|11372087|FG002|Overall Study|Death|1
7172264|NCT02090114|11372088|FG003|Overall Study|Death|0
7172265|NCT01915498|11372116|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7172266|NCT01915498|11372117|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7172267|NCT01915498|11372118|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7172268|NCT01915498|11372119|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
7172269|NCT01915498|11372120|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
7172270|NCT01915498|11372121|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7172271|NCT01915498|11372122|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7172272|NCT01915498|11372123|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7172273|NCT01915498|11372124|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7172274|NCT01915498|11372125|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
7172275|NCT01915498|11372126|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7172276|NCT01915498|11372127|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7172277|NCT01915498|11372128|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
7172278|NCT01915498|11372129|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5
7172279|NCT01915498|11372130|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
7172280|NCT01915498|11372131|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2
7172281|NCT01915498|11372132|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2
7172282|NCT01915498|11372133|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5
7172283|NCT01915498|11372134|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7172284|NCT01915498|11372116|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
7172285|NCT01915498|11372117|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
7172286|NCT01915498|11372118|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
7172287|NCT01915498|11372119|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
7172288|NCT01915498|11372120|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
7080624|NCT02123797|11190123|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36
7080625|NCT02123797|11190124|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0
7172289|NCT01915498|11372121|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
7172290|NCT01915498|11372122|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
7172291|NCT01915498|11372123|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4
7172292|NCT01915498|11372124|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
7172293|NCT01915498|11372125|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
7172294|NCT01915498|11372126|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
7172295|NCT01915498|11372127|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
7172296|NCT01915498|11372128|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
7172297|NCT01915498|11372129|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4
7172298|NCT01915498|11372130|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
7172299|NCT01915498|11372131|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4
7172300|NCT01915498|11372132|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
7172301|NCT01915498|11372133|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16
7172302|NCT01915498|11372134|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
7172303|NCT01915498|11372116|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1
7172304|NCT01915498|11372117|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
7172305|NCT01915498|11372118|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
7172306|NCT01915498|11372119|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4
7172307|NCT01915498|11372120|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2
7172308|NCT01915498|11372121|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5
7172309|NCT01915498|11372122|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5
7172310|NCT01915498|11372123|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15
7172311|NCT01915498|11372124|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4
7172312|NCT01915498|11372125|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7
7172313|NCT01915498|11372126|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
7172314|NCT01915498|11372127|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2
7172315|NCT01915498|11372128|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
7172316|NCT01915498|11372129|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24
7172317|NCT01915498|11372130|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14
7172318|NCT01915498|11372131|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9
7172319|NCT01915498|11372132|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8
7172320|NCT01915498|11372133|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41
7172321|NCT01915498|11372134|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0
7172322|NCT01915498|11372116|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7172323|NCT01915498|11372117|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7172324|NCT01915498|11372118|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7172325|NCT01915498|11372119|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7172326|NCT01915498|11372120|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7172327|NCT01915498|11372121|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7172328|NCT01915498|11372122|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7172329|NCT01915498|11372123|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7172330|NCT01915498|11372124|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7172331|NCT01915498|11372125|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7172332|NCT01915498|11372126|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1
7172333|NCT01915498|11372127|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7172334|NCT01915498|11372128|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7172335|NCT01915498|11372129|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7172336|NCT01915498|11372130|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7172337|NCT01915498|11372131|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7172338|NCT01915498|11372132|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7172339|NCT01915498|11372133|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7172340|NCT01915498|11372134|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7172341|NCT01915498|11372116|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2
7172342|NCT01915498|11372117|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1
7172343|NCT01915498|11372118|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1
7172344|NCT01915498|11372119|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1
7172345|NCT01915498|11372120|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1
7172346|NCT01915498|11372121|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2
7172347|NCT01915498|11372122|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0
7172348|NCT01915498|11372123|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1
7172349|NCT01915498|11372124|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0
7172350|NCT01915498|11372125|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0
7172351|NCT01915498|11372126|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2
7172352|NCT01915498|11372127|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0
7172353|NCT01915498|11372128|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0
7172354|NCT01915498|11372129|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4
7172355|NCT01915498|11372130|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1
7172356|NCT01915498|11372131|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4
7172357|NCT01915498|11372132|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3
7172358|NCT01915498|11372133|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16
7172359|NCT01915498|11372134|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0
7172360|NCT01915498|11372116|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7172361|NCT01915498|11372117|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7172362|NCT01915498|11372118|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7172363|NCT01915498|11372119|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7172364|NCT01915498|11372120|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1
7172365|NCT01915498|11372121|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7172366|NCT01915498|11372122|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7172367|NCT01915498|11372123|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7172368|NCT01915498|11372124|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7172369|NCT01915498|11372125|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1
7172370|NCT01915498|11372126|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7172371|NCT01915498|11372127|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7172372|NCT01915498|11372128|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7172373|NCT01915498|11372129|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7172374|NCT01915498|11372130|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7172375|NCT01915498|11372131|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7172376|NCT01915498|11372132|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7172377|NCT01915498|11372133|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7172378|NCT01915498|11372134|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7172379|NCT01915498|11372116|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
7185420|NCT02076178|11385808|FG000|Oral Phase|Adverse Event|0
7172380|NCT01915498|11372117|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
7172381|NCT01915498|11372118|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2
7172382|NCT01915498|11372119|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
7172383|NCT01915498|11372120|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
7172384|NCT01915498|11372121|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
7172385|NCT01915498|11372122|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
7172386|NCT01915498|11372123|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
7172387|NCT01915498|11372124|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
7172388|NCT01915498|11372125|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
7172389|NCT01915498|11372126|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
7172390|NCT01915498|11372127|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
7172391|NCT01915498|11372128|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
7172392|NCT01915498|11372129|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
7172393|NCT01915498|11372130|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
7172394|NCT01915498|11372131|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
7172395|NCT01915498|11372132|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4
7172396|NCT01915498|11372133|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8
7172397|NCT01915498|11372134|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
7172398|NCT01915498|11372116|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
7172399|NCT01915498|11372117|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2
7172400|NCT01915498|11372118|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
7172401|NCT01915498|11372119|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
7172402|NCT01915498|11372120|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
7172403|NCT01915498|11372121|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
7172404|NCT01915498|11372122|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
7172405|NCT01915498|11372123|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
7172406|NCT01915498|11372124|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
7172407|NCT01915498|11372125|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
7172408|NCT01915498|11372126|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
7172409|NCT01915498|11372127|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
7172410|NCT01915498|11372128|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
7172411|NCT01915498|11372129|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6
7172412|NCT01915498|11372130|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5
7172413|NCT01915498|11372131|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2
7172414|NCT01915498|11372132|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2
7172415|NCT01915498|11372133|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9
7172416|NCT01915498|11372134|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
7172417|NCT01915498|11372116|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7172418|NCT01915498|11372117|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7172419|NCT01915498|11372118|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7172420|NCT01915498|11372119|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7172421|NCT01915498|11372120|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7172422|NCT01915498|11372121|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7172423|NCT01915498|11372122|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7172424|NCT01915498|11372123|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7172425|NCT01915498|11372124|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7172426|NCT01915498|11372125|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7172427|NCT01915498|11372126|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
7172428|NCT01915498|11372127|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7172429|NCT01915498|11372128|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7172430|NCT01915498|11372129|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
7172431|NCT01915498|11372130|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7172432|NCT01915498|11372131|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7172433|NCT01915498|11372132|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
7172434|NCT01915498|11372133|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
7172435|NCT01915498|11372134|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7172436|NCT01915498|11372116|FG000|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1
7172437|NCT01915498|11372117|FG001|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7172438|NCT01915498|11372118|FG002|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7172439|NCT01915498|11372119|FG003|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7172440|NCT01915498|11372120|FG004|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7172441|NCT01915498|11372121|FG005|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1
7080626|NCT02123797|11190125|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0
7080627|NCT02123797|11190126|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0
7080628|NCT02123797|11190122|FG000|6-month Follow up (Cumulative Counts)|Death|51
7080629|NCT02123797|11190123|FG001|6-month Follow up (Cumulative Counts)|Death|97
7080630|NCT02123797|11190124|FG002|6-month Follow up (Cumulative Counts)|Death|0
7080631|NCT02123797|11190125|FG003|6-month Follow up (Cumulative Counts)|Death|0
7080632|NCT02123797|11190126|FG004|6-month Follow up (Cumulative Counts)|Death|0
7080633|NCT02123797|11190122|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3
7172442|NCT01915498|11372122|FG006|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7172443|NCT01915498|11372123|FG007|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7172444|NCT01915498|11372124|FG008|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7172445|NCT01915498|11372125|FG009|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7172446|NCT01915498|11372126|FG010|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7172447|NCT01915498|11372127|FG011|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7172448|NCT01915498|11372128|FG012|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7172449|NCT01915498|11372129|FG013|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7172450|NCT01915498|11372130|FG014|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1
7172451|NCT01915498|11372131|FG015|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7172452|NCT01915498|11372132|FG016|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7172453|NCT01915498|11372133|FG017|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|2
7172454|NCT01915498|11372134|FG018|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7172455|NCT01915498|11372116|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7172456|NCT01915498|11372117|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7172457|NCT01915498|11372118|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7172458|NCT01915498|11372119|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7172459|NCT01915498|11372120|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7172460|NCT01915498|11372121|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1
7172461|NCT01915498|11372122|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7172462|NCT01915498|11372123|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7172463|NCT01915498|11372124|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7172464|NCT01915498|11372125|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
7172465|NCT01915498|11372126|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7172466|NCT01915498|11372127|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7172467|NCT01915498|11372128|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7172468|NCT01915498|11372129|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1
7172469|NCT01915498|11372130|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
7172470|NCT01915498|11372131|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1
7172471|NCT01915498|11372132|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
7172472|NCT01915498|11372133|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
7172473|NCT01915498|11372134|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7172474|NCT01915498|11372116|FG000|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7172475|NCT01915498|11372117|FG001|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7172476|NCT01915498|11372118|FG002|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7172477|NCT01915498|11372119|FG003|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7041585|NCT01728376|11125199|FG004|Overall Study|Adverse Event|1
7041586|NCT01728376|11125200|FG005|Overall Study|Adverse Event|0
7041587|NCT01728376|11125195|FG000|Overall Study|Persistent Positive Blood Cultures|1
7041588|NCT01728376|11125196|FG001|Overall Study|Persistent Positive Blood Cultures|0
7041589|NCT01728376|11125197|FG002|Overall Study|Persistent Positive Blood Cultures|1
7041590|NCT01728376|11125198|FG003|Overall Study|Persistent Positive Blood Cultures|0
7041591|NCT01728376|11125199|FG004|Overall Study|Persistent Positive Blood Cultures|0
7041592|NCT01728376|11125200|FG005|Overall Study|Persistent Positive Blood Cultures|0
7041593|NCT01728376|11125195|FG000|Overall Study|No relevant bacteria|2
7041594|NCT01728376|11125196|FG001|Overall Study|No relevant bacteria|0
7041595|NCT01728376|11125197|FG002|Overall Study|No relevant bacteria|0
7041596|NCT01728376|11125198|FG003|Overall Study|No relevant bacteria|0
7041597|NCT01728376|11125199|FG004|Overall Study|No relevant bacteria|1
7041598|NCT01728376|11125200|FG005|Overall Study|No relevant bacteria|1
7041599|NCT01728376|11125195|FG000|Overall Study|Did not receive treatment|0
7041600|NCT01728376|11125196|FG001|Overall Study|Did not receive treatment|1
7041601|NCT01728376|11125197|FG002|Overall Study|Did not receive treatment|0
7041602|NCT01728376|11125198|FG003|Overall Study|Did not receive treatment|0
7041603|NCT01728376|11125199|FG004|Overall Study|Did not receive treatment|0
7041604|NCT01728376|11125200|FG005|Overall Study|Did not receive treatment|0
7041605|NCT01728376|11125195|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0
7041606|NCT01728376|11125196|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0
7041607|NCT01728376|11125197|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0
7041608|NCT01728376|11125198|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1
7044867|NCT01759407|11131025|FG001|Overall Study|Protocol Violation|2
7080634|NCT02123797|11190123|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20
7172478|NCT01915498|11372120|FG004|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7041609|NCT01728376|11125199|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0
7041610|NCT01728376|11125200|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1
7041611|NCT01728454|11125217|FG000|Stage 1 and 2|Pregnancy|1
7041612|NCT01728454|11125218|FG001|Stage 1 and 2|Pregnancy|0
7041613|NCT01728454|11125219|FG002|Stage 1 and 2|Pregnancy|0
7041614|NCT01728454|11125217|FG000|Stage 1 and 2|Non-compliance with Protocol|0
7041615|NCT01728454|11125218|FG001|Stage 1 and 2|Non-compliance with Protocol|0
7041616|NCT01728454|11125219|FG002|Stage 1 and 2|Non-compliance with Protocol|1
7172479|NCT01915498|11372121|FG005|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7172480|NCT01915498|11372122|FG006|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7172481|NCT01915498|11372123|FG007|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7172482|NCT01915498|11372124|FG008|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7172483|NCT01915498|11372125|FG009|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7172484|NCT01915498|11372126|FG010|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7172485|NCT01915498|11372127|FG011|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7172486|NCT01915498|11372128|FG012|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7172487|NCT01915498|11372129|FG013|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7172488|NCT01915498|11372130|FG014|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7172489|NCT01915498|11372131|FG015|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7172490|NCT01915498|11372132|FG016|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7172491|NCT01915498|11372133|FG017|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7172492|NCT01915498|11372134|FG018|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|2
7172493|NCT00121485|11372233|FG000|Overall Study|Not implanted|1
7172494|NCT00121485|11372234|FG001|Overall Study|Not implanted|5
7172495|NCT00121485|11372233|FG000|Overall Study|Crossover|0
7172496|NCT00121485|11372234|FG001|Overall Study|Crossover|2
7185421|NCT02076178|11385809|FG001|Oral Phase|Adverse Event|7
7185422|NCT02076178|11385808|FG000|Oral Phase|Withdrawal by Subject|0
7185423|NCT02076178|11385809|FG001|Oral Phase|Withdrawal by Subject|4
7185424|NCT02076178|11385808|FG000|Oral Phase|Physician Decision|0
7185425|NCT02076178|11385809|FG001|Oral Phase|Physician Decision|1
7185426|NCT02076178|11385808|FG000|Injection Phase|Protocol defined stopping criteria|1
7185427|NCT02076178|11385809|FG001|Injection Phase|Protocol defined stopping criteria|0
7185428|NCT02076178|11385808|FG000|Injection Phase|Withdrawal by Subject|0
7185429|NCT02076178|11385809|FG001|Injection Phase|Withdrawal by Subject|3
7185430|NCT02076178|11385808|FG000|Injection Phase|Physician Decision|0
7185431|NCT02076178|11385809|FG001|Injection Phase|Physician Decision|3
7185432|NCT02076178|11385808|FG000|Injection Phase|Lost to Follow-up|0
7185433|NCT02076178|11385809|FG001|Injection Phase|Lost to Follow-up|1
7187898|NCT02269917|11388580|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0
7187899|NCT02269917|11388581|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0
7187900|NCT02269917|11388582|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10
7187901|NCT02269917|11388580|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0
7187902|NCT02269917|11388581|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0
7187903|NCT02269917|11388582|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11
7187904|NCT02269917|11388580|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0
7187905|NCT02269917|11388581|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0
7187906|NCT02269917|11388582|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1
7187907|NCT02269917|11388580|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0
7187908|NCT02269917|11388581|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0
7187909|NCT02269917|11388582|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2
7187910|NCT02269917|11388580|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0
7187911|NCT02269917|11388581|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0
7187912|NCT02269917|11388582|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5
7187913|NCT02269917|11388580|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0
7187914|NCT02269917|11388581|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0
7187915|NCT02269917|11388582|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8
7187916|NCT02225366|11388593|FG000|Overall Study|Lack of Efficacy|1
7187917|NCT02225366|11388594|FG001|Overall Study|Lack of Efficacy|0
7187918|NCT01530997|11388600|FG000|Overall Study|Physician Decision|1
7187919|NCT01530997|11388600|FG000|Overall Study|Withdrawal by Subject|1
7187920|NCT01067521|11388626|FG000|Double-Blind Placebo-Controlled Period|Death|0
7187921|NCT01067521|11388627|FG001|Double-Blind Placebo-Controlled Period|Death|1
7187922|NCT01067521|11388626|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29
7187923|NCT01067521|11388627|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6
7187924|NCT01067521|11388626|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34
7187925|NCT01067521|11388627|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17
7187926|NCT01067521|11388626|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1
7187927|NCT01067521|11388627|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1
7041617|NCT01728454|11125217|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1
7172497|NCT00078806|11372249|FG000|Part 1A|Adverse Event|2
7172498|NCT00078806|11372250|FG001|Part 1A|Adverse Event|0
7172499|NCT00078806|11372251|FG002|Part 1A|Adverse Event|0
7172500|NCT00078806|11372252|FG003|Part 1A|Adverse Event|0
7172501|NCT00078806|11372249|FG000|Part 1A|Lack of Efficacy|7
7172502|NCT00078806|11372250|FG001|Part 1A|Lack of Efficacy|0
7172503|NCT00078806|11372251|FG002|Part 1A|Lack of Efficacy|0
7172504|NCT00078806|11372252|FG003|Part 1A|Lack of Efficacy|0
7172505|NCT00078806|11372249|FG000|Part 1A|Other|1
7172506|NCT00078806|11372250|FG001|Part 1A|Other|0
7172507|NCT00078806|11372251|FG002|Part 1A|Other|0
7172508|NCT00078806|11372252|FG003|Part 1A|Other|0
7172509|NCT00078806|11372249|FG000|Part 1B|Adverse Event|1
7172510|NCT00078806|11372250|FG001|Part 1B|Adverse Event|0
7172511|NCT00078806|11372251|FG002|Part 1B|Adverse Event|0
7172512|NCT00078806|11372252|FG003|Part 1B|Adverse Event|0
7172513|NCT00078806|11372249|FG000|Part 1B|Lack of Efficacy|7
7172514|NCT00078806|11372250|FG001|Part 1B|Lack of Efficacy|0
7172515|NCT00078806|11372251|FG002|Part 1B|Lack of Efficacy|0
7172516|NCT00078806|11372252|FG003|Part 1B|Lack of Efficacy|0
7172517|NCT00078806|11372249|FG000|Part 2|Adverse Event|0
7172518|NCT00078806|11372250|FG001|Part 2|Adverse Event|1
7172519|NCT00078806|11372251|FG002|Part 2|Adverse Event|0
7172520|NCT00078806|11372252|FG003|Part 2|Adverse Event|0
7172521|NCT00162370|11372267|FG000|Efficacy Population|Lost to Follow-up|51
7172522|NCT00214500|11372283|FG000|Treatment Period|Adverse Event|1
7172523|NCT00214500|11372283|FG000|Extension Period|Withdrawal by Subject|2
7172524|NCT00283959|11372295|FG000|Extension Period|Low Compliance|1
7172525|NCT00290758|11372301|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1
7172526|NCT00290758|11372302|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2
7172527|NCT00290758|11372301|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1
7172528|NCT00290758|11372302|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0
7172529|NCT00290758|11372301|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3
7172530|NCT00290758|11372302|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1
7172531|NCT00290758|11372301|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
7172532|NCT00290758|11372302|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
7172533|NCT00290758|11372301|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0
7172534|NCT00290758|11372302|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5
7172535|NCT00290758|11372301|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1
7172536|NCT00290758|11372302|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0
7172537|NCT00290758|11372301|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0
7172538|NCT00290758|11372302|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1
7172539|NCT00290758|11372301|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6
7172540|NCT00290758|11372302|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5
7172541|NCT00310388|11372312|FG000|Primary Reporting Phase|Adverse Event|101
7172542|NCT00310388|11372313|FG001|Primary Reporting Phase|Adverse Event|0
7172543|NCT00310388|11372312|FG000|Primary Reporting Phase|Lack of Efficacy|56
7172544|NCT00310388|11372313|FG001|Primary Reporting Phase|Lack of Efficacy|0
7172545|NCT00310388|11372312|FG000|Primary Reporting Phase|Withdrawal by Subject|97
7172546|NCT00310388|11372313|FG001|Primary Reporting Phase|Withdrawal by Subject|0
7172547|NCT00310388|11372312|FG000|Primary Reporting Phase|Protocol Violation|10
7080635|NCT02123797|11190124|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66
7080636|NCT02123797|11190125|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113
7080637|NCT02123797|11190126|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3
7080638|NCT02123797|11190122|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1
7080639|NCT02123797|11190123|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9
7080640|NCT02123797|11190124|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
7080641|NCT02123797|11190125|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
7172548|NCT00310388|11372313|FG001|Primary Reporting Phase|Protocol Violation|0
7172549|NCT00310388|11372312|FG000|Primary Reporting Phase|Pregnancy|3
7172550|NCT00310388|11372313|FG001|Primary Reporting Phase|Pregnancy|0
7172551|NCT00310388|11372312|FG000|Primary Reporting Phase|Change in participant medical condition|3
7172552|NCT00310388|11372313|FG001|Primary Reporting Phase|Change in participant medical condition|0
7172553|NCT00310388|11372312|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3
7172554|NCT00310388|11372313|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0
7172555|NCT00310388|11372312|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3
7172556|NCT00310388|11372313|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0
7172557|NCT00310388|11372312|FG000|Primary Reporting Phase|Physician Decision|2
7172558|NCT00310388|11372313|FG001|Primary Reporting Phase|Physician Decision|0
7172559|NCT00310388|11372312|FG000|Primary Reporting Phase|Request of the sponsor|19
7172560|NCT00310388|11372313|FG001|Primary Reporting Phase|Request of the sponsor|0
7172561|NCT00310388|11372312|FG000|Primary Reporting Phase|Failed to return|8
7172562|NCT00310388|11372313|FG001|Primary Reporting Phase|Failed to return|0
7172563|NCT00310388|11372312|FG000|Primary Reporting Phase|Participant request unrelated to study|2
7172564|NCT00310388|11372313|FG001|Primary Reporting Phase|Participant request unrelated to study|0
7172565|NCT00310388|11372312|FG000|Primary Reporting Phase|Participant request|2
7172566|NCT00310388|11372313|FG001|Primary Reporting Phase|Participant request|0
7172567|NCT00310388|11372312|FG000|Primary Reporting Phase|Ministry of Health decision|25
7172568|NCT00310388|11372313|FG001|Primary Reporting Phase|Ministry of Health decision|0
7172569|NCT00310388|11372312|FG000|Primary Reporting Phase|Discontinuation of study|1
7172570|NCT00310388|11372313|FG001|Primary Reporting Phase|Discontinuation of study|0
7172571|NCT00310388|11372312|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1
7172572|NCT00310388|11372313|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0
7172573|NCT00310388|11372312|FG000|Primary Reporting Phase|Termination of study at sponsor request|3
7172574|NCT00310388|11372313|FG001|Primary Reporting Phase|Termination of study at sponsor request|0
7172575|NCT00310388|11372312|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1
7172576|NCT00310388|11372313|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0
7172577|NCT00310388|11372312|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2
7172578|NCT00310388|11372313|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0
7172579|NCT00310388|11372312|FG000|Primary Reporting Phase|Participant passed away|1
7172580|NCT00310388|11372313|FG001|Primary Reporting Phase|Participant passed away|0
7172581|NCT00310388|11372312|FG000|Primary Reporting Phase|Participant retired the informed consent|1
7172582|NCT00310388|11372313|FG001|Primary Reporting Phase|Participant retired the informed consent|0
7172583|NCT00310388|11372312|FG000|Primary Reporting Phase|Missing|1
7172584|NCT00310388|11372313|FG001|Primary Reporting Phase|Missing|0
7172585|NCT00310388|11372312|FG000|Primary Reporting Phase|Other|1
7172586|NCT00310388|11372313|FG001|Primary Reporting Phase|Other|0
7172587|NCT00310388|11372312|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0
7172588|NCT00310388|11372313|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5
7172589|NCT00310388|11372312|FG000|Safety Follow-up Continuation Phase|Adverse Event|0
7172590|NCT00310388|11372313|FG001|Safety Follow-up Continuation Phase|Adverse Event|1
7172591|NCT00310388|11372312|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0
7172592|NCT00310388|11372313|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5
7172593|NCT00310388|11372312|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0
7172594|NCT00310388|11372313|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2
7185434|NCT02079766|11385819|FG000|Overall Study|Physician Decision|1
7185435|NCT02079766|11385820|FG001|Overall Study|Physician Decision|0
7185436|NCT02079766|11385819|FG000|Overall Study|Withdrawal by Subject|1
7185437|NCT02079766|11385820|FG001|Overall Study|Withdrawal by Subject|0
7187928|NCT01067521|11388626|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4
7187929|NCT01067521|11388627|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1
7080642|NCT02123797|11190126|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
7187930|NCT01067521|11388626|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2
7187931|NCT01067521|11388627|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0
7187932|NCT01067521|11388626|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2
7187933|NCT01067521|11388627|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0
7187934|NCT01067521|11388626|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7
7187935|NCT01067521|11388627|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4
7187936|NCT01067521|11388626|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5
7187937|NCT01067521|11388627|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1
7187938|NCT01067521|11388626|FG000|Open-Label Period|Death|3
7187939|NCT01067521|11388627|FG001|Open-Label Period|Death|1
7187940|NCT01067521|11388626|FG000|Open-Label Period|Adverse Event|30
7187941|NCT01067521|11388627|FG001|Open-Label Period|Adverse Event|28
7187942|NCT01067521|11388626|FG000|Open-Label Period|Withdrawal by Subject|160
7187943|NCT01067521|11388627|FG001|Open-Label Period|Withdrawal by Subject|88
7187944|NCT01067521|11388626|FG000|Open-Label Period|Physician Decision|13
7187945|NCT01067521|11388627|FG001|Open-Label Period|Physician Decision|11
7187946|NCT01067521|11388626|FG000|Open-Label Period|Non-compliance with study drug|5
7187947|NCT01067521|11388627|FG001|Open-Label Period|Non-compliance with study drug|0
7187948|NCT01067521|11388626|FG000|Open-Label Period|Protocol Violation|3
7187949|NCT01067521|11388627|FG001|Open-Label Period|Protocol Violation|0
7187950|NCT01067521|11388626|FG000|Open-Label Period|Pregnancy|14
7187951|NCT01067521|11388627|FG001|Open-Label Period|Pregnancy|8
7187952|NCT01067521|11388626|FG000|Open-Label Period|Teva requested subject to be withdrawn|5
7187953|NCT01067521|11388627|FG001|Open-Label Period|Teva requested subject to be withdrawn|2
7187954|NCT01067521|11388626|FG000|Open-Label Period|Lost to Follow-up|21
7187955|NCT01067521|11388627|FG001|Open-Label Period|Lost to Follow-up|20
7187956|NCT01047319|11388641|FG000|Overall Study|Teva requested participant withdrawal|3
7187957|NCT01047319|11388642|FG001|Overall Study|Teva requested participant withdrawal|0
7187958|NCT01047319|11388643|FG002|Overall Study|Teva requested participant withdrawal|1
7187959|NCT01047319|11388641|FG000|Overall Study|Protocol Violation|3
7187960|NCT01047319|11388642|FG001|Overall Study|Protocol Violation|2
7187961|NCT01047319|11388643|FG002|Overall Study|Protocol Violation|4
7187962|NCT01047319|11388641|FG000|Overall Study|Lack of Efficacy|4
7187963|NCT01047319|11388642|FG001|Overall Study|Lack of Efficacy|3
7187964|NCT01047319|11388643|FG002|Overall Study|Lack of Efficacy|3
7187965|NCT01047319|11388641|FG000|Overall Study|Death|5
7187966|NCT01047319|11388642|FG001|Overall Study|Death|1
7187967|NCT01047319|11388643|FG002|Overall Study|Death|5
7187968|NCT01047319|11388641|FG000|Overall Study|Pregnancy|13
7187969|NCT01047319|11388642|FG001|Overall Study|Pregnancy|8
7187970|NCT01047319|11388643|FG002|Overall Study|Pregnancy|8
7187971|NCT01047319|11388641|FG000|Overall Study|Physician Decision|12
7172595|NCT00345358|11372322|FG000|Primary Vaccination Phase|Other|0
7172596|NCT00345358|11372323|FG001|Primary Vaccination Phase|Other|1
7172597|NCT00345358|11372324|FG002|Primary Vaccination Phase|Other|1
7172598|NCT00345358|11372325|FG003|Primary Vaccination Phase|Other|0
7172599|NCT00345358|11372322|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3
7172600|NCT00345358|11372323|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1
7172601|NCT00345358|11372324|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1
7172602|NCT00345358|11372325|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0
7172603|NCT00345358|11372322|FG000|Primary Vaccination Phase|Withdrawal by Subject|1
7172604|NCT00345358|11372323|FG001|Primary Vaccination Phase|Withdrawal by Subject|2
7172605|NCT00345358|11372324|FG002|Primary Vaccination Phase|Withdrawal by Subject|4
7172606|NCT00345358|11372325|FG003|Primary Vaccination Phase|Withdrawal by Subject|0
7172607|NCT00345358|11372322|FG000|Primary Vaccination Phase|Lost to Follow-up|1
7172608|NCT00345358|11372323|FG001|Primary Vaccination Phase|Lost to Follow-up|0
7172609|NCT00345358|11372324|FG002|Primary Vaccination Phase|Lost to Follow-up|2
7172610|NCT00345358|11372325|FG003|Primary Vaccination Phase|Lost to Follow-up|2
7172611|NCT00345358|11372322|FG000|Booster Vaccination Phase|Withdrawal by Subject|1
7172612|NCT00345358|11372323|FG001|Booster Vaccination Phase|Withdrawal by Subject|0
7172613|NCT00345358|11372324|FG002|Booster Vaccination Phase|Withdrawal by Subject|0
7172614|NCT00345358|11372325|FG003|Booster Vaccination Phase|Withdrawal by Subject|0
7172615|NCT00345358|11372322|FG000|Booster Vaccination Phase|Lost to Follow-up|3
7172616|NCT00345358|11372323|FG001|Booster Vaccination Phase|Lost to Follow-up|0
7172617|NCT00345358|11372324|FG002|Booster Vaccination Phase|Lost to Follow-up|0
7172618|NCT00345358|11372325|FG003|Booster Vaccination Phase|Lost to Follow-up|0
7172619|NCT00372229|11372341|FG000|Study Phase|Graft loss|0
7172620|NCT00372229|11372342|FG001|Study Phase|Graft loss|3
7172621|NCT00372229|11372341|FG000|Study Phase|Protocol Violation|3
7172622|NCT00372229|11372342|FG001|Study Phase|Protocol Violation|4
7172623|NCT00372229|11372341|FG000|Study Phase|Consent withdrawn|16
7172624|NCT00372229|11372342|FG001|Study Phase|Consent withdrawn|14
7172625|NCT00372229|11372341|FG000|Study Phase|Refused treatment/did not cooperate|3
7080643|NCT02123797|11190122|FG000|6-month Follow up (Cumulative Counts)|Relocation|0
7080644|NCT02123797|11190123|FG001|6-month Follow up (Cumulative Counts)|Relocation|2
7080645|NCT02123797|11190124|FG002|6-month Follow up (Cumulative Counts)|Relocation|0
7080646|NCT02123797|11190125|FG003|6-month Follow up (Cumulative Counts)|Relocation|0
7080647|NCT02123797|11190126|FG004|6-month Follow up (Cumulative Counts)|Relocation|0
7080648|NCT02123966|11190157|FG000|Overall Study|Intercurrent Illness|1
7080649|NCT02124161|11190201|FG000|Overall Study|Other unspecified|0
7172626|NCT00372229|11372342|FG001|Study Phase|Refused treatment/did not cooperate|1
7172627|NCT00372229|11372341|FG000|Study Phase|Death|3
7172628|NCT00372229|11372342|FG001|Study Phase|Death|2
7172629|NCT00372229|11372341|FG000|Study Phase|Reason not specified|3
7172630|NCT00372229|11372342|FG001|Study Phase|Reason not specified|2
7172631|NCT00372229|11372341|FG000|Study Phase|Lost to Follow-up|3
7172632|NCT00372229|11372342|FG001|Study Phase|Lost to Follow-up|3
7172633|NCT00372229|11372341|FG000|Follow-Up Phase|Graft loss|8
7172634|NCT00372229|11372342|FG001|Follow-Up Phase|Graft loss|7
7172635|NCT00372229|11372341|FG000|Follow-Up Phase|Consent withdrawn|13
7172636|NCT00372229|11372342|FG001|Follow-Up Phase|Consent withdrawn|19
7172637|NCT00372229|11372341|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0
7172638|NCT00372229|11372342|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1
7172639|NCT00372229|11372341|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1
7172640|NCT00372229|11372342|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0
7172641|NCT00372229|11372341|FG000|Follow-Up Phase|Death|9
7172642|NCT00372229|11372342|FG001|Follow-Up Phase|Death|12
7172643|NCT00372229|11372341|FG000|Follow-Up Phase|Administrative|1
7172644|NCT00372229|11372342|FG001|Follow-Up Phase|Administrative|0
7172645|NCT00372229|11372341|FG000|Follow-Up Phase|Reason not specified|2
7172646|NCT00372229|11372342|FG001|Follow-Up Phase|Reason not specified|3
7172647|NCT00372229|11372341|FG000|Follow-Up Phase|Lost to Follow-up|12
7172648|NCT00372229|11372342|FG001|Follow-Up Phase|Lost to Follow-up|10
7172649|NCT00383708|11372352|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1
7172650|NCT00383708|11372352|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32
7172651|NCT00383708|11372352|FG000|Run-in Period|Protocol Violation|4
7172652|NCT00383708|11372352|FG000|Run-in Period|Adverse Event|2
7172653|NCT00383708|11372352|FG000|Run-in Period|Claustrophobia|1
7172654|NCT00383708|11372352|FG000|Co-administration Period|Adverse Event|5
7172655|NCT00413699|11372359|FG000|Initial Period|Death|25
7172656|NCT00413699|11372360|FG001|Initial Period|Death|30
7172657|NCT00413699|11372361|FG002|Initial Period|Death|0
7172658|NCT00413699|11372359|FG000|Initial Period|Lack of Efficacy|59
7172659|NCT00413699|11372360|FG001|Initial Period|Lack of Efficacy|115
7172660|NCT00413699|11372361|FG002|Initial Period|Lack of Efficacy|0
7172661|NCT00413699|11372359|FG000|Initial Period|Lost to Follow-up|31
7172662|NCT00413699|11372360|FG001|Initial Period|Lost to Follow-up|101
7172663|NCT00413699|11372361|FG002|Initial Period|Lost to Follow-up|0
7172664|NCT00413699|11372359|FG000|Initial Period|Protocol Violation|38
7172665|NCT00413699|11372360|FG001|Initial Period|Protocol Violation|89
7172666|NCT00413699|11372361|FG002|Initial Period|Protocol Violation|0
7172667|NCT00413699|11372359|FG000|Initial Period|Pregnancy|10
7172668|NCT00413699|11372360|FG001|Initial Period|Pregnancy|8
7172669|NCT00413699|11372361|FG002|Initial Period|Pregnancy|0
7172670|NCT00413699|11372359|FG000|Initial Period|Did not meet entrance criteria|2
7172671|NCT00413699|11372360|FG001|Initial Period|Did not meet entrance criteria|2
7172672|NCT00413699|11372361|FG002|Initial Period|Did not meet entrance criteria|0
7172673|NCT00413699|11372359|FG000|Initial Period|Medication error without adverse event|0
7172674|NCT00413699|11372360|FG001|Initial Period|Medication error without adverse event|1
7172675|NCT00413699|11372361|FG002|Initial Period|Medication error without adverse event|0
7172676|NCT00413699|11372359|FG000|Initial Period|Study terminated by Sponsor|0
7172677|NCT00413699|11372360|FG001|Initial Period|Study terminated by Sponsor|1
7172678|NCT00413699|11372361|FG002|Initial Period|Study terminated by Sponsor|0
7172679|NCT00413699|11372359|FG000|Initial Period|Other|67
7172680|NCT00413699|11372360|FG001|Initial Period|Other|211
7172681|NCT00413699|11372361|FG002|Initial Period|Other|0
7172682|NCT00413699|11372359|FG000|Initial Period|Adverse event related to study drug|178
7172683|NCT00413699|11372360|FG001|Initial Period|Adverse event related to study drug|527
7172684|NCT00413699|11372361|FG002|Initial Period|Adverse event related to study drug|0
7172685|NCT00413699|11372359|FG000|Initial Period|Adverse event not related to study drug|113
7172686|NCT00413699|11372360|FG001|Initial Period|Adverse event not related to study drug|248
7172687|NCT00413699|11372361|FG002|Initial Period|Adverse event not related to study drug|0
7172688|NCT00413699|11372359|FG000|Initial Period|Missing end of study page|0
7172689|NCT00413699|11372360|FG001|Initial Period|Missing end of study page|4
7172690|NCT00413699|11372361|FG002|Initial Period|Missing end of study page|0
7172691|NCT00413699|11372359|FG000|Initial Period|No longer willing to participate|116
7172692|NCT00413699|11372360|FG001|Initial Period|No longer willing to participate|368
7172693|NCT00413699|11372361|FG002|Initial Period|No longer willing to participate|0
7172694|NCT00413699|11372359|FG000|Extension Period|No Longer Willing to Participate|0
7172695|NCT00413699|11372360|FG001|Extension Period|No Longer Willing to Participate|0
7172696|NCT00413699|11372361|FG002|Extension Period|No Longer Willing to Participate|2
7172697|NCT00413699|11372359|FG000|Extension Period|Protocol Violation|0
7172698|NCT00413699|11372360|FG001|Extension Period|Protocol Violation|0
7172699|NCT00413699|11372361|FG002|Extension Period|Protocol Violation|1
7172700|NCT00413699|11372359|FG000|Extension Period|Adverse Event|0
7172701|NCT00413699|11372360|FG001|Extension Period|Adverse Event|0
7172702|NCT00413699|11372361|FG002|Extension Period|Adverse Event|2
7185438|NCT02081391|11385830|FG000|12-hour Treatment|Withdrawal by Subject|3
7185439|NCT02081391|11385831|FG001|12-hour Treatment|Withdrawal by Subject|2
7185440|NCT02081391|11385832|FG002|12-hour Treatment|Withdrawal by Subject|0
7185441|NCT02081391|11385833|FG003|12-hour Treatment|Withdrawal by Subject|0
7185442|NCT02081391|11385830|FG000|12-hour Treatment|Physician Decision|4
7185443|NCT02081391|11385831|FG001|12-hour Treatment|Physician Decision|1
7185444|NCT02081391|11385832|FG002|12-hour Treatment|Physician Decision|0
7185445|NCT02081391|11385833|FG003|12-hour Treatment|Physician Decision|0
7185446|NCT02081391|11385830|FG000|12-hour Treatment|Lack of Efficacy|3
7185447|NCT02081391|11385831|FG001|12-hour Treatment|Lack of Efficacy|0
7185448|NCT02081391|11385832|FG002|12-hour Treatment|Lack of Efficacy|0
7185449|NCT02081391|11385833|FG003|12-hour Treatment|Lack of Efficacy|0
7185450|NCT02081391|11385830|FG000|12-hour Treatment|Adverse Event|4
7185451|NCT02081391|11385831|FG001|12-hour Treatment|Adverse Event|2
7185452|NCT02081391|11385832|FG002|12-hour Treatment|Adverse Event|0
7185453|NCT02081391|11385833|FG003|12-hour Treatment|Adverse Event|0
7185454|NCT02081391|11385830|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2
7185455|NCT02081391|11385831|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0
7185456|NCT02081391|11385832|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1
7185457|NCT02081391|11385833|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0
7185458|NCT02081391|11385830|FG000|12-hour Treatment|Further reasons|2
7185459|NCT02081391|11385831|FG001|12-hour Treatment|Further reasons|1
7185460|NCT02081391|11385832|FG002|12-hour Treatment|Further reasons|0
7185461|NCT02081391|11385833|FG003|12-hour Treatment|Further reasons|0
7185462|NCT02081391|11385830|FG000|24-hour Treatment and Trial Completion|Physician Decision|10
7185463|NCT02081391|11385831|FG001|24-hour Treatment and Trial Completion|Physician Decision|5
7185464|NCT02081391|11385832|FG002|24-hour Treatment and Trial Completion|Physician Decision|0
7185465|NCT02081391|11385833|FG003|24-hour Treatment and Trial Completion|Physician Decision|0
7185466|NCT02081391|11385830|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1
7185467|NCT02081391|11385831|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3
7185468|NCT02081391|11385832|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0
7185469|NCT02081391|11385833|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0
7185470|NCT02081391|11385830|FG000|24-hour Treatment and Trial Completion|Adverse Event|1
7185471|NCT02081391|11385831|FG001|24-hour Treatment and Trial Completion|Adverse Event|0
7185472|NCT02081391|11385832|FG002|24-hour Treatment and Trial Completion|Adverse Event|0
7185473|NCT02081391|11385833|FG003|24-hour Treatment and Trial Completion|Adverse Event|0
7185474|NCT02081391|11385830|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11
7185475|NCT02081391|11385831|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5
7185476|NCT02081391|11385832|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1
7185477|NCT02081391|11385833|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0
7185478|NCT02081391|11385830|FG000|24-hour Treatment and Trial Completion|Technical Problems|1
7185479|NCT02081391|11385831|FG001|24-hour Treatment and Trial Completion|Technical Problems|1
7172703|NCT00436826|11372399|FG000|Double Blind Period (DBP)|Adverse Event|2
7172704|NCT00436826|11372400|FG001|Double Blind Period (DBP)|Adverse Event|0
7172705|NCT00436826|11372401|FG002|Double Blind Period (DBP)|Adverse Event|0
7172706|NCT00436826|11372402|FG003|Double Blind Period (DBP)|Adverse Event|0
7172707|NCT00436826|11372403|FG004|Double Blind Period (DBP)|Adverse Event|0
7172708|NCT00436826|11372404|FG005|Double Blind Period (DBP)|Adverse Event|0
7172709|NCT00436826|11372399|FG000|Double Blind Period (DBP)|Protocol Violation|1
7172710|NCT00436826|11372400|FG001|Double Blind Period (DBP)|Protocol Violation|0
7172711|NCT00436826|11372401|FG002|Double Blind Period (DBP)|Protocol Violation|0
7172712|NCT00436826|11372402|FG003|Double Blind Period (DBP)|Protocol Violation|0
7172713|NCT00436826|11372403|FG004|Double Blind Period (DBP)|Protocol Violation|0
7172714|NCT00436826|11372404|FG005|Double Blind Period (DBP)|Protocol Violation|0
7172715|NCT00436826|11372399|FG000|Double Blind Period (DBP)|Other|10
7172716|NCT00436826|11372400|FG001|Double Blind Period (DBP)|Other|11
7172717|NCT00436826|11372401|FG002|Double Blind Period (DBP)|Other|0
7172718|NCT00436826|11372402|FG003|Double Blind Period (DBP)|Other|0
7172719|NCT00436826|11372403|FG004|Double Blind Period (DBP)|Other|0
7172720|NCT00436826|11372404|FG005|Double Blind Period (DBP)|Other|0
7172721|NCT00436826|11372399|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
7172722|NCT00436826|11372400|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
7172723|NCT00436826|11372401|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
7172724|NCT00436826|11372402|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1
7172725|NCT00436826|11372403|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
7172726|NCT00436826|11372404|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
7172727|NCT00436826|11372399|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0
7172728|NCT00436826|11372400|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0
7172729|NCT00436826|11372401|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46
7172730|NCT00436826|11372402|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25
7172731|NCT00436826|11372403|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0
7172732|NCT00436826|11372404|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0
7172733|NCT00436826|11372399|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
7172734|NCT00436826|11372400|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
7172735|NCT00436826|11372401|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
7172736|NCT00436826|11372402|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
7172737|NCT00436826|11372403|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51
7172738|NCT00436826|11372404|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7
7172739|NCT00442546|11372423|FG000|Overall Study|Adverse Event|11
7172740|NCT00442546|11372424|FG001|Overall Study|Adverse Event|17
7172741|NCT00442546|11372425|FG002|Overall Study|Adverse Event|13
7172742|NCT00442546|11372423|FG000|Overall Study|Lost to Follow-up|1
7172743|NCT00442546|11372424|FG001|Overall Study|Lost to Follow-up|2
7172744|NCT00442546|11372425|FG002|Overall Study|Lost to Follow-up|1
7172745|NCT00442546|11372423|FG000|Overall Study|Other|4
7172746|NCT00442546|11372424|FG001|Overall Study|Other|9
7080650|NCT02124161|11190202|FG001|Overall Study|Other unspecified|1
7080651|NCT02124161|11190201|FG000|Overall Study|Death|1
7080652|NCT02124161|11190202|FG001|Overall Study|Death|0
7080653|NCT02124161|11190201|FG000|Overall Study|Protocol Violation|2
7080654|NCT02124161|11190202|FG001|Overall Study|Protocol Violation|1
7080655|NCT02124161|11190201|FG000|Overall Study|Withdrawal by Subject|1
7080656|NCT02124161|11190202|FG001|Overall Study|Withdrawal by Subject|2
7080657|NCT02124161|11190201|FG000|Overall Study|Adverse Event|2
7080658|NCT02124161|11190202|FG001|Overall Study|Adverse Event|0
7080659|NCT02124161|11190201|FG000|Overall Study|Does not meet entrance criteria|2
7080660|NCT02124161|11190202|FG001|Overall Study|Does not meet entrance criteria|3
7080661|NCT02124161|11190201|FG000|Overall Study|No longer meets eligibility criteria|5
7080662|NCT02124161|11190202|FG001|Overall Study|No longer meets eligibility criteria|4
7080663|NCT02124161|11190201|FG000|Overall Study|Lost to Follow-up|3
7172747|NCT00442546|11372425|FG002|Overall Study|Other|6
7172748|NCT00442546|11372423|FG000|Overall Study|Withdrawal by Subject|5
7172749|NCT00442546|11372424|FG001|Overall Study|Withdrawal by Subject|5
7172750|NCT00442546|11372425|FG002|Overall Study|Withdrawal by Subject|7
7172751|NCT00442546|11372423|FG000|Overall Study|Randomized But Not Treated|5
7172752|NCT00442546|11372424|FG001|Overall Study|Randomized But Not Treated|4
7172753|NCT00442546|11372425|FG002|Overall Study|Randomized But Not Treated|6
7172754|NCT04715932|11372437|FG000|Overall Study|Lost to Follow-up|1
7172755|NCT04715932|11372438|FG001|Overall Study|Lost to Follow-up|0
7172756|NCT04666441|11372452|FG000|Overall Study|Lost to Follow-up|1
7172757|NCT04666441|11372453|FG001|Overall Study|Lost to Follow-up|4
7172758|NCT04666441|11372454|FG002|Overall Study|Lost to Follow-up|1
7172759|NCT04666441|11372455|FG003|Overall Study|Lost to Follow-up|3
7172760|NCT04666441|11372456|FG004|Overall Study|Lost to Follow-up|0
7172761|NCT04666441|11372457|FG005|Overall Study|Lost to Follow-up|2
7172762|NCT04666441|11372458|FG006|Overall Study|Lost to Follow-up|2
7172763|NCT04666441|11372459|FG007|Overall Study|Lost to Follow-up|2
7080664|NCT02124161|11190202|FG001|Overall Study|Lost to Follow-up|4
7080665|NCT02124265|11190215|FG000|Overall Study|Adverse Event|1
7080666|NCT02124564|11190247|FG000|Treatment Period|Adverse Event|2
7172764|NCT04666441|11372452|FG000|Overall Study|Subject Decision|1
7172765|NCT04666441|11372453|FG001|Overall Study|Subject Decision|1
7172766|NCT04666441|11372454|FG002|Overall Study|Subject Decision|3
7172767|NCT04666441|11372455|FG003|Overall Study|Subject Decision|1
7172768|NCT04666441|11372456|FG004|Overall Study|Subject Decision|0
7172769|NCT04666441|11372457|FG005|Overall Study|Subject Decision|1
7172770|NCT04666441|11372458|FG006|Overall Study|Subject Decision|3
7172771|NCT04666441|11372459|FG007|Overall Study|Subject Decision|2
7185480|NCT02081391|11385832|FG002|24-hour Treatment and Trial Completion|Technical Problems|0
7185481|NCT02081391|11385833|FG003|24-hour Treatment and Trial Completion|Technical Problems|0
7185482|NCT02081391|11385830|FG000|24-hour Treatment and Trial Completion|Further reasons|3
7185483|NCT02081391|11385831|FG001|24-hour Treatment and Trial Completion|Further reasons|4
7185484|NCT02081391|11385832|FG002|24-hour Treatment and Trial Completion|Further reasons|0
7185485|NCT02081391|11385833|FG003|24-hour Treatment and Trial Completion|Further reasons|0
7187972|NCT01047319|11388642|FG001|Overall Study|Physician Decision|9
7187973|NCT01047319|11388643|FG002|Overall Study|Physician Decision|10
7187974|NCT01047319|11388641|FG000|Overall Study|Lost to Follow-up|14
7187975|NCT01047319|11388642|FG001|Overall Study|Lost to Follow-up|10
7187976|NCT01047319|11388643|FG002|Overall Study|Lost to Follow-up|10
7187977|NCT01047319|11388641|FG000|Overall Study|Adverse Event|16
7187978|NCT01047319|11388642|FG001|Overall Study|Adverse Event|27
7187979|NCT01047319|11388643|FG002|Overall Study|Adverse Event|21
7187980|NCT01047319|11388641|FG000|Overall Study|Withdrawal by Subject|77
7187981|NCT01047319|11388642|FG001|Overall Study|Withdrawal by Subject|75
7187982|NCT01047319|11388643|FG002|Overall Study|Withdrawal by Subject|87
7187983|NCT01047319|11388641|FG000|Overall Study|Study terminated by Sponsor|198
7187984|NCT01047319|11388642|FG001|Overall Study|Study terminated by Sponsor|215
7187985|NCT01047319|11388643|FG002|Overall Study|Study terminated by Sponsor|203
7187986|NCT00988052|11388653|FG000|Overall Study|Missing|1
7187987|NCT00988052|11388654|FG001|Overall Study|Missing|0
7187988|NCT00988052|11388653|FG000|Overall Study|Teva requested subject withdrawal|3
7187989|NCT00988052|11388654|FG001|Overall Study|Teva requested subject withdrawal|1
7187990|NCT00988052|11388653|FG000|Overall Study|Death|1
7187991|NCT00988052|11388654|FG001|Overall Study|Death|3
7187992|NCT00988052|11388653|FG000|Overall Study|Protocol Violation|6
7187993|NCT00988052|11388654|FG001|Overall Study|Protocol Violation|5
7187994|NCT00988052|11388653|FG000|Overall Study|Pregnancy|6
7187995|NCT00988052|11388654|FG001|Overall Study|Pregnancy|6
7187996|NCT00988052|11388653|FG000|Overall Study|Lack of Efficacy|8
7187997|NCT00988052|11388654|FG001|Overall Study|Lack of Efficacy|7
7187998|NCT00988052|11388653|FG000|Overall Study|Lost to Follow-up|6
7187999|NCT00988052|11388654|FG001|Overall Study|Lost to Follow-up|11
7188000|NCT00988052|11388653|FG000|Overall Study|Physician Decision|27
7188001|NCT00988052|11388654|FG001|Overall Study|Physician Decision|28
7188002|NCT00988052|11388653|FG000|Overall Study|Adverse Event|35
7188003|NCT00988052|11388654|FG001|Overall Study|Adverse Event|28
7188004|NCT00988052|11388653|FG000|Overall Study|Withdrawal by Subject|90
7188005|NCT00988052|11388654|FG001|Overall Study|Withdrawal by Subject|91
7188006|NCT00988052|11388653|FG000|Overall Study|Study terminated by sponsor|240
7188007|NCT00988052|11388654|FG001|Overall Study|Study terminated by sponsor|236
7188008|NCT02021773|11388663|FG000|Overall Study|Adverse Event|1
7188009|NCT02021773|11388664|FG001|Overall Study|Adverse Event|4
7188010|NCT02021773|11388665|FG002|Overall Study|Adverse Event|3
7188011|NCT02021773|11388663|FG000|Overall Study|Lack of Efficacy|2
7188012|NCT02021773|11388664|FG001|Overall Study|Lack of Efficacy|2
7188013|NCT02021773|11388665|FG002|Overall Study|Lack of Efficacy|2
7188014|NCT02021773|11388663|FG000|Overall Study|Protocol Violation|2
7188015|NCT02021773|11388664|FG001|Overall Study|Protocol Violation|3
7188016|NCT02021773|11388665|FG002|Overall Study|Protocol Violation|1
7188017|NCT02021773|11388663|FG000|Overall Study|Withdrawal by Subject|3
7188018|NCT02021773|11388664|FG001|Overall Study|Withdrawal by Subject|4
7188019|NCT02021773|11388665|FG002|Overall Study|Withdrawal by Subject|5
7188020|NCT02021773|11388663|FG000|Overall Study|Lost to Follow-up|1
7188021|NCT02021773|11388664|FG001|Overall Study|Lost to Follow-up|3
7188022|NCT02021773|11388665|FG002|Overall Study|Lost to Follow-up|0
7188023|NCT02021773|11388663|FG000|Overall Study|Reason not specified|3
7188024|NCT02021773|11388664|FG001|Overall Study|Reason not specified|0
7188025|NCT02021773|11388665|FG002|Overall Study|Reason not specified|0
7188364|NCT02891226|11388858|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7188365|NCT02891226|11388859|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7188366|NCT02891226|11388860|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7188367|NCT02891226|11388861|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2
7188368|NCT02891226|11388862|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7188369|NCT02891226|11388863|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7188370|NCT02891226|11388864|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7188371|NCT02891226|11388865|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7188372|NCT02891226|11388866|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7188373|NCT02891226|11388867|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7188374|NCT02891226|11388868|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7188375|NCT02891226|11388869|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7188376|NCT02891226|11388870|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7188377|NCT02891226|11388871|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7188378|NCT02891226|11388872|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7172772|NCT04259346|11372513|FG000|Overall Study|Lost to Follow-up|1
7172773|NCT04259346|11372514|FG001|Overall Study|Lost to Follow-up|3
7172774|NCT04259346|11372513|FG000|Overall Study|Protocol Violation|1
7172775|NCT04259346|11372514|FG001|Overall Study|Protocol Violation|0
7172776|NCT04259346|11372513|FG000|Overall Study|Withdrawal by Subject|1
7172777|NCT04259346|11372514|FG001|Overall Study|Withdrawal by Subject|0
7172778|NCT04259346|11372513|FG000|Overall Study|Adverse Event|1
7172779|NCT04259346|11372514|FG001|Overall Study|Adverse Event|1
7172780|NCT03959423|11372522|FG000|Overall Study|Withdrawal by Subject|2
7172781|NCT03959423|11372523|FG001|Overall Study|Withdrawal by Subject|3
7172782|NCT03959423|11372522|FG000|Overall Study|Physician Decision|0
7172783|NCT03959423|11372523|FG001|Overall Study|Physician Decision|1
7172784|NCT03959423|11372522|FG000|Overall Study|Lost to Follow-up|1
7172785|NCT03959423|11372523|FG001|Overall Study|Lost to Follow-up|0
7172786|NCT03959423|11372522|FG000|Overall Study|Withdrawal by Parent/Guardian|6
7172787|NCT03959423|11372523|FG001|Overall Study|Withdrawal by Parent/Guardian|0
7172788|NCT03713320|11372531|FG000|Randomized Period|Adverse Event|1
7172789|NCT03713320|11372532|FG001|Randomized Period|Adverse Event|5
7172790|NCT03713320|11372533|FG002|Randomized Period|Adverse Event|0
7172791|NCT03713320|11372531|FG000|Randomized Period|Physician Decision|1
7172792|NCT03713320|11372532|FG001|Randomized Period|Physician Decision|1
7172793|NCT03713320|11372533|FG002|Randomized Period|Physician Decision|0
7172794|NCT03713320|11372531|FG000|Randomized Period|Withdrawal by Subject|4
7172795|NCT03713320|11372532|FG001|Randomized Period|Withdrawal by Subject|0
7172796|NCT03713320|11372533|FG002|Randomized Period|Withdrawal by Subject|0
7172797|NCT03713320|11372531|FG000|Randomized Period|Participant decision|3
7172798|NCT03713320|11372532|FG001|Randomized Period|Participant decision|1
7172799|NCT03713320|11372533|FG002|Randomized Period|Participant decision|0
7172800|NCT03713320|11372531|FG000|Randomized Period|Study terminated by sponsor|6
7172801|NCT03713320|11372532|FG001|Randomized Period|Study terminated by sponsor|3
7172802|NCT03713320|11372533|FG002|Randomized Period|Study terminated by sponsor|0
7172803|NCT03713320|11372531|FG000|Cobomarsen Crossover Period|Physician Decision|0
7172804|NCT03713320|11372532|FG001|Cobomarsen Crossover Period|Physician Decision|0
7172805|NCT03713320|11372533|FG002|Cobomarsen Crossover Period|Physician Decision|2
7172806|NCT03713320|11372531|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0
7172807|NCT03713320|11372532|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0
7172808|NCT03713320|11372533|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5
7172809|NCT03429049|11372542|FG000|Overall Study|Adverse Event|2
7172810|NCT03429049|11372543|FG001|Overall Study|Adverse Event|3
7172811|NCT03429049|11372542|FG000|Overall Study|Death|0
7172812|NCT03429049|11372543|FG001|Overall Study|Death|1
7172813|NCT03429049|11372542|FG000|Overall Study|Lack of Efficacy|4
6972873|NCT01175213|11024219|FG000|IGSC, 10%/rHuPH20|Death|1
6972874|NCT01175213|11024220|FG001|IGSC, 10%/rHuPH20|Death|0
7172814|NCT03429049|11372543|FG001|Overall Study|Lack of Efficacy|2
7172815|NCT03429049|11372542|FG000|Overall Study|Lost to Follow-up|9
7172816|NCT03429049|11372543|FG001|Overall Study|Lost to Follow-up|8
7172817|NCT03429049|11372542|FG000|Overall Study|Physician Decision|1
7172818|NCT03429049|11372543|FG001|Overall Study|Physician Decision|0
7172819|NCT03429049|11372542|FG000|Overall Study|Protocol Violation|3
7172820|NCT03429049|11372543|FG001|Overall Study|Protocol Violation|0
7172821|NCT03429049|11372542|FG000|Overall Study|Sponsor Decision|2
7172822|NCT03429049|11372543|FG001|Overall Study|Sponsor Decision|0
7172823|NCT03429049|11372542|FG000|Overall Study|Withdrawal by Subject|4
7172824|NCT03429049|11372543|FG001|Overall Study|Withdrawal by Subject|20
7172825|NCT03429049|11372542|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3
7172826|NCT03429049|11372543|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8
7172827|NCT03409731|11372549|FG000|Overall Study|Withdrawal by Subject|1
7172828|NCT03409731|11372549|FG000|Overall Study|Death|2
7172829|NCT03283566|11372555|FG000|Overall Study|Lost to Follow-up|1
7172830|NCT03283566|11372556|FG001|Overall Study|Lost to Follow-up|2
7172831|NCT03077412|11372565|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1
7172832|NCT03077412|11372566|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5
7172833|NCT03077412|11372567|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3
7172834|NCT03077412|11372565|FG000|Overall Study|Protocol-Specified Disease Worsening|1
7172835|NCT03077412|11372566|FG001|Overall Study|Protocol-Specified Disease Worsening|3
7172836|NCT03077412|11372567|FG002|Overall Study|Protocol-Specified Disease Worsening|3
7172837|NCT03077412|11372565|FG000|Overall Study|Adverse Event|1
7172838|NCT03077412|11372566|FG001|Overall Study|Adverse Event|2
7172839|NCT03077412|11372567|FG002|Overall Study|Adverse Event|2
7172840|NCT03077412|11372565|FG000|Overall Study|Investigator's Discretion|0
7172841|NCT03077412|11372566|FG001|Overall Study|Investigator's Discretion|1
7172842|NCT03077412|11372567|FG002|Overall Study|Investigator's Discretion|1
7172843|NCT03077412|11372565|FG000|Overall Study|Withdrew Consent|0
7172844|NCT03077412|11372566|FG001|Overall Study|Withdrew Consent|2
7172845|NCT03077412|11372567|FG002|Overall Study|Withdrew Consent|0
7172846|NCT02384850|11372612|FG000|Overall Study|Withdrawal by Subject|2
7172847|NCT02384850|11372613|FG001|Overall Study|Withdrawal by Subject|2
7172848|NCT02352090|11372622|FG000|Overall Study|general malaise|1
7172849|NCT02352090|11372623|FG001|Overall Study|general malaise|0
7172850|NCT02352090|11372624|FG002|Overall Study|general malaise|0
7172851|NCT02352090|11372622|FG000|Overall Study|non-specified mild side-effects|0
7172852|NCT02352090|11372623|FG001|Overall Study|non-specified mild side-effects|0
7172853|NCT02352090|11372624|FG002|Overall Study|non-specified mild side-effects|2
7185486|NCT02087189|11385853|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2
7185487|NCT02112916|11385878|FG000|Overall Study|Adverse Event|6
7185488|NCT02112916|11385879|FG001|Overall Study|Adverse Event|9
7185489|NCT02112916|11385880|FG002|Overall Study|Adverse Event|3
7185490|NCT02112916|11385881|FG003|Overall Study|Adverse Event|2
7185491|NCT02112916|11385878|FG000|Overall Study|Death|9
7185492|NCT02112916|11385879|FG001|Overall Study|Death|9
7185493|NCT02112916|11385880|FG002|Overall Study|Death|3
7185494|NCT02112916|11385881|FG003|Overall Study|Death|4
7185495|NCT02112916|11385878|FG000|Overall Study|Lost to Follow-up|1
7185496|NCT02112916|11385879|FG001|Overall Study|Lost to Follow-up|0
7185497|NCT02112916|11385880|FG002|Overall Study|Lost to Follow-up|0
7185498|NCT02112916|11385881|FG003|Overall Study|Lost to Follow-up|0
7185499|NCT02112916|11385878|FG000|Overall Study|Physician Decision|94
7185500|NCT02112916|11385879|FG001|Overall Study|Physician Decision|72
7185501|NCT02112916|11385880|FG002|Overall Study|Physician Decision|24
7185502|NCT02112916|11385881|FG003|Overall Study|Physician Decision|15
7185503|NCT02112916|11385878|FG000|Overall Study|Withdrawal by Subject|5
7185504|NCT02112916|11385879|FG001|Overall Study|Withdrawal by Subject|3
7185505|NCT02112916|11385880|FG002|Overall Study|Withdrawal by Subject|1
7185506|NCT02112916|11385881|FG003|Overall Study|Withdrawal by Subject|1
7185507|NCT02112916|11385878|FG000|Overall Study|Ineligible|4
7185508|NCT02112916|11385879|FG001|Overall Study|Ineligible|8
7185509|NCT02112916|11385880|FG002|Overall Study|Ineligible|3
7185510|NCT02112916|11385881|FG003|Overall Study|Ineligible|8
7185511|NCT02112916|11385878|FG000|Overall Study|Inevaluable|6
7185512|NCT02112916|11385879|FG001|Overall Study|Inevaluable|4
7185513|NCT02112916|11385880|FG002|Overall Study|Inevaluable|5
7185514|NCT02112916|11385881|FG003|Overall Study|Inevaluable|5
7185515|NCT02112916|11385878|FG000|Overall Study|Refusal of further protocol therapy|19
7185516|NCT02112916|11385879|FG001|Overall Study|Refusal of further protocol therapy|16
7185517|NCT02112916|11385880|FG002|Overall Study|Refusal of further protocol therapy|1
7185518|NCT02112916|11385881|FG003|Overall Study|Refusal of further protocol therapy|7
7185519|NCT02112916|11385878|FG000|Overall Study|Development of SMN|1
7185520|NCT02112916|11385879|FG001|Overall Study|Development of SMN|0
7185521|NCT02112916|11385880|FG002|Overall Study|Development of SMN|0
7185522|NCT02112916|11385881|FG003|Overall Study|Development of SMN|1
7185523|NCT02112916|11385878|FG000|Overall Study|Relapse/Progression|10
7185524|NCT02112916|11385879|FG001|Overall Study|Relapse/Progression|18
7185525|NCT02112916|11385880|FG002|Overall Study|Relapse/Progression|15
7185526|NCT02112916|11385881|FG003|Overall Study|Relapse/Progression|2
7185527|NCT02112916|11385878|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5
7185528|NCT02112916|11385879|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5
7185529|NCT02112916|11385880|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0
7185530|NCT02112916|11385881|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0
7185531|NCT02112916|11385878|FG000|Overall Study|Still on Therapy|44
7185532|NCT02112916|11385879|FG001|Overall Study|Still on Therapy|47
7185533|NCT02112916|11385880|FG002|Overall Study|Still on Therapy|3
7185534|NCT02112916|11385881|FG003|Overall Study|Still on Therapy|2
7185535|NCT02112916|11385878|FG000|Overall Study|Identified to have Ph+ T-ALL|0
7185536|NCT02112916|11385879|FG001|Overall Study|Identified to have Ph+ T-ALL|1
7185537|NCT02112916|11385880|FG002|Overall Study|Identified to have Ph+ T-ALL|0
7185538|NCT02112916|11385881|FG003|Overall Study|Identified to have Ph+ T-ALL|0
7185539|NCT02112916|11385878|FG000|Overall Study|Identified to have Ph+ T-Lly|0
7185540|NCT02112916|11385879|FG001|Overall Study|Identified to have Ph+ T-Lly|0
7185541|NCT02112916|11385880|FG002|Overall Study|Identified to have Ph+ T-Lly|1
7185542|NCT02112916|11385881|FG003|Overall Study|Identified to have Ph+ T-Lly|0
7185545|NCT02135029|11385912|FG000|Overall Study|Adverse Event|2
7185546|NCT02135029|11385913|FG001|Overall Study|Adverse Event|2
7185547|NCT02135029|11385914|FG002|Overall Study|Adverse Event|2
7185548|NCT02135029|11385912|FG000|Overall Study|Lost to Follow-up|0
7185549|NCT02135029|11385913|FG001|Overall Study|Lost to Follow-up|1
7185550|NCT02135029|11385914|FG002|Overall Study|Lost to Follow-up|0
7185551|NCT02135029|11385912|FG000|Overall Study|Withdrawal by Subject|2
7185552|NCT02135029|11385913|FG001|Overall Study|Withdrawal by Subject|0
7185553|NCT02135029|11385914|FG002|Overall Study|Withdrawal by Subject|1
7185554|NCT02135029|11385912|FG000|Overall Study|Other|0
7185555|NCT02135029|11385913|FG001|Overall Study|Other|1
7185556|NCT02135029|11385914|FG002|Overall Study|Other|0
7185557|NCT02135029|11385912|FG000|Overall Study|Death|0
7185558|NCT02135029|11385913|FG001|Overall Study|Death|1
7185559|NCT02135029|11385914|FG002|Overall Study|Death|0
7185560|NCT02137239|11385925|FG000|Overall Study|Discontinued Study Treatment|0
7185561|NCT02137239|11385926|FG001|Overall Study|Discontinued Study Treatment|3
7185562|NCT02137239|11385925|FG000|Overall Study|Withdrew Consent|1
7185563|NCT02137239|11385926|FG001|Overall Study|Withdrew Consent|1
7185564|NCT02137239|11385925|FG000|Overall Study|Adverse Event|2
7185565|NCT02137239|11385926|FG001|Overall Study|Adverse Event|2
7172854|NCT01078662|11372659|FG000|Overall Study|Death|41
7172855|NCT01078662|11372660|FG001|Overall Study|Death|103
7172856|NCT01078662|11372661|FG002|Overall Study|Death|18
7172857|NCT01078662|11372662|FG003|Overall Study|Death|5
7172858|NCT01078662|11372663|FG004|Overall Study|Death|8
7172859|NCT01078662|11372659|FG000|Overall Study|Patients reached data cut-off|12
7172860|NCT01078662|11372660|FG001|Overall Study|Patients reached data cut-off|53
7172861|NCT01078662|11372661|FG002|Overall Study|Patients reached data cut-off|2
7172862|NCT01078662|11372662|FG003|Overall Study|Patients reached data cut-off|2
7172863|NCT01078662|11372663|FG004|Overall Study|Patients reached data cut-off|3
7172864|NCT01078662|11372659|FG000|Overall Study|Withdrawal by Subject|4
7172865|NCT01078662|11372660|FG001|Overall Study|Withdrawal by Subject|11
7172866|NCT01078662|11372661|FG002|Overall Study|Withdrawal by Subject|1
7172867|NCT01078662|11372662|FG003|Overall Study|Withdrawal by Subject|0
7172868|NCT01078662|11372663|FG004|Overall Study|Withdrawal by Subject|0
7172869|NCT01078662|11372659|FG000|Overall Study|Protocol Violation|0
7172870|NCT01078662|11372660|FG001|Overall Study|Protocol Violation|1
7172871|NCT01078662|11372661|FG002|Overall Study|Protocol Violation|0
7172872|NCT01078662|11372662|FG003|Overall Study|Protocol Violation|0
7172873|NCT01078662|11372663|FG004|Overall Study|Protocol Violation|0
7172874|NCT01078662|11372659|FG000|Overall Study|Lost to Follow-up|1
7172875|NCT01078662|11372660|FG001|Overall Study|Lost to Follow-up|0
7172876|NCT01078662|11372661|FG002|Overall Study|Lost to Follow-up|0
7172877|NCT01078662|11372662|FG003|Overall Study|Lost to Follow-up|0
7172878|NCT01078662|11372663|FG004|Overall Study|Lost to Follow-up|0
7172879|NCT00971867|11372672|FG000|Overall Study|Adverse Event|4
7172880|NCT00971867|11372672|FG000|Overall Study|Participant Withdrew Consent|1
7172881|NCT00971867|11372672|FG000|Overall Study|Disease Progression|6
7172882|NCT00853307|11372678|FG000|Overall Study|Adverse Event|1
7172883|NCT00853307|11372679|FG001|Overall Study|Adverse Event|2
7172884|NCT00853307|11372678|FG000|Overall Study|Withdrawal by Subject|1
7172885|NCT00853307|11372679|FG001|Overall Study|Withdrawal by Subject|2
7172886|NCT00853307|11372678|FG000|Overall Study|Reason Not Specified|0
7172887|NCT00853307|11372679|FG001|Overall Study|Reason Not Specified|1
7172888|NCT00545129|11372693|FG000|Overall Study|Lack of Efficacy|2
7172889|NCT00545129|11372694|FG001|Overall Study|Lack of Efficacy|5
7172890|NCT00545129|11372693|FG000|Overall Study|Death|2
7172891|NCT00545129|11372694|FG001|Overall Study|Death|1
7172892|NCT00545129|11372693|FG000|Overall Study|Adverse Event|1
7172893|NCT00545129|11372694|FG001|Overall Study|Adverse Event|1
7172894|NCT00545129|11372693|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9
7172895|NCT00545129|11372694|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14
7172896|NCT00545129|11372693|FG000|Overall Study|Other|3
7172897|NCT00545129|11372694|FG001|Overall Study|Other|3
7172910|NCT00554606|11372712|FG000|Overall Study|Adverse Event|3
7172911|NCT00554606|11372712|FG000|Overall Study|Abnormal laboratory values|1
7172912|NCT00554606|11372712|FG000|Overall Study|Unsatisfactory therapeutic effect|14
7172913|NCT00554606|11372712|FG000|Overall Study|Subject withdrew consent|2
7172914|NCT00554606|11372712|FG000|Overall Study|Lost to Follow-up|2
7172915|NCT00554606|11372712|FG000|Overall Study|Administrative problems|60
7172916|NCT00554606|11372712|FG000|Overall Study|Death|1
7172917|NCT00554606|11372712|FG000|Overall Study|Protocol deviation|2
7172922|NCT00566995|11372750|FG000|Overall Study|Toxicity|4
7172923|NCT00566995|11372750|FG000|Overall Study|Withdrew consent|3
7172924|NCT00586924|11372760|FG000|Overall Study|Adverse event/serious adverse event|0
7172925|NCT00586924|11372761|FG001|Overall Study|Adverse event/serious adverse event|0
7172926|NCT00586924|11372762|FG002|Overall Study|Adverse event/serious adverse event|0
7172927|NCT00586924|11372763|FG003|Overall Study|Adverse event/serious adverse event|1
7172928|NCT00586924|11372764|FG004|Overall Study|Adverse event/serious adverse event|0
7172929|NCT00586924|11372765|FG005|Overall Study|Adverse event/serious adverse event|2
7172930|NCT00586924|11372760|FG000|Overall Study|Initiation of alternative cancer therapy|0
7172931|NCT00586924|11372761|FG001|Overall Study|Initiation of alternative cancer therapy|0
7172932|NCT00586924|11372762|FG002|Overall Study|Initiation of alternative cancer therapy|0
7172933|NCT00586924|11372763|FG003|Overall Study|Initiation of alternative cancer therapy|0
7172934|NCT00586924|11372764|FG004|Overall Study|Initiation of alternative cancer therapy|0
7172935|NCT00586924|11372765|FG005|Overall Study|Initiation of alternative cancer therapy|1
6972875|NCT01175213|11024219|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1
6972876|NCT01175213|11024220|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0
6972877|NCT01175213|11024219|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6
6972878|NCT01175213|11024220|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0
6972879|NCT01175213|11024219|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3
6972880|NCT01175213|11024220|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0
7172936|NCT00586924|11372760|FG000|Overall Study|Disease progression|0
6972881|NCT01175213|11024219|FG000|Safety Follow-up|Adverse Event|1
6972882|NCT01175213|11024220|FG001|Safety Follow-up|Adverse Event|0
7172937|NCT00586924|11372761|FG001|Overall Study|Disease progression|0
7172938|NCT00586924|11372762|FG002|Overall Study|Disease progression|0
7172939|NCT00586924|11372763|FG003|Overall Study|Disease progression|1
7172940|NCT00586924|11372764|FG004|Overall Study|Disease progression|1
7172941|NCT00586924|11372765|FG005|Overall Study|Disease progression|0
7172942|NCT00586924|11372760|FG000|Overall Study|Development of neutralizing antibodies|2
7172943|NCT00586924|11372761|FG001|Overall Study|Development of neutralizing antibodies|2
7172898|NCT00548093|11372702|FG000|Overall Study|Death|33
7172899|NCT00548093|11372703|FG001|Overall Study|Death|13
7172900|NCT00548093|11372702|FG000|Overall Study|Lost to Follow-up|3
7172901|NCT00548093|11372703|FG001|Overall Study|Lost to Follow-up|1
7172902|NCT00548093|11372702|FG000|Overall Study|Objective progression or relapse|1
7172903|NCT00548093|11372703|FG001|Overall Study|Objective progression or relapse|1
7172904|NCT00548093|11372702|FG000|Overall Study|Other|11
7172905|NCT00548093|11372703|FG001|Overall Study|Other|1
7172906|NCT00548093|11372702|FG000|Overall Study|Withdrawal by Subject|1
7172907|NCT00548093|11372703|FG001|Overall Study|Withdrawal by Subject|0
7172908|NCT00548093|11372702|FG000|Overall Study|Completed post-treatment follow-up|1
7172909|NCT00548093|11372703|FG001|Overall Study|Completed post-treatment follow-up|0
7172918|NCT00555009|11372720|FG000|Overall Study|Withdrawal by Subject|0
7172919|NCT00555009|11372721|FG001|Overall Study|Withdrawal by Subject|1
7172920|NCT00555009|11372720|FG000|Overall Study|Terminated by Sponsor|2
7172921|NCT00555009|11372721|FG001|Overall Study|Terminated by Sponsor|5
7172944|NCT00586924|11372762|FG002|Overall Study|Development of neutralizing antibodies|2
7172945|NCT00586924|11372763|FG003|Overall Study|Development of neutralizing antibodies|0
7172946|NCT00586924|11372764|FG004|Overall Study|Development of neutralizing antibodies|0
7080667|NCT02124564|11190247|FG000|Treatment Period|Lack of Efficacy|3
7080668|NCT02124564|11190247|FG000|Treatment Period|Withdrawal by Subject|2
7080669|NCT02124707|11190257|FG000|Overall Study|Adverse Event|5
7172947|NCT00586924|11372765|FG005|Overall Study|Development of neutralizing antibodies|22
7172948|NCT00586924|11372760|FG000|Overall Study|Complete response|0
7172949|NCT00586924|11372761|FG001|Overall Study|Complete response|1
7172950|NCT00586924|11372762|FG002|Overall Study|Complete response|0
7172951|NCT00586924|11372763|FG003|Overall Study|Complete response|0
7172952|NCT00586924|11372764|FG004|Overall Study|Complete response|2
7172953|NCT00586924|11372765|FG005|Overall Study|Complete response|2
7172954|NCT00586924|11372760|FG000|Overall Study|Other|1
7172955|NCT00586924|11372761|FG001|Overall Study|Other|0
7172956|NCT00586924|11372762|FG002|Overall Study|Other|1
7172957|NCT00586924|11372763|FG003|Overall Study|Other|1
7172958|NCT00586924|11372764|FG004|Overall Study|Other|1
7172959|NCT00586924|11372765|FG005|Overall Study|Other|6
7185543|NCT02114697|11385898|FG000|Overall Study|Study terminated|5
7185544|NCT02114697|11385899|FG001|Overall Study|Study terminated|4
7185566|NCT02148133|11385932|FG000|Overall Study|Investigator discretion|1
7185567|NCT02148133|11385932|FG000|Overall Study|Lack of Efficacy|1
7185568|NCT02148133|11385932|FG000|Overall Study|Protocol deviation|1
7185569|NCT02148133|11385932|FG000|Overall Study|Protocol-defined stopping criteria|2
7188026|NCT04553406|11388689|FG000|Overall Study|Study Discontinuation|0
7188027|NCT04553406|11388690|FG001|Overall Study|Study Discontinuation|1
7188028|NCT03792750|11388696|FG000|Overall Study|Death|3
7188029|NCT03739138|11388717|FG000|Overall Study|Death|0
7188030|NCT03739138|11388718|FG001|Overall Study|Death|7
7188031|NCT03739138|11388719|FG002|Overall Study|Death|4
7188032|NCT03739138|11388720|FG003|Overall Study|Death|13
6972883|NCT01175382|11024263|FG000|Overall Study|Lost to Follow-up|4
6972884|NCT01175382|11024264|FG001|Overall Study|Lost to Follow-up|3
6972885|NCT01175382|11024265|FG002|Overall Study|Lost to Follow-up|1
6972886|NCT01175382|11024263|FG000|Overall Study|Physician Decision|0
7188033|NCT03739138|11388721|FG004|Overall Study|Death|0
7188034|NCT03739138|11388717|FG000|Overall Study|Lost to Follow-up|0
7080670|NCT02124707|11190257|FG000|Overall Study|Physician Decision|1
7188035|NCT03739138|11388718|FG001|Overall Study|Lost to Follow-up|0
7188036|NCT03739138|11388719|FG002|Overall Study|Lost to Follow-up|1
7188037|NCT03739138|11388720|FG003|Overall Study|Lost to Follow-up|0
7188038|NCT03739138|11388721|FG004|Overall Study|Lost to Follow-up|0
7188039|NCT03739138|11388717|FG000|Overall Study|Study Terminated By Sponsor|0
7188040|NCT03739138|11388718|FG001|Overall Study|Study Terminated By Sponsor|0
7188041|NCT03739138|11388719|FG002|Overall Study|Study Terminated By Sponsor|0
7188042|NCT03739138|11388720|FG003|Overall Study|Study Terminated By Sponsor|4
7188043|NCT03739138|11388721|FG004|Overall Study|Study Terminated By Sponsor|0
7188044|NCT03739138|11388717|FG000|Overall Study|Withdrawal by Subject|0
7188045|NCT03739138|11388718|FG001|Overall Study|Withdrawal by Subject|0
7188046|NCT03739138|11388719|FG002|Overall Study|Withdrawal by Subject|0
7188047|NCT03739138|11388720|FG003|Overall Study|Withdrawal by Subject|1
7188048|NCT03739138|11388721|FG004|Overall Study|Withdrawal by Subject|0
7188049|NCT03518086|11388731|FG000|Overall Study|Adverse Event|23
7188050|NCT03518086|11388732|FG001|Overall Study|Adverse Event|15
7188051|NCT03518086|11388733|FG002|Overall Study|Adverse Event|0
7188052|NCT03518086|11388734|FG003|Overall Study|Adverse Event|0
7188053|NCT03518086|11388731|FG000|Overall Study|Withdrawal by Subject|8
7188054|NCT03518086|11388732|FG001|Overall Study|Withdrawal by Subject|5
7188055|NCT03518086|11388733|FG002|Overall Study|Withdrawal by Subject|0
6972887|NCT01175382|11024264|FG001|Overall Study|Physician Decision|1
7188056|NCT03518086|11388734|FG003|Overall Study|Withdrawal by Subject|0
7188057|NCT03518086|11388731|FG000|Overall Study|Lack of Efficacy|5
7188058|NCT03518086|11388732|FG001|Overall Study|Lack of Efficacy|5
7188059|NCT03518086|11388733|FG002|Overall Study|Lack of Efficacy|0
7188060|NCT03518086|11388734|FG003|Overall Study|Lack of Efficacy|0
7188061|NCT03518086|11388731|FG000|Overall Study|Protocol Violation|1
7188062|NCT03518086|11388732|FG001|Overall Study|Protocol Violation|5
7188063|NCT03518086|11388733|FG002|Overall Study|Protocol Violation|0
7188064|NCT03518086|11388734|FG003|Overall Study|Protocol Violation|0
7172960|NCT00588861|11372781|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95
7172961|NCT00588861|11372782|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86
7172962|NCT00588861|11372781|FG000|6 Months|Patients did not return for follow-up|98
7172963|NCT00588861|11372782|FG001|6 Months|Patients did not return for follow-up|73
7172964|NCT00588861|11372781|FG000|1 Year|Patients did not return for follow-up|89
7172965|NCT00588861|11372782|FG001|1 Year|Patients did not return for follow-up|82
7172966|NCT00588861|11372781|FG000|2 Years|Patients did not return for follow-up|92
7172967|NCT00588861|11372782|FG001|2 Years|Patients did not return for follow-up|87
7172968|NCT00588861|11372781|FG000|4 Years|Patients did not return for follow-up|91
7172969|NCT00588861|11372782|FG001|4 Years|Patients did not return for follow-up|103
7172970|NCT00588861|11372781|FG000|6 Years|Patients did not return for follow-up|104
7172971|NCT00588861|11372782|FG001|6 Years|Patients did not return for follow-up|109
7172972|NCT00588861|11372781|FG000|8 Years|Patients did not return for follow-up|105
7172973|NCT00588861|11372782|FG001|8 Years|Patients did not return for follow-up|114
7172974|NCT00588861|11372781|FG000|10 Years|Incomplete due to study termination|107
7172975|NCT00588861|11372782|FG001|10 Years|Incomplete due to study termination|114
7185570|NCT02165215|11385952|FG000|Induction Phase|Adverse Event|1
7185571|NCT02165215|11385953|FG001|Induction Phase|Adverse Event|0
7185572|NCT02165215|11385954|FG002|Induction Phase|Adverse Event|0
7185573|NCT02165215|11385952|FG000|Induction Phase|Withdrawal by Subject|10
7185574|NCT02165215|11385953|FG001|Induction Phase|Withdrawal by Subject|0
7185575|NCT02165215|11385954|FG002|Induction Phase|Withdrawal by Subject|0
7185576|NCT02165215|11385952|FG000|Induction Phase|Protocol Violation|1
7185577|NCT02165215|11385953|FG001|Induction Phase|Protocol Violation|0
7185578|NCT02165215|11385954|FG002|Induction Phase|Protocol Violation|0
7185579|NCT02165215|11385952|FG000|Induction Phase|Physician Decision|1
7185580|NCT02165215|11385953|FG001|Induction Phase|Physician Decision|0
7185581|NCT02165215|11385954|FG002|Induction Phase|Physician Decision|0
7185582|NCT02165215|11385952|FG000|Induction Phase|Lack of Efficacy|2
7185583|NCT02165215|11385953|FG001|Induction Phase|Lack of Efficacy|0
7185584|NCT02165215|11385954|FG002|Induction Phase|Lack of Efficacy|0
7185585|NCT02165215|11385952|FG000|Induction Phase|Non-Compliance|2
7185586|NCT02165215|11385953|FG001|Induction Phase|Non-Compliance|0
7185587|NCT02165215|11385954|FG002|Induction Phase|Non-Compliance|0
7185588|NCT02165215|11385952|FG000|Induction Phase|Lost to Follow-up|6
7185589|NCT02165215|11385953|FG001|Induction Phase|Lost to Follow-up|0
7185590|NCT02165215|11385954|FG002|Induction Phase|Lost to Follow-up|0
7185591|NCT02165215|11385952|FG000|Maintenance Phase|Withdrawal by Subject|0
7185592|NCT02165215|11385953|FG001|Maintenance Phase|Withdrawal by Subject|7
7185593|NCT02165215|11385954|FG002|Maintenance Phase|Withdrawal by Subject|3
7185594|NCT02165215|11385952|FG000|Maintenance Phase|Multiple reasons|0
7185595|NCT02165215|11385953|FG001|Maintenance Phase|Multiple reasons|2
7185596|NCT02165215|11385954|FG002|Maintenance Phase|Multiple reasons|1
7185597|NCT02165215|11385952|FG000|Maintenance Phase|Lost to Follow-up|0
7185598|NCT02165215|11385953|FG001|Maintenance Phase|Lost to Follow-up|2
7185599|NCT02165215|11385954|FG002|Maintenance Phase|Lost to Follow-up|0
7185600|NCT02165215|11385952|FG000|Maintenance Phase|Adverse Event|0
7185601|NCT02165215|11385953|FG001|Maintenance Phase|Adverse Event|1
7185602|NCT02165215|11385954|FG002|Maintenance Phase|Adverse Event|1
7185603|NCT02180217|11385968|FG000|Overall Study|Adverse Event|3
7185604|NCT02180217|11385969|FG001|Overall Study|Adverse Event|2
7185605|NCT02180217|11385970|FG002|Overall Study|Adverse Event|22
7185606|NCT02180217|11385968|FG000|Overall Study|Death|1
7185607|NCT02180217|11385969|FG001|Overall Study|Death|1
7185608|NCT02180217|11385970|FG002|Overall Study|Death|0
7185609|NCT02180217|11385968|FG000|Overall Study|Withdrawal by Subject|1
7185610|NCT02180217|11385969|FG001|Overall Study|Withdrawal by Subject|1
7185611|NCT02180217|11385970|FG002|Overall Study|Withdrawal by Subject|4
7185612|NCT02180217|11385968|FG000|Overall Study|Subject/Guardian decision|5
7185613|NCT02180217|11385969|FG001|Overall Study|Subject/Guardian decision|3
7185614|NCT02180217|11385970|FG002|Overall Study|Subject/Guardian decision|6
7185615|NCT02180217|11385968|FG000|Overall Study|Physician Decision|1
7185616|NCT02180217|11385969|FG001|Overall Study|Physician Decision|1
7185617|NCT02180217|11385970|FG002|Overall Study|Physician Decision|6
7185618|NCT02180217|11385968|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7185619|NCT02180217|11385969|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7185620|NCT02180217|11385970|FG002|Overall Study|Unsatisfactory therapeutic effect|0
7185621|NCT02193867|11385994|FG000|Overall Study|Death|2
7185622|NCT02193867|11385994|FG000|Overall Study|Sponsor Study Termination|2
7185623|NCT02215096|11386001|FG000|Run-In Period (Up to Week 2)|Adverse Event|1
7185624|NCT02215096|11386002|FG001|Run-In Period (Up to Week 2)|Adverse Event|0
7185625|NCT02215096|11386003|FG002|Run-In Period (Up to Week 2)|Adverse Event|0
7185626|NCT02215096|11386004|FG003|Run-In Period (Up to Week 2)|Adverse Event|0
7185627|NCT02215096|11386005|FG004|Run-In Period (Up to Week 2)|Adverse Event|0
7185628|NCT02215096|11386001|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
7185629|NCT02215096|11386002|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
7185630|NCT02215096|11386003|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
7185631|NCT02215096|11386004|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
7185632|NCT02215096|11386005|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1
7185633|NCT02215096|11386001|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
7172976|NCT00602030|11372792|FG000|Lead-in Phase|Disease Progression|2
7080671|NCT02124707|11190257|FG000|Overall Study|Death|1
7080672|NCT02124746|11190265|FG000|Overall Study|Adverse Event|2
7080673|NCT02124746|11190266|FG001|Overall Study|Adverse Event|1
7080674|NCT02124746|11190267|FG002|Overall Study|Adverse Event|2
7080675|NCT02124746|11190265|FG000|Overall Study|Death|2
7080676|NCT02124746|11190266|FG001|Overall Study|Death|1
7080677|NCT02124746|11190267|FG002|Overall Study|Death|3
7080678|NCT02124746|11190265|FG000|Overall Study|Lack of Efficacy|3
7080679|NCT02124746|11190266|FG001|Overall Study|Lack of Efficacy|2
7080680|NCT02124746|11190267|FG002|Overall Study|Lack of Efficacy|2
7172977|NCT00602030|11372793|FG001|Lead-in Phase|Disease Progression|3
7172978|NCT00602030|11372794|FG002|Lead-in Phase|Disease Progression|0
7172979|NCT00602030|11372795|FG003|Lead-in Phase|Disease Progression|0
7172980|NCT00602030|11372796|FG004|Lead-in Phase|Disease Progression|0
7172981|NCT00602030|11372792|FG000|Lead-in Phase|Adverse Event|0
7172982|NCT00602030|11372793|FG001|Lead-in Phase|Adverse Event|2
7172983|NCT00602030|11372794|FG002|Lead-in Phase|Adverse Event|0
7172984|NCT00602030|11372795|FG003|Lead-in Phase|Adverse Event|0
7172985|NCT00602030|11372796|FG004|Lead-in Phase|Adverse Event|0
7172986|NCT00602030|11372792|FG000|Double-blind Phase|Disease progression|0
7172987|NCT00602030|11372793|FG001|Double-blind Phase|Disease progression|0
7172988|NCT00602030|11372794|FG002|Double-blind Phase|Disease progression|33
7172989|NCT00602030|11372795|FG003|Double-blind Phase|Disease progression|30
7172990|NCT00602030|11372796|FG004|Double-blind Phase|Disease progression|0
7172991|NCT00602030|11372792|FG000|Double-blind Phase|Adverse Event|0
7172992|NCT00602030|11372793|FG001|Double-blind Phase|Adverse Event|0
7172993|NCT00602030|11372794|FG002|Double-blind Phase|Adverse Event|9
7172994|NCT00602030|11372795|FG003|Double-blind Phase|Adverse Event|18
7172995|NCT00602030|11372796|FG004|Double-blind Phase|Adverse Event|0
7172996|NCT00602030|11372792|FG000|Double-blind Phase|Consent withdrawal|0
7172997|NCT00602030|11372793|FG001|Double-blind Phase|Consent withdrawal|0
7172998|NCT00602030|11372794|FG002|Double-blind Phase|Consent withdrawal|4
7172999|NCT00602030|11372795|FG003|Double-blind Phase|Consent withdrawal|3
7173000|NCT00602030|11372796|FG004|Double-blind Phase|Consent withdrawal|0
7173001|NCT00602030|11372792|FG000|Double-blind Phase|Death|0
7173002|NCT00602030|11372793|FG001|Double-blind Phase|Death|0
7173003|NCT00602030|11372794|FG002|Double-blind Phase|Death|3
7173004|NCT00602030|11372795|FG003|Double-blind Phase|Death|3
7173005|NCT00602030|11372796|FG004|Double-blind Phase|Death|0
7173006|NCT00602030|11372792|FG000|Double-blind Phase|Administrative decision|0
7173007|NCT00602030|11372793|FG001|Double-blind Phase|Administrative decision|0
7173008|NCT00602030|11372794|FG002|Double-blind Phase|Administrative decision|0
7173009|NCT00602030|11372795|FG003|Double-blind Phase|Administrative decision|2
7173010|NCT00602030|11372796|FG004|Double-blind Phase|Administrative decision|0
7173011|NCT00602030|11372792|FG000|Double-blind Phase|Ineligibility|0
7173012|NCT00602030|11372793|FG001|Double-blind Phase|Ineligibility|0
7173013|NCT00602030|11372794|FG002|Double-blind Phase|Ineligibility|0
7173014|NCT00602030|11372795|FG003|Double-blind Phase|Ineligibility|1
7173015|NCT00602030|11372796|FG004|Double-blind Phase|Ineligibility|0
7173016|NCT00602030|11372792|FG000|Double-blind Phase|Protocol deviation/noncompliance|0
7173017|NCT00602030|11372793|FG001|Double-blind Phase|Protocol deviation/noncompliance|0
7173018|NCT00602030|11372794|FG002|Double-blind Phase|Protocol deviation/noncompliance|1
7173019|NCT00602030|11372795|FG003|Double-blind Phase|Protocol deviation/noncompliance|0
7173020|NCT00602030|11372796|FG004|Double-blind Phase|Protocol deviation/noncompliance|0
7173021|NCT00602030|11372792|FG000|Double-blind Phase|Reason not specified|0
7173022|NCT00602030|11372793|FG001|Double-blind Phase|Reason not specified|0
7173023|NCT00602030|11372794|FG002|Double-blind Phase|Reason not specified|4
7173024|NCT00602030|11372795|FG003|Double-blind Phase|Reason not specified|2
7173025|NCT00602030|11372796|FG004|Double-blind Phase|Reason not specified|0
7173026|NCT00602030|11372792|FG000|Crossover Phase|Disease Progression|0
7173027|NCT00602030|11372793|FG001|Crossover Phase|Disease Progression|0
7173028|NCT00602030|11372794|FG002|Crossover Phase|Disease Progression|0
7173029|NCT00602030|11372795|FG003|Crossover Phase|Disease Progression|0
7173030|NCT00602030|11372796|FG004|Crossover Phase|Disease Progression|11
7173031|NCT00602030|11372792|FG000|Crossover Phase|Adverse Event|0
7173032|NCT00602030|11372793|FG001|Crossover Phase|Adverse Event|0
7173033|NCT00602030|11372794|FG002|Crossover Phase|Adverse Event|0
7173034|NCT00602030|11372795|FG003|Crossover Phase|Adverse Event|0
7173035|NCT00602030|11372796|FG004|Crossover Phase|Adverse Event|3
7173036|NCT00602030|11372792|FG000|Crossover Phase|Consent withdrawal|0
7173037|NCT00602030|11372793|FG001|Crossover Phase|Consent withdrawal|0
7173038|NCT00602030|11372794|FG002|Crossover Phase|Consent withdrawal|0
7173039|NCT00602030|11372795|FG003|Crossover Phase|Consent withdrawal|0
7173040|NCT00602030|11372796|FG004|Crossover Phase|Consent withdrawal|2
7173041|NCT03288142|11372810|FG000|Overall Study|Lost to Follow-up|22
7173042|NCT03288142|11372811|FG001|Overall Study|Lost to Follow-up|15
7173043|NCT03112603|11372821|FG000|End of Randomization Period|Lost to Follow-up|1
7173044|NCT03112603|11372822|FG001|End of Randomization Period|Lost to Follow-up|0
7080681|NCT02124746|11190265|FG000|Overall Study|Physician Decision|6
7080682|NCT02124746|11190266|FG001|Overall Study|Physician Decision|4
7173045|NCT03112603|11372823|FG002|End of Randomization Period|Lost to Follow-up|0
7173046|NCT03112603|11372821|FG000|End of Randomization Period|Subject/Guardian Decision|4
7173047|NCT03112603|11372822|FG001|End of Randomization Period|Subject/Guardian Decision|11
7173048|NCT03112603|11372823|FG002|End of Randomization Period|Subject/Guardian Decision|0
7173049|NCT03112603|11372821|FG000|End of Randomization Period|Physician Decision|4
7173050|NCT03112603|11372822|FG001|End of Randomization Period|Physician Decision|14
7173051|NCT03112603|11372823|FG002|End of Randomization Period|Physician Decision|0
7173052|NCT03112603|11372821|FG000|End of Randomization Period|Failure to meet protocol continuation criteria|4
7173053|NCT03112603|11372822|FG001|End of Randomization Period|Failure to meet protocol continuation criteria|5
7173054|NCT03112603|11372823|FG002|End of Randomization Period|Failure to meet protocol continuation criteria|0
7173055|NCT03112603|11372821|FG000|End of Randomization Period|Death|8
7173056|NCT03112603|11372822|FG001|End of Randomization Period|Death|7
7173057|NCT03112603|11372823|FG002|End of Randomization Period|Death|0
7173058|NCT03112603|11372821|FG000|End of Randomization Period|Disease Relapse|9
7173059|NCT03112603|11372822|FG001|End of Randomization Period|Disease Relapse|7
7173060|NCT03112603|11372823|FG002|End of Randomization Period|Disease Relapse|0
7173061|NCT03112603|11372821|FG000|End of Randomization Period|Lack of Efficacy|24
7173062|NCT03112603|11372822|FG001|End of Randomization Period|Lack of Efficacy|70
7173063|NCT03112603|11372823|FG002|End of Randomization Period|Lack of Efficacy|0
7173064|NCT03112603|11372821|FG000|End of Randomization Period|Adverse Event|28
7173065|NCT03112603|11372822|FG001|End of Randomization Period|Adverse Event|8
7173066|NCT03112603|11372823|FG002|End of Randomization Period|Adverse Event|0
7173067|NCT03112603|11372821|FG000|End of Randomization Period|Ongoing Treatment|83
7173068|NCT03112603|11372822|FG001|End of Randomization Period|Ongoing Treatment|42
7173069|NCT03112603|11372823|FG002|End of Randomization Period|Ongoing Treatment|0
7173070|NCT03112603|11372821|FG000|End of Cross Over Period|Death|0
7173071|NCT03112603|11372822|FG001|End of Cross Over Period|Death|0
7173072|NCT03112603|11372823|FG002|End of Cross Over Period|Death|1
7173073|NCT03112603|11372821|FG000|End of Cross Over Period|Subject/Guardian Decision|0
7173074|NCT03112603|11372822|FG001|End of Cross Over Period|Subject/Guardian Decision|0
7173075|NCT03112603|11372823|FG002|End of Cross Over Period|Subject/Guardian Decision|3
7173076|NCT03112603|11372821|FG000|End of Cross Over Period|Physician Decision|0
7173077|NCT03112603|11372822|FG001|End of Cross Over Period|Physician Decision|0
7173078|NCT03112603|11372823|FG002|End of Cross Over Period|Physician Decision|3
7173079|NCT03112603|11372821|FG000|End of Cross Over Period|Lack of Efficacy|0
7173080|NCT03112603|11372822|FG001|End of Cross Over Period|Lack of Efficacy|0
7173081|NCT03112603|11372823|FG002|End of Cross Over Period|Lack of Efficacy|4
7173082|NCT03112603|11372821|FG000|End of Cross Over Period|Adverse Event|0
7173083|NCT03112603|11372822|FG001|End of Cross Over Period|Adverse Event|0
7173084|NCT03112603|11372823|FG002|End of Cross Over Period|Adverse Event|4
7173085|NCT03112603|11372821|FG000|End of Cross Over Period|Treatment Ongoing|0
7173086|NCT03112603|11372822|FG001|End of Cross Over Period|Treatment Ongoing|0
7173087|NCT03112603|11372823|FG002|End of Cross Over Period|Treatment Ongoing|46
7173088|NCT02908672|11372831|FG000|Overall Study|Death|112
7173089|NCT02908672|11372832|FG001|Overall Study|Death|93
7173090|NCT02908672|11372831|FG000|Overall Study|Lost to Follow-up|3
7173091|NCT02908672|11372832|FG001|Overall Study|Lost to Follow-up|3
7173092|NCT02908672|11372831|FG000|Overall Study|Other|2
7173093|NCT02908672|11372832|FG001|Overall Study|Other|0
7173094|NCT02908672|11372831|FG000|Overall Study|Protocol Violation|1
7173095|NCT02908672|11372832|FG001|Overall Study|Protocol Violation|1
7173096|NCT02908672|11372831|FG000|Overall Study|Withdrawal by Subject|13
7173097|NCT02908672|11372832|FG001|Overall Study|Withdrawal by Subject|18
7173098|NCT02908672|11372831|FG000|Overall Study|Study is ongoing|124
7173099|NCT02908672|11372832|FG001|Overall Study|Study is ongoing|141
7173100|NCT02908672|11372831|FG000|Overall Study|Discontinued the study during run-in|3
7173101|NCT02908672|11372832|FG001|Overall Study|Discontinued the study during run-in|0
7185634|NCT02215096|11386002|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
7185635|NCT02215096|11386003|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
7185636|NCT02215096|11386004|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1
7185637|NCT02215096|11386005|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
7185638|NCT02215096|11386001|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0
7185639|NCT02215096|11386002|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2
7185640|NCT02215096|11386003|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1
7185641|NCT02215096|11386004|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1
7185642|NCT02215096|11386005|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0
7188065|NCT03518086|11388731|FG000|Overall Study|Lost to Follow-up|0
7188066|NCT03518086|11388732|FG001|Overall Study|Lost to Follow-up|3
7188067|NCT03518086|11388733|FG002|Overall Study|Lost to Follow-up|0
7188068|NCT03518086|11388734|FG003|Overall Study|Lost to Follow-up|0
7188069|NCT03518086|11388731|FG000|Overall Study|Insufficient Diary Data|0
7188070|NCT03518086|11388732|FG001|Overall Study|Insufficient Diary Data|2
7188071|NCT03518086|11388733|FG002|Overall Study|Insufficient Diary Data|0
7188072|NCT03518086|11388734|FG003|Overall Study|Insufficient Diary Data|0
7188073|NCT03518086|11388731|FG000|Overall Study|Non- compliance to Protocol|0
7188074|NCT03518086|11388732|FG001|Overall Study|Non- compliance to Protocol|1
7188075|NCT03518086|11388733|FG002|Overall Study|Non- compliance to Protocol|0
7188076|NCT03518086|11388734|FG003|Overall Study|Non- compliance to Protocol|0
7188077|NCT03518086|11388731|FG000|Overall Study|COVID-19 Related Study Disruption|0
7173102|NCT02767570|11372840|FG000|Overall Study|Lost to Follow-up|3
7173103|NCT02767570|11372841|FG001|Overall Study|Lost to Follow-up|0
7173104|NCT02767570|11372840|FG000|Overall Study|COVID shutdown|2
7173105|NCT02767570|11372841|FG001|Overall Study|COVID shutdown|5
7173106|NCT02767570|11372840|FG000|Overall Study|Increased pain|2
7173107|NCT02767570|11372841|FG001|Overall Study|Increased pain|0
7173108|NCT02767570|11372840|FG000|Overall Study|Withdrawal by Subject|1
7173109|NCT02767570|11372841|FG001|Overall Study|Withdrawal by Subject|3
7173110|NCT02767570|11372840|FG000|Overall Study|Unrelated medical issue|1
7173111|NCT02767570|11372841|FG001|Overall Study|Unrelated medical issue|1
7173112|NCT02767570|11372840|FG000|Overall Study|Received intra-articular injection|0
7173113|NCT02767570|11372841|FG001|Overall Study|Received intra-articular injection|1
7173114|NCT02702180|11372850|FG000|Double-blind Treatment Period|Withdrawal by Subject|1
7173115|NCT02702180|11372851|FG001|Double-blind Treatment Period|Withdrawal by Subject|1
7173116|NCT02702180|11372852|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
7173117|NCT02702180|11372850|FG000|Double-blind Treatment Period|Adverse Event|0
6972888|NCT01175382|11024265|FG002|Overall Study|Physician Decision|0
6972889|NCT01175382|11024263|FG000|Overall Study|Withdrawal by Subject|0
6972890|NCT01175382|11024264|FG001|Overall Study|Withdrawal by Subject|0
6972891|NCT01175382|11024265|FG002|Overall Study|Withdrawal by Subject|1
6972892|NCT01175382|11024263|FG000|Overall Study|No longer having problem|1
6972893|NCT01175382|11024264|FG001|Overall Study|No longer having problem|0
6972894|NCT01175382|11024265|FG002|Overall Study|No longer having problem|1
6972895|NCT01175382|11024263|FG000|Overall Study|Unable/unwilling to attend visits|3
6972896|NCT01175382|11024264|FG001|Overall Study|Unable/unwilling to attend visits|1
6972897|NCT01175382|11024265|FG002|Overall Study|Unable/unwilling to attend visits|2
6972898|NCT01175382|11024263|FG000|Overall Study|Unwilling to follow protocol|0
6972899|NCT01175382|11024264|FG001|Overall Study|Unwilling to follow protocol|1
7173118|NCT02702180|11372851|FG001|Double-blind Treatment Period|Adverse Event|0
7173119|NCT02702180|11372852|FG002|Double-blind Treatment Period|Adverse Event|1
7173120|NCT02702180|11372850|FG000|Double-blind Treatment Period|Lack of Efficacy|0
7173121|NCT02702180|11372851|FG001|Double-blind Treatment Period|Lack of Efficacy|0
7173122|NCT02702180|11372852|FG002|Double-blind Treatment Period|Lack of Efficacy|1
7173123|NCT02702180|11372850|FG000|Double-blind Treatment Period|Protocol Violation|0
7173124|NCT02702180|11372851|FG001|Double-blind Treatment Period|Protocol Violation|0
7173125|NCT02702180|11372852|FG002|Double-blind Treatment Period|Protocol Violation|2
7173126|NCT02702180|11372850|FG000|Open-label Treatment Period|Withdrawal by Subject|0
7173127|NCT02702180|11372851|FG001|Open-label Treatment Period|Withdrawal by Subject|1
7173128|NCT02702180|11372852|FG002|Open-label Treatment Period|Withdrawal by Subject|1
7173129|NCT02702180|11372850|FG000|Open-label Treatment Period|Withdrawn in error|0
7173130|NCT02702180|11372851|FG001|Open-label Treatment Period|Withdrawn in error|0
7173131|NCT02702180|11372852|FG002|Open-label Treatment Period|Withdrawn in error|1
7173132|NCT02545049|11372863|FG000|Overall Study|Withdrawal by Subject|1
7173133|NCT02545049|11372864|FG001|Overall Study|Withdrawal by Subject|7
7173134|NCT02545049|11372863|FG000|Overall Study|Lost to Follow-up|4
7173135|NCT02545049|11372864|FG001|Overall Study|Lost to Follow-up|6
7173136|NCT02545049|11372863|FG000|Overall Study|GCP violations|37
7173137|NCT02545049|11372864|FG001|Overall Study|GCP violations|48
7173138|NCT02448381|11372872|FG000|Overall Study|Adverse Event|2
7173139|NCT02448381|11372873|FG001|Overall Study|Adverse Event|0
7173140|NCT02448381|11372872|FG000|Overall Study|Lost to Follow-up|16
7173141|NCT02448381|11372873|FG001|Overall Study|Lost to Follow-up|9
7173142|NCT02448381|11372872|FG000|Overall Study|Physician Decision|1
7173143|NCT02448381|11372873|FG001|Overall Study|Physician Decision|1
7173144|NCT02448381|11372872|FG000|Overall Study|Pregnancy|1
7173145|NCT02448381|11372873|FG001|Overall Study|Pregnancy|0
7173146|NCT02448381|11372872|FG000|Overall Study|Withdrawal by Subject|13
7173147|NCT02448381|11372873|FG001|Overall Study|Withdrawal by Subject|9
7173148|NCT02448381|11372872|FG000|Overall Study|Noncompliance with Study Procedures|2
7173149|NCT02448381|11372873|FG001|Overall Study|Noncompliance with Study Procedures|0
7173150|NCT02151981|11372887|FG000|Overall Study|Death|184
7173151|NCT02151981|11372888|FG001|Overall Study|Death|88
7173152|NCT02151981|11372887|FG000|Overall Study|Lost to Follow-up|7
7173153|NCT02151981|11372888|FG001|Overall Study|Lost to Follow-up|1
7173154|NCT02151981|11372887|FG000|Overall Study|Withdrawal by Subject|27
7173155|NCT02151981|11372888|FG001|Overall Study|Withdrawal by Subject|21
7173156|NCT02151981|11372887|FG000|Overall Study|Ongoing Study at Data Cut-off|60
7173157|NCT02151981|11372888|FG001|Overall Study|Ongoing Study at Data Cut-off|27
7173158|NCT02151981|11372887|FG000|Overall Study|Eligibility criteria not fulfilled|0
7173159|NCT02151981|11372888|FG001|Overall Study|Eligibility criteria not fulfilled|1
7173160|NCT02151981|11372887|FG000|Overall Study|Patient had no clinical benefit|1
7173161|NCT02151981|11372888|FG001|Overall Study|Patient had no clinical benefit|0
7173162|NCT02151981|11372887|FG000|Overall Study|Unwilling to continue to follow up visit|0
7173163|NCT02151981|11372888|FG001|Overall Study|Unwilling to continue to follow up visit|1
7173164|NCT02151981|11372887|FG000|Overall Study|Study terminated|0
7173165|NCT02151981|11372888|FG001|Overall Study|Study terminated|1
7173166|NCT01972217|11372898|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
6972900|NCT01175382|11024265|FG002|Overall Study|Unwilling to follow protocol|0
6972901|NCT01175382|11024263|FG000|Overall Study|Unable to tolerate study meds|0
6972902|NCT01175382|11024264|FG001|Overall Study|Unable to tolerate study meds|1
7173167|NCT01972217|11372899|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1
7173168|NCT01972217|11372900|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
7173169|NCT01972217|11372901|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
7173170|NCT01972217|11372898|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1
7173171|NCT01972217|11372899|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9
7173172|NCT01972217|11372900|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0
7173173|NCT01972217|11372901|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0
7173174|NCT01972217|11372898|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0
7173175|NCT01972217|11372899|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1
7173176|NCT01972217|11372900|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0
7173177|NCT01972217|11372901|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0
7173178|NCT01972217|11372898|FG000|Part A: Open-label Safety Run-in Period|Death|0
7173179|NCT01972217|11372899|FG001|Part A: Open-label Safety Run-in Period|Death|1
7173180|NCT01972217|11372900|FG002|Part A: Open-label Safety Run-in Period|Death|0
7173181|NCT01972217|11372901|FG003|Part A: Open-label Safety Run-in Period|Death|0
7173182|NCT01972217|11372898|FG000|Part B Double-blind, Randomised Period|Death|0
7173183|NCT01972217|11372899|FG001|Part B Double-blind, Randomised Period|Death|0
7173184|NCT01972217|11372900|FG002|Part B Double-blind, Randomised Period|Death|43
7173185|NCT01972217|11372901|FG003|Part B Double-blind, Randomised Period|Death|44
7173186|NCT01972217|11372898|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0
7173187|NCT01972217|11372899|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0
7173188|NCT01972217|11372900|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1
7173189|NCT01972217|11372901|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0
7173190|NCT01972217|11372898|FG000|Part B Double-blind, Randomised Period|Screen failure|0
7173191|NCT01972217|11372899|FG001|Part B Double-blind, Randomised Period|Screen failure|0
7173192|NCT01972217|11372900|FG002|Part B Double-blind, Randomised Period|Screen failure|0
7173193|NCT01972217|11372901|FG003|Part B Double-blind, Randomised Period|Screen failure|1
7173194|NCT01972217|11372898|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0
7173195|NCT01972217|11372899|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0
7173196|NCT01972217|11372900|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2
7173197|NCT01972217|11372901|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1
7173198|NCT01972217|11372898|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
7173199|NCT01972217|11372899|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
7173200|NCT01972217|11372900|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
7173201|NCT01972217|11372901|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1
7173202|NCT01849874|11372915|FG000|Overall Study|Death|34
7173203|NCT01849874|11372916|FG001|Overall Study|Death|16
7173204|NCT01849874|11372915|FG000|Overall Study|Withdrawal by Subject|4
7173205|NCT01849874|11372916|FG001|Overall Study|Withdrawal by Subject|8
7173206|NCT01849874|11372915|FG000|Overall Study|Lost to Follow-up|0
7173207|NCT01849874|11372916|FG001|Overall Study|Lost to Follow-up|1
7173208|NCT01849874|11372915|FG000|Overall Study|Randomized but Never Treated|1
7173209|NCT01849874|11372916|FG001|Overall Study|Randomized but Never Treated|8
7173210|NCT01849874|11372915|FG000|Overall Study|Ongoing|162
7173211|NCT01849874|11372916|FG001|Overall Study|Ongoing|69
7173212|NCT01724866|11372926|FG000|Overall Study|Adverse Event|0
7173213|NCT01724866|11372927|FG001|Overall Study|Adverse Event|0
7173214|NCT01724866|11372928|FG002|Overall Study|Adverse Event|1
7173215|NCT01724866|11372929|FG003|Overall Study|Adverse Event|1
7173216|NCT01724866|11372926|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0
7173217|NCT01724866|11372927|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2
7173218|NCT01724866|11372928|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0
7173219|NCT01724866|11372929|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0
7173220|NCT01724866|11372926|FG000|Overall Study|Investigator's Discretion|0
7173221|NCT01724866|11372927|FG001|Overall Study|Investigator's Discretion|1
7173222|NCT01724866|11372928|FG002|Overall Study|Investigator's Discretion|1
7173223|NCT01724866|11372929|FG003|Overall Study|Investigator's Discretion|0
7173224|NCT01724866|11372926|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1
7173225|NCT01724866|11372927|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0
7173226|NCT01724866|11372928|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0
7173227|NCT01724866|11372929|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0
7173228|NCT01724866|11372926|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0
7173229|NCT01724866|11372927|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2
7173230|NCT01724866|11372928|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1
7173231|NCT01724866|11372929|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0
7173232|NCT01670877|11372943|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0
7173233|NCT01670877|11372944|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1
7173234|NCT01670877|11372945|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0
7173235|NCT01670877|11372946|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0
7173236|NCT01670877|11372947|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0
7173237|NCT01670877|11372948|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0
7173238|NCT01670877|11372943|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0
7173239|NCT01670877|11372944|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0
7173240|NCT01670877|11372945|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1
7173241|NCT01670877|11372946|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0
7173242|NCT01670877|11372947|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0
7173243|NCT01670877|11372948|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0
7173244|NCT01670877|11372943|FG000|Part I and Part 2|Grade 2 vomiting|0
7173245|NCT01670877|11372944|FG001|Part I and Part 2|Grade 2 vomiting|0
7173246|NCT01670877|11372945|FG002|Part I and Part 2|Grade 2 vomiting|0
7173247|NCT01670877|11372946|FG003|Part I and Part 2|Grade 2 vomiting|1
7173248|NCT01670877|11372947|FG004|Part I and Part 2|Grade 2 vomiting|0
7173249|NCT01670877|11372948|FG005|Part I and Part 2|Grade 2 vomiting|0
7173250|NCT01670877|11372943|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0
7173251|NCT01670877|11372944|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0
7173252|NCT01670877|11372945|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0
7173253|NCT01670877|11372946|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1
7173254|NCT01670877|11372947|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0
7173255|NCT01670877|11372948|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0
7173256|NCT01670877|11372943|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0
7173257|NCT01670877|11372944|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0
7173258|NCT01670877|11372945|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0
7173259|NCT01670877|11372946|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1
7173260|NCT01670877|11372947|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0
7173261|NCT01670877|11372948|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0
7173262|NCT01602380|11372964|FG000|Overall Study|Death|63
7173263|NCT01602380|11372965|FG001|Overall Study|Death|68
7173264|NCT01602380|11372964|FG000|Overall Study|Withdrawal by Subject|22
7173265|NCT01602380|11372965|FG001|Overall Study|Withdrawal by Subject|29
7173266|NCT01602380|11372964|FG000|Overall Study|Lost to Follow-up|6
7173267|NCT01602380|11372965|FG001|Overall Study|Lost to Follow-up|1
7173268|NCT01602380|11372964|FG000|Overall Study|Eligibility criteria not fulfilled|2
7173269|NCT01602380|11372965|FG001|Overall Study|Eligibility criteria not fulfilled|3
7173270|NCT01412333|11372973|FG000|Overall Study|Death|1
7173271|NCT01412333|11372974|FG001|Overall Study|Death|1
7173272|NCT01412333|11372973|FG000|Overall Study|Physician Decision|0
7173273|NCT01412333|11372974|FG001|Overall Study|Physician Decision|1
7173274|NCT01412333|11372973|FG000|Overall Study|Reason not specified|16
7173275|NCT01412333|11372974|FG001|Overall Study|Reason not specified|10
7173276|NCT01412333|11372973|FG000|Overall Study|Non-compliance with study drug|1
7173277|NCT01412333|11372974|FG001|Overall Study|Non-compliance with study drug|1
7173278|NCT01412333|11372973|FG000|Overall Study|Protocol Violation|1
7173279|NCT01412333|11372974|FG001|Overall Study|Protocol Violation|1
7173280|NCT01412333|11372973|FG000|Overall Study|Non-compliance|1
7173281|NCT01412333|11372974|FG001|Overall Study|Non-compliance|3
7173282|NCT01412333|11372973|FG000|Overall Study|Lack of Efficacy|15
7173283|NCT01412333|11372974|FG001|Overall Study|Lack of Efficacy|6
7173284|NCT01412333|11372973|FG000|Overall Study|Pregnancy|3
7173285|NCT01412333|11372974|FG001|Overall Study|Pregnancy|0
7173286|NCT01412333|11372973|FG000|Overall Study|Consent withdrawn by participant|25
7173287|NCT01412333|11372974|FG001|Overall Study|Consent withdrawn by participant|12
7173288|NCT01412333|11372973|FG000|Overall Study|Adverse Event|25
7173289|NCT01412333|11372974|FG001|Overall Study|Adverse Event|16
7173290|NCT01412333|11372973|FG000|Overall Study|Lost to Follow-up|10
7173291|NCT01412333|11372974|FG001|Overall Study|Lost to Follow-up|6
7173292|NCT01247324|11372983|FG000|Overall Study|Death|1
7173293|NCT01247324|11372984|FG001|Overall Study|Death|0
7173294|NCT01247324|11372983|FG000|Overall Study|Physician Decision|0
7173295|NCT01247324|11372984|FG001|Overall Study|Physician Decision|1
7173296|NCT01247324|11372983|FG000|Overall Study|Non-compliance with study drug|3
7173297|NCT01247324|11372984|FG001|Overall Study|Non-compliance with study drug|0
7173298|NCT01247324|11372983|FG000|Overall Study|Lack of Efficacy|12
7173299|NCT01247324|11372984|FG001|Overall Study|Lack of Efficacy|8
7173300|NCT01247324|11372983|FG000|Overall Study|Non-compliance|2
7173301|NCT01247324|11372984|FG001|Overall Study|Non-compliance|0
7173302|NCT01247324|11372983|FG000|Overall Study|Pregnancy|2
7173303|NCT01247324|11372984|FG001|Overall Study|Pregnancy|3
7173304|NCT01247324|11372983|FG000|Overall Study|Protocol Violation|1
7173305|NCT01247324|11372984|FG001|Overall Study|Protocol Violation|2
7173306|NCT01247324|11372983|FG000|Overall Study|Reason not specified|11
7173307|NCT01247324|11372984|FG001|Overall Study|Reason not specified|8
7173308|NCT01247324|11372983|FG000|Overall Study|Consent withdrawn by participant|13
7173309|NCT01247324|11372984|FG001|Overall Study|Consent withdrawn by participant|8
7173310|NCT01247324|11372983|FG000|Overall Study|Adverse Event|25
7173311|NCT01247324|11372984|FG001|Overall Study|Adverse Event|13
7173312|NCT01247324|11372983|FG000|Overall Study|Lost to Follow-up|1
7173313|NCT01247324|11372984|FG001|Overall Study|Lost to Follow-up|1
7173314|NCT00667628|11372993|FG000|Overall Study|Lost to Follow-up|1
7173315|NCT00667628|11372994|FG001|Overall Study|Lost to Follow-up|0
7173316|NCT00667628|11372993|FG000|Overall Study|Death|6
7173317|NCT00667628|11372994|FG001|Overall Study|Death|6
7173318|NCT00667628|11372993|FG000|Overall Study|Investigator Considers in Best Interest|1
7173319|NCT00667628|11372994|FG001|Overall Study|Investigator Considers in Best Interest|0
7173320|NCT00667628|11372993|FG000|Overall Study|Sponsor Terminated Study|17
7173321|NCT00667628|11372994|FG001|Overall Study|Sponsor Terminated Study|21
7185643|NCT02218697|11386023|FG000|Overall Study|Adverse Event|0
7185644|NCT02218697|11386024|FG001|Overall Study|Adverse Event|2
7185645|NCT02218697|11386023|FG000|Overall Study|Unwilling to be vaccinated in left arm|0
7185646|NCT02218697|11386024|FG001|Overall Study|Unwilling to be vaccinated in left arm|1
7185647|NCT02218697|11386023|FG000|Overall Study|Withdrawal by Subject|2
7185648|NCT02218697|11386024|FG001|Overall Study|Withdrawal by Subject|3
7185649|NCT02221037|11386034|FG000|Overall Study|Physician Decision|0
7185650|NCT02221037|11386035|FG001|Overall Study|Physician Decision|0
7185651|NCT02221037|11386036|FG002|Overall Study|Physician Decision|1
7185652|NCT02221037|11386037|FG003|Overall Study|Physician Decision|0
7185653|NCT02224456|11386051|FG000|Overall Study|Lack of Efficacy|1
7185654|NCT02224456|11386051|FG000|Overall Study|Lost to Follow-up|15
7185655|NCT02224456|11386051|FG000|Overall Study|Withdrawal by Subject|9
7185656|NCT02224456|11386051|FG000|Overall Study|Physician Decision|3
7185657|NCT02224456|11386051|FG000|Overall Study|Death|2
7185658|NCT02224456|11386051|FG000|Overall Study|Pregnancy|4
7185659|NCT02224456|11386051|FG000|Overall Study|Protocol Violation|1
7185660|NCT02224456|11386051|FG000|Overall Study|Treatment Interruptions of ≥28 days|1
7185661|NCT02231762|11386055|FG000|Combination Phase|Adverse Event|10
7185662|NCT02231762|11386056|FG001|Combination Phase|Adverse Event|0
7185663|NCT02231762|11386057|FG002|Combination Phase|Adverse Event|0
7185664|NCT02231762|11386058|FG003|Combination Phase|Adverse Event|0
7185665|NCT02231762|11386055|FG000|Combination Phase|Withdrawal by Subject|2
7185666|NCT02231762|11386056|FG001|Combination Phase|Withdrawal by Subject|0
7185667|NCT02231762|11386057|FG002|Combination Phase|Withdrawal by Subject|0
7185668|NCT02231762|11386058|FG003|Combination Phase|Withdrawal by Subject|0
7185669|NCT02231762|11386055|FG000|Combination Phase|Disease Progression|6
7185670|NCT02231762|11386056|FG001|Combination Phase|Disease Progression|0
7185671|NCT02231762|11386057|FG002|Combination Phase|Disease Progression|0
7185672|NCT02231762|11386058|FG003|Combination Phase|Disease Progression|0
7185673|NCT02231762|11386055|FG000|Combination Phase|Did not meet inclusion criteria|1
7185674|NCT02231762|11386056|FG001|Combination Phase|Did not meet inclusion criteria|0
7185675|NCT02231762|11386057|FG002|Combination Phase|Did not meet inclusion criteria|0
7185676|NCT02231762|11386058|FG003|Combination Phase|Did not meet inclusion criteria|0
7185677|NCT02231762|11386055|FG000|Combination Phase|Protocol Violation|1
7185678|NCT02231762|11386056|FG001|Combination Phase|Protocol Violation|0
7185679|NCT02231762|11386057|FG002|Combination Phase|Protocol Violation|0
7185680|NCT02231762|11386058|FG003|Combination Phase|Protocol Violation|0
7185681|NCT02231762|11386055|FG000|Maintenance Phase|Disease progression|0
7185682|NCT02231762|11386056|FG001|Maintenance Phase|Disease progression|3
7185683|NCT02231762|11386057|FG002|Maintenance Phase|Disease progression|4
7185684|NCT02231762|11386058|FG003|Maintenance Phase|Disease progression|3
7185685|NCT02231762|11386055|FG000|Maintenance Phase|Adverse Event|0
7185686|NCT02231762|11386056|FG001|Maintenance Phase|Adverse Event|0
7185687|NCT02231762|11386057|FG002|Maintenance Phase|Adverse Event|1
7185688|NCT02231762|11386058|FG003|Maintenance Phase|Adverse Event|2
7185689|NCT02234843|11386082|FG000|Overall Study|Death|1
7185690|NCT02234843|11386083|FG001|Overall Study|Death|0
7185691|NCT02234843|11386084|FG002|Overall Study|Death|0
7185692|NCT02234843|11386085|FG003|Overall Study|Death|0
7185693|NCT02234843|11386086|FG004|Overall Study|Death|0
7185694|NCT02234843|11386087|FG005|Overall Study|Death|0
7185695|NCT02234843|11386088|FG006|Overall Study|Death|0
7185696|NCT02234843|11386089|FG007|Overall Study|Death|0
7185697|NCT02234843|11386090|FG008|Overall Study|Death|0
7185698|NCT02234843|11386091|FG009|Overall Study|Death|0
7185699|NCT02234843|11386082|FG000|Overall Study|Protocol Violation|1
7185700|NCT02234843|11386083|FG001|Overall Study|Protocol Violation|0
7185701|NCT02234843|11386084|FG002|Overall Study|Protocol Violation|1
7185702|NCT02234843|11386085|FG003|Overall Study|Protocol Violation|0
7185703|NCT02234843|11386086|FG004|Overall Study|Protocol Violation|0
7185704|NCT02234843|11386087|FG005|Overall Study|Protocol Violation|0
7185705|NCT02234843|11386088|FG006|Overall Study|Protocol Violation|0
7185706|NCT02234843|11386089|FG007|Overall Study|Protocol Violation|0
7185707|NCT02234843|11386090|FG008|Overall Study|Protocol Violation|0
7185708|NCT02234843|11386091|FG009|Overall Study|Protocol Violation|0
7185709|NCT02234843|11386082|FG000|Overall Study|Efficacy outcome reached|2
7185710|NCT02234843|11386083|FG001|Overall Study|Efficacy outcome reached|0
7185711|NCT02234843|11386084|FG002|Overall Study|Efficacy outcome reached|0
7185712|NCT02234843|11386085|FG003|Overall Study|Efficacy outcome reached|0
7185713|NCT02234843|11386086|FG004|Overall Study|Efficacy outcome reached|0
7185714|NCT02234843|11386087|FG005|Overall Study|Efficacy outcome reached|2
7185715|NCT02234843|11386088|FG006|Overall Study|Efficacy outcome reached|0
7185716|NCT02234843|11386089|FG007|Overall Study|Efficacy outcome reached|0
7185717|NCT02234843|11386090|FG008|Overall Study|Efficacy outcome reached|0
7185718|NCT02234843|11386091|FG009|Overall Study|Efficacy outcome reached|0
7173322|NCT03581786|11373019|FG000|Overall Study|Death|17
7173323|NCT03581786|11373020|FG001|Overall Study|Death|12
7173324|NCT03581786|11373019|FG000|Overall Study|Withdrawal by Subject|2
7080683|NCT02124746|11190267|FG002|Overall Study|Physician Decision|5
7080684|NCT02124746|11190265|FG000|Overall Study|Non-Compliance with Study Drug|0
7173325|NCT03581786|11373020|FG001|Overall Study|Withdrawal by Subject|4
7173326|NCT03581786|11373019|FG000|Overall Study|Lost to Follow-up|1
7173327|NCT03581786|11373020|FG001|Overall Study|Lost to Follow-up|0
7173328|NCT03581786|11373019|FG000|Overall Study|reason other than specified above|0
7173329|NCT03581786|11373020|FG001|Overall Study|reason other than specified above|1
7173330|NCT03581786|11373019|FG000|Overall Study|Ongoing in the study|123
7173331|NCT03581786|11373020|FG001|Overall Study|Ongoing in the study|129
7173402|NCT01928394|11373142|FG007|Treatment Period|Disease progression|16
7173403|NCT01928394|11373143|FG008|Treatment Period|Disease progression|3
7173404|NCT01928394|11373144|FG009|Treatment Period|Disease progression|11
7173405|NCT01928394|11373145|FG010|Treatment Period|Disease progression|22
7173406|NCT01928394|11373146|FG011|Treatment Period|Disease progression|73
7173407|NCT01928394|11373147|FG012|Treatment Period|Disease progression|38
7173408|NCT01928394|11373148|FG013|Treatment Period|Disease progression|118
7173409|NCT01928394|11373149|FG014|Treatment Period|Disease progression|59
7173410|NCT01928394|11373150|FG015|Treatment Period|Disease progression|1
7173411|NCT01928394|11373151|FG016|Treatment Period|Disease progression|43
7173412|NCT01928394|11373152|FG017|Treatment Period|Disease progression|56
7173413|NCT01928394|11373153|FG018|Treatment Period|Disease progression|50
7173414|NCT01928394|11373154|FG019|Treatment Period|Disease progression|71
7173415|NCT01928394|11373155|FG020|Treatment Period|Disease progression|30
7173416|NCT01928394|11373156|FG021|Treatment Period|Disease progression|31
7173417|NCT01928394|11373157|FG022|Treatment Period|Disease progression|31
7173418|NCT01928394|11373135|FG000|Treatment Period|Study drug toxicity|1
7173419|NCT01928394|11373136|FG001|Treatment Period|Study drug toxicity|1
7173420|NCT01928394|11373137|FG002|Treatment Period|Study drug toxicity|3
7173421|NCT01928394|11373138|FG003|Treatment Period|Study drug toxicity|3
7173422|NCT01928394|11373139|FG004|Treatment Period|Study drug toxicity|0
7173423|NCT01928394|11373140|FG005|Treatment Period|Study drug toxicity|9
7173424|NCT01928394|11373141|FG006|Treatment Period|Study drug toxicity|7
7173425|NCT01928394|11373142|FG007|Treatment Period|Study drug toxicity|1
7173426|NCT01928394|11373143|FG008|Treatment Period|Study drug toxicity|0
7173427|NCT01928394|11373144|FG009|Treatment Period|Study drug toxicity|5
7173428|NCT01928394|11373145|FG010|Treatment Period|Study drug toxicity|2
7173429|NCT01928394|11373146|FG011|Treatment Period|Study drug toxicity|3
7173430|NCT01928394|11373147|FG012|Treatment Period|Study drug toxicity|7
7173431|NCT01928394|11373148|FG013|Treatment Period|Study drug toxicity|5
7173432|NCT01928394|11373149|FG014|Treatment Period|Study drug toxicity|12
7173433|NCT01928394|11373150|FG015|Treatment Period|Study drug toxicity|0
7173434|NCT01928394|11373151|FG016|Treatment Period|Study drug toxicity|3
7173435|NCT01928394|11373152|FG017|Treatment Period|Study drug toxicity|3
7173436|NCT01928394|11373153|FG018|Treatment Period|Study drug toxicity|12
7173437|NCT01928394|11373154|FG019|Treatment Period|Study drug toxicity|15
7173438|NCT01928394|11373155|FG020|Treatment Period|Study drug toxicity|4
7173439|NCT01928394|11373156|FG021|Treatment Period|Study drug toxicity|7
7173440|NCT01928394|11373157|FG022|Treatment Period|Study drug toxicity|4
7173441|NCT01928394|11373135|FG000|Treatment Period|AE unrelated to study drug|0
7173442|NCT01928394|11373136|FG001|Treatment Period|AE unrelated to study drug|0
7173443|NCT01928394|11373137|FG002|Treatment Period|AE unrelated to study drug|2
7173444|NCT01928394|11373138|FG003|Treatment Period|AE unrelated to study drug|3
7173445|NCT01928394|11373139|FG004|Treatment Period|AE unrelated to study drug|0
7173446|NCT01928394|11373140|FG005|Treatment Period|AE unrelated to study drug|5
7173447|NCT01928394|11373141|FG006|Treatment Period|AE unrelated to study drug|1
7173448|NCT01928394|11373142|FG007|Treatment Period|AE unrelated to study drug|0
7173449|NCT01928394|11373143|FG008|Treatment Period|AE unrelated to study drug|0
7173450|NCT01928394|11373144|FG009|Treatment Period|AE unrelated to study drug|2
7173451|NCT01928394|11373145|FG010|Treatment Period|AE unrelated to study drug|0
7173452|NCT01928394|11373146|FG011|Treatment Period|AE unrelated to study drug|12
7173453|NCT01928394|11373147|FG012|Treatment Period|AE unrelated to study drug|6
7173454|NCT01928394|11373148|FG013|Treatment Period|AE unrelated to study drug|13
7173455|NCT01928394|11373149|FG014|Treatment Period|AE unrelated to study drug|6
7173456|NCT01928394|11373150|FG015|Treatment Period|AE unrelated to study drug|1
7173457|NCT01928394|11373151|FG016|Treatment Period|AE unrelated to study drug|1
7173458|NCT01928394|11373152|FG017|Treatment Period|AE unrelated to study drug|6
7173459|NCT01928394|11373153|FG018|Treatment Period|AE unrelated to study drug|3
7173460|NCT01928394|11373154|FG019|Treatment Period|AE unrelated to study drug|5
7173461|NCT01928394|11373155|FG020|Treatment Period|AE unrelated to study drug|1
7173462|NCT01928394|11373156|FG021|Treatment Period|AE unrelated to study drug|1
7080685|NCT02124746|11190266|FG001|Overall Study|Non-Compliance with Study Drug|1
7080686|NCT02124746|11190267|FG002|Overall Study|Non-Compliance with Study Drug|0
7173463|NCT01928394|11373157|FG022|Treatment Period|AE unrelated to study drug|0
7173464|NCT01928394|11373135|FG000|Treatment Period|Participant request to stop therapy|0
7173465|NCT01928394|11373136|FG001|Treatment Period|Participant request to stop therapy|0
7173466|NCT01928394|11373137|FG002|Treatment Period|Participant request to stop therapy|0
7173332|NCT03486314|11373043|FG000|Part A|Adverse Event|1
7173333|NCT03486314|11373044|FG001|Part A|Adverse Event|0
7173334|NCT03486314|11373045|FG002|Part A|Adverse Event|0
7173335|NCT03486314|11373043|FG000|Part A|Symptomatic Deterioration|2
7173336|NCT03486314|11373044|FG001|Part A|Symptomatic Deterioration|0
7173337|NCT03486314|11373045|FG002|Part A|Symptomatic Deterioration|0
7173338|NCT02988713|11373053|FG000|Overall Study|Withdrawal by Subject|1
7173339|NCT02988713|11373053|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2
7173340|NCT02794883|11373060|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0
7173341|NCT02794883|11373061|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0
7173342|NCT02794883|11373062|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1
7173343|NCT02794883|11373060|FG000|Pre-Surgical Treatment|Progressive Disease|0
7173344|NCT02794883|11373061|FG001|Pre-Surgical Treatment|Progressive Disease|1
7173345|NCT02794883|11373062|FG002|Pre-Surgical Treatment|Progressive Disease|0
7173346|NCT02794883|11373060|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1
7173347|NCT02794883|11373061|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4
7173348|NCT02794883|11373062|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0
7173349|NCT02794883|11373060|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1
7173350|NCT02794883|11373061|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0
7173351|NCT02794883|11373062|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0
7173352|NCT02794883|11373060|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10
7173353|NCT02794883|11373061|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6
7173354|NCT02794883|11373062|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10
7173355|NCT02794883|11373060|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0
7173356|NCT02794883|11373061|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1
7173357|NCT02794883|11373062|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1
7173358|NCT02794883|11373060|FG000|Follow-up Period (up to 2 Years)|Death|12
7173359|NCT02794883|11373061|FG001|Follow-up Period (up to 2 Years)|Death|10
7173360|NCT02794883|11373062|FG002|Follow-up Period (up to 2 Years)|Death|10
7173361|NCT02677987|11373072|FG000|Overall Study|Withdrawal by Subject|3
7173362|NCT02677987|11373073|FG001|Overall Study|Withdrawal by Subject|0
7173363|NCT02677987|11373072|FG000|Overall Study|Lost to Follow-up|1
7173364|NCT02677987|11373073|FG001|Overall Study|Lost to Follow-up|0
7173365|NCT02659059|11373085|FG000|Overall Study|Completed|1
7173366|NCT02659059|11373086|FG001|Overall Study|Completed|0
7173367|NCT02659059|11373085|FG000|Overall Study|Other reasons|8
7173368|NCT02659059|11373086|FG001|Overall Study|Other reasons|2
7173369|NCT02659059|11373085|FG000|Overall Study|Disease Progression|120
7173370|NCT02659059|11373086|FG001|Overall Study|Disease Progression|16
7173371|NCT02659059|11373085|FG000|Overall Study|Study Drug toxicity|37
7173372|NCT02659059|11373086|FG001|Overall Study|Study Drug toxicity|9
7173373|NCT02659059|11373085|FG000|Overall Study|Death|2
7173374|NCT02659059|11373086|FG001|Overall Study|Death|1
7173375|NCT02659059|11373085|FG000|Overall Study|Adverse Event unrelated to Study drug|22
7173376|NCT02659059|11373086|FG001|Overall Study|Adverse Event unrelated to Study drug|4
7173377|NCT02659059|11373085|FG000|Overall Study|Participant request to discontinue study treatment|5
7173378|NCT02659059|11373086|FG001|Overall Study|Participant request to discontinue study treatment|0
7173379|NCT02659059|11373085|FG000|Overall Study|Participant withdrew consent|4
7173380|NCT02659059|11373086|FG001|Overall Study|Participant withdrew consent|0
7173381|NCT02659059|11373085|FG000|Overall Study|Lost to Follow-up|1
7173382|NCT02659059|11373086|FG001|Overall Study|Lost to Follow-up|0
7173383|NCT02337829|11373097|FG000|Overall Study|Death|0
7173384|NCT02337829|11373098|FG001|Overall Study|Death|1
7173385|NCT02337829|11373099|FG002|Overall Study|Death|0
7173386|NCT02337829|11373100|FG003|Overall Study|Death|0
7173387|NCT02337829|11373097|FG000|Overall Study|Study terminated by sponsor|12
7173388|NCT02337829|11373098|FG001|Overall Study|Study terminated by sponsor|10
7173389|NCT02337829|11373099|FG002|Overall Study|Study terminated by sponsor|5
7173390|NCT02337829|11373100|FG003|Overall Study|Study terminated by sponsor|6
7173391|NCT02337829|11373097|FG000|Overall Study|discontinued for other reasons|6
7173392|NCT02337829|11373098|FG001|Overall Study|discontinued for other reasons|3
7173393|NCT02337829|11373099|FG002|Overall Study|discontinued for other reasons|1
7173394|NCT02337829|11373100|FG003|Overall Study|discontinued for other reasons|4
7173395|NCT01928394|11373135|FG000|Treatment Period|Disease progression|17
7173396|NCT01928394|11373136|FG001|Treatment Period|Disease progression|2
7173397|NCT01928394|11373137|FG002|Treatment Period|Disease progression|12
7173398|NCT01928394|11373138|FG003|Treatment Period|Disease progression|48
7173399|NCT01928394|11373139|FG004|Treatment Period|Disease progression|3
7173400|NCT01928394|11373140|FG005|Treatment Period|Disease progression|25
7173401|NCT01928394|11373141|FG006|Treatment Period|Disease progression|38
7173467|NCT01928394|11373138|FG003|Treatment Period|Participant request to stop therapy|0
7173468|NCT01928394|11373139|FG004|Treatment Period|Participant request to stop therapy|0
7173469|NCT01928394|11373140|FG005|Treatment Period|Participant request to stop therapy|3
7173470|NCT01928394|11373141|FG006|Treatment Period|Participant request to stop therapy|3
7173471|NCT01928394|11373142|FG007|Treatment Period|Participant request to stop therapy|0
7173472|NCT01928394|11373143|FG008|Treatment Period|Participant request to stop therapy|0
7173473|NCT01928394|11373144|FG009|Treatment Period|Participant request to stop therapy|0
7173474|NCT01928394|11373145|FG010|Treatment Period|Participant request to stop therapy|3
7173475|NCT01928394|11373146|FG011|Treatment Period|Participant request to stop therapy|2
7173476|NCT01928394|11373147|FG012|Treatment Period|Participant request to stop therapy|1
7173477|NCT01928394|11373148|FG013|Treatment Period|Participant request to stop therapy|2
7173478|NCT01928394|11373149|FG014|Treatment Period|Participant request to stop therapy|4
7173479|NCT01928394|11373150|FG015|Treatment Period|Participant request to stop therapy|0
7173480|NCT01928394|11373151|FG016|Treatment Period|Participant request to stop therapy|1
7173481|NCT01928394|11373152|FG017|Treatment Period|Participant request to stop therapy|3
7173482|NCT01928394|11373153|FG018|Treatment Period|Participant request to stop therapy|1
7173483|NCT01928394|11373154|FG019|Treatment Period|Participant request to stop therapy|1
7173484|NCT01928394|11373155|FG020|Treatment Period|Participant request to stop therapy|3
7173485|NCT01928394|11373156|FG021|Treatment Period|Participant request to stop therapy|1
7173486|NCT01928394|11373157|FG022|Treatment Period|Participant request to stop therapy|3
7173487|NCT01928394|11373135|FG000|Treatment Period|Participant withdrew consent|0
7173488|NCT01928394|11373136|FG001|Treatment Period|Participant withdrew consent|0
7173489|NCT01928394|11373137|FG002|Treatment Period|Participant withdrew consent|1
7173490|NCT01928394|11373138|FG003|Treatment Period|Participant withdrew consent|1
7173491|NCT01928394|11373139|FG004|Treatment Period|Participant withdrew consent|0
7173492|NCT01928394|11373140|FG005|Treatment Period|Participant withdrew consent|1
7173493|NCT01928394|11373141|FG006|Treatment Period|Participant withdrew consent|0
7173494|NCT01928394|11373142|FG007|Treatment Period|Participant withdrew consent|1
7173495|NCT01928394|11373143|FG008|Treatment Period|Participant withdrew consent|0
7173496|NCT01928394|11373144|FG009|Treatment Period|Participant withdrew consent|0
7173497|NCT01928394|11373145|FG010|Treatment Period|Participant withdrew consent|1
7173498|NCT01928394|11373146|FG011|Treatment Period|Participant withdrew consent|1
7173499|NCT01928394|11373147|FG012|Treatment Period|Participant withdrew consent|1
7173500|NCT01928394|11373148|FG013|Treatment Period|Participant withdrew consent|0
7173501|NCT01928394|11373149|FG014|Treatment Period|Participant withdrew consent|2
7173502|NCT01928394|11373150|FG015|Treatment Period|Participant withdrew consent|0
7173503|NCT01928394|11373151|FG016|Treatment Period|Participant withdrew consent|2
7173504|NCT01928394|11373152|FG017|Treatment Period|Participant withdrew consent|1
7173505|NCT01928394|11373153|FG018|Treatment Period|Participant withdrew consent|1
7173506|NCT01928394|11373154|FG019|Treatment Period|Participant withdrew consent|1
7173507|NCT01928394|11373155|FG020|Treatment Period|Participant withdrew consent|0
7173508|NCT01928394|11373156|FG021|Treatment Period|Participant withdrew consent|2
7173509|NCT01928394|11373157|FG022|Treatment Period|Participant withdrew consent|0
7173510|NCT01928394|11373135|FG000|Treatment Period|Poor/non-compliance|0
7173511|NCT01928394|11373136|FG001|Treatment Period|Poor/non-compliance|0
7173512|NCT01928394|11373137|FG002|Treatment Period|Poor/non-compliance|0
7173513|NCT01928394|11373138|FG003|Treatment Period|Poor/non-compliance|1
7173514|NCT01928394|11373139|FG004|Treatment Period|Poor/non-compliance|0
7173515|NCT01928394|11373140|FG005|Treatment Period|Poor/non-compliance|0
7173516|NCT01928394|11373141|FG006|Treatment Period|Poor/non-compliance|0
7173517|NCT01928394|11373142|FG007|Treatment Period|Poor/non-compliance|0
7173518|NCT01928394|11373143|FG008|Treatment Period|Poor/non-compliance|0
7173519|NCT01928394|11373144|FG009|Treatment Period|Poor/non-compliance|0
7173520|NCT01928394|11373145|FG010|Treatment Period|Poor/non-compliance|0
7173521|NCT01928394|11373146|FG011|Treatment Period|Poor/non-compliance|0
7173522|NCT01928394|11373147|FG012|Treatment Period|Poor/non-compliance|1
7173523|NCT01928394|11373148|FG013|Treatment Period|Poor/non-compliance|0
7173524|NCT01928394|11373149|FG014|Treatment Period|Poor/non-compliance|1
7080687|NCT02124746|11190265|FG000|Overall Study|Withdrawal by Subject|3
7080688|NCT02124746|11190266|FG001|Overall Study|Withdrawal by Subject|3
7080689|NCT02124746|11190267|FG002|Overall Study|Withdrawal by Subject|0
7080690|NCT02124746|11190265|FG000|Overall Study|Study Terminated by Sponsor|0
7080691|NCT02124746|11190266|FG001|Overall Study|Study Terminated by Sponsor|0
7080692|NCT02124746|11190267|FG002|Overall Study|Study Terminated by Sponsor|6
7080693|NCT02124746|11190265|FG000|Overall Study|Disease Progression|3
7080694|NCT02124746|11190266|FG001|Overall Study|Disease Progression|6
7080695|NCT02124746|11190267|FG002|Overall Study|Disease Progression|4
7080696|NCT02124759|11190278|FG000|Overall Study|Withdrawal by Subject|3
7080697|NCT02124759|11190279|FG001|Overall Study|Withdrawal by Subject|1
7080698|NCT02124759|11190280|FG002|Overall Study|Withdrawal by Subject|1
7080699|NCT02124759|11190278|FG000|Overall Study|Screen Fail|2
7080700|NCT02124759|11190279|FG001|Overall Study|Screen Fail|2
7080701|NCT02124759|11190280|FG002|Overall Study|Screen Fail|3
7173525|NCT01928394|11373150|FG015|Treatment Period|Poor/non-compliance|0
7173526|NCT01928394|11373151|FG016|Treatment Period|Poor/non-compliance|0
7080702|NCT02124772|11190306|FG000|Overall Study|Lack of Efficacy|2
7080703|NCT02124772|11190307|FG001|Overall Study|Lack of Efficacy|0
7080704|NCT02124772|11190308|FG002|Overall Study|Lack of Efficacy|0
7080705|NCT02124772|11190309|FG003|Overall Study|Lack of Efficacy|1
7080706|NCT02124772|11190310|FG004|Overall Study|Lack of Efficacy|2
7080707|NCT02124772|11190311|FG005|Overall Study|Lack of Efficacy|3
7080708|NCT02124772|11190312|FG006|Overall Study|Lack of Efficacy|0
7080709|NCT02124772|11190313|FG007|Overall Study|Lack of Efficacy|2
7080710|NCT02124772|11190314|FG008|Overall Study|Lack of Efficacy|0
7080711|NCT02124772|11190315|FG009|Overall Study|Lack of Efficacy|1
7080712|NCT02124772|11190316|FG010|Overall Study|Lack of Efficacy|0
7080713|NCT02124772|11190317|FG011|Overall Study|Lack of Efficacy|0
7080714|NCT02124772|11190318|FG012|Overall Study|Lack of Efficacy|1
7080715|NCT02124772|11190306|FG000|Overall Study|Adverse Event|1
7080716|NCT02124772|11190307|FG001|Overall Study|Adverse Event|4
7080717|NCT02124772|11190308|FG002|Overall Study|Adverse Event|1
7080718|NCT02124772|11190309|FG003|Overall Study|Adverse Event|5
7080719|NCT02124772|11190310|FG004|Overall Study|Adverse Event|2
7080720|NCT02124772|11190311|FG005|Overall Study|Adverse Event|1
7080721|NCT02124772|11190312|FG006|Overall Study|Adverse Event|1
7080722|NCT02124772|11190313|FG007|Overall Study|Adverse Event|5
7080723|NCT02124772|11190314|FG008|Overall Study|Adverse Event|0
7080724|NCT02124772|11190315|FG009|Overall Study|Adverse Event|3
7080725|NCT02124772|11190316|FG010|Overall Study|Adverse Event|1
7080726|NCT02124772|11190317|FG011|Overall Study|Adverse Event|3
7080727|NCT02124772|11190318|FG012|Overall Study|Adverse Event|1
7080728|NCT02124772|11190306|FG000|Overall Study|Withdrawal consent|0
7080729|NCT02124772|11190307|FG001|Overall Study|Withdrawal consent|1
7080730|NCT02124772|11190308|FG002|Overall Study|Withdrawal consent|1
7080731|NCT02124772|11190309|FG003|Overall Study|Withdrawal consent|1
7080732|NCT02124772|11190310|FG004|Overall Study|Withdrawal consent|0
7080733|NCT02124772|11190311|FG005|Overall Study|Withdrawal consent|1
7080734|NCT02124772|11190312|FG006|Overall Study|Withdrawal consent|1
7080735|NCT02124772|11190313|FG007|Overall Study|Withdrawal consent|0
7080736|NCT02124772|11190314|FG008|Overall Study|Withdrawal consent|0
7080737|NCT02124772|11190315|FG009|Overall Study|Withdrawal consent|1
7080738|NCT02124772|11190316|FG010|Overall Study|Withdrawal consent|0
7080739|NCT02124772|11190317|FG011|Overall Study|Withdrawal consent|1
7080740|NCT02124772|11190318|FG012|Overall Study|Withdrawal consent|0
7080741|NCT02124772|11190306|FG000|Overall Study|Investigator discretion|0
7080742|NCT02124772|11190307|FG001|Overall Study|Investigator discretion|2
7080743|NCT02124772|11190308|FG002|Overall Study|Investigator discretion|2
7080744|NCT02124772|11190309|FG003|Overall Study|Investigator discretion|1
7080745|NCT02124772|11190310|FG004|Overall Study|Investigator discretion|1
7080746|NCT02124772|11190311|FG005|Overall Study|Investigator discretion|0
7080747|NCT02124772|11190312|FG006|Overall Study|Investigator discretion|1
7080748|NCT02124772|11190313|FG007|Overall Study|Investigator discretion|0
7080749|NCT02124772|11190314|FG008|Overall Study|Investigator discretion|0
7080750|NCT02124772|11190315|FG009|Overall Study|Investigator discretion|1
7173527|NCT01928394|11373152|FG017|Treatment Period|Poor/non-compliance|1
7173528|NCT01928394|11373153|FG018|Treatment Period|Poor/non-compliance|0
7173529|NCT01928394|11373154|FG019|Treatment Period|Poor/non-compliance|1
7173530|NCT01928394|11373155|FG020|Treatment Period|Poor/non-compliance|0
7173531|NCT01928394|11373156|FG021|Treatment Period|Poor/non-compliance|0
7173532|NCT01928394|11373157|FG022|Treatment Period|Poor/non-compliance|0
7173533|NCT01928394|11373135|FG000|Treatment Period|other reason|0
7173534|NCT01928394|11373136|FG001|Treatment Period|other reason|0
7173535|NCT01928394|11373137|FG002|Treatment Period|other reason|0
7173536|NCT01928394|11373138|FG003|Treatment Period|other reason|0
7173537|NCT01928394|11373139|FG004|Treatment Period|other reason|0
7173538|NCT01928394|11373140|FG005|Treatment Period|other reason|0
7173539|NCT01928394|11373141|FG006|Treatment Period|other reason|0
7173540|NCT01928394|11373142|FG007|Treatment Period|other reason|0
7173541|NCT01928394|11373143|FG008|Treatment Period|other reason|0
7173542|NCT01928394|11373144|FG009|Treatment Period|other reason|0
7173543|NCT01928394|11373145|FG010|Treatment Period|other reason|1
7173544|NCT01928394|11373146|FG011|Treatment Period|other reason|1
7173545|NCT01928394|11373147|FG012|Treatment Period|other reason|1
7173546|NCT01928394|11373148|FG013|Treatment Period|other reason|0
7173547|NCT01928394|11373149|FG014|Treatment Period|other reason|1
7080751|NCT02124772|11190316|FG010|Overall Study|Investigator discretion|0
7173548|NCT01928394|11373150|FG015|Treatment Period|other reason|0
7080752|NCT02124772|11190317|FG011|Overall Study|Investigator discretion|1
7080753|NCT02124772|11190318|FG012|Overall Study|Investigator discretion|0
7080754|NCT02124772|11190306|FG000|Overall Study|Progressive disease|0
7080755|NCT02124772|11190307|FG001|Overall Study|Progressive disease|0
7080756|NCT02124772|11190308|FG002|Overall Study|Progressive disease|0
7173549|NCT01928394|11373151|FG016|Treatment Period|other reason|0
7173550|NCT01928394|11373152|FG017|Treatment Period|other reason|0
7173551|NCT01928394|11373153|FG018|Treatment Period|other reason|2
7173552|NCT01928394|11373154|FG019|Treatment Period|other reason|2
7173553|NCT01928394|11373155|FG020|Treatment Period|other reason|0
7173554|NCT01928394|11373156|FG021|Treatment Period|other reason|0
7080757|NCT02124772|11190309|FG003|Overall Study|Progressive disease|0
7080758|NCT02124772|11190310|FG004|Overall Study|Progressive disease|0
7080759|NCT02124772|11190311|FG005|Overall Study|Progressive disease|0
7080760|NCT02124772|11190312|FG006|Overall Study|Progressive disease|1
7080761|NCT02124772|11190313|FG007|Overall Study|Progressive disease|1
7173555|NCT01928394|11373157|FG022|Treatment Period|other reason|0
7173556|NCT01928394|11373135|FG000|Treatment Period|Maximum clinical benefit|0
7173557|NCT01928394|11373136|FG001|Treatment Period|Maximum clinical benefit|0
7173558|NCT01928394|11373137|FG002|Treatment Period|Maximum clinical benefit|0
7173559|NCT01928394|11373138|FG003|Treatment Period|Maximum clinical benefit|0
7173560|NCT01928394|11373139|FG004|Treatment Period|Maximum clinical benefit|0
7173561|NCT01928394|11373140|FG005|Treatment Period|Maximum clinical benefit|0
7173562|NCT01928394|11373141|FG006|Treatment Period|Maximum clinical benefit|0
7173563|NCT01928394|11373142|FG007|Treatment Period|Maximum clinical benefit|0
7173564|NCT01928394|11373143|FG008|Treatment Period|Maximum clinical benefit|0
7173565|NCT01928394|11373144|FG009|Treatment Period|Maximum clinical benefit|0
7173566|NCT01928394|11373145|FG010|Treatment Period|Maximum clinical benefit|1
7173567|NCT01928394|11373146|FG011|Treatment Period|Maximum clinical benefit|1
7173568|NCT01928394|11373147|FG012|Treatment Period|Maximum clinical benefit|0
7173569|NCT01928394|11373148|FG013|Treatment Period|Maximum clinical benefit|0
7173570|NCT01928394|11373149|FG014|Treatment Period|Maximum clinical benefit|1
7173571|NCT01928394|11373150|FG015|Treatment Period|Maximum clinical benefit|0
7173572|NCT01928394|11373151|FG016|Treatment Period|Maximum clinical benefit|0
7173573|NCT01928394|11373152|FG017|Treatment Period|Maximum clinical benefit|1
7173574|NCT01928394|11373153|FG018|Treatment Period|Maximum clinical benefit|1
7173575|NCT01928394|11373154|FG019|Treatment Period|Maximum clinical benefit|0
7173576|NCT01928394|11373155|FG020|Treatment Period|Maximum clinical benefit|2
7173577|NCT01928394|11373156|FG021|Treatment Period|Maximum clinical benefit|0
7173578|NCT01928394|11373157|FG022|Treatment Period|Maximum clinical benefit|0
7173579|NCT01928394|11373135|FG000|Treatment Period|Lost to Follow-up|0
7173580|NCT01928394|11373136|FG001|Treatment Period|Lost to Follow-up|0
7173581|NCT01928394|11373137|FG002|Treatment Period|Lost to Follow-up|0
7173582|NCT01928394|11373138|FG003|Treatment Period|Lost to Follow-up|0
7173583|NCT01928394|11373139|FG004|Treatment Period|Lost to Follow-up|0
7173584|NCT01928394|11373140|FG005|Treatment Period|Lost to Follow-up|0
7173585|NCT01928394|11373141|FG006|Treatment Period|Lost to Follow-up|0
7173586|NCT01928394|11373142|FG007|Treatment Period|Lost to Follow-up|0
7173587|NCT01928394|11373143|FG008|Treatment Period|Lost to Follow-up|0
7173588|NCT01928394|11373144|FG009|Treatment Period|Lost to Follow-up|0
7173589|NCT01928394|11373145|FG010|Treatment Period|Lost to Follow-up|0
7173590|NCT01928394|11373146|FG011|Treatment Period|Lost to Follow-up|0
7173591|NCT01928394|11373147|FG012|Treatment Period|Lost to Follow-up|0
7173592|NCT01928394|11373148|FG013|Treatment Period|Lost to Follow-up|0
7173593|NCT01928394|11373149|FG014|Treatment Period|Lost to Follow-up|0
7173594|NCT01928394|11373150|FG015|Treatment Period|Lost to Follow-up|0
7173595|NCT01928394|11373151|FG016|Treatment Period|Lost to Follow-up|0
7173596|NCT01928394|11373152|FG017|Treatment Period|Lost to Follow-up|0
7173597|NCT01928394|11373153|FG018|Treatment Period|Lost to Follow-up|0
7173598|NCT01928394|11373154|FG019|Treatment Period|Lost to Follow-up|0
7173599|NCT01928394|11373155|FG020|Treatment Period|Lost to Follow-up|0
7173600|NCT01928394|11373156|FG021|Treatment Period|Lost to Follow-up|0
7173601|NCT01928394|11373157|FG022|Treatment Period|Lost to Follow-up|1
7173602|NCT01928394|11373135|FG000|Treatment Period|Death|0
7173603|NCT01928394|11373136|FG001|Treatment Period|Death|0
7173604|NCT01928394|11373137|FG002|Treatment Period|Death|0
7173605|NCT01928394|11373138|FG003|Treatment Period|Death|0
7173606|NCT01928394|11373139|FG004|Treatment Period|Death|0
7173607|NCT01928394|11373140|FG005|Treatment Period|Death|0
7173608|NCT01928394|11373141|FG006|Treatment Period|Death|0
7173609|NCT01928394|11373142|FG007|Treatment Period|Death|0
7173610|NCT01928394|11373143|FG008|Treatment Period|Death|0
7173611|NCT01928394|11373144|FG009|Treatment Period|Death|0
7173612|NCT01928394|11373145|FG010|Treatment Period|Death|0
7173613|NCT01928394|11373146|FG011|Treatment Period|Death|0
7173614|NCT01928394|11373147|FG012|Treatment Period|Death|0
7173615|NCT01928394|11373148|FG013|Treatment Period|Death|1
7173616|NCT01928394|11373149|FG014|Treatment Period|Death|2
7173617|NCT01928394|11373150|FG015|Treatment Period|Death|0
7173618|NCT01928394|11373151|FG016|Treatment Period|Death|0
7173619|NCT01928394|11373152|FG017|Treatment Period|Death|0
7173620|NCT01928394|11373153|FG018|Treatment Period|Death|0
7173621|NCT01928394|11373154|FG019|Treatment Period|Death|0
7173622|NCT01928394|11373155|FG020|Treatment Period|Death|0
7173623|NCT01928394|11373156|FG021|Treatment Period|Death|0
7173624|NCT01928394|11373157|FG022|Treatment Period|Death|0
7173625|NCT01928394|11373135|FG000|Follow-up Period|Participant withdrew consent|3
7173626|NCT01928394|11373136|FG001|Follow-up Period|Participant withdrew consent|0
7173627|NCT01928394|11373137|FG002|Follow-up Period|Participant withdrew consent|1
7173628|NCT01928394|11373138|FG003|Follow-up Period|Participant withdrew consent|4
7173629|NCT01928394|11373139|FG004|Follow-up Period|Participant withdrew consent|0
7173630|NCT01928394|11373140|FG005|Follow-up Period|Participant withdrew consent|2
7173631|NCT01928394|11373141|FG006|Follow-up Period|Participant withdrew consent|5
7173632|NCT01928394|11373142|FG007|Follow-up Period|Participant withdrew consent|1
7173633|NCT01928394|11373143|FG008|Follow-up Period|Participant withdrew consent|0
7173634|NCT01928394|11373144|FG009|Follow-up Period|Participant withdrew consent|0
7173635|NCT01928394|11373145|FG010|Follow-up Period|Participant withdrew consent|5
7173636|NCT01928394|11373146|FG011|Follow-up Period|Participant withdrew consent|8
7173637|NCT01928394|11373147|FG012|Follow-up Period|Participant withdrew consent|2
7173638|NCT01928394|11373148|FG013|Follow-up Period|Participant withdrew consent|12
7173639|NCT01928394|11373149|FG014|Follow-up Period|Participant withdrew consent|7
7173640|NCT01928394|11373150|FG015|Follow-up Period|Participant withdrew consent|0
7173641|NCT01928394|11373151|FG016|Follow-up Period|Participant withdrew consent|5
7173642|NCT01928394|11373152|FG017|Follow-up Period|Participant withdrew consent|3
7173643|NCT01928394|11373153|FG018|Follow-up Period|Participant withdrew consent|2
7173644|NCT01928394|11373154|FG019|Follow-up Period|Participant withdrew consent|7
7173645|NCT01928394|11373155|FG020|Follow-up Period|Participant withdrew consent|4
7173646|NCT01928394|11373156|FG021|Follow-up Period|Participant withdrew consent|6
7173647|NCT01928394|11373157|FG022|Follow-up Period|Participant withdrew consent|2
7173648|NCT01928394|11373135|FG000|Follow-up Period|Death|0
7173649|NCT01928394|11373136|FG001|Follow-up Period|Death|0
7173650|NCT01928394|11373137|FG002|Follow-up Period|Death|2
7173651|NCT01928394|11373138|FG003|Follow-up Period|Death|6
7173652|NCT01928394|11373139|FG004|Follow-up Period|Death|0
7173653|NCT01928394|11373140|FG005|Follow-up Period|Death|6
7173654|NCT01928394|11373141|FG006|Follow-up Period|Death|6
7173655|NCT01928394|11373142|FG007|Follow-up Period|Death|2
7173656|NCT01928394|11373143|FG008|Follow-up Period|Death|1
7173657|NCT01928394|11373144|FG009|Follow-up Period|Death|2
7173658|NCT01928394|11373145|FG010|Follow-up Period|Death|4
7173659|NCT01928394|11373146|FG011|Follow-up Period|Death|12
7173660|NCT01928394|11373147|FG012|Follow-up Period|Death|11
7173661|NCT01928394|11373148|FG013|Follow-up Period|Death|25
7173662|NCT01928394|11373149|FG014|Follow-up Period|Death|18
7173663|NCT01928394|11373150|FG015|Follow-up Period|Death|0
7173664|NCT01928394|11373151|FG016|Follow-up Period|Death|6
7173665|NCT01928394|11373152|FG017|Follow-up Period|Death|5
7173666|NCT01928394|11373153|FG018|Follow-up Period|Death|13
7173667|NCT01928394|11373154|FG019|Follow-up Period|Death|13
7173668|NCT01928394|11373155|FG020|Follow-up Period|Death|5
7173669|NCT01928394|11373156|FG021|Follow-up Period|Death|3
7173670|NCT01928394|11373157|FG022|Follow-up Period|Death|2
7173671|NCT01928394|11373135|FG000|Follow-up Period|other reason|0
7173672|NCT01928394|11373136|FG001|Follow-up Period|other reason|0
7173673|NCT01928394|11373137|FG002|Follow-up Period|other reason|0
7173674|NCT01928394|11373138|FG003|Follow-up Period|other reason|0
7173675|NCT01928394|11373139|FG004|Follow-up Period|other reason|0
7173676|NCT01928394|11373140|FG005|Follow-up Period|other reason|0
7173677|NCT01928394|11373141|FG006|Follow-up Period|other reason|1
7173678|NCT01928394|11373142|FG007|Follow-up Period|other reason|3
7173679|NCT01928394|11373143|FG008|Follow-up Period|other reason|0
7173680|NCT01928394|11373144|FG009|Follow-up Period|other reason|0
7173681|NCT01928394|11373145|FG010|Follow-up Period|other reason|2
7173682|NCT01928394|11373146|FG011|Follow-up Period|other reason|1
7173683|NCT01928394|11373147|FG012|Follow-up Period|other reason|0
7173684|NCT01928394|11373148|FG013|Follow-up Period|other reason|1
7173685|NCT01928394|11373149|FG014|Follow-up Period|other reason|4
7173686|NCT01928394|11373150|FG015|Follow-up Period|other reason|0
7173687|NCT01928394|11373151|FG016|Follow-up Period|other reason|2
7173688|NCT01928394|11373152|FG017|Follow-up Period|other reason|0
7173689|NCT01928394|11373153|FG018|Follow-up Period|other reason|1
7173690|NCT01928394|11373154|FG019|Follow-up Period|other reason|1
7173691|NCT01928394|11373155|FG020|Follow-up Period|other reason|0
7173692|NCT01928394|11373156|FG021|Follow-up Period|other reason|0
7173693|NCT01928394|11373157|FG022|Follow-up Period|other reason|1
7173694|NCT01928394|11373135|FG000|Follow-up Period|Lost to Follow-up|0
7173695|NCT01928394|11373136|FG001|Follow-up Period|Lost to Follow-up|0
7173696|NCT01928394|11373137|FG002|Follow-up Period|Lost to Follow-up|0
7173697|NCT01928394|11373138|FG003|Follow-up Period|Lost to Follow-up|0
7173698|NCT01928394|11373139|FG004|Follow-up Period|Lost to Follow-up|0
7173699|NCT01928394|11373140|FG005|Follow-up Period|Lost to Follow-up|0
7173700|NCT01928394|11373141|FG006|Follow-up Period|Lost to Follow-up|0
7173701|NCT01928394|11373142|FG007|Follow-up Period|Lost to Follow-up|0
7173702|NCT01928394|11373143|FG008|Follow-up Period|Lost to Follow-up|0
7173703|NCT01928394|11373144|FG009|Follow-up Period|Lost to Follow-up|0
7173704|NCT01928394|11373145|FG010|Follow-up Period|Lost to Follow-up|0
7173705|NCT01928394|11373146|FG011|Follow-up Period|Lost to Follow-up|1
7173706|NCT01928394|11373147|FG012|Follow-up Period|Lost to Follow-up|1
7173707|NCT01928394|11373148|FG013|Follow-up Period|Lost to Follow-up|0
7173708|NCT01928394|11373149|FG014|Follow-up Period|Lost to Follow-up|1
7173709|NCT01928394|11373150|FG015|Follow-up Period|Lost to Follow-up|0
7173710|NCT01928394|11373151|FG016|Follow-up Period|Lost to Follow-up|1
7173711|NCT01928394|11373152|FG017|Follow-up Period|Lost to Follow-up|0
7173712|NCT01928394|11373153|FG018|Follow-up Period|Lost to Follow-up|0
7173713|NCT01928394|11373154|FG019|Follow-up Period|Lost to Follow-up|0
7173714|NCT01928394|11373155|FG020|Follow-up Period|Lost to Follow-up|0
7173715|NCT01928394|11373156|FG021|Follow-up Period|Lost to Follow-up|0
7173716|NCT01928394|11373157|FG022|Follow-up Period|Lost to Follow-up|1
7173717|NCT01657500|11373207|FG000|Overall Study|set impropperly matched|3
7173718|NCT01657500|11373208|FG001|Overall Study|set impropperly matched|3
7173719|NCT01657500|11373207|FG000|Overall Study|Lost to Follow-up|2
7173720|NCT01657500|11373208|FG001|Overall Study|Lost to Follow-up|2
7185719|NCT02234843|11386082|FG000|Overall Study|Patient convenience|2
7185720|NCT02234843|11386083|FG001|Overall Study|Patient convenience|0
7185721|NCT02234843|11386084|FG002|Overall Study|Patient convenience|0
7173721|NCT04810221|11373214|FG000|Overall Study|Physician Decision|3
7173722|NCT04575038|11373220|FG000|Overall Study|Withdrawal by Subject|1
7173723|NCT04575038|11373221|FG001|Overall Study|Withdrawal by Subject|1
7173742|NCT04112303|11373290|FG000|Overall Study|Death|1
7173743|NCT03896477|11373297|FG000|Overall Study|Met Ineligibility Criteria During the Study|1
7173744|NCT03896477|11373298|FG001|Overall Study|Met Ineligibility Criteria During the Study|1
7173745|NCT03896477|11373299|FG002|Overall Study|Met Ineligibility Criteria During the Study|2
7173746|NCT03896477|11373297|FG000|Overall Study|Parent Requested Withdrawal|8
7173747|NCT03896477|11373298|FG001|Overall Study|Parent Requested Withdrawal|12
7173748|NCT03896477|11373299|FG002|Overall Study|Parent Requested Withdrawal|9
7173749|NCT03896477|11373297|FG000|Overall Study|Adverse Event|0
7173750|NCT03896477|11373298|FG001|Overall Study|Adverse Event|0
7173751|NCT03896477|11373299|FG002|Overall Study|Adverse Event|1
7173752|NCT03896477|11373297|FG000|Overall Study|Death|1
7173753|NCT03896477|11373298|FG001|Overall Study|Death|0
7173754|NCT03896477|11373299|FG002|Overall Study|Death|0
7173755|NCT03896477|11373297|FG000|Overall Study|Other|5
7080762|NCT02124772|11190314|FG008|Overall Study|Progressive disease|0
7080763|NCT02124772|11190315|FG009|Overall Study|Progressive disease|0
7080764|NCT02124772|11190316|FG010|Overall Study|Progressive disease|0
7173756|NCT03896477|11373298|FG001|Overall Study|Other|6
7173757|NCT03896477|11373299|FG002|Overall Study|Other|7
7173758|NCT03896477|11373297|FG000|Overall Study|Lost to Follow-up|2
7173759|NCT03896477|11373298|FG001|Overall Study|Lost to Follow-up|1
7173760|NCT03896477|11373299|FG002|Overall Study|Lost to Follow-up|1
7173761|NCT03760185|11373310|FG000|Overall Study|Lost to Follow-up|1
7173762|NCT03760185|11373311|FG001|Overall Study|Lost to Follow-up|1
7173783|NCT03205163|11373409|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1
7173784|NCT03205163|11373410|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0
7173785|NCT03178045|11373427|FG000|Overall Study|Withdrawal by Subject|5
7173786|NCT03178045|11373428|FG001|Overall Study|Withdrawal by Subject|7
7173787|NCT03178045|11373427|FG000|Overall Study|Surgery Cancelled/Relocated|34
7173788|NCT03178045|11373428|FG001|Overall Study|Surgery Cancelled/Relocated|30
7173789|NCT03178045|11373427|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47
7173790|NCT03178045|11373428|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46
7173791|NCT03145766|11373440|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1
7173792|NCT03145766|11373441|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1
7173793|NCT03145766|11373442|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0
7173794|NCT03145766|11373443|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1
7173795|NCT03145766|11373444|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2
7173796|NCT03145766|11373440|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0
7173797|NCT03145766|11373441|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0
7173798|NCT03145766|11373442|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1
7173799|NCT03145766|11373443|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2
7173800|NCT03145766|11373444|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1
7173801|NCT03145766|11373440|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1
7173802|NCT03145766|11373441|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1
7173803|NCT03145766|11373442|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0
7173804|NCT03145766|11373443|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3
7173805|NCT03145766|11373444|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0
7173806|NCT03145766|11373440|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4
7173807|NCT03145766|11373441|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1
7173808|NCT03145766|11373442|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1
7173809|NCT03145766|11373443|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1
7173810|NCT03145766|11373444|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0
7173811|NCT03145766|11373440|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2
7173812|NCT03145766|11373441|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0
7173813|NCT03145766|11373442|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0
7173814|NCT03145766|11373443|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1
7173815|NCT03145766|11373444|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0
7173816|NCT03145766|11373440|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4
7173817|NCT03145766|11373441|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1
7173818|NCT03145766|11373442|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4
7173819|NCT03145766|11373443|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2
7173820|NCT03145766|11373444|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3
7173821|NCT03145766|11373440|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1
7173822|NCT03145766|11373441|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1
7173823|NCT03145766|11373442|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1
7173824|NCT03145766|11373443|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0
7173825|NCT03145766|11373444|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0
7173826|NCT03106987|11373461|FG000|Overall Study|Death|37
7173827|NCT03106987|11373462|FG001|Overall Study|Death|22
7173828|NCT03106987|11373463|FG002|Overall Study|Death|12
7173724|NCT04545567|11373229|FG000|Overall Study|tested positive for SARS-co-V2|1
7173725|NCT04545567|11373230|FG001|Overall Study|tested positive for SARS-co-V2|1
7173726|NCT04545567|11373229|FG000|Overall Study|Withdrawal by Subject|0
7173727|NCT04545567|11373230|FG001|Overall Study|Withdrawal by Subject|1
7173728|NCT04397757|11373242|FG000|Overall Study|Death|3
7173729|NCT04397757|11373243|FG001|Overall Study|Death|11
7173730|NCT04397757|11373242|FG000|Overall Study|Withdrawal by Subject|2
7173731|NCT04397757|11373243|FG001|Overall Study|Withdrawal by Subject|0
7173732|NCT04397757|11373242|FG000|Overall Study|Lost to Follow-up|4
7173733|NCT04397757|11373243|FG001|Overall Study|Lost to Follow-up|3
7173734|NCT04382651|11373265|FG000|Overall Study|Death|26
7173735|NCT04382651|11373266|FG001|Overall Study|Death|23
7173736|NCT04382651|11373265|FG000|Overall Study|Lost to Follow-up|3
7173737|NCT04382651|11373266|FG001|Overall Study|Lost to Follow-up|4
7173738|NCT04382651|11373265|FG000|Overall Study|Withdrawal by Subject|2
7173739|NCT04382651|11373266|FG001|Overall Study|Withdrawal by Subject|0
7173740|NCT04382651|11373265|FG000|Overall Study|Physician Decision|0
7173741|NCT04382651|11373266|FG001|Overall Study|Physician Decision|1
7173763|NCT03732534|11373319|FG000|Overall Study|Study terminated by Sponsor|6
7173764|NCT03692910|11373323|FG000|Overall Study|Lost to Follow-up|4
7173765|NCT03692910|11373324|FG001|Overall Study|Lost to Follow-up|0
7173766|NCT03692910|11373325|FG002|Overall Study|Lost to Follow-up|0
7173767|NCT03692910|11373323|FG000|Overall Study|Withdrawal by Subject|2
7173768|NCT03692910|11373324|FG001|Overall Study|Withdrawal by Subject|0
7173769|NCT03692910|11373325|FG002|Overall Study|Withdrawal by Subject|0
7173770|NCT03673956|11373335|FG000|Overall Study|Lost to Follow-up|1
7173771|NCT03673956|11373336|FG001|Overall Study|Lost to Follow-up|0
7173772|NCT03673956|11373337|FG002|Overall Study|Lost to Follow-up|0
7173773|NCT03673956|11373338|FG003|Overall Study|Lost to Follow-up|0
7173774|NCT03673956|11373335|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1
7173775|NCT03673956|11373336|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0
7173776|NCT03673956|11373337|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0
7173777|NCT03673956|11373338|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0
7173778|NCT03364036|11373403|FG000|Overall Study|Adverse Event|1
7173779|NCT03364036|11373403|FG000|Overall Study|Lost to Follow-up|1
7173780|NCT03364036|11373403|FG000|Overall Study|Withdrew Consent|1
7173781|NCT03364036|11373403|FG000|Overall Study|Protocol Non-Compliance|1
7173782|NCT03364036|11373403|FG000|Overall Study|Other|2
7173829|NCT03106987|11373464|FG003|Overall Study|Death|8
7173830|NCT03106987|11373461|FG000|Overall Study|Lost to Follow-up|2
7173831|NCT03106987|11373462|FG001|Overall Study|Lost to Follow-up|0
7173832|NCT03106987|11373463|FG002|Overall Study|Lost to Follow-up|2
7173833|NCT03106987|11373464|FG003|Overall Study|Lost to Follow-up|2
7173834|NCT03106987|11373461|FG000|Overall Study|Withdrawal by Subject|5
7173835|NCT03106987|11373462|FG001|Overall Study|Withdrawal by Subject|1
7173836|NCT03106987|11373463|FG002|Overall Study|Withdrawal by Subject|4
7173837|NCT03106987|11373464|FG003|Overall Study|Withdrawal by Subject|1
7173838|NCT03103087|11373477|FG000|Overall Study|Did not receive any study drug|1
7173839|NCT03103087|11373478|FG001|Overall Study|Did not receive any study drug|0
7173840|NCT03103087|11373479|FG002|Overall Study|Did not receive any study drug|0
7173841|NCT03103087|11373477|FG000|Overall Study|Protocol Violation|1
7173842|NCT03103087|11373478|FG001|Overall Study|Protocol Violation|2
7173843|NCT03103087|11373479|FG002|Overall Study|Protocol Violation|1
7173844|NCT03103087|11373477|FG000|Overall Study|Lack of Efficacy|2
7173845|NCT03103087|11373478|FG001|Overall Study|Lack of Efficacy|1
7173846|NCT03103087|11373479|FG002|Overall Study|Lack of Efficacy|1
7173847|NCT03103087|11373477|FG000|Overall Study|Pregnancy|0
7173848|NCT03103087|11373478|FG001|Overall Study|Pregnancy|0
7173849|NCT03103087|11373479|FG002|Overall Study|Pregnancy|1
7173850|NCT03103087|11373477|FG000|Overall Study|Adverse Event|2
7173851|NCT03103087|11373478|FG001|Overall Study|Adverse Event|15
7173852|NCT03103087|11373479|FG002|Overall Study|Adverse Event|6
7173853|NCT03103087|11373477|FG000|Overall Study|Withdrawal by Subject|13
7173854|NCT03103087|11373478|FG001|Overall Study|Withdrawal by Subject|6
7173855|NCT03103087|11373479|FG002|Overall Study|Withdrawal by Subject|6
7173856|NCT03103087|11373477|FG000|Overall Study|Lost to Follow-up|4
7173857|NCT03103087|11373478|FG001|Overall Study|Lost to Follow-up|2
7173858|NCT03103087|11373479|FG002|Overall Study|Lost to Follow-up|7
7173859|NCT03103087|11373477|FG000|Overall Study|Other reason not reported|1
7173860|NCT03103087|11373478|FG001|Overall Study|Other reason not reported|3
7173861|NCT03103087|11373479|FG002|Overall Study|Other reason not reported|5
7173862|NCT03049735|11373492|FG000|Overall Study|Discontinued due to AE (not dosed)|0
7173863|NCT03049735|11373493|FG001|Overall Study|Discontinued due to AE (not dosed)|0
7173864|NCT03049735|11373494|FG002|Overall Study|Discontinued due to AE (not dosed)|1
7173865|NCT03049735|11373492|FG000|Overall Study|Other|5
7173866|NCT03049735|11373493|FG001|Overall Study|Other|3
7173867|NCT03049735|11373494|FG002|Overall Study|Other|1
7173868|NCT03049735|11373492|FG000|Overall Study|Lack of Efficacy|4
7173869|NCT03049735|11373493|FG001|Overall Study|Lack of Efficacy|0
7173870|NCT03049735|11373494|FG002|Overall Study|Lack of Efficacy|3
7173871|NCT03049735|11373492|FG000|Overall Study|Protocol deviation|1
7173872|NCT03049735|11373493|FG001|Overall Study|Protocol deviation|0
7173873|NCT03049735|11373494|FG002|Overall Study|Protocol deviation|0
7173874|NCT03049735|11373492|FG000|Overall Study|Pregnancy|0
7173875|NCT03049735|11373493|FG001|Overall Study|Pregnancy|0
7173876|NCT03049735|11373494|FG002|Overall Study|Pregnancy|1
7173877|NCT03049735|11373492|FG000|Overall Study|Adverse Event|7
7173878|NCT03049735|11373493|FG001|Overall Study|Adverse Event|18
7173879|NCT03049735|11373494|FG002|Overall Study|Adverse Event|5
7173880|NCT03049735|11373492|FG000|Overall Study|Withdrawal by Subject|10
7173881|NCT03049735|11373493|FG001|Overall Study|Withdrawal by Subject|3
7173882|NCT03049735|11373494|FG002|Overall Study|Withdrawal by Subject|7
7173883|NCT03049735|11373492|FG000|Overall Study|Lost to Follow-up|1
7173884|NCT03049735|11373493|FG001|Overall Study|Lost to Follow-up|5
7173885|NCT03049735|11373494|FG002|Overall Study|Lost to Follow-up|5
7173886|NCT03021551|11373502|FG000|Overall Study|Equipment Issues|2
7173887|NCT03021551|11373502|FG000|Overall Study|Protocol Violation|1
7173888|NCT02990338|11373508|FG000|Overall Study|Adverse Event|19
7173889|NCT02990338|11373509|FG001|Overall Study|Adverse Event|11
7173890|NCT02990338|11373508|FG000|Overall Study|Progressive disease|88
7173891|NCT02990338|11373509|FG001|Overall Study|Progressive disease|66
7173892|NCT02990338|11373508|FG000|Overall Study|Poor compliance to protocol|0
7173893|NCT02990338|11373509|FG001|Overall Study|Poor compliance to protocol|1
7173894|NCT02990338|11373508|FG000|Overall Study|Withdrawal by Subject|6
7173895|NCT02990338|11373509|FG001|Overall Study|Withdrawal by Subject|5
7173896|NCT02990338|11373508|FG000|Overall Study|Other|1
7173897|NCT02990338|11373509|FG001|Overall Study|Other|4
7173898|NCT02990338|11373508|FG000|Overall Study|Randomized but not treated|4
7173899|NCT02990338|11373509|FG001|Overall Study|Randomized but not treated|2
7173900|NCT02932332|11373529|FG000|Overall Study|Withdrawal by Subject|1
7173901|NCT02932332|11373530|FG001|Overall Study|Withdrawal by Subject|1
7173902|NCT02932332|11373531|FG002|Overall Study|Withdrawal by Subject|0
7173903|NCT02932332|11373532|FG003|Overall Study|Withdrawal by Subject|1
7173904|NCT02932332|11373529|FG000|Overall Study|Chest pain|0
7173905|NCT02932332|11373530|FG001|Overall Study|Chest pain|0
7173906|NCT02932332|11373531|FG002|Overall Study|Chest pain|0
7173907|NCT02932332|11373532|FG003|Overall Study|Chest pain|1
7173908|NCT02932332|11373529|FG000|Overall Study|Not Dyspneic cough|1
7173909|NCT02932332|11373530|FG001|Overall Study|Not Dyspneic cough|2
7173910|NCT02932332|11373531|FG002|Overall Study|Not Dyspneic cough|1
7173911|NCT02932332|11373532|FG003|Overall Study|Not Dyspneic cough|0
7185722|NCT02234843|11386085|FG003|Overall Study|Patient convenience|0
7185723|NCT02234843|11386086|FG004|Overall Study|Patient convenience|0
7185724|NCT02234843|11386087|FG005|Overall Study|Patient convenience|1
7185725|NCT02234843|11386088|FG006|Overall Study|Patient convenience|0
7185726|NCT02234843|11386089|FG007|Overall Study|Patient convenience|0
7185727|NCT02234843|11386090|FG008|Overall Study|Patient convenience|0
7185728|NCT02234843|11386091|FG009|Overall Study|Patient convenience|0
7185729|NCT02234843|11386082|FG000|Overall Study|Withdrawal by Subject|5
7185730|NCT02234843|11386083|FG001|Overall Study|Withdrawal by Subject|1
7185731|NCT02234843|11386084|FG002|Overall Study|Withdrawal by Subject|1
7185732|NCT02234843|11386085|FG003|Overall Study|Withdrawal by Subject|0
7185733|NCT02234843|11386086|FG004|Overall Study|Withdrawal by Subject|0
7185734|NCT02234843|11386087|FG005|Overall Study|Withdrawal by Subject|7
7185735|NCT02234843|11386088|FG006|Overall Study|Withdrawal by Subject|0
7185736|NCT02234843|11386089|FG007|Overall Study|Withdrawal by Subject|0
7185737|NCT02234843|11386090|FG008|Overall Study|Withdrawal by Subject|0
7185738|NCT02234843|11386091|FG009|Overall Study|Withdrawal by Subject|0
7185739|NCT02234843|11386082|FG000|Overall Study|Recovery|1
7185740|NCT02234843|11386083|FG001|Overall Study|Recovery|0
7185741|NCT02234843|11386084|FG002|Overall Study|Recovery|0
7185742|NCT02234843|11386085|FG003|Overall Study|Recovery|0
7185743|NCT02234843|11386086|FG004|Overall Study|Recovery|0
7185744|NCT02234843|11386087|FG005|Overall Study|Recovery|0
7185745|NCT02234843|11386088|FG006|Overall Study|Recovery|0
7185746|NCT02234843|11386089|FG007|Overall Study|Recovery|0
7185747|NCT02234843|11386090|FG008|Overall Study|Recovery|0
7185748|NCT02234843|11386091|FG009|Overall Study|Recovery|0
7185749|NCT02234843|11386082|FG000|Overall Study|Other|0
7185750|NCT02234843|11386083|FG001|Overall Study|Other|2
7185751|NCT02234843|11386084|FG002|Overall Study|Other|0
7185752|NCT02234843|11386085|FG003|Overall Study|Other|1
7185753|NCT02234843|11386086|FG004|Overall Study|Other|0
7185754|NCT02234843|11386087|FG005|Overall Study|Other|1
7185755|NCT02234843|11386088|FG006|Overall Study|Other|0
7185756|NCT02234843|11386089|FG007|Overall Study|Other|1
7185757|NCT02234843|11386090|FG008|Overall Study|Other|0
7185758|NCT02234843|11386091|FG009|Overall Study|Other|0
7185759|NCT02234843|11386082|FG000|Overall Study|Physician Decision|4
7185760|NCT02234843|11386083|FG001|Overall Study|Physician Decision|1
7185761|NCT02234843|11386084|FG002|Overall Study|Physician Decision|0
7185762|NCT02234843|11386085|FG003|Overall Study|Physician Decision|1
7185763|NCT02234843|11386086|FG004|Overall Study|Physician Decision|0
7185764|NCT02234843|11386087|FG005|Overall Study|Physician Decision|0
7185765|NCT02234843|11386088|FG006|Overall Study|Physician Decision|0
7185766|NCT02234843|11386089|FG007|Overall Study|Physician Decision|1
7185767|NCT02234843|11386090|FG008|Overall Study|Physician Decision|0
7185768|NCT02234843|11386091|FG009|Overall Study|Physician Decision|0
7185769|NCT02234843|11386082|FG000|Overall Study|Adverse Event|5
7185770|NCT02234843|11386083|FG001|Overall Study|Adverse Event|1
7185771|NCT02234843|11386084|FG002|Overall Study|Adverse Event|1
7185772|NCT02234843|11386085|FG003|Overall Study|Adverse Event|3
7185773|NCT02234843|11386086|FG004|Overall Study|Adverse Event|2
7173912|NCT02588248|11373575|FG000|Overall Study|Physician Decision|4
7173913|NCT02588248|11373576|FG001|Overall Study|Physician Decision|3
7173914|NCT02535065|11373587|FG000|Overall Study|Death|13
7173915|NCT02535065|11373587|FG000|Overall Study|Lost to Follow-up|1
7173916|NCT02535065|11373587|FG000|Overall Study|Withdrawal by Subject|6
7173917|NCT02451358|11373599|FG000|Overall Study|Withdrawal by Subject|1
7173918|NCT02451358|11373600|FG001|Overall Study|Withdrawal by Subject|1
7173919|NCT02451358|11373601|FG002|Overall Study|Withdrawal by Subject|0
7173920|NCT02451358|11373602|FG003|Overall Study|Withdrawal by Subject|0
7173921|NCT02451358|11373599|FG000|Overall Study|Protocol Violation|0
7173922|NCT02451358|11373600|FG001|Overall Study|Protocol Violation|1
7173923|NCT02451358|11373601|FG002|Overall Study|Protocol Violation|1
7173924|NCT02451358|11373602|FG003|Overall Study|Protocol Violation|0
7173925|NCT02178709|11373621|FG000|Overall Study|Adverse Event|5
7173926|NCT02178709|11373621|FG000|Overall Study|Death|2
7173927|NCT02178709|11373621|FG000|Overall Study|Withdrawal by Subject|2
7173928|NCT02178709|11373621|FG000|Overall Study|Physician Decision|2
7173929|NCT02178709|11373621|FG000|Overall Study|Disease Progression|5
7173930|NCT01980017|11373631|FG000|Overall Study|Lost to Follow-up|30
7173931|NCT01980017|11373632|FG001|Overall Study|Lost to Follow-up|21
7173932|NCT01980017|11373631|FG000|Overall Study|Death|0
7173933|NCT01980017|11373632|FG001|Overall Study|Death|1
7173934|NCT01890759|11373643|FG000|Overall Study|Protocol Violation|0
7173935|NCT01890759|11373644|FG001|Overall Study|Protocol Violation|2
7173936|NCT01890759|11373643|FG000|Overall Study|Lost to Follow-up|0
7173937|NCT01890759|11373644|FG001|Overall Study|Lost to Follow-up|2
7173938|NCT01890759|11373643|FG000|Overall Study|Withdrawal by Subject|2
7173939|NCT01890759|11373644|FG001|Overall Study|Withdrawal by Subject|8
7173940|NCT01721746|11373657|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0
7173941|NCT01721746|11373658|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13
6972903|NCT01175382|11024265|FG002|Overall Study|Unable to tolerate study meds|1
6972904|NCT01175473|11024288|FG000|Overall Study|Adverse Event|2
6972905|NCT01175473|11024289|FG001|Overall Study|Adverse Event|2
6972906|NCT01175590|11024297|FG000|Overall Study|Lost to Follow-up|1
7173942|NCT01721746|11373657|FG000|Pre-Treatment|Withdrawal by Subject|1
7173943|NCT01721746|11373658|FG001|Pre-Treatment|Withdrawal by Subject|16
7173944|NCT01721746|11373657|FG000|Pre-Treatment|Poor/Non-compliance|1
7173945|NCT01721746|11373658|FG001|Pre-Treatment|Poor/Non-compliance|0
7173946|NCT01721746|11373657|FG000|Pre-Treatment|Participant no longer met study criteria|2
7173947|NCT01721746|11373658|FG001|Pre-Treatment|Participant no longer met study criteria|2
7173948|NCT01721746|11373657|FG000|Treatment|Disease Progression|192
7173949|NCT01721746|11373658|FG001|Treatment|Disease Progression|74
7173950|NCT01721746|11373657|FG000|Treatment|Study Drug Toxicity|19
7173951|NCT01721746|11373658|FG001|Treatment|Study Drug Toxicity|11
7173952|NCT01721746|11373657|FG000|Treatment|Adverse Event unrelated to Study Drug|6
7173953|NCT01721746|11373658|FG001|Treatment|Adverse Event unrelated to Study Drug|3
7173954|NCT01721746|11373657|FG000|Treatment|Participant request to discontinue Study treatment|26
7173955|NCT01721746|11373658|FG001|Treatment|Participant request to discontinue Study treatment|7
7173956|NCT01721746|11373657|FG000|Treatment|Participant withdrew consent|4
7173957|NCT01721746|11373658|FG001|Treatment|Participant withdrew consent|2
7173958|NCT01721746|11373657|FG000|Treatment|Maximum Clinical Benefit|9
7173959|NCT01721746|11373658|FG001|Treatment|Maximum Clinical Benefit|3
7173960|NCT01721746|11373657|FG000|Treatment|Poor/Non-compliance|2
7173961|NCT01721746|11373658|FG001|Treatment|Poor/Non-compliance|0
7173962|NCT01721746|11373657|FG000|Treatment|Participant no longer met Study criteria|4
7173963|NCT01721746|11373658|FG001|Treatment|Participant no longer met Study criteria|0
7173964|NCT01721746|11373657|FG000|Treatment|Other reasons|6
7173965|NCT01721746|11373658|FG001|Treatment|Other reasons|2
7173966|NCT01705977|11373667|FG000|Overall Study|Withdrawal by Subject|128
7173967|NCT01705977|11373668|FG001|Overall Study|Withdrawal by Subject|128
7173968|NCT01705977|11373667|FG000|Overall Study|Adverse Event|57
7173969|NCT01705977|11373668|FG001|Overall Study|Adverse Event|49
7173970|NCT01705977|11373667|FG000|Overall Study|Protocol Violation|2
7173971|NCT01705977|11373668|FG001|Overall Study|Protocol Violation|4
7173972|NCT01705977|11373667|FG000|Overall Study|Site closure|3
7173973|NCT01705977|11373668|FG001|Overall Study|Site closure|2
7173974|NCT01705977|11373667|FG000|Overall Study|Lost to Follow-up|33
7173975|NCT01705977|11373668|FG001|Overall Study|Lost to Follow-up|37
7173976|NCT01705977|11373667|FG000|Overall Study|Physician Decision|48
7173977|NCT01705977|11373668|FG001|Overall Study|Physician Decision|38
6972907|NCT01175590|11024298|FG001|Overall Study|Lost to Follow-up|0
6972908|NCT01175590|11024297|FG000|Overall Study|Withdrawal by Subject|0
6972909|NCT01175590|11024298|FG001|Overall Study|Withdrawal by Subject|2
6972910|NCT01175590|11024297|FG000|Overall Study|Adverse Event|4
6972911|NCT01175590|11024298|FG001|Overall Study|Adverse Event|0
7173978|NCT01705977|11373667|FG000|Overall Study|Missing study conclusion form|2
7173979|NCT01705977|11373668|FG001|Overall Study|Missing study conclusion form|2
7173980|NCT01587040|11373678|FG000|Overall Study|Protocol Violation|0
7173981|NCT01587040|11373679|FG001|Overall Study|Protocol Violation|0
7173982|NCT01587040|11373680|FG002|Overall Study|Protocol Violation|1
7173983|NCT01587040|11373681|FG003|Overall Study|Protocol Violation|0
6972912|NCT01175590|11024297|FG000|Overall Study|Physician Decision|1
7173984|NCT01587040|11373678|FG000|Overall Study|Adverse Event|0
7173985|NCT01587040|11373679|FG001|Overall Study|Adverse Event|1
7173986|NCT01587040|11373680|FG002|Overall Study|Adverse Event|10
7173987|NCT01587040|11373681|FG003|Overall Study|Adverse Event|0
7173988|NCT01587040|11373678|FG000|Overall Study|Disease progression|12
7173989|NCT01587040|11373679|FG001|Overall Study|Disease progression|1
7173990|NCT01587040|11373680|FG002|Overall Study|Disease progression|15
7173991|NCT01587040|11373681|FG003|Overall Study|Disease progression|3
7173992|NCT01587040|11373678|FG000|Overall Study|Other than specified|5
7173993|NCT01587040|11373679|FG001|Overall Study|Other than specified|1
7173994|NCT01587040|11373680|FG002|Overall Study|Other than specified|11
7173995|NCT01587040|11373681|FG003|Overall Study|Other than specified|1
7173996|NCT01254409|11373699|FG000|Overall Study|Adverse Event|0
7173997|NCT01254409|11373700|FG001|Overall Study|Adverse Event|1
7173998|NCT01254409|11373701|FG002|Overall Study|Adverse Event|0
7173999|NCT01254409|11373702|FG003|Overall Study|Adverse Event|0
7174000|NCT01253161|11373715|FG000|Overall Study|Adverse Event|1
7174001|NCT01084252|11373733|FG000|Phase 1 (120 Weeks)|Adverse Event|0
7174002|NCT01084252|11373734|FG001|Phase 1 (120 Weeks)|Adverse Event|0
7174003|NCT01084252|11373735|FG002|Phase 1 (120 Weeks)|Adverse Event|1
7174004|NCT01084252|11373736|FG003|Phase 1 (120 Weeks)|Adverse Event|1
7174005|NCT01084252|11373737|FG004|Phase 1 (120 Weeks)|Adverse Event|1
7174006|NCT01084252|11373738|FG005|Phase 1 (120 Weeks)|Adverse Event|0
7174007|NCT01084252|11373739|FG006|Phase 1 (120 Weeks)|Adverse Event|1
7174008|NCT01084252|11373740|FG007|Phase 1 (120 Weeks)|Adverse Event|0
7174009|NCT01084252|11373741|FG008|Phase 1 (120 Weeks)|Adverse Event|0
7174010|NCT01084252|11373742|FG009|Phase 1 (120 Weeks)|Adverse Event|0
7174011|NCT01084252|11373743|FG010|Phase 1 (120 Weeks)|Adverse Event|0
7174012|NCT01084252|11373744|FG011|Phase 1 (120 Weeks)|Adverse Event|0
7174013|NCT01084252|11373745|FG012|Phase 1 (120 Weeks)|Adverse Event|0
7174014|NCT01084252|11373746|FG013|Phase 1 (120 Weeks)|Adverse Event|0
7174015|NCT01084252|11373733|FG000|Phase 1 (120 Weeks)|Progressive disease|15
7174016|NCT01084252|11373734|FG001|Phase 1 (120 Weeks)|Progressive disease|5
7174017|NCT01084252|11373735|FG002|Phase 1 (120 Weeks)|Progressive disease|2
7174018|NCT01084252|11373736|FG003|Phase 1 (120 Weeks)|Progressive disease|22
7174019|NCT01084252|11373737|FG004|Phase 1 (120 Weeks)|Progressive disease|16
7174020|NCT01084252|11373738|FG005|Phase 1 (120 Weeks)|Progressive disease|6
7174021|NCT01084252|11373739|FG006|Phase 1 (120 Weeks)|Progressive disease|5
6895294|NCT00624065|10913132|FG001|Overall Study|Lack of Efficacy|3
6895295|NCT00624065|10913131|FG000|Overall Study|Met protocol-defined stopping criteria|4
6895296|NCT00624065|10913132|FG001|Overall Study|Met protocol-defined stopping criteria|9
6895297|NCT00624286|10913158|FG000|Overall Study|Protocol Deviation|7
6895298|NCT00624286|10913159|FG001|Overall Study|Protocol Deviation|9
6895299|NCT00624286|10913158|FG000|Overall Study|Adverse Event|6
6895300|NCT00624286|10913159|FG001|Overall Study|Adverse Event|3
6895301|NCT00624286|10913158|FG000|Overall Study|Withdrawal by Subject|5
6895302|NCT00624286|10913159|FG001|Overall Study|Withdrawal by Subject|4
6895303|NCT00624286|10913158|FG000|Overall Study|Lost to Follow-up|3
7174022|NCT01084252|11373740|FG007|Phase 1 (120 Weeks)|Progressive disease|6
7174023|NCT01084252|11373741|FG008|Phase 1 (120 Weeks)|Progressive disease|0
7174024|NCT01084252|11373742|FG009|Phase 1 (120 Weeks)|Progressive disease|0
7174025|NCT01084252|11373743|FG010|Phase 1 (120 Weeks)|Progressive disease|0
7174026|NCT01084252|11373744|FG011|Phase 1 (120 Weeks)|Progressive disease|0
7174027|NCT01084252|11373745|FG012|Phase 1 (120 Weeks)|Progressive disease|0
7174028|NCT01084252|11373746|FG013|Phase 1 (120 Weeks)|Progressive disease|0
7174029|NCT01084252|11373733|FG000|Phase 1 (120 Weeks)|Other than specified above|1
7174030|NCT01084252|11373734|FG001|Phase 1 (120 Weeks)|Other than specified above|1
7174031|NCT01084252|11373735|FG002|Phase 1 (120 Weeks)|Other than specified above|0
7174032|NCT01084252|11373736|FG003|Phase 1 (120 Weeks)|Other than specified above|3
7174033|NCT01084252|11373737|FG004|Phase 1 (120 Weeks)|Other than specified above|1
7174034|NCT01084252|11373738|FG005|Phase 1 (120 Weeks)|Other than specified above|0
7174035|NCT01084252|11373739|FG006|Phase 1 (120 Weeks)|Other than specified above|1
7174036|NCT01084252|11373740|FG007|Phase 1 (120 Weeks)|Other than specified above|1
7174037|NCT01084252|11373741|FG008|Phase 1 (120 Weeks)|Other than specified above|0
7174038|NCT01084252|11373742|FG009|Phase 1 (120 Weeks)|Other than specified above|0
7174039|NCT01084252|11373743|FG010|Phase 1 (120 Weeks)|Other than specified above|0
7174040|NCT01084252|11373744|FG011|Phase 1 (120 Weeks)|Other than specified above|0
7174041|NCT01084252|11373745|FG012|Phase 1 (120 Weeks)|Other than specified above|0
7174042|NCT01084252|11373746|FG013|Phase 1 (120 Weeks)|Other than specified above|0
7174043|NCT01084252|11373733|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7174044|NCT01084252|11373734|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7174045|NCT01084252|11373735|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7174046|NCT01084252|11373736|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7174047|NCT01084252|11373737|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7174048|NCT01084252|11373738|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7174049|NCT01084252|11373739|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7174050|NCT01084252|11373740|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7174051|NCT01084252|11373741|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7174052|NCT01084252|11373742|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2
7174053|NCT01084252|11373743|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2
7174054|NCT01084252|11373744|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|1
7174055|NCT01084252|11373745|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7174056|NCT01084252|11373746|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7174057|NCT01084252|11373733|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7174058|NCT01084252|11373734|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7174059|NCT01084252|11373735|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7174060|NCT01084252|11373736|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7174061|NCT01084252|11373737|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7174062|NCT01084252|11373738|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7174063|NCT01084252|11373739|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7174064|NCT01084252|11373740|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7174065|NCT01084252|11373741|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|20
7174066|NCT01084252|11373742|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|18
7174067|NCT01084252|11373743|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|17
7174068|NCT01084252|11373744|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|19
7174069|NCT01084252|11373745|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7174070|NCT01084252|11373746|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7174071|NCT01084252|11373733|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7174072|NCT01084252|11373734|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7174073|NCT01084252|11373735|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7174074|NCT01084252|11373736|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7174075|NCT01084252|11373737|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7174076|NCT01084252|11373738|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7174077|NCT01084252|11373739|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7174078|NCT01084252|11373740|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7174079|NCT01084252|11373741|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|2
7174080|NCT01084252|11373742|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7174081|NCT01084252|11373743|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|4
7174082|NCT01084252|11373744|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|3
7174083|NCT01084252|11373745|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7174084|NCT01084252|11373746|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7174085|NCT01084252|11373733|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7174086|NCT01084252|11373734|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7174087|NCT01084252|11373735|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7174088|NCT01084252|11373736|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7174089|NCT01084252|11373737|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7174090|NCT01084252|11373738|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7174091|NCT01084252|11373739|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7174092|NCT01084252|11373740|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7174093|NCT01084252|11373741|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|1
7174094|NCT01084252|11373742|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|4
7174095|NCT01084252|11373743|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2
7174096|NCT01084252|11373744|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2
7174097|NCT01084252|11373745|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7174098|NCT01084252|11373746|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7174099|NCT01084252|11373733|FG000|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7174100|NCT01084252|11373734|FG001|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7174101|NCT01084252|11373735|FG002|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7174102|NCT01084252|11373736|FG003|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7174103|NCT01084252|11373737|FG004|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7174104|NCT01084252|11373738|FG005|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7174105|NCT01084252|11373739|FG006|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7174106|NCT01084252|11373740|FG007|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7174107|NCT01084252|11373741|FG008|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7174108|NCT01084252|11373742|FG009|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7174109|NCT01084252|11373743|FG010|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7174110|NCT01084252|11373744|FG011|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7174111|NCT01084252|11373745|FG012|Phase 2 Stage 2 (97 Weeks)|Adverse Event|13
7174112|NCT01084252|11373746|FG013|Phase 2 Stage 2 (97 Weeks)|Adverse Event|5
7174113|NCT01084252|11373733|FG000|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7174114|NCT01084252|11373734|FG001|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7174115|NCT01084252|11373735|FG002|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7174116|NCT01084252|11373736|FG003|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7174117|NCT01084252|11373737|FG004|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7174118|NCT01084252|11373738|FG005|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7174119|NCT01084252|11373739|FG006|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7174120|NCT01084252|11373740|FG007|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7174121|NCT01084252|11373741|FG008|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7174122|NCT01084252|11373742|FG009|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7174123|NCT01084252|11373743|FG010|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7174124|NCT01084252|11373744|FG011|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7174125|NCT01084252|11373745|FG012|Phase 2 Stage 2 (97 Weeks)|Progressive disease|70
7174126|NCT01084252|11373746|FG013|Phase 2 Stage 2 (97 Weeks)|Progressive disease|33
7174127|NCT01084252|11373733|FG000|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7174128|NCT01084252|11373734|FG001|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7174129|NCT01084252|11373735|FG002|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7174130|NCT01084252|11373736|FG003|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7174131|NCT01084252|11373737|FG004|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7174132|NCT01084252|11373738|FG005|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7174133|NCT01084252|11373739|FG006|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7174134|NCT01084252|11373740|FG007|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7174135|NCT01084252|11373741|FG008|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7174136|NCT01084252|11373742|FG009|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7174137|NCT01084252|11373743|FG010|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7174138|NCT01084252|11373744|FG011|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7174139|NCT01084252|11373745|FG012|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|1
7174140|NCT01084252|11373746|FG013|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7174141|NCT01084252|11373733|FG000|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7174142|NCT01084252|11373734|FG001|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7174143|NCT01084252|11373735|FG002|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7174144|NCT01084252|11373736|FG003|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7174145|NCT01084252|11373737|FG004|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7174146|NCT01084252|11373738|FG005|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7174147|NCT01084252|11373739|FG006|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7174148|NCT01084252|11373740|FG007|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7174149|NCT01084252|11373741|FG008|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7174150|NCT01084252|11373742|FG009|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7174151|NCT01084252|11373743|FG010|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7174152|NCT01084252|11373744|FG011|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7174153|NCT01084252|11373745|FG012|Phase 2 Stage 2 (97 Weeks)|Other than specified above|12
7174154|NCT01084252|11373746|FG013|Phase 2 Stage 2 (97 Weeks)|Other than specified above|2
7174155|NCT01084252|11373733|FG000|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7174156|NCT01084252|11373734|FG001|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7174157|NCT01084252|11373735|FG002|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7174158|NCT01084252|11373736|FG003|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7174159|NCT01084252|11373737|FG004|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7174160|NCT01084252|11373738|FG005|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7174161|NCT01084252|11373739|FG006|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7174162|NCT01084252|11373740|FG007|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7174163|NCT01084252|11373741|FG008|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7174164|NCT01084252|11373742|FG009|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7174165|NCT01084252|11373743|FG010|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7174166|NCT01084252|11373744|FG011|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7174167|NCT01084252|11373745|FG012|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|13
7174168|NCT01084252|11373746|FG013|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|15
7174169|NCT01084252|11373733|FG000|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7174170|NCT01084252|11373734|FG001|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7174171|NCT01084252|11373735|FG002|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7174172|NCT01084252|11373736|FG003|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7174173|NCT01084252|11373737|FG004|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7174174|NCT01084252|11373738|FG005|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7174175|NCT01084252|11373739|FG006|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7174176|NCT01084252|11373740|FG007|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7174177|NCT01084252|11373741|FG008|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7174178|NCT01084252|11373742|FG009|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7174179|NCT01084252|11373743|FG010|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7174180|NCT01084252|11373744|FG011|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7174181|NCT01084252|11373745|FG012|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|1
7174182|NCT01084252|11373746|FG013|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7174183|NCT00728962|11373833|FG000|Implant Placement Surgery|Adverse Event|8
7174184|NCT00728962|11373833|FG000|Implant Placement Surgery|Lost to Follow-up|1
7174185|NCT00728962|11373833|FG000|Implant Placement Surgery|Protocol Violation|1
7174186|NCT00728962|11373833|FG000|Permanent Prosthesis Placement|Adverse Event|3
7174187|NCT00728962|11373833|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3
7174188|NCT00728754|11373839|FG000|Permanent Prosthesis Placement|Adverse Event|1
7174189|NCT00728754|11373840|FG001|Permanent Prosthesis Placement|Adverse Event|1
7174190|NCT00728754|11373839|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3
7174191|NCT00728754|11373840|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3
7174192|NCT00728754|11373839|FG000|One Year Post Placement Follow-up|Adverse Event|1
7174193|NCT00728754|11373840|FG001|One Year Post Placement Follow-up|Adverse Event|0
7185774|NCT02234843|11386087|FG005|Overall Study|Adverse Event|1
7174194|NCT00723944|11373848|FG000|Permanent Prosthesis Placement|Adverse Event|1
7174195|NCT00723944|11373849|FG001|Permanent Prosthesis Placement|Adverse Event|7
7174196|NCT00723944|11373848|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2
7174197|NCT00723944|11373849|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2
6972913|NCT01175590|11024298|FG001|Overall Study|Physician Decision|4
6972914|NCT01175590|11024297|FG000|Overall Study|Lack of Efficacy|1
6972915|NCT01175590|11024298|FG001|Overall Study|Lack of Efficacy|1
6972916|NCT01175590|11024297|FG000|Overall Study|Residual Bacterial Conjunctivitis|1
6972917|NCT01175590|11024298|FG001|Overall Study|Residual Bacterial Conjunctivitis|0
6972918|NCT01175590|11024297|FG000|Overall Study|Treated not as randomized|3
6972919|NCT01175590|11024298|FG001|Overall Study|Treated not as randomized|2
6972920|NCT01175590|11024297|FG000|Overall Study|Herpes Simplex Dermatitis|1
6972921|NCT01175590|11024298|FG001|Overall Study|Herpes Simplex Dermatitis|0
6972922|NCT01175590|11024297|FG000|Overall Study|Protocol Violation|0
6972923|NCT01175590|11024298|FG001|Overall Study|Protocol Violation|1
6972924|NCT01175668|11024307|FG000|Overall Study|Withdrawal by Subject|2
6972925|NCT01175668|11024308|FG001|Overall Study|Withdrawal by Subject|0
6972926|NCT01175707|11024316|FG000|Overall Study|Adverse Event|4
6972927|NCT01175707|11024317|FG001|Overall Study|Adverse Event|6
6972928|NCT01175811|11024335|FG000|Overall Study|Adverse Event|1
6972929|NCT01175811|11024336|FG001|Overall Study|Adverse Event|1
6972930|NCT01175811|11024335|FG000|Overall Study|Entry criteria not met|3
6972931|NCT01175811|11024336|FG001|Overall Study|Entry criteria not met|1
6972932|NCT01175811|11024335|FG000|Overall Study|Lack of Efficacy|1
6972933|NCT01175811|11024336|FG001|Overall Study|Lack of Efficacy|0
6972934|NCT01175811|11024335|FG000|Overall Study|Lost to Follow-up|3
6972935|NCT01175811|11024336|FG001|Overall Study|Lost to Follow-up|2
6972936|NCT01175811|11024335|FG000|Overall Study|Physician Decision|1
6972937|NCT01175811|11024336|FG001|Overall Study|Physician Decision|1
6972938|NCT01175811|11024335|FG000|Overall Study|Protocol Violation|1
6972939|NCT01175811|11024336|FG001|Overall Study|Protocol Violation|2
6972940|NCT01175811|11024335|FG000|Overall Study|Withdrawal by Subject|6
6972941|NCT01175811|11024336|FG001|Overall Study|Withdrawal by Subject|7
6972942|NCT01175824|11024344|FG000|Overall Study|Adverse Event|2
6972943|NCT01175824|11024345|FG001|Overall Study|Adverse Event|1
6972944|NCT01175824|11024344|FG000|Overall Study|Lack of Efficacy|2
6972945|NCT01175824|11024345|FG001|Overall Study|Lack of Efficacy|0
6972946|NCT01175824|11024344|FG000|Overall Study|Lost to Follow-up|0
6972947|NCT01175824|11024345|FG001|Overall Study|Lost to Follow-up|1
6972948|NCT01175824|11024344|FG000|Overall Study|Physician Decision|0
6972949|NCT01175824|11024345|FG001|Overall Study|Physician Decision|4
6972950|NCT01175824|11024344|FG000|Overall Study|Protocol Violation|2
6972951|NCT01175824|11024345|FG001|Overall Study|Protocol Violation|5
6972952|NCT01175824|11024344|FG000|Overall Study|Withdrawal by Subject|3
7174198|NCT00723944|11373848|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1
7174199|NCT00723944|11373849|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4
7174200|NCT00467142|11373855|FG000|Overall Study|Withdrawal by Subject|1
7174201|NCT00467142|11373855|FG000|Overall Study|Adverse Event|1
7174202|NCT00467142|11373855|FG000|Overall Study|Protocol Violation|1
7185775|NCT02234843|11386088|FG006|Overall Study|Adverse Event|0
7185776|NCT02234843|11386089|FG007|Overall Study|Adverse Event|0
7185777|NCT02234843|11386090|FG008|Overall Study|Adverse Event|1
7185778|NCT02234843|11386091|FG009|Overall Study|Adverse Event|0
7185779|NCT02234843|11386082|FG000|Overall Study|Non-compliance with study drug|1
7185780|NCT02234843|11386083|FG001|Overall Study|Non-compliance with study drug|0
7185781|NCT02234843|11386084|FG002|Overall Study|Non-compliance with study drug|0
7185782|NCT02234843|11386085|FG003|Overall Study|Non-compliance with study drug|0
7185783|NCT02234843|11386086|FG004|Overall Study|Non-compliance with study drug|0
7185784|NCT02234843|11386087|FG005|Overall Study|Non-compliance with study drug|1
7185785|NCT02234843|11386088|FG006|Overall Study|Non-compliance with study drug|1
7185786|NCT02234843|11386089|FG007|Overall Study|Non-compliance with study drug|0
7185787|NCT02234843|11386090|FG008|Overall Study|Non-compliance with study drug|0
7185788|NCT02234843|11386091|FG009|Overall Study|Non-compliance with study drug|0
7185789|NCT02234843|11386082|FG000|Overall Study|Lost to Follow-up|0
7185790|NCT02234843|11386083|FG001|Overall Study|Lost to Follow-up|1
7185791|NCT02234843|11386084|FG002|Overall Study|Lost to Follow-up|0
7185792|NCT02234843|11386085|FG003|Overall Study|Lost to Follow-up|0
7185793|NCT02234843|11386086|FG004|Overall Study|Lost to Follow-up|0
7185794|NCT02234843|11386087|FG005|Overall Study|Lost to Follow-up|0
7185795|NCT02234843|11386088|FG006|Overall Study|Lost to Follow-up|1
6972953|NCT01175824|11024345|FG001|Overall Study|Withdrawal by Subject|7
7185796|NCT02234843|11386089|FG007|Overall Study|Lost to Follow-up|0
6972954|NCT01175824|11024344|FG000|Overall Study|Sponsor Decision|1
6972955|NCT01175824|11024345|FG001|Overall Study|Sponsor Decision|0
6972956|NCT01175824|11024344|FG000|Overall Study|Entry Criteria Not Met|6
6972957|NCT01175824|11024345|FG001|Overall Study|Entry Criteria Not Met|4
6972958|NCT01176032|11024378|FG000|Overall Study|Adverse Event|1
7185797|NCT02234843|11386090|FG008|Overall Study|Lost to Follow-up|0
7185798|NCT02234843|11386091|FG009|Overall Study|Lost to Follow-up|0
7188078|NCT03518086|11388732|FG001|Overall Study|COVID-19 Related Study Disruption|2
7188079|NCT03518086|11388733|FG002|Overall Study|COVID-19 Related Study Disruption|0
7188080|NCT03518086|11388734|FG003|Overall Study|COVID-19 Related Study Disruption|0
7174203|NCT04557371|11373892|FG000|Overall Study|Covid-19-related|0
7174204|NCT04557371|11373893|FG001|Overall Study|Covid-19-related|1
7174205|NCT04557371|11373894|FG002|Overall Study|Covid-19-related|0
7174206|NCT04557371|11373892|FG000|Overall Study|Withdrawal by Subject|0
7174207|NCT04557371|11373893|FG001|Overall Study|Withdrawal by Subject|1
7174208|NCT04557371|11373894|FG002|Overall Study|Withdrawal by Subject|0
7174209|NCT04557371|11373892|FG000|Overall Study|Adverse Event|1
7174210|NCT04557371|11373893|FG001|Overall Study|Adverse Event|0
7174211|NCT04557371|11373894|FG002|Overall Study|Adverse Event|0
7174212|NCT04369742|11373915|FG000|Overall Study|Lost to Follow-Up (Day 14)|7
7174213|NCT04369742|11373916|FG001|Overall Study|Lost to Follow-Up (Day 14)|4
7174214|NCT04369742|11373915|FG000|Overall Study|Lost to Follow-Up (Day 30)|7
7174215|NCT04369742|11373916|FG001|Overall Study|Lost to Follow-Up (Day 30)|7
7174216|NCT04346628|11373924|FG000|Overall Study|Lost to Follow-up|4
7174217|NCT04346628|11373925|FG001|Overall Study|Lost to Follow-up|4
7174218|NCT04346628|11373924|FG000|Overall Study|Withdrew (had personal reasons)|2
7174219|NCT04346628|11373925|FG001|Overall Study|Withdrew (had personal reasons)|5
7174220|NCT04346628|11373924|FG000|Overall Study|Withdrew (medication intolerant)|0
7174221|NCT04346628|11373925|FG001|Overall Study|Withdrew (medication intolerant)|3
7174222|NCT04346628|11373924|FG000|Overall Study|Withdrew (declined intervention)|0
7174223|NCT04346628|11373925|FG001|Overall Study|Withdrew (declined intervention)|1
7174224|NCT03969589|11373955|FG000|Overall Study|Lost to Follow-up|3
7174225|NCT03969589|11373956|FG001|Overall Study|Lost to Follow-up|2
7174226|NCT03969589|11373955|FG000|Overall Study|Declined Follow-Up|0
7174227|NCT03969589|11373956|FG001|Overall Study|Declined Follow-Up|1
7174228|NCT03655691|11373999|FG000|Overall Study|Adverse Event|0
7174229|NCT03655691|11374000|FG001|Overall Study|Adverse Event|0
7174230|NCT03655691|11374001|FG002|Overall Study|Adverse Event|1
7174231|NCT03655691|11373999|FG000|Overall Study|Lost to Follow-up|1
7174232|NCT03655691|11374000|FG001|Overall Study|Lost to Follow-up|1
7174233|NCT03655691|11374001|FG002|Overall Study|Lost to Follow-up|2
7174234|NCT03655691|11373999|FG000|Overall Study|Protocol Violation|0
7174235|NCT03655691|11374000|FG001|Overall Study|Protocol Violation|1
7174236|NCT03655691|11374001|FG002|Overall Study|Protocol Violation|0
7174237|NCT03655691|11373999|FG000|Overall Study|Withdrawal by Subject|1
7174238|NCT03655691|11374000|FG001|Overall Study|Withdrawal by Subject|1
7174239|NCT03655691|11374001|FG002|Overall Study|Withdrawal by Subject|0
7174240|NCT03364686|11374013|FG000|Overall Study|Physician Decision|2
7174241|NCT03326856|11374031|FG000|Overall Study|Lost to Follow-up|1
7174242|NCT03326856|11374032|FG001|Overall Study|Lost to Follow-up|1
7174243|NCT03326856|11374033|FG002|Overall Study|Lost to Follow-up|0
7174244|NCT03326856|11374034|FG003|Overall Study|Lost to Follow-up|0
6972959|NCT01176032|11024379|FG001|Overall Study|Adverse Event|0
6972960|NCT01176032|11024378|FG000|Overall Study|Unsatisfactory therapeutic effect|0
6972961|NCT01176032|11024379|FG001|Overall Study|Unsatisfactory therapeutic effect|1
6972962|NCT01176032|11024378|FG000|Overall Study|Protocol Violation|1
6972963|NCT01176032|11024379|FG001|Overall Study|Protocol Violation|0
6972964|NCT01176032|11024378|FG000|Overall Study|Informed consent withdrawn|3
7174245|NCT03326856|11374035|FG004|Overall Study|Lost to Follow-up|0
7174246|NCT03287089|11374053|FG000|Overall Study|Lost to Follow-up|0
7174247|NCT03287089|11374054|FG001|Overall Study|Lost to Follow-up|2
7174248|NCT03287089|11374053|FG000|Overall Study|Physician Decision|0
7174249|NCT03287089|11374054|FG001|Overall Study|Physician Decision|2
7174250|NCT03287089|11374053|FG000|Overall Study|Withdrawal by Subject|0
7174251|NCT03287089|11374054|FG001|Overall Study|Withdrawal by Subject|2
7174252|NCT03240692|11374060|FG000|Overall Study|Physician Decision|1
7174253|NCT03240692|11374060|FG000|Overall Study|Withdrawal by Subject|1
7174254|NCT03227029|11374067|FG000|Overall Study|Child Wheezed (no treatment)|0
7174255|NCT03227029|11374068|FG001|Overall Study|Child Wheezed (no treatment)|1
7174256|NCT03227029|11374069|FG002|Overall Study|Child Wheezed (no treatment)|0
7174257|NCT03227029|11374067|FG000|Overall Study|No post RSV season visit due to COVID|3
7174258|NCT03227029|11374068|FG001|Overall Study|No post RSV season visit due to COVID|3
7174259|NCT03227029|11374069|FG002|Overall Study|No post RSV season visit due to COVID|2
7174260|NCT03227029|11374067|FG000|Overall Study|Not able to get to clinic|0
7174261|NCT03227029|11374068|FG001|Overall Study|Not able to get to clinic|0
7174262|NCT03227029|11374069|FG002|Overall Study|Not able to get to clinic|1
7174263|NCT03227029|11374067|FG000|Overall Study|Withdrawal by Subject|1
7174264|NCT03227029|11374068|FG001|Overall Study|Withdrawal by Subject|0
7174265|NCT03227029|11374069|FG002|Overall Study|Withdrawal by Subject|0
7174266|NCT03227029|11374067|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0
6972965|NCT01176032|11024379|FG001|Overall Study|Informed consent withdrawn|0
6972966|NCT01176032|11024378|FG000|Overall Study|Other|1
7174267|NCT03227029|11374068|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0
7174268|NCT03227029|11374069|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1
7174269|NCT03182829|11374097|FG000|Overall Study|Protocol Violation|12
7174270|NCT03182829|11374098|FG001|Overall Study|Protocol Violation|12
7174271|NCT03182829|11374097|FG000|Overall Study|Other|4
7174272|NCT03182829|11374098|FG001|Overall Study|Other|3
7174273|NCT03181789|11374108|FG000|Overall Study|Withdrawal by Subject|0
7174274|NCT03181789|11374109|FG001|Overall Study|Withdrawal by Subject|1
7174275|NCT03181789|11374110|FG002|Overall Study|Withdrawal by Subject|1
7174276|NCT03181789|11374111|FG003|Overall Study|Withdrawal by Subject|0
7174277|NCT03181789|11374108|FG000|Overall Study|Lost to Follow-up|7
7174278|NCT03181789|11374109|FG001|Overall Study|Lost to Follow-up|1
7174279|NCT03181789|11374110|FG002|Overall Study|Lost to Follow-up|0
7174280|NCT03181789|11374111|FG003|Overall Study|Lost to Follow-up|0
7174281|NCT03181789|11374108|FG000|Overall Study|Participant unable to adhere to visit|0
7174282|NCT03181789|11374109|FG001|Overall Study|Participant unable to adhere to visit|1
7174283|NCT03181789|11374110|FG002|Overall Study|Participant unable to adhere to visit|0
7174284|NCT03181789|11374111|FG003|Overall Study|Participant unable to adhere to visit|0
7174285|NCT03164356|11374126|FG000|Overall Study|Lost to Follow-up|1
7174286|NCT03164356|11374127|FG001|Overall Study|Lost to Follow-up|1
7174287|NCT03164356|11374128|FG002|Overall Study|Lost to Follow-up|2
7174288|NCT03164356|11374129|FG003|Overall Study|Lost to Follow-up|1
7174289|NCT03164356|11374126|FG000|Overall Study|Physician Decision|0
7174290|NCT03164356|11374127|FG001|Overall Study|Physician Decision|0
7174291|NCT03164356|11374128|FG002|Overall Study|Physician Decision|3
7174292|NCT03164356|11374129|FG003|Overall Study|Physician Decision|0
7174293|NCT03164356|11374126|FG000|Overall Study|Protocol Violation|2
7174294|NCT03164356|11374127|FG001|Overall Study|Protocol Violation|1
7174295|NCT03164356|11374128|FG002|Overall Study|Protocol Violation|0
7174296|NCT03164356|11374129|FG003|Overall Study|Protocol Violation|0
7174297|NCT03164356|11374126|FG000|Overall Study|Withdrawal by Subject|1
7174298|NCT03164356|11374127|FG001|Overall Study|Withdrawal by Subject|0
7174299|NCT03164356|11374128|FG002|Overall Study|Withdrawal by Subject|0
7174300|NCT03164356|11374129|FG003|Overall Study|Withdrawal by Subject|0
7174301|NCT03164356|11374126|FG000|Overall Study|Study timeframe interrupted by COVID-19|1
7174302|NCT03164356|11374127|FG001|Overall Study|Study timeframe interrupted by COVID-19|0
7174303|NCT03164356|11374128|FG002|Overall Study|Study timeframe interrupted by COVID-19|0
7174304|NCT03164356|11374129|FG003|Overall Study|Study timeframe interrupted by COVID-19|1
7174305|NCT03164356|11374126|FG000|Overall Study|Subject Incarcerated|0
7174306|NCT03164356|11374127|FG001|Overall Study|Subject Incarcerated|1
7174307|NCT03164356|11374128|FG002|Overall Study|Subject Incarcerated|0
7174308|NCT03164356|11374129|FG003|Overall Study|Subject Incarcerated|0
7174309|NCT03164356|11374126|FG000|Overall Study|Prosthetist unable to participate|0
7174310|NCT03164356|11374127|FG001|Overall Study|Prosthetist unable to participate|2
7174311|NCT03164356|11374128|FG002|Overall Study|Prosthetist unable to participate|1
7174312|NCT03164356|11374129|FG003|Overall Study|Prosthetist unable to participate|0
7174313|NCT02975700|11374149|FG000|Overall Study|Adverse Event|1
7174314|NCT02975700|11374149|FG000|Overall Study|Progressive disease|3
7174315|NCT02975700|11374149|FG000|Overall Study|Failed screening criteria|2
7174316|NCT02941549|11374156|FG000|Overall Study|Adverse Event|1
7174317|NCT02941549|11374157|FG001|Overall Study|Adverse Event|0
7174318|NCT02941549|11374158|FG002|Overall Study|Adverse Event|0
7174319|NCT02941549|11374156|FG000|Overall Study|Withdrawal by Subject|2
7174320|NCT02941549|11374157|FG001|Overall Study|Withdrawal by Subject|1
7174321|NCT02941549|11374158|FG002|Overall Study|Withdrawal by Subject|2
7174322|NCT02927938|11374182|FG000|Overall Study|Death|0
7174323|NCT02927938|11374183|FG001|Overall Study|Death|1
7174324|NCT02927938|11374184|FG002|Overall Study|Death|0
7174325|NCT02927938|11374185|FG003|Overall Study|Death|4
7174326|NCT02927938|11374182|FG000|Overall Study|Early Study Termination|1
7174327|NCT02927938|11374183|FG001|Overall Study|Early Study Termination|5
7174328|NCT02927938|11374184|FG002|Overall Study|Early Study Termination|4
7174329|NCT02927938|11374185|FG003|Overall Study|Early Study Termination|3
7185799|NCT02243306|11386126|FG000|Overall Study|Adverse Event|0
7185800|NCT02243306|11386127|FG001|Overall Study|Adverse Event|1
7185801|NCT02243306|11386126|FG000|Overall Study|Other: Reached stopping criteria|0
7185802|NCT02243306|11386127|FG001|Overall Study|Other: Reached stopping criteria|1
7185803|NCT02243306|11386126|FG000|Overall Study|Physician Decision|0
7185804|NCT02243306|11386127|FG001|Overall Study|Physician Decision|1
7185805|NCT02246621|11386136|FG000|Overall Study|Withdrawal by Subject|28
7185806|NCT02246621|11386137|FG001|Overall Study|Withdrawal by Subject|16
7185807|NCT02246621|11386136|FG000|Overall Study|Lost to Follow-up|1
7185808|NCT02246621|11386137|FG001|Overall Study|Lost to Follow-up|0
7185809|NCT02246621|11386136|FG000|Overall Study|On Study Treatment/ Follow Up|236
7185810|NCT02246621|11386137|FG001|Overall Study|On Study Treatment/ Follow Up|119
7185811|NCT03926611|11386154|FG000|Overall Study|Adverse Event|0
7185812|NCT03926611|11386155|FG001|Overall Study|Adverse Event|0
7185813|NCT03926611|11386156|FG002|Overall Study|Adverse Event|0
7185814|NCT03926611|11386157|FG003|Overall Study|Adverse Event|3
7185815|NCT03926611|11386158|FG004|Overall Study|Adverse Event|1
7185816|NCT03926611|11386159|FG005|Overall Study|Adverse Event|3
7185817|NCT03926611|11386160|FG006|Overall Study|Adverse Event|0
7185818|NCT03926611|11386154|FG000|Overall Study|Lack of Efficacy|1
7185819|NCT03926611|11386155|FG001|Overall Study|Lack of Efficacy|2
7185820|NCT03926611|11386156|FG002|Overall Study|Lack of Efficacy|0
7185821|NCT03926611|11386157|FG003|Overall Study|Lack of Efficacy|0
7185822|NCT03926611|11386158|FG004|Overall Study|Lack of Efficacy|1
7185823|NCT03926611|11386159|FG005|Overall Study|Lack of Efficacy|0
7185824|NCT03926611|11386160|FG006|Overall Study|Lack of Efficacy|1
7185825|NCT03926611|11386154|FG000|Overall Study|Physician Decision|0
7185826|NCT03926611|11386155|FG001|Overall Study|Physician Decision|0
7185827|NCT03926611|11386156|FG002|Overall Study|Physician Decision|0
7185828|NCT03926611|11386157|FG003|Overall Study|Physician Decision|0
7185829|NCT03926611|11386158|FG004|Overall Study|Physician Decision|0
7174330|NCT02823574|11374225|FG000|Pre-Treatment Period|Adverse Event Unrelated to Study drug|1
7174331|NCT02823574|11374226|FG001|Pre-Treatment Period|Adverse Event Unrelated to Study drug|0
7174332|NCT02823574|11374227|FG002|Pre-Treatment Period|Adverse Event Unrelated to Study drug|0
7174333|NCT02823574|11374228|FG003|Pre-Treatment Period|Adverse Event Unrelated to Study drug|0
7174334|NCT02823574|11374225|FG000|Pre-Treatment Period|Disease progression|0
7174335|NCT02823574|11374226|FG001|Pre-Treatment Period|Disease progression|0
7174336|NCT02823574|11374227|FG002|Pre-Treatment Period|Disease progression|1
7174337|NCT02823574|11374228|FG003|Pre-Treatment Period|Disease progression|0
7174338|NCT02823574|11374225|FG000|Treatment Period|Poor/Non Compliance|1
7174339|NCT02823574|11374226|FG001|Treatment Period|Poor/Non Compliance|0
7174340|NCT02823574|11374227|FG002|Treatment Period|Poor/Non Compliance|0
7174341|NCT02823574|11374228|FG003|Treatment Period|Poor/Non Compliance|1
7174342|NCT02823574|11374225|FG000|Treatment Period|Maximum Clinical Benefit|1
7174343|NCT02823574|11374226|FG001|Treatment Period|Maximum Clinical Benefit|0
7174344|NCT02823574|11374227|FG002|Treatment Period|Maximum Clinical Benefit|2
7174345|NCT02823574|11374228|FG003|Treatment Period|Maximum Clinical Benefit|0
7174346|NCT02823574|11374225|FG000|Treatment Period|Lost to Follow-up|1
7174347|NCT02823574|11374226|FG001|Treatment Period|Lost to Follow-up|0
7174348|NCT02823574|11374227|FG002|Treatment Period|Lost to Follow-up|0
7174349|NCT02823574|11374228|FG003|Treatment Period|Lost to Follow-up|0
7174350|NCT02823574|11374225|FG000|Treatment Period|Participant withdrew consent|2
7174351|NCT02823574|11374226|FG001|Treatment Period|Participant withdrew consent|0
7174352|NCT02823574|11374227|FG002|Treatment Period|Participant withdrew consent|0
7174353|NCT02823574|11374228|FG003|Treatment Period|Participant withdrew consent|0
7174354|NCT02823574|11374225|FG000|Treatment Period|Participant request to discontinue|4
7174355|NCT02823574|11374226|FG001|Treatment Period|Participant request to discontinue|0
7174356|NCT02823574|11374227|FG002|Treatment Period|Participant request to discontinue|2
7174357|NCT02823574|11374228|FG003|Treatment Period|Participant request to discontinue|3
7174358|NCT02823574|11374225|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10
7174359|NCT02823574|11374226|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2
7174360|NCT02823574|11374227|FG002|Treatment Period|Adverse Event unrelated to to study Drug|8
7174361|NCT02823574|11374228|FG003|Treatment Period|Adverse Event unrelated to to study Drug|1
7174362|NCT02823574|11374225|FG000|Treatment Period|Study Drug Toxicity|7
7174363|NCT02823574|11374226|FG001|Treatment Period|Study Drug Toxicity|2
7174364|NCT02823574|11374227|FG002|Treatment Period|Study Drug Toxicity|13
7174365|NCT02823574|11374228|FG003|Treatment Period|Study Drug Toxicity|3
7174366|NCT02823574|11374225|FG000|Treatment Period|Disease Progression|112
7174367|NCT02823574|11374226|FG001|Treatment Period|Disease Progression|60
7174368|NCT02823574|11374227|FG002|Treatment Period|Disease Progression|80
7174369|NCT02823574|11374228|FG003|Treatment Period|Disease Progression|41
7174370|NCT02823574|11374225|FG000|Treatment Period|participant no longer meets study criteria|0
7174371|NCT02823574|11374226|FG001|Treatment Period|participant no longer meets study criteria|0
7174372|NCT02823574|11374227|FG002|Treatment Period|participant no longer meets study criteria|1
7174373|NCT02823574|11374228|FG003|Treatment Period|participant no longer meets study criteria|0
7174374|NCT02823574|11374225|FG000|Treatment Period|Death|0
7174375|NCT02823574|11374226|FG001|Treatment Period|Death|0
7174376|NCT02823574|11374227|FG002|Treatment Period|Death|2
7174377|NCT02823574|11374228|FG003|Treatment Period|Death|1
7174378|NCT02823574|11374225|FG000|Treatment Period|Other reasons|1
7174379|NCT02823574|11374226|FG001|Treatment Period|Other reasons|2
7174380|NCT02823574|11374227|FG002|Treatment Period|Other reasons|0
7174381|NCT02823574|11374228|FG003|Treatment Period|Other reasons|1
7174382|NCT02743819|11374250|FG000|Overall Study|Lack of Efficacy|5
7174383|NCT02743819|11374250|FG000|Overall Study|Death|2
7174384|NCT02743819|11374250|FG000|Overall Study|Adverse Event|1
7174385|NCT02729753|11374256|FG000|Overall Study|Device Malfunction. No units in stock.|0
7174386|NCT02729753|11374257|FG001|Overall Study|Device Malfunction. No units in stock.|1
7174387|NCT02704130|11374268|FG000|Overall Study|Physician Decision|5
7174388|NCT02704130|11374269|FG001|Overall Study|Physician Decision|3
7174389|NCT02701192|11374275|FG000|Overall Study|Protocol Violation|2
7174390|NCT02701192|11374275|FG000|Overall Study|Lost to Follow-up|4
7174391|NCT02653482|11374309|FG000|Overall Study|Death|1
7174392|NCT02653482|11374310|FG001|Overall Study|Death|1
7174393|NCT02632409|11374318|FG000|Randomized|AE unrelated to study Drug|0
7174394|NCT02632409|11374319|FG001|Randomized|AE unrelated to study Drug|1
7174395|NCT02632409|11374318|FG000|Randomized|Participant withdrew consent|2
7174396|NCT02632409|11374319|FG001|Randomized|Participant withdrew consent|1
7174397|NCT02632409|11374318|FG000|Randomized|No Longer meets study criteria|5
7174398|NCT02632409|11374319|FG001|Randomized|No Longer meets study criteria|0
7174399|NCT02632409|11374318|FG000|Randomized|other reasons|1
7174400|NCT02632409|11374319|FG001|Randomized|other reasons|0
7174401|NCT02632409|11374318|FG000|Treatment Period|Ongoing Treatment|20
7174402|NCT02632409|11374319|FG001|Treatment Period|Ongoing Treatment|21
7174403|NCT02632409|11374318|FG000|Treatment Period|Disease Recurrence|147
7174404|NCT02632409|11374319|FG001|Treatment Period|Disease Recurrence|90
7174405|NCT02632409|11374318|FG000|Treatment Period|Study Drug Toxicity|8
7174406|NCT02632409|11374319|FG001|Treatment Period|Study Drug Toxicity|49
7174407|NCT02632409|11374318|FG000|Treatment Period|Death|1
7174408|NCT02632409|11374319|FG001|Treatment Period|Death|0
7174409|NCT02632409|11374318|FG000|Treatment Period|AE unrelated to study drug|15
7174410|NCT02632409|11374319|FG001|Treatment Period|AE unrelated to study drug|16
7174411|NCT02632409|11374318|FG000|Treatment Period|Request to discontinue treatment|4
7174412|NCT02632409|11374319|FG001|Treatment Period|Request to discontinue treatment|19
7174413|NCT02632409|11374318|FG000|Treatment Period|Participant withdrew consent|7
7174414|NCT02632409|11374319|FG001|Treatment Period|Participant withdrew consent|5
7174415|NCT02632409|11374318|FG000|Treatment Period|Lost to Follow-up|0
7174416|NCT02632409|11374319|FG001|Treatment Period|Lost to Follow-up|1
7174417|NCT02632409|11374318|FG000|Treatment Period|Maximum clinical benefit|1
7174418|NCT02632409|11374319|FG001|Treatment Period|Maximum clinical benefit|0
7174419|NCT02632409|11374318|FG000|Treatment Period|No longer meets study criteria|3
7174420|NCT02632409|11374319|FG001|Treatment Period|No longer meets study criteria|0
7174421|NCT02632409|11374318|FG000|Treatment Period|Administrative Reason by sponsor|0
7174422|NCT02632409|11374319|FG001|Treatment Period|Administrative Reason by sponsor|1
7174423|NCT02632409|11374318|FG000|Treatment Period|Other Reasons|10
7174424|NCT02632409|11374319|FG001|Treatment Period|Other Reasons|6
7174425|NCT02612194|11374328|FG000|Overall Study|Death|5
7174426|NCT02612194|11374329|FG001|Overall Study|Death|0
7174427|NCT02612194|11374330|FG002|Overall Study|Death|2
7174428|NCT02612194|11374328|FG000|Overall Study|Early Study Termination|1
7174429|NCT02612194|11374329|FG001|Overall Study|Early Study Termination|0
7174430|NCT02612194|11374330|FG002|Overall Study|Early Study Termination|0
7174431|NCT02586207|11374337|FG000|Overall Study|Physician Decision|1
7174432|NCT02586207|11374337|FG000|Overall Study|Withdrawal by Subject|1
7174433|NCT02542397|11374341|FG000|Overall Study|Death|2
7174434|NCT02542397|11374341|FG000|Overall Study|Physician Decision|6
7174435|NCT02542397|11374341|FG000|Overall Study|Withdrawal by Subject|6
7174436|NCT02542397|11374341|FG000|Overall Study|Lost to Follow-up|2
7174437|NCT02519777|11374349|FG000|Overall Study|Death|1
7174438|NCT02519777|11374350|FG001|Overall Study|Death|0
7174439|NCT02519777|11374351|FG002|Overall Study|Death|0
7174440|NCT02519777|11374349|FG000|Overall Study|Lost to Follow-up|0
7174441|NCT02519777|11374350|FG001|Overall Study|Lost to Follow-up|4
7174442|NCT02519777|11374351|FG002|Overall Study|Lost to Follow-up|2
7174443|NCT02519777|11374349|FG000|Overall Study|Withdrawal by Subject|3
7174444|NCT02519777|11374350|FG001|Overall Study|Withdrawal by Subject|1
7174445|NCT02519777|11374351|FG002|Overall Study|Withdrawal by Subject|0
7174446|NCT02519777|11374349|FG000|Overall Study|Severe Debilitation|1
7174447|NCT02519777|11374350|FG001|Overall Study|Severe Debilitation|1
7174448|NCT02519777|11374351|FG002|Overall Study|Severe Debilitation|1
7174449|NCT02519777|11374349|FG000|Overall Study|Not able to get to clinic|1
7174450|NCT02519777|11374350|FG001|Overall Study|Not able to get to clinic|2
7174451|NCT02519777|11374351|FG002|Overall Study|Not able to get to clinic|1
7174452|NCT02484443|11374359|FG000|Overall Study|Lack of Efficacy|28
7174453|NCT02484443|11374359|FG000|Overall Study|Physician Decision|2
7174454|NCT02484443|11374359|FG000|Overall Study|Ineligible|2
7174455|NCT02395666|11374365|FG000|Overall Study|Physician Decision|3
7174456|NCT02395666|11374366|FG001|Overall Study|Physician Decision|0
7174457|NCT02395666|11374365|FG000|Overall Study|Lost to Follow-up|1
7174458|NCT02395666|11374366|FG001|Overall Study|Lost to Follow-up|0
7174459|NCT02395666|11374365|FG000|Overall Study|Withdrawal by Subject|2
7174460|NCT02395666|11374366|FG001|Overall Study|Withdrawal by Subject|1
7174461|NCT02357810|11374376|FG000|Registered and Started Treatment|Withdrawal by Subject|1
7174462|NCT02357810|11374376|FG000|Registered and Started Treatment|Found not to be eligible for the study|26
7174463|NCT02357810|11374376|FG000|Reached 12 Weeks Response|Adverse Event|5
7174464|NCT02357810|11374376|FG000|Reached 12 Weeks Response|Progressive Disease|39
7174465|NCT02357810|11374376|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8
7174466|NCT02357810|11374376|FG000|Reached 12 Weeks Response|Protocol Violation|1
7174467|NCT02357810|11374376|FG000|Reached 12 Weeks Response|Death|1
7174468|NCT02357810|11374376|FG000|Reached 12 Weeks Response|Physician Decision|1
7174469|NCT02357810|11374376|FG000|Reached 12 Weeks Response|Other|1
7174470|NCT02357810|11374376|FG000|12 Week Response and Further Treatment|Adverse Event|5
7174471|NCT02357810|11374376|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1
7174472|NCT02357810|11374376|FG000|12 Week Response and Further Treatment|Progressive Disease|15
7174473|NCT02357810|11374376|FG000|12 Week Response and Further Treatment|Wound Complications|1
7174474|NCT02357810|11374376|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4
7174475|NCT02357810|11374376|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3
7174476|NCT02343549|11374380|FG000|Overall Study|Death|11
7174477|NCT02343549|11374380|FG000|Overall Study|Withdrawal by Subject|2
7174478|NCT02328105|11374388|FG000|Overall Study|Death|6
7174479|NCT02328105|11374388|FG000|Overall Study|Withdrawal by Subject|1
7174480|NCT02328105|11374388|FG000|Overall Study|Still On Study in Follow-Up|4
7174481|NCT02315066|11374415|FG000|Overall Study|Lost to Follow-up|0
7174482|NCT02315066|11374416|FG001|Overall Study|Lost to Follow-up|1
7174483|NCT02315066|11374417|FG002|Overall Study|Lost to Follow-up|1
7174484|NCT02315066|11374418|FG003|Overall Study|Lost to Follow-up|0
7174485|NCT02315066|11374419|FG004|Overall Study|Lost to Follow-up|1
7174486|NCT02315066|11374420|FG005|Overall Study|Lost to Follow-up|0
7174487|NCT02315066|11374421|FG006|Overall Study|Lost to Follow-up|2
7174488|NCT02315066|11374422|FG007|Overall Study|Lost to Follow-up|1
7174489|NCT02315066|11374423|FG008|Overall Study|Lost to Follow-up|0
7174490|NCT02315066|11374424|FG009|Overall Study|Lost to Follow-up|0
7174491|NCT02315066|11374425|FG010|Overall Study|Lost to Follow-up|1
7174492|NCT02315066|11374426|FG011|Overall Study|Lost to Follow-up|2
7174493|NCT02315066|11374427|FG012|Overall Study|Lost to Follow-up|0
7174494|NCT02315066|11374428|FG013|Overall Study|Lost to Follow-up|4
7174495|NCT02315066|11374415|FG000|Overall Study|Death|2
7174496|NCT02315066|11374416|FG001|Overall Study|Death|7
7174497|NCT02315066|11374417|FG002|Overall Study|Death|6
7174498|NCT02315066|11374418|FG003|Overall Study|Death|11
7174499|NCT02315066|11374419|FG004|Overall Study|Death|10
7174500|NCT02315066|11374420|FG005|Overall Study|Death|3
7174501|NCT02315066|11374421|FG006|Overall Study|Death|9
7174502|NCT02315066|11374422|FG007|Overall Study|Death|9
7174503|NCT02315066|11374423|FG008|Overall Study|Death|10
7174504|NCT02315066|11374424|FG009|Overall Study|Death|8
7174505|NCT02315066|11374425|FG010|Overall Study|Death|10
7174506|NCT02315066|11374426|FG011|Overall Study|Death|7
7174507|NCT02315066|11374427|FG012|Overall Study|Death|8
7174508|NCT02315066|11374428|FG013|Overall Study|Death|21
7174509|NCT02315066|11374415|FG000|Overall Study|Other|0
6972967|NCT01176032|11024379|FG001|Overall Study|Other|0
6972968|NCT01176058|11024392|FG000|Overall Study|Adverse Event|1
6972969|NCT01176058|11024393|FG001|Overall Study|Adverse Event|0
6972970|NCT01176058|11024392|FG000|Overall Study|Insufficient clinical response|2
6972971|NCT01176058|11024393|FG001|Overall Study|Insufficient clinical response|2
6972972|NCT01176058|11024392|FG000|Overall Study|Insufficient mycological response|0
6972973|NCT01176058|11024393|FG001|Overall Study|Insufficient mycological response|1
6972974|NCT01176058|11024392|FG000|Overall Study|Withdrawal by Subject|1
6972975|NCT01176058|11024393|FG001|Overall Study|Withdrawal by Subject|0
6977087|NCT01204710|11030073|FG000|Randomization Treatment|Withdrawal by Subject|6
7174510|NCT02315066|11374416|FG001|Overall Study|Other|0
7174511|NCT02315066|11374417|FG002|Overall Study|Other|0
6977088|NCT01204710|11030074|FG001|Randomization Treatment|Withdrawal by Subject|5
6977089|NCT01204710|11030073|FG000|Randomization Treatment|Physician Decision|3
6977090|NCT01204710|11030074|FG001|Randomization Treatment|Physician Decision|2
6977091|NCT01204710|11030073|FG000|Randomization Treatment|Entry criteria not met|0
6977092|NCT01204710|11030074|FG001|Randomization Treatment|Entry criteria not met|1
6977093|NCT01204710|11030073|FG000|Randomization Treatment|Adverse Event|4
6977094|NCT01204710|11030074|FG001|Randomization Treatment|Adverse Event|2
6977095|NCT01204710|11030073|FG000|Randomization Treatment|Sponsor Decision|0
6977096|NCT01204710|11030074|FG001|Randomization Treatment|Sponsor Decision|1
6977097|NCT01204710|11030073|FG000|Randomization Treatment|Worsening of General condition|0
6977098|NCT01204710|11030074|FG001|Randomization Treatment|Worsening of General condition|1
6977099|NCT01204710|11030073|FG000|Randomization Treatment|Moved and Followed for Survival|0
6977100|NCT01204710|11030074|FG001|Randomization Treatment|Moved and Followed for Survival|1
6977101|NCT01204710|11030073|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0
6977102|NCT01204710|11030074|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1
6977103|NCT01204710|11030073|FG000|Optional Olaratumab Monotherapy|Physician Decision|0
6977104|NCT01204710|11030074|FG001|Optional Olaratumab Monotherapy|Physician Decision|1
6977105|NCT01204710|11030073|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0
6977106|NCT01204710|11030074|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1
6977107|NCT01204775|11030106|FG000|Overall Study|Poor/non-compliance|0
6977108|NCT01204775|11030107|FG001|Overall Study|Poor/non-compliance|1
6977109|NCT01204775|11030106|FG000|Overall Study|Withdrawal by Subject|1
6977110|NCT01204775|11030107|FG001|Overall Study|Withdrawal by Subject|0
6977111|NCT01204918|11030124|FG000|Overall Study|Withdrawal by Subject|4
6977112|NCT01204918|11030125|FG001|Overall Study|Withdrawal by Subject|10
6977113|NCT01204918|11030126|FG002|Overall Study|Withdrawal by Subject|5
6977114|NCT01205035|11030136|FG000|Overall Study|Withdrawal by Subject|1
6977115|NCT01205035|11030137|FG001|Overall Study|Withdrawal by Subject|0
6977116|NCT01205035|11030136|FG000|Overall Study|Physician Decision|1
6977117|NCT01205035|11030137|FG001|Overall Study|Physician Decision|0
6977118|NCT01205126|11030145|FG000|Titration Phase|Adverse Event|5
7174512|NCT02315066|11374418|FG003|Overall Study|Other|0
7174513|NCT02315066|11374419|FG004|Overall Study|Other|0
7174514|NCT02315066|11374420|FG005|Overall Study|Other|0
7174515|NCT02315066|11374421|FG006|Overall Study|Other|0
7174516|NCT02315066|11374422|FG007|Overall Study|Other|1
7174517|NCT02315066|11374423|FG008|Overall Study|Other|1
7174518|NCT02315066|11374424|FG009|Overall Study|Other|2
7174519|NCT02315066|11374425|FG010|Overall Study|Other|0
7174520|NCT02315066|11374426|FG011|Overall Study|Other|0
7174521|NCT02315066|11374427|FG012|Overall Study|Other|0
7174522|NCT02315066|11374428|FG013|Overall Study|Other|0
7174523|NCT02315066|11374415|FG000|Overall Study|Subject refused further follow-up|0
7174524|NCT02315066|11374416|FG001|Overall Study|Subject refused further follow-up|2
7174525|NCT02315066|11374417|FG002|Overall Study|Subject refused further follow-up|2
7174526|NCT02315066|11374418|FG003|Overall Study|Subject refused further follow-up|0
7174527|NCT02315066|11374419|FG004|Overall Study|Subject refused further follow-up|0
7174528|NCT02315066|11374420|FG005|Overall Study|Subject refused further follow-up|0
7174529|NCT02315066|11374421|FG006|Overall Study|Subject refused further follow-up|2
7174530|NCT02315066|11374422|FG007|Overall Study|Subject refused further follow-up|3
7174531|NCT02315066|11374423|FG008|Overall Study|Subject refused further follow-up|0
7174532|NCT02315066|11374424|FG009|Overall Study|Subject refused further follow-up|1
6972976|NCT01176240|11024403|FG000|Study 306A|Lack of Efficacy|2
6972977|NCT01176240|11024404|FG001|Study 306A|Lack of Efficacy|1
6972978|NCT01176240|11024403|FG000|Study 306A|Protocol Violation|0
6972979|NCT01176240|11024404|FG001|Study 306A|Protocol Violation|1
6972980|NCT01176240|11024403|FG000|Study 306A|Withdrawal by Subject|0
6972981|NCT01176240|11024404|FG001|Study 306A|Withdrawal by Subject|1
6972982|NCT01176240|11024403|FG000|Study 306A|Stop due to diverse problems|1
6972983|NCT01176240|11024404|FG001|Study 306A|Stop due to diverse problems|0
6972984|NCT01176240|11024403|FG000|Study 306B|Lack of Efficacy|5
6972985|NCT01176240|11024404|FG001|Study 306B|Lack of Efficacy|3
6972986|NCT01176240|11024403|FG000|Study 306B|Adverse Event|10
6972987|NCT01176240|11024404|FG001|Study 306B|Adverse Event|5
6972988|NCT01176240|11024403|FG000|Study 306B|Protocol Violation|2
6972989|NCT01176240|11024404|FG001|Study 306B|Protocol Violation|3
6972990|NCT01176240|11024403|FG000|Study 306B|Withdrawal by Subject|4
6972991|NCT01176240|11024404|FG001|Study 306B|Withdrawal by Subject|1
6972992|NCT01176240|11024403|FG000|Study 306B|Physician Decision|2
6972993|NCT01176240|11024404|FG001|Study 306B|Physician Decision|1
6972994|NCT01176240|11024403|FG000|Study 306B|Supine Hypertension|1
6972995|NCT01176240|11024404|FG001|Study 306B|Supine Hypertension|2
6972996|NCT01176240|11024403|FG000|Study 306B|Lost to Follow-up|0
6972997|NCT01176240|11024404|FG001|Study 306B|Lost to Follow-up|1
6972998|NCT01176240|11024403|FG000|Study 306B|withdrew prior to dosing|2
6972999|NCT01176240|11024404|FG001|Study 306B|withdrew prior to dosing|1
6973000|NCT01176266|11024410|FG000|Overall Study|Death|6
6973001|NCT01176266|11024410|FG000|Overall Study|Withdrawal by Subject|3
6973002|NCT01176292|11024420|FG000|Overall Study|Lost to Follow-up|2
6973003|NCT01176292|11024421|FG001|Overall Study|Lost to Follow-up|4
6973004|NCT01176292|11024420|FG000|Overall Study|Adverse Event|1
6973005|NCT01176292|11024421|FG001|Overall Study|Adverse Event|1
6973006|NCT01176292|11024420|FG000|Overall Study|Physician Decision|0
6973007|NCT01176292|11024421|FG001|Overall Study|Physician Decision|2
6973008|NCT01176292|11024420|FG000|Overall Study|Has not scheduled one-year visit yet|2
6973009|NCT01176292|11024421|FG001|Overall Study|Has not scheduled one-year visit yet|2
6973010|NCT01176565|11024450|FG000|Overall Study|Lost to Follow-up|12
6973011|NCT01176565|11024451|FG001|Overall Study|Lost to Follow-up|16
6973012|NCT01176565|11024450|FG000|Overall Study|Withdrawal by Subject|7
6973013|NCT01176565|11024451|FG001|Overall Study|Withdrawal by Subject|1
6973014|NCT01176565|11024450|FG000|Overall Study|Not Analyzed (any other reason)|1
6973015|NCT01176565|11024451|FG001|Overall Study|Not Analyzed (any other reason)|2
6973016|NCT01176773|11024480|FG000|Overall Study|Screen Failure|2
6973017|NCT01176773|11024480|FG000|Overall Study|Withdrew consent|1
6973018|NCT01176916|11024490|FG000|Overall Study|Adverse Event|61
6973019|NCT01176916|11024490|FG000|Overall Study|Death|1
6973020|NCT01176916|11024490|FG000|Overall Study|Lost to Follow-up|15
6973021|NCT01176916|11024490|FG000|Overall Study|Objective progression or relapse|17
6973022|NCT01176916|11024490|FG000|Overall Study|Protocol Violation|24
6973023|NCT01176916|11024490|FG000|Overall Study|Withdrawal by Subject|37
6973024|NCT01176916|11024490|FG000|Overall Study|Other|6
6973025|NCT01176916|11024490|FG000|Overall Study|Withdrawal prior to Treatment|6
7080765|NCT02124772|11190317|FG011|Overall Study|Progressive disease|0
7080766|NCT02124772|11190318|FG012|Overall Study|Progressive disease|0
7080767|NCT02124772|11190306|FG000|Overall Study|Other|0
7080768|NCT02124772|11190307|FG001|Overall Study|Other|7
7080769|NCT02124772|11190308|FG002|Overall Study|Other|2
7080770|NCT02124772|11190309|FG003|Overall Study|Other|5
7080771|NCT02124772|11190310|FG004|Overall Study|Other|4
7080772|NCT02124772|11190311|FG005|Overall Study|Other|3
7080773|NCT02124772|11190312|FG006|Overall Study|Other|4
7080774|NCT02124772|11190313|FG007|Overall Study|Other|1
7080775|NCT02124772|11190314|FG008|Overall Study|Other|1
7080776|NCT02124772|11190315|FG009|Overall Study|Other|1
7080777|NCT02124772|11190316|FG010|Overall Study|Other|1
7174533|NCT02315066|11374425|FG010|Overall Study|Subject refused further follow-up|1
7174534|NCT02315066|11374426|FG011|Overall Study|Subject refused further follow-up|2
7174535|NCT02315066|11374427|FG012|Overall Study|Subject refused further follow-up|2
6973026|NCT01176968|11024508|FG000|Overall Study|Adverse Event|10
7174536|NCT02315066|11374428|FG013|Overall Study|Subject refused further follow-up|4
7174537|NCT02315066|11374415|FG000|Overall Study|Study ongoing at date of cut-off|0
7174538|NCT02315066|11374416|FG001|Overall Study|Study ongoing at date of cut-off|0
7174539|NCT02315066|11374417|FG002|Overall Study|Study ongoing at date of cut-off|0
7174540|NCT02315066|11374418|FG003|Overall Study|Study ongoing at date of cut-off|0
7174541|NCT02315066|11374419|FG004|Overall Study|Study ongoing at date of cut-off|0
7174542|NCT02315066|11374420|FG005|Overall Study|Study ongoing at date of cut-off|0
7174543|NCT02315066|11374421|FG006|Overall Study|Study ongoing at date of cut-off|0
6973027|NCT01176968|11024509|FG001|Overall Study|Adverse Event|11
6973028|NCT01176968|11024508|FG000|Overall Study|Death|2
6973029|NCT01176968|11024509|FG001|Overall Study|Death|3
6973030|NCT01176968|11024508|FG000|Overall Study|Lack of Efficacy|0
6973031|NCT01176968|11024509|FG001|Overall Study|Lack of Efficacy|1
6973032|NCT01176968|11024508|FG000|Overall Study|Lost to Follow-up|16
7080778|NCT02124772|11190317|FG011|Overall Study|Other|1
7080779|NCT02124772|11190318|FG012|Overall Study|Other|0
7080780|NCT02124798|11190370|FG000|Overall Study|Adverse Event|3
7080781|NCT02124798|11190370|FG000|Overall Study|Lost to Follow-up|1
7080782|NCT02124811|11190376|FG000|Overall Study|Early termination|2
7174544|NCT02315066|11374422|FG007|Overall Study|Study ongoing at date of cut-off|0
7174545|NCT02315066|11374423|FG008|Overall Study|Study ongoing at date of cut-off|0
7174546|NCT02315066|11374424|FG009|Overall Study|Study ongoing at date of cut-off|0
7174547|NCT02315066|11374425|FG010|Overall Study|Study ongoing at date of cut-off|0
7174548|NCT02315066|11374426|FG011|Overall Study|Study ongoing at date of cut-off|0
7174549|NCT02315066|11374427|FG012|Overall Study|Study ongoing at date of cut-off|0
7174550|NCT02315066|11374428|FG013|Overall Study|Study ongoing at date of cut-off|1
7174551|NCT02256631|11374474|FG000|Overall Study|Lost to Follow-up|1
7080783|NCT02124811|11190377|FG001|Overall Study|Early termination|2
7080784|NCT02124811|11190376|FG000|Overall Study|Withdrawal by Subject|1
7080785|NCT02124811|11190377|FG001|Overall Study|Withdrawal by Subject|0
7174552|NCT02256631|11374475|FG001|Overall Study|Lost to Follow-up|1
7174553|NCT02256631|11374476|FG002|Overall Study|Lost to Follow-up|0
7174554|NCT02256631|11374477|FG003|Overall Study|Lost to Follow-up|2
7174555|NCT02256631|11374478|FG004|Overall Study|Lost to Follow-up|0
7174556|NCT02256631|11374479|FG005|Overall Study|Lost to Follow-up|1
7174557|NCT02256631|11374480|FG006|Overall Study|Lost to Follow-up|1
7174558|NCT02256631|11374474|FG000|Overall Study|Withdrawal by Subject|0
7174559|NCT02256631|11374475|FG001|Overall Study|Withdrawal by Subject|0
6973033|NCT01176968|11024509|FG001|Overall Study|Lost to Follow-up|14
6973034|NCT01176968|11024508|FG000|Overall Study|Withdrawal by Subject|48
6973035|NCT01176968|11024509|FG001|Overall Study|Withdrawal by Subject|48
6973036|NCT01176968|11024508|FG000|Overall Study|Protocol Violation|2
6973037|NCT01176968|11024509|FG001|Overall Study|Protocol Violation|1
6973038|NCT01176968|11024508|FG000|Overall Study|Did Not Meet Entrance Criteria|1
6973039|NCT01176968|11024509|FG001|Overall Study|Did Not Meet Entrance Criteria|0
6973040|NCT01176968|11024508|FG000|Overall Study|Study terminated by sponsor|0
6973041|NCT01176968|11024509|FG001|Overall Study|Study terminated by sponsor|1
6973042|NCT01176968|11024508|FG000|Overall Study|Reason not defined|5
6973043|NCT01176968|11024509|FG001|Overall Study|Reason not defined|3
6973044|NCT01177007|11024519|FG000|Overall Study|Lost to Follow-up|2
6973045|NCT01177007|11024519|FG000|Overall Study|Death|4
6973046|NCT01177007|11024519|FG000|Overall Study|Entered hospice care|5
6973047|NCT01177007|11024519|FG000|Overall Study|Required additional Y90 treatment|6
6973048|NCT01177007|11024519|FG000|Overall Study|Change in treatment modality|21
7174560|NCT02256631|11374476|FG002|Overall Study|Withdrawal by Subject|0
6973049|NCT01177059|11024525|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30
6973050|NCT01177059|11024525|FG000|Overall Study|Withdrew consent|2
6973051|NCT01177059|11024525|FG000|Overall Study|Lost to Follow-up|18
6973052|NCT01177137|11024541|FG000|Overall Study|Withdrawal by Subject|10
6973053|NCT01177137|11024542|FG001|Overall Study|Withdrawal by Subject|10
6973054|NCT01177137|11024543|FG002|Overall Study|Withdrawal by Subject|2
6973055|NCT01177228|11024567|FG000|Overall Study|Positive tuberculosis test|0
6973056|NCT01177228|11024568|FG001|Overall Study|Positive tuberculosis test|1
6973057|NCT01177228|11024569|FG002|Overall Study|Positive tuberculosis test|0
6973058|NCT01177228|11024570|FG003|Overall Study|Positive tuberculosis test|0
6973059|NCT01177228|11024567|FG000|Overall Study|Worsening disease activity|1
6973060|NCT01177228|11024568|FG001|Overall Study|Worsening disease activity|0
6973061|NCT01177228|11024569|FG002|Overall Study|Worsening disease activity|0
6973062|NCT01177228|11024570|FG003|Overall Study|Worsening disease activity|0
6973063|NCT01177228|11024567|FG000|Overall Study|Withdrawal by Subject|0
6973064|NCT01177228|11024568|FG001|Overall Study|Withdrawal by Subject|1
6973065|NCT01177228|11024569|FG002|Overall Study|Withdrawal by Subject|0
6973066|NCT01177228|11024570|FG003|Overall Study|Withdrawal by Subject|0
6973067|NCT01177293|11024585|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0
6973068|NCT01177293|11024586|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1
6973069|NCT01177384|11024594|FG000|Overall Study|Adverse Event|6
6973070|NCT01177384|11024595|FG001|Overall Study|Adverse Event|4
6973071|NCT01177384|11024594|FG000|Overall Study|Lack of Efficacy|0
6973072|NCT01177384|11024595|FG001|Overall Study|Lack of Efficacy|1
6973073|NCT01177384|11024594|FG000|Overall Study|Lost to Follow-up|3
6973074|NCT01177384|11024595|FG001|Overall Study|Lost to Follow-up|4
6973075|NCT01177384|11024594|FG000|Overall Study|Physician Decision|0
7080786|NCT02125279|11190398|FG000|Overall Study|Lack of Efficacy|2
7080787|NCT02125279|11190398|FG000|Overall Study|Withdrawal by Subject|6
7080788|NCT02125279|11190398|FG000|Overall Study|Protocol Violation|1
7080789|NCT02125279|11190398|FG000|Overall Study|Lost to Follow-up|4
7080790|NCT02125331|11190420|FG000|Overall Study|Protocol Violation|1
7080791|NCT02125331|11190421|FG001|Overall Study|Protocol Violation|0
7080792|NCT02125331|11190420|FG000|Overall Study|technical problem|2
7080793|NCT02125331|11190421|FG001|Overall Study|technical problem|0
7080794|NCT02125331|11190420|FG000|Overall Study|screen failure|2
7080795|NCT02125331|11190421|FG001|Overall Study|screen failure|0
7080796|NCT02125604|11190427|FG000|Overall Study|Other|4
7174561|NCT02256631|11374477|FG003|Overall Study|Withdrawal by Subject|1
7174562|NCT02256631|11374478|FG004|Overall Study|Withdrawal by Subject|1
7174563|NCT02256631|11374479|FG005|Overall Study|Withdrawal by Subject|0
7174564|NCT02256631|11374480|FG006|Overall Study|Withdrawal by Subject|1
7080797|NCT02125604|11190427|FG000|Overall Study|Investigator Decision|1
7080798|NCT02125604|11190427|FG000|Overall Study|Lost to Follow-up|2
7080799|NCT02125604|11190427|FG000|Overall Study|Consent Withdrawn|4
7080800|NCT02125604|11190427|FG000|Overall Study|Adverse Event|20
7080801|NCT02125734|11190437|FG000|Period 2|Adverse Event|0
6973076|NCT01177384|11024595|FG001|Overall Study|Physician Decision|3
6973077|NCT01177384|11024594|FG000|Overall Study|Protocol Violation|0
6973078|NCT01177384|11024595|FG001|Overall Study|Protocol Violation|2
6973079|NCT01177384|11024594|FG000|Overall Study|Withdrawal by Subject|5
6973080|NCT01177384|11024595|FG001|Overall Study|Withdrawal by Subject|12
6973081|NCT01177410|11024604|FG000|Overall Study|Adverse Event|0
6973082|NCT01177410|11024605|FG001|Overall Study|Adverse Event|2
6973083|NCT01177410|11024606|FG002|Overall Study|Adverse Event|2
6973084|NCT01177410|11024604|FG000|Overall Study|Withdrawal by Subject|1
6973085|NCT01177410|11024605|FG001|Overall Study|Withdrawal by Subject|4
6973086|NCT01177410|11024606|FG002|Overall Study|Withdrawal by Subject|3
6973087|NCT01177410|11024604|FG000|Overall Study|Lost to Follow-up|0
6973088|NCT01177410|11024605|FG001|Overall Study|Lost to Follow-up|1
7174565|NCT02256631|11374474|FG000|Overall Study|Unable to get to clinic|0
7174566|NCT02256631|11374475|FG001|Overall Study|Unable to get to clinic|2
7174567|NCT02256631|11374476|FG002|Overall Study|Unable to get to clinic|0
7174568|NCT02256631|11374477|FG003|Overall Study|Unable to get to clinic|1
7174569|NCT02256631|11374478|FG004|Overall Study|Unable to get to clinic|0
7174570|NCT02256631|11374479|FG005|Overall Study|Unable to get to clinic|1
7174571|NCT02256631|11374480|FG006|Overall Study|Unable to get to clinic|2
7174572|NCT02173379|11374498|FG000|Overall Study|Lost to Follow-up|48
7174573|NCT02173379|11374499|FG001|Overall Study|Lost to Follow-up|34
7174574|NCT02173379|11374498|FG000|Overall Study|Withdrawal by Subject|14
7174575|NCT02173379|11374499|FG001|Overall Study|Withdrawal by Subject|17
7174576|NCT02173379|11374498|FG000|Overall Study|Physician Decision|7
7174577|NCT02173379|11374499|FG001|Overall Study|Physician Decision|4
7174578|NCT02173379|11374498|FG000|Overall Study|Death|22
7174579|NCT02173379|11374499|FG001|Overall Study|Death|22
7174580|NCT02080260|11374515|FG000|Overall Study|Death|18
7174581|NCT02080260|11374515|FG000|Overall Study|Withdrawal by Subject|1
7174582|NCT02051933|11374521|FG000|Overall Study|Physician Decision|0
7174583|NCT02051933|11374522|FG001|Overall Study|Physician Decision|1
7185830|NCT03926611|11386159|FG005|Overall Study|Physician Decision|1
7185831|NCT03926611|11386160|FG006|Overall Study|Physician Decision|0
7185832|NCT03926611|11386154|FG000|Overall Study|Protocol Violation|1
7185833|NCT03926611|11386155|FG001|Overall Study|Protocol Violation|0
7185834|NCT03926611|11386156|FG002|Overall Study|Protocol Violation|0
7185835|NCT03926611|11386157|FG003|Overall Study|Protocol Violation|1
7185836|NCT03926611|11386158|FG004|Overall Study|Protocol Violation|1
7185837|NCT03926611|11386159|FG005|Overall Study|Protocol Violation|1
7185838|NCT03926611|11386160|FG006|Overall Study|Protocol Violation|1
7185839|NCT03926611|11386154|FG000|Overall Study|Technical problems|0
7185840|NCT03926611|11386155|FG001|Overall Study|Technical problems|0
7185841|NCT03926611|11386156|FG002|Overall Study|Technical problems|0
7185842|NCT03926611|11386157|FG003|Overall Study|Technical problems|0
7185843|NCT03926611|11386158|FG004|Overall Study|Technical problems|0
7185844|NCT03926611|11386159|FG005|Overall Study|Technical problems|1
7185845|NCT03926611|11386160|FG006|Overall Study|Technical problems|0
7185846|NCT03926611|11386154|FG000|Overall Study|Withdrawal by Subject|1
7185847|NCT03926611|11386155|FG001|Overall Study|Withdrawal by Subject|1
7185848|NCT03926611|11386156|FG002|Overall Study|Withdrawal by Subject|1
7185849|NCT03926611|11386157|FG003|Overall Study|Withdrawal by Subject|0
7185850|NCT03926611|11386158|FG004|Overall Study|Withdrawal by Subject|0
7185851|NCT03926611|11386159|FG005|Overall Study|Withdrawal by Subject|1
7185852|NCT03926611|11386160|FG006|Overall Study|Withdrawal by Subject|3
7185853|NCT03926611|11386154|FG000|Overall Study|Covid-19 pandemic|0
7185854|NCT03926611|11386155|FG001|Overall Study|Covid-19 pandemic|0
7185855|NCT03926611|11386156|FG002|Overall Study|Covid-19 pandemic|1
7185856|NCT03926611|11386157|FG003|Overall Study|Covid-19 pandemic|0
7185857|NCT03926611|11386158|FG004|Overall Study|Covid-19 pandemic|1
7185858|NCT03926611|11386159|FG005|Overall Study|Covid-19 pandemic|2
7185859|NCT03926611|11386160|FG006|Overall Study|Covid-19 pandemic|0
7185860|NCT03838484|11386184|FG000|Overall Study|Lost to Follow-up|0
7185861|NCT03838484|11386185|FG001|Overall Study|Lost to Follow-up|1
7185862|NCT03838484|11386186|FG002|Overall Study|Lost to Follow-up|0
7185863|NCT03838484|11386187|FG003|Overall Study|Lost to Follow-up|0
7185864|NCT03814720|11386208|FG000|Overall Study|Lost to Follow-up|0
7185865|NCT03814720|11386209|FG001|Overall Study|Lost to Follow-up|1
7185866|NCT03814720|11386210|FG002|Overall Study|Lost to Follow-up|0
7185867|NCT03814720|11386211|FG003|Overall Study|Lost to Follow-up|0
7185868|NCT03814720|11386212|FG004|Overall Study|Lost to Follow-up|0
7185869|NCT03635424|11386226|FG000|Overall Study|Adverse Event|1
7185870|NCT03635424|11386226|FG000|Overall Study|Death|1
7185871|NCT03635424|11386226|FG000|Overall Study|Device not implanted|1
7185872|NCT03529110|11386232|FG000|Overall Study|Progressive Disease|66
7185873|NCT03529110|11386233|FG001|Overall Study|Progressive Disease|158
7185874|NCT03529110|11386232|FG000|Overall Study|Clinical Progression|4
7185875|NCT03529110|11386233|FG001|Overall Study|Clinical Progression|12
6973089|NCT01177410|11024606|FG002|Overall Study|Lost to Follow-up|0
6973090|NCT01177553|11024616|FG000|Overall Study|babies not yet 6 months of age|1
6973091|NCT01177553|11024617|FG001|Overall Study|babies not yet 6 months of age|0
7185876|NCT03529110|11386232|FG000|Overall Study|Adverse Event|35
7185877|NCT03529110|11386233|FG001|Overall Study|Adverse Event|17
7185878|NCT03529110|11386232|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13
7185879|NCT03529110|11386233|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11
7185880|NCT03529110|11386232|FG000|Overall Study|Lack of Efficacy|3
7174584|NCT01802281|11374594|FG000|Overall Study|Death|1
7174585|NCT01802281|11374595|FG001|Overall Study|Death|2
7174586|NCT01802281|11374594|FG000|Overall Study|Withdrawal by Subject|2
7174587|NCT01802281|11374595|FG001|Overall Study|Withdrawal by Subject|1
7174588|NCT01802281|11374594|FG000|Overall Study|Ineligible|5
7174589|NCT01802281|11374595|FG001|Overall Study|Ineligible|3
7174590|NCT01774253|11374601|FG000|Overall Study|Lack of Efficacy|4
7174591|NCT01774253|11374601|FG000|Overall Study|Physician Decision|2
7174592|NCT01774253|11374601|FG000|Overall Study|Withdrawal by Subject|2
7174593|NCT01774253|11374601|FG000|Overall Study|Death|1
7174594|NCT01505608|11374611|FG000|Phase I|Lack of Efficacy|0
7174595|NCT01505608|11374612|FG001|Phase I|Lack of Efficacy|4
7174596|NCT01505608|11374611|FG000|Phase I|Adverse Event|0
7174597|NCT01505608|11374612|FG001|Phase I|Adverse Event|1
7174598|NCT01505608|11374611|FG000|Phase I|Withdrawal by Subject|0
7174599|NCT01505608|11374612|FG001|Phase I|Withdrawal by Subject|1
7174600|NCT01505608|11374611|FG000|Phase II|Lack of Efficacy|2
7174601|NCT01505608|11374612|FG001|Phase II|Lack of Efficacy|1
7174602|NCT01505608|11374611|FG000|Phase II|Protocol Violation|0
7174603|NCT01505608|11374612|FG001|Phase II|Protocol Violation|1
7174604|NCT01483820|11374621|FG000|Overall Study|Lack of Efficacy|6
7174605|NCT01483820|11374621|FG000|Overall Study|Adverse Event|1
7174606|NCT01483820|11374621|FG000|Overall Study|Death|1
7174607|NCT01355679|11374625|FG000|Overall Study|benign tumor types found at biopsy|2
7174608|NCT01166386|11374650|FG000|Overall Study|Withdrawal by Subject|3
7174609|NCT01166386|11374651|FG001|Overall Study|Withdrawal by Subject|5
7174610|NCT01114217|11374659|FG000|Overall Study|Adverse Event|5
7174611|NCT01114217|11374660|FG001|Overall Study|Adverse Event|3
7174612|NCT01114217|11374659|FG000|Overall Study|Lost to Follow-up|17
7174613|NCT01114217|11374660|FG001|Overall Study|Lost to Follow-up|33
7174614|NCT01114217|11374659|FG000|Overall Study|Withdrawal by Subject|21
7174615|NCT01114217|11374660|FG001|Overall Study|Withdrawal by Subject|28
7174616|NCT01114217|11374659|FG000|Overall Study|Other-Clerical Error|3
7174617|NCT01114217|11374660|FG001|Overall Study|Other-Clerical Error|0
7174618|NCT01114217|11374659|FG000|Overall Study|Other-Early termination|6
7174619|NCT01114217|11374660|FG001|Overall Study|Other-Early termination|10
7174620|NCT01114217|11374659|FG000|Overall Study|Other-Procedure|1
7174621|NCT01114217|11374660|FG001|Overall Study|Other-Procedure|1
7174622|NCT01114217|11374659|FG000|Overall Study|Other-Pregnancy|2
7174623|NCT01114217|11374660|FG001|Overall Study|Other-Pregnancy|4
7174624|NCT01114217|11374659|FG000|Overall Study|Other-Protocol Violation|1
7174625|NCT01114217|11374660|FG001|Overall Study|Other-Protocol Violation|3
7174626|NCT01114217|11374659|FG000|Overall Study|Other-Lack of Efficacy|1
7174627|NCT01114217|11374660|FG001|Overall Study|Other-Lack of Efficacy|0
7174628|NCT01114217|11374659|FG000|Overall Study|Other-Non Compliance|2
7174629|NCT01114217|11374660|FG001|Overall Study|Other-Non Compliance|0
7174630|NCT01114217|11374659|FG000|Overall Study|Other-Physician Decision|1
7174631|NCT01114217|11374660|FG001|Overall Study|Other-Physician Decision|1
7174632|NCT01114217|11374659|FG000|Overall Study|Other-Sponsor Decision|10
7174633|NCT01114217|11374660|FG001|Overall Study|Other-Sponsor Decision|12
7174634|NCT01114217|11374659|FG000|Overall Study|Other-Study Termination|0
7174635|NCT01114217|11374660|FG001|Overall Study|Other-Study Termination|1
7174636|NCT01114217|11374659|FG000|Overall Study|Other-Study Withdrawn|1
7174637|NCT01114217|11374660|FG001|Overall Study|Other-Study Withdrawn|1
7174638|NCT01114217|11374659|FG000|Overall Study|Other-Site Stopped Communicating|2
7174639|NCT01114217|11374660|FG001|Overall Study|Other-Site Stopped Communicating|0
7174640|NCT01114217|11374659|FG000|Overall Study|Other-Lost to Follow-up|1
7174641|NCT01114217|11374660|FG001|Overall Study|Other-Lost to Follow-up|0
7174642|NCT01114217|11374659|FG000|Overall Study|Other-Withdrawal by Subject|1
7174643|NCT01114217|11374660|FG001|Overall Study|Other-Withdrawal by Subject|1
7174644|NCT01114204|11374666|FG000|Overall Study|Adverse Event|3
7174645|NCT01114204|11374667|FG001|Overall Study|Adverse Event|2
7174646|NCT01114204|11374666|FG000|Overall Study|Lost to Follow-up|1
7174647|NCT01114204|11374667|FG001|Overall Study|Lost to Follow-up|0
7174648|NCT01114204|11374666|FG000|Overall Study|Withdrawal by Subject|10
7174649|NCT01114204|11374667|FG001|Overall Study|Withdrawal by Subject|6
7174650|NCT01114204|11374666|FG000|Overall Study|Death|1
7174651|NCT01114204|11374667|FG001|Overall Study|Death|0
7174652|NCT01114204|11374666|FG000|Overall Study|Other-Personal reasons|2
7174653|NCT01114204|11374667|FG001|Overall Study|Other-Personal reasons|0
7174654|NCT01114204|11374666|FG000|Overall Study|Other-Medical monitor request|1
7174655|NCT01114204|11374667|FG001|Overall Study|Other-Medical monitor request|0
7174656|NCT01114204|11374666|FG000|Overall Study|Other-Participant request|2
7174657|NCT01114204|11374667|FG001|Overall Study|Other-Participant request|0
7174658|NCT01114204|11374666|FG000|Overall Study|Other-Protocol Violation|1
7174659|NCT01114204|11374667|FG001|Overall Study|Other-Protocol Violation|0
7174660|NCT01114139|11374675|FG000|Overall Study|Adverse Event|3
7174661|NCT01114139|11374676|FG001|Overall Study|Adverse Event|2
7174662|NCT01114139|11374675|FG000|Overall Study|Lost to Follow-up|15
7174663|NCT01114139|11374676|FG001|Overall Study|Lost to Follow-up|3
7174664|NCT01114139|11374675|FG000|Overall Study|Withdrawal by Subject|17
7174665|NCT01114139|11374676|FG001|Overall Study|Withdrawal by Subject|6
7174666|NCT01114139|11374675|FG000|Overall Study|Other-Missed 1 visit|1
7174667|NCT01114139|11374676|FG001|Overall Study|Other-Missed 1 visit|0
7174668|NCT01114139|11374675|FG000|Overall Study|Other-Protocol Violation|1
7174669|NCT01114139|11374676|FG001|Overall Study|Other-Protocol Violation|0
7174670|NCT01114139|11374675|FG000|Overall Study|Other-Out of window for study drug dose|1
7174671|NCT01114139|11374676|FG001|Overall Study|Other-Out of window for study drug dose|0
7174672|NCT01114139|11374675|FG000|Overall Study|Other-Participant falsified records|0
7174673|NCT01114139|11374676|FG001|Overall Study|Other-Participant falsified records|1
7174674|NCT01114139|11374675|FG000|Overall Study|Other-Participant went on hospice|0
7174675|NCT01114139|11374676|FG001|Overall Study|Other-Participant went on hospice|1
7174676|NCT01114139|11374675|FG000|Overall Study|Other-Physician changed treatment|1
7174677|NCT01114139|11374676|FG001|Overall Study|Other-Physician changed treatment|0
7174678|NCT01114139|11374675|FG000|Overall Study|Other-Withdrew prior to receiving dose|1
7174679|NCT01114139|11374676|FG001|Overall Study|Other-Withdrew prior to receiving dose|3
7174680|NCT01059071|11374682|FG000|Overall Study|Lack of Efficacy|1
7174681|NCT01059071|11374683|FG001|Overall Study|Lack of Efficacy|4
7174682|NCT01059071|11374684|FG002|Overall Study|Lack of Efficacy|2
7174683|NCT01059071|11374685|FG003|Overall Study|Lack of Efficacy|3
7174684|NCT01059071|11374682|FG000|Overall Study|Withdrawal by Subject|1
7174685|NCT01059071|11374683|FG001|Overall Study|Withdrawal by Subject|0
7174686|NCT01059071|11374684|FG002|Overall Study|Withdrawal by Subject|0
7174687|NCT01059071|11374685|FG003|Overall Study|Withdrawal by Subject|2
7174688|NCT01059071|11374682|FG000|Overall Study|Physician Decision|0
7174689|NCT01059071|11374683|FG001|Overall Study|Physician Decision|0
7174690|NCT01059071|11374684|FG002|Overall Study|Physician Decision|0
7174691|NCT01059071|11374685|FG003|Overall Study|Physician Decision|1
7174692|NCT01027702|11374693|FG000|Overall Study|Received subsequent therapy|1
7174693|NCT01027702|11374694|FG001|Overall Study|Received subsequent therapy|2
7174694|NCT01027702|11374695|FG002|Overall Study|Received subsequent therapy|0
7174695|NCT01027702|11374696|FG003|Overall Study|Received subsequent therapy|4
7174696|NCT01027702|11374697|FG004|Overall Study|Received subsequent therapy|1
7174697|NCT01027702|11374698|FG005|Overall Study|Received subsequent therapy|0
7174698|NCT01027702|11374699|FG006|Overall Study|Received subsequent therapy|1
7174699|NCT01027702|11374693|FG000|Overall Study|Death|0
7174700|NCT01027702|11374694|FG001|Overall Study|Death|0
7174701|NCT01027702|11374695|FG002|Overall Study|Death|1
7174702|NCT01027702|11374696|FG003|Overall Study|Death|0
7174703|NCT01027702|11374697|FG004|Overall Study|Death|0
7174704|NCT01027702|11374698|FG005|Overall Study|Death|0
7174705|NCT01027702|11374699|FG006|Overall Study|Death|0
7174706|NCT00991887|11374712|FG000|Overall Study|Lost to Follow-up|2
7174707|NCT00991887|11374713|FG001|Overall Study|Lost to Follow-up|1
7174708|NCT00968864|11374719|FG000|Overall Study|Protocol exception/ not evaluable|1
7174709|NCT00934700|11374730|FG000|Overall Study|missing scan|5
7174710|NCT00934700|11374731|FG001|Overall Study|missing scan|9
7174711|NCT00934700|11374730|FG000|Overall Study|Death|8
7174712|NCT00934700|11374731|FG001|Overall Study|Death|3
7174713|NCT00867568|11374738|FG000|Overall Study|Lack of Efficacy|10
7174714|NCT00867568|11374738|FG000|Overall Study|Adverse Event|4
7174715|NCT00867568|11374738|FG000|Overall Study|Withdrawal by Subject|1
7174716|NCT00785291|11374745|FG000|Overall Study|Never began treatment|8
7174717|NCT00785291|11374746|FG001|Overall Study|Never began treatment|4
7174718|NCT00785291|11374747|FG002|Overall Study|Never began treatment|4
7174719|NCT00785291|11374745|FG000|Overall Study|Adverse Event|39
7174720|NCT00785291|11374746|FG001|Overall Study|Adverse Event|70
7174721|NCT00785291|11374747|FG002|Overall Study|Adverse Event|56
7174722|NCT00785291|11374745|FG000|Overall Study|Death|7
7174723|NCT00785291|11374746|FG001|Overall Study|Death|4
7174724|NCT00785291|11374747|FG002|Overall Study|Death|3
7174725|NCT00785291|11374745|FG000|Overall Study|Withdrawal by Subject|35
7174726|NCT00785291|11374746|FG001|Overall Study|Withdrawal by Subject|36
7174727|NCT00785291|11374747|FG002|Overall Study|Withdrawal by Subject|17
7174728|NCT00785291|11374745|FG000|Overall Study|Alternative Therapy|12
7174729|NCT00785291|11374746|FG001|Overall Study|Alternative Therapy|6
7174730|NCT00785291|11374747|FG002|Overall Study|Alternative Therapy|7
7174731|NCT00785291|11374745|FG000|Overall Study|Complicating illness|6
7174732|NCT00785291|11374746|FG001|Overall Study|Complicating illness|4
7174733|NCT00785291|11374747|FG002|Overall Study|Complicating illness|4
7174734|NCT00785291|11374745|FG000|Overall Study|Other Medical Reasons|29
7174735|NCT00785291|11374746|FG001|Overall Study|Other Medical Reasons|25
7174736|NCT00785291|11374747|FG002|Overall Study|Other Medical Reasons|15
7174755|NCT00628446|11374788|FG000|Overall Study|Lost to Follow-up|3
7174756|NCT00628446|11374788|FG000|Overall Study|Withdrawal by Subject|1
7174757|NCT00628446|11374788|FG000|Overall Study|Protocol Violation|3
7174758|NCT00621751|11374795|FG000|Overall Study|Adverse Event|0
7174759|NCT00621751|11374796|FG001|Overall Study|Adverse Event|1
7174760|NCT00605215|11374805|FG000|Overall Study|Death|0
7174761|NCT00605215|11374806|FG001|Overall Study|Death|0
7174762|NCT00605215|11374807|FG002|Overall Study|Death|1
7174763|NCT00605215|11374805|FG000|Overall Study|Adverse Event|19
7174764|NCT00605215|11374806|FG001|Overall Study|Adverse Event|21
7174765|NCT00605215|11374807|FG002|Overall Study|Adverse Event|26
7174766|NCT00605215|11374805|FG000|Overall Study|Refusal to sign the re-consent form|8
7174767|NCT00605215|11374806|FG001|Overall Study|Refusal to sign the re-consent form|3
7174768|NCT00605215|11374807|FG002|Overall Study|Refusal to sign the re-consent form|3
7174769|NCT00605215|11374805|FG000|Overall Study|Withdrawal by Subject|39
7174770|NCT00605215|11374806|FG001|Overall Study|Withdrawal by Subject|37
7174771|NCT00605215|11374807|FG002|Overall Study|Withdrawal by Subject|27
7174772|NCT00605215|11374805|FG000|Overall Study|Request of Primary Care Physician or Investigator|6
7174773|NCT00605215|11374806|FG001|Overall Study|Request of Primary Care Physician or Investigator|4
7174774|NCT00605215|11374807|FG002|Overall Study|Request of Primary Care Physician or Investigator|4
7174775|NCT00605215|11374805|FG000|Overall Study|Protocol Violation|3
7174776|NCT00605215|11374806|FG001|Overall Study|Protocol Violation|4
7174777|NCT00605215|11374807|FG002|Overall Study|Protocol Violation|1
7174778|NCT00605215|11374805|FG000|Overall Study|Pregnancy|8
7174779|NCT00605215|11374806|FG001|Overall Study|Pregnancy|5
7174780|NCT00605215|11374807|FG002|Overall Study|Pregnancy|4
7174781|NCT00605215|11374805|FG000|Overall Study|Lost to Follow-up|8
7174782|NCT00605215|11374806|FG001|Overall Study|Lost to Follow-up|5
7174783|NCT00605215|11374807|FG002|Overall Study|Lost to Follow-up|2
7174784|NCT00605215|11374805|FG000|Overall Study|Other than specified|0
7174785|NCT00605215|11374806|FG001|Overall Study|Other than specified|2
7174786|NCT00605215|11374807|FG002|Overall Study|Other than specified|1
7174787|NCT00552513|11374821|FG000|Overall Study|Lost to Follow-up|5
7174788|NCT00552513|11374822|FG001|Overall Study|Lost to Follow-up|1
7174789|NCT00368836|11374832|FG000|Phase II|Screen Failure|1
7174790|NCT00368836|11374832|FG000|Phase II|Withdrawal by Subject|1
7174791|NCT00368836|11374832|FG000|Phase II|unable to collect blood and/or breath|17
7174792|NCT00368836|11374832|FG000|Phase II|Protocol Violation|2
7174793|NCT00290511|11374839|FG000|Overall Study|Adverse Event|1
7174794|NCT00290511|11374839|FG000|Overall Study|Death|1
6973092|NCT01177670|11024623|FG000|Overall Study|Study Terminated|115
6973093|NCT01177670|11024623|FG000|Overall Study|Physician Decision|50
6973094|NCT01177670|11024623|FG000|Overall Study|Withdrawal by Subject|4
6973095|NCT01177722|11024635|FG000|Overall Study|Serious Adverse Event|0
7080802|NCT02125734|11190438|FG001|Period 2|Adverse Event|1
7174795|NCT00290511|11374839|FG000|Overall Study|Physician Decision|1
6973096|NCT01177722|11024636|FG001|Overall Study|Serious Adverse Event|0
6973097|NCT01177722|11024637|FG002|Overall Study|Serious Adverse Event|1
6973098|NCT01177722|11024638|FG003|Overall Study|Serious Adverse Event|0
6973099|NCT01177722|11024635|FG000|Overall Study|Protocol Violation|0
6973100|NCT01177722|11024636|FG001|Overall Study|Protocol Violation|0
6973101|NCT01177722|11024637|FG002|Overall Study|Protocol Violation|1
6973102|NCT01177722|11024638|FG003|Overall Study|Protocol Violation|0
6973103|NCT01177722|11024635|FG000|Overall Study|Lost to Follow-up|3
6973104|NCT01177722|11024636|FG001|Overall Study|Lost to Follow-up|4
6973105|NCT01177722|11024637|FG002|Overall Study|Lost to Follow-up|3
6973106|NCT01177722|11024638|FG003|Overall Study|Lost to Follow-up|1
6973107|NCT01177722|11024635|FG000|Overall Study|Withdrawal by Subject|10
6973108|NCT01177722|11024636|FG001|Overall Study|Withdrawal by Subject|6
6973109|NCT01177722|11024637|FG002|Overall Study|Withdrawal by Subject|4
6973110|NCT01177722|11024638|FG003|Overall Study|Withdrawal by Subject|6
6973111|NCT01177787|11024653|FG000|Cryolipolysis on Thigh|Protocol Violation|4
6973112|NCT01177787|11024653|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9
6973113|NCT01177787|11024653|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1
6973114|NCT01177800|11024667|FG000|Overall Study|Adverse Event|9
6973115|NCT01177800|11024668|FG001|Overall Study|Adverse Event|3
6973116|NCT01177800|11024667|FG000|Overall Study|Protocol Violation|0
6973117|NCT01177800|11024668|FG001|Overall Study|Protocol Violation|1
6973118|NCT01177800|11024667|FG000|Overall Study|Physician Decision|1
6973119|NCT01177800|11024668|FG001|Overall Study|Physician Decision|0
6973120|NCT01177800|11024667|FG000|Overall Study|Withdrawal of informed consent|0
6973121|NCT01177800|11024668|FG001|Overall Study|Withdrawal of informed consent|1
6973122|NCT01177813|11024679|FG000|Overall Study|Adverse Event|8
6973123|NCT01177813|11024680|FG001|Overall Study|Adverse Event|2
6973124|NCT01177813|11024681|FG002|Overall Study|Adverse Event|4
6973125|NCT01177813|11024682|FG003|Overall Study|Adverse Event|6
6973126|NCT01177813|11024683|FG004|Overall Study|Adverse Event|3
6973127|NCT01177813|11024679|FG000|Overall Study|Lack of Efficacy|1
6973128|NCT01177813|11024680|FG001|Overall Study|Lack of Efficacy|0
7174796|NCT00290511|11374839|FG000|Overall Study|Withdrawal by Subject|1
7185881|NCT03529110|11386233|FG001|Overall Study|Lack of Efficacy|3
7185882|NCT03529110|11386232|FG000|Overall Study|Physician Decision|2
7185883|NCT03529110|11386233|FG001|Overall Study|Physician Decision|8
7185884|NCT03529110|11386232|FG000|Overall Study|Miscellaneous|2
7185885|NCT03529110|11386233|FG001|Overall Study|Miscellaneous|5
6973129|NCT01177813|11024681|FG002|Overall Study|Lack of Efficacy|0
6973130|NCT01177813|11024682|FG003|Overall Study|Lack of Efficacy|0
6973131|NCT01177813|11024683|FG004|Overall Study|Lack of Efficacy|0
6973132|NCT01177813|11024679|FG000|Overall Study|Protocol Violation|3
6973133|NCT01177813|11024680|FG001|Overall Study|Protocol Violation|2
6973134|NCT01177813|11024681|FG002|Overall Study|Protocol Violation|2
6973135|NCT01177813|11024682|FG003|Overall Study|Protocol Violation|0
6973136|NCT01177813|11024683|FG004|Overall Study|Protocol Violation|1
6973137|NCT01177813|11024679|FG000|Overall Study|Lost to Follow-up|12
6973138|NCT01177813|11024680|FG001|Overall Study|Lost to Follow-up|5
6973139|NCT01177813|11024681|FG002|Overall Study|Lost to Follow-up|6
6973140|NCT01177813|11024682|FG003|Overall Study|Lost to Follow-up|3
6973141|NCT01177813|11024683|FG004|Overall Study|Lost to Follow-up|0
6973142|NCT01177813|11024679|FG000|Overall Study|Withdrawal by Subject|12
6973143|NCT01177813|11024680|FG001|Overall Study|Withdrawal by Subject|7
6973144|NCT01177813|11024681|FG002|Overall Study|Withdrawal by Subject|6
6973145|NCT01177813|11024682|FG003|Overall Study|Withdrawal by Subject|5
6973146|NCT01177813|11024683|FG004|Overall Study|Withdrawal by Subject|3
6973147|NCT01177813|11024679|FG000|Overall Study|Other reason not defined above|5
6973148|NCT01177813|11024680|FG001|Overall Study|Other reason not defined above|2
6973149|NCT01177813|11024681|FG002|Overall Study|Other reason not defined above|2
6973150|NCT01177813|11024682|FG003|Overall Study|Other reason not defined above|3
6973151|NCT01177813|11024683|FG004|Overall Study|Other reason not defined above|2
7174797|NCT00641537|11374852|FG000|96-week Period|Adverse Event|0
7174798|NCT00641537|11374853|FG001|96-week Period|Adverse Event|1
7174799|NCT00641537|11374854|FG002|96-week Period|Adverse Event|3
7174800|NCT00641537|11374855|FG003|96-week Period|Adverse Event|0
7174801|NCT00641537|11374856|FG004|96-week Period|Adverse Event|2
7174802|NCT00641537|11374857|FG005|96-week Period|Adverse Event|0
7174803|NCT00641537|11374858|FG006|96-week Period|Adverse Event|0
7174804|NCT00641537|11374859|FG007|96-week Period|Adverse Event|0
7174805|NCT00641537|11374852|FG000|96-week Period|Lost to Follow-up|3
7174806|NCT00641537|11374853|FG001|96-week Period|Lost to Follow-up|1
7174807|NCT00641537|11374854|FG002|96-week Period|Lost to Follow-up|2
7174808|NCT00641537|11374855|FG003|96-week Period|Lost to Follow-up|2
7174809|NCT00641537|11374856|FG004|96-week Period|Lost to Follow-up|4
7174810|NCT00641537|11374857|FG005|96-week Period|Lost to Follow-up|0
7174811|NCT00641537|11374858|FG006|96-week Period|Lost to Follow-up|1
7174812|NCT00641537|11374859|FG007|96-week Period|Lost to Follow-up|0
7174813|NCT00641537|11374852|FG000|96-week Period|Protocol Violation|0
7174814|NCT00641537|11374853|FG001|96-week Period|Protocol Violation|1
7174815|NCT00641537|11374854|FG002|96-week Period|Protocol Violation|0
7174816|NCT00641537|11374855|FG003|96-week Period|Protocol Violation|1
7174817|NCT00641537|11374856|FG004|96-week Period|Protocol Violation|0
7174818|NCT00641537|11374857|FG005|96-week Period|Protocol Violation|1
7174819|NCT00641537|11374858|FG006|96-week Period|Protocol Violation|0
7174820|NCT00641537|11374859|FG007|96-week Period|Protocol Violation|0
7174821|NCT00641537|11374852|FG000|96-week Period|Death|2
7174822|NCT00641537|11374853|FG001|96-week Period|Death|0
7174823|NCT00641537|11374854|FG002|96-week Period|Death|1
7174824|NCT00641537|11374855|FG003|96-week Period|Death|0
7174825|NCT00641537|11374856|FG004|96-week Period|Death|0
7174826|NCT00641537|11374857|FG005|96-week Period|Death|0
7174827|NCT00641537|11374858|FG006|96-week Period|Death|0
7174828|NCT00641537|11374859|FG007|96-week Period|Death|0
7174829|NCT00641537|11374852|FG000|96-week Period|Other|4
7174830|NCT00641537|11374853|FG001|96-week Period|Other|7
7174831|NCT00641537|11374854|FG002|96-week Period|Other|14
7174832|NCT00641537|11374855|FG003|96-week Period|Other|9
7174833|NCT00641537|11374856|FG004|96-week Period|Other|11
7174834|NCT00641537|11374857|FG005|96-week Period|Other|6
7174835|NCT00641537|11374858|FG006|96-week Period|Other|4
7174836|NCT00641537|11374859|FG007|96-week Period|Other|6
7174837|NCT00641537|11374852|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
7174838|NCT00641537|11374853|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
7174839|NCT00641537|11374854|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
7174840|NCT00641537|11374855|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3
7174841|NCT00641537|11374856|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2
7174842|NCT00641537|11374857|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
7174843|NCT00641537|11374858|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
7174844|NCT00641537|11374859|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
7174845|NCT00641537|11374852|FG000|24-Week Supplemental Follow-up Period|Other|0
6973152|NCT01177943|11024697|FG000|First Intervention|Withdrawal by Subject|2
7174846|NCT00641537|11374853|FG001|24-Week Supplemental Follow-up Period|Other|2
7174847|NCT00641537|11374854|FG002|24-Week Supplemental Follow-up Period|Other|2
7174848|NCT00641537|11374855|FG003|24-Week Supplemental Follow-up Period|Other|1
7174849|NCT00641537|11374856|FG004|24-Week Supplemental Follow-up Period|Other|3
7174850|NCT00641537|11374857|FG005|24-Week Supplemental Follow-up Period|Other|0
6973153|NCT01177943|11024698|FG001|First Intervention|Withdrawal by Subject|0
7174851|NCT00641537|11374858|FG006|24-Week Supplemental Follow-up Period|Other|1
7174852|NCT00641537|11374859|FG007|24-Week Supplemental Follow-up Period|Other|1
7174853|NCT00655824|11374877|FG000|Overall Study|Adverse Event|3
7174854|NCT00655824|11374877|FG000|Overall Study|Early Termination of Study by Sponsor|74
7174855|NCT00655824|11374877|FG000|Overall Study|Protocol Violation|1
7174856|NCT00655824|11374877|FG000|Overall Study|Withdrawal by Subject|4
7174857|NCT00655824|11374877|FG000|Overall Study|Deterioration of Trial Disease|2
7185886|NCT03517540|11386243|FG000|Overall Study|Protocol Violation|2
7185887|NCT03517540|11386244|FG001|Overall Study|Protocol Violation|0
7185888|NCT03517540|11386245|FG002|Overall Study|Protocol Violation|0
7185889|NCT03517540|11386246|FG003|Overall Study|Protocol Violation|1
7185890|NCT03517540|11386243|FG000|Overall Study|Adverse Event|9
7185891|NCT03517540|11386244|FG001|Overall Study|Adverse Event|3
7185892|NCT03517540|11386245|FG002|Overall Study|Adverse Event|8
7185893|NCT03517540|11386246|FG003|Overall Study|Adverse Event|1
7185894|NCT03517540|11386243|FG000|Overall Study|Withdrawal by Subject|3
7185895|NCT03517540|11386244|FG001|Overall Study|Withdrawal by Subject|4
7185896|NCT03517540|11386245|FG002|Overall Study|Withdrawal by Subject|1
7185897|NCT03517540|11386246|FG003|Overall Study|Withdrawal by Subject|3
7185898|NCT03437278|11386268|FG000|Overall Study|Adverse Event|0
7185899|NCT03437278|11386269|FG001|Overall Study|Adverse Event|0
7185900|NCT03437278|11386270|FG002|Overall Study|Adverse Event|1
7185901|NCT03437278|11386268|FG000|Overall Study|Progressive disease|1
7185902|NCT03437278|11386269|FG001|Overall Study|Progressive disease|0
7185903|NCT03437278|11386270|FG002|Overall Study|Progressive disease|0
7185904|NCT03437278|11386268|FG000|Overall Study|Physician Decision|1
7185905|NCT03437278|11386269|FG001|Overall Study|Physician Decision|0
7185906|NCT03437278|11386270|FG002|Overall Study|Physician Decision|1
7185907|NCT03350815|11386280|FG000|Period 1|Adverse Event|10
7185908|NCT03350815|11386281|FG001|Period 1|Adverse Event|0
7185909|NCT03350815|11386282|FG002|Period 1|Adverse Event|0
7185910|NCT03350815|11386283|FG003|Period 1|Adverse Event|0
7185911|NCT03350815|11386280|FG000|Period 1|Technical problems|1
7185912|NCT03350815|11386281|FG001|Period 1|Technical problems|0
7185913|NCT03350815|11386282|FG002|Period 1|Technical problems|0
7185914|NCT03350815|11386283|FG003|Period 1|Technical problems|0
7185915|NCT03350815|11386280|FG000|Period 1|Lost to Follow-up|3
7185916|NCT03350815|11386281|FG001|Period 1|Lost to Follow-up|0
7185917|NCT03350815|11386282|FG002|Period 1|Lost to Follow-up|0
7185918|NCT03350815|11386283|FG003|Period 1|Lost to Follow-up|0
7185919|NCT03350815|11386280|FG000|Period 1|Physician Decision|1
7185920|NCT03350815|11386281|FG001|Period 1|Physician Decision|0
7185921|NCT03350815|11386282|FG002|Period 1|Physician Decision|0
7185922|NCT03350815|11386283|FG003|Period 1|Physician Decision|0
7185923|NCT03350815|11386280|FG000|Period 1|Withdrawal by Subject|8
7185924|NCT03350815|11386281|FG001|Period 1|Withdrawal by Subject|0
7185925|NCT03350815|11386282|FG002|Period 1|Withdrawal by Subject|0
7185926|NCT03350815|11386283|FG003|Period 1|Withdrawal by Subject|0
7185927|NCT03350815|11386280|FG000|Period 1|Lack of Efficacy|15
7185928|NCT03350815|11386281|FG001|Period 1|Lack of Efficacy|0
7185929|NCT03350815|11386282|FG002|Period 1|Lack of Efficacy|0
7185930|NCT03350815|11386283|FG003|Period 1|Lack of Efficacy|0
7185931|NCT03350815|11386280|FG000|Period 1|Non-compliance with study treatment|2
7185932|NCT03350815|11386281|FG001|Period 1|Non-compliance with study treatment|0
7185933|NCT03350815|11386282|FG002|Period 1|Non-compliance with study treatment|0
7185934|NCT03350815|11386283|FG003|Period 1|Non-compliance with study treatment|0
7185935|NCT03350815|11386280|FG000|Period 1|Protocol Violation|3
7185936|NCT03350815|11386281|FG001|Period 1|Protocol Violation|0
7185937|NCT03350815|11386282|FG002|Period 1|Protocol Violation|0
7185938|NCT03350815|11386283|FG003|Period 1|Protocol Violation|0
7185939|NCT03350815|11386280|FG000|Period 2|Adverse Event|0
7185940|NCT03350815|11386281|FG001|Period 2|Adverse Event|3
7185941|NCT03350815|11386282|FG002|Period 2|Adverse Event|5
7185942|NCT03350815|11386283|FG003|Period 2|Adverse Event|0
7185943|NCT03350815|11386280|FG000|Period 2|Technical problem|0
7185944|NCT03350815|11386281|FG001|Period 2|Technical problem|1
7185945|NCT03350815|11386282|FG002|Period 2|Technical problem|0
7185946|NCT03350815|11386283|FG003|Period 2|Technical problem|0
7185947|NCT03350815|11386280|FG000|Period 2|Lost to Follow-up|0
7185948|NCT03350815|11386281|FG001|Period 2|Lost to Follow-up|3
7185949|NCT03350815|11386282|FG002|Period 2|Lost to Follow-up|3
7185950|NCT03350815|11386283|FG003|Period 2|Lost to Follow-up|0
7185951|NCT03350815|11386280|FG000|Period 2|Physician Decision|0
7185952|NCT03350815|11386281|FG001|Period 2|Physician Decision|0
7185953|NCT03350815|11386282|FG002|Period 2|Physician Decision|1
7185954|NCT03350815|11386283|FG003|Period 2|Physician Decision|0
7185955|NCT03350815|11386280|FG000|Period 2|Withdrawal by Subject|0
7185956|NCT03350815|11386281|FG001|Period 2|Withdrawal by Subject|3
7185957|NCT03350815|11386282|FG002|Period 2|Withdrawal by Subject|4
7185958|NCT03350815|11386283|FG003|Period 2|Withdrawal by Subject|0
7185959|NCT03350815|11386280|FG000|Period 2|Lack of Efficacy|0
7185960|NCT03350815|11386281|FG001|Period 2|Lack of Efficacy|6
7185961|NCT03350815|11386282|FG002|Period 2|Lack of Efficacy|2
7185962|NCT03350815|11386283|FG003|Period 2|Lack of Efficacy|0
7185963|NCT03350815|11386280|FG000|Period 2|Protocol Violation|0
7185964|NCT03350815|11386281|FG001|Period 2|Protocol Violation|0
7185965|NCT03350815|11386282|FG002|Period 2|Protocol Violation|1
7185966|NCT03350815|11386283|FG003|Period 2|Protocol Violation|0
7185967|NCT03350815|11386280|FG000|Period 2|New therapy for study indication|0
7185968|NCT03350815|11386281|FG001|Period 2|New therapy for study indication|0
7185969|NCT03350815|11386282|FG002|Period 2|New therapy for study indication|1
7185970|NCT03350815|11386283|FG003|Period 2|New therapy for study indication|0
7188081|NCT03518086|11388731|FG000|Overall Study|Site Terminated by Sponsor|0
7174858|NCT00663052|11374883|FG000|Overall Study|Adverse Event|6
7174859|NCT00663052|11374884|FG001|Overall Study|Adverse Event|3
7174860|NCT00663052|11374883|FG000|Overall Study|Discontinuation of Study by Sponsor|2
7174861|NCT00663052|11374884|FG001|Overall Study|Discontinuation of Study by Sponsor|0
7174862|NCT00663052|11374883|FG000|Overall Study|Protocol Violation|1
7174863|NCT00663052|11374884|FG001|Overall Study|Protocol Violation|0
7174864|NCT00663052|11374883|FG000|Overall Study|Withdrawal by Subject|2
7174865|NCT00663052|11374884|FG001|Overall Study|Withdrawal by Subject|5
7174866|NCT00663052|11374883|FG000|Overall Study|Unsatisfactory Response - Efficacy|1
7174867|NCT00663052|11374884|FG001|Overall Study|Unsatisfactory Response - Efficacy|1
7174868|NCT00663052|11374883|FG000|Overall Study|Other|0
7174869|NCT00663052|11374884|FG001|Overall Study|Other|1
7174870|NCT00686374|11374890|FG000|Overall Study|Lack of Efficacy|10
7174871|NCT00686374|11374890|FG000|Overall Study|Adverse Event|8
7174872|NCT00686374|11374890|FG000|Overall Study|Withdrew consent|5
7174873|NCT00686374|11374890|FG000|Overall Study|Lost to Follow-up|1
7174874|NCT00686374|11374890|FG000|Overall Study|Missing reason|33
7174875|NCT00686374|11374890|FG000|Overall Study|Other, not specified|4
7174876|NCT00698828|11374897|FG000|Overall Study|Adverse Event|3
7174877|NCT00698828|11374898|FG001|Overall Study|Adverse Event|4
7174878|NCT00698828|11374899|FG002|Overall Study|Adverse Event|4
7174879|NCT00698828|11374897|FG000|Overall Study|Death|0
7174880|NCT00698828|11374898|FG001|Overall Study|Death|0
7174881|NCT00698828|11374899|FG002|Overall Study|Death|1
7174882|NCT00698828|11374897|FG000|Overall Study|Exacerbation of COPD|1
7174883|NCT00698828|11374898|FG001|Overall Study|Exacerbation of COPD|3
7174884|NCT00698828|11374899|FG002|Overall Study|Exacerbation of COPD|0
7174885|NCT00698828|11374897|FG000|Overall Study|Exacerbation of COPD (Not treated)|1
7174886|NCT00698828|11374898|FG001|Overall Study|Exacerbation of COPD (Not treated)|0
7174887|NCT00698828|11374899|FG002|Overall Study|Exacerbation of COPD (Not treated)|0
7174888|NCT00698828|11374897|FG000|Overall Study|Investigator/Sponsor decision|1
7174889|NCT00698828|11374898|FG001|Overall Study|Investigator/Sponsor decision|0
7174890|NCT00698828|11374899|FG002|Overall Study|Investigator/Sponsor decision|2
7174891|NCT00698828|11374897|FG000|Overall Study|Lost to Follow-up|1
7174892|NCT00698828|11374898|FG001|Overall Study|Lost to Follow-up|1
7174893|NCT00698828|11374899|FG002|Overall Study|Lost to Follow-up|0
7174894|NCT00698828|11374897|FG000|Overall Study|Withdrew consent|0
7174895|NCT00698828|11374898|FG001|Overall Study|Withdrew consent|7
7174896|NCT00698828|11374899|FG002|Overall Study|Withdrew consent|4
7174897|NCT00698828|11374897|FG000|Overall Study|Withdrew consent (not treated)|2
7174898|NCT00698828|11374898|FG001|Overall Study|Withdrew consent (not treated)|0
7174899|NCT00698828|11374899|FG002|Overall Study|Withdrew consent (not treated)|0
7174900|NCT00712933|11374907|FG000|Overall Study|Adverse Event|69
7174901|NCT00712933|11374907|FG000|Overall Study|Lack of Efficacy|6
7174902|NCT00712933|11374907|FG000|Overall Study|Lost to Follow-up|22
7174903|NCT00712933|11374907|FG000|Overall Study|Non-compliance with study drug|13
7174904|NCT00712933|11374907|FG000|Overall Study|Other Pregnancy|37
7174905|NCT00712933|11374907|FG000|Overall Study|Sponsor decision|14
7174906|NCT00712933|11374907|FG000|Overall Study|Withdrew consent|4
7174907|NCT00712933|11374907|FG000|Overall Study|Hip replacement surgery|1
7174908|NCT00712933|11374907|FG000|Overall Study|Involved in Clinical research|3
7174909|NCT00712933|11374907|FG000|Overall Study|Participant hospitalized|1
7174910|NCT00712933|11374907|FG000|Overall Study|Participant travelled overseas|2
7174911|NCT00712933|11374907|FG000|Overall Study|Death of patient|1
7174912|NCT00712933|11374907|FG000|Overall Study|Other Physician decision|1
7174913|NCT00712933|11374907|FG000|Overall Study|Not committed to contraception|1
7174914|NCT00712933|11374907|FG000|Overall Study|Participant received medication|1
7174915|NCT00712933|11374907|FG000|Overall Study|Physician Decision|36
7174916|NCT00712933|11374907|FG000|Overall Study|Protocol Violation|4
7174917|NCT00712933|11374907|FG000|Overall Study|Withdrawal by Subject|151
7174918|NCT00725985|11374931|FG000|ITP- Treatment Disposition|Adverse Event|20
7174919|NCT00725985|11374932|FG001|ITP- Treatment Disposition|Adverse Event|10
7174920|NCT00725985|11374933|FG002|ITP- Treatment Disposition|Adverse Event|5
7174921|NCT00725985|11374934|FG003|ITP- Treatment Disposition|Adverse Event|0
7174922|NCT00725985|11374935|FG004|ITP- Treatment Disposition|Adverse Event|0
7174923|NCT00725985|11374936|FG005|ITP- Treatment Disposition|Adverse Event|0
7174924|NCT00725985|11374937|FG006|ITP- Treatment Disposition|Adverse Event|0
7174925|NCT00725985|11374938|FG007|ITP- Treatment Disposition|Adverse Event|0
7174926|NCT00725985|11374939|FG008|ITP- Treatment Disposition|Adverse Event|0
7174927|NCT00725985|11374940|FG009|ITP- Treatment Disposition|Adverse Event|0
7174928|NCT00725985|11374941|FG010|ITP- Treatment Disposition|Adverse Event|0
7174929|NCT00725985|11374942|FG011|ITP- Treatment Disposition|Adverse Event|0
7174930|NCT00725985|11374931|FG000|ITP- Treatment Disposition|Lost to Follow-up|0
7174931|NCT00725985|11374932|FG001|ITP- Treatment Disposition|Lost to Follow-up|0
7174932|NCT00725985|11374933|FG002|ITP- Treatment Disposition|Lost to Follow-up|2
7174933|NCT00725985|11374934|FG003|ITP- Treatment Disposition|Lost to Follow-up|0
6973154|NCT01177969|11024711|FG000|Overall Study|Protocol Violation|2
6973155|NCT01177969|11024712|FG001|Overall Study|Protocol Violation|1
7174934|NCT00725985|11374935|FG004|ITP- Treatment Disposition|Lost to Follow-up|0
7174935|NCT00725985|11374936|FG005|ITP- Treatment Disposition|Lost to Follow-up|0
7174936|NCT00725985|11374937|FG006|ITP- Treatment Disposition|Lost to Follow-up|0
7174937|NCT00725985|11374938|FG007|ITP- Treatment Disposition|Lost to Follow-up|0
6973156|NCT01177969|11024711|FG000|Overall Study|Withdrawal by Subject|1
6973157|NCT01177969|11024712|FG001|Overall Study|Withdrawal by Subject|2
6973158|NCT01178073|11024721|FG000|Overall Study|Adverse Event|34
6973159|NCT01178073|11024722|FG001|Overall Study|Adverse Event|27
7174938|NCT00725985|11374939|FG008|ITP- Treatment Disposition|Lost to Follow-up|0
7174939|NCT00725985|11374940|FG009|ITP- Treatment Disposition|Lost to Follow-up|0
7174940|NCT00725985|11374941|FG010|ITP- Treatment Disposition|Lost to Follow-up|0
7174941|NCT00725985|11374942|FG011|ITP- Treatment Disposition|Lost to Follow-up|0
7174942|NCT00725985|11374931|FG000|ITP- Treatment Disposition|Randomized but not treated|1
7174943|NCT00725985|11374932|FG001|ITP- Treatment Disposition|Randomized but not treated|0
7174944|NCT00725985|11374933|FG002|ITP- Treatment Disposition|Randomized but not treated|0
7174945|NCT00725985|11374934|FG003|ITP- Treatment Disposition|Randomized but not treated|0
7174946|NCT00725985|11374935|FG004|ITP- Treatment Disposition|Randomized but not treated|0
7174947|NCT00725985|11374936|FG005|ITP- Treatment Disposition|Randomized but not treated|0
7174948|NCT00725985|11374937|FG006|ITP- Treatment Disposition|Randomized but not treated|0
7174949|NCT00725985|11374938|FG007|ITP- Treatment Disposition|Randomized but not treated|0
7174950|NCT00725985|11374939|FG008|ITP- Treatment Disposition|Randomized but not treated|0
7174951|NCT00725985|11374940|FG009|ITP- Treatment Disposition|Randomized but not treated|0
7174952|NCT00725985|11374941|FG010|ITP- Treatment Disposition|Randomized but not treated|0
7174953|NCT00725985|11374942|FG011|ITP- Treatment Disposition|Randomized but not treated|0
7174954|NCT00725985|11374931|FG000|ITP- Treatment Disposition|Converted to CDMS|30
7174955|NCT00725985|11374932|FG001|ITP- Treatment Disposition|Converted to CDMS|27
7174956|NCT00725985|11374933|FG002|ITP- Treatment Disposition|Converted to CDMS|71
7174957|NCT00725985|11374934|FG003|ITP- Treatment Disposition|Converted to CDMS|0
7174958|NCT00725985|11374935|FG004|ITP- Treatment Disposition|Converted to CDMS|0
7174959|NCT00725985|11374936|FG005|ITP- Treatment Disposition|Converted to CDMS|0
7174960|NCT00725985|11374937|FG006|ITP- Treatment Disposition|Converted to CDMS|0
7174961|NCT00725985|11374938|FG007|ITP- Treatment Disposition|Converted to CDMS|0
7174962|NCT00725985|11374939|FG008|ITP- Treatment Disposition|Converted to CDMS|0
7174963|NCT00725985|11374940|FG009|ITP- Treatment Disposition|Converted to CDMS|0
7174964|NCT00725985|11374941|FG010|ITP- Treatment Disposition|Converted to CDMS|0
7174965|NCT00725985|11374942|FG011|ITP- Treatment Disposition|Converted to CDMS|0
7174966|NCT00725985|11374931|FG000|ITP- Treatment Disposition|Other|50
7174967|NCT00725985|11374932|FG001|ITP- Treatment Disposition|Other|38
7174968|NCT00725985|11374933|FG002|ITP- Treatment Disposition|Other|24
7174969|NCT00725985|11374934|FG003|ITP- Treatment Disposition|Other|0
7174970|NCT00725985|11374935|FG004|ITP- Treatment Disposition|Other|0
7174971|NCT00725985|11374936|FG005|ITP- Treatment Disposition|Other|0
7174972|NCT00725985|11374937|FG006|ITP- Treatment Disposition|Other|0
7174973|NCT00725985|11374938|FG007|ITP- Treatment Disposition|Other|0
7174974|NCT00725985|11374939|FG008|ITP- Treatment Disposition|Other|0
7174975|NCT00725985|11374940|FG009|ITP- Treatment Disposition|Other|0
7174976|NCT00725985|11374941|FG010|ITP- Treatment Disposition|Other|0
7174977|NCT00725985|11374942|FG011|ITP- Treatment Disposition|Other|0
7174978|NCT00725985|11374931|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0
7174979|NCT00725985|11374932|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0
7080803|NCT02125838|11190446|FG000|Overall Study|Lost to Follow-up|4
7174980|NCT00725985|11374933|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0
7174981|NCT00725985|11374934|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2
7174982|NCT00725985|11374935|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2
7080804|NCT02125838|11190447|FG001|Overall Study|Lost to Follow-up|4
7080805|NCT02125877|11190455|FG000|Overall Study|Physician Decision|1
7174983|NCT00725985|11374936|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5
7174984|NCT00725985|11374937|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0
7174985|NCT00725985|11374938|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0
7174986|NCT00725985|11374939|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0
7174987|NCT00725985|11374940|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0
7174988|NCT00725985|11374941|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0
7174989|NCT00725985|11374942|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0
7174990|NCT00725985|11374931|FG000|OLMP (Up to 96 Weeks)|Death|0
7174991|NCT00725985|11374932|FG001|OLMP (Up to 96 Weeks)|Death|0
7174992|NCT00725985|11374933|FG002|OLMP (Up to 96 Weeks)|Death|0
7174993|NCT00725985|11374934|FG003|OLMP (Up to 96 Weeks)|Death|0
7174994|NCT00725985|11374935|FG004|OLMP (Up to 96 Weeks)|Death|1
7174995|NCT00725985|11374936|FG005|OLMP (Up to 96 Weeks)|Death|0
7174996|NCT00725985|11374937|FG006|OLMP (Up to 96 Weeks)|Death|0
7174997|NCT00725985|11374938|FG007|OLMP (Up to 96 Weeks)|Death|0
7174998|NCT00725985|11374939|FG008|OLMP (Up to 96 Weeks)|Death|0
7174999|NCT00725985|11374940|FG009|OLMP (Up to 96 Weeks)|Death|0
7175000|NCT00725985|11374941|FG010|OLMP (Up to 96 Weeks)|Death|0
7175001|NCT00725985|11374942|FG011|OLMP (Up to 96 Weeks)|Death|0
7175002|NCT00725985|11374931|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
6973160|NCT01178073|11024723|FG002|Overall Study|Adverse Event|24
7175003|NCT00725985|11374932|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7175004|NCT00725985|11374933|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7175005|NCT00725985|11374934|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1
7175006|NCT00725985|11374935|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7175007|NCT00725985|11374936|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7175008|NCT00725985|11374937|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7080806|NCT02125877|11190456|FG001|Overall Study|Physician Decision|0
7080807|NCT02125877|11190455|FG000|Overall Study|Death|0
7080808|NCT02125877|11190456|FG001|Overall Study|Death|1
7080809|NCT02125877|11190455|FG000|Overall Study|Administrative problems|0
7080810|NCT02125877|11190456|FG001|Overall Study|Administrative problems|1
7080811|NCT02125877|11190455|FG000|Overall Study|Participant/guardian decision|0
7080812|NCT02125877|11190456|FG001|Overall Study|Participant/guardian decision|2
7080813|NCT02125877|11190455|FG000|Overall Study|Withdrawal by Subject|2
7080814|NCT02125877|11190456|FG001|Overall Study|Withdrawal by Subject|1
7080815|NCT02125877|11190455|FG000|Overall Study|Protocol deviation|4
7080816|NCT02125877|11190456|FG001|Overall Study|Protocol deviation|1
7080817|NCT02125877|11190455|FG000|Overall Study|Adverse Event|6
7080818|NCT02125877|11190456|FG001|Overall Study|Adverse Event|4
7080819|NCT02126670|11190486|FG000|Overall Study|Withdrawal by Subject|1
7080820|NCT02126670|11190487|FG001|Overall Study|Withdrawal by Subject|0
7175009|NCT00725985|11374938|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7175010|NCT00725985|11374939|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7175011|NCT00725985|11374940|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7175012|NCT00725985|11374941|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7175013|NCT00725985|11374942|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7175014|NCT00725985|11374931|FG000|OLMP (Up to 96 Weeks)|Disease progression|0
7175015|NCT00725985|11374932|FG001|OLMP (Up to 96 Weeks)|Disease progression|0
7175016|NCT00725985|11374933|FG002|OLMP (Up to 96 Weeks)|Disease progression|0
7175017|NCT00725985|11374934|FG003|OLMP (Up to 96 Weeks)|Disease progression|0
7175018|NCT00725985|11374935|FG004|OLMP (Up to 96 Weeks)|Disease progression|0
7175019|NCT00725985|11374936|FG005|OLMP (Up to 96 Weeks)|Disease progression|4
7175020|NCT00725985|11374937|FG006|OLMP (Up to 96 Weeks)|Disease progression|0
7175021|NCT00725985|11374938|FG007|OLMP (Up to 96 Weeks)|Disease progression|0
7175022|NCT00725985|11374939|FG008|OLMP (Up to 96 Weeks)|Disease progression|0
7175023|NCT00725985|11374940|FG009|OLMP (Up to 96 Weeks)|Disease progression|0
7175024|NCT00725985|11374941|FG010|OLMP (Up to 96 Weeks)|Disease progression|0
7175025|NCT00725985|11374942|FG011|OLMP (Up to 96 Weeks)|Disease progression|0
7175026|NCT00725985|11374931|FG000|OLMP (Up to 96 Weeks)|Other|0
7175027|NCT00725985|11374932|FG001|OLMP (Up to 96 Weeks)|Other|0
7175028|NCT00725985|11374933|FG002|OLMP (Up to 96 Weeks)|Other|0
7175029|NCT00725985|11374934|FG003|OLMP (Up to 96 Weeks)|Other|15
7175030|NCT00725985|11374935|FG004|OLMP (Up to 96 Weeks)|Other|20
7175031|NCT00725985|11374936|FG005|OLMP (Up to 96 Weeks)|Other|44
7175032|NCT00725985|11374937|FG006|OLMP (Up to 96 Weeks)|Other|0
7175033|NCT00725985|11374938|FG007|OLMP (Up to 96 Weeks)|Other|0
7175034|NCT00725985|11374939|FG008|OLMP (Up to 96 Weeks)|Other|0
7175035|NCT00725985|11374940|FG009|OLMP (Up to 96 Weeks)|Other|0
7175036|NCT00725985|11374941|FG010|OLMP (Up to 96 Weeks)|Other|0
6973161|NCT01178073|11024721|FG000|Overall Study|Protocol Violation|1
6973162|NCT01178073|11024722|FG001|Overall Study|Protocol Violation|1
6973163|NCT01178073|11024723|FG002|Overall Study|Protocol Violation|1
6973164|NCT01178073|11024721|FG000|Overall Study|Lost to Follow-up|2
6973165|NCT01178073|11024722|FG001|Overall Study|Lost to Follow-up|0
6973166|NCT01178073|11024723|FG002|Overall Study|Lost to Follow-up|3
6973167|NCT01178073|11024721|FG000|Overall Study|Physician Decision|14
6973168|NCT01178073|11024722|FG001|Overall Study|Physician Decision|10
6973169|NCT01178073|11024723|FG002|Overall Study|Physician Decision|10
6973170|NCT01178073|11024721|FG000|Overall Study|Withdrawal by Subject|10
6973171|NCT01178073|11024722|FG001|Overall Study|Withdrawal by Subject|6
6973172|NCT01178073|11024723|FG002|Overall Study|Withdrawal by Subject|8
6973173|NCT01178073|11024721|FG000|Overall Study|Missing Completion Status|1
6973174|NCT01178073|11024722|FG001|Overall Study|Missing Completion Status|0
6973175|NCT01178073|11024723|FG002|Overall Study|Missing Completion Status|0
6973176|NCT01178086|11024734|FG000|Overall Study|Participant refusal|7
6973177|NCT01178086|11024734|FG000|Overall Study|Physician Decision|44
6973178|NCT01178086|11024734|FG000|Overall Study|Switch to other CLL therapy|113
6973179|NCT01178086|11024734|FG000|Overall Study|Death|59
7080821|NCT02126670|11190488|FG002|Overall Study|Withdrawal by Subject|0
7175037|NCT00725985|11374942|FG011|OLMP (Up to 96 Weeks)|Other|0
7175038|NCT00725985|11374931|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7175039|NCT00725985|11374932|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7175040|NCT00725985|11374933|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7175041|NCT00725985|11374934|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7175042|NCT00725985|11374935|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7175043|NCT00725985|11374936|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7175044|NCT00725985|11374937|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7175045|NCT00725985|11374938|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1
7175046|NCT00725985|11374939|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7175047|NCT00725985|11374940|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7175048|NCT00725985|11374941|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
6973180|NCT01178086|11024734|FG000|Overall Study|Other unspecified|89
7080822|NCT02126670|11190489|FG003|Overall Study|Withdrawal by Subject|1
7080823|NCT02126826|11190519|FG000|Overall Study|Withdrawal by Subject|0
7080824|NCT02126826|11190520|FG001|Overall Study|Withdrawal by Subject|0
7080825|NCT02126826|11190521|FG002|Overall Study|Withdrawal by Subject|0
7175049|NCT00725985|11374942|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7175050|NCT00725985|11374931|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7175051|NCT00725985|11374932|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7175052|NCT00725985|11374933|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7175053|NCT00725985|11374934|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7175054|NCT00725985|11374935|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7175055|NCT00725985|11374936|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7175056|NCT00725985|11374937|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7175057|NCT00725985|11374938|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7175058|NCT00725985|11374939|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1
7175059|NCT00725985|11374940|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7175060|NCT00725985|11374941|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7175061|NCT00725985|11374942|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7175062|NCT00725985|11374931|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
7175063|NCT00725985|11374932|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
7175064|NCT00725985|11374933|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
7175065|NCT00725985|11374934|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
7175066|NCT00725985|11374935|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
7175067|NCT00725985|11374936|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
7175068|NCT00725985|11374937|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9
7175069|NCT00725985|11374938|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8
7175070|NCT00725985|11374939|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16
7175071|NCT00725985|11374940|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
7175072|NCT00725985|11374941|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
7175073|NCT00725985|11374942|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
7175074|NCT00725985|11374931|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0
7175075|NCT00725985|11374932|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0
7175076|NCT00725985|11374933|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0
7175077|NCT00725985|11374934|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0
7175078|NCT00725985|11374935|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0
7175079|NCT00725985|11374936|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0
7175080|NCT00725985|11374937|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0
7175081|NCT00725985|11374938|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0
7175082|NCT00725985|11374939|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0
7175083|NCT00725985|11374940|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34
7175084|NCT00725985|11374941|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36
7175085|NCT00725985|11374942|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14
7185971|NCT03249714|11386296|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1
7185972|NCT03249714|11386297|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1
7185973|NCT03249714|11386296|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1
7185974|NCT03249714|11386297|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1
7185975|NCT03249714|11386296|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1
7185976|NCT03249714|11386297|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0
7185977|NCT03249714|11386296|FG000|Open-label Treatment (Extension Part)|Adverse Event|2
7185978|NCT03249714|11386297|FG001|Open-label Treatment (Extension Part)|Adverse Event|0
7185979|NCT03170882|11386321|FG000|Overall Study|Ongoing|10
7185980|NCT03170882|11386322|FG001|Overall Study|Ongoing|14
7185981|NCT03170882|11386321|FG000|Overall Study|Death|15
7185982|NCT03170882|11386322|FG001|Overall Study|Death|29
7185983|NCT03170882|11386321|FG000|Overall Study|Lost to Follow-up|0
7185984|NCT03170882|11386322|FG001|Overall Study|Lost to Follow-up|1
7185985|NCT03170882|11386321|FG000|Overall Study|Withdrawal by Subject|4
7185986|NCT03170882|11386322|FG001|Overall Study|Withdrawal by Subject|6
7185987|NCT03170882|11386321|FG000|Overall Study|Reason not Specified|0
7185988|NCT03170882|11386322|FG001|Overall Study|Reason not Specified|1
7185989|NCT03074318|11386332|FG000|Overall Study|Adverse Event|0
7185990|NCT03074318|11386333|FG001|Overall Study|Adverse Event|1
7185991|NCT03074318|11386334|FG002|Overall Study|Adverse Event|1
7185992|NCT03074318|11386335|FG003|Overall Study|Adverse Event|1
7185993|NCT03074318|11386332|FG000|Overall Study|Death|1
7185994|NCT03074318|11386333|FG001|Overall Study|Death|0
7185995|NCT03074318|11386334|FG002|Overall Study|Death|0
7185996|NCT03074318|11386335|FG003|Overall Study|Death|0
7185997|NCT03074318|11386332|FG000|Overall Study|Withdrawal by Subject|1
7185998|NCT03074318|11386333|FG001|Overall Study|Withdrawal by Subject|2
7185999|NCT03074318|11386334|FG002|Overall Study|Withdrawal by Subject|2
7186000|NCT03074318|11386335|FG003|Overall Study|Withdrawal by Subject|4
7186001|NCT03074318|11386332|FG000|Overall Study|Trial Closure|2
7186002|NCT03074318|11386333|FG001|Overall Study|Trial Closure|2
7186003|NCT03074318|11386334|FG002|Overall Study|Trial Closure|3
7186004|NCT03074318|11386335|FG003|Overall Study|Trial Closure|11
7186005|NCT03010319|11386356|FG000|Overall Study|Adverse Event|15
7186006|NCT03010319|11386357|FG001|Overall Study|Adverse Event|9
7186007|NCT03010319|11386356|FG000|Overall Study|Withdrawal by Subject|1
7186008|NCT03010319|11386357|FG001|Overall Study|Withdrawal by Subject|6
7186009|NCT03010319|11386356|FG000|Overall Study|Physician Decision|2
7186010|NCT03010319|11386357|FG001|Overall Study|Physician Decision|4
7186011|NCT03010319|11386356|FG000|Overall Study|Sponsor requested withdrawal|2
7186012|NCT03010319|11386357|FG001|Overall Study|Sponsor requested withdrawal|2
7186013|NCT03010319|11386356|FG000|Overall Study|Death|1
7186014|NCT03010319|11386357|FG001|Overall Study|Death|0
7080826|NCT02126826|11190522|FG003|Overall Study|Withdrawal by Subject|1
7080827|NCT02126826|11190523|FG004|Overall Study|Withdrawal by Subject|0
7175086|NCT04860258|11374975|FG000|Overall Study|Withdrawal by Subject|0
7175087|NCT04860258|11374976|FG001|Overall Study|Withdrawal by Subject|0
7175088|NCT04860258|11374977|FG002|Overall Study|Withdrawal by Subject|4
7175089|NCT04860258|11374978|FG003|Overall Study|Withdrawal by Subject|1
7175090|NCT04860258|11374979|FG004|Overall Study|Withdrawal by Subject|4
7175091|NCT04860258|11374980|FG005|Overall Study|Withdrawal by Subject|1
7175092|NCT04860258|11374981|FG006|Overall Study|Withdrawal by Subject|0
7175093|NCT04428645|11374997|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1
7175094|NCT03787303|11375014|FG000|Overall Study|Death|1
7175095|NCT03787303|11375014|FG000|Overall Study|Premature Termination of Study|1
7175096|NCT03673098|11375024|FG000|Overall Study|Lost to Follow-up|2
7175097|NCT03673098|11375025|FG001|Overall Study|Lost to Follow-up|3
7175098|NCT03673098|11375024|FG000|Overall Study|Withdrawal by Subject|6
7175099|NCT03673098|11375025|FG001|Overall Study|Withdrawal by Subject|1
7175100|NCT03673098|11375024|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2
7175101|NCT03673098|11375025|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0
7175102|NCT03525678|11375041|FG000|Overall Study|Ongoing at the time of interim analysis|60
7175103|NCT03525678|11375042|FG001|Overall Study|Ongoing at the time of interim analysis|65
7175104|NCT03525678|11375043|FG002|Overall Study|Ongoing at the time of interim analysis|21
7175105|NCT03525678|11375041|FG000|Overall Study|Withdrawal by Subject|3
7175106|NCT03525678|11375042|FG001|Overall Study|Withdrawal by Subject|1
7175107|NCT03525678|11375043|FG002|Overall Study|Withdrawal by Subject|0
7175108|NCT03525678|11375041|FG000|Overall Study|Physician Decision|1
7175109|NCT03525678|11375042|FG001|Overall Study|Physician Decision|2
7175110|NCT03525678|11375043|FG002|Overall Study|Physician Decision|0
7175111|NCT03525678|11375041|FG000|Overall Study|Lost to Follow-up|1
7175112|NCT03525678|11375042|FG001|Overall Study|Lost to Follow-up|0
7175113|NCT03525678|11375043|FG002|Overall Study|Lost to Follow-up|0
7175114|NCT03525678|11375041|FG000|Overall Study|Death|32
7175115|NCT03525678|11375042|FG001|Overall Study|Death|31
7175116|NCT03525678|11375043|FG002|Overall Study|Death|4
7175117|NCT03520569|11375051|FG000|Overall Study|Withdrawal by Subject|1
7175118|NCT03499899|11375064|FG000|Overall Study|Adverse Event|2
7175119|NCT03499899|11375065|FG001|Overall Study|Adverse Event|3
7175120|NCT03499899|11375066|FG002|Overall Study|Adverse Event|3
7175121|NCT03499899|11375064|FG000|Overall Study|Death|0
7175122|NCT03499899|11375065|FG001|Overall Study|Death|0
7175123|NCT03499899|11375066|FG002|Overall Study|Death|1
7175124|NCT03499899|11375064|FG000|Overall Study|Physician Decision|3
7175125|NCT03499899|11375065|FG001|Overall Study|Physician Decision|6
7175126|NCT03499899|11375066|FG002|Overall Study|Physician Decision|6
7175127|NCT03499899|11375064|FG000|Overall Study|Progressive disease|15
7175128|NCT03499899|11375065|FG001|Overall Study|Progressive disease|23
7175129|NCT03499899|11375066|FG002|Overall Study|Progressive disease|23
7175130|NCT03499899|11375064|FG000|Overall Study|Patient decision|0
7175131|NCT03499899|11375065|FG001|Overall Study|Patient decision|1
7175132|NCT03499899|11375066|FG002|Overall Study|Patient decision|1
7175133|NCT03499899|11375064|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0
7175134|NCT03499899|11375065|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1
7175135|NCT03499899|11375066|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0
7175136|NCT03462563|11375076|FG000|Overall Study|Death|1
7175137|NCT03462563|11375077|FG001|Overall Study|Death|1
7175138|NCT03462563|11375076|FG000|Overall Study|Termination of study|2
7175139|NCT03462563|11375077|FG001|Overall Study|Termination of study|1
7175140|NCT03462563|11375076|FG000|Overall Study|Adverse Event|1
7175141|NCT03462563|11375077|FG001|Overall Study|Adverse Event|3
7175142|NCT03462563|11375076|FG000|Overall Study|Unspecified reason|10
7175143|NCT03462563|11375077|FG001|Overall Study|Unspecified reason|12
7175144|NCT03462563|11375076|FG000|Overall Study|Physician Decision|1
7175145|NCT03462563|11375077|FG001|Overall Study|Physician Decision|0
7175146|NCT03419741|11375085|FG000|Overall Study|Adverse Event|1
7175147|NCT03419741|11375086|FG001|Overall Study|Adverse Event|0
7175148|NCT03419741|11375085|FG000|Overall Study|Withdrawal by Subject|1
7175149|NCT03419741|11375086|FG001|Overall Study|Withdrawal by Subject|2
7175150|NCT02759185|11375105|FG000|Stage 1|Adverse Event|0
7175151|NCT02759185|11375106|FG001|Stage 1|Adverse Event|1
7175152|NCT02759185|11375107|FG002|Stage 1|Adverse Event|3
7175153|NCT02759185|11375108|FG003|Stage 1|Adverse Event|0
7175154|NCT02759185|11375109|FG004|Stage 1|Adverse Event|0
7175155|NCT02759185|11375110|FG005|Stage 1|Adverse Event|0
7175156|NCT02759185|11375111|FG006|Stage 1|Adverse Event|0
7175157|NCT02759185|11375105|FG000|Stage 1|Withdrawal by Subject|1
7175158|NCT02759185|11375106|FG001|Stage 1|Withdrawal by Subject|0
7175159|NCT02759185|11375107|FG002|Stage 1|Withdrawal by Subject|0
7175160|NCT02759185|11375108|FG003|Stage 1|Withdrawal by Subject|0
7175161|NCT02759185|11375109|FG004|Stage 1|Withdrawal by Subject|0
7175162|NCT02759185|11375110|FG005|Stage 1|Withdrawal by Subject|0
7175163|NCT02759185|11375111|FG006|Stage 1|Withdrawal by Subject|0
7175164|NCT02759185|11375105|FG000|Stage 2|Adverse Event|0
7175165|NCT02759185|11375106|FG001|Stage 2|Adverse Event|0
7175166|NCT02759185|11375107|FG002|Stage 2|Adverse Event|0
7175167|NCT02759185|11375108|FG003|Stage 2|Adverse Event|0
7175168|NCT02759185|11375109|FG004|Stage 2|Adverse Event|1
7175169|NCT02759185|11375110|FG005|Stage 2|Adverse Event|2
7175170|NCT02759185|11375111|FG006|Stage 2|Adverse Event|0
7175171|NCT02759185|11375105|FG000|Stage 2|Withdrawal by Subject|0
7175172|NCT02759185|11375106|FG001|Stage 2|Withdrawal by Subject|0
7175173|NCT02759185|11375107|FG002|Stage 2|Withdrawal by Subject|0
7175174|NCT02759185|11375108|FG003|Stage 2|Withdrawal by Subject|0
7175175|NCT02759185|11375109|FG004|Stage 2|Withdrawal by Subject|1
7175176|NCT02759185|11375110|FG005|Stage 2|Withdrawal by Subject|1
7175177|NCT02759185|11375111|FG006|Stage 2|Withdrawal by Subject|1
7175178|NCT02688530|11375146|FG000|Overall Study|Withdrawal by Subject|0
7175179|NCT02688530|11375147|FG001|Overall Study|Withdrawal by Subject|1
7175180|NCT02688530|11375148|FG002|Overall Study|Withdrawal by Subject|0
7175181|NCT02688530|11375149|FG003|Overall Study|Withdrawal by Subject|0
7175182|NCT02688530|11375146|FG000|Overall Study|Lost to Follow-up|0
7175183|NCT02688530|11375147|FG001|Overall Study|Lost to Follow-up|0
7175184|NCT02688530|11375148|FG002|Overall Study|Lost to Follow-up|2
7175185|NCT02688530|11375149|FG003|Overall Study|Lost to Follow-up|0
7175186|NCT02657434|11375165|FG000|Overall Study|On-Going in Study|77
7175187|NCT02657434|11375166|FG001|Overall Study|On-Going in Study|91
7175188|NCT02657434|11375165|FG000|Overall Study|Death|177
7175189|NCT02657434|11375166|FG001|Overall Study|Death|183
7175190|NCT02657434|11375165|FG000|Overall Study|Lost to Follow-up|2
7175191|NCT02657434|11375166|FG001|Overall Study|Lost to Follow-up|2
7175192|NCT02657434|11375165|FG000|Overall Study|Randomization by Error|2
7175193|NCT02657434|11375166|FG001|Overall Study|Randomization by Error|0
7175194|NCT02657434|11375165|FG000|Overall Study|Withdrawal by Subject|27
7175195|NCT02657434|11375166|FG001|Overall Study|Withdrawal by Subject|16
7175196|NCT02657434|11375165|FG000|Overall Study|Protocol Violation|1
7175197|NCT02657434|11375166|FG001|Overall Study|Protocol Violation|0
7175198|NCT02383966|11375175|FG000|Overall Study|Ongoing at clinical cut-off date|25
7175199|NCT02383966|11375176|FG001|Overall Study|Ongoing at clinical cut-off date|4
7175200|NCT02383966|11375175|FG000|Overall Study|Randomized, but not treated|1
7175201|NCT02383966|11375176|FG001|Overall Study|Randomized, but not treated|3
7175202|NCT02073565|11375184|FG000|Cohort A|Withdrawal by Subject|1
7175203|NCT02073565|11375185|FG001|Cohort A|Withdrawal by Subject|0
7175204|NCT02073565|11375184|FG000|Cohort B|Withdrawal by Subject|1
7175205|NCT02073565|11375185|FG001|Cohort B|Withdrawal by Subject|2
7175206|NCT02073565|11375184|FG000|Cohort C|Withdrawal by Subject|0
7175207|NCT02073565|11375185|FG001|Cohort C|Withdrawal by Subject|2
7175208|NCT02073565|11375184|FG000|Cohort C|Lost to Follow-up|0
7175209|NCT02073565|11375185|FG001|Cohort C|Lost to Follow-up|2
7175210|NCT02060487|11375194|FG000|Overall Study|Other|1
7175211|NCT02060487|11375195|FG001|Overall Study|Other|2
7175212|NCT02060487|11375196|FG002|Overall Study|Other|1
7175213|NCT02060487|11375194|FG000|Overall Study|Lack of Efficacy|0
7175214|NCT02060487|11375195|FG001|Overall Study|Lack of Efficacy|1
7175215|NCT02060487|11375196|FG002|Overall Study|Lack of Efficacy|0
7175216|NCT02060487|11375194|FG000|Overall Study|Withdrawal by Subject|3
7175217|NCT02060487|11375195|FG001|Overall Study|Withdrawal by Subject|10
7175218|NCT02060487|11375196|FG002|Overall Study|Withdrawal by Subject|4
7175219|NCT02060487|11375194|FG000|Overall Study|Study Terminated By Sponsor|87
7175220|NCT02060487|11375195|FG001|Overall Study|Study Terminated By Sponsor|89
7175221|NCT02060487|11375196|FG002|Overall Study|Study Terminated By Sponsor|100
7175222|NCT02060487|11375194|FG000|Overall Study|Randomized in error|1
7175223|NCT02060487|11375195|FG001|Overall Study|Randomized in error|0
7175224|NCT02060487|11375196|FG002|Overall Study|Randomized in error|0
7175225|NCT02060487|11375194|FG000|Overall Study|Protocol Violation|0
7175226|NCT02060487|11375195|FG001|Overall Study|Protocol Violation|1
7175227|NCT02060487|11375196|FG002|Overall Study|Protocol Violation|1
7175228|NCT02060487|11375194|FG000|Overall Study|Lost to Follow-up|3
7175229|NCT02060487|11375195|FG001|Overall Study|Lost to Follow-up|0
7175230|NCT02060487|11375196|FG002|Overall Study|Lost to Follow-up|2
7175231|NCT02060487|11375194|FG000|Overall Study|Death|34
7175232|NCT02060487|11375195|FG001|Overall Study|Death|25
7175233|NCT02060487|11375196|FG002|Overall Study|Death|19
7175234|NCT02060487|11375194|FG000|Overall Study|Adverse Event|0
7175235|NCT02060487|11375195|FG001|Overall Study|Adverse Event|0
7175236|NCT02060487|11375196|FG002|Overall Study|Adverse Event|1
7175237|NCT00331773|11375241|FG000|Overall Study|Withdrawal by Subject|6
7175238|NCT00331773|11375242|FG001|Overall Study|Withdrawal by Subject|4
7175239|NCT00331773|11375241|FG000|Overall Study|Protocol Violation|10
7175240|NCT00331773|11375242|FG001|Overall Study|Protocol Violation|3
7186015|NCT03010319|11386356|FG000|Overall Study|Lost to Follow-up|0
7186016|NCT03010319|11386357|FG001|Overall Study|Lost to Follow-up|1
7186017|NCT03010319|11386356|FG000|Overall Study|Other Reason|5
7186018|NCT03010319|11386357|FG001|Overall Study|Other Reason|7
7186019|NCT02915016|11386371|FG000|Overall Study|Lost to Follow-up|4
7186020|NCT02915016|11386372|FG001|Overall Study|Lost to Follow-up|2
7186021|NCT02915016|11386373|FG002|Overall Study|Lost to Follow-up|5
7186022|NCT02915016|11386374|FG003|Overall Study|Lost to Follow-up|3
7186023|NCT02915016|11386375|FG004|Overall Study|Lost to Follow-up|5
7186024|NCT02915016|11386376|FG005|Overall Study|Lost to Follow-up|2
7186025|NCT02915016|11386377|FG006|Overall Study|Lost to Follow-up|8
7186026|NCT02915016|11386378|FG007|Overall Study|Lost to Follow-up|2
7186027|NCT02915016|11386371|FG000|Overall Study|Physician Decision|0
7186028|NCT02915016|11386372|FG001|Overall Study|Physician Decision|0
7186029|NCT02915016|11386373|FG002|Overall Study|Physician Decision|1
7175241|NCT04882995|11375290|FG000|Overall Study|Withdrawal by Subject|1
7175242|NCT04882995|11375291|FG001|Overall Study|Withdrawal by Subject|2
7175243|NCT04882995|11375290|FG000|Overall Study|Protocol Violation|4
7175244|NCT04882995|11375291|FG001|Overall Study|Protocol Violation|4
7175245|NCT04882995|11375290|FG000|Overall Study|Surgery postponed due to COVID|1
7175246|NCT04882995|11375291|FG001|Overall Study|Surgery postponed due to COVID|1
7175247|NCT04640168|11375308|FG000|Overall Study|Withdrawal by Subject|8
7175248|NCT04640168|11375309|FG001|Overall Study|Withdrawal by Subject|7
7175249|NCT04640168|11375308|FG000|Overall Study|Lost to Follow-up|1
7175250|NCT04640168|11375309|FG001|Overall Study|Lost to Follow-up|0
7175251|NCT04640168|11375308|FG000|Overall Study|Enrolled but not treated|12
7175252|NCT04640168|11375309|FG001|Overall Study|Enrolled but not treated|12
7175253|NCT04465630|11375315|FG000|Overall Study|Sponsor Decision to terminate the study|54
7175254|NCT04465630|11375315|FG000|Overall Study|Screen failure|8
7175255|NCT04465630|11375315|FG000|Overall Study|Baseline failure|16
7175256|NCT04459598|11375322|FG000|Overall Study|Adverse Event|1
7175257|NCT04459598|11375323|FG001|Overall Study|Adverse Event|1
7175258|NCT04439344|11375329|FG000|Overall Study|Never started threapy|3
7175259|NCT04439344|11375329|FG000|Overall Study|Ineligible|3
7175260|NCT04439344|11375329|FG000|Overall Study|Adverse Event|13
7175261|NCT04439344|11375329|FG000|Overall Study|Death|2
7175262|NCT04439344|11375329|FG000|Overall Study|Disease progression|29
7175263|NCT04439344|11375329|FG000|Overall Study|Withdrawal by Subject|2
7175264|NCT04439344|11375329|FG000|Overall Study|Alternative therapy|1
7175265|NCT04439279|11375333|FG000|Overall Study|Adverse Event|7
7175266|NCT04439279|11375333|FG000|Overall Study|Death|4
7175267|NCT04439279|11375333|FG000|Overall Study|Disease progression|17
7175268|NCT04439279|11375333|FG000|Overall Study|Complicating disease|3
7175269|NCT04439279|11375333|FG000|Overall Study|Withdrawal by Subject|2
7175270|NCT04439279|11375333|FG000|Overall Study|Ineligible|1
7175271|NCT04439279|11375333|FG000|Overall Study|Treatment still ongoing|1
7175272|NCT04439123|11375337|FG000|Overall Study|Adverse Event|11
7175273|NCT04439123|11375337|FG000|Overall Study|Death|1
7175274|NCT04439123|11375337|FG000|Overall Study|Disease progression|19
7175275|NCT04439123|11375337|FG000|Overall Study|Withdrawal by Subject|2
7175276|NCT04439123|11375337|FG000|Overall Study|Still on treatment|2
7175277|NCT04439110|11375341|FG000|Overall Study|Ineligible|2
7175278|NCT04439110|11375341|FG000|Overall Study|Adverse Event|4
7175279|NCT04439110|11375341|FG000|Overall Study|Death|2
7175280|NCT04439110|11375341|FG000|Overall Study|Disease proression|25
7175281|NCT04439110|11375341|FG000|Overall Study|Withdrawal by Subject|1
7175282|NCT04439110|11375341|FG000|Overall Study|Alternative therapy|1
7175283|NCT04439110|11375341|FG000|Overall Study|Other complicating disease|1
7175284|NCT04439110|11375341|FG000|Overall Study|Personal reasons|1
7175285|NCT04439110|11375341|FG000|Overall Study|Still on treatment|1
7175286|NCT04387136|11375347|FG000|Overall Study|Protocol Deviation by SOC staff|1
7175287|NCT04387136|11375348|FG001|Overall Study|Protocol Deviation by SOC staff|2
7175288|NCT04351269|11375357|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70
7175289|NCT04351269|11375358|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32
7175290|NCT04351269|11375359|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29
7175291|NCT04351269|11375357|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0
7175292|NCT04351269|11375358|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1
7175293|NCT04351269|11375359|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0
7175294|NCT04351269|11375357|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1
7175295|NCT04351269|11375358|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1
7175296|NCT04351269|11375359|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0
7175297|NCT04351269|11375357|FG000|Overall Study|Subjects followed long-term at different health care system|0
7175298|NCT04351269|11375358|FG001|Overall Study|Subjects followed long-term at different health care system|4
7175299|NCT04351269|11375359|FG002|Overall Study|Subjects followed long-term at different health care system|0
7175300|NCT04351269|11375357|FG000|Overall Study|Lost to Follow-up|1
7175301|NCT04351269|11375358|FG001|Overall Study|Lost to Follow-up|3
7175302|NCT04351269|11375359|FG002|Overall Study|Lost to Follow-up|0
7175303|NCT04285229|11375376|FG000|Overall Study|Adverse Event|1
7175304|NCT04285229|11375377|FG001|Overall Study|Adverse Event|2
7175305|NCT04285229|11375376|FG000|Overall Study|Withdrawal by Subject|1
7175306|NCT04285229|11375377|FG001|Overall Study|Withdrawal by Subject|0
7175307|NCT04285229|11375376|FG000|Overall Study|Sponsor Decision|1
7175308|NCT04285229|11375377|FG001|Overall Study|Sponsor Decision|0
7175309|NCT03668808|11375427|FG000|First Intervention|Withdrawal by Subject|2
7175310|NCT03668808|11375428|FG001|First Intervention|Withdrawal by Subject|2
7175311|NCT03656874|11375447|FG000|Overall Study|Lost to Follow-up|3
7175312|NCT03656874|11375448|FG001|Overall Study|Lost to Follow-up|17
7175313|NCT03584009|11375456|FG000|Overall Study|Death|25
7175314|NCT03584009|11375457|FG001|Overall Study|Death|18
7175315|NCT03584009|11375456|FG000|Overall Study|Lost to Follow-up|0
7175316|NCT03584009|11375457|FG001|Overall Study|Lost to Follow-up|1
7175317|NCT03584009|11375456|FG000|Overall Study|Physician Decision|1
7175318|NCT03584009|11375457|FG001|Overall Study|Physician Decision|1
7175319|NCT03584009|11375456|FG000|Overall Study|Study Terminated by Sponsor|22
7175320|NCT03584009|11375457|FG001|Overall Study|Study Terminated by Sponsor|30
7175321|NCT03584009|11375456|FG000|Overall Study|Withdrawal by Subject|3
7175322|NCT03584009|11375457|FG001|Overall Study|Withdrawal by Subject|2
7175323|NCT03583359|11375468|FG000|Overall Study|Withdrawal by Subject|15
7175324|NCT03583359|11375469|FG001|Overall Study|Withdrawal by Subject|6
7175325|NCT03583359|11375468|FG000|Overall Study|Lost to Follow-up|12
7175326|NCT03583359|11375469|FG001|Overall Study|Lost to Follow-up|3
7175327|NCT03583359|11375468|FG000|Overall Study|Adverse Event|0
7175328|NCT03583359|11375469|FG001|Overall Study|Adverse Event|1
7175329|NCT03583359|11375468|FG000|Overall Study|Protocol Violation|0
7175330|NCT03583359|11375469|FG001|Overall Study|Protocol Violation|1
7175331|NCT03583359|11375468|FG000|Overall Study|Other|2
7175332|NCT03583359|11375469|FG001|Overall Study|Other|1
7175333|NCT03568162|11375481|FG000|Overall Study|Adverse Event|0
7175334|NCT03568162|11375482|FG001|Overall Study|Adverse Event|1
7175335|NCT03568162|11375483|FG002|Overall Study|Adverse Event|2
7175336|NCT03568162|11375484|FG003|Overall Study|Adverse Event|0
7175337|NCT03568162|11375485|FG004|Overall Study|Adverse Event|0
7175338|NCT03568162|11375486|FG005|Overall Study|Adverse Event|1
7175339|NCT03568162|11375481|FG000|Overall Study|Death|0
7175340|NCT03568162|11375482|FG001|Overall Study|Death|0
7175341|NCT03568162|11375483|FG002|Overall Study|Death|0
7175342|NCT03568162|11375484|FG003|Overall Study|Death|0
7175343|NCT03568162|11375485|FG004|Overall Study|Death|1
7175344|NCT03568162|11375486|FG005|Overall Study|Death|0
7175345|NCT03568162|11375481|FG000|Overall Study|Lost to Follow-up|3
7175346|NCT03568162|11375482|FG001|Overall Study|Lost to Follow-up|2
7175347|NCT03568162|11375483|FG002|Overall Study|Lost to Follow-up|4
7175348|NCT03568162|11375484|FG003|Overall Study|Lost to Follow-up|2
7175349|NCT03568162|11375485|FG004|Overall Study|Lost to Follow-up|3
7175350|NCT03568162|11375486|FG005|Overall Study|Lost to Follow-up|2
7175351|NCT03568162|11375481|FG000|Overall Study|Physician Decision|0
7175352|NCT03568162|11375482|FG001|Overall Study|Physician Decision|1
7175353|NCT03568162|11375483|FG002|Overall Study|Physician Decision|1
7175354|NCT03568162|11375484|FG003|Overall Study|Physician Decision|0
7175355|NCT03568162|11375485|FG004|Overall Study|Physician Decision|1
7175356|NCT03568162|11375486|FG005|Overall Study|Physician Decision|0
7175357|NCT03568162|11375481|FG000|Overall Study|Pregnancy|0
7175358|NCT03568162|11375482|FG001|Overall Study|Pregnancy|0
7175359|NCT03568162|11375483|FG002|Overall Study|Pregnancy|0
7175360|NCT03568162|11375484|FG003|Overall Study|Pregnancy|1
7175361|NCT03568162|11375485|FG004|Overall Study|Pregnancy|0
7175362|NCT03568162|11375486|FG005|Overall Study|Pregnancy|0
7175363|NCT03568162|11375481|FG000|Overall Study|Protocol Violation|1
7175364|NCT03568162|11375482|FG001|Overall Study|Protocol Violation|0
7175365|NCT03568162|11375483|FG002|Overall Study|Protocol Violation|1
7175366|NCT03568162|11375484|FG003|Overall Study|Protocol Violation|1
7175367|NCT03568162|11375485|FG004|Overall Study|Protocol Violation|1
7175368|NCT03568162|11375486|FG005|Overall Study|Protocol Violation|1
7175369|NCT03568162|11375481|FG000|Overall Study|Withdrawal by Subject|15
7175370|NCT03568162|11375482|FG001|Overall Study|Withdrawal by Subject|15
7175371|NCT03568162|11375483|FG002|Overall Study|Withdrawal by Subject|26
7175372|NCT03568162|11375484|FG003|Overall Study|Withdrawal by Subject|22
7175373|NCT03568162|11375485|FG004|Overall Study|Withdrawal by Subject|6
7175374|NCT03568162|11375486|FG005|Overall Study|Withdrawal by Subject|9
7175375|NCT03568162|11375481|FG000|Overall Study|Others|3
7175376|NCT03568162|11375482|FG001|Overall Study|Others|4
7175377|NCT03568162|11375483|FG002|Overall Study|Others|1
7175378|NCT03568162|11375484|FG003|Overall Study|Others|4
7175379|NCT03568162|11375485|FG004|Overall Study|Others|2
7175380|NCT03568162|11375486|FG005|Overall Study|Others|1
7175381|NCT03557307|11375503|FG000|To End of OCS Reduction Phase|Withdrawal by Subject|10
7175382|NCT03557307|11375503|FG000|To End of OCS Reduction Phase|Adverse Event|7
7175383|NCT03557307|11375503|FG000|To End of OCS Reduction Phase|Protocol Violation|6
7175384|NCT03557307|11375503|FG000|To End of OCS Reduction Phase|Lost to Follow-up|5
7175385|NCT03557307|11375503|FG000|To End of OCS Reduction Phase|other|3
7175386|NCT03557307|11375503|FG000|To End of OCS Reduction Phase|Death|2
7175387|NCT03557307|11375503|FG000|To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2
7175388|NCT03557307|11375503|FG000|Maintenance Phase|Adverse Event|4
7175389|NCT03557307|11375503|FG000|Maintenance Phase|Death|3
7175390|NCT03557307|11375503|FG000|Maintenance Phase|Lost to Follow-up|2
7175391|NCT03557307|11375503|FG000|Maintenance Phase|Pregnancy|2
7175392|NCT03557307|11375503|FG000|Maintenance Phase|Protocol Violation|11
7175393|NCT03557307|11375503|FG000|Maintenance Phase|Withdrawal by Subject|2
7175394|NCT03557307|11375503|FG000|Maintenance Phase|other|3
7175395|NCT03379675|11375550|FG000|Overall Study|Lost to Follow-up|0
7175396|NCT03379675|11375551|FG001|Overall Study|Lost to Follow-up|1
7175397|NCT03379675|11375552|FG002|Overall Study|Lost to Follow-up|0
7175398|NCT03379675|11375550|FG000|Overall Study|Adverse Event|2
7175399|NCT03379675|11375551|FG001|Overall Study|Adverse Event|0
7175400|NCT03379675|11375552|FG002|Overall Study|Adverse Event|0
7175401|NCT03379675|11375550|FG000|Overall Study|Withdrawal by Subject|2
7175402|NCT03379675|11375551|FG001|Overall Study|Withdrawal by Subject|1
7175403|NCT03379675|11375552|FG002|Overall Study|Withdrawal by Subject|2
7175404|NCT03336619|11375573|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192
7175405|NCT03336619|11375574|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204
7175406|NCT03336619|11375573|FG000|Overall Study|Withdrawal by Subject|17
7175407|NCT03336619|11375574|FG001|Overall Study|Withdrawal by Subject|16
7175408|NCT03336619|11375573|FG000|Overall Study|Adverse Event|2
7175409|NCT03336619|11375574|FG001|Overall Study|Adverse Event|5
7175410|NCT03336619|11375573|FG000|Overall Study|Physician Decision|3
7175411|NCT03336619|11375574|FG001|Overall Study|Physician Decision|0
7175412|NCT03274687|11375585|FG000|Overall Study|Protocol Violation|1
7175413|NCT03274687|11375586|FG001|Overall Study|Protocol Violation|1
7175414|NCT03245450|11375599|FG000|Overall Study|Radiological disease progression|3
7175415|NCT03245450|11375600|FG001|Overall Study|Radiological disease progression|3
7175416|NCT03245450|11375601|FG002|Overall Study|Radiological disease progression|2
7175417|NCT03245450|11375602|FG003|Overall Study|Radiological disease progression|2
7175418|NCT03245450|11375603|FG004|Overall Study|Radiological disease progression|7
7175419|NCT03245450|11375604|FG005|Overall Study|Radiological disease progression|6
7175420|NCT03245450|11375605|FG006|Overall Study|Radiological disease progression|6
7175421|NCT03245450|11375599|FG000|Overall Study|Clinical disease progression|0
7175422|NCT03245450|11375600|FG001|Overall Study|Clinical disease progression|0
7175423|NCT03245450|11375601|FG002|Overall Study|Clinical disease progression|1
7175424|NCT03245450|11375602|FG003|Overall Study|Clinical disease progression|0
7175425|NCT03245450|11375603|FG004|Overall Study|Clinical disease progression|0
7175426|NCT03245450|11375604|FG005|Overall Study|Clinical disease progression|2
7175427|NCT03245450|11375605|FG006|Overall Study|Clinical disease progression|0
7175428|NCT03245450|11375599|FG000|Overall Study|Other|0
7175429|NCT03245450|11375600|FG001|Overall Study|Other|0
7175430|NCT03245450|11375601|FG002|Overall Study|Other|0
7175431|NCT03245450|11375602|FG003|Overall Study|Other|1
7175432|NCT03245450|11375603|FG004|Overall Study|Other|1
7175433|NCT03245450|11375604|FG005|Overall Study|Other|1
7175434|NCT03245450|11375605|FG006|Overall Study|Other|1
7175435|NCT03245450|11375599|FG000|Overall Study|Withdrawal by Subject|0
7175436|NCT03245450|11375600|FG001|Overall Study|Withdrawal by Subject|1
7175437|NCT03245450|11375601|FG002|Overall Study|Withdrawal by Subject|0
7175438|NCT03245450|11375602|FG003|Overall Study|Withdrawal by Subject|0
7175439|NCT03245450|11375603|FG004|Overall Study|Withdrawal by Subject|0
7175440|NCT03245450|11375604|FG005|Overall Study|Withdrawal by Subject|0
7175441|NCT03245450|11375605|FG006|Overall Study|Withdrawal by Subject|0
7175442|NCT03245450|11375599|FG000|Overall Study|Adverse Event|0
7175443|NCT03245450|11375600|FG001|Overall Study|Adverse Event|0
7175444|NCT03245450|11375601|FG002|Overall Study|Adverse Event|0
7175445|NCT03245450|11375602|FG003|Overall Study|Adverse Event|0
7175446|NCT03245450|11375603|FG004|Overall Study|Adverse Event|1
7175447|NCT03245450|11375604|FG005|Overall Study|Adverse Event|0
7175448|NCT03245450|11375605|FG006|Overall Study|Adverse Event|2
7175449|NCT03086369|11375632|FG000|Overall Study|Lost to Follow-up|1
7175450|NCT03086369|11375633|FG001|Overall Study|Lost to Follow-up|0
7175451|NCT03086369|11375634|FG002|Overall Study|Lost to Follow-up|0
7175452|NCT03086369|11375635|FG003|Overall Study|Lost to Follow-up|2
7175453|NCT03086369|11375636|FG004|Overall Study|Lost to Follow-up|1
7175454|NCT03086369|11375632|FG000|Overall Study|Physician Decision|0
7175455|NCT03086369|11375633|FG001|Overall Study|Physician Decision|0
7175456|NCT03086369|11375634|FG002|Overall Study|Physician Decision|0
7175457|NCT03086369|11375635|FG003|Overall Study|Physician Decision|1
7175458|NCT03086369|11375636|FG004|Overall Study|Physician Decision|2
7175459|NCT03086369|11375632|FG000|Overall Study|Withdrawal by Subject|0
7175460|NCT03086369|11375633|FG001|Overall Study|Withdrawal by Subject|0
7175461|NCT03086369|11375634|FG002|Overall Study|Withdrawal by Subject|0
7175462|NCT03086369|11375635|FG003|Overall Study|Withdrawal by Subject|5
7175463|NCT03086369|11375636|FG004|Overall Study|Withdrawal by Subject|3
7175464|NCT03086369|11375632|FG000|Overall Study|Progressive Disease|0
7175465|NCT03086369|11375633|FG001|Overall Study|Progressive Disease|0
7175466|NCT03086369|11375634|FG002|Overall Study|Progressive Disease|0
7175467|NCT03086369|11375635|FG003|Overall Study|Progressive Disease|1
7175468|NCT03086369|11375636|FG004|Overall Study|Progressive Disease|1
7175469|NCT02951767|11375654|FG000|Overall Study|Ongoing at data cutoff 04 July 2016|54
7175470|NCT02951767|11375654|FG000|Overall Study|Withdrawal by Subject|5
7175471|NCT02951767|11375654|FG000|Overall Study|Death|59
7175472|NCT02951767|11375654|FG000|Overall Study|Lost to Follow-up|1
7175473|NCT02927847|11375660|FG000|Overall Study|Lost to Follow-up|1
7175474|NCT02927847|11375661|FG001|Overall Study|Lost to Follow-up|0
7175475|NCT02927847|11375660|FG000|Overall Study|Withdrawal by Subject|4
7175476|NCT02927847|11375661|FG001|Overall Study|Withdrawal by Subject|2
7175477|NCT02927847|11375660|FG000|Overall Study|PI withdrawn due to missed visits|1
7175478|NCT02927847|11375661|FG001|Overall Study|PI withdrawn due to missed visits|1
7175479|NCT02892149|11375678|FG000|Overall Study|Death|262
7175480|NCT02892149|11375679|FG001|Overall Study|Death|278
7175481|NCT02892149|11375678|FG000|Overall Study|Withdrawal by Subject|53
7175482|NCT02892149|11375679|FG001|Overall Study|Withdrawal by Subject|47
7175483|NCT02892149|11375678|FG000|Overall Study|Lost to Follow-up|37
7175484|NCT02892149|11375679|FG001|Overall Study|Lost to Follow-up|31
7175485|NCT02872116|11375688|FG000|Pre-Treatment|Disease Progression|0
7175486|NCT02872116|11375689|FG001|Pre-Treatment|Disease Progression|1
7175487|NCT02872116|11375690|FG002|Pre-Treatment|Disease Progression|0
7175488|NCT02872116|11375688|FG000|Pre-Treatment|Adverse event unrelated to study drug|0
7175489|NCT02872116|11375689|FG001|Pre-Treatment|Adverse event unrelated to study drug|2
7175490|NCT02872116|11375690|FG002|Pre-Treatment|Adverse event unrelated to study drug|1
7175491|NCT02872116|11375688|FG000|Pre-Treatment|Participants request to discontinue study treatment|0
7175492|NCT02872116|11375689|FG001|Pre-Treatment|Participants request to discontinue study treatment|2
7175493|NCT02872116|11375690|FG002|Pre-Treatment|Participants request to discontinue study treatment|0
7175494|NCT02872116|11375688|FG000|Pre-Treatment|Participant withdrew consent|2
7175495|NCT02872116|11375689|FG001|Pre-Treatment|Participant withdrew consent|20
7175496|NCT02872116|11375690|FG002|Pre-Treatment|Participant withdrew consent|3
7175497|NCT02872116|11375688|FG000|Pre-Treatment|Participant no longer meets study criteria|4
7175498|NCT02872116|11375689|FG001|Pre-Treatment|Participant no longer meets study criteria|0
7175499|NCT02872116|11375690|FG002|Pre-Treatment|Participant no longer meets study criteria|0
7175500|NCT02872116|11375688|FG000|Pre-Treatment|Other reasons|1
7175501|NCT02872116|11375689|FG001|Pre-Treatment|Other reasons|2
7175502|NCT02872116|11375690|FG002|Pre-Treatment|Other reasons|2
7175503|NCT02872116|11375688|FG000|Treatment|Death|122
7175504|NCT02872116|11375689|FG001|Treatment|Death|94
7175505|NCT02872116|11375690|FG002|Treatment|Death|68
7175506|NCT02872116|11375688|FG000|Treatment|Lost to Follow-up|5
7175507|NCT02872116|11375689|FG001|Treatment|Lost to Follow-up|7
7175508|NCT02872116|11375690|FG002|Treatment|Lost to Follow-up|3
7175509|NCT02872116|11375688|FG000|Treatment|Participant withdrew consent|20
7175510|NCT02872116|11375689|FG001|Treatment|Participant withdrew consent|40
7175511|NCT02872116|11375690|FG002|Treatment|Participant withdrew consent|8
7175512|NCT02872116|11375688|FG000|Treatment|Other reasons|12
7175513|NCT02872116|11375689|FG001|Treatment|Other reasons|12
7175514|NCT02872116|11375690|FG002|Treatment|Other reasons|5
7175515|NCT02720523|11375715|FG000|Period 1: Placebo-controlled Period|Adverse Event|0
7175516|NCT02720523|11375716|FG001|Period 1: Placebo-controlled Period|Adverse Event|0
7175517|NCT02720523|11375717|FG002|Period 1: Placebo-controlled Period|Adverse Event|1
7175518|NCT02720523|11375718|FG003|Period 1: Placebo-controlled Period|Adverse Event|5
7175519|NCT02720523|11375719|FG004|Period 1: Placebo-controlled Period|Adverse Event|0
7175520|NCT02720523|11375720|FG005|Period 1: Placebo-controlled Period|Adverse Event|0
7175521|NCT02720523|11375721|FG006|Period 1: Placebo-controlled Period|Adverse Event|0
7175522|NCT02720523|11375715|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1
7175523|NCT02720523|11375716|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
7175524|NCT02720523|11375717|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
7175525|NCT02720523|11375718|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
7175526|NCT02720523|11375719|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
7175527|NCT02720523|11375720|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
7175528|NCT02720523|11375721|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
7175529|NCT02720523|11375715|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1
7175530|NCT02720523|11375716|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0
7175531|NCT02720523|11375717|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0
7175532|NCT02720523|11375718|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0
7175533|NCT02720523|11375719|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0
7175534|NCT02720523|11375720|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0
7175535|NCT02720523|11375721|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0
7175536|NCT02720523|11375715|FG000|Period 1: Placebo-controlled Period|Other|0
7175537|NCT02720523|11375716|FG001|Period 1: Placebo-controlled Period|Other|0
7175538|NCT02720523|11375717|FG002|Period 1: Placebo-controlled Period|Other|1
7175539|NCT02720523|11375718|FG003|Period 1: Placebo-controlled Period|Other|1
7175540|NCT02720523|11375719|FG004|Period 1: Placebo-controlled Period|Other|0
7175541|NCT02720523|11375720|FG005|Period 1: Placebo-controlled Period|Other|0
7175542|NCT02720523|11375721|FG006|Period 1: Placebo-controlled Period|Other|0
7175543|NCT02720523|11375715|FG000|Period 2: Long-term Extension Period|Ongoing|0
7175544|NCT02720523|11375716|FG001|Period 2: Long-term Extension Period|Ongoing|0
7175545|NCT02720523|11375717|FG002|Period 2: Long-term Extension Period|Ongoing|0
7175546|NCT02720523|11375718|FG003|Period 2: Long-term Extension Period|Ongoing|0
7175547|NCT02720523|11375719|FG004|Period 2: Long-term Extension Period|Ongoing|57
7175548|NCT02720523|11375720|FG005|Period 2: Long-term Extension Period|Ongoing|54
7175549|NCT02720523|11375721|FG006|Period 2: Long-term Extension Period|Ongoing|45
7175550|NCT02720523|11375715|FG000|Period 2: Long-term Extension Period|Adverse Event|0
7175551|NCT02720523|11375716|FG001|Period 2: Long-term Extension Period|Adverse Event|0
7175552|NCT02720523|11375717|FG002|Period 2: Long-term Extension Period|Adverse Event|0
7175553|NCT02720523|11375718|FG003|Period 2: Long-term Extension Period|Adverse Event|0
7175554|NCT02720523|11375719|FG004|Period 2: Long-term Extension Period|Adverse Event|4
7175555|NCT02720523|11375720|FG005|Period 2: Long-term Extension Period|Adverse Event|7
7175556|NCT02720523|11375721|FG006|Period 2: Long-term Extension Period|Adverse Event|11
7175557|NCT02720523|11375715|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0
7175558|NCT02720523|11375716|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0
7175559|NCT02720523|11375717|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0
7175560|NCT02720523|11375718|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0
7175561|NCT02720523|11375719|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2
7175562|NCT02720523|11375720|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1
7186030|NCT02915016|11386374|FG003|Overall Study|Physician Decision|0
7175563|NCT02720523|11375721|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1
7175564|NCT02720523|11375715|FG000|Period 2: Long-term Extension Period|Other|0
7175565|NCT02720523|11375716|FG001|Period 2: Long-term Extension Period|Other|0
7175566|NCT02720523|11375717|FG002|Period 2: Long-term Extension Period|Other|0
7175567|NCT02720523|11375718|FG003|Period 2: Long-term Extension Period|Other|0
7175568|NCT02720523|11375719|FG004|Period 2: Long-term Extension Period|Other|2
7175569|NCT02720523|11375720|FG005|Period 2: Long-term Extension Period|Other|0
7175570|NCT02720523|11375721|FG006|Period 2: Long-term Extension Period|Other|3
7175571|NCT02625324|11375734|FG000|30-Day Follow-up for Primary Endpoint|Death|1
7175572|NCT02625324|11375734|FG000|30-Day Follow-up for Secondary Endpoint|Death|1
7175573|NCT02625324|11375734|FG000|6-Month Follow-up Subject Accountability|Death|5
7175574|NCT02625324|11375734|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2
7175575|NCT02625324|11375734|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1
7175576|NCT02625324|11375734|FG000|12-Month Follow-up Secondary Endpoint|Death|4
7175577|NCT02625324|11375734|FG000|24-Month Follow-up Secondary Endpoint|Death|2
7175578|NCT02625324|11375734|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3
7175579|NCT02625324|11375734|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2
7175580|NCT02625324|11375734|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|27
7175581|NCT02625324|11375734|FG000|36-Month Follow-up Secondary Endpoint|Death|2
7175582|NCT02625324|11375734|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1
7175583|NCT02625324|11375734|FG000|36-Month Follow-up Secondary Endpoint|Subject declined extended follow up at 12 month timepoint. Data entry error to be corrected by site|1
7175584|NCT02581930|11375745|FG000|Overall Study|Withdrawal by Subject|1
7175585|NCT02581930|11375745|FG000|Overall Study|patient declined further treatment|1
7175586|NCT02550652|11375759|FG000|Overall Study|Death|1
7175587|NCT02550652|11375760|FG001|Overall Study|Death|4
7175588|NCT02550652|11375759|FG000|Overall Study|Lack of Efficacy|1
7175589|NCT02550652|11375760|FG001|Overall Study|Lack of Efficacy|0
7175590|NCT02550652|11375759|FG000|Overall Study|Withdrawal by Subject|3
7175591|NCT02550652|11375760|FG001|Overall Study|Withdrawal by Subject|7
7175592|NCT02550652|11375759|FG000|Overall Study|Post Trial Access|1
7175593|NCT02550652|11375760|FG001|Overall Study|Post Trial Access|0
7175594|NCT02550652|11375759|FG000|Overall Study|Lost to Follow-up|1
7175595|NCT02550652|11375760|FG001|Overall Study|Lost to Follow-up|3
7175596|NCT02550652|11375759|FG000|Overall Study|Physician Decision|0
7175597|NCT02550652|11375760|FG001|Overall Study|Physician Decision|2
7175598|NCT02550652|11375759|FG000|Overall Study|Ongoing in safety/B-cell follow-up period|14
7175599|NCT02550652|11375760|FG001|Overall Study|Ongoing in safety/B-cell follow-up period|5
7175600|NCT02468778|11375778|FG000|Overall Study|Death|2
7175601|NCT02468778|11375779|FG001|Overall Study|Death|1
7175602|NCT02468778|11375780|FG002|Overall Study|Death|0
7175603|NCT02468778|11375778|FG000|Overall Study|Lost to Follow-up|1
7175604|NCT02468778|11375779|FG001|Overall Study|Lost to Follow-up|2
7175605|NCT02468778|11375780|FG002|Overall Study|Lost to Follow-up|2
7175606|NCT02468778|11375778|FG000|Overall Study|Withdrawal by Subject|0
7175607|NCT02468778|11375779|FG001|Overall Study|Withdrawal by Subject|1
7175608|NCT02468778|11375780|FG002|Overall Study|Withdrawal by Subject|1
7175609|NCT02435849|11375788|FG000|Overall Study|Enrolled but not infused|18
7175610|NCT02435849|11375788|FG000|Overall Study|Death|16
7175611|NCT02435849|11375788|FG000|Overall Study|Lack of Efficacy|9
7175612|NCT02435849|11375788|FG000|Overall Study|New therapy for study indication|7
7175613|NCT02435849|11375788|FG000|Overall Study|Subject/guardian decision|2
7175614|NCT02435849|11375788|FG000|Overall Study|Study follow-up ongoing|45
7175615|NCT02432274|11375800|FG000|Overall Study|Radiological Disease Progression|3
7175616|NCT02432274|11375801|FG001|Overall Study|Radiological Disease Progression|4
7175617|NCT02432274|11375802|FG002|Overall Study|Radiological Disease Progression|7
7175618|NCT02432274|11375803|FG003|Overall Study|Radiological Disease Progression|0
7175619|NCT02432274|11375804|FG004|Overall Study|Radiological Disease Progression|24
7175620|NCT02432274|11375805|FG005|Overall Study|Radiological Disease Progression|6
7175621|NCT02432274|11375806|FG006|Overall Study|Radiological Disease Progression|11
7175622|NCT02432274|11375807|FG007|Overall Study|Radiological Disease Progression|9
7175623|NCT02432274|11375800|FG000|Overall Study|Clinical Disease Progression|0
7175624|NCT02432274|11375801|FG001|Overall Study|Clinical Disease Progression|4
7175625|NCT02432274|11375802|FG002|Overall Study|Clinical Disease Progression|1
7175626|NCT02432274|11375803|FG003|Overall Study|Clinical Disease Progression|0
7175627|NCT02432274|11375804|FG004|Overall Study|Clinical Disease Progression|1
7175628|NCT02432274|11375805|FG005|Overall Study|Clinical Disease Progression|0
7175629|NCT02432274|11375806|FG006|Overall Study|Clinical Disease Progression|0
7175630|NCT02432274|11375807|FG007|Overall Study|Clinical Disease Progression|1
7175631|NCT02432274|11375800|FG000|Overall Study|Adverse Event|0
7175632|NCT02432274|11375801|FG001|Overall Study|Adverse Event|0
7175633|NCT02432274|11375802|FG002|Overall Study|Adverse Event|1
7175634|NCT02432274|11375803|FG003|Overall Study|Adverse Event|0
7175635|NCT02432274|11375804|FG004|Overall Study|Adverse Event|1
7175636|NCT02432274|11375805|FG005|Overall Study|Adverse Event|0
7175637|NCT02432274|11375806|FG006|Overall Study|Adverse Event|2
7175638|NCT02432274|11375807|FG007|Overall Study|Adverse Event|0
7175639|NCT02432274|11375800|FG000|Overall Study|Withdrawal by Subject|0
7175640|NCT02432274|11375801|FG001|Overall Study|Withdrawal by Subject|0
7175641|NCT02432274|11375802|FG002|Overall Study|Withdrawal by Subject|0
7175642|NCT02432274|11375803|FG003|Overall Study|Withdrawal by Subject|0
7175643|NCT02432274|11375804|FG004|Overall Study|Withdrawal by Subject|2
7175644|NCT02432274|11375805|FG005|Overall Study|Withdrawal by Subject|0
7175645|NCT02432274|11375806|FG006|Overall Study|Withdrawal by Subject|1
7175646|NCT02432274|11375807|FG007|Overall Study|Withdrawal by Subject|2
7175647|NCT02432274|11375800|FG000|Overall Study|Participant Choice|0
7175648|NCT02432274|11375801|FG001|Overall Study|Participant Choice|0
7175649|NCT02432274|11375802|FG002|Overall Study|Participant Choice|1
7175650|NCT02432274|11375803|FG003|Overall Study|Participant Choice|0
7175651|NCT02432274|11375804|FG004|Overall Study|Participant Choice|0
7175652|NCT02432274|11375805|FG005|Overall Study|Participant Choice|0
7175653|NCT02432274|11375806|FG006|Overall Study|Participant Choice|1
7175654|NCT02432274|11375807|FG007|Overall Study|Participant Choice|0
7175655|NCT02432274|11375800|FG000|Overall Study|Other than specified|0
7175656|NCT02432274|11375801|FG001|Overall Study|Other than specified|1
7175657|NCT02432274|11375802|FG002|Overall Study|Other than specified|0
7175658|NCT02432274|11375803|FG003|Overall Study|Other than specified|0
7175659|NCT02432274|11375804|FG004|Overall Study|Other than specified|0
7175660|NCT02432274|11375805|FG005|Overall Study|Other than specified|1
7175661|NCT02432274|11375806|FG006|Overall Study|Other than specified|0
7175662|NCT02432274|11375807|FG007|Overall Study|Other than specified|1
7175663|NCT02432274|11375800|FG000|Overall Study|Ongoing|0
7175664|NCT02432274|11375801|FG001|Overall Study|Ongoing|0
7175665|NCT02432274|11375802|FG002|Overall Study|Ongoing|1
7175666|NCT02432274|11375803|FG003|Overall Study|Ongoing|1
7175667|NCT02432274|11375804|FG004|Overall Study|Ongoing|3
7175668|NCT02432274|11375805|FG005|Overall Study|Ongoing|0
7175669|NCT02432274|11375806|FG006|Overall Study|Ongoing|0
7175670|NCT02432274|11375807|FG007|Overall Study|Ongoing|7
7175671|NCT02399215|11375847|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1
7175672|NCT02399215|11375847|FG000|Overall Study|Withdrawal by Subject|1
7175673|NCT02311478|11375851|FG000|Overall Study|Withdrawal by Subject|1
7175674|NCT02311478|11375851|FG000|Overall Study|Lost to Follow-up|5
7175675|NCT02311478|11375851|FG000|Overall Study|Failed IUD Insertion|1
7175676|NCT02292238|11375858|FG000|Overall Study|Protocol Violation|1
7175677|NCT02292238|11375859|FG001|Overall Study|Protocol Violation|2
7175678|NCT02292238|11375858|FG000|Overall Study|Withdrawal by Subject|2
7175679|NCT02292238|11375859|FG001|Overall Study|Withdrawal by Subject|1
7175680|NCT02292238|11375858|FG000|Overall Study|Lost to Follow-up|1
7175681|NCT02292238|11375859|FG001|Overall Study|Lost to Follow-up|0
7175682|NCT02292238|11375858|FG000|Overall Study|Physician Decision|0
7175683|NCT02292238|11375859|FG001|Overall Study|Physician Decision|1
7175684|NCT02277119|11375878|FG000|Overall Study|Lack of Efficacy|1
7175685|NCT02277119|11375879|FG001|Overall Study|Lack of Efficacy|1
7175686|NCT02277119|11375880|FG002|Overall Study|Lack of Efficacy|1
7175687|NCT02277119|11375878|FG000|Overall Study|Protocol Violation|2
7175688|NCT02277119|11375879|FG001|Overall Study|Protocol Violation|3
7175689|NCT02277119|11375880|FG002|Overall Study|Protocol Violation|7
7175690|NCT02264977|11375888|FG000|Overall Study|Death|3
7175691|NCT02264977|11375888|FG000|Overall Study|Withdrawal by Subject|1
7175692|NCT02264977|11375888|FG000|Overall Study|Physician Decision|1
7175693|NCT02255097|11375892|FG000|Overall Study|Death|151
7175694|NCT02255097|11375892|FG000|Overall Study|Lost to Follow-up|5
7175695|NCT02255097|11375892|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8
7175696|NCT02255097|11375892|FG000|Overall Study|Withdrawal by Subject|7
7175697|NCT02255097|11375892|FG000|Overall Study|Allocated but not treated|1
7175698|NCT02200614|11375903|FG000|Double Blind Treatment|Adverse Event|86
7175699|NCT02200614|11375904|FG001|Double Blind Treatment|Adverse Event|48
7175700|NCT02200614|11375903|FG000|Double Blind Treatment|Confirmed metastasis|120
7175701|NCT02200614|11375904|FG001|Double Blind Treatment|Confirmed metastasis|140
7175702|NCT02200614|11375903|FG000|Double Blind Treatment|Judgment of the investigator|59
7175703|NCT02200614|11375904|FG001|Double Blind Treatment|Judgment of the investigator|99
7175704|NCT02200614|11375903|FG000|Double Blind Treatment|Metastasis by local reading|1
7175705|NCT02200614|11375904|FG001|Double Blind Treatment|Metastasis by local reading|3
7175706|NCT02200614|11375903|FG000|Double Blind Treatment|Other reason|6
7175707|NCT02200614|11375904|FG001|Double Blind Treatment|Other reason|2
7175708|NCT02200614|11375903|FG000|Double Blind Treatment|Personal reason|77
7175709|NCT02200614|11375904|FG001|Double Blind Treatment|Personal reason|85
7175710|NCT02200614|11375903|FG000|Double Blind Treatment|Protocol deviation|14
7175711|NCT02200614|11375904|FG001|Double Blind Treatment|Protocol deviation|7
7175712|NCT02200614|11375903|FG000|Double Blind Treatment|Not treated|1
7175713|NCT02200614|11375904|FG001|Double Blind Treatment|Not treated|0
7175714|NCT02200614|11375903|FG000|Open Label|Adverse Event|41
7175715|NCT02200614|11375904|FG001|Open Label|Adverse Event|11
7175716|NCT02200614|11375903|FG000|Open Label|Confirmed metastasis|1
7175717|NCT02200614|11375904|FG001|Open Label|Confirmed metastasis|0
7175718|NCT02200614|11375903|FG000|Open Label|Judgment of the investigator|29
7175719|NCT02200614|11375904|FG001|Open Label|Judgment of the investigator|2
7175720|NCT02200614|11375903|FG000|Open Label|Metastasis by local reading|138
7175721|NCT02200614|11375904|FG001|Open Label|Metastasis by local reading|27
7175722|NCT02200614|11375903|FG000|Open Label|Other reason|22
7175723|NCT02200614|11375904|FG001|Open Label|Other reason|4
7175724|NCT02200614|11375903|FG000|Open Label|Personal reason|60
7175725|NCT02200614|11375904|FG001|Open Label|Personal reason|8
7175726|NCT02200614|11375903|FG000|Open Label|Protocol deviation|3
7175727|NCT02200614|11375904|FG001|Open Label|Protocol deviation|2
7175728|NCT02200614|11375903|FG000|Open Label|Missing|2
7175729|NCT02200614|11375904|FG001|Open Label|Missing|2
7175730|NCT02108652|11375912|FG000|Overall Study|Death|226
7175731|NCT02108652|11375912|FG000|Overall Study|Lost to Follow-up|2
7175732|NCT02108652|11375912|FG000|Overall Study|Withdrawal by Subject|8
7175733|NCT02108652|11375912|FG000|Overall Study|Ongoing at data cutoff 04 July 2016|74
7175734|NCT02083081|11375918|FG000|Overall Study|Lost to Follow-up|31
7175735|NCT02083081|11375919|FG001|Overall Study|Lost to Follow-up|9
7175736|NCT02069899|11375928|FG000|Overall Study|Adverse Event|6
7175737|NCT02069899|11375929|FG001|Overall Study|Adverse Event|0
7175738|NCT02069899|11375930|FG002|Overall Study|Adverse Event|1
7175739|NCT02069899|11375928|FG000|Overall Study|Withdrawal by Participant|2
6895304|NCT00624286|10913159|FG001|Overall Study|Lost to Follow-up|2
6895305|NCT00624286|10913158|FG000|Overall Study|Administrative problems|3
6895306|NCT00624286|10913159|FG001|Overall Study|Administrative problems|0
6895307|NCT00624286|10913158|FG000|Overall Study|Lack of Efficacy|1
6895308|NCT00624286|10913159|FG001|Overall Study|Lack of Efficacy|6
6895309|NCT00624286|10913158|FG000|Overall Study|Not stated|0
6895310|NCT00624286|10913159|FG001|Overall Study|Not stated|1
6895311|NCT00624286|10913158|FG000|Overall Study|Abnormal test procedure result(s)|0
6895312|NCT00624286|10913159|FG001|Overall Study|Abnormal test procedure result(s)|1
6895313|NCT00624286|10913158|FG000|Overall Study|Death|0
6895314|NCT00624286|10913159|FG001|Overall Study|Death|1
6895315|NCT00624338|10913168|FG000|Overall Study|Adverse Event|14
7175740|NCT02069899|11375929|FG001|Overall Study|Withdrawal by Participant|0
7175741|NCT02069899|11375930|FG002|Overall Study|Withdrawal by Participant|0
7175742|NCT02069899|11375928|FG000|Overall Study|Lost to Follow-up|1
7175743|NCT02069899|11375929|FG001|Overall Study|Lost to Follow-up|0
7175744|NCT02069899|11375930|FG002|Overall Study|Lost to Follow-up|1
7175745|NCT02069899|11375928|FG000|Overall Study|Other|4
7175746|NCT02069899|11375929|FG001|Overall Study|Other|0
7175747|NCT02069899|11375930|FG002|Overall Study|Other|0
7175748|NCT02069899|11375928|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0
7175749|NCT02069899|11375929|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1
7175750|NCT02069899|11375930|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0
7175751|NCT02069899|11375928|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0
7175752|NCT02069899|11375929|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0
7175753|NCT02069899|11375930|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1
7175754|NCT02021812|11375939|FG000|Overall Study|Death|8
7175755|NCT02021812|11375939|FG000|Overall Study|Withdrawal by Subject|3
7175756|NCT02021812|11375939|FG000|Overall Study|Lost to Follow-up|1
7175757|NCT02021812|11375939|FG000|Overall Study|Refuse to return, COVD 19, in hospice, and didn't return for visit|4
7175758|NCT02021812|11375939|FG000|Overall Study|Still in study|6
7175759|NCT02018861|11375953|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0
7175760|NCT02018861|11375954|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2
7175761|NCT02018861|11375955|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1
7175762|NCT02018861|11375956|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6
7175763|NCT02018861|11375957|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4
7175764|NCT02018861|11375958|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1
7175765|NCT02018861|11375959|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0
7175766|NCT02018861|11375960|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0
7175767|NCT02018861|11375961|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0
7175768|NCT02018861|11375962|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0
7175769|NCT02018861|11375953|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0
7175770|NCT02018861|11375954|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0
7175771|NCT02018861|11375955|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0
7175772|NCT02018861|11375956|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1
7041618|NCT01728454|11125218|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0
7041619|NCT01728454|11125219|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0
7041620|NCT01728454|11125217|FG000|Stage 1 and 2|Lost to Follow-up|1
7041621|NCT01728454|11125218|FG001|Stage 1 and 2|Lost to Follow-up|1
7041622|NCT01728454|11125219|FG002|Stage 1 and 2|Lost to Follow-up|0
7041623|NCT01728454|11125217|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2
7041624|NCT01728454|11125218|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3
7041625|NCT01728454|11125219|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3
7041626|NCT01728454|11125217|FG000|Stage 3|Reason Missing|0
7041627|NCT01728454|11125218|FG001|Stage 3|Reason Missing|0
7041628|NCT01728454|11125219|FG002|Stage 3|Reason Missing|1
7041629|NCT01728454|11125217|FG000|Stage 3|Subject Required Other Treatment|0
7041630|NCT01728454|11125218|FG001|Stage 3|Subject Required Other Treatment|1
7041631|NCT01728454|11125219|FG002|Stage 3|Subject Required Other Treatment|0
7041632|NCT01728454|11125217|FG000|Stage 3|Pregnancy|1
7041633|NCT01728454|11125218|FG001|Stage 3|Pregnancy|0
7041634|NCT01728454|11125219|FG002|Stage 3|Pregnancy|0
7041635|NCT01728454|11125217|FG000|Stage 3|Withdrew Consent|1
7041636|NCT01728454|11125218|FG001|Stage 3|Withdrew Consent|0
7041637|NCT01728454|11125219|FG002|Stage 3|Withdrew Consent|1
7041638|NCT01728454|11125217|FG000|Stage 3|Non-compliance with Protocol|0
7041639|NCT01728454|11125218|FG001|Stage 3|Non-compliance with Protocol|0
7175773|NCT02018861|11375957|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1
7175774|NCT02018861|11375958|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0
7175775|NCT02018861|11375959|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0
7080828|NCT02126826|11190524|FG005|Overall Study|Withdrawal by Subject|0
7080829|NCT02126826|11190525|FG006|Overall Study|Withdrawal by Subject|0
7080830|NCT02126839|11190548|FG000|Overall Study|Adverse Event|0
7080831|NCT02126839|11190549|FG001|Overall Study|Adverse Event|1
7080832|NCT02126839|11190548|FG000|Overall Study|Withdrawal by Subject|1
7080833|NCT02126839|11190549|FG001|Overall Study|Withdrawal by Subject|0
7080834|NCT02126839|11190548|FG000|Overall Study|Withdrawal by parent/guardian|1
7080835|NCT02126839|11190549|FG001|Overall Study|Withdrawal by parent/guardian|0
7041640|NCT01728454|11125219|FG002|Stage 3|Non-compliance with Protocol|1
7041641|NCT01728454|11125217|FG000|Stage 3|Lost to Follow-up|0
7041642|NCT01728454|11125218|FG001|Stage 3|Lost to Follow-up|3
7041643|NCT01728454|11125219|FG002|Stage 3|Lost to Follow-up|1
7041644|NCT01728454|11125217|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1
7041645|NCT01728454|11125218|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0
7041646|NCT01728454|11125219|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0
7041647|NCT01728584|11125234|FG000|Overall Study|Adverse Event|1
7041648|NCT01728584|11125235|FG001|Overall Study|Adverse Event|0
7080836|NCT02126839|11190548|FG000|Overall Study|Protocol Violation|2
7080837|NCT02126839|11190549|FG001|Overall Study|Protocol Violation|3
7175776|NCT02018861|11375960|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0
7175777|NCT02018861|11375961|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0
7175778|NCT02018861|11375962|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0
7175779|NCT02018861|11375953|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0
7175780|NCT02018861|11375954|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1
7175781|NCT02018861|11375955|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1
7175782|NCT02018861|11375956|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13
7175783|NCT02018861|11375957|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18
7175784|NCT02018861|11375958|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1
7175785|NCT02018861|11375959|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0
7175786|NCT02018861|11375960|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0
7175787|NCT02018861|11375961|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0
7175788|NCT02018861|11375962|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0
7175789|NCT02018861|11375953|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1
7175790|NCT02018861|11375954|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0
7175791|NCT02018861|11375955|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0
7175792|NCT02018861|11375956|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3
7175793|NCT02018861|11375957|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1
7175794|NCT02018861|11375958|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0
7175795|NCT02018861|11375959|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0
7175796|NCT02018861|11375960|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0
7175797|NCT02018861|11375961|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0
7175798|NCT02018861|11375962|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0
7175799|NCT02018861|11375953|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0
7175800|NCT02018861|11375954|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0
7175801|NCT02018861|11375955|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1
7175802|NCT02018861|11375956|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1
7175803|NCT02018861|11375957|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0
7175804|NCT02018861|11375958|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0
7175805|NCT02018861|11375959|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0
7175806|NCT02018861|11375960|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0
7175807|NCT02018861|11375961|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0
7175808|NCT02018861|11375962|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0
7175809|NCT02018861|11375953|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0
7175810|NCT02018861|11375954|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0
7175811|NCT02018861|11375955|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0
7175812|NCT02018861|11375956|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0
7175813|NCT02018861|11375957|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1
7175814|NCT02018861|11375958|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0
7175815|NCT02018861|11375959|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0
7175816|NCT02018861|11375960|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0
7175817|NCT02018861|11375961|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0
7175818|NCT02018861|11375962|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0
7175819|NCT02018861|11375953|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0
7175820|NCT02018861|11375954|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0
7175821|NCT02018861|11375955|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0
7175822|NCT02018861|11375956|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4
7175823|NCT02018861|11375957|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1
7175824|NCT02018861|11375958|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2
7175825|NCT02018861|11375959|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0
7175826|NCT02018861|11375960|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0
7175827|NCT02018861|11375961|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0
7175828|NCT02018861|11375962|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0
7175829|NCT02018861|11375953|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0
7175830|NCT02018861|11375954|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0
7175831|NCT02018861|11375955|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0
7175832|NCT02018861|11375956|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2
7175833|NCT02018861|11375957|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1
7175834|NCT02018861|11375958|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0
7175835|NCT02018861|11375959|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0
7175836|NCT02018861|11375960|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0
7175837|NCT02018861|11375961|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0
7175838|NCT02018861|11375962|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0
7175839|NCT02018861|11375953|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0
7175840|NCT02018861|11375954|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0
7175841|NCT02018861|11375955|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0
7175842|NCT02018861|11375956|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0
7175843|NCT02018861|11375957|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0
7175844|NCT02018861|11375958|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0
7175845|NCT02018861|11375959|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5
7175846|NCT02018861|11375960|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2
7175847|NCT02018861|11375961|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0
7175848|NCT02018861|11375962|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0
7175849|NCT02018861|11375953|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0
7175850|NCT02018861|11375954|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0
7175851|NCT02018861|11375955|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0
7175852|NCT02018861|11375956|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0
7175853|NCT02018861|11375957|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0
7175854|NCT02018861|11375958|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0
7175855|NCT02018861|11375959|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3
7175856|NCT02018861|11375960|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1
7175857|NCT02018861|11375961|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0
7175858|NCT02018861|11375962|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0
7175859|NCT02018861|11375953|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0
7175860|NCT02018861|11375954|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0
7175861|NCT02018861|11375955|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0
7175862|NCT02018861|11375956|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0
7175863|NCT02018861|11375957|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0
7175864|NCT02018861|11375958|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0
7175865|NCT02018861|11375959|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0
7175866|NCT02018861|11375960|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0
7175867|NCT02018861|11375961|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1
7175868|NCT02018861|11375962|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0
7175869|NCT02018861|11375953|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0
7175870|NCT02018861|11375954|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0
7175871|NCT02018861|11375955|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0
7175872|NCT02018861|11375956|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0
7175873|NCT02018861|11375957|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0
7175874|NCT02018861|11375958|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0
7175875|NCT02018861|11375959|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0
7175876|NCT02018861|11375960|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0
7175877|NCT02018861|11375961|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1
7175878|NCT02018861|11375962|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0
7175879|NCT02018861|11375953|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0
7175880|NCT02018861|11375954|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0
7175881|NCT02018861|11375955|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0
7175882|NCT02018861|11375956|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0
7175883|NCT02018861|11375957|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0
7175884|NCT02018861|11375958|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0
7175885|NCT02018861|11375959|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0
7175886|NCT02018861|11375960|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0
7175887|NCT02018861|11375961|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1
7175888|NCT02018861|11375962|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0
7175889|NCT01772472|11375993|FG000|Overall Study|Death|56
7175890|NCT01772472|11375994|FG001|Overall Study|Death|42
7175891|NCT01772472|11375993|FG000|Overall Study|Physician Decision|1
7175892|NCT01772472|11375994|FG001|Overall Study|Physician Decision|3
7175893|NCT01772472|11375993|FG000|Overall Study|Other|5
7175894|NCT01772472|11375994|FG001|Overall Study|Other|5
7175895|NCT01772472|11375993|FG000|Overall Study|Lost to Follow-up|12
7175896|NCT01772472|11375994|FG001|Overall Study|Lost to Follow-up|8
7175897|NCT01772472|11375993|FG000|Overall Study|Withdrawal by Subject|72
7175898|NCT01772472|11375994|FG001|Overall Study|Withdrawal by Subject|50
7175899|NCT01772472|11375993|FG000|Overall Study|Ongoing|597
7175900|NCT01772472|11375994|FG001|Overall Study|Ongoing|635
7175901|NCT01721759|11376000|FG000|Treatment Period|Disease Progression|85
7175902|NCT01721759|11376000|FG000|Treatment Period|Study drug toxicity|14
7175903|NCT01721759|11376000|FG000|Treatment Period|Death|1
7175904|NCT01721759|11376000|FG000|Treatment Period|Adverse event unrelated to study drug|11
7175905|NCT01721759|11376000|FG000|Treatment Period|Participant request to withdraw|3
7175906|NCT01721759|11376000|FG000|Treatment Period|Other Reasons|3
7175907|NCT01721759|11376000|FG000|End of Study Period|Participant Withdrew Consent|5
7175908|NCT01721759|11376000|FG000|End of Study Period|Death|101
7175909|NCT01721759|11376000|FG000|End of Study Period|Lost to Follow-up|1
7175910|NCT01721759|11376000|FG000|End of Study Period|Other Reasons|10
7175911|NCT01711541|11376009|FG000|Overall Study|Cancel prior to treatment|0
7175912|NCT01711541|11376010|FG001|Overall Study|Cancel prior to treatment|0
7175913|NCT01711541|11376011|FG002|Overall Study|Cancel prior to treatment|0
7175914|NCT01711541|11376012|FG003|Overall Study|Cancel prior to treatment|1
7175915|NCT01711541|11376013|FG004|Overall Study|Cancel prior to treatment|0
7175916|NCT01711541|11376009|FG000|Overall Study|Ineligible|0
7175917|NCT01711541|11376010|FG001|Overall Study|Ineligible|1
7175918|NCT01711541|11376011|FG002|Overall Study|Ineligible|0
7175919|NCT01711541|11376012|FG003|Overall Study|Ineligible|0
7175920|NCT01711541|11376013|FG004|Overall Study|Ineligible|0
7175921|NCT01696994|11376032|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0
7175922|NCT01696994|11376033|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2
7175923|NCT01696994|11376032|FG000|Overall Study|Died Before Randomization|1
7175924|NCT01696994|11376033|FG001|Overall Study|Died Before Randomization|2
7175925|NCT01696994|11376032|FG000|Overall Study|Died Before ASU (Control)|73
7175926|NCT01696994|11376033|FG001|Overall Study|Died Before ASU (Control)|0
7175927|NCT01696994|11376032|FG000|Overall Study|No Ovaries at Baseline|4807
7175928|NCT01696994|11376033|FG001|Overall Study|No Ovaries at Baseline|4851
7175929|NCT01696994|11376032|FG000|Overall Study|Refused ASU (Control)|311
7175930|NCT01696994|11376033|FG001|Overall Study|Refused ASU (Control)|0
7175931|NCT01696994|11376032|FG000|Overall Study|Refused Screen (Ovarian Screening)|0
7175932|NCT01696994|11376033|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582
7175933|NCT01696981|11376043|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0
7175934|NCT01696981|11376044|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20
7175935|NCT01696981|11376043|FG000|Overall Study|Died Before Randomization|3
7175936|NCT01696981|11376044|FG001|Overall Study|Died Before Randomization|8
7175937|NCT01696981|11376043|FG000|Overall Study|Died Before ASU (Control)|278
7175938|NCT01696981|11376044|FG001|Overall Study|Died Before ASU (Control)|0
7175939|NCT01696981|11376043|FG000|Overall Study|Refused ASU (Control)|920
7175940|NCT01696981|11376044|FG001|Overall Study|Refused ASU (Control)|0
7175941|NCT01696981|11376043|FG000|Overall Study|Refused Screen (Colorectal Screening)|0
7175942|NCT01696981|11376044|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346
7175943|NCT01696968|11376052|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0
7175944|NCT01696968|11376053|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8
7175945|NCT01696968|11376052|FG000|Overall Study|Died Before Randomization|3
7175946|NCT01696968|11376053|FG001|Overall Study|Died Before Randomization|8
7175947|NCT01696968|11376052|FG000|Overall Study|Died Before ASU (Control)|278
7175948|NCT01696968|11376053|FG001|Overall Study|Died Before ASU (Control)|0
7175949|NCT01696968|11376052|FG000|Overall Study|Refused ASU (Control)|920
7175950|NCT01696968|11376053|FG001|Overall Study|Refused ASU (Control)|0
7175951|NCT01696968|11376052|FG000|Overall Study|Refused Screen (Lung Screening)|0
7175952|NCT01696968|11376053|FG001|Overall Study|Refused Screen (Lung Screening)|6796
7175953|NCT01553149|11376062|FG000|Overall Study|Adverse Event|0
7175954|NCT01553149|11376063|FG001|Overall Study|Adverse Event|9
7175955|NCT01553149|11376062|FG000|Overall Study|Physician Decision|5
7175956|NCT01553149|11376063|FG001|Overall Study|Physician Decision|10
7175957|NCT01553149|11376062|FG000|Overall Study|Ineligible|0
7175958|NCT01553149|11376063|FG001|Overall Study|Ineligible|1
7175959|NCT01544335|11376069|FG000|Overall Study|Lost to Follow-up|27
7175960|NCT01544335|11376069|FG000|Overall Study|Death|4
7175961|NCT01544335|11376069|FG000|Overall Study|Disease progression|3
7175962|NCT01544335|11376069|FG000|Overall Study|Baseline Measurements not Available|19
7175963|NCT01522976|11376076|FG000|Overall Study|Ineligible|4
7175964|NCT01522976|11376077|FG001|Overall Study|Ineligible|0
7175965|NCT01522976|11376078|FG002|Overall Study|Ineligible|1
7175966|NCT01522976|11376076|FG000|Overall Study|Death|7
7175967|NCT01522976|11376077|FG001|Overall Study|Death|6
7175968|NCT01522976|11376078|FG002|Overall Study|Death|2
7175969|NCT01522976|11376076|FG000|Overall Study|Still on treatment|9
7175970|NCT01522976|11376077|FG001|Overall Study|Still on treatment|9
7175971|NCT01522976|11376078|FG002|Overall Study|Still on treatment|6
7175972|NCT01522976|11376076|FG000|Overall Study|Disease progression|28
7175973|NCT01522976|11376077|FG001|Overall Study|Disease progression|30
7175974|NCT01522976|11376078|FG002|Overall Study|Disease progression|25
7175975|NCT01522976|11376076|FG000|Overall Study|Adverse Event|17
7175976|NCT01522976|11376077|FG001|Overall Study|Adverse Event|7
7175977|NCT01522976|11376078|FG002|Overall Study|Adverse Event|18
7175978|NCT01522976|11376076|FG000|Overall Study|Refusal unrelated to adverse event|10
7175979|NCT01522976|11376077|FG001|Overall Study|Refusal unrelated to adverse event|13
7175980|NCT01522976|11376078|FG002|Overall Study|Refusal unrelated to adverse event|14
7175981|NCT01522976|11376076|FG000|Overall Study|Not protocol specified|22
7175982|NCT01522976|11376077|FG001|Overall Study|Not protocol specified|27
7175983|NCT01522976|11376078|FG002|Overall Study|Not protocol specified|27
7175984|NCT01451515|11376102|FG000|Overall Study|Death|0
7175985|NCT01451515|11376103|FG001|Overall Study|Death|1
7175986|NCT01451515|11376104|FG002|Overall Study|Death|0
7175987|NCT01451515|11376102|FG000|Overall Study|Withdrawal by Subject|0
7175988|NCT01451515|11376103|FG001|Overall Study|Withdrawal by Subject|1
7175989|NCT01451515|11376104|FG002|Overall Study|Withdrawal by Subject|0
7175990|NCT01451515|11376102|FG000|Overall Study|Development of unacceptable toxicity during treatment|0
7175991|NCT01451515|11376103|FG001|Overall Study|Development of unacceptable toxicity during treatment|0
7175992|NCT01451515|11376104|FG002|Overall Study|Development of unacceptable toxicity during treatment|1
7175993|NCT01451515|11376102|FG000|Overall Study|Relapse (except CNS)|1
7175994|NCT01451515|11376103|FG001|Overall Study|Relapse (except CNS)|1
7175995|NCT01451515|11376104|FG002|Overall Study|Relapse (except CNS)|0
7175996|NCT01420926|11376117|FG000|Overall Study|Adverse Event|6
7175997|NCT01420926|11376118|FG001|Overall Study|Adverse Event|4
7175998|NCT01420926|11376117|FG000|Overall Study|Death|18
7175999|NCT01420926|11376118|FG001|Overall Study|Death|17
7176000|NCT01420926|11376117|FG000|Overall Study|Withdrawal by Subject|11
7176001|NCT01420926|11376118|FG001|Overall Study|Withdrawal by Subject|16
7176002|NCT01420926|11376117|FG000|Overall Study|Non-protocol treatment|17
7176003|NCT01420926|11376118|FG001|Overall Study|Non-protocol treatment|20
7176004|NCT01420926|11376117|FG000|Overall Study|Physician Decision|7
7176005|NCT01420926|11376118|FG001|Overall Study|Physician Decision|5
7176006|NCT01420926|11376117|FG000|Overall Study|Continues on active treatment|1
7176007|NCT01420926|11376118|FG001|Overall Study|Continues on active treatment|3
7176008|NCT01386385|11376138|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1
7176009|NCT01386385|11376139|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0
7176010|NCT01386385|11376140|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0
7176011|NCT01386385|11376141|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0
7176012|NCT01386385|11376142|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0
7176013|NCT01386385|11376143|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0
7176014|NCT01386385|11376144|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0
7176015|NCT01386385|11376145|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0
7176016|NCT01386385|11376138|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1
7176017|NCT01386385|11376139|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
7176018|NCT01386385|11376140|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
7176019|NCT01386385|11376141|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
7176020|NCT01386385|11376142|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
7176021|NCT01386385|11376143|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
7176022|NCT01386385|11376144|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
7176023|NCT01386385|11376145|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
7176024|NCT01386385|11376138|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0
7176025|NCT01386385|11376139|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0
7176026|NCT01386385|11376140|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2
7176027|NCT01386385|11376141|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0
7176028|NCT01386385|11376142|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0
7176029|NCT01386385|11376143|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0
7176030|NCT01386385|11376144|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0
7176031|NCT01386385|11376145|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0
7176032|NCT01386385|11376138|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
7080838|NCT02126839|11190548|FG000|Overall Study|Sponsor request|0
7080839|NCT02126839|11190549|FG001|Overall Study|Sponsor request|1
7080840|NCT02126839|11190548|FG000|Overall Study|Lost to Follow-up|1
7080841|NCT02126839|11190549|FG001|Overall Study|Lost to Follow-up|4
7080842|NCT02126839|11190548|FG000|Overall Study|Other|5
7080843|NCT02126839|11190549|FG001|Overall Study|Other|5
7080844|NCT02126969|11190557|FG000|Overall Study|Withdrawal by Subject|1
7080845|NCT02126969|11190558|FG001|Overall Study|Withdrawal by Subject|2
7080846|NCT02127125|11190573|FG000|Overall Study|Lost to Follow-up|0
7080847|NCT02127125|11190574|FG001|Overall Study|Lost to Follow-up|0
7080848|NCT02127125|11190575|FG002|Overall Study|Lost to Follow-up|0
7080849|NCT02127125|11190576|FG003|Overall Study|Lost to Follow-up|0
7080850|NCT02127125|11190577|FG004|Overall Study|Lost to Follow-up|2
7080851|NCT02127125|11190578|FG005|Overall Study|Lost to Follow-up|1
7080852|NCT02127125|11190579|FG006|Overall Study|Lost to Follow-up|0
7080853|NCT02127125|11190580|FG007|Overall Study|Lost to Follow-up|0
7080854|NCT02127125|11190581|FG008|Overall Study|Lost to Follow-up|0
7080855|NCT02127125|11190573|FG000|Overall Study|Withdrawal by Subject|0
7080856|NCT02127125|11190574|FG001|Overall Study|Withdrawal by Subject|0
7080857|NCT02127125|11190575|FG002|Overall Study|Withdrawal by Subject|0
7080858|NCT02127125|11190576|FG003|Overall Study|Withdrawal by Subject|1
7080859|NCT02127125|11190577|FG004|Overall Study|Withdrawal by Subject|0
7080860|NCT02127125|11190578|FG005|Overall Study|Withdrawal by Subject|0
7080861|NCT02127125|11190579|FG006|Overall Study|Withdrawal by Subject|0
7080862|NCT02127125|11190580|FG007|Overall Study|Withdrawal by Subject|0
7080863|NCT02127125|11190581|FG008|Overall Study|Withdrawal by Subject|0
7080864|NCT02127125|11190573|FG000|Overall Study|Physician Decision|0
7080865|NCT02127125|11190574|FG001|Overall Study|Physician Decision|0
7080866|NCT02127125|11190575|FG002|Overall Study|Physician Decision|1
7080867|NCT02127125|11190576|FG003|Overall Study|Physician Decision|0
7080868|NCT02127125|11190577|FG004|Overall Study|Physician Decision|1
7080869|NCT02127125|11190578|FG005|Overall Study|Physician Decision|2
7080870|NCT02127125|11190579|FG006|Overall Study|Physician Decision|0
7080871|NCT02127125|11190580|FG007|Overall Study|Physician Decision|0
7080872|NCT02127125|11190581|FG008|Overall Study|Physician Decision|0
7080873|NCT02127281|11190603|FG000|Overall Study|Lost to Follow-up|1
7080874|NCT02127281|11190604|FG001|Overall Study|Lost to Follow-up|0
7080875|NCT02127307|11190610|FG000|Overall Study|Protocol Violation|36
7080876|NCT02127307|11190610|FG000|Overall Study|Lost to Follow-up|2
7080877|NCT02127307|11190610|FG000|Overall Study|Death|101
7080878|NCT02127307|11190610|FG000|Overall Study|Other than specified above|169
7080879|NCT02127372|11190616|FG000|Overall Study|Withdrawal by Subject|1
7080880|NCT02127372|11190617|FG001|Overall Study|Withdrawal by Subject|0
7080881|NCT02127931|11190678|FG000|Overall Study|Glitch in Game|1
7080882|NCT02127970|11190685|FG000|Overall Study|Adverse Event|2
7080883|NCT02127970|11190686|FG001|Overall Study|Adverse Event|1
7176033|NCT01386385|11376139|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
7080884|NCT02127970|11190685|FG000|Overall Study|Death|1
7080885|NCT02127970|11190686|FG001|Overall Study|Death|1
7080886|NCT02127970|11190685|FG000|Overall Study|Lost to Follow-up|14
7080887|NCT02127970|11190686|FG001|Overall Study|Lost to Follow-up|14
7080888|NCT02127970|11190685|FG000|Overall Study|Reason not Specified|4
7176034|NCT01386385|11376140|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
7176035|NCT01386385|11376141|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
7176036|NCT01386385|11376142|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1
7176037|NCT01386385|11376143|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
7176038|NCT01386385|11376144|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
7176039|NCT01386385|11376145|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
7176040|NCT01386385|11376138|FG000|Phase II Concurrent CRT|Adverse Event|0
7176041|NCT01386385|11376139|FG001|Phase II Concurrent CRT|Adverse Event|0
7176042|NCT01386385|11376140|FG002|Phase II Concurrent CRT|Adverse Event|0
7176043|NCT01386385|11376141|FG003|Phase II Concurrent CRT|Adverse Event|0
7176044|NCT01386385|11376142|FG004|Phase II Concurrent CRT|Adverse Event|0
7176045|NCT01386385|11376143|FG005|Phase II Concurrent CRT|Adverse Event|0
7176046|NCT01386385|11376144|FG006|Phase II Concurrent CRT|Adverse Event|3
7176047|NCT01386385|11376145|FG007|Phase II Concurrent CRT|Adverse Event|3
7176048|NCT01386385|11376138|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0
7176049|NCT01386385|11376139|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0
7176050|NCT01386385|11376140|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0
7176051|NCT01386385|11376141|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0
7176052|NCT01386385|11376142|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0
7176053|NCT01386385|11376143|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0
7176054|NCT01386385|11376144|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3
7176055|NCT01386385|11376145|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0
7176056|NCT01386385|11376138|FG000|Phase II: Consolidation Therapy|Adverse Event|0
7176057|NCT01386385|11376139|FG001|Phase II: Consolidation Therapy|Adverse Event|0
7176058|NCT01386385|11376140|FG002|Phase II: Consolidation Therapy|Adverse Event|0
7176059|NCT01386385|11376141|FG003|Phase II: Consolidation Therapy|Adverse Event|0
7176060|NCT01386385|11376142|FG004|Phase II: Consolidation Therapy|Adverse Event|0
7176061|NCT01386385|11376143|FG005|Phase II: Consolidation Therapy|Adverse Event|0
7176062|NCT01386385|11376144|FG006|Phase II: Consolidation Therapy|Adverse Event|2
7176063|NCT01386385|11376145|FG007|Phase II: Consolidation Therapy|Adverse Event|1
7176064|NCT01386385|11376138|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
7176065|NCT01386385|11376139|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
7176066|NCT01386385|11376140|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
7176067|NCT01386385|11376141|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
7176068|NCT01386385|11376142|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
7176069|NCT01386385|11376143|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
7176070|NCT01386385|11376144|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2
7176071|NCT01386385|11376145|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
7176072|NCT01386385|11376138|FG000|Phase II: Consolidation Therapy|Progression/relapse|0
7176073|NCT01386385|11376139|FG001|Phase II: Consolidation Therapy|Progression/relapse|0
7176074|NCT01386385|11376140|FG002|Phase II: Consolidation Therapy|Progression/relapse|0
7176075|NCT01386385|11376141|FG003|Phase II: Consolidation Therapy|Progression/relapse|0
6973181|NCT01178086|11024734|FG000|Overall Study|Excluded from EAS|20
6973182|NCT01178099|11024744|FG000|Overall Study|Physician Decision|0
6973183|NCT01178099|11024745|FG001|Overall Study|Physician Decision|1
6895316|NCT00624338|10913169|FG001|Overall Study|Adverse Event|14
6895317|NCT00624338|10913170|FG002|Overall Study|Adverse Event|18
6895318|NCT00624338|10913168|FG000|Overall Study|Lost to Follow-up|1
6895319|NCT00624338|10913169|FG001|Overall Study|Lost to Follow-up|0
6895320|NCT00624338|10913170|FG002|Overall Study|Lost to Follow-up|0
6895321|NCT00624338|10913168|FG000|Overall Study|Lack of Efficacy|11
6895322|NCT00624338|10913169|FG001|Overall Study|Lack of Efficacy|3
7176076|NCT01386385|11376142|FG004|Phase II: Consolidation Therapy|Progression/relapse|0
7176077|NCT01386385|11376143|FG005|Phase II: Consolidation Therapy|Progression/relapse|0
7176078|NCT01386385|11376144|FG006|Phase II: Consolidation Therapy|Progression/relapse|1
7176079|NCT01386385|11376145|FG007|Phase II: Consolidation Therapy|Progression/relapse|1
7176080|NCT01371981|11376172|FG000|Overall Study|Adverse Event|12
7176081|NCT01371981|11376173|FG001|Overall Study|Adverse Event|17
7176082|NCT01371981|11376174|FG002|Overall Study|Adverse Event|0
7176083|NCT01371981|11376175|FG003|Overall Study|Adverse Event|4
7176084|NCT01371981|11376176|FG004|Overall Study|Adverse Event|1
7176085|NCT01371981|11376177|FG005|Overall Study|Adverse Event|0
7176086|NCT01371981|11376172|FG000|Overall Study|Death|22
7176087|NCT01371981|11376173|FG001|Overall Study|Death|16
7176088|NCT01371981|11376174|FG002|Overall Study|Death|0
7176089|NCT01371981|11376175|FG003|Overall Study|Death|0
7176090|NCT01371981|11376176|FG004|Overall Study|Death|2
7176091|NCT01371981|11376177|FG005|Overall Study|Death|2
7176092|NCT01371981|11376172|FG000|Overall Study|Lack of Efficacy|69
7176093|NCT01371981|11376173|FG001|Overall Study|Lack of Efficacy|61
7176094|NCT01371981|11376174|FG002|Overall Study|Lack of Efficacy|4
7176095|NCT01371981|11376175|FG003|Overall Study|Lack of Efficacy|8
7176096|NCT01371981|11376176|FG004|Overall Study|Lack of Efficacy|5
6895323|NCT00624338|10913170|FG002|Overall Study|Lack of Efficacy|14
6895324|NCT00624338|10913168|FG000|Overall Study|Protocol Violation|3
7176097|NCT01371981|11376177|FG005|Overall Study|Lack of Efficacy|0
6895325|NCT00624338|10913169|FG001|Overall Study|Protocol Violation|3
6895326|NCT00624338|10913170|FG002|Overall Study|Protocol Violation|2
6973184|NCT01178125|11024755|FG000|Overall Study|Lost to Follow-up|397
7176098|NCT01371981|11376172|FG000|Overall Study|Physician Decision|48
7176099|NCT01371981|11376173|FG001|Overall Study|Physician Decision|63
7176100|NCT01371981|11376174|FG002|Overall Study|Physician Decision|1
7176101|NCT01371981|11376175|FG003|Overall Study|Physician Decision|7
7176102|NCT01371981|11376176|FG004|Overall Study|Physician Decision|14
7176103|NCT01371981|11376177|FG005|Overall Study|Physician Decision|3
7176104|NCT01371981|11376172|FG000|Overall Study|Withdrawal by Subject|12
7176105|NCT01371981|11376173|FG001|Overall Study|Withdrawal by Subject|19
7176106|NCT01371981|11376174|FG002|Overall Study|Withdrawal by Subject|1
7176107|NCT01371981|11376175|FG003|Overall Study|Withdrawal by Subject|2
7176108|NCT01371981|11376176|FG004|Overall Study|Withdrawal by Subject|10
7176109|NCT01371981|11376177|FG005|Overall Study|Withdrawal by Subject|3
7176110|NCT01371981|11376172|FG000|Overall Study|Ineligible|19
7176111|NCT01371981|11376173|FG001|Overall Study|Ineligible|13
7176112|NCT01371981|11376174|FG002|Overall Study|Ineligible|0
7176113|NCT01371981|11376175|FG003|Overall Study|Ineligible|0
7176114|NCT01371981|11376176|FG004|Overall Study|Ineligible|0
7176115|NCT01371981|11376177|FG005|Overall Study|Ineligible|4
7176116|NCT01371981|11376172|FG000|Overall Study|Did not start treatment|2
7176117|NCT01371981|11376173|FG001|Overall Study|Did not start treatment|3
7176118|NCT01371981|11376174|FG002|Overall Study|Did not start treatment|0
7176119|NCT01371981|11376175|FG003|Overall Study|Did not start treatment|0
7176120|NCT01371981|11376176|FG004|Overall Study|Did not start treatment|0
7176121|NCT01371981|11376177|FG005|Overall Study|Did not start treatment|2
7176122|NCT01302834|11376198|FG000|Overall Study|Protocol Violation|17
7176123|NCT01302834|11376199|FG001|Overall Study|Protocol Violation|23
7176124|NCT01302834|11376198|FG000|Overall Study|HIV positive|1
7176125|NCT01302834|11376199|FG001|Overall Study|HIV positive|3
7176126|NCT01286272|11376207|FG000|Overall Study|Ineligible after beginning treatment|1
7176127|NCT01286272|11376208|FG001|Overall Study|Ineligible after beginning treatment|3
7176128|NCT01267955|11376223|FG000|Stage 1 (6 Months)|Death|3
7176129|NCT01267955|11376223|FG000|Stage 2 (6 Months)|Death|5
7176130|NCT01267955|11376223|FG000|Stage 2 (6 Months)|Protocol Violation|1
7176131|NCT01238211|11376232|FG000|Overall Study|Continues active treatment|31
7176132|NCT01238211|11376232|FG000|Overall Study|Adverse Event|7
7176133|NCT01238211|11376232|FG000|Overall Study|Death|4
7176134|NCT01238211|11376232|FG000|Overall Study|Relapse/Progression|2
7176135|NCT01238211|11376232|FG000|Overall Study|Withdrawal by Subject|7
7176136|NCT01238211|11376232|FG000|Overall Study|Non-protocol treatment|4
7176137|NCT01238211|11376232|FG000|Overall Study|Investigator/Patient Decision|3
7176138|NCT01177540|11376238|FG000|Overall Study|Adverse Event|1
7176139|NCT01177540|11376239|FG001|Overall Study|Adverse Event|0
7176140|NCT01038778|11376247|FG000|Overall Study|Withdrawal by Subject|0
7176141|NCT01038778|11376248|FG001|Overall Study|Withdrawal by Subject|2
7176142|NCT01038778|11376249|FG002|Overall Study|Withdrawal by Subject|3
7176143|NCT00980538|11376256|FG000|Overall Study|Lost to Follow-up|20
7176144|NCT00980538|11376256|FG000|Overall Study|Sponsor's Decision|4
7176145|NCT00980538|11376256|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34
7176146|NCT00980538|11376256|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12
7176147|NCT00980538|11376256|FG000|Overall Study|Switch to Commercially Available Medication|25
7176148|NCT00980538|11376256|FG000|Overall Study|Participant Non-Compliant|9
7176149|NCT00980538|11376256|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9
7176150|NCT00980538|11376256|FG000|Overall Study|Participant Ineligible to Continue the Trial|6
7176151|NCT00980538|11376256|FG000|Overall Study|Other|60
7176152|NCT00980538|11376256|FG000|Overall Study|Other|1
7176153|NCT00980460|11376265|FG000|Overall Study|Death|0
7176154|NCT00980460|11376266|FG001|Overall Study|Death|0
7176155|NCT00980460|11376267|FG002|Overall Study|Death|1
7176156|NCT00980460|11376268|FG003|Overall Study|Death|2
7176157|NCT00980460|11376269|FG004|Overall Study|Death|1
7176158|NCT00980460|11376265|FG000|Overall Study|Lack of Efficacy|0
7176159|NCT00980460|11376266|FG001|Overall Study|Lack of Efficacy|0
7176160|NCT00980460|11376267|FG002|Overall Study|Lack of Efficacy|10
7176161|NCT00980460|11376268|FG003|Overall Study|Lack of Efficacy|6
7176162|NCT00980460|11376269|FG004|Overall Study|Lack of Efficacy|8
7176163|NCT00980460|11376265|FG000|Overall Study|Lost to Follow-up|0
7176164|NCT00980460|11376266|FG001|Overall Study|Lost to Follow-up|0
7176165|NCT00980460|11376267|FG002|Overall Study|Lost to Follow-up|0
7176166|NCT00980460|11376268|FG003|Overall Study|Lost to Follow-up|1
7176167|NCT00980460|11376269|FG004|Overall Study|Lost to Follow-up|0
7176168|NCT00980460|11376265|FG000|Overall Study|Physician Decision|0
7176169|NCT00980460|11376266|FG001|Overall Study|Physician Decision|0
7176170|NCT00980460|11376267|FG002|Overall Study|Physician Decision|11
7176171|NCT00980460|11376268|FG003|Overall Study|Physician Decision|5
7176172|NCT00980460|11376269|FG004|Overall Study|Physician Decision|3
7176173|NCT00980460|11376265|FG000|Overall Study|Withdrawal by Subject|0
7176174|NCT00980460|11376266|FG001|Overall Study|Withdrawal by Subject|0
7176175|NCT00980460|11376267|FG002|Overall Study|Withdrawal by Subject|1
7176176|NCT00980460|11376268|FG003|Overall Study|Withdrawal by Subject|0
7176177|NCT00980460|11376269|FG004|Overall Study|Withdrawal by Subject|0
7176178|NCT00980460|11376265|FG000|Overall Study|Ineligible|0
7176179|NCT00980460|11376266|FG001|Overall Study|Ineligible|2
7176180|NCT00980460|11376267|FG002|Overall Study|Ineligible|3
7176181|NCT00980460|11376268|FG003|Overall Study|Ineligible|1
7176182|NCT00980460|11376269|FG004|Overall Study|Ineligible|4
7176183|NCT00980460|11376265|FG000|Overall Study|Refusal of further therapy|0
7176184|NCT00980460|11376266|FG001|Overall Study|Refusal of further therapy|2
7176185|NCT00980460|11376267|FG002|Overall Study|Refusal of further therapy|3
7176186|NCT00980460|11376268|FG003|Overall Study|Refusal of further therapy|2
7176187|NCT00980460|11376269|FG004|Overall Study|Refusal of further therapy|0
7176188|NCT00980460|11376265|FG000|Overall Study|No therapy within 42 days of resection|0
7176189|NCT00980460|11376266|FG001|Overall Study|No therapy within 42 days of resection|0
7176190|NCT00980460|11376267|FG002|Overall Study|No therapy within 42 days of resection|3
7176191|NCT00980460|11376268|FG003|Overall Study|No therapy within 42 days of resection|1
7176192|NCT00980460|11376269|FG004|Overall Study|No therapy within 42 days of resection|0
7176193|NCT00980460|11376265|FG000|Overall Study|No transplant by protocol timepoints|0
7176194|NCT00980460|11376266|FG001|Overall Study|No transplant by protocol timepoints|0
7176195|NCT00980460|11376267|FG002|Overall Study|No transplant by protocol timepoints|3
7176196|NCT00980460|11376268|FG003|Overall Study|No transplant by protocol timepoints|0
7176197|NCT00980460|11376269|FG004|Overall Study|No transplant by protocol timepoints|0
7176198|NCT00972478|11376290|FG000|Overall Study|Adverse Event|3
7176199|NCT00972478|11376291|FG001|Overall Study|Adverse Event|16
7176200|NCT00972478|11376290|FG000|Overall Study|Withdrawal by Subject|1
7176201|NCT00972478|11376291|FG001|Overall Study|Withdrawal by Subject|8
7176202|NCT00972478|11376290|FG000|Overall Study|Progression/Relapse|0
7176203|NCT00972478|11376291|FG001|Overall Study|Progression/Relapse|2
7176204|NCT00972478|11376290|FG000|Overall Study|Death|0
7176205|NCT00972478|11376291|FG001|Overall Study|Death|2
7176206|NCT00972478|11376290|FG000|Overall Study|Not protocol specified|1
7176207|NCT00972478|11376291|FG001|Overall Study|Not protocol specified|1
7176208|NCT00972478|11376290|FG000|Overall Study|Ineligible|1
7176209|NCT00972478|11376291|FG001|Overall Study|Ineligible|7
7176210|NCT00972478|11376290|FG000|Overall Study|Not start protocol treatment|1
7176211|NCT00972478|11376291|FG001|Overall Study|Not start protocol treatment|2
7176212|NCT00792259|11376301|FG000|Overall Study|Poor Quality Scans|1
7176213|NCT00792259|11376302|FG001|Overall Study|Poor Quality Scans|0
7176214|NCT00792259|11376303|FG002|Overall Study|Poor Quality Scans|0
7176215|NCT00662792|11376311|FG000|Period 1|Personal Reasons|0
7176216|NCT00662792|11376312|FG001|Period 1|Personal Reasons|0
7176217|NCT00662792|11376313|FG002|Period 1|Personal Reasons|1
7176218|NCT00662792|11376314|FG003|Period 1|Personal Reasons|0
7176219|NCT00662792|11376311|FG000|Period 1|Refused continuing medication|0
7176220|NCT00662792|11376312|FG001|Period 1|Refused continuing medication|1
7176221|NCT00662792|11376313|FG002|Period 1|Refused continuing medication|1
7176222|NCT00662792|11376314|FG003|Period 1|Refused continuing medication|0
7176223|NCT00662792|11376311|FG000|Period 1|Lost to Follow-up|1
7176224|NCT00662792|11376312|FG001|Period 1|Lost to Follow-up|0
7176225|NCT00662792|11376313|FG002|Period 1|Lost to Follow-up|0
7176226|NCT00662792|11376314|FG003|Period 1|Lost to Follow-up|0
7176227|NCT00662792|11376311|FG000|Period 1|Other adverse event (AE)|0
7176228|NCT00662792|11376312|FG001|Period 1|Other adverse event (AE)|2
7176229|NCT00662792|11376313|FG002|Period 1|Other adverse event (AE)|0
7176230|NCT00662792|11376314|FG003|Period 1|Other adverse event (AE)|0
7176231|NCT00662792|11376311|FG000|Period 1|Worsening of disease under study (AE)|1
7176232|NCT00662792|11376312|FG001|Period 1|Worsening of disease under study (AE)|3
7176233|NCT00662792|11376313|FG002|Period 1|Worsening of disease under study (AE)|2
7176234|NCT00662792|11376314|FG003|Period 1|Worsening of disease under study (AE)|0
7176235|NCT00662792|11376311|FG000|Period 1|Not treated|0
7176236|NCT00662792|11376312|FG001|Period 1|Not treated|1
7176237|NCT00662792|11376313|FG002|Period 1|Not treated|0
7176238|NCT00662792|11376314|FG003|Period 1|Not treated|0
7176239|NCT00662792|11376311|FG000|Period 2|Worsening of disease under study|1
7176240|NCT00662792|11376312|FG001|Period 2|Worsening of disease under study|0
7176241|NCT00662792|11376313|FG002|Period 2|Worsening of disease under study|0
7176242|NCT00662792|11376314|FG003|Period 2|Worsening of disease under study|3
7176243|NCT00662792|11376311|FG000|Period 3|Refused continuing medication|1
7176244|NCT00662792|11376312|FG001|Period 3|Refused continuing medication|0
7176245|NCT00662792|11376313|FG002|Period 3|Refused continuing medication|1
7176246|NCT00662792|11376314|FG003|Period 3|Refused continuing medication|0
7176247|NCT00662792|11376311|FG000|Period 3|Other adverse event (AE)|0
7176248|NCT00662792|11376312|FG001|Period 3|Other adverse event (AE)|0
7176249|NCT00662792|11376313|FG002|Period 3|Other adverse event (AE)|1
7176250|NCT00662792|11376314|FG003|Period 3|Other adverse event (AE)|1
7176251|NCT00662792|11376311|FG000|Period 4|Refused continuing medication|0
7176252|NCT00662792|11376312|FG001|Period 4|Refused continuing medication|1
7176253|NCT00662792|11376313|FG002|Period 4|Refused continuing medication|0
7176254|NCT00662792|11376314|FG003|Period 4|Refused continuing medication|0
7176255|NCT00662792|11376311|FG000|Period 4|Other adverse event (AE)|1
7176256|NCT00662792|11376312|FG001|Period 4|Other adverse event (AE)|0
7176257|NCT00662792|11376313|FG002|Period 4|Other adverse event (AE)|0
7176258|NCT00662792|11376314|FG003|Period 4|Other adverse event (AE)|0
7176259|NCT00662792|11376311|FG000|Period 4|Worsening of disease under study (AE)|0
7176260|NCT00662792|11376312|FG001|Period 4|Worsening of disease under study (AE)|0
7176261|NCT00662792|11376313|FG002|Period 4|Worsening of disease under study (AE)|0
7176262|NCT00662792|11376314|FG003|Period 4|Worsening of disease under study (AE)|1
7176263|NCT00593840|11376349|FG000|Overall Study|Withdrawal by Subject|1
7176264|NCT00567580|11376356|FG000|Overall Study|Protocol Violation|28
7176265|NCT00567580|11376357|FG001|Overall Study|Protocol Violation|24
7176266|NCT00567580|11376358|FG002|Overall Study|Protocol Violation|24
7176267|NCT00528021|11376373|FG000|Overall Study|Lack of Efficacy|17
7176268|NCT00528021|11376374|FG001|Overall Study|Lack of Efficacy|13
7176269|NCT00528021|11376375|FG002|Overall Study|Lack of Efficacy|7
7176270|NCT00528021|11376376|FG003|Overall Study|Lack of Efficacy|9
7176271|NCT00381641|11376413|FG000|Overall Study|Withdrawal by Subject|0
7176272|NCT00381641|11376414|FG001|Overall Study|Withdrawal by Subject|2
7176273|NCT00026312|11376433|FG000|Overall Study|Adverse Event|0
7176274|NCT00026312|11376434|FG001|Overall Study|Adverse Event|32
7176275|NCT00026312|11376433|FG000|Overall Study|Death|1
7176276|NCT00026312|11376434|FG001|Overall Study|Death|7
7176277|NCT00026312|11376433|FG000|Overall Study|Lack of Efficacy|19
7176278|NCT00026312|11376434|FG001|Overall Study|Lack of Efficacy|114
7176279|NCT00026312|11376433|FG000|Overall Study|Lost to Follow-up|0
7176280|NCT00026312|11376434|FG001|Overall Study|Lost to Follow-up|5
7176281|NCT00026312|11376433|FG000|Overall Study|Physician Decision|1
7176282|NCT00026312|11376434|FG001|Overall Study|Physician Decision|37
7176283|NCT00026312|11376433|FG000|Overall Study|Protocol Violation|0
7176284|NCT00026312|11376434|FG001|Overall Study|Protocol Violation|3
7176285|NCT00026312|11376433|FG000|Overall Study|Withdrawal by Subject|1
7176286|NCT00026312|11376434|FG001|Overall Study|Withdrawal by Subject|6
7176287|NCT00026312|11376433|FG000|Overall Study|Ineligible|4
7176288|NCT00026312|11376434|FG001|Overall Study|Ineligible|5
7176289|NCT00026312|11376433|FG000|Overall Study|Entry onto another COG study|0
7176290|NCT00026312|11376434|FG001|Overall Study|Entry onto another COG study|1
7176291|NCT00026312|11376433|FG000|Overall Study|Refusal by patient/parent/guardian|8
7176292|NCT00026312|11376434|FG001|Overall Study|Refusal by patient/parent/guardian|59
7176293|NCT00006436|11376444|FG000|Overall Study|Refused further treatment|2
7176294|NCT00006436|11376444|FG000|Overall Study|Declined to participate (before treatment started)|1
7176295|NCT00002540|11376453|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0
7176296|NCT00002540|11376454|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25
7176297|NCT00002540|11376453|FG000|Overall Study|Died Before Randomization|2
7176298|NCT00002540|11376454|FG001|Overall Study|Died Before Randomization|6
7176299|NCT00002540|11376453|FG000|Overall Study|Died Before ASU (Control)|202
7176300|NCT00002540|11376454|FG001|Overall Study|Died Before ASU (Control)|0
7176301|NCT00002540|11376453|FG000|Overall Study|Refused ASU (Control)|597
7176302|NCT00002540|11376454|FG001|Overall Study|Refused ASU (Control)|0
7176303|NCT00002540|11376453|FG000|Overall Study|Refused Screen (Prostate Screening)|0
7176304|NCT00002540|11376454|FG001|Overall Study|Refused Screen (Prostate Screening)|2433
7186031|NCT02915016|11386375|FG004|Overall Study|Physician Decision|0
7186032|NCT02915016|11386376|FG005|Overall Study|Physician Decision|1
7186033|NCT02915016|11386377|FG006|Overall Study|Physician Decision|2
7186034|NCT02915016|11386378|FG007|Overall Study|Physician Decision|0
7186035|NCT02915016|11386371|FG000|Overall Study|Withdrawal by Subject|2
7186036|NCT02915016|11386372|FG001|Overall Study|Withdrawal by Subject|0
7186037|NCT02915016|11386373|FG002|Overall Study|Withdrawal by Subject|1
7186038|NCT02915016|11386374|FG003|Overall Study|Withdrawal by Subject|0
7186039|NCT02915016|11386375|FG004|Overall Study|Withdrawal by Subject|1
7186040|NCT02915016|11386376|FG005|Overall Study|Withdrawal by Subject|3
7186041|NCT02915016|11386377|FG006|Overall Study|Withdrawal by Subject|1
7186042|NCT02915016|11386378|FG007|Overall Study|Withdrawal by Subject|1
7186043|NCT02915016|11386371|FG000|Overall Study|Elected not to continue|0
7186044|NCT02915016|11386372|FG001|Overall Study|Elected not to continue|0
7186045|NCT02915016|11386373|FG002|Overall Study|Elected not to continue|0
7186046|NCT02915016|11386374|FG003|Overall Study|Elected not to continue|1
7186047|NCT02915016|11386375|FG004|Overall Study|Elected not to continue|0
7186048|NCT02915016|11386376|FG005|Overall Study|Elected not to continue|0
7186049|NCT02915016|11386377|FG006|Overall Study|Elected not to continue|1
7186050|NCT02915016|11386378|FG007|Overall Study|Elected not to continue|0
7186051|NCT02915016|11386371|FG000|Overall Study|HIV infection|1
7186052|NCT02915016|11386372|FG001|Overall Study|HIV infection|1
7186053|NCT02915016|11386373|FG002|Overall Study|HIV infection|1
7186054|NCT02915016|11386374|FG003|Overall Study|HIV infection|0
7186055|NCT02915016|11386375|FG004|Overall Study|HIV infection|1
7186056|NCT02915016|11386376|FG005|Overall Study|HIV infection|0
7186057|NCT02915016|11386377|FG006|Overall Study|HIV infection|0
7186058|NCT02915016|11386378|FG007|Overall Study|HIV infection|0
7186059|NCT02915016|11386371|FG000|Overall Study|Participant unable to adhere|0
7186060|NCT02915016|11386372|FG001|Overall Study|Participant unable to adhere|0
7186061|NCT02915016|11386373|FG002|Overall Study|Participant unable to adhere|0
7186062|NCT02915016|11386374|FG003|Overall Study|Participant unable to adhere|0
7186063|NCT02915016|11386375|FG004|Overall Study|Participant unable to adhere|0
7186064|NCT02915016|11386376|FG005|Overall Study|Participant unable to adhere|0
7186065|NCT02915016|11386377|FG006|Overall Study|Participant unable to adhere|0
7186066|NCT02915016|11386378|FG007|Overall Study|Participant unable to adhere|1
7186067|NCT02871401|11386398|FG000|Overall Study|Adverse Event|1
7186068|NCT02871401|11386399|FG001|Overall Study|Adverse Event|0
7186069|NCT02701283|11386417|FG000|Overall Study|Death|25
7186070|NCT02701283|11386418|FG001|Overall Study|Death|29
7186071|NCT02701283|11386419|FG002|Overall Study|Death|19
7186072|NCT02701283|11386417|FG000|Overall Study|Lost to Follow-up|3
7186073|NCT02701283|11386418|FG001|Overall Study|Lost to Follow-up|8
7176305|NCT00788671|11376460|FG000|Overall Study|Death|2
7176306|NCT00788671|11376460|FG000|Overall Study|Unable to biopsy|1
7176307|NCT00788671|11376460|FG000|Overall Study|Withdrawal by Subject|4
7176308|NCT00788671|11376460|FG000|Overall Study|IUD expulsed|1
7176309|NCT00788671|11376460|FG000|Overall Study|Lost to follow up|2
7176310|NCT00799266|11376466|FG000|Overall Study|Adverse Event|0
7176311|NCT00799266|11376467|FG001|Overall Study|Adverse Event|1
7176312|NCT00799266|11376466|FG000|Overall Study|Subject withdrew consent|3
7176313|NCT00799266|11376467|FG001|Overall Study|Subject withdrew consent|0
7176314|NCT00844480|11376479|FG000|Overall Study|Withdrawal by Subject|2
7176315|NCT00844480|11376480|FG001|Overall Study|Withdrawal by Subject|3
7176316|NCT00873366|11376490|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1
7176317|NCT00873366|11376490|FG000|Overall Study|Off tamoxifen due to side effects|2
7176318|NCT00873366|11376490|FG000|Overall Study|Refused to continue DM-BT testing|3
7176319|NCT00930722|11376526|FG000|Overall Study|Lost to Follow-up|16
7176320|NCT00930722|11376526|FG000|Overall Study|No longer willing to participate|9
7176321|NCT00930722|11376526|FG000|Overall Study|Study terminated by sponsor|2
7176322|NCT00940498|11376538|FG000|Overall Study|Death|2
7176323|NCT00940498|11376539|FG001|Overall Study|Death|0
7176324|NCT00940498|11376540|FG002|Overall Study|Death|0
7176325|NCT00940498|11376541|FG003|Overall Study|Death|1
7176326|NCT00940498|11376542|FG004|Overall Study|Death|5
7176327|NCT00940498|11376543|FG005|Overall Study|Death|0
7176328|NCT00940498|11376544|FG006|Overall Study|Death|1
7176329|NCT00940498|11376545|FG007|Overall Study|Death|0
7176330|NCT00940498|11376538|FG000|Overall Study|Lost to Follow-up|1
7176331|NCT00940498|11376539|FG001|Overall Study|Lost to Follow-up|1
7176332|NCT00940498|11376540|FG002|Overall Study|Lost to Follow-up|2
7176333|NCT00940498|11376541|FG003|Overall Study|Lost to Follow-up|0
7176334|NCT00940498|11376542|FG004|Overall Study|Lost to Follow-up|1
7176335|NCT00940498|11376543|FG005|Overall Study|Lost to Follow-up|0
7176336|NCT00940498|11376544|FG006|Overall Study|Lost to Follow-up|0
7176337|NCT00940498|11376545|FG007|Overall Study|Lost to Follow-up|1
7176338|NCT00940498|11376538|FG000|Overall Study|Disease Progression|0
7176339|NCT00940498|11376539|FG001|Overall Study|Disease Progression|0
7176340|NCT00940498|11376540|FG002|Overall Study|Disease Progression|1
7176341|NCT00940498|11376541|FG003|Overall Study|Disease Progression|1
7176342|NCT00940498|11376542|FG004|Overall Study|Disease Progression|0
7176343|NCT00940498|11376543|FG005|Overall Study|Disease Progression|1
7176344|NCT00940498|11376544|FG006|Overall Study|Disease Progression|0
7176345|NCT00940498|11376545|FG007|Overall Study|Disease Progression|0
7176346|NCT00940498|11376538|FG000|Overall Study|Physician Decision|0
7176347|NCT00940498|11376539|FG001|Overall Study|Physician Decision|0
7176348|NCT00940498|11376540|FG002|Overall Study|Physician Decision|0
7176349|NCT00940498|11376541|FG003|Overall Study|Physician Decision|0
7176350|NCT00940498|11376542|FG004|Overall Study|Physician Decision|2
7176351|NCT00940498|11376543|FG005|Overall Study|Physician Decision|0
7176352|NCT00940498|11376544|FG006|Overall Study|Physician Decision|0
7176353|NCT00940498|11376545|FG007|Overall Study|Physician Decision|0
7176354|NCT00940498|11376538|FG000|Overall Study|Not treated due to disease related pain|0
7176355|NCT00940498|11376539|FG001|Overall Study|Not treated due to disease related pain|0
7176356|NCT00940498|11376540|FG002|Overall Study|Not treated due to disease related pain|0
7176357|NCT00940498|11376541|FG003|Overall Study|Not treated due to disease related pain|0
7176358|NCT00940498|11376542|FG004|Overall Study|Not treated due to disease related pain|1
7176359|NCT00940498|11376543|FG005|Overall Study|Not treated due to disease related pain|0
7176360|NCT00940498|11376544|FG006|Overall Study|Not treated due to disease related pain|0
7176361|NCT00940498|11376545|FG007|Overall Study|Not treated due to disease related pain|0
7176362|NCT04553913|11376578|FG000|Overall Study|patient's block resolved prior to PACU|1
7176363|NCT04553913|11376578|FG000|Overall Study|did not use the device properly|5
7176364|NCT04009824|11376593|FG000|Overall Study|COVID-19 pandemic restriction/closure|2
7176365|NCT04009824|11376594|FG001|Overall Study|COVID-19 pandemic restriction/closure|3
7176366|NCT04009824|11376595|FG002|Overall Study|COVID-19 pandemic restriction/closure|5
7176367|NCT04009824|11376596|FG003|Overall Study|COVID-19 pandemic restriction/closure|2
7176368|NCT04009824|11376597|FG004|Overall Study|COVID-19 pandemic restriction/closure|3
7176369|NCT03449758|11376619|FG000|Overall Study|Major protocol deviation|1
7176370|NCT03449758|11376619|FG000|Overall Study|Treatment inefficacy|5
7176371|NCT03449758|11376619|FG000|Overall Study|Adverse Event|9
7176372|NCT03449758|11376619|FG000|Overall Study|Consent withdrawal|1
7176373|NCT03449758|11376619|FG000|Overall Study|Other unspecified reason|3
7176374|NCT03222973|11376626|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3
7176375|NCT03222973|11376627|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0
7176376|NCT03222973|11376628|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0
7176377|NCT03222973|11376629|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0
7176378|NCT03222973|11376626|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1
7176379|NCT03222973|11376627|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1
7176380|NCT03222973|11376628|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0
7176381|NCT03222973|11376629|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0
7176382|NCT03222973|11376626|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12
7176383|NCT03222973|11376627|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9
7176384|NCT03222973|11376628|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0
7176385|NCT03222973|11376629|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0
7176386|NCT03222973|11376626|FG000|Part 1 (Week 0 to Week 72)|Death|0
7176387|NCT03222973|11376627|FG001|Part 1 (Week 0 to Week 72)|Death|1
7176388|NCT03222973|11376628|FG002|Part 1 (Week 0 to Week 72)|Death|0
7176389|NCT03222973|11376629|FG003|Part 1 (Week 0 to Week 72)|Death|0
7176390|NCT03222973|11376626|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0
7176391|NCT03222973|11376627|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1
7176392|NCT03222973|11376628|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0
7176393|NCT03222973|11376629|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0
7176394|NCT03222973|11376626|FG000|Part 1 (Week 0 to Week 72)|Other|8
7176395|NCT03222973|11376627|FG001|Part 1 (Week 0 to Week 72)|Other|2
7176396|NCT03222973|11376628|FG002|Part 1 (Week 0 to Week 72)|Other|0
7176397|NCT03222973|11376629|FG003|Part 1 (Week 0 to Week 72)|Other|0
7176398|NCT03222973|11376626|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0
7176399|NCT03222973|11376627|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0
7176400|NCT03222973|11376628|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2
7176401|NCT03222973|11376629|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0
7176402|NCT03222973|11376626|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0
7176403|NCT03222973|11376627|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0
7176404|NCT03222973|11376628|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10
7176405|NCT03222973|11376629|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11
7176406|NCT03222973|11376626|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0
7176407|NCT03222973|11376627|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0
7176408|NCT03222973|11376628|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2
7176409|NCT03222973|11376629|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1
7176410|NCT03222973|11376626|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0
7176411|NCT03222973|11376627|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0
7176412|NCT03222973|11376628|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2
7176413|NCT03222973|11376629|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1
7176414|NCT03222973|11376626|FG000|Part 2 (Week 73 to Week 168)|Other|0
7176415|NCT03222973|11376627|FG001|Part 2 (Week 73 to Week 168)|Other|0
7176416|NCT03222973|11376628|FG002|Part 2 (Week 73 to Week 168)|Other|84
7176417|NCT03222973|11376629|FG003|Part 2 (Week 73 to Week 168)|Other|100
7176418|NCT03222973|11376626|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0
7176419|NCT03222973|11376627|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0
7176420|NCT03222973|11376628|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1
7176421|NCT03222973|11376629|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0
7176422|NCT03187262|11376639|FG000|Induction|Lack of Efficacy|2
7176423|NCT03187262|11376639|FG000|Induction|Progressive Disease|4
7176424|NCT03187262|11376639|FG000|Consolidation|Progressive Disease|5
7176425|NCT02987959|11376647|FG000|Overall Study|Grantor stopped supply of drugs|6
7176426|NCT02985541|11376651|FG000|Overall Study|Withdrawal by Subject|33
7176427|NCT02985541|11376651|FG000|Overall Study|Lost to Follow-up|26
7176428|NCT02985541|11376651|FG000|Overall Study|Adverse Event|27
7176429|NCT02985541|11376651|FG000|Overall Study|Physician Decision|2
7176430|NCT02985541|11376651|FG000|Overall Study|Pregnancy|2
7176431|NCT02985541|11376651|FG000|Overall Study|Wish for pregnancy|44
7176432|NCT02985541|11376651|FG000|Overall Study|Other reason|5
7176433|NCT02985541|11376651|FG000|Overall Study|Not valid for analysis|2
7176434|NCT02960893|11376657|FG000|Randomization Phase (8-week)|Adverse Event|5
7176435|NCT02960893|11376658|FG001|Randomization Phase (8-week)|Adverse Event|0
7176436|NCT02960893|11376657|FG000|Randomization Phase (8-week)|Withdrawal by Subject|2
7176437|NCT02960893|11376658|FG001|Randomization Phase (8-week)|Withdrawal by Subject|1
7176438|NCT02960893|11376657|FG000|Randomization Phase (8-week)|Reason Not Specified|0
7176439|NCT02960893|11376658|FG001|Randomization Phase (8-week)|Reason Not Specified|1
7176440|NCT02960893|11376657|FG000|Extension Phase (48-week)|Adverse Event|2
7176441|NCT02960893|11376658|FG001|Extension Phase (48-week)|Adverse Event|3
7176442|NCT02960893|11376657|FG000|Extension Phase (48-week)|Withdrawal by Subject|8
7176443|NCT02960893|11376658|FG001|Extension Phase (48-week)|Withdrawal by Subject|8
7176444|NCT02960893|11376657|FG000|Extension Phase (48-week)|Other Reason|2
7176445|NCT02960893|11376658|FG001|Extension Phase (48-week)|Other Reason|1
7176446|NCT02960893|11376657|FG000|Extension Phase (48-week)|Lost to Follow-up|1
7176447|NCT02960893|11376658|FG001|Extension Phase (48-week)|Lost to Follow-up|1
7176448|NCT02960893|11376657|FG000|Extension Phase (48-week)|Sponsors Decision|1
7176449|NCT02960893|11376658|FG001|Extension Phase (48-week)|Sponsors Decision|0
7176450|NCT02940522|11376673|FG000|Overall Study|Lost to Follow-up|1
7176451|NCT02940522|11376674|FG001|Overall Study|Lost to Follow-up|2
7176452|NCT02940522|11376673|FG000|Overall Study|Withdrawal by Subject|1
7176453|NCT02940522|11376674|FG001|Overall Study|Withdrawal by Subject|0
7186074|NCT02701283|11386419|FG002|Overall Study|Lost to Follow-up|1
7186075|NCT02701283|11386417|FG000|Overall Study|Withdrawal by Subject|12
7186076|NCT02701283|11386418|FG001|Overall Study|Withdrawal by Subject|41
7186077|NCT02701283|11386419|FG002|Overall Study|Withdrawal by Subject|1
7186078|NCT02701283|11386417|FG000|Overall Study|Missed 2-year visit|22
7186079|NCT02701283|11386418|FG001|Overall Study|Missed 2-year visit|27
7186080|NCT02701283|11386419|FG002|Overall Study|Missed 2-year visit|0
7186081|NCT02701283|11386417|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7
7186082|NCT02701283|11386418|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57
7186083|NCT02701283|11386419|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0
7186084|NCT02696031|11386433|FG000|Up to Week 24|Adverse Event|2
7176454|NCT02711137|11376695|FG000|Overall Study|Death|1
7176455|NCT02711137|11376696|FG001|Overall Study|Death|4
7176456|NCT02711137|11376697|FG002|Overall Study|Death|5
7176457|NCT02711137|11376698|FG003|Overall Study|Death|5
7176458|NCT02711137|11376699|FG004|Overall Study|Death|3
7176459|NCT02711137|11376700|FG005|Overall Study|Death|1
7176460|NCT02711137|11376701|FG006|Overall Study|Death|61
7176461|NCT02711137|11376702|FG007|Overall Study|Death|3
7176462|NCT02711137|11376703|FG008|Overall Study|Death|0
7176463|NCT02711137|11376704|FG009|Overall Study|Death|1
7176464|NCT02711137|11376705|FG010|Overall Study|Death|1
7176465|NCT02711137|11376706|FG011|Overall Study|Death|1
7176466|NCT02711137|11376707|FG012|Overall Study|Death|0
7176467|NCT02711137|11376708|FG013|Overall Study|Death|0
7176468|NCT02711137|11376709|FG014|Overall Study|Death|0
7176469|NCT02711137|11376695|FG000|Overall Study|Study Terminated by Sponsor|0
7176470|NCT02711137|11376696|FG001|Overall Study|Study Terminated by Sponsor|0
7176471|NCT02711137|11376697|FG002|Overall Study|Study Terminated by Sponsor|1
7176472|NCT02711137|11376698|FG003|Overall Study|Study Terminated by Sponsor|0
7176473|NCT02711137|11376699|FG004|Overall Study|Study Terminated by Sponsor|0
7176474|NCT02711137|11376700|FG005|Overall Study|Study Terminated by Sponsor|0
7176475|NCT02711137|11376701|FG006|Overall Study|Study Terminated by Sponsor|1
7176476|NCT02711137|11376702|FG007|Overall Study|Study Terminated by Sponsor|0
7176477|NCT02711137|11376703|FG008|Overall Study|Study Terminated by Sponsor|0
7176478|NCT02711137|11376704|FG009|Overall Study|Study Terminated by Sponsor|0
7176479|NCT02711137|11376705|FG010|Overall Study|Study Terminated by Sponsor|0
7176480|NCT02711137|11376706|FG011|Overall Study|Study Terminated by Sponsor|0
7176481|NCT02711137|11376707|FG012|Overall Study|Study Terminated by Sponsor|0
7176482|NCT02711137|11376708|FG013|Overall Study|Study Terminated by Sponsor|0
7176483|NCT02711137|11376709|FG014|Overall Study|Study Terminated by Sponsor|0
7176484|NCT02711137|11376695|FG000|Overall Study|Physician Decision|1
7176485|NCT02711137|11376696|FG001|Overall Study|Physician Decision|0
7176486|NCT02711137|11376697|FG002|Overall Study|Physician Decision|2
7176487|NCT02711137|11376698|FG003|Overall Study|Physician Decision|1
7176488|NCT02711137|11376699|FG004|Overall Study|Physician Decision|1
7176489|NCT02711137|11376700|FG005|Overall Study|Physician Decision|0
7176490|NCT02711137|11376701|FG006|Overall Study|Physician Decision|12
7176491|NCT02711137|11376702|FG007|Overall Study|Physician Decision|2
7176492|NCT02711137|11376703|FG008|Overall Study|Physician Decision|1
7176493|NCT02711137|11376704|FG009|Overall Study|Physician Decision|1
7176494|NCT02711137|11376705|FG010|Overall Study|Physician Decision|3
7176495|NCT02711137|11376706|FG011|Overall Study|Physician Decision|2
7176496|NCT02711137|11376707|FG012|Overall Study|Physician Decision|1
7176497|NCT02711137|11376708|FG013|Overall Study|Physician Decision|1
7176498|NCT02711137|11376709|FG014|Overall Study|Physician Decision|2
7176499|NCT02711137|11376695|FG000|Overall Study|Other|0
7176500|NCT02711137|11376696|FG001|Overall Study|Other|1
7176501|NCT02711137|11376697|FG002|Overall Study|Other|0
7176502|NCT02711137|11376698|FG003|Overall Study|Other|0
7176503|NCT02711137|11376699|FG004|Overall Study|Other|0
7176504|NCT02711137|11376700|FG005|Overall Study|Other|0
7176505|NCT02711137|11376701|FG006|Overall Study|Other|3
7176506|NCT02711137|11376702|FG007|Overall Study|Other|0
7176507|NCT02711137|11376703|FG008|Overall Study|Other|0
7176508|NCT02711137|11376704|FG009|Overall Study|Other|0
7176509|NCT02711137|11376705|FG010|Overall Study|Other|0
7176510|NCT02711137|11376706|FG011|Overall Study|Other|0
7176511|NCT02711137|11376707|FG012|Overall Study|Other|0
7176512|NCT02711137|11376708|FG013|Overall Study|Other|0
7176513|NCT02711137|11376709|FG014|Overall Study|Other|1
7176514|NCT02711137|11376695|FG000|Overall Study|Withdrawal by Subject|1
7176515|NCT02711137|11376696|FG001|Overall Study|Withdrawal by Subject|0
7176516|NCT02711137|11376697|FG002|Overall Study|Withdrawal by Subject|0
7176517|NCT02711137|11376698|FG003|Overall Study|Withdrawal by Subject|1
7176518|NCT02711137|11376699|FG004|Overall Study|Withdrawal by Subject|1
7176519|NCT02711137|11376700|FG005|Overall Study|Withdrawal by Subject|0
7176520|NCT02711137|11376701|FG006|Overall Study|Withdrawal by Subject|7
7176521|NCT02711137|11376702|FG007|Overall Study|Withdrawal by Subject|0
7176522|NCT02711137|11376703|FG008|Overall Study|Withdrawal by Subject|0
7176523|NCT02711137|11376704|FG009|Overall Study|Withdrawal by Subject|0
7176524|NCT02711137|11376705|FG010|Overall Study|Withdrawal by Subject|0
7176525|NCT02711137|11376706|FG011|Overall Study|Withdrawal by Subject|0
7176526|NCT02711137|11376707|FG012|Overall Study|Withdrawal by Subject|0
7176527|NCT02711137|11376708|FG013|Overall Study|Withdrawal by Subject|1
7176528|NCT02711137|11376709|FG014|Overall Study|Withdrawal by Subject|0
7176529|NCT02711137|11376695|FG000|Overall Study|Lost to Follow-up|1
7176530|NCT02711137|11376696|FG001|Overall Study|Lost to Follow-up|0
7176531|NCT02711137|11376697|FG002|Overall Study|Lost to Follow-up|0
7176532|NCT02711137|11376698|FG003|Overall Study|Lost to Follow-up|0
7176533|NCT02711137|11376699|FG004|Overall Study|Lost to Follow-up|0
7176534|NCT02711137|11376700|FG005|Overall Study|Lost to Follow-up|0
7176535|NCT02711137|11376701|FG006|Overall Study|Lost to Follow-up|2
7176536|NCT02711137|11376702|FG007|Overall Study|Lost to Follow-up|0
7176537|NCT02711137|11376703|FG008|Overall Study|Lost to Follow-up|0
7176538|NCT02711137|11376704|FG009|Overall Study|Lost to Follow-up|0
7176539|NCT02711137|11376705|FG010|Overall Study|Lost to Follow-up|0
7176540|NCT02711137|11376706|FG011|Overall Study|Lost to Follow-up|0
7176541|NCT02711137|11376707|FG012|Overall Study|Lost to Follow-up|0
7176542|NCT02711137|11376708|FG013|Overall Study|Lost to Follow-up|0
7176543|NCT02711137|11376709|FG014|Overall Study|Lost to Follow-up|0
7176544|NCT02630459|11376750|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
7176545|NCT02630459|11376751|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1
7176546|NCT02630459|11376752|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
7176547|NCT02630459|11376753|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2
7176548|NCT02630459|11376754|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
7176549|NCT02630459|11376755|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
7176550|NCT02630459|11376756|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
7176551|NCT02630459|11376757|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
7176552|NCT02630459|11376750|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
7176553|NCT02630459|11376751|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
7176554|NCT02630459|11376752|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1
7176555|NCT02630459|11376753|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
7176556|NCT02630459|11376754|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
7176557|NCT02630459|11376755|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
7176558|NCT02630459|11376756|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
7176559|NCT02630459|11376757|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
7176560|NCT02630459|11376750|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2
7176561|NCT02630459|11376751|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1
7176562|NCT02630459|11376752|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4
7176563|NCT02630459|11376753|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1
7176564|NCT02630459|11376754|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
7176565|NCT02630459|11376755|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
7176566|NCT02630459|11376756|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
7176567|NCT02630459|11376757|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
7176568|NCT02630459|11376750|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1
7176569|NCT02630459|11376751|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
7176570|NCT02630459|11376752|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
7176571|NCT02630459|11376753|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
7176572|NCT02630459|11376754|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
7176573|NCT02630459|11376755|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
7176574|NCT02630459|11376756|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
7176575|NCT02630459|11376757|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
7176576|NCT02630459|11376750|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
7176577|NCT02630459|11376751|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
7176578|NCT02630459|11376752|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
7176579|NCT02630459|11376753|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
7176580|NCT02630459|11376754|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4
7176581|NCT02630459|11376755|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1
7176582|NCT02630459|11376756|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
7176583|NCT02630459|11376757|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
7176584|NCT02630459|11376750|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0
7176585|NCT02630459|11376751|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0
7176586|NCT02630459|11376752|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0
7176587|NCT02630459|11376753|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0
7176588|NCT02630459|11376754|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24
7176589|NCT02630459|11376755|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3
7176590|NCT02630459|11376756|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0
7176591|NCT02630459|11376757|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0
7176592|NCT02630459|11376750|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
7176593|NCT02630459|11376751|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
7176594|NCT02630459|11376752|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
7176595|NCT02630459|11376753|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
7176596|NCT02630459|11376754|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1
7176597|NCT02630459|11376755|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
7176598|NCT02630459|11376756|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
7176599|NCT02630459|11376757|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
7176600|NCT02545868|11376807|FG000|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|33
7176601|NCT02545868|11376808|FG001|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|35
7176602|NCT02545868|11376809|FG002|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|34
7176603|NCT02470091|11376824|FG000|Overall Study|Withdrawal by Subject|1
7176604|NCT02470091|11376825|FG001|Overall Study|Withdrawal by Subject|0
7176605|NCT02470091|11376824|FG000|Overall Study|Ineligible|0
7176606|NCT02470091|11376825|FG001|Overall Study|Ineligible|2
7176607|NCT02440425|11376833|FG000|Overall Study|Death likely due to disease progression|1
7176608|NCT02440425|11376833|FG000|Overall Study|Withdrawal by Subject|2
7176609|NCT02440425|11376833|FG000|Overall Study|Adverse Event|1
7176610|NCT02440425|11376833|FG000|Overall Study|Adverse Event/Ineligible|1
7176611|NCT02343120|11376842|FG000|Part 1: Dose Escalation|Sponsor decision|1
7176612|NCT02343120|11376843|FG001|Part 1: Dose Escalation|Sponsor decision|2
7176613|NCT02343120|11376844|FG002|Part 1: Dose Escalation|Sponsor decision|3
7176614|NCT02343120|11376845|FG003|Part 1: Dose Escalation|Sponsor decision|2
7176615|NCT02343120|11376846|FG004|Part 1: Dose Escalation|Sponsor decision|0
7176616|NCT02343120|11376842|FG000|Part 1: Dose Escalation|Death|1
7176617|NCT02343120|11376843|FG001|Part 1: Dose Escalation|Death|2
7176618|NCT02343120|11376844|FG002|Part 1: Dose Escalation|Death|2
7176619|NCT02343120|11376845|FG003|Part 1: Dose Escalation|Death|2
7176620|NCT02343120|11376846|FG004|Part 1: Dose Escalation|Death|1
7176621|NCT02343120|11376842|FG000|Part 1: Dose Escalation|Lost to Follow-up|1
7176622|NCT02343120|11376843|FG001|Part 1: Dose Escalation|Lost to Follow-up|0
7176623|NCT02343120|11376844|FG002|Part 1: Dose Escalation|Lost to Follow-up|0
7176624|NCT02343120|11376845|FG003|Part 1: Dose Escalation|Lost to Follow-up|0
7176625|NCT02343120|11376846|FG004|Part 1: Dose Escalation|Lost to Follow-up|0
7176626|NCT02343120|11376842|FG000|Part 2: Expansion|Sponsor decision|0
7176627|NCT02343120|11376843|FG001|Part 2: Expansion|Sponsor decision|0
7176628|NCT02343120|11376844|FG002|Part 2: Expansion|Sponsor decision|0
7176629|NCT02343120|11376845|FG003|Part 2: Expansion|Sponsor decision|165
7176630|NCT02343120|11376846|FG004|Part 2: Expansion|Sponsor decision|67
7176631|NCT02343120|11376842|FG000|Part 2: Expansion|Death|0
7176632|NCT02343120|11376843|FG001|Part 2: Expansion|Death|0
7176633|NCT02343120|11376844|FG002|Part 2: Expansion|Death|0
7176634|NCT02343120|11376845|FG003|Part 2: Expansion|Death|74
7176635|NCT02343120|11376846|FG004|Part 2: Expansion|Death|17
7176636|NCT02343120|11376842|FG000|Part 2: Expansion|Withdrawal by Subject|0
7176637|NCT02343120|11376843|FG001|Part 2: Expansion|Withdrawal by Subject|0
7176638|NCT02343120|11376844|FG002|Part 2: Expansion|Withdrawal by Subject|0
7176639|NCT02343120|11376845|FG003|Part 2: Expansion|Withdrawal by Subject|28
7176640|NCT02343120|11376846|FG004|Part 2: Expansion|Withdrawal by Subject|2
7176641|NCT02343120|11376842|FG000|Part 2: Expansion|Lost to Follow-up|0
7176642|NCT02343120|11376843|FG001|Part 2: Expansion|Lost to Follow-up|0
7176643|NCT02343120|11376844|FG002|Part 2: Expansion|Lost to Follow-up|0
7176644|NCT02343120|11376845|FG003|Part 2: Expansion|Lost to Follow-up|5
7176645|NCT02343120|11376846|FG004|Part 2: Expansion|Lost to Follow-up|2
7176646|NCT02343120|11376842|FG000|Part 2: Expansion|Other|0
7176647|NCT02343120|11376843|FG001|Part 2: Expansion|Other|0
7176648|NCT02343120|11376844|FG002|Part 2: Expansion|Other|0
7176649|NCT02343120|11376845|FG003|Part 2: Expansion|Other|1
7176650|NCT02343120|11376846|FG004|Part 2: Expansion|Other|5
7176651|NCT02343120|11376842|FG000|Part 2: Expansion|Adverse Event|0
7176652|NCT02343120|11376843|FG001|Part 2: Expansion|Adverse Event|0
7176653|NCT02343120|11376844|FG002|Part 2: Expansion|Adverse Event|0
7176654|NCT02343120|11376845|FG003|Part 2: Expansion|Adverse Event|1
7176655|NCT02343120|11376846|FG004|Part 2: Expansion|Adverse Event|1
7176656|NCT02066415|11376868|FG000|Overall Study|Decision by Sponsor|5
7176657|NCT02066415|11376869|FG001|Overall Study|Decision by Sponsor|4
7176658|NCT02066415|11376870|FG002|Overall Study|Decision by Sponsor|2
7176659|NCT02066415|11376868|FG000|Overall Study|Withdrawal by Subject|9
7176660|NCT02066415|11376869|FG001|Overall Study|Withdrawal by Subject|1
7176661|NCT02066415|11376870|FG002|Overall Study|Withdrawal by Subject|4
7176662|NCT02066415|11376868|FG000|Overall Study|Lost to Follow-up|7
7176663|NCT02066415|11376869|FG001|Overall Study|Lost to Follow-up|2
7176664|NCT02066415|11376870|FG002|Overall Study|Lost to Follow-up|2
7176665|NCT01952574|11376882|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9
7176666|NCT01952574|11376883|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3
7176667|NCT01952574|11376884|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3
7176668|NCT01952574|11376885|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4
7176669|NCT01952574|11376886|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0
7176670|NCT01952574|11376887|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0
7176671|NCT01952574|11376888|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0
7176672|NCT01952574|11376882|FG000|Double-blind Treatment Phase|Sponsor Decision|6
7176673|NCT01952574|11376883|FG001|Double-blind Treatment Phase|Sponsor Decision|0
7176674|NCT01952574|11376884|FG002|Double-blind Treatment Phase|Sponsor Decision|5
7176675|NCT01952574|11376885|FG003|Double-blind Treatment Phase|Sponsor Decision|2
7176676|NCT01952574|11376886|FG004|Double-blind Treatment Phase|Sponsor Decision|0
7176677|NCT01952574|11376887|FG005|Double-blind Treatment Phase|Sponsor Decision|0
7176678|NCT01952574|11376888|FG006|Double-blind Treatment Phase|Sponsor Decision|0
7176679|NCT01952574|11376882|FG000|Double-blind Treatment Phase|Lost to Follow-up|2
7176680|NCT01952574|11376883|FG001|Double-blind Treatment Phase|Lost to Follow-up|0
7176681|NCT01952574|11376884|FG002|Double-blind Treatment Phase|Lost to Follow-up|1
7176682|NCT01952574|11376885|FG003|Double-blind Treatment Phase|Lost to Follow-up|0
7176683|NCT01952574|11376886|FG004|Double-blind Treatment Phase|Lost to Follow-up|0
7176684|NCT01952574|11376887|FG005|Double-blind Treatment Phase|Lost to Follow-up|0
7176685|NCT01952574|11376888|FG006|Double-blind Treatment Phase|Lost to Follow-up|0
7176686|NCT01952574|11376882|FG000|Open-label Treatment Phase|Withdrawal by Subject|0
7176687|NCT01952574|11376883|FG001|Open-label Treatment Phase|Withdrawal by Subject|0
7176688|NCT01952574|11376884|FG002|Open-label Treatment Phase|Withdrawal by Subject|0
7176689|NCT01952574|11376885|FG003|Open-label Treatment Phase|Withdrawal by Subject|0
7176690|NCT01952574|11376886|FG004|Open-label Treatment Phase|Withdrawal by Subject|121
7176691|NCT01952574|11376887|FG005|Open-label Treatment Phase|Withdrawal by Subject|0
7176692|NCT01952574|11376888|FG006|Open-label Treatment Phase|Withdrawal by Subject|0
7176693|NCT01952574|11376882|FG000|Open-label Treatment Phase|Decision by Sponsor|0
7176694|NCT01952574|11376883|FG001|Open-label Treatment Phase|Decision by Sponsor|0
7176695|NCT01952574|11376884|FG002|Open-label Treatment Phase|Decision by Sponsor|0
7176696|NCT01952574|11376885|FG003|Open-label Treatment Phase|Decision by Sponsor|0
7176697|NCT01952574|11376886|FG004|Open-label Treatment Phase|Decision by Sponsor|17
7176698|NCT01952574|11376887|FG005|Open-label Treatment Phase|Decision by Sponsor|0
7176699|NCT01952574|11376888|FG006|Open-label Treatment Phase|Decision by Sponsor|0
7176700|NCT01952574|11376882|FG000|Open-label Treatment Phase|Missing|0
7176701|NCT01952574|11376883|FG001|Open-label Treatment Phase|Missing|0
7176702|NCT01952574|11376884|FG002|Open-label Treatment Phase|Missing|0
7176703|NCT01952574|11376885|FG003|Open-label Treatment Phase|Missing|0
7176704|NCT01952574|11376886|FG004|Open-label Treatment Phase|Missing|4
7176705|NCT01952574|11376887|FG005|Open-label Treatment Phase|Missing|0
7176706|NCT01952574|11376888|FG006|Open-label Treatment Phase|Missing|0
7176707|NCT01952574|11376882|FG000|Open-label Treatment Phase|Lost to Follow-up|0
7176708|NCT01952574|11376883|FG001|Open-label Treatment Phase|Lost to Follow-up|0
7176709|NCT01952574|11376884|FG002|Open-label Treatment Phase|Lost to Follow-up|0
7176710|NCT01952574|11376885|FG003|Open-label Treatment Phase|Lost to Follow-up|0
7176711|NCT01952574|11376886|FG004|Open-label Treatment Phase|Lost to Follow-up|19
7176712|NCT01952574|11376887|FG005|Open-label Treatment Phase|Lost to Follow-up|0
7176713|NCT01952574|11376888|FG006|Open-label Treatment Phase|Lost to Follow-up|0
7176714|NCT01952574|11376882|FG000|Open-label Treatment Phase|Death|0
7176715|NCT01952574|11376883|FG001|Open-label Treatment Phase|Death|0
7176716|NCT01952574|11376884|FG002|Open-label Treatment Phase|Death|0
7176717|NCT01952574|11376885|FG003|Open-label Treatment Phase|Death|0
7176718|NCT01952574|11376886|FG004|Open-label Treatment Phase|Death|1
7176719|NCT01952574|11376887|FG005|Open-label Treatment Phase|Death|0
7176720|NCT01952574|11376888|FG006|Open-label Treatment Phase|Death|0
7176721|NCT01952574|11376882|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0
7176722|NCT01952574|11376883|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0
7176723|NCT01952574|11376884|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0
7176724|NCT01952574|11376885|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0
7176725|NCT01952574|11376886|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0
7176726|NCT01952574|11376887|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1
7176727|NCT01952574|11376888|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0
7176728|NCT01952574|11376882|FG000|Clinical Home Use Substudy|Decision by Sponsor|0
7176729|NCT01952574|11376883|FG001|Clinical Home Use Substudy|Decision by Sponsor|0
7176730|NCT01952574|11376884|FG002|Clinical Home Use Substudy|Decision by Sponsor|0
7176731|NCT01952574|11376885|FG003|Clinical Home Use Substudy|Decision by Sponsor|0
7176732|NCT01952574|11376886|FG004|Clinical Home Use Substudy|Decision by Sponsor|0
7176733|NCT01952574|11376887|FG005|Clinical Home Use Substudy|Decision by Sponsor|2
7176734|NCT01952574|11376888|FG006|Clinical Home Use Substudy|Decision by Sponsor|1
7176735|NCT01659151|11376913|FG000|Overall Study|Inadequate TIL growth|1
7176736|NCT01539863|11376928|FG000|Overall Study|Lost to Follow-up|5
7176737|NCT01539863|11376929|FG001|Overall Study|Lost to Follow-up|4
7176738|NCT01439165|11376950|FG000|Overall Study|Protocol Violation|3
7176739|NCT01439165|11376951|FG001|Overall Study|Protocol Violation|0
7176740|NCT01439165|11376950|FG000|Overall Study|Lost to Follow-up|11
7176741|NCT01439165|11376951|FG001|Overall Study|Lost to Follow-up|1
7176742|NCT01439165|11376950|FG000|Overall Study|Withdrawal by Subject|7
7176743|NCT01439165|11376951|FG001|Overall Study|Withdrawal by Subject|1
7176744|NCT01264679|11376957|FG000|Overall Study|Participation in Another Clinical Trial|1
7176745|NCT01264679|11376957|FG000|Overall Study|Physician Decision|1
7176746|NCT01264679|11376957|FG000|Overall Study|Sponsor's Suspension of Dosing|2
7176747|NCT01264679|11376957|FG000|Overall Study|Withdrawal by Subject|1
7176748|NCT01155388|11376964|FG000|Overall Study|Adverse Event|1
7176749|NCT01155388|11376965|FG001|Overall Study|Adverse Event|0
7176750|NCT01137435|11376972|FG000|Overall Study|Lost to Follow-up|24
7176751|NCT01137435|11376972|FG000|Overall Study|Off label usage|4
7176752|NCT01064817|11376989|FG000|Study Completion|Physician Decision|1
7176753|NCT01064817|11376990|FG001|Study Completion|Physician Decision|0
7176754|NCT01064817|11376989|FG000|Study Completion|Withdrawal by Subject|1
7176755|NCT01064817|11376990|FG001|Study Completion|Withdrawal by Subject|0
7176756|NCT01026220|11376996|FG000|Induction|Death|1
7176757|NCT01026220|11376997|FG001|Induction|Death|0
7176758|NCT01026220|11376998|FG002|Induction|Death|0
7176759|NCT01026220|11376996|FG000|Induction|Lack of Efficacy|2
7176760|NCT01026220|11376997|FG001|Induction|Lack of Efficacy|0
7176761|NCT01026220|11376998|FG002|Induction|Lack of Efficacy|0
7176762|NCT01026220|11376996|FG000|Induction|Physician Decision|12
7176763|NCT01026220|11376997|FG001|Induction|Physician Decision|0
7176764|NCT01026220|11376998|FG002|Induction|Physician Decision|0
7176765|NCT01026220|11376996|FG000|Induction|Withdrawal by Subject|9
7176766|NCT01026220|11376997|FG001|Induction|Withdrawal by Subject|0
7176767|NCT01026220|11376998|FG002|Induction|Withdrawal by Subject|0
7176768|NCT01026220|11376996|FG000|Induction|Ineligible|1
7176769|NCT01026220|11376997|FG001|Induction|Ineligible|0
7176770|NCT01026220|11376998|FG002|Induction|Ineligible|0
7176771|NCT01026220|11376996|FG000|Consolidation Maintenance|Death|0
7176772|NCT01026220|11376997|FG001|Consolidation Maintenance|Death|1
7176773|NCT01026220|11376998|FG002|Consolidation Maintenance|Death|0
7176774|NCT01026220|11376996|FG000|Consolidation Maintenance|Lack of Efficacy|0
7176775|NCT01026220|11376997|FG001|Consolidation Maintenance|Lack of Efficacy|1
7176776|NCT01026220|11376998|FG002|Consolidation Maintenance|Lack of Efficacy|1
7176777|NCT01026220|11376996|FG000|Consolidation Maintenance|Physician Decision|0
7176778|NCT01026220|11376997|FG001|Consolidation Maintenance|Physician Decision|2
7176779|NCT01026220|11376998|FG002|Consolidation Maintenance|Physician Decision|7
7176780|NCT01026220|11376996|FG000|Consolidation Maintenance|Withdrawal by Subject|0
7176781|NCT01026220|11376997|FG001|Consolidation Maintenance|Withdrawal by Subject|2
7176782|NCT01026220|11376998|FG002|Consolidation Maintenance|Withdrawal by Subject|6
7176783|NCT00567567|11377020|FG000|Overall Study|Adverse Event|0
7176784|NCT00567567|11377021|FG001|Overall Study|Adverse Event|2
7176785|NCT00567567|11377022|FG002|Overall Study|Adverse Event|5
7176786|NCT00567567|11377020|FG000|Overall Study|Death|8
7176787|NCT00567567|11377021|FG001|Overall Study|Death|1
7176788|NCT00567567|11377022|FG002|Overall Study|Death|5
7176789|NCT00567567|11377020|FG000|Overall Study|Lack of Efficacy|16
7176790|NCT00567567|11377021|FG001|Overall Study|Lack of Efficacy|17
7176791|NCT00567567|11377022|FG002|Overall Study|Lack of Efficacy|48
7176792|NCT00567567|11377020|FG000|Overall Study|Lost to Follow-up|0
7176793|NCT00567567|11377021|FG001|Overall Study|Lost to Follow-up|0
7176794|NCT00567567|11377022|FG002|Overall Study|Lost to Follow-up|1
7176795|NCT00567567|11377020|FG000|Overall Study|Physician Decision|16
7176796|NCT00567567|11377021|FG001|Overall Study|Physician Decision|18
7176797|NCT00567567|11377022|FG002|Overall Study|Physician Decision|84
7176798|NCT00567567|11377020|FG000|Overall Study|Withdrawal by Subject|0
7176799|NCT00567567|11377021|FG001|Overall Study|Withdrawal by Subject|0
7176800|NCT00567567|11377022|FG002|Overall Study|Withdrawal by Subject|2
7176801|NCT00567567|11377020|FG000|Overall Study|Ineligible|4
7176802|NCT00567567|11377021|FG001|Overall Study|Ineligible|0
7176803|NCT00567567|11377022|FG002|Overall Study|Ineligible|9
7176804|NCT00567567|11377020|FG000|Overall Study|Refusal by patient/parent/guardian|9
7176805|NCT00567567|11377021|FG001|Overall Study|Refusal by patient/parent/guardian|16
7176806|NCT00567567|11377022|FG002|Overall Study|Refusal by patient/parent/guardian|122
7176807|NCT00567567|11377020|FG000|Overall Study|Enrolled another COG therapeutic study|99
7176808|NCT00567567|11377021|FG001|Overall Study|Enrolled another COG therapeutic study|80
7176809|NCT00567567|11377022|FG002|Overall Study|Enrolled another COG therapeutic study|0
7176810|NCT00567567|11377020|FG000|Overall Study|Unable adequate stem cell for transplant|0
7176811|NCT00567567|11377021|FG001|Overall Study|Unable adequate stem cell for transplant|0
7176812|NCT00567567|11377022|FG002|Overall Study|Unable adequate stem cell for transplant|2
7176813|NCT00450450|11377034|FG000|Overall Study|Death|1
7176814|NCT00450450|11377035|FG001|Overall Study|Death|3
7176815|NCT00450450|11377034|FG000|Overall Study|Relapse|2
7176816|NCT00450450|11377035|FG001|Overall Study|Relapse|0
7176817|NCT00450450|11377034|FG000|Overall Study|Missing Data|2
7176818|NCT00450450|11377035|FG001|Overall Study|Missing Data|0
7176819|NCT00346164|11377045|FG000|Overall Study|Adverse Event|0
7176820|NCT00346164|11377046|FG001|Overall Study|Adverse Event|0
7176821|NCT00346164|11377047|FG002|Overall Study|Adverse Event|0
7176822|NCT00346164|11377048|FG003|Overall Study|Adverse Event|1
7176823|NCT00346164|11377045|FG000|Overall Study|Lack of Efficacy|0
7176824|NCT00346164|11377046|FG001|Overall Study|Lack of Efficacy|1
7176825|NCT00346164|11377047|FG002|Overall Study|Lack of Efficacy|7
7176826|NCT00346164|11377048|FG003|Overall Study|Lack of Efficacy|25
7176827|NCT00346164|11377045|FG000|Overall Study|Physician Decision|0
7176828|NCT00346164|11377046|FG001|Overall Study|Physician Decision|1
7176829|NCT00346164|11377047|FG002|Overall Study|Physician Decision|2
7176830|NCT00346164|11377048|FG003|Overall Study|Physician Decision|27
7176831|NCT00346164|11377045|FG000|Overall Study|Protocol Violation|6
7176832|NCT00346164|11377046|FG001|Overall Study|Protocol Violation|2
7176833|NCT00346164|11377047|FG002|Overall Study|Protocol Violation|10
7176834|NCT00346164|11377048|FG003|Overall Study|Protocol Violation|4
7176835|NCT00346164|11377045|FG000|Overall Study|Withdrawal by Subject|0
7176836|NCT00346164|11377046|FG001|Overall Study|Withdrawal by Subject|0
7176837|NCT00346164|11377047|FG002|Overall Study|Withdrawal by Subject|2
7176838|NCT00346164|11377048|FG003|Overall Study|Withdrawal by Subject|0
7176839|NCT00346164|11377045|FG000|Overall Study|Ineligible|11
7176840|NCT00346164|11377046|FG001|Overall Study|Ineligible|2
7176841|NCT00346164|11377047|FG002|Overall Study|Ineligible|2
7176842|NCT00346164|11377048|FG003|Overall Study|Ineligible|23
7176843|NCT00346164|11377045|FG000|Overall Study|Refusal of further protocol therapy|0
7176844|NCT00346164|11377046|FG001|Overall Study|Refusal of further protocol therapy|1
7176845|NCT00346164|11377047|FG002|Overall Study|Refusal of further protocol therapy|3
7176846|NCT00346164|11377048|FG003|Overall Study|Refusal of further protocol therapy|15
7176847|NCT00346164|11377045|FG000|Overall Study|Inability to start week 16 tx on time|0
7176848|NCT00346164|11377046|FG001|Overall Study|Inability to start week 16 tx on time|0
7176849|NCT00346164|11377047|FG002|Overall Study|Inability to start week 16 tx on time|0
7176850|NCT00346164|11377048|FG003|Overall Study|Inability to start week 16 tx on time|11
7186085|NCT02696031|11386434|FG001|Up to Week 24|Adverse Event|4
7186086|NCT02696031|11386435|FG002|Up to Week 24|Adverse Event|2
7186087|NCT02696031|11386436|FG003|Up to Week 24|Adverse Event|0
7186088|NCT02696031|11386437|FG004|Up to Week 24|Adverse Event|0
7186089|NCT02696031|11386438|FG005|Up to Week 24|Adverse Event|0
7176851|NCT00972179|11377081|FG000|Overall Study|Noncompliance|1
7176852|NCT00972179|11377082|FG001|Overall Study|Noncompliance|0
7176853|NCT00972179|11377083|FG002|Overall Study|Noncompliance|0
7176854|NCT00972179|11377084|FG003|Overall Study|Noncompliance|0
7176855|NCT00972179|11377085|FG004|Overall Study|Noncompliance|1
7176856|NCT00972179|11377086|FG005|Overall Study|Noncompliance|0
7176857|NCT00972179|11377087|FG006|Overall Study|Noncompliance|1
7080889|NCT02127970|11190686|FG001|Overall Study|Reason not Specified|7
7176858|NCT00972179|11377081|FG000|Overall Study|Withdrawal by Subject|0
7176859|NCT00972179|11377082|FG001|Overall Study|Withdrawal by Subject|3
7176860|NCT00972179|11377083|FG002|Overall Study|Withdrawal by Subject|0
7176861|NCT00972179|11377084|FG003|Overall Study|Withdrawal by Subject|1
7176862|NCT00972179|11377085|FG004|Overall Study|Withdrawal by Subject|0
7176863|NCT00972179|11377086|FG005|Overall Study|Withdrawal by Subject|0
7176864|NCT00972179|11377087|FG006|Overall Study|Withdrawal by Subject|2
7176865|NCT00972179|11377081|FG000|Overall Study|Administrative Decision|0
7176866|NCT00972179|11377082|FG001|Overall Study|Administrative Decision|0
7176867|NCT00972179|11377083|FG002|Overall Study|Administrative Decision|0
7176868|NCT00972179|11377084|FG003|Overall Study|Administrative Decision|0
7176869|NCT00972179|11377085|FG004|Overall Study|Administrative Decision|1
7176870|NCT00972179|11377086|FG005|Overall Study|Administrative Decision|0
7176871|NCT00972179|11377087|FG006|Overall Study|Administrative Decision|0
7176872|NCT00972179|11377081|FG000|Overall Study|Lost to Follow-up|0
7176873|NCT00972179|11377082|FG001|Overall Study|Lost to Follow-up|0
7176874|NCT00972179|11377083|FG002|Overall Study|Lost to Follow-up|1
7176875|NCT00972179|11377084|FG003|Overall Study|Lost to Follow-up|0
7176876|NCT00972179|11377085|FG004|Overall Study|Lost to Follow-up|0
7176877|NCT00972179|11377086|FG005|Overall Study|Lost to Follow-up|3
7176878|NCT00972179|11377087|FG006|Overall Study|Lost to Follow-up|1
7176879|NCT04360187|11377109|FG000|Double-Blind Treatment|Adverse Event|9
7176880|NCT04360187|11377110|FG001|Double-Blind Treatment|Adverse Event|11
7176881|NCT04360187|11377109|FG000|Double-Blind Treatment|Lack of Efficacy|7
7176882|NCT04360187|11377110|FG001|Double-Blind Treatment|Lack of Efficacy|2
7176883|NCT04360187|11377109|FG000|Double-Blind Treatment|Physician Decision|1
7176884|NCT04360187|11377110|FG001|Double-Blind Treatment|Physician Decision|0
7176885|NCT04360187|11377109|FG000|Double-Blind Treatment|Withdrawal by Subject|4
7176886|NCT04360187|11377110|FG001|Double-Blind Treatment|Withdrawal by Subject|2
7176887|NCT04360187|11377109|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2
7176888|NCT04360187|11377110|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0
7176889|NCT04360187|11377109|FG000|Follow-Up|Lost to Follow-up|1
7176890|NCT04360187|11377110|FG001|Follow-Up|Lost to Follow-up|0
7176976|NCT03197935|11377268|FG001|Overall Study|Did not receive any study treatment|1
7176977|NCT03164616|11377287|FG000|Overall Study|Death|250
7176978|NCT03164616|11377288|FG001|Overall Study|Death|264
7176979|NCT03164616|11377289|FG002|Overall Study|Death|279
7176980|NCT03164616|11377287|FG000|Overall Study|Lost to Follow-up|2
7176981|NCT03164616|11377288|FG001|Overall Study|Lost to Follow-up|2
7176982|NCT03164616|11377289|FG002|Overall Study|Lost to Follow-up|2
7176983|NCT03164616|11377287|FG000|Overall Study|Withdrawal by Subject|6
7176984|NCT03164616|11377288|FG001|Overall Study|Withdrawal by Subject|7
7176985|NCT03164616|11377289|FG002|Overall Study|Withdrawal by Subject|16
7186090|NCT02696031|11386433|FG000|Up to Week 24|Lack of Efficacy|2
7186091|NCT02696031|11386434|FG001|Up to Week 24|Lack of Efficacy|1
7186092|NCT02696031|11386435|FG002|Up to Week 24|Lack of Efficacy|2
7186093|NCT02696031|11386436|FG003|Up to Week 24|Lack of Efficacy|0
7186094|NCT02696031|11386437|FG004|Up to Week 24|Lack of Efficacy|0
7186095|NCT02696031|11386438|FG005|Up to Week 24|Lack of Efficacy|0
7186096|NCT02696031|11386433|FG000|Up to Week 24|Lost to Follow-up|0
7186097|NCT02696031|11386434|FG001|Up to Week 24|Lost to Follow-up|1
7186098|NCT02696031|11386435|FG002|Up to Week 24|Lost to Follow-up|1
7186099|NCT02696031|11386436|FG003|Up to Week 24|Lost to Follow-up|0
7186100|NCT02696031|11386437|FG004|Up to Week 24|Lost to Follow-up|0
7186101|NCT02696031|11386438|FG005|Up to Week 24|Lost to Follow-up|0
7186102|NCT02696031|11386433|FG000|Up to Week 24|Physician Decision|1
7186103|NCT02696031|11386434|FG001|Up to Week 24|Physician Decision|0
7186104|NCT02696031|11386435|FG002|Up to Week 24|Physician Decision|1
7186105|NCT02696031|11386436|FG003|Up to Week 24|Physician Decision|0
7186106|NCT02696031|11386437|FG004|Up to Week 24|Physician Decision|0
7186107|NCT02696031|11386438|FG005|Up to Week 24|Physician Decision|0
7080890|NCT02127970|11190685|FG000|Overall Study|Pregnancy|0
7080891|NCT02127970|11190686|FG001|Overall Study|Pregnancy|1
7186108|NCT02696031|11386433|FG000|Up to Week 24|Protocol Violation|1
7186109|NCT02696031|11386434|FG001|Up to Week 24|Protocol Violation|0
7186110|NCT02696031|11386435|FG002|Up to Week 24|Protocol Violation|0
7186111|NCT02696031|11386436|FG003|Up to Week 24|Protocol Violation|0
7186112|NCT02696031|11386437|FG004|Up to Week 24|Protocol Violation|0
7186113|NCT02696031|11386438|FG005|Up to Week 24|Protocol Violation|0
7186114|NCT02696031|11386433|FG000|Up to Week 24|Withdrawal by Subject|4
7186115|NCT02696031|11386434|FG001|Up to Week 24|Withdrawal by Subject|1
7186116|NCT02696031|11386435|FG002|Up to Week 24|Withdrawal by Subject|5
7186117|NCT02696031|11386436|FG003|Up to Week 24|Withdrawal by Subject|0
7186118|NCT02696031|11386437|FG004|Up to Week 24|Withdrawal by Subject|0
7186119|NCT02696031|11386438|FG005|Up to Week 24|Withdrawal by Subject|0
7186120|NCT02696031|11386433|FG000|Up to Week 52|Adverse Event|4
7186121|NCT02696031|11386434|FG001|Up to Week 52|Adverse Event|5
7176891|NCT04025632|11377118|FG000|Overall Study|Adverse Event|1
7176892|NCT04025632|11377119|FG001|Overall Study|Adverse Event|1
7176893|NCT04025632|11377118|FG000|Overall Study|Withdrawal by Subject|1
7176894|NCT04025632|11377119|FG001|Overall Study|Withdrawal by Subject|1
7176895|NCT04025632|11377118|FG000|Overall Study|Study Terminated by Sponsor|10
7176896|NCT04025632|11377119|FG001|Overall Study|Study Terminated by Sponsor|9
7176897|NCT04025632|11377118|FG000|Overall Study|Physician Decision|3
7176898|NCT04025632|11377119|FG001|Overall Study|Physician Decision|1
7176899|NCT03978091|11377134|FG000|Overall Study|Lost to Follow-up|0
7176900|NCT03978091|11377135|FG001|Overall Study|Lost to Follow-up|0
7176901|NCT03978091|11377136|FG002|Overall Study|Lost to Follow-up|1
7176902|NCT03978091|11377137|FG003|Overall Study|Lost to Follow-up|0
7176903|NCT03978091|11377138|FG004|Overall Study|Lost to Follow-up|0
7176904|NCT03978091|11377139|FG005|Overall Study|Lost to Follow-up|0
7176905|NCT03978091|11377134|FG000|Overall Study|Withdrawal by Subject|0
7176906|NCT03978091|11377135|FG001|Overall Study|Withdrawal by Subject|0
7176907|NCT03978091|11377136|FG002|Overall Study|Withdrawal by Subject|0
7176908|NCT03978091|11377137|FG003|Overall Study|Withdrawal by Subject|1
7176909|NCT03978091|11377138|FG004|Overall Study|Withdrawal by Subject|1
7176910|NCT03978091|11377139|FG005|Overall Study|Withdrawal by Subject|0
7176911|NCT03853291|11377163|FG000|Overall Study|Lost to Follow-up|1
7176912|NCT03853291|11377164|FG001|Overall Study|Lost to Follow-up|2
7176913|NCT03853291|11377165|FG002|Overall Study|Lost to Follow-up|0
7176914|NCT03853291|11377166|FG003|Overall Study|Lost to Follow-up|0
7176915|NCT03853291|11377167|FG004|Overall Study|Lost to Follow-up|0
7176916|NCT03853291|11377168|FG005|Overall Study|Lost to Follow-up|0
7176917|NCT03853291|11377163|FG000|Overall Study|Determined to be ineligible|1
7176918|NCT03853291|11377164|FG001|Overall Study|Determined to be ineligible|1
7176919|NCT03853291|11377165|FG002|Overall Study|Determined to be ineligible|0
7176920|NCT03853291|11377166|FG003|Overall Study|Determined to be ineligible|0
7176921|NCT03853291|11377167|FG004|Overall Study|Determined to be ineligible|0
7176922|NCT03853291|11377168|FG005|Overall Study|Determined to be ineligible|0
7176923|NCT03850444|11377181|FG000|Overall Study|Adverse Event|12
7176924|NCT03850444|11377182|FG001|Overall Study|Adverse Event|9
7176925|NCT03850444|11377181|FG000|Overall Study|Death|38
7176926|NCT03850444|11377182|FG001|Overall Study|Death|64
7176927|NCT03850444|11377181|FG000|Overall Study|Lost to Follow-up|0
7176928|NCT03850444|11377182|FG001|Overall Study|Lost to Follow-up|1
7176929|NCT03850444|11377181|FG000|Overall Study|Withdrawal by Subject|0
7176930|NCT03850444|11377182|FG001|Overall Study|Withdrawal by Subject|1
7176931|NCT03850444|11377181|FG000|Overall Study|Ongoing in Study|78
7176932|NCT03850444|11377182|FG001|Overall Study|Ongoing in Study|59
7176933|NCT03794089|11377190|FG000|Overall Study|Lost to Follow-up|4
7176934|NCT03794089|11377191|FG001|Overall Study|Lost to Follow-up|1
7176935|NCT03794089|11377190|FG000|Overall Study|Withdrawal by Subject|2
7176936|NCT03794089|11377191|FG001|Overall Study|Withdrawal by Subject|0
7176937|NCT03631407|11377208|FG000|Overall Study|Withdrawal by Subject|3
7176938|NCT03631407|11377209|FG001|Overall Study|Withdrawal by Subject|2
7176939|NCT03631407|11377208|FG000|Overall Study|Sponsor Decision|0
7176940|NCT03631407|11377209|FG001|Overall Study|Sponsor Decision|2
7176941|NCT03631407|11377208|FG000|Overall Study|Death|16
7176942|NCT03631407|11377209|FG001|Overall Study|Death|16
7176943|NCT03631407|11377208|FG000|Overall Study|Randomized by mistake without study treatment|1
7176944|NCT03631407|11377209|FG001|Overall Study|Randomized by mistake without study treatment|0
7176945|NCT03358472|11377241|FG000|Overall Study|Death|6
7176946|NCT03358472|11377242|FG001|Overall Study|Death|3
7176947|NCT03358472|11377243|FG002|Overall Study|Death|10
7176948|NCT03358472|11377241|FG000|Overall Study|Physician Decision|0
7176949|NCT03358472|11377242|FG001|Overall Study|Physician Decision|1
7176950|NCT03358472|11377243|FG002|Overall Study|Physician Decision|0
7176951|NCT03358472|11377241|FG000|Overall Study|Withdrawal by Subject|0
7176952|NCT03358472|11377242|FG001|Overall Study|Withdrawal by Subject|0
7176953|NCT03358472|11377243|FG002|Overall Study|Withdrawal by Subject|1
7176954|NCT03358472|11377241|FG000|Overall Study|On-going at clinical cut off date|9
7176955|NCT03358472|11377242|FG001|Overall Study|On-going at clinical cut off date|6
7176956|NCT03358472|11377243|FG002|Overall Study|On-going at clinical cut off date|5
7176957|NCT03281304|11377253|FG000|Overall Study|Adverse Event|5
7176958|NCT03281304|11377254|FG001|Overall Study|Adverse Event|2
7176959|NCT03281304|11377253|FG000|Overall Study|Lack of Efficacy|2
7176960|NCT03281304|11377254|FG001|Overall Study|Lack of Efficacy|0
7176961|NCT03281304|11377253|FG000|Overall Study|Pregnancy|1
7176962|NCT03281304|11377254|FG001|Overall Study|Pregnancy|0
7176963|NCT03281304|11377253|FG000|Overall Study|Withdrawal by Subject|5
7176964|NCT03281304|11377254|FG001|Overall Study|Withdrawal by Subject|10
7176965|NCT03197935|11377267|FG000|Overall Study|Death due to any cause|9
7176966|NCT03197935|11377268|FG001|Overall Study|Death due to any cause|7
7176967|NCT03197935|11377267|FG000|Overall Study|Lost to Follow-up|0
7176968|NCT03197935|11377268|FG001|Overall Study|Lost to Follow-up|3
7176969|NCT03197935|11377267|FG000|Overall Study|Physician Decision|0
7176970|NCT03197935|11377268|FG001|Overall Study|Physician Decision|1
7176971|NCT03197935|11377267|FG000|Overall Study|Withdrawal by Subject|11
7176972|NCT03197935|11377268|FG001|Overall Study|Withdrawal by Subject|7
7176973|NCT03197935|11377267|FG000|Overall Study|On-Going in Study|147
7176974|NCT03197935|11377268|FG001|Overall Study|On-Going in Study|146
7176975|NCT03197935|11377267|FG000|Overall Study|Did not receive any study treatment|1
7176986|NCT03120949|11377301|FG000|Overall Study|randomized in error|1
7176987|NCT03120949|11377302|FG001|Overall Study|randomized in error|0
7176988|NCT03120949|11377301|FG000|Overall Study|Death|13
7176989|NCT03120949|11377302|FG001|Overall Study|Death|13
7176990|NCT03120949|11377301|FG000|Overall Study|Lost to Follow-up|23
7176991|NCT03120949|11377302|FG001|Overall Study|Lost to Follow-up|13
7176992|NCT03120949|11377301|FG000|Overall Study|Withdrawal by Subject|139
7176993|NCT03120949|11377302|FG001|Overall Study|Withdrawal by Subject|124
7176994|NCT03120949|11377301|FG000|Overall Study|Covid-19|43
7176995|NCT03120949|11377302|FG001|Overall Study|Covid-19|34
7176996|NCT03120949|11377301|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1
7176997|NCT03120949|11377302|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3
7176998|NCT03120949|11377301|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1
7176999|NCT03120949|11377302|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0
7177000|NCT03120949|11377301|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1
7177001|NCT03120949|11377302|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0
7177002|NCT03120949|11377301|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1
7177003|NCT03120949|11377302|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0
7177004|NCT03120949|11377301|FG000|Overall Study|Site was closed|2
7177005|NCT03120949|11377302|FG001|Overall Study|Site was closed|3
7177006|NCT03120949|11377301|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1
7177007|NCT03120949|11377302|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0
7177008|NCT03120949|11377301|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0
7177009|NCT03120949|11377302|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1
7177010|NCT03120949|11377301|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1
7177011|NCT03120949|11377302|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0
7177012|NCT03120949|11377301|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1
7177013|NCT03120949|11377302|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0
7177014|NCT03120949|11377301|FG000|Overall Study|Other: Adverse Event|0
7177015|NCT03120949|11377302|FG001|Overall Study|Other: Adverse Event|1
7177016|NCT03120949|11377301|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0
7177017|NCT03120949|11377302|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1
7177018|NCT03120949|11377301|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0
7177019|NCT03120949|11377302|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2
7177020|NCT03120949|11377301|FG000|Overall Study|Subject Refusal To Attend Visit|0
7177021|NCT03120949|11377302|FG001|Overall Study|Subject Refusal To Attend Visit|1
7177022|NCT03120949|11377301|FG000|Overall Study|Personal Reasons|0
7177023|NCT03120949|11377302|FG001|Overall Study|Personal Reasons|1
7177024|NCT03120949|11377301|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0
7177025|NCT03120949|11377302|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1
7177026|NCT03120949|11377301|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0
7177027|NCT03120949|11377302|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1
7177028|NCT03120949|11377301|FG000|Overall Study|Compliance With Medication|0
7177029|NCT03120949|11377302|FG001|Overall Study|Compliance With Medication|1
7177030|NCT03120949|11377301|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0
7177031|NCT03120949|11377302|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1
7177032|NCT03120949|11377301|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0
7177033|NCT03120949|11377302|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1
7177034|NCT03120949|11377301|FG000|Overall Study|Study Terminated By Principal Investigator|0
7177035|NCT03120949|11377302|FG001|Overall Study|Study Terminated By Principal Investigator|1
7177036|NCT03077698|11377323|FG000|Progestin Monotherapy|Stable Disease|8
7177037|NCT03077698|11377324|FG001|Progestin Monotherapy|Stable Disease|0
7177038|NCT03077698|11377323|FG000|Progestin Monotherapy|Adverse Event|1
7177039|NCT03077698|11377324|FG001|Progestin Monotherapy|Adverse Event|0
7177040|NCT03077698|11377323|FG000|Progestin Monotherapy|Death|1
7177041|NCT03077698|11377324|FG001|Progestin Monotherapy|Death|0
7177042|NCT03077698|11377323|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0
7177043|NCT03077698|11377324|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2
7177044|NCT03077698|11377323|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6
7177045|NCT03077698|11377324|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5
7177046|NCT03077698|11377323|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0
7177047|NCT03077698|11377324|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2
7177048|NCT03077698|11377323|FG000|Safety Follow Up|Withdrawal by Subject|2
7177049|NCT03077698|11377324|FG001|Safety Follow Up|Withdrawal by Subject|1
7177050|NCT03077698|11377323|FG000|Safety Follow Up|Transfer of care to hospice|1
7177051|NCT03077698|11377324|FG001|Safety Follow Up|Transfer of care to hospice|0
7177052|NCT02911935|11377331|FG000|Overall Study|Lost to Follow-up|5
7177053|NCT02911935|11377332|FG001|Overall Study|Lost to Follow-up|7
7177054|NCT02874742|11377341|FG000|Overall Study|Death|3
7177055|NCT02874742|11377342|FG001|Overall Study|Death|1
7177056|NCT02874742|11377343|FG002|Overall Study|Death|1
7177057|NCT02874742|11377341|FG000|Overall Study|Lost to Follow-up|2
7177058|NCT02874742|11377342|FG001|Overall Study|Lost to Follow-up|0
7177059|NCT02874742|11377343|FG002|Overall Study|Lost to Follow-up|0
7177060|NCT02874742|11377341|FG000|Overall Study|Withdrawal by Subject|8
7177061|NCT02874742|11377342|FG001|Overall Study|Withdrawal by Subject|4
7177062|NCT02874742|11377343|FG002|Overall Study|Withdrawal by Subject|0
7177063|NCT02874742|11377341|FG000|Overall Study|Other|3
7177064|NCT02874742|11377342|FG001|Overall Study|Other|1
7177065|NCT02874742|11377343|FG002|Overall Study|Other|0
7177066|NCT02874742|11377341|FG000|Overall Study|Ongoing|87
7177067|NCT02874742|11377342|FG001|Overall Study|Ongoing|98
7177068|NCT02874742|11377343|FG002|Overall Study|Ongoing|15
7177069|NCT02610777|11377370|FG000|Overall Study|Ongoing in Follow-up|14
7177070|NCT02610777|11377371|FG001|Overall Study|Ongoing in Follow-up|12
7177071|NCT02610777|11377370|FG000|Overall Study|Withdrawal by Subject|1
7177072|NCT02610777|11377371|FG001|Overall Study|Withdrawal by Subject|2
7177073|NCT02610777|11377370|FG000|Overall Study|Other|0
7177074|NCT02610777|11377371|FG001|Overall Study|Other|1
7177075|NCT02610777|11377370|FG000|Overall Study|Ongoing on Treatment|6
7177076|NCT02610777|11377371|FG001|Overall Study|Ongoing on Treatment|7
7177077|NCT02557672|11377379|FG000|Overall Study|Withdrawal by Subject|4
7177078|NCT02557672|11377380|FG001|Overall Study|Withdrawal by Subject|2
7177079|NCT02524379|11377386|FG000|Overall Study|Death|1
7177080|NCT02509312|11377392|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5
7177081|NCT02509312|11377393|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3
7177082|NCT02509312|11377392|FG000|Overall Study|Obstetrician refusal|0
7177083|NCT02509312|11377393|FG001|Overall Study|Obstetrician refusal|1
7177084|NCT02509312|11377392|FG000|Overall Study|Patient elected for TOLAC|1
7177085|NCT02509312|11377393|FG001|Overall Study|Patient elected for TOLAC|0
7177086|NCT02509312|11377392|FG000|Overall Study|Cesarean deemed stat|1
7177087|NCT02509312|11377393|FG001|Overall Study|Cesarean deemed stat|0
7177088|NCT02509312|11377392|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0
7177089|NCT02509312|11377393|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1
7177090|NCT02360280|11377423|FG000|Overall Study|Withdrawal by Subject|2
7177091|NCT02360280|11377424|FG001|Overall Study|Withdrawal by Subject|0
7177092|NCT02360280|11377423|FG000|Overall Study|Adverse Event|0
7177093|NCT02360280|11377424|FG001|Overall Study|Adverse Event|1
7177094|NCT02360280|11377423|FG000|Overall Study|Lost to Follow-up|1
7177095|NCT02360280|11377424|FG001|Overall Study|Lost to Follow-up|0
7177096|NCT02294461|11377432|FG000|Double-blind Period (up to 29.4 Months)|Death|6
7177097|NCT02294461|11377433|FG001|Double-blind Period (up to 29.4 Months)|Death|4
7177098|NCT02294461|11377432|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30
7177099|NCT02294461|11377433|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66
7177100|NCT02294461|11377432|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27
7177101|NCT02294461|11377433|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54
7177102|NCT02294461|11377432|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0
7177103|NCT02294461|11377433|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2
7177104|NCT02294461|11377432|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1
7177105|NCT02294461|11377433|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0
7177106|NCT02294461|11377432|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38
7177107|NCT02294461|11377433|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51
7177108|NCT02294461|11377432|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16
7177109|NCT02294461|11377433|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15
7177110|NCT02294461|11377432|FG000|Open-label Period (up to 54.3 Months)|Ongoing|19
7177111|NCT02294461|11377433|FG001|Open-label Period (up to 54.3 Months)|Ongoing|9
7177112|NCT02294461|11377432|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|16
7177113|NCT02294461|11377433|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|12
7177114|NCT02294461|11377432|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|18
7177115|NCT02294461|11377433|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|9
7177116|NCT02294461|11377432|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2
7177117|NCT02294461|11377433|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0
7177118|NCT02294461|11377432|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|3
7177119|NCT02294461|11377433|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|1
7177120|NCT02294461|11377432|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|15
7177121|NCT02294461|11377433|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|9
7177122|NCT02294461|11377432|FG000|Open-label Period (up to 54.3 Months)|Death|6
7177123|NCT02294461|11377433|FG001|Open-label Period (up to 54.3 Months)|Death|5
7177124|NCT02294461|11377432|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6
7177125|NCT02294461|11377433|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|6
7177126|NCT02163395|11377451|FG000|Overall Study|Withdrawal by Subject|1
7177127|NCT02163395|11377451|FG000|Overall Study|Lost to Follow-up|3
7177128|NCT02163395|11377451|FG000|Overall Study|Adverse Event|1
7177129|NCT02097134|11377455|FG000|Overall Study|Physician Decision|4
7177130|NCT02097134|11377455|FG000|Overall Study|Non-Protocol Therapy|1
7177131|NCT02097134|11377455|FG000|Overall Study|Progressive Disease|3
7177132|NCT02097134|11377455|FG000|Overall Study|Refusal of Further Protocol Therapy|1
7177133|NCT02096588|11377462|FG000|Overall Study|Lack of Efficacy|2
7177134|NCT02096588|11377463|FG001|Overall Study|Lack of Efficacy|0
7177135|NCT02096588|11377462|FG000|Overall Study|Withdrawal by Subject|0
7177136|NCT02096588|11377463|FG001|Overall Study|Withdrawal by Subject|1
7177137|NCT02053350|11377469|FG000|Overall Study|Withdrawal by Subject|1
7177138|NCT02053350|11377469|FG000|Overall Study|Adverse Event|4
7177139|NCT02005471|11377475|FG000|Overall Study|Ongoing in Study|144
7177140|NCT02005471|11377476|FG001|Overall Study|Ongoing in Study|171
7177141|NCT02005471|11377475|FG000|Overall Study|Adverse Event|1
7177142|NCT02005471|11377476|FG001|Overall Study|Adverse Event|0
7177143|NCT02005471|11377475|FG000|Overall Study|Death|26
7177144|NCT02005471|11377476|FG001|Overall Study|Death|15
7177145|NCT02005471|11377475|FG000|Overall Study|Lost to Follow-up|1
7177146|NCT02005471|11377476|FG001|Overall Study|Lost to Follow-up|0
7177147|NCT02005471|11377475|FG000|Overall Study|Physician Decision|2
7177148|NCT02005471|11377476|FG001|Overall Study|Physician Decision|1
7177149|NCT02005471|11377475|FG000|Overall Study|Progressive Disease|3
7177150|NCT02005471|11377476|FG001|Overall Study|Progressive Disease|0
7177151|NCT02005471|11377475|FG000|Overall Study|Withdrawal by Subject|18
7177152|NCT02005471|11377476|FG001|Overall Study|Withdrawal by Subject|7
7177153|NCT01965704|11377489|FG000|Overall Study|Withdrawal by Subject|2
7177154|NCT01965704|11377490|FG001|Overall Study|Withdrawal by Subject|2
7177155|NCT01965704|11377491|FG002|Overall Study|Withdrawal by Subject|1
7177156|NCT01965704|11377492|FG003|Overall Study|Withdrawal by Subject|1
7177157|NCT01965704|11377489|FG000|Overall Study|Delivered at home|1
7177158|NCT01965704|11377490|FG001|Overall Study|Delivered at home|1
7177159|NCT01965704|11377491|FG002|Overall Study|Delivered at home|0
7177160|NCT01965704|11377492|FG003|Overall Study|Delivered at home|0
7177161|NCT01965704|11377489|FG000|Overall Study|Experienced complications|0
7177162|NCT01965704|11377490|FG001|Overall Study|Experienced complications|0
7177163|NCT01965704|11377491|FG002|Overall Study|Experienced complications|2
7177164|NCT01965704|11377492|FG003|Overall Study|Experienced complications|2
7177165|NCT01965704|11377489|FG000|Overall Study|Adverse Event|0
7177166|NCT01965704|11377490|FG001|Overall Study|Adverse Event|0
7177167|NCT01965704|11377491|FG002|Overall Study|Adverse Event|1
7177168|NCT01965704|11377492|FG003|Overall Study|Adverse Event|1
7177169|NCT01965704|11377489|FG000|Overall Study|Did not meet inclusion criteria|0
7177170|NCT01965704|11377490|FG001|Overall Study|Did not meet inclusion criteria|0
7177171|NCT01965704|11377491|FG002|Overall Study|Did not meet inclusion criteria|1
7177172|NCT01965704|11377492|FG003|Overall Study|Did not meet inclusion criteria|1
7177173|NCT01855412|11377520|FG000|Overall Study|Death|77
7177174|NCT01855412|11377521|FG001|Overall Study|Death|123
7177175|NCT01855412|11377522|FG002|Overall Study|Death|30
7177176|NCT01855412|11377520|FG000|Overall Study|Lost to Follow-up|28
7177177|NCT01855412|11377521|FG001|Overall Study|Lost to Follow-up|46
7177178|NCT01855412|11377522|FG002|Overall Study|Lost to Follow-up|15
7177179|NCT01855412|11377520|FG000|Overall Study|Withdrawal by Subject|77
7177180|NCT01855412|11377521|FG001|Overall Study|Withdrawal by Subject|123
7177181|NCT01855412|11377522|FG002|Overall Study|Withdrawal by Subject|24
7177182|NCT01855412|11377520|FG000|Overall Study|Physician Decision|25
7177183|NCT01855412|11377521|FG001|Overall Study|Physician Decision|31
7177184|NCT01855412|11377522|FG002|Overall Study|Physician Decision|3
7177185|NCT01855412|11377520|FG000|Overall Study|Site Closure|4
7177186|NCT01855412|11377521|FG001|Overall Study|Site Closure|18
7177187|NCT01855412|11377522|FG002|Overall Study|Site Closure|1
7177188|NCT01855412|11377520|FG000|Overall Study|Reason not Specified|1
7177189|NCT01855412|11377521|FG001|Overall Study|Reason not Specified|2
7177190|NCT01855412|11377522|FG002|Overall Study|Reason not Specified|3
7177191|NCT01661881|11377545|FG000|Overall Study|Disease Progression|1
7177192|NCT01621568|11377560|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1
7177193|NCT01621568|11377561|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0
7177194|NCT01621568|11377560|FG000|Week 5-6 No Treatment|Death|1
7177195|NCT01621568|11377561|FG001|Week 5-6 No Treatment|Death|0
7177196|NCT01070069|11377584|FG000|Overall Study|Death|1
7177197|NCT01070069|11377585|FG001|Overall Study|Death|0
7177198|NCT01070069|11377586|FG002|Overall Study|Death|2
7177199|NCT01070069|11377587|FG003|Overall Study|Death|0
7177200|NCT01070069|11377588|FG004|Overall Study|Death|1
7177201|NCT01070069|11377584|FG000|Overall Study|Withdrawal by Subject|1
7177202|NCT01070069|11377585|FG001|Overall Study|Withdrawal by Subject|1
7177203|NCT01070069|11377586|FG002|Overall Study|Withdrawal by Subject|4
7177204|NCT01070069|11377587|FG003|Overall Study|Withdrawal by Subject|0
7177205|NCT01070069|11377588|FG004|Overall Study|Withdrawal by Subject|0
7177206|NCT01070069|11377584|FG000|Overall Study|Lost to Follow-up|4
7177207|NCT01070069|11377585|FG001|Overall Study|Lost to Follow-up|1
7177208|NCT01070069|11377586|FG002|Overall Study|Lost to Follow-up|0
7177209|NCT01070069|11377587|FG003|Overall Study|Lost to Follow-up|0
7177210|NCT01070069|11377588|FG004|Overall Study|Lost to Follow-up|3
7177211|NCT00501046|11377627|FG000|Overall Study|Adverse Event|21
7177212|NCT00501046|11377628|FG001|Overall Study|Adverse Event|25
7177213|NCT00501046|11377627|FG000|Overall Study|Death|23
7177214|NCT00501046|11377628|FG001|Overall Study|Death|30
7177215|NCT00501046|11377627|FG000|Overall Study|Lost to Follow-up|14
7177216|NCT00501046|11377628|FG001|Overall Study|Lost to Follow-up|13
7177217|NCT00501046|11377627|FG000|Overall Study|Physician Decision|7
7177218|NCT00501046|11377628|FG001|Overall Study|Physician Decision|2
7177219|NCT00501046|11377627|FG000|Overall Study|Pregnancy|0
7177220|NCT00501046|11377628|FG001|Overall Study|Pregnancy|3
7177221|NCT00501046|11377627|FG000|Overall Study|Protocol Violation|2
7177222|NCT00501046|11377628|FG001|Overall Study|Protocol Violation|1
7177223|NCT00501046|11377627|FG000|Overall Study|Withdrawal by Subject|84
7177224|NCT00501046|11377628|FG001|Overall Study|Withdrawal by Subject|83
7177225|NCT00501046|11377627|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119
7177226|NCT00501046|11377628|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137
7177227|NCT00500682|11377636|FG000|Overall Study|Adverse Event|37
7177228|NCT00500682|11377637|FG001|Overall Study|Adverse Event|29
7177229|NCT00500682|11377636|FG000|Overall Study|Death|25
7177230|NCT00500682|11377637|FG001|Overall Study|Death|16
7177231|NCT00500682|11377636|FG000|Overall Study|Lost to Follow-up|11
7177232|NCT00500682|11377637|FG001|Overall Study|Lost to Follow-up|11
7177233|NCT00500682|11377636|FG000|Overall Study|Physician Decision|6
7177234|NCT00500682|11377637|FG001|Overall Study|Physician Decision|10
7177235|NCT00500682|11377636|FG000|Overall Study|Pregnancy|2
7177236|NCT00500682|11377637|FG001|Overall Study|Pregnancy|0
7177237|NCT00500682|11377636|FG000|Overall Study|Protocol Violation|1
7177238|NCT00500682|11377637|FG001|Overall Study|Protocol Violation|3
7177239|NCT00500682|11377636|FG000|Overall Study|Withdrawal by Subject|80
7177240|NCT00500682|11377637|FG001|Overall Study|Withdrawal by Subject|74
7177241|NCT00500682|11377636|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144
7177242|NCT00500682|11377637|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144
7177243|NCT00334815|11377645|FG000|Overall Study|Adverse Event|3
7177244|NCT00334815|11377646|FG001|Overall Study|Adverse Event|2
7177245|NCT00334815|11377645|FG000|Overall Study|Death|0
7177246|NCT00334815|11377646|FG001|Overall Study|Death|2
7177247|NCT00334815|11377645|FG000|Overall Study|Progression|1
7177248|NCT00334815|11377646|FG001|Overall Study|Progression|0
7177249|NCT00334815|11377645|FG000|Overall Study|ineligible|1
7177250|NCT00334815|11377646|FG001|Overall Study|ineligible|1
7177251|NCT00334815|11377645|FG000|Overall Study|patient refused treatment|0
7177252|NCT00334815|11377646|FG001|Overall Study|patient refused treatment|1
7177253|NCT00334815|11377645|FG000|Overall Study|Physician Decision|2
7177254|NCT00334815|11377646|FG001|Overall Study|Physician Decision|4
7177255|NCT00001277|11377657|FG000|Overall Study|Adverse Event|0
7177256|NCT00001277|11377658|FG001|Overall Study|Adverse Event|0
7177257|NCT00001277|11377659|FG002|Overall Study|Adverse Event|1
7177258|NCT00001277|11377657|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0
7177259|NCT00001277|11377658|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0
7177260|NCT00001277|11377659|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2
7186122|NCT02696031|11386435|FG002|Up to Week 52|Adverse Event|3
7186123|NCT02696031|11386436|FG003|Up to Week 52|Adverse Event|0
7186124|NCT02696031|11386437|FG004|Up to Week 52|Adverse Event|0
7186125|NCT02696031|11386438|FG005|Up to Week 52|Adverse Event|0
7186126|NCT02696031|11386433|FG000|Up to Week 52|Lack of Efficacy|10
7186127|NCT02696031|11386434|FG001|Up to Week 52|Lack of Efficacy|7
7186128|NCT02696031|11386435|FG002|Up to Week 52|Lack of Efficacy|11
7186129|NCT02696031|11386436|FG003|Up to Week 52|Lack of Efficacy|0
7186130|NCT02696031|11386437|FG004|Up to Week 52|Lack of Efficacy|0
7186131|NCT02696031|11386438|FG005|Up to Week 52|Lack of Efficacy|0
7186132|NCT02696031|11386433|FG000|Up to Week 52|Lost to Follow-up|1
7186133|NCT02696031|11386434|FG001|Up to Week 52|Lost to Follow-up|1
7186134|NCT02696031|11386435|FG002|Up to Week 52|Lost to Follow-up|1
7186135|NCT02696031|11386436|FG003|Up to Week 52|Lost to Follow-up|0
7186136|NCT02696031|11386437|FG004|Up to Week 52|Lost to Follow-up|0
7186137|NCT02696031|11386438|FG005|Up to Week 52|Lost to Follow-up|0
7186138|NCT02696031|11386433|FG000|Up to Week 52|Physician Decision|1
7186139|NCT02696031|11386434|FG001|Up to Week 52|Physician Decision|1
7186140|NCT02696031|11386435|FG002|Up to Week 52|Physician Decision|2
7186141|NCT02696031|11386436|FG003|Up to Week 52|Physician Decision|0
7186142|NCT02696031|11386437|FG004|Up to Week 52|Physician Decision|0
7186143|NCT02696031|11386438|FG005|Up to Week 52|Physician Decision|0
7186144|NCT02696031|11386433|FG000|Up to Week 52|Pregnancy|0
7186145|NCT02696031|11386434|FG001|Up to Week 52|Pregnancy|2
7186146|NCT02696031|11386435|FG002|Up to Week 52|Pregnancy|0
7186147|NCT02696031|11386436|FG003|Up to Week 52|Pregnancy|0
7186148|NCT02696031|11386437|FG004|Up to Week 52|Pregnancy|0
7186149|NCT02696031|11386438|FG005|Up to Week 52|Pregnancy|0
7186150|NCT02696031|11386433|FG000|Up to Week 52|Protocol Violation|1
7186151|NCT02696031|11386434|FG001|Up to Week 52|Protocol Violation|0
7186152|NCT02696031|11386435|FG002|Up to Week 52|Protocol Violation|0
7186153|NCT02696031|11386436|FG003|Up to Week 52|Protocol Violation|0
7186154|NCT02696031|11386437|FG004|Up to Week 52|Protocol Violation|0
7186155|NCT02696031|11386438|FG005|Up to Week 52|Protocol Violation|0
7186156|NCT02696031|11386433|FG000|Up to Week 52|Withdrawal by Subject|12
7186157|NCT02696031|11386434|FG001|Up to Week 52|Withdrawal by Subject|3
7186158|NCT02696031|11386435|FG002|Up to Week 52|Withdrawal by Subject|9
7186159|NCT02696031|11386436|FG003|Up to Week 52|Withdrawal by Subject|0
7177261|NCT01009294|11377668|FG000|Overall Study|Study discontinued by Sponsor|6
7177262|NCT01072175|11377693|FG000|Part A (Drug-Drug Interaction)|Death|1
7177263|NCT01072175|11377694|FG001|Part A (Drug-Drug Interaction)|Death|0
7177264|NCT01072175|11377695|FG002|Part A (Drug-Drug Interaction)|Death|0
7177265|NCT01072175|11377696|FG003|Part A (Drug-Drug Interaction)|Death|0
7177266|NCT01072175|11377697|FG004|Part A (Drug-Drug Interaction)|Death|0
7177267|NCT01072175|11377698|FG005|Part A (Drug-Drug Interaction)|Death|0
7177268|NCT01072175|11377699|FG006|Part A (Drug-Drug Interaction)|Death|0
7177269|NCT01072175|11377700|FG007|Part A (Drug-Drug Interaction)|Death|0
7177270|NCT01072175|11377701|FG008|Part A (Drug-Drug Interaction)|Death|0
7177271|NCT01072175|11377702|FG009|Part A (Drug-Drug Interaction)|Death|0
7177272|NCT01072175|11377703|FG010|Part A (Drug-Drug Interaction)|Death|0
7177273|NCT01072175|11377704|FG011|Part A (Drug-Drug Interaction)|Death|0
7177274|NCT01072175|11377705|FG012|Part A (Drug-Drug Interaction)|Death|0
7177275|NCT01072175|11377693|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6
7177276|NCT01072175|11377694|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0
7177277|NCT01072175|11377695|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0
7177278|NCT01072175|11377696|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0
7177279|NCT01072175|11377697|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0
7177280|NCT01072175|11377698|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0
7177281|NCT01072175|11377699|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0
7177282|NCT01072175|11377700|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0
7177283|NCT01072175|11377701|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0
7177284|NCT01072175|11377702|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0
7177285|NCT01072175|11377703|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0
7177286|NCT01072175|11377704|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0
7177287|NCT01072175|11377705|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0
7177288|NCT01072175|11377693|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1
7177289|NCT01072175|11377694|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7177290|NCT01072175|11377695|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7177291|NCT01072175|11377696|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7177292|NCT01072175|11377697|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7177293|NCT01072175|11377698|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7177294|NCT01072175|11377699|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7177295|NCT01072175|11377700|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7177296|NCT01072175|11377701|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7177297|NCT01072175|11377702|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7177298|NCT01072175|11377703|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7177299|NCT01072175|11377704|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7177300|NCT01072175|11377705|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7177301|NCT01072175|11377693|FG000|Part B (Dose Escalation and Expansion)|Death|0
7177302|NCT01072175|11377694|FG001|Part B (Dose Escalation and Expansion)|Death|4
7177303|NCT01072175|11377695|FG002|Part B (Dose Escalation and Expansion)|Death|18
7177304|NCT01072175|11377696|FG003|Part B (Dose Escalation and Expansion)|Death|21
7177305|NCT01072175|11377697|FG004|Part B (Dose Escalation and Expansion)|Death|68
7177306|NCT01072175|11377698|FG005|Part B (Dose Escalation and Expansion)|Death|0
7177307|NCT01072175|11377699|FG006|Part B (Dose Escalation and Expansion)|Death|0
7177308|NCT01072175|11377700|FG007|Part B (Dose Escalation and Expansion)|Death|0
7177309|NCT01072175|11377701|FG008|Part B (Dose Escalation and Expansion)|Death|0
7177310|NCT01072175|11377702|FG009|Part B (Dose Escalation and Expansion)|Death|0
7177311|NCT01072175|11377703|FG010|Part B (Dose Escalation and Expansion)|Death|0
7177312|NCT01072175|11377704|FG011|Part B (Dose Escalation and Expansion)|Death|0
7177313|NCT01072175|11377705|FG012|Part B (Dose Escalation and Expansion)|Death|0
7177314|NCT01072175|11377693|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0
7177315|NCT01072175|11377694|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0
7177316|NCT01072175|11377695|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2
7177317|NCT01072175|11377696|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0
7177318|NCT01072175|11377697|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4
7177319|NCT01072175|11377698|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0
7177320|NCT01072175|11377699|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0
7177321|NCT01072175|11377700|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0
7177322|NCT01072175|11377701|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0
7177323|NCT01072175|11377702|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0
7177324|NCT01072175|11377703|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0
7177325|NCT01072175|11377704|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0
7177326|NCT01072175|11377705|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0
7177327|NCT01072175|11377693|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7177328|NCT01072175|11377694|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1
7177329|NCT01072175|11377695|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7177330|NCT01072175|11377696|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1
7177331|NCT01072175|11377697|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6
7177332|NCT01072175|11377698|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7177333|NCT01072175|11377699|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7177334|NCT01072175|11377700|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7177335|NCT01072175|11377701|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7177336|NCT01072175|11377702|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7177337|NCT01072175|11377703|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7177338|NCT01072175|11377704|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7177339|NCT01072175|11377705|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7177340|NCT01072175|11377693|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7177341|NCT01072175|11377694|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7177342|NCT01072175|11377695|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3
7177343|NCT01072175|11377696|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2
7177344|NCT01072175|11377697|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10
7177345|NCT01072175|11377698|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7177346|NCT01072175|11377699|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7177347|NCT01072175|11377700|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7177348|NCT01072175|11377701|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7177349|NCT01072175|11377702|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7177350|NCT01072175|11377703|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7177351|NCT01072175|11377704|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7177352|NCT01072175|11377705|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7177353|NCT01072175|11377693|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7177354|NCT01072175|11377694|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1
7177355|NCT01072175|11377695|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7177356|NCT01072175|11377696|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3
7177357|NCT01072175|11377697|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6
7177358|NCT01072175|11377698|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7177359|NCT01072175|11377699|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7177360|NCT01072175|11377700|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7177361|NCT01072175|11377701|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7177362|NCT01072175|11377702|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7177363|NCT01072175|11377703|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7177364|NCT01072175|11377704|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7177365|NCT01072175|11377705|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7177366|NCT01072175|11377693|FG000|Part C (Phase II: Randomized Phase)|Death|0
7177367|NCT01072175|11377694|FG001|Part C (Phase II: Randomized Phase)|Death|0
7177368|NCT01072175|11377695|FG002|Part C (Phase II: Randomized Phase)|Death|0
7177369|NCT01072175|11377696|FG003|Part C (Phase II: Randomized Phase)|Death|0
7177370|NCT01072175|11377697|FG004|Part C (Phase II: Randomized Phase)|Death|0
7177371|NCT01072175|11377698|FG005|Part C (Phase II: Randomized Phase)|Death|44
7177372|NCT01072175|11377699|FG006|Part C (Phase II: Randomized Phase)|Death|34
7177373|NCT01072175|11377700|FG007|Part C (Phase II: Randomized Phase)|Death|39
7177374|NCT01072175|11377701|FG008|Part C (Phase II: Randomized Phase)|Death|0
7177375|NCT01072175|11377702|FG009|Part C (Phase II: Randomized Phase)|Death|0
7177376|NCT01072175|11377703|FG010|Part C (Phase II: Randomized Phase)|Death|0
7177377|NCT01072175|11377704|FG011|Part C (Phase II: Randomized Phase)|Death|0
7177378|NCT01072175|11377705|FG012|Part C (Phase II: Randomized Phase)|Death|0
7177379|NCT01072175|11377693|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0
7177380|NCT01072175|11377694|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0
7177381|NCT01072175|11377695|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0
7177382|NCT01072175|11377696|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0
7177383|NCT01072175|11377697|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0
7177384|NCT01072175|11377698|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1
7177385|NCT01072175|11377699|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1
7177386|NCT01072175|11377700|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1
7177387|NCT01072175|11377701|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0
7177388|NCT01072175|11377702|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0
7177389|NCT01072175|11377703|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0
7177390|NCT01072175|11377704|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0
7177391|NCT01072175|11377705|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0
7177392|NCT01072175|11377693|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7177393|NCT01072175|11377694|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7177394|NCT01072175|11377695|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7177395|NCT01072175|11377696|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7177396|NCT01072175|11377697|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7177397|NCT01072175|11377698|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7177398|NCT01072175|11377699|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3
7177399|NCT01072175|11377700|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3
7177400|NCT01072175|11377701|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7177401|NCT01072175|11377702|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7177402|NCT01072175|11377703|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7177403|NCT01072175|11377704|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7177404|NCT01072175|11377705|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7177405|NCT01072175|11377693|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7177406|NCT01072175|11377694|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7177407|NCT01072175|11377695|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7177408|NCT01072175|11377696|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7177409|NCT01072175|11377697|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7177410|NCT01072175|11377698|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6
7177411|NCT01072175|11377699|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9
7177412|NCT01072175|11377700|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11
7177413|NCT01072175|11377701|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7177414|NCT01072175|11377702|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7177415|NCT01072175|11377703|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7177416|NCT01072175|11377704|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7177417|NCT01072175|11377705|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7177418|NCT01072175|11377693|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7177419|NCT01072175|11377694|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7177420|NCT01072175|11377695|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7177421|NCT01072175|11377696|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7177422|NCT01072175|11377697|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7177423|NCT01072175|11377698|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3
7177424|NCT01072175|11377699|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7
7177425|NCT01072175|11377700|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7177426|NCT01072175|11377701|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7177427|NCT01072175|11377702|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
6895327|NCT00624338|10913168|FG000|Overall Study|Death|0
6895328|NCT00624338|10913169|FG001|Overall Study|Death|2
6895329|NCT00624338|10913170|FG002|Overall Study|Death|0
6895330|NCT00624338|10913168|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1
6895331|NCT00624338|10913169|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0
6895332|NCT00624338|10913170|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0
6895333|NCT00624338|10913168|FG000|Overall Study|Termination of 150 mg group by Sponsor|0
6895334|NCT00624338|10913169|FG001|Overall Study|Termination of 150 mg group by Sponsor|55
6895335|NCT00624338|10913170|FG002|Overall Study|Termination of 150 mg group by Sponsor|0
6895336|NCT00624338|10913168|FG000|Overall Study|Other|15
6895337|NCT00624338|10913169|FG001|Overall Study|Other|5
6895338|NCT00624338|10913170|FG002|Overall Study|Other|9
6895339|NCT00624338|10913168|FG000|Overall Study|Randomized but not treated|2
6895340|NCT00624338|10913169|FG001|Overall Study|Randomized but not treated|1
6895341|NCT00624338|10913170|FG002|Overall Study|Randomized but not treated|3
6895342|NCT00624377|10913178|FG000|Overall Study|Lost to Follow-up|355
6895343|NCT00624377|10913178|FG000|Overall Study|Withdrawal by Subject|100
6895344|NCT00624377|10913178|FG000|Overall Study|Adverse Event|14
6895345|NCT00624377|10913178|FG000|Overall Study|Other|91
6895346|NCT00624377|10913178|FG000|Overall Study|Non-evaluable population|84
6895347|NCT00624468|10913230|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13
6895348|NCT00624468|10913231|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12
6895349|NCT00624468|10913232|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0
7177428|NCT01072175|11377703|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7177429|NCT01072175|11377704|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7177430|NCT01072175|11377705|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7177431|NCT01072175|11377693|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0
7177432|NCT01072175|11377694|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0
7177433|NCT01072175|11377695|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0
7177434|NCT01072175|11377696|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0
7177435|NCT01072175|11377697|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0
7177436|NCT01072175|11377698|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0
7177437|NCT01072175|11377699|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0
7177438|NCT01072175|11377700|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0
7177439|NCT01072175|11377701|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37
7080892|NCT02127970|11190685|FG000|Overall Study|Subject Withdrew Consent|5
7080893|NCT02127970|11190686|FG001|Overall Study|Subject Withdrew Consent|3
7080894|NCT02128217|11190698|FG000|Overall Study|Lost to Follow-up|0
7080895|NCT02128217|11190699|FG001|Overall Study|Lost to Follow-up|1
7080896|NCT02128269|11190714|FG000|Treatment Period|Adverse Event|1
7177440|NCT01072175|11377702|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0
7177441|NCT01072175|11377703|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0
7177442|NCT01072175|11377704|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0
7177443|NCT01072175|11377705|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0
7177444|NCT01072175|11377693|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7177445|NCT01072175|11377694|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7177446|NCT01072175|11377695|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7177447|NCT01072175|11377696|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7177448|NCT01072175|11377697|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7177449|NCT01072175|11377698|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7177450|NCT01072175|11377699|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7177451|NCT01072175|11377700|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7177452|NCT01072175|11377701|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1
7177453|NCT01072175|11377702|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7177454|NCT01072175|11377703|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7177455|NCT01072175|11377704|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7177456|NCT01072175|11377705|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7177457|NCT01072175|11377693|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7177458|NCT01072175|11377694|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7177459|NCT01072175|11377695|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7177460|NCT01072175|11377696|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7177461|NCT01072175|11377697|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7177462|NCT01072175|11377698|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7177463|NCT01072175|11377699|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7177464|NCT01072175|11377700|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7177465|NCT01072175|11377701|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4
7177466|NCT01072175|11377702|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7177467|NCT01072175|11377703|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7177468|NCT01072175|11377704|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7177469|NCT01072175|11377705|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7177470|NCT01072175|11377693|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7177471|NCT01072175|11377694|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7177472|NCT01072175|11377695|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7177473|NCT01072175|11377696|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7177474|NCT01072175|11377697|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7177475|NCT01072175|11377698|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7177476|NCT01072175|11377699|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7177477|NCT01072175|11377700|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7177478|NCT01072175|11377701|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3
7177479|NCT01072175|11377702|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7177480|NCT01072175|11377703|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7177481|NCT01072175|11377704|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7177482|NCT01072175|11377705|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7177483|NCT01072175|11377693|FG000|Part D (HPMC Capsules)|Death|0
7177484|NCT01072175|11377694|FG001|Part D (HPMC Capsules)|Death|0
7177485|NCT01072175|11377695|FG002|Part D (HPMC Capsules)|Death|0
7177486|NCT01072175|11377696|FG003|Part D (HPMC Capsules)|Death|0
7177487|NCT01072175|11377697|FG004|Part D (HPMC Capsules)|Death|0
7177488|NCT01072175|11377698|FG005|Part D (HPMC Capsules)|Death|0
7177489|NCT01072175|11377699|FG006|Part D (HPMC Capsules)|Death|0
7177490|NCT01072175|11377700|FG007|Part D (HPMC Capsules)|Death|0
7177491|NCT01072175|11377701|FG008|Part D (HPMC Capsules)|Death|0
7177492|NCT01072175|11377702|FG009|Part D (HPMC Capsules)|Death|10
7177493|NCT01072175|11377703|FG010|Part D (HPMC Capsules)|Death|12
7080897|NCT02128269|11190714|FG000|Treatment Period|Physician Decision|1
7177494|NCT01072175|11377704|FG011|Part D (HPMC Capsules)|Death|28
7177495|NCT01072175|11377705|FG012|Part D (HPMC Capsules)|Death|26
7177496|NCT01072175|11377693|FG000|Part D (HPMC Capsules)|Physician Decision|0
7177497|NCT01072175|11377694|FG001|Part D (HPMC Capsules)|Physician Decision|0
7177498|NCT01072175|11377695|FG002|Part D (HPMC Capsules)|Physician Decision|0
7177499|NCT01072175|11377696|FG003|Part D (HPMC Capsules)|Physician Decision|0
7080898|NCT02128490|11190723|FG000|Overall Study|Pretreatment Event/Adverse Event|1
7080899|NCT02128490|11190724|FG001|Overall Study|Pretreatment Event/Adverse Event|0
7080900|NCT02128490|11190725|FG002|Overall Study|Pretreatment Event/Adverse Event|1
7080901|NCT02128490|11190726|FG003|Overall Study|Pretreatment Event/Adverse Event|1
7080902|NCT02128490|11190727|FG004|Overall Study|Pretreatment Event/Adverse Event|0
7080903|NCT02128490|11190723|FG000|Overall Study|Major Protocol Deviation|1
7080904|NCT02128490|11190724|FG001|Overall Study|Major Protocol Deviation|2
7080905|NCT02128490|11190725|FG002|Overall Study|Major Protocol Deviation|0
7080906|NCT02128490|11190726|FG003|Overall Study|Major Protocol Deviation|2
7080907|NCT02128490|11190727|FG004|Overall Study|Major Protocol Deviation|2
7177500|NCT01072175|11377697|FG004|Part D (HPMC Capsules)|Physician Decision|0
6895350|NCT00624468|10913233|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0
6895351|NCT00624468|10913230|FG000|Double-blind Period|Withdrew Prematurely|1
6895352|NCT00624468|10913231|FG001|Double-blind Period|Withdrew Prematurely|1
6895353|NCT00624468|10913232|FG002|Double-blind Period|Withdrew Prematurely|0
6895354|NCT00624468|10913233|FG003|Double-blind Period|Withdrew Prematurely|0
6895355|NCT00624468|10913230|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0
6895356|NCT00624468|10913231|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0
7177501|NCT01072175|11377698|FG005|Part D (HPMC Capsules)|Physician Decision|0
7177502|NCT01072175|11377699|FG006|Part D (HPMC Capsules)|Physician Decision|0
7177503|NCT01072175|11377700|FG007|Part D (HPMC Capsules)|Physician Decision|0
7177504|NCT01072175|11377701|FG008|Part D (HPMC Capsules)|Physician Decision|0
7177505|NCT01072175|11377702|FG009|Part D (HPMC Capsules)|Physician Decision|0
7177506|NCT01072175|11377703|FG010|Part D (HPMC Capsules)|Physician Decision|1
7177507|NCT01072175|11377704|FG011|Part D (HPMC Capsules)|Physician Decision|1
7177508|NCT01072175|11377705|FG012|Part D (HPMC Capsules)|Physician Decision|1
7177509|NCT01072175|11377693|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0
7177510|NCT01072175|11377694|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0
7177511|NCT01072175|11377695|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0
7177512|NCT01072175|11377696|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0
7177513|NCT01072175|11377697|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0
7177514|NCT01072175|11377698|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0
7177515|NCT01072175|11377699|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0
7177516|NCT01072175|11377700|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0
7177517|NCT01072175|11377701|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0
7177518|NCT01072175|11377702|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0
7177519|NCT01072175|11377703|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1
7177520|NCT01072175|11377704|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1
7177521|NCT01072175|11377705|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3
7177522|NCT01072175|11377693|FG000|Part D (HPMC Capsules)|Study closed/terminated|0
7177523|NCT01072175|11377694|FG001|Part D (HPMC Capsules)|Study closed/terminated|0
7177524|NCT01072175|11377695|FG002|Part D (HPMC Capsules)|Study closed/terminated|0
7177525|NCT01072175|11377696|FG003|Part D (HPMC Capsules)|Study closed/terminated|0
7177526|NCT01072175|11377697|FG004|Part D (HPMC Capsules)|Study closed/terminated|0
7177527|NCT01072175|11377698|FG005|Part D (HPMC Capsules)|Study closed/terminated|0
7177528|NCT01072175|11377699|FG006|Part D (HPMC Capsules)|Study closed/terminated|0
7177529|NCT01072175|11377700|FG007|Part D (HPMC Capsules)|Study closed/terminated|0
7177530|NCT01072175|11377701|FG008|Part D (HPMC Capsules)|Study closed/terminated|0
7177531|NCT01072175|11377702|FG009|Part D (HPMC Capsules)|Study closed/terminated|2
7177532|NCT01072175|11377703|FG010|Part D (HPMC Capsules)|Study closed/terminated|1
7177533|NCT01072175|11377704|FG011|Part D (HPMC Capsules)|Study closed/terminated|10
7177534|NCT01072175|11377705|FG012|Part D (HPMC Capsules)|Study closed/terminated|9
7177535|NCT01072175|11377693|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0
7177536|NCT01072175|11377694|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0
7177537|NCT01072175|11377695|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0
7177538|NCT01072175|11377696|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0
7177539|NCT01072175|11377697|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0
7177540|NCT01072175|11377698|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0
7177541|NCT01072175|11377699|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0
7177542|NCT01072175|11377700|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0
7177543|NCT01072175|11377701|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0
7177544|NCT01072175|11377702|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0
7177545|NCT01072175|11377703|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1
6895357|NCT00624468|10913232|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1
6895358|NCT00624468|10913233|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2
6895359|NCT00624468|10913230|FG000|Safety Follow-up (SFU) Period|Other|0
6895360|NCT00624468|10913231|FG001|Safety Follow-up (SFU) Period|Other|0
6895361|NCT00624468|10913232|FG002|Safety Follow-up (SFU) Period|Other|1
6895362|NCT00624468|10913233|FG003|Safety Follow-up (SFU) Period|Other|1
6895363|NCT00624520|10913243|FG000|Overall Study|Withdrawal by Subject|12
6895364|NCT00624520|10913244|FG001|Overall Study|Withdrawal by Subject|7
6895365|NCT00624520|10913243|FG000|Overall Study|Death|0
7177546|NCT01072175|11377704|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3
7177547|NCT01072175|11377705|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0
7177548|NCT01087203|11377739|FG000|Overall Study|Lost to Follow-up|2
7177549|NCT01087203|11377740|FG001|Overall Study|Lost to Follow-up|0
7177550|NCT01087203|11377739|FG000|Overall Study|Withdrawal by Subject|2
7177551|NCT01087203|11377740|FG001|Overall Study|Withdrawal by Subject|6
7177552|NCT01087203|11377739|FG000|Overall Study|Lack of Efficacy|1
7177553|NCT01087203|11377740|FG001|Overall Study|Lack of Efficacy|2
7177554|NCT01087203|11377739|FG000|Overall Study|Study terminated by sponsor|27
7177555|NCT01087203|11377740|FG001|Overall Study|Study terminated by sponsor|27
7177556|NCT01108055|11377751|FG000|Overall Study|Ineligible|11
7177557|NCT01108055|11377751|FG000|Overall Study|Not evaluable- didn't complete treatment|4
7177558|NCT01111019|11377755|FG000|Overall Study|Withdrew Prematurely|2
7177559|NCT01111019|11377755|FG000|Overall Study|Other|1
7177560|NCT01136967|11377761|FG000|Overall Study|Adverse Event|9
7177561|NCT01136967|11377762|FG001|Overall Study|Adverse Event|12
7177562|NCT01136967|11377761|FG000|Overall Study|Participant Choice|8
7177563|NCT01136967|11377762|FG001|Overall Study|Participant Choice|3
7177564|NCT01136967|11377761|FG000|Overall Study|Lost to Follow-up|0
7177565|NCT01136967|11377762|FG001|Overall Study|Lost to Follow-up|1
7177566|NCT01136967|11377761|FG000|Overall Study|Withdrawal by Subject|1
7177567|NCT01136967|11377762|FG001|Overall Study|Withdrawal by Subject|2
7177568|NCT01136967|11377761|FG000|Overall Study|Clinical Progression|3
7177569|NCT01136967|11377762|FG001|Overall Study|Clinical Progression|5
7177570|NCT01136967|11377761|FG000|Overall Study|Radiation|1
7177571|NCT01136967|11377762|FG001|Overall Study|Radiation|0
7177572|NCT01136967|11377761|FG000|Overall Study|Non-compliance|1
7177573|NCT01136967|11377762|FG001|Overall Study|Non-compliance|0
7177574|NCT01136967|11377761|FG000|Overall Study|Investigator's Choice|1
7177575|NCT01136967|11377762|FG001|Overall Study|Investigator's Choice|1
7177576|NCT01136967|11377761|FG000|Overall Study|Increase in Lesion Size|0
7177577|NCT01136967|11377762|FG001|Overall Study|Increase in Lesion Size|2
7177578|NCT01136967|11377761|FG000|Overall Study|Diagnosis of Second Primary Cancer|0
7177579|NCT01136967|11377762|FG001|Overall Study|Diagnosis of Second Primary Cancer|1
7177580|NCT01137955|11377779|FG000|Overall Study|Withdrawal by Subject|5
7177581|NCT01137955|11377780|FG001|Overall Study|Withdrawal by Subject|4
7177582|NCT01140451|11377789|FG000|Overall Study|Withdrawal by Subject|26
7177583|NCT01140451|11377790|FG001|Overall Study|Withdrawal by Subject|33
7177584|NCT01140451|11377789|FG000|Overall Study|Adverse Event|2
7177585|NCT01140451|11377790|FG001|Overall Study|Adverse Event|6
7177586|NCT01140451|11377789|FG000|Overall Study|Physician Decision|5
7177587|NCT01140451|11377790|FG001|Overall Study|Physician Decision|3
7177588|NCT01140451|11377789|FG000|Overall Study|Lost to Follow-up|2
7177589|NCT01140451|11377790|FG001|Overall Study|Lost to Follow-up|0
7177590|NCT01140451|11377789|FG000|Overall Study|Participants Planning Pregnancy|3
7177591|NCT01140451|11377790|FG001|Overall Study|Participants Planning Pregnancy|0
7177592|NCT01174563|11377797|FG000|Overall Study|Progressive Disease|45
7177593|NCT01174563|11377797|FG000|Overall Study|Death|5
7177594|NCT01174563|11377797|FG000|Overall Study|Investigator's Discretion|5
7177595|NCT01174563|11377797|FG000|Overall Study|Participant Withdrew Consent|3
7177596|NCT01174563|11377797|FG000|Overall Study|Rash Adverse Event|1
7177597|NCT01174563|11377797|FG000|Overall Study|Sponsor's decision|1
7177598|NCT01235962|11377877|FG000|Overall Study|Withdrawal by Subject|20
7177599|NCT01235962|11377878|FG001|Overall Study|Withdrawal by Subject|19
7177600|NCT01235962|11377879|FG002|Overall Study|Withdrawal by Subject|62
7177601|NCT01235962|11377880|FG003|Overall Study|Withdrawal by Subject|49
7177602|NCT01235962|11377877|FG000|Overall Study|Lost to Follow-up|21
7177603|NCT01235962|11377878|FG001|Overall Study|Lost to Follow-up|16
7177604|NCT01235962|11377879|FG002|Overall Study|Lost to Follow-up|47
7177605|NCT01235962|11377880|FG003|Overall Study|Lost to Follow-up|32
7177606|NCT01235962|11377877|FG000|Overall Study|Physician Decision|5
7177607|NCT01235962|11377878|FG001|Overall Study|Physician Decision|0
7177608|NCT01235962|11377879|FG002|Overall Study|Physician Decision|9
7177609|NCT01235962|11377880|FG003|Overall Study|Physician Decision|5
7177610|NCT01239368|11377908|FG000|Overall Study|Principal investigator discretion|1
7177611|NCT01239368|11377909|FG001|Overall Study|Principal investigator discretion|0
7177612|NCT01239368|11377910|FG002|Overall Study|Principal investigator discretion|0
7177613|NCT01239368|11377911|FG003|Overall Study|Principal investigator discretion|0
7177614|NCT01239368|11377912|FG004|Overall Study|Principal investigator discretion|1
7177615|NCT01239368|11377913|FG005|Overall Study|Principal investigator discretion|2
7177616|NCT01239368|11377914|FG006|Overall Study|Principal investigator discretion|0
7177617|NCT01239368|11377915|FG007|Overall Study|Principal investigator discretion|0
7177618|NCT01239368|11377916|FG008|Overall Study|Principal investigator discretion|0
7177619|NCT01239368|11377917|FG009|Overall Study|Principal investigator discretion|1
7177620|NCT01239368|11377908|FG000|Overall Study|Disease progression on study|1
7177621|NCT01239368|11377909|FG001|Overall Study|Disease progression on study|1
7177622|NCT01239368|11377910|FG002|Overall Study|Disease progression on study|1
7177623|NCT01239368|11377911|FG003|Overall Study|Disease progression on study|1
7177624|NCT01239368|11377912|FG004|Overall Study|Disease progression on study|4
7177625|NCT01239368|11377913|FG005|Overall Study|Disease progression on study|2
7177626|NCT01239368|11377914|FG006|Overall Study|Disease progression on study|5
7177627|NCT01239368|11377915|FG007|Overall Study|Disease progression on study|0
7177628|NCT01239368|11377916|FG008|Overall Study|Disease progression on study|0
7177629|NCT01239368|11377917|FG009|Overall Study|Disease progression on study|2
7177630|NCT01239368|11377908|FG000|Overall Study|Refused further treatment|0
7177631|NCT01239368|11377909|FG001|Overall Study|Refused further treatment|0
7177632|NCT01239368|11377910|FG002|Overall Study|Refused further treatment|0
7177633|NCT01239368|11377911|FG003|Overall Study|Refused further treatment|0
7177634|NCT01239368|11377912|FG004|Overall Study|Refused further treatment|0
7177635|NCT01239368|11377913|FG005|Overall Study|Refused further treatment|0
7177636|NCT01239368|11377914|FG006|Overall Study|Refused further treatment|0
7177637|NCT01239368|11377915|FG007|Overall Study|Refused further treatment|0
7177638|NCT01239368|11377916|FG008|Overall Study|Refused further treatment|0
7177639|NCT01239368|11377917|FG009|Overall Study|Refused further treatment|1
7177640|NCT01239368|11377908|FG000|Overall Study|Death|0
7177641|NCT01239368|11377909|FG001|Overall Study|Death|0
7177642|NCT01239368|11377910|FG002|Overall Study|Death|0
7177643|NCT01239368|11377911|FG003|Overall Study|Death|0
7177644|NCT01239368|11377912|FG004|Overall Study|Death|0
7177645|NCT01239368|11377913|FG005|Overall Study|Death|0
7177646|NCT01239368|11377914|FG006|Overall Study|Death|1
7177647|NCT01239368|11377915|FG007|Overall Study|Death|0
7177648|NCT01239368|11377916|FG008|Overall Study|Death|0
7177649|NCT01239368|11377917|FG009|Overall Study|Death|0
7186160|NCT02696031|11386437|FG004|Up to Week 52|Withdrawal by Subject|0
7186161|NCT02696031|11386438|FG005|Up to Week 52|Withdrawal by Subject|0
7186162|NCT02696031|11386433|FG000|Up to Week 104|Pregnancy|0
7186163|NCT02696031|11386434|FG001|Up to Week 104|Pregnancy|2
7186164|NCT02696031|11386435|FG002|Up to Week 104|Pregnancy|1
7186165|NCT02696031|11386436|FG003|Up to Week 104|Pregnancy|0
7186166|NCT02696031|11386437|FG004|Up to Week 104|Pregnancy|0
7186167|NCT02696031|11386438|FG005|Up to Week 104|Pregnancy|0
7186168|NCT02696031|11386433|FG000|Up to Week 104|Withdrawal by Subject|15
7186169|NCT02696031|11386434|FG001|Up to Week 104|Withdrawal by Subject|10
7186170|NCT02696031|11386435|FG002|Up to Week 104|Withdrawal by Subject|16
7186171|NCT02696031|11386436|FG003|Up to Week 104|Withdrawal by Subject|0
7186172|NCT02696031|11386437|FG004|Up to Week 104|Withdrawal by Subject|0
7186173|NCT02696031|11386438|FG005|Up to Week 104|Withdrawal by Subject|0
7186174|NCT02696031|11386433|FG000|Up to Week 104|Protocol Violation|1
7186175|NCT02696031|11386434|FG001|Up to Week 104|Protocol Violation|0
7186176|NCT02696031|11386435|FG002|Up to Week 104|Protocol Violation|0
7186177|NCT02696031|11386436|FG003|Up to Week 104|Protocol Violation|0
7186178|NCT02696031|11386437|FG004|Up to Week 104|Protocol Violation|0
7186179|NCT02696031|11386438|FG005|Up to Week 104|Protocol Violation|0
7186180|NCT02696031|11386433|FG000|Up to Week 104|Physician Decision|1
7186181|NCT02696031|11386434|FG001|Up to Week 104|Physician Decision|2
7186182|NCT02696031|11386435|FG002|Up to Week 104|Physician Decision|3
7186183|NCT02696031|11386436|FG003|Up to Week 104|Physician Decision|0
7186184|NCT02696031|11386437|FG004|Up to Week 104|Physician Decision|0
7186185|NCT02696031|11386438|FG005|Up to Week 104|Physician Decision|0
7186186|NCT02696031|11386433|FG000|Up to Week 104|Lost to Follow-up|2
7186187|NCT02696031|11386434|FG001|Up to Week 104|Lost to Follow-up|3
7186188|NCT02696031|11386435|FG002|Up to Week 104|Lost to Follow-up|1
7186189|NCT02696031|11386436|FG003|Up to Week 104|Lost to Follow-up|0
7186190|NCT02696031|11386437|FG004|Up to Week 104|Lost to Follow-up|0
7186191|NCT02696031|11386438|FG005|Up to Week 104|Lost to Follow-up|0
7186192|NCT02696031|11386433|FG000|Up to Week 104|Lack of Efficacy|13
7186193|NCT02696031|11386434|FG001|Up to Week 104|Lack of Efficacy|12
7186194|NCT02696031|11386435|FG002|Up to Week 104|Lack of Efficacy|11
7186195|NCT02696031|11386436|FG003|Up to Week 104|Lack of Efficacy|0
7186196|NCT02696031|11386437|FG004|Up to Week 104|Lack of Efficacy|0
7186197|NCT02696031|11386438|FG005|Up to Week 104|Lack of Efficacy|0
7186198|NCT02696031|11386433|FG000|Up to Week 104|Adverse Event|7
7186199|NCT02696031|11386434|FG001|Up to Week 104|Adverse Event|11
7186200|NCT02696031|11386435|FG002|Up to Week 104|Adverse Event|5
7186201|NCT02696031|11386436|FG003|Up to Week 104|Adverse Event|0
7186202|NCT02696031|11386437|FG004|Up to Week 104|Adverse Event|0
7186203|NCT02696031|11386438|FG005|Up to Week 104|Adverse Event|0
7186204|NCT02696031|11386433|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0
7186205|NCT02696031|11386434|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1
7186206|NCT02696031|11386435|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0
7186207|NCT02696031|11386436|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0
7186208|NCT02696031|11386437|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0
7186209|NCT02696031|11386438|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0
7186210|NCT02696031|11386433|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0
7186211|NCT02696031|11386434|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0
7186212|NCT02696031|11386435|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0
7186213|NCT02696031|11386436|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6
7186214|NCT02696031|11386437|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8
7186215|NCT02696031|11386438|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2
7186216|NCT02696031|11386433|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0
7186217|NCT02696031|11386434|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0
7186218|NCT02696031|11386435|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0
7186219|NCT02696031|11386436|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1
7186220|NCT02696031|11386437|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1
7186221|NCT02696031|11386438|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0
7177650|NCT01247701|11377950|FG000|Overall Study|Death|2
7177651|NCT01247701|11377950|FG000|Overall Study|Relapsed|8
7177652|NCT01266031|11377957|FG000|Overall Study|Not treated|0
7177653|NCT01266031|11377958|FG001|Overall Study|Not treated|3
7177654|NCT01266031|11377959|FG002|Overall Study|Not treated|2
7177655|NCT01287741|11377980|FG000|Overall Study|Withdrawal by Subject|35
7177656|NCT01287741|11377981|FG001|Overall Study|Withdrawal by Subject|38
7177657|NCT01287741|11377980|FG000|Overall Study|Protocol Violation|2
7177658|NCT01287741|11377981|FG001|Overall Study|Protocol Violation|0
7177659|NCT01287741|11377980|FG000|Overall Study|Physician Decision|15
7177660|NCT01287741|11377981|FG001|Overall Study|Physician Decision|23
7177661|NCT01287741|11377980|FG000|Overall Study|Non-compliance|8
7177662|NCT01287741|11377981|FG001|Overall Study|Non-compliance|6
7177663|NCT01287741|11377980|FG000|Overall Study|Lost to Follow-up|10
7177664|NCT01287741|11377981|FG001|Overall Study|Lost to Follow-up|8
7177665|NCT01287741|11377980|FG000|Overall Study|Death|32
7177666|NCT01287741|11377981|FG001|Overall Study|Death|44
7177667|NCT01287741|11377980|FG000|Overall Study|Adverse Event|4
7177668|NCT01287741|11377981|FG001|Overall Study|Adverse Event|6
7177669|NCT01287741|11377980|FG000|Overall Study|Study terminated by Sponsor|307
7177670|NCT01287741|11377981|FG001|Overall Study|Study terminated by Sponsor|315
7177671|NCT01287741|11377980|FG000|Overall Study|Progressive disease|190
7177672|NCT01287741|11377981|FG001|Overall Study|Progressive disease|166
7177673|NCT01287741|11377980|FG000|Overall Study|Reason not specified|23
7177674|NCT01287741|11377981|FG001|Overall Study|Reason not specified|9
7177675|NCT01313689|11377998|FG000|24-Week Randomization 1|Adverse Event|10
7177676|NCT01313689|11377999|FG001|24-Week Randomization 1|Adverse Event|5
7177677|NCT01313689|11378000|FG002|24-Week Randomization 1|Adverse Event|0
7177678|NCT01313689|11378001|FG003|24-Week Randomization 1|Adverse Event|0
7177679|NCT01313689|11378002|FG004|24-Week Randomization 1|Adverse Event|0
7177680|NCT01313689|11377998|FG000|24-Week Randomization 1|Physician Decision|4
7177681|NCT01313689|11377999|FG001|24-Week Randomization 1|Physician Decision|5
7177682|NCT01313689|11378000|FG002|24-Week Randomization 1|Physician Decision|0
7177683|NCT01313689|11378001|FG003|24-Week Randomization 1|Physician Decision|0
7177684|NCT01313689|11378002|FG004|24-Week Randomization 1|Physician Decision|0
7177685|NCT01313689|11377998|FG000|24-Week Randomization 1|Withdrawal by Subject|5
7177686|NCT01313689|11377999|FG001|24-Week Randomization 1|Withdrawal by Subject|0
7177687|NCT01313689|11378000|FG002|24-Week Randomization 1|Withdrawal by Subject|0
7177688|NCT01313689|11378001|FG003|24-Week Randomization 1|Withdrawal by Subject|0
7177689|NCT01313689|11378002|FG004|24-Week Randomization 1|Withdrawal by Subject|0
7177690|NCT01313689|11377998|FG000|24-Week Randomization 2|Adverse Event|0
7177691|NCT01313689|11377999|FG001|24-Week Randomization 2|Adverse Event|0
7177692|NCT01313689|11378000|FG002|24-Week Randomization 2|Adverse Event|2
7177693|NCT01313689|11378001|FG003|24-Week Randomization 2|Adverse Event|0
7177694|NCT01313689|11378002|FG004|24-Week Randomization 2|Adverse Event|8
7177695|NCT01313689|11377998|FG000|24-Week Randomization 2|Withdrawal by Subject|0
7177696|NCT01313689|11377999|FG001|24-Week Randomization 2|Withdrawal by Subject|0
7177697|NCT01313689|11378000|FG002|24-Week Randomization 2|Withdrawal by Subject|1
7177698|NCT01313689|11378001|FG003|24-Week Randomization 2|Withdrawal by Subject|1
7177699|NCT01313689|11378002|FG004|24-Week Randomization 2|Withdrawal by Subject|3
7177700|NCT01313689|11377998|FG000|24-Week Randomization 2|Physician Decision|0
7177701|NCT01313689|11377999|FG001|24-Week Randomization 2|Physician Decision|0
7177702|NCT01313689|11378000|FG002|24-Week Randomization 2|Physician Decision|0
7177703|NCT01313689|11378001|FG003|24-Week Randomization 2|Physician Decision|0
7177704|NCT01313689|11378002|FG004|24-Week Randomization 2|Physician Decision|4
7177726|NCT01318993|11378034|FG000|Overall Study|Adverse Event|53
7177727|NCT01318993|11378034|FG000|Overall Study|Lack of Efficacy|121
7177728|NCT01318993|11378034|FG000|Overall Study|Protocol Violation|3
7177729|NCT01318993|11378034|FG000|Overall Study|Protocol based stopping criteria|6
7177730|NCT01318993|11378034|FG000|Overall Study|Study closed or terminated|174
7177731|NCT01318993|11378034|FG000|Overall Study|Lost to Follow-up|4
7177732|NCT01318993|11378034|FG000|Overall Study|Physician Decision|13
7177733|NCT01318993|11378034|FG000|Overall Study|Withdrawal by Subject|24
7177734|NCT01335685|11378042|FG000|Overall Study|Study Terminated by Sponsor|2
7177735|NCT01335685|11378043|FG001|Overall Study|Study Terminated by Sponsor|1
7177736|NCT01335685|11378044|FG002|Overall Study|Study Terminated by Sponsor|1
7177737|NCT01335685|11378045|FG003|Overall Study|Study Terminated by Sponsor|10
7177738|NCT01335685|11378046|FG004|Overall Study|Study Terminated by Sponsor|0
7177739|NCT01335685|11378047|FG005|Overall Study|Study Terminated by Sponsor|4
7177740|NCT01335685|11378048|FG006|Overall Study|Study Terminated by Sponsor|2
7177741|NCT01335685|11378049|FG007|Overall Study|Study Terminated by Sponsor|3
7177742|NCT01335685|11378042|FG000|Overall Study|Withdrawal by Subject|1
7177743|NCT01335685|11378043|FG001|Overall Study|Withdrawal by Subject|0
7177744|NCT01335685|11378044|FG002|Overall Study|Withdrawal by Subject|0
7177745|NCT01335685|11378045|FG003|Overall Study|Withdrawal by Subject|1
7177746|NCT01335685|11378046|FG004|Overall Study|Withdrawal by Subject|0
7177747|NCT01335685|11378047|FG005|Overall Study|Withdrawal by Subject|0
7177748|NCT01335685|11378048|FG006|Overall Study|Withdrawal by Subject|0
7177749|NCT01335685|11378049|FG007|Overall Study|Withdrawal by Subject|0
7177750|NCT01335685|11378042|FG000|Overall Study|Reason not Specified|0
7177751|NCT01335685|11378043|FG001|Overall Study|Reason not Specified|0
7177752|NCT01335685|11378044|FG002|Overall Study|Reason not Specified|1
7177705|NCT01315353|11378024|FG000|Overall Study|Death|2
7177706|NCT01315353|11378025|FG001|Overall Study|Death|1
7177707|NCT01315353|11378026|FG002|Overall Study|Death|0
7177708|NCT01315353|11378024|FG000|Overall Study|Withdrawal by Subject|2
7177709|NCT01315353|11378025|FG001|Overall Study|Withdrawal by Subject|6
7177710|NCT01315353|11378026|FG002|Overall Study|Withdrawal by Subject|1
7177711|NCT01315353|11378024|FG000|Overall Study|Lost to Follow-up|13
7177712|NCT01315353|11378025|FG001|Overall Study|Lost to Follow-up|6
7177713|NCT01315353|11378026|FG002|Overall Study|Lost to Follow-up|6
7177714|NCT01315353|11378024|FG000|Overall Study|Unwilling to adhere to requirements|5
7177715|NCT01315353|11378025|FG001|Overall Study|Unwilling to adhere to requirements|5
7177716|NCT01315353|11378026|FG002|Overall Study|Unwilling to adhere to requirements|4
7177717|NCT01315353|11378024|FG000|Overall Study|Site closing|7
7177718|NCT01315353|11378025|FG001|Overall Study|Site closing|4
7177719|NCT01315353|11378026|FG002|Overall Study|Site closing|0
7177720|NCT01315353|11378024|FG000|Overall Study|Taken off study by site in error|0
7177721|NCT01315353|11378025|FG001|Overall Study|Taken off study by site in error|1
7177722|NCT01315353|11378026|FG002|Overall Study|Taken off study by site in error|0
7177723|NCT01315353|11378024|FG000|Overall Study|Inadvertent randomization/assignment|0
7177724|NCT01315353|11378025|FG001|Overall Study|Inadvertent randomization/assignment|0
7177725|NCT01315353|11378026|FG002|Overall Study|Inadvertent randomization/assignment|2
7177753|NCT01335685|11378045|FG003|Overall Study|Reason not Specified|0
7177754|NCT01335685|11378046|FG004|Overall Study|Reason not Specified|0
7177755|NCT01335685|11378047|FG005|Overall Study|Reason not Specified|1
7177756|NCT01335685|11378048|FG006|Overall Study|Reason not Specified|0
7177757|NCT01335685|11378049|FG007|Overall Study|Reason not Specified|0
7186222|NCT02696031|11386433|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0
7186223|NCT02696031|11386434|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0
7186224|NCT02696031|11386435|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0
7186225|NCT02696031|11386436|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1
7186226|NCT02696031|11386437|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0
7186227|NCT02696031|11386438|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0
7186228|NCT02696031|11386433|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0
7186229|NCT02696031|11386434|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0
7186230|NCT02696031|11386435|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0
7186231|NCT02696031|11386436|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0
7186232|NCT02696031|11386437|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1
7186233|NCT02696031|11386438|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0
7186234|NCT02696031|11386433|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0
7186235|NCT02696031|11386434|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0
7186236|NCT02696031|11386435|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0
7186237|NCT02696031|11386436|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1
7186238|NCT02696031|11386437|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1
7186239|NCT02696031|11386438|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3
7186240|NCT02696031|11386433|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0
7186241|NCT02696031|11386434|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0
7186242|NCT02696031|11386435|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0
7186243|NCT02696031|11386436|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1
7186244|NCT02696031|11386437|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4
7186245|NCT02696031|11386438|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1
7186246|NCT02689453|11386450|FG000|Overall Study|Progressive disease|0
7186247|NCT02689453|11386451|FG001|Overall Study|Progressive disease|1
7186248|NCT02689453|11386452|FG002|Overall Study|Progressive disease|1
7186249|NCT02476851|11386464|FG000|Overall Study|Protocol Violation|1
7186250|NCT02476851|11386465|FG001|Overall Study|Protocol Violation|1
7186251|NCT02208024|11386490|FG000|Overall Study|Withdrawal by Subject|1
7186252|NCT02180867|11386501|FG000|Overall Study|Adverse Event|3
7186253|NCT02180867|11386502|FG001|Overall Study|Adverse Event|4
7186254|NCT02180867|11386503|FG002|Overall Study|Adverse Event|1
7186255|NCT02180867|11386504|FG003|Overall Study|Adverse Event|5
7186256|NCT02180867|11386505|FG004|Overall Study|Adverse Event|0
7186257|NCT02180867|11386506|FG005|Overall Study|Adverse Event|0
7186258|NCT02180867|11386507|FG006|Overall Study|Adverse Event|0
7186259|NCT02180867|11386501|FG000|Overall Study|Death|0
7186260|NCT02180867|11386502|FG001|Overall Study|Death|0
7186261|NCT02180867|11386503|FG002|Overall Study|Death|0
7186262|NCT02180867|11386504|FG003|Overall Study|Death|0
7186263|NCT02180867|11386505|FG004|Overall Study|Death|1
7186264|NCT02180867|11386506|FG005|Overall Study|Death|0
7186265|NCT02180867|11386507|FG006|Overall Study|Death|0
7186266|NCT02180867|11386501|FG000|Overall Study|Lack of Efficacy|0
7186267|NCT02180867|11386502|FG001|Overall Study|Lack of Efficacy|2
7186268|NCT02180867|11386503|FG002|Overall Study|Lack of Efficacy|0
7186269|NCT02180867|11386504|FG003|Overall Study|Lack of Efficacy|1
7186270|NCT02180867|11386505|FG004|Overall Study|Lack of Efficacy|6
7186271|NCT02180867|11386506|FG005|Overall Study|Lack of Efficacy|0
7186272|NCT02180867|11386507|FG006|Overall Study|Lack of Efficacy|1
7186273|NCT02180867|11386501|FG000|Overall Study|Physician Decision|1
7186274|NCT02180867|11386502|FG001|Overall Study|Physician Decision|3
7177758|NCT01336621|11378072|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11
7177759|NCT01336621|11378072|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2
7177760|NCT01336621|11378072|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12
7177761|NCT01336621|11378072|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27
7177762|NCT01336621|11378072|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11
7177763|NCT01336621|11378072|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2
7177764|NCT01336621|11378072|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22
7177765|NCT01336621|11378072|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2
7177766|NCT01336621|11378072|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9
7177767|NCT01336621|11378072|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1
7177768|NCT01336621|11378072|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1
7177769|NCT01336621|11378072|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3
7177770|NCT01336621|11378072|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1
7177771|NCT01336621|11378072|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3
7186275|NCT02180867|11386503|FG002|Overall Study|Physician Decision|1
7186276|NCT02180867|11386504|FG003|Overall Study|Physician Decision|10
7186277|NCT02180867|11386505|FG004|Overall Study|Physician Decision|9
7186278|NCT02180867|11386506|FG005|Overall Study|Physician Decision|3
7186279|NCT02180867|11386507|FG006|Overall Study|Physician Decision|4
7186280|NCT02180867|11386501|FG000|Overall Study|Withdrawal by Subject|0
7186281|NCT02180867|11386502|FG001|Overall Study|Withdrawal by Subject|0
7186282|NCT02180867|11386503|FG002|Overall Study|Withdrawal by Subject|0
7186283|NCT02180867|11386504|FG003|Overall Study|Withdrawal by Subject|1
7186284|NCT02180867|11386505|FG004|Overall Study|Withdrawal by Subject|1
7186285|NCT02180867|11386506|FG005|Overall Study|Withdrawal by Subject|0
7186286|NCT02180867|11386507|FG006|Overall Study|Withdrawal by Subject|0
7186287|NCT02180867|11386501|FG000|Overall Study|Ineligible|1
7186288|NCT02180867|11386502|FG001|Overall Study|Ineligible|2
7186289|NCT02180867|11386503|FG002|Overall Study|Ineligible|0
7186290|NCT02180867|11386504|FG003|Overall Study|Ineligible|3
7186291|NCT02180867|11386505|FG004|Overall Study|Ineligible|5
7186292|NCT02180867|11386506|FG005|Overall Study|Ineligible|0
7186293|NCT02180867|11386507|FG006|Overall Study|Ineligible|0
7186294|NCT02180867|11386501|FG000|Overall Study|Repeat Eligibility Studies|0
7186295|NCT02180867|11386502|FG001|Overall Study|Repeat Eligibility Studies|0
7186296|NCT02180867|11386503|FG002|Overall Study|Repeat Eligibility Studies|0
7186297|NCT02180867|11386504|FG003|Overall Study|Repeat Eligibility Studies|0
7186298|NCT02180867|11386505|FG004|Overall Study|Repeat Eligibility Studies|1
7186299|NCT02180867|11386506|FG005|Overall Study|Repeat Eligibility Studies|0
7186300|NCT02180867|11386507|FG006|Overall Study|Repeat Eligibility Studies|0
7186301|NCT02180867|11386501|FG000|Overall Study|Refusal of further protocol therapy|1
7186302|NCT02180867|11386502|FG001|Overall Study|Refusal of further protocol therapy|0
7186303|NCT02180867|11386503|FG002|Overall Study|Refusal of further protocol therapy|2
7186304|NCT02180867|11386504|FG003|Overall Study|Refusal of further protocol therapy|6
7186305|NCT02180867|11386505|FG004|Overall Study|Refusal of further protocol therapy|4
7186306|NCT02180867|11386506|FG005|Overall Study|Refusal of further protocol therapy|0
7186307|NCT02180867|11386507|FG006|Overall Study|Refusal of further protocol therapy|0
7186308|NCT01866111|11386539|FG000|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|14
7186309|NCT01866111|11386540|FG001|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|13
7186310|NCT01866111|11386541|FG002|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|20
7186311|NCT01866111|11386542|FG003|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|30
7186312|NCT01866111|11386539|FG000|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|65
7186313|NCT01866111|11386540|FG001|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|67
7186314|NCT01866111|11386541|FG002|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|63
7186315|NCT01866111|11386542|FG003|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|52
7186316|NCT01767129|11386552|FG000|Treatment Period 1 (14 Days)|Adverse Event|1
7186317|NCT01767129|11386553|FG001|Treatment Period 1 (14 Days)|Adverse Event|0
7186318|NCT01622868|11386562|FG000|Overall Study|Protocol Violation|7
7186319|NCT01622868|11386563|FG001|Overall Study|Protocol Violation|0
7186320|NCT01609790|11386572|FG000|Overall Study|Protocol Violation|1
7186321|NCT01609790|11386573|FG001|Overall Study|Protocol Violation|7
7186322|NCT01609790|11386574|FG002|Overall Study|Protocol Violation|8
7186323|NCT01586910|11386584|FG000|Overall Study|Death|4
7186324|NCT01586910|11386585|FG001|Overall Study|Death|4
7186325|NCT01586910|11386584|FG000|Overall Study|Withdrawal by Subject|6
7186326|NCT01586910|11386585|FG001|Overall Study|Withdrawal by Subject|43
7186327|NCT01586910|11386584|FG000|Overall Study|Physician withdrew Subject|5
7186328|NCT01586910|11386585|FG001|Overall Study|Physician withdrew Subject|24
7186329|NCT01236560|11386599|FG000|Overall Study|Adverse Event|0
7186330|NCT01236560|11386600|FG001|Overall Study|Adverse Event|2
7186331|NCT01236560|11386601|FG002|Overall Study|Adverse Event|1
7186332|NCT01236560|11386602|FG003|Overall Study|Adverse Event|3
7186333|NCT01236560|11386603|FG004|Overall Study|Adverse Event|0
7186334|NCT01236560|11386604|FG005|Overall Study|Adverse Event|0
7186335|NCT01236560|11386599|FG000|Overall Study|Death|0
7186336|NCT01236560|11386600|FG001|Overall Study|Death|1
7177772|NCT04170296|11378092|FG000|Overall Study|Adverse Event|1
7177773|NCT04170296|11378093|FG001|Overall Study|Adverse Event|0
7177774|NCT04170296|11378092|FG000|Overall Study|Withdrawal by Subject|3
7177775|NCT04170296|11378093|FG001|Overall Study|Withdrawal by Subject|2
7177776|NCT04170296|11378092|FG000|Overall Study|Lost to Follow-up|4
7177777|NCT04170296|11378093|FG001|Overall Study|Lost to Follow-up|2
7177778|NCT04039217|11378105|FG000|Overall Study|Lost to Follow-up|1
7177779|NCT03078192|11378159|FG000|Overall Study|Withdrawal by Subject|2
7177780|NCT03078192|11378160|FG001|Overall Study|Withdrawal by Subject|1
7177781|NCT03078192|11378159|FG000|Overall Study|screen failure|0
7177782|NCT03078192|11378160|FG001|Overall Study|screen failure|3
7177783|NCT02903823|11378175|FG000|Overall Study|Physician Decision|5
7177784|NCT02903823|11378175|FG000|Overall Study|Could not advance catheter|1
7177785|NCT02903823|11378175|FG000|Overall Study|Catheter dislodgement|1
7177786|NCT01547117|11378197|FG000|Overall Study|Physician Decision|0
7177787|NCT01547117|11378198|FG001|Overall Study|Physician Decision|1
7177788|NCT01547117|11378199|FG002|Overall Study|Physician Decision|1
7177789|NCT01547117|11378200|FG003|Overall Study|Physician Decision|3
7177790|NCT01547117|11378197|FG000|Overall Study|Withdrawal by Subject|1
7177791|NCT01547117|11378198|FG001|Overall Study|Withdrawal by Subject|2
7177792|NCT01547117|11378199|FG002|Overall Study|Withdrawal by Subject|1
7177793|NCT01547117|11378200|FG003|Overall Study|Withdrawal by Subject|2
7177794|NCT01431508|11378226|FG000|Overall Study|Lack of Efficacy|1
7177795|NCT01431508|11378226|FG000|Overall Study|Unable to Follow Protocol Procedures|1
7177796|NCT00871351|11378233|FG000|Overall Study|Withdrawal by Subject|1
7177797|NCT00871351|11378234|FG001|Overall Study|Withdrawal by Subject|0
7177798|NCT00871351|11378235|FG002|Overall Study|Withdrawal by Subject|0
7177799|NCT00871351|11378233|FG000|Overall Study|Adverse Event|3
7177800|NCT00871351|11378234|FG001|Overall Study|Adverse Event|1
7177801|NCT00871351|11378235|FG002|Overall Study|Adverse Event|0
7177802|NCT00832455|11378243|FG000|Overall Study|Adverse Event|13
7177803|NCT00832455|11378243|FG000|Overall Study|Lost to Follow-up|26
7177804|NCT00832455|11378243|FG000|Overall Study|Protocol Violation|4
7177805|NCT00832455|11378243|FG000|Overall Study|Withdrawal by Subject|17
7177806|NCT00832455|11378243|FG000|Overall Study|Screening Failure|2
7177807|NCT00832455|11378243|FG000|Overall Study|Stopped Medication|4
7177808|NCT00832455|11378243|FG000|Overall Study|Parent misunderstood study|1
7177809|NCT00832455|11378243|FG000|Overall Study|Parent dissatisfied|1
7177810|NCT00832455|11378243|FG000|Overall Study|No improvement|3
7177811|NCT00832455|11378243|FG000|Overall Study|Patient moved|1
7177812|NCT00812006|11378259|FG000|Overall Study|Lost to Follow-up|0
7177813|NCT00812006|11378260|FG001|Overall Study|Lost to Follow-up|0
7177814|NCT00812006|11378261|FG002|Overall Study|Lost to Follow-up|2
7177815|NCT00812006|11378259|FG000|Overall Study|Physician Decision|0
7177816|NCT00812006|11378260|FG001|Overall Study|Physician Decision|0
7177817|NCT00812006|11378261|FG002|Overall Study|Physician Decision|1
7177818|NCT00812006|11378259|FG000|Overall Study|Withdrawal by Subject|2
7177819|NCT00812006|11378260|FG001|Overall Study|Withdrawal by Subject|1
7177820|NCT00812006|11378261|FG002|Overall Study|Withdrawal by Subject|1
7177821|NCT00812006|11378259|FG000|Overall Study|Lack of Qualifying Event|4
7177822|NCT00812006|11378260|FG001|Overall Study|Lack of Qualifying Event|2
7177823|NCT00812006|11378261|FG002|Overall Study|Lack of Qualifying Event|2
7177824|NCT00687531|11378274|FG000|Overall Study|Did not meet protocol eligibility|104
7177825|NCT00687531|11378274|FG000|Overall Study|Adverse Event|5
7177826|NCT00687531|11378274|FG000|Overall Study|Lost to Follow-up|26
7177827|NCT00654628|11378278|FG000|6-week Active Treatment Period|Adverse Event|9
7177828|NCT00654628|11378278|FG000|6-week Active Treatment Period|Lost to Follow-up|10
7177829|NCT00654628|11378278|FG000|6-week Active Treatment Period|Transferred to branch hospital|1
7177830|NCT00654628|11378278|FG000|6-week Active Treatment Period|Out of window period|1
7177831|NCT00654628|11378278|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4
7177832|NCT00654628|11378278|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1
7177833|NCT00536380|11378304|FG000|Overall Study|Adverse Event|0
7177834|NCT00536380|11378305|FG001|Overall Study|Adverse Event|2
7177835|NCT00536380|11378306|FG002|Overall Study|Adverse Event|2
7177836|NCT00536380|11378304|FG000|Overall Study|Lost to Follow-up|0
7177837|NCT00536380|11378305|FG001|Overall Study|Lost to Follow-up|0
7177838|NCT00536380|11378306|FG002|Overall Study|Lost to Follow-up|1
7177839|NCT00536380|11378304|FG000|Overall Study|Withdrawal unrelated to study drug|2
7177840|NCT00536380|11378305|FG001|Overall Study|Withdrawal unrelated to study drug|0
7177841|NCT00536380|11378306|FG002|Overall Study|Withdrawal unrelated to study drug|1
7177842|NCT00536380|11378304|FG000|Overall Study|Withdrawal related to study drug|7
7177843|NCT00536380|11378305|FG001|Overall Study|Withdrawal related to study drug|5
7177844|NCT00536380|11378306|FG002|Overall Study|Withdrawal related to study drug|2
7177845|NCT00536380|11378304|FG000|Overall Study|Noncompliance with protocol|3
7177846|NCT00536380|11378305|FG001|Overall Study|Noncompliance with protocol|2
7177847|NCT00536380|11378306|FG002|Overall Study|Noncompliance with protocol|2
7177848|NCT00536380|11378304|FG000|Overall Study|Did not meet protocol eligibility|0
7177849|NCT00536380|11378305|FG001|Overall Study|Did not meet protocol eligibility|0
7177850|NCT00536380|11378306|FG002|Overall Study|Did not meet protocol eligibility|1
7177851|NCT00536380|11378304|FG000|Overall Study|Administrative|0
7177852|NCT00536380|11378305|FG001|Overall Study|Administrative|0
7177853|NCT00536380|11378306|FG002|Overall Study|Administrative|1
7177854|NCT00521599|11378317|FG000|Overall Study|Adverse Event|5
7177855|NCT00521599|11378318|FG001|Overall Study|Adverse Event|7
7177856|NCT00521599|11378319|FG002|Overall Study|Adverse Event|6
7177857|NCT00521599|11378317|FG000|Overall Study|Treatment Failure|8
7177858|NCT00521599|11378318|FG001|Overall Study|Treatment Failure|9
7177859|NCT00521599|11378319|FG002|Overall Study|Treatment Failure|22
7177860|NCT00521599|11378317|FG000|Overall Study|Lost to Follow-up|2
7177861|NCT00521599|11378318|FG001|Overall Study|Lost to Follow-up|1
7177862|NCT00521599|11378319|FG002|Overall Study|Lost to Follow-up|2
7177863|NCT00521599|11378317|FG000|Overall Study|Withdrawal by Subject|3
7177864|NCT00521599|11378318|FG001|Overall Study|Withdrawal by Subject|5
7177865|NCT00521599|11378319|FG002|Overall Study|Withdrawal by Subject|1
7177866|NCT00521599|11378317|FG000|Overall Study|Withdrawal by subject treatment related|3
7177867|NCT00521599|11378318|FG001|Overall Study|Withdrawal by subject treatment related|1
7177868|NCT00521599|11378319|FG002|Overall Study|Withdrawal by subject treatment related|2
7177869|NCT00521599|11378317|FG000|Overall Study|Protocol Violation|2
7177870|NCT00521599|11378318|FG001|Overall Study|Protocol Violation|4
7177871|NCT00521599|11378319|FG002|Overall Study|Protocol Violation|2
7177872|NCT00521599|11378317|FG000|Overall Study|Did not meet protocol eligibility|2
7177873|NCT00521599|11378318|FG001|Overall Study|Did not meet protocol eligibility|2
7177874|NCT00521599|11378319|FG002|Overall Study|Did not meet protocol eligibility|1
7177875|NCT00496834|11378330|FG000|Overall Study|Withdrawal by Subject|4
7177876|NCT00496834|11378331|FG001|Overall Study|Withdrawal by Subject|6
7177877|NCT00496834|11378330|FG000|Overall Study|Contraindicated medication administered|0
7177878|NCT00496834|11378331|FG001|Overall Study|Contraindicated medication administered|1
7177879|NCT00496834|11378330|FG000|Overall Study|Inclusion/exclusion criteria not met|3
7177880|NCT00496834|11378331|FG001|Overall Study|Inclusion/exclusion criteria not met|2
7177881|NCT00496834|11378330|FG000|Overall Study|Adverse Event|5
7177882|NCT00496834|11378331|FG001|Overall Study|Adverse Event|3
7177883|NCT00496834|11378330|FG000|Overall Study|IP administration violation|2
7177884|NCT00496834|11378331|FG001|Overall Study|IP administration violation|0
7177885|NCT00496834|11378330|FG000|Overall Study|Lost to Follow-up|2
7177886|NCT00496834|11378331|FG001|Overall Study|Lost to Follow-up|0
7177887|NCT00496834|11378330|FG000|Overall Study|Blood Pressure control failure|2
7177888|NCT00496834|11378331|FG001|Overall Study|Blood Pressure control failure|1
7177889|NCT00442897|11378341|FG000|Base Study (12 Week Follow-up)|Adverse Event|1
7177890|NCT00442897|11378342|FG001|Base Study (12 Week Follow-up)|Adverse Event|0
7177891|NCT00442897|11378341|FG000|Base Study (12 Week Follow-up)|Death|0
7177892|NCT00442897|11378342|FG001|Base Study (12 Week Follow-up)|Death|1
7177893|NCT00442897|11378341|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7
7177894|NCT00442897|11378342|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3
7177895|NCT00442897|11378341|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9
7177896|NCT00442897|11378342|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8
7177897|NCT00442897|11378341|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1
7177898|NCT00442897|11378342|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0
7177899|NCT00442897|11378341|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
7177900|NCT00442897|11378342|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
6895366|NCT00624520|10913244|FG001|Overall Study|Death|1
6895367|NCT00624585|10913267|FG000|Overall Study|Death|3
7177901|NCT00442897|11378341|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2
7177902|NCT00442897|11378342|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1
7177903|NCT00442897|11378341|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1
7177904|NCT00442897|11378342|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3
7177905|NCT00423579|11378350|FG000|Overall Study|Lost to Follow-up|3
7177906|NCT00423579|11378351|FG001|Overall Study|Lost to Follow-up|0
7177907|NCT00423579|11378350|FG000|Overall Study|Protocol Violation|1
7177908|NCT00423579|11378351|FG001|Overall Study|Protocol Violation|3
7177909|NCT00423579|11378350|FG000|Overall Study|Diagnosis of diabetes|0
7177910|NCT00423579|11378351|FG001|Overall Study|Diagnosis of diabetes|1
7177911|NCT00394355|11378361|FG000|Overall Study|Adverse Event|10
7177912|NCT00394355|11378362|FG001|Overall Study|Adverse Event|6
7177913|NCT00394355|11378363|FG002|Overall Study|Adverse Event|7
7177914|NCT00394355|11378364|FG003|Overall Study|Adverse Event|8
7177915|NCT00394355|11378361|FG000|Overall Study|Did not meet protocol eligibility|1
7177916|NCT00394355|11378362|FG001|Overall Study|Did not meet protocol eligibility|5
7177917|NCT00394355|11378363|FG002|Overall Study|Did not meet protocol eligibility|4
7177918|NCT00394355|11378364|FG003|Overall Study|Did not meet protocol eligibility|2
7177919|NCT00394355|11378361|FG000|Overall Study|Subject withdrawal - unrelated to drug|12
7177920|NCT00394355|11378362|FG001|Overall Study|Subject withdrawal - unrelated to drug|14
7177921|NCT00394355|11378363|FG002|Overall Study|Subject withdrawal - unrelated to drug|10
7177922|NCT00394355|11378364|FG003|Overall Study|Subject withdrawal - unrelated to drug|6
6895368|NCT00624585|10913267|FG000|Overall Study|Disease Progression|6
6895369|NCT00624585|10913267|FG000|Overall Study|Adverse Event|3
7177923|NCT00394355|11378361|FG000|Overall Study|Subject withdrawal - related to drug|1
7177924|NCT00394355|11378362|FG001|Overall Study|Subject withdrawal - related to drug|0
7177925|NCT00394355|11378363|FG002|Overall Study|Subject withdrawal - related to drug|0
7177926|NCT00394355|11378364|FG003|Overall Study|Subject withdrawal - related to drug|0
7177927|NCT00394355|11378361|FG000|Overall Study|Lost to Follow-up|7
7177928|NCT00394355|11378362|FG001|Overall Study|Lost to Follow-up|5
7177929|NCT00394355|11378363|FG002|Overall Study|Lost to Follow-up|4
7177930|NCT00394355|11378364|FG003|Overall Study|Lost to Follow-up|3
7177931|NCT00394355|11378361|FG000|Overall Study|Noncompliance with protocol|4
7177932|NCT00394355|11378362|FG001|Overall Study|Noncompliance with protocol|3
7177933|NCT00394355|11378363|FG002|Overall Study|Noncompliance with protocol|10
7177934|NCT00394355|11378364|FG003|Overall Study|Noncompliance with protocol|8
7177935|NCT00394355|11378361|FG000|Overall Study|Administrative|0
7177936|NCT00394355|11378362|FG001|Overall Study|Administrative|1
7177937|NCT00394355|11378363|FG002|Overall Study|Administrative|1
7177938|NCT00394355|11378364|FG003|Overall Study|Administrative|1
7177939|NCT00394355|11378361|FG000|Overall Study|Lack of Efficacy|0
7177940|NCT00394355|11378362|FG001|Overall Study|Lack of Efficacy|0
7177941|NCT00394355|11378363|FG002|Overall Study|Lack of Efficacy|2
7177942|NCT00394355|11378364|FG003|Overall Study|Lack of Efficacy|3
7177943|NCT00166504|11378385|FG000|Overall Study|Adverse Event|3
7177944|NCT00166504|11378386|FG001|Overall Study|Adverse Event|3
7177945|NCT00166504|11378385|FG000|Overall Study|Lost to Follow-up|1
7177946|NCT00166504|11378386|FG001|Overall Study|Lost to Follow-up|1
7177947|NCT00166504|11378385|FG000|Overall Study|Withdrawal by Subject|1
7177948|NCT00166504|11378386|FG001|Overall Study|Withdrawal by Subject|0
7186337|NCT01236560|11386601|FG002|Overall Study|Death|0
7186338|NCT01236560|11386602|FG003|Overall Study|Death|1
7186339|NCT01236560|11386603|FG004|Overall Study|Death|0
7186340|NCT01236560|11386604|FG005|Overall Study|Death|0
7186341|NCT01236560|11386599|FG000|Overall Study|Lost to Follow-up|0
7186342|NCT01236560|11386600|FG001|Overall Study|Lost to Follow-up|1
7186343|NCT01236560|11386601|FG002|Overall Study|Lost to Follow-up|1
7186344|NCT01236560|11386602|FG003|Overall Study|Lost to Follow-up|0
7186345|NCT01236560|11386603|FG004|Overall Study|Lost to Follow-up|0
7186346|NCT01236560|11386604|FG005|Overall Study|Lost to Follow-up|0
7186347|NCT01236560|11386599|FG000|Overall Study|Physician Decision|0
7186348|NCT01236560|11386600|FG001|Overall Study|Physician Decision|1
7186349|NCT01236560|11386601|FG002|Overall Study|Physician Decision|8
7186350|NCT01236560|11386602|FG003|Overall Study|Physician Decision|0
7186351|NCT01236560|11386603|FG004|Overall Study|Physician Decision|0
7186352|NCT01236560|11386604|FG005|Overall Study|Physician Decision|0
7186353|NCT01236560|11386599|FG000|Overall Study|Withdrawal by Subject|0
7186354|NCT01236560|11386600|FG001|Overall Study|Withdrawal by Subject|0
7186355|NCT01236560|11386601|FG002|Overall Study|Withdrawal by Subject|1
7186356|NCT01236560|11386602|FG003|Overall Study|Withdrawal by Subject|2
7186357|NCT01236560|11386603|FG004|Overall Study|Withdrawal by Subject|0
7186358|NCT01236560|11386604|FG005|Overall Study|Withdrawal by Subject|0
7186359|NCT01236560|11386599|FG000|Overall Study|Progressive disease|5
7186360|NCT01236560|11386600|FG001|Overall Study|Progressive disease|19
7186361|NCT01236560|11386601|FG002|Overall Study|Progressive disease|9
7186362|NCT01236560|11386602|FG003|Overall Study|Progressive disease|16
7186363|NCT01236560|11386603|FG004|Overall Study|Progressive disease|0
7186364|NCT01236560|11386604|FG005|Overall Study|Progressive disease|0
7186365|NCT01236547|11386619|FG000|Overall Study|Protocol Violation|0
7186366|NCT01236547|11386620|FG001|Overall Study|Protocol Violation|1
7186367|NCT01236547|11386621|FG002|Overall Study|Protocol Violation|1
7186368|NCT01236547|11386622|FG003|Overall Study|Protocol Violation|6
7186369|NCT01236547|11386623|FG004|Overall Study|Protocol Violation|12
7186370|NCT01062425|11386638|FG000|Overall Study|Protocol Violation|3
7186371|NCT01062425|11386639|FG001|Overall Study|Protocol Violation|6
7186372|NCT00504582|11386652|FG000|Overall Study|Lost to Follow-up|1
7186373|NCT00504582|11386653|FG001|Overall Study|Lost to Follow-up|0
7186374|NCT00504582|11386654|FG002|Overall Study|Lost to Follow-up|0
7188082|NCT03518086|11388732|FG001|Overall Study|Site Terminated by Sponsor|1
7188083|NCT03518086|11388733|FG002|Overall Study|Site Terminated by Sponsor|0
7188084|NCT03518086|11388734|FG003|Overall Study|Site Terminated by Sponsor|0
7188085|NCT03468309|11388741|FG000|Overall Study|Lost to Follow-up|4
7188086|NCT03468309|11388741|FG000|Overall Study|Withdrawal by Subject|2
7188087|NCT03347123|11388747|FG000|Overall Study|Death|1
7188088|NCT03347123|11388748|FG001|Overall Study|Death|2
7188089|NCT03347123|11388749|FG002|Overall Study|Death|0
7188090|NCT03347123|11388750|FG003|Overall Study|Death|0
7188091|NCT03347123|11388751|FG004|Overall Study|Death|0
7188092|NCT03347123|11388752|FG005|Overall Study|Death|0
7188093|NCT03347123|11388753|FG006|Overall Study|Death|0
7188094|NCT03347123|11388747|FG000|Overall Study|Withdrawal by Subject|1
7188095|NCT03347123|11388748|FG001|Overall Study|Withdrawal by Subject|0
7188096|NCT03347123|11388749|FG002|Overall Study|Withdrawal by Subject|0
7188097|NCT03347123|11388750|FG003|Overall Study|Withdrawal by Subject|0
7188098|NCT03347123|11388751|FG004|Overall Study|Withdrawal by Subject|0
7188099|NCT03347123|11388752|FG005|Overall Study|Withdrawal by Subject|0
7188100|NCT03347123|11388753|FG006|Overall Study|Withdrawal by Subject|0
7188101|NCT03347123|11388747|FG000|Overall Study|Reason not Specified|3
7188102|NCT03347123|11388748|FG001|Overall Study|Reason not Specified|4
7188103|NCT03347123|11388749|FG002|Overall Study|Reason not Specified|0
7188104|NCT03347123|11388750|FG003|Overall Study|Reason not Specified|0
7188105|NCT03347123|11388751|FG004|Overall Study|Reason not Specified|0
7188106|NCT03347123|11388752|FG005|Overall Study|Reason not Specified|0
7188107|NCT03347123|11388753|FG006|Overall Study|Reason not Specified|0
7188108|NCT03318523|11388768|FG000|PC Period: Up to Year 1|Adverse Event|1
7177949|NCT01345240|11378397|FG000|Overall Study|Adverse Event|3
7177950|NCT01345240|11378398|FG001|Overall Study|Adverse Event|5
7177951|NCT01345240|11378399|FG002|Overall Study|Adverse Event|4
7177952|NCT01345240|11378400|FG003|Overall Study|Adverse Event|2
7177953|NCT01345240|11378401|FG004|Overall Study|Adverse Event|1
7177954|NCT01345240|11378397|FG000|Overall Study|Lost to Follow-up|8
7177955|NCT01345240|11378398|FG001|Overall Study|Lost to Follow-up|9
7177956|NCT01345240|11378399|FG002|Overall Study|Lost to Follow-up|14
7177957|NCT01345240|11378400|FG003|Overall Study|Lost to Follow-up|7
7177958|NCT01345240|11378401|FG004|Overall Study|Lost to Follow-up|9
7177959|NCT01371305|11378428|FG000|Overall Study|Adverse Event|0
7177960|NCT01371305|11378429|FG001|Overall Study|Adverse Event|0
7177961|NCT01371305|11378430|FG002|Overall Study|Adverse Event|0
7177962|NCT01371305|11378431|FG003|Overall Study|Adverse Event|2
7177963|NCT01371305|11378432|FG004|Overall Study|Adverse Event|1
7177964|NCT01371305|11378433|FG005|Overall Study|Adverse Event|0
7177965|NCT01371305|11378428|FG000|Overall Study|Study terminated by sponsor|0
7177966|NCT01371305|11378429|FG001|Overall Study|Study terminated by sponsor|0
7177967|NCT01371305|11378430|FG002|Overall Study|Study terminated by sponsor|0
7177968|NCT01371305|11378431|FG003|Overall Study|Study terminated by sponsor|0
7177969|NCT01371305|11378432|FG004|Overall Study|Study terminated by sponsor|3
7177970|NCT01371305|11378433|FG005|Overall Study|Study terminated by sponsor|1
7177971|NCT01371305|11378428|FG000|Overall Study|Subject request|0
7177972|NCT01371305|11378429|FG001|Overall Study|Subject request|0
7177973|NCT01371305|11378430|FG002|Overall Study|Subject request|0
7177974|NCT01371305|11378431|FG003|Overall Study|Subject request|0
7177975|NCT01371305|11378432|FG004|Overall Study|Subject request|0
7177976|NCT01371305|11378433|FG005|Overall Study|Subject request|1
7177977|NCT01376323|11378453|FG000|Overall Study|Adverse Event|1
7177978|NCT01376323|11378454|FG001|Overall Study|Adverse Event|0
7177979|NCT01376323|11378455|FG002|Overall Study|Adverse Event|0
7177980|NCT01376323|11378456|FG003|Overall Study|Adverse Event|2
7177981|NCT01376323|11378457|FG004|Overall Study|Adverse Event|0
7177982|NCT01376323|11378453|FG000|Overall Study|Lost to Follow-up|0
7177983|NCT01376323|11378454|FG001|Overall Study|Lost to Follow-up|0
7177984|NCT01376323|11378455|FG002|Overall Study|Lost to Follow-up|0
7177985|NCT01376323|11378456|FG003|Overall Study|Lost to Follow-up|2
7177986|NCT01376323|11378457|FG004|Overall Study|Lost to Follow-up|0
7177987|NCT01376323|11378453|FG000|Overall Study|Physician Decision|1
7177988|NCT01376323|11378454|FG001|Overall Study|Physician Decision|0
7177989|NCT01376323|11378455|FG002|Overall Study|Physician Decision|2
7177990|NCT01376323|11378456|FG003|Overall Study|Physician Decision|1
7177991|NCT01376323|11378457|FG004|Overall Study|Physician Decision|1
7177992|NCT01376323|11378453|FG000|Overall Study|Withdrawal by Subject|0
7177993|NCT01376323|11378454|FG001|Overall Study|Withdrawal by Subject|1
7177994|NCT01376323|11378455|FG002|Overall Study|Withdrawal by Subject|1
7177995|NCT01376323|11378456|FG003|Overall Study|Withdrawal by Subject|0
7177996|NCT01376323|11378457|FG004|Overall Study|Withdrawal by Subject|0
7177997|NCT01386658|11378481|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0
7177998|NCT01386658|11378482|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9
7177999|NCT01386658|11378481|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0
7178000|NCT01386658|11378482|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3
7178001|NCT01386684|11378492|FG000|Overall Study|Lost to Follow-up|51
7178002|NCT01386684|11378492|FG000|Overall Study|Other|51
7178003|NCT01386684|11378492|FG000|Overall Study|Death|47
7178004|NCT01386684|11378492|FG000|Overall Study|Withdrawal of Consent|44
7178005|NCT01386684|11378492|FG000|Overall Study|Alternative Therapy Required|37
7178006|NCT01386684|11378492|FG000|Overall Study|Disease Progression|28
7178007|NCT01386684|11378492|FG000|Overall Study|Adverse Event|20
7178008|NCT01386684|11378492|FG000|Overall Study|Noncompliance|8
7178009|NCT01386684|11378492|FG000|Overall Study|Protocol Violation|4
7178010|NCT01386684|11378492|FG000|Overall Study|Missing|3
7178011|NCT04980014|11378509|FG000|Overall Study|Participants who are Duplicated|1
7178012|NCT04980014|11378509|FG000|Overall Study|Follow-up Failure|13
7178013|NCT04980014|11378509|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2
7178014|NCT04980014|11378509|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2
7178015|NCT04980014|11378509|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57
7178016|NCT04427501|11378540|FG000|Overall Study|Death|0
7178017|NCT04427501|11378541|FG001|Overall Study|Death|0
7178018|NCT04427501|11378542|FG002|Overall Study|Death|0
7178019|NCT04427501|11378543|FG003|Overall Study|Death|0
7178020|NCT04427501|11378544|FG004|Overall Study|Death|0
7178021|NCT04427501|11378545|FG005|Overall Study|Death|15
7178022|NCT04427501|11378546|FG006|Overall Study|Death|0
7178023|NCT04427501|11378547|FG007|Overall Study|Death|0
7178024|NCT04427501|11378548|FG008|Overall Study|Death|0
7178025|NCT04427501|11378549|FG009|Overall Study|Death|0
7178026|NCT04427501|11378540|FG000|Overall Study|Lost to Follow-up|5
7178027|NCT04427501|11378541|FG001|Overall Study|Lost to Follow-up|1
7178028|NCT04427501|11378542|FG002|Overall Study|Lost to Follow-up|2
7178029|NCT04427501|11378543|FG003|Overall Study|Lost to Follow-up|0
7178030|NCT04427501|11378544|FG004|Overall Study|Lost to Follow-up|2
7178031|NCT04427501|11378545|FG005|Overall Study|Lost to Follow-up|11
7178032|NCT04427501|11378546|FG006|Overall Study|Lost to Follow-up|10
7178033|NCT04427501|11378547|FG007|Overall Study|Lost to Follow-up|10
7178034|NCT04427501|11378548|FG008|Overall Study|Lost to Follow-up|2
7178035|NCT04427501|11378549|FG009|Overall Study|Lost to Follow-up|5
7178036|NCT04427501|11378540|FG000|Overall Study|Physician Decision|0
7178037|NCT04427501|11378541|FG001|Overall Study|Physician Decision|3
7178038|NCT04427501|11378542|FG002|Overall Study|Physician Decision|0
7178039|NCT04427501|11378543|FG003|Overall Study|Physician Decision|0
7178040|NCT04427501|11378544|FG004|Overall Study|Physician Decision|0
7178041|NCT04427501|11378545|FG005|Overall Study|Physician Decision|0
7178042|NCT04427501|11378546|FG006|Overall Study|Physician Decision|2
7178043|NCT04427501|11378547|FG007|Overall Study|Physician Decision|0
7178044|NCT04427501|11378548|FG008|Overall Study|Physician Decision|0
7178045|NCT04427501|11378549|FG009|Overall Study|Physician Decision|0
7178046|NCT04427501|11378540|FG000|Overall Study|Withdrawal by Subject|9
7178047|NCT04427501|11378541|FG001|Overall Study|Withdrawal by Subject|2
7178048|NCT04427501|11378542|FG002|Overall Study|Withdrawal by Subject|2
7178049|NCT04427501|11378543|FG003|Overall Study|Withdrawal by Subject|3
7178050|NCT04427501|11378544|FG004|Overall Study|Withdrawal by Subject|7
6895370|NCT00624780|10913277|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7
7178051|NCT04427501|11378545|FG005|Overall Study|Withdrawal by Subject|25
7178052|NCT04427501|11378546|FG006|Overall Study|Withdrawal by Subject|15
7178053|NCT04427501|11378547|FG007|Overall Study|Withdrawal by Subject|7
7178054|NCT04427501|11378548|FG008|Overall Study|Withdrawal by Subject|4
7178055|NCT04427501|11378549|FG009|Overall Study|Withdrawal by Subject|1
7178056|NCT04427501|11378540|FG000|Overall Study|Other - as reported by the investigator|1
7178057|NCT04427501|11378541|FG001|Overall Study|Other - as reported by the investigator|0
7178058|NCT04427501|11378542|FG002|Overall Study|Other - as reported by the investigator|0
7178059|NCT04427501|11378543|FG003|Overall Study|Other - as reported by the investigator|0
7178060|NCT04427501|11378544|FG004|Overall Study|Other - as reported by the investigator|0
7178061|NCT04427501|11378545|FG005|Overall Study|Other - as reported by the investigator|6
7178062|NCT04427501|11378546|FG006|Overall Study|Other - as reported by the investigator|6
7178063|NCT04427501|11378547|FG007|Overall Study|Other - as reported by the investigator|0
7178064|NCT04427501|11378548|FG008|Overall Study|Other - as reported by the investigator|0
7178065|NCT04427501|11378549|FG009|Overall Study|Other - as reported by the investigator|0
7178066|NCT03735849|11378585|FG000|Overall Study|Lost to Follow-up|1
7178067|NCT03735849|11378586|FG001|Overall Study|Lost to Follow-up|0
7178068|NCT03735849|11378587|FG002|Overall Study|Lost to Follow-up|0
7178069|NCT03735849|11378585|FG000|Overall Study|Participant unable to adhere to visit|1
7178070|NCT03735849|11378586|FG001|Overall Study|Participant unable to adhere to visit|0
7178071|NCT03735849|11378587|FG002|Overall Study|Participant unable to adhere to visit|0
7178072|NCT03735849|11378585|FG000|Overall Study|Not Randomized|0
7178073|NCT03735849|11378586|FG001|Overall Study|Not Randomized|0
7178074|NCT03735849|11378587|FG002|Overall Study|Not Randomized|4
7178075|NCT03552393|11378603|FG000|Core Period|Kidney Transplant|1
7178076|NCT03552393|11378603|FG000|Core Period|Prohibited Medication|1
7178077|NCT03552393|11378603|FG000|Safety Extension Period|Kidney Transplant|4
7186375|NCT02257918|11386675|FG000|Overall Study|Lost to Follow-up|4
7186376|NCT02257918|11386676|FG001|Overall Study|Lost to Follow-up|1
7186377|NCT02257918|11386677|FG002|Overall Study|Lost to Follow-up|0
7186378|NCT02257918|11386675|FG000|Overall Study|Withdrawal by Subject|0
7186379|NCT02257918|11386676|FG001|Overall Study|Withdrawal by Subject|0
7186380|NCT02257918|11386677|FG002|Overall Study|Withdrawal by Subject|1
7186381|NCT02257918|11386675|FG000|Overall Study|Pregnancy|0
7186382|NCT02257918|11386676|FG001|Overall Study|Pregnancy|0
7186383|NCT02257918|11386677|FG002|Overall Study|Pregnancy|1
7186384|NCT02258542|11386689|FG000|Overall Study|eg. not made to the visit|7
7186385|NCT02258542|11386690|FG001|Overall Study|eg. not made to the visit|4
7186386|NCT02258542|11386691|FG002|Overall Study|eg. not made to the visit|0
7186387|NCT02258542|11386692|FG003|Overall Study|eg. not made to the visit|1
7186388|NCT02258542|11386689|FG000|Overall Study|study specific discount. criteria|1
7186389|NCT02258542|11386690|FG001|Overall Study|study specific discount. criteria|1
7186390|NCT02258542|11386691|FG002|Overall Study|study specific discount. criteria|0
7186391|NCT02258542|11386692|FG003|Overall Study|study specific discount. criteria|0
7186392|NCT02258542|11386689|FG000|Overall Study|Withdrawal by Subject|20
7186393|NCT02258542|11386690|FG001|Overall Study|Withdrawal by Subject|20
7186394|NCT02258542|11386691|FG002|Overall Study|Withdrawal by Subject|7
7186395|NCT02258542|11386692|FG003|Overall Study|Withdrawal by Subject|1
7186396|NCT02258542|11386689|FG000|Overall Study|Lost to Follow-up|5
7186397|NCT02258542|11386690|FG001|Overall Study|Lost to Follow-up|12
7186398|NCT02258542|11386691|FG002|Overall Study|Lost to Follow-up|1
7186399|NCT02258542|11386692|FG003|Overall Study|Lost to Follow-up|2
7186400|NCT02258542|11386689|FG000|Overall Study|Death|5
7186401|NCT02258542|11386690|FG001|Overall Study|Death|4
7186402|NCT02258542|11386691|FG002|Overall Study|Death|0
7186403|NCT02258542|11386692|FG003|Overall Study|Death|1
7186404|NCT02258542|11386689|FG000|Overall Study|Adverse Event|3
7186405|NCT02258542|11386690|FG001|Overall Study|Adverse Event|4
7186406|NCT02258542|11386691|FG002|Overall Study|Adverse Event|0
7186407|NCT02258542|11386692|FG003|Overall Study|Adverse Event|0
7186408|NCT02258542|11386689|FG000|Overall Study|Protocol Violation|1
6895371|NCT00624780|10913278|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5
7186409|NCT02258542|11386690|FG001|Overall Study|Protocol Violation|2
7186410|NCT02258542|11386691|FG002|Overall Study|Protocol Violation|0
7178078|NCT03412747|11378610|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2
7178079|NCT03412747|11378611|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2
7178080|NCT03412747|11378612|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3
7178081|NCT03412747|11378610|FG000|Initial Treatment Period: Wk0-Wk16|Death|0
7178082|NCT03412747|11378611|FG001|Initial Treatment Period: Wk0-Wk16|Death|0
7178083|NCT03412747|11378612|FG002|Initial Treatment Period: Wk0-Wk16|Death|1
7178084|NCT03412747|11378610|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0
7178085|NCT03412747|11378611|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0
7178086|NCT03412747|11378612|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1
7178087|NCT03412747|11378610|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0
7178088|NCT03412747|11378611|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0
7178089|NCT03412747|11378612|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2
7178090|NCT03412747|11378610|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0
7178091|NCT03412747|11378611|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2
7178092|NCT03412747|11378612|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1
7178093|NCT03412747|11378610|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4
7178094|NCT03412747|11378611|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1
7178095|NCT03412747|11378612|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1
7178096|NCT03412747|11378610|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1
7178097|NCT03412747|11378611|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0
7178098|NCT03412747|11378612|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0
7178099|NCT03412747|11378610|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3
7178100|NCT03412747|11378611|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1
7178101|NCT03412747|11378612|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0
7178102|NCT03412747|11378610|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1
7178103|NCT03412747|11378611|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0
7178104|NCT03412747|11378612|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0
7178105|NCT03412747|11378610|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0
7178106|NCT03412747|11378611|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0
7178107|NCT03412747|11378612|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1
7178108|NCT03412747|11378610|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1
7178109|NCT03412747|11378611|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0
7178110|NCT03412747|11378612|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0
7178111|NCT03412747|11378610|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3
7178112|NCT03412747|11378611|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4
7178113|NCT03412747|11378612|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6
7178114|NCT03412747|11378610|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0
7178115|NCT03412747|11378611|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1
7178116|NCT03412747|11378612|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1
7178117|NCT03412747|11378610|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0
7178118|NCT03412747|11378611|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2
7178119|NCT03412747|11378612|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5
7178120|NCT03412747|11378610|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3
7178121|NCT03412747|11378611|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1
7178122|NCT03412747|11378612|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4
7178123|NCT03412747|11378610|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0
7178124|NCT03412747|11378611|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1
7178125|NCT03412747|11378612|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0
7178126|NCT03333382|11378632|FG000|Overall Study|Lost to Follow-up|1
7178127|NCT03333382|11378633|FG001|Overall Study|Lost to Follow-up|0
7178128|NCT03107611|11378672|FG000|Overall Study|Adverse Event|1
7178129|NCT03107611|11378673|FG001|Overall Study|Adverse Event|0
7178130|NCT03107611|11378674|FG002|Overall Study|Adverse Event|2
7178131|NCT03107611|11378672|FG000|Overall Study|Lost to Follow-up|3
6895372|NCT00624780|10913279|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15
6895373|NCT00624780|10913280|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3
6895374|NCT00624780|10913281|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9
6895375|NCT00624780|10913282|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5
6895376|NCT00624780|10913277|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
6895377|NCT00624780|10913278|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2
6895378|NCT00624780|10913279|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10
6895379|NCT00624780|10913280|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
6895380|NCT00624780|10913281|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9
6895381|NCT00624780|10913282|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1
6895382|NCT00624780|10913277|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
6895383|NCT00624780|10913278|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
6895384|NCT00624780|10913279|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
6895385|NCT00624780|10913280|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
6895386|NCT00624780|10913281|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
6895387|NCT00624780|10913282|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
6973185|NCT01178125|11024755|FG000|Overall Study|Adverse Event|244
6895388|NCT00624780|10913277|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
6895389|NCT00624780|10913278|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2
6895390|NCT00624780|10913279|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7
6895391|NCT00624780|10913280|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
6895392|NCT00624780|10913281|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
6895393|NCT00624780|10913282|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
7178132|NCT03107611|11378673|FG001|Overall Study|Lost to Follow-up|3
7178133|NCT03107611|11378674|FG002|Overall Study|Lost to Follow-up|3
7178134|NCT03107611|11378672|FG000|Overall Study|Protocol Violation|0
7178135|NCT03107611|11378673|FG001|Overall Study|Protocol Violation|0
7178136|NCT03107611|11378674|FG002|Overall Study|Protocol Violation|1
7178137|NCT03107611|11378672|FG000|Overall Study|Withdrawal by Subject|1
7178138|NCT03107611|11378673|FG001|Overall Study|Withdrawal by Subject|0
7178139|NCT03107611|11378674|FG002|Overall Study|Withdrawal by Subject|1
7178140|NCT03107611|11378672|FG000|Overall Study|Worsening signs/symptoms|2
7178141|NCT03107611|11378673|FG001|Overall Study|Worsening signs/symptoms|1
7178142|NCT03107611|11378674|FG002|Overall Study|Worsening signs/symptoms|2
7178143|NCT02720016|11378685|FG000|Overall Study|Separation of couple|6
7178144|NCT02720016|11378686|FG001|Overall Study|Separation of couple|8
7178145|NCT02720016|11378687|FG002|Overall Study|Separation of couple|2
7178146|NCT02720016|11378685|FG000|Overall Study|Withdrawal by Subject|6
7178147|NCT02720016|11378686|FG001|Overall Study|Withdrawal by Subject|6
7178148|NCT02720016|11378687|FG002|Overall Study|Withdrawal by Subject|4
7178149|NCT02720016|11378685|FG000|Overall Study|Scheduling issues|2
7178150|NCT02720016|11378686|FG001|Overall Study|Scheduling issues|4
7178151|NCT02720016|11378687|FG002|Overall Study|Scheduling issues|7
7178152|NCT02720016|11378685|FG000|Overall Study|Childcare|2
7178153|NCT02720016|11378686|FG001|Overall Study|Childcare|0
7178154|NCT02720016|11378687|FG002|Overall Study|Childcare|2
7178155|NCT02720016|11378685|FG000|Overall Study|Withdrawal by PI|2
7178156|NCT02720016|11378686|FG001|Overall Study|Withdrawal by PI|2
7178157|NCT02720016|11378687|FG002|Overall Study|Withdrawal by PI|0
7178158|NCT02720016|11378685|FG000|Overall Study|Moved away|2
7178159|NCT02720016|11378686|FG001|Overall Study|Moved away|0
7178160|NCT02720016|11378687|FG002|Overall Study|Moved away|0
7178161|NCT02720016|11378685|FG000|Overall Study|Not Primary Health Concern|0
7178162|NCT02720016|11378686|FG001|Overall Study|Not Primary Health Concern|0
7178163|NCT02720016|11378687|FG002|Overall Study|Not Primary Health Concern|2
7178164|NCT02720016|11378685|FG000|Overall Study|Transportation issues|0
7178165|NCT02720016|11378686|FG001|Overall Study|Transportation issues|0
7178166|NCT02720016|11378687|FG002|Overall Study|Transportation issues|1
7178167|NCT02720016|11378685|FG000|Overall Study|Other|0
7178168|NCT02720016|11378686|FG001|Overall Study|Other|0
7178169|NCT02720016|11378687|FG002|Overall Study|Other|2
7178170|NCT02607956|11378698|FG000|Double-Blinded Phase|Withdrew Consent|17
7178171|NCT02607956|11378699|FG001|Double-Blinded Phase|Withdrew Consent|19
7178172|NCT02607956|11378700|FG002|Double-Blinded Phase|Withdrew Consent|0
7178173|NCT02607956|11378701|FG003|Double-Blinded Phase|Withdrew Consent|0
7178174|NCT02607956|11378698|FG000|Double-Blinded Phase|Lost to Follow-up|19
7178175|NCT02607956|11378699|FG001|Double-Blinded Phase|Lost to Follow-up|16
7178176|NCT02607956|11378700|FG002|Double-Blinded Phase|Lost to Follow-up|0
7178177|NCT02607956|11378701|FG003|Double-Blinded Phase|Lost to Follow-up|0
7178178|NCT02607956|11378698|FG000|Double-Blinded Phase|Randomized but never treated|7
7178179|NCT02607956|11378699|FG001|Double-Blinded Phase|Randomized but never treated|5
7178180|NCT02607956|11378700|FG002|Double-Blinded Phase|Randomized but never treated|0
7178181|NCT02607956|11378701|FG003|Double-Blinded Phase|Randomized but never treated|0
7178182|NCT02607956|11378698|FG000|Double-Blinded Phase|Investigator's Discretion|7
7178183|NCT02607956|11378699|FG001|Double-Blinded Phase|Investigator's Discretion|2
7178184|NCT02607956|11378700|FG002|Double-Blinded Phase|Investigator's Discretion|0
7178185|NCT02607956|11378701|FG003|Double-Blinded Phase|Investigator's Discretion|0
7178186|NCT02607956|11378698|FG000|Double-Blinded Phase|Death|4
7178187|NCT02607956|11378699|FG001|Double-Blinded Phase|Death|4
7178188|NCT02607956|11378700|FG002|Double-Blinded Phase|Death|0
7178189|NCT02607956|11378701|FG003|Double-Blinded Phase|Death|0
7178190|NCT02607956|11378698|FG000|Double-Blinded Phase|Adverse Event|4
7178191|NCT02607956|11378699|FG001|Double-Blinded Phase|Adverse Event|3
7178192|NCT02607956|11378700|FG002|Double-Blinded Phase|Adverse Event|0
7178193|NCT02607956|11378701|FG003|Double-Blinded Phase|Adverse Event|0
7178194|NCT02607956|11378698|FG000|Double-Blinded Phase|Protocol Violation|3
7178195|NCT02607956|11378699|FG001|Double-Blinded Phase|Protocol Violation|1
7178196|NCT02607956|11378700|FG002|Double-Blinded Phase|Protocol Violation|0
7178197|NCT02607956|11378701|FG003|Double-Blinded Phase|Protocol Violation|0
7178198|NCT02607956|11378698|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0
7178199|NCT02607956|11378699|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3
7178200|NCT02607956|11378700|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0
7178201|NCT02607956|11378701|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0
7178202|NCT02607956|11378698|FG000|Open-Label Extension Phase|Withdrew Consent|0
7178203|NCT02607956|11378699|FG001|Open-Label Extension Phase|Withdrew Consent|0
7178204|NCT02607956|11378700|FG002|Open-Label Extension Phase|Withdrew Consent|10
7178205|NCT02607956|11378701|FG003|Open-Label Extension Phase|Withdrew Consent|16
7178206|NCT02607956|11378698|FG000|Open-Label Extension Phase|Lost to Follow-up|0
7178207|NCT02607956|11378699|FG001|Open-Label Extension Phase|Lost to Follow-up|0
7178208|NCT02607956|11378700|FG002|Open-Label Extension Phase|Lost to Follow-up|14
7178209|NCT02607956|11378701|FG003|Open-Label Extension Phase|Lost to Follow-up|6
7178210|NCT02607956|11378698|FG000|Open-Label Extension Phase|Death|0
7178211|NCT02607956|11378699|FG001|Open-Label Extension Phase|Death|0
7178212|NCT02607956|11378700|FG002|Open-Label Extension Phase|Death|1
7178213|NCT02607956|11378701|FG003|Open-Label Extension Phase|Death|3
7178214|NCT02607956|11378698|FG000|Open-Label Extension Phase|Investigator's Discretion|0
7178215|NCT02607956|11378699|FG001|Open-Label Extension Phase|Investigator's Discretion|0
7178216|NCT02607956|11378700|FG002|Open-Label Extension Phase|Investigator's Discretion|2
7178217|NCT02607956|11378701|FG003|Open-Label Extension Phase|Investigator's Discretion|2
7178218|NCT02607956|11378698|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0
7178219|NCT02607956|11378699|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0
7178220|NCT02607956|11378700|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2
7178221|NCT02607956|11378701|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0
7178222|NCT02607956|11378698|FG000|Open-Label Extension Phase|Protocol Violation|0
7178223|NCT02607956|11378699|FG001|Open-Label Extension Phase|Protocol Violation|0
7178224|NCT02607956|11378700|FG002|Open-Label Extension Phase|Protocol Violation|0
7178225|NCT02607956|11378701|FG003|Open-Label Extension Phase|Protocol Violation|2
7178226|NCT02607956|11378698|FG000|Open-Label Extension Phase|Pregnancy|0
7178227|NCT02607956|11378699|FG001|Open-Label Extension Phase|Pregnancy|0
7178228|NCT02607956|11378700|FG002|Open-Label Extension Phase|Pregnancy|0
7178229|NCT02607956|11378701|FG003|Open-Label Extension Phase|Pregnancy|1
7178230|NCT02564523|11378731|FG000|Overall Study|Withdrawal by Subject|3
7178231|NCT02564523|11378732|FG001|Overall Study|Withdrawal by Subject|0
7178232|NCT02564523|11378733|FG002|Overall Study|Withdrawal by Subject|1
7178233|NCT02564523|11378734|FG003|Overall Study|Withdrawal by Subject|0
7178234|NCT02564523|11378735|FG004|Overall Study|Withdrawal by Subject|1
7178235|NCT02564523|11378736|FG005|Overall Study|Withdrawal by Subject|0
6895394|NCT00624780|10913277|FG000|Treatment Optimization (Up to Week 12)|Other|10
6895395|NCT00624780|10913278|FG001|Treatment Optimization (Up to Week 12)|Other|4
7178236|NCT02564523|11378737|FG006|Overall Study|Withdrawal by Subject|1
7178237|NCT02564523|11378738|FG007|Overall Study|Withdrawal by Subject|0
7178238|NCT02564523|11378739|FG008|Overall Study|Withdrawal by Subject|0
7178239|NCT02564523|11378740|FG009|Overall Study|Withdrawal by Subject|0
7178240|NCT02564523|11378741|FG010|Overall Study|Withdrawal by Subject|1
6895396|NCT00624780|10913279|FG002|Treatment Optimization (Up to Week 12)|Other|8
7178241|NCT02564523|11378742|FG011|Overall Study|Withdrawal by Subject|0
7178242|NCT02564523|11378743|FG012|Overall Study|Withdrawal by Subject|1
7178243|NCT02564523|11378744|FG013|Overall Study|Withdrawal by Subject|0
7178244|NCT02564523|11378745|FG014|Overall Study|Withdrawal by Subject|0
7178245|NCT02564523|11378746|FG015|Overall Study|Withdrawal by Subject|0
7178246|NCT02564523|11378747|FG016|Overall Study|Withdrawal by Subject|0
7178247|NCT02564523|11378748|FG017|Overall Study|Withdrawal by Subject|0
7178248|NCT02564523|11378731|FG000|Overall Study|Adverse Event|0
7178249|NCT02564523|11378732|FG001|Overall Study|Adverse Event|0
7178250|NCT02564523|11378733|FG002|Overall Study|Adverse Event|0
7178251|NCT02564523|11378734|FG003|Overall Study|Adverse Event|0
7178252|NCT02564523|11378735|FG004|Overall Study|Adverse Event|0
7178253|NCT02564523|11378736|FG005|Overall Study|Adverse Event|0
7178254|NCT02564523|11378737|FG006|Overall Study|Adverse Event|0
7178255|NCT02564523|11378738|FG007|Overall Study|Adverse Event|0
7178256|NCT02564523|11378739|FG008|Overall Study|Adverse Event|0
7178257|NCT02564523|11378740|FG009|Overall Study|Adverse Event|0
7178258|NCT02564523|11378741|FG010|Overall Study|Adverse Event|0
7178259|NCT02564523|11378742|FG011|Overall Study|Adverse Event|0
7178260|NCT02564523|11378743|FG012|Overall Study|Adverse Event|0
7178261|NCT02564523|11378744|FG013|Overall Study|Adverse Event|0
7178262|NCT02564523|11378745|FG014|Overall Study|Adverse Event|0
7178263|NCT02564523|11378746|FG015|Overall Study|Adverse Event|0
7178264|NCT02564523|11378747|FG016|Overall Study|Adverse Event|0
7178265|NCT02564523|11378748|FG017|Overall Study|Adverse Event|1
7178266|NCT02564523|11378731|FG000|Overall Study|Death|0
7178267|NCT02564523|11378732|FG001|Overall Study|Death|0
6895397|NCT00624780|10913280|FG003|Treatment Optimization (Up to Week 12)|Other|2
6895398|NCT00624780|10913281|FG004|Treatment Optimization (Up to Week 12)|Other|9
6895399|NCT00624780|10913282|FG005|Treatment Optimization (Up to Week 12)|Other|0
6895400|NCT00624780|10913277|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
6895401|NCT00624780|10913278|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4
7178268|NCT02564523|11378733|FG002|Overall Study|Death|0
7178269|NCT02564523|11378734|FG003|Overall Study|Death|0
7178270|NCT02564523|11378735|FG004|Overall Study|Death|0
7178271|NCT02564523|11378736|FG005|Overall Study|Death|0
7178272|NCT02564523|11378737|FG006|Overall Study|Death|1
7178273|NCT02564523|11378738|FG007|Overall Study|Death|0
7178274|NCT02564523|11378739|FG008|Overall Study|Death|0
7178275|NCT02564523|11378740|FG009|Overall Study|Death|0
7178276|NCT02564523|11378741|FG010|Overall Study|Death|1
7178277|NCT02564523|11378742|FG011|Overall Study|Death|0
7178278|NCT02564523|11378743|FG012|Overall Study|Death|0
7178279|NCT02564523|11378744|FG013|Overall Study|Death|0
7178280|NCT02564523|11378745|FG014|Overall Study|Death|0
7178281|NCT02564523|11378746|FG015|Overall Study|Death|0
7178282|NCT02564523|11378747|FG016|Overall Study|Death|0
7178283|NCT02564523|11378748|FG017|Overall Study|Death|0
7178284|NCT02564523|11378731|FG000|Overall Study|Lost to Follow-up|2
7178285|NCT02564523|11378732|FG001|Overall Study|Lost to Follow-up|1
7178286|NCT02564523|11378733|FG002|Overall Study|Lost to Follow-up|4
7178287|NCT02564523|11378734|FG003|Overall Study|Lost to Follow-up|0
7178288|NCT02564523|11378735|FG004|Overall Study|Lost to Follow-up|1
7178289|NCT02564523|11378736|FG005|Overall Study|Lost to Follow-up|0
7178290|NCT02564523|11378737|FG006|Overall Study|Lost to Follow-up|1
7178291|NCT02564523|11378738|FG007|Overall Study|Lost to Follow-up|0
7178292|NCT02564523|11378739|FG008|Overall Study|Lost to Follow-up|0
7178293|NCT02564523|11378740|FG009|Overall Study|Lost to Follow-up|0
7178294|NCT02564523|11378741|FG010|Overall Study|Lost to Follow-up|0
7178295|NCT02564523|11378742|FG011|Overall Study|Lost to Follow-up|1
7178296|NCT02564523|11378743|FG012|Overall Study|Lost to Follow-up|1
7178297|NCT02564523|11378744|FG013|Overall Study|Lost to Follow-up|0
7178298|NCT02564523|11378745|FG014|Overall Study|Lost to Follow-up|0
7178299|NCT02564523|11378746|FG015|Overall Study|Lost to Follow-up|0
7178300|NCT02564523|11378747|FG016|Overall Study|Lost to Follow-up|0
7178301|NCT02564523|11378748|FG017|Overall Study|Lost to Follow-up|0
7178302|NCT02564523|11378731|FG000|Overall Study|Physician Decision|0
7178303|NCT02564523|11378732|FG001|Overall Study|Physician Decision|0
7178304|NCT02564523|11378733|FG002|Overall Study|Physician Decision|0
7178305|NCT02564523|11378734|FG003|Overall Study|Physician Decision|0
7178306|NCT02564523|11378735|FG004|Overall Study|Physician Decision|1
7178307|NCT02564523|11378736|FG005|Overall Study|Physician Decision|0
7178308|NCT02564523|11378737|FG006|Overall Study|Physician Decision|0
7178309|NCT02564523|11378738|FG007|Overall Study|Physician Decision|0
7178310|NCT02564523|11378739|FG008|Overall Study|Physician Decision|0
7178311|NCT02564523|11378740|FG009|Overall Study|Physician Decision|0
7178312|NCT02564523|11378741|FG010|Overall Study|Physician Decision|1
7178313|NCT02564523|11378742|FG011|Overall Study|Physician Decision|0
7178314|NCT02564523|11378743|FG012|Overall Study|Physician Decision|0
6895402|NCT00624780|10913279|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
7178315|NCT02564523|11378744|FG013|Overall Study|Physician Decision|0
7178316|NCT02564523|11378745|FG014|Overall Study|Physician Decision|0
7178317|NCT02564523|11378746|FG015|Overall Study|Physician Decision|0
7178318|NCT02564523|11378747|FG016|Overall Study|Physician Decision|0
7178319|NCT02564523|11378748|FG017|Overall Study|Physician Decision|0
7178320|NCT02564523|11378731|FG000|Overall Study|Protocol Violation|2
7178321|NCT02564523|11378732|FG001|Overall Study|Protocol Violation|2
7178322|NCT02564523|11378733|FG002|Overall Study|Protocol Violation|5
7178323|NCT02564523|11378734|FG003|Overall Study|Protocol Violation|0
7178324|NCT02564523|11378735|FG004|Overall Study|Protocol Violation|1
7178325|NCT02564523|11378736|FG005|Overall Study|Protocol Violation|0
7178326|NCT02564523|11378737|FG006|Overall Study|Protocol Violation|0
6895403|NCT00624780|10913280|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2
6895404|NCT00624780|10913281|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3
6895405|NCT00624780|10913282|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1
6895406|NCT00624780|10913277|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
6895407|NCT00624780|10913278|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1
6895408|NCT00624780|10913279|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
6895409|NCT00624780|10913280|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
6895410|NCT00624780|10913281|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
7178327|NCT02564523|11378738|FG007|Overall Study|Protocol Violation|0
7178328|NCT02564523|11378739|FG008|Overall Study|Protocol Violation|0
6895411|NCT00624780|10913282|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
6895412|NCT00624780|10913277|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
6895413|NCT00624780|10913278|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
7178329|NCT02564523|11378740|FG009|Overall Study|Protocol Violation|0
7178330|NCT02564523|11378741|FG010|Overall Study|Protocol Violation|0
7178331|NCT02564523|11378742|FG011|Overall Study|Protocol Violation|0
7178332|NCT02564523|11378743|FG012|Overall Study|Protocol Violation|0
7178333|NCT02564523|11378744|FG013|Overall Study|Protocol Violation|0
7178334|NCT02564523|11378745|FG014|Overall Study|Protocol Violation|0
7178335|NCT02564523|11378746|FG015|Overall Study|Protocol Violation|0
7178336|NCT02564523|11378747|FG016|Overall Study|Protocol Violation|0
7178337|NCT02564523|11378748|FG017|Overall Study|Protocol Violation|0
7178338|NCT02564523|11378731|FG000|Overall Study|Other|3
7178339|NCT02564523|11378732|FG001|Overall Study|Other|0
7178340|NCT02564523|11378733|FG002|Overall Study|Other|0
7178341|NCT02564523|11378734|FG003|Overall Study|Other|1
7178342|NCT02564523|11378735|FG004|Overall Study|Other|0
7178343|NCT02564523|11378736|FG005|Overall Study|Other|0
7178344|NCT02564523|11378737|FG006|Overall Study|Other|0
7178345|NCT02564523|11378738|FG007|Overall Study|Other|0
7178346|NCT02564523|11378739|FG008|Overall Study|Other|0
7178347|NCT02564523|11378740|FG009|Overall Study|Other|0
7178348|NCT02564523|11378741|FG010|Overall Study|Other|0
7178349|NCT02564523|11378742|FG011|Overall Study|Other|0
7178350|NCT02564523|11378743|FG012|Overall Study|Other|0
7178351|NCT02564523|11378744|FG013|Overall Study|Other|0
7178352|NCT02564523|11378745|FG014|Overall Study|Other|0
7178353|NCT02564523|11378746|FG015|Overall Study|Other|0
7178354|NCT02564523|11378747|FG016|Overall Study|Other|0
7178355|NCT02564523|11378748|FG017|Overall Study|Other|0
7178356|NCT01988493|11378832|FG000|Overall Study|Randomized but not treated|0
7178357|NCT01988493|11378833|FG001|Overall Study|Randomized but not treated|0
7178358|NCT01988493|11378834|FG002|Overall Study|Randomized but not treated|0
6895414|NCT00624780|10913279|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
6895415|NCT00624780|10913280|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
6895416|NCT00624780|10913281|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
6895417|NCT00624780|10913282|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
6895418|NCT00624780|10913277|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
6895419|NCT00624780|10913278|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
6895420|NCT00624780|10913279|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
6895421|NCT00624780|10913280|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
7178359|NCT01988493|11378835|FG003|Overall Study|Randomized but not treated|0
7178360|NCT01988493|11378836|FG004|Overall Study|Randomized but not treated|1
7178361|NCT01798004|11378853|FG000|Overall Study|Death|2
7178362|NCT01798004|11378853|FG000|Overall Study|Lack of Efficacy|8
7178363|NCT01798004|11378853|FG000|Overall Study|Physician Decision|25
7178364|NCT01798004|11378853|FG000|Overall Study|Withdrawal by Subject|4
7178365|NCT01798004|11378853|FG000|Overall Study|Ineligible|4
7178366|NCT01798004|11378853|FG000|Overall Study|Patient/parent refusal|7
7178367|NCT01798004|11378853|FG000|Overall Study|Initiation of other non-protocol therapy|5
7178368|NCT01798004|11378853|FG000|Overall Study|Enrollment another COG therapeutic trial|32
7178369|NCT01447628|11378880|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0
7178370|NCT01447628|11378881|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0
7178371|NCT01447628|11378882|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0
7178372|NCT01447628|11378883|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1
7178373|NCT01175356|11378903|FG000|Overall Study|Death|1
7178374|NCT01175356|11378903|FG000|Overall Study|Lack of Efficacy|12
7178375|NCT01175356|11378903|FG000|Overall Study|Lost to Follow-up|1
7178376|NCT01175356|11378903|FG000|Overall Study|Physician Decision|23
7178377|NCT01175356|11378903|FG000|Overall Study|Ineligible|1
7178378|NCT01175356|11378903|FG000|Overall Study|Treatment Slot Not Available|18
7178379|NCT01175356|11378903|FG000|Overall Study|Refusal by patient/parent/guardian|6
6895422|NCT00624780|10913281|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
6895423|NCT00624780|10913282|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
7178380|NCT01175356|11378903|FG000|Overall Study|Pts MIBG non-avid after enrollment|2
7178381|NCT01175356|11378903|FG000|Overall Study|On other COG study w/tumor tx intent|7
7178382|NCT01175356|11378903|FG000|Overall Study|Inadequate stem cell for transplant|1
7186411|NCT02258542|11386692|FG003|Overall Study|Protocol Violation|0
7178383|NCT01175356|11378903|FG000|Overall Study|Initiation other tx prior to completion|9
6895424|NCT00624780|10913277|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5
6895425|NCT00624780|10913278|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3
6895426|NCT00624780|10913279|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4
6895427|NCT00624780|10913280|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1
6895428|NCT00624780|10913281|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4
6895429|NCT00624780|10913282|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3
6895430|NCT00624780|10913277|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1
6895431|NCT00624780|10913278|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0
6895432|NCT00624780|10913279|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2
6895433|NCT00624780|10913280|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1
7178384|NCT00515853|11378909|FG000|Overall Study|Lost to Follow-up|9
7178385|NCT00515853|11378910|FG001|Overall Study|Lost to Follow-up|13
7178386|NCT00515853|11378909|FG000|Overall Study|Withdrawal by Subject|6
7178387|NCT00515853|11378910|FG001|Overall Study|Withdrawal by Subject|4
7178388|NCT00003458|11378916|FG000|Overall Study|Not evaluable|4
7186412|NCT02258542|11386689|FG000|Overall Study|Eligibility criteria not fulfilled|0
6895434|NCT00624780|10913281|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0
6895435|NCT00624780|10913282|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1
6895436|NCT00624780|10913277|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1
6895437|NCT00624780|10913278|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
6895438|NCT00624780|10913279|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
6895439|NCT00624780|10913280|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
6895440|NCT00624780|10913281|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
6895441|NCT00624780|10913282|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
6895442|NCT00624780|10913277|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
6895443|NCT00624780|10913278|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
6895444|NCT00624780|10913279|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1
6895445|NCT00624780|10913280|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
6895446|NCT00624780|10913281|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
6895447|NCT00624780|10913282|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
6895448|NCT00624780|10913277|FG000|Follow-up (Week 26)|Death|0
6895449|NCT00624780|10913278|FG001|Follow-up (Week 26)|Death|0
6895450|NCT00624780|10913279|FG002|Follow-up (Week 26)|Death|1
6895451|NCT00624780|10913280|FG003|Follow-up (Week 26)|Death|0
6895452|NCT00624780|10913281|FG004|Follow-up (Week 26)|Death|0
6895453|NCT00624780|10913282|FG005|Follow-up (Week 26)|Death|0
6895454|NCT00624780|10913277|FG000|Follow-up (Week 26)|Adverse Event|0
6895455|NCT00624780|10913278|FG001|Follow-up (Week 26)|Adverse Event|0
6895456|NCT00624780|10913279|FG002|Follow-up (Week 26)|Adverse Event|0
6895457|NCT00624780|10913280|FG003|Follow-up (Week 26)|Adverse Event|0
6895458|NCT00624780|10913281|FG004|Follow-up (Week 26)|Adverse Event|1
6895459|NCT00624780|10913282|FG005|Follow-up (Week 26)|Adverse Event|0
6895460|NCT00624780|10913277|FG000|Follow-up (Week 26)|Lost to Follow-up|0
6895461|NCT00624780|10913278|FG001|Follow-up (Week 26)|Lost to Follow-up|0
6895462|NCT00624780|10913279|FG002|Follow-up (Week 26)|Lost to Follow-up|1
6895463|NCT00624780|10913280|FG003|Follow-up (Week 26)|Lost to Follow-up|0
6895464|NCT00624780|10913281|FG004|Follow-up (Week 26)|Lost to Follow-up|1
6895465|NCT00624780|10913282|FG005|Follow-up (Week 26)|Lost to Follow-up|0
6895466|NCT00624780|10913277|FG000|Follow-up (Week 26)|Withdrawal by Subject|1
6895467|NCT00624780|10913278|FG001|Follow-up (Week 26)|Withdrawal by Subject|0
6895468|NCT00624780|10913279|FG002|Follow-up (Week 26)|Withdrawal by Subject|0
6895469|NCT00624780|10913280|FG003|Follow-up (Week 26)|Withdrawal by Subject|0
6895470|NCT00624780|10913281|FG004|Follow-up (Week 26)|Withdrawal by Subject|0
6895471|NCT00624780|10913282|FG005|Follow-up (Week 26)|Withdrawal by Subject|0
6895472|NCT00624780|10913277|FG000|Follow-up (Week 26)|Other|1
6895473|NCT00624780|10913278|FG001|Follow-up (Week 26)|Other|1
6895474|NCT00624780|10913279|FG002|Follow-up (Week 26)|Other|0
6895475|NCT00624780|10913280|FG003|Follow-up (Week 26)|Other|0
6895476|NCT00624780|10913281|FG004|Follow-up (Week 26)|Other|0
7186413|NCT02258542|11386690|FG001|Overall Study|Eligibility criteria not fulfilled|2
6895477|NCT00624780|10913282|FG005|Follow-up (Week 26)|Other|0
6895478|NCT00624819|10913312|FG000|Follow-up Period: Year 4|Parents decision|0
6895479|NCT00624819|10913313|FG001|Follow-up Period: Year 4|Parents decision|0
6895480|NCT00624819|10913314|FG002|Follow-up Period: Year 4|Parents decision|1
6895481|NCT00624819|10913315|FG003|Follow-up Period: Year 4|Parents decision|0
6895482|NCT00624819|10913312|FG000|Follow-up Period: Year 4|Lost to Follow-up|1
6895483|NCT00624819|10913313|FG001|Follow-up Period: Year 4|Lost to Follow-up|1
6895484|NCT00624819|10913314|FG002|Follow-up Period: Year 4|Lost to Follow-up|0
6895485|NCT00624819|10913315|FG003|Follow-up Period: Year 4|Lost to Follow-up|0
6895486|NCT00624832|10913329|FG000|Overall Study|Adverse Event|0
6895487|NCT00624832|10913330|FG001|Overall Study|Adverse Event|1
6895488|NCT00624832|10913331|FG002|Overall Study|Adverse Event|0
6895489|NCT00624832|10913332|FG003|Overall Study|Adverse Event|1
6895490|NCT00624832|10913329|FG000|Overall Study|Abnormal Laboratory Value|2
6895491|NCT00624832|10913330|FG001|Overall Study|Abnormal Laboratory Value|0
6895492|NCT00624832|10913331|FG002|Overall Study|Abnormal Laboratory Value|0
6895493|NCT00624832|10913332|FG003|Overall Study|Abnormal Laboratory Value|0
6895494|NCT00625131|10913367|FG000|Overall Study|Lost to Follow-up|3
6895495|NCT00625131|10913368|FG001|Overall Study|Lost to Follow-up|2
6895496|NCT00625131|10913369|FG002|Overall Study|Lost to Follow-up|0
6895497|NCT00625131|10913367|FG000|Overall Study|Withdrawal by Subject|1
6895498|NCT00625131|10913368|FG001|Overall Study|Withdrawal by Subject|0
6895499|NCT00625131|10913369|FG002|Overall Study|Withdrawal by Subject|5
6895500|NCT00625183|10913375|FG000|Overall Study|Disease Progression|1
6895501|NCT00625365|10913381|FG000|Overall Study|Withdrawal by Subject|1
6895502|NCT00625365|10913381|FG000|Overall Study|No IV access|5
6895503|NCT00625365|10913381|FG000|Overall Study|VSD|1
6895504|NCT00625443|10913418|FG000|Overall Study|Adverse Event|1
6895505|NCT00625443|10913419|FG001|Overall Study|Adverse Event|4
6895506|NCT00625443|10913420|FG002|Overall Study|Adverse Event|0
6895507|NCT00625443|10913418|FG000|Overall Study|Non-compliance with protocol|0
6895508|NCT00625443|10913419|FG001|Overall Study|Non-compliance with protocol|1
6895509|NCT00625443|10913420|FG002|Overall Study|Non-compliance with protocol|0
6895510|NCT00625443|10913418|FG000|Overall Study|Platelet count increase >=500,000/mm3|1
6895511|NCT00625443|10913419|FG001|Overall Study|Platelet count increase >=500,000/mm3|0
6895512|NCT00625443|10913420|FG002|Overall Study|Platelet count increase >=500,000/mm3|0
6895513|NCT00625443|10913418|FG000|Overall Study|Withdrawal by Subject|0
6895514|NCT00625443|10913419|FG001|Overall Study|Withdrawal by Subject|1
6895515|NCT00625443|10913420|FG002|Overall Study|Withdrawal by Subject|2
6895516|NCT00625443|10913418|FG000|Overall Study|Physician Decision|0
6895517|NCT00625443|10913419|FG001|Overall Study|Physician Decision|4
6895518|NCT00625443|10913420|FG002|Overall Study|Physician Decision|2
6895519|NCT00625443|10913418|FG000|Overall Study|Other|0
6895520|NCT00625443|10913419|FG001|Overall Study|Other|1
6895521|NCT00625443|10913420|FG002|Overall Study|Other|1
6895522|NCT00625807|10913438|FG000|Overall Study|schedule conflict|2
6895523|NCT00625807|10913439|FG001|Overall Study|schedule conflict|8
6895524|NCT00625820|10913447|FG000|Overall Study|Withdrawal by Subject|1
6895525|NCT00625846|10913456|FG000|Overall Study|Withdrawal by Subject|2
6895526|NCT00625846|10913457|FG001|Overall Study|Withdrawal by Subject|0
6895527|NCT00625846|10913458|FG002|Overall Study|Withdrawal by Subject|1
6895528|NCT00625846|10913459|FG003|Overall Study|Withdrawal by Subject|2
6895529|NCT00625872|10913475|FG000|Overall Study|Withdrawal by Subject|1
6895530|NCT00625872|10913476|FG001|Overall Study|Withdrawal by Subject|0
6895531|NCT00625872|10913475|FG000|Overall Study|Does not meet inclusion criteria|1
6895532|NCT00625872|10913476|FG001|Overall Study|Does not meet inclusion criteria|0
6895533|NCT00625872|10913475|FG000|Overall Study|Terminated by sponsor|2
6895534|NCT00625872|10913476|FG001|Overall Study|Terminated by sponsor|5
6895535|NCT00625872|10913475|FG000|Overall Study|Randomized but not treated|0
6895536|NCT00625872|10913476|FG001|Overall Study|Randomized but not treated|1
7178389|NCT04613739|11378941|FG000|Overall Study|Lost to Follow-up|6
7178390|NCT04613739|11378942|FG001|Overall Study|Lost to Follow-up|9
7178391|NCT04613739|11378941|FG000|Overall Study|potentially duplicative/fraudulent|1
7178392|NCT04613739|11378942|FG001|Overall Study|potentially duplicative/fraudulent|3
7178395|NCT04407806|11378969|FG000|Overall Study|Withdrawal by Subject|1
7178396|NCT04407806|11378970|FG001|Overall Study|Withdrawal by Subject|2
7178397|NCT04324021|11378979|FG000|Overall Study|Adverse Event|1
7178398|NCT04324021|11378980|FG001|Overall Study|Adverse Event|0
7178399|NCT04324021|11378981|FG002|Overall Study|Adverse Event|0
7178400|NCT04324021|11378979|FG000|Overall Study|Lack of Efficacy|0
7178401|NCT04324021|11378980|FG001|Overall Study|Lack of Efficacy|0
7178402|NCT04324021|11378981|FG002|Overall Study|Lack of Efficacy|1
7178403|NCT04324021|11378979|FG000|Overall Study|Death|1
7178404|NCT04324021|11378980|FG001|Overall Study|Death|1
7178405|NCT04324021|11378981|FG002|Overall Study|Death|0
7178406|NCT04209621|11378992|FG000|Overall Study|Death|1
7178407|NCT04209621|11378992|FG000|Overall Study|Study Terminated Early|2
7178408|NCT04186663|11378997|FG000|Overall Study|Lost to Follow-up|1
7178409|NCT04186663|11378997|FG000|Overall Study|Unable to complete blood draw|3
7178410|NCT04158219|11379001|FG000|Overall Study|Lost to Follow-up|1
7178411|NCT04056299|11379021|FG000|Overall Study|Sponsor discontinued study|3
7178412|NCT04056299|11379022|FG001|Overall Study|Sponsor discontinued study|3
7178413|NCT03954743|11379070|FG000|Overall Study|Adverse Event|1
7178414|NCT03954743|11379071|FG001|Overall Study|Adverse Event|0
7178415|NCT03954743|11379070|FG000|Overall Study|Lost to Follow-up|6
7178416|NCT03954743|11379071|FG001|Overall Study|Lost to Follow-up|4
7178417|NCT03954743|11379070|FG000|Overall Study|Protocol Violation|1
7178418|NCT03954743|11379071|FG001|Overall Study|Protocol Violation|0
7178419|NCT03954743|11379070|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13
7178420|NCT03954743|11379071|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12
6895537|NCT00626028|10913490|FG000|Overall Study|Adverse Event|1
6895538|NCT00626028|10913491|FG001|Overall Study|Adverse Event|1
6895539|NCT00626028|10913490|FG000|Overall Study|Device Failure|0
6895540|NCT00626028|10913491|FG001|Overall Study|Device Failure|1
6895541|NCT00626028|10913490|FG000|Overall Study|Physician Decision|2
6895542|NCT00626028|10913491|FG001|Overall Study|Physician Decision|1
6895543|NCT00626028|10913490|FG000|Overall Study|Inclusion/Exclusion Criteria|3
6895544|NCT00626028|10913491|FG001|Overall Study|Inclusion/Exclusion Criteria|6
6973186|NCT01178125|11024755|FG000|Overall Study|Withdrawal by Subject|209
6973187|NCT01178125|11024755|FG000|Overall Study|Noncompliance|184
6973188|NCT01178125|11024755|FG000|Overall Study|Pregnancy|55
7178421|NCT03954743|11379070|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3
7178422|NCT03954743|11379071|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
7178393|NCT04573972|11378950|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32
7178394|NCT04573972|11378951|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14
7178423|NCT03880565|11379079|FG000|Overall Study|Withdrawal by Subject|1
7178424|NCT03880565|11379080|FG001|Overall Study|Withdrawal by Subject|0
7186414|NCT02258542|11386691|FG002|Overall Study|Eligibility criteria not fulfilled|0
7186415|NCT02258542|11386692|FG003|Overall Study|Eligibility criteria not fulfilled|0
7188109|NCT03318523|11388769|FG001|PC Period: Up to Year 1|Adverse Event|0
7188110|NCT03318523|11388770|FG002|PC Period: Up to Year 1|Adverse Event|2
7188111|NCT03318523|11388771|FG003|PC Period: Up to Year 1|Adverse Event|0
7188112|NCT03318523|11388772|FG004|PC Period: Up to Year 1|Adverse Event|0
7188113|NCT03318523|11388773|FG005|PC Period: Up to Year 1|Adverse Event|0
7188114|NCT03318523|11388774|FG006|PC Period: Up to Year 1|Adverse Event|0
7188115|NCT03318523|11388775|FG007|PC Period: Up to Year 1|Adverse Event|0
7188116|NCT03318523|11388776|FG008|PC Period: Up to Year 1|Adverse Event|0
6895545|NCT00626093|10913497|FG000|Overall Study|Lost to Follow-up|5
6895546|NCT00626093|10913497|FG000|Overall Study|Death|1
6895547|NCT00626093|10913497|FG000|Overall Study|Physician Decision|4
7188117|NCT03318523|11388777|FG009|PC Period: Up to Year 1|Adverse Event|0
7188118|NCT03318523|11388768|FG000|PC Period: Up to Year 1|Consent Withdrawn|3
7188119|NCT03318523|11388769|FG001|PC Period: Up to Year 1|Consent Withdrawn|2
7188120|NCT03318523|11388770|FG002|PC Period: Up to Year 1|Consent Withdrawn|0
7188121|NCT03318523|11388771|FG003|PC Period: Up to Year 1|Consent Withdrawn|4
7188122|NCT03318523|11388772|FG004|PC Period: Up to Year 1|Consent Withdrawn|0
7188123|NCT03318523|11388773|FG005|PC Period: Up to Year 1|Consent Withdrawn|0
7188124|NCT03318523|11388774|FG006|PC Period: Up to Year 1|Consent Withdrawn|0
7188125|NCT03318523|11388775|FG007|PC Period: Up to Year 1|Consent Withdrawn|0
7188126|NCT03318523|11388776|FG008|PC Period: Up to Year 1|Consent Withdrawn|0
7188127|NCT03318523|11388777|FG009|PC Period: Up to Year 1|Consent Withdrawn|0
7188128|NCT03318523|11388768|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
7188129|NCT03318523|11388769|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
7188130|NCT03318523|11388770|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
7188131|NCT03318523|11388771|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
7188132|NCT03318523|11388772|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1
7188133|NCT03318523|11388773|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
7188134|NCT03318523|11388774|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
7188135|NCT03318523|11388775|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1
7188136|NCT03318523|11388776|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
7188137|NCT03318523|11388777|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2
7188138|NCT03318523|11388768|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0
7188139|NCT03318523|11388769|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0
7188140|NCT03318523|11388770|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0
7188141|NCT03318523|11388771|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0
7188142|NCT03318523|11388772|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1
7188143|NCT03318523|11388773|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0
7188144|NCT03318523|11388774|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0
7188145|NCT03318523|11388775|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1
7188146|NCT03318523|11388776|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3
7188147|NCT03318523|11388777|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2
7188148|NCT03318523|11388768|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
7188149|NCT03318523|11388769|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
7188150|NCT03318523|11388770|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
7188151|NCT03318523|11388771|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
7188152|NCT03318523|11388772|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
7188153|NCT03318523|11388773|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1
7188154|NCT03318523|11388774|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
7188155|NCT03318523|11388775|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
7188156|NCT03318523|11388776|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
7188157|NCT03318523|11388777|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
7188158|NCT03318523|11388768|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
7188159|NCT03318523|11388769|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
7188160|NCT03318523|11388770|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
7188161|NCT03318523|11388771|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
7188162|NCT03318523|11388772|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
7188163|NCT03318523|11388773|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
7188164|NCT03318523|11388774|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
7188165|NCT03318523|11388775|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
7188166|NCT03318523|11388776|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
7188167|NCT03318523|11388777|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1
7188168|NCT03318523|11388768|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0
7188169|NCT03318523|11388769|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0
7188170|NCT03318523|11388770|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0
7188171|NCT03318523|11388771|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0
7178425|NCT03833661|11379086|FG000|Overall Study|Treatment ongoing|9
7178426|NCT03809663|11379094|FG000|Overall Study|Decision by sponsor|24
7178427|NCT03809663|11379095|FG001|Overall Study|Decision by sponsor|18
7178428|NCT03809663|11379096|FG002|Overall Study|Decision by sponsor|20
7178429|NCT03809663|11379097|FG003|Overall Study|Decision by sponsor|20
7178430|NCT03809663|11379098|FG004|Overall Study|Decision by sponsor|0
7178431|NCT03809663|11379099|FG005|Overall Study|Decision by sponsor|0
6895548|NCT00626093|10913497|FG000|Overall Study|Withdrawal by Subject|6
6895549|NCT00626093|10913497|FG000|Overall Study|Protocol Violation|1
6895550|NCT00626093|10913497|FG000|Overall Study|One of the required devices not implante|6
7178432|NCT03809663|11379094|FG000|Overall Study|Withdrawal by Subject|26
7178433|NCT03809663|11379095|FG001|Overall Study|Withdrawal by Subject|22
7178434|NCT03809663|11379096|FG002|Overall Study|Withdrawal by Subject|27
7178435|NCT03809663|11379097|FG003|Overall Study|Withdrawal by Subject|26
7178436|NCT03809663|11379098|FG004|Overall Study|Withdrawal by Subject|0
7178437|NCT03809663|11379099|FG005|Overall Study|Withdrawal by Subject|0
7178438|NCT03809663|11379094|FG000|Overall Study|Lost to Follow-up|1
6895551|NCT00626197|10913504|FG000|Overall Study|Did not cooperate|2
6895552|NCT00626197|10913505|FG001|Overall Study|Did not cooperate|6
6895553|NCT00626197|10913506|FG002|Overall Study|Did not cooperate|1
6895554|NCT00626197|10913504|FG000|Overall Study|Failure to return|6
6895555|NCT00626197|10913505|FG001|Overall Study|Failure to return|5
6973189|NCT01178125|11024755|FG000|Overall Study|Other Reason|39
6973190|NCT01178125|11024755|FG000|Overall Study|Sponsor Decision|28
6973191|NCT01178125|11024755|FG000|Overall Study|Protocol Violation|17
6973192|NCT01178125|11024755|FG000|Overall Study|Investigator Decision|5
6973193|NCT01178138|11024764|FG000|Overall Study|Lost to Follow-up|8
6973194|NCT01178138|11024764|FG000|Overall Study|Withdrawal by Subject|7
6973195|NCT01178138|11024764|FG000|Overall Study|Physician Decision|8
6973196|NCT01178294|11024801|FG000|Overall Study|Adverse Event|4
6973197|NCT01178294|11024801|FG000|Overall Study|Lost to Follow-up|2
6973198|NCT01178294|11024801|FG000|Overall Study|Lack of Efficacy|1
6973199|NCT01178294|11024801|FG000|Overall Study|Death|1
6973200|NCT01178294|11024801|FG000|Overall Study|Development of inhibitors to OBI-1|1
6973201|NCT01178294|11024801|FG000|Overall Study|Subject status is terminal|1
6973202|NCT01178294|11024801|FG000|Overall Study|Completion status could not be verified|1
6973203|NCT01178385|11024822|FG000|Overall Study|Withdrawal by Subject|2
6973204|NCT01178385|11024823|FG001|Overall Study|Withdrawal by Subject|0
6973205|NCT01178411|11024829|FG000|Overall Study|Adverse Event|5
6973206|NCT01178411|11024829|FG000|Overall Study|Withdrawal by Subject|4
6973207|NCT01178411|11024829|FG000|Overall Study|Protocol Violation|1
6973208|NCT01178411|11024829|FG000|Overall Study|Progressive disease per RECIST|32
6973209|NCT01178411|11024829|FG000|Overall Study|Progressive disease per clinician|9
6973210|NCT01178411|11024829|FG000|Overall Study|Physician Decision|6
6973211|NCT01178411|11024829|FG000|Overall Study|Death|1
6973212|NCT01178411|11024829|FG000|Overall Study|No reason provided|1
6973213|NCT01178411|11024829|FG000|Overall Study|Drug manufacturing ended|1
6973214|NCT01178671|11024849|FG000|Overall Study|Adverse Event|4
6973215|NCT01178671|11024850|FG001|Overall Study|Adverse Event|6
6973216|NCT01178671|11024849|FG000|Overall Study|Protocol Violation|1
6973217|NCT01178671|11024850|FG001|Overall Study|Protocol Violation|1
6973218|NCT01178671|11024849|FG000|Overall Study|Lack of Efficacy|0
6973219|NCT01178671|11024850|FG001|Overall Study|Lack of Efficacy|1
6973220|NCT01178671|11024849|FG000|Overall Study|Lost to Follow-up|3
6973221|NCT01178671|11024850|FG001|Overall Study|Lost to Follow-up|1
6973222|NCT01178671|11024849|FG000|Overall Study|Physician Decision|4
6973223|NCT01178671|11024850|FG001|Overall Study|Physician Decision|6
6973224|NCT01178762|11024856|FG000|Overall Study|Lost to Follow-up|15
6973225|NCT01178853|11024875|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1
6973226|NCT01178853|11024876|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2
6973227|NCT01178853|11024875|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1
6973228|NCT01178853|11024876|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0
6973229|NCT01178853|11024875|FG000|Period 3 (Warfarin Titration)|Adverse Event|1
6973230|NCT01178853|11024876|FG001|Period 3 (Warfarin Titration)|Adverse Event|0
6973231|NCT01178853|11024875|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0
6973232|NCT01178853|11024876|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2
6973233|NCT01178853|11024875|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0
7178439|NCT03809663|11379095|FG001|Overall Study|Lost to Follow-up|4
7178440|NCT03809663|11379096|FG002|Overall Study|Lost to Follow-up|1
6895556|NCT00626197|10913506|FG002|Overall Study|Failure to return|6
6895557|NCT00626197|10913504|FG000|Overall Study|Adverse event, serious fatal|3
6895558|NCT00626197|10913505|FG001|Overall Study|Adverse event, serious fatal|6
6895559|NCT00626197|10913506|FG002|Overall Study|Adverse event, serious fatal|6
6895560|NCT00626197|10913504|FG000|Overall Study|Adverse Event|1
6895561|NCT00626197|10913505|FG001|Overall Study|Adverse Event|1
6895562|NCT00626197|10913506|FG002|Overall Study|Adverse Event|2
6895563|NCT00626197|10913504|FG000|Overall Study|Withdrawal by Subject|17
6895564|NCT00626197|10913505|FG001|Overall Study|Withdrawal by Subject|17
6973234|NCT01178853|11024876|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1
6973235|NCT01179048|11024888|FG000|Overall Study|Withdrawn - does not allow contact|4
6973236|NCT01179048|11024889|FG001|Overall Study|Withdrawn - does not allow contact|8
6973237|NCT01179048|11024888|FG000|Overall Study|Lost to Follow-up|8
7178441|NCT03809663|11379097|FG003|Overall Study|Lost to Follow-up|1
6895565|NCT00626197|10913506|FG002|Overall Study|Withdrawal by Subject|7
6895566|NCT00626197|10913504|FG000|Overall Study|Administrative reasons|15
6895567|NCT00626197|10913505|FG001|Overall Study|Administrative reasons|19
6895568|NCT00626197|10913506|FG002|Overall Study|Administrative reasons|55
6895569|NCT00626275|10913524|FG000|Part A - Treatment Period 1|Adverse Event|1
6895570|NCT00626275|10913525|FG001|Part A - Treatment Period 1|Adverse Event|0
6895571|NCT00626275|10913526|FG002|Part A - Treatment Period 1|Adverse Event|0
6895572|NCT00626275|10913527|FG003|Part A - Treatment Period 1|Adverse Event|0
6895573|NCT00626275|10913528|FG004|Part A - Treatment Period 1|Adverse Event|0
6895574|NCT00626275|10913529|FG005|Part A - Treatment Period 1|Adverse Event|0
6895575|NCT00626275|10913530|FG006|Part A - Treatment Period 1|Adverse Event|0
6895576|NCT00626275|10913531|FG007|Part A - Treatment Period 1|Adverse Event|0
6895577|NCT00626275|10913524|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0
6895578|NCT00626275|10913525|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0
6895579|NCT00626275|10913526|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1
6895580|NCT00626275|10913527|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0
6895581|NCT00626275|10913528|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0
6895582|NCT00626275|10913529|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0
6895583|NCT00626275|10913530|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0
6895584|NCT00626275|10913531|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0
6895585|NCT00626275|10913524|FG000|Part B|Lost to Follow-up|0
6895586|NCT00626275|10913525|FG001|Part B|Lost to Follow-up|0
7178442|NCT03809663|11379098|FG004|Overall Study|Lost to Follow-up|0
7178443|NCT03809663|11379099|FG005|Overall Study|Lost to Follow-up|0
7178444|NCT03782792|11379126|FG000|Overall Study|Patient left the country|0
7178445|NCT03782792|11379127|FG001|Overall Study|Patient left the country|1
7178446|NCT03782792|11379126|FG000|Overall Study|Withdrawal by Subject|1
7178447|NCT03782792|11379127|FG001|Overall Study|Withdrawal by Subject|2
7178448|NCT03733119|11379146|FG000|Overall Study|Physician Decision|2
7178449|NCT03733119|11379147|FG001|Overall Study|Physician Decision|1
7178450|NCT03733119|11379146|FG000|Overall Study|ineligible to treat per protocol|0
7178451|NCT03733119|11379147|FG001|Overall Study|ineligible to treat per protocol|1
7178452|NCT03661996|11379158|FG000|Overall Study|Adverse Event|0
7178453|NCT03661996|11379159|FG001|Overall Study|Adverse Event|0
7178454|NCT03661996|11379160|FG002|Overall Study|Adverse Event|1
7178455|NCT03661996|11379161|FG003|Overall Study|Adverse Event|1
7178456|NCT03661996|11379162|FG004|Overall Study|Adverse Event|0
7178457|NCT03661996|11379158|FG000|Overall Study|Lost to Follow-up|5
7178458|NCT03661996|11379159|FG001|Overall Study|Lost to Follow-up|1
7178459|NCT03661996|11379160|FG002|Overall Study|Lost to Follow-up|2
7178460|NCT03661996|11379161|FG003|Overall Study|Lost to Follow-up|2
7178461|NCT03661996|11379162|FG004|Overall Study|Lost to Follow-up|6
7178462|NCT03661996|11379158|FG000|Overall Study|Physician Decision|1
7178463|NCT03661996|11379159|FG001|Overall Study|Physician Decision|1
7178464|NCT03661996|11379160|FG002|Overall Study|Physician Decision|1
7178465|NCT03661996|11379161|FG003|Overall Study|Physician Decision|2
7178466|NCT03661996|11379162|FG004|Overall Study|Physician Decision|0
7178467|NCT03661996|11379158|FG000|Overall Study|Protocol Violation|0
7178468|NCT03661996|11379159|FG001|Overall Study|Protocol Violation|0
6895587|NCT00626275|10913526|FG002|Part B|Lost to Follow-up|0
6895588|NCT00626275|10913527|FG003|Part B|Lost to Follow-up|0
6895589|NCT00626275|10913528|FG004|Part B|Lost to Follow-up|0
6895590|NCT00626275|10913529|FG005|Part B|Lost to Follow-up|0
6895591|NCT00626275|10913530|FG006|Part B|Lost to Follow-up|1
6895592|NCT00626275|10913531|FG007|Part B|Lost to Follow-up|0
6895593|NCT00626275|10913524|FG000|Part B|Withdrawal by Subject|0
6895594|NCT00626275|10913525|FG001|Part B|Withdrawal by Subject|0
6895595|NCT00626275|10913526|FG002|Part B|Withdrawal by Subject|0
6895596|NCT00626275|10913527|FG003|Part B|Withdrawal by Subject|0
6895597|NCT00626275|10913528|FG004|Part B|Withdrawal by Subject|0
6895598|NCT00626275|10913529|FG005|Part B|Withdrawal by Subject|0
7178469|NCT03661996|11379160|FG002|Overall Study|Protocol Violation|0
7178470|NCT03661996|11379161|FG003|Overall Study|Protocol Violation|0
7178471|NCT03661996|11379162|FG004|Overall Study|Protocol Violation|1
7178472|NCT03661996|11379158|FG000|Overall Study|Withdrawal by Subject|3
7178473|NCT03661996|11379159|FG001|Overall Study|Withdrawal by Subject|5
7178474|NCT03661996|11379160|FG002|Overall Study|Withdrawal by Subject|1
7178475|NCT03661996|11379161|FG003|Overall Study|Withdrawal by Subject|7
6895599|NCT00626275|10913530|FG006|Part B|Withdrawal by Subject|0
6895600|NCT00626275|10913531|FG007|Part B|Withdrawal by Subject|1
6895601|NCT00626327|10913548|FG000|Overall Study|Withdrawal by Subject|21
6895602|NCT00626327|10913549|FG001|Overall Study|Withdrawal by Subject|29
6895603|NCT00626327|10913550|FG002|Overall Study|Withdrawal by Subject|30
6895604|NCT00626327|10913548|FG000|Overall Study|Adverse Event|1
6895605|NCT00626327|10913549|FG001|Overall Study|Adverse Event|0
6895606|NCT00626327|10913550|FG002|Overall Study|Adverse Event|0
6895607|NCT00626327|10913548|FG000|Overall Study|Lost to Follow-up|24
6895608|NCT00626327|10913549|FG001|Overall Study|Lost to Follow-up|21
6895609|NCT00626327|10913550|FG002|Overall Study|Lost to Follow-up|23
6895610|NCT00626327|10913548|FG000|Overall Study|Inappropriate enrollment|4
6895611|NCT00626327|10913549|FG001|Overall Study|Inappropriate enrollment|5
6895612|NCT00626327|10913550|FG002|Overall Study|Inappropriate enrollment|3
6895613|NCT00626327|10913548|FG000|Overall Study|Administrative Reason|2
7178476|NCT03661996|11379162|FG004|Overall Study|Withdrawal by Subject|7
7178477|NCT03661996|11379158|FG000|Overall Study|Sponsors Decision|2
7178478|NCT03661996|11379159|FG001|Overall Study|Sponsors Decision|0
7178479|NCT03661996|11379160|FG002|Overall Study|Sponsors Decision|0
7178480|NCT03661996|11379161|FG003|Overall Study|Sponsors Decision|0
7178481|NCT03661996|11379162|FG004|Overall Study|Sponsors Decision|0
7178482|NCT03661996|11379158|FG000|Overall Study|Other|1
7178483|NCT03661996|11379159|FG001|Overall Study|Other|1
7178484|NCT03661996|11379160|FG002|Overall Study|Other|1
7178485|NCT03661996|11379161|FG003|Overall Study|Other|1
7178486|NCT03661996|11379162|FG004|Overall Study|Other|0
7178487|NCT03633461|11379179|FG000|Overall Study|Lost to Follow-up|0
7178488|NCT03633461|11379180|FG001|Overall Study|Lost to Follow-up|1
7186416|NCT02290431|11386720|FG000|Overall Study|Adverse Event|20
7186417|NCT02290431|11386720|FG000|Overall Study|Progressive disease|4
7186418|NCT02290431|11386720|FG000|Overall Study|Study terminated by Sponsor|1
7186419|NCT02290431|11386720|FG000|Overall Study|Physician Decision|2
7186420|NCT02314923|11386734|FG000|Overall Study|Death|0
7186421|NCT02314923|11386735|FG001|Overall Study|Death|0
7186422|NCT02314923|11386736|FG002|Overall Study|Death|0
7186423|NCT02314923|11386737|FG003|Overall Study|Death|1
7186424|NCT02314923|11386738|FG004|Overall Study|Death|0
7186425|NCT02314923|11386739|FG005|Overall Study|Death|0
7186426|NCT02314923|11386740|FG006|Overall Study|Death|0
7186427|NCT02314923|11386741|FG007|Overall Study|Death|0
7186428|NCT02314923|11386742|FG008|Overall Study|Death|0
7186429|NCT02314923|11386743|FG009|Overall Study|Death|0
7186430|NCT02314923|11386734|FG000|Overall Study|Lost to Follow-up|2
7186431|NCT02314923|11386735|FG001|Overall Study|Lost to Follow-up|3
7186432|NCT02314923|11386736|FG002|Overall Study|Lost to Follow-up|1
7186433|NCT02314923|11386737|FG003|Overall Study|Lost to Follow-up|0
7186434|NCT02314923|11386738|FG004|Overall Study|Lost to Follow-up|0
7186435|NCT02314923|11386739|FG005|Overall Study|Lost to Follow-up|0
7186436|NCT02314923|11386740|FG006|Overall Study|Lost to Follow-up|3
7186437|NCT02314923|11386741|FG007|Overall Study|Lost to Follow-up|4
7186438|NCT02314923|11386742|FG008|Overall Study|Lost to Follow-up|2
7186439|NCT02314923|11386743|FG009|Overall Study|Lost to Follow-up|0
7186440|NCT02314923|11386734|FG000|Overall Study|Withdrawal by Subject|0
7186441|NCT02314923|11386735|FG001|Overall Study|Withdrawal by Subject|0
7186442|NCT02314923|11386736|FG002|Overall Study|Withdrawal by Subject|1
7186443|NCT02314923|11386737|FG003|Overall Study|Withdrawal by Subject|0
7186444|NCT02314923|11386738|FG004|Overall Study|Withdrawal by Subject|1
7186445|NCT02314923|11386739|FG005|Overall Study|Withdrawal by Subject|0
7186446|NCT02314923|11386740|FG006|Overall Study|Withdrawal by Subject|1
7186447|NCT02314923|11386741|FG007|Overall Study|Withdrawal by Subject|0
7186448|NCT02314923|11386742|FG008|Overall Study|Withdrawal by Subject|0
7186449|NCT02314923|11386743|FG009|Overall Study|Withdrawal by Subject|0
7186450|NCT02314923|11386734|FG000|Overall Study|Physician Decision|0
7186451|NCT02314923|11386735|FG001|Overall Study|Physician Decision|1
7186452|NCT02314923|11386736|FG002|Overall Study|Physician Decision|0
7186453|NCT02314923|11386737|FG003|Overall Study|Physician Decision|0
7186454|NCT02314923|11386738|FG004|Overall Study|Physician Decision|0
7186455|NCT02314923|11386739|FG005|Overall Study|Physician Decision|0
7186456|NCT02314923|11386740|FG006|Overall Study|Physician Decision|0
7186457|NCT02314923|11386741|FG007|Overall Study|Physician Decision|0
7186458|NCT02314923|11386742|FG008|Overall Study|Physician Decision|0
7186459|NCT02314923|11386743|FG009|Overall Study|Physician Decision|0
7186460|NCT02314923|11386734|FG000|Overall Study|Participant unavailable|0
7186461|NCT02314923|11386735|FG001|Overall Study|Participant unavailable|0
7186462|NCT02314923|11386736|FG002|Overall Study|Participant unavailable|0
7186463|NCT02314923|11386737|FG003|Overall Study|Participant unavailable|0
7186464|NCT02314923|11386738|FG004|Overall Study|Participant unavailable|0
7186465|NCT02314923|11386739|FG005|Overall Study|Participant unavailable|1
7186466|NCT02314923|11386740|FG006|Overall Study|Participant unavailable|0
7186467|NCT02314923|11386741|FG007|Overall Study|Participant unavailable|0
7186468|NCT02314923|11386742|FG008|Overall Study|Participant unavailable|0
7186469|NCT02314923|11386743|FG009|Overall Study|Participant unavailable|0
7186470|NCT02314923|11386734|FG000|Overall Study|Screen failure|0
7186471|NCT02314923|11386735|FG001|Overall Study|Screen failure|0
7186472|NCT02314923|11386736|FG002|Overall Study|Screen failure|0
7186473|NCT02314923|11386737|FG003|Overall Study|Screen failure|0
7186474|NCT02314923|11386738|FG004|Overall Study|Screen failure|0
7186475|NCT02314923|11386739|FG005|Overall Study|Screen failure|0
7186476|NCT02314923|11386740|FG006|Overall Study|Screen failure|1
7186477|NCT02314923|11386741|FG007|Overall Study|Screen failure|0
7186478|NCT02314923|11386742|FG008|Overall Study|Screen failure|0
7186479|NCT02314923|11386743|FG009|Overall Study|Screen failure|0
7186480|NCT02314923|11386734|FG000|Overall Study|Participant relocation|1
7186481|NCT02314923|11386735|FG001|Overall Study|Participant relocation|0
7186482|NCT02314923|11386736|FG002|Overall Study|Participant relocation|0
7186483|NCT02314923|11386737|FG003|Overall Study|Participant relocation|0
7186484|NCT02314923|11386738|FG004|Overall Study|Participant relocation|0
7186485|NCT02314923|11386739|FG005|Overall Study|Participant relocation|0
7186486|NCT02314923|11386740|FG006|Overall Study|Participant relocation|0
7186487|NCT02314923|11386741|FG007|Overall Study|Participant relocation|1
7186488|NCT02314923|11386742|FG008|Overall Study|Participant relocation|0
7186489|NCT02314923|11386743|FG009|Overall Study|Participant relocation|0
7186490|NCT04524507|11386784|FG000|Overall Study|Lost to Follow-up|2
7186491|NCT04524507|11386785|FG001|Overall Study|Lost to Follow-up|4
7178489|NCT03517722|11379208|FG000|Double Blind Period: Week 0-52|Adverse Event|9
6895614|NCT00626327|10913549|FG001|Overall Study|Administrative Reason|0
6895615|NCT00626327|10913550|FG002|Overall Study|Administrative Reason|6
6895616|NCT00626327|10913548|FG000|Overall Study|Protocol Violation|26
6895617|NCT00626327|10913549|FG001|Overall Study|Protocol Violation|4
6895618|NCT00626327|10913550|FG002|Overall Study|Protocol Violation|26
6895619|NCT00626392|10913585|FG000|Run-in Period|Adverse Event|0
6895620|NCT00626392|10913586|FG001|Run-in Period|Adverse Event|0
6895621|NCT00626392|10913587|FG002|Run-in Period|Adverse Event|1
6895622|NCT00626392|10913588|FG003|Run-in Period|Adverse Event|0
6895623|NCT00626392|10913589|FG004|Run-in Period|Adverse Event|1
6895624|NCT00626392|10913590|FG005|Run-in Period|Adverse Event|0
6895625|NCT00626392|10913585|FG000|Run-in Period|Withdrawal by Subject|0
6895626|NCT00626392|10913586|FG001|Run-in Period|Withdrawal by Subject|1
6895627|NCT00626392|10913587|FG002|Run-in Period|Withdrawal by Subject|1
6895628|NCT00626392|10913588|FG003|Run-in Period|Withdrawal by Subject|1
6895629|NCT00626392|10913589|FG004|Run-in Period|Withdrawal by Subject|3
6895630|NCT00626392|10913590|FG005|Run-in Period|Withdrawal by Subject|1
6895631|NCT00626392|10913585|FG000|Run-in Period|Noncompliance|1
6895632|NCT00626392|10913586|FG001|Run-in Period|Noncompliance|0
6895633|NCT00626392|10913587|FG002|Run-in Period|Noncompliance|1
6895634|NCT00626392|10913588|FG003|Run-in Period|Noncompliance|0
6895635|NCT00626392|10913589|FG004|Run-in Period|Noncompliance|0
6895636|NCT00626392|10913590|FG005|Run-in Period|Noncompliance|0
6895637|NCT00626392|10913585|FG000|Coadministration Period|Adverse Event|3
6895638|NCT00626392|10913586|FG001|Coadministration Period|Adverse Event|1
6895639|NCT00626392|10913587|FG002|Coadministration Period|Adverse Event|7
6895640|NCT00626392|10913588|FG003|Coadministration Period|Adverse Event|4
6895641|NCT00626392|10913589|FG004|Coadministration Period|Adverse Event|3
6895642|NCT00626392|10913590|FG005|Coadministration Period|Adverse Event|4
6895643|NCT00626392|10913585|FG000|Coadministration Period|Withdrawal by Subject|1
6895644|NCT00626392|10913586|FG001|Coadministration Period|Withdrawal by Subject|1
6895645|NCT00626392|10913587|FG002|Coadministration Period|Withdrawal by Subject|0
6895646|NCT00626392|10913588|FG003|Coadministration Period|Withdrawal by Subject|1
6895647|NCT00626392|10913589|FG004|Coadministration Period|Withdrawal by Subject|0
6895648|NCT00626392|10913590|FG005|Coadministration Period|Withdrawal by Subject|1
6895649|NCT00626392|10913585|FG000|Coadministration Period|Protocol Violation|0
6895650|NCT00626392|10913586|FG001|Coadministration Period|Protocol Violation|1
6895651|NCT00626392|10913587|FG002|Coadministration Period|Protocol Violation|0
6895652|NCT00626392|10913588|FG003|Coadministration Period|Protocol Violation|1
6895653|NCT00626392|10913589|FG004|Coadministration Period|Protocol Violation|1
6895654|NCT00626392|10913590|FG005|Coadministration Period|Protocol Violation|0
6895655|NCT00626392|10913585|FG000|Coadministration Period|Other|0
6895656|NCT00626392|10913586|FG001|Coadministration Period|Other|2
6895657|NCT00626392|10913587|FG002|Coadministration Period|Other|3
6895658|NCT00626392|10913588|FG003|Coadministration Period|Other|1
6895659|NCT00626392|10913589|FG004|Coadministration Period|Other|1
6895660|NCT00626392|10913590|FG005|Coadministration Period|Other|1
6895661|NCT00626405|10913598|FG000|Overall Study|Deemed Ineligible|1
6895662|NCT00626405|10913599|FG001|Overall Study|Deemed Ineligible|0
6895663|NCT00626405|10913598|FG000|Overall Study|Withdrawal by Subject|0
6895664|NCT00626405|10913599|FG001|Overall Study|Withdrawal by Subject|1
6895665|NCT00626522|10913620|FG000|Overall Study|Protocol Violation|0
6895666|NCT00626522|10913621|FG001|Overall Study|Protocol Violation|0
6895667|NCT00626522|10913622|FG002|Overall Study|Protocol Violation|0
6895668|NCT00626522|10913623|FG003|Overall Study|Protocol Violation|0
6895669|NCT00626522|10913624|FG004|Overall Study|Protocol Violation|1
6895670|NCT00626522|10913625|FG005|Overall Study|Protocol Violation|0
6895671|NCT00626522|10913620|FG000|Overall Study|Adverse Event|2
6895672|NCT00626522|10913621|FG001|Overall Study|Adverse Event|1
6895673|NCT00626522|10913622|FG002|Overall Study|Adverse Event|2
6895674|NCT00626522|10913623|FG003|Overall Study|Adverse Event|0
6895675|NCT00626522|10913624|FG004|Overall Study|Adverse Event|1
6895676|NCT00626522|10913625|FG005|Overall Study|Adverse Event|1
6895677|NCT00626522|10913620|FG000|Overall Study|Withdrawal by Subject|2
6895678|NCT00626522|10913621|FG001|Overall Study|Withdrawal by Subject|5
6895679|NCT00626522|10913622|FG002|Overall Study|Withdrawal by Subject|5
6895680|NCT00626522|10913623|FG003|Overall Study|Withdrawal by Subject|0
6895681|NCT00626522|10913624|FG004|Overall Study|Withdrawal by Subject|4
6895682|NCT00626522|10913625|FG005|Overall Study|Withdrawal by Subject|1
6895683|NCT00626522|10913620|FG000|Overall Study|COPD exacerbation|0
6895684|NCT00626522|10913621|FG001|Overall Study|COPD exacerbation|0
7178490|NCT03517722|11379209|FG001|Double Blind Period: Week 0-52|Adverse Event|11
6895685|NCT00626522|10913622|FG002|Overall Study|COPD exacerbation|0
6895686|NCT00626522|10913623|FG003|Overall Study|COPD exacerbation|1
6895687|NCT00626522|10913624|FG004|Overall Study|COPD exacerbation|1
6895688|NCT00626522|10913625|FG005|Overall Study|COPD exacerbation|0
6895689|NCT00626522|10913620|FG000|Overall Study|Lost to Follow-up|0
6895690|NCT00626522|10913621|FG001|Overall Study|Lost to Follow-up|1
6895691|NCT00626522|10913622|FG002|Overall Study|Lost to Follow-up|0
6895692|NCT00626522|10913623|FG003|Overall Study|Lost to Follow-up|0
6895693|NCT00626522|10913624|FG004|Overall Study|Lost to Follow-up|0
6895694|NCT00626522|10913625|FG005|Overall Study|Lost to Follow-up|0
6895695|NCT00626522|10913620|FG000|Overall Study|Inconsistent reason reported|1
6895696|NCT00626522|10913621|FG001|Overall Study|Inconsistent reason reported|0
6895697|NCT00626522|10913622|FG002|Overall Study|Inconsistent reason reported|0
6895698|NCT00626522|10913623|FG003|Overall Study|Inconsistent reason reported|0
6895699|NCT00626522|10913624|FG004|Overall Study|Inconsistent reason reported|0
6895700|NCT00626522|10913625|FG005|Overall Study|Inconsistent reason reported|0
6895701|NCT00626522|10913620|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1
6895702|NCT00626522|10913621|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0
6895703|NCT00626522|10913622|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1
6895704|NCT00626522|10913623|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1
6895705|NCT00626522|10913624|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0
6895706|NCT00626522|10913625|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0
6895707|NCT00626548|10913641|FG000|Overall Study|Adverse Event|164
6895708|NCT00626548|10913642|FG001|Overall Study|Adverse Event|44
6895709|NCT00626548|10913641|FG000|Overall Study|Withdrawal by Subject|42
6895710|NCT00626548|10913642|FG001|Overall Study|Withdrawal by Subject|46
6895711|NCT00626548|10913641|FG000|Overall Study|Protocol Violation|4
6895712|NCT00626548|10913642|FG001|Overall Study|Protocol Violation|11
6895713|NCT00626548|10913641|FG000|Overall Study|Lost to Follow-up|2
6895714|NCT00626548|10913642|FG001|Overall Study|Lost to Follow-up|2
6895715|NCT00626548|10913641|FG000|Overall Study|Other termination reason|493
6895716|NCT00626548|10913642|FG001|Overall Study|Other termination reason|613
6895717|NCT00626639|10913671|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2
6895718|NCT00626639|10913672|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2
6895719|NCT00626795|10913703|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0
6895720|NCT00626795|10913704|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1
6895721|NCT00626795|10913705|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0
6895722|NCT00626795|10913703|FG000|Blinded Treatment|Lack of Efficacy|2
6895723|NCT00626795|10913704|FG001|Blinded Treatment|Lack of Efficacy|0
6895724|NCT00626795|10913705|FG002|Blinded Treatment|Lack of Efficacy|0
6895725|NCT00626795|10913703|FG000|Blinded Treatment|Unacceptable adverse event|0
6895726|NCT00626795|10913704|FG001|Blinded Treatment|Unacceptable adverse event|0
6895727|NCT00626795|10913705|FG002|Blinded Treatment|Unacceptable adverse event|1
6895728|NCT00626795|10913703|FG000|Blinded Treatment|Protocol Violation|0
6895729|NCT00626795|10913704|FG001|Blinded Treatment|Protocol Violation|1
6895730|NCT00626795|10913705|FG002|Blinded Treatment|Protocol Violation|1
6895731|NCT00626795|10913703|FG000|Blinded Treatment|Withdrawal by Subject|1
6895732|NCT00626795|10913704|FG001|Blinded Treatment|Withdrawal by Subject|1
6895733|NCT00626795|10913705|FG002|Blinded Treatment|Withdrawal by Subject|0
6895734|NCT00626795|10913703|FG000|Blinded Treatment|Other reasons|2
6895735|NCT00626795|10913704|FG001|Blinded Treatment|Other reasons|0
7178491|NCT03517722|11379208|FG000|Double Blind Period: Week 0-52|Death|0
6895736|NCT00626795|10913705|FG002|Blinded Treatment|Other reasons|2
6895737|NCT00626795|10913703|FG000|Blinded Treatment|Missing reason for withdrawal|5
6895738|NCT00626795|10913704|FG001|Blinded Treatment|Missing reason for withdrawal|3
6895739|NCT00626795|10913705|FG002|Blinded Treatment|Missing reason for withdrawal|5
6895740|NCT00626821|10913734|FG000|Overall Study|Adverse Event|44
6895741|NCT00626821|10913734|FG000|Overall Study|Protocol Violation|33
7178492|NCT03517722|11379209|FG001|Double Blind Period: Week 0-52|Death|4
7178493|NCT03517722|11379208|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2
7178494|NCT03517722|11379209|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3
7178495|NCT03517722|11379208|FG000|Double Blind Period: Week 0-52|Pregnancy|0
7178496|NCT03517722|11379209|FG001|Double Blind Period: Week 0-52|Pregnancy|1
7178497|NCT03517722|11379208|FG000|Double Blind Period: Week 0-52|Protocol Violation|1
7178498|NCT03517722|11379209|FG001|Double Blind Period: Week 0-52|Protocol Violation|0
7178499|NCT03517722|11379208|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11
7178500|NCT03517722|11379209|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11
7178501|NCT03517722|11379208|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76
7178502|NCT03517722|11379209|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120
7178503|NCT03517722|11379208|FG000|Double Blind Period: Week 0-52|Other|4
7178504|NCT03517722|11379209|FG001|Double Blind Period: Week 0-52|Other|3
7178505|NCT03517722|11379208|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0
7178506|NCT03517722|11379209|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2
7178507|NCT03517722|11379208|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0
7178508|NCT03517722|11379209|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1
7178509|NCT03517722|11379208|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0
7178510|NCT03517722|11379209|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1
7178511|NCT03517722|11379208|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1
7178512|NCT03517722|11379209|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1
7178513|NCT03517722|11379208|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87
7178514|NCT03517722|11379209|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134
7178515|NCT03499314|11379218|FG000|Overall Study|Time Commitment|1
7178516|NCT03499314|11379219|FG001|Overall Study|Time Commitment|2
7178517|NCT03499314|11379218|FG000|Overall Study|Medical issue unrelated to research study|1
7178518|NCT03499314|11379219|FG001|Overall Study|Medical issue unrelated to research study|1
7178519|NCT03439124|11379227|FG000|Overall Study|Adverse Event|2
6895742|NCT00626821|10913734|FG000|Overall Study|Withdrawal by Subject|10
6895743|NCT00626821|10913734|FG000|Overall Study|Physician Decision|9
6895744|NCT00626821|10913734|FG000|Overall Study|Product dysfunction|21
6895745|NCT00626821|10913734|FG000|Overall Study|other/unknown reason|104
6895746|NCT00626925|10913758|FG000|Overall Study|Lost to Follow-up|1
6895747|NCT00626925|10913759|FG001|Overall Study|Lost to Follow-up|2
6895748|NCT00626925|10913758|FG000|Overall Study|relapse|1
6895749|NCT00626925|10913759|FG001|Overall Study|relapse|0
6895750|NCT00626925|10913758|FG000|Overall Study|Adverse effect|6
6895751|NCT00626925|10913759|FG001|Overall Study|Adverse effect|2
6895752|NCT00626925|10913758|FG000|Overall Study|Lack of Efficacy|1
6895753|NCT00626925|10913759|FG001|Overall Study|Lack of Efficacy|4
6895754|NCT00626925|10913758|FG000|Overall Study|Time constraints|3
6895755|NCT00626925|10913759|FG001|Overall Study|Time constraints|1
6895756|NCT00627016|10913781|FG000|Overall Study|Adverse Event|1
6895757|NCT00627016|10913782|FG001|Overall Study|Adverse Event|1
6895758|NCT00627016|10913781|FG000|Overall Study|Protocol Violation|0
6895759|NCT00627016|10913782|FG001|Overall Study|Protocol Violation|2
7178520|NCT03439124|11379228|FG001|Overall Study|Adverse Event|0
7178521|NCT03439124|11379227|FG000|Overall Study|Lost to Follow-up|1
7178522|NCT03439124|11379228|FG001|Overall Study|Lost to Follow-up|0
7178523|NCT03439124|11379227|FG000|Overall Study|Other reasons|1
7178524|NCT03439124|11379228|FG001|Overall Study|Other reasons|0
7178525|NCT03369431|11379236|FG000|Overall Study|Lost to Follow-up|1
6895760|NCT00627016|10913781|FG000|Overall Study|Lost to Follow-up|0
6895761|NCT00627016|10913782|FG001|Overall Study|Lost to Follow-up|1
6895762|NCT00627016|10913781|FG000|Overall Study|Withdrawal by Subject|2
6895763|NCT00627016|10913782|FG001|Overall Study|Withdrawal by Subject|1
6895764|NCT00627016|10913781|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0
6895765|NCT00627016|10913782|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1
6895766|NCT00627016|10913781|FG000|Overall Study|Lack of Efficacy|1
6895767|NCT00627016|10913782|FG001|Overall Study|Lack of Efficacy|0
6895768|NCT00627016|10913781|FG000|Overall Study|Placed on Excluded Drugs|1
6895769|NCT00627016|10913782|FG001|Overall Study|Placed on Excluded Drugs|0
6895770|NCT00627016|10913781|FG000|Overall Study|Pregnancy|1
6895771|NCT00627016|10913782|FG001|Overall Study|Pregnancy|0
6895772|NCT00627042|10913788|FG000|Overall Study|Withdrawal by Subject|2
6895773|NCT00627094|10913794|FG000|Overall Study|Adverse Event|8
6895774|NCT00627094|10913795|FG001|Overall Study|Adverse Event|7
6895775|NCT00627094|10913794|FG000|Overall Study|Lost to Follow-up|1
6895776|NCT00627094|10913795|FG001|Overall Study|Lost to Follow-up|0
6895777|NCT00627094|10913794|FG000|Overall Study|Withdrawal by Subject|1
6895778|NCT00627094|10913795|FG001|Overall Study|Withdrawal by Subject|1
6895779|NCT00627094|10913794|FG000|Overall Study|ulcer healed|1
6895780|NCT00627094|10913795|FG001|Overall Study|ulcer healed|7
6895781|NCT00627094|10913794|FG000|Overall Study|Other reason|1
6895782|NCT00627094|10913795|FG001|Overall Study|Other reason|0
6895783|NCT00627393|10913815|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5
6895784|NCT00627393|10913816|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3
6895785|NCT00627393|10913815|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4
6895786|NCT00627393|10913816|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5
6895787|NCT00627393|10913815|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6
6895788|NCT00627393|10913816|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3
6895789|NCT00627393|10913815|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4
6895790|NCT00627393|10913816|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10
6895791|NCT00627445|10913843|FG000|Overall Study|Adverse Event|3
6895792|NCT00627445|10913844|FG001|Overall Study|Adverse Event|3
6895793|NCT00627445|10913843|FG000|Overall Study|Lack of Efficacy|0
6895794|NCT00627445|10913844|FG001|Overall Study|Lack of Efficacy|1
6895795|NCT00627445|10913843|FG000|Overall Study|Other|6
6895796|NCT00627445|10913844|FG001|Overall Study|Other|8
6895797|NCT00627458|10913855|FG000|Overall Study|Migrated from study area|1
6895798|NCT00627458|10913856|FG001|Overall Study|Migrated from study area|0
6895799|NCT00627458|10913857|FG002|Overall Study|Migrated from study area|1
6895800|NCT00627458|10913855|FG000|Overall Study|Withdrawal by Subject|2
6895801|NCT00627458|10913856|FG001|Overall Study|Withdrawal by Subject|6
6895802|NCT00627458|10913857|FG002|Overall Study|Withdrawal by Subject|5
6895803|NCT00627458|10913855|FG000|Overall Study|Lost to Follow-up|1
6895804|NCT00627458|10913856|FG001|Overall Study|Lost to Follow-up|1
6895805|NCT00627458|10913857|FG002|Overall Study|Lost to Follow-up|0
6895806|NCT00627497|10913870|FG000|Overall Study|Lost to Follow-up|1
6895807|NCT00627497|10913871|FG001|Overall Study|Lost to Follow-up|1
6895808|NCT00627497|10913872|FG002|Overall Study|Lost to Follow-up|0
6895809|NCT00627497|10913873|FG003|Overall Study|Lost to Follow-up|0
6895810|NCT00627523|10913885|FG000|Overall Study|Lack of Efficacy|1
6895811|NCT00627523|10913886|FG001|Overall Study|Lack of Efficacy|0
6895812|NCT00627523|10913885|FG000|Overall Study|Withdrawal by Subject|0
6895813|NCT00627523|10913886|FG001|Overall Study|Withdrawal by Subject|2
6895814|NCT00627523|10913885|FG000|Overall Study|Other|1
6895815|NCT00627523|10913886|FG001|Overall Study|Other|0
7178526|NCT03369431|11379237|FG001|Overall Study|Lost to Follow-up|3
7178527|NCT03369431|11379236|FG000|Overall Study|Withdrawal by Subject|2
7178528|NCT03369431|11379237|FG001|Overall Study|Withdrawal by Subject|3
7178529|NCT03369431|11379236|FG000|Overall Study|Protocol Violation|1
6895816|NCT00627705|10913907|FG000|Overall Study|Unwilling to take the compound (taste)|1
6895817|NCT00627705|10913908|FG001|Overall Study|Unwilling to take the compound (taste)|3
7178530|NCT03369431|11379237|FG001|Overall Study|Protocol Violation|1
7186492|NCT04524507|11386784|FG000|Overall Study|Withdrawal by Subject|2
6895818|NCT00627705|10913907|FG000|Overall Study|Adverse Event|1
6895819|NCT00627705|10913908|FG001|Overall Study|Adverse Event|0
6895820|NCT00627705|10913907|FG000|Overall Study|Withdrawal by Subject|0
6895821|NCT00627705|10913908|FG001|Overall Study|Withdrawal by Subject|2
6895822|NCT00627705|10913907|FG000|Overall Study|Lost to Follow-up|0
6895823|NCT00627705|10913908|FG001|Overall Study|Lost to Follow-up|1
6895824|NCT00627926|10913923|FG000|Overall Study|Adverse Event|26
6895825|NCT00627926|10913924|FG001|Overall Study|Adverse Event|37
6895826|NCT00627926|10913925|FG002|Overall Study|Adverse Event|36
7186493|NCT04524507|11386785|FG001|Overall Study|Withdrawal by Subject|9
7186494|NCT04524507|11386784|FG000|Overall Study|Death|2
7186495|NCT04524507|11386785|FG001|Overall Study|Death|10
7186496|NCT04382924|11386794|FG000|Overall Study|Death|2
7186497|NCT04382924|11386795|FG001|Overall Study|Death|5
7186498|NCT04382924|11386796|FG002|Overall Study|Death|4
7186499|NCT04382924|11386794|FG000|Overall Study|Protocol Violation|0
7186500|NCT04382924|11386795|FG001|Overall Study|Protocol Violation|1
7186501|NCT04382924|11386796|FG002|Overall Study|Protocol Violation|1
7186502|NCT04382924|11386794|FG000|Overall Study|Transferred to other hospital/declined in person visits|0
7186503|NCT04382924|11386795|FG001|Overall Study|Transferred to other hospital/declined in person visits|1
7186504|NCT04382924|11386796|FG002|Overall Study|Transferred to other hospital/declined in person visits|1
7186505|NCT04382924|11386794|FG000|Overall Study|Withdrawal by Subject|6
7186506|NCT04382924|11386795|FG001|Overall Study|Withdrawal by Subject|3
7186507|NCT04382924|11386796|FG002|Overall Study|Withdrawal by Subject|6
7186508|NCT03842436|11386827|FG000|Overall Study|Lost to Follow-up|1
7188172|NCT03318523|11388772|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17
7188173|NCT03318523|11388773|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36
7188174|NCT03318523|11388774|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39
7188175|NCT03318523|11388775|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48
7188176|NCT03318523|11388776|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94
7188177|NCT03318523|11388777|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91
7188178|NCT03318523|11388768|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
7188179|NCT03318523|11388769|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
7188180|NCT03318523|11388770|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
7188181|NCT03318523|11388771|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
7188182|NCT03318523|11388772|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1
7188183|NCT03318523|11388773|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
7188184|NCT03318523|11388774|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
7188185|NCT03318523|11388775|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2
7188186|NCT03318523|11388776|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3
7188187|NCT03318523|11388777|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
7188188|NCT02906020|11388811|FG000|Part 1: Dose Escalation Period|Adverse Event|0
7188189|NCT02906020|11388812|FG001|Part 1: Dose Escalation Period|Adverse Event|1
7188190|NCT02906020|11388813|FG002|Part 1: Dose Escalation Period|Adverse Event|0
7188191|NCT02906020|11388814|FG003|Part 1: Dose Escalation Period|Adverse Event|1
6895827|NCT00627926|10913923|FG000|Overall Study|Death|1
6895828|NCT00627926|10913924|FG001|Overall Study|Death|0
6895829|NCT00627926|10913925|FG002|Overall Study|Death|0
6895830|NCT00627926|10913923|FG000|Overall Study|Lost to Follow-up|4
6895831|NCT00627926|10913924|FG001|Overall Study|Lost to Follow-up|3
6895832|NCT00627926|10913925|FG002|Overall Study|Lost to Follow-up|4
6895833|NCT00627926|10913923|FG000|Overall Study|Withdrawal by Subject|2
6895834|NCT00627926|10913924|FG001|Overall Study|Withdrawal by Subject|1
6895835|NCT00627926|10913925|FG002|Overall Study|Withdrawal by Subject|0
6895836|NCT00627926|10913923|FG000|Overall Study|Lack of Efficacy|118
6895837|NCT00627926|10913924|FG001|Overall Study|Lack of Efficacy|40
6895838|NCT00627926|10913925|FG002|Overall Study|Lack of Efficacy|38
6895839|NCT00627926|10913923|FG000|Overall Study|Noncompliance/unspecified|8
6895840|NCT00627926|10913924|FG001|Overall Study|Noncompliance/unspecified|23
6895841|NCT00627926|10913925|FG002|Overall Study|Noncompliance/unspecified|17
6895842|NCT00628030|10913944|FG000|Baseline to Post-Assessment|Lost to Follow-up|28
6895843|NCT00628030|10913945|FG001|Baseline to Post-Assessment|Lost to Follow-up|29
6973238|NCT01179048|11024889|FG001|Overall Study|Lost to Follow-up|9
7188192|NCT02906020|11388815|FG004|Part 1: Dose Escalation Period|Adverse Event|0
7188193|NCT02906020|11388816|FG005|Part 1: Dose Escalation Period|Adverse Event|0
7188194|NCT02906020|11388817|FG006|Part 1: Dose Escalation Period|Adverse Event|0
7188195|NCT02906020|11388818|FG007|Part 1: Dose Escalation Period|Adverse Event|0
7188196|NCT02906020|11388819|FG008|Part 1: Dose Escalation Period|Adverse Event|0
7188197|NCT02906020|11388820|FG009|Part 1: Dose Escalation Period|Adverse Event|0
6895844|NCT00628030|10913944|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5
6895845|NCT00628030|10913945|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0
6895846|NCT00628030|10913944|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32
6895847|NCT00628030|10913945|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30
6895848|NCT00628108|10913953|FG000|Overall Study|Adverse Event|0
7178531|NCT03343054|11379246|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2
7178532|NCT03343054|11379247|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6
7178533|NCT03343054|11379248|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0
7178534|NCT03343054|11379246|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1
7178535|NCT03343054|11379247|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0
7178536|NCT03343054|11379248|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0
7178537|NCT03343054|11379246|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0
7178538|NCT03343054|11379247|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0
7178539|NCT03343054|11379248|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11
7178540|NCT03343054|11379246|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0
7178541|NCT03343054|11379247|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0
7178542|NCT03343054|11379248|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8
7178543|NCT03336866|11379260|FG000|Overall Study|Lost to Follow-up|2
7178544|NCT03336866|11379261|FG001|Overall Study|Lost to Follow-up|0
7178545|NCT03336866|11379262|FG002|Overall Study|Lost to Follow-up|3
7178546|NCT03336866|11379260|FG000|Overall Study|Withdrawal by Subject|1
7178547|NCT03336866|11379261|FG001|Overall Study|Withdrawal by Subject|1
7178548|NCT03336866|11379262|FG002|Overall Study|Withdrawal by Subject|0
7178549|NCT03336866|11379260|FG000|Overall Study|Noncompliance with clinic house rules|0
7178550|NCT03336866|11379261|FG001|Overall Study|Noncompliance with clinic house rules|0
7178551|NCT03336866|11379262|FG002|Overall Study|Noncompliance with clinic house rules|1
7178552|NCT03332173|11379275|FG000|Overall Study|Death|7
7178553|NCT03332173|11379275|FG000|Overall Study|Withdrawal by Subject|6
7178554|NCT03332173|11379275|FG000|Overall Study|Lost to Follow-up|2
7178555|NCT03332173|11379275|FG000|Overall Study|Transferred to long-term extension study|29
7178556|NCT03322293|11379282|FG000|Overall Study|Lost to Follow-up|0
7178557|NCT03322293|11379283|FG001|Overall Study|Lost to Follow-up|0
7178558|NCT03322293|11379284|FG002|Overall Study|Lost to Follow-up|1
7178559|NCT03254394|11379306|FG000|Overall Study|Withdrawal by Subject|0
7178560|NCT03254394|11379307|FG001|Overall Study|Withdrawal by Subject|2
7178561|NCT03253809|11379313|FG000|Overall Study|Unable to obtain study related data|14
7178562|NCT03151408|11379333|FG000|Overall Study|Adverse Event|24
7178563|NCT03151408|11379334|FG001|Overall Study|Adverse Event|23
7178564|NCT03151408|11379333|FG000|Overall Study|Death|46
7178565|NCT03151408|11379334|FG001|Overall Study|Death|26
7178566|NCT03151408|11379333|FG000|Overall Study|Physician Decision|13
7178567|NCT03151408|11379334|FG001|Overall Study|Physician Decision|19
7178568|NCT03151408|11379333|FG000|Overall Study|Withdrawal by Subject|16
7178569|NCT03151408|11379334|FG001|Overall Study|Withdrawal by Subject|20
7178570|NCT03151408|11379333|FG000|Overall Study|Progressive disease|45
7178571|NCT03151408|11379334|FG001|Overall Study|Progressive disease|61
7178572|NCT03151408|11379333|FG000|Overall Study|non-compliance by patient|1
7178573|NCT03151408|11379334|FG001|Overall Study|non-compliance by patient|0
7178574|NCT03151408|11379333|FG000|Overall Study|other reasons|56
7178575|NCT03151408|11379334|FG001|Overall Study|other reasons|52
7178576|NCT03151408|11379333|FG000|Overall Study|randomized and not treated|2
7178577|NCT03151408|11379334|FG001|Overall Study|randomized and not treated|2
7178578|NCT03137173|11379342|FG000|Overall Study|Withdrawal by Subject|8
7178579|NCT03137173|11379343|FG001|Overall Study|Withdrawal by Subject|13
7178580|NCT03137173|11379342|FG000|Overall Study|Death|1
7178581|NCT03137173|11379343|FG001|Overall Study|Death|3
7178582|NCT03137173|11379342|FG000|Overall Study|Physician Decision|1
7178583|NCT03137173|11379343|FG001|Overall Study|Physician Decision|0
7178584|NCT03137173|11379342|FG000|Overall Study|Lost to Follow-up|13
7178585|NCT03137173|11379343|FG001|Overall Study|Lost to Follow-up|18
7178586|NCT03137173|11379342|FG000|Overall Study|Other reasons|3
7178587|NCT03137173|11379343|FG001|Overall Study|Other reasons|2
7186509|NCT03462030|11386848|FG000|Overall Study|Withdrawal by Subject|1
7186510|NCT03462030|11386849|FG001|Overall Study|Withdrawal by Subject|1
7186511|NCT03446768|11386857|FG000|Overall Study|Withdrawal by Subject|0
7186512|NCT03446768|11386858|FG001|Overall Study|Withdrawal by Subject|1
7186513|NCT03253393|11386903|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6
7186514|NCT03253393|11386904|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7
7186515|NCT03253393|11386905|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0
7186516|NCT03188822|11386919|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6
7186517|NCT03188822|11386919|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1
7186518|NCT03128671|11386925|FG000|Allocation|ICU discharge prior to intervention initiation|4
7186519|NCT03128671|11386926|FG001|Allocation|ICU discharge prior to intervention initiation|0
7186520|NCT03128671|11386925|FG000|Allocation|Death|1
7186521|NCT03128671|11386926|FG001|Allocation|Death|0
7186522|NCT03128671|11386925|FG000|Allocation|Withdrawal by Subject|4
7186523|NCT03128671|11386926|FG001|Allocation|Withdrawal by Subject|0
7186524|NCT03128671|11386925|FG000|Intervention|Withdrawal by Subject|11
7186525|NCT03128671|11386926|FG001|Intervention|Withdrawal by Subject|10
7186526|NCT03128671|11386925|FG000|Intervention|Palliative/hospice care initiated|9
7186527|NCT03128671|11386926|FG001|Intervention|Palliative/hospice care initiated|10
7186528|NCT03128671|11386925|FG000|Intervention|Death|13
7186529|NCT03128671|11386926|FG001|Intervention|Death|11
7178588|NCT03028740|11379382|FG000|Overall Study|Did not Receive Study Drug|4
7178589|NCT03028740|11379383|FG001|Overall Study|Did not Receive Study Drug|5
7178590|NCT03028740|11379382|FG000|Overall Study|Adverse Event|8
7178591|NCT03028740|11379383|FG001|Overall Study|Adverse Event|26
7178592|NCT03028740|11379382|FG000|Overall Study|Lack of Efficacy|0
7178593|NCT03028740|11379383|FG001|Overall Study|Lack of Efficacy|1
7178594|NCT03028740|11379382|FG000|Overall Study|Withdrawal by Subject|48
7178595|NCT03028740|11379383|FG001|Overall Study|Withdrawal by Subject|101
7178596|NCT03028740|11379382|FG000|Overall Study|Lost to Follow-up|30
7178597|NCT03028740|11379383|FG001|Overall Study|Lost to Follow-up|54
7178598|NCT03028740|11379382|FG000|Overall Study|Physician Decision|4
7178599|NCT03028740|11379383|FG001|Overall Study|Physician Decision|11
7178600|NCT03028740|11379382|FG000|Overall Study|Protocol Violation|4
7178601|NCT03028740|11379383|FG001|Overall Study|Protocol Violation|8
7178602|NCT03028740|11379382|FG000|Overall Study|Non-compliance with Study Drug|0
7178603|NCT03028740|11379383|FG001|Overall Study|Non-compliance with Study Drug|2
7178604|NCT03028740|11379382|FG000|Overall Study|Study Terminated by Sponsor|467
7178605|NCT03028740|11379383|FG001|Overall Study|Study Terminated by Sponsor|917
7178606|NCT03028740|11379382|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27
7178607|NCT03028740|11379383|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55
7178608|NCT03028740|11379382|FG000|Overall Study|Reason not Specified|1
7178609|NCT03028740|11379383|FG001|Overall Study|Reason not Specified|5
7178610|NCT02998476|11379435|FG000|Overall Study|Lost to Follow-up|1
7178611|NCT02998476|11379436|FG001|Overall Study|Lost to Follow-up|0
7178612|NCT02998476|11379435|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2
7178613|NCT02998476|11379436|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0
7178614|NCT02998476|11379435|FG000|Overall Study|Withdrawal by Subject|1
7178615|NCT02998476|11379436|FG001|Overall Study|Withdrawal by Subject|2
7178616|NCT02998476|11379435|FG000|Overall Study|Death|45
7178617|NCT02998476|11379436|FG001|Overall Study|Death|2
7178618|NCT02998476|11379435|FG000|Overall Study|Other|6
7178619|NCT02998476|11379436|FG001|Overall Study|Other|1
7178620|NCT02949128|11379452|FG000|Initial Evaluation Period|Failed to Meet Eligibility Criteria|2
7178621|NCT02949128|11379452|FG000|Initial Evaluation Period|Adverse Event|3
7178622|NCT02949128|11379452|FG000|Initial Evaluation Period|Death|2
7178623|NCT02949128|11379452|FG000|Initial Evaluation Period|Physician Decision|1
7178624|NCT02949128|11379452|FG000|Initial Evaluation Period|Protocol Violation|1
7178625|NCT02949128|11379452|FG000|Extension Period|Physician Decision|1
7178626|NCT02949128|11379452|FG000|Extension Period|Withdrawal by Subject|1
7178627|NCT02924064|11379458|FG000|Overall Study|Adverse Event|2
7178628|NCT02924064|11379459|FG001|Overall Study|Adverse Event|2
7178629|NCT02924064|11379458|FG000|Overall Study|Lost to Follow-up|0
7178630|NCT02924064|11379459|FG001|Overall Study|Lost to Follow-up|2
7178631|NCT02924064|11379458|FG000|Overall Study|Physician Decision|0
7178632|NCT02924064|11379459|FG001|Overall Study|Physician Decision|2
7178633|NCT02924064|11379458|FG000|Overall Study|Protocol Violation|1
7178634|NCT02924064|11379459|FG001|Overall Study|Protocol Violation|3
7178635|NCT02924064|11379458|FG000|Overall Study|Withdrawal by Subject|4
7178636|NCT02924064|11379459|FG001|Overall Study|Withdrawal by Subject|5
7178637|NCT02924064|11379458|FG000|Overall Study|Other|17
7178638|NCT02924064|11379459|FG001|Overall Study|Other|29
7178639|NCT02916706|11379467|FG000|Overall Study|Adverse Event|0
7178640|NCT02916706|11379468|FG001|Overall Study|Adverse Event|1
7178641|NCT02916706|11379467|FG000|Overall Study|Lost to Follow-up|0
7178642|NCT02916706|11379468|FG001|Overall Study|Lost to Follow-up|1
7178643|NCT02916706|11379467|FG000|Overall Study|Physician Decision|1
7178644|NCT02916706|11379468|FG001|Overall Study|Physician Decision|0
7178645|NCT02916706|11379467|FG000|Overall Study|Protocol Violation|3
7178646|NCT02916706|11379468|FG001|Overall Study|Protocol Violation|1
7178647|NCT02916706|11379467|FG000|Overall Study|Withdrawal by Subject|6
7178648|NCT02916706|11379468|FG001|Overall Study|Withdrawal by Subject|9
7178649|NCT02916706|11379467|FG000|Overall Study|Other|5
7178650|NCT02916706|11379468|FG001|Overall Study|Other|19
7178651|NCT02889900|11379474|FG000|Overall Study|Adverse Event|11
7178652|NCT02889900|11379474|FG000|Overall Study|Condition under investigation worsened|32
7178653|NCT02889900|11379474|FG000|Overall Study|Other|5
7178654|NCT02889900|11379474|FG000|Overall Study|Withdrawal by Subject|7
7178655|NCT02889900|11379474|FG000|Overall Study|Not treated|2
7178656|NCT02866695|11379478|FG000|Overall Study|Adverse Event|1
7178657|NCT02866695|11379478|FG000|Overall Study|Lost to Follow-up|1
7178658|NCT02854436|11379482|FG000|Overall Study|Adverse Event|1
7178659|NCT02854436|11379482|FG000|Overall Study|Death|208
7178660|NCT02854436|11379482|FG000|Overall Study|Lost to Follow-up|5
7178661|NCT02854436|11379482|FG000|Overall Study|Withdrawal by Subject|12
7178662|NCT02854436|11379482|FG000|Overall Study|Other|45
7178663|NCT02854436|11379482|FG000|Overall Study|Ongoing|18
7178664|NCT02834793|11379488|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2
7178665|NCT02834793|11379489|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1
7178666|NCT02834793|11379490|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0
7178667|NCT02834793|11379491|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0
7178668|NCT02834793|11379488|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1
7178669|NCT02834793|11379489|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0
7178670|NCT02834793|11379490|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0
7178671|NCT02834793|11379491|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0
7178672|NCT02834793|11379488|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1
7178673|NCT02834793|11379489|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0
7178674|NCT02834793|11379490|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0
7178675|NCT02834793|11379491|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0
7178676|NCT02834793|11379488|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0
7178677|NCT02834793|11379489|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3
7178678|NCT02834793|11379490|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0
7178679|NCT02834793|11379491|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0
7178680|NCT02834793|11379488|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0
7178681|NCT02834793|11379489|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1
7178682|NCT02834793|11379490|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0
7178683|NCT02834793|11379491|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0
7178684|NCT02834793|11379488|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0
7178685|NCT02834793|11379489|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0
7178686|NCT02834793|11379490|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7
7178687|NCT02834793|11379491|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0
7178688|NCT02834793|11379488|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0
7178689|NCT02834793|11379489|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0
7178690|NCT02834793|11379490|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4
7178691|NCT02834793|11379491|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0
7178692|NCT02834793|11379488|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0
7178693|NCT02834793|11379489|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0
7178694|NCT02834793|11379490|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5
7178695|NCT02834793|11379491|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0
7178696|NCT02834793|11379488|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0
7178697|NCT02834793|11379489|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0
7178698|NCT02834793|11379490|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9
7178699|NCT02834793|11379491|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0
7178700|NCT02834793|11379488|FG000|Extension Phase A (up to 52 Weeks)|Other|0
7178701|NCT02834793|11379489|FG001|Extension Phase A (up to 52 Weeks)|Other|0
7178702|NCT02834793|11379490|FG002|Extension Phase A (up to 52 Weeks)|Other|1
7178703|NCT02834793|11379491|FG003|Extension Phase A (up to 52 Weeks)|Other|0
7178704|NCT02834793|11379488|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0
7178705|NCT02834793|11379489|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0
7178706|NCT02834793|11379490|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0
7178707|NCT02834793|11379491|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1
7178708|NCT02834793|11379488|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0
7178709|NCT02834793|11379489|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0
7178710|NCT02834793|11379490|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0
7178711|NCT02834793|11379491|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1
7178712|NCT02834793|11379488|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0
7178713|NCT02834793|11379489|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0
7178714|NCT02834793|11379490|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0
7178715|NCT02834793|11379491|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8
7178716|NCT02834793|11379488|FG000|Extension Phase B (up to 188 Weeks)|Other|0
7178717|NCT02834793|11379489|FG001|Extension Phase B (up to 188 Weeks)|Other|0
7178718|NCT02834793|11379490|FG002|Extension Phase B (up to 188 Weeks)|Other|0
7178719|NCT02834793|11379491|FG003|Extension Phase B (up to 188 Weeks)|Other|1
7178720|NCT02834793|11379488|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0
7178721|NCT02834793|11379489|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0
7178722|NCT02834793|11379490|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0
7178723|NCT02834793|11379491|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1
7178724|NCT02810457|11379501|FG000|Overall Study|Randomised but no treatment received|2
7178725|NCT02810457|11379502|FG001|Overall Study|Randomised but no treatment received|1
7178726|NCT02810457|11379501|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191
7178727|NCT02810457|11379502|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199
7178728|NCT02810457|11379501|FG000|Overall Study|Adverse Event|37
7178729|NCT02810457|11379502|FG001|Overall Study|Adverse Event|43
7178730|NCT02810457|11379501|FG000|Overall Study|Patient decision|31
7178731|NCT02810457|11379502|FG001|Overall Study|Patient decision|35
7178732|NCT02810457|11379501|FG000|Overall Study|Patient lost to follow-up|2
7178733|NCT02810457|11379502|FG001|Overall Study|Patient lost to follow-up|2
7178734|NCT02810457|11379501|FG000|Overall Study|Death|39
7178735|NCT02810457|11379502|FG001|Overall Study|Death|28
7178736|NCT02810457|11379501|FG000|Overall Study|Ongoing at data cutoff and discontinued|3
7178737|NCT02810457|11379502|FG001|Overall Study|Ongoing at data cutoff and discontinued|2
7178738|NCT02810457|11379501|FG000|Overall Study|Clinical progression|15
7178739|NCT02810457|11379502|FG001|Overall Study|Clinical progression|16
7178740|NCT02810457|11379501|FG000|Overall Study|Investigator decision|3
7178741|NCT02810457|11379502|FG001|Overall Study|Investigator decision|2
7178742|NCT02810457|11379501|FG000|Overall Study|Patient ineligibility|3
7178743|NCT02810457|11379502|FG001|Overall Study|Patient ineligibility|0
7178744|NCT02810457|11379501|FG000|Overall Study|Miscalculated PD|1
7178745|NCT02810457|11379502|FG001|Overall Study|Miscalculated PD|0
7178746|NCT02810457|11379501|FG000|Overall Study|Physician Decision|0
7178747|NCT02810457|11379502|FG001|Overall Study|Physician Decision|1
7178748|NCT02745535|11379538|FG000|Overall Study|Death|1
7178749|NCT02745535|11379538|FG000|Overall Study|Adverse Event|3
7178750|NCT02745535|11379538|FG000|Overall Study|Lost to Follow-up|2
7178751|NCT02625090|11379576|FG000|Overall Study|Participant wants to be pregnant|2
7178752|NCT02625090|11379576|FG000|Overall Study|For the Promoter|1
7178753|NCT02625090|11379576|FG000|Overall Study|Sponsor's Decision|9
7178754|NCT02625090|11379576|FG000|Overall Study|Somnolence|1
7178755|NCT02625090|11379576|FG000|Overall Study|Study terminated by Sponsor|7
7178756|NCT02625090|11379576|FG000|Overall Study|Negative Benefit/Risk|1
7178757|NCT02625090|11379576|FG000|Overall Study|Protocol Deviation|2
7178758|NCT02625090|11379576|FG000|Overall Study|Lack of Efficacy|16
7178759|NCT02625090|11379576|FG000|Overall Study|Adverse Event|3
7186530|NCT03128671|11386925|FG000|Intervention|Interrupted by hurricane|1
7186531|NCT03128671|11386926|FG001|Intervention|Interrupted by hurricane|0
7186532|NCT03128671|11386925|FG000|Intervention|Physician Decision|2
7186533|NCT03128671|11386926|FG001|Intervention|Physician Decision|3
7186534|NCT03111732|11386932|FG000|Overall Study|Enrolled in different study|1
7186535|NCT03111732|11386932|FG000|Overall Study|Progressive disease|3
7186536|NCT03111732|11386932|FG000|Overall Study|Withdrawal by Subject|1
7186537|NCT03065244|11386943|FG000|Overall Study|Lost to Follow-up|1
7186538|NCT03065244|11386944|FG001|Overall Study|Lost to Follow-up|1
7186539|NCT03065244|11386943|FG000|Overall Study|Diagnosed with a different disease|1
7186540|NCT03065244|11386944|FG001|Overall Study|Diagnosed with a different disease|1
7186541|NCT03065244|11386943|FG000|Overall Study|Protocol Violation|0
7186542|NCT03065244|11386944|FG001|Overall Study|Protocol Violation|1
7186543|NCT03065244|11386943|FG000|Overall Study|Withdrawal by Subject|1
7186544|NCT03065244|11386944|FG001|Overall Study|Withdrawal by Subject|1
7186545|NCT02879305|11386952|FG000|Overall Study|Investigator Site Closed|55
7186546|NCT02879305|11386953|FG001|Overall Study|Investigator Site Closed|57
7186547|NCT02879305|11386952|FG000|Overall Study|Withdrawal by Subject|44
7186548|NCT02879305|11386953|FG001|Overall Study|Withdrawal by Subject|42
7186549|NCT02879305|11386952|FG000|Overall Study|Lost to Follow-up|17
7186550|NCT02879305|11386953|FG001|Overall Study|Lost to Follow-up|12
7186551|NCT02879305|11386952|FG000|Overall Study|Other|1
7186552|NCT02879305|11386953|FG001|Overall Study|Other|0
7186553|NCT02787850|11386970|FG000|Overall Study|Withdrawal by Subject|0
7186554|NCT02787850|11386971|FG001|Overall Study|Withdrawal by Subject|1
7186555|NCT02676284|11386990|FG000|Overall Study|Withdrawal by Subject|1
7186556|NCT02431702|11386994|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7
7186557|NCT02431702|11386995|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
7186558|NCT02431702|11386996|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
7186559|NCT02431702|11386997|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
7186560|NCT02431702|11386998|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
7186561|NCT02431702|11386999|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
7186562|NCT02431702|11387000|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
7186563|NCT02431702|11386994|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11
7186564|NCT02431702|11386995|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
7186565|NCT02431702|11386996|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
7186566|NCT02431702|11386997|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
7186567|NCT02431702|11386998|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
7186568|NCT02431702|11386999|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
7186569|NCT02431702|11387000|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23
7186570|NCT02431702|11386994|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9
7186571|NCT02431702|11386995|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
7186572|NCT02431702|11386996|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
7186573|NCT02431702|11386997|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
7186574|NCT02431702|11386998|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
7186575|NCT02431702|11386999|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
7178760|NCT02539225|11379583|FG000|Part A|Adverse Event|13
7178761|NCT02539225|11379584|FG001|Part A|Adverse Event|4
7178762|NCT02539225|11379583|FG000|Part A|Withdrawal by Subject|2
7178763|NCT02539225|11379584|FG001|Part A|Withdrawal by Subject|4
7178764|NCT02539225|11379583|FG000|Part A|Physician Decision|4
7178765|NCT02539225|11379584|FG001|Part A|Physician Decision|7
7178766|NCT02539225|11379583|FG000|Part A|Did Not Receive study Drug|1
7178767|NCT02539225|11379584|FG001|Part A|Did Not Receive study Drug|1
7178768|NCT02539225|11379583|FG000|Pre Treatment for Part B|Progressive disease|1
7178769|NCT02539225|11379584|FG001|Pre Treatment for Part B|Progressive disease|1
7178770|NCT02539225|11379583|FG000|Pre Treatment for Part B|Adverse Event|1
7178771|NCT02539225|11379584|FG001|Pre Treatment for Part B|Adverse Event|1
7178772|NCT02539225|11379583|FG000|Pre Treatment for Part B|Withdrawal by Subject|1
7178773|NCT02539225|11379584|FG001|Pre Treatment for Part B|Withdrawal by Subject|0
7178774|NCT02539225|11379583|FG000|Pre Treatment for Part B|Physician Decision|2
7178775|NCT02539225|11379584|FG001|Pre Treatment for Part B|Physician Decision|0
6895849|NCT00628108|10913954|FG001|Overall Study|Adverse Event|3
6895850|NCT00628108|10913953|FG000|Overall Study|Withdrawal by Subject|1
6895851|NCT00628108|10913954|FG001|Overall Study|Withdrawal by Subject|0
6895852|NCT00628212|10913980|FG000|Overall Study|Adverse Event|2
6895853|NCT00628212|10913981|FG001|Overall Study|Adverse Event|0
6895854|NCT00628212|10913982|FG002|Overall Study|Adverse Event|1
6895855|NCT00628212|10913983|FG003|Overall Study|Adverse Event|2
6895856|NCT00628212|10913980|FG000|Overall Study|Physician Decision|1
6895857|NCT00628212|10913981|FG001|Overall Study|Physician Decision|1
6895858|NCT00628212|10913982|FG002|Overall Study|Physician Decision|2
6895859|NCT00628212|10913983|FG003|Overall Study|Physician Decision|3
6895860|NCT00628251|10913996|FG000|Randomised Part|Withdrawal by Subject|0
6895861|NCT00628251|10913997|FG001|Randomised Part|Withdrawal by Subject|0
6895862|NCT00628251|10913998|FG002|Randomised Part|Withdrawal by Subject|1
6895863|NCT00628251|10913996|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1
6895864|NCT00628251|10913997|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2
6895865|NCT00628251|10913998|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3
6895866|NCT00628251|10913996|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19
6895867|NCT00628251|10913997|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15
6895868|NCT00628251|10913998|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13
6895869|NCT00628251|10913996|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1
6895870|NCT00628251|10913997|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2
6895871|NCT00628251|10913998|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1
6895872|NCT00628251|10913996|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0
6895873|NCT00628251|10913997|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1
6895874|NCT00628251|10913998|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6
6895875|NCT00628251|10913996|FG000|Ongoing Initial Study Treatment at DCO|Other|1
6895876|NCT00628251|10913997|FG001|Ongoing Initial Study Treatment at DCO|Other|0
6895877|NCT00628251|10913998|FG002|Ongoing Initial Study Treatment at DCO|Other|2
7178776|NCT02539225|11379583|FG000|Part B|Adverse Event|4
7178777|NCT02539225|11379584|FG001|Part B|Adverse Event|4
7178778|NCT02539225|11379583|FG000|Part B|Withdrawal by Subject|0
7178779|NCT02539225|11379584|FG001|Part B|Withdrawal by Subject|3
7178780|NCT02539225|11379583|FG000|Part B|Physician Decision|0
7178781|NCT02539225|11379584|FG001|Part B|Physician Decision|9
7178782|NCT02526017|11379612|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0
7178783|NCT02526017|11379613|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0
7178784|NCT02526017|11379614|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0
7178785|NCT02526017|11379615|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0
7178786|NCT02526017|11379616|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1
7178787|NCT02526017|11379617|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0
7178788|NCT02526017|11379618|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0
7178789|NCT02526017|11379619|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0
7178790|NCT02526017|11379620|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0
7178791|NCT02482233|11379682|FG000|Overall Study|Lost to Follow-up|1
7178792|NCT02482233|11379683|FG001|Overall Study|Lost to Follow-up|1
7178793|NCT02450331|11379693|FG000|Overall Study|Death|120
7178794|NCT02450331|11379694|FG001|Overall Study|Death|114
7178795|NCT02450331|11379693|FG000|Overall Study|Lost to Follow-up|9
7178796|NCT02450331|11379694|FG001|Overall Study|Lost to Follow-up|7
7178797|NCT02450331|11379693|FG000|Overall Study|Withdrawal by Subject|50
7178798|NCT02450331|11379694|FG001|Overall Study|Withdrawal by Subject|39
7178799|NCT02450331|11379693|FG000|Overall Study|On-Study Status: In Disease recurrence follow-up|179
7178800|NCT02450331|11379694|FG001|Overall Study|On-Study Status: In Disease recurrence follow-up|208
7178801|NCT02450331|11379693|FG000|Overall Study|On-Study Status: In Survival follow-up|45
7178802|NCT02450331|11379694|FG001|Overall Study|On-Study Status: In Survival follow-up|38
7178803|NCT02400736|11379710|FG000|Overall Study|Lost to Follow-up|6
7178804|NCT02400736|11379711|FG001|Overall Study|Lost to Follow-up|6
7178805|NCT02400736|11379710|FG000|Overall Study|Withdrawal by Subject|2
7178806|NCT02400736|11379711|FG001|Overall Study|Withdrawal by Subject|1
7178807|NCT02400736|11379710|FG000|Overall Study|Moved from the area|3
7178808|NCT02400736|11379711|FG001|Overall Study|Moved from the area|1
7178809|NCT02369653|11379723|FG000|Overall Study|Lost to Follow-up|0
7178810|NCT02369653|11379724|FG001|Overall Study|Lost to Follow-up|1
7178811|NCT02369653|11379723|FG000|Overall Study|Administrative reason by sponsor|0
7178812|NCT02369653|11379724|FG001|Overall Study|Administrative reason by sponsor|1
7178813|NCT02369653|11379723|FG000|Overall Study|Death|1
7178814|NCT02369653|11379724|FG001|Overall Study|Death|2
6973239|NCT01179048|11024888|FG000|Overall Study|Alive|127
7178815|NCT02369653|11379723|FG000|Overall Study|Participant withdrew consent|13
7178816|NCT02369653|11379724|FG001|Overall Study|Participant withdrew consent|3
7178817|NCT02335424|11379734|FG000|Overall Study|Withdrawal by Subject|12
7178818|NCT02335424|11379734|FG000|Overall Study|Ongoing In Study|89
7178819|NCT02335424|11379734|FG000|Overall Study|Adverse Event|25
7178820|NCT02335424|11379734|FG000|Overall Study|Death|239
7178821|NCT02335424|11379734|FG000|Overall Study|Lost to Follow-up|2
7178822|NCT02335424|11379734|FG000|Overall Study|Physician Decision|3
7178823|NCT02335424|11379734|FG000|Overall Study|Not treated|4
7178824|NCT02326974|11379738|FG000|Overall Study|Withdrawal by Subject|2
7178825|NCT02326974|11379738|FG000|Overall Study|failed heterogenity evaluation|5
7178826|NCT02284568|11379749|FG000|Overall Study|Adverse Event|2
7178827|NCT02284568|11379750|FG001|Overall Study|Adverse Event|9
7178828|NCT02284568|11379751|FG002|Overall Study|Adverse Event|4
7178829|NCT02284568|11379749|FG000|Overall Study|Withdrawal by Subject|22
7178830|NCT02284568|11379750|FG001|Overall Study|Withdrawal by Subject|21
7178831|NCT02284568|11379751|FG002|Overall Study|Withdrawal by Subject|1
7178832|NCT02284568|11379749|FG000|Overall Study|Noncompliance with study drug admin|1
7178833|NCT02284568|11379750|FG001|Overall Study|Noncompliance with study drug admin|2
7178834|NCT02284568|11379751|FG002|Overall Study|Noncompliance with study drug admin|0
7178835|NCT02284568|11379749|FG000|Overall Study|Noncompliance|1
7178836|NCT02284568|11379750|FG001|Overall Study|Noncompliance|0
7178837|NCT02284568|11379751|FG002|Overall Study|Noncompliance|0
7178838|NCT02284568|11379749|FG000|Overall Study|Protocol Violation|0
7178839|NCT02284568|11379750|FG001|Overall Study|Protocol Violation|1
7178840|NCT02284568|11379751|FG002|Overall Study|Protocol Violation|0
7178841|NCT02284568|11379749|FG000|Overall Study|Sponsor requested patient stop treatment|0
7178842|NCT02284568|11379750|FG001|Overall Study|Sponsor requested patient stop treatment|0
7178843|NCT02284568|11379751|FG002|Overall Study|Sponsor requested patient stop treatment|90
7178844|NCT02284568|11379749|FG000|Overall Study|Lost to Follow-up|0
7178845|NCT02284568|11379750|FG001|Overall Study|Lost to Follow-up|3
7178846|NCT02284568|11379751|FG002|Overall Study|Lost to Follow-up|0
7178847|NCT02284568|11379749|FG000|Overall Study|Lack of Efficacy|4
7178848|NCT02284568|11379750|FG001|Overall Study|Lack of Efficacy|7
7178849|NCT02284568|11379751|FG002|Overall Study|Lack of Efficacy|0
7178850|NCT02284568|11379749|FG000|Overall Study|Other|1
7178851|NCT02284568|11379750|FG001|Overall Study|Other|2
7178852|NCT02284568|11379751|FG002|Overall Study|Other|0
7178853|NCT02284568|11379749|FG000|Overall Study|Withdrew before taking study drug|0
7178854|NCT02284568|11379750|FG001|Overall Study|Withdrew before taking study drug|1
7178855|NCT02284568|11379751|FG002|Overall Study|Withdrew before taking study drug|0
7178856|NCT02227238|11379765|FG000|Overall Study|Other: Reached stopping criteria|0
7178857|NCT02227238|11379766|FG001|Overall Study|Other: Reached stopping criteria|1
7178858|NCT02227238|11379765|FG000|Overall Study|Adverse Event|8
7178859|NCT02227238|11379766|FG001|Overall Study|Adverse Event|18
7178860|NCT02227238|11379765|FG000|Overall Study|Lack of Efficacy|10
7178861|NCT02227238|11379766|FG001|Overall Study|Lack of Efficacy|22
7178862|NCT02227238|11379765|FG000|Overall Study|Protocol Violation|7
7178863|NCT02227238|11379766|FG001|Overall Study|Protocol Violation|8
7178864|NCT02227238|11379765|FG000|Overall Study|Withdrawal by Subject|5
7178865|NCT02227238|11379766|FG001|Overall Study|Withdrawal by Subject|4
7178866|NCT02227238|11379765|FG000|Overall Study|Physician Decision|0
7178867|NCT02227238|11379766|FG001|Overall Study|Physician Decision|9
7178868|NCT02227238|11379765|FG000|Overall Study|Lost to Follow-up|7
7178869|NCT02227238|11379766|FG001|Overall Study|Lost to Follow-up|5
7178870|NCT02195986|11379775|FG000|Overall Study|Adverse Event|3
7178871|NCT02195986|11379776|FG001|Overall Study|Adverse Event|0
7178872|NCT02195986|11379777|FG002|Overall Study|Adverse Event|0
7178873|NCT02195986|11379775|FG000|Overall Study|Withdrawal by Subject|0
7178874|NCT02195986|11379776|FG001|Overall Study|Withdrawal by Subject|3
7178875|NCT02195986|11379777|FG002|Overall Study|Withdrawal by Subject|0
7178876|NCT02195986|11379775|FG000|Overall Study|Family Emergency|0
7178877|NCT02195986|11379776|FG001|Overall Study|Family Emergency|0
7178878|NCT02195986|11379777|FG002|Overall Study|Family Emergency|1
7178879|NCT02195986|11379775|FG000|Overall Study|Protocol Violation|0
7178880|NCT02195986|11379776|FG001|Overall Study|Protocol Violation|1
7178881|NCT02195986|11379777|FG002|Overall Study|Protocol Violation|1
7178882|NCT02195986|11379775|FG000|Overall Study|Non-compliance|0
7178883|NCT02195986|11379776|FG001|Overall Study|Non-compliance|1
7178884|NCT02195986|11379777|FG002|Overall Study|Non-compliance|0
7178885|NCT02086448|11379798|FG000|Overall Study|Withdrawal by Subject|1
7178886|NCT02086448|11379799|FG001|Overall Study|Withdrawal by Subject|0
7178887|NCT02086448|11379800|FG002|Overall Study|Withdrawal by Subject|0
7178888|NCT02086448|11379801|FG003|Overall Study|Withdrawal by Subject|2
7178889|NCT01982630|11379819|FG000|Overall Study|Adverse Event|2
7178890|NCT01982630|11379820|FG001|Overall Study|Adverse Event|0
7178891|NCT01982630|11379821|FG002|Overall Study|Adverse Event|1
7178892|NCT01982630|11379822|FG003|Overall Study|Adverse Event|0
7178893|NCT01982630|11379823|FG004|Overall Study|Adverse Event|1
7178894|NCT01982630|11379824|FG005|Overall Study|Adverse Event|2
7178895|NCT01982630|11379825|FG006|Overall Study|Adverse Event|1
7178896|NCT01982630|11379826|FG007|Overall Study|Adverse Event|0
7178897|NCT01982630|11379819|FG000|Overall Study|Physician Decision|1
7178898|NCT01982630|11379820|FG001|Overall Study|Physician Decision|0
7178899|NCT01982630|11379821|FG002|Overall Study|Physician Decision|2
7178900|NCT01982630|11379822|FG003|Overall Study|Physician Decision|1
6895878|NCT00628355|10914010|FG000|Overall Study|Withdrawal by Subject|1
6895879|NCT00628355|10914011|FG001|Overall Study|Withdrawal by Subject|1
6895880|NCT00628758|10914067|FG000|Overall Study|Adverse Event|2
7178901|NCT01982630|11379823|FG004|Overall Study|Physician Decision|2
7178902|NCT01982630|11379824|FG005|Overall Study|Physician Decision|0
7178903|NCT01982630|11379825|FG006|Overall Study|Physician Decision|0
7178904|NCT01982630|11379826|FG007|Overall Study|Physician Decision|0
7178905|NCT01982630|11379819|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0
7178906|NCT01982630|11379820|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0
7178907|NCT01982630|11379821|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2
7178908|NCT01982630|11379822|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0
7178909|NCT01982630|11379823|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0
7178910|NCT01982630|11379824|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0
7178911|NCT01982630|11379825|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0
7178912|NCT01982630|11379826|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0
7178913|NCT01982630|11379819|FG000|Overall Study|Withdrawal by Subject|0
7178914|NCT01982630|11379820|FG001|Overall Study|Withdrawal by Subject|0
7178915|NCT01982630|11379821|FG002|Overall Study|Withdrawal by Subject|0
7178916|NCT01982630|11379822|FG003|Overall Study|Withdrawal by Subject|0
7178917|NCT01982630|11379823|FG004|Overall Study|Withdrawal by Subject|0
7178918|NCT01982630|11379824|FG005|Overall Study|Withdrawal by Subject|1
7178919|NCT01982630|11379825|FG006|Overall Study|Withdrawal by Subject|0
7178920|NCT01982630|11379826|FG007|Overall Study|Withdrawal by Subject|0
7178921|NCT01982448|11379881|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2
7178922|NCT01982448|11379882|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2
7178923|NCT01982448|11379881|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1
7178924|NCT01982448|11379882|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0
7178925|NCT01982448|11379881|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0
7178926|NCT01982448|11379882|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2
7178927|NCT01982448|11379881|FG000|Preoperative Chemotherapy|Lost to Follow-up|0
7178928|NCT01982448|11379882|FG001|Preoperative Chemotherapy|Lost to Follow-up|1
7178929|NCT01752920|11379914|FG000|Overall Study|Adverse Event|1
7178930|NCT01752920|11379915|FG001|Overall Study|Adverse Event|0
7178931|NCT01752920|11379916|FG002|Overall Study|Adverse Event|5
7178932|NCT01752920|11379917|FG003|Overall Study|Adverse Event|10
7178933|NCT01752920|11379914|FG000|Overall Study|Clinical Disease Progression|6
7178934|NCT01752920|11379915|FG001|Overall Study|Clinical Disease Progression|4
7178935|NCT01752920|11379916|FG002|Overall Study|Clinical Disease Progression|1
7178936|NCT01752920|11379917|FG003|Overall Study|Clinical Disease Progression|13
7178937|NCT01752920|11379914|FG000|Overall Study|Physician Decision|1
7178938|NCT01752920|11379915|FG001|Overall Study|Physician Decision|0
7178939|NCT01752920|11379916|FG002|Overall Study|Physician Decision|0
7178940|NCT01752920|11379917|FG003|Overall Study|Physician Decision|3
7178941|NCT01752920|11379914|FG000|Overall Study|Radiographic Disease Progression|20
7178942|NCT01752920|11379915|FG001|Overall Study|Radiographic Disease Progression|7
7178943|NCT01752920|11379916|FG002|Overall Study|Radiographic Disease Progression|12
7178944|NCT01752920|11379917|FG003|Overall Study|Radiographic Disease Progression|29
7178945|NCT01752920|11379914|FG000|Overall Study|Study Terminated by Sponsor|0
7178946|NCT01752920|11379915|FG001|Overall Study|Study Terminated by Sponsor|0
7178947|NCT01752920|11379916|FG002|Overall Study|Study Terminated by Sponsor|0
7178948|NCT01752920|11379917|FG003|Overall Study|Study Terminated by Sponsor|1
7178949|NCT01752920|11379914|FG000|Overall Study|Withdrawal by Subject|0
7178950|NCT01752920|11379915|FG001|Overall Study|Withdrawal by Subject|1
7178951|NCT01752920|11379916|FG002|Overall Study|Withdrawal by Subject|0
7178952|NCT01752920|11379917|FG003|Overall Study|Withdrawal by Subject|1
7178953|NCT01752920|11379914|FG000|Overall Study|Lack of clinical benefit|1
7178954|NCT01752920|11379915|FG001|Overall Study|Lack of clinical benefit|1
7178955|NCT01752920|11379916|FG002|Overall Study|Lack of clinical benefit|1
7178956|NCT01752920|11379917|FG003|Overall Study|Lack of clinical benefit|1
7178957|NCT01744093|11379931|FG000|Overall Study|Withdrawal by Subject|6
7178958|NCT01744093|11379932|FG001|Overall Study|Withdrawal by Subject|1
7178959|NCT01740297|11379949|FG000|Overall Study|Withdrawal by Subject|4
7178960|NCT01740297|11379950|FG001|Overall Study|Withdrawal by Subject|16
7178961|NCT01740297|11379951|FG002|Overall Study|Withdrawal by Subject|17
7178962|NCT01740297|11379949|FG000|Overall Study|Death|8
7178963|NCT01740297|11379950|FG001|Overall Study|Death|46
7178964|NCT01740297|11379951|FG002|Overall Study|Death|40
7178965|NCT01740297|11379949|FG000|Overall Study|Lost to Follow-up|1
7178966|NCT01740297|11379950|FG001|Overall Study|Lost to Follow-up|2
7178967|NCT01740297|11379951|FG002|Overall Study|Lost to Follow-up|4
7186576|NCT02431702|11387000|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6
7178968|NCT01729754|11379965|FG000|Part 1|Adverse Event|2
7178969|NCT01729754|11379966|FG001|Part 1|Adverse Event|0
7178970|NCT01729754|11379967|FG002|Part 1|Adverse Event|0
7178971|NCT01729754|11379968|FG003|Part 1|Adverse Event|1
7178972|NCT01729754|11379969|FG004|Part 1|Adverse Event|0
7178973|NCT01729754|11379970|FG005|Part 1|Adverse Event|0
7178974|NCT01729754|11379971|FG006|Part 1|Adverse Event|2
7178975|NCT01729754|11379972|FG007|Part 1|Adverse Event|0
7178976|NCT01729754|11379973|FG008|Part 1|Adverse Event|0
7178977|NCT01729754|11379974|FG009|Part 1|Adverse Event|5
7178978|NCT01729754|11379965|FG000|Part 1|Lack of Efficacy|1
7178979|NCT01729754|11379966|FG001|Part 1|Lack of Efficacy|0
7178980|NCT01729754|11379967|FG002|Part 1|Lack of Efficacy|0
7178981|NCT01729754|11379968|FG003|Part 1|Lack of Efficacy|0
7178982|NCT01729754|11379969|FG004|Part 1|Lack of Efficacy|0
7178983|NCT01729754|11379970|FG005|Part 1|Lack of Efficacy|0
7178984|NCT01729754|11379971|FG006|Part 1|Lack of Efficacy|2
7178985|NCT01729754|11379972|FG007|Part 1|Lack of Efficacy|0
7178986|NCT01729754|11379973|FG008|Part 1|Lack of Efficacy|0
7178987|NCT01729754|11379974|FG009|Part 1|Lack of Efficacy|0
7178988|NCT01729754|11379965|FG000|Part 1|Lost to Follow-up|1
7178989|NCT01729754|11379966|FG001|Part 1|Lost to Follow-up|0
7178990|NCT01729754|11379967|FG002|Part 1|Lost to Follow-up|0
7178991|NCT01729754|11379968|FG003|Part 1|Lost to Follow-up|2
7178992|NCT01729754|11379969|FG004|Part 1|Lost to Follow-up|0
7178993|NCT01729754|11379970|FG005|Part 1|Lost to Follow-up|0
7178994|NCT01729754|11379971|FG006|Part 1|Lost to Follow-up|3
7178995|NCT01729754|11379972|FG007|Part 1|Lost to Follow-up|0
7178996|NCT01729754|11379973|FG008|Part 1|Lost to Follow-up|0
7178997|NCT01729754|11379974|FG009|Part 1|Lost to Follow-up|3
7178998|NCT01729754|11379965|FG000|Part 1|Non-compliance with Study Drug|1
7178999|NCT01729754|11379966|FG001|Part 1|Non-compliance with Study Drug|0
7179000|NCT01729754|11379967|FG002|Part 1|Non-compliance with Study Drug|0
7179001|NCT01729754|11379968|FG003|Part 1|Non-compliance with Study Drug|0
7179002|NCT01729754|11379969|FG004|Part 1|Non-compliance with Study Drug|0
7179003|NCT01729754|11379970|FG005|Part 1|Non-compliance with Study Drug|0
7179004|NCT01729754|11379971|FG006|Part 1|Non-compliance with Study Drug|0
7179005|NCT01729754|11379972|FG007|Part 1|Non-compliance with Study Drug|0
7179006|NCT01729754|11379973|FG008|Part 1|Non-compliance with Study Drug|0
7179007|NCT01729754|11379974|FG009|Part 1|Non-compliance with Study Drug|0
7179008|NCT01729754|11379965|FG000|Part 1|Physician Decision|0
7179009|NCT01729754|11379966|FG001|Part 1|Physician Decision|0
7179010|NCT01729754|11379967|FG002|Part 1|Physician Decision|0
7179011|NCT01729754|11379968|FG003|Part 1|Physician Decision|0
7179012|NCT01729754|11379969|FG004|Part 1|Physician Decision|0
7179013|NCT01729754|11379970|FG005|Part 1|Physician Decision|0
7179014|NCT01729754|11379971|FG006|Part 1|Physician Decision|0
7179015|NCT01729754|11379972|FG007|Part 1|Physician Decision|0
7179016|NCT01729754|11379973|FG008|Part 1|Physician Decision|0
7179017|NCT01729754|11379974|FG009|Part 1|Physician Decision|4
7179018|NCT01729754|11379965|FG000|Part 1|Pregnancy|0
7179019|NCT01729754|11379966|FG001|Part 1|Pregnancy|0
7179020|NCT01729754|11379967|FG002|Part 1|Pregnancy|0
7179021|NCT01729754|11379968|FG003|Part 1|Pregnancy|1
7179022|NCT01729754|11379969|FG004|Part 1|Pregnancy|0
7179023|NCT01729754|11379970|FG005|Part 1|Pregnancy|0
7179024|NCT01729754|11379971|FG006|Part 1|Pregnancy|0
7179025|NCT01729754|11379972|FG007|Part 1|Pregnancy|0
7179026|NCT01729754|11379973|FG008|Part 1|Pregnancy|0
7179027|NCT01729754|11379974|FG009|Part 1|Pregnancy|1
7179028|NCT01729754|11379965|FG000|Part 1|Progressive Disease|0
7179029|NCT01729754|11379966|FG001|Part 1|Progressive Disease|0
7179030|NCT01729754|11379967|FG002|Part 1|Progressive Disease|0
7179031|NCT01729754|11379968|FG003|Part 1|Progressive Disease|0
7179032|NCT01729754|11379969|FG004|Part 1|Progressive Disease|0
7179033|NCT01729754|11379970|FG005|Part 1|Progressive Disease|0
7179034|NCT01729754|11379971|FG006|Part 1|Progressive Disease|0
7179035|NCT01729754|11379972|FG007|Part 1|Progressive Disease|0
7179036|NCT01729754|11379973|FG008|Part 1|Progressive Disease|0
7179037|NCT01729754|11379974|FG009|Part 1|Progressive Disease|1
7179038|NCT01729754|11379965|FG000|Part 1|Protocol Violation|2
7179039|NCT01729754|11379966|FG001|Part 1|Protocol Violation|0
7179040|NCT01729754|11379967|FG002|Part 1|Protocol Violation|0
7179041|NCT01729754|11379968|FG003|Part 1|Protocol Violation|1
7179042|NCT01729754|11379969|FG004|Part 1|Protocol Violation|0
7179043|NCT01729754|11379970|FG005|Part 1|Protocol Violation|0
7179044|NCT01729754|11379971|FG006|Part 1|Protocol Violation|1
7179045|NCT01729754|11379972|FG007|Part 1|Protocol Violation|0
7179046|NCT01729754|11379973|FG008|Part 1|Protocol Violation|0
7179047|NCT01729754|11379974|FG009|Part 1|Protocol Violation|0
7179048|NCT01729754|11379965|FG000|Part 1|Withdrawal by Subject|5
7179049|NCT01729754|11379966|FG001|Part 1|Withdrawal by Subject|0
7179050|NCT01729754|11379967|FG002|Part 1|Withdrawal by Subject|0
7179051|NCT01729754|11379968|FG003|Part 1|Withdrawal by Subject|7
7179052|NCT01729754|11379969|FG004|Part 1|Withdrawal by Subject|0
7179053|NCT01729754|11379970|FG005|Part 1|Withdrawal by Subject|0
7179054|NCT01729754|11379971|FG006|Part 1|Withdrawal by Subject|5
7179055|NCT01729754|11379972|FG007|Part 1|Withdrawal by Subject|0
7179056|NCT01729754|11379973|FG008|Part 1|Withdrawal by Subject|0
7179057|NCT01729754|11379974|FG009|Part 1|Withdrawal by Subject|6
7179058|NCT01729754|11379965|FG000|Part 1|Other Protocol Specified Criteria|2
7179059|NCT01729754|11379966|FG001|Part 1|Other Protocol Specified Criteria|0
7179060|NCT01729754|11379967|FG002|Part 1|Other Protocol Specified Criteria|0
7179061|NCT01729754|11379968|FG003|Part 1|Other Protocol Specified Criteria|0
7179062|NCT01729754|11379969|FG004|Part 1|Other Protocol Specified Criteria|0
7179063|NCT01729754|11379970|FG005|Part 1|Other Protocol Specified Criteria|0
7179064|NCT01729754|11379971|FG006|Part 1|Other Protocol Specified Criteria|1
7179065|NCT01729754|11379972|FG007|Part 1|Other Protocol Specified Criteria|0
7179066|NCT01729754|11379973|FG008|Part 1|Other Protocol Specified Criteria|0
7179067|NCT01729754|11379974|FG009|Part 1|Other Protocol Specified Criteria|4
7179068|NCT01729754|11379965|FG000|Part 2|Adverse Event|2
7179069|NCT01729754|11379966|FG001|Part 2|Adverse Event|0
7179070|NCT01729754|11379967|FG002|Part 2|Adverse Event|0
7179071|NCT01729754|11379968|FG003|Part 2|Adverse Event|0
7179072|NCT01729754|11379969|FG004|Part 2|Adverse Event|0
7179073|NCT01729754|11379970|FG005|Part 2|Adverse Event|0
7179074|NCT01729754|11379971|FG006|Part 2|Adverse Event|0
7179075|NCT01729754|11379972|FG007|Part 2|Adverse Event|0
7179076|NCT01729754|11379973|FG008|Part 2|Adverse Event|1
7179077|NCT01729754|11379974|FG009|Part 2|Adverse Event|2
7179078|NCT01729754|11379965|FG000|Part 2|Lack of Efficacy|0
7179079|NCT01729754|11379966|FG001|Part 2|Lack of Efficacy|0
7179080|NCT01729754|11379967|FG002|Part 2|Lack of Efficacy|0
7179081|NCT01729754|11379968|FG003|Part 2|Lack of Efficacy|0
7179082|NCT01729754|11379969|FG004|Part 2|Lack of Efficacy|0
7179083|NCT01729754|11379970|FG005|Part 2|Lack of Efficacy|0
7179084|NCT01729754|11379971|FG006|Part 2|Lack of Efficacy|0
7179085|NCT01729754|11379972|FG007|Part 2|Lack of Efficacy|0
7179086|NCT01729754|11379973|FG008|Part 2|Lack of Efficacy|2
7179087|NCT01729754|11379974|FG009|Part 2|Lack of Efficacy|2
7179088|NCT01729754|11379965|FG000|Part 2|Lost to Follow-up|0
7179089|NCT01729754|11379966|FG001|Part 2|Lost to Follow-up|0
7179090|NCT01729754|11379967|FG002|Part 2|Lost to Follow-up|0
7179091|NCT01729754|11379968|FG003|Part 2|Lost to Follow-up|2
7179092|NCT01729754|11379969|FG004|Part 2|Lost to Follow-up|0
7179093|NCT01729754|11379970|FG005|Part 2|Lost to Follow-up|0
7179094|NCT01729754|11379971|FG006|Part 2|Lost to Follow-up|0
7179095|NCT01729754|11379972|FG007|Part 2|Lost to Follow-up|1
7179096|NCT01729754|11379973|FG008|Part 2|Lost to Follow-up|0
7179097|NCT01729754|11379974|FG009|Part 2|Lost to Follow-up|2
7179098|NCT01729754|11379965|FG000|Part 2|Non-Compliance with Study Drug|0
7179099|NCT01729754|11379966|FG001|Part 2|Non-Compliance with Study Drug|0
7179100|NCT01729754|11379967|FG002|Part 2|Non-Compliance with Study Drug|0
7179101|NCT01729754|11379968|FG003|Part 2|Non-Compliance with Study Drug|0
7179102|NCT01729754|11379969|FG004|Part 2|Non-Compliance with Study Drug|0
7179103|NCT01729754|11379970|FG005|Part 2|Non-Compliance with Study Drug|0
7179104|NCT01729754|11379971|FG006|Part 2|Non-Compliance with Study Drug|0
7179105|NCT01729754|11379972|FG007|Part 2|Non-Compliance with Study Drug|0
6895881|NCT00628758|10914068|FG001|Overall Study|Adverse Event|3
7179106|NCT01729754|11379973|FG008|Part 2|Non-Compliance with Study Drug|0
7179107|NCT01729754|11379974|FG009|Part 2|Non-Compliance with Study Drug|1
7179108|NCT01729754|11379965|FG000|Part 2|Pregnancy|0
7179109|NCT01729754|11379966|FG001|Part 2|Pregnancy|0
7179110|NCT01729754|11379967|FG002|Part 2|Pregnancy|0
7179111|NCT01729754|11379968|FG003|Part 2|Pregnancy|1
7179112|NCT01729754|11379969|FG004|Part 2|Pregnancy|0
7179113|NCT01729754|11379970|FG005|Part 2|Pregnancy|0
7179114|NCT01729754|11379971|FG006|Part 2|Pregnancy|0
7179115|NCT01729754|11379972|FG007|Part 2|Pregnancy|0
6895882|NCT00628758|10914067|FG000|Overall Study|Withdrawal by Subject|6
7179116|NCT01729754|11379973|FG008|Part 2|Pregnancy|0
7179117|NCT01729754|11379974|FG009|Part 2|Pregnancy|1
7179118|NCT01729754|11379965|FG000|Part 2|Withdrawal by Subject|3
7179119|NCT01729754|11379966|FG001|Part 2|Withdrawal by Subject|0
7179120|NCT01729754|11379967|FG002|Part 2|Withdrawal by Subject|0
7179121|NCT01729754|11379968|FG003|Part 2|Withdrawal by Subject|2
7179122|NCT01729754|11379969|FG004|Part 2|Withdrawal by Subject|0
7179123|NCT01729754|11379970|FG005|Part 2|Withdrawal by Subject|0
7179124|NCT01729754|11379971|FG006|Part 2|Withdrawal by Subject|0
7179125|NCT01729754|11379972|FG007|Part 2|Withdrawal by Subject|1
7179126|NCT01729754|11379973|FG008|Part 2|Withdrawal by Subject|1
7179127|NCT01729754|11379974|FG009|Part 2|Withdrawal by Subject|4
7179128|NCT01729754|11379965|FG000|Part 2|Other Protocol Specified Criteria|1
7179129|NCT01729754|11379966|FG001|Part 2|Other Protocol Specified Criteria|0
7179130|NCT01729754|11379967|FG002|Part 2|Other Protocol Specified Criteria|0
7179131|NCT01729754|11379968|FG003|Part 2|Other Protocol Specified Criteria|0
7179132|NCT01729754|11379969|FG004|Part 2|Other Protocol Specified Criteria|0
7179133|NCT01729754|11379970|FG005|Part 2|Other Protocol Specified Criteria|0
7179134|NCT01729754|11379971|FG006|Part 2|Other Protocol Specified Criteria|0
7179135|NCT01729754|11379972|FG007|Part 2|Other Protocol Specified Criteria|1
7179136|NCT01729754|11379973|FG008|Part 2|Other Protocol Specified Criteria|0
7179137|NCT01729754|11379974|FG009|Part 2|Other Protocol Specified Criteria|0
7179138|NCT01729754|11379965|FG000|Part 3|Adverse Event|0
7179139|NCT01729754|11379966|FG001|Part 3|Adverse Event|0
7179140|NCT01729754|11379967|FG002|Part 3|Adverse Event|1
7179141|NCT01729754|11379968|FG003|Part 3|Adverse Event|0
7179142|NCT01729754|11379969|FG004|Part 3|Adverse Event|0
7179143|NCT01729754|11379970|FG005|Part 3|Adverse Event|5
7179144|NCT01729754|11379971|FG006|Part 3|Adverse Event|0
7179145|NCT01729754|11379972|FG007|Part 3|Adverse Event|0
7179146|NCT01729754|11379973|FG008|Part 3|Adverse Event|0
7179147|NCT01729754|11379974|FG009|Part 3|Adverse Event|3
7179148|NCT01729754|11379965|FG000|Part 3|Death|0
7179149|NCT01729754|11379966|FG001|Part 3|Death|0
7179150|NCT01729754|11379967|FG002|Part 3|Death|0
7179151|NCT01729754|11379968|FG003|Part 3|Death|0
7179152|NCT01729754|11379969|FG004|Part 3|Death|0
7179153|NCT01729754|11379970|FG005|Part 3|Death|2
7179154|NCT01729754|11379971|FG006|Part 3|Death|0
7179155|NCT01729754|11379972|FG007|Part 3|Death|0
7179156|NCT01729754|11379973|FG008|Part 3|Death|0
7179157|NCT01729754|11379974|FG009|Part 3|Death|0
7179158|NCT01729754|11379965|FG000|Part 3|Lack of Efficacy|0
7179159|NCT01729754|11379966|FG001|Part 3|Lack of Efficacy|0
7179160|NCT01729754|11379967|FG002|Part 3|Lack of Efficacy|0
7179161|NCT01729754|11379968|FG003|Part 3|Lack of Efficacy|0
7179162|NCT01729754|11379969|FG004|Part 3|Lack of Efficacy|2
7179163|NCT01729754|11379970|FG005|Part 3|Lack of Efficacy|0
7179164|NCT01729754|11379971|FG006|Part 3|Lack of Efficacy|0
7179165|NCT01729754|11379972|FG007|Part 3|Lack of Efficacy|0
7179166|NCT01729754|11379973|FG008|Part 3|Lack of Efficacy|0
7179167|NCT01729754|11379974|FG009|Part 3|Lack of Efficacy|4
7179168|NCT01729754|11379965|FG000|Part 3|Lost to Follow-up|0
7179169|NCT01729754|11379966|FG001|Part 3|Lost to Follow-up|1
7179170|NCT01729754|11379967|FG002|Part 3|Lost to Follow-up|2
7179171|NCT01729754|11379968|FG003|Part 3|Lost to Follow-up|0
7179172|NCT01729754|11379969|FG004|Part 3|Lost to Follow-up|0
7179173|NCT01729754|11379970|FG005|Part 3|Lost to Follow-up|3
7179174|NCT01729754|11379971|FG006|Part 3|Lost to Follow-up|0
7179175|NCT01729754|11379972|FG007|Part 3|Lost to Follow-up|0
7179176|NCT01729754|11379973|FG008|Part 3|Lost to Follow-up|1
7179177|NCT01729754|11379974|FG009|Part 3|Lost to Follow-up|0
7179178|NCT01729754|11379965|FG000|Part 3|Physician Decision|0
7179179|NCT01729754|11379966|FG001|Part 3|Physician Decision|0
7179180|NCT01729754|11379967|FG002|Part 3|Physician Decision|1
7179181|NCT01729754|11379968|FG003|Part 3|Physician Decision|0
7179182|NCT01729754|11379969|FG004|Part 3|Physician Decision|0
7179183|NCT01729754|11379970|FG005|Part 3|Physician Decision|0
7179184|NCT01729754|11379971|FG006|Part 3|Physician Decision|0
7179185|NCT01729754|11379972|FG007|Part 3|Physician Decision|0
7179186|NCT01729754|11379973|FG008|Part 3|Physician Decision|0
7179187|NCT01729754|11379974|FG009|Part 3|Physician Decision|0
7179188|NCT01729754|11379965|FG000|Part 3|Withdrawal by Subject|0
7179189|NCT01729754|11379966|FG001|Part 3|Withdrawal by Subject|4
7179190|NCT01729754|11379967|FG002|Part 3|Withdrawal by Subject|1
7179191|NCT01729754|11379968|FG003|Part 3|Withdrawal by Subject|0
7179192|NCT01729754|11379969|FG004|Part 3|Withdrawal by Subject|2
7179193|NCT01729754|11379970|FG005|Part 3|Withdrawal by Subject|1
7179194|NCT01729754|11379971|FG006|Part 3|Withdrawal by Subject|0
7179195|NCT01729754|11379972|FG007|Part 3|Withdrawal by Subject|2
7179196|NCT01729754|11379973|FG008|Part 3|Withdrawal by Subject|0
7179197|NCT01729754|11379974|FG009|Part 3|Withdrawal by Subject|0
7179198|NCT01729754|11379965|FG000|Part 3|Other Protocol Specified Criteria|0
7179199|NCT01729754|11379966|FG001|Part 3|Other Protocol Specified Criteria|0
7179200|NCT01729754|11379967|FG002|Part 3|Other Protocol Specified Criteria|0
7179201|NCT01729754|11379968|FG003|Part 3|Other Protocol Specified Criteria|0
7179202|NCT01729754|11379969|FG004|Part 3|Other Protocol Specified Criteria|0
7179203|NCT01729754|11379970|FG005|Part 3|Other Protocol Specified Criteria|2
7179204|NCT01729754|11379971|FG006|Part 3|Other Protocol Specified Criteria|0
7179205|NCT01729754|11379972|FG007|Part 3|Other Protocol Specified Criteria|1
7179206|NCT01729754|11379973|FG008|Part 3|Other Protocol Specified Criteria|0
7179207|NCT01729754|11379974|FG009|Part 3|Other Protocol Specified Criteria|0
7179208|NCT01668784|11380017|FG000|Randomized (Pre-treatment)|Disease Progression|0
7179209|NCT01668784|11380018|FG001|Randomized (Pre-treatment)|Disease Progression|1
7179210|NCT01668784|11380017|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0
7179211|NCT01668784|11380018|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3
7179212|NCT01668784|11380017|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1
7179213|NCT01668784|11380018|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8
7179214|NCT01668784|11380017|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1
7179215|NCT01668784|11380018|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0
7179216|NCT01668784|11380017|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2
7179217|NCT01668784|11380018|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1
7179218|NCT01668784|11380017|FG000|Randomized (Pre-treatment)|Other|0
7179219|NCT01668784|11380018|FG001|Randomized (Pre-treatment)|Other|1
7179220|NCT01668784|11380017|FG000|Treated (Overall)|Disease Progression|285
7179221|NCT01668784|11380018|FG001|Treated (Overall)|Disease Progression|273
7179222|NCT01668784|11380017|FG000|Treated (Overall)|Study Drug Toxicity|35
7179223|NCT01668784|11380018|FG001|Treated (Overall)|Study Drug Toxicity|53
7179224|NCT01668784|11380017|FG000|Treated (Overall)|Death|1
7179225|NCT01668784|11380018|FG001|Treated (Overall)|Death|1
7179226|NCT01668784|11380017|FG000|Treated (Overall)|Adverse Event Unrelated to Study Drug|9
7179227|NCT01668784|11380018|FG001|Treated (Overall)|Adverse Event Unrelated to Study Drug|14
7179228|NCT01668784|11380017|FG000|Treated (Overall)|Request to Discontinue Study Treatment|5
7179229|NCT01668784|11380018|FG001|Treated (Overall)|Request to Discontinue Study Treatment|18
7179230|NCT01668784|11380017|FG000|Treated (Overall)|Withdrawal by Subject|2
6895883|NCT00628758|10914068|FG001|Overall Study|Withdrawal by Subject|3
6895884|NCT00628758|10914067|FG000|Overall Study|Death|1
7179231|NCT01668784|11380018|FG001|Treated (Overall)|Withdrawal by Subject|3
7179232|NCT01668784|11380017|FG000|Treated (Overall)|Maximal Clinical Benefit|2
7179233|NCT01668784|11380018|FG001|Treated (Overall)|Maximal Clinical Benefit|3
7179234|NCT01668784|11380017|FG000|Treated (Overall)|Other|0
7179235|NCT01668784|11380018|FG001|Treated (Overall)|Other|4
7179236|NCT01564537|11380039|FG000|Overall Study|Withdrawal by Participant|4
7179237|NCT01564537|11380040|FG001|Overall Study|Withdrawal by Participant|4
7179238|NCT01564537|11380039|FG000|Overall Study|Lost to Follow-up|1
7179239|NCT01564537|11380040|FG001|Overall Study|Lost to Follow-up|0
7179240|NCT01564537|11380039|FG000|Overall Study|Other Miscellaneous Reasons|1
7179241|NCT01564537|11380040|FG001|Overall Study|Other Miscellaneous Reasons|2
7179242|NCT01515306|11380049|FG000|Overall Study|Adverse Event|3
7179243|NCT01515306|11380050|FG001|Overall Study|Adverse Event|2
7179244|NCT01515306|11380049|FG000|Overall Study|Progressive Disease|19
7179245|NCT01515306|11380050|FG001|Overall Study|Progressive Disease|9
7179246|NCT01515306|11380049|FG000|Overall Study|Withdrawal by Subject|1
7179247|NCT01515306|11380050|FG001|Overall Study|Withdrawal by Subject|2
7179248|NCT01515306|11380049|FG000|Overall Study|Physician Decision|1
7179249|NCT01515306|11380050|FG001|Overall Study|Physician Decision|1
7179250|NCT01423851|11380071|FG000|Whole Study|Disease progression|2
7179251|NCT01423851|11380072|FG001|Whole Study|Disease progression|1
7179252|NCT01423851|11380073|FG002|Whole Study|Disease progression|1
7179253|NCT01423851|11380074|FG003|Whole Study|Disease progression|4
7179254|NCT01423851|11380075|FG004|Whole Study|Disease progression|1
7179255|NCT01423851|11380076|FG005|Whole Study|Disease progression|3
7179256|NCT01423851|11380077|FG006|Whole Study|Disease progression|1
7179257|NCT01423851|11380078|FG007|Whole Study|Disease progression|4
7179258|NCT01423851|11380079|FG008|Whole Study|Disease progression|0
6895885|NCT00628758|10914068|FG001|Overall Study|Death|0
6895886|NCT00628758|10914067|FG000|Overall Study|Protocol Violation|5
6895887|NCT00628758|10914068|FG001|Overall Study|Protocol Violation|1
6895888|NCT00628758|10914067|FG000|Overall Study|Lost to Follow-up|25
6895889|NCT00628758|10914068|FG001|Overall Study|Lost to Follow-up|31
6895890|NCT00628758|10914067|FG000|Overall Study|Pregnancy|2
6895891|NCT00628758|10914068|FG001|Overall Study|Pregnancy|2
6895892|NCT00628758|10914067|FG000|Overall Study|Investigator Moved|3
6895893|NCT00628758|10914068|FG001|Overall Study|Investigator Moved|0
6895894|NCT00628758|10914067|FG000|Overall Study|Treatment Failure|0
6895895|NCT00628758|10914068|FG001|Overall Study|Treatment Failure|2
6895896|NCT00628862|10914079|FG000|Overall Study|Adverse Event|6
6895897|NCT00628862|10914080|FG001|Overall Study|Adverse Event|8
6895898|NCT00628862|10914081|FG002|Overall Study|Adverse Event|10
6895899|NCT00628862|10914079|FG000|Overall Study|Withdrawal by Subject|4
6895900|NCT00628862|10914080|FG001|Overall Study|Withdrawal by Subject|6
6895901|NCT00628862|10914081|FG002|Overall Study|Withdrawal by Subject|11
6895902|NCT00628862|10914079|FG000|Overall Study|Lost to Follow-up|0
6895903|NCT00628862|10914080|FG001|Overall Study|Lost to Follow-up|2
6895904|NCT00628862|10914081|FG002|Overall Study|Lost to Follow-up|1
6895905|NCT00628862|10914079|FG000|Overall Study|Protocol Violation|1
6895906|NCT00628862|10914080|FG001|Overall Study|Protocol Violation|0
7179259|NCT01423851|11380080|FG009|Whole Study|Disease progression|2
7179260|NCT01423851|11380081|FG010|Whole Study|Disease progression|10
7179261|NCT01423851|11380071|FG000|Whole Study|Physician Decision|0
7179262|NCT01423851|11380072|FG001|Whole Study|Physician Decision|1
7179263|NCT01423851|11380073|FG002|Whole Study|Physician Decision|2
7179264|NCT01423851|11380074|FG003|Whole Study|Physician Decision|0
7179265|NCT01423851|11380075|FG004|Whole Study|Physician Decision|2
6895907|NCT00628862|10914081|FG002|Overall Study|Protocol Violation|0
6895908|NCT00628862|10914079|FG000|Overall Study|COPD Exacerbation|0
6895909|NCT00628862|10914080|FG001|Overall Study|COPD Exacerbation|1
6895910|NCT00628862|10914081|FG002|Overall Study|COPD Exacerbation|0
6895911|NCT00628927|10914100|FG000|Overall Study|Problems performing blood draw|6
6895912|NCT00628927|10914101|FG001|Overall Study|Problems performing blood draw|0
7179266|NCT01423851|11380076|FG005|Whole Study|Physician Decision|0
7179267|NCT01423851|11380077|FG006|Whole Study|Physician Decision|2
6895913|NCT00628927|10914100|FG000|Overall Study|Lost to Follow-up|1
6895914|NCT00628927|10914101|FG001|Overall Study|Lost to Follow-up|0
6895915|NCT00628927|10914100|FG000|Overall Study|Equipment failure|1
6895916|NCT00628927|10914101|FG001|Overall Study|Equipment failure|0
6895917|NCT00629083|10914123|FG000|Overall Study|Adverse Event|0
6895918|NCT00629083|10914124|FG001|Overall Study|Adverse Event|2
6895919|NCT00629083|10914123|FG000|Overall Study|Lack of Efficacy|3
6895920|NCT00629083|10914124|FG001|Overall Study|Lack of Efficacy|1
6895921|NCT00629083|10914123|FG000|Overall Study|Withdrawal by Subject|10
6895922|NCT00629083|10914124|FG001|Overall Study|Withdrawal by Subject|2
6895923|NCT00629083|10914123|FG000|Overall Study|Lost to Follow-up|12
6895924|NCT00629083|10914124|FG001|Overall Study|Lost to Follow-up|8
6895925|NCT00629083|10914123|FG000|Overall Study|Moved out of country/state|2
6895926|NCT00629083|10914124|FG001|Overall Study|Moved out of country/state|1
6895927|NCT00629083|10914123|FG000|Overall Study|Refused to return for 12 month visit|1
6895928|NCT00629083|10914124|FG001|Overall Study|Refused to return for 12 month visit|0
6895929|NCT00629239|10914143|FG000|Overall Study|Adverse Event|7
6895930|NCT00629239|10914144|FG001|Overall Study|Adverse Event|4
6895931|NCT00629239|10914143|FG000|Overall Study|Physician Decision|1
7179268|NCT01423851|11380078|FG007|Whole Study|Physician Decision|1
7179269|NCT01423851|11380079|FG008|Whole Study|Physician Decision|3
7179270|NCT01423851|11380080|FG009|Whole Study|Physician Decision|4
7179271|NCT01423851|11380081|FG010|Whole Study|Physician Decision|12
7179272|NCT01423851|11380071|FG000|Whole Study|Withdrawal by Subject|1
7179273|NCT01423851|11380072|FG001|Whole Study|Withdrawal by Subject|1
7179274|NCT01423851|11380073|FG002|Whole Study|Withdrawal by Subject|0
7179275|NCT01423851|11380074|FG003|Whole Study|Withdrawal by Subject|0
7179276|NCT01423851|11380075|FG004|Whole Study|Withdrawal by Subject|0
7179277|NCT01423851|11380076|FG005|Whole Study|Withdrawal by Subject|0
7179278|NCT01423851|11380077|FG006|Whole Study|Withdrawal by Subject|0
7179279|NCT01423851|11380078|FG007|Whole Study|Withdrawal by Subject|0
7179280|NCT01423851|11380079|FG008|Whole Study|Withdrawal by Subject|2
7179281|NCT01423851|11380080|FG009|Whole Study|Withdrawal by Subject|0
7179282|NCT01423851|11380081|FG010|Whole Study|Withdrawal by Subject|4
7179283|NCT01423851|11380071|FG000|Whole Study|Adverse Event|0
7179284|NCT01423851|11380072|FG001|Whole Study|Adverse Event|0
7179285|NCT01423851|11380073|FG002|Whole Study|Adverse Event|0
7179286|NCT01423851|11380074|FG003|Whole Study|Adverse Event|2
7179287|NCT01423851|11380075|FG004|Whole Study|Adverse Event|0
7179288|NCT01423851|11380076|FG005|Whole Study|Adverse Event|0
7179289|NCT01423851|11380077|FG006|Whole Study|Adverse Event|0
7179290|NCT01423851|11380078|FG007|Whole Study|Adverse Event|3
7179291|NCT01423851|11380079|FG008|Whole Study|Adverse Event|3
7179292|NCT01423851|11380080|FG009|Whole Study|Adverse Event|2
7179293|NCT01423851|11380081|FG010|Whole Study|Adverse Event|3
7179294|NCT01385176|11380112|FG000|Randomization Phase|Death|1
7179295|NCT01385176|11380113|FG001|Randomization Phase|Death|2
7179296|NCT01385176|11380112|FG000|6-18 Month All VNS Active|Death|1
7179297|NCT01385176|11380113|FG001|6-18 Month All VNS Active|Death|2
7179298|NCT01385176|11380112|FG000|6-18 Month All VNS Active|Physician Decision|0
7179299|NCT01385176|11380113|FG001|6-18 Month All VNS Active|Physician Decision|1
7179300|NCT01385176|11380112|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2
7179301|NCT01385176|11380113|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0
7179302|NCT01385176|11380112|FG000|6-18 Month All VNS Active|Heart Transplant|1
7179303|NCT01385176|11380113|FG001|6-18 Month All VNS Active|Heart Transplant|0
7179304|NCT01334606|11380137|FG000|Overall Study|Study Terminated due to slow enrolment|18
7179305|NCT01317875|11380153|FG000|Overall Study|Other|0
7179306|NCT01317875|11380154|FG001|Overall Study|Other|0
7179307|NCT01317875|11380155|FG002|Overall Study|Other|1
7179308|NCT01317875|11380156|FG003|Overall Study|Other|0
7179309|NCT01317875|11380157|FG004|Overall Study|Other|0
7179310|NCT01317875|11380158|FG005|Overall Study|Other|0
7179311|NCT01317875|11380159|FG006|Overall Study|Other|0
7179312|NCT01317875|11380160|FG007|Overall Study|Other|0
7179313|NCT01317875|11380161|FG008|Overall Study|Other|0
7179314|NCT01317875|11380162|FG009|Overall Study|Other|0
6895932|NCT00629239|10914144|FG001|Overall Study|Physician Decision|0
6895933|NCT00629265|10914152|FG000|Overall Study|Lost to Follow-up|4
6895934|NCT00629265|10914153|FG001|Overall Study|Lost to Follow-up|5
6895935|NCT00629265|10914152|FG000|Overall Study|Withdrawal by Subject|11
6895936|NCT00629265|10914153|FG001|Overall Study|Withdrawal by Subject|8
6895937|NCT00629265|10914152|FG000|Overall Study|Death|1
6895938|NCT00629265|10914153|FG001|Overall Study|Death|0
6895939|NCT00629265|10914152|FG000|Overall Study|Adverse Event|2
6895940|NCT00629265|10914153|FG001|Overall Study|Adverse Event|0
6895941|NCT00629265|10914152|FG000|Overall Study|HNC Recurrence|4
6895942|NCT00629265|10914153|FG001|Overall Study|HNC Recurrence|0
6895943|NCT00629265|10914152|FG000|Overall Study|Other CA Requiring Treatment|1
6895944|NCT00629265|10914153|FG001|Overall Study|Other CA Requiring Treatment|3
7179315|NCT01317875|11380153|FG000|Overall Study|Noncompliance with study drug|0
7179316|NCT01317875|11380154|FG001|Overall Study|Noncompliance with study drug|0
7179317|NCT01317875|11380155|FG002|Overall Study|Noncompliance with study drug|1
6895945|NCT00629265|10914152|FG000|Overall Study|Needed Esophageal Dilation|4
7179318|NCT01317875|11380156|FG003|Overall Study|Noncompliance with study drug|0
7179319|NCT01317875|11380157|FG004|Overall Study|Noncompliance with study drug|0
7179320|NCT01317875|11380158|FG005|Overall Study|Noncompliance with study drug|0
7179321|NCT01317875|11380159|FG006|Overall Study|Noncompliance with study drug|0
7179322|NCT01317875|11380160|FG007|Overall Study|Noncompliance with study drug|0
7179323|NCT01317875|11380161|FG008|Overall Study|Noncompliance with study drug|0
7179324|NCT01317875|11380162|FG009|Overall Study|Noncompliance with study drug|0
7179325|NCT01317875|11380153|FG000|Overall Study|Progressive Disease|1
7179326|NCT01317875|11380154|FG001|Overall Study|Progressive Disease|0
7179327|NCT01317875|11380155|FG002|Overall Study|Progressive Disease|2
7179328|NCT01317875|11380156|FG003|Overall Study|Progressive Disease|0
7179329|NCT01317875|11380157|FG004|Overall Study|Progressive Disease|1
7179330|NCT01317875|11380158|FG005|Overall Study|Progressive Disease|0
7179331|NCT01317875|11380159|FG006|Overall Study|Progressive Disease|0
7179332|NCT01317875|11380160|FG007|Overall Study|Progressive Disease|1
7179333|NCT01317875|11380161|FG008|Overall Study|Progressive Disease|0
7179334|NCT01317875|11380162|FG009|Overall Study|Progressive Disease|0
7179335|NCT01317875|11380153|FG000|Overall Study|Withdrawal by Subject|0
7179336|NCT01317875|11380154|FG001|Overall Study|Withdrawal by Subject|0
7179337|NCT01317875|11380155|FG002|Overall Study|Withdrawal by Subject|0
7179338|NCT01317875|11380156|FG003|Overall Study|Withdrawal by Subject|0
7179339|NCT01317875|11380157|FG004|Overall Study|Withdrawal by Subject|1
7179340|NCT01317875|11380158|FG005|Overall Study|Withdrawal by Subject|0
7179341|NCT01317875|11380159|FG006|Overall Study|Withdrawal by Subject|0
7179342|NCT01317875|11380160|FG007|Overall Study|Withdrawal by Subject|3
7179343|NCT01317875|11380161|FG008|Overall Study|Withdrawal by Subject|0
7179344|NCT01317875|11380162|FG009|Overall Study|Withdrawal by Subject|0
7179345|NCT01317875|11380153|FG000|Overall Study|Physician Decision|0
7179346|NCT01317875|11380154|FG001|Overall Study|Physician Decision|1
7179347|NCT01317875|11380155|FG002|Overall Study|Physician Decision|1
7179348|NCT01317875|11380156|FG003|Overall Study|Physician Decision|0
7179349|NCT01317875|11380157|FG004|Overall Study|Physician Decision|2
7179350|NCT01317875|11380158|FG005|Overall Study|Physician Decision|0
7179351|NCT01317875|11380159|FG006|Overall Study|Physician Decision|0
7179352|NCT01317875|11380160|FG007|Overall Study|Physician Decision|2
7179353|NCT01317875|11380161|FG008|Overall Study|Physician Decision|0
7179354|NCT01317875|11380162|FG009|Overall Study|Physician Decision|0
7179355|NCT01317875|11380153|FG000|Overall Study|Death|0
7179356|NCT01317875|11380154|FG001|Overall Study|Death|0
7179357|NCT01317875|11380155|FG002|Overall Study|Death|2
7179358|NCT01317875|11380156|FG003|Overall Study|Death|1
7179359|NCT01317875|11380157|FG004|Overall Study|Death|0
7179360|NCT01317875|11380158|FG005|Overall Study|Death|1
7179361|NCT01317875|11380159|FG006|Overall Study|Death|0
7179362|NCT01317875|11380160|FG007|Overall Study|Death|4
7179363|NCT01317875|11380161|FG008|Overall Study|Death|0
7179364|NCT01317875|11380162|FG009|Overall Study|Death|0
7179365|NCT01317875|11380153|FG000|Overall Study|Adverse Event|2
7179366|NCT01317875|11380154|FG001|Overall Study|Adverse Event|1
7179367|NCT01317875|11380155|FG002|Overall Study|Adverse Event|2
7179368|NCT01317875|11380156|FG003|Overall Study|Adverse Event|1
7179369|NCT01317875|11380157|FG004|Overall Study|Adverse Event|5
7179370|NCT01317875|11380158|FG005|Overall Study|Adverse Event|1
7179371|NCT01317875|11380159|FG006|Overall Study|Adverse Event|2
7179372|NCT01317875|11380160|FG007|Overall Study|Adverse Event|5
7179373|NCT01317875|11380161|FG008|Overall Study|Adverse Event|0
7179374|NCT01317875|11380162|FG009|Overall Study|Adverse Event|0
7179375|NCT01216683|11380227|FG000|Induction|Never started treatment|0
7179376|NCT01216683|11380228|FG001|Induction|Never started treatment|6
7179377|NCT01216683|11380229|FG002|Induction|Never started treatment|3
7179378|NCT01216683|11380227|FG000|Induction|Lack of Efficacy|4
7179379|NCT01216683|11380228|FG001|Induction|Lack of Efficacy|3
7179380|NCT01216683|11380229|FG002|Induction|Lack of Efficacy|7
7179381|NCT01216683|11380227|FG000|Induction|Adverse Event|0
7179382|NCT01216683|11380228|FG001|Induction|Adverse Event|5
7179383|NCT01216683|11380229|FG002|Induction|Adverse Event|5
7179384|NCT01216683|11380227|FG000|Induction|Death|0
7179385|NCT01216683|11380228|FG001|Induction|Death|0
7179386|NCT01216683|11380229|FG002|Induction|Death|2
7179387|NCT01216683|11380227|FG000|Induction|Withdrawal by Subject|0
7179388|NCT01216683|11380228|FG001|Induction|Withdrawal by Subject|4
7179389|NCT01216683|11380229|FG002|Induction|Withdrawal by Subject|2
7179390|NCT01216683|11380227|FG000|Induction|Other disease|0
7179391|NCT01216683|11380228|FG001|Induction|Other disease|1
7179392|NCT01216683|11380229|FG002|Induction|Other disease|2
7179393|NCT01216683|11380227|FG000|Continuation|Lack of Efficacy|3
7179394|NCT01216683|11380228|FG001|Continuation|Lack of Efficacy|2
7179395|NCT01216683|11380229|FG002|Continuation|Lack of Efficacy|7
7179396|NCT01216683|11380227|FG000|Continuation|Adverse Event|5
7179397|NCT01216683|11380228|FG001|Continuation|Adverse Event|3
7179398|NCT01216683|11380229|FG002|Continuation|Adverse Event|16
7179399|NCT01216683|11380227|FG000|Continuation|Death|1
7179400|NCT01216683|11380228|FG001|Continuation|Death|0
7179401|NCT01216683|11380229|FG002|Continuation|Death|2
7179402|NCT01216683|11380227|FG000|Continuation|Withdrawal by Subject|4
7179403|NCT01216683|11380228|FG001|Continuation|Withdrawal by Subject|5
7179404|NCT01216683|11380229|FG002|Continuation|Withdrawal by Subject|9
7179405|NCT01216683|11380227|FG000|Continuation|Other diseases|0
7179406|NCT01216683|11380228|FG001|Continuation|Other diseases|2
7179407|NCT01216683|11380229|FG002|Continuation|Other diseases|1
7179408|NCT01216683|11380227|FG000|Continuation|Physician Decision|1
7179409|NCT01216683|11380228|FG001|Continuation|Physician Decision|0
7179410|NCT01216683|11380229|FG002|Continuation|Physician Decision|1
7179411|NCT01216683|11380227|FG000|Continuation|Non-compliance|1
7179412|NCT01216683|11380228|FG001|Continuation|Non-compliance|0
7179413|NCT01216683|11380229|FG002|Continuation|Non-compliance|1
7179414|NCT01216683|11380227|FG000|Continuation|Insurance change|0
7179415|NCT01216683|11380228|FG001|Continuation|Insurance change|1
7179416|NCT01216683|11380229|FG002|Continuation|Insurance change|0
7179417|NCT01216683|11380227|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0
7179418|NCT01216683|11380228|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1
7179419|NCT01216683|11380229|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0
7179420|NCT01216683|11380227|FG000|Continuation|Not reported|0
7179421|NCT01216683|11380228|FG001|Continuation|Not reported|0
7179422|NCT01216683|11380229|FG002|Continuation|Not reported|1
7179423|NCT01216683|11380227|FG000|Continuation|Never started treatment|0
7179424|NCT01216683|11380228|FG001|Continuation|Never started treatment|1
7179425|NCT01216683|11380229|FG002|Continuation|Never started treatment|5
7179426|NCT01085097|11380253|FG000|Overall Study|Adverse Event|0
7179427|NCT01085097|11380254|FG001|Overall Study|Adverse Event|0
7179428|NCT01085097|11380255|FG002|Overall Study|Adverse Event|2
7179429|NCT01085097|11380253|FG000|Overall Study|Treatment failure|2
7179430|NCT01085097|11380254|FG001|Overall Study|Treatment failure|0
7179431|NCT01085097|11380255|FG002|Overall Study|Treatment failure|0
7179432|NCT00920621|11380267|FG000|Overall Study|Lost to Follow-up|16
7179433|NCT00920621|11380268|FG001|Overall Study|Lost to Follow-up|17
7179434|NCT00920621|11380269|FG002|Overall Study|Lost to Follow-up|19
7179435|NCT00920621|11380270|FG003|Overall Study|Lost to Follow-up|21
7179436|NCT00920621|11380267|FG000|Overall Study|Fetal/neonatal deaths|16
7179437|NCT00920621|11380268|FG001|Overall Study|Fetal/neonatal deaths|14
7179438|NCT00920621|11380269|FG002|Overall Study|Fetal/neonatal deaths|16
7179439|NCT00920621|11380270|FG003|Overall Study|Fetal/neonatal deaths|14
7179440|NCT00920621|11380267|FG000|Overall Study|Blood sample not collected|22
7179441|NCT00920621|11380268|FG001|Overall Study|Blood sample not collected|14
7179442|NCT00920621|11380269|FG002|Overall Study|Blood sample not collected|0
7179443|NCT00920621|11380270|FG003|Overall Study|Blood sample not collected|0
7179444|NCT00680901|11380287|FG000|Overall Study|Lost to Follow-up|8
7179445|NCT00680901|11380288|FG001|Overall Study|Lost to Follow-up|8
7179446|NCT00680901|11380287|FG000|Overall Study|Withdrawal by Subject|4
7179447|NCT00680901|11380288|FG001|Overall Study|Withdrawal by Subject|13
7179448|NCT00680901|11380287|FG000|Overall Study|Physician Decision|0
7179449|NCT00680901|11380288|FG001|Overall Study|Physician Decision|1
7179450|NCT00680901|11380287|FG000|Overall Study|Ongoing: On Study Treatment|16
7179451|NCT00680901|11380288|FG001|Overall Study|Ongoing: On Study Treatment|13
7179452|NCT00680901|11380287|FG000|Overall Study|Ongoing: In Follow Up|45
7179453|NCT00680901|11380288|FG001|Overall Study|Ongoing: In Follow Up|41
7179454|NCT00667251|11380296|FG000|Overall Study|Adverse Event|13
7179455|NCT00667251|11380297|FG001|Overall Study|Adverse Event|4
7179456|NCT00667251|11380296|FG000|Overall Study|Withdrawal by Subject|6
7179457|NCT00667251|11380297|FG001|Overall Study|Withdrawal by Subject|2
7179458|NCT00667251|11380296|FG000|Overall Study|Other/missing|46
7179459|NCT00667251|11380297|FG001|Overall Study|Other/missing|84
7179460|NCT00667251|11380296|FG000|Overall Study|Intercurrent Illness|4
7179461|NCT00667251|11380297|FG001|Overall Study|Intercurrent Illness|3
7179462|NCT00667251|11380296|FG000|Overall Study|Symptomatic progression|1
7179463|NCT00667251|11380297|FG001|Overall Study|Symptomatic progression|2
7179464|NCT00500071|11380313|FG000|Screening and Washout Phase|Protocol Violation|1
7179465|NCT00500071|11380313|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13
7179466|NCT00500071|11380313|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2
7179467|NCT00500071|11380313|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2
7179468|NCT00500071|11380313|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1
7179469|NCT00500071|11380313|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4
7179470|NCT00500071|11380313|FG000|30-day Safety Follow-up|Lost to Follow-up|17
7179471|NCT00447122|11380321|FG000|Overall Study|worsening medical condition -came off|0
7179472|NCT00447122|11380322|FG001|Overall Study|worsening medical condition -came off|1
7179473|NCT00447122|11380323|FG002|Overall Study|worsening medical condition -came off|0
7179474|NCT00447122|11380324|FG003|Overall Study|worsening medical condition -came off|0
7179475|NCT00382252|11380334|FG000|Overall Study|Death|4
7179476|NCT00382252|11380334|FG000|Overall Study|Protocol Violation|8
7179477|NCT00382252|11380334|FG000|Overall Study|Not treated by RFA|1
7179478|NCT00324805|11380340|FG000|Overall Study|Adverse Event|62
7179479|NCT00324805|11380341|FG001|Overall Study|Adverse Event|203
7179480|NCT00324805|11380340|FG000|Overall Study|Progression|7
7179481|NCT00324805|11380341|FG001|Overall Study|Progression|35
7179482|NCT00324805|11380340|FG000|Overall Study|Withdrawal by Subject|51
7179483|NCT00324805|11380341|FG001|Overall Study|Withdrawal by Subject|174
7179484|NCT00324805|11380340|FG000|Overall Study|Death|6
7179485|NCT00324805|11380341|FG001|Overall Study|Death|9
7179486|NCT00324805|11380340|FG000|Overall Study|Alternative therapy|4
7179487|NCT00324805|11380341|FG001|Overall Study|Alternative therapy|8
7179488|NCT00324805|11380340|FG000|Overall Study|Other complicating disease|1
7179489|NCT00324805|11380341|FG001|Overall Study|Other complicating disease|9
7179490|NCT00324805|11380340|FG000|Overall Study|Other reasons|7
7179491|NCT00324805|11380341|FG001|Overall Study|Other reasons|26
7179492|NCT00324805|11380340|FG000|Overall Study|Other|0
7179493|NCT00324805|11380341|FG001|Overall Study|Other|2
7179494|NCT00324805|11380340|FG000|Overall Study|Did not start therapy|12
7179495|NCT00324805|11380341|FG001|Overall Study|Did not start therapy|17
7179496|NCT00309985|11380366|FG000|Overall Study|Disease progression|12
7179497|NCT00309985|11380367|FG001|Overall Study|Disease progression|0
7179498|NCT00309985|11380366|FG000|Overall Study|Adverse Event|30
7179499|NCT00309985|11380367|FG001|Overall Study|Adverse Event|0
7179500|NCT00309985|11380366|FG000|Overall Study|Death|2
7179501|NCT00309985|11380367|FG001|Overall Study|Death|0
7179502|NCT00309985|11380366|FG000|Overall Study|Withdrawal by Subject|5
7179503|NCT00309985|11380367|FG001|Overall Study|Withdrawal by Subject|1
7179504|NCT00309985|11380366|FG000|Overall Study|Physician Decision|3
7179505|NCT00309985|11380367|FG001|Overall Study|Physician Decision|0
7179506|NCT00309985|11380366|FG000|Overall Study|Never started treatment|7
7179507|NCT00309985|11380367|FG001|Overall Study|Never started treatment|0
7179508|NCT00309985|11380366|FG000|Overall Study|Complicating disease|1
7179509|NCT00309985|11380367|FG001|Overall Study|Complicating disease|0
7179510|NCT00309985|11380366|FG000|Overall Study|Non-compliance|1
7179511|NCT00309985|11380367|FG001|Overall Study|Non-compliance|0
7179512|NCT00309985|11380366|FG000|Overall Study|Chemotherapy discontinued only|1
7179513|NCT00309985|11380367|FG001|Overall Study|Chemotherapy discontinued only|0
7179514|NCT00290251|11380376|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0
7179515|NCT00290251|11380377|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0
7179516|NCT00290251|11380378|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0
7179517|NCT00290251|11380379|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0
7179518|NCT00290251|11380380|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0
7179519|NCT00290251|11380381|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2
7179520|NCT00290251|11380376|FG000|Treatment 1 (Months 2-4)|headache|0
7179521|NCT00290251|11380377|FG001|Treatment 1 (Months 2-4)|headache|0
7179522|NCT00290251|11380378|FG002|Treatment 1 (Months 2-4)|headache|0
7179523|NCT00290251|11380379|FG003|Treatment 1 (Months 2-4)|headache|0
7179524|NCT00290251|11380380|FG004|Treatment 1 (Months 2-4)|headache|1
7179525|NCT00290251|11380381|FG005|Treatment 1 (Months 2-4)|headache|0
7179526|NCT00290251|11380376|FG000|Treatment 1 (Months 2-4)|Out of body experience|0
7179527|NCT00290251|11380377|FG001|Treatment 1 (Months 2-4)|Out of body experience|0
7179528|NCT00290251|11380378|FG002|Treatment 1 (Months 2-4)|Out of body experience|0
7179529|NCT00290251|11380379|FG003|Treatment 1 (Months 2-4)|Out of body experience|1
7179530|NCT00290251|11380380|FG004|Treatment 1 (Months 2-4)|Out of body experience|0
7179531|NCT00290251|11380381|FG005|Treatment 1 (Months 2-4)|Out of body experience|0
7186577|NCT02431702|11386994|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5
7186578|NCT02431702|11386995|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0
7186579|NCT02431702|11386996|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0
7186580|NCT02431702|11386997|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0
7186581|NCT02431702|11386998|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0
7186582|NCT02431702|11386999|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0
7186583|NCT02431702|11387000|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3
7186584|NCT02431702|11386994|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2
7186585|NCT02431702|11386995|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
7186586|NCT02431702|11386996|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
7186587|NCT02431702|11386997|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
7186588|NCT02431702|11386998|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
7186589|NCT02431702|11386999|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
7186590|NCT02431702|11387000|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
7186591|NCT02431702|11386994|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0
7186592|NCT02431702|11386995|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5
7186593|NCT02431702|11386996|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1
7186594|NCT02431702|11386997|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0
7186595|NCT02431702|11386998|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0
7186596|NCT02431702|11386999|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0
7179532|NCT01403948|11380417|FG000|Overall Study|Progressive disease|0
7179533|NCT01403948|11380418|FG001|Overall Study|Progressive disease|2
7179534|NCT01403948|11380419|FG002|Overall Study|Progressive disease|2
7179535|NCT01403948|11380420|FG003|Overall Study|Progressive disease|4
7179536|NCT01403948|11380421|FG004|Overall Study|Progressive disease|2
7179537|NCT01403948|11380422|FG005|Overall Study|Progressive disease|6
7179538|NCT01403948|11380423|FG006|Overall Study|Progressive disease|2
7179539|NCT01403948|11380424|FG007|Overall Study|Progressive disease|4
7179540|NCT01403948|11380425|FG008|Overall Study|Progressive disease|5
7179541|NCT01403948|11380426|FG009|Overall Study|Progressive disease|5
7179542|NCT01403948|11380417|FG000|Overall Study|Other Adverse Event (Other than DLT)|0
7179543|NCT01403948|11380418|FG001|Overall Study|Other Adverse Event (Other than DLT)|0
7179544|NCT01403948|11380419|FG002|Overall Study|Other Adverse Event (Other than DLT)|0
7179545|NCT01403948|11380420|FG003|Overall Study|Other Adverse Event (Other than DLT)|0
7179546|NCT01403948|11380421|FG004|Overall Study|Other Adverse Event (Other than DLT)|2
7179547|NCT01403948|11380422|FG005|Overall Study|Other Adverse Event (Other than DLT)|0
7179548|NCT01403948|11380423|FG006|Overall Study|Other Adverse Event (Other than DLT)|2
7179549|NCT01403948|11380424|FG007|Overall Study|Other Adverse Event (Other than DLT)|0
7179550|NCT01403948|11380425|FG008|Overall Study|Other Adverse Event (Other than DLT)|1
7179551|NCT01403948|11380426|FG009|Overall Study|Other Adverse Event (Other than DLT)|0
7179552|NCT01403948|11380417|FG000|Overall Study|Lost to Follow-up|0
7179553|NCT01403948|11380418|FG001|Overall Study|Lost to Follow-up|0
7179554|NCT01403948|11380419|FG002|Overall Study|Lost to Follow-up|0
7179555|NCT01403948|11380420|FG003|Overall Study|Lost to Follow-up|0
7179556|NCT01403948|11380421|FG004|Overall Study|Lost to Follow-up|0
7179557|NCT01403948|11380422|FG005|Overall Study|Lost to Follow-up|0
7179558|NCT01403948|11380423|FG006|Overall Study|Lost to Follow-up|0
7179559|NCT01403948|11380424|FG007|Overall Study|Lost to Follow-up|0
7179560|NCT01403948|11380425|FG008|Overall Study|Lost to Follow-up|0
7179561|NCT01403948|11380426|FG009|Overall Study|Lost to Follow-up|1
7179562|NCT01403948|11380417|FG000|Overall Study|Refused cont. medication|0
7179563|NCT01403948|11380418|FG001|Overall Study|Refused cont. medication|0
7179564|NCT01403948|11380419|FG002|Overall Study|Refused cont. medication|0
7179565|NCT01403948|11380420|FG003|Overall Study|Refused cont. medication|0
7179566|NCT01403948|11380421|FG004|Overall Study|Refused cont. medication|1
7179567|NCT01403948|11380422|FG005|Overall Study|Refused cont. medication|0
7179568|NCT01403948|11380423|FG006|Overall Study|Refused cont. medication|0
7179569|NCT01403948|11380424|FG007|Overall Study|Refused cont. medication|0
7179570|NCT01403948|11380425|FG008|Overall Study|Refused cont. medication|0
7179571|NCT01403948|11380426|FG009|Overall Study|Refused cont. medication|1
7179572|NCT01403948|11380417|FG000|Overall Study|other than above|1
7179573|NCT01403948|11380418|FG001|Overall Study|other than above|2
7179574|NCT01403948|11380419|FG002|Overall Study|other than above|1
7179575|NCT01403948|11380420|FG003|Overall Study|other than above|0
7179576|NCT01403948|11380421|FG004|Overall Study|other than above|1
7179577|NCT01403948|11380422|FG005|Overall Study|other than above|1
7179578|NCT01403948|11380423|FG006|Overall Study|other than above|2
7179579|NCT01403948|11380424|FG007|Overall Study|other than above|0
7179580|NCT01403948|11380425|FG008|Overall Study|other than above|0
7179581|NCT01403948|11380426|FG009|Overall Study|other than above|0
7179582|NCT01404312|11380454|FG000|Overall Study|Death|21
7179583|NCT01404312|11380455|FG001|Overall Study|Death|27
7179584|NCT01404312|11380454|FG000|Overall Study|Withdrawal by Subject|15
7179585|NCT01404312|11380455|FG001|Overall Study|Withdrawal by Subject|18
7179586|NCT01404312|11380454|FG000|Overall Study|Participant Unable to get to clinic|93
7179587|NCT01404312|11380455|FG001|Overall Study|Participant Unable to get to clinic|103
7179588|NCT01404312|11380454|FG000|Overall Study|Lost to Follow-up|115
7179589|NCT01404312|11380455|FG001|Overall Study|Lost to Follow-up|111
7179590|NCT01404312|11380454|FG000|Overall Study|Site closed|22
7179591|NCT01404312|11380455|FG001|Overall Study|Site closed|21
7179592|NCT01404312|11380454|FG000|Overall Study|Participant not willing to adhere to req|31
7179593|NCT01404312|11380455|FG001|Overall Study|Participant not willing to adhere to req|29
7179594|NCT01404312|11380454|FG000|Overall Study|Severe debilitation, unable to continue|1
7179595|NCT01404312|11380455|FG001|Overall Study|Severe debilitation, unable to continue|2
7179596|NCT01425008|11380481|FG000|Dose Escalation Phase|Progressive Disease|2
7179597|NCT01425008|11380482|FG001|Dose Escalation Phase|Progressive Disease|3
7179598|NCT01425008|11380483|FG002|Dose Escalation Phase|Progressive Disease|2
7179599|NCT01425008|11380484|FG003|Dose Escalation Phase|Progressive Disease|3
7179600|NCT01425008|11380485|FG004|Dose Escalation Phase|Progressive Disease|5
7179601|NCT01425008|11380486|FG005|Dose Escalation Phase|Progressive Disease|4
7179602|NCT01425008|11380487|FG006|Dose Escalation Phase|Progressive Disease|0
7179603|NCT01425008|11380488|FG007|Dose Escalation Phase|Progressive Disease|2
7179604|NCT01425008|11380489|FG008|Dose Escalation Phase|Progressive Disease|6
7179605|NCT01425008|11380490|FG009|Dose Escalation Phase|Progressive Disease|2
7179606|NCT01425008|11380491|FG010|Dose Escalation Phase|Progressive Disease|0
7179607|NCT01425008|11380492|FG011|Dose Escalation Phase|Progressive Disease|0
7179608|NCT01425008|11380493|FG012|Dose Escalation Phase|Progressive Disease|0
7179609|NCT01425008|11380494|FG013|Dose Escalation Phase|Progressive Disease|0
7179610|NCT01425008|11380495|FG014|Dose Escalation Phase|Progressive Disease|0
7179611|NCT01425008|11380496|FG015|Dose Escalation Phase|Progressive Disease|0
7179612|NCT01425008|11380497|FG016|Dose Escalation Phase|Progressive Disease|0
7179613|NCT01425008|11380498|FG017|Dose Escalation Phase|Progressive Disease|0
7179614|NCT01425008|11380499|FG018|Dose Escalation Phase|Progressive Disease|0
7179615|NCT01425008|11380481|FG000|Dose Escalation Phase|Adverse Event|2
7179616|NCT01425008|11380482|FG001|Dose Escalation Phase|Adverse Event|0
7179617|NCT01425008|11380483|FG002|Dose Escalation Phase|Adverse Event|0
7179618|NCT01425008|11380484|FG003|Dose Escalation Phase|Adverse Event|0
7179619|NCT01425008|11380485|FG004|Dose Escalation Phase|Adverse Event|0
7179620|NCT01425008|11380486|FG005|Dose Escalation Phase|Adverse Event|2
7179621|NCT01425008|11380487|FG006|Dose Escalation Phase|Adverse Event|0
7179622|NCT01425008|11380488|FG007|Dose Escalation Phase|Adverse Event|0
7179623|NCT01425008|11380489|FG008|Dose Escalation Phase|Adverse Event|2
7179624|NCT01425008|11380490|FG009|Dose Escalation Phase|Adverse Event|0
7179625|NCT01425008|11380491|FG010|Dose Escalation Phase|Adverse Event|0
7179626|NCT01425008|11380492|FG011|Dose Escalation Phase|Adverse Event|0
7179627|NCT01425008|11380493|FG012|Dose Escalation Phase|Adverse Event|0
7179628|NCT01425008|11380494|FG013|Dose Escalation Phase|Adverse Event|0
7179629|NCT01425008|11380495|FG014|Dose Escalation Phase|Adverse Event|0
7179630|NCT01425008|11380496|FG015|Dose Escalation Phase|Adverse Event|0
7179631|NCT01425008|11380497|FG016|Dose Escalation Phase|Adverse Event|0
7179632|NCT01425008|11380498|FG017|Dose Escalation Phase|Adverse Event|0
7179633|NCT01425008|11380499|FG018|Dose Escalation Phase|Adverse Event|0
7179634|NCT01425008|11380481|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7179635|NCT01425008|11380482|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7179636|NCT01425008|11380483|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7179637|NCT01425008|11380484|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7179638|NCT01425008|11380485|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
7179639|NCT01425008|11380486|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7179640|NCT01425008|11380487|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2
7179641|NCT01425008|11380488|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
7179642|NCT01425008|11380489|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
7179643|NCT01425008|11380490|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7179644|NCT01425008|11380491|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7179645|NCT01425008|11380492|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7179646|NCT01425008|11380493|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7179647|NCT01425008|11380494|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7179648|NCT01425008|11380495|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7179649|NCT01425008|11380496|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7179650|NCT01425008|11380497|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7179651|NCT01425008|11380498|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7179652|NCT01425008|11380499|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7179653|NCT01425008|11380481|FG000|Dose Escalation Phase|Withdrawal by Subject|0
7179654|NCT01425008|11380482|FG001|Dose Escalation Phase|Withdrawal by Subject|0
7179655|NCT01425008|11380483|FG002|Dose Escalation Phase|Withdrawal by Subject|0
7179656|NCT01425008|11380484|FG003|Dose Escalation Phase|Withdrawal by Subject|0
7179657|NCT01425008|11380485|FG004|Dose Escalation Phase|Withdrawal by Subject|1
7179658|NCT01425008|11380486|FG005|Dose Escalation Phase|Withdrawal by Subject|1
7179659|NCT01425008|11380487|FG006|Dose Escalation Phase|Withdrawal by Subject|1
7179660|NCT01425008|11380488|FG007|Dose Escalation Phase|Withdrawal by Subject|0
7179661|NCT01425008|11380489|FG008|Dose Escalation Phase|Withdrawal by Subject|1
7179662|NCT01425008|11380490|FG009|Dose Escalation Phase|Withdrawal by Subject|0
7179663|NCT01425008|11380491|FG010|Dose Escalation Phase|Withdrawal by Subject|0
7179664|NCT01425008|11380492|FG011|Dose Escalation Phase|Withdrawal by Subject|0
7179665|NCT01425008|11380493|FG012|Dose Escalation Phase|Withdrawal by Subject|0
7179666|NCT01425008|11380494|FG013|Dose Escalation Phase|Withdrawal by Subject|0
7179667|NCT01425008|11380495|FG014|Dose Escalation Phase|Withdrawal by Subject|0
7179668|NCT01425008|11380496|FG015|Dose Escalation Phase|Withdrawal by Subject|0
7179669|NCT01425008|11380497|FG016|Dose Escalation Phase|Withdrawal by Subject|0
7179670|NCT01425008|11380498|FG017|Dose Escalation Phase|Withdrawal by Subject|0
7179671|NCT01425008|11380499|FG018|Dose Escalation Phase|Withdrawal by Subject|0
7179672|NCT01425008|11380481|FG000|Dose Escalation Phase|Symptomatic Deterioration|0
7179673|NCT01425008|11380482|FG001|Dose Escalation Phase|Symptomatic Deterioration|0
7179674|NCT01425008|11380483|FG002|Dose Escalation Phase|Symptomatic Deterioration|1
7179675|NCT01425008|11380484|FG003|Dose Escalation Phase|Symptomatic Deterioration|0
7179676|NCT01425008|11380485|FG004|Dose Escalation Phase|Symptomatic Deterioration|0
7179677|NCT01425008|11380486|FG005|Dose Escalation Phase|Symptomatic Deterioration|0
7179678|NCT01425008|11380487|FG006|Dose Escalation Phase|Symptomatic Deterioration|0
7179679|NCT01425008|11380488|FG007|Dose Escalation Phase|Symptomatic Deterioration|0
7179680|NCT01425008|11380489|FG008|Dose Escalation Phase|Symptomatic Deterioration|2
7179681|NCT01425008|11380490|FG009|Dose Escalation Phase|Symptomatic Deterioration|2
7179682|NCT01425008|11380491|FG010|Dose Escalation Phase|Symptomatic Deterioration|0
7179683|NCT01425008|11380492|FG011|Dose Escalation Phase|Symptomatic Deterioration|0
7179684|NCT01425008|11380493|FG012|Dose Escalation Phase|Symptomatic Deterioration|0
7179685|NCT01425008|11380494|FG013|Dose Escalation Phase|Symptomatic Deterioration|0
7179686|NCT01425008|11380495|FG014|Dose Escalation Phase|Symptomatic Deterioration|0
7179687|NCT01425008|11380496|FG015|Dose Escalation Phase|Symptomatic Deterioration|0
7179688|NCT01425008|11380497|FG016|Dose Escalation Phase|Symptomatic Deterioration|0
7179689|NCT01425008|11380498|FG017|Dose Escalation Phase|Symptomatic Deterioration|0
7179690|NCT01425008|11380499|FG018|Dose Escalation Phase|Symptomatic Deterioration|0
7179691|NCT01425008|11380481|FG000|Dose Escalation Phase|Other|0
7179692|NCT01425008|11380482|FG001|Dose Escalation Phase|Other|0
7179693|NCT01425008|11380483|FG002|Dose Escalation Phase|Other|0
7179694|NCT01425008|11380484|FG003|Dose Escalation Phase|Other|0
7179695|NCT01425008|11380485|FG004|Dose Escalation Phase|Other|0
7179696|NCT01425008|11380486|FG005|Dose Escalation Phase|Other|0
7179697|NCT01425008|11380487|FG006|Dose Escalation Phase|Other|0
7179698|NCT01425008|11380488|FG007|Dose Escalation Phase|Other|0
7179699|NCT01425008|11380489|FG008|Dose Escalation Phase|Other|1
7179700|NCT01425008|11380490|FG009|Dose Escalation Phase|Other|0
7179701|NCT01425008|11380491|FG010|Dose Escalation Phase|Other|0
7179702|NCT01425008|11380492|FG011|Dose Escalation Phase|Other|0
7179703|NCT01425008|11380493|FG012|Dose Escalation Phase|Other|0
7179704|NCT01425008|11380494|FG013|Dose Escalation Phase|Other|0
7179705|NCT01425008|11380495|FG014|Dose Escalation Phase|Other|0
7179706|NCT01425008|11380496|FG015|Dose Escalation Phase|Other|0
7179707|NCT01425008|11380497|FG016|Dose Escalation Phase|Other|0
7179708|NCT01425008|11380498|FG017|Dose Escalation Phase|Other|0
7179709|NCT01425008|11380499|FG018|Dose Escalation Phase|Other|0
7179710|NCT01425008|11380481|FG000|Dose Expansion Phase|Progressive Disease|0
7179711|NCT01425008|11380482|FG001|Dose Expansion Phase|Progressive Disease|0
7179712|NCT01425008|11380483|FG002|Dose Expansion Phase|Progressive Disease|0
7179713|NCT01425008|11380484|FG003|Dose Expansion Phase|Progressive Disease|0
7179714|NCT01425008|11380485|FG004|Dose Expansion Phase|Progressive Disease|0
7179715|NCT01425008|11380486|FG005|Dose Expansion Phase|Progressive Disease|0
7179716|NCT01425008|11380487|FG006|Dose Expansion Phase|Progressive Disease|0
7179717|NCT01425008|11380488|FG007|Dose Expansion Phase|Progressive Disease|0
7179718|NCT01425008|11380489|FG008|Dose Expansion Phase|Progressive Disease|0
7179719|NCT01425008|11380490|FG009|Dose Expansion Phase|Progressive Disease|0
7179720|NCT01425008|11380491|FG010|Dose Expansion Phase|Progressive Disease|10
7179721|NCT01425008|11380492|FG011|Dose Expansion Phase|Progressive Disease|4
7179722|NCT01425008|11380493|FG012|Dose Expansion Phase|Progressive Disease|12
7179723|NCT01425008|11380494|FG013|Dose Expansion Phase|Progressive Disease|1
7179724|NCT01425008|11380495|FG014|Dose Expansion Phase|Progressive Disease|5
7179725|NCT01425008|11380496|FG015|Dose Expansion Phase|Progressive Disease|8
7179726|NCT01425008|11380497|FG016|Dose Expansion Phase|Progressive Disease|9
7179727|NCT01425008|11380498|FG017|Dose Expansion Phase|Progressive Disease|2
7179728|NCT01425008|11380499|FG018|Dose Expansion Phase|Progressive Disease|10
7179729|NCT01425008|11380481|FG000|Dose Expansion Phase|Withdrawal by Subject|0
7179730|NCT01425008|11380482|FG001|Dose Expansion Phase|Withdrawal by Subject|0
7179731|NCT01425008|11380483|FG002|Dose Expansion Phase|Withdrawal by Subject|0
7179732|NCT01425008|11380484|FG003|Dose Expansion Phase|Withdrawal by Subject|0
7179733|NCT01425008|11380485|FG004|Dose Expansion Phase|Withdrawal by Subject|0
7179734|NCT01425008|11380486|FG005|Dose Expansion Phase|Withdrawal by Subject|0
7179735|NCT01425008|11380487|FG006|Dose Expansion Phase|Withdrawal by Subject|0
7179736|NCT01425008|11380488|FG007|Dose Expansion Phase|Withdrawal by Subject|0
7179737|NCT01425008|11380489|FG008|Dose Expansion Phase|Withdrawal by Subject|0
7179738|NCT01425008|11380490|FG009|Dose Expansion Phase|Withdrawal by Subject|0
7179739|NCT01425008|11380491|FG010|Dose Expansion Phase|Withdrawal by Subject|1
7179740|NCT01425008|11380492|FG011|Dose Expansion Phase|Withdrawal by Subject|0
7179741|NCT01425008|11380493|FG012|Dose Expansion Phase|Withdrawal by Subject|0
7179742|NCT01425008|11380494|FG013|Dose Expansion Phase|Withdrawal by Subject|0
7179743|NCT01425008|11380495|FG014|Dose Expansion Phase|Withdrawal by Subject|0
7179744|NCT01425008|11380496|FG015|Dose Expansion Phase|Withdrawal by Subject|1
7179745|NCT01425008|11380497|FG016|Dose Expansion Phase|Withdrawal by Subject|1
7179746|NCT01425008|11380498|FG017|Dose Expansion Phase|Withdrawal by Subject|0
7179747|NCT01425008|11380499|FG018|Dose Expansion Phase|Withdrawal by Subject|0
7179748|NCT01425008|11380481|FG000|Dose Expansion Phase|Other|0
7179749|NCT01425008|11380482|FG001|Dose Expansion Phase|Other|0
7179750|NCT01425008|11380483|FG002|Dose Expansion Phase|Other|0
7179751|NCT01425008|11380484|FG003|Dose Expansion Phase|Other|0
7179752|NCT01425008|11380485|FG004|Dose Expansion Phase|Other|0
7179753|NCT01425008|11380486|FG005|Dose Expansion Phase|Other|0
7179754|NCT01425008|11380487|FG006|Dose Expansion Phase|Other|0
7179755|NCT01425008|11380488|FG007|Dose Expansion Phase|Other|0
7179756|NCT01425008|11380489|FG008|Dose Expansion Phase|Other|0
7179757|NCT01425008|11380490|FG009|Dose Expansion Phase|Other|0
7179758|NCT01425008|11380491|FG010|Dose Expansion Phase|Other|0
7179759|NCT01425008|11380492|FG011|Dose Expansion Phase|Other|0
7179760|NCT01425008|11380493|FG012|Dose Expansion Phase|Other|1
7179761|NCT01425008|11380494|FG013|Dose Expansion Phase|Other|0
7179762|NCT01425008|11380495|FG014|Dose Expansion Phase|Other|0
7179763|NCT01425008|11380496|FG015|Dose Expansion Phase|Other|0
7179764|NCT01425008|11380497|FG016|Dose Expansion Phase|Other|2
7179765|NCT01425008|11380498|FG017|Dose Expansion Phase|Other|0
7179766|NCT01425008|11380499|FG018|Dose Expansion Phase|Other|4
7179767|NCT01425008|11380481|FG000|Dose Expansion Phase|Symptomatic Deterioration|0
7179768|NCT01425008|11380482|FG001|Dose Expansion Phase|Symptomatic Deterioration|0
7179769|NCT01425008|11380483|FG002|Dose Expansion Phase|Symptomatic Deterioration|0
7179770|NCT01425008|11380484|FG003|Dose Expansion Phase|Symptomatic Deterioration|0
7179771|NCT01425008|11380485|FG004|Dose Expansion Phase|Symptomatic Deterioration|0
7179772|NCT01425008|11380486|FG005|Dose Expansion Phase|Symptomatic Deterioration|0
7179773|NCT01425008|11380487|FG006|Dose Expansion Phase|Symptomatic Deterioration|0
7179774|NCT01425008|11380488|FG007|Dose Expansion Phase|Symptomatic Deterioration|0
7179775|NCT01425008|11380489|FG008|Dose Expansion Phase|Symptomatic Deterioration|0
7179776|NCT01425008|11380490|FG009|Dose Expansion Phase|Symptomatic Deterioration|0
7179777|NCT01425008|11380491|FG010|Dose Expansion Phase|Symptomatic Deterioration|2
7179778|NCT01425008|11380492|FG011|Dose Expansion Phase|Symptomatic Deterioration|1
7179779|NCT01425008|11380493|FG012|Dose Expansion Phase|Symptomatic Deterioration|0
7179780|NCT01425008|11380494|FG013|Dose Expansion Phase|Symptomatic Deterioration|0
7179781|NCT01425008|11380495|FG014|Dose Expansion Phase|Symptomatic Deterioration|0
7179782|NCT01425008|11380496|FG015|Dose Expansion Phase|Symptomatic Deterioration|1
7179783|NCT01425008|11380497|FG016|Dose Expansion Phase|Symptomatic Deterioration|2
7179784|NCT01425008|11380498|FG017|Dose Expansion Phase|Symptomatic Deterioration|0
7179785|NCT01425008|11380499|FG018|Dose Expansion Phase|Symptomatic Deterioration|1
7179786|NCT01425008|11380481|FG000|Dose Expansion Phase|Adverse Event|0
7179787|NCT01425008|11380482|FG001|Dose Expansion Phase|Adverse Event|0
7179788|NCT01425008|11380483|FG002|Dose Expansion Phase|Adverse Event|0
7179789|NCT01425008|11380484|FG003|Dose Expansion Phase|Adverse Event|0
7179790|NCT01425008|11380485|FG004|Dose Expansion Phase|Adverse Event|0
7179791|NCT01425008|11380486|FG005|Dose Expansion Phase|Adverse Event|0
7179792|NCT01425008|11380487|FG006|Dose Expansion Phase|Adverse Event|0
7179793|NCT01425008|11380488|FG007|Dose Expansion Phase|Adverse Event|0
7179794|NCT01425008|11380489|FG008|Dose Expansion Phase|Adverse Event|0
7179795|NCT01425008|11380490|FG009|Dose Expansion Phase|Adverse Event|0
7179796|NCT01425008|11380491|FG010|Dose Expansion Phase|Adverse Event|2
7179797|NCT01425008|11380492|FG011|Dose Expansion Phase|Adverse Event|3
7179798|NCT01425008|11380493|FG012|Dose Expansion Phase|Adverse Event|3
7179799|NCT01425008|11380494|FG013|Dose Expansion Phase|Adverse Event|0
7179800|NCT01425008|11380495|FG014|Dose Expansion Phase|Adverse Event|1
7179801|NCT01425008|11380496|FG015|Dose Expansion Phase|Adverse Event|1
7179802|NCT01425008|11380497|FG016|Dose Expansion Phase|Adverse Event|5
7179803|NCT01425008|11380498|FG017|Dose Expansion Phase|Adverse Event|0
7179804|NCT01425008|11380499|FG018|Dose Expansion Phase|Adverse Event|3
7179805|NCT01425008|11380481|FG000|Dose Expansion Phase|Lost to Follow-up|0
7179806|NCT01425008|11380482|FG001|Dose Expansion Phase|Lost to Follow-up|0
7179807|NCT01425008|11380483|FG002|Dose Expansion Phase|Lost to Follow-up|0
7179808|NCT01425008|11380484|FG003|Dose Expansion Phase|Lost to Follow-up|0
7179809|NCT01425008|11380485|FG004|Dose Expansion Phase|Lost to Follow-up|0
7179810|NCT01425008|11380486|FG005|Dose Expansion Phase|Lost to Follow-up|0
7179811|NCT01425008|11380487|FG006|Dose Expansion Phase|Lost to Follow-up|0
7179812|NCT01425008|11380488|FG007|Dose Expansion Phase|Lost to Follow-up|0
7179813|NCT01425008|11380489|FG008|Dose Expansion Phase|Lost to Follow-up|0
7179814|NCT01425008|11380490|FG009|Dose Expansion Phase|Lost to Follow-up|0
7179815|NCT01425008|11380491|FG010|Dose Expansion Phase|Lost to Follow-up|0
7179816|NCT01425008|11380492|FG011|Dose Expansion Phase|Lost to Follow-up|0
7179817|NCT01425008|11380493|FG012|Dose Expansion Phase|Lost to Follow-up|0
7179818|NCT01425008|11380494|FG013|Dose Expansion Phase|Lost to Follow-up|0
7179819|NCT01425008|11380495|FG014|Dose Expansion Phase|Lost to Follow-up|0
7179820|NCT01425008|11380496|FG015|Dose Expansion Phase|Lost to Follow-up|0
7179821|NCT01425008|11380497|FG016|Dose Expansion Phase|Lost to Follow-up|1
7179822|NCT01425008|11380498|FG017|Dose Expansion Phase|Lost to Follow-up|0
7179823|NCT01425008|11380499|FG018|Dose Expansion Phase|Lost to Follow-up|0
7179824|NCT01425008|11380481|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7179825|NCT01425008|11380482|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7179826|NCT01425008|11380483|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7179827|NCT01425008|11380484|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7179828|NCT01425008|11380485|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7179829|NCT01425008|11380486|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7179830|NCT01425008|11380487|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7179831|NCT01425008|11380488|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7179832|NCT01425008|11380489|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7179833|NCT01425008|11380490|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7179834|NCT01425008|11380491|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7179835|NCT01425008|11380492|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7179836|NCT01425008|11380493|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7179837|NCT01425008|11380494|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7179838|NCT01425008|11380495|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7179839|NCT01425008|11380496|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7179840|NCT01425008|11380497|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7179841|NCT01425008|11380498|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7179842|NCT01425008|11380499|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1
7186597|NCT02431702|11387000|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0
7186598|NCT02431702|11386994|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
7186599|NCT02431702|11386995|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6
7179843|NCT04425902|11380552|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1
7179844|NCT04072146|11380565|FG000|Overall Study|Adverse Event|0
7179845|NCT04072146|11380566|FG001|Overall Study|Adverse Event|1
7179846|NCT03861481|11380580|FG000|Overall Study|COVID-19 pandemic circumstances|0
7179847|NCT03861481|11380581|FG001|Overall Study|COVID-19 pandemic circumstances|1
7179848|NCT03861481|11380580|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1
7179849|NCT03861481|11380581|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0
7179850|NCT03861481|11380580|FG000|Overall Study|Relapse|1
7179851|NCT03861481|11380581|FG001|Overall Study|Relapse|0
7179852|NCT03861481|11380580|FG000|Overall Study|Withdrawal by Subject|0
7179853|NCT03861481|11380581|FG001|Overall Study|Withdrawal by Subject|1
7179854|NCT03861481|11380580|FG000|Overall Study|Lack of Efficacy|4
7179855|NCT03861481|11380581|FG001|Overall Study|Lack of Efficacy|5
7179856|NCT03692052|11380591|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1
7179857|NCT03692052|11380591|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1
7179858|NCT03692052|11380591|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1
7179859|NCT03692052|11380591|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17
7179860|NCT03648476|11380597|FG000|Overall Study|Withdrawal by Subject|2
7179861|NCT03648476|11380598|FG001|Overall Study|Withdrawal by Subject|1
7179862|NCT03375203|11380610|FG000|Overall Study|Protocol Violation|0
7179863|NCT03375203|11380611|FG001|Overall Study|Protocol Violation|0
7179864|NCT03375203|11380612|FG002|Overall Study|Protocol Violation|1
7179865|NCT03375203|11380613|FG003|Overall Study|Protocol Violation|0
7179866|NCT03375203|11380614|FG004|Overall Study|Protocol Violation|0
7179867|NCT03375203|11380610|FG000|Overall Study|Adverse Event|2
7179868|NCT03375203|11380611|FG001|Overall Study|Adverse Event|3
7179869|NCT03375203|11380612|FG002|Overall Study|Adverse Event|0
7179870|NCT03375203|11380613|FG003|Overall Study|Adverse Event|2
7179871|NCT03375203|11380614|FG004|Overall Study|Adverse Event|2
7179872|NCT03375203|11380610|FG000|Overall Study|Withdrawal by Subject|3
7179873|NCT03375203|11380611|FG001|Overall Study|Withdrawal by Subject|0
7179874|NCT03375203|11380612|FG002|Overall Study|Withdrawal by Subject|1
7179875|NCT03375203|11380613|FG003|Overall Study|Withdrawal by Subject|0
7179876|NCT03375203|11380614|FG004|Overall Study|Withdrawal by Subject|2
7179877|NCT03375203|11380610|FG000|Overall Study|Non-compliance with study drug|1
7179878|NCT03375203|11380611|FG001|Overall Study|Non-compliance with study drug|0
7179879|NCT03375203|11380612|FG002|Overall Study|Non-compliance with study drug|0
7179880|NCT03375203|11380613|FG003|Overall Study|Non-compliance with study drug|0
7179881|NCT03375203|11380614|FG004|Overall Study|Non-compliance with study drug|0
7179882|NCT03375203|11380610|FG000|Overall Study|Randomized, not treated.|0
7179883|NCT03375203|11380611|FG001|Overall Study|Randomized, not treated.|1
7179884|NCT03375203|11380612|FG002|Overall Study|Randomized, not treated.|0
7179885|NCT03375203|11380613|FG003|Overall Study|Randomized, not treated.|0
7179886|NCT03375203|11380614|FG004|Overall Study|Randomized, not treated.|0
7179887|NCT02926833|11380631|FG000|Overall Study|Full Consent Withdrawal|0
7179888|NCT02926833|11380632|FG001|Overall Study|Full Consent Withdrawal|0
7179889|NCT02926833|11380633|FG002|Overall Study|Full Consent Withdrawal|0
7179890|NCT02926833|11380634|FG003|Overall Study|Full Consent Withdrawal|2
7179891|NCT02926833|11380631|FG000|Overall Study|Death|1
7179892|NCT02926833|11380632|FG001|Overall Study|Death|1
7179893|NCT02926833|11380633|FG002|Overall Study|Death|1
7179894|NCT02926833|11380634|FG003|Overall Study|Death|7
7179895|NCT02926833|11380631|FG000|Overall Study|Still on study|2
7179896|NCT02926833|11380632|FG001|Overall Study|Still on study|3
7179897|NCT02926833|11380633|FG002|Overall Study|Still on study|5
7179898|NCT02926833|11380634|FG003|Overall Study|Still on study|14
7179899|NCT02926833|11380631|FG000|Overall Study|Adverse Event|0
7179900|NCT02926833|11380632|FG001|Overall Study|Adverse Event|0
7179901|NCT02926833|11380633|FG002|Overall Study|Adverse Event|1
7179902|NCT02926833|11380634|FG003|Overall Study|Adverse Event|0
7179903|NCT02899299|11380647|FG000|Pre-treatment|Participant request to discontinue study treatment|0
7179904|NCT02899299|11380648|FG001|Pre-treatment|Participant request to discontinue study treatment|3
7179905|NCT02899299|11380647|FG000|Pre-treatment|Participant withdrew consent|1
7179906|NCT02899299|11380648|FG001|Pre-treatment|Participant withdrew consent|11
7179907|NCT02899299|11380647|FG000|Pre-treatment|Participant no longer meets study criteria|2
7179908|NCT02899299|11380648|FG001|Pre-treatment|Participant no longer meets study criteria|3
7179909|NCT02899299|11380647|FG000|Pre-treatment|Not reported|0
7179910|NCT02899299|11380648|FG001|Pre-treatment|Not reported|1
7179911|NCT02899299|11380647|FG000|Treatment|Disease Progression|182
7179912|NCT02899299|11380648|FG001|Treatment|Disease Progression|44
7179913|NCT02899299|11380647|FG000|Treatment|Study Drug Toxicity|59
7179914|NCT02899299|11380648|FG001|Treatment|Study Drug Toxicity|24
7179915|NCT02899299|11380647|FG000|Treatment|Adverse Event unrelated to Study Drug|12
7179916|NCT02899299|11380648|FG001|Treatment|Adverse Event unrelated to Study Drug|9
7179917|NCT02899299|11380647|FG000|Treatment|Participant request to discontinue Study treatment|4
7179918|NCT02899299|11380648|FG001|Treatment|Participant request to discontinue Study treatment|10
7179919|NCT02899299|11380647|FG000|Treatment|Participant withdrew consent|6
7179920|NCT02899299|11380648|FG001|Treatment|Participant withdrew consent|3
7179921|NCT02899299|11380647|FG000|Treatment|Lost to Follow-up|0
7179922|NCT02899299|11380648|FG001|Treatment|Lost to Follow-up|1
7179923|NCT02899299|11380647|FG000|Treatment|Maximum Clinical Benefit|10
7179924|NCT02899299|11380648|FG001|Treatment|Maximum Clinical Benefit|2
7179925|NCT02899299|11380647|FG000|Treatment|Poor/Non-compliance|1
7179926|NCT02899299|11380648|FG001|Treatment|Poor/Non-compliance|0
7179927|NCT02899299|11380647|FG000|Treatment|Participant no longer meets Study criteria|4
7179928|NCT02899299|11380648|FG001|Treatment|Participant no longer meets Study criteria|0
7179929|NCT02899299|11380647|FG000|Treatment|Administrative reason by Sponsor|2
7179930|NCT02899299|11380648|FG001|Treatment|Administrative reason by Sponsor|0
7179931|NCT02899299|11380647|FG000|Treatment|Other reasons|11
7179932|NCT02899299|11380648|FG001|Treatment|Other reasons|2
7179933|NCT02899299|11380647|FG000|Treatment|Not reported: Includes participants who achieved max duration of treatment|4
7179934|NCT02899299|11380648|FG001|Treatment|Not reported: Includes participants who achieved max duration of treatment|189
7179935|NCT02879448|11380656|FG000|Overall Study|No implant attempt|17
7179936|NCT02879448|11380657|FG001|Overall Study|No implant attempt|28
7179937|NCT02879448|11380656|FG000|Overall Study|Withdrawal by Subject|20
7179938|NCT02879448|11380657|FG001|Overall Study|Withdrawal by Subject|46
7179939|NCT02879448|11380656|FG000|Overall Study|Death|63
7179940|NCT02879448|11380657|FG001|Overall Study|Death|85
7179941|NCT02879448|11380656|FG000|Overall Study|Lost to Follow-up|3
7179942|NCT02879448|11380657|FG001|Overall Study|Lost to Follow-up|4
7179943|NCT02879448|11380656|FG000|Overall Study|Missing visit|34
7179944|NCT02879448|11380657|FG001|Overall Study|Missing visit|39
7179945|NCT02879448|11380656|FG000|Overall Study|Pending evaluation|1
7179946|NCT02879448|11380657|FG001|Overall Study|Pending evaluation|0
7179947|NCT02348216|11380674|FG000|Overall Study|Death|4
7179948|NCT02348216|11380675|FG001|Overall Study|Death|27
7179949|NCT02348216|11380676|FG002|Overall Study|Death|3
7179950|NCT02348216|11380677|FG003|Overall Study|Death|18
7179951|NCT02348216|11380678|FG004|Overall Study|Death|9
7179952|NCT02348216|11380679|FG005|Overall Study|Death|23
7179953|NCT02348216|11380680|FG006|Overall Study|Death|6
7179954|NCT02348216|11380674|FG000|Overall Study|Full consent withdrawal|0
7179955|NCT02348216|11380675|FG001|Overall Study|Full consent withdrawal|0
7179956|NCT02348216|11380676|FG002|Overall Study|Full consent withdrawal|0
7179957|NCT02348216|11380677|FG003|Overall Study|Full consent withdrawal|1
7179958|NCT02348216|11380678|FG004|Overall Study|Full consent withdrawal|0
7179959|NCT02348216|11380679|FG005|Overall Study|Full consent withdrawal|0
7179960|NCT02348216|11380680|FG006|Overall Study|Full consent withdrawal|1
7179961|NCT02348216|11380674|FG000|Overall Study|Lost to Follow-up|0
7179962|NCT02348216|11380675|FG001|Overall Study|Lost to Follow-up|0
7179963|NCT02348216|11380676|FG002|Overall Study|Lost to Follow-up|0
7179964|NCT02348216|11380677|FG003|Overall Study|Lost to Follow-up|0
7179965|NCT02348216|11380678|FG004|Overall Study|Lost to Follow-up|0
7179966|NCT02348216|11380679|FG005|Overall Study|Lost to Follow-up|0
7179967|NCT02348216|11380680|FG006|Overall Study|Lost to Follow-up|1
7179968|NCT02348216|11380674|FG000|Overall Study|Still on study|3
7179969|NCT02348216|11380675|FG001|Overall Study|Still on study|50
7179970|NCT02348216|11380676|FG002|Overall Study|Still on study|21
7179971|NCT02348216|11380677|FG003|Overall Study|Still on study|19
7179972|NCT02348216|11380678|FG004|Overall Study|Still on study|32
7179973|NCT02348216|11380679|FG005|Overall Study|Still on study|27
7179974|NCT02348216|11380680|FG006|Overall Study|Still on study|32
7179975|NCT02348216|11380674|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1
7179976|NCT02348216|11380675|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4
7179977|NCT02348216|11380676|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6
7179978|NCT02348216|11380677|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4
7179979|NCT02348216|11380678|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5
7179980|NCT02348216|11380679|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8
7179981|NCT02348216|11380680|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2
7179982|NCT01332968|11380735|FG000|Induction Period|Withdrawal by Subject|3
7179983|NCT01332968|11380736|FG001|Induction Period|Withdrawal by Subject|5
7179984|NCT01332968|11380737|FG002|Induction Period|Withdrawal by Subject|0
7179985|NCT01332968|11380738|FG003|Induction Period|Withdrawal by Subject|0
7179986|NCT01332968|11380739|FG004|Induction Period|Withdrawal by Subject|0
7179987|NCT01332968|11380740|FG005|Induction Period|Withdrawal by Subject|0
7179988|NCT01332968|11380741|FG006|Induction Period|Withdrawal by Subject|0
7179989|NCT01332968|11380742|FG007|Induction Period|Withdrawal by Subject|0
7179990|NCT01332968|11380735|FG000|Induction Period|Protocol Violation|3
7179991|NCT01332968|11380736|FG001|Induction Period|Protocol Violation|4
7179992|NCT01332968|11380737|FG002|Induction Period|Protocol Violation|0
7179993|NCT01332968|11380738|FG003|Induction Period|Protocol Violation|0
7179994|NCT01332968|11380739|FG004|Induction Period|Protocol Violation|0
7179995|NCT01332968|11380740|FG005|Induction Period|Protocol Violation|0
7179996|NCT01332968|11380741|FG006|Induction Period|Protocol Violation|0
7179997|NCT01332968|11380742|FG007|Induction Period|Protocol Violation|0
7179998|NCT01332968|11380735|FG000|Induction Period|Progressive disease|15
7179999|NCT01332968|11380736|FG001|Induction Period|Progressive disease|7
7180000|NCT01332968|11380737|FG002|Induction Period|Progressive disease|0
7180001|NCT01332968|11380738|FG003|Induction Period|Progressive disease|0
7180002|NCT01332968|11380739|FG004|Induction Period|Progressive disease|0
7180003|NCT01332968|11380740|FG005|Induction Period|Progressive disease|0
7180004|NCT01332968|11380741|FG006|Induction Period|Progressive disease|0
7180005|NCT01332968|11380742|FG007|Induction Period|Progressive disease|0
7180006|NCT01332968|11380735|FG000|Induction Period|Physician Decision|6
7180007|NCT01332968|11380736|FG001|Induction Period|Physician Decision|1
7180008|NCT01332968|11380737|FG002|Induction Period|Physician Decision|0
7180009|NCT01332968|11380738|FG003|Induction Period|Physician Decision|0
7180010|NCT01332968|11380739|FG004|Induction Period|Physician Decision|0
7180011|NCT01332968|11380740|FG005|Induction Period|Physician Decision|0
7180012|NCT01332968|11380741|FG006|Induction Period|Physician Decision|0
7180013|NCT01332968|11380742|FG007|Induction Period|Physician Decision|0
7180014|NCT01332968|11380735|FG000|Induction Period|Other|2
7180015|NCT01332968|11380736|FG001|Induction Period|Other|2
7180016|NCT01332968|11380737|FG002|Induction Period|Other|0
7180017|NCT01332968|11380738|FG003|Induction Period|Other|0
7180018|NCT01332968|11380739|FG004|Induction Period|Other|0
7180019|NCT01332968|11380740|FG005|Induction Period|Other|0
7180020|NCT01332968|11380741|FG006|Induction Period|Other|0
7180021|NCT01332968|11380742|FG007|Induction Period|Other|0
7180022|NCT01332968|11380735|FG000|Induction Period|Non-compliance|1
7180023|NCT01332968|11380736|FG001|Induction Period|Non-compliance|0
7180024|NCT01332968|11380737|FG002|Induction Period|Non-compliance|0
7180025|NCT01332968|11380738|FG003|Induction Period|Non-compliance|0
7180026|NCT01332968|11380739|FG004|Induction Period|Non-compliance|0
7180027|NCT01332968|11380740|FG005|Induction Period|Non-compliance|0
7180028|NCT01332968|11380741|FG006|Induction Period|Non-compliance|0
7180029|NCT01332968|11380742|FG007|Induction Period|Non-compliance|0
7180030|NCT01332968|11380735|FG000|Induction Period|Death|1
7180031|NCT01332968|11380736|FG001|Induction Period|Death|4
7180032|NCT01332968|11380737|FG002|Induction Period|Death|0
7180033|NCT01332968|11380738|FG003|Induction Period|Death|0
7180034|NCT01332968|11380739|FG004|Induction Period|Death|0
7180035|NCT01332968|11380740|FG005|Induction Period|Death|0
7180036|NCT01332968|11380741|FG006|Induction Period|Death|0
7180037|NCT01332968|11380742|FG007|Induction Period|Death|0
7180038|NCT01332968|11380735|FG000|Induction Period|Adverse Event|23
7180039|NCT01332968|11380736|FG001|Induction Period|Adverse Event|26
7180040|NCT01332968|11380737|FG002|Induction Period|Adverse Event|0
7180041|NCT01332968|11380738|FG003|Induction Period|Adverse Event|0
7180042|NCT01332968|11380739|FG004|Induction Period|Adverse Event|0
7180043|NCT01332968|11380740|FG005|Induction Period|Adverse Event|0
7180044|NCT01332968|11380741|FG006|Induction Period|Adverse Event|0
7180045|NCT01332968|11380742|FG007|Induction Period|Adverse Event|0
7180046|NCT01332968|11380735|FG000|Induction Period|Randomized, but not treated|4
7180047|NCT01332968|11380736|FG001|Induction Period|Randomized, but not treated|7
7180048|NCT01332968|11380737|FG002|Induction Period|Randomized, but not treated|0
7180049|NCT01332968|11380738|FG003|Induction Period|Randomized, but not treated|0
7180050|NCT01332968|11380739|FG004|Induction Period|Randomized, but not treated|0
7180051|NCT01332968|11380740|FG005|Induction Period|Randomized, but not treated|0
7180052|NCT01332968|11380741|FG006|Induction Period|Randomized, but not treated|0
7180053|NCT01332968|11380742|FG007|Induction Period|Randomized, but not treated|0
7180054|NCT01332968|11380735|FG000|Maintenance/Observation Period|Withdrawal by Subject|0
7180055|NCT01332968|11380736|FG001|Maintenance/Observation Period|Withdrawal by Subject|0
7180056|NCT01332968|11380737|FG002|Maintenance/Observation Period|Withdrawal by Subject|10
7180057|NCT01332968|11380738|FG003|Maintenance/Observation Period|Withdrawal by Subject|5
7180058|NCT01332968|11380739|FG004|Maintenance/Observation Period|Withdrawal by Subject|0
7180059|NCT01332968|11380740|FG005|Maintenance/Observation Period|Withdrawal by Subject|0
7180060|NCT01332968|11380741|FG006|Maintenance/Observation Period|Withdrawal by Subject|0
7180061|NCT01332968|11380742|FG007|Maintenance/Observation Period|Withdrawal by Subject|0
7180062|NCT01332968|11380735|FG000|Maintenance/Observation Period|Protocol Violation|0
7180063|NCT01332968|11380736|FG001|Maintenance/Observation Period|Protocol Violation|0
7180064|NCT01332968|11380737|FG002|Maintenance/Observation Period|Protocol Violation|1
7180065|NCT01332968|11380738|FG003|Maintenance/Observation Period|Protocol Violation|1
7180066|NCT01332968|11380739|FG004|Maintenance/Observation Period|Protocol Violation|0
7180067|NCT01332968|11380740|FG005|Maintenance/Observation Period|Protocol Violation|0
7180068|NCT01332968|11380741|FG006|Maintenance/Observation Period|Protocol Violation|0
7180069|NCT01332968|11380742|FG007|Maintenance/Observation Period|Protocol Violation|0
7180070|NCT01332968|11380735|FG000|Maintenance/Observation Period|Progressive disease|0
7180071|NCT01332968|11380736|FG001|Maintenance/Observation Period|Progressive disease|0
7180072|NCT01332968|11380737|FG002|Maintenance/Observation Period|Progressive disease|72
6895946|NCT00629265|10914153|FG001|Overall Study|Needed Esophageal Dilation|1
6895947|NCT00629265|10914152|FG000|Overall Study|Unrelated Medical Complications|3
7180073|NCT01332968|11380738|FG003|Maintenance/Observation Period|Progressive disease|39
7180074|NCT01332968|11380739|FG004|Maintenance/Observation Period|Progressive disease|0
7180075|NCT01332968|11380740|FG005|Maintenance/Observation Period|Progressive disease|0
7180076|NCT01332968|11380741|FG006|Maintenance/Observation Period|Progressive disease|0
7180077|NCT01332968|11380742|FG007|Maintenance/Observation Period|Progressive disease|0
7180078|NCT01332968|11380735|FG000|Maintenance/Observation Period|Physician Decision|0
7180079|NCT01332968|11380736|FG001|Maintenance/Observation Period|Physician Decision|0
7180080|NCT01332968|11380737|FG002|Maintenance/Observation Period|Physician Decision|14
7180081|NCT01332968|11380738|FG003|Maintenance/Observation Period|Physician Decision|19
7180082|NCT01332968|11380739|FG004|Maintenance/Observation Period|Physician Decision|0
7180083|NCT01332968|11380740|FG005|Maintenance/Observation Period|Physician Decision|0
7180084|NCT01332968|11380741|FG006|Maintenance/Observation Period|Physician Decision|0
6895948|NCT00629265|10914153|FG001|Overall Study|Unrelated Medical Complications|1
6895949|NCT00629265|10914152|FG000|Overall Study|Unknown Reason|2
6895950|NCT00629265|10914153|FG001|Overall Study|Unknown Reason|2
6895951|NCT00629707|10914169|FG000|Overall Study|Withdrawal by Subject|0
6895952|NCT00629707|10914170|FG001|Overall Study|Withdrawal by Subject|1
7180085|NCT01332968|11380742|FG007|Maintenance/Observation Period|Physician Decision|0
7180086|NCT01332968|11380735|FG000|Maintenance/Observation Period|Other|0
7180087|NCT01332968|11380736|FG001|Maintenance/Observation Period|Other|0
7180088|NCT01332968|11380737|FG002|Maintenance/Observation Period|Other|4
7180089|NCT01332968|11380738|FG003|Maintenance/Observation Period|Other|5
7180090|NCT01332968|11380739|FG004|Maintenance/Observation Period|Other|0
7180091|NCT01332968|11380740|FG005|Maintenance/Observation Period|Other|0
7180092|NCT01332968|11380741|FG006|Maintenance/Observation Period|Other|0
7180093|NCT01332968|11380742|FG007|Maintenance/Observation Period|Other|0
7180094|NCT01332968|11380735|FG000|Maintenance/Observation Period|Non-compliance|0
7180095|NCT01332968|11380736|FG001|Maintenance/Observation Period|Non-compliance|0
7180096|NCT01332968|11380737|FG002|Maintenance/Observation Period|Non-compliance|2
7180097|NCT01332968|11380738|FG003|Maintenance/Observation Period|Non-compliance|3
7180098|NCT01332968|11380739|FG004|Maintenance/Observation Period|Non-compliance|0
7180099|NCT01332968|11380740|FG005|Maintenance/Observation Period|Non-compliance|1
7180100|NCT01332968|11380741|FG006|Maintenance/Observation Period|Non-compliance|0
7180101|NCT01332968|11380742|FG007|Maintenance/Observation Period|Non-compliance|0
7180102|NCT01332968|11380735|FG000|Maintenance/Observation Period|Lost to Follow-up|0
7180103|NCT01332968|11380736|FG001|Maintenance/Observation Period|Lost to Follow-up|0
7180104|NCT01332968|11380737|FG002|Maintenance/Observation Period|Lost to Follow-up|1
7180105|NCT01332968|11380738|FG003|Maintenance/Observation Period|Lost to Follow-up|2
7180106|NCT01332968|11380739|FG004|Maintenance/Observation Period|Lost to Follow-up|0
7180107|NCT01332968|11380740|FG005|Maintenance/Observation Period|Lost to Follow-up|0
7180108|NCT01332968|11380741|FG006|Maintenance/Observation Period|Lost to Follow-up|0
7180109|NCT01332968|11380742|FG007|Maintenance/Observation Period|Lost to Follow-up|0
7180110|NCT01332968|11380735|FG000|Maintenance/Observation Period|Death|0
7180111|NCT01332968|11380736|FG001|Maintenance/Observation Period|Death|0
7180112|NCT01332968|11380737|FG002|Maintenance/Observation Period|Death|5
7180113|NCT01332968|11380738|FG003|Maintenance/Observation Period|Death|6
7180114|NCT01332968|11380739|FG004|Maintenance/Observation Period|Death|0
7180115|NCT01332968|11380740|FG005|Maintenance/Observation Period|Death|0
7180116|NCT01332968|11380741|FG006|Maintenance/Observation Period|Death|0
7180117|NCT01332968|11380742|FG007|Maintenance/Observation Period|Death|0
7180118|NCT01332968|11380735|FG000|Maintenance/Observation Period|Adverse Event|0
7180119|NCT01332968|11380736|FG001|Maintenance/Observation Period|Adverse Event|0
7180120|NCT01332968|11380737|FG002|Maintenance/Observation Period|Adverse Event|50
7180121|NCT01332968|11380738|FG003|Maintenance/Observation Period|Adverse Event|65
7180122|NCT01332968|11380739|FG004|Maintenance/Observation Period|Adverse Event|0
7180123|NCT01332968|11380740|FG005|Maintenance/Observation Period|Adverse Event|0
7180124|NCT01332968|11380741|FG006|Maintenance/Observation Period|Adverse Event|0
7180125|NCT01332968|11380742|FG007|Maintenance/Observation Period|Adverse Event|0
7180126|NCT01332968|11380735|FG000|Maintenance/Observation Period|Treatment ongoing|0
7180127|NCT01332968|11380736|FG001|Maintenance/Observation Period|Treatment ongoing|0
7180128|NCT01332968|11380737|FG002|Maintenance/Observation Period|Treatment ongoing|54
7180129|NCT01332968|11380738|FG003|Maintenance/Observation Period|Treatment ongoing|62
7180130|NCT01332968|11380739|FG004|Maintenance/Observation Period|Treatment ongoing|10
7180131|NCT01332968|11380740|FG005|Maintenance/Observation Period|Treatment ongoing|8
7180132|NCT01332968|11380741|FG006|Maintenance/Observation Period|Treatment ongoing|0
7180133|NCT01332968|11380742|FG007|Maintenance/Observation Period|Treatment ongoing|0
7180134|NCT01332968|11380735|FG000|Follow-Up Period|Death|0
7180135|NCT01332968|11380736|FG001|Follow-Up Period|Death|0
7180136|NCT01332968|11380737|FG002|Follow-Up Period|Death|0
7180137|NCT01332968|11380738|FG003|Follow-Up Period|Death|0
7180138|NCT01332968|11380739|FG004|Follow-Up Period|Death|0
7180139|NCT01332968|11380740|FG005|Follow-Up Period|Death|0
7180140|NCT01332968|11380741|FG006|Follow-Up Period|Death|38
7180141|NCT01332968|11380742|FG007|Follow-Up Period|Death|22
7180142|NCT01332968|11380735|FG000|Follow-Up Period|Follow-up ongoing|0
7180143|NCT01332968|11380736|FG001|Follow-Up Period|Follow-up ongoing|0
7180144|NCT01332968|11380737|FG002|Follow-Up Period|Follow-up ongoing|0
7180145|NCT01332968|11380738|FG003|Follow-Up Period|Follow-up ongoing|0
7180146|NCT01332968|11380739|FG004|Follow-Up Period|Follow-up ongoing|0
7180147|NCT01332968|11380740|FG005|Follow-Up Period|Follow-up ongoing|0
7180148|NCT01332968|11380741|FG006|Follow-Up Period|Follow-up ongoing|502
7180149|NCT01332968|11380742|FG007|Follow-Up Period|Follow-up ongoing|505
7180150|NCT01332968|11380735|FG000|Follow-Up Period|Withdrawal by Subject|0
7180151|NCT01332968|11380736|FG001|Follow-Up Period|Withdrawal by Subject|0
7180152|NCT01332968|11380737|FG002|Follow-Up Period|Withdrawal by Subject|0
7180153|NCT01332968|11380738|FG003|Follow-Up Period|Withdrawal by Subject|0
6895953|NCT00629707|10914169|FG000|Overall Study|Physician Decision|0
6895954|NCT00629707|10914170|FG001|Overall Study|Physician Decision|1
6973240|NCT01179048|11024889|FG001|Overall Study|Alive|142
7180154|NCT01332968|11380739|FG004|Follow-Up Period|Withdrawal by Subject|0
7180155|NCT01332968|11380740|FG005|Follow-Up Period|Withdrawal by Subject|0
7180156|NCT01332968|11380741|FG006|Follow-Up Period|Withdrawal by Subject|1
7180157|NCT01332968|11380742|FG007|Follow-Up Period|Withdrawal by Subject|2
7180158|NCT01332968|11380735|FG000|Follow-Up Period|Lost to Follow-up|0
7180159|NCT01332968|11380736|FG001|Follow-Up Period|Lost to Follow-up|0
7180160|NCT01332968|11380737|FG002|Follow-Up Period|Lost to Follow-up|0
7180161|NCT01332968|11380738|FG003|Follow-Up Period|Lost to Follow-up|0
7180162|NCT01332968|11380739|FG004|Follow-Up Period|Lost to Follow-up|0
7180163|NCT01332968|11380740|FG005|Follow-Up Period|Lost to Follow-up|0
7180164|NCT01332968|11380741|FG006|Follow-Up Period|Lost to Follow-up|1
7180165|NCT01332968|11380742|FG007|Follow-Up Period|Lost to Follow-up|2
7180166|NCT01231906|11380752|FG000|Overall Study|Lack of Efficacy|75
7180167|NCT01231906|11380753|FG001|Overall Study|Lack of Efficacy|68
7180168|NCT01231906|11380752|FG000|Overall Study|Lost to Follow-up|1
7180169|NCT01231906|11380753|FG001|Overall Study|Lost to Follow-up|0
7180170|NCT01231906|11380752|FG000|Overall Study|Physician Decision|34
7180171|NCT01231906|11380753|FG001|Overall Study|Physician Decision|24
7180172|NCT01231906|11380752|FG000|Overall Study|Withdrawal by Subject|0
7180173|NCT01231906|11380753|FG001|Overall Study|Withdrawal by Subject|4
7180174|NCT01231906|11380752|FG000|Overall Study|Ineligible|10
7180175|NCT01231906|11380753|FG001|Overall Study|Ineligible|3
7180176|NCT01231906|11380752|FG000|Overall Study|No treatment|1
7180177|NCT01231906|11380753|FG001|Overall Study|No treatment|2
7186600|NCT02431702|11386996|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13
7186601|NCT02431702|11386997|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
7186602|NCT02431702|11386998|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
7186603|NCT02431702|11386999|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
7186604|NCT02431702|11387000|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
7186605|NCT02431702|11386994|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
7186606|NCT02431702|11386995|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11
7186607|NCT02431702|11386996|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8
7186608|NCT02431702|11386997|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
7186609|NCT02431702|11386998|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
7186610|NCT02431702|11386999|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
7186611|NCT02431702|11387000|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
7186612|NCT02431702|11386994|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
7186613|NCT02431702|11386995|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2
7186614|NCT02431702|11386996|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
7186615|NCT02431702|11386997|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
7186616|NCT02431702|11386998|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
7186617|NCT02431702|11386999|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
7186618|NCT02431702|11387000|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
7186619|NCT02431702|11386994|FG000|Part 2: 9Month Disease Progression Phase|Other|0
7186620|NCT02431702|11386995|FG001|Part 2: 9Month Disease Progression Phase|Other|2
7186621|NCT02431702|11386996|FG002|Part 2: 9Month Disease Progression Phase|Other|2
7186622|NCT02431702|11386997|FG003|Part 2: 9Month Disease Progression Phase|Other|0
7186623|NCT02431702|11386998|FG004|Part 2: 9Month Disease Progression Phase|Other|0
7186624|NCT02431702|11386999|FG005|Part 2: 9Month Disease Progression Phase|Other|0
7186625|NCT02431702|11387000|FG006|Part 2: 9Month Disease Progression Phase|Other|0
7186626|NCT02431702|11386994|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
7186627|NCT02431702|11386995|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
7186628|NCT02431702|11386996|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5
7186629|NCT02431702|11386997|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
7186630|NCT02431702|11386998|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
7186631|NCT02431702|11386999|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
7186632|NCT02431702|11387000|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
7186633|NCT02431702|11386994|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0
7186634|NCT02431702|11386995|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0
7186635|NCT02431702|11386996|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0
7186636|NCT02431702|11386997|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2
7186637|NCT02431702|11386998|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3
7186638|NCT02431702|11386999|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0
7186639|NCT02431702|11387000|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0
7186640|NCT02431702|11386994|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
7186641|NCT02431702|11386995|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
7186642|NCT02431702|11386996|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
7186643|NCT02431702|11386997|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1
7186644|NCT02431702|11386998|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
7186645|NCT02431702|11386999|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5
7186646|NCT02431702|11387000|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
7180178|NCT01470326|11380759|FG000|Overall Study|Protocol Violation|32
7180179|NCT01470326|11380759|FG000|Overall Study|No Drug Administration Information|2
7180180|NCT01470326|11380759|FG000|Overall Study|No Visit After 1st Day of Treatment|119
7180181|NCT01480180|11380765|FG000|Main Phase|Withdrawal criteria|12
7180182|NCT01480180|11380766|FG001|Main Phase|Withdrawal criteria|1
7180183|NCT01480180|11380767|FG002|Main Phase|Withdrawal criteria|0
7180184|NCT01480180|11380768|FG003|Main Phase|Withdrawal criteria|0
7180185|NCT01480180|11380769|FG004|Main Phase|Withdrawal criteria|0
7180186|NCT01480180|11380770|FG005|Main Phase|Withdrawal criteria|0
7180187|NCT01480180|11380765|FG000|Main Phase|Lack of Efficacy|1
7180188|NCT01480180|11380766|FG001|Main Phase|Lack of Efficacy|0
7180189|NCT01480180|11380767|FG002|Main Phase|Lack of Efficacy|0
7180190|NCT01480180|11380768|FG003|Main Phase|Lack of Efficacy|0
7180191|NCT01480180|11380769|FG004|Main Phase|Lack of Efficacy|0
6895955|NCT00629772|10914178|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1
6895956|NCT00629772|10914179|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1
6895957|NCT00629772|10914178|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0
6895958|NCT00629772|10914179|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1
6895959|NCT00630032|10914188|FG000|Overall Study|Death|55
7180192|NCT01480180|11380770|FG005|Main Phase|Lack of Efficacy|0
7180193|NCT01480180|11380765|FG000|Main Phase|Non-compliance|3
7180194|NCT01480180|11380766|FG001|Main Phase|Non-compliance|0
7180195|NCT01480180|11380767|FG002|Main Phase|Non-compliance|0
7180196|NCT01480180|11380768|FG003|Main Phase|Non-compliance|0
7180197|NCT01480180|11380769|FG004|Main Phase|Non-compliance|0
7180198|NCT01480180|11380770|FG005|Main Phase|Non-compliance|0
7180199|NCT01480180|11380765|FG000|Main Phase|Unclassified|3
7180200|NCT01480180|11380766|FG001|Main Phase|Unclassified|0
7180201|NCT01480180|11380767|FG002|Main Phase|Unclassified|0
7180202|NCT01480180|11380768|FG003|Main Phase|Unclassified|0
7180203|NCT01480180|11380769|FG004|Main Phase|Unclassified|0
7180204|NCT01480180|11380770|FG005|Main Phase|Unclassified|0
7180205|NCT01480180|11380765|FG000|Extension Phase, Part 1|Withdrawal criteria|0
7180206|NCT01480180|11380766|FG001|Extension Phase, Part 1|Withdrawal criteria|0
7180207|NCT01480180|11380767|FG002|Extension Phase, Part 1|Withdrawal criteria|5
7180208|NCT01480180|11380768|FG003|Extension Phase, Part 1|Withdrawal criteria|0
7180209|NCT01480180|11380769|FG004|Extension Phase, Part 1|Withdrawal criteria|0
7180210|NCT01480180|11380770|FG005|Extension Phase, Part 1|Withdrawal criteria|0
7180211|NCT01480180|11380765|FG000|Extension Phase, Part 1|Unclassified|0
7180212|NCT01480180|11380766|FG001|Extension Phase, Part 1|Unclassified|0
7180213|NCT01480180|11380767|FG002|Extension Phase, Part 1|Unclassified|1
7180214|NCT01480180|11380768|FG003|Extension Phase, Part 1|Unclassified|0
6895960|NCT00630032|10914189|FG001|Overall Study|Death|49
6895961|NCT00630032|10914188|FG000|Overall Study|Withdrawal by Subject|3
6895962|NCT00630032|10914189|FG001|Overall Study|Withdrawal by Subject|2
6895963|NCT00630032|10914188|FG000|Overall Study|Lost to Follow-up|18
6895964|NCT00630032|10914189|FG001|Overall Study|Lost to Follow-up|31
6895965|NCT00630032|10914188|FG000|Overall Study|Protocol Violation|1
6895966|NCT00630032|10914189|FG001|Overall Study|Protocol Violation|0
6895967|NCT00630032|10914188|FG000|Overall Study|Patient has moved|1
6895968|NCT00630032|10914189|FG001|Overall Study|Patient has moved|1
6895969|NCT00630032|10914188|FG000|Overall Study|Disease progression|1
6895970|NCT00630032|10914189|FG001|Overall Study|Disease progression|1
6895971|NCT00630032|10914188|FG000|Overall Study|End of monitoring in US centers|11
6895972|NCT00630032|10914189|FG001|Overall Study|End of monitoring in US centers|11
6895973|NCT00630058|10914197|FG000|Overall Study|Adverse Event|1
6895974|NCT00630058|10914198|FG001|Overall Study|Adverse Event|1
6895975|NCT00630058|10914197|FG000|Overall Study|Withdrawal by Subject|0
6895976|NCT00630058|10914198|FG001|Overall Study|Withdrawal by Subject|1
6895977|NCT00630058|10914197|FG000|Overall Study|stopping criteria|3
6895978|NCT00630058|10914198|FG001|Overall Study|stopping criteria|2
6895979|NCT00630305|10914217|FG000|Overall Study|Withdrawal by Subject|1
6895980|NCT00630305|10914217|FG000|Overall Study|Inability to insert contact lens|1
6895981|NCT00630331|10914233|FG000|Overall Study|Death|2
6895982|NCT00630331|10914234|FG001|Overall Study|Death|1
6895983|NCT00630331|10914235|FG002|Overall Study|Death|1
6895984|NCT00630331|10914233|FG000|Overall Study|Adverse Event|1
6895985|NCT00630331|10914234|FG001|Overall Study|Adverse Event|0
6895986|NCT00630331|10914235|FG002|Overall Study|Adverse Event|0
6895987|NCT00630331|10914233|FG000|Overall Study|Withdrawal by Subject|12
6895988|NCT00630331|10914234|FG001|Overall Study|Withdrawal by Subject|7
6895989|NCT00630331|10914235|FG002|Overall Study|Withdrawal by Subject|5
6895990|NCT00630331|10914233|FG000|Overall Study|Lost to Follow-up|175
7180215|NCT01480180|11380769|FG004|Extension Phase, Part 1|Unclassified|0
7180216|NCT01480180|11380770|FG005|Extension Phase, Part 1|Unclassified|0
6895991|NCT00630331|10914234|FG001|Overall Study|Lost to Follow-up|143
6895992|NCT00630331|10914235|FG002|Overall Study|Lost to Follow-up|170
6895993|NCT00630331|10914233|FG000|Overall Study|Inappropriate enrollment|3
6895994|NCT00630331|10914234|FG001|Overall Study|Inappropriate enrollment|6
6895995|NCT00630331|10914235|FG002|Overall Study|Inappropriate enrollment|3
7180217|NCT01480180|11380765|FG000|Extension Phase, Part 1|Adverse Event|0
7180218|NCT01480180|11380766|FG001|Extension Phase, Part 1|Adverse Event|0
7180219|NCT01480180|11380767|FG002|Extension Phase, Part 1|Adverse Event|4
6895996|NCT00630331|10914233|FG000|Overall Study|Unable to classify|9
6895997|NCT00630331|10914234|FG001|Overall Study|Unable to classify|4
6895998|NCT00630331|10914235|FG002|Overall Study|Unable to classify|3
6895999|NCT00630331|10914233|FG000|Overall Study|Protocol Violation|4
6896000|NCT00630331|10914234|FG001|Overall Study|Protocol Violation|5
6896001|NCT00630331|10914235|FG002|Overall Study|Protocol Violation|6
6896002|NCT00630344|10914243|FG000|Overall Study|Adverse Event|5
6896003|NCT00630344|10914243|FG000|Overall Study|Progressive Disease|19
6896004|NCT00630344|10914243|FG000|Overall Study|Physician Decision|9
6896005|NCT00630344|10914243|FG000|Overall Study|Withdrawal by Subject|1
6896006|NCT00630344|10914243|FG000|Overall Study|Intercurrent Illness|1
6896007|NCT00630344|10914243|FG000|Overall Study|Other|1
6896008|NCT00630396|10914248|FG000|Overall Study|Death|4
6896009|NCT00630396|10914248|FG000|Overall Study|Lost to Follow-up|3
6896010|NCT00630539|10914261|FG000|Overall Study|Adverse Event|1
7080908|NCT02128490|11190723|FG000|Overall Study|Lost to Follow-up|0
7080909|NCT02128490|11190724|FG001|Overall Study|Lost to Follow-up|0
7080910|NCT02128490|11190725|FG002|Overall Study|Lost to Follow-up|1
7080911|NCT02128490|11190726|FG003|Overall Study|Lost to Follow-up|1
7080912|NCT02128490|11190727|FG004|Overall Study|Lost to Follow-up|1
7080913|NCT02128490|11190723|FG000|Overall Study|Voluntary Withdrawal|3
7080914|NCT02128490|11190724|FG001|Overall Study|Voluntary Withdrawal|3
7080915|NCT02128490|11190725|FG002|Overall Study|Voluntary Withdrawal|1
7080916|NCT02128490|11190726|FG003|Overall Study|Voluntary Withdrawal|1
7080917|NCT02128490|11190727|FG004|Overall Study|Voluntary Withdrawal|2
7080918|NCT02128490|11190723|FG000|Overall Study|Lack of Efficacy|0
7080919|NCT02128490|11190724|FG001|Overall Study|Lack of Efficacy|1
7080920|NCT02128490|11190725|FG002|Overall Study|Lack of Efficacy|0
7080921|NCT02128490|11190726|FG003|Overall Study|Lack of Efficacy|0
7080922|NCT02128490|11190727|FG004|Overall Study|Lack of Efficacy|0
7080923|NCT02128490|11190723|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0
7080924|NCT02128490|11190724|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0
7080925|NCT02128490|11190725|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0
7080926|NCT02128490|11190726|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0
7080927|NCT02128490|11190727|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1
7080928|NCT02128490|11190723|FG000|Overall Study|Other Miscellaneous Reasons|0
7080929|NCT02128490|11190724|FG001|Overall Study|Other Miscellaneous Reasons|0
7080930|NCT02128490|11190725|FG002|Overall Study|Other Miscellaneous Reasons|2
7080931|NCT02128490|11190726|FG003|Overall Study|Other Miscellaneous Reasons|1
7080932|NCT02128490|11190727|FG004|Overall Study|Other Miscellaneous Reasons|1
7080933|NCT02128542|11190741|FG000|Overall Study|Lost to Follow-up|3
7080934|NCT02128542|11190742|FG001|Overall Study|Lost to Follow-up|0
7080935|NCT02128542|11190741|FG000|Overall Study|Withdrew Consent|1
7080936|NCT02128542|11190742|FG001|Overall Study|Withdrew Consent|0
7080937|NCT02128724|11190754|FG000|Overall Study|Death|1
7080938|NCT02128724|11190755|FG001|Overall Study|Death|0
7080939|NCT02128724|11190756|FG002|Overall Study|Death|0
7080940|NCT02128724|11190757|FG003|Overall Study|Death|0
7080941|NCT02128724|11190754|FG000|Overall Study|Adverse Event|0
7080942|NCT02128724|11190755|FG001|Overall Study|Adverse Event|1
7080943|NCT02128724|11190756|FG002|Overall Study|Adverse Event|0
7080944|NCT02128724|11190757|FG003|Overall Study|Adverse Event|0
7080945|NCT02128724|11190754|FG000|Overall Study|Physician Decision|0
7080946|NCT02128724|11190755|FG001|Overall Study|Physician Decision|0
7080947|NCT02128724|11190756|FG002|Overall Study|Physician Decision|0
7080948|NCT02128724|11190757|FG003|Overall Study|Physician Decision|2
7080949|NCT02128724|11190754|FG000|Overall Study|Withdrawal by Subject|0
7080950|NCT02128724|11190755|FG001|Overall Study|Withdrawal by Subject|0
7080951|NCT02128724|11190756|FG002|Overall Study|Withdrawal by Subject|0
7080952|NCT02128724|11190757|FG003|Overall Study|Withdrawal by Subject|1
7080953|NCT02128763|11190768|FG000|Overall Study|Death|1
7080954|NCT02128763|11190769|FG001|Overall Study|Death|0
7080955|NCT02128763|11190768|FG000|Overall Study|Lost to Follow-up|19
7080956|NCT02128763|11190769|FG001|Overall Study|Lost to Follow-up|16
7080957|NCT02128932|11190808|FG000|Overall Study|Withdrawal by Subject|11
7080958|NCT02128932|11190809|FG001|Overall Study|Withdrawal by Subject|7
7080959|NCT02128932|11190810|FG002|Overall Study|Withdrawal by Subject|8
7080960|NCT02128932|11190808|FG000|Overall Study|Death|2
7080961|NCT02128932|11190809|FG001|Overall Study|Death|0
7080962|NCT02128932|11190810|FG002|Overall Study|Death|2
7080963|NCT02128932|11190808|FG000|Overall Study|Lost to Follow-up|2
7080964|NCT02128932|11190809|FG001|Overall Study|Lost to Follow-up|1
7080965|NCT02128932|11190810|FG002|Overall Study|Lost to Follow-up|1
7080966|NCT02128932|11190808|FG000|Overall Study|No reason for withdrawal|12
7080967|NCT02128932|11190809|FG001|Overall Study|No reason for withdrawal|11
7080968|NCT02128932|11190810|FG002|Overall Study|No reason for withdrawal|7
7080969|NCT02128997|11190820|FG000|Overall Study|Lost to Follow-up|6
6896011|NCT00630539|10914262|FG001|Overall Study|Adverse Event|3
6896012|NCT00630539|10914263|FG002|Overall Study|Adverse Event|1
6896013|NCT00630539|10914264|FG003|Overall Study|Adverse Event|2
7080970|NCT02128997|11190821|FG001|Overall Study|Lost to Follow-up|11
7080971|NCT02129062|11190827|FG000|Overall Study|Death|1
7080972|NCT02129062|11190827|FG000|Overall Study|Disease Progression|2
7080973|NCT02129192|11190844|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0
7080974|NCT02129192|11190845|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1
7080975|NCT02129205|11190864|FG000|Overall Study|Withdrawal by Subject|0
7080976|NCT02129205|11190865|FG001|Overall Study|Withdrawal by Subject|0
7080977|NCT02129205|11190866|FG002|Overall Study|Withdrawal by Subject|0
7080978|NCT02129205|11190867|FG003|Overall Study|Withdrawal by Subject|0
7080979|NCT02129205|11190868|FG004|Overall Study|Withdrawal by Subject|1
7080980|NCT02129205|11190869|FG005|Overall Study|Withdrawal by Subject|1
7080981|NCT02129205|11190870|FG006|Overall Study|Withdrawal by Subject|1
7080982|NCT02129205|11190871|FG007|Overall Study|Withdrawal by Subject|0
7080983|NCT02129205|11190872|FG008|Overall Study|Withdrawal by Subject|1
7080984|NCT02129205|11190873|FG009|Overall Study|Withdrawal by Subject|0
7080985|NCT02129205|11190864|FG000|Overall Study|Other|1
7080986|NCT02129205|11190865|FG001|Overall Study|Other|0
7080987|NCT02129205|11190866|FG002|Overall Study|Other|0
7080988|NCT02129205|11190867|FG003|Overall Study|Other|0
7080989|NCT02129205|11190868|FG004|Overall Study|Other|2
7080990|NCT02129205|11190869|FG005|Overall Study|Other|3
7080991|NCT02129205|11190870|FG006|Overall Study|Other|3
7080992|NCT02129205|11190871|FG007|Overall Study|Other|2
7080993|NCT02129205|11190872|FG008|Overall Study|Other|1
7080994|NCT02129205|11190873|FG009|Overall Study|Other|0
7082952|NCT02147158|11193690|FG004|Off-Treatment Interval 2|Protocol Violation|0
7082953|NCT02147158|11193691|FG005|Off-Treatment Interval 2|Protocol Violation|0
7082954|NCT02147158|11193686|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0
7082955|NCT02147158|11193687|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3
7082956|NCT02147158|11193688|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1
7082957|NCT02147158|11193689|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4
7082958|NCT02147158|11193690|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0
7082959|NCT02147158|11193691|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1
7082960|NCT02147197|11193711|FG000|Overall Study|Adverse Event|1
7082961|NCT02147197|11193712|FG001|Overall Study|Adverse Event|0
7082962|NCT02147197|11193713|FG002|Overall Study|Adverse Event|0
7082963|NCT02147197|11193711|FG000|Overall Study|Withdrawal of Consent|4
7082964|NCT02147197|11193712|FG001|Overall Study|Withdrawal of Consent|3
7082965|NCT02147197|11193713|FG002|Overall Study|Withdrawal of Consent|2
7082966|NCT02147197|11193711|FG000|Overall Study|Lost to Follow-up|2
7082967|NCT02147197|11193712|FG001|Overall Study|Lost to Follow-up|3
7082968|NCT02147197|11193713|FG002|Overall Study|Lost to Follow-up|1
7082969|NCT02147197|11193711|FG000|Overall Study|Protocol Violation|1
7082970|NCT02147197|11193712|FG001|Overall Study|Protocol Violation|0
7082971|NCT02147197|11193713|FG002|Overall Study|Protocol Violation|3
7082972|NCT02147197|11193711|FG000|Overall Study|Other Miscellaneous Reasons|1
7082973|NCT02147197|11193712|FG001|Overall Study|Other Miscellaneous Reasons|0
7082974|NCT02147197|11193713|FG002|Overall Study|Other Miscellaneous Reasons|3
7082975|NCT02147288|11193723|FG000|Overall Study|post-operative hematoma|1
7180220|NCT01480180|11380768|FG003|Extension Phase, Part 1|Adverse Event|1
7180221|NCT01480180|11380769|FG004|Extension Phase, Part 1|Adverse Event|0
7180222|NCT01480180|11380770|FG005|Extension Phase, Part 1|Adverse Event|0
7180223|NCT01480180|11380765|FG000|Extension Phase, Part 1|Change of treatment|0
7180224|NCT01480180|11380766|FG001|Extension Phase, Part 1|Change of treatment|0
7180225|NCT01480180|11380767|FG002|Extension Phase, Part 1|Change of treatment|0
7180226|NCT01480180|11380768|FG003|Extension Phase, Part 1|Change of treatment|9
7180227|NCT01480180|11380769|FG004|Extension Phase, Part 1|Change of treatment|0
7180228|NCT01480180|11380770|FG005|Extension Phase, Part 1|Change of treatment|0
7180229|NCT01480180|11380765|FG000|Extension Phase, Part 2|Withdrawal criteria|0
7180230|NCT01480180|11380766|FG001|Extension Phase, Part 2|Withdrawal criteria|0
7180231|NCT01480180|11380767|FG002|Extension Phase, Part 2|Withdrawal criteria|10
7180232|NCT01480180|11380768|FG003|Extension Phase, Part 2|Withdrawal criteria|6
7180233|NCT01480180|11380769|FG004|Extension Phase, Part 2|Withdrawal criteria|1
7180234|NCT01480180|11380770|FG005|Extension Phase, Part 2|Withdrawal criteria|0
7180235|NCT01480180|11380765|FG000|Extension Phase, Part 2|Lack of Efficacy|0
7180236|NCT01480180|11380766|FG001|Extension Phase, Part 2|Lack of Efficacy|0
7180237|NCT01480180|11380767|FG002|Extension Phase, Part 2|Lack of Efficacy|4
7180238|NCT01480180|11380768|FG003|Extension Phase, Part 2|Lack of Efficacy|0
7180239|NCT01480180|11380769|FG004|Extension Phase, Part 2|Lack of Efficacy|0
7180240|NCT01480180|11380770|FG005|Extension Phase, Part 2|Lack of Efficacy|0
7180241|NCT01480180|11380765|FG000|Extension Phase, Part 2|Unclassified|0
7180242|NCT01480180|11380766|FG001|Extension Phase, Part 2|Unclassified|0
7180243|NCT01480180|11380767|FG002|Extension Phase, Part 2|Unclassified|3
7180244|NCT01480180|11380768|FG003|Extension Phase, Part 2|Unclassified|1
7180245|NCT01480180|11380769|FG004|Extension Phase, Part 2|Unclassified|1
6973241|NCT01179191|11024904|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47
7082976|NCT02147288|11193724|FG001|Overall Study|post-operative hematoma|1
7082977|NCT02147288|11193725|FG002|Overall Study|post-operative hematoma|0
7082978|NCT02147288|11193726|FG003|Overall Study|post-operative hematoma|0
7082979|NCT02147288|11193727|FG004|Overall Study|post-operative hematoma|0
7082980|NCT02147288|11193728|FG005|Overall Study|post-operative hematoma|0
7082981|NCT02147288|11193729|FG006|Overall Study|post-operative hematoma|0
7082982|NCT02147288|11193730|FG007|Overall Study|post-operative hematoma|0
7082983|NCT02147288|11193731|FG008|Overall Study|post-operative hematoma|0
7082984|NCT02147288|11193732|FG009|Overall Study|post-operative hematoma|0
7082985|NCT02147288|11193723|FG000|Overall Study|complications from concurrent hernia rep|0
7082986|NCT02147288|11193724|FG001|Overall Study|complications from concurrent hernia rep|1
7180246|NCT01480180|11380770|FG005|Extension Phase, Part 2|Unclassified|0
6973242|NCT01179191|11024904|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19
6973243|NCT01179191|11024904|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30
6973244|NCT01179191|11024904|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162
7180247|NCT01545050|11380806|FG000|Overall Study|Lack of Efficacy|0
7180248|NCT01545050|11380807|FG001|Overall Study|Lack of Efficacy|0
7180249|NCT01545050|11380808|FG002|Overall Study|Lack of Efficacy|0
7180250|NCT01545050|11380809|FG003|Overall Study|Lack of Efficacy|3
7180251|NCT01545050|11380810|FG004|Overall Study|Lack of Efficacy|2
7180252|NCT01545050|11380806|FG000|Overall Study|Adverse Event|1
7180253|NCT01545050|11380807|FG001|Overall Study|Adverse Event|1
7180254|NCT01545050|11380808|FG002|Overall Study|Adverse Event|2
7180255|NCT01545050|11380809|FG003|Overall Study|Adverse Event|2
7180256|NCT01545050|11380810|FG004|Overall Study|Adverse Event|0
7180257|NCT01545050|11380806|FG000|Overall Study|Discontinued study treatment|1
7180258|NCT01545050|11380807|FG001|Overall Study|Discontinued study treatment|0
7180259|NCT01545050|11380808|FG002|Overall Study|Discontinued study treatment|0
7180260|NCT01545050|11380809|FG003|Overall Study|Discontinued study treatment|0
7180261|NCT01545050|11380810|FG004|Overall Study|Discontinued study treatment|0
7180262|NCT01545050|11380806|FG000|Overall Study|Withdrawal by Subject|1
7180263|NCT01545050|11380807|FG001|Overall Study|Withdrawal by Subject|0
7180264|NCT01545050|11380808|FG002|Overall Study|Withdrawal by Subject|0
7180265|NCT01545050|11380809|FG003|Overall Study|Withdrawal by Subject|2
7180266|NCT01545050|11380810|FG004|Overall Study|Withdrawal by Subject|1
7180267|NCT01545050|11380806|FG000|Overall Study|Participant no longer meets study criteria|0
7180268|NCT01545050|11380807|FG001|Overall Study|Participant no longer meets study criteria|2
7180269|NCT01545050|11380808|FG002|Overall Study|Participant no longer meets study criteria|0
7180270|NCT01545050|11380809|FG003|Overall Study|Participant no longer meets study criteria|0
7180271|NCT01545050|11380810|FG004|Overall Study|Participant no longer meets study criteria|1
7180272|NCT01545050|11380806|FG000|Overall Study|Administrative reason by sponsor|4
7180273|NCT01545050|11380807|FG001|Overall Study|Administrative reason by sponsor|2
7180274|NCT01545050|11380808|FG002|Overall Study|Administrative reason by sponsor|3
7180275|NCT01545050|11380809|FG003|Overall Study|Administrative reason by sponsor|5
7180276|NCT01545050|11380810|FG004|Overall Study|Administrative reason by sponsor|5
7186647|NCT02431702|11386994|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0
7186648|NCT02431702|11386995|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0
7186649|NCT02431702|11386996|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0
7186650|NCT02431702|11386997|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5
7186651|NCT02431702|11386998|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6
7186652|NCT02431702|11386999|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6
7186653|NCT02431702|11387000|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0
7186654|NCT02431702|11386994|FG000|Part 3: 9 Month of Additional Treatment|Other|0
7186655|NCT02431702|11386995|FG001|Part 3: 9 Month of Additional Treatment|Other|0
7186656|NCT02431702|11386996|FG002|Part 3: 9 Month of Additional Treatment|Other|0
7186657|NCT02431702|11386997|FG003|Part 3: 9 Month of Additional Treatment|Other|1
7186658|NCT02431702|11386998|FG004|Part 3: 9 Month of Additional Treatment|Other|1
7186659|NCT02431702|11386999|FG005|Part 3: 9 Month of Additional Treatment|Other|6
7186660|NCT02431702|11387000|FG006|Part 3: 9 Month of Additional Treatment|Other|0
7186661|NCT02200770|11387037|FG000|Randomized-controlled Period (RCP)|Adverse Event|0
7186662|NCT02200770|11387038|FG001|Randomized-controlled Period (RCP)|Adverse Event|2
7186663|NCT02200770|11387037|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1
7186664|NCT02200770|11387038|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1
7186665|NCT02200770|11387037|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0
7186666|NCT02200770|11387038|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1
7186667|NCT02200770|11387037|FG000|Randomized-controlled Period (RCP)|Other|1
7186668|NCT02200770|11387038|FG001|Randomized-controlled Period (RCP)|Other|2
7186669|NCT02200770|11387037|FG000|Open-label Period (OLP)|Adverse Event|1
7186670|NCT02200770|11387038|FG001|Open-label Period (OLP)|Adverse Event|2
7186671|NCT02200770|11387037|FG000|Open-label Period (OLP)|Death|1
7186672|NCT02200770|11387038|FG001|Open-label Period (OLP)|Death|2
7186673|NCT02200770|11387037|FG000|Open-label Period (OLP)|Lost to Follow-up|0
7186674|NCT02200770|11387038|FG001|Open-label Period (OLP)|Lost to Follow-up|1
7186675|NCT02200770|11387037|FG000|Open-label Period (OLP)|Withdrawal by Subject|0
7186676|NCT02200770|11387038|FG001|Open-label Period (OLP)|Withdrawal by Subject|14
7186677|NCT02200770|11387037|FG000|Open-label Period (OLP)|Other|6
7186678|NCT02200770|11387038|FG001|Open-label Period (OLP)|Other|15
7186679|NCT02136069|11387048|FG000|Overall Study|UC flare-up|1
7186680|NCT02136069|11387049|FG001|Overall Study|UC flare-up|0
7186681|NCT02136069|11387048|FG000|Overall Study|Adverse Event|6
7186682|NCT02136069|11387049|FG001|Overall Study|Adverse Event|8
7186683|NCT02136069|11387048|FG000|Overall Study|Death|0
7186684|NCT02136069|11387049|FG001|Overall Study|Death|1
7186685|NCT02136069|11387048|FG000|Overall Study|Lack of Efficacy|10
7186686|NCT02136069|11387049|FG001|Overall Study|Lack of Efficacy|4
7186687|NCT02136069|11387048|FG000|Overall Study|Lost to Follow-up|1
7186688|NCT02136069|11387049|FG001|Overall Study|Lost to Follow-up|0
7186689|NCT02136069|11387048|FG000|Overall Study|Non-Compliance|1
7186690|NCT02136069|11387049|FG001|Overall Study|Non-Compliance|0
7186691|NCT02136069|11387048|FG000|Overall Study|Physician Decision|5
7186692|NCT02136069|11387049|FG001|Overall Study|Physician Decision|4
7186693|NCT02136069|11387048|FG000|Overall Study|Withdrawal by Subject|10
7186694|NCT02136069|11387049|FG001|Overall Study|Withdrawal by Subject|11
7186695|NCT02086552|11387055|FG000|Overall Study|Withdrawal by Subject|1
7186696|NCT01209767|11387064|FG000|Overall Study|Withdrawal by Subject|1
7186697|NCT01209767|11387064|FG000|Overall Study|Lost to Follow-up|3
7186698|NCT01186848|11387072|FG000|Overall Study|Lost to Follow-up|4
7186699|NCT01186848|11387072|FG000|Overall Study|Withdrawal by Subject|2
7186700|NCT01186848|11387072|FG000|Overall Study|Adverse Event|2
7186701|NCT01024608|11387089|FG000|Overall Study|Adverse Event|1
7186702|NCT01024608|11387090|FG001|Overall Study|Adverse Event|0
7186703|NCT01024608|11387089|FG000|Overall Study|Withdrawal by Subject|1
7186704|NCT01024608|11387090|FG001|Overall Study|Withdrawal by Subject|0
7186705|NCT01024608|11387089|FG000|Overall Study|Lost to Follow-up|0
7186706|NCT01024608|11387090|FG001|Overall Study|Lost to Follow-up|1
7186707|NCT01024608|11387089|FG000|Overall Study|Protocol Violation|0
7186708|NCT01024608|11387090|FG001|Overall Study|Protocol Violation|3
7186709|NCT01024608|11387089|FG000|Overall Study|Never received study treatment|2
7186710|NCT01024608|11387090|FG001|Overall Study|Never received study treatment|0
7186711|NCT00988247|11387098|FG000|Overall Study|Adverse Event|17
7180277|NCT01555021|11380837|FG000|Overall Study|Lost to Follow-up|1
7180278|NCT01555021|11380838|FG001|Overall Study|Lost to Follow-up|2
7180279|NCT01561430|11380854|FG000|Overall Study|Adverse Event|0
7180280|NCT01561430|11380855|FG001|Overall Study|Adverse Event|0
7180281|NCT01561430|11380856|FG002|Overall Study|Adverse Event|3
7180282|NCT01561430|11380857|FG003|Overall Study|Adverse Event|1
7180283|NCT01561430|11380854|FG000|Overall Study|Withdrawal by Subject|0
7180284|NCT01561430|11380855|FG001|Overall Study|Withdrawal by Subject|0
7180285|NCT01561430|11380856|FG002|Overall Study|Withdrawal by Subject|1
7180286|NCT01561430|11380857|FG003|Overall Study|Withdrawal by Subject|0
7180287|NCT01561430|11380854|FG000|Overall Study|Physician Decision|0
7180288|NCT01561430|11380855|FG001|Overall Study|Physician Decision|1
7180289|NCT01561430|11380856|FG002|Overall Study|Physician Decision|0
7180290|NCT01561430|11380857|FG003|Overall Study|Physician Decision|0
7180291|NCT01561430|11380854|FG000|Overall Study|Sponsor Decision|1
7180292|NCT01561430|11380855|FG001|Overall Study|Sponsor Decision|14
7180293|NCT01561430|11380856|FG002|Overall Study|Sponsor Decision|13
7180294|NCT01561430|11380857|FG003|Overall Study|Sponsor Decision|12
7180295|NCT01595009|11380877|FG000|Core|Patients completed per protocol|85
7180296|NCT01595009|11380878|FG001|Core|Patients completed per protocol|44
7180297|NCT01595009|11380879|FG002|Core|Patients completed per protocol|0
7180298|NCT01595009|11380880|FG003|Core|Patients completed per protocol|0
7180299|NCT01595009|11380877|FG000|Core|Adverse Event|19
7180300|NCT01595009|11380878|FG001|Core|Adverse Event|23
7180301|NCT01595009|11380879|FG002|Core|Adverse Event|0
7180302|NCT01595009|11380880|FG003|Core|Adverse Event|0
7180303|NCT01595009|11380877|FG000|Core|Disease progression|14
7180304|NCT01595009|11380878|FG001|Core|Disease progression|26
7180305|NCT01595009|11380879|FG002|Core|Disease progression|0
7180306|NCT01595009|11380880|FG003|Core|Disease progression|0
7180307|NCT01595009|11380877|FG000|Core|Withdrawal by Subject|4
7180308|NCT01595009|11380878|FG001|Core|Withdrawal by Subject|17
7180309|NCT01595009|11380879|FG002|Core|Withdrawal by Subject|0
7180310|NCT01595009|11380880|FG003|Core|Withdrawal by Subject|0
7180311|NCT01595009|11380877|FG000|Core|Death|3
7180312|NCT01595009|11380878|FG001|Core|Death|6
7180313|NCT01595009|11380879|FG002|Core|Death|0
7180314|NCT01595009|11380880|FG003|Core|Death|0
7180315|NCT01595009|11380877|FG000|Core|Lost to Follow-up|1
7180316|NCT01595009|11380878|FG001|Core|Lost to Follow-up|2
7180317|NCT01595009|11380879|FG002|Core|Lost to Follow-up|0
7180318|NCT01595009|11380880|FG003|Core|Lost to Follow-up|0
7180319|NCT01595009|11380877|FG000|Core|Protocol deviation|0
7180320|NCT01595009|11380878|FG001|Core|Protocol deviation|1
7180321|NCT01595009|11380879|FG002|Core|Protocol deviation|0
7180322|NCT01595009|11380880|FG003|Core|Protocol deviation|0
7180323|NCT01595009|11380877|FG000|Core|Administrative problems|0
7180324|NCT01595009|11380878|FG001|Core|Administrative problems|1
7180325|NCT01595009|11380879|FG002|Core|Administrative problems|0
7180326|NCT01595009|11380880|FG003|Core|Administrative problems|0
7180327|NCT01595009|11380877|FG000|Extension|Administrative problems|0
7180328|NCT01595009|11380878|FG001|Extension|Administrative problems|0
7180329|NCT01595009|11380879|FG002|Extension|Administrative problems|0
7180330|NCT01595009|11380880|FG003|Extension|Administrative problems|1
7180331|NCT01595009|11380877|FG000|Extension|Patients completed per protocol|0
7180332|NCT01595009|11380878|FG001|Extension|Patients completed per protocol|0
7180333|NCT01595009|11380879|FG002|Extension|Patients completed per protocol|0
7180334|NCT01595009|11380880|FG003|Extension|Patients completed per protocol|2
7180335|NCT01595009|11380877|FG000|Extension|Disease progression|0
7180336|NCT01595009|11380878|FG001|Extension|Disease progression|0
7180337|NCT01595009|11380879|FG002|Extension|Disease progression|4
7180338|NCT01595009|11380880|FG003|Extension|Disease progression|7
7180339|NCT01595009|11380877|FG000|Extension|Adverse Event|0
7180340|NCT01595009|11380878|FG001|Extension|Adverse Event|0
7180341|NCT01595009|11380879|FG002|Extension|Adverse Event|0
7180342|NCT01595009|11380880|FG003|Extension|Adverse Event|1
7180343|NCT01620944|11380908|FG000|Overall Study|Early termination of Study|2
7180344|NCT01620944|11380909|FG001|Overall Study|Early termination of Study|1
7180345|NCT01627561|11380917|FG000|Overall Study|Lost to Follow-up|1
7180346|NCT01627561|11380918|FG001|Overall Study|Lost to Follow-up|0
7180347|NCT01627561|11380917|FG000|Overall Study|Withdrawal by Subject|0
7180348|NCT01627561|11380918|FG001|Overall Study|Withdrawal by Subject|1
7180349|NCT01627561|11380917|FG000|Overall Study|Migrated/moved from study area|0
7180350|NCT01627561|11380918|FG001|Overall Study|Migrated/moved from study area|2
7180351|NCT01652534|11380943|FG000|Overall Study|Lack of Efficacy|1
7180352|NCT01652534|11380944|FG001|Overall Study|Lack of Efficacy|0
7180353|NCT04799405|11380970|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2
7180354|NCT04537949|11380986|FG000|Overall Study|personal reasons not related to the IMP|1
7180355|NCT04537949|11380987|FG001|Overall Study|personal reasons not related to the IMP|0
7180356|NCT04537949|11380988|FG002|Overall Study|personal reasons not related to the IMP|0
7180357|NCT04537949|11380989|FG003|Overall Study|personal reasons not related to the IMP|0
7180358|NCT04537949|11380990|FG004|Overall Study|personal reasons not related to the IMP|0
7180359|NCT04537949|11380991|FG005|Overall Study|personal reasons not related to the IMP|0
7180360|NCT04537949|11380992|FG006|Overall Study|personal reasons not related to the IMP|0
7180361|NCT04537949|11380993|FG007|Overall Study|personal reasons not related to the IMP|0
7180362|NCT04529499|11381013|FG000|Overall Study|Withdrawal by Subject|9
7180363|NCT04529499|11381014|FG001|Overall Study|Withdrawal by Subject|11
7180364|NCT04529499|11381013|FG000|Overall Study|Physician Decision|1
7180365|NCT04529499|11381014|FG001|Overall Study|Physician Decision|2
7180366|NCT04529499|11381013|FG000|Overall Study|Adverse Event|4
7180367|NCT04529499|11381014|FG001|Overall Study|Adverse Event|4
7180368|NCT04529499|11381013|FG000|Overall Study|Death|14
7180369|NCT04529499|11381014|FG001|Overall Study|Death|11
7180370|NCT04529499|11381013|FG000|Overall Study|Lost to Follow-up|1
7180371|NCT04529499|11381014|FG001|Overall Study|Lost to Follow-up|1
7180372|NCT04529499|11381013|FG000|Overall Study|Others|7
7180373|NCT04529499|11381014|FG001|Overall Study|Others|11
7180374|NCT04501094|11381022|FG000|Overall Study|Death (unrelated to research)|1
7180375|NCT04501094|11381023|FG001|Overall Study|Death (unrelated to research)|0
7186712|NCT00988247|11387099|FG001|Overall Study|Adverse Event|3
7186713|NCT00988247|11387098|FG000|Overall Study|Withdrawal by Subject|44
7186714|NCT00988247|11387099|FG001|Overall Study|Withdrawal by Subject|13
7186715|NCT00988247|11387098|FG000|Overall Study|Pregnancy|1
7186716|NCT00988247|11387099|FG001|Overall Study|Pregnancy|2
7186717|NCT00988247|11387098|FG000|Overall Study|Lost to Follow-up|11
7186718|NCT00988247|11387099|FG001|Overall Study|Lost to Follow-up|2
7186719|NCT00988247|11387098|FG000|Overall Study|Protocol Violation|4
7186720|NCT00988247|11387099|FG001|Overall Study|Protocol Violation|5
7186721|NCT00988247|11387098|FG000|Overall Study|Sponsor requested withdrawal|3
7186722|NCT00988247|11387099|FG001|Overall Study|Sponsor requested withdrawal|1
7186723|NCT00988247|11387098|FG000|Overall Study|Other|3
7186724|NCT00988247|11387099|FG001|Overall Study|Other|0
7186725|NCT00730639|11387131|FG000|Overall Study|Adverse Event|3
7186726|NCT00730639|11387132|FG001|Overall Study|Adverse Event|0
7186727|NCT00730639|11387133|FG002|Overall Study|Adverse Event|9
7186728|NCT00730639|11387134|FG003|Overall Study|Adverse Event|8
7186729|NCT00730639|11387135|FG004|Overall Study|Adverse Event|23
7186730|NCT00730639|11387131|FG000|Overall Study|Complete Response|0
7186731|NCT00730639|11387132|FG001|Overall Study|Complete Response|0
7186732|NCT00730639|11387133|FG002|Overall Study|Complete Response|2
7186733|NCT00730639|11387134|FG003|Overall Study|Complete Response|2
7186734|NCT00730639|11387135|FG004|Overall Study|Complete Response|1
7186735|NCT00730639|11387131|FG000|Overall Study|Completed Maximum Cycles|0
7186736|NCT00730639|11387132|FG001|Overall Study|Completed Maximum Cycles|0
7186737|NCT00730639|11387133|FG002|Overall Study|Completed Maximum Cycles|11
7186738|NCT00730639|11387134|FG003|Overall Study|Completed Maximum Cycles|3
7186739|NCT00730639|11387135|FG004|Overall Study|Completed Maximum Cycles|6
7186740|NCT00730639|11387131|FG000|Overall Study|Death|0
7186741|NCT00730639|11387132|FG001|Overall Study|Death|0
7186742|NCT00730639|11387133|FG002|Overall Study|Death|0
7186743|NCT00730639|11387134|FG003|Overall Study|Death|0
7186744|NCT00730639|11387135|FG004|Overall Study|Death|2
7186745|NCT00730639|11387131|FG000|Overall Study|Disease Progression|12
7186746|NCT00730639|11387132|FG001|Overall Study|Disease Progression|13
7186747|NCT00730639|11387133|FG002|Overall Study|Disease Progression|48
7186748|NCT00730639|11387134|FG003|Overall Study|Disease Progression|32
7186749|NCT00730639|11387135|FG004|Overall Study|Disease Progression|88
7186750|NCT00730639|11387131|FG000|Overall Study|non-specified|0
7186751|NCT00730639|11387132|FG001|Overall Study|non-specified|0
7186752|NCT00730639|11387133|FG002|Overall Study|non-specified|4
7186753|NCT00730639|11387134|FG003|Overall Study|non-specified|2
7186754|NCT00730639|11387135|FG004|Overall Study|non-specified|3
7186755|NCT00730639|11387131|FG000|Overall Study|Protocol Violation|0
7186756|NCT00730639|11387132|FG001|Overall Study|Protocol Violation|0
7186757|NCT00730639|11387133|FG002|Overall Study|Protocol Violation|1
7186758|NCT00730639|11387134|FG003|Overall Study|Protocol Violation|0
7186759|NCT00730639|11387135|FG004|Overall Study|Protocol Violation|0
7186760|NCT00730639|11387131|FG000|Overall Study|Withdrawal by Subject|0
7186761|NCT00730639|11387132|FG001|Overall Study|Withdrawal by Subject|0
7186762|NCT00730639|11387133|FG002|Overall Study|Withdrawal by Subject|6
7186763|NCT00730639|11387134|FG003|Overall Study|Withdrawal by Subject|3
7186764|NCT00730639|11387135|FG004|Overall Study|Withdrawal by Subject|4
7186765|NCT00730639|11387131|FG000|Overall Study|Treatment on-going|2
7186766|NCT00730639|11387132|FG001|Overall Study|Treatment on-going|5
7186767|NCT00730639|11387133|FG002|Overall Study|Treatment on-going|5
7186768|NCT00730639|11387134|FG003|Overall Study|Treatment on-going|4
7186769|NCT00730639|11387135|FG004|Overall Study|Treatment on-going|4
7188198|NCT02906020|11388821|FG010|Part 1: Dose Escalation Period|Adverse Event|0
7188199|NCT02906020|11388822|FG011|Part 1: Dose Escalation Period|Adverse Event|0
7188200|NCT02906020|11388823|FG012|Part 1: Dose Escalation Period|Adverse Event|0
7188201|NCT02906020|11388824|FG013|Part 1: Dose Escalation Period|Adverse Event|0
7188202|NCT02906020|11388825|FG014|Part 1: Dose Escalation Period|Adverse Event|0
7188203|NCT02906020|11388826|FG015|Part 1: Dose Escalation Period|Adverse Event|0
7188204|NCT02906020|11388811|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0
7188205|NCT02906020|11388812|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0
7188206|NCT02906020|11388813|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0
7188207|NCT02906020|11388814|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0
7188208|NCT02906020|11388815|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0
7188209|NCT02906020|11388816|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0
7180376|NCT04414618|11381031|FG000|Overall Study|Death|3
7180377|NCT04414618|11381032|FG001|Overall Study|Death|3
7180378|NCT04414618|11381031|FG000|Overall Study|Withdrawal by Subject|2
7180379|NCT04414618|11381032|FG001|Overall Study|Withdrawal by Subject|1
7180380|NCT04414618|11381031|FG000|Overall Study|Lost to Follow-up|2
7180381|NCT04414618|11381032|FG001|Overall Study|Lost to Follow-up|3
7180382|NCT04414618|11381031|FG000|Overall Study|Physician Decision|1
7180383|NCT04414618|11381032|FG001|Overall Study|Physician Decision|0
7180384|NCT04412057|11381041|FG000|Overall Study|Death|3
7180385|NCT04412057|11381042|FG001|Overall Study|Death|7
7180386|NCT04412057|11381041|FG000|Overall Study|Discharged prior to receiving study treatment|1
7180387|NCT04412057|11381042|FG001|Overall Study|Discharged prior to receiving study treatment|0
7180388|NCT04402060|11381051|FG000|Overall Study|Death|1
7180389|NCT04402060|11381052|FG001|Overall Study|Death|12
7180390|NCT04402060|11381053|FG002|Overall Study|Death|7
7180391|NCT04402060|11381051|FG000|Overall Study|Adverse Event|0
7180392|NCT04402060|11381052|FG001|Overall Study|Adverse Event|0
7180393|NCT04402060|11381053|FG002|Overall Study|Adverse Event|1
7180394|NCT04402060|11381051|FG000|Overall Study|Withdrawal by Subject|0
7180395|NCT04402060|11381052|FG001|Overall Study|Withdrawal by Subject|1
7180396|NCT04402060|11381053|FG002|Overall Study|Withdrawal by Subject|2
7180397|NCT04402060|11381051|FG000|Overall Study|Sponsor Request|0
7180398|NCT04402060|11381052|FG001|Overall Study|Sponsor Request|2
7180399|NCT04402060|11381053|FG002|Overall Study|Sponsor Request|0
7180400|NCT04402060|11381051|FG000|Overall Study|Physician Decision|0
7180401|NCT04402060|11381052|FG001|Overall Study|Physician Decision|0
7180402|NCT04402060|11381053|FG002|Overall Study|Physician Decision|1
7180403|NCT04402060|11381051|FG000|Overall Study|Other|0
7180404|NCT04402060|11381052|FG001|Overall Study|Other|1
7180405|NCT04402060|11381053|FG002|Overall Study|Other|0
7180406|NCT04396626|11381066|FG000|Overall Study|Premature termination of study|975
7180407|NCT04376684|11381092|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7
7180408|NCT04376684|11381093|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8
7180409|NCT04376684|11381094|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0
7180410|NCT04376684|11381095|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0
7180411|NCT04376684|11381092|FG000|Part 1 (Up to Day 60)|Protocol Violation|2
7180412|NCT04376684|11381093|FG001|Part 1 (Up to Day 60)|Protocol Violation|3
7180413|NCT04376684|11381094|FG002|Part 1 (Up to Day 60)|Protocol Violation|0
7180414|NCT04376684|11381095|FG003|Part 1 (Up to Day 60)|Protocol Violation|0
7180415|NCT04376684|11381092|FG000|Part 1 (Up to Day 60)|Physician Decision|2
7180416|NCT04376684|11381093|FG001|Part 1 (Up to Day 60)|Physician Decision|5
7180417|NCT04376684|11381094|FG002|Part 1 (Up to Day 60)|Physician Decision|0
7180418|NCT04376684|11381095|FG003|Part 1 (Up to Day 60)|Physician Decision|0
7180419|NCT04376684|11381092|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4
7180420|NCT04376684|11381093|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8
7180421|NCT04376684|11381094|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0
7180422|NCT04376684|11381095|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0
7180423|NCT04376684|11381092|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0
7180424|NCT04376684|11381093|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0
7180425|NCT04376684|11381094|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1
7180426|NCT04376684|11381095|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1
7180427|NCT04376684|11381092|FG000|Part 2 (Up to Day 60)|Physician Decision|0
7180428|NCT04376684|11381093|FG001|Part 2 (Up to Day 60)|Physician Decision|0
7180429|NCT04376684|11381094|FG002|Part 2 (Up to Day 60)|Physician Decision|1
7180430|NCT04376684|11381095|FG003|Part 2 (Up to Day 60)|Physician Decision|1
7180431|NCT04376684|11381092|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0
7180432|NCT04376684|11381093|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0
7180433|NCT04376684|11381094|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3
7180434|NCT04376684|11381095|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2
7180435|NCT04353284|11381107|FG000|Overall Study|Adverse Event|1
7180436|NCT04353284|11381108|FG001|Overall Study|Adverse Event|1
7180437|NCT04353284|11381107|FG000|Overall Study|Lost to Follow-up|1
7180438|NCT04353284|11381108|FG001|Overall Study|Lost to Follow-up|0
7180439|NCT04294147|11381116|FG000|Overall Study|Protocol Violation|2
7180440|NCT04294147|11381117|FG001|Overall Study|Protocol Violation|0
7180441|NCT04231825|11381129|FG000|Overall Study|Protocol Violation|3
7180442|NCT04231825|11381130|FG001|Overall Study|Protocol Violation|3
7180443|NCT04231825|11381129|FG000|Overall Study|Lost to Follow-up|0
7180444|NCT04231825|11381130|FG001|Overall Study|Lost to Follow-up|1
7180445|NCT04196686|11381136|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0
7180446|NCT04196686|11381137|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3
7180447|NCT04178772|11381143|FG000|Overall Study|Unsatisfacotry VIsual Response|1
7180448|NCT04178772|11381143|FG000|Overall Study|study terminated early due to COVID-19|7
7180449|NCT04148651|11381147|FG000|Overall Study|Lost to Follow-up|2
7180450|NCT03893448|11381162|FG000|Overall Study|Withdrawal by Parent/Guardian|59
7180451|NCT03893448|11381163|FG001|Overall Study|Withdrawal by Parent/Guardian|85
7180452|NCT03893448|11381162|FG000|Overall Study|Physician Decision|8
7180453|NCT03893448|11381163|FG001|Overall Study|Physician Decision|14
7180454|NCT03893448|11381162|FG000|Overall Study|Lost to Follow-up|34
7180455|NCT03893448|11381163|FG001|Overall Study|Lost to Follow-up|27
7180456|NCT03893448|11381162|FG000|Overall Study|Death|1
7180457|NCT03893448|11381163|FG001|Overall Study|Death|0
7180458|NCT03814590|11381218|FG000|Overall Study|Adverse Event|0
7180459|NCT03814590|11381219|FG001|Overall Study|Adverse Event|0
7180460|NCT03814590|11381220|FG002|Overall Study|Adverse Event|0
7180461|NCT03814590|11381221|FG003|Overall Study|Adverse Event|0
7180462|NCT03814590|11381222|FG004|Overall Study|Adverse Event|0
7180463|NCT03814590|11381223|FG005|Overall Study|Adverse Event|1
7180464|NCT03814590|11381224|FG006|Overall Study|Adverse Event|1
7180465|NCT03814590|11381225|FG007|Overall Study|Adverse Event|1
7180466|NCT03814590|11381226|FG008|Overall Study|Adverse Event|0
7180467|NCT03814590|11381227|FG009|Overall Study|Adverse Event|0
7180468|NCT03814590|11381228|FG010|Overall Study|Adverse Event|1
7180469|NCT03814590|11381229|FG011|Overall Study|Adverse Event|0
7180470|NCT03814590|11381230|FG012|Overall Study|Adverse Event|3
7180471|NCT03814590|11381231|FG013|Overall Study|Adverse Event|0
7180472|NCT03814590|11381218|FG000|Overall Study|Lost to Follow-up|0
7180473|NCT03814590|11381219|FG001|Overall Study|Lost to Follow-up|2
7180474|NCT03814590|11381220|FG002|Overall Study|Lost to Follow-up|1
7180475|NCT03814590|11381221|FG003|Overall Study|Lost to Follow-up|0
7180476|NCT03814590|11381222|FG004|Overall Study|Lost to Follow-up|1
7180477|NCT03814590|11381223|FG005|Overall Study|Lost to Follow-up|1
7180478|NCT03814590|11381224|FG006|Overall Study|Lost to Follow-up|1
7180479|NCT03814590|11381225|FG007|Overall Study|Lost to Follow-up|1
7180480|NCT03814590|11381226|FG008|Overall Study|Lost to Follow-up|0
7180481|NCT03814590|11381227|FG009|Overall Study|Lost to Follow-up|0
7180482|NCT03814590|11381228|FG010|Overall Study|Lost to Follow-up|1
7180483|NCT03814590|11381229|FG011|Overall Study|Lost to Follow-up|0
7180484|NCT03814590|11381230|FG012|Overall Study|Lost to Follow-up|0
7180485|NCT03814590|11381231|FG013|Overall Study|Lost to Follow-up|1
7180486|NCT03814590|11381218|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
7180487|NCT03814590|11381219|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
7180488|NCT03814590|11381220|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
7180489|NCT03814590|11381221|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
7180490|NCT03814590|11381222|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
7180491|NCT03814590|11381223|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
7180492|NCT03814590|11381224|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
7180493|NCT03814590|11381225|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
7180494|NCT03814590|11381226|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
7180495|NCT03814590|11381227|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1
7180496|NCT03814590|11381228|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
7180497|NCT03814590|11381229|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
7180498|NCT03814590|11381230|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
7180499|NCT03814590|11381231|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
7180500|NCT03814590|11381218|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0
7180501|NCT03814590|11381219|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0
7180502|NCT03814590|11381220|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0
7180503|NCT03814590|11381221|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0
7180504|NCT03814590|11381222|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0
7180505|NCT03814590|11381223|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3
7180506|NCT03814590|11381224|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1
7180507|NCT03814590|11381225|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2
7180508|NCT03814590|11381226|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0
7180509|NCT03814590|11381227|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3
7180510|NCT03814590|11381228|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1
7180511|NCT03814590|11381229|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0
7180512|NCT03814590|11381230|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1
7180513|NCT03814590|11381231|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2
7180514|NCT03814590|11381218|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7180515|NCT03814590|11381219|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7180516|NCT03814590|11381220|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7180517|NCT03814590|11381221|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7180518|NCT03814590|11381222|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7180519|NCT03814590|11381223|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7180520|NCT03814590|11381224|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7180521|NCT03814590|11381225|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
7180522|NCT03814590|11381226|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7180523|NCT03814590|11381227|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
7180524|NCT03814590|11381228|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7180525|NCT03814590|11381229|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7180526|NCT03814590|11381230|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7180527|NCT03814590|11381231|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7180528|NCT03814590|11381218|FG000|Overall Study|UNKNOWN REASON|0
7180529|NCT03814590|11381219|FG001|Overall Study|UNKNOWN REASON|0
7180530|NCT03814590|11381220|FG002|Overall Study|UNKNOWN REASON|0
7180531|NCT03814590|11381221|FG003|Overall Study|UNKNOWN REASON|0
7180532|NCT03814590|11381222|FG004|Overall Study|UNKNOWN REASON|0
7180533|NCT03814590|11381223|FG005|Overall Study|UNKNOWN REASON|0
7180534|NCT03814590|11381224|FG006|Overall Study|UNKNOWN REASON|0
7180535|NCT03814590|11381225|FG007|Overall Study|UNKNOWN REASON|1
7180536|NCT03814590|11381226|FG008|Overall Study|UNKNOWN REASON|0
7180537|NCT03814590|11381227|FG009|Overall Study|UNKNOWN REASON|0
7180538|NCT03814590|11381228|FG010|Overall Study|UNKNOWN REASON|0
7180539|NCT03814590|11381229|FG011|Overall Study|UNKNOWN REASON|0
7180540|NCT03814590|11381230|FG012|Overall Study|UNKNOWN REASON|0
7180541|NCT03814590|11381231|FG013|Overall Study|UNKNOWN REASON|0
7186770|NCT04834362|11387164|FG000|Overall Study|Death|1
7186771|NCT04834362|11387165|FG001|Overall Study|Death|2
7186772|NCT04611789|11387191|FG000|Overall Study|Lost to Follow-up|1
7186773|NCT04611789|11387192|FG001|Overall Study|Lost to Follow-up|0
7186774|NCT04611789|11387193|FG002|Overall Study|Lost to Follow-up|0
7188210|NCT02906020|11388817|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0
7188211|NCT02906020|11388818|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0
7188212|NCT02906020|11388819|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6
7188213|NCT02906020|11388820|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15
7188214|NCT02906020|11388821|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0
7188215|NCT02906020|11388822|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0
7188216|NCT02906020|11388823|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0
7188217|NCT02906020|11388824|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0
7188218|NCT02906020|11388825|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0
7188219|NCT02906020|11388826|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0
7188220|NCT02906020|11388811|FG000|Part 2: Double-blind Treatment Period|Other|0
7188221|NCT02906020|11388812|FG001|Part 2: Double-blind Treatment Period|Other|0
7188222|NCT02906020|11388813|FG002|Part 2: Double-blind Treatment Period|Other|0
7188223|NCT02906020|11388814|FG003|Part 2: Double-blind Treatment Period|Other|0
7188224|NCT02906020|11388815|FG004|Part 2: Double-blind Treatment Period|Other|0
7188225|NCT02906020|11388816|FG005|Part 2: Double-blind Treatment Period|Other|0
7188226|NCT02906020|11388817|FG006|Part 2: Double-blind Treatment Period|Other|0
7188227|NCT02906020|11388818|FG007|Part 2: Double-blind Treatment Period|Other|0
7188228|NCT02906020|11388819|FG008|Part 2: Double-blind Treatment Period|Other|6
7188229|NCT02906020|11388820|FG009|Part 2: Double-blind Treatment Period|Other|10
7188230|NCT02906020|11388821|FG010|Part 2: Double-blind Treatment Period|Other|0
7188231|NCT02906020|11388822|FG011|Part 2: Double-blind Treatment Period|Other|0
7188232|NCT02906020|11388823|FG012|Part 2: Double-blind Treatment Period|Other|0
7188233|NCT02906020|11388824|FG013|Part 2: Double-blind Treatment Period|Other|0
7188234|NCT02906020|11388825|FG014|Part 2: Double-blind Treatment Period|Other|0
7188235|NCT02906020|11388826|FG015|Part 2: Double-blind Treatment Period|Other|0
7188236|NCT02906020|11388811|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0
7188237|NCT02906020|11388812|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0
7188238|NCT02906020|11388813|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0
7188239|NCT02906020|11388814|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0
7188240|NCT02906020|11388815|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0
7188241|NCT02906020|11388816|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0
7188242|NCT02906020|11388817|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0
7188243|NCT02906020|11388818|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0
7188244|NCT02906020|11388819|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0
7188245|NCT02906020|11388820|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0
7188246|NCT02906020|11388821|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0
7188247|NCT02906020|11388822|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0
7188248|NCT02906020|11388823|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10
7188249|NCT02906020|11388824|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4
7188250|NCT02906020|11388825|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0
7188251|NCT02906020|11388826|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0
7188252|NCT02906020|11388811|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0
7188253|NCT02906020|11388812|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0
7188254|NCT02906020|11388813|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0
7188255|NCT02906020|11388814|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0
7188256|NCT02906020|11388815|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0
7188257|NCT02906020|11388816|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0
7188258|NCT02906020|11388817|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0
7188259|NCT02906020|11388818|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0
7188260|NCT02906020|11388819|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0
7188261|NCT02906020|11388820|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0
7188262|NCT02906020|11388821|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0
7188263|NCT02906020|11388822|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0
7188264|NCT02906020|11388823|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7
7180542|NCT03811574|11381274|FG000|Overall Study|Withdrawal by Subject|2
7180543|NCT03811574|11381275|FG001|Overall Study|Withdrawal by Subject|4
7180544|NCT03811574|11381276|FG002|Overall Study|Withdrawal by Subject|0
7180545|NCT03727750|11381312|FG000|Overall Study|Death|45
7180546|NCT03727750|11381312|FG000|Overall Study|Withdrawal by Subject|2
7180547|NCT03727750|11381312|FG000|Overall Study|Lost to Follow-up|1
7180548|NCT03727750|11381312|FG000|Overall Study|Other|1
7180549|NCT03715829|11381322|FG000|Dose Ranging Period|Adverse Event|2
7180550|NCT03715829|11381323|FG001|Dose Ranging Period|Adverse Event|4
7180551|NCT03715829|11381324|FG002|Dose Ranging Period|Adverse Event|5
7180552|NCT03715829|11381325|FG003|Dose Ranging Period|Adverse Event|2
7180553|NCT03715829|11381326|FG004|Dose Ranging Period|Adverse Event|3
7180554|NCT03715829|11381327|FG005|Dose Ranging Period|Adverse Event|3
7180555|NCT03715829|11381328|FG006|Dose Ranging Period|Adverse Event|0
7180556|NCT03715829|11381329|FG007|Dose Ranging Period|Adverse Event|0
7180557|NCT03715829|11381330|FG008|Dose Ranging Period|Adverse Event|0
7180558|NCT03715829|11381331|FG009|Dose Ranging Period|Adverse Event|0
7180559|NCT03715829|11381332|FG010|Dose Ranging Period|Adverse Event|0
7180560|NCT03715829|11381322|FG000|Dose Ranging Period|Lack of Efficacy|0
7180561|NCT03715829|11381323|FG001|Dose Ranging Period|Lack of Efficacy|1
7180562|NCT03715829|11381324|FG002|Dose Ranging Period|Lack of Efficacy|0
7180563|NCT03715829|11381325|FG003|Dose Ranging Period|Lack of Efficacy|1
7180564|NCT03715829|11381326|FG004|Dose Ranging Period|Lack of Efficacy|0
7180565|NCT03715829|11381327|FG005|Dose Ranging Period|Lack of Efficacy|0
7180566|NCT03715829|11381328|FG006|Dose Ranging Period|Lack of Efficacy|0
7180567|NCT03715829|11381329|FG007|Dose Ranging Period|Lack of Efficacy|0
7180568|NCT03715829|11381330|FG008|Dose Ranging Period|Lack of Efficacy|0
7180569|NCT03715829|11381331|FG009|Dose Ranging Period|Lack of Efficacy|0
7180570|NCT03715829|11381332|FG010|Dose Ranging Period|Lack of Efficacy|0
7180571|NCT03715829|11381322|FG000|Dose Ranging Period|Lost to Follow-up|2
7180572|NCT03715829|11381323|FG001|Dose Ranging Period|Lost to Follow-up|0
7180573|NCT03715829|11381324|FG002|Dose Ranging Period|Lost to Follow-up|1
7180574|NCT03715829|11381325|FG003|Dose Ranging Period|Lost to Follow-up|1
7180575|NCT03715829|11381326|FG004|Dose Ranging Period|Lost to Follow-up|1
7180576|NCT03715829|11381327|FG005|Dose Ranging Period|Lost to Follow-up|2
7180577|NCT03715829|11381328|FG006|Dose Ranging Period|Lost to Follow-up|0
7180578|NCT03715829|11381329|FG007|Dose Ranging Period|Lost to Follow-up|0
7180579|NCT03715829|11381330|FG008|Dose Ranging Period|Lost to Follow-up|0
7180580|NCT03715829|11381331|FG009|Dose Ranging Period|Lost to Follow-up|0
7180581|NCT03715829|11381332|FG010|Dose Ranging Period|Lost to Follow-up|0
7180582|NCT03715829|11381322|FG000|Dose Ranging Period|Protocol Violation|0
7180583|NCT03715829|11381323|FG001|Dose Ranging Period|Protocol Violation|0
7180584|NCT03715829|11381324|FG002|Dose Ranging Period|Protocol Violation|0
7180585|NCT03715829|11381325|FG003|Dose Ranging Period|Protocol Violation|1
7180586|NCT03715829|11381326|FG004|Dose Ranging Period|Protocol Violation|0
7180587|NCT03715829|11381327|FG005|Dose Ranging Period|Protocol Violation|0
7180588|NCT03715829|11381328|FG006|Dose Ranging Period|Protocol Violation|0
7180589|NCT03715829|11381329|FG007|Dose Ranging Period|Protocol Violation|0
7180590|NCT03715829|11381330|FG008|Dose Ranging Period|Protocol Violation|0
7180591|NCT03715829|11381331|FG009|Dose Ranging Period|Protocol Violation|0
7180592|NCT03715829|11381332|FG010|Dose Ranging Period|Protocol Violation|0
7180593|NCT03715829|11381322|FG000|Dose Ranging Period|Withdrawal by Subject|8
7180594|NCT03715829|11381323|FG001|Dose Ranging Period|Withdrawal by Subject|4
7180595|NCT03715829|11381324|FG002|Dose Ranging Period|Withdrawal by Subject|3
7180596|NCT03715829|11381325|FG003|Dose Ranging Period|Withdrawal by Subject|9
7180597|NCT03715829|11381326|FG004|Dose Ranging Period|Withdrawal by Subject|2
7180598|NCT03715829|11381327|FG005|Dose Ranging Period|Withdrawal by Subject|3
7180599|NCT03715829|11381328|FG006|Dose Ranging Period|Withdrawal by Subject|0
7180600|NCT03715829|11381329|FG007|Dose Ranging Period|Withdrawal by Subject|0
7180601|NCT03715829|11381330|FG008|Dose Ranging Period|Withdrawal by Subject|0
7180602|NCT03715829|11381331|FG009|Dose Ranging Period|Withdrawal by Subject|0
7180603|NCT03715829|11381332|FG010|Dose Ranging Period|Withdrawal by Subject|0
7180604|NCT03715829|11381322|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
7180605|NCT03715829|11381323|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
7180606|NCT03715829|11381324|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1
7180607|NCT03715829|11381325|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
7180608|NCT03715829|11381326|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
7180609|NCT03715829|11381327|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
7180610|NCT03715829|11381328|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
7180611|NCT03715829|11381329|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
7180612|NCT03715829|11381330|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
7180613|NCT03715829|11381331|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
7180614|NCT03715829|11381332|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
7180615|NCT03715829|11381322|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0
7180616|NCT03715829|11381323|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0
7180617|NCT03715829|11381324|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1
7180618|NCT03715829|11381325|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0
7180619|NCT03715829|11381326|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1
7180620|NCT03715829|11381327|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0
7180621|NCT03715829|11381328|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0
7180622|NCT03715829|11381329|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0
7180623|NCT03715829|11381330|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0
7180624|NCT03715829|11381331|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0
7180625|NCT03715829|11381332|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0
7180626|NCT03715829|11381322|FG000|Dose Ranging Period|Other|0
7180627|NCT03715829|11381323|FG001|Dose Ranging Period|Other|0
7180628|NCT03715829|11381324|FG002|Dose Ranging Period|Other|2
7080995|NCT02129608|11190928|FG000|Overall Study|Lost to Follow-up|0
7080996|NCT02129608|11190929|FG001|Overall Study|Lost to Follow-up|1
7180629|NCT03715829|11381325|FG003|Dose Ranging Period|Other|0
7180630|NCT03715829|11381326|FG004|Dose Ranging Period|Other|0
7180631|NCT03715829|11381327|FG005|Dose Ranging Period|Other|3
7180632|NCT03715829|11381328|FG006|Dose Ranging Period|Other|0
7180633|NCT03715829|11381329|FG007|Dose Ranging Period|Other|0
7180634|NCT03715829|11381330|FG008|Dose Ranging Period|Other|0
7180635|NCT03715829|11381331|FG009|Dose Ranging Period|Other|0
7180636|NCT03715829|11381332|FG010|Dose Ranging Period|Other|0
7180637|NCT03715829|11381322|FG000|Extension Period|Adverse Event|0
7180638|NCT03715829|11381323|FG001|Extension Period|Adverse Event|0
7180639|NCT03715829|11381324|FG002|Extension Period|Adverse Event|0
7180640|NCT03715829|11381325|FG003|Extension Period|Adverse Event|0
7180641|NCT03715829|11381326|FG004|Extension Period|Adverse Event|0
7180642|NCT03715829|11381327|FG005|Extension Period|Adverse Event|0
7180643|NCT03715829|11381328|FG006|Extension Period|Adverse Event|3
7180644|NCT03715829|11381329|FG007|Extension Period|Adverse Event|1
7180645|NCT03715829|11381330|FG008|Extension Period|Adverse Event|6
7180646|NCT03715829|11381331|FG009|Extension Period|Adverse Event|0
7180647|NCT03715829|11381332|FG010|Extension Period|Adverse Event|0
7180648|NCT03715829|11381322|FG000|Extension Period|Lack of Efficacy|0
7180649|NCT03715829|11381323|FG001|Extension Period|Lack of Efficacy|0
7180650|NCT03715829|11381324|FG002|Extension Period|Lack of Efficacy|0
7180651|NCT03715829|11381325|FG003|Extension Period|Lack of Efficacy|0
7180652|NCT03715829|11381326|FG004|Extension Period|Lack of Efficacy|0
7180653|NCT03715829|11381327|FG005|Extension Period|Lack of Efficacy|0
7180654|NCT03715829|11381328|FG006|Extension Period|Lack of Efficacy|1
7180655|NCT03715829|11381329|FG007|Extension Period|Lack of Efficacy|9
7180656|NCT03715829|11381330|FG008|Extension Period|Lack of Efficacy|2
7180657|NCT03715829|11381331|FG009|Extension Period|Lack of Efficacy|0
7180658|NCT03715829|11381332|FG010|Extension Period|Lack of Efficacy|0
7180659|NCT03715829|11381322|FG000|Extension Period|Lost to Follow-up|0
7180660|NCT03715829|11381323|FG001|Extension Period|Lost to Follow-up|0
7180661|NCT03715829|11381324|FG002|Extension Period|Lost to Follow-up|0
7180662|NCT03715829|11381325|FG003|Extension Period|Lost to Follow-up|0
7180663|NCT03715829|11381326|FG004|Extension Period|Lost to Follow-up|0
7180664|NCT03715829|11381327|FG005|Extension Period|Lost to Follow-up|0
7180665|NCT03715829|11381328|FG006|Extension Period|Lost to Follow-up|0
7180666|NCT03715829|11381329|FG007|Extension Period|Lost to Follow-up|0
7180667|NCT03715829|11381330|FG008|Extension Period|Lost to Follow-up|2
7180668|NCT03715829|11381331|FG009|Extension Period|Lost to Follow-up|0
7180669|NCT03715829|11381332|FG010|Extension Period|Lost to Follow-up|0
7180670|NCT03715829|11381322|FG000|Extension Period|Protocol Violation|0
7180671|NCT03715829|11381323|FG001|Extension Period|Protocol Violation|0
7180672|NCT03715829|11381324|FG002|Extension Period|Protocol Violation|0
7180673|NCT03715829|11381325|FG003|Extension Period|Protocol Violation|0
7180674|NCT03715829|11381326|FG004|Extension Period|Protocol Violation|0
7180675|NCT03715829|11381327|FG005|Extension Period|Protocol Violation|0
7180676|NCT03715829|11381328|FG006|Extension Period|Protocol Violation|0
7180677|NCT03715829|11381329|FG007|Extension Period|Protocol Violation|0
7180678|NCT03715829|11381330|FG008|Extension Period|Protocol Violation|1
7180679|NCT03715829|11381331|FG009|Extension Period|Protocol Violation|0
7180680|NCT03715829|11381332|FG010|Extension Period|Protocol Violation|0
7180681|NCT03715829|11381322|FG000|Extension Period|Withdrawal by Subject|0
7180682|NCT03715829|11381323|FG001|Extension Period|Withdrawal by Subject|0
7180683|NCT03715829|11381324|FG002|Extension Period|Withdrawal by Subject|0
7180684|NCT03715829|11381325|FG003|Extension Period|Withdrawal by Subject|0
7180685|NCT03715829|11381326|FG004|Extension Period|Withdrawal by Subject|0
7180686|NCT03715829|11381327|FG005|Extension Period|Withdrawal by Subject|0
7180687|NCT03715829|11381328|FG006|Extension Period|Withdrawal by Subject|3
7180688|NCT03715829|11381329|FG007|Extension Period|Withdrawal by Subject|3
7180689|NCT03715829|11381330|FG008|Extension Period|Withdrawal by Subject|12
7180690|NCT03715829|11381331|FG009|Extension Period|Withdrawal by Subject|3
7180691|NCT03715829|11381332|FG010|Extension Period|Withdrawal by Subject|0
7180692|NCT03715829|11381322|FG000|Extension Period|Medication Error Without Associated Adverse Event|0
7180693|NCT03715829|11381323|FG001|Extension Period|Medication Error Without Associated Adverse Event|0
7180694|NCT03715829|11381324|FG002|Extension Period|Medication Error Without Associated Adverse Event|0
7180695|NCT03715829|11381325|FG003|Extension Period|Medication Error Without Associated Adverse Event|0
7180696|NCT03715829|11381326|FG004|Extension Period|Medication Error Without Associated Adverse Event|0
7180697|NCT03715829|11381327|FG005|Extension Period|Medication Error Without Associated Adverse Event|0
7186775|NCT04254809|11387256|FG000|Overall Study|Lost to Follow-up|5
7186776|NCT04254809|11387257|FG001|Overall Study|Lost to Follow-up|10
7180698|NCT03715829|11381328|FG006|Extension Period|Medication Error Without Associated Adverse Event|0
7180699|NCT03715829|11381329|FG007|Extension Period|Medication Error Without Associated Adverse Event|1
7180700|NCT03715829|11381330|FG008|Extension Period|Medication Error Without Associated Adverse Event|1
7180701|NCT03715829|11381331|FG009|Extension Period|Medication Error Without Associated Adverse Event|0
7180702|NCT03715829|11381332|FG010|Extension Period|Medication Error Without Associated Adverse Event|0
7180703|NCT03715829|11381322|FG000|Extension Period|No Longer Meets Eligibility Criteria|0
7180704|NCT03715829|11381323|FG001|Extension Period|No Longer Meets Eligibility Criteria|0
7180705|NCT03715829|11381324|FG002|Extension Period|No Longer Meets Eligibility Criteria|0
7180706|NCT03715829|11381325|FG003|Extension Period|No Longer Meets Eligibility Criteria|0
7180707|NCT03715829|11381326|FG004|Extension Period|No Longer Meets Eligibility Criteria|0
7180708|NCT03715829|11381327|FG005|Extension Period|No Longer Meets Eligibility Criteria|0
7180709|NCT03715829|11381328|FG006|Extension Period|No Longer Meets Eligibility Criteria|0
7180710|NCT03715829|11381329|FG007|Extension Period|No Longer Meets Eligibility Criteria|0
7180711|NCT03715829|11381330|FG008|Extension Period|No Longer Meets Eligibility Criteria|1
7180712|NCT03715829|11381331|FG009|Extension Period|No Longer Meets Eligibility Criteria|0
7180713|NCT03715829|11381332|FG010|Extension Period|No Longer Meets Eligibility Criteria|0
7180714|NCT03715829|11381322|FG000|Extension Period|Other|0
7180715|NCT03715829|11381323|FG001|Extension Period|Other|0
7180716|NCT03715829|11381324|FG002|Extension Period|Other|0
7180717|NCT03715829|11381325|FG003|Extension Period|Other|0
7180718|NCT03715829|11381326|FG004|Extension Period|Other|0
7180719|NCT03715829|11381327|FG005|Extension Period|Other|0
7180720|NCT03715829|11381328|FG006|Extension Period|Other|1
7180721|NCT03715829|11381329|FG007|Extension Period|Other|2
7180722|NCT03715829|11381330|FG008|Extension Period|Other|4
7180723|NCT03715829|11381331|FG009|Extension Period|Other|0
7180724|NCT03715829|11381332|FG010|Extension Period|Other|0
7180725|NCT03693430|11381360|FG000|Overall Study|Lost to Follow-up|3
7180726|NCT03693430|11381361|FG001|Overall Study|Lost to Follow-up|14
7180727|NCT03693430|11381360|FG000|Overall Study|Death|1
7180728|NCT03693430|11381361|FG001|Overall Study|Death|0
7180729|NCT03693430|11381360|FG000|Overall Study|Withdrawal by Subject|0
7180730|NCT03693430|11381361|FG001|Overall Study|Withdrawal by Subject|4
7180731|NCT03677934|11381369|FG000|Overall Study|Study is ongoing|240
7180732|NCT03677934|11381370|FG001|Overall Study|Study is ongoing|161
7180733|NCT03677934|11381369|FG000|Overall Study|Adverse Event|5
7180734|NCT03677934|11381370|FG001|Overall Study|Adverse Event|0
7180735|NCT03677934|11381369|FG000|Overall Study|Death|2
7180736|NCT03677934|11381370|FG001|Overall Study|Death|0
7180737|NCT03677934|11381369|FG000|Overall Study|Withdrawal by Subject|0
7180738|NCT03677934|11381370|FG001|Overall Study|Withdrawal by Subject|5
7180739|NCT03677934|11381369|FG000|Overall Study|Physician Decision|0
7180740|NCT03677934|11381370|FG001|Overall Study|Physician Decision|1
7180741|NCT03677934|11381369|FG000|Overall Study|Damaged implant (no associated AE reported)|1
7180742|NCT03677934|11381370|FG001|Overall Study|Damaged implant (no associated AE reported)|0
7186777|NCT04230122|11387265|FG000|Overall Study|Lost to Follow-up|1
7186778|NCT04230122|11387266|FG001|Overall Study|Lost to Follow-up|0
7186779|NCT04033068|11387295|FG000|Overall Study|Withdrawal by Subject|0
7186780|NCT04033068|11387296|FG001|Overall Study|Withdrawal by Subject|0
7186781|NCT04033068|11387297|FG002|Overall Study|Withdrawal by Subject|1
7186782|NCT04033068|11387298|FG003|Overall Study|Withdrawal by Subject|0
7186783|NCT04033068|11387295|FG000|Overall Study|Lost to Follow-up|0
7186784|NCT04033068|11387296|FG001|Overall Study|Lost to Follow-up|1
7186785|NCT04033068|11387297|FG002|Overall Study|Lost to Follow-up|0
7186786|NCT04033068|11387298|FG003|Overall Study|Lost to Follow-up|0
7186787|NCT04033068|11387295|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0
7186788|NCT04033068|11387296|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0
7186789|NCT04033068|11387297|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0
7186790|NCT04033068|11387298|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1
7186791|NCT03561597|11387308|FG000|Overall Study|Lost to Follow-up|20
7186792|NCT03350984|11387323|FG000|Overall Study|Death|1
7186793|NCT03350984|11387324|FG001|Overall Study|Death|0
7186794|NCT03350984|11387323|FG000|Overall Study|Lost to Follow-up|5
7186795|NCT03350984|11387324|FG001|Overall Study|Lost to Follow-up|6
7186796|NCT03350984|11387323|FG000|Overall Study|Protocol Violation|1
7186797|NCT03350984|11387324|FG001|Overall Study|Protocol Violation|2
7186798|NCT03350984|11387323|FG000|Overall Study|Physician Decision|1
7186799|NCT03350984|11387324|FG001|Overall Study|Physician Decision|0
7186800|NCT03277261|11387332|FG000|Overall Study|Adverse Event|17
7186801|NCT03277261|11387333|FG001|Overall Study|Adverse Event|1
7186802|NCT03277261|11387332|FG000|Overall Study|Participant Withdrawal of Consent|6
7186803|NCT03277261|11387333|FG001|Overall Study|Participant Withdrawal of Consent|15
7186804|NCT03277261|11387332|FG000|Overall Study|Investigator / Sponsor Decision|4
7186805|NCT03277261|11387333|FG001|Overall Study|Investigator / Sponsor Decision|2
7186806|NCT03277261|11387332|FG000|Overall Study|Pregnancy|2
7186807|NCT03277261|11387333|FG001|Overall Study|Pregnancy|0
7186808|NCT03277261|11387332|FG000|Overall Study|Lost to Follow-up|2
7186809|NCT03277261|11387333|FG001|Overall Study|Lost to Follow-up|2
7186810|NCT03277261|11387332|FG000|Overall Study|Lack of Efficacy|2
7186811|NCT03277261|11387333|FG001|Overall Study|Lack of Efficacy|2
7186812|NCT03277261|11387332|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1
7180743|NCT03575104|11381412|FG000|Overall Study|Adverse Event|4
7180744|NCT03575104|11381413|FG001|Overall Study|Adverse Event|3
7180745|NCT03575104|11381414|FG002|Overall Study|Adverse Event|4
7180746|NCT03575104|11381412|FG000|Overall Study|Withdrawal by Subject|13
7180747|NCT03575104|11381413|FG001|Overall Study|Withdrawal by Subject|16
7180748|NCT03575104|11381414|FG002|Overall Study|Withdrawal by Subject|11
7180749|NCT03575104|11381412|FG000|Overall Study|Other reasons|6
7180750|NCT03575104|11381413|FG001|Overall Study|Other reasons|8
7180751|NCT03575104|11381414|FG002|Overall Study|Other reasons|6
7180752|NCT03575104|11381412|FG000|Overall Study|Lost to Follow-up|1
7180753|NCT03575104|11381413|FG001|Overall Study|Lost to Follow-up|2
7180754|NCT03575104|11381414|FG002|Overall Study|Lost to Follow-up|1
7180755|NCT03569475|11381425|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
7180756|NCT03569475|11381426|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2
7180757|NCT03569475|11381427|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5
7180758|NCT03569475|11381425|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0
7180759|NCT03569475|11381426|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
7180760|NCT03569475|11381427|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0
7180761|NCT03569475|11381425|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7
7180762|NCT03569475|11381426|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10
7180763|NCT03569475|11381427|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9
7180764|NCT03569475|11381425|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7
7180765|NCT03569475|11381426|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7
7180766|NCT03569475|11381427|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6
7180767|NCT03569475|11381425|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1
7180768|NCT03569475|11381426|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1
7180769|NCT03569475|11381427|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1
7180770|NCT03569475|11381425|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1
7180771|NCT03569475|11381426|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1
7180772|NCT03569475|11381427|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1
7180773|NCT03569475|11381425|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1
7180774|NCT03569475|11381426|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1
7180775|NCT03569475|11381427|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2
7180776|NCT03569475|11381425|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0
7180777|NCT03569475|11381426|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1
7180778|NCT03569475|11381427|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1
7180779|NCT03569475|11381425|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0
7180780|NCT03569475|11381426|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1
7180781|NCT03569475|11381427|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1
7180782|NCT03545191|11381481|FG000|Overall Study|Death|1
7180783|NCT03545191|11381482|FG001|Overall Study|Death|0
7180784|NCT03545191|11381483|FG002|Overall Study|Death|0
7180785|NCT03545191|11381481|FG000|Overall Study|Adverse Event|4
7180786|NCT03545191|11381482|FG001|Overall Study|Adverse Event|2
7180787|NCT03545191|11381483|FG002|Overall Study|Adverse Event|7
7180788|NCT03545191|11381481|FG000|Overall Study|Other reasons|3
7180789|NCT03545191|11381482|FG001|Overall Study|Other reasons|11
7180790|NCT03545191|11381483|FG002|Overall Study|Other reasons|8
7180791|NCT03545191|11381481|FG000|Overall Study|Withdrawal by Subject|13
7180792|NCT03545191|11381482|FG001|Overall Study|Withdrawal by Subject|10
7180793|NCT03545191|11381483|FG002|Overall Study|Withdrawal by Subject|12
7180794|NCT03545191|11381481|FG000|Overall Study|Lost to Follow-up|1
7180795|NCT03545191|11381482|FG001|Overall Study|Lost to Follow-up|2
7180796|NCT03545191|11381483|FG002|Overall Study|Lost to Follow-up|3
7180797|NCT03500549|11381493|FG000|RCP (Day 1 - Week 16)|Adverse Event|3
7180798|NCT03500549|11381494|FG001|RCP (Day 1 - Week 16)|Adverse Event|0
7180799|NCT03500549|11381493|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3
7180800|NCT03500549|11381494|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7
7180801|NCT03456700|11381505|FG000|Overall Study|Withdrawal by Subject|1
7180802|NCT03427411|11381520|FG000|Overall Study|Screen failure - platelets too low|0
7180803|NCT03427411|11381521|FG001|Overall Study|Screen failure - platelets too low|1
7180804|NCT03387150|11381534|FG000|Overall Study|Withdrawal by Subject|3
7180805|NCT03387150|11381535|FG001|Overall Study|Withdrawal by Subject|0
7180806|NCT03387150|11381536|FG002|Overall Study|Withdrawal by Subject|3
7180807|NCT03387150|11381537|FG003|Overall Study|Withdrawal by Subject|4
7180808|NCT03387150|11381538|FG004|Overall Study|Withdrawal by Subject|1
7180809|NCT03387150|11381539|FG005|Overall Study|Withdrawal by Subject|2
7180810|NCT03387150|11381540|FG006|Overall Study|Withdrawal by Subject|0
7180811|NCT03387150|11381534|FG000|Overall Study|Lost to Follow-up|3
7180812|NCT03387150|11381535|FG001|Overall Study|Lost to Follow-up|2
7180813|NCT03387150|11381536|FG002|Overall Study|Lost to Follow-up|2
7180814|NCT03387150|11381537|FG003|Overall Study|Lost to Follow-up|3
7180815|NCT03387150|11381538|FG004|Overall Study|Lost to Follow-up|3
7180816|NCT03387150|11381539|FG005|Overall Study|Lost to Follow-up|3
7180817|NCT03387150|11381540|FG006|Overall Study|Lost to Follow-up|0
7180818|NCT03387150|11381534|FG000|Overall Study|Participant unable to adhere to visit|0
7180819|NCT03387150|11381535|FG001|Overall Study|Participant unable to adhere to visit|1
7180820|NCT03387150|11381536|FG002|Overall Study|Participant unable to adhere to visit|0
7180821|NCT03387150|11381537|FG003|Overall Study|Participant unable to adhere to visit|0
7180822|NCT03387150|11381538|FG004|Overall Study|Participant unable to adhere to visit|2
7180823|NCT03387150|11381539|FG005|Overall Study|Participant unable to adhere to visit|2
7180824|NCT03387150|11381540|FG006|Overall Study|Participant unable to adhere to visit|0
7180825|NCT03370133|11381559|FG000|Initial Treatment Period (WK 16)|Adverse Event|5
7180826|NCT03370133|11381560|FG001|Initial Treatment Period (WK 16)|Adverse Event|5
7180827|NCT03370133|11381561|FG002|Initial Treatment Period (WK 16)|Adverse Event|2
7180828|NCT03370133|11381562|FG003|Initial Treatment Period (WK 16)|Adverse Event|0
7180829|NCT03370133|11381563|FG004|Initial Treatment Period (WK 16)|Adverse Event|0
7180830|NCT03370133|11381564|FG005|Initial Treatment Period (WK 16)|Adverse Event|0
7180831|NCT03370133|11381559|FG000|Initial Treatment Period (WK 16)|Death|1
7180832|NCT03370133|11381560|FG001|Initial Treatment Period (WK 16)|Death|1
7180833|NCT03370133|11381561|FG002|Initial Treatment Period (WK 16)|Death|1
7180834|NCT03370133|11381562|FG003|Initial Treatment Period (WK 16)|Death|0
7180835|NCT03370133|11381563|FG004|Initial Treatment Period (WK 16)|Death|0
7180836|NCT03370133|11381564|FG005|Initial Treatment Period (WK 16)|Death|0
7180837|NCT03370133|11381559|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2
7180838|NCT03370133|11381560|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1
7180839|NCT03370133|11381561|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0
7180840|NCT03370133|11381562|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0
7180841|NCT03370133|11381563|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0
7180842|NCT03370133|11381564|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0
7180843|NCT03370133|11381559|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0
7180844|NCT03370133|11381560|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0
7180845|NCT03370133|11381561|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2
7180846|NCT03370133|11381562|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0
7180847|NCT03370133|11381563|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0
7180848|NCT03370133|11381564|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0
7180849|NCT03370133|11381559|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0
7180850|NCT03370133|11381560|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3
7180851|NCT03370133|11381561|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0
7180852|NCT03370133|11381562|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0
7180853|NCT03370133|11381563|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0
7180854|NCT03370133|11381564|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0
7180855|NCT03370133|11381559|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1
7180856|NCT03370133|11381560|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2
7180857|NCT03370133|11381561|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1
7180858|NCT03370133|11381562|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0
7180859|NCT03370133|11381563|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0
7180860|NCT03370133|11381564|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0
7180861|NCT03370133|11381559|FG000|Initial Treatment Period (WK 16)|Non-compliance|0
7180862|NCT03370133|11381560|FG001|Initial Treatment Period (WK 16)|Non-compliance|1
7180863|NCT03370133|11381561|FG002|Initial Treatment Period (WK 16)|Non-compliance|0
7180864|NCT03370133|11381562|FG003|Initial Treatment Period (WK 16)|Non-compliance|0
7180865|NCT03370133|11381563|FG004|Initial Treatment Period (WK 16)|Non-compliance|0
7180866|NCT03370133|11381564|FG005|Initial Treatment Period (WK 16)|Non-compliance|0
7180867|NCT03370133|11381559|FG000|Initial Treatment Period (WK 16)|Site closed|0
7180868|NCT03370133|11381560|FG001|Initial Treatment Period (WK 16)|Site closed|2
7180869|NCT03370133|11381561|FG002|Initial Treatment Period (WK 16)|Site closed|0
7180870|NCT03370133|11381562|FG003|Initial Treatment Period (WK 16)|Site closed|0
7180871|NCT03370133|11381563|FG004|Initial Treatment Period (WK 16)|Site closed|0
7180872|NCT03370133|11381564|FG005|Initial Treatment Period (WK 16)|Site closed|0
7180873|NCT03370133|11381559|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0
7180874|NCT03370133|11381560|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0
7180875|NCT03370133|11381561|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0
7180876|NCT03370133|11381562|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3
7180877|NCT03370133|11381563|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12
7180878|NCT03370133|11381564|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4
7180879|NCT03370133|11381559|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0
7180880|NCT03370133|11381560|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0
7180881|NCT03370133|11381561|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0
7180882|NCT03370133|11381562|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0
7180883|NCT03370133|11381563|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1
7180884|NCT03370133|11381564|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4
7180885|NCT03370133|11381559|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0
7180886|NCT03370133|11381560|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0
7180887|NCT03370133|11381561|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0
7180888|NCT03370133|11381562|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1
7180889|NCT03370133|11381563|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1
7180890|NCT03370133|11381564|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0
7180891|NCT03370133|11381559|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0
7180892|NCT03370133|11381560|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0
7180893|NCT03370133|11381561|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0
7180894|NCT03370133|11381562|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0
7180895|NCT03370133|11381563|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4
7180896|NCT03370133|11381564|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3
7180897|NCT03370133|11381559|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0
7180898|NCT03370133|11381560|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0
7180899|NCT03370133|11381561|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0
7180900|NCT03370133|11381562|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1
7180901|NCT03370133|11381563|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4
7180902|NCT03370133|11381564|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4
7180903|NCT03370133|11381559|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0
7180904|NCT03370133|11381560|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0
7180905|NCT03370133|11381561|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0
7180906|NCT03370133|11381562|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0
7180907|NCT03370133|11381563|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1
7180908|NCT03370133|11381564|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0
7180909|NCT03370133|11381559|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0
7180910|NCT03370133|11381560|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0
7180911|NCT03370133|11381561|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0
7180912|NCT03370133|11381562|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0
7180913|NCT03370133|11381563|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0
7180914|NCT03370133|11381564|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1
7180915|NCT03366792|11381582|FG000|Overall Study|Withdrawal by Subject|7
7180916|NCT03366792|11381582|FG000|Overall Study|Lost to Follow-up|2
7180917|NCT03366792|11381582|FG000|Overall Study|Ineligible (could not reach perinium)|2
7180918|NCT03366792|11381582|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4
7180919|NCT03366337|11381590|FG000|Overall Study|Lost to Follow-up|1
7180920|NCT03366337|11381591|FG001|Overall Study|Lost to Follow-up|0
7180921|NCT03366337|11381592|FG002|Overall Study|Lost to Follow-up|1
7180922|NCT03366337|11381593|FG003|Overall Study|Lost to Follow-up|0
7180923|NCT03366337|11381590|FG000|Overall Study|Withdrawal by Subject|2
7180924|NCT03366337|11381591|FG001|Overall Study|Withdrawal by Subject|0
7180925|NCT03366337|11381592|FG002|Overall Study|Withdrawal by Subject|1
7180926|NCT03366337|11381593|FG003|Overall Study|Withdrawal by Subject|1
7180927|NCT03342053|11381605|FG000|Overall Study|Adverse Event|2
7180928|NCT03342053|11381606|FG001|Overall Study|Adverse Event|0
7180929|NCT03342053|11381605|FG000|Overall Study|Withdrawal by Subject|0
7180930|NCT03342053|11381606|FG001|Overall Study|Withdrawal by Subject|1
7180931|NCT03330847|11381615|FG000|Overall Study|Patients ongoing study|62
7180932|NCT03330847|11381616|FG001|Overall Study|Patients ongoing study|65
7180933|NCT03330847|11381617|FG002|Overall Study|Patients ongoing study|15
7180934|NCT03283241|11381629|FG000|Overall Study|Adverse Event|4
7180935|NCT03283241|11381630|FG001|Overall Study|Adverse Event|1
7180936|NCT03283241|11381629|FG000|Overall Study|Withdrawal by Subject|0
7180937|NCT03283241|11381630|FG001|Overall Study|Withdrawal by Subject|1
7180938|NCT03283241|11381629|FG000|Overall Study|Subject relocated to Finland|0
7180939|NCT03283241|11381630|FG001|Overall Study|Subject relocated to Finland|1
7180940|NCT03242772|11381638|FG000|Overall Study|Lost to Follow-up|2
7180941|NCT03242772|11381639|FG001|Overall Study|Lost to Follow-up|0
7180942|NCT03242772|11381638|FG000|Overall Study|Physician Decision|0
7180943|NCT03242772|11381639|FG001|Overall Study|Physician Decision|1
7180944|NCT03242772|11381638|FG000|Overall Study|Withdrawal by Subject|1
7180945|NCT03242772|11381639|FG001|Overall Study|Withdrawal by Subject|0
7180946|NCT03236311|11381647|FG000|Overall Study|Study terminated by sponsor|0
7180947|NCT03236311|11381648|FG001|Overall Study|Study terminated by sponsor|2
7180948|NCT03236311|11381647|FG000|Overall Study|Adverse Event|0
7180949|NCT03236311|11381648|FG001|Overall Study|Adverse Event|1
7180950|NCT03192046|11381656|FG000|Overall Study|Withdrawal by Subject|1
7180951|NCT03192046|11381657|FG001|Overall Study|Withdrawal by Subject|1
7180952|NCT03190369|11381665|FG000|Overall Study|Poor compliance to protocol|0
7180953|NCT03190369|11381666|FG001|Overall Study|Poor compliance to protocol|1
7180954|NCT03190369|11381665|FG000|Overall Study|Withdraw before treatment|1
7180955|NCT03190369|11381666|FG001|Overall Study|Withdraw before treatment|5
7180956|NCT03190369|11381665|FG000|Overall Study|Randomized but not treated|0
7180957|NCT03190369|11381666|FG001|Overall Study|Randomized but not treated|2
7186813|NCT03277261|11387333|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1
7186814|NCT03277248|11387342|FG000|Overall Study|Adverse Event|3
7186815|NCT03277248|11387343|FG001|Overall Study|Adverse Event|1
7186816|NCT03277248|11387342|FG000|Overall Study|Subject Withdrawal of Consent|6
7186817|NCT03277248|11387343|FG001|Overall Study|Subject Withdrawal of Consent|23
7186818|NCT03277248|11387342|FG000|Overall Study|Investigator/Sponsor Decision|2
7186819|NCT03277248|11387343|FG001|Overall Study|Investigator/Sponsor Decision|2
7186820|NCT03277248|11387342|FG000|Overall Study|Pregnancy|4
7186821|NCT03277248|11387343|FG001|Overall Study|Pregnancy|1
7186822|NCT03277248|11387342|FG000|Overall Study|Lost to Follow-up|0
7180958|NCT04657198|11381675|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1
7180959|NCT04657198|11381676|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0
7180960|NCT04657198|11381677|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0
7180961|NCT04590586|11381691|FG000|Overall Study|Death|7
7180962|NCT04590586|11381692|FG001|Overall Study|Death|1
7180963|NCT04590586|11381693|FG002|Overall Study|Death|37
7180964|NCT04590586|11381694|FG003|Overall Study|Death|34
7180965|NCT04590586|11381695|FG004|Overall Study|Death|19
7180966|NCT04590586|11381696|FG005|Overall Study|Death|3
7180967|NCT04590586|11381691|FG000|Overall Study|Lost to Follow-up|3
7180968|NCT04590586|11381692|FG001|Overall Study|Lost to Follow-up|0
7180969|NCT04590586|11381693|FG002|Overall Study|Lost to Follow-up|11
7180970|NCT04590586|11381694|FG003|Overall Study|Lost to Follow-up|11
7180971|NCT04590586|11381695|FG004|Overall Study|Lost to Follow-up|6
7180972|NCT04590586|11381696|FG005|Overall Study|Lost to Follow-up|0
7180973|NCT04590586|11381691|FG000|Overall Study|Withdrawal by Subject|0
7180974|NCT04590586|11381692|FG001|Overall Study|Withdrawal by Subject|0
7180975|NCT04590586|11381693|FG002|Overall Study|Withdrawal by Subject|6
7180976|NCT04590586|11381694|FG003|Overall Study|Withdrawal by Subject|0
7180977|NCT04590586|11381695|FG004|Overall Study|Withdrawal by Subject|3
7180978|NCT04590586|11381696|FG005|Overall Study|Withdrawal by Subject|0
7180979|NCT04590586|11381691|FG000|Overall Study|Other|3
7180980|NCT04590586|11381692|FG001|Overall Study|Other|0
7180981|NCT04590586|11381693|FG002|Overall Study|Other|1
7180982|NCT04590586|11381694|FG003|Overall Study|Other|1
7180983|NCT04590586|11381695|FG004|Overall Study|Other|2
7180984|NCT04590586|11381696|FG005|Overall Study|Other|1
7180985|NCT04312009|11381722|FG000|Overall Study|Withdrawal by Subject|2
7180986|NCT04312009|11381723|FG001|Overall Study|Withdrawal by Subject|1
7180987|NCT04191382|11381732|FG000|Overall Study|Withdrawal by Subject|1
7180988|NCT04191382|11381733|FG001|Overall Study|Withdrawal by Subject|0
7180989|NCT04191382|11381734|FG002|Overall Study|Withdrawal by Subject|0
7180990|NCT03937466|11381751|FG000|Overall Study|not eligbile after the 2-week diary|9
7180991|NCT03937466|11381751|FG000|Overall Study|never returned their diary|6
7180992|NCT03937466|11381751|FG000|Overall Study|dropped out of study before getting Chilipad|5
7180993|NCT03937466|11381751|FG000|Overall Study|3 did not complete follow-up questionnaire.|3
7180994|NCT03850483|11381764|FG000|Treatment for Stage 1|Adverse Event|1
7180995|NCT03850483|11381765|FG001|Treatment for Stage 1|Adverse Event|1
7180996|NCT03850483|11381766|FG002|Treatment for Stage 1|Adverse Event|3
7180997|NCT03850483|11381767|FG003|Treatment for Stage 1|Adverse Event|0
7180998|NCT03850483|11381768|FG004|Treatment for Stage 1|Adverse Event|2
7180999|NCT03850483|11381769|FG005|Treatment for Stage 1|Adverse Event|0
7181000|NCT03850483|11381770|FG006|Treatment for Stage 1|Adverse Event|2
7181001|NCT03850483|11381771|FG007|Treatment for Stage 1|Adverse Event|2
7181002|NCT03850483|11381772|FG008|Treatment for Stage 1|Adverse Event|0
7181003|NCT03850483|11381773|FG009|Treatment for Stage 1|Adverse Event|0
7181004|NCT03850483|11381764|FG000|Treatment for Stage 1|Withdrawal by Subject|4
7181005|NCT03850483|11381765|FG001|Treatment for Stage 1|Withdrawal by Subject|4
7181006|NCT03850483|11381766|FG002|Treatment for Stage 1|Withdrawal by Subject|2
7181007|NCT03850483|11381767|FG003|Treatment for Stage 1|Withdrawal by Subject|2
7181008|NCT03850483|11381768|FG004|Treatment for Stage 1|Withdrawal by Subject|2
7181009|NCT03850483|11381769|FG005|Treatment for Stage 1|Withdrawal by Subject|1
7181010|NCT03850483|11381770|FG006|Treatment for Stage 1|Withdrawal by Subject|2
7181011|NCT03850483|11381771|FG007|Treatment for Stage 1|Withdrawal by Subject|3
7181012|NCT03850483|11381772|FG008|Treatment for Stage 1|Withdrawal by Subject|0
7181013|NCT03850483|11381773|FG009|Treatment for Stage 1|Withdrawal by Subject|0
7181014|NCT03850483|11381764|FG000|Treatment for Stage 1|Protocol Violation|1
7181015|NCT03850483|11381765|FG001|Treatment for Stage 1|Protocol Violation|0
7181016|NCT03850483|11381766|FG002|Treatment for Stage 1|Protocol Violation|0
7181017|NCT03850483|11381767|FG003|Treatment for Stage 1|Protocol Violation|0
7181018|NCT03850483|11381768|FG004|Treatment for Stage 1|Protocol Violation|0
7181019|NCT03850483|11381769|FG005|Treatment for Stage 1|Protocol Violation|0
7181020|NCT03850483|11381770|FG006|Treatment for Stage 1|Protocol Violation|1
7181021|NCT03850483|11381771|FG007|Treatment for Stage 1|Protocol Violation|0
7181022|NCT03850483|11381772|FG008|Treatment for Stage 1|Protocol Violation|0
7181023|NCT03850483|11381773|FG009|Treatment for Stage 1|Protocol Violation|0
7181024|NCT03850483|11381764|FG000|Treatment for Stage 1|Physician Decision|0
7181025|NCT03850483|11381765|FG001|Treatment for Stage 1|Physician Decision|0
7181026|NCT03850483|11381766|FG002|Treatment for Stage 1|Physician Decision|0
7181027|NCT03850483|11381767|FG003|Treatment for Stage 1|Physician Decision|0
7181028|NCT03850483|11381768|FG004|Treatment for Stage 1|Physician Decision|0
7181029|NCT03850483|11381769|FG005|Treatment for Stage 1|Physician Decision|1
7181030|NCT03850483|11381770|FG006|Treatment for Stage 1|Physician Decision|0
7181031|NCT03850483|11381771|FG007|Treatment for Stage 1|Physician Decision|0
7181032|NCT03850483|11381772|FG008|Treatment for Stage 1|Physician Decision|0
7181033|NCT03850483|11381773|FG009|Treatment for Stage 1|Physician Decision|0
7181034|NCT03850483|11381764|FG000|Treatment for Stage 1|Other|0
7181035|NCT03850483|11381765|FG001|Treatment for Stage 1|Other|0
7181036|NCT03850483|11381766|FG002|Treatment for Stage 1|Other|0
7181037|NCT03850483|11381767|FG003|Treatment for Stage 1|Other|0
7181038|NCT03850483|11381768|FG004|Treatment for Stage 1|Other|2
7181039|NCT03850483|11381769|FG005|Treatment for Stage 1|Other|1
7181040|NCT03850483|11381770|FG006|Treatment for Stage 1|Other|0
7181041|NCT03850483|11381771|FG007|Treatment for Stage 1|Other|0
7181042|NCT03850483|11381772|FG008|Treatment for Stage 1|Other|0
7181043|NCT03850483|11381773|FG009|Treatment for Stage 1|Other|0
7181044|NCT03850483|11381764|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0
7181045|NCT03850483|11381765|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0
7181046|NCT03850483|11381766|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1
7181047|NCT03850483|11381767|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0
7181048|NCT03850483|11381768|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0
7181049|NCT03850483|11381769|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0
7181050|NCT03850483|11381770|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0
7181051|NCT03850483|11381771|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0
7181052|NCT03850483|11381772|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0
7181053|NCT03850483|11381773|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0
7181054|NCT03850483|11381764|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0
7181055|NCT03850483|11381765|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0
7181056|NCT03850483|11381766|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0
7181057|NCT03850483|11381767|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0
7181058|NCT03850483|11381768|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0
7181059|NCT03850483|11381769|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1
7181060|NCT03850483|11381770|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0
7181061|NCT03850483|11381771|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0
7181062|NCT03850483|11381772|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0
7181063|NCT03850483|11381773|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0
7181064|NCT03850483|11381764|FG000|Treatment for Stage 1|Lost to Follow-up|0
7181065|NCT03850483|11381765|FG001|Treatment for Stage 1|Lost to Follow-up|1
7181066|NCT03850483|11381766|FG002|Treatment for Stage 1|Lost to Follow-up|1
7181067|NCT03850483|11381767|FG003|Treatment for Stage 1|Lost to Follow-up|1
7181068|NCT03850483|11381768|FG004|Treatment for Stage 1|Lost to Follow-up|0
7181069|NCT03850483|11381769|FG005|Treatment for Stage 1|Lost to Follow-up|1
7181070|NCT03850483|11381770|FG006|Treatment for Stage 1|Lost to Follow-up|2
7181071|NCT03850483|11381771|FG007|Treatment for Stage 1|Lost to Follow-up|0
7181072|NCT03850483|11381772|FG008|Treatment for Stage 1|Lost to Follow-up|0
7181073|NCT03850483|11381773|FG009|Treatment for Stage 1|Lost to Follow-up|0
7181074|NCT03850483|11381764|FG000|Treatment for Stage 1|Lack of Efficacy|1
7181075|NCT03850483|11381765|FG001|Treatment for Stage 1|Lack of Efficacy|2
7181076|NCT03850483|11381766|FG002|Treatment for Stage 1|Lack of Efficacy|2
7181077|NCT03850483|11381767|FG003|Treatment for Stage 1|Lack of Efficacy|3
7181078|NCT03850483|11381768|FG004|Treatment for Stage 1|Lack of Efficacy|2
7181079|NCT03850483|11381769|FG005|Treatment for Stage 1|Lack of Efficacy|4
7181080|NCT03850483|11381770|FG006|Treatment for Stage 1|Lack of Efficacy|3
7181081|NCT03850483|11381771|FG007|Treatment for Stage 1|Lack of Efficacy|1
7181082|NCT03850483|11381772|FG008|Treatment for Stage 1|Lack of Efficacy|0
7181083|NCT03850483|11381773|FG009|Treatment for Stage 1|Lack of Efficacy|0
7181084|NCT03850483|11381764|FG000|Treatment for Stage 1|Death|0
7181085|NCT03850483|11381765|FG001|Treatment for Stage 1|Death|0
7181086|NCT03850483|11381766|FG002|Treatment for Stage 1|Death|0
7181087|NCT03850483|11381767|FG003|Treatment for Stage 1|Death|0
7181088|NCT03850483|11381768|FG004|Treatment for Stage 1|Death|0
7181089|NCT03850483|11381769|FG005|Treatment for Stage 1|Death|1
7181090|NCT03850483|11381770|FG006|Treatment for Stage 1|Death|0
7181091|NCT03850483|11381771|FG007|Treatment for Stage 1|Death|0
7181092|NCT03850483|11381772|FG008|Treatment for Stage 1|Death|0
7181093|NCT03850483|11381773|FG009|Treatment for Stage 1|Death|0
7181094|NCT03850483|11381764|FG000|Treatment for Stage 1|Refused Further Treatment|1
7181095|NCT03850483|11381765|FG001|Treatment for Stage 1|Refused Further Treatment|0
7181096|NCT03850483|11381766|FG002|Treatment for Stage 1|Refused Further Treatment|2
7181097|NCT03850483|11381767|FG003|Treatment for Stage 1|Refused Further Treatment|0
7181098|NCT03850483|11381768|FG004|Treatment for Stage 1|Refused Further Treatment|1
7181099|NCT03850483|11381769|FG005|Treatment for Stage 1|Refused Further Treatment|0
7181100|NCT03850483|11381770|FG006|Treatment for Stage 1|Refused Further Treatment|1
7181101|NCT03850483|11381771|FG007|Treatment for Stage 1|Refused Further Treatment|0
7181102|NCT03850483|11381772|FG008|Treatment for Stage 1|Refused Further Treatment|0
7181103|NCT03850483|11381773|FG009|Treatment for Stage 1|Refused Further Treatment|0
7181104|NCT03850483|11381764|FG000|Treatment for Stage 1|Randomized but not Treated|0
7181105|NCT03850483|11381765|FG001|Treatment for Stage 1|Randomized but not Treated|0
7181106|NCT03850483|11381766|FG002|Treatment for Stage 1|Randomized but not Treated|0
7181107|NCT03850483|11381767|FG003|Treatment for Stage 1|Randomized but not Treated|0
7181108|NCT03850483|11381768|FG004|Treatment for Stage 1|Randomized but not Treated|0
7181109|NCT03850483|11381769|FG005|Treatment for Stage 1|Randomized but not Treated|1
7181110|NCT03850483|11381770|FG006|Treatment for Stage 1|Randomized but not Treated|0
7181111|NCT03850483|11381771|FG007|Treatment for Stage 1|Randomized but not Treated|0
7181112|NCT03850483|11381772|FG008|Treatment for Stage 1|Randomized but not Treated|0
7181113|NCT03850483|11381773|FG009|Treatment for Stage 1|Randomized but not Treated|0
7181114|NCT03850483|11381764|FG000|Follow-up for Stage 1|Withdrawal by Subject|0
7181115|NCT03850483|11381765|FG001|Follow-up for Stage 1|Withdrawal by Subject|0
7181116|NCT03850483|11381766|FG002|Follow-up for Stage 1|Withdrawal by Subject|0
7181117|NCT03850483|11381767|FG003|Follow-up for Stage 1|Withdrawal by Subject|0
7181118|NCT03850483|11381768|FG004|Follow-up for Stage 1|Withdrawal by Subject|0
7181119|NCT03850483|11381769|FG005|Follow-up for Stage 1|Withdrawal by Subject|0
7181120|NCT03850483|11381770|FG006|Follow-up for Stage 1|Withdrawal by Subject|1
7181121|NCT03850483|11381771|FG007|Follow-up for Stage 1|Withdrawal by Subject|2
7181122|NCT03850483|11381772|FG008|Follow-up for Stage 1|Withdrawal by Subject|0
7181123|NCT03850483|11381773|FG009|Follow-up for Stage 1|Withdrawal by Subject|0
7181124|NCT03850483|11381764|FG000|Follow-up for Stage 1|Physician Decision|0
7181125|NCT03850483|11381765|FG001|Follow-up for Stage 1|Physician Decision|0
7181126|NCT03850483|11381766|FG002|Follow-up for Stage 1|Physician Decision|0
7181127|NCT03850483|11381767|FG003|Follow-up for Stage 1|Physician Decision|0
7181128|NCT03850483|11381768|FG004|Follow-up for Stage 1|Physician Decision|1
7181129|NCT03850483|11381769|FG005|Follow-up for Stage 1|Physician Decision|0
7181130|NCT03850483|11381770|FG006|Follow-up for Stage 1|Physician Decision|1
7181131|NCT03850483|11381771|FG007|Follow-up for Stage 1|Physician Decision|0
7181132|NCT03850483|11381772|FG008|Follow-up for Stage 1|Physician Decision|0
7181133|NCT03850483|11381773|FG009|Follow-up for Stage 1|Physician Decision|0
7181134|NCT03850483|11381764|FG000|Follow-up for Stage 1|Lack of Efficacy|0
7181135|NCT03850483|11381765|FG001|Follow-up for Stage 1|Lack of Efficacy|0
7181136|NCT03850483|11381766|FG002|Follow-up for Stage 1|Lack of Efficacy|1
7181137|NCT03850483|11381767|FG003|Follow-up for Stage 1|Lack of Efficacy|0
7181138|NCT03850483|11381768|FG004|Follow-up for Stage 1|Lack of Efficacy|0
7181139|NCT03850483|11381769|FG005|Follow-up for Stage 1|Lack of Efficacy|0
7181140|NCT03850483|11381770|FG006|Follow-up for Stage 1|Lack of Efficacy|0
7181141|NCT03850483|11381771|FG007|Follow-up for Stage 1|Lack of Efficacy|1
7181142|NCT03850483|11381772|FG008|Follow-up for Stage 1|Lack of Efficacy|0
7181143|NCT03850483|11381773|FG009|Follow-up for Stage 1|Lack of Efficacy|0
7181144|NCT03850483|11381764|FG000|Follow-up for Stage 1|Adverse Event|0
7181145|NCT03850483|11381765|FG001|Follow-up for Stage 1|Adverse Event|0
7181146|NCT03850483|11381766|FG002|Follow-up for Stage 1|Adverse Event|1
7181147|NCT03850483|11381767|FG003|Follow-up for Stage 1|Adverse Event|0
7181148|NCT03850483|11381768|FG004|Follow-up for Stage 1|Adverse Event|0
7181149|NCT03850483|11381769|FG005|Follow-up for Stage 1|Adverse Event|1
7181150|NCT03850483|11381770|FG006|Follow-up for Stage 1|Adverse Event|0
7181151|NCT03850483|11381771|FG007|Follow-up for Stage 1|Adverse Event|0
7181152|NCT03850483|11381772|FG008|Follow-up for Stage 1|Adverse Event|0
7181153|NCT03850483|11381773|FG009|Follow-up for Stage 1|Adverse Event|0
7181154|NCT03850483|11381764|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0
7181155|NCT03850483|11381765|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1
7181156|NCT03850483|11381766|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0
7181157|NCT03850483|11381767|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0
7181158|NCT03850483|11381768|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2
7181159|NCT03850483|11381769|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2
7181160|NCT03850483|11381770|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0
7181161|NCT03850483|11381771|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0
7181162|NCT03850483|11381772|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0
7181163|NCT03850483|11381773|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0
7181164|NCT03850483|11381764|FG000|Follow-up for Stage 1|Other|0
7181165|NCT03850483|11381765|FG001|Follow-up for Stage 1|Other|2
7181166|NCT03850483|11381766|FG002|Follow-up for Stage 1|Other|0
7181167|NCT03850483|11381767|FG003|Follow-up for Stage 1|Other|2
7181168|NCT03850483|11381768|FG004|Follow-up for Stage 1|Other|0
7181169|NCT03850483|11381769|FG005|Follow-up for Stage 1|Other|1
7181170|NCT03850483|11381770|FG006|Follow-up for Stage 1|Other|0
7181171|NCT03850483|11381771|FG007|Follow-up for Stage 1|Other|0
7181172|NCT03850483|11381772|FG008|Follow-up for Stage 1|Other|0
7181173|NCT03850483|11381773|FG009|Follow-up for Stage 1|Other|0
7181174|NCT03850483|11381764|FG000|Treatment for Stage 2|Adverse Event|0
7181175|NCT03850483|11381765|FG001|Treatment for Stage 2|Adverse Event|0
7181176|NCT03850483|11381766|FG002|Treatment for Stage 2|Adverse Event|0
7181177|NCT03850483|11381767|FG003|Treatment for Stage 2|Adverse Event|0
7181178|NCT03850483|11381768|FG004|Treatment for Stage 2|Adverse Event|0
7181179|NCT03850483|11381769|FG005|Treatment for Stage 2|Adverse Event|0
7181180|NCT03850483|11381770|FG006|Treatment for Stage 2|Adverse Event|0
7181181|NCT03850483|11381771|FG007|Treatment for Stage 2|Adverse Event|0
7181182|NCT03850483|11381772|FG008|Treatment for Stage 2|Adverse Event|0
7181183|NCT03850483|11381773|FG009|Treatment for Stage 2|Adverse Event|1
7181184|NCT03850483|11381764|FG000|Treatment for Stage 2|Lack of Efficacy|0
7181185|NCT03850483|11381765|FG001|Treatment for Stage 2|Lack of Efficacy|0
7181186|NCT03850483|11381766|FG002|Treatment for Stage 2|Lack of Efficacy|0
7181187|NCT03850483|11381767|FG003|Treatment for Stage 2|Lack of Efficacy|0
7181188|NCT03850483|11381768|FG004|Treatment for Stage 2|Lack of Efficacy|0
7181189|NCT03850483|11381769|FG005|Treatment for Stage 2|Lack of Efficacy|0
7181190|NCT03850483|11381770|FG006|Treatment for Stage 2|Lack of Efficacy|0
7181191|NCT03850483|11381771|FG007|Treatment for Stage 2|Lack of Efficacy|0
7181192|NCT03850483|11381772|FG008|Treatment for Stage 2|Lack of Efficacy|1
7181193|NCT03850483|11381773|FG009|Treatment for Stage 2|Lack of Efficacy|0
7181194|NCT03850483|11381764|FG000|Treatment for Stage 2|Lost to Follow-up|0
7181195|NCT03850483|11381765|FG001|Treatment for Stage 2|Lost to Follow-up|0
7181196|NCT03850483|11381766|FG002|Treatment for Stage 2|Lost to Follow-up|0
7181197|NCT03850483|11381767|FG003|Treatment for Stage 2|Lost to Follow-up|0
7181198|NCT03850483|11381768|FG004|Treatment for Stage 2|Lost to Follow-up|0
7181199|NCT03850483|11381769|FG005|Treatment for Stage 2|Lost to Follow-up|0
7181200|NCT03850483|11381770|FG006|Treatment for Stage 2|Lost to Follow-up|0
7181201|NCT03850483|11381771|FG007|Treatment for Stage 2|Lost to Follow-up|0
7181202|NCT03850483|11381772|FG008|Treatment for Stage 2|Lost to Follow-up|0
7181203|NCT03850483|11381773|FG009|Treatment for Stage 2|Lost to Follow-up|3
7181204|NCT03850483|11381764|FG000|Treatment for Stage 2|Physician Decision|0
7181205|NCT03850483|11381765|FG001|Treatment for Stage 2|Physician Decision|0
7181206|NCT03850483|11381766|FG002|Treatment for Stage 2|Physician Decision|0
7181207|NCT03850483|11381767|FG003|Treatment for Stage 2|Physician Decision|0
7181208|NCT03850483|11381768|FG004|Treatment for Stage 2|Physician Decision|0
7181209|NCT03850483|11381769|FG005|Treatment for Stage 2|Physician Decision|0
7181210|NCT03850483|11381770|FG006|Treatment for Stage 2|Physician Decision|0
7181211|NCT03850483|11381771|FG007|Treatment for Stage 2|Physician Decision|0
7181212|NCT03850483|11381772|FG008|Treatment for Stage 2|Physician Decision|0
7181213|NCT03850483|11381773|FG009|Treatment for Stage 2|Physician Decision|1
7181214|NCT03850483|11381764|FG000|Treatment for Stage 2|Protocol Violation|0
7181215|NCT03850483|11381765|FG001|Treatment for Stage 2|Protocol Violation|0
7181216|NCT03850483|11381766|FG002|Treatment for Stage 2|Protocol Violation|0
7181217|NCT03850483|11381767|FG003|Treatment for Stage 2|Protocol Violation|0
7080997|NCT02129608|11190930|FG002|Overall Study|Lost to Follow-up|1
7080998|NCT02129608|11190928|FG000|Overall Study|Withdrawal by Subject|0
7080999|NCT02129608|11190929|FG001|Overall Study|Withdrawal by Subject|0
7081000|NCT02129608|11190930|FG002|Overall Study|Withdrawal by Subject|2
6896014|NCT00630539|10914261|FG000|Overall Study|Withdrawal by Subject|0
6896015|NCT00630539|10914262|FG001|Overall Study|Withdrawal by Subject|1
7081001|NCT02129777|11190974|FG000|Double-Blind Period|Adverse Event|0
7081002|NCT02129777|11190975|FG001|Double-Blind Period|Adverse Event|0
7081003|NCT02129777|11190976|FG002|Double-Blind Period|Adverse Event|0
7081004|NCT02129777|11190977|FG003|Double-Blind Period|Adverse Event|0
7081005|NCT02129777|11190978|FG004|Double-Blind Period|Adverse Event|1
7081006|NCT02129777|11190979|FG005|Double-Blind Period|Adverse Event|0
7081007|NCT02129777|11190980|FG006|Double-Blind Period|Adverse Event|0
7081008|NCT02129777|11190974|FG000|Double-Blind Period|Lost to Follow-up|1
7081009|NCT02129777|11190975|FG001|Double-Blind Period|Lost to Follow-up|1
7081010|NCT02129777|11190976|FG002|Double-Blind Period|Lost to Follow-up|1
7081011|NCT02129777|11190977|FG003|Double-Blind Period|Lost to Follow-up|2
7081012|NCT02129777|11190978|FG004|Double-Blind Period|Lost to Follow-up|0
7081013|NCT02129777|11190979|FG005|Double-Blind Period|Lost to Follow-up|0
7081014|NCT02129777|11190980|FG006|Double-Blind Period|Lost to Follow-up|0
7081015|NCT02129777|11190974|FG000|Double-Blind Period|Withdrawal by Subject|2
7081016|NCT02129777|11190975|FG001|Double-Blind Period|Withdrawal by Subject|4
7081017|NCT02129777|11190976|FG002|Double-Blind Period|Withdrawal by Subject|3
7181218|NCT03850483|11381768|FG004|Treatment for Stage 2|Protocol Violation|0
7181219|NCT03850483|11381769|FG005|Treatment for Stage 2|Protocol Violation|0
7181220|NCT03850483|11381770|FG006|Treatment for Stage 2|Protocol Violation|0
7181221|NCT03850483|11381771|FG007|Treatment for Stage 2|Protocol Violation|0
7181222|NCT03850483|11381772|FG008|Treatment for Stage 2|Protocol Violation|1
7181223|NCT03850483|11381773|FG009|Treatment for Stage 2|Protocol Violation|0
7181224|NCT03850483|11381764|FG000|Treatment for Stage 2|Withdrawal by Subject|0
7181225|NCT03850483|11381765|FG001|Treatment for Stage 2|Withdrawal by Subject|0
7181226|NCT03850483|11381766|FG002|Treatment for Stage 2|Withdrawal by Subject|0
7181227|NCT03850483|11381767|FG003|Treatment for Stage 2|Withdrawal by Subject|0
7181228|NCT03850483|11381768|FG004|Treatment for Stage 2|Withdrawal by Subject|0
7181229|NCT03850483|11381769|FG005|Treatment for Stage 2|Withdrawal by Subject|0
7181230|NCT03850483|11381770|FG006|Treatment for Stage 2|Withdrawal by Subject|0
7181231|NCT03850483|11381771|FG007|Treatment for Stage 2|Withdrawal by Subject|0
7181232|NCT03850483|11381772|FG008|Treatment for Stage 2|Withdrawal by Subject|2
7081018|NCT02129777|11190977|FG003|Double-Blind Period|Withdrawal by Subject|2
7181233|NCT03850483|11381773|FG009|Treatment for Stage 2|Withdrawal by Subject|5
7181234|NCT03850483|11381764|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0
7181235|NCT03850483|11381765|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0
7081019|NCT02129777|11190978|FG004|Double-Blind Period|Withdrawal by Subject|3
7081020|NCT02129777|11190979|FG005|Double-Blind Period|Withdrawal by Subject|0
7081021|NCT02129777|11190980|FG006|Double-Blind Period|Withdrawal by Subject|0
7081022|NCT02129777|11190974|FG000|Double-Blind Period|Pregnancy|0
7081023|NCT02129777|11190975|FG001|Double-Blind Period|Pregnancy|0
7081024|NCT02129777|11190976|FG002|Double-Blind Period|Pregnancy|0
7081025|NCT02129777|11190977|FG003|Double-Blind Period|Pregnancy|0
7081026|NCT02129777|11190978|FG004|Double-Blind Period|Pregnancy|1
7081027|NCT02129777|11190979|FG005|Double-Blind Period|Pregnancy|0
7081028|NCT02129777|11190980|FG006|Double-Blind Period|Pregnancy|0
7081029|NCT02129777|11190974|FG000|Double-Blind Period|Lack of Efficacy|3
7081030|NCT02129777|11190975|FG001|Double-Blind Period|Lack of Efficacy|1
7081031|NCT02129777|11190976|FG002|Double-Blind Period|Lack of Efficacy|0
7081032|NCT02129777|11190977|FG003|Double-Blind Period|Lack of Efficacy|3
7081033|NCT02129777|11190978|FG004|Double-Blind Period|Lack of Efficacy|2
7081034|NCT02129777|11190979|FG005|Double-Blind Period|Lack of Efficacy|0
7081035|NCT02129777|11190980|FG006|Double-Blind Period|Lack of Efficacy|0
7081036|NCT02129777|11190974|FG000|Double-Blind Period|Other|1
7081037|NCT02129777|11190975|FG001|Double-Blind Period|Other|2
7081038|NCT02129777|11190976|FG002|Double-Blind Period|Other|0
7081039|NCT02129777|11190977|FG003|Double-Blind Period|Other|0
7181236|NCT03850483|11381766|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0
7181237|NCT03850483|11381767|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0
7181238|NCT03850483|11381768|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0
7181239|NCT03850483|11381769|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0
7181240|NCT03850483|11381770|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0
7181241|NCT03850483|11381771|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0
7181242|NCT03850483|11381772|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0
7181243|NCT03850483|11381773|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1
7181244|NCT03850483|11381764|FG000|Treatment for Stage 2|Refused Further Treatment|0
7181245|NCT03850483|11381765|FG001|Treatment for Stage 2|Refused Further Treatment|0
7181246|NCT03850483|11381766|FG002|Treatment for Stage 2|Refused Further Treatment|0
6896016|NCT00630539|10914263|FG002|Overall Study|Withdrawal by Subject|0
6896017|NCT00630539|10914264|FG003|Overall Study|Withdrawal by Subject|1
7081040|NCT02129777|11190978|FG004|Double-Blind Period|Other|0
7081041|NCT02129777|11190979|FG005|Double-Blind Period|Other|0
7081042|NCT02129777|11190980|FG006|Double-Blind Period|Other|0
7081043|NCT02129777|11190974|FG000|Open-Label Period|Lack of Efficacy|0
7081044|NCT02129777|11190975|FG001|Open-Label Period|Lack of Efficacy|0
7081045|NCT02129777|11190976|FG002|Open-Label Period|Lack of Efficacy|0
7081046|NCT02129777|11190977|FG003|Open-Label Period|Lack of Efficacy|0
7181247|NCT03850483|11381767|FG003|Treatment for Stage 2|Refused Further Treatment|0
7181248|NCT03850483|11381768|FG004|Treatment for Stage 2|Refused Further Treatment|0
7181249|NCT03850483|11381769|FG005|Treatment for Stage 2|Refused Further Treatment|0
7181250|NCT03850483|11381770|FG006|Treatment for Stage 2|Refused Further Treatment|0
7181251|NCT03850483|11381771|FG007|Treatment for Stage 2|Refused Further Treatment|0
7181252|NCT03850483|11381772|FG008|Treatment for Stage 2|Refused Further Treatment|1
7181253|NCT03850483|11381773|FG009|Treatment for Stage 2|Refused Further Treatment|0
7181254|NCT03850483|11381764|FG000|Follow-up For Stage 2|Lost to Follow-up|0
7181255|NCT03850483|11381765|FG001|Follow-up For Stage 2|Lost to Follow-up|0
7181256|NCT03850483|11381766|FG002|Follow-up For Stage 2|Lost to Follow-up|0
7181257|NCT03850483|11381767|FG003|Follow-up For Stage 2|Lost to Follow-up|0
7181258|NCT03850483|11381768|FG004|Follow-up For Stage 2|Lost to Follow-up|0
7181259|NCT03850483|11381769|FG005|Follow-up For Stage 2|Lost to Follow-up|0
7181260|NCT03850483|11381770|FG006|Follow-up For Stage 2|Lost to Follow-up|0
7081047|NCT02129777|11190978|FG004|Open-Label Period|Lack of Efficacy|0
7181261|NCT03850483|11381771|FG007|Follow-up For Stage 2|Lost to Follow-up|0
7181262|NCT03850483|11381772|FG008|Follow-up For Stage 2|Lost to Follow-up|0
7181263|NCT03850483|11381773|FG009|Follow-up For Stage 2|Lost to Follow-up|1
7181264|NCT03850483|11381764|FG000|Follow-up For Stage 2|Other|0
7181265|NCT03850483|11381765|FG001|Follow-up For Stage 2|Other|0
7181266|NCT03850483|11381766|FG002|Follow-up For Stage 2|Other|0
7181267|NCT03850483|11381767|FG003|Follow-up For Stage 2|Other|0
7181268|NCT03850483|11381768|FG004|Follow-up For Stage 2|Other|0
7181269|NCT03850483|11381769|FG005|Follow-up For Stage 2|Other|0
7181270|NCT03850483|11381770|FG006|Follow-up For Stage 2|Other|0
7181271|NCT03850483|11381771|FG007|Follow-up For Stage 2|Other|0
7181272|NCT03850483|11381772|FG008|Follow-up For Stage 2|Other|0
7181273|NCT03850483|11381773|FG009|Follow-up For Stage 2|Other|1
7181274|NCT03804879|11381795|FG000|Overall Study|Adverse Event|3
7181275|NCT03804879|11381796|FG001|Overall Study|Adverse Event|0
7181276|NCT03804879|11381795|FG000|Overall Study|Study Terminated By Sponsor|10
7181277|NCT03804879|11381796|FG001|Overall Study|Study Terminated By Sponsor|12
7181278|NCT03804879|11381795|FG000|Overall Study|Withdrawal by Subject|3
7181279|NCT03804879|11381796|FG001|Overall Study|Withdrawal by Subject|1
7181280|NCT03804684|11381805|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3
7181281|NCT03804684|11381806|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18
7181282|NCT03631706|11381816|FG000|Overall Study|Randomized, not treated|1
7181283|NCT03631706|11381817|FG001|Overall Study|Randomized, not treated|0
7181284|NCT03631706|11381816|FG000|Overall Study|Treatment ongoing|26
7181285|NCT03631706|11381817|FG001|Overall Study|Treatment ongoing|57
7181286|NCT03631706|11381816|FG000|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|65
7181287|NCT03631706|11381817|FG001|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|41
7181288|NCT03473925|11381847|FG000|Overall Study|Death|48
7181289|NCT03473925|11381848|FG001|Overall Study|Death|44
7181290|NCT03473925|11381847|FG000|Overall Study|Sponsor Decision|2
7181291|NCT03473925|11381848|FG001|Overall Study|Sponsor Decision|7
7181292|NCT03473925|11381847|FG000|Overall Study|Withdrawal by Subject|1
7181293|NCT03473925|11381848|FG001|Overall Study|Withdrawal by Subject|3
7181294|NCT03473925|11381847|FG000|Overall Study|Not Treated|1
7181295|NCT03473925|11381848|FG001|Overall Study|Not Treated|1
7181296|NCT03462641|11381856|FG000|Visit 1|Failed to complete dopaminergic PET scan|1
7181297|NCT03462641|11381857|FG001|Visit 1|Failed to complete dopaminergic PET scan|0
7181298|NCT03462641|11381856|FG000|Visit 2|Withdrawal by Subject|0
7181299|NCT03462641|11381857|FG001|Visit 2|Withdrawal by Subject|1
7181300|NCT03230097|11381876|FG000|Overall Study|Adverse Event|2
7181301|NCT03230097|11381877|FG001|Overall Study|Adverse Event|1
7181302|NCT03230097|11381876|FG000|Overall Study|non-compliance|0
7181303|NCT03230097|11381877|FG001|Overall Study|non-compliance|1
7181304|NCT03230097|11381876|FG000|Overall Study|Lost to Follow-up|2
7181305|NCT03230097|11381877|FG001|Overall Study|Lost to Follow-up|4
7181306|NCT03230097|11381876|FG000|Overall Study|Withdrawal by Subject|7
7181307|NCT03230097|11381877|FG001|Overall Study|Withdrawal by Subject|3
7181308|NCT03230097|11381876|FG000|Overall Study|Trial termination|4
7181309|NCT03230097|11381877|FG001|Overall Study|Trial termination|5
7181310|NCT03230097|11381876|FG000|Overall Study|Covid-19 pandemic outbreak|0
7181311|NCT03230097|11381877|FG001|Overall Study|Covid-19 pandemic outbreak|1
7181312|NCT03230097|11381876|FG000|Overall Study|outcome event|0
7181313|NCT03230097|11381877|FG001|Overall Study|outcome event|1
7181314|NCT03029780|11381898|FG000|Overall Study|Disease Progression|20
7181315|NCT03029780|11381899|FG001|Overall Study|Disease Progression|22
7181316|NCT03029780|11381898|FG000|Overall Study|Study Drug Toxicity|15
7181317|NCT03029780|11381899|FG001|Overall Study|Study Drug Toxicity|11
7181318|NCT03029780|11381898|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2
7181319|NCT03029780|11381899|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3
7181320|NCT03029780|11381898|FG000|Overall Study|Participant request to discontinue study treatment|4
7181321|NCT03029780|11381899|FG001|Overall Study|Participant request to discontinue study treatment|1
7181322|NCT03029780|11381898|FG000|Overall Study|Maximum clinical benefit|1
7181323|NCT03029780|11381899|FG001|Overall Study|Maximum clinical benefit|0
6896018|NCT00630747|10914296|FG000|Overall Study|Death|1
6896019|NCT00630747|10914296|FG000|Overall Study|Transferred to Study TKT031NPU|7
7081048|NCT02129777|11190979|FG005|Open-Label Period|Lack of Efficacy|0
7081049|NCT02129777|11190980|FG006|Open-Label Period|Lack of Efficacy|5
7081050|NCT02129777|11190974|FG000|Open-Label Period|Lost to Follow-up|0
6973245|NCT01179191|11024904|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13
6973246|NCT01179191|11024904|FG000|Titration Phase (up to 6 Weeks)|Other|62
6973247|NCT01179191|11024904|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10
6973248|NCT01179191|11024904|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9
7181324|NCT03029780|11381898|FG000|Overall Study|Participant no longer meets study criteria|0
7181325|NCT03029780|11381899|FG001|Overall Study|Participant no longer meets study criteria|1
7181326|NCT03029780|11381898|FG000|Overall Study|Other reasons|6
7181327|NCT03029780|11381899|FG001|Overall Study|Other reasons|6
6973249|NCT01179191|11024904|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3
6973250|NCT01179191|11024904|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29
7181328|NCT03029780|11381898|FG000|Overall Study|Not reported|1
7181329|NCT03029780|11381899|FG001|Overall Study|Not reported|1
7181330|NCT03029780|11381898|FG000|Overall Study|Death|2
7181331|NCT03029780|11381899|FG001|Overall Study|Death|6
7181332|NCT02893930|11381917|FG000|Overall Study|Adverse Event|3
7181333|NCT02893930|11381917|FG000|Overall Study|Death|1
7081051|NCT02129777|11190975|FG001|Open-Label Period|Lost to Follow-up|0
7081052|NCT02129777|11190976|FG002|Open-Label Period|Lost to Follow-up|0
7081053|NCT02129777|11190977|FG003|Open-Label Period|Lost to Follow-up|0
7081054|NCT02129777|11190978|FG004|Open-Label Period|Lost to Follow-up|0
7081055|NCT02129777|11190979|FG005|Open-Label Period|Lost to Follow-up|1
7081056|NCT02129777|11190980|FG006|Open-Label Period|Lost to Follow-up|1
7081057|NCT02129777|11190974|FG000|Open-Label Period|Withdrawal by Subject|0
7081058|NCT02129777|11190975|FG001|Open-Label Period|Withdrawal by Subject|0
7081059|NCT02129777|11190976|FG002|Open-Label Period|Withdrawal by Subject|0
7081060|NCT02129777|11190977|FG003|Open-Label Period|Withdrawal by Subject|0
7081061|NCT02129777|11190978|FG004|Open-Label Period|Withdrawal by Subject|0
7081062|NCT02129777|11190979|FG005|Open-Label Period|Withdrawal by Subject|1
7181334|NCT02893930|11381917|FG000|Overall Study|Disease progression|5
7181335|NCT02893930|11381917|FG000|Overall Study|Withdrawal by Subject|2
7181336|NCT02893930|11381917|FG000|Overall Study|Physician Decision|1
7181337|NCT02893930|11381917|FG000|Overall Study|Ineligible|1
7181338|NCT02890355|11381923|FG000|Overall Study|Adverse Event|5
7181339|NCT02890355|11381924|FG001|Overall Study|Adverse Event|5
7181340|NCT02890355|11381923|FG000|Overall Study|Refusal unrelated to adverse event|5
7181341|NCT02890355|11381924|FG001|Overall Study|Refusal unrelated to adverse event|10
7181342|NCT02890355|11381923|FG000|Overall Study|Progression/relapse|46
7181343|NCT02890355|11381924|FG001|Overall Study|Progression/relapse|39
7181344|NCT02890355|11381923|FG000|Overall Study|Not protocol specified|3
7181345|NCT02890355|11381924|FG001|Overall Study|Not protocol specified|4
7181346|NCT02853305|11381935|FG000|Overall Study|Death|244
7181347|NCT02853305|11381936|FG001|Overall Study|Death|207
7181348|NCT02853305|11381937|FG002|Overall Study|Death|263
7181349|NCT02853305|11381935|FG000|Overall Study|Withdrawal by Subject|2
7181350|NCT02853305|11381936|FG001|Overall Study|Withdrawal by Subject|4
7181351|NCT02853305|11381937|FG002|Overall Study|Withdrawal by Subject|2
7181352|NCT02853305|11381935|FG000|Overall Study|Ongoing in Trial|105
7181353|NCT02853305|11381936|FG001|Overall Study|Ongoing in Trial|96
7181354|NCT02853305|11381937|FG002|Overall Study|Ongoing in Trial|87
7181355|NCT02803593|11381947|FG000|Overall Study|Lost to Follow-up|17
7181356|NCT02803593|11381948|FG001|Overall Study|Lost to Follow-up|35
7181357|NCT02663908|11381956|FG000|Overall Study|Withdrawal by Subject|8
7181358|NCT02663908|11381957|FG001|Overall Study|Withdrawal by Subject|5
7181359|NCT02663908|11381956|FG000|Overall Study|Lost to Follow-up|1
7181360|NCT02663908|11381957|FG001|Overall Study|Lost to Follow-up|5
7181361|NCT02663908|11381956|FG000|Overall Study|Adverse Event|13
7181362|NCT02663908|11381957|FG001|Overall Study|Adverse Event|11
7181363|NCT02663908|11381956|FG000|Overall Study|Protocol Violation|1
7181364|NCT02663908|11381957|FG001|Overall Study|Protocol Violation|2
7181365|NCT02663908|11381956|FG000|Overall Study|Lack of therapeutic response|2
7181366|NCT02663908|11381957|FG001|Overall Study|Lack of therapeutic response|0
7181367|NCT02663908|11381956|FG000|Overall Study|COVID-19|1
7181368|NCT02663908|11381957|FG001|Overall Study|COVID-19|0
7181369|NCT02663908|11381956|FG000|Overall Study|Site closed|1
7181370|NCT02663908|11381957|FG001|Overall Study|Site closed|0
7181371|NCT02663908|11381956|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1
7181372|NCT02663908|11381957|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0
7181373|NCT02663908|11381956|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1
7181374|NCT02663908|11381957|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0
7181375|NCT02663908|11381956|FG000|Overall Study|Intolerance to FIRMAGON therapy|1
7181376|NCT02663908|11381957|FG001|Overall Study|Intolerance to FIRMAGON therapy|0
7181377|NCT02663908|11381956|FG000|Overall Study|Death|1
7181378|NCT02663908|11381957|FG001|Overall Study|Death|0
7181379|NCT02663908|11381956|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1
7181380|NCT02663908|11381957|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0
7181381|NCT02663908|11381956|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0
7181382|NCT02663908|11381957|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1
7181383|NCT02650284|11381965|FG000|Overall Study|Lost to Follow-up|3
7181384|NCT02650284|11381966|FG001|Overall Study|Lost to Follow-up|3
7181385|NCT02650284|11381965|FG000|Overall Study|Consent incorrectly taken|0
7181386|NCT02650284|11381966|FG001|Overall Study|Consent incorrectly taken|1
7181387|NCT02642042|11381972|FG000|Overall Study|Adverse Event|22
7181388|NCT02642042|11381972|FG000|Overall Study|Refusal Unrelated to Adverse Event|1
7181389|NCT02642042|11381972|FG000|Overall Study|Progression/Relapse|28
7181390|NCT02642042|11381972|FG000|Overall Study|Death|1
7181391|NCT02642042|11381972|FG000|Overall Study|Not Protocol Specified|2
7081063|NCT02129777|11190980|FG006|Open-Label Period|Withdrawal by Subject|3
7186823|NCT03277248|11387343|FG001|Overall Study|Lost to Follow-up|2
7186824|NCT03277248|11387342|FG000|Overall Study|Lack of Efficacy|0
7186825|NCT03277248|11387343|FG001|Overall Study|Lack of Efficacy|2
7186826|NCT03277248|11387342|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3
7186827|NCT03277248|11387343|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3
7186828|NCT03179462|11387352|FG000|Overall Study|screening failure|1
7186829|NCT03179462|11387353|FG001|Overall Study|screening failure|2
7186830|NCT03179462|11387354|FG002|Overall Study|screening failure|0
7081064|NCT02129777|11190974|FG000|Open-Label Period|Study Termination|0
7081065|NCT02129777|11190975|FG001|Open-Label Period|Study Termination|0
7081066|NCT02129777|11190976|FG002|Open-Label Period|Study Termination|0
7081067|NCT02129777|11190977|FG003|Open-Label Period|Study Termination|0
7081068|NCT02129777|11190978|FG004|Open-Label Period|Study Termination|0
7081069|NCT02129777|11190979|FG005|Open-Label Period|Study Termination|10
7081070|NCT02129777|11190980|FG006|Open-Label Period|Study Termination|39
7081071|NCT02129803|11191001|FG000|Overall Study|Protocol Violation|4
7081072|NCT02129803|11191002|FG001|Overall Study|Protocol Violation|0
7081073|NCT02129803|11191001|FG000|Overall Study|Physician Decision|0
7081074|NCT02129803|11191002|FG001|Overall Study|Physician Decision|1
7081075|NCT02129803|11191001|FG000|Overall Study|Difficulty sleeping|1
7081076|NCT02129803|11191002|FG001|Overall Study|Difficulty sleeping|0
7081077|NCT02129803|11191001|FG000|Overall Study|Morning headache|0
7081078|NCT02129803|11191002|FG001|Overall Study|Morning headache|1
7081079|NCT02129803|11191001|FG000|Overall Study|Withdrawal by Subject|1
7081080|NCT02129803|11191002|FG001|Overall Study|Withdrawal by Subject|1
7081081|NCT02130024|11191010|FG000|Overall Study|Adverse Event|10
7081082|NCT02130024|11191011|FG001|Overall Study|Adverse Event|11
7081083|NCT02130024|11191010|FG000|Overall Study|Death|2
7081084|NCT02130024|11191011|FG001|Overall Study|Death|2
7081085|NCT02130024|11191010|FG000|Overall Study|Lost to Follow-up|1
7081086|NCT02130024|11191011|FG001|Overall Study|Lost to Follow-up|1
6973251|NCT01179191|11024904|FG000|Maintenance Phase (8 Weeks)|Other|66
6973252|NCT01179334|11024921|FG000|Treatment Period|Adverse Event|1
6973253|NCT01179334|11024922|FG001|Treatment Period|Adverse Event|0
6973254|NCT01179334|11024921|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6
6973255|NCT01179334|11024922|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2
6973256|NCT01179334|11024921|FG000|Long-term Extension (LTE) Period|Death|3
6973257|NCT01179334|11024922|FG001|Long-term Extension (LTE) Period|Death|0
6973258|NCT01179334|11024921|FG000|Long-term Extension (LTE) Period|Adverse Event|2
6973259|NCT01179334|11024922|FG001|Long-term Extension (LTE) Period|Adverse Event|4
6973260|NCT01179347|11024930|FG000|Double-blind Period (12 Weeks)|Adverse Event|2
6973261|NCT01179347|11024931|FG001|Double-blind Period (12 Weeks)|Adverse Event|6
6973262|NCT01179347|11024930|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2
6973263|NCT01179347|11024931|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0
6973264|NCT01179347|11024930|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1
6973265|NCT01179347|11024931|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2
6973266|NCT01179347|11024930|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1
6973267|NCT01179347|11024931|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2
6973268|NCT01179347|11024930|FG000|Double-blind Period (12 Weeks)|Other|2
6973269|NCT01179347|11024931|FG001|Double-blind Period (12 Weeks)|Other|4
6973270|NCT01179347|11024930|FG000|Open-label Period (12 Weeks)|Adverse Event|5
6973271|NCT01179347|11024931|FG001|Open-label Period (12 Weeks)|Adverse Event|9
6973272|NCT01179347|11024930|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0
6973273|NCT01179347|11024931|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2
6973274|NCT01179347|11024930|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1
6973275|NCT01179347|11024931|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0
6973276|NCT01179347|11024930|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1
6973277|NCT01179347|11024931|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1
6973278|NCT01179347|11024930|FG000|Open-label Period (12 Weeks)|Protocol Violation|1
6973279|NCT01179347|11024931|FG001|Open-label Period (12 Weeks)|Protocol Violation|0
6973280|NCT01179347|11024930|FG000|Open-label Period (12 Weeks)|Other|7
6973281|NCT01179347|11024931|FG001|Open-label Period (12 Weeks)|Other|4
6973282|NCT01179477|11024939|FG000|Overall Study|Death|542
7081087|NCT02130024|11191010|FG000|Overall Study|Physician Decision|1
7081088|NCT02130024|11191011|FG001|Overall Study|Physician Decision|3
7081089|NCT02130024|11191010|FG000|Overall Study|Protocol Deviation|4
7081090|NCT02130024|11191011|FG001|Overall Study|Protocol Deviation|0
7081091|NCT02130024|11191010|FG000|Overall Study|Site Administration Problems|1
6896020|NCT00630747|10914296|FG000|Overall Study|Returned to country of origin|1
6896021|NCT00630786|10914303|FG000|Overall Study|Physician Decision|0
7081092|NCT02130024|11191011|FG001|Overall Study|Site Administration Problems|0
7081093|NCT02130024|11191010|FG000|Overall Study|Subject Withdrew Consent|6
7081094|NCT02130024|11191011|FG001|Overall Study|Subject Withdrew Consent|14
7081095|NCT02130193|11191028|FG000|Part B: 52-week Double-blind Period|Adverse Event|0
7081096|NCT02130193|11191029|FG001|Part B: 52-week Double-blind Period|Adverse Event|5
7081097|NCT02130193|11191030|FG002|Part B: 52-week Double-blind Period|Adverse Event|3
7081098|NCT02130193|11191028|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0
7081099|NCT02130193|11191029|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2
7081100|NCT02130193|11191030|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1
7081101|NCT02130193|11191028|FG000|Part B: 52-week Double-blind Period|Physician Decision|0
7081102|NCT02130193|11191029|FG001|Part B: 52-week Double-blind Period|Physician Decision|0
7081103|NCT02130193|11191030|FG002|Part B: 52-week Double-blind Period|Physician Decision|1
7081104|NCT02130193|11191028|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0
7081105|NCT02130193|11191029|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
7081106|NCT02130193|11191030|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
7081107|NCT02130284|11191048|FG000|Overall Study|Withdrawal by Subject|3
7081108|NCT02130284|11191048|FG000|Overall Study|Subject Withdrew Consent|1
7081109|NCT02130284|11191048|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1
7081110|NCT02130284|11191048|FG000|Overall Study|Subject was screened as backup for study|3
7081111|NCT02130284|11191048|FG000|Overall Study|Screen Failure|1
7081112|NCT02130297|11191052|FG000|Overall Study|Lost to Follow-up|4
7081113|NCT02130427|11191056|FG000|Overall Study|Imaging results not interpretable|30
7081114|NCT02130557|11191062|FG000|Overall Study|Withdrawal by Subject|12
7081115|NCT02130557|11191063|FG001|Overall Study|Withdrawal by Subject|12
7081116|NCT02130557|11191062|FG000|Overall Study|Investigator Request|0
7081117|NCT02130557|11191063|FG001|Overall Study|Investigator Request|2
7081118|NCT02130557|11191062|FG000|Overall Study|Deceased|14
7081119|NCT02130557|11191063|FG001|Overall Study|Deceased|14
7081120|NCT02130557|11191062|FG000|Overall Study|Lost to Follow-up|6
7081121|NCT02130557|11191063|FG001|Overall Study|Lost to Follow-up|7
7081122|NCT02130557|11191062|FG000|Overall Study|Other|2
7081123|NCT02130557|11191063|FG001|Overall Study|Other|1
7081124|NCT02130557|11191062|FG000|Overall Study|Missing|2
7081125|NCT02130557|11191063|FG001|Overall Study|Missing|1
7081126|NCT02130570|11191071|FG000|Overall Study|Death|3
7081127|NCT02130570|11191072|FG001|Overall Study|Death|5
7081128|NCT02130570|11191071|FG000|Overall Study|Withdrawal by Subject|6
7081129|NCT02130570|11191072|FG001|Overall Study|Withdrawal by Subject|3
7081130|NCT02130570|11191071|FG000|Overall Study|Part of practice that discontinued study|0
7081131|NCT02130570|11191072|FG001|Overall Study|Part of practice that discontinued study|5
7081132|NCT02130765|11191136|FG000|Overall Study|Did not receive treatment|4
6896022|NCT00630786|10914304|FG001|Overall Study|Physician Decision|0
6896023|NCT00630786|10914305|FG002|Overall Study|Physician Decision|1
6896024|NCT00630786|10914303|FG000|Overall Study|Withdrawal by Subject|0
6896025|NCT00630786|10914304|FG001|Overall Study|Withdrawal by Subject|1
6896026|NCT00630786|10914305|FG002|Overall Study|Withdrawal by Subject|1
6896027|NCT00630786|10914303|FG000|Overall Study|Lost to Follow-up|0
6896028|NCT00630786|10914304|FG001|Overall Study|Lost to Follow-up|1
6896029|NCT00630786|10914305|FG002|Overall Study|Lost to Follow-up|0
7081133|NCT02130765|11191137|FG001|Overall Study|Did not receive treatment|0
7081134|NCT02130765|11191138|FG002|Overall Study|Did not receive treatment|0
7081135|NCT02130765|11191139|FG003|Overall Study|Did not receive treatment|0
7181410|NCT02500797|11382028|FG000|Overall Study|Cancel (rapid disease progression)|0
7181411|NCT02500797|11382029|FG001|Overall Study|Cancel (rapid disease progression)|0
7181412|NCT02500797|11382030|FG002|Overall Study|Cancel (rapid disease progression)|0
7181413|NCT02500797|11382031|FG003|Overall Study|Cancel (rapid disease progression)|0
7181414|NCT02500797|11382032|FG004|Overall Study|Cancel (rapid disease progression)|1
7181415|NCT02500797|11382033|FG005|Overall Study|Cancel (rapid disease progression)|1
7181416|NCT02500797|11382034|FG006|Overall Study|Cancel (rapid disease progression)|0
7181417|NCT02500797|11382035|FG007|Overall Study|Cancel (rapid disease progression)|0
7181418|NCT02500797|11382028|FG000|Overall Study|Withdrawal by Subject|1
7181419|NCT02500797|11382029|FG001|Overall Study|Withdrawal by Subject|0
7181420|NCT02500797|11382030|FG002|Overall Study|Withdrawal by Subject|0
7181421|NCT02500797|11382031|FG003|Overall Study|Withdrawal by Subject|0
7181422|NCT02500797|11382032|FG004|Overall Study|Withdrawal by Subject|0
7181423|NCT02500797|11382033|FG005|Overall Study|Withdrawal by Subject|0
7181424|NCT02500797|11382034|FG006|Overall Study|Withdrawal by Subject|0
7181425|NCT02500797|11382035|FG007|Overall Study|Withdrawal by Subject|0
7181426|NCT02446600|11382070|FG000|Overall Study|Never treated|20
7181427|NCT02446600|11382071|FG001|Overall Study|Never treated|2
7181428|NCT02446600|11382072|FG002|Overall Study|Never treated|6
6896030|NCT00630786|10914303|FG000|Overall Study|Other|1
7081136|NCT02130986|11191153|FG000|Overall Study|Withdrawal by Subject|4
7081137|NCT02130986|11191154|FG001|Overall Study|Withdrawal by Subject|4
7081138|NCT02130986|11191153|FG000|Overall Study|Lost to Follow-up|151
7081139|NCT02130986|11191154|FG001|Overall Study|Lost to Follow-up|160
7081140|NCT02131064|11191176|FG000|Overall Study|Death|5
7081141|NCT02131064|11191177|FG001|Overall Study|Death|6
7081142|NCT02131064|11191176|FG000|Overall Study|Lost to Follow-up|4
7081143|NCT02131064|11191177|FG001|Overall Study|Lost to Follow-up|8
7081144|NCT02131064|11191176|FG000|Overall Study|Withdrawal by Subject|14
7081145|NCT02131064|11191177|FG001|Overall Study|Withdrawal by Subject|18
7081146|NCT02131064|11191176|FG000|Overall Study|Other|2
7081147|NCT02131064|11191177|FG001|Overall Study|Other|2
7081148|NCT02131129|11191186|FG000|Overall Study|Withdrawal by Subject|1
7081149|NCT02131129|11191187|FG001|Overall Study|Withdrawal by Subject|0
7081150|NCT02131233|11191195|FG000|Overall Study|Not Treated|2
7081151|NCT02131233|11191196|FG001|Overall Study|Not Treated|3
7081152|NCT02131233|11191195|FG000|Overall Study|Adverse Event|7
7081153|NCT02131233|11191196|FG001|Overall Study|Adverse Event|6
7081154|NCT02131233|11191195|FG000|Overall Study|Death|0
7081155|NCT02131233|11191196|FG001|Overall Study|Death|1
7081156|NCT02131233|11191195|FG000|Overall Study|Lack of Efficacy|6
7081157|NCT02131233|11191196|FG001|Overall Study|Lack of Efficacy|3
7081158|NCT02131233|11191195|FG000|Overall Study|Lost to Follow-up|14
7081159|NCT02131233|11191196|FG001|Overall Study|Lost to Follow-up|13
7081160|NCT02131233|11191195|FG000|Overall Study|Non-Compliance With Study Drug|8
7081161|NCT02131233|11191196|FG001|Overall Study|Non-Compliance With Study Drug|5
7081162|NCT02131233|11191195|FG000|Overall Study|Physician Decision|7
7081163|NCT02131233|11191196|FG001|Overall Study|Physician Decision|0
7081164|NCT02131233|11191195|FG000|Overall Study|Pregnancy|4
7081165|NCT02131233|11191196|FG001|Overall Study|Pregnancy|0
7081166|NCT02131233|11191195|FG000|Overall Study|Withdrawal by Subject|18
7081167|NCT02131233|11191196|FG001|Overall Study|Withdrawal by Subject|11
7081168|NCT02131259|11191202|FG000|Overall Study|Progressive disease|751
7081169|NCT02131259|11191202|FG000|Overall Study|Adverse Event|341
7081170|NCT02131259|11191202|FG000|Overall Study|Lost to Follow-up|7
7081171|NCT02131259|11191202|FG000|Overall Study|Relocation|32
7081172|NCT02131259|11191202|FG000|Overall Study|Other|63
6973283|NCT01179477|11024939|FG000|Overall Study|Unsuccessful implant|80
6973284|NCT01179477|11024939|FG000|Overall Study|Non-death withdrawal|438
6973285|NCT01179477|11024939|FG000|Overall Study|Did not complete final visit|27
6973286|NCT01179516|11024950|FG000|Overall Study|Pretreatment Event or Adverse Event|6
7081173|NCT02131259|11191202|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22
7181429|NCT02446600|11382073|FG003|Overall Study|Never treated|0
7181430|NCT02446600|11382070|FG000|Overall Study|Withdrawal by Subject|19
7181431|NCT02446600|11382071|FG001|Overall Study|Withdrawal by Subject|5
7181432|NCT02446600|11382072|FG002|Overall Study|Withdrawal by Subject|17
7181433|NCT02446600|11382073|FG003|Overall Study|Withdrawal by Subject|0
7181434|NCT02446600|11382070|FG000|Overall Study|Ineligible|1
7181435|NCT02446600|11382071|FG001|Overall Study|Ineligible|4
7181436|NCT02446600|11382072|FG002|Overall Study|Ineligible|4
7181437|NCT02446600|11382073|FG003|Overall Study|Ineligible|1
7181438|NCT02446600|11382070|FG000|Overall Study|Duplicate Enrollment|0
7181439|NCT02446600|11382071|FG001|Overall Study|Duplicate Enrollment|1
7181440|NCT02446600|11382072|FG002|Overall Study|Duplicate Enrollment|0
7181441|NCT02446600|11382073|FG003|Overall Study|Duplicate Enrollment|0
7181442|NCT02426658|11382083|FG000|Overall Study|Withdrawal by Subject|1
7181443|NCT02426658|11382083|FG000|Overall Study|Patient expired before treatment|2
7181444|NCT02281084|11382091|FG000|Overall Study|Adverse Event|1
7181445|NCT02281084|11382092|FG001|Overall Study|Adverse Event|0
7181446|NCT02281084|11382093|FG002|Overall Study|Adverse Event|0
7181447|NCT02281084|11382094|FG003|Overall Study|Adverse Event|0
7181448|NCT02281084|11382091|FG000|Overall Study|Withdrawal by Subject|1
7181449|NCT02281084|11382092|FG001|Overall Study|Withdrawal by Subject|2
7181450|NCT02281084|11382093|FG002|Overall Study|Withdrawal by Subject|0
7181451|NCT02281084|11382094|FG003|Overall Study|Withdrawal by Subject|0
7181452|NCT02281084|11382091|FG000|Overall Study|Death|20
7181453|NCT02281084|11382092|FG001|Overall Study|Death|16
7181454|NCT02281084|11382093|FG002|Overall Study|Death|3
7181455|NCT02281084|11382094|FG003|Overall Study|Death|5
7181456|NCT02281084|11382091|FG000|Overall Study|Physician Decision|0
7181457|NCT02281084|11382092|FG001|Overall Study|Physician Decision|0
7181458|NCT02281084|11382093|FG002|Overall Study|Physician Decision|1
7181459|NCT02281084|11382094|FG003|Overall Study|Physician Decision|0
7181460|NCT02277106|11382104|FG000|Stage 2|Adverse Event|0
7181461|NCT02277106|11382105|FG001|Stage 2|Adverse Event|0
7181462|NCT02277106|11382106|FG002|Stage 2|Adverse Event|1
7181463|NCT02175030|11382119|FG000|Overall Study|Failed screen after consent|7
7181464|NCT02175030|11382120|FG001|Overall Study|Failed screen after consent|6
7181465|NCT02175030|11382119|FG000|Overall Study|Failed IUD Insertion|20
7181466|NCT02175030|11382120|FG001|Overall Study|Failed IUD Insertion|21
7181467|NCT02175030|11382119|FG000|Overall Study|Physician Decision|1
7181468|NCT02175030|11382120|FG001|Overall Study|Physician Decision|1
7181469|NCT02175030|11382119|FG000|Overall Study|Lost to Follow-up|6
7181470|NCT02175030|11382120|FG001|Overall Study|Lost to Follow-up|6
7181471|NCT02175030|11382119|FG000|Overall Study|Withdrawal by Subject|1
7181472|NCT02175030|11382120|FG001|Overall Study|Withdrawal by Subject|4
7181473|NCT02059265|11382126|FG000|Overall Study|Ineligible|4
7181474|NCT02017717|11382139|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0
7181475|NCT02017717|11382140|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0
7181476|NCT02017717|11382141|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0
7181477|NCT02017717|11382142|FG003|Before Treatment Period|Adverse Event unrelated to study drug|1
7181478|NCT02017717|11382143|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0
7181479|NCT02017717|11382144|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0
7181480|NCT02017717|11382145|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0
7181481|NCT02017717|11382146|FG007|Before Treatment Period|Adverse Event unrelated to study drug|0
7181482|NCT02017717|11382147|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0
7181483|NCT02017717|11382139|FG000|Before Treatment Period|Participant request to stop therapy|0
7181484|NCT02017717|11382140|FG001|Before Treatment Period|Participant request to stop therapy|0
7181485|NCT02017717|11382141|FG002|Before Treatment Period|Participant request to stop therapy|0
7181486|NCT02017717|11382142|FG003|Before Treatment Period|Participant request to stop therapy|0
7181487|NCT02017717|11382143|FG004|Before Treatment Period|Participant request to stop therapy|5
7181488|NCT02017717|11382144|FG005|Before Treatment Period|Participant request to stop therapy|0
7181489|NCT02017717|11382145|FG006|Before Treatment Period|Participant request to stop therapy|0
7181490|NCT02017717|11382146|FG007|Before Treatment Period|Participant request to stop therapy|0
7181491|NCT02017717|11382147|FG008|Before Treatment Period|Participant request to stop therapy|0
7181492|NCT02017717|11382139|FG000|Before Treatment Period|Participant withdrew consent|0
7181493|NCT02017717|11382140|FG001|Before Treatment Period|Participant withdrew consent|0
7181494|NCT02017717|11382141|FG002|Before Treatment Period|Participant withdrew consent|0
7181495|NCT02017717|11382142|FG003|Before Treatment Period|Participant withdrew consent|0
7181496|NCT02017717|11382143|FG004|Before Treatment Period|Participant withdrew consent|11
7181497|NCT02017717|11382144|FG005|Before Treatment Period|Participant withdrew consent|0
7181498|NCT02017717|11382145|FG006|Before Treatment Period|Participant withdrew consent|0
7181499|NCT02017717|11382146|FG007|Before Treatment Period|Participant withdrew consent|0
7181500|NCT02017717|11382147|FG008|Before Treatment Period|Participant withdrew consent|2
7181501|NCT02017717|11382139|FG000|Before Treatment Period|Lost to Follow-up|0
7181502|NCT02017717|11382140|FG001|Before Treatment Period|Lost to Follow-up|0
7181503|NCT02017717|11382141|FG002|Before Treatment Period|Lost to Follow-up|0
7181504|NCT02017717|11382142|FG003|Before Treatment Period|Lost to Follow-up|0
7181505|NCT02017717|11382143|FG004|Before Treatment Period|Lost to Follow-up|1
7181506|NCT02017717|11382144|FG005|Before Treatment Period|Lost to Follow-up|0
7181507|NCT02017717|11382145|FG006|Before Treatment Period|Lost to Follow-up|0
7181508|NCT02017717|11382146|FG007|Before Treatment Period|Lost to Follow-up|0
7181509|NCT02017717|11382147|FG008|Before Treatment Period|Lost to Follow-up|0
7181510|NCT02017717|11382139|FG000|Before Treatment Period|Participant no longer met criteria|0
7181511|NCT02017717|11382140|FG001|Before Treatment Period|Participant no longer met criteria|0
7181512|NCT02017717|11382141|FG002|Before Treatment Period|Participant no longer met criteria|0
7181513|NCT02017717|11382142|FG003|Before Treatment Period|Participant no longer met criteria|1
7081174|NCT02131259|11191202|FG000|Overall Study|Progressive disease/relocation|1
7081175|NCT02131259|11191202|FG000|Overall Study|Progressive disease/other|2
7081176|NCT02131259|11191202|FG000|Overall Study|AE/lost to follow-up|1
7081177|NCT02131259|11191202|FG000|Overall Study|AE/other|1
7081178|NCT02131259|11191202|FG000|Overall Study|Progressive disease/AE/other|1
7081179|NCT02131259|11191202|FG000|Overall Study|Missing|3
7081180|NCT02131272|11191208|FG000|Overall Study|Withdrawal by parent|0
7081181|NCT02131272|11191209|FG001|Overall Study|Withdrawal by parent|1
6973287|NCT01179516|11024951|FG001|Overall Study|Pretreatment Event or Adverse Event|8
6973288|NCT01179516|11024952|FG002|Overall Study|Pretreatment Event or Adverse Event|12
6973289|NCT01179516|11024950|FG000|Overall Study|Lack of Efficacy|4
6973290|NCT01179516|11024951|FG001|Overall Study|Lack of Efficacy|2
6973291|NCT01179516|11024952|FG002|Overall Study|Lack of Efficacy|0
6973292|NCT01179516|11024950|FG000|Overall Study|Noncompliance with Study Drug|2
6973293|NCT01179516|11024951|FG001|Overall Study|Noncompliance with Study Drug|0
7081182|NCT02131272|11191208|FG000|Overall Study|Withdrawal by Subject|0
7081183|NCT02131272|11191209|FG001|Overall Study|Withdrawal by Subject|1
7081184|NCT02131272|11191208|FG000|Overall Study|Withdrawal Criteria|1
7081185|NCT02131272|11191209|FG001|Overall Study|Withdrawal Criteria|0
7081186|NCT02131311|11191215|FG000|Overall Study|Adverse Event|2
7081187|NCT02131311|11191215|FG000|Overall Study|Protocol Violation|1
7081188|NCT02131311|11191215|FG000|Overall Study|Lost to Follow-up|1
7081189|NCT02131324|11191222|FG000|Overall Study|Withdrawal by Subject|1
7081190|NCT02131324|11191223|FG001|Overall Study|Withdrawal by Subject|2
7081191|NCT02131324|11191222|FG000|Overall Study|Lost to Follow-up|1
7081192|NCT02131324|11191223|FG001|Overall Study|Lost to Follow-up|1
7081193|NCT02131532|11191292|FG000|Overall Study|Withdrawal by Subject|1
7081194|NCT02131532|11191292|FG000|Overall Study|Physician Decision|1
7081195|NCT02131532|11191292|FG000|Overall Study|Other health conditions|2
7081196|NCT02131636|11191299|FG000|Overall Study|Personal Reasons|4
7081197|NCT02131636|11191300|FG001|Overall Study|Personal Reasons|4
7081198|NCT02131636|11191299|FG000|Overall Study|Lost to Follow-up|4
7081199|NCT02131636|11191300|FG001|Overall Study|Lost to Follow-up|0
7081200|NCT02131636|11191299|FG000|Overall Study|Adverse Event|4
7081201|NCT02131636|11191300|FG001|Overall Study|Adverse Event|1
7081202|NCT02131662|11191311|FG000|Overall Study|Protocol Violation|1
7081203|NCT02131662|11191312|FG001|Overall Study|Protocol Violation|0
7081204|NCT02131662|11191313|FG002|Overall Study|Protocol Violation|0
6896031|NCT00630786|10914304|FG001|Overall Study|Other|0
6896032|NCT00630786|10914305|FG002|Overall Study|Other|0
7081205|NCT02131662|11191314|FG003|Overall Study|Protocol Violation|0
7081206|NCT02131662|11191315|FG004|Overall Study|Protocol Violation|0
7081207|NCT02131662|11191311|FG000|Overall Study|Other|2
7081208|NCT02131662|11191312|FG001|Overall Study|Other|4
7081209|NCT02131662|11191313|FG002|Overall Study|Other|3
7081210|NCT02131662|11191314|FG003|Overall Study|Other|3
7081211|NCT02131662|11191315|FG004|Overall Study|Other|4
7081212|NCT02131662|11191311|FG000|Overall Study|Adverse Event|0
7081213|NCT02131662|11191312|FG001|Overall Study|Adverse Event|1
7081214|NCT02131662|11191313|FG002|Overall Study|Adverse Event|1
7081215|NCT02131662|11191314|FG003|Overall Study|Adverse Event|1
7081216|NCT02131662|11191315|FG004|Overall Study|Adverse Event|3
7081217|NCT02131662|11191311|FG000|Overall Study|Pregnancy|0
7081218|NCT02131662|11191312|FG001|Overall Study|Pregnancy|1
7081219|NCT02131662|11191313|FG002|Overall Study|Pregnancy|0
7081220|NCT02131662|11191314|FG003|Overall Study|Pregnancy|1
7081221|NCT02131662|11191315|FG004|Overall Study|Pregnancy|0
7081222|NCT02131662|11191311|FG000|Overall Study|Wish for pregnancy|0
7081223|NCT02131662|11191312|FG001|Overall Study|Wish for pregnancy|0
7081224|NCT02131662|11191313|FG002|Overall Study|Wish for pregnancy|0
7081225|NCT02131662|11191314|FG003|Overall Study|Wish for pregnancy|0
7081226|NCT02131662|11191315|FG004|Overall Study|Wish for pregnancy|1
7081227|NCT02131662|11191311|FG000|Overall Study|Lack of Efficacy|1
7081228|NCT02131662|11191312|FG001|Overall Study|Lack of Efficacy|0
7081229|NCT02131662|11191313|FG002|Overall Study|Lack of Efficacy|0
6896033|NCT00630812|10914313|FG000|Randomisation to First Dose|Adverse Event|1
6896034|NCT00630812|10914314|FG001|Randomisation to First Dose|Adverse Event|1
6896035|NCT00630812|10914313|FG000|Randomisation to First Dose|Withdrawal by Subject|2
6896036|NCT00630812|10914314|FG001|Randomisation to First Dose|Withdrawal by Subject|3
6896037|NCT00630812|10914313|FG000|Randomisation to First Dose|Lost to Follow-up|1
6896038|NCT00630812|10914314|FG001|Randomisation to First Dose|Lost to Follow-up|0
6896039|NCT00630812|10914313|FG000|Randomisation to First Dose|Protocol Violation|4
6896040|NCT00630812|10914314|FG001|Randomisation to First Dose|Protocol Violation|1
6896041|NCT00630812|10914313|FG000|Double Blind Treatment Period|Adverse Event|13
6896042|NCT00630812|10914314|FG001|Double Blind Treatment Period|Adverse Event|5
6896043|NCT00630812|10914313|FG000|Double Blind Treatment Period|Lost to Follow-up|1
6896044|NCT00630812|10914314|FG001|Double Blind Treatment Period|Lost to Follow-up|0
6896045|NCT00630812|10914313|FG000|Double Blind Treatment Period|Physician Decision|2
6896046|NCT00630812|10914314|FG001|Double Blind Treatment Period|Physician Decision|1
6896047|NCT00630812|10914313|FG000|Double Blind Treatment Period|Protocol Violation|1
6896048|NCT00630812|10914314|FG001|Double Blind Treatment Period|Protocol Violation|0
6896049|NCT00630812|10914313|FG000|Double Blind Treatment Period|Withdrawal by Subject|13
6896050|NCT00630812|10914314|FG001|Double Blind Treatment Period|Withdrawal by Subject|7
6896051|NCT00630812|10914313|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1
7181514|NCT02017717|11382143|FG004|Before Treatment Period|Participant no longer met criteria|2
7181515|NCT02017717|11382144|FG005|Before Treatment Period|Participant no longer met criteria|0
7181516|NCT02017717|11382145|FG006|Before Treatment Period|Participant no longer met criteria|0
7181517|NCT02017717|11382146|FG007|Before Treatment Period|Participant no longer met criteria|1
7181518|NCT02017717|11382147|FG008|Before Treatment Period|Participant no longer met criteria|0
7181519|NCT02017717|11382139|FG000|Before Treatment Period|other reason|0
7181520|NCT02017717|11382140|FG001|Before Treatment Period|other reason|0
7181521|NCT02017717|11382141|FG002|Before Treatment Period|other reason|0
7181522|NCT02017717|11382142|FG003|Before Treatment Period|other reason|0
7181523|NCT02017717|11382143|FG004|Before Treatment Period|other reason|1
6896052|NCT00630812|10914314|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0
6896053|NCT00630812|10914313|FG000|Double Blind Treatment Period|Non-compliance|0
6896054|NCT00630812|10914314|FG001|Double Blind Treatment Period|Non-compliance|1
6896055|NCT00630825|10914324|FG000|Overall Study|Adverse Event|4
6896056|NCT00630825|10914325|FG001|Overall Study|Adverse Event|4
6896057|NCT00630825|10914326|FG002|Overall Study|Adverse Event|3
6896058|NCT00630825|10914327|FG003|Overall Study|Adverse Event|1
6896059|NCT00630825|10914324|FG000|Overall Study|Entry Criteria Not Met|1
6896060|NCT00630825|10914325|FG001|Overall Study|Entry Criteria Not Met|0
6896061|NCT00630825|10914326|FG002|Overall Study|Entry Criteria Not Met|2
6896062|NCT00630825|10914327|FG003|Overall Study|Entry Criteria Not Met|1
6896063|NCT00630825|10914324|FG000|Overall Study|Lost to Follow-up|1
7081230|NCT02131662|11191314|FG003|Overall Study|Lack of Efficacy|0
6896064|NCT00630825|10914325|FG001|Overall Study|Lost to Follow-up|1
6896065|NCT00630825|10914326|FG002|Overall Study|Lost to Follow-up|1
6896066|NCT00630825|10914327|FG003|Overall Study|Lost to Follow-up|1
6896067|NCT00630825|10914324|FG000|Overall Study|Physician Decision|1
6896068|NCT00630825|10914325|FG001|Overall Study|Physician Decision|0
6896069|NCT00630825|10914326|FG002|Overall Study|Physician Decision|0
6896070|NCT00630825|10914327|FG003|Overall Study|Physician Decision|0
6896071|NCT00630825|10914324|FG000|Overall Study|Withdrawal by Subject|2
6896072|NCT00630825|10914325|FG001|Overall Study|Withdrawal by Subject|2
6896073|NCT00630825|10914326|FG002|Overall Study|Withdrawal by Subject|2
6896074|NCT00630825|10914327|FG003|Overall Study|Withdrawal by Subject|3
6896075|NCT00630838|10914339|FG000|Overall Study|Death|0
6896076|NCT00630838|10914340|FG001|Overall Study|Death|1
6896077|NCT00630838|10914339|FG000|Overall Study|Lost to Follow-up|0
6896078|NCT00630838|10914340|FG001|Overall Study|Lost to Follow-up|1
6896079|NCT00630864|10914348|FG000|Part 1 (up to Week 6)|Adverse Event|1
6896080|NCT00630864|10914348|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2
6896081|NCT00630877|10914355|FG000|Overall Study|Adverse Event|11
6896082|NCT00630877|10914356|FG001|Overall Study|Adverse Event|8
6896083|NCT00630877|10914357|FG002|Overall Study|Adverse Event|7
6896084|NCT00630877|10914355|FG000|Overall Study|Withdrawal by Subject|3
6896085|NCT00630877|10914356|FG001|Overall Study|Withdrawal by Subject|4
6896086|NCT00630877|10914357|FG002|Overall Study|Withdrawal by Subject|0
6896087|NCT00630877|10914355|FG000|Overall Study|Lost to Follow-up|2
6896088|NCT00630877|10914356|FG001|Overall Study|Lost to Follow-up|0
6896089|NCT00630877|10914357|FG002|Overall Study|Lost to Follow-up|0
6896090|NCT00630877|10914355|FG000|Overall Study|Noncompliance|2
6896091|NCT00630877|10914356|FG001|Overall Study|Noncompliance|3
6896092|NCT00630877|10914357|FG002|Overall Study|Noncompliance|1
6896093|NCT00630877|10914355|FG000|Overall Study|Protocol violation|1
6896094|NCT00630877|10914356|FG001|Overall Study|Protocol violation|0
6896095|NCT00630877|10914357|FG002|Overall Study|Protocol violation|1
6896096|NCT00630877|10914355|FG000|Overall Study|Personal reasons|0
6896097|NCT00630877|10914356|FG001|Overall Study|Personal reasons|0
6896098|NCT00630877|10914357|FG002|Overall Study|Personal reasons|1
6896099|NCT00630916|10914369|FG000|Overall Study|Death|110
6896100|NCT00630916|10914369|FG000|Overall Study|Explant|8
6896101|NCT00630916|10914369|FG000|Overall Study|Lost to Follow-up|5
6896102|NCT00630916|10914369|FG000|Overall Study|Withdrawal by Subject|30
6896103|NCT00630916|10914369|FG000|Overall Study|Protocol Violation|7
6896104|NCT00630916|10914369|FG000|Overall Study|Physician Decision|47
6896105|NCT00630916|10914369|FG000|Overall Study|Lack of Efficacy|3
6896106|NCT00630994|10914386|FG000|Overall Study|Adverse Event|1
6896107|NCT00630994|10914386|FG000|Overall Study|Disease Progression|1
6896108|NCT00630994|10914386|FG000|Overall Study|Lack of Efficacy|1
6896109|NCT00630994|10914386|FG000|Overall Study|Other|1
6896110|NCT00631007|10914396|FG000|Overall Study|Adverse Event|0
6896111|NCT00631007|10914397|FG001|Overall Study|Adverse Event|2
6896112|NCT00631007|10914398|FG002|Overall Study|Adverse Event|0
6896113|NCT00631007|10914399|FG003|Overall Study|Adverse Event|2
6896114|NCT00631007|10914400|FG004|Overall Study|Adverse Event|3
6896115|NCT00631007|10914401|FG005|Overall Study|Adverse Event|2
6896116|NCT00631007|10914396|FG000|Overall Study|Lost to Follow-up|2
6896117|NCT00631007|10914397|FG001|Overall Study|Lost to Follow-up|1
6896118|NCT00631007|10914398|FG002|Overall Study|Lost to Follow-up|2
6896119|NCT00631007|10914399|FG003|Overall Study|Lost to Follow-up|4
6896120|NCT00631007|10914400|FG004|Overall Study|Lost to Follow-up|5
6896121|NCT00631007|10914401|FG005|Overall Study|Lost to Follow-up|3
6896122|NCT00631007|10914396|FG000|Overall Study|Physician Decision|1
6896123|NCT00631007|10914397|FG001|Overall Study|Physician Decision|0
6896124|NCT00631007|10914398|FG002|Overall Study|Physician Decision|1
6896125|NCT00631007|10914399|FG003|Overall Study|Physician Decision|0
6896126|NCT00631007|10914400|FG004|Overall Study|Physician Decision|0
6896127|NCT00631007|10914401|FG005|Overall Study|Physician Decision|2
7081231|NCT02131662|11191315|FG004|Overall Study|Lack of Efficacy|1
6896128|NCT00631007|10914396|FG000|Overall Study|Persistent Hyperglycemia|2
6896129|NCT00631007|10914397|FG001|Overall Study|Persistent Hyperglycemia|2
6896130|NCT00631007|10914398|FG002|Overall Study|Persistent Hyperglycemia|5
6896131|NCT00631007|10914399|FG003|Overall Study|Persistent Hyperglycemia|1
7081232|NCT02131662|11191311|FG000|Overall Study|Withdrawal by Subject|1
6896132|NCT00631007|10914400|FG004|Overall Study|Persistent Hyperglycemia|2
6896133|NCT00631007|10914401|FG005|Overall Study|Persistent Hyperglycemia|5
6896134|NCT00631007|10914396|FG000|Overall Study|Withdrawal by Subject|4
6896135|NCT00631007|10914397|FG001|Overall Study|Withdrawal by Subject|5
6896136|NCT00631007|10914398|FG002|Overall Study|Withdrawal by Subject|2
6896137|NCT00631007|10914399|FG003|Overall Study|Withdrawal by Subject|2
6896138|NCT00631007|10914400|FG004|Overall Study|Withdrawal by Subject|1
6896139|NCT00631007|10914401|FG005|Overall Study|Withdrawal by Subject|3
6896140|NCT00631007|10914396|FG000|Overall Study|Other|2
6896141|NCT00631007|10914397|FG001|Overall Study|Other|1
6896142|NCT00631007|10914398|FG002|Overall Study|Other|0
6896143|NCT00631007|10914399|FG003|Overall Study|Other|0
6896144|NCT00631007|10914400|FG004|Overall Study|Other|1
6896145|NCT00631007|10914401|FG005|Overall Study|Other|0
6896146|NCT00631020|10914415|FG000|Overall Study|Lost to Follow-up|7
6896147|NCT00631020|10914415|FG000|Overall Study|Incarcerated|1
6896148|NCT00631163|10914419|FG000|Number of Participants in Year 1|Adverse Event|12
6896149|NCT00631163|10914419|FG000|Number of Participants in Year 1|Withdrawal by Subject|8
6896150|NCT00631163|10914419|FG000|Number of Participants in Year 1|Death|6
6896151|NCT00631163|10914419|FG000|Number of Participants in Year 1|Lost to Follow-up|1
6896152|NCT00631163|10914419|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1
6896153|NCT00631163|10914419|FG000|Number of Participants in Year 1|Administrative problems|6
6896154|NCT00631163|10914419|FG000|Number of Participants in Year 2|Withdrawal by Subject|2
6896155|NCT00631163|10914419|FG000|Number of Participants in Year 2|Adverse Event|1
6896156|NCT00631163|10914419|FG000|Number of Participants in Year 2|Protocol Violation|1
6896157|NCT00631163|10914419|FG000|Number of Participants in Year 2|Abnormal laboratory value|1
6896158|NCT00631189|10914434|FG000|Initial Phase|Protocol Violation|347
6896159|NCT00631189|10914435|FG001|Initial Phase|Protocol Violation|0
6896160|NCT00631189|10914436|FG002|Initial Phase|Protocol Violation|0
6896161|NCT00631189|10914437|FG003|Initial Phase|Protocol Violation|0
6896162|NCT00631189|10914434|FG000|Initial Phase|Withdrawal by Subject|4
6896163|NCT00631189|10914435|FG001|Initial Phase|Withdrawal by Subject|0
6896164|NCT00631189|10914436|FG002|Initial Phase|Withdrawal by Subject|0
6896165|NCT00631189|10914437|FG003|Initial Phase|Withdrawal by Subject|0
6896166|NCT00631189|10914434|FG000|Treatment Phase|Withdrawal by Subject|0
6896167|NCT00631189|10914435|FG001|Treatment Phase|Withdrawal by Subject|2
6896168|NCT00631189|10914436|FG002|Treatment Phase|Withdrawal by Subject|1
6896169|NCT00631189|10914437|FG003|Treatment Phase|Withdrawal by Subject|1
6896170|NCT00631189|10914434|FG000|Treatment Phase|Protocol Violation|0
6896171|NCT00631189|10914435|FG001|Treatment Phase|Protocol Violation|1
6896172|NCT00631189|10914436|FG002|Treatment Phase|Protocol Violation|6
6896173|NCT00631189|10914437|FG003|Treatment Phase|Protocol Violation|2
6896174|NCT00631189|10914434|FG000|Treatment Phase|Adverse Event|0
6896175|NCT00631189|10914435|FG001|Treatment Phase|Adverse Event|3
6896176|NCT00631189|10914436|FG002|Treatment Phase|Adverse Event|2
6896177|NCT00631189|10914437|FG003|Treatment Phase|Adverse Event|4
6896178|NCT00631189|10914434|FG000|Treatment Phase|Lost to Follow-up|0
6896179|NCT00631189|10914435|FG001|Treatment Phase|Lost to Follow-up|1
6896180|NCT00631189|10914436|FG002|Treatment Phase|Lost to Follow-up|0
6896181|NCT00631189|10914437|FG003|Treatment Phase|Lost to Follow-up|0
6896182|NCT00631189|10914434|FG000|Treatment Phase|Pregnancy|0
6896183|NCT00631189|10914435|FG001|Treatment Phase|Pregnancy|0
6896184|NCT00631189|10914436|FG002|Treatment Phase|Pregnancy|1
6896185|NCT00631189|10914437|FG003|Treatment Phase|Pregnancy|0
6896186|NCT00631189|10914434|FG000|Treatment Phase|patient did not take pravastatin|0
6896187|NCT00631189|10914435|FG001|Treatment Phase|patient did not take pravastatin|0
6896188|NCT00631189|10914436|FG002|Treatment Phase|patient did not take pravastatin|1
6896189|NCT00631189|10914437|FG003|Treatment Phase|patient did not take pravastatin|0
6896190|NCT00631371|10914468|FG000|Overall Study|Lost to Follow-up|24
6896191|NCT00631371|10914469|FG001|Overall Study|Lost to Follow-up|19
6896192|NCT00631371|10914468|FG000|Overall Study|Other reason|5
6896193|NCT00631371|10914469|FG001|Overall Study|Other reason|12
6896194|NCT00631371|10914468|FG000|Overall Study|subject request|38
6896195|NCT00631371|10914469|FG001|Overall Study|subject request|45
6896196|NCT00631371|10914468|FG000|Overall Study|Discontinuation of study by Sponsor|70
6896197|NCT00631371|10914469|FG001|Overall Study|Discontinuation of study by Sponsor|76
6896198|NCT00631371|10914468|FG000|Overall Study|Death|263
6896199|NCT00631371|10914469|FG001|Overall Study|Death|239
6896200|NCT00631410|10914477|FG000|Overall Study|Adverse Event|1
6896201|NCT00631410|10914478|FG001|Overall Study|Adverse Event|3
6977119|NCT01205126|11030146|FG001|Titration Phase|Adverse Event|3
7181524|NCT02017717|11382144|FG005|Before Treatment Period|other reason|0
7181525|NCT02017717|11382145|FG006|Before Treatment Period|other reason|0
7181526|NCT02017717|11382146|FG007|Before Treatment Period|other reason|0
7181527|NCT02017717|11382147|FG008|Before Treatment Period|other reason|0
7181528|NCT02017717|11382139|FG000|Treatment Period|Disease progression|7
7181529|NCT02017717|11382140|FG001|Treatment Period|Disease progression|9
7181530|NCT02017717|11382141|FG002|Treatment Period|Disease progression|12
7181531|NCT02017717|11382142|FG003|Treatment Period|Disease progression|165
7181532|NCT02017717|11382143|FG004|Treatment Period|Disease progression|134
7181533|NCT02017717|11382144|FG005|Treatment Period|Disease progression|20
7181534|NCT02017717|11382145|FG006|Treatment Period|Disease progression|26
7181535|NCT02017717|11382146|FG007|Treatment Period|Disease progression|17
7181536|NCT02017717|11382147|FG008|Treatment Period|Disease progression|22
7181537|NCT02017717|11382139|FG000|Treatment Period|Study drug toxicity|3
7181538|NCT02017717|11382140|FG001|Treatment Period|Study drug toxicity|0
7181539|NCT02017717|11382141|FG002|Treatment Period|Study drug toxicity|1
7181540|NCT02017717|11382142|FG003|Treatment Period|Study drug toxicity|7
7181541|NCT02017717|11382143|FG004|Treatment Period|Study drug toxicity|11
7181542|NCT02017717|11382144|FG005|Treatment Period|Study drug toxicity|4
7181543|NCT02017717|11382145|FG006|Treatment Period|Study drug toxicity|4
7181544|NCT02017717|11382146|FG007|Treatment Period|Study drug toxicity|5
7181545|NCT02017717|11382147|FG008|Treatment Period|Study drug toxicity|3
7181546|NCT02017717|11382139|FG000|Treatment Period|Death|0
7181547|NCT02017717|11382140|FG001|Treatment Period|Death|0
7181548|NCT02017717|11382141|FG002|Treatment Period|Death|1
7181549|NCT02017717|11382142|FG003|Treatment Period|Death|0
7181550|NCT02017717|11382143|FG004|Treatment Period|Death|0
7181551|NCT02017717|11382144|FG005|Treatment Period|Death|0
7081233|NCT02131662|11191312|FG001|Overall Study|Withdrawal by Subject|5
7081234|NCT02131662|11191313|FG002|Overall Study|Withdrawal by Subject|1
7081235|NCT02131662|11191314|FG003|Overall Study|Withdrawal by Subject|5
7081236|NCT02131662|11191315|FG004|Overall Study|Withdrawal by Subject|6
7081237|NCT02131662|11191311|FG000|Overall Study|Lost to Follow-up|1
7181552|NCT02017717|11382145|FG006|Treatment Period|Death|0
7181553|NCT02017717|11382146|FG007|Treatment Period|Death|1
7181554|NCT02017717|11382147|FG008|Treatment Period|Death|0
7181555|NCT02017717|11382139|FG000|Treatment Period|Adverse event unrelated to study drug|0
7181556|NCT02017717|11382140|FG001|Treatment Period|Adverse event unrelated to study drug|0
7181557|NCT02017717|11382141|FG002|Treatment Period|Adverse event unrelated to study drug|2
7081238|NCT02131662|11191312|FG001|Overall Study|Lost to Follow-up|3
7081239|NCT02131662|11191313|FG002|Overall Study|Lost to Follow-up|0
7081240|NCT02131662|11191314|FG003|Overall Study|Lost to Follow-up|9
7081241|NCT02131662|11191315|FG004|Overall Study|Lost to Follow-up|0
7081242|NCT02131662|11191311|FG000|Overall Study|Not treated|2
7081243|NCT02131662|11191312|FG001|Overall Study|Not treated|0
7081244|NCT02131662|11191313|FG002|Overall Study|Not treated|2
7081245|NCT02131662|11191314|FG003|Overall Study|Not treated|2
7081246|NCT02131662|11191315|FG004|Overall Study|Not treated|3
7081247|NCT02131766|11191331|FG000|Overall Study|Withdrawal by Subject|4
7081248|NCT02132117|11191340|FG000|Overall Study|Adverse Event|6
7081249|NCT02132117|11191341|FG001|Overall Study|Adverse Event|1
7081250|NCT02132117|11191340|FG000|Overall Study|Lost to Follow-up|2
7081251|NCT02132117|11191341|FG001|Overall Study|Lost to Follow-up|2
7081252|NCT02132117|11191340|FG000|Overall Study|Personal Reasons|1
7181558|NCT02017717|11382142|FG003|Treatment Period|Adverse event unrelated to study drug|4
7181559|NCT02017717|11382143|FG004|Treatment Period|Adverse event unrelated to study drug|5
7181560|NCT02017717|11382144|FG005|Treatment Period|Adverse event unrelated to study drug|0
7181561|NCT02017717|11382145|FG006|Treatment Period|Adverse event unrelated to study drug|0
7181562|NCT02017717|11382146|FG007|Treatment Period|Adverse event unrelated to study drug|0
7181563|NCT02017717|11382147|FG008|Treatment Period|Adverse event unrelated to study drug|1
7181564|NCT02017717|11382139|FG000|Treatment Period|Participant request to stop therapy|0
7181565|NCT02017717|11382140|FG001|Treatment Period|Participant request to stop therapy|0
7181566|NCT02017717|11382141|FG002|Treatment Period|Participant request to stop therapy|3
7181567|NCT02017717|11382142|FG003|Treatment Period|Participant request to stop therapy|4
7181568|NCT02017717|11382143|FG004|Treatment Period|Participant request to stop therapy|7
7181569|NCT02017717|11382144|FG005|Treatment Period|Participant request to stop therapy|5
7181570|NCT02017717|11382145|FG006|Treatment Period|Participant request to stop therapy|0
7181571|NCT02017717|11382146|FG007|Treatment Period|Participant request to stop therapy|2
7181572|NCT02017717|11382147|FG008|Treatment Period|Participant request to stop therapy|1
7181573|NCT02017717|11382139|FG000|Treatment Period|Participant withdrew consent|0
7081253|NCT02132117|11191341|FG001|Overall Study|Personal Reasons|2
7081254|NCT02132117|11191340|FG000|Overall Study|Other Miscellaneous Reasons|2
7081255|NCT02132117|11191341|FG001|Overall Study|Other Miscellaneous Reasons|0
7081256|NCT02132130|11191351|FG000|Overall Study|Lost to Follow-up|0
7081257|NCT02132130|11191352|FG001|Overall Study|Lost to Follow-up|2
7081258|NCT02132130|11191353|FG002|Overall Study|Lost to Follow-up|0
7081259|NCT02132130|11191354|FG003|Overall Study|Lost to Follow-up|0
7081260|NCT02132130|11191351|FG000|Overall Study|Withdrawal by Subject|0
7081261|NCT02132130|11191352|FG001|Overall Study|Withdrawal by Subject|0
7081262|NCT02132130|11191353|FG002|Overall Study|Withdrawal by Subject|0
7081263|NCT02132130|11191354|FG003|Overall Study|Withdrawal by Subject|1
7081264|NCT02132195|11191380|FG000|Initial Assignment|Relapsed|14
7081265|NCT02132195|11191381|FG001|Initial Assignment|Relapsed|0
7081266|NCT02132195|11191382|FG002|Initial Assignment|Relapsed|0
7081267|NCT02132195|11191380|FG000|Rescue Therapy|Relapsed|0
7081268|NCT02132195|11191381|FG001|Rescue Therapy|Relapsed|0
7081269|NCT02132195|11191382|FG002|Rescue Therapy|Relapsed|7
7081270|NCT02132195|11191380|FG000|Rescue Therapy|Physician Decision|0
7081271|NCT02132195|11191381|FG001|Rescue Therapy|Physician Decision|0
7081272|NCT02132195|11191382|FG002|Rescue Therapy|Physician Decision|1
7081273|NCT02132195|11191380|FG000|Rescue Therapy|Withdrawal by Subject|0
7081274|NCT02132195|11191381|FG001|Rescue Therapy|Withdrawal by Subject|0
7081275|NCT02132195|11191382|FG002|Rescue Therapy|Withdrawal by Subject|1
7081276|NCT02132195|11191380|FG000|Rescue Therapy|Adverse Event|0
7081277|NCT02132195|11191381|FG001|Rescue Therapy|Adverse Event|0
7081278|NCT02132195|11191382|FG002|Rescue Therapy|Adverse Event|2
7081279|NCT02132247|11191392|FG000|Overall Study|Protocol Violation|1
7081280|NCT02132247|11191393|FG001|Overall Study|Protocol Violation|0
7081281|NCT02132312|11191401|FG000|Overall Study|Adverse Event|2
7081282|NCT02132312|11191402|FG001|Overall Study|Adverse Event|0
7081283|NCT02132312|11191401|FG000|Overall Study|Physician Decision|1
7081284|NCT02132312|11191402|FG001|Overall Study|Physician Decision|1
7081285|NCT02132312|11191401|FG000|Overall Study|Protocol Violation|0
7081286|NCT02132312|11191402|FG001|Overall Study|Protocol Violation|1
7081287|NCT02132312|11191401|FG000|Overall Study|Withdrawal by Subject|1
7081288|NCT02132312|11191402|FG001|Overall Study|Withdrawal by Subject|0
6896202|NCT00631410|10914477|FG000|Overall Study|Objective Progression or Relapse|4
6896203|NCT00631410|10914478|FG001|Overall Study|Objective Progression or Relapse|3
6896204|NCT00631410|10914477|FG000|Overall Study|Surgery|1
6896205|NCT00631410|10914478|FG001|Overall Study|Surgery|0
6896206|NCT00631475|10914498|FG000|Overall Study|Death|18
6896207|NCT00631475|10914498|FG000|Overall Study|Adverse Event|14
6896208|NCT00631475|10914498|FG000|Overall Study|Withdrew consent|5
6896209|NCT00631475|10914498|FG000|Overall Study|Preparation for lung transplant|8
6896210|NCT00631488|10914505|FG000|Overall Study|Adverse Event|1
6896211|NCT00631488|10914506|FG001|Overall Study|Adverse Event|0
6896212|NCT00631488|10914507|FG002|Overall Study|Adverse Event|0
6896213|NCT00631488|10914505|FG000|Overall Study|Lost to Follow-up|2
6896214|NCT00631488|10914506|FG001|Overall Study|Lost to Follow-up|2
6896215|NCT00631488|10914507|FG002|Overall Study|Lost to Follow-up|0
7081289|NCT02132312|11191401|FG000|Overall Study|Lost to Follow-up|2
7081290|NCT02132312|11191402|FG001|Overall Study|Lost to Follow-up|1
7081291|NCT02132637|11191443|FG000|Study Period 1|Withdrawal by Subject|0
7081292|NCT02132637|11191444|FG001|Study Period 1|Withdrawal by Subject|4
7081293|NCT02132637|11191443|FG000|Study Period 1|Physician Decision|1
7081294|NCT02132637|11191444|FG001|Study Period 1|Physician Decision|0
7081295|NCT02132637|11191443|FG000|Study Period 2 (Crossover)|Adverse Event|0
7081296|NCT02132637|11191444|FG001|Study Period 2 (Crossover)|Adverse Event|1
7081297|NCT02132637|11191443|FG000|Study Period 2 (Crossover)|Physician Decision|2
7081298|NCT02132637|11191444|FG001|Study Period 2 (Crossover)|Physician Decision|0
7081299|NCT02132754|11191494|FG000|Overall Study|Adverse Event|0
7081300|NCT02132754|11191495|FG001|Overall Study|Adverse Event|0
7081301|NCT02132754|11191496|FG002|Overall Study|Adverse Event|0
7081302|NCT02132754|11191497|FG003|Overall Study|Adverse Event|0
7181574|NCT02017717|11382140|FG001|Treatment Period|Participant withdrew consent|0
7181575|NCT02017717|11382141|FG002|Treatment Period|Participant withdrew consent|1
7181576|NCT02017717|11382142|FG003|Treatment Period|Participant withdrew consent|1
7181577|NCT02017717|11382143|FG004|Treatment Period|Participant withdrew consent|4
7181578|NCT02017717|11382144|FG005|Treatment Period|Participant withdrew consent|0
7181579|NCT02017717|11382145|FG006|Treatment Period|Participant withdrew consent|0
7181580|NCT02017717|11382146|FG007|Treatment Period|Participant withdrew consent|2
7181581|NCT02017717|11382147|FG008|Treatment Period|Participant withdrew consent|0
7181582|NCT02017717|11382139|FG000|Treatment Period|Participant no longer met criteria|0
7181583|NCT02017717|11382140|FG001|Treatment Period|Participant no longer met criteria|0
7181584|NCT02017717|11382141|FG002|Treatment Period|Participant no longer met criteria|0
7181585|NCT02017717|11382142|FG003|Treatment Period|Participant no longer met criteria|0
7181586|NCT02017717|11382143|FG004|Treatment Period|Participant no longer met criteria|1
7181587|NCT02017717|11382144|FG005|Treatment Period|Participant no longer met criteria|0
7181588|NCT02017717|11382145|FG006|Treatment Period|Participant no longer met criteria|0
7181589|NCT02017717|11382146|FG007|Treatment Period|Participant no longer met criteria|0
7181590|NCT02017717|11382147|FG008|Treatment Period|Participant no longer met criteria|0
7181591|NCT02017717|11382139|FG000|Treatment Period|other reasons|0
7181592|NCT02017717|11382140|FG001|Treatment Period|other reasons|0
7181593|NCT02017717|11382141|FG002|Treatment Period|other reasons|0
7181594|NCT02017717|11382142|FG003|Treatment Period|other reasons|0
7181595|NCT02017717|11382143|FG004|Treatment Period|other reasons|1
7181596|NCT02017717|11382144|FG005|Treatment Period|other reasons|0
7181597|NCT02017717|11382145|FG006|Treatment Period|other reasons|0
7181598|NCT02017717|11382146|FG007|Treatment Period|other reasons|1
7181599|NCT02017717|11382147|FG008|Treatment Period|other reasons|1
7181600|NCT02017717|11382139|FG000|Treatment Period|Maximum clinical benefit|0
7181601|NCT02017717|11382140|FG001|Treatment Period|Maximum clinical benefit|0
7181602|NCT02017717|11382141|FG002|Treatment Period|Maximum clinical benefit|0
7181603|NCT02017717|11382142|FG003|Treatment Period|Maximum clinical benefit|0
7181604|NCT02017717|11382143|FG004|Treatment Period|Maximum clinical benefit|1
7181605|NCT02017717|11382144|FG005|Treatment Period|Maximum clinical benefit|0
7181606|NCT02017717|11382145|FG006|Treatment Period|Maximum clinical benefit|0
7181607|NCT02017717|11382146|FG007|Treatment Period|Maximum clinical benefit|0
7181608|NCT02017717|11382147|FG008|Treatment Period|Maximum clinical benefit|0
7181609|NCT01886872|11382174|FG000|Overall Study|Ineligible|7
7181610|NCT01886872|11382175|FG001|Overall Study|Ineligible|4
7181611|NCT01886872|11382176|FG002|Overall Study|Ineligible|12
7181612|NCT01880957|11382187|FG000|Overall Study|Diagnosis: Unipolar Depression|12
7181613|NCT01880957|11382188|FG001|Overall Study|Diagnosis: Unipolar Depression|0
7181614|NCT01880957|11382187|FG000|Overall Study|Lost to Follow-up|11
7181615|NCT01880957|11382188|FG001|Overall Study|Lost to Follow-up|0
7181616|NCT01880957|11382187|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5
7181617|NCT01880957|11382188|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0
7181618|NCT01856192|11382205|FG000|Overall Study|Adverse Event|12
7181619|NCT01856192|11382206|FG001|Overall Study|Adverse Event|4
7181620|NCT01856192|11382205|FG000|Overall Study|Alternative therapy|0
7181621|NCT01856192|11382206|FG001|Overall Study|Alternative therapy|3
7181622|NCT01856192|11382205|FG000|Overall Study|Death|3
7181623|NCT01856192|11382206|FG001|Overall Study|Death|5
7181624|NCT01856192|11382205|FG000|Overall Study|Lack of Efficacy|0
7181625|NCT01856192|11382206|FG001|Overall Study|Lack of Efficacy|5
7181626|NCT01856192|11382205|FG000|Overall Study|Withdrawal by Subject|1
7181627|NCT01856192|11382206|FG001|Overall Study|Withdrawal by Subject|1
7181628|NCT01856192|11382205|FG000|Overall Study|Other diseases|1
7181629|NCT01856192|11382206|FG001|Overall Study|Other diseases|0
7181630|NCT01856192|11382205|FG000|Overall Study|Never started treatment|7
7181631|NCT01856192|11382206|FG001|Overall Study|Never started treatment|5
7181632|NCT01856192|11382205|FG000|Overall Study|Path ineligible|20
7081303|NCT02132754|11191498|FG004|Overall Study|Adverse Event|0
7081304|NCT02132754|11191499|FG005|Overall Study|Adverse Event|0
7081305|NCT02132754|11191500|FG006|Overall Study|Adverse Event|0
7081306|NCT02132754|11191501|FG007|Overall Study|Adverse Event|0
7081307|NCT02132754|11191502|FG008|Overall Study|Adverse Event|0
7081308|NCT02132754|11191503|FG009|Overall Study|Adverse Event|0
7081309|NCT02132754|11191504|FG010|Overall Study|Adverse Event|0
7081310|NCT02132754|11191505|FG011|Overall Study|Adverse Event|0
7081311|NCT02132754|11191506|FG012|Overall Study|Adverse Event|0
7081312|NCT02132754|11191507|FG013|Overall Study|Adverse Event|0
7181633|NCT01856192|11382206|FG001|Overall Study|Path ineligible|34
7181634|NCT01856192|11382205|FG000|Overall Study|Non-path ineligible|2
7181635|NCT01856192|11382206|FG001|Overall Study|Non-path ineligible|2
7181636|NCT01856192|11382205|FG000|Overall Study|Physician Decision|1
7181637|NCT01856192|11382206|FG001|Overall Study|Physician Decision|1
7181638|NCT01856192|11382205|FG000|Overall Study|Suspicion of progressive disease|1
7181639|NCT01856192|11382206|FG001|Overall Study|Suspicion of progressive disease|0
7181640|NCT01856192|11382205|FG000|Overall Study|Non-compliance|1
7181641|NCT01856192|11382206|FG001|Overall Study|Non-compliance|0
7181642|NCT01767194|11382224|FG000|Overall Study|Adverse Event|1
7181643|NCT01767194|11382225|FG001|Overall Study|Adverse Event|1
7181644|NCT01767194|11382224|FG000|Overall Study|Death|0
7181645|NCT01767194|11382225|FG001|Overall Study|Death|1
7081313|NCT02132754|11191508|FG014|Overall Study|Adverse Event|0
7181646|NCT01767194|11382224|FG000|Overall Study|Lack of Efficacy|12
7181647|NCT01767194|11382225|FG001|Overall Study|Lack of Efficacy|11
7081314|NCT02132754|11191509|FG015|Overall Study|Adverse Event|0
7081315|NCT02132754|11191510|FG016|Overall Study|Adverse Event|0
7081316|NCT02132754|11191511|FG017|Overall Study|Adverse Event|1
7081317|NCT02132754|11191512|FG018|Overall Study|Adverse Event|0
7081318|NCT02132754|11191513|FG019|Overall Study|Adverse Event|0
6973294|NCT01179516|11024952|FG002|Overall Study|Noncompliance with Study Drug|1
6973295|NCT01179516|11024950|FG000|Overall Study|Protocol Deviations|4
6973296|NCT01179516|11024951|FG001|Overall Study|Protocol Deviations|3
6973297|NCT01179516|11024952|FG002|Overall Study|Protocol Deviations|3
6973298|NCT01179516|11024950|FG000|Overall Study|Withdrawal of Consent|2
6973299|NCT01179516|11024951|FG001|Overall Study|Withdrawal of Consent|6
6973300|NCT01179516|11024952|FG002|Overall Study|Withdrawal of Consent|10
6973301|NCT01179516|11024950|FG000|Overall Study|Lost to Follow-up|7
6973302|NCT01179516|11024951|FG001|Overall Study|Lost to Follow-up|7
6973303|NCT01179516|11024952|FG002|Overall Study|Lost to Follow-up|3
6973304|NCT01179516|11024950|FG000|Overall Study|Other|2
7181648|NCT01767194|11382224|FG000|Overall Study|Physician Decision|2
7181649|NCT01767194|11382225|FG001|Overall Study|Physician Decision|23
7181650|NCT01767194|11382224|FG000|Overall Study|Withdrawal by Subject|0
7181651|NCT01767194|11382225|FG001|Overall Study|Withdrawal by Subject|1
7181652|NCT01767194|11382224|FG000|Overall Study|Ineligible|1
7181653|NCT01767194|11382225|FG001|Overall Study|Ineligible|1
7181654|NCT01767194|11382224|FG000|Overall Study|Refusal by patient/parent|2
7181655|NCT01767194|11382225|FG001|Overall Study|Refusal by patient/parent|4
7181656|NCT01767194|11382224|FG000|Overall Study|Criteria not met on time for next cycle|0
7181657|NCT01767194|11382225|FG001|Overall Study|Criteria not met on time for next cycle|1
7181658|NCT01746173|11382232|FG000|Overall Study|Disease Progression|2
7181659|NCT01708954|11382243|FG000|Step 1|Disease progression|26
7181660|NCT01708954|11382244|FG001|Step 1|Disease progression|17
7181661|NCT01708954|11382245|FG002|Step 1|Disease progression|14
7181662|NCT01708954|11382243|FG000|Step 1|Adverse Event|3
7181663|NCT01708954|11382244|FG001|Step 1|Adverse Event|11
7181664|NCT01708954|11382245|FG002|Step 1|Adverse Event|13
7181665|NCT01708954|11382243|FG000|Step 1|Death|3
7181666|NCT01708954|11382244|FG001|Step 1|Death|2
7181667|NCT01708954|11382245|FG002|Step 1|Death|3
7181668|NCT01708954|11382243|FG000|Step 1|Withdrawal by Subject|2
7181669|NCT01708954|11382244|FG001|Step 1|Withdrawal by Subject|5
7181670|NCT01708954|11382245|FG002|Step 1|Withdrawal by Subject|3
6973305|NCT01179516|11024951|FG001|Overall Study|Other|0
6973306|NCT01179516|11024952|FG002|Overall Study|Other|2
6973307|NCT01179672|11024982|FG000|Overall Study|Adverse Event|17
7181671|NCT01708954|11382243|FG000|Step 1|Other complicating disease|0
7181672|NCT01708954|11382244|FG001|Step 1|Other complicating disease|2
7181673|NCT01708954|11382245|FG002|Step 1|Other complicating disease|0
6896216|NCT00631488|10914505|FG000|Overall Study|Physician Decision|1
6896217|NCT00631488|10914506|FG001|Overall Study|Physician Decision|0
7081319|NCT02132754|11191514|FG020|Overall Study|Adverse Event|0
7081320|NCT02132754|11191515|FG021|Overall Study|Adverse Event|0
7081321|NCT02132754|11191516|FG022|Overall Study|Adverse Event|0
7181674|NCT01708954|11382243|FG000|Step 1|Crossed over to Step 2|2
7181675|NCT01708954|11382244|FG001|Step 1|Crossed over to Step 2|0
7181676|NCT01708954|11382245|FG002|Step 1|Crossed over to Step 2|0
7181677|NCT01708954|11382243|FG000|Step 1|Symptomatic deterioration|1
7181678|NCT01708954|11382244|FG001|Step 1|Symptomatic deterioration|0
7181679|NCT01708954|11382245|FG002|Step 1|Symptomatic deterioration|1
7181680|NCT01708954|11382243|FG000|Step 1|Off-treatment reason not submitted|1
7181681|NCT01708954|11382244|FG001|Step 1|Off-treatment reason not submitted|1
7181682|NCT01708954|11382245|FG002|Step 1|Off-treatment reason not submitted|1
7181683|NCT01708954|11382243|FG000|Step 1|Ineligible or never received treatment|4
7181684|NCT01708954|11382244|FG001|Step 1|Ineligible or never received treatment|2
7181685|NCT01708954|11382245|FG002|Step 1|Ineligible or never received treatment|8
7181686|NCT01708954|11382243|FG000|Step 2|Disease progression|9
7181687|NCT01708954|11382244|FG001|Step 2|Disease progression|4
7181688|NCT01708954|11382245|FG002|Step 2|Disease progression|0
7181689|NCT01708954|11382243|FG000|Step 2|Adverse Event|3
7181690|NCT01708954|11382244|FG001|Step 2|Adverse Event|2
7181691|NCT01708954|11382245|FG002|Step 2|Adverse Event|0
7181692|NCT01708954|11382243|FG000|Step 2|Withdrawal by Subject|1
7181693|NCT01708954|11382244|FG001|Step 2|Withdrawal by Subject|1
7181694|NCT01708954|11382245|FG002|Step 2|Withdrawal by Subject|0
7081322|NCT02132754|11191517|FG023|Overall Study|Adverse Event|0
7081323|NCT02132754|11191518|FG024|Overall Study|Adverse Event|0
7081324|NCT02132754|11191519|FG025|Overall Study|Adverse Event|1
7081325|NCT02132754|11191520|FG026|Overall Study|Adverse Event|1
7081326|NCT02132754|11191521|FG027|Overall Study|Adverse Event|0
7081327|NCT02132754|11191522|FG028|Overall Study|Adverse Event|0
7081328|NCT02132754|11191523|FG029|Overall Study|Adverse Event|0
7081329|NCT02132754|11191524|FG030|Overall Study|Adverse Event|1
7181695|NCT01708941|11382258|FG000|Overall Study|Adverse Event|4
7181696|NCT01708941|11382259|FG001|Overall Study|Adverse Event|6
7181697|NCT01708941|11382260|FG002|Overall Study|Adverse Event|1
7081330|NCT02132754|11191525|FG031|Overall Study|Adverse Event|0
7181698|NCT01708941|11382261|FG003|Overall Study|Adverse Event|0
7181699|NCT01708941|11382258|FG000|Overall Study|Death|1
7181700|NCT01708941|11382259|FG001|Overall Study|Death|1
7081331|NCT02132754|11191526|FG032|Overall Study|Adverse Event|1
7081332|NCT02132754|11191527|FG033|Overall Study|Adverse Event|1
7081333|NCT02132754|11191494|FG000|Overall Study|Clinical Progression|0
7081334|NCT02132754|11191495|FG001|Overall Study|Clinical Progression|0
7081335|NCT02132754|11191496|FG002|Overall Study|Clinical Progression|0
7081336|NCT02132754|11191497|FG003|Overall Study|Clinical Progression|0
7081337|NCT02132754|11191498|FG004|Overall Study|Clinical Progression|0
7081338|NCT02132754|11191499|FG005|Overall Study|Clinical Progression|0
6811322|NCT01709318|10815273|FG004|Overall Study|Non-compliance with Study Drug|0
7041649|NCT01728584|11125236|FG002|Overall Study|Adverse Event|0
7041650|NCT01728584|11125237|FG003|Overall Study|Adverse Event|0
7041651|NCT01728584|11125234|FG000|Overall Study|Physician Decision|4
7041652|NCT01728584|11125235|FG001|Overall Study|Physician Decision|0
7041653|NCT01728584|11125236|FG002|Overall Study|Physician Decision|1
7041654|NCT01728584|11125237|FG003|Overall Study|Physician Decision|0
7041655|NCT01728584|11125234|FG000|Overall Study|Withdrawal by Subject|1
7041656|NCT01728584|11125235|FG001|Overall Study|Withdrawal by Subject|0
7041657|NCT01728584|11125236|FG002|Overall Study|Withdrawal by Subject|0
7041658|NCT01728584|11125237|FG003|Overall Study|Withdrawal by Subject|0
7041659|NCT01728584|11125234|FG000|Overall Study|Screen failure|1
6896218|NCT00631488|10914507|FG002|Overall Study|Physician Decision|1
6896219|NCT00631488|10914505|FG000|Overall Study|Protocol Violation|0
6896220|NCT00631488|10914506|FG001|Overall Study|Protocol Violation|0
6896221|NCT00631488|10914507|FG002|Overall Study|Protocol Violation|1
6896222|NCT00631540|10914515|FG000|Overall Study|Withdrawal by Subject|5
6896223|NCT00631540|10914515|FG000|Overall Study|Death|4
6896224|NCT00631540|10914515|FG000|Overall Study|Lost to Follow-up|2
6896225|NCT00631540|10914515|FG000|Overall Study|Core Lab Data Unavailable|3
6896226|NCT00631657|10914534|FG000|6-Month Treatment Period|Adverse Event|47
6896227|NCT00631657|10914535|FG001|6-Month Treatment Period|Adverse Event|0
6896228|NCT00631657|10914536|FG002|6-Month Treatment Period|Adverse Event|7
6896229|NCT00631657|10914534|FG000|6-Month Treatment Period|Withdrawal by Subject|14
6896230|NCT00631657|10914535|FG001|6-Month Treatment Period|Withdrawal by Subject|0
6896231|NCT00631657|10914536|FG002|6-Month Treatment Period|Withdrawal by Subject|5
6896232|NCT00631657|10914534|FG000|6-Month Treatment Period|Lack of Efficacy|34
6896233|NCT00631657|10914535|FG001|6-Month Treatment Period|Lack of Efficacy|0
6896234|NCT00631657|10914536|FG002|6-Month Treatment Period|Lack of Efficacy|25
6896235|NCT00631657|10914534|FG000|6-Month Treatment Period|Lost to Follow-up|7
6896236|NCT00631657|10914535|FG001|6-Month Treatment Period|Lost to Follow-up|0
6896237|NCT00631657|10914536|FG002|6-Month Treatment Period|Lost to Follow-up|2
6896238|NCT00631657|10914534|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21
6896239|NCT00631657|10914535|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0
6896240|NCT00631657|10914536|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6
6896241|NCT00631657|10914534|FG000|6-Month Treatment Period|Other|16
6896242|NCT00631657|10914535|FG001|6-Month Treatment Period|Other|0
6896243|NCT00631657|10914536|FG002|6-Month Treatment Period|Other|4
6896244|NCT00631657|10914534|FG000|6-Month Treatment Period|Not Treated|2
6896245|NCT00631657|10914535|FG001|6-Month Treatment Period|Not Treated|0
6896246|NCT00631657|10914536|FG002|6-Month Treatment Period|Not Treated|1
6896247|NCT00631657|10914534|FG000|7-Day Discontinuation Period|Not Treated|1
6896248|NCT00631657|10914535|FG001|7-Day Discontinuation Period|Not Treated|1
6896249|NCT00631657|10914536|FG002|7-Day Discontinuation Period|Not Treated|1
6896250|NCT00631657|10914534|FG000|7-Day Discontinuation Period|Other|1
6896251|NCT00631657|10914535|FG001|7-Day Discontinuation Period|Other|0
6896252|NCT00631657|10914536|FG002|7-Day Discontinuation Period|Other|0
6896253|NCT00631696|10914562|FG000|Overall Study|Entered, not randomized to treatment|1
6896254|NCT00631696|10914563|FG001|Overall Study|Entered, not randomized to treatment|1
6896255|NCT00631696|10914562|FG000|Overall Study|Discontinued after database release date|1
6896256|NCT00631696|10914563|FG001|Overall Study|Discontinued after database release date|0
6896257|NCT00631696|10914562|FG000|Overall Study|Follow up after database release date|1
6896258|NCT00631696|10914563|FG001|Overall Study|Follow up after database release date|0
6896259|NCT00631696|10914562|FG000|Overall Study|Lost to Follow-up|7
6896260|NCT00631696|10914563|FG001|Overall Study|Lost to Follow-up|10
6896261|NCT00631696|10914562|FG000|Overall Study|Withdrawal by Subject|2
6896262|NCT00631696|10914563|FG001|Overall Study|Withdrawal by Subject|9
6896263|NCT00631696|10914562|FG000|Overall Study|Other|8
6896264|NCT00631696|10914563|FG001|Overall Study|Other|8
6896265|NCT00631696|10914562|FG000|Overall Study|Protocol Violation|9
6896266|NCT00631696|10914563|FG001|Overall Study|Protocol Violation|9
6896267|NCT00631696|10914562|FG000|Overall Study|Study terminated by sponsor|3
6896268|NCT00631696|10914563|FG001|Overall Study|Study terminated by sponsor|3
6896269|NCT00631696|10914562|FG000|Overall Study|Adverse Event|5
6896270|NCT00631696|10914563|FG001|Overall Study|Adverse Event|0
6973308|NCT01179672|11024983|FG001|Overall Study|Adverse Event|8
6973309|NCT01179672|11024982|FG000|Overall Study|Withdrawal by Subject|10
6973310|NCT01179672|11024983|FG001|Overall Study|Withdrawal by Subject|12
6973311|NCT01179672|11024982|FG000|Overall Study|Entry Criteria Not Met|0
6973312|NCT01179672|11024983|FG001|Overall Study|Entry Criteria Not Met|2
6973313|NCT01179672|11024982|FG000|Overall Study|Lost to Follow-up|0
6973314|NCT01179672|11024983|FG001|Overall Study|Lost to Follow-up|1
6973315|NCT01179672|11024982|FG000|Overall Study|Protocol Violation|2
6973316|NCT01179672|11024983|FG001|Overall Study|Protocol Violation|2
6973317|NCT01179672|11024982|FG000|Overall Study|Physician Decision|1
6973318|NCT01179672|11024983|FG001|Overall Study|Physician Decision|1
6973319|NCT01179919|11024993|FG000|Overall Study|Protocol Violation|1
6973320|NCT01179919|11024993|FG000|Overall Study|Adverse Event|1
6973321|NCT01180049|11025015|FG000|Overall Study|Other|9
6973322|NCT01180049|11025016|FG001|Overall Study|Other|7
7081339|NCT02132754|11191500|FG006|Overall Study|Clinical Progression|0
7081340|NCT02132754|11191501|FG007|Overall Study|Clinical Progression|0
7081341|NCT02132754|11191502|FG008|Overall Study|Clinical Progression|0
7081342|NCT02132754|11191503|FG009|Overall Study|Clinical Progression|1
7081343|NCT02132754|11191504|FG010|Overall Study|Clinical Progression|0
7081344|NCT02132754|11191505|FG011|Overall Study|Clinical Progression|0
7081345|NCT02132754|11191506|FG012|Overall Study|Clinical Progression|0
7081346|NCT02132754|11191507|FG013|Overall Study|Clinical Progression|0
7081347|NCT02132754|11191508|FG014|Overall Study|Clinical Progression|0
7081348|NCT02132754|11191509|FG015|Overall Study|Clinical Progression|0
7081349|NCT02132754|11191510|FG016|Overall Study|Clinical Progression|1
7081350|NCT02132754|11191511|FG017|Overall Study|Clinical Progression|1
7081351|NCT02132754|11191512|FG018|Overall Study|Clinical Progression|0
7081352|NCT02132754|11191513|FG019|Overall Study|Clinical Progression|1
7081353|NCT02132754|11191514|FG020|Overall Study|Clinical Progression|0
7081354|NCT02132754|11191515|FG021|Overall Study|Clinical Progression|0
7081355|NCT02132754|11191516|FG022|Overall Study|Clinical Progression|1
7081356|NCT02132754|11191517|FG023|Overall Study|Clinical Progression|0
7081357|NCT02132754|11191518|FG024|Overall Study|Clinical Progression|1
7081358|NCT02132754|11191519|FG025|Overall Study|Clinical Progression|1
7081359|NCT02132754|11191520|FG026|Overall Study|Clinical Progression|0
7081360|NCT02132754|11191521|FG027|Overall Study|Clinical Progression|1
7081361|NCT02132754|11191522|FG028|Overall Study|Clinical Progression|1
7081362|NCT02132754|11191523|FG029|Overall Study|Clinical Progression|0
7081363|NCT02132754|11191524|FG030|Overall Study|Clinical Progression|1
7181701|NCT01708941|11382260|FG002|Overall Study|Death|2
7181702|NCT01708941|11382261|FG003|Overall Study|Death|14
7181703|NCT01708941|11382258|FG000|Overall Study|Withdrawal by Subject|1
7181704|NCT01708941|11382259|FG001|Overall Study|Withdrawal by Subject|0
7181705|NCT01708941|11382260|FG002|Overall Study|Withdrawal by Subject|3
7181706|NCT01708941|11382261|FG003|Overall Study|Withdrawal by Subject|4
7181707|NCT01708941|11382258|FG000|Overall Study|Disease progression|9
7181708|NCT01708941|11382259|FG001|Overall Study|Disease progression|10
7181709|NCT01708941|11382260|FG002|Overall Study|Disease progression|8
7181710|NCT01708941|11382261|FG003|Overall Study|Disease progression|0
7181711|NCT01708941|11382258|FG000|Overall Study|Alternative therapy|0
7181712|NCT01708941|11382259|FG001|Overall Study|Alternative therapy|0
7181713|NCT01708941|11382260|FG002|Overall Study|Alternative therapy|2
7181714|NCT01708941|11382261|FG003|Overall Study|Alternative therapy|0
7186831|NCT03099707|11387364|FG000|Overall Study|Withdrawal by Subject|0
7186832|NCT03099707|11387365|FG001|Overall Study|Withdrawal by Subject|3
7186833|NCT03099707|11387364|FG000|Overall Study|Lost to Follow-up|0
7186834|NCT03099707|11387365|FG001|Overall Study|Lost to Follow-up|1
7186835|NCT03064763|11387371|FG000|Overall Study|Ongoing in study|10
7186836|NCT03064763|11387371|FG000|Overall Study|Death|8
7186837|NCT02906033|11387396|FG000|Baseline|Protocol Violation|37
7186838|NCT02906033|11387397|FG001|Baseline|Protocol Violation|33
7186839|NCT02906033|11387396|FG000|Follow-up|Lost to Follow-up|46
7186840|NCT02906033|11387397|FG001|Follow-up|Lost to Follow-up|62
7186841|NCT02837783|11387405|FG000|Overall Study|Adverse Event|1
7186842|NCT02837783|11387406|FG001|Overall Study|Adverse Event|0
7186843|NCT02837783|11387405|FG000|Overall Study|Other, Not Specified|1
7186844|NCT02837783|11387406|FG001|Overall Study|Other, Not Specified|2
7186845|NCT02786537|11387418|FG000|As Randomized|Adverse Event|0
7186846|NCT02786537|11387419|FG001|As Randomized|Adverse Event|11
7186847|NCT02786537|11387420|FG002|As Randomized|Adverse Event|0
7186848|NCT02786537|11387421|FG003|As Randomized|Adverse Event|4
7186849|NCT02786537|11387422|FG004|As Randomized|Adverse Event|6
7186850|NCT02786537|11387423|FG005|As Randomized|Adverse Event|2
7186851|NCT02786537|11387418|FG000|As Randomized|Lack of Efficacy|0
7186852|NCT02786537|11387419|FG001|As Randomized|Lack of Efficacy|0
7186853|NCT02786537|11387420|FG002|As Randomized|Lack of Efficacy|0
7186854|NCT02786537|11387421|FG003|As Randomized|Lack of Efficacy|1
7186855|NCT02786537|11387422|FG004|As Randomized|Lack of Efficacy|0
7186856|NCT02786537|11387423|FG005|As Randomized|Lack of Efficacy|0
7186857|NCT02786537|11387418|FG000|As Randomized|Withdrawal by Subject|1
7186858|NCT02786537|11387419|FG001|As Randomized|Withdrawal by Subject|2
7186859|NCT02786537|11387420|FG002|As Randomized|Withdrawal by Subject|0
7186860|NCT02786537|11387421|FG003|As Randomized|Withdrawal by Subject|1
7186861|NCT02786537|11387422|FG004|As Randomized|Withdrawal by Subject|1
7186862|NCT02786537|11387423|FG005|As Randomized|Withdrawal by Subject|0
7186863|NCT02786537|11387418|FG000|As Randomized|Death|0
7186864|NCT02786537|11387419|FG001|As Randomized|Death|2
7186865|NCT02786537|11387420|FG002|As Randomized|Death|0
7186866|NCT02786537|11387421|FG003|As Randomized|Death|3
7186867|NCT02786537|11387422|FG004|As Randomized|Death|1
7186868|NCT02786537|11387423|FG005|As Randomized|Death|0
7186869|NCT02786537|11387418|FG000|As Randomized|Non-compliance with study drug|1
7186870|NCT02786537|11387419|FG001|As Randomized|Non-compliance with study drug|11
7186871|NCT02786537|11387420|FG002|As Randomized|Non-compliance with study drug|0
7186872|NCT02786537|11387421|FG003|As Randomized|Non-compliance with study drug|1
7186873|NCT02786537|11387422|FG004|As Randomized|Non-compliance with study drug|0
7186874|NCT02786537|11387423|FG005|As Randomized|Non-compliance with study drug|1
7186875|NCT02786537|11387418|FG000|As Randomized|Lost to treatment follow-up|4
7186876|NCT02786537|11387419|FG001|As Randomized|Lost to treatment follow-up|32
7186877|NCT02786537|11387420|FG002|As Randomized|Lost to treatment follow-up|0
7186878|NCT02786537|11387421|FG003|As Randomized|Lost to treatment follow-up|24
7186879|NCT02786537|11387422|FG004|As Randomized|Lost to treatment follow-up|4
7186880|NCT02786537|11387423|FG005|As Randomized|Lost to treatment follow-up|4
7186881|NCT02786537|11387418|FG000|As Randomized|Incarceration|0
7186882|NCT02786537|11387419|FG001|As Randomized|Incarceration|1
7186883|NCT02786537|11387420|FG002|As Randomized|Incarceration|0
7186884|NCT02786537|11387421|FG003|As Randomized|Incarceration|0
7186885|NCT02786537|11387422|FG004|As Randomized|Incarceration|0
7186886|NCT02786537|11387423|FG005|As Randomized|Incarceration|0
7186887|NCT02786537|11387418|FG000|As Randomized|Opiate Dependency Relapse|0
7186888|NCT02786537|11387419|FG001|As Randomized|Opiate Dependency Relapse|1
7186889|NCT02786537|11387420|FG002|As Randomized|Opiate Dependency Relapse|0
7186890|NCT02786537|11387421|FG003|As Randomized|Opiate Dependency Relapse|0
7186891|NCT02786537|11387422|FG004|As Randomized|Opiate Dependency Relapse|0
7186892|NCT02786537|11387423|FG005|As Randomized|Opiate Dependency Relapse|0
7186893|NCT02786537|11387418|FG000|As Randomized|HCV drugs stolen from pt|0
7186894|NCT02786537|11387419|FG001|As Randomized|HCV drugs stolen from pt|1
7186895|NCT02786537|11387420|FG002|As Randomized|HCV drugs stolen from pt|0
7081364|NCT02132754|11191525|FG031|Overall Study|Clinical Progression|0
7181715|NCT01708941|11382258|FG000|Overall Study|Ineligible and never started treatment|1
7181716|NCT01708941|11382259|FG001|Overall Study|Ineligible and never started treatment|0
7181717|NCT01708941|11382260|FG002|Overall Study|Ineligible and never started treatment|1
7181718|NCT01708941|11382261|FG003|Overall Study|Ineligible and never started treatment|0
7181719|NCT01708941|11382258|FG000|Overall Study|Never started treatment|2
7181720|NCT01708941|11382259|FG001|Overall Study|Never started treatment|1
7181721|NCT01708941|11382260|FG002|Overall Study|Never started treatment|0
7181722|NCT01708941|11382261|FG003|Overall Study|Never started treatment|0
7181723|NCT01708941|11382258|FG000|Overall Study|Ineligible|0
7181724|NCT01708941|11382259|FG001|Overall Study|Ineligible|0
7181725|NCT01708941|11382260|FG002|Overall Study|Ineligible|2
7181726|NCT01708941|11382261|FG003|Overall Study|Ineligible|0
7181727|NCT01349959|11382288|FG000|Overall Study|Adverse Event|7
7181728|NCT01275677|11382294|FG000|Overall Study|Not at risk for recurrence.|1
7181729|NCT01275677|11382295|FG001|Overall Study|Not at risk for recurrence.|1
7181730|NCT01275677|11382294|FG000|Overall Study|No follow-up|26
7181731|NCT01275677|11382295|FG001|Overall Study|No follow-up|37
7181732|NCT01275677|11382294|FG000|Overall Study|No clinical follow up.|1
7181733|NCT01275677|11382295|FG001|Overall Study|No clinical follow up.|4
7181734|NCT01251861|11382303|FG000|Overall Study|Disease progression|6
7181735|NCT01251861|11382304|FG001|Overall Study|Disease progression|6
7181736|NCT01251861|11382303|FG000|Overall Study|Adverse Event|2
7081365|NCT02132754|11191526|FG032|Overall Study|Clinical Progression|0
7081366|NCT02132754|11191527|FG033|Overall Study|Clinical Progression|2
7081367|NCT02132754|11191494|FG000|Overall Study|Death|0
7081368|NCT02132754|11191495|FG001|Overall Study|Death|0
7081369|NCT02132754|11191496|FG002|Overall Study|Death|0
7081370|NCT02132754|11191497|FG003|Overall Study|Death|0
7081371|NCT02132754|11191498|FG004|Overall Study|Death|0
7081372|NCT02132754|11191499|FG005|Overall Study|Death|0
7181737|NCT01251861|11382304|FG001|Overall Study|Adverse Event|17
7181738|NCT01251861|11382303|FG000|Overall Study|Withdrawal by Subject|2
7181739|NCT01251861|11382304|FG001|Overall Study|Withdrawal by Subject|2
7181740|NCT01251861|11382303|FG000|Overall Study|Alternative therapy|1
7181741|NCT01251861|11382304|FG001|Overall Study|Alternative therapy|0
7181742|NCT01251861|11382303|FG000|Overall Study|Other complicating disease|0
7181743|NCT01251861|11382304|FG001|Overall Study|Other complicating disease|1
7181744|NCT01251861|11382303|FG000|Overall Study|Physician Decision|1
7181745|NCT01251861|11382304|FG001|Overall Study|Physician Decision|0
7181746|NCT01251861|11382303|FG000|Overall Study|Continued treatment beyond 18 cycles|1
6896271|NCT00631917|10914585|FG000|Overall Study|Adverse Event|34
6896272|NCT00631917|10914586|FG001|Overall Study|Adverse Event|45
6896273|NCT00631917|10914585|FG000|Overall Study|Abnormal laboratory value(s)|2
6896274|NCT00631917|10914586|FG001|Overall Study|Abnormal laboratory value(s)|1
6896275|NCT00631917|10914585|FG000|Overall Study|Abnormal test procedure result(s)|3
6896276|NCT00631917|10914586|FG001|Overall Study|Abnormal test procedure result(s)|2
6896277|NCT00631917|10914585|FG000|Overall Study|Unsatisfactory therapeutic effect|8
6896278|NCT00631917|10914586|FG001|Overall Study|Unsatisfactory therapeutic effect|14
6896279|NCT00631917|10914585|FG000|Overall Study|No longer required study drug|0
6896280|NCT00631917|10914586|FG001|Overall Study|No longer required study drug|1
6896281|NCT00631917|10914585|FG000|Overall Study|Protocol deviation|6
6896282|NCT00631917|10914586|FG001|Overall Study|Protocol deviation|5
6896283|NCT00631917|10914585|FG000|Overall Study|Subject withdrew consent|25
6896284|NCT00631917|10914586|FG001|Overall Study|Subject withdrew consent|33
6896285|NCT00631917|10914585|FG000|Overall Study|Lost to Follow-up|7
6896286|NCT00631917|10914586|FG001|Overall Study|Lost to Follow-up|7
7081373|NCT02132754|11191500|FG006|Overall Study|Death|0
7081374|NCT02132754|11191501|FG007|Overall Study|Death|0
7081375|NCT02132754|11191502|FG008|Overall Study|Death|0
7081376|NCT02132754|11191503|FG009|Overall Study|Death|0
7081377|NCT02132754|11191504|FG010|Overall Study|Death|0
7181747|NCT01251861|11382304|FG001|Overall Study|Continued treatment beyond 18 cycles|0
7181748|NCT01251861|11382303|FG000|Overall Study|Other|1
7181749|NCT01251861|11382304|FG001|Overall Study|Other|0
7181750|NCT01251861|11382303|FG000|Overall Study|Never started therapy|4
7181751|NCT01251861|11382304|FG001|Overall Study|Never started therapy|1
7181752|NCT01251861|11382303|FG000|Overall Study|Potential interaction of drugs|0
7181753|NCT01251861|11382304|FG001|Overall Study|Potential interaction of drugs|1
7181754|NCT01196390|11382312|FG000|Overall Study|Protocol Violation|4
7181755|NCT01196390|11382313|FG001|Overall Study|Protocol Violation|5
7181756|NCT01168219|11382321|FG000|Overall Study|off study before starting treatment|2
7181757|NCT01168219|11382321|FG000|Overall Study|withdrew before transplant|1
7181758|NCT01168219|11382321|FG000|Overall Study|ineligible due to CML|2
7181759|NCT01145495|11382325|FG000|Overall Study|Adverse Event|6
7181760|NCT01145495|11382325|FG000|Overall Study|Withdrawal by Subject|5
7181761|NCT01145495|11382325|FG000|Overall Study|Disease progression after respone|1
7181762|NCT01142388|11382331|FG000|Overall Study|Lack of Efficacy|21
7181763|NCT01142388|11382332|FG001|Overall Study|Lack of Efficacy|31
7181764|NCT01142388|11382331|FG000|Overall Study|Adverse Event|9
7181765|NCT01142388|11382332|FG001|Overall Study|Adverse Event|5
7181766|NCT01142388|11382331|FG000|Overall Study|Death|3
7181767|NCT01142388|11382332|FG001|Overall Study|Death|2
7181768|NCT01142388|11382331|FG000|Overall Study|Withdrawal by Subject|5
7181769|NCT01142388|11382332|FG001|Overall Study|Withdrawal by Subject|3
7181770|NCT01142388|11382331|FG000|Overall Study|Alternative therapy|1
7181771|NCT01142388|11382332|FG001|Overall Study|Alternative therapy|0
7181772|NCT01142388|11382331|FG000|Overall Study|Other complications|0
7181773|NCT01142388|11382332|FG001|Overall Study|Other complications|2
7181774|NCT01142388|11382331|FG000|Overall Study|Other|1
7181775|NCT01142388|11382332|FG001|Overall Study|Other|1
7181776|NCT01142388|11382331|FG000|Overall Study|Never started therapy|7
7181777|NCT01142388|11382332|FG001|Overall Study|Never started therapy|3
7181778|NCT01134614|11382340|FG000|Overall Study|Still on treatment as of March 2013|21
7181779|NCT01134614|11382341|FG001|Overall Study|Still on treatment as of March 2013|13
7181780|NCT01134614|11382340|FG000|Overall Study|Progressive disease|60
7181781|NCT01134614|11382341|FG001|Overall Study|Progressive disease|54
7181782|NCT01134614|11382340|FG000|Overall Study|Adverse Event|26
7181783|NCT01134614|11382341|FG001|Overall Study|Adverse Event|39
7181784|NCT01134614|11382340|FG000|Overall Study|Death|5
7181785|NCT01134614|11382341|FG001|Overall Study|Death|8
7181786|NCT01134614|11382340|FG000|Overall Study|Withdrawal by Subject|3
7181787|NCT01134614|11382341|FG001|Overall Study|Withdrawal by Subject|2
7181788|NCT01134614|11382340|FG000|Overall Study|Alternative therapy|2
7181789|NCT01134614|11382341|FG001|Overall Study|Alternative therapy|0
7181790|NCT01134614|11382340|FG000|Overall Study|Complicating disease|2
7181791|NCT01134614|11382341|FG001|Overall Study|Complicating disease|1
7181792|NCT01134614|11382340|FG000|Overall Study|Physician's decision|0
7181793|NCT01134614|11382341|FG001|Overall Study|Physician's decision|1
7181794|NCT01134614|11382340|FG000|Overall Study|Never started treatment|4
7181795|NCT01134614|11382341|FG001|Overall Study|Never started treatment|1
7181796|NCT01134614|11382340|FG000|Overall Study|Pt received tx not allowed on study|0
7181797|NCT01134614|11382341|FG001|Overall Study|Pt received tx not allowed on study|1
7181798|NCT01134614|11382340|FG000|Overall Study|Symptomatic deterioration|0
7181799|NCT01134614|11382341|FG001|Overall Study|Symptomatic deterioration|1
7181800|NCT01134614|11382340|FG000|Overall Study|Patient in hospice care|0
7181801|NCT01134614|11382341|FG001|Overall Study|Patient in hospice care|1
7181802|NCT01116648|11382362|FG000|Phase 1 Dose Level 3|Adverse Event|0
7181803|NCT01116648|11382363|FG001|Phase 1 Dose Level 3|Adverse Event|0
7181804|NCT01116648|11382364|FG002|Phase 1 Dose Level 3|Adverse Event|0
7181805|NCT01116648|11382365|FG003|Phase 1 Dose Level 3|Adverse Event|2
7181806|NCT01116648|11382366|FG004|Phase 1 Dose Level 3|Adverse Event|0
7181807|NCT01116648|11382367|FG005|Phase 1 Dose Level 3|Adverse Event|0
7181808|NCT01116648|11382368|FG006|Phase 1 Dose Level 3|Adverse Event|0
7181809|NCT01116648|11382369|FG007|Phase 1 Dose Level 3|Adverse Event|0
7181810|NCT01116648|11382370|FG008|Phase 1 Dose Level 3|Adverse Event|0
7181811|NCT01116648|11382371|FG009|Phase 1 Dose Level 3|Adverse Event|0
7181812|NCT01116648|11382372|FG010|Phase 1 Dose Level 3|Adverse Event|0
7181813|NCT01116648|11382373|FG011|Phase 1 Dose Level 3|Adverse Event|0
7181814|NCT01116648|11382374|FG012|Phase 1 Dose Level 3|Adverse Event|0
7181815|NCT01116648|11382375|FG013|Phase 1 Dose Level 3|Adverse Event|0
7181816|NCT01116648|11382376|FG014|Phase 1 Dose Level 3|Adverse Event|0
7181817|NCT01065454|11382405|FG000|Treatment|Adverse Event|7
7181818|NCT01065454|11382406|FG001|Treatment|Adverse Event|4
7081378|NCT02132754|11191505|FG011|Overall Study|Death|0
7081379|NCT02132754|11191506|FG012|Overall Study|Death|0
6973323|NCT01180049|11025015|FG000|Overall Study|Lost to Follow-up|8
7081380|NCT02132754|11191507|FG013|Overall Study|Death|0
7081381|NCT02132754|11191508|FG014|Overall Study|Death|0
7081382|NCT02132754|11191509|FG015|Overall Study|Death|1
7081383|NCT02132754|11191510|FG016|Overall Study|Death|0
7081384|NCT02132754|11191511|FG017|Overall Study|Death|0
7081385|NCT02132754|11191512|FG018|Overall Study|Death|0
7081386|NCT02132754|11191513|FG019|Overall Study|Death|1
6896287|NCT00631917|10914585|FG000|Overall Study|Administrative problems|2
6896288|NCT00631917|10914586|FG001|Overall Study|Administrative problems|0
7081387|NCT02132754|11191514|FG020|Overall Study|Death|0
7081388|NCT02132754|11191515|FG021|Overall Study|Death|1
7081389|NCT02132754|11191516|FG022|Overall Study|Death|0
7081390|NCT02132754|11191517|FG023|Overall Study|Death|0
7081391|NCT02132754|11191518|FG024|Overall Study|Death|0
7081392|NCT02132754|11191519|FG025|Overall Study|Death|0
7081393|NCT02132754|11191520|FG026|Overall Study|Death|1
7081394|NCT02132754|11191521|FG027|Overall Study|Death|0
7081395|NCT02132754|11191522|FG028|Overall Study|Death|0
7081396|NCT02132754|11191523|FG029|Overall Study|Death|0
7081397|NCT02132754|11191524|FG030|Overall Study|Death|0
7081398|NCT02132754|11191525|FG031|Overall Study|Death|0
7081399|NCT02132754|11191526|FG032|Overall Study|Death|0
7081400|NCT02132754|11191527|FG033|Overall Study|Death|2
7081401|NCT02132754|11191494|FG000|Overall Study|Excluded Medication|0
7081402|NCT02132754|11191495|FG001|Overall Study|Excluded Medication|0
7081403|NCT02132754|11191496|FG002|Overall Study|Excluded Medication|0
7081404|NCT02132754|11191497|FG003|Overall Study|Excluded Medication|0
7081405|NCT02132754|11191498|FG004|Overall Study|Excluded Medication|0
7081406|NCT02132754|11191499|FG005|Overall Study|Excluded Medication|0
7081407|NCT02132754|11191500|FG006|Overall Study|Excluded Medication|0
7081408|NCT02132754|11191501|FG007|Overall Study|Excluded Medication|0
7081409|NCT02132754|11191502|FG008|Overall Study|Excluded Medication|0
7081410|NCT02132754|11191503|FG009|Overall Study|Excluded Medication|0
7081411|NCT02132754|11191504|FG010|Overall Study|Excluded Medication|0
7181819|NCT01065454|11382407|FG002|Treatment|Adverse Event|3
7181820|NCT01065454|11382408|FG003|Treatment|Adverse Event|6
7181821|NCT01065454|11382405|FG000|Treatment|Death|1
7181822|NCT01065454|11382406|FG001|Treatment|Death|0
7181823|NCT01065454|11382407|FG002|Treatment|Death|0
7181824|NCT01065454|11382408|FG003|Treatment|Death|0
7181825|NCT01065454|11382405|FG000|Treatment|Non-compliance|1
7181826|NCT01065454|11382406|FG001|Treatment|Non-compliance|0
7181827|NCT01065454|11382407|FG002|Treatment|Non-compliance|0
7181828|NCT01065454|11382408|FG003|Treatment|Non-compliance|1
7181829|NCT01065454|11382405|FG000|Treatment|Protocol Decision|0
7181830|NCT01065454|11382406|FG001|Treatment|Protocol Decision|0
7181831|NCT01065454|11382407|FG002|Treatment|Protocol Decision|3
7181832|NCT01065454|11382408|FG003|Treatment|Protocol Decision|2
7181833|NCT01065454|11382405|FG000|Treatment|Protocol Violation|1
7181834|NCT01065454|11382406|FG001|Treatment|Protocol Violation|0
7181835|NCT01065454|11382407|FG002|Treatment|Protocol Violation|1
7081412|NCT02132754|11191505|FG011|Overall Study|Excluded Medication|0
7181836|NCT01065454|11382408|FG003|Treatment|Protocol Violation|0
7181837|NCT01065454|11382405|FG000|Treatment|Withdrawal by Subject|3
7181838|NCT01065454|11382406|FG001|Treatment|Withdrawal by Subject|1
7181839|NCT01065454|11382407|FG002|Treatment|Withdrawal by Subject|2
7181840|NCT01065454|11382408|FG003|Treatment|Withdrawal by Subject|3
7181841|NCT01065454|11382405|FG000|Follow up|Adverse Event|1
7181842|NCT01065454|11382406|FG001|Follow up|Adverse Event|0
7181843|NCT01065454|11382407|FG002|Follow up|Adverse Event|0
7181844|NCT01065454|11382408|FG003|Follow up|Adverse Event|1
7181845|NCT01065454|11382405|FG000|Follow up|Death|0
7181846|NCT01065454|11382406|FG001|Follow up|Death|1
7181847|NCT01065454|11382407|FG002|Follow up|Death|1
7181848|NCT01065454|11382408|FG003|Follow up|Death|0
7181849|NCT01065454|11382405|FG000|Follow up|Lost to Follow-up|0
7181850|NCT01065454|11382406|FG001|Follow up|Lost to Follow-up|0
7181851|NCT01065454|11382407|FG002|Follow up|Lost to Follow-up|0
7181852|NCT01065454|11382408|FG003|Follow up|Lost to Follow-up|1
7181853|NCT01065454|11382405|FG000|Follow up|Progressive disease|0
7181854|NCT01065454|11382406|FG001|Follow up|Progressive disease|0
7181855|NCT01065454|11382407|FG002|Follow up|Progressive disease|0
7181856|NCT01065454|11382408|FG003|Follow up|Progressive disease|1
7181857|NCT01065454|11382405|FG000|Follow up|Withdrawal by Subject|1
7181858|NCT01065454|11382406|FG001|Follow up|Withdrawal by Subject|1
7181859|NCT01065454|11382407|FG002|Follow up|Withdrawal by Subject|1
7181860|NCT01065454|11382408|FG003|Follow up|Withdrawal by Subject|0
7181861|NCT01065454|11382405|FG000|Follow up|study ongoing|37
7181862|NCT01065454|11382406|FG001|Follow up|study ongoing|22
7181863|NCT01065454|11382407|FG002|Follow up|study ongoing|15
7181864|NCT01065454|11382408|FG003|Follow up|study ongoing|41
7181865|NCT01064648|11382421|FG000|Phase I Cohort1: Dose Level 1|Progression|5
7181866|NCT01064648|11382422|FG001|Phase I Cohort1: Dose Level 1|Progression|0
7181867|NCT01064648|11382423|FG002|Phase I Cohort1: Dose Level 1|Progression|0
7181868|NCT01064648|11382424|FG003|Phase I Cohort1: Dose Level 1|Progression|0
7181869|NCT01064648|11382421|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2
7181870|NCT01064648|11382422|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
7181871|NCT01064648|11382423|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
7181872|NCT01064648|11382424|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
6973324|NCT01180049|11025016|FG001|Overall Study|Lost to Follow-up|6
6973325|NCT01180049|11025015|FG000|Overall Study|Death|36
6973326|NCT01180049|11025016|FG001|Overall Study|Death|35
6973327|NCT01180244|11025045|FG000|Overall Study|Lack of Efficacy|0
6973328|NCT01180244|11025046|FG001|Overall Study|Lack of Efficacy|7
6896289|NCT00631917|10914585|FG000|Overall Study|Death|1
6896290|NCT00631917|10914586|FG001|Overall Study|Death|0
6896291|NCT00631969|10914594|FG000|Overall Study|Adverse Event|3
6896292|NCT00631969|10914595|FG001|Overall Study|Adverse Event|1
6896293|NCT00631969|10914594|FG000|Overall Study|Lack of Efficacy|2
6896294|NCT00631969|10914595|FG001|Overall Study|Lack of Efficacy|8
6896295|NCT00631969|10914594|FG000|Overall Study|Lost to Follow-up|2
6896296|NCT00631969|10914595|FG001|Overall Study|Lost to Follow-up|1
7181873|NCT01064648|11382421|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0
7181874|NCT01064648|11382422|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3
7181875|NCT01064648|11382423|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0
7181876|NCT01064648|11382424|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0
7181877|NCT01064648|11382421|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
7181878|NCT01064648|11382422|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1
7181879|NCT01064648|11382423|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
7181880|NCT01064648|11382424|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
7181881|NCT01064648|11382421|FG000|Phase I Cohort 2: Dose Level 2|Progression|0
7181882|NCT01064648|11382422|FG001|Phase I Cohort 2: Dose Level 2|Progression|5
7181883|NCT01064648|11382423|FG002|Phase I Cohort 2: Dose Level 2|Progression|0
7181884|NCT01064648|11382424|FG003|Phase I Cohort 2: Dose Level 2|Progression|0
7181885|NCT01064648|11382421|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
7181886|NCT01064648|11382422|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4
7186896|NCT02786537|11387421|FG003|As Randomized|HCV drugs stolen from pt|0
7186897|NCT02786537|11387422|FG004|As Randomized|HCV drugs stolen from pt|0
7186898|NCT02786537|11387423|FG005|As Randomized|HCV drugs stolen from pt|0
7186899|NCT02786537|11387418|FG000|As Randomized|Advised to stop after lapse in dosing|0
7186900|NCT02786537|11387419|FG001|As Randomized|Advised to stop after lapse in dosing|1
7186901|NCT02786537|11387420|FG002|As Randomized|Advised to stop after lapse in dosing|0
7186902|NCT02786537|11387421|FG003|As Randomized|Advised to stop after lapse in dosing|0
7186903|NCT02786537|11387422|FG004|As Randomized|Advised to stop after lapse in dosing|0
7186904|NCT02786537|11387423|FG005|As Randomized|Advised to stop after lapse in dosing|0
7186905|NCT02786537|11387418|FG000|As Randomized|Subject lost insurance|0
7186906|NCT02786537|11387419|FG001|As Randomized|Subject lost insurance|0
7186907|NCT02786537|11387420|FG002|As Randomized|Subject lost insurance|0
7186908|NCT02786537|11387421|FG003|As Randomized|Subject lost insurance|1
7186909|NCT02786537|11387422|FG004|As Randomized|Subject lost insurance|0
7186910|NCT02786537|11387423|FG005|As Randomized|Subject lost insurance|0
7186911|NCT02786537|11387418|FG000|As Treated|Adverse Event|0
7186912|NCT02786537|11387419|FG001|As Treated|Adverse Event|11
7186913|NCT02786537|11387420|FG002|As Treated|Adverse Event|0
7186914|NCT02786537|11387421|FG003|As Treated|Adverse Event|4
7186915|NCT02786537|11387422|FG004|As Treated|Adverse Event|6
7186916|NCT02786537|11387423|FG005|As Treated|Adverse Event|2
7186917|NCT02786537|11387418|FG000|As Treated|Death|0
7186918|NCT02786537|11387419|FG001|As Treated|Death|2
7186919|NCT02786537|11387420|FG002|As Treated|Death|0
7186920|NCT02786537|11387421|FG003|As Treated|Death|3
7186921|NCT02786537|11387422|FG004|As Treated|Death|1
7186922|NCT02786537|11387423|FG005|As Treated|Death|0
7186923|NCT02786537|11387418|FG000|As Treated|Lack of Efficacy|0
7186924|NCT02786537|11387419|FG001|As Treated|Lack of Efficacy|0
7186925|NCT02786537|11387420|FG002|As Treated|Lack of Efficacy|0
7186926|NCT02786537|11387421|FG003|As Treated|Lack of Efficacy|1
7186927|NCT02786537|11387422|FG004|As Treated|Lack of Efficacy|0
7186928|NCT02786537|11387423|FG005|As Treated|Lack of Efficacy|0
7186929|NCT02786537|11387418|FG000|As Treated|Lost to Follow-up|4
7186930|NCT02786537|11387419|FG001|As Treated|Lost to Follow-up|32
7186931|NCT02786537|11387420|FG002|As Treated|Lost to Follow-up|0
7186932|NCT02786537|11387421|FG003|As Treated|Lost to Follow-up|25
7186933|NCT02786537|11387422|FG004|As Treated|Lost to Follow-up|4
7186934|NCT02786537|11387423|FG005|As Treated|Lost to Follow-up|4
7186935|NCT02786537|11387418|FG000|As Treated|Non-compliance with study drug|1
7186936|NCT02786537|11387419|FG001|As Treated|Non-compliance with study drug|11
7186937|NCT02786537|11387420|FG002|As Treated|Non-compliance with study drug|0
7186938|NCT02786537|11387421|FG003|As Treated|Non-compliance with study drug|1
7186939|NCT02786537|11387422|FG004|As Treated|Non-compliance with study drug|0
7186940|NCT02786537|11387423|FG005|As Treated|Non-compliance with study drug|1
7186941|NCT02786537|11387418|FG000|As Treated|Lost insurance|0
7186942|NCT02786537|11387419|FG001|As Treated|Lost insurance|0
7186943|NCT02786537|11387420|FG002|As Treated|Lost insurance|0
7186944|NCT02786537|11387421|FG003|As Treated|Lost insurance|1
7186945|NCT02786537|11387422|FG004|As Treated|Lost insurance|0
7186946|NCT02786537|11387423|FG005|As Treated|Lost insurance|0
7186947|NCT02786537|11387418|FG000|As Treated|Withdrawal by Subject|1
7186948|NCT02786537|11387419|FG001|As Treated|Withdrawal by Subject|2
7186949|NCT02786537|11387420|FG002|As Treated|Withdrawal by Subject|0
7186950|NCT02786537|11387421|FG003|As Treated|Withdrawal by Subject|0
7186951|NCT02786537|11387422|FG004|As Treated|Withdrawal by Subject|1
7186952|NCT02786537|11387423|FG005|As Treated|Withdrawal by Subject|0
7186953|NCT02786537|11387418|FG000|As Treated|Incarceration|0
7186954|NCT02786537|11387419|FG001|As Treated|Incarceration|1
7186955|NCT02786537|11387420|FG002|As Treated|Incarceration|0
7186956|NCT02786537|11387421|FG003|As Treated|Incarceration|0
7186957|NCT02786537|11387422|FG004|As Treated|Incarceration|0
7186958|NCT02786537|11387423|FG005|As Treated|Incarceration|0
7186959|NCT02786537|11387418|FG000|As Treated|Opiate dependency relapse|0
7186960|NCT02786537|11387419|FG001|As Treated|Opiate dependency relapse|1
7186961|NCT02786537|11387420|FG002|As Treated|Opiate dependency relapse|0
7186962|NCT02786537|11387421|FG003|As Treated|Opiate dependency relapse|0
7186963|NCT02786537|11387422|FG004|As Treated|Opiate dependency relapse|0
6973329|NCT01180244|11025045|FG000|Overall Study|Physician Decision|3
6973330|NCT01180244|11025046|FG001|Overall Study|Physician Decision|0
6973331|NCT01180244|11025045|FG000|Overall Study|Adverse Event|1
6973332|NCT01180244|11025046|FG001|Overall Study|Adverse Event|0
6973333|NCT01180244|11025045|FG000|Overall Study|Withdrawal by Subject|0
7081413|NCT02132754|11191506|FG012|Overall Study|Excluded Medication|0
7081414|NCT02132754|11191507|FG013|Overall Study|Excluded Medication|0
7081415|NCT02132754|11191508|FG014|Overall Study|Excluded Medication|0
7081416|NCT02132754|11191509|FG015|Overall Study|Excluded Medication|0
7081417|NCT02132754|11191510|FG016|Overall Study|Excluded Medication|0
7081418|NCT02132754|11191511|FG017|Overall Study|Excluded Medication|0
7181887|NCT01064648|11382423|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
7181888|NCT01064648|11382424|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
7181889|NCT01064648|11382421|FG000|Phase II|Adverse Event|0
7181890|NCT01064648|11382422|FG001|Phase II|Adverse Event|0
7181891|NCT01064648|11382423|FG002|Phase II|Adverse Event|15
7181892|NCT01064648|11382424|FG003|Phase II|Adverse Event|8
7181893|NCT01064648|11382421|FG000|Phase II|Death|0
7181894|NCT01064648|11382422|FG001|Phase II|Death|0
7181895|NCT01064648|11382423|FG002|Phase II|Death|4
7181896|NCT01064648|11382424|FG003|Phase II|Death|5
7181897|NCT01064648|11382421|FG000|Phase II|Withdrawal by Subject|0
7181898|NCT01064648|11382422|FG001|Phase II|Withdrawal by Subject|0
7181899|NCT01064648|11382423|FG002|Phase II|Withdrawal by Subject|2
7181900|NCT01064648|11382424|FG003|Phase II|Withdrawal by Subject|5
7181901|NCT01064648|11382421|FG000|Phase II|Progression|0
7181902|NCT01064648|11382422|FG001|Phase II|Progression|0
7181903|NCT01064648|11382423|FG002|Phase II|Progression|21
7181904|NCT01064648|11382424|FG003|Phase II|Progression|27
7181905|NCT01064648|11382421|FG000|Phase II|Non-protocol specified|0
7181906|NCT01064648|11382422|FG001|Phase II|Non-protocol specified|0
7181907|NCT01064648|11382423|FG002|Phase II|Non-protocol specified|5
7181908|NCT01064648|11382424|FG003|Phase II|Non-protocol specified|3
7181909|NCT01064648|11382421|FG000|Phase II|Under Review|0
7181910|NCT01064648|11382422|FG001|Phase II|Under Review|0
7181911|NCT01064648|11382423|FG002|Phase II|Under Review|2
7181912|NCT01064648|11382424|FG003|Phase II|Under Review|0
7181913|NCT01063517|11382439|FG000|Overall Study|Consent withdrawal|1
7181914|NCT01063517|11382440|FG001|Overall Study|Consent withdrawal|0
7181915|NCT01063517|11382439|FG000|Overall Study|Study reached data cut-off|19
7181916|NCT01063517|11382440|FG001|Overall Study|Study reached data cut-off|7
7181917|NCT01063517|11382439|FG000|Overall Study|Lost to Follow-up|4
7181918|NCT01063517|11382440|FG001|Overall Study|Lost to Follow-up|3
7181919|NCT01063517|11382439|FG000|Overall Study|Withdrawal by Subject|1
7181920|NCT01063517|11382440|FG001|Overall Study|Withdrawal by Subject|2
7181921|NCT01063517|11382439|FG000|Overall Study|Death|33
7181922|NCT01063517|11382440|FG001|Overall Study|Death|48
7181923|NCT01015833|11382448|FG000|Overall Study|Death|1
7181924|NCT01015833|11382449|FG001|Overall Study|Death|0
7181925|NCT01015833|11382448|FG000|Overall Study|Withdrawal by Subject|3
7181926|NCT01015833|11382449|FG001|Overall Study|Withdrawal by Subject|2
7181927|NCT01015833|11382448|FG000|Overall Study|Adverse Event|0
7181928|NCT01015833|11382449|FG001|Overall Study|Adverse Event|1
7181929|NCT01015833|11382448|FG000|Overall Study|Physician Decision|2
7181930|NCT01015833|11382449|FG001|Overall Study|Physician Decision|0
7181931|NCT01015833|11382448|FG000|Overall Study|Symptomatic deterioration|0
7181932|NCT01015833|11382449|FG001|Overall Study|Symptomatic deterioration|1
7181933|NCT01015833|11382448|FG000|Overall Study|Other|5
7181934|NCT01015833|11382449|FG001|Overall Study|Other|1
7181935|NCT01015833|11382448|FG000|Overall Study|Motor Vehicle Accidents|1
7181936|NCT01015833|11382449|FG001|Overall Study|Motor Vehicle Accidents|0
7181937|NCT01015833|11382448|FG000|Overall Study|Did not start treatment|1
7181938|NCT01015833|11382449|FG001|Overall Study|Did not start treatment|0
7181939|NCT00937937|11382455|FG000|Overall Study|Adverse Event|6
7181940|NCT00937937|11382455|FG000|Overall Study|Withdrawal by Subject|2
7181941|NCT00937937|11382455|FG000|Overall Study|Progression/relapse|61
7181942|NCT00937937|11382455|FG000|Overall Study|Death|1
7181943|NCT00937937|11382455|FG000|Overall Study|Other|2
7181944|NCT00843882|11382463|FG000|Step 1|Lack of Efficacy|14
7181945|NCT00843882|11382464|FG001|Step 1|Lack of Efficacy|10
7181946|NCT00843882|11382465|FG002|Step 1|Lack of Efficacy|21
7181947|NCT00843882|11382463|FG000|Step 1|Adverse Event|8
7181948|NCT00843882|11382464|FG001|Step 1|Adverse Event|17
6973334|NCT01180244|11025046|FG001|Overall Study|Withdrawal by Subject|1
6973335|NCT01180244|11025045|FG000|Overall Study|Protocol Violation|1
6973336|NCT01180244|11025046|FG001|Overall Study|Protocol Violation|0
6973337|NCT01180244|11025045|FG000|Overall Study|Lost to Follow-up|1
6973338|NCT01180244|11025046|FG001|Overall Study|Lost to Follow-up|0
6973339|NCT01180296|11025054|FG000|Overall Study|Protocol Violation|1
6973340|NCT01180296|11025055|FG001|Overall Study|Protocol Violation|2
6973341|NCT01180400|11025065|FG000|Overall Study|Withdrawal by Subject|5
6973342|NCT01180400|11025066|FG001|Overall Study|Withdrawal by Subject|6
7081419|NCT02132754|11191512|FG018|Overall Study|Excluded Medication|0
7081420|NCT02132754|11191513|FG019|Overall Study|Excluded Medication|0
7081421|NCT02132754|11191514|FG020|Overall Study|Excluded Medication|1
6973343|NCT01180400|11025065|FG000|Overall Study|Eligibility criteria not fulfilled|0
6973344|NCT01180400|11025066|FG001|Overall Study|Eligibility criteria not fulfilled|2
6973345|NCT01180400|11025065|FG000|Overall Study|Adverse Event|12
6973346|NCT01180400|11025066|FG001|Overall Study|Adverse Event|10
6973347|NCT01180400|11025065|FG000|Overall Study|Severe non-compliance to protocol|1
6973348|NCT01180400|11025066|FG001|Overall Study|Severe non-compliance to protocol|2
6973349|NCT01180400|11025065|FG000|Overall Study|Condition under investigation worsened|2
6973350|NCT01180400|11025066|FG001|Overall Study|Condition under investigation worsened|1
6973351|NCT01180400|11025065|FG000|Overall Study|Lack of Efficacy|2
6973352|NCT01180400|11025066|FG001|Overall Study|Lack of Efficacy|0
6973353|NCT01180400|11025065|FG000|Overall Study|Study-specific withdrawal criteria|1
6973354|NCT01180400|11025066|FG001|Overall Study|Study-specific withdrawal criteria|2
7081422|NCT02132754|11191515|FG021|Overall Study|Excluded Medication|0
7081423|NCT02132754|11191516|FG022|Overall Study|Excluded Medication|0
6973355|NCT01180400|11025065|FG000|Overall Study|Lost to Follow-up|2
6973356|NCT01180400|11025066|FG001|Overall Study|Lost to Follow-up|3
6973357|NCT01180400|11025065|FG000|Overall Study|Other|0
6973358|NCT01180400|11025066|FG001|Overall Study|Other|1
6973359|NCT01180647|11025085|FG000|Overall Study|Lost to Follow-up|5
7081424|NCT02132754|11191517|FG023|Overall Study|Excluded Medication|0
7081425|NCT02132754|11191518|FG024|Overall Study|Excluded Medication|0
7081426|NCT02132754|11191519|FG025|Overall Study|Excluded Medication|0
7081427|NCT02132754|11191520|FG026|Overall Study|Excluded Medication|0
7081428|NCT02132754|11191521|FG027|Overall Study|Excluded Medication|0
7081429|NCT02132754|11191522|FG028|Overall Study|Excluded Medication|0
7081430|NCT02132754|11191523|FG029|Overall Study|Excluded Medication|0
7181949|NCT00843882|11382465|FG002|Step 1|Adverse Event|20
7181950|NCT00843882|11382463|FG000|Step 1|Death|1
7181951|NCT00843882|11382464|FG001|Step 1|Death|2
7181952|NCT00843882|11382465|FG002|Step 1|Death|4
7181953|NCT00843882|11382463|FG000|Step 1|Withdrawal by Subject|6
7181954|NCT00843882|11382464|FG001|Step 1|Withdrawal by Subject|12
7181955|NCT00843882|11382465|FG002|Step 1|Withdrawal by Subject|9
7181956|NCT00843882|11382463|FG000|Step 1|Physician Decision|0
7181957|NCT00843882|11382464|FG001|Step 1|Physician Decision|5
7181958|NCT00843882|11382465|FG002|Step 1|Physician Decision|1
7181959|NCT00843882|11382463|FG000|Step 1|Patient and physician's decision|0
7181960|NCT00843882|11382464|FG001|Step 1|Patient and physician's decision|0
7181961|NCT00843882|11382465|FG002|Step 1|Patient and physician's decision|1
7181962|NCT00843882|11382463|FG000|Step 1|Other complicating disease|1
7181963|NCT00843882|11382464|FG001|Step 1|Other complicating disease|3
7181964|NCT00843882|11382465|FG002|Step 1|Other complicating disease|4
7181965|NCT00843882|11382463|FG000|Step 1|Alternative therapy|0
7181966|NCT00843882|11382464|FG001|Step 1|Alternative therapy|1
7181967|NCT00843882|11382465|FG002|Step 1|Alternative therapy|1
7181968|NCT00843882|11382463|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0
7181969|NCT00843882|11382464|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4
7181970|NCT00843882|11382465|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0
7181971|NCT00843882|11382463|FG000|Step 1|Off treatment reason unknown|0
7181972|NCT00843882|11382464|FG001|Step 1|Off treatment reason unknown|1
7181973|NCT00843882|11382465|FG002|Step 1|Off treatment reason unknown|4
7181974|NCT00843882|11382463|FG000|Step 1|Never started treatment|2
7181975|NCT00843882|11382464|FG001|Step 1|Never started treatment|0
7181976|NCT00843882|11382465|FG002|Step 1|Never started treatment|0
7181977|NCT00843882|11382463|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1
7181978|NCT00843882|11382464|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9
7181979|NCT00843882|11382465|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0
7181980|NCT00843882|11382463|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0
7181981|NCT00843882|11382464|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6
7181982|NCT00843882|11382465|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0
7181983|NCT00843882|11382463|FG000|Step 2 (Cross-over to Arm B)|Death|0
7181984|NCT00843882|11382464|FG001|Step 2 (Cross-over to Arm B)|Death|3
7181985|NCT00843882|11382465|FG002|Step 2 (Cross-over to Arm B)|Death|0
7181986|NCT00843882|11382463|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2
7181987|NCT00843882|11382464|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5
7181988|NCT00843882|11382465|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0
7181989|NCT00843882|11382463|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1
7181990|NCT00843882|11382464|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1
7181991|NCT00843882|11382465|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0
7181992|NCT00843882|11382463|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0
7181993|NCT00843882|11382464|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1
7181994|NCT00843882|11382465|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0
7181995|NCT00843882|11382463|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0
7181996|NCT00843882|11382464|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1
7181997|NCT00843882|11382465|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0
7181998|NCT00792948|11382478|FG000|Overall Study|Adverse Event|6
7181999|NCT00792948|11382478|FG000|Overall Study|Death|4
7182000|NCT00792948|11382478|FG000|Overall Study|Withdrawal by Subject|3
7182001|NCT00792948|11382478|FG000|Overall Study|Ineligible|2
7182002|NCT00792948|11382478|FG000|Overall Study|Insurance denial - not treated|1
7182003|NCT00792948|11382478|FG000|Overall Study|Physician Decision|11
7182004|NCT00792948|11382478|FG000|Overall Study|Protocol Violation|1
7182005|NCT00770809|11382488|FG000|Overall Study|Adverse Event|9
7182006|NCT00770809|11382489|FG001|Overall Study|Adverse Event|1
7182007|NCT00770809|11382490|FG002|Overall Study|Adverse Event|12
7182008|NCT00770809|11382488|FG000|Overall Study|Death|1
7182009|NCT00770809|11382489|FG001|Overall Study|Death|0
7182010|NCT00770809|11382490|FG002|Overall Study|Death|0
7182011|NCT00770809|11382488|FG000|Overall Study|Withdrawal by Subject|3
7182012|NCT00770809|11382489|FG001|Overall Study|Withdrawal by Subject|3
7182013|NCT00770809|11382490|FG002|Overall Study|Withdrawal by Subject|7
7182014|NCT00770809|11382488|FG000|Overall Study|Progression|2
7182015|NCT00770809|11382489|FG001|Overall Study|Progression|2
7081431|NCT02132754|11191524|FG030|Overall Study|Excluded Medication|0
6973360|NCT01180647|11025086|FG001|Overall Study|Lost to Follow-up|6
6973361|NCT01180660|11025094|FG000|Overall Study|Changed to open surgery|1
6973362|NCT01180660|11025095|FG001|Overall Study|Changed to open surgery|0
6973363|NCT01180777|11025101|FG000|Overall Study|Protocol Violation|6
6973364|NCT01180777|11025101|FG000|Overall Study|Poor lens fit|4
6973365|NCT01180777|11025101|FG000|Overall Study|Lost to Follow-up|1
6973366|NCT01180777|11025101|FG000|Overall Study|Adverse Event|1
6973367|NCT01180790|11025114|FG000|Overall Study|Adverse Event|1
6973368|NCT01180790|11025115|FG001|Overall Study|Adverse Event|1
7081432|NCT02132754|11191525|FG031|Overall Study|Excluded Medication|0
7081433|NCT02132754|11191526|FG032|Overall Study|Excluded Medication|0
7081434|NCT02132754|11191527|FG033|Overall Study|Excluded Medication|1
7081435|NCT02132754|11191494|FG000|Overall Study|Physician Decision|0
7081436|NCT02132754|11191495|FG001|Overall Study|Physician Decision|0
7081437|NCT02132754|11191496|FG002|Overall Study|Physician Decision|0
7081438|NCT02132754|11191497|FG003|Overall Study|Physician Decision|0
6973369|NCT01180790|11025116|FG002|Overall Study|Adverse Event|2
6973370|NCT01180790|11025117|FG003|Overall Study|Adverse Event|0
6973371|NCT01180790|11025118|FG004|Overall Study|Adverse Event|1
6973372|NCT01180790|11025119|FG005|Overall Study|Adverse Event|3
6973373|NCT01180790|11025120|FG006|Overall Study|Adverse Event|0
6973374|NCT01180790|11025114|FG000|Overall Study|Withdrawal by Subject|3
6973375|NCT01180790|11025115|FG001|Overall Study|Withdrawal by Subject|0
6973376|NCT01180790|11025116|FG002|Overall Study|Withdrawal by Subject|5
6973377|NCT01180790|11025117|FG003|Overall Study|Withdrawal by Subject|0
6973378|NCT01180790|11025118|FG004|Overall Study|Withdrawal by Subject|2
6973379|NCT01180790|11025119|FG005|Overall Study|Withdrawal by Subject|1
6973380|NCT01180790|11025120|FG006|Overall Study|Withdrawal by Subject|0
6973381|NCT01180790|11025114|FG000|Overall Study|Lost to Follow-up|3
6973382|NCT01180790|11025115|FG001|Overall Study|Lost to Follow-up|1
6973383|NCT01180790|11025116|FG002|Overall Study|Lost to Follow-up|0
6973384|NCT01180790|11025117|FG003|Overall Study|Lost to Follow-up|2
6973385|NCT01180790|11025118|FG004|Overall Study|Lost to Follow-up|1
6973386|NCT01180790|11025119|FG005|Overall Study|Lost to Follow-up|0
6973387|NCT01180790|11025120|FG006|Overall Study|Lost to Follow-up|1
6973388|NCT01180790|11025114|FG000|Overall Study|Physician Decision|1
6973389|NCT01180790|11025115|FG001|Overall Study|Physician Decision|0
6973390|NCT01180790|11025116|FG002|Overall Study|Physician Decision|0
6973391|NCT01180790|11025117|FG003|Overall Study|Physician Decision|1
6973392|NCT01180790|11025118|FG004|Overall Study|Physician Decision|0
6973393|NCT01180790|11025119|FG005|Overall Study|Physician Decision|0
7081439|NCT02132754|11191498|FG004|Overall Study|Physician Decision|0
6973394|NCT01180790|11025120|FG006|Overall Study|Physician Decision|0
6973395|NCT01180790|11025114|FG000|Overall Study|Lack of Efficacy|1
6973396|NCT01180790|11025115|FG001|Overall Study|Lack of Efficacy|2
6973397|NCT01180790|11025116|FG002|Overall Study|Lack of Efficacy|5
6973398|NCT01180790|11025117|FG003|Overall Study|Lack of Efficacy|6
6973399|NCT01180790|11025118|FG004|Overall Study|Lack of Efficacy|1
6973400|NCT01180790|11025119|FG005|Overall Study|Lack of Efficacy|3
6973401|NCT01180790|11025120|FG006|Overall Study|Lack of Efficacy|0
7081440|NCT02132754|11191499|FG005|Overall Study|Physician Decision|0
6896297|NCT00631969|10914594|FG000|Overall Study|Protocol Violation|1
6896298|NCT00631969|10914595|FG001|Overall Study|Protocol Violation|1
7081441|NCT02132754|11191500|FG006|Overall Study|Physician Decision|0
7081442|NCT02132754|11191501|FG007|Overall Study|Physician Decision|0
7081443|NCT02132754|11191502|FG008|Overall Study|Physician Decision|0
7182016|NCT00770809|11382490|FG002|Overall Study|Progression|0
7182017|NCT00770809|11382488|FG000|Overall Study|Complicating illness|0
7182018|NCT00770809|11382489|FG001|Overall Study|Complicating illness|0
7182019|NCT00770809|11382490|FG002|Overall Study|Complicating illness|1
7182020|NCT00770809|11382488|FG000|Overall Study|Other Medical Reasons|2
7182021|NCT00770809|11382489|FG001|Overall Study|Other Medical Reasons|4
7182022|NCT00770809|11382490|FG002|Overall Study|Other Medical Reasons|3
7182023|NCT00769379|11382500|FG000|Overall Study|No follow up data mapped to Other.|3
7182024|NCT00769379|11382501|FG001|Overall Study|No follow up data mapped to Other.|13
7182025|NCT00731731|11382510|FG000|Overall Study|Protocol Violation|0
7081444|NCT02132754|11191503|FG009|Overall Study|Physician Decision|1
7081445|NCT02132754|11191504|FG010|Overall Study|Physician Decision|0
7081446|NCT02132754|11191505|FG011|Overall Study|Physician Decision|1
7081447|NCT02132754|11191506|FG012|Overall Study|Physician Decision|1
7081448|NCT02132754|11191507|FG013|Overall Study|Physician Decision|0
7182026|NCT00731731|11382511|FG001|Overall Study|Protocol Violation|0
7182027|NCT00731731|11382512|FG002|Overall Study|Protocol Violation|1
7182028|NCT00731731|11382510|FG000|Overall Study|Cancel prior to treatment|0
7182029|NCT00731731|11382511|FG001|Overall Study|Cancel prior to treatment|0
7182030|NCT00731731|11382512|FG002|Overall Study|Cancel prior to treatment|2
7182031|NCT00700882|11382525|FG000|Overall Study|Never received treatment|6
7182032|NCT00700882|11382525|FG000|Overall Study|Ineligible|2
7182033|NCT00700882|11382525|FG000|Overall Study|No KIT mutation|51
7182034|NCT00658814|11382531|FG000|Remission Induction Chemotherapy|Adverse Event|1
7182035|NCT00658814|11382532|FG001|Remission Induction Chemotherapy|Adverse Event|3
7182036|NCT00658814|11382531|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3
7182037|NCT00658814|11382532|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4
7182038|NCT00658814|11382531|FG000|Remission Induction Chemotherapy|Progression/Relapse|0
7182039|NCT00658814|11382532|FG001|Remission Induction Chemotherapy|Progression/Relapse|1
7182040|NCT00658814|11382531|FG000|Remission Induction Chemotherapy|Death|1
7182041|NCT00658814|11382532|FG001|Remission Induction Chemotherapy|Death|4
7182042|NCT00658814|11382531|FG000|Remission Induction Chemotherapy|Not protocol specified|2
7182043|NCT00658814|11382532|FG001|Remission Induction Chemotherapy|Not protocol specified|4
7182044|NCT00658814|11382531|FG000|Remission Induction Chemotherapy|Not eligible|1
7182045|NCT00658814|11382532|FG001|Remission Induction Chemotherapy|Not eligible|2
7081449|NCT02132754|11191508|FG014|Overall Study|Physician Decision|0
7081450|NCT02132754|11191509|FG015|Overall Study|Physician Decision|1
7081451|NCT02132754|11191510|FG016|Overall Study|Physician Decision|0
7081452|NCT02132754|11191511|FG017|Overall Study|Physician Decision|0
7081453|NCT02132754|11191512|FG018|Overall Study|Physician Decision|0
7081454|NCT02132754|11191513|FG019|Overall Study|Physician Decision|0
7081455|NCT02132754|11191514|FG020|Overall Study|Physician Decision|0
7081456|NCT02132754|11191515|FG021|Overall Study|Physician Decision|0
7081457|NCT02132754|11191516|FG022|Overall Study|Physician Decision|0
7081458|NCT02132754|11191517|FG023|Overall Study|Physician Decision|0
7081459|NCT02132754|11191518|FG024|Overall Study|Physician Decision|1
7081460|NCT02132754|11191519|FG025|Overall Study|Physician Decision|0
7081461|NCT02132754|11191520|FG026|Overall Study|Physician Decision|0
7081462|NCT02132754|11191521|FG027|Overall Study|Physician Decision|0
7081463|NCT02132754|11191522|FG028|Overall Study|Physician Decision|0
7081464|NCT02132754|11191523|FG029|Overall Study|Physician Decision|0
7081465|NCT02132754|11191524|FG030|Overall Study|Physician Decision|0
7081466|NCT02132754|11191525|FG031|Overall Study|Physician Decision|1
7081467|NCT02132754|11191526|FG032|Overall Study|Physician Decision|0
7081468|NCT02132754|11191527|FG033|Overall Study|Physician Decision|3
7081469|NCT02132754|11191494|FG000|Overall Study|Progressive Disease|1
7081470|NCT02132754|11191495|FG001|Overall Study|Progressive Disease|1
7081471|NCT02132754|11191496|FG002|Overall Study|Progressive Disease|1
7081472|NCT02132754|11191497|FG003|Overall Study|Progressive Disease|1
7081473|NCT02132754|11191498|FG004|Overall Study|Progressive Disease|1
7081474|NCT02132754|11191499|FG005|Overall Study|Progressive Disease|1
7081475|NCT02132754|11191500|FG006|Overall Study|Progressive Disease|1
7081476|NCT02132754|11191501|FG007|Overall Study|Progressive Disease|1
7081477|NCT02132754|11191502|FG008|Overall Study|Progressive Disease|1
7081478|NCT02132754|11191503|FG009|Overall Study|Progressive Disease|3
7081479|NCT02132754|11191504|FG010|Overall Study|Progressive Disease|3
7081480|NCT02132754|11191505|FG011|Overall Study|Progressive Disease|2
7081481|NCT02132754|11191506|FG012|Overall Study|Progressive Disease|2
7182046|NCT00658814|11382531|FG000|Consolidation Therapy|Not protocol specified|0
7182047|NCT00658814|11382532|FG001|Consolidation Therapy|Not protocol specified|1
7182048|NCT00658814|11382531|FG000|Consolidation Therapy|Not eligible|2
7182049|NCT00658814|11382532|FG001|Consolidation Therapy|Not eligible|2
7182050|NCT00658814|11382531|FG000|Maintenance Therapy|Adverse Event|1
7182051|NCT00658814|11382532|FG001|Maintenance Therapy|Adverse Event|1
7182052|NCT00658814|11382531|FG000|Maintenance Therapy|Not protocol specified|1
7182053|NCT00658814|11382532|FG001|Maintenance Therapy|Not protocol specified|0
7182054|NCT00658814|11382531|FG000|Maintenance Therapy|Not eligible|1
7182055|NCT00658814|11382532|FG001|Maintenance Therapy|Not eligible|0
7182056|NCT00644228|11382544|FG000|Randomization & Eligibility|Ineligible|31
7182057|NCT00644228|11382545|FG001|Randomization & Eligibility|Ineligible|21
7081482|NCT02132754|11191507|FG013|Overall Study|Progressive Disease|3
7081483|NCT02132754|11191508|FG014|Overall Study|Progressive Disease|2
7081484|NCT02132754|11191509|FG015|Overall Study|Progressive Disease|1
7081485|NCT02132754|11191510|FG016|Overall Study|Progressive Disease|2
7081486|NCT02132754|11191511|FG017|Overall Study|Progressive Disease|1
7081487|NCT02132754|11191512|FG018|Overall Study|Progressive Disease|3
7081488|NCT02132754|11191513|FG019|Overall Study|Progressive Disease|1
7081489|NCT02132754|11191514|FG020|Overall Study|Progressive Disease|1
7081490|NCT02132754|11191515|FG021|Overall Study|Progressive Disease|3
7081491|NCT02132754|11191516|FG022|Overall Study|Progressive Disease|2
7081492|NCT02132754|11191517|FG023|Overall Study|Progressive Disease|3
7081493|NCT02132754|11191518|FG024|Overall Study|Progressive Disease|0
7081494|NCT02132754|11191519|FG025|Overall Study|Progressive Disease|1
7081495|NCT02132754|11191520|FG026|Overall Study|Progressive Disease|2
7081496|NCT02132754|11191521|FG027|Overall Study|Progressive Disease|1
7081497|NCT02132754|11191522|FG028|Overall Study|Progressive Disease|2
7081498|NCT02132754|11191523|FG029|Overall Study|Progressive Disease|3
7081499|NCT02132754|11191524|FG030|Overall Study|Progressive Disease|1
7081500|NCT02132754|11191525|FG031|Overall Study|Progressive Disease|1
7081501|NCT02132754|11191526|FG032|Overall Study|Progressive Disease|3
7081502|NCT02132754|11191527|FG033|Overall Study|Progressive Disease|6
7081503|NCT02132754|11191494|FG000|Overall Study|Screen Failure|0
7081504|NCT02132754|11191495|FG001|Overall Study|Screen Failure|0
7081505|NCT02132754|11191496|FG002|Overall Study|Screen Failure|0
7081506|NCT02132754|11191497|FG003|Overall Study|Screen Failure|0
7081507|NCT02132754|11191498|FG004|Overall Study|Screen Failure|0
7081508|NCT02132754|11191499|FG005|Overall Study|Screen Failure|0
7081509|NCT02132754|11191500|FG006|Overall Study|Screen Failure|0
7081510|NCT02132754|11191501|FG007|Overall Study|Screen Failure|0
7081511|NCT02132754|11191502|FG008|Overall Study|Screen Failure|0
7081512|NCT02132754|11191503|FG009|Overall Study|Screen Failure|0
7081513|NCT02132754|11191504|FG010|Overall Study|Screen Failure|0
7081514|NCT02132754|11191505|FG011|Overall Study|Screen Failure|0
7081515|NCT02132754|11191506|FG012|Overall Study|Screen Failure|0
7081516|NCT02132754|11191507|FG013|Overall Study|Screen Failure|0
7081517|NCT02132754|11191508|FG014|Overall Study|Screen Failure|0
7081518|NCT02132754|11191509|FG015|Overall Study|Screen Failure|0
7081519|NCT02132754|11191510|FG016|Overall Study|Screen Failure|0
7081520|NCT02132754|11191511|FG017|Overall Study|Screen Failure|0
7081521|NCT02132754|11191512|FG018|Overall Study|Screen Failure|0
7081522|NCT02132754|11191513|FG019|Overall Study|Screen Failure|1
7081523|NCT02132754|11191514|FG020|Overall Study|Screen Failure|0
7081524|NCT02132754|11191515|FG021|Overall Study|Screen Failure|1
7081525|NCT02132754|11191516|FG022|Overall Study|Screen Failure|0
7081526|NCT02132754|11191517|FG023|Overall Study|Screen Failure|0
7081527|NCT02132754|11191518|FG024|Overall Study|Screen Failure|0
7081528|NCT02132754|11191519|FG025|Overall Study|Screen Failure|0
7081529|NCT02132754|11191520|FG026|Overall Study|Screen Failure|0
7081530|NCT02132754|11191521|FG027|Overall Study|Screen Failure|0
7081531|NCT02132754|11191522|FG028|Overall Study|Screen Failure|0
7081532|NCT02132754|11191523|FG029|Overall Study|Screen Failure|0
7081533|NCT02132754|11191524|FG030|Overall Study|Screen Failure|0
7081534|NCT02132754|11191525|FG031|Overall Study|Screen Failure|0
7081535|NCT02132754|11191526|FG032|Overall Study|Screen Failure|0
7081536|NCT02132754|11191527|FG033|Overall Study|Screen Failure|0
7081537|NCT02132754|11191494|FG000|Overall Study|Transferred to Extension Study|0
7081538|NCT02132754|11191495|FG001|Overall Study|Transferred to Extension Study|0
7081539|NCT02132754|11191496|FG002|Overall Study|Transferred to Extension Study|0
7081540|NCT02132754|11191497|FG003|Overall Study|Transferred to Extension Study|0
7081541|NCT02132754|11191498|FG004|Overall Study|Transferred to Extension Study|0
7081542|NCT02132754|11191499|FG005|Overall Study|Transferred to Extension Study|0
7081543|NCT02132754|11191500|FG006|Overall Study|Transferred to Extension Study|0
7081544|NCT02132754|11191501|FG007|Overall Study|Transferred to Extension Study|0
7081545|NCT02132754|11191502|FG008|Overall Study|Transferred to Extension Study|0
7182058|NCT00644228|11382544|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1
7081546|NCT02132754|11191503|FG009|Overall Study|Transferred to Extension Study|0
7081547|NCT02132754|11191504|FG010|Overall Study|Transferred to Extension Study|0
7081548|NCT02132754|11191505|FG011|Overall Study|Transferred to Extension Study|0
7081549|NCT02132754|11191506|FG012|Overall Study|Transferred to Extension Study|0
7081550|NCT02132754|11191507|FG013|Overall Study|Transferred to Extension Study|0
7081551|NCT02132754|11191508|FG014|Overall Study|Transferred to Extension Study|0
7081552|NCT02132754|11191509|FG015|Overall Study|Transferred to Extension Study|0
7081553|NCT02132754|11191510|FG016|Overall Study|Transferred to Extension Study|0
7081554|NCT02132754|11191511|FG017|Overall Study|Transferred to Extension Study|0
7081555|NCT02132754|11191512|FG018|Overall Study|Transferred to Extension Study|0
7081556|NCT02132754|11191513|FG019|Overall Study|Transferred to Extension Study|0
7081557|NCT02132754|11191514|FG020|Overall Study|Transferred to Extension Study|0
7081558|NCT02132754|11191515|FG021|Overall Study|Transferred to Extension Study|0
7081559|NCT02132754|11191516|FG022|Overall Study|Transferred to Extension Study|0
7081560|NCT02132754|11191517|FG023|Overall Study|Transferred to Extension Study|0
7081561|NCT02132754|11191518|FG024|Overall Study|Transferred to Extension Study|0
7081562|NCT02132754|11191519|FG025|Overall Study|Transferred to Extension Study|0
7081563|NCT02132754|11191520|FG026|Overall Study|Transferred to Extension Study|0
7081564|NCT02132754|11191521|FG027|Overall Study|Transferred to Extension Study|0
7081565|NCT02132754|11191522|FG028|Overall Study|Transferred to Extension Study|0
7081566|NCT02132754|11191523|FG029|Overall Study|Transferred to Extension Study|0
7081567|NCT02132754|11191524|FG030|Overall Study|Transferred to Extension Study|0
7081568|NCT02132754|11191525|FG031|Overall Study|Transferred to Extension Study|0
7081569|NCT02132754|11191526|FG032|Overall Study|Transferred to Extension Study|0
7081570|NCT02132754|11191527|FG033|Overall Study|Transferred to Extension Study|6
7081571|NCT02132754|11191494|FG000|Overall Study|Withdrawal by Subject|0
7081572|NCT02132754|11191495|FG001|Overall Study|Withdrawal by Subject|0
7081573|NCT02132754|11191496|FG002|Overall Study|Withdrawal by Subject|0
7081574|NCT02132754|11191497|FG003|Overall Study|Withdrawal by Subject|0
7081575|NCT02132754|11191498|FG004|Overall Study|Withdrawal by Subject|0
7081576|NCT02132754|11191499|FG005|Overall Study|Withdrawal by Subject|0
7081577|NCT02132754|11191500|FG006|Overall Study|Withdrawal by Subject|0
7081578|NCT02132754|11191501|FG007|Overall Study|Withdrawal by Subject|0
7081579|NCT02132754|11191502|FG008|Overall Study|Withdrawal by Subject|0
7081580|NCT02132754|11191503|FG009|Overall Study|Withdrawal by Subject|1
7081581|NCT02132754|11191504|FG010|Overall Study|Withdrawal by Subject|0
7081582|NCT02132754|11191505|FG011|Overall Study|Withdrawal by Subject|0
7081583|NCT02132754|11191506|FG012|Overall Study|Withdrawal by Subject|1
7081584|NCT02132754|11191507|FG013|Overall Study|Withdrawal by Subject|0
7081585|NCT02132754|11191508|FG014|Overall Study|Withdrawal by Subject|1
7081586|NCT02132754|11191509|FG015|Overall Study|Withdrawal by Subject|2
7081587|NCT02132754|11191510|FG016|Overall Study|Withdrawal by Subject|1
7081588|NCT02132754|11191511|FG017|Overall Study|Withdrawal by Subject|0
7081589|NCT02132754|11191512|FG018|Overall Study|Withdrawal by Subject|0
7081590|NCT02132754|11191513|FG019|Overall Study|Withdrawal by Subject|0
7081591|NCT02132754|11191514|FG020|Overall Study|Withdrawal by Subject|1
7081592|NCT02132754|11191515|FG021|Overall Study|Withdrawal by Subject|0
7081593|NCT02132754|11191516|FG022|Overall Study|Withdrawal by Subject|0
7081594|NCT02132754|11191517|FG023|Overall Study|Withdrawal by Subject|0
7081595|NCT02132754|11191518|FG024|Overall Study|Withdrawal by Subject|1
7081596|NCT02132754|11191519|FG025|Overall Study|Withdrawal by Subject|0
7081597|NCT02132754|11191520|FG026|Overall Study|Withdrawal by Subject|0
7081598|NCT02132754|11191521|FG027|Overall Study|Withdrawal by Subject|1
7081599|NCT02132754|11191522|FG028|Overall Study|Withdrawal by Subject|0
7081600|NCT02132754|11191523|FG029|Overall Study|Withdrawal by Subject|0
7081601|NCT02132754|11191524|FG030|Overall Study|Withdrawal by Subject|0
7081602|NCT02132754|11191525|FG031|Overall Study|Withdrawal by Subject|1
7081603|NCT02132754|11191526|FG032|Overall Study|Withdrawal by Subject|0
7081604|NCT02132754|11191527|FG033|Overall Study|Withdrawal by Subject|2
7081605|NCT02132767|11191639|FG000|Overall Study|Death|3
7081606|NCT02132767|11191640|FG001|Overall Study|Death|2
7081607|NCT02132767|11191639|FG000|Overall Study|Withdrawal by Subject|10
7081608|NCT02132767|11191640|FG001|Overall Study|Withdrawal by Subject|9
7081609|NCT02132767|11191639|FG000|Overall Study|Lost to Follow-up|4
7081610|NCT02132767|11191640|FG001|Overall Study|Lost to Follow-up|4
7081611|NCT02132949|11191684|FG000|Overall Study|Death|7
7081612|NCT02132949|11191685|FG001|Overall Study|Death|13
7081613|NCT02132949|11191684|FG000|Overall Study|Lost to Follow-up|14
7081614|NCT02132949|11191685|FG001|Overall Study|Lost to Follow-up|4
7081615|NCT02132949|11191684|FG000|Overall Study|Withdrawal by Subject|6
7081616|NCT02132949|11191685|FG001|Overall Study|Withdrawal by Subject|5
7081617|NCT02132949|11191684|FG000|Overall Study|Noncompliance|5
7081618|NCT02132949|11191685|FG001|Overall Study|Noncompliance|1
7081619|NCT02132949|11191684|FG000|Overall Study|Physician Decision|3
7081620|NCT02132949|11191685|FG001|Overall Study|Physician Decision|1
7081621|NCT02132949|11191684|FG000|Overall Study|Disease Progression|3
7081622|NCT02132949|11191685|FG001|Overall Study|Disease Progression|0
7081623|NCT02132949|11191684|FG000|Overall Study|Adverse Event|2
7081624|NCT02132949|11191685|FG001|Overall Study|Adverse Event|1
7081625|NCT02132949|11191684|FG000|Overall Study|Withdrew Prior to Treatment|1
7081626|NCT02132949|11191685|FG001|Overall Study|Withdrew Prior to Treatment|2
7081627|NCT02132949|11191684|FG000|Overall Study|Reason Unspecified|0
7081628|NCT02132949|11191685|FG001|Overall Study|Reason Unspecified|1
7081629|NCT02133001|11191693|FG000|Double Blind (Day 1-25)|Adverse Event|1
7081630|NCT02133001|11191694|FG001|Double Blind (Day 1-25)|Adverse Event|5
7081631|NCT02133001|11191693|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4
7081632|NCT02133001|11191694|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1
7081633|NCT02133001|11191693|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2
7081634|NCT02133001|11191694|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0
7081635|NCT02133001|11191693|FG000|Double Blind (Day 1-25)|Other|2
7081636|NCT02133001|11191694|FG001|Double Blind (Day 1-25)|Other|2
7081637|NCT02133001|11191693|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1
7081638|NCT02133001|11191694|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1
7081639|NCT02133001|11191693|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1
7081640|NCT02133001|11191694|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1
7081641|NCT02133001|11191693|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1
7182059|NCT00644228|11382545|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0
6973402|NCT01180790|11025114|FG000|Overall Study|compliance|0
6973403|NCT01180790|11025115|FG001|Overall Study|compliance|1
6973404|NCT01180790|11025116|FG002|Overall Study|compliance|0
6973405|NCT01180790|11025117|FG003|Overall Study|compliance|0
6973406|NCT01180790|11025118|FG004|Overall Study|compliance|0
6973407|NCT01180790|11025119|FG005|Overall Study|compliance|0
6973408|NCT01180790|11025120|FG006|Overall Study|compliance|0
6973409|NCT01180790|11025114|FG000|Overall Study|Severe coronary atherosclerosis (death)|0
6973410|NCT01180790|11025115|FG001|Overall Study|Severe coronary atherosclerosis (death)|0
6973411|NCT01180790|11025116|FG002|Overall Study|Severe coronary atherosclerosis (death)|1
6973412|NCT01180790|11025117|FG003|Overall Study|Severe coronary atherosclerosis (death)|0
6973413|NCT01180790|11025118|FG004|Overall Study|Severe coronary atherosclerosis (death)|0
6973414|NCT01180790|11025119|FG005|Overall Study|Severe coronary atherosclerosis (death)|0
6973415|NCT01180790|11025120|FG006|Overall Study|Severe coronary atherosclerosis (death)|0
6973416|NCT01180985|11025175|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1
6973417|NCT01180985|11025176|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0
6973418|NCT01180998|11025186|FG000|Overall Study|Poor Vision|0
6973419|NCT01180998|11025187|FG001|Overall Study|Poor Vision|2
6973420|NCT01180998|11025188|FG002|Overall Study|Poor Vision|2
6973421|NCT01180998|11025186|FG000|Overall Study|Lost to Follow-up|0
6973422|NCT01180998|11025187|FG001|Overall Study|Lost to Follow-up|0
6973423|NCT01180998|11025188|FG002|Overall Study|Lost to Follow-up|1
6973424|NCT01180998|11025186|FG000|Overall Study|Protocol Violation|1
6973425|NCT01180998|11025187|FG001|Overall Study|Protocol Violation|2
6973426|NCT01180998|11025188|FG002|Overall Study|Protocol Violation|0
6973427|NCT01180998|11025186|FG000|Overall Study|Withdrawal by Subject|0
7081642|NCT02133001|11191694|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1
7081643|NCT02133001|11191693|FG000|Follow-Up Phase (Day 26-81)|Other|0
7182060|NCT00644228|11382544|FG000|Randomization & Eligibility|Invalid Consent|0
7182061|NCT00644228|11382545|FG001|Randomization & Eligibility|Invalid Consent|1
7182062|NCT00644228|11382544|FG000|Induction Therapy|Adverse Event|22
7182063|NCT00644228|11382545|FG001|Induction Therapy|Adverse Event|55
7182064|NCT00644228|11382544|FG000|Induction Therapy|Withdrawal by Subject|10
7182065|NCT00644228|11382545|FG001|Induction Therapy|Withdrawal by Subject|3
7182066|NCT00644228|11382544|FG000|Induction Therapy|Progression/Relapse|24
7182067|NCT00644228|11382545|FG001|Induction Therapy|Progression/Relapse|12
7182068|NCT00644228|11382544|FG000|Induction Therapy|Death|3
7182069|NCT00644228|11382545|FG001|Induction Therapy|Death|7
7182070|NCT00644228|11382544|FG000|Induction Therapy|Not Protocol-Specified|24
7182071|NCT00644228|11382545|FG001|Induction Therapy|Not Protocol-Specified|28
7182072|NCT00644228|11382544|FG000|Maintenance|Adverse Event|27
7182073|NCT00644228|11382545|FG001|Maintenance|Adverse Event|31
7182074|NCT00644228|11382544|FG000|Maintenance|Withdrawal by Subject|6
7182075|NCT00644228|11382545|FG001|Maintenance|Withdrawal by Subject|4
7182076|NCT00644228|11382544|FG000|Maintenance|Progression/Relapse|67
7182077|NCT00644228|11382545|FG001|Maintenance|Progression/Relapse|42
7182078|NCT00644228|11382544|FG000|Maintenance|Death|3
7182079|NCT00644228|11382545|FG001|Maintenance|Death|3
7182080|NCT00644228|11382544|FG000|Maintenance|Not Protocol-Specified|14
7182081|NCT00644228|11382545|FG001|Maintenance|Not Protocol-Specified|15
7182082|NCT00644228|11382544|FG000|Maintenance|On Treatment|26
7182083|NCT00644228|11382545|FG001|Maintenance|On Treatment|40
7182084|NCT00602641|11382553|FG000|Overall Study|Never started protocol therapy|6
6973428|NCT01180998|11025187|FG001|Overall Study|Withdrawal by Subject|0
7182085|NCT00602641|11382554|FG001|Overall Study|Never started protocol therapy|2
7182086|NCT00602641|11382553|FG000|Overall Study|Still on treatment at time of analysis|8
7182087|NCT00602641|11382554|FG001|Overall Study|Still on treatment at time of analysis|15
6973429|NCT01180998|11025188|FG002|Overall Study|Withdrawal by Subject|1
6973430|NCT01180998|11025186|FG000|Overall Study|Poor comfort|3
6973431|NCT01180998|11025187|FG001|Overall Study|Poor comfort|0
6973432|NCT01180998|11025188|FG002|Overall Study|Poor comfort|4
7081644|NCT02133001|11191694|FG001|Follow-Up Phase (Day 26-81)|Other|1
7081645|NCT02133131|11191718|FG000|Overall Study|Adverse Event|0
7081646|NCT02133131|11191719|FG001|Overall Study|Adverse Event|0
7081647|NCT02133131|11191720|FG002|Overall Study|Adverse Event|0
7081648|NCT02133131|11191721|FG003|Overall Study|Adverse Event|1
7081649|NCT02133131|11191722|FG004|Overall Study|Adverse Event|0
7081650|NCT02133131|11191723|FG005|Overall Study|Adverse Event|0
7081651|NCT02133131|11191724|FG006|Overall Study|Adverse Event|0
7081652|NCT02133131|11191718|FG000|Overall Study|Lost to Follow-up|1
7081653|NCT02133131|11191719|FG001|Overall Study|Lost to Follow-up|0
7081654|NCT02133131|11191720|FG002|Overall Study|Lost to Follow-up|0
7081655|NCT02133131|11191721|FG003|Overall Study|Lost to Follow-up|1
7081656|NCT02133131|11191722|FG004|Overall Study|Lost to Follow-up|0
7081657|NCT02133131|11191723|FG005|Overall Study|Lost to Follow-up|0
7081658|NCT02133131|11191724|FG006|Overall Study|Lost to Follow-up|0
7081659|NCT02133131|11191718|FG000|Overall Study|Status not recorded|4
7081660|NCT02133131|11191719|FG001|Overall Study|Status not recorded|5
7081661|NCT02133131|11191720|FG002|Overall Study|Status not recorded|1
7081662|NCT02133131|11191721|FG003|Overall Study|Status not recorded|4
7081663|NCT02133131|11191722|FG004|Overall Study|Status not recorded|0
7081664|NCT02133131|11191723|FG005|Overall Study|Status not recorded|0
7081665|NCT02133131|11191724|FG006|Overall Study|Status not recorded|0
7081666|NCT02133131|11191718|FG000|Overall Study|Ongoing in study|0
7081667|NCT02133131|11191719|FG001|Overall Study|Ongoing in study|0
7081668|NCT02133131|11191720|FG002|Overall Study|Ongoing in study|0
7081669|NCT02133131|11191721|FG003|Overall Study|Ongoing in study|0
7081670|NCT02133131|11191722|FG004|Overall Study|Ongoing in study|15
7081671|NCT02133131|11191723|FG005|Overall Study|Ongoing in study|14
7081672|NCT02133131|11191724|FG006|Overall Study|Ongoing in study|11
7081673|NCT02133131|11191718|FG000|Overall Study|Protocol Violation|0
7081674|NCT02133131|11191719|FG001|Overall Study|Protocol Violation|0
7081675|NCT02133131|11191720|FG002|Overall Study|Protocol Violation|0
7081676|NCT02133131|11191721|FG003|Overall Study|Protocol Violation|0
7081677|NCT02133131|11191722|FG004|Overall Study|Protocol Violation|0
7081678|NCT02133131|11191723|FG005|Overall Study|Protocol Violation|0
7081679|NCT02133131|11191724|FG006|Overall Study|Protocol Violation|1
7081680|NCT02133352|11191755|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6
7081681|NCT02133508|11191759|FG000|Overall Study|Decision of Investigator or Sponsor|1
7081682|NCT02133508|11191759|FG000|Overall Study|Death|12
7081683|NCT02133508|11191759|FG000|Overall Study|Lost to Follow-up|2
7081684|NCT02133664|11191765|FG000|Overall Study|Lost to Follow-up|2
7081685|NCT02133664|11191766|FG001|Overall Study|Lost to Follow-up|1
7182088|NCT00602641|11382553|FG000|Overall Study|Adverse Event|62
7182089|NCT00602641|11382554|FG001|Overall Study|Adverse Event|53
7182090|NCT00602641|11382553|FG000|Overall Study|Disease progression|38
7182091|NCT00602641|11382554|FG001|Overall Study|Disease progression|55
7182092|NCT00602641|11382553|FG000|Overall Study|Death|6
7182093|NCT00602641|11382554|FG001|Overall Study|Death|5
7182094|NCT00602641|11382553|FG000|Overall Study|Withdrawal by Subject|15
7182095|NCT00602641|11382554|FG001|Overall Study|Withdrawal by Subject|12
7182096|NCT00602641|11382553|FG000|Overall Study|Alternative therapy|5
7182097|NCT00602641|11382554|FG001|Overall Study|Alternative therapy|2
7182098|NCT00602641|11382553|FG000|Overall Study|Other Complicating Disease|5
7182099|NCT00602641|11382554|FG001|Overall Study|Other Complicating Disease|2
7182100|NCT00602641|11382553|FG000|Overall Study|Physician Decision|5
7182101|NCT00602641|11382554|FG001|Overall Study|Physician Decision|4
7182102|NCT00602641|11382553|FG000|Overall Study|Administrative Closure|1
7182103|NCT00602641|11382554|FG001|Overall Study|Administrative Closure|1
7182104|NCT00602641|11382553|FG000|Overall Study|Other|3
7182105|NCT00602641|11382554|FG001|Overall Study|Other|1
7182106|NCT00408005|11382562|FG000|Induction|Adverse Event|19
7182107|NCT00408005|11382563|FG001|Induction|Adverse Event|3
7182108|NCT00408005|11382564|FG002|Induction|Adverse Event|0
7182109|NCT00408005|11382565|FG003|Induction|Adverse Event|0
7182110|NCT00408005|11382566|FG004|Induction|Adverse Event|0
7182111|NCT00408005|11382567|FG005|Induction|Adverse Event|0
7182112|NCT00408005|11382568|FG006|Induction|Adverse Event|0
7182113|NCT00408005|11382569|FG007|Induction|Adverse Event|0
7182114|NCT00408005|11382562|FG000|Induction|Death|6
7182115|NCT00408005|11382563|FG001|Induction|Death|0
7182116|NCT00408005|11382564|FG002|Induction|Death|0
7182117|NCT00408005|11382565|FG003|Induction|Death|0
7182118|NCT00408005|11382566|FG004|Induction|Death|0
7182119|NCT00408005|11382567|FG005|Induction|Death|0
7182120|NCT00408005|11382568|FG006|Induction|Death|0
7182121|NCT00408005|11382569|FG007|Induction|Death|0
7182122|NCT00408005|11382562|FG000|Induction|Physician Decision|83
7182123|NCT00408005|11382563|FG001|Induction|Physician Decision|9
7182124|NCT00408005|11382564|FG002|Induction|Physician Decision|0
7182125|NCT00408005|11382565|FG003|Induction|Physician Decision|0
7182126|NCT00408005|11382566|FG004|Induction|Physician Decision|0
7182127|NCT00408005|11382567|FG005|Induction|Physician Decision|0
7081686|NCT02133664|11191765|FG000|Overall Study|Adverse Event|3
7081687|NCT02133664|11191766|FG001|Overall Study|Adverse Event|6
7182128|NCT00408005|11382568|FG006|Induction|Physician Decision|0
7182129|NCT00408005|11382569|FG007|Induction|Physician Decision|0
7182130|NCT00408005|11382562|FG000|Induction|Withdrawal by Subject|2
7182131|NCT00408005|11382563|FG001|Induction|Withdrawal by Subject|4
7182132|NCT00408005|11382564|FG002|Induction|Withdrawal by Subject|0
7182133|NCT00408005|11382565|FG003|Induction|Withdrawal by Subject|0
7182134|NCT00408005|11382566|FG004|Induction|Withdrawal by Subject|0
7182135|NCT00408005|11382567|FG005|Induction|Withdrawal by Subject|0
7182136|NCT00408005|11382568|FG006|Induction|Withdrawal by Subject|0
7182137|NCT00408005|11382569|FG007|Induction|Withdrawal by Subject|0
7182138|NCT00408005|11382562|FG000|Induction|Ineligible|33
7182139|NCT00408005|11382563|FG001|Induction|Ineligible|14
7182140|NCT00408005|11382564|FG002|Induction|Ineligible|0
7182141|NCT00408005|11382565|FG003|Induction|Ineligible|0
7182142|NCT00408005|11382566|FG004|Induction|Ineligible|0
7182143|NCT00408005|11382567|FG005|Induction|Ineligible|0
7182144|NCT00408005|11382568|FG006|Induction|Ineligible|0
7182145|NCT00408005|11382569|FG007|Induction|Ineligible|0
7182146|NCT00408005|11382562|FG000|Induction|Refusal of Further Protocol Therapy|225
7182147|NCT00408005|11382563|FG001|Induction|Refusal of Further Protocol Therapy|44
7182148|NCT00408005|11382564|FG002|Induction|Refusal of Further Protocol Therapy|0
7182149|NCT00408005|11382565|FG003|Induction|Refusal of Further Protocol Therapy|0
7182150|NCT00408005|11382566|FG004|Induction|Refusal of Further Protocol Therapy|0
7182151|NCT00408005|11382567|FG005|Induction|Refusal of Further Protocol Therapy|0
7182152|NCT00408005|11382568|FG006|Induction|Refusal of Further Protocol Therapy|0
7182153|NCT00408005|11382569|FG007|Induction|Refusal of Further Protocol Therapy|0
7182154|NCT00408005|11382562|FG000|Induction|Entered another COG therapeutic protocol|4
7182155|NCT00408005|11382563|FG001|Induction|Entered another COG therapeutic protocol|0
7182156|NCT00408005|11382564|FG002|Induction|Entered another COG therapeutic protocol|0
7182157|NCT00408005|11382565|FG003|Induction|Entered another COG therapeutic protocol|0
7182158|NCT00408005|11382566|FG004|Induction|Entered another COG therapeutic protocol|0
7182159|NCT00408005|11382567|FG005|Induction|Entered another COG therapeutic protocol|0
6973433|NCT01180998|11025186|FG000|Overall Study|Poor lens handling|0
7182160|NCT00408005|11382568|FG006|Induction|Entered another COG therapeutic protocol|0
7182161|NCT00408005|11382569|FG007|Induction|Entered another COG therapeutic protocol|0
7182162|NCT00408005|11382562|FG000|Induction|Patient transferred Tx to Non-COG Site|3
7182163|NCT00408005|11382563|FG001|Induction|Patient transferred Tx to Non-COG Site|2
7182164|NCT00408005|11382564|FG002|Induction|Patient transferred Tx to Non-COG Site|0
7182165|NCT00408005|11382565|FG003|Induction|Patient transferred Tx to Non-COG Site|0
7182166|NCT00408005|11382566|FG004|Induction|Patient transferred Tx to Non-COG Site|0
7182167|NCT00408005|11382567|FG005|Induction|Patient transferred Tx to Non-COG Site|0
7182168|NCT00408005|11382568|FG006|Induction|Patient transferred Tx to Non-COG Site|0
7182169|NCT00408005|11382569|FG007|Induction|Patient transferred Tx to Non-COG Site|0
7182170|NCT00408005|11382562|FG000|Induction|Identified as Philadelphia Chr. Positive|6
7182171|NCT00408005|11382563|FG001|Induction|Identified as Philadelphia Chr. Positive|0
7182172|NCT00408005|11382564|FG002|Induction|Identified as Philadelphia Chr. Positive|0
7182173|NCT00408005|11382565|FG003|Induction|Identified as Philadelphia Chr. Positive|0
7182174|NCT00408005|11382566|FG004|Induction|Identified as Philadelphia Chr. Positive|0
6973434|NCT01180998|11025187|FG001|Overall Study|Poor lens handling|0
6973435|NCT01180998|11025188|FG002|Overall Study|Poor lens handling|2
6973436|NCT01181011|11025197|FG000|Overall Study|Adverse Event|2
6973437|NCT01181011|11025197|FG000|Overall Study|Lost to Follow-up|1
7182175|NCT00408005|11382567|FG005|Induction|Identified as Philadelphia Chr. Positive|0
6973438|NCT01181102|11025226|FG000|Overall Study|Adverse Event|28
7182176|NCT00408005|11382568|FG006|Induction|Identified as Philadelphia Chr. Positive|0
7182177|NCT00408005|11382569|FG007|Induction|Identified as Philadelphia Chr. Positive|0
7182178|NCT00408005|11382562|FG000|Induction|Progressive Disease|0
7182179|NCT00408005|11382563|FG001|Induction|Progressive Disease|1
7182180|NCT00408005|11382564|FG002|Induction|Progressive Disease|0
7182181|NCT00408005|11382565|FG003|Induction|Progressive Disease|0
7182182|NCT00408005|11382566|FG004|Induction|Progressive Disease|0
7182183|NCT00408005|11382567|FG005|Induction|Progressive Disease|0
7182184|NCT00408005|11382568|FG006|Induction|Progressive Disease|0
7182185|NCT00408005|11382569|FG007|Induction|Progressive Disease|0
7182186|NCT00408005|11382562|FG000|Induction|Inevaluable|18
7182187|NCT00408005|11382563|FG001|Induction|Inevaluable|14
7182188|NCT00408005|11382564|FG002|Induction|Inevaluable|0
7182189|NCT00408005|11382565|FG003|Induction|Inevaluable|0
7182190|NCT00408005|11382566|FG004|Induction|Inevaluable|0
7182191|NCT00408005|11382567|FG005|Induction|Inevaluable|0
7182192|NCT00408005|11382568|FG006|Induction|Inevaluable|0
7182193|NCT00408005|11382569|FG007|Induction|Inevaluable|0
7182194|NCT00408005|11382562|FG000|Induction|Failed to Complete Randomization|3
7182195|NCT00408005|11382563|FG001|Induction|Failed to Complete Randomization|2
7182196|NCT00408005|11382564|FG002|Induction|Failed to Complete Randomization|0
7182197|NCT00408005|11382565|FG003|Induction|Failed to Complete Randomization|0
7182198|NCT00408005|11382566|FG004|Induction|Failed to Complete Randomization|0
7182199|NCT00408005|11382567|FG005|Induction|Failed to Complete Randomization|0
7182200|NCT00408005|11382568|FG006|Induction|Failed to Complete Randomization|0
7182201|NCT00408005|11382569|FG007|Induction|Failed to Complete Randomization|0
7182202|NCT00408005|11382562|FG000|Induction|Protocol Deviation|3
7182203|NCT00408005|11382563|FG001|Induction|Protocol Deviation|1
7182204|NCT00408005|11382564|FG002|Induction|Protocol Deviation|0
7182205|NCT00408005|11382565|FG003|Induction|Protocol Deviation|0
7182206|NCT00408005|11382566|FG004|Induction|Protocol Deviation|0
7182207|NCT00408005|11382567|FG005|Induction|Protocol Deviation|0
7182208|NCT00408005|11382568|FG006|Induction|Protocol Deviation|0
7182209|NCT00408005|11382569|FG007|Induction|Protocol Deviation|0
7182210|NCT00408005|11382562|FG000|Induction|Hematopoietic Stem Cell Transplantation|1
7182211|NCT00408005|11382563|FG001|Induction|Hematopoietic Stem Cell Transplantation|0
7182212|NCT00408005|11382564|FG002|Induction|Hematopoietic Stem Cell Transplantation|0
7182213|NCT00408005|11382565|FG003|Induction|Hematopoietic Stem Cell Transplantation|0
7182214|NCT00408005|11382566|FG004|Induction|Hematopoietic Stem Cell Transplantation|0
7182215|NCT00408005|11382567|FG005|Induction|Hematopoietic Stem Cell Transplantation|0
7182216|NCT00408005|11382568|FG006|Induction|Hematopoietic Stem Cell Transplantation|0
7182217|NCT00408005|11382569|FG007|Induction|Hematopoietic Stem Cell Transplantation|0
7182218|NCT00408005|11382562|FG000|Induction|Recurrent leukemia|1
7182219|NCT00408005|11382563|FG001|Induction|Recurrent leukemia|0
7182220|NCT00408005|11382564|FG002|Induction|Recurrent leukemia|0
7182221|NCT00408005|11382565|FG003|Induction|Recurrent leukemia|0
7182222|NCT00408005|11382566|FG004|Induction|Recurrent leukemia|0
7182223|NCT00408005|11382567|FG005|Induction|Recurrent leukemia|0
7182224|NCT00408005|11382568|FG006|Induction|Recurrent leukemia|0
7182225|NCT00408005|11382569|FG007|Induction|Recurrent leukemia|0
7182226|NCT00408005|11382562|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0
7182227|NCT00408005|11382563|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0
7182228|NCT00408005|11382564|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7
7182229|NCT00408005|11382565|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4
7182230|NCT00408005|11382566|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8
7182231|NCT00408005|11382567|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12
7182232|NCT00408005|11382568|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2
7182233|NCT00408005|11382569|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0
7182234|NCT00408005|11382562|FG000|Post Induction Therapy by Tx Assignment|Death|0
7182235|NCT00408005|11382563|FG001|Post Induction Therapy by Tx Assignment|Death|0
7182236|NCT00408005|11382564|FG002|Post Induction Therapy by Tx Assignment|Death|3
7182237|NCT00408005|11382565|FG003|Post Induction Therapy by Tx Assignment|Death|0
7182238|NCT00408005|11382566|FG004|Post Induction Therapy by Tx Assignment|Death|5
7182239|NCT00408005|11382567|FG005|Post Induction Therapy by Tx Assignment|Death|5
7182240|NCT00408005|11382568|FG006|Post Induction Therapy by Tx Assignment|Death|3
7182241|NCT00408005|11382569|FG007|Post Induction Therapy by Tx Assignment|Death|1
7182242|NCT00408005|11382562|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
7182243|NCT00408005|11382563|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
7182244|NCT00408005|11382564|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2
7182245|NCT00408005|11382565|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
7182246|NCT00408005|11382566|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1
7182247|NCT00408005|11382567|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
7182248|NCT00408005|11382568|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
7182249|NCT00408005|11382569|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
7182250|NCT00408005|11382562|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0
7182251|NCT00408005|11382563|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0
7182252|NCT00408005|11382564|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24
7182253|NCT00408005|11382565|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19
7182254|NCT00408005|11382566|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27
7182255|NCT00408005|11382567|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45
7182256|NCT00408005|11382568|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10
7182257|NCT00408005|11382569|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4
7182258|NCT00408005|11382562|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
7182259|NCT00408005|11382563|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
7182260|NCT00408005|11382564|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1
7182261|NCT00408005|11382565|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1
7182262|NCT00408005|11382566|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
7182263|NCT00408005|11382567|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2
7182264|NCT00408005|11382568|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
7182265|NCT00408005|11382569|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
7182266|NCT00408005|11382562|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0
7182267|NCT00408005|11382563|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0
7182268|NCT00408005|11382564|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27
7182269|NCT00408005|11382565|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10
7182270|NCT00408005|11382566|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36
7182271|NCT00408005|11382567|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16
7182272|NCT00408005|11382568|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4
7182273|NCT00408005|11382569|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2
7182274|NCT00408005|11382562|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
7182275|NCT00408005|11382563|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
7182276|NCT00408005|11382564|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
7182277|NCT00408005|11382565|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
7182278|NCT00408005|11382566|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1
7182279|NCT00408005|11382567|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
7182280|NCT00408005|11382568|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
7182281|NCT00408005|11382569|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
7182282|NCT00408005|11382562|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
7182283|NCT00408005|11382563|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
7182284|NCT00408005|11382564|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3
7182285|NCT00408005|11382565|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
7182286|NCT00408005|11382566|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
7182287|NCT00408005|11382567|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
7182288|NCT00408005|11382568|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
7182289|NCT00408005|11382569|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
7182290|NCT00408005|11382562|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0
7182291|NCT00408005|11382563|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0
7182292|NCT00408005|11382564|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0
7182293|NCT00408005|11382565|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0
7182294|NCT00408005|11382566|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1
7182295|NCT00408005|11382567|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0
7182296|NCT00408005|11382568|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7
7182297|NCT00408005|11382569|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7
7182298|NCT00408005|11382562|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0
7182299|NCT00408005|11382563|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0
7182300|NCT00408005|11382564|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0
7182301|NCT00408005|11382565|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0
7182302|NCT00408005|11382566|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0
7182303|NCT00408005|11382567|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1
7182304|NCT00408005|11382568|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0
7182305|NCT00408005|11382569|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0
7182306|NCT00408005|11382562|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
7182307|NCT00408005|11382563|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
6896299|NCT00631969|10914594|FG000|Overall Study|Consent Withdrawn|5
6896300|NCT00631969|10914595|FG001|Overall Study|Consent Withdrawn|7
6896301|NCT00631969|10914594|FG000|Overall Study|Noncompliant With Study Medication|0
6896302|NCT00631969|10914595|FG001|Overall Study|Noncompliant With Study Medication|1
7041660|NCT01728584|11125235|FG001|Overall Study|Screen failure|0
7041661|NCT01728584|11125236|FG002|Overall Study|Screen failure|0
7041662|NCT01728584|11125237|FG003|Overall Study|Screen failure|0
7041663|NCT01728584|11125234|FG000|Overall Study|Other reason (not specified)|1
7041664|NCT01728584|11125235|FG001|Overall Study|Other reason (not specified)|0
7041665|NCT01728584|11125236|FG002|Overall Study|Other reason (not specified)|0
7041666|NCT01728584|11125237|FG003|Overall Study|Other reason (not specified)|1
7041667|NCT01728623|11125254|FG000|Overall Study|Disease progression|26
7041668|NCT01728623|11125254|FG000|Overall Study|Adverse Event|1
7041669|NCT01728623|11125254|FG000|Overall Study|Withdrawal by Subject|1
7041670|NCT01728779|11125270|FG000|Overall Study|Withdrawal by Subject|1
7041671|NCT01728792|11125279|FG000|Overall Study|Withdrawal of Consent|1
7041672|NCT01728792|11125280|FG001|Overall Study|Withdrawal of Consent|1
7041673|NCT01728792|11125281|FG002|Overall Study|Withdrawal of Consent|0
7041674|NCT01728792|11125282|FG003|Overall Study|Withdrawal of Consent|1
7041675|NCT01728792|11125283|FG004|Overall Study|Withdrawal of Consent|0
7041676|NCT01728792|11125279|FG000|Overall Study|Lost to Follow-up|2
7041677|NCT01728792|11125280|FG001|Overall Study|Lost to Follow-up|1
7041678|NCT01728792|11125281|FG002|Overall Study|Lost to Follow-up|4
7041679|NCT01728792|11125282|FG003|Overall Study|Lost to Follow-up|2
7041680|NCT01728792|11125283|FG004|Overall Study|Lost to Follow-up|0
7041681|NCT01729026|11125325|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2
7041682|NCT01729026|11125326|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2
7041683|NCT01729026|11125325|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1
7041684|NCT01729026|11125326|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2
7041685|NCT01729039|11125337|FG000|Overall Study|disqualified|2
7041686|NCT01729039|11125338|FG001|Overall Study|disqualified|5
7041687|NCT01729039|11125337|FG000|Overall Study|Withdrawal by Subject|8
7041688|NCT01729039|11125338|FG001|Overall Study|Withdrawal by Subject|7
7041689|NCT01729156|11125350|FG000|Overall Study|Withdrawal by Subject|1
7041690|NCT01729156|11125351|FG001|Overall Study|Withdrawal by Subject|0
7041691|NCT01729156|11125352|FG002|Overall Study|Withdrawal by Subject|0
7041692|NCT01729208|11125363|FG000|Baseline|Physician Decision|5
7041693|NCT01729208|11125364|FG001|Baseline|Physician Decision|4
7041694|NCT01729208|11125363|FG000|12 Months Follow-up|Withdrawal by Subject|4
7041695|NCT01729208|11125364|FG001|12 Months Follow-up|Withdrawal by Subject|7
7041696|NCT01729208|11125363|FG000|12 Months Follow-up|Lost to Follow-up|3
7041697|NCT01729208|11125364|FG001|12 Months Follow-up|Lost to Follow-up|3
7041698|NCT01729208|11125363|FG000|24 Months Follow-up|Lost to Follow-up|3
7041699|NCT01729208|11125364|FG001|24 Months Follow-up|Lost to Follow-up|0
7041700|NCT01729208|11125363|FG000|36 Months Follow-up|Physician Decision|1
7041701|NCT01729208|11125364|FG001|36 Months Follow-up|Physician Decision|0
7041702|NCT01729208|11125363|FG000|36 Months Follow-up|Withdrawal by Subject|2
7041703|NCT01729208|11125364|FG001|36 Months Follow-up|Withdrawal by Subject|4
7041704|NCT01729559|11125400|FG000|Overall Study|Protocol Violation|31
7041705|NCT01729559|11125401|FG001|Overall Study|Protocol Violation|28
7041706|NCT01729728|11125419|FG000|Overall Study|Adverse Event|0
7041707|NCT01729728|11125420|FG001|Overall Study|Adverse Event|6
7041708|NCT01729728|11125421|FG002|Overall Study|Adverse Event|0
7041709|NCT01729728|11125419|FG000|Overall Study|Protocol Violation|1
7041710|NCT01729728|11125420|FG001|Overall Study|Protocol Violation|0
7041711|NCT01729728|11125421|FG002|Overall Study|Protocol Violation|1
7041712|NCT01729819|11125554|FG000|Overall Study|Adverse Event|2
7041713|NCT01729819|11125555|FG001|Overall Study|Adverse Event|4
7041714|NCT01729819|11125554|FG000|Overall Study|Lack of Efficacy|1
7041715|NCT01729819|11125555|FG001|Overall Study|Lack of Efficacy|0
7041716|NCT01729819|11125554|FG000|Overall Study|Lost to Follow-up|2
7041717|NCT01729819|11125555|FG001|Overall Study|Lost to Follow-up|0
7041718|NCT01729819|11125554|FG000|Overall Study|Other reason|1
7041719|NCT01729819|11125555|FG001|Overall Study|Other reason|0
7041720|NCT01729819|11125554|FG000|Overall Study|Protocol Violation|0
7041721|NCT01729819|11125555|FG001|Overall Study|Protocol Violation|1
7041722|NCT01729819|11125554|FG000|Overall Study|Withdrawal by Subject|0
7041723|NCT01729819|11125555|FG001|Overall Study|Withdrawal by Subject|2
7041724|NCT01729871|11125581|FG000|Overall Study|Adverse Event|7
7041725|NCT01729871|11125582|FG001|Overall Study|Adverse Event|7
7041726|NCT01729871|11125581|FG000|Overall Study|Death|0
7041727|NCT01729871|11125582|FG001|Overall Study|Death|1
7041728|NCT01729871|11125581|FG000|Overall Study|Lack of Efficacy|0
7041729|NCT01729871|11125582|FG001|Overall Study|Lack of Efficacy|1
7041730|NCT01729871|11125581|FG000|Overall Study|Physician Decision|0
7041731|NCT01729871|11125582|FG001|Overall Study|Physician Decision|2
7041732|NCT01729871|11125581|FG000|Overall Study|Protocol Violation|1
7041733|NCT01729871|11125582|FG001|Overall Study|Protocol Violation|0
7041734|NCT01729871|11125581|FG000|Overall Study|Withdrawal by Subject|0
7182308|NCT00408005|11382564|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2
7182309|NCT00408005|11382565|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1
7182310|NCT00408005|11382566|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1
7182311|NCT00408005|11382567|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2
7182312|NCT00408005|11382568|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
7182313|NCT00408005|11382569|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
7182314|NCT00408005|11382562|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
7182315|NCT00408005|11382563|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
7182316|NCT00408005|11382564|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
7182317|NCT00408005|11382565|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
7182318|NCT00408005|11382566|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1
7182319|NCT00408005|11382567|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2
7182320|NCT00408005|11382568|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
7182321|NCT00408005|11382569|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
7182322|NCT00408005|11382562|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
7182323|NCT00408005|11382563|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
7182324|NCT00408005|11382564|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13
7182325|NCT00408005|11382565|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7
7182326|NCT00408005|11382566|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49
7182327|NCT00408005|11382567|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15
7182328|NCT00408005|11382568|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1
7182329|NCT00408005|11382569|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
7182330|NCT00408005|11382562|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0
7182331|NCT00408005|11382563|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0
7182332|NCT00408005|11382564|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3
7182333|NCT00408005|11382565|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1
7041735|NCT01729871|11125582|FG001|Overall Study|Withdrawal by Subject|3
7041736|NCT01729871|11125581|FG000|Overall Study|Other|4
7041737|NCT01729871|11125582|FG001|Overall Study|Other|9
7041738|NCT01730040|11125599|FG000|Overall Study|Randomized but not treated|0
7041739|NCT01730040|11125600|FG001|Overall Study|Randomized but not treated|0
7182334|NCT00408005|11382566|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1
7182335|NCT00408005|11382567|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1
7182336|NCT00408005|11382568|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0
7182337|NCT00408005|11382569|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0
7182338|NCT00378482|11382589|FG000|Overall Study|Lost to Follow-up|1
7182339|NCT00378482|11382589|FG000|Overall Study|Lack of Efficacy|8
7182340|NCT00378482|11382589|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9
7182341|NCT00378482|11382589|FG000|Overall Study|Withdrawal by Subject|4
7182342|NCT00378482|11382589|FG000|Overall Study|Adverse Event|9
7182343|NCT00316888|11382595|FG000|Overall Study|Adverse Event|4
7182344|NCT00316888|11382596|FG001|Overall Study|Adverse Event|5
7182345|NCT00316888|11382595|FG000|Overall Study|Withdrawal by Subject|2
7182346|NCT00316888|11382596|FG001|Overall Study|Withdrawal by Subject|2
7182347|NCT00316888|11382595|FG000|Overall Study|Not start protocol therapy|0
7182348|NCT00316888|11382596|FG001|Overall Study|Not start protocol therapy|1
7182349|NCT00098475|11382604|FG000|Step 1|Progressive disease|33
7182350|NCT00098475|11382605|FG001|Step 1|Progressive disease|35
7182351|NCT00098475|11382606|FG002|Step 1|Progressive disease|2
6896303|NCT00631969|10914594|FG000|Overall Study|No Drug Exposure|2
6896304|NCT00631969|10914595|FG001|Overall Study|No Drug Exposure|2
6896305|NCT00632021|10914605|FG000|Overall Study|Withdrawal/death|4
6896306|NCT00632021|10914606|FG001|Overall Study|Withdrawal/death|7
6896307|NCT00632099|10914615|FG000|Overall Study|Lost to Follow-up|3
6896308|NCT00632099|10914616|FG001|Overall Study|Lost to Follow-up|3
6896309|NCT00632125|10914622|FG000|Overall Study|Death|82
7182352|NCT00098475|11382607|FG003|Step 1|Progressive disease|1
7182353|NCT00098475|11382604|FG000|Step 1|Adverse Event|56
7182354|NCT00098475|11382605|FG001|Step 1|Adverse Event|37
7182355|NCT00098475|11382606|FG002|Step 1|Adverse Event|0
7182356|NCT00098475|11382607|FG003|Step 1|Adverse Event|1
7182357|NCT00098475|11382604|FG000|Step 1|Death|8
7182358|NCT00098475|11382605|FG001|Step 1|Death|5
7182359|NCT00098475|11382606|FG002|Step 1|Death|0
7182360|NCT00098475|11382607|FG003|Step 1|Death|1
7182361|NCT00098475|11382604|FG000|Step 1|Withdrawal by Subject|14
7182362|NCT00098475|11382605|FG001|Step 1|Withdrawal by Subject|11
7182363|NCT00098475|11382606|FG002|Step 1|Withdrawal by Subject|0
7182364|NCT00098475|11382607|FG003|Step 1|Withdrawal by Subject|0
7182365|NCT00098475|11382604|FG000|Step 1|Physician Decision|5
7182366|NCT00098475|11382605|FG001|Step 1|Physician Decision|2
7182367|NCT00098475|11382606|FG002|Step 1|Physician Decision|0
7182368|NCT00098475|11382607|FG003|Step 1|Physician Decision|0
7182369|NCT00098475|11382604|FG000|Step 1|Alternative therapy|31
7182370|NCT00098475|11382605|FG001|Step 1|Alternative therapy|43
7182371|NCT00098475|11382606|FG002|Step 1|Alternative therapy|1
7182372|NCT00098475|11382607|FG003|Step 1|Alternative therapy|0
7182373|NCT00098475|11382604|FG000|Step 1|Other disease|2
7182374|NCT00098475|11382605|FG001|Step 1|Other disease|1
7182375|NCT00098475|11382606|FG002|Step 1|Other disease|1
7182376|NCT00098475|11382607|FG003|Step 1|Other disease|0
7182377|NCT00098475|11382604|FG000|Step 1|Never started treatment|0
7182378|NCT00098475|11382605|FG001|Step 1|Never started treatment|2
7182379|NCT00098475|11382606|FG002|Step 1|Never started treatment|0
7182380|NCT00098475|11382607|FG003|Step 1|Never started treatment|0
7182381|NCT00098475|11382604|FG000|Step 1|Still on treatment as of this analysis|14
7182382|NCT00098475|11382605|FG001|Step 1|Still on treatment as of this analysis|27
7182383|NCT00098475|11382606|FG002|Step 1|Still on treatment as of this analysis|0
7182384|NCT00098475|11382607|FG003|Step 1|Still on treatment as of this analysis|0
7182385|NCT00098475|11382604|FG000|Step 1|Knee surgery|1
7182386|NCT00098475|11382605|FG001|Step 1|Knee surgery|0
7182387|NCT00098475|11382606|FG002|Step 1|Knee surgery|0
7182388|NCT00098475|11382607|FG003|Step 1|Knee surgery|0
7182389|NCT00098475|11382604|FG000|Step 1|Complications|1
7182390|NCT00098475|11382605|FG001|Step 1|Complications|0
7182391|NCT00098475|11382606|FG002|Step 1|Complications|0
7182392|NCT00098475|11382607|FG003|Step 1|Complications|0
7182393|NCT00098475|11382604|FG000|Step 1|Cannot comply due to other tx|0
7182394|NCT00098475|11382605|FG001|Step 1|Cannot comply due to other tx|1
7182395|NCT00098475|11382606|FG002|Step 1|Cannot comply due to other tx|0
7182396|NCT00098475|11382607|FG003|Step 1|Cannot comply due to other tx|0
7182397|NCT00098475|11382604|FG000|Step 1|Both patient and physician's decision|2
7182398|NCT00098475|11382605|FG001|Step 1|Both patient and physician's decision|1
7182399|NCT00098475|11382606|FG002|Step 1|Both patient and physician's decision|0
7182400|NCT00098475|11382607|FG003|Step 1|Both patient and physician's decision|0
7182401|NCT00098475|11382604|FG000|Step 1|Incorrect disease assessment|2
7182402|NCT00098475|11382605|FG001|Step 1|Incorrect disease assessment|0
7182403|NCT00098475|11382606|FG002|Step 1|Incorrect disease assessment|0
7182404|NCT00098475|11382607|FG003|Step 1|Incorrect disease assessment|0
7182405|NCT00098475|11382604|FG000|Step 1|Off treatment for > specified timeframe|1
7182406|NCT00098475|11382605|FG001|Step 1|Off treatment for > specified timeframe|1
7182407|NCT00098475|11382606|FG002|Step 1|Off treatment for > specified timeframe|0
7182408|NCT00098475|11382607|FG003|Step 1|Off treatment for > specified timeframe|0
7182409|NCT00098475|11382604|FG000|Step 1|Declining performance status|0
7182410|NCT00098475|11382605|FG001|Step 1|Declining performance status|1
7182411|NCT00098475|11382606|FG002|Step 1|Declining performance status|0
7182412|NCT00098475|11382607|FG003|Step 1|Declining performance status|0
7182413|NCT00098475|11382604|FG000|Step 1|Insurance issue|0
7182414|NCT00098475|11382605|FG001|Step 1|Insurance issue|1
7182415|NCT00098475|11382606|FG002|Step 1|Insurance issue|0
7182416|NCT00098475|11382607|FG003|Step 1|Insurance issue|0
7182417|NCT00098475|11382604|FG000|Step 1|Rising paraprotein|0
7182418|NCT00098475|11382605|FG001|Step 1|Rising paraprotein|1
7182419|NCT00098475|11382606|FG002|Step 1|Rising paraprotein|0
7182420|NCT00098475|11382607|FG003|Step 1|Rising paraprotein|0
7182421|NCT00098475|11382604|FG000|Step 1|Referred to other physicians|0
7182422|NCT00098475|11382605|FG001|Step 1|Referred to other physicians|1
7182423|NCT00098475|11382606|FG002|Step 1|Referred to other physicians|0
7182424|NCT00098475|11382607|FG003|Step 1|Referred to other physicians|0
7182425|NCT00098475|11382604|FG000|Step 1|Criteria to continue treatment not met|0
7182426|NCT00098475|11382605|FG001|Step 1|Criteria to continue treatment not met|1
7182427|NCT00098475|11382606|FG002|Step 1|Criteria to continue treatment not met|0
7182428|NCT00098475|11382607|FG003|Step 1|Criteria to continue treatment not met|0
7182429|NCT00098475|11382604|FG000|Step 1|Misinterpretation of lab data|0
7182430|NCT00098475|11382605|FG001|Step 1|Misinterpretation of lab data|1
7182431|NCT00098475|11382606|FG002|Step 1|Misinterpretation of lab data|0
7182432|NCT00098475|11382607|FG003|Step 1|Misinterpretation of lab data|0
7182433|NCT00098475|11382604|FG000|Step 1|Patient fell with fracture|1
7182434|NCT00098475|11382605|FG001|Step 1|Patient fell with fracture|0
7182435|NCT00098475|11382606|FG002|Step 1|Patient fell with fracture|0
7182436|NCT00098475|11382607|FG003|Step 1|Patient fell with fracture|0
7182437|NCT00098475|11382604|FG000|Step 1|Not documented|0
7182438|NCT00098475|11382605|FG001|Step 1|Not documented|1
7182439|NCT00098475|11382606|FG002|Step 1|Not documented|0
7182440|NCT00098475|11382607|FG003|Step 1|Not documented|0
7182441|NCT00098475|11382604|FG000|Step 2|Disease progression|1
7182442|NCT00098475|11382605|FG001|Step 2|Disease progression|4
7182443|NCT00098475|11382606|FG002|Step 2|Disease progression|0
7182444|NCT00098475|11382607|FG003|Step 2|Disease progression|0
7182445|NCT00098475|11382604|FG000|Step 2|Adverse Event|2
7182446|NCT00098475|11382605|FG001|Step 2|Adverse Event|0
7182447|NCT00098475|11382606|FG002|Step 2|Adverse Event|0
7182448|NCT00098475|11382607|FG003|Step 2|Adverse Event|0
7182449|NCT00098475|11382604|FG000|Step 2|Withdrawal by Subject|0
7182450|NCT00098475|11382605|FG001|Step 2|Withdrawal by Subject|2
7182451|NCT00098475|11382606|FG002|Step 2|Withdrawal by Subject|0
7182452|NCT00098475|11382607|FG003|Step 2|Withdrawal by Subject|0
7182453|NCT00098475|11382604|FG000|Step 2|Physician Decision|0
7182454|NCT00098475|11382605|FG001|Step 2|Physician Decision|1
7182455|NCT00098475|11382606|FG002|Step 2|Physician Decision|0
7182456|NCT00098475|11382607|FG003|Step 2|Physician Decision|0
7182457|NCT00098475|11382604|FG000|Step 2|Alternative therapy|1
7182458|NCT00098475|11382605|FG001|Step 2|Alternative therapy|2
7182459|NCT00098475|11382606|FG002|Step 2|Alternative therapy|0
7182460|NCT00098475|11382607|FG003|Step 2|Alternative therapy|0
7081688|NCT02133742|11191772|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2
7081689|NCT02133742|11191772|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31
7081690|NCT02133742|11191772|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13
7081691|NCT02133742|11191772|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5
7182461|NCT00098475|11382604|FG000|Step 2|Never started treatment|1
7182462|NCT00098475|11382605|FG001|Step 2|Never started treatment|1
7182463|NCT00098475|11382606|FG002|Step 2|Never started treatment|0
7182464|NCT00098475|11382607|FG003|Step 2|Never started treatment|0
7182465|NCT00070499|11382626|FG000|Overall Study|Adverse Event|6
7182466|NCT00070499|11382627|FG001|Overall Study|Adverse Event|6
7182467|NCT00070499|11382628|FG002|Overall Study|Adverse Event|19
7182468|NCT00070499|11382629|FG003|Overall Study|Adverse Event|15
7182469|NCT00070499|11382626|FG000|Overall Study|Refusal unrelated to adverse effects|7
7182470|NCT00070499|11382627|FG001|Overall Study|Refusal unrelated to adverse effects|5
7182471|NCT00070499|11382628|FG002|Overall Study|Refusal unrelated to adverse effects|5
7182472|NCT00070499|11382629|FG003|Overall Study|Refusal unrelated to adverse effects|8
7182473|NCT00070499|11382626|FG000|Overall Study|Progression/relapse|4
7182474|NCT00070499|11382627|FG001|Overall Study|Progression/relapse|2
7182475|NCT00070499|11382628|FG002|Overall Study|Progression/relapse|1
7182476|NCT00070499|11382629|FG003|Overall Study|Progression/relapse|4
7182477|NCT00070499|11382626|FG000|Overall Study|Death|1
7182478|NCT00070499|11382627|FG001|Overall Study|Death|1
7182479|NCT00070499|11382628|FG002|Overall Study|Death|1
7182480|NCT00070499|11382629|FG003|Overall Study|Death|2
7182481|NCT00070499|11382626|FG000|Overall Study|Other - not protocol specified|7
7182482|NCT00070499|11382627|FG001|Overall Study|Other - not protocol specified|3
7182483|NCT00070499|11382628|FG002|Overall Study|Other - not protocol specified|12
7182484|NCT00070499|11382629|FG003|Overall Study|Other - not protocol specified|20
7182485|NCT00070499|11382626|FG000|Overall Study|Still on protocol treatment|10
7182486|NCT00070499|11382627|FG001|Overall Study|Still on protocol treatment|4
7182487|NCT00070499|11382628|FG002|Overall Study|Still on protocol treatment|79
7182488|NCT00070499|11382629|FG003|Overall Study|Still on protocol treatment|57
7182489|NCT00070499|11382626|FG000|Overall Study|Did not start treatment|1
7182490|NCT00070499|11382627|FG001|Overall Study|Did not start treatment|0
7182491|NCT00070499|11382628|FG002|Overall Study|Did not start treatment|0
7182492|NCT00070499|11382629|FG003|Overall Study|Did not start treatment|2
7182493|NCT00070499|11382626|FG000|Overall Study|Not eligible|2
7182494|NCT00070499|11382627|FG001|Overall Study|Not eligible|5
7182495|NCT00070499|11382628|FG002|Overall Study|Not eligible|3
7182496|NCT00070499|11382629|FG003|Overall Study|Not eligible|2
7186964|NCT02786537|11387423|FG005|As Treated|Opiate dependency relapse|0
7186965|NCT02786537|11387418|FG000|As Treated|Drugs stolen from patient|0
7186966|NCT02786537|11387419|FG001|As Treated|Drugs stolen from patient|1
7186967|NCT02786537|11387420|FG002|As Treated|Drugs stolen from patient|0
7186968|NCT02786537|11387421|FG003|As Treated|Drugs stolen from patient|0
7186969|NCT02786537|11387422|FG004|As Treated|Drugs stolen from patient|0
7186970|NCT02786537|11387423|FG005|As Treated|Drugs stolen from patient|0
7186971|NCT02786537|11387418|FG000|As Treated|Advised to stop tx after loss of meds|0
7186972|NCT02786537|11387419|FG001|As Treated|Advised to stop tx after loss of meds|1
7186973|NCT02786537|11387420|FG002|As Treated|Advised to stop tx after loss of meds|0
7186974|NCT02786537|11387421|FG003|As Treated|Advised to stop tx after loss of meds|0
7186975|NCT02786537|11387422|FG004|As Treated|Advised to stop tx after loss of meds|0
7186976|NCT02786537|11387423|FG005|As Treated|Advised to stop tx after loss of meds|0
7186977|NCT02740231|11387533|FG000|Overall Study|Withdrawal by Subject|1
7186978|NCT02740231|11387534|FG001|Overall Study|Withdrawal by Subject|1
7186979|NCT02740231|11387535|FG002|Overall Study|Withdrawal by Subject|1
7186980|NCT02740231|11387536|FG003|Overall Study|Withdrawal by Subject|0
7186981|NCT02740231|11387533|FG000|Overall Study|Lack of Efficacy|0
7186982|NCT02740231|11387534|FG001|Overall Study|Lack of Efficacy|1
7186983|NCT02740231|11387535|FG002|Overall Study|Lack of Efficacy|0
7186984|NCT02740231|11387536|FG003|Overall Study|Lack of Efficacy|4
7186985|NCT02740231|11387533|FG000|Overall Study|Lost to Follow-up|1
7186986|NCT02740231|11387534|FG001|Overall Study|Lost to Follow-up|3
7186987|NCT02740231|11387535|FG002|Overall Study|Lost to Follow-up|0
7186988|NCT02740231|11387536|FG003|Overall Study|Lost to Follow-up|3
7186989|NCT02740231|11387533|FG000|Overall Study|Adverse Event|0
7186990|NCT02740231|11387534|FG001|Overall Study|Adverse Event|1
7186991|NCT02740231|11387535|FG002|Overall Study|Adverse Event|0
7186992|NCT02740231|11387536|FG003|Overall Study|Adverse Event|1
7186993|NCT02710084|11387548|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3
7186994|NCT02710084|11387549|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1
7186995|NCT02660034|11387570|FG000|Overall Study|Progressive Disease (Radiographic)|3
7186996|NCT02660034|11387571|FG001|Overall Study|Progressive Disease (Radiographic)|1
7186997|NCT02660034|11387572|FG002|Overall Study|Progressive Disease (Radiographic)|0
7186998|NCT02660034|11387573|FG003|Overall Study|Progressive Disease (Radiographic)|1
7186999|NCT02660034|11387574|FG004|Overall Study|Progressive Disease (Radiographic)|0
7187000|NCT02660034|11387575|FG005|Overall Study|Progressive Disease (Radiographic)|0
7187001|NCT02660034|11387576|FG006|Overall Study|Progressive Disease (Radiographic)|0
7187002|NCT02660034|11387577|FG007|Overall Study|Progressive Disease (Radiographic)|0
7187003|NCT02660034|11387578|FG008|Overall Study|Progressive Disease (Radiographic)|0
7187004|NCT02660034|11387579|FG009|Overall Study|Progressive Disease (Radiographic)|0
7187005|NCT02660034|11387580|FG010|Overall Study|Progressive Disease (Radiographic)|0
7187006|NCT02660034|11387581|FG011|Overall Study|Progressive Disease (Radiographic)|0
7187007|NCT02660034|11387582|FG012|Overall Study|Progressive Disease (Radiographic)|0
7187008|NCT02660034|11387583|FG013|Overall Study|Progressive Disease (Radiographic)|0
7187009|NCT02660034|11387570|FG000|Overall Study|Progressive Disease (Clinical)|7
7187010|NCT02660034|11387571|FG001|Overall Study|Progressive Disease (Clinical)|8
7187011|NCT02660034|11387572|FG002|Overall Study|Progressive Disease (Clinical)|3
7187012|NCT02660034|11387573|FG003|Overall Study|Progressive Disease (Clinical)|9
7187013|NCT02660034|11387574|FG004|Overall Study|Progressive Disease (Clinical)|3
7187014|NCT02660034|11387575|FG005|Overall Study|Progressive Disease (Clinical)|0
7187015|NCT02660034|11387576|FG006|Overall Study|Progressive Disease (Clinical)|0
7187016|NCT02660034|11387577|FG007|Overall Study|Progressive Disease (Clinical)|0
7187017|NCT02660034|11387578|FG008|Overall Study|Progressive Disease (Clinical)|0
7187018|NCT02660034|11387579|FG009|Overall Study|Progressive Disease (Clinical)|0
7187019|NCT02660034|11387580|FG010|Overall Study|Progressive Disease (Clinical)|0
7187020|NCT02660034|11387581|FG011|Overall Study|Progressive Disease (Clinical)|0
7187021|NCT02660034|11387582|FG012|Overall Study|Progressive Disease (Clinical)|0
7187022|NCT02660034|11387583|FG013|Overall Study|Progressive Disease (Clinical)|0
7081692|NCT02133742|11191772|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1
7081693|NCT02134015|11191793|FG000|Overall Study|Protocol Violation|0
7081694|NCT02134015|11191794|FG001|Overall Study|Protocol Violation|1
7081695|NCT02134015|11191793|FG000|Overall Study|Death|2
7182497|NCT03178487|11382649|FG000|Overall Study|Adverse Event|1
7182498|NCT03178487|11382650|FG001|Overall Study|Adverse Event|1
7182499|NCT03178487|11382649|FG000|Overall Study|Withdrawal by Subject|2
7182500|NCT03178487|11382650|FG001|Overall Study|Withdrawal by Subject|1
7182501|NCT03178487|11382649|FG000|Overall Study|Lost to Follow-up|1
7182502|NCT03178487|11382650|FG001|Overall Study|Lost to Follow-up|0
7182503|NCT03178487|11382649|FG000|Overall Study|Other|0
7182504|NCT03178487|11382650|FG001|Overall Study|Other|2
7182505|NCT03106779|11382663|FG000|Overall Study|Lack of Efficacy|33
7182506|NCT03106779|11382664|FG001|Overall Study|Lack of Efficacy|24
7182507|NCT03106779|11382663|FG000|Overall Study|Adverse Event|8
7182508|NCT03106779|11382664|FG001|Overall Study|Adverse Event|16
7182509|NCT03106779|11382663|FG000|Overall Study|Physician Decision|10
7182510|NCT03106779|11382664|FG001|Overall Study|Physician Decision|6
7182511|NCT03106779|11382663|FG000|Overall Study|Patient/guardian decision|4
7182512|NCT03106779|11382664|FG001|Overall Study|Patient/guardian decision|3
7182513|NCT03106779|11382663|FG000|Overall Study|Progressive disease|1
7081696|NCT02134015|11191794|FG001|Overall Study|Death|1
7081697|NCT02134015|11191793|FG000|Overall Study|Reason not provided|1
7081698|NCT02134015|11191794|FG001|Overall Study|Reason not provided|2
7081699|NCT02134015|11191793|FG000|Overall Study|Clinical progression|14
7081700|NCT02134015|11191794|FG001|Overall Study|Clinical progression|7
7081701|NCT02134015|11191793|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40
7081702|NCT02134015|11191794|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43
7081703|NCT02134015|11191793|FG000|Overall Study|Study terminated by sponsor|2
7081704|NCT02134015|11191794|FG001|Overall Study|Study terminated by sponsor|3
7081705|NCT02134015|11191793|FG000|Overall Study|Adverse Event|9
7081706|NCT02134015|11191794|FG001|Overall Study|Adverse Event|10
7081707|NCT02134015|11191793|FG000|Overall Study|Withdrawal by Subject|3
7081708|NCT02134015|11191794|FG001|Overall Study|Withdrawal by Subject|7
7081709|NCT02134353|11191843|FG000|Overall Study|Adverse Event|10
7182514|NCT03106779|11382664|FG001|Overall Study|Progressive disease|3
7182515|NCT03106779|11382663|FG000|Overall Study|Lost to Follow-up|1
7182516|NCT03106779|11382664|FG001|Overall Study|Lost to Follow-up|2
7182517|NCT03106779|11382663|FG000|Overall Study|Death|1
7182518|NCT03106779|11382664|FG001|Overall Study|Death|0
7182519|NCT03106779|11382663|FG000|Overall Study|Protocol Violation|1
7182520|NCT03106779|11382664|FG001|Overall Study|Protocol Violation|0
7182521|NCT03106779|11382663|FG000|Overall Study|Not treated|1
7182522|NCT03106779|11382664|FG001|Overall Study|Not treated|0
7182523|NCT03096834|11382672|FG000|Double-Blind Treatment Epoch|Protocol deviation|2
7182524|NCT03096834|11382673|FG001|Double-Blind Treatment Epoch|Protocol deviation|1
7182525|NCT03096834|11382674|FG002|Double-Blind Treatment Epoch|Protocol deviation|0
7182526|NCT03096834|11382675|FG003|Double-Blind Treatment Epoch|Protocol deviation|0
7182527|NCT03096834|11382672|FG000|Double-Blind Treatment Epoch|Pregnancy|0
7182528|NCT03096834|11382673|FG001|Double-Blind Treatment Epoch|Pregnancy|1
7182529|NCT03096834|11382674|FG002|Double-Blind Treatment Epoch|Pregnancy|0
7182530|NCT03096834|11382675|FG003|Double-Blind Treatment Epoch|Pregnancy|0
7182531|NCT03096834|11382672|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1
7182532|NCT03096834|11382673|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1
7182533|NCT03096834|11382674|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0
7182534|NCT03096834|11382675|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0
7182535|NCT03096834|11382672|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0
7182536|NCT03096834|11382673|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0
7182537|NCT03096834|11382674|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15
7182538|NCT03096834|11382675|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15
7182539|NCT03096834|11382672|FG000|Open-Label Treatment Epoch|Adverse Event|0
7182540|NCT03096834|11382673|FG001|Open-Label Treatment Epoch|Adverse Event|0
7182541|NCT03096834|11382674|FG002|Open-Label Treatment Epoch|Adverse Event|5
7182542|NCT03096834|11382675|FG003|Open-Label Treatment Epoch|Adverse Event|6
7182543|NCT03096834|11382672|FG000|Open-Label Treatment Epoch|New therapy for study indication|0
7182544|NCT03096834|11382673|FG001|Open-Label Treatment Epoch|New therapy for study indication|0
7182545|NCT03096834|11382674|FG002|Open-Label Treatment Epoch|New therapy for study indication|1
7182546|NCT03096834|11382675|FG003|Open-Label Treatment Epoch|New therapy for study indication|1
7182547|NCT03096834|11382672|FG000|Open-Label Treatment Epoch|Physician Decision|0
7182548|NCT03096834|11382673|FG001|Open-Label Treatment Epoch|Physician Decision|0
7182549|NCT03096834|11382674|FG002|Open-Label Treatment Epoch|Physician Decision|1
7182550|NCT03096834|11382675|FG003|Open-Label Treatment Epoch|Physician Decision|0
7182551|NCT03096834|11382672|FG000|Open-Label Treatment Epoch|Pregnancy|0
7182552|NCT03096834|11382673|FG001|Open-Label Treatment Epoch|Pregnancy|0
7182553|NCT03096834|11382674|FG002|Open-Label Treatment Epoch|Pregnancy|1
7182554|NCT03096834|11382675|FG003|Open-Label Treatment Epoch|Pregnancy|0
7182555|NCT03096834|11382672|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0
7182556|NCT03096834|11382673|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0
7182557|NCT03096834|11382674|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9
7182558|NCT03096834|11382675|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17
7182559|NCT03096834|11382672|FG000|Safety Follow-Up Epoch|New therapy for study indication|0
7182560|NCT03096834|11382673|FG001|Safety Follow-Up Epoch|New therapy for study indication|0
7081710|NCT02134353|11191844|FG001|Overall Study|Adverse Event|6
7081711|NCT02134353|11191843|FG000|Overall Study|Lost to Follow-up|1
7081712|NCT02134353|11191844|FG001|Overall Study|Lost to Follow-up|1
7081713|NCT02134353|11191843|FG000|Overall Study|Lack of Efficacy|2
7081714|NCT02134353|11191844|FG001|Overall Study|Lack of Efficacy|1
7081715|NCT02134353|11191843|FG000|Overall Study|Withdrawal by Subject|12
7081716|NCT02134353|11191844|FG001|Overall Study|Withdrawal by Subject|13
7081717|NCT02134353|11191843|FG000|Overall Study|Death|0
7081718|NCT02134353|11191844|FG001|Overall Study|Death|1
7182561|NCT03096834|11382674|FG002|Safety Follow-Up Epoch|New therapy for study indication|0
7182562|NCT03096834|11382675|FG003|Safety Follow-Up Epoch|New therapy for study indication|1
7182563|NCT03096834|11382672|FG000|Safety Follow-Up Epoch|Protocol deviation|0
7182564|NCT03096834|11382673|FG001|Safety Follow-Up Epoch|Protocol deviation|0
7182565|NCT03096834|11382674|FG002|Safety Follow-Up Epoch|Protocol deviation|0
7182566|NCT03096834|11382675|FG003|Safety Follow-Up Epoch|Protocol deviation|1
7182567|NCT03096834|11382672|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0
7182568|NCT03096834|11382673|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0
7182569|NCT03096834|11382674|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1
7182570|NCT03096834|11382675|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0
7182571|NCT03089853|11382686|FG000|Overall Study|Lost to Follow-up|2
7182572|NCT03089853|11382687|FG001|Overall Study|Lost to Follow-up|1
7182573|NCT03070392|11382695|FG000|Overall Study|Not Treated|7
7182574|NCT03070392|11382696|FG001|Overall Study|Not Treated|0
7182575|NCT03070392|11382697|FG002|Overall Study|Not Treated|3
7182576|NCT03070392|11382698|FG003|Overall Study|Not Treated|12
7182577|NCT03070392|11382695|FG000|Overall Study|Death|3
7182578|NCT03070392|11382696|FG001|Overall Study|Death|0
7182579|NCT03070392|11382697|FG002|Overall Study|Death|0
7182580|NCT03070392|11382698|FG003|Overall Study|Death|1
7182581|NCT03070392|11382695|FG000|Overall Study|Withdrawal by Subject|7
7182582|NCT03070392|11382696|FG001|Overall Study|Withdrawal by Subject|0
7182583|NCT03070392|11382697|FG002|Overall Study|Withdrawal by Subject|0
7182584|NCT03070392|11382698|FG003|Overall Study|Withdrawal by Subject|3
7182585|NCT03070392|11382695|FG000|Overall Study|Physician Decision|1
7182586|NCT03070392|11382696|FG001|Overall Study|Physician Decision|0
7081719|NCT02134353|11191843|FG000|Overall Study|Pregnancy|0
7182587|NCT03070392|11382697|FG002|Overall Study|Physician Decision|0
7182588|NCT03070392|11382698|FG003|Overall Study|Physician Decision|2
7182589|NCT03070392|11382695|FG000|Overall Study|Progressive Disease|154
6973439|NCT01181102|11025227|FG001|Overall Study|Adverse Event|26
7182590|NCT03070392|11382696|FG001|Overall Study|Progressive Disease|6
7182591|NCT03070392|11382697|FG002|Overall Study|Progressive Disease|2
7182592|NCT03070392|11382698|FG003|Overall Study|Progressive Disease|70
7182593|NCT03070392|11382695|FG000|Overall Study|Adverse Event|6
7182594|NCT03070392|11382696|FG001|Overall Study|Adverse Event|1
7182595|NCT03070392|11382697|FG002|Overall Study|Adverse Event|1
7182596|NCT03070392|11382698|FG003|Overall Study|Adverse Event|3
7182597|NCT03070392|11382695|FG000|Overall Study|Alternate anticancer treatment|1
7182598|NCT03070392|11382696|FG001|Overall Study|Alternate anticancer treatment|0
7182599|NCT03070392|11382697|FG002|Overall Study|Alternate anticancer treatment|0
7182600|NCT03070392|11382698|FG003|Overall Study|Alternate anticancer treatment|1
7182601|NCT03070392|11382695|FG000|Overall Study|Ongoing|73
7182602|NCT03070392|11382696|FG001|Overall Study|Ongoing|0
7182603|NCT03070392|11382697|FG002|Overall Study|Ongoing|0
7182604|NCT03070392|11382698|FG003|Overall Study|Ongoing|11
7182605|NCT03048578|11382706|FG000|Overall Study|Withdrawal by Subject|5
7182606|NCT03048578|11382707|FG001|Overall Study|Withdrawal by Subject|6
7182607|NCT03048578|11382706|FG000|Overall Study|Lost to Follow-up|22
7182608|NCT03048578|11382707|FG001|Overall Study|Lost to Follow-up|10
7182609|NCT03048578|11382706|FG000|Overall Study|Adverse Event|1
7182610|NCT03048578|11382707|FG001|Overall Study|Adverse Event|2
7182611|NCT03048578|11382706|FG000|Overall Study|Terminated|3
7182612|NCT03048578|11382707|FG001|Overall Study|Terminated|2
7182613|NCT03015194|11382713|FG000|Overall Study|Death|10
7182614|NCT03015194|11382713|FG000|Overall Study|Withdrawal by Subject|2
7182615|NCT03012815|11382720|FG000|Overall Study|Lost to Follow-up|1
7182616|NCT03012815|11382721|FG001|Overall Study|Lost to Follow-up|0
7182617|NCT03012815|11382720|FG000|Overall Study|Physician Decision|3
7182618|NCT03012815|11382721|FG001|Overall Study|Physician Decision|2
7182619|NCT03012815|11382720|FG000|Overall Study|Adverse Event|1
7182620|NCT03012815|11382721|FG001|Overall Study|Adverse Event|0
7182621|NCT03001011|11382730|FG000|Overall Study|Adverse Event|9
7182622|NCT03001011|11382731|FG001|Overall Study|Adverse Event|3
7182623|NCT03001011|11382730|FG000|Overall Study|Chronic kidney disease lead to dialysis|15
7182624|NCT03001011|11382731|FG001|Overall Study|Chronic kidney disease lead to dialysis|10
7182625|NCT03001011|11382730|FG000|Overall Study|Other than specified above|3
7182626|NCT03001011|11382731|FG001|Overall Study|Other than specified above|8
7182627|NCT02999633|11382738|FG000|Overall Study|Adverse Event|2
7182628|NCT02999633|11382738|FG000|Overall Study|Progressive disease|12
7182629|NCT02993757|11382744|FG000|Overall Study|Non compliance with the protocol|155
7182630|NCT02993757|11382745|FG001|Overall Study|Non compliance with the protocol|170
7182631|NCT02993757|11382744|FG000|Overall Study|Lost to Follow-up|1
7182632|NCT02993757|11382745|FG001|Overall Study|Lost to Follow-up|0
7182633|NCT02993757|11382744|FG000|Overall Study|Voluntary withdraw not due adverse event|8
7182634|NCT02993757|11382745|FG001|Overall Study|Voluntary withdraw not due adverse event|8
7182635|NCT02992418|11382753|FG000|Overall Study|Withdrawal by Subject|11
7182636|NCT02992418|11382754|FG001|Overall Study|Withdrawal by Subject|12
7182637|NCT02992418|11382753|FG000|Overall Study|Non-compliance with the protocol|308
7182638|NCT02992418|11382754|FG001|Overall Study|Non-compliance with the protocol|308
7182639|NCT02992418|11382753|FG000|Overall Study|Lost to Follow-up|27
7182640|NCT02992418|11382754|FG001|Overall Study|Lost to Follow-up|22
7182641|NCT02979535|11382762|FG000|Overall Study|Non compliance with the protocol|78
7182642|NCT02979535|11382763|FG001|Overall Study|Non compliance with the protocol|82
7182643|NCT02979535|11382762|FG000|Overall Study|Consent withdrawn by participant|11
7182644|NCT02979535|11382763|FG001|Overall Study|Consent withdrawn by participant|18
7182645|NCT02979535|11382762|FG000|Overall Study|Lost to Follow-up|6
7182646|NCT02979535|11382763|FG001|Overall Study|Lost to Follow-up|1
6896310|NCT00632125|10914622|FG000|Overall Study|Withdrawal by Subject|44
6896311|NCT00632125|10914622|FG000|Overall Study|Adverse Event|36
6896312|NCT00632125|10914622|FG000|Overall Study|Renal transplantation|17
6896313|NCT00632125|10914622|FG000|Overall Study|Need for systemic immunosuppressive medi|8
6896314|NCT00632125|10914622|FG000|Overall Study|Non-compliance|8
6896315|NCT00632125|10914622|FG000|Overall Study|Development of uncontrolled hypertension|5
6896316|NCT00632125|10914622|FG000|Overall Study|Moved to other dialysis unit, etc.|102
6896317|NCT00632203|10914628|FG000|Overall Study|Did not start study treatment|1
6896318|NCT00632203|10914629|FG001|Overall Study|Did not start study treatment|0
6896319|NCT00632229|10914637|FG000|Overall Study|Adverse Event|6
6896320|NCT00632229|10914638|FG001|Overall Study|Adverse Event|0
6896321|NCT00632229|10914637|FG000|Overall Study|Lost to Follow-up|0
7182647|NCT02978716|11382772|FG000|Overall Study|Death|25
7182648|NCT02978716|11382773|FG001|Overall Study|Death|13
7182649|NCT02978716|11382774|FG002|Overall Study|Death|20
7182650|NCT02978716|11382772|FG000|Overall Study|Lost to Follow-up|0
7182651|NCT02978716|11382773|FG001|Overall Study|Lost to Follow-up|0
7182652|NCT02978716|11382774|FG002|Overall Study|Lost to Follow-up|1
7182653|NCT02978716|11382772|FG000|Overall Study|Withdrawal by Subject|6
7182654|NCT02978716|11382773|FG001|Overall Study|Withdrawal by Subject|4
7182655|NCT02978716|11382774|FG002|Overall Study|Withdrawal by Subject|5
7182656|NCT02978716|11382772|FG000|Overall Study|Sponsor terminated|2
7182657|NCT02978716|11382773|FG001|Overall Study|Sponsor terminated|13
7182658|NCT02978716|11382774|FG002|Overall Study|Sponsor terminated|9
7182659|NCT02978716|11382772|FG000|Overall Study|Other|1
7182660|NCT02978716|11382773|FG001|Overall Study|Other|3
7182661|NCT02978716|11382774|FG002|Overall Study|Other|0
7182662|NCT02973321|11382789|FG000|Overall Study|Other than specified|0
7182663|NCT02973321|11382790|FG001|Overall Study|Other than specified|5
7182664|NCT02973321|11382791|FG002|Overall Study|Other than specified|3
7182665|NCT02973321|11382792|FG003|Overall Study|Other than specified|3
7182666|NCT02973321|11382793|FG004|Overall Study|Other than specified|1
7182667|NCT02973321|11382789|FG000|Overall Study|Lack of Efficacy|0
7182668|NCT02973321|11382790|FG001|Overall Study|Lack of Efficacy|0
6973440|NCT01181102|11025226|FG000|Overall Study|Lack of Efficacy|3
6973441|NCT01181102|11025227|FG001|Overall Study|Lack of Efficacy|1
6973442|NCT01181102|11025226|FG000|Overall Study|Lost to Follow-up|2
6973443|NCT01181102|11025227|FG001|Overall Study|Lost to Follow-up|0
6973444|NCT01181102|11025226|FG000|Overall Study|Physician Decision|3
7182669|NCT02973321|11382791|FG002|Overall Study|Lack of Efficacy|0
7182670|NCT02973321|11382792|FG003|Overall Study|Lack of Efficacy|0
7182671|NCT02973321|11382793|FG004|Overall Study|Lack of Efficacy|1
7182672|NCT02973321|11382789|FG000|Overall Study|Adverse Event|1
7182673|NCT02973321|11382790|FG001|Overall Study|Adverse Event|10
7182674|NCT02973321|11382791|FG002|Overall Study|Adverse Event|11
7182675|NCT02973321|11382792|FG003|Overall Study|Adverse Event|13
7182676|NCT02973321|11382793|FG004|Overall Study|Adverse Event|3
7182677|NCT02943785|11382808|FG000|Overall Study|Adverse Event|112
7182678|NCT02943785|11382809|FG001|Overall Study|Adverse Event|97
7182679|NCT02943785|11382808|FG000|Overall Study|Withdrawal by Subject|63
7182680|NCT02943785|11382809|FG001|Overall Study|Withdrawal by Subject|126
7182681|NCT02943785|11382808|FG000|Overall Study|Physician Decision|23
7182682|NCT02943785|11382809|FG001|Overall Study|Physician Decision|47
7182683|NCT02943785|11382808|FG000|Overall Study|Death|46
7182684|NCT02943785|11382809|FG001|Overall Study|Death|46
7182685|NCT02943785|11382808|FG000|Overall Study|Lost to Follow-up|1
7182686|NCT02943785|11382809|FG001|Overall Study|Lost to Follow-up|0
7182687|NCT02943785|11382808|FG000|Overall Study|Other|16
7182688|NCT02943785|11382809|FG001|Overall Study|Other|19
7182689|NCT02943785|11382808|FG000|Overall Study|Did not receive any study medication|21
7182690|NCT02943785|11382809|FG001|Overall Study|Did not receive any study medication|28
7187023|NCT02660034|11387570|FG000|Overall Study|Lost to Follow-up|0
7187024|NCT02660034|11387571|FG001|Overall Study|Lost to Follow-up|0
7187025|NCT02660034|11387572|FG002|Overall Study|Lost to Follow-up|1
7187026|NCT02660034|11387573|FG003|Overall Study|Lost to Follow-up|1
7187027|NCT02660034|11387574|FG004|Overall Study|Lost to Follow-up|0
7187028|NCT02660034|11387575|FG005|Overall Study|Lost to Follow-up|0
7187029|NCT02660034|11387576|FG006|Overall Study|Lost to Follow-up|0
7187030|NCT02660034|11387577|FG007|Overall Study|Lost to Follow-up|0
7187031|NCT02660034|11387578|FG008|Overall Study|Lost to Follow-up|0
7187032|NCT02660034|11387579|FG009|Overall Study|Lost to Follow-up|1
7187033|NCT02660034|11387580|FG010|Overall Study|Lost to Follow-up|1
7187034|NCT02660034|11387581|FG011|Overall Study|Lost to Follow-up|1
7187035|NCT02660034|11387582|FG012|Overall Study|Lost to Follow-up|0
7187036|NCT02660034|11387583|FG013|Overall Study|Lost to Follow-up|0
7187037|NCT02660034|11387570|FG000|Overall Study|Participant moved into special access scheme|1
7187038|NCT02660034|11387571|FG001|Overall Study|Participant moved into special access scheme|2
7187039|NCT02660034|11387572|FG002|Overall Study|Participant moved into special access scheme|0
7187040|NCT02660034|11387573|FG003|Overall Study|Participant moved into special access scheme|0
7187041|NCT02660034|11387574|FG004|Overall Study|Participant moved into special access scheme|0
7187042|NCT02660034|11387575|FG005|Overall Study|Participant moved into special access scheme|0
7187043|NCT02660034|11387576|FG006|Overall Study|Participant moved into special access scheme|0
7187044|NCT02660034|11387577|FG007|Overall Study|Participant moved into special access scheme|0
7187045|NCT02660034|11387578|FG008|Overall Study|Participant moved into special access scheme|0
7182691|NCT02923674|11382818|FG000|Overall Study|Clinic Closed Due to COVID-19|14
7182692|NCT02923674|11382819|FG001|Overall Study|Clinic Closed Due to COVID-19|11
7182693|NCT02923674|11382820|FG002|Overall Study|Clinic Closed Due to COVID-19|14
7182694|NCT02923674|11382818|FG000|Overall Study|Lost to Follow-up|7
7182695|NCT02923674|11382819|FG001|Overall Study|Lost to Follow-up|12
7182696|NCT02923674|11382820|FG002|Overall Study|Lost to Follow-up|7
7182697|NCT02923674|11382818|FG000|Overall Study|Problem with intervention|2
7182698|NCT02923674|11382819|FG001|Overall Study|Problem with intervention|2
7182699|NCT02923674|11382820|FG002|Overall Study|Problem with intervention|1
7182700|NCT02923674|11382818|FG000|Overall Study|Adverse Event|3
7182701|NCT02923674|11382819|FG001|Overall Study|Adverse Event|1
7182702|NCT02923674|11382820|FG002|Overall Study|Adverse Event|1
7182703|NCT02923674|11382818|FG000|Overall Study|Withdrawal by Subject|2
7182704|NCT02923674|11382819|FG001|Overall Study|Withdrawal by Subject|2
7182705|NCT02923674|11382820|FG002|Overall Study|Withdrawal by Subject|2
7182706|NCT02921971|11382830|FG000|Overall Study|Adverse Event|1
7182707|NCT02921971|11382831|FG001|Overall Study|Adverse Event|2
7182708|NCT02921971|11382830|FG000|Overall Study|Lack of Efficacy|3
7182709|NCT02921971|11382831|FG001|Overall Study|Lack of Efficacy|1
7182710|NCT02921971|11382830|FG000|Overall Study|Other than specified above|2
7182711|NCT02921971|11382831|FG001|Overall Study|Other than specified above|1
7182712|NCT02886286|11382839|FG000|Overall Study|pump motor stall|0
7182713|NCT02886286|11382840|FG001|Overall Study|pump motor stall|1
7182714|NCT02865187|11382848|FG000|Overall Study|Lost to Follow-up|12
7182715|NCT02865187|11382849|FG001|Overall Study|Lost to Follow-up|7
7182716|NCT02865187|11382848|FG000|Overall Study|Adverse Event|1
7182717|NCT02865187|11382849|FG001|Overall Study|Adverse Event|0
7182718|NCT02836249|11382857|FG000|Overall Study|Randomized but Never Treated|0
7182719|NCT02836249|11382858|FG001|Overall Study|Randomized but Never Treated|1
7182720|NCT02836249|11382857|FG000|Overall Study|Pregnancy|2
7182721|NCT02836249|11382858|FG001|Overall Study|Pregnancy|0
7182722|NCT02836249|11382857|FG000|Overall Study|Withdrew Consent|0
7182723|NCT02836249|11382858|FG001|Overall Study|Withdrew Consent|1
7182724|NCT02836249|11382857|FG000|Overall Study|Lost to Follow-up|0
7182725|NCT02836249|11382858|FG001|Overall Study|Lost to Follow-up|1
7182726|NCT02836249|11382857|FG000|Overall Study|Still on Study|121
7182727|NCT02836249|11382858|FG001|Overall Study|Still on Study|55
7182728|NCT02829918|11382864|FG000|Overall Study|Death|2
7182729|NCT02829918|11382864|FG000|Overall Study|Withdrawal by Subject|4
7182730|NCT02829918|11382864|FG000|Overall Study|Adverse Event|1
7182731|NCT02829918|11382864|FG000|Overall Study|Progression|1
7182732|NCT02824198|11382870|FG000|Overall Study|Non-compliance with the protocol|5
7182733|NCT02824198|11382871|FG001|Overall Study|Non-compliance with the protocol|1
7182734|NCT02824198|11382870|FG000|Overall Study|Lost to Follow-up|5
7182735|NCT02824198|11382871|FG001|Overall Study|Lost to Follow-up|2
7182736|NCT02824198|11382870|FG000|Overall Study|Withdrawal by Subject|5
7182737|NCT02824198|11382871|FG001|Overall Study|Withdrawal by Subject|0
7182738|NCT02821754|11382882|FG000|Overall Study|Procedure not required prior to amendment change|13
7182739|NCT02821754|11382883|FG001|Overall Study|Procedure not required prior to amendment change|11
7182740|NCT02821754|11382884|FG002|Overall Study|Procedure not required prior to amendment change|0
7182741|NCT02821754|11382882|FG000|Overall Study|Participant's Clinical status|2
7182742|NCT02821754|11382883|FG001|Overall Study|Participant's Clinical status|0
7182743|NCT02821754|11382884|FG002|Overall Study|Participant's Clinical status|0
7182744|NCT02821754|11382882|FG000|Overall Study|Participant removed for noncompliance|1
7182745|NCT02821754|11382883|FG001|Overall Study|Participant removed for noncompliance|0
7182746|NCT02821754|11382884|FG002|Overall Study|Participant removed for noncompliance|0
7182747|NCT02821754|11382882|FG000|Overall Study|Drug not available.|0
7182748|NCT02821754|11382883|FG001|Overall Study|Drug not available.|0
7182749|NCT02821754|11382884|FG002|Overall Study|Drug not available.|1
7182750|NCT02821754|11382882|FG000|Overall Study|Participant declined to participate (before treatment started.)|0
7182751|NCT02821754|11382883|FG001|Overall Study|Participant declined to participate (before treatment started.)|1
7182752|NCT02821754|11382884|FG002|Overall Study|Participant declined to participate (before treatment started.)|1
7182753|NCT02787551|11382892|FG000|Core Period: 26 Weeks|Adverse Event|10
7182754|NCT02787551|11382893|FG001|Core Period: 26 Weeks|Adverse Event|0
7182755|NCT02787551|11382892|FG000|Core Period: 26 Weeks|Lack of Efficacy|1
7182756|NCT02787551|11382893|FG001|Core Period: 26 Weeks|Lack of Efficacy|0
7182757|NCT02787551|11382892|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2
7182758|NCT02787551|11382893|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0
7182759|NCT02787551|11382892|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9
7182760|NCT02787551|11382893|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9
7182761|NCT02787551|11382892|FG000|Core Period: 26 Weeks|Randomized but not treated|2
7182762|NCT02787551|11382893|FG001|Core Period: 26 Weeks|Randomized but not treated|1
7182763|NCT02787551|11382892|FG000|Core Period: 26 Weeks|Other than specified|3
7182764|NCT02787551|11382893|FG001|Core Period: 26 Weeks|Other than specified|1
7182765|NCT02787551|11382892|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1
7182766|NCT02787551|11382893|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0
7182767|NCT02787551|11382892|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3
7182768|NCT02787551|11382893|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0
7182769|NCT02787551|11382892|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5
7182770|NCT02787551|11382893|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0
7182771|NCT02735044|11382913|FG000|Overall Study|Adverse Event|3
7182772|NCT02735044|11382914|FG001|Overall Study|Adverse Event|3
7182773|NCT02735044|11382913|FG000|Overall Study|Lack of Efficacy|1
7182774|NCT02735044|11382914|FG001|Overall Study|Lack of Efficacy|0
7182775|NCT02735044|11382913|FG000|Overall Study|Poor compliance to protocol|7
7182776|NCT02735044|11382914|FG001|Overall Study|Poor compliance to protocol|7
7182777|NCT02735044|11382913|FG000|Overall Study|Randomized and not treated|0
7182778|NCT02735044|11382914|FG001|Overall Study|Randomized and not treated|2
7182779|NCT02735044|11382913|FG000|Overall Study|Other, not specified above|5
7182780|NCT02735044|11382914|FG001|Overall Study|Other, not specified above|11
7182781|NCT02720744|11382922|FG000|Overall Study|Protocol Violation|0
7182782|NCT02720744|11382923|FG001|Overall Study|Protocol Violation|2
7182783|NCT02720744|11382922|FG000|Overall Study|Pregnancy|2
7182784|NCT02720744|11382923|FG001|Overall Study|Pregnancy|0
7182785|NCT02720744|11382922|FG000|Overall Study|Lack of Efficacy|2
6973445|NCT01181102|11025227|FG001|Overall Study|Physician Decision|1
6973446|NCT01181102|11025226|FG000|Overall Study|Protocol Violation|5
7182786|NCT02720744|11382923|FG001|Overall Study|Lack of Efficacy|8
7182787|NCT02720744|11382922|FG000|Overall Study|Adverse Event|21
7182788|NCT02720744|11382923|FG001|Overall Study|Adverse Event|3
7182789|NCT02720744|11382922|FG000|Overall Study|Withdrawal by Subject|11
7182790|NCT02720744|11382923|FG001|Overall Study|Withdrawal by Subject|11
7182791|NCT02720744|11382922|FG000|Overall Study|Lost to follow up|2
7182792|NCT02720744|11382923|FG001|Overall Study|Lost to follow up|0
7182793|NCT02720744|11382922|FG000|Overall Study|Non Compliance with Investigational Product|0
7182794|NCT02720744|11382923|FG001|Overall Study|Non Compliance with Investigational Product|1
7182795|NCT02720744|11382922|FG000|Overall Study|Excluded Concomitant Medication|0
7182796|NCT02720744|11382923|FG001|Overall Study|Excluded Concomitant Medication|1
7182797|NCT02713867|11382931|FG000|Randomization|Other Reason|2
7182798|NCT02713867|11382932|FG001|Randomization|Other Reason|1
7182799|NCT02713867|11382931|FG000|Randomization|Participant Withdrew consent|0
7182800|NCT02713867|11382932|FG001|Randomization|Participant Withdrew consent|2
7182801|NCT02713867|11382931|FG000|Treatment Period|Not Reported|1
7182802|NCT02713867|11382932|FG001|Treatment Period|Not Reported|0
7182803|NCT02713867|11382931|FG000|Treatment Period|Other Reasons|12
7182804|NCT02713867|11382932|FG001|Treatment Period|Other Reasons|18
7081720|NCT02134353|11191844|FG001|Overall Study|Pregnancy|1
7081721|NCT02134353|11191843|FG000|Overall Study|Relocation|1
7081722|NCT02134353|11191844|FG001|Overall Study|Relocation|0
7081723|NCT02134353|11191843|FG000|Overall Study|Other - Patient's Choice|0
7081724|NCT02134353|11191844|FG001|Overall Study|Other - Patient's Choice|1
7081725|NCT02134587|11191854|FG000|Overall Study|Did not completed all meetings|30
7081726|NCT02134977|11191881|FG000|Overall Study|Protocol Deviation|102
7081727|NCT02135107|11191909|FG000|Treatment Period|Withdrawal by Subject|11
7081728|NCT02135107|11191910|FG001|Treatment Period|Withdrawal by Subject|0
7182805|NCT02713867|11382931|FG000|Treatment Period|Administrative reason by sponsor|9
7182806|NCT02713867|11382932|FG001|Treatment Period|Administrative reason by sponsor|4
7182807|NCT02713867|11382931|FG000|Treatment Period|No longer meets study criteria|2
7182808|NCT02713867|11382932|FG001|Treatment Period|No longer meets study criteria|1
7182809|NCT02713867|11382931|FG000|Treatment Period|Poor/Non Compliance|1
7182810|NCT02713867|11382932|FG001|Treatment Period|Poor/Non Compliance|0
7182811|NCT02713867|11382931|FG000|Treatment Period|Maximum Clinical Benefit|3
7182812|NCT02713867|11382932|FG001|Treatment Period|Maximum Clinical Benefit|4
7182813|NCT02713867|11382931|FG000|Treatment Period|Withdrew consent|1
7182814|NCT02713867|11382932|FG001|Treatment Period|Withdrew consent|6
7182815|NCT02713867|11382931|FG000|Treatment Period|Requested to Discontinue|8
7182816|NCT02713867|11382932|FG001|Treatment Period|Requested to Discontinue|7
7182817|NCT02713867|11382931|FG000|Treatment Period|AE unrelated to Study Drug|8
7182818|NCT02713867|11382932|FG001|Treatment Period|AE unrelated to Study Drug|9
7182819|NCT02713867|11382931|FG000|Treatment Period|Death|7
7182820|NCT02713867|11382932|FG001|Treatment Period|Death|3
7182821|NCT02713867|11382931|FG000|Treatment Period|Study Drug Toxicity|16
7182822|NCT02713867|11382932|FG001|Treatment Period|Study Drug Toxicity|20
7182823|NCT02713867|11382931|FG000|Treatment Period|Disease Progression|79
7182824|NCT02713867|11382932|FG001|Treatment Period|Disease Progression|78
7182825|NCT02704403|11382940|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4
7182826|NCT02704403|11382941|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3
6973447|NCT01181102|11025227|FG001|Overall Study|Protocol Violation|6
6973448|NCT01181102|11025226|FG000|Overall Study|Withdrawal by Subject|10
6973449|NCT01181102|11025227|FG001|Overall Study|Withdrawal by Subject|12
6973450|NCT01181128|11025236|FG000|Overall Study|Withdrawal by Subject|2
6973451|NCT01181128|11025237|FG001|Overall Study|Withdrawal by Subject|2
7182827|NCT02704403|11382940|FG000|Overall Study|Administrative reasons by sponsor|1251
7182828|NCT02704403|11382941|FG001|Overall Study|Administrative reasons by sponsor|616
7182829|NCT02704403|11382940|FG000|Overall Study|Death|4
7182830|NCT02704403|11382941|FG001|Overall Study|Death|3
7182831|NCT02704403|11382940|FG000|Overall Study|Endpoint event|52
7182832|NCT02704403|11382941|FG001|Overall Study|Endpoint event|24
7182833|NCT02704403|11382940|FG000|Overall Study|Lost to Follow-up|22
7182834|NCT02704403|11382941|FG001|Overall Study|Lost to Follow-up|11
7182835|NCT02704403|11382940|FG000|Overall Study|Protocol Violation|15
7182836|NCT02704403|11382941|FG001|Overall Study|Protocol Violation|15
7182837|NCT02704403|11382940|FG000|Overall Study|Adverse Event|2
7182838|NCT02704403|11382941|FG001|Overall Study|Adverse Event|0
7182839|NCT02704403|11382940|FG000|Overall Study|Withdrawal by Subject|85
7182840|NCT02704403|11382941|FG001|Overall Study|Withdrawal by Subject|45
7182841|NCT02704403|11382940|FG000|Overall Study|Investigator decision|1
7182842|NCT02704403|11382941|FG001|Overall Study|Investigator decision|1
7182843|NCT02704403|11382940|FG000|Overall Study|Follow-up not possible|1
7182844|NCT02704403|11382941|FG001|Overall Study|Follow-up not possible|2
7182845|NCT02694185|11382949|FG000|Overall Study|Withdrawal by Subject|45
7182846|NCT02694185|11382950|FG001|Overall Study|Withdrawal by Subject|0
6973452|NCT01181128|11025238|FG002|Overall Study|Withdrawal by Subject|0
7081729|NCT02135107|11191911|FG002|Treatment Period|Withdrawal by Subject|0
7182847|NCT02692651|11382958|FG000|Study Treatment|Death|7
7182848|NCT02692651|11382959|FG001|Study Treatment|Death|3
7182849|NCT02692651|11382958|FG000|Study Treatment|comfort care|1
7182850|NCT02692651|11382959|FG001|Study Treatment|comfort care|1
7182851|NCT02692651|11382958|FG000|Study Treatment|Protocol violation per treating team preference|8
7182852|NCT02692651|11382959|FG001|Study Treatment|Protocol violation per treating team preference|6
7182853|NCT02692651|11382958|FG000|Post Study Treatment Follow-up|Death|4
7182854|NCT02692651|11382959|FG001|Post Study Treatment Follow-up|Death|4
7182855|NCT02674061|11382967|FG000|Overall Study|Death|229
7182856|NCT02674061|11382968|FG001|Overall Study|Death|77
7182857|NCT02674061|11382967|FG000|Overall Study|Lost to Follow-up|3
7182858|NCT02674061|11382968|FG001|Overall Study|Lost to Follow-up|3
7182859|NCT02674061|11382967|FG000|Overall Study|Withdrawal by Subject|9
7182860|NCT02674061|11382968|FG001|Overall Study|Withdrawal by Subject|1
7182861|NCT02674061|11382967|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44
7182862|NCT02674061|11382968|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10
7182863|NCT02656706|11382976|FG000|Overall Study|Insurance Denial|1
7187046|NCT02660034|11387579|FG009|Overall Study|Participant moved into special access scheme|0
7187047|NCT02660034|11387580|FG010|Overall Study|Participant moved into special access scheme|0
7187048|NCT02660034|11387581|FG011|Overall Study|Participant moved into special access scheme|0
7187049|NCT02660034|11387582|FG012|Overall Study|Participant moved into special access scheme|0
7187050|NCT02660034|11387583|FG013|Overall Study|Participant moved into special access scheme|0
7187051|NCT02660034|11387570|FG000|Overall Study|Adverse Event|1
7187052|NCT02660034|11387571|FG001|Overall Study|Adverse Event|0
7187053|NCT02660034|11387572|FG002|Overall Study|Adverse Event|0
7187054|NCT02660034|11387573|FG003|Overall Study|Adverse Event|0
7187055|NCT02660034|11387574|FG004|Overall Study|Adverse Event|0
7187056|NCT02660034|11387575|FG005|Overall Study|Adverse Event|0
7187057|NCT02660034|11387576|FG006|Overall Study|Adverse Event|0
7187058|NCT02660034|11387577|FG007|Overall Study|Adverse Event|0
7187059|NCT02660034|11387578|FG008|Overall Study|Adverse Event|0
7187060|NCT02660034|11387579|FG009|Overall Study|Adverse Event|0
7187061|NCT02660034|11387580|FG010|Overall Study|Adverse Event|0
7187062|NCT02660034|11387581|FG011|Overall Study|Adverse Event|0
7187063|NCT02660034|11387582|FG012|Overall Study|Adverse Event|0
7187064|NCT02660034|11387583|FG013|Overall Study|Adverse Event|0
7187065|NCT02660034|11387570|FG000|Overall Study|Sponsor Decision|0
7187066|NCT02660034|11387571|FG001|Overall Study|Sponsor Decision|1
7187067|NCT02660034|11387572|FG002|Overall Study|Sponsor Decision|2
7187068|NCT02660034|11387573|FG003|Overall Study|Sponsor Decision|2
7187069|NCT02660034|11387574|FG004|Overall Study|Sponsor Decision|3
7187070|NCT02660034|11387575|FG005|Overall Study|Sponsor Decision|0
7187071|NCT02660034|11387576|FG006|Overall Study|Sponsor Decision|0
7187072|NCT02660034|11387577|FG007|Overall Study|Sponsor Decision|0
7187073|NCT02660034|11387578|FG008|Overall Study|Sponsor Decision|0
7187074|NCT02660034|11387579|FG009|Overall Study|Sponsor Decision|0
7187075|NCT02660034|11387580|FG010|Overall Study|Sponsor Decision|0
7187076|NCT02660034|11387581|FG011|Overall Study|Sponsor Decision|0
7187077|NCT02660034|11387582|FG012|Overall Study|Sponsor Decision|0
7187078|NCT02660034|11387583|FG013|Overall Study|Sponsor Decision|1
7187079|NCT02660034|11387570|FG000|Overall Study|Withdrawal by Subject|0
7187080|NCT02660034|11387571|FG001|Overall Study|Withdrawal by Subject|0
7187081|NCT02660034|11387572|FG002|Overall Study|Withdrawal by Subject|0
7187082|NCT02660034|11387573|FG003|Overall Study|Withdrawal by Subject|0
7187083|NCT02660034|11387574|FG004|Overall Study|Withdrawal by Subject|0
7187084|NCT02660034|11387575|FG005|Overall Study|Withdrawal by Subject|0
7187085|NCT02660034|11387576|FG006|Overall Study|Withdrawal by Subject|1
7187086|NCT02660034|11387577|FG007|Overall Study|Withdrawal by Subject|1
7187087|NCT02660034|11387578|FG008|Overall Study|Withdrawal by Subject|1
7187088|NCT02660034|11387579|FG009|Overall Study|Withdrawal by Subject|0
7187089|NCT02660034|11387580|FG010|Overall Study|Withdrawal by Subject|0
7187090|NCT02660034|11387581|FG011|Overall Study|Withdrawal by Subject|1
7187091|NCT02660034|11387582|FG012|Overall Study|Withdrawal by Subject|2
7187092|NCT02660034|11387583|FG013|Overall Study|Withdrawal by Subject|0
7187093|NCT02660034|11387570|FG000|Overall Study|Death|0
7187094|NCT02660034|11387571|FG001|Overall Study|Death|0
7187095|NCT02660034|11387572|FG002|Overall Study|Death|0
7187096|NCT02660034|11387573|FG003|Overall Study|Death|0
7187097|NCT02660034|11387574|FG004|Overall Study|Death|0
7187098|NCT02660034|11387575|FG005|Overall Study|Death|13
7187099|NCT02660034|11387576|FG006|Overall Study|Death|14
7187100|NCT02660034|11387577|FG007|Overall Study|Death|10
7187101|NCT02660034|11387578|FG008|Overall Study|Death|9
7187102|NCT02660034|11387579|FG009|Overall Study|Death|21
7187103|NCT02660034|11387580|FG010|Overall Study|Death|17
7187104|NCT02660034|11387581|FG011|Overall Study|Death|15
7187105|NCT02660034|11387582|FG012|Overall Study|Death|18
7187106|NCT02660034|11387583|FG013|Overall Study|Death|7
7187107|NCT02660034|11387570|FG000|Overall Study|Physician Decision|0
7187108|NCT02660034|11387571|FG001|Overall Study|Physician Decision|0
7187109|NCT02660034|11387572|FG002|Overall Study|Physician Decision|0
7187110|NCT02660034|11387573|FG003|Overall Study|Physician Decision|0
7187111|NCT02660034|11387574|FG004|Overall Study|Physician Decision|0
7187112|NCT02660034|11387575|FG005|Overall Study|Physician Decision|0
7187113|NCT02660034|11387576|FG006|Overall Study|Physician Decision|0
7182864|NCT02628444|11382992|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1
7182865|NCT02628444|11382993|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
7182866|NCT02628444|11382994|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
7182867|NCT02628444|11382995|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
7182868|NCT02628444|11382996|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
7182869|NCT02628444|11382997|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
7182870|NCT02628444|11382998|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
7182871|NCT02628444|11382999|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
7182872|NCT02628444|11383000|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
7182873|NCT02628444|11382992|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
7182874|NCT02628444|11382993|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4
7182875|NCT02628444|11382994|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3
7182876|NCT02628444|11382995|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
7182877|NCT02628444|11382996|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
7182878|NCT02628444|11382997|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
7182879|NCT02628444|11382998|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
7182880|NCT02628444|11382999|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
7182881|NCT02628444|11383000|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
7182882|NCT02628444|11382992|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21
7182883|NCT02628444|11382993|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16
7182884|NCT02628444|11382994|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25
7182885|NCT02628444|11382995|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
7182886|NCT02628444|11382996|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
7182887|NCT02628444|11382997|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
7182888|NCT02628444|11382998|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
7182889|NCT02628444|11382999|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
7182890|NCT02628444|11383000|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
7182891|NCT02628444|11382992|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9
7182892|NCT02628444|11382993|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16
7182893|NCT02628444|11382994|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9
7182894|NCT02628444|11382995|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
7182895|NCT02628444|11382996|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
7081730|NCT02135107|11191912|FG003|Treatment Period|Withdrawal by Subject|0
7081731|NCT02135107|11191909|FG000|Treatment Period|Adverse Event|5
7081732|NCT02135107|11191910|FG001|Treatment Period|Adverse Event|2
7081733|NCT02135107|11191911|FG002|Treatment Period|Adverse Event|0
7081734|NCT02135107|11191912|FG003|Treatment Period|Adverse Event|0
7081735|NCT02135107|11191909|FG000|Treatment Period|Pregnancy|1
7081736|NCT02135107|11191910|FG001|Treatment Period|Pregnancy|0
7081737|NCT02135107|11191911|FG002|Treatment Period|Pregnancy|0
7081738|NCT02135107|11191912|FG003|Treatment Period|Pregnancy|0
7081739|NCT02135107|11191909|FG000|Treatment Period|Other|115
7081740|NCT02135107|11191910|FG001|Treatment Period|Other|24
7081741|NCT02135107|11191911|FG002|Treatment Period|Other|0
7081742|NCT02135107|11191912|FG003|Treatment Period|Other|0
7081743|NCT02135107|11191909|FG000|Maintenance Therapy Period|Adverse Event|0
7081744|NCT02135107|11191910|FG001|Maintenance Therapy Period|Adverse Event|0
7182896|NCT02628444|11382997|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
7182897|NCT02628444|11382998|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
7182898|NCT02628444|11382999|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
7182899|NCT02628444|11383000|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
7182900|NCT02628444|11382992|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5
7182901|NCT02628444|11382993|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3
7182902|NCT02628444|11382994|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5
7182903|NCT02628444|11382995|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
7182904|NCT02628444|11382996|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
7182905|NCT02628444|11382997|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
7182906|NCT02628444|11382998|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
7182907|NCT02628444|11382999|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
7182908|NCT02628444|11383000|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
7182909|NCT02628444|11382992|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
7182910|NCT02628444|11382993|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
7182911|NCT02628444|11382994|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
7182912|NCT02628444|11382995|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1
7182913|NCT02628444|11382996|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
7182914|NCT02628444|11382997|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
7182915|NCT02628444|11382998|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
7182916|NCT02628444|11382999|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
7081745|NCT02135107|11191911|FG002|Maintenance Therapy Period|Adverse Event|3
7081746|NCT02135107|11191912|FG003|Maintenance Therapy Period|Adverse Event|7
7081747|NCT02135107|11191909|FG000|Maintenance Therapy Period|Withdrawal by Subject|0
7081748|NCT02135107|11191910|FG001|Maintenance Therapy Period|Withdrawal by Subject|0
7182917|NCT02628444|11383000|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
7182918|NCT02628444|11382992|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0
7182919|NCT02628444|11382993|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0
7182920|NCT02628444|11382994|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0
7182921|NCT02628444|11382995|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83
7182922|NCT02628444|11382996|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83
7182923|NCT02628444|11382997|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83
7182924|NCT02628444|11382998|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81
7182925|NCT02628444|11382999|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84
7182926|NCT02628444|11383000|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85
7182927|NCT02628444|11382992|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0
7182928|NCT02628444|11382993|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0
7182929|NCT02628444|11382994|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0
7182930|NCT02628444|11382995|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5
7182931|NCT02628444|11382996|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6
7182932|NCT02628444|11382997|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10
7182933|NCT02628444|11382998|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12
7182934|NCT02628444|11382999|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11
7182935|NCT02628444|11383000|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9
7182936|NCT02628444|11382992|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
7182937|NCT02628444|11382993|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
7182938|NCT02628444|11382994|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
7182939|NCT02628444|11382995|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
7182940|NCT02628444|11382996|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3
7182941|NCT02628444|11382997|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
7182942|NCT02628444|11382998|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
7182943|NCT02628444|11382999|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2
7182944|NCT02628444|11383000|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3
7182945|NCT02628444|11382992|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0
7182946|NCT02628444|11382993|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0
7182947|NCT02628444|11382994|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0
7182948|NCT02628444|11382995|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1
7182949|NCT02628444|11382996|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1
7182950|NCT02628444|11382997|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2
7182951|NCT02628444|11382998|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3
7182952|NCT02628444|11382999|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1
7182953|NCT02628444|11383000|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2
7182954|NCT02623725|11383036|FG000|Overall Study|Non compliance with protocol|9
7182955|NCT02623725|11383037|FG001|Overall Study|Non compliance with protocol|3
7182956|NCT02623725|11383036|FG000|Overall Study|Serious adverse event|0
7182957|NCT02623725|11383037|FG001|Overall Study|Serious adverse event|2
7182958|NCT02623725|11383036|FG000|Overall Study|Withdrawal by Subject|7
7182959|NCT02623725|11383037|FG001|Overall Study|Withdrawal by Subject|1
7182960|NCT02608684|11383045|FG000|Overall Study|Physician Decision|2
7182961|NCT02608684|11383045|FG000|Overall Study|Withdrawal by Subject|1
7182962|NCT02603887|11383049|FG000|Stage 1|Adverse Event|4
7182963|NCT02603887|11383049|FG000|Stage 1|Disease progression|1
7182964|NCT02603887|11383049|FG000|Stage 2|FDA guidance|1
7182965|NCT02587520|11383071|FG000|Overall Study|Protocol Violation|2
7182966|NCT02587520|11383072|FG001|Overall Study|Protocol Violation|0
7182967|NCT02587520|11383073|FG002|Overall Study|Protocol Violation|0
7182968|NCT02587520|11383074|FG003|Overall Study|Protocol Violation|2
7182969|NCT02587520|11383075|FG004|Overall Study|Protocol Violation|0
7182970|NCT02587520|11383076|FG005|Overall Study|Protocol Violation|1
7182971|NCT02587520|11383077|FG006|Overall Study|Protocol Violation|1
7182972|NCT02587520|11383078|FG007|Overall Study|Protocol Violation|1
7182973|NCT02587520|11383079|FG008|Overall Study|Protocol Violation|3
7182974|NCT02587520|11383080|FG009|Overall Study|Protocol Violation|3
7182975|NCT02587520|11383081|FG010|Overall Study|Protocol Violation|1
7182976|NCT02587520|11383082|FG011|Overall Study|Protocol Violation|2
7182977|NCT02587520|11383083|FG012|Overall Study|Protocol Violation|0
7182978|NCT02587520|11383084|FG013|Overall Study|Protocol Violation|0
7182979|NCT02587520|11383085|FG014|Overall Study|Protocol Violation|0
7182980|NCT02587520|11383086|FG015|Overall Study|Protocol Violation|0
7182981|NCT02587520|11383087|FG016|Overall Study|Protocol Violation|0
7182982|NCT02587520|11383088|FG017|Overall Study|Protocol Violation|0
7182983|NCT02587520|11383071|FG000|Overall Study|Adverse Event|0
7182984|NCT02587520|11383072|FG001|Overall Study|Adverse Event|0
7182985|NCT02587520|11383073|FG002|Overall Study|Adverse Event|0
7182986|NCT02587520|11383074|FG003|Overall Study|Adverse Event|0
7182987|NCT02587520|11383075|FG004|Overall Study|Adverse Event|0
7182988|NCT02587520|11383076|FG005|Overall Study|Adverse Event|0
7182989|NCT02587520|11383077|FG006|Overall Study|Adverse Event|0
7182990|NCT02587520|11383078|FG007|Overall Study|Adverse Event|0
7182991|NCT02587520|11383079|FG008|Overall Study|Adverse Event|0
7182992|NCT02587520|11383080|FG009|Overall Study|Adverse Event|0
7182993|NCT02587520|11383081|FG010|Overall Study|Adverse Event|0
7182994|NCT02587520|11383082|FG011|Overall Study|Adverse Event|1
7182995|NCT02587520|11383083|FG012|Overall Study|Adverse Event|0
7182996|NCT02587520|11383084|FG013|Overall Study|Adverse Event|0
7182997|NCT02587520|11383085|FG014|Overall Study|Adverse Event|0
7182998|NCT02587520|11383086|FG015|Overall Study|Adverse Event|0
7182999|NCT02587520|11383087|FG016|Overall Study|Adverse Event|0
7183000|NCT02587520|11383088|FG017|Overall Study|Adverse Event|0
7183001|NCT02587520|11383071|FG000|Overall Study|Withdrawal by Subject|0
7183002|NCT02587520|11383072|FG001|Overall Study|Withdrawal by Subject|0
7183003|NCT02587520|11383073|FG002|Overall Study|Withdrawal by Subject|1
7183004|NCT02587520|11383074|FG003|Overall Study|Withdrawal by Subject|1
7183005|NCT02587520|11383075|FG004|Overall Study|Withdrawal by Subject|0
7183006|NCT02587520|11383076|FG005|Overall Study|Withdrawal by Subject|1
7183007|NCT02587520|11383077|FG006|Overall Study|Withdrawal by Subject|1
7183008|NCT02587520|11383078|FG007|Overall Study|Withdrawal by Subject|0
7183009|NCT02587520|11383079|FG008|Overall Study|Withdrawal by Subject|0
7183010|NCT02587520|11383080|FG009|Overall Study|Withdrawal by Subject|0
7183011|NCT02587520|11383081|FG010|Overall Study|Withdrawal by Subject|0
7183012|NCT02587520|11383082|FG011|Overall Study|Withdrawal by Subject|0
7183013|NCT02587520|11383083|FG012|Overall Study|Withdrawal by Subject|0
7183014|NCT02587520|11383084|FG013|Overall Study|Withdrawal by Subject|1
7183015|NCT02587520|11383085|FG014|Overall Study|Withdrawal by Subject|0
7183016|NCT02587520|11383086|FG015|Overall Study|Withdrawal by Subject|0
7183017|NCT02587520|11383087|FG016|Overall Study|Withdrawal by Subject|0
7183018|NCT02587520|11383088|FG017|Overall Study|Withdrawal by Subject|0
7183019|NCT02587520|11383071|FG000|Overall Study|Lost to Follow-up|0
7183020|NCT02587520|11383072|FG001|Overall Study|Lost to Follow-up|2
7183021|NCT02587520|11383073|FG002|Overall Study|Lost to Follow-up|0
7183022|NCT02587520|11383074|FG003|Overall Study|Lost to Follow-up|2
7183023|NCT02587520|11383075|FG004|Overall Study|Lost to Follow-up|0
7183024|NCT02587520|11383076|FG005|Overall Study|Lost to Follow-up|1
7183025|NCT02587520|11383077|FG006|Overall Study|Lost to Follow-up|1
7183026|NCT02587520|11383078|FG007|Overall Study|Lost to Follow-up|1
7183027|NCT02587520|11383079|FG008|Overall Study|Lost to Follow-up|0
7183028|NCT02587520|11383080|FG009|Overall Study|Lost to Follow-up|2
7183029|NCT02587520|11383081|FG010|Overall Study|Lost to Follow-up|2
7183030|NCT02587520|11383082|FG011|Overall Study|Lost to Follow-up|1
7183031|NCT02587520|11383083|FG012|Overall Study|Lost to Follow-up|0
7183032|NCT02587520|11383084|FG013|Overall Study|Lost to Follow-up|0
7183033|NCT02587520|11383085|FG014|Overall Study|Lost to Follow-up|0
7183034|NCT02587520|11383086|FG015|Overall Study|Lost to Follow-up|0
7183035|NCT02587520|11383087|FG016|Overall Study|Lost to Follow-up|0
7183036|NCT02587520|11383088|FG017|Overall Study|Lost to Follow-up|0
7183037|NCT02584829|11383128|FG000|Overall Study|Physician Decision|1
7183038|NCT02584829|11383129|FG001|Overall Study|Physician Decision|0
7183039|NCT02584829|11383128|FG000|Overall Study|Withdrawal by Subject|0
7183040|NCT02584829|11383129|FG001|Overall Study|Withdrawal by Subject|1
7183041|NCT02584829|11383128|FG000|Overall Study|Progressive Disease|0
7183042|NCT02584829|11383129|FG001|Overall Study|Progressive Disease|3
7183043|NCT02570308|11383142|FG000|Overall Study|Death|1
7183044|NCT02570308|11383143|FG001|Overall Study|Death|5
7183045|NCT02570308|11383144|FG002|Overall Study|Death|4
7183046|NCT02570308|11383145|FG003|Overall Study|Death|4
7183047|NCT02570308|11383146|FG004|Overall Study|Death|69
7183048|NCT02570308|11383142|FG000|Overall Study|Lost to Follow-up|0
7183049|NCT02570308|11383143|FG001|Overall Study|Lost to Follow-up|0
7183050|NCT02570308|11383144|FG002|Overall Study|Lost to Follow-up|0
7183051|NCT02570308|11383145|FG003|Overall Study|Lost to Follow-up|0
7183052|NCT02570308|11383146|FG004|Overall Study|Lost to Follow-up|2
7183053|NCT02570308|11383142|FG000|Overall Study|Withdrawal by Subject|0
7183054|NCT02570308|11383143|FG001|Overall Study|Withdrawal by Subject|0
7183055|NCT02570308|11383144|FG002|Overall Study|Withdrawal by Subject|0
7183056|NCT02570308|11383145|FG003|Overall Study|Withdrawal by Subject|0
7183057|NCT02570308|11383146|FG004|Overall Study|Withdrawal by Subject|1
7183058|NCT02570308|11383142|FG000|Overall Study|Other|0
7183059|NCT02570308|11383143|FG001|Overall Study|Other|0
7183060|NCT02570308|11383144|FG002|Overall Study|Other|0
7183061|NCT02570308|11383145|FG003|Overall Study|Other|0
7183062|NCT02570308|11383146|FG004|Overall Study|Other|2
7183063|NCT02516241|11383167|FG000|Overall Study|Death|255
7183064|NCT02516241|11383168|FG001|Overall Study|Death|262
7183065|NCT02516241|11383169|FG002|Overall Study|Death|270
7183066|NCT02516241|11383167|FG000|Overall Study|Lost to Follow-up|1
7183067|NCT02516241|11383168|FG001|Overall Study|Lost to Follow-up|1
7183068|NCT02516241|11383169|FG002|Overall Study|Lost to Follow-up|3
7183069|NCT02516241|11383167|FG000|Overall Study|Withdrawal by Subject|2
7183070|NCT02516241|11383168|FG001|Overall Study|Withdrawal by Subject|7
7183071|NCT02516241|11383169|FG002|Overall Study|Withdrawal by Subject|12
7183072|NCT02516241|11383167|FG000|Overall Study|participants ongoing at data cut-off|84
7183073|NCT02516241|11383168|FG001|Overall Study|participants ongoing at data cut-off|76
7183074|NCT02516241|11383169|FG002|Overall Study|participants ongoing at data cut-off|59
7183075|NCT02514083|11383182|FG000|Overall Study|Adverse Event|1
7183076|NCT02497612|11383190|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57
7183077|NCT02497612|11383191|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51
7183078|NCT02497612|11383192|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39
7183079|NCT02497612|11383193|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41
7183080|NCT02497612|11383190|FG000|Overall Study|Participant's request|2
7183081|NCT02497612|11383191|FG001|Overall Study|Participant's request|3
7183082|NCT02497612|11383192|FG002|Overall Study|Participant's request|4
7183083|NCT02497612|11383193|FG003|Overall Study|Participant's request|1
7183084|NCT02497612|11383190|FG000|Overall Study|Investigator's judgement|1
7183085|NCT02497612|11383191|FG001|Overall Study|Investigator's judgement|0
7183086|NCT02497612|11383192|FG002|Overall Study|Investigator's judgement|0
7183087|NCT02497612|11383193|FG003|Overall Study|Investigator's judgement|2
7183088|NCT02497612|11383190|FG000|Overall Study|Adverse Event|3
7183089|NCT02497612|11383191|FG001|Overall Study|Adverse Event|1
7183090|NCT02497612|11383192|FG002|Overall Study|Adverse Event|4
7183091|NCT02497612|11383193|FG003|Overall Study|Adverse Event|1
7183092|NCT02497612|11383190|FG000|Overall Study|Lost to Follow-up|1
7183093|NCT02497612|11383191|FG001|Overall Study|Lost to Follow-up|1
7183094|NCT02497612|11383192|FG002|Overall Study|Lost to Follow-up|0
7183095|NCT02497612|11383193|FG003|Overall Study|Lost to Follow-up|1
7183096|NCT02497612|11383190|FG000|Overall Study|Other unspecified|1
7183097|NCT02497612|11383191|FG001|Overall Study|Other unspecified|1
7183098|NCT02497612|11383192|FG002|Overall Study|Other unspecified|2
7183099|NCT02497612|11383193|FG003|Overall Study|Other unspecified|0
7183100|NCT02497612|11383190|FG000|Overall Study|Not eligible|1
7183101|NCT02497612|11383191|FG001|Overall Study|Not eligible|0
7183102|NCT02497612|11383192|FG002|Overall Study|Not eligible|0
7183103|NCT02497612|11383193|FG003|Overall Study|Not eligible|1
7183104|NCT02460458|11383203|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analyses|47
7183105|NCT02460458|11383203|FG000|Confirmatory Phase|Patients excluded due to lack of samples for central analyses|27
7183106|NCT02460458|11383203|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|14
7183107|NCT02460458|11383203|FG000|First Prospective Phase|Lost to Follow-up|16
7183108|NCT02460458|11383203|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|9
7183109|NCT02457559|11383218|FG000|Overall Study|Progressive Disease|1
7183110|NCT02457559|11383219|FG001|Overall Study|Progressive Disease|2
7183111|NCT02457559|11383220|FG002|Overall Study|Progressive Disease|3
7183112|NCT02457559|11383221|FG003|Overall Study|Progressive Disease|0
7183113|NCT02457559|11383222|FG004|Overall Study|Progressive Disease|0
7183114|NCT02457559|11383223|FG005|Overall Study|Progressive Disease|2
7183115|NCT02457559|11383224|FG006|Overall Study|Progressive Disease|1
7183116|NCT02457559|11383225|FG007|Overall Study|Progressive Disease|0
7183117|NCT02457559|11383226|FG008|Overall Study|Progressive Disease|1
7183118|NCT02457559|11383227|FG009|Overall Study|Progressive Disease|1
7183119|NCT02457559|11383228|FG010|Overall Study|Progressive Disease|1
7183120|NCT02457559|11383218|FG000|Overall Study|Investigator's Discretion|0
7183121|NCT02457559|11383219|FG001|Overall Study|Investigator's Discretion|0
7183122|NCT02457559|11383220|FG002|Overall Study|Investigator's Discretion|2
7183123|NCT02457559|11383221|FG003|Overall Study|Investigator's Discretion|0
7183124|NCT02457559|11383222|FG004|Overall Study|Investigator's Discretion|1
7183125|NCT02457559|11383223|FG005|Overall Study|Investigator's Discretion|0
7081749|NCT02135107|11191911|FG002|Maintenance Therapy Period|Withdrawal by Subject|5
7081750|NCT02135107|11191912|FG003|Maintenance Therapy Period|Withdrawal by Subject|4
7081751|NCT02135107|11191909|FG000|Maintenance Therapy Period|Pregnancy|0
7081752|NCT02135107|11191910|FG001|Maintenance Therapy Period|Pregnancy|0
7081753|NCT02135107|11191911|FG002|Maintenance Therapy Period|Pregnancy|0
7183126|NCT02457559|11383224|FG006|Overall Study|Investigator's Discretion|1
7183127|NCT02457559|11383225|FG007|Overall Study|Investigator's Discretion|0
7183128|NCT02457559|11383226|FG008|Overall Study|Investigator's Discretion|1
7183129|NCT02457559|11383227|FG009|Overall Study|Investigator's Discretion|0
7183130|NCT02457559|11383228|FG010|Overall Study|Investigator's Discretion|1
7183131|NCT02457559|11383218|FG000|Overall Study|Adverse Event|0
7183132|NCT02457559|11383219|FG001|Overall Study|Adverse Event|1
7183133|NCT02457559|11383220|FG002|Overall Study|Adverse Event|2
7183134|NCT02457559|11383221|FG003|Overall Study|Adverse Event|0
7183135|NCT02457559|11383222|FG004|Overall Study|Adverse Event|0
7183136|NCT02457559|11383223|FG005|Overall Study|Adverse Event|0
7183137|NCT02457559|11383224|FG006|Overall Study|Adverse Event|0
7183138|NCT02457559|11383225|FG007|Overall Study|Adverse Event|0
7183139|NCT02457559|11383226|FG008|Overall Study|Adverse Event|0
7183140|NCT02457559|11383227|FG009|Overall Study|Adverse Event|0
7183141|NCT02457559|11383228|FG010|Overall Study|Adverse Event|0
7081754|NCT02135107|11191912|FG003|Maintenance Therapy Period|Pregnancy|1
6896322|NCT00632229|10914638|FG001|Overall Study|Lost to Follow-up|3
6896323|NCT00632229|10914637|FG000|Overall Study|Lack of Efficacy|0
7081755|NCT02135107|11191909|FG000|Maintenance Therapy Period|Other|0
7081756|NCT02135107|11191910|FG001|Maintenance Therapy Period|Other|0
7081757|NCT02135107|11191911|FG002|Maintenance Therapy Period|Other|7
7081758|NCT02135107|11191912|FG003|Maintenance Therapy Period|Other|8
7081759|NCT02135445|11191945|FG000|Overall Study|Lost to Follow-up|1
7081760|NCT02135445|11191946|FG001|Overall Study|Lost to Follow-up|0
7081761|NCT02135445|11191945|FG000|Overall Study|Withdrawal by Subject|1
7081762|NCT02135445|11191946|FG001|Overall Study|Withdrawal by Subject|0
7081763|NCT02135614|11191954|FG000|Overall Study|Randomized but Not Treated|2
7081764|NCT02135614|11191955|FG001|Overall Study|Randomized but Not Treated|1
7081765|NCT02135614|11191954|FG000|Overall Study|Adverse Event|0
7081766|NCT02135614|11191955|FG001|Overall Study|Adverse Event|1
7081767|NCT02135614|11191954|FG000|Overall Study|Death|1
7081768|NCT02135614|11191955|FG001|Overall Study|Death|0
7081769|NCT02135614|11191954|FG000|Overall Study|Investigator's Discretion|0
7081770|NCT02135614|11191955|FG001|Overall Study|Investigator's Discretion|1
7081771|NCT02135614|11191954|FG000|Overall Study|Withdrew Consent|2
7081772|NCT02135614|11191955|FG001|Overall Study|Withdrew Consent|2
7081773|NCT02135614|11191954|FG000|Overall Study|Lost to Follow-up|3
7081774|NCT02135614|11191955|FG001|Overall Study|Lost to Follow-up|0
7081775|NCT02135692|11191972|FG000|Overall Study|Adverse Event|3
7081776|NCT02135692|11191972|FG000|Overall Study|Lack of Efficacy|2
7183142|NCT02457559|11383218|FG000|Overall Study|Reason not Specified|1
7183143|NCT02457559|11383219|FG001|Overall Study|Reason not Specified|0
7081777|NCT02135692|11191972|FG000|Overall Study|Protocol Violation|2
7081778|NCT02135692|11191972|FG000|Overall Study|Subject met Liver Stopping Criteria|1
7081779|NCT02135692|11191972|FG000|Overall Study|Product commercially available|159
7081780|NCT02135692|11191972|FG000|Overall Study|Study closed/terminated|153
7183144|NCT02457559|11383220|FG002|Overall Study|Reason not Specified|0
7183145|NCT02457559|11383221|FG003|Overall Study|Reason not Specified|0
7183146|NCT02457559|11383222|FG004|Overall Study|Reason not Specified|0
7183147|NCT02457559|11383223|FG005|Overall Study|Reason not Specified|0
7183148|NCT02457559|11383224|FG006|Overall Study|Reason not Specified|0
7183149|NCT02457559|11383225|FG007|Overall Study|Reason not Specified|0
7183150|NCT02457559|11383226|FG008|Overall Study|Reason not Specified|0
7183151|NCT02457559|11383227|FG009|Overall Study|Reason not Specified|2
7183152|NCT02457559|11383228|FG010|Overall Study|Reason not Specified|0
7183153|NCT02457559|11383218|FG000|Overall Study|Death|0
7183154|NCT02457559|11383219|FG001|Overall Study|Death|0
7183155|NCT02457559|11383220|FG002|Overall Study|Death|0
7183156|NCT02457559|11383221|FG003|Overall Study|Death|0
7183157|NCT02457559|11383222|FG004|Overall Study|Death|0
7183158|NCT02457559|11383223|FG005|Overall Study|Death|0
7183159|NCT02457559|11383224|FG006|Overall Study|Death|0
7183160|NCT02457559|11383225|FG007|Overall Study|Death|0
7183161|NCT02457559|11383226|FG008|Overall Study|Death|1
7183162|NCT02457559|11383227|FG009|Overall Study|Death|1
7183163|NCT02457559|11383228|FG010|Overall Study|Death|0
7183164|NCT02442349|11383266|FG000|Overall Study|Death|14
7183165|NCT02442349|11383266|FG000|Overall Study|Withdrawal by Subject|8
7183166|NCT02442349|11383266|FG000|Overall Study|On-going Study at Data Cut-off|149
7183167|NCT02381652|11383282|FG000|Overall Study|Withdrawal by Subject|0
7183168|NCT02381652|11383283|FG001|Overall Study|Withdrawal by Subject|0
7183169|NCT02381652|11383284|FG002|Overall Study|Withdrawal by Subject|1
7183170|NCT02367794|11383293|FG000|Overall Study|Death|252
7183171|NCT02367794|11383294|FG001|Overall Study|Death|245
7081781|NCT02135692|11191972|FG000|Overall Study|Lost to Follow-up|4
7041740|NCT01730040|11125601|FG002|Overall Study|Randomized but not treated|0
7041741|NCT01730040|11125602|FG003|Overall Study|Randomized but not treated|0
7041742|NCT01730040|11125603|FG004|Overall Study|Randomized but not treated|0
7041743|NCT01730040|11125604|FG005|Overall Study|Randomized but not treated|1
7041744|NCT01730040|11125605|FG006|Overall Study|Randomized but not treated|0
7041745|NCT01730040|11125599|FG000|Overall Study|Subject moved|0
7041746|NCT01730040|11125600|FG001|Overall Study|Subject moved|0
6896324|NCT00632229|10914638|FG001|Overall Study|Lack of Efficacy|2
6896325|NCT00632229|10914637|FG000|Overall Study|Undisclosed reasons within the first wee|0
6896326|NCT00632229|10914638|FG001|Overall Study|Undisclosed reasons within the first wee|1
6896327|NCT00632359|10914648|FG000|Overall Study|Withdrawal by Subject|2
6896328|NCT00632424|10914665|FG000|Overall Study|Disease Progression|17
6896329|NCT00632424|10914665|FG000|Overall Study|Study Drug Toxicity|1
6896330|NCT00632463|10914682|FG000|Overall Study|Adverse Event|0
7041747|NCT01730040|11125601|FG002|Overall Study|Subject moved|1
7041748|NCT01730040|11125602|FG003|Overall Study|Subject moved|0
7041749|NCT01730040|11125603|FG004|Overall Study|Subject moved|0
6896331|NCT00632463|10914683|FG001|Overall Study|Adverse Event|1
6896332|NCT00632463|10914684|FG002|Overall Study|Adverse Event|0
6896333|NCT00632502|10914707|FG000|Overall Study|Adverse Event|0
6896334|NCT00632502|10914708|FG001|Overall Study|Adverse Event|1
6896335|NCT00632502|10914707|FG000|Overall Study|Randomized not treated|3
6896336|NCT00632502|10914708|FG001|Overall Study|Randomized not treated|0
6896337|NCT00632541|10914715|FG000|Overall Study|Adverse Event|7
6896338|NCT00632736|10914737|FG000|Overall Study|Adverse Event|104
6896339|NCT00632736|10914737|FG000|Overall Study|Lost to Follow-up|15
6896340|NCT00632736|10914737|FG000|Overall Study|Protocol Violation|14
6896341|NCT00632736|10914737|FG000|Overall Study|Withdrawal by Subject|99
6896342|NCT00632736|10914737|FG000|Overall Study|Lack of Efficacy|5
6896343|NCT00632736|10914737|FG000|Overall Study|Sponsor terminated study|5
7183172|NCT02367794|11383295|FG002|Overall Study|Death|243
7183173|NCT02367794|11383293|FG000|Overall Study|Lost to Follow-up|1
7183174|NCT02367794|11383294|FG001|Overall Study|Lost to Follow-up|2
7183175|NCT02367794|11383295|FG002|Overall Study|Lost to Follow-up|2
7183176|NCT02367794|11383293|FG000|Overall Study|Physician Decision|0
7183177|NCT02367794|11383294|FG001|Overall Study|Physician Decision|5
7183178|NCT02367794|11383295|FG002|Overall Study|Physician Decision|3
7183179|NCT02367794|11383293|FG000|Overall Study|Protocol Violation|1
7183180|NCT02367794|11383294|FG001|Overall Study|Protocol Violation|0
7183181|NCT02367794|11383295|FG002|Overall Study|Protocol Violation|1
7183182|NCT02367794|11383293|FG000|Overall Study|Withdrawal by Subject|25
7081782|NCT02135692|11191972|FG000|Overall Study|Withdrawal by Subject|15
7081783|NCT02135848|11191978|FG000|Overall Study|Adverse Event|2
7081784|NCT02135848|11191979|FG001|Overall Study|Adverse Event|0
7081785|NCT02135848|11191978|FG000|Overall Study|Withdrawal by Subject|1
7183183|NCT02367794|11383294|FG001|Overall Study|Withdrawal by Subject|12
7183184|NCT02367794|11383295|FG002|Overall Study|Withdrawal by Subject|20
7183185|NCT02367794|11383293|FG000|Overall Study|Brain metastasis|1
7183186|NCT02367794|11383294|FG001|Overall Study|Brain metastasis|0
7183187|NCT02367794|11383295|FG002|Overall Study|Brain metastasis|0
7183188|NCT02367794|11383293|FG000|Overall Study|Randomized in error|0
7183189|NCT02367794|11383294|FG001|Overall Study|Randomized in error|0
7183190|NCT02367794|11383295|FG002|Overall Study|Randomized in error|1
7183191|NCT02367794|11383293|FG000|Overall Study|Patient unable to receive carboplatin|0
7183192|NCT02367794|11383294|FG001|Overall Study|Patient unable to receive carboplatin|0
7081786|NCT02135848|11191979|FG001|Overall Study|Withdrawal by Subject|1
7082987|NCT02147288|11193725|FG002|Overall Study|complications from concurrent hernia rep|0
7082988|NCT02147288|11193726|FG003|Overall Study|complications from concurrent hernia rep|0
7082989|NCT02147288|11193727|FG004|Overall Study|complications from concurrent hernia rep|0
7082990|NCT02147288|11193728|FG005|Overall Study|complications from concurrent hernia rep|0
7082991|NCT02147288|11193729|FG006|Overall Study|complications from concurrent hernia rep|0
7082992|NCT02147288|11193730|FG007|Overall Study|complications from concurrent hernia rep|0
7081787|NCT02136576|11192072|FG000|Overall Study|Lost to Follow-up|2
7081788|NCT02136576|11192073|FG001|Overall Study|Lost to Follow-up|0
7081789|NCT02136576|11192074|FG002|Overall Study|Lost to Follow-up|0
7081790|NCT02136680|11192084|FG000|Overall Study|No Longer Interested|1
7081791|NCT02136680|11192085|FG001|Overall Study|No Longer Interested|1
7081792|NCT02136680|11192084|FG000|Overall Study|No longer receiving care at clinic|3
7081793|NCT02136680|11192085|FG001|Overall Study|No longer receiving care at clinic|5
7081794|NCT02136680|11192084|FG000|Overall Study|Moved away|5
7081795|NCT02136680|11192085|FG001|Overall Study|Moved away|4
7081796|NCT02136680|11192084|FG000|Overall Study|Unable to schedule|17
7081797|NCT02136680|11192085|FG001|Overall Study|Unable to schedule|16
7081798|NCT02136680|11192084|FG000|Overall Study|Study ended before interview due|6
7081799|NCT02136680|11192085|FG001|Overall Study|Study ended before interview due|3
7081800|NCT02136914|11192097|FG000|Overall Study|Sponsor's Decision to Stop the Study|7
7081801|NCT02136914|11192098|FG001|Overall Study|Sponsor's Decision to Stop the Study|7
7081802|NCT02136914|11192097|FG000|Overall Study|Withdrawal by Subject|3
7081803|NCT02136914|11192098|FG001|Overall Study|Withdrawal by Subject|10
7081804|NCT02136914|11192097|FG000|Overall Study|Subject Unwilling to Proceed|7
7081805|NCT02136914|11192098|FG001|Overall Study|Subject Unwilling to Proceed|2
7081806|NCT02136914|11192097|FG000|Overall Study|Lost to Follow-up|1
7081807|NCT02136914|11192098|FG001|Overall Study|Lost to Follow-up|1
7081808|NCT02136914|11192097|FG000|Overall Study|Did Not Receive Study Drug|2
7081809|NCT02136914|11192098|FG001|Overall Study|Did Not Receive Study Drug|0
7081810|NCT02136914|11192097|FG000|Overall Study|Lack of Efficacy|1
7081811|NCT02136914|11192098|FG001|Overall Study|Lack of Efficacy|0
7081812|NCT02136914|11192097|FG000|Overall Study|Death|0
7081813|NCT02136914|11192098|FG001|Overall Study|Death|1
7081814|NCT02137226|11192106|FG000|Period 1 (Initial Randomization)|Adverse Event|3
7081815|NCT02137226|11192107|FG001|Period 1 (Initial Randomization)|Adverse Event|3
7081816|NCT02137226|11192108|FG002|Period 1 (Initial Randomization)|Adverse Event|0
7081817|NCT02137226|11192109|FG003|Period 1 (Initial Randomization)|Adverse Event|0
7081818|NCT02137226|11192110|FG004|Period 1 (Initial Randomization)|Adverse Event|0
7081819|NCT02137226|11192106|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11
7081820|NCT02137226|11192107|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5
7081821|NCT02137226|11192108|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0
7081822|NCT02137226|11192109|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0
7081823|NCT02137226|11192110|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0
7081824|NCT02137226|11192106|FG000|Period 1 (Initial Randomization)|Physician Decision|1
7081825|NCT02137226|11192107|FG001|Period 1 (Initial Randomization)|Physician Decision|3
7081826|NCT02137226|11192108|FG002|Period 1 (Initial Randomization)|Physician Decision|0
7081827|NCT02137226|11192109|FG003|Period 1 (Initial Randomization)|Physician Decision|0
7081828|NCT02137226|11192110|FG004|Period 1 (Initial Randomization)|Physician Decision|0
7081829|NCT02137226|11192106|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3
7081830|NCT02137226|11192107|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2
7081831|NCT02137226|11192108|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0
7081832|NCT02137226|11192109|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0
7081833|NCT02137226|11192110|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0
7081834|NCT02137226|11192106|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1
7081835|NCT02137226|11192107|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0
7081836|NCT02137226|11192108|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0
7187114|NCT02660034|11387577|FG007|Overall Study|Physician Decision|0
7187115|NCT02660034|11387578|FG008|Overall Study|Physician Decision|0
7187116|NCT02660034|11387579|FG009|Overall Study|Physician Decision|0
7187117|NCT02660034|11387580|FG010|Overall Study|Physician Decision|0
7187118|NCT02660034|11387581|FG011|Overall Study|Physician Decision|0
7187119|NCT02660034|11387582|FG012|Overall Study|Physician Decision|0
7187120|NCT02660034|11387583|FG013|Overall Study|Physician Decision|1
7187121|NCT02660034|11387570|FG000|Overall Study|Participants transferred to LTE|0
7187122|NCT02660034|11387571|FG001|Overall Study|Participants transferred to LTE|0
7187123|NCT02660034|11387572|FG002|Overall Study|Participants transferred to LTE|0
7081837|NCT02137226|11192109|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0
7081838|NCT02137226|11192110|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0
7081839|NCT02137226|11192106|FG000|Period 1 (Initial Randomization)|Other Reason|1
7081840|NCT02137226|11192107|FG001|Period 1 (Initial Randomization)|Other Reason|3
7081841|NCT02137226|11192108|FG002|Period 1 (Initial Randomization)|Other Reason|0
7081842|NCT02137226|11192109|FG003|Period 1 (Initial Randomization)|Other Reason|0
7081843|NCT02137226|11192110|FG004|Period 1 (Initial Randomization)|Other Reason|0
7081844|NCT02137226|11192106|FG000|Period 2 (Re - Randomization)|Adverse Event|0
7081845|NCT02137226|11192107|FG001|Period 2 (Re - Randomization)|Adverse Event|0
7081846|NCT02137226|11192108|FG002|Period 2 (Re - Randomization)|Adverse Event|3
7081847|NCT02137226|11192109|FG003|Period 2 (Re - Randomization)|Adverse Event|1
7081848|NCT02137226|11192110|FG004|Period 2 (Re - Randomization)|Adverse Event|4
7081849|NCT02137226|11192106|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0
7081850|NCT02137226|11192107|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0
7081851|NCT02137226|11192108|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8
7081852|NCT02137226|11192109|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5
7081853|NCT02137226|11192110|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4
7081854|NCT02137226|11192106|FG000|Period 2 (Re - Randomization)|Physician Decision|0
7081855|NCT02137226|11192107|FG001|Period 2 (Re - Randomization)|Physician Decision|0
7081856|NCT02137226|11192108|FG002|Period 2 (Re - Randomization)|Physician Decision|0
7081857|NCT02137226|11192109|FG003|Period 2 (Re - Randomization)|Physician Decision|1
7081858|NCT02137226|11192110|FG004|Period 2 (Re - Randomization)|Physician Decision|0
7081859|NCT02137226|11192106|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0
7081860|NCT02137226|11192107|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0
7081861|NCT02137226|11192108|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3
7081862|NCT02137226|11192109|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0
7081863|NCT02137226|11192110|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0
7081864|NCT02137226|11192106|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0
7081865|NCT02137226|11192107|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0
7081866|NCT02137226|11192108|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2
7081867|NCT02137226|11192109|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0
7081868|NCT02137226|11192110|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0
7081869|NCT02137226|11192106|FG000|Period 2 (Re - Randomization)|Other Reason|0
7081870|NCT02137226|11192107|FG001|Period 2 (Re - Randomization)|Other Reason|0
7081871|NCT02137226|11192108|FG002|Period 2 (Re - Randomization)|Other Reason|1
7081872|NCT02137226|11192109|FG003|Period 2 (Re - Randomization)|Other Reason|1
7081873|NCT02137226|11192110|FG004|Period 2 (Re - Randomization)|Other Reason|1
7081874|NCT02137369|11192120|FG000|Overall Study|Withdrawal by Subject|3
7081875|NCT02137369|11192121|FG001|Overall Study|Withdrawal by Subject|2
7081876|NCT02137369|11192120|FG000|Overall Study|Adverse Event|2
7081877|NCT02137369|11192121|FG001|Overall Study|Adverse Event|0
7081878|NCT02137369|11192120|FG000|Overall Study|Lost to Follow-up|1
7081879|NCT02137369|11192121|FG001|Overall Study|Lost to Follow-up|0
7081880|NCT02137369|11192120|FG000|Overall Study|Moved away|2
7081881|NCT02137369|11192121|FG001|Overall Study|Moved away|0
7081882|NCT02137772|11192198|FG000|Overall Study|Adverse Event|6
7081883|NCT02137772|11192199|FG001|Overall Study|Adverse Event|3
7081884|NCT02137772|11192198|FG000|Overall Study|Death|71
7081885|NCT02137772|11192199|FG001|Overall Study|Death|44
7081886|NCT02137772|11192198|FG000|Overall Study|Lost to Follow-up|8
7081887|NCT02137772|11192199|FG001|Overall Study|Lost to Follow-up|4
7081888|NCT02137772|11192198|FG000|Overall Study|Physician Decision|15
7081889|NCT02137772|11192199|FG001|Overall Study|Physician Decision|5
7081890|NCT02137772|11192198|FG000|Overall Study|Withdrawal by Subject|28
7081891|NCT02137772|11192199|FG001|Overall Study|Withdrawal by Subject|17
7081892|NCT02137772|11192198|FG000|Overall Study|Non-compliance with study drug|1
7081893|NCT02137772|11192199|FG001|Overall Study|Non-compliance with study drug|0
7081894|NCT02137772|11192198|FG000|Overall Study|Not treated|3
7081895|NCT02137772|11192199|FG001|Overall Study|Not treated|2
7081896|NCT02137785|11192207|FG000|Overall Study|Lost to Follow-up|1
7081897|NCT02137785|11192208|FG001|Overall Study|Lost to Follow-up|0
7081898|NCT02137785|11192207|FG000|Overall Study|Withdrawal by Subject|1
7081899|NCT02137785|11192208|FG001|Overall Study|Withdrawal by Subject|4
7081900|NCT02137785|11192207|FG000|Overall Study|subject moved out of state|1
7081901|NCT02137785|11192208|FG001|Overall Study|subject moved out of state|0
7081902|NCT02137837|11192217|FG000|Overall Study|Adverse Event|0
7081903|NCT02137837|11192218|FG001|Overall Study|Adverse Event|2
7081904|NCT02137837|11192219|FG002|Overall Study|Adverse Event|1
7081905|NCT02137837|11192217|FG000|Overall Study|Refusal unrelated to adverse event|2
7081906|NCT02137837|11192218|FG001|Overall Study|Refusal unrelated to adverse event|2
7081907|NCT02137837|11192219|FG002|Overall Study|Refusal unrelated to adverse event|1
7081908|NCT02137837|11192217|FG000|Overall Study|Progression/relapse|9
7081909|NCT02137837|11192218|FG001|Overall Study|Progression/relapse|7
7081910|NCT02137837|11192219|FG002|Overall Study|Progression/relapse|7
7081911|NCT02137837|11192217|FG000|Overall Study|Not protocol specified|2
7081912|NCT02137837|11192218|FG001|Overall Study|Not protocol specified|1
7081913|NCT02137837|11192219|FG002|Overall Study|Not protocol specified|3
7081914|NCT02138110|11192284|FG000|Enrolled for Scaffold Implantation|Physician Decision|1
7081915|NCT02138110|11192284|FG000|Overall Scaffold Implantation|Death|3
7081916|NCT02138136|11192288|FG000|Overall Study|Protocol Violation|4
7081917|NCT02138136|11192288|FG000|Overall Study|Physician Decision|7
7081918|NCT02138136|11192288|FG000|Overall Study|Lack of Efficacy|35
7081919|NCT02138136|11192288|FG000|Overall Study|Pregnancy|2
7081920|NCT02138136|11192288|FG000|Overall Study|Adverse Event|18
7081921|NCT02138136|11192288|FG000|Overall Study|Withdrawal by Subject|36
7081922|NCT02138136|11192288|FG000|Overall Study|Lost to Follow-up|32
7081923|NCT02138136|11192288|FG000|Overall Study|Withdrawn by Sponsor|5
7081924|NCT02138214|11192296|FG000|Overall Study|Withdrawal by Subject|0
7081925|NCT02138214|11192297|FG001|Overall Study|Withdrawal by Subject|1
7081926|NCT02138214|11192298|FG002|Overall Study|Withdrawal by Subject|0
7081927|NCT02138214|11192296|FG000|Overall Study|Lost to Follow-up|0
7081928|NCT02138214|11192297|FG001|Overall Study|Lost to Follow-up|2
7081929|NCT02138214|11192298|FG002|Overall Study|Lost to Follow-up|4
7081930|NCT02138214|11192296|FG000|Overall Study|Screen Failure|0
7081931|NCT02138214|11192297|FG001|Overall Study|Screen Failure|1
7081932|NCT02138214|11192298|FG002|Overall Study|Screen Failure|0
7081933|NCT02138253|11192345|FG000|Overall Study|Adverse Event|3
7081934|NCT02138253|11192346|FG001|Overall Study|Adverse Event|3
7081935|NCT02138253|11192345|FG000|Overall Study|Lost to Follow-up|2
7081936|NCT02138253|11192346|FG001|Overall Study|Lost to Follow-up|1
7081937|NCT02138253|11192345|FG000|Overall Study|Physician Decision|2
7081938|NCT02138253|11192346|FG001|Overall Study|Physician Decision|0
7081939|NCT02138253|11192345|FG000|Overall Study|Non compliance|1
7081940|NCT02138253|11192346|FG001|Overall Study|Non compliance|0
7081941|NCT02138253|11192345|FG000|Overall Study|Withdrawal by Subject|1
7081942|NCT02138253|11192346|FG001|Overall Study|Withdrawal by Subject|0
7081943|NCT02138747|11192378|FG000|Treatment Period 1|Adverse Event|10
7081944|NCT02138747|11192379|FG001|Treatment Period 1|Adverse Event|14
7081945|NCT02138747|11192380|FG002|Treatment Period 1|Adverse Event|2
7081946|NCT02138747|11192381|FG003|Treatment Period 1|Adverse Event|1
7081947|NCT02138747|11192378|FG000|Treatment Period 1|Lost to Follow-up|0
7081948|NCT02138747|11192379|FG001|Treatment Period 1|Lost to Follow-up|1
7081949|NCT02138747|11192380|FG002|Treatment Period 1|Lost to Follow-up|1
7081950|NCT02138747|11192381|FG003|Treatment Period 1|Lost to Follow-up|0
7081951|NCT02138747|11192378|FG000|Treatment Period 1|Protocol Violation|0
7081952|NCT02138747|11192379|FG001|Treatment Period 1|Protocol Violation|2
7081953|NCT02138747|11192380|FG002|Treatment Period 1|Protocol Violation|0
7081954|NCT02138747|11192381|FG003|Treatment Period 1|Protocol Violation|0
7081955|NCT02138747|11192378|FG000|Treatment Period 1|Withdrawal by Subject|8
7081956|NCT02138747|11192379|FG001|Treatment Period 1|Withdrawal by Subject|4
7081957|NCT02138747|11192380|FG002|Treatment Period 1|Withdrawal by Subject|1
7081958|NCT02138747|11192381|FG003|Treatment Period 1|Withdrawal by Subject|3
7081959|NCT02138747|11192378|FG000|Treatment Period 1|Other - Miscellaneous|2
7081960|NCT02138747|11192379|FG001|Treatment Period 1|Other - Miscellaneous|4
7081961|NCT02138747|11192380|FG002|Treatment Period 1|Other - Miscellaneous|0
7081962|NCT02138747|11192381|FG003|Treatment Period 1|Other - Miscellaneous|0
7081963|NCT02138747|11192378|FG000|Treatment Period 2|Adverse Event|6
7081964|NCT02138747|11192379|FG001|Treatment Period 2|Adverse Event|3
7081965|NCT02138747|11192380|FG002|Treatment Period 2|Adverse Event|1
7081966|NCT02138747|11192381|FG003|Treatment Period 2|Adverse Event|1
7081967|NCT02138747|11192378|FG000|Treatment Period 2|Lost to Follow-up|2
7081968|NCT02138747|11192379|FG001|Treatment Period 2|Lost to Follow-up|0
7081969|NCT02138747|11192380|FG002|Treatment Period 2|Lost to Follow-up|0
7081970|NCT02138747|11192381|FG003|Treatment Period 2|Lost to Follow-up|0
7081971|NCT02138747|11192378|FG000|Treatment Period 2|Protocol Violation|1
7081972|NCT02138747|11192379|FG001|Treatment Period 2|Protocol Violation|0
7081973|NCT02138747|11192380|FG002|Treatment Period 2|Protocol Violation|0
7081974|NCT02138747|11192381|FG003|Treatment Period 2|Protocol Violation|0
7081975|NCT02138747|11192378|FG000|Treatment Period 2|Withdrawal by Subject|5
7081976|NCT02138747|11192379|FG001|Treatment Period 2|Withdrawal by Subject|4
7081977|NCT02138747|11192380|FG002|Treatment Period 2|Withdrawal by Subject|1
7081978|NCT02138747|11192381|FG003|Treatment Period 2|Withdrawal by Subject|2
7081979|NCT02138747|11192378|FG000|Treatment Period 2|Other - Miscellaneous|3
7183193|NCT02367794|11383295|FG002|Overall Study|Patient unable to receive carboplatin|1
7183194|NCT02367794|11383293|FG000|Overall Study|Hypercalcemia prior to C1D1|0
7183195|NCT02367794|11383294|FG001|Overall Study|Hypercalcemia prior to C1D1|0
7183196|NCT02367794|11383295|FG002|Overall Study|Hypercalcemia prior to C1D1|1
7183197|NCT02367794|11383293|FG000|Overall Study|Adverse Event|0
7183198|NCT02367794|11383294|FG001|Overall Study|Adverse Event|0
7183199|NCT02367794|11383295|FG002|Overall Study|Adverse Event|2
7183200|NCT02367794|11383293|FG000|Overall Study|Study Terminated By Sponsor|0
7183201|NCT02367794|11383294|FG001|Overall Study|Study Terminated By Sponsor|1
7183202|NCT02367794|11383295|FG002|Overall Study|Study Terminated By Sponsor|1
7183203|NCT02367794|11383293|FG000|Overall Study|Moved to Roll-Over Study|0
7183204|NCT02367794|11383294|FG001|Overall Study|Moved to Roll-Over Study|15
7183205|NCT02367794|11383295|FG002|Overall Study|Moved to Roll-Over Study|13
7081980|NCT02138747|11192379|FG001|Treatment Period 2|Other - Miscellaneous|0
7081981|NCT02138747|11192380|FG002|Treatment Period 2|Other - Miscellaneous|0
7081982|NCT02138747|11192381|FG003|Treatment Period 2|Other - Miscellaneous|0
7081983|NCT02138786|11192394|FG000|Overall Study|Adverse Event|0
7081984|NCT02138786|11192395|FG001|Overall Study|Adverse Event|2
7081985|NCT02138786|11192396|FG002|Overall Study|Adverse Event|1
7183206|NCT02367794|11383293|FG000|Overall Study|Sponsor Request|60
7183207|NCT02367794|11383294|FG001|Overall Study|Sponsor Request|57
7081986|NCT02138786|11192394|FG000|Overall Study|Death|1
7081987|NCT02138786|11192395|FG001|Overall Study|Death|7
7081988|NCT02138786|11192396|FG002|Overall Study|Death|2
7081989|NCT02138786|11192394|FG000|Overall Study|Disease Progression|1
7183208|NCT02367794|11383295|FG002|Overall Study|Sponsor Request|45
7183209|NCT02367794|11383293|FG000|Overall Study|Moved into PTAP Study|0
7183210|NCT02367794|11383294|FG001|Overall Study|Moved into PTAP Study|2
7183211|NCT02367794|11383295|FG002|Overall Study|Moved into PTAP Study|3
7183212|NCT02367794|11383293|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0
7183213|NCT02367794|11383294|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2
7183214|NCT02367794|11383295|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1
7183215|NCT02367794|11383293|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0
7183216|NCT02367794|11383294|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1
7183217|NCT02367794|11383295|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0
7183218|NCT02367794|11383293|FG000|Overall Study|Participant Enrolled in Extended Protocol|0
7183219|NCT02367794|11383294|FG001|Overall Study|Participant Enrolled in Extended Protocol|1
7183220|NCT02367794|11383295|FG002|Overall Study|Participant Enrolled in Extended Protocol|0
7183221|NCT02367794|11383293|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0
7183222|NCT02367794|11383294|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0
7183223|NCT02367794|11383295|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1
7183224|NCT02353832|11383328|FG000|Overall Study|Ineligible after enrollment|1
7183225|NCT02353832|11383328|FG000|Overall Study|Lost to Follow-up|1
7183226|NCT02353728|11383332|FG000|Overall Study|Subject non-compliance|1
7183227|NCT02345070|11383339|FG000|Overall Study|Adverse Event|12
7183228|NCT02345070|11383340|FG001|Overall Study|Adverse Event|8
7183229|NCT02345070|11383341|FG002|Overall Study|Adverse Event|16
7183230|NCT02345070|11383339|FG000|Overall Study|Poor compliance to protocol|2
7183231|NCT02345070|11383340|FG001|Overall Study|Poor compliance to protocol|0
7183232|NCT02345070|11383341|FG002|Overall Study|Poor compliance to protocol|0
7183233|NCT02345070|11383339|FG000|Overall Study|Other than specified above|6
7183234|NCT02345070|11383340|FG001|Overall Study|Other than specified above|3
7183235|NCT02345070|11383341|FG002|Overall Study|Other than specified above|7
7183236|NCT02325466|11383349|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0
7183237|NCT02325466|11383350|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0
7183238|NCT02325466|11383351|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1
7183239|NCT02325466|11383349|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0
7183240|NCT02325466|11383350|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2
7081990|NCT02138786|11192395|FG001|Overall Study|Disease Progression|1
7081991|NCT02138786|11192396|FG002|Overall Study|Disease Progression|3
7081992|NCT02138786|11192394|FG000|Overall Study|Withdrawal by Subject|1
7081993|NCT02138786|11192395|FG001|Overall Study|Withdrawal by Subject|2
7081994|NCT02138786|11192396|FG002|Overall Study|Withdrawal by Subject|0
7081995|NCT02138786|11192394|FG000|Overall Study|Patient's Wish|0
7081996|NCT02138786|11192395|FG001|Overall Study|Patient's Wish|2
7081997|NCT02138786|11192396|FG002|Overall Study|Patient's Wish|0
7081998|NCT02138786|11192394|FG000|Overall Study|Sponsor Terminated Study|0
7081999|NCT02138786|11192395|FG001|Overall Study|Sponsor Terminated Study|1
7082000|NCT02138786|11192396|FG002|Overall Study|Sponsor Terminated Study|1
7082001|NCT02138786|11192394|FG000|Overall Study|Non-Compliance|0
7082002|NCT02138786|11192395|FG001|Overall Study|Non-Compliance|0
7082003|NCT02138786|11192396|FG002|Overall Study|Non-Compliance|1
7082004|NCT02138825|11192404|FG000|Main Study Treatment|Adverse Event|11
7082005|NCT02138825|11192405|FG001|Main Study Treatment|Adverse Event|3
7082006|NCT02138825|11192404|FG000|Main Study Treatment|Death|1
7082007|NCT02138825|11192405|FG001|Main Study Treatment|Death|2
7082008|NCT02138825|11192404|FG000|Main Study Treatment|Protocol Violation|2
7082009|NCT02138825|11192405|FG001|Main Study Treatment|Protocol Violation|2
7082010|NCT02138825|11192404|FG000|Main Study Treatment|Sponsor decision|12
7082011|NCT02138825|11192405|FG001|Main Study Treatment|Sponsor decision|18
7183241|NCT02325466|11383351|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0
7183242|NCT02325466|11383349|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1
7183243|NCT02325466|11383350|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0
7183244|NCT02325466|11383351|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2
7183245|NCT02325466|11383349|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1
7183246|NCT02325466|11383350|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0
7183247|NCT02325466|11383351|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0
7183248|NCT02325466|11383349|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1
7183249|NCT02325466|11383350|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1
7183250|NCT02325466|11383351|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0
7183251|NCT02325466|11383349|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1
7183252|NCT02325466|11383350|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0
7183253|NCT02325466|11383351|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0
7183254|NCT02325466|11383349|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1
7183255|NCT02325466|11383350|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0
7183256|NCT02325466|11383351|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0
7183257|NCT02325466|11383349|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0
7183258|NCT02325466|11383350|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1
7183259|NCT02325466|11383351|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0
7183260|NCT02325466|11383349|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0
7183261|NCT02325466|11383350|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1
7183262|NCT02325466|11383351|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0
7183263|NCT02322710|11383362|FG000|Overall Study|No efficacy assessment post-baseline|0
7183264|NCT02322710|11383363|FG001|Overall Study|No efficacy assessment post-baseline|1
7183265|NCT02322710|11383362|FG000|Overall Study|Protocol Violation|20
7183266|NCT02322710|11383363|FG001|Overall Study|Protocol Violation|25
7183267|NCT02234310|11383411|FG000|Overall Study|Physician Decision|1
7183268|NCT02234310|11383411|FG000|Overall Study|Adverse Event|1
7183269|NCT02234310|11383411|FG000|Overall Study|Eligibility Criteria not fulfilled|2
7183270|NCT02234310|11383411|FG000|Overall Study|Withdrawal by Subject|2
7183271|NCT02158091|11383425|FG000|Overall Study|DLT|2
7183272|NCT02158091|11383426|FG001|Overall Study|DLT|1
7183273|NCT02158091|11383427|FG002|Overall Study|DLT|0
7187124|NCT02660034|11387573|FG003|Overall Study|Participants transferred to LTE|0
7187125|NCT02660034|11387574|FG004|Overall Study|Participants transferred to LTE|0
7187126|NCT02660034|11387575|FG005|Overall Study|Participants transferred to LTE|10
7187127|NCT02660034|11387576|FG006|Overall Study|Participants transferred to LTE|8
7187128|NCT02660034|11387577|FG007|Overall Study|Participants transferred to LTE|8
7187129|NCT02660034|11387578|FG008|Overall Study|Participants transferred to LTE|10
7187130|NCT02660034|11387579|FG009|Overall Study|Participants transferred to LTE|1
7187131|NCT02660034|11387580|FG010|Overall Study|Participants transferred to LTE|2
7187132|NCT02660034|11387581|FG011|Overall Study|Participants transferred to LTE|4
7187133|NCT02660034|11387582|FG012|Overall Study|Participants transferred to LTE|1
7187134|NCT02660034|11387583|FG013|Overall Study|Participants transferred to LTE|1
7187135|NCT02640625|11387617|FG000|Overall Study|Adverse Event|1
7187136|NCT02561962|11387631|FG000|Overall Study|Ongoing in study|1
7187137|NCT02561962|11387632|FG001|Overall Study|Ongoing in study|0
7187138|NCT02561962|11387633|FG002|Overall Study|Ongoing in study|0
7187139|NCT02561962|11387634|FG003|Overall Study|Ongoing in study|1
7187140|NCT02561962|11387635|FG004|Overall Study|Ongoing in study|0
7187141|NCT02561962|11387636|FG005|Overall Study|Ongoing in study|1
7187142|NCT02561962|11387637|FG006|Overall Study|Ongoing in study|0
7187143|NCT02561962|11387638|FG007|Overall Study|Ongoing in study|4
7187144|NCT02561962|11387639|FG008|Overall Study|Ongoing in study|1
7187145|NCT02561962|11387631|FG000|Overall Study|Withdrawal by Subject|1
7187146|NCT02561962|11387632|FG001|Overall Study|Withdrawal by Subject|0
7187147|NCT02561962|11387633|FG002|Overall Study|Withdrawal by Subject|0
7082012|NCT02138825|11192404|FG000|Main Study Treatment|Study terminated by sponsor|10
7082013|NCT02138825|11192405|FG001|Main Study Treatment|Study terminated by sponsor|9
6896344|NCT00632736|10914737|FG000|Overall Study|Non-compliance|10
6896345|NCT00632736|10914737|FG000|Overall Study|Other|16
6896346|NCT00632749|10914755|FG000|Overall Study|Progressive disease|3
6896347|NCT00632749|10914756|FG001|Overall Study|Progressive disease|2
6896348|NCT00632749|10914757|FG002|Overall Study|Progressive disease|2
6896349|NCT00632749|10914758|FG003|Overall Study|Progressive disease|2
6896350|NCT00632749|10914759|FG004|Overall Study|Progressive disease|4
6896351|NCT00632749|10914760|FG005|Overall Study|Progressive disease|4
6896352|NCT00632749|10914761|FG006|Overall Study|Progressive disease|3
6896353|NCT00632749|10914762|FG007|Overall Study|Progressive disease|2
6896354|NCT00632749|10914763|FG008|Overall Study|Progressive disease|3
6896355|NCT00632749|10914764|FG009|Overall Study|Progressive disease|2
6896356|NCT00632749|10914765|FG010|Overall Study|Progressive disease|4
6896357|NCT00632749|10914766|FG011|Overall Study|Progressive disease|3
6896358|NCT00632749|10914767|FG012|Overall Study|Progressive disease|2
6896359|NCT00632749|10914768|FG013|Overall Study|Progressive disease|4
6896360|NCT00632749|10914755|FG000|Overall Study|Other Adverse event|1
6896361|NCT00632749|10914756|FG001|Overall Study|Other Adverse event|1
6896362|NCT00632749|10914757|FG002|Overall Study|Other Adverse event|1
6896363|NCT00632749|10914758|FG003|Overall Study|Other Adverse event|1
6896364|NCT00632749|10914759|FG004|Overall Study|Other Adverse event|2
6896365|NCT00632749|10914760|FG005|Overall Study|Other Adverse event|4
6896366|NCT00632749|10914761|FG006|Overall Study|Other Adverse event|1
6896367|NCT00632749|10914762|FG007|Overall Study|Other Adverse event|2
6896368|NCT00632749|10914763|FG008|Overall Study|Other Adverse event|2
6896369|NCT00632749|10914764|FG009|Overall Study|Other Adverse event|0
6896370|NCT00632749|10914765|FG010|Overall Study|Other Adverse event|1
6896371|NCT00632749|10914766|FG011|Overall Study|Other Adverse event|0
6896372|NCT00632749|10914767|FG012|Overall Study|Other Adverse event|1
6896373|NCT00632749|10914768|FG013|Overall Study|Other Adverse event|0
6896374|NCT00632749|10914755|FG000|Overall Study|Refuse to continue medication|0
6896375|NCT00632749|10914756|FG001|Overall Study|Refuse to continue medication|0
6896376|NCT00632749|10914757|FG002|Overall Study|Refuse to continue medication|0
6896377|NCT00632749|10914758|FG003|Overall Study|Refuse to continue medication|1
6896378|NCT00632749|10914759|FG004|Overall Study|Refuse to continue medication|0
6896379|NCT00632749|10914760|FG005|Overall Study|Refuse to continue medication|0
6896380|NCT00632749|10914761|FG006|Overall Study|Refuse to continue medication|0
6896381|NCT00632749|10914762|FG007|Overall Study|Refuse to continue medication|0
6896382|NCT00632749|10914763|FG008|Overall Study|Refuse to continue medication|0
6896383|NCT00632749|10914764|FG009|Overall Study|Refuse to continue medication|1
6896384|NCT00632749|10914765|FG010|Overall Study|Refuse to continue medication|0
6896385|NCT00632749|10914766|FG011|Overall Study|Refuse to continue medication|0
6896386|NCT00632749|10914767|FG012|Overall Study|Refuse to continue medication|0
6896387|NCT00632749|10914768|FG013|Overall Study|Refuse to continue medication|0
6896388|NCT00632749|10914755|FG000|Overall Study|Reason other than those specified above|0
6896389|NCT00632749|10914756|FG001|Overall Study|Reason other than those specified above|2
6973453|NCT01181128|11025236|FG000|Overall Study|Death|1
6973454|NCT01181128|11025237|FG001|Overall Study|Death|0
6973455|NCT01181128|11025238|FG002|Overall Study|Death|0
7082014|NCT02138825|11192404|FG000|Main Study Treatment|Withdrawal by Subject|3
7082015|NCT02138825|11192405|FG001|Main Study Treatment|Withdrawal by Subject|1
7082016|NCT02138825|11192404|FG000|Main Study Treatment|Medical decision|1
6896390|NCT00632749|10914757|FG002|Overall Study|Reason other than those specified above|0
6896391|NCT00632749|10914758|FG003|Overall Study|Reason other than those specified above|0
6896392|NCT00632749|10914759|FG004|Overall Study|Reason other than those specified above|1
6896393|NCT00632749|10914760|FG005|Overall Study|Reason other than those specified above|0
6896394|NCT00632749|10914761|FG006|Overall Study|Reason other than those specified above|1
6896395|NCT00632749|10914762|FG007|Overall Study|Reason other than those specified above|0
6896396|NCT00632749|10914763|FG008|Overall Study|Reason other than those specified above|0
6896397|NCT00632749|10914764|FG009|Overall Study|Reason other than those specified above|0
6896398|NCT00632749|10914765|FG010|Overall Study|Reason other than those specified above|2
6896399|NCT00632749|10914766|FG011|Overall Study|Reason other than those specified above|1
6896400|NCT00632749|10914767|FG012|Overall Study|Reason other than those specified above|0
6896401|NCT00632749|10914768|FG013|Overall Study|Reason other than those specified above|2
6896402|NCT00632827|10914817|FG000|Overall Study|Excluded after GVD (Not evaluable)|2
6896403|NCT00632827|10914817|FG000|Overall Study|Death|2
6896404|NCT00632827|10914817|FG000|Overall Study|Adverse Event|5
6896405|NCT00632827|10914817|FG000|Overall Study|Lost to Follow-up|1
6896406|NCT00632931|10914822|FG000|Part 1, Period 1|Protocol Violation|1
6896407|NCT00632931|10914823|FG001|Part 1, Period 1|Protocol Violation|0
6896408|NCT00632931|10914824|FG002|Part 1, Period 1|Protocol Violation|0
6896409|NCT00632931|10914822|FG000|Part 1, Period 1|Withdrawal by Subject|1
6896410|NCT00632931|10914823|FG001|Part 1, Period 1|Withdrawal by Subject|0
6896411|NCT00632931|10914824|FG002|Part 1, Period 1|Withdrawal by Subject|0
6896412|NCT00632931|10914822|FG000|Part 2|Adverse Event|0
6896413|NCT00632931|10914823|FG001|Part 2|Adverse Event|0
6896414|NCT00632931|10914824|FG002|Part 2|Adverse Event|3
6896415|NCT00632931|10914822|FG000|Part 2|Death|0
6896416|NCT00632931|10914823|FG001|Part 2|Death|0
6896417|NCT00632931|10914824|FG002|Part 2|Death|1
6896418|NCT00632931|10914822|FG000|Part 2|Lack of Efficacy|0
6896419|NCT00632931|10914823|FG001|Part 2|Lack of Efficacy|0
6896420|NCT00632931|10914824|FG002|Part 2|Lack of Efficacy|17
6896421|NCT00632931|10914822|FG000|Part 2|Withdrawal by Subject|0
6896422|NCT00632931|10914823|FG001|Part 2|Withdrawal by Subject|0
6896423|NCT00632931|10914824|FG002|Part 2|Withdrawal by Subject|3
6896424|NCT00633022|10914857|FG000|Overall Study|Adverse Event|1
6896425|NCT00633022|10914858|FG001|Overall Study|Adverse Event|0
6896426|NCT00633022|10914859|FG002|Overall Study|Adverse Event|5
6896427|NCT00633022|10914857|FG000|Overall Study|Physician Decision|0
7082017|NCT02138825|11192405|FG001|Main Study Treatment|Medical decision|0
7082018|NCT02138825|11192404|FG000|Long-term Extension|Study termination by sponsor|32
7082019|NCT02138825|11192405|FG001|Long-term Extension|Study termination by sponsor|38
7082020|NCT02138825|11192404|FG000|Safety Follow-up|Adverse Event|4
7082021|NCT02138825|11192405|FG001|Safety Follow-up|Adverse Event|3
7082022|NCT02138825|11192404|FG000|Safety Follow-up|Death|11
7082023|NCT02138825|11192405|FG001|Safety Follow-up|Death|5
6896428|NCT00633022|10914858|FG001|Overall Study|Physician Decision|1
6896429|NCT00633022|10914859|FG002|Overall Study|Physician Decision|0
6896430|NCT00633074|10914869|FG000|Overall Study|Adverse Event|1
6896431|NCT00633074|10914870|FG001|Overall Study|Adverse Event|0
6896432|NCT00633126|10914876|FG000|Overall Study|Did not receive full dose|1
7082024|NCT02138825|11192404|FG000|Safety Follow-up|Withdrawal by Subject|5
7082025|NCT02138825|11192405|FG001|Safety Follow-up|Withdrawal by Subject|3
7082026|NCT02138825|11192404|FG000|Safety Follow-up|clinic worsening|1
7082027|NCT02138825|11192405|FG001|Safety Follow-up|clinic worsening|0
7183274|NCT02106195|11383464|FG000|Overall Study|Adverse Event|2
7183275|NCT02106195|11383464|FG000|Overall Study|Protocol Violation|1
7183276|NCT02104180|11383476|FG000|Overall Study|Protocol Violation|1
7183277|NCT02104180|11383477|FG001|Overall Study|Protocol Violation|0
7183278|NCT02066181|11383485|FG000|Overall Study|Withdrawal by Subject|1
7082028|NCT02138825|11192404|FG000|Safety Follow-up|withdrawal by PI|1
7082029|NCT02138825|11192405|FG001|Safety Follow-up|withdrawal by PI|0
7082030|NCT02138825|11192404|FG000|Safety Follow-up|logistical difficulties|0
7082031|NCT02138825|11192405|FG001|Safety Follow-up|logistical difficulties|1
7082032|NCT02138825|11192404|FG000|Safety Follow-up|progressive disease|0
7082033|NCT02138825|11192405|FG001|Safety Follow-up|progressive disease|2
7082034|NCT02138825|11192404|FG000|Safety Follow-up|too unwell to attend the visit|0
7082035|NCT02138825|11192405|FG001|Safety Follow-up|too unwell to attend the visit|1
7082036|NCT02138825|11192404|FG000|Safety Follow-up|treatment unblinded|0
7082037|NCT02138825|11192405|FG001|Safety Follow-up|treatment unblinded|1
7183279|NCT02066181|11383486|FG001|Overall Study|Withdrawal by Subject|1
7183280|NCT02040857|11383499|FG000|Overall Study|Adverse Event|14
7183281|NCT02040857|11383499|FG000|Overall Study|Physician Decision|5
7183282|NCT02040857|11383499|FG000|Overall Study|Withdrawal by Subject|31
7183283|NCT02040857|11383499|FG000|Overall Study|patient non-compliance|3
7183284|NCT02040857|11383499|FG000|Overall Study|Lost to Follow-up|2
7183285|NCT02040857|11383499|FG000|Overall Study|recurrence|4
7183286|NCT02040857|11383499|FG000|Overall Study|ineligible|1
7183287|NCT01943825|11383519|FG000|Overall Study|Lost to Follow-up|9
7183288|NCT01943825|11383520|FG001|Overall Study|Lost to Follow-up|3
7183289|NCT01943825|11383521|FG002|Overall Study|Lost to Follow-up|12
7183290|NCT01943825|11383522|FG003|Overall Study|Lost to Follow-up|8
7183291|NCT01943825|11383519|FG000|Overall Study|Withdrawal by Subject|1
7183292|NCT01943825|11383520|FG001|Overall Study|Withdrawal by Subject|0
7183293|NCT01943825|11383521|FG002|Overall Study|Withdrawal by Subject|3
7183294|NCT01943825|11383522|FG003|Overall Study|Withdrawal by Subject|2
7183295|NCT01943825|11383519|FG000|Overall Study|Other than specified above|0
7183296|NCT01943825|11383520|FG001|Overall Study|Other than specified above|1
7183297|NCT01943825|11383521|FG002|Overall Study|Other than specified above|0
7183298|NCT01943825|11383522|FG003|Overall Study|Other than specified above|1
7183299|NCT01940471|11383538|FG000|Double-Blind Phase|Randomized but Never Treated|1
7183300|NCT01940471|11383539|FG001|Double-Blind Phase|Randomized but Never Treated|1
7183301|NCT01940471|11383538|FG000|Double-Blind Phase|Withdrew Consent|13
7183302|NCT01940471|11383539|FG001|Double-Blind Phase|Withdrew Consent|7
7183303|NCT01940471|11383538|FG000|Double-Blind Phase|Adverse Event|1
7183304|NCT01940471|11383539|FG001|Double-Blind Phase|Adverse Event|2
7183305|NCT01940471|11383538|FG000|Double-Blind Phase|Lost to Follow-up|3
7183306|NCT01940471|11383539|FG001|Double-Blind Phase|Lost to Follow-up|2
7183307|NCT01940471|11383538|FG000|Double-Blind Phase|Pregnancy|2
7183308|NCT01940471|11383539|FG001|Double-Blind Phase|Pregnancy|1
7183309|NCT01940471|11383538|FG000|Double-Blind Phase|Investigator's Discretion|5
7183310|NCT01940471|11383539|FG001|Double-Blind Phase|Investigator's Discretion|0
7183311|NCT01940471|11383538|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1
7183312|NCT01940471|11383539|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1
7183313|NCT01940471|11383538|FG000|Double-Blind Phase|Protocol-Specified Criteria|1
7183314|NCT01940471|11383539|FG001|Double-Blind Phase|Protocol-Specified Criteria|0
7183315|NCT01940471|11383538|FG000|Double-Blind Phase|Death|1
7183316|NCT01940471|11383539|FG001|Double-Blind Phase|Death|0
7183317|NCT01940471|11383538|FG000|Double-Blind Phase|Lack of Efficacy|1
7183318|NCT01940471|11383539|FG001|Double-Blind Phase|Lack of Efficacy|0
7183319|NCT01940471|11383538|FG000|Double-Blind Phase|Protocol Violation|0
7183320|NCT01940471|11383539|FG001|Double-Blind Phase|Protocol Violation|1
7183321|NCT01940471|11383538|FG000|Double-Blind Phase|Still in Double-Blind Phase|539
7183322|NCT01940471|11383539|FG001|Double-Blind Phase|Still in Double-Blind Phase|270
7183323|NCT01940471|11383538|FG000|Open-Label Extension|Still in Open-Label Extension Phase|14
7183324|NCT01940471|11383539|FG001|Open-Label Extension|Still in Open-Label Extension Phase|8
7183325|NCT01874353|11383548|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2
7183326|NCT01874353|11383549|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0
7082038|NCT02138825|11192404|FG000|Safety Follow-up|withdrawn due to lung transplant|0
7082039|NCT02138825|11192405|FG001|Safety Follow-up|withdrawn due to lung transplant|1
7187148|NCT02561962|11387634|FG003|Overall Study|Withdrawal by Subject|0
6896433|NCT00633139|10914883|FG000|Overall Study|Non compliance|0
6896434|NCT00633139|10914884|FG001|Overall Study|Non compliance|0
7183327|NCT01874353|11383550|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0
7183328|NCT01874353|11383551|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0
7183329|NCT01874353|11383548|FG000|Overall Study|Lost to Follow-up|2
7183330|NCT01874353|11383549|FG001|Overall Study|Lost to Follow-up|2
7183331|NCT01874353|11383550|FG002|Overall Study|Lost to Follow-up|2
7183332|NCT01874353|11383551|FG003|Overall Study|Lost to Follow-up|0
7183333|NCT01874353|11383548|FG000|Overall Study|Death|110
7183334|NCT01874353|11383549|FG001|Overall Study|Death|60
7183335|NCT01874353|11383550|FG002|Overall Study|Death|13
7183336|NCT01874353|11383551|FG003|Overall Study|Death|7
7183337|NCT01874353|11383548|FG000|Overall Study|Withdrawal by Subject|13
7183338|NCT01874353|11383549|FG001|Overall Study|Withdrawal by Subject|11
7183339|NCT01874353|11383550|FG002|Overall Study|Withdrawal by Subject|0
7183340|NCT01874353|11383551|FG003|Overall Study|Withdrawal by Subject|0
7183341|NCT01853748|11383580|FG000|Allocation|Withdrawal by Subject|1
7082040|NCT02138838|11192418|FG000|Overall Study|Study Closure|7
7082041|NCT02138838|11192419|FG001|Overall Study|Study Closure|6
7082042|NCT02138838|11192418|FG000|Overall Study|Withdrawal by Subject|1
7082043|NCT02138838|11192419|FG001|Overall Study|Withdrawal by Subject|5
7082044|NCT02138890|11192427|FG000|Overall Study|Adverse Event|1
7082045|NCT02138890|11192428|FG001|Overall Study|Adverse Event|0
7082046|NCT02138916|11192438|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6
7082047|NCT02138916|11192439|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9
7082048|NCT02138916|11192440|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7
7183342|NCT01853748|11383581|FG001|Allocation|Withdrawal by Subject|13
7183343|NCT01853748|11383580|FG000|Allocation|not sufficient to receive intervention|0
7183344|NCT01853748|11383581|FG001|Allocation|not sufficient to receive intervention|1
7183345|NCT01853748|11383580|FG000|Follow-Up|Withdrawal by Subject|7
7183346|NCT01853748|11383581|FG001|Follow-Up|Withdrawal by Subject|6
7183347|NCT01853748|11383580|FG000|Follow-Up|Adverse Event|67
7183348|NCT01853748|11383581|FG001|Follow-Up|Adverse Event|7
7183349|NCT01853748|11383580|FG000|Follow-Up|not available for data collection|16
7183350|NCT01853748|11383581|FG001|Follow-Up|not available for data collection|4
7183351|NCT01817751|11383596|FG000|Overall Study|Physician Decision|1
7183352|NCT01722331|11383603|FG000|Part 1|Adverse Event|5
7183353|NCT01722331|11383604|FG001|Part 1|Adverse Event|0
7183354|NCT01722331|11383605|FG002|Part 1|Adverse Event|0
7183355|NCT01722331|11383606|FG003|Part 1|Adverse Event|0
7183356|NCT01722331|11383607|FG004|Part 1|Adverse Event|0
7183357|NCT01722331|11383608|FG005|Part 1|Adverse Event|0
7183358|NCT01722331|11383609|FG006|Part 1|Adverse Event|0
7183359|NCT01722331|11383603|FG000|Part 1|Lack of Efficacy|0
7183360|NCT01722331|11383604|FG001|Part 1|Lack of Efficacy|0
7183361|NCT01722331|11383605|FG002|Part 1|Lack of Efficacy|1
7183362|NCT01722331|11383606|FG003|Part 1|Lack of Efficacy|0
7183363|NCT01722331|11383607|FG004|Part 1|Lack of Efficacy|2
7183364|NCT01722331|11383608|FG005|Part 1|Lack of Efficacy|0
7183365|NCT01722331|11383609|FG006|Part 1|Lack of Efficacy|0
7183366|NCT01722331|11383603|FG000|Part 1|Lost to Follow-up|1
7183367|NCT01722331|11383604|FG001|Part 1|Lost to Follow-up|0
7183368|NCT01722331|11383605|FG002|Part 1|Lost to Follow-up|2
7183369|NCT01722331|11383606|FG003|Part 1|Lost to Follow-up|0
7183370|NCT01722331|11383607|FG004|Part 1|Lost to Follow-up|1
7183371|NCT01722331|11383608|FG005|Part 1|Lost to Follow-up|0
7183372|NCT01722331|11383609|FG006|Part 1|Lost to Follow-up|0
7183373|NCT01722331|11383603|FG000|Part 1|Physician Decision|0
7183374|NCT01722331|11383604|FG001|Part 1|Physician Decision|0
7183375|NCT01722331|11383605|FG002|Part 1|Physician Decision|3
7183376|NCT01722331|11383606|FG003|Part 1|Physician Decision|0
7183377|NCT01722331|11383607|FG004|Part 1|Physician Decision|1
7183378|NCT01722331|11383608|FG005|Part 1|Physician Decision|0
7183379|NCT01722331|11383609|FG006|Part 1|Physician Decision|0
7183380|NCT01722331|11383603|FG000|Part 1|Pregnancy|1
7183381|NCT01722331|11383604|FG001|Part 1|Pregnancy|0
7183382|NCT01722331|11383605|FG002|Part 1|Pregnancy|0
7183383|NCT01722331|11383606|FG003|Part 1|Pregnancy|0
7183384|NCT01722331|11383607|FG004|Part 1|Pregnancy|0
7183385|NCT01722331|11383608|FG005|Part 1|Pregnancy|0
7183386|NCT01722331|11383609|FG006|Part 1|Pregnancy|0
7183387|NCT01722331|11383603|FG000|Part 1|Progressive Disease|0
7183388|NCT01722331|11383604|FG001|Part 1|Progressive Disease|0
7183389|NCT01722331|11383605|FG002|Part 1|Progressive Disease|0
7183390|NCT01722331|11383606|FG003|Part 1|Progressive Disease|0
7183391|NCT01722331|11383607|FG004|Part 1|Progressive Disease|1
7082049|NCT02138916|11192438|FG000|Overall Study|Death|14
7082050|NCT02138916|11192439|FG001|Overall Study|Death|11
7082051|NCT02138916|11192440|FG002|Overall Study|Death|12
7082052|NCT02138916|11192438|FG000|Overall Study|Withdrawal by Subject|27
7082053|NCT02138916|11192439|FG001|Overall Study|Withdrawal by Subject|31
7082054|NCT02138916|11192440|FG002|Overall Study|Withdrawal by Subject|32
7082055|NCT02138916|11192438|FG000|Overall Study|Study specific withdrawal criteria|0
7082056|NCT02138916|11192439|FG001|Overall Study|Study specific withdrawal criteria|0
7082057|NCT02138916|11192440|FG002|Overall Study|Study specific withdrawal criteria|1
7082058|NCT02138916|11192438|FG000|Overall Study|incorrect enrolment|1
7082059|NCT02138916|11192439|FG001|Overall Study|incorrect enrolment|1
7082060|NCT02138916|11192440|FG002|Overall Study|incorrect enrolment|0
7082061|NCT02138916|11192438|FG000|Overall Study|Severe non-compliance|1
7082062|NCT02138916|11192439|FG001|Overall Study|Severe non-compliance|2
7082063|NCT02138916|11192440|FG002|Overall Study|Severe non-compliance|1
7082064|NCT02138916|11192438|FG000|Overall Study|Lost to Follow-up|4
7082065|NCT02138916|11192439|FG001|Overall Study|Lost to Follow-up|2
7082066|NCT02138916|11192440|FG002|Overall Study|Lost to Follow-up|3
7082067|NCT02138916|11192438|FG000|Overall Study|Adverse Event|4
7082068|NCT02138916|11192439|FG001|Overall Study|Adverse Event|4
7082069|NCT02138916|11192440|FG002|Overall Study|Adverse Event|3
7082070|NCT02139046|11192465|FG000|Overall Study|Pretreatment Event/Adverse Event|9
7082071|NCT02139046|11192466|FG001|Overall Study|Pretreatment Event/Adverse Event|9
7082072|NCT02139046|11192467|FG002|Overall Study|Pretreatment Event/Adverse Event|10
7082073|NCT02139046|11192468|FG003|Overall Study|Pretreatment Event/Adverse Event|13
7082074|NCT02139046|11192469|FG004|Overall Study|Pretreatment Event/Adverse Event|7
7082075|NCT02139046|11192465|FG000|Overall Study|Major Protocol Deviation|9
7082076|NCT02139046|11192466|FG001|Overall Study|Major Protocol Deviation|10
7082077|NCT02139046|11192467|FG002|Overall Study|Major Protocol Deviation|16
7082078|NCT02139046|11192468|FG003|Overall Study|Major Protocol Deviation|12
7082079|NCT02139046|11192469|FG004|Overall Study|Major Protocol Deviation|6
7082080|NCT02139046|11192465|FG000|Overall Study|Lost to Follow-up|13
7082081|NCT02139046|11192466|FG001|Overall Study|Lost to Follow-up|16
7183392|NCT01722331|11383608|FG005|Part 1|Progressive Disease|0
7183393|NCT01722331|11383609|FG006|Part 1|Progressive Disease|0
7183394|NCT01722331|11383603|FG000|Part 1|Protocol Violation|1
7183395|NCT01722331|11383604|FG001|Part 1|Protocol Violation|0
7183396|NCT01722331|11383605|FG002|Part 1|Protocol Violation|0
7183397|NCT01722331|11383606|FG003|Part 1|Protocol Violation|0
7183398|NCT01722331|11383607|FG004|Part 1|Protocol Violation|1
7183399|NCT01722331|11383608|FG005|Part 1|Protocol Violation|0
7183400|NCT01722331|11383609|FG006|Part 1|Protocol Violation|0
7183401|NCT01722331|11383603|FG000|Part 1|Withdrawal by Subject|2
7183402|NCT01722331|11383604|FG001|Part 1|Withdrawal by Subject|0
7183403|NCT01722331|11383605|FG002|Part 1|Withdrawal by Subject|3
7183404|NCT01722331|11383606|FG003|Part 1|Withdrawal by Subject|0
7183405|NCT01722331|11383607|FG004|Part 1|Withdrawal by Subject|3
7183406|NCT01722331|11383608|FG005|Part 1|Withdrawal by Subject|0
7183407|NCT01722331|11383609|FG006|Part 1|Withdrawal by Subject|0
7183408|NCT01722331|11383603|FG000|Part 2|Adverse Event|3
7183409|NCT01722331|11383604|FG001|Part 2|Adverse Event|0
7183410|NCT01722331|11383605|FG002|Part 2|Adverse Event|0
7183411|NCT01722331|11383606|FG003|Part 2|Adverse Event|0
7183412|NCT01722331|11383607|FG004|Part 2|Adverse Event|0
7183413|NCT01722331|11383608|FG005|Part 2|Adverse Event|1
7183414|NCT01722331|11383609|FG006|Part 2|Adverse Event|0
7183415|NCT01722331|11383603|FG000|Part 2|Lack of Efficacy|3
7183416|NCT01722331|11383604|FG001|Part 2|Lack of Efficacy|0
7183417|NCT01722331|11383605|FG002|Part 2|Lack of Efficacy|11
7183418|NCT01722331|11383606|FG003|Part 2|Lack of Efficacy|0
7183419|NCT01722331|11383607|FG004|Part 2|Lack of Efficacy|0
7183420|NCT01722331|11383608|FG005|Part 2|Lack of Efficacy|3
7183421|NCT01722331|11383609|FG006|Part 2|Lack of Efficacy|3
7183422|NCT01722331|11383603|FG000|Part 2|Lost to Follow-up|0
7183423|NCT01722331|11383604|FG001|Part 2|Lost to Follow-up|0
7183424|NCT01722331|11383605|FG002|Part 2|Lost to Follow-up|3
7183425|NCT01722331|11383606|FG003|Part 2|Lost to Follow-up|0
7183426|NCT01722331|11383607|FG004|Part 2|Lost to Follow-up|0
7183427|NCT01722331|11383608|FG005|Part 2|Lost to Follow-up|1
7082082|NCT02139046|11192467|FG002|Overall Study|Lost to Follow-up|16
7082083|NCT02139046|11192468|FG003|Overall Study|Lost to Follow-up|18
7082084|NCT02139046|11192469|FG004|Overall Study|Lost to Follow-up|13
7183428|NCT01722331|11383609|FG006|Part 2|Lost to Follow-up|1
7183429|NCT01722331|11383603|FG000|Part 2|Non-Compliance with Study Drug|1
7183430|NCT01722331|11383604|FG001|Part 2|Non-Compliance with Study Drug|0
7183431|NCT01722331|11383605|FG002|Part 2|Non-Compliance with Study Drug|1
7183432|NCT01722331|11383606|FG003|Part 2|Non-Compliance with Study Drug|0
7183433|NCT01722331|11383607|FG004|Part 2|Non-Compliance with Study Drug|0
7183434|NCT01722331|11383608|FG005|Part 2|Non-Compliance with Study Drug|0
7183435|NCT01722331|11383609|FG006|Part 2|Non-Compliance with Study Drug|0
7183436|NCT01722331|11383603|FG000|Part 2|Physician Decision|0
7183437|NCT01722331|11383604|FG001|Part 2|Physician Decision|0
7183438|NCT01722331|11383605|FG002|Part 2|Physician Decision|2
7183439|NCT01722331|11383606|FG003|Part 2|Physician Decision|0
7183440|NCT01722331|11383607|FG004|Part 2|Physician Decision|0
7183441|NCT01722331|11383608|FG005|Part 2|Physician Decision|0
7183442|NCT01722331|11383609|FG006|Part 2|Physician Decision|0
7183443|NCT01722331|11383603|FG000|Part 2|Pregnancy|0
7183444|NCT01722331|11383604|FG001|Part 2|Pregnancy|0
7183445|NCT01722331|11383605|FG002|Part 2|Pregnancy|0
7082085|NCT02139046|11192465|FG000|Overall Study|Voluntary Withdrawal|20
7082086|NCT02139046|11192466|FG001|Overall Study|Voluntary Withdrawal|8
7082087|NCT02139046|11192467|FG002|Overall Study|Voluntary Withdrawal|10
7082088|NCT02139046|11192468|FG003|Overall Study|Voluntary Withdrawal|15
7082089|NCT02139046|11192469|FG004|Overall Study|Voluntary Withdrawal|16
7183446|NCT01722331|11383606|FG003|Part 2|Pregnancy|0
7183447|NCT01722331|11383607|FG004|Part 2|Pregnancy|0
7183448|NCT01722331|11383608|FG005|Part 2|Pregnancy|1
7183449|NCT01722331|11383609|FG006|Part 2|Pregnancy|0
7183450|NCT01722331|11383603|FG000|Part 2|Progressive Disease|0
7183451|NCT01722331|11383604|FG001|Part 2|Progressive Disease|0
7183452|NCT01722331|11383605|FG002|Part 2|Progressive Disease|1
7183453|NCT01722331|11383606|FG003|Part 2|Progressive Disease|0
7183454|NCT01722331|11383607|FG004|Part 2|Progressive Disease|0
7183455|NCT01722331|11383608|FG005|Part 2|Progressive Disease|0
7082090|NCT02139046|11192465|FG000|Overall Study|Lack of Efficacy|0
7183456|NCT01722331|11383609|FG006|Part 2|Progressive Disease|0
7183457|NCT01722331|11383603|FG000|Part 2|Protocol Violation|1
7183458|NCT01722331|11383604|FG001|Part 2|Protocol Violation|0
7183459|NCT01722331|11383605|FG002|Part 2|Protocol Violation|0
7183460|NCT01722331|11383606|FG003|Part 2|Protocol Violation|0
7183461|NCT01722331|11383607|FG004|Part 2|Protocol Violation|0
7082091|NCT02139046|11192466|FG001|Overall Study|Lack of Efficacy|1
7082092|NCT02139046|11192467|FG002|Overall Study|Lack of Efficacy|2
7082093|NCT02139046|11192468|FG003|Overall Study|Lack of Efficacy|1
7082094|NCT02139046|11192469|FG004|Overall Study|Lack of Efficacy|2
7082095|NCT02139046|11192465|FG000|Overall Study|Withdrawal due to a Gout Flare|1
7082096|NCT02139046|11192466|FG001|Overall Study|Withdrawal due to a Gout Flare|1
7082097|NCT02139046|11192467|FG002|Overall Study|Withdrawal due to a Gout Flare|1
7082098|NCT02139046|11192468|FG003|Overall Study|Withdrawal due to a Gout Flare|0
7082099|NCT02139046|11192469|FG004|Overall Study|Withdrawal due to a Gout Flare|1
7183462|NCT01722331|11383608|FG005|Part 2|Protocol Violation|0
7183463|NCT01722331|11383609|FG006|Part 2|Protocol Violation|0
7183464|NCT01722331|11383603|FG000|Part 2|Withdrawal by Subject|5
7183465|NCT01722331|11383604|FG001|Part 2|Withdrawal by Subject|0
7183466|NCT01722331|11383605|FG002|Part 2|Withdrawal by Subject|3
7183467|NCT01722331|11383606|FG003|Part 2|Withdrawal by Subject|0
7183468|NCT01722331|11383607|FG004|Part 2|Withdrawal by Subject|0
7183469|NCT01722331|11383608|FG005|Part 2|Withdrawal by Subject|2
7183470|NCT01722331|11383609|FG006|Part 2|Withdrawal by Subject|2
7183471|NCT01722331|11383603|FG000|Part 2|Other Protocol Specified Criteria|6
7183472|NCT01722331|11383604|FG001|Part 2|Other Protocol Specified Criteria|0
7183473|NCT01722331|11383605|FG002|Part 2|Other Protocol Specified Criteria|10
7183474|NCT01722331|11383606|FG003|Part 2|Other Protocol Specified Criteria|0
7183475|NCT01722331|11383607|FG004|Part 2|Other Protocol Specified Criteria|0
7183476|NCT01722331|11383608|FG005|Part 2|Other Protocol Specified Criteria|2
7183477|NCT01722331|11383609|FG006|Part 2|Other Protocol Specified Criteria|1
7183478|NCT01722331|11383603|FG000|Part 3|Adverse Event|2
7183479|NCT01722331|11383604|FG001|Part 3|Adverse Event|2
7183480|NCT01722331|11383605|FG002|Part 3|Adverse Event|0
7183481|NCT01722331|11383606|FG003|Part 3|Adverse Event|1
6896435|NCT00633139|10914885|FG002|Overall Study|Non compliance|1
7082100|NCT02139046|11192465|FG000|Overall Study|Other Miscellaneous Reasons|10
7082101|NCT02139046|11192466|FG001|Overall Study|Other Miscellaneous Reasons|9
7082102|NCT02139046|11192467|FG002|Overall Study|Other Miscellaneous Reasons|4
7183482|NCT01722331|11383607|FG004|Part 3|Adverse Event|0
7082103|NCT02139046|11192468|FG003|Overall Study|Other Miscellaneous Reasons|9
7183483|NCT01722331|11383608|FG005|Part 3|Adverse Event|0
7183484|NCT01722331|11383609|FG006|Part 3|Adverse Event|0
7183485|NCT01722331|11383603|FG000|Part 3|Death|1
7183486|NCT01722331|11383604|FG001|Part 3|Death|0
7183487|NCT01722331|11383605|FG002|Part 3|Death|0
7183488|NCT01722331|11383606|FG003|Part 3|Death|0
7183489|NCT01722331|11383607|FG004|Part 3|Death|0
7183490|NCT01722331|11383608|FG005|Part 3|Death|0
7183491|NCT01722331|11383609|FG006|Part 3|Death|0
7183492|NCT01722331|11383603|FG000|Part 3|Lack of Efficacy|1
7183493|NCT01722331|11383604|FG001|Part 3|Lack of Efficacy|0
7183494|NCT01722331|11383605|FG002|Part 3|Lack of Efficacy|0
7183495|NCT01722331|11383606|FG003|Part 3|Lack of Efficacy|0
7183496|NCT01722331|11383607|FG004|Part 3|Lack of Efficacy|0
7183497|NCT01722331|11383608|FG005|Part 3|Lack of Efficacy|0
7183498|NCT01722331|11383609|FG006|Part 3|Lack of Efficacy|0
7183499|NCT01722331|11383603|FG000|Part 3|Lost to Follow-up|3
7183500|NCT01722331|11383604|FG001|Part 3|Lost to Follow-up|4
7183501|NCT01722331|11383605|FG002|Part 3|Lost to Follow-up|0
7183502|NCT01722331|11383606|FG003|Part 3|Lost to Follow-up|0
7183503|NCT01722331|11383607|FG004|Part 3|Lost to Follow-up|0
7183504|NCT01722331|11383608|FG005|Part 3|Lost to Follow-up|1
7183505|NCT01722331|11383609|FG006|Part 3|Lost to Follow-up|0
7183506|NCT01722331|11383603|FG000|Part 3|Non-Compliance with Study Drug|0
7183507|NCT01722331|11383604|FG001|Part 3|Non-Compliance with Study Drug|1
6896436|NCT00633139|10914883|FG000|Overall Study|Withdrawal by Subject|0
6896437|NCT00633139|10914884|FG001|Overall Study|Withdrawal by Subject|1
6896438|NCT00633139|10914885|FG002|Overall Study|Withdrawal by Subject|0
6896439|NCT00633152|10914895|FG000|Overall Study|Adverse Event|1
7082104|NCT02139046|11192469|FG004|Overall Study|Other Miscellaneous Reasons|12
7082105|NCT02139124|11192486|FG000|Overall Study|Adverse Event|2
7082106|NCT02139124|11192487|FG001|Overall Study|Adverse Event|0
7082107|NCT02139124|11192488|FG002|Overall Study|Adverse Event|1
7082108|NCT02139124|11192489|FG003|Overall Study|Adverse Event|2
7082109|NCT02139124|11192490|FG004|Overall Study|Adverse Event|5
7082110|NCT02139124|11192486|FG000|Overall Study|Withdrawal by Subject|2
7082111|NCT02139124|11192487|FG001|Overall Study|Withdrawal by Subject|2
7082112|NCT02139124|11192488|FG002|Overall Study|Withdrawal by Subject|2
7082113|NCT02139124|11192489|FG003|Overall Study|Withdrawal by Subject|2
7082114|NCT02139124|11192490|FG004|Overall Study|Withdrawal by Subject|3
7082115|NCT02139124|11192486|FG000|Overall Study|Protocol Violation|0
7082116|NCT02139124|11192487|FG001|Overall Study|Protocol Violation|0
7082117|NCT02139124|11192488|FG002|Overall Study|Protocol Violation|0
7082118|NCT02139124|11192489|FG003|Overall Study|Protocol Violation|1
7082119|NCT02139124|11192490|FG004|Overall Study|Protocol Violation|1
7183508|NCT01722331|11383605|FG002|Part 3|Non-Compliance with Study Drug|0
7183509|NCT01722331|11383606|FG003|Part 3|Non-Compliance with Study Drug|0
7183510|NCT01722331|11383607|FG004|Part 3|Non-Compliance with Study Drug|0
7183511|NCT01722331|11383608|FG005|Part 3|Non-Compliance with Study Drug|0
7183512|NCT01722331|11383609|FG006|Part 3|Non-Compliance with Study Drug|0
7183513|NCT01722331|11383603|FG000|Part 3|Physician Decision|1
7183514|NCT01722331|11383604|FG001|Part 3|Physician Decision|1
7183515|NCT01722331|11383605|FG002|Part 3|Physician Decision|0
7183516|NCT01722331|11383606|FG003|Part 3|Physician Decision|0
7183517|NCT01722331|11383607|FG004|Part 3|Physician Decision|0
7183518|NCT01722331|11383608|FG005|Part 3|Physician Decision|0
7183519|NCT01722331|11383609|FG006|Part 3|Physician Decision|1
7183520|NCT01722331|11383603|FG000|Part 3|Protocol Violation|2
7183521|NCT01722331|11383604|FG001|Part 3|Protocol Violation|1
7183522|NCT01722331|11383605|FG002|Part 3|Protocol Violation|0
7183523|NCT01722331|11383606|FG003|Part 3|Protocol Violation|0
7183524|NCT01722331|11383607|FG004|Part 3|Protocol Violation|0
7183525|NCT01722331|11383608|FG005|Part 3|Protocol Violation|0
7183526|NCT01722331|11383609|FG006|Part 3|Protocol Violation|0
7183527|NCT01722331|11383603|FG000|Part 3|Withdrawal by Subject|4
7082120|NCT02139124|11192486|FG000|Overall Study|non-compliant|1
7082121|NCT02139124|11192487|FG001|Overall Study|non-compliant|0
7082122|NCT02139124|11192488|FG002|Overall Study|non-compliant|0
7082123|NCT02139124|11192489|FG003|Overall Study|non-compliant|2
7082124|NCT02139124|11192490|FG004|Overall Study|non-compliant|0
7082125|NCT02139124|11192486|FG000|Overall Study|incarceration|0
7082126|NCT02139124|11192487|FG001|Overall Study|incarceration|0
7082127|NCT02139124|11192488|FG002|Overall Study|incarceration|1
7082128|NCT02139124|11192489|FG003|Overall Study|incarceration|0
7183528|NCT01722331|11383604|FG001|Part 3|Withdrawal by Subject|7
7183529|NCT01722331|11383605|FG002|Part 3|Withdrawal by Subject|0
7183530|NCT01722331|11383606|FG003|Part 3|Withdrawal by Subject|0
7183531|NCT01722331|11383607|FG004|Part 3|Withdrawal by Subject|0
7183532|NCT01722331|11383608|FG005|Part 3|Withdrawal by Subject|2
7183533|NCT01722331|11383609|FG006|Part 3|Withdrawal by Subject|1
7183534|NCT01722331|11383603|FG000|Part 3|Other Protocol Specified Criteria|1
7183535|NCT01722331|11383604|FG001|Part 3|Other Protocol Specified Criteria|1
7183536|NCT01722331|11383605|FG002|Part 3|Other Protocol Specified Criteria|0
7183537|NCT01722331|11383606|FG003|Part 3|Other Protocol Specified Criteria|0
7183538|NCT01722331|11383607|FG004|Part 3|Other Protocol Specified Criteria|0
7183539|NCT01722331|11383608|FG005|Part 3|Other Protocol Specified Criteria|0
7183540|NCT01722331|11383609|FG006|Part 3|Other Protocol Specified Criteria|0
7183541|NCT01716117|11383623|FG000|Overall Study|Death|5
7183542|NCT01716117|11383624|FG001|Overall Study|Death|2
7183543|NCT01716117|11383623|FG000|Overall Study|Withdrawal by Subject|2
7183544|NCT01716117|11383624|FG001|Overall Study|Withdrawal by Subject|0
7183545|NCT01698905|11383638|FG000|Overall Study|Adverse Event|4
6896440|NCT00633152|10914896|FG001|Overall Study|Adverse Event|0
6896441|NCT00633152|10914895|FG000|Overall Study|Randomized, did not receive study drug|5
6896442|NCT00633152|10914896|FG001|Overall Study|Randomized, did not receive study drug|2
6896443|NCT00633152|10914895|FG000|Overall Study|Withdrawal by Subject|1
6896444|NCT00633152|10914896|FG001|Overall Study|Withdrawal by Subject|1
6896445|NCT00633152|10914895|FG000|Overall Study|Lost to Follow-up|4
6896446|NCT00633152|10914896|FG001|Overall Study|Lost to Follow-up|1
6896447|NCT00633152|10914895|FG000|Overall Study|Miscellaneous Other|3
6896448|NCT00633152|10914896|FG001|Overall Study|Miscellaneous Other|2
6896449|NCT00633217|10914906|FG000|Overall Study|Adverse Event|5
6896450|NCT00633217|10914907|FG001|Overall Study|Adverse Event|9
6896451|NCT00633217|10914906|FG000|Overall Study|Lack of Efficacy|0
6896452|NCT00633217|10914907|FG001|Overall Study|Lack of Efficacy|2
6896453|NCT00633217|10914906|FG000|Overall Study|Protocol Violation|3
6896454|NCT00633217|10914907|FG001|Overall Study|Protocol Violation|7
6896455|NCT00633217|10914906|FG000|Overall Study|Lost to Follow-up|2
6896456|NCT00633217|10914907|FG001|Overall Study|Lost to Follow-up|2
6896457|NCT00633217|10914906|FG000|Overall Study|Investigator Discretion|2
6896458|NCT00633217|10914907|FG001|Overall Study|Investigator Discretion|0
6896459|NCT00633217|10914906|FG000|Overall Study|Withdrew Consent|3
6896460|NCT00633217|10914907|FG001|Overall Study|Withdrew Consent|3
6896461|NCT00633243|10914915|FG000|Overall Study|Withdrawal by Subject|0
6896462|NCT00633243|10914916|FG001|Overall Study|Withdrawal by Subject|1
7082129|NCT02139124|11192490|FG004|Overall Study|incarceration|0
7082130|NCT02139124|11192486|FG000|Overall Study|subject moved|1
7082131|NCT02139124|11192487|FG001|Overall Study|subject moved|0
7082132|NCT02139124|11192488|FG002|Overall Study|subject moved|0
7082133|NCT02139124|11192489|FG003|Overall Study|subject moved|0
7082134|NCT02139124|11192490|FG004|Overall Study|subject moved|0
7082135|NCT02139124|11192486|FG000|Overall Study|Lost to Follow-up|3
7082136|NCT02139124|11192487|FG001|Overall Study|Lost to Follow-up|2
7082137|NCT02139124|11192488|FG002|Overall Study|Lost to Follow-up|0
7082138|NCT02139124|11192489|FG003|Overall Study|Lost to Follow-up|5
7082139|NCT02139124|11192490|FG004|Overall Study|Lost to Follow-up|4
7082140|NCT02139280|11192532|FG000|Overall Study|No longer eligible|2
7082141|NCT02139280|11192533|FG001|Overall Study|No longer eligible|0
7082142|NCT02139306|11192541|FG000|Overall Study|Withdrawal by Subject|4
7082143|NCT02139306|11192542|FG001|Overall Study|Withdrawal by Subject|6
7082144|NCT02139306|11192541|FG000|Overall Study|Adverse Event|3
7082145|NCT02139306|11192542|FG001|Overall Study|Adverse Event|4
7082146|NCT02139306|11192541|FG000|Overall Study|Physician Decision|0
7082147|NCT02139306|11192542|FG001|Overall Study|Physician Decision|1
7082148|NCT02139306|11192541|FG000|Overall Study|Other Unspecified|2
6896463|NCT00633243|10914915|FG000|Overall Study|incarceration|0
7082149|NCT02139306|11192542|FG001|Overall Study|Other Unspecified|3
7082150|NCT02139306|11192541|FG000|Overall Study|Protocol Violation|4
7082151|NCT02139306|11192542|FG001|Overall Study|Protocol Violation|0
7082152|NCT02139592|11192553|FG000|Overall Study|Case Report Forms Uncollected|8
7082153|NCT02139644|11192562|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70
7082154|NCT02139644|11192563|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7082155|NCT02139644|11192564|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7082156|NCT02139644|11192565|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7082157|NCT02139644|11192566|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7082158|NCT02139644|11192567|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7082159|NCT02139644|11192562|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30
7082160|NCT02139644|11192563|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7082161|NCT02139644|11192564|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7082162|NCT02139644|11192565|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7082163|NCT02139644|11192566|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7082164|NCT02139644|11192567|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7082165|NCT02139644|11192562|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12
7082166|NCT02139644|11192563|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7082167|NCT02139644|11192564|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7082168|NCT02139644|11192565|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7082169|NCT02139644|11192566|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7082170|NCT02139644|11192567|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7082171|NCT02139644|11192562|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11
7183546|NCT01698905|11383638|FG000|Overall Study|Physician Decision|2
6896464|NCT00633243|10914916|FG001|Overall Study|incarceration|2
7183547|NCT01698905|11383638|FG000|Overall Study|Pregnancy|1
6973456|NCT01181128|11025236|FG000|Overall Study|Physician Decision|2
7183548|NCT01698905|11383638|FG000|Overall Study|Protocol Violation|1
7183549|NCT01698905|11383638|FG000|Overall Study|Subject/guardian decision|2
7183550|NCT01698905|11383638|FG000|Overall Study|Death|1
7183551|NCT01630590|11383659|FG000|Overall Study|Adverse Event|9
7183552|NCT01630590|11383659|FG000|Overall Study|Lack of Efficacy|37
7183553|NCT01630590|11383659|FG000|Overall Study|Withdrawal by Subject|4
7183554|NCT01630590|11383659|FG000|Overall Study|2nd primary tumor|2
7183555|NCT01630590|11383659|FG000|Overall Study|Automobile accident|1
7183556|NCT01630590|11383659|FG000|Overall Study|Maximum benefit|4
7183557|NCT01619085|11383663|FG000|Overall Study|Adverse Event|231
7183558|NCT01619085|11383663|FG000|Overall Study|Protocol Violation|4
7183559|NCT01619085|11383663|FG000|Overall Study|Lost to Follow-up|3
7183560|NCT01619085|11383663|FG000|Overall Study|Withdrawal by Subject|45
7183561|NCT01619085|11383663|FG000|Overall Study|Other than specified|96
7183562|NCT01619085|11383663|FG000|Overall Study|Not treated|1
7183563|NCT01619085|11383663|FG000|Overall Study|Death|145
7183564|NCT01499095|11383676|FG000|Overall Study|Randomized But Not Treated|1
7183565|NCT01499095|11383677|FG001|Overall Study|Randomized But Not Treated|1
7183566|NCT01499095|11383676|FG000|Overall Study|Adverse Event|12
7183567|NCT01499095|11383677|FG001|Overall Study|Adverse Event|7
7183568|NCT01499095|11383676|FG000|Overall Study|Lack of Efficacy|2
7082172|NCT02139644|11192563|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7082173|NCT02139644|11192564|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7082174|NCT02139644|11192565|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7082175|NCT02139644|11192566|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7082176|NCT02139644|11192567|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7082177|NCT02139644|11192562|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8
7082178|NCT02139644|11192563|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7082179|NCT02139644|11192564|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7082180|NCT02139644|11192565|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7082181|NCT02139644|11192566|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7082182|NCT02139644|11192567|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0
6896465|NCT00633243|10914915|FG000|Overall Study|Homeless--no refrigeration for meds|0
7041750|NCT01730040|11125604|FG005|Overall Study|Subject moved|0
7041751|NCT01730040|11125605|FG006|Overall Study|Subject moved|1
7041752|NCT01730040|11125599|FG000|Overall Study|Physician Decision|0
7041753|NCT01730040|11125600|FG001|Overall Study|Physician Decision|0
7041754|NCT01730040|11125601|FG002|Overall Study|Physician Decision|0
7041755|NCT01730040|11125602|FG003|Overall Study|Physician Decision|0
7041756|NCT01730040|11125603|FG004|Overall Study|Physician Decision|0
7041757|NCT01730040|11125604|FG005|Overall Study|Physician Decision|1
7041758|NCT01730040|11125605|FG006|Overall Study|Physician Decision|1
7041759|NCT01730040|11125599|FG000|Overall Study|Other than specified|7
7041760|NCT01730040|11125600|FG001|Overall Study|Other than specified|8
7041761|NCT01730040|11125601|FG002|Overall Study|Other than specified|5
7041762|NCT01730040|11125602|FG003|Overall Study|Other than specified|5
7041763|NCT01730040|11125603|FG004|Overall Study|Other than specified|5
7041764|NCT01730040|11125604|FG005|Overall Study|Other than specified|4
7041765|NCT01730040|11125605|FG006|Overall Study|Other than specified|4
7041766|NCT01730040|11125599|FG000|Overall Study|Adverse Event|4
7041767|NCT01730040|11125600|FG001|Overall Study|Adverse Event|3
7041768|NCT01730040|11125601|FG002|Overall Study|Adverse Event|5
7041769|NCT01730040|11125602|FG003|Overall Study|Adverse Event|3
7082183|NCT02139644|11192562|FG000|Run-In Period (Pre-assignment)|Adverse Event|3
7082184|NCT02139644|11192563|FG001|Run-In Period (Pre-assignment)|Adverse Event|0
7041770|NCT01730040|11125603|FG004|Overall Study|Adverse Event|1
7041771|NCT01730040|11125604|FG005|Overall Study|Adverse Event|1
7041772|NCT01730040|11125605|FG006|Overall Study|Adverse Event|2
6977297|NCT01207427|11030535|FG000|Double-blind Treatment Period|Withdrawal by Subject|1
6977298|NCT01207427|11030536|FG001|Double-blind Treatment Period|Withdrawal by Subject|0
6977299|NCT01207427|11030537|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
6977300|NCT01207440|11030552|FG000|Overall Study|Adverse Event|46
6977301|NCT01207440|11030553|FG001|Overall Study|Adverse Event|11
6977302|NCT01207440|11030554|FG002|Overall Study|Adverse Event|7
6977303|NCT01207440|11030555|FG003|Overall Study|Adverse Event|2
6977304|NCT01207440|11030556|FG004|Overall Study|Adverse Event|6
6977305|NCT01207440|11030557|FG005|Overall Study|Adverse Event|6
6977306|NCT01207440|11030558|FG006|Overall Study|Adverse Event|2
6977307|NCT01207440|11030552|FG000|Overall Study|Death|6
6977308|NCT01207440|11030553|FG001|Overall Study|Death|3
6977309|NCT01207440|11030554|FG002|Overall Study|Death|2
6977310|NCT01207440|11030555|FG003|Overall Study|Death|2
6977311|NCT01207440|11030556|FG004|Overall Study|Death|7
6977312|NCT01207440|11030557|FG005|Overall Study|Death|5
6977313|NCT01207440|11030558|FG006|Overall Study|Death|1
6977314|NCT01207440|11030552|FG000|Overall Study|Lack of Efficacy|13
6977315|NCT01207440|11030553|FG001|Overall Study|Lack of Efficacy|2
6977316|NCT01207440|11030554|FG002|Overall Study|Lack of Efficacy|5
6977317|NCT01207440|11030555|FG003|Overall Study|Lack of Efficacy|1
6977318|NCT01207440|11030556|FG004|Overall Study|Lack of Efficacy|2
6977319|NCT01207440|11030557|FG005|Overall Study|Lack of Efficacy|3
6977320|NCT01207440|11030558|FG006|Overall Study|Lack of Efficacy|0
6977321|NCT01207440|11030552|FG000|Overall Study|Lost to Follow-up|0
6977322|NCT01207440|11030553|FG001|Overall Study|Lost to Follow-up|0
6977323|NCT01207440|11030554|FG002|Overall Study|Lost to Follow-up|2
6977324|NCT01207440|11030555|FG003|Overall Study|Lost to Follow-up|1
6977325|NCT01207440|11030556|FG004|Overall Study|Lost to Follow-up|0
6977326|NCT01207440|11030557|FG005|Overall Study|Lost to Follow-up|0
6977327|NCT01207440|11030558|FG006|Overall Study|Lost to Follow-up|0
6977328|NCT01207440|11030552|FG000|Overall Study|Non-compliance with Study Drug|3
6977329|NCT01207440|11030553|FG001|Overall Study|Non-compliance with Study Drug|0
6977330|NCT01207440|11030554|FG002|Overall Study|Non-compliance with Study Drug|1
6977331|NCT01207440|11030555|FG003|Overall Study|Non-compliance with Study Drug|0
6977332|NCT01207440|11030556|FG004|Overall Study|Non-compliance with Study Drug|0
6977333|NCT01207440|11030557|FG005|Overall Study|Non-compliance with Study Drug|0
6977334|NCT01207440|11030558|FG006|Overall Study|Non-compliance with Study Drug|0
6977335|NCT01207440|11030552|FG000|Overall Study|Physician Decision|6
6977336|NCT01207440|11030553|FG001|Overall Study|Physician Decision|5
6977337|NCT01207440|11030554|FG002|Overall Study|Physician Decision|5
6977338|NCT01207440|11030555|FG003|Overall Study|Physician Decision|0
6977339|NCT01207440|11030556|FG004|Overall Study|Physician Decision|1
6977340|NCT01207440|11030557|FG005|Overall Study|Physician Decision|0
6977341|NCT01207440|11030558|FG006|Overall Study|Physician Decision|0
6977342|NCT01207440|11030552|FG000|Overall Study|Progressive Disease|19
6977343|NCT01207440|11030553|FG001|Overall Study|Progressive Disease|10
6977344|NCT01207440|11030554|FG002|Overall Study|Progressive Disease|19
6977345|NCT01207440|11030555|FG003|Overall Study|Progressive Disease|7
6977346|NCT01207440|11030556|FG004|Overall Study|Progressive Disease|23
6977347|NCT01207440|11030557|FG005|Overall Study|Progressive Disease|27
6977348|NCT01207440|11030558|FG006|Overall Study|Progressive Disease|0
6977349|NCT01207440|11030552|FG000|Overall Study|Protocol Violation|2
6977350|NCT01207440|11030553|FG001|Overall Study|Protocol Violation|0
6977351|NCT01207440|11030554|FG002|Overall Study|Protocol Violation|0
6977352|NCT01207440|11030555|FG003|Overall Study|Protocol Violation|0
6977353|NCT01207440|11030556|FG004|Overall Study|Protocol Violation|0
6977354|NCT01207440|11030557|FG005|Overall Study|Protocol Violation|0
6803770|NCT02617589|10805544|FG001|Treatment Period|Not reported|0
6803771|NCT02617589|10805543|FG000|Treatment Period|Poor/Non compliance|1
6803772|NCT02617589|10805544|FG001|Treatment Period|Poor/Non compliance|1
6803773|NCT02617589|10805543|FG000|Treatment Period|Maximum Clinical Benefit|0
6803774|NCT02617589|10805544|FG001|Treatment Period|Maximum Clinical Benefit|2
6803775|NCT02617589|10805543|FG000|Treatment Period|Participant Withdrew Consent|2
6803776|NCT02617589|10805544|FG001|Treatment Period|Participant Withdrew Consent|6
6803777|NCT02617589|10805543|FG000|Treatment Period|Participant Request to discontinue|12
6803778|NCT02617589|10805544|FG001|Treatment Period|Participant Request to discontinue|20
6803779|NCT02617589|10805543|FG000|Treatment Period|Adverse event unrelated to study drug|15
6803780|NCT02617589|10805544|FG001|Treatment Period|Adverse event unrelated to study drug|9
6803781|NCT02617589|10805543|FG000|Treatment Period|Death|1
6803782|NCT02617589|10805544|FG001|Treatment Period|Death|1
6803783|NCT02617589|10805543|FG000|Treatment Period|Study Drug Toxicity|26
6803784|NCT02617589|10805544|FG001|Treatment Period|Study Drug Toxicity|20
6803785|NCT02617589|10805543|FG000|Treatment Period|Disease Progression|214
6803786|NCT02617589|10805544|FG001|Treatment Period|Disease Progression|137
6803787|NCT02617589|10805543|FG000|Treatment Period|Completed Treatment|0
6803788|NCT02617589|10805544|FG001|Treatment Period|Completed Treatment|76
6803789|NCT02614859|10805552|FG000|Overall Study|Physician Decision|0
6803790|NCT02614859|10805553|FG001|Overall Study|Physician Decision|1
6803791|NCT02614066|10805565|FG000|Overall Study|Initiated KTE-X19 and Died|5
6803792|NCT02614066|10805566|FG001|Overall Study|Initiated KTE-X19 and Died|12
6803793|NCT02614066|10805567|FG002|Overall Study|Initiated KTE-X19 and Died|11
6803794|NCT02614066|10805568|FG003|Overall Study|Initiated KTE-X19 and Died|20
6803795|NCT02614066|10805565|FG000|Overall Study|Full Consent Withdrawn|0
6803796|NCT02614066|10805566|FG001|Overall Study|Full Consent Withdrawn|1
6803797|NCT02614066|10805567|FG002|Overall Study|Full Consent Withdrawn|0
6803798|NCT02614066|10805568|FG003|Overall Study|Full Consent Withdrawn|3
6803799|NCT02614066|10805565|FG000|Overall Study|Lost to Follow-up|0
6803800|NCT02614066|10805566|FG001|Overall Study|Lost to Follow-up|1
6803801|NCT02614066|10805567|FG002|Overall Study|Lost to Follow-up|0
6803802|NCT02614066|10805568|FG003|Overall Study|Lost to Follow-up|0
6803803|NCT02614066|10805565|FG000|Overall Study|Still on-study|1
6803804|NCT02614066|10805566|FG001|Overall Study|Still on-study|9
6803805|NCT02614066|10805567|FG002|Overall Study|Still on-study|5
6803806|NCT02614066|10805568|FG003|Overall Study|Still on-study|32
6803807|NCT02614066|10805565|FG000|Overall Study|Enrolled But Did Not Initiate KTE-X19|0
6803808|NCT02614066|10805566|FG001|Overall Study|Enrolled But Did Not Initiate KTE-X19|5
6803809|NCT02614066|10805567|FG002|Overall Study|Enrolled But Did Not Initiate KTE-X19|4
6803810|NCT02614066|10805568|FG003|Overall Study|Enrolled But Did Not Initiate KTE-X19|16
6803811|NCT02519348|10805585|FG000|Overall Study|Death|31
6803812|NCT02519348|10805586|FG001|Overall Study|Death|74
6803813|NCT02519348|10805587|FG002|Overall Study|Death|47
6803814|NCT02519348|10805588|FG003|Overall Study|Death|54
6803815|NCT02519348|10805589|FG004|Overall Study|Death|63
6803816|NCT02519348|10805590|FG005|Overall Study|Death|18
7083002|NCT02147561|11193760|FG000|Overall Study|Subjects who didn't receive BOTOX|1
7083003|NCT02147587|11193766|FG000|Overall Study|Adverse Event|9
7083004|NCT02147587|11193767|FG001|Overall Study|Adverse Event|4
7083005|NCT02147587|11193766|FG000|Overall Study|Lack of Efficacy|2
7083006|NCT02147587|11193767|FG001|Overall Study|Lack of Efficacy|1
7083007|NCT02147626|11193784|FG000|Overall Study|Lost to Follow-up|4
6803817|NCT02519348|10805591|FG006|Overall Study|Death|2
6803818|NCT02519348|10805592|FG007|Overall Study|Death|5
6803819|NCT02519348|10805593|FG008|Overall Study|Death|5
6803820|NCT02519348|10805585|FG000|Overall Study|Withdrawal by Subject|4
6803821|NCT02519348|10805586|FG001|Overall Study|Withdrawal by Subject|7
6803822|NCT02519348|10805587|FG002|Overall Study|Withdrawal by Subject|4
7083008|NCT02147626|11193785|FG001|Overall Study|Lost to Follow-up|4
6803823|NCT02519348|10805588|FG003|Overall Study|Withdrawal by Subject|3
6803824|NCT02519348|10805589|FG004|Overall Study|Withdrawal by Subject|3
6803825|NCT02519348|10805590|FG005|Overall Study|Withdrawal by Subject|2
6803826|NCT02519348|10805591|FG006|Overall Study|Withdrawal by Subject|0
6803827|NCT02519348|10805592|FG007|Overall Study|Withdrawal by Subject|0
6803828|NCT02519348|10805593|FG008|Overall Study|Withdrawal by Subject|1
6803829|NCT02519348|10805585|FG000|Overall Study|Lost to Follow-up|0
6803830|NCT02519348|10805586|FG001|Overall Study|Lost to Follow-up|0
6803831|NCT02519348|10805587|FG002|Overall Study|Lost to Follow-up|1
6803832|NCT02519348|10805588|FG003|Overall Study|Lost to Follow-up|0
6803833|NCT02519348|10805589|FG004|Overall Study|Lost to Follow-up|2
6803834|NCT02519348|10805590|FG005|Overall Study|Lost to Follow-up|1
7083009|NCT02147626|11193784|FG000|Overall Study|Pregnancy|1
6977355|NCT01207440|11030558|FG006|Overall Study|Protocol Violation|0
6977356|NCT01207440|11030552|FG000|Overall Study|Site Terminated by Sponsor|69
6977357|NCT01207440|11030553|FG001|Overall Study|Site Terminated by Sponsor|19
6977358|NCT01207440|11030554|FG002|Overall Study|Site Terminated by Sponsor|12
6977359|NCT01207440|11030555|FG003|Overall Study|Site Terminated by Sponsor|2
6977360|NCT01207440|11030556|FG004|Overall Study|Site Terminated by Sponsor|3
6977361|NCT01207440|11030557|FG005|Overall Study|Site Terminated by Sponsor|0
6977362|NCT01207440|11030558|FG006|Overall Study|Site Terminated by Sponsor|2
6977363|NCT01207440|11030552|FG000|Overall Study|Withdrawal by Subject|29
6977364|NCT01207440|11030553|FG001|Overall Study|Withdrawal by Subject|4
6977365|NCT01207440|11030554|FG002|Overall Study|Withdrawal by Subject|5
6977366|NCT01207440|11030555|FG003|Overall Study|Withdrawal by Subject|3
6977367|NCT01207440|11030556|FG004|Overall Study|Withdrawal by Subject|2
6977368|NCT01207440|11030557|FG005|Overall Study|Withdrawal by Subject|2
6977369|NCT01207440|11030558|FG006|Overall Study|Withdrawal by Subject|0
6977370|NCT01207440|11030552|FG000|Overall Study|Reason Not Specified|10
6977371|NCT01207440|11030553|FG001|Overall Study|Reason Not Specified|10
6977372|NCT01207440|11030554|FG002|Overall Study|Reason Not Specified|7
6977373|NCT01207440|11030555|FG003|Overall Study|Reason Not Specified|0
6977374|NCT01207440|11030556|FG004|Overall Study|Reason Not Specified|4
6977375|NCT01207440|11030557|FG005|Overall Study|Reason Not Specified|3
6977376|NCT01207440|11030558|FG006|Overall Study|Reason Not Specified|0
6977377|NCT01207453|11030582|FG000|First Intervention|Adverse Event|2
6977378|NCT01207453|11030583|FG001|First Intervention|Adverse Event|1
6977379|NCT01207453|11030582|FG000|Washout|Adverse Event|1
6977380|NCT01207453|11030583|FG001|Washout|Adverse Event|0
6977381|NCT01207453|11030582|FG000|Washout|Lost to Follow-up|1
6977382|NCT01207453|11030583|FG001|Washout|Lost to Follow-up|0
6977383|NCT01207453|11030582|FG000|2nd Intervention|Adverse Event|1
6977384|NCT01207453|11030583|FG001|2nd Intervention|Adverse Event|2
6977385|NCT01207453|11030582|FG000|2nd Intervention|Lost to Follow-up|1
6977386|NCT01207453|11030583|FG001|2nd Intervention|Lost to Follow-up|0
6977387|NCT01207583|11030613|FG000|Overall Study|Withdrawal by Subject|0
6977388|NCT01207583|11030614|FG001|Overall Study|Withdrawal by Subject|3
6977389|NCT01207583|11030615|FG002|Overall Study|Withdrawal by Subject|1
6977390|NCT01207583|11030613|FG000|Overall Study|Participant failed to return|1
6977391|NCT01207583|11030614|FG001|Overall Study|Participant failed to return|0
6977392|NCT01207583|11030615|FG002|Overall Study|Participant failed to return|0
6977393|NCT01207583|11030613|FG000|Overall Study|Lost to Follow-up|0
6977394|NCT01207583|11030614|FG001|Overall Study|Lost to Follow-up|2
6977395|NCT01207583|11030615|FG002|Overall Study|Lost to Follow-up|0
6977396|NCT01207596|11030636|FG000|Overall Study|Physician Decision|4
6977397|NCT01207596|11030636|FG000|Overall Study|Lack of Efficacy|1
6977398|NCT01207596|11030636|FG000|Overall Study|Adverse Event|3
6977399|NCT01207596|11030636|FG000|Overall Study|Withdrawal by Subject|1
6977400|NCT01207687|11030644|FG000|Overall Study|Adverse Event|1
6977401|NCT01207687|11030644|FG000|Overall Study|Withdrawal by Subject|1
6977402|NCT01208038|11030689|FG000|Overall Study|Withdrawal by Subject|1
6977403|NCT01208051|11030698|FG000|Total Enrollment|Withdrawal by Subject|0
6977404|NCT01208051|11030699|FG001|Total Enrollment|Withdrawal by Subject|1
6977405|NCT01208051|11030700|FG002|Total Enrollment|Withdrawal by Subject|0
6977406|NCT01208051|11030701|FG003|Total Enrollment|Withdrawal by Subject|0
6977407|NCT01208051|11030702|FG004|Total Enrollment|Withdrawal by Subject|2
7044973|NCT01760954|11131189|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2
7044974|NCT01760954|11131190|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0
7044975|NCT01760954|11131187|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6
6977408|NCT01208051|11030698|FG000|Total Enrollment|Brain metastases|0
6977409|NCT01208051|11030699|FG001|Total Enrollment|Brain metastases|0
6977410|NCT01208051|11030700|FG002|Total Enrollment|Brain metastases|1
6977411|NCT01208051|11030701|FG003|Total Enrollment|Brain metastases|0
6977412|NCT01208051|11030702|FG004|Total Enrollment|Brain metastases|0
6977413|NCT01208103|11030718|FG000|Overall Study|Adverse Event|1
7083010|NCT02147626|11193785|FG001|Overall Study|Pregnancy|2
7083011|NCT02147626|11193784|FG000|Overall Study|Withdrawal by Subject|0
6803835|NCT02519348|10805591|FG006|Overall Study|Lost to Follow-up|1
6803836|NCT02519348|10805592|FG007|Overall Study|Lost to Follow-up|0
6803837|NCT02519348|10805593|FG008|Overall Study|Lost to Follow-up|0
6803838|NCT02519348|10805585|FG000|Overall Study|Other|0
6803839|NCT02519348|10805586|FG001|Overall Study|Other|3
6803840|NCT02519348|10805587|FG002|Overall Study|Other|0
6803841|NCT02519348|10805588|FG003|Overall Study|Other|0
6803842|NCT02519348|10805589|FG004|Overall Study|Other|1
6803843|NCT02519348|10805590|FG005|Overall Study|Other|0
6803844|NCT02519348|10805591|FG006|Overall Study|Other|0
6803845|NCT02519348|10805592|FG007|Overall Study|Other|0
6803846|NCT02519348|10805593|FG008|Overall Study|Other|0
6803847|NCT02519348|10805585|FG000|Overall Study|Ongoing at the time of data cut-off date|5
6803848|NCT02519348|10805586|FG001|Overall Study|Ongoing at the time of data cut-off date|20
6803849|NCT02519348|10805587|FG002|Overall Study|Ongoing at the time of data cut-off date|23
6803850|NCT02519348|10805588|FG003|Overall Study|Ongoing at the time of data cut-off date|12
6803851|NCT02519348|10805589|FG004|Overall Study|Ongoing at the time of data cut-off date|15
6803852|NCT02519348|10805590|FG005|Overall Study|Ongoing at the time of data cut-off date|26
6803853|NCT02519348|10805591|FG006|Overall Study|Ongoing at the time of data cut-off date|0
6803854|NCT02519348|10805592|FG007|Overall Study|Ongoing at the time of data cut-off date|0
6803855|NCT02519348|10805593|FG008|Overall Study|Ongoing at the time of data cut-off date|0
6803856|NCT02429414|10805616|FG000|Overall Study|Physician Decision|0
6803857|NCT02429414|10805617|FG001|Overall Study|Physician Decision|1
6803858|NCT02258659|10805627|FG000|Overall Study|Withdrawal by Subject|1
6803859|NCT02111850|10805642|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
6803860|NCT02111850|10805643|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
6803861|NCT02111850|10805644|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
6803862|NCT02111850|10805645|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
6803863|NCT02111850|10805646|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1
6803864|NCT02111850|10805647|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
6803865|NCT02111850|10805648|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
6803866|NCT02111850|10805649|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
6803867|NCT02111850|10805650|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
6803868|NCT02111850|10805651|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
6803869|NCT02111850|10805652|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
6803870|NCT01483027|10805693|FG000|Overall Study|Administrative Reasons|2
6803871|NCT01483027|10805694|FG001|Overall Study|Administrative Reasons|1
6803872|NCT01483027|10805693|FG000|Overall Study|Withdrawal by Subject|21
6803873|NCT01483027|10805694|FG001|Overall Study|Withdrawal by Subject|32
6803874|NCT01483027|10805693|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22
6803875|NCT01483027|10805694|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24
6803876|NCT01483027|10805693|FG000|Overall Study|Lost to Follow-up|1
6803877|NCT01483027|10805694|FG001|Overall Study|Lost to Follow-up|1
6803878|NCT01483027|10805693|FG000|Overall Study|Adverse Event|0
6803879|NCT01483027|10805694|FG001|Overall Study|Adverse Event|1
6803880|NCT01483027|10805693|FG000|Overall Study|Withdrawal by Subject|0
6803881|NCT01483027|10805694|FG001|Overall Study|Withdrawal by Subject|1
6803882|NCT01379781|10805706|FG000|Overall Study|Lost to Follow-up|11
6803883|NCT01379781|10805707|FG001|Overall Study|Lost to Follow-up|8
6810128|NCT01090024|10814008|FG001|Period 1|Lost to Follow-up|1
6810129|NCT01090024|10814009|FG002|Period 1|Lost to Follow-up|0
6810130|NCT01090024|10814010|FG003|Period 1|Lost to Follow-up|0
6810131|NCT01090024|10814011|FG004|Period 1|Lost to Follow-up|0
6810132|NCT01090024|10814012|FG005|Period 1|Lost to Follow-up|0
6810133|NCT01090024|10814013|FG006|Period 1|Lost to Follow-up|0
6810134|NCT01090024|10814014|FG007|Period 1|Lost to Follow-up|0
6810135|NCT01090024|10814015|FG008|Period 1|Lost to Follow-up|0
6810136|NCT01090024|10814016|FG009|Period 1|Lost to Follow-up|0
6810137|NCT01090024|10814017|FG010|Period 1|Lost to Follow-up|0
6810138|NCT01090024|10814018|FG011|Period 1|Lost to Follow-up|0
6810139|NCT01090024|10814019|FG012|Period 1|Lost to Follow-up|0
6810140|NCT01090024|10814020|FG013|Period 1|Lost to Follow-up|0
6810141|NCT01090024|10814021|FG014|Period 1|Lost to Follow-up|0
6810142|NCT01090024|10814022|FG015|Period 1|Lost to Follow-up|0
6810143|NCT01090024|10814023|FG016|Period 1|Lost to Follow-up|0
6810144|NCT01090024|10814024|FG017|Period 1|Lost to Follow-up|0
6810145|NCT01090024|10814007|FG000|Period 2|Lost to Follow-up|0
6810146|NCT01090024|10814008|FG001|Period 2|Lost to Follow-up|0
6810147|NCT01090024|10814009|FG002|Period 2|Lost to Follow-up|0
6810148|NCT01090024|10814010|FG003|Period 2|Lost to Follow-up|1
6810149|NCT01090024|10814011|FG004|Period 2|Lost to Follow-up|0
6810150|NCT01090024|10814012|FG005|Period 2|Lost to Follow-up|0
6810151|NCT01090024|10814013|FG006|Period 2|Lost to Follow-up|0
6810152|NCT01090024|10814014|FG007|Period 2|Lost to Follow-up|0
6810153|NCT01090024|10814015|FG008|Period 2|Lost to Follow-up|0
6977414|NCT01208103|11030718|FG000|Overall Study|Withdrawal by Subject|1
6977415|NCT01208233|11030738|FG000|Overall Study|Adverse Event|0
6977416|NCT01208233|11030739|FG001|Overall Study|Adverse Event|1
6977417|NCT01208233|11030740|FG002|Overall Study|Adverse Event|2
6977418|NCT01208233|11030741|FG003|Overall Study|Adverse Event|0
6977419|NCT01208233|11030742|FG004|Overall Study|Adverse Event|3
6977420|NCT01208233|11030743|FG005|Overall Study|Adverse Event|5
6977421|NCT01208233|11030738|FG000|Overall Study|Death|0
6977422|NCT01208233|11030739|FG001|Overall Study|Death|0
6977423|NCT01208233|11030740|FG002|Overall Study|Death|0
6977424|NCT01208233|11030741|FG003|Overall Study|Death|0
6977425|NCT01208233|11030742|FG004|Overall Study|Death|3
6977426|NCT01208233|11030743|FG005|Overall Study|Death|5
6977427|NCT01208233|11030738|FG000|Overall Study|Did not meet entrance criteria|2
6977428|NCT01208233|11030739|FG001|Overall Study|Did not meet entrance criteria|1
6977429|NCT01208233|11030740|FG002|Overall Study|Did not meet entrance criteria|1
6977430|NCT01208233|11030741|FG003|Overall Study|Did not meet entrance criteria|0
6977431|NCT01208233|11030742|FG004|Overall Study|Did not meet entrance criteria|1
6977432|NCT01208233|11030743|FG005|Overall Study|Did not meet entrance criteria|0
6977433|NCT01208233|11030738|FG000|Overall Study|Medication error without adverse event|0
6977434|NCT01208233|11030739|FG001|Overall Study|Medication error without adverse event|0
6977435|NCT01208233|11030740|FG002|Overall Study|Medication error without adverse event|0
6977436|NCT01208233|11030741|FG003|Overall Study|Medication error without adverse event|0
6977437|NCT01208233|11030742|FG004|Overall Study|Medication error without adverse event|0
6977438|NCT01208233|11030743|FG005|Overall Study|Medication error without adverse event|1
6977439|NCT01208233|11030738|FG000|Overall Study|Study terminated by sponsor|0
6977440|NCT01208233|11030739|FG001|Overall Study|Study terminated by sponsor|0
6977441|NCT01208233|11030740|FG002|Overall Study|Study terminated by sponsor|0
6977442|NCT01208233|11030741|FG003|Overall Study|Study terminated by sponsor|0
6977443|NCT01208233|11030742|FG004|Overall Study|Study terminated by sponsor|10
6977444|NCT01208233|11030743|FG005|Overall Study|Study terminated by sponsor|7
6977445|NCT01208233|11030738|FG000|Overall Study|Protocol Violation|0
6977446|NCT01208233|11030739|FG001|Overall Study|Protocol Violation|0
6977447|NCT01208233|11030740|FG002|Overall Study|Protocol Violation|0
6977448|NCT01208233|11030741|FG003|Overall Study|Protocol Violation|0
6977449|NCT01208233|11030742|FG004|Overall Study|Protocol Violation|3
6977450|NCT01208233|11030743|FG005|Overall Study|Protocol Violation|0
6977451|NCT01208233|11030738|FG000|Overall Study|Other|2
6977452|NCT01208233|11030739|FG001|Overall Study|Other|1
6977453|NCT01208233|11030740|FG002|Overall Study|Other|0
6977454|NCT01208233|11030741|FG003|Overall Study|Other|0
6977455|NCT01208233|11030742|FG004|Overall Study|Other|0
6977456|NCT01208233|11030743|FG005|Overall Study|Other|1
6977457|NCT01208233|11030738|FG000|Overall Study|Withdrawal by Subject|1
6977458|NCT01208233|11030739|FG001|Overall Study|Withdrawal by Subject|0
6977459|NCT01208233|11030740|FG002|Overall Study|Withdrawal by Subject|1
6977460|NCT01208233|11030741|FG003|Overall Study|Withdrawal by Subject|1
6977461|NCT01208233|11030742|FG004|Overall Study|Withdrawal by Subject|4
6977462|NCT01208233|11030743|FG005|Overall Study|Withdrawal by Subject|2
6977463|NCT01208324|11030767|FG000|Post-randomization of Patch|Withdrawal by Subject|1
6977464|NCT01208324|11030768|FG001|Post-randomization of Patch|Withdrawal by Subject|0
6977465|NCT01208324|11030769|FG002|Post-randomization of Patch|Withdrawal by Subject|0
6977466|NCT01208324|11030770|FG003|Post-randomization of Patch|Withdrawal by Subject|0
6977467|NCT01208337|11030780|FG000|Overall Study|Death|3
6977468|NCT01208402|11030786|FG000|Overall Study|Withdrawal by Subject|1
6977469|NCT01208402|11030787|FG001|Overall Study|Withdrawal by Subject|0
6977470|NCT01208415|11030793|FG000|Overall Study|Death|1
6977471|NCT01208415|11030793|FG000|Overall Study|Lost to Follow-up|2
6977472|NCT01208415|11030793|FG000|Overall Study|Withdrawal by Subject|3
6977473|NCT01208415|11030793|FG000|Overall Study|Device not placed|1
6977474|NCT01208415|11030793|FG000|Overall Study|Still be eligible for follow-up|33
6977475|NCT01208870|11030799|FG000|Overall Study|Lost to Follow-up|2
6977476|NCT01208870|11030800|FG001|Overall Study|Lost to Follow-up|8
6977477|NCT01208961|11030817|FG000|High-Fat Period III|Protocol Violation|1
6977478|NCT01208961|11030818|FG001|High-Fat Period III|Protocol Violation|0
6977479|NCT01209078|11030825|FG000|Overall Study|Adverse Event|5
6977480|NCT01209078|11030826|FG001|Overall Study|Adverse Event|0
6977481|NCT01209078|11030825|FG000|Overall Study|Lost to Follow-up|4
6977482|NCT01209078|11030826|FG001|Overall Study|Lost to Follow-up|0
6977483|NCT01209078|11030825|FG000|Overall Study|Physician Decision|5
6977484|NCT01209078|11030826|FG001|Overall Study|Physician Decision|2
6977485|NCT01209078|11030825|FG000|Overall Study|Withdrawal by Subject|2
6977486|NCT01209078|11030826|FG001|Overall Study|Withdrawal by Subject|1
6977487|NCT01209143|11030836|FG000|Overall Study|Adverse Event|2
6977488|NCT01209143|11030837|FG001|Overall Study|Adverse Event|1
6977489|NCT01209143|11030836|FG000|Overall Study|Death|0
6977490|NCT01209143|11030837|FG001|Overall Study|Death|1
6977491|NCT01209143|11030836|FG000|Overall Study|Physician Decision|3
6977492|NCT01209143|11030837|FG001|Overall Study|Physician Decision|1
6977493|NCT01209143|11030836|FG000|Overall Study|Lost to Follow-up|1
6977494|NCT01209143|11030837|FG001|Overall Study|Lost to Follow-up|0
6977495|NCT01209143|11030836|FG000|Overall Study|Withdrawal by Subject|2
6977496|NCT01209143|11030837|FG001|Overall Study|Withdrawal by Subject|1
6977497|NCT01209143|11030836|FG000|Overall Study|Disease progression|11
6977498|NCT01209143|11030837|FG001|Overall Study|Disease progression|16
6977499|NCT01209286|11030889|FG000|Overall Study|Adverse Event|4
6977500|NCT01209286|11030890|FG001|Overall Study|Adverse Event|3
6977501|NCT01209286|11030891|FG002|Overall Study|Adverse Event|1
6977502|NCT01209286|11030889|FG000|Overall Study|Hematological Relapse After Remission|0
6977503|NCT01209286|11030890|FG001|Overall Study|Hematological Relapse After Remission|1
6977504|NCT01209286|11030891|FG002|Overall Study|Hematological Relapse After Remission|1
6977505|NCT01209286|11030889|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1
6977506|NCT01209286|11030890|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3
6977507|NCT01209286|11030891|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1
6977508|NCT01209286|11030889|FG000|Overall Study|Physician Decision|0
6977509|NCT01209286|11030890|FG001|Overall Study|Physician Decision|2
6977510|NCT01209286|11030891|FG002|Overall Study|Physician Decision|0
6977511|NCT01209286|11030889|FG000|Overall Study|Other|0
6977512|NCT01209286|11030890|FG001|Overall Study|Other|1
6977513|NCT01209286|11030891|FG002|Overall Study|Other|0
6977514|NCT01209325|11030908|FG000|Overall Study|Lost to Follow-up|24
6977515|NCT01209325|11030908|FG000|Overall Study|Adverse Event|1
6977516|NCT01209325|11030908|FG000|Overall Study|Relocated|3
6977517|NCT01209325|11030908|FG000|Overall Study|Refusal after starting therapy|8
6977518|NCT01209325|11030908|FG000|Overall Study|Protocol Violation|4
6977519|NCT01209325|11030908|FG000|Overall Study|Refusal prior to therapy|1
6977520|NCT01209325|11030908|FG000|Overall Study|Incarceration|2
6977521|NCT01209598|11030940|FG000|Overall Study|Withdrawal by Subject|1
6977522|NCT01209598|11030941|FG001|Overall Study|Withdrawal by Subject|0
6977523|NCT01209624|11030948|FG000|Overall Study|Death|2
6977524|NCT01209624|11030948|FG000|Overall Study|Adverse Event|13
6977525|NCT01209624|11030948|FG000|Overall Study|Lack of Efficacy|17
6977526|NCT01209624|11030948|FG000|Overall Study|Lost to Follow-up|290
6977527|NCT01209624|11030948|FG000|Overall Study|Other|4
6977528|NCT01209689|11030954|FG000|Overall Study|Insufficient Therapeutic Response|7
6977529|NCT01209689|11030955|FG001|Overall Study|Insufficient Therapeutic Response|2
6977530|NCT01209689|11030954|FG000|Overall Study|Refused Treatment|8
6803884|NCT02513394|10805719|FG000|Overall Study|Withdrawal by Subject|11
6803885|NCT02513394|10805720|FG001|Overall Study|Withdrawal by Subject|23
6803886|NCT02513394|10805719|FG000|Overall Study|Ineligible|1
6803887|NCT02513394|10805720|FG001|Overall Study|Ineligible|0
6803888|NCT02445339|10805755|FG000|Overall Study|Physician Decision|1
6803889|NCT02445339|10805756|FG001|Overall Study|Physician Decision|0
6803890|NCT02445339|10805755|FG000|Overall Study|Lost to Follow-up|11
6803891|NCT02445339|10805756|FG001|Overall Study|Lost to Follow-up|15
6803892|NCT03298867|10805777|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1
6803893|NCT03298867|10805778|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1
6803894|NCT03298867|10805777|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1
6803895|NCT03298867|10805778|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1
6803896|NCT03298867|10805777|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1
6803897|NCT03298867|10805778|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9
6803898|NCT03298867|10805777|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0
6803899|NCT03298867|10805778|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1
6803900|NCT03298867|10805777|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0
6803901|NCT03298867|10805778|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1
6803902|NCT03298867|10805777|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0
6803903|NCT03298867|10805778|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2
6803904|NCT03298867|10805777|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0
6803905|NCT03298867|10805778|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1
6803906|NCT03298867|10805777|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0
6803907|NCT03298867|10805778|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2
6803908|NCT03298867|10805777|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0
6803909|NCT03298867|10805778|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1
6803910|NCT03227224|10805788|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1
6803911|NCT03227224|10805789|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0
6803912|NCT03227224|10805790|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2
6803913|NCT03227224|10805791|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0
6803914|NCT03227224|10805788|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2
6803915|NCT03227224|10805789|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2
6803916|NCT03227224|10805790|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0
6803917|NCT03227224|10805791|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0
6803918|NCT03227224|10805788|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3
6803919|NCT03227224|10805789|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2
6803920|NCT03227224|10805790|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3
6803921|NCT03227224|10805791|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2
6803922|NCT03227224|10805788|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1
6803923|NCT03227224|10805789|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0
6803924|NCT03227224|10805790|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0
6803925|NCT03227224|10805791|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0
6803926|NCT03227224|10805788|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0
6803927|NCT03227224|10805789|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0
6977531|NCT01209689|11030955|FG001|Overall Study|Refused Treatment|3
6977532|NCT01209689|11030954|FG000|Overall Study|Adverse Event|4
6977533|NCT01209689|11030955|FG001|Overall Study|Adverse Event|0
6977534|NCT01209689|11030954|FG000|Overall Study|Violation of Selection Criteria at Entry|1
6977535|NCT01209689|11030955|FG001|Overall Study|Violation of Selection Criteria at Entry|0
6977536|NCT01209689|11030954|FG000|Overall Study|Failure to Return|3
6977537|NCT01209689|11030955|FG001|Overall Study|Failure to Return|0
6977538|NCT01209689|11030954|FG000|Overall Study|Sponsor's Decision to Stop the Study|68
6977539|NCT01209689|11030955|FG001|Overall Study|Sponsor's Decision to Stop the Study|17
7044976|NCT01760954|11131188|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10
7044977|NCT01760954|11131189|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5
7044978|NCT01760954|11131190|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5
7044979|NCT01760954|11131187|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1
7044980|NCT01760954|11131188|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4
6810154|NCT01090024|10814016|FG009|Period 2|Lost to Follow-up|0
6810155|NCT01090024|10814017|FG010|Period 2|Lost to Follow-up|0
6810156|NCT01090024|10814018|FG011|Period 2|Lost to Follow-up|0
6810157|NCT01090024|10814019|FG012|Period 2|Lost to Follow-up|0
6810158|NCT01090024|10814020|FG013|Period 2|Lost to Follow-up|0
6803928|NCT03227224|10805790|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1
6803929|NCT03227224|10805791|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0
6803930|NCT03227224|10805788|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2
6803931|NCT03227224|10805789|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1
6803932|NCT03227224|10805790|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1
6803933|NCT03227224|10805791|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4
6977540|NCT01209780|11030989|FG000|Overall Study|Adverse Event|0
6977541|NCT01209780|11030990|FG001|Overall Study|Adverse Event|1
6977542|NCT01209780|11030991|FG002|Overall Study|Adverse Event|0
6977543|NCT01209780|11030992|FG003|Overall Study|Adverse Event|0
6977544|NCT01209780|11030993|FG004|Overall Study|Adverse Event|0
6977545|NCT01209780|11030989|FG000|Overall Study|Withdrawal by Subject|9
6977546|NCT01209780|11030990|FG001|Overall Study|Withdrawal by Subject|2
6977547|NCT01209780|11030991|FG002|Overall Study|Withdrawal by Subject|1
6803934|NCT03227224|10805788|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2
6803935|NCT03227224|10805789|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1
6803936|NCT03227224|10805790|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0
6977548|NCT01209780|11030992|FG003|Overall Study|Withdrawal by Subject|1
6977549|NCT01209780|11030993|FG004|Overall Study|Withdrawal by Subject|0
6977550|NCT01209780|11030989|FG000|Overall Study|Lost to Follow-up|17
6977551|NCT01209780|11030990|FG001|Overall Study|Lost to Follow-up|12
6977552|NCT01209780|11030991|FG002|Overall Study|Lost to Follow-up|3
6977553|NCT01209780|11030992|FG003|Overall Study|Lost to Follow-up|9
6977554|NCT01209780|11030993|FG004|Overall Study|Lost to Follow-up|4
6977555|NCT01209780|11030989|FG000|Overall Study|Protocol Violation|0
6977556|NCT01209780|11030990|FG001|Overall Study|Protocol Violation|1
6977557|NCT01209780|11030991|FG002|Overall Study|Protocol Violation|0
6977558|NCT01209780|11030992|FG003|Overall Study|Protocol Violation|0
6977559|NCT01209780|11030993|FG004|Overall Study|Protocol Violation|0
6977560|NCT01209780|11030989|FG000|Overall Study|Inappropriate enrollment|0
6977561|NCT01209780|11030990|FG001|Overall Study|Inappropriate enrollment|2
6977562|NCT01209780|11030991|FG002|Overall Study|Inappropriate enrollment|0
6977563|NCT01209780|11030992|FG003|Overall Study|Inappropriate enrollment|0
6977564|NCT01209780|11030993|FG004|Overall Study|Inappropriate enrollment|1
6977565|NCT01209832|11031006|FG000|Period 1|Sponsor Decision and was not dosed|1
6977566|NCT01209832|11031006|FG000|Period 2|Sponsor Decision|1
6977567|NCT01209949|11031017|FG000|Overall Study|Lost to Follow-up|3
6977568|NCT01210001|11031024|FG000|Overall Study|Not treated|1
6977569|NCT01210001|11031025|FG001|Overall Study|Not treated|0
6977570|NCT01210001|11031026|FG002|Overall Study|Not treated|0
6977571|NCT01210001|11031024|FG000|Overall Study|Adverse Event|4
6977572|NCT01210001|11031025|FG001|Overall Study|Adverse Event|2
6977573|NCT01210001|11031026|FG002|Overall Study|Adverse Event|5
6977574|NCT01210001|11031024|FG000|Overall Study|Non compliant with protocol|2
6977575|NCT01210001|11031025|FG001|Overall Study|Non compliant with protocol|2
6977576|NCT01210001|11031026|FG002|Overall Study|Non compliant with protocol|3
6977577|NCT01210001|11031024|FG000|Overall Study|Lost to Follow-up|4
6977578|NCT01210001|11031025|FG001|Overall Study|Lost to Follow-up|3
6977579|NCT01210001|11031026|FG002|Overall Study|Lost to Follow-up|2
6977580|NCT01210001|11031024|FG000|Overall Study|Patient refusal to continue,not due toAE|6
6977581|NCT01210001|11031025|FG001|Overall Study|Patient refusal to continue,not due toAE|2
6977582|NCT01210001|11031026|FG002|Overall Study|Patient refusal to continue,not due toAE|1
6977583|NCT01210001|11031024|FG000|Overall Study|Other reason not defined above|2
6977584|NCT01210001|11031025|FG001|Overall Study|Other reason not defined above|2
6977585|NCT01210001|11031026|FG002|Overall Study|Other reason not defined above|1
6977586|NCT01210118|11031045|FG000|Overall Study|Lost to Follow-up|1
6977587|NCT01210118|11031046|FG001|Overall Study|Lost to Follow-up|1
6977588|NCT01210118|11031045|FG000|Overall Study|Protocol Violation|1
6977589|NCT01210118|11031046|FG001|Overall Study|Protocol Violation|1
6977590|NCT01210118|11031045|FG000|Overall Study|Spontaneous abortion|1
6977591|NCT01210118|11031046|FG001|Overall Study|Spontaneous abortion|3
6977592|NCT01210144|11031057|FG000|Overall Study|Lack of ovarian response|1
6977593|NCT01210144|11031058|FG001|Overall Study|Lack of ovarian response|0
6977594|NCT01210144|11031057|FG000|Overall Study|No fertilization|1
6977595|NCT01210144|11031058|FG001|Overall Study|No fertilization|0
6977596|NCT01210144|11031057|FG000|Overall Study|No transfer|1
6977597|NCT01210144|11031058|FG001|Overall Study|No transfer|0
6977598|NCT01210222|11031086|FG000|Overall Study|Ineligible|2
6977599|NCT01210222|11031086|FG000|Overall Study|Never treated|1
6977600|NCT01210352|11031105|FG000|Overall Study|Adverse Event|0
6977601|NCT01210352|11031106|FG001|Overall Study|Adverse Event|0
6977602|NCT01210352|11031107|FG002|Overall Study|Adverse Event|0
6977603|NCT01210352|11031108|FG003|Overall Study|Adverse Event|0
6977604|NCT01210352|11031109|FG004|Overall Study|Adverse Event|0
6977605|NCT01210352|11031110|FG005|Overall Study|Adverse Event|0
6977606|NCT01210352|11031111|FG006|Overall Study|Adverse Event|0
6977607|NCT01210352|11031112|FG007|Overall Study|Adverse Event|2
6977608|NCT01210352|11031113|FG008|Overall Study|Adverse Event|1
6977609|NCT01210352|11031105|FG000|Overall Study|Lack of Efficacy|0
6977610|NCT01210352|11031106|FG001|Overall Study|Lack of Efficacy|0
6977611|NCT01210352|11031107|FG002|Overall Study|Lack of Efficacy|0
6977612|NCT01210352|11031108|FG003|Overall Study|Lack of Efficacy|0
6977613|NCT01210352|11031109|FG004|Overall Study|Lack of Efficacy|0
6977614|NCT01210352|11031110|FG005|Overall Study|Lack of Efficacy|0
6977615|NCT01210352|11031111|FG006|Overall Study|Lack of Efficacy|1
6977616|NCT01210352|11031112|FG007|Overall Study|Lack of Efficacy|0
6977617|NCT01210352|11031113|FG008|Overall Study|Lack of Efficacy|0
6977618|NCT01210352|11031105|FG000|Overall Study|Physician Decision|0
6977619|NCT01210352|11031106|FG001|Overall Study|Physician Decision|0
6977620|NCT01210352|11031107|FG002|Overall Study|Physician Decision|0
6977621|NCT01210352|11031108|FG003|Overall Study|Physician Decision|0
6977622|NCT01210352|11031109|FG004|Overall Study|Physician Decision|0
6977623|NCT01210352|11031110|FG005|Overall Study|Physician Decision|0
6977624|NCT01210352|11031111|FG006|Overall Study|Physician Decision|0
6977625|NCT01210352|11031112|FG007|Overall Study|Physician Decision|1
6977626|NCT01210352|11031113|FG008|Overall Study|Physician Decision|2
6977627|NCT01210352|11031105|FG000|Overall Study|Withdrawal by Subject|0
6977628|NCT01210352|11031106|FG001|Overall Study|Withdrawal by Subject|0
6977629|NCT01210352|11031107|FG002|Overall Study|Withdrawal by Subject|1
6977630|NCT01210352|11031108|FG003|Overall Study|Withdrawal by Subject|0
6977631|NCT01210352|11031109|FG004|Overall Study|Withdrawal by Subject|0
6977632|NCT01210352|11031110|FG005|Overall Study|Withdrawal by Subject|0
6977633|NCT01210352|11031111|FG006|Overall Study|Withdrawal by Subject|1
6977634|NCT01210352|11031112|FG007|Overall Study|Withdrawal by Subject|0
6977635|NCT01210352|11031113|FG008|Overall Study|Withdrawal by Subject|1
6977636|NCT01210352|11031105|FG000|Overall Study|Patient Discharged Early|0
6977637|NCT01210352|11031106|FG001|Overall Study|Patient Discharged Early|0
6977638|NCT01210352|11031107|FG002|Overall Study|Patient Discharged Early|1
6977639|NCT01210352|11031108|FG003|Overall Study|Patient Discharged Early|0
6803937|NCT03227224|10805791|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1
6803938|NCT03227224|10805788|FG000|Double-blind Treatment Period (6 Weeks)|Other|4
6803939|NCT03227224|10805789|FG001|Double-blind Treatment Period (6 Weeks)|Other|0
6803940|NCT03227224|10805790|FG002|Double-blind Treatment Period (6 Weeks)|Other|1
6803941|NCT03227224|10805791|FG003|Double-blind Treatment Period (6 Weeks)|Other|0
6803942|NCT03227224|10805788|FG000|Follow-up Phase (2 Weeks)|Other|4
6803943|NCT03227224|10805789|FG001|Follow-up Phase (2 Weeks)|Other|4
6803944|NCT03227224|10805790|FG002|Follow-up Phase (2 Weeks)|Other|6
6803945|NCT03227224|10805791|FG003|Follow-up Phase (2 Weeks)|Other|3
6803946|NCT03220581|10805810|FG000|Overall Study|Withdrawal by Subject|0
6803947|NCT03220581|10805811|FG001|Overall Study|Withdrawal by Subject|1
6803948|NCT03220581|10805810|FG000|Overall Study|Lost to Follow-up|3
6803949|NCT03220581|10805811|FG001|Overall Study|Lost to Follow-up|6
6803950|NCT02991482|10805825|FG000|Overall Study|Disease progression|56
6803951|NCT02991482|10805826|FG001|Overall Study|Disease progression|47
6803952|NCT02991482|10805825|FG000|Overall Study|Death|4
6803953|NCT02991482|10805826|FG001|Overall Study|Death|4
6803954|NCT02991482|10805825|FG000|Overall Study|Adverse Event|1
6803955|NCT02991482|10805826|FG001|Overall Study|Adverse Event|6
6803956|NCT02991482|10805825|FG000|Overall Study|Patient decision|1
6803957|NCT02991482|10805826|FG001|Overall Study|Patient decision|1
6803958|NCT02991482|10805825|FG000|Overall Study|Physician Decision|0
6803959|NCT02991482|10805826|FG001|Overall Study|Physician Decision|6
6977640|NCT01210352|11031109|FG004|Overall Study|Patient Discharged Early|0
6977641|NCT01210352|11031110|FG005|Overall Study|Patient Discharged Early|0
7044981|NCT01760954|11131189|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0
7044982|NCT01760954|11131190|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0
7044983|NCT01760954|11131187|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
6803960|NCT02991482|10805825|FG000|Overall Study|Clinical deterioration|1
6803961|NCT02991482|10805826|FG001|Overall Study|Clinical deterioration|0
6803962|NCT02991482|10805825|FG000|Overall Study|Patient feeling too unwell|1
6803963|NCT02991482|10805826|FG001|Overall Study|Patient feeling too unwell|0
6803964|NCT02991482|10805825|FG000|Overall Study|Worsening of performance status|0
6803965|NCT02991482|10805826|FG001|Overall Study|Worsening of performance status|1
6803966|NCT02991482|10805825|FG000|Overall Study|Death prior to study drug initiation|1
6803967|NCT02991482|10805826|FG001|Overall Study|Death prior to study drug initiation|0
6803968|NCT02991482|10805825|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0
6810159|NCT01090024|10814021|FG014|Period 2|Lost to Follow-up|0
7044984|NCT01760954|11131188|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
7044985|NCT01760954|11131189|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1
7044986|NCT01760954|11131190|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
7044987|NCT01760954|11131187|FG000|Post-treatment Follow-up (12 Months)|Other|13
7044988|NCT01760954|11131188|FG001|Post-treatment Follow-up (12 Months)|Other|8
7044989|NCT01760954|11131189|FG002|Post-treatment Follow-up (12 Months)|Other|9
7044990|NCT01760954|11131190|FG003|Post-treatment Follow-up (12 Months)|Other|6
7044991|NCT01761162|11131214|FG000|Overall Study|Withdrawal by Subject|3
7044992|NCT01761292|11131236|FG000|Part 1|Adverse Event|1
7044993|NCT01761292|11131236|FG000|Part 1|not receiving treatment in Part 1|1
7044994|NCT01761292|11131236|FG000|Extension 1|Withdrawal by Subject|1
7044995|NCT01761565|11131247|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1
7044996|NCT01762345|11131277|FG000|Overall Study|Adverse Event|5
7044997|NCT01762345|11131277|FG000|Overall Study|Protocol Violation|2
7044998|NCT01762800|11131311|FG000|Overall Study|Adverse Event|8
7044999|NCT01762800|11131312|FG001|Overall Study|Adverse Event|13
7045000|NCT01762800|11131311|FG000|Overall Study|Lack of Efficacy|3
7045001|NCT01762800|11131312|FG001|Overall Study|Lack of Efficacy|2
7045002|NCT01762800|11131311|FG000|Overall Study|Study Closed/Terminated|0
7045003|NCT01762800|11131312|FG001|Overall Study|Study Closed/Terminated|1
7045004|NCT01762800|11131311|FG000|Overall Study|Physician Decision|1
7045005|NCT01762800|11131312|FG001|Overall Study|Physician Decision|1
6803969|NCT02991482|10805826|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1
6803970|NCT02768870|10805832|FG000|Overall Study|Not Implanted with Device|2
6803971|NCT02768870|10805832|FG000|Overall Study|Death|1
6803972|NCT02768870|10805832|FG000|Overall Study|Reoperation|4
6803973|NCT02768870|10805832|FG000|Overall Study|On Study|19
6810160|NCT01090024|10814022|FG015|Period 2|Lost to Follow-up|0
6810161|NCT01090024|10814023|FG016|Period 2|Lost to Follow-up|0
6810162|NCT01090024|10814024|FG017|Period 2|Lost to Follow-up|0
6810163|NCT01090024|10814007|FG000|Period 2|Adverse Event|1
6810164|NCT01090024|10814008|FG001|Period 2|Adverse Event|0
6810165|NCT01090024|10814009|FG002|Period 2|Adverse Event|0
6810166|NCT01090024|10814010|FG003|Period 2|Adverse Event|0
6810167|NCT01090024|10814011|FG004|Period 2|Adverse Event|0
6810168|NCT01090024|10814012|FG005|Period 2|Adverse Event|0
6810169|NCT01090024|10814013|FG006|Period 2|Adverse Event|0
6810170|NCT01090024|10814014|FG007|Period 2|Adverse Event|0
6810171|NCT01090024|10814015|FG008|Period 2|Adverse Event|0
6810172|NCT01090024|10814016|FG009|Period 2|Adverse Event|0
6810173|NCT01090024|10814017|FG010|Period 2|Adverse Event|0
6977642|NCT01210352|11031111|FG006|Overall Study|Patient Discharged Early|0
6977643|NCT01210352|11031112|FG007|Overall Study|Patient Discharged Early|0
6977644|NCT01210352|11031113|FG008|Overall Study|Patient Discharged Early|0
7083012|NCT02147626|11193785|FG001|Overall Study|Withdrawal by Subject|1
6977645|NCT01210443|11031218|FG000|Overall Study|Study terminated by sponsor|2
6977646|NCT01210495|11031226|FG000|Overall Study|Participant Refused Further Follow-Up|1
6977647|NCT01210495|11031227|FG001|Overall Study|Participant Refused Further Follow-Up|0
6977648|NCT01210495|11031228|FG002|Overall Study|Participant Refused Further Follow-Up|11
6977649|NCT01210495|11031229|FG003|Overall Study|Participant Refused Further Follow-Up|2
6977650|NCT01210495|11031226|FG000|Overall Study|Death|14
6977651|NCT01210495|11031227|FG001|Overall Study|Death|7
6977652|NCT01210495|11031228|FG002|Overall Study|Death|112
6977653|NCT01210495|11031229|FG003|Overall Study|Death|54
6977654|NCT01210495|11031226|FG000|Overall Study|Study Terminated by Sponsor|0
6977655|NCT01210495|11031227|FG001|Overall Study|Study Terminated by Sponsor|0
6977656|NCT01210495|11031228|FG002|Overall Study|Study Terminated by Sponsor|4
6977657|NCT01210495|11031229|FG003|Overall Study|Study Terminated by Sponsor|11
6977658|NCT01210495|11031226|FG000|Overall Study|Lost to Follow-up|0
6977659|NCT01210495|11031227|FG001|Overall Study|Lost to Follow-up|0
6977660|NCT01210495|11031228|FG002|Overall Study|Lost to Follow-up|1
6977661|NCT01210495|11031229|FG003|Overall Study|Lost to Follow-up|1
6810174|NCT01090024|10814018|FG011|Period 2|Adverse Event|0
6810175|NCT01090024|10814019|FG012|Period 2|Adverse Event|0
6810176|NCT01090024|10814020|FG013|Period 2|Adverse Event|0
6810177|NCT01090024|10814021|FG014|Period 2|Adverse Event|0
6977662|NCT01210495|11031226|FG000|Overall Study|Other unspecified|0
6977663|NCT01210495|11031227|FG001|Overall Study|Other unspecified|0
6977664|NCT01210495|11031228|FG002|Overall Study|Other unspecified|6
6977665|NCT01210495|11031229|FG003|Overall Study|Other unspecified|0
6977666|NCT01210651|11031264|FG000|Overall Study|Lost to Follow-up|1
6977667|NCT01210651|11031265|FG001|Overall Study|Lost to Follow-up|1
6810178|NCT01090024|10814022|FG015|Period 2|Adverse Event|0
6977668|NCT01210651|11031264|FG000|Overall Study|schedule conflicts|1
6977669|NCT01210651|11031265|FG001|Overall Study|schedule conflicts|5
6977670|NCT01210651|11031264|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0
6977671|NCT01210651|11031265|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1
6977672|NCT01210651|11031264|FG000|Overall Study|Withdrawal by Subject|1
6977673|NCT01210651|11031265|FG001|Overall Study|Withdrawal by Subject|1
6977674|NCT01210651|11031264|FG000|Overall Study|Injury outside study|2
6977675|NCT01210651|11031265|FG001|Overall Study|Injury outside study|0
6977676|NCT01210664|11031275|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
6977677|NCT01210664|11031276|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
6977678|NCT01210664|11031277|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1
6977679|NCT01210664|11031278|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
6977680|NCT01210664|11031275|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
6977681|NCT01210664|11031276|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
6977682|NCT01210664|11031277|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1
6977683|NCT01210664|11031278|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
6977684|NCT01210664|11031275|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
6977685|NCT01210664|11031276|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
6977686|NCT01210664|11031277|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
6977687|NCT01210664|11031278|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1
6977688|NCT01210690|11031288|FG000|Overall Study|Adverse Event|7
6977689|NCT01210690|11031288|FG000|Overall Study|Lack of Efficacy|12
6977690|NCT01210690|11031288|FG000|Overall Study|Lost to Follow-up|3
6977691|NCT01210690|11031288|FG000|Overall Study|Disease Remission|1
6977692|NCT01210690|11031288|FG000|Overall Study|Withdrawal by Subject|1
6977693|NCT01210690|11031288|FG000|Overall Study|Patient refused to swallow|1
6977694|NCT01210690|11031288|FG000|Overall Study|Patient could not take glucose|1
7188380|NCT02891226|11388858|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7188381|NCT02891226|11388859|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7188382|NCT02891226|11388860|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1
7188383|NCT02891226|11388861|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7188384|NCT02891226|11388862|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7188385|NCT02891226|11388863|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7188386|NCT02891226|11388864|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7188387|NCT02891226|11388865|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7188388|NCT02891226|11388866|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7188389|NCT02891226|11388867|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7188390|NCT02891226|11388868|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7188391|NCT02891226|11388869|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7188392|NCT02891226|11388870|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7188393|NCT02891226|11388871|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7188394|NCT02891226|11388872|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7188395|NCT02891226|11388873|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7188396|NCT02891226|11388858|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7188397|NCT02891226|11388859|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7188398|NCT02891226|11388860|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7188399|NCT02891226|11388861|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1
7188400|NCT02891226|11388862|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7188401|NCT02891226|11388863|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7188402|NCT02891226|11388864|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7188403|NCT02891226|11388865|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7188404|NCT02891226|11388866|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7188405|NCT02891226|11388867|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7188406|NCT02891226|11388868|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7188407|NCT02891226|11388869|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7188408|NCT02891226|11388870|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7188409|NCT02891226|11388871|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7188410|NCT02891226|11388872|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7188411|NCT02891226|11388873|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7188412|NCT02891226|11388858|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7188413|NCT02891226|11388859|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7188414|NCT02891226|11388860|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7188415|NCT02891226|11388861|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1
7188416|NCT02891226|11388862|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7188417|NCT02891226|11388863|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7188418|NCT02891226|11388864|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7188419|NCT02891226|11388865|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
6977695|NCT01210807|11031302|FG000|Overall Study|Lost to Follow-up|1
6977696|NCT01210807|11031303|FG001|Overall Study|Lost to Follow-up|2
7188420|NCT02891226|11388866|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
6977697|NCT01210807|11031302|FG000|Overall Study|Not implanted bilaterally|2
6977698|NCT01210807|11031303|FG001|Overall Study|Not implanted bilaterally|1
6977699|NCT01211145|11031333|FG000|Overall Study|Reason not specified|3
6977700|NCT01211145|11031334|FG001|Overall Study|Reason not specified|2
6977701|NCT01211145|11031335|FG002|Overall Study|Reason not specified|2
6977702|NCT01211145|11031336|FG003|Overall Study|Reason not specified|1
6977703|NCT01211145|11031333|FG000|Overall Study|Lost to Follow-up|3
6977704|NCT01211145|11031334|FG001|Overall Study|Lost to Follow-up|2
6977705|NCT01211145|11031335|FG002|Overall Study|Lost to Follow-up|1
6977706|NCT01211145|11031336|FG003|Overall Study|Lost to Follow-up|2
6977707|NCT01211145|11031333|FG000|Overall Study|Study-specific withdrawal criteria|1
6977708|NCT01211145|11031334|FG001|Overall Study|Study-specific withdrawal criteria|0
6977709|NCT01211145|11031335|FG002|Overall Study|Study-specific withdrawal criteria|0
6977710|NCT01211145|11031336|FG003|Overall Study|Study-specific withdrawal criteria|0
6977711|NCT01211145|11031333|FG000|Overall Study|Severe noncompliance to protocol|1
6977712|NCT01211145|11031334|FG001|Overall Study|Severe noncompliance to protocol|0
7045006|NCT01762800|11131311|FG000|Overall Study|Withdrawal by Subject|7
7045007|NCT01762800|11131312|FG001|Overall Study|Withdrawal by Subject|4
7083013|NCT02147691|11193793|FG000|Overall Study|Withdrawal by Subject|2
7083014|NCT02147691|11193794|FG001|Overall Study|Withdrawal by Subject|0
7083015|NCT02147691|11193793|FG000|Overall Study|Adverse Event|2
7083016|NCT02147691|11193794|FG001|Overall Study|Adverse Event|0
7083017|NCT02147691|11193793|FG000|Overall Study|Lost to Follow-up|0
7083018|NCT02147691|11193794|FG001|Overall Study|Lost to Follow-up|1
7083019|NCT02148211|11193844|FG000|Overall Study|Lost to Follow-up|352
7083020|NCT02148250|11193848|FG000|Screening|Withdrawal by Subject|5
7083021|NCT02148250|11193849|FG001|Screening|Withdrawal by Subject|0
7083022|NCT02148445|11193867|FG000|Overall Study|Death|1
7083023|NCT02148445|11193868|FG001|Overall Study|Death|3
7083024|NCT02148718|11193893|FG000|Overall Study|Protocol Violation|26
7083025|NCT02148718|11193893|FG000|Overall Study|Discontinued Study Prematurely|5
7083026|NCT02148952|11193922|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241
7083027|NCT02148952|11193923|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591
7083028|NCT02148952|11193922|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862
7188421|NCT02891226|11388867|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7188422|NCT02891226|11388868|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7188423|NCT02891226|11388869|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7188424|NCT02891226|11388870|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7188425|NCT02891226|11388871|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7188426|NCT02891226|11388872|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7188427|NCT02891226|11388873|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7188428|NCT02891226|11388858|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0
7188429|NCT02891226|11388859|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0
7188430|NCT02891226|11388860|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0
7188431|NCT02891226|11388861|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0
7188432|NCT02891226|11388862|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0
7188433|NCT02891226|11388863|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0
7188434|NCT02891226|11388864|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1
7188435|NCT02891226|11388865|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1
7188436|NCT02891226|11388866|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3
7188437|NCT02891226|11388867|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7
7188438|NCT02891226|11388868|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0
7188439|NCT02891226|11388869|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0
7188440|NCT02891226|11388870|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0
6977713|NCT01211145|11031335|FG002|Overall Study|Severe noncompliance to protocol|0
6977714|NCT01211145|11031336|FG003|Overall Study|Severe noncompliance to protocol|0
6977715|NCT01211145|11031333|FG000|Overall Study|Eligibility criteria not fulfilled|16
7045008|NCT01762943|11131333|FG000|Overall Study|Physician Decision|1
7045009|NCT01762943|11131334|FG001|Overall Study|Physician Decision|1
7045010|NCT01762943|11131333|FG000|Overall Study|Protocol Violation|1
7045011|NCT01762943|11131334|FG001|Overall Study|Protocol Violation|0
7045012|NCT01762943|11131333|FG000|Overall Study|Withdrawal by Subject|2
7045013|NCT01762943|11131334|FG001|Overall Study|Withdrawal by Subject|1
7045014|NCT01763047|11131350|FG000|Period 1|Test Article Not Available|4
7045015|NCT01763047|11131351|FG001|Period 1|Test Article Not Available|1
7045016|NCT01763047|11131350|FG000|Period 1|Protocol Violation|4
6803974|NCT02648698|10805838|FG000|Overall Study|Protocol Violation|1
6803975|NCT02648698|10805839|FG001|Overall Study|Protocol Violation|5
6803976|NCT02432196|10805845|FG000|Overall Study|Not Implanted with Device|1
6803977|NCT02432196|10805845|FG000|Overall Study|Death|2
6803978|NCT02432196|10805845|FG000|Overall Study|Reoperation|3
6803979|NCT02432196|10805845|FG000|Overall Study|On Study|20
6803980|NCT02000882|10805853|FG000|Overall Study|Adverse Event|3
6803981|NCT02000882|10805853|FG000|Overall Study|Physician Decision|2
6803982|NCT02000882|10805853|FG000|Overall Study|Withdrawal by Subject|1
6803983|NCT01642004|10805872|FG000|Randomization|Adverse Event unrelated to study drug|1
6803984|NCT01642004|10805873|FG001|Randomization|Adverse Event unrelated to study drug|0
6803985|NCT01642004|10805872|FG000|Randomization|Withdrawal by Subject|1
6803986|NCT01642004|10805873|FG001|Randomization|Withdrawal by Subject|6
6803987|NCT01642004|10805872|FG000|Randomization|No longer meets study criteria|2
6803988|NCT01642004|10805873|FG001|Randomization|No longer meets study criteria|2
6803989|NCT01642004|10805872|FG000|Treatment|Disease progression|88
6803990|NCT01642004|10805873|FG001|Treatment|Disease progression|80
6803991|NCT01642004|10805872|FG000|Treatment|Study drug toxicity|5
6803992|NCT01642004|10805873|FG001|Treatment|Study drug toxicity|13
6803993|NCT01642004|10805872|FG000|Treatment|Death|1
6803994|NCT01642004|10805873|FG001|Treatment|Death|0
6803995|NCT01642004|10805872|FG000|Treatment|Adverse event unrelated to study drug|6
6803996|NCT01642004|10805873|FG001|Treatment|Adverse event unrelated to study drug|13
6803997|NCT01642004|10805872|FG000|Treatment|Withdrawal by Subject|5
6803998|NCT01642004|10805873|FG001|Treatment|Withdrawal by Subject|9
6803999|NCT01642004|10805872|FG000|Treatment|Maximum clinical benefit|2
6804000|NCT01642004|10805873|FG001|Treatment|Maximum clinical benefit|7
6804001|NCT01642004|10805872|FG000|Treatment|Poor/non-compliance|1
6804002|NCT01642004|10805873|FG001|Treatment|Poor/non-compliance|0
6804003|NCT01642004|10805872|FG000|Treatment|No longer meets study criteria|1
6804004|NCT01642004|10805873|FG001|Treatment|No longer meets study criteria|2
6804005|NCT01642004|10805872|FG000|Treatment|Other|1
6804006|NCT01642004|10805873|FG001|Treatment|Other|2
6804007|NCT01642004|10805872|FG000|Treatment|Missing from data|0
6804008|NCT01642004|10805873|FG001|Treatment|Missing from data|1
6804009|NCT01366092|10805879|FG000|Overall Study|Progressive cGVHD|2
6804010|NCT01366092|10805879|FG000|Overall Study|Physician Decision|1
6804011|NCT01366092|10805879|FG000|Overall Study|Withdrawal by Subject|1
6804012|NCT01326104|10805885|FG000|Overall Study|progressed prior to vaccine|0
6804013|NCT01326104|10805886|FG001|Overall Study|progressed prior to vaccine|2
6804014|NCT01326104|10805885|FG000|Overall Study|unable to make vaccine|0
6804015|NCT01326104|10805886|FG001|Overall Study|unable to make vaccine|2
6804016|NCT01244815|10805896|FG000|Overall Study|Not Treated|0
6804017|NCT01244815|10805897|FG001|Overall Study|Not Treated|1
6804018|NCT01244815|10805898|FG002|Overall Study|Not Treated|0
6804019|NCT01244815|10805899|FG003|Overall Study|Not Treated|0
6804020|NCT01244815|10805896|FG000|Overall Study|Adverse Event|4
6804021|NCT01244815|10805897|FG001|Overall Study|Adverse Event|7
7188441|NCT02891226|11388871|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0
7188442|NCT02891226|11388872|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0
7188443|NCT02891226|11388873|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0
7188444|NCT02891226|11388858|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7188445|NCT02891226|11388859|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7188446|NCT02891226|11388860|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7188447|NCT02891226|11388861|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7188448|NCT02891226|11388862|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7188449|NCT02891226|11388863|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1
7188450|NCT02891226|11388864|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
6804022|NCT01244815|10805898|FG002|Overall Study|Adverse Event|5
6804023|NCT01244815|10805899|FG003|Overall Study|Adverse Event|5
6804024|NCT01244815|10805896|FG000|Overall Study|Treatment Failure|0
6804025|NCT01244815|10805897|FG001|Overall Study|Treatment Failure|0
6804026|NCT01244815|10805898|FG002|Overall Study|Treatment Failure|0
6804027|NCT01244815|10805899|FG003|Overall Study|Treatment Failure|1
6804028|NCT01244815|10805896|FG000|Overall Study|Lost to Follow-up|3
6804029|NCT01244815|10805897|FG001|Overall Study|Lost to Follow-up|2
6804030|NCT01244815|10805898|FG002|Overall Study|Lost to Follow-up|3
6804031|NCT01244815|10805899|FG003|Overall Study|Lost to Follow-up|2
6804032|NCT01244815|10805896|FG000|Overall Study|Withdrawal by Subject|0
7188451|NCT02891226|11388865|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
6804033|NCT01244815|10805897|FG001|Overall Study|Withdrawal by Subject|2
6804034|NCT01244815|10805898|FG002|Overall Study|Withdrawal by Subject|0
7188452|NCT02891226|11388866|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7188453|NCT02891226|11388867|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1
6977716|NCT01211145|11031334|FG001|Overall Study|Eligibility criteria not fulfilled|12
6977717|NCT01211145|11031335|FG002|Overall Study|Eligibility criteria not fulfilled|10
6977718|NCT01211145|11031336|FG003|Overall Study|Eligibility criteria not fulfilled|15
6977719|NCT01211145|11031333|FG000|Overall Study|Patient decision|2
6977720|NCT01211145|11031334|FG001|Overall Study|Patient decision|1
6977721|NCT01211145|11031335|FG002|Overall Study|Patient decision|0
6977722|NCT01211145|11031336|FG003|Overall Study|Patient decision|2
6977723|NCT01211184|11031349|FG000|Overall Study|Withdrawal by Subject|0
6977724|NCT01211184|11031350|FG001|Overall Study|Withdrawal by Subject|2
6977725|NCT01211184|11031351|FG002|Overall Study|Withdrawal by Subject|1
6977726|NCT01211197|11031362|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0
6977727|NCT01211197|11031363|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0
6977728|NCT01211197|11031364|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1
6977729|NCT01211197|11031365|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0
6977730|NCT01211197|11031366|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0
6977731|NCT01211197|11031367|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0
6977732|NCT01211197|11031362|FG000|Washout Period 2 (7 Days)|Adverse Event|1
6977733|NCT01211197|11031363|FG001|Washout Period 2 (7 Days)|Adverse Event|0
6977734|NCT01211197|11031364|FG002|Washout Period 2 (7 Days)|Adverse Event|0
6977735|NCT01211197|11031365|FG003|Washout Period 2 (7 Days)|Adverse Event|0
6977736|NCT01211197|11031366|FG004|Washout Period 2 (7 Days)|Adverse Event|0
6977737|NCT01211197|11031367|FG005|Washout Period 2 (7 Days)|Adverse Event|0
6977738|NCT01211262|11031377|FG000|Overall Study|Progressive Disease|18
6977739|NCT01211262|11031378|FG001|Overall Study|Progressive Disease|9
7188454|NCT02891226|11388868|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7188455|NCT02891226|11388869|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7188456|NCT02891226|11388870|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7188457|NCT02891226|11388871|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7188458|NCT02891226|11388872|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7188459|NCT02891226|11388873|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7188460|NCT02891226|11388858|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
7188461|NCT02891226|11388859|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
7188462|NCT02891226|11388860|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
7188463|NCT02891226|11388861|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
7188464|NCT02891226|11388862|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
7188465|NCT02891226|11388863|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
7188466|NCT02891226|11388864|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1
7188467|NCT02891226|11388865|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2
7188468|NCT02891226|11388866|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1
7188469|NCT02891226|11388867|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6
7188470|NCT02891226|11388868|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
7188471|NCT02891226|11388869|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
7188472|NCT02891226|11388870|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
7188473|NCT02891226|11388871|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
7188474|NCT02891226|11388872|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
7188475|NCT02891226|11388873|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
7188476|NCT02891226|11388858|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7188477|NCT02891226|11388859|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7188478|NCT02891226|11388860|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7188479|NCT02891226|11388861|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7188480|NCT02891226|11388862|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1
7188481|NCT02891226|11388863|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7188482|NCT02891226|11388864|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7188483|NCT02891226|11388865|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7188484|NCT02891226|11388866|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7188485|NCT02891226|11388867|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7188486|NCT02891226|11388868|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
6977740|NCT01211262|11031377|FG000|Overall Study|Adverse Event|4
6977741|NCT01211262|11031378|FG001|Overall Study|Adverse Event|0
6977742|NCT01211262|11031377|FG000|Overall Study|Withdrawal of Consent|1
6977743|NCT01211262|11031378|FG001|Overall Study|Withdrawal of Consent|0
6977744|NCT01211262|11031377|FG000|Overall Study|Other|0
6977745|NCT01211262|11031378|FG001|Overall Study|Other|1
6977746|NCT01211288|11031389|FG000|Overall Study|Lost to Follow-up|1
6977747|NCT01211288|11031390|FG001|Overall Study|Lost to Follow-up|1
6977748|NCT01211483|11031411|FG000|Phase 1b|Death|6
6977749|NCT01211483|11031412|FG001|Phase 1b|Death|0
6977750|NCT01211483|11031413|FG002|Phase 1b|Death|0
6977751|NCT01211483|11031414|FG003|Phase 1b|Death|0
6977752|NCT01211483|11031411|FG000|Phase 1b|Withdrawal by Subject|1
6977753|NCT01211483|11031412|FG001|Phase 1b|Withdrawal by Subject|0
6977754|NCT01211483|11031413|FG002|Phase 1b|Withdrawal by Subject|0
6977755|NCT01211483|11031414|FG003|Phase 1b|Withdrawal by Subject|0
6977756|NCT01211483|11031411|FG000|Phase 2|Lost to Follow-up|0
6977757|NCT01211483|11031412|FG001|Phase 2|Lost to Follow-up|1
6977758|NCT01211483|11031413|FG002|Phase 2|Lost to Follow-up|1
6977759|NCT01211483|11031414|FG003|Phase 2|Lost to Follow-up|2
6977760|NCT01211483|11031411|FG000|Phase 2|Death|0
6977761|NCT01211483|11031412|FG001|Phase 2|Death|64
6977762|NCT01211483|11031413|FG002|Phase 2|Death|53
6977763|NCT01211483|11031414|FG003|Phase 2|Death|53
6977764|NCT01211483|11031411|FG000|Phase 2|Withdrawal by Subject|0
6977765|NCT01211483|11031412|FG001|Phase 2|Withdrawal by Subject|1
6977766|NCT01211483|11031413|FG002|Phase 2|Withdrawal by Subject|10
6977767|NCT01211483|11031414|FG003|Phase 2|Withdrawal by Subject|5
6977768|NCT01211483|11031411|FG000|Phase 2|Study terminated by Sponsor|0
6977769|NCT01211483|11031412|FG001|Phase 2|Study terminated by Sponsor|6
6977770|NCT01211483|11031413|FG002|Phase 2|Study terminated by Sponsor|8
7045017|NCT01763047|11131351|FG001|Period 1|Protocol Violation|4
7045018|NCT01763047|11131350|FG000|Period 1|No Longer Meets Eligibility criteria|1
7045019|NCT01763047|11131351|FG001|Period 1|No Longer Meets Eligibility criteria|0
7045020|NCT01763047|11131350|FG000|Period 1|Adverse Event|0
7045021|NCT01763047|11131351|FG001|Period 1|Adverse Event|1
7045022|NCT01763047|11131350|FG000|Period 1|Unsatisfactory Visual Response|0
7045023|NCT01763047|11131351|FG001|Period 1|Unsatisfactory Visual Response|3
7045024|NCT01763047|11131350|FG000|Period 1|Lens Power Not Available|0
7045025|NCT01763047|11131351|FG001|Period 1|Lens Power Not Available|1
7045026|NCT01763047|11131350|FG000|Period 1|Study Site office Closed|0
7045027|NCT01763047|11131351|FG001|Period 1|Study Site office Closed|1
7045028|NCT01763047|11131350|FG000|Period 2|Lens Discomfort|1
7045029|NCT01763047|11131351|FG001|Period 2|Lens Discomfort|0
7045030|NCT01763047|11131350|FG000|Period 2|No longer meets Eligibility Criteria|1
7045031|NCT01763047|11131351|FG001|Period 2|No longer meets Eligibility Criteria|0
7045032|NCT01763047|11131350|FG000|Period 2|Study Site office Closed|1
7045033|NCT01763047|11131351|FG001|Period 2|Study Site office Closed|1
7045034|NCT01763047|11131350|FG000|Period 2|Unsatisfactory Visual Response|1
7045035|NCT01763047|11131351|FG001|Period 2|Unsatisfactory Visual Response|1
7045036|NCT01763047|11131350|FG000|Period 2|Protocol Violation|0
7045037|NCT01763047|11131351|FG001|Period 2|Protocol Violation|2
7045038|NCT01763047|11131350|FG000|Period 2|Unsatisfactory lens Fitting|0
7045039|NCT01763047|11131351|FG001|Period 2|Unsatisfactory lens Fitting|1
7045040|NCT01763164|11131362|FG000|Treatment Phase|Participant/Guardian decision|26
7045041|NCT01763164|11131363|FG001|Treatment Phase|Participant/Guardian decision|14
7045042|NCT01763164|11131362|FG000|Treatment Phase|Protocol Violation|1
7045043|NCT01763164|11131363|FG001|Treatment Phase|Protocol Violation|1
7045044|NCT01763164|11131362|FG000|Treatment Phase|Progressive Disease|142
6804035|NCT01244815|10805899|FG003|Overall Study|Withdrawal by Subject|3
6804036|NCT01244815|10805896|FG000|Overall Study|Protocol Violation|7
6977771|NCT01211483|11031414|FG003|Phase 2|Study terminated by Sponsor|11
7045045|NCT01763164|11131363|FG001|Treatment Phase|Progressive Disease|76
7045046|NCT01763164|11131362|FG000|Treatment Phase|Physician Decision|24
7045047|NCT01763164|11131363|FG001|Treatment Phase|Physician Decision|13
7045048|NCT01763164|11131362|FG000|Treatment Phase|Death|10
6977772|NCT01211522|11031431|FG000|Overall Study|Withdrawal by Subject|3
6977773|NCT01211522|11031432|FG001|Overall Study|Withdrawal by Subject|7
7045049|NCT01763164|11131363|FG001|Treatment Phase|Death|1
7045050|NCT01763164|11131362|FG000|Treatment Phase|Adverse Event|66
6977774|NCT01211522|11031433|FG002|Overall Study|Withdrawal by Subject|5
6977775|NCT01211535|11031443|FG000|Overall Study|Adverse Event|0
6977776|NCT01211535|11031444|FG001|Overall Study|Adverse Event|1
6977777|NCT01211613|11031464|FG000|Overall Study|Lost to Follow-up|2
6977778|NCT01211613|11031465|FG001|Overall Study|Lost to Follow-up|2
6977779|NCT01211613|11031466|FG002|Overall Study|Lost to Follow-up|2
6977780|NCT01211613|11031464|FG000|Overall Study|Withdrawal by Subject|1
6977781|NCT01211613|11031465|FG001|Overall Study|Withdrawal by Subject|0
6977782|NCT01211613|11031466|FG002|Overall Study|Withdrawal by Subject|0
6977783|NCT01211665|11031476|FG000|Overall Study|Withdrawal by Subject|1
6977784|NCT01211665|11031477|FG001|Overall Study|Withdrawal by Subject|0
6977785|NCT01211665|11031476|FG000|Overall Study|Death|1
6977786|NCT01211665|11031477|FG001|Overall Study|Death|0
6977787|NCT01211769|11031496|FG000|Overall Study|Lost to Follow-up|7
6977788|NCT01211769|11031497|FG001|Overall Study|Lost to Follow-up|9
6977789|NCT01211769|11031498|FG002|Overall Study|Lost to Follow-up|5
6977790|NCT01211769|11031499|FG003|Overall Study|Lost to Follow-up|9
6977791|NCT01211769|11031496|FG000|Overall Study|Physician Decision|2
6977792|NCT01211769|11031497|FG001|Overall Study|Physician Decision|0
6977793|NCT01211769|11031498|FG002|Overall Study|Physician Decision|2
6977794|NCT01211769|11031499|FG003|Overall Study|Physician Decision|1
6977795|NCT01211769|11031496|FG000|Overall Study|Adverse Event|0
6977796|NCT01211769|11031497|FG001|Overall Study|Adverse Event|1
6977797|NCT01211769|11031498|FG002|Overall Study|Adverse Event|1
6977798|NCT01211769|11031499|FG003|Overall Study|Adverse Event|1
6977799|NCT01212094|11031526|FG000|Year 1: Baseline Monitoring|Study terminated|7
6977800|NCT01212094|11031527|FG001|Year 1: Baseline Monitoring|Study terminated|0
6977801|NCT01212094|11031528|FG002|Year 1: Baseline Monitoring|Study terminated|0
6977802|NCT01212094|11031526|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7
6977803|NCT01212094|11031527|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0
6977804|NCT01212094|11031528|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0
6977805|NCT01212094|11031526|FG000|Year 1: Baseline Monitoring|Started on DMT|2
6977806|NCT01212094|11031527|FG001|Year 1: Baseline Monitoring|Started on DMT|0
6977807|NCT01212094|11031528|FG002|Year 1: Baseline Monitoring|Started on DMT|0
6977808|NCT01212094|11031526|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0
6977809|NCT01212094|11031527|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4
6977810|NCT01212094|11031528|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7
6977811|NCT01212094|11031526|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
6977812|NCT01212094|11031527|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
6977813|NCT01212094|11031528|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3
6977814|NCT01212094|11031526|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0
6977815|NCT01212094|11031527|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0
7083029|NCT02148952|11193923|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556
7083030|NCT02148952|11193922|FG000|Follow-Up|Lost to Follow-up|219
7083031|NCT02148952|11193923|FG001|Follow-Up|Lost to Follow-up|231
7083032|NCT02148952|11193922|FG000|Follow-Up|Withdrawal by Subject|46
7083033|NCT02148952|11193923|FG001|Follow-Up|Withdrawal by Subject|48
7083034|NCT02149108|11193939|FG000|Overall Study|Not treated|1
7083035|NCT02149108|11193940|FG001|Overall Study|Not treated|2
7083036|NCT02149108|11193939|FG000|Overall Study|Progressive Disease (PD)|324
7083037|NCT02149108|11193940|FG001|Overall Study|Progressive Disease (PD)|318
7083038|NCT02149108|11193939|FG000|Overall Study|Worsening/adverse event cancer disease|31
7188487|NCT02891226|11388869|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
6977816|NCT01212094|11031528|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1
6977817|NCT01212159|11031602|FG000|Overall Study|Withdrawal by Subject|12
6977818|NCT01212159|11031603|FG001|Overall Study|Withdrawal by Subject|12
6977819|NCT01212185|11031620|FG000|Overall Study|Protocol Violation|2
6977820|NCT01212185|11031621|FG001|Overall Study|Protocol Violation|1
6977821|NCT01212588|11031667|FG000|Overall Study|Physician Decision|0
6977822|NCT01212588|11031668|FG001|Overall Study|Physician Decision|1
6977823|NCT01212588|11031667|FG000|Overall Study|Protocol Violation|1
6977824|NCT01212588|11031668|FG001|Overall Study|Protocol Violation|1
6977825|NCT01212744|11031678|FG000|Overall Study|Withdrawal by Subject|1
6977826|NCT01212757|11031687|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
6977827|NCT01212757|11031688|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5
6977828|NCT01212757|11031689|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
6977829|NCT01212757|11031690|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
6977830|NCT01212757|11031691|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
6977831|NCT01212757|11031692|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
6977832|NCT01212757|11031693|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
6977833|NCT01212757|11031694|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
6977834|NCT01212757|11031695|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
6977835|NCT01212757|11031687|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
6977836|NCT01212757|11031688|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
6977837|NCT01212757|11031689|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
7188488|NCT02891226|11388870|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7188489|NCT02891226|11388871|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7188490|NCT02891226|11388872|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7188491|NCT02891226|11388873|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7188492|NCT02891226|11388858|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7188493|NCT02891226|11388859|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7188494|NCT02891226|11388860|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7188495|NCT02891226|11388861|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7188496|NCT02891226|11388862|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7188497|NCT02891226|11388863|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7188498|NCT02891226|11388864|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1
7188499|NCT02891226|11388865|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7188500|NCT02891226|11388866|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7188501|NCT02891226|11388867|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7188502|NCT02891226|11388868|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7188503|NCT02891226|11388869|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7188504|NCT02891226|11388870|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
6977838|NCT01212757|11031690|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
6977839|NCT01212757|11031691|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
6977840|NCT01212757|11031692|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
6977841|NCT01212757|11031693|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7083039|NCT02149108|11193940|FG001|Overall Study|Worsening/adverse event cancer disease|32
6977842|NCT01212757|11031694|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
6977843|NCT01212757|11031695|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
6977844|NCT01212757|11031687|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7
6977845|NCT01212757|11031688|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9
6977846|NCT01212757|11031689|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
6977847|NCT01212757|11031690|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
6977848|NCT01212757|11031691|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
6977849|NCT01212757|11031692|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
6977850|NCT01212757|11031693|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
6977851|NCT01212757|11031694|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
6977852|NCT01212757|11031695|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
6977853|NCT01212757|11031687|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3
6977854|NCT01212757|11031688|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
6977855|NCT01212757|11031689|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
6977856|NCT01212757|11031690|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
6977857|NCT01212757|11031691|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
6977858|NCT01212757|11031692|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
6977859|NCT01212757|11031693|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
6977860|NCT01212757|11031694|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
6977861|NCT01212757|11031695|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
6977862|NCT01212757|11031687|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
6977863|NCT01212757|11031688|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
6977864|NCT01212757|11031689|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
6977865|NCT01212757|11031690|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
6977866|NCT01212757|11031691|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
6977867|NCT01212757|11031692|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
6977868|NCT01212757|11031693|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
6977869|NCT01212757|11031694|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
6977870|NCT01212757|11031695|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
6977871|NCT01212757|11031687|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
6977872|NCT01212757|11031688|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
6977873|NCT01212757|11031689|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
6977874|NCT01212757|11031690|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
6977875|NCT01212757|11031691|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
6977876|NCT01212757|11031692|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
6977877|NCT01212757|11031693|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
6977878|NCT01212757|11031694|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
6977879|NCT01212757|11031695|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
6977880|NCT01212757|11031687|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1
6977881|NCT01212757|11031688|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2
6977882|NCT01212757|11031689|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0
6977883|NCT01212757|11031690|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0
6977884|NCT01212757|11031691|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0
6977885|NCT01212757|11031692|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0
6977886|NCT01212757|11031693|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0
6977887|NCT01212757|11031694|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0
6977888|NCT01212757|11031695|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0
6977889|NCT01212757|11031687|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
6977890|NCT01212757|11031688|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
6977891|NCT01212757|11031689|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3
6977892|NCT01212757|11031690|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1
6977893|NCT01212757|11031691|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
6977894|NCT01212757|11031692|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
6977895|NCT01212757|11031693|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
6977896|NCT01212757|11031694|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
6977897|NCT01212757|11031695|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
6977898|NCT01212757|11031687|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
6977899|NCT01212757|11031688|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5
6977900|NCT01212757|11031689|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7
6977901|NCT01212757|11031690|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4
6977902|NCT01212757|11031691|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
6977903|NCT01212757|11031692|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2
6977904|NCT01212757|11031693|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
6977905|NCT01212757|11031694|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
6977906|NCT01212757|11031695|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
6977907|NCT01212757|11031687|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
6977908|NCT01212757|11031688|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
7045051|NCT01763164|11131363|FG001|Treatment Phase|Adverse Event|8
6977909|NCT01212757|11031689|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2
6977910|NCT01212757|11031690|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
6977911|NCT01212757|11031691|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
6977912|NCT01212757|11031692|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
6977913|NCT01212757|11031693|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
6977914|NCT01212757|11031694|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
6977915|NCT01212757|11031695|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
6977916|NCT01212757|11031687|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
6977917|NCT01212757|11031688|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
6977918|NCT01212757|11031689|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7
6977919|NCT01212757|11031690|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
6977920|NCT01212757|11031691|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1
6977921|NCT01212757|11031692|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
6977922|NCT01212757|11031693|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
6977923|NCT01212757|11031694|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
6977924|NCT01212757|11031695|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
6977925|NCT01212757|11031687|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
6977926|NCT01212757|11031688|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
6977927|NCT01212757|11031689|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
6977928|NCT01212757|11031690|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
6977929|NCT01212757|11031691|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
6977930|NCT01212757|11031692|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
6977931|NCT01212757|11031693|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
6977932|NCT01212757|11031694|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
6977933|NCT01212757|11031695|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
6977934|NCT01212757|11031687|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0
6977935|NCT01212757|11031688|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1
6977936|NCT01212757|11031689|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1
6977937|NCT01212757|11031690|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0
6977938|NCT01212757|11031691|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0
6977939|NCT01212757|11031692|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0
6977940|NCT01212757|11031693|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0
6977941|NCT01212757|11031694|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0
6977942|NCT01212757|11031695|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0
6977943|NCT01212757|11031687|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0
6977944|NCT01212757|11031688|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0
7188505|NCT02891226|11388871|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7188506|NCT02891226|11388872|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7188507|NCT02891226|11388873|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7188508|NCT02891226|11388858|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
7188509|NCT02891226|11388859|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
7188510|NCT02891226|11388860|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
7188511|NCT02891226|11388861|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
7188512|NCT02891226|11388862|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
7188513|NCT02891226|11388863|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
7188514|NCT02891226|11388864|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
7188515|NCT02891226|11388865|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1
7188516|NCT02891226|11388866|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1
7188517|NCT02891226|11388867|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1
7188518|NCT02891226|11388868|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
7188519|NCT02891226|11388869|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
7188520|NCT02891226|11388870|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
7188521|NCT02891226|11388871|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
7188522|NCT02891226|11388872|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
7188523|NCT02891226|11388873|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
6977945|NCT01212757|11031689|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0
6977946|NCT01212757|11031690|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0
6977947|NCT01212757|11031691|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0
6977948|NCT01212757|11031692|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0
6977949|NCT01212757|11031693|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0
6977950|NCT01212757|11031694|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0
6977951|NCT01212757|11031695|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1
6977952|NCT01212757|11031687|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0
6977953|NCT01212757|11031688|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1
6977954|NCT01212757|11031689|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1
6977955|NCT01212757|11031690|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0
6977956|NCT01212757|11031691|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0
6977957|NCT01212757|11031692|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0
6977958|NCT01212757|11031693|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0
6977959|NCT01212757|11031694|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2
6977960|NCT01212757|11031695|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2
6977961|NCT01212757|11031687|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
6977962|NCT01212757|11031688|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
6977963|NCT01212757|11031689|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2
6977964|NCT01212757|11031690|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
6977965|NCT01212757|11031691|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
6977966|NCT01212757|11031692|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
6977967|NCT01212757|11031693|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
6977968|NCT01212757|11031694|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
6977969|NCT01212757|11031695|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
6977970|NCT01212757|11031687|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
6977971|NCT01212757|11031688|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7
6977972|NCT01212757|11031689|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9
6977973|NCT01212757|11031690|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
7188524|NCT02891226|11388858|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
6804037|NCT01244815|10805897|FG001|Overall Study|Protocol Violation|4
6804038|NCT01244815|10805898|FG002|Overall Study|Protocol Violation|3
6804039|NCT01244815|10805899|FG003|Overall Study|Protocol Violation|1
6804040|NCT01244815|10805896|FG000|Overall Study|Did Not Meet Protocol Eligibility|0
6804041|NCT01244815|10805897|FG001|Overall Study|Did Not Meet Protocol Eligibility|1
6804042|NCT01244815|10805898|FG002|Overall Study|Did Not Meet Protocol Eligibility|0
6804043|NCT01244815|10805899|FG003|Overall Study|Did Not Meet Protocol Eligibility|0
6804044|NCT01142596|10805911|FG000|Overall Study|Withdrawal by Subject|9
6804045|NCT01142596|10805912|FG001|Overall Study|Withdrawal by Subject|35
6977974|NCT01212757|11031691|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
6977975|NCT01212757|11031692|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
6977976|NCT01212757|11031693|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
6977977|NCT01212757|11031694|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4
6977978|NCT01212757|11031695|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6
6977979|NCT01212757|11031687|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
6977980|NCT01212757|11031688|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
6977981|NCT01212757|11031689|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2
6977982|NCT01212757|11031690|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
6977983|NCT01212757|11031691|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
7083040|NCT02149108|11193939|FG000|Overall Study|Other Adverse Event (AE)|8
7083041|NCT02149108|11193940|FG001|Overall Study|Other Adverse Event (AE)|18
7083042|NCT02149108|11193939|FG000|Overall Study|Other not defined above|0
7083043|NCT02149108|11193940|FG001|Overall Study|Other not defined above|2
7083044|NCT02149108|11193939|FG000|Overall Study|Refusal to continue trial medication|15
7083045|NCT02149108|11193940|FG001|Overall Study|Refusal to continue trial medication|11
7083046|NCT02149108|11193939|FG000|Overall Study|Lost to Follow-up|1
7188525|NCT02891226|11388859|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7188526|NCT02891226|11388860|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7188527|NCT02891226|11388861|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7188528|NCT02891226|11388862|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7188529|NCT02891226|11388863|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7188530|NCT02891226|11388864|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7188531|NCT02891226|11388865|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1
7188532|NCT02891226|11388866|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
6977984|NCT01212757|11031692|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
6977985|NCT01212757|11031693|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
6977986|NCT01212757|11031694|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
6977987|NCT01212757|11031695|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
6977988|NCT01212757|11031687|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0
6977989|NCT01212757|11031688|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4
6977990|NCT01212757|11031689|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1
6977991|NCT01212757|11031690|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0
6977992|NCT01212757|11031691|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0
6977993|NCT01212757|11031692|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0
6977994|NCT01212757|11031693|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0
6977995|NCT01212757|11031694|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2
6977996|NCT01212757|11031695|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0
6977997|NCT01212757|11031687|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
6977998|NCT01212757|11031688|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8
6977999|NCT01212757|11031689|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5
6978000|NCT01212757|11031690|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
6978001|NCT01212757|11031691|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
6978002|NCT01212757|11031692|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
6978003|NCT01212757|11031693|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
6978004|NCT01212757|11031694|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3
6978005|NCT01212757|11031695|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1
6978006|NCT01212757|11031687|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
6978007|NCT01212757|11031688|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
6978008|NCT01212757|11031689|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1
6978009|NCT01212757|11031690|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
6978010|NCT01212757|11031691|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
6978011|NCT01212757|11031692|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
6978012|NCT01212757|11031693|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
6978013|NCT01212757|11031694|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
6978014|NCT01212757|11031695|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
6978015|NCT01212757|11031687|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
6978016|NCT01212757|11031688|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5
6978017|NCT01212757|11031689|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
6978018|NCT01212757|11031690|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
6978019|NCT01212757|11031691|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
6978020|NCT01212757|11031692|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
6978021|NCT01212757|11031693|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
6978022|NCT01212757|11031694|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
6978023|NCT01212757|11031695|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
6978024|NCT01212757|11031687|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
6978025|NCT01212757|11031688|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
6978026|NCT01212757|11031689|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
6978027|NCT01212757|11031690|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
6978028|NCT01212757|11031691|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
6978029|NCT01212757|11031692|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
6978030|NCT01212757|11031693|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
6978031|NCT01212757|11031694|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
6978032|NCT01212757|11031695|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1
6978033|NCT01212757|11031687|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0
6978034|NCT01212757|11031688|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1
6978035|NCT01212757|11031689|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0
6978036|NCT01212757|11031690|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0
6978037|NCT01212757|11031691|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0
6978038|NCT01212757|11031692|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0
6978039|NCT01212757|11031693|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0
6978040|NCT01212757|11031694|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0
6978041|NCT01212757|11031695|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0
6978042|NCT01212757|11031687|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0
6978043|NCT01212757|11031688|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0
6978044|NCT01212757|11031689|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3
6978045|NCT01212757|11031690|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0
6978046|NCT01212757|11031691|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0
6978047|NCT01212757|11031692|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0
6978048|NCT01212757|11031693|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0
6978049|NCT01212757|11031694|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0
6978050|NCT01212757|11031695|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2
6978051|NCT01212757|11031687|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0
6978052|NCT01212757|11031688|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2
6978053|NCT01212757|11031689|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0
6978054|NCT01212757|11031690|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0
6978055|NCT01212757|11031691|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0
6978056|NCT01212757|11031692|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0
6978057|NCT01212757|11031693|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0
6978058|NCT01212757|11031694|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0
6978059|NCT01212757|11031695|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1
6978060|NCT01212757|11031687|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0
6978061|NCT01212757|11031688|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1
6978062|NCT01212757|11031689|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2
6978063|NCT01212757|11031690|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0
6978064|NCT01212757|11031691|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0
6978065|NCT01212757|11031692|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0
6978066|NCT01212757|11031693|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0
6978067|NCT01212757|11031694|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1
6978068|NCT01212757|11031695|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1
6978069|NCT01212757|11031687|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
6978070|NCT01212757|11031688|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
6978071|NCT01212757|11031689|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
6978072|NCT01212757|11031690|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
6978073|NCT01212757|11031691|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
6978074|NCT01212757|11031692|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
6978075|NCT01212757|11031693|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
6978076|NCT01212757|11031694|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
6978077|NCT01212757|11031695|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
6978078|NCT01212757|11031687|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
6978079|NCT01212757|11031688|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4
6978080|NCT01212757|11031689|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2
6978081|NCT01212757|11031690|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
6978082|NCT01212757|11031691|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
6978083|NCT01212757|11031692|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
6978084|NCT01212757|11031693|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
6978085|NCT01212757|11031694|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1
6978086|NCT01212757|11031695|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3
6978087|NCT01212757|11031687|FG000|Long-Term Safety Phase (Year 4)|Death|0
6978088|NCT01212757|11031688|FG001|Long-Term Safety Phase (Year 4)|Death|0
6978089|NCT01212757|11031689|FG002|Long-Term Safety Phase (Year 4)|Death|1
6978090|NCT01212757|11031690|FG003|Long-Term Safety Phase (Year 4)|Death|0
6978091|NCT01212757|11031691|FG004|Long-Term Safety Phase (Year 4)|Death|0
6978092|NCT01212757|11031692|FG005|Long-Term Safety Phase (Year 4)|Death|0
6978093|NCT01212757|11031693|FG006|Long-Term Safety Phase (Year 4)|Death|0
6978094|NCT01212757|11031694|FG007|Long-Term Safety Phase (Year 4)|Death|0
6978095|NCT01212757|11031695|FG008|Long-Term Safety Phase (Year 4)|Death|1
6978096|NCT01212757|11031687|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
6978097|NCT01212757|11031688|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
6978098|NCT01212757|11031689|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
6978099|NCT01212757|11031690|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
6978100|NCT01212757|11031691|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
6978101|NCT01212757|11031692|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
6978102|NCT01212757|11031693|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
6978103|NCT01212757|11031694|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1
6978104|NCT01212757|11031695|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
6978105|NCT01212757|11031687|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
6978106|NCT01212757|11031688|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
6978107|NCT01212757|11031689|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
6978108|NCT01212757|11031690|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
6978109|NCT01212757|11031691|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
6978110|NCT01212757|11031692|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
6978111|NCT01212757|11031693|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
6978112|NCT01212757|11031694|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
6978113|NCT01212757|11031695|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
6978114|NCT01212757|11031687|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0
6978115|NCT01212757|11031688|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2
6978116|NCT01212757|11031689|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2
6978117|NCT01212757|11031690|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0
6978118|NCT01212757|11031691|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0
6978119|NCT01212757|11031692|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0
6978120|NCT01212757|11031693|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0
6978121|NCT01212757|11031694|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2
7188533|NCT02891226|11388867|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7188534|NCT02891226|11388868|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7188535|NCT02891226|11388869|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7188536|NCT02891226|11388870|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7188537|NCT02891226|11388871|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7188538|NCT02891226|11388872|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7188539|NCT02891226|11388873|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7188540|NCT02891226|11388858|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7188541|NCT02891226|11388859|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7188542|NCT02891226|11388860|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
6978122|NCT01212757|11031695|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0
6978123|NCT01212757|11031687|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
6978124|NCT01212757|11031688|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
6978125|NCT01212757|11031689|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
6978126|NCT01212757|11031690|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
6978127|NCT01212757|11031691|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
6978128|NCT01212757|11031692|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
6978129|NCT01212757|11031693|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
6978130|NCT01212757|11031694|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
6978131|NCT01212757|11031695|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
6978132|NCT01212757|11031687|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
6978133|NCT01212757|11031688|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1
6978134|NCT01212757|11031689|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
6978135|NCT01212757|11031690|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
7083047|NCT02149108|11193940|FG001|Overall Study|Lost to Follow-up|0
7083048|NCT02149199|11193959|FG000|Overall Study|Study specific withdrawal criteria|4
7083049|NCT02149199|11193960|FG001|Overall Study|Study specific withdrawal criteria|21
7083050|NCT02149199|11193961|FG002|Overall Study|Study specific withdrawal criteria|6
7083051|NCT02149199|11193959|FG000|Overall Study|Other|20
7083052|NCT02149199|11193960|FG001|Overall Study|Other|25
7083053|NCT02149199|11193961|FG002|Overall Study|Other|20
7083054|NCT02149199|11193959|FG000|Overall Study|Eligibility criteria not fulfilled|9
7083055|NCT02149199|11193960|FG001|Overall Study|Eligibility criteria not fulfilled|14
7083056|NCT02149199|11193961|FG002|Overall Study|Eligibility criteria not fulfilled|8
7083057|NCT02149199|11193959|FG000|Overall Study|Withdrawal by Subject|75
7083058|NCT02149199|11193960|FG001|Overall Study|Withdrawal by Subject|93
7083059|NCT02149199|11193961|FG002|Overall Study|Withdrawal by Subject|77
7083060|NCT02149199|11193959|FG000|Overall Study|Protocol Violation|16
7083061|NCT02149199|11193960|FG001|Overall Study|Protocol Violation|13
7083062|NCT02149199|11193961|FG002|Overall Study|Protocol Violation|15
7083063|NCT02149199|11193959|FG000|Overall Study|Lost to Follow-up|3
7083064|NCT02149199|11193960|FG001|Overall Study|Lost to Follow-up|12
7083065|NCT02149199|11193961|FG002|Overall Study|Lost to Follow-up|11
7083066|NCT02149199|11193959|FG000|Overall Study|Death|0
7083067|NCT02149199|11193960|FG001|Overall Study|Death|0
7083068|NCT02149199|11193961|FG002|Overall Study|Death|1
7083069|NCT02149199|11193959|FG000|Overall Study|Adverse Event|6
6978136|NCT01212757|11031691|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
6978137|NCT01212757|11031692|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
6978138|NCT01212757|11031693|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
6978139|NCT01212757|11031694|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
6978140|NCT01212757|11031695|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
6978141|NCT01212757|11031687|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0
6978142|NCT01212757|11031688|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1
6978143|NCT01212757|11031689|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1
6978144|NCT01212757|11031690|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0
6978145|NCT01212757|11031691|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0
6978146|NCT01212757|11031692|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0
6978147|NCT01212757|11031693|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0
6978148|NCT01212757|11031694|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0
6978149|NCT01212757|11031695|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0
7045052|NCT01763164|11131362|FG000|Treatment Phase|Randomized but not Treated|0
7045053|NCT01763164|11131363|FG001|Treatment Phase|Randomized but not Treated|19
7045054|NCT01763164|11131362|FG000|Treatment Phase|Other|0
7045055|NCT01763164|11131363|FG001|Treatment Phase|Other|1
7045056|NCT01763164|11131362|FG000|Follow up Phase|New therapy for study indication|12
7045057|NCT01763164|11131363|FG001|Follow up Phase|New therapy for study indication|3
7045058|NCT01763164|11131362|FG000|Follow up Phase|Death|21
7045059|NCT01763164|11131363|FG001|Follow up Phase|Death|4
7045060|NCT01763164|11131362|FG000|Follow up Phase|Subject/guardian decision|9
7045061|NCT01763164|11131363|FG001|Follow up Phase|Subject/guardian decision|2
7045062|NCT01763164|11131362|FG000|Follow up Phase|Progressive disease|127
7045063|NCT01763164|11131363|FG001|Follow up Phase|Progressive disease|62
7045064|NCT01763164|11131362|FG000|Follow up Phase|Physician Decision|10
7045065|NCT01763164|11131363|FG001|Follow up Phase|Physician Decision|3
7045066|NCT01763164|11131362|FG000|Follow up Phase|Lost to Follow-up|1
7045067|NCT01763164|11131363|FG001|Follow up Phase|Lost to Follow-up|0
7045068|NCT01763164|11131362|FG000|Follow up Phase|Adverse Event|17
7045069|NCT01763164|11131363|FG001|Follow up Phase|Adverse Event|1
7045070|NCT01763203|11131371|FG000|Overall Study|Death|4
7045071|NCT01763203|11131372|FG001|Overall Study|Death|7
7045072|NCT01763203|11131371|FG000|Overall Study|Lost to Follow-up|12
7045073|NCT01763203|11131372|FG001|Overall Study|Lost to Follow-up|12
7045074|NCT01763203|11131371|FG000|Overall Study|Withdrawal by Subject|8
7045075|NCT01763203|11131372|FG001|Overall Study|Withdrawal by Subject|12
7045076|NCT01763203|11131371|FG000|Overall Study|Moved out of study region|7
7045077|NCT01763203|11131372|FG001|Overall Study|Moved out of study region|10
7045078|NCT01763203|11131371|FG000|Overall Study|Physician Decision|2
7045079|NCT01763203|11131372|FG001|Overall Study|Physician Decision|1
7045080|NCT01763684|11131474|FG000|Overall Study|Study terminated early due to low enrollment|126
7045081|NCT01763684|11131475|FG001|Overall Study|Study terminated early due to low enrollment|127
7045082|NCT01763684|11131474|FG000|Overall Study|Study surgery not performed|7
7045083|NCT01763684|11131475|FG001|Overall Study|Study surgery not performed|6
7045084|NCT01763827|11131487|FG000|Overall Study|Withdrawal by Subject|1
7045085|NCT01763827|11131488|FG001|Overall Study|Withdrawal by Subject|0
7045086|NCT01763827|11131489|FG002|Overall Study|Withdrawal by Subject|0
7045087|NCT01763827|11131490|FG003|Overall Study|Withdrawal by Subject|0
7045088|NCT01763827|11131491|FG004|Overall Study|Withdrawal by Subject|2
7045089|NCT01763827|11131492|FG005|Overall Study|Withdrawal by Subject|0
7045090|NCT01763827|11131487|FG000|Overall Study|Decision by sponsor|2
7045091|NCT01763827|11131488|FG001|Overall Study|Decision by sponsor|0
7045092|NCT01763827|11131489|FG002|Overall Study|Decision by sponsor|3
7045093|NCT01763827|11131490|FG003|Overall Study|Decision by sponsor|0
7045094|NCT01763827|11131491|FG004|Overall Study|Decision by sponsor|2
7045095|NCT01763827|11131492|FG005|Overall Study|Decision by sponsor|1
7045096|NCT01763827|11131487|FG000|Overall Study|Lost to Follow-up|0
7045097|NCT01763827|11131488|FG001|Overall Study|Lost to Follow-up|1
7045098|NCT01763827|11131489|FG002|Overall Study|Lost to Follow-up|1
7045099|NCT01763827|11131490|FG003|Overall Study|Lost to Follow-up|1
7045100|NCT01763827|11131491|FG004|Overall Study|Lost to Follow-up|2
7045101|NCT01763827|11131492|FG005|Overall Study|Lost to Follow-up|1
7045102|NCT01763866|11131530|FG000|Overall Study|Withdrawal by Subject|2
7045103|NCT01763866|11131531|FG001|Overall Study|Withdrawal by Subject|1
7045104|NCT01763866|11131532|FG002|Overall Study|Withdrawal by Subject|4
7045105|NCT01763866|11131533|FG003|Overall Study|Withdrawal by Subject|0
7045106|NCT01763866|11131534|FG004|Overall Study|Withdrawal by Subject|0
7045107|NCT01763866|11131535|FG005|Overall Study|Withdrawal by Subject|3
7045108|NCT01763866|11131536|FG006|Overall Study|Withdrawal by Subject|4
7045109|NCT01763866|11131537|FG007|Overall Study|Withdrawal by Subject|0
7045110|NCT01763866|11131538|FG008|Overall Study|Withdrawal by Subject|1
7045111|NCT01763866|11131539|FG009|Overall Study|Withdrawal by Subject|1
7045112|NCT01763866|11131540|FG010|Overall Study|Withdrawal by Subject|2
7045113|NCT01763866|11131541|FG011|Overall Study|Withdrawal by Subject|2
7045114|NCT01763866|11131542|FG012|Overall Study|Withdrawal by Subject|2
7045115|NCT01763866|11131543|FG013|Overall Study|Withdrawal by Subject|0
7045116|NCT01763866|11131544|FG014|Overall Study|Withdrawal by Subject|6
7045117|NCT01763866|11131545|FG015|Overall Study|Withdrawal by Subject|3
7045118|NCT01763866|11131546|FG016|Overall Study|Withdrawal by Subject|0
7045119|NCT01763866|11131547|FG017|Overall Study|Withdrawal by Subject|1
7045120|NCT01763866|11131548|FG018|Overall Study|Withdrawal by Subject|1
7045121|NCT01763866|11131549|FG019|Overall Study|Withdrawal by Subject|1
7045122|NCT01763866|11131550|FG020|Overall Study|Withdrawal by Subject|2
7045123|NCT01763866|11131551|FG021|Overall Study|Withdrawal by Subject|1
7045124|NCT01763866|11131552|FG022|Overall Study|Withdrawal by Subject|2
7045125|NCT01763866|11131553|FG023|Overall Study|Withdrawal by Subject|1
7045126|NCT01763866|11131530|FG000|Overall Study|Decision by sponsor|0
7045127|NCT01763866|11131531|FG001|Overall Study|Decision by sponsor|0
7045128|NCT01763866|11131532|FG002|Overall Study|Decision by sponsor|1
7045129|NCT01763866|11131533|FG003|Overall Study|Decision by sponsor|0
7045130|NCT01763866|11131534|FG004|Overall Study|Decision by sponsor|2
7045131|NCT01763866|11131535|FG005|Overall Study|Decision by sponsor|0
7045132|NCT01763866|11131536|FG006|Overall Study|Decision by sponsor|2
7045133|NCT01763866|11131537|FG007|Overall Study|Decision by sponsor|0
7045134|NCT01763866|11131538|FG008|Overall Study|Decision by sponsor|2
7045135|NCT01763866|11131539|FG009|Overall Study|Decision by sponsor|0
7045136|NCT01763866|11131540|FG010|Overall Study|Decision by sponsor|6
7045137|NCT01763866|11131541|FG011|Overall Study|Decision by sponsor|0
7045138|NCT01763866|11131542|FG012|Overall Study|Decision by sponsor|1
7045139|NCT01763866|11131543|FG013|Overall Study|Decision by sponsor|0
7045140|NCT01763866|11131544|FG014|Overall Study|Decision by sponsor|5
7045141|NCT01763866|11131545|FG015|Overall Study|Decision by sponsor|0
7045142|NCT01763866|11131546|FG016|Overall Study|Decision by sponsor|0
7045143|NCT01763866|11131547|FG017|Overall Study|Decision by sponsor|0
7045144|NCT01763866|11131548|FG018|Overall Study|Decision by sponsor|4
7045145|NCT01763866|11131549|FG019|Overall Study|Decision by sponsor|0
7045146|NCT01763866|11131550|FG020|Overall Study|Decision by sponsor|2
7045147|NCT01763866|11131551|FG021|Overall Study|Decision by sponsor|0
7045148|NCT01763866|11131552|FG022|Overall Study|Decision by sponsor|1
7045149|NCT01763866|11131553|FG023|Overall Study|Decision by sponsor|0
7045150|NCT01763866|11131530|FG000|Overall Study|Lost to Follow-up|0
7045151|NCT01763866|11131531|FG001|Overall Study|Lost to Follow-up|0
7045152|NCT01763866|11131532|FG002|Overall Study|Lost to Follow-up|0
7045153|NCT01763866|11131533|FG003|Overall Study|Lost to Follow-up|0
7045154|NCT01763866|11131534|FG004|Overall Study|Lost to Follow-up|0
7045155|NCT01763866|11131535|FG005|Overall Study|Lost to Follow-up|0
7045156|NCT01763866|11131536|FG006|Overall Study|Lost to Follow-up|1
7045157|NCT01763866|11131537|FG007|Overall Study|Lost to Follow-up|0
7045158|NCT01763866|11131538|FG008|Overall Study|Lost to Follow-up|0
7045159|NCT01763866|11131539|FG009|Overall Study|Lost to Follow-up|0
7045160|NCT01763866|11131540|FG010|Overall Study|Lost to Follow-up|0
7045161|NCT01763866|11131541|FG011|Overall Study|Lost to Follow-up|0
7045162|NCT01763866|11131542|FG012|Overall Study|Lost to Follow-up|1
7045163|NCT01763866|11131543|FG013|Overall Study|Lost to Follow-up|0
7045164|NCT01763866|11131544|FG014|Overall Study|Lost to Follow-up|1
7045165|NCT01763866|11131545|FG015|Overall Study|Lost to Follow-up|0
7045166|NCT01763866|11131546|FG016|Overall Study|Lost to Follow-up|0
7045167|NCT01763866|11131547|FG017|Overall Study|Lost to Follow-up|0
7045168|NCT01763866|11131548|FG018|Overall Study|Lost to Follow-up|1
7045169|NCT01763866|11131549|FG019|Overall Study|Lost to Follow-up|1
7045170|NCT01763866|11131550|FG020|Overall Study|Lost to Follow-up|0
7045171|NCT01763866|11131551|FG021|Overall Study|Lost to Follow-up|0
7045172|NCT01763866|11131552|FG022|Overall Study|Lost to Follow-up|0
7045173|NCT01763866|11131553|FG023|Overall Study|Lost to Follow-up|1
7045174|NCT01763866|11131530|FG000|Overall Study|Death|0
7045175|NCT01763866|11131531|FG001|Overall Study|Death|0
7045176|NCT01763866|11131532|FG002|Overall Study|Death|0
7045177|NCT01763866|11131533|FG003|Overall Study|Death|0
7045178|NCT01763866|11131534|FG004|Overall Study|Death|0
7045179|NCT01763866|11131535|FG005|Overall Study|Death|0
7045180|NCT01763866|11131536|FG006|Overall Study|Death|0
7045181|NCT01763866|11131537|FG007|Overall Study|Death|0
7045182|NCT01763866|11131538|FG008|Overall Study|Death|0
7045183|NCT01763866|11131539|FG009|Overall Study|Death|0
7045184|NCT01763866|11131540|FG010|Overall Study|Death|0
7045185|NCT01763866|11131541|FG011|Overall Study|Death|0
7045186|NCT01763866|11131542|FG012|Overall Study|Death|0
7045187|NCT01763866|11131543|FG013|Overall Study|Death|0
7045188|NCT01763866|11131544|FG014|Overall Study|Death|0
7045189|NCT01763866|11131545|FG015|Overall Study|Death|0
7045190|NCT01763866|11131546|FG016|Overall Study|Death|1
7045191|NCT01763866|11131547|FG017|Overall Study|Death|0
7045192|NCT01763866|11131548|FG018|Overall Study|Death|0
7045193|NCT01763866|11131549|FG019|Overall Study|Death|0
7045194|NCT01763866|11131550|FG020|Overall Study|Death|0
7045195|NCT01763866|11131551|FG021|Overall Study|Death|0
7045196|NCT01763866|11131552|FG022|Overall Study|Death|0
7045197|NCT01763866|11131553|FG023|Overall Study|Death|0
7045198|NCT01763905|11131607|FG000|Overall Study|Withdrawal by Subject|1
7045199|NCT01763905|11131608|FG001|Overall Study|Withdrawal by Subject|1
7045200|NCT01763905|11131609|FG002|Overall Study|Withdrawal by Subject|0
7045201|NCT01763905|11131610|FG003|Overall Study|Withdrawal by Subject|1
7045202|NCT01763905|11131607|FG000|Overall Study|Decision by sponsor|5
7045203|NCT01763905|11131608|FG001|Overall Study|Decision by sponsor|0
7045204|NCT01763905|11131609|FG002|Overall Study|Decision by sponsor|8
7045205|NCT01763905|11131610|FG003|Overall Study|Decision by sponsor|0
7045206|NCT01763905|11131607|FG000|Overall Study|Lost to Follow-up|0
7045207|NCT01763905|11131608|FG001|Overall Study|Lost to Follow-up|0
7045208|NCT01763905|11131609|FG002|Overall Study|Lost to Follow-up|1
7045209|NCT01763905|11131610|FG003|Overall Study|Lost to Follow-up|0
7045210|NCT01763918|11131624|FG000|Overall Study|Withdrawal by Subject|2
7045211|NCT01763918|11131625|FG001|Overall Study|Withdrawal by Subject|1
7045212|NCT01763918|11131626|FG002|Overall Study|Withdrawal by Subject|1
7045213|NCT01763918|11131627|FG003|Overall Study|Withdrawal by Subject|2
7045214|NCT01763918|11131624|FG000|Overall Study|Sponsor Decision|4
7045215|NCT01763918|11131625|FG001|Overall Study|Sponsor Decision|0
7045216|NCT01763918|11131626|FG002|Overall Study|Sponsor Decision|9
7083070|NCT02149199|11193960|FG001|Overall Study|Adverse Event|15
7083071|NCT02149199|11193961|FG002|Overall Study|Adverse Event|9
7083072|NCT02149264|11193969|FG000|Overall Study|Withdrawal by Subject|9
7083073|NCT02149264|11193969|FG000|Overall Study|Adverse Event|7
7083074|NCT02149264|11193969|FG000|Overall Study|Physician Decision|3
7083075|NCT02149264|11193969|FG000|Overall Study|Protocol Violation|1
7083076|NCT02149420|11193993|FG000|Core Study|Administrative problems|0
7083077|NCT02149420|11193994|FG001|Core Study|Administrative problems|1
7083078|NCT02149420|11193995|FG002|Core Study|Administrative problems|2
7083079|NCT02149420|11193993|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1
7045217|NCT01763918|11131627|FG003|Overall Study|Sponsor Decision|0
7045218|NCT01763996|11131653|FG000|Treatment Period 2|Adverse Event|0
7045219|NCT01763996|11131654|FG001|Treatment Period 2|Adverse Event|1
7045220|NCT01764022|11131662|FG000|Overall Study|Death|3
7045221|NCT01764022|11131663|FG001|Overall Study|Death|5
7045222|NCT01764022|11131662|FG000|Overall Study|Withdrawal by Subject|2
7045223|NCT01764022|11131663|FG001|Overall Study|Withdrawal by Subject|6
7045224|NCT01764022|11131662|FG000|Overall Study|Lack of Efficacy|0
7045225|NCT01764022|11131663|FG001|Overall Study|Lack of Efficacy|1
7045226|NCT01764022|11131662|FG000|Overall Study|Physician Decision|0
7045227|NCT01764022|11131663|FG001|Overall Study|Physician Decision|2
7045228|NCT01764022|11131662|FG000|Overall Study|Lost to Follow-up|2
7045229|NCT01764022|11131663|FG001|Overall Study|Lost to Follow-up|0
7045230|NCT01764022|11131662|FG000|Overall Study|Protocol Violation|1
7045231|NCT01764022|11131663|FG001|Overall Study|Protocol Violation|0
7045232|NCT01764256|11131675|FG000|Received All Vaccinations|Adverse Event|1
7045233|NCT01764256|11131676|FG001|Received All Vaccinations|Adverse Event|1
7045234|NCT01764256|11131677|FG002|Received All Vaccinations|Adverse Event|0
7045235|NCT01764256|11131678|FG003|Received All Vaccinations|Adverse Event|0
7045236|NCT01764256|11131675|FG000|Received All Vaccinations|Did not meet inclusion criteria|0
7045237|NCT01764256|11131676|FG001|Received All Vaccinations|Did not meet inclusion criteria|0
7045238|NCT01764256|11131677|FG002|Received All Vaccinations|Did not meet inclusion criteria|1
7045239|NCT01764256|11131678|FG003|Received All Vaccinations|Did not meet inclusion criteria|0
7045240|NCT01764256|11131675|FG000|Received All Vaccinations|Lost to Follow-up|1
7045241|NCT01764256|11131676|FG001|Received All Vaccinations|Lost to Follow-up|0
7045242|NCT01764256|11131677|FG002|Received All Vaccinations|Lost to Follow-up|0
7045243|NCT01764256|11131678|FG003|Received All Vaccinations|Lost to Follow-up|0
7045244|NCT01764256|11131675|FG000|Completed Study|Lost to Follow-up|0
7045245|NCT01764256|11131676|FG001|Completed Study|Lost to Follow-up|0
7045246|NCT01764256|11131677|FG002|Completed Study|Lost to Follow-up|0
7045247|NCT01764256|11131678|FG003|Completed Study|Lost to Follow-up|1
7045248|NCT01764386|11131694|FG000|Controlled Treatment Period (CTP)|Adverse Event|35
7083080|NCT02149420|11193994|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0
7083081|NCT02149420|11193995|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0
7045249|NCT01764386|11131695|FG001|Controlled Treatment Period (CTP)|Adverse Event|0
7045250|NCT01764386|11131694|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32
7045251|NCT01764386|11131695|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0
7045252|NCT01764386|11131694|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9
7045253|NCT01764386|11131695|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5
7045254|NCT01764386|11131694|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6
7045255|NCT01764386|11131695|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2
7045256|NCT01764386|11131694|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2
7045257|NCT01764386|11131695|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13
7045258|NCT01764386|11131694|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0
7045259|NCT01764386|11131695|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26
7045260|NCT01764386|11131694|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
7045261|NCT01764386|11131695|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
7045262|NCT01764386|11131694|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
7045263|NCT01764386|11131695|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
7045264|NCT01764464|11131704|FG000|First Intervention|Withdrawal by Subject|1
7045265|NCT01764464|11131705|FG001|First Intervention|Withdrawal by Subject|0
7045266|NCT01764464|11131704|FG000|First Intervention|Lost to Follow-up|1
7045267|NCT01764464|11131705|FG001|First Intervention|Lost to Follow-up|0
7045268|NCT01764464|11131704|FG000|First Intervention|Adverse Event|0
7045269|NCT01764464|11131705|FG001|First Intervention|Adverse Event|2
7045270|NCT01764464|11131704|FG000|First Intervention|did not receive study drug|0
7045271|NCT01764464|11131705|FG001|First Intervention|did not receive study drug|1
7045272|NCT01764464|11131704|FG000|Second Intervention (Cross-over)|Adverse Event|2
7045273|NCT01764464|11131705|FG001|Second Intervention (Cross-over)|Adverse Event|0
7045274|NCT01764633|11131717|FG000|Overall Study|Withdrawal by Subject|105
7045275|NCT01764633|11131718|FG001|Overall Study|Withdrawal by Subject|88
7045276|NCT01764633|11131717|FG000|Overall Study|Lost to Follow-up|13
7045277|NCT01764633|11131718|FG001|Overall Study|Lost to Follow-up|5
7045278|NCT01764659|11131724|FG000|Overall Study|Death|1
7045279|NCT01764659|11131724|FG000|Overall Study|Physician Decision|1
7045280|NCT01764841|11131743|FG000|Overall Study|Logistical Difficulties|0
7045281|NCT01764841|11131744|FG001|Overall Study|Logistical Difficulties|1
7045282|NCT01764841|11131745|FG002|Overall Study|Logistical Difficulties|0
7045283|NCT01764841|11131746|FG003|Overall Study|Logistical Difficulties|0
7045284|NCT01764841|11131743|FG000|Overall Study|Death|3
7045285|NCT01764841|11131744|FG001|Overall Study|Death|0
7045286|NCT01764841|11131745|FG002|Overall Study|Death|1
7045287|NCT01764841|11131746|FG003|Overall Study|Death|4
7045288|NCT01764841|11131743|FG000|Overall Study|No Follow Up|1
7045289|NCT01764841|11131744|FG001|Overall Study|No Follow Up|0
7045290|NCT01764841|11131745|FG002|Overall Study|No Follow Up|1
7045291|NCT01764841|11131746|FG003|Overall Study|No Follow Up|0
7045292|NCT01764841|11131743|FG000|Overall Study|Protocol Violation|0
7045293|NCT01764841|11131744|FG001|Overall Study|Protocol Violation|1
7045294|NCT01764841|11131745|FG002|Overall Study|Protocol Violation|0
7045295|NCT01764841|11131746|FG003|Overall Study|Protocol Violation|0
7045296|NCT01764841|11131743|FG000|Overall Study|Withdrawal by Subject|16
7045297|NCT01764841|11131744|FG001|Overall Study|Withdrawal by Subject|24
7045298|NCT01764841|11131745|FG002|Overall Study|Withdrawal by Subject|11
7045299|NCT01764841|11131746|FG003|Overall Study|Withdrawal by Subject|15
7045300|NCT01764841|11131743|FG000|Overall Study|Lost to Follow-up|3
7045301|NCT01764841|11131744|FG001|Overall Study|Lost to Follow-up|0
7045302|NCT01764841|11131745|FG002|Overall Study|Lost to Follow-up|1
7045303|NCT01764841|11131746|FG003|Overall Study|Lost to Follow-up|0
7045304|NCT01764854|11131760|FG000|Overall Study|Adverse Event|0
7045305|NCT01764854|11131761|FG001|Overall Study|Adverse Event|0
7045306|NCT01764854|11131762|FG002|Overall Study|Adverse Event|2
7045307|NCT01764854|11131763|FG003|Overall Study|Adverse Event|0
7045308|NCT01764854|11131760|FG000|Overall Study|Withdrawal by Subject|0
7045309|NCT01764854|11131761|FG001|Overall Study|Withdrawal by Subject|0
7045310|NCT01764854|11131762|FG002|Overall Study|Withdrawal by Subject|1
7045311|NCT01764854|11131763|FG003|Overall Study|Withdrawal by Subject|0
7045312|NCT01764854|11131760|FG000|Overall Study|relocation|0
7045313|NCT01764854|11131761|FG001|Overall Study|relocation|0
7045314|NCT01764854|11131762|FG002|Overall Study|relocation|2
7045315|NCT01764854|11131763|FG003|Overall Study|relocation|0
7045316|NCT01764854|11131760|FG000|Overall Study|Protocol Violation|0
7045317|NCT01764854|11131761|FG001|Overall Study|Protocol Violation|0
7045318|NCT01764854|11131762|FG002|Overall Study|Protocol Violation|1
7045319|NCT01764854|11131763|FG003|Overall Study|Protocol Violation|2
7045320|NCT01764945|11131785|FG000|Overall Study|Adverse Event|0
7045321|NCT01764945|11131786|FG001|Overall Study|Adverse Event|1
7045322|NCT01764945|11131787|FG002|Overall Study|Adverse Event|0
7083082|NCT02149810|11194019|FG000|Overall Study|Physician Decision|1
7045323|NCT01764945|11131788|FG003|Overall Study|Adverse Event|0
7045324|NCT01764945|11131789|FG004|Overall Study|Adverse Event|0
7045325|NCT01764945|11131790|FG005|Overall Study|Adverse Event|0
7045326|NCT01764945|11131791|FG006|Overall Study|Adverse Event|1
7045327|NCT01764945|11131792|FG007|Overall Study|Adverse Event|0
7045328|NCT01765153|11131812|FG000|Training Phase 1|Format of intervention differed|1
7045329|NCT01765153|11131813|FG001|Training Phase 1|Format of intervention differed|0
7045330|NCT01765153|11131812|FG000|Training Phase 1|Poor participation in intervention|0
7045331|NCT01765153|11131813|FG001|Training Phase 1|Poor participation in intervention|1
7045332|NCT01765153|11131812|FG000|Rest Phase 1|Withdrawal by Subject|0
7045333|NCT01765153|11131813|FG001|Rest Phase 1|Withdrawal by Subject|1
7045334|NCT01765153|11131812|FG000|Training Phase 2|Withdrawal by Subject|0
7045335|NCT01765153|11131813|FG001|Training Phase 2|Withdrawal by Subject|1
7045336|NCT01765153|11131812|FG000|Rest Phase 2|Lost to Follow-up|2
7045337|NCT01765153|11131813|FG001|Rest Phase 2|Lost to Follow-up|1
7045338|NCT01765179|11131823|FG000|Overall Study|Adverse Event|3
7045339|NCT01765179|11131823|FG000|Overall Study|Lost to Follow-up|5
7045340|NCT01765179|11131823|FG000|Overall Study|Non-compliance with study drug|2
7045341|NCT01765179|11131823|FG000|Overall Study|Protocol Violation|1
7045342|NCT01765179|11131823|FG000|Overall Study|Withdrawal by Subject|8
7045343|NCT01765179|11131823|FG000|Overall Study|Hematocrit >54%|3
7045344|NCT01765179|11131823|FG000|Overall Study|prohibited med|1
7045345|NCT01765179|11131823|FG000|Overall Study|Out of country unable to finish study|1
7045346|NCT01765179|11131823|FG000|Overall Study|lack of venous access|1
7045347|NCT01765179|11131823|FG000|Overall Study|work conflict|1
7045348|NCT01765179|11131823|FG000|Overall Study|Ca elevated 10.6|1
7045349|NCT01765192|11131829|FG000|Treatment Period 1|Adverse Event|0
7045350|NCT01765192|11131830|FG001|Treatment Period 1|Adverse Event|1
7045351|NCT01765192|11131829|FG000|Washout Period|Voluntary Withdrawal|1
7045352|NCT01765192|11131830|FG001|Washout Period|Voluntary Withdrawal|1
7045353|NCT01765192|11131829|FG000|Washout Period|Reason not specified|1
7045354|NCT01765192|11131830|FG001|Washout Period|Reason not specified|0
7045355|NCT01765192|11131829|FG000|Treatment Period 2|Reason not specified|0
7045356|NCT01765192|11131830|FG001|Treatment Period 2|Reason not specified|2
7045357|NCT01765192|11131829|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0
7045358|NCT01765192|11131830|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1
7045359|NCT01765270|11131838|FG000|Overall Study|Physician Decision|1
7045360|NCT01765270|11131839|FG001|Overall Study|Physician Decision|0
7045361|NCT01765270|11131838|FG000|Overall Study|Withdrawal by Subject|0
7045362|NCT01765270|11131839|FG001|Overall Study|Withdrawal by Subject|1
7045363|NCT01765426|11131850|FG000|Overall Study|Lost to Follow-up|0
7045364|NCT01765426|11131851|FG001|Overall Study|Lost to Follow-up|1
7045365|NCT01765426|11131852|FG002|Overall Study|Lost to Follow-up|0
7045366|NCT01765426|11131853|FG003|Overall Study|Lost to Follow-up|0
7045367|NCT01765543|11131883|FG000|Overall Study|Death|1
7045368|NCT01765543|11131883|FG000|Overall Study|Withdrawal by Subject|2
7045369|NCT01765569|11131891|FG000|Period B|Withdrawal by Subject|1
7045370|NCT01765569|11131891|FG000|Period C|Death|1
7045371|NCT01765582|11131901|FG000|Overall Study|Other|3
7045372|NCT01765582|11131902|FG001|Overall Study|Other|6
7045373|NCT01765582|11131903|FG002|Overall Study|Other|9
7045374|NCT01765582|11131901|FG000|Overall Study|Lost to Follow-up|2
7045375|NCT01765582|11131902|FG001|Overall Study|Lost to Follow-up|2
7045376|NCT01765582|11131903|FG002|Overall Study|Lost to Follow-up|1
7045377|NCT01765582|11131901|FG000|Overall Study|Death|31
7045378|NCT01765582|11131902|FG001|Overall Study|Death|36
7045379|NCT01765582|11131903|FG002|Overall Study|Death|33
7045380|NCT01765582|11131901|FG000|Overall Study|Sponsor Decision|46
7045381|NCT01765582|11131902|FG001|Overall Study|Sponsor Decision|42
7045382|NCT01765582|11131903|FG002|Overall Study|Sponsor Decision|42
7045383|NCT01765582|11131901|FG000|Overall Study|Withdrawal of Consent|11
7045384|NCT01765582|11131902|FG001|Overall Study|Withdrawal of Consent|6
7045385|NCT01765582|11131903|FG002|Overall Study|Withdrawal of Consent|10
7045386|NCT01765673|11131916|FG000|Overall Study|No transportation for 2nd/3rd visits|1
7045387|NCT01765751|11131935|FG000|Overall Study|Lost to Follow-up|0
7045388|NCT01765751|11131936|FG001|Overall Study|Lost to Follow-up|2
7045389|NCT01765751|11131937|FG002|Overall Study|Lost to Follow-up|1
7045390|NCT01765764|11131951|FG000|Treatment Period|Adverse Event|1
7045391|NCT01765764|11131952|FG001|Treatment Period|Adverse Event|2
7045392|NCT01765764|11131953|FG002|Treatment Period|Adverse Event|1
7045393|NCT01765764|11131951|FG000|Treatment Period|Lost to Follow-up|0
7045394|NCT01765764|11131952|FG001|Treatment Period|Lost to Follow-up|3
7045395|NCT01765764|11131953|FG002|Treatment Period|Lost to Follow-up|2
7045396|NCT01765764|11131951|FG000|Treatment Period|Personal Reasons|1
7045397|NCT01765764|11131952|FG001|Treatment Period|Personal Reasons|2
7045398|NCT01765764|11131953|FG002|Treatment Period|Personal Reasons|1
7045399|NCT01765764|11131951|FG000|Treatment Period|Other Miscellaneous Reasons|1
7045400|NCT01765764|11131952|FG001|Treatment Period|Other Miscellaneous Reasons|2
7045401|NCT01765764|11131953|FG002|Treatment Period|Other Miscellaneous Reasons|2
7045402|NCT01765920|11131967|FG000|Overall Study|Incorrect inclusion ineligible patient|2
7045403|NCT01765920|11131968|FG001|Overall Study|Incorrect inclusion ineligible patient|5
7045404|NCT01765920|11131967|FG000|Overall Study|Patient code disclosure|0
7045405|NCT01765920|11131968|FG001|Overall Study|Patient code disclosure|1
7045406|NCT01766037|11132000|FG000|Overall Study|Adverse Event|1
7045407|NCT01766037|11132001|FG001|Overall Study|Adverse Event|0
7045408|NCT01766037|11132000|FG000|Overall Study|Lack of Efficacy|1
7045409|NCT01766037|11132001|FG001|Overall Study|Lack of Efficacy|0
7045410|NCT01766037|11132000|FG000|Overall Study|Lost to Follow-up|0
7045411|NCT01766037|11132001|FG001|Overall Study|Lost to Follow-up|10
7045412|NCT01766037|11132000|FG000|Overall Study|Physician Decision|0
7045413|NCT01766037|11132001|FG001|Overall Study|Physician Decision|1
7045414|NCT01766037|11132000|FG000|Overall Study|Withdrawal by Subject|18
7045415|NCT01766037|11132001|FG001|Overall Study|Withdrawal by Subject|16
7045416|NCT01766037|11132000|FG000|Overall Study|Moved from area|5
7045417|NCT01766037|11132001|FG001|Overall Study|Moved from area|0
7045418|NCT01766037|11132000|FG000|Overall Study|medical - unrelated|1
7045419|NCT01766037|11132001|FG001|Overall Study|medical - unrelated|2
7045420|NCT01766037|11132000|FG000|Overall Study|nausea / discomfort|3
7045421|NCT01766037|11132001|FG001|Overall Study|nausea / discomfort|0
7045422|NCT01766050|11132007|FG000|Overall Study|Adverse Event|1
7045423|NCT01766050|11132007|FG000|Overall Study|Lost to Follow-up|1
7045424|NCT01766050|11132007|FG000|Overall Study|Withdrawal by Subject|2
7083083|NCT02149810|11194020|FG001|Overall Study|Physician Decision|2
7083084|NCT02149810|11194019|FG000|Overall Study|Lost to Follow-up|2
7083085|NCT02149810|11194020|FG001|Overall Study|Lost to Follow-up|1
7083086|NCT02149810|11194019|FG000|Overall Study|Withdrawal by Subject|5
7083087|NCT02149810|11194020|FG001|Overall Study|Withdrawal by Subject|1
7083088|NCT02149836|11194026|FG000|Overall Study|Withdrawal by Subject|1
7083089|NCT02149875|11194033|FG000|Overall Study|Lost to Follow-up|3
7083090|NCT02149875|11194034|FG001|Overall Study|Lost to Follow-up|4
7083091|NCT02149875|11194035|FG002|Overall Study|Lost to Follow-up|5
7083092|NCT02149875|11194033|FG000|Overall Study|Withdrawal by Subject|3
7083093|NCT02149875|11194034|FG001|Overall Study|Withdrawal by Subject|2
7083094|NCT02149875|11194035|FG002|Overall Study|Withdrawal by Subject|2
7083095|NCT02149875|11194033|FG000|Overall Study|Physician Decision|1
7083096|NCT02149875|11194034|FG001|Overall Study|Physician Decision|2
7083097|NCT02149875|11194035|FG002|Overall Study|Physician Decision|2
7083098|NCT02150057|11194049|FG000|Overall Study|Lost to Follow-up|6
7083099|NCT02150057|11194050|FG001|Overall Study|Lost to Follow-up|4
7083100|NCT02150213|11194066|FG000|Overall Study|Lost to Follow-up|1
7083101|NCT02150213|11194066|FG000|Overall Study|Withdrawal by Subject|1
7083102|NCT02150343|11194074|FG000|Overall Study|Adverse Event|2
7083103|NCT02150343|11194075|FG001|Overall Study|Adverse Event|0
7083104|NCT02150343|11194076|FG002|Overall Study|Adverse Event|1
7083105|NCT02150343|11194077|FG003|Overall Study|Adverse Event|1
7083106|NCT02150343|11194074|FG000|Overall Study|Withdrawal by Subject|13
7083107|NCT02150343|11194075|FG001|Overall Study|Withdrawal by Subject|10
7083108|NCT02150343|11194076|FG002|Overall Study|Withdrawal by Subject|9
7083109|NCT02150343|11194077|FG003|Overall Study|Withdrawal by Subject|4
7083110|NCT02150343|11194074|FG000|Overall Study|Lost to Follow-up|4
7083111|NCT02150343|11194075|FG001|Overall Study|Lost to Follow-up|4
7083112|NCT02150343|11194076|FG002|Overall Study|Lost to Follow-up|2
7083113|NCT02150343|11194077|FG003|Overall Study|Lost to Follow-up|3
7083114|NCT02150343|11194074|FG000|Overall Study|Other|2
7083115|NCT02150343|11194075|FG001|Overall Study|Other|6
7083116|NCT02150343|11194076|FG002|Overall Study|Other|0
7083117|NCT02150343|11194077|FG003|Overall Study|Other|2
7083118|NCT02150954|11194125|FG000|Overall Study|Protocol Violation|1
7083119|NCT02150954|11194126|FG001|Overall Study|Protocol Violation|0
7083120|NCT02151058|11194135|FG000|Overall Study|Withdrawal by Subject|1
7083121|NCT02151058|11194136|FG001|Overall Study|Withdrawal by Subject|1
7083122|NCT02151058|11194137|FG002|Overall Study|Withdrawal by Subject|3
7083123|NCT02151058|11194135|FG000|Overall Study|Lost to Follow-up|1
7083124|NCT02151058|11194136|FG001|Overall Study|Lost to Follow-up|0
7083125|NCT02151058|11194137|FG002|Overall Study|Lost to Follow-up|2
7083126|NCT02151110|11194153|FG000|Overall Study|Withdrawal by Subject|0
7083127|NCT02151110|11194154|FG001|Overall Study|Withdrawal by Subject|0
7083128|NCT02151110|11194155|FG002|Overall Study|Withdrawal by Subject|0
7083129|NCT02151110|11194156|FG003|Overall Study|Withdrawal by Subject|0
7083130|NCT02151110|11194157|FG004|Overall Study|Withdrawal by Subject|0
7083131|NCT02151110|11194158|FG005|Overall Study|Withdrawal by Subject|0
7083132|NCT02151110|11194159|FG006|Overall Study|Withdrawal by Subject|0
7083133|NCT02151110|11194160|FG007|Overall Study|Withdrawal by Subject|1
7083134|NCT02151110|11194153|FG000|Overall Study|Lost to Follow-up|0
7083135|NCT02151110|11194154|FG001|Overall Study|Lost to Follow-up|0
7083136|NCT02151110|11194155|FG002|Overall Study|Lost to Follow-up|0
7083137|NCT02151110|11194156|FG003|Overall Study|Lost to Follow-up|0
7083138|NCT02151110|11194157|FG004|Overall Study|Lost to Follow-up|0
7083139|NCT02151110|11194158|FG005|Overall Study|Lost to Follow-up|0
7083140|NCT02151110|11194159|FG006|Overall Study|Lost to Follow-up|0
7083141|NCT02151110|11194160|FG007|Overall Study|Lost to Follow-up|2
7083142|NCT02151149|11194187|FG000|Treatment Period|Death|2
7083143|NCT02151149|11194188|FG001|Treatment Period|Death|3
7083144|NCT02151149|11194187|FG000|Treatment Period|Adverse Event|17
7083145|NCT02151149|11194188|FG001|Treatment Period|Adverse Event|14
7083146|NCT02151149|11194187|FG000|Treatment Period|Progressive Disease|25
7083147|NCT02151149|11194188|FG001|Treatment Period|Progressive Disease|24
7083148|NCT02151149|11194187|FG000|Treatment Period|Symptomatic Deterioration|2
7083149|NCT02151149|11194188|FG001|Treatment Period|Symptomatic Deterioration|10
7083150|NCT02151149|11194187|FG000|Treatment Period|Withdrawal by Subject|13
7083151|NCT02151149|11194188|FG001|Treatment Period|Withdrawal by Subject|11
7083152|NCT02151149|11194187|FG000|Treatment Period|Miscellaneous|8
7083153|NCT02151149|11194188|FG001|Treatment Period|Miscellaneous|7
7083154|NCT02151149|11194187|FG000|Treatment Period|Participants randomized but not treated|3
7083155|NCT02151149|11194188|FG001|Treatment Period|Participants randomized but not treated|2
7083156|NCT02151149|11194187|FG000|Follow-Up Period|Lost to Follow-up|2
7045425|NCT01766206|11132043|FG000|Overall Study|Withdrawal by Subject|22
7045426|NCT01766206|11132043|FG000|Overall Study|Lost to Follow-up|10
7045427|NCT01766206|11132043|FG000|Overall Study|Inappropriate enrollment|18
7045428|NCT01766206|11132043|FG000|Overall Study|Withdrawal and inappropriate enrollment|1
7045429|NCT01766310|11132063|FG000|Overall Study|Lost to Follow-up|1
7045430|NCT01766310|11132064|FG001|Overall Study|Lost to Follow-up|3
7045431|NCT01766336|11132072|FG000|Overall Study|Adverse Event|11
7045432|NCT01766336|11132073|FG001|Overall Study|Adverse Event|8
7045433|NCT01766336|11132072|FG000|Overall Study|Death|4
7045434|NCT01766336|11132073|FG001|Overall Study|Death|3
7045435|NCT01766336|11132072|FG000|Overall Study|Lost to Follow-up|1
7045436|NCT01766336|11132073|FG001|Overall Study|Lost to Follow-up|3
7045437|NCT01766336|11132072|FG000|Overall Study|Physician Decision|4
7045438|NCT01766336|11132073|FG001|Overall Study|Physician Decision|2
7045439|NCT01766336|11132072|FG000|Overall Study|Protocol Violation|0
7045440|NCT01766336|11132073|FG001|Overall Study|Protocol Violation|1
7045441|NCT01766336|11132072|FG000|Overall Study|Sponsor Decision|52
7045442|NCT01766336|11132073|FG001|Overall Study|Sponsor Decision|43
7045443|NCT01766336|11132072|FG000|Overall Study|Withdrawal by Subject|18
7045444|NCT01766336|11132073|FG001|Overall Study|Withdrawal by Subject|15
7045445|NCT01766401|11132081|FG000|Overall Study|Adverse Event|7
7045446|NCT01766401|11132082|FG001|Overall Study|Adverse Event|22
7045447|NCT01766401|11132081|FG000|Overall Study|Lack of Efficacy|1
7045448|NCT01766401|11132082|FG001|Overall Study|Lack of Efficacy|2
7045449|NCT01766401|11132081|FG000|Overall Study|Protocol Violation|3
7045450|NCT01766401|11132082|FG001|Overall Study|Protocol Violation|8
7045451|NCT01766401|11132081|FG000|Overall Study|Withdrawal by Subject|15
7045452|NCT01766401|11132082|FG001|Overall Study|Withdrawal by Subject|12
7045453|NCT01766401|11132081|FG000|Overall Study|Lost to Follow-up|10
7045454|NCT01766401|11132082|FG001|Overall Study|Lost to Follow-up|11
7045455|NCT01766401|11132081|FG000|Overall Study|Pregnancy|1
7045456|NCT01766401|11132082|FG001|Overall Study|Pregnancy|1
7045457|NCT01766778|11132117|FG000|Overall Study|Adverse Event|4
7045458|NCT01766778|11132118|FG001|Overall Study|Adverse Event|4
7045459|NCT01766778|11132117|FG000|Overall Study|Withdrawal by Subject|1
7045460|NCT01766778|11132118|FG001|Overall Study|Withdrawal by Subject|0
7045461|NCT01766817|11132127|FG000|Overall Study|Drug-related adverse event|1
7045462|NCT01766817|11132128|FG001|Overall Study|Drug-related adverse event|2
7045463|NCT01766817|11132129|FG002|Overall Study|Drug-related adverse event|1
7045464|NCT01766817|11132127|FG000|Overall Study|Drug-unrelated adverse event|3
7045465|NCT01766817|11132128|FG001|Overall Study|Drug-unrelated adverse event|3
7045466|NCT01766817|11132129|FG002|Overall Study|Drug-unrelated adverse event|3
7045467|NCT01766817|11132127|FG000|Overall Study|Death|1
7045468|NCT01766817|11132128|FG001|Overall Study|Death|1
7045469|NCT01766817|11132129|FG002|Overall Study|Death|0
7045470|NCT01766817|11132127|FG000|Overall Study|Unable to take study drug|0
7045471|NCT01766817|11132128|FG001|Overall Study|Unable to take study drug|1
7045472|NCT01766817|11132129|FG002|Overall Study|Unable to take study drug|0
7045473|NCT01766817|11132127|FG000|Overall Study|Withdrawal by Subject|2
7045474|NCT01766817|11132128|FG001|Overall Study|Withdrawal by Subject|0
7045475|NCT01766817|11132129|FG002|Overall Study|Withdrawal by Subject|3
7045476|NCT01766817|11132127|FG000|Overall Study|Subject non-compliance|0
7045477|NCT01766817|11132128|FG001|Overall Study|Subject non-compliance|1
7045478|NCT01766817|11132129|FG002|Overall Study|Subject non-compliance|2
7045479|NCT01766817|11132127|FG000|Overall Study|Physician Decision|3
7045480|NCT01766817|11132128|FG001|Overall Study|Physician Decision|3
7045481|NCT01766817|11132129|FG002|Overall Study|Physician Decision|4
7045482|NCT01766817|11132127|FG000|Overall Study|Other|1
7045483|NCT01766817|11132128|FG001|Overall Study|Other|0
7045484|NCT01766817|11132129|FG002|Overall Study|Other|0
7045485|NCT01766921|11132139|FG000|Overall Study|Administrative Reason|5
7045486|NCT01766921|11132140|FG001|Overall Study|Administrative Reason|5
7045487|NCT01766921|11132139|FG000|Overall Study|Death|1
7045488|NCT01766921|11132140|FG001|Overall Study|Death|1
7045489|NCT01766921|11132139|FG000|Overall Study|Lost to Follow-up|1
7045490|NCT01766921|11132140|FG001|Overall Study|Lost to Follow-up|3
7045491|NCT01766921|11132139|FG000|Overall Study|Unclassified|2
7045492|NCT01766921|11132140|FG001|Overall Study|Unclassified|2
7045493|NCT01766921|11132139|FG000|Overall Study|Protocol Violation|1
7045494|NCT01766921|11132140|FG001|Overall Study|Protocol Violation|1
7188543|NCT02891226|11388861|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7188544|NCT02891226|11388862|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7188545|NCT02891226|11388863|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7188546|NCT02891226|11388864|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7045495|NCT01766921|11132139|FG000|Overall Study|Withdrawal by Subject|14
7045496|NCT01766921|11132140|FG001|Overall Study|Withdrawal by Subject|5
7045497|NCT01767116|11132185|FG000|Overall Study|Lost to Follow-up|2
7045498|NCT01767116|11132186|FG001|Overall Study|Lost to Follow-up|2
7045499|NCT01767142|11132192|FG000|Overall Study|Lost to Follow-up|3
7045500|NCT01767376|11132217|FG000|Overall Study|Lost to Follow-up|3
7045501|NCT01767376|11132218|FG001|Overall Study|Lost to Follow-up|2
7045502|NCT01767376|11132219|FG002|Overall Study|Lost to Follow-up|0
7045503|NCT01767376|11132217|FG000|Overall Study|Withdrawal by Subject|1
7045504|NCT01767376|11132218|FG001|Overall Study|Withdrawal by Subject|1
7045505|NCT01767376|11132219|FG002|Overall Study|Withdrawal by Subject|0
7045506|NCT01767467|11132235|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8
7045507|NCT01767467|11132236|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8
7045508|NCT01767467|11132235|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1
7045509|NCT01767467|11132236|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0
7045510|NCT01767467|11132235|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7
7045511|NCT01767467|11132236|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10
7045512|NCT01767467|11132235|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0
7045513|NCT01767467|11132236|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1
7045514|NCT01767467|11132235|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1
7045515|NCT01767467|11132236|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0
7045516|NCT01767467|11132235|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0
7045517|NCT01767467|11132236|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1
7045518|NCT01767467|11132235|FG000|End of Study Phase (up to Month 13)|Adverse Event|29
7045519|NCT01767467|11132236|FG001|End of Study Phase (up to Month 13)|Adverse Event|39
7045520|NCT01767467|11132235|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2
7045521|NCT01767467|11132236|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0
7045522|NCT01767467|11132235|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9
7045523|NCT01767467|11132236|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14
7045524|NCT01767467|11132235|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0
7045525|NCT01767467|11132236|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3
7045526|NCT01767467|11132235|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6
7045527|NCT01767467|11132236|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4
7045528|NCT01767467|11132235|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0
7045529|NCT01767467|11132236|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1
7045530|NCT01767467|11132235|FG000|End of Study Phase (up to Month 13)|Physician Decision|1
7045531|NCT01767467|11132236|FG001|End of Study Phase (up to Month 13)|Physician Decision|0
7045532|NCT01767467|11132235|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0
7045533|NCT01767467|11132236|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2
7045534|NCT01767493|11132249|FG000|Overall Study|screen failures|3
7045535|NCT01767519|11132265|FG000|Overall Study|Other Reasons|4
7045536|NCT01767519|11132266|FG001|Overall Study|Other Reasons|4
7045537|NCT01767519|11132267|FG002|Overall Study|Other Reasons|2
7045538|NCT01767519|11132265|FG000|Overall Study|Protocol Violation|0
7045539|NCT01767519|11132266|FG001|Overall Study|Protocol Violation|3
7045540|NCT01767519|11132267|FG002|Overall Study|Protocol Violation|0
7045541|NCT01767519|11132265|FG000|Overall Study|Personal Reasons|1
7045542|NCT01767519|11132266|FG001|Overall Study|Personal Reasons|0
7045543|NCT01767519|11132267|FG002|Overall Study|Personal Reasons|0
7045544|NCT01767519|11132265|FG000|Overall Study|Lost to Follow-up|3
7045545|NCT01767519|11132266|FG001|Overall Study|Lost to Follow-up|1
7045546|NCT01767519|11132267|FG002|Overall Study|Lost to Follow-up|2
7045547|NCT01767519|11132265|FG000|Overall Study|Lack of Efficacy|1
7045548|NCT01767519|11132266|FG001|Overall Study|Lack of Efficacy|0
7045549|NCT01767519|11132267|FG002|Overall Study|Lack of Efficacy|0
7045550|NCT01767519|11132265|FG000|Overall Study|Adverse Event|5
7045551|NCT01767519|11132266|FG001|Overall Study|Adverse Event|5
7045552|NCT01767519|11132267|FG002|Overall Study|Adverse Event|1
7045553|NCT01767597|11132277|FG000|Overall Study|Incomplete intervention|3
7045554|NCT01767597|11132278|FG001|Overall Study|Incomplete intervention|1
7045555|NCT01767597|11132277|FG000|Overall Study|Withdrawal by Subject|1
7045556|NCT01767597|11132278|FG001|Overall Study|Withdrawal by Subject|0
7045557|NCT01767857|11132309|FG000|Overall Study|Adverse Event|27
7045558|NCT01767857|11132310|FG001|Overall Study|Adverse Event|7
7045559|NCT01767857|11132309|FG000|Overall Study|Death|28
7045560|NCT01767857|11132310|FG001|Overall Study|Death|13
7045561|NCT01767857|11132309|FG000|Overall Study|Lack of Efficacy|299
7045562|NCT01767857|11132310|FG001|Overall Study|Lack of Efficacy|151
7045563|NCT01767857|11132309|FG000|Overall Study|Lost to Follow-up|1
7045564|NCT01767857|11132310|FG001|Overall Study|Lost to Follow-up|1
7045565|NCT01767857|11132309|FG000|Overall Study|Withdrawal by Subject|38
7045566|NCT01767857|11132310|FG001|Overall Study|Withdrawal by Subject|18
7045567|NCT01767857|11132309|FG000|Overall Study|Physician Decision|17
7045568|NCT01767857|11132310|FG001|Overall Study|Physician Decision|10
7045569|NCT01767857|11132309|FG000|Overall Study|Protocol Terminated|1
7045570|NCT01767857|11132310|FG001|Overall Study|Protocol Terminated|0
7045571|NCT01767857|11132309|FG000|Overall Study|Randomized But Never Treated|19
7045572|NCT01767857|11132310|FG001|Overall Study|Randomized But Never Treated|13
7045573|NCT01767909|11132319|FG000|Overall Study|Withdrawal by Subject|4
7045574|NCT01767909|11132320|FG001|Overall Study|Withdrawal by Subject|7
7045575|NCT01767909|11132319|FG000|Overall Study|Adverse Event|3
7045576|NCT01767909|11132320|FG001|Overall Study|Adverse Event|1
7045577|NCT01767909|11132319|FG000|Overall Study|Withdrawal by Study Partner|3
7045578|NCT01767909|11132320|FG001|Overall Study|Withdrawal by Study Partner|1
7045579|NCT01767909|11132319|FG000|Overall Study|Non-Compliance|2
7045580|NCT01767909|11132320|FG001|Overall Study|Non-Compliance|0
7045581|NCT01767909|11132319|FG000|Overall Study|Perceived Lack of Efficacy|1
7045582|NCT01767909|11132320|FG001|Overall Study|Perceived Lack of Efficacy|0
7045583|NCT01767909|11132319|FG000|Overall Study|Investigator Recommendation|0
7045584|NCT01767909|11132320|FG001|Overall Study|Investigator Recommendation|1
7045585|NCT01767909|11132319|FG000|Overall Study|Lost to Follow-up|0
7045586|NCT01767909|11132320|FG001|Overall Study|Lost to Follow-up|1
7045587|NCT01767909|11132319|FG000|Overall Study|LP uncessessful|0
7045588|NCT01767909|11132320|FG001|Overall Study|LP uncessessful|1
7045589|NCT01767987|11132334|FG000|Overall Study|Physician Decision|4
7045590|NCT01767987|11132335|FG001|Overall Study|Physician Decision|1
7045591|NCT01768117|11132364|FG000|Overall Study|Lost to Follow-up|1
7045592|NCT01768117|11132364|FG000|Overall Study|Withdrawal by Subject|2
7045593|NCT01768117|11132364|FG000|Overall Study|Protocol Violation|3
7045594|NCT01768286|11132372|FG000|Overall Study|Randomized But Not Treated|0
7045595|NCT01768286|11132373|FG001|Overall Study|Randomized But Not Treated|0
7045596|NCT01768286|11132374|FG002|Overall Study|Randomized But Not Treated|1
7045597|NCT01768286|11132375|FG003|Overall Study|Randomized But Not Treated|0
7045598|NCT01768286|11132372|FG000|Overall Study|Lack of Efficacy|7
7045599|NCT01768286|11132373|FG001|Overall Study|Lack of Efficacy|4
7045600|NCT01768286|11132374|FG002|Overall Study|Lack of Efficacy|0
7045601|NCT01768286|11132375|FG003|Overall Study|Lack of Efficacy|1
7045602|NCT01768286|11132372|FG000|Overall Study|Withdrew Consent|0
7045603|NCT01768286|11132373|FG001|Overall Study|Withdrew Consent|0
7045604|NCT01768286|11132374|FG002|Overall Study|Withdrew Consent|1
7045605|NCT01768286|11132375|FG003|Overall Study|Withdrew Consent|0
7045606|NCT01768559|11132412|FG000|Overall Study|Randomized but not treated|0
7045607|NCT01768559|11132413|FG001|Overall Study|Randomized but not treated|0
7045608|NCT01768559|11132414|FG002|Overall Study|Randomized but not treated|1
7045609|NCT01768559|11132412|FG000|Overall Study|Adverse Event|15
7045610|NCT01768559|11132413|FG001|Overall Study|Adverse Event|2
7045611|NCT01768559|11132414|FG002|Overall Study|Adverse Event|5
7045612|NCT01768559|11132412|FG000|Overall Study|Lack of Efficacy|6
7045613|NCT01768559|11132413|FG001|Overall Study|Lack of Efficacy|4
7045614|NCT01768559|11132414|FG002|Overall Study|Lack of Efficacy|0
7045615|NCT01768559|11132412|FG000|Overall Study|Poor compliance to protocol|0
7045616|NCT01768559|11132413|FG001|Overall Study|Poor compliance to protocol|3
7045617|NCT01768559|11132414|FG002|Overall Study|Poor compliance to protocol|2
7045618|NCT01768559|11132412|FG000|Overall Study|Other than specified|9
7045619|NCT01768559|11132413|FG001|Overall Study|Other than specified|8
7045620|NCT01768559|11132414|FG002|Overall Study|Other than specified|5
7045621|NCT01768572|11132429|FG000|Overall Study|Adverse Event|7
7045622|NCT01768572|11132430|FG001|Overall Study|Adverse Event|8
7045623|NCT01768572|11132431|FG002|Overall Study|Adverse Event|4
7045624|NCT01768572|11132429|FG000|Overall Study|Lack of Efficacy|1
7045625|NCT01768572|11132430|FG001|Overall Study|Lack of Efficacy|3
7045626|NCT01768572|11132431|FG002|Overall Study|Lack of Efficacy|1
7045627|NCT01768572|11132429|FG000|Overall Study|Other, Not due to an adverse event|1
7045628|NCT01768572|11132430|FG001|Overall Study|Other, Not due to an adverse event|1
7045629|NCT01768572|11132431|FG002|Overall Study|Other, Not due to an adverse event|1
7045630|NCT01768637|11132441|FG000|Overall Study|Lost to Follow-up|2
7045631|NCT01768637|11132442|FG001|Overall Study|Lost to Follow-up|7
7045632|NCT01768637|11132441|FG000|Overall Study|Difficult blood draw|1
7045633|NCT01768637|11132442|FG001|Overall Study|Difficult blood draw|0
7045634|NCT01768676|11132450|FG000|Overall Study|Adverse Event|3
7045635|NCT01768676|11132451|FG001|Overall Study|Adverse Event|3
7045636|NCT01768676|11132450|FG000|Overall Study|Lost to Follow-up|13
7045637|NCT01768676|11132451|FG001|Overall Study|Lost to Follow-up|16
7045638|NCT01768676|11132450|FG000|Overall Study|Protocol Violation|1
7045639|NCT01768676|11132451|FG001|Overall Study|Protocol Violation|1
7188547|NCT02891226|11388865|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7188548|NCT02891226|11388866|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1
7188549|NCT02891226|11388867|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7083157|NCT02151149|11194188|FG001|Follow-Up Period|Lost to Follow-up|3
7083158|NCT02151149|11194187|FG000|Follow-Up Period|Death|37
7083159|NCT02151149|11194188|FG001|Follow-Up Period|Death|34
7083160|NCT02151266|11194204|FG000|Overall Study|Lost to Follow-up|1
7083161|NCT02151266|11194205|FG001|Overall Study|Lost to Follow-up|4
7083162|NCT02151266|11194206|FG002|Overall Study|Lost to Follow-up|1
7083163|NCT02151266|11194204|FG000|Overall Study|Did NOT receive intervention|3
7083164|NCT02151266|11194205|FG001|Overall Study|Did NOT receive intervention|6
7083165|NCT02151266|11194206|FG002|Overall Study|Did NOT receive intervention|2
7083166|NCT02151266|11194204|FG000|Overall Study|Not able to exercise|4
7083167|NCT02151266|11194205|FG001|Overall Study|Not able to exercise|5
7083168|NCT02151266|11194206|FG002|Overall Study|Not able to exercise|4
7083169|NCT02151461|11194235|FG000|Overall Study|Adverse Event|5
7083170|NCT02151461|11194236|FG001|Overall Study|Adverse Event|1
7083171|NCT02151461|11194237|FG002|Overall Study|Adverse Event|0
7045640|NCT01768676|11132450|FG000|Overall Study|Physician Decision|4
7045641|NCT01768676|11132451|FG001|Overall Study|Physician Decision|1
7045642|NCT01768676|11132450|FG000|Overall Study|Withdrawal by Subject|3
7045643|NCT01768676|11132451|FG001|Overall Study|Withdrawal by Subject|10
7083172|NCT02151461|11194238|FG003|Overall Study|Adverse Event|2
7083173|NCT02151461|11194235|FG000|Overall Study|Lost to Follow-up|0
7083174|NCT02151461|11194236|FG001|Overall Study|Lost to Follow-up|0
7045644|NCT01768858|11132474|FG000|Overall Study|Lost to Follow-up|9
7045645|NCT01768858|11132474|FG000|Overall Study|Lack of Efficacy|8
7045646|NCT01768858|11132474|FG000|Overall Study|Serious Adverse Event|1
7045647|NCT01768858|11132474|FG000|Overall Study|Participant moved to Germany|1
7045648|NCT01768858|11132474|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1
7045649|NCT01768858|11132474|FG000|Overall Study|Exanthema|1
7045650|NCT01768858|11132474|FG000|Overall Study|Withdrawal by Subject|1
7045651|NCT01769105|11132480|FG000|First Intervention|Protocol Violation|2
7045652|NCT01769105|11132481|FG001|First Intervention|Protocol Violation|2
7045653|NCT01769105|11132480|FG000|Cross-over|Lost to Follow-up|5
7045654|NCT01769105|11132481|FG001|Cross-over|Lost to Follow-up|0
7045655|NCT01769196|11132500|FG000|Overall Study|Adverse Event|24
7045656|NCT01769196|11132501|FG001|Overall Study|Adverse Event|20
7045657|NCT01769196|11132500|FG000|Overall Study|Death|21
7045658|NCT01769196|11132501|FG001|Overall Study|Death|26
7045659|NCT01769196|11132500|FG000|Overall Study|Investigator Discretion|7
7045660|NCT01769196|11132501|FG001|Overall Study|Investigator Discretion|3
7045661|NCT01769196|11132500|FG000|Overall Study|Lack of Efficacy|3
7045662|NCT01769196|11132501|FG001|Overall Study|Lack of Efficacy|2
7045663|NCT01769196|11132500|FG000|Overall Study|Progressive disease|11
7045664|NCT01769196|11132501|FG001|Overall Study|Progressive disease|6
7045665|NCT01769196|11132500|FG000|Overall Study|Protocol defined criteria for withdrawal|9
7045666|NCT01769196|11132501|FG001|Overall Study|Protocol defined criteria for withdrawal|11
7045667|NCT01769196|11132500|FG000|Overall Study|Protocol Violation|0
7045668|NCT01769196|11132501|FG001|Overall Study|Protocol Violation|3
7045669|NCT01769196|11132500|FG000|Overall Study|Study terminated by sponsor|160
7045670|NCT01769196|11132501|FG001|Overall Study|Study terminated by sponsor|161
7045671|NCT01769196|11132500|FG000|Overall Study|Participant never dosed with study drug|1
7045672|NCT01769196|11132501|FG001|Overall Study|Participant never dosed with study drug|0
7045673|NCT01769196|11132500|FG000|Overall Study|Withdrew consent|36
7045674|NCT01769196|11132501|FG001|Overall Study|Withdrew consent|40
7045675|NCT01769326|11132548|FG000|Overall Study|Lost to Follow-up|1
7045676|NCT01769326|11132549|FG001|Overall Study|Lost to Follow-up|2
7045677|NCT01769326|11132550|FG002|Overall Study|Lost to Follow-up|0
7045678|NCT01769326|11132551|FG003|Overall Study|Lost to Follow-up|0
7045679|NCT01769326|11132548|FG000|Overall Study|unrelated injry|1
7045680|NCT01769326|11132549|FG001|Overall Study|unrelated injry|1
7045681|NCT01769326|11132550|FG002|Overall Study|unrelated injry|0
7045682|NCT01769326|11132551|FG003|Overall Study|unrelated injry|0
7045683|NCT01769326|11132548|FG000|Overall Study|got a job|0
7045684|NCT01769326|11132549|FG001|Overall Study|got a job|1
7045685|NCT01769326|11132550|FG002|Overall Study|got a job|0
7045686|NCT01769326|11132551|FG003|Overall Study|got a job|0
7045687|NCT01769326|11132548|FG000|Overall Study|Got sick and could not complete study|0
7045688|NCT01769326|11132549|FG001|Overall Study|Got sick and could not complete study|0
7045689|NCT01769326|11132550|FG002|Overall Study|Got sick and could not complete study|1
7045690|NCT01769326|11132551|FG003|Overall Study|Got sick and could not complete study|0
7045691|NCT01769339|11132561|FG000|Overall Study|Lost to Follow-up|42
7045692|NCT01769339|11132561|FG000|Overall Study|Adverse Event|1
7045693|NCT01769378|11132598|FG000|Overall Study|Adverse Event|10
7045694|NCT01769378|11132599|FG001|Overall Study|Adverse Event|0
7045695|NCT01769378|11132598|FG000|Overall Study|Entry criteria not met|1
7045696|NCT01769378|11132599|FG001|Overall Study|Entry criteria not met|0
7045697|NCT01769378|11132598|FG000|Overall Study|Protocol Violation|1
7045698|NCT01769378|11132599|FG001|Overall Study|Protocol Violation|1
7045699|NCT01769378|11132598|FG000|Overall Study|Withdrawal by Subject|10
7045700|NCT01769378|11132599|FG001|Overall Study|Withdrawal by Subject|3
7045701|NCT01769378|11132598|FG000|Overall Study|Sponsor Decision|1
7045702|NCT01769378|11132599|FG001|Overall Study|Sponsor Decision|0
7045703|NCT01769378|11132598|FG000|Overall Study|Lost to Follow-up|2
7045704|NCT01769378|11132599|FG001|Overall Study|Lost to Follow-up|0
7045705|NCT01769391|11132607|FG000|Overall Study|Death|10
7045706|NCT01769391|11132608|FG001|Overall Study|Death|1
7045707|NCT01769391|11132607|FG000|Overall Study|Adverse Event|0
7045708|NCT01769391|11132608|FG001|Overall Study|Adverse Event|3
7045709|NCT01769391|11132607|FG000|Overall Study|Progressive Disease|1
7045710|NCT01769391|11132608|FG001|Overall Study|Progressive Disease|2
7045711|NCT01769391|11132607|FG000|Overall Study|Withdrawal by Subject|4
7045712|NCT01769391|11132608|FG001|Overall Study|Withdrawal by Subject|3
7045713|NCT01769391|11132607|FG000|Overall Study|Investigator Decision|2
7045714|NCT01769391|11132608|FG001|Overall Study|Investigator Decision|0
7045715|NCT01769404|11132620|FG000|Treatment Period 1|Did not meet eligibility criteria|1
7045716|NCT01769404|11132621|FG001|Treatment Period 1|Did not meet eligibility criteria|0
7045717|NCT01769404|11132620|FG000|Treatment Period 1|Withdrawal by Subject|3
7045718|NCT01769404|11132621|FG001|Treatment Period 1|Withdrawal by Subject|0
7045719|NCT01769404|11132620|FG000|Treatment Period 1|Sponsor decision|1
7045720|NCT01769404|11132621|FG001|Treatment Period 1|Sponsor decision|0
7045721|NCT01769404|11132620|FG000|Treatment Period 2|Sponsor decision|7
7045722|NCT01769404|11132621|FG001|Treatment Period 2|Sponsor decision|0
7045723|NCT01769456|11132629|FG000|Overall Study|Lost to Follow-up|19
7045724|NCT01769456|11132629|FG000|Overall Study|Withdrawal by Subject|3
7045725|NCT01769456|11132629|FG000|Overall Study|Did not receive PCC intervention|6
7045726|NCT01769456|11132629|FG000|Overall Study|Moved out of the area|3
7045727|NCT01769456|11132629|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5
7045728|NCT01769456|11132629|FG000|Overall Study|Parental request to youth to withdraw|1
7045729|NCT01769469|11132634|FG000|Overall Study|Consent Withdrawn|5
7045730|NCT01769469|11132634|FG000|Overall Study|Moved Out Of Area|3
7045731|NCT01769469|11132634|FG000|Overall Study|Lost to Follow-up|17
7045732|NCT01769469|11132634|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7
7045733|NCT01769469|11132634|FG000|Overall Study|Subject Confirmed HIV Positive|3
7045734|NCT01769508|11132640|FG000|Overall Study|Death|3
7045735|NCT01769508|11132640|FG000|Overall Study|Withdrawal by Subject|1
7045736|NCT01769508|11132640|FG000|Overall Study|Adverse Event|1
7045737|NCT01769508|11132640|FG000|Overall Study|Lost to Follow-up|1
7045738|NCT01770145|11132680|FG000|Baseline|Adverse Event|20
7045739|NCT01770145|11132680|FG000|Baseline|Withdrawal by Subject|1
7045740|NCT01770145|11132680|FG000|Baseline|Lost to Follow-up|1
7045741|NCT01770145|11132680|FG000|Baseline|Unable to define optimal dose|4
7045742|NCT01770145|11132680|FG000|Treatment|Adverse Event|3
7045743|NCT01770145|11132680|FG000|Treatment|Withdrawal by Subject|1
7045744|NCT01770353|11132695|FG000|Overall Study|Progressive disease|2
7045745|NCT01770353|11132696|FG001|Overall Study|Progressive disease|1
7045746|NCT01770353|11132695|FG000|Overall Study|Adverse Event|0
7045747|NCT01770353|11132696|FG001|Overall Study|Adverse Event|1
7045748|NCT01770353|11132695|FG000|Overall Study|Protocol Violation|1
7045749|NCT01770353|11132696|FG001|Overall Study|Protocol Violation|0
7045750|NCT01770353|11132695|FG000|Overall Study|Physician Decision|0
7045751|NCT01770353|11132696|FG001|Overall Study|Physician Decision|3
7045752|NCT01770353|11132695|FG000|Overall Study|Clinical deterioration|3
7045753|NCT01770353|11132696|FG001|Overall Study|Clinical deterioration|6
7045754|NCT01770353|11132695|FG000|Overall Study|Toxicity related diarrhoea + progression|0
7045755|NCT01770353|11132696|FG001|Overall Study|Toxicity related diarrhoea + progression|1
7045756|NCT01770379|11132722|FG000|Overall Study|Technical issues|1
7045757|NCT01770379|11132723|FG001|Overall Study|Technical issues|0
7045758|NCT01770379|11132724|FG002|Overall Study|Technical issues|0
7045759|NCT01770379|11132722|FG000|Overall Study|Withdrawal by Subject|7
7045760|NCT01770379|11132723|FG001|Overall Study|Withdrawal by Subject|10
7045761|NCT01770379|11132724|FG002|Overall Study|Withdrawal by Subject|7
7045762|NCT01770379|11132722|FG000|Overall Study|study terminated by sponsor|22
7045763|NCT01770379|11132723|FG001|Overall Study|study terminated by sponsor|23
7045764|NCT01770379|11132724|FG002|Overall Study|study terminated by sponsor|22
7045765|NCT01770379|11132722|FG000|Overall Study|Protocol Violation|0
7045766|NCT01770379|11132723|FG001|Overall Study|Protocol Violation|1
7045767|NCT01770379|11132724|FG002|Overall Study|Protocol Violation|1
7045768|NCT01770379|11132722|FG000|Overall Study|Physician Decision|0
7045769|NCT01770379|11132723|FG001|Overall Study|Physician Decision|1
7045770|NCT01770379|11132724|FG002|Overall Study|Physician Decision|2
7045771|NCT01770379|11132722|FG000|Overall Study|Lost to Follow-up|0
7045772|NCT01770379|11132723|FG001|Overall Study|Lost to Follow-up|0
7045773|NCT01770379|11132724|FG002|Overall Study|Lost to Follow-up|2
7045774|NCT01770379|11132722|FG000|Overall Study|Lack of Efficacy|8
7045775|NCT01770379|11132723|FG001|Overall Study|Lack of Efficacy|6
7045776|NCT01770379|11132724|FG002|Overall Study|Lack of Efficacy|6
7045777|NCT01770379|11132722|FG000|Overall Study|Adverse Event|1
7045778|NCT01770379|11132723|FG001|Overall Study|Adverse Event|3
7045779|NCT01770379|11132724|FG002|Overall Study|Adverse Event|2
7045780|NCT01770392|11132734|FG000|Washout Period of at Least 14 Days|Adverse Event|1
7045781|NCT01770509|11132765|FG000|Overall Study|Injury|0
7045782|NCT01770509|11132766|FG001|Overall Study|Injury|1
7045783|NCT01770509|11132765|FG000|Overall Study|Lost to Follow-up|1
7045784|NCT01770509|11132766|FG001|Overall Study|Lost to Follow-up|2
7045785|NCT01770743|11132805|FG000|Overall Study|Adverse Event|1
7045786|NCT01770743|11132806|FG001|Overall Study|Adverse Event|0
7045787|NCT01770743|11132807|FG002|Overall Study|Adverse Event|0
7045788|NCT01770743|11132808|FG003|Overall Study|Adverse Event|0
7045789|NCT01770743|11132809|FG004|Overall Study|Adverse Event|0
7045790|NCT01770743|11132805|FG000|Overall Study|Withdrawal by Subject|0
7045791|NCT01770743|11132806|FG001|Overall Study|Withdrawal by Subject|0
7045792|NCT01770743|11132807|FG002|Overall Study|Withdrawal by Subject|1
7045793|NCT01770743|11132808|FG003|Overall Study|Withdrawal by Subject|1
7045794|NCT01770743|11132809|FG004|Overall Study|Withdrawal by Subject|1
7045795|NCT01770743|11132805|FG000|Overall Study|Lost to Follow-up|0
7045796|NCT01770743|11132806|FG001|Overall Study|Lost to Follow-up|2
7045797|NCT01770743|11132807|FG002|Overall Study|Lost to Follow-up|0
7045798|NCT01770743|11132808|FG003|Overall Study|Lost to Follow-up|0
7045799|NCT01770743|11132809|FG004|Overall Study|Lost to Follow-up|1
7045800|NCT01770743|11132805|FG000|Overall Study|Sponsor Terminated Subject|1
7045801|NCT01770743|11132806|FG001|Overall Study|Sponsor Terminated Subject|0
7045802|NCT01770743|11132807|FG002|Overall Study|Sponsor Terminated Subject|0
7045803|NCT01770743|11132808|FG003|Overall Study|Sponsor Terminated Subject|1
7045804|NCT01770743|11132809|FG004|Overall Study|Sponsor Terminated Subject|0
7045805|NCT01770743|11132805|FG000|Overall Study|Moving Out of State|0
7045806|NCT01770743|11132806|FG001|Overall Study|Moving Out of State|1
7045807|NCT01770743|11132807|FG002|Overall Study|Moving Out of State|0
7045808|NCT01770743|11132808|FG003|Overall Study|Moving Out of State|0
7045809|NCT01770743|11132809|FG004|Overall Study|Moving Out of State|0
7045810|NCT01770860|11132821|FG000|Overall Study|Withdrawal by Subject|4
7045811|NCT01770860|11132821|FG000|Overall Study|Lost to Follow-up|1
7045812|NCT01770860|11132821|FG000|Overall Study|Administrative decision made by the PI|1
7045813|NCT01770912|11132831|FG000|Overall Study|Lost to Follow-up|2
7045814|NCT01770912|11132832|FG001|Overall Study|Lost to Follow-up|0
7045815|NCT01771250|11132851|FG000|Period 1|Met exclusion criteria|1
7045816|NCT01771250|11132852|FG001|Period 1|Met exclusion criteria|0
7045817|NCT01771731|11132873|FG000|Overall Study|Physician Decision|1
7045818|NCT01771731|11132874|FG001|Overall Study|Physician Decision|0
7045819|NCT01771731|11132873|FG000|Overall Study|Protocol Violation|0
7045820|NCT01771731|11132874|FG001|Overall Study|Protocol Violation|1
7045821|NCT01771731|11132873|FG000|Overall Study|Adverse event: Pain Crisis|1
7045822|NCT01771731|11132874|FG001|Overall Study|Adverse event: Pain Crisis|1
7045823|NCT01771809|11132882|FG000|Overall Study|Adverse Event|4
7045824|NCT01771809|11132883|FG001|Overall Study|Adverse Event|12
7045825|NCT01771809|11132882|FG000|Overall Study|Protocol Violation|0
7045826|NCT01771809|11132883|FG001|Overall Study|Protocol Violation|1
7045827|NCT01771809|11132882|FG000|Overall Study|Withdrawal by Subject|34
7045828|NCT01771809|11132883|FG001|Overall Study|Withdrawal by Subject|42
7045829|NCT01771809|11132882|FG000|Overall Study|Lost to Follow-up|1
7045830|NCT01771809|11132883|FG001|Overall Study|Lost to Follow-up|3
7045831|NCT01771809|11132882|FG000|Overall Study|Other (Insufficient clinical response)|22
7045832|NCT01771809|11132883|FG001|Overall Study|Other (Insufficient clinical response)|20
7045833|NCT01771809|11132882|FG000|Overall Study|Death|1
7045834|NCT01771809|11132883|FG001|Overall Study|Death|0
7045835|NCT01771809|11132882|FG000|Overall Study|Other (other)|9
7045836|NCT01771809|11132883|FG001|Overall Study|Other (other)|5
7045837|NCT01771913|11132891|FG000|Overall Study|Withdrawal by Subject|1
7045838|NCT01771913|11132892|FG001|Overall Study|Withdrawal by Subject|0
7045839|NCT01772134|11132929|FG000|Overall Study|Adverse Event|6
7045840|NCT01772134|11132930|FG001|Overall Study|Adverse Event|5
7045841|NCT01772134|11132931|FG002|Overall Study|Adverse Event|10
7045842|NCT01772134|11132929|FG000|Overall Study|Withdrew Consent|3
7045843|NCT01772134|11132930|FG001|Overall Study|Withdrew Consent|1
7045844|NCT01772134|11132931|FG002|Overall Study|Withdrew Consent|5
7045845|NCT01772134|11132929|FG000|Overall Study|Lost to Follow-up|2
7045846|NCT01772134|11132930|FG001|Overall Study|Lost to Follow-up|0
7045847|NCT01772134|11132931|FG002|Overall Study|Lost to Follow-up|0
7045848|NCT01772134|11132929|FG000|Overall Study|Protocol Deviation|4
7045849|NCT01772134|11132930|FG001|Overall Study|Protocol Deviation|3
7045850|NCT01772134|11132931|FG002|Overall Study|Protocol Deviation|3
7045851|NCT01772134|11132929|FG000|Overall Study|Lack of Efficacy|11
7045852|NCT01772134|11132930|FG001|Overall Study|Lack of Efficacy|5
7045853|NCT01772134|11132931|FG002|Overall Study|Lack of Efficacy|3
7045854|NCT01772134|11132929|FG000|Overall Study|Protocol-defined Stopping Criteria|1
7045855|NCT01772134|11132930|FG001|Overall Study|Protocol-defined Stopping Criteria|0
7045856|NCT01772134|11132931|FG002|Overall Study|Protocol-defined Stopping Criteria|0
7045857|NCT01772134|11132929|FG000|Overall Study|Randomized Study Medication Not Received|2
7045858|NCT01772134|11132930|FG001|Overall Study|Randomized Study Medication Not Received|0
7045859|NCT01772134|11132931|FG002|Overall Study|Randomized Study Medication Not Received|1
7045860|NCT01772147|11132942|FG000|Overall Study|Adverse Event|13
7045861|NCT01772147|11132943|FG001|Overall Study|Adverse Event|10
7045862|NCT01772147|11132944|FG002|Overall Study|Adverse Event|6
7045863|NCT01772147|11132942|FG000|Overall Study|Withdrew Consent|7
7045864|NCT01772147|11132943|FG001|Overall Study|Withdrew Consent|8
7045865|NCT01772147|11132944|FG002|Overall Study|Withdrew Consent|4
7045866|NCT01772147|11132942|FG000|Overall Study|Lost to Follow-up|1
7045867|NCT01772147|11132943|FG001|Overall Study|Lost to Follow-up|0
7045868|NCT01772147|11132944|FG002|Overall Study|Lost to Follow-up|1
7045869|NCT01772147|11132942|FG000|Overall Study|Protocol Deviation|2
7045870|NCT01772147|11132943|FG001|Overall Study|Protocol Deviation|1
7045871|NCT01772147|11132944|FG002|Overall Study|Protocol Deviation|1
7045872|NCT01772147|11132942|FG000|Overall Study|Lack of Efficacy|8
7045873|NCT01772147|11132943|FG001|Overall Study|Lack of Efficacy|6
7045874|NCT01772147|11132944|FG002|Overall Study|Lack of Efficacy|6
7045875|NCT01772160|11132952|FG000|Overall Study|Death|3
7045876|NCT01772160|11132952|FG000|Overall Study|Eligibility criteria not fulfilled|3
7045877|NCT01772160|11132952|FG000|Overall Study|Consent withdrawal|3
7045878|NCT01772160|11132952|FG000|Overall Study|Migrated / moved from the study area|4
7045879|NCT01772160|11132952|FG000|Overall Study|Lost to Follow-up|30
7045880|NCT01772160|11132952|FG000|Overall Study|Other|5
7045881|NCT01772316|11132956|FG000|Overall Study|Serious adverse event|1
7045882|NCT01772316|11132956|FG000|Overall Study|Inform consent withdrawn|1
7045883|NCT01772316|11132956|FG000|Overall Study|Withdrawn by sponsor decision|5
7045884|NCT01772368|11132960|FG000|Overall Study|Adverse Event|1
7045885|NCT01772368|11132960|FG000|Overall Study|Withdrawal by Subject|3
7045886|NCT01772368|11132960|FG000|Overall Study|Protocol Violation|2
7045887|NCT01772368|11132960|FG000|Overall Study|Other|1
7045888|NCT01772537|11132979|FG000|Overall Study|unsuccessful lumbar drain placement|1
7045889|NCT01772537|11132980|FG001|Overall Study|unsuccessful lumbar drain placement|0
7045890|NCT01772537|11132981|FG002|Overall Study|unsuccessful lumbar drain placement|0
7045891|NCT01772550|11132994|FG000|Overall Study|Unable to insert IV in antecubital vein|1
7045892|NCT01772550|11132995|FG001|Overall Study|Unable to insert IV in antecubital vein|1
7045893|NCT01772550|11132996|FG002|Overall Study|Unable to insert IV in antecubital vein|5
7045894|NCT01772550|11132994|FG000|Overall Study|Adverse Event|0
7045895|NCT01772550|11132995|FG001|Overall Study|Adverse Event|0
7045896|NCT01772550|11132996|FG002|Overall Study|Adverse Event|1
7083175|NCT02151461|11194237|FG002|Overall Study|Lost to Follow-up|1
7045897|NCT01772576|11133004|FG000|Overall Study|Death|15
7045898|NCT01772576|11133004|FG000|Overall Study|Protocol Violation|1
7045899|NCT01772576|11133004|FG000|Overall Study|Lost to Follow-up|3
7045900|NCT01772576|11133004|FG000|Overall Study|Study device not used|3
7045901|NCT01772576|11133004|FG000|Overall Study|Adverse Event|6
7045902|NCT01772576|11133004|FG000|Overall Study|Withdrawal by Subject|6
7045903|NCT01772693|11133019|FG000|Overall Study|Health Concerns Unrelated to Study|2
7045904|NCT01772693|11133020|FG001|Overall Study|Health Concerns Unrelated to Study|1
7045905|NCT01772693|11133019|FG000|Overall Study|Withdrawal by Subject|2
7045906|NCT01772693|11133020|FG001|Overall Study|Withdrawal by Subject|0
7045907|NCT01772693|11133019|FG000|Overall Study|Alternative Treatment|2
7045908|NCT01772693|11133020|FG001|Overall Study|Alternative Treatment|0
7045909|NCT01772823|11133045|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1
7045910|NCT01772823|11133046|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0
7045911|NCT01772823|11133045|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
7045912|NCT01772823|11133046|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
7045913|NCT01772823|11133045|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1
7045914|NCT01772823|11133046|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0
7045915|NCT01772823|11133045|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2
7045916|NCT01772823|11133046|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1
7045917|NCT01772823|11133045|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6
7045918|NCT01772823|11133046|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0
7045919|NCT01772823|11133045|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1
7045920|NCT01772823|11133046|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0
7045921|NCT01772823|11133045|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15
7045922|NCT01772823|11133046|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13
7045923|NCT01772823|11133045|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6
7045924|NCT01772823|11133046|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1
7045925|NCT01772823|11133045|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4
7045926|NCT01772823|11133046|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3
7045927|NCT01772823|11133045|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1
7045928|NCT01772823|11133046|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0
7045929|NCT01772823|11133045|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1
7045930|NCT01772823|11133046|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0
7045931|NCT01772823|11133045|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
7045932|NCT01772823|11133046|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
7045933|NCT01772823|11133045|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6
7045934|NCT01772823|11133046|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5
7045935|NCT01772823|11133045|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1
7045936|NCT01772823|11133046|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2
7045937|NCT01772823|11133045|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
7045938|NCT01772823|11133046|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
7045939|NCT01772823|11133045|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1
7045940|NCT01772823|11133046|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0
7045941|NCT01773070|11133057|FG000|Overall Study|Withdrawal by Subject|24
7045942|NCT01773070|11133057|FG000|Overall Study|Lost to Follow-up|39
7045943|NCT01773070|11133057|FG000|Overall Study|Other|15
7045944|NCT01773070|11133057|FG000|Overall Study|Death (unrelated to study procedures)|3
7045945|NCT01773109|11133061|FG000|Overall Study|Symptomatic Progression|2
7045946|NCT01773109|11133061|FG000|Overall Study|Death|1
7045947|NCT01773122|11133069|FG000|Overall Study|Due to amended age eligibility criteria|3
7045948|NCT01773122|11133070|FG001|Overall Study|Due to amended age eligibility criteria|1
7045949|NCT01773122|11133071|FG002|Overall Study|Due to amended age eligibility criteria|0
7045950|NCT01773122|11133072|FG003|Overall Study|Due to amended age eligibility criteria|1
7045951|NCT01773226|11133098|FG000|Overall Study|Withdrawal by Subject|1
7045952|NCT01773291|11133105|FG000|Overall Study|Protocol Violation|1
7045953|NCT01773291|11133106|FG001|Overall Study|Protocol Violation|0
7045954|NCT01773291|11133107|FG002|Overall Study|Protocol Violation|0
7045955|NCT01773291|11133105|FG000|Overall Study|Withdrawal by Subject|0
7045956|NCT01773291|11133106|FG001|Overall Study|Withdrawal by Subject|0
7045957|NCT01773291|11133107|FG002|Overall Study|Withdrawal by Subject|1
7045958|NCT01773421|11133120|FG000|Treatment Phase|Other|0
7045959|NCT01773421|11133121|FG001|Treatment Phase|Other|0
7045960|NCT01773421|11133122|FG002|Treatment Phase|Other|2
7045961|NCT01773421|11133123|FG003|Treatment Phase|Other|0
7045962|NCT01773421|11133124|FG004|Treatment Phase|Other|0
7045963|NCT01773421|11133125|FG005|Treatment Phase|Other|0
7045964|NCT01773421|11133126|FG006|Treatment Phase|Other|0
7045965|NCT01773421|11133120|FG000|Treatment Phase|Adverse Event|0
7045966|NCT01773421|11133121|FG001|Treatment Phase|Adverse Event|0
7045967|NCT01773421|11133122|FG002|Treatment Phase|Adverse Event|3
7045968|NCT01773421|11133123|FG003|Treatment Phase|Adverse Event|1
7045969|NCT01773421|11133124|FG004|Treatment Phase|Adverse Event|0
7045970|NCT01773421|11133125|FG005|Treatment Phase|Adverse Event|0
7045971|NCT01773421|11133126|FG006|Treatment Phase|Adverse Event|0
7045972|NCT01773421|11133120|FG000|Treatment Phase|Withdrawal by Subject|0
7045973|NCT01773421|11133121|FG001|Treatment Phase|Withdrawal by Subject|0
7045974|NCT01773421|11133122|FG002|Treatment Phase|Withdrawal by Subject|1
7045975|NCT01773421|11133123|FG003|Treatment Phase|Withdrawal by Subject|1
7045976|NCT01773421|11133124|FG004|Treatment Phase|Withdrawal by Subject|0
7045977|NCT01773421|11133125|FG005|Treatment Phase|Withdrawal by Subject|0
7045978|NCT01773421|11133126|FG006|Treatment Phase|Withdrawal by Subject|0
7045979|NCT01773421|11133120|FG000|Extension Phase|Other|0
7045980|NCT01773421|11133121|FG001|Extension Phase|Other|0
7045981|NCT01773421|11133122|FG002|Extension Phase|Other|0
7045982|NCT01773421|11133123|FG003|Extension Phase|Other|0
7045983|NCT01773421|11133124|FG004|Extension Phase|Other|1
7045984|NCT01773421|11133125|FG005|Extension Phase|Other|2
7045985|NCT01773421|11133126|FG006|Extension Phase|Other|0
7045986|NCT01773421|11133120|FG000|Extension Phase|Adverse Event|0
7045987|NCT01773421|11133121|FG001|Extension Phase|Adverse Event|0
7045988|NCT01773421|11133122|FG002|Extension Phase|Adverse Event|0
7045989|NCT01773421|11133123|FG003|Extension Phase|Adverse Event|0
7045990|NCT01773421|11133124|FG004|Extension Phase|Adverse Event|2
7045991|NCT01773421|11133125|FG005|Extension Phase|Adverse Event|0
7045992|NCT01773421|11133126|FG006|Extension Phase|Adverse Event|0
7045993|NCT01773473|11133144|FG000|Overall Study|Adverse Event|3
7045994|NCT01773473|11133145|FG001|Overall Study|Adverse Event|2
7045995|NCT01773473|11133144|FG000|Overall Study|Protocol Violation|0
7045996|NCT01773473|11133145|FG001|Overall Study|Protocol Violation|4
7045997|NCT01773473|11133144|FG000|Overall Study|Physician Decision|3
7045998|NCT01773473|11133145|FG001|Overall Study|Physician Decision|5
7045999|NCT01773473|11133144|FG000|Overall Study|Sponsor Decision|2
7046000|NCT01773473|11133145|FG001|Overall Study|Sponsor Decision|0
7046001|NCT01773473|11133144|FG000|Overall Study|Lack of Efficacy|0
7046002|NCT01773473|11133145|FG001|Overall Study|Lack of Efficacy|1
7046003|NCT01773473|11133144|FG000|Overall Study|Non-Compliance with study drug|1
7046004|NCT01773473|11133145|FG001|Overall Study|Non-Compliance with study drug|4
7046005|NCT01773473|11133144|FG000|Overall Study|Withdrawal by Subject|5
7046006|NCT01773473|11133145|FG001|Overall Study|Withdrawal by Subject|3
7046007|NCT01773473|11133144|FG000|Overall Study|Lost to Follow-up|2
7046008|NCT01773473|11133145|FG001|Overall Study|Lost to Follow-up|0
7046009|NCT01773889|11133151|FG000|Overall Study|lack of funding|2
7046010|NCT01773967|11133161|FG000|Overall Study|Lost to Follow-up|15
7046011|NCT01773967|11133162|FG001|Overall Study|Lost to Follow-up|13
7046012|NCT01773993|11133168|FG000|Overall Study|No Visit After Treatment|35
7046013|NCT01774084|11133184|FG000|Overall Study|Personal reasons|1
7046014|NCT01774084|11133185|FG001|Overall Study|Personal reasons|0
7046015|NCT01774097|11133193|FG000|Overall Study|Withdrawal by Subject|1
7046016|NCT01774097|11133194|FG001|Overall Study|Withdrawal by Subject|1
7046017|NCT01774097|11133193|FG000|Overall Study|Adverse Event|1
7046018|NCT01774097|11133194|FG001|Overall Study|Adverse Event|1
7046019|NCT01774110|11133202|FG000|Overall Study|Lost to Follow-up|7
7046020|NCT01774305|11133218|FG000|Overall Study|Physician Decision|1
7046021|NCT01774305|11133219|FG001|Overall Study|Physician Decision|0
7046022|NCT01774344|11133227|FG000|Overall Study|Withdrawal by Subject|3
7046023|NCT01774344|11133228|FG001|Overall Study|Withdrawal by Subject|10
7046024|NCT01774344|11133227|FG000|Overall Study|Protocol Violation|0
7046025|NCT01774344|11133228|FG001|Overall Study|Protocol Violation|1
7046026|NCT01774344|11133227|FG000|Overall Study|Lost to Follow-up|4
7046027|NCT01774344|11133228|FG001|Overall Study|Lost to Follow-up|10
7046028|NCT01774344|11133227|FG000|Overall Study|End of survival follow-up not available|2
7046029|NCT01774344|11133228|FG001|Overall Study|End of survival follow-up not available|2
7046030|NCT01774344|11133227|FG000|Overall Study|Data collection finished|4
7046031|NCT01774344|11133228|FG001|Overall Study|Data collection finished|14
7046032|NCT01774344|11133227|FG000|Overall Study|Other|0
7046033|NCT01774344|11133228|FG001|Overall Study|Other|1
7046034|NCT01774344|11133227|FG000|Overall Study|Did not enter Survival Follow up|49
7046035|NCT01774344|11133228|FG001|Overall Study|Did not enter Survival Follow up|83
7046036|NCT01774591|11133236|FG000|Overall Study|Physician Decision|1
7046037|NCT01774591|11133237|FG001|Overall Study|Physician Decision|1
7046038|NCT01774591|11133236|FG000|Overall Study|Withdrawal by Subject|0
7046039|NCT01774591|11133237|FG001|Overall Study|Withdrawal by Subject|1
7046040|NCT01774591|11133236|FG000|Overall Study|Adverse Event|0
7046041|NCT01774591|11133237|FG001|Overall Study|Adverse Event|2
7046042|NCT01774786|11133258|FG000|Overall Study|Death|300
7046043|NCT01774786|11133259|FG001|Overall Study|Death|319
7046044|NCT01774786|11133258|FG000|Overall Study|Lost to Follow-up|6
7046045|NCT01774786|11133259|FG001|Overall Study|Lost to Follow-up|7
7046046|NCT01774786|11133258|FG000|Overall Study|Withdrawal by Subject|18
7046047|NCT01774786|11133259|FG001|Overall Study|Withdrawal by Subject|14
7046048|NCT01774786|11133258|FG000|Overall Study|Physician Decision|2
7046049|NCT01774786|11133259|FG001|Overall Study|Physician Decision|0
7046050|NCT01774786|11133258|FG000|Overall Study|Non-compliance|0
7046051|NCT01774786|11133259|FG001|Overall Study|Non-compliance|1
7046052|NCT01774786|11133258|FG000|Overall Study|Reason Not Specified|2
7046053|NCT01774786|11133259|FG001|Overall Study|Reason Not Specified|5
7046054|NCT01774799|11133269|FG000|Overall Study|Lost to Follow-up|1
7046055|NCT01774799|11133270|FG001|Overall Study|Lost to Follow-up|1
7046056|NCT01774799|11133271|FG002|Overall Study|Lost to Follow-up|0
7046057|NCT01774799|11133272|FG003|Overall Study|Lost to Follow-up|0
7046058|NCT01774903|11133287|FG000|Overall Study|Adverse Event|7
7046059|NCT01774903|11133287|FG000|Overall Study|Withdrawal by Subject|2
7046060|NCT01774903|11133287|FG000|Overall Study|Lack of Efficacy|1
7046061|NCT01774903|11133287|FG000|Overall Study|Ineligible to continue the trial|1
7046062|NCT01774929|11133292|FG000|Overall Study|Adverse Event|3
7046063|NCT01774968|11133298|FG000|Overall Study|Adverse Event|4
7046064|NCT01774968|11133299|FG001|Overall Study|Adverse Event|4
7046065|NCT01774968|11133298|FG000|Overall Study|Death|0
7046066|NCT01774968|11133299|FG001|Overall Study|Death|1
7046067|NCT01774968|11133298|FG000|Overall Study|Lost to Follow-up|1
7046068|NCT01774968|11133299|FG001|Overall Study|Lost to Follow-up|3
7046069|NCT01774968|11133298|FG000|Overall Study|Physician Decision|5
7046070|NCT01774968|11133299|FG001|Overall Study|Physician Decision|1
7046071|NCT01774968|11133298|FG000|Overall Study|Protocol Violation|14
7046072|NCT01774968|11133299|FG001|Overall Study|Protocol Violation|13
7046073|NCT01774968|11133298|FG000|Overall Study|Sponsor Decision|0
7046074|NCT01774968|11133299|FG001|Overall Study|Sponsor Decision|2
7046075|NCT01774968|11133298|FG000|Overall Study|Withdrawal by Subject|6
7046076|NCT01774968|11133299|FG001|Overall Study|Withdrawal by Subject|11
7046077|NCT01774981|11133313|FG000|Overall Study|Adverse Event|0
7046078|NCT01774981|11133314|FG001|Overall Study|Adverse Event|0
7046079|NCT01774981|11133315|FG002|Overall Study|Adverse Event|0
7046080|NCT01774981|11133316|FG003|Overall Study|Adverse Event|0
7046081|NCT01774981|11133317|FG004|Overall Study|Adverse Event|0
7046082|NCT01774981|11133318|FG005|Overall Study|Adverse Event|1
7046083|NCT01774981|11133319|FG006|Overall Study|Adverse Event|0
7046084|NCT01774981|11133320|FG007|Overall Study|Adverse Event|0
7046085|NCT01774981|11133313|FG000|Overall Study|Withdrawal by Subject|0
7046086|NCT01774981|11133314|FG001|Overall Study|Withdrawal by Subject|0
7046087|NCT01774981|11133315|FG002|Overall Study|Withdrawal by Subject|0
7046088|NCT01774981|11133316|FG003|Overall Study|Withdrawal by Subject|0
7046089|NCT01774981|11133317|FG004|Overall Study|Withdrawal by Subject|0
7046090|NCT01774981|11133318|FG005|Overall Study|Withdrawal by Subject|0
7046091|NCT01774981|11133319|FG006|Overall Study|Withdrawal by Subject|0
7046092|NCT01774981|11133320|FG007|Overall Study|Withdrawal by Subject|1
7046093|NCT01774981|11133313|FG000|Overall Study|Death|0
7046094|NCT01774981|11133314|FG001|Overall Study|Death|0
7046095|NCT01774981|11133315|FG002|Overall Study|Death|0
7046096|NCT01774981|11133316|FG003|Overall Study|Death|0
7046097|NCT01774981|11133317|FG004|Overall Study|Death|1
7046098|NCT01774981|11133318|FG005|Overall Study|Death|0
7046099|NCT01774981|11133319|FG006|Overall Study|Death|0
7046100|NCT01774981|11133320|FG007|Overall Study|Death|0
7046101|NCT01775124|11133345|FG000|Core Period|Disease Progression|0
7046102|NCT01775124|11133346|FG001|Core Period|Disease Progression|1
7046103|NCT01775124|11133345|FG000|Core Period|Physician Decision|1
7046104|NCT01775124|11133346|FG001|Core Period|Physician Decision|1
7046105|NCT01775124|11133345|FG000|Core Period|Death|0
7046106|NCT01775124|11133346|FG001|Core Period|Death|1
7046107|NCT01775124|11133345|FG000|Core Period|Administrative problems|1
7046108|NCT01775124|11133346|FG001|Core Period|Administrative problems|0
7046109|NCT01775124|11133345|FG000|Core Period|Withdrawal by Subject|4
7046110|NCT01775124|11133346|FG001|Core Period|Withdrawal by Subject|2
7046111|NCT01775124|11133345|FG000|Core Period|Adverse Event|5
7046112|NCT01775124|11133346|FG001|Core Period|Adverse Event|5
7046113|NCT01775124|11133345|FG000|Extension Period|Adverse Event|3
7046114|NCT01775124|11133346|FG001|Extension Period|Adverse Event|2
7046115|NCT01775124|11133345|FG000|Extension Period|Physician Decision|0
7046116|NCT01775124|11133346|FG001|Extension Period|Physician Decision|2
7046117|NCT01775124|11133345|FG000|Extension Period|Administrative problems|0
7046118|NCT01775124|11133346|FG001|Extension Period|Administrative problems|1
7046119|NCT01775124|11133345|FG000|Extension Period|Lost to Follow-up|0
7046120|NCT01775124|11133346|FG001|Extension Period|Lost to Follow-up|1
7046121|NCT01775124|11133345|FG000|Extension Period|Withdrawal by Subject|9
7046122|NCT01775124|11133346|FG001|Extension Period|Withdrawal by Subject|12
7046123|NCT01775137|11133353|FG000|Overall Study|Death|1
7046124|NCT01775137|11133353|FG000|Overall Study|Protocol deviation|2
7046125|NCT01775137|11133353|FG000|Overall Study|Unsatisfactory therapeutic effect|2
7046126|NCT01775137|11133353|FG000|Overall Study|Adverse Event|1
7046127|NCT01775137|11133353|FG000|Overall Study|Withdrawal by participants|5
7046128|NCT01775189|11133360|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0
7046129|NCT01775189|11133361|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3
7046130|NCT01775189|11133362|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0
7046131|NCT01775189|11133363|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0
7046132|NCT01775189|11133364|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0
7046133|NCT01775189|11133365|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0
7046134|NCT01775189|11133366|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0
7046135|NCT01775189|11133360|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0
7046136|NCT01775189|11133361|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1
7046137|NCT01775189|11133362|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0
7046138|NCT01775189|11133363|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0
7046139|NCT01775189|11133364|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0
7046140|NCT01775189|11133365|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0
7046141|NCT01775189|11133366|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0
7046142|NCT01775189|11133360|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
7046143|NCT01775189|11133361|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2
7046144|NCT01775189|11133362|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7
7046145|NCT01775189|11133363|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
7046146|NCT01775189|11133364|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
7046147|NCT01775189|11133365|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
7046148|NCT01775189|11133366|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
7046149|NCT01775189|11133360|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0
7046150|NCT01775189|11133361|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0
7046151|NCT01775189|11133362|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0
7046152|NCT01775189|11133363|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0
7046153|NCT01775189|11133364|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0
7046154|NCT01775189|11133365|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1
7046155|NCT01775189|11133366|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0
7046156|NCT01775189|11133360|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0
7046157|NCT01775189|11133361|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0
7046158|NCT01775189|11133362|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0
7046159|NCT01775189|11133363|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1
7046160|NCT01775189|11133364|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0
7046161|NCT01775189|11133365|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0
7046162|NCT01775189|11133366|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0
7046163|NCT01775189|11133360|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0
7046164|NCT01775189|11133361|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0
7046165|NCT01775189|11133362|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0
7046166|NCT01775189|11133363|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1
7046167|NCT01775189|11133364|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0
7046168|NCT01775189|11133365|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0
7046169|NCT01775189|11133366|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1
7046170|NCT01775501|11133409|FG000|Overall Study|Discontinued prior to treatment|1
7046171|NCT01775553|11133413|FG000|Overall Study|Adverse Event|1
7046172|NCT01775553|11133413|FG000|Overall Study|Disease Progression|12
7046173|NCT01775670|11133419|FG000|Overall Study|Lost to Follow-up|1
7046174|NCT01775670|11133420|FG001|Overall Study|Lost to Follow-up|1
7046175|NCT01775787|11133454|FG000|First 7-10 Days|Adverse Event|0
7046176|NCT01775787|11133455|FG001|First 7-10 Days|Adverse Event|1
7046177|NCT01775787|11133454|FG000|First 7-10 Days|family emergency|0
7046178|NCT01775787|11133455|FG001|First 7-10 Days|family emergency|1
7046179|NCT01775787|11133454|FG000|First 7-10 Days|time commitment|0
7046180|NCT01775787|11133455|FG001|First 7-10 Days|time commitment|2
7046181|NCT01775787|11133454|FG000|First 7-10 Days|concerns with using IV|1
7046182|NCT01775787|11133455|FG001|First 7-10 Days|concerns with using IV|2
7046183|NCT01775787|11133454|FG000|Second 7-10 Days|time commitment|0
7046184|NCT01775787|11133455|FG001|Second 7-10 Days|time commitment|1
7046185|NCT01775787|11133454|FG000|Second 7-10 Days|concerns with using IV|0
7046186|NCT01775787|11133455|FG001|Second 7-10 Days|concerns with using IV|1
7046187|NCT01775904|11133500|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1
7046188|NCT01775904|11133500|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1
7046189|NCT01775930|11133510|FG000|Overall Study|Futility stopping boundary met|1
7046190|NCT01775995|11133516|FG000|Overall Study|Lost to Follow-up|1
7046191|NCT01775995|11133517|FG001|Overall Study|Lost to Follow-up|1
7046192|NCT01776008|11133523|FG000|Overall Study|ineligible|2
7046193|NCT01776424|11133540|FG000|Overall Study|Lost to Follow-up|10
7046194|NCT01776424|11133541|FG001|Overall Study|Lost to Follow-up|8
7046195|NCT01776424|11133542|FG002|Overall Study|Lost to Follow-up|9
7046196|NCT01776424|11133540|FG000|Overall Study|Withdrawal by Subject|10
7046197|NCT01776424|11133541|FG001|Overall Study|Withdrawal by Subject|11
7046198|NCT01776424|11133542|FG002|Overall Study|Withdrawal by Subject|15
7046199|NCT01776541|11133552|FG000|Overall Study|Administrative Reason|6
7046200|NCT01776541|11133553|FG001|Overall Study|Administrative Reason|2
7046201|NCT01776541|11133552|FG000|Overall Study|Death|4
7046202|NCT01776541|11133553|FG001|Overall Study|Death|0
7046203|NCT01776541|11133552|FG000|Overall Study|Lost to Follow-up|27
7046204|NCT01776541|11133553|FG001|Overall Study|Lost to Follow-up|48
7046205|NCT01776541|11133552|FG000|Overall Study|Unclassified|5
7046206|NCT01776541|11133553|FG001|Overall Study|Unclassified|4
7046207|NCT01776541|11133552|FG000|Overall Study|Protocol Violation|2
7046208|NCT01776541|11133553|FG001|Overall Study|Protocol Violation|1
7046209|NCT01776541|11133552|FG000|Overall Study|Withdrawal by Subject|12
7046210|NCT01776541|11133553|FG001|Overall Study|Withdrawal by Subject|20
7046211|NCT01776554|11133562|FG000|Overall Study|Adverse Event|1
7046212|NCT01776554|11133563|FG001|Overall Study|Adverse Event|0
7046213|NCT01776554|11133562|FG000|Overall Study|Withdrawal by Subject|3
7046214|NCT01776554|11133563|FG001|Overall Study|Withdrawal by Subject|8
7046215|NCT01776554|11133562|FG000|Overall Study|Lost to Follow-up|6
7046216|NCT01776554|11133563|FG001|Overall Study|Lost to Follow-up|9
7046217|NCT01776554|11133562|FG000|Overall Study|Administrative Reason|2
7046218|NCT01776554|11133563|FG001|Overall Study|Administrative Reason|5
7046219|NCT01776554|11133562|FG000|Overall Study|Protocol Violation|1
7046220|NCT01776554|11133563|FG001|Overall Study|Protocol Violation|0
7046221|NCT01776554|11133562|FG000|Overall Study|Unclassified|4
7046222|NCT01776554|11133563|FG001|Overall Study|Unclassified|1
7046223|NCT01777139|11133598|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7
7046224|NCT01777139|11133599|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0
7046225|NCT01777139|11133598|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6
7046226|NCT01777139|11133599|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0
7046227|NCT01777139|11133598|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8
7046228|NCT01777139|11133599|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0
7046229|NCT01777139|11133598|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3
7046230|NCT01777139|11133599|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0
7046231|NCT01777139|11133598|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2
7046232|NCT01777139|11133599|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0
7046233|NCT01777139|11133598|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4
7046234|NCT01777139|11133599|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0
7046235|NCT01777139|11133598|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0
7046236|NCT01777139|11133599|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1
7046237|NCT01777139|11133598|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0
7046238|NCT01777139|11133599|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3
7046239|NCT01777152|11133608|FG000|Overall Study|Withdrawal by Subject|22
7046240|NCT01777152|11133609|FG001|Overall Study|Withdrawal by Subject|16
7046241|NCT01777152|11133608|FG000|Overall Study|Lost to Follow-up|3
7046242|NCT01777152|11133609|FG001|Overall Study|Lost to Follow-up|5
7046243|NCT01777152|11133608|FG000|Overall Study|Death|68
7046244|NCT01777152|11133609|FG001|Overall Study|Death|89
7046245|NCT01777152|11133608|FG000|Overall Study|Not eligible, no study drug received|1
7046246|NCT01777152|11133609|FG001|Overall Study|Not eligible, no study drug received|0
7046247|NCT01777152|11133608|FG000|Overall Study|Change of diagnosis|1
7046248|NCT01777152|11133609|FG001|Overall Study|Change of diagnosis|0
7046249|NCT01777191|11133618|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2
7046250|NCT01777191|11133619|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1
7046251|NCT01777191|11133618|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
7046252|NCT01777191|11133619|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
7046253|NCT01777191|11133618|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1
7046254|NCT01777191|11133619|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2
7046255|NCT01777191|11133618|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0
7046256|NCT01777191|11133619|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3
7046257|NCT01777191|11133618|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
7046258|NCT01777191|11133619|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
7046259|NCT01777191|11133618|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1
7046260|NCT01777191|11133619|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0
7046261|NCT01777191|11133618|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
7046262|NCT01777191|11133619|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
7046263|NCT01777191|11133618|FG000|Safety Extension Per (Week 12-Week 48)|Death|0
7046264|NCT01777191|11133619|FG001|Safety Extension Per (Week 12-Week 48)|Death|1
7046265|NCT01777191|11133618|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
7046266|NCT01777191|11133619|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
7046267|NCT01777191|11133618|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1
7046268|NCT01777191|11133619|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2
7046269|NCT01777191|11133618|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1
7046270|NCT01777191|11133619|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3
7046271|NCT01777269|11133639|FG000|Overall Study|Adverse Event|24
7046272|NCT01777269|11133640|FG001|Overall Study|Adverse Event|33
7046273|NCT01777269|11133639|FG000|Overall Study|Lack of Efficacy|8
7046274|NCT01777269|11133640|FG001|Overall Study|Lack of Efficacy|10
7046275|NCT01777269|11133639|FG000|Overall Study|Protocol Violation|4
7046276|NCT01777269|11133640|FG001|Overall Study|Protocol Violation|4
7046277|NCT01777269|11133639|FG000|Overall Study|Participants reached stopping criteria|1
7046278|NCT01777269|11133640|FG001|Overall Study|Participants reached stopping criteria|1
7046279|NCT01777269|11133639|FG000|Overall Study|Lost to Follow-up|4
7046280|NCT01777269|11133640|FG001|Overall Study|Lost to Follow-up|0
7046281|NCT01777269|11133639|FG000|Overall Study|Physician Decision|5
7046282|NCT01777269|11133640|FG001|Overall Study|Physician Decision|2
7046283|NCT01777269|11133639|FG000|Overall Study|Withdrawal by Subject|9
7046284|NCT01777269|11133640|FG001|Overall Study|Withdrawal by Subject|9
7046285|NCT01777282|11133651|FG000|Overall Study|Persistent Hyperglycemia|0
7046286|NCT01777282|11133652|FG001|Overall Study|Persistent Hyperglycemia|0
7046287|NCT01777282|11133653|FG002|Overall Study|Persistent Hyperglycemia|1
7046288|NCT01777282|11133654|FG003|Overall Study|Persistent Hyperglycemia|0
7046289|NCT01777282|11133655|FG004|Overall Study|Persistent Hyperglycemia|0
7046290|NCT01777282|11133651|FG000|Overall Study|New Antidiabetic Medication|0
7046291|NCT01777282|11133652|FG001|Overall Study|New Antidiabetic Medication|0
7083176|NCT02151461|11194238|FG003|Overall Study|Lost to Follow-up|1
7188550|NCT02891226|11388868|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7046292|NCT01777282|11133653|FG002|Overall Study|New Antidiabetic Medication|1
7046293|NCT01777282|11133654|FG003|Overall Study|New Antidiabetic Medication|0
7046294|NCT01777282|11133655|FG004|Overall Study|New Antidiabetic Medication|0
7046295|NCT01777282|11133651|FG000|Overall Study|Adverse Event|4
7046296|NCT01777282|11133652|FG001|Overall Study|Adverse Event|4
7046297|NCT01777282|11133653|FG002|Overall Study|Adverse Event|2
7046298|NCT01777282|11133654|FG003|Overall Study|Adverse Event|1
7046299|NCT01777282|11133655|FG004|Overall Study|Adverse Event|3
7046300|NCT01777282|11133651|FG000|Overall Study|Withdrawal by Subject|4
7046301|NCT01777282|11133652|FG001|Overall Study|Withdrawal by Subject|0
7046302|NCT01777282|11133653|FG002|Overall Study|Withdrawal by Subject|0
7046303|NCT01777282|11133654|FG003|Overall Study|Withdrawal by Subject|1
7046304|NCT01777282|11133655|FG004|Overall Study|Withdrawal by Subject|2
7046305|NCT01777282|11133651|FG000|Overall Study|Protocol Violation|2
7046306|NCT01777282|11133652|FG001|Overall Study|Protocol Violation|0
7046307|NCT01777282|11133653|FG002|Overall Study|Protocol Violation|1
7046308|NCT01777282|11133654|FG003|Overall Study|Protocol Violation|0
7046309|NCT01777282|11133655|FG004|Overall Study|Protocol Violation|2
7046310|NCT01777282|11133651|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1
7046311|NCT01777282|11133652|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0
7046312|NCT01777282|11133653|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1
7046313|NCT01777282|11133654|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0
7046314|NCT01777282|11133655|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0
7046315|NCT01777308|11133669|FG000|Overall Study|Withdrawal by Subject|5
7046316|NCT01777308|11133670|FG001|Overall Study|Withdrawal by Subject|1
7046317|NCT01777308|11133669|FG000|Overall Study|Migrated/moved from study area|1
7046318|NCT01777308|11133670|FG001|Overall Study|Migrated/moved from study area|0
7046319|NCT01777308|11133669|FG000|Overall Study|Lost to Follow-up|7
7046320|NCT01777308|11133670|FG001|Overall Study|Lost to Follow-up|2
7046321|NCT01777308|11133669|FG000|Overall Study|Blood draw refusal at Visit 3|1
7046322|NCT01777308|11133670|FG001|Overall Study|Blood draw refusal at Visit 3|0
7046323|NCT01777321|11133679|FG000|Overall Study|Withdrawal by Subject|0
7046324|NCT01777321|11133680|FG001|Overall Study|Withdrawal by Subject|1
7046325|NCT01777334|11133688|FG000|Overall Study|Adverse Event|18
7046326|NCT01777334|11133689|FG001|Overall Study|Adverse Event|14
7046327|NCT01777334|11133688|FG000|Overall Study|Lack of Efficacy|15
7046328|NCT01777334|11133689|FG001|Overall Study|Lack of Efficacy|29
7046329|NCT01777334|11133688|FG000|Overall Study|Protocol Violation|3
7046330|NCT01777334|11133689|FG001|Overall Study|Protocol Violation|7
7046331|NCT01777334|11133688|FG000|Overall Study|Lost to Follow-up|3
7046332|NCT01777334|11133689|FG001|Overall Study|Lost to Follow-up|2
7046333|NCT01777334|11133688|FG000|Overall Study|Withdrawal by Subject|14
7046334|NCT01777334|11133689|FG001|Overall Study|Withdrawal by Subject|11
7046335|NCT01777490|11133717|FG000|Overall Study|Dyad withdrew with data use prohibition|0
7046336|NCT01777490|11133718|FG001|Overall Study|Dyad withdrew with data use prohibition|0
7046337|NCT01777490|11133719|FG002|Overall Study|Dyad withdrew with data use prohibition|1
7046338|NCT01777490|11133720|FG003|Overall Study|Dyad withdrew with data use prohibition|1
7046339|NCT01777542|11133732|FG000|Second Intervention (20 Weeks)|Adverse Event|0
7046340|NCT01777542|11133733|FG001|Second Intervention (20 Weeks)|Adverse Event|1
7046341|NCT01777581|11133751|FG000|Overall Study|Lost to Follow-up|1
7046342|NCT01777581|11133752|FG001|Overall Study|Lost to Follow-up|1
7046343|NCT01777581|11133751|FG000|Overall Study|Adverse Event|2
7046344|NCT01777581|11133752|FG001|Overall Study|Adverse Event|0
7046345|NCT01777581|11133751|FG000|Overall Study|Lack of Efficacy|0
7046346|NCT01777581|11133752|FG001|Overall Study|Lack of Efficacy|1
7046347|NCT01777620|11133760|FG000|Overall Study|Subject Withdrawal|1
7046348|NCT01777620|11133761|FG001|Overall Study|Subject Withdrawal|0
7046349|NCT01777763|11133769|FG000|Overall Study|Adverse Event|2
7046350|NCT01777763|11133770|FG001|Overall Study|Adverse Event|32
7046351|NCT01777763|11133769|FG000|Overall Study|Protocol Violation|1
7046352|NCT01777763|11133770|FG001|Overall Study|Protocol Violation|7
7046353|NCT01777763|11133769|FG000|Overall Study|Withdrawal by Subject|0
7046354|NCT01777763|11133770|FG001|Overall Study|Withdrawal by Subject|2
7046355|NCT01777763|11133769|FG000|Overall Study|Treatment Failure|1
7046356|NCT01777763|11133770|FG001|Overall Study|Treatment Failure|6
7046357|NCT01777776|11133780|FG000|Overall Study|Adverse Event|2
7046358|NCT01777776|11133781|FG001|Overall Study|Adverse Event|4
7046359|NCT01777776|11133782|FG002|Overall Study|Adverse Event|0
7046360|NCT01777776|11133783|FG003|Overall Study|Adverse Event|0
7046361|NCT01777776|11133780|FG000|Overall Study|Disease Progression|4
7046362|NCT01777776|11133781|FG001|Overall Study|Disease Progression|8
7046363|NCT01777776|11133782|FG002|Overall Study|Disease Progression|6
7046364|NCT01777776|11133783|FG003|Overall Study|Disease Progression|3
7046365|NCT01777776|11133780|FG000|Overall Study|Withdrawal by Subject|0
7046366|NCT01777776|11133781|FG001|Overall Study|Withdrawal by Subject|0
7046367|NCT01777776|11133782|FG002|Overall Study|Withdrawal by Subject|0
7046368|NCT01777776|11133783|FG003|Overall Study|Withdrawal by Subject|1
7046369|NCT01777932|11133802|FG000|Overall Study|Disease progression|136
7046370|NCT01777932|11133802|FG000|Overall Study|Death|3
7046371|NCT01777932|11133802|FG000|Overall Study|Adverse Event|34
7046372|NCT01777932|11133802|FG000|Overall Study|Lost to Follow-up|3
7046373|NCT01777932|11133802|FG000|Overall Study|Investigator decision|10
7046374|NCT01777932|11133802|FG000|Overall Study|Reimbursement limit|9
7046375|NCT01777932|11133802|FG000|Overall Study|Patient refused further treatment|10
7046376|NCT01777997|11133810|FG000|12 Week lead-in of no ART|Severe debilitation|2
7046377|NCT01777997|11133810|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1
7046378|NCT01777997|11133810|FG000|Weeks 48 to 72/96 on ART|Death|1
7046379|NCT01777997|11133810|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1
7046380|NCT01778010|11133814|FG000|Overall Study|Withdrawal by Subject|2
7046381|NCT01778010|11133814|FG000|Overall Study|abnormal ECG before meds|1
7046382|NCT01778010|11133814|FG000|Overall Study|Arrested|1
7046383|NCT01778010|11133814|FG000|Overall Study|rash while on placebo|1
7046384|NCT01778023|11133833|FG000|Overall Study|Withdrawal by Subject|0
7046385|NCT01778023|11133834|FG001|Overall Study|Withdrawal by Subject|3
7046386|NCT01778049|11133842|FG000|Open Label Treatment Period|Adverse Event|5
7046387|NCT01778049|11133843|FG001|Open Label Treatment Period|Adverse Event|15
7046388|NCT01778049|11133844|FG002|Open Label Treatment Period|Adverse Event|0
7046389|NCT01778049|11133845|FG003|Open Label Treatment Period|Adverse Event|0
7046390|NCT01778049|11133846|FG004|Open Label Treatment Period|Adverse Event|0
7046391|NCT01778049|11133847|FG005|Open Label Treatment Period|Adverse Event|0
7046392|NCT01778049|11133842|FG000|Open Label Treatment Period|Lack of Efficacy|1
7046393|NCT01778049|11133843|FG001|Open Label Treatment Period|Lack of Efficacy|1
7046394|NCT01778049|11133844|FG002|Open Label Treatment Period|Lack of Efficacy|0
7046395|NCT01778049|11133845|FG003|Open Label Treatment Period|Lack of Efficacy|0
7046396|NCT01778049|11133846|FG004|Open Label Treatment Period|Lack of Efficacy|0
7046397|NCT01778049|11133847|FG005|Open Label Treatment Period|Lack of Efficacy|0
7046398|NCT01778049|11133842|FG000|Open Label Treatment Period|Protocol Violation|5
7046399|NCT01778049|11133843|FG001|Open Label Treatment Period|Protocol Violation|5
7046400|NCT01778049|11133844|FG002|Open Label Treatment Period|Protocol Violation|0
7046401|NCT01778049|11133845|FG003|Open Label Treatment Period|Protocol Violation|0
7046402|NCT01778049|11133846|FG004|Open Label Treatment Period|Protocol Violation|0
7046403|NCT01778049|11133847|FG005|Open Label Treatment Period|Protocol Violation|0
7046404|NCT01778049|11133842|FG000|Open Label Treatment Period|Lost to Follow-up|4
7046405|NCT01778049|11133843|FG001|Open Label Treatment Period|Lost to Follow-up|3
7083177|NCT02151461|11194235|FG000|Overall Study|Withdrawal by Subject|1
7083178|NCT02151461|11194236|FG001|Overall Study|Withdrawal by Subject|0
7083179|NCT02151461|11194237|FG002|Overall Study|Withdrawal by Subject|1
7083180|NCT02151461|11194238|FG003|Overall Study|Withdrawal by Subject|1
7083181|NCT02151461|11194235|FG000|Overall Study|Treatment discontinuation|0
7083182|NCT02151461|11194236|FG001|Overall Study|Treatment discontinuation|0
7083183|NCT02151461|11194237|FG002|Overall Study|Treatment discontinuation|1
7083184|NCT02151461|11194238|FG003|Overall Study|Treatment discontinuation|0
7083185|NCT02151591|11194267|FG000|Overall Study|Lost to Follow-up|6
7083186|NCT02151591|11194268|FG001|Overall Study|Lost to Follow-up|3
7083187|NCT02151643|11194279|FG000|Overall Study|Adverse Event|2
7046406|NCT01778049|11133844|FG002|Open Label Treatment Period|Lost to Follow-up|0
7046407|NCT01778049|11133845|FG003|Open Label Treatment Period|Lost to Follow-up|0
7046408|NCT01778049|11133846|FG004|Open Label Treatment Period|Lost to Follow-up|0
7046409|NCT01778049|11133847|FG005|Open Label Treatment Period|Lost to Follow-up|0
7046410|NCT01778049|11133842|FG000|Open Label Treatment Period|Withdrawal by Subject|4
7046411|NCT01778049|11133843|FG001|Open Label Treatment Period|Withdrawal by Subject|10
7046412|NCT01778049|11133844|FG002|Open Label Treatment Period|Withdrawal by Subject|0
7046413|NCT01778049|11133845|FG003|Open Label Treatment Period|Withdrawal by Subject|0
7046414|NCT01778049|11133846|FG004|Open Label Treatment Period|Withdrawal by Subject|0
7046415|NCT01778049|11133847|FG005|Open Label Treatment Period|Withdrawal by Subject|0
7046416|NCT01778049|11133842|FG000|Open Label Treatment Period|Not treated|2
7046417|NCT01778049|11133843|FG001|Open Label Treatment Period|Not treated|1
7046418|NCT01778049|11133844|FG002|Open Label Treatment Period|Not treated|0
7046419|NCT01778049|11133845|FG003|Open Label Treatment Period|Not treated|0
7046420|NCT01778049|11133846|FG004|Open Label Treatment Period|Not treated|0
7046421|NCT01778049|11133847|FG005|Open Label Treatment Period|Not treated|0
7046422|NCT01778049|11133842|FG000|Open Label Treatment Period|Other reason not defined above|77
7046423|NCT01778049|11133843|FG001|Open Label Treatment Period|Other reason not defined above|94
7046424|NCT01778049|11133844|FG002|Open Label Treatment Period|Other reason not defined above|0
7046425|NCT01778049|11133845|FG003|Open Label Treatment Period|Other reason not defined above|0
7046426|NCT01778049|11133846|FG004|Open Label Treatment Period|Other reason not defined above|0
7046427|NCT01778049|11133847|FG005|Open Label Treatment Period|Other reason not defined above|0
7046428|NCT01778049|11133842|FG000|Double Blind Treatment Period|Adverse Event|0
7046429|NCT01778049|11133843|FG001|Double Blind Treatment Period|Adverse Event|0
7046430|NCT01778049|11133844|FG002|Double Blind Treatment Period|Adverse Event|4
7046431|NCT01778049|11133845|FG003|Double Blind Treatment Period|Adverse Event|5
7046432|NCT01778049|11133846|FG004|Double Blind Treatment Period|Adverse Event|3
7046433|NCT01778049|11133847|FG005|Double Blind Treatment Period|Adverse Event|2
7046434|NCT01778049|11133842|FG000|Double Blind Treatment Period|Lack of Efficacy|0
7046435|NCT01778049|11133843|FG001|Double Blind Treatment Period|Lack of Efficacy|0
7046436|NCT01778049|11133844|FG002|Double Blind Treatment Period|Lack of Efficacy|0
7046437|NCT01778049|11133845|FG003|Double Blind Treatment Period|Lack of Efficacy|0
7046438|NCT01778049|11133846|FG004|Double Blind Treatment Period|Lack of Efficacy|0
7046439|NCT01778049|11133847|FG005|Double Blind Treatment Period|Lack of Efficacy|1
7046440|NCT01778049|11133842|FG000|Double Blind Treatment Period|Protocol Violation|0
7046441|NCT01778049|11133843|FG001|Double Blind Treatment Period|Protocol Violation|0
7046442|NCT01778049|11133844|FG002|Double Blind Treatment Period|Protocol Violation|2
7046443|NCT01778049|11133845|FG003|Double Blind Treatment Period|Protocol Violation|0
7046444|NCT01778049|11133846|FG004|Double Blind Treatment Period|Protocol Violation|0
7046445|NCT01778049|11133847|FG005|Double Blind Treatment Period|Protocol Violation|0
7046446|NCT01778049|11133842|FG000|Double Blind Treatment Period|Lost to Follow-up|0
7046447|NCT01778049|11133843|FG001|Double Blind Treatment Period|Lost to Follow-up|0
7046448|NCT01778049|11133844|FG002|Double Blind Treatment Period|Lost to Follow-up|4
7046449|NCT01778049|11133845|FG003|Double Blind Treatment Period|Lost to Follow-up|1
7046450|NCT01778049|11133846|FG004|Double Blind Treatment Period|Lost to Follow-up|5
7046451|NCT01778049|11133847|FG005|Double Blind Treatment Period|Lost to Follow-up|2
7046452|NCT01778049|11133842|FG000|Double Blind Treatment Period|Withdrawal by Subject|0
7046453|NCT01778049|11133843|FG001|Double Blind Treatment Period|Withdrawal by Subject|0
7046454|NCT01778049|11133844|FG002|Double Blind Treatment Period|Withdrawal by Subject|1
7046455|NCT01778049|11133845|FG003|Double Blind Treatment Period|Withdrawal by Subject|2
7046456|NCT01778049|11133846|FG004|Double Blind Treatment Period|Withdrawal by Subject|0
7046457|NCT01778049|11133847|FG005|Double Blind Treatment Period|Withdrawal by Subject|1
7046458|NCT01778049|11133842|FG000|Double Blind Treatment Period|Not treated|0
7046459|NCT01778049|11133843|FG001|Double Blind Treatment Period|Not treated|0
7046460|NCT01778049|11133844|FG002|Double Blind Treatment Period|Not treated|0
7046461|NCT01778049|11133845|FG003|Double Blind Treatment Period|Not treated|2
7046462|NCT01778049|11133846|FG004|Double Blind Treatment Period|Not treated|2
7046463|NCT01778049|11133847|FG005|Double Blind Treatment Period|Not treated|0
7046464|NCT01778049|11133842|FG000|Double Blind Treatment Period|Other reason not defined above|0
7046465|NCT01778049|11133843|FG001|Double Blind Treatment Period|Other reason not defined above|0
7046466|NCT01778049|11133844|FG002|Double Blind Treatment Period|Other reason not defined above|4
7046467|NCT01778049|11133845|FG003|Double Blind Treatment Period|Other reason not defined above|2
7046468|NCT01778049|11133846|FG004|Double Blind Treatment Period|Other reason not defined above|2
7046469|NCT01778049|11133847|FG005|Double Blind Treatment Period|Other reason not defined above|1
7046470|NCT01778062|11133861|FG000|Overall Study|Adverse Event|1
7046471|NCT01778062|11133862|FG001|Overall Study|Adverse Event|3
7046472|NCT01778062|11133861|FG000|Overall Study|Consent Withdrawal|1
7046473|NCT01778062|11133862|FG001|Overall Study|Consent Withdrawal|5
7046474|NCT01778062|11133861|FG000|Overall Study|major protocol deviation|4
7046475|NCT01778062|11133862|FG001|Overall Study|major protocol deviation|3
7046476|NCT01778127|11133871|FG000|Overall Study|Lost to Follow-up|5
7046477|NCT01778127|11133872|FG001|Overall Study|Lost to Follow-up|1
7046478|NCT01778127|11133873|FG002|Overall Study|Lost to Follow-up|2
7046479|NCT01778127|11133871|FG000|Overall Study|Withdrawal by Subject|3
7046480|NCT01778127|11133872|FG001|Overall Study|Withdrawal by Subject|1
7046481|NCT01778127|11133873|FG002|Overall Study|Withdrawal by Subject|4
7046482|NCT01778530|11133916|FG000|Overall Study|Progression on study|1
7046483|NCT01778530|11133916|FG000|Overall Study|Adverse event/side effect|1
7046484|NCT01778556|11133922|FG000|Intervention 1 (5 Days)|Protocol Violation|0
7046485|NCT01778556|11133923|FG001|Intervention 1 (5 Days)|Protocol Violation|1
7046486|NCT01778556|11133922|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0
7046487|NCT01778556|11133923|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1
7046488|NCT01778556|11133922|FG000|Intervention 2 (14 Days)|Protocol Violation|1
7046489|NCT01778556|11133923|FG001|Intervention 2 (14 Days)|Protocol Violation|0
7046490|NCT01778556|11133922|FG000|Long-term Follow-up|noncompliance with metreleptin|1
7046491|NCT01778556|11133923|FG001|Long-term Follow-up|noncompliance with metreleptin|0
7046492|NCT01778751|11133944|FG000|Overall Study|Lost to Follow-up|1
7046493|NCT01778751|11133945|FG001|Overall Study|Lost to Follow-up|0
7046494|NCT01778751|11133944|FG000|Overall Study|Withdrawal by Subject|0
7046495|NCT01778751|11133945|FG001|Overall Study|Withdrawal by Subject|2
7046496|NCT01778751|11133944|FG000|Overall Study|Transfered care|1
7046497|NCT01778751|11133945|FG001|Overall Study|Transfered care|0
7046498|NCT01778855|11133953|FG000|Overall Study|Death|0
7046499|NCT01778855|11133954|FG001|Overall Study|Death|1
7046500|NCT01778985|11133962|FG000|Overall Study|Lost to Follow-up|1
7046501|NCT01778985|11133963|FG001|Overall Study|Lost to Follow-up|0
7046502|NCT01778985|11133962|FG000|Overall Study|Physician Decision|2
7046503|NCT01778985|11133963|FG001|Overall Study|Physician Decision|2
7046504|NCT01778985|11133962|FG000|Overall Study|Protocol Violation|4
7046505|NCT01778985|11133963|FG001|Overall Study|Protocol Violation|1
7083188|NCT02151643|11194280|FG001|Overall Study|Adverse Event|0
7083189|NCT02151643|11194281|FG002|Overall Study|Adverse Event|1
7083190|NCT02151643|11194282|FG003|Overall Study|Adverse Event|4
7083191|NCT02151643|11194283|FG004|Overall Study|Adverse Event|0
7083192|NCT02151643|11194279|FG000|Overall Study|Withdrawal by Subject|0
7083193|NCT02151643|11194280|FG001|Overall Study|Withdrawal by Subject|1
7083194|NCT02151643|11194281|FG002|Overall Study|Withdrawal by Subject|1
7083195|NCT02151643|11194282|FG003|Overall Study|Withdrawal by Subject|1
7083196|NCT02151643|11194283|FG004|Overall Study|Withdrawal by Subject|1
7083197|NCT02151643|11194279|FG000|Overall Study|Hyperphosphataemia|1
7083198|NCT02151643|11194280|FG001|Overall Study|Hyperphosphataemia|0
7083199|NCT02151643|11194281|FG002|Overall Study|Hyperphosphataemia|0
7083200|NCT02151643|11194282|FG003|Overall Study|Hyperphosphataemia|0
7046506|NCT01779440|11134006|FG000|Overall Study|Withdrawal by Subject|3
7046507|NCT01779440|11134007|FG001|Overall Study|Withdrawal by Subject|5
7046508|NCT01779648|11134015|FG000|Overall Study|Protocol Violation|1
7046509|NCT01779648|11134016|FG001|Overall Study|Protocol Violation|0
7046510|NCT01779700|11134024|FG000|Overall Study|Adverse Event|4
7046511|NCT01779700|11134025|FG001|Overall Study|Adverse Event|3
7046512|NCT01779700|11134024|FG000|Overall Study|Withdrawal by Subject|0
7046513|NCT01779700|11134025|FG001|Overall Study|Withdrawal by Subject|2
7046514|NCT01779856|11134031|FG000|Overall Study|Withdrawal by Subject|15
7046515|NCT01779856|11134031|FG000|Overall Study|Death|3
7046516|NCT01779856|11134031|FG000|Overall Study|Physician Decision|1
7046517|NCT01779856|11134031|FG000|Overall Study|Inclusion/Exclusion Not Met|2
7046518|NCT01779856|11134031|FG000|Overall Study|Delays in scheduling implant|1
7046519|NCT01779856|11134031|FG000|Overall Study|Subject ineligible for Implant|2
7046520|NCT01779869|11134042|FG000|Overall Study|Physician Decision|2
7046521|NCT01780389|11134068|FG000|Overall Study|Adverse Event|1
7046522|NCT01780506|11134079|FG000|Double-Blind Phase|Randomized but not Treated|3
7046523|NCT01780506|11134080|FG001|Double-Blind Phase|Randomized but not Treated|2
7046524|NCT01780506|11134079|FG000|Double-Blind Phase|Adverse Event|4
7046525|NCT01780506|11134080|FG001|Double-Blind Phase|Adverse Event|14
7046526|NCT01780506|11134079|FG000|Double-Blind Phase|Death|1
7046527|NCT01780506|11134080|FG001|Double-Blind Phase|Death|2
7046528|NCT01780506|11134079|FG000|Double-Blind Phase|Pregnancy|2
7046529|NCT01780506|11134080|FG001|Double-Blind Phase|Pregnancy|1
7046530|NCT01780506|11134079|FG000|Double-Blind Phase|Lack of Efficacy|1
7046531|NCT01780506|11134080|FG001|Double-Blind Phase|Lack of Efficacy|1
7046532|NCT01780506|11134079|FG000|Double-Blind Phase|Investigator's Discretion|5
7046533|NCT01780506|11134080|FG001|Double-Blind Phase|Investigator's Discretion|2
7046534|NCT01780506|11134079|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4
7046535|NCT01780506|11134080|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3
7046536|NCT01780506|11134079|FG000|Double-Blind Phase|Protocol Violation|4
7046537|NCT01780506|11134080|FG001|Double-Blind Phase|Protocol Violation|3
7046538|NCT01780506|11134079|FG000|Double-Blind Phase|Withdrew Consent|23
7046539|NCT01780506|11134080|FG001|Double-Blind Phase|Withdrew Consent|24
7046540|NCT01780506|11134079|FG000|Double-Blind Phase|Lost to Follow-up|23
7046541|NCT01780506|11134080|FG001|Double-Blind Phase|Lost to Follow-up|26
7046542|NCT01780506|11134079|FG000|Open-Label Extension Phase|Enrolled but not Treated|0
7046543|NCT01780506|11134080|FG001|Open-Label Extension Phase|Enrolled but not Treated|1
7046544|NCT01780545|11134090|FG000|Overall Study|Withdrawal by Subject|3
7046545|NCT01780545|11134091|FG001|Overall Study|Withdrawal by Subject|1
7046546|NCT01780545|11134090|FG000|Overall Study|Lost to Follow-up|1
7046547|NCT01780545|11134091|FG001|Overall Study|Lost to Follow-up|1
7046548|NCT01780584|11134103|FG000|Overall Study|Death|1
7046549|NCT01780584|11134104|FG001|Overall Study|Death|0
7046550|NCT01780584|11134105|FG002|Overall Study|Death|1
7046551|NCT01780584|11134103|FG000|Overall Study|Adverse Event|0
7046552|NCT01780584|11134104|FG001|Overall Study|Adverse Event|1
7046553|NCT01780584|11134105|FG002|Overall Study|Adverse Event|0
7046554|NCT01780584|11134103|FG000|Overall Study|Protocol Violation|0
7046555|NCT01780584|11134104|FG001|Overall Study|Protocol Violation|0
7046556|NCT01780584|11134105|FG002|Overall Study|Protocol Violation|1
7046557|NCT01780662|11134116|FG000|Overall Study|Adverse Event|1
7046558|NCT01780662|11134117|FG001|Overall Study|Adverse Event|0
7046559|NCT01780662|11134118|FG002|Overall Study|Adverse Event|2
7046560|NCT01780662|11134116|FG000|Overall Study|Physician Decision|0
7046561|NCT01780662|11134117|FG001|Overall Study|Physician Decision|5
7046562|NCT01780662|11134118|FG002|Overall Study|Physician Decision|7
7046563|NCT01780662|11134116|FG000|Overall Study|Protocol Violation|0
7046564|NCT01780662|11134117|FG001|Overall Study|Protocol Violation|1
7046565|NCT01780662|11134118|FG002|Overall Study|Protocol Violation|0
7046566|NCT01780662|11134116|FG000|Overall Study|Ineligible|0
7046567|NCT01780662|11134117|FG001|Overall Study|Ineligible|0
7046568|NCT01780662|11134118|FG002|Overall Study|Ineligible|1
7046569|NCT01780831|11134131|FG000|Overall Study|Withdrawal by Subject|0
7046570|NCT01780831|11134132|FG001|Overall Study|Withdrawal by Subject|0
7046571|NCT01780831|11134133|FG002|Overall Study|Withdrawal by Subject|4
7046572|NCT01780831|11134134|FG003|Overall Study|Withdrawal by Subject|0
7046573|NCT01780831|11134131|FG000|Overall Study|Lost to Follow-up|0
7046574|NCT01780831|11134132|FG001|Overall Study|Lost to Follow-up|0
7046575|NCT01780831|11134133|FG002|Overall Study|Lost to Follow-up|0
7046576|NCT01780831|11134134|FG003|Overall Study|Lost to Follow-up|1
7046577|NCT01780935|11134215|FG000|Overall Study|Admin problems due to early termination|321
7046578|NCT01780935|11134216|FG001|Overall Study|Admin problems due to early termination|309
7046579|NCT01780935|11134215|FG000|Overall Study|Adverse Event|2
7046580|NCT01780935|11134216|FG001|Overall Study|Adverse Event|4
7046581|NCT01780935|11134215|FG000|Overall Study|Death|1
7046582|NCT01780935|11134216|FG001|Overall Study|Death|6
7046583|NCT01780935|11134215|FG000|Overall Study|Lost to Follow-up|2
7046584|NCT01780935|11134216|FG001|Overall Study|Lost to Follow-up|6
7046585|NCT01780935|11134215|FG000|Overall Study|Physician Decision|1
7046586|NCT01780935|11134216|FG001|Overall Study|Physician Decision|1
7046587|NCT01780935|11134215|FG000|Overall Study|Protocol deviation|0
7046588|NCT01780935|11134216|FG001|Overall Study|Protocol deviation|1
7046589|NCT01780935|11134215|FG000|Overall Study|Patient withdrew consent|8
7046590|NCT01780935|11134216|FG001|Overall Study|Patient withdrew consent|9
7046591|NCT01780974|11134224|FG000|Overall Study|Death|1
7046592|NCT01780974|11134225|FG001|Overall Study|Death|0
7046593|NCT01780974|11134224|FG000|Overall Study|Adverse Event|1
7046594|NCT01780974|11134225|FG001|Overall Study|Adverse Event|3
7046595|NCT01780987|11134233|FG000|Overall Study|Adverse Event|0
7046596|NCT01780987|11134234|FG001|Overall Study|Adverse Event|4
7046597|NCT01780987|11134233|FG000|Overall Study|Withdrawal by Subject|2
7046598|NCT01780987|11134234|FG001|Overall Study|Withdrawal by Subject|0
7046599|NCT01780987|11134233|FG000|Overall Study|Request of Changing Hospital|0
7046600|NCT01780987|11134234|FG001|Overall Study|Request of Changing Hospital|1
7046601|NCT01780987|11134233|FG000|Overall Study|Changing Residence|1
7046602|NCT01780987|11134234|FG001|Overall Study|Changing Residence|0
7046603|NCT01780987|11134233|FG000|Overall Study|Not Receiving any Study Medication|0
7046604|NCT01780987|11134234|FG001|Overall Study|Not Receiving any Study Medication|1
7046605|NCT01781234|11134269|FG000|Overall Study|Adverse Event|2
7046606|NCT01781234|11134270|FG001|Overall Study|Adverse Event|0
7046607|NCT01781234|11134269|FG000|Overall Study|Protocol Violation|3
7046608|NCT01781234|11134270|FG001|Overall Study|Protocol Violation|0
7046609|NCT01781234|11134269|FG000|Overall Study|Withdrawal by Subject|4
7046610|NCT01781234|11134270|FG001|Overall Study|Withdrawal by Subject|3
7046611|NCT01781286|11134278|FG000|Overall Study|Lost to Follow-up|0
7046612|NCT01781286|11134279|FG001|Overall Study|Lost to Follow-up|0
7046613|NCT01781286|11134280|FG002|Overall Study|Lost to Follow-up|0
7046614|NCT01781286|11134281|FG003|Overall Study|Lost to Follow-up|0
7046615|NCT01781286|11134282|FG004|Overall Study|Lost to Follow-up|0
7046616|NCT01781286|11134283|FG005|Overall Study|Lost to Follow-up|1
7046617|NCT01781286|11134278|FG000|Overall Study|Time Constraints|2
7046618|NCT01781286|11134279|FG001|Overall Study|Time Constraints|0
7046619|NCT01781286|11134280|FG002|Overall Study|Time Constraints|2
7046620|NCT01781286|11134281|FG003|Overall Study|Time Constraints|0
7046621|NCT01781286|11134282|FG004|Overall Study|Time Constraints|0
7046622|NCT01781286|11134283|FG005|Overall Study|Time Constraints|0
7046623|NCT01781286|11134278|FG000|Overall Study|Noncompliance|0
7046624|NCT01781286|11134279|FG001|Overall Study|Noncompliance|0
7046625|NCT01781286|11134280|FG002|Overall Study|Noncompliance|0
7046626|NCT01781286|11134281|FG003|Overall Study|Noncompliance|1
7046627|NCT01781286|11134282|FG004|Overall Study|Noncompliance|0
7046628|NCT01781286|11134283|FG005|Overall Study|Noncompliance|0
7046629|NCT01781299|11134295|FG000|Overall Study|Withdrawal by Subject|0
7046630|NCT01781299|11134296|FG001|Overall Study|Withdrawal by Subject|1
7046631|NCT01781429|11134329|FG000|Overall Study|Death|0
7046632|NCT01781429|11134330|FG001|Overall Study|Death|0
7046633|NCT01781429|11134331|FG002|Overall Study|Death|0
7046634|NCT01781429|11134332|FG003|Overall Study|Death|0
7046635|NCT01781429|11134333|FG004|Overall Study|Death|0
7046636|NCT01781429|11134334|FG005|Overall Study|Death|0
7046637|NCT01781429|11134335|FG006|Overall Study|Death|0
7046638|NCT01781429|11134336|FG007|Overall Study|Death|0
7046639|NCT01781429|11134337|FG008|Overall Study|Death|0
7046640|NCT01781429|11134338|FG009|Overall Study|Death|1
7046641|NCT01781429|11134339|FG010|Overall Study|Death|0
7046642|NCT01781429|11134340|FG011|Overall Study|Death|0
7046643|NCT01781429|11134341|FG012|Overall Study|Death|1
7046644|NCT01781429|11134342|FG013|Overall Study|Death|0
7046645|NCT01781429|11134343|FG014|Overall Study|Death|1
7046646|NCT01781429|11134344|FG015|Overall Study|Death|0
7046647|NCT01781429|11134329|FG000|Overall Study|Withdrawal by Subject|0
7046648|NCT01781429|11134330|FG001|Overall Study|Withdrawal by Subject|0
7046649|NCT01781429|11134331|FG002|Overall Study|Withdrawal by Subject|0
7046650|NCT01781429|11134332|FG003|Overall Study|Withdrawal by Subject|0
7046651|NCT01781429|11134333|FG004|Overall Study|Withdrawal by Subject|0
7046652|NCT01781429|11134334|FG005|Overall Study|Withdrawal by Subject|0
7046653|NCT01781429|11134335|FG006|Overall Study|Withdrawal by Subject|0
7046654|NCT01781429|11134336|FG007|Overall Study|Withdrawal by Subject|0
7046655|NCT01781429|11134337|FG008|Overall Study|Withdrawal by Subject|1
7046656|NCT01781429|11134338|FG009|Overall Study|Withdrawal by Subject|3
7046657|NCT01781429|11134339|FG010|Overall Study|Withdrawal by Subject|1
7046658|NCT01781429|11134340|FG011|Overall Study|Withdrawal by Subject|1
7046659|NCT01781429|11134341|FG012|Overall Study|Withdrawal by Subject|5
7046660|NCT01781429|11134342|FG013|Overall Study|Withdrawal by Subject|2
7046661|NCT01781429|11134343|FG014|Overall Study|Withdrawal by Subject|3
7046662|NCT01781429|11134344|FG015|Overall Study|Withdrawal by Subject|0
7046663|NCT01781429|11134329|FG000|Overall Study|Disease Progression|1
7046664|NCT01781429|11134330|FG001|Overall Study|Disease Progression|0
7046665|NCT01781429|11134331|FG002|Overall Study|Disease Progression|1
7046666|NCT01781429|11134332|FG003|Overall Study|Disease Progression|1
7046667|NCT01781429|11134333|FG004|Overall Study|Disease Progression|1
7046668|NCT01781429|11134334|FG005|Overall Study|Disease Progression|4
7046669|NCT01781429|11134335|FG006|Overall Study|Disease Progression|7
7046670|NCT01781429|11134336|FG007|Overall Study|Disease Progression|4
7046671|NCT01781429|11134337|FG008|Overall Study|Disease Progression|6
7046672|NCT01781429|11134338|FG009|Overall Study|Disease Progression|15
7046673|NCT01781429|11134339|FG010|Overall Study|Disease Progression|15
7046674|NCT01781429|11134340|FG011|Overall Study|Disease Progression|15
7046675|NCT01781429|11134341|FG012|Overall Study|Disease Progression|15
7046676|NCT01781429|11134342|FG013|Overall Study|Disease Progression|4
7046677|NCT01781429|11134343|FG014|Overall Study|Disease Progression|11
7046678|NCT01781429|11134344|FG015|Overall Study|Disease Progression|0
7046679|NCT01781429|11134329|FG000|Overall Study|Unacceptable Toxicity|0
7046680|NCT01781429|11134330|FG001|Overall Study|Unacceptable Toxicity|0
7046681|NCT01781429|11134331|FG002|Overall Study|Unacceptable Toxicity|0
7046682|NCT01781429|11134332|FG003|Overall Study|Unacceptable Toxicity|0
7046683|NCT01781429|11134333|FG004|Overall Study|Unacceptable Toxicity|0
7046684|NCT01781429|11134334|FG005|Overall Study|Unacceptable Toxicity|0
7046685|NCT01781429|11134335|FG006|Overall Study|Unacceptable Toxicity|0
7046686|NCT01781429|11134336|FG007|Overall Study|Unacceptable Toxicity|0
7046687|NCT01781429|11134337|FG008|Overall Study|Unacceptable Toxicity|0
7046688|NCT01781429|11134338|FG009|Overall Study|Unacceptable Toxicity|0
7046689|NCT01781429|11134339|FG010|Overall Study|Unacceptable Toxicity|0
7046690|NCT01781429|11134340|FG011|Overall Study|Unacceptable Toxicity|2
7188551|NCT02891226|11388869|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7046691|NCT01781429|11134341|FG012|Overall Study|Unacceptable Toxicity|0
7046692|NCT01781429|11134342|FG013|Overall Study|Unacceptable Toxicity|0
7046693|NCT01781429|11134343|FG014|Overall Study|Unacceptable Toxicity|0
7046694|NCT01781429|11134344|FG015|Overall Study|Unacceptable Toxicity|0
7046695|NCT01781429|11134329|FG000|Overall Study|Patient Condition Changed|0
7046696|NCT01781429|11134330|FG001|Overall Study|Patient Condition Changed|0
7046697|NCT01781429|11134331|FG002|Overall Study|Patient Condition Changed|0
7046698|NCT01781429|11134332|FG003|Overall Study|Patient Condition Changed|0
7046699|NCT01781429|11134333|FG004|Overall Study|Patient Condition Changed|0
7046700|NCT01781429|11134334|FG005|Overall Study|Patient Condition Changed|0
7046701|NCT01781429|11134335|FG006|Overall Study|Patient Condition Changed|0
7046702|NCT01781429|11134336|FG007|Overall Study|Patient Condition Changed|0
7046703|NCT01781429|11134337|FG008|Overall Study|Patient Condition Changed|0
7046704|NCT01781429|11134338|FG009|Overall Study|Patient Condition Changed|4
7046705|NCT01781429|11134339|FG010|Overall Study|Patient Condition Changed|0
7046706|NCT01781429|11134340|FG011|Overall Study|Patient Condition Changed|1
7046707|NCT01781429|11134341|FG012|Overall Study|Patient Condition Changed|0
7046708|NCT01781429|11134342|FG013|Overall Study|Patient Condition Changed|1
7046709|NCT01781429|11134343|FG014|Overall Study|Patient Condition Changed|0
7046710|NCT01781429|11134344|FG015|Overall Study|Patient Condition Changed|0
7046711|NCT01781429|11134329|FG000|Overall Study|Other - as entered by PI in eCRF|0
7046712|NCT01781429|11134330|FG001|Overall Study|Other - as entered by PI in eCRF|1
7046713|NCT01781429|11134331|FG002|Overall Study|Other - as entered by PI in eCRF|0
7046714|NCT01781429|11134332|FG003|Overall Study|Other - as entered by PI in eCRF|0
7046715|NCT01781429|11134333|FG004|Overall Study|Other - as entered by PI in eCRF|0
7046716|NCT01781429|11134334|FG005|Overall Study|Other - as entered by PI in eCRF|0
7046717|NCT01781429|11134335|FG006|Overall Study|Other - as entered by PI in eCRF|0
7046718|NCT01781429|11134336|FG007|Overall Study|Other - as entered by PI in eCRF|0
7046719|NCT01781429|11134337|FG008|Overall Study|Other - as entered by PI in eCRF|0
7046720|NCT01781429|11134338|FG009|Overall Study|Other - as entered by PI in eCRF|1
7046721|NCT01781429|11134339|FG010|Overall Study|Other - as entered by PI in eCRF|1
7046722|NCT01781429|11134340|FG011|Overall Study|Other - as entered by PI in eCRF|2
7046723|NCT01781429|11134341|FG012|Overall Study|Other - as entered by PI in eCRF|1
7046724|NCT01781429|11134342|FG013|Overall Study|Other - as entered by PI in eCRF|1
7046725|NCT01781429|11134343|FG014|Overall Study|Other - as entered by PI in eCRF|1
7046726|NCT01781429|11134344|FG015|Overall Study|Other - as entered by PI in eCRF|0
7046727|NCT01781429|11134329|FG000|Overall Study|Enrolled, but not treated|0
7046728|NCT01781429|11134330|FG001|Overall Study|Enrolled, but not treated|0
7046729|NCT01781429|11134331|FG002|Overall Study|Enrolled, but not treated|0
7046730|NCT01781429|11134332|FG003|Overall Study|Enrolled, but not treated|0
7046731|NCT01781429|11134333|FG004|Overall Study|Enrolled, but not treated|0
7046732|NCT01781429|11134334|FG005|Overall Study|Enrolled, but not treated|0
7046733|NCT01781429|11134335|FG006|Overall Study|Enrolled, but not treated|0
7046734|NCT01781429|11134336|FG007|Overall Study|Enrolled, but not treated|0
7046735|NCT01781429|11134337|FG008|Overall Study|Enrolled, but not treated|0
7046736|NCT01781429|11134338|FG009|Overall Study|Enrolled, but not treated|0
7046737|NCT01781429|11134339|FG010|Overall Study|Enrolled, but not treated|1
7083201|NCT02151643|11194283|FG004|Overall Study|Hyperphosphataemia|1
7083202|NCT02151643|11194279|FG000|Overall Study|High Ferritin levels|3
7083203|NCT02151643|11194280|FG001|Overall Study|High Ferritin levels|3
7083204|NCT02151643|11194281|FG002|Overall Study|High Ferritin levels|2
7083205|NCT02151643|11194282|FG003|Overall Study|High Ferritin levels|2
7083206|NCT02151643|11194283|FG004|Overall Study|High Ferritin levels|1
7083207|NCT02151682|11194297|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
7083208|NCT02151682|11194298|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2
7083209|NCT02151682|11194299|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
7083210|NCT02151682|11194300|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
7083211|NCT02151682|11194301|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
7083212|NCT02151682|11194302|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
7083213|NCT02151682|11194297|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
7083214|NCT02151682|11194298|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1
7188552|NCT02891226|11388870|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7046738|NCT01781429|11134340|FG011|Overall Study|Enrolled, but not treated|0
7046739|NCT01781429|11134341|FG012|Overall Study|Enrolled, but not treated|0
7046740|NCT01781429|11134342|FG013|Overall Study|Enrolled, but not treated|0
7046741|NCT01781429|11134343|FG014|Overall Study|Enrolled, but not treated|0
7046742|NCT01781429|11134344|FG015|Overall Study|Enrolled, but not treated|0
7046743|NCT01781572|11134447|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7
7046744|NCT01781572|11134448|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0
7046745|NCT01781572|11134449|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11
7046746|NCT01781572|11134447|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8
7046747|NCT01781572|11134448|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6
7046748|NCT01781572|11134449|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23
7046749|NCT01781572|11134447|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1
7046750|NCT01781572|11134448|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0
7046751|NCT01781572|11134449|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2
7046752|NCT01781572|11134447|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0
7046753|NCT01781572|11134448|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0
7046754|NCT01781572|11134449|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4
7046755|NCT01781572|11134447|FG000|MEK162 45mg BID+LEE011 200mg|Death|0
7046756|NCT01781572|11134448|FG001|MEK162 45mg BID+LEE011 200mg|Death|0
7046757|NCT01781572|11134449|FG002|MEK162 45mg BID+LEE011 200mg|Death|1
7046758|NCT01781572|11134447|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2
7046759|NCT01781572|11134448|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0
7046760|NCT01781572|11134449|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0
7046761|NCT01781572|11134447|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1
7046762|NCT01781572|11134448|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0
7046763|NCT01781572|11134449|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0
7046764|NCT01781572|11134447|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1
7046765|NCT01781572|11134448|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0
7188553|NCT02891226|11388871|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7046766|NCT01781572|11134449|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0
7046767|NCT01781572|11134447|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3
7046768|NCT01781572|11134448|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2
7046769|NCT01781572|11134449|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0
7046770|NCT01781572|11134447|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1
7046771|NCT01781572|11134448|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1
7046772|NCT01781572|11134449|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0
7046773|NCT01781572|11134447|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4
7046774|NCT01781572|11134448|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3
7046775|NCT01781572|11134449|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0
7046776|NCT01781572|11134447|FG000|MEK162 45mg BID+LEE011 300mg|Death|1
7046777|NCT01781572|11134448|FG001|MEK162 45mg BID+LEE011 300mg|Death|0
7046778|NCT01781572|11134449|FG002|MEK162 45mg BID+LEE011 300mg|Death|0
7046779|NCT01781572|11134447|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0
7046780|NCT01781572|11134448|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5
7046781|NCT01781572|11134449|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0
7046782|NCT01781572|11134447|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0
7046783|NCT01781572|11134448|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1
7046784|NCT01781572|11134449|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0
7046785|NCT01781572|11134447|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0
7046786|NCT01781572|11134448|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2
7046787|NCT01781572|11134449|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0
7046788|NCT01781572|11134447|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0
7046789|NCT01781572|11134448|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6
7046790|NCT01781572|11134449|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0
7046791|NCT01781572|11134447|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0
7046792|NCT01781572|11134448|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1
7046793|NCT01781572|11134449|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0
7046794|NCT01781572|11134447|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0
7046795|NCT01781572|11134448|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5
7046796|NCT01781572|11134449|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0
7046797|NCT01781611|11134480|FG000|Overall Study|Adverse Event|4
7046798|NCT01781611|11134481|FG001|Overall Study|Adverse Event|0
7046799|NCT01781832|11134497|FG000|Overall Study|Withdrawal by Subject|1
7046800|NCT01781962|11134501|FG000|Overall Study|Other Miscellaneous Reasons|5
7046801|NCT01781975|11134507|FG000|Overall Study|Death|1
7046802|NCT01781975|11134508|FG001|Overall Study|Death|0
7046803|NCT01781975|11134507|FG000|Overall Study|Withdrawal by Subject|1
7046804|NCT01781975|11134508|FG001|Overall Study|Withdrawal by Subject|1
7046805|NCT01782131|11134516|FG000|Overall Study|Death|93
7046806|NCT01782131|11134517|FG001|Overall Study|Death|96
7046807|NCT01782131|11134516|FG000|Overall Study|Lost to Follow-up|1
7046808|NCT01782131|11134517|FG001|Overall Study|Lost to Follow-up|3
7046809|NCT01782131|11134516|FG000|Overall Study|Withdrawal by Subject|10
7046810|NCT01782131|11134517|FG001|Overall Study|Withdrawal by Subject|10
7046811|NCT01782131|11134516|FG000|Overall Study|Randomized but not treated|5
7046812|NCT01782131|11134517|FG001|Overall Study|Randomized but not treated|5
7046813|NCT01782131|11134516|FG000|Overall Study|Reason not provided|0
7046814|NCT01782131|11134517|FG001|Overall Study|Reason not provided|1
7046815|NCT01782222|11134530|FG000|Overall Study|Adverse Event|4
7046816|NCT01782222|11134531|FG001|Overall Study|Adverse Event|5
7046817|NCT01782222|11134532|FG002|Overall Study|Adverse Event|3
7046818|NCT01782222|11134530|FG000|Overall Study|Lack of Efficacy|2
7046819|NCT01782222|11134531|FG001|Overall Study|Lack of Efficacy|1
7046820|NCT01782222|11134532|FG002|Overall Study|Lack of Efficacy|0
7046821|NCT01782222|11134530|FG000|Overall Study|Protocol Violation|1
7046822|NCT01782222|11134531|FG001|Overall Study|Protocol Violation|0
7046823|NCT01782222|11134532|FG002|Overall Study|Protocol Violation|0
7046824|NCT01782222|11134530|FG000|Overall Study|Withdrawal by Subject|1
7046825|NCT01782222|11134531|FG001|Overall Study|Withdrawal by Subject|4
7046826|NCT01782222|11134532|FG002|Overall Study|Withdrawal by Subject|1
7046827|NCT01782222|11134530|FG000|Overall Study|Moved to other state|0
7046828|NCT01782222|11134531|FG001|Overall Study|Moved to other state|1
7046829|NCT01782222|11134532|FG002|Overall Study|Moved to other state|0
7046830|NCT01782313|11134540|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3
7046831|NCT01782313|11134540|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3
7046832|NCT01782313|11134540|FG000|Treated Cycle 3|Progressive Disease|21
7046833|NCT01782313|11134540|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5
7046834|NCT01782313|11134540|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1
7046835|NCT01782313|11134540|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6
7046836|NCT01782313|11134540|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1
7046837|NCT01782313|11134540|FG000|Survival Follow up|Lost to Follow-up|1
7046838|NCT01782326|11134546|FG000|Planned Treatment Epoch|Subject/guardian decision|149
7046839|NCT01782326|11134547|FG001|Planned Treatment Epoch|Subject/guardian decision|151
7046840|NCT01782326|11134546|FG000|Planned Treatment Epoch|Death|29
7188554|NCT02891226|11388872|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7188555|NCT02891226|11388873|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7046841|NCT01782326|11134547|FG001|Planned Treatment Epoch|Death|30
7188556|NCT02891226|11388858|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7188557|NCT02891226|11388859|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7188558|NCT02891226|11388860|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7188559|NCT02891226|11388861|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7188560|NCT02891226|11388862|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7188561|NCT02891226|11388863|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7046842|NCT01782326|11134546|FG000|Planned Treatment Epoch|Physician Decision|18
7046843|NCT01782326|11134547|FG001|Planned Treatment Epoch|Physician Decision|16
7046844|NCT01782326|11134546|FG000|Planned Treatment Epoch|Protocol deviation|2
7046845|NCT01782326|11134547|FG001|Planned Treatment Epoch|Protocol deviation|3
7046846|NCT01782326|11134546|FG000|Planned Treatment Epoch|Lost to Follow-up|4
7046847|NCT01782326|11134547|FG001|Planned Treatment Epoch|Lost to Follow-up|4
7046848|NCT01782326|11134546|FG000|Planned Treatment Epoch|Technical problems|0
7046849|NCT01782326|11134547|FG001|Planned Treatment Epoch|Technical problems|4
7046850|NCT01782326|11134546|FG000|Double-blind Treatment|Adverse Event|129
7046851|NCT01782326|11134547|FG001|Double-blind Treatment|Adverse Event|145
7046852|NCT01782326|11134546|FG000|Double-blind Treatment|Subject/guardian decision|111
7046853|NCT01782326|11134547|FG001|Double-blind Treatment|Subject/guardian decision|125
7046854|NCT01782326|11134546|FG000|Double-blind Treatment|Lack of Efficacy|17
7046855|NCT01782326|11134547|FG001|Double-blind Treatment|Lack of Efficacy|22
7046856|NCT01782326|11134546|FG000|Double-blind Treatment|Physician Decision|13
7046857|NCT01782326|11134547|FG001|Double-blind Treatment|Physician Decision|16
7046858|NCT01782326|11134546|FG000|Double-blind Treatment|Protocol deviation|8
7046859|NCT01782326|11134547|FG001|Double-blind Treatment|Protocol deviation|7
7046860|NCT01782326|11134546|FG000|Double-blind Treatment|Technical problems|0
7046861|NCT01782326|11134547|FG001|Double-blind Treatment|Technical problems|5
7046862|NCT01782378|11134555|FG000|First Series|Lost to Follow-up|7
7046863|NCT01782378|11134556|FG001|First Series|Lost to Follow-up|8
7046864|NCT01782378|11134555|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0
7046865|NCT01782378|11134556|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25
7046866|NCT01782378|11134555|FG000|Second Series|Lost to Follow-up|8
7046867|NCT01782378|11134556|FG001|Second Series|Lost to Follow-up|7
7046868|NCT01782378|11134555|FG000|Second Series|Did not choose to complete S2 Optional|18
7046869|NCT01782378|11134556|FG001|Second Series|Did not choose to complete S2 Optional|0
7046870|NCT01782469|11134562|FG000|Overall Study|Lost to Follow-up|1
7046871|NCT01782482|11134568|FG000|Overall Study|Adverse Event|2
7046872|NCT01782482|11134569|FG001|Overall Study|Adverse Event|1
7046873|NCT01782482|11134568|FG000|Overall Study|Lost to Follow-up|2
7046874|NCT01782482|11134569|FG001|Overall Study|Lost to Follow-up|3
7046875|NCT01782482|11134568|FG000|Overall Study|Physician Decision|1
7046876|NCT01782482|11134569|FG001|Overall Study|Physician Decision|0
7046877|NCT01782482|11134568|FG000|Overall Study|Protocol Violation|1
7046878|NCT01782482|11134569|FG001|Overall Study|Protocol Violation|0
7046879|NCT01782482|11134568|FG000|Overall Study|Withdrawal by Subject|2
7046880|NCT01782482|11134569|FG001|Overall Study|Withdrawal by Subject|3
7046881|NCT01782482|11134568|FG000|Overall Study|Randomized in Error|2
7046882|NCT01782482|11134569|FG001|Overall Study|Randomized in Error|2
7046883|NCT01782482|11134568|FG000|Overall Study|Habitually wearing toric lens OS|0
7046884|NCT01782482|11134569|FG001|Overall Study|Habitually wearing toric lens OS|1
7046885|NCT01782495|11134586|FG000|Overall Study|Adverse Event|0
7046886|NCT01782495|11134587|FG001|Overall Study|Adverse Event|0
7046887|NCT01782495|11134588|FG002|Overall Study|Adverse Event|0
7046888|NCT01782495|11134589|FG003|Overall Study|Adverse Event|0
7046889|NCT01782495|11134590|FG004|Overall Study|Adverse Event|0
7046890|NCT01782495|11134591|FG005|Overall Study|Adverse Event|0
7046891|NCT01782495|11134592|FG006|Overall Study|Adverse Event|0
7046892|NCT01782495|11134593|FG007|Overall Study|Adverse Event|2
7046893|NCT01782495|11134594|FG008|Overall Study|Adverse Event|0
7046894|NCT01782495|11134595|FG009|Overall Study|Adverse Event|0
7046895|NCT01782495|11134596|FG010|Overall Study|Adverse Event|0
7083215|NCT02151682|11194299|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
7083216|NCT02151682|11194300|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
7046896|NCT01782495|11134586|FG000|Overall Study|Withdrew Consent|0
7046897|NCT01782495|11134587|FG001|Overall Study|Withdrew Consent|1
7046898|NCT01782495|11134588|FG002|Overall Study|Withdrew Consent|0
7046899|NCT01782495|11134589|FG003|Overall Study|Withdrew Consent|0
7046900|NCT01782495|11134590|FG004|Overall Study|Withdrew Consent|0
7046901|NCT01782495|11134591|FG005|Overall Study|Withdrew Consent|0
7046902|NCT01782495|11134592|FG006|Overall Study|Withdrew Consent|0
7046903|NCT01782495|11134593|FG007|Overall Study|Withdrew Consent|1
7046904|NCT01782495|11134594|FG008|Overall Study|Withdrew Consent|0
7046905|NCT01782495|11134595|FG009|Overall Study|Withdrew Consent|0
7046906|NCT01782495|11134596|FG010|Overall Study|Withdrew Consent|0
7046907|NCT01782664|11134626|FG000|Overall Study|Adverse Event|2
7046908|NCT01782664|11134627|FG001|Overall Study|Adverse Event|2
7046909|NCT01782664|11134628|FG002|Overall Study|Adverse Event|2
7046910|NCT01782664|11134629|FG003|Overall Study|Adverse Event|2
7046911|NCT01782664|11134630|FG004|Overall Study|Adverse Event|0
7046912|NCT01782664|11134631|FG005|Overall Study|Adverse Event|0
7046913|NCT01782664|11134626|FG000|Overall Study|Lack of Efficacy|2
7046914|NCT01782664|11134627|FG001|Overall Study|Lack of Efficacy|0
7046915|NCT01782664|11134628|FG002|Overall Study|Lack of Efficacy|2
7046916|NCT01782664|11134629|FG003|Overall Study|Lack of Efficacy|2
7046917|NCT01782664|11134630|FG004|Overall Study|Lack of Efficacy|0
7046918|NCT01782664|11134631|FG005|Overall Study|Lack of Efficacy|0
7046919|NCT01782664|11134626|FG000|Overall Study|Protocol Violation|0
7046920|NCT01782664|11134627|FG001|Overall Study|Protocol Violation|1
7046921|NCT01782664|11134628|FG002|Overall Study|Protocol Violation|0
7046922|NCT01782664|11134629|FG003|Overall Study|Protocol Violation|1
7046923|NCT01782664|11134630|FG004|Overall Study|Protocol Violation|0
7046924|NCT01782664|11134631|FG005|Overall Study|Protocol Violation|0
7046925|NCT01782664|11134626|FG000|Overall Study|Withdrawal by Subject|2
7046926|NCT01782664|11134627|FG001|Overall Study|Withdrawal by Subject|2
7046927|NCT01782664|11134628|FG002|Overall Study|Withdrawal by Subject|0
7046928|NCT01782664|11134629|FG003|Overall Study|Withdrawal by Subject|0
7046929|NCT01782664|11134630|FG004|Overall Study|Withdrawal by Subject|0
7046930|NCT01782664|11134631|FG005|Overall Study|Withdrawal by Subject|0
7046931|NCT01782690|11134645|FG000|Overall Study|Not reported|7
7046932|NCT01782690|11134645|FG000|Overall Study|Toxicity of gemcitabine|1
7046933|NCT01782690|11134645|FG000|Overall Study|Toxicity of erlotinib|1
7046934|NCT01782690|11134645|FG000|Overall Study|Lost to Follow-up|31
7046935|NCT01782690|11134645|FG000|Overall Study|Withdrawal of informed consent|2
7046936|NCT01782690|11134645|FG000|Overall Study|Absent rash|9
7046937|NCT01782690|11134645|FG000|Overall Study|Physician Decision|13
7046938|NCT01782690|11134645|FG000|Overall Study|Patient's wish|21
7046939|NCT01782690|11134645|FG000|Overall Study|Tumor progression|74
7046940|NCT01782690|11134645|FG000|Overall Study|Death|133
7046941|NCT01782690|11134645|FG000|Overall Study|Study completion unknown|7
7046942|NCT01782742|11134651|FG000|Double-blind Treatment Phase|Adverse Event|1
7046943|NCT01782742|11134652|FG001|Double-blind Treatment Phase|Adverse Event|0
7046944|NCT01782859|11134666|FG000|Overall Study|Protocol Violation|6
7046945|NCT01782859|11134667|FG001|Overall Study|Protocol Violation|6
7046946|NCT01782859|11134666|FG000|Overall Study|Withdrawal by Subject|0
7046947|NCT01782859|11134667|FG001|Overall Study|Withdrawal by Subject|1
7046948|NCT01782872|11134678|FG000|Overall Study|Protocol Violation|0
7046949|NCT01782872|11134679|FG001|Overall Study|Protocol Violation|0
7046950|NCT01782872|11134680|FG002|Overall Study|Protocol Violation|0
7046951|NCT01782872|11134681|FG003|Overall Study|Protocol Violation|1
7046952|NCT01782872|11134678|FG000|Overall Study|Withdrawal by Subject|0
7046953|NCT01782872|11134679|FG001|Overall Study|Withdrawal by Subject|1
7046954|NCT01782872|11134680|FG002|Overall Study|Withdrawal by Subject|0
7046955|NCT01782872|11134681|FG003|Overall Study|Withdrawal by Subject|0
7046956|NCT01782885|11134693|FG000|Overall Study|Lost to Follow-up|4
7046957|NCT01782885|11134694|FG001|Overall Study|Lost to Follow-up|6
7046958|NCT01783418|11134736|FG000|Overall Study|Withdrawal by Subject|1
7046959|NCT01783418|11134737|FG001|Overall Study|Withdrawal by Subject|0
7046960|NCT01783444|11134746|FG000|Treatment Phase|Adverse Event|9
7046961|NCT01783444|11134747|FG001|Treatment Phase|Adverse Event|20
7046962|NCT01783444|11134748|FG002|Treatment Phase|Adverse Event|19
7046963|NCT01783444|11134746|FG000|Treatment Phase|Disease Progression|76
7046964|NCT01783444|11134747|FG001|Treatment Phase|Disease Progression|66
7046965|NCT01783444|11134748|FG002|Treatment Phase|Disease Progression|64
7046966|NCT01783444|11134746|FG000|Treatment Phase|Death|2
7046967|NCT01783444|11134747|FG001|Treatment Phase|Death|2
7046968|NCT01783444|11134748|FG002|Treatment Phase|Death|2
7046969|NCT01783444|11134746|FG000|Treatment Phase|Protocol Violation|1
7046970|NCT01783444|11134747|FG001|Treatment Phase|Protocol Violation|1
7046971|NCT01783444|11134748|FG002|Treatment Phase|Protocol Violation|2
7046972|NCT01783444|11134746|FG000|Treatment Phase|Withdrawal by Subject|6
7046973|NCT01783444|11134747|FG001|Treatment Phase|Withdrawal by Subject|8
7046974|NCT01783444|11134748|FG002|Treatment Phase|Withdrawal by Subject|9
7046975|NCT01783444|11134746|FG000|Treatment Phase|Administrative problems|2
7046976|NCT01783444|11134747|FG001|Treatment Phase|Administrative problems|0
7046977|NCT01783444|11134748|FG002|Treatment Phase|Administrative problems|1
7046978|NCT01783444|11134746|FG000|Treatment Phase|Physician Decision|8
7046979|NCT01783444|11134747|FG001|Treatment Phase|Physician Decision|6
7046980|NCT01783444|11134748|FG002|Treatment Phase|Physician Decision|5
7046981|NCT01783444|11134746|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7
7046982|NCT01783444|11134747|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8
7046983|NCT01783444|11134748|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11
7046984|NCT01783444|11134746|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9
7046985|NCT01783444|11134747|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7
7046986|NCT01783444|11134748|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5
7046987|NCT01783444|11134746|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4
7046988|NCT01783444|11134747|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8
7046989|NCT01783444|11134748|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8
7046990|NCT01783444|11134746|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0
7046991|NCT01783444|11134747|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1
7046992|NCT01783444|11134748|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0
7046993|NCT01783444|11134746|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7
7046994|NCT01783444|11134747|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16
7046995|NCT01783444|11134748|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15
7046996|NCT01783444|11134746|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69
7046997|NCT01783444|11134747|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53
7046998|NCT01783444|11134748|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52
7046999|NCT01783483|11134767|FG000|Overall Study|Death|3
7047000|NCT01783483|11134768|FG001|Overall Study|Death|3
7047001|NCT01783483|11134767|FG000|Overall Study|Lost to Follow-up|14
7047002|NCT01783483|11134768|FG001|Overall Study|Lost to Follow-up|10
7047003|NCT01783483|11134767|FG000|Overall Study|Withdrawal by Subject|2
7047004|NCT01783483|11134768|FG001|Overall Study|Withdrawal by Subject|1
7047005|NCT01783483|11134767|FG000|Overall Study|Physician Decision|1
7047006|NCT01783483|11134768|FG001|Overall Study|Physician Decision|1
7047007|NCT01783496|11134780|FG000|Overall Study|Lost to Follow-up|0
7083217|NCT02151682|11194301|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
7083218|NCT02151682|11194302|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
7083219|NCT02151682|11194297|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
7083220|NCT02151682|11194298|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1
7083221|NCT02151682|11194299|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
7083222|NCT02151682|11194300|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
7083223|NCT02151682|11194301|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
7047008|NCT01783496|11134781|FG001|Overall Study|Lost to Follow-up|0
7047009|NCT01783496|11134782|FG002|Overall Study|Lost to Follow-up|0
7047010|NCT01783496|11134783|FG003|Overall Study|Lost to Follow-up|2
7047011|NCT01783496|11134784|FG004|Overall Study|Lost to Follow-up|0
7047012|NCT01783496|11134785|FG005|Overall Study|Lost to Follow-up|1
7047013|NCT01783496|11134780|FG000|Overall Study|Withdrawal by Subject|1
7047014|NCT01783496|11134781|FG001|Overall Study|Withdrawal by Subject|0
7047015|NCT01783496|11134782|FG002|Overall Study|Withdrawal by Subject|0
7047016|NCT01783496|11134783|FG003|Overall Study|Withdrawal by Subject|0
7047017|NCT01783496|11134784|FG004|Overall Study|Withdrawal by Subject|0
7047018|NCT01783496|11134785|FG005|Overall Study|Withdrawal by Subject|0
7047019|NCT01783548|11134810|FG000|Overall Study|Adverse Event|8
7047020|NCT01783548|11134811|FG001|Overall Study|Adverse Event|4
7047021|NCT01783548|11134810|FG000|Overall Study|Withdrawal by Subject|11
7047022|NCT01783548|11134811|FG001|Overall Study|Withdrawal by Subject|8
7047023|NCT01783548|11134810|FG000|Overall Study|Non-compliance|4
7047024|NCT01783548|11134811|FG001|Overall Study|Non-compliance|0
7047025|NCT01783548|11134810|FG000|Overall Study|Protocol Violation|2
7047026|NCT01783548|11134811|FG001|Overall Study|Protocol Violation|2
7047027|NCT01783548|11134810|FG000|Overall Study|Lost to Follow-up|8
7047028|NCT01783548|11134811|FG001|Overall Study|Lost to Follow-up|3
7047029|NCT01783548|11134810|FG000|Overall Study|Lack of Efficacy|1
7047030|NCT01783548|11134811|FG001|Overall Study|Lack of Efficacy|1
7047031|NCT01783678|11134845|FG000|Overall Study|Randomized but Not Treated|0
7047032|NCT01783678|11134846|FG001|Overall Study|Randomized but Not Treated|0
7047033|NCT01783678|11134847|FG002|Overall Study|Randomized but Not Treated|0
7047034|NCT01783678|11134848|FG003|Overall Study|Randomized but Not Treated|1
7047035|NCT01783678|11134849|FG004|Overall Study|Randomized but Not Treated|0
7047036|NCT01783678|11134850|FG005|Overall Study|Randomized but Not Treated|0
7047037|NCT01783678|11134845|FG000|Overall Study|Lack of Efficacy|1
7047038|NCT01783678|11134846|FG001|Overall Study|Lack of Efficacy|13
7047039|NCT01783678|11134847|FG002|Overall Study|Lack of Efficacy|1
7047040|NCT01783678|11134848|FG003|Overall Study|Lack of Efficacy|3
7047041|NCT01783678|11134849|FG004|Overall Study|Lack of Efficacy|6
7047042|NCT01783678|11134850|FG005|Overall Study|Lack of Efficacy|5
7047043|NCT01783678|11134845|FG000|Overall Study|Lost to Follow-up|0
7047044|NCT01783678|11134846|FG001|Overall Study|Lost to Follow-up|4
7047045|NCT01783678|11134847|FG002|Overall Study|Lost to Follow-up|0
7047046|NCT01783678|11134848|FG003|Overall Study|Lost to Follow-up|2
7047047|NCT01783678|11134849|FG004|Overall Study|Lost to Follow-up|1
7047048|NCT01783678|11134850|FG005|Overall Study|Lost to Follow-up|0
7047049|NCT01783678|11134845|FG000|Overall Study|Withdrew Consent|1
7047050|NCT01783678|11134846|FG001|Overall Study|Withdrew Consent|1
7188562|NCT02891226|11388864|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7047051|NCT01783678|11134847|FG002|Overall Study|Withdrew Consent|0
7047052|NCT01783678|11134848|FG003|Overall Study|Withdrew Consent|2
7047053|NCT01783678|11134849|FG004|Overall Study|Withdrew Consent|0
7047054|NCT01783678|11134850|FG005|Overall Study|Withdrew Consent|0
7047055|NCT01783730|11134865|FG000|Overall Study|Failed to meet inclusion criteria|6
7047056|NCT01783743|11134871|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427
7083224|NCT02151682|11194302|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
7083225|NCT02151682|11194297|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1
7083226|NCT02151682|11194298|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1
7083227|NCT02151682|11194299|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
7083228|NCT02151682|11194300|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
7083229|NCT02151682|11194301|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
7083230|NCT02151682|11194302|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
7083231|NCT02151682|11194297|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1
7083232|NCT02151682|11194298|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0
7083233|NCT02151682|11194299|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0
7083234|NCT02151682|11194300|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0
7083235|NCT02151682|11194301|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0
7083236|NCT02151682|11194302|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0
7083237|NCT02151682|11194297|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0
7083238|NCT02151682|11194298|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0
7083239|NCT02151682|11194299|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3
7083240|NCT02151682|11194300|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0
7083241|NCT02151682|11194301|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0
7083242|NCT02151682|11194302|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0
7083243|NCT02151682|11194297|FG000|Part 2: Tapent. Extension or Observation|Death|0
7083244|NCT02151682|11194298|FG001|Part 2: Tapent. Extension or Observation|Death|0
7083245|NCT02151682|11194299|FG002|Part 2: Tapent. Extension or Observation|Death|0
7083246|NCT02151682|11194300|FG003|Part 2: Tapent. Extension or Observation|Death|2
7083247|NCT02151682|11194301|FG004|Part 2: Tapent. Extension or Observation|Death|0
7083248|NCT02151682|11194302|FG005|Part 2: Tapent. Extension or Observation|Death|0
7083249|NCT02151682|11194297|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
7083250|NCT02151682|11194298|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
7083251|NCT02151682|11194299|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1
7083252|NCT02151682|11194300|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1
7083253|NCT02151682|11194301|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
7083254|NCT02151682|11194302|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
7083255|NCT02151682|11194297|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
7083256|NCT02151682|11194298|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
7083257|NCT02151682|11194299|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3
7083258|NCT02151682|11194300|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
7083259|NCT02151682|11194301|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
7083260|NCT02151682|11194302|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
7083261|NCT02151682|11194297|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0
7083262|NCT02151682|11194298|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0
7188563|NCT02891226|11388865|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7188564|NCT02891226|11388866|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7188565|NCT02891226|11388867|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1
7188566|NCT02891226|11388868|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7188567|NCT02891226|11388869|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7188568|NCT02891226|11388870|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7188569|NCT02891226|11388871|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7188570|NCT02891226|11388872|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7188571|NCT02891226|11388873|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7188572|NCT02891226|11388858|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7188573|NCT02891226|11388859|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7188574|NCT02891226|11388860|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7188575|NCT02891226|11388861|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7188576|NCT02891226|11388862|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7047057|NCT01783743|11134872|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439
7047058|NCT01783743|11134871|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591
7047059|NCT01783743|11134872|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684
7047060|NCT01783743|11134871|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305
7047061|NCT01783743|11134872|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236
7047062|NCT01783821|11134880|FG000|Overall Study|Screen Failure|1
7047063|NCT01783821|11134881|FG001|Overall Study|Screen Failure|1
7047064|NCT01783886|11134915|FG000|Overall Study|Lost to Follow-up|0
7047065|NCT01783886|11134916|FG001|Overall Study|Lost to Follow-up|3
7047066|NCT01783886|11134917|FG002|Overall Study|Lost to Follow-up|0
7047067|NCT01783886|11134915|FG000|Overall Study|Protocol deviation|0
7047068|NCT01783886|11134916|FG001|Overall Study|Protocol deviation|0
7047069|NCT01783886|11134917|FG002|Overall Study|Protocol deviation|2
7047070|NCT01783886|11134915|FG000|Overall Study|Withdrawal of consent by participant|1
7047071|NCT01783886|11134916|FG001|Overall Study|Withdrawal of consent by participant|3
7047072|NCT01783886|11134917|FG002|Overall Study|Withdrawal of consent by participant|4
7047073|NCT01783886|11134915|FG000|Overall Study|Adverse Event|4
7047074|NCT01783886|11134916|FG001|Overall Study|Adverse Event|5
7047075|NCT01783886|11134917|FG002|Overall Study|Adverse Event|4
7047076|NCT01783938|11134940|FG000|Overall Study|Disease Progression|18
7047077|NCT01783938|11134941|FG001|Overall Study|Disease Progression|41
7047078|NCT01783938|11134940|FG000|Overall Study|Study Drug Toxicity|27
7047079|NCT01783938|11134941|FG001|Overall Study|Study Drug Toxicity|14
7047080|NCT01783938|11134940|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4
7047081|NCT01783938|11134941|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2
7047082|NCT01783938|11134940|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2
7047083|NCT01783938|11134941|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3
7047084|NCT01783938|11134940|FG000|Overall Study|Participant Withdrew Consent|2
7047085|NCT01783938|11134941|FG001|Overall Study|Participant Withdrew Consent|0
7047086|NCT01783938|11134940|FG000|Overall Study|Maximum Clinical Benefit|1
7047087|NCT01783938|11134941|FG001|Overall Study|Maximum Clinical Benefit|0
7047088|NCT01783938|11134940|FG000|Overall Study|Other Reasons|3
7047089|NCT01783938|11134941|FG001|Overall Study|Other Reasons|1
7047090|NCT01784029|11134961|FG000|Overall Study|Lost to Follow-up|19
7047091|NCT01784029|11134962|FG001|Overall Study|Lost to Follow-up|20
7047092|NCT01784029|11134963|FG002|Overall Study|Lost to Follow-up|22
7047093|NCT01784068|11134975|FG000|NTCS Phase|Adverse Event|5
7047094|NCT01784068|11134976|FG001|NTCS Phase|Adverse Event|0
7047095|NCT01784068|11134975|FG000|NTCS Phase|Physician Decision|2
7047096|NCT01784068|11134976|FG001|NTCS Phase|Physician Decision|0
7047097|NCT01784068|11134975|FG000|NTCS Phase|Patient/guardian decision|3
7047098|NCT01784068|11134976|FG001|NTCS Phase|Patient/guardian decision|0
7047099|NCT01784068|11134975|FG000|NTCS Phase|Death|2
7047100|NCT01784068|11134976|FG001|NTCS Phase|Death|0
7047101|NCT01784068|11134975|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203
7047102|NCT01784068|11134976|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0
7047103|NCT01784068|11134975|FG000|TFR Phase|Physician Decision|0
7047104|NCT01784068|11134976|FG001|TFR Phase|Physician Decision|1
7047105|NCT01784068|11134975|FG000|TFR Phase|Patient/guardian decision|0
7047106|NCT01784068|11134976|FG001|TFR Phase|Patient/guardian decision|3
7047107|NCT01784068|11134975|FG000|TFR Phase|Death|0
7047108|NCT01784068|11134976|FG001|TFR Phase|Death|1
7047109|NCT01784068|11134975|FG000|TFR Phase|Lack of Efficacy|0
7047110|NCT01784068|11134976|FG001|TFR Phase|Lack of Efficacy|88
7047111|NCT01784211|11134989|FG000|Part A (Days 1-15)|Adverse Event|1
7047112|NCT01784211|11134990|FG001|Part A (Days 1-15)|Adverse Event|1
7047113|NCT01784211|11134991|FG002|Part A (Days 1-15)|Adverse Event|0
7047114|NCT01784211|11134992|FG003|Part A (Days 1-15)|Adverse Event|0
7047115|NCT01784211|11134993|FG004|Part A (Days 1-15)|Adverse Event|0
7047116|NCT01784211|11134994|FG005|Part A (Days 1-15)|Adverse Event|0
7047117|NCT01784211|11134989|FG000|Part A (Days 1-15)|Withdrawal by Subject|2
7047118|NCT01784211|11134990|FG001|Part A (Days 1-15)|Withdrawal by Subject|1
7047119|NCT01784211|11134991|FG002|Part A (Days 1-15)|Withdrawal by Subject|0
7047120|NCT01784211|11134992|FG003|Part A (Days 1-15)|Withdrawal by Subject|0
7047121|NCT01784211|11134993|FG004|Part A (Days 1-15)|Withdrawal by Subject|0
7047122|NCT01784211|11134994|FG005|Part A (Days 1-15)|Withdrawal by Subject|0
7047123|NCT01784419|11135006|FG000|Overall Study|Adverse Event|3
7047124|NCT01784523|11135012|FG000|Overall Study|Study closed early|7
7047125|NCT01784523|11135013|FG001|Overall Study|Study closed early|4
7047126|NCT01784861|11135088|FG000|Overall Study|Adverse Event|0
7047127|NCT01784861|11135089|FG001|Overall Study|Adverse Event|0
7047128|NCT01784861|11135090|FG002|Overall Study|Adverse Event|1
7047129|NCT01784861|11135091|FG003|Overall Study|Adverse Event|2
7047130|NCT01784861|11135092|FG004|Overall Study|Adverse Event|1
7047131|NCT01784861|11135093|FG005|Overall Study|Adverse Event|0
7047132|NCT01784861|11135088|FG000|Overall Study|Withdrawal by Subject|0
7047133|NCT01784861|11135089|FG001|Overall Study|Withdrawal by Subject|0
7047134|NCT01784861|11135090|FG002|Overall Study|Withdrawal by Subject|0
7047135|NCT01784861|11135091|FG003|Overall Study|Withdrawal by Subject|1
7047136|NCT01784861|11135092|FG004|Overall Study|Withdrawal by Subject|0
7047137|NCT01784861|11135093|FG005|Overall Study|Withdrawal by Subject|0
7047138|NCT01784861|11135088|FG000|Overall Study|Physician Decision|0
7047139|NCT01784861|11135089|FG001|Overall Study|Physician Decision|0
7047140|NCT01784861|11135090|FG002|Overall Study|Physician Decision|0
7047141|NCT01784861|11135091|FG003|Overall Study|Physician Decision|2
7047142|NCT01784861|11135092|FG004|Overall Study|Physician Decision|0
7047143|NCT01784861|11135093|FG005|Overall Study|Physician Decision|1
7047144|NCT01784965|11135120|FG000|Overall Study|Withdrawal by Subject|6
7047145|NCT01784965|11135121|FG001|Overall Study|Withdrawal by Subject|3
7047146|NCT01784965|11135120|FG000|Overall Study|Adverse Event|0
7047147|NCT01784965|11135121|FG001|Overall Study|Adverse Event|8
7047148|NCT01785069|11135133|FG000|Overall Study|Implanted with nonstudy device|1
7047149|NCT01785069|11135134|FG001|Overall Study|Implanted with nonstudy device|2
7047150|NCT01785069|11135135|FG002|Overall Study|Implanted with nonstudy device|1
7047151|NCT01785069|11135136|FG003|Overall Study|Implanted with nonstudy device|0
7047152|NCT01785069|11135133|FG000|Overall Study|Death|0
7047153|NCT01785069|11135134|FG001|Overall Study|Death|0
7047154|NCT01785069|11135135|FG002|Overall Study|Death|2
7047155|NCT01785069|11135136|FG003|Overall Study|Death|0
7047156|NCT01785069|11135133|FG000|Overall Study|Subject choice|2
7047157|NCT01785069|11135134|FG001|Overall Study|Subject choice|2
7047158|NCT01785069|11135135|FG002|Overall Study|Subject choice|0
7047159|NCT01785069|11135136|FG003|Overall Study|Subject choice|1
7047160|NCT01785069|11135133|FG000|Overall Study|Lost to Follow-up|1
7047161|NCT01785069|11135134|FG001|Overall Study|Lost to Follow-up|2
7047162|NCT01785069|11135135|FG002|Overall Study|Lost to Follow-up|4
7047163|NCT01785069|11135136|FG003|Overall Study|Lost to Follow-up|1
7047164|NCT01785069|11135133|FG000|Overall Study|Reason not Specified|1
7047165|NCT01785069|11135134|FG001|Overall Study|Reason not Specified|2
7047166|NCT01785069|11135135|FG002|Overall Study|Reason not Specified|1
7047167|NCT01785069|11135136|FG003|Overall Study|Reason not Specified|4
7047168|NCT01785069|11135133|FG000|Overall Study|Not evaluable|7
7047169|NCT01785069|11135134|FG001|Overall Study|Not evaluable|4
7047170|NCT01785069|11135135|FG002|Overall Study|Not evaluable|5
7047171|NCT01785069|11135136|FG003|Overall Study|Not evaluable|8
7047172|NCT01785160|11135162|FG000|Treatment Period 1: Raltegravir|Not treated|1
7047173|NCT01785160|11135162|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1
7083263|NCT02151682|11194299|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1
7083264|NCT02151682|11194300|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0
7083265|NCT02151682|11194301|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0
7083266|NCT02151682|11194302|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0
7083267|NCT02151682|11194297|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0
7083268|NCT02151682|11194298|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0
7083269|NCT02151682|11194299|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13
7083270|NCT02151682|11194300|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0
7083271|NCT02151682|11194301|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0
7083272|NCT02151682|11194302|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0
7083273|NCT02151682|11194297|FG000|Part 2: Tapent. Extension or Observation|Missing|0
7083274|NCT02151682|11194298|FG001|Part 2: Tapent. Extension or Observation|Missing|0
7083275|NCT02151682|11194299|FG002|Part 2: Tapent. Extension or Observation|Missing|0
7083276|NCT02151682|11194300|FG003|Part 2: Tapent. Extension or Observation|Missing|1
7083277|NCT02151682|11194301|FG004|Part 2: Tapent. Extension or Observation|Missing|0
7083278|NCT02151682|11194302|FG005|Part 2: Tapent. Extension or Observation|Missing|0
7083279|NCT02151682|11194297|FG000|Part 2: Tapent. Extension or Observation|Various other|0
7188577|NCT02891226|11388863|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7188578|NCT02891226|11388864|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7188579|NCT02891226|11388865|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7188580|NCT02891226|11388866|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7188581|NCT02891226|11388867|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1
7188582|NCT02891226|11388868|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7188583|NCT02891226|11388869|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7188584|NCT02891226|11388870|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7188585|NCT02891226|11388871|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7188586|NCT02891226|11388872|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7188587|NCT02891226|11388873|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7083280|NCT02151682|11194298|FG001|Part 2: Tapent. Extension or Observation|Various other|0
7083281|NCT02151682|11194299|FG002|Part 2: Tapent. Extension or Observation|Various other|6
7083282|NCT02151682|11194300|FG003|Part 2: Tapent. Extension or Observation|Various other|0
7083283|NCT02151682|11194301|FG004|Part 2: Tapent. Extension or Observation|Various other|0
7047174|NCT01785472|11135203|FG000|Overall Study|Adverse Event|5
7047175|NCT01785472|11135204|FG001|Overall Study|Adverse Event|4
7047176|NCT01785472|11135205|FG002|Overall Study|Adverse Event|6
7047177|NCT01785472|11135203|FG000|Overall Study|Lack of Efficacy|2
7047178|NCT01785472|11135204|FG001|Overall Study|Lack of Efficacy|0
7047179|NCT01785472|11135205|FG002|Overall Study|Lack of Efficacy|1
7047180|NCT01785472|11135203|FG000|Overall Study|Lost to Follow-up|1
7047181|NCT01785472|11135204|FG001|Overall Study|Lost to Follow-up|2
7047182|NCT01785472|11135205|FG002|Overall Study|Lost to Follow-up|0
7047183|NCT01785472|11135203|FG000|Overall Study|Physician Decision|1
7047184|NCT01785472|11135204|FG001|Overall Study|Physician Decision|1
7047185|NCT01785472|11135205|FG002|Overall Study|Physician Decision|1
7047186|NCT01785472|11135203|FG000|Overall Study|Protocol deviation|0
7047187|NCT01785472|11135204|FG001|Overall Study|Protocol deviation|2
7047188|NCT01785472|11135205|FG002|Overall Study|Protocol deviation|2
7047189|NCT01785472|11135203|FG000|Overall Study|Subject/guardian decision|15
7047190|NCT01785472|11135204|FG001|Overall Study|Subject/guardian decision|10
7047191|NCT01785472|11135205|FG002|Overall Study|Subject/guardian decision|11
7047192|NCT01785472|11135203|FG000|Overall Study|Technical problems|0
7047193|NCT01785472|11135204|FG001|Overall Study|Technical problems|0
7047194|NCT01785472|11135205|FG002|Overall Study|Technical problems|1
7047195|NCT01785524|11135217|FG000|Overall Study|Withdrawal by Subject|2
7047196|NCT01785524|11135218|FG001|Overall Study|Withdrawal by Subject|2
7047197|NCT01785602|11135226|FG000|Overall Study|Withdrawal by Subject|2
7047198|NCT01785602|11135227|FG001|Overall Study|Withdrawal by Subject|0
7047199|NCT01785602|11135226|FG000|Overall Study|Lost to Follow-up|1
7047200|NCT01785602|11135227|FG001|Overall Study|Lost to Follow-up|1
7047201|NCT01785602|11135226|FG000|Overall Study|Adverse Event|3
7047202|NCT01785602|11135227|FG001|Overall Study|Adverse Event|5
7047203|NCT01785602|11135226|FG000|Overall Study|Administrative problems|7
7047204|NCT01785602|11135227|FG001|Overall Study|Administrative problems|3
7047205|NCT01785615|11135236|FG000|Dietary Phase|Lost to Follow-up|0
7047206|NCT01785615|11135237|FG001|Dietary Phase|Lost to Follow-up|0
7047207|NCT01785615|11135238|FG002|Dietary Phase|Lost to Follow-up|0
7047208|NCT01785615|11135239|FG003|Dietary Phase|Lost to Follow-up|24
7047209|NCT01785628|11135253|FG000|Overall Study|Lost to Follow-up|2
7047210|NCT01785628|11135254|FG001|Overall Study|Lost to Follow-up|3
7047211|NCT01785849|11135275|FG000|Overall Study|Death|7
7047212|NCT01785849|11135276|FG001|Overall Study|Death|9
7047213|NCT01785849|11135275|FG000|Overall Study|Protocol Specified Criteria|29
7047214|NCT01785849|11135276|FG001|Overall Study|Protocol Specified Criteria|1
7047215|NCT01785849|11135275|FG000|Overall Study|Withdrawal by Subject|15
7047216|NCT01785849|11135276|FG001|Overall Study|Withdrawal by Subject|12
7047217|NCT01785849|11135275|FG000|Overall Study|Sponsor Decision|0
7047218|NCT01785849|11135276|FG001|Overall Study|Sponsor Decision|1
7047219|NCT01785849|11135275|FG000|Overall Study|Lost to Follow-up|10
7047220|NCT01785849|11135276|FG001|Overall Study|Lost to Follow-up|11
7047221|NCT01785875|11135282|FG000|Overall Study|Withdrawal by Subject|41
7047222|NCT01785875|11135283|FG001|Overall Study|Withdrawal by Subject|34
7047223|NCT01785875|11135284|FG002|Overall Study|Withdrawal by Subject|36
7047224|NCT01785875|11135282|FG000|Overall Study|Lost to Follow-up|19
7047225|NCT01785875|11135283|FG001|Overall Study|Lost to Follow-up|22
7047226|NCT01785875|11135284|FG002|Overall Study|Lost to Follow-up|6
7047227|NCT01785875|11135282|FG000|Overall Study|Death|27
7047228|NCT01785875|11135283|FG001|Overall Study|Death|16
7047229|NCT01785875|11135284|FG002|Overall Study|Death|7
7047230|NCT01785875|11135282|FG000|Overall Study|Sponsor Decision|0
7047231|NCT01785875|11135283|FG001|Overall Study|Sponsor Decision|2
7047232|NCT01785875|11135284|FG002|Overall Study|Sponsor Decision|0
7047233|NCT01785875|11135282|FG000|Overall Study|Protocol Specified Criteria|207
7047234|NCT01785875|11135283|FG001|Overall Study|Protocol Specified Criteria|214
7047235|NCT01785875|11135284|FG002|Overall Study|Protocol Specified Criteria|55
7047236|NCT01785875|11135282|FG000|Overall Study|Missing|0
7047237|NCT01785875|11135283|FG001|Overall Study|Missing|1
7047238|NCT01785875|11135284|FG002|Overall Study|Missing|3
7047239|NCT01786109|11135298|FG000|Overall Study|fail manometry barostat tube placement|1
7047240|NCT01786109|11135299|FG001|Overall Study|fail manometry barostat tube placement|0
7047241|NCT01786109|11135300|FG002|Overall Study|fail manometry barostat tube placement|0
7047242|NCT01786109|11135298|FG000|Overall Study|unrelated illness|0
7047243|NCT01786109|11135299|FG001|Overall Study|unrelated illness|0
7047244|NCT01786109|11135300|FG002|Overall Study|unrelated illness|1
7047245|NCT01786109|11135298|FG000|Overall Study|adverse effects colon preparation|0
7047246|NCT01786109|11135299|FG001|Overall Study|adverse effects colon preparation|0
7047247|NCT01786109|11135300|FG002|Overall Study|adverse effects colon preparation|1
7047248|NCT01786148|11135310|FG000|Overall Study|Lost to Follow-up|21
7047249|NCT01786148|11135311|FG001|Overall Study|Lost to Follow-up|13
7047250|NCT01786148|11135310|FG000|Overall Study|Death|0
7047251|NCT01786148|11135311|FG001|Overall Study|Death|1
7047252|NCT01786148|11135310|FG000|Overall Study|Withdrawal by Subject|0
7047253|NCT01786148|11135311|FG001|Overall Study|Withdrawal by Subject|7
7047254|NCT01786148|11135310|FG000|Overall Study|Incarceration|1
7047255|NCT01786148|11135311|FG001|Overall Study|Incarceration|1
7047256|NCT01786174|11135330|FG000|Overall Study|Discontinued Study Drug|2
7047257|NCT01786174|11135331|FG001|Overall Study|Discontinued Study Drug|0
7047258|NCT01786330|11135369|FG000|Overall Study|Withdrawal by Subject|0
7047259|NCT01786330|11135370|FG001|Overall Study|Withdrawal by Subject|1
7047260|NCT01786330|11135369|FG000|Overall Study|Lost to Follow-up|0
7047261|NCT01786330|11135370|FG001|Overall Study|Lost to Follow-up|1
7047262|NCT01786330|11135369|FG000|Overall Study|Excluded intraoperatively|0
7047263|NCT01786330|11135370|FG001|Overall Study|Excluded intraoperatively|1
7047264|NCT01786330|11135369|FG000|Overall Study|Protocol Violation|1
7047265|NCT01786330|11135370|FG001|Overall Study|Protocol Violation|0
7047266|NCT01786512|11135396|FG000|Overall Study|Lost to Follow-up|0
7047267|NCT01786512|11135397|FG001|Overall Study|Lost to Follow-up|0
7047268|NCT01786512|11135398|FG002|Overall Study|Lost to Follow-up|0
7047269|NCT01786512|11135399|FG003|Overall Study|Lost to Follow-up|0
7047270|NCT01786512|11135400|FG004|Overall Study|Lost to Follow-up|0
7047271|NCT01786512|11135401|FG005|Overall Study|Lost to Follow-up|0
7047272|NCT01786512|11135402|FG006|Overall Study|Lost to Follow-up|0
7047273|NCT01786512|11135403|FG007|Overall Study|Lost to Follow-up|0
7047274|NCT01786512|11135404|FG008|Overall Study|Lost to Follow-up|0
7047275|NCT01786512|11135405|FG009|Overall Study|Lost to Follow-up|1
7047276|NCT01786512|11135406|FG010|Overall Study|Lost to Follow-up|0
7047277|NCT01786512|11135396|FG000|Overall Study|Decision by sponsor|0
7047278|NCT01786512|11135397|FG001|Overall Study|Decision by sponsor|0
7047279|NCT01786512|11135398|FG002|Overall Study|Decision by sponsor|0
7047280|NCT01786512|11135399|FG003|Overall Study|Decision by sponsor|0
7047281|NCT01786512|11135400|FG004|Overall Study|Decision by sponsor|0
7047282|NCT01786512|11135401|FG005|Overall Study|Decision by sponsor|0
7047283|NCT01786512|11135402|FG006|Overall Study|Decision by sponsor|0
7047284|NCT01786512|11135403|FG007|Overall Study|Decision by sponsor|0
7047285|NCT01786512|11135404|FG008|Overall Study|Decision by sponsor|0
7047286|NCT01786512|11135405|FG009|Overall Study|Decision by sponsor|0
7047287|NCT01786512|11135406|FG010|Overall Study|Decision by sponsor|2
7047288|NCT01786512|11135396|FG000|Overall Study|Withdrawal by Subject|0
7047289|NCT01786512|11135397|FG001|Overall Study|Withdrawal by Subject|1
7047290|NCT01786512|11135398|FG002|Overall Study|Withdrawal by Subject|0
7047291|NCT01786512|11135399|FG003|Overall Study|Withdrawal by Subject|0
7047292|NCT01786512|11135400|FG004|Overall Study|Withdrawal by Subject|0
7047293|NCT01786512|11135401|FG005|Overall Study|Withdrawal by Subject|0
7047294|NCT01786512|11135402|FG006|Overall Study|Withdrawal by Subject|1
7047295|NCT01786512|11135403|FG007|Overall Study|Withdrawal by Subject|0
7047296|NCT01786512|11135404|FG008|Overall Study|Withdrawal by Subject|0
7188588|NCT02891226|11388858|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0
7188589|NCT02891226|11388859|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0
7188590|NCT02891226|11388860|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0
7188591|NCT02891226|11388861|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0
7047297|NCT01786512|11135405|FG009|Overall Study|Withdrawal by Subject|3
7047298|NCT01786512|11135406|FG010|Overall Study|Withdrawal by Subject|7
7047299|NCT01786512|11135396|FG000|Overall Study|Death|0
7047300|NCT01786512|11135397|FG001|Overall Study|Death|0
7047301|NCT01786512|11135398|FG002|Overall Study|Death|0
7047302|NCT01786512|11135399|FG003|Overall Study|Death|0
7047303|NCT01786512|11135400|FG004|Overall Study|Death|0
7047304|NCT01786512|11135401|FG005|Overall Study|Death|0
7047305|NCT01786512|11135402|FG006|Overall Study|Death|0
7047306|NCT01786512|11135403|FG007|Overall Study|Death|0
7047307|NCT01786512|11135404|FG008|Overall Study|Death|4
7047308|NCT01786512|11135405|FG009|Overall Study|Death|1
7047309|NCT01786512|11135406|FG010|Overall Study|Death|3
7047310|NCT01786551|11135438|FG000|Overall Study|Participant withdrew consent|2
7047311|NCT01786564|11135442|FG000|Overall Study|Lost to Follow-up|47
7047312|NCT01786564|11135442|FG000|Overall Study|Ineligible|17
7047313|NCT01786603|11135448|FG000|Overall Study|Death|5
7188592|NCT02891226|11388862|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0
7188593|NCT02891226|11388863|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0
7188594|NCT02891226|11388864|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0
7188595|NCT02891226|11388865|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0
7188596|NCT02891226|11388866|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0
7188597|NCT02891226|11388867|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0
7188598|NCT02891226|11388868|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5
7188599|NCT02891226|11388869|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0
7188600|NCT02891226|11388870|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0
7188601|NCT02891226|11388871|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0
7188602|NCT02891226|11388872|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0
7188603|NCT02891226|11388873|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0
7047314|NCT01786603|11135449|FG001|Overall Study|Death|1
7047315|NCT01786603|11135448|FG000|Overall Study|Adverse Event|6
7047316|NCT01786603|11135449|FG001|Overall Study|Adverse Event|2
7047317|NCT01786603|11135448|FG000|Overall Study|Physician decision to withdraw|6
7047318|NCT01786603|11135449|FG001|Overall Study|Physician decision to withdraw|7
7047319|NCT01786603|11135448|FG000|Overall Study|Lost to Follow-up|1
7047320|NCT01786603|11135449|FG001|Overall Study|Lost to Follow-up|2
7188604|NCT02891226|11388858|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7047321|NCT01786629|11135457|FG000|Overall Study|Lack of Efficacy|0
7047322|NCT01786629|11135458|FG001|Overall Study|Lack of Efficacy|4
7047323|NCT01786629|11135457|FG000|Overall Study|Adverse Event|0
7047324|NCT01786629|11135458|FG001|Overall Study|Adverse Event|1
7047325|NCT01786668|11135468|FG000|Overall Study|Adverse Event|0
7047326|NCT01786668|11135469|FG001|Overall Study|Adverse Event|1
7047327|NCT01786668|11135470|FG002|Overall Study|Adverse Event|1
7047328|NCT01786668|11135471|FG003|Overall Study|Adverse Event|2
7047329|NCT01786668|11135468|FG000|Overall Study|Withdrawal by Subject|0
7047330|NCT01786668|11135469|FG001|Overall Study|Withdrawal by Subject|0
7047331|NCT01786668|11135470|FG002|Overall Study|Withdrawal by Subject|3
7047332|NCT01786668|11135471|FG003|Overall Study|Withdrawal by Subject|1
7047333|NCT01786668|11135468|FG000|Overall Study|Pregnancy|0
7047334|NCT01786668|11135469|FG001|Overall Study|Pregnancy|0
7047335|NCT01786668|11135470|FG002|Overall Study|Pregnancy|0
7047336|NCT01786668|11135471|FG003|Overall Study|Pregnancy|1
7047337|NCT01786668|11135468|FG000|Overall Study|Lost to Follow-up|1
7047338|NCT01786668|11135469|FG001|Overall Study|Lost to Follow-up|0
7047339|NCT01786668|11135470|FG002|Overall Study|Lost to Follow-up|1
7047340|NCT01786668|11135471|FG003|Overall Study|Lost to Follow-up|0
7047341|NCT01786707|11135483|FG000|Overall Study|Lost to Follow-up|1
7047342|NCT01786707|11135484|FG001|Overall Study|Lost to Follow-up|1
7047343|NCT01786993|11135525|FG000|Overall Study|Death|6
7047344|NCT01786993|11135526|FG001|Overall Study|Death|7
7047345|NCT01786993|11135525|FG000|Overall Study|Withdrawal by Subject|3
7047346|NCT01786993|11135526|FG001|Overall Study|Withdrawal by Subject|2
7047347|NCT01786993|11135525|FG000|Overall Study|Lost to Follow-up|0
7047348|NCT01786993|11135526|FG001|Overall Study|Lost to Follow-up|1
7047349|NCT01786993|11135525|FG000|Overall Study|Subject Non-Compliance|1
7083284|NCT02151682|11194302|FG005|Part 2: Tapent. Extension or Observation|Various other|0
7083285|NCT02151682|11194297|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
7083286|NCT02151682|11194298|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
7083287|NCT02151682|11194299|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1
7083288|NCT02151682|11194300|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
7083289|NCT02151682|11194301|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
7083290|NCT02151682|11194302|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
7083291|NCT02151682|11194297|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
7083292|NCT02151682|11194298|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
7083293|NCT02151682|11194299|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
7083294|NCT02151682|11194300|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
7083295|NCT02151682|11194301|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
7083296|NCT02151682|11194302|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1
7083297|NCT02151682|11194297|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0
7083298|NCT02151682|11194298|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0
7083299|NCT02151682|11194299|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0
7047350|NCT01786993|11135526|FG001|Overall Study|Subject Non-Compliance|0
7047351|NCT01786993|11135525|FG000|Overall Study|System Explant|1
7047352|NCT01786993|11135526|FG001|Overall Study|System Explant|0
7047353|NCT01786993|11135525|FG000|Overall Study|Hospice Admission|1
7047354|NCT01786993|11135526|FG001|Overall Study|Hospice Admission|0
7047355|NCT01787032|11135548|FG000|Overall Study|Protocol Violation|0
7047356|NCT01787032|11135549|FG001|Overall Study|Protocol Violation|0
7047357|NCT01787032|11135550|FG002|Overall Study|Protocol Violation|0
7047358|NCT01787032|11135551|FG003|Overall Study|Protocol Violation|0
7047359|NCT01787032|11135552|FG004|Overall Study|Protocol Violation|1
7047360|NCT01787032|11135553|FG005|Overall Study|Protocol Violation|1
7047361|NCT01787097|11135563|FG000|Overall Study|Withdrawal by Subject|1
7047362|NCT01787097|11135564|FG001|Overall Study|Withdrawal by Subject|0
7047363|NCT01787097|11135565|FG002|Overall Study|Withdrawal by Subject|0
7047364|NCT01787097|11135566|FG003|Overall Study|Withdrawal by Subject|0
7047365|NCT01787188|11135598|FG000|Overall Study|Adverse Event|2
7047366|NCT01787188|11135599|FG001|Overall Study|Adverse Event|4
7047367|NCT01787188|11135600|FG002|Overall Study|Adverse Event|6
7047368|NCT01787188|11135598|FG000|Overall Study|Lack of Efficacy|7
7047369|NCT01787188|11135599|FG001|Overall Study|Lack of Efficacy|3
7047370|NCT01787188|11135600|FG002|Overall Study|Lack of Efficacy|5
7047371|NCT01787188|11135598|FG000|Overall Study|Non-compliance with Study Drug|0
7047372|NCT01787188|11135599|FG001|Overall Study|Non-compliance with Study Drug|1
7047373|NCT01787188|11135600|FG002|Overall Study|Non-compliance with Study Drug|0
7047374|NCT01787188|11135598|FG000|Overall Study|Withdrawal by Subject|4
7047375|NCT01787188|11135599|FG001|Overall Study|Withdrawal by Subject|3
7047376|NCT01787188|11135600|FG002|Overall Study|Withdrawal by Subject|2
7047377|NCT01787188|11135598|FG000|Overall Study|Protocol Violation|3
7047378|NCT01787188|11135599|FG001|Overall Study|Protocol Violation|2
7047379|NCT01787188|11135600|FG002|Overall Study|Protocol Violation|3
7047380|NCT01787188|11135598|FG000|Overall Study|Lost to Follow-up|1
7047381|NCT01787188|11135599|FG001|Overall Study|Lost to Follow-up|2
7047382|NCT01787188|11135600|FG002|Overall Study|Lost to Follow-up|2
7047383|NCT01787188|11135598|FG000|Overall Study|Other, including patient moved|0
7047384|NCT01787188|11135599|FG001|Overall Study|Other, including patient moved|3
7047385|NCT01787188|11135600|FG002|Overall Study|Other, including patient moved|0
7047386|NCT01787279|11135620|FG000|Overall Study|Lost to Follow-up|2
7047387|NCT01787279|11135620|FG000|Overall Study|Lack of Efficacy|1
7047388|NCT01787292|11135624|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2
7047389|NCT01787292|11135625|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2
7047390|NCT01787292|11135624|FG000|Home Based Exercise Program|Withdrawal by Subject|3
7047391|NCT01787292|11135625|FG001|Home Based Exercise Program|Withdrawal by Subject|1
7047392|NCT01787331|11135636|FG000|Overall Study|Physician Decision|1
7047393|NCT01787331|11135636|FG000|Overall Study|Withdrawal by Subject|1
7047394|NCT01787461|11135659|FG000|Overall Study|Adverse Event|4
7047395|NCT01787461|11135660|FG001|Overall Study|Adverse Event|3
7047396|NCT01787461|11135659|FG000|Overall Study|Lost to Follow-up|3
7047397|NCT01787461|11135660|FG001|Overall Study|Lost to Follow-up|2
7047398|NCT01787461|11135659|FG000|Overall Study|No longer met eligibility criteria|1
7047399|NCT01787461|11135660|FG001|Overall Study|No longer met eligibility criteria|0
7047400|NCT01787461|11135659|FG000|Overall Study|Withdrawal by Subject|3
7047401|NCT01787461|11135660|FG001|Overall Study|Withdrawal by Subject|4
7047402|NCT01787461|11135659|FG000|Overall Study|Protocol Violation|3
7047403|NCT01787461|11135660|FG001|Overall Study|Protocol Violation|0
7047404|NCT01787591|11135668|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
7047405|NCT01787591|11135669|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
7047406|NCT01787591|11135670|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
7047407|NCT01787591|11135671|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1
7047408|NCT01787760|11135694|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1
7047409|NCT01787760|11135695|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0
7047410|NCT01787760|11135696|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0
7047411|NCT01787760|11135694|FG000|Overall Study|Decompensated on left exotropia|0
7047412|NCT01787760|11135695|FG001|Overall Study|Decompensated on left exotropia|0
7047413|NCT01787760|11135696|FG002|Overall Study|Decompensated on left exotropia|1
7047414|NCT01787760|11135694|FG000|Overall Study|Dryness|0
7047415|NCT01787760|11135695|FG001|Overall Study|Dryness|1
7083300|NCT02151682|11194300|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0
7083301|NCT02151682|11194301|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0
7083302|NCT02151682|11194302|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1
7083303|NCT02151682|11194297|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0
7047416|NCT01787760|11135696|FG002|Overall Study|Dryness|0
7047417|NCT01787760|11135694|FG000|Overall Study|Relocation|1
7047418|NCT01787760|11135695|FG001|Overall Study|Relocation|1
7047419|NCT01787760|11135696|FG002|Overall Study|Relocation|0
7047420|NCT01787760|11135694|FG000|Overall Study|Lens discomfort|3
7047421|NCT01787760|11135695|FG001|Overall Study|Lens discomfort|0
7047422|NCT01787760|11135696|FG002|Overall Study|Lens discomfort|0
7047423|NCT01787760|11135694|FG000|Overall Study|Lens handling difficulty|1
7047424|NCT01787760|11135695|FG001|Overall Study|Lens handling difficulty|2
7047425|NCT01787760|11135696|FG002|Overall Study|Lens handling difficulty|0
7047426|NCT01787760|11135694|FG000|Overall Study|Protocol Violation|6
7047427|NCT01787760|11135695|FG001|Overall Study|Protocol Violation|0
7047428|NCT01787760|11135696|FG002|Overall Study|Protocol Violation|1
7047429|NCT01787760|11135694|FG000|Overall Study|Withdrawal by Subject|5
7047430|NCT01787760|11135695|FG001|Overall Study|Withdrawal by Subject|1
7047431|NCT01787760|11135696|FG002|Overall Study|Withdrawal by Subject|2
7047432|NCT01787760|11135694|FG000|Overall Study|Lost to Follow-up|1
7047433|NCT01787760|11135695|FG001|Overall Study|Lost to Follow-up|0
7047434|NCT01787760|11135696|FG002|Overall Study|Lost to Follow-up|1
7047435|NCT01787760|11135694|FG000|Overall Study|Stroke|1
7047436|NCT01787760|11135695|FG001|Overall Study|Stroke|0
7047437|NCT01787760|11135696|FG002|Overall Study|Stroke|0
7047438|NCT01787760|11135694|FG000|Overall Study|Unsatisfactory lens fitting performance|3
7047439|NCT01787760|11135695|FG001|Overall Study|Unsatisfactory lens fitting performance|6
7047440|NCT01787760|11135696|FG002|Overall Study|Unsatisfactory lens fitting performance|0
7047441|NCT01787760|11135694|FG000|Overall Study|Unsatisfactory physiological response|2
7047442|NCT01787760|11135695|FG001|Overall Study|Unsatisfactory physiological response|4
7047443|NCT01787760|11135696|FG002|Overall Study|Unsatisfactory physiological response|0
7047444|NCT01787760|11135694|FG000|Overall Study|Unsatisfactory visual response|1
7047445|NCT01787760|11135695|FG001|Overall Study|Unsatisfactory visual response|1
7047446|NCT01787760|11135696|FG002|Overall Study|Unsatisfactory visual response|0
7047447|NCT01787760|11135694|FG000|Overall Study|Near vision blur|1
7047448|NCT01787760|11135695|FG001|Overall Study|Near vision blur|0
7083304|NCT02151682|11194298|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0
7083305|NCT02151682|11194299|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0
7083306|NCT02151682|11194300|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0
7083307|NCT02151682|11194301|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0
7083308|NCT02151682|11194302|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3
7083309|NCT02151682|11194297|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0
7083310|NCT02151682|11194298|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0
7083311|NCT02151682|11194299|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0
7047449|NCT01787760|11135696|FG002|Overall Study|Near vision blur|0
7047450|NCT01787825|11135709|FG000|Overall Study|Subject Did Not Ingest Capsules|1
7047451|NCT01787825|11135710|FG001|Overall Study|Subject Did Not Ingest Capsules|0
7047452|NCT01787825|11135709|FG000|Overall Study|Data Not Analyzable|5
7047453|NCT01787825|11135710|FG001|Overall Study|Data Not Analyzable|1
7047454|NCT01787838|11135717|FG000|Overall Study|refused|1413
7047455|NCT01788046|11135730|FG000|Overall Study|Withdrawal by Subject|12
7083312|NCT02151682|11194300|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0
7047456|NCT01788046|11135731|FG001|Overall Study|Withdrawal by Subject|12
7047457|NCT01788046|11135730|FG000|Overall Study|Lost to Follow-up|12
7047458|NCT01788046|11135731|FG001|Overall Study|Lost to Follow-up|19
7047459|NCT01788046|11135730|FG000|Overall Study|Death|7
7047460|NCT01788046|11135731|FG001|Overall Study|Death|5
7047461|NCT01788046|11135730|FG000|Overall Study|Protocol Specified Criteria|25
7047462|NCT01788046|11135731|FG001|Overall Study|Protocol Specified Criteria|1
7047463|NCT01788163|11135755|FG000|Overall Study|Other|53
7047464|NCT01788163|11135756|FG001|Overall Study|Other|0
7047465|NCT01788163|11135757|FG002|Overall Study|Other|0
7047466|NCT01788163|11135758|FG003|Overall Study|Other|0
7047467|NCT01788163|11135759|FG004|Overall Study|Other|0
7047468|NCT01788163|11135760|FG005|Overall Study|Other|7
7047469|NCT01788163|11135761|FG006|Overall Study|Other|1
7047470|NCT01788163|11135762|FG007|Overall Study|Other|48
7047471|NCT01788163|11135763|FG008|Overall Study|Other|15
7047472|NCT01788163|11135755|FG000|Overall Study|Withdrawal by Subject|2
7047473|NCT01788163|11135756|FG001|Overall Study|Withdrawal by Subject|0
7047474|NCT01788163|11135757|FG002|Overall Study|Withdrawal by Subject|0
7047475|NCT01788163|11135758|FG003|Overall Study|Withdrawal by Subject|0
7047476|NCT01788163|11135759|FG004|Overall Study|Withdrawal by Subject|0
7047477|NCT01788163|11135760|FG005|Overall Study|Withdrawal by Subject|0
7047478|NCT01788163|11135761|FG006|Overall Study|Withdrawal by Subject|0
7047479|NCT01788163|11135762|FG007|Overall Study|Withdrawal by Subject|0
7047480|NCT01788163|11135763|FG008|Overall Study|Withdrawal by Subject|1
7047481|NCT01788215|11135844|FG000|Overall Study|Withdrawal by Subject|0
7047482|NCT01788215|11135845|FG001|Overall Study|Withdrawal by Subject|1
7047483|NCT01788215|11135844|FG000|Overall Study|Lost to Follow-up|2
7047484|NCT01788215|11135845|FG001|Overall Study|Lost to Follow-up|0
7047485|NCT01788228|11135853|FG000|Overall Study|Migrated/moved from study area|1
7047486|NCT01788228|11135854|FG001|Overall Study|Migrated/moved from study area|0
7047487|NCT01788358|11135863|FG000|Overall Study|Other|11
7047488|NCT01788358|11135863|FG000|Overall Study|Logistical difficulties|1
7047489|NCT01788358|11135863|FG000|Overall Study|Lost to Follow-up|5
7047490|NCT01788358|11135863|FG000|Overall Study|Protocol Violation|3
7047491|NCT01788358|11135863|FG000|Overall Study|Withdrawal by Subject|26
7047492|NCT01788358|11135863|FG000|Overall Study|Lack of Efficacy|1
7047493|NCT01788358|11135863|FG000|Overall Study|Adverse Event|51
7047494|NCT01788423|11135870|FG000|Overall Study|See Comments in Completed (above)|0
7047495|NCT01788423|11135871|FG001|Overall Study|See Comments in Completed (above)|4
7047496|NCT01788423|11135872|FG002|Overall Study|See Comments in Completed (above)|5
7047497|NCT01788566|11135880|FG000|Overall Study|Death|4
7047498|NCT01788566|11135880|FG000|Overall Study|Adverse Event|1
7047499|NCT01788566|11135880|FG000|Overall Study|Clinical Progressive Disease|3
7047500|NCT01788943|11135895|FG000|Overall Study|Withdrawal by Subject|1
7047501|NCT01788943|11135896|FG001|Overall Study|Withdrawal by Subject|0
7047502|NCT01789047|11135904|FG000|Overall Study|Adverse Event|3
7047503|NCT01789047|11135905|FG001|Overall Study|Adverse Event|2
7047504|NCT01789047|11135904|FG000|Overall Study|Withdrawal by Subject|1
7047505|NCT01789047|11135905|FG001|Overall Study|Withdrawal by Subject|2
7047506|NCT01789203|11135922|FG000|Overall Study|Adverse Event|2
7047507|NCT01789203|11135923|FG001|Overall Study|Adverse Event|2
7047508|NCT01789203|11135922|FG000|Overall Study|Withdrawal by Subject|1
7047509|NCT01789203|11135923|FG001|Overall Study|Withdrawal by Subject|0
7047510|NCT01789203|11135922|FG000|Overall Study|Death|1
7047511|NCT01789203|11135923|FG001|Overall Study|Death|0
7047512|NCT01789203|11135922|FG000|Overall Study|Protocol Violation|2
7047513|NCT01789203|11135923|FG001|Overall Study|Protocol Violation|1
7047514|NCT01789203|11135922|FG000|Overall Study|Other|1
7047515|NCT01789203|11135923|FG001|Overall Study|Other|1
7047516|NCT01789203|11135922|FG000|Overall Study|patient non-adherent|2
7047517|NCT01789203|11135923|FG001|Overall Study|patient non-adherent|0
7047518|NCT01789281|11135937|FG000|Overall Study|Disease progression|15
7047519|NCT01789281|11135938|FG001|Overall Study|Disease progression|4
7047520|NCT01789281|11135937|FG000|Overall Study|Adverse Event|5
7047521|NCT01789281|11135938|FG001|Overall Study|Adverse Event|5
7047522|NCT01789281|11135937|FG000|Overall Study|Withdrawal by Subject|1
7047523|NCT01789281|11135938|FG001|Overall Study|Withdrawal by Subject|0
7047524|NCT01789281|11135937|FG000|Overall Study|Lost to Follow-up|1
7047525|NCT01789281|11135938|FG001|Overall Study|Lost to Follow-up|0
7047526|NCT01789281|11135937|FG000|Overall Study|Administrative problems|0
7047527|NCT01789281|11135938|FG001|Overall Study|Administrative problems|1
7047528|NCT01789320|11135945|FG000|Overall Study|Re-enrolled into study|1
7047529|NCT01789320|11135945|FG000|Overall Study|Lost to Follow-up|1
7047530|NCT01789476|11135951|FG000|Overall Study|Lack of Efficacy|6
7047531|NCT01789476|11135952|FG001|Overall Study|Lack of Efficacy|2
7047532|NCT01789476|11135951|FG000|Overall Study|Adverse Event|1
7047533|NCT01789476|11135952|FG001|Overall Study|Adverse Event|0
7047534|NCT01789476|11135951|FG000|Overall Study|Unable to get IV access|1
7047535|NCT01789476|11135952|FG001|Overall Study|Unable to get IV access|0
7047536|NCT01789567|11135958|FG000|Overall Study|Death|6
7047537|NCT01789606|11135964|FG000|Overall Study|Participant not Purchased the Product|0
7047538|NCT01789606|11135965|FG001|Overall Study|Participant not Purchased the Product|20
7047539|NCT01789606|11135964|FG000|Overall Study|Withdrawal by Subject|0
7047540|NCT01789606|11135965|FG001|Overall Study|Withdrawal by Subject|1
7047541|NCT01789606|11135964|FG000|Overall Study|Ineligible|6
7047542|NCT01789606|11135965|FG001|Overall Study|Ineligible|2
7047543|NCT01789606|11135964|FG000|Overall Study|Administrative Reasons|17
7047544|NCT01789606|11135965|FG001|Overall Study|Administrative Reasons|6
7047545|NCT01789606|11135964|FG000|Overall Study|No Study Medication Taken|0
7047546|NCT01789606|11135965|FG001|Overall Study|No Study Medication Taken|1
7047547|NCT01789606|11135964|FG000|Overall Study|Protocol Violation|0
7047548|NCT01789606|11135965|FG001|Overall Study|Protocol Violation|55
7047549|NCT01789606|11135964|FG000|Overall Study|Adverse Event|0
7047550|NCT01789606|11135965|FG001|Overall Study|Adverse Event|3
7047551|NCT01789606|11135964|FG000|Overall Study|Lost to Follow-up|0
7047552|NCT01789606|11135965|FG001|Overall Study|Lost to Follow-up|14
7047553|NCT01789606|11135964|FG000|Overall Study|Ineligible or not Willing to Continue|0
7047554|NCT01789606|11135965|FG001|Overall Study|Ineligible or not Willing to Continue|348
7047555|NCT01789970|11136005|FG000|Open-label Titration Period|Adverse Event|68
7047556|NCT01789970|11136006|FG001|Open-label Titration Period|Adverse Event|0
7047557|NCT01789970|11136007|FG002|Open-label Titration Period|Adverse Event|0
7047558|NCT01789970|11136005|FG000|Open-label Titration Period|Lack of Efficacy|31
7047559|NCT01789970|11136006|FG001|Open-label Titration Period|Lack of Efficacy|0
7047560|NCT01789970|11136007|FG002|Open-label Titration Period|Lack of Efficacy|0
7047561|NCT01789970|11136005|FG000|Open-label Titration Period|Withdrawal by Subject|31
7047562|NCT01789970|11136006|FG001|Open-label Titration Period|Withdrawal by Subject|0
7047563|NCT01789970|11136007|FG002|Open-label Titration Period|Withdrawal by Subject|0
7047564|NCT01789970|11136005|FG000|Open-label Titration Period|Protocol Violation|18
7047565|NCT01789970|11136006|FG001|Open-label Titration Period|Protocol Violation|0
7047566|NCT01789970|11136007|FG002|Open-label Titration Period|Protocol Violation|0
7047567|NCT01789970|11136005|FG000|Open-label Titration Period|Lost to Follow-up|5
7047568|NCT01789970|11136006|FG001|Open-label Titration Period|Lost to Follow-up|0
7047569|NCT01789970|11136007|FG002|Open-label Titration Period|Lost to Follow-up|0
7047570|NCT01789970|11136005|FG000|Open-label Titration Period|Noncompliance to study drug admin|11
7047571|NCT01789970|11136006|FG001|Open-label Titration Period|Noncompliance to study drug admin|0
7047572|NCT01789970|11136007|FG002|Open-label Titration Period|Noncompliance to study drug admin|0
7047573|NCT01789970|11136005|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2
7047574|NCT01789970|11136006|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0
7047575|NCT01789970|11136007|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0
7047576|NCT01789970|11136005|FG000|Open-label Titration Period|Noncompliance with study procedures|8
7047577|NCT01789970|11136006|FG001|Open-label Titration Period|Noncompliance with study procedures|0
7047578|NCT01789970|11136007|FG002|Open-label Titration Period|Noncompliance with study procedures|0
7047579|NCT01789970|11136005|FG000|Open-label Titration Period|Pregnancy|2
7047580|NCT01789970|11136006|FG001|Open-label Titration Period|Pregnancy|0
7047581|NCT01789970|11136007|FG002|Open-label Titration Period|Pregnancy|0
7047582|NCT01789970|11136005|FG000|Open-label Titration Period|Other|76
7047583|NCT01789970|11136006|FG001|Open-label Titration Period|Other|0
7047584|NCT01789970|11136007|FG002|Open-label Titration Period|Other|0
7047585|NCT01789970|11136005|FG000|Open-label Titration Period|Dropped out prior to dosing|2
7047586|NCT01789970|11136006|FG001|Open-label Titration Period|Dropped out prior to dosing|0
7047587|NCT01789970|11136007|FG002|Open-label Titration Period|Dropped out prior to dosing|0
7047588|NCT01789970|11136005|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
7047589|NCT01789970|11136006|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9
7047590|NCT01789970|11136007|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15
7047591|NCT01789970|11136005|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
7047592|NCT01789970|11136006|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
7047593|NCT01789970|11136007|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
7047594|NCT01789970|11136005|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
7047595|NCT01789970|11136006|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7
7083313|NCT02151682|11194301|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0
7083314|NCT02151682|11194302|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2
7083315|NCT02151773|11194320|FG000|Overall Study|Protocol Deviation|64
7083316|NCT02151786|11194324|FG000|Overall Study|Unavailability of Case Report Form|26
7083317|NCT02151786|11194324|FG000|Overall Study|Outside the Contract Period|1
7083318|NCT02151786|11194324|FG000|Overall Study|Randomized, not Treated|1
7083319|NCT02151786|11194324|FG000|Overall Study|Unavailability of Information|8
7083320|NCT02151851|11194330|FG000|Overall Study|Lack of Efficacy|67
7083321|NCT02151851|11194331|FG001|Overall Study|Lack of Efficacy|94
7083322|NCT02151851|11194330|FG000|Overall Study|Protocol Violation|0
7083323|NCT02151851|11194331|FG001|Overall Study|Protocol Violation|1
7083324|NCT02151851|11194330|FG000|Overall Study|Withdrawal by Subject|2
7083325|NCT02151851|11194331|FG001|Overall Study|Withdrawal by Subject|5
7083326|NCT02151851|11194330|FG000|Overall Study|Medical impairment|1
7083327|NCT02151851|11194331|FG001|Overall Study|Medical impairment|0
7083328|NCT02151851|11194330|FG000|Overall Study|Low compliance to study visits|0
7083329|NCT02151851|11194331|FG001|Overall Study|Low compliance to study visits|1
7083330|NCT02151851|11194330|FG000|Overall Study|Subject entered into study in error|0
7083331|NCT02151851|11194331|FG001|Overall Study|Subject entered into study in error|1
7083332|NCT02151851|11194330|FG000|Overall Study|Adverse Event|6
7083333|NCT02151851|11194331|FG001|Overall Study|Adverse Event|28
7083334|NCT02151903|11194350|FG000|Overall Study|Withdrawal by Subject|1
7083335|NCT02151903|11194351|FG001|Overall Study|Withdrawal by Subject|0
7083336|NCT02151903|11194350|FG000|Overall Study|Progressive disease|2
7047596|NCT01789970|11136007|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9
7047597|NCT01789970|11136005|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
7047598|NCT01789970|11136006|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
7047599|NCT01789970|11136007|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7
7047600|NCT01789970|11136005|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
7047601|NCT01789970|11136006|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
7047602|NCT01789970|11136007|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
7047603|NCT01789970|11136005|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0
7047604|NCT01789970|11136006|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2
7047605|NCT01789970|11136007|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1
7047606|NCT01789970|11136005|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0
7047607|NCT01789970|11136006|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1
7047608|NCT01789970|11136007|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2
7047609|NCT01789970|11136005|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
7047610|NCT01789970|11136006|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1
7047611|NCT01789970|11136007|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
7047612|NCT01789970|11136005|FG000|Double-blind Treatment Period (12 Weeks)|Other|0
7047613|NCT01789970|11136006|FG001|Double-blind Treatment Period (12 Weeks)|Other|1
7047614|NCT01789970|11136007|FG002|Double-blind Treatment Period (12 Weeks)|Other|3
7047615|NCT01789970|11136005|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
7047616|NCT01789970|11136006|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1
7047617|NCT01789970|11136007|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
7047618|NCT01790048|11136023|FG000|Overall Study|Incorrect Age|9
7047619|NCT01790048|11136024|FG001|Overall Study|Incorrect Age|14
7047620|NCT01790048|11136023|FG000|Overall Study|data entry error|0
7047621|NCT01790048|11136024|FG001|Overall Study|data entry error|1
7047622|NCT01790048|11136023|FG000|Overall Study|Other|0
7047623|NCT01790048|11136024|FG001|Overall Study|Other|2
7047624|NCT01790048|11136023|FG000|Overall Study|SAM at Enrollment|2
7047625|NCT01790048|11136024|FG001|Overall Study|SAM at Enrollment|0
7047626|NCT01790048|11136023|FG000|Overall Study|Measurement error|1
7047627|NCT01790048|11136024|FG001|Overall Study|Measurement error|0
7047628|NCT01790113|11136034|FG000|Overall Study|Adverse Event|2
7047629|NCT01790113|11136035|FG001|Overall Study|Adverse Event|7
7047630|NCT01790113|11136034|FG000|Overall Study|Study ended due to FDA clearance|1
7047631|NCT01790113|11136035|FG001|Overall Study|Study ended due to FDA clearance|68
7047632|NCT01790126|11136044|FG000|Overall Study|PSA Progression|12
7047633|NCT01790126|11136045|FG001|Overall Study|PSA Progression|16
7047634|NCT01790126|11136046|FG002|Overall Study|PSA Progression|16
7047635|NCT01790126|11136044|FG000|Overall Study|Other|5
7047636|NCT01790126|11136045|FG001|Overall Study|Other|4
7047637|NCT01790126|11136046|FG002|Overall Study|Other|8
7047638|NCT01790126|11136044|FG000|Overall Study|Initiation of Non-Protocol Therapy|3
7047639|NCT01790126|11136045|FG001|Overall Study|Initiation of Non-Protocol Therapy|4
7047640|NCT01790126|11136046|FG002|Overall Study|Initiation of Non-Protocol Therapy|2
7047641|NCT01790126|11136044|FG000|Overall Study|Withdrawal by Physician|1
7047642|NCT01790126|11136045|FG001|Overall Study|Withdrawal by Physician|1
7047643|NCT01790126|11136046|FG002|Overall Study|Withdrawal by Physician|2
7047644|NCT01790126|11136044|FG000|Overall Study|Withdrawal by Subject|3
7047645|NCT01790126|11136045|FG001|Overall Study|Withdrawal by Subject|1
7047646|NCT01790126|11136046|FG002|Overall Study|Withdrawal by Subject|2
7047647|NCT01790126|11136044|FG000|Overall Study|Lost to Follow-up|1
7047648|NCT01790126|11136045|FG001|Overall Study|Lost to Follow-up|0
7047649|NCT01790126|11136046|FG002|Overall Study|Lost to Follow-up|1
7047650|NCT01790126|11136044|FG000|Overall Study|Adverse Event|0
7047651|NCT01790126|11136045|FG001|Overall Study|Adverse Event|2
7047652|NCT01790126|11136046|FG002|Overall Study|Adverse Event|0
7047653|NCT01790126|11136044|FG000|Overall Study|Death|2
7047654|NCT01790126|11136045|FG001|Overall Study|Death|0
7047655|NCT01790126|11136046|FG002|Overall Study|Death|0
7047656|NCT01790126|11136044|FG000|Overall Study|Radiographic Progression|3
7047657|NCT01790126|11136045|FG001|Overall Study|Radiographic Progression|1
7047658|NCT01790126|11136046|FG002|Overall Study|Radiographic Progression|0
7047659|NCT01790295|11136073|FG000|Overall Study|Adverse Event|1
7047660|NCT01790295|11136073|FG000|Overall Study|Death|4
7047661|NCT01790295|11136073|FG000|Overall Study|Lack of Efficacy|2
7047662|NCT01790295|11136073|FG000|Overall Study|Study closure|4
7047663|NCT01790438|11136080|FG000|Overall Study|Adverse Event|3
7047664|NCT01790438|11136081|FG001|Overall Study|Adverse Event|2
7047665|NCT01790438|11136080|FG000|Overall Study|Death|4
7047666|NCT01790438|11136081|FG001|Overall Study|Death|0
7047667|NCT01790438|11136080|FG000|Overall Study|Lost to Follow-up|5
7047668|NCT01790438|11136081|FG001|Overall Study|Lost to Follow-up|2
7047669|NCT01790438|11136080|FG000|Overall Study|Withdrawal by Subject|13
7047670|NCT01790438|11136081|FG001|Overall Study|Withdrawal by Subject|2
7047671|NCT01790438|11136080|FG000|Overall Study|Physician Decision|3
7047672|NCT01790438|11136081|FG001|Overall Study|Physician Decision|1
7047673|NCT01790438|11136080|FG000|Overall Study|Sponsor Decision|0
7047674|NCT01790438|11136081|FG001|Overall Study|Sponsor Decision|3
7047675|NCT01790438|11136080|FG000|Overall Study|Protocol Required Discontinuation|7
7047676|NCT01790438|11136081|FG001|Overall Study|Protocol Required Discontinuation|1
7047677|NCT01790503|11136116|FG000|Overall Study|Adverse Event|1
7047678|NCT01790503|11136117|FG001|Overall Study|Adverse Event|0
7047679|NCT01790503|11136118|FG002|Overall Study|Adverse Event|0
7047680|NCT01790503|11136119|FG003|Overall Study|Adverse Event|0
7047681|NCT01790503|11136120|FG004|Overall Study|Adverse Event|0
7047682|NCT01790503|11136121|FG005|Overall Study|Adverse Event|2
7047683|NCT01790503|11136122|FG006|Overall Study|Adverse Event|0
7047684|NCT01790503|11136123|FG007|Overall Study|Adverse Event|0
7047685|NCT01790503|11136124|FG008|Overall Study|Adverse Event|2
7047686|NCT01790503|11136125|FG009|Overall Study|Adverse Event|4
7047687|NCT01790503|11136126|FG010|Overall Study|Adverse Event|7
7047688|NCT01790503|11136116|FG000|Overall Study|Withdrawal by Subject|0
7047689|NCT01790503|11136117|FG001|Overall Study|Withdrawal by Subject|0
7083337|NCT02151903|11194351|FG001|Overall Study|Progressive disease|1
7083338|NCT02152007|11194409|FG000|Overall Study|Withdrawal by Subject|1
7083339|NCT02152137|11194423|FG000|Overall Study|Withdrawal by Subject|1
7083340|NCT02152137|11194423|FG000|Overall Study|Originally assigned to Arm B|3
7083341|NCT02152163|11194429|FG000|Overall Study|Physician Decision|12
7083342|NCT02152163|11194430|FG001|Overall Study|Physician Decision|13
7083343|NCT02152345|11194438|FG000|Overall Study|Case Cancellations|2
7083344|NCT02152345|11194439|FG001|Overall Study|Case Cancellations|4
7083345|NCT02152345|11194438|FG000|Overall Study|Withdrawal by Subject|2
7083346|NCT02152345|11194439|FG001|Overall Study|Withdrawal by Subject|1
7083347|NCT02152371|11194447|FG000|Overall Study|Adverse Event|6
7083348|NCT02152371|11194448|FG001|Overall Study|Adverse Event|2
7083349|NCT02152371|11194447|FG000|Overall Study|Withdrawal by Subject|3
7083350|NCT02152371|11194448|FG001|Overall Study|Withdrawal by Subject|7
7083351|NCT02152371|11194447|FG000|Overall Study|Protocol Violation|2
7083352|NCT02152371|11194448|FG001|Overall Study|Protocol Violation|3
7083353|NCT02152371|11194447|FG000|Overall Study|Lost to Follow-up|1
7083354|NCT02152371|11194448|FG001|Overall Study|Lost to Follow-up|0
7083355|NCT02152371|11194447|FG000|Overall Study|Lack of Efficacy|0
7083356|NCT02152371|11194448|FG001|Overall Study|Lack of Efficacy|1
7083357|NCT02152371|11194447|FG000|Overall Study|Physician Decision|0
7083358|NCT02152371|11194448|FG001|Overall Study|Physician Decision|2
7083359|NCT02152371|11194447|FG000|Overall Study|Reason Not Given|0
7083360|NCT02152371|11194448|FG001|Overall Study|Reason Not Given|1
7083361|NCT02152384|11194454|FG000|Period 1|Withdrawal by Subject|0
7083362|NCT02152384|11194455|FG001|Period 1|Withdrawal by Subject|1
7083363|NCT02152384|11194454|FG000|Period 1|Adverse Event|1
7083364|NCT02152384|11194455|FG001|Period 1|Adverse Event|1
7083365|NCT02152605|11194483|FG000|Overall Study|Adverse Event|6
7083366|NCT02152605|11194484|FG001|Overall Study|Adverse Event|8
7083367|NCT02152605|11194483|FG000|Overall Study|Lack of Efficacy|7
7083368|NCT02152605|11194484|FG001|Overall Study|Lack of Efficacy|4
7083369|NCT02152605|11194483|FG000|Overall Study|Protocol deviation|1
7083370|NCT02152605|11194484|FG001|Overall Study|Protocol deviation|4
7083371|NCT02152605|11194483|FG000|Overall Study|Lost to Follow-up|1
7083372|NCT02152605|11194484|FG001|Overall Study|Lost to Follow-up|0
7083373|NCT02152605|11194483|FG000|Overall Study|Withdrew consent|4
7083374|NCT02152605|11194484|FG001|Overall Study|Withdrew consent|2
7188605|NCT02891226|11388859|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7188606|NCT02891226|11388860|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7188607|NCT02891226|11388861|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7188608|NCT02891226|11388862|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7188609|NCT02891226|11388863|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7188610|NCT02891226|11388864|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7188611|NCT02891226|11388865|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7188612|NCT02891226|11388866|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7047690|NCT01790503|11136118|FG002|Overall Study|Withdrawal by Subject|1
7047691|NCT01790503|11136119|FG003|Overall Study|Withdrawal by Subject|1
7047692|NCT01790503|11136120|FG004|Overall Study|Withdrawal by Subject|1
7047693|NCT01790503|11136121|FG005|Overall Study|Withdrawal by Subject|2
7047694|NCT01790503|11136122|FG006|Overall Study|Withdrawal by Subject|1
7047695|NCT01790503|11136123|FG007|Overall Study|Withdrawal by Subject|0
7047696|NCT01790503|11136124|FG008|Overall Study|Withdrawal by Subject|0
7047697|NCT01790503|11136125|FG009|Overall Study|Withdrawal by Subject|0
7047698|NCT01790503|11136126|FG010|Overall Study|Withdrawal by Subject|1
7047699|NCT01790503|11136116|FG000|Overall Study|Disease progression|2
7047700|NCT01790503|11136117|FG001|Overall Study|Disease progression|1
7047701|NCT01790503|11136118|FG002|Overall Study|Disease progression|0
7047702|NCT01790503|11136119|FG003|Overall Study|Disease progression|1
7047703|NCT01790503|11136120|FG004|Overall Study|Disease progression|2
7047704|NCT01790503|11136121|FG005|Overall Study|Disease progression|1
7188613|NCT02891226|11388867|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7188614|NCT02891226|11388868|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1
7188615|NCT02891226|11388869|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7188616|NCT02891226|11388870|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7188617|NCT02891226|11388871|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7188618|NCT02891226|11388872|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7047705|NCT01790503|11136122|FG006|Overall Study|Disease progression|0
7047706|NCT01790503|11136123|FG007|Overall Study|Disease progression|1
7047707|NCT01790503|11136124|FG008|Overall Study|Disease progression|0
7047708|NCT01790503|11136125|FG009|Overall Study|Disease progression|17
7047709|NCT01790503|11136126|FG010|Overall Study|Disease progression|7
7047710|NCT01790503|11136116|FG000|Overall Study|Protocol Violation|0
7047711|NCT01790503|11136117|FG001|Overall Study|Protocol Violation|0
7047712|NCT01790503|11136118|FG002|Overall Study|Protocol Violation|0
7047713|NCT01790503|11136119|FG003|Overall Study|Protocol Violation|0
7047714|NCT01790503|11136120|FG004|Overall Study|Protocol Violation|0
7047715|NCT01790503|11136121|FG005|Overall Study|Protocol Violation|0
7047716|NCT01790503|11136122|FG006|Overall Study|Protocol Violation|0
7047717|NCT01790503|11136123|FG007|Overall Study|Protocol Violation|0
7047718|NCT01790503|11136124|FG008|Overall Study|Protocol Violation|0
7047719|NCT01790503|11136125|FG009|Overall Study|Protocol Violation|1
7047720|NCT01790503|11136126|FG010|Overall Study|Protocol Violation|0
7047721|NCT01790503|11136116|FG000|Overall Study|Physician Decision|0
7047722|NCT01790503|11136117|FG001|Overall Study|Physician Decision|0
7047723|NCT01790503|11136118|FG002|Overall Study|Physician Decision|0
7047724|NCT01790503|11136119|FG003|Overall Study|Physician Decision|0
7047725|NCT01790503|11136120|FG004|Overall Study|Physician Decision|0
7047726|NCT01790503|11136121|FG005|Overall Study|Physician Decision|0
7047727|NCT01790503|11136122|FG006|Overall Study|Physician Decision|0
7047728|NCT01790503|11136123|FG007|Overall Study|Physician Decision|0
7047729|NCT01790503|11136124|FG008|Overall Study|Physician Decision|0
7047730|NCT01790503|11136125|FG009|Overall Study|Physician Decision|1
7047731|NCT01790503|11136126|FG010|Overall Study|Physician Decision|1
7047732|NCT01790503|11136116|FG000|Overall Study|Death|0
7047733|NCT01790503|11136117|FG001|Overall Study|Death|0
7047734|NCT01790503|11136118|FG002|Overall Study|Death|0
7047735|NCT01790503|11136119|FG003|Overall Study|Death|0
7047736|NCT01790503|11136120|FG004|Overall Study|Death|0
7047737|NCT01790503|11136121|FG005|Overall Study|Death|0
7047738|NCT01790503|11136122|FG006|Overall Study|Death|0
7047739|NCT01790503|11136123|FG007|Overall Study|Death|0
7047740|NCT01790503|11136124|FG008|Overall Study|Death|0
7047741|NCT01790503|11136125|FG009|Overall Study|Death|1
7047742|NCT01790503|11136126|FG010|Overall Study|Death|0
7047743|NCT01790503|11136116|FG000|Overall Study|Non Compliance|0
7047744|NCT01790503|11136117|FG001|Overall Study|Non Compliance|0
7047745|NCT01790503|11136118|FG002|Overall Study|Non Compliance|0
7047746|NCT01790503|11136119|FG003|Overall Study|Non Compliance|0
7047747|NCT01790503|11136120|FG004|Overall Study|Non Compliance|1
7047748|NCT01790503|11136121|FG005|Overall Study|Non Compliance|0
7047749|NCT01790503|11136122|FG006|Overall Study|Non Compliance|0
7047750|NCT01790503|11136123|FG007|Overall Study|Non Compliance|0
7047751|NCT01790503|11136124|FG008|Overall Study|Non Compliance|0
7047752|NCT01790503|11136125|FG009|Overall Study|Non Compliance|0
7047753|NCT01790503|11136126|FG010|Overall Study|Non Compliance|0
7047754|NCT01790503|11136116|FG000|Overall Study|Other|0
7047755|NCT01790503|11136117|FG001|Overall Study|Other|0
7047756|NCT01790503|11136118|FG002|Overall Study|Other|0
7047757|NCT01790503|11136119|FG003|Overall Study|Other|0
7047758|NCT01790503|11136120|FG004|Overall Study|Other|1
7047759|NCT01790503|11136121|FG005|Overall Study|Other|0
7047760|NCT01790503|11136122|FG006|Overall Study|Other|0
7047761|NCT01790503|11136123|FG007|Overall Study|Other|0
7047762|NCT01790503|11136124|FG008|Overall Study|Other|1
7047763|NCT01790503|11136125|FG009|Overall Study|Other|2
7047764|NCT01790503|11136126|FG010|Overall Study|Other|0
7047765|NCT01790516|11136165|FG000|Overall Study|Physician Decision|1
7047766|NCT01790516|11136166|FG001|Overall Study|Physician Decision|0
7047767|NCT01790568|11136172|FG000|Overall Study|Progression prior to transplant|0
7047768|NCT01790568|11136173|FG001|Overall Study|Progression prior to transplant|1
7047769|NCT01790594|11136188|FG000|Overall Study|Death|1
7047770|NCT01790594|11136189|FG001|Overall Study|Death|0
7047771|NCT01790594|11136190|FG002|Overall Study|Death|0
7047772|NCT01790594|11136188|FG000|Overall Study|Physician Decision|2
7047773|NCT01790594|11136189|FG001|Overall Study|Physician Decision|1
7047774|NCT01790594|11136190|FG002|Overall Study|Physician Decision|0
7047775|NCT01790594|11136188|FG000|Overall Study|Withdrawal by Subject|2
7047776|NCT01790594|11136189|FG001|Overall Study|Withdrawal by Subject|0
7047777|NCT01790594|11136190|FG002|Overall Study|Withdrawal by Subject|0
7047778|NCT01790594|11136188|FG000|Overall Study|Transplant was not done|0
7047779|NCT01790594|11136189|FG001|Overall Study|Transplant was not done|0
7047780|NCT01790594|11136190|FG002|Overall Study|Transplant was not done|3
7047781|NCT01790594|11136188|FG000|Overall Study|Terminated prior to week 76|0
7047782|NCT01790594|11136189|FG001|Overall Study|Terminated prior to week 76|2
7047783|NCT01790594|11136190|FG002|Overall Study|Terminated prior to week 76|0
7047784|NCT01790633|11136199|FG000|Overall Study|Protocol Violation|1
7047785|NCT01790633|11136200|FG001|Overall Study|Protocol Violation|2
7047786|NCT01790633|11136199|FG000|Overall Study|Did not have serology performed|47
7047787|NCT01790633|11136200|FG001|Overall Study|Did not have serology performed|0
7047788|NCT01790633|11136199|FG000|Overall Study|RT failure and no follow-up ELISA|0
7047789|NCT01790633|11136200|FG001|Overall Study|RT failure and no follow-up ELISA|3
7047790|NCT01790828|11136230|FG000|Overall Study|Other|34
7047791|NCT01790932|11136234|FG000|Overall Study|Disease Progression|41
7047792|NCT01790932|11136234|FG000|Overall Study|Adverse Event|7
7047793|NCT01790932|11136234|FG000|Overall Study|Physician Decision|1
7047794|NCT01790932|11136234|FG000|Overall Study|Withdrawal by Subject|1
7083375|NCT02152631|11194493|FG000|Overall Study|Adverse Event|32
7047795|NCT01790984|11136240|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1
7047796|NCT01790984|11136241|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1
7047797|NCT01790984|11136242|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0
7047798|NCT01790984|11136243|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0
7047799|NCT01791127|11136266|FG000|Overall Study|Death|356
7047800|NCT01791127|11136266|FG000|Overall Study|Patient has withdrawn from study|293
7047801|NCT01791127|11136266|FG000|Overall Study|Lost to Follow-up|42
7047802|NCT01791127|11136266|FG000|Overall Study|All Siello leads are explanted|31
7047803|NCT01791127|11136266|FG000|Overall Study|Completion of 30 day safety registry|1
7047804|NCT01791127|11136266|FG000|Overall Study|Study terminated for EP Passion|749
7047805|NCT01791153|11136287|FG000|Part 1: Blinded Period|Adverse Event|7
7047806|NCT01791153|11136288|FG001|Part 1: Blinded Period|Adverse Event|3
7047807|NCT01791153|11136289|FG002|Part 1: Blinded Period|Adverse Event|2
7047808|NCT01791153|11136290|FG003|Part 1: Blinded Period|Adverse Event|0
7047809|NCT01791153|11136291|FG004|Part 1: Blinded Period|Adverse Event|0
7047810|NCT01791153|11136292|FG005|Part 1: Blinded Period|Adverse Event|0
7047811|NCT01791153|11136293|FG006|Part 1: Blinded Period|Adverse Event|0
7047812|NCT01791153|11136294|FG007|Part 1: Blinded Period|Adverse Event|0
7047813|NCT01791153|11136287|FG000|Part 1: Blinded Period|Lack of Efficacy|1
7047814|NCT01791153|11136288|FG001|Part 1: Blinded Period|Lack of Efficacy|3
7047815|NCT01791153|11136289|FG002|Part 1: Blinded Period|Lack of Efficacy|2
7047816|NCT01791153|11136290|FG003|Part 1: Blinded Period|Lack of Efficacy|2
7047817|NCT01791153|11136291|FG004|Part 1: Blinded Period|Lack of Efficacy|0
7047818|NCT01791153|11136292|FG005|Part 1: Blinded Period|Lack of Efficacy|0
7047819|NCT01791153|11136293|FG006|Part 1: Blinded Period|Lack of Efficacy|0
7047820|NCT01791153|11136294|FG007|Part 1: Blinded Period|Lack of Efficacy|0
7083376|NCT02152631|11194494|FG001|Overall Study|Adverse Event|4
7083377|NCT02152631|11194493|FG000|Overall Study|Withdrawal by Subject|13
7083378|NCT02152631|11194494|FG001|Overall Study|Withdrawal by Subject|16
7083379|NCT02152631|11194493|FG000|Overall Study|Noncompliance with study drug|1
7083380|NCT02152631|11194494|FG001|Overall Study|Noncompliance with study drug|0
7083381|NCT02152631|11194493|FG000|Overall Study|Physician Decision|1
7083382|NCT02152631|11194494|FG001|Overall Study|Physician Decision|2
7083383|NCT02152631|11194493|FG000|Overall Study|Lost to Follow-up|0
7083384|NCT02152631|11194494|FG001|Overall Study|Lost to Follow-up|1
7083385|NCT02152631|11194493|FG000|Overall Study|On Treatment|19
7083386|NCT02152631|11194494|FG001|Overall Study|On Treatment|3
7083387|NCT02152761|11194517|FG000|Epoch: Treatment Epoch|Technical problems|0
7083388|NCT02152761|11194518|FG001|Epoch: Treatment Epoch|Technical problems|0
7083389|NCT02152761|11194519|FG002|Epoch: Treatment Epoch|Technical problems|0
7083390|NCT02152761|11194520|FG003|Epoch: Treatment Epoch|Technical problems|1
7083391|NCT02152761|11194517|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0
7083392|NCT02152761|11194518|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2
7083393|NCT02152761|11194519|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0
7083394|NCT02152761|11194520|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0
7083395|NCT02152761|11194517|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7
7083396|NCT02152761|11194518|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8
7083397|NCT02152761|11194519|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3
7047821|NCT01791153|11136287|FG000|Part 1: Blinded Period|Non-Compliance|1
7047822|NCT01791153|11136288|FG001|Part 1: Blinded Period|Non-Compliance|0
7047823|NCT01791153|11136289|FG002|Part 1: Blinded Period|Non-Compliance|0
7047824|NCT01791153|11136290|FG003|Part 1: Blinded Period|Non-Compliance|0
7047825|NCT01791153|11136291|FG004|Part 1: Blinded Period|Non-Compliance|0
7047826|NCT01791153|11136292|FG005|Part 1: Blinded Period|Non-Compliance|0
7083398|NCT02152761|11194520|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5
7083399|NCT02152761|11194517|FG000|Epoch: Treatment Epoch|Adverse Event|3
7083400|NCT02152761|11194518|FG001|Epoch: Treatment Epoch|Adverse Event|6
7083401|NCT02152761|11194519|FG002|Epoch: Treatment Epoch|Adverse Event|1
7083402|NCT02152761|11194520|FG003|Epoch: Treatment Epoch|Adverse Event|2
7047827|NCT01791153|11136293|FG006|Part 1: Blinded Period|Non-Compliance|0
7047828|NCT01791153|11136294|FG007|Part 1: Blinded Period|Non-Compliance|0
7047829|NCT01791153|11136287|FG000|Part 1: Blinded Period|Physician Decision|0
7047830|NCT01791153|11136288|FG001|Part 1: Blinded Period|Physician Decision|0
7047831|NCT01791153|11136289|FG002|Part 1: Blinded Period|Physician Decision|0
7047832|NCT01791153|11136290|FG003|Part 1: Blinded Period|Physician Decision|1
7047833|NCT01791153|11136291|FG004|Part 1: Blinded Period|Physician Decision|0
7047834|NCT01791153|11136292|FG005|Part 1: Blinded Period|Physician Decision|0
7047835|NCT01791153|11136293|FG006|Part 1: Blinded Period|Physician Decision|0
7047836|NCT01791153|11136294|FG007|Part 1: Blinded Period|Physician Decision|0
7047837|NCT01791153|11136287|FG000|Part 1: Blinded Period|Protocol Violation|0
7047838|NCT01791153|11136288|FG001|Part 1: Blinded Period|Protocol Violation|0
7047839|NCT01791153|11136289|FG002|Part 1: Blinded Period|Protocol Violation|0
7047840|NCT01791153|11136290|FG003|Part 1: Blinded Period|Protocol Violation|1
7047841|NCT01791153|11136291|FG004|Part 1: Blinded Period|Protocol Violation|0
7047842|NCT01791153|11136292|FG005|Part 1: Blinded Period|Protocol Violation|0
7047843|NCT01791153|11136293|FG006|Part 1: Blinded Period|Protocol Violation|0
7047844|NCT01791153|11136294|FG007|Part 1: Blinded Period|Protocol Violation|0
7047845|NCT01791153|11136287|FG000|Part 1: Blinded Period|Withdrawal by Subject|6
7047846|NCT01791153|11136288|FG001|Part 1: Blinded Period|Withdrawal by Subject|2
7047847|NCT01791153|11136289|FG002|Part 1: Blinded Period|Withdrawal by Subject|2
7047848|NCT01791153|11136290|FG003|Part 1: Blinded Period|Withdrawal by Subject|1
7047849|NCT01791153|11136291|FG004|Part 1: Blinded Period|Withdrawal by Subject|0
7047850|NCT01791153|11136292|FG005|Part 1: Blinded Period|Withdrawal by Subject|0
7047851|NCT01791153|11136293|FG006|Part 1: Blinded Period|Withdrawal by Subject|0
7047852|NCT01791153|11136294|FG007|Part 1: Blinded Period|Withdrawal by Subject|0
7047853|NCT01791153|11136287|FG000|Part 2: Open-label Period|Adverse Event|0
7047854|NCT01791153|11136288|FG001|Part 2: Open-label Period|Adverse Event|0
7047855|NCT01791153|11136289|FG002|Part 2: Open-label Period|Adverse Event|0
7047856|NCT01791153|11136290|FG003|Part 2: Open-label Period|Adverse Event|0
7047857|NCT01791153|11136291|FG004|Part 2: Open-label Period|Adverse Event|0
7047858|NCT01791153|11136292|FG005|Part 2: Open-label Period|Adverse Event|1
7047859|NCT01791153|11136293|FG006|Part 2: Open-label Period|Adverse Event|1
7047860|NCT01791153|11136294|FG007|Part 2: Open-label Period|Adverse Event|2
7047861|NCT01791153|11136287|FG000|Part 2: Open-label Period|Death|0
7047862|NCT01791153|11136288|FG001|Part 2: Open-label Period|Death|0
7047863|NCT01791153|11136289|FG002|Part 2: Open-label Period|Death|0
7047864|NCT01791153|11136290|FG003|Part 2: Open-label Period|Death|0
7047865|NCT01791153|11136291|FG004|Part 2: Open-label Period|Death|0
7047866|NCT01791153|11136292|FG005|Part 2: Open-label Period|Death|1
7047867|NCT01791153|11136293|FG006|Part 2: Open-label Period|Death|1
7047868|NCT01791153|11136294|FG007|Part 2: Open-label Period|Death|1
7047869|NCT01791153|11136287|FG000|Part 2: Open-label Period|Lost to Follow-up|0
7047870|NCT01791153|11136288|FG001|Part 2: Open-label Period|Lost to Follow-up|0
7047871|NCT01791153|11136289|FG002|Part 2: Open-label Period|Lost to Follow-up|0
7047872|NCT01791153|11136290|FG003|Part 2: Open-label Period|Lost to Follow-up|0
7047873|NCT01791153|11136291|FG004|Part 2: Open-label Period|Lost to Follow-up|0
7047874|NCT01791153|11136292|FG005|Part 2: Open-label Period|Lost to Follow-up|0
7047875|NCT01791153|11136293|FG006|Part 2: Open-label Period|Lost to Follow-up|1
7047876|NCT01791153|11136294|FG007|Part 2: Open-label Period|Lost to Follow-up|0
7047877|NCT01791153|11136287|FG000|Part 2: Open-label Period|Lack of Efficacy|0
7047878|NCT01791153|11136288|FG001|Part 2: Open-label Period|Lack of Efficacy|0
7047879|NCT01791153|11136289|FG002|Part 2: Open-label Period|Lack of Efficacy|0
7047880|NCT01791153|11136290|FG003|Part 2: Open-label Period|Lack of Efficacy|0
7047881|NCT01791153|11136291|FG004|Part 2: Open-label Period|Lack of Efficacy|0
7047882|NCT01791153|11136292|FG005|Part 2: Open-label Period|Lack of Efficacy|0
7047883|NCT01791153|11136293|FG006|Part 2: Open-label Period|Lack of Efficacy|0
7047884|NCT01791153|11136294|FG007|Part 2: Open-label Period|Lack of Efficacy|1
7047885|NCT01791153|11136287|FG000|Part 2: Open-label Period|Withdrawal by Subject|0
7047886|NCT01791153|11136288|FG001|Part 2: Open-label Period|Withdrawal by Subject|0
7047887|NCT01791153|11136289|FG002|Part 2: Open-label Period|Withdrawal by Subject|0
7047888|NCT01791153|11136290|FG003|Part 2: Open-label Period|Withdrawal by Subject|0
7047889|NCT01791153|11136291|FG004|Part 2: Open-label Period|Withdrawal by Subject|1
7047890|NCT01791153|11136292|FG005|Part 2: Open-label Period|Withdrawal by Subject|1
7047891|NCT01791153|11136293|FG006|Part 2: Open-label Period|Withdrawal by Subject|3
7047892|NCT01791153|11136294|FG007|Part 2: Open-label Period|Withdrawal by Subject|2
7047893|NCT01791153|11136287|FG000|Part 2: Open-label Period|Physician Decision|0
7047894|NCT01791153|11136288|FG001|Part 2: Open-label Period|Physician Decision|0
7047895|NCT01791153|11136289|FG002|Part 2: Open-label Period|Physician Decision|0
7047896|NCT01791153|11136290|FG003|Part 2: Open-label Period|Physician Decision|0
7047897|NCT01791153|11136291|FG004|Part 2: Open-label Period|Physician Decision|1
7047898|NCT01791153|11136292|FG005|Part 2: Open-label Period|Physician Decision|1
7047899|NCT01791153|11136293|FG006|Part 2: Open-label Period|Physician Decision|0
7047900|NCT01791153|11136294|FG007|Part 2: Open-label Period|Physician Decision|0
7047901|NCT01791205|11136311|FG000|Phase II|Lack of Efficacy|6
7047902|NCT01791205|11136312|FG001|Phase II|Lack of Efficacy|0
7047903|NCT01791205|11136311|FG000|Phase II|Adverse Event|2
7047904|NCT01791205|11136312|FG001|Phase II|Adverse Event|0
7047905|NCT01791205|11136311|FG000|Phase II|Safety|1
7047906|NCT01791205|11136312|FG001|Phase II|Safety|0
7047907|NCT01791205|11136311|FG000|Phase II|Lost to Follow-up|1
7047908|NCT01791205|11136312|FG001|Phase II|Lost to Follow-up|0
7047909|NCT01791205|11136311|FG000|Phase II|Remission of disease|1
7047910|NCT01791205|11136312|FG001|Phase II|Remission of disease|0
7047911|NCT01791205|11136311|FG000|Phase II|Physician's decision|1
7047912|NCT01791205|11136312|FG001|Phase II|Physician's decision|0
7047913|NCT01791244|11136320|FG000|Overall Study|Adverse Event|5
7047914|NCT01791244|11136321|FG001|Overall Study|Adverse Event|7
7047915|NCT01791244|11136320|FG000|Overall Study|Insufficient clinical response|10
7047916|NCT01791244|11136321|FG001|Overall Study|Insufficient clinical response|10
7047917|NCT01791244|11136320|FG000|Overall Study|Laboratory Abnormality|0
7047918|NCT01791244|11136321|FG001|Overall Study|Laboratory Abnormality|1
7047919|NCT01791413|11136331|FG000|Overall Study|Lost to Follow-up|5
7047920|NCT01791413|11136332|FG001|Overall Study|Lost to Follow-up|1
7047921|NCT01791517|11136351|FG000|Phase I: Period 1|Withdrawal by Subject|0
7047922|NCT01791517|11136352|FG001|Phase I: Period 1|Withdrawal by Subject|1
7047923|NCT01791517|11136353|FG002|Phase I: Period 1|Withdrawal by Subject|1
7047924|NCT01791517|11136354|FG003|Phase I: Period 1|Withdrawal by Subject|0
7047925|NCT01791517|11136355|FG004|Phase I: Period 1|Withdrawal by Subject|1
7047926|NCT01791517|11136356|FG005|Phase I: Period 1|Withdrawal by Subject|1
7047927|NCT01791517|11136357|FG006|Phase I: Period 1|Withdrawal by Subject|0
7047928|NCT01791517|11136358|FG007|Phase I: Period 1|Withdrawal by Subject|0
7047929|NCT01791517|11136359|FG008|Phase I: Period 1|Withdrawal by Subject|0
7047930|NCT01791517|11136360|FG009|Phase I: Period 1|Withdrawal by Subject|0
7047931|NCT01791517|11136361|FG010|Phase I: Period 1|Withdrawal by Subject|0
7047932|NCT01791517|11136362|FG011|Phase I: Period 1|Withdrawal by Subject|0
7047933|NCT01791517|11136351|FG000|Phase I: Period 1|Adverse Event|0
7047934|NCT01791517|11136352|FG001|Phase I: Period 1|Adverse Event|0
7047935|NCT01791517|11136353|FG002|Phase I: Period 1|Adverse Event|1
7047936|NCT01791517|11136354|FG003|Phase I: Period 1|Adverse Event|1
7047937|NCT01791517|11136355|FG004|Phase I: Period 1|Adverse Event|0
7047938|NCT01791517|11136356|FG005|Phase I: Period 1|Adverse Event|0
7047939|NCT01791517|11136357|FG006|Phase I: Period 1|Adverse Event|0
7047940|NCT01791517|11136358|FG007|Phase I: Period 1|Adverse Event|0
7047941|NCT01791517|11136359|FG008|Phase I: Period 1|Adverse Event|0
7047942|NCT01791517|11136360|FG009|Phase I: Period 1|Adverse Event|0
7047943|NCT01791517|11136361|FG010|Phase I: Period 1|Adverse Event|0
7047944|NCT01791517|11136362|FG011|Phase I: Period 1|Adverse Event|0
7047945|NCT01791517|11136351|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1
7047946|NCT01791517|11136352|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7047947|NCT01791517|11136353|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7047948|NCT01791517|11136354|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7047949|NCT01791517|11136355|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7047950|NCT01791517|11136356|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7047951|NCT01791517|11136357|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7047952|NCT01791517|11136358|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7047953|NCT01791517|11136359|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7047954|NCT01791517|11136360|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7047955|NCT01791517|11136361|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7047956|NCT01791517|11136362|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7047957|NCT01791517|11136351|FG000|Phase I: Period 1|Protocol Violation|0
7047958|NCT01791517|11136352|FG001|Phase I: Period 1|Protocol Violation|1
7047959|NCT01791517|11136353|FG002|Phase I: Period 1|Protocol Violation|0
7047960|NCT01791517|11136354|FG003|Phase I: Period 1|Protocol Violation|0
7047961|NCT01791517|11136355|FG004|Phase I: Period 1|Protocol Violation|0
7047962|NCT01791517|11136356|FG005|Phase I: Period 1|Protocol Violation|0
7047963|NCT01791517|11136357|FG006|Phase I: Period 1|Protocol Violation|0
7047964|NCT01791517|11136358|FG007|Phase I: Period 1|Protocol Violation|0
7047965|NCT01791517|11136359|FG008|Phase I: Period 1|Protocol Violation|0
7047966|NCT01791517|11136360|FG009|Phase I: Period 1|Protocol Violation|0
7047967|NCT01791517|11136361|FG010|Phase I: Period 1|Protocol Violation|0
7047968|NCT01791517|11136362|FG011|Phase I: Period 1|Protocol Violation|0
7047969|NCT01791517|11136351|FG000|Phase I: Period 1|Lost to Follow-up|0
7047970|NCT01791517|11136352|FG001|Phase I: Period 1|Lost to Follow-up|0
7047971|NCT01791517|11136353|FG002|Phase I: Period 1|Lost to Follow-up|0
7047972|NCT01791517|11136354|FG003|Phase I: Period 1|Lost to Follow-up|1
7047973|NCT01791517|11136355|FG004|Phase I: Period 1|Lost to Follow-up|0
7047974|NCT01791517|11136356|FG005|Phase I: Period 1|Lost to Follow-up|0
7047975|NCT01791517|11136357|FG006|Phase I: Period 1|Lost to Follow-up|1
7047976|NCT01791517|11136358|FG007|Phase I: Period 1|Lost to Follow-up|0
7047977|NCT01791517|11136359|FG008|Phase I: Period 1|Lost to Follow-up|1
7047978|NCT01791517|11136360|FG009|Phase I: Period 1|Lost to Follow-up|1
7047979|NCT01791517|11136361|FG010|Phase I: Period 1|Lost to Follow-up|0
7047980|NCT01791517|11136362|FG011|Phase I: Period 1|Lost to Follow-up|0
7047981|NCT01791517|11136351|FG000|Phase I: Period 1|Lens Handling DIfficulties|0
7047982|NCT01791517|11136352|FG001|Phase I: Period 1|Lens Handling DIfficulties|0
7047983|NCT01791517|11136353|FG002|Phase I: Period 1|Lens Handling DIfficulties|0
7047984|NCT01791517|11136354|FG003|Phase I: Period 1|Lens Handling DIfficulties|0
7047985|NCT01791517|11136355|FG004|Phase I: Period 1|Lens Handling DIfficulties|0
7047986|NCT01791517|11136356|FG005|Phase I: Period 1|Lens Handling DIfficulties|0
7047987|NCT01791517|11136357|FG006|Phase I: Period 1|Lens Handling DIfficulties|0
7047988|NCT01791517|11136358|FG007|Phase I: Period 1|Lens Handling DIfficulties|0
7047989|NCT01791517|11136359|FG008|Phase I: Period 1|Lens Handling DIfficulties|0
7047990|NCT01791517|11136360|FG009|Phase I: Period 1|Lens Handling DIfficulties|0
7047991|NCT01791517|11136361|FG010|Phase I: Period 1|Lens Handling DIfficulties|0
7047992|NCT01791517|11136362|FG011|Phase I: Period 1|Lens Handling DIfficulties|1
7047993|NCT01791517|11136351|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1
7047994|NCT01791517|11136352|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0
7047995|NCT01791517|11136353|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0
7047996|NCT01791517|11136354|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0
7047997|NCT01791517|11136355|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0
7047998|NCT01791517|11136356|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0
7047999|NCT01791517|11136357|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0
7048000|NCT01791517|11136358|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0
7048001|NCT01791517|11136359|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0
7048002|NCT01791517|11136360|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0
7048003|NCT01791517|11136361|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0
7048004|NCT01791517|11136362|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0
7048005|NCT01791517|11136351|FG000|Phase I: Period 2|Protocol Violation|0
7048006|NCT01791517|11136352|FG001|Phase I: Period 2|Protocol Violation|0
7048007|NCT01791517|11136353|FG002|Phase I: Period 2|Protocol Violation|0
7048008|NCT01791517|11136354|FG003|Phase I: Period 2|Protocol Violation|1
7048009|NCT01791517|11136355|FG004|Phase I: Period 2|Protocol Violation|0
7048010|NCT01791517|11136356|FG005|Phase I: Period 2|Protocol Violation|0
7048011|NCT01791517|11136357|FG006|Phase I: Period 2|Protocol Violation|0
7048012|NCT01791517|11136358|FG007|Phase I: Period 2|Protocol Violation|0
7048013|NCT01791517|11136359|FG008|Phase I: Period 2|Protocol Violation|0
7188619|NCT02891226|11388873|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7188620|NCT02891226|11388858|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7188621|NCT02891226|11388859|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7188622|NCT02891226|11388860|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7188623|NCT02891226|11388861|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7188624|NCT02891226|11388862|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7188625|NCT02891226|11388863|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7188626|NCT02891226|11388864|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7188627|NCT02891226|11388865|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7188628|NCT02891226|11388866|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7188629|NCT02891226|11388867|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7188630|NCT02891226|11388868|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14
7188631|NCT02891226|11388869|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7188632|NCT02891226|11388870|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7188633|NCT02891226|11388871|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7188634|NCT02891226|11388872|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7188635|NCT02891226|11388873|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7188636|NCT02891226|11388858|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7188637|NCT02891226|11388859|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7188638|NCT02891226|11388860|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7188639|NCT02891226|11388861|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7048014|NCT01791517|11136360|FG009|Phase I: Period 2|Protocol Violation|0
7048015|NCT01791517|11136361|FG010|Phase I: Period 2|Protocol Violation|0
7048016|NCT01791517|11136362|FG011|Phase I: Period 2|Protocol Violation|0
7048017|NCT01791517|11136351|FG000|Phase I: Period 2|Withdrawal by Subject|0
7048018|NCT01791517|11136352|FG001|Phase I: Period 2|Withdrawal by Subject|0
7048019|NCT01791517|11136353|FG002|Phase I: Period 2|Withdrawal by Subject|0
7048020|NCT01791517|11136354|FG003|Phase I: Period 2|Withdrawal by Subject|0
7048021|NCT01791517|11136355|FG004|Phase I: Period 2|Withdrawal by Subject|0
7048022|NCT01791517|11136356|FG005|Phase I: Period 2|Withdrawal by Subject|0
7048023|NCT01791517|11136357|FG006|Phase I: Period 2|Withdrawal by Subject|0
7048024|NCT01791517|11136358|FG007|Phase I: Period 2|Withdrawal by Subject|0
7048025|NCT01791517|11136359|FG008|Phase I: Period 2|Withdrawal by Subject|0
7048026|NCT01791517|11136360|FG009|Phase I: Period 2|Withdrawal by Subject|1
7048027|NCT01791517|11136361|FG010|Phase I: Period 2|Withdrawal by Subject|1
7048028|NCT01791517|11136362|FG011|Phase I: Period 2|Withdrawal by Subject|0
7048029|NCT01791517|11136351|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0
7048030|NCT01791517|11136352|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0
7048031|NCT01791517|11136353|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0
7048032|NCT01791517|11136354|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0
7048033|NCT01791517|11136355|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0
7048034|NCT01791517|11136356|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0
7048035|NCT01791517|11136357|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0
7048036|NCT01791517|11136358|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0
7048037|NCT01791517|11136359|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0
7048038|NCT01791517|11136360|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0
7048039|NCT01791517|11136361|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1
7048040|NCT01791517|11136362|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0
7048041|NCT01791517|11136351|FG000|Phase I: Period 2|Lens Discomfort|0
7048042|NCT01791517|11136352|FG001|Phase I: Period 2|Lens Discomfort|0
7048043|NCT01791517|11136353|FG002|Phase I: Period 2|Lens Discomfort|0
7048044|NCT01791517|11136354|FG003|Phase I: Period 2|Lens Discomfort|0
7048045|NCT01791517|11136355|FG004|Phase I: Period 2|Lens Discomfort|0
7048046|NCT01791517|11136356|FG005|Phase I: Period 2|Lens Discomfort|1
7048047|NCT01791517|11136357|FG006|Phase I: Period 2|Lens Discomfort|0
7048048|NCT01791517|11136358|FG007|Phase I: Period 2|Lens Discomfort|0
7048049|NCT01791517|11136359|FG008|Phase I: Period 2|Lens Discomfort|0
7048050|NCT01791517|11136360|FG009|Phase I: Period 2|Lens Discomfort|0
7048051|NCT01791517|11136361|FG010|Phase I: Period 2|Lens Discomfort|0
7048052|NCT01791517|11136362|FG011|Phase I: Period 2|Lens Discomfort|0
7048053|NCT01791517|11136351|FG000|Phase I: Period 2|Lost to Follow-up|0
7048054|NCT01791517|11136352|FG001|Phase I: Period 2|Lost to Follow-up|3
7048055|NCT01791517|11136353|FG002|Phase I: Period 2|Lost to Follow-up|2
7048056|NCT01791517|11136354|FG003|Phase I: Period 2|Lost to Follow-up|0
7048057|NCT01791517|11136355|FG004|Phase I: Period 2|Lost to Follow-up|0
7048058|NCT01791517|11136356|FG005|Phase I: Period 2|Lost to Follow-up|0
7048059|NCT01791517|11136357|FG006|Phase I: Period 2|Lost to Follow-up|0
7048060|NCT01791517|11136358|FG007|Phase I: Period 2|Lost to Follow-up|0
7048061|NCT01791517|11136359|FG008|Phase I: Period 2|Lost to Follow-up|0
7048062|NCT01791517|11136360|FG009|Phase I: Period 2|Lost to Follow-up|0
7048063|NCT01791517|11136361|FG010|Phase I: Period 2|Lost to Follow-up|0
7048064|NCT01791517|11136362|FG011|Phase I: Period 2|Lost to Follow-up|0
7048065|NCT01791517|11136351|FG000|Phase I: Period 3|Lens Discomfort|0
7048066|NCT01791517|11136352|FG001|Phase I: Period 3|Lens Discomfort|0
7048067|NCT01791517|11136353|FG002|Phase I: Period 3|Lens Discomfort|0
7048068|NCT01791517|11136354|FG003|Phase I: Period 3|Lens Discomfort|0
7048069|NCT01791517|11136355|FG004|Phase I: Period 3|Lens Discomfort|0
7048070|NCT01791517|11136356|FG005|Phase I: Period 3|Lens Discomfort|0
7048071|NCT01791517|11136357|FG006|Phase I: Period 3|Lens Discomfort|0
7048072|NCT01791517|11136358|FG007|Phase I: Period 3|Lens Discomfort|0
7048073|NCT01791517|11136359|FG008|Phase I: Period 3|Lens Discomfort|0
7048074|NCT01791517|11136360|FG009|Phase I: Period 3|Lens Discomfort|0
7048075|NCT01791517|11136361|FG010|Phase I: Period 3|Lens Discomfort|0
7048076|NCT01791517|11136362|FG011|Phase I: Period 3|Lens Discomfort|1
7048077|NCT01791517|11136351|FG000|Phase I: Period 3|Lost to Follow-up|0
7048078|NCT01791517|11136352|FG001|Phase I: Period 3|Lost to Follow-up|1
7048079|NCT01791517|11136353|FG002|Phase I: Period 3|Lost to Follow-up|0
7048080|NCT01791517|11136354|FG003|Phase I: Period 3|Lost to Follow-up|0
7048081|NCT01791517|11136355|FG004|Phase I: Period 3|Lost to Follow-up|1
7048082|NCT01791517|11136356|FG005|Phase I: Period 3|Lost to Follow-up|0
7048083|NCT01791517|11136357|FG006|Phase I: Period 3|Lost to Follow-up|0
7048084|NCT01791517|11136358|FG007|Phase I: Period 3|Lost to Follow-up|0
7048085|NCT01791517|11136359|FG008|Phase I: Period 3|Lost to Follow-up|0
7048086|NCT01791517|11136360|FG009|Phase I: Period 3|Lost to Follow-up|0
7048087|NCT01791517|11136361|FG010|Phase I: Period 3|Lost to Follow-up|0
7048088|NCT01791517|11136362|FG011|Phase I: Period 3|Lost to Follow-up|0
7048089|NCT01791517|11136351|FG000|Phase I: Period 3|Adverse Event|0
7048090|NCT01791517|11136352|FG001|Phase I: Period 3|Adverse Event|0
7048091|NCT01791517|11136353|FG002|Phase I: Period 3|Adverse Event|0
7048092|NCT01791517|11136354|FG003|Phase I: Period 3|Adverse Event|1
7048093|NCT01791517|11136355|FG004|Phase I: Period 3|Adverse Event|0
7048094|NCT01791517|11136356|FG005|Phase I: Period 3|Adverse Event|0
7048095|NCT01791517|11136357|FG006|Phase I: Period 3|Adverse Event|0
7048096|NCT01791517|11136358|FG007|Phase I: Period 3|Adverse Event|0
7048097|NCT01791517|11136359|FG008|Phase I: Period 3|Adverse Event|0
7048098|NCT01791517|11136360|FG009|Phase I: Period 3|Adverse Event|0
7048099|NCT01791517|11136361|FG010|Phase I: Period 3|Adverse Event|0
7048100|NCT01791517|11136362|FG011|Phase I: Period 3|Adverse Event|0
7048101|NCT01791517|11136351|FG000|Phase II|Lost to Follow-up|1
7048102|NCT01791517|11136352|FG001|Phase II|Lost to Follow-up|0
7048103|NCT01791517|11136353|FG002|Phase II|Lost to Follow-up|1
7048104|NCT01791517|11136354|FG003|Phase II|Lost to Follow-up|0
7048105|NCT01791517|11136355|FG004|Phase II|Lost to Follow-up|1
7048106|NCT01791517|11136356|FG005|Phase II|Lost to Follow-up|2
7048107|NCT01791517|11136357|FG006|Phase II|Lost to Follow-up|0
7048108|NCT01791517|11136358|FG007|Phase II|Lost to Follow-up|1
7048109|NCT01791517|11136359|FG008|Phase II|Lost to Follow-up|1
7048110|NCT01791517|11136360|FG009|Phase II|Lost to Follow-up|1
7048111|NCT01791517|11136361|FG010|Phase II|Lost to Follow-up|0
7048112|NCT01791517|11136362|FG011|Phase II|Lost to Follow-up|0
7048113|NCT01791517|11136351|FG000|Phase II|Withdrawal by Subject|1
7048114|NCT01791517|11136352|FG001|Phase II|Withdrawal by Subject|0
7048115|NCT01791517|11136353|FG002|Phase II|Withdrawal by Subject|0
7048116|NCT01791517|11136354|FG003|Phase II|Withdrawal by Subject|0
7048117|NCT01791517|11136355|FG004|Phase II|Withdrawal by Subject|0
7048118|NCT01791517|11136356|FG005|Phase II|Withdrawal by Subject|2
7048119|NCT01791517|11136357|FG006|Phase II|Withdrawal by Subject|0
7048120|NCT01791517|11136358|FG007|Phase II|Withdrawal by Subject|1
7048121|NCT01791517|11136359|FG008|Phase II|Withdrawal by Subject|0
7188640|NCT02891226|11388862|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7188641|NCT02891226|11388863|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7188642|NCT02891226|11388864|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7188643|NCT02891226|11388865|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7188644|NCT02891226|11388866|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7188645|NCT02891226|11388867|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7188646|NCT02891226|11388868|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108
7188647|NCT02891226|11388869|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7188648|NCT02891226|11388870|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7188649|NCT02891226|11388871|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7188650|NCT02891226|11388872|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7188651|NCT02891226|11388873|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7188652|NCT02891226|11388858|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7188653|NCT02891226|11388859|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7188654|NCT02891226|11388860|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7048122|NCT01791517|11136360|FG009|Phase II|Withdrawal by Subject|0
7048123|NCT01791517|11136361|FG010|Phase II|Withdrawal by Subject|1
7048124|NCT01791517|11136362|FG011|Phase II|Withdrawal by Subject|0
7048125|NCT01791517|11136351|FG000|Phase II|Lack of Efficacy|0
7048126|NCT01791517|11136352|FG001|Phase II|Lack of Efficacy|0
7048127|NCT01791517|11136353|FG002|Phase II|Lack of Efficacy|0
7048128|NCT01791517|11136354|FG003|Phase II|Lack of Efficacy|0
7048129|NCT01791517|11136355|FG004|Phase II|Lack of Efficacy|1
7048130|NCT01791517|11136356|FG005|Phase II|Lack of Efficacy|0
7048131|NCT01791517|11136357|FG006|Phase II|Lack of Efficacy|0
7048132|NCT01791517|11136358|FG007|Phase II|Lack of Efficacy|0
7048133|NCT01791517|11136359|FG008|Phase II|Lack of Efficacy|0
7048134|NCT01791517|11136360|FG009|Phase II|Lack of Efficacy|0
7048135|NCT01791517|11136361|FG010|Phase II|Lack of Efficacy|0
7048136|NCT01791517|11136362|FG011|Phase II|Lack of Efficacy|0
7048137|NCT01791517|11136351|FG000|Phase II|Adverse Event|0
7048138|NCT01791517|11136352|FG001|Phase II|Adverse Event|0
7048139|NCT01791517|11136353|FG002|Phase II|Adverse Event|0
7048140|NCT01791517|11136354|FG003|Phase II|Adverse Event|0
7048141|NCT01791517|11136355|FG004|Phase II|Adverse Event|0
7048142|NCT01791517|11136356|FG005|Phase II|Adverse Event|0
7048143|NCT01791517|11136357|FG006|Phase II|Adverse Event|2
7048144|NCT01791517|11136358|FG007|Phase II|Adverse Event|1
7048145|NCT01791517|11136359|FG008|Phase II|Adverse Event|0
7048146|NCT01791517|11136360|FG009|Phase II|Adverse Event|1
7048147|NCT01791517|11136361|FG010|Phase II|Adverse Event|0
7048148|NCT01791517|11136362|FG011|Phase II|Adverse Event|0
7048149|NCT01791517|11136351|FG000|Phase II|Lens Handling Difficulties|0
7048150|NCT01791517|11136352|FG001|Phase II|Lens Handling Difficulties|0
7048151|NCT01791517|11136353|FG002|Phase II|Lens Handling Difficulties|0
7048152|NCT01791517|11136354|FG003|Phase II|Lens Handling Difficulties|0
7048153|NCT01791517|11136355|FG004|Phase II|Lens Handling Difficulties|0
7048154|NCT01791517|11136356|FG005|Phase II|Lens Handling Difficulties|0
7048155|NCT01791517|11136357|FG006|Phase II|Lens Handling Difficulties|0
7048156|NCT01791517|11136358|FG007|Phase II|Lens Handling Difficulties|0
7048157|NCT01791517|11136359|FG008|Phase II|Lens Handling Difficulties|1
7083403|NCT02152761|11194517|FG000|Epoch: Treatment Epoch|Death|0
7083404|NCT02152761|11194518|FG001|Epoch: Treatment Epoch|Death|3
7083405|NCT02152761|11194519|FG002|Epoch: Treatment Epoch|Death|1
7083406|NCT02152761|11194520|FG003|Epoch: Treatment Epoch|Death|0
7083407|NCT02152761|11194517|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1
7083408|NCT02152761|11194518|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1
7083409|NCT02152761|11194519|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0
7083410|NCT02152761|11194520|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0
7083411|NCT02152761|11194517|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1
7083412|NCT02152761|11194518|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3
7083413|NCT02152761|11194519|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0
7188655|NCT02891226|11388861|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7188656|NCT02891226|11388862|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7188657|NCT02891226|11388863|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7188658|NCT02891226|11388864|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7188659|NCT02891226|11388865|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7188660|NCT02891226|11388866|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7188661|NCT02891226|11388867|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7188662|NCT02891226|11388868|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2
7188663|NCT02891226|11388869|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7188664|NCT02891226|11388870|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7048158|NCT01791517|11136360|FG009|Phase II|Lens Handling Difficulties|0
7048159|NCT01791517|11136361|FG010|Phase II|Lens Handling Difficulties|0
7048160|NCT01791517|11136362|FG011|Phase II|Lens Handling Difficulties|0
7048161|NCT01791517|11136351|FG000|Phase II|Unsatisfactory Lens Fitting|0
7048162|NCT01791517|11136352|FG001|Phase II|Unsatisfactory Lens Fitting|0
7048163|NCT01791517|11136353|FG002|Phase II|Unsatisfactory Lens Fitting|0
7048164|NCT01791517|11136354|FG003|Phase II|Unsatisfactory Lens Fitting|0
7048165|NCT01791517|11136355|FG004|Phase II|Unsatisfactory Lens Fitting|0
7048166|NCT01791517|11136356|FG005|Phase II|Unsatisfactory Lens Fitting|0
7048167|NCT01791517|11136357|FG006|Phase II|Unsatisfactory Lens Fitting|0
7048168|NCT01791517|11136358|FG007|Phase II|Unsatisfactory Lens Fitting|0
7048169|NCT01791517|11136359|FG008|Phase II|Unsatisfactory Lens Fitting|0
7048170|NCT01791517|11136360|FG009|Phase II|Unsatisfactory Lens Fitting|1
7048171|NCT01791517|11136361|FG010|Phase II|Unsatisfactory Lens Fitting|0
7048172|NCT01791517|11136362|FG011|Phase II|Unsatisfactory Lens Fitting|0
7048173|NCT01791517|11136351|FG000|Phase II|Pre-Existing Ocular Issue|0
7048174|NCT01791517|11136352|FG001|Phase II|Pre-Existing Ocular Issue|0
7048175|NCT01791517|11136353|FG002|Phase II|Pre-Existing Ocular Issue|0
7048176|NCT01791517|11136354|FG003|Phase II|Pre-Existing Ocular Issue|0
7048177|NCT01791517|11136355|FG004|Phase II|Pre-Existing Ocular Issue|0
7048178|NCT01791517|11136356|FG005|Phase II|Pre-Existing Ocular Issue|0
7048179|NCT01791517|11136357|FG006|Phase II|Pre-Existing Ocular Issue|0
7048180|NCT01791517|11136358|FG007|Phase II|Pre-Existing Ocular Issue|0
7048181|NCT01791517|11136359|FG008|Phase II|Pre-Existing Ocular Issue|0
7048182|NCT01791517|11136360|FG009|Phase II|Pre-Existing Ocular Issue|0
7048183|NCT01791517|11136361|FG010|Phase II|Pre-Existing Ocular Issue|0
7048184|NCT01791517|11136362|FG011|Phase II|Pre-Existing Ocular Issue|1
7083414|NCT02152761|11194520|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1
7083415|NCT02152761|11194517|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1
7083416|NCT02152761|11194518|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4
7083417|NCT02152761|11194519|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0
7083418|NCT02152761|11194520|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0
7083419|NCT02152761|11194517|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1
7083420|NCT02152761|11194518|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0
7083421|NCT02152761|11194519|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0
7083422|NCT02152761|11194520|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0
7083423|NCT02152761|11194517|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1
7083424|NCT02152761|11194518|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0
7083425|NCT02152761|11194519|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0
7083426|NCT02152761|11194520|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1
7083427|NCT02153073|11194545|FG000|Overall Study|Case Report Forms Uncollected|230
7083428|NCT02153073|11194545|FG000|Overall Study|Protocol Deviation|68
7083429|NCT02153086|11194549|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2
7083430|NCT02153086|11194549|FG000|Overall Study|Other|2
7083431|NCT02153112|11194592|FG000|Overall Study|Adverse Event|0
7083432|NCT02153112|11194593|FG001|Overall Study|Adverse Event|0
7083433|NCT02153112|11194594|FG002|Overall Study|Adverse Event|1
7083434|NCT02153112|11194595|FG003|Overall Study|Adverse Event|0
7083435|NCT02153112|11194596|FG004|Overall Study|Adverse Event|0
7083436|NCT02153112|11194597|FG005|Overall Study|Adverse Event|0
7083437|NCT02153112|11194598|FG006|Overall Study|Adverse Event|0
7083438|NCT02153112|11194599|FG007|Overall Study|Adverse Event|0
7083439|NCT02153112|11194600|FG008|Overall Study|Adverse Event|0
7083440|NCT02153112|11194601|FG009|Overall Study|Adverse Event|0
7083441|NCT02153112|11194592|FG000|Overall Study|Lost to Follow-up|1
7083442|NCT02153112|11194593|FG001|Overall Study|Lost to Follow-up|1
7083443|NCT02153112|11194594|FG002|Overall Study|Lost to Follow-up|0
7083444|NCT02153112|11194595|FG003|Overall Study|Lost to Follow-up|0
7083445|NCT02153112|11194596|FG004|Overall Study|Lost to Follow-up|2
7083446|NCT02153112|11194597|FG005|Overall Study|Lost to Follow-up|1
7083447|NCT02153112|11194598|FG006|Overall Study|Lost to Follow-up|1
7083448|NCT02153112|11194599|FG007|Overall Study|Lost to Follow-up|0
7083449|NCT02153112|11194600|FG008|Overall Study|Lost to Follow-up|1
7083450|NCT02153112|11194601|FG009|Overall Study|Lost to Follow-up|1
7083451|NCT02153112|11194592|FG000|Overall Study|Withdrawal by Subject|3
7083452|NCT02153112|11194593|FG001|Overall Study|Withdrawal by Subject|1
7083453|NCT02153112|11194594|FG002|Overall Study|Withdrawal by Subject|2
7083454|NCT02153112|11194595|FG003|Overall Study|Withdrawal by Subject|2
7083455|NCT02153112|11194596|FG004|Overall Study|Withdrawal by Subject|1
7083456|NCT02153112|11194597|FG005|Overall Study|Withdrawal by Subject|1
7083457|NCT02153112|11194598|FG006|Overall Study|Withdrawal by Subject|7
7083458|NCT02153112|11194599|FG007|Overall Study|Withdrawal by Subject|2
7083459|NCT02153112|11194600|FG008|Overall Study|Withdrawal by Subject|13
7083460|NCT02153112|11194601|FG009|Overall Study|Withdrawal by Subject|12
7083461|NCT02153112|11194592|FG000|Overall Study|Reason not Specified|0
7083462|NCT02153112|11194593|FG001|Overall Study|Reason not Specified|0
7083463|NCT02153112|11194594|FG002|Overall Study|Reason not Specified|0
7083464|NCT02153112|11194595|FG003|Overall Study|Reason not Specified|0
7083465|NCT02153112|11194596|FG004|Overall Study|Reason not Specified|0
7083466|NCT02153112|11194597|FG005|Overall Study|Reason not Specified|0
7083467|NCT02153112|11194598|FG006|Overall Study|Reason not Specified|0
7083468|NCT02153112|11194599|FG007|Overall Study|Reason not Specified|0
7083469|NCT02153112|11194600|FG008|Overall Study|Reason not Specified|1
7083470|NCT02153112|11194601|FG009|Overall Study|Reason not Specified|1
7083471|NCT02153346|11194625|FG000|Overall Study|Lost to Follow-up|11
7083472|NCT02153359|11194630|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0
7083473|NCT02153359|11194631|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2
7083474|NCT02153398|11194645|FG000|Overall Study|Withdrawal by Subject|1
7083475|NCT02153398|11194646|FG001|Overall Study|Withdrawal by Subject|0
7083476|NCT02153398|11194647|FG002|Overall Study|Withdrawal by Subject|0
7083477|NCT02153398|11194648|FG003|Overall Study|Withdrawal by Subject|0
7083478|NCT02153398|11194649|FG004|Overall Study|Withdrawal by Subject|0
7083479|NCT02153398|11194645|FG000|Overall Study|Adverse Event|0
7083480|NCT02153398|11194646|FG001|Overall Study|Adverse Event|0
7083481|NCT02153398|11194647|FG002|Overall Study|Adverse Event|1
7083482|NCT02153398|11194648|FG003|Overall Study|Adverse Event|1
7083483|NCT02153398|11194649|FG004|Overall Study|Adverse Event|0
7083484|NCT02153736|11194712|FG000|Overall Study|Lost to Follow-up|1
7083485|NCT02153736|11194713|FG001|Overall Study|Lost to Follow-up|0
7083486|NCT02153736|11194712|FG000|Overall Study|Medical status change made ineligible|1
7083487|NCT02153736|11194713|FG001|Overall Study|Medical status change made ineligible|0
7083488|NCT02153736|11194712|FG000|Overall Study|Death|0
7083489|NCT02153736|11194713|FG001|Overall Study|Death|1
7083490|NCT02153736|11194712|FG000|Overall Study|Withdrawal by Subject|0
7083491|NCT02153736|11194713|FG001|Overall Study|Withdrawal by Subject|1
7083492|NCT02153788|11194721|FG000|Overall Study|Physician Decision|2
7048185|NCT01791725|11136383|FG000|Overall Study|Withdrawal by Subject|0
7048186|NCT01791725|11136384|FG001|Overall Study|Withdrawal by Subject|1
7048187|NCT01791725|11136385|FG002|Overall Study|Withdrawal by Subject|0
7048188|NCT01791803|11136397|FG000|Overall Study|Withdrawal by Subject|0
7048189|NCT01791803|11136398|FG001|Overall Study|Withdrawal by Subject|0
7048190|NCT01791803|11136399|FG002|Overall Study|Withdrawal by Subject|0
7048191|NCT01791803|11136400|FG003|Overall Study|Withdrawal by Subject|2
7048192|NCT01791803|11136397|FG000|Overall Study|Physician Decision|0
7048193|NCT01791803|11136398|FG001|Overall Study|Physician Decision|2
7048194|NCT01791803|11136399|FG002|Overall Study|Physician Decision|0
7048195|NCT01791803|11136400|FG003|Overall Study|Physician Decision|1
7048196|NCT01791803|11136397|FG000|Overall Study|Death|0
7048197|NCT01791803|11136398|FG001|Overall Study|Death|0
7048198|NCT01791803|11136399|FG002|Overall Study|Death|2
7048199|NCT01791803|11136400|FG003|Overall Study|Death|2
7048200|NCT01791894|11136413|FG000|Overall Study|Adverse Event|1
7048201|NCT01792115|11136434|FG000|Overall Study|Lost to Follow-up|0
7048202|NCT01792115|11136435|FG001|Overall Study|Lost to Follow-up|1
7083493|NCT02153788|11194722|FG001|Overall Study|Physician Decision|1
7083494|NCT02153827|11194730|FG000|Overall Study|Lost to Follow-up|3
7048203|NCT01792115|11136436|FG002|Overall Study|Lost to Follow-up|0
7048204|NCT01792284|11136444|FG000|Lead-in Period|Adverse Event|15
7048205|NCT01792284|11136445|FG001|Lead-in Period|Adverse Event|0
7048206|NCT01792284|11136446|FG002|Lead-in Period|Adverse Event|0
7048207|NCT01792284|11136444|FG000|Lead-in Period|Lost to Follow-up|2
7048208|NCT01792284|11136445|FG001|Lead-in Period|Lost to Follow-up|0
7048209|NCT01792284|11136446|FG002|Lead-in Period|Lost to Follow-up|0
7048210|NCT01792284|11136444|FG000|Lead-in Period|Protocol Violation|1
7048211|NCT01792284|11136445|FG001|Lead-in Period|Protocol Violation|0
7048212|NCT01792284|11136446|FG002|Lead-in Period|Protocol Violation|0
7048213|NCT01792284|11136444|FG000|Lead-in Period|Withdrawal by Subject|10
7048214|NCT01792284|11136445|FG001|Lead-in Period|Withdrawal by Subject|0
7048215|NCT01792284|11136446|FG002|Lead-in Period|Withdrawal by Subject|0
7048216|NCT01792284|11136444|FG000|Lead-in Period|Physician Decision|1
7048217|NCT01792284|11136445|FG001|Lead-in Period|Physician Decision|0
7048218|NCT01792284|11136446|FG002|Lead-in Period|Physician Decision|0
7083495|NCT02153827|11194731|FG001|Overall Study|Lost to Follow-up|9
7083496|NCT02153905|11194739|FG000|Overall Study|Death|1
7083497|NCT02153905|11194740|FG001|Overall Study|Death|0
7083498|NCT02153918|11194746|FG000|Overall Study|Refused further treatment|1
7083499|NCT02154061|11194790|FG000|Overall Study|Pregnancy|1
7083500|NCT02154061|11194791|FG001|Overall Study|Pregnancy|0
7083501|NCT02154061|11194790|FG000|Overall Study|enrolled but not vaccinated|1
7083502|NCT02154061|11194791|FG001|Overall Study|enrolled but not vaccinated|0
7083503|NCT02154139|11194797|FG000|Overall Study|Injection not administered|2
7083504|NCT02154139|11194797|FG000|Overall Study|Other|2
7083505|NCT02154139|11194797|FG000|Overall Study|Investigator transferred|3
7083506|NCT02154347|11194816|FG000|Double-blind Period|Adverse Event|1
7083507|NCT02154347|11194817|FG001|Double-blind Period|Adverse Event|2
7083508|NCT02154347|11194816|FG000|Double-blind Period|Lack of Efficacy|1
7083509|NCT02154347|11194817|FG001|Double-blind Period|Lack of Efficacy|0
7083510|NCT02154347|11194816|FG000|Double-blind Period|Physician Decision|0
7083511|NCT02154347|11194817|FG001|Double-blind Period|Physician Decision|1
7083512|NCT02154347|11194816|FG000|Double-blind Period|Withdrawal by Subject|1
7083513|NCT02154347|11194817|FG001|Double-blind Period|Withdrawal by Subject|1
7083514|NCT02154347|11194816|FG000|Open-label Period|Adverse Event|3
7083515|NCT02154347|11194817|FG001|Open-label Period|Adverse Event|4
7083516|NCT02154347|11194816|FG000|Open-label Period|Lack of Efficacy|4
7083517|NCT02154347|11194817|FG001|Open-label Period|Lack of Efficacy|19
7083518|NCT02154347|11194816|FG000|Open-label Period|Protocol Violation|0
7048219|NCT01792284|11136444|FG000|Lead-in Period|Protocol Required Discontinuation|1
7048220|NCT01792284|11136445|FG001|Lead-in Period|Protocol Required Discontinuation|0
7048221|NCT01792284|11136446|FG002|Lead-in Period|Protocol Required Discontinuation|0
7048222|NCT01792284|11136444|FG000|Randomization Period 1|Withdrawal by Subject|0
7048223|NCT01792284|11136445|FG001|Randomization Period 1|Withdrawal by Subject|1
7048224|NCT01792284|11136446|FG002|Randomization Period 1|Withdrawal by Subject|1
7048225|NCT01792284|11136444|FG000|Randomization Period 1|Physician Decision|0
7048226|NCT01792284|11136445|FG001|Randomization Period 1|Physician Decision|1
7048227|NCT01792284|11136446|FG002|Randomization Period 1|Physician Decision|1
7048228|NCT01792284|11136444|FG000|Randomization Period 1|Adverse Event|0
7048229|NCT01792284|11136445|FG001|Randomization Period 1|Adverse Event|0
7048230|NCT01792284|11136446|FG002|Randomization Period 1|Adverse Event|2
7048231|NCT01792284|11136444|FG000|Randomization Period 1|Lost to Follow-up|0
7048232|NCT01792284|11136445|FG001|Randomization Period 1|Lost to Follow-up|0
7048233|NCT01792284|11136446|FG002|Randomization Period 1|Lost to Follow-up|1
7048234|NCT01792284|11136444|FG000|Randomization Period 2|Protocol Violation|0
7083519|NCT02154347|11194817|FG001|Open-label Period|Protocol Violation|1
7048235|NCT01792284|11136445|FG001|Randomization Period 2|Protocol Violation|1
7048236|NCT01792284|11136446|FG002|Randomization Period 2|Protocol Violation|0
7048237|NCT01792284|11136444|FG000|Randomization Period 2|Withdrawal by Subject|0
7048238|NCT01792284|11136445|FG001|Randomization Period 2|Withdrawal by Subject|2
7048239|NCT01792284|11136446|FG002|Randomization Period 2|Withdrawal by Subject|0
7083520|NCT02154347|11194816|FG000|Open-label Period|Withdrawal by Subject|0
7048240|NCT01792518|11136456|FG000|Overall Study|Adverse Event|3
7048241|NCT01792518|11136457|FG001|Overall Study|Adverse Event|4
7048242|NCT01792518|11136456|FG000|Overall Study|Protocol Violation|0
7048243|NCT01792518|11136457|FG001|Overall Study|Protocol Violation|1
7048244|NCT01792518|11136456|FG000|Overall Study|Lost to Follow-up|3
7048245|NCT01792518|11136457|FG001|Overall Study|Lost to Follow-up|1
7048246|NCT01792518|11136456|FG000|Overall Study|Withdrawal by Subject|2
7048247|NCT01792518|11136457|FG001|Overall Study|Withdrawal by Subject|0
7048248|NCT01792518|11136456|FG000|Overall Study|Other Reason|0
7048249|NCT01792518|11136457|FG001|Overall Study|Other Reason|1
7048250|NCT01792635|11136466|FG000|Part B|Adverse Event|0
7048251|NCT01792635|11136467|FG001|Part B|Adverse Event|0
7048252|NCT01792635|11136468|FG002|Part B|Adverse Event|1
7048253|NCT01792635|11136466|FG000|Part B|Study terminated|0
7048254|NCT01792635|11136467|FG001|Part B|Study terminated|4
7048255|NCT01792635|11136468|FG002|Part B|Study terminated|3
7048256|NCT01792830|11136499|FG000|Overall Study|Withdrawal by Subject|22
7048257|NCT01792830|11136500|FG001|Overall Study|Withdrawal by Subject|0
7048258|NCT01792830|11136501|FG002|Overall Study|Withdrawal by Subject|0
7048259|NCT01792830|11136502|FG003|Overall Study|Withdrawal by Subject|2
7048260|NCT01792830|11136503|FG004|Overall Study|Withdrawal by Subject|1
7048261|NCT01792830|11136504|FG005|Overall Study|Withdrawal by Subject|1
7048262|NCT01792830|11136505|FG006|Overall Study|Withdrawal by Subject|1
7048263|NCT01792830|11136506|FG007|Overall Study|Withdrawal by Subject|1
7048264|NCT01792830|11136507|FG008|Overall Study|Withdrawal by Subject|7
7048265|NCT01792830|11136508|FG009|Overall Study|Withdrawal by Subject|0
7048266|NCT01792830|11136509|FG010|Overall Study|Withdrawal by Subject|2
7048267|NCT01792830|11136499|FG000|Overall Study|Death|3
7048268|NCT01792830|11136500|FG001|Overall Study|Death|0
7048269|NCT01792830|11136501|FG002|Overall Study|Death|0
7048270|NCT01792830|11136502|FG003|Overall Study|Death|1
7048271|NCT01792830|11136503|FG004|Overall Study|Death|0
7048272|NCT01792830|11136504|FG005|Overall Study|Death|0
7048273|NCT01792830|11136505|FG006|Overall Study|Death|1
7048274|NCT01792830|11136506|FG007|Overall Study|Death|0
7048275|NCT01792830|11136507|FG008|Overall Study|Death|1
7048276|NCT01792830|11136508|FG009|Overall Study|Death|0
7048277|NCT01792830|11136509|FG010|Overall Study|Death|1
7048278|NCT01792830|11136499|FG000|Overall Study|Adverse Event|0
7048279|NCT01792830|11136500|FG001|Overall Study|Adverse Event|0
7048280|NCT01792830|11136501|FG002|Overall Study|Adverse Event|0
7048281|NCT01792830|11136502|FG003|Overall Study|Adverse Event|0
7048282|NCT01792830|11136503|FG004|Overall Study|Adverse Event|0
7048283|NCT01792830|11136504|FG005|Overall Study|Adverse Event|0
7048284|NCT01792830|11136505|FG006|Overall Study|Adverse Event|0
7048285|NCT01792830|11136506|FG007|Overall Study|Adverse Event|0
7048286|NCT01792830|11136507|FG008|Overall Study|Adverse Event|1
7048287|NCT01792830|11136508|FG009|Overall Study|Adverse Event|0
7083521|NCT02154347|11194817|FG001|Open-label Period|Withdrawal by Subject|1
7083522|NCT02154425|11194833|FG000|Screening Period|Adverse Event|1
7083523|NCT02154581|11194852|FG000|Overall Study|Lost to Follow-up|7
7083524|NCT02154581|11194853|FG001|Overall Study|Lost to Follow-up|8
7083525|NCT02155283|11194916|FG000|Overall Study|Lost to Follow-up|3
7083526|NCT02155283|11194916|FG000|Overall Study|Withdrawal by Subject|1
7083527|NCT02155283|11194916|FG000|Overall Study|Protocol Violation|3
7083528|NCT02155309|11194922|FG000|Overall Study|Protocol Violation|0
7083529|NCT02155309|11194923|FG001|Overall Study|Protocol Violation|0
7083530|NCT02155309|11194924|FG002|Overall Study|Protocol Violation|1
7083531|NCT02155322|11194931|FG000|Overall Study|Adverse Event|1
7083532|NCT02155322|11194931|FG000|Overall Study|Physician Decision|1
7083533|NCT02155322|11194931|FG000|Overall Study|Relapse/Recurrence|8
7083534|NCT02155322|11194931|FG000|Overall Study|Withdrawal by Subject|4
7083535|NCT02155608|11195000|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0
7083536|NCT02155608|11195001|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1
7083537|NCT02155608|11195000|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1
7083538|NCT02155608|11195001|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1
7083539|NCT02155660|11195017|FG000|Overall Study|Other Reason|8
7083540|NCT02155660|11195018|FG001|Overall Study|Other Reason|6
7083541|NCT02155660|11195019|FG002|Overall Study|Other Reason|10
7083542|NCT02155660|11195020|FG003|Overall Study|Other Reason|10
7083543|NCT02155660|11195017|FG000|Overall Study|Study-specific withdrawal criteria|0
7083544|NCT02155660|11195018|FG001|Overall Study|Study-specific withdrawal criteria|1
7083545|NCT02155660|11195019|FG002|Overall Study|Study-specific withdrawal criteria|1
7083546|NCT02155660|11195020|FG003|Overall Study|Study-specific withdrawal criteria|1
7083547|NCT02155660|11195017|FG000|Overall Study|Severe non-compliance|0
7083548|NCT02155660|11195018|FG001|Overall Study|Severe non-compliance|4
7083549|NCT02155660|11195019|FG002|Overall Study|Severe non-compliance|0
7083550|NCT02155660|11195020|FG003|Overall Study|Severe non-compliance|1
7083551|NCT02155660|11195017|FG000|Overall Study|Adverse Event|2
7083552|NCT02155660|11195018|FG001|Overall Study|Adverse Event|6
7083553|NCT02155660|11195019|FG002|Overall Study|Adverse Event|3
7083554|NCT02155660|11195020|FG003|Overall Study|Adverse Event|1
7083555|NCT02155660|11195017|FG000|Overall Study|Lost to Follow-up|3
7083556|NCT02155660|11195018|FG001|Overall Study|Lost to Follow-up|6
7048288|NCT01792830|11136509|FG010|Overall Study|Adverse Event|0
7048289|NCT01793051|11136545|FG000|Overall Study|Withdrawal by Subject|6
7048290|NCT01793051|11136546|FG001|Overall Study|Withdrawal by Subject|4
7048291|NCT01793051|11136545|FG000|Overall Study|Adverse Event|0
7048292|NCT01793051|11136546|FG001|Overall Study|Adverse Event|2
7048293|NCT01793051|11136545|FG000|Overall Study|Too ill to continue|1
7048294|NCT01793051|11136546|FG001|Overall Study|Too ill to continue|0
7048295|NCT01793051|11136545|FG000|Overall Study|Switched chemo|1
7048296|NCT01793051|11136546|FG001|Overall Study|Switched chemo|1
7048297|NCT01793051|11136545|FG000|Overall Study|Lack of compliance|1
7048298|NCT01793051|11136546|FG001|Overall Study|Lack of compliance|0
7048299|NCT01793051|11136545|FG000|Overall Study|Requested to be removed from the study|1
7048300|NCT01793051|11136546|FG001|Overall Study|Requested to be removed from the study|1
7048301|NCT01793142|11136552|FG000|Overall Study|Randomized not treated|7
7048302|NCT01793688|11136560|FG000|Overall Study|Protocol Violation|2
7048303|NCT01793792|11136564|FG000|Overall Study|Death|5
7048304|NCT01793792|11136564|FG000|Overall Study|Lost to Follow-up|5
7048305|NCT01793792|11136564|FG000|Overall Study|Withdrawal by Subject|1
7048306|NCT01793792|11136564|FG000|Overall Study|Device Not Implanted|1
7048307|NCT01793883|11136571|FG000|Overall Study|Withdrawal by Subject|3
7048308|NCT01793883|11136572|FG001|Overall Study|Withdrawal by Subject|7
7048309|NCT01793883|11136573|FG002|Overall Study|Withdrawal by Subject|3
7048310|NCT01793883|11136571|FG000|Overall Study|Subject noncompliance|0
7048311|NCT01793883|11136572|FG001|Overall Study|Subject noncompliance|1
7048312|NCT01793883|11136573|FG002|Overall Study|Subject noncompliance|1
7048313|NCT01793883|11136571|FG000|Overall Study|Lost to Follow-up|5
7048314|NCT01793883|11136572|FG001|Overall Study|Lost to Follow-up|1
7048315|NCT01793883|11136573|FG002|Overall Study|Lost to Follow-up|3
7048316|NCT01793883|11136571|FG000|Overall Study|Randomized in error|1
7048317|NCT01793883|11136572|FG001|Overall Study|Randomized in error|0
7048318|NCT01793883|11136573|FG002|Overall Study|Randomized in error|0
7048319|NCT01793883|11136571|FG000|Overall Study|Unable to complete spriometry|1
7048320|NCT01793883|11136572|FG001|Overall Study|Unable to complete spriometry|0
7048321|NCT01793883|11136573|FG002|Overall Study|Unable to complete spriometry|0
7048322|NCT01793883|11136571|FG000|Overall Study|Unable to complete measurements|1
7048323|NCT01793883|11136572|FG001|Overall Study|Unable to complete measurements|0
7048324|NCT01793883|11136573|FG002|Overall Study|Unable to complete measurements|0
7048325|NCT01793883|11136571|FG000|Overall Study|Met exclusion criteria|1
7048326|NCT01793883|11136572|FG001|Overall Study|Met exclusion criteria|0
7048327|NCT01793883|11136573|FG002|Overall Study|Met exclusion criteria|0
7048328|NCT01793883|11136571|FG000|Overall Study|Dosing error|0
7048329|NCT01793883|11136572|FG001|Overall Study|Dosing error|1
7048330|NCT01793883|11136573|FG002|Overall Study|Dosing error|0
7048331|NCT01793883|11136571|FG000|Overall Study|Respiratory distress during spirometry|0
7048332|NCT01793883|11136572|FG001|Overall Study|Respiratory distress during spirometry|0
7048333|NCT01793883|11136573|FG002|Overall Study|Respiratory distress during spirometry|1
7048334|NCT01793935|11136592|FG000|Overall Study|Pregnancy|1
7048335|NCT01793935|11136593|FG001|Overall Study|Pregnancy|0
7048336|NCT01793935|11136592|FG000|Overall Study|Protocol Violation|2
7048337|NCT01793935|11136593|FG001|Overall Study|Protocol Violation|1
7048338|NCT01793935|11136592|FG000|Overall Study|Adverse Event|2
7048339|NCT01793935|11136593|FG001|Overall Study|Adverse Event|0
7048340|NCT01793935|11136592|FG000|Overall Study|Patient did not take study medication|1
7048341|NCT01793935|11136593|FG001|Overall Study|Patient did not take study medication|1
7048342|NCT01793935|11136592|FG000|Overall Study|Lost to Follow-up|0
7048343|NCT01793935|11136593|FG001|Overall Study|Lost to Follow-up|1
7048344|NCT01794000|11136601|FG000|Double-Blind Phase (DBP)|Adverse Event|5
7048345|NCT01794000|11136602|FG001|Double-Blind Phase (DBP)|Adverse Event|2
7048346|NCT01794000|11136601|FG000|Double-Blind Phase (DBP)|Death|1
7048347|NCT01794000|11136602|FG001|Double-Blind Phase (DBP)|Death|2
7048348|NCT01794000|11136601|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2
7048349|NCT01794000|11136602|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0
7048350|NCT01794000|11136601|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5
7048351|NCT01794000|11136602|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2
7048352|NCT01794000|11136601|FG000|Double-Blind Phase (DBP)|Physician Decision|2
7048353|NCT01794000|11136602|FG001|Double-Blind Phase (DBP)|Physician Decision|0
7048354|NCT01794000|11136601|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148
7048355|NCT01794000|11136602|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149
7048356|NCT01794000|11136601|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6
7048357|NCT01794000|11136602|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11
7048358|NCT01794000|11136601|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3
7048359|NCT01794000|11136602|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0
7048360|NCT01794117|11136624|FG000|Overall Study|Adverse Event|1
7048361|NCT01794117|11136625|FG001|Overall Study|Adverse Event|0
7048362|NCT01794117|11136626|FG002|Overall Study|Adverse Event|0
7048363|NCT01794117|11136627|FG003|Overall Study|Adverse Event|0
7048364|NCT01794117|11136624|FG000|Overall Study|Participant noncompliance|0
7048365|NCT01794117|11136625|FG001|Overall Study|Participant noncompliance|1
7048366|NCT01794117|11136626|FG002|Overall Study|Participant noncompliance|0
7048367|NCT01794117|11136627|FG003|Overall Study|Participant noncompliance|0
7048368|NCT01794117|11136624|FG000|Overall Study|Refused further treatment|0
7048369|NCT01794117|11136625|FG001|Overall Study|Refused further treatment|2
7048370|NCT01794117|11136626|FG002|Overall Study|Refused further treatment|0
7048371|NCT01794117|11136627|FG003|Overall Study|Refused further treatment|0
7048372|NCT01794299|11136638|FG000|Overall Study|ATIR manufacturing not possible|1
7048373|NCT01794299|11136638|FG000|Overall Study|Death|14
7048374|NCT01794299|11136638|FG000|Overall Study|Graft failure|1
7048375|NCT01794299|11136638|FG000|Overall Study|ATIR batch rejected|2
7048376|NCT01794299|11136638|FG000|Overall Study|Relapse|2
7048377|NCT01794299|11136638|FG000|Overall Study|Discontinued from active follow-up|1
7048378|NCT01794299|11136638|FG000|Overall Study|Relapse and rejection of ATIR batch|1
7048379|NCT01794689|11136664|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3
7048380|NCT01794689|11136665|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0
7048381|NCT01794689|11136666|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2
7048382|NCT01794689|11136667|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4
7048383|NCT01794689|11136664|FG000|Intervention 1 (2 Nights)|Protocol Violation|1
7048384|NCT01794689|11136665|FG001|Intervention 1 (2 Nights)|Protocol Violation|0
7048385|NCT01794689|11136666|FG002|Intervention 1 (2 Nights)|Protocol Violation|1
7048386|NCT01794689|11136667|FG003|Intervention 1 (2 Nights)|Protocol Violation|0
7048387|NCT01794689|11136664|FG000|Intervention 1 (2 Nights)|Physician Decision|1
7048388|NCT01794689|11136665|FG001|Intervention 1 (2 Nights)|Physician Decision|1
7048389|NCT01794689|11136666|FG002|Intervention 1 (2 Nights)|Physician Decision|0
7048390|NCT01794689|11136667|FG003|Intervention 1 (2 Nights)|Physician Decision|0
7048391|NCT01794689|11136664|FG000|Intervention 1 (2 Nights)|Adverse Event|0
7048392|NCT01794689|11136665|FG001|Intervention 1 (2 Nights)|Adverse Event|1
7048393|NCT01794689|11136666|FG002|Intervention 1 (2 Nights)|Adverse Event|0
7048394|NCT01794689|11136667|FG003|Intervention 1 (2 Nights)|Adverse Event|0
7048395|NCT01794780|11136713|FG000|Overall Study|Adverse Event|0
7048396|NCT01794780|11136714|FG001|Overall Study|Adverse Event|1
7048397|NCT01794780|11136715|FG002|Overall Study|Adverse Event|2
7048398|NCT01794780|11136716|FG003|Overall Study|Adverse Event|0
7048399|NCT01794780|11136717|FG004|Overall Study|Adverse Event|0
7048400|NCT01794780|11136718|FG005|Overall Study|Adverse Event|0
7048401|NCT01794780|11136719|FG006|Overall Study|Adverse Event|0
7048402|NCT01794780|11136720|FG007|Overall Study|Adverse Event|0
7048403|NCT01794780|11136713|FG000|Overall Study|Death|0
7048404|NCT01794780|11136714|FG001|Overall Study|Death|2
7048405|NCT01794780|11136715|FG002|Overall Study|Death|14
7048406|NCT01794780|11136716|FG003|Overall Study|Death|1
7048407|NCT01794780|11136717|FG004|Overall Study|Death|0
7048408|NCT01794780|11136718|FG005|Overall Study|Death|9
7048409|NCT01794780|11136719|FG006|Overall Study|Death|4
7048410|NCT01794780|11136720|FG007|Overall Study|Death|0
7048411|NCT01794780|11136713|FG000|Overall Study|Lost to Follow-up|10
7048412|NCT01794780|11136714|FG001|Overall Study|Lost to Follow-up|64
7048413|NCT01794780|11136715|FG002|Overall Study|Lost to Follow-up|165
7048414|NCT01794780|11136716|FG003|Overall Study|Lost to Follow-up|53
7048415|NCT01794780|11136717|FG004|Overall Study|Lost to Follow-up|2
7048416|NCT01794780|11136718|FG005|Overall Study|Lost to Follow-up|99
7048417|NCT01794780|11136719|FG006|Overall Study|Lost to Follow-up|30
7048418|NCT01794780|11136720|FG007|Overall Study|Lost to Follow-up|5
7083557|NCT02155660|11195019|FG002|Overall Study|Lost to Follow-up|5
7083558|NCT02155660|11195020|FG003|Overall Study|Lost to Follow-up|8
7083559|NCT02155660|11195017|FG000|Overall Study|Death|17
7083560|NCT02155660|11195018|FG001|Overall Study|Death|19
7083561|NCT02155660|11195019|FG002|Overall Study|Death|17
7083562|NCT02155660|11195020|FG003|Overall Study|Death|19
7083563|NCT02155660|11195017|FG000|Overall Study|Withdrawal by Subject|28
7083564|NCT02155660|11195018|FG001|Overall Study|Withdrawal by Subject|31
7083565|NCT02155660|11195019|FG002|Overall Study|Withdrawal by Subject|24
7048419|NCT01794780|11136713|FG000|Overall Study|Withdrew informed consent|7
7048420|NCT01794780|11136714|FG001|Overall Study|Withdrew informed consent|17
7048421|NCT01794780|11136715|FG002|Overall Study|Withdrew informed consent|36
7048422|NCT01794780|11136716|FG003|Overall Study|Withdrew informed consent|9
7048423|NCT01794780|11136717|FG004|Overall Study|Withdrew informed consent|0
7048424|NCT01794780|11136718|FG005|Overall Study|Withdrew informed consent|48
7048425|NCT01794780|11136719|FG006|Overall Study|Withdrew informed consent|4
7048426|NCT01794780|11136720|FG007|Overall Study|Withdrew informed consent|3
7048427|NCT01794780|11136713|FG000|Overall Study|Other|0
7048428|NCT01794780|11136714|FG001|Overall Study|Other|12
7048429|NCT01794780|11136715|FG002|Overall Study|Other|25
7048430|NCT01794780|11136716|FG003|Overall Study|Other|20
7048431|NCT01794780|11136717|FG004|Overall Study|Other|1
7048432|NCT01794780|11136718|FG005|Overall Study|Other|24
7048433|NCT01794780|11136719|FG006|Overall Study|Other|4
7048434|NCT01794780|11136720|FG007|Overall Study|Other|1
7048435|NCT01794845|11136754|FG000|Overall Study|Withdrawal by Subject|1
7048436|NCT01794923|11136761|FG000|Overall Study|Adverse Event|0
7083566|NCT02155660|11195020|FG003|Overall Study|Withdrawal by Subject|21
7083567|NCT02155712|11195032|FG000|Primary Objective|Death|3
7048437|NCT01794923|11136762|FG001|Overall Study|Adverse Event|0
7083568|NCT02155712|11195033|FG001|Primary Objective|Death|0
7083569|NCT02155712|11195032|FG000|Primary Objective|Lost to Follow-up|22
7048438|NCT01794923|11136763|FG002|Overall Study|Adverse Event|1
7048439|NCT01794949|11136773|FG000|Overall Study|Lost to Follow-up|1
7048440|NCT01794949|11136774|FG001|Overall Study|Lost to Follow-up|0
7048441|NCT01795495|11136797|FG000|Overall Study|Protocol Violation|1
7048442|NCT01795495|11136798|FG001|Overall Study|Protocol Violation|0
7083570|NCT02155712|11195033|FG001|Primary Objective|Lost to Follow-up|0
7048443|NCT01795495|11136799|FG002|Overall Study|Protocol Violation|1
7048444|NCT01795495|11136797|FG000|Overall Study|Physician Decision|0
7048445|NCT01795495|11136798|FG001|Overall Study|Physician Decision|0
7048446|NCT01795495|11136799|FG002|Overall Study|Physician Decision|1
7048447|NCT01795547|11136816|FG000|Overall Study|Adverse Event|16
7048448|NCT01795547|11136817|FG001|Overall Study|Adverse Event|27
7048449|NCT01795547|11136816|FG000|Overall Study|Lack of Efficacy|8
7048450|NCT01795547|11136817|FG001|Overall Study|Lack of Efficacy|3
7048451|NCT01795547|11136816|FG000|Overall Study|Protocol Violation|6
7048452|NCT01795547|11136817|FG001|Overall Study|Protocol Violation|4
7048453|NCT01795547|11136816|FG000|Overall Study|Lost to Follow-up|2
7048454|NCT01795547|11136817|FG001|Overall Study|Lost to Follow-up|5
7048455|NCT01795547|11136816|FG000|Overall Study|Withdrawal of consent|7
7048456|NCT01795547|11136817|FG001|Overall Study|Withdrawal of consent|12
7048457|NCT01795547|11136816|FG000|Overall Study|Not Treated|4
7048458|NCT01795547|11136817|FG001|Overall Study|Not Treated|10
7048459|NCT01795547|11136816|FG000|Overall Study|Non-compliance with IMP|1
7048460|NCT01795547|11136817|FG001|Overall Study|Non-compliance with IMP|1
7048461|NCT01795547|11136816|FG000|Overall Study|Others|4
7048462|NCT01795547|11136817|FG001|Overall Study|Others|1
7048463|NCT01795547|11136816|FG000|Overall Study|Not stated|0
7048464|NCT01795547|11136817|FG001|Overall Study|Not stated|1
7048465|NCT01795638|11136827|FG000|Overall Study|Death|0
7048466|NCT01795638|11136828|FG001|Overall Study|Death|3
7048467|NCT01795638|11136827|FG000|Overall Study|transferred to quaternary hospital|2
7048468|NCT01795638|11136828|FG001|Overall Study|transferred to quaternary hospital|3
7048469|NCT01795638|11136827|FG000|Overall Study|Protocol Violation|3
7048470|NCT01795638|11136828|FG001|Overall Study|Protocol Violation|0
7048471|NCT01795638|11136827|FG000|Overall Study|discharged from hospital|7
7048472|NCT01795638|11136828|FG001|Overall Study|discharged from hospital|5
7048473|NCT01795638|11136827|FG000|Overall Study|Withdrawal by Subject|1
7048474|NCT01795638|11136828|FG001|Overall Study|Withdrawal by Subject|0
7048475|NCT01795898|11136863|FG000|Overall Study|Adverse Event|27
7048476|NCT01795898|11136863|FG000|Overall Study|Lost to Follow-up|20
7048477|NCT01795898|11136863|FG000|Overall Study|Withdrawal of consent|6
7048478|NCT01795898|11136863|FG000|Overall Study|Diagnosed with metastasis|1
7048479|NCT01795898|11136863|FG000|Overall Study|No pain|1
7048480|NCT01795898|11136863|FG000|Overall Study|Death|1
7048481|NCT01795898|11136863|FG000|Overall Study|Withdrew consent & had adverse events|3
7048482|NCT01795898|11136863|FG000|Overall Study|Physician Decision|1
7048483|NCT01795937|11136870|FG000|Overall Study|Withdrawal by Subject|1
7048484|NCT01795937|11136871|FG001|Overall Study|Withdrawal by Subject|0
7048485|NCT01795937|11136872|FG002|Overall Study|Withdrawal by Subject|0
7048486|NCT01795937|11136870|FG000|Overall Study|Physician Decision|0
7048487|NCT01795937|11136871|FG001|Overall Study|Physician Decision|1
7048488|NCT01795937|11136872|FG002|Overall Study|Physician Decision|0
7048489|NCT01796301|11136900|FG000|Overall Study|Withdrawal by Subject|15
7048490|NCT01796301|11136901|FG001|Overall Study|Withdrawal by Subject|15
7048491|NCT01796301|11136900|FG000|Overall Study|Lost to Follow-up|3
7048492|NCT01796301|11136901|FG001|Overall Study|Lost to Follow-up|3
7048493|NCT01796301|11136900|FG000|Overall Study|Death|0
7048494|NCT01796301|11136901|FG001|Overall Study|Death|1
7048495|NCT01796301|11136900|FG000|Overall Study|Decision by Sponsor|0
7048496|NCT01796301|11136901|FG001|Overall Study|Decision by Sponsor|1
7048497|NCT01796392|11136909|FG000|Overall Study|Withdrawal by Subject|2
7048498|NCT01796392|11136910|FG001|Overall Study|Withdrawal by Subject|0
7048499|NCT01796392|11136909|FG000|Overall Study|Death|5
7048500|NCT01796392|11136910|FG001|Overall Study|Death|1
7048501|NCT01796392|11136909|FG000|Overall Study|Excluded for medical reasons|1
7048502|NCT01796392|11136910|FG001|Overall Study|Excluded for medical reasons|2
7048503|NCT01796392|11136909|FG000|Overall Study|Lost to Follow-up|1
7048504|NCT01796392|11136910|FG001|Overall Study|Lost to Follow-up|0
7048505|NCT01796470|11136921|FG000|Overall Study|Adverse Event|4
7048506|NCT01796470|11136922|FG001|Overall Study|Adverse Event|2
7048507|NCT01796470|11136923|FG002|Overall Study|Adverse Event|2
7048508|NCT01796470|11136924|FG003|Overall Study|Adverse Event|1
7048509|NCT01796470|11136925|FG004|Overall Study|Adverse Event|3
7048510|NCT01796470|11136921|FG000|Overall Study|Death|2
7048511|NCT01796470|11136922|FG001|Overall Study|Death|0
7048512|NCT01796470|11136923|FG002|Overall Study|Death|0
7048513|NCT01796470|11136924|FG003|Overall Study|Death|0
7048514|NCT01796470|11136925|FG004|Overall Study|Death|1
7083571|NCT02155712|11195032|FG000|Primary Objective|No 2-Year Forms but not Terminated|13
7048515|NCT01796470|11136921|FG000|Overall Study|Initiated New Therapy|9
7048516|NCT01796470|11136922|FG001|Overall Study|Initiated New Therapy|0
7048517|NCT01796470|11136923|FG002|Overall Study|Initiated New Therapy|0
7048518|NCT01796470|11136924|FG003|Overall Study|Initiated New Therapy|0
7048519|NCT01796470|11136925|FG004|Overall Study|Initiated New Therapy|2
7048520|NCT01796470|11136921|FG000|Overall Study|Lost to Follow-up|0
7048521|NCT01796470|11136922|FG001|Overall Study|Lost to Follow-up|1
7048522|NCT01796470|11136923|FG002|Overall Study|Lost to Follow-up|0
7048523|NCT01796470|11136924|FG003|Overall Study|Lost to Follow-up|0
7048524|NCT01796470|11136925|FG004|Overall Study|Lost to Follow-up|0
7048525|NCT01796470|11136921|FG000|Overall Study|Physician Decision|5
7048526|NCT01796470|11136922|FG001|Overall Study|Physician Decision|4
7048527|NCT01796470|11136923|FG002|Overall Study|Physician Decision|1
7048528|NCT01796470|11136924|FG003|Overall Study|Physician Decision|0
7048529|NCT01796470|11136925|FG004|Overall Study|Physician Decision|1
7048530|NCT01796470|11136921|FG000|Overall Study|Progressive Disease|7
7048531|NCT01796470|11136922|FG001|Overall Study|Progressive Disease|7
7048532|NCT01796470|11136923|FG002|Overall Study|Progressive Disease|3
7048533|NCT01796470|11136924|FG003|Overall Study|Progressive Disease|2
7048534|NCT01796470|11136925|FG004|Overall Study|Progressive Disease|0
7048535|NCT01796470|11136921|FG000|Overall Study|Protocol Criteria for Withdrawal|1
7048536|NCT01796470|11136922|FG001|Overall Study|Protocol Criteria for Withdrawal|0
7048537|NCT01796470|11136923|FG002|Overall Study|Protocol Criteria for Withdrawal|0
7048538|NCT01796470|11136924|FG003|Overall Study|Protocol Criteria for Withdrawal|0
7048539|NCT01796470|11136925|FG004|Overall Study|Protocol Criteria for Withdrawal|0
7048540|NCT01796470|11136921|FG000|Overall Study|Withdrawal by Subject|7
7048541|NCT01796470|11136922|FG001|Overall Study|Withdrawal by Subject|0
7048542|NCT01796470|11136923|FG002|Overall Study|Withdrawal by Subject|0
7048543|NCT01796470|11136924|FG003|Overall Study|Withdrawal by Subject|0
7048544|NCT01796470|11136925|FG004|Overall Study|Withdrawal by Subject|1
7048545|NCT01796548|11136941|FG000|Overall Study|Lost to Follow-up|1
7048546|NCT01796548|11136941|FG000|Overall Study|Other|2
7048547|NCT01796860|11136958|FG000|Overall Study|Withdrawal by Subject|3
7048548|NCT01796964|11136973|FG000|Overall Study|Adverse Event|1
7048549|NCT01796964|11136974|FG001|Overall Study|Adverse Event|1
7048550|NCT01796964|11136973|FG000|Overall Study|Death|1
7048551|NCT01796964|11136974|FG001|Overall Study|Death|0
7048552|NCT01796964|11136973|FG000|Overall Study|Protocol Violation|0
7048553|NCT01796964|11136974|FG001|Overall Study|Protocol Violation|1
7048554|NCT01796964|11136973|FG000|Overall Study|Withdrawal by Subject|1
7048555|NCT01796964|11136974|FG001|Overall Study|Withdrawal by Subject|1
7048556|NCT01797081|11137003|FG000|Overall Study|Adverse Event|1
7083572|NCT02155712|11195033|FG001|Primary Objective|No 2-Year Forms but not Terminated|0
7083573|NCT02155712|11195032|FG000|Primary Objective|Revision/Removal of Tibial Baseplate|1
7083574|NCT02155712|11195033|FG001|Primary Objective|Revision/Removal of Tibial Baseplate|0
7083575|NCT02155712|11195032|FG000|Primary Objective|Withdrawal by Subject|21
7083576|NCT02155712|11195033|FG001|Primary Objective|Withdrawal by Subject|0
7083577|NCT02155738|11195058|FG000|Overall Study|Missing critical information|1
7083578|NCT02155738|11195059|FG001|Overall Study|Missing critical information|0
7083579|NCT02155738|11195060|FG002|Overall Study|Missing critical information|0
7083580|NCT02155738|11195061|FG003|Overall Study|Missing critical information|1
7083581|NCT02155829|11195073|FG000|Overall Study|Adverse Event|1
7083582|NCT02155829|11195074|FG001|Overall Study|Adverse Event|0
7083583|NCT02155829|11195073|FG000|Overall Study|Withdrawal by Subject|3
7083584|NCT02155829|11195074|FG001|Overall Study|Withdrawal by Subject|3
7083585|NCT02155829|11195073|FG000|Overall Study|Protocol Violation|2
7083586|NCT02155829|11195074|FG001|Overall Study|Protocol Violation|0
7083587|NCT02155881|11195083|FG000|Overall Study|Withdrawal by Subject|0
7083588|NCT02155881|11195084|FG001|Overall Study|Withdrawal by Subject|2
7083589|NCT02155881|11195083|FG000|Overall Study|Inappropriately randomized|2
7083590|NCT02155881|11195084|FG001|Overall Study|Inappropriately randomized|2
7083591|NCT02155985|11195093|FG000|Overall Study|Withdrawal by Subject|0
7083592|NCT02155985|11195094|FG001|Overall Study|Withdrawal by Subject|0
7083593|NCT02155985|11195095|FG002|Overall Study|Withdrawal by Subject|1
7083594|NCT02155985|11195093|FG000|Overall Study|Lost to Follow-up|1
7083595|NCT02155985|11195094|FG001|Overall Study|Lost to Follow-up|0
7083596|NCT02155985|11195095|FG002|Overall Study|Lost to Follow-up|0
7083597|NCT02156076|11195107|FG000|Treatment Period|no longer meets study criteria|0
7083598|NCT02156076|11195108|FG001|Treatment Period|no longer meets study criteria|0
7083599|NCT02156076|11195109|FG002|Treatment Period|no longer meets study criteria|1
7083600|NCT02156076|11195110|FG003|Treatment Period|no longer meets study criteria|0
7083601|NCT02156076|11195107|FG000|Treatment Period|Poor/non-compliance|0
7083602|NCT02156076|11195108|FG001|Treatment Period|Poor/non-compliance|1
7083603|NCT02156076|11195109|FG002|Treatment Period|Poor/non-compliance|0
7083604|NCT02156076|11195110|FG003|Treatment Period|Poor/non-compliance|0
7083605|NCT02156076|11195107|FG000|Treatment Period|Lost to Follow-up|0
7083606|NCT02156076|11195108|FG001|Treatment Period|Lost to Follow-up|0
7083607|NCT02156076|11195109|FG002|Treatment Period|Lost to Follow-up|0
7083608|NCT02156076|11195110|FG003|Treatment Period|Lost to Follow-up|1
7083609|NCT02156076|11195107|FG000|Treatment Period|Withdrawal by Subject|0
7083610|NCT02156076|11195108|FG001|Treatment Period|Withdrawal by Subject|0
7083611|NCT02156076|11195109|FG002|Treatment Period|Withdrawal by Subject|1
7083612|NCT02156076|11195110|FG003|Treatment Period|Withdrawal by Subject|0
7083613|NCT02156076|11195107|FG000|Treatment Period|Subject request to discontinue treatment|0
7083614|NCT02156076|11195108|FG001|Treatment Period|Subject request to discontinue treatment|1
7083615|NCT02156076|11195109|FG002|Treatment Period|Subject request to discontinue treatment|0
7083616|NCT02156076|11195110|FG003|Treatment Period|Subject request to discontinue treatment|0
7083617|NCT02156076|11195107|FG000|Treatment Period|Adverse Event|0
7083618|NCT02156076|11195108|FG001|Treatment Period|Adverse Event|0
7048557|NCT01797081|11137004|FG001|Overall Study|Adverse Event|0
7048558|NCT01797081|11137005|FG002|Overall Study|Adverse Event|1
7048559|NCT01797081|11137006|FG003|Overall Study|Adverse Event|0
7048560|NCT01797081|11137003|FG000|Overall Study|Pregnancy|1
7048561|NCT01797081|11137004|FG001|Overall Study|Pregnancy|0
7048562|NCT01797081|11137005|FG002|Overall Study|Pregnancy|0
7048563|NCT01797081|11137006|FG003|Overall Study|Pregnancy|0
7048564|NCT01797081|11137003|FG000|Overall Study|Personal Reasons|12
7048565|NCT01797081|11137004|FG001|Overall Study|Personal Reasons|4
7048566|NCT01797081|11137005|FG002|Overall Study|Personal Reasons|4
7048567|NCT01797081|11137006|FG003|Overall Study|Personal Reasons|8
7048568|NCT01797081|11137003|FG000|Overall Study|Protocol Violation|0
7048569|NCT01797081|11137004|FG001|Overall Study|Protocol Violation|0
7048570|NCT01797081|11137005|FG002|Overall Study|Protocol Violation|0
7048571|NCT01797081|11137006|FG003|Overall Study|Protocol Violation|1
7048572|NCT01797094|11137016|FG000|Overall Study|Adverse Event|1
7048573|NCT01797094|11137017|FG001|Overall Study|Adverse Event|1
7048574|NCT01797094|11137016|FG000|Overall Study|Personal Reasons|4
7048575|NCT01797094|11137017|FG001|Overall Study|Personal Reasons|0
7048576|NCT01797094|11137016|FG000|Overall Study|Protocol Violation|0
7048577|NCT01797094|11137017|FG001|Overall Study|Protocol Violation|1
7048578|NCT01797094|11137016|FG000|Overall Study|Other Miscellaneous Reasons|1
7048579|NCT01797094|11137017|FG001|Overall Study|Other Miscellaneous Reasons|0
7048580|NCT01797120|11137025|FG000|Overall Study|Disesae progression|37
7048581|NCT01797120|11137026|FG001|Overall Study|Disesae progression|49
7048582|NCT01797120|11137025|FG000|Overall Study|Adverse Event|13
7048583|NCT01797120|11137026|FG001|Overall Study|Adverse Event|5
7048584|NCT01797120|11137025|FG000|Overall Study|Withdrawal by Subject|6
7048585|NCT01797120|11137026|FG001|Overall Study|Withdrawal by Subject|6
7048586|NCT01797120|11137025|FG000|Overall Study|Symptomatic progression|2
7048587|NCT01797120|11137026|FG001|Overall Study|Symptomatic progression|1
7048588|NCT01797120|11137025|FG000|Overall Study|Non-compliance|1
7048589|NCT01797120|11137026|FG001|Overall Study|Non-compliance|0
7048590|NCT01797120|11137025|FG000|Overall Study|Physician Decision|3
7048591|NCT01797120|11137026|FG001|Overall Study|Physician Decision|0
7048592|NCT01797120|11137025|FG000|Overall Study|still on treatment|2
7048593|NCT01797120|11137026|FG001|Overall Study|still on treatment|4
7048594|NCT01797120|11137025|FG000|Overall Study|never start protocol therapy|2
7048595|NCT01797120|11137026|FG001|Overall Study|never start protocol therapy|0
7048596|NCT01797185|11137040|FG000|Overall Study|Adverse Event|5
7048597|NCT01797185|11137041|FG001|Overall Study|Adverse Event|15
7048598|NCT01797185|11137042|FG002|Overall Study|Adverse Event|6
7048599|NCT01797185|11137040|FG000|Overall Study|Withdrawal by Subject|6
7048600|NCT01797185|11137041|FG001|Overall Study|Withdrawal by Subject|9
7048601|NCT01797185|11137042|FG002|Overall Study|Withdrawal by Subject|5
7048602|NCT01797185|11137040|FG000|Overall Study|Site terminated|8
7048603|NCT01797185|11137041|FG001|Overall Study|Site terminated|4
7048604|NCT01797185|11137042|FG002|Overall Study|Site terminated|0
7048605|NCT01797185|11137040|FG000|Overall Study|Lost to Follow-up|2
7048606|NCT01797185|11137041|FG001|Overall Study|Lost to Follow-up|6
7048607|NCT01797185|11137042|FG002|Overall Study|Lost to Follow-up|1
7048608|NCT01797185|11137040|FG000|Overall Study|Withdrawn per sponsor|5
7048609|NCT01797185|11137041|FG001|Overall Study|Withdrawn per sponsor|0
7048610|NCT01797185|11137042|FG002|Overall Study|Withdrawn per sponsor|0
7048611|NCT01797185|11137040|FG000|Overall Study|Physician Decision|1
7048612|NCT01797185|11137041|FG001|Overall Study|Physician Decision|3
7048613|NCT01797185|11137042|FG002|Overall Study|Physician Decision|0
7048614|NCT01797185|11137040|FG000|Overall Study|Protocol Violation|1
7048615|NCT01797185|11137041|FG001|Overall Study|Protocol Violation|1
7048616|NCT01797185|11137042|FG002|Overall Study|Protocol Violation|0
7048617|NCT01797263|11137052|FG000|Overall Study|Withdrawal by Subject|21
7048618|NCT01797263|11137053|FG001|Overall Study|Withdrawal by Subject|25
7048619|NCT01797263|11137052|FG000|Overall Study|Death|1
7048620|NCT01797263|11137053|FG001|Overall Study|Death|0
7048621|NCT01797263|11137052|FG000|Overall Study|Lost to Follow-up|15
7048622|NCT01797263|11137053|FG001|Overall Study|Lost to Follow-up|15
7048623|NCT01797302|11137062|FG000|Overall Study|Lost to Follow-up|16
7048624|NCT01797302|11137063|FG001|Overall Study|Lost to Follow-up|23
7048625|NCT01797302|11137064|FG002|Overall Study|Lost to Follow-up|22
7048626|NCT01797302|11137062|FG000|Overall Study|Withdrawal by Subject|1
7048627|NCT01797302|11137063|FG001|Overall Study|Withdrawal by Subject|3
7048628|NCT01797302|11137064|FG002|Overall Study|Withdrawal by Subject|4
7048629|NCT01797432|11137081|FG000|Overall Study|Lost to Follow-up|1
7048630|NCT01797432|11137081|FG000|Overall Study|Adverse Event|1
7048631|NCT01797432|11137081|FG000|Overall Study|Withdrawal by Subject|1
7048632|NCT01797432|11137081|FG000|Overall Study|lived too far from study site|1
7048633|NCT01797445|11137087|FG000|Double-Blind Phase|Randomized but Not Treated|4
7048634|NCT01797445|11137088|FG001|Double-Blind Phase|Randomized but Not Treated|2
7048635|NCT01797445|11137087|FG000|Double-Blind Phase|Adverse Event|3
7048636|NCT01797445|11137088|FG001|Double-Blind Phase|Adverse Event|0
7048637|NCT01797445|11137087|FG000|Double-Blind Phase|Death|5
7048638|NCT01797445|11137088|FG001|Double-Blind Phase|Death|4
7048639|NCT01797445|11137087|FG000|Double-Blind Phase|Pregnancy|0
7048640|NCT01797445|11137088|FG001|Double-Blind Phase|Pregnancy|1
7048641|NCT01797445|11137087|FG000|Double-Blind Phase|Lack of Efficacy|1
7048642|NCT01797445|11137088|FG001|Double-Blind Phase|Lack of Efficacy|2
7048643|NCT01797445|11137087|FG000|Double-Blind Phase|Investigator's Discretion|15
7048644|NCT01797445|11137088|FG001|Double-Blind Phase|Investigator's Discretion|17
7048645|NCT01797445|11137087|FG000|Double-Blind Phase|Noncompliance with Study Drug|5
7048646|NCT01797445|11137088|FG001|Double-Blind Phase|Noncompliance with Study Drug|1
7048647|NCT01797445|11137087|FG000|Double-Blind Phase|Protocol Violation|0
7048648|NCT01797445|11137088|FG001|Double-Blind Phase|Protocol Violation|1
7048649|NCT01797445|11137087|FG000|Double-Blind Phase|Withdrew Consent|20
7048650|NCT01797445|11137088|FG001|Double-Blind Phase|Withdrew Consent|35
7048651|NCT01797445|11137087|FG000|Double-Blind Phase|Lost to Follow-up|34
7048652|NCT01797445|11137088|FG001|Double-Blind Phase|Lost to Follow-up|26
7048653|NCT01797445|11137087|FG000|Open-Label Extension Phase|Investigator's Discretion|1
7048654|NCT01797445|11137088|FG001|Open-Label Extension Phase|Investigator's Discretion|0
7048655|NCT01797536|11137135|FG000|Overall Study|Adverse Event|0
7048656|NCT01797536|11137136|FG001|Overall Study|Adverse Event|1
7048657|NCT01797536|11137137|FG002|Overall Study|Adverse Event|0
7048658|NCT01797536|11137138|FG003|Overall Study|Adverse Event|0
7048659|NCT01797562|11137148|FG000|Overall Study|Protocol Violation|5
7048660|NCT01797705|11137174|FG000|Overall Study|Equipment anomalies during sleep studies|4
7048661|NCT01797705|11137174|FG000|Overall Study|Withdrawal by Subject|1
7048662|NCT01797731|11137180|FG000|Overall Study|Didn't have proper radiographs required|3
7048663|NCT01797731|11137181|FG001|Overall Study|Didn't have proper radiographs required|3
7048664|NCT01797783|11137189|FG000|Overall Study|Adverse Event|1
7048665|NCT01797783|11137190|FG001|Overall Study|Adverse Event|1
7048666|NCT01797783|11137189|FG000|Overall Study|Withdrawal by Subject|1
7048667|NCT01797783|11137190|FG001|Overall Study|Withdrawal by Subject|0
7048668|NCT01797835|11137212|FG000|Overall Study|Lost to Follow-up|31
7048669|NCT01797835|11137213|FG001|Overall Study|Lost to Follow-up|27
7048670|NCT01797965|11137223|FG000|Overall Study|Adverse Event|104
7048671|NCT01797965|11137224|FG001|Overall Study|Adverse Event|129
7048672|NCT01797965|11137225|FG002|Overall Study|Adverse Event|4
7048673|NCT01797965|11137226|FG003|Overall Study|Adverse Event|21
7048674|NCT01797965|11137223|FG000|Overall Study|Lost to Follow-up|9
7048675|NCT01797965|11137224|FG001|Overall Study|Lost to Follow-up|8
7048676|NCT01797965|11137225|FG002|Overall Study|Lost to Follow-up|1
7048677|NCT01797965|11137226|FG003|Overall Study|Lost to Follow-up|2
7048678|NCT01797965|11137223|FG000|Overall Study|Consent withdrawn|130
7048679|NCT01797965|11137224|FG001|Overall Study|Consent withdrawn|117
7048680|NCT01797965|11137225|FG002|Overall Study|Consent withdrawn|3
7048681|NCT01797965|11137226|FG003|Overall Study|Consent withdrawn|35
7048682|NCT01797965|11137223|FG000|Overall Study|Investigator decision|21
7048683|NCT01797965|11137224|FG001|Overall Study|Investigator decision|15
7048684|NCT01797965|11137225|FG002|Overall Study|Investigator decision|0
7048685|NCT01797965|11137226|FG003|Overall Study|Investigator decision|0
7048686|NCT01797965|11137223|FG000|Overall Study|Death|2
7048687|NCT01797965|11137224|FG001|Overall Study|Death|4
7048688|NCT01797965|11137225|FG002|Overall Study|Death|0
7048689|NCT01797965|11137226|FG003|Overall Study|Death|0
7048690|NCT01797965|11137223|FG000|Overall Study|Disease progression, defined by protocol|3
7048691|NCT01797965|11137224|FG001|Overall Study|Disease progression, defined by protocol|1
7048692|NCT01797965|11137225|FG002|Overall Study|Disease progression, defined by protocol|0
7048693|NCT01797965|11137226|FG003|Overall Study|Disease progression, defined by protocol|0
7048694|NCT01797965|11137223|FG000|Overall Study|Reason Not Specified|280
7048695|NCT01797965|11137224|FG001|Overall Study|Reason Not Specified|295
7048696|NCT01797965|11137225|FG002|Overall Study|Reason Not Specified|0
7048697|NCT01797965|11137226|FG003|Overall Study|Reason Not Specified|15
7048698|NCT01798056|11137239|FG000|Overall Study|Serious Adverse Event|13
7048699|NCT01798056|11137240|FG001|Overall Study|Serious Adverse Event|12
7048700|NCT01798056|11137239|FG000|Overall Study|Withdrawal by Subject|12
7048701|NCT01798056|11137240|FG001|Overall Study|Withdrawal by Subject|9
7048702|NCT01798056|11137239|FG000|Overall Study|Migrated/moved from study area|1
7048703|NCT01798056|11137240|FG001|Overall Study|Migrated/moved from study area|1
7048704|NCT01798056|11137239|FG000|Overall Study|Lost to Follow-up|1
7048705|NCT01798056|11137240|FG001|Overall Study|Lost to Follow-up|1
7048706|NCT01798056|11137239|FG000|Overall Study|Other|0
7048707|NCT01798056|11137240|FG001|Overall Study|Other|2
7048708|NCT01798134|11137248|FG000|Overall Study|Lost to Follow-up|1
7048709|NCT01798134|11137248|FG000|Overall Study|Withdrawal by Subject|3
7048710|NCT01798134|11137248|FG000|Overall Study|Death|2
7048711|NCT01798134|11137248|FG000|Overall Study|Adverse Event|3
7188665|NCT02891226|11388871|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7188666|NCT02891226|11388872|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7188667|NCT02891226|11388873|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7188668|NCT02891226|11388858|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7188669|NCT02891226|11388859|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7188670|NCT02891226|11388860|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7188671|NCT02891226|11388861|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7188672|NCT02891226|11388862|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7188673|NCT02891226|11388863|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7048712|NCT01798134|11137248|FG000|Overall Study|Physician Decision|3
7048713|NCT01798134|11137248|FG000|Overall Study|Liver transplant/surgery|4
7048714|NCT01798485|11137320|FG000|Overall Study|Adverse Event|32
7048715|NCT01798485|11137321|FG001|Overall Study|Adverse Event|40
7048716|NCT01798485|11137320|FG000|Overall Study|Withdrawal by Subject|27
7048717|NCT01798485|11137321|FG001|Overall Study|Withdrawal by Subject|31
7048718|NCT01798485|11137320|FG000|Overall Study|Lost to Follow-up|0
7048719|NCT01798485|11137321|FG001|Overall Study|Lost to Follow-up|3
7048720|NCT01798485|11137320|FG000|Overall Study|Physician Decision|14
7048721|NCT01798485|11137321|FG001|Overall Study|Physician Decision|10
7048722|NCT01798485|11137320|FG000|Overall Study|Objective Disease Progression|152
7048723|NCT01798485|11137321|FG001|Overall Study|Objective Disease Progression|106
7048724|NCT01798485|11137320|FG000|Overall Study|Death|25
7048725|NCT01798485|11137321|FG001|Overall Study|Death|22
7048726|NCT01798485|11137320|FG000|Overall Study|Sponsor Decision|61
7048727|NCT01798485|11137321|FG001|Overall Study|Sponsor Decision|54
7048728|NCT01798485|11137320|FG000|Overall Study|Clinical Progression|35
7048729|NCT01798485|11137321|FG001|Overall Study|Clinical Progression|24
7048730|NCT01798706|11137356|FG000|Overall Study|Adverse Event|15
7048731|NCT01798706|11137357|FG001|Overall Study|Adverse Event|10
7048732|NCT01798706|11137356|FG000|Overall Study|Lack of Efficacy|0
7048733|NCT01798706|11137357|FG001|Overall Study|Lack of Efficacy|2
7048734|NCT01798706|11137356|FG000|Overall Study|Poor compliance to protocol|1
7048735|NCT01798706|11137357|FG001|Overall Study|Poor compliance to protocol|0
7048736|NCT01798706|11137356|FG000|Overall Study|Other than specified above|5
7048737|NCT01798706|11137357|FG001|Overall Study|Other than specified above|9
7048738|NCT01798849|11137366|FG000|Overall Study|Physician Decision|0
7048739|NCT01798849|11137367|FG001|Overall Study|Physician Decision|0
7048740|NCT01798849|11137368|FG002|Overall Study|Physician Decision|1
7048741|NCT01798927|11137405|FG000|Overall Study|Withdrawal by Subject|1
7048742|NCT01798992|11137418|FG000|Overall Study|Administrative withdrawal|0
7048743|NCT01798992|11137419|FG001|Overall Study|Administrative withdrawal|1
7048744|NCT01798992|11137420|FG002|Overall Study|Administrative withdrawal|0
7083619|NCT02156076|11195109|FG002|Treatment Period|Adverse Event|0
7083620|NCT02156076|11195110|FG003|Treatment Period|Adverse Event|1
7083621|NCT02156076|11195107|FG000|Follow-up Period|Withdrawal by Subject|1
7048745|NCT01798992|11137421|FG003|Overall Study|Administrative withdrawal|1
7048746|NCT01798992|11137418|FG000|Overall Study|Lost to Follow-up|0
7048747|NCT01798992|11137419|FG001|Overall Study|Lost to Follow-up|1
7048748|NCT01798992|11137420|FG002|Overall Study|Lost to Follow-up|1
7048749|NCT01798992|11137421|FG003|Overall Study|Lost to Follow-up|0
7048750|NCT01798992|11137418|FG000|Overall Study|Insufficient biopsy tissue|0
7048751|NCT01798992|11137419|FG001|Overall Study|Insufficient biopsy tissue|0
7048752|NCT01798992|11137420|FG002|Overall Study|Insufficient biopsy tissue|1
7048753|NCT01798992|11137421|FG003|Overall Study|Insufficient biopsy tissue|0
7048754|NCT01799226|11137451|FG000|Overall Study|Withdrawal by Subject|1
7048755|NCT01799226|11137452|FG001|Overall Study|Withdrawal by Subject|0
7048756|NCT01799226|11137451|FG000|Overall Study|Disqualified at Day 14|1
7048757|NCT01799226|11137452|FG001|Overall Study|Disqualified at Day 14|0
7048758|NCT01799239|11137458|FG000|Period 1 (7 Days)|Lack of Efficacy|1
7048759|NCT01799239|11137459|FG001|Period 1 (7 Days)|Lack of Efficacy|0
7048760|NCT01799239|11137458|FG000|Period 1 (7 Days)|Withdrawal by Subject|2
7048761|NCT01799239|11137459|FG001|Period 1 (7 Days)|Withdrawal by Subject|0
7048762|NCT01799239|11137458|FG000|Period 1 (7 Days)|Protocol Violation|0
7048763|NCT01799239|11137459|FG001|Period 1 (7 Days)|Protocol Violation|1
7048764|NCT01799239|11137458|FG000|Period 2 (7 Days)|Withdrawal by Subject|1
7048765|NCT01799239|11137459|FG001|Period 2 (7 Days)|Withdrawal by Subject|1
7048766|NCT01799239|11137458|FG000|Period 2 (7 Days)|Protocol Violation|1
7048767|NCT01799239|11137459|FG001|Period 2 (7 Days)|Protocol Violation|0
7048768|NCT01799590|11137476|FG000|Overall Study|Adverse Event|13
7048769|NCT01799590|11137477|FG001|Overall Study|Adverse Event|7
7048770|NCT01799590|11137478|FG002|Overall Study|Adverse Event|5
7048771|NCT01799590|11137476|FG000|Overall Study|Pregnancy|2
7048772|NCT01799590|11137477|FG001|Overall Study|Pregnancy|0
7083622|NCT02156076|11195108|FG001|Follow-up Period|Withdrawal by Subject|0
7083623|NCT02156076|11195109|FG002|Follow-up Period|Withdrawal by Subject|0
7083624|NCT02156076|11195110|FG003|Follow-up Period|Withdrawal by Subject|0
7083625|NCT02156271|11195148|FG000|Overall Study|Physician Decision|4
7083626|NCT02156271|11195149|FG001|Overall Study|Physician Decision|3
7083627|NCT02156466|11195160|FG000|Overall Study|Adverse Event|0
7083628|NCT02156466|11195161|FG001|Overall Study|Adverse Event|0
7083629|NCT02156466|11195162|FG002|Overall Study|Adverse Event|1
7083630|NCT02156466|11195163|FG003|Overall Study|Adverse Event|1
7188674|NCT02891226|11388864|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7188675|NCT02891226|11388865|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7188676|NCT02891226|11388866|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7188677|NCT02891226|11388867|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7188678|NCT02891226|11388868|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3
7188679|NCT02891226|11388869|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7188680|NCT02891226|11388870|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7188681|NCT02891226|11388871|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7188682|NCT02891226|11388872|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7188683|NCT02891226|11388873|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7048773|NCT01799590|11137478|FG002|Overall Study|Pregnancy|0
7048774|NCT01799590|11137476|FG000|Overall Study|Lack of Efficacy|3
7048775|NCT01799590|11137477|FG001|Overall Study|Lack of Efficacy|1
7188684|NCT02891226|11388858|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7048776|NCT01799590|11137478|FG002|Overall Study|Lack of Efficacy|3
7083631|NCT02156466|11195164|FG004|Overall Study|Adverse Event|0
7083632|NCT02156466|11195160|FG000|Overall Study|Quantiferon Positivity|0
7083633|NCT02156466|11195161|FG001|Overall Study|Quantiferon Positivity|0
7083634|NCT02156466|11195162|FG002|Overall Study|Quantiferon Positivity|0
7083635|NCT02156466|11195163|FG003|Overall Study|Quantiferon Positivity|1
7083636|NCT02156466|11195164|FG004|Overall Study|Quantiferon Positivity|0
7083637|NCT02156492|11195188|FG000|Period 1|No Reason Given|0
7083638|NCT02156492|11195189|FG001|Period 1|No Reason Given|1
7083639|NCT02156492|11195190|FG002|Period 1|No Reason Given|0
7083640|NCT02156492|11195188|FG000|Period 3|Adverse Event|0
7083641|NCT02156492|11195189|FG001|Period 3|Adverse Event|1
7083642|NCT02156492|11195190|FG002|Period 3|Adverse Event|0
7048777|NCT01799590|11137476|FG000|Overall Study|Participants convenience|4
7048778|NCT01799590|11137477|FG001|Overall Study|Participants convenience|4
7048779|NCT01799590|11137478|FG002|Overall Study|Participants convenience|2
7048780|NCT01799590|11137476|FG000|Overall Study|Aggravation of complications|0
7048781|NCT01799590|11137477|FG001|Overall Study|Aggravation of complications|1
7048782|NCT01799590|11137478|FG002|Overall Study|Aggravation of complications|1
7048783|NCT01799590|11137476|FG000|Overall Study|Using drugs with restricted days of use|0
7048784|NCT01799590|11137477|FG001|Overall Study|Using drugs with restricted days of use|3
7048785|NCT01799590|11137478|FG002|Overall Study|Using drugs with restricted days of use|2
7048786|NCT01799590|11137476|FG000|Overall Study|Use of prohibited concomitant drugs|1
7048787|NCT01799590|11137477|FG001|Overall Study|Use of prohibited concomitant drugs|0
7048788|NCT01799590|11137478|FG002|Overall Study|Use of prohibited concomitant drugs|0
7048789|NCT01799590|11137476|FG000|Overall Study|Other|3
7048790|NCT01799590|11137477|FG001|Overall Study|Other|0
7048791|NCT01799590|11137478|FG002|Overall Study|Other|1
7083643|NCT02156804|11195221|FG000|Overall Study|Withdrawal by Subject|1
7083644|NCT02157298|11195257|FG000|Overall Study|Adverse Event|1
7083645|NCT02157298|11195258|FG001|Overall Study|Adverse Event|0
7083646|NCT02157298|11195257|FG000|Overall Study|Subject no longer meets study criteria|1
7083647|NCT02157298|11195258|FG001|Overall Study|Subject no longer meets study criteria|2
7083648|NCT02157298|11195257|FG000|Overall Study|Poor/Non-compliance|1
7083649|NCT02157298|11195258|FG001|Overall Study|Poor/Non-compliance|0
7083650|NCT02157298|11195257|FG000|Overall Study|Withdrawal by Subject|1
7083651|NCT02157298|11195258|FG001|Overall Study|Withdrawal by Subject|0
7083652|NCT02157376|11195266|FG000|Overall Study|Death|10
7083653|NCT02157376|11195267|FG001|Overall Study|Death|4
7083654|NCT02157376|11195266|FG000|Overall Study|Eligibility criteria not fulfilled|0
7083655|NCT02157376|11195267|FG001|Overall Study|Eligibility criteria not fulfilled|1
7083656|NCT02157376|11195266|FG000|Overall Study|Withdrawal by Subject|3
7083657|NCT02157376|11195267|FG001|Overall Study|Withdrawal by Subject|8
7083658|NCT02157376|11195266|FG000|Overall Study|Not treated|8
7083659|NCT02157376|11195267|FG001|Overall Study|Not treated|3
7083660|NCT02157376|11195266|FG000|Overall Study|Investigator's misjudgement|1
7083661|NCT02157376|11195267|FG001|Overall Study|Investigator's misjudgement|2
7083662|NCT02157506|11195278|FG000|Overall Study|Adverse Event|0
7083663|NCT02157506|11195279|FG001|Overall Study|Adverse Event|1
7083664|NCT02157506|11195280|FG002|Overall Study|Adverse Event|0
7083665|NCT02157506|11195281|FG003|Overall Study|Adverse Event|0
7083666|NCT02157506|11195282|FG004|Overall Study|Adverse Event|0
7083667|NCT02157506|11195278|FG000|Overall Study|Lost to Follow-up|0
7083668|NCT02157506|11195279|FG001|Overall Study|Lost to Follow-up|0
7083669|NCT02157506|11195280|FG002|Overall Study|Lost to Follow-up|1
7083670|NCT02157506|11195281|FG003|Overall Study|Lost to Follow-up|0
7083671|NCT02157506|11195282|FG004|Overall Study|Lost to Follow-up|0
7083672|NCT02157519|11195296|FG000|Overall Study|Death|3
7083673|NCT02157519|11195297|FG001|Overall Study|Death|1
7083674|NCT02157519|11195296|FG000|Overall Study|Withdrawal by Subject|7
7083675|NCT02157519|11195297|FG001|Overall Study|Withdrawal by Subject|0
7083676|NCT02157519|11195296|FG000|Overall Study|Lost to Follow-up|1
7083677|NCT02157519|11195297|FG001|Overall Study|Lost to Follow-up|0
7083678|NCT02157779|11195315|FG000|Overall Study|Logistical|9
7083679|NCT02157779|11195316|FG001|Overall Study|Logistical|3
7083680|NCT02157779|11195315|FG000|Overall Study|Stopped attending, reason unknown|11
7083681|NCT02157779|11195316|FG001|Overall Study|Stopped attending, reason unknown|7
7083682|NCT02157779|11195315|FG000|Overall Study|No response to outreach after Baseline|1
7083683|NCT02157779|11195316|FG001|Overall Study|No response to outreach after Baseline|1
7083684|NCT02157779|11195315|FG000|Overall Study|Moved|1
7083685|NCT02157779|11195316|FG001|Overall Study|Moved|0
7083686|NCT02157779|11195315|FG000|Overall Study|Medical|1
7083687|NCT02157779|11195316|FG001|Overall Study|Medical|0
7083688|NCT02157779|11195315|FG000|Overall Study|Legal issue|1
7083689|NCT02157779|11195316|FG001|Overall Study|Legal issue|0
7083690|NCT02157935|11195337|FG000|Overall Study|Withdrawal by Subject|25
7083691|NCT02157935|11195338|FG001|Overall Study|Withdrawal by Subject|39
7083692|NCT02157935|11195337|FG000|Overall Study|Screen failure|1
7083693|NCT02157935|11195338|FG001|Overall Study|Screen failure|2
7083694|NCT02157935|11195337|FG000|Overall Study|Protocol Violation|1
7083695|NCT02157935|11195338|FG001|Overall Study|Protocol Violation|0
7083696|NCT02157935|11195337|FG000|Overall Study|Progressive disease|0
7083697|NCT02157935|11195338|FG001|Overall Study|Progressive disease|2
7083698|NCT02157935|11195337|FG000|Overall Study|Other|5
7083699|NCT02157935|11195338|FG001|Overall Study|Other|12
7083700|NCT02157935|11195337|FG000|Overall Study|Lack of Efficacy|0
7083701|NCT02157935|11195338|FG001|Overall Study|Lack of Efficacy|1
7048792|NCT01799720|11137489|FG000|Overall Study|Withdrawal by Subject|3
7048793|NCT01799720|11137490|FG001|Overall Study|Withdrawal by Subject|0
7048794|NCT01799720|11137491|FG002|Overall Study|Withdrawal by Subject|0
7048795|NCT01799720|11137489|FG000|Overall Study|Protocol Violation|0
7048796|NCT01799720|11137490|FG001|Overall Study|Protocol Violation|1
7048797|NCT01799720|11137491|FG002|Overall Study|Protocol Violation|0
7048798|NCT01799720|11137489|FG000|Overall Study|Pregnancy|0
7048799|NCT01799720|11137490|FG001|Overall Study|Pregnancy|0
7048800|NCT01799720|11137491|FG002|Overall Study|Pregnancy|1
7048801|NCT01799889|11137511|FG000|Overall Study|Adverse Event|4
7048802|NCT01799889|11137512|FG001|Overall Study|Adverse Event|4
7048803|NCT01799889|11137513|FG002|Overall Study|Adverse Event|5
7048804|NCT01799889|11137514|FG003|Overall Study|Adverse Event|1
7048805|NCT01799889|11137515|FG004|Overall Study|Adverse Event|11
7048806|NCT01799889|11137516|FG005|Overall Study|Adverse Event|1
7048807|NCT01799889|11137517|FG006|Overall Study|Adverse Event|5
7048808|NCT01799889|11137518|FG007|Overall Study|Adverse Event|2
7048809|NCT01799889|11137519|FG008|Overall Study|Adverse Event|3
7048810|NCT01799889|11137520|FG009|Overall Study|Adverse Event|1
7048811|NCT01799889|11137521|FG010|Overall Study|Adverse Event|1
7048812|NCT01799889|11137522|FG011|Overall Study|Adverse Event|0
7048813|NCT01799889|11137511|FG000|Overall Study|Death|1
7048814|NCT01799889|11137512|FG001|Overall Study|Death|0
7048815|NCT01799889|11137513|FG002|Overall Study|Death|5
7048816|NCT01799889|11137514|FG003|Overall Study|Death|3
7048817|NCT01799889|11137515|FG004|Overall Study|Death|1
7048818|NCT01799889|11137516|FG005|Overall Study|Death|0
7048819|NCT01799889|11137517|FG006|Overall Study|Death|0
7048820|NCT01799889|11137518|FG007|Overall Study|Death|0
7048821|NCT01799889|11137519|FG008|Overall Study|Death|1
7048822|NCT01799889|11137520|FG009|Overall Study|Death|0
7048823|NCT01799889|11137521|FG010|Overall Study|Death|1
7048824|NCT01799889|11137522|FG011|Overall Study|Death|0
7048825|NCT01799889|11137511|FG000|Overall Study|Lack of Efficacy|1
7048826|NCT01799889|11137512|FG001|Overall Study|Lack of Efficacy|1
7048827|NCT01799889|11137513|FG002|Overall Study|Lack of Efficacy|0
7048828|NCT01799889|11137514|FG003|Overall Study|Lack of Efficacy|1
7048829|NCT01799889|11137515|FG004|Overall Study|Lack of Efficacy|2
7048830|NCT01799889|11137516|FG005|Overall Study|Lack of Efficacy|2
7048831|NCT01799889|11137517|FG006|Overall Study|Lack of Efficacy|0
7048832|NCT01799889|11137518|FG007|Overall Study|Lack of Efficacy|0
7048833|NCT01799889|11137519|FG008|Overall Study|Lack of Efficacy|2
7048834|NCT01799889|11137520|FG009|Overall Study|Lack of Efficacy|0
7048835|NCT01799889|11137521|FG010|Overall Study|Lack of Efficacy|1
7048836|NCT01799889|11137522|FG011|Overall Study|Lack of Efficacy|0
7048837|NCT01799889|11137511|FG000|Overall Study|Lost to Follow-up|0
7048838|NCT01799889|11137512|FG001|Overall Study|Lost to Follow-up|1
7048839|NCT01799889|11137513|FG002|Overall Study|Lost to Follow-up|0
7048840|NCT01799889|11137514|FG003|Overall Study|Lost to Follow-up|0
7048841|NCT01799889|11137515|FG004|Overall Study|Lost to Follow-up|0
7048842|NCT01799889|11137516|FG005|Overall Study|Lost to Follow-up|0
7048843|NCT01799889|11137517|FG006|Overall Study|Lost to Follow-up|0
7048844|NCT01799889|11137518|FG007|Overall Study|Lost to Follow-up|0
7048845|NCT01799889|11137519|FG008|Overall Study|Lost to Follow-up|0
7048846|NCT01799889|11137520|FG009|Overall Study|Lost to Follow-up|0
7048847|NCT01799889|11137521|FG010|Overall Study|Lost to Follow-up|0
7048848|NCT01799889|11137522|FG011|Overall Study|Lost to Follow-up|0
7048849|NCT01799889|11137511|FG000|Overall Study|Physician Decision|3
7048850|NCT01799889|11137512|FG001|Overall Study|Physician Decision|2
7048851|NCT01799889|11137513|FG002|Overall Study|Physician Decision|4
7048852|NCT01799889|11137514|FG003|Overall Study|Physician Decision|4
7048853|NCT01799889|11137515|FG004|Overall Study|Physician Decision|5
7048854|NCT01799889|11137516|FG005|Overall Study|Physician Decision|5
7048855|NCT01799889|11137517|FG006|Overall Study|Physician Decision|5
7048856|NCT01799889|11137518|FG007|Overall Study|Physician Decision|2
7048857|NCT01799889|11137519|FG008|Overall Study|Physician Decision|6
7048858|NCT01799889|11137520|FG009|Overall Study|Physician Decision|0
7048859|NCT01799889|11137521|FG010|Overall Study|Physician Decision|0
7048860|NCT01799889|11137522|FG011|Overall Study|Physician Decision|1
7048861|NCT01799889|11137511|FG000|Overall Study|Progressive Disease|30
7048862|NCT01799889|11137512|FG001|Overall Study|Progressive Disease|26
7048863|NCT01799889|11137513|FG002|Overall Study|Progressive Disease|25
7048864|NCT01799889|11137514|FG003|Overall Study|Progressive Disease|30
7048865|NCT01799889|11137515|FG004|Overall Study|Progressive Disease|23
7048866|NCT01799889|11137516|FG005|Overall Study|Progressive Disease|9
7048867|NCT01799889|11137517|FG006|Overall Study|Progressive Disease|8
7048868|NCT01799889|11137518|FG007|Overall Study|Progressive Disease|13
7048869|NCT01799889|11137519|FG008|Overall Study|Progressive Disease|18
7048870|NCT01799889|11137520|FG009|Overall Study|Progressive Disease|5
7048871|NCT01799889|11137521|FG010|Overall Study|Progressive Disease|3
7048872|NCT01799889|11137522|FG011|Overall Study|Progressive Disease|1
7048873|NCT01799889|11137511|FG000|Overall Study|Specified Criteria for Withdrawal|0
7048874|NCT01799889|11137512|FG001|Overall Study|Specified Criteria for Withdrawal|1
7048875|NCT01799889|11137513|FG002|Overall Study|Specified Criteria for Withdrawal|1
7048876|NCT01799889|11137514|FG003|Overall Study|Specified Criteria for Withdrawal|0
7048877|NCT01799889|11137515|FG004|Overall Study|Specified Criteria for Withdrawal|0
7048878|NCT01799889|11137516|FG005|Overall Study|Specified Criteria for Withdrawal|0
7048879|NCT01799889|11137517|FG006|Overall Study|Specified Criteria for Withdrawal|0
7048880|NCT01799889|11137518|FG007|Overall Study|Specified Criteria for Withdrawal|0
7048881|NCT01799889|11137519|FG008|Overall Study|Specified Criteria for Withdrawal|0
7048882|NCT01799889|11137520|FG009|Overall Study|Specified Criteria for Withdrawal|0
7048883|NCT01799889|11137521|FG010|Overall Study|Specified Criteria for Withdrawal|0
7048884|NCT01799889|11137522|FG011|Overall Study|Specified Criteria for Withdrawal|0
7048885|NCT01799889|11137511|FG000|Overall Study|Study Terminated By Sponsor|1
7048886|NCT01799889|11137512|FG001|Overall Study|Study Terminated By Sponsor|0
7048887|NCT01799889|11137513|FG002|Overall Study|Study Terminated By Sponsor|0
7048888|NCT01799889|11137514|FG003|Overall Study|Study Terminated By Sponsor|0
7048889|NCT01799889|11137515|FG004|Overall Study|Study Terminated By Sponsor|2
7048890|NCT01799889|11137516|FG005|Overall Study|Study Terminated By Sponsor|1
7048891|NCT01799889|11137517|FG006|Overall Study|Study Terminated By Sponsor|0
7048892|NCT01799889|11137518|FG007|Overall Study|Study Terminated By Sponsor|2
7048893|NCT01799889|11137519|FG008|Overall Study|Study Terminated By Sponsor|1
7048894|NCT01799889|11137520|FG009|Overall Study|Study Terminated By Sponsor|1
7048895|NCT01799889|11137521|FG010|Overall Study|Study Terminated By Sponsor|0
7048896|NCT01799889|11137522|FG011|Overall Study|Study Terminated By Sponsor|0
7048897|NCT01799889|11137511|FG000|Overall Study|Withdrawal by Subject|1
7048898|NCT01799889|11137512|FG001|Overall Study|Withdrawal by Subject|6
7048899|NCT01799889|11137513|FG002|Overall Study|Withdrawal by Subject|4
7048900|NCT01799889|11137514|FG003|Overall Study|Withdrawal by Subject|0
7048901|NCT01799889|11137515|FG004|Overall Study|Withdrawal by Subject|5
7048902|NCT01799889|11137516|FG005|Overall Study|Withdrawal by Subject|1
7048903|NCT01799889|11137517|FG006|Overall Study|Withdrawal by Subject|3
7048904|NCT01799889|11137518|FG007|Overall Study|Withdrawal by Subject|1
7048905|NCT01799889|11137519|FG008|Overall Study|Withdrawal by Subject|2
7048906|NCT01799889|11137520|FG009|Overall Study|Withdrawal by Subject|1
7048907|NCT01799889|11137521|FG010|Overall Study|Withdrawal by Subject|1
7188685|NCT02891226|11388859|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7188686|NCT02891226|11388860|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7188687|NCT02891226|11388861|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7188688|NCT02891226|11388862|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7188689|NCT02891226|11388863|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7188690|NCT02891226|11388864|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
6804046|NCT01142596|10805911|FG000|Overall Study|Adverse Event|8
6804047|NCT01142596|10805912|FG001|Overall Study|Adverse Event|35
6804048|NCT01142596|10805911|FG000|Overall Study|Lack of Efficacy|5
6804049|NCT01142596|10805912|FG001|Overall Study|Lack of Efficacy|9
6804050|NCT01142596|10805911|FG000|Overall Study|Lost to Follow-up|2
6804051|NCT01142596|10805912|FG001|Overall Study|Lost to Follow-up|3
6804052|NCT01142596|10805911|FG000|Overall Study|Other reason (not specified)|5
6804053|NCT01142596|10805912|FG001|Overall Study|Other reason (not specified)|4
6804054|NCT01098110|10805921|FG000|Overall Study|Withdrawal by Subject|14
7048908|NCT01799889|11137522|FG011|Overall Study|Withdrawal by Subject|1
7048909|NCT01799889|11137511|FG000|Overall Study|Non-Compliance With Study Drug|0
7048910|NCT01799889|11137512|FG001|Overall Study|Non-Compliance With Study Drug|0
7048911|NCT01799889|11137513|FG002|Overall Study|Non-Compliance With Study Drug|0
7048912|NCT01799889|11137514|FG003|Overall Study|Non-Compliance With Study Drug|0
7048913|NCT01799889|11137515|FG004|Overall Study|Non-Compliance With Study Drug|0
7048914|NCT01799889|11137516|FG005|Overall Study|Non-Compliance With Study Drug|1
7048915|NCT01799889|11137517|FG006|Overall Study|Non-Compliance With Study Drug|0
7048916|NCT01799889|11137518|FG007|Overall Study|Non-Compliance With Study Drug|0
7048917|NCT01799889|11137519|FG008|Overall Study|Non-Compliance With Study Drug|0
7048918|NCT01799889|11137520|FG009|Overall Study|Non-Compliance With Study Drug|0
7048919|NCT01799889|11137521|FG010|Overall Study|Non-Compliance With Study Drug|0
7048920|NCT01799889|11137522|FG011|Overall Study|Non-Compliance With Study Drug|0
7048921|NCT01799941|11137559|FG000|Overall Study|Adverse Event|34
7048922|NCT01799941|11137559|FG000|Overall Study|Withdrawal by Subject|21
7048923|NCT01799941|11137559|FG000|Overall Study|Death|2
7048924|NCT01799941|11137559|FG000|Overall Study|Investigator Decision|4
7048925|NCT01799941|11137559|FG000|Overall Study|Lack of Efficacy|3
7048926|NCT01799941|11137559|FG000|Overall Study|Lost to Follow-up|17
7048927|NCT01799941|11137559|FG000|Overall Study|Other|15
7048928|NCT01799993|11137571|FG000|Overall Study|"Didn't complete CRF page End of FU"|30
7048929|NCT01799993|11137572|FG001|Overall Study|"Didn't complete CRF page End of FU"|40
7048930|NCT01799993|11137571|FG000|Overall Study|Death|61
7048931|NCT01799993|11137572|FG001|Overall Study|Death|45
7048932|NCT01799993|11137571|FG000|Overall Study|Withdrawal by Subject|23
7048933|NCT01799993|11137572|FG001|Overall Study|Withdrawal by Subject|24
7048934|NCT01799993|11137571|FG000|Overall Study|Lost to Follow-up|5
7048935|NCT01799993|11137572|FG001|Overall Study|Lost to Follow-up|8
7048936|NCT01799993|11137571|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5
7048937|NCT01799993|11137572|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3
7048938|NCT01799993|11137571|FG000|Overall Study|Protocol driven decision point|0
7048939|NCT01799993|11137572|FG001|Overall Study|Protocol driven decision point|3
7048940|NCT01799993|11137571|FG000|Overall Study|Protocol Violation|1
7048941|NCT01799993|11137572|FG001|Overall Study|Protocol Violation|1
7048942|NCT01799993|11137571|FG000|Overall Study|Deterioration of general conditions|2
7048943|NCT01799993|11137572|FG001|Overall Study|Deterioration of general conditions|0
7048944|NCT01799993|11137571|FG000|Overall Study|Screen failure|0
7048945|NCT01799993|11137572|FG001|Overall Study|Screen failure|1
7048946|NCT01799993|11137571|FG000|Overall Study|Adverse Event|1
7048947|NCT01799993|11137572|FG001|Overall Study|Adverse Event|0
7048948|NCT01799993|11137571|FG000|Overall Study|Lack of Efficacy|1
7048949|NCT01799993|11137572|FG001|Overall Study|Lack of Efficacy|0
7048950|NCT01799993|11137571|FG000|Overall Study|Recovery|0
7048951|NCT01799993|11137572|FG001|Overall Study|Recovery|1
7048952|NCT01799993|11137571|FG000|Overall Study|Logistical difficulties|1
7048953|NCT01799993|11137572|FG001|Overall Study|Logistical difficulties|0
7048954|NCT01799993|11137571|FG000|Overall Study|Protocol deviation|1
7048955|NCT01799993|11137572|FG001|Overall Study|Protocol deviation|0
7048956|NCT01799993|11137571|FG000|Overall Study|Non-compliance with medical device|1
7048957|NCT01799993|11137572|FG001|Overall Study|Non-compliance with medical device|0
7048958|NCT01799993|11137571|FG000|Overall Study|Withdrawal by parent/guardian|0
7048959|NCT01799993|11137572|FG001|Overall Study|Withdrawal by parent/guardian|1
7048960|NCT01799993|11137571|FG000|Overall Study|Other|1
7048961|NCT01799993|11137572|FG001|Overall Study|Other|0
7048962|NCT01799993|11137571|FG000|Overall Study|Subject didn't return for follow-up|0
7048963|NCT01799993|11137572|FG001|Overall Study|Subject didn't return for follow-up|1
7048964|NCT01800058|11137578|FG000|Overall Study|Lost to Follow-up|1
7048965|NCT01800201|11137585|FG000|Overall Study|Withdrawal by Subject|2
7048966|NCT01800201|11137586|FG001|Overall Study|Withdrawal by Subject|0
7048967|NCT01800201|11137585|FG000|Overall Study|patient privacy concerns|1
7048968|NCT01800201|11137586|FG001|Overall Study|patient privacy concerns|1
7048969|NCT01800201|11137585|FG000|Overall Study|did not want to use device|0
7048970|NCT01800201|11137586|FG001|Overall Study|did not want to use device|1
7048971|NCT01800201|11137585|FG000|Overall Study|PI withdrawal, cognitive concerns|0
7048972|NCT01800201|11137586|FG001|Overall Study|PI withdrawal, cognitive concerns|1
7048973|NCT01800903|11137661|FG000|Second Test Period|unable to catheterise|1
7048974|NCT01800903|11137662|FG001|Second Test Period|unable to catheterise|0
7083702|NCT02157935|11195337|FG000|Overall Study|Death|4
7188691|NCT02891226|11388865|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7188692|NCT02891226|11388866|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7188693|NCT02891226|11388867|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7188694|NCT02891226|11388868|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2
7188695|NCT02891226|11388869|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7188696|NCT02891226|11388870|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7048975|NCT01800903|11137663|FG002|Second Test Period|unable to catheterise|0
7048976|NCT01800903|11137664|FG003|Second Test Period|unable to catheterise|0
7083703|NCT02157935|11195338|FG001|Overall Study|Death|4
7083704|NCT02157935|11195337|FG000|Overall Study|Adverse Event|3
7083705|NCT02157935|11195338|FG001|Overall Study|Adverse Event|5
7083706|NCT02157948|11195346|FG000|Overall Study|Withdrawal by Subject|4
7083707|NCT02157948|11195347|FG001|Overall Study|Withdrawal by Subject|5
7083708|NCT02157948|11195346|FG000|Overall Study|Lost to Follow-up|3
7083709|NCT02157948|11195347|FG001|Overall Study|Lost to Follow-up|2
7083710|NCT02157948|11195346|FG000|Overall Study|Protocol Specified Criteria|2
7083711|NCT02157948|11195347|FG001|Overall Study|Protocol Specified Criteria|1
7083712|NCT02157948|11195346|FG000|Overall Study|Decision by Sponsor|0
7083713|NCT02157948|11195347|FG001|Overall Study|Decision by Sponsor|1
7083714|NCT02158039|11195353|FG000|Overall Study|Withdrawal by Subject|1
7083715|NCT02158039|11195353|FG000|Overall Study|Screen Failure|9
7083716|NCT02158247|11195359|FG000|Overall Study|Invisible vocal cords|5
7083717|NCT02158364|11195384|FG000|Overall Study|Case report forms uncollected|10
7083718|NCT02158364|11195384|FG000|Overall Study|Protocol Deviation|50
7048977|NCT01800903|11137665|FG004|Second Test Period|unable to catheterise|0
7083719|NCT02158442|11195390|FG000|Overall Study|Withdrawal by Subject|1
7083720|NCT02158442|11195391|FG001|Overall Study|Withdrawal by Subject|0
7083721|NCT02158442|11195390|FG000|Overall Study|Perfusion staff not available|1
7083722|NCT02158442|11195391|FG001|Overall Study|Perfusion staff not available|0
7048978|NCT01800903|11137666|FG005|Second Test Period|unable to catheterise|0
7048979|NCT01800916|11137672|FG000|Test Period 1 (1 Week)|Convex product user|0
7048980|NCT01800916|11137673|FG001|Test Period 1 (1 Week)|Convex product user|0
7048981|NCT01800916|11137674|FG002|Test Period 1 (1 Week)|Convex product user|0
7048982|NCT01800916|11137675|FG003|Test Period 1 (1 Week)|Convex product user|1
7048983|NCT01800916|11137676|FG004|Test Period 1 (1 Week)|Convex product user|0
7048984|NCT01800916|11137677|FG005|Test Period 1 (1 Week)|Convex product user|0
7048985|NCT01800916|11137678|FG006|Test Period 1 (1 Week)|Convex product user|0
7048986|NCT01800916|11137679|FG007|Test Period 1 (1 Week)|Convex product user|0
7048987|NCT01800916|11137680|FG008|Test Period 1 (1 Week)|Convex product user|0
7048988|NCT01800916|11137672|FG000|Test Period 1 (1 Week)|Adverse Event|0
7048989|NCT01800916|11137673|FG001|Test Period 1 (1 Week)|Adverse Event|0
7048990|NCT01800916|11137674|FG002|Test Period 1 (1 Week)|Adverse Event|0
7048991|NCT01800916|11137675|FG003|Test Period 1 (1 Week)|Adverse Event|0
7048992|NCT01800916|11137676|FG004|Test Period 1 (1 Week)|Adverse Event|1
7048993|NCT01800916|11137677|FG005|Test Period 1 (1 Week)|Adverse Event|0
7048994|NCT01800916|11137678|FG006|Test Period 1 (1 Week)|Adverse Event|0
7048995|NCT01800916|11137679|FG007|Test Period 1 (1 Week)|Adverse Event|0
7048996|NCT01800916|11137680|FG008|Test Period 1 (1 Week)|Adverse Event|0
7048997|NCT01800968|11137692|FG000|Overall Study|Death|23
7048998|NCT01800968|11137693|FG001|Overall Study|Death|16
7048999|NCT01800968|11137692|FG000|Overall Study|Lost to Follow-up|5
7049000|NCT01800968|11137693|FG001|Overall Study|Lost to Follow-up|7
7049001|NCT01800968|11137692|FG000|Overall Study|Withdrawal by Subject|7
7083723|NCT02158533|11195425|FG000|Stage 1|Adverse Event|6
7083724|NCT02158533|11195426|FG001|Stage 1|Adverse Event|4
7083725|NCT02158533|11195427|FG002|Stage 1|Adverse Event|7
7083726|NCT02158533|11195428|FG003|Stage 1|Adverse Event|0
7083727|NCT02158533|11195429|FG004|Stage 1|Adverse Event|0
7083728|NCT02158533|11195430|FG005|Stage 1|Adverse Event|0
7083729|NCT02158533|11195425|FG000|Stage 1|Withdrawal by Subject|3
7083730|NCT02158533|11195426|FG001|Stage 1|Withdrawal by Subject|2
7083731|NCT02158533|11195427|FG002|Stage 1|Withdrawal by Subject|1
7083732|NCT02158533|11195428|FG003|Stage 1|Withdrawal by Subject|0
7083733|NCT02158533|11195429|FG004|Stage 1|Withdrawal by Subject|0
7083734|NCT02158533|11195430|FG005|Stage 1|Withdrawal by Subject|0
7083735|NCT02158533|11195425|FG000|Stage 1|Lack of Efficacy|1
7083736|NCT02158533|11195426|FG001|Stage 1|Lack of Efficacy|0
7083737|NCT02158533|11195427|FG002|Stage 1|Lack of Efficacy|0
7083738|NCT02158533|11195428|FG003|Stage 1|Lack of Efficacy|0
7083739|NCT02158533|11195429|FG004|Stage 1|Lack of Efficacy|0
7083740|NCT02158533|11195430|FG005|Stage 1|Lack of Efficacy|0
7083741|NCT02158533|11195425|FG000|Stage 1|Lost to Follow-up|3
7083742|NCT02158533|11195426|FG001|Stage 1|Lost to Follow-up|1
7083743|NCT02158533|11195427|FG002|Stage 1|Lost to Follow-up|0
7083744|NCT02158533|11195428|FG003|Stage 1|Lost to Follow-up|0
7083745|NCT02158533|11195429|FG004|Stage 1|Lost to Follow-up|0
7083746|NCT02158533|11195430|FG005|Stage 1|Lost to Follow-up|0
7083747|NCT02158533|11195425|FG000|Stage 1|Failure to Meet Eligibility Criteria|0
7083748|NCT02158533|11195426|FG001|Stage 1|Failure to Meet Eligibility Criteria|1
7083749|NCT02158533|11195427|FG002|Stage 1|Failure to Meet Eligibility Criteria|0
7083750|NCT02158533|11195428|FG003|Stage 1|Failure to Meet Eligibility Criteria|0
7083751|NCT02158533|11195429|FG004|Stage 1|Failure to Meet Eligibility Criteria|0
7083752|NCT02158533|11195430|FG005|Stage 1|Failure to Meet Eligibility Criteria|0
7083753|NCT02158533|11195425|FG000|Stage 1|Non-compliance with study visits|1
7083754|NCT02158533|11195426|FG001|Stage 1|Non-compliance with study visits|0
7083755|NCT02158533|11195427|FG002|Stage 1|Non-compliance with study visits|0
7083756|NCT02158533|11195428|FG003|Stage 1|Non-compliance with study visits|0
7083757|NCT02158533|11195429|FG004|Stage 1|Non-compliance with study visits|0
7083758|NCT02158533|11195430|FG005|Stage 1|Non-compliance with study visits|0
7083759|NCT02158533|11195425|FG000|Stage 2|Adverse Event|0
7083760|NCT02158533|11195426|FG001|Stage 2|Adverse Event|0
7083761|NCT02158533|11195427|FG002|Stage 2|Adverse Event|0
7083762|NCT02158533|11195428|FG003|Stage 2|Adverse Event|0
7083763|NCT02158533|11195429|FG004|Stage 2|Adverse Event|0
7083764|NCT02158533|11195430|FG005|Stage 2|Adverse Event|1
7083765|NCT02158533|11195425|FG000|Stage 2|Lack of Efficacy|0
7083766|NCT02158533|11195426|FG001|Stage 2|Lack of Efficacy|0
7083767|NCT02158533|11195427|FG002|Stage 2|Lack of Efficacy|0
7083768|NCT02158533|11195428|FG003|Stage 2|Lack of Efficacy|0
7083769|NCT02158533|11195429|FG004|Stage 2|Lack of Efficacy|1
7083770|NCT02158533|11195430|FG005|Stage 2|Lack of Efficacy|0
7083771|NCT02158533|11195425|FG000|Stage 2|Lost to Follow-up|0
7083772|NCT02158533|11195426|FG001|Stage 2|Lost to Follow-up|0
7083773|NCT02158533|11195427|FG002|Stage 2|Lost to Follow-up|0
7083774|NCT02158533|11195428|FG003|Stage 2|Lost to Follow-up|1
7083775|NCT02158533|11195429|FG004|Stage 2|Lost to Follow-up|1
7083776|NCT02158533|11195430|FG005|Stage 2|Lost to Follow-up|2
7083777|NCT02158533|11195425|FG000|Stage 2|Withdrawal by Subject|0
7083778|NCT02158533|11195426|FG001|Stage 2|Withdrawal by Subject|0
7083779|NCT02158533|11195427|FG002|Stage 2|Withdrawal by Subject|0
7083780|NCT02158533|11195428|FG003|Stage 2|Withdrawal by Subject|0
7083781|NCT02158533|11195429|FG004|Stage 2|Withdrawal by Subject|1
7083782|NCT02158533|11195430|FG005|Stage 2|Withdrawal by Subject|2
7083783|NCT02158533|11195425|FG000|Stage 2|Physician Decision|0
7083784|NCT02158533|11195426|FG001|Stage 2|Physician Decision|0
7049002|NCT01800968|11137693|FG001|Overall Study|Withdrawal by Subject|9
7049003|NCT01800968|11137692|FG000|Overall Study|Physician Decision|1
7049004|NCT01800968|11137693|FG001|Overall Study|Physician Decision|0
7049005|NCT01801007|11137699|FG000|Overall Study|Adverse Event|2
7049006|NCT01801007|11137699|FG000|Overall Study|Lost to Follow-up|4
7049007|NCT01801007|11137699|FG000|Overall Study|Withdrawal by Subject|5
7049008|NCT01801111|11137703|FG000|Overall Study|Adverse Event|12
7049009|NCT01801111|11137703|FG000|Overall Study|Death|8
7049010|NCT01801111|11137703|FG000|Overall Study|Physician Decision|5
7049011|NCT01801111|11137703|FG000|Overall Study|Other|1
7049012|NCT01801111|11137703|FG000|Overall Study|Withdrawal by Subject|4
7049013|NCT01801111|11137703|FG000|Overall Study|Study Terminated by Sponsor|27
7049014|NCT01801111|11137703|FG000|Overall Study|Progressive Disease|81
7049015|NCT01801280|11137724|FG000|Period 1|Withdrawal by Subject|0
7049016|NCT01801280|11137725|FG001|Period 1|Withdrawal by Subject|1
7049017|NCT01801280|11137726|FG002|Period 1|Withdrawal by Subject|0
7049018|NCT01801280|11137727|FG003|Period 1|Withdrawal by Subject|0
7049019|NCT01801280|11137724|FG000|Period 2|Withdrawal by Subject|1
7049020|NCT01801280|11137725|FG001|Period 2|Withdrawal by Subject|0
7049021|NCT01801280|11137726|FG002|Period 2|Withdrawal by Subject|0
7049022|NCT01801280|11137727|FG003|Period 2|Withdrawal by Subject|0
7049023|NCT01801280|11137724|FG000|Period 4|Protocol Violation|0
7049024|NCT01801280|11137725|FG001|Period 4|Protocol Violation|0
7049025|NCT01801280|11137726|FG002|Period 4|Protocol Violation|1
7049026|NCT01801280|11137727|FG003|Period 4|Protocol Violation|0
7049027|NCT01801358|11137743|FG000|Overall Study|Adverse Event|0
7049028|NCT01801358|11137744|FG001|Overall Study|Adverse Event|2
7049029|NCT01801358|11137745|FG002|Overall Study|Adverse Event|1
7049030|NCT01801358|11137746|FG003|Overall Study|Adverse Event|0
7049031|NCT01801358|11137747|FG004|Overall Study|Adverse Event|0
7049032|NCT01801358|11137748|FG005|Overall Study|Adverse Event|1
7049033|NCT01801358|11137743|FG000|Overall Study|Physician Decision|0
7049034|NCT01801358|11137744|FG001|Overall Study|Physician Decision|0
7049035|NCT01801358|11137745|FG002|Overall Study|Physician Decision|1
7049036|NCT01801358|11137746|FG003|Overall Study|Physician Decision|0
7049037|NCT01801358|11137747|FG004|Overall Study|Physician Decision|0
7049038|NCT01801358|11137748|FG005|Overall Study|Physician Decision|0
7049039|NCT01801358|11137743|FG000|Overall Study|Progressive Disease|6
7049040|NCT01801358|11137744|FG001|Overall Study|Progressive Disease|4
7049041|NCT01801358|11137745|FG002|Overall Study|Progressive Disease|4
7049042|NCT01801358|11137746|FG003|Overall Study|Progressive Disease|5
7049043|NCT01801358|11137747|FG004|Overall Study|Progressive Disease|6
7049044|NCT01801358|11137748|FG005|Overall Study|Progressive Disease|5
7049045|NCT01801358|11137743|FG000|Overall Study|Withdrawal by Subject|0
7049046|NCT01801358|11137744|FG001|Overall Study|Withdrawal by Subject|0
7049047|NCT01801358|11137745|FG002|Overall Study|Withdrawal by Subject|0
7049048|NCT01801358|11137746|FG003|Overall Study|Withdrawal by Subject|1
7049049|NCT01801358|11137747|FG004|Overall Study|Withdrawal by Subject|0
7049050|NCT01801358|11137748|FG005|Overall Study|Withdrawal by Subject|2
7049051|NCT01801436|11137783|FG000|Overall Study|Withdrawal by Subject|3
7049052|NCT01801436|11137783|FG000|Overall Study|Adverse Event|2
7049053|NCT01801436|11137783|FG000|Overall Study|Progressive disease|4
7049054|NCT01801475|11137795|FG000|Overall Study|Withdrawal by Subject|0
7049055|NCT01801475|11137796|FG001|Overall Study|Withdrawal by Subject|0
7049056|NCT01801475|11137797|FG002|Overall Study|Withdrawal by Subject|0
7049057|NCT01801475|11137798|FG003|Overall Study|Withdrawal by Subject|0
7049058|NCT01801475|11137799|FG004|Overall Study|Withdrawal by Subject|1
7049059|NCT01801735|11137808|FG000|Overall Study|Adverse Event|79
7049060|NCT01801735|11137808|FG000|Overall Study|Lack of Efficacy|28
7049061|NCT01801735|11137808|FG000|Overall Study|Withdrawal by Subject|27
7049062|NCT01801735|11137808|FG000|Overall Study|Protocol Violation|25
7049063|NCT01801735|11137808|FG000|Overall Study|Lost to Follow-up|15
7049064|NCT01801735|11137808|FG000|Overall Study|Non-compliance with Trial Drug|13
7049065|NCT01801735|11137808|FG000|Overall Study|Physician Decision|3
7049066|NCT01801735|11137808|FG000|Overall Study|Death|1
7049067|NCT01801735|11137808|FG000|Overall Study|Other, including site closure|19
7049068|NCT01801865|11137812|FG000|Overall Study|Patients scanned on another MRI scanner|35
7049069|NCT01801865|11137812|FG000|Overall Study|Physician Decision|7
7049070|NCT01801917|11137820|FG000|Period 1 - Randomized|Adverse Event|1
7049071|NCT01801917|11137821|FG001|Period 1 - Randomized|Adverse Event|0
7049072|NCT01801917|11137822|FG002|Period 1 - Randomized|Adverse Event|1
7049073|NCT01801917|11137823|FG003|Period 1 - Randomized|Adverse Event|0
7049074|NCT01801930|11137838|FG000|Overall Study|Clear progression of the primary disease is observed|6
7049075|NCT01801930|11137839|FG001|Overall Study|Clear progression of the primary disease is observed|5
7049076|NCT01801930|11137840|FG002|Overall Study|Clear progression of the primary disease is observed|6
7049077|NCT01801930|11137841|FG003|Overall Study|Clear progression of the primary disease is observed|6
7049078|NCT01801930|11137838|FG000|Overall Study|DLT occurs|0
7049079|NCT01801930|11137839|FG001|Overall Study|DLT occurs|1
7049080|NCT01801930|11137840|FG002|Overall Study|DLT occurs|0
7049081|NCT01801930|11137841|FG003|Overall Study|DLT occurs|0
7049082|NCT01801982|11137851|FG000|Overall Study|Lost to Follow-up|1
7049083|NCT01802073|11137857|FG000|Overall Study|Lost to Follow-up|0
7049084|NCT01802073|11137858|FG001|Overall Study|Lost to Follow-up|1
7049085|NCT01802073|11137857|FG000|Overall Study|Non-compliant|4
7049086|NCT01802073|11137858|FG001|Overall Study|Non-compliant|2
7049087|NCT01802073|11137857|FG000|Overall Study|Withdrawal by Subject|1
7049088|NCT01802073|11137858|FG001|Overall Study|Withdrawal by Subject|1
7049089|NCT01802073|11137857|FG000|Overall Study|Physician Decision|0
7049090|NCT01802073|11137858|FG001|Overall Study|Physician Decision|7
7049091|NCT01802216|11137883|FG000|4 Month Visit|Participant did not show to visit|3
7049092|NCT01802216|11137884|FG001|4 Month Visit|Participant did not show to visit|4
7049093|NCT01802216|11137883|FG000|8 Month Visit|Participant did not show to visit|3
7049094|NCT01802216|11137884|FG001|8 Month Visit|Participant did not show to visit|5
7049095|NCT01802216|11137883|FG000|12 Month Visit|Participant did not show to visit|3
7049096|NCT01802216|11137884|FG001|12 Month Visit|Participant did not show to visit|4
7049097|NCT01802320|11137890|FG000|Overall Study|Death|1
7049098|NCT01802320|11137890|FG000|Overall Study|Withdrawal by Subject|1
7049099|NCT01802333|11137897|FG000|Overall Study|Ineligible|2
7049100|NCT01802333|11137898|FG001|Overall Study|Ineligible|6
7049101|NCT01802333|11137899|FG002|Overall Study|Ineligible|8
7049102|NCT01802333|11137897|FG000|Overall Study|Adverse Event|1
7049103|NCT01802333|11137898|FG001|Overall Study|Adverse Event|8
7049104|NCT01802333|11137899|FG002|Overall Study|Adverse Event|8
7049105|NCT01802333|11137897|FG000|Overall Study|Withdrawal by Subject|6
7049106|NCT01802333|11137898|FG001|Overall Study|Withdrawal by Subject|6
7049107|NCT01802333|11137899|FG002|Overall Study|Withdrawal by Subject|5
7049108|NCT01802333|11137897|FG000|Overall Study|Progression/relapse|1
7049109|NCT01802333|11137898|FG001|Overall Study|Progression/relapse|3
7049110|NCT01802333|11137899|FG002|Overall Study|Progression/relapse|0
7049111|NCT01802333|11137897|FG000|Overall Study|Death|7
7049112|NCT01802333|11137898|FG001|Overall Study|Death|14
7049113|NCT01802333|11137899|FG002|Overall Study|Death|13
7049114|NCT01802333|11137897|FG000|Overall Study|Other - not protocol specified|32
7049115|NCT01802333|11137898|FG001|Overall Study|Other - not protocol specified|22
7049116|NCT01802333|11137899|FG002|Overall Study|Other - not protocol specified|24
7049117|NCT01802333|11137897|FG000|Overall Study|Did not start treatment|0
7049118|NCT01802333|11137898|FG001|Overall Study|Did not start treatment|2
7049119|NCT01802333|11137899|FG002|Overall Study|Did not start treatment|5
7049120|NCT01802385|11137915|FG000|Overall Study|Death|106
7049121|NCT01802385|11137916|FG001|Overall Study|Death|120
7049122|NCT01802411|11137924|FG000|Overall Study|Death|2
7049123|NCT01802411|11137925|FG001|Overall Study|Death|1
7049124|NCT01802411|11137924|FG000|Overall Study|Adverse Event|2
7049125|NCT01802411|11137925|FG001|Overall Study|Adverse Event|7
7049126|NCT01802411|11137924|FG000|Overall Study|Lack of Efficacy|8
7049127|NCT01802411|11137925|FG001|Overall Study|Lack of Efficacy|10
7049128|NCT01802411|11137924|FG000|Overall Study|Withdrawal by Subject|0
7049129|NCT01802411|11137925|FG001|Overall Study|Withdrawal by Subject|2
7049130|NCT01802411|11137924|FG000|Overall Study|Planned pleurodesis as part of the proc|1
7049131|NCT01802411|11137925|FG001|Overall Study|Planned pleurodesis as part of the proc|0
7049132|NCT01802411|11137924|FG000|Overall Study|Surgery aborted after bronchoscopy|1
7049133|NCT01802411|11137925|FG001|Overall Study|Surgery aborted after bronchoscopy|0
7049134|NCT01802411|11137924|FG000|Overall Study|Proc changed to video-asst thorascopic|0
7049135|NCT01802411|11137925|FG001|Overall Study|Proc changed to video-asst thorascopic|1
7049136|NCT01802437|11137933|FG000|Overall Study|Lost to Follow-up|1
7049137|NCT01802437|11137934|FG001|Overall Study|Lost to Follow-up|0
7049138|NCT01802437|11137933|FG000|Overall Study|Withdrawal by Subject|3
7049139|NCT01802437|11137934|FG001|Overall Study|Withdrawal by Subject|4
7049140|NCT01802515|11137943|FG000|Overall Study|Withdrawal by Subject|3
7049141|NCT01802515|11137944|FG001|Overall Study|Withdrawal by Subject|0
7049142|NCT01802515|11137945|FG002|Overall Study|Withdrawal by Subject|0
7049143|NCT01802580|11137964|FG000|Overall Study|Physician Decision|1
7049144|NCT01802580|11137965|FG001|Overall Study|Physician Decision|0
7049145|NCT01802580|11137964|FG000|Overall Study|Protocol Violation|2
7049146|NCT01802580|11137965|FG001|Overall Study|Protocol Violation|0
7049147|NCT01802580|11137964|FG000|Overall Study|Withdrawal by Subject|5
7049148|NCT01802580|11137965|FG001|Overall Study|Withdrawal by Subject|6
7049149|NCT01802580|11137964|FG000|Overall Study|Other|1
7049150|NCT01802580|11137965|FG001|Overall Study|Other|3
7049151|NCT01802580|11137964|FG000|Overall Study|Lack of Efficacy|0
7049152|NCT01802580|11137965|FG001|Overall Study|Lack of Efficacy|2
7049153|NCT01802775|11137984|FG000|Overall Study|Death|0
7049154|NCT01802775|11137985|FG001|Overall Study|Death|3
7049155|NCT01802775|11137984|FG000|Overall Study|Reason not provided|0
7049156|NCT01802775|11137985|FG001|Overall Study|Reason not provided|1
7049157|NCT01802775|11137984|FG000|Overall Study|Physician Decision|1
7049158|NCT01802775|11137985|FG001|Overall Study|Physician Decision|0
7049159|NCT01802775|11137984|FG000|Overall Study|Adverse Event|1
7049160|NCT01802775|11137985|FG001|Overall Study|Adverse Event|1
7049161|NCT01802775|11137984|FG000|Overall Study|Withdrawal by Subject|3
7049162|NCT01802775|11137985|FG001|Overall Study|Withdrawal by Subject|5
7049163|NCT01802775|11137984|FG000|Overall Study|Lost to Follow-up|1
7049164|NCT01802775|11137985|FG001|Overall Study|Lost to Follow-up|2
7049165|NCT01802879|11137991|FG000|Overall Study|Administrative problems|2
7049166|NCT01802879|11137991|FG000|Overall Study|Disease progression|6
7049167|NCT01803269|11138073|FG000|Overall Study|Withdrawal by Subject|3
7049168|NCT01803269|11138074|FG001|Overall Study|Withdrawal by Subject|0
7049169|NCT01803269|11138075|FG002|Overall Study|Withdrawal by Subject|0
7049170|NCT01803282|11138095|FG000|Overall Study|Progressive Disease|4
7049171|NCT01803282|11138096|FG001|Overall Study|Progressive Disease|3
7049172|NCT01803282|11138097|FG002|Overall Study|Progressive Disease|6
7049173|NCT01803282|11138098|FG003|Overall Study|Progressive Disease|22
7049174|NCT01803282|11138099|FG004|Overall Study|Progressive Disease|5
7049175|NCT01803282|11138100|FG005|Overall Study|Progressive Disease|8
7049176|NCT01803282|11138101|FG006|Overall Study|Progressive Disease|23
7049177|NCT01803282|11138102|FG007|Overall Study|Progressive Disease|24
7049178|NCT01803282|11138103|FG008|Overall Study|Progressive Disease|3
7049179|NCT01803282|11138104|FG009|Overall Study|Progressive Disease|29
7049180|NCT01803282|11138105|FG010|Overall Study|Progressive Disease|6
7049181|NCT01803282|11138106|FG011|Overall Study|Progressive Disease|11
7049182|NCT01803282|11138095|FG000|Overall Study|Death|0
7049183|NCT01803282|11138096|FG001|Overall Study|Death|0
7049184|NCT01803282|11138097|FG002|Overall Study|Death|0
7049185|NCT01803282|11138098|FG003|Overall Study|Death|0
7049186|NCT01803282|11138099|FG004|Overall Study|Death|2
7049187|NCT01803282|11138100|FG005|Overall Study|Death|1
7049188|NCT01803282|11138101|FG006|Overall Study|Death|1
7049189|NCT01803282|11138102|FG007|Overall Study|Death|5
7049190|NCT01803282|11138103|FG008|Overall Study|Death|1
7049191|NCT01803282|11138104|FG009|Overall Study|Death|1
7049192|NCT01803282|11138105|FG010|Overall Study|Death|0
7049193|NCT01803282|11138106|FG011|Overall Study|Death|0
7049194|NCT01803282|11138095|FG000|Overall Study|Withdrew Consent|0
7049195|NCT01803282|11138096|FG001|Overall Study|Withdrew Consent|0
7049196|NCT01803282|11138097|FG002|Overall Study|Withdrew Consent|0
7049197|NCT01803282|11138098|FG003|Overall Study|Withdrew Consent|6
7049198|NCT01803282|11138099|FG004|Overall Study|Withdrew Consent|1
7049199|NCT01803282|11138100|FG005|Overall Study|Withdrew Consent|0
7049200|NCT01803282|11138101|FG006|Overall Study|Withdrew Consent|8
7049201|NCT01803282|11138102|FG007|Overall Study|Withdrew Consent|3
7049202|NCT01803282|11138103|FG008|Overall Study|Withdrew Consent|1
7049203|NCT01803282|11138104|FG009|Overall Study|Withdrew Consent|5
7049204|NCT01803282|11138105|FG010|Overall Study|Withdrew Consent|0
7049205|NCT01803282|11138106|FG011|Overall Study|Withdrew Consent|1
7049206|NCT01803282|11138095|FG000|Overall Study|Investigator's Discretion|0
7049207|NCT01803282|11138096|FG001|Overall Study|Investigator's Discretion|0
7049208|NCT01803282|11138097|FG002|Overall Study|Investigator's Discretion|0
7049209|NCT01803282|11138098|FG003|Overall Study|Investigator's Discretion|7
7049210|NCT01803282|11138099|FG004|Overall Study|Investigator's Discretion|2
7049211|NCT01803282|11138100|FG005|Overall Study|Investigator's Discretion|1
7049212|NCT01803282|11138101|FG006|Overall Study|Investigator's Discretion|7
7049213|NCT01803282|11138102|FG007|Overall Study|Investigator's Discretion|10
7049214|NCT01803282|11138103|FG008|Overall Study|Investigator's Discretion|6
7188697|NCT02891226|11388871|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7188698|NCT02891226|11388872|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7188699|NCT02891226|11388873|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7188700|NCT02891226|11388858|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7188701|NCT02891226|11388859|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7188702|NCT02891226|11388860|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7188703|NCT02891226|11388861|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7188704|NCT02891226|11388862|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7188705|NCT02891226|11388863|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7188706|NCT02891226|11388864|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7188707|NCT02891226|11388865|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7188708|NCT02891226|11388866|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7188709|NCT02891226|11388867|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7188710|NCT02891226|11388868|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2
7188711|NCT02891226|11388869|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7188712|NCT02891226|11388870|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7188713|NCT02891226|11388871|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7188714|NCT02891226|11388872|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7188715|NCT02891226|11388873|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7049215|NCT01803282|11138104|FG009|Overall Study|Investigator's Discretion|7
7049216|NCT01803282|11138105|FG010|Overall Study|Investigator's Discretion|1
7049217|NCT01803282|11138106|FG011|Overall Study|Investigator's Discretion|0
7049218|NCT01803282|11138095|FG000|Overall Study|Adverse Event|0
7049219|NCT01803282|11138096|FG001|Overall Study|Adverse Event|0
7049220|NCT01803282|11138097|FG002|Overall Study|Adverse Event|0
7049221|NCT01803282|11138098|FG003|Overall Study|Adverse Event|0
7049222|NCT01803282|11138099|FG004|Overall Study|Adverse Event|0
7049223|NCT01803282|11138100|FG005|Overall Study|Adverse Event|0
7049224|NCT01803282|11138101|FG006|Overall Study|Adverse Event|1
7049225|NCT01803282|11138102|FG007|Overall Study|Adverse Event|2
7049226|NCT01803282|11138103|FG008|Overall Study|Adverse Event|0
7049227|NCT01803282|11138104|FG009|Overall Study|Adverse Event|1
7049228|NCT01803282|11138105|FG010|Overall Study|Adverse Event|0
7049229|NCT01803282|11138106|FG011|Overall Study|Adverse Event|3
7049230|NCT01803282|11138095|FG000|Overall Study|Non-Compliance with Study Drug|0
7049231|NCT01803282|11138096|FG001|Overall Study|Non-Compliance with Study Drug|0
7049232|NCT01803282|11138097|FG002|Overall Study|Non-Compliance with Study Drug|0
7049233|NCT01803282|11138098|FG003|Overall Study|Non-Compliance with Study Drug|1
7049234|NCT01803282|11138099|FG004|Overall Study|Non-Compliance with Study Drug|0
7049235|NCT01803282|11138100|FG005|Overall Study|Non-Compliance with Study Drug|0
7049236|NCT01803282|11138101|FG006|Overall Study|Non-Compliance with Study Drug|0
7049237|NCT01803282|11138102|FG007|Overall Study|Non-Compliance with Study Drug|0
7049238|NCT01803282|11138103|FG008|Overall Study|Non-Compliance with Study Drug|0
7049239|NCT01803282|11138104|FG009|Overall Study|Non-Compliance with Study Drug|0
7049240|NCT01803282|11138105|FG010|Overall Study|Non-Compliance with Study Drug|0
7049241|NCT01803282|11138106|FG011|Overall Study|Non-Compliance with Study Drug|0
7049242|NCT01803282|11138095|FG000|Overall Study|Unknown Reason|0
7049243|NCT01803282|11138096|FG001|Overall Study|Unknown Reason|0
7049244|NCT01803282|11138097|FG002|Overall Study|Unknown Reason|0
7049245|NCT01803282|11138098|FG003|Overall Study|Unknown Reason|0
7049246|NCT01803282|11138099|FG004|Overall Study|Unknown Reason|0
7049247|NCT01803282|11138100|FG005|Overall Study|Unknown Reason|0
7049248|NCT01803282|11138101|FG006|Overall Study|Unknown Reason|0
7049249|NCT01803282|11138102|FG007|Overall Study|Unknown Reason|1
7049250|NCT01803282|11138103|FG008|Overall Study|Unknown Reason|0
7049251|NCT01803282|11138104|FG009|Overall Study|Unknown Reason|0
7049252|NCT01803282|11138105|FG010|Overall Study|Unknown Reason|0
7049253|NCT01803282|11138106|FG011|Overall Study|Unknown Reason|0
7049254|NCT01803282|11138095|FG000|Overall Study|Specified Criteria for Withdrawal|0
7049255|NCT01803282|11138096|FG001|Overall Study|Specified Criteria for Withdrawal|0
7049256|NCT01803282|11138097|FG002|Overall Study|Specified Criteria for Withdrawal|0
7049257|NCT01803282|11138098|FG003|Overall Study|Specified Criteria for Withdrawal|0
7049258|NCT01803282|11138099|FG004|Overall Study|Specified Criteria for Withdrawal|0
7049259|NCT01803282|11138100|FG005|Overall Study|Specified Criteria for Withdrawal|0
7049260|NCT01803282|11138101|FG006|Overall Study|Specified Criteria for Withdrawal|0
7049261|NCT01803282|11138102|FG007|Overall Study|Specified Criteria for Withdrawal|0
7049262|NCT01803282|11138103|FG008|Overall Study|Specified Criteria for Withdrawal|0
7049263|NCT01803282|11138104|FG009|Overall Study|Specified Criteria for Withdrawal|1
7049264|NCT01803282|11138105|FG010|Overall Study|Specified Criteria for Withdrawal|1
7049265|NCT01803282|11138106|FG011|Overall Study|Specified Criteria for Withdrawal|0
7049266|NCT01803282|11138095|FG000|Overall Study|Enrolled but Never Treated|0
7049267|NCT01803282|11138096|FG001|Overall Study|Enrolled but Never Treated|0
7049268|NCT01803282|11138097|FG002|Overall Study|Enrolled but Never Treated|0
7049269|NCT01803282|11138098|FG003|Overall Study|Enrolled but Never Treated|0
7049270|NCT01803282|11138099|FG004|Overall Study|Enrolled but Never Treated|1
7049271|NCT01803282|11138100|FG005|Overall Study|Enrolled but Never Treated|0
7049272|NCT01803282|11138101|FG006|Overall Study|Enrolled but Never Treated|1
7049273|NCT01803282|11138102|FG007|Overall Study|Enrolled but Never Treated|1
7049274|NCT01803282|11138103|FG008|Overall Study|Enrolled but Never Treated|0
7049275|NCT01803282|11138104|FG009|Overall Study|Enrolled but Never Treated|1
7049276|NCT01803282|11138105|FG010|Overall Study|Enrolled but Never Treated|0
7049277|NCT01803282|11138106|FG011|Overall Study|Enrolled but Never Treated|0
7049278|NCT01803464|11138136|FG000|Overall Study|Incomplete data|0
7049279|NCT01803464|11138137|FG001|Overall Study|Incomplete data|0
7049280|NCT01803464|11138138|FG002|Overall Study|Incomplete data|4
7049281|NCT01803464|11138139|FG003|Overall Study|Incomplete data|0
7049282|NCT01803464|11138136|FG000|Overall Study|Withdrawal by Subject|1
7049283|NCT01803464|11138137|FG001|Overall Study|Withdrawal by Subject|0
7049284|NCT01803464|11138138|FG002|Overall Study|Withdrawal by Subject|0
7049285|NCT01803464|11138139|FG003|Overall Study|Withdrawal by Subject|0
7049286|NCT01803607|11138155|FG000|Overall Study|Adverse Event|5
7049287|NCT01803607|11138156|FG001|Overall Study|Adverse Event|3
7049288|NCT01803607|11138155|FG000|Overall Study|Lack of Efficacy|0
7049289|NCT01803607|11138156|FG001|Overall Study|Lack of Efficacy|1
7049290|NCT01803607|11138155|FG000|Overall Study|Protocol Violation|3
7049291|NCT01803607|11138156|FG001|Overall Study|Protocol Violation|2
7049292|NCT01803607|11138155|FG000|Overall Study|Study terminated by sponsor|54
7049293|NCT01803607|11138156|FG001|Overall Study|Study terminated by sponsor|56
7049294|NCT01803607|11138155|FG000|Overall Study|Withdrawal by Subject|6
7049295|NCT01803607|11138156|FG001|Overall Study|Withdrawal by Subject|5
7049296|NCT01803646|11138164|FG000|Overall Study|Protocol Violation|1
7049297|NCT01803646|11138165|FG001|Overall Study|Protocol Violation|0
7049298|NCT01803646|11138164|FG000|Overall Study|Adverse Event|1
7049299|NCT01803646|11138165|FG001|Overall Study|Adverse Event|1
7049300|NCT01803646|11138164|FG000|Overall Study|Withdrawal by Subject|9
7049301|NCT01803646|11138165|FG001|Overall Study|Withdrawal by Subject|6
7049302|NCT01803646|11138164|FG000|Overall Study|Randomization error|1
7049303|NCT01803646|11138165|FG001|Overall Study|Randomization error|2
7049304|NCT01803646|11138164|FG000|Overall Study|Lost to Follow-up|5
7049305|NCT01803646|11138165|FG001|Overall Study|Lost to Follow-up|1
7049306|NCT01803737|11138173|FG000|Overall Study|Lack of Time|1
7049307|NCT01803737|11138174|FG001|Overall Study|Lack of Time|0
7049308|NCT01803737|11138173|FG000|Overall Study|Medical Reason|0
7049309|NCT01803737|11138174|FG001|Overall Study|Medical Reason|1
7049310|NCT01803737|11138173|FG000|Overall Study|Lost to Follow-up|0
7049311|NCT01803737|11138174|FG001|Overall Study|Lost to Follow-up|2
7049312|NCT01803880|11138183|FG000|Overall Study|Adverse Event|1
7049313|NCT01803880|11138184|FG001|Overall Study|Adverse Event|0
7049314|NCT01803880|11138185|FG002|Overall Study|Adverse Event|0
7049315|NCT01803880|11138183|FG000|Overall Study|Withdrawal by Subject|1
7049316|NCT01803880|11138184|FG001|Overall Study|Withdrawal by Subject|1
7049317|NCT01803880|11138185|FG002|Overall Study|Withdrawal by Subject|4
7049318|NCT01803880|11138183|FG000|Overall Study|Physician Decision|0
7049319|NCT01803880|11138184|FG001|Overall Study|Physician Decision|0
7049320|NCT01803880|11138185|FG002|Overall Study|Physician Decision|1
7049321|NCT01803880|11138183|FG000|Overall Study|Unable to return for follow-up visits|0
7049322|NCT01803880|11138184|FG001|Overall Study|Unable to return for follow-up visits|1
7049323|NCT01803880|11138185|FG002|Overall Study|Unable to return for follow-up visits|2
7049324|NCT01803880|11138183|FG000|Overall Study|Lost to Follow-up|1
7049325|NCT01803880|11138184|FG001|Overall Study|Lost to Follow-up|2
7049326|NCT01803880|11138185|FG002|Overall Study|Lost to Follow-up|3
7049327|NCT01803880|11138183|FG000|Overall Study|Protocol Violation|1
7049328|NCT01803880|11138184|FG001|Overall Study|Protocol Violation|0
7049329|NCT01803880|11138185|FG002|Overall Study|Protocol Violation|0
7049330|NCT01803880|11138183|FG000|Overall Study|Early study termination|0
7049331|NCT01803880|11138184|FG001|Overall Study|Early study termination|6
7049332|NCT01803880|11138185|FG002|Overall Study|Early study termination|5
7049333|NCT01803880|11138183|FG000|Overall Study|Incomplete data entry by sites|2
7049334|NCT01803880|11138184|FG001|Overall Study|Incomplete data entry by sites|0
7049335|NCT01803880|11138185|FG002|Overall Study|Incomplete data entry by sites|0
7049336|NCT01804049|11138207|FG000|Overall Study|Adverse Event|2
7049337|NCT01804049|11138208|FG001|Overall Study|Adverse Event|10
7049338|NCT01804049|11138207|FG000|Overall Study|Lost to Follow-up|2
7049339|NCT01804049|11138208|FG001|Overall Study|Lost to Follow-up|1
7049340|NCT01804049|11138207|FG000|Overall Study|Decreased interest/personal|4
7049341|NCT01804049|11138208|FG001|Overall Study|Decreased interest/personal|5
7049342|NCT01804049|11138207|FG000|Overall Study|Other health concerns|2
7049343|NCT01804049|11138208|FG001|Overall Study|Other health concerns|7
7049344|NCT01804049|11138207|FG000|Overall Study|Moved out of area|0
7049345|NCT01804049|11138208|FG001|Overall Study|Moved out of area|7
7049346|NCT01804049|11138207|FG000|Overall Study|other MD recommended|1
7049347|NCT01804049|11138208|FG001|Overall Study|other MD recommended|1
7049348|NCT01804049|11138207|FG000|Overall Study|Enrollment in dual studies|0
7049349|NCT01804049|11138208|FG001|Overall Study|Enrollment in dual studies|1
7049350|NCT01804140|11138251|FG000|Overall Study|No sampling or biopsy procedures done|114
7049351|NCT01804582|11138270|FG000|Overall Study|Lost to Follow-up|47
7049352|NCT01804582|11138271|FG001|Overall Study|Lost to Follow-up|56
7049353|NCT01804582|11138270|FG000|Overall Study|Physician Decision|2
7049354|NCT01804582|11138271|FG001|Overall Study|Physician Decision|0
7049355|NCT01804673|11138278|FG000|Overall Study|Adverse Event|4
7049356|NCT01804673|11138278|FG000|Overall Study|Withdrawal by Subject|1
7188716|NCT02891226|11388858|FG000|Follow-up Period|Withdrawal by Subject|0
7188717|NCT02891226|11388859|FG001|Follow-up Period|Withdrawal by Subject|0
7188718|NCT02891226|11388860|FG002|Follow-up Period|Withdrawal by Subject|0
7188719|NCT02891226|11388861|FG003|Follow-up Period|Withdrawal by Subject|0
7188720|NCT02891226|11388862|FG004|Follow-up Period|Withdrawal by Subject|0
7188721|NCT02891226|11388863|FG005|Follow-up Period|Withdrawal by Subject|0
7188722|NCT02891226|11388864|FG006|Follow-up Period|Withdrawal by Subject|0
7188723|NCT02891226|11388865|FG007|Follow-up Period|Withdrawal by Subject|0
7188724|NCT02891226|11388866|FG008|Follow-up Period|Withdrawal by Subject|0
7188725|NCT02891226|11388867|FG009|Follow-up Period|Withdrawal by Subject|0
7188726|NCT02891226|11388868|FG010|Follow-up Period|Withdrawal by Subject|0
7049357|NCT01804673|11138278|FG000|Overall Study|Lack of Efficacy|9
7049358|NCT01804673|11138278|FG000|Overall Study|Change to Oral Therapy|37
7049359|NCT01804673|11138278|FG000|Overall Study|No Further Therapy Required|84
7049360|NCT01804673|11138278|FG000|Overall Study|Use of Prohibited Medication|1
7188727|NCT02891226|11388869|FG011|Follow-up Period|Withdrawal by Subject|1
7188728|NCT02891226|11388870|FG012|Follow-up Period|Withdrawal by Subject|0
7049361|NCT01804673|11138278|FG000|Overall Study|Other|4
7049362|NCT01804842|11138285|FG000|Overall Study|Adverse Event|1
7049363|NCT01804842|11138286|FG001|Overall Study|Adverse Event|1
7049364|NCT01804842|11138287|FG002|Overall Study|Adverse Event|0
7049365|NCT01804842|11138285|FG000|Overall Study|Lost to Follow-up|1
7049366|NCT01804842|11138286|FG001|Overall Study|Lost to Follow-up|0
7049367|NCT01804842|11138287|FG002|Overall Study|Lost to Follow-up|0
7049368|NCT01804842|11138285|FG000|Overall Study|Non-Compliance|1
7049369|NCT01804842|11138286|FG001|Overall Study|Non-Compliance|1
7049370|NCT01804842|11138287|FG002|Overall Study|Non-Compliance|0
7049371|NCT01804842|11138285|FG000|Overall Study|Personal Reason|0
7049372|NCT01804842|11138286|FG001|Overall Study|Personal Reason|0
7049373|NCT01804842|11138287|FG002|Overall Study|Personal Reason|1
7049374|NCT01804946|11138308|FG000|Overall Study|Protocol Violation|1
7049375|NCT01804946|11138309|FG001|Overall Study|Protocol Violation|0
7049376|NCT01804946|11138308|FG000|Overall Study|Adverse Event|0
7049377|NCT01804946|11138309|FG001|Overall Study|Adverse Event|1
7049378|NCT01804946|11138308|FG000|Overall Study|Insufficient data available|0
7049379|NCT01804946|11138309|FG001|Overall Study|Insufficient data available|1
7049380|NCT01804946|11138308|FG000|Overall Study|Do not meet inclusion criteria|1
7049381|NCT01804946|11138309|FG001|Overall Study|Do not meet inclusion criteria|2
7049382|NCT01805037|11138334|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0
7049383|NCT01805037|11138335|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2
7049384|NCT01805037|11138334|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0
7049385|NCT01805037|11138335|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2
7049386|NCT01805037|11138334|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0
7049387|NCT01805037|11138335|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1
7049388|NCT01805037|11138334|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0
7049389|NCT01805037|11138335|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1
7049390|NCT01805037|11138334|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0
7049391|NCT01805037|11138335|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10
7049392|NCT01805037|11138334|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0
7049393|NCT01805037|11138335|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1
7049394|NCT01805037|11138334|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0
7049395|NCT01805037|11138335|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1
7049396|NCT01805037|11138334|FG000|Follow Up (up to 3 Years)|Death|0
7049397|NCT01805037|11138335|FG001|Follow Up (up to 3 Years)|Death|2
7049398|NCT01805037|11138334|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0
7049399|NCT01805037|11138335|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3
7049400|NCT01805037|11138334|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0
7049401|NCT01805037|11138335|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1
7188729|NCT02891226|11388871|FG013|Follow-up Period|Withdrawal by Subject|0
7188730|NCT02891226|11388872|FG014|Follow-up Period|Withdrawal by Subject|1
7188731|NCT02891226|11388873|FG015|Follow-up Period|Withdrawal by Subject|1
7188732|NCT02549092|11388906|FG000|Treatment Period|Adverse Event|2
7188733|NCT02549092|11388907|FG001|Treatment Period|Adverse Event|2
7188734|NCT02549092|11388906|FG000|Treatment Period|Withdrawal by Subject|1
7188735|NCT02549092|11388907|FG001|Treatment Period|Withdrawal by Subject|3
7188736|NCT02549092|11388906|FG000|Treatment Period|Lack of Efficacy|0
7188737|NCT02549092|11388907|FG001|Treatment Period|Lack of Efficacy|2
7188738|NCT02549092|11388906|FG000|Extension/Transition Period|Still in Extension/Transition Period|4
7188739|NCT02549092|11388907|FG001|Extension/Transition Period|Still in Extension/Transition Period|8
7188740|NCT02549092|11388906|FG000|Extension/Transition Period|Premature Discontinuation for Unspecified Reason|1
7188741|NCT02549092|11388907|FG001|Extension/Transition Period|Premature Discontinuation for Unspecified Reason|1
7188742|NCT02323126|11388928|FG000|Overall Study|Patient / guardian decision|0
7188743|NCT02323126|11388929|FG001|Overall Study|Patient / guardian decision|1
7188744|NCT02323126|11388930|FG002|Overall Study|Patient / guardian decision|2
7188745|NCT02323126|11388928|FG000|Overall Study|Progressive disease|14
7188746|NCT02323126|11388929|FG001|Overall Study|Progressive disease|8
7049402|NCT01805180|11138357|FG000|Lead-in Donor Phase|screen failure|1
7049403|NCT01805180|11138358|FG001|Lead-in Donor Phase|screen failure|0
7049404|NCT01805180|11138359|FG002|Lead-in Donor Phase|screen failure|0
7049405|NCT01806064|11138461|FG000|Overall Study|Randomized Not Enrolled|0
7049406|NCT01806064|11138462|FG001|Overall Study|Randomized Not Enrolled|0
7049407|NCT01806064|11138463|FG002|Overall Study|Randomized Not Enrolled|0
7049408|NCT01806064|11138464|FG003|Overall Study|Randomized Not Enrolled|1
7049409|NCT01806064|11138465|FG004|Overall Study|Randomized Not Enrolled|2
7049410|NCT01806168|11138484|FG000|Overall Study|Adverse Event|1
7049411|NCT01806168|11138485|FG001|Overall Study|Adverse Event|0
7049412|NCT01806168|11138486|FG002|Overall Study|Adverse Event|0
7049413|NCT01806168|11138484|FG000|Overall Study|Withdrawal by Subject|0
7049414|NCT01806168|11138485|FG001|Overall Study|Withdrawal by Subject|1
7049415|NCT01806168|11138486|FG002|Overall Study|Withdrawal by Subject|2
7049416|NCT01806168|11138484|FG000|Overall Study|Protocol Violation|0
7049417|NCT01806168|11138485|FG001|Overall Study|Protocol Violation|0
7049418|NCT01806168|11138486|FG002|Overall Study|Protocol Violation|1
7049419|NCT01806298|11138507|FG000|Overall Study|Adverse Event|3
7049420|NCT01806298|11138507|FG000|Overall Study|Protocol Non-compliance|1
7188747|NCT02323126|11388930|FG002|Overall Study|Progressive disease|14
7188748|NCT02323126|11388928|FG000|Overall Study|Physician Decision|0
7188749|NCT02323126|11388929|FG001|Overall Study|Physician Decision|1
7049421|NCT01806298|11138507|FG000|Overall Study|Withdrawal by Subject|1
7049422|NCT01806298|11138507|FG000|Overall Study|Other|5
7049423|NCT01806389|11138511|FG000|Overall Study|Withdrawal by Subject|4
7049424|NCT01806506|11138527|FG000|Overall Study|Lost to Follow-up|2
7049425|NCT01806506|11138528|FG001|Overall Study|Lost to Follow-up|1
7049426|NCT01806545|11138536|FG000|Overall Study|Adverse Event|2
7049427|NCT01806545|11138537|FG001|Overall Study|Adverse Event|3
7049428|NCT01806545|11138536|FG000|Overall Study|Lost to Follow-up|1
7049429|NCT01806545|11138537|FG001|Overall Study|Lost to Follow-up|0
7049430|NCT01806545|11138536|FG000|Overall Study|Withdrawal by Subject|3
7049431|NCT01806545|11138537|FG001|Overall Study|Withdrawal by Subject|2
7049432|NCT01806584|11138549|FG000|Overall Study|Adverse Event|2
7049433|NCT01806584|11138550|FG001|Overall Study|Adverse Event|1
7049434|NCT01806584|11138549|FG000|Overall Study|Death|1
7049435|NCT01806584|11138550|FG001|Overall Study|Death|0
7049436|NCT01806584|11138549|FG000|Overall Study|Lost to Follow-up|0
7049437|NCT01806584|11138550|FG001|Overall Study|Lost to Follow-up|2
7049438|NCT01806584|11138549|FG000|Overall Study|Study terminated by sponsor|9
7049439|NCT01806584|11138550|FG001|Overall Study|Study terminated by sponsor|14
7049440|NCT01806584|11138549|FG000|Overall Study|Withdrawal by Subject|1
7049441|NCT01806584|11138550|FG001|Overall Study|Withdrawal by Subject|1
7049442|NCT01806584|11138549|FG000|Overall Study|Other unspecified|1
7049443|NCT01806584|11138550|FG001|Overall Study|Other unspecified|0
7049444|NCT01806597|11138559|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1
7049445|NCT01806597|11138560|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1
7049446|NCT01806597|11138561|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0
7049447|NCT01806597|11138562|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0
7049448|NCT01806597|11138563|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2
7049449|NCT01806597|11138564|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0
7049450|NCT01806597|11138559|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
7049451|NCT01806597|11138560|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
7049452|NCT01806597|11138561|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
7049453|NCT01806597|11138562|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
7049454|NCT01806597|11138563|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
7049455|NCT01806597|11138564|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
7049456|NCT01806597|11138559|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0
7049457|NCT01806597|11138560|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1
7049458|NCT01806597|11138561|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0
7049459|NCT01806597|11138562|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0
7049460|NCT01806597|11138563|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0
7049461|NCT01806597|11138564|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0
7049462|NCT01806597|11138559|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3
7049463|NCT01806597|11138560|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
7049464|NCT01806597|11138561|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
7049465|NCT01806597|11138562|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
7049466|NCT01806597|11138563|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
7049467|NCT01806597|11138564|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
7049468|NCT01806597|11138559|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0
7049469|NCT01806597|11138560|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1
7049470|NCT01806597|11138561|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0
7049471|NCT01806597|11138562|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0
7049472|NCT01806597|11138563|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0
7049473|NCT01806597|11138564|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0
7049474|NCT01806597|11138559|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9
7049475|NCT01806597|11138560|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6
7049476|NCT01806597|11138561|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4
7049477|NCT01806597|11138562|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3
7049478|NCT01806597|11138563|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1
7049479|NCT01806597|11138564|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0
7049480|NCT01806597|11138559|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12
7049481|NCT01806597|11138560|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5
7049482|NCT01806597|11138561|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3
7049483|NCT01806597|11138562|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1
7049484|NCT01806597|11138563|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
7049485|NCT01806597|11138564|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
7049486|NCT01806597|11138559|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2
7049487|NCT01806597|11138560|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
7049488|NCT01806597|11138561|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
7049489|NCT01806597|11138562|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
7049490|NCT01806597|11138563|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
7049491|NCT01806597|11138564|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
7049492|NCT01806597|11138559|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
7049493|NCT01806597|11138560|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
7049494|NCT01806597|11138561|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
7188750|NCT02323126|11388930|FG002|Overall Study|Physician Decision|3
7049495|NCT01806597|11138562|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
7049496|NCT01806597|11138563|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
7188751|NCT02323126|11388928|FG000|Overall Study|Death|1
7188752|NCT02323126|11388929|FG001|Overall Study|Death|1
7188753|NCT02323126|11388930|FG002|Overall Study|Death|4
7188754|NCT02323126|11388928|FG000|Overall Study|Adverse Event|3
7188755|NCT02323126|11388929|FG001|Overall Study|Adverse Event|5
7188756|NCT02323126|11388930|FG002|Overall Study|Adverse Event|7
7188757|NCT01902290|11388943|FG000|Overall Study|Withdrawal by Subject|19
7188758|NCT01902290|11388944|FG001|Overall Study|Withdrawal by Subject|27
7188759|NCT01902290|11388943|FG000|Overall Study|Lost to Follow-up|2
7188760|NCT01902290|11388944|FG001|Overall Study|Lost to Follow-up|2
7188761|NCT01902290|11388943|FG000|Overall Study|Death|1
7188762|NCT01902290|11388944|FG001|Overall Study|Death|0
7188763|NCT01902290|11388943|FG000|Overall Study|Sponsor Decision|26
7188764|NCT01902290|11388944|FG001|Overall Study|Sponsor Decision|24
7188765|NCT01126749|11388955|FG000|Phase 1b|Other|0
7188766|NCT01126749|11388956|FG001|Phase 1b|Other|1
7188767|NCT01126749|11388957|FG002|Phase 1b|Other|0
7188768|NCT01126749|11388958|FG003|Phase 1b|Other|0
7049497|NCT01806597|11138564|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
7049498|NCT01806597|11138559|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2
7049499|NCT01806597|11138560|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
7049500|NCT01806597|11138561|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
7049501|NCT01806597|11138562|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
7049502|NCT01806597|11138563|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
7049503|NCT01806597|11138564|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
7049504|NCT01806597|11138559|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
7049505|NCT01806597|11138560|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
7049506|NCT01806597|11138561|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
7049507|NCT01806597|11138562|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
7049508|NCT01806597|11138563|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
7049509|NCT01806597|11138564|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
7049510|NCT01806597|11138559|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10
7049511|NCT01806597|11138560|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
7049512|NCT01806597|11138561|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6
7049513|NCT01806597|11138562|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
7049514|NCT01806597|11138563|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
7049515|NCT01806597|11138564|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
7049516|NCT01806597|11138559|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
7049517|NCT01806597|11138560|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
7049518|NCT01806597|11138561|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
7049519|NCT01806597|11138562|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
7049520|NCT01806597|11138563|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
7049521|NCT01806597|11138564|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
7188769|NCT01126749|11388955|FG000|Phase 1b|Withdrawal by Subject|0
7188770|NCT01126749|11388956|FG001|Phase 1b|Withdrawal by Subject|1
7188771|NCT01126749|11388957|FG002|Phase 1b|Withdrawal by Subject|0
7049522|NCT01806597|11138559|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1
7049523|NCT01806597|11138560|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0
7049524|NCT01806597|11138561|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0
7049525|NCT01806597|11138562|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0
7049526|NCT01806597|11138563|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0
7049527|NCT01806597|11138564|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0
7049528|NCT01806597|11138559|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
7049529|NCT01806597|11138560|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
7188772|NCT01126749|11388958|FG003|Phase 1b|Withdrawal by Subject|0
7188773|NCT01126749|11388955|FG000|Phase 1b|Death|3
7188774|NCT01126749|11388956|FG001|Phase 1b|Death|4
7188775|NCT01126749|11388957|FG002|Phase 1b|Death|0
7188776|NCT01126749|11388958|FG003|Phase 1b|Death|0
7049530|NCT01806597|11138561|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
7049531|NCT01806597|11138562|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
7049532|NCT01806597|11138563|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
7049533|NCT01806597|11138564|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5
7049534|NCT01806597|11138559|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
7188777|NCT01126749|11388955|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0
7188778|NCT01126749|11388956|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0
7188779|NCT01126749|11388957|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4
7188780|NCT01126749|11388958|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7
7188781|NCT01126749|11388955|FG000|Phase 2|Study Termination by Sponsor|0
7188782|NCT01126749|11388956|FG001|Phase 2|Study Termination by Sponsor|0
7049535|NCT01806597|11138560|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
7049536|NCT01806597|11138561|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
7049537|NCT01806597|11138562|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
7049538|NCT01806597|11138563|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
7049539|NCT01806597|11138564|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2
7049540|NCT01806597|11138559|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
7049541|NCT01806597|11138560|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
7049542|NCT01806597|11138561|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
7049543|NCT01806597|11138562|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
7049544|NCT01806597|11138563|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
7049545|NCT01806597|11138564|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2
7049546|NCT01806597|11138559|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
7049547|NCT01806597|11138560|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
7049548|NCT01806597|11138561|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
7049549|NCT01806597|11138562|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
7049550|NCT01806597|11138563|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
7049551|NCT01806597|11138564|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2
7049552|NCT01806597|11138559|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
7049553|NCT01806597|11138560|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
7049554|NCT01806597|11138561|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
7049555|NCT01806597|11138562|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
7049556|NCT01806597|11138563|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
7049557|NCT01806597|11138564|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1
7049558|NCT01806623|11138578|FG000|Overall Study|Withdrawal by Subject|1
7049559|NCT01806623|11138578|FG000|Overall Study|Adverse Event|1
7049560|NCT01806623|11138578|FG000|Overall Study|Did not meet the inclusion criteria|56
7049561|NCT01806662|11138582|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4
7049562|NCT01806662|11138583|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0
7049563|NCT01806662|11138582|FG000|First Intervention (Weeks 0-16)|Adverse Event|0
7049564|NCT01806662|11138583|FG001|First Intervention (Weeks 0-16)|Adverse Event|1
7049565|NCT01806662|11138582|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2
7049566|NCT01806662|11138583|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3
7049567|NCT01806662|11138582|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0
7049568|NCT01806662|11138583|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1
7049569|NCT01806714|11138616|FG000|Overall Study|No functioning phone number|200
7049570|NCT01806714|11138617|FG001|Overall Study|No functioning phone number|170
7049571|NCT01806740|11138623|FG000|Overall Study|Withdrawal by Subject|4
7049572|NCT01806740|11138623|FG000|Overall Study|Physician Decision|1
7049573|NCT01806740|11138623|FG000|Overall Study|Patient's refusal of treatment|1
7049574|NCT01806779|11138632|FG000|Overall Study|Physician Decision|2
7049575|NCT01806779|11138633|FG001|Overall Study|Physician Decision|0
7049576|NCT01806779|11138634|FG002|Overall Study|Physician Decision|1
7049577|NCT01806779|11138632|FG000|Overall Study|Lack of Efficacy|1
7049578|NCT01806779|11138633|FG001|Overall Study|Lack of Efficacy|1
7188783|NCT01126749|11388957|FG002|Phase 2|Study Termination by Sponsor|12
7188784|NCT01126749|11388958|FG003|Phase 2|Study Termination by Sponsor|6
7188785|NCT01126749|11388955|FG000|Phase 2|Other|0
7188786|NCT01126749|11388956|FG001|Phase 2|Other|0
7188787|NCT01126749|11388957|FG002|Phase 2|Other|4
7188788|NCT01126749|11388958|FG003|Phase 2|Other|2
7188789|NCT01126749|11388955|FG000|Phase 2|Withdrawal by Subject|0
7188790|NCT01126749|11388956|FG001|Phase 2|Withdrawal by Subject|0
7188791|NCT01126749|11388957|FG002|Phase 2|Withdrawal by Subject|0
7188792|NCT01126749|11388958|FG003|Phase 2|Withdrawal by Subject|2
7188793|NCT01126749|11388955|FG000|Phase 2|Lost to Follow-up|0
7188794|NCT01126749|11388956|FG001|Phase 2|Lost to Follow-up|0
7188795|NCT01126749|11388957|FG002|Phase 2|Lost to Follow-up|0
7188796|NCT01126749|11388958|FG003|Phase 2|Lost to Follow-up|1
7188797|NCT01126749|11388955|FG000|Phase 2|Death|0
7188798|NCT01126749|11388956|FG001|Phase 2|Death|0
7188799|NCT01126749|11388957|FG002|Phase 2|Death|22
7188800|NCT01126749|11388958|FG003|Phase 2|Death|22
7188801|NCT01126749|11388955|FG000|Phase 2|Adverse Event|0
7188802|NCT01126749|11388956|FG001|Phase 2|Adverse Event|0
7188803|NCT01126749|11388957|FG002|Phase 2|Adverse Event|0
7188804|NCT01126749|11388958|FG003|Phase 2|Adverse Event|1
7049579|NCT01806779|11138634|FG002|Overall Study|Lack of Efficacy|0
7049580|NCT01806779|11138632|FG000|Overall Study|Lost to Follow-up|19
7049581|NCT01806779|11138633|FG001|Overall Study|Lost to Follow-up|20
7049582|NCT01806779|11138634|FG002|Overall Study|Lost to Follow-up|0
7049583|NCT01806779|11138632|FG000|Overall Study|Withdrawal by Subject|20
7049584|NCT01806779|11138633|FG001|Overall Study|Withdrawal by Subject|23
7049585|NCT01806779|11138634|FG002|Overall Study|Withdrawal by Subject|22
7049586|NCT01806896|11138651|FG000|Overall Study|Adverse Event|2
7188805|NCT01059448|11388981|FG000|Overall Study|Adverse Event|1
7188806|NCT01059448|11388982|FG001|Overall Study|Adverse Event|3
7188807|NCT01059448|11388983|FG002|Overall Study|Adverse Event|0
7188808|NCT01059448|11388984|FG003|Overall Study|Adverse Event|1
7188809|NCT01059448|11388981|FG000|Overall Study|Withdrawal by Subject|2
7188810|NCT01059448|11388982|FG001|Overall Study|Withdrawal by Subject|0
7188811|NCT01059448|11388983|FG002|Overall Study|Withdrawal by Subject|2
7188812|NCT01059448|11388984|FG003|Overall Study|Withdrawal by Subject|4
7188813|NCT01059448|11388981|FG000|Overall Study|Disease Progression|2
7188814|NCT01059448|11388982|FG001|Overall Study|Disease Progression|1
7188815|NCT01059448|11388983|FG002|Overall Study|Disease Progression|4
7188816|NCT01059448|11388984|FG003|Overall Study|Disease Progression|2
7188817|NCT01059448|11388981|FG000|Overall Study|Administrative Decision|43
7188818|NCT01059448|11388982|FG001|Overall Study|Administrative Decision|49
7188819|NCT01059448|11388983|FG002|Overall Study|Administrative Decision|45
7188820|NCT01059448|11388984|FG003|Overall Study|Administrative Decision|46
7188821|NCT01059448|11388981|FG000|Overall Study|Lost to Follow-up|0
7188822|NCT01059448|11388982|FG001|Overall Study|Lost to Follow-up|0
7188823|NCT01059448|11388983|FG002|Overall Study|Lost to Follow-up|2
7188824|NCT01059448|11388984|FG003|Overall Study|Lost to Follow-up|0
7188825|NCT01059448|11388981|FG000|Overall Study|Death|0
7188826|NCT01059448|11388982|FG001|Overall Study|Death|1
7188827|NCT01059448|11388983|FG002|Overall Study|Death|0
7188828|NCT01059448|11388984|FG003|Overall Study|Death|0
7188829|NCT01059448|11388981|FG000|Overall Study|Other|1
7188830|NCT01059448|11388982|FG001|Overall Study|Other|1
7188831|NCT01059448|11388983|FG002|Overall Study|Other|0
7188832|NCT01059448|11388984|FG003|Overall Study|Other|1
7188833|NCT00821587|11388996|FG000|Overall Study|Physician Decision|0
7188834|NCT00821587|11388997|FG001|Overall Study|Physician Decision|1
7188835|NCT00585195|11389024|FG000|Overall Study|Adverse Event|0
7188836|NCT00585195|11389025|FG001|Overall Study|Adverse Event|0
7188837|NCT00585195|11389026|FG002|Overall Study|Adverse Event|0
7188838|NCT00585195|11389027|FG003|Overall Study|Adverse Event|0
7188839|NCT00585195|11389028|FG004|Overall Study|Adverse Event|2
7188840|NCT00585195|11389029|FG005|Overall Study|Adverse Event|1
7188841|NCT00585195|11389030|FG006|Overall Study|Adverse Event|0
7049587|NCT01806896|11138652|FG001|Overall Study|Adverse Event|0
7049588|NCT01806896|11138651|FG000|Overall Study|Other|1
7188842|NCT00585195|11389031|FG007|Overall Study|Adverse Event|1
7188843|NCT00585195|11389032|FG008|Overall Study|Adverse Event|0
7188844|NCT00585195|11389033|FG009|Overall Study|Adverse Event|0
7188845|NCT00585195|11389034|FG010|Overall Study|Adverse Event|3
7049589|NCT01806896|11138652|FG001|Overall Study|Other|0
7049590|NCT01807065|11138694|FG000|Overall Study|Receive no sip-T due to IV access|1
7049591|NCT01807065|11138695|FG001|Overall Study|Receive no sip-T due to IV access|1
7083785|NCT02158533|11195427|FG002|Stage 2|Physician Decision|0
7083786|NCT02158533|11195428|FG003|Stage 2|Physician Decision|0
7083787|NCT02158533|11195429|FG004|Stage 2|Physician Decision|1
7083788|NCT02158533|11195430|FG005|Stage 2|Physician Decision|0
7188846|NCT00585195|11389035|FG011|Overall Study|Adverse Event|0
7188847|NCT00585195|11389036|FG012|Overall Study|Adverse Event|8
7188848|NCT00585195|11389037|FG013|Overall Study|Adverse Event|6
7188849|NCT00585195|11389038|FG014|Overall Study|Adverse Event|4
7083789|NCT02158533|11195425|FG000|Stage 2|Pregnancy|0
7083790|NCT02158533|11195426|FG001|Stage 2|Pregnancy|0
7083791|NCT02158533|11195427|FG002|Stage 2|Pregnancy|0
7083792|NCT02158533|11195428|FG003|Stage 2|Pregnancy|1
7083793|NCT02158533|11195429|FG004|Stage 2|Pregnancy|0
7083794|NCT02158533|11195430|FG005|Stage 2|Pregnancy|0
7083795|NCT02158533|11195425|FG000|Stage 2|Psychiatrist decision to try new tx|0
7083796|NCT02158533|11195426|FG001|Stage 2|Psychiatrist decision to try new tx|0
7188850|NCT00585195|11389039|FG015|Overall Study|Adverse Event|1
7188851|NCT00585195|11389040|FG016|Overall Study|Adverse Event|14
7188852|NCT00585195|11389041|FG017|Overall Study|Adverse Event|9
7188853|NCT00585195|11389042|FG018|Overall Study|Adverse Event|2
7188854|NCT00585195|11389043|FG019|Overall Study|Adverse Event|3
7188855|NCT00585195|11389044|FG020|Overall Study|Adverse Event|1
7188856|NCT00585195|11389024|FG000|Overall Study|Progressive Disease|2
7188857|NCT00585195|11389025|FG001|Overall Study|Progressive Disease|2
7188858|NCT00585195|11389026|FG002|Overall Study|Progressive Disease|5
7188859|NCT00585195|11389027|FG003|Overall Study|Progressive Disease|4
7188860|NCT00585195|11389028|FG004|Overall Study|Progressive Disease|6
7188861|NCT00585195|11389029|FG005|Overall Study|Progressive Disease|4
7188862|NCT00585195|11389030|FG006|Overall Study|Progressive Disease|6
7188863|NCT00585195|11389031|FG007|Overall Study|Progressive Disease|3
7188864|NCT00585195|11389032|FG008|Overall Study|Progressive Disease|0
7188865|NCT00585195|11389033|FG009|Overall Study|Progressive Disease|5
7049592|NCT01807156|11138714|FG000|Overall Study|Physician Decision|1
7049593|NCT01807221|11138724|FG000|Overall Study|Progressive disease|1
7049594|NCT01807221|11138725|FG001|Overall Study|Progressive disease|0
7049595|NCT01807221|11138726|FG002|Overall Study|Progressive disease|1
7049596|NCT01807221|11138727|FG003|Overall Study|Progressive disease|0
7049597|NCT01807221|11138728|FG004|Overall Study|Progressive disease|0
7049598|NCT01807221|11138729|FG005|Overall Study|Progressive disease|0
7049599|NCT01807221|11138724|FG000|Overall Study|Death|7
7049600|NCT01807221|11138725|FG001|Overall Study|Death|9
7049601|NCT01807221|11138726|FG002|Overall Study|Death|4
7049602|NCT01807221|11138727|FG003|Overall Study|Death|2
7049603|NCT01807221|11138728|FG004|Overall Study|Death|1
7049604|NCT01807221|11138729|FG005|Overall Study|Death|6
7049605|NCT01807221|11138724|FG000|Overall Study|Physician Decision|2
7049606|NCT01807221|11138725|FG001|Overall Study|Physician Decision|1
7049607|NCT01807221|11138726|FG002|Overall Study|Physician Decision|0
7049608|NCT01807221|11138727|FG003|Overall Study|Physician Decision|0
7049609|NCT01807221|11138728|FG004|Overall Study|Physician Decision|0
7049610|NCT01807221|11138729|FG005|Overall Study|Physician Decision|0
7049611|NCT01807221|11138724|FG000|Overall Study|Adverse Event|33
7049612|NCT01807221|11138725|FG001|Overall Study|Adverse Event|22
7083797|NCT02158533|11195427|FG002|Stage 2|Psychiatrist decision to try new tx|0
7083798|NCT02158533|11195428|FG003|Stage 2|Psychiatrist decision to try new tx|1
7083799|NCT02158533|11195429|FG004|Stage 2|Psychiatrist decision to try new tx|0
7083800|NCT02158533|11195430|FG005|Stage 2|Psychiatrist decision to try new tx|0
7083801|NCT02158533|11195425|FG000|Stage 2|Non-adherence with study visits|0
7188866|NCT00585195|11389034|FG010|Overall Study|Progressive Disease|2
7188867|NCT00585195|11389035|FG011|Overall Study|Progressive Disease|25
7188868|NCT00585195|11389036|FG012|Overall Study|Progressive Disease|29
7188869|NCT00585195|11389037|FG013|Overall Study|Progressive Disease|26
7188870|NCT00585195|11389038|FG014|Overall Study|Progressive Disease|21
7188871|NCT00585195|11389039|FG015|Overall Study|Progressive Disease|12
7188872|NCT00585195|11389040|FG016|Overall Study|Progressive Disease|94
7188873|NCT00585195|11389041|FG017|Overall Study|Progressive Disease|42
7188874|NCT00585195|11389042|FG018|Overall Study|Progressive Disease|4
7188875|NCT00585195|11389043|FG019|Overall Study|Progressive Disease|9
7188876|NCT00585195|11389044|FG020|Overall Study|Progressive Disease|8
7188877|NCT00585195|11389024|FG000|Overall Study|Withdrawal by Subject|1
7188878|NCT00585195|11389025|FG001|Overall Study|Withdrawal by Subject|1
7188879|NCT00585195|11389026|FG002|Overall Study|Withdrawal by Subject|2
7188880|NCT00585195|11389027|FG003|Overall Study|Withdrawal by Subject|2
7188881|NCT00585195|11389028|FG004|Overall Study|Withdrawal by Subject|0
7188882|NCT00585195|11389029|FG005|Overall Study|Withdrawal by Subject|0
7188883|NCT00585195|11389030|FG006|Overall Study|Withdrawal by Subject|0
7188884|NCT00585195|11389031|FG007|Overall Study|Withdrawal by Subject|1
7188885|NCT00585195|11389032|FG008|Overall Study|Withdrawal by Subject|0
7188886|NCT00585195|11389033|FG009|Overall Study|Withdrawal by Subject|0
7188887|NCT00585195|11389034|FG010|Overall Study|Withdrawal by Subject|3
7188888|NCT00585195|11389035|FG011|Overall Study|Withdrawal by Subject|8
7188889|NCT00585195|11389036|FG012|Overall Study|Withdrawal by Subject|15
7188890|NCT00585195|11389037|FG013|Overall Study|Withdrawal by Subject|0
7188891|NCT00585195|11389038|FG014|Overall Study|Withdrawal by Subject|3
7188892|NCT00585195|11389039|FG015|Overall Study|Withdrawal by Subject|0
7049613|NCT01807221|11138726|FG002|Overall Study|Adverse Event|26
7083802|NCT02158533|11195426|FG001|Stage 2|Non-adherence with study visits|0
7083803|NCT02158533|11195427|FG002|Stage 2|Non-adherence with study visits|0
7083804|NCT02158533|11195428|FG003|Stage 2|Non-adherence with study visits|0
7083805|NCT02158533|11195429|FG004|Stage 2|Non-adherence with study visits|0
7083806|NCT02158533|11195430|FG005|Stage 2|Non-adherence with study visits|1
7083807|NCT02158546|11195448|FG000|Overall Study|Physician Decision|0
7083808|NCT02158546|11195449|FG001|Overall Study|Physician Decision|1
7083809|NCT02158546|11195450|FG002|Overall Study|Physician Decision|0
7083810|NCT02158546|11195451|FG003|Overall Study|Physician Decision|0
7049614|NCT01807221|11138727|FG003|Overall Study|Adverse Event|25
7049615|NCT01807221|11138728|FG004|Overall Study|Adverse Event|18
7049616|NCT01807221|11138729|FG005|Overall Study|Adverse Event|21
7049617|NCT01807221|11138724|FG000|Overall Study|Protocol Violation|0
7049618|NCT01807221|11138725|FG001|Overall Study|Protocol Violation|2
7049619|NCT01807221|11138726|FG002|Overall Study|Protocol Violation|1
7049620|NCT01807221|11138727|FG003|Overall Study|Protocol Violation|2
7049621|NCT01807221|11138728|FG004|Overall Study|Protocol Violation|0
7049622|NCT01807221|11138729|FG005|Overall Study|Protocol Violation|1
7049623|NCT01807221|11138724|FG000|Overall Study|Non-compliance|1
7049624|NCT01807221|11138725|FG001|Overall Study|Non-compliance|2
7049625|NCT01807221|11138726|FG002|Overall Study|Non-compliance|0
7049626|NCT01807221|11138727|FG003|Overall Study|Non-compliance|1
7049627|NCT01807221|11138728|FG004|Overall Study|Non-compliance|0
7049628|NCT01807221|11138729|FG005|Overall Study|Non-compliance|0
7049629|NCT01807221|11138724|FG000|Overall Study|Logistical difficulties|0
7049630|NCT01807221|11138725|FG001|Overall Study|Logistical difficulties|1
7049631|NCT01807221|11138726|FG002|Overall Study|Logistical difficulties|0
7049632|NCT01807221|11138727|FG003|Overall Study|Logistical difficulties|0
7049633|NCT01807221|11138728|FG004|Overall Study|Logistical difficulties|1
7049634|NCT01807221|11138729|FG005|Overall Study|Logistical difficulties|0
7049635|NCT01807221|11138724|FG000|Overall Study|Withdrawal by Subject|33
7049636|NCT01807221|11138725|FG001|Overall Study|Withdrawal by Subject|15
7049637|NCT01807221|11138726|FG002|Overall Study|Withdrawal by Subject|8
7049638|NCT01807221|11138727|FG003|Overall Study|Withdrawal by Subject|14
7049639|NCT01807221|11138728|FG004|Overall Study|Withdrawal by Subject|16
7049640|NCT01807221|11138729|FG005|Overall Study|Withdrawal by Subject|13
7049641|NCT01807221|11138724|FG000|Overall Study|Sponsor decision|2
7049642|NCT01807221|11138725|FG001|Overall Study|Sponsor decision|0
7049643|NCT01807221|11138726|FG002|Overall Study|Sponsor decision|1
7049644|NCT01807221|11138727|FG003|Overall Study|Sponsor decision|1
7049645|NCT01807221|11138728|FG004|Overall Study|Sponsor decision|0
7049646|NCT01807221|11138729|FG005|Overall Study|Sponsor decision|0
7049647|NCT01807221|11138724|FG000|Overall Study|Lost to Follow-up|1
7049648|NCT01807221|11138725|FG001|Overall Study|Lost to Follow-up|0
7049649|NCT01807221|11138726|FG002|Overall Study|Lost to Follow-up|2
7188893|NCT00585195|11389040|FG016|Overall Study|Withdrawal by Subject|7
7188894|NCT00585195|11389041|FG017|Overall Study|Withdrawal by Subject|1
7188895|NCT00585195|11389042|FG018|Overall Study|Withdrawal by Subject|2
7188896|NCT00585195|11389043|FG019|Overall Study|Withdrawal by Subject|2
7188897|NCT00585195|11389044|FG020|Overall Study|Withdrawal by Subject|0
7049650|NCT01807221|11138727|FG003|Overall Study|Lost to Follow-up|1
7049651|NCT01807221|11138728|FG004|Overall Study|Lost to Follow-up|0
7049652|NCT01807221|11138729|FG005|Overall Study|Lost to Follow-up|0
7049653|NCT01807234|11138749|FG000|Overall Study|Lost to Follow-up|2
7049654|NCT01807234|11138750|FG001|Overall Study|Lost to Follow-up|5
7049655|NCT01807234|11138751|FG002|Overall Study|Lost to Follow-up|1
7188898|NCT00585195|11389024|FG000|Overall Study|Other|0
7188899|NCT00585195|11389025|FG001|Overall Study|Other|1
7188900|NCT00585195|11389026|FG002|Overall Study|Other|1
7188901|NCT00585195|11389027|FG003|Overall Study|Other|1
7188902|NCT00585195|11389028|FG004|Overall Study|Other|0
7188903|NCT00585195|11389029|FG005|Overall Study|Other|1
7188904|NCT00585195|11389030|FG006|Overall Study|Other|0
7188905|NCT00585195|11389031|FG007|Overall Study|Other|0
7188906|NCT00585195|11389032|FG008|Overall Study|Other|2
7188907|NCT00585195|11389033|FG009|Overall Study|Other|1
7188908|NCT00585195|11389034|FG010|Overall Study|Other|0
7188909|NCT00585195|11389035|FG011|Overall Study|Other|19
7188910|NCT00585195|11389036|FG012|Overall Study|Other|23
7049656|NCT01807234|11138752|FG003|Overall Study|Lost to Follow-up|1
7049657|NCT01807234|11138753|FG004|Overall Study|Lost to Follow-up|1
7049658|NCT01807234|11138754|FG005|Overall Study|Lost to Follow-up|2
7049659|NCT01807234|11138749|FG000|Overall Study|Withdrawal by Subject|3
7049660|NCT01807234|11138750|FG001|Overall Study|Withdrawal by Subject|1
7049661|NCT01807234|11138751|FG002|Overall Study|Withdrawal by Subject|1
7049662|NCT01807234|11138752|FG003|Overall Study|Withdrawal by Subject|1
7049663|NCT01807234|11138753|FG004|Overall Study|Withdrawal by Subject|2
7049664|NCT01807234|11138754|FG005|Overall Study|Withdrawal by Subject|1
7188911|NCT00585195|11389037|FG013|Overall Study|Other|7
7188912|NCT00585195|11389038|FG014|Overall Study|Other|11
7188913|NCT00585195|11389039|FG015|Overall Study|Other|3
7049665|NCT01807234|11138749|FG000|Overall Study|Lack of Efficacy|0
7049666|NCT01807234|11138750|FG001|Overall Study|Lack of Efficacy|0
7049667|NCT01807234|11138751|FG002|Overall Study|Lack of Efficacy|0
7049668|NCT01807234|11138752|FG003|Overall Study|Lack of Efficacy|0
7049669|NCT01807234|11138753|FG004|Overall Study|Lack of Efficacy|1
7049670|NCT01807234|11138754|FG005|Overall Study|Lack of Efficacy|1
7049671|NCT01807299|11138768|FG000|Overall Study|Protocol Violation|3
7049672|NCT01807299|11138769|FG001|Overall Study|Protocol Violation|1
7049673|NCT01807299|11138770|FG002|Overall Study|Protocol Violation|0
7049674|NCT01807299|11138771|FG003|Overall Study|Protocol Violation|2
7049675|NCT01807520|11138788|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
7049676|NCT01807520|11138789|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1
7049677|NCT01807520|11138790|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3
7049678|NCT01807520|11138791|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
7049679|NCT01807520|11138792|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
7049680|NCT01807520|11138793|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
7049681|NCT01807520|11138794|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
7049682|NCT01807520|11138788|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
7049683|NCT01807520|11138789|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
7049684|NCT01807520|11138790|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
7049685|NCT01807520|11138791|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
7049686|NCT01807520|11138792|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
7049687|NCT01807520|11138793|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
7049688|NCT01807520|11138794|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
7049689|NCT01807520|11138788|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
7188914|NCT00585195|11389040|FG016|Overall Study|Other|28
7188915|NCT00585195|11389041|FG017|Overall Study|Other|12
7188916|NCT00585195|11389042|FG018|Overall Study|Other|10
7188917|NCT00585195|11389043|FG019|Overall Study|Other|4
7188918|NCT00585195|11389044|FG020|Overall Study|Other|2
7188919|NCT00585195|11389024|FG000|Overall Study|Randomized not treated|0
7188920|NCT00585195|11389025|FG001|Overall Study|Randomized not treated|0
7188921|NCT00585195|11389026|FG002|Overall Study|Randomized not treated|1
7188922|NCT00585195|11389027|FG003|Overall Study|Randomized not treated|0
7188923|NCT00585195|11389028|FG004|Overall Study|Randomized not treated|1
7188924|NCT00585195|11389029|FG005|Overall Study|Randomized not treated|0
7188925|NCT00585195|11389030|FG006|Overall Study|Randomized not treated|1
7188926|NCT00585195|11389031|FG007|Overall Study|Randomized not treated|0
7049690|NCT01807520|11138789|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
7049691|NCT01807520|11138790|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1
7188927|NCT00585195|11389032|FG008|Overall Study|Randomized not treated|0
7049692|NCT01807520|11138791|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
7049693|NCT01807520|11138792|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
7049694|NCT01807520|11138793|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
7049695|NCT01807520|11138794|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
7049696|NCT01807520|11138788|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1
7049697|NCT01807520|11138789|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
7049698|NCT01807520|11138790|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
7049699|NCT01807520|11138791|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
7049700|NCT01807520|11138792|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
7049701|NCT01807520|11138793|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
7049702|NCT01807520|11138794|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
7049703|NCT01807520|11138788|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
7049704|NCT01807520|11138789|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
7049705|NCT01807520|11138790|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2
7049706|NCT01807520|11138791|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
7049707|NCT01807520|11138792|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
7049708|NCT01807520|11138793|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
7049709|NCT01807520|11138794|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
7049710|NCT01807520|11138788|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2
7049711|NCT01807520|11138789|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
7049712|NCT01807520|11138790|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
7049713|NCT01807520|11138791|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
7049714|NCT01807520|11138792|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
7049715|NCT01807520|11138793|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
7049716|NCT01807520|11138794|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
7049717|NCT01807520|11138788|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7
7049718|NCT01807520|11138789|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4
7049719|NCT01807520|11138790|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0
7049720|NCT01807520|11138791|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0
7049721|NCT01807520|11138792|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2
7049722|NCT01807520|11138793|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0
7049723|NCT01807520|11138794|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0
7049724|NCT01807520|11138788|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
7049725|NCT01807520|11138789|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
7049726|NCT01807520|11138790|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
7049727|NCT01807520|11138791|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1
7049728|NCT01807520|11138792|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
7083811|NCT02158546|11195448|FG000|Overall Study|Non-compliance|0
7083812|NCT02158546|11195449|FG001|Overall Study|Non-compliance|1
7049729|NCT01807520|11138793|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
7049730|NCT01807520|11138794|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
7049731|NCT01807520|11138788|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1
7049732|NCT01807520|11138789|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
7049733|NCT01807520|11138790|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
7049734|NCT01807520|11138791|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
7049735|NCT01807520|11138792|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
7049736|NCT01807520|11138793|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
7049737|NCT01807520|11138794|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
7049738|NCT01807520|11138788|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
7049739|NCT01807520|11138789|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2
7049740|NCT01807520|11138790|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
7049741|NCT01807520|11138791|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
7188928|NCT00585195|11389033|FG009|Overall Study|Randomized not treated|0
7188929|NCT00585195|11389034|FG010|Overall Study|Randomized not treated|2
7188930|NCT00585195|11389035|FG011|Overall Study|Randomized not treated|0
7188931|NCT00585195|11389036|FG012|Overall Study|Randomized not treated|0
7188932|NCT00585195|11389037|FG013|Overall Study|Randomized not treated|0
7188933|NCT00585195|11389038|FG014|Overall Study|Randomized not treated|0
7188934|NCT00585195|11389039|FG015|Overall Study|Randomized not treated|1
7188935|NCT00585195|11389040|FG016|Overall Study|Randomized not treated|0
7188936|NCT00585195|11389041|FG017|Overall Study|Randomized not treated|1
7188937|NCT00585195|11389042|FG018|Overall Study|Randomized not treated|3
7188938|NCT00585195|11389043|FG019|Overall Study|Randomized not treated|0
7188939|NCT00585195|11389044|FG020|Overall Study|Randomized not treated|2
7188940|NCT00585195|11389024|FG000|Overall Study|Death|0
7188941|NCT00585195|11389025|FG001|Overall Study|Death|0
7188942|NCT00585195|11389026|FG002|Overall Study|Death|0
7188943|NCT00585195|11389027|FG003|Overall Study|Death|0
7188944|NCT00585195|11389028|FG004|Overall Study|Death|0
7188945|NCT00585195|11389029|FG005|Overall Study|Death|0
7049742|NCT01807520|11138792|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
7049743|NCT01807520|11138793|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
7049744|NCT01807520|11138794|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
7188946|NCT00585195|11389030|FG006|Overall Study|Death|0
7188947|NCT00585195|11389031|FG007|Overall Study|Death|0
7049745|NCT01807520|11138788|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4
7188948|NCT00585195|11389032|FG008|Overall Study|Death|1
7188949|NCT00585195|11389033|FG009|Overall Study|Death|0
7188950|NCT00585195|11389034|FG010|Overall Study|Death|1
7188951|NCT00585195|11389035|FG011|Overall Study|Death|1
7188952|NCT00585195|11389036|FG012|Overall Study|Death|7
7188953|NCT00585195|11389037|FG013|Overall Study|Death|2
7049746|NCT01807520|11138789|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
7188954|NCT00585195|11389038|FG014|Overall Study|Death|8
7188955|NCT00585195|11389039|FG015|Overall Study|Death|2
7188956|NCT00585195|11389040|FG016|Overall Study|Death|11
7188957|NCT00585195|11389041|FG017|Overall Study|Death|0
7188958|NCT00585195|11389042|FG018|Overall Study|Death|0
7188959|NCT00585195|11389043|FG019|Overall Study|Death|0
7188960|NCT00585195|11389044|FG020|Overall Study|Death|1
7188961|NCT00585195|11389024|FG000|Overall Study|Lost to Follow-up|0
7188962|NCT00585195|11389025|FG001|Overall Study|Lost to Follow-up|0
7188963|NCT00585195|11389026|FG002|Overall Study|Lost to Follow-up|0
7188964|NCT00585195|11389027|FG003|Overall Study|Lost to Follow-up|0
7188965|NCT00585195|11389028|FG004|Overall Study|Lost to Follow-up|0
7188966|NCT00585195|11389029|FG005|Overall Study|Lost to Follow-up|0
7188967|NCT00585195|11389030|FG006|Overall Study|Lost to Follow-up|0
7188968|NCT00585195|11389031|FG007|Overall Study|Lost to Follow-up|0
7188969|NCT00585195|11389032|FG008|Overall Study|Lost to Follow-up|0
7188970|NCT00585195|11389033|FG009|Overall Study|Lost to Follow-up|0
7188971|NCT00585195|11389034|FG010|Overall Study|Lost to Follow-up|0
7188972|NCT00585195|11389035|FG011|Overall Study|Lost to Follow-up|0
7188973|NCT00585195|11389036|FG012|Overall Study|Lost to Follow-up|1
7188974|NCT00585195|11389037|FG013|Overall Study|Lost to Follow-up|0
7188975|NCT00585195|11389038|FG014|Overall Study|Lost to Follow-up|0
7188976|NCT00585195|11389039|FG015|Overall Study|Lost to Follow-up|0
7188977|NCT00585195|11389040|FG016|Overall Study|Lost to Follow-up|0
7049747|NCT01807520|11138790|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
7188978|NCT00585195|11389041|FG017|Overall Study|Lost to Follow-up|2
7188979|NCT00585195|11389042|FG018|Overall Study|Lost to Follow-up|0
7049748|NCT01807520|11138791|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1
7049749|NCT01807520|11138792|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
7049750|NCT01807520|11138793|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
7049751|NCT01807520|11138794|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
7049752|NCT01807520|11138788|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5
7188980|NCT00585195|11389043|FG019|Overall Study|Lost to Follow-up|0
7188981|NCT00585195|11389044|FG020|Overall Study|Lost to Follow-up|0
7188982|NCT00585195|11389024|FG000|Overall Study|Ongoing|0
7049753|NCT01807520|11138789|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3
7049754|NCT01807520|11138790|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
7049755|NCT01807520|11138791|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
7049756|NCT01807520|11138792|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1
7049757|NCT01807520|11138793|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
7049758|NCT01807520|11138794|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
7049759|NCT01807520|11138788|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
7049760|NCT01807520|11138789|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
7049761|NCT01807520|11138790|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
7049762|NCT01807520|11138791|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
7049763|NCT01807520|11138792|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
7049764|NCT01807520|11138793|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
7049765|NCT01807520|11138794|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
7049766|NCT01807520|11138788|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5
7049767|NCT01807520|11138789|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6
7049768|NCT01807520|11138790|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
7049769|NCT01807520|11138791|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
7049770|NCT01807520|11138792|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
7049771|NCT01807520|11138793|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
7049772|NCT01807520|11138794|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
7049773|NCT01807520|11138788|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
7049774|NCT01807520|11138789|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
7049775|NCT01807520|11138790|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
7049776|NCT01807520|11138791|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
7049777|NCT01807520|11138792|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
7049778|NCT01807520|11138793|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1
7049779|NCT01807520|11138794|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
7049780|NCT01807520|11138788|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0
7049781|NCT01807520|11138789|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0
7049782|NCT01807520|11138790|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0
7049783|NCT01807520|11138791|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0
7049784|NCT01807520|11138792|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0
7049785|NCT01807520|11138793|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1
7049786|NCT01807520|11138794|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0
7049787|NCT01807520|11138788|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
7049788|NCT01807520|11138789|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
7049789|NCT01807520|11138790|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
7049790|NCT01807520|11138791|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
7049791|NCT01807520|11138792|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
7049792|NCT01807520|11138793|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2
7049793|NCT01807520|11138794|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1
7188983|NCT00585195|11389025|FG001|Overall Study|Ongoing|0
7188984|NCT00585195|11389026|FG002|Overall Study|Ongoing|0
7188985|NCT00585195|11389027|FG003|Overall Study|Ongoing|0
7188986|NCT00585195|11389028|FG004|Overall Study|Ongoing|0
7188987|NCT00585195|11389029|FG005|Overall Study|Ongoing|0
7188988|NCT00585195|11389030|FG006|Overall Study|Ongoing|0
7188989|NCT00585195|11389031|FG007|Overall Study|Ongoing|0
7188990|NCT00585195|11389032|FG008|Overall Study|Ongoing|0
7188991|NCT00585195|11389033|FG009|Overall Study|Ongoing|0
7188992|NCT00585195|11389034|FG010|Overall Study|Ongoing|0
7188993|NCT00585195|11389035|FG011|Overall Study|Ongoing|0
7188994|NCT00585195|11389036|FG012|Overall Study|Ongoing|2
7188995|NCT00585195|11389037|FG013|Overall Study|Ongoing|0
7188996|NCT00585195|11389038|FG014|Overall Study|Ongoing|0
7188997|NCT00585195|11389039|FG015|Overall Study|Ongoing|0
7188998|NCT00585195|11389040|FG016|Overall Study|Ongoing|0
7188999|NCT00585195|11389041|FG017|Overall Study|Ongoing|0
7189000|NCT00585195|11389042|FG018|Overall Study|Ongoing|0
7189001|NCT00585195|11389043|FG019|Overall Study|Ongoing|0
7189002|NCT00585195|11389044|FG020|Overall Study|Ongoing|0
7189003|NCT00585195|11389024|FG000|Overall Study|Withdrawn Due to Pregnancy|0
7189004|NCT00585195|11389025|FG001|Overall Study|Withdrawn Due to Pregnancy|0
7189005|NCT00585195|11389026|FG002|Overall Study|Withdrawn Due to Pregnancy|0
7049794|NCT01807598|11138821|FG000|Overall Study|Withdrawal by Subject|4
7049795|NCT01807598|11138821|FG000|Overall Study|Adverse Event|1
7049796|NCT01807598|11138821|FG000|Overall Study|Other Physician Decision|1
7049797|NCT01807650|11138840|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13
7049798|NCT01807650|11138840|FG000|Overall Study|Adverse Event|5
7049799|NCT01807650|11138840|FG000|Overall Study|Other|2
7049800|NCT01807923|11138893|FG000|Overall Study|Adverse Event|2
7049801|NCT01807923|11138894|FG001|Overall Study|Adverse Event|1
7049802|NCT01807923|11138895|FG002|Overall Study|Adverse Event|2
7049803|NCT01807923|11138893|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0
7049804|NCT01807923|11138894|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3
7189006|NCT00585195|11389027|FG003|Overall Study|Withdrawn Due to Pregnancy|0
7189007|NCT00585195|11389028|FG004|Overall Study|Withdrawn Due to Pregnancy|0
7189008|NCT00585195|11389029|FG005|Overall Study|Withdrawn Due to Pregnancy|0
7049805|NCT01807923|11138895|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2
7049806|NCT01807923|11138893|FG000|Overall Study|Physician Decision|0
7049807|NCT01807923|11138894|FG001|Overall Study|Physician Decision|0
7049808|NCT01807923|11138895|FG002|Overall Study|Physician Decision|1
7049809|NCT01807923|11138893|FG000|Overall Study|Not Eligible (Genotype)|0
7049810|NCT01807923|11138894|FG001|Overall Study|Not Eligible (Genotype)|0
7049811|NCT01807923|11138895|FG002|Overall Study|Not Eligible (Genotype)|1
7049812|NCT01807923|11138893|FG000|Overall Study|Randomized But Not Treated|3
7049813|NCT01807923|11138894|FG001|Overall Study|Randomized But Not Treated|2
7049814|NCT01807923|11138895|FG002|Overall Study|Randomized But Not Treated|5
7049815|NCT01807949|11138908|FG000|Overall Study|Adverse Event|1
7049816|NCT01807949|11138909|FG001|Overall Study|Adverse Event|2
7049817|NCT01807949|11138910|FG002|Overall Study|Adverse Event|2
7049818|NCT01807949|11138908|FG000|Overall Study|Withdrawal by Subject|1
7049819|NCT01807949|11138909|FG001|Overall Study|Withdrawal by Subject|2
7049820|NCT01807949|11138910|FG002|Overall Study|Withdrawal by Subject|2
7049821|NCT01807949|11138908|FG000|Overall Study|Non-Compliance|0
7049822|NCT01807949|11138909|FG001|Overall Study|Non-Compliance|0
7049823|NCT01807949|11138910|FG002|Overall Study|Non-Compliance|1
7049824|NCT01807949|11138908|FG000|Overall Study|Undefined|0
7083813|NCT02158546|11195450|FG002|Overall Study|Non-compliance|0
7083814|NCT02158546|11195451|FG003|Overall Study|Non-compliance|1
7083815|NCT02158546|11195448|FG000|Overall Study|Failure to meet eligibility criteria|0
7189009|NCT00585195|11389030|FG006|Overall Study|Withdrawn Due to Pregnancy|0
7189010|NCT00585195|11389031|FG007|Overall Study|Withdrawn Due to Pregnancy|0
7189011|NCT00585195|11389032|FG008|Overall Study|Withdrawn Due to Pregnancy|0
7189012|NCT00585195|11389033|FG009|Overall Study|Withdrawn Due to Pregnancy|0
7189013|NCT00585195|11389034|FG010|Overall Study|Withdrawn Due to Pregnancy|0
7189014|NCT00585195|11389035|FG011|Overall Study|Withdrawn Due to Pregnancy|0
7189015|NCT00585195|11389036|FG012|Overall Study|Withdrawn Due to Pregnancy|0
7189016|NCT00585195|11389037|FG013|Overall Study|Withdrawn Due to Pregnancy|0
7189017|NCT00585195|11389038|FG014|Overall Study|Withdrawn Due to Pregnancy|1
7189018|NCT00585195|11389039|FG015|Overall Study|Withdrawn Due to Pregnancy|0
7189019|NCT00585195|11389040|FG016|Overall Study|Withdrawn Due to Pregnancy|0
7189020|NCT00585195|11389041|FG017|Overall Study|Withdrawn Due to Pregnancy|0
7189021|NCT00585195|11389042|FG018|Overall Study|Withdrawn Due to Pregnancy|0
7189022|NCT00585195|11389043|FG019|Overall Study|Withdrawn Due to Pregnancy|0
7189023|NCT00585195|11389044|FG020|Overall Study|Withdrawn Due to Pregnancy|0
7189024|NCT04446429|11389129|FG000|Overall Study|Lost to Follow-up|6
7189025|NCT04446429|11389130|FG001|Overall Study|Lost to Follow-up|0
7189026|NCT04194528|11389153|FG000|Overall Study|Adverse Event|1
6804055|NCT01098110|10805922|FG001|Overall Study|Withdrawal by Subject|24
7049825|NCT01807949|11138909|FG001|Overall Study|Undefined|1
7049826|NCT01807949|11138910|FG002|Overall Study|Undefined|2
7049827|NCT01807949|11138908|FG000|Overall Study|Randomized But Not Treated|0
7049828|NCT01807949|11138909|FG001|Overall Study|Randomized But Not Treated|2
7049829|NCT01807949|11138910|FG002|Overall Study|Randomized But Not Treated|2
7049830|NCT01808066|11138920|FG000|Overall Study|Withdrawal by Subject|15
7049831|NCT01808092|11138927|FG000|Overall Study|Death|39
7049832|NCT01808092|11138928|FG001|Overall Study|Death|29
7049833|NCT01808092|11138927|FG000|Overall Study|Lost to Follow-up|3
7049834|NCT01808092|11138928|FG001|Overall Study|Lost to Follow-up|7
7049835|NCT01808092|11138927|FG000|Overall Study|Withdrawal by Subject|9
7049836|NCT01808092|11138928|FG001|Overall Study|Withdrawal by Subject|4
7049837|NCT01808092|11138927|FG000|Overall Study|Other Eligibility criteria|3
7049838|NCT01808092|11138928|FG001|Overall Study|Other Eligibility criteria|5
7049839|NCT01808118|11138934|FG000|Period 1|Adverse Event|15
7049840|NCT01808118|11138935|FG001|Period 1|Adverse Event|0
7049841|NCT01808118|11138936|FG002|Period 1|Adverse Event|0
7049842|NCT01808118|11138934|FG000|Period 1|Withdrew consent|24
7049843|NCT01808118|11138935|FG001|Period 1|Withdrew consent|0
7049844|NCT01808118|11138936|FG002|Period 1|Withdrew consent|0
7049845|NCT01808118|11138934|FG000|Period 1|Lost to Follow-up|9
7049846|NCT01808118|11138935|FG001|Period 1|Lost to Follow-up|0
7083816|NCT02158546|11195449|FG001|Overall Study|Failure to meet eligibility criteria|1
7083817|NCT02158546|11195450|FG002|Overall Study|Failure to meet eligibility criteria|0
7083818|NCT02158546|11195451|FG003|Overall Study|Failure to meet eligibility criteria|0
7083819|NCT02158546|11195448|FG000|Overall Study|Lack of Efficacy|1
7189027|NCT03116685|11389185|FG000|Overall Study|Physician Decision|0
7189028|NCT03116685|11389186|FG001|Overall Study|Physician Decision|1
7189029|NCT03099304|11389197|FG000|DB Period Day 1 to Week 24|Adverse Event|1
7189030|NCT03099304|11389198|FG001|DB Period Day 1 to Week 24|Adverse Event|1
7189031|NCT03099304|11389199|FG002|DB Period Day 1 to Week 24|Adverse Event|0
7189032|NCT03099304|11389200|FG003|DB Period Day 1 to Week 24|Adverse Event|0
7189033|NCT03099304|11389201|FG004|DB Period Day 1 to Week 24|Adverse Event|1
7189034|NCT03099304|11389197|FG000|DB Period Day 1 to Week 24|Lost to Follow-up|1
7189035|NCT03099304|11389198|FG001|DB Period Day 1 to Week 24|Lost to Follow-up|1
7189036|NCT03099304|11389199|FG002|DB Period Day 1 to Week 24|Lost to Follow-up|0
7189037|NCT03099304|11389200|FG003|DB Period Day 1 to Week 24|Lost to Follow-up|0
7049847|NCT01808118|11138936|FG002|Period 1|Lost to Follow-up|0
7049848|NCT01808118|11138934|FG000|Period 1|Did not meet criteria for remission|303
7049849|NCT01808118|11138935|FG001|Period 1|Did not meet criteria for remission|0
7049850|NCT01808118|11138936|FG002|Period 1|Did not meet criteria for remission|0
7049851|NCT01808118|11138934|FG000|Period 1|Enrolled in error|7
7049852|NCT01808118|11138935|FG001|Period 1|Enrolled in error|0
7189038|NCT03099304|11389201|FG004|DB Period Day 1 to Week 24|Lost to Follow-up|0
7049853|NCT01808118|11138936|FG002|Period 1|Enrolled in error|0
7049854|NCT01808118|11138934|FG000|Period 1|Did not meet inclusion criteria|3
7049855|NCT01808118|11138935|FG001|Period 1|Did not meet inclusion criteria|0
7049856|NCT01808118|11138936|FG002|Period 1|Did not meet inclusion criteria|0
7049857|NCT01808118|11138934|FG000|Period 1|Non-conformance with inclusion criteria|3
7049858|NCT01808118|11138935|FG001|Period 1|Non-conformance with inclusion criteria|0
7049859|NCT01808118|11138936|FG002|Period 1|Non-conformance with inclusion criteria|0
7049860|NCT01808118|11138934|FG000|Period 1|Investigator decision: site closure|2
7049861|NCT01808118|11138935|FG001|Period 1|Investigator decision: site closure|0
7049862|NCT01808118|11138936|FG002|Period 1|Investigator decision: site closure|0
7189039|NCT03099304|11389197|FG000|DB Period Day 1 to Week 24|Reason not specified|0
7189040|NCT03099304|11389198|FG001|DB Period Day 1 to Week 24|Reason not specified|0
7189041|NCT03099304|11389199|FG002|DB Period Day 1 to Week 24|Reason not specified|0
7189042|NCT03099304|11389200|FG003|DB Period Day 1 to Week 24|Reason not specified|1
7189043|NCT03099304|11389201|FG004|DB Period Day 1 to Week 24|Reason not specified|0
7189044|NCT03099304|11389197|FG000|DB Period Day 1 to Week 24|Withdrawal by Subject|3
7189045|NCT03099304|11389198|FG001|DB Period Day 1 to Week 24|Withdrawal by Subject|3
7189046|NCT03099304|11389199|FG002|DB Period Day 1 to Week 24|Withdrawal by Subject|0
7189047|NCT03099304|11389200|FG003|DB Period Day 1 to Week 24|Withdrawal by Subject|2
7189048|NCT03099304|11389201|FG004|DB Period Day 1 to Week 24|Withdrawal by Subject|2
7189049|NCT03099304|11389197|FG000|DB Period Day 1 to Week 24|Protocol Violation|0
7189050|NCT03099304|11389198|FG001|DB Period Day 1 to Week 24|Protocol Violation|0
7189051|NCT03099304|11389199|FG002|DB Period Day 1 to Week 24|Protocol Violation|1
7189052|NCT03099304|11389200|FG003|DB Period Day 1 to Week 24|Protocol Violation|1
7189053|NCT03099304|11389201|FG004|DB Period Day 1 to Week 24|Protocol Violation|0
7189054|NCT03099304|11389197|FG000|DB Period Weeks 24 to 52|Protocol Violation|0
7189055|NCT03099304|11389198|FG001|DB Period Weeks 24 to 52|Protocol Violation|0
7189056|NCT03099304|11389199|FG002|DB Period Weeks 24 to 52|Protocol Violation|1
7189057|NCT03099304|11389200|FG003|DB Period Weeks 24 to 52|Protocol Violation|0
7189058|NCT03099304|11389201|FG004|DB Period Weeks 24 to 52|Protocol Violation|0
7189059|NCT03099304|11389197|FG000|DB Period Weeks 24 to 52|Lost to Follow-up|0
7189060|NCT03099304|11389198|FG001|DB Period Weeks 24 to 52|Lost to Follow-up|1
7189061|NCT03099304|11389199|FG002|DB Period Weeks 24 to 52|Lost to Follow-up|1
7189062|NCT03099304|11389200|FG003|DB Period Weeks 24 to 52|Lost to Follow-up|1
7189063|NCT03099304|11389201|FG004|DB Period Weeks 24 to 52|Lost to Follow-up|0
7189064|NCT03099304|11389197|FG000|DB Period Weeks 24 to 52|Adverse Event|0
7189065|NCT03099304|11389198|FG001|DB Period Weeks 24 to 52|Adverse Event|0
7189066|NCT03099304|11389199|FG002|DB Period Weeks 24 to 52|Adverse Event|0
7189067|NCT03099304|11389200|FG003|DB Period Weeks 24 to 52|Adverse Event|1
7189068|NCT03099304|11389201|FG004|DB Period Weeks 24 to 52|Adverse Event|1
7189069|NCT03099304|11389197|FG000|DB Period Weeks 24 to 52|Withdrawal by Subject|0
7189070|NCT03099304|11389198|FG001|DB Period Weeks 24 to 52|Withdrawal by Subject|0
7189071|NCT03099304|11389199|FG002|DB Period Weeks 24 to 52|Withdrawal by Subject|0
7189072|NCT03099304|11389200|FG003|DB Period Weeks 24 to 52|Withdrawal by Subject|4
7189073|NCT03099304|11389201|FG004|DB Period Weeks 24 to 52|Withdrawal by Subject|1
7189074|NCT03099304|11389197|FG000|DB Period Weeks 24 to 52|Reason not specified|0
7189075|NCT03099304|11389198|FG001|DB Period Weeks 24 to 52|Reason not specified|0
7189076|NCT03099304|11389199|FG002|DB Period Weeks 24 to 52|Reason not specified|0
7189077|NCT03099304|11389200|FG003|DB Period Weeks 24 to 52|Reason not specified|1
7189078|NCT03099304|11389201|FG004|DB Period Weeks 24 to 52|Reason not specified|0
7189079|NCT02682901|11389247|FG000|Overall Study|Adverse Event|10
7189080|NCT02682901|11389248|FG001|Overall Study|Adverse Event|3
7189081|NCT02682901|11389247|FG000|Overall Study|Lack of Efficacy|0
7189082|NCT02682901|11389248|FG001|Overall Study|Lack of Efficacy|1
7189083|NCT02567825|11389256|FG000|Overall Study|No follow-up post-randomization|5
7189084|NCT02567825|11389257|FG001|Overall Study|No follow-up post-randomization|1
7189085|NCT02567825|11389256|FG000|Overall Study|Follow-up less than 23 months|16
7189086|NCT02567825|11389257|FG001|Overall Study|Follow-up less than 23 months|20
7189087|NCT02555657|11389265|FG000|Overall Study|Death|274
7189088|NCT02555657|11389266|FG001|Overall Study|Death|262
7189089|NCT02555657|11389265|FG000|Overall Study|Physician Decision|0
7189090|NCT02555657|11389266|FG001|Overall Study|Physician Decision|1
7189091|NCT02555657|11389265|FG000|Overall Study|Sponsor Decision|27
7189092|NCT02555657|11389266|FG001|Overall Study|Sponsor Decision|15
7189093|NCT02555657|11389265|FG000|Overall Study|Withdrawal by Subject|11
7189094|NCT02555657|11389266|FG001|Overall Study|Withdrawal by Subject|32
7049863|NCT01808118|11138934|FG000|Period 1|Non-compliance per sponsor|1
7049864|NCT01808118|11138935|FG001|Period 1|Non-compliance per sponsor|0
7049865|NCT01808118|11138936|FG002|Period 1|Non-compliance per sponsor|0
7049866|NCT01808118|11138934|FG000|Period 1|Lack of Efficacy|1
7189095|NCT02190721|11389276|FG000|Overall Study|Patient was out of the city|0
7189096|NCT02190721|11389277|FG001|Overall Study|Patient was out of the city|1
7189097|NCT02190721|11389278|FG002|Overall Study|Patient was out of the city|0
7189098|NCT00739401|11389311|FG000|Overall Study|patients were not due for the 2 year follow-up|34
7189099|NCT00739401|11389311|FG000|Overall Study|Death|3
7189100|NCT00739401|11389311|FG000|Overall Study|Withdrawal by Subject|4
7189101|NCT00651742|11389315|FG000|Overall Study|Objective Disease Progression|22
7189102|NCT00651742|11389315|FG000|Overall Study|Toxicity|3
6804056|NCT01098110|10805923|FG002|Overall Study|Withdrawal by Subject|19
6804057|NCT01098110|10805921|FG000|Overall Study|Adverse Event|30
6804058|NCT01098110|10805922|FG001|Overall Study|Adverse Event|32
6804059|NCT01098110|10805923|FG002|Overall Study|Adverse Event|43
6804060|NCT01098110|10805921|FG000|Overall Study|Lack of Efficacy|13
6804061|NCT01098110|10805922|FG001|Overall Study|Lack of Efficacy|9
6804062|NCT01098110|10805923|FG002|Overall Study|Lack of Efficacy|27
6804063|NCT01098110|10805921|FG000|Overall Study|Other|4
6804064|NCT01098110|10805922|FG001|Overall Study|Other|7
7049867|NCT01808118|11138935|FG001|Period 1|Lack of Efficacy|0
7049868|NCT01808118|11138936|FG002|Period 1|Lack of Efficacy|0
7049869|NCT01808118|11138934|FG000|Period 2|Adverse Event|0
7049870|NCT01808118|11138935|FG001|Period 2|Adverse Event|4
7049871|NCT01808118|11138936|FG002|Period 2|Adverse Event|0
7049872|NCT01808118|11138934|FG000|Period 2|Withdrew consent|0
7049873|NCT01808118|11138935|FG001|Period 2|Withdrew consent|7
7049874|NCT01808118|11138936|FG002|Period 2|Withdrew consent|6
7049875|NCT01808118|11138934|FG000|Period 2|Lost to Follow-up|0
7049876|NCT01808118|11138935|FG001|Period 2|Lost to Follow-up|0
7049877|NCT01808118|11138936|FG002|Period 2|Lost to Follow-up|2
7049878|NCT01808118|11138934|FG000|Period 2|Investigator no longer conducting trials|0
7049879|NCT01808118|11138935|FG001|Period 2|Investigator no longer conducting trials|1
7049880|NCT01808118|11138936|FG002|Period 2|Investigator no longer conducting trials|0
7049881|NCT01808118|11138934|FG000|Period 2|Switched to other therapy|0
7049882|NCT01808118|11138935|FG001|Period 2|Switched to other therapy|1
7049883|NCT01808118|11138936|FG002|Period 2|Switched to other therapy|0
7049884|NCT01808144|11138952|FG000|Overall Study|Death|1
7049885|NCT01808144|11138953|FG001|Overall Study|Death|0
7189103|NCT00651742|11389315|FG000|Overall Study|Investigator Judgment|1
7049886|NCT01808144|11138952|FG000|Overall Study|Withdrawal by Subject|16
7049887|NCT01808144|11138953|FG001|Overall Study|Withdrawal by Subject|23
7049888|NCT01808144|11138952|FG000|Overall Study|Lost to Follow-up|6
7049889|NCT01808144|11138953|FG001|Overall Study|Lost to Follow-up|3
7049890|NCT01808144|11138952|FG000|Overall Study|Protocol Violation|6
7049891|NCT01808144|11138953|FG001|Overall Study|Protocol Violation|6
7049892|NCT01808144|11138952|FG000|Overall Study|Gout flare|0
7049893|NCT01808144|11138953|FG001|Overall Study|Gout flare|1
7049894|NCT01808144|11138952|FG000|Overall Study|Adverse Event|11
7049895|NCT01808144|11138953|FG001|Overall Study|Adverse Event|15
7049896|NCT01808196|11138959|FG000|Overall Study|Lost to Follow-up|1
7083820|NCT02158546|11195449|FG001|Overall Study|Lack of Efficacy|1
7083821|NCT02158546|11195450|FG002|Overall Study|Lack of Efficacy|0
7189104|NCT00651742|11389315|FG000|Overall Study|Withdrawal of Consent|1
7189105|NCT00651742|11389315|FG000|Overall Study|Enrolled but not treated|1
7189106|NCT04930263|11389334|FG000|Overall Study|Withdrawal by Subject|3
7189107|NCT04930263|11389335|FG001|Overall Study|Withdrawal by Subject|5
7049897|NCT01808209|11138965|FG000|Overall Study|Lost to Follow-up|0
7049898|NCT01808209|11138966|FG001|Overall Study|Lost to Follow-up|1
7049899|NCT01808222|11138976|FG000|Overall Study|mpMR scan was not performed|1
7049900|NCT01808248|11138982|FG000|Overall Study|Lack of Efficacy|3
7049901|NCT01808248|11138982|FG000|Overall Study|Withdrawal by Subject|1
7049902|NCT01808248|11138982|FG000|Overall Study|Lost to Follow-up|1
7049903|NCT01808313|11138988|FG000|Overall Study|Adverse Event|5
7049904|NCT01808313|11138988|FG000|Overall Study|Protocol Violation|2
7083822|NCT02158546|11195451|FG003|Overall Study|Lack of Efficacy|0
7049905|NCT01808313|11138988|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1
7049906|NCT01808313|11138988|FG000|Overall Study|Lost to Follow-up|1
7049907|NCT01808313|11138988|FG000|Overall Study|Physician Decision|1
7049908|NCT01808339|11138996|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
7049909|NCT01808339|11138997|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
7049910|NCT01808339|11138998|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
7049911|NCT01808339|11138999|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
7049912|NCT01808339|11139000|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2
7049913|NCT01808339|11139001|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
7049914|NCT01808339|11138996|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7049915|NCT01808339|11138997|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
7049916|NCT01808339|11138998|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7083823|NCT02158546|11195448|FG000|Overall Study|Adverse Event|2
7083824|NCT02158546|11195449|FG001|Overall Study|Adverse Event|2
7083825|NCT02158546|11195450|FG002|Overall Study|Adverse Event|0
7083826|NCT02158546|11195451|FG003|Overall Study|Adverse Event|0
7083827|NCT02158546|11195448|FG000|Overall Study|Withdrawal by Subject|6
7083828|NCT02158546|11195449|FG001|Overall Study|Withdrawal by Subject|2
7083829|NCT02158546|11195450|FG002|Overall Study|Withdrawal by Subject|1
7083830|NCT02158546|11195451|FG003|Overall Study|Withdrawal by Subject|0
7083831|NCT02158546|11195448|FG000|Overall Study|Lost to Follow-up|5
7083832|NCT02158546|11195449|FG001|Overall Study|Lost to Follow-up|4
7083833|NCT02158546|11195450|FG002|Overall Study|Lost to Follow-up|0
7083834|NCT02158546|11195451|FG003|Overall Study|Lost to Follow-up|1
7083835|NCT02158546|11195448|FG000|Overall Study|Site Excluded|5
7189108|NCT04321252|11389350|FG000|Overall Study|Withdrawal by Subject|0
7189109|NCT04321252|11389351|FG001|Overall Study|Withdrawal by Subject|0
7189110|NCT04321252|11389352|FG002|Overall Study|Withdrawal by Subject|0
7189111|NCT04321252|11389353|FG003|Overall Study|Withdrawal by Subject|0
7189112|NCT04321252|11389354|FG004|Overall Study|Withdrawal by Subject|0
7189113|NCT04321252|11389355|FG005|Overall Study|Withdrawal by Subject|1
7189114|NCT04321252|11389356|FG006|Overall Study|Withdrawal by Subject|0
7189115|NCT04321252|11389357|FG007|Overall Study|Withdrawal by Subject|0
7189116|NCT04321252|11389358|FG008|Overall Study|Withdrawal by Subject|0
7189117|NCT04176445|11389388|FG000|Overall Study|Adverse Event|0
7189118|NCT04176445|11389389|FG001|Overall Study|Adverse Event|1
7189119|NCT04176445|11389388|FG000|Overall Study|change plans weaning after first intervention|0
7189120|NCT04176445|11389389|FG001|Overall Study|change plans weaning after first intervention|1
7189121|NCT04126213|11389401|FG000|Overall Study|Lost to Follow-up|9
7189122|NCT04126213|11389402|FG001|Overall Study|Lost to Follow-up|1
7189123|NCT04126213|11389403|FG002|Overall Study|Lost to Follow-up|5
7189124|NCT04126213|11389404|FG003|Overall Study|Lost to Follow-up|10
7189125|NCT04126213|11389405|FG004|Overall Study|Lost to Follow-up|4
7189126|NCT04126213|11389406|FG005|Overall Study|Lost to Follow-up|7
7189127|NCT04126213|11389401|FG000|Overall Study|Withdrawal by Subject|3
7189128|NCT04126213|11389402|FG001|Overall Study|Withdrawal by Subject|2
7189129|NCT04126213|11389403|FG002|Overall Study|Withdrawal by Subject|1
7189130|NCT04126213|11389404|FG003|Overall Study|Withdrawal by Subject|1
7189131|NCT04126213|11389405|FG004|Overall Study|Withdrawal by Subject|1
7189132|NCT04126213|11389406|FG005|Overall Study|Withdrawal by Subject|1
7189133|NCT04126213|11389401|FG000|Overall Study|Other|0
7049917|NCT01808339|11138999|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
7049918|NCT01808339|11139000|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7049919|NCT01808339|11139001|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7049920|NCT01808339|11138996|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
7049921|NCT01808339|11138997|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
7049922|NCT01808339|11138998|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1
7049923|NCT01808339|11138999|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
7049924|NCT01808339|11139000|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
7049925|NCT01808339|11139001|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
7049926|NCT01808508|11139012|FG000|Overall Study|Lost to Follow-up|1
7049927|NCT01808508|11139013|FG001|Overall Study|Lost to Follow-up|0
7049928|NCT01808508|11139014|FG002|Overall Study|Lost to Follow-up|0
7049929|NCT01808534|11139022|FG000|Overall Study|Disease progression|3
7189134|NCT04126213|11389402|FG001|Overall Study|Other|0
7189135|NCT04126213|11389403|FG002|Overall Study|Other|2
7189136|NCT04126213|11389404|FG003|Overall Study|Other|2
7189137|NCT04126213|11389405|FG004|Overall Study|Other|0
7189138|NCT04126213|11389406|FG005|Overall Study|Other|1
7189139|NCT04126213|11389401|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7189140|NCT04126213|11389402|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2
7189141|NCT04126213|11389403|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
7189142|NCT04126213|11389404|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7189143|NCT04126213|11389405|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
7189144|NCT04126213|11389406|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2
7189145|NCT03672188|11389442|FG000|Overall Study|Withdrawal by Subject|0
7189146|NCT03672188|11389443|FG001|Overall Study|Withdrawal by Subject|0
7189147|NCT03672188|11389444|FG002|Overall Study|Withdrawal by Subject|0
7189148|NCT03672188|11389445|FG003|Overall Study|Withdrawal by Subject|3
6804065|NCT01098110|10805923|FG002|Overall Study|Other|5
6804066|NCT01098110|10805921|FG000|Overall Study|Untreated|1
6804067|NCT01098110|10805922|FG001|Overall Study|Untreated|1
6804068|NCT01098110|10805923|FG002|Overall Study|Untreated|0
6804069|NCT01006265|10805935|FG000|Overall Study|Lost to Follow-up|1
6804070|NCT01006265|10805936|FG001|Overall Study|Lost to Follow-up|0
6804071|NCT01006265|10805937|FG002|Overall Study|Lost to Follow-up|1
6804072|NCT01006265|10805938|FG003|Overall Study|Lost to Follow-up|0
6804073|NCT01006265|10805935|FG000|Overall Study|Withdrawal by Subject|4
6804074|NCT01006265|10805936|FG001|Overall Study|Withdrawal by Subject|7
7049930|NCT01808534|11139022|FG000|Overall Study|Physician Decision|1
7049931|NCT01808573|11139050|FG000|Overall Study|Death|212
7049932|NCT01808573|11139051|FG001|Overall Study|Death|240
7049933|NCT01808573|11139050|FG000|Overall Study|Withdrawal by Subject|12
7049934|NCT01808573|11139051|FG001|Overall Study|Withdrawal by Subject|10
7049935|NCT01808573|11139050|FG000|Overall Study|Lost to Follow-up|3
7049936|NCT01808573|11139051|FG001|Overall Study|Lost to Follow-up|0
7049937|NCT01808573|11139050|FG000|Overall Study|Discontinuation of study by sponsor|79
7049938|NCT01808573|11139051|FG001|Overall Study|Discontinuation of study by sponsor|64
7049939|NCT01808573|11139050|FG000|Overall Study|Randomized in Error|1
7049940|NCT01808573|11139051|FG001|Overall Study|Randomized in Error|0
7049941|NCT01808612|11139060|FG000|Treatment Period|Adverse Event|8
7049942|NCT01808612|11139061|FG001|Treatment Period|Adverse Event|4
7049943|NCT01808612|11139062|FG002|Treatment Period|Adverse Event|3
7049944|NCT01808612|11139060|FG000|Treatment Period|Lost to Follow-up|2
7049945|NCT01808612|11139061|FG001|Treatment Period|Lost to Follow-up|2
7049946|NCT01808612|11139062|FG002|Treatment Period|Lost to Follow-up|1
7049947|NCT01808612|11139060|FG000|Treatment Period|Protocol Violation|1
7049948|NCT01808612|11139061|FG001|Treatment Period|Protocol Violation|0
7049949|NCT01808612|11139062|FG002|Treatment Period|Protocol Violation|0
7049950|NCT01808612|11139060|FG000|Treatment Period|Withdrawal by Subject|1
7049951|NCT01808612|11139061|FG001|Treatment Period|Withdrawal by Subject|0
7049952|NCT01808612|11139062|FG002|Treatment Period|Withdrawal by Subject|4
7049953|NCT01808612|11139060|FG000|Treatment Period|Physician Decision|1
7049954|NCT01808612|11139061|FG001|Treatment Period|Physician Decision|0
7049955|NCT01808612|11139062|FG002|Treatment Period|Physician Decision|4
7049956|NCT01808612|11139060|FG000|Treatment Period|Sponsor Decision|1
7049957|NCT01808612|11139061|FG001|Treatment Period|Sponsor Decision|0
7049958|NCT01808612|11139062|FG002|Treatment Period|Sponsor Decision|0
7049959|NCT01808612|11139060|FG000|Treatment Period|Lack of Efficacy|1
7049960|NCT01808612|11139061|FG001|Treatment Period|Lack of Efficacy|1
7049961|NCT01808612|11139062|FG002|Treatment Period|Lack of Efficacy|2
7049962|NCT01808612|11139060|FG000|Discontinuation Period|Adverse Event|1
7049963|NCT01808612|11139061|FG001|Discontinuation Period|Adverse Event|0
7049964|NCT01808612|11139062|FG002|Discontinuation Period|Adverse Event|0
7049965|NCT01808612|11139060|FG000|Discontinuation Period|Physician Decision|1
7049966|NCT01808612|11139061|FG001|Discontinuation Period|Physician Decision|0
7049967|NCT01808612|11139062|FG002|Discontinuation Period|Physician Decision|0
7049968|NCT01808612|11139060|FG000|Discontinuation Period|Lost to Follow-up|0
7049969|NCT01808612|11139061|FG001|Discontinuation Period|Lost to Follow-up|1
7049970|NCT01808612|11139062|FG002|Discontinuation Period|Lost to Follow-up|0
7049971|NCT01808651|11139076|FG000|Study Period 1|Lost to Follow-up|1
7049972|NCT01808651|11139077|FG001|Study Period 1|Lost to Follow-up|3
7049973|NCT01808651|11139078|FG002|Study Period 1|Lost to Follow-up|0
7049974|NCT01808651|11139076|FG000|Study Period 1|Protocol Violation|1
7049975|NCT01808651|11139077|FG001|Study Period 1|Protocol Violation|0
7049976|NCT01808651|11139078|FG002|Study Period 1|Protocol Violation|1
7049977|NCT01808651|11139076|FG000|Study Period 1|Physician Decision|3
7049978|NCT01808651|11139077|FG001|Study Period 1|Physician Decision|2
7049979|NCT01808651|11139078|FG002|Study Period 1|Physician Decision|0
7049980|NCT01808651|11139076|FG000|Study Period 1|Lack of Efficacy|2
7049981|NCT01808651|11139077|FG001|Study Period 1|Lack of Efficacy|1
7049982|NCT01808651|11139078|FG002|Study Period 1|Lack of Efficacy|0
7049983|NCT01808651|11139076|FG000|Study Period 1|Adverse Event|10
7049984|NCT01808651|11139077|FG001|Study Period 1|Adverse Event|4
7049985|NCT01808651|11139078|FG002|Study Period 1|Adverse Event|1
7049986|NCT01808651|11139076|FG000|Study Period 1|Participant Decision|9
7049987|NCT01808651|11139077|FG001|Study Period 1|Participant Decision|7
7049988|NCT01808651|11139078|FG002|Study Period 1|Participant Decision|3
7049989|NCT01808690|11139091|FG000|Overall Study|Withdrawal by Subject|1
7189149|NCT03672188|11389446|FG004|Overall Study|Withdrawal by Subject|0
7189150|NCT03672188|11389447|FG005|Overall Study|Withdrawal by Subject|0
7189151|NCT03672188|11389448|FG006|Overall Study|Withdrawal by Subject|0
7189152|NCT03672188|11389449|FG007|Overall Study|Withdrawal by Subject|0
7189153|NCT03672188|11389450|FG008|Overall Study|Withdrawal by Subject|0
7189154|NCT03672188|11389451|FG009|Overall Study|Withdrawal by Subject|0
7189155|NCT03672188|11389452|FG010|Overall Study|Withdrawal by Subject|0
7189156|NCT03672188|11389453|FG011|Overall Study|Withdrawal by Subject|0
7189157|NCT03672188|11389454|FG012|Overall Study|Withdrawal by Subject|0
7189158|NCT03672188|11389455|FG013|Overall Study|Withdrawal by Subject|0
7189159|NCT03672188|11389456|FG014|Overall Study|Withdrawal by Subject|0
7189160|NCT03672188|11389442|FG000|Overall Study|Death|0
7189161|NCT03672188|11389443|FG001|Overall Study|Death|0
7189162|NCT03672188|11389444|FG002|Overall Study|Death|0
7189163|NCT03672188|11389445|FG003|Overall Study|Death|0
7189164|NCT03672188|11389446|FG004|Overall Study|Death|0
7189165|NCT03672188|11389447|FG005|Overall Study|Death|0
7189166|NCT03672188|11389448|FG006|Overall Study|Death|0
7189167|NCT03672188|11389449|FG007|Overall Study|Death|0
7189168|NCT03672188|11389450|FG008|Overall Study|Death|0
7189169|NCT03672188|11389451|FG009|Overall Study|Death|0
7189170|NCT03672188|11389452|FG010|Overall Study|Death|0
7189171|NCT03672188|11389453|FG011|Overall Study|Death|0
7189172|NCT03672188|11389454|FG012|Overall Study|Death|1
7189173|NCT03672188|11389455|FG013|Overall Study|Death|0
7189174|NCT03672188|11389456|FG014|Overall Study|Death|0
7189175|NCT03672188|11389442|FG000|Overall Study|Lost to Follow-up|0
7189176|NCT03672188|11389443|FG001|Overall Study|Lost to Follow-up|0
7189177|NCT03672188|11389444|FG002|Overall Study|Lost to Follow-up|1
7189178|NCT03672188|11389445|FG003|Overall Study|Lost to Follow-up|0
7189179|NCT03672188|11389446|FG004|Overall Study|Lost to Follow-up|0
7189180|NCT03672188|11389447|FG005|Overall Study|Lost to Follow-up|0
7189181|NCT03672188|11389448|FG006|Overall Study|Lost to Follow-up|0
7189182|NCT03672188|11389449|FG007|Overall Study|Lost to Follow-up|0
7189183|NCT03672188|11389450|FG008|Overall Study|Lost to Follow-up|0
7189184|NCT03672188|11389451|FG009|Overall Study|Lost to Follow-up|0
7189185|NCT03672188|11389452|FG010|Overall Study|Lost to Follow-up|0
7189186|NCT03672188|11389453|FG011|Overall Study|Lost to Follow-up|0
7189187|NCT03672188|11389454|FG012|Overall Study|Lost to Follow-up|0
7189188|NCT03672188|11389455|FG013|Overall Study|Lost to Follow-up|0
7189189|NCT03672188|11389456|FG014|Overall Study|Lost to Follow-up|0
7049990|NCT01808690|11139092|FG001|Overall Study|Withdrawal by Subject|2
7049991|NCT01809132|11139137|FG000|Overall Study|Withdrawal by Subject|0
7049992|NCT01809132|11139138|FG001|Overall Study|Withdrawal by Subject|0
7049993|NCT01809132|11139139|FG002|Overall Study|Withdrawal by Subject|1
7049994|NCT01809197|11139149|FG000|Overall Study|Lost to Follow-up|4
7049995|NCT01809197|11139150|FG001|Overall Study|Lost to Follow-up|2
7049996|NCT01809197|11139149|FG000|Overall Study|Adverse Event|2
7049997|NCT01809197|11139150|FG001|Overall Study|Adverse Event|3
7049998|NCT01809197|11139149|FG000|Overall Study|Failed slit lamp exam|1
7049999|NCT01809197|11139150|FG001|Overall Study|Failed slit lamp exam|0
7050000|NCT01809197|11139149|FG000|Overall Study|Non-Compliance|1
7050001|NCT01809197|11139150|FG001|Overall Study|Non-Compliance|1
7050002|NCT01809197|11139149|FG000|Overall Study|Decision Unrelated to an Adverse Event|1
7050003|NCT01809197|11139150|FG001|Overall Study|Decision Unrelated to an Adverse Event|0
7083836|NCT02158546|11195449|FG001|Overall Study|Site Excluded|5
7083837|NCT02158546|11195450|FG002|Overall Study|Site Excluded|3
7050004|NCT01809197|11139149|FG000|Overall Study|Withdrawal by Subject|1
7050005|NCT01809197|11139150|FG001|Overall Study|Withdrawal by Subject|1
7050006|NCT01809197|11139149|FG000|Overall Study|Product not available|0
7050007|NCT01809197|11139150|FG001|Overall Study|Product not available|1
7050008|NCT01809210|11139163|FG000|Overall Study|Withdrawal by Subject|0
7050009|NCT01809210|11139164|FG001|Overall Study|Withdrawal by Subject|0
7050010|NCT01809210|11139165|FG002|Overall Study|Withdrawal by Subject|1
7050011|NCT01809210|11139166|FG003|Overall Study|Withdrawal by Subject|1
7050012|NCT01809210|11139167|FG004|Overall Study|Withdrawal by Subject|1
7050013|NCT01809210|11139168|FG005|Overall Study|Withdrawal by Subject|0
7050014|NCT01809210|11139169|FG006|Overall Study|Withdrawal by Subject|4
7050015|NCT01809210|11139163|FG000|Overall Study|Death|1
7050016|NCT01809210|11139164|FG001|Overall Study|Death|1
7050017|NCT01809210|11139165|FG002|Overall Study|Death|2
7050018|NCT01809210|11139166|FG003|Overall Study|Death|0
7050019|NCT01809210|11139167|FG004|Overall Study|Death|1
7050020|NCT01809210|11139168|FG005|Overall Study|Death|3
7050021|NCT01809210|11139169|FG006|Overall Study|Death|1
7050022|NCT01809262|11139185|FG000|Period 1 (First Dose + Washout)|Adverse Event|0
7050023|NCT01809262|11139186|FG001|Period 1 (First Dose + Washout)|Adverse Event|0
7050024|NCT01809262|11139187|FG002|Period 1 (First Dose + Washout)|Adverse Event|0
7050025|NCT01809262|11139188|FG003|Period 1 (First Dose + Washout)|Adverse Event|0
7050026|NCT01809262|11139189|FG004|Period 1 (First Dose + Washout)|Adverse Event|1
7050027|NCT01809262|11139190|FG005|Period 1 (First Dose + Washout)|Adverse Event|0
7050028|NCT01809262|11139191|FG006|Period 1 (First Dose + Washout)|Adverse Event|0
7050029|NCT01809262|11139192|FG007|Period 1 (First Dose + Washout)|Adverse Event|0
7050030|NCT01809262|11139193|FG008|Period 1 (First Dose + Washout)|Adverse Event|0
7050031|NCT01809262|11139194|FG009|Period 1 (First Dose + Washout)|Adverse Event|0
7050032|NCT01809262|11139185|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0
7050033|NCT01809262|11139186|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1
7050034|NCT01809262|11139187|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0
7050035|NCT01809262|11139188|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0
7050036|NCT01809262|11139189|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0
7050037|NCT01809262|11139190|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0
7050038|NCT01809262|11139191|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0
7050039|NCT01809262|11139192|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0
7050040|NCT01809262|11139193|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0
7050041|NCT01809262|11139194|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0
7050042|NCT01809314|11139206|FG000|Overall Study|Withdrawal Prior to Treatment|1
7050043|NCT01809314|11139206|FG000|Overall Study|Adverse Event|6
7050044|NCT01809314|11139206|FG000|Overall Study|Insufficient Therapeutic Response|14
7050045|NCT01809314|11139206|FG000|Overall Study|Lost to Follow-up|724
7050046|NCT01809327|11139215|FG000|Overall Study|Lost to Follow-up|5
7050047|NCT01809327|11139216|FG001|Overall Study|Lost to Follow-up|2
7050048|NCT01809327|11139217|FG002|Overall Study|Lost to Follow-up|4
7050049|NCT01809327|11139218|FG003|Overall Study|Lost to Follow-up|2
7050050|NCT01809327|11139219|FG004|Overall Study|Lost to Follow-up|3
7050051|NCT01809327|11139215|FG000|Overall Study|Withdrawal by Subject|6
7050052|NCT01809327|11139216|FG001|Overall Study|Withdrawal by Subject|4
7083838|NCT02158546|11195451|FG003|Overall Study|Site Excluded|4
7083839|NCT02158663|11195467|FG000|Overall Study|Withdrawal by Subject|5
7050053|NCT01809327|11139217|FG002|Overall Study|Withdrawal by Subject|4
7050054|NCT01809327|11139218|FG003|Overall Study|Withdrawal by Subject|2
7050055|NCT01809327|11139219|FG004|Overall Study|Withdrawal by Subject|5
7050056|NCT01809327|11139215|FG000|Overall Study|Adverse Event|4
7050057|NCT01809327|11139216|FG001|Overall Study|Adverse Event|3
7050058|NCT01809327|11139217|FG002|Overall Study|Adverse Event|7
7050059|NCT01809327|11139218|FG003|Overall Study|Adverse Event|4
7050060|NCT01809327|11139219|FG004|Overall Study|Adverse Event|8
7050061|NCT01809327|11139215|FG000|Overall Study|Death|1
7083840|NCT02158663|11195468|FG001|Overall Study|Withdrawal by Subject|4
7050062|NCT01809327|11139216|FG001|Overall Study|Death|0
7050063|NCT01809327|11139217|FG002|Overall Study|Death|0
7050064|NCT01809327|11139218|FG003|Overall Study|Death|0
7050065|NCT01809327|11139219|FG004|Overall Study|Death|0
7050066|NCT01809327|11139215|FG000|Overall Study|Protocol Violation|0
7189190|NCT03230916|11389537|FG000|Overall Study|Withdrawal by Subject|0
7189191|NCT03230916|11389538|FG001|Overall Study|Withdrawal by Subject|0
7189192|NCT03230916|11389539|FG002|Overall Study|Withdrawal by Subject|0
7189193|NCT03230916|11389540|FG003|Overall Study|Withdrawal by Subject|0
7189194|NCT03230916|11389541|FG004|Overall Study|Withdrawal by Subject|0
7189195|NCT03230916|11389542|FG005|Overall Study|Withdrawal by Subject|1
7189196|NCT03230916|11389543|FG006|Overall Study|Withdrawal by Subject|0
7189197|NCT03230916|11389544|FG007|Overall Study|Withdrawal by Subject|0
7189198|NCT03230916|11389545|FG008|Overall Study|Withdrawal by Subject|0
7189199|NCT03230916|11389546|FG009|Overall Study|Withdrawal by Subject|0
7189200|NCT03230916|11389547|FG010|Overall Study|Withdrawal by Subject|0
7189201|NCT03195894|11389590|FG000|Overall Study|"An example is Started other treatment."|4
7189202|NCT03195894|11389591|FG001|Overall Study|"An example is Started other treatment."|5
7189203|NCT03195894|11389590|FG000|Overall Study|Withdrawal by Subject|15
7189204|NCT03195894|11389591|FG001|Overall Study|Withdrawal by Subject|4
7189205|NCT03195894|11389590|FG000|Overall Study|Lost to Follow-up|14
7189206|NCT03195894|11389591|FG001|Overall Study|Lost to Follow-up|19
7189207|NCT03032705|11389602|FG000|Overall Study|Lost to Follow-up|16
7189208|NCT03032705|11389603|FG001|Overall Study|Lost to Follow-up|17
7189209|NCT03032705|11389602|FG000|Overall Study|did not quality|6
7189210|NCT03032705|11389603|FG001|Overall Study|did not quality|6
7189211|NCT02573259|11389616|FG000|Overall Study|Death|1
7189212|NCT02573259|11389617|FG001|Overall Study|Death|6
7189213|NCT02573259|11389618|FG002|Overall Study|Death|5
7189214|NCT02573259|11389619|FG003|Overall Study|Death|6
7189215|NCT02573259|11389620|FG004|Overall Study|Death|9
7189216|NCT02573259|11389621|FG005|Overall Study|Death|32
7189217|NCT02573259|11389622|FG006|Overall Study|Death|21
7189218|NCT02573259|11389616|FG000|Overall Study|Lost to Follow-up|0
7189219|NCT02573259|11389617|FG001|Overall Study|Lost to Follow-up|0
7189220|NCT02573259|11389618|FG002|Overall Study|Lost to Follow-up|0
7189221|NCT02573259|11389619|FG003|Overall Study|Lost to Follow-up|0
7189222|NCT02573259|11389620|FG004|Overall Study|Lost to Follow-up|0
7189223|NCT02573259|11389621|FG005|Overall Study|Lost to Follow-up|2
7189224|NCT02573259|11389622|FG006|Overall Study|Lost to Follow-up|1
7189225|NCT02573259|11389616|FG000|Overall Study|Participant refused further follow-up|0
7189226|NCT02573259|11389617|FG001|Overall Study|Participant refused further follow-up|2
7189227|NCT02573259|11389618|FG002|Overall Study|Participant refused further follow-up|1
7189228|NCT02573259|11389619|FG003|Overall Study|Participant refused further follow-up|0
7189229|NCT02573259|11389620|FG004|Overall Study|Participant refused further follow-up|3
7189230|NCT02573259|11389621|FG005|Overall Study|Participant refused further follow-up|20
6804075|NCT01006265|10805937|FG002|Overall Study|Withdrawal by Subject|5
6804076|NCT01006265|10805938|FG003|Overall Study|Withdrawal by Subject|5
6804077|NCT01006265|10805935|FG000|Overall Study|Administrative reason|1
6804078|NCT01006265|10805936|FG001|Overall Study|Administrative reason|2
6804079|NCT01006265|10805937|FG002|Overall Study|Administrative reason|3
6804080|NCT01006265|10805938|FG003|Overall Study|Administrative reason|0
6804081|NCT00534976|10805960|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0
6804082|NCT00534976|10805961|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1
6804083|NCT00534976|10805960|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1
6804084|NCT00534976|10805961|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0
6804085|NCT00534976|10805960|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1
6804086|NCT00534976|10805961|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0
6804087|NCT00337675|10805970|FG000|Overall Study|Adverse Event|10
6804088|NCT00337675|10805971|FG001|Overall Study|Adverse Event|9
6804089|NCT00337675|10805972|FG002|Overall Study|Adverse Event|19
7050067|NCT01809327|11139216|FG001|Overall Study|Protocol Violation|1
7050068|NCT01809327|11139217|FG002|Overall Study|Protocol Violation|0
7050069|NCT01809327|11139218|FG003|Overall Study|Protocol Violation|0
7050070|NCT01809327|11139219|FG004|Overall Study|Protocol Violation|0
6804090|NCT00337675|10805970|FG000|Overall Study|Lack of Efficacy|10
6804091|NCT00337675|10805971|FG001|Overall Study|Lack of Efficacy|7
6804092|NCT00337675|10805972|FG002|Overall Study|Lack of Efficacy|9
6804093|NCT00337675|10805970|FG000|Overall Study|Lost to Follow-up|22
7050071|NCT01809327|11139215|FG000|Overall Study|Physician Decision|1
7050072|NCT01809327|11139216|FG001|Overall Study|Physician Decision|1
7050073|NCT01809327|11139217|FG002|Overall Study|Physician Decision|0
7050074|NCT01809327|11139218|FG003|Overall Study|Physician Decision|0
7050075|NCT01809327|11139219|FG004|Overall Study|Physician Decision|0
7050076|NCT01809327|11139215|FG000|Overall Study|Pregnancy|1
7050077|NCT01809327|11139216|FG001|Overall Study|Pregnancy|0
7189231|NCT02573259|11389622|FG006|Overall Study|Participant refused further follow-up|7
7189232|NCT02573259|11389616|FG000|Overall Study|Other|0
7189233|NCT02573259|11389617|FG001|Overall Study|Other|0
7189234|NCT02573259|11389618|FG002|Overall Study|Other|0
7189235|NCT02573259|11389619|FG003|Overall Study|Other|0
7189236|NCT02573259|11389620|FG004|Overall Study|Other|1
7189237|NCT02573259|11389621|FG005|Overall Study|Other|4
7189238|NCT02573259|11389622|FG006|Overall Study|Other|5
7189239|NCT02318329|11389664|FG000|Overall Study|Progressive Disease|2
7189240|NCT02318329|11389665|FG001|Overall Study|Progressive Disease|3
7189241|NCT02318329|11389666|FG002|Overall Study|Progressive Disease|2
7189242|NCT02318329|11389667|FG003|Overall Study|Progressive Disease|3
7189243|NCT02318329|11389668|FG004|Overall Study|Progressive Disease|3
7189244|NCT02318329|11389669|FG005|Overall Study|Progressive Disease|3
7189245|NCT02318329|11389670|FG006|Overall Study|Progressive Disease|1
7189246|NCT02318329|11389671|FG007|Overall Study|Progressive Disease|1
7189247|NCT02318329|11389672|FG008|Overall Study|Progressive Disease|5
7189248|NCT02318329|11389673|FG009|Overall Study|Progressive Disease|39
7189249|NCT02318329|11389664|FG000|Overall Study|Death|0
7189250|NCT02318329|11389665|FG001|Overall Study|Death|0
7189251|NCT02318329|11389666|FG002|Overall Study|Death|0
7189252|NCT02318329|11389667|FG003|Overall Study|Death|0
7189253|NCT02318329|11389668|FG004|Overall Study|Death|0
7189254|NCT02318329|11389669|FG005|Overall Study|Death|0
7189255|NCT02318329|11389670|FG006|Overall Study|Death|0
7189256|NCT02318329|11389671|FG007|Overall Study|Death|0
7189257|NCT02318329|11389672|FG008|Overall Study|Death|0
7189258|NCT02318329|11389673|FG009|Overall Study|Death|5
6804094|NCT00337675|10805971|FG001|Overall Study|Lost to Follow-up|19
6804095|NCT00337675|10805972|FG002|Overall Study|Lost to Follow-up|17
6804096|NCT00337675|10805970|FG000|Overall Study|Physician Decision|9
6804097|NCT00337675|10805971|FG001|Overall Study|Physician Decision|17
6804098|NCT00337675|10805972|FG002|Overall Study|Physician Decision|14
6804099|NCT00337675|10805970|FG000|Overall Study|Protocol Violation|21
6804100|NCT00337675|10805971|FG001|Overall Study|Protocol Violation|24
6804101|NCT00337675|10805972|FG002|Overall Study|Protocol Violation|19
6804102|NCT00337675|10805970|FG000|Overall Study|Withdrawal by Subject|25
6804103|NCT00337675|10805971|FG001|Overall Study|Withdrawal by Subject|25
6804104|NCT00337675|10805972|FG002|Overall Study|Withdrawal by Subject|19
6804105|NCT00337675|10805970|FG000|Overall Study|Progressive Disease|0
6804106|NCT00337675|10805971|FG001|Overall Study|Progressive Disease|2
6804107|NCT00337675|10805972|FG002|Overall Study|Progressive Disease|0
6804108|NCT00337675|10805970|FG000|Overall Study|Trial Terminated|0
6804109|NCT00337675|10805971|FG001|Overall Study|Trial Terminated|0
6804110|NCT00337675|10805972|FG002|Overall Study|Trial Terminated|2
6804111|NCT00317772|10805984|FG000|Overall Study|Adverse Event|0
6804112|NCT00317772|10805985|FG001|Overall Study|Adverse Event|0
6804113|NCT00317772|10805986|FG002|Overall Study|Adverse Event|0
6804114|NCT00317772|10805987|FG003|Overall Study|Adverse Event|2
6804115|NCT00317772|10805984|FG000|Overall Study|Disease Progression|2
6804116|NCT00317772|10805985|FG001|Overall Study|Disease Progression|2
7050078|NCT01809327|11139217|FG002|Overall Study|Pregnancy|0
6804117|NCT00317772|10805986|FG002|Overall Study|Disease Progression|1
6804118|NCT00317772|10805987|FG003|Overall Study|Disease Progression|7
6804119|NCT00291486|10806003|FG000|Overall Study|Adverse Event|0
6804120|NCT00291486|10806004|FG001|Overall Study|Adverse Event|3
6804121|NCT00291486|10806005|FG002|Overall Study|Adverse Event|0
7050079|NCT01809327|11139218|FG003|Overall Study|Pregnancy|0
7189259|NCT02318329|11389664|FG000|Overall Study|Lost to Follow-up|0
7189260|NCT02318329|11389665|FG001|Overall Study|Lost to Follow-up|0
7189261|NCT02318329|11389666|FG002|Overall Study|Lost to Follow-up|0
7189262|NCT02318329|11389667|FG003|Overall Study|Lost to Follow-up|0
7050080|NCT01809327|11139219|FG004|Overall Study|Pregnancy|0
7050081|NCT01809327|11139215|FG000|Overall Study|Other|14
7050082|NCT01809327|11139216|FG001|Overall Study|Other|15
7050083|NCT01809327|11139217|FG002|Overall Study|Other|7
7050084|NCT01809327|11139218|FG003|Overall Study|Other|4
7050085|NCT01809327|11139219|FG004|Overall Study|Other|9
7050086|NCT01810016|11139255|FG000|Overall Study|Progressive disease|1
7050087|NCT01810016|11139256|FG001|Overall Study|Progressive disease|1
7050088|NCT01810016|11139257|FG002|Overall Study|Progressive disease|0
7050089|NCT01810016|11139255|FG000|Overall Study|Death|0
7050090|NCT01810016|11139256|FG001|Overall Study|Death|0
7050091|NCT01810016|11139257|FG002|Overall Study|Death|1
7050092|NCT01810042|11139265|FG000|Overall Study|Lost to Follow-up|10
7050093|NCT01810263|11139271|FG000|Overall Study|Lost to Follow-up|8
7050094|NCT01810263|11139272|FG001|Overall Study|Lost to Follow-up|7
7050095|NCT01810380|11139290|FG000|Overall Study|Randomised not treated|2
7050096|NCT01810380|11139291|FG001|Overall Study|Randomised not treated|1
7050097|NCT01810380|11139292|FG002|Overall Study|Randomised not treated|1
7050098|NCT01810380|11139290|FG000|Overall Study|Adverse Event|11
7050099|NCT01810380|11139291|FG001|Overall Study|Adverse Event|14
7050100|NCT01810380|11139292|FG002|Overall Study|Adverse Event|4
7050101|NCT01810380|11139290|FG000|Overall Study|Lack of Efficacy|24
7050102|NCT01810380|11139291|FG001|Overall Study|Lack of Efficacy|10
7050103|NCT01810380|11139292|FG002|Overall Study|Lack of Efficacy|11
7050104|NCT01810380|11139290|FG000|Overall Study|Protocol Violation|1
7050105|NCT01810380|11139291|FG001|Overall Study|Protocol Violation|0
7050106|NCT01810380|11139292|FG002|Overall Study|Protocol Violation|1
7050107|NCT01810380|11139290|FG000|Overall Study|Withdrawal by Subject|6
7050108|NCT01810380|11139291|FG001|Overall Study|Withdrawal by Subject|0
7050109|NCT01810380|11139292|FG002|Overall Study|Withdrawal by Subject|6
7050110|NCT01810380|11139290|FG000|Overall Study|Administrative or other reasons|11
7050111|NCT01810380|11139291|FG001|Overall Study|Administrative or other reasons|13
7050112|NCT01810380|11139292|FG002|Overall Study|Administrative or other reasons|9
7189263|NCT02318329|11389668|FG004|Overall Study|Lost to Follow-up|0
7189264|NCT02318329|11389669|FG005|Overall Study|Lost to Follow-up|0
7189265|NCT02318329|11389670|FG006|Overall Study|Lost to Follow-up|0
7189266|NCT02318329|11389671|FG007|Overall Study|Lost to Follow-up|0
7189267|NCT02318329|11389672|FG008|Overall Study|Lost to Follow-up|0
7189268|NCT02318329|11389673|FG009|Overall Study|Lost to Follow-up|1
7189269|NCT02318329|11389664|FG000|Overall Study|Withdrawal by Subject|0
7189270|NCT02318329|11389665|FG001|Overall Study|Withdrawal by Subject|0
7189271|NCT02318329|11389666|FG002|Overall Study|Withdrawal by Subject|0
7050113|NCT01810432|11139300|FG000|Washout|Protocol Violation|0
7050114|NCT01810432|11139301|FG001|Washout|Protocol Violation|1
7050115|NCT01810432|11139300|FG000|Washout|Adverse Event|1
7050116|NCT01810432|11139301|FG001|Washout|Adverse Event|0
7050117|NCT01810432|11139300|FG000|Period 2|Withdrawal by Subject|2
7050118|NCT01810432|11139301|FG001|Period 2|Withdrawal by Subject|1
7050119|NCT01810432|11139300|FG000|Period 2|Physician Decision|1
7050120|NCT01810432|11139301|FG001|Period 2|Physician Decision|0
7189272|NCT02318329|11389667|FG003|Overall Study|Withdrawal by Subject|0
7189273|NCT02318329|11389668|FG004|Overall Study|Withdrawal by Subject|0
7189274|NCT02318329|11389669|FG005|Overall Study|Withdrawal by Subject|0
7189275|NCT02318329|11389670|FG006|Overall Study|Withdrawal by Subject|0
7189276|NCT02318329|11389671|FG007|Overall Study|Withdrawal by Subject|0
7189277|NCT02318329|11389672|FG008|Overall Study|Withdrawal by Subject|0
7189278|NCT02318329|11389673|FG009|Overall Study|Withdrawal by Subject|6
7189279|NCT02318329|11389664|FG000|Overall Study|Other|1
7189280|NCT02318329|11389665|FG001|Overall Study|Other|1
7189281|NCT02318329|11389666|FG002|Overall Study|Other|1
7189282|NCT02318329|11389667|FG003|Overall Study|Other|0
7189283|NCT02318329|11389668|FG004|Overall Study|Other|0
7189284|NCT02318329|11389669|FG005|Overall Study|Other|0
7189285|NCT02318329|11389670|FG006|Overall Study|Other|0
7050121|NCT01810432|11139300|FG000|Period 2|Lost to Follow-up|1
7050122|NCT01810432|11139301|FG001|Period 2|Lost to Follow-up|1
7050123|NCT01810783|11139320|FG000|Overall Study|Adverse Event|32
7050124|NCT01810783|11139320|FG000|Overall Study|Withdrawal by Subject|22
7050125|NCT01810783|11139320|FG000|Overall Study|Lack of Efficacy|12
7189286|NCT02318329|11389671|FG007|Overall Study|Other|0
7189287|NCT02318329|11389672|FG008|Overall Study|Other|1
7189288|NCT02318329|11389673|FG009|Overall Study|Other|1
7189289|NCT01602666|11389716|FG000|Induction Chemotherapy|Death|2
7189290|NCT01602666|11389717|FG001|Induction Chemotherapy|Death|1
7189291|NCT01602666|11389716|FG000|Induction Chemotherapy|Lack of Efficacy|16
7189292|NCT01602666|11389717|FG001|Induction Chemotherapy|Lack of Efficacy|7
7189293|NCT01602666|11389716|FG000|Induction Chemotherapy|Physician Decision|12
7189294|NCT01602666|11389717|FG001|Induction Chemotherapy|Physician Decision|5
7189295|NCT01602666|11389716|FG000|Induction Chemotherapy|Withdrawal by Subject|0
7189296|NCT01602666|11389717|FG001|Induction Chemotherapy|Withdrawal by Subject|2
7189297|NCT01602666|11389716|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5
7189298|NCT01602666|11389717|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6
7189299|NCT01602666|11389716|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2
7189300|NCT01602666|11389717|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3
7189301|NCT01602666|11389716|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4
7189302|NCT01602666|11389717|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5
7189303|NCT01602666|11389716|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2
7189304|NCT01602666|11389717|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3
7189305|NCT01602666|11389716|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4
7189306|NCT01602666|11389717|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0
7189307|NCT01602666|11389716|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0
7189308|NCT01602666|11389717|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14
7189309|NCT01602666|11389716|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0
7189310|NCT01602666|11389717|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9
7189311|NCT01375959|11389727|FG000|First Intervention (6 Weeks)|Adverse Event|2
7189312|NCT01375959|11389728|FG001|First Intervention (6 Weeks)|Adverse Event|3
7189313|NCT01375959|11389727|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0
7189314|NCT01375959|11389728|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1
7189315|NCT01375959|11389727|FG000|Second Intervention (6 Weeks)|Adverse Event|0
7189316|NCT01375959|11389728|FG001|Second Intervention (6 Weeks)|Adverse Event|2
6804122|NCT00291486|10806006|FG003|Overall Study|Adverse Event|1
6804123|NCT00291486|10806007|FG004|Overall Study|Adverse Event|0
6804124|NCT00291486|10806003|FG000|Overall Study|Withdrawal by Subject|0
6804125|NCT00291486|10806004|FG001|Overall Study|Withdrawal by Subject|0
6804126|NCT00291486|10806005|FG002|Overall Study|Withdrawal by Subject|0
6804127|NCT00291486|10806006|FG003|Overall Study|Withdrawal by Subject|0
7189317|NCT01224106|11389739|FG000|Double-Blind Treatment Phase|Death|3
6804128|NCT00291486|10806007|FG004|Overall Study|Withdrawal by Subject|1
6804129|NCT00291486|10806003|FG000|Overall Study|Disease progression|1
7189318|NCT01224106|11389740|FG001|Double-Blind Treatment Phase|Death|0
7189319|NCT01224106|11389741|FG002|Double-Blind Treatment Phase|Death|0
7189320|NCT01224106|11389742|FG003|Double-Blind Treatment Phase|Death|0
7189321|NCT01224106|11389743|FG004|Double-Blind Treatment Phase|Death|0
7189322|NCT01224106|11389739|FG000|Double-Blind Treatment Phase|Physician Decision|6
7189323|NCT01224106|11389740|FG001|Double-Blind Treatment Phase|Physician Decision|5
7189324|NCT01224106|11389741|FG002|Double-Blind Treatment Phase|Physician Decision|4
7189325|NCT01224106|11389742|FG003|Double-Blind Treatment Phase|Physician Decision|0
7189326|NCT01224106|11389743|FG004|Double-Blind Treatment Phase|Physician Decision|0
7189327|NCT01224106|11389739|FG000|Double-Blind Treatment Phase|Adverse Event|0
7189328|NCT01224106|11389740|FG001|Double-Blind Treatment Phase|Adverse Event|5
7189329|NCT01224106|11389741|FG002|Double-Blind Treatment Phase|Adverse Event|3
7189330|NCT01224106|11389742|FG003|Double-Blind Treatment Phase|Adverse Event|0
7189331|NCT01224106|11389743|FG004|Double-Blind Treatment Phase|Adverse Event|0
7189332|NCT01224106|11389739|FG000|Double-Blind Treatment Phase|Other|0
7189333|NCT01224106|11389740|FG001|Double-Blind Treatment Phase|Other|0
7189334|NCT01224106|11389741|FG002|Double-Blind Treatment Phase|Other|1
7189335|NCT01224106|11389742|FG003|Double-Blind Treatment Phase|Other|0
7189336|NCT01224106|11389743|FG004|Double-Blind Treatment Phase|Other|0
7189337|NCT01224106|11389739|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7
7189338|NCT01224106|11389740|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8
7189339|NCT01224106|11389741|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8
7189340|NCT01224106|11389742|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0
7189341|NCT01224106|11389743|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0
7189342|NCT01224106|11389739|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62
7189343|NCT01224106|11389740|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68
7189344|NCT01224106|11389741|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63
7189345|NCT01224106|11389742|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0
7189346|NCT01224106|11389743|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0
7189347|NCT01224106|11389739|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1
7189348|NCT01224106|11389740|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0
7189349|NCT01224106|11389741|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1
7189350|NCT01224106|11389742|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0
7189351|NCT01224106|11389743|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0
7189352|NCT01224106|11389739|FG000|Open-Label Extension (OLE) Phase|Death|0
7189353|NCT01224106|11389740|FG001|Open-Label Extension (OLE) Phase|Death|0
7189354|NCT01224106|11389741|FG002|Open-Label Extension (OLE) Phase|Death|0
7189355|NCT01224106|11389742|FG003|Open-Label Extension (OLE) Phase|Death|1
7189356|NCT01224106|11389743|FG004|Open-Label Extension (OLE) Phase|Death|3
7050126|NCT01810783|11139320|FG000|Overall Study|Lost to Follow-up|10
7050127|NCT01810783|11139320|FG000|Overall Study|Protocol Violation|5
7050128|NCT01810783|11139320|FG000|Overall Study|Non-compliance with IMP|4
7050129|NCT01810783|11139320|FG000|Overall Study|Adminstrative or other reason(s)|23
7050130|NCT01810783|11139320|FG000|Overall Study|Enrolled, not treated|1
7050131|NCT01810939|11139324|FG000|Part A Treatment Period|Non-compliance with Study Drug|1
7050132|NCT01810939|11139325|FG001|Part A Treatment Period|Non-compliance with Study Drug|0
7050133|NCT01810939|11139326|FG002|Part A Treatment Period|Non-compliance with Study Drug|0
7050134|NCT01810939|11139324|FG000|Part A Treatment Period|Protocol Violation|2
7050135|NCT01810939|11139325|FG001|Part A Treatment Period|Protocol Violation|0
7050136|NCT01810939|11139326|FG002|Part A Treatment Period|Protocol Violation|0
7050137|NCT01810939|11139324|FG000|Part A Treatment Period|Adverse Event|10
7050138|NCT01810939|11139325|FG001|Part A Treatment Period|Adverse Event|0
7050139|NCT01810939|11139326|FG002|Part A Treatment Period|Adverse Event|0
7050140|NCT01810939|11139324|FG000|Part A Treatment Period|Withdrawal by Subject|5
7050141|NCT01810939|11139325|FG001|Part A Treatment Period|Withdrawal by Subject|0
7050142|NCT01810939|11139326|FG002|Part A Treatment Period|Withdrawal by Subject|0
7050143|NCT01810939|11139324|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2
7050144|NCT01810939|11139325|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0
7050145|NCT01810939|11139326|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0
7189357|NCT01224106|11389739|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0
7189358|NCT01224106|11389740|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0
7189359|NCT01224106|11389741|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0
7189360|NCT01224106|11389742|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2
7189361|NCT01224106|11389743|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6
7189362|NCT01224106|11389739|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0
7189363|NCT01224106|11389740|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0
7189364|NCT01224106|11389741|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0
7189365|NCT01224106|11389742|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2
7189366|NCT01224106|11389743|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7
7189367|NCT01224106|11389739|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0
7189368|NCT01224106|11389740|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0
7189369|NCT01224106|11389741|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0
7189370|NCT01224106|11389742|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6
7189371|NCT01224106|11389743|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15
7189372|NCT01224106|11389739|FG000|Open-Label Extension (OLE) Phase|Other|0
7189373|NCT01224106|11389740|FG001|Open-Label Extension (OLE) Phase|Other|0
7189374|NCT01224106|11389741|FG002|Open-Label Extension (OLE) Phase|Other|0
7189375|NCT01224106|11389742|FG003|Open-Label Extension (OLE) Phase|Other|5
7189376|NCT01224106|11389743|FG004|Open-Label Extension (OLE) Phase|Other|3
7189377|NCT00354835|11389772|FG000|Overall Study|Death|1
7189378|NCT00354835|11389773|FG001|Overall Study|Death|1
7189379|NCT00354835|11389772|FG000|Overall Study|Physician Decision|8
7189380|NCT00354835|11389773|FG001|Overall Study|Physician Decision|13
7189381|NCT00354835|11389772|FG000|Overall Study|Withdrawal by Subject|2
7189382|NCT00354835|11389773|FG001|Overall Study|Withdrawal by Subject|1
7189383|NCT00354835|11389772|FG000|Overall Study|Ineligible|17
7189384|NCT00354835|11389773|FG001|Overall Study|Ineligible|16
7189385|NCT00354835|11389772|FG000|Overall Study|Disease progression or relapse|15
7189386|NCT00354835|11389773|FG001|Overall Study|Disease progression or relapse|22
7189387|NCT00354835|11389772|FG000|Overall Study|Adverse Event|6
7189388|NCT00354835|11389773|FG001|Overall Study|Adverse Event|0
7189389|NCT00354835|11389772|FG000|Overall Study|Refusal of further therapy|3
7189390|NCT00354835|11389773|FG001|Overall Study|Refusal of further therapy|8
7050146|NCT01810939|11139324|FG000|Part A Treatment Period|Protocol-specified (High K+)|3
7050147|NCT01810939|11139325|FG001|Part A Treatment Period|Protocol-specified (High K+)|0
7050148|NCT01810939|11139326|FG002|Part A Treatment Period|Protocol-specified (High K+)|0
7050149|NCT01810939|11139324|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1
7050150|NCT01810939|11139325|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0
7189391|NCT04531241|11389794|FG000|Period 1|Withdrawal by Subject|2
7189392|NCT04531241|11389795|FG001|Period 1|Withdrawal by Subject|0
7189393|NCT04531241|11389794|FG000|Period 1|Dispesed incorrect lens power|1
7189394|NCT04531241|11389795|FG001|Period 1|Dispesed incorrect lens power|0
7189395|NCT04531241|11389794|FG000|Period 1|Protocol Violation|1
7189396|NCT04531241|11389795|FG001|Period 1|Protocol Violation|0
7189397|NCT04531241|11389794|FG000|Period 1|No longer eligible|0
7189398|NCT04531241|11389795|FG001|Period 1|No longer eligible|1
7189399|NCT04531241|11389794|FG000|Period 1|Lens Discomfort|0
7189400|NCT04531241|11389795|FG001|Period 1|Lens Discomfort|1
7189401|NCT04531241|11389794|FG000|Period 2|Covid-19 Related|1
7189402|NCT04531241|11389795|FG001|Period 2|Covid-19 Related|1
7050151|NCT01810939|11139326|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0
7050152|NCT01810939|11139324|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0
7050153|NCT01810939|11139325|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1
7050154|NCT01810939|11139326|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1
7189403|NCT04185220|11389840|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0
7189404|NCT04185220|11389841|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1
7189405|NCT04185220|11389840|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0
7189406|NCT04185220|11389841|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1
7189407|NCT03600714|11389858|FG000|Overall Study|Out of country and could not return for post-treatment visits|1
7189408|NCT03470441|11389879|FG000|Overall Study|Death|0
7189409|NCT03470441|11389880|FG001|Overall Study|Death|1
7189410|NCT03470441|11389881|FG002|Overall Study|Death|1
7189411|NCT03470441|11389882|FG003|Overall Study|Death|0
7189412|NCT03470441|11389879|FG000|Overall Study|Adverse Event|0
7189413|NCT03470441|11389880|FG001|Overall Study|Adverse Event|0
7189414|NCT03470441|11389881|FG002|Overall Study|Adverse Event|0
7189415|NCT03470441|11389882|FG003|Overall Study|Adverse Event|1
7189416|NCT03470441|11389879|FG000|Overall Study|Withdrawal by Subject|1
7189417|NCT03470441|11389880|FG001|Overall Study|Withdrawal by Subject|4
7189418|NCT03470441|11389881|FG002|Overall Study|Withdrawal by Subject|1
7189419|NCT03470441|11389882|FG003|Overall Study|Withdrawal by Subject|3
7189420|NCT03452397|11389896|FG000|Overall Study|Adverse Event|1
7189421|NCT03452397|11389897|FG001|Overall Study|Adverse Event|0
7189422|NCT03452397|11389898|FG002|Overall Study|Adverse Event|0
7189423|NCT03452397|11389899|FG003|Overall Study|Adverse Event|0
7189424|NCT03452397|11389896|FG000|Overall Study|Administrative reason|0
7189425|NCT03452397|11389897|FG001|Overall Study|Administrative reason|0
7189426|NCT03452397|11389898|FG002|Overall Study|Administrative reason|1
7189427|NCT03452397|11389899|FG003|Overall Study|Administrative reason|1
7189428|NCT03452397|11389896|FG000|Overall Study|Withdrawal by Subject|0
7189429|NCT03452397|11389897|FG001|Overall Study|Withdrawal by Subject|0
7189430|NCT03452397|11389898|FG002|Overall Study|Withdrawal by Subject|1
7189431|NCT03452397|11389899|FG003|Overall Study|Withdrawal by Subject|0
7189432|NCT03448939|11389913|FG000|Overall Study|Adverse Event|5
7189433|NCT03448939|11389914|FG001|Overall Study|Adverse Event|1
7189434|NCT03448939|11389913|FG000|Overall Study|Lost to Follow-up|6
7189435|NCT03448939|11389914|FG001|Overall Study|Lost to Follow-up|6
7189436|NCT03448939|11389913|FG000|Overall Study|Pregnancy|1
7189437|NCT03448939|11389914|FG001|Overall Study|Pregnancy|1
7189438|NCT03448939|11389913|FG000|Overall Study|Withdrawal by Subject|9
7189439|NCT03448939|11389914|FG001|Overall Study|Withdrawal by Subject|3
7189440|NCT03410108|11389920|FG000|Overall Study|Ongoing|41
7189441|NCT03410108|11389920|FG000|Overall Study|Adverse Event|4
7189442|NCT03410108|11389920|FG000|Overall Study|Progressive Disease|58
7189443|NCT03410108|11389920|FG000|Overall Study|Withdrawal by Subject|1
7189444|NCT03283371|11389938|FG000|Placebo-controlled|Adverse Event|1
7189445|NCT03283371|11389939|FG001|Placebo-controlled|Adverse Event|1
7189446|NCT03283371|11389940|FG002|Placebo-controlled|Adverse Event|0
7189447|NCT03283371|11389941|FG003|Placebo-controlled|Adverse Event|0
7189448|NCT03283371|11389938|FG000|Placebo-controlled|Lack of Efficacy|1
7189449|NCT03283371|11389939|FG001|Placebo-controlled|Lack of Efficacy|0
7189450|NCT03283371|11389940|FG002|Placebo-controlled|Lack of Efficacy|0
7189451|NCT03283371|11389941|FG003|Placebo-controlled|Lack of Efficacy|0
7189452|NCT03283371|11389938|FG000|Placebo-controlled|Withdrawal by Subject|1
7189453|NCT03283371|11389939|FG001|Placebo-controlled|Withdrawal by Subject|1
7189454|NCT03283371|11389940|FG002|Placebo-controlled|Withdrawal by Subject|0
7050155|NCT01810939|11139324|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
7050156|NCT01810939|11139325|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1
7050157|NCT01810939|11139326|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
7050158|NCT01810939|11139324|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0
7050159|NCT01810939|11139325|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1
7189455|NCT03283371|11389941|FG003|Placebo-controlled|Withdrawal by Subject|0
7189456|NCT03283371|11389938|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0
7189457|NCT03283371|11389939|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1
7189458|NCT03283371|11389940|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0
7189459|NCT03283371|11389941|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0
7189460|NCT03283371|11389938|FG000|Open-label Phase|Adverse Event|0
7189461|NCT03283371|11389939|FG001|Open-label Phase|Adverse Event|0
7189462|NCT03283371|11389940|FG002|Open-label Phase|Adverse Event|2
7189463|NCT03283371|11389941|FG003|Open-label Phase|Adverse Event|0
7189464|NCT03283371|11389938|FG000|Open-label Phase|Withdrawal by Subject|0
7189465|NCT03283371|11389939|FG001|Open-label Phase|Withdrawal by Subject|0
7189466|NCT03283371|11389940|FG002|Open-label Phase|Withdrawal by Subject|1
7189467|NCT03283371|11389941|FG003|Open-label Phase|Withdrawal by Subject|0
7189468|NCT03283371|11389938|FG000|Open-label Phase|Other|0
7189469|NCT03283371|11389939|FG001|Open-label Phase|Other|0
7189470|NCT03283371|11389940|FG002|Open-label Phase|Other|1
7189471|NCT03283371|11389941|FG003|Open-label Phase|Other|1
7189472|NCT03257254|11389951|FG000|Overall Study|Withdrawal by Subject|7
7189473|NCT03257254|11389951|FG000|Overall Study|Lost to Follow-up|9
7189474|NCT03257254|11389951|FG000|Overall Study|Study discontinued by sponsor|5
7189475|NCT03084718|11389960|FG000|Overall Study|Withdrawal by Subject|4
7189476|NCT03084718|11389961|FG001|Overall Study|Withdrawal by Subject|3
7189477|NCT03084718|11389962|FG002|Overall Study|Withdrawal by Subject|4
7189478|NCT03084718|11389963|FG003|Overall Study|Withdrawal by Subject|0
7189479|NCT03084718|11389964|FG004|Overall Study|Withdrawal by Subject|0
7189480|NCT03084718|11389960|FG000|Overall Study|Physician Decision|1
7189481|NCT03084718|11389961|FG001|Overall Study|Physician Decision|0
7189482|NCT03084718|11389962|FG002|Overall Study|Physician Decision|0
7189483|NCT03084718|11389963|FG003|Overall Study|Physician Decision|0
7189484|NCT03084718|11389964|FG004|Overall Study|Physician Decision|0
7189485|NCT03084718|11389960|FG000|Overall Study|Adverse Event|3
7189486|NCT03084718|11389961|FG001|Overall Study|Adverse Event|5
7189487|NCT03084718|11389962|FG002|Overall Study|Adverse Event|5
7189488|NCT03084718|11389963|FG003|Overall Study|Adverse Event|8
7189489|NCT03084718|11389964|FG004|Overall Study|Adverse Event|2
7189490|NCT03084718|11389960|FG000|Overall Study|Lack of Efficacy|2
7189491|NCT03084718|11389961|FG001|Overall Study|Lack of Efficacy|0
7189492|NCT03084718|11389962|FG002|Overall Study|Lack of Efficacy|1
7189493|NCT03084718|11389963|FG003|Overall Study|Lack of Efficacy|4
7189494|NCT03084718|11389964|FG004|Overall Study|Lack of Efficacy|0
7189495|NCT03084718|11389960|FG000|Overall Study|Lost to Follow-up|0
7189496|NCT03084718|11389961|FG001|Overall Study|Lost to Follow-up|1
7189497|NCT03084718|11389962|FG002|Overall Study|Lost to Follow-up|0
7189498|NCT03084718|11389963|FG003|Overall Study|Lost to Follow-up|0
7189499|NCT03084718|11389964|FG004|Overall Study|Lost to Follow-up|2
7189500|NCT03084718|11389960|FG000|Overall Study|Protocol Violation|0
7189501|NCT03084718|11389961|FG001|Overall Study|Protocol Violation|0
7189502|NCT03084718|11389962|FG002|Overall Study|Protocol Violation|1
7189503|NCT03084718|11389963|FG003|Overall Study|Protocol Violation|0
7189504|NCT03084718|11389964|FG004|Overall Study|Protocol Violation|0
7189505|NCT03084718|11389960|FG000|Overall Study|Death|0
7189506|NCT03084718|11389961|FG001|Overall Study|Death|1
7189507|NCT03084718|11389962|FG002|Overall Study|Death|0
7189508|NCT03084718|11389963|FG003|Overall Study|Death|0
7050160|NCT01810939|11139326|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1
7050161|NCT01810939|11139324|FG000|Part B Placebo-Controlled Withdrawal|Death|0
7050162|NCT01810939|11139325|FG001|Part B Placebo-Controlled Withdrawal|Death|0
7050163|NCT01810939|11139326|FG002|Part B Placebo-Controlled Withdrawal|Death|1
7050164|NCT01810939|11139324|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
7050165|NCT01810939|11139325|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
7050166|NCT01810939|11139326|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1
7189509|NCT03084718|11389964|FG004|Overall Study|Death|0
7189510|NCT03084718|11389960|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1
7189511|NCT03084718|11389961|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0
7189512|NCT03084718|11389962|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1
7189513|NCT03084718|11389963|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2
7189514|NCT03084718|11389964|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0
7189515|NCT03069417|11389981|FG000|Overall Study|Lost to Follow-up|2
7189516|NCT03069417|11389982|FG001|Overall Study|Lost to Follow-up|0
7189517|NCT03069417|11389981|FG000|Overall Study|Reason Unknown|4
7189518|NCT03069417|11389982|FG001|Overall Study|Reason Unknown|7
7189519|NCT02936323|11390011|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0
7189520|NCT02936323|11390012|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1
7189521|NCT02936323|11390013|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0
7189522|NCT02936323|11390014|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1
7189523|NCT02936323|11390015|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1
7189524|NCT02936323|11390016|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1
7189525|NCT02936323|11390017|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0
7189526|NCT02936323|11390018|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0
7189527|NCT02936323|11390019|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0
7189528|NCT02936323|11390020|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0
7189529|NCT02936323|11390011|FG000|Phase 1 Dose Escalation|Death|2
7189530|NCT02936323|11390012|FG001|Phase 1 Dose Escalation|Death|1
7189531|NCT02936323|11390013|FG002|Phase 1 Dose Escalation|Death|3
7189532|NCT02936323|11390014|FG003|Phase 1 Dose Escalation|Death|1
7189533|NCT02936323|11390015|FG004|Phase 1 Dose Escalation|Death|2
7189534|NCT02936323|11390016|FG005|Phase 1 Dose Escalation|Death|3
7189535|NCT02936323|11390017|FG006|Phase 1 Dose Escalation|Death|3
7189536|NCT02936323|11390018|FG007|Phase 1 Dose Escalation|Death|0
7189537|NCT02936323|11390019|FG008|Phase 1 Dose Escalation|Death|0
7189538|NCT02936323|11390020|FG009|Phase 1 Dose Escalation|Death|0
7189539|NCT02936323|11390011|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0
7189540|NCT02936323|11390012|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0
7189541|NCT02936323|11390013|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0
7189542|NCT02936323|11390014|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0
7189543|NCT02936323|11390015|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0
7189544|NCT02936323|11390016|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1
7189545|NCT02936323|11390017|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0
7050167|NCT01810939|11139324|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0
7050168|NCT01810939|11139325|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
7050169|NCT01810939|11139326|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
7050170|NCT01810939|11139324|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0
7050171|NCT01810939|11139325|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1
7050172|NCT01810939|11139326|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2
7050173|NCT01810939|11139324|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0
7050174|NCT01810939|11139325|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2
7050175|NCT01810939|11139326|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14
7050176|NCT01810939|11139324|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0
7050177|NCT01810939|11139325|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2
7050178|NCT01810939|11139326|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1
7050179|NCT01810939|11139324|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
7189546|NCT02936323|11390018|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0
7189547|NCT02936323|11390019|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0
7189548|NCT02936323|11390020|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0
7189549|NCT02936323|11390011|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
7189550|NCT02936323|11390012|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
7189551|NCT02936323|11390013|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
7189552|NCT02936323|11390014|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
7189553|NCT02936323|11390015|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
7189554|NCT02936323|11390016|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
7189555|NCT02936323|11390017|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
7189556|NCT02936323|11390018|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11
7050180|NCT01810939|11139325|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1
7050181|NCT01810939|11139326|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
7050182|NCT01811186|11139388|FG000|Overall Study|Adverse Event|54
7050183|NCT01811186|11139389|FG001|Overall Study|Adverse Event|38
7050184|NCT01811186|11139388|FG000|Overall Study|Protocol Violation|5
7050185|NCT01811186|11139389|FG001|Overall Study|Protocol Violation|6
7050186|NCT01811186|11139388|FG000|Overall Study|Withdrawal by Subject|5
7050187|NCT01811186|11139389|FG001|Overall Study|Withdrawal by Subject|10
7050188|NCT01811186|11139388|FG000|Overall Study|Lack of Efficacy|3
7050189|NCT01811186|11139389|FG001|Overall Study|Lack of Efficacy|6
7050190|NCT01811186|11139388|FG000|Overall Study|Lost to Follow-up|4
7050191|NCT01811186|11139389|FG001|Overall Study|Lost to Follow-up|2
7050192|NCT01811225|11139403|FG000|Treatment Period 1|Adverse Event|2
7050193|NCT01811225|11139404|FG001|Treatment Period 1|Adverse Event|3
7050194|NCT01811225|11139403|FG000|Treatment Period 1|Lost to Follow-up|12
7050195|NCT01811225|11139404|FG001|Treatment Period 1|Lost to Follow-up|8
7050196|NCT01811225|11139403|FG000|Treatment Period 1|transporation|1
7050197|NCT01811225|11139404|FG001|Treatment Period 1|transporation|0
7050198|NCT01811225|11139403|FG000|Treatment Period 1|unable to remain smoke free overnight|10
7050199|NCT01811225|11139404|FG001|Treatment Period 1|unable to remain smoke free overnight|6
7050200|NCT01811225|11139403|FG000|Treatment Period 2|Lost to Follow-up|1
7050201|NCT01811225|11139404|FG001|Treatment Period 2|Lost to Follow-up|2
7050202|NCT01811225|11139403|FG000|Treatment Period 2|unable to remain smoke free overnight|3
7050203|NCT01811225|11139404|FG001|Treatment Period 2|unable to remain smoke free overnight|4
7050204|NCT01811238|11139410|FG000|Overall Study|Withdrawal by Subject|42
7050205|NCT01811238|11139410|FG000|Overall Study|Adverse Event|25
7050206|NCT01811238|11139410|FG000|Overall Study|Protocol Violation|4
7050207|NCT01811238|11139410|FG000|Overall Study|Lack of Efficacy|4
7050208|NCT01811238|11139410|FG000|Overall Study|subject refused study medication|6
7050209|NCT01811472|11139451|FG000|Overall Study|Adverse Event|1
7050210|NCT01811472|11139452|FG001|Overall Study|Adverse Event|0
7050211|NCT01811472|11139453|FG002|Overall Study|Adverse Event|4
7050212|NCT01811472|11139451|FG000|Overall Study|Lost to Follow-up|0
7050213|NCT01811472|11139452|FG001|Overall Study|Lost to Follow-up|0
7050214|NCT01811472|11139453|FG002|Overall Study|Lost to Follow-up|1
7050215|NCT01811472|11139451|FG000|Overall Study|Subject/guardian decision|1
7050216|NCT01811472|11139452|FG001|Overall Study|Subject/guardian decision|0
7050217|NCT01811472|11139453|FG002|Overall Study|Subject/guardian decision|0
7050218|NCT01811485|11139465|FG000|Overall Study|Adverse Event|1
7050219|NCT01811485|11139466|FG001|Overall Study|Adverse Event|3
7050220|NCT01811485|11139467|FG002|Overall Study|Adverse Event|2
7189557|NCT02936323|11390019|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4
7189558|NCT02936323|11390020|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2
7189559|NCT02936323|11390011|FG000|Phase 2a Dose Expansion|Physician Decision|0
7189560|NCT02936323|11390012|FG001|Phase 2a Dose Expansion|Physician Decision|0
7189561|NCT02936323|11390013|FG002|Phase 2a Dose Expansion|Physician Decision|0
7189562|NCT02936323|11390014|FG003|Phase 2a Dose Expansion|Physician Decision|0
7189563|NCT02936323|11390015|FG004|Phase 2a Dose Expansion|Physician Decision|0
7189564|NCT02936323|11390016|FG005|Phase 2a Dose Expansion|Physician Decision|0
7189565|NCT02936323|11390017|FG006|Phase 2a Dose Expansion|Physician Decision|0
7189566|NCT02936323|11390018|FG007|Phase 2a Dose Expansion|Physician Decision|0
7189567|NCT02936323|11390019|FG008|Phase 2a Dose Expansion|Physician Decision|0
7189568|NCT02936323|11390020|FG009|Phase 2a Dose Expansion|Physician Decision|1
7189569|NCT02936323|11390011|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0
7189570|NCT02936323|11390012|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0
7189571|NCT02936323|11390013|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0
7189572|NCT02936323|11390014|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0
7189573|NCT02936323|11390015|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0
7189574|NCT02936323|11390016|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0
7189575|NCT02936323|11390017|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0
7189576|NCT02936323|11390018|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2
7050221|NCT01811485|11139465|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7050222|NCT01811485|11139466|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7050223|NCT01811485|11139467|FG002|Overall Study|Unsatisfactory therapeutic effect|3
7050224|NCT01811485|11139465|FG000|Overall Study|Administrative problems|1
7189577|NCT02936323|11390019|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1
7189578|NCT02936323|11390020|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0
7189579|NCT02936323|11390011|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0
7189580|NCT02936323|11390012|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0
7189581|NCT02936323|11390013|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0
7189582|NCT02936323|11390014|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0
7189583|NCT02936323|11390015|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0
7189584|NCT02936323|11390016|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0
7189585|NCT02936323|11390017|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0
7189586|NCT02936323|11390018|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0
7189587|NCT02936323|11390019|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0
7189588|NCT02936323|11390020|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1
7189589|NCT02936323|11390011|FG000|Phase 2a Dose Expansion|Death|0
7189590|NCT02936323|11390012|FG001|Phase 2a Dose Expansion|Death|0
7189591|NCT02936323|11390013|FG002|Phase 2a Dose Expansion|Death|0
7189592|NCT02936323|11390014|FG003|Phase 2a Dose Expansion|Death|0
7189593|NCT02936323|11390015|FG004|Phase 2a Dose Expansion|Death|0
7050225|NCT01811485|11139466|FG001|Overall Study|Administrative problems|0
7050226|NCT01811485|11139467|FG002|Overall Study|Administrative problems|0
7050227|NCT01811485|11139465|FG000|Overall Study|Protocol Deviation|0
7050228|NCT01811485|11139466|FG001|Overall Study|Protocol Deviation|1
7050229|NCT01811485|11139467|FG002|Overall Study|Protocol Deviation|0
7050230|NCT01811563|11139480|FG000|Overall Study|Lost to Follow-up|5
7050231|NCT01811563|11139481|FG001|Overall Study|Lost to Follow-up|2
7050232|NCT01811563|11139480|FG000|Overall Study|Incorrect Randomization procedure|0
7050233|NCT01811563|11139481|FG001|Overall Study|Incorrect Randomization procedure|1
7050234|NCT01811706|11139510|FG000|First Intervention ( 4 Weeks)|Adverse Event|1
7050235|NCT01811706|11139511|FG001|First Intervention ( 4 Weeks)|Adverse Event|0
7189594|NCT02936323|11390016|FG005|Phase 2a Dose Expansion|Death|0
7189595|NCT02936323|11390017|FG006|Phase 2a Dose Expansion|Death|0
7189596|NCT02936323|11390018|FG007|Phase 2a Dose Expansion|Death|4
7189597|NCT02936323|11390019|FG008|Phase 2a Dose Expansion|Death|8
7189598|NCT02936323|11390020|FG009|Phase 2a Dose Expansion|Death|10
7189599|NCT02437318|11390063|FG000|Overall Study|Progressive disease|173
7189600|NCT02437318|11390064|FG001|Overall Study|Progressive disease|208
7189601|NCT02437318|11390063|FG000|Overall Study|Subject/guardian decision|22
7189602|NCT02437318|11390064|FG001|Overall Study|Subject/guardian decision|10
7189603|NCT02437318|11390063|FG000|Overall Study|Physician Decision|11
7189604|NCT02437318|11390064|FG001|Overall Study|Physician Decision|10
7189605|NCT02437318|11390063|FG000|Overall Study|Adverse Event|14
7189606|NCT02437318|11390064|FG001|Overall Study|Adverse Event|3
7189607|NCT02437318|11390063|FG000|Overall Study|Death|4
7189608|NCT02437318|11390064|FG001|Overall Study|Death|4
7189609|NCT02437318|11390063|FG000|Overall Study|Protocol Violation|5
7189610|NCT02437318|11390064|FG001|Overall Study|Protocol Violation|6
7189611|NCT02437318|11390063|FG000|Overall Study|Untreated|0
7189612|NCT02437318|11390064|FG001|Overall Study|Untreated|1
7189613|NCT02429791|11390072|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6
7189614|NCT02429791|11390073|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2
7189615|NCT02429791|11390072|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0
7189616|NCT02429791|11390073|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2
7189617|NCT02429791|11390072|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2
7189618|NCT02429791|11390073|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1
7189619|NCT02429791|11390072|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
7050236|NCT01811732|11139521|FG000|Overall Study|Lost to Follow-up|24
7050237|NCT01811732|11139522|FG001|Overall Study|Lost to Follow-up|30
7050238|NCT01811732|11139521|FG000|Overall Study|Withdrawal by Subject|16
7050239|NCT01811732|11139522|FG001|Overall Study|Withdrawal by Subject|10
7050240|NCT01811732|11139521|FG000|Overall Study|Adverse Event|3
7050241|NCT01811732|11139522|FG001|Overall Study|Adverse Event|9
7050242|NCT01811732|11139521|FG000|Overall Study|Lack of Efficacy|3
7050243|NCT01811732|11139522|FG001|Overall Study|Lack of Efficacy|1
7050244|NCT01811732|11139521|FG000|Overall Study|Non-compliance with study drug/procedure|3
7050245|NCT01811732|11139522|FG001|Overall Study|Non-compliance with study drug/procedure|3
7050246|NCT01811732|11139521|FG000|Overall Study|Physician Decision|2
7050247|NCT01811732|11139522|FG001|Overall Study|Physician Decision|0
7050248|NCT01811732|11139521|FG000|Overall Study|Death|1
7050249|NCT01811732|11139522|FG001|Overall Study|Death|1
7050250|NCT01811732|11139521|FG000|Overall Study|Insufficient venous access|0
7050251|NCT01811732|11139522|FG001|Overall Study|Insufficient venous access|1
7050252|NCT01811732|11139521|FG000|Overall Study|Protocol Violation|0
7050253|NCT01811732|11139522|FG001|Overall Study|Protocol Violation|1
7050254|NCT01811732|11139521|FG000|Overall Study|Subject incarcerated|1
7050255|NCT01811732|11139522|FG001|Overall Study|Subject incarcerated|2
7050256|NCT01811732|11139521|FG000|Overall Study|Admitted to another facility|1
7050257|NCT01811732|11139522|FG001|Overall Study|Admitted to another facility|0
7050258|NCT01811732|11139521|FG000|Overall Study|Correct study drug not available on site|1
7050259|NCT01811732|11139522|FG001|Overall Study|Correct study drug not available on site|0
7050260|NCT01811953|11139548|FG000|Overall Study|Adverse Event|0
7050261|NCT01811953|11139549|FG001|Overall Study|Adverse Event|0
7050262|NCT01811953|11139550|FG002|Overall Study|Adverse Event|0
7189620|NCT02429791|11390073|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2
7189621|NCT02429791|11390072|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1
7189622|NCT02429791|11390073|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4
7189623|NCT02429791|11390072|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3
7189624|NCT02429791|11390073|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7
7189625|NCT02429791|11390072|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11
7189626|NCT02429791|11390073|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12
7189627|NCT02429791|11390072|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0
7189628|NCT02429791|11390073|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4
7189629|NCT02429791|11390072|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4
7189630|NCT02429791|11390073|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3
7189631|NCT02429791|11390072|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0
7189632|NCT02429791|11390073|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1
7189633|NCT02429791|11390072|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
7050263|NCT01811953|11139551|FG003|Overall Study|Adverse Event|1
7050264|NCT01811953|11139552|FG004|Overall Study|Adverse Event|0
7050265|NCT01811953|11139553|FG005|Overall Study|Adverse Event|1
7189634|NCT02429791|11390073|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
7189635|NCT02429791|11390072|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7
7189636|NCT02429791|11390073|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5
7189637|NCT02422797|11390088|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11
7189638|NCT02422797|11390089|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1
7189639|NCT02422797|11390088|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0
7189640|NCT02422797|11390089|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1
7189641|NCT02422797|11390088|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1
7189642|NCT02422797|11390089|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2
7189643|NCT02422797|11390088|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
7189644|NCT02422797|11390089|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
7189645|NCT02422797|11390088|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0
7189646|NCT02422797|11390089|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3
6804130|NCT00291486|10806004|FG001|Overall Study|Disease progression|0
6804131|NCT00291486|10806005|FG002|Overall Study|Disease progression|1
6804132|NCT00291486|10806006|FG003|Overall Study|Disease progression|0
6804133|NCT00291486|10806007|FG004|Overall Study|Disease progression|0
6804134|NCT00284856|10806031|FG000|Overall Study|Adverse Event|3
6804135|NCT00284856|10806032|FG001|Overall Study|Adverse Event|3
6804136|NCT00284856|10806033|FG002|Overall Study|Adverse Event|3
6804137|NCT00284856|10806031|FG000|Overall Study|Lack of Efficacy|2
6804138|NCT00284856|10806032|FG001|Overall Study|Lack of Efficacy|1
6804139|NCT00284856|10806033|FG002|Overall Study|Lack of Efficacy|8
7083841|NCT02158728|11195476|FG000|Overall Study|no procedure according to CIP done|3
7189647|NCT02422797|11390088|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1
7189648|NCT02422797|11390089|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1
7189649|NCT02422797|11390088|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2
7189650|NCT02422797|11390089|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7
7189651|NCT02422797|11390088|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0
7189652|NCT02422797|11390089|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1
7189653|NCT02422797|11390088|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10
7189654|NCT02422797|11390089|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6
7189655|NCT02422797|11390088|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5
7189656|NCT02422797|11390089|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3
7189657|NCT02422797|11390088|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2
7189658|NCT02422797|11390089|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2
7189659|NCT02422797|11390088|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2
7189660|NCT02422797|11390089|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6
7189661|NCT02422797|11390088|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1
7189662|NCT02422797|11390089|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0
7189663|NCT02422797|11390088|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
7189664|NCT02422797|11390089|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0
7189665|NCT02132611|11390118|FG000|Overall Study|Death|2
7189666|NCT01147822|11390124|FG000|Overall Study|Death|66
7189667|NCT01147822|11390125|FG001|Overall Study|Death|59
7189668|NCT01147822|11390124|FG000|Overall Study|Protocol Violation|0
7189669|NCT01147822|11390125|FG001|Overall Study|Protocol Violation|1
7189670|NCT01147822|11390124|FG000|Overall Study|Lost to Follow-up|3
7189671|NCT01147822|11390125|FG001|Overall Study|Lost to Follow-up|2
7189672|NCT01147822|11390124|FG000|Overall Study|Physician Decision|0
7189673|NCT01147822|11390125|FG001|Overall Study|Physician Decision|2
7189674|NCT01147822|11390124|FG000|Overall Study|Withdrawal by Subject|8
7189675|NCT01147822|11390125|FG001|Overall Study|Withdrawal by Subject|13
7189676|NCT01147822|11390124|FG000|Overall Study|Not Completed/Ongoing|111
7189677|NCT01147822|11390125|FG001|Overall Study|Not Completed/Ongoing|102
7189678|NCT04476251|11390146|FG000|Overall Study|Not treated|1
7189679|NCT03915860|11390154|FG000|Overall Study|Adverse Event|3
7189680|NCT03915860|11390154|FG000|Overall Study|Withdrawal by Subject|6
7189681|NCT03915860|11390154|FG000|Overall Study|Lost to Follow-up|2
7189682|NCT03915860|11390154|FG000|Overall Study|Other than specified|3
7189683|NCT03795233|11390173|FG000|Overall Study|Withdrawal by Subject|2
7189684|NCT03795233|11390174|FG001|Overall Study|Withdrawal by Subject|1
7189685|NCT03795233|11390173|FG000|Overall Study|Lost to Follow-up|1
7189686|NCT03795233|11390174|FG001|Overall Study|Lost to Follow-up|0
7189687|NCT03795233|11390173|FG000|Overall Study|Death|1
7189688|NCT03795233|11390174|FG001|Overall Study|Death|0
7189689|NCT03786380|11390185|FG000|Overall Study|Adverse Event|1
7189690|NCT03786380|11390186|FG001|Overall Study|Adverse Event|0
7189691|NCT03786380|11390187|FG002|Overall Study|Adverse Event|0
7189692|NCT03786380|11390188|FG003|Overall Study|Adverse Event|3
7189693|NCT03786380|11390189|FG004|Overall Study|Adverse Event|1
7189694|NCT03786380|11390185|FG000|Overall Study|Lack of Efficacy|0
7189695|NCT03786380|11390186|FG001|Overall Study|Lack of Efficacy|0
7189696|NCT03786380|11390187|FG002|Overall Study|Lack of Efficacy|0
7189697|NCT03786380|11390188|FG003|Overall Study|Lack of Efficacy|0
7189698|NCT03786380|11390189|FG004|Overall Study|Lack of Efficacy|1
7189699|NCT03786380|11390185|FG000|Overall Study|Withdrawal by Subject|1
7189700|NCT03786380|11390186|FG001|Overall Study|Withdrawal by Subject|2
7189701|NCT03786380|11390187|FG002|Overall Study|Withdrawal by Subject|2
7189702|NCT03786380|11390188|FG003|Overall Study|Withdrawal by Subject|1
7189703|NCT03786380|11390189|FG004|Overall Study|Withdrawal by Subject|2
7189704|NCT03786380|11390185|FG000|Overall Study|Lost to Follow-up|3
7189705|NCT03786380|11390186|FG001|Overall Study|Lost to Follow-up|0
7189706|NCT03786380|11390187|FG002|Overall Study|Lost to Follow-up|1
7189707|NCT03786380|11390188|FG003|Overall Study|Lost to Follow-up|2
7189708|NCT03786380|11390189|FG004|Overall Study|Lost to Follow-up|0
7189709|NCT03786380|11390185|FG000|Overall Study|Physician Decision|0
7189710|NCT03786380|11390186|FG001|Overall Study|Physician Decision|0
7189711|NCT03786380|11390187|FG002|Overall Study|Physician Decision|1
7189712|NCT03786380|11390188|FG003|Overall Study|Physician Decision|0
7189713|NCT03786380|11390189|FG004|Overall Study|Physician Decision|0
7189714|NCT03786380|11390185|FG000|Overall Study|Study Terminated by the Sponsor|30
7189715|NCT03786380|11390186|FG001|Overall Study|Study Terminated by the Sponsor|20
7189716|NCT03786380|11390187|FG002|Overall Study|Study Terminated by the Sponsor|50
6804140|NCT00284856|10806031|FG000|Overall Study|Lost to Follow-up|25
6804141|NCT00284856|10806032|FG001|Overall Study|Lost to Follow-up|21
6804142|NCT00284856|10806033|FG002|Overall Study|Lost to Follow-up|22
6804143|NCT00284856|10806031|FG000|Overall Study|Protocol Violation|5
6804144|NCT00284856|10806032|FG001|Overall Study|Protocol Violation|4
6804145|NCT00284856|10806033|FG002|Overall Study|Protocol Violation|5
6804146|NCT00284856|10806031|FG000|Overall Study|Withdrawal by Subject|12
6804147|NCT00284856|10806032|FG001|Overall Study|Withdrawal by Subject|16
6804148|NCT00284856|10806033|FG002|Overall Study|Withdrawal by Subject|18
6804149|NCT00284856|10806031|FG000|Overall Study|Other|4
6804150|NCT00284856|10806032|FG001|Overall Study|Other|5
6804151|NCT00284856|10806033|FG002|Overall Study|Other|4
6804152|NCT00070707|10806043|FG000|Overall Study|Adverse Event|1
6804153|NCT00070707|10806044|FG001|Overall Study|Adverse Event|2
6804154|NCT00070707|10806043|FG000|Overall Study|Lack of Efficacy|4
6804155|NCT00070707|10806044|FG001|Overall Study|Lack of Efficacy|1
6804156|NCT00070707|10806043|FG000|Overall Study|Protocol Violation|8
6804157|NCT00070707|10806044|FG001|Overall Study|Protocol Violation|4
6804158|NCT00070707|10806043|FG000|Overall Study|Unrelated to Study Medication|1
7050266|NCT01811953|11139548|FG000|Overall Study|Protocol Violation|0
7050267|NCT01811953|11139549|FG001|Overall Study|Protocol Violation|0
7050268|NCT01811953|11139550|FG002|Overall Study|Protocol Violation|0
7050269|NCT01811953|11139551|FG003|Overall Study|Protocol Violation|0
7050270|NCT01811953|11139552|FG004|Overall Study|Protocol Violation|1
7050271|NCT01811953|11139553|FG005|Overall Study|Protocol Violation|0
7050272|NCT01812057|11139591|FG000|Overall Study|Protocol Violation|1
7050273|NCT01812057|11139592|FG001|Overall Study|Protocol Violation|0
7050274|NCT01812057|11139591|FG000|Overall Study|Physician Decision|1
7050275|NCT01812057|11139592|FG001|Overall Study|Physician Decision|0
7050276|NCT01812109|11139602|FG000|Overall Study|research personnel delay|16
7050277|NCT01812109|11139602|FG000|Overall Study|NIRS Unattainable|17
7050278|NCT01812655|11139618|FG000|Overall Study|Protocol Violation|1
7050279|NCT01812655|11139619|FG001|Overall Study|Protocol Violation|1
7189717|NCT03786380|11390188|FG003|Overall Study|Study Terminated by the Sponsor|57
7189718|NCT03786380|11390189|FG004|Overall Study|Study Terminated by the Sponsor|23
7189719|NCT03786380|11390185|FG000|Overall Study|Reason Not Specified|0
6804159|NCT00070707|10806044|FG001|Overall Study|Unrelated to Study Medication|0
6810179|NCT01090024|10814023|FG016|Period 2|Adverse Event|0
6810180|NCT01090024|10814024|FG017|Period 2|Adverse Event|0
7050280|NCT01812655|11139620|FG002|Overall Study|Protocol Violation|0
7050281|NCT01812707|11139648|FG000|Overall Study|Adverse Event|0
7050282|NCT01812707|11139649|FG001|Overall Study|Adverse Event|0
7050283|NCT01812707|11139650|FG002|Overall Study|Adverse Event|0
7050284|NCT01812707|11139651|FG003|Overall Study|Adverse Event|2
7189720|NCT03786380|11390186|FG001|Overall Study|Reason Not Specified|0
7189721|NCT03786380|11390187|FG002|Overall Study|Reason Not Specified|0
7189722|NCT03786380|11390188|FG003|Overall Study|Reason Not Specified|0
7189723|NCT03786380|11390189|FG004|Overall Study|Reason Not Specified|1
7189724|NCT03645863|11390213|FG000|Overall Study|Withdrawal by Subject|1
7189725|NCT03645863|11390214|FG001|Overall Study|Withdrawal by Subject|0
7189726|NCT03645863|11390215|FG002|Overall Study|Withdrawal by Subject|0
7189727|NCT03564145|11390223|FG000|Overall Study|Adverse Event|4
7189728|NCT03564145|11390223|FG000|Overall Study|Lost to Follow-up|21
7189729|NCT03564145|11390223|FG000|Overall Study|Protocol Violation|2
7189730|NCT03564145|11390223|FG000|Overall Study|Withdrawal by Subject|48
7189731|NCT03564145|11390223|FG000|Overall Study|Study Terminated by Sponsor|146
7189732|NCT03564145|11390223|FG000|Overall Study|Physician Decision|1
7189733|NCT03564145|11390223|FG000|Overall Study|Other Than Specified|1
7189734|NCT03564145|11390223|FG000|Overall Study|Pregnancy|1
7189735|NCT03564119|11390229|FG000|Overall Study|Adverse Event|4
7189736|NCT03564119|11390230|FG001|Overall Study|Adverse Event|0
7189737|NCT03564119|11390229|FG000|Overall Study|Lost to Follow-up|1
7189738|NCT03564119|11390230|FG001|Overall Study|Lost to Follow-up|4
7189739|NCT03564119|11390229|FG000|Overall Study|Protocol Violation|1
7189740|NCT03564119|11390230|FG001|Overall Study|Protocol Violation|0
7189741|NCT03564119|11390229|FG000|Overall Study|Withdrawal by Subject|9
7050285|NCT01812707|11139648|FG000|Overall Study|Poor compliance to protocol|1
7050286|NCT01812707|11139649|FG001|Overall Study|Poor compliance to protocol|0
7050287|NCT01812707|11139650|FG002|Overall Study|Poor compliance to protocol|0
7050288|NCT01812707|11139651|FG003|Overall Study|Poor compliance to protocol|0
7050289|NCT01812707|11139648|FG000|Overall Study|Consent withdrawn by participant|1
7050290|NCT01812707|11139649|FG001|Overall Study|Consent withdrawn by participant|0
7050291|NCT01812707|11139650|FG002|Overall Study|Consent withdrawn by participant|0
7050292|NCT01812707|11139651|FG003|Overall Study|Consent withdrawn by participant|0
7050293|NCT01812759|11139665|FG000|Overall Study|Physician Decision|0
7050294|NCT01812759|11139666|FG001|Overall Study|Physician Decision|0
7050295|NCT01812759|11139667|FG002|Overall Study|Physician Decision|1
7050296|NCT01812837|11139678|FG000|Overall Study|Lost to Follow-up|1
7050297|NCT01812837|11139679|FG001|Overall Study|Lost to Follow-up|1
7050298|NCT01812837|11139680|FG002|Overall Study|Lost to Follow-up|0
7050299|NCT01812837|11139678|FG000|Overall Study|Protocol Violation|1
7050300|NCT01812837|11139679|FG001|Overall Study|Protocol Violation|0
7050301|NCT01812837|11139680|FG002|Overall Study|Protocol Violation|0
7050302|NCT01813019|11139690|FG000|Overall Study|Adverse Event|0
7050303|NCT01813019|11139691|FG001|Overall Study|Adverse Event|3
7050304|NCT01813019|11139690|FG000|Overall Study|Withdrawal by Subject|3
7050305|NCT01813019|11139691|FG001|Overall Study|Withdrawal by Subject|2
7050306|NCT01813019|11139690|FG000|Overall Study|administrative problems|2
7050307|NCT01813019|11139691|FG001|Overall Study|administrative problems|0
7050308|NCT01813019|11139690|FG000|Overall Study|Protocol Deviation|2
7050309|NCT01813019|11139691|FG001|Overall Study|Protocol Deviation|1
7050310|NCT01813058|11139699|FG000|Overall Study|Withdrawal by Subject|5
7050311|NCT01813058|11139700|FG001|Overall Study|Withdrawal by Subject|4
7050312|NCT01813071|11139715|FG000|Overall Study|Protocol Violation|0
7050313|NCT01813071|11139716|FG001|Overall Study|Protocol Violation|0
7050314|NCT01813071|11139717|FG002|Overall Study|Protocol Violation|0
7050315|NCT01813071|11139718|FG003|Overall Study|Protocol Violation|0
7050316|NCT01813071|11139719|FG004|Overall Study|Protocol Violation|1
7050317|NCT01813071|11139720|FG005|Overall Study|Protocol Violation|4
7050318|NCT01813071|11139721|FG006|Overall Study|Protocol Violation|2
7050319|NCT01813071|11139722|FG007|Overall Study|Protocol Violation|4
7050320|NCT01813071|11139723|FG008|Overall Study|Protocol Violation|2
7050321|NCT01813071|11139715|FG000|Overall Study|Withdrawal by Subject|0
7050322|NCT01813071|11139716|FG001|Overall Study|Withdrawal by Subject|0
7050323|NCT01813071|11139717|FG002|Overall Study|Withdrawal by Subject|0
7050324|NCT01813071|11139718|FG003|Overall Study|Withdrawal by Subject|0
7189742|NCT03564119|11390230|FG001|Overall Study|Withdrawal by Subject|4
7189743|NCT03564119|11390229|FG000|Overall Study|Other Than Specified|0
7189744|NCT03564119|11390230|FG001|Overall Study|Other Than Specified|1
7189745|NCT03181529|11390285|FG000|Overall Study|Withdrawal by Subject|1
7189746|NCT03181529|11390286|FG001|Overall Study|Withdrawal by Subject|1
7189747|NCT03181529|11390285|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1
7189748|NCT03181529|11390286|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0
7189749|NCT02946931|11390292|FG000|Overall Study|Did not require collection of CRFs|573
7189750|NCT02946931|11390292|FG000|Overall Study|Other than listed|38
7189751|NCT02946931|11390292|FG000|Overall Study|Discharge from hospital|117
7189752|NCT02946931|11390292|FG000|Overall Study|Adverse Event|81
7189753|NCT02946931|11390292|FG000|Overall Study|CRFs not fixed|2
7189754|NCT02946931|11390292|FG000|Overall Study|CRFs not valid|1
7189755|NCT02946931|11390292|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6
7189756|NCT02779556|11390298|FG000|Baseline|Partial baseline interview completed|1
7189757|NCT02779556|11390299|FG001|Baseline|Partial baseline interview completed|0
7189758|NCT02779556|11390298|FG000|3 Months|Lost to Follow-up|40
7189759|NCT02779556|11390299|FG001|3 Months|Lost to Follow-up|29
7189760|NCT02779556|11390298|FG000|3 Months|Missed 3 month clinic visit|27
7189761|NCT02779556|11390299|FG001|3 Months|Missed 3 month clinic visit|19
7189762|NCT02779556|11390298|FG000|6 Month|Lost to Follow-up|33
7189763|NCT02779556|11390299|FG001|6 Month|Lost to Follow-up|39
7189764|NCT02779556|11390298|FG000|6 Month HbA1c|No value collected during window|69
7189765|NCT02779556|11390299|FG001|6 Month HbA1c|No value collected during window|50
7189766|NCT02779556|11390298|FG000|12 Month HbA1c|No value collected during window|138
7189767|NCT02779556|11390299|FG001|12 Month HbA1c|No value collected during window|102
7189768|NCT02675751|11390314|FG000|Overall Study|Lost to Follow-up|16
7189769|NCT02621424|11390329|FG000|Overall Study|Withdrawal by Subject|1
7189770|NCT02621424|11390330|FG001|Overall Study|Withdrawal by Subject|2
7189771|NCT02595372|11390336|FG000|Overall Study|Adverse Event|6
7189772|NCT02595372|11390336|FG000|Overall Study|Physician Decision|2
7189773|NCT02595372|11390336|FG000|Overall Study|Disease Progression|1
7189774|NCT02334722|11390342|FG000|Overall Study|Lost to Follow-up|4
7189775|NCT02334722|11390343|FG001|Overall Study|Lost to Follow-up|0
7189776|NCT02334722|11390342|FG000|Overall Study|6 week questionnaire not completed|2
7189777|NCT02334722|11390343|FG001|Overall Study|6 week questionnaire not completed|0
7189778|NCT02334722|11390342|FG000|Overall Study|Unable to obtain medication|1
7189779|NCT02334722|11390343|FG001|Overall Study|Unable to obtain medication|1
7189780|NCT02334722|11390342|FG000|Overall Study|Withdrawal by Subject|0
7189781|NCT02334722|11390343|FG001|Overall Study|Withdrawal by Subject|3
7189782|NCT02334722|11390342|FG000|Overall Study|Adverse Event|0
7189783|NCT02334722|11390343|FG001|Overall Study|Adverse Event|2
7189784|NCT02334722|11390342|FG000|Overall Study|Physician Decision|0
7189785|NCT02334722|11390343|FG001|Overall Study|Physician Decision|1
7189786|NCT01966731|11390353|FG000|Overall Study|Death|2
7189787|NCT01966731|11390353|FG000|Overall Study|Lost to Follow-up|1
7189788|NCT01966731|11390353|FG000|Overall Study|Physician Decision|2
7189789|NCT01966731|11390353|FG000|Overall Study|Follow up is not complete|600
7189790|NCT01966731|11390353|FG000|Overall Study|Screening Failure|29
7189791|NCT01966731|11390353|FG000|Overall Study|Found to be ineligible|1
6804160|NCT04474197|10806074|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0
6804161|NCT04474197|10806075|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1
6804162|NCT04474197|10806076|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0
6804163|NCT04474197|10806077|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0
6804164|NCT04369950|10806094|FG000|Overall Study|Protocol Violation|2
6804165|NCT04369950|10806095|FG001|Overall Study|Protocol Violation|2
6804166|NCT04070326|10806103|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1
6804167|NCT04070326|10806104|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0
6804168|NCT04003610|10806115|FG000|Overall Study|Lost to Follow-up|0
6804169|NCT04003610|10806116|FG001|Overall Study|Lost to Follow-up|1
6804170|NCT04003610|10806117|FG002|Overall Study|Lost to Follow-up|0
7083842|NCT02158728|11195476|FG000|Overall Study|no qualified dataset|24
7189792|NCT01844518|11390377|FG000|Overall Study|Adverse Event|7
7189793|NCT01844518|11390378|FG001|Overall Study|Adverse Event|1
6804171|NCT04003610|10806115|FG000|Overall Study|Death|0
6804172|NCT04003610|10806116|FG001|Overall Study|Death|0
6804173|NCT04003610|10806117|FG002|Overall Study|Death|3
6804174|NCT04003610|10806115|FG000|Overall Study|Study Terminated by Sponsor|0
6804175|NCT04003610|10806116|FG001|Overall Study|Study Terminated by Sponsor|0
6804176|NCT04003610|10806117|FG002|Overall Study|Study Terminated by Sponsor|3
6804177|NCT03920293|10806128|FG000|Overall Study|Withdrawal by Subject|2
6804178|NCT03920293|10806129|FG001|Overall Study|Withdrawal by Subject|1
6804179|NCT03920293|10806128|FG000|Overall Study|Physician Decision|1
6804180|NCT03920293|10806129|FG001|Overall Study|Physician Decision|2
6804181|NCT03920293|10806128|FG000|Overall Study|Adverse Event|0
7050325|NCT01813071|11139719|FG004|Overall Study|Withdrawal by Subject|0
7050326|NCT01813071|11139720|FG005|Overall Study|Withdrawal by Subject|1
7050327|NCT01813071|11139721|FG006|Overall Study|Withdrawal by Subject|0
7050328|NCT01813071|11139722|FG007|Overall Study|Withdrawal by Subject|0
7050329|NCT01813071|11139723|FG008|Overall Study|Withdrawal by Subject|0
7050330|NCT01813071|11139715|FG000|Overall Study|Adverse Event|0
7050331|NCT01813071|11139716|FG001|Overall Study|Adverse Event|0
7050332|NCT01813071|11139717|FG002|Overall Study|Adverse Event|0
7050333|NCT01813071|11139718|FG003|Overall Study|Adverse Event|0
7050334|NCT01813071|11139719|FG004|Overall Study|Adverse Event|0
7050335|NCT01813071|11139720|FG005|Overall Study|Adverse Event|1
7189794|NCT01844518|11390377|FG000|Overall Study|Lack of Efficacy|17
7189795|NCT01844518|11390378|FG001|Overall Study|Lack of Efficacy|5
7189796|NCT01844518|11390377|FG000|Overall Study|Participant's request to discontinue|4
7189797|NCT01844518|11390378|FG001|Overall Study|Participant's request to discontinue|1
7189798|NCT01844518|11390377|FG000|Overall Study|Poor/Non-compliance|1
7189799|NCT01844518|11390378|FG001|Overall Study|Poor/Non-compliance|0
7189800|NCT01844518|11390377|FG000|Overall Study|No Longer Met Study Criteria|2
7189801|NCT01844518|11390378|FG001|Overall Study|No Longer Met Study Criteria|0
7189802|NCT01844518|11390377|FG000|Overall Study|Withdrawal by Subject|9
7189803|NCT01844518|11390378|FG001|Overall Study|Withdrawal by Subject|0
7189804|NCT01844518|11390377|FG000|Overall Study|Pregnancy|1
7189805|NCT01844518|11390378|FG001|Overall Study|Pregnancy|0
7189806|NCT01675479|11390387|FG000|Overall Study|Lost to Follow-up|11
7189807|NCT00812708|11390391|FG000|Overall Study|Device could not be implanted|2
7189808|NCT00812708|11390391|FG000|Overall Study|Lack of medical insurance|1
7189809|NCT00812708|11390391|FG000|Overall Study|Switched to another study|1
7189810|NCT00812708|11390391|FG000|Overall Study|Surgery cancelled due to uveitis|1
7189811|NCT00812708|11390391|FG000|Overall Study|Signed consent but later withdrew|3
7189812|NCT00741988|11390398|FG000|Overall Study|Adverse Event|2
7189813|NCT00741988|11390399|FG001|Overall Study|Adverse Event|4
7189814|NCT00741988|11390398|FG000|Overall Study|Lack of Efficacy|2
7189815|NCT00741988|11390399|FG001|Overall Study|Lack of Efficacy|0
7189816|NCT00515671|11390416|FG000|Overall Study|Lost to Follow-up|13
7189817|NCT00515671|11390417|FG001|Overall Study|Lost to Follow-up|10
7189818|NCT00515671|11390416|FG000|Overall Study|Withdrawal by Subject|3
7189819|NCT00515671|11390417|FG001|Overall Study|Withdrawal by Subject|5
7189820|NCT00515671|11390416|FG000|Overall Study|incarcerated|1
7189821|NCT00515671|11390417|FG001|Overall Study|incarcerated|2
7189822|NCT00455403|11390425|FG000|Overall Study|Lost to Follow-up|2
7189823|NCT00455403|11390426|FG001|Overall Study|Lost to Follow-up|1
7189824|NCT00455403|11390425|FG000|Overall Study|Withdrawal by Subject|1
7189825|NCT00455403|11390426|FG001|Overall Study|Withdrawal by Subject|3
7189826|NCT00455403|11390425|FG000|Overall Study|Protocol Violation|0
7189827|NCT00455403|11390426|FG001|Overall Study|Protocol Violation|2
7189828|NCT00238420|11390434|FG000|Overall Study|Protocol Violation|1
7189829|NCT00238420|11390435|FG001|Overall Study|Protocol Violation|1
7189830|NCT04128319|11390450|FG000|Overall Study|Death|3
7189831|NCT03761810|11390456|FG000|Overall Study|Adverse Event|12
7189832|NCT03761810|11390457|FG001|Overall Study|Adverse Event|0
7189833|NCT03761810|11390456|FG000|Overall Study|Lost to Follow-up|15
7189834|NCT03761810|11390457|FG001|Overall Study|Lost to Follow-up|7
7189835|NCT03761810|11390456|FG000|Overall Study|Pregnancy|1
7189836|NCT03761810|11390457|FG001|Overall Study|Pregnancy|0
7189837|NCT03761810|11390456|FG000|Overall Study|Withdrawal by Subject|14
7189838|NCT03761810|11390457|FG001|Overall Study|Withdrawal by Subject|5
7189839|NCT03761810|11390456|FG000|Overall Study|Physician Decision|1
7189840|NCT03761810|11390457|FG001|Overall Study|Physician Decision|0
7189841|NCT03761810|11390456|FG000|Overall Study|Withdrawal by Parent/Guardian|4
7189842|NCT03761810|11390457|FG001|Overall Study|Withdrawal by Parent/Guardian|0
7189843|NCT03761810|11390456|FG000|Overall Study|Other Than Specified|1
7189844|NCT03761810|11390457|FG001|Overall Study|Other Than Specified|0
7189845|NCT03761784|11390465|FG000|Overall Study|Adverse Event|4
7189846|NCT03761784|11390466|FG001|Overall Study|Adverse Event|0
7189847|NCT03761784|11390465|FG000|Overall Study|Lost to Follow-up|10
7189848|NCT03761784|11390466|FG001|Overall Study|Lost to Follow-up|7
7189849|NCT03761784|11390465|FG000|Overall Study|Pregnancy|1
7189850|NCT03761784|11390466|FG001|Overall Study|Pregnancy|0
7189851|NCT03761784|11390465|FG000|Overall Study|Protocol Violation|2
7189852|NCT03761784|11390466|FG001|Overall Study|Protocol Violation|0
7189853|NCT03761784|11390465|FG000|Overall Study|Withdrawal by Parent or Guardian|4
7189854|NCT03761784|11390466|FG001|Overall Study|Withdrawal by Parent or Guardian|1
7189855|NCT03761784|11390465|FG000|Overall Study|Withdrawal by Subject|9
7189856|NCT03761784|11390466|FG001|Overall Study|Withdrawal by Subject|4
7189857|NCT03761784|11390465|FG000|Overall Study|Physician Decision|1
7189858|NCT03761784|11390466|FG001|Overall Study|Physician Decision|0
7189859|NCT03761784|11390465|FG000|Overall Study|Other Than Specified|1
7189860|NCT03761784|11390466|FG001|Overall Study|Other Than Specified|0
7189861|NCT03361865|11390474|FG000|Overall Study|Death|17
7189862|NCT03361865|11390475|FG001|Overall Study|Death|18
7189863|NCT03361865|11390474|FG000|Overall Study|Physician Decision|1
7189864|NCT03361865|11390475|FG001|Overall Study|Physician Decision|9
7189865|NCT03361865|11390474|FG000|Overall Study|Withdrawal by Subject|1
7189866|NCT03361865|11390475|FG001|Overall Study|Withdrawal by Subject|0
7189867|NCT02929056|11390501|FG000|Overall Study|Lost to Follow-up|0
7189868|NCT02929056|11390502|FG001|Overall Study|Lost to Follow-up|1
7189869|NCT02896855|11390510|FG000|Overall Study|Death|50
7189870|NCT02896855|11390511|FG001|Overall Study|Death|40
7189871|NCT02896855|11390510|FG000|Overall Study|Lost to Follow-up|15
7189872|NCT02896855|11390511|FG001|Overall Study|Lost to Follow-up|9
7189873|NCT02896855|11390510|FG000|Overall Study|Withdrawal by Subject|7
7189874|NCT02896855|11390511|FG001|Overall Study|Withdrawal by Subject|4
7189875|NCT02871778|11390524|FG000|Part A: Treatment Period 1|Adverse Event|1
7189876|NCT02871778|11390525|FG001|Part A: Treatment Period 1|Adverse Event|1
7189877|NCT02871778|11390526|FG002|Part A: Treatment Period 1|Adverse Event|1
7189878|NCT02871778|11390527|FG003|Part A: Treatment Period 1|Adverse Event|0
7189879|NCT02871778|11390528|FG004|Part A: Treatment Period 1|Adverse Event|0
7189880|NCT02871778|11390529|FG005|Part A: Treatment Period 1|Adverse Event|0
7189881|NCT02871778|11390530|FG006|Part A: Treatment Period 1|Adverse Event|0
7189882|NCT02871778|11390531|FG007|Part A: Treatment Period 1|Adverse Event|0
7083843|NCT02158806|11195482|FG000|Overall Study|Death|2
7189883|NCT02871778|11390524|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2
7189884|NCT02871778|11390525|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2
7189885|NCT02871778|11390526|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0
7189886|NCT02871778|11390527|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2
7189887|NCT02871778|11390528|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0
7189888|NCT02871778|11390529|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0
7083844|NCT02158806|11195483|FG001|Overall Study|Death|0
7083845|NCT02158806|11195482|FG000|Overall Study|Withdrawal by Subject|2
7083846|NCT02158806|11195483|FG001|Overall Study|Withdrawal by Subject|0
7083847|NCT02158806|11195482|FG000|Overall Study|Lost to Follow-up|0
7083848|NCT02158806|11195483|FG001|Overall Study|Lost to Follow-up|3
7083849|NCT02158806|11195482|FG000|Overall Study|Moved out of area|0
7083850|NCT02158806|11195483|FG001|Overall Study|Moved out of area|1
7083851|NCT02158806|11195482|FG000|Overall Study|Transferred to palliative care|0
7083852|NCT02158806|11195483|FG001|Overall Study|Transferred to palliative care|1
7083853|NCT02158884|11195489|FG000|Baseline Assessment|Missed performance assessment|3
7189889|NCT02871778|11390530|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0
7189890|NCT02871778|11390531|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0
7189891|NCT02871778|11390524|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0
7189892|NCT02871778|11390525|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0
7083854|NCT02158884|11195489|FG000|Baseline Assessment|Missed SMFA|1
7189893|NCT02871778|11390526|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1
7189894|NCT02871778|11390527|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0
7189895|NCT02871778|11390528|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0
7189896|NCT02871778|11390529|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0
7189897|NCT02871778|11390530|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0
7189898|NCT02871778|11390531|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0
7189899|NCT02871778|11390524|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0
7189900|NCT02871778|11390525|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0
7189901|NCT02871778|11390526|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1
7189902|NCT02871778|11390527|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0
7189903|NCT02871778|11390528|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0
7189904|NCT02871778|11390529|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0
7189905|NCT02871778|11390530|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0
7189906|NCT02871778|11390531|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0
7189907|NCT02871778|11390524|FG000|Part A: Treatment Period 1|Wrong drug shipment|0
7189908|NCT02871778|11390525|FG001|Part A: Treatment Period 1|Wrong drug shipment|1
7189909|NCT02871778|11390526|FG002|Part A: Treatment Period 1|Wrong drug shipment|0
7189910|NCT02871778|11390527|FG003|Part A: Treatment Period 1|Wrong drug shipment|0
7189911|NCT02871778|11390528|FG004|Part A: Treatment Period 1|Wrong drug shipment|0
7189912|NCT02871778|11390529|FG005|Part A: Treatment Period 1|Wrong drug shipment|0
7189913|NCT02871778|11390530|FG006|Part A: Treatment Period 1|Wrong drug shipment|0
7189914|NCT02871778|11390531|FG007|Part A: Treatment Period 1|Wrong drug shipment|0
7189915|NCT02871778|11390524|FG000|Part A: Treatment Period 2|Adverse Event|2
7189916|NCT02871778|11390525|FG001|Part A: Treatment Period 2|Adverse Event|2
7189917|NCT02871778|11390526|FG002|Part A: Treatment Period 2|Adverse Event|0
7189918|NCT02871778|11390527|FG003|Part A: Treatment Period 2|Adverse Event|0
7189919|NCT02871778|11390528|FG004|Part A: Treatment Period 2|Adverse Event|0
7189920|NCT02871778|11390529|FG005|Part A: Treatment Period 2|Adverse Event|0
7189921|NCT02871778|11390530|FG006|Part A: Treatment Period 2|Adverse Event|0
7189922|NCT02871778|11390531|FG007|Part A: Treatment Period 2|Adverse Event|0
7189923|NCT02871778|11390524|FG000|Part A: Treatment Period 2|Lost to Follow-up|0
7189924|NCT02871778|11390525|FG001|Part A: Treatment Period 2|Lost to Follow-up|0
7189925|NCT02871778|11390526|FG002|Part A: Treatment Period 2|Lost to Follow-up|0
7189926|NCT02871778|11390527|FG003|Part A: Treatment Period 2|Lost to Follow-up|1
7189927|NCT02871778|11390528|FG004|Part A: Treatment Period 2|Lost to Follow-up|0
7189928|NCT02871778|11390529|FG005|Part A: Treatment Period 2|Lost to Follow-up|0
7189929|NCT02871778|11390530|FG006|Part A: Treatment Period 2|Lost to Follow-up|0
7189930|NCT02871778|11390531|FG007|Part A: Treatment Period 2|Lost to Follow-up|0
7189931|NCT02871778|11390524|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1
7189932|NCT02871778|11390525|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0
7189933|NCT02871778|11390526|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1
7189934|NCT02871778|11390527|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0
7189935|NCT02871778|11390528|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0
7189936|NCT02871778|11390529|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0
7189937|NCT02871778|11390530|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0
7189938|NCT02871778|11390531|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0
7189939|NCT02871778|11390524|FG000|Part B: Treatment Period 3|Adverse Event|0
7189940|NCT02871778|11390525|FG001|Part B: Treatment Period 3|Adverse Event|0
7189941|NCT02871778|11390526|FG002|Part B: Treatment Period 3|Adverse Event|0
7189942|NCT02871778|11390527|FG003|Part B: Treatment Period 3|Adverse Event|0
7189943|NCT02871778|11390528|FG004|Part B: Treatment Period 3|Adverse Event|1
7050336|NCT01813071|11139721|FG006|Overall Study|Adverse Event|0
7050337|NCT01813071|11139722|FG007|Overall Study|Adverse Event|0
7050338|NCT01813071|11139723|FG008|Overall Study|Adverse Event|0
7050339|NCT01813071|11139715|FG000|Overall Study|Physician Decision|0
7050340|NCT01813071|11139716|FG001|Overall Study|Physician Decision|0
7050341|NCT01813071|11139717|FG002|Overall Study|Physician Decision|0
7050342|NCT01813071|11139718|FG003|Overall Study|Physician Decision|0
7050343|NCT01813071|11139719|FG004|Overall Study|Physician Decision|0
7050344|NCT01813071|11139720|FG005|Overall Study|Physician Decision|0
7050345|NCT01813071|11139721|FG006|Overall Study|Physician Decision|1
7050346|NCT01813071|11139722|FG007|Overall Study|Physician Decision|0
7050347|NCT01813071|11139723|FG008|Overall Study|Physician Decision|0
7050348|NCT01813071|11139715|FG000|Overall Study|Met inc/exc criteria|0
7050349|NCT01813071|11139716|FG001|Overall Study|Met inc/exc criteria|0
7050350|NCT01813071|11139717|FG002|Overall Study|Met inc/exc criteria|0
7050351|NCT01813071|11139718|FG003|Overall Study|Met inc/exc criteria|0
7050352|NCT01813071|11139719|FG004|Overall Study|Met inc/exc criteria|0
7050353|NCT01813071|11139720|FG005|Overall Study|Met inc/exc criteria|1
7050354|NCT01813071|11139721|FG006|Overall Study|Met inc/exc criteria|0
7050355|NCT01813071|11139722|FG007|Overall Study|Met inc/exc criteria|1
7189944|NCT02871778|11390529|FG005|Part B: Treatment Period 3|Adverse Event|1
7189945|NCT02871778|11390530|FG006|Part B: Treatment Period 3|Adverse Event|1
7050356|NCT01813071|11139723|FG008|Overall Study|Met inc/exc criteria|1
7050357|NCT01813357|11139790|FG000|Overall Study|Lost to Follow-up|5
7050358|NCT01813357|11139791|FG001|Overall Study|Lost to Follow-up|6
7189946|NCT02871778|11390531|FG007|Part B: Treatment Period 3|Adverse Event|0
7189947|NCT02756208|11390564|FG000|Overall Study|Withdrawal by Subject|1
7189948|NCT02756208|11390565|FG001|Overall Study|Withdrawal by Subject|0
7189949|NCT02756208|11390566|FG002|Overall Study|Withdrawal by Subject|1
7189950|NCT02756208|11390567|FG003|Overall Study|Withdrawal by Subject|3
7189951|NCT02756208|11390564|FG000|Overall Study|Lost to Follow-up|3
7189952|NCT02756208|11390565|FG001|Overall Study|Lost to Follow-up|1
7189953|NCT02756208|11390566|FG002|Overall Study|Lost to Follow-up|1
7189954|NCT02756208|11390567|FG003|Overall Study|Lost to Follow-up|1
7189955|NCT02756208|11390564|FG000|Overall Study|Physician Decision|1
7189956|NCT02756208|11390565|FG001|Overall Study|Physician Decision|0
7189957|NCT02756208|11390566|FG002|Overall Study|Physician Decision|0
7189958|NCT02756208|11390567|FG003|Overall Study|Physician Decision|0
7189959|NCT02756208|11390564|FG000|Overall Study|Protocol Violation|0
7189960|NCT02756208|11390565|FG001|Overall Study|Protocol Violation|1
7189961|NCT02756208|11390566|FG002|Overall Study|Protocol Violation|0
7189962|NCT02756208|11390567|FG003|Overall Study|Protocol Violation|0
7050359|NCT01813422|11139799|FG000|Overall Study|Withdrawal by Subject|14
7050360|NCT01813422|11139800|FG001|Overall Study|Withdrawal by Subject|8
7050361|NCT01813422|11139799|FG000|Overall Study|Death|2
7050362|NCT01813422|11139800|FG001|Overall Study|Death|3
7050363|NCT01813422|11139799|FG000|Overall Study|Sponsor Decision|2
7050364|NCT01813422|11139800|FG001|Overall Study|Sponsor Decision|1
7050365|NCT01813422|11139799|FG000|Overall Study|Lost to Follow-up|2
7050366|NCT01813422|11139800|FG001|Overall Study|Lost to Follow-up|4
7050367|NCT01813474|11139809|FG000|Overall Study|Withdrawal by Subject|0
7050368|NCT01813474|11139810|FG001|Overall Study|Withdrawal by Subject|0
7050369|NCT01813474|11139811|FG002|Overall Study|Withdrawal by Subject|1
7050370|NCT01813474|11139809|FG000|Overall Study|Adverse Event|1
7050371|NCT01813474|11139810|FG001|Overall Study|Adverse Event|1
7050372|NCT01813474|11139811|FG002|Overall Study|Adverse Event|0
7050373|NCT01813474|11139809|FG000|Overall Study|Lack of Efficacy|2
7050374|NCT01813474|11139810|FG001|Overall Study|Lack of Efficacy|6
7050375|NCT01813474|11139811|FG002|Overall Study|Lack of Efficacy|9
7050376|NCT01813474|11139809|FG000|Overall Study|Death|0
7050377|NCT01813474|11139810|FG001|Overall Study|Death|0
7050378|NCT01813474|11139811|FG002|Overall Study|Death|1
7083855|NCT02158884|11195489|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6
7083856|NCT02158884|11195489|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10
7083857|NCT02158884|11195489|FG000|6 Month Assessment|Missed SMFA|20
7083858|NCT02158884|11195489|FG000|12 Month Assessment|Missed SMFA|17
7083859|NCT02158936|11195496|FG000|Overall Study|Study closed/ terminated|57
7083860|NCT02158936|11195497|FG001|Overall Study|Study closed/ terminated|77
7083861|NCT02158936|11195496|FG000|Overall Study|Azacitidine tx discontinued|53
7189963|NCT02149121|11390584|FG000|Main Study Period|Lack of Efficacy|2
7189964|NCT02149121|11390585|FG001|Main Study Period|Lack of Efficacy|2
7189965|NCT02149121|11390586|FG002|Main Study Period|Lack of Efficacy|1
7083862|NCT02158936|11195497|FG001|Overall Study|Azacitidine tx discontinued|46
7083863|NCT02158936|11195496|FG000|Overall Study|Adverse Event|39
7083864|NCT02158936|11195497|FG001|Overall Study|Adverse Event|24
7189966|NCT02149121|11390587|FG003|Main Study Period|Lack of Efficacy|0
7083865|NCT02158936|11195496|FG000|Overall Study|Withdrawal by Subject|15
7189967|NCT02149121|11390588|FG004|Main Study Period|Lack of Efficacy|0
7189968|NCT02149121|11390589|FG005|Main Study Period|Lack of Efficacy|0
7189969|NCT02149121|11390590|FG006|Main Study Period|Lack of Efficacy|0
7189970|NCT02149121|11390584|FG000|Main Study Period|Withdrawal by Subject|9
7189971|NCT02149121|11390585|FG001|Main Study Period|Withdrawal by Subject|5
7189972|NCT02149121|11390586|FG002|Main Study Period|Withdrawal by Subject|1
7189973|NCT02149121|11390587|FG003|Main Study Period|Withdrawal by Subject|0
7189974|NCT02149121|11390588|FG004|Main Study Period|Withdrawal by Subject|0
7189975|NCT02149121|11390589|FG005|Main Study Period|Withdrawal by Subject|0
7189976|NCT02149121|11390590|FG006|Main Study Period|Withdrawal by Subject|0
7189977|NCT02149121|11390584|FG000|Main Study Period|Adverse Event|2
7189978|NCT02149121|11390585|FG001|Main Study Period|Adverse Event|5
7189979|NCT02149121|11390586|FG002|Main Study Period|Adverse Event|1
7189980|NCT02149121|11390587|FG003|Main Study Period|Adverse Event|0
7189981|NCT02149121|11390588|FG004|Main Study Period|Adverse Event|0
6804182|NCT03920293|10806129|FG001|Overall Study|Adverse Event|2
6804183|NCT03920293|10806128|FG000|Overall Study|Sponsor Decision|0
6804184|NCT03920293|10806129|FG001|Overall Study|Sponsor Decision|1
6804185|NCT03920293|10806128|FG000|Overall Study|Death|2
6804186|NCT03920293|10806129|FG001|Overall Study|Death|0
6804187|NCT03920293|10806128|FG000|Overall Study|Protocol Violation|1
6804188|NCT03920293|10806129|FG001|Overall Study|Protocol Violation|0
6804189|NCT03920293|10806128|FG000|Overall Study|Noncompliance|1
6804190|NCT03920293|10806129|FG001|Overall Study|Noncompliance|0
6804191|NCT03712345|10806155|FG000|Overall Study|Failure to meet randomization criteria|0
6804192|NCT03712345|10806156|FG001|Overall Study|Failure to meet randomization criteria|0
6804193|NCT03712345|10806157|FG002|Overall Study|Failure to meet randomization criteria|1
6804194|NCT03694275|10806167|FG000|Overall Study|Adverse Event|0
6804195|NCT03694275|10806168|FG001|Overall Study|Adverse Event|1
6804196|NCT03694275|10806167|FG000|Overall Study|Reason not Specified|0
6804197|NCT03694275|10806168|FG001|Overall Study|Reason not Specified|1
6810181|NCT01090024|10814007|FG000|Period 3|Withdrawal by Subject|0
6810182|NCT01090024|10814008|FG001|Period 3|Withdrawal by Subject|0
6810183|NCT01090024|10814009|FG002|Period 3|Withdrawal by Subject|0
6810184|NCT01090024|10814010|FG003|Period 3|Withdrawal by Subject|0
6810185|NCT01090024|10814011|FG004|Period 3|Withdrawal by Subject|0
6810186|NCT01090024|10814012|FG005|Period 3|Withdrawal by Subject|0
6810187|NCT01090024|10814013|FG006|Period 3|Withdrawal by Subject|0
6810188|NCT01090024|10814014|FG007|Period 3|Withdrawal by Subject|0
6810189|NCT01090024|10814015|FG008|Period 3|Withdrawal by Subject|0
6810190|NCT01090024|10814016|FG009|Period 3|Withdrawal by Subject|0
6810191|NCT01090024|10814017|FG010|Period 3|Withdrawal by Subject|0
6810192|NCT01090024|10814018|FG011|Period 3|Withdrawal by Subject|0
6810193|NCT01090024|10814019|FG012|Period 3|Withdrawal by Subject|0
6810194|NCT01090024|10814020|FG013|Period 3|Withdrawal by Subject|0
6810195|NCT01090024|10814021|FG014|Period 3|Withdrawal by Subject|0
6810196|NCT01090024|10814022|FG015|Period 3|Withdrawal by Subject|1
6810197|NCT01090024|10814023|FG016|Period 3|Withdrawal by Subject|0
6810198|NCT01090024|10814024|FG017|Period 3|Withdrawal by Subject|0
6810199|NCT01090024|10814007|FG000|Period 3|Protocol Violation|0
7189982|NCT02149121|11390589|FG005|Main Study Period|Adverse Event|0
7189983|NCT02149121|11390590|FG006|Main Study Period|Adverse Event|0
6810200|NCT01090024|10814008|FG001|Period 3|Protocol Violation|0
7189984|NCT02149121|11390584|FG000|Main Study Period|Protocol Violation|2
7189985|NCT02149121|11390585|FG001|Main Study Period|Protocol Violation|0
7189986|NCT02149121|11390586|FG002|Main Study Period|Protocol Violation|0
7189987|NCT02149121|11390587|FG003|Main Study Period|Protocol Violation|0
7189988|NCT02149121|11390588|FG004|Main Study Period|Protocol Violation|0
7189989|NCT02149121|11390589|FG005|Main Study Period|Protocol Violation|0
7189990|NCT02149121|11390590|FG006|Main Study Period|Protocol Violation|0
7189991|NCT02149121|11390584|FG000|Main Study Period|Lost to Follow-up|2
7189992|NCT02149121|11390585|FG001|Main Study Period|Lost to Follow-up|1
7189993|NCT02149121|11390586|FG002|Main Study Period|Lost to Follow-up|0
7189994|NCT02149121|11390587|FG003|Main Study Period|Lost to Follow-up|0
7189995|NCT02149121|11390588|FG004|Main Study Period|Lost to Follow-up|0
7189996|NCT02149121|11390589|FG005|Main Study Period|Lost to Follow-up|0
7189997|NCT02149121|11390590|FG006|Main Study Period|Lost to Follow-up|0
7083866|NCT02158936|11195497|FG001|Overall Study|Withdrawal by Subject|16
7189998|NCT02149121|11390584|FG000|Main Study Period|Death|1
7189999|NCT02149121|11390585|FG001|Main Study Period|Death|0
7190000|NCT02149121|11390586|FG002|Main Study Period|Death|0
7190001|NCT02149121|11390587|FG003|Main Study Period|Death|0
7190002|NCT02149121|11390588|FG004|Main Study Period|Death|0
7190003|NCT02149121|11390589|FG005|Main Study Period|Death|0
7190004|NCT02149121|11390590|FG006|Main Study Period|Death|0
7083867|NCT02158936|11195496|FG000|Overall Study|Physician Decision|15
7190005|NCT02149121|11390584|FG000|Main Study Period|Physician Decision|1
7190006|NCT02149121|11390585|FG001|Main Study Period|Physician Decision|0
7190007|NCT02149121|11390586|FG002|Main Study Period|Physician Decision|0
7190008|NCT02149121|11390587|FG003|Main Study Period|Physician Decision|0
7190009|NCT02149121|11390588|FG004|Main Study Period|Physician Decision|0
7190010|NCT02149121|11390589|FG005|Main Study Period|Physician Decision|0
7190011|NCT02149121|11390590|FG006|Main Study Period|Physician Decision|0
7190012|NCT02149121|11390584|FG000|Main Study Period|Developed any malignancy|0
7190013|NCT02149121|11390585|FG001|Main Study Period|Developed any malignancy|1
7190014|NCT02149121|11390586|FG002|Main Study Period|Developed any malignancy|1
7190015|NCT02149121|11390587|FG003|Main Study Period|Developed any malignancy|0
7190016|NCT02149121|11390588|FG004|Main Study Period|Developed any malignancy|0
7190017|NCT02149121|11390589|FG005|Main Study Period|Developed any malignancy|0
7190018|NCT02149121|11390590|FG006|Main Study Period|Developed any malignancy|0
7190019|NCT02149121|11390584|FG000|Main Study Period|Unmet predefined eligibility criteria|2
7190020|NCT02149121|11390585|FG001|Main Study Period|Unmet predefined eligibility criteria|2
7190021|NCT02149121|11390586|FG002|Main Study Period|Unmet predefined eligibility criteria|0
7190022|NCT02149121|11390587|FG003|Main Study Period|Unmet predefined eligibility criteria|0
7190023|NCT02149121|11390588|FG004|Main Study Period|Unmet predefined eligibility criteria|0
7190024|NCT02149121|11390589|FG005|Main Study Period|Unmet predefined eligibility criteria|0
7190025|NCT02149121|11390590|FG006|Main Study Period|Unmet predefined eligibility criteria|0
7190026|NCT02149121|11390584|FG000|Main Study Period|Disease progression|0
7190027|NCT02149121|11390585|FG001|Main Study Period|Disease progression|1
7190028|NCT02149121|11390586|FG002|Main Study Period|Disease progression|0
7190029|NCT02149121|11390587|FG003|Main Study Period|Disease progression|0
7190030|NCT02149121|11390588|FG004|Main Study Period|Disease progression|0
7190031|NCT02149121|11390589|FG005|Main Study Period|Disease progression|0
7190032|NCT02149121|11390590|FG006|Main Study Period|Disease progression|0
7190033|NCT02149121|11390584|FG000|Extension Study Period|Withdrawal by Subject|0
7190034|NCT02149121|11390585|FG001|Extension Study Period|Withdrawal by Subject|0
7190035|NCT02149121|11390586|FG002|Extension Study Period|Withdrawal by Subject|0
7190036|NCT02149121|11390587|FG003|Extension Study Period|Withdrawal by Subject|1
7190037|NCT02149121|11390588|FG004|Extension Study Period|Withdrawal by Subject|0
7190038|NCT02149121|11390589|FG005|Extension Study Period|Withdrawal by Subject|2
7190039|NCT02149121|11390590|FG006|Extension Study Period|Withdrawal by Subject|0
7190040|NCT01889186|11390613|FG000|Overall Study|Adverse event- not related to progression|18
7190041|NCT01889186|11390614|FG001|Overall Study|Adverse event- not related to progression|5
7190042|NCT01889186|11390613|FG000|Overall Study|Adverse event- related to progression|7
7190043|NCT01889186|11390614|FG001|Overall Study|Adverse event- related to progression|2
7190044|NCT01889186|11390613|FG000|Overall Study|COVID-19 logistical restrictions|1
7190045|NCT01889186|11390614|FG001|Overall Study|COVID-19 logistical restrictions|0
7190046|NCT01889186|11390613|FG000|Overall Study|Investigator request|1
7190047|NCT01889186|11390614|FG001|Overall Study|Investigator request|1
7190048|NCT01889186|11390613|FG000|Overall Study|Progressive disease- Richter's|12
7190049|NCT01889186|11390614|FG001|Overall Study|Progressive disease- Richter's|7
7190050|NCT01889186|11390613|FG000|Overall Study|Progressive disease per protocol|46
7190051|NCT01889186|11390614|FG001|Overall Study|Progressive disease per protocol|17
7190052|NCT01889186|11390613|FG000|Overall Study|Stem cell transplant|2
7190053|NCT01889186|11390614|FG001|Overall Study|Stem cell transplant|1
7190054|NCT01889186|11390613|FG000|Overall Study|Withdrew consent|2
7190055|NCT01889186|11390614|FG001|Overall Study|Withdrew consent|3
7190056|NCT01889186|11390613|FG000|Overall Study|Other, not specified|18
7190057|NCT01889186|11390614|FG001|Overall Study|Other, not specified|15
7190058|NCT01850004|11390622|FG000|Overall Study|Subject Moved|1
7083868|NCT02158936|11195497|FG001|Overall Study|Physician Decision|13
7190059|NCT01850004|11390622|FG000|Overall Study|Poor/Non-compliance|1
7190060|NCT01850004|11390622|FG000|Overall Study|Subject Withdrew Consent|4
7190061|NCT01850004|11390622|FG000|Overall Study|Subject Request to Discontinue Treatment|1
7190062|NCT01850004|11390622|FG000|Overall Study|AE Unrelated to Study Drug|1
7190063|NCT01510184|11390629|FG000|Overall Study|Sponsor discretion|28
7190064|NCT01510184|11390630|FG001|Overall Study|Sponsor discretion|28
7190065|NCT01510184|11390629|FG000|Overall Study|Death|1
7190066|NCT01510184|11390630|FG001|Overall Study|Death|2
7190067|NCT01510184|11390629|FG000|Overall Study|Withdrawal by Subject|1
7190068|NCT01510184|11390630|FG001|Overall Study|Withdrawal by Subject|4
7190069|NCT01510184|11390629|FG000|Overall Study|Other|0
7190070|NCT01510184|11390630|FG001|Overall Study|Other|1
7190071|NCT01471444|11390638|FG000|Overall Study|Physician Decision|3
7190072|NCT01471444|11390639|FG001|Overall Study|Physician Decision|2
7190073|NCT01471444|11390638|FG000|Overall Study|Withdrawal by Subject|0
7190074|NCT01471444|11390639|FG001|Overall Study|Withdrawal by Subject|1
7050379|NCT01813721|11139820|FG000|Overall Study|Ineligibility determined|63
7050380|NCT01813721|11139820|FG000|Overall Study|Withdrawal by Subject|1
7050381|NCT01813890|11139849|FG000|Overall Study|Adverse Event|0
7050382|NCT01813890|11139850|FG001|Overall Study|Adverse Event|3
7050383|NCT01813890|11139851|FG002|Overall Study|Adverse Event|4
7050384|NCT01813890|11139849|FG000|Overall Study|Lack of Efficacy|9
7050385|NCT01813890|11139850|FG001|Overall Study|Lack of Efficacy|1
7050386|NCT01813890|11139851|FG002|Overall Study|Lack of Efficacy|2
7050387|NCT01814007|11139859|FG000|Overall Study|Withdrawal by Subject|1
7050388|NCT01814046|11139866|FG000|Drug Administration|Death due to complications of RSV|1
7050389|NCT01814046|11139867|FG001|Drug Administration|Death due to complications of RSV|0
7050390|NCT01814046|11139868|FG002|Drug Administration|Death due to complications of RSV|0
7050391|NCT01814072|11139907|FG000|Overall Study|Lost to Follow-up|2
7190075|NCT03745651|11390690|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1
7190076|NCT03745651|11390691|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1
7190077|NCT03745651|11390692|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
7190078|NCT03745651|11390693|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
7190079|NCT03745651|11390694|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
7190080|NCT03745651|11390695|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
7190081|NCT03745651|11390696|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
7190082|NCT03745651|11390690|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3
7190083|NCT03745651|11390691|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13
7190084|NCT03745651|11390692|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4
7190085|NCT03745651|11390693|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
7190086|NCT03745651|11390694|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
7190087|NCT03745651|11390695|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
7190088|NCT03745651|11390696|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
7083869|NCT02158936|11195496|FG000|Overall Study|Lost to Follow-up|0
7083870|NCT02158936|11195497|FG001|Overall Study|Lost to Follow-up|1
7190089|NCT03745651|11390690|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3
7190090|NCT03745651|11390691|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
7190091|NCT03745651|11390692|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1
7190092|NCT03745651|11390693|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
7190093|NCT03745651|11390694|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
7190094|NCT03745651|11390695|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
7190095|NCT03745651|11390696|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
7190096|NCT03745651|11390690|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
7190097|NCT03745651|11390691|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2
7190098|NCT03745651|11390692|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
7190099|NCT03745651|11390693|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
7190100|NCT03745651|11390694|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
7190101|NCT03745651|11390695|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
7190102|NCT03745651|11390696|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
7190103|NCT03745651|11390690|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11
7190104|NCT03745651|11390691|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21
7190105|NCT03745651|11390692|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15
7190106|NCT03745651|11390693|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
7190107|NCT03745651|11390694|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
7190108|NCT03745651|11390695|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
7190109|NCT03745651|11390696|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
7190110|NCT03745651|11390690|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1
7190111|NCT03745651|11390691|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2
7190112|NCT03745651|11390692|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2
7190113|NCT03745651|11390693|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0
7190114|NCT03745651|11390694|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0
7190115|NCT03745651|11390695|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0
7190116|NCT03745651|11390696|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0
7190117|NCT03745651|11390690|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
7190118|NCT03745651|11390691|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
7190119|NCT03745651|11390692|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
7190120|NCT03745651|11390693|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
7190121|NCT03745651|11390694|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
7190122|NCT03745651|11390695|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4
7190123|NCT03745651|11390696|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
7190124|NCT03745651|11390690|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
7190125|NCT03745651|11390691|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
7190126|NCT03745651|11390692|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
7190127|NCT03745651|11390693|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1
7190128|NCT03745651|11390694|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
7190129|NCT03745651|11390695|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4
7190130|NCT03745651|11390696|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4
7190131|NCT03745651|11390690|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0
7190132|NCT03745651|11390691|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0
7083871|NCT02158949|11195505|FG000|Overall Study|Withdrawal by Subject|1
7083872|NCT02158949|11195506|FG001|Overall Study|Withdrawal by Subject|0
7083873|NCT02158949|11195505|FG000|Overall Study|Lost to Follow-up|5
7083874|NCT02158949|11195506|FG001|Overall Study|Lost to Follow-up|11
7083875|NCT02158975|11195512|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1
7083876|NCT02159053|11195520|FG000|Overall Study|Death|2
7083877|NCT02159053|11195521|FG001|Overall Study|Death|0
7083878|NCT02159053|11195522|FG002|Overall Study|Death|1
7083879|NCT02159053|11195520|FG000|Overall Study|Physician Decision|0
7083880|NCT02159053|11195521|FG001|Overall Study|Physician Decision|1
7083881|NCT02159053|11195522|FG002|Overall Study|Physician Decision|1
7083882|NCT02159053|11195520|FG000|Overall Study|Lack of Efficacy|3
7083883|NCT02159053|11195521|FG001|Overall Study|Lack of Efficacy|4
7190133|NCT03745651|11390692|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0
7190134|NCT03745651|11390693|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4
7190135|NCT03745651|11390694|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2
7190136|NCT03745651|11390695|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13
7190137|NCT03745651|11390696|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10
7050392|NCT01814072|11139908|FG001|Overall Study|Lost to Follow-up|2
7050393|NCT01814072|11139909|FG002|Overall Study|Lost to Follow-up|2
7050394|NCT01814072|11139910|FG003|Overall Study|Lost to Follow-up|0
7050395|NCT01814072|11139911|FG004|Overall Study|Lost to Follow-up|2
7050396|NCT01814072|11139912|FG005|Overall Study|Lost to Follow-up|3
7050397|NCT01814072|11139913|FG006|Overall Study|Lost to Follow-up|3
7050398|NCT01814072|11139914|FG007|Overall Study|Lost to Follow-up|1
7050399|NCT01814072|11139915|FG008|Overall Study|Lost to Follow-up|2
7050400|NCT01814072|11139916|FG009|Overall Study|Lost to Follow-up|3
7190138|NCT03745651|11390690|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
7190139|NCT03745651|11390691|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
7190140|NCT03745651|11390692|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
7190141|NCT03745651|11390693|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1
7190142|NCT03745651|11390694|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
7190143|NCT03745651|11390695|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4
7190144|NCT03745651|11390696|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2
7190145|NCT03745651|11390690|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0
7190146|NCT03745651|11390691|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0
7190147|NCT03745651|11390692|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0
7190148|NCT03745651|11390693|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1
7190149|NCT03745651|11390694|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0
7190150|NCT03745651|11390695|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0
7190151|NCT03745651|11390696|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1
7190152|NCT03745651|11390690|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
7190153|NCT03745651|11390691|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
7190154|NCT03745651|11390692|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
7190155|NCT03745651|11390693|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
7083884|NCT02159053|11195522|FG002|Overall Study|Lack of Efficacy|7
7190156|NCT03745651|11390694|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
7190157|NCT03745651|11390695|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1
7190158|NCT03745651|11390696|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
7190159|NCT03745651|11390690|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0
7190160|NCT03745651|11390691|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0
7190161|NCT03745651|11390692|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0
7190162|NCT03745651|11390693|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12
7190163|NCT03745651|11390694|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8
7190164|NCT03745651|11390695|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26
7190165|NCT03745651|11390696|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34
7190166|NCT03745651|11390690|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0
7190167|NCT03745651|11390691|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0
7190168|NCT03745651|11390692|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0
7190169|NCT03745651|11390693|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1
7190170|NCT03745651|11390694|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1
7190171|NCT03745651|11390695|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1
7050401|NCT01814072|11139917|FG010|Overall Study|Lost to Follow-up|1
7050402|NCT01814072|11139918|FG011|Overall Study|Lost to Follow-up|2
7050403|NCT01814072|11139919|FG012|Overall Study|Lost to Follow-up|2
7190172|NCT03745651|11390696|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0
7190173|NCT03745638|11390715|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4
7190174|NCT03745638|11390716|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2
7190175|NCT03745638|11390717|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1
7050404|NCT01814072|11139920|FG013|Overall Study|Lost to Follow-up|1
7050405|NCT01814072|11139921|FG014|Overall Study|Lost to Follow-up|2
7050406|NCT01814072|11139922|FG015|Overall Study|Lost to Follow-up|1
7050407|NCT01814072|11139923|FG016|Overall Study|Lost to Follow-up|3
7050408|NCT01814072|11139924|FG017|Overall Study|Lost to Follow-up|1
7050409|NCT01814072|11139925|FG018|Overall Study|Lost to Follow-up|3
7050410|NCT01814072|11139926|FG019|Overall Study|Lost to Follow-up|3
7050411|NCT01814072|11139927|FG020|Overall Study|Lost to Follow-up|2
7050412|NCT01814072|11139928|FG021|Overall Study|Lost to Follow-up|1
7050413|NCT01814072|11139929|FG022|Overall Study|Lost to Follow-up|3
7050414|NCT01814072|11139930|FG023|Overall Study|Lost to Follow-up|1
7050415|NCT01814072|11139931|FG024|Overall Study|Lost to Follow-up|4
7050416|NCT01814072|11139932|FG025|Overall Study|Lost to Follow-up|1
7050417|NCT01814072|11139933|FG026|Overall Study|Lost to Follow-up|1
7050418|NCT01814072|11139934|FG027|Overall Study|Lost to Follow-up|2
7190176|NCT03745638|11390718|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
7190177|NCT03745638|11390719|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
7190178|NCT03745638|11390720|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
7190179|NCT03745638|11390721|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
7190180|NCT03745638|11390715|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1
7190181|NCT03745638|11390716|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0
7190182|NCT03745638|11390717|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0
7190183|NCT03745638|11390718|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0
7190184|NCT03745638|11390719|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0
7190185|NCT03745638|11390720|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0
7190186|NCT03745638|11390721|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0
7190187|NCT03745638|11390715|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5
7190188|NCT03745638|11390716|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12
7190189|NCT03745638|11390717|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8
7190190|NCT03745638|11390718|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
7190191|NCT03745638|11390719|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
7190192|NCT03745638|11390720|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
7190193|NCT03745638|11390721|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
7190194|NCT03745638|11390715|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1
7190195|NCT03745638|11390716|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1
7190196|NCT03745638|11390717|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
7190197|NCT03745638|11390718|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
7190198|NCT03745638|11390719|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
7190199|NCT03745638|11390720|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
7190200|NCT03745638|11390721|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
7190201|NCT03745638|11390715|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1
7190202|NCT03745638|11390716|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0
7190203|NCT03745638|11390717|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0
7190204|NCT03745638|11390718|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0
7190205|NCT03745638|11390719|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0
7190206|NCT03745638|11390720|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0
7190207|NCT03745638|11390721|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0
7190208|NCT03745638|11390715|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
7190209|NCT03745638|11390716|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3
7190210|NCT03745638|11390717|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
7190211|NCT03745638|11390718|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
7190212|NCT03745638|11390719|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
7190213|NCT03745638|11390720|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
7190214|NCT03745638|11390721|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
7190215|NCT03745638|11390715|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17
7190216|NCT03745638|11390716|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11
7190217|NCT03745638|11390717|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19
7190218|NCT03745638|11390718|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
7190219|NCT03745638|11390719|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
7190220|NCT03745638|11390720|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
7190221|NCT03745638|11390721|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
7190222|NCT03745638|11390715|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2
7190223|NCT03745638|11390716|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1
7190224|NCT03745638|11390717|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0
7190225|NCT03745638|11390718|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0
7190226|NCT03745638|11390719|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0
7190227|NCT03745638|11390720|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0
7190228|NCT03745638|11390721|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0
7190229|NCT03745638|11390715|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
7190230|NCT03745638|11390716|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
7190231|NCT03745638|11390717|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
7190232|NCT03745638|11390718|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
7190233|NCT03745638|11390719|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
7190234|NCT03745638|11390720|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6
7190235|NCT03745638|11390721|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1
7190236|NCT03745638|11390715|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
7190237|NCT03745638|11390716|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
7190238|NCT03745638|11390717|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
7190239|NCT03745638|11390718|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1
7190240|NCT03745638|11390719|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
7190241|NCT03745638|11390720|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2
7190242|NCT03745638|11390721|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2
7190243|NCT03745638|11390715|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0
7190244|NCT03745638|11390716|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0
7190245|NCT03745638|11390717|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0
7190246|NCT03745638|11390718|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3
7190247|NCT03745638|11390719|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5
7190248|NCT03745638|11390720|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13
7190249|NCT03745638|11390721|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24
7190250|NCT03745638|11390715|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
7190251|NCT03745638|11390716|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
7050419|NCT01814072|11139935|FG028|Overall Study|Lost to Follow-up|3
7050420|NCT01814072|11139936|FG029|Overall Study|Lost to Follow-up|3
7050421|NCT01814072|11139937|FG030|Overall Study|Lost to Follow-up|2
7050422|NCT01814072|11139938|FG031|Overall Study|Lost to Follow-up|0
7050423|NCT01814072|11139907|FG000|Overall Study|Withdrawal by Subject|2
7050424|NCT01814072|11139908|FG001|Overall Study|Withdrawal by Subject|0
7050425|NCT01814072|11139909|FG002|Overall Study|Withdrawal by Subject|1
7083885|NCT02159053|11195520|FG000|Overall Study|Adverse Event|7
7083886|NCT02159053|11195521|FG001|Overall Study|Adverse Event|6
7083887|NCT02159053|11195522|FG002|Overall Study|Adverse Event|5
7083888|NCT02159053|11195520|FG000|Overall Study|Participants/guardian decision|8
7083889|NCT02159053|11195521|FG001|Overall Study|Participants/guardian decision|10
7083890|NCT02159053|11195522|FG002|Overall Study|Participants/guardian decision|6
7083891|NCT02159183|11195552|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2
7083892|NCT02159183|11195553|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1
7083893|NCT02159183|11195552|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1
7083894|NCT02159183|11195553|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0
7083895|NCT02159183|11195552|FG000|Analysis After the 36 Months Follow-up|Death|0
7083896|NCT02159183|11195553|FG001|Analysis After the 36 Months Follow-up|Death|1
7083897|NCT02159183|11195552|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1
7083898|NCT02159183|11195553|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0
7083899|NCT02159183|11195552|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2
7083900|NCT02159183|11195553|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1
7083901|NCT02159352|11195561|FG000|Overall Study|Adverse Event|3
7083902|NCT02159352|11195562|FG001|Overall Study|Adverse Event|1
7083903|NCT02159352|11195561|FG000|Overall Study|Withdrawal by Subject|0
7083904|NCT02159352|11195562|FG001|Overall Study|Withdrawal by Subject|1
7083905|NCT02159365|11195587|FG000|Overall Study|Disease Progression|23
7083906|NCT02159365|11195587|FG000|Overall Study|Other reasons|11
7083907|NCT02159365|11195587|FG000|Overall Study|Administrative reason by Sponsor|9
7190252|NCT03745638|11390717|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
7190253|NCT03745638|11390718|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
7190254|NCT03745638|11390719|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1
7190255|NCT03745638|11390720|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3
7190256|NCT03745638|11390721|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
7190257|NCT03745638|11390715|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
7190258|NCT03745638|11390716|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
7190259|NCT03745638|11390717|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
7190260|NCT03745638|11390718|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
7190261|NCT03745638|11390719|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
7190262|NCT03745638|11390720|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1
7190263|NCT03745638|11390721|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
7190264|NCT03745638|11390715|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0
7190265|NCT03745638|11390716|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0
7190266|NCT03745638|11390717|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0
7190267|NCT03745638|11390718|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7
7190268|NCT03745638|11390719|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3
7190269|NCT03745638|11390720|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17
7190270|NCT03745638|11390721|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21
7190271|NCT03745638|11390715|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0
7190272|NCT03745638|11390716|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0
7190273|NCT03745638|11390717|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0
7190274|NCT03745638|11390718|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0
7190275|NCT03745638|11390719|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0
7190276|NCT03745638|11390720|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4
7050426|NCT01814072|11139910|FG003|Overall Study|Withdrawal by Subject|0
7050427|NCT01814072|11139911|FG004|Overall Study|Withdrawal by Subject|2
7083908|NCT02159365|11195587|FG000|Overall Study|Adverse Event unrelated to study drug|9
7083909|NCT02159365|11195587|FG000|Overall Study|Study drug toxicity|7
7050428|NCT01814072|11139912|FG005|Overall Study|Withdrawal by Subject|3
7083910|NCT02159365|11195587|FG000|Overall Study|Maximum clinical benefit|3
7083911|NCT02159365|11195587|FG000|Overall Study|Subject request to discontinue treatment|3
7083912|NCT02159365|11195587|FG000|Overall Study|Subject withdrew consent|3
7083913|NCT02159365|11195587|FG000|Overall Study|Death|1
7083914|NCT02159365|11195587|FG000|Overall Study|Lost to Follow-up|1
7083915|NCT02159469|11195591|FG000|Overall Study|Missing Completion status|1
7083916|NCT02159469|11195591|FG000|Overall Study|Adverse Event|5
7083917|NCT02159469|11195591|FG000|Overall Study|Non-compliance|2
7083918|NCT02159469|11195591|FG000|Overall Study|Withdrawal by Subject|9
7083919|NCT02159469|11195591|FG000|Overall Study|Lost to Follow-up|1
7083920|NCT02159469|11195591|FG000|Overall Study|Sponsor's request|2
7083921|NCT02159469|11195591|FG000|Overall Study|Met Stopping Criteria|3
7083922|NCT02159469|11195591|FG000|Overall Study|Other|1
7083923|NCT02159469|11195591|FG000|Overall Study|Multiple|29
7083924|NCT02159482|11195596|FG000|Overall Study|Withdrawal by Subject|2
7083925|NCT02159482|11195596|FG000|Overall Study|Physician Decision|3
7083926|NCT02159521|11195600|FG000|Overall Study|Enrolled but not treated|3
7083927|NCT02159521|11195600|FG000|Overall Study|Withdrawal by Subject|7
7083928|NCT02159521|11195600|FG000|Overall Study|Lost to Follow-up|6
7083929|NCT02159521|11195600|FG000|Overall Study|Death|1
7083930|NCT02159521|11195600|FG000|Overall Study|Other than specified|1
7190277|NCT03745638|11390721|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3
7190278|NCT03715764|11390740|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2
7190279|NCT03715764|11390741|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3
7190280|NCT03715764|11390740|FG000|3 Month Follow-up|Lost to Follow-up|2
7190281|NCT03715764|11390741|FG001|3 Month Follow-up|Lost to Follow-up|2
7190282|NCT03715764|11390740|FG000|3 Month Follow-up|Withdrawal by Subject|1
7190283|NCT03715764|11390741|FG001|3 Month Follow-up|Withdrawal by Subject|1
7190284|NCT03715764|11390740|FG000|6 Month Follow-up|Lost to Follow-up|3
7190285|NCT03715764|11390741|FG001|6 Month Follow-up|Lost to Follow-up|0
7190286|NCT03715764|11390740|FG000|12 Month Follow-up|Lost to Follow-up|2
7190287|NCT03715764|11390741|FG001|12 Month Follow-up|Lost to Follow-up|3
7190288|NCT03715764|11390740|FG000|12 Month Follow-up|Pregnancy|0
7190289|NCT03715764|11390741|FG001|12 Month Follow-up|Pregnancy|1
7190290|NCT03715764|11390740|FG000|12 Month Follow-up|Surgery|2
7190291|NCT03715764|11390741|FG001|12 Month Follow-up|Surgery|0
7190292|NCT03715764|11390740|FG000|12 Month Follow-up|Wrong address|1
7190293|NCT03715764|11390741|FG001|12 Month Follow-up|Wrong address|0
7190294|NCT03715764|11390740|FG000|12 Month Follow-up|No symptoms|1
7190295|NCT03715764|11390741|FG001|12 Month Follow-up|No symptoms|0
7190296|NCT03715764|11390740|FG000|12 Month Follow-up|Changed primary care centre|0
7190297|NCT03715764|11390741|FG001|12 Month Follow-up|Changed primary care centre|1
7190298|NCT03654729|11390754|FG000|Overall Study|Death|9
7190299|NCT03654729|11390755|FG001|Overall Study|Death|9
7190300|NCT03654729|11390756|FG002|Overall Study|Death|16
7190301|NCT03654729|11390754|FG000|Overall Study|Withdrawal by Subject|8
7190302|NCT03654729|11390755|FG001|Overall Study|Withdrawal by Subject|6
7190303|NCT03654729|11390756|FG002|Overall Study|Withdrawal by Subject|4
7190304|NCT03654729|11390754|FG000|Overall Study|Study terminated by Sponsor|3
7190305|NCT03654729|11390755|FG001|Overall Study|Study terminated by Sponsor|5
7190306|NCT03654729|11390756|FG002|Overall Study|Study terminated by Sponsor|4
7190307|NCT03654729|11390754|FG000|Overall Study|Not reported|2
7190308|NCT03654729|11390755|FG001|Overall Study|Not reported|4
7190309|NCT03654729|11390756|FG002|Overall Study|Not reported|5
7190310|NCT03654729|11390754|FG000|Overall Study|Progressive disease|3
7190311|NCT03654729|11390755|FG001|Overall Study|Progressive disease|0
7190312|NCT03654729|11390756|FG002|Overall Study|Progressive disease|0
7190313|NCT03654729|11390754|FG000|Overall Study|Lost to Follow-up|2
7190314|NCT03654729|11390755|FG001|Overall Study|Lost to Follow-up|0
7190315|NCT03654729|11390756|FG002|Overall Study|Lost to Follow-up|0
7190316|NCT03654729|11390754|FG000|Overall Study|Physician Decision|2
7190317|NCT03654729|11390755|FG001|Overall Study|Physician Decision|0
7190318|NCT03654729|11390756|FG002|Overall Study|Physician Decision|0
7190319|NCT03654729|11390754|FG000|Overall Study|Protocol Violation|1
7190320|NCT03654729|11390755|FG001|Overall Study|Protocol Violation|1
7190321|NCT03654729|11390756|FG002|Overall Study|Protocol Violation|0
7190322|NCT03654729|11390754|FG000|Overall Study|Non-compliance with study drug|0
7190323|NCT03654729|11390755|FG001|Overall Study|Non-compliance with study drug|1
7190324|NCT03654729|11390756|FG002|Overall Study|Non-compliance with study drug|0
7190325|NCT03654729|11390754|FG000|Overall Study|Site terminated by Sponsor|1
7190326|NCT03654729|11390755|FG001|Overall Study|Site terminated by Sponsor|0
7190327|NCT03654729|11390756|FG002|Overall Study|Site terminated by Sponsor|0
7190328|NCT02976038|11390808|FG000|Overall Study|Physician Decision|22
7190329|NCT02976038|11390808|FG000|Overall Study|Withdrawal by Subject|3
7190330|NCT02976038|11390808|FG000|Overall Study|Lost to Follow-up|2
7190331|NCT02976038|11390808|FG000|Overall Study|Adverse Event|1
7190332|NCT02631070|11390824|FG000|Overall Study|Withdrawal by Subject|35
7190333|NCT02631070|11390825|FG001|Overall Study|Withdrawal by Subject|13
7190334|NCT02631070|11390824|FG000|Overall Study|Death|45
7190335|NCT02631070|11390825|FG001|Overall Study|Death|24
7190336|NCT02631070|11390824|FG000|Overall Study|Lost to Follow-up|5
7190337|NCT02631070|11390825|FG001|Overall Study|Lost to Follow-up|1
7190338|NCT02631070|11390824|FG000|Overall Study|Transition to rollover protocol|52
7190339|NCT02631070|11390825|FG001|Overall Study|Transition to rollover protocol|21
7190340|NCT02631070|11390824|FG000|Overall Study|Other reasons|12
7190341|NCT02631070|11390825|FG001|Overall Study|Other reasons|5
7190342|NCT02281955|11390831|FG000|Overall Study|Death|1
7190343|NCT02202434|11390839|FG000|Overall Study|Death|70
7190344|NCT02202434|11390840|FG001|Overall Study|Death|39
7190345|NCT02202434|11390841|FG002|Overall Study|Death|13
7190346|NCT02202434|11390842|FG003|Overall Study|Death|27
7190347|NCT02202434|11390839|FG000|Overall Study|Lost to Follow-up|1
7190348|NCT02202434|11390840|FG001|Overall Study|Lost to Follow-up|1
7190349|NCT02202434|11390841|FG002|Overall Study|Lost to Follow-up|1
7190350|NCT02202434|11390842|FG003|Overall Study|Lost to Follow-up|0
7190351|NCT02202434|11390839|FG000|Overall Study|Physician Decision|2
7190352|NCT02202434|11390840|FG001|Overall Study|Physician Decision|3
7190353|NCT02202434|11390841|FG002|Overall Study|Physician Decision|0
7190354|NCT02202434|11390842|FG003|Overall Study|Physician Decision|0
7050429|NCT01814072|11139913|FG006|Overall Study|Withdrawal by Subject|1
7190355|NCT02202434|11390839|FG000|Overall Study|Withdrawal by Subject|13
7190356|NCT02202434|11390840|FG001|Overall Study|Withdrawal by Subject|14
7190357|NCT02202434|11390841|FG002|Overall Study|Withdrawal by Subject|1
7190358|NCT02202434|11390842|FG003|Overall Study|Withdrawal by Subject|4
7190359|NCT02202434|11390839|FG000|Overall Study|Completed Study|1
7190360|NCT02202434|11390840|FG001|Overall Study|Completed Study|0
7190361|NCT02202434|11390841|FG002|Overall Study|Completed Study|0
7190362|NCT02202434|11390842|FG003|Overall Study|Completed Study|0
7190363|NCT02202434|11390839|FG000|Overall Study|Visit Missed|21
7190364|NCT02202434|11390840|FG001|Overall Study|Visit Missed|12
7190365|NCT02202434|11390841|FG002|Overall Study|Visit Missed|0
7190366|NCT02202434|11390842|FG003|Overall Study|Visit Missed|5
7190367|NCT02202434|11390839|FG000|Overall Study|Other|1
7190368|NCT02202434|11390840|FG001|Overall Study|Other|0
7190369|NCT02202434|11390841|FG002|Overall Study|Other|0
7190370|NCT02202434|11390842|FG003|Overall Study|Other|1
7190371|NCT01230242|11390856|FG000|Overall Study|Physician Decision|2
7190372|NCT01230242|11390856|FG000|Overall Study|Withdrawal by Subject|1
7190373|NCT00983437|11390860|FG000|Overall Study|Adverse Event|9
7190374|NCT00983437|11390860|FG000|Overall Study|Lack of Efficacy|1
7190375|NCT00983437|11390860|FG000|Overall Study|Withdrawal by Subject|8
7190376|NCT00983437|11390860|FG000|Overall Study|Noncompliance to Study Procedures|1
7190377|NCT00983437|11390860|FG000|Overall Study|Lost to Follow-up|2
7190378|NCT00983437|11390860|FG000|Overall Study|Other Reason|26
6804198|NCT03391232|10806177|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0
6804199|NCT03391232|10806178|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1
6804200|NCT03391232|10806177|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0
6804201|NCT03391232|10806178|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2
6804202|NCT03323736|10806189|FG000|Overall Study|Screen Failure|14
6804203|NCT03323736|10806190|FG001|Overall Study|Screen Failure|9
7050430|NCT01814072|11139914|FG007|Overall Study|Withdrawal by Subject|0
7050431|NCT01814072|11139915|FG008|Overall Study|Withdrawal by Subject|1
7050432|NCT01814072|11139916|FG009|Overall Study|Withdrawal by Subject|2
7050433|NCT01814072|11139917|FG010|Overall Study|Withdrawal by Subject|0
7050434|NCT01814072|11139918|FG011|Overall Study|Withdrawal by Subject|0
7050435|NCT01814072|11139919|FG012|Overall Study|Withdrawal by Subject|1
7050436|NCT01814072|11139920|FG013|Overall Study|Withdrawal by Subject|1
7050437|NCT01814072|11139921|FG014|Overall Study|Withdrawal by Subject|1
7050438|NCT01814072|11139922|FG015|Overall Study|Withdrawal by Subject|1
7050439|NCT01814072|11139923|FG016|Overall Study|Withdrawal by Subject|0
7050440|NCT01814072|11139924|FG017|Overall Study|Withdrawal by Subject|0
7050441|NCT01814072|11139925|FG018|Overall Study|Withdrawal by Subject|0
7050442|NCT01814072|11139926|FG019|Overall Study|Withdrawal by Subject|2
7050443|NCT01814072|11139927|FG020|Overall Study|Withdrawal by Subject|0
7050444|NCT01814072|11139928|FG021|Overall Study|Withdrawal by Subject|0
7050445|NCT01814072|11139929|FG022|Overall Study|Withdrawal by Subject|1
7050446|NCT01814072|11139930|FG023|Overall Study|Withdrawal by Subject|0
7050447|NCT01814072|11139931|FG024|Overall Study|Withdrawal by Subject|2
7050448|NCT01814072|11139932|FG025|Overall Study|Withdrawal by Subject|1
7050449|NCT01814072|11139933|FG026|Overall Study|Withdrawal by Subject|1
7050450|NCT01814072|11139934|FG027|Overall Study|Withdrawal by Subject|2
7050451|NCT01814072|11139935|FG028|Overall Study|Withdrawal by Subject|1
7050452|NCT01814072|11139936|FG029|Overall Study|Withdrawal by Subject|0
7050453|NCT01814072|11139937|FG030|Overall Study|Withdrawal by Subject|0
7050454|NCT01814072|11139938|FG031|Overall Study|Withdrawal by Subject|0
7050455|NCT01814137|11139980|FG000|Overall Study|Adverse Event|0
7050456|NCT01814137|11139981|FG001|Overall Study|Adverse Event|1
7083931|NCT02159729|11195620|FG000|Overall Study|Adverse Event|0
7083932|NCT02159729|11195621|FG001|Overall Study|Adverse Event|1
7083933|NCT02159729|11195620|FG000|Overall Study|Subject's Request|13
7083934|NCT02159729|11195621|FG001|Overall Study|Subject's Request|10
7190379|NCT00965757|11390866|FG000|Double-blind Phase|Progression of concomitant disease|1
7190380|NCT00965757|11390867|FG001|Double-blind Phase|Progression of concomitant disease|2
7190381|NCT00965757|11390868|FG002|Double-blind Phase|Progression of concomitant disease|0
6804204|NCT03323736|10806191|FG002|Overall Study|Screen Failure|1
6804205|NCT03323736|10806189|FG000|Overall Study|Withdrawal Before Treatment|3
7050457|NCT01814137|11139980|FG000|Overall Study|Withdrawal by Subject|2
7050458|NCT01814137|11139981|FG001|Overall Study|Withdrawal by Subject|2
7050459|NCT01814137|11139980|FG000|Overall Study|Physician Decision|1
7050460|NCT01814137|11139981|FG001|Overall Study|Physician Decision|1
7050461|NCT01814137|11139980|FG000|Overall Study|Unclassified|2
7050462|NCT01814137|11139981|FG001|Overall Study|Unclassified|1
7050463|NCT01814332|11139994|FG000|Overall Study|Adverse Event|8
7050464|NCT01814332|11139995|FG001|Overall Study|Adverse Event|3
6804206|NCT03323736|10806190|FG001|Overall Study|Withdrawal Before Treatment|1
6804207|NCT03323736|10806191|FG002|Overall Study|Withdrawal Before Treatment|1
7083935|NCT02159729|11195620|FG000|Overall Study|Lost to Follow-up|24
7190382|NCT00965757|11390869|FG003|Double-blind Phase|Progression of concomitant disease|0
7083936|NCT02159729|11195621|FG001|Overall Study|Lost to Follow-up|9
7083937|NCT02159729|11195620|FG000|Overall Study|Non compliance|2
7083938|NCT02159729|11195621|FG001|Overall Study|Non compliance|0
7083939|NCT02159729|11195620|FG000|Overall Study|Other Unspecified|3
7083940|NCT02159729|11195621|FG001|Overall Study|Other Unspecified|1
7083941|NCT02159807|11195634|FG000|Overall Study|Adverse Event|0
7083942|NCT02159807|11195635|FG001|Overall Study|Adverse Event|0
7083943|NCT02159807|11195636|FG002|Overall Study|Adverse Event|1
7083944|NCT02159807|11195634|FG000|Overall Study|No CSF|1
7083945|NCT02159807|11195635|FG001|Overall Study|No CSF|1
7083946|NCT02159807|11195636|FG002|Overall Study|No CSF|1
7083947|NCT02159807|11195634|FG000|Overall Study|elevated blood pressure|0
7083948|NCT02159807|11195635|FG001|Overall Study|elevated blood pressure|0
7083949|NCT02159807|11195636|FG002|Overall Study|elevated blood pressure|1
7083950|NCT02159950|11195665|FG000|Overall Study|Adverse Event|0
7083951|NCT02159950|11195666|FG001|Overall Study|Adverse Event|1
7083952|NCT02159950|11195665|FG000|Overall Study|Progression|0
7083953|NCT02159950|11195666|FG001|Overall Study|Progression|1
7083954|NCT02160002|11195685|FG000|Overall Study|Withdrawal by Subject|2
7083955|NCT02160002|11195686|FG001|Overall Study|Withdrawal by Subject|1
7083956|NCT02160041|11195692|FG000|Overall Study|Adverse Event|11
7083957|NCT02160041|11195692|FG000|Overall Study|Death|2
7083958|NCT02160041|11195692|FG000|Overall Study|disease progression|57
7083959|NCT02160041|11195692|FG000|Overall Study|Protocol Violation|1
7083960|NCT02160041|11195692|FG000|Overall Study|non-compliance with study|1
7083961|NCT02160041|11195692|FG000|Overall Study|Physician Decision|3
7083962|NCT02160041|11195692|FG000|Overall Study|Withdrawal by Subject|8
7083963|NCT02160041|11195692|FG000|Overall Study|study terminated by by sponsor|1
7083964|NCT02160145|11195698|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23
7083965|NCT02160145|11195699|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0
7083966|NCT02160145|11195700|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0
7083967|NCT02160145|11195698|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126
7083968|NCT02160145|11195699|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0
7083969|NCT02160145|11195700|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0
7083970|NCT02160145|11195698|FG000|Randomized Double-blind Period|Subject decision|0
7190383|NCT00965757|11390866|FG000|Double-blind Phase|Adverse drug reaction|2
7190384|NCT00965757|11390867|FG001|Double-blind Phase|Adverse drug reaction|1
7190385|NCT00965757|11390868|FG002|Double-blind Phase|Adverse drug reaction|0
7190386|NCT00965757|11390869|FG003|Double-blind Phase|Adverse drug reaction|0
7190387|NCT00965757|11390866|FG000|Double-blind Phase|Abnormal Laboratory Value|2
7190388|NCT00965757|11390867|FG001|Double-blind Phase|Abnormal Laboratory Value|0
7190389|NCT00965757|11390868|FG002|Double-blind Phase|Abnormal Laboratory Value|0
7190390|NCT00965757|11390869|FG003|Double-blind Phase|Abnormal Laboratory Value|0
7190391|NCT00965757|11390866|FG000|Double-blind Phase|Lack of Efficacy|7
7190392|NCT00965757|11390867|FG001|Double-blind Phase|Lack of Efficacy|11
7190393|NCT00965757|11390868|FG002|Double-blind Phase|Lack of Efficacy|0
7190394|NCT00965757|11390869|FG003|Double-blind Phase|Lack of Efficacy|0
7190395|NCT00965757|11390866|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2
7190396|NCT00965757|11390867|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0
7190397|NCT00965757|11390868|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0
7190398|NCT00965757|11390869|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0
7190399|NCT00965757|11390866|FG000|Double-blind Phase|Lost to Follow-up|0
7190400|NCT00965757|11390867|FG001|Double-blind Phase|Lost to Follow-up|1
7190401|NCT00965757|11390868|FG002|Double-blind Phase|Lost to Follow-up|0
7190402|NCT00965757|11390869|FG003|Double-blind Phase|Lost to Follow-up|0
7190403|NCT00965757|11390866|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2
7190404|NCT00965757|11390867|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3
7190405|NCT00965757|11390868|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0
7190406|NCT00965757|11390869|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0
7190407|NCT00965757|11390866|FG000|Double-blind Phase|Other|1
7190408|NCT00965757|11390867|FG001|Double-blind Phase|Other|0
7190409|NCT00965757|11390868|FG002|Double-blind Phase|Other|0
7190410|NCT00965757|11390869|FG003|Double-blind Phase|Other|0
7190411|NCT00965757|11390866|FG000|Extension Phase|Progression of concomitant disease|0
7190412|NCT00965757|11390867|FG001|Extension Phase|Progression of concomitant disease|0
7190413|NCT00965757|11390868|FG002|Extension Phase|Progression of concomitant disease|4
7190414|NCT00965757|11390869|FG003|Extension Phase|Progression of concomitant disease|2
7190415|NCT00965757|11390866|FG000|Extension Phase|Adverse drug reaction|0
7190416|NCT00965757|11390867|FG001|Extension Phase|Adverse drug reaction|0
7190417|NCT00965757|11390868|FG002|Extension Phase|Adverse drug reaction|6
7083971|NCT02160145|11195699|FG001|Randomized Double-blind Period|Subject decision|21
7083972|NCT02160145|11195700|FG002|Randomized Double-blind Period|Subject decision|20
7083973|NCT02160145|11195698|FG000|Randomized Double-blind Period|Lost to Follow-up|0
7083974|NCT02160145|11195699|FG001|Randomized Double-blind Period|Lost to Follow-up|1
7190418|NCT00965757|11390869|FG003|Extension Phase|Adverse drug reaction|3
7190419|NCT00965757|11390866|FG000|Extension Phase|Abnormal Laboratory Value|0
7190420|NCT00965757|11390867|FG001|Extension Phase|Abnormal Laboratory Value|0
7190421|NCT00965757|11390868|FG002|Extension Phase|Abnormal Laboratory Value|6
7190422|NCT00965757|11390869|FG003|Extension Phase|Abnormal Laboratory Value|1
7190423|NCT00965757|11390866|FG000|Extension Phase|Lack of Efficacy|0
7190424|NCT00965757|11390867|FG001|Extension Phase|Lack of Efficacy|0
7190425|NCT00965757|11390868|FG002|Extension Phase|Lack of Efficacy|8
7190426|NCT00965757|11390869|FG003|Extension Phase|Lack of Efficacy|12
7190427|NCT00965757|11390866|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0
7190428|NCT00965757|11390867|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0
7190429|NCT00965757|11390868|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4
7190430|NCT00965757|11390869|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0
7190431|NCT00965757|11390866|FG000|Extension Phase|Lost to Follow-up|0
7190432|NCT00965757|11390867|FG001|Extension Phase|Lost to Follow-up|0
7190433|NCT00965757|11390868|FG002|Extension Phase|Lost to Follow-up|0
7190434|NCT00965757|11390869|FG003|Extension Phase|Lost to Follow-up|1
7190435|NCT00965757|11390866|FG000|Extension Phase|Ineligible after Taking Study Drug|0
7190436|NCT00965757|11390867|FG001|Extension Phase|Ineligible after Taking Study Drug|0
7190437|NCT00965757|11390868|FG002|Extension Phase|Ineligible after Taking Study Drug|3
7190438|NCT00965757|11390869|FG003|Extension Phase|Ineligible after Taking Study Drug|3
7190439|NCT00965757|11390866|FG000|Extension Phase|Protocol Violation|0
7190440|NCT00965757|11390867|FG001|Extension Phase|Protocol Violation|0
7190441|NCT00965757|11390868|FG002|Extension Phase|Protocol Violation|0
7190442|NCT00965757|11390869|FG003|Extension Phase|Protocol Violation|1
7050465|NCT01814332|11139994|FG000|Overall Study|Withdrawal by Subject|3
7050466|NCT01814332|11139995|FG001|Overall Study|Withdrawal by Subject|8
7050467|NCT01814332|11139994|FG000|Overall Study|Protocol Violation|0
7050468|NCT01814332|11139995|FG001|Overall Study|Protocol Violation|4
7050469|NCT01814332|11139994|FG000|Overall Study|Lost to Follow-up|5
7050470|NCT01814332|11139995|FG001|Overall Study|Lost to Follow-up|1
7050471|NCT01814371|11140003|FG000|Overall Study|Lost to Follow-up|30
7050472|NCT01814371|11140004|FG001|Overall Study|Lost to Follow-up|27
7050473|NCT01814397|11140013|FG000|Overall Study|Adverse Event|7
7050474|NCT01814397|11140013|FG000|Overall Study|Withdrawal by Subject|7
7050475|NCT01814553|11140019|FG000|Overall Study|PD per clinical progression|6
7050476|NCT01814553|11140020|FG001|Overall Study|PD per clinical progression|8
7050477|NCT01814553|11140019|FG000|Overall Study|Other Adverse Event|4
7050478|NCT01814553|11140020|FG001|Overall Study|Other Adverse Event|5
7050479|NCT01814553|11140019|FG000|Overall Study|Withdrawal by Subject|1
7050480|NCT01814553|11140020|FG001|Overall Study|Withdrawal by Subject|1
7050481|NCT01814553|11140019|FG000|Overall Study|Other than stated|7
7050482|NCT01814553|11140020|FG001|Overall Study|Other than stated|8
7050483|NCT01814670|11140026|FG000|Overall Study|Protocol Violation|12
7050484|NCT01814696|11140032|FG000|Overall Study|Withdrawal by Subject|1
7050485|NCT01814696|11140033|FG001|Overall Study|Withdrawal by Subject|0
7050486|NCT01814696|11140032|FG000|Overall Study|Randomized to wrong group|1
7050487|NCT01814696|11140033|FG001|Overall Study|Randomized to wrong group|0
7050488|NCT01814748|11140041|FG000|Overall Study|Lost to Follow-up|1
7190443|NCT00965757|11390866|FG000|Extension Phase|Other|0
7190444|NCT00965757|11390867|FG001|Extension Phase|Other|0
7190445|NCT00965757|11390868|FG002|Extension Phase|Other|2
7190446|NCT00965757|11390869|FG003|Extension Phase|Other|1
7050489|NCT01814748|11140042|FG001|Overall Study|Lost to Follow-up|2
7190447|NCT00928447|11390877|FG000|Overall Study|Withdrawal by Subject|1
7190448|NCT00928447|11390877|FG000|Overall Study|Investigator's decision|1
7190449|NCT00893789|11390885|FG000|Overall Study|Withdrawal by Subject|3
7190450|NCT00893789|11390886|FG001|Overall Study|Withdrawal by Subject|1
7190451|NCT00893789|11390887|FG002|Overall Study|Withdrawal by Subject|3
7190452|NCT00893789|11390888|FG003|Overall Study|Withdrawal by Subject|1
7190453|NCT00893789|11390885|FG000|Overall Study|Noncompliance With Study Drug|1
7190454|NCT00893789|11390886|FG001|Overall Study|Noncompliance With Study Drug|0
7190455|NCT00893789|11390887|FG002|Overall Study|Noncompliance With Study Drug|1
7190456|NCT00893789|11390888|FG003|Overall Study|Noncompliance With Study Drug|2
7190457|NCT00893789|11390885|FG000|Overall Study|Noncompliance With Study Procedures|1
7190458|NCT00893789|11390886|FG001|Overall Study|Noncompliance With Study Procedures|0
7190459|NCT00893789|11390887|FG002|Overall Study|Noncompliance With Study Procedures|0
7190460|NCT00893789|11390888|FG003|Overall Study|Noncompliance With Study Procedures|0
7190461|NCT00893789|11390885|FG000|Overall Study|Taking Excluded Concomitant Medication|1
7190462|NCT00893789|11390886|FG001|Overall Study|Taking Excluded Concomitant Medication|0
7190463|NCT00893789|11390887|FG002|Overall Study|Taking Excluded Concomitant Medication|1
7190464|NCT00893789|11390888|FG003|Overall Study|Taking Excluded Concomitant Medication|0
7190465|NCT00893789|11390885|FG000|Overall Study|Adverse Event|0
7190466|NCT00893789|11390886|FG001|Overall Study|Adverse Event|2
7190467|NCT00893789|11390887|FG002|Overall Study|Adverse Event|1
7190468|NCT00893789|11390888|FG003|Overall Study|Adverse Event|5
7190469|NCT00893789|11390885|FG000|Overall Study|Protocol Violation|0
7190470|NCT00893789|11390886|FG001|Overall Study|Protocol Violation|1
7190471|NCT00893789|11390887|FG002|Overall Study|Protocol Violation|1
7190472|NCT00893789|11390888|FG003|Overall Study|Protocol Violation|4
7190473|NCT00893789|11390885|FG000|Overall Study|Lost to Follow-up|0
7190474|NCT00893789|11390886|FG001|Overall Study|Lost to Follow-up|0
7190475|NCT00893789|11390887|FG002|Overall Study|Lost to Follow-up|0
7190476|NCT00893789|11390888|FG003|Overall Study|Lost to Follow-up|1
7050490|NCT01814748|11140041|FG000|Overall Study|Study site terminated by sponsor|1
7190477|NCT03901144|11390906|FG000|Overall Study|Lost to Follow-up|1
7190478|NCT03901144|11390907|FG001|Overall Study|Lost to Follow-up|1
7190479|NCT03901144|11390908|FG002|Overall Study|Lost to Follow-up|1
7190480|NCT03901144|11390909|FG003|Overall Study|Lost to Follow-up|1
7190481|NCT03461211|11390934|FG000|Overall Study|Adverse Event|1
7190482|NCT03461211|11390935|FG001|Overall Study|Adverse Event|1
7190483|NCT03461211|11390934|FG000|Overall Study|Lack of Efficacy|0
7190484|NCT03461211|11390935|FG001|Overall Study|Lack of Efficacy|1
7190485|NCT03276780|11390945|FG000|Overall Study|Withdrawal by Subject|5
7190486|NCT03276780|11390946|FG001|Overall Study|Withdrawal by Subject|3
7190487|NCT03276780|11390945|FG000|Overall Study|Lost to Follow-up|3
7190488|NCT03276780|11390946|FG001|Overall Study|Lost to Follow-up|5
7190489|NCT03276780|11390945|FG000|Overall Study|Moved out of state|1
7190490|NCT03276780|11390946|FG001|Overall Study|Moved out of state|1
7190491|NCT03276780|11390945|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1
7190492|NCT03276780|11390946|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0
7190493|NCT03276780|11390945|FG000|Overall Study|No show to appointments after baseline through Week 5|8
7190494|NCT03276780|11390946|FG001|Overall Study|No show to appointments after baseline through Week 5|1
7190495|NCT03050814|11390970|FG000|Overall Study|Screen failures|0
7190496|NCT03050814|11390971|FG001|Overall Study|Screen failures|0
7190497|NCT03050814|11390972|FG002|Overall Study|Screen failures|4
7190498|NCT02797262|11390980|FG000|Overall Study|Withdrawal by Subject|5
7190499|NCT02797262|11390981|FG001|Overall Study|Withdrawal by Subject|1
7190500|NCT02797262|11390980|FG000|Overall Study|Lost to Follow-up|10
7190501|NCT02797262|11390981|FG001|Overall Study|Lost to Follow-up|7
7190502|NCT02797262|11390980|FG000|Overall Study|Death|1
7190503|NCT02797262|11390981|FG001|Overall Study|Death|2
7190504|NCT02797262|11390980|FG000|Overall Study|Adverse Event|1
7190505|NCT02797262|11390981|FG001|Overall Study|Adverse Event|0
7190506|NCT02797262|11390980|FG000|Overall Study|COVID-19|2
7190507|NCT02797262|11390981|FG001|Overall Study|COVID-19|1
7190508|NCT02797262|11390980|FG000|Overall Study|Out-of-country|1
7190509|NCT02797262|11390981|FG001|Overall Study|Out-of-country|0
7190510|NCT02409368|11390999|FG000|Overall Study|Adverse event unrelated to study drug|16
7190511|NCT02409368|11391000|FG001|Overall Study|Adverse event unrelated to study drug|42
7190512|NCT02409368|11391001|FG002|Overall Study|Adverse event unrelated to study drug|10
7190513|NCT02409368|11390999|FG000|Overall Study|Death|5
7190514|NCT02409368|11391000|FG001|Overall Study|Death|17
7190515|NCT02409368|11391001|FG002|Overall Study|Death|5
7190516|NCT02409368|11390999|FG000|Overall Study|Disease Progression|101
7050491|NCT01814748|11140042|FG001|Overall Study|Study site terminated by sponsor|1
7050492|NCT01814748|11140041|FG000|Overall Study|Withdrawal by Subject|6
7050493|NCT01814748|11140042|FG001|Overall Study|Withdrawal by Subject|4
7050494|NCT01814761|11140050|FG000|Overall Study|Other Reasons|1
7050495|NCT01814761|11140051|FG001|Overall Study|Other Reasons|10
7050496|NCT01814761|11140050|FG000|Overall Study|Ocular Adverse Event|6
7050497|NCT01814761|11140051|FG001|Overall Study|Ocular Adverse Event|15
7050498|NCT01814761|11140050|FG000|Overall Study|Lost to Follow-up|1
7050499|NCT01814761|11140051|FG001|Overall Study|Lost to Follow-up|5
7050500|NCT01814800|11140072|FG000|Overall Study|Adverse Event|2
7050501|NCT01814800|11140072|FG000|Overall Study|Pregnancy|1
7050502|NCT01814800|11140072|FG000|Overall Study|Sponsor decision|1
7050503|NCT01814800|11140072|FG000|Overall Study|Subject relocation|1
7050504|NCT01814878|11140091|FG000|Overall Study|Adverse Event|16
7050505|NCT01814878|11140092|FG001|Overall Study|Adverse Event|5
7050506|NCT01814878|11140091|FG000|Overall Study|Withdrawal by Subject|20
7050507|NCT01814878|11140092|FG001|Overall Study|Withdrawal by Subject|16
7050508|NCT01814878|11140091|FG000|Overall Study|Protocol Violation|5
7190517|NCT02409368|11391000|FG001|Overall Study|Disease Progression|346
7190518|NCT02409368|11391001|FG002|Overall Study|Disease Progression|63
7190519|NCT02409368|11390999|FG000|Overall Study|Lost to Follow-up|1
7190520|NCT02409368|11391000|FG001|Overall Study|Lost to Follow-up|5
7190521|NCT02409368|11391001|FG002|Overall Study|Lost to Follow-up|0
7190522|NCT02409368|11390999|FG000|Overall Study|maximum clinical benefit|3
7190523|NCT02409368|11391000|FG001|Overall Study|maximum clinical benefit|8
7190524|NCT02409368|11391001|FG002|Overall Study|maximum clinical benefit|1
7190525|NCT02409368|11390999|FG000|Overall Study|poor/non compliant|0
7190526|NCT02409368|11391000|FG001|Overall Study|poor/non compliant|2
7190527|NCT02409368|11391001|FG002|Overall Study|poor/non compliant|2
7190528|NCT02409368|11390999|FG000|Overall Study|study drug toxicity|12
7190529|NCT02409368|11391000|FG001|Overall Study|study drug toxicity|35
7190530|NCT02409368|11391001|FG002|Overall Study|study drug toxicity|6
7190531|NCT02409368|11390999|FG000|Overall Study|no longer meets study criteria|3
7190532|NCT02409368|11391000|FG001|Overall Study|no longer meets study criteria|9
7190533|NCT02409368|11391001|FG002|Overall Study|no longer meets study criteria|3
7050509|NCT01814878|11140092|FG001|Overall Study|Protocol Violation|5
7050510|NCT01814878|11140091|FG000|Overall Study|Physician Decision|3
7050511|NCT01814878|11140092|FG001|Overall Study|Physician Decision|1
7050512|NCT01814878|11140091|FG000|Overall Study|Screening failure (drop-out)|0
7050513|NCT01814878|11140092|FG001|Overall Study|Screening failure (drop-out)|3
7050514|NCT01814878|11140091|FG000|Overall Study|Other|2
7050515|NCT01814878|11140092|FG001|Overall Study|Other|0
7050516|NCT01815099|11140104|FG000|Overall Study|Lack of Efficacy|1
7050517|NCT01815099|11140104|FG000|Overall Study|unable to attend study visits|1
7050518|NCT01815138|11140111|FG000|Overall Study|Withdrawal by Subject|0
7050519|NCT01815138|11140112|FG001|Overall Study|Withdrawal by Subject|1
7050520|NCT01815138|11140111|FG000|Overall Study|Physician Decision|8
7050521|NCT01815138|11140112|FG001|Overall Study|Physician Decision|5
7050522|NCT01815424|11140137|FG000|Week 0 to 16|Adverse Event|1
7050523|NCT01815424|11140138|FG001|Week 0 to 16|Adverse Event|3
7050524|NCT01815424|11140139|FG002|Week 0 to 16|Adverse Event|3
7050525|NCT01815424|11140140|FG003|Week 0 to 16|Adverse Event|0
7050526|NCT01815424|11140141|FG004|Week 0 to 16|Adverse Event|0
7050527|NCT01815424|11140137|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2
7190534|NCT02409368|11390999|FG000|Overall Study|Participant request to discontinue|3
7050528|NCT01815424|11140138|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0
7050529|NCT01815424|11140139|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0
7050530|NCT01815424|11140140|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0
7050531|NCT01815424|11140141|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0
7050532|NCT01815424|11140137|FG000|Week 0 to 16|Lost to Follow-up|0
7050533|NCT01815424|11140138|FG001|Week 0 to 16|Lost to Follow-up|1
7050534|NCT01815424|11140139|FG002|Week 0 to 16|Lost to Follow-up|0
7050535|NCT01815424|11140140|FG003|Week 0 to 16|Lost to Follow-up|0
7050536|NCT01815424|11140141|FG004|Week 0 to 16|Lost to Follow-up|0
7050537|NCT01815424|11140137|FG000|Week 0 to 16|Withdrawal by Subject|0
7050538|NCT01815424|11140138|FG001|Week 0 to 16|Withdrawal by Subject|0
7050539|NCT01815424|11140139|FG002|Week 0 to 16|Withdrawal by Subject|1
7050540|NCT01815424|11140140|FG003|Week 0 to 16|Withdrawal by Subject|0
7050541|NCT01815424|11140141|FG004|Week 0 to 16|Withdrawal by Subject|0
7050542|NCT01815424|11140137|FG000|Week 0 to 16|Other|1
7050543|NCT01815424|11140138|FG001|Week 0 to 16|Other|0
7050544|NCT01815424|11140139|FG002|Week 0 to 16|Other|3
7050545|NCT01815424|11140140|FG003|Week 0 to 16|Other|0
7050546|NCT01815424|11140141|FG004|Week 0 to 16|Other|0
7050547|NCT01815424|11140137|FG000|Week 0 to 16|Protocol Violation|1
7050548|NCT01815424|11140138|FG001|Week 0 to 16|Protocol Violation|0
7050549|NCT01815424|11140139|FG002|Week 0 to 16|Protocol Violation|0
7050550|NCT01815424|11140140|FG003|Week 0 to 16|Protocol Violation|0
7050551|NCT01815424|11140141|FG004|Week 0 to 16|Protocol Violation|0
7050552|NCT01815424|11140137|FG000|Week 0 to 16|Insufficient Clinical Response|2
7050553|NCT01815424|11140138|FG001|Week 0 to 16|Insufficient Clinical Response|0
7050554|NCT01815424|11140139|FG002|Week 0 to 16|Insufficient Clinical Response|4
7050555|NCT01815424|11140140|FG003|Week 0 to 16|Insufficient Clinical Response|0
7190535|NCT02409368|11391000|FG001|Overall Study|Participant request to discontinue|3
7190536|NCT02409368|11391001|FG002|Overall Study|Participant request to discontinue|3
7190537|NCT02409368|11390999|FG000|Overall Study|Participant withdrew consent|2
7190538|NCT02409368|11391000|FG001|Overall Study|Participant withdrew consent|4
7190539|NCT02409368|11391001|FG002|Overall Study|Participant withdrew consent|3
7190540|NCT02409368|11390999|FG000|Overall Study|Other Reasons|2
7190541|NCT02409368|11391000|FG001|Overall Study|Other Reasons|17
7190542|NCT02409368|11391001|FG002|Overall Study|Other Reasons|3
7190543|NCT02409368|11390999|FG000|Overall Study|Not Reported|0
7190544|NCT02409368|11391000|FG001|Overall Study|Not Reported|1
7190545|NCT02409368|11391001|FG002|Overall Study|Not Reported|0
7190546|NCT01285102|11391177|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4
7190547|NCT03877926|11391262|FG000|Overall Study|Adverse Event|1
7190548|NCT03877926|11391263|FG001|Overall Study|Adverse Event|0
7190549|NCT03877926|11391264|FG002|Overall Study|Adverse Event|0
7190550|NCT03877926|11391265|FG003|Overall Study|Adverse Event|0
7190551|NCT03877926|11391262|FG000|Overall Study|Death|2
7190552|NCT03877926|11391263|FG001|Overall Study|Death|2
7190553|NCT03877926|11391264|FG002|Overall Study|Death|2
7190554|NCT03877926|11391265|FG003|Overall Study|Death|0
7190555|NCT03877926|11391262|FG000|Overall Study|Lost to Follow-up|41
7190556|NCT03877926|11391263|FG001|Overall Study|Lost to Follow-up|52
7190557|NCT03877926|11391264|FG002|Overall Study|Lost to Follow-up|45
7190558|NCT03877926|11391265|FG003|Overall Study|Lost to Follow-up|17
7190559|NCT03877926|11391262|FG000|Overall Study|Physician Decision|2
7190560|NCT03877926|11391263|FG001|Overall Study|Physician Decision|0
7190561|NCT03877926|11391264|FG002|Overall Study|Physician Decision|2
7190562|NCT03877926|11391265|FG003|Overall Study|Physician Decision|0
7190563|NCT03877926|11391262|FG000|Overall Study|Withdrawal by Subject|18
7190564|NCT03877926|11391263|FG001|Overall Study|Withdrawal by Subject|21
7190565|NCT03877926|11391264|FG002|Overall Study|Withdrawal by Subject|12
7190566|NCT03877926|11391265|FG003|Overall Study|Withdrawal by Subject|4
7190567|NCT03877926|11391262|FG000|Overall Study|Other - Various|4
7050556|NCT01815424|11140141|FG004|Week 0 to 16|Insufficient Clinical Response|0
7050557|NCT01815424|11140137|FG000|Week 16 to 52|Other|0
7050558|NCT01815424|11140138|FG001|Week 16 to 52|Other|1
7050559|NCT01815424|11140139|FG002|Week 16 to 52|Other|0
7050560|NCT01815424|11140140|FG003|Week 16 to 52|Other|0
7050561|NCT01815424|11140141|FG004|Week 16 to 52|Other|0
7050562|NCT01815424|11140137|FG000|Week 16 to 52|Adverse Event|0
7050563|NCT01815424|11140138|FG001|Week 16 to 52|Adverse Event|0
7050564|NCT01815424|11140139|FG002|Week 16 to 52|Adverse Event|0
7050565|NCT01815424|11140140|FG003|Week 16 to 52|Adverse Event|0
7050566|NCT01815424|11140141|FG004|Week 16 to 52|Adverse Event|1
7050567|NCT01815424|11140137|FG000|Week 16 to 52|Insufficient Clinical Response|1
7050568|NCT01815424|11140138|FG001|Week 16 to 52|Insufficient Clinical Response|0
7050569|NCT01815424|11140139|FG002|Week 16 to 52|Insufficient Clinical Response|0
7050570|NCT01815424|11140140|FG003|Week 16 to 52|Insufficient Clinical Response|1
7050571|NCT01815424|11140141|FG004|Week 16 to 52|Insufficient Clinical Response|1
7050572|NCT01815424|11140137|FG000|Week 16 to 52|Lost to Follow-up|0
7050573|NCT01815424|11140138|FG001|Week 16 to 52|Lost to Follow-up|2
7050574|NCT01815424|11140139|FG002|Week 16 to 52|Lost to Follow-up|0
7050575|NCT01815424|11140140|FG003|Week 16 to 52|Lost to Follow-up|2
7050576|NCT01815424|11140141|FG004|Week 16 to 52|Lost to Follow-up|1
7050577|NCT01815424|11140137|FG000|Week 16 to 52|Withdrawal by Subject|1
7050578|NCT01815424|11140138|FG001|Week 16 to 52|Withdrawal by Subject|2
7050579|NCT01815424|11140139|FG002|Week 16 to 52|Withdrawal by Subject|0
7050580|NCT01815424|11140140|FG003|Week 16 to 52|Withdrawal by Subject|0
7050581|NCT01815424|11140141|FG004|Week 16 to 52|Withdrawal by Subject|0
7050582|NCT01815736|11140192|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11
7050583|NCT01815736|11140193|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17
7050584|NCT01815736|11140192|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10
7050585|NCT01815736|11140193|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9
7050586|NCT01815736|11140192|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11
7050587|NCT01815736|11140193|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2
7050588|NCT01815736|11140192|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7
7050589|NCT01815736|11140193|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4
7050590|NCT01815736|11140192|FG000|Randomized Treatment Phase-Up to Week 96|Death|4
7050591|NCT01815736|11140193|FG001|Randomized Treatment Phase-Up to Week 96|Death|0
7050592|NCT01815736|11140192|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1
7050593|NCT01815736|11140193|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0
7190568|NCT03877926|11391263|FG001|Overall Study|Other - Various|1
7190569|NCT03877926|11391264|FG002|Overall Study|Other - Various|1
7190570|NCT03877926|11391265|FG003|Overall Study|Other - Various|0
7190571|NCT03877926|11391262|FG000|Overall Study|Not Treated|3
7190572|NCT03877926|11391263|FG001|Overall Study|Not Treated|1
7190573|NCT03877926|11391264|FG002|Overall Study|Not Treated|1
7190574|NCT03877926|11391265|FG003|Overall Study|Not Treated|0
7190575|NCT03862807|11391288|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1
7190576|NCT03857867|11391292|FG000|Overall Study|Physician Decision|1
7190577|NCT03691571|11391299|FG000|Overall Study|Withdrawal by Subject|9
7190578|NCT03691571|11391300|FG001|Overall Study|Withdrawal by Subject|2
7190579|NCT03436199|11391310|FG000|Overall Study|Adverse Event|15
7190580|NCT03436199|11391311|FG001|Overall Study|Adverse Event|40
7190581|NCT03436199|11391312|FG002|Overall Study|Adverse Event|7
7190582|NCT03436199|11391310|FG000|Overall Study|Withdrawal by Subject|4
7190583|NCT03436199|11391311|FG001|Overall Study|Withdrawal by Subject|10
7190584|NCT03436199|11391312|FG002|Overall Study|Withdrawal by Subject|3
7190585|NCT03436199|11391310|FG000|Overall Study|Lost to Follow-up|1
7190586|NCT03436199|11391311|FG001|Overall Study|Lost to Follow-up|0
7190587|NCT03436199|11391312|FG002|Overall Study|Lost to Follow-up|2
7190588|NCT03436199|11391310|FG000|Overall Study|Protocol Violation|1
7190589|NCT03436199|11391311|FG001|Overall Study|Protocol Violation|1
7190590|NCT03436199|11391312|FG002|Overall Study|Protocol Violation|0
7190591|NCT03436199|11391310|FG000|Overall Study|Physician Decision|0
7190592|NCT03436199|11391311|FG001|Overall Study|Physician Decision|1
7190593|NCT03436199|11391312|FG002|Overall Study|Physician Decision|0
7190594|NCT03436199|11391310|FG000|Overall Study|Could not return to clinic|1
7190595|NCT03436199|11391311|FG001|Overall Study|Could not return to clinic|0
7190596|NCT03436199|11391312|FG002|Overall Study|Could not return to clinic|0
7190597|NCT03436199|11391310|FG000|Overall Study|Withdrawn per physician|0
7190598|NCT03436199|11391311|FG001|Overall Study|Withdrawn per physician|1
7190599|NCT03436199|11391312|FG002|Overall Study|Withdrawn per physician|0
7190600|NCT03250273|11391331|FG000|Overall Study|Disease Progression|2
7190601|NCT03250273|11391332|FG001|Overall Study|Disease Progression|9
7190602|NCT03250273|11391331|FG000|Overall Study|Adverse Event|0
7190603|NCT03250273|11391332|FG001|Overall Study|Adverse Event|1
7190604|NCT03250273|11391331|FG000|Overall Study|Death|0
7190605|NCT03250273|11391332|FG001|Overall Study|Death|1
7190606|NCT03250273|11391331|FG000|Overall Study|Failed to Maintain Eligibility|0
7190607|NCT03250273|11391332|FG001|Overall Study|Failed to Maintain Eligibility|1
7190608|NCT03217136|11391340|FG000|Overall Study|Lost to Follow-up|2
7190609|NCT03217136|11391341|FG001|Overall Study|Lost to Follow-up|1
7190610|NCT03217136|11391340|FG000|Overall Study|Site Randomized Participant in Error|0
7190611|NCT03217136|11391341|FG001|Overall Study|Site Randomized Participant in Error|1
7190612|NCT03217136|11391340|FG000|Overall Study|Did Not Meet Criteria after Randomization|0
7190613|NCT03217136|11391341|FG001|Overall Study|Did Not Meet Criteria after Randomization|1
7190614|NCT03217136|11391340|FG000|Overall Study|Dispensing Error|1
7190615|NCT03217136|11391341|FG001|Overall Study|Dispensing Error|0
7190616|NCT03217136|11391340|FG000|Overall Study|Withdrawal by Parent/Guardian|1
7190617|NCT03217136|11391341|FG001|Overall Study|Withdrawal by Parent/Guardian|0
7190618|NCT03181542|11391349|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1
7190619|NCT03181542|11391350|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0
7190620|NCT03985293|11391405|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5
7190621|NCT03985293|11391406|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2
7190622|NCT03985293|11391407|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3
7190623|NCT03985293|11391408|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8
7190624|NCT03985293|11391409|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15
7190625|NCT03985293|11391410|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24
7190626|NCT03985293|11391405|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1
7190627|NCT03985293|11391406|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3
7190628|NCT03985293|11391407|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0
7190629|NCT03985293|11391408|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3
7190630|NCT03985293|11391409|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3
7190631|NCT03985293|11391410|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1
6804208|NCT03323736|10806189|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2
6804209|NCT03323736|10806190|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2
6804210|NCT03323736|10806191|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0
6804211|NCT03073980|10806213|FG000|Overall Study|Lost to Follow-up|10
6804212|NCT03073980|10806214|FG001|Overall Study|Lost to Follow-up|2
6804213|NCT03073980|10806215|FG002|Overall Study|Lost to Follow-up|9
6804214|NCT03073980|10806213|FG000|Overall Study|No post-procedure data|0
6804215|NCT03073980|10806214|FG001|Overall Study|No post-procedure data|0
6804216|NCT03073980|10806215|FG002|Overall Study|No post-procedure data|2
6804217|NCT02544074|10806257|FG000|Overall Study|Withdrawal by Subject|0
6804218|NCT02544074|10806258|FG001|Overall Study|Withdrawal by Subject|1
6804219|NCT02544074|10806259|FG002|Overall Study|Withdrawal by Subject|0
6804220|NCT02544074|10806260|FG003|Overall Study|Withdrawal by Subject|0
6804221|NCT02544074|10806261|FG004|Overall Study|Withdrawal by Subject|0
6804222|NCT02544074|10806262|FG005|Overall Study|Withdrawal by Subject|0
6804223|NCT02544074|10806263|FG006|Overall Study|Withdrawal by Subject|0
6804224|NCT02544074|10806264|FG007|Overall Study|Withdrawal by Subject|0
6804225|NCT02544074|10806265|FG008|Overall Study|Withdrawal by Subject|0
6804226|NCT02544074|10806266|FG009|Overall Study|Withdrawal by Subject|0
6804227|NCT02544074|10806267|FG010|Overall Study|Withdrawal by Subject|0
6804228|NCT02544074|10806268|FG011|Overall Study|Withdrawal by Subject|0
7050594|NCT01815736|11140192|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1
6804229|NCT02544074|10806269|FG012|Overall Study|Withdrawal by Subject|0
6804230|NCT02544074|10806270|FG013|Overall Study|Withdrawal by Subject|0
6804231|NCT02544074|10806271|FG014|Overall Study|Withdrawal by Subject|0
6804232|NCT02544074|10806272|FG015|Overall Study|Withdrawal by Subject|0
6804233|NCT02544074|10806273|FG016|Overall Study|Withdrawal by Subject|0
6804234|NCT02544074|10806274|FG017|Overall Study|Withdrawal by Subject|0
6804235|NCT02544074|10806275|FG018|Overall Study|Withdrawal by Subject|0
6804236|NCT02544074|10806276|FG019|Overall Study|Withdrawal by Subject|0
7190632|NCT03985293|11391405|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1
7190633|NCT03985293|11391406|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1
7190634|NCT03985293|11391407|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0
7190635|NCT03985293|11391408|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1
7190636|NCT03985293|11391409|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0
7190637|NCT03985293|11391410|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0
7190638|NCT03985293|11391405|FG000|DOUBLE-BLIND TREATMENT|Other|1
7190639|NCT03985293|11391406|FG001|DOUBLE-BLIND TREATMENT|Other|2
7190640|NCT03985293|11391407|FG002|DOUBLE-BLIND TREATMENT|Other|0
7190641|NCT03985293|11391408|FG003|DOUBLE-BLIND TREATMENT|Other|2
7190642|NCT03985293|11391409|FG004|DOUBLE-BLIND TREATMENT|Other|1
7190643|NCT03985293|11391410|FG005|DOUBLE-BLIND TREATMENT|Other|0
7190644|NCT03985293|11391405|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1
7190645|NCT03985293|11391406|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2
7190646|NCT03985293|11391407|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0
7190647|NCT03985293|11391408|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0
7190648|NCT03985293|11391409|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0
7190649|NCT03985293|11391410|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1
7190650|NCT03985293|11391405|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0
7190651|NCT03985293|11391406|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4
7190652|NCT03985293|11391407|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2
7190653|NCT03985293|11391408|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0
7190654|NCT03985293|11391409|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1
7190655|NCT03985293|11391410|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7
7190656|NCT03985293|11391405|FG000|FOLLOW-UP|Lost to Follow-up|0
7190657|NCT03985293|11391406|FG001|FOLLOW-UP|Lost to Follow-up|0
7190658|NCT03985293|11391407|FG002|FOLLOW-UP|Lost to Follow-up|1
7190659|NCT03985293|11391408|FG003|FOLLOW-UP|Lost to Follow-up|0
6804237|NCT02544074|10806277|FG020|Overall Study|Withdrawal by Subject|0
6804238|NCT02544074|10806257|FG000|Overall Study|Tablet error|0
6804239|NCT02544074|10806258|FG001|Overall Study|Tablet error|0
6804240|NCT02544074|10806259|FG002|Overall Study|Tablet error|0
6804241|NCT02544074|10806260|FG003|Overall Study|Tablet error|0
6804242|NCT02544074|10806261|FG004|Overall Study|Tablet error|0
6804243|NCT02544074|10806262|FG005|Overall Study|Tablet error|1
6804244|NCT02544074|10806263|FG006|Overall Study|Tablet error|0
6804245|NCT02544074|10806264|FG007|Overall Study|Tablet error|0
6804246|NCT02544074|10806265|FG008|Overall Study|Tablet error|0
7050595|NCT01815736|11140193|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0
7050596|NCT01815736|11140192|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4
7050597|NCT01815736|11140193|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3
7050598|NCT01815736|11140192|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31
7050599|NCT01815736|11140193|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15
7050600|NCT01815736|11140192|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13
7050601|NCT01815736|11140193|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9
7050602|NCT01815736|11140192|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5
7050603|NCT01815736|11140193|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1
7050604|NCT01815736|11140192|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1
7050605|NCT01815736|11140193|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1
7050606|NCT01815736|11140192|FG000|Extension Treatment Phase- After Week 96|Death|1
7050607|NCT01815736|11140193|FG001|Extension Treatment Phase- After Week 96|Death|0
7050608|NCT01815840|11140203|FG000|Overall Study|Missing|1
7050609|NCT01815840|11140204|FG001|Overall Study|Missing|0
7050610|NCT01815840|11140203|FG000|Overall Study|Withdrew Consent|31
7050611|NCT01815840|11140204|FG001|Overall Study|Withdrew Consent|30
7050612|NCT01815840|11140203|FG000|Overall Study|Administrative/Other|1
7050613|NCT01815840|11140204|FG001|Overall Study|Administrative/Other|3
7050614|NCT01815840|11140203|FG000|Overall Study|Adverse Event|10
7050615|NCT01815840|11140204|FG001|Overall Study|Adverse Event|16
7050616|NCT01815840|11140203|FG000|Overall Study|Death|2
7050617|NCT01815840|11140204|FG001|Overall Study|Death|2
7050618|NCT01815840|11140203|FG000|Overall Study|Disease progression|3
7050619|NCT01815840|11140204|FG001|Overall Study|Disease progression|2
7050620|NCT01815840|11140203|FG000|Overall Study|Investigators Decision|2
7050621|NCT01815840|11140204|FG001|Overall Study|Investigators Decision|3
7050622|NCT01815840|11140203|FG000|Overall Study|Lost to Follow-up|3
7050623|NCT01815840|11140204|FG001|Overall Study|Lost to Follow-up|6
7050624|NCT01815840|11140203|FG000|Overall Study|Refused Treatment|5
7050625|NCT01815840|11140204|FG001|Overall Study|Refused Treatment|1
7050626|NCT01815840|11140203|FG000|Overall Study|Sponsor Termination Treatment|1
7050627|NCT01815840|11140204|FG001|Overall Study|Sponsor Termination Treatment|0
7050628|NCT01815918|11140212|FG000|Overall Study|Patient samples not analyzable|3
7050629|NCT01815918|11140213|FG001|Overall Study|Patient samples not analyzable|4
7050630|NCT01815918|11140212|FG000|Overall Study|Lack of Efficacy|15
7050631|NCT01815918|11140213|FG001|Overall Study|Lack of Efficacy|15
7050632|NCT01816048|11140223|FG000|Overall Study|Adverse Event|1
7050633|NCT01816048|11140223|FG000|Overall Study|Death|1
7050634|NCT01816048|11140223|FG000|Overall Study|Withdrawal by Subject|1
7050635|NCT01816048|11140223|FG000|Overall Study|Disease Progression|3
7050636|NCT01816061|11140230|FG000|Overall Study|Lost to Follow-up|13
7050637|NCT01816061|11140231|FG001|Overall Study|Lost to Follow-up|24
7050638|NCT01816074|11140241|FG000|Phase 1|Time commitment issues|0
6804247|NCT02544074|10806266|FG009|Overall Study|Tablet error|1
6804248|NCT02544074|10806267|FG010|Overall Study|Tablet error|0
6804249|NCT02544074|10806268|FG011|Overall Study|Tablet error|0
7050639|NCT01816074|11140242|FG001|Phase 1|Time commitment issues|0
7050640|NCT01816074|11140243|FG002|Phase 1|Time commitment issues|1
7050641|NCT01816074|11140244|FG003|Phase 1|Time commitment issues|0
7050642|NCT01816074|11140241|FG000|Phase 2|Time commitment Issues|0
7050643|NCT01816074|11140242|FG001|Phase 2|Time commitment Issues|2
7190660|NCT03985293|11391409|FG004|FOLLOW-UP|Lost to Follow-up|0
7190661|NCT03985293|11391410|FG005|FOLLOW-UP|Lost to Follow-up|0
7190662|NCT03846427|11391424|FG000|Overall Study|Death|7
7190663|NCT03846427|11391424|FG000|Overall Study|Withdrawal by Subject|2
7190664|NCT03846427|11391424|FG000|Overall Study|Remaining in study|59
7190665|NCT03785340|11391430|FG000|Overall Study|Withdrawal by Subject|3
7190666|NCT03785340|11391431|FG001|Overall Study|Withdrawal by Subject|0
7190667|NCT03776357|11391437|FG000|Overall Study|Lost to Follow-up|3
7190668|NCT03656068|11391441|FG000|Overall Study|Withdrawal by Subject|4
7190669|NCT03656068|11391441|FG000|Overall Study|Adverse Event|1
7190670|NCT03400956|11391457|FG000|Treatment Period 1|Adverse Event|0
7190671|NCT03400956|11391458|FG001|Treatment Period 1|Adverse Event|1
7190672|NCT03400956|11391459|FG002|Treatment Period 1|Adverse Event|0
7190673|NCT03400956|11391457|FG000|Treatment Period 1|Lost to Follow-up|0
7190674|NCT03400956|11391458|FG001|Treatment Period 1|Lost to Follow-up|0
7190675|NCT03400956|11391459|FG002|Treatment Period 1|Lost to Follow-up|1
7190676|NCT03400956|11391457|FG000|Treatment Period 1|Protocol Violation|0
7190677|NCT03400956|11391458|FG001|Treatment Period 1|Protocol Violation|2
7190678|NCT03400956|11391459|FG002|Treatment Period 1|Protocol Violation|0
7190679|NCT03400956|11391457|FG000|Treatment Period 1|Study terminated by sponsor|3
7190680|NCT03400956|11391458|FG001|Treatment Period 1|Study terminated by sponsor|1
7190681|NCT03400956|11391459|FG002|Treatment Period 1|Study terminated by sponsor|1
7190682|NCT03400956|11391457|FG000|Treatment Period 1|Withdrawal by Subject|0
7190683|NCT03400956|11391458|FG001|Treatment Period 1|Withdrawal by Subject|2
7190684|NCT03400956|11391459|FG002|Treatment Period 1|Withdrawal by Subject|4
7190685|NCT03400956|11391457|FG000|Treatment Period 1|Other|1
7190686|NCT03400956|11391458|FG001|Treatment Period 1|Other|2
7190687|NCT03400956|11391459|FG002|Treatment Period 1|Other|3
7190688|NCT03400956|11391457|FG000|Post-treatment Period 1|Adverse Event|0
7190689|NCT03400956|11391458|FG001|Post-treatment Period 1|Adverse Event|0
7190690|NCT03400956|11391459|FG002|Post-treatment Period 1|Adverse Event|1
7190691|NCT03400956|11391457|FG000|Post-treatment Period 1|Physician Decision|2
7190692|NCT03400956|11391458|FG001|Post-treatment Period 1|Physician Decision|3
7190693|NCT03400956|11391459|FG002|Post-treatment Period 1|Physician Decision|0
7190694|NCT03400956|11391457|FG000|Post-treatment Period 1|Study terminated by sponsor|11
7190695|NCT03400956|11391458|FG001|Post-treatment Period 1|Study terminated by sponsor|10
7190696|NCT03400956|11391459|FG002|Post-treatment Period 1|Study terminated by sponsor|11
7190697|NCT03400956|11391457|FG000|Post-treatment Period 1|Withdrawal by Subject|5
7190698|NCT03400956|11391458|FG001|Post-treatment Period 1|Withdrawal by Subject|0
7190699|NCT03400956|11391459|FG002|Post-treatment Period 1|Withdrawal by Subject|0
7083975|NCT02160145|11195700|FG002|Randomized Double-blind Period|Lost to Follow-up|3
7190700|NCT03400956|11391457|FG000|Post-treatment Period 1|Other|4
7190701|NCT03400956|11391458|FG001|Post-treatment Period 1|Other|3
7190702|NCT03400956|11391459|FG002|Post-treatment Period 1|Other|4
7083976|NCT02160145|11195698|FG000|Randomized Double-blind Period|Physician Decision|0
7083977|NCT02160145|11195699|FG001|Randomized Double-blind Period|Physician Decision|7
7083978|NCT02160145|11195700|FG002|Randomized Double-blind Period|Physician Decision|5
7083979|NCT02160314|11195718|FG000|Overall Study|Adverse Event|0
7083980|NCT02160314|11195719|FG001|Overall Study|Adverse Event|6
7083981|NCT02160314|11195718|FG000|Overall Study|Protocol Violation|0
7083982|NCT02160314|11195719|FG001|Overall Study|Protocol Violation|4
7083983|NCT02160314|11195718|FG000|Overall Study|Withdrawal by Subject|1
7083984|NCT02160314|11195719|FG001|Overall Study|Withdrawal by Subject|2
7083985|NCT02160314|11195718|FG000|Overall Study|Lost to Follow-up|0
7083986|NCT02160314|11195719|FG001|Overall Study|Lost to Follow-up|1
7083987|NCT02160626|11195732|FG000|Overall Study|Adverse Event|1
7083988|NCT02160626|11195733|FG001|Overall Study|Adverse Event|0
7083989|NCT02160626|11195734|FG002|Overall Study|Adverse Event|0
7083990|NCT02160626|11195732|FG000|Overall Study|Schedule not conducive to study visits|0
7083991|NCT02160626|11195733|FG001|Overall Study|Schedule not conducive to study visits|0
7083992|NCT02160626|11195734|FG002|Overall Study|Schedule not conducive to study visits|1
7083993|NCT02160626|11195732|FG000|Overall Study|Withdrawal by Subject|0
7083994|NCT02160626|11195733|FG001|Overall Study|Withdrawal by Subject|1
7083995|NCT02160626|11195734|FG002|Overall Study|Withdrawal by Subject|0
7083996|NCT02160782|11195749|FG000|Open-label Period: Maralixibat|Adverse Event|2
7083997|NCT02160782|11195750|FG001|Open-label Period: Maralixibat|Adverse Event|0
7083998|NCT02160782|11195751|FG002|Open-label Period: Maralixibat|Adverse Event|0
7083999|NCT02160782|11195752|FG003|Open-label Period: Maralixibat|Adverse Event|0
7084000|NCT02160782|11195753|FG004|Open-label Period: Maralixibat|Adverse Event|0
7084001|NCT02160782|11195749|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0
7084002|NCT02160782|11195750|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0
7084003|NCT02160782|11195751|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0
7084004|NCT02160782|11195752|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1
7084005|NCT02160782|11195753|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0
7190703|NCT03400956|11391457|FG000|Treatment Period 2|Adverse Event|2
7190704|NCT03400956|11391458|FG001|Treatment Period 2|Adverse Event|1
7190705|NCT03400956|11391459|FG002|Treatment Period 2|Adverse Event|1
7190706|NCT03400956|11391457|FG000|Treatment Period 2|Lost to Follow-up|1
7190707|NCT03400956|11391458|FG001|Treatment Period 2|Lost to Follow-up|1
7190708|NCT03400956|11391459|FG002|Treatment Period 2|Lost to Follow-up|0
7190709|NCT03400956|11391457|FG000|Treatment Period 2|Withdrawal by Subject|0
7190710|NCT03400956|11391458|FG001|Treatment Period 2|Withdrawal by Subject|0
7190711|NCT03400956|11391459|FG002|Treatment Period 2|Withdrawal by Subject|3
7190712|NCT03400956|11391457|FG000|Treatment Period 2|Other|1
7190713|NCT03400956|11391458|FG001|Treatment Period 2|Other|1
7190714|NCT03400956|11391459|FG002|Treatment Period 2|Other|0
7190715|NCT03400956|11391457|FG000|Follow-up Period|Withdrawal by Subject|0
7190716|NCT03400956|11391458|FG001|Follow-up Period|Withdrawal by Subject|0
7190717|NCT03400956|11391459|FG002|Follow-up Period|Withdrawal by Subject|1
7190718|NCT03400956|11391457|FG000|Follow-up Period|Other|0
7190719|NCT03400956|11391458|FG001|Follow-up Period|Other|0
7190720|NCT03400956|11391459|FG002|Follow-up Period|Other|1
7190721|NCT03338790|11391474|FG000|Overall Study|Disease Progression|65
7190722|NCT03338790|11391475|FG001|Overall Study|Disease Progression|43
7190723|NCT03338790|11391476|FG002|Overall Study|Disease Progression|50
7190724|NCT03338790|11391477|FG003|Overall Study|Disease Progression|37
7190725|NCT03338790|11391474|FG000|Overall Study|Study Drug Toxicity|9
7190726|NCT03338790|11391475|FG001|Overall Study|Study Drug Toxicity|8
7190727|NCT03338790|11391476|FG002|Overall Study|Study Drug Toxicity|15
7190728|NCT03338790|11391477|FG003|Overall Study|Study Drug Toxicity|0
7190729|NCT03338790|11391474|FG000|Overall Study|Death|1
7190730|NCT03338790|11391475|FG001|Overall Study|Death|1
7190731|NCT03338790|11391476|FG002|Overall Study|Death|1
7190732|NCT03338790|11391477|FG003|Overall Study|Death|0
7190733|NCT03338790|11391474|FG000|Overall Study|Adverse Event unrelated to Study Drug|4
7190734|NCT03338790|11391475|FG001|Overall Study|Adverse Event unrelated to Study Drug|4
7190735|NCT03338790|11391476|FG002|Overall Study|Adverse Event unrelated to Study Drug|6
7190736|NCT03338790|11391477|FG003|Overall Study|Adverse Event unrelated to Study Drug|4
7190737|NCT03338790|11391474|FG000|Overall Study|Participant request to discontinue study treatment|3
7190738|NCT03338790|11391475|FG001|Overall Study|Participant request to discontinue study treatment|3
7190739|NCT03338790|11391476|FG002|Overall Study|Participant request to discontinue study treatment|2
7190740|NCT03338790|11391477|FG003|Overall Study|Participant request to discontinue study treatment|1
7190741|NCT03338790|11391474|FG000|Overall Study|Poor/non-compliance|0
7190742|NCT03338790|11391475|FG001|Overall Study|Poor/non-compliance|1
7190743|NCT03338790|11391476|FG002|Overall Study|Poor/non-compliance|0
7190744|NCT03338790|11391477|FG003|Overall Study|Poor/non-compliance|0
7190745|NCT03338790|11391474|FG000|Overall Study|Participant withdrew consent|1
7190746|NCT03338790|11391475|FG001|Overall Study|Participant withdrew consent|0
7190747|NCT03338790|11391476|FG002|Overall Study|Participant withdrew consent|1
7190748|NCT03338790|11391477|FG003|Overall Study|Participant withdrew consent|1
7190749|NCT03338790|11391474|FG000|Overall Study|Other reasons|0
7190750|NCT03338790|11391475|FG001|Overall Study|Other reasons|5
7190751|NCT03338790|11391476|FG002|Overall Study|Other reasons|0
7190752|NCT03338790|11391477|FG003|Overall Study|Other reasons|2
7190753|NCT03338790|11391474|FG000|Overall Study|Not reported|0
7190754|NCT03338790|11391475|FG001|Overall Study|Not reported|0
7190755|NCT03338790|11391476|FG002|Overall Study|Not reported|1
7190756|NCT03338790|11391477|FG003|Overall Study|Not reported|0
7190757|NCT03338790|11391474|FG000|Overall Study|Completed treatment period|1
7190758|NCT03338790|11391475|FG001|Overall Study|Completed treatment period|2
7190759|NCT03338790|11391476|FG002|Overall Study|Completed treatment period|0
7190760|NCT03338790|11391477|FG003|Overall Study|Completed treatment period|0
7190761|NCT03126539|11391489|FG000|Overall Study|Lost to Follow-up|1
7190762|NCT03126539|11391490|FG001|Overall Study|Lost to Follow-up|1
7190763|NCT03126539|11391491|FG002|Overall Study|Lost to Follow-up|1
7190764|NCT03126539|11391492|FG003|Overall Study|Lost to Follow-up|0
7190765|NCT03126539|11391493|FG004|Overall Study|Lost to Follow-up|0
7190766|NCT02898259|11391515|FG000|Overall Study|Adverse Event|0
7190767|NCT02898259|11391516|FG001|Overall Study|Adverse Event|0
7190768|NCT02898259|11391517|FG002|Overall Study|Adverse Event|1
7190769|NCT02898259|11391518|FG003|Overall Study|Adverse Event|0
7190770|NCT02898259|11391519|FG004|Overall Study|Adverse Event|0
7190771|NCT02898259|11391515|FG000|Overall Study|Lack of Efficacy|1
7190772|NCT02898259|11391516|FG001|Overall Study|Lack of Efficacy|1
7190773|NCT02898259|11391517|FG002|Overall Study|Lack of Efficacy|3
7190774|NCT02898259|11391518|FG003|Overall Study|Lack of Efficacy|0
7190775|NCT02898259|11391519|FG004|Overall Study|Lack of Efficacy|0
7190776|NCT02898259|11391515|FG000|Overall Study|Lost to Follow-up|0
7190777|NCT02898259|11391516|FG001|Overall Study|Lost to Follow-up|0
7190778|NCT02898259|11391517|FG002|Overall Study|Lost to Follow-up|1
7190779|NCT02898259|11391518|FG003|Overall Study|Lost to Follow-up|0
7190780|NCT02898259|11391519|FG004|Overall Study|Lost to Follow-up|0
7190781|NCT02898259|11391515|FG000|Overall Study|Transformation before study began|0
7190782|NCT02898259|11391516|FG001|Overall Study|Transformation before study began|0
7190783|NCT02898259|11391517|FG002|Overall Study|Transformation before study began|0
7190784|NCT02898259|11391518|FG003|Overall Study|Transformation before study began|1
7190785|NCT02898259|11391519|FG004|Overall Study|Transformation before study began|0
7190786|NCT02819635|11391544|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3
7190787|NCT02819635|11391545|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1
7190788|NCT02819635|11391546|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3
7190789|NCT02819635|11391547|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5
7190790|NCT02819635|11391548|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4
7190791|NCT02819635|11391549|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9
7190792|NCT02819635|11391550|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6
7190793|NCT02819635|11391551|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0
7190794|NCT02819635|11391552|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0
7190795|NCT02819635|11391553|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0
7190796|NCT02819635|11391554|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0
7190797|NCT02819635|11391555|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0
7190798|NCT02819635|11391544|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0
7190799|NCT02819635|11391545|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0
7190800|NCT02819635|11391546|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0
7190801|NCT02819635|11391547|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0
7190802|NCT02819635|11391548|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1
7190803|NCT02819635|11391549|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3
7190804|NCT02819635|11391550|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2
7190805|NCT02819635|11391551|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0
7190806|NCT02819635|11391552|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0
7190807|NCT02819635|11391553|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0
7190808|NCT02819635|11391554|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0
7190809|NCT02819635|11391555|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0
7190810|NCT02819635|11391544|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0
7190811|NCT02819635|11391545|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0
7190812|NCT02819635|11391546|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0
7190813|NCT02819635|11391547|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0
7190814|NCT02819635|11391548|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0
7190815|NCT02819635|11391549|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1
7190816|NCT02819635|11391550|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1
7190817|NCT02819635|11391551|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0
7190818|NCT02819635|11391552|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0
7190819|NCT02819635|11391553|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0
7050644|NCT01816074|11140243|FG002|Phase 2|Time commitment Issues|0
7050645|NCT01816074|11140244|FG003|Phase 2|Time commitment Issues|0
7050646|NCT01816074|11140241|FG000|Phase 2|Unsatisfied with Randomization assignmen|1
7050647|NCT01816074|11140242|FG001|Phase 2|Unsatisfied with Randomization assignmen|0
7050648|NCT01816074|11140243|FG002|Phase 2|Unsatisfied with Randomization assignmen|0
7050649|NCT01816074|11140244|FG003|Phase 2|Unsatisfied with Randomization assignmen|0
7050650|NCT01816074|11140241|FG000|Phase 2|Physician Decision|0
7050651|NCT01816074|11140242|FG001|Phase 2|Physician Decision|0
7050652|NCT01816074|11140243|FG002|Phase 2|Physician Decision|0
7050653|NCT01816074|11140244|FG003|Phase 2|Physician Decision|1
7050654|NCT01816074|11140241|FG000|Phase 2|Withdrawal by Subject|1
7050655|NCT01816074|11140242|FG001|Phase 2|Withdrawal by Subject|0
7050656|NCT01816074|11140243|FG002|Phase 2|Withdrawal by Subject|0
7050657|NCT01816074|11140244|FG003|Phase 2|Withdrawal by Subject|0
7050658|NCT01816243|11140272|FG000|Overall Study|Adverse Event|6
7050659|NCT01816243|11140272|FG000|Overall Study|Lost to Follow-up|1
7050660|NCT01816243|11140272|FG000|Overall Study|Lack of Efficacy|1
7050661|NCT01816243|11140272|FG000|Overall Study|Not eligible for the study|1
7050662|NCT01816243|11140272|FG000|Overall Study|Amputation|3
7050663|NCT01816295|11140278|FG000|Double Blind Phase|Adverse Event|11
7050664|NCT01816295|11140279|FG001|Double Blind Phase|Adverse Event|8
7050665|NCT01816295|11140278|FG000|Double Blind Phase|Entry Criteria Not Met|0
7050666|NCT01816295|11140279|FG001|Double Blind Phase|Entry Criteria Not Met|2
7050667|NCT01816295|11140278|FG000|Double Blind Phase|Lost to Follow-up|3
7050668|NCT01816295|11140279|FG001|Double Blind Phase|Lost to Follow-up|5
7050669|NCT01816295|11140278|FG000|Double Blind Phase|Physician Decision|2
7050670|NCT01816295|11140279|FG001|Double Blind Phase|Physician Decision|2
7050671|NCT01816295|11140278|FG000|Double Blind Phase|Protocol Violation|17
7050672|NCT01816295|11140279|FG001|Double Blind Phase|Protocol Violation|11
7050673|NCT01816295|11140278|FG000|Double Blind Phase|Sponsor Decision|8
7190820|NCT02819635|11391554|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0
7190821|NCT02819635|11391555|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0
7190822|NCT02819635|11391544|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0
7190823|NCT02819635|11391545|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0
7190824|NCT02819635|11391546|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0
7190825|NCT02819635|11391547|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0
7190826|NCT02819635|11391548|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0
7190827|NCT02819635|11391549|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0
7190828|NCT02819635|11391550|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1
7190829|NCT02819635|11391551|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0
7190830|NCT02819635|11391552|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0
7190831|NCT02819635|11391553|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0
7190832|NCT02819635|11391554|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0
7190833|NCT02819635|11391555|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0
7190834|NCT02819635|11391544|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2
7190835|NCT02819635|11391545|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1
7190836|NCT02819635|11391546|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1
7190837|NCT02819635|11391547|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7
7190838|NCT02819635|11391548|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5
7190839|NCT02819635|11391549|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7
7190840|NCT02819635|11391550|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3
6804250|NCT02544074|10806269|FG012|Overall Study|Tablet error|0
6804251|NCT02544074|10806270|FG013|Overall Study|Tablet error|0
6804252|NCT02544074|10806271|FG014|Overall Study|Tablet error|0
6804253|NCT02544074|10806272|FG015|Overall Study|Tablet error|0
6804254|NCT02544074|10806273|FG016|Overall Study|Tablet error|0
6804255|NCT02544074|10806274|FG017|Overall Study|Tablet error|0
6804256|NCT02544074|10806275|FG018|Overall Study|Tablet error|0
6804257|NCT02544074|10806276|FG019|Overall Study|Tablet error|0
6804258|NCT02544074|10806277|FG020|Overall Study|Tablet error|0
6804259|NCT02367040|10806313|FG000|Overall Study|Lost to Follow-up|1
6804260|NCT02367040|10806314|FG001|Overall Study|Lost to Follow-up|1
6804261|NCT02367040|10806313|FG000|Overall Study|Lack of Efficacy|1
6804262|NCT02367040|10806314|FG001|Overall Study|Lack of Efficacy|0
6804263|NCT02367040|10806313|FG000|Overall Study|Additional primary malignancy|0
6804264|NCT02367040|10806314|FG001|Overall Study|Additional primary malignancy|1
6804265|NCT02367040|10806313|FG000|Overall Study|AE not associated with clinical disease progression|104
6804266|NCT02367040|10806314|FG001|Overall Study|AE not associated with clinical disease progression|9
6804267|NCT02367040|10806313|FG000|Overall Study|AE associated with clinical disease progression|1
6804268|NCT02367040|10806314|FG001|Overall Study|AE associated with clinical disease progression|3
6804269|NCT02367040|10806313|FG000|Overall Study|Physician Decision|2
6804270|NCT02367040|10806314|FG001|Overall Study|Physician Decision|8
6804271|NCT02367040|10806313|FG000|Overall Study|Non-compliance with study drug|1
6804272|NCT02367040|10806314|FG001|Overall Study|Non-compliance with study drug|0
6804273|NCT02367040|10806313|FG000|Overall Study|Failure to meet continuation criteria|1
6804274|NCT02367040|10806314|FG001|Overall Study|Failure to meet continuation criteria|0
6804275|NCT02367040|10806313|FG000|Overall Study|Switching to other therapy|2
6804276|NCT02367040|10806314|FG001|Overall Study|Switching to other therapy|0
6804277|NCT02367040|10806313|FG000|Overall Study|Withdrawal by Subject|41
6804278|NCT02367040|10806314|FG001|Overall Study|Withdrawal by Subject|14
6804279|NCT02367040|10806313|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1
6804280|NCT02367040|10806314|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0
6804281|NCT02367040|10806313|FG000|Overall Study|Patient decision|35
6804282|NCT02367040|10806314|FG001|Overall Study|Patient decision|11
6804283|NCT02367040|10806313|FG000|Overall Study|Required procedure failed|1
6804284|NCT02367040|10806314|FG001|Overall Study|Required procedure failed|0
6804285|NCT02367040|10806313|FG000|Overall Study|Randomized by mistake with study treatment|1
6804286|NCT02367040|10806314|FG001|Overall Study|Randomized by mistake with study treatment|0
6804287|NCT02367040|10806313|FG000|Overall Study|Protocol Violation|1
6804288|NCT02367040|10806314|FG001|Overall Study|Protocol Violation|0
6804289|NCT02367040|10806313|FG000|Overall Study|Progressive disease - radiological progression|39
6804290|NCT02367040|10806314|FG001|Overall Study|Progressive disease - radiological progression|67
6804291|NCT02367040|10806313|FG000|Overall Study|Progressive disease - clinical progression|2
6804292|NCT02367040|10806314|FG001|Overall Study|Progressive disease - clinical progression|6
6804293|NCT02367040|10806313|FG000|Overall Study|Drug not administered|3
6804294|NCT02367040|10806314|FG001|Overall Study|Drug not administered|2
6804295|NCT02317627|10806323|FG000|Overall Study|Withdrawal by Subject|0
7190841|NCT02819635|11391551|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0
7190842|NCT02819635|11391552|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0
7190843|NCT02819635|11391553|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0
7190844|NCT02819635|11391554|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0
7190845|NCT02819635|11391555|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0
7190846|NCT02819635|11391544|FG000|Substudy 2, Part 2|Adverse Event|0
7190847|NCT02819635|11391545|FG001|Substudy 2, Part 2|Adverse Event|0
7190848|NCT02819635|11391546|FG002|Substudy 2, Part 2|Adverse Event|0
7190849|NCT02819635|11391547|FG003|Substudy 2, Part 2|Adverse Event|0
7190850|NCT02819635|11391548|FG004|Substudy 2, Part 2|Adverse Event|0
7190851|NCT02819635|11391549|FG005|Substudy 2, Part 2|Adverse Event|4
7190852|NCT02819635|11391550|FG006|Substudy 2, Part 2|Adverse Event|0
7190853|NCT02819635|11391551|FG007|Substudy 2, Part 2|Adverse Event|0
7190854|NCT02819635|11391552|FG008|Substudy 2, Part 2|Adverse Event|0
7190855|NCT02819635|11391553|FG009|Substudy 2, Part 2|Adverse Event|0
7190856|NCT02819635|11391554|FG010|Substudy 2, Part 2|Adverse Event|0
7190857|NCT02819635|11391555|FG011|Substudy 2, Part 2|Adverse Event|0
7190858|NCT02819635|11391544|FG000|Substudy 2, Part 2|Withdrew consent|0
7190859|NCT02819635|11391545|FG001|Substudy 2, Part 2|Withdrew consent|0
7190860|NCT02819635|11391546|FG002|Substudy 2, Part 2|Withdrew consent|0
7190861|NCT02819635|11391547|FG003|Substudy 2, Part 2|Withdrew consent|0
7190862|NCT02819635|11391548|FG004|Substudy 2, Part 2|Withdrew consent|0
7190863|NCT02819635|11391549|FG005|Substudy 2, Part 2|Withdrew consent|3
7190864|NCT02819635|11391550|FG006|Substudy 2, Part 2|Withdrew consent|1
7190865|NCT02819635|11391551|FG007|Substudy 2, Part 2|Withdrew consent|0
7190866|NCT02819635|11391552|FG008|Substudy 2, Part 2|Withdrew consent|0
7190867|NCT02819635|11391553|FG009|Substudy 2, Part 2|Withdrew consent|0
7190868|NCT02819635|11391554|FG010|Substudy 2, Part 2|Withdrew consent|0
7190869|NCT02819635|11391555|FG011|Substudy 2, Part 2|Withdrew consent|0
7190870|NCT02819635|11391544|FG000|Substudy 2, Part 2|Lost to Follow-up|0
7190871|NCT02819635|11391545|FG001|Substudy 2, Part 2|Lost to Follow-up|0
7190872|NCT02819635|11391546|FG002|Substudy 2, Part 2|Lost to Follow-up|0
7190873|NCT02819635|11391547|FG003|Substudy 2, Part 2|Lost to Follow-up|0
7190874|NCT02819635|11391548|FG004|Substudy 2, Part 2|Lost to Follow-up|0
7190875|NCT02819635|11391549|FG005|Substudy 2, Part 2|Lost to Follow-up|0
7190876|NCT02819635|11391550|FG006|Substudy 2, Part 2|Lost to Follow-up|1
7190877|NCT02819635|11391551|FG007|Substudy 2, Part 2|Lost to Follow-up|0
7190878|NCT02819635|11391552|FG008|Substudy 2, Part 2|Lost to Follow-up|0
7190879|NCT02819635|11391553|FG009|Substudy 2, Part 2|Lost to Follow-up|0
7190880|NCT02819635|11391554|FG010|Substudy 2, Part 2|Lost to Follow-up|0
7190881|NCT02819635|11391555|FG011|Substudy 2, Part 2|Lost to Follow-up|0
7190882|NCT02819635|11391544|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0
7190883|NCT02819635|11391545|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0
7190884|NCT02819635|11391546|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0
7190885|NCT02819635|11391547|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0
7190886|NCT02819635|11391548|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0
7190887|NCT02819635|11391549|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0
7190888|NCT02819635|11391550|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2
7190889|NCT02819635|11391551|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0
7190890|NCT02819635|11391552|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0
7190891|NCT02819635|11391553|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0
7190892|NCT02819635|11391554|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0
7190893|NCT02819635|11391555|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0
7190894|NCT02819635|11391544|FG000|Substudy 2, Part 2|Other, not specified|0
7190895|NCT02819635|11391545|FG001|Substudy 2, Part 2|Other, not specified|0
7190896|NCT02819635|11391546|FG002|Substudy 2, Part 2|Other, not specified|0
7190897|NCT02819635|11391547|FG003|Substudy 2, Part 2|Other, not specified|0
7190898|NCT02819635|11391548|FG004|Substudy 2, Part 2|Other, not specified|0
7190899|NCT02819635|11391549|FG005|Substudy 2, Part 2|Other, not specified|4
7190900|NCT02819635|11391550|FG006|Substudy 2, Part 2|Other, not specified|8
7190901|NCT02819635|11391551|FG007|Substudy 2, Part 2|Other, not specified|0
7190902|NCT02819635|11391552|FG008|Substudy 2, Part 2|Other, not specified|0
7190903|NCT02819635|11391553|FG009|Substudy 2, Part 2|Other, not specified|0
7190904|NCT02819635|11391554|FG010|Substudy 2, Part 2|Other, not specified|0
7190905|NCT02819635|11391555|FG011|Substudy 2, Part 2|Other, not specified|0
7190906|NCT02819635|11391544|FG000|Substudy 3|Adverse Event|0
7190907|NCT02819635|11391545|FG001|Substudy 3|Adverse Event|0
7190908|NCT02819635|11391546|FG002|Substudy 3|Adverse Event|0
7190909|NCT02819635|11391547|FG003|Substudy 3|Adverse Event|0
7190910|NCT02819635|11391548|FG004|Substudy 3|Adverse Event|0
7190911|NCT02819635|11391549|FG005|Substudy 3|Adverse Event|0
7190912|NCT02819635|11391550|FG006|Substudy 3|Adverse Event|0
7190913|NCT02819635|11391551|FG007|Substudy 3|Adverse Event|0
7190914|NCT02819635|11391552|FG008|Substudy 3|Adverse Event|32
7190915|NCT02819635|11391553|FG009|Substudy 3|Adverse Event|3
7190916|NCT02819635|11391554|FG010|Substudy 3|Adverse Event|12
7190917|NCT02819635|11391555|FG011|Substudy 3|Adverse Event|18
7190918|NCT02819635|11391544|FG000|Substudy 3|Withdrew consent|0
7190919|NCT02819635|11391545|FG001|Substudy 3|Withdrew consent|0
7190920|NCT02819635|11391546|FG002|Substudy 3|Withdrew consent|0
7190921|NCT02819635|11391547|FG003|Substudy 3|Withdrew consent|0
7190922|NCT02819635|11391548|FG004|Substudy 3|Withdrew consent|0
7190923|NCT02819635|11391549|FG005|Substudy 3|Withdrew consent|0
7190924|NCT02819635|11391550|FG006|Substudy 3|Withdrew consent|0
7190925|NCT02819635|11391551|FG007|Substudy 3|Withdrew consent|0
7190926|NCT02819635|11391552|FG008|Substudy 3|Withdrew consent|11
7190927|NCT02819635|11391553|FG009|Substudy 3|Withdrew consent|1
7190928|NCT02819635|11391554|FG010|Substudy 3|Withdrew consent|4
7190929|NCT02819635|11391555|FG011|Substudy 3|Withdrew consent|9
7190930|NCT02819635|11391544|FG000|Substudy 3|Lost to Follow-up|0
7190931|NCT02819635|11391545|FG001|Substudy 3|Lost to Follow-up|0
7190932|NCT02819635|11391546|FG002|Substudy 3|Lost to Follow-up|0
7190933|NCT02819635|11391547|FG003|Substudy 3|Lost to Follow-up|0
7190934|NCT02819635|11391548|FG004|Substudy 3|Lost to Follow-up|0
7190935|NCT02819635|11391549|FG005|Substudy 3|Lost to Follow-up|0
7190936|NCT02819635|11391550|FG006|Substudy 3|Lost to Follow-up|0
7190937|NCT02819635|11391551|FG007|Substudy 3|Lost to Follow-up|0
7190938|NCT02819635|11391552|FG008|Substudy 3|Lost to Follow-up|1
7190939|NCT02819635|11391553|FG009|Substudy 3|Lost to Follow-up|0
7190940|NCT02819635|11391554|FG010|Substudy 3|Lost to Follow-up|1
7190941|NCT02819635|11391555|FG011|Substudy 3|Lost to Follow-up|1
7190942|NCT02819635|11391544|FG000|Substudy 3|COVID-19 Logistical Restrictions|0
7190943|NCT02819635|11391545|FG001|Substudy 3|COVID-19 Logistical Restrictions|0
7190944|NCT02819635|11391546|FG002|Substudy 3|COVID-19 Logistical Restrictions|0
7190945|NCT02819635|11391547|FG003|Substudy 3|COVID-19 Logistical Restrictions|0
7190946|NCT02819635|11391548|FG004|Substudy 3|COVID-19 Logistical Restrictions|0
7190947|NCT02819635|11391549|FG005|Substudy 3|COVID-19 Logistical Restrictions|0
7050674|NCT01816295|11140279|FG001|Double Blind Phase|Sponsor Decision|8
7050675|NCT01816295|11140278|FG000|Double Blind Phase|Withdrawal by Subject|22
7050676|NCT01816295|11140279|FG001|Double Blind Phase|Withdrawal by Subject|20
7050677|NCT01816295|11140278|FG000|OLE Phase|Adverse Event|17
7050678|NCT01816295|11140279|FG001|OLE Phase|Adverse Event|15
7050679|NCT01816295|11140278|FG000|OLE Phase|Death|1
7050680|NCT01816295|11140279|FG001|OLE Phase|Death|0
7050681|NCT01816295|11140278|FG000|OLE Phase|Entry Criteria Not Met|3
7050682|NCT01816295|11140279|FG001|OLE Phase|Entry Criteria Not Met|5
7050683|NCT01816295|11140278|FG000|OLE Phase|Lost to Follow-up|5
7050684|NCT01816295|11140279|FG001|OLE Phase|Lost to Follow-up|5
7050685|NCT01816295|11140278|FG000|OLE Phase|Physician Decision|3
7050686|NCT01816295|11140279|FG001|OLE Phase|Physician Decision|1
7050687|NCT01816295|11140278|FG000|OLE Phase|Protocol Violation|4
7050688|NCT01816295|11140279|FG001|OLE Phase|Protocol Violation|4
7050689|NCT01816295|11140278|FG000|OLE Phase|Sponsor Decision|7
7050690|NCT01816295|11140279|FG001|OLE Phase|Sponsor Decision|9
7050691|NCT01816295|11140278|FG000|OLE Phase|Withdrawal by Subject|10
7050692|NCT01816295|11140279|FG001|OLE Phase|Withdrawal by Subject|10
7050693|NCT01816295|11140278|FG000|OLE Phase|Lack of Efficacy|3
7050694|NCT01816295|11140279|FG001|OLE Phase|Lack of Efficacy|7
7050695|NCT01816477|11140303|FG000|Overall Study|Withdrawal by Subject|13
7050696|NCT01816477|11140304|FG001|Overall Study|Withdrawal by Subject|1
7050697|NCT01816477|11140303|FG000|Overall Study|Unable to tolerate catheter placement|3
7050698|NCT01816477|11140304|FG001|Overall Study|Unable to tolerate catheter placement|0
7050699|NCT01816594|11140312|FG000|Overall Study|Local Progress|0
7050700|NCT01816594|11140313|FG001|Overall Study|Local Progress|2
7050701|NCT01816594|11140312|FG000|Overall Study|Adverse Event|9
7050702|NCT01816594|11140313|FG001|Overall Study|Adverse Event|0
7050703|NCT01816594|11140312|FG000|Overall Study|Withdrawal by Subject|1
7050704|NCT01816594|11140313|FG001|Overall Study|Withdrawal by Subject|0
7050705|NCT01816594|11140312|FG000|Overall Study|Physician Decision|1
7050706|NCT01816594|11140313|FG001|Overall Study|Physician Decision|0
7050707|NCT01816685|11140327|FG000|Overall Study|Lost to Follow-up|7
7050708|NCT01816685|11140328|FG001|Overall Study|Lost to Follow-up|9
7050709|NCT01816685|11140327|FG000|Overall Study|Surgery Cancelled|3
7050710|NCT01816685|11140328|FG001|Overall Study|Surgery Cancelled|2
7050711|NCT01816763|11140346|FG000|Overall Study|The main reason for an incomplete survey|4
7050712|NCT01816763|11140347|FG001|Overall Study|The main reason for an incomplete survey|15
7050713|NCT01816763|11140348|FG002|Overall Study|The main reason for an incomplete survey|11
7050714|NCT01816893|11140370|FG000|Washout Period|Withdrawal by Subject|2
7050715|NCT01816893|11140371|FG001|Washout Period|Withdrawal by Subject|0
7050716|NCT01816906|11140379|FG000|Six Months|Did Not Show Up for Baseline Measurement|7
7050717|NCT01816906|11140380|FG001|Six Months|Did Not Show Up for Baseline Measurement|6
7050718|NCT01816906|11140379|FG000|Six Months|Lost to Follow-up|14
7050719|NCT01816906|11140380|FG001|Six Months|Lost to Follow-up|16
7050720|NCT01816906|11140379|FG000|12 Months|Adverse Event|2
7050721|NCT01816906|11140380|FG001|12 Months|Adverse Event|2
7050722|NCT01816906|11140379|FG000|12 Months|Death|0
7050723|NCT01816906|11140380|FG001|12 Months|Death|2
7050724|NCT01816906|11140379|FG000|12 Months|Lost to Follow-up|2
7050725|NCT01816906|11140380|FG001|12 Months|Lost to Follow-up|1
7050726|NCT01816984|11140396|FG000|Overall Study|declining health status|1
7050727|NCT01817075|11140402|FG000|Overall Study|Adverse Event|7
7050728|NCT01817075|11140403|FG001|Overall Study|Adverse Event|5
7050729|NCT01817075|11140402|FG000|Overall Study|Physician Decision|9
7050730|NCT01817075|11140403|FG001|Overall Study|Physician Decision|12
7050731|NCT01817075|11140402|FG000|Overall Study|Withdrawal by Subject|31
7050732|NCT01817075|11140403|FG001|Overall Study|Withdrawal by Subject|15
7050733|NCT01817075|11140402|FG000|Overall Study|Received Sorafenib after enrollment|0
7050734|NCT01817075|11140403|FG001|Overall Study|Received Sorafenib after enrollment|1
7050735|NCT01817075|11140402|FG000|Overall Study|Ineligible|0
7190948|NCT02819635|11391550|FG006|Substudy 3|COVID-19 Logistical Restrictions|0
7190949|NCT02819635|11391551|FG007|Substudy 3|COVID-19 Logistical Restrictions|0
7190950|NCT02819635|11391552|FG008|Substudy 3|COVID-19 Logistical Restrictions|0
7190951|NCT02819635|11391553|FG009|Substudy 3|COVID-19 Logistical Restrictions|0
7190952|NCT02819635|11391554|FG010|Substudy 3|COVID-19 Logistical Restrictions|0
7190953|NCT02819635|11391555|FG011|Substudy 3|COVID-19 Logistical Restrictions|1
7190954|NCT02819635|11391544|FG000|Substudy 3|Other, not specified|0
7190955|NCT02819635|11391545|FG001|Substudy 3|Other, not specified|0
7190956|NCT02819635|11391546|FG002|Substudy 3|Other, not specified|0
7190957|NCT02819635|11391547|FG003|Substudy 3|Other, not specified|0
7190958|NCT02819635|11391548|FG004|Substudy 3|Other, not specified|0
7190959|NCT02819635|11391549|FG005|Substudy 3|Other, not specified|0
7190960|NCT02819635|11391550|FG006|Substudy 3|Other, not specified|0
7190961|NCT02819635|11391551|FG007|Substudy 3|Other, not specified|0
7190962|NCT02819635|11391552|FG008|Substudy 3|Other, not specified|202
7190963|NCT02819635|11391553|FG009|Substudy 3|Other, not specified|5
7190964|NCT02819635|11391554|FG010|Substudy 3|Other, not specified|89
7190965|NCT02819635|11391555|FG011|Substudy 3|Other, not specified|39
7190966|NCT02756013|11391583|FG000|Overall Study|Adverse Event|1
7190967|NCT02756013|11391583|FG000|Overall Study|Hypersensitivity|1
7190968|NCT02601209|11391609|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1
7190969|NCT02601209|11391610|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1
7190970|NCT02601209|11391611|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1
7190971|NCT02601209|11391612|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
7190972|NCT02601209|11391613|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
7190973|NCT02601209|11391614|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
7190974|NCT02601209|11391615|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
7190975|NCT02601209|11391616|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
7190976|NCT02601209|11391617|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
7190977|NCT02601209|11391609|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
7190978|NCT02601209|11391610|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
7190979|NCT02601209|11391611|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
7190980|NCT02601209|11391612|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
7190981|NCT02601209|11391613|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1
7190982|NCT02601209|11391614|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2
7190983|NCT02601209|11391615|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1
7190984|NCT02601209|11391616|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
7190985|NCT02601209|11391617|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
7190986|NCT02419807|11391636|FG000|Overall Study|Withdrawal by Subject|4
7190987|NCT02419807|11391636|FG000|Overall Study|Physician Decision|1
7190988|NCT02419807|11391636|FG000|Overall Study|Protocol Violation|5
7190989|NCT02278120|11391642|FG000|Overall Study|Progressive disease|122
7190990|NCT02278120|11391643|FG001|Overall Study|Progressive disease|174
7190991|NCT02278120|11391642|FG000|Overall Study|Patient/guardian decision|14
7190992|NCT02278120|11391643|FG001|Overall Study|Patient/guardian decision|8
7050736|NCT01817075|11140403|FG001|Overall Study|Ineligible|2
7050737|NCT01817530|11140433|FG000|Overall Study|Exclusionary Medication Received|0
7050738|NCT01817530|11140434|FG001|Overall Study|Exclusionary Medication Received|0
7050739|NCT01817530|11140435|FG002|Overall Study|Exclusionary Medication Received|0
7050740|NCT01817530|11140436|FG003|Overall Study|Exclusionary Medication Received|0
7050741|NCT01817530|11140437|FG004|Overall Study|Exclusionary Medication Received|1
7050742|NCT01817530|11140438|FG005|Overall Study|Exclusionary Medication Received|0
7050743|NCT01817530|11140439|FG006|Overall Study|Exclusionary Medication Received|0
7050744|NCT01817530|11140440|FG007|Overall Study|Exclusionary Medication Received|0
7190993|NCT02278120|11391642|FG000|Overall Study|Adverse Event|12
7190994|NCT02278120|11391643|FG001|Overall Study|Adverse Event|10
7190995|NCT02278120|11391642|FG000|Overall Study|Physician Decision|8
7190996|NCT02278120|11391643|FG001|Overall Study|Physician Decision|19
7190997|NCT02278120|11391642|FG000|Overall Study|Death|3
7190998|NCT02278120|11391643|FG001|Overall Study|Death|3
7190999|NCT02278120|11391642|FG000|Overall Study|Lost to Follow-up|2
7191000|NCT02278120|11391643|FG001|Overall Study|Lost to Follow-up|0
7191001|NCT02278120|11391642|FG000|Overall Study|Protocol Violation|0
7191002|NCT02278120|11391643|FG001|Overall Study|Protocol Violation|2
7191003|NCT02242942|11391652|FG000|Overall Study|Death|17
7191004|NCT02242942|11391653|FG001|Overall Study|Death|20
7191005|NCT02242942|11391654|FG002|Overall Study|Death|2
7191006|NCT02242942|11391652|FG000|Overall Study|Physician Decision|1
7191007|NCT02242942|11391653|FG001|Overall Study|Physician Decision|0
7191008|NCT02242942|11391654|FG002|Overall Study|Physician Decision|0
7191009|NCT02242942|11391652|FG000|Overall Study|Withdrawal by Subject|8
7191010|NCT02242942|11391653|FG001|Overall Study|Withdrawal by Subject|10
7191011|NCT02242942|11391654|FG002|Overall Study|Withdrawal by Subject|0
7191012|NCT02242942|11391652|FG000|Overall Study|On-going in Study|190
7191013|NCT02242942|11391653|FG001|Overall Study|On-going in Study|186
7191014|NCT02242942|11391654|FG002|Overall Study|On-going in Study|11
7191015|NCT02231749|11391666|FG000|Overall Study|Disease progression|229
7191016|NCT02231749|11391667|FG001|Overall Study|Disease progression|297
7191017|NCT02231749|11391666|FG000|Overall Study|Study Drug Toxicity|134
7191018|NCT02231749|11391667|FG001|Overall Study|Study Drug Toxicity|63
7191019|NCT02231749|11391666|FG000|Overall Study|Death|1
7191020|NCT02231749|11391667|FG001|Overall Study|Death|1
6804296|NCT02317627|10806324|FG001|Overall Study|Withdrawal by Subject|1
6804297|NCT02317627|10806325|FG002|Overall Study|Withdrawal by Subject|1
6804298|NCT02317627|10806323|FG000|Overall Study|Lost to Follow-up|2
6804299|NCT02317627|10806324|FG001|Overall Study|Lost to Follow-up|0
6804300|NCT02317627|10806325|FG002|Overall Study|Lost to Follow-up|0
6804301|NCT02317627|10806323|FG000|Overall Study|Stopped by Investigator|0
6804302|NCT02317627|10806324|FG001|Overall Study|Stopped by Investigator|1
6804303|NCT02317627|10806325|FG002|Overall Study|Stopped by Investigator|0
6804304|NCT02317627|10806323|FG000|Overall Study|Adverse Event|0
6804305|NCT02317627|10806324|FG001|Overall Study|Adverse Event|2
6804306|NCT02317627|10806325|FG002|Overall Study|Adverse Event|3
6804307|NCT02317627|10806323|FG000|Overall Study|Non-compliance with study drug|0
6804308|NCT02317627|10806324|FG001|Overall Study|Non-compliance with study drug|1
6804309|NCT02317627|10806325|FG002|Overall Study|Non-compliance with study drug|0
6804310|NCT01935128|10806339|FG000|Overall Study|Death|1
6804311|NCT01935128|10806339|FG000|Overall Study|Adverse Event|6
7191021|NCT02231749|11391666|FG000|Overall Study|AE unrelated to Study drug|32
7191022|NCT02231749|11391667|FG001|Overall Study|AE unrelated to Study drug|31
7191023|NCT02231749|11391666|FG000|Overall Study|Participant's request to discontinue|10
7191024|NCT02231749|11391667|FG001|Overall Study|Participant's request to discontinue|21
7191025|NCT02231749|11391666|FG000|Overall Study|Participant withdrew Consent|8
7191026|NCT02231749|11391667|FG001|Overall Study|Participant withdrew Consent|15
7191027|NCT02231749|11391666|FG000|Overall Study|Lost to Follow-up|1
7191028|NCT02231749|11391667|FG001|Overall Study|Lost to Follow-up|2
7191029|NCT02231749|11391666|FG000|Overall Study|Maximum Clinical Benefit|5
7191030|NCT02231749|11391667|FG001|Overall Study|Maximum Clinical Benefit|8
7191031|NCT02231749|11391666|FG000|Overall Study|Poor/Non-Compliance|0
7191032|NCT02231749|11391667|FG001|Overall Study|Poor/Non-Compliance|3
7191033|NCT02231749|11391666|FG000|Overall Study|Pregnancy|1
7191034|NCT02231749|11391667|FG001|Overall Study|Pregnancy|0
7191035|NCT02231749|11391666|FG000|Overall Study|other|0
7191036|NCT02231749|11391667|FG001|Overall Study|other|8
7191037|NCT02231749|11391666|FG000|Overall Study|No longer meets Study Criteria|1
7191038|NCT02231749|11391667|FG001|Overall Study|No longer meets Study Criteria|0
7191039|NCT02227199|11391676|FG000|Overall Study|Physician Decision|0
7191040|NCT02227199|11391677|FG001|Overall Study|Physician Decision|0
7191041|NCT02227199|11391678|FG002|Overall Study|Physician Decision|1
7191042|NCT02227199|11391676|FG000|Overall Study|Adverse Event|0
7191043|NCT02227199|11391677|FG001|Overall Study|Adverse Event|0
7191044|NCT02227199|11391678|FG002|Overall Study|Adverse Event|3
7191045|NCT02181413|11391692|FG000|Overall Study|Adverse Event|7
7191046|NCT02181413|11391693|FG001|Overall Study|Adverse Event|24
7191047|NCT02181413|11391692|FG000|Overall Study|Progressive Disease|121
7191048|NCT02181413|11391693|FG001|Overall Study|Progressive Disease|143
7191049|NCT02181413|11391692|FG000|Overall Study|Withdrawal by Subject|5
7191050|NCT02181413|11391693|FG001|Overall Study|Withdrawal by Subject|8
7191051|NCT02181413|11391692|FG000|Overall Study|Reason Not Specified|19
7191052|NCT02181413|11391693|FG001|Overall Study|Reason Not Specified|20
7191053|NCT02181413|11391692|FG000|Overall Study|Ongoing Study Treatment|0
7191054|NCT02181413|11391693|FG001|Overall Study|Ongoing Study Treatment|1
7191055|NCT02181413|11391692|FG000|Overall Study|Lost to Follow-up|0
7191056|NCT02181413|11391693|FG001|Overall Study|Lost to Follow-up|1
7191057|NCT02095678|11391701|FG000|Overall Study|Withdrawal by Subject|0
7191058|NCT02095678|11391702|FG001|Overall Study|Withdrawal by Subject|1
7191059|NCT02095678|11391701|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11
7191060|NCT02095678|11391702|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12
7191061|NCT02095678|11391701|FG000|Overall Study|lesion impacted by previous treatment|1
7191062|NCT02095678|11391702|FG001|Overall Study|lesion impacted by previous treatment|1
7191063|NCT02095678|11391701|FG000|Overall Study|No Confirmed Diagnosis|0
7050745|NCT01817530|11140433|FG000|Overall Study|Adverse Event|6
7050746|NCT01817530|11140434|FG001|Overall Study|Adverse Event|3
7050747|NCT01817530|11140435|FG002|Overall Study|Adverse Event|2
7050748|NCT01817530|11140436|FG003|Overall Study|Adverse Event|5
7050749|NCT01817530|11140437|FG004|Overall Study|Adverse Event|0
7050750|NCT01817530|11140438|FG005|Overall Study|Adverse Event|10
7050751|NCT01817530|11140439|FG006|Overall Study|Adverse Event|5
7050752|NCT01817530|11140440|FG007|Overall Study|Adverse Event|8
7050753|NCT01817530|11140433|FG000|Overall Study|Subject Noncompliant|3
7050754|NCT01817530|11140434|FG001|Overall Study|Subject Noncompliant|1
7050755|NCT01817530|11140435|FG002|Overall Study|Subject Noncompliant|0
7050756|NCT01817530|11140436|FG003|Overall Study|Subject Noncompliant|4
7050757|NCT01817530|11140437|FG004|Overall Study|Subject Noncompliant|0
7050758|NCT01817530|11140438|FG005|Overall Study|Subject Noncompliant|1
7050759|NCT01817530|11140439|FG006|Overall Study|Subject Noncompliant|1
7050760|NCT01817530|11140440|FG007|Overall Study|Subject Noncompliant|1
7050761|NCT01817530|11140433|FG000|Overall Study|Lack of Efficacy|1
7050762|NCT01817530|11140434|FG001|Overall Study|Lack of Efficacy|0
7050763|NCT01817530|11140435|FG002|Overall Study|Lack of Efficacy|0
7191064|NCT02095678|11391702|FG001|Overall Study|No Confirmed Diagnosis|3
7191065|NCT02095678|11391701|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1
7191066|NCT02095678|11391702|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1
7191067|NCT02095678|11391701|FG000|Overall Study|No Visible Lesion or Pathological Finding|4
7050764|NCT01817530|11140436|FG003|Overall Study|Lack of Efficacy|0
7050765|NCT01817530|11140437|FG004|Overall Study|Lack of Efficacy|0
7191068|NCT02095678|11391702|FG001|Overall Study|No Visible Lesion or Pathological Finding|0
7191069|NCT01958021|11391722|FG000|Overall Study|Progressive disease|87
7191070|NCT01958021|11391723|FG001|Overall Study|Progressive disease|146
7191071|NCT01958021|11391722|FG000|Overall Study|Adverse Event|25
7191072|NCT01958021|11391723|FG001|Overall Study|Adverse Event|7
7191073|NCT01958021|11391722|FG000|Overall Study|Subject/guardian decision|12
7191074|NCT01958021|11391723|FG001|Overall Study|Subject/guardian decision|13
7191075|NCT01958021|11391722|FG000|Overall Study|Physician Decision|10
7191076|NCT01958021|11391723|FG001|Overall Study|Physician Decision|13
7191077|NCT01958021|11391722|FG000|Overall Study|Protocol Violation|3
7191078|NCT01958021|11391723|FG001|Overall Study|Protocol Violation|1
7191079|NCT01958021|11391722|FG000|Overall Study|Death|2
7191080|NCT01958021|11391723|FG001|Overall Study|Death|0
7191081|NCT01955109|11391731|FG000|Overall Study|Adverse Event|2
7191082|NCT01955109|11391732|FG001|Overall Study|Adverse Event|0
7191083|NCT01955109|11391731|FG000|Overall Study|Participant unwilling to continue|35
7191084|NCT01955109|11391732|FG001|Overall Study|Participant unwilling to continue|7
7191085|NCT01955109|11391731|FG000|Overall Study|Physician Decision|2
7191086|NCT01955109|11391732|FG001|Overall Study|Physician Decision|0
7191087|NCT01955109|11391731|FG000|Overall Study|Lost to Follow-up|3
7191088|NCT01955109|11391732|FG001|Overall Study|Lost to Follow-up|1
7191089|NCT01955109|11391731|FG000|Overall Study|Non-compliance|3
7191090|NCT01955109|11391732|FG001|Overall Study|Non-compliance|1
7191091|NCT01902173|11391756|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1
7191092|NCT01902173|11391757|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
7191093|NCT01902173|11391758|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
7191094|NCT01902173|11391759|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
7191095|NCT01902173|11391760|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
7191096|NCT01902173|11391761|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
7191097|NCT01902173|11391756|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2
7191098|NCT01902173|11391757|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
7191099|NCT01902173|11391758|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
7191100|NCT01902173|11391759|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
7191101|NCT01902173|11391760|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
7191102|NCT01902173|11391761|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
7191103|NCT01902173|11391756|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
7191104|NCT01902173|11391757|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5
7191105|NCT01902173|11391758|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
7191106|NCT01902173|11391759|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
7191107|NCT01902173|11391760|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
7191108|NCT01902173|11391761|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
7191109|NCT01902173|11391756|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
7191110|NCT01902173|11391757|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1
7191111|NCT01902173|11391758|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
7191112|NCT01902173|11391759|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
7191113|NCT01902173|11391760|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
7191114|NCT01902173|11391761|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
7191115|NCT01902173|11391756|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0
7191116|NCT01902173|11391757|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3
7191117|NCT01902173|11391758|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0
7191118|NCT01902173|11391759|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0
7191119|NCT01902173|11391760|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0
7191120|NCT01902173|11391761|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0
7191121|NCT01902173|11391756|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
7191122|NCT01902173|11391757|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
7191123|NCT01902173|11391758|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3
7050766|NCT01817530|11140438|FG005|Overall Study|Lack of Efficacy|1
7050767|NCT01817530|11140439|FG006|Overall Study|Lack of Efficacy|0
7050768|NCT01817530|11140440|FG007|Overall Study|Lack of Efficacy|1
7050769|NCT01817530|11140433|FG000|Overall Study|Pregnancy|0
7050770|NCT01817530|11140434|FG001|Overall Study|Pregnancy|0
7050771|NCT01817530|11140435|FG002|Overall Study|Pregnancy|0
7050772|NCT01817530|11140436|FG003|Overall Study|Pregnancy|0
7050773|NCT01817530|11140437|FG004|Overall Study|Pregnancy|0
7050774|NCT01817530|11140438|FG005|Overall Study|Pregnancy|1
7050775|NCT01817530|11140439|FG006|Overall Study|Pregnancy|0
7050776|NCT01817530|11140440|FG007|Overall Study|Pregnancy|0
7050777|NCT01817530|11140433|FG000|Overall Study|Other|0
7050778|NCT01817530|11140434|FG001|Overall Study|Other|1
7191124|NCT01902173|11391759|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
7191125|NCT01902173|11391760|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
7191126|NCT01902173|11391761|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
7191127|NCT01902173|11391756|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
7191128|NCT01902173|11391757|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
7191129|NCT01902173|11391758|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1
7191130|NCT01902173|11391759|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
7191131|NCT01902173|11391760|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
7191132|NCT01902173|11391761|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
7191133|NCT01902173|11391756|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
7191134|NCT01902173|11391757|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
7191135|NCT01902173|11391758|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
7191136|NCT01902173|11391759|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1
7191137|NCT01902173|11391760|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
7191138|NCT01902173|11391761|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
7191139|NCT01902173|11391756|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
7191140|NCT01902173|11391757|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
7191141|NCT01902173|11391758|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
7191142|NCT01902173|11391759|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2
7191143|NCT01902173|11391760|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
7191144|NCT01902173|11391761|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
7191145|NCT01902173|11391756|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
7191146|NCT01902173|11391757|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
7191147|NCT01902173|11391758|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
7191148|NCT01902173|11391759|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
7191149|NCT01902173|11391760|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1
7191150|NCT01902173|11391761|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
7191151|NCT01902173|11391756|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
7191152|NCT01902173|11391757|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
7191153|NCT01902173|11391758|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
7191154|NCT01902173|11391759|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
7191155|NCT01902173|11391760|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2
7191156|NCT01902173|11391761|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
7191157|NCT01902173|11391756|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
7191158|NCT01902173|11391757|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
7191159|NCT01902173|11391758|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
7191160|NCT01902173|11391759|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
7191161|NCT01902173|11391760|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
7191162|NCT01902173|11391761|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1
7191163|NCT01902173|11391756|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
7191164|NCT01902173|11391757|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
7191165|NCT01902173|11391758|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
7191166|NCT01902173|11391759|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
7050779|NCT01817530|11140435|FG002|Overall Study|Other|0
7050780|NCT01817530|11140436|FG003|Overall Study|Other|0
7050781|NCT01817530|11140437|FG004|Overall Study|Other|1
7050782|NCT01817530|11140438|FG005|Overall Study|Other|0
7050783|NCT01817530|11140439|FG006|Overall Study|Other|5
7050784|NCT01817530|11140440|FG007|Overall Study|Other|0
7050785|NCT01817530|11140433|FG000|Overall Study|Surgery or Invasive Intervention|1
7050786|NCT01817530|11140434|FG001|Overall Study|Surgery or Invasive Intervention|0
7050787|NCT01817530|11140435|FG002|Overall Study|Surgery or Invasive Intervention|0
7191167|NCT01902173|11391760|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
7191168|NCT01902173|11391761|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3
7191169|NCT01902173|11391756|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0
7191170|NCT01902173|11391757|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0
7191171|NCT01902173|11391758|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0
7191172|NCT01902173|11391759|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0
7191173|NCT01902173|11391760|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0
7191174|NCT01902173|11391761|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1
7191175|NCT01854775|11391781|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1
7191176|NCT01854775|11391782|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1
7191177|NCT01854775|11391783|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0
7191178|NCT01854775|11391781|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1
7191179|NCT01854775|11391782|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0
7191180|NCT01854775|11391783|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0
7191181|NCT01854775|11391781|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0
7191182|NCT01854775|11391782|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0
7191183|NCT01854775|11391783|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9
7050788|NCT01817530|11140436|FG003|Overall Study|Surgery or Invasive Intervention|0
7050789|NCT01817530|11140437|FG004|Overall Study|Surgery or Invasive Intervention|1
7050790|NCT01817530|11140438|FG005|Overall Study|Surgery or Invasive Intervention|1
7050791|NCT01817530|11140439|FG006|Overall Study|Surgery or Invasive Intervention|1
7050792|NCT01817530|11140440|FG007|Overall Study|Surgery or Invasive Intervention|0
7050793|NCT01817530|11140433|FG000|Overall Study|Consent Withdrawn by Subject|3
7050794|NCT01817530|11140434|FG001|Overall Study|Consent Withdrawn by Subject|4
7050795|NCT01817530|11140435|FG002|Overall Study|Consent Withdrawn by Subject|7
7050796|NCT01817530|11140436|FG003|Overall Study|Consent Withdrawn by Subject|3
7050797|NCT01817530|11140437|FG004|Overall Study|Consent Withdrawn by Subject|5
7050798|NCT01817530|11140438|FG005|Overall Study|Consent Withdrawn by Subject|3
7050799|NCT01817530|11140439|FG006|Overall Study|Consent Withdrawn by Subject|3
7050800|NCT01817530|11140440|FG007|Overall Study|Consent Withdrawn by Subject|10
7050801|NCT01817530|11140433|FG000|Overall Study|Lost to Follow-up|1
7050802|NCT01817530|11140434|FG001|Overall Study|Lost to Follow-up|4
7050803|NCT01817530|11140435|FG002|Overall Study|Lost to Follow-up|2
7050804|NCT01817530|11140436|FG003|Overall Study|Lost to Follow-up|1
7050805|NCT01817530|11140437|FG004|Overall Study|Lost to Follow-up|3
7050806|NCT01817530|11140438|FG005|Overall Study|Lost to Follow-up|2
7050807|NCT01817530|11140439|FG006|Overall Study|Lost to Follow-up|8
7050808|NCT01817530|11140440|FG007|Overall Study|Lost to Follow-up|4
7050809|NCT01817582|11140461|FG000|Overall Study|Withdrawal by Subject|0
7050810|NCT01817582|11140462|FG001|Overall Study|Withdrawal by Subject|1
7050811|NCT01817582|11140463|FG002|Overall Study|Withdrawal by Subject|0
7050812|NCT01817582|11140461|FG000|Overall Study|Participant revealed masked treatment|1
7050813|NCT01817582|11140462|FG001|Overall Study|Participant revealed masked treatment|0
7050814|NCT01817582|11140463|FG002|Overall Study|Participant revealed masked treatment|0
7050815|NCT01817582|11140461|FG000|Overall Study|Randomized but exclusion criteria met|1
7050816|NCT01817582|11140462|FG001|Overall Study|Randomized but exclusion criteria met|0
7050817|NCT01817582|11140463|FG002|Overall Study|Randomized but exclusion criteria met|0
7050818|NCT01817725|11140480|FG000|Overall Study|Withdrawal by Subject|1
7050819|NCT01817764|11140486|FG000|Overall Study|Adverse Event|7
7084006|NCT02160782|11195749|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0
7050820|NCT01817764|11140487|FG001|Overall Study|Adverse Event|10
7050821|NCT01817764|11140486|FG000|Overall Study|Lack of Efficacy|9
7050822|NCT01817764|11140487|FG001|Overall Study|Lack of Efficacy|7
7050823|NCT01817764|11140486|FG000|Overall Study|Protocol Violation|7
7050824|NCT01817764|11140487|FG001|Overall Study|Protocol Violation|5
7050825|NCT01817764|11140486|FG000|Overall Study|Lost to Follow-up|1
7050826|NCT01817764|11140487|FG001|Overall Study|Lost to Follow-up|4
7050827|NCT01817764|11140486|FG000|Overall Study|Withdrawal by Subject|10
7050828|NCT01817764|11140487|FG001|Overall Study|Withdrawal by Subject|12
7050829|NCT01817777|11140495|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3
7191184|NCT01854775|11391781|FG000|Extension Phase|Pregnancy|3
7191185|NCT01854775|11391782|FG001|Extension Phase|Pregnancy|0
7191186|NCT01854775|11391783|FG002|Extension Phase|Pregnancy|0
7191187|NCT01854775|11391781|FG000|Extension Phase|Investigator's Discretion|1
7191188|NCT01854775|11391782|FG001|Extension Phase|Investigator's Discretion|0
7191189|NCT01854775|11391783|FG002|Extension Phase|Investigator's Discretion|0
7191190|NCT01854775|11391781|FG000|Extension Phase|Non-Compliance with Study Drug|1
7191191|NCT01854775|11391782|FG001|Extension Phase|Non-Compliance with Study Drug|0
7191192|NCT01854775|11391783|FG002|Extension Phase|Non-Compliance with Study Drug|0
7191193|NCT01854775|11391781|FG000|Extension Phase|Lost to Follow-up|2
7191194|NCT01854775|11391782|FG001|Extension Phase|Lost to Follow-up|0
7191195|NCT01854775|11391783|FG002|Extension Phase|Lost to Follow-up|0
7191196|NCT01854775|11391781|FG000|Extension Phase|Still on Study|32
7191197|NCT01854775|11391782|FG001|Extension Phase|Still on Study|47
7191198|NCT01854775|11391783|FG002|Extension Phase|Still on Study|18
7191199|NCT01839331|11391809|FG000|Overall Study|Early Termination|3
7191200|NCT01839331|11391810|FG001|Overall Study|Early Termination|0
7191201|NCT01839331|11391811|FG002|Overall Study|Early Termination|1
7191202|NCT01839331|11391812|FG003|Overall Study|Early Termination|2
7191203|NCT01839331|11391809|FG000|Overall Study|Protocol Violation|1
7191204|NCT01839331|11391810|FG001|Overall Study|Protocol Violation|6
7084007|NCT02160782|11195750|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0
7084008|NCT02160782|11195751|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0
7084009|NCT02160782|11195752|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5
7084010|NCT02160782|11195753|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0
7084011|NCT02160782|11195749|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0
7050830|NCT01817777|11140496|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0
7191205|NCT01839331|11391811|FG002|Overall Study|Protocol Violation|4
7191206|NCT01839331|11391812|FG003|Overall Study|Protocol Violation|3
7050831|NCT01817777|11140497|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0
7050832|NCT01817777|11140495|FG000|Observational Phase (8 Weeks)|Early Study Termination|2
7050833|NCT01817777|11140496|FG001|Observational Phase (8 Weeks)|Early Study Termination|0
7050834|NCT01817777|11140497|FG002|Observational Phase (8 Weeks)|Early Study Termination|0
7050835|NCT01817777|11140495|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
7050836|NCT01817777|11140496|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3
7050837|NCT01817777|11140497|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
7050838|NCT01817777|11140495|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0
7050839|NCT01817777|11140496|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1
7050840|NCT01817777|11140497|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2
7050841|NCT01817777|11140495|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0
7050842|NCT01817777|11140496|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1
7050843|NCT01817777|11140497|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3
7191207|NCT01835145|11391830|FG000|Overall Study|Ineligible prior to treatment|1
7191208|NCT01835145|11391831|FG001|Overall Study|Ineligible prior to treatment|0
7191209|NCT01235234|11391851|FG000|Overall Study|Adverse Event|2
7050844|NCT01817790|11140505|FG000|Overall Study|Adverse Event|0
7050845|NCT01817790|11140506|FG001|Overall Study|Adverse Event|2
7050846|NCT01817790|11140505|FG000|Overall Study|Lost to Follow-up|0
7050847|NCT01817790|11140506|FG001|Overall Study|Lost to Follow-up|1
7050848|NCT01817790|11140505|FG000|Overall Study|Protocol Violation|2
7050849|NCT01817790|11140506|FG001|Overall Study|Protocol Violation|1
7050850|NCT01817790|11140505|FG000|Overall Study|Withdrawal by Subject|1
7050851|NCT01817790|11140506|FG001|Overall Study|Withdrawal by Subject|3
7050852|NCT01817790|11140505|FG000|Overall Study|Other: Could not attend appointment|1
7050853|NCT01817790|11140506|FG001|Overall Study|Other: Could not attend appointment|1
7050854|NCT01817959|11140548|FG000|Overall Study|Graft loss|1
7050855|NCT01817959|11140549|FG001|Overall Study|Graft loss|1
7050856|NCT01817959|11140548|FG000|Overall Study|forbidden medication|1
7050857|NCT01817959|11140549|FG001|Overall Study|forbidden medication|1
7050858|NCT01817959|11140548|FG000|Overall Study|Adverse Event|1
7050859|NCT01817959|11140549|FG001|Overall Study|Adverse Event|0
7050860|NCT01817959|11140548|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1
7050861|NCT01817959|11140549|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1
7050862|NCT01818141|11140566|FG000|Overall Study|Withdrawal by Subject|2
7050863|NCT01818141|11140567|FG001|Overall Study|Withdrawal by Subject|0
7050864|NCT01818141|11140566|FG000|Overall Study|No baseline C.diff colonies|1
7050865|NCT01818141|11140567|FG001|Overall Study|No baseline C.diff colonies|1
7050866|NCT01818141|11140566|FG000|Overall Study|Lost to Follow-up|0
7050867|NCT01818141|11140567|FG001|Overall Study|Lost to Follow-up|2
7050868|NCT01818258|11140589|FG000|Overall Study|Death|3
7050869|NCT01818258|11140590|FG001|Overall Study|Death|0
7050870|NCT01818258|11140589|FG000|Overall Study|Withdrawal by Subject|0
7050871|NCT01818258|11140590|FG001|Overall Study|Withdrawal by Subject|1
7050872|NCT01818258|11140589|FG000|Overall Study|Lost to Follow-up|0
7050873|NCT01818258|11140590|FG001|Overall Study|Lost to Follow-up|1
7050874|NCT01818258|11140589|FG000|Overall Study|Unable to Travel to Clinic|0
7050875|NCT01818258|11140590|FG001|Overall Study|Unable to Travel to Clinic|1
7050876|NCT01818284|11140599|FG000|Overall Study|Not eligible due to White Blood Counts|4
7050877|NCT01818284|11140600|FG001|Overall Study|Not eligible due to White Blood Counts|4
7050878|NCT01818284|11140599|FG000|Overall Study|Death|0
7050879|NCT01818284|11140600|FG001|Overall Study|Death|2
7050880|NCT01818297|11140607|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0
7050881|NCT01818297|11140608|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1
7050882|NCT01818297|11140607|FG000|Open Label Phase (3-12 Months)|Physician Decision|1
7050883|NCT01818297|11140608|FG001|Open Label Phase (3-12 Months)|Physician Decision|0
7050884|NCT01818297|11140607|FG000|Open Label Phase (3-12 Months)|Early study closure|17
7050885|NCT01818297|11140608|FG001|Open Label Phase (3-12 Months)|Early study closure|10
7050886|NCT01818336|11140614|FG000|Overall Study|Declined retest visit|0
7050887|NCT01818336|11140615|FG001|Overall Study|Declined retest visit|11
7050888|NCT01818336|11140614|FG000|Overall Study|Lost to Follow-up|0
7050889|NCT01818336|11140615|FG001|Overall Study|Lost to Follow-up|1
7191210|NCT01235234|11391852|FG001|Overall Study|Adverse Event|2
7191211|NCT01235234|11391853|FG002|Overall Study|Adverse Event|1
7191212|NCT01160211|11391864|FG000|Overall Study|ongoing|90
7191213|NCT01160211|11391865|FG001|Overall Study|ongoing|75
7191214|NCT01160211|11391866|FG002|Overall Study|ongoing|79
7191215|NCT01160211|11391864|FG000|Overall Study|Withdrawal by Subject|3
7191216|NCT01160211|11391865|FG001|Overall Study|Withdrawal by Subject|5
7191217|NCT01160211|11391866|FG002|Overall Study|Withdrawal by Subject|3
7191218|NCT01160211|11391864|FG000|Overall Study|Physician Decision|2
7191219|NCT01160211|11391865|FG001|Overall Study|Physician Decision|0
7191220|NCT01160211|11391866|FG002|Overall Study|Physician Decision|0
7191221|NCT01160211|11391864|FG000|Overall Study|Lost to Follow-up|4
7050890|NCT01818492|11140641|FG000|Overall Study|Adverse Event|2
7050891|NCT01818492|11140641|FG000|Overall Study|Death|3
7050892|NCT01818492|11140641|FG000|Overall Study|Withdrawal by Subject|1
7050893|NCT01818492|11140641|FG000|Overall Study|Additional therapy when not allowed PP|4
7050894|NCT01818531|11140673|FG000|Overall Study|Withdrawn for case delay after block|1
7050895|NCT01818531|11140674|FG001|Overall Study|Withdrawn for case delay after block|0
7050896|NCT01818531|11140673|FG000|Overall Study|Withdrawn for long-acting opioid patch|0
7050897|NCT01818531|11140674|FG001|Overall Study|Withdrawn for long-acting opioid patch|1
7050898|NCT01818531|11140673|FG000|Overall Study|Withdrawn for failure to place block|0
7050899|NCT01818531|11140674|FG001|Overall Study|Withdrawn for failure to place block|1
7191222|NCT01160211|11391865|FG001|Overall Study|Lost to Follow-up|7
7191223|NCT01160211|11391866|FG002|Overall Study|Lost to Follow-up|5
7191224|NCT01093573|11391878|FG000|Overall Study|Physician Decision|0
7191225|NCT01093573|11391879|FG001|Overall Study|Physician Decision|0
7191226|NCT01093573|11391880|FG002|Overall Study|Physician Decision|1
7191227|NCT01093573|11391878|FG000|Overall Study|Insurance Denied|0
7191228|NCT01093573|11391879|FG001|Overall Study|Insurance Denied|0
7191229|NCT01093573|11391880|FG002|Overall Study|Insurance Denied|1
7191230|NCT00828854|11391891|FG000|Overall Study|Disease Progression|17
7191231|NCT00828854|11391891|FG000|Overall Study|Adverse Event|9
7191232|NCT00828854|11391891|FG000|Overall Study|Reason not Specified|1
7191233|NCT00753545|11391897|FG000|Overall Study|Death|98
7191234|NCT00753545|11391898|FG001|Overall Study|Death|112
7191235|NCT00753545|11391897|FG000|Overall Study|Lost to Follow-up|2
7191236|NCT00753545|11391898|FG001|Overall Study|Lost to Follow-up|3
7191237|NCT00753545|11391897|FG000|Overall Study|Protocol Violation|1
7191238|NCT00753545|11391898|FG001|Overall Study|Protocol Violation|0
7191239|NCT00753545|11391897|FG000|Overall Study|Voluntary Discontinuation of Patient|7
7191240|NCT00753545|11391898|FG001|Overall Study|Voluntary Discontinuation of Patient|3
7191241|NCT00494234|11391906|FG000|Overall Study|Lack of Efficacy|12
7191242|NCT00494234|11391907|FG001|Overall Study|Lack of Efficacy|9
7191243|NCT00494234|11391906|FG000|Overall Study|Withdrawal by Subject|1
7191244|NCT00494234|11391907|FG001|Overall Study|Withdrawal by Subject|0
7191245|NCT00494234|11391906|FG000|Overall Study|Death|2
7191246|NCT00494234|11391907|FG001|Overall Study|Death|1
7050900|NCT01818596|11140682|FG000|Overall Study|Enrolled but Not Treated|4
7050901|NCT01818596|11140683|FG001|Overall Study|Enrolled but Not Treated|0
7050902|NCT01818596|11140682|FG000|Overall Study|Adverse Event|7
7050903|NCT01818596|11140683|FG001|Overall Study|Adverse Event|0
7050904|NCT01818596|11140682|FG000|Overall Study|Death|3
7050905|NCT01818596|11140683|FG001|Overall Study|Death|0
7050906|NCT01818596|11140682|FG000|Overall Study|Investigator's Discretion|4
7050907|NCT01818596|11140683|FG001|Overall Study|Investigator's Discretion|0
7050908|NCT01818596|11140682|FG000|Overall Study|Protocol Violation|1
7050909|NCT01818596|11140683|FG001|Overall Study|Protocol Violation|0
7050910|NCT01818596|11140682|FG000|Overall Study|Withdrew Consent|5
7050911|NCT01818596|11140683|FG001|Overall Study|Withdrew Consent|0
7050912|NCT01818596|11140682|FG000|Overall Study|Lost to Follow-up|7
7050913|NCT01818596|11140683|FG001|Overall Study|Lost to Follow-up|0
7050914|NCT01818700|11140690|FG000|Overall Study|Adverse Event|67
7050915|NCT01818700|11140690|FG000|Overall Study|Lack of Efficacy|2
7050916|NCT01818700|11140690|FG000|Overall Study|Lost to Follow-up|5
7050917|NCT01818700|11140690|FG000|Overall Study|Withdrawal by Subject|27
7050918|NCT01818700|11140690|FG000|Overall Study|Protocol Violation|2
6810201|NCT01090024|10814009|FG002|Period 3|Protocol Violation|0
6810202|NCT01090024|10814010|FG003|Period 3|Protocol Violation|0
7050919|NCT01818700|11140690|FG000|Overall Study|Other|1
7050920|NCT01818726|11140698|FG000|Overall Study|Administrative reasons|5
7050921|NCT01818726|11140699|FG001|Overall Study|Administrative reasons|1
7050922|NCT01818726|11140698|FG000|Overall Study|Withdrawal by Subject|0
7050923|NCT01818726|11140699|FG001|Overall Study|Withdrawal by Subject|1
7050924|NCT01818726|11140698|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1
7050925|NCT01818726|11140699|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0
7050926|NCT01818752|11140712|FG000|Overall Study|Adverse Event|64
7050927|NCT01818752|11140713|FG001|Overall Study|Adverse Event|74
7050928|NCT01818752|11140712|FG000|Overall Study|Death|14
6810203|NCT01090024|10814011|FG004|Period 3|Protocol Violation|0
6810204|NCT01090024|10814012|FG005|Period 3|Protocol Violation|0
6810205|NCT01090024|10814013|FG006|Period 3|Protocol Violation|0
6810206|NCT01090024|10814014|FG007|Period 3|Protocol Violation|0
6810207|NCT01090024|10814015|FG008|Period 3|Protocol Violation|1
6810208|NCT01090024|10814016|FG009|Period 3|Protocol Violation|0
6810209|NCT01090024|10814017|FG010|Period 3|Protocol Violation|0
6810210|NCT01090024|10814018|FG011|Period 3|Protocol Violation|0
6810211|NCT01090024|10814019|FG012|Period 3|Protocol Violation|0
6810212|NCT01090024|10814020|FG013|Period 3|Protocol Violation|0
6810213|NCT01090024|10814021|FG014|Period 3|Protocol Violation|0
6810214|NCT01090024|10814022|FG015|Period 3|Protocol Violation|0
6810215|NCT01090024|10814023|FG016|Period 3|Protocol Violation|0
6810216|NCT01090024|10814024|FG017|Period 3|Protocol Violation|0
6810217|NCT01090024|10814007|FG000|Period 3|Adverse Event|0
6810218|NCT01090024|10814008|FG001|Period 3|Adverse Event|0
7050929|NCT01818752|11140713|FG001|Overall Study|Death|18
7050930|NCT01818752|11140712|FG000|Overall Study|Non-compliance|16
7050931|NCT01818752|11140713|FG001|Overall Study|Non-compliance|20
7050932|NCT01818752|11140712|FG000|Overall Study|Withdrawal by Subject|15
7050933|NCT01818752|11140713|FG001|Overall Study|Withdrawal by Subject|14
7050934|NCT01818752|11140712|FG000|Overall Study|Physician Decision|9
7050935|NCT01818752|11140713|FG001|Overall Study|Physician Decision|8
7050936|NCT01818752|11140712|FG000|Overall Study|Disease Progression|54
7050937|NCT01818752|11140713|FG001|Overall Study|Disease Progression|48
7050938|NCT01818752|11140712|FG000|Overall Study|Other|7
7050939|NCT01818752|11140713|FG001|Overall Study|Other|8
7050940|NCT01818752|11140712|FG000|Overall Study|Continuing Treatment|1
7050941|NCT01818752|11140713|FG001|Overall Study|Continuing Treatment|4
7050942|NCT01818752|11140712|FG000|Overall Study|Randomized but not Dosed|7
7050943|NCT01818752|11140713|FG001|Overall Study|Randomized but not Dosed|4
7050944|NCT01818765|11140719|FG000|Overall Study|Death|2
7050945|NCT01819129|11140735|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1
7050946|NCT01819129|11140736|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0
7050947|NCT01819129|11140735|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1
7050948|NCT01819129|11140736|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0
7050949|NCT01819129|11140735|FG000|Overall Study|Other, Subject moved out of the country|0
7050950|NCT01819129|11140736|FG001|Overall Study|Other, Subject moved out of the country|1
7050951|NCT01819129|11140735|FG000|Overall Study|Withdrawal by Subject|15
7050952|NCT01819129|11140736|FG001|Overall Study|Withdrawal by Subject|15
7050953|NCT01819129|11140735|FG000|Overall Study|Lost to Follow-up|5
7050954|NCT01819129|11140736|FG001|Overall Study|Lost to Follow-up|2
7050955|NCT01819129|11140735|FG000|Overall Study|Lack of Efficacy|0
7050956|NCT01819129|11140736|FG001|Overall Study|Lack of Efficacy|1
7050957|NCT01819129|11140735|FG000|Overall Study|Adverse Event|1
7050958|NCT01819129|11140736|FG001|Overall Study|Adverse Event|4
7050959|NCT01819129|11140735|FG000|Overall Study|Death|1
7050960|NCT01819129|11140736|FG001|Overall Study|Death|1
7050961|NCT01819129|11140735|FG000|Overall Study|Withdrawal Criteria|20
7050962|NCT01819129|11140736|FG001|Overall Study|Withdrawal Criteria|15
7050963|NCT01819194|11140742|FG000|Overall Study|Loss of study articles|2
7050964|NCT01819272|11140756|FG000|Overall Study|Adverse Event|1
7050965|NCT01819272|11140757|FG001|Overall Study|Adverse Event|0
7050966|NCT01819272|11140758|FG002|Overall Study|Adverse Event|0
7050967|NCT01819272|11140759|FG003|Overall Study|Adverse Event|2
7050968|NCT01819272|11140760|FG004|Overall Study|Adverse Event|0
7050969|NCT01819272|11140761|FG005|Overall Study|Adverse Event|0
7050970|NCT01819272|11140756|FG000|Overall Study|Lost to Follow-up|3
7050971|NCT01819272|11140757|FG001|Overall Study|Lost to Follow-up|0
7050972|NCT01819272|11140758|FG002|Overall Study|Lost to Follow-up|1
7050973|NCT01819272|11140759|FG003|Overall Study|Lost to Follow-up|0
7050974|NCT01819272|11140760|FG004|Overall Study|Lost to Follow-up|0
7050975|NCT01819272|11140761|FG005|Overall Study|Lost to Follow-up|3
7050976|NCT01819272|11140756|FG000|Overall Study|Protocol Violation|0
7050977|NCT01819272|11140757|FG001|Overall Study|Protocol Violation|0
7050978|NCT01819272|11140758|FG002|Overall Study|Protocol Violation|0
7050979|NCT01819272|11140759|FG003|Overall Study|Protocol Violation|1
7050980|NCT01819272|11140760|FG004|Overall Study|Protocol Violation|2
7050981|NCT01819272|11140761|FG005|Overall Study|Protocol Violation|3
7050982|NCT01819272|11140756|FG000|Overall Study|Physician Decision|0
7050983|NCT01819272|11140757|FG001|Overall Study|Physician Decision|1
7050984|NCT01819272|11140758|FG002|Overall Study|Physician Decision|0
7050985|NCT01819272|11140759|FG003|Overall Study|Physician Decision|0
7050986|NCT01819272|11140760|FG004|Overall Study|Physician Decision|0
7050987|NCT01819272|11140761|FG005|Overall Study|Physician Decision|0
7050988|NCT01819272|11140756|FG000|Overall Study|Withdrawal of Consent|0
7050989|NCT01819272|11140757|FG001|Overall Study|Withdrawal of Consent|1
7050990|NCT01819272|11140758|FG002|Overall Study|Withdrawal of Consent|2
7050991|NCT01819272|11140759|FG003|Overall Study|Withdrawal of Consent|1
7050992|NCT01819272|11140760|FG004|Overall Study|Withdrawal of Consent|0
7050993|NCT01819272|11140761|FG005|Overall Study|Withdrawal of Consent|1
7050994|NCT01819272|11140756|FG000|Overall Study|Loss of Glucose Control|2
7050995|NCT01819272|11140757|FG001|Overall Study|Loss of Glucose Control|1
7050996|NCT01819272|11140758|FG002|Overall Study|Loss of Glucose Control|0
7050997|NCT01819272|11140759|FG003|Overall Study|Loss of Glucose Control|1
7050998|NCT01819272|11140760|FG004|Overall Study|Loss of Glucose Control|2
7050999|NCT01819272|11140761|FG005|Overall Study|Loss of Glucose Control|0
7051000|NCT01819506|11140803|FG000|Overall Study|Physician Decision|5
7051001|NCT01819506|11140804|FG001|Overall Study|Physician Decision|2
7051002|NCT01819506|11140803|FG000|Overall Study|Withdrawal by Subject|3
7084012|NCT02160782|11195750|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0
7084013|NCT02160782|11195751|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0
7084014|NCT02160782|11195752|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0
7084015|NCT02160782|11195753|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4
7051003|NCT01819506|11140804|FG001|Overall Study|Withdrawal by Subject|3
7051004|NCT01819727|11140816|FG000|Overall Study|Adverse Event|8
7051005|NCT01819727|11140817|FG001|Overall Study|Adverse Event|9
7051006|NCT01819727|11140816|FG000|Overall Study|Death|1
7051007|NCT01819727|11140817|FG001|Overall Study|Death|0
7051008|NCT01819727|11140816|FG000|Overall Study|Lost to Follow-up|1
7051009|NCT01819727|11140817|FG001|Overall Study|Lost to Follow-up|1
7051010|NCT01819727|11140816|FG000|Overall Study|Physician Decision|3
7051011|NCT01819727|11140817|FG001|Overall Study|Physician Decision|2
7051012|NCT01819727|11140816|FG000|Overall Study|Pregnancy|1
7051013|NCT01819727|11140817|FG001|Overall Study|Pregnancy|0
7051014|NCT01819727|11140816|FG000|Overall Study|Protocol Violation|0
7051015|NCT01819727|11140817|FG001|Overall Study|Protocol Violation|2
7051016|NCT01819727|11140816|FG000|Overall Study|Study Terminated by Sponsor|0
7051017|NCT01819727|11140817|FG001|Overall Study|Study Terminated by Sponsor|1
7051018|NCT01819727|11140816|FG000|Overall Study|Withdrawal by Subject|6
7051019|NCT01819727|11140817|FG001|Overall Study|Withdrawal by Subject|11
7051020|NCT01819727|11140816|FG000|Overall Study|Unable to demostrate ability self-inject|0
7051021|NCT01819727|11140817|FG001|Overall Study|Unable to demostrate ability self-inject|1
7051022|NCT01819727|11140816|FG000|Overall Study|Quit due to lack of health benifits|0
7051023|NCT01819727|11140817|FG001|Overall Study|Quit due to lack of health benifits|1
7051024|NCT01820260|11140866|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7051025|NCT01820260|11140867|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7051026|NCT01820260|11140868|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7051027|NCT01820260|11140869|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7051028|NCT01820260|11140870|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7051029|NCT01820260|11140871|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7051030|NCT01820260|11140872|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1
7051031|NCT01820260|11140873|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7051032|NCT01820260|11140874|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7051033|NCT01820260|11140875|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7051034|NCT01820260|11140876|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7051035|NCT01820260|11140877|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7051036|NCT01820260|11140878|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7051037|NCT01820260|11140879|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7051038|NCT01820260|11140866|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0
7051039|NCT01820260|11140867|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0
7051040|NCT01820260|11140868|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0
7051041|NCT01820260|11140869|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0
7051042|NCT01820260|11140870|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0
7051043|NCT01820260|11140871|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0
7051044|NCT01820260|11140872|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0
7051045|NCT01820260|11140873|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0
7051046|NCT01820260|11140874|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0
7051047|NCT01820260|11140875|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1
7051048|NCT01820260|11140876|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0
7051049|NCT01820260|11140877|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0
7051050|NCT01820260|11140878|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0
7051051|NCT01820260|11140879|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0
7051052|NCT01820364|11140915|FG000|Part I: LGX818|Death|1
7051053|NCT01820364|11140916|FG001|Part I: LGX818|Death|0
7051054|NCT01820364|11140915|FG000|Part I: LGX818|Administrative Problems|3
7051055|NCT01820364|11140916|FG001|Part I: LGX818|Administrative Problems|0
7051056|NCT01820364|11140915|FG000|Part I: LGX818|Adverse Event|6
7051057|NCT01820364|11140916|FG001|Part I: LGX818|Adverse Event|0
7051058|NCT01820364|11140915|FG000|Part I: LGX818|Disease Progression|4
7051059|NCT01820364|11140916|FG001|Part I: LGX818|Disease Progression|0
7051060|NCT01820364|11140915|FG000|Part II: LGX818 + MEK162|Study Termination|0
7084016|NCT02160782|11195749|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0
7084017|NCT02160782|11195750|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0
7084018|NCT02160782|11195751|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0
7084019|NCT02160782|11195752|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0
7084020|NCT02160782|11195753|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1
7084021|NCT02160782|11195749|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0
7084022|NCT02160782|11195750|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0
7084023|NCT02160782|11195751|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0
7084024|NCT02160782|11195752|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0
7084025|NCT02160782|11195753|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3
7084026|NCT02160782|11195749|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0
7084027|NCT02160782|11195750|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0
7084028|NCT02160782|11195751|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0
7084029|NCT02160782|11195752|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0
7084030|NCT02160782|11195753|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1
7084031|NCT02160899|11195816|FG000|Overall Study|Adverse Event or Serious Adverse Event|0
7084032|NCT02160899|11195817|FG001|Overall Study|Adverse Event or Serious Adverse Event|1
7084033|NCT02160899|11195818|FG002|Overall Study|Adverse Event or Serious Adverse Event|0
7084034|NCT02160899|11195819|FG003|Overall Study|Adverse Event or Serious Adverse Event|1
7084035|NCT02160899|11195820|FG004|Overall Study|Adverse Event or Serious Adverse Event|2
7084036|NCT02160899|11195821|FG005|Overall Study|Adverse Event or Serious Adverse Event|0
7084037|NCT02160977|11195837|FG000|Six Weeks After Surgery|Lost to Follow-up|1
7084038|NCT02160977|11195838|FG001|Six Weeks After Surgery|Lost to Follow-up|0
7084039|NCT02160977|11195837|FG000|Three Months After Surgery|Lost to Follow-up|0
7084040|NCT02160977|11195838|FG001|Three Months After Surgery|Lost to Follow-up|2
7084041|NCT02160977|11195837|FG000|Six Months After Surgery|Lost to Follow-up|2
7084042|NCT02160977|11195838|FG001|Six Months After Surgery|Lost to Follow-up|1
7084043|NCT02161146|11195867|FG000|Overall Study|Adverse Event|1
7084044|NCT02161146|11195868|FG001|Overall Study|Adverse Event|1
7084045|NCT02161146|11195869|FG002|Overall Study|Adverse Event|0
7084046|NCT02161146|11195870|FG003|Overall Study|Adverse Event|1
7084047|NCT02161146|11195871|FG004|Overall Study|Adverse Event|0
7084048|NCT02161146|11195867|FG000|Overall Study|Lost to Follow-up|0
7084049|NCT02161146|11195868|FG001|Overall Study|Lost to Follow-up|1
7084050|NCT02161146|11195869|FG002|Overall Study|Lost to Follow-up|0
7051061|NCT01820364|11140916|FG001|Part II: LGX818 + MEK162|Study Termination|1
7051062|NCT01820559|11140938|FG000|Overall Study|Adverse Event|4
7051063|NCT01820559|11140939|FG001|Overall Study|Adverse Event|6
7051064|NCT01820559|11140940|FG002|Overall Study|Adverse Event|13
7051065|NCT01820559|11140938|FG000|Overall Study|Withdrawal by Subject|1
7051066|NCT01820559|11140939|FG001|Overall Study|Withdrawal by Subject|2
7051067|NCT01820559|11140940|FG002|Overall Study|Withdrawal by Subject|5
7051068|NCT01820559|11140938|FG000|Overall Study|Protocol Violation|2
7051069|NCT01820559|11140939|FG001|Overall Study|Protocol Violation|1
7051070|NCT01820559|11140940|FG002|Overall Study|Protocol Violation|3
7051071|NCT01820559|11140938|FG000|Overall Study|Subject's non-compliance|1
7051072|NCT01820559|11140939|FG001|Overall Study|Subject's non-compliance|0
7051073|NCT01820559|11140940|FG002|Overall Study|Subject's non-compliance|2
7051074|NCT01820559|11140938|FG000|Overall Study|Lost to Follow-up|3
7051075|NCT01820559|11140939|FG001|Overall Study|Lost to Follow-up|2
7051076|NCT01820559|11140940|FG002|Overall Study|Lost to Follow-up|2
7051077|NCT01820559|11140938|FG000|Overall Study|At sponsor request|0
7051078|NCT01820559|11140939|FG001|Overall Study|At sponsor request|0
7051079|NCT01820559|11140940|FG002|Overall Study|At sponsor request|1
7051080|NCT01820559|11140938|FG000|Overall Study|Lack of Efficacy|3
7051081|NCT01820559|11140939|FG001|Overall Study|Lack of Efficacy|2
7051082|NCT01820559|11140940|FG002|Overall Study|Lack of Efficacy|3
7084051|NCT02161146|11195870|FG003|Overall Study|Lost to Follow-up|0
7084052|NCT02161146|11195871|FG004|Overall Study|Lost to Follow-up|0
7084053|NCT02161146|11195867|FG000|Overall Study|Personal Reasons|0
7084054|NCT02161146|11195868|FG001|Overall Study|Personal Reasons|1
7084055|NCT02161146|11195869|FG002|Overall Study|Personal Reasons|0
7084056|NCT02161146|11195870|FG003|Overall Study|Personal Reasons|2
7084057|NCT02161146|11195871|FG004|Overall Study|Personal Reasons|1
7084058|NCT02161146|11195867|FG000|Overall Study|Other Miscellaneous Reasons|0
7084059|NCT02161146|11195868|FG001|Overall Study|Other Miscellaneous Reasons|1
7084060|NCT02161146|11195869|FG002|Overall Study|Other Miscellaneous Reasons|0
7084061|NCT02161146|11195870|FG003|Overall Study|Other Miscellaneous Reasons|0
7084062|NCT02161146|11195871|FG004|Overall Study|Other Miscellaneous Reasons|0
7084063|NCT02161185|11195881|FG000|Treatment Phase|Administrative/Other|7
7084064|NCT02161406|11195887|FG000|Overall Study|Death|2
7084065|NCT02161406|11195888|FG001|Overall Study|Death|1
7084066|NCT02161406|11195887|FG000|Overall Study|Lost to Follow-up|2
7084067|NCT02161406|11195888|FG001|Overall Study|Lost to Follow-up|1
7084068|NCT02161406|11195887|FG000|Overall Study|Withdrawal by Subject|2
7084069|NCT02161406|11195888|FG001|Overall Study|Withdrawal by Subject|4
7084070|NCT02161406|11195887|FG000|Overall Study|investigator withdrew subject|3
7084071|NCT02161406|11195888|FG001|Overall Study|investigator withdrew subject|1
7084072|NCT02161406|11195887|FG000|Overall Study|Lack of Efficacy|1
7084073|NCT02161406|11195888|FG001|Overall Study|Lack of Efficacy|1
7084074|NCT02161406|11195887|FG000|Overall Study|relocation|0
7084075|NCT02161406|11195888|FG001|Overall Study|relocation|1
7084076|NCT02161458|11195898|FG000|Overall Study|Withdrawal by Subject|0
7084077|NCT02161458|11195899|FG001|Overall Study|Withdrawal by Subject|4
7084078|NCT02161458|11195900|FG002|Overall Study|Withdrawal by Subject|4
7084079|NCT02161458|11195901|FG003|Overall Study|Withdrawal by Subject|0
7084080|NCT02161458|11195898|FG000|Overall Study|Lost to Follow-up|0
7084081|NCT02161458|11195899|FG001|Overall Study|Lost to Follow-up|2
7084082|NCT02161458|11195900|FG002|Overall Study|Lost to Follow-up|1
7084083|NCT02161458|11195901|FG003|Overall Study|Lost to Follow-up|0
7051083|NCT01820572|11140950|FG000|Randomization|Not Treated|2
7051084|NCT01820572|11140951|FG001|Randomization|Not Treated|1
7051085|NCT01820572|11140950|FG000|Treatment Period|Adverse Event|12
7051086|NCT01820572|11140951|FG001|Treatment Period|Adverse Event|7
7051087|NCT01820572|11140950|FG000|Treatment Period|Death|3
7051088|NCT01820572|11140951|FG001|Treatment Period|Death|3
7051089|NCT01820572|11140950|FG000|Treatment Period|Lack of Efficacy|1
7051090|NCT01820572|11140951|FG001|Treatment Period|Lack of Efficacy|0
7051091|NCT01820572|11140950|FG000|Treatment Period|poor/non compliance|0
7051092|NCT01820572|11140951|FG001|Treatment Period|poor/non compliance|3
7051093|NCT01820572|11140950|FG000|Treatment Period|request to discontinue|6
7051094|NCT01820572|11140951|FG001|Treatment Period|request to discontinue|11
7051095|NCT01820572|11140950|FG000|Treatment Period|No longer meets study criteria|3
7051096|NCT01820572|11140951|FG001|Treatment Period|No longer meets study criteria|10
7051097|NCT01820572|11140950|FG000|Treatment Period|withdrew consent|1
7051098|NCT01820572|11140951|FG001|Treatment Period|withdrew consent|2
7051099|NCT01820585|11140961|FG000|Overall Study|Adverse Event|9
7051100|NCT01820585|11140962|FG001|Overall Study|Adverse Event|13
7051101|NCT01820585|11140963|FG002|Overall Study|Adverse Event|23
7051102|NCT01820585|11140964|FG003|Overall Study|Adverse Event|34
7051103|NCT01820585|11140961|FG000|Overall Study|Lack of Efficacy|9
7051104|NCT01820585|11140962|FG001|Overall Study|Lack of Efficacy|7
7051105|NCT01820585|11140963|FG002|Overall Study|Lack of Efficacy|5
7051106|NCT01820585|11140964|FG003|Overall Study|Lack of Efficacy|1
7051107|NCT01820585|11140961|FG000|Overall Study|Withdrawal by Subject|3
7051108|NCT01820585|11140962|FG001|Overall Study|Withdrawal by Subject|7
7051109|NCT01820585|11140963|FG002|Overall Study|Withdrawal by Subject|3
7051110|NCT01820585|11140964|FG003|Overall Study|Withdrawal by Subject|8
7051111|NCT01820585|11140961|FG000|Overall Study|Lost to Follow-up|3
7051112|NCT01820585|11140962|FG001|Overall Study|Lost to Follow-up|3
7051113|NCT01820585|11140963|FG002|Overall Study|Lost to Follow-up|0
7051114|NCT01820585|11140964|FG003|Overall Study|Lost to Follow-up|3
7051115|NCT01820585|11140961|FG000|Overall Study|Protocol Violation|3
7051116|NCT01820585|11140962|FG001|Overall Study|Protocol Violation|1
7051117|NCT01820585|11140963|FG002|Overall Study|Protocol Violation|1
7051118|NCT01820585|11140964|FG003|Overall Study|Protocol Violation|1
7051119|NCT01820585|11140961|FG000|Overall Study|Subject non-compliance|0
7051120|NCT01820585|11140962|FG001|Overall Study|Subject non-compliance|0
7051121|NCT01820585|11140963|FG002|Overall Study|Subject non-compliance|1
7051122|NCT01820585|11140964|FG003|Overall Study|Subject non-compliance|2
7051123|NCT01820585|11140961|FG000|Overall Study|at sponsor request|0
7051124|NCT01820585|11140962|FG001|Overall Study|at sponsor request|0
7051125|NCT01820585|11140963|FG002|Overall Study|at sponsor request|1
7051126|NCT01820585|11140964|FG003|Overall Study|at sponsor request|0
7051127|NCT01820585|11140961|FG000|Overall Study|Pregnancy|0
7051128|NCT01820585|11140962|FG001|Overall Study|Pregnancy|1
7051129|NCT01820585|11140963|FG002|Overall Study|Pregnancy|0
7051130|NCT01820585|11140964|FG003|Overall Study|Pregnancy|0
7051131|NCT01820637|11140974|FG000|Overall Study|Death|2
7051132|NCT01820637|11140974|FG000|Overall Study|Withdrawal by Subject|1
7051133|NCT01821118|11140988|FG000|Overall Study|Death|0
7051134|NCT01821118|11140989|FG001|Overall Study|Death|1
7051135|NCT01821391|11141043|FG000|Overall Study|Adverse Event|1
7051136|NCT01821391|11141044|FG001|Overall Study|Adverse Event|0
7051137|NCT01821560|11141067|FG000|Overall Study|Lost to Follow-up|5
7051138|NCT01821560|11141068|FG001|Overall Study|Lost to Follow-up|5
7051139|NCT01821560|11141067|FG000|Overall Study|Withdrawal by Subject|1
7051140|NCT01821560|11141068|FG001|Overall Study|Withdrawal by Subject|1
7051141|NCT01821560|11141067|FG000|Overall Study|Protocol Violation|0
7051142|NCT01821560|11141068|FG001|Overall Study|Protocol Violation|1
7051143|NCT01821625|11141074|FG000|Overall Study|Withdrawal by Subject|2
7051144|NCT01821625|11141074|FG000|Overall Study|Lack of Efficacy|2
7051145|NCT01821625|11141074|FG000|Overall Study|Adverse Event|1
7051146|NCT01821625|11141074|FG000|Overall Study|Medical contraindication|1
7051147|NCT01821729|11141078|FG000|Overall Study|Withdrawal by Subject|1
7051148|NCT01821807|11141084|FG000|Overall Study|Lost to Follow-up|3
7084084|NCT02161549|11195935|FG000|Overall Study|Physician Decision|6
7051149|NCT01821807|11141085|FG001|Overall Study|Lost to Follow-up|1
7051150|NCT01821937|11141093|FG000|Overall Study|Adverse Event|0
7051151|NCT01821937|11141094|FG001|Overall Study|Adverse Event|3
7051152|NCT01822132|11141108|FG000|Overall Study|Lost to Follow-up|4
7051153|NCT01822132|11141109|FG001|Overall Study|Lost to Follow-up|2
7051154|NCT01822223|11141127|FG000|Overall Study|Death|0
7051155|NCT01822223|11141128|FG001|Overall Study|Death|1
7051156|NCT01822353|11141149|FG000|Overall Study|Adverse Event|1
7051157|NCT01822353|11141150|FG001|Overall Study|Adverse Event|3
7051158|NCT01822353|11141151|FG002|Overall Study|Adverse Event|1
7051159|NCT01822353|11141149|FG000|Overall Study|Pregnancy|0
7051160|NCT01822353|11141150|FG001|Overall Study|Pregnancy|1
7051161|NCT01822353|11141151|FG002|Overall Study|Pregnancy|0
7084085|NCT02161549|11195936|FG001|Overall Study|Physician Decision|2
7084086|NCT02161562|11195944|FG000|Overall Study|Withdrawal by Subject|5
7084087|NCT02161562|11195945|FG001|Overall Study|Withdrawal by Subject|8
7084088|NCT02161562|11195944|FG000|Overall Study|Protocol Violation|9
7084089|NCT02161562|11195945|FG001|Overall Study|Protocol Violation|4
7084090|NCT02161562|11195944|FG000|Overall Study|Pregnancy|1
7084091|NCT02161562|11195945|FG001|Overall Study|Pregnancy|2
7051162|NCT01822353|11141149|FG000|Overall Study|Withdrawal by Subject|3
7051163|NCT01822353|11141150|FG001|Overall Study|Withdrawal by Subject|1
7051164|NCT01822353|11141151|FG002|Overall Study|Withdrawal by Subject|0
7051165|NCT01822366|11141166|FG000|Overall Study|Lost to Follow-up|5
7051166|NCT01822366|11141167|FG001|Overall Study|Lost to Follow-up|1
7051167|NCT01822366|11141168|FG002|Overall Study|Lost to Follow-up|5
7051168|NCT01822366|11141169|FG003|Overall Study|Lost to Follow-up|1
7051169|NCT01822366|11141166|FG000|Overall Study|Withdrawal by Subject|0
7051170|NCT01822366|11141167|FG001|Overall Study|Withdrawal by Subject|6
7051171|NCT01822366|11141168|FG002|Overall Study|Withdrawal by Subject|0
7051172|NCT01822366|11141169|FG003|Overall Study|Withdrawal by Subject|6
7051173|NCT01822366|11141166|FG000|Overall Study|Partial Intervention Completion|0
7051174|NCT01822366|11141167|FG001|Overall Study|Partial Intervention Completion|15
7051175|NCT01822366|11141168|FG002|Overall Study|Partial Intervention Completion|0
7051176|NCT01822366|11141169|FG003|Overall Study|Partial Intervention Completion|15
7051177|NCT01822496|11141210|FG000|Overall Study|Protocol Violation|2
7051178|NCT01822496|11141211|FG001|Overall Study|Protocol Violation|2
7084092|NCT02161562|11195944|FG000|Overall Study|Lost to Follow-up|3
6810219|NCT01090024|10814009|FG002|Period 3|Adverse Event|0
7051179|NCT01822496|11141212|FG002|Overall Study|Protocol Violation|0
7051180|NCT01822496|11141213|FG003|Overall Study|Protocol Violation|1
7051181|NCT01822496|11141210|FG000|Overall Study|Withdrawal by Subject|0
7051182|NCT01822496|11141211|FG001|Overall Study|Withdrawal by Subject|0
7051183|NCT01822496|11141212|FG002|Overall Study|Withdrawal by Subject|0
7084093|NCT02161562|11195945|FG001|Overall Study|Lost to Follow-up|1
7084094|NCT02161562|11195944|FG000|Overall Study|Lack of Efficacy|4
7051184|NCT01822496|11141213|FG003|Overall Study|Withdrawal by Subject|3
7051185|NCT01822535|11141225|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2
7051186|NCT01822535|11141226|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0
7051187|NCT01822535|11141225|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4
7051188|NCT01822535|11141226|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2
7051189|NCT01822535|11141225|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1
7051190|NCT01822535|11141226|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0
7051191|NCT01822561|11141244|FG000|Overall Study|Withdrawal by Subject|2
7051192|NCT01822587|11141268|FG000|Overall Study|Lost to Follow-up|7
7051193|NCT01822587|11141269|FG001|Overall Study|Lost to Follow-up|9
7051194|NCT01822587|11141270|FG002|Overall Study|Lost to Follow-up|12
7051195|NCT01822587|11141268|FG000|Overall Study|Physician Decision|9
7051196|NCT01822587|11141269|FG001|Overall Study|Physician Decision|6
7051197|NCT01822587|11141270|FG002|Overall Study|Physician Decision|6
7051198|NCT01822665|11141278|FG000|Overall Study|Adverse Event|3
7051199|NCT01822665|11141278|FG000|Overall Study|Other Reason|5
7051200|NCT01822678|11141299|FG000|Overall Study|Withdrawal by Subject|5
7051201|NCT01822678|11141300|FG001|Overall Study|Withdrawal by Subject|4
7051202|NCT01822678|11141301|FG002|Overall Study|Withdrawal by Subject|4
7051203|NCT01822678|11141299|FG000|Overall Study|Adverse Event|4
7051204|NCT01822678|11141300|FG001|Overall Study|Adverse Event|3
7084095|NCT02161562|11195945|FG001|Overall Study|Lack of Efficacy|1
7084096|NCT02161562|11195944|FG000|Overall Study|Adverse Event|1
7084097|NCT02161562|11195945|FG001|Overall Study|Adverse Event|1
7084098|NCT02161562|11195944|FG000|Overall Study|Participant moved back to home country|1
7084099|NCT02161562|11195945|FG001|Overall Study|Participant moved back to home country|0
7084100|NCT02161562|11195944|FG000|Overall Study|Withdrew due to being out of the country|1
7051205|NCT01822678|11141301|FG002|Overall Study|Adverse Event|1
7051206|NCT01822678|11141299|FG000|Overall Study|Lack of Efficacy|3
7051207|NCT01822678|11141300|FG001|Overall Study|Lack of Efficacy|6
7051208|NCT01822678|11141301|FG002|Overall Study|Lack of Efficacy|5
7051209|NCT01822678|11141299|FG000|Overall Study|Lost to Follow-up|0
7051210|NCT01822678|11141300|FG001|Overall Study|Lost to Follow-up|2
7084101|NCT02161562|11195945|FG001|Overall Study|Withdrew due to being out of the country|0
7084102|NCT02161562|11195944|FG000|Overall Study|Participant moved out of province|1
7084103|NCT02161562|11195945|FG001|Overall Study|Participant moved out of province|0
7084104|NCT02161575|11195964|FG000|Overall Study|Protocol Violation|8
7084105|NCT02161575|11195964|FG000|Overall Study|Lack of Efficacy|1
7084106|NCT02161575|11195964|FG000|Overall Study|Adverse Event|2
7084107|NCT02161718|11195979|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2
7084108|NCT02161718|11195980|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0
7084109|NCT02161718|11195981|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0
7084110|NCT02161718|11195979|FG000|Open-Label ALKS 3831 Period|Physician Decision|1
7084111|NCT02161718|11195980|FG001|Open-Label ALKS 3831 Period|Physician Decision|0
7084112|NCT02161718|11195981|FG002|Open-Label ALKS 3831 Period|Physician Decision|0
7084113|NCT02161718|11195979|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1
7084114|NCT02161718|11195980|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0
7084115|NCT02161718|11195981|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0
7084116|NCT02161718|11195979|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1
7051211|NCT01822678|11141301|FG002|Overall Study|Lost to Follow-up|1
7051212|NCT01822691|11141309|FG000|Overall Study|Withdrawal by Subject|2
7051213|NCT01822756|11141318|FG000|Overall Study|Adverse Event|0
7051214|NCT01822756|11141319|FG001|Overall Study|Adverse Event|0
7051215|NCT01822756|11141320|FG002|Overall Study|Adverse Event|0
7051216|NCT01822756|11141321|FG003|Overall Study|Adverse Event|2
7051217|NCT01822756|11141322|FG004|Overall Study|Adverse Event|0
7051218|NCT01822756|11141318|FG000|Overall Study|Disease progression|11
7051219|NCT01822756|11141319|FG001|Overall Study|Disease progression|1
7051220|NCT01822756|11141320|FG002|Overall Study|Disease progression|7
7051221|NCT01822756|11141321|FG003|Overall Study|Disease progression|2
7051222|NCT01822756|11141322|FG004|Overall Study|Disease progression|6
7051223|NCT01822756|11141318|FG000|Overall Study|Death|2
7051224|NCT01822756|11141319|FG001|Overall Study|Death|2
7084117|NCT02161718|11195980|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0
7084118|NCT02161718|11195981|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0
7084119|NCT02161718|11195979|FG000|Open-Label ALKS 3831 Period|Adverse Event|3
7084120|NCT02161718|11195980|FG001|Open-Label ALKS 3831 Period|Adverse Event|0
7084121|NCT02161718|11195981|FG002|Open-Label ALKS 3831 Period|Adverse Event|0
7051225|NCT01822756|11141320|FG002|Overall Study|Death|1
7051226|NCT01822756|11141321|FG003|Overall Study|Death|0
7051227|NCT01822756|11141322|FG004|Overall Study|Death|0
7084122|NCT02161718|11195979|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4
7084123|NCT02161718|11195980|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0
7084124|NCT02161718|11195981|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0
7084125|NCT02161718|11195979|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3
7084126|NCT02161718|11195980|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0
7084127|NCT02161718|11195981|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0
7051228|NCT01822756|11141318|FG000|Overall Study|Lost to Follow-up|1
7051229|NCT01822756|11141319|FG001|Overall Study|Lost to Follow-up|0
7051230|NCT01822756|11141320|FG002|Overall Study|Lost to Follow-up|1
7051231|NCT01822756|11141321|FG003|Overall Study|Lost to Follow-up|0
7051232|NCT01822756|11141322|FG004|Overall Study|Lost to Follow-up|1
7051233|NCT01822756|11141318|FG000|Overall Study|Physician Decision|0
7051234|NCT01822756|11141319|FG001|Overall Study|Physician Decision|1
7051235|NCT01822756|11141320|FG002|Overall Study|Physician Decision|0
7051236|NCT01822756|11141321|FG003|Overall Study|Physician Decision|0
7051237|NCT01822756|11141322|FG004|Overall Study|Physician Decision|0
7051238|NCT01822756|11141318|FG000|Overall Study|disease progression & patient preference|2
7051239|NCT01822756|11141319|FG001|Overall Study|disease progression & patient preference|0
7051240|NCT01822756|11141320|FG002|Overall Study|disease progression & patient preference|1
7051241|NCT01822756|11141321|FG003|Overall Study|disease progression & patient preference|0
7051242|NCT01822756|11141322|FG004|Overall Study|disease progression & patient preference|0
7051243|NCT01822821|11141336|FG000|Overall Study|Eligible surgery cancelled|1
7051244|NCT01822821|11141337|FG001|Overall Study|Eligible surgery cancelled|1
7051245|NCT01822821|11141336|FG000|Overall Study|Other reasons|1
7051246|NCT01822821|11141337|FG001|Overall Study|Other reasons|0
7051247|NCT01822899|11141349|FG000|Overall Study|Adverse Event|6
7051248|NCT01822899|11141350|FG001|Overall Study|Adverse Event|5
7051249|NCT01822899|11141349|FG000|Overall Study|Lack of Efficacy|6
7051250|NCT01822899|11141350|FG001|Overall Study|Lack of Efficacy|3
7051251|NCT01822899|11141349|FG000|Overall Study|Protocol Violation|6
7051252|NCT01822899|11141350|FG001|Overall Study|Protocol Violation|3
7051253|NCT01822899|11141349|FG000|Overall Study|Lost to Follow-up|1
7051254|NCT01822899|11141350|FG001|Overall Study|Lost to Follow-up|0
7051255|NCT01822899|11141349|FG000|Overall Study|Withdrawal by Subject|5
7051256|NCT01822899|11141350|FG001|Overall Study|Withdrawal by Subject|7
7051257|NCT01822925|11141360|FG000|Overall Study|Adverse Event|1
7051258|NCT01822925|11141361|FG001|Overall Study|Adverse Event|1
7051259|NCT01822925|11141362|FG002|Overall Study|Adverse Event|1
7051260|NCT01822925|11141363|FG003|Overall Study|Adverse Event|1
7051261|NCT01822925|11141360|FG000|Overall Study|Lost to Follow-up|0
7051262|NCT01822925|11141361|FG001|Overall Study|Lost to Follow-up|1
7051263|NCT01822925|11141362|FG002|Overall Study|Lost to Follow-up|0
7051264|NCT01822925|11141363|FG003|Overall Study|Lost to Follow-up|0
7051265|NCT01822925|11141360|FG000|Overall Study|Protocol Violation|1
7051266|NCT01822925|11141361|FG001|Overall Study|Protocol Violation|0
7051267|NCT01822925|11141362|FG002|Overall Study|Protocol Violation|0
7051268|NCT01822925|11141363|FG003|Overall Study|Protocol Violation|1
7051269|NCT01822925|11141360|FG000|Overall Study|Withdrawal by Subject|2
7051270|NCT01822925|11141361|FG001|Overall Study|Withdrawal by Subject|0
7051271|NCT01822925|11141362|FG002|Overall Study|Withdrawal by Subject|2
7051272|NCT01822925|11141363|FG003|Overall Study|Withdrawal by Subject|2
7051273|NCT01822925|11141360|FG000|Overall Study|Taking prohibited medication|2
7051274|NCT01822925|11141361|FG001|Overall Study|Taking prohibited medication|0
7051275|NCT01822925|11141362|FG002|Overall Study|Taking prohibited medication|0
7051276|NCT01822925|11141363|FG003|Overall Study|Taking prohibited medication|1
7051277|NCT01823107|11141373|FG000|Overall Study|Withdrawal by Subject|1
7051278|NCT01823146|11141379|FG000|Overall Study|Withdrawal by Subject|0
7051279|NCT01823146|11141380|FG001|Overall Study|Withdrawal by Subject|1
7051280|NCT01823146|11141379|FG000|Overall Study|Lost to Follow-up|2
7051281|NCT01823146|11141380|FG001|Overall Study|Lost to Follow-up|1
7051282|NCT01823224|11141388|FG000|Overall Study|Lost to Follow-up|5
7051283|NCT01823224|11141389|FG001|Overall Study|Lost to Follow-up|6
7051284|NCT01823224|11141388|FG000|Overall Study|didn't qualify|1
7051285|NCT01823224|11141389|FG001|Overall Study|didn't qualify|2
7051286|NCT01823224|11141388|FG000|Overall Study|pharmacy error|0
7051287|NCT01823224|11141389|FG001|Overall Study|pharmacy error|1
7051288|NCT01823224|11141388|FG000|Overall Study|missed med dose|0
7051289|NCT01823224|11141389|FG001|Overall Study|missed med dose|1
7051290|NCT01823224|11141388|FG000|Overall Study|Withdrawal by Subject|0
7051291|NCT01823224|11141389|FG001|Overall Study|Withdrawal by Subject|1
7051292|NCT01823289|11141397|FG000|Overall Study|Lost to Follow-up|5
7051293|NCT01823289|11141397|FG000|Overall Study|Adverse Event|5
7051294|NCT01823289|11141397|FG000|Overall Study|Lack of Efficacy|1
7051295|NCT01823289|11141397|FG000|Overall Study|Physician Decision|9
7051296|NCT01823289|11141397|FG000|Overall Study|Administered contraindicated medicine|1
7051297|NCT01823289|11141397|FG000|Overall Study|Transaminase increased more than 3 times|1
7051298|NCT01823289|11141397|FG000|Overall Study|Drug affected efficacy and safety|1
7051299|NCT01823289|11141397|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1
7051300|NCT01823328|11141403|FG000|Overall Study|Withdrawal by Subject|8
7051301|NCT01823328|11141404|FG001|Overall Study|Withdrawal by Subject|6
7051302|NCT01823341|11141410|FG000|Overall Study|Failed run-in|7
7051303|NCT01823341|11141410|FG000|Overall Study|Withdrawal by Subject|7
7051304|NCT01823341|11141410|FG000|Overall Study|Adverse Event|1
7051305|NCT01823536|11141439|FG000|Overall Study|Lost to Follow-up|1
7051306|NCT01823536|11141440|FG001|Overall Study|Lost to Follow-up|0
7051307|NCT01823536|11141441|FG002|Overall Study|Lost to Follow-up|0
7051308|NCT01823536|11141442|FG003|Overall Study|Lost to Follow-up|1
7051309|NCT01823536|11141443|FG004|Overall Study|Lost to Follow-up|1
7051310|NCT01823536|11141444|FG005|Overall Study|Lost to Follow-up|0
7051311|NCT01823536|11141439|FG000|Overall Study|Protocol Violation|0
7051312|NCT01823536|11141440|FG001|Overall Study|Protocol Violation|1
7051313|NCT01823536|11141441|FG002|Overall Study|Protocol Violation|0
7051314|NCT01823536|11141442|FG003|Overall Study|Protocol Violation|0
7051315|NCT01823536|11141443|FG004|Overall Study|Protocol Violation|0
7051316|NCT01823536|11141444|FG005|Overall Study|Protocol Violation|0
7051317|NCT01823536|11141439|FG000|Overall Study|Withdrawal by Subject|1
7051318|NCT01823536|11141440|FG001|Overall Study|Withdrawal by Subject|1
7051319|NCT01823536|11141441|FG002|Overall Study|Withdrawal by Subject|0
7051320|NCT01823536|11141442|FG003|Overall Study|Withdrawal by Subject|0
7051321|NCT01823536|11141443|FG004|Overall Study|Withdrawal by Subject|0
7051322|NCT01823536|11141444|FG005|Overall Study|Withdrawal by Subject|0
7051323|NCT01823536|11141439|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0
7051324|NCT01823536|11141440|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0
7051325|NCT01823536|11141441|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1
7051326|NCT01823536|11141442|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0
7051327|NCT01823536|11141443|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0
7051328|NCT01823536|11141444|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0
7051329|NCT01823536|11141439|FG000|Overall Study|Met exclusion criterion No 6|0
7051330|NCT01823536|11141440|FG001|Overall Study|Met exclusion criterion No 6|0
7051331|NCT01823536|11141441|FG002|Overall Study|Met exclusion criterion No 6|0
7051332|NCT01823536|11141442|FG003|Overall Study|Met exclusion criterion No 6|1
7051333|NCT01823536|11141443|FG004|Overall Study|Met exclusion criterion No 6|0
7051334|NCT01823536|11141444|FG005|Overall Study|Met exclusion criterion No 6|0
7051335|NCT01823536|11141439|FG000|Overall Study|Subject moved out of the state|0
7051336|NCT01823536|11141440|FG001|Overall Study|Subject moved out of the state|0
7051337|NCT01823536|11141441|FG002|Overall Study|Subject moved out of the state|0
7051338|NCT01823536|11141442|FG003|Overall Study|Subject moved out of the state|0
7051339|NCT01823536|11141443|FG004|Overall Study|Subject moved out of the state|1
7051340|NCT01823536|11141444|FG005|Overall Study|Subject moved out of the state|0
7051341|NCT01823679|11141495|FG000|Overall Study|Death|1
7051342|NCT01823835|11141515|FG000|Overall Study|Adverse Event|0
7051343|NCT01823835|11141516|FG001|Overall Study|Adverse Event|0
7051344|NCT01823835|11141517|FG002|Overall Study|Adverse Event|0
7051345|NCT01823835|11141518|FG003|Overall Study|Adverse Event|0
7051346|NCT01823835|11141519|FG004|Overall Study|Adverse Event|1
7051347|NCT01823835|11141520|FG005|Overall Study|Adverse Event|0
7051348|NCT01823835|11141521|FG006|Overall Study|Adverse Event|1
7051349|NCT01823835|11141522|FG007|Overall Study|Adverse Event|0
7051350|NCT01823835|11141523|FG008|Overall Study|Adverse Event|0
7051351|NCT01823835|11141524|FG009|Overall Study|Adverse Event|0
7051352|NCT01823835|11141525|FG010|Overall Study|Adverse Event|1
7051353|NCT01823835|11141526|FG011|Overall Study|Adverse Event|2
7051354|NCT01823835|11141527|FG012|Overall Study|Adverse Event|0
7051355|NCT01823835|11141528|FG013|Overall Study|Adverse Event|0
7051356|NCT01823835|11141529|FG014|Overall Study|Adverse Event|0
7051357|NCT01823835|11141515|FG000|Overall Study|Physician Decision|0
7051358|NCT01823835|11141516|FG001|Overall Study|Physician Decision|0
7051359|NCT01823835|11141517|FG002|Overall Study|Physician Decision|0
7051360|NCT01823835|11141518|FG003|Overall Study|Physician Decision|0
7051361|NCT01823835|11141519|FG004|Overall Study|Physician Decision|0
7051362|NCT01823835|11141520|FG005|Overall Study|Physician Decision|0
7051363|NCT01823835|11141521|FG006|Overall Study|Physician Decision|0
7051364|NCT01823835|11141522|FG007|Overall Study|Physician Decision|0
7051365|NCT01823835|11141523|FG008|Overall Study|Physician Decision|0
7051366|NCT01823835|11141524|FG009|Overall Study|Physician Decision|0
7051367|NCT01823835|11141525|FG010|Overall Study|Physician Decision|0
7051368|NCT01823835|11141526|FG011|Overall Study|Physician Decision|2
7051369|NCT01823835|11141527|FG012|Overall Study|Physician Decision|0
7051370|NCT01823835|11141528|FG013|Overall Study|Physician Decision|0
7051371|NCT01823835|11141529|FG014|Overall Study|Physician Decision|0
7051372|NCT01823835|11141515|FG000|Overall Study|Progressive Disease|3
7051373|NCT01823835|11141516|FG001|Overall Study|Progressive Disease|4
7051374|NCT01823835|11141517|FG002|Overall Study|Progressive Disease|3
7051375|NCT01823835|11141518|FG003|Overall Study|Progressive Disease|6
7051376|NCT01823835|11141519|FG004|Overall Study|Progressive Disease|4
7051377|NCT01823835|11141520|FG005|Overall Study|Progressive Disease|6
7051378|NCT01823835|11141521|FG006|Overall Study|Progressive Disease|5
7051379|NCT01823835|11141522|FG007|Overall Study|Progressive Disease|3
7051380|NCT01823835|11141523|FG008|Overall Study|Progressive Disease|3
7051381|NCT01823835|11141524|FG009|Overall Study|Progressive Disease|18
7051382|NCT01823835|11141525|FG010|Overall Study|Progressive Disease|8
7051383|NCT01823835|11141526|FG011|Overall Study|Progressive Disease|46
7051384|NCT01823835|11141527|FG012|Overall Study|Progressive Disease|18
7051385|NCT01823835|11141528|FG013|Overall Study|Progressive Disease|4
7051386|NCT01823835|11141529|FG014|Overall Study|Progressive Disease|6
7051387|NCT01823835|11141515|FG000|Overall Study|Study Termination|0
7051388|NCT01823835|11141516|FG001|Overall Study|Study Termination|0
7051389|NCT01823835|11141517|FG002|Overall Study|Study Termination|0
7051390|NCT01823835|11141518|FG003|Overall Study|Study Termination|0
7051391|NCT01823835|11141519|FG004|Overall Study|Study Termination|1
7051392|NCT01823835|11141520|FG005|Overall Study|Study Termination|0
7051393|NCT01823835|11141521|FG006|Overall Study|Study Termination|0
7051394|NCT01823835|11141522|FG007|Overall Study|Study Termination|0
7051395|NCT01823835|11141523|FG008|Overall Study|Study Termination|0
7051396|NCT01823835|11141524|FG009|Overall Study|Study Termination|0
7051397|NCT01823835|11141525|FG010|Overall Study|Study Termination|0
7051398|NCT01823835|11141526|FG011|Overall Study|Study Termination|1
7051399|NCT01823835|11141527|FG012|Overall Study|Study Termination|0
7051400|NCT01823835|11141528|FG013|Overall Study|Study Termination|0
7051401|NCT01823835|11141529|FG014|Overall Study|Study Termination|0
7051402|NCT01823835|11141515|FG000|Overall Study|Withdrawal by Subject|0
7051403|NCT01823835|11141516|FG001|Overall Study|Withdrawal by Subject|0
7051404|NCT01823835|11141517|FG002|Overall Study|Withdrawal by Subject|1
7051405|NCT01823835|11141518|FG003|Overall Study|Withdrawal by Subject|0
7051406|NCT01823835|11141519|FG004|Overall Study|Withdrawal by Subject|0
7051407|NCT01823835|11141520|FG005|Overall Study|Withdrawal by Subject|0
7051408|NCT01823835|11141521|FG006|Overall Study|Withdrawal by Subject|0
7051409|NCT01823835|11141522|FG007|Overall Study|Withdrawal by Subject|0
7051410|NCT01823835|11141523|FG008|Overall Study|Withdrawal by Subject|0
7051411|NCT01823835|11141524|FG009|Overall Study|Withdrawal by Subject|1
7051412|NCT01823835|11141525|FG010|Overall Study|Withdrawal by Subject|1
7051413|NCT01823835|11141526|FG011|Overall Study|Withdrawal by Subject|2
7051414|NCT01823835|11141527|FG012|Overall Study|Withdrawal by Subject|1
7051415|NCT01823835|11141528|FG013|Overall Study|Withdrawal by Subject|0
7051416|NCT01823835|11141529|FG014|Overall Study|Withdrawal by Subject|0
7051417|NCT01823991|11141580|FG000|Overall Study|Withdrawal by Subject|8
7051418|NCT01823991|11141581|FG001|Overall Study|Withdrawal by Subject|5
7051419|NCT01824290|11141610|FG000|Period 1: Double Blind|Entry Criteria Not Met|1
7051420|NCT01824290|11141611|FG001|Period 1: Double Blind|Entry Criteria Not Met|0
7051421|NCT01824290|11141612|FG002|Period 1: Double Blind|Entry Criteria Not Met|0
7051422|NCT01824290|11141613|FG003|Period 1: Double Blind|Entry Criteria Not Met|0
7051423|NCT01824290|11141610|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1
7051424|NCT01824290|11141611|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1
7051425|NCT01824290|11141612|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0
7051426|NCT01824290|11141613|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0
7051427|NCT01824290|11141610|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1
7051428|NCT01824290|11141611|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1
7051429|NCT01824290|11141612|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0
7051430|NCT01824290|11141613|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0
7084128|NCT02161718|11195979|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6
7084129|NCT02161718|11195980|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0
7084130|NCT02161718|11195981|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0
7084131|NCT02161718|11195979|FG000|Post- Randomization Period|Withdrawal by Subject|0
7084132|NCT02161718|11195980|FG001|Post- Randomization Period|Withdrawal by Subject|23
7084133|NCT02161718|11195981|FG002|Post- Randomization Period|Withdrawal by Subject|18
7084134|NCT02161718|11195979|FG000|Post- Randomization Period|Lost to Follow-up|0
7084135|NCT02161718|11195980|FG001|Post- Randomization Period|Lost to Follow-up|9
7084136|NCT02161718|11195981|FG002|Post- Randomization Period|Lost to Follow-up|15
7051431|NCT01824290|11141610|FG000|Period 2: Open-Label Treatment|Adverse Event|0
7084137|NCT02161718|11195979|FG000|Post- Randomization Period|Adverse Event|0
7051432|NCT01824290|11141611|FG001|Period 2: Open-Label Treatment|Adverse Event|0
7051433|NCT01824290|11141612|FG002|Period 2: Open-Label Treatment|Adverse Event|0
7051434|NCT01824290|11141613|FG003|Period 2: Open-Label Treatment|Adverse Event|1
7051435|NCT01824290|11141610|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0
7051436|NCT01824290|11141611|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0
7051437|NCT01824290|11141612|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1
7051438|NCT01824290|11141613|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1
7051439|NCT01824290|11141610|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0
7051440|NCT01824290|11141611|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0
7051441|NCT01824290|11141612|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2
7051442|NCT01824290|11141613|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1
7051443|NCT01824303|11141627|FG000|Randomized Study|Withdrawal by Subject|1
7051444|NCT01824303|11141628|FG001|Randomized Study|Withdrawal by Subject|1
7051445|NCT01824303|11141627|FG000|Randomized Study|Other Miscellaneous Reasons|1
7051446|NCT01824303|11141628|FG001|Randomized Study|Other Miscellaneous Reasons|0
7084138|NCT02161718|11195980|FG001|Post- Randomization Period|Adverse Event|9
7084139|NCT02161718|11195981|FG002|Post- Randomization Period|Adverse Event|10
7084140|NCT02161718|11195979|FG000|Post- Randomization Period|Non- compliance with study drug|0
7084141|NCT02161718|11195980|FG001|Post- Randomization Period|Non- compliance with study drug|8
7084142|NCT02161718|11195981|FG002|Post- Randomization Period|Non- compliance with study drug|2
7084143|NCT02161718|11195979|FG000|Post- Randomization Period|Physician Decision|0
7084144|NCT02161718|11195980|FG001|Post- Randomization Period|Physician Decision|2
7084145|NCT02161718|11195981|FG002|Post- Randomization Period|Physician Decision|4
7084146|NCT02161718|11195979|FG000|Post- Randomization Period|Protocol Violation|0
7084147|NCT02161718|11195980|FG001|Post- Randomization Period|Protocol Violation|2
7084148|NCT02161718|11195981|FG002|Post- Randomization Period|Protocol Violation|3
7084149|NCT02161718|11195979|FG000|Post- Randomization Period|Lack of Efficacy|0
7084150|NCT02161718|11195980|FG001|Post- Randomization Period|Lack of Efficacy|0
7084151|NCT02161718|11195981|FG002|Post- Randomization Period|Lack of Efficacy|1
7084152|NCT02161718|11195979|FG000|Post- Randomization Period|Non-compliance with study procedures|0
7084153|NCT02161718|11195980|FG001|Post- Randomization Period|Non-compliance with study procedures|2
7084154|NCT02161718|11195981|FG002|Post- Randomization Period|Non-compliance with study procedures|4
7084155|NCT02161718|11195979|FG000|Post- Randomization Period|Received prohibitive treatment|0
7084156|NCT02161718|11195980|FG001|Post- Randomization Period|Received prohibitive treatment|1
7084157|NCT02161718|11195981|FG002|Post- Randomization Period|Received prohibitive treatment|2
7084158|NCT02161718|11195979|FG000|Post- Randomization Period|Relocation|0
7084159|NCT02161718|11195980|FG001|Post- Randomization Period|Relocation|3
7084160|NCT02161718|11195981|FG002|Post- Randomization Period|Relocation|0
7084161|NCT02161731|11195988|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0
7084162|NCT02161731|11195989|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1
7084163|NCT02161731|11195988|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0
7084164|NCT02161731|11195989|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1
7084165|NCT02161757|11195999|FG000|Randomised Through Start Treatment|Did not receive treatment|3
7084166|NCT02161757|11196000|FG001|Randomised Through Start Treatment|Did not receive treatment|2
7084167|NCT02161757|11196001|FG002|Randomised Through Start Treatment|Did not receive treatment|0
7084168|NCT02161757|11195999|FG000|Treatment Through Study Completion|Adverse Event|1
7084169|NCT02161757|11196000|FG001|Treatment Through Study Completion|Adverse Event|1
7084170|NCT02161757|11196001|FG002|Treatment Through Study Completion|Adverse Event|0
7084171|NCT02161757|11195999|FG000|Treatment Through Study Completion|Protocol Violation|0
7051447|NCT01824342|11141638|FG000|Overall Study|Withdrawal by Subject|0
7051448|NCT01824342|11141639|FG001|Overall Study|Withdrawal by Subject|3
7051449|NCT01824342|11141638|FG000|Overall Study|Adverse Event|1
7051450|NCT01824342|11141639|FG001|Overall Study|Adverse Event|1
7051451|NCT01824342|11141638|FG000|Overall Study|Disease Progression|1
7051452|NCT01824342|11141639|FG001|Overall Study|Disease Progression|1
7051453|NCT01824342|11141638|FG000|Overall Study|Physician Decision|5
7051454|NCT01824342|11141639|FG001|Overall Study|Physician Decision|0
7051455|NCT01824342|11141638|FG000|Overall Study|Death|2
7051456|NCT01824342|11141639|FG001|Overall Study|Death|0
7051457|NCT01824355|11141645|FG000|Overall Study|Adverse Event|2
7051458|NCT01824355|11141645|FG000|Overall Study|unevaluable reference method results per|1
7051459|NCT01824394|11141652|FG000|Overall Study|Early Termination|1
7051460|NCT01824394|11141653|FG001|Overall Study|Early Termination|1
7051461|NCT01824394|11141654|FG002|Overall Study|Early Termination|3
7051462|NCT01824394|11141652|FG000|Overall Study|Withdrawn due to Study Termination|91
7051463|NCT01824394|11141653|FG001|Overall Study|Withdrawn due to Study Termination|83
7051464|NCT01824394|11141654|FG002|Overall Study|Withdrawn due to Study Termination|41
7084172|NCT02161757|11196000|FG001|Treatment Through Study Completion|Protocol Violation|1
7084173|NCT02161757|11196001|FG002|Treatment Through Study Completion|Protocol Violation|2
7051465|NCT01824394|11141652|FG000|Overall Study|Lost to Follow-up|0
7051466|NCT01824394|11141653|FG001|Overall Study|Lost to Follow-up|9
7051467|NCT01824394|11141654|FG002|Overall Study|Lost to Follow-up|3
7051468|NCT01824394|11141652|FG000|Overall Study|Death|3
7051469|NCT01824394|11141653|FG001|Overall Study|Death|2
7051470|NCT01824394|11141654|FG002|Overall Study|Death|4
7051471|NCT01824394|11141652|FG000|Overall Study|Discontinued Subjects|1
7051472|NCT01824394|11141653|FG001|Overall Study|Discontinued Subjects|1
7051473|NCT01824394|11141654|FG002|Overall Study|Discontinued Subjects|2
7051474|NCT01824394|11141652|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23
7051475|NCT01824394|11141653|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20
7051476|NCT01824394|11141654|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21
7051477|NCT01824472|11141669|FG000|Overall Study|Lost to Follow-up|0
7051478|NCT01824472|11141670|FG001|Overall Study|Lost to Follow-up|0
7051479|NCT01824472|11141671|FG002|Overall Study|Lost to Follow-up|1
7051480|NCT01824472|11141669|FG000|Overall Study|Withdrawal by Subject|1
7051481|NCT01824472|11141670|FG001|Overall Study|Withdrawal by Subject|5
7051482|NCT01824472|11141671|FG002|Overall Study|Withdrawal by Subject|3
7051483|NCT01824472|11141669|FG000|Overall Study|Ineligible post randomization&screening|0
7051484|NCT01824472|11141670|FG001|Overall Study|Ineligible post randomization&screening|2
7051485|NCT01824472|11141671|FG002|Overall Study|Ineligible post randomization&screening|0
7051486|NCT01824498|11141685|FG000|Washout (8 Weeks)|Withdrawal by Subject|2
7051487|NCT01824498|11141686|FG001|Washout (8 Weeks)|Withdrawal by Subject|0
7051488|NCT01824498|11141687|FG002|Washout (8 Weeks)|Withdrawal by Subject|2
7051489|NCT01824498|11141688|FG003|Washout (8 Weeks)|Withdrawal by Subject|1
7051490|NCT01824498|11141689|FG004|Washout (8 Weeks)|Withdrawal by Subject|1
7051491|NCT01824498|11141690|FG005|Washout (8 Weeks)|Withdrawal by Subject|0
7051492|NCT01824576|11141698|FG000|Overall Study|Device deficiency|2
7051493|NCT01824602|11141723|FG000|Overall Study|Withdrawal by Subject|0
7051494|NCT01824602|11141724|FG001|Overall Study|Withdrawal by Subject|0
7051495|NCT01824602|11141725|FG002|Overall Study|Withdrawal by Subject|1
7051496|NCT01824602|11141726|FG003|Overall Study|Withdrawal by Subject|2
7051497|NCT01824602|11141723|FG000|Overall Study|Patient non-compliance|0
7051498|NCT01824602|11141724|FG001|Overall Study|Patient non-compliance|0
7051499|NCT01824602|11141725|FG002|Overall Study|Patient non-compliance|1
7051500|NCT01824602|11141726|FG003|Overall Study|Patient non-compliance|0
7051501|NCT01824602|11141723|FG000|Overall Study|Adverse Event|1
7051502|NCT01824602|11141724|FG001|Overall Study|Adverse Event|0
7051503|NCT01824602|11141725|FG002|Overall Study|Adverse Event|2
7051504|NCT01824602|11141726|FG003|Overall Study|Adverse Event|2
7051505|NCT01824602|11141723|FG000|Overall Study|Treatment failure|0
7051506|NCT01824602|11141724|FG001|Overall Study|Treatment failure|0
7051507|NCT01824602|11141725|FG002|Overall Study|Treatment failure|0
7051508|NCT01824602|11141726|FG003|Overall Study|Treatment failure|1
7051509|NCT01824693|11141739|FG000|Overall Study|Death|0
7051510|NCT01824693|11141740|FG001|Overall Study|Death|1
7051511|NCT01824693|11141741|FG002|Overall Study|Death|0
7051512|NCT01824693|11141739|FG000|Overall Study|Physician Decision|1
7051513|NCT01824693|11141740|FG001|Overall Study|Physician Decision|1
7051514|NCT01824693|11141741|FG002|Overall Study|Physician Decision|1
7051515|NCT01824693|11141739|FG000|Overall Study|Withdrawal by Subject|0
7051516|NCT01824693|11141740|FG001|Overall Study|Withdrawal by Subject|0
7051517|NCT01824693|11141741|FG002|Overall Study|Withdrawal by Subject|1
7051518|NCT01824693|11141739|FG000|Overall Study|Progressive Disease|0
7051519|NCT01824693|11141740|FG001|Overall Study|Progressive Disease|5
7051520|NCT01824693|11141741|FG002|Overall Study|Progressive Disease|0
7051521|NCT01824693|11141739|FG000|Overall Study|Ineligible|0
7051522|NCT01824693|11141740|FG001|Overall Study|Ineligible|0
7051523|NCT01824693|11141741|FG002|Overall Study|Ineligible|3
7051524|NCT01824693|11141739|FG000|Overall Study|No Transplant Planned|0
7051525|NCT01824693|11141740|FG001|Overall Study|No Transplant Planned|0
7051526|NCT01824693|11141741|FG002|Overall Study|No Transplant Planned|10
7084174|NCT02161757|11195999|FG000|Treatment Through Study Completion|Withdrawal by Subject|27
7084175|NCT02161757|11196000|FG001|Treatment Through Study Completion|Withdrawal by Subject|19
7084176|NCT02161757|11196001|FG002|Treatment Through Study Completion|Withdrawal by Subject|20
7084177|NCT02161757|11195999|FG000|Treatment Through Study Completion|Lost to Follow-up|7
7084178|NCT02161757|11196000|FG001|Treatment Through Study Completion|Lost to Follow-up|2
7084179|NCT02161757|11196001|FG002|Treatment Through Study Completion|Lost to Follow-up|4
7084180|NCT02161757|11195999|FG000|Treatment Through Study Completion|Other|20
7084181|NCT02161757|11196000|FG001|Treatment Through Study Completion|Other|19
7084182|NCT02161757|11196001|FG002|Treatment Through Study Completion|Other|12
7084183|NCT02161757|11195999|FG000|Treatment Through Study Completion|Death|2
7084184|NCT02161757|11196000|FG001|Treatment Through Study Completion|Death|1
7051527|NCT01824823|11141750|FG000|Overall Study|Lack of Efficacy|1
7051528|NCT01824823|11141751|FG001|Overall Study|Lack of Efficacy|1
7051529|NCT01824823|11141750|FG000|Overall Study|Off-treatment reason not submitted|1
7051530|NCT01824823|11141751|FG001|Overall Study|Off-treatment reason not submitted|0
7051531|NCT01824979|11141766|FG000|Overall Study|Withdrawal by Subject|5
7051532|NCT01824979|11141767|FG001|Overall Study|Withdrawal by Subject|0
7051533|NCT01824979|11141766|FG000|Overall Study|Physician Decision|2
7051534|NCT01824979|11141767|FG001|Overall Study|Physician Decision|0
7051535|NCT01824979|11141766|FG000|Overall Study|Protocol Violation|6
7051536|NCT01824979|11141767|FG001|Overall Study|Protocol Violation|13
7051537|NCT01825200|11141800|FG000|Overall Study|Lost to Follow-up|5
7051538|NCT01825200|11141801|FG001|Overall Study|Lost to Follow-up|6
7051539|NCT01825200|11141800|FG000|Overall Study|Withdrawal by Subject|0
7051540|NCT01825200|11141801|FG001|Overall Study|Withdrawal by Subject|1
7051541|NCT01825577|11141833|FG000|Overall Study|Physician Decision|2
7051542|NCT01825577|11141833|FG000|Overall Study|Withdrawal by Subject|1
7051543|NCT01825577|11141833|FG000|Overall Study|Withdrawn by family members|2
7051544|NCT01825577|11141833|FG000|Overall Study|Lack of Efficacy|3
7051545|NCT01825785|11141853|FG000|Overall Study|Adverse Event|0
7051546|NCT01825785|11141854|FG001|Overall Study|Adverse Event|0
7051547|NCT01825785|11141855|FG002|Overall Study|Adverse Event|0
7051548|NCT01825785|11141856|FG003|Overall Study|Adverse Event|0
7051549|NCT01825785|11141857|FG004|Overall Study|Adverse Event|1
7051550|NCT01825785|11141858|FG005|Overall Study|Adverse Event|0
7051551|NCT01825785|11141859|FG006|Overall Study|Adverse Event|0
7051552|NCT01825785|11141853|FG000|Overall Study|Withdrawal by Subject|0
7051553|NCT01825785|11141854|FG001|Overall Study|Withdrawal by Subject|0
7051554|NCT01825785|11141855|FG002|Overall Study|Withdrawal by Subject|0
7051555|NCT01825785|11141856|FG003|Overall Study|Withdrawal by Subject|0
7051556|NCT01825785|11141857|FG004|Overall Study|Withdrawal by Subject|1
7051557|NCT01825785|11141858|FG005|Overall Study|Withdrawal by Subject|1
7084185|NCT02161757|11196001|FG002|Treatment Through Study Completion|Death|1
7084186|NCT02162719|11196068|FG000|Overall Study|Death|41
7051558|NCT01825785|11141859|FG006|Overall Study|Withdrawal by Subject|0
7051559|NCT01825798|11141883|FG000|Overall Study|Adverse Event|1
7051560|NCT01825798|11141884|FG001|Overall Study|Adverse Event|5
7051561|NCT01825798|11141883|FG000|Overall Study|Lost to Follow-up|1
7051562|NCT01825798|11141884|FG001|Overall Study|Lost to Follow-up|0
7051563|NCT01825837|11141894|FG000|PART I|Withdrawal by Subject|0
7051564|NCT01825837|11141895|FG001|PART I|Withdrawal by Subject|0
7051565|NCT01825837|11141896|FG002|PART I|Withdrawal by Subject|0
7051566|NCT01825837|11141897|FG003|PART I|Withdrawal by Subject|6
7051567|NCT01825837|11141894|FG000|PART I|Patient non-compliance|0
7051568|NCT01825837|11141895|FG001|PART I|Patient non-compliance|0
7051569|NCT01825837|11141896|FG002|PART I|Patient non-compliance|0
7051570|NCT01825837|11141897|FG003|PART I|Patient non-compliance|1
7051571|NCT01825837|11141894|FG000|PART I|Treatment failure|0
7051572|NCT01825837|11141895|FG001|PART I|Treatment failure|0
7051573|NCT01825837|11141896|FG002|PART I|Treatment failure|0
7051574|NCT01825837|11141897|FG003|PART I|Treatment failure|7
7051575|NCT01825837|11141894|FG000|PART I|reason unspecified|0
7051576|NCT01825837|11141895|FG001|PART I|reason unspecified|0
7051577|NCT01825837|11141896|FG002|PART I|reason unspecified|0
7051578|NCT01825837|11141897|FG003|PART I|reason unspecified|3
7051579|NCT01825837|11141894|FG000|PART II|Withdrawal by Subject|3
7051580|NCT01825837|11141895|FG001|PART II|Withdrawal by Subject|3
7051581|NCT01825837|11141896|FG002|PART II|Withdrawal by Subject|7
7051582|NCT01825837|11141897|FG003|PART II|Withdrawal by Subject|0
7051583|NCT01825837|11141894|FG000|PART II|Patient non-compliance|5
7051584|NCT01825837|11141895|FG001|PART II|Patient non-compliance|2
7051585|NCT01825837|11141896|FG002|PART II|Patient non-compliance|4
7051586|NCT01825837|11141897|FG003|PART II|Patient non-compliance|0
7051587|NCT01825837|11141894|FG000|PART II|Adverse Event|3
7051588|NCT01825837|11141895|FG001|PART II|Adverse Event|3
7051589|NCT01825837|11141896|FG002|PART II|Adverse Event|1
7051590|NCT01825837|11141897|FG003|PART II|Adverse Event|0
7051591|NCT01825837|11141894|FG000|PART II|Treatment failure|6
7051592|NCT01825837|11141895|FG001|PART II|Treatment failure|4
7051593|NCT01825837|11141896|FG002|PART II|Treatment failure|5
7051594|NCT01825837|11141897|FG003|PART II|Treatment failure|0
7051595|NCT01825837|11141894|FG000|PART II|reason unspecified|2
7051596|NCT01825837|11141895|FG001|PART II|reason unspecified|2
7051597|NCT01825837|11141896|FG002|PART II|reason unspecified|2
7051598|NCT01825837|11141897|FG003|PART II|reason unspecified|0
7051599|NCT01825876|11141905|FG000|Period 2|Withdrawal by Subject|0
7051600|NCT01825876|11141906|FG001|Period 2|Withdrawal by Subject|1
7051601|NCT01825941|11141926|FG000|Overall Study|Lost to Follow-up|4
7051602|NCT01825941|11141927|FG001|Overall Study|Lost to Follow-up|1
7051603|NCT01826201|11141933|FG000|Overall Study|Non compliance with protocol|4
7051604|NCT01826214|11141941|FG000|Overall Study|Adverse Event|7
7051605|NCT01826214|11141942|FG001|Overall Study|Adverse Event|6
7051606|NCT01826214|11141941|FG000|Overall Study|Death|3
7051607|NCT01826214|11141942|FG001|Overall Study|Death|1
7051608|NCT01826214|11141941|FG000|Overall Study|Lost to Follow-up|1
7051609|NCT01826214|11141942|FG001|Overall Study|Lost to Follow-up|0
7051610|NCT01826214|11141941|FG000|Overall Study|Physician Decision|0
7051611|NCT01826214|11141942|FG001|Overall Study|Physician Decision|2
7051612|NCT01826214|11141941|FG000|Overall Study|Progressive disease|22
7051613|NCT01826214|11141942|FG001|Overall Study|Progressive disease|21
7051614|NCT01826214|11141941|FG000|Overall Study|Study terminated by Sponsor|0
7051615|NCT01826214|11141942|FG001|Overall Study|Study terminated by Sponsor|1
7051616|NCT01826214|11141941|FG000|Overall Study|Subject/guardian decision|2
7051617|NCT01826214|11141942|FG001|Overall Study|Subject/guardian decision|3
7051618|NCT01826370|11141952|FG000|Overall Study|Protocol Violation|6
7051619|NCT01826370|11141952|FG000|Overall Study|Lost to Follow-up|12
7051620|NCT01826370|11141952|FG000|Overall Study|Other reason not defined above|2
7051621|NCT01826422|11141958|FG000|Overall Study|Withdrawal by Subject|1
7051622|NCT01826422|11141959|FG001|Overall Study|Withdrawal by Subject|3
7051623|NCT01826448|11141967|FG000|Overall Study|Adverse Event|1
7051624|NCT01826448|11141968|FG001|Overall Study|Adverse Event|3
7051625|NCT01826448|11141967|FG000|Overall Study|Disease progression|2
7051626|NCT01826448|11141968|FG001|Overall Study|Disease progression|4
7051627|NCT01826448|11141967|FG000|Overall Study|Withdrawal by Subject|1
7051628|NCT01826448|11141968|FG001|Overall Study|Withdrawal by Subject|0
7051629|NCT01826448|11141967|FG000|Overall Study|Physician Decision|0
7051630|NCT01826448|11141968|FG001|Overall Study|Physician Decision|1
7051631|NCT01826448|11141967|FG000|Overall Study|2 active cancers|0
7051632|NCT01826448|11141968|FG001|Overall Study|2 active cancers|1
7051633|NCT01826487|11141976|FG000|Overall Study|Adverse Event|1
7051634|NCT01826487|11141977|FG001|Overall Study|Adverse Event|1
7051635|NCT01826487|11141976|FG000|Overall Study|Lost to Follow-up|1
7051636|NCT01826487|11141977|FG001|Overall Study|Lost to Follow-up|0
7051637|NCT01826487|11141976|FG000|Overall Study|Withdrawal by Subject|1
7051638|NCT01826487|11141977|FG001|Overall Study|Withdrawal by Subject|3
7051639|NCT01826487|11141976|FG000|Overall Study|Protocol Violation|1
7051640|NCT01826487|11141977|FG001|Overall Study|Protocol Violation|1
7051641|NCT01826604|11141998|FG000|Overall Study|Lost to Follow-up|8
7051642|NCT01826604|11141999|FG001|Overall Study|Lost to Follow-up|9
7051643|NCT01826825|11142018|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0
7051644|NCT01826825|11142019|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2
7051645|NCT01826981|11142051|FG000|Overall Study|Lack of Efficacy|0
7051646|NCT01826981|11142052|FG001|Overall Study|Lack of Efficacy|1
7051647|NCT01826981|11142053|FG002|Overall Study|Lack of Efficacy|0
7051648|NCT01826981|11142054|FG003|Overall Study|Lack of Efficacy|0
7051649|NCT01826981|11142055|FG004|Overall Study|Lack of Efficacy|5
7051650|NCT01826981|11142056|FG005|Overall Study|Lack of Efficacy|0
7051651|NCT01826981|11142057|FG006|Overall Study|Lack of Efficacy|0
7051652|NCT01826981|11142058|FG007|Overall Study|Lack of Efficacy|8
7051653|NCT01826981|11142059|FG008|Overall Study|Lack of Efficacy|7
7051654|NCT01826981|11142060|FG009|Overall Study|Lack of Efficacy|0
7084187|NCT02162719|11196069|FG001|Overall Study|Death|46
7084188|NCT02162719|11196068|FG000|Overall Study|Lost to Follow-up|1
7084189|NCT02162719|11196069|FG001|Overall Study|Lost to Follow-up|3
7084190|NCT02162719|11196068|FG000|Overall Study|Disease Progression|2
7084191|NCT02162719|11196069|FG001|Overall Study|Disease Progression|1
7084192|NCT02162719|11196068|FG000|Overall Study|Withdrawal by Subject|8
7084193|NCT02162719|11196069|FG001|Overall Study|Withdrawal by Subject|2
7084194|NCT02162719|11196068|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10
7084195|NCT02162719|11196069|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10
7084196|NCT02162758|11196077|FG000|Overall Study|Study termination|0
7084197|NCT02162758|11196078|FG001|Overall Study|Study termination|1
7084198|NCT02162771|11196086|FG000|Core Study Period (Part 2)|Progressive Disease|2
7084199|NCT02162771|11196087|FG001|Core Study Period (Part 2)|Progressive Disease|3
7084200|NCT02162771|11196086|FG000|Core Study Period (Part 2)|Adverse Event|4
7084201|NCT02162771|11196087|FG001|Core Study Period (Part 2)|Adverse Event|1
7084202|NCT02162771|11196086|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1
7084203|NCT02162771|11196087|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2
7084204|NCT02162771|11196086|FG000|Core Study Period (Part 2)|Physician Decision|0
7084205|NCT02162771|11196087|FG001|Core Study Period (Part 2)|Physician Decision|2
7084206|NCT02162771|11196086|FG000|Core Study Period (Part 2)|Death|1
7084207|NCT02162771|11196087|FG001|Core Study Period (Part 2)|Death|0
7084208|NCT02162771|11196086|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11
7084209|NCT02162771|11196087|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13
7084210|NCT02162771|11196086|FG000|Maintenance Study Period (Part 2)|Adverse Event|3
7084211|NCT02162771|11196087|FG001|Maintenance Study Period (Part 2)|Adverse Event|3
7084212|NCT02162771|11196086|FG000|Maintenance Study Period (Part 2)|Death|2
7084213|NCT02162771|11196087|FG001|Maintenance Study Period (Part 2)|Death|1
7084214|NCT02162771|11196086|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0
7084215|NCT02162771|11196087|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3
7084216|NCT02162771|11196086|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0
7084217|NCT02162771|11196087|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1
7084218|NCT02162771|11196086|FG000|Maintenance Study Period (Part 2)|Stable Disease|0
7084219|NCT02162771|11196087|FG001|Maintenance Study Period (Part 2)|Stable Disease|1
7084220|NCT02162862|11196096|FG000|Overall Study|Lost to Follow-up|0
7084221|NCT02162862|11196097|FG001|Overall Study|Lost to Follow-up|11
7084222|NCT02162862|11196098|FG002|Overall Study|Lost to Follow-up|0
7084223|NCT02162862|11196096|FG000|Overall Study|Subject did not feel the med was needed|0
7084224|NCT02162862|11196097|FG001|Overall Study|Subject did not feel the med was needed|0
7084225|NCT02162862|11196098|FG002|Overall Study|Subject did not feel the med was needed|4
7084226|NCT02163057|11196119|FG000|Overall Study|Participant Refusal to Continue|2
7084227|NCT02163057|11196120|FG001|Overall Study|Participant Refusal to Continue|2
7084228|NCT02163057|11196119|FG000|Overall Study|Participant Significant Noncompliance|0
7084229|NCT02163057|11196120|FG001|Overall Study|Participant Significant Noncompliance|1
7084230|NCT02163057|11196119|FG000|Overall Study|Progression of Disease|1
7084231|NCT02163057|11196120|FG001|Overall Study|Progression of Disease|2
7084232|NCT02163226|11196130|FG000|Overall Study|Death|2
7084233|NCT02163226|11196131|FG001|Overall Study|Death|1
7084234|NCT02163226|11196130|FG000|Overall Study|Withdrawal by Subject|5
7084235|NCT02163226|11196131|FG001|Overall Study|Withdrawal by Subject|2
7084236|NCT02163226|11196130|FG000|Overall Study|Returned home, local radiotherapy|3
7084237|NCT02163226|11196131|FG001|Overall Study|Returned home, local radiotherapy|0
7051655|NCT01826981|11142061|FG010|Overall Study|Lack of Efficacy|1
7051656|NCT01826981|11142062|FG011|Overall Study|Lack of Efficacy|0
7051657|NCT01826981|11142063|FG012|Overall Study|Lack of Efficacy|0
7051658|NCT01826981|11142064|FG013|Overall Study|Lack of Efficacy|3
7051659|NCT01826981|11142065|FG014|Overall Study|Lack of Efficacy|0
7051660|NCT01826981|11142051|FG000|Overall Study|Lost to Follow-up|0
7051661|NCT01826981|11142052|FG001|Overall Study|Lost to Follow-up|0
7051662|NCT01826981|11142053|FG002|Overall Study|Lost to Follow-up|0
7051663|NCT01826981|11142054|FG003|Overall Study|Lost to Follow-up|0
7051664|NCT01826981|11142055|FG004|Overall Study|Lost to Follow-up|1
7051665|NCT01826981|11142056|FG005|Overall Study|Lost to Follow-up|1
7051666|NCT01826981|11142057|FG006|Overall Study|Lost to Follow-up|0
7051667|NCT01826981|11142058|FG007|Overall Study|Lost to Follow-up|1
7051668|NCT01826981|11142059|FG008|Overall Study|Lost to Follow-up|0
7084238|NCT02163226|11196130|FG000|Overall Study|Repeat imaging showed no disease|2
7084239|NCT02163226|11196131|FG001|Overall Study|Repeat imaging showed no disease|0
7084240|NCT02163226|11196130|FG000|Overall Study|Incomplete radiotherapy|3
6810220|NCT01090024|10814010|FG003|Period 3|Adverse Event|0
7051669|NCT01826981|11142060|FG009|Overall Study|Lost to Follow-up|1
7051670|NCT01826981|11142061|FG010|Overall Study|Lost to Follow-up|1
7051671|NCT01826981|11142062|FG011|Overall Study|Lost to Follow-up|1
7051672|NCT01826981|11142063|FG012|Overall Study|Lost to Follow-up|1
7051673|NCT01826981|11142064|FG013|Overall Study|Lost to Follow-up|0
7051674|NCT01826981|11142065|FG014|Overall Study|Lost to Follow-up|0
7051675|NCT01826981|11142051|FG000|Overall Study|Withdrew Consent|0
7051676|NCT01826981|11142052|FG001|Overall Study|Withdrew Consent|0
7051677|NCT01826981|11142053|FG002|Overall Study|Withdrew Consent|0
7051678|NCT01826981|11142054|FG003|Overall Study|Withdrew Consent|0
7051679|NCT01826981|11142055|FG004|Overall Study|Withdrew Consent|0
7051680|NCT01826981|11142056|FG005|Overall Study|Withdrew Consent|0
7051681|NCT01826981|11142057|FG006|Overall Study|Withdrew Consent|1
7051682|NCT01826981|11142058|FG007|Overall Study|Withdrew Consent|1
7051683|NCT01826981|11142059|FG008|Overall Study|Withdrew Consent|0
7051684|NCT01826981|11142060|FG009|Overall Study|Withdrew Consent|0
7051685|NCT01826981|11142061|FG010|Overall Study|Withdrew Consent|0
7051686|NCT01826981|11142062|FG011|Overall Study|Withdrew Consent|1
7051687|NCT01826981|11142063|FG012|Overall Study|Withdrew Consent|0
7051688|NCT01826981|11142064|FG013|Overall Study|Withdrew Consent|1
7051689|NCT01826981|11142065|FG014|Overall Study|Withdrew Consent|0
7051690|NCT01826981|11142051|FG000|Overall Study|Adverse Event|0
7051691|NCT01826981|11142052|FG001|Overall Study|Adverse Event|0
7051692|NCT01826981|11142053|FG002|Overall Study|Adverse Event|0
7051693|NCT01826981|11142054|FG003|Overall Study|Adverse Event|0
7051694|NCT01826981|11142055|FG004|Overall Study|Adverse Event|1
7051695|NCT01826981|11142056|FG005|Overall Study|Adverse Event|0
7051696|NCT01826981|11142057|FG006|Overall Study|Adverse Event|0
7051697|NCT01826981|11142058|FG007|Overall Study|Adverse Event|0
7051698|NCT01826981|11142059|FG008|Overall Study|Adverse Event|0
7051699|NCT01826981|11142060|FG009|Overall Study|Adverse Event|0
7051700|NCT01826981|11142061|FG010|Overall Study|Adverse Event|0
7051701|NCT01826981|11142062|FG011|Overall Study|Adverse Event|0
7051702|NCT01826981|11142063|FG012|Overall Study|Adverse Event|0
7051703|NCT01826981|11142064|FG013|Overall Study|Adverse Event|0
7051704|NCT01826981|11142065|FG014|Overall Study|Adverse Event|0
7084241|NCT02163226|11196131|FG001|Overall Study|Incomplete radiotherapy|0
7084242|NCT02163226|11196130|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1
7051705|NCT01826981|11142051|FG000|Overall Study|Upper G-I Haemorrhage|0
7051706|NCT01826981|11142052|FG001|Overall Study|Upper G-I Haemorrhage|0
7051707|NCT01826981|11142053|FG002|Overall Study|Upper G-I Haemorrhage|0
7051708|NCT01826981|11142054|FG003|Overall Study|Upper G-I Haemorrhage|0
7051709|NCT01826981|11142055|FG004|Overall Study|Upper G-I Haemorrhage|0
7051710|NCT01826981|11142056|FG005|Overall Study|Upper G-I Haemorrhage|0
7051711|NCT01826981|11142057|FG006|Overall Study|Upper G-I Haemorrhage|0
7051712|NCT01826981|11142058|FG007|Overall Study|Upper G-I Haemorrhage|0
7084243|NCT02163226|11196131|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0
7084244|NCT02163226|11196130|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0
7084245|NCT02163226|11196131|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5
7084246|NCT02163226|11196130|FG000|Overall Study|ineligible|0
7084247|NCT02163226|11196131|FG001|Overall Study|ineligible|3
7084248|NCT02163447|11196163|FG000|Overall Study|Withdrawal by Subject|2
7084249|NCT02163447|11196164|FG001|Overall Study|Withdrawal by Subject|0
7084250|NCT02163447|11196165|FG002|Overall Study|Withdrawal by Subject|1
7084251|NCT02163447|11196163|FG000|Overall Study|Lost to Follow-up|1
7084252|NCT02163447|11196164|FG001|Overall Study|Lost to Follow-up|3
7084253|NCT02163447|11196165|FG002|Overall Study|Lost to Follow-up|0
7084254|NCT02163447|11196163|FG000|Overall Study|Moved out of study area|2
7051713|NCT01826981|11142059|FG008|Overall Study|Upper G-I Haemorrhage|0
7051714|NCT01826981|11142060|FG009|Overall Study|Upper G-I Haemorrhage|0
7051715|NCT01826981|11142061|FG010|Overall Study|Upper G-I Haemorrhage|0
7051716|NCT01826981|11142062|FG011|Overall Study|Upper G-I Haemorrhage|0
7051717|NCT01826981|11142063|FG012|Overall Study|Upper G-I Haemorrhage|0
7051718|NCT01826981|11142064|FG013|Overall Study|Upper G-I Haemorrhage|1
7051719|NCT01826981|11142065|FG014|Overall Study|Upper G-I Haemorrhage|0
7084255|NCT02163447|11196164|FG001|Overall Study|Moved out of study area|3
7084256|NCT02163447|11196165|FG002|Overall Study|Moved out of study area|2
7084257|NCT02163447|11196163|FG000|Overall Study|Became HIV infected at time of delivery|1
7084258|NCT02163447|11196164|FG001|Overall Study|Became HIV infected at time of delivery|0
7084259|NCT02163447|11196165|FG002|Overall Study|Became HIV infected at time of delivery|0
7084260|NCT02163499|11196192|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1
7084261|NCT02163499|11196192|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1
7084262|NCT02163499|11196192|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1
7084263|NCT02163499|11196192|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1
7084264|NCT02163499|11196192|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1
7084265|NCT02163499|11196192|FG000|Extended Dosing Phase: ZS|Adverse Event|51
7084266|NCT02163499|11196192|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40
7084267|NCT02163499|11196192|FG000|Extended Dosing Phase: ZS|Hypokalemia|9
7084268|NCT02163499|11196192|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5
7084269|NCT02163499|11196192|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7
7084270|NCT02163499|11196192|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81
7084271|NCT02163499|11196192|FG000|Extended Dosing Phase: ZS|Physician Decision|8
7084272|NCT02163499|11196192|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31
7084273|NCT02163499|11196192|FG000|Extended Dosing Phase: ZS|Protocol Violation|2
7084274|NCT02163499|11196192|FG000|Extended Dosing Phase: ZS|Death|8
7084275|NCT02163499|11196192|FG000|Extended Dosing Phase: ZS|Subject Compliance|17
7084276|NCT02163499|11196192|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5
7084277|NCT02163499|11196192|FG000|Extended Dosing Phase: ZS|Various reasons|16
7084278|NCT02163538|11196202|FG000|Overall Study|Protocol Violation|1
7084279|NCT02163538|11196203|FG001|Overall Study|Protocol Violation|0
7084280|NCT02163538|11196202|FG000|Overall Study|Physician Decision|0
7084281|NCT02163538|11196203|FG001|Overall Study|Physician Decision|1
7084282|NCT02163759|11196221|FG000|Overall Study|Withdrawal by Subject|1
7084283|NCT02163759|11196222|FG001|Overall Study|Withdrawal by Subject|5
7084284|NCT02163759|11196223|FG002|Overall Study|Withdrawal by Subject|1
7084285|NCT02163759|11196221|FG000|Overall Study|Adverse Event|0
7084286|NCT02163759|11196222|FG001|Overall Study|Adverse Event|0
7084287|NCT02163759|11196223|FG002|Overall Study|Adverse Event|1
7084288|NCT02163759|11196221|FG000|Overall Study|Death|0
7084289|NCT02163759|11196222|FG001|Overall Study|Death|0
7084290|NCT02163759|11196223|FG002|Overall Study|Death|1
7084291|NCT02163902|11196262|FG000|Overall Study|Subject's Request|3
7084292|NCT02163902|11196263|FG001|Overall Study|Subject's Request|4
7084293|NCT02163902|11196262|FG000|Overall Study|Lost to Follow-up|6
7084294|NCT02163902|11196263|FG001|Overall Study|Lost to Follow-up|7
7084295|NCT02163902|11196262|FG000|Overall Study|Administrative Decision|2
7084296|NCT02163902|11196263|FG001|Overall Study|Administrative Decision|2
7084297|NCT02163915|11196274|FG000|Overall Study|Withdrawal by Subject|2
7084298|NCT02163915|11196275|FG001|Overall Study|Withdrawal by Subject|0
7084299|NCT02163915|11196276|FG002|Overall Study|Withdrawal by Subject|2
7084300|NCT02163915|11196277|FG003|Overall Study|Withdrawal by Subject|2
7084301|NCT02163915|11196278|FG004|Overall Study|Withdrawal by Subject|2
7084302|NCT02163915|11196274|FG000|Overall Study|Study termination|1
7084303|NCT02163915|11196275|FG001|Overall Study|Study termination|0
7084304|NCT02163915|11196276|FG002|Overall Study|Study termination|0
7084305|NCT02163915|11196277|FG003|Overall Study|Study termination|0
7084306|NCT02163915|11196278|FG004|Overall Study|Study termination|2
7084307|NCT02163915|11196274|FG000|Overall Study|Physician Decision|0
7084308|NCT02163915|11196275|FG001|Overall Study|Physician Decision|0
7084309|NCT02163915|11196276|FG002|Overall Study|Physician Decision|0
7084310|NCT02163915|11196277|FG003|Overall Study|Physician Decision|1
7084311|NCT02163915|11196278|FG004|Overall Study|Physician Decision|0
7084312|NCT02163993|11196315|FG000|Treatment Period|Adverse Event|0
7084313|NCT02163993|11196316|FG001|Treatment Period|Adverse Event|1
7084314|NCT02163993|11196317|FG002|Treatment Period|Adverse Event|0
7084315|NCT02163993|11196318|FG003|Treatment Period|Adverse Event|0
7084316|NCT02163993|11196319|FG004|Treatment Period|Adverse Event|1
7084317|NCT02163993|11196315|FG000|Treatment Period|Lost to Follow-up|2
7084318|NCT02163993|11196316|FG001|Treatment Period|Lost to Follow-up|3
7084319|NCT02163993|11196317|FG002|Treatment Period|Lost to Follow-up|1
7084320|NCT02163993|11196318|FG003|Treatment Period|Lost to Follow-up|3
7084321|NCT02163993|11196319|FG004|Treatment Period|Lost to Follow-up|1
7084322|NCT02163993|11196315|FG000|Treatment Period|Physician Decision|1
7084323|NCT02163993|11196316|FG001|Treatment Period|Physician Decision|0
7084324|NCT02163993|11196317|FG002|Treatment Period|Physician Decision|0
7084325|NCT02163993|11196318|FG003|Treatment Period|Physician Decision|0
7084326|NCT02163993|11196319|FG004|Treatment Period|Physician Decision|0
7084327|NCT02163993|11196315|FG000|Treatment Period|Protocol Violation|2
7084328|NCT02163993|11196316|FG001|Treatment Period|Protocol Violation|1
7084329|NCT02163993|11196317|FG002|Treatment Period|Protocol Violation|0
7084330|NCT02163993|11196318|FG003|Treatment Period|Protocol Violation|1
7084331|NCT02163993|11196319|FG004|Treatment Period|Protocol Violation|2
7084332|NCT02163993|11196315|FG000|Treatment Period|Withdrawal by Subject|6
7084333|NCT02163993|11196316|FG001|Treatment Period|Withdrawal by Subject|4
7084334|NCT02163993|11196317|FG002|Treatment Period|Withdrawal by Subject|1
7084335|NCT02163993|11196318|FG003|Treatment Period|Withdrawal by Subject|4
7084336|NCT02163993|11196319|FG004|Treatment Period|Withdrawal by Subject|1
7084337|NCT02163993|11196315|FG000|Treatment Period|Not treated|1
7084338|NCT02163993|11196316|FG001|Treatment Period|Not treated|0
7084339|NCT02163993|11196317|FG002|Treatment Period|Not treated|0
7084340|NCT02163993|11196318|FG003|Treatment Period|Not treated|1
7084341|NCT02163993|11196319|FG004|Treatment Period|Not treated|2
7084342|NCT02163993|11196315|FG000|Post-treatment Period|Adverse Event|0
7084343|NCT02163993|11196316|FG001|Post-treatment Period|Adverse Event|0
7084344|NCT02163993|11196317|FG002|Post-treatment Period|Adverse Event|1
7084345|NCT02163993|11196318|FG003|Post-treatment Period|Adverse Event|0
7084346|NCT02163993|11196319|FG004|Post-treatment Period|Adverse Event|0
7084347|NCT02163993|11196315|FG000|Post-treatment Period|Lost to Follow-up|2
7084348|NCT02163993|11196316|FG001|Post-treatment Period|Lost to Follow-up|2
7084349|NCT02163993|11196317|FG002|Post-treatment Period|Lost to Follow-up|3
7084350|NCT02163993|11196318|FG003|Post-treatment Period|Lost to Follow-up|1
7084351|NCT02163993|11196319|FG004|Post-treatment Period|Lost to Follow-up|0
7084352|NCT02163993|11196315|FG000|Post-treatment Period|Protocol Violation|0
7084353|NCT02163993|11196316|FG001|Post-treatment Period|Protocol Violation|0
7084354|NCT02163993|11196317|FG002|Post-treatment Period|Protocol Violation|0
7084355|NCT02163993|11196318|FG003|Post-treatment Period|Protocol Violation|0
7084356|NCT02163993|11196319|FG004|Post-treatment Period|Protocol Violation|1
7084357|NCT02163993|11196315|FG000|Post-treatment Period|Withdrawal by Subject|2
7084358|NCT02163993|11196316|FG001|Post-treatment Period|Withdrawal by Subject|4
7084359|NCT02163993|11196317|FG002|Post-treatment Period|Withdrawal by Subject|0
7084360|NCT02163993|11196318|FG003|Post-treatment Period|Withdrawal by Subject|1
7084361|NCT02163993|11196319|FG004|Post-treatment Period|Withdrawal by Subject|2
7084362|NCT02164318|11196355|FG000|Overall Study|Withdrawal by Subject|0
7084363|NCT02164318|11196356|FG001|Overall Study|Withdrawal by Subject|1
7084364|NCT02164318|11196357|FG002|Overall Study|Withdrawal by Subject|0
7084365|NCT02164318|11196358|FG003|Overall Study|Withdrawal by Subject|1
7084366|NCT02164383|11196370|FG000|Overall Study|Lost to Follow-up|1
7084367|NCT02164383|11196371|FG001|Overall Study|Lost to Follow-up|0
7084368|NCT02164513|11196406|FG000|Overall Study|Adverse Event|162
7084369|NCT02164513|11196407|FG001|Overall Study|Adverse Event|180
7084370|NCT02164513|11196408|FG002|Overall Study|Adverse Event|111
7084371|NCT02164513|11196406|FG000|Overall Study|Other: Study Closed or terminated|5
7084372|NCT02164513|11196407|FG001|Overall Study|Other: Study Closed or terminated|2
7084373|NCT02164513|11196408|FG002|Overall Study|Other: Study Closed or terminated|4
7084374|NCT02164513|11196406|FG000|Overall Study|Lost to Follow-up|30
7084375|NCT02164513|11196407|FG001|Overall Study|Lost to Follow-up|36
7084376|NCT02164513|11196408|FG002|Overall Study|Lost to Follow-up|22
7084377|NCT02164513|11196406|FG000|Overall Study|Physician Decision|47
7084378|NCT02164513|11196407|FG001|Overall Study|Physician Decision|57
7084379|NCT02164513|11196408|FG002|Overall Study|Physician Decision|28
7084380|NCT02164513|11196406|FG000|Overall Study|Withdrawal by Subject|192
7084381|NCT02164513|11196407|FG001|Overall Study|Withdrawal by Subject|261
7084382|NCT02164513|11196408|FG002|Overall Study|Withdrawal by Subject|130
7084383|NCT02164513|11196406|FG000|Overall Study|Other: Reason not provided by site|1
7084384|NCT02164513|11196407|FG001|Overall Study|Other: Reason not provided by site|0
7084385|NCT02164513|11196408|FG002|Overall Study|Other: Reason not provided by site|0
7084386|NCT02164539|11196423|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
7084387|NCT02164539|11196424|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
7084388|NCT02164539|11196425|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
7084389|NCT02164539|11196426|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
7084390|NCT02164539|11196427|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3
7084391|NCT02164539|11196428|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
7084392|NCT02164539|11196429|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
7084393|NCT02164539|11196423|FG000|Treatment Phase B (1 Week)|Adverse Event|0
7084394|NCT02164539|11196424|FG001|Treatment Phase B (1 Week)|Adverse Event|0
7084395|NCT02164539|11196425|FG002|Treatment Phase B (1 Week)|Adverse Event|0
7084396|NCT02164539|11196426|FG003|Treatment Phase B (1 Week)|Adverse Event|0
7084397|NCT02164539|11196427|FG004|Treatment Phase B (1 Week)|Adverse Event|2
7084398|NCT02164539|11196428|FG005|Treatment Phase B (1 Week)|Adverse Event|0
7084399|NCT02164539|11196429|FG006|Treatment Phase B (1 Week)|Adverse Event|0
7084400|NCT02164539|11196423|FG000|Treatment Phase B (1 Week)|Physician Decision|0
7084401|NCT02164539|11196424|FG001|Treatment Phase B (1 Week)|Physician Decision|0
7084402|NCT02164539|11196425|FG002|Treatment Phase B (1 Week)|Physician Decision|0
7084403|NCT02164539|11196426|FG003|Treatment Phase B (1 Week)|Physician Decision|0
7084404|NCT02164539|11196427|FG004|Treatment Phase B (1 Week)|Physician Decision|1
7084405|NCT02164539|11196428|FG005|Treatment Phase B (1 Week)|Physician Decision|0
7084406|NCT02164539|11196429|FG006|Treatment Phase B (1 Week)|Physician Decision|1
7084407|NCT02164539|11196423|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1
7084408|NCT02164539|11196424|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0
7084409|NCT02164539|11196425|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0
7084410|NCT02164539|11196426|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0
6804540|NCT01909934|10806467|FG000|Overall Study|Ongoing|23
6804541|NCT01909934|10806467|FG000|Overall Study|Withdrawal by Subject|3
6804542|NCT01909934|10806467|FG000|Overall Study|Lost to Follow-up|1
6804543|NCT01909934|10806467|FG000|Overall Study|Withdrawal of Informed Consent|1
6804544|NCT01909934|10806467|FG000|Overall Study|Death|22
6804545|NCT01841359|10806471|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2
6804546|NCT01841359|10806471|FG000|Overall Study|Concommitant medical issues|2
6804547|NCT01841359|10806471|FG000|Overall Study|Adverse Event|3
6804548|NCT01841359|10806471|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1
6804549|NCT01459666|10806480|FG000|Overall Study|PI left institution|5
6804550|NCT01459666|10806481|FG001|Overall Study|PI left institution|4
6804551|NCT01369199|10806487|FG000|Overall Study|Withdrawal by Subject|1
6804552|NCT01369199|10806487|FG000|Overall Study|Lost to Follow-up|2
6804553|NCT01368497|10806491|FG000|Overall Study|Lost to Follow-up|2
7084411|NCT02164539|11196427|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0
7051720|NCT01826981|11142051|FG000|Overall Study|Enrolled/Randomized but Not Treated|0
7051721|NCT01826981|11142052|FG001|Overall Study|Enrolled/Randomized but Not Treated|0
7051722|NCT01826981|11142053|FG002|Overall Study|Enrolled/Randomized but Not Treated|0
7051723|NCT01826981|11142054|FG003|Overall Study|Enrolled/Randomized but Not Treated|0
7051724|NCT01826981|11142055|FG004|Overall Study|Enrolled/Randomized but Not Treated|0
7051725|NCT01826981|11142056|FG005|Overall Study|Enrolled/Randomized but Not Treated|0
7051726|NCT01826981|11142057|FG006|Overall Study|Enrolled/Randomized but Not Treated|0
7051727|NCT01826981|11142058|FG007|Overall Study|Enrolled/Randomized but Not Treated|1
7051728|NCT01826981|11142059|FG008|Overall Study|Enrolled/Randomized but Not Treated|0
7051729|NCT01826981|11142060|FG009|Overall Study|Enrolled/Randomized but Not Treated|0
7051730|NCT01826981|11142061|FG010|Overall Study|Enrolled/Randomized but Not Treated|0
7051731|NCT01826981|11142062|FG011|Overall Study|Enrolled/Randomized but Not Treated|0
7051732|NCT01826981|11142063|FG012|Overall Study|Enrolled/Randomized but Not Treated|0
7051733|NCT01826981|11142064|FG013|Overall Study|Enrolled/Randomized but Not Treated|0
7051734|NCT01826981|11142065|FG014|Overall Study|Enrolled/Randomized but Not Treated|0
7051735|NCT01827046|11142103|FG000|Overall Study|Lost to Follow-up|1
7051736|NCT01827046|11142104|FG001|Overall Study|Lost to Follow-up|5
7051737|NCT01827046|11142103|FG000|Overall Study|Withdrawal by Subject|0
7051738|NCT01827046|11142104|FG001|Overall Study|Withdrawal by Subject|4
7051739|NCT01827163|11142110|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2
7051740|NCT01827163|11142110|FG000|Overall Study|Adverse Event|9
7084412|NCT02164539|11196428|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0
7084413|NCT02164539|11196429|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0
7084414|NCT02164539|11196423|FG000|Treatment Phase C (1 Week)|Adverse Event|0
7084415|NCT02164539|11196424|FG001|Treatment Phase C (1 Week)|Adverse Event|0
7084416|NCT02164539|11196425|FG002|Treatment Phase C (1 Week)|Adverse Event|0
7084417|NCT02164539|11196426|FG003|Treatment Phase C (1 Week)|Adverse Event|0
7084418|NCT02164539|11196427|FG004|Treatment Phase C (1 Week)|Adverse Event|0
7084419|NCT02164539|11196428|FG005|Treatment Phase C (1 Week)|Adverse Event|0
7084420|NCT02164539|11196429|FG006|Treatment Phase C (1 Week)|Adverse Event|1
7084421|NCT02164539|11196423|FG000|Treatment Phase C (1 Week)|Physician Decision|0
7084422|NCT02164539|11196424|FG001|Treatment Phase C (1 Week)|Physician Decision|0
7084423|NCT02164539|11196425|FG002|Treatment Phase C (1 Week)|Physician Decision|0
7084424|NCT02164539|11196426|FG003|Treatment Phase C (1 Week)|Physician Decision|0
7084425|NCT02164539|11196427|FG004|Treatment Phase C (1 Week)|Physician Decision|0
7084426|NCT02164539|11196428|FG005|Treatment Phase C (1 Week)|Physician Decision|0
7084427|NCT02164539|11196429|FG006|Treatment Phase C (1 Week)|Physician Decision|1
7084428|NCT02164864|11196452|FG000|Overall Study|Trial disease worsening|7
7084429|NCT02164864|11196453|FG001|Overall Study|Trial disease worsening|5
7084430|NCT02164864|11196454|FG002|Overall Study|Trial disease worsening|1
7084431|NCT02164864|11196452|FG000|Overall Study|Other pre-existing disease worsening|6
7084432|NCT02164864|11196453|FG001|Overall Study|Other pre-existing disease worsening|4
7084433|NCT02164864|11196454|FG002|Overall Study|Other pre-existing disease worsening|9
7084434|NCT02164864|11196452|FG000|Overall Study|Other Adverse Event (AE)|52
7084435|NCT02164864|11196453|FG001|Overall Study|Other Adverse Event (AE)|32
7084436|NCT02164864|11196454|FG002|Overall Study|Other Adverse Event (AE)|49
7084437|NCT02164864|11196452|FG000|Overall Study|Protocol Violation|2
7084438|NCT02164864|11196453|FG001|Overall Study|Protocol Violation|4
7084439|NCT02164864|11196454|FG002|Overall Study|Protocol Violation|1
7084440|NCT02164864|11196452|FG000|Overall Study|Lost to Follow-up|4
7084441|NCT02164864|11196453|FG001|Overall Study|Lost to Follow-up|3
7084442|NCT02164864|11196454|FG002|Overall Study|Lost to Follow-up|2
7084443|NCT02164864|11196452|FG000|Overall Study|Consent withdrawn, not due to AE|21
7051741|NCT01827254|11142114|FG000|Overall Study|Death|10
7051742|NCT01827254|11142114|FG000|Overall Study|Case report form not completed|4
7051743|NCT01827254|11142114|FG000|Overall Study|Invalidated centre|3
6804602|NCT00977574|10806515|FG000|Overall Study|Never Treated|4
6804603|NCT00977574|10806516|FG001|Overall Study|Never Treated|2
6804604|NCT00977574|10806517|FG002|Overall Study|Never Treated|4
7051744|NCT01827254|11142114|FG000|Overall Study|Discontinued prior initiation: sunitinib|1
7051745|NCT01827254|11142114|FG000|Overall Study|Did not complete re-challenge|1
7051746|NCT01827254|11142114|FG000|Overall Study|Disease progression|36
7051747|NCT01827254|11142114|FG000|Overall Study|Intolerance to treatment|4
7051748|NCT01827267|11142124|FG000|Overall Study|Did not receive study drug|1
7051749|NCT01827267|11142125|FG001|Overall Study|Did not receive study drug|1
7051750|NCT01827267|11142124|FG000|Overall Study|Physician Decision|1
7051751|NCT01827267|11142125|FG001|Overall Study|Physician Decision|0
7051752|NCT01827267|11142124|FG000|Overall Study|Disease Progression|1
7051753|NCT01827267|11142125|FG001|Overall Study|Disease Progression|1
7051754|NCT01827267|11142124|FG000|Overall Study|Sponsor Discontinued Study|2
7051755|NCT01827267|11142125|FG001|Overall Study|Sponsor Discontinued Study|8
7051756|NCT01827267|11142124|FG000|Overall Study|Still on study|0
7051757|NCT01827267|11142125|FG001|Overall Study|Still on study|2
7051758|NCT01827319|11142141|FG000|Overall Study|Lost to Follow-up|3
7051759|NCT01827332|11142147|FG000|Overall Study|Lost to Follow-up|2
7051760|NCT01827332|11142148|FG001|Overall Study|Lost to Follow-up|1
7051761|NCT01827371|11142167|FG000|Overall Study|Adverse Event|0
7051762|NCT01827371|11142168|FG001|Overall Study|Adverse Event|0
6804605|NCT05096312|10806527|FG000|Overall Study|Lost to Follow-up|2
6804606|NCT05096312|10806528|FG001|Overall Study|Lost to Follow-up|4
6804607|NCT05096312|10806527|FG000|Overall Study|Adverse Event|1
6804608|NCT05096312|10806528|FG001|Overall Study|Adverse Event|0
6804609|NCT02853344|10806536|FG000|Overall Study|Death|23
6804610|NCT02853344|10806537|FG001|Overall Study|Death|84
6804611|NCT02853344|10806536|FG000|Overall Study|Withdrawal by Subject|1
6804612|NCT02853344|10806537|FG001|Overall Study|Withdrawal by Subject|3
6804613|NCT02853344|10806536|FG000|Overall Study|Ongoing|86
6804614|NCT02853344|10806537|FG001|Overall Study|Ongoing|78
6804615|NCT03560258|10806548|FG000|Overall Study|Lost to Follow-up|3
6804616|NCT03560258|10806549|FG001|Overall Study|Lost to Follow-up|0
6804617|NCT03560258|10806550|FG002|Overall Study|Lost to Follow-up|0
6804618|NCT03560258|10806548|FG000|Overall Study|Protocol Violation|0
6804619|NCT03560258|10806549|FG001|Overall Study|Protocol Violation|1
6804620|NCT03560258|10806550|FG002|Overall Study|Protocol Violation|0
6804621|NCT03560258|10806548|FG000|Overall Study|Withdrawal by Subject|0
6804622|NCT03560258|10806549|FG001|Overall Study|Withdrawal by Subject|0
6804623|NCT03560258|10806550|FG002|Overall Study|Withdrawal by Subject|1
6804624|NCT03684304|10806560|FG000|Overall Study|Lost to Follow-up|19
6804625|NCT03684304|10806561|FG001|Overall Study|Lost to Follow-up|17
6804626|NCT04528641|10806582|FG000|Overall Study|Withdrawal by Subject|0
6804627|NCT04528641|10806583|FG001|Overall Study|Withdrawal by Subject|0
6804628|NCT04528641|10806584|FG002|Overall Study|Withdrawal by Subject|0
6804629|NCT04528641|10806585|FG003|Overall Study|Withdrawal by Subject|1
6804630|NCT04528641|10806586|FG004|Overall Study|Withdrawal by Subject|0
6804631|NCT04528641|10806587|FG005|Overall Study|Withdrawal by Subject|1
6804632|NCT04034238|10806623|FG000|Dose Escalation Phase|Withdrawal by Subject|1
6804633|NCT04034238|10806624|FG001|Dose Escalation Phase|Withdrawal by Subject|0
6804634|NCT04034238|10806625|FG002|Dose Escalation Phase|Withdrawal by Subject|0
6804635|NCT04034238|10806626|FG003|Dose Escalation Phase|Withdrawal by Subject|0
6804636|NCT04034238|10806623|FG000|Dose Escalation Phase|Screen failures|0
6804637|NCT04034238|10806624|FG001|Dose Escalation Phase|Screen failures|0
6804638|NCT04034238|10806625|FG002|Dose Escalation Phase|Screen failures|0
6804639|NCT04034238|10806626|FG003|Dose Escalation Phase|Screen failures|2
6804640|NCT04034238|10806623|FG000|Dose Expansion Phase|Not treated due to study hold.|0
6804641|NCT04034238|10806624|FG001|Dose Expansion Phase|Not treated due to study hold.|0
6804642|NCT04034238|10806625|FG002|Dose Expansion Phase|Not treated due to study hold.|0
6804643|NCT04034238|10806626|FG003|Dose Expansion Phase|Not treated due to study hold.|1
6804644|NCT04034238|10806623|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0
6804645|NCT04034238|10806624|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0
6804646|NCT04034238|10806625|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1
6804647|NCT04034238|10806626|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0
6804648|NCT03984305|10806639|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19
6804649|NCT03984305|10806640|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15
6804650|NCT03984305|10806639|FG000|Overall Study|Withdrawal by Subject|3
6804651|NCT03984305|10806640|FG001|Overall Study|Withdrawal by Subject|3
6804652|NCT03984305|10806639|FG000|Overall Study|Lost to Follow-up|1
6804653|NCT03984305|10806640|FG001|Overall Study|Lost to Follow-up|0
6804654|NCT03982368|10806649|FG000|Overall Study|Adverse Event|6
6804655|NCT03982368|10806650|FG001|Overall Study|Adverse Event|4
6804656|NCT03982368|10806651|FG002|Overall Study|Adverse Event|3
6804657|NCT03982368|10806649|FG000|Overall Study|Lost to Follow-up|2
6804658|NCT03982368|10806650|FG001|Overall Study|Lost to Follow-up|1
6804659|NCT03982368|10806651|FG002|Overall Study|Lost to Follow-up|0
6804660|NCT03982368|10806649|FG000|Overall Study|Withdrawal by Subject|1
6804661|NCT03982368|10806650|FG001|Overall Study|Withdrawal by Subject|2
6804662|NCT03982368|10806651|FG002|Overall Study|Withdrawal by Subject|0
6804663|NCT03982368|10806649|FG000|Overall Study|unknow|4
6804664|NCT03982368|10806650|FG001|Overall Study|unknow|0
6804665|NCT03982368|10806651|FG002|Overall Study|unknow|2
7051763|NCT01827371|11142169|FG002|Overall Study|Adverse Event|4
7051764|NCT01827371|11142170|FG003|Overall Study|Adverse Event|2
7051765|NCT01827371|11142167|FG000|Overall Study|Lost to Follow-up|0
7051766|NCT01827371|11142168|FG001|Overall Study|Lost to Follow-up|2
7051767|NCT01827371|11142169|FG002|Overall Study|Lost to Follow-up|0
7051768|NCT01827371|11142170|FG003|Overall Study|Lost to Follow-up|4
7051769|NCT01827371|11142167|FG000|Overall Study|Protocol Violation|1
7051770|NCT01827371|11142168|FG001|Overall Study|Protocol Violation|0
7051771|NCT01827371|11142169|FG002|Overall Study|Protocol Violation|0
7051772|NCT01827371|11142170|FG003|Overall Study|Protocol Violation|0
7051773|NCT01827371|11142167|FG000|Overall Study|Withdrawal by Subject|1
7051774|NCT01827371|11142168|FG001|Overall Study|Withdrawal by Subject|2
7051775|NCT01827371|11142169|FG002|Overall Study|Withdrawal by Subject|2
7051776|NCT01827371|11142170|FG003|Overall Study|Withdrawal by Subject|3
7051777|NCT01827371|11142167|FG000|Overall Study|Physician Decision|0
7051778|NCT01827371|11142168|FG001|Overall Study|Physician Decision|1
7051779|NCT01827371|11142169|FG002|Overall Study|Physician Decision|0
7051780|NCT01827371|11142170|FG003|Overall Study|Physician Decision|1
7084444|NCT02164864|11196453|FG001|Overall Study|Consent withdrawn, not due to AE|8
7084445|NCT02164864|11196454|FG002|Overall Study|Consent withdrawn, not due to AE|56
7084446|NCT02164864|11196452|FG000|Overall Study|Other than stated|3
7084447|NCT02164864|11196453|FG001|Overall Study|Other than stated|4
7084448|NCT02164864|11196454|FG002|Overall Study|Other than stated|14
7084449|NCT02164916|11196467|FG000|Overall Study|Adverse Event|3
7084450|NCT02164916|11196468|FG001|Overall Study|Adverse Event|8
7084451|NCT02164916|11196467|FG000|Overall Study|Death|1
7084452|NCT02164916|11196468|FG001|Overall Study|Death|1
7084453|NCT02164916|11196467|FG000|Overall Study|Refusal unrelated to adverse event|3
7084454|NCT02164916|11196468|FG001|Overall Study|Refusal unrelated to adverse event|7
7084455|NCT02164916|11196467|FG000|Overall Study|Progression|37
7084456|NCT02164916|11196468|FG001|Overall Study|Progression|26
7084457|NCT02164916|11196467|FG000|Overall Study|Not protocol specified|5
7084458|NCT02164916|11196468|FG001|Overall Study|Not protocol specified|1
7084459|NCT02164916|11196467|FG000|Overall Study|Reason under review|1
7084460|NCT02164916|11196468|FG001|Overall Study|Reason under review|6
7084461|NCT02164916|11196467|FG000|Overall Study|Not eligible|2
7084462|NCT02164916|11196468|FG001|Overall Study|Not eligible|5
7084463|NCT02164929|11196483|FG000|Overall Study|Converted to open procedure|1
7084464|NCT02164929|11196484|FG001|Overall Study|Converted to open procedure|0
7084465|NCT02164929|11196485|FG002|Overall Study|Converted to open procedure|0
7084466|NCT02164929|11196486|FG003|Overall Study|Converted to open procedure|2
7084467|NCT02164929|11196483|FG000|Overall Study|Failed regional block|0
7084468|NCT02164929|11196484|FG001|Overall Study|Failed regional block|0
7084469|NCT02164929|11196485|FG002|Overall Study|Failed regional block|1
7084470|NCT02164929|11196486|FG003|Overall Study|Failed regional block|0
7084471|NCT02164981|11196499|FG000|Started|Withdrawal by Subject|2
7084472|NCT02164981|11196500|FG001|Started|Withdrawal by Subject|1
7084473|NCT02164981|11196501|FG002|Started|Withdrawal by Subject|0
7084474|NCT02164981|11196499|FG000|Started|Protocol Violation|2
7084475|NCT02164981|11196500|FG001|Started|Protocol Violation|0
7084476|NCT02164981|11196501|FG002|Started|Protocol Violation|0
7084477|NCT02164981|11196499|FG000|Started|Adverse Event|1
7084478|NCT02164981|11196500|FG001|Started|Adverse Event|2
7084479|NCT02164981|11196501|FG002|Started|Adverse Event|0
7084480|NCT02164981|11196499|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0
7084481|NCT02164981|11196500|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2
7084482|NCT02164981|11196501|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0
7084483|NCT02164981|11196499|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2
7084484|NCT02164981|11196500|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1
7084485|NCT02164981|11196501|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0
7084486|NCT02164981|11196499|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0
7084487|NCT02164981|11196500|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1
7051781|NCT01827371|11142167|FG000|Overall Study|Temporary study halt to vaccinations|11
7084488|NCT02164981|11196501|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0
7084489|NCT02165202|11196543|FG000|Oral Phase|Refused further participation|5
7084490|NCT02165202|11196544|FG001|Oral Phase|Refused further participation|1
7084491|NCT02165202|11196543|FG000|Oral Phase|Study product Related Toxicity|1
7084492|NCT02165202|11196544|FG001|Oral Phase|Study product Related Toxicity|0
7051782|NCT01827371|11142168|FG001|Overall Study|Temporary study halt to vaccinations|2
7051783|NCT01827371|11142169|FG002|Overall Study|Temporary study halt to vaccinations|5
7051784|NCT01827371|11142170|FG003|Overall Study|Temporary study halt to vaccinations|13
7051785|NCT01827592|11142212|FG000|Overall Study|Adverse Event|11
7051786|NCT01827592|11142213|FG001|Overall Study|Adverse Event|9
7051787|NCT01827592|11142214|FG002|Overall Study|Adverse Event|2
7051788|NCT01827592|11142212|FG000|Overall Study|Physician Decision|0
7051789|NCT01827592|11142213|FG001|Overall Study|Physician Decision|2
7051790|NCT01827592|11142214|FG002|Overall Study|Physician Decision|1
7051791|NCT01827592|11142212|FG000|Overall Study|Protocol Violation|2
7051792|NCT01827592|11142213|FG001|Overall Study|Protocol Violation|1
7051793|NCT01827592|11142214|FG002|Overall Study|Protocol Violation|0
7051794|NCT01827592|11142212|FG000|Overall Study|Lost to Follow-up|1
7051795|NCT01827592|11142213|FG001|Overall Study|Lost to Follow-up|2
7051796|NCT01827592|11142214|FG002|Overall Study|Lost to Follow-up|2
7051797|NCT01827592|11142212|FG000|Overall Study|Withdrawal by Subject|12
7051798|NCT01827592|11142213|FG001|Overall Study|Withdrawal by Subject|11
7051799|NCT01827592|11142214|FG002|Overall Study|Withdrawal by Subject|11
7051800|NCT01827592|11142212|FG000|Overall Study|Patient's substantial non-compliance|1
7051801|NCT01827592|11142213|FG001|Overall Study|Patient's substantial non-compliance|1
7051802|NCT01827592|11142214|FG002|Overall Study|Patient's substantial non-compliance|6
7051803|NCT01827592|11142212|FG000|Overall Study|Trial terminated by Sponsor|47
7051804|NCT01827592|11142213|FG001|Overall Study|Trial terminated by Sponsor|53
7051805|NCT01827592|11142214|FG002|Overall Study|Trial terminated by Sponsor|51
7051806|NCT01827592|11142212|FG000|Overall Study|Others|0
7051807|NCT01827592|11142213|FG001|Overall Study|Others|1
7051808|NCT01827592|11142214|FG002|Overall Study|Others|3
7051809|NCT01827670|11142224|FG000|Overall Study|Withdrawal of Consent|3
7051810|NCT01827670|11142225|FG001|Overall Study|Withdrawal of Consent|2
7051811|NCT01827670|11142224|FG000|Overall Study|Lost to Follow-up|0
7051812|NCT01827670|11142225|FG001|Overall Study|Lost to Follow-up|1
7051813|NCT01827839|11142248|FG000|Overall Study|Adverse Event|1
7051814|NCT01827839|11142248|FG000|Overall Study|Consent Withdrawal|2
7051815|NCT01827943|11142272|FG000|Overall Study|Protocol Violation|8
7051816|NCT01827943|11142272|FG000|Overall Study|Never treated because of an rapid progression|1
7051817|NCT01828034|11142280|FG000|Overall Study|Withdrawal by Subject|0
7051818|NCT01828034|11142281|FG001|Overall Study|Withdrawal by Subject|0
7051819|NCT01828034|11142282|FG002|Overall Study|Withdrawal by Subject|0
7051820|NCT01828034|11142283|FG003|Overall Study|Withdrawal by Subject|1
7051821|NCT01828073|11142292|FG000|Overall Study|Lost to Follow-up|1
7051822|NCT01828073|11142293|FG001|Overall Study|Lost to Follow-up|2
7051823|NCT01828281|11142337|FG000|Overall Study|Withdrawal by Subject|1
7051824|NCT01828281|11142338|FG001|Overall Study|Withdrawal by Subject|0
7051825|NCT01828567|11142369|FG000|Overall Study|Lost to Follow-up|27
7051826|NCT01828567|11142370|FG001|Overall Study|Lost to Follow-up|9
7051827|NCT01828567|11142369|FG000|Overall Study|Excluded - did not meet criteria|4
7051828|NCT01828567|11142370|FG001|Overall Study|Excluded - did not meet criteria|1
7051829|NCT01829048|11142406|FG000|Overall Study|Withdrawal by Subject|0
7051830|NCT01829048|11142407|FG001|Overall Study|Withdrawal by Subject|0
7051831|NCT01829048|11142408|FG002|Overall Study|Withdrawal by Subject|0
7051832|NCT01829048|11142409|FG003|Overall Study|Withdrawal by Subject|2
7051833|NCT01829048|11142410|FG004|Overall Study|Withdrawal by Subject|0
7051834|NCT01829113|11142425|FG000|Overall Study|Disease Progression|37
7051835|NCT01829113|11142426|FG001|Overall Study|Disease Progression|48
7051836|NCT01829113|11142425|FG000|Overall Study|Adverse Event|14
7051837|NCT01829113|11142426|FG001|Overall Study|Adverse Event|10
7051838|NCT01829113|11142425|FG000|Overall Study|Withdrawal by Subject|17
7051839|NCT01829113|11142426|FG001|Overall Study|Withdrawal by Subject|10
7051840|NCT01829113|11142425|FG000|Overall Study|Death|4
7051841|NCT01829113|11142426|FG001|Overall Study|Death|6
7051842|NCT01829113|11142425|FG000|Overall Study|Sponsor Decision|1
7051843|NCT01829113|11142426|FG001|Overall Study|Sponsor Decision|1
7051844|NCT01829113|11142425|FG000|Overall Study|No Study Treatment Received|3
7051845|NCT01829113|11142426|FG001|Overall Study|No Study Treatment Received|2
7051846|NCT01829113|11142425|FG000|Overall Study|Physician Decision|1
7051847|NCT01829113|11142426|FG001|Overall Study|Physician Decision|1
7051848|NCT01829165|11142436|FG000|Overall Study|Did not complete intervention|2
7051849|NCT01829165|11142437|FG001|Overall Study|Did not complete intervention|0
7051850|NCT01829191|11142445|FG000|Overall Study|Relocation|0
7051851|NCT01829191|11142446|FG001|Overall Study|Relocation|1
7051852|NCT01829191|11142445|FG000|Overall Study|Lens discomfort|0
7051853|NCT01829191|11142446|FG001|Overall Study|Lens discomfort|3
7051854|NCT01829191|11142445|FG000|Overall Study|Lens handling difficulty|1
7051855|NCT01829191|11142446|FG001|Overall Study|Lens handling difficulty|4
7051856|NCT01829191|11142445|FG000|Overall Study|Protocol Violation|4
7051857|NCT01829191|11142446|FG001|Overall Study|Protocol Violation|1
7051858|NCT01829191|11142445|FG000|Overall Study|Withdrawal by Subject|2
7051859|NCT01829191|11142446|FG001|Overall Study|Withdrawal by Subject|3
7051860|NCT01829191|11142445|FG000|Overall Study|Lost to Follow-up|0
7051861|NCT01829191|11142446|FG001|Overall Study|Lost to Follow-up|1
7051862|NCT01829191|11142445|FG000|Overall Study|Subject was fit for ortho - k|0
7051863|NCT01829191|11142446|FG001|Overall Study|Subject was fit for ortho - k|1
7051864|NCT01829230|11142457|FG000|Overall Study|Protocol Violation|0
7051865|NCT01829230|11142458|FG001|Overall Study|Protocol Violation|2
7051866|NCT01829230|11142457|FG000|Overall Study|Withdrawal by Subject|0
7051867|NCT01829230|11142458|FG001|Overall Study|Withdrawal by Subject|1
7051868|NCT01829230|11142457|FG000|Overall Study|Lost to Follow-up|1
7051869|NCT01829230|11142458|FG001|Overall Study|Lost to Follow-up|1
7051870|NCT01829243|11142464|FG000|First Intervention|Screen Failure|4
7051871|NCT01829243|11142465|FG001|First Intervention|Screen Failure|2
7051872|NCT01829295|11142475|FG000|6-12 Months|Did not want to switch antimetabolites|0
7051873|NCT01829295|11142476|FG001|6-12 Months|Did not want to switch antimetabolites|0
7051874|NCT01829295|11142477|FG002|6-12 Months|Did not want to switch antimetabolites|9
7051875|NCT01829295|11142478|FG003|6-12 Months|Did not want to switch antimetabolites|11
7051876|NCT01829295|11142475|FG000|6-12 Months|Adverse Event|0
7051877|NCT01829295|11142476|FG001|6-12 Months|Adverse Event|0
7051878|NCT01829295|11142477|FG002|6-12 Months|Adverse Event|3
7051879|NCT01829295|11142478|FG003|6-12 Months|Adverse Event|2
7051880|NCT01829295|11142475|FG000|6-12 Months|Lost to Follow-up|2
7051881|NCT01829295|11142476|FG001|6-12 Months|Lost to Follow-up|0
7051882|NCT01829295|11142477|FG002|6-12 Months|Lost to Follow-up|0
7051883|NCT01829295|11142478|FG003|6-12 Months|Lost to Follow-up|0
7051884|NCT01829295|11142475|FG000|6-12 Months|Withdrawal by Subject|2
7051885|NCT01829295|11142476|FG001|6-12 Months|Withdrawal by Subject|2
7051886|NCT01829295|11142477|FG002|6-12 Months|Withdrawal by Subject|0
7051887|NCT01829295|11142478|FG003|6-12 Months|Withdrawal by Subject|0
7051888|NCT01829347|11142490|FG000|VTI-210|Death|5
7051889|NCT01829347|11142491|FG001|VTI-210|Death|3
7051890|NCT01829347|11142490|FG000|VTI-210|Withdrawal by Subject|1
7051891|NCT01829347|11142491|FG001|VTI-210|Withdrawal by Subject|0
7051892|NCT01829347|11142490|FG000|VTI-210E|Death|2
7051893|NCT01829347|11142491|FG001|VTI-210E|Death|1
7051894|NCT01829347|11142490|FG000|VTI-210E|Study terminated prematurely|1
7051895|NCT01829347|11142491|FG001|VTI-210E|Study terminated prematurely|5
7051896|NCT01829360|11142501|FG000|Overall Study|Protocol Violation|0
7051897|NCT01829360|11142502|FG001|Overall Study|Protocol Violation|0
7051898|NCT01829360|11142503|FG002|Overall Study|Protocol Violation|1
7051899|NCT01829360|11142504|FG003|Overall Study|Protocol Violation|0
7051900|NCT01829425|11142531|FG000|Overall Study|Withdrawal by Subject|4
7051901|NCT01829425|11142532|FG001|Overall Study|Withdrawal by Subject|3
7051902|NCT01829425|11142531|FG000|Overall Study|Lost to Follow-up|2
7051903|NCT01829425|11142532|FG001|Overall Study|Lost to Follow-up|1
7051904|NCT01829464|11142541|FG000|Overall Study|Adverse Event|1
7051905|NCT01829464|11142542|FG001|Overall Study|Adverse Event|0
7051906|NCT01829464|11142543|FG002|Overall Study|Adverse Event|0
7051907|NCT01829464|11142541|FG000|Overall Study|Lost to Follow-up|0
7051908|NCT01829464|11142542|FG001|Overall Study|Lost to Follow-up|0
7051909|NCT01829464|11142543|FG002|Overall Study|Lost to Follow-up|1
7051910|NCT01829464|11142541|FG000|Overall Study|Withdrawal by Subject|2
7051911|NCT01829464|11142542|FG001|Overall Study|Withdrawal by Subject|0
7051912|NCT01829464|11142543|FG002|Overall Study|Withdrawal by Subject|0
7051913|NCT01829464|11142541|FG000|Overall Study|Study terminated by sponsor|25
7051914|NCT01829464|11142542|FG001|Overall Study|Study terminated by sponsor|28
7051915|NCT01829464|11142543|FG002|Overall Study|Study terminated by sponsor|25
7051916|NCT01829464|11142541|FG000|Overall Study|Lack of Efficacy|0
7051917|NCT01829464|11142542|FG001|Overall Study|Lack of Efficacy|1
7051918|NCT01829464|11142543|FG002|Overall Study|Lack of Efficacy|0
7051919|NCT01830127|11142576|FG000|Overall Study|Adverse Event|1
7051920|NCT01830127|11142577|FG001|Overall Study|Adverse Event|6
7051921|NCT01830127|11142576|FG000|Overall Study|Lack of Efficacy|3
7051922|NCT01830127|11142577|FG001|Overall Study|Lack of Efficacy|0
7051923|NCT01830127|11142576|FG000|Overall Study|Withdrawal by Subject|1
7051924|NCT01830127|11142577|FG001|Overall Study|Withdrawal by Subject|1
7051925|NCT01830127|11142576|FG000|Overall Study|Other reason not defined above|0
7051926|NCT01830127|11142577|FG001|Overall Study|Other reason not defined above|2
7051927|NCT01830543|11142623|FG000|Overall Study|Subject Decision|19
7051928|NCT01830543|11142624|FG001|Overall Study|Subject Decision|21
7051929|NCT01830543|11142625|FG002|Overall Study|Subject Decision|57
7051930|NCT01830543|11142623|FG000|Overall Study|Adverse Event|91
7051931|NCT01830543|11142624|FG001|Overall Study|Adverse Event|77
7051932|NCT01830543|11142625|FG002|Overall Study|Adverse Event|76
7051933|NCT01830543|11142623|FG000|Overall Study|Death|20
7051934|NCT01830543|11142624|FG001|Overall Study|Death|22
7051935|NCT01830543|11142625|FG002|Overall Study|Death|22
7051936|NCT01830543|11142623|FG000|Overall Study|Protocol Violation|3
7051937|NCT01830543|11142624|FG001|Overall Study|Protocol Violation|7
7051938|NCT01830543|11142625|FG002|Overall Study|Protocol Violation|7
7051939|NCT01830543|11142623|FG000|Overall Study|Physician Decision|11
7051940|NCT01830543|11142624|FG001|Overall Study|Physician Decision|5
7051941|NCT01830543|11142625|FG002|Overall Study|Physician Decision|12
7051942|NCT01830543|11142623|FG000|Overall Study|Withdrawal by consent|3
7051943|NCT01830543|11142624|FG001|Overall Study|Withdrawal by consent|3
7051944|NCT01830543|11142625|FG002|Overall Study|Withdrawal by consent|3
7051945|NCT01830543|11142623|FG000|Overall Study|Other|12
7051946|NCT01830543|11142624|FG001|Overall Study|Other|17
7051947|NCT01830543|11142625|FG002|Overall Study|Other|37
7051948|NCT01830595|11142633|FG000|First Period|Withdrawal by Subject|1
7051949|NCT01830595|11142634|FG001|First Period|Withdrawal by Subject|3
7051950|NCT01830595|11142633|FG000|Washout|Withdrawal by Subject|2
7051951|NCT01830595|11142634|FG001|Washout|Withdrawal by Subject|2
7051952|NCT01830816|11142661|FG000|Overall Study|Progressive Disease|12
7051953|NCT01830816|11142662|FG001|Overall Study|Progressive Disease|7
7051954|NCT01830816|11142663|FG002|Overall Study|Progressive Disease|7
7051955|NCT01830816|11142661|FG000|Overall Study|Adverse Event|3
7051956|NCT01830816|11142662|FG001|Overall Study|Adverse Event|4
7051957|NCT01830816|11142663|FG002|Overall Study|Adverse Event|0
7051958|NCT01830816|11142661|FG000|Overall Study|Study Terminated by Sponsor|1
7051959|NCT01830816|11142662|FG001|Overall Study|Study Terminated by Sponsor|1
7051960|NCT01830816|11142663|FG002|Overall Study|Study Terminated by Sponsor|0
7051961|NCT01830816|11142661|FG000|Overall Study|Withdrawal by Subject|1
7051962|NCT01830816|11142662|FG001|Overall Study|Withdrawal by Subject|1
7051963|NCT01830816|11142663|FG002|Overall Study|Withdrawal by Subject|0
7051964|NCT01830816|11142661|FG000|Overall Study|Lost to Follow-up|0
7051965|NCT01830816|11142662|FG001|Overall Study|Lost to Follow-up|1
7051966|NCT01830816|11142663|FG002|Overall Study|Lost to Follow-up|0
7051967|NCT01830816|11142661|FG000|Overall Study|Symptomatic Deterioration|1
7051968|NCT01830816|11142662|FG001|Overall Study|Symptomatic Deterioration|0
7051969|NCT01830816|11142663|FG002|Overall Study|Symptomatic Deterioration|0
7051970|NCT01830816|11142661|FG000|Overall Study|Reason not Specified|2
7051971|NCT01830816|11142662|FG001|Overall Study|Reason not Specified|0
7051972|NCT01830816|11142663|FG002|Overall Study|Reason not Specified|0
7051973|NCT01830855|11142687|FG000|Overall Study|Other|7
7051974|NCT01830855|11142688|FG001|Overall Study|Other|1
7051975|NCT01830855|11142689|FG002|Overall Study|Other|4
7051976|NCT01830855|11142690|FG003|Overall Study|Other|4
7051977|NCT01830855|11142687|FG000|Overall Study|Medication error without associated AE|1
7051978|NCT01830855|11142688|FG001|Overall Study|Medication error without associated AE|0
7051979|NCT01830855|11142689|FG002|Overall Study|Medication error without associated AE|0
7051980|NCT01830855|11142690|FG003|Overall Study|Medication error without associated AE|1
7051981|NCT01830855|11142687|FG000|Overall Study|Pregnancy|3
7051982|NCT01830855|11142688|FG001|Overall Study|Pregnancy|1
7051983|NCT01830855|11142689|FG002|Overall Study|Pregnancy|2
7051984|NCT01830855|11142690|FG003|Overall Study|Pregnancy|1
7051985|NCT01830855|11142687|FG000|Overall Study|No longer meets eligibility criteria|11
7051986|NCT01830855|11142688|FG001|Overall Study|No longer meets eligibility criteria|2
7084493|NCT02165202|11196543|FG000|Oral Phase|Unable to contact Participant|1
7084494|NCT02165202|11196544|FG001|Oral Phase|Unable to contact Participant|1
7084495|NCT02165202|11196543|FG000|Oral Phase|Clinical reasons|1
7084496|NCT02165202|11196544|FG001|Oral Phase|Clinical reasons|0
7084497|NCT02165202|11196543|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1
7084498|NCT02165202|11196544|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0
7051987|NCT01830855|11142689|FG002|Overall Study|No longer meets eligibility criteria|3
7051988|NCT01830855|11142690|FG003|Overall Study|No longer meets eligibility criteria|5
7051989|NCT01830855|11142687|FG000|Overall Study|Adverse Event|11
7051990|NCT01830855|11142688|FG001|Overall Study|Adverse Event|5
7051991|NCT01830855|11142689|FG002|Overall Study|Adverse Event|6
7051992|NCT01830855|11142690|FG003|Overall Study|Adverse Event|3
7051993|NCT01830855|11142687|FG000|Overall Study|Protocol deviation|10
7051994|NCT01830855|11142688|FG001|Overall Study|Protocol deviation|5
7051995|NCT01830855|11142689|FG002|Overall Study|Protocol deviation|6
7051996|NCT01830855|11142690|FG003|Overall Study|Protocol deviation|6
7051997|NCT01830855|11142687|FG000|Overall Study|Withdrawal by Subject|33
7051998|NCT01830855|11142688|FG001|Overall Study|Withdrawal by Subject|14
7051999|NCT01830855|11142689|FG002|Overall Study|Withdrawal by Subject|10
7052000|NCT01830855|11142690|FG003|Overall Study|Withdrawal by Subject|12
7052001|NCT01830855|11142687|FG000|Overall Study|No longer willing to participate|32
7052002|NCT01830855|11142688|FG001|Overall Study|No longer willing to participate|13
7052003|NCT01830855|11142689|FG002|Overall Study|No longer willing to participate|12
7052004|NCT01830855|11142690|FG003|Overall Study|No longer willing to participate|17
7052005|NCT01830855|11142687|FG000|Overall Study|Lost to Follow-up|47
7052006|NCT01830855|11142688|FG001|Overall Study|Lost to Follow-up|20
7052007|NCT01830855|11142689|FG002|Overall Study|Lost to Follow-up|23
7052008|NCT01830855|11142690|FG003|Overall Study|Lost to Follow-up|33
7052009|NCT01830881|11142707|FG000|Overall Study|Changed decision to have an abortion|0
7052010|NCT01830881|11142708|FG001|Overall Study|Changed decision to have an abortion|1
7052011|NCT01830920|11142721|FG000|Overall Study|Adverse Event|1
7052012|NCT01830920|11142722|FG001|Overall Study|Adverse Event|0
7052013|NCT01830920|11142723|FG002|Overall Study|Adverse Event|1
7052014|NCT01830920|11142724|FG003|Overall Study|Adverse Event|0
7052015|NCT01830920|11142725|FG004|Overall Study|Adverse Event|0
7052016|NCT01830920|11142721|FG000|Overall Study|Withdrawal by Subject|2
7052017|NCT01830920|11142722|FG001|Overall Study|Withdrawal by Subject|2
7084499|NCT02165202|11196543|FG000|Oral Phase|CMC advised termination|1
7084500|NCT02165202|11196544|FG001|Oral Phase|CMC advised termination|0
7084501|NCT02165202|11196543|FG000|Oral Phase|Relocated, no follow-up planned|1
7084502|NCT02165202|11196544|FG001|Oral Phase|Relocated, no follow-up planned|0
6804666|NCT03952143|10806664|FG000|Lead-In Period|Adverse Event|2
7084503|NCT02165202|11196543|FG000|Oral Phase|Abnormal EKG|0
6804667|NCT03952143|10806665|FG001|Lead-In Period|Adverse Event|0
6804668|NCT03952143|10806666|FG002|Lead-In Period|Adverse Event|0
6804669|NCT03952143|10806664|FG000|Lead-In Period|Lack of Efficacy|2
6804670|NCT03952143|10806665|FG001|Lead-In Period|Lack of Efficacy|0
6804671|NCT03952143|10806666|FG002|Lead-In Period|Lack of Efficacy|0
6804672|NCT03952143|10806664|FG000|Lead-In Period|Physician Decision|5
6804673|NCT03952143|10806665|FG001|Lead-In Period|Physician Decision|0
6804674|NCT03952143|10806666|FG002|Lead-In Period|Physician Decision|0
6804675|NCT03952143|10806664|FG000|Lead-In Period|Protocol Violation|5
6804676|NCT03952143|10806665|FG001|Lead-In Period|Protocol Violation|0
6804677|NCT03952143|10806666|FG002|Lead-In Period|Protocol Violation|0
6804678|NCT03952143|10806664|FG000|Lead-In Period|Withdrawal by Subject|19
6804679|NCT03952143|10806665|FG001|Lead-In Period|Withdrawal by Subject|0
6804680|NCT03952143|10806666|FG002|Lead-In Period|Withdrawal by Subject|0
7052018|NCT01830920|11142723|FG002|Overall Study|Withdrawal by Subject|1
7052019|NCT01830920|11142724|FG003|Overall Study|Withdrawal by Subject|7
7052020|NCT01830920|11142725|FG004|Overall Study|Withdrawal by Subject|1
7052021|NCT01830920|11142721|FG000|Overall Study|Death|3
7052022|NCT01830920|11142722|FG001|Overall Study|Death|3
7052023|NCT01830920|11142723|FG002|Overall Study|Death|5
7052024|NCT01830920|11142724|FG003|Overall Study|Death|4
7052025|NCT01830920|11142725|FG004|Overall Study|Death|4
7052026|NCT01830920|11142721|FG000|Overall Study|Other|15
7052027|NCT01830920|11142722|FG001|Overall Study|Other|1
7052028|NCT01830920|11142723|FG002|Overall Study|Other|1
7052029|NCT01830920|11142724|FG003|Overall Study|Other|5
7052030|NCT01830920|11142725|FG004|Overall Study|Other|3
7052031|NCT01830972|11142748|FG000|Part II|Withdrawal by Subject|2
6804681|NCT03952143|10806664|FG000|Treatment Period|Adverse Event|0
6804682|NCT03952143|10806665|FG001|Treatment Period|Adverse Event|0
6804683|NCT03952143|10806666|FG002|Treatment Period|Adverse Event|1
6804684|NCT03952143|10806664|FG000|Treatment Period|Lost to Follow-up|0
6804685|NCT03952143|10806665|FG001|Treatment Period|Lost to Follow-up|2
6804686|NCT03952143|10806666|FG002|Treatment Period|Lost to Follow-up|0
7084504|NCT02165202|11196544|FG001|Oral Phase|Abnormal EKG|1
7052032|NCT01830972|11142749|FG001|Part II|Withdrawal by Subject|2
7052033|NCT01830972|11142748|FG000|Part III|Withdrawal by Subject|1
7052034|NCT01830972|11142749|FG001|Part III|Withdrawal by Subject|0
7052035|NCT01830972|11142748|FG000|Part III|Noncompliance|1
7052036|NCT01830972|11142749|FG001|Part III|Noncompliance|0
7052037|NCT01830972|11142748|FG000|Part IV|Withdrawal by Subject|2
7052038|NCT01830972|11142749|FG001|Part IV|Withdrawal by Subject|1
7052039|NCT01830972|11142748|FG000|Part IV|Non-Compliance|1
7052040|NCT01830972|11142749|FG001|Part IV|Non-Compliance|0
7052041|NCT01831089|11142771|FG000|Cohort I: Dose Level 1|Progressive disease|3
7052042|NCT01831089|11142772|FG001|Cohort I: Dose Level 1|Progressive disease|0
7052043|NCT01831089|11142773|FG002|Cohort I: Dose Level 1|Progressive disease|0
7052044|NCT01831089|11142774|FG003|Cohort I: Dose Level 1|Progressive disease|0
7052045|NCT01831089|11142775|FG004|Cohort I: Dose Level 1|Progressive disease|0
7052046|NCT01831089|11142776|FG005|Cohort I: Dose Level 1|Progressive disease|0
7052047|NCT01831089|11142771|FG000|Cohort II: Dose Level 2|Progressive disease|0
7052048|NCT01831089|11142772|FG001|Cohort II: Dose Level 2|Progressive disease|2
7052049|NCT01831089|11142773|FG002|Cohort II: Dose Level 2|Progressive disease|0
7052050|NCT01831089|11142774|FG003|Cohort II: Dose Level 2|Progressive disease|0
7052051|NCT01831089|11142775|FG004|Cohort II: Dose Level 2|Progressive disease|0
7052052|NCT01831089|11142776|FG005|Cohort II: Dose Level 2|Progressive disease|0
7052053|NCT01831089|11142771|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0
7052054|NCT01831089|11142772|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1
7052055|NCT01831089|11142773|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0
7084505|NCT02165202|11196543|FG000|Injection Phase|Abnormal Lab Value|5
7052056|NCT01831089|11142774|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0
7052057|NCT01831089|11142775|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0
7052058|NCT01831089|11142776|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0
7052059|NCT01831089|11142771|FG000|Cohort III: Dose Level 3|Progressive disease|0
6804687|NCT03952143|10806664|FG000|Treatment Period|Physician Decision|0
6804688|NCT03952143|10806665|FG001|Treatment Period|Physician Decision|0
7084506|NCT02165202|11196544|FG001|Injection Phase|Abnormal Lab Value|1
7084507|NCT02165202|11196543|FG000|Injection Phase|Reactive HIV or HIV Suspected|0
7084508|NCT02165202|11196544|FG001|Injection Phase|Reactive HIV or HIV Suspected|2
7084509|NCT02165202|11196543|FG000|Injection Phase|Unable to attend within Visit Window|1
7084510|NCT02165202|11196544|FG001|Injection Phase|Unable to attend within Visit Window|0
7084511|NCT02165202|11196543|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0
7084512|NCT02165202|11196544|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1
7084513|NCT02165202|11196543|FG000|Injection Phase|End of Study|2
7084514|NCT02165202|11196544|FG001|Injection Phase|End of Study|1
7084515|NCT02165202|11196543|FG000|Injection Phase|Study Product related Toxicity|1
7084516|NCT02165202|11196544|FG001|Injection Phase|Study Product related Toxicity|0
7084517|NCT02165202|11196543|FG000|Injection Phase|No longer interested|0
7084518|NCT02165202|11196544|FG001|Injection Phase|No longer interested|1
7084519|NCT02165202|11196543|FG000|Injection Phase|Participant unwilling to comply|1
7084520|NCT02165202|11196544|FG001|Injection Phase|Participant unwilling to comply|0
7084521|NCT02165397|11196557|FG000|Overall Study|Death|7
6804689|NCT03952143|10806666|FG002|Treatment Period|Physician Decision|2
6804690|NCT03952143|10806664|FG000|Treatment Period|Protocol Violation|0
6804691|NCT03952143|10806665|FG001|Treatment Period|Protocol Violation|0
7052060|NCT01831089|11142772|FG001|Cohort III: Dose Level 3|Progressive disease|0
7052061|NCT01831089|11142773|FG002|Cohort III: Dose Level 3|Progressive disease|3
7052062|NCT01831089|11142774|FG003|Cohort III: Dose Level 3|Progressive disease|0
7052063|NCT01831089|11142775|FG004|Cohort III: Dose Level 3|Progressive disease|0
7052064|NCT01831089|11142776|FG005|Cohort III: Dose Level 3|Progressive disease|0
7052065|NCT01831089|11142771|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0
7052066|NCT01831089|11142772|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0
7052067|NCT01831089|11142773|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1
7052068|NCT01831089|11142774|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0
7052069|NCT01831089|11142775|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0
7052070|NCT01831089|11142776|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0
7052071|NCT01831089|11142771|FG000|Cohort III: Dose Level 3|Adverse Event|0
7052072|NCT01831089|11142772|FG001|Cohort III: Dose Level 3|Adverse Event|0
7052073|NCT01831089|11142773|FG002|Cohort III: Dose Level 3|Adverse Event|1
7052074|NCT01831089|11142774|FG003|Cohort III: Dose Level 3|Adverse Event|0
7052075|NCT01831089|11142775|FG004|Cohort III: Dose Level 3|Adverse Event|0
7052076|NCT01831089|11142776|FG005|Cohort III: Dose Level 3|Adverse Event|0
7052077|NCT01831089|11142771|FG000|Cohort III: Dose Level 3|Global end of study|0
7084522|NCT02165397|11196558|FG001|Overall Study|Death|10
7084523|NCT02165397|11196559|FG002|Overall Study|Death|8
7084524|NCT02165397|11196557|FG000|Overall Study|Lost to Follow-up|1
6804692|NCT03952143|10806666|FG002|Treatment Period|Protocol Violation|1
6804693|NCT03952143|10806664|FG000|Treatment Period|Withdrawal by Subject|0
6804694|NCT03952143|10806665|FG001|Treatment Period|Withdrawal by Subject|5
6804695|NCT03952143|10806666|FG002|Treatment Period|Withdrawal by Subject|26
7084525|NCT02165397|11196558|FG001|Overall Study|Lost to Follow-up|3
7084526|NCT02165397|11196559|FG002|Overall Study|Lost to Follow-up|0
7084527|NCT02165397|11196557|FG000|Overall Study|Withdrawal by Subject|6
7052078|NCT01831089|11142772|FG001|Cohort III: Dose Level 3|Global end of study|0
7052079|NCT01831089|11142773|FG002|Cohort III: Dose Level 3|Global end of study|1
7052080|NCT01831089|11142774|FG003|Cohort III: Dose Level 3|Global end of study|0
7052081|NCT01831089|11142775|FG004|Cohort III: Dose Level 3|Global end of study|0
7052082|NCT01831089|11142776|FG005|Cohort III: Dose Level 3|Global end of study|0
7052083|NCT01831089|11142771|FG000|Cohort IV: Dose Level 4|Progressive disease|0
7052084|NCT01831089|11142772|FG001|Cohort IV: Dose Level 4|Progressive disease|0
7052085|NCT01831089|11142773|FG002|Cohort IV: Dose Level 4|Progressive disease|0
7052086|NCT01831089|11142774|FG003|Cohort IV: Dose Level 4|Progressive disease|6
7052087|NCT01831089|11142775|FG004|Cohort IV: Dose Level 4|Progressive disease|0
7052088|NCT01831089|11142776|FG005|Cohort IV: Dose Level 4|Progressive disease|0
7052089|NCT01831089|11142771|FG000|Cohort V: Dose Level 5|Progressive disease|0
7052090|NCT01831089|11142772|FG001|Cohort V: Dose Level 5|Progressive disease|0
7052091|NCT01831089|11142773|FG002|Cohort V: Dose Level 5|Progressive disease|0
7052092|NCT01831089|11142774|FG003|Cohort V: Dose Level 5|Progressive disease|0
7052093|NCT01831089|11142775|FG004|Cohort V: Dose Level 5|Progressive disease|30
7052094|NCT01831089|11142776|FG005|Cohort V: Dose Level 5|Progressive disease|0
6804696|NCT03952143|10806664|FG000|Treatment Period|Due to COVID 19 restrictions|0
6804697|NCT03952143|10806665|FG001|Treatment Period|Due to COVID 19 restrictions|2
6804698|NCT03952143|10806666|FG002|Treatment Period|Due to COVID 19 restrictions|5
6804699|NCT03952143|10806664|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0
6804700|NCT03952143|10806665|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0
6804701|NCT03952143|10806666|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1
6804702|NCT03691428|10806683|FG000|Overall Study|Withdrawal by Subject|6
6804703|NCT03691428|10806684|FG001|Overall Study|Withdrawal by Subject|8
6804704|NCT03685708|10806693|FG000|Overall Study|Withdrawal by Subject|0
6804705|NCT03685708|10806694|FG001|Overall Study|Withdrawal by Subject|0
6804706|NCT03685708|10806695|FG002|Overall Study|Withdrawal by Subject|1
6804707|NCT03685708|10806693|FG000|Overall Study|Screen Fail|0
6804708|NCT03685708|10806694|FG001|Overall Study|Screen Fail|1
6804709|NCT03685708|10806695|FG002|Overall Study|Screen Fail|1
6804710|NCT03685708|10806693|FG000|Overall Study|COVID 19 Pandemic|1
6804711|NCT03685708|10806694|FG001|Overall Study|COVID 19 Pandemic|1
6804712|NCT03685708|10806695|FG002|Overall Study|COVID 19 Pandemic|6
6804713|NCT03685708|10806693|FG000|Overall Study|Disease Progression|0
6804714|NCT03685708|10806694|FG001|Overall Study|Disease Progression|0
6804715|NCT03685708|10806695|FG002|Overall Study|Disease Progression|1
6804716|NCT03669588|10806705|FG000|Overall Study|Adverse Event|1
6804717|NCT03669588|10806706|FG001|Overall Study|Adverse Event|0
6804718|NCT03669588|10806705|FG000|Overall Study|Physician Decision|0
6804719|NCT03669588|10806706|FG001|Overall Study|Physician Decision|1
6804720|NCT03669588|10806705|FG000|Overall Study|Protocol Violation|1
6804721|NCT03669588|10806706|FG001|Overall Study|Protocol Violation|0
6804722|NCT03669588|10806705|FG000|Overall Study|Sponsor Decision|1
6804723|NCT03669588|10806706|FG001|Overall Study|Sponsor Decision|1
6804724|NCT03669588|10806705|FG000|Overall Study|Withdrawal by Subject|1
6804725|NCT03669588|10806706|FG001|Overall Study|Withdrawal by Subject|4
6804726|NCT03669588|10806705|FG000|Overall Study|Rescue Therapy Needed|0
6804727|NCT03669588|10806706|FG001|Overall Study|Rescue Therapy Needed|1
6804728|NCT03531632|10806715|FG000|Overall Study|Adverse Event|0
6804729|NCT03531632|10806716|FG001|Overall Study|Adverse Event|0
6804730|NCT03531632|10806717|FG002|Overall Study|Adverse Event|1
7052095|NCT01831089|11142771|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0
7052096|NCT01831089|11142772|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0
7052097|NCT01831089|11142773|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0
7052098|NCT01831089|11142774|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0
7052099|NCT01831089|11142775|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3
7052100|NCT01831089|11142776|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0
7052101|NCT01831089|11142771|FG000|Cohort V: Dose Level 5|Death|0
7052102|NCT01831089|11142772|FG001|Cohort V: Dose Level 5|Death|0
7052103|NCT01831089|11142773|FG002|Cohort V: Dose Level 5|Death|0
7052104|NCT01831089|11142774|FG003|Cohort V: Dose Level 5|Death|0
7052105|NCT01831089|11142775|FG004|Cohort V: Dose Level 5|Death|1
7052106|NCT01831089|11142776|FG005|Cohort V: Dose Level 5|Death|0
7052107|NCT01831089|11142771|FG000|Cohort V: Dose Level 5|Global end of study|0
7052108|NCT01831089|11142772|FG001|Cohort V: Dose Level 5|Global end of study|0
7052109|NCT01831089|11142773|FG002|Cohort V: Dose Level 5|Global end of study|0
7052110|NCT01831089|11142774|FG003|Cohort V: Dose Level 5|Global end of study|0
7052111|NCT01831089|11142775|FG004|Cohort V: Dose Level 5|Global end of study|2
7084528|NCT02165397|11196558|FG001|Overall Study|Withdrawal by Subject|6
7084529|NCT02165397|11196559|FG002|Overall Study|Withdrawal by Subject|1
7052112|NCT01831089|11142776|FG005|Cohort V: Dose Level 5|Global end of study|0
6804731|NCT03531632|10806715|FG000|Overall Study|Death|4
6804732|NCT03531632|10806716|FG001|Overall Study|Death|0
6804733|NCT03531632|10806717|FG002|Overall Study|Death|14
6804734|NCT03531632|10806715|FG000|Overall Study|Study Terminated|1
6804735|NCT03531632|10806716|FG001|Overall Study|Study Terminated|3
6804736|NCT03531632|10806717|FG002|Overall Study|Study Terminated|11
6804737|NCT03412604|10806740|FG000|Overall Study|Withdrawal by Subject|1
6810221|NCT01090024|10814011|FG004|Period 3|Adverse Event|0
6810222|NCT01090024|10814012|FG005|Period 3|Adverse Event|1
6810223|NCT01090024|10814013|FG006|Period 3|Adverse Event|0
6810224|NCT01090024|10814014|FG007|Period 3|Adverse Event|0
6810225|NCT01090024|10814015|FG008|Period 3|Adverse Event|0
6810226|NCT01090024|10814016|FG009|Period 3|Adverse Event|0
6810227|NCT01090024|10814017|FG010|Period 3|Adverse Event|0
6810228|NCT01090024|10814018|FG011|Period 3|Adverse Event|0
6810229|NCT01090024|10814019|FG012|Period 3|Adverse Event|0
6810230|NCT01090024|10814020|FG013|Period 3|Adverse Event|0
6810231|NCT01090024|10814021|FG014|Period 3|Adverse Event|0
6810232|NCT01090024|10814022|FG015|Period 3|Adverse Event|0
6810233|NCT01090024|10814023|FG016|Period 3|Adverse Event|0
6810234|NCT01090024|10814024|FG017|Period 3|Adverse Event|0
6810245|NCT00943722|10814043|FG000|Base Study|Adverse Event|0
6810246|NCT00943722|10814044|FG001|Base Study|Adverse Event|0
6810247|NCT00943722|10814045|FG002|Base Study|Adverse Event|0
6810248|NCT00943722|10814046|FG003|Base Study|Adverse Event|1
6810249|NCT00943722|10814047|FG004|Base Study|Adverse Event|0
6810250|NCT00943722|10814048|FG005|Base Study|Adverse Event|0
6810251|NCT00943722|10814049|FG006|Base Study|Adverse Event|0
6810252|NCT00943722|10814043|FG000|Base Study|Lost to Follow-up|12
6810253|NCT00943722|10814044|FG001|Base Study|Lost to Follow-up|8
7052113|NCT01831089|11142771|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0
7052114|NCT01831089|11142772|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0
7052115|NCT01831089|11142773|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0
7052116|NCT01831089|11142774|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0
7052117|NCT01831089|11142775|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1
7052118|NCT01831089|11142776|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0
7052119|NCT01831089|11142771|FG000|Cohort B: Arm B|Progressive disease|0
6810254|NCT00943722|10814045|FG002|Base Study|Lost to Follow-up|10
6810255|NCT00943722|10814046|FG003|Base Study|Lost to Follow-up|8
6810256|NCT00943722|10814047|FG004|Base Study|Lost to Follow-up|11
6810257|NCT00943722|10814048|FG005|Base Study|Lost to Follow-up|0
6810258|NCT00943722|10814049|FG006|Base Study|Lost to Follow-up|0
6810259|NCT00943722|10814043|FG000|Base Study|Physician Decision|1
6810260|NCT00943722|10814044|FG001|Base Study|Physician Decision|0
6810261|NCT00943722|10814045|FG002|Base Study|Physician Decision|0
7052120|NCT01831089|11142772|FG001|Cohort B: Arm B|Progressive disease|0
7052121|NCT01831089|11142773|FG002|Cohort B: Arm B|Progressive disease|0
7052122|NCT01831089|11142774|FG003|Cohort B: Arm B|Progressive disease|0
7052123|NCT01831089|11142775|FG004|Cohort B: Arm B|Progressive disease|0
7052124|NCT01831089|11142776|FG005|Cohort B: Arm B|Progressive disease|8
7052125|NCT01831089|11142771|FG000|Cohort B: Arm B|Physician Decision|0
7052126|NCT01831089|11142772|FG001|Cohort B: Arm B|Physician Decision|0
7052127|NCT01831089|11142773|FG002|Cohort B: Arm B|Physician Decision|0
7052128|NCT01831089|11142774|FG003|Cohort B: Arm B|Physician Decision|0
7052129|NCT01831089|11142775|FG004|Cohort B: Arm B|Physician Decision|0
7052130|NCT01831089|11142776|FG005|Cohort B: Arm B|Physician Decision|2
7052131|NCT01831089|11142771|FG000|Cohort B: Arm B|Never treated|0
7052132|NCT01831089|11142772|FG001|Cohort B: Arm B|Never treated|0
7052133|NCT01831089|11142773|FG002|Cohort B: Arm B|Never treated|0
7052134|NCT01831089|11142774|FG003|Cohort B: Arm B|Never treated|0
7052135|NCT01831089|11142775|FG004|Cohort B: Arm B|Never treated|0
7052136|NCT01831089|11142776|FG005|Cohort B: Arm B|Never treated|2
7052137|NCT01831089|11142771|FG000|Cohort B: Arm B|Adverse Event|0
7052138|NCT01831089|11142772|FG001|Cohort B: Arm B|Adverse Event|0
7052139|NCT01831089|11142773|FG002|Cohort B: Arm B|Adverse Event|0
7052140|NCT01831089|11142774|FG003|Cohort B: Arm B|Adverse Event|0
7052141|NCT01831089|11142775|FG004|Cohort B: Arm B|Adverse Event|0
7052142|NCT01831089|11142776|FG005|Cohort B: Arm B|Adverse Event|1
7052143|NCT01831089|11142771|FG000|Cohort B: Arm B|Global end of study|0
7052144|NCT01831089|11142772|FG001|Cohort B: Arm B|Global end of study|0
7052145|NCT01831089|11142773|FG002|Cohort B: Arm B|Global end of study|0
7052146|NCT01831089|11142774|FG003|Cohort B: Arm B|Global end of study|0
7052147|NCT01831089|11142775|FG004|Cohort B: Arm B|Global end of study|0
7052148|NCT01831089|11142776|FG005|Cohort B: Arm B|Global end of study|1
7052149|NCT01831258|11142817|FG000|Overall Study|Withdrawal by Subject|2
7052150|NCT01831258|11142818|FG001|Overall Study|Withdrawal by Subject|1
7052151|NCT01831258|11142817|FG000|Overall Study|Lost to Follow-up|3
7052152|NCT01831258|11142818|FG001|Overall Study|Lost to Follow-up|2
7052153|NCT01831427|11142837|FG000|Overall Study|Adverse Event|0
7052154|NCT01831427|11142838|FG001|Overall Study|Adverse Event|1
7052155|NCT01831427|11142839|FG002|Overall Study|Adverse Event|0
7052156|NCT01831427|11142840|FG003|Overall Study|Adverse Event|0
7052157|NCT01831427|11142841|FG004|Overall Study|Adverse Event|0
7052158|NCT01831427|11142842|FG005|Overall Study|Adverse Event|1
7052159|NCT01831427|11142843|FG006|Overall Study|Adverse Event|0
7052160|NCT01831427|11142844|FG007|Overall Study|Adverse Event|1
7052161|NCT01831427|11142845|FG008|Overall Study|Adverse Event|0
7052162|NCT01831427|11142846|FG009|Overall Study|Adverse Event|0
7052163|NCT01831427|11142847|FG010|Overall Study|Adverse Event|2
7052164|NCT01831427|11142837|FG000|Overall Study|Investigator's Discretion|0
7052165|NCT01831427|11142838|FG001|Overall Study|Investigator's Discretion|0
7052166|NCT01831427|11142839|FG002|Overall Study|Investigator's Discretion|0
7052167|NCT01831427|11142840|FG003|Overall Study|Investigator's Discretion|1
7052168|NCT01831427|11142841|FG004|Overall Study|Investigator's Discretion|0
7052169|NCT01831427|11142842|FG005|Overall Study|Investigator's Discretion|0
7052170|NCT01831427|11142843|FG006|Overall Study|Investigator's Discretion|0
7052171|NCT01831427|11142844|FG007|Overall Study|Investigator's Discretion|0
7052172|NCT01831427|11142845|FG008|Overall Study|Investigator's Discretion|0
7052173|NCT01831427|11142846|FG009|Overall Study|Investigator's Discretion|0
7052174|NCT01831427|11142847|FG010|Overall Study|Investigator's Discretion|0
7052175|NCT01831427|11142837|FG000|Overall Study|Withdrew Consent|0
7052176|NCT01831427|11142838|FG001|Overall Study|Withdrew Consent|0
7052177|NCT01831427|11142839|FG002|Overall Study|Withdrew Consent|0
7052178|NCT01831427|11142840|FG003|Overall Study|Withdrew Consent|0
7052179|NCT01831427|11142841|FG004|Overall Study|Withdrew Consent|0
7052180|NCT01831427|11142842|FG005|Overall Study|Withdrew Consent|0
7052181|NCT01831427|11142843|FG006|Overall Study|Withdrew Consent|2
7052182|NCT01831427|11142844|FG007|Overall Study|Withdrew Consent|0
7052183|NCT01831427|11142845|FG008|Overall Study|Withdrew Consent|0
7052184|NCT01831427|11142846|FG009|Overall Study|Withdrew Consent|1
7052185|NCT01831427|11142847|FG010|Overall Study|Withdrew Consent|1
7052186|NCT01831466|11142894|FG000|Overall Study|Protocol Violation|1
7052187|NCT01831466|11142895|FG001|Overall Study|Protocol Violation|1
7052188|NCT01831466|11142896|FG002|Overall Study|Protocol Violation|2
7052189|NCT01831466|11142897|FG003|Overall Study|Protocol Violation|0
7052190|NCT01831466|11142898|FG004|Overall Study|Protocol Violation|0
7052191|NCT01831466|11142899|FG005|Overall Study|Protocol Violation|1
7052192|NCT01831466|11142900|FG006|Overall Study|Protocol Violation|0
7052193|NCT01831466|11142901|FG007|Overall Study|Protocol Violation|0
7052194|NCT01831466|11142902|FG008|Overall Study|Protocol Violation|0
7052195|NCT01831466|11142903|FG009|Overall Study|Protocol Violation|0
7052196|NCT01831466|11142904|FG010|Overall Study|Protocol Violation|0
7052197|NCT01831466|11142905|FG011|Overall Study|Protocol Violation|0
7052198|NCT01831466|11142894|FG000|Overall Study|Other|2
7052199|NCT01831466|11142895|FG001|Overall Study|Other|3
7052200|NCT01831466|11142896|FG002|Overall Study|Other|2
7052201|NCT01831466|11142897|FG003|Overall Study|Other|2
7052202|NCT01831466|11142898|FG004|Overall Study|Other|2
7052203|NCT01831466|11142899|FG005|Overall Study|Other|1
7052204|NCT01831466|11142900|FG006|Overall Study|Other|0
7052205|NCT01831466|11142901|FG007|Overall Study|Other|0
7052206|NCT01831466|11142902|FG008|Overall Study|Other|0
7052207|NCT01831466|11142903|FG009|Overall Study|Other|0
7052208|NCT01831466|11142904|FG010|Overall Study|Other|0
7052209|NCT01831466|11142905|FG011|Overall Study|Other|0
7052210|NCT01831466|11142894|FG000|Overall Study|Non-compliance with study treatment|2
7052211|NCT01831466|11142895|FG001|Overall Study|Non-compliance with study treatment|1
7052212|NCT01831466|11142896|FG002|Overall Study|Non-compliance with study treatment|1
7052213|NCT01831466|11142897|FG003|Overall Study|Non-compliance with study treatment|0
7052214|NCT01831466|11142898|FG004|Overall Study|Non-compliance with study treatment|0
7052215|NCT01831466|11142899|FG005|Overall Study|Non-compliance with study treatment|1
7052216|NCT01831466|11142900|FG006|Overall Study|Non-compliance with study treatment|0
7052217|NCT01831466|11142901|FG007|Overall Study|Non-compliance with study treatment|0
7052218|NCT01831466|11142902|FG008|Overall Study|Non-compliance with study treatment|0
7052219|NCT01831466|11142903|FG009|Overall Study|Non-compliance with study treatment|0
7052220|NCT01831466|11142904|FG010|Overall Study|Non-compliance with study treatment|0
7052221|NCT01831466|11142905|FG011|Overall Study|Non-compliance with study treatment|0
7052222|NCT01831466|11142894|FG000|Overall Study|Death|0
7052223|NCT01831466|11142895|FG001|Overall Study|Death|1
7052224|NCT01831466|11142896|FG002|Overall Study|Death|0
7052225|NCT01831466|11142897|FG003|Overall Study|Death|0
7052226|NCT01831466|11142898|FG004|Overall Study|Death|0
7052227|NCT01831466|11142899|FG005|Overall Study|Death|0
7052228|NCT01831466|11142900|FG006|Overall Study|Death|0
7052229|NCT01831466|11142901|FG007|Overall Study|Death|0
7052230|NCT01831466|11142902|FG008|Overall Study|Death|0
7052231|NCT01831466|11142903|FG009|Overall Study|Death|0
7052232|NCT01831466|11142904|FG010|Overall Study|Death|0
7052233|NCT01831466|11142905|FG011|Overall Study|Death|0
7052234|NCT01831466|11142894|FG000|Overall Study|Withdrawal by Subject|6
7052235|NCT01831466|11142895|FG001|Overall Study|Withdrawal by Subject|3
7052236|NCT01831466|11142896|FG002|Overall Study|Withdrawal by Subject|3
7052237|NCT01831466|11142897|FG003|Overall Study|Withdrawal by Subject|3
7052238|NCT01831466|11142898|FG004|Overall Study|Withdrawal by Subject|3
7052239|NCT01831466|11142899|FG005|Overall Study|Withdrawal by Subject|5
7052240|NCT01831466|11142900|FG006|Overall Study|Withdrawal by Subject|0
7052241|NCT01831466|11142901|FG007|Overall Study|Withdrawal by Subject|0
7052242|NCT01831466|11142902|FG008|Overall Study|Withdrawal by Subject|0
7052243|NCT01831466|11142903|FG009|Overall Study|Withdrawal by Subject|1
7052244|NCT01831466|11142904|FG010|Overall Study|Withdrawal by Subject|0
7052245|NCT01831466|11142905|FG011|Overall Study|Withdrawal by Subject|1
7052246|NCT01831466|11142894|FG000|Overall Study|Lost to Follow-up|0
7052247|NCT01831466|11142895|FG001|Overall Study|Lost to Follow-up|1
7052248|NCT01831466|11142896|FG002|Overall Study|Lost to Follow-up|4
7052249|NCT01831466|11142897|FG003|Overall Study|Lost to Follow-up|2
7052250|NCT01831466|11142898|FG004|Overall Study|Lost to Follow-up|0
7052251|NCT01831466|11142899|FG005|Overall Study|Lost to Follow-up|3
7052252|NCT01831466|11142900|FG006|Overall Study|Lost to Follow-up|0
7052253|NCT01831466|11142901|FG007|Overall Study|Lost to Follow-up|0
7052254|NCT01831466|11142902|FG008|Overall Study|Lost to Follow-up|0
7052255|NCT01831466|11142903|FG009|Overall Study|Lost to Follow-up|1
7052256|NCT01831466|11142904|FG010|Overall Study|Lost to Follow-up|0
7052257|NCT01831466|11142905|FG011|Overall Study|Lost to Follow-up|1
7052258|NCT01831466|11142894|FG000|Overall Study|Lack of Efficacy|5
7052259|NCT01831466|11142895|FG001|Overall Study|Lack of Efficacy|8
7052260|NCT01831466|11142896|FG002|Overall Study|Lack of Efficacy|7
7052261|NCT01831466|11142897|FG003|Overall Study|Lack of Efficacy|6
7052262|NCT01831466|11142898|FG004|Overall Study|Lack of Efficacy|9
7052263|NCT01831466|11142899|FG005|Overall Study|Lack of Efficacy|8
7052264|NCT01831466|11142900|FG006|Overall Study|Lack of Efficacy|1
7052265|NCT01831466|11142901|FG007|Overall Study|Lack of Efficacy|1
7052266|NCT01831466|11142902|FG008|Overall Study|Lack of Efficacy|2
7052267|NCT01831466|11142903|FG009|Overall Study|Lack of Efficacy|2
7052268|NCT01831466|11142904|FG010|Overall Study|Lack of Efficacy|2
7052269|NCT01831466|11142905|FG011|Overall Study|Lack of Efficacy|0
7052270|NCT01831466|11142894|FG000|Overall Study|Adverse Event|0
7052271|NCT01831466|11142895|FG001|Overall Study|Adverse Event|0
7052272|NCT01831466|11142896|FG002|Overall Study|Adverse Event|4
7052273|NCT01831466|11142897|FG003|Overall Study|Adverse Event|6
7052274|NCT01831466|11142898|FG004|Overall Study|Adverse Event|3
7052275|NCT01831466|11142899|FG005|Overall Study|Adverse Event|7
7052276|NCT01831466|11142900|FG006|Overall Study|Adverse Event|0
7052277|NCT01831466|11142901|FG007|Overall Study|Adverse Event|1
7052278|NCT01831466|11142902|FG008|Overall Study|Adverse Event|1
7052279|NCT01831466|11142903|FG009|Overall Study|Adverse Event|1
7052280|NCT01831466|11142904|FG010|Overall Study|Adverse Event|0
7052281|NCT01831466|11142905|FG011|Overall Study|Adverse Event|2
7052282|NCT01831544|11142925|FG000|Overall Study|Death|1
7052283|NCT01831544|11142925|FG000|Overall Study|Still on original MVAD device|2
7052284|NCT01831726|11142929|FG000|Overall Study|Adverse Event|16
7052285|NCT01831726|11142929|FG000|Overall Study|Death|7
7052286|NCT01831726|11142929|FG000|Overall Study|Disease Progression|49
7052287|NCT01831726|11142929|FG000|Overall Study|Physician Decision|1
7052288|NCT01831726|11142929|FG000|Overall Study|Subject/guardian decision|7
7052289|NCT01831765|11142936|FG000|Overall Study|Lack of Efficacy|1
7052290|NCT01831765|11142937|FG001|Overall Study|Lack of Efficacy|0
7052291|NCT01831765|11142938|FG002|Overall Study|Lack of Efficacy|0
7084530|NCT02165397|11196557|FG000|Overall Study|Other, Not Specified|0
7084531|NCT02165397|11196558|FG001|Overall Study|Other, Not Specified|0
7052292|NCT01831765|11142936|FG000|Overall Study|Other, sponsor withdrew subject|0
7052293|NCT01831765|11142937|FG001|Overall Study|Other, sponsor withdrew subject|1
7052294|NCT01831765|11142938|FG002|Overall Study|Other, sponsor withdrew subject|0
7052295|NCT01831765|11142936|FG000|Overall Study|Pregnancy|1
7052296|NCT01831765|11142937|FG001|Overall Study|Pregnancy|1
7052297|NCT01831765|11142938|FG002|Overall Study|Pregnancy|2
7052298|NCT01831765|11142936|FG000|Overall Study|Death|0
7052299|NCT01831765|11142937|FG001|Overall Study|Death|1
7052300|NCT01831765|11142938|FG002|Overall Study|Death|1
7052301|NCT01831765|11142936|FG000|Overall Study|Other, site closed|1
7052302|NCT01831765|11142937|FG001|Overall Study|Other, site closed|1
7052303|NCT01831765|11142938|FG002|Overall Study|Other, site closed|0
7052304|NCT01831765|11142936|FG000|Overall Study|Adverse Event|5
7052305|NCT01831765|11142937|FG001|Overall Study|Adverse Event|3
7052306|NCT01831765|11142938|FG002|Overall Study|Adverse Event|3
7052307|NCT01831765|11142936|FG000|Overall Study|Withdrawal by Subject|22
7052308|NCT01831765|11142937|FG001|Overall Study|Withdrawal by Subject|7
7052309|NCT01831765|11142938|FG002|Overall Study|Withdrawal by Subject|17
7052310|NCT01831765|11142936|FG000|Overall Study|Withdrawal criteria|12
7052311|NCT01831765|11142937|FG001|Overall Study|Withdrawal criteria|10
7052312|NCT01831765|11142938|FG002|Overall Study|Withdrawal criteria|16
7052313|NCT01831765|11142936|FG000|Overall Study|Lost to Follow-up|2
7052314|NCT01831765|11142937|FG001|Overall Study|Lost to Follow-up|3
7052315|NCT01831765|11142938|FG002|Overall Study|Lost to Follow-up|3
7052316|NCT01831791|11142948|FG000|Overall Study|Withdrawal by Subject|10
7052317|NCT01831804|11142961|FG000|Overall Study|Adverse Event|0
7052318|NCT01831804|11142962|FG001|Overall Study|Adverse Event|0
7052319|NCT01831804|11142963|FG002|Overall Study|Adverse Event|0
7052320|NCT01831804|11142964|FG003|Overall Study|Adverse Event|0
7052321|NCT01831804|11142965|FG004|Overall Study|Adverse Event|0
7052322|NCT01831804|11142966|FG005|Overall Study|Adverse Event|0
7052323|NCT01831804|11142967|FG006|Overall Study|Adverse Event|1
7052324|NCT01831804|11142968|FG007|Overall Study|Adverse Event|0
7052325|NCT01831804|11142969|FG008|Overall Study|Adverse Event|1
7052326|NCT01831804|11142961|FG000|Overall Study|Protocol Violation|0
7052327|NCT01831804|11142962|FG001|Overall Study|Protocol Violation|0
7052328|NCT01831804|11142963|FG002|Overall Study|Protocol Violation|2
7052329|NCT01831804|11142964|FG003|Overall Study|Protocol Violation|0
7052330|NCT01831804|11142965|FG004|Overall Study|Protocol Violation|0
7052331|NCT01831804|11142966|FG005|Overall Study|Protocol Violation|0
7052332|NCT01831804|11142967|FG006|Overall Study|Protocol Violation|0
7052333|NCT01831804|11142968|FG007|Overall Study|Protocol Violation|0
7052334|NCT01831804|11142969|FG008|Overall Study|Protocol Violation|0
7052335|NCT01831804|11142961|FG000|Overall Study|Protocol defined stopping criteria|1
7052336|NCT01831804|11142962|FG001|Overall Study|Protocol defined stopping criteria|1
7052337|NCT01831804|11142963|FG002|Overall Study|Protocol defined stopping criteria|3
7052338|NCT01831804|11142964|FG003|Overall Study|Protocol defined stopping criteria|0
7052339|NCT01831804|11142965|FG004|Overall Study|Protocol defined stopping criteria|1
7052340|NCT01831804|11142966|FG005|Overall Study|Protocol defined stopping criteria|0
7052341|NCT01831804|11142967|FG006|Overall Study|Protocol defined stopping criteria|0
7052342|NCT01831804|11142968|FG007|Overall Study|Protocol defined stopping criteria|0
7052343|NCT01831804|11142969|FG008|Overall Study|Protocol defined stopping criteria|0
7052344|NCT01831804|11142961|FG000|Overall Study|Lost to Follow-up|0
7052345|NCT01831804|11142962|FG001|Overall Study|Lost to Follow-up|0
7084532|NCT02165397|11196559|FG002|Overall Study|Other, Not Specified|1
7084533|NCT02165735|11196597|FG000|Overall Study|Lost to Follow-up|12
7084534|NCT02165735|11196598|FG001|Overall Study|Lost to Follow-up|10
7084535|NCT02165735|11196597|FG000|Overall Study|Withdrawal by Subject|3
7084536|NCT02165735|11196598|FG001|Overall Study|Withdrawal by Subject|0
7052346|NCT01831804|11142963|FG002|Overall Study|Lost to Follow-up|1
7052347|NCT01831804|11142964|FG003|Overall Study|Lost to Follow-up|0
7052348|NCT01831804|11142965|FG004|Overall Study|Lost to Follow-up|0
7052349|NCT01831804|11142966|FG005|Overall Study|Lost to Follow-up|0
7052350|NCT01831804|11142967|FG006|Overall Study|Lost to Follow-up|0
7052351|NCT01831804|11142968|FG007|Overall Study|Lost to Follow-up|0
7052352|NCT01831804|11142969|FG008|Overall Study|Lost to Follow-up|1
7052353|NCT01831804|11142961|FG000|Overall Study|Investigator discretion|0
7052354|NCT01831804|11142962|FG001|Overall Study|Investigator discretion|0
7052355|NCT01831804|11142963|FG002|Overall Study|Investigator discretion|0
7052356|NCT01831804|11142964|FG003|Overall Study|Investigator discretion|0
7052357|NCT01831804|11142965|FG004|Overall Study|Investigator discretion|1
7052358|NCT01831804|11142966|FG005|Overall Study|Investigator discretion|0
7052359|NCT01831804|11142967|FG006|Overall Study|Investigator discretion|0
7052360|NCT01831804|11142968|FG007|Overall Study|Investigator discretion|1
7052361|NCT01831804|11142969|FG008|Overall Study|Investigator discretion|0
7052362|NCT01831804|11142961|FG000|Overall Study|Withdrew Consent|0
7052363|NCT01831804|11142962|FG001|Overall Study|Withdrew Consent|1
7052364|NCT01831804|11142963|FG002|Overall Study|Withdrew Consent|0
7052365|NCT01831804|11142964|FG003|Overall Study|Withdrew Consent|0
7052366|NCT01831804|11142965|FG004|Overall Study|Withdrew Consent|0
7052367|NCT01831804|11142966|FG005|Overall Study|Withdrew Consent|0
7052368|NCT01831804|11142967|FG006|Overall Study|Withdrew Consent|0
7052369|NCT01831804|11142968|FG007|Overall Study|Withdrew Consent|2
7052370|NCT01831804|11142969|FG008|Overall Study|Withdrew Consent|0
7052371|NCT01831817|11143002|FG000|Overall Study|Lost to Follow-up|1
7052372|NCT01831817|11143003|FG001|Overall Study|Lost to Follow-up|0
7052373|NCT01831817|11143004|FG002|Overall Study|Lost to Follow-up|0
7052374|NCT01831817|11143005|FG003|Overall Study|Lost to Follow-up|0
7052375|NCT01831817|11143002|FG000|Overall Study|Withdrawl of Consent|3
7052376|NCT01831817|11143003|FG001|Overall Study|Withdrawl of Consent|0
7052377|NCT01831817|11143004|FG002|Overall Study|Withdrawl of Consent|0
7052378|NCT01831817|11143005|FG003|Overall Study|Withdrawl of Consent|0
7052379|NCT01831856|11143017|FG000|Overall Study|Adverse Event|5
7052380|NCT01831856|11143018|FG001|Overall Study|Adverse Event|8
7052381|NCT01831856|11143017|FG000|Overall Study|Lack of Efficacy|13
7052382|NCT01831856|11143018|FG001|Overall Study|Lack of Efficacy|11
7052383|NCT01831856|11143017|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16
7052384|NCT01831856|11143018|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18
7052385|NCT01832038|11143055|FG000|Overall Study|Death|5
7052386|NCT01832038|11143055|FG000|Overall Study|Adverse Event|50
7052387|NCT01832038|11143055|FG000|Overall Study|Lack of Efficacy|81
7052388|NCT01832038|11143055|FG000|Overall Study|Protocol Violation|7
7052389|NCT01832038|11143055|FG000|Overall Study|Lost to Follow-up|10
7052390|NCT01832038|11143055|FG000|Overall Study|Withdrawal by Subject|49
7052391|NCT01832038|11143055|FG000|Overall Study|Visit non-compliance|2
7052392|NCT01832038|11143055|FG000|Overall Study|Subject refused to return visit|2
7052393|NCT01832038|11143055|FG000|Overall Study|Not convenient to come back to site|2
7052394|NCT01832038|11143055|FG000|Overall Study|Participant was asked to quit|5
7052395|NCT01832038|11143055|FG000|Overall Study|Back home|1
7052396|NCT01832038|11143055|FG000|Overall Study|Pregnancy|1
7052397|NCT01832038|11143055|FG000|Overall Study|Low compliance|3
7052398|NCT01832038|11143055|FG000|Overall Study|Prohibit procedure|2
7052399|NCT01832038|11143055|FG000|Overall Study|Not possible to visit the hospital|1
7052400|NCT01832038|11143055|FG000|Overall Study|Changes of implementation system|3
7052401|NCT01832038|11143055|FG000|Overall Study|Plan to pregnancy|7
7052402|NCT01832038|11143055|FG000|Overall Study|Bad mood and has suicidal thought|1
7052403|NCT01832038|11143055|FG000|Overall Study|Prohibited concomitant medication|1
7052404|NCT01832038|11143055|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1
7052405|NCT01832038|11143055|FG000|Overall Study|Subject considered the efficacy was poor|1
7052406|NCT01832155|11143091|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1
7052407|NCT01832155|11143092|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0
7052408|NCT01832155|11143091|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1
7052409|NCT01832155|11143092|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0
7052410|NCT01832402|11143115|FG000|Overall Study|Lost to Follow-up|2
7052411|NCT01832402|11143116|FG001|Overall Study|Lost to Follow-up|0
7052412|NCT01832402|11143115|FG000|Overall Study|Withdrawal by Subject|3
7052413|NCT01832402|11143116|FG001|Overall Study|Withdrawal by Subject|3
7052414|NCT01832402|11143115|FG000|Overall Study|Declining Performance status|2
7052415|NCT01832402|11143116|FG001|Overall Study|Declining Performance status|1
7052416|NCT01832480|11143128|FG000|Overall Study|Lost to Follow-up|33
7052417|NCT01832480|11143129|FG001|Overall Study|Lost to Follow-up|30
7052418|NCT01832480|11143128|FG000|Overall Study|Withdrawal by Subject|0
7052419|NCT01832480|11143129|FG001|Overall Study|Withdrawal by Subject|2
7052420|NCT01832480|11143128|FG000|Overall Study|post randomization ineligible|8
7052421|NCT01832480|11143129|FG001|Overall Study|post randomization ineligible|10
7052422|NCT01832493|11143135|FG000|Overall Study|Physician Decision|2
7052423|NCT01832493|11143135|FG000|Overall Study|Protocol Violation|4
7052424|NCT01832493|11143135|FG000|Overall Study|Unable to place LV lead|2
7052425|NCT01832532|11143159|FG000|Overall Study|Withdrawal by Subject|5
7052426|NCT01832532|11143160|FG001|Overall Study|Withdrawal by Subject|2
7052427|NCT01832727|11143179|FG000|Overall Study|Adverse Event|4
7052428|NCT01832727|11143180|FG001|Overall Study|Adverse Event|6
7052429|NCT01832727|11143181|FG002|Overall Study|Adverse Event|1
7052430|NCT01832727|11143182|FG003|Overall Study|Adverse Event|0
7052431|NCT01832727|11143183|FG004|Overall Study|Adverse Event|1
7052432|NCT01832727|11143184|FG005|Overall Study|Adverse Event|1
7052433|NCT01832727|11143185|FG006|Overall Study|Adverse Event|2
7052434|NCT01832727|11143186|FG007|Overall Study|Adverse Event|1
7052435|NCT01832727|11143187|FG008|Overall Study|Adverse Event|9
7052436|NCT01832727|11143179|FG000|Overall Study|Disease progression|3
7052437|NCT01832727|11143180|FG001|Overall Study|Disease progression|0
7052438|NCT01832727|11143181|FG002|Overall Study|Disease progression|2
7052439|NCT01832727|11143182|FG003|Overall Study|Disease progression|1
7052440|NCT01832727|11143183|FG004|Overall Study|Disease progression|3
7052441|NCT01832727|11143184|FG005|Overall Study|Disease progression|3
7052442|NCT01832727|11143185|FG006|Overall Study|Disease progression|6
7052443|NCT01832727|11143186|FG007|Overall Study|Disease progression|2
7052444|NCT01832727|11143187|FG008|Overall Study|Disease progression|7
7052445|NCT01832727|11143179|FG000|Overall Study|Lost to Follow-up|0
7052446|NCT01832727|11143180|FG001|Overall Study|Lost to Follow-up|0
7052447|NCT01832727|11143181|FG002|Overall Study|Lost to Follow-up|0
7052448|NCT01832727|11143182|FG003|Overall Study|Lost to Follow-up|1
7052449|NCT01832727|11143183|FG004|Overall Study|Lost to Follow-up|0
7052450|NCT01832727|11143184|FG005|Overall Study|Lost to Follow-up|0
7052451|NCT01832727|11143185|FG006|Overall Study|Lost to Follow-up|0
7052452|NCT01832727|11143186|FG007|Overall Study|Lost to Follow-up|0
7052453|NCT01832727|11143187|FG008|Overall Study|Lost to Follow-up|0
7052454|NCT01832727|11143179|FG000|Overall Study|Physician Decision|1
7052455|NCT01832727|11143180|FG001|Overall Study|Physician Decision|0
7052456|NCT01832727|11143181|FG002|Overall Study|Physician Decision|0
7052457|NCT01832727|11143182|FG003|Overall Study|Physician Decision|1
7052458|NCT01832727|11143183|FG004|Overall Study|Physician Decision|0
7052459|NCT01832727|11143184|FG005|Overall Study|Physician Decision|1
7084537|NCT02165735|11196597|FG000|Overall Study|Participant indicated lack of time|1
6804738|NCT03206073|10806748|FG000|Overall Study|Participant Noncompliance|0
6804739|NCT03206073|10806749|FG001|Overall Study|Participant Noncompliance|1
7084538|NCT02165735|11196598|FG001|Overall Study|Participant indicated lack of time|3
7084539|NCT02165735|11196597|FG000|Overall Study|Protocol Violation|0
7084540|NCT02165735|11196598|FG001|Overall Study|Protocol Violation|1
7084541|NCT02165826|11196616|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44
7084542|NCT02165826|11196617|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57
7084543|NCT02165826|11196618|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68
7084544|NCT02165826|11196616|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0
7084545|NCT02165826|11196617|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1
6804740|NCT03206073|10806750|FG002|Overall Study|Participant Noncompliance|0
6804741|NCT03206073|10806751|FG003|Overall Study|Participant Noncompliance|0
6804742|NCT03206073|10806748|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1
6804743|NCT03206073|10806749|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0
7052460|NCT01832727|11143185|FG006|Overall Study|Physician Decision|0
7052461|NCT01832727|11143186|FG007|Overall Study|Physician Decision|0
7052462|NCT01832727|11143187|FG008|Overall Study|Physician Decision|0
7052463|NCT01832727|11143179|FG000|Overall Study|Withdrawal by Subject|1
7052464|NCT01832727|11143180|FG001|Overall Study|Withdrawal by Subject|1
7052465|NCT01832727|11143181|FG002|Overall Study|Withdrawal by Subject|0
7052466|NCT01832727|11143182|FG003|Overall Study|Withdrawal by Subject|1
7052467|NCT01832727|11143183|FG004|Overall Study|Withdrawal by Subject|0
7052468|NCT01832727|11143184|FG005|Overall Study|Withdrawal by Subject|1
7052469|NCT01832727|11143185|FG006|Overall Study|Withdrawal by Subject|0
7052470|NCT01832727|11143186|FG007|Overall Study|Withdrawal by Subject|2
7052471|NCT01832727|11143187|FG008|Overall Study|Withdrawal by Subject|1
7052472|NCT01832727|11143179|FG000|Overall Study|Study terminated by sponsor|0
7052473|NCT01832727|11143180|FG001|Overall Study|Study terminated by sponsor|0
7052474|NCT01832727|11143181|FG002|Overall Study|Study terminated by sponsor|0
7052475|NCT01832727|11143182|FG003|Overall Study|Study terminated by sponsor|0
7052476|NCT01832727|11143183|FG004|Overall Study|Study terminated by sponsor|0
7052477|NCT01832727|11143184|FG005|Overall Study|Study terminated by sponsor|0
7052478|NCT01832727|11143185|FG006|Overall Study|Study terminated by sponsor|0
7052479|NCT01832727|11143186|FG007|Overall Study|Study terminated by sponsor|1
7052480|NCT01832727|11143187|FG008|Overall Study|Study terminated by sponsor|1
7052481|NCT01832766|11143230|FG000|Washout|Lost to Follow-up|0
7052482|NCT01832766|11143231|FG001|Washout|Lost to Follow-up|1
7052483|NCT01832818|11143237|FG000|Overall Study|Lost to Follow-up|6
7052484|NCT01833065|11143269|FG000|Overall Study|Adverse Event|6
7052485|NCT01833065|11143270|FG001|Overall Study|Adverse Event|1
7052486|NCT01833065|11143271|FG002|Overall Study|Adverse Event|0
7052487|NCT01833065|11143272|FG003|Overall Study|Adverse Event|2
7052488|NCT01833065|11143273|FG004|Overall Study|Adverse Event|3
7052489|NCT01833065|11143269|FG000|Overall Study|Protocol Violation|1
7052490|NCT01833065|11143270|FG001|Overall Study|Protocol Violation|0
7052491|NCT01833065|11143271|FG002|Overall Study|Protocol Violation|0
7052492|NCT01833065|11143272|FG003|Overall Study|Protocol Violation|0
7052493|NCT01833065|11143273|FG004|Overall Study|Protocol Violation|2
7052494|NCT01833065|11143269|FG000|Overall Study|Lost to Follow-up|1
7052495|NCT01833065|11143270|FG001|Overall Study|Lost to Follow-up|0
7052496|NCT01833065|11143271|FG002|Overall Study|Lost to Follow-up|0
7052497|NCT01833065|11143272|FG003|Overall Study|Lost to Follow-up|0
7052498|NCT01833065|11143273|FG004|Overall Study|Lost to Follow-up|3
7052499|NCT01833065|11143269|FG000|Overall Study|Withdrawal by Subject|6
7052500|NCT01833065|11143270|FG001|Overall Study|Withdrawal by Subject|2
7052501|NCT01833065|11143271|FG002|Overall Study|Withdrawal by Subject|4
7052502|NCT01833065|11143272|FG003|Overall Study|Withdrawal by Subject|3
7052503|NCT01833065|11143273|FG004|Overall Study|Withdrawal by Subject|11
7052504|NCT01833065|11143269|FG000|Overall Study|Subject's substantial non-compliance|0
7052505|NCT01833065|11143270|FG001|Overall Study|Subject's substantial non-compliance|1
7052506|NCT01833065|11143271|FG002|Overall Study|Subject's substantial non-compliance|0
7052507|NCT01833065|11143272|FG003|Overall Study|Subject's substantial non-compliance|0
7052508|NCT01833065|11143273|FG004|Overall Study|Subject's substantial non-compliance|0
7052509|NCT01833065|11143269|FG000|Overall Study|Trial terminated by sponsor|8
7052510|NCT01833065|11143270|FG001|Overall Study|Trial terminated by sponsor|8
7052511|NCT01833065|11143271|FG002|Overall Study|Trial terminated by sponsor|7
7052512|NCT01833065|11143272|FG003|Overall Study|Trial terminated by sponsor|3
7052513|NCT01833065|11143273|FG004|Overall Study|Trial terminated by sponsor|13
7052514|NCT01833065|11143269|FG000|Overall Study|Others|2
7052515|NCT01833065|11143270|FG001|Overall Study|Others|1
7052516|NCT01833065|11143271|FG002|Overall Study|Others|1
7052517|NCT01833065|11143272|FG003|Overall Study|Others|1
7052518|NCT01833065|11143273|FG004|Overall Study|Others|4
7052519|NCT01833143|11143305|FG000|Overall Study|Not Treated|1
7052520|NCT01833169|11143309|FG000|Overall Study|Disease Progression|99
7052521|NCT01833169|11143309|FG000|Overall Study|Adverse Event|33
7052522|NCT01833169|11143309|FG000|Overall Study|Withdrawal by Subject|9
7052523|NCT01833169|11143309|FG000|Overall Study|Death|3
7052524|NCT01833169|11143309|FG000|Overall Study|Physician Decision|2
7052525|NCT01833455|11143324|FG000|Overall Study|Withdrawal by Subject|1
7052526|NCT01833455|11143325|FG001|Overall Study|Withdrawal by Subject|0
7052527|NCT01833494|11143356|FG000|Overall Study|Adverse Event|24
7052528|NCT01833494|11143356|FG000|Overall Study|Physician Decision|6
7052529|NCT01833494|11143356|FG000|Overall Study|Withdrawal by Subject|6
7052530|NCT01833494|11143356|FG000|Overall Study|Decrease in serum phosphorus|4
7052531|NCT01833494|11143356|FG000|Overall Study|Decrease in serum calcium|4
7052532|NCT01833494|11143356|FG000|Overall Study|Increase in serum ferritin|1
7052533|NCT01833520|11143362|FG000|Overall Study|Lack of Efficacy|3
7052534|NCT01833520|11143363|FG001|Overall Study|Lack of Efficacy|3
7052535|NCT01833520|11143364|FG002|Overall Study|Lack of Efficacy|8
7052536|NCT01833520|11143365|FG003|Overall Study|Lack of Efficacy|3
7052537|NCT01833533|11143379|FG000|Overall Study|Adverse Event|0
7052538|NCT01833533|11143380|FG001|Overall Study|Adverse Event|1
7052539|NCT01833533|11143379|FG000|Overall Study|Lost to Follow-up|4
7052540|NCT01833533|11143380|FG001|Overall Study|Lost to Follow-up|9
7052541|NCT01833533|11143379|FG000|Overall Study|To Enter an Extension Study|0
7052542|NCT01833533|11143380|FG001|Overall Study|To Enter an Extension Study|4
7052543|NCT01833533|11143379|FG000|Overall Study|Other|2
7052544|NCT01833533|11143380|FG001|Overall Study|Other|7
7052545|NCT01833832|11143421|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1
7052546|NCT01833897|11143429|FG000|Overall Study|Lack of Efficacy|1
7052547|NCT01834222|11143463|FG000|Overall Study|Not meet inclusion/exclusion criteria|1
7052548|NCT01834274|11143478|FG000|Overall Study|Study Termination|41
7052549|NCT01834274|11143479|FG001|Overall Study|Study Termination|38
7052550|NCT01834274|11143478|FG000|Overall Study|Withdrawal by Subject|1
7052551|NCT01834274|11143479|FG001|Overall Study|Withdrawal by Subject|1
7052552|NCT01834274|11143478|FG000|Overall Study|Lost to Follow-up|3
7052553|NCT01834274|11143479|FG001|Overall Study|Lost to Follow-up|1
7052554|NCT01834274|11143478|FG000|Overall Study|Other|2
7052555|NCT01834274|11143479|FG001|Overall Study|Other|1
7052556|NCT01834586|11143503|FG000|Overall Study|Adverse Event|1
7052557|NCT01834729|11143526|FG000|Overall Study|Did not return bowel diaries|0
7052558|NCT01834729|11143527|FG001|Overall Study|Did not return bowel diaries|0
7052559|NCT01834729|11143528|FG002|Overall Study|Did not return bowel diaries|3
7052560|NCT01834729|11143529|FG003|Overall Study|Did not return bowel diaries|0
7052561|NCT01834729|11143526|FG000|Overall Study|Withdrawal by Subject|1
7052562|NCT01834729|11143527|FG001|Overall Study|Withdrawal by Subject|1
7052563|NCT01834729|11143528|FG002|Overall Study|Withdrawal by Subject|0
7052564|NCT01834729|11143529|FG003|Overall Study|Withdrawal by Subject|0
7052565|NCT01834729|11143526|FG000|Overall Study|Adverse Event|0
7052566|NCT01834729|11143527|FG001|Overall Study|Adverse Event|0
7052567|NCT01834729|11143528|FG002|Overall Study|Adverse Event|0
7052568|NCT01834729|11143529|FG003|Overall Study|Adverse Event|2
7052569|NCT01835015|11143545|FG000|Overall Study|Adverse Event|0
7052570|NCT01835015|11143546|FG001|Overall Study|Adverse Event|0
7052571|NCT01835015|11143547|FG002|Overall Study|Adverse Event|1
7052572|NCT01835015|11143548|FG003|Overall Study|Adverse Event|0
7052573|NCT01835015|11143549|FG004|Overall Study|Adverse Event|0
7052574|NCT01835132|11143562|FG000|Initial Phase|Insufficient Therapeutic Response|2
7052575|NCT01835158|11143568|FG000|Overall Study|Withdrawal by Subject|1
7052576|NCT01835158|11143569|FG001|Overall Study|Withdrawal by Subject|6
7052577|NCT01835223|11143577|FG000|Overall Study|Adverse Event|1
7052578|NCT01835223|11143578|FG001|Overall Study|Adverse Event|0
6804744|NCT03206073|10806750|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0
6804745|NCT03206073|10806751|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0
6804746|NCT03206073|10806748|FG000|Overall Study|Death|0
7052579|NCT01835223|11143577|FG000|Overall Study|Withdrawal by Subject|2
7052580|NCT01835223|11143578|FG001|Overall Study|Withdrawal by Subject|0
7052581|NCT01835223|11143577|FG000|Overall Study|Disease progression|2
7052582|NCT01835223|11143578|FG001|Overall Study|Disease progression|1
7052583|NCT01835223|11143577|FG000|Overall Study|Became Inelligible|4
7052584|NCT01835223|11143578|FG001|Overall Study|Became Inelligible|0
7052585|NCT01835431|11143606|FG000|Overall Study|Adverse Event|1
7052586|NCT01835431|11143607|FG001|Overall Study|Adverse Event|0
7052587|NCT01835431|11143606|FG000|Overall Study|other|0
7052588|NCT01835431|11143607|FG001|Overall Study|other|2
7052589|NCT01835431|11143606|FG000|Overall Study|Withdrawal by Subject|6
7052590|NCT01835431|11143607|FG001|Overall Study|Withdrawal by Subject|10
7052591|NCT01835431|11143606|FG000|Overall Study|Protocol Violation|1
7052592|NCT01835431|11143607|FG001|Overall Study|Protocol Violation|0
7052593|NCT01835470|11143613|FG000|Long Term Treatment Period|Subject Request to Discontinue|1
7052594|NCT01835470|11143613|FG000|Long Term Treatment Period|Lack of Efficacy|3
7052595|NCT01835548|11143624|FG000|Dose Optimization Period|Adverse Event|0
7052596|NCT01835548|11143625|FG001|Dose Optimization Period|Adverse Event|0
7052597|NCT01835548|11143626|FG002|Dose Optimization Period|Adverse Event|1
7052598|NCT01835548|11143624|FG000|Dose Optimization Period|Withdrawal by Subject|0
7084546|NCT02165826|11196618|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3
7084547|NCT02165826|11196616|FG000|Main Treatment Period|Lost to Follow-up|4
7084548|NCT02165826|11196617|FG001|Main Treatment Period|Lost to Follow-up|2
7084549|NCT02165826|11196618|FG002|Main Treatment Period|Lost to Follow-up|1
7084550|NCT02165826|11196616|FG000|Main Treatment Period|Voluntary Withdrawal|23
7084551|NCT02165826|11196617|FG001|Main Treatment Period|Voluntary Withdrawal|23
7084552|NCT02165826|11196618|FG002|Main Treatment Period|Voluntary Withdrawal|21
7084553|NCT02165826|11196616|FG000|Main Treatment Period|Lack of Efficacy|2
7084554|NCT02165826|11196617|FG001|Main Treatment Period|Lack of Efficacy|0
7052599|NCT01835548|11143625|FG001|Dose Optimization Period|Withdrawal by Subject|0
6804747|NCT03206073|10806749|FG001|Overall Study|Death|0
6804748|NCT03206073|10806750|FG002|Overall Study|Death|1
6804749|NCT03206073|10806751|FG003|Overall Study|Death|0
6804750|NCT03206073|10806748|FG000|Overall Study|Taken off active treatment|0
6804751|NCT03206073|10806749|FG001|Overall Study|Taken off active treatment|0
6804752|NCT03206073|10806750|FG002|Overall Study|Taken off active treatment|3
6804753|NCT03206073|10806751|FG003|Overall Study|Taken off active treatment|0
6804754|NCT03102034|10806776|FG000|Overall Study|Withdrawal by Subject|1
6804755|NCT03102034|10806777|FG001|Overall Study|Withdrawal by Subject|0
6804756|NCT02723864|10806794|FG000|Overall Study|Refused further treatment|1
6804757|NCT02723864|10806795|FG001|Overall Study|Refused further treatment|0
6804758|NCT02723864|10806796|FG002|Overall Study|Refused further treatment|0
6804759|NCT02723864|10806797|FG003|Overall Study|Refused further treatment|0
6804760|NCT02723864|10806798|FG004|Overall Study|Refused further treatment|1
6804761|NCT02723864|10806799|FG005|Overall Study|Refused further treatment|2
6804762|NCT02723864|10806800|FG006|Overall Study|Refused further treatment|0
6804763|NCT02723864|10806794|FG000|Overall Study|Exceed treatment hold time|0
6804764|NCT02723864|10806795|FG001|Overall Study|Exceed treatment hold time|1
6804765|NCT02723864|10806796|FG002|Overall Study|Exceed treatment hold time|0
6804766|NCT02723864|10806797|FG003|Overall Study|Exceed treatment hold time|0
6804767|NCT02723864|10806798|FG004|Overall Study|Exceed treatment hold time|0
6804768|NCT02723864|10806799|FG005|Overall Study|Exceed treatment hold time|0
6804769|NCT02723864|10806800|FG006|Overall Study|Exceed treatment hold time|0
6804770|NCT02723864|10806794|FG000|Overall Study|Clinical progression|0
6804771|NCT02723864|10806795|FG001|Overall Study|Clinical progression|0
6804772|NCT02723864|10806796|FG002|Overall Study|Clinical progression|1
6804773|NCT02723864|10806797|FG003|Overall Study|Clinical progression|0
6804774|NCT02723864|10806798|FG004|Overall Study|Clinical progression|0
6804775|NCT02723864|10806799|FG005|Overall Study|Clinical progression|3
6804776|NCT02723864|10806800|FG006|Overall Study|Clinical progression|1
6804777|NCT02723864|10806794|FG000|Overall Study|Physician Decision|0
6804778|NCT02723864|10806795|FG001|Overall Study|Physician Decision|0
6804779|NCT02723864|10806796|FG002|Overall Study|Physician Decision|0
6804780|NCT02723864|10806797|FG003|Overall Study|Physician Decision|0
6804781|NCT02723864|10806798|FG004|Overall Study|Physician Decision|0
6804782|NCT02723864|10806799|FG005|Overall Study|Physician Decision|0
6804783|NCT02723864|10806800|FG006|Overall Study|Physician Decision|1
6804784|NCT02723864|10806794|FG000|Overall Study|Changes in patient condition|0
6804785|NCT02723864|10806795|FG001|Overall Study|Changes in patient condition|0
6804786|NCT02723864|10806796|FG002|Overall Study|Changes in patient condition|0
6804787|NCT02723864|10806797|FG003|Overall Study|Changes in patient condition|0
6804788|NCT02723864|10806798|FG004|Overall Study|Changes in patient condition|0
6804789|NCT02723864|10806799|FG005|Overall Study|Changes in patient condition|1
6804790|NCT02723864|10806800|FG006|Overall Study|Changes in patient condition|0
6804791|NCT02723864|10806794|FG000|Overall Study|Patient choice|0
6804792|NCT02723864|10806795|FG001|Overall Study|Patient choice|0
6804793|NCT02723864|10806796|FG002|Overall Study|Patient choice|0
7052600|NCT01835548|11143626|FG002|Dose Optimization Period|Withdrawal by Subject|1
7052601|NCT01835548|11143624|FG000|Double-Blind Treatment Period|Adverse Event|0
7052602|NCT01835548|11143625|FG001|Double-Blind Treatment Period|Adverse Event|1
7052603|NCT01835548|11143626|FG002|Double-Blind Treatment Period|Adverse Event|0
7052604|NCT01835548|11143624|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
7052605|NCT01835548|11143625|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1
7052606|NCT01835548|11143626|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0
7052607|NCT01835587|11143642|FG000|Overall Study|Disease Recurrence or Relapse|0
7052608|NCT01835587|11143643|FG001|Overall Study|Disease Recurrence or Relapse|3
7052609|NCT01835587|11143644|FG002|Overall Study|Disease Recurrence or Relapse|0
7052610|NCT01835587|11143645|FG003|Overall Study|Disease Recurrence or Relapse|3
7052611|NCT01835587|11143642|FG000|Overall Study|Withdrawal by Subject|2
7052612|NCT01835587|11143643|FG001|Overall Study|Withdrawal by Subject|0
7052613|NCT01835587|11143644|FG002|Overall Study|Withdrawal by Subject|0
7052614|NCT01835587|11143645|FG003|Overall Study|Withdrawal by Subject|3
7052615|NCT01835587|11143642|FG000|Overall Study|Adverse Event|0
7052616|NCT01835587|11143643|FG001|Overall Study|Adverse Event|0
7052617|NCT01835587|11143644|FG002|Overall Study|Adverse Event|2
7052618|NCT01835587|11143645|FG003|Overall Study|Adverse Event|2
7052619|NCT01835587|11143642|FG000|Overall Study|Death|0
7052620|NCT01835587|11143643|FG001|Overall Study|Death|0
7052621|NCT01835587|11143644|FG002|Overall Study|Death|0
7052622|NCT01835587|11143645|FG003|Overall Study|Death|1
7052623|NCT01835587|11143642|FG000|Overall Study|Miscellaneous|0
7052624|NCT01835587|11143643|FG001|Overall Study|Miscellaneous|1
7052625|NCT01835587|11143644|FG002|Overall Study|Miscellaneous|0
7052626|NCT01835587|11143645|FG003|Overall Study|Miscellaneous|0
7052627|NCT01835899|11143689|FG000|Overall Study|Adverse Event|0
7052628|NCT01835899|11143690|FG001|Overall Study|Adverse Event|0
7052629|NCT01835899|11143691|FG002|Overall Study|Adverse Event|1
7052630|NCT01835899|11143689|FG000|Overall Study|Other than stated above|0
7052631|NCT01835899|11143690|FG001|Overall Study|Other than stated above|1
7052632|NCT01835899|11143691|FG002|Overall Study|Other than stated above|0
7052633|NCT01836198|11143756|FG000|Part A, Period 2|Protocol Violation|0
7052634|NCT01836198|11143757|FG001|Part A, Period 2|Protocol Violation|1
7052635|NCT01836198|11143758|FG002|Part A, Period 2|Protocol Violation|0
7052636|NCT01836276|11143776|FG000|Overall Study|Lost to Follow-up|28
7052637|NCT01836276|11143777|FG001|Overall Study|Lost to Follow-up|51
7052638|NCT01836458|11143796|FG000|Overall Study|Unsatisfactory therapeutic effect|3
7052639|NCT01836458|11143797|FG001|Overall Study|Unsatisfactory therapeutic effect|2
7052640|NCT01836458|11143798|FG002|Overall Study|Unsatisfactory therapeutic effect|5
7052641|NCT01836458|11143799|FG003|Overall Study|Unsatisfactory therapeutic effect|6
7052642|NCT01836471|11143814|FG000|Overall Study|Pregnancy|1
7052643|NCT01836471|11143815|FG001|Overall Study|Pregnancy|0
7052644|NCT01836471|11143816|FG002|Overall Study|Pregnancy|0
7052645|NCT01836471|11143817|FG003|Overall Study|Pregnancy|0
7052646|NCT01836471|11143818|FG004|Overall Study|Pregnancy|0
7052647|NCT01836471|11143814|FG000|Overall Study|Withdrawal by Subject|3
7052648|NCT01836471|11143815|FG001|Overall Study|Withdrawal by Subject|4
7052649|NCT01836471|11143816|FG002|Overall Study|Withdrawal by Subject|1
7052650|NCT01836471|11143817|FG003|Overall Study|Withdrawal by Subject|0
7052651|NCT01836471|11143818|FG004|Overall Study|Withdrawal by Subject|2
7052652|NCT01836471|11143814|FG000|Overall Study|Physician Decision|0
7052653|NCT01836471|11143815|FG001|Overall Study|Physician Decision|1
7052654|NCT01836471|11143816|FG002|Overall Study|Physician Decision|0
7052655|NCT01836471|11143817|FG003|Overall Study|Physician Decision|0
7052656|NCT01836471|11143818|FG004|Overall Study|Physician Decision|0
7052657|NCT01836471|11143814|FG000|Overall Study|Lost to Follow-up|0
7052658|NCT01836471|11143815|FG001|Overall Study|Lost to Follow-up|0
7052659|NCT01836471|11143816|FG002|Overall Study|Lost to Follow-up|0
7052660|NCT01836471|11143817|FG003|Overall Study|Lost to Follow-up|1
7052661|NCT01836471|11143818|FG004|Overall Study|Lost to Follow-up|1
7052662|NCT01836471|11143814|FG000|Overall Study|Adverse Event|6
7052663|NCT01836471|11143815|FG001|Overall Study|Adverse Event|3
7052664|NCT01836471|11143816|FG002|Overall Study|Adverse Event|1
7052665|NCT01836471|11143817|FG003|Overall Study|Adverse Event|1
7052666|NCT01836471|11143818|FG004|Overall Study|Adverse Event|2
7052667|NCT01836471|11143814|FG000|Overall Study|Non compliance with tx|1
7052668|NCT01836471|11143815|FG001|Overall Study|Non compliance with tx|1
7052669|NCT01836471|11143816|FG002|Overall Study|Non compliance with tx|0
7052670|NCT01836471|11143817|FG003|Overall Study|Non compliance with tx|0
7052671|NCT01836471|11143818|FG004|Overall Study|Non compliance with tx|0
7052672|NCT01836523|11143835|FG000|Overall Study|Adverse Event|15
7052673|NCT01836523|11143836|FG001|Overall Study|Adverse Event|41
7052674|NCT01836523|11143837|FG002|Overall Study|Adverse Event|49
7052675|NCT01836523|11143838|FG003|Overall Study|Adverse Event|14
7052676|NCT01836523|11143835|FG000|Overall Study|Protocol Violation|6
7052677|NCT01836523|11143836|FG001|Overall Study|Protocol Violation|3
7052678|NCT01836523|11143837|FG002|Overall Study|Protocol Violation|2
7052679|NCT01836523|11143838|FG003|Overall Study|Protocol Violation|4
7052680|NCT01836523|11143835|FG000|Overall Study|Met Withdrawal Criteria|13
7052681|NCT01836523|11143836|FG001|Overall Study|Met Withdrawal Criteria|13
7052682|NCT01836523|11143837|FG002|Overall Study|Met Withdrawal Criteria|21
7052683|NCT01836523|11143838|FG003|Overall Study|Met Withdrawal Criteria|27
7052684|NCT01836523|11143835|FG000|Overall Study|Unclassified|17
7052685|NCT01836523|11143836|FG001|Overall Study|Unclassified|28
7052686|NCT01836523|11143837|FG002|Overall Study|Unclassified|19
7052687|NCT01836523|11143838|FG003|Overall Study|Unclassified|29
7052688|NCT01836549|11143854|FG000|Overall Study|Did not receive study drug|0
7052689|NCT01836549|11143855|FG001|Overall Study|Did not receive study drug|0
7052690|NCT01836549|11143856|FG002|Overall Study|Did not receive study drug|1
7052691|NCT01836549|11143857|FG003|Overall Study|Did not receive study drug|0
7052692|NCT01836549|11143858|FG004|Overall Study|Did not receive study drug|0
7052693|NCT01836549|11143859|FG005|Overall Study|Did not receive study drug|0
7052694|NCT01836549|11143860|FG006|Overall Study|Did not receive study drug|0
7052695|NCT01836549|11143854|FG000|Overall Study|Patient declared ineligible|0
7052696|NCT01836549|11143855|FG001|Overall Study|Patient declared ineligible|0
7052697|NCT01836549|11143856|FG002|Overall Study|Patient declared ineligible|0
7052698|NCT01836549|11143857|FG003|Overall Study|Patient declared ineligible|1
7052699|NCT01836549|11143858|FG004|Overall Study|Patient declared ineligible|0
7052700|NCT01836549|11143859|FG005|Overall Study|Patient declared ineligible|0
7052701|NCT01836549|11143860|FG006|Overall Study|Patient declared ineligible|0
7052702|NCT01836549|11143854|FG000|Overall Study|Patient inevaluable to start therapy|0
7052703|NCT01836549|11143855|FG001|Overall Study|Patient inevaluable to start therapy|0
7052704|NCT01836549|11143856|FG002|Overall Study|Patient inevaluable to start therapy|0
7052705|NCT01836549|11143857|FG003|Overall Study|Patient inevaluable to start therapy|0
7052706|NCT01836549|11143858|FG004|Overall Study|Patient inevaluable to start therapy|0
7052707|NCT01836549|11143859|FG005|Overall Study|Patient inevaluable to start therapy|0
7052708|NCT01836549|11143860|FG006|Overall Study|Patient inevaluable to start therapy|1
7052709|NCT01837680|11143918|FG000|Overall Study|Lost to Follow-up|2
7052710|NCT01837680|11143919|FG001|Overall Study|Lost to Follow-up|2
7052711|NCT01837680|11143918|FG000|Overall Study|lack of insurance|0
7052712|NCT01837680|11143919|FG001|Overall Study|lack of insurance|2
7052713|NCT01837680|11143918|FG000|Overall Study|allergic reaction|6
7052714|NCT01837680|11143919|FG001|Overall Study|allergic reaction|0
7052715|NCT01837680|11143918|FG000|Overall Study|switched to oral hypoglycemic or diet|2
7052716|NCT01837680|11143919|FG001|Overall Study|switched to oral hypoglycemic or diet|4
7052717|NCT01837719|11143925|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1
7052718|NCT01837719|11143925|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1
7052719|NCT01837797|11143943|FG000|Period 1|Adverse Event|9
7052720|NCT01837797|11143944|FG001|Period 1|Adverse Event|0
7052721|NCT01837797|11143945|FG002|Period 1|Adverse Event|0
7052722|NCT01837797|11143946|FG003|Period 1|Adverse Event|0
7052723|NCT01837797|11143947|FG004|Period 1|Adverse Event|0
7052724|NCT01837797|11143943|FG000|Period 1|Withdrawal by Subject|6
7052725|NCT01837797|11143944|FG001|Period 1|Withdrawal by Subject|0
7052726|NCT01837797|11143945|FG002|Period 1|Withdrawal by Subject|0
7052727|NCT01837797|11143946|FG003|Period 1|Withdrawal by Subject|0
7052728|NCT01837797|11143947|FG004|Period 1|Withdrawal by Subject|0
7052729|NCT01837797|11143943|FG000|Period 1|Administrative reasons|76
7052730|NCT01837797|11143944|FG001|Period 1|Administrative reasons|0
7052731|NCT01837797|11143945|FG002|Period 1|Administrative reasons|0
7052732|NCT01837797|11143946|FG003|Period 1|Administrative reasons|0
7052733|NCT01837797|11143947|FG004|Period 1|Administrative reasons|0
7052734|NCT01837797|11143943|FG000|Period 1|Withdrawal of consent before treatment|1
7052735|NCT01837797|11143944|FG001|Period 1|Withdrawal of consent before treatment|0
7052736|NCT01837797|11143945|FG002|Period 1|Withdrawal of consent before treatment|0
7052737|NCT01837797|11143946|FG003|Period 1|Withdrawal of consent before treatment|0
7052738|NCT01837797|11143947|FG004|Period 1|Withdrawal of consent before treatment|0
7052739|NCT01837797|11143943|FG000|Period 1|Other|10
7052740|NCT01837797|11143944|FG001|Period 1|Other|0
7052741|NCT01837797|11143945|FG002|Period 1|Other|0
7052742|NCT01837797|11143946|FG003|Period 1|Other|0
7052743|NCT01837797|11143947|FG004|Period 1|Other|0
7052744|NCT01837797|11143943|FG000|Period 2|Administrative or other reasons|0
7052745|NCT01837797|11143944|FG001|Period 2|Administrative or other reasons|5
7052746|NCT01837797|11143945|FG002|Period 2|Administrative or other reasons|2
7052747|NCT01837797|11143946|FG003|Period 2|Administrative or other reasons|4
7052748|NCT01837797|11143947|FG004|Period 2|Administrative or other reasons|0
7052749|NCT01837797|11143943|FG000|Period 2|Adverse Event|0
7052750|NCT01837797|11143944|FG001|Period 2|Adverse Event|0
7052751|NCT01837797|11143945|FG002|Period 2|Adverse Event|0
7052752|NCT01837797|11143946|FG003|Period 2|Adverse Event|1
7052753|NCT01837797|11143947|FG004|Period 2|Adverse Event|0
7052754|NCT01837797|11143943|FG000|Period 3|Adverse Event|0
7052755|NCT01837797|11143944|FG001|Period 3|Adverse Event|0
7052756|NCT01837797|11143945|FG002|Period 3|Adverse Event|0
7052757|NCT01837797|11143946|FG003|Period 3|Adverse Event|0
7052758|NCT01837797|11143947|FG004|Period 3|Adverse Event|1
7052759|NCT01837797|11143943|FG000|Period 3|Administrative reasons|0
7052760|NCT01837797|11143944|FG001|Period 3|Administrative reasons|0
7052761|NCT01837797|11143945|FG002|Period 3|Administrative reasons|0
7052762|NCT01837797|11143946|FG003|Period 3|Administrative reasons|0
7052763|NCT01837797|11143947|FG004|Period 3|Administrative reasons|20
7052764|NCT01837797|11143943|FG000|Period 3|Other|0
7052765|NCT01837797|11143944|FG001|Period 3|Other|0
7052766|NCT01837797|11143945|FG002|Period 3|Other|0
7052767|NCT01837797|11143946|FG003|Period 3|Other|0
7052768|NCT01837797|11143947|FG004|Period 3|Other|2
7052769|NCT01837823|11143955|FG000|Overall Study|Lost to Follow-up|6
7052770|NCT01837966|11143978|FG000|Overall Study|Withdrawal by Subject|2
7052771|NCT01837966|11143979|FG001|Overall Study|Withdrawal by Subject|1
7052772|NCT01838044|11143987|FG000|Overall Study|Adverse Event|4
7052773|NCT01838044|11143988|FG001|Overall Study|Adverse Event|6
7052774|NCT01838044|11143987|FG000|Overall Study|Protocol Violation|3
7052775|NCT01838044|11143988|FG001|Overall Study|Protocol Violation|3
7052776|NCT01838044|11143987|FG000|Overall Study|Withdrawal by Subject|0
7052777|NCT01838044|11143988|FG001|Overall Study|Withdrawal by Subject|2
7052778|NCT01838044|11143987|FG000|Overall Study|Insufficient clinical response|1
7052779|NCT01838044|11143988|FG001|Overall Study|Insufficient clinical response|2
7052780|NCT01838044|11143987|FG000|Overall Study|Medication error without associated AE|0
7052781|NCT01838044|11143988|FG001|Overall Study|Medication error without associated AE|1
7052782|NCT01838044|11143987|FG000|Overall Study|Lost to Follow-up|0
7052783|NCT01838044|11143988|FG001|Overall Study|Lost to Follow-up|2
7052784|NCT01838200|11143997|FG000|Overall Study|Adverse Event|0
7052785|NCT01838200|11143998|FG001|Overall Study|Adverse Event|2
7052786|NCT01838200|11143997|FG000|Overall Study|Progressive disease|3
7052787|NCT01838200|11143998|FG001|Overall Study|Progressive disease|0
7052788|NCT01838213|11144006|FG000|Overall Study|Ineligible|166
7052789|NCT01838213|11144007|FG001|Overall Study|Ineligible|191
7052790|NCT01838447|11144042|FG000|Overall Study|Change in surgical plan|1
7052791|NCT01838447|11144043|FG001|Overall Study|Change in surgical plan|2
7052792|NCT01838447|11144042|FG000|Overall Study|Withdrawal by Subject|1
7052793|NCT01838447|11144043|FG001|Overall Study|Withdrawal by Subject|1
7052794|NCT01838499|11144051|FG000|Overall Study|Protocol Violation|0
7052795|NCT01838499|11144052|FG001|Overall Study|Protocol Violation|1
7052796|NCT01838499|11144051|FG000|Overall Study|Lost to Follow-up|2
7052797|NCT01838499|11144052|FG001|Overall Study|Lost to Follow-up|4
7052798|NCT01838499|11144051|FG000|Overall Study|Lack of Efficacy|1
7052799|NCT01838499|11144052|FG001|Overall Study|Lack of Efficacy|2
7052800|NCT01838499|11144051|FG000|Overall Study|Adverse Event|2
7052801|NCT01838499|11144052|FG001|Overall Study|Adverse Event|1
7052802|NCT01838499|11144051|FG000|Overall Study|Withdrawal by Subject|19
7052803|NCT01838499|11144052|FG001|Overall Study|Withdrawal by Subject|9
7052804|NCT01838551|11144058|FG000|Overall Study|Adverse Event|16
7052805|NCT01838551|11144058|FG000|Overall Study|Death|1
7052806|NCT01838551|11144058|FG000|Overall Study|Lack of Efficacy|10
7052807|NCT01838551|11144058|FG000|Overall Study|Physician Decision|4
7052808|NCT01838551|11144058|FG000|Overall Study|Withdrawal by Subject|10
7052809|NCT01838551|11144058|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7
7052810|NCT01838590|11144066|FG000|Overall Study|Lack of Efficacy|12
7052811|NCT01838590|11144067|FG001|Overall Study|Lack of Efficacy|4
7052812|NCT01838590|11144066|FG000|Overall Study|Lost to Follow-up|0
7052813|NCT01838590|11144067|FG001|Overall Study|Lost to Follow-up|1
7052814|NCT01838616|11144079|FG000|Titration Period|Adverse Event|18
7052815|NCT01838616|11144080|FG001|Titration Period|Adverse Event|48
7052816|NCT01838616|11144079|FG000|Titration Period|Lack of Efficacy|5
7052817|NCT01838616|11144080|FG001|Titration Period|Lack of Efficacy|12
7052818|NCT01838616|11144079|FG000|Titration Period|Withdrawal by Subject|5
7052819|NCT01838616|11144080|FG001|Titration Period|Withdrawal by Subject|5
7052820|NCT01838616|11144079|FG000|Titration Period|Technical problems|1
7052821|NCT01838616|11144080|FG001|Titration Period|Technical problems|0
7052822|NCT01838616|11144079|FG000|Titration Period|Other|1
7052823|NCT01838616|11144080|FG001|Titration Period|Other|0
7052824|NCT01838616|11144079|FG000|Titration Period|Protocol Violation|0
7052825|NCT01838616|11144080|FG001|Titration Period|Protocol Violation|1
7052826|NCT01838616|11144079|FG000|Continuation Period|Lack of Efficacy|3
7052827|NCT01838616|11144080|FG001|Continuation Period|Lack of Efficacy|5
7052828|NCT01838616|11144079|FG000|Continuation Period|Adverse Event|8
7052829|NCT01838616|11144080|FG001|Continuation Period|Adverse Event|4
7052830|NCT01838616|11144079|FG000|Continuation Period|Protocol Violation|2
7052831|NCT01838616|11144080|FG001|Continuation Period|Protocol Violation|0
7052832|NCT01838616|11144079|FG000|Continuation Period|Lost to Follow-up|1
7052833|NCT01838616|11144080|FG001|Continuation Period|Lost to Follow-up|0
7052834|NCT01838616|11144079|FG000|Continuation Period|Withdrawal by Subject|0
7052835|NCT01838616|11144080|FG001|Continuation Period|Withdrawal by Subject|4
7052836|NCT01838616|11144079|FG000|Continuation Period|Technical problems|0
7052837|NCT01838616|11144080|FG001|Continuation Period|Technical problems|1
7052838|NCT01838616|11144079|FG000|Pick-up Arm|Lack of Efficacy|4
7052839|NCT01838616|11144080|FG001|Pick-up Arm|Lack of Efficacy|0
7052840|NCT01838616|11144079|FG000|Pick-up Arm|Adverse Event|9
7052841|NCT01838616|11144080|FG001|Pick-up Arm|Adverse Event|0
7052842|NCT01838616|11144079|FG000|Pick-up Arm|Withdrawal by Subject|1
7052843|NCT01838616|11144080|FG001|Pick-up Arm|Withdrawal by Subject|0
6804794|NCT02723864|10806797|FG003|Overall Study|Patient choice|0
6804795|NCT02723864|10806798|FG004|Overall Study|Patient choice|0
6804796|NCT02723864|10806799|FG005|Overall Study|Patient choice|1
6804797|NCT02723864|10806800|FG006|Overall Study|Patient choice|0
6804798|NCT02723864|10806794|FG000|Overall Study|Adverse Event|0
6804799|NCT02723864|10806795|FG001|Overall Study|Adverse Event|0
6804800|NCT02723864|10806796|FG002|Overall Study|Adverse Event|0
6804801|NCT02723864|10806797|FG003|Overall Study|Adverse Event|0
6804802|NCT02723864|10806798|FG004|Overall Study|Adverse Event|0
7052844|NCT01838616|11144079|FG000|Pick-up Arm|Technical problems|1
7052845|NCT01838616|11144080|FG001|Pick-up Arm|Technical problems|0
7052846|NCT01838642|11144091|FG000|Overall Study|Died on study|1
7052847|NCT01838681|11144100|FG000|Period A|Adverse Event|39
7052848|NCT01838681|11144101|FG001|Period A|Adverse Event|0
7052849|NCT01838681|11144102|FG002|Period A|Adverse Event|0
7052850|NCT01838681|11144103|FG003|Period A|Adverse Event|0
7052851|NCT01838681|11144100|FG000|Period A|Lack of Efficacy|21
7052852|NCT01838681|11144101|FG001|Period A|Lack of Efficacy|0
7052853|NCT01838681|11144102|FG002|Period A|Lack of Efficacy|0
7052854|NCT01838681|11144103|FG003|Period A|Lack of Efficacy|0
7052855|NCT01838681|11144100|FG000|Period A|Early response|148
7052856|NCT01838681|11144101|FG001|Period A|Early response|0
7052857|NCT01838681|11144102|FG002|Period A|Early response|0
7052858|NCT01838681|11144103|FG003|Period A|Early response|0
7052859|NCT01838681|11144100|FG000|Period A|Withdrawal by Subject|70
7052860|NCT01838681|11144101|FG001|Period A|Withdrawal by Subject|0
7052861|NCT01838681|11144102|FG002|Period A|Withdrawal by Subject|0
7052862|NCT01838681|11144103|FG003|Period A|Withdrawal by Subject|0
7052863|NCT01838681|11144100|FG000|Period A|Protocol Violation|16
7052864|NCT01838681|11144101|FG001|Period A|Protocol Violation|0
7052865|NCT01838681|11144102|FG002|Period A|Protocol Violation|0
7052866|NCT01838681|11144103|FG003|Period A|Protocol Violation|0
7052867|NCT01838681|11144100|FG000|Period A|Non-compliance with IMP|6
7052868|NCT01838681|11144101|FG001|Period A|Non-compliance with IMP|0
7052869|NCT01838681|11144102|FG002|Period A|Non-compliance with IMP|0
7052870|NCT01838681|11144103|FG003|Period A|Non-compliance with IMP|0
7052871|NCT01838681|11144100|FG000|Period A|Lost to Follow-up|4
7052872|NCT01838681|11144101|FG001|Period A|Lost to Follow-up|0
7052873|NCT01838681|11144102|FG002|Period A|Lost to Follow-up|0
7052874|NCT01838681|11144103|FG003|Period A|Lost to Follow-up|0
7052875|NCT01838681|11144100|FG000|Period A|Withdrawal before treatment|4
7052876|NCT01838681|11144101|FG001|Period A|Withdrawal before treatment|0
7052877|NCT01838681|11144102|FG002|Period A|Withdrawal before treatment|0
7052878|NCT01838681|11144103|FG003|Period A|Withdrawal before treatment|0
7052879|NCT01838681|11144100|FG000|Period A|Administrative or other reasons|17
7052880|NCT01838681|11144101|FG001|Period A|Administrative or other reasons|0
7052881|NCT01838681|11144102|FG002|Period A|Administrative or other reasons|0
7052882|NCT01838681|11144103|FG003|Period A|Administrative or other reasons|0
7052883|NCT01838681|11144100|FG000|Period B/A+|Adverse Event|0
7052884|NCT01838681|11144101|FG001|Period B/A+|Adverse Event|13
7052885|NCT01838681|11144102|FG002|Period B/A+|Adverse Event|27
7052886|NCT01838681|11144103|FG003|Period B/A+|Adverse Event|16
7052887|NCT01838681|11144100|FG000|Period B/A+|Lack of Efficacy|0
7052888|NCT01838681|11144101|FG001|Period B/A+|Lack of Efficacy|9
7052889|NCT01838681|11144102|FG002|Period B/A+|Lack of Efficacy|11
7052890|NCT01838681|11144103|FG003|Period B/A+|Lack of Efficacy|6
7052891|NCT01838681|11144100|FG000|Period B/A+|Withdrawal by Subject|0
7052892|NCT01838681|11144101|FG001|Period B/A+|Withdrawal by Subject|28
7052893|NCT01838681|11144102|FG002|Period B/A+|Withdrawal by Subject|35
7052894|NCT01838681|11144103|FG003|Period B/A+|Withdrawal by Subject|47
7052895|NCT01838681|11144100|FG000|Period B/A+|Protocol Violation|0
7052896|NCT01838681|11144101|FG001|Period B/A+|Protocol Violation|1
7052897|NCT01838681|11144102|FG002|Period B/A+|Protocol Violation|4
7052898|NCT01838681|11144103|FG003|Period B/A+|Protocol Violation|6
7052899|NCT01838681|11144100|FG000|Period B/A+|Non-compliance with IMP|0
7052900|NCT01838681|11144101|FG001|Period B/A+|Non-compliance with IMP|2
7052901|NCT01838681|11144102|FG002|Period B/A+|Non-compliance with IMP|3
7052902|NCT01838681|11144103|FG003|Period B/A+|Non-compliance with IMP|3
7052903|NCT01838681|11144100|FG000|Period B/A+|Lost to Follow-up|0
7052904|NCT01838681|11144101|FG001|Period B/A+|Lost to Follow-up|2
7052905|NCT01838681|11144102|FG002|Period B/A+|Lost to Follow-up|5
7052906|NCT01838681|11144103|FG003|Period B/A+|Lost to Follow-up|11
7052907|NCT01838681|11144100|FG000|Period B/A+|Withdrawal before treatment|0
7052908|NCT01838681|11144101|FG001|Period B/A+|Withdrawal before treatment|1
7052909|NCT01838681|11144102|FG002|Period B/A+|Withdrawal before treatment|0
7052910|NCT01838681|11144103|FG003|Period B/A+|Withdrawal before treatment|0
7052911|NCT01838681|11144100|FG000|Period B/A+|Administrative or other reasons|0
7052912|NCT01838681|11144101|FG001|Period B/A+|Administrative or other reasons|6
7052913|NCT01838681|11144102|FG002|Period B/A+|Administrative or other reasons|10
7052914|NCT01838681|11144103|FG003|Period B/A+|Administrative or other reasons|28
7052915|NCT01838694|11144111|FG000|Overall Study|Adverse Event|0
7052916|NCT01838694|11144112|FG001|Overall Study|Adverse Event|1
7052917|NCT01838876|11144134|FG000|Overall Study|Adverse Event|49
7052918|NCT01838876|11144134|FG000|Overall Study|Insufficient Therapeutic Response|10
7052919|NCT01838876|11144134|FG000|Overall Study|Protocol Violation|34
7052920|NCT01838876|11144134|FG000|Overall Study|Withdrawal of Consent|33
7052921|NCT01838876|11144134|FG000|Overall Study|Lost to Follow-up|21
7052922|NCT01838876|11144134|FG000|Overall Study|Study or Site Terminated by Sponsor|1
7052923|NCT01838876|11144134|FG000|Overall Study|Reason not Specified|7
7052924|NCT01838876|11144134|FG000|Overall Study|Did not meet eligibility criteria|78
7052925|NCT01838941|11144140|FG000|Overall Study|Adverse Event|1
7052926|NCT01838941|11144140|FG000|Overall Study|Withdrawal by Subject|1
7052927|NCT01839188|11144171|FG000|Overall Study|Withdrawal by Subject|1
7052928|NCT01839279|11144183|FG000|Overall Study|Adverse Event|4
7052929|NCT01839279|11144184|FG001|Overall Study|Adverse Event|1
7052930|NCT01839279|11144185|FG002|Overall Study|Adverse Event|1
7052931|NCT01839279|11144183|FG000|Overall Study|Withdrawal by Subject|4
7052932|NCT01839279|11144184|FG001|Overall Study|Withdrawal by Subject|1
7052933|NCT01839279|11144185|FG002|Overall Study|Withdrawal by Subject|1
7052934|NCT01839279|11144183|FG000|Overall Study|Classified as 'Other'|5
7052935|NCT01839279|11144184|FG001|Overall Study|Classified as 'Other'|0
7052936|NCT01839279|11144185|FG002|Overall Study|Classified as 'Other'|0
7052937|NCT01839487|11144215|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1
7052938|NCT01839487|11144216|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
7052939|NCT01839487|11144217|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
7052940|NCT01839487|11144218|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
7052941|NCT01839487|11144219|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
7052942|NCT01839487|11144220|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
7052943|NCT01839487|11144215|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14
7052944|NCT01839487|11144216|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6
7052945|NCT01839487|11144217|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0
7052946|NCT01839487|11144218|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0
7052947|NCT01839487|11144219|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0
7052948|NCT01839487|11144220|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0
7052949|NCT01839487|11144215|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
7052950|NCT01839487|11144216|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1
7052951|NCT01839487|11144217|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
7052952|NCT01839487|11144218|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
7052953|NCT01839487|11144219|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
7052954|NCT01839487|11144220|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
7052955|NCT01839487|11144215|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1
7052956|NCT01839487|11144216|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
7052957|NCT01839487|11144217|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
7052958|NCT01839487|11144218|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
7052959|NCT01839487|11144219|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
7052960|NCT01839487|11144220|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
7052961|NCT01839487|11144215|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0
7052962|NCT01839487|11144216|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0
7052963|NCT01839487|11144217|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12
7052964|NCT01839487|11144218|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9
7052965|NCT01839487|11144219|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4
7052966|NCT01839487|11144220|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8
7052967|NCT01839487|11144215|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0
7052968|NCT01839487|11144216|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0
7052969|NCT01839487|11144217|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46
7052970|NCT01839487|11144218|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49
7052971|NCT01839487|11144219|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71
7052972|NCT01839487|11144220|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32
7052973|NCT01839487|11144215|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
7052974|NCT01839487|11144216|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
6804803|NCT02723864|10806799|FG005|Overall Study|Adverse Event|1
6804804|NCT02723864|10806800|FG006|Overall Study|Adverse Event|0
6804805|NCT02723864|10806794|FG000|Overall Study|Started new treatment|0
6804806|NCT02723864|10806795|FG001|Overall Study|Started new treatment|0
6804807|NCT02723864|10806796|FG002|Overall Study|Started new treatment|0
6804808|NCT02723864|10806797|FG003|Overall Study|Started new treatment|0
6804809|NCT02723864|10806798|FG004|Overall Study|Started new treatment|0
6804810|NCT02723864|10806799|FG005|Overall Study|Started new treatment|1
6804811|NCT02723864|10806800|FG006|Overall Study|Started new treatment|0
6804812|NCT02723864|10806794|FG000|Overall Study|Switched to alternative treatment|0
6804813|NCT02723864|10806795|FG001|Overall Study|Switched to alternative treatment|0
6804814|NCT02723864|10806796|FG002|Overall Study|Switched to alternative treatment|0
6804815|NCT02723864|10806797|FG003|Overall Study|Switched to alternative treatment|0
6804816|NCT02723864|10806798|FG004|Overall Study|Switched to alternative treatment|0
6804817|NCT02723864|10806799|FG005|Overall Study|Switched to alternative treatment|1
6804818|NCT02723864|10806800|FG006|Overall Study|Switched to alternative treatment|0
6804819|NCT02723864|10806794|FG000|Overall Study|Late determination of ineligibility|0
6804820|NCT02723864|10806795|FG001|Overall Study|Late determination of ineligibility|0
6804821|NCT02723864|10806796|FG002|Overall Study|Late determination of ineligibility|0
6804822|NCT02723864|10806797|FG003|Overall Study|Late determination of ineligibility|0
6804823|NCT02723864|10806798|FG004|Overall Study|Late determination of ineligibility|0
6804824|NCT02723864|10806799|FG005|Overall Study|Late determination of ineligibility|1
6804825|NCT02723864|10806800|FG006|Overall Study|Late determination of ineligibility|0
6804826|NCT02691013|10806848|FG000|Overall Study|Withdrawal by Subject|3
6804827|NCT02691013|10806849|FG001|Overall Study|Withdrawal by Subject|0
6804828|NCT02597062|10806857|FG000|Overall Study|Ineligible|1
6804829|NCT02130882|10806863|FG000|Overall Study|Withdrawal by Subject|0
6804830|NCT02130882|10806864|FG001|Overall Study|Withdrawal by Subject|1
6804831|NCT01850563|10806872|FG000|Overall Study|Not eligible|3
7052975|NCT01839487|11144217|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2
7052976|NCT01839487|11144218|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
7052977|NCT01839487|11144219|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1
7052978|NCT01839487|11144220|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
7052979|NCT01839487|11144215|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0
7052980|NCT01839487|11144216|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0
7052981|NCT01839487|11144217|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0
7052982|NCT01839487|11144218|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1
7052983|NCT01839487|11144219|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10
7052984|NCT01839487|11144220|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3
7052985|NCT01839487|11144215|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0
7052986|NCT01839487|11144216|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0
7052987|NCT01839487|11144217|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1
7052988|NCT01839487|11144218|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3
7052989|NCT01839487|11144219|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2
7052990|NCT01839487|11144220|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1
7052991|NCT01839656|11144251|FG000|Overall Study|Withdrawal by Subject|1
7052992|NCT01839656|11144252|FG001|Overall Study|Withdrawal by Subject|1
7052993|NCT01839656|11144251|FG000|Overall Study|Adverse event, serious fatal|1
7052994|NCT01839656|11144252|FG001|Overall Study|Adverse event, serious fatal|4
7052995|NCT01839656|11144251|FG000|Overall Study|Early study closure|0
7052996|NCT01839656|11144252|FG001|Overall Study|Early study closure|11
7052997|NCT01839656|11144251|FG000|Overall Study|Adverse Event|1
7052998|NCT01839656|11144252|FG001|Overall Study|Adverse Event|0
7052999|NCT01839916|11144280|FG000|Overall Study|Death|9
7053000|NCT01839916|11144280|FG000|Overall Study|Physician Decision|17
7053001|NCT01839916|11144280|FG000|Overall Study|Relapse|12
7053002|NCT01839916|11144280|FG000|Overall Study|GVHD|2
7053003|NCT01839916|11144280|FG000|Overall Study|Graft Failure|1
7053004|NCT01840163|11144297|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19
7053005|NCT01840163|11144298|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16
7053006|NCT01840163|11144297|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48
7053007|NCT01840163|11144298|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40
7053008|NCT01840163|11144297|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43
7053009|NCT01840163|11144298|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35
7053010|NCT01840228|11144306|FG000|Overall Study|Lost to Follow-up|1
7053011|NCT01840228|11144307|FG001|Overall Study|Lost to Follow-up|1
7053012|NCT01840410|11144327|FG000|Overall Study|Physician Decision|1
7053013|NCT01840410|11144328|FG001|Overall Study|Physician Decision|2
7053014|NCT01840410|11144327|FG000|Overall Study|Pregnancy|1
7053015|NCT01840410|11144328|FG001|Overall Study|Pregnancy|0
7053016|NCT01840410|11144327|FG000|Overall Study|Protocol deviation|1
7053017|NCT01840410|11144328|FG001|Overall Study|Protocol deviation|0
7053018|NCT01840410|11144327|FG000|Overall Study|Lost to Follow-up|1
7053019|NCT01840410|11144328|FG001|Overall Study|Lost to Follow-up|0
7053020|NCT01840410|11144327|FG000|Overall Study|Withdrawal by Subject|2
7053021|NCT01840410|11144328|FG001|Overall Study|Withdrawal by Subject|1
7053022|NCT01840410|11144327|FG000|Overall Study|Adverse Event|1
7053023|NCT01840410|11144328|FG001|Overall Study|Adverse Event|1
7053024|NCT01840579|11144346|FG000|Overall Study|Status not recorded|0
7053025|NCT01840579|11144347|FG001|Overall Study|Status not recorded|0
7053026|NCT01840579|11144348|FG002|Overall Study|Status not recorded|2
7053027|NCT01840579|11144349|FG003|Overall Study|Status not recorded|3
7053028|NCT01840579|11144350|FG004|Overall Study|Status not recorded|4
7053029|NCT01840579|11144351|FG005|Overall Study|Status not recorded|3
7053030|NCT01840579|11144352|FG006|Overall Study|Status not recorded|0
7053031|NCT01840579|11144353|FG007|Overall Study|Status not recorded|3
7053032|NCT01840579|11144354|FG008|Overall Study|Status not recorded|3
7053033|NCT01840579|11144355|FG009|Overall Study|Status not recorded|3
7053034|NCT01840579|11144346|FG000|Overall Study|Progressive disease|3
7053035|NCT01840579|11144347|FG001|Overall Study|Progressive disease|5
7053036|NCT01840579|11144348|FG002|Overall Study|Progressive disease|0
7053037|NCT01840579|11144349|FG003|Overall Study|Progressive disease|0
7053038|NCT01840579|11144350|FG004|Overall Study|Progressive disease|0
7053039|NCT01840579|11144351|FG005|Overall Study|Progressive disease|0
7053040|NCT01840579|11144352|FG006|Overall Study|Progressive disease|0
7053041|NCT01840579|11144353|FG007|Overall Study|Progressive disease|0
7053042|NCT01840579|11144354|FG008|Overall Study|Progressive disease|0
7053043|NCT01840579|11144355|FG009|Overall Study|Progressive disease|0
7053044|NCT01840579|11144346|FG000|Overall Study|Ongoing in study|0
7053045|NCT01840579|11144347|FG001|Overall Study|Ongoing in study|1
7053046|NCT01840579|11144348|FG002|Overall Study|Ongoing in study|0
7053047|NCT01840579|11144349|FG003|Overall Study|Ongoing in study|0
7053048|NCT01840579|11144350|FG004|Overall Study|Ongoing in study|0
7053049|NCT01840579|11144351|FG005|Overall Study|Ongoing in study|0
7053050|NCT01840579|11144352|FG006|Overall Study|Ongoing in study|0
7053051|NCT01840579|11144353|FG007|Overall Study|Ongoing in study|0
7053052|NCT01840579|11144354|FG008|Overall Study|Ongoing in study|0
7053053|NCT01840579|11144355|FG009|Overall Study|Ongoing in study|0
7053054|NCT01840579|11144346|FG000|Overall Study|Death|0
7053055|NCT01840579|11144347|FG001|Overall Study|Death|0
7053056|NCT01840579|11144348|FG002|Overall Study|Death|0
7053057|NCT01840579|11144349|FG003|Overall Study|Death|0
7053058|NCT01840579|11144350|FG004|Overall Study|Death|0
7053059|NCT01840579|11144351|FG005|Overall Study|Death|1
7053060|NCT01840579|11144352|FG006|Overall Study|Death|0
7053061|NCT01840579|11144353|FG007|Overall Study|Death|0
7053062|NCT01840579|11144354|FG008|Overall Study|Death|0
7053063|NCT01840579|11144355|FG009|Overall Study|Death|0
7053064|NCT01840579|11144346|FG000|Overall Study|Adverse Event|0
7053065|NCT01840579|11144347|FG001|Overall Study|Adverse Event|1
7053066|NCT01840579|11144348|FG002|Overall Study|Adverse Event|0
7053067|NCT01840579|11144349|FG003|Overall Study|Adverse Event|0
7053068|NCT01840579|11144350|FG004|Overall Study|Adverse Event|0
7053069|NCT01840579|11144351|FG005|Overall Study|Adverse Event|0
7053070|NCT01840579|11144352|FG006|Overall Study|Adverse Event|0
7053071|NCT01840579|11144353|FG007|Overall Study|Adverse Event|0
7053072|NCT01840579|11144354|FG008|Overall Study|Adverse Event|0
7053073|NCT01840579|11144355|FG009|Overall Study|Adverse Event|0
7053074|NCT01840579|11144346|FG000|Overall Study|Follow-up ended by Sponsor|0
7053075|NCT01840579|11144347|FG001|Overall Study|Follow-up ended by Sponsor|0
7053076|NCT01840579|11144348|FG002|Overall Study|Follow-up ended by Sponsor|0
7053077|NCT01840579|11144349|FG003|Overall Study|Follow-up ended by Sponsor|0
7053078|NCT01840579|11144350|FG004|Overall Study|Follow-up ended by Sponsor|0
7053079|NCT01840579|11144351|FG005|Overall Study|Follow-up ended by Sponsor|0
7053080|NCT01840579|11144352|FG006|Overall Study|Follow-up ended by Sponsor|2
7053081|NCT01840579|11144353|FG007|Overall Study|Follow-up ended by Sponsor|0
7053082|NCT01840579|11144354|FG008|Overall Study|Follow-up ended by Sponsor|0
7053083|NCT01840579|11144355|FG009|Overall Study|Follow-up ended by Sponsor|0
7053084|NCT01840605|11144391|FG000|Overall Study|Adverse Event|0
7053085|NCT01840605|11144392|FG001|Overall Study|Adverse Event|1
7053086|NCT01840605|11144391|FG000|Overall Study|Physician Decision|2
7053087|NCT01840605|11144392|FG001|Overall Study|Physician Decision|1
7084555|NCT02165826|11196618|FG002|Main Treatment Period|Lack of Efficacy|0
7084556|NCT02165826|11196616|FG000|Main Treatment Period|Reason Not Specified|8
7084557|NCT02165826|11196617|FG001|Main Treatment Period|Reason Not Specified|5
7084558|NCT02165826|11196618|FG002|Main Treatment Period|Reason Not Specified|16
7084559|NCT02165826|11196616|FG000|Main Treatment Period|Did Not Receive Study Drug|0
7084560|NCT02165826|11196617|FG001|Main Treatment Period|Did Not Receive Study Drug|2
7084561|NCT02165826|11196618|FG002|Main Treatment Period|Did Not Receive Study Drug|0
7084562|NCT02165826|11196616|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4
7084563|NCT02165826|11196617|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10
7084564|NCT02165826|11196618|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3
7084565|NCT02165826|11196616|FG000|Down-Titration Period|Voluntary Withdrawal|2
7084566|NCT02165826|11196617|FG001|Down-Titration Period|Voluntary Withdrawal|1
7084567|NCT02165826|11196618|FG002|Down-Titration Period|Voluntary Withdrawal|2
7084568|NCT02165826|11196616|FG000|Down-Titration Period|Reason Not Specified|1
7084569|NCT02165826|11196617|FG001|Down-Titration Period|Reason Not Specified|0
7084570|NCT02165826|11196618|FG002|Down-Titration Period|Reason Not Specified|2
7084571|NCT02166047|11196669|FG000|Overall Study|Withdrawal by Participant|0
7084572|NCT02166047|11196670|FG001|Overall Study|Withdrawal by Participant|1
7084573|NCT02166047|11196671|FG002|Overall Study|Withdrawal by Participant|2
7084574|NCT02166047|11196672|FG003|Overall Study|Withdrawal by Participant|0
7084575|NCT02166047|11196673|FG004|Overall Study|Withdrawal by Participant|0
7084576|NCT02166047|11196674|FG005|Overall Study|Withdrawal by Participant|0
7084577|NCT02166047|11196675|FG006|Overall Study|Withdrawal by Participant|1
7084578|NCT02166047|11196676|FG007|Overall Study|Withdrawal by Participant|0
7084579|NCT02166047|11196677|FG008|Overall Study|Withdrawal by Participant|0
7084580|NCT02166047|11196678|FG009|Overall Study|Withdrawal by Participant|0
7084581|NCT02166047|11196679|FG010|Overall Study|Withdrawal by Participant|0
7084582|NCT02166047|11196680|FG011|Overall Study|Withdrawal by Participant|0
7084583|NCT02166047|11196669|FG000|Overall Study|Adverse Event|0
7084584|NCT02166047|11196670|FG001|Overall Study|Adverse Event|0
7084585|NCT02166047|11196671|FG002|Overall Study|Adverse Event|0
7084586|NCT02166047|11196672|FG003|Overall Study|Adverse Event|0
7084587|NCT02166047|11196673|FG004|Overall Study|Adverse Event|1
7084588|NCT02166047|11196674|FG005|Overall Study|Adverse Event|0
7084589|NCT02166047|11196675|FG006|Overall Study|Adverse Event|1
7084590|NCT02166047|11196676|FG007|Overall Study|Adverse Event|0
7084591|NCT02166047|11196677|FG008|Overall Study|Adverse Event|0
7084592|NCT02166047|11196678|FG009|Overall Study|Adverse Event|0
7084593|NCT02166047|11196679|FG010|Overall Study|Adverse Event|2
7084594|NCT02166047|11196680|FG011|Overall Study|Adverse Event|0
7084595|NCT02166333|11196710|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4
7084596|NCT02166333|11196711|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0
7084597|NCT02166333|11196712|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0
7053088|NCT01840943|11144409|FG000|Overall Study|Withdrawal by Subject|5
7053089|NCT01840943|11144410|FG001|Overall Study|Withdrawal by Subject|6
7053090|NCT01840943|11144409|FG000|Overall Study|Physician Decision|4
7053091|NCT01840943|11144410|FG001|Overall Study|Physician Decision|2
7053092|NCT01840943|11144409|FG000|Overall Study|Lost to Follow-up|4
7053093|NCT01840943|11144410|FG001|Overall Study|Lost to Follow-up|4
7053094|NCT01841060|11144424|FG000|Overall Study|Protocol Violation|10
7053095|NCT01841073|11144430|FG000|Overall Study|Adverse Event|1
7053096|NCT01841073|11144431|FG001|Overall Study|Adverse Event|1
7053097|NCT01841073|11144430|FG000|Overall Study|Physician Decision|1
7053098|NCT01841073|11144431|FG001|Overall Study|Physician Decision|0
7053099|NCT01841073|11144430|FG000|Overall Study|Lost to Follow-up|0
7053100|NCT01841073|11144431|FG001|Overall Study|Lost to Follow-up|2
7053101|NCT01841554|11144469|FG000|Overall Study|Death|7
7053102|NCT01841554|11144469|FG000|Overall Study|No Implantation|1
7053103|NCT01841554|11144469|FG000|Overall Study|Discontinued Follow Up|5
7053104|NCT01841554|11144469|FG000|Overall Study|Study exit due to secondary intervention|6
7053105|NCT01841567|11144473|FG000|Overall Study|Adverse Event|3
7053106|NCT01841593|11144479|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0
7053107|NCT01841593|11144480|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1
7053108|NCT01841593|11144479|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1
7053109|NCT01841593|11144480|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0
7053110|NCT01841697|11144509|FG000|Overall Study|Death|0
7053111|NCT01841697|11144510|FG001|Overall Study|Death|1
7053112|NCT01841697|11144509|FG000|Overall Study|Lost to Follow-up|4
7053113|NCT01841697|11144510|FG001|Overall Study|Lost to Follow-up|1
6804832|NCT01850563|10806873|FG001|Overall Study|Not eligible|0
6804833|NCT01827111|10806880|FG000|Overall Study|Disease Progression|1
6804834|NCT01437111|10806884|FG000|Overall Study|Adverse Event|2
6804835|NCT01437111|10806884|FG000|Overall Study|Withdrawal by Subject|4
7053114|NCT01841697|11144509|FG000|Overall Study|Withdrawal by Subject|16
7053115|NCT01841697|11144510|FG001|Overall Study|Withdrawal by Subject|16
7053116|NCT01841762|11144516|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51
6804836|NCT01437111|10806884|FG000|Overall Study|Not reported|5
6804837|NCT01437111|10806884|FG000|Overall Study|Physician Decision|1
7053117|NCT01841762|11144516|FG000|Treatment Period|Adverse Event|16
7053118|NCT01841762|11144516|FG000|Treatment Period|Death|1
7053119|NCT01841762|11144516|FG000|Treatment Period|Withdrawal by Subject|7
7053120|NCT01841762|11144516|FG000|Treatment Period|Lost to Follow-up|1
7053121|NCT01841762|11144516|FG000|Treatment Period|Physician Decision|2
7053122|NCT01841762|11144516|FG000|Treatment Period|Other, including non-compliance|5
7053123|NCT01841762|11144516|FG000|Post-Treatment Safety Follow-Up Period|Death|1
7053124|NCT01841762|11144516|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7
7053125|NCT01841762|11144516|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6
7053126|NCT01841762|11144516|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1
7053127|NCT01841970|11144520|FG000|Overall Study|Withdrawal by Subject|1
7053128|NCT01841970|11144520|FG000|Overall Study|Physician Decision|2
7053129|NCT01841970|11144520|FG000|Overall Study|Lost to Follow-up|8
7053130|NCT01842308|11144541|FG000|Overall Study|Withdrawal by Subject|0
7053131|NCT01842308|11144542|FG001|Overall Study|Withdrawal by Subject|0
7053132|NCT01842308|11144543|FG002|Overall Study|Withdrawal by Subject|0
7053133|NCT01842308|11144544|FG003|Overall Study|Withdrawal by Subject|0
7053134|NCT01842308|11144545|FG004|Overall Study|Withdrawal by Subject|1
7053135|NCT01842334|11144560|FG000|Overall Study|Withdrawal by Subject|3
7053136|NCT01842334|11144561|FG001|Overall Study|Withdrawal by Subject|3
7053137|NCT01842334|11144560|FG000|Overall Study|Moved away mid-study|0
7053138|NCT01842334|11144561|FG001|Overall Study|Moved away mid-study|1
7053139|NCT01842438|11144569|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6
7053140|NCT01842438|11144570|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8
7053141|NCT01842438|11144569|FG000|T2: 6month Follow-up|Withdrawal by Subject|4
7053142|NCT01842438|11144570|FG001|T2: 6month Follow-up|Withdrawal by Subject|3
7053143|NCT01842438|11144569|FG000|T2: 6month Follow-up|Death|0
7053144|NCT01842438|11144570|FG001|T2: 6month Follow-up|Death|1
7053145|NCT01842581|11144587|FG000|Overall Study|Adverse Event|6
7053146|NCT01842581|11144588|FG001|Overall Study|Adverse Event|4
7053147|NCT01842581|11144587|FG000|Overall Study|HE breakthrough|26
7053148|NCT01842581|11144588|FG001|Overall Study|HE breakthrough|13
7053149|NCT01842581|11144587|FG000|Overall Study|Liver transplant|2
7053150|NCT01842581|11144588|FG001|Overall Study|Liver transplant|0
7053151|NCT01842581|11144587|FG000|Overall Study|Lost to Follow-up|2
7053152|NCT01842581|11144588|FG001|Overall Study|Lost to Follow-up|5
7053153|NCT01842581|11144587|FG000|Overall Study|Withdrawal by Subject|5
7053154|NCT01842581|11144588|FG001|Overall Study|Withdrawal by Subject|7
7053155|NCT01842581|11144587|FG000|Overall Study|Other than specified|3
7053156|NCT01842581|11144588|FG001|Overall Study|Other than specified|1
7053157|NCT01842607|11144598|FG000|Overall Study|Adverse Event|11
7053158|NCT01842607|11144598|FG000|Overall Study|Lack of Efficacy|19
7053159|NCT01842607|11144598|FG000|Overall Study|Protocol Violation|8
7053160|NCT01842607|11144598|FG000|Overall Study|Protocol defined stopping criteria|2
7053161|NCT01842607|11144598|FG000|Overall Study|Lost to Follow-up|3
7053162|NCT01842607|11144598|FG000|Overall Study|Physician Decision|9
7053163|NCT01842607|11144598|FG000|Overall Study|Withdrawal by Subject|14
7053164|NCT01842620|11144602|FG000|Period 1|Withdrawal by Subject|1
7053165|NCT01842620|11144603|FG001|Period 1|Withdrawal by Subject|0
7053166|NCT01842633|11144612|FG000|Overall Study|Screen Failure|1
7053167|NCT01842633|11144613|FG001|Overall Study|Screen Failure|0
7053168|NCT01842633|11144614|FG002|Overall Study|Screen Failure|0
7053169|NCT01842633|11144612|FG000|Overall Study|Adverse Event|1
7053170|NCT01842633|11144613|FG001|Overall Study|Adverse Event|1
7053171|NCT01842633|11144614|FG002|Overall Study|Adverse Event|0
7053172|NCT01842633|11144612|FG000|Overall Study|Withdrawal by Subject|0
7053173|NCT01842633|11144613|FG001|Overall Study|Withdrawal by Subject|1
7053174|NCT01842633|11144614|FG002|Overall Study|Withdrawal by Subject|0
7053175|NCT01842633|11144612|FG000|Overall Study|Technical issues|1
7053176|NCT01842633|11144613|FG001|Overall Study|Technical issues|0
7053177|NCT01842633|11144614|FG002|Overall Study|Technical issues|0
7053178|NCT01842958|11144658|FG000|Overall Study|Lost to Follow-up|1
7084598|NCT02166333|11196713|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0
7084599|NCT02166333|11196714|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3
7084600|NCT02166333|11196715|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1
7084601|NCT02166333|11196710|FG000|Stage 1|Death|4
7084602|NCT02166333|11196711|FG001|Stage 1|Death|0
7084603|NCT02166333|11196712|FG002|Stage 1|Death|2
7084604|NCT02166333|11196713|FG003|Stage 1|Death|0
7084605|NCT02166333|11196714|FG004|Stage 1|Death|3
7084606|NCT02166333|11196715|FG005|Stage 1|Death|2
7084607|NCT02166333|11196710|FG000|Stage 1|Lost to Follow-up|12
7084608|NCT02166333|11196711|FG001|Stage 1|Lost to Follow-up|0
7084609|NCT02166333|11196712|FG002|Stage 1|Lost to Follow-up|6
7084610|NCT02166333|11196713|FG003|Stage 1|Lost to Follow-up|0
7084611|NCT02166333|11196714|FG004|Stage 1|Lost to Follow-up|3
7084612|NCT02166333|11196715|FG005|Stage 1|Lost to Follow-up|3
7084613|NCT02166333|11196710|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180
7053179|NCT01842958|11144659|FG001|Overall Study|Lost to Follow-up|1
7053180|NCT01843023|11144667|FG000|Overall Study|Death|1
7053181|NCT01843023|11144668|FG001|Overall Study|Death|0
7053182|NCT01843023|11144667|FG000|Overall Study|Lost to Follow-up|24
7084614|NCT02166333|11196711|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0
7084615|NCT02166333|11196712|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63
7084616|NCT02166333|11196713|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0
7053183|NCT01843023|11144668|FG001|Overall Study|Lost to Follow-up|29
7053184|NCT01843023|11144667|FG000|Overall Study|Withdrawal by Subject|8
7053185|NCT01843023|11144668|FG001|Overall Study|Withdrawal by Subject|6
7053186|NCT01843062|11144676|FG000|Overall Study|Protocol Violation|1
7053187|NCT01843062|11144677|FG001|Overall Study|Protocol Violation|0
7053188|NCT01843062|11144676|FG000|Overall Study|New treatment following progression|2
7053189|NCT01843062|11144677|FG001|Overall Study|New treatment following progression|0
7053190|NCT01843062|11144676|FG000|Overall Study|Pregnancy|1
7053191|NCT01843062|11144677|FG001|Overall Study|Pregnancy|0
7053192|NCT01843062|11144676|FG000|Overall Study|Adverse Event|2
7053193|NCT01843062|11144677|FG001|Overall Study|Adverse Event|0
7053194|NCT01843062|11144676|FG000|Overall Study|Incorrect randomisation|1
7053195|NCT01843062|11144677|FG001|Overall Study|Incorrect randomisation|0
7053196|NCT01843062|11144676|FG000|Overall Study|Withdrawal by Subject|12
7053197|NCT01843062|11144677|FG001|Overall Study|Withdrawal by Subject|3
7053198|NCT01843062|11144676|FG000|Overall Study|Death|1
7053199|NCT01843062|11144677|FG001|Overall Study|Death|2
7053200|NCT01843062|11144676|FG000|Overall Study|Lost to Follow-up|2
7053201|NCT01843062|11144677|FG001|Overall Study|Lost to Follow-up|4
7053202|NCT01843192|11144686|FG000|Overall Study|Intra-operative exclusions per protocol|2
7053203|NCT01843192|11144687|FG001|Overall Study|Intra-operative exclusions per protocol|6
7053204|NCT01843192|11144688|FG002|Overall Study|Intra-operative exclusions per protocol|2
7053205|NCT01843205|11144696|FG000|First Treatment (11 Days)|Withdrawal by Subject|1
7053206|NCT01843205|11144697|FG001|First Treatment (11 Days)|Withdrawal by Subject|0
7053207|NCT01843348|11144706|FG000|Overall Study|Withdrawal by Subject|4
7053208|NCT01843348|11144707|FG001|Overall Study|Withdrawal by Subject|16
7053209|NCT01843348|11144708|FG002|Overall Study|Withdrawal by Subject|18
7053210|NCT01843348|11144706|FG000|Overall Study|Lost to Follow-up|5
7053211|NCT01843348|11144707|FG001|Overall Study|Lost to Follow-up|4
7053212|NCT01843348|11144708|FG002|Overall Study|Lost to Follow-up|2
7053213|NCT01843348|11144706|FG000|Overall Study|Death|5
7053214|NCT01843348|11144707|FG001|Overall Study|Death|3
7053215|NCT01843348|11144708|FG002|Overall Study|Death|4
7053216|NCT01843348|11144706|FG000|Overall Study|Graft loss/retransplantation|5
7053217|NCT01843348|11144707|FG001|Overall Study|Graft loss/retransplantation|8
7053218|NCT01843348|11144708|FG002|Overall Study|Graft loss/retransplantation|11
7053219|NCT01843348|11144706|FG000|Overall Study|Various reasons|4
7053220|NCT01843348|11144707|FG001|Overall Study|Various reasons|9
7053221|NCT01843348|11144708|FG002|Overall Study|Various reasons|6
7053222|NCT01843660|11144734|FG000|Overall Study|Other|30
7053223|NCT01843673|11144738|FG000|Overall Study|Lack of Efficacy|2
7084617|NCT02166333|11196714|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54
7053224|NCT01843673|11144738|FG000|Overall Study|Withdrawal by Subject|4
7053225|NCT01843777|11144755|FG000|Overall Study|Withdrawal by Subject|1
7053226|NCT01843777|11144756|FG001|Overall Study|Withdrawal by Subject|0
7053227|NCT01843803|11144764|FG000|Overall Study|not a Veteran, did not see provider|1
7053228|NCT01843803|11144765|FG001|Overall Study|not a Veteran, did not see provider|3
7053229|NCT01843842|11144773|FG000|Overall Study|Do not meet inclusion criteria|1
7053230|NCT01843842|11144774|FG001|Overall Study|Do not meet inclusion criteria|1
7053231|NCT01843933|11144791|FG000|Overall Study|Data lost|6
7084618|NCT02166333|11196715|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52
7084619|NCT02166333|11196710|FG000|Stage 2|Death|4
7084620|NCT02166333|11196711|FG001|Stage 2|Death|2
7084621|NCT02166333|11196712|FG002|Stage 2|Death|1
7084622|NCT02166333|11196713|FG003|Stage 2|Death|0
7084623|NCT02166333|11196714|FG004|Stage 2|Death|0
7084624|NCT02166333|11196715|FG005|Stage 2|Death|1
7084625|NCT02166333|11196710|FG000|Stage 2|Lost to Follow-up|23
7084626|NCT02166333|11196711|FG001|Stage 2|Lost to Follow-up|4
7084627|NCT02166333|11196712|FG002|Stage 2|Lost to Follow-up|11
7084628|NCT02166333|11196713|FG003|Stage 2|Lost to Follow-up|9
7084629|NCT02166333|11196714|FG004|Stage 2|Lost to Follow-up|3
7084630|NCT02166333|11196715|FG005|Stage 2|Lost to Follow-up|6
7084631|NCT02166476|11196736|FG000|Overall Study|Withdrawal by Subject|5
7053232|NCT01843933|11144792|FG001|Overall Study|Data lost|4
7053233|NCT01843972|11144808|FG000|Overall Study|Withdrawal by Subject|0
7053234|NCT01843972|11144809|FG001|Overall Study|Withdrawal by Subject|0
7053235|NCT01843972|11144810|FG002|Overall Study|Withdrawal by Subject|0
7053236|NCT01843972|11144811|FG003|Overall Study|Withdrawal by Subject|0
7053237|NCT01843972|11144812|FG004|Overall Study|Withdrawal by Subject|1
7053238|NCT01843972|11144813|FG005|Overall Study|Withdrawal by Subject|0
7053239|NCT01843972|11144814|FG006|Overall Study|Withdrawal by Subject|0
7053240|NCT01843972|11144815|FG007|Overall Study|Withdrawal by Subject|0
7053241|NCT01843972|11144816|FG008|Overall Study|Withdrawal by Subject|0
7053242|NCT01843972|11144817|FG009|Overall Study|Withdrawal by Subject|0
7053243|NCT01844076|11144857|FG000|Overall Study|Adverse Event|1
7053244|NCT01844076|11144858|FG001|Overall Study|Adverse Event|0
7053245|NCT01844076|11144859|FG002|Overall Study|Adverse Event|0
7053246|NCT01844076|11144860|FG003|Overall Study|Adverse Event|0
7053247|NCT01844076|11144857|FG000|Overall Study|Withdrawal by Subject|1
7053248|NCT01844076|11144858|FG001|Overall Study|Withdrawal by Subject|0
7084632|NCT02166476|11196737|FG001|Overall Study|Withdrawal by Subject|7
7053249|NCT01844076|11144859|FG002|Overall Study|Withdrawal by Subject|0
7053250|NCT01844076|11144860|FG003|Overall Study|Withdrawal by Subject|0
7053251|NCT01844115|11144872|FG000|Overall Study|Adverse Event|4
7053252|NCT01844115|11144873|FG001|Overall Study|Adverse Event|22
7084633|NCT02166476|11196736|FG000|Overall Study|Adverse Event|3
7084634|NCT02166476|11196737|FG001|Overall Study|Adverse Event|3
7084635|NCT02166476|11196736|FG000|Overall Study|Lost to Follow-up|5
7084636|NCT02166476|11196737|FG001|Overall Study|Lost to Follow-up|10
7084637|NCT02166476|11196736|FG000|Overall Study|Physician Decision|1
7084638|NCT02166476|11196737|FG001|Overall Study|Physician Decision|0
7084639|NCT02166476|11196736|FG000|Overall Study|Unable to Come for Visit|0
7084640|NCT02166476|11196737|FG001|Overall Study|Unable to Come for Visit|3
7084641|NCT02166606|11196746|FG000|Overall Study|Adverse Event|3
7084642|NCT02166606|11196746|FG000|Overall Study|Death|31
7084643|NCT02166606|11196746|FG000|Overall Study|Protocol Violation|7
7084644|NCT02166606|11196746|FG000|Overall Study|Lost to Follow-up|30
7084645|NCT02166606|11196746|FG000|Overall Study|Withdrawal by Subject|1
7084646|NCT02166606|11196746|FG000|Overall Study|Physician Decision|1
7084647|NCT02166606|11196746|FG000|Overall Study|Device upgrade|1
7084648|NCT02166606|11196746|FG000|Overall Study|Enrolled after End of Enrollment|4
7084649|NCT02166697|11196750|FG000|Overall Study|Protocol Violation|347
7084650|NCT02167035|11196756|FG000|Overall Study|Adverse Event|2
7084651|NCT02167035|11196757|FG001|Overall Study|Adverse Event|2
7084652|NCT02167035|11196756|FG000|Overall Study|Lost to Follow-up|3
7084653|NCT02167035|11196757|FG001|Overall Study|Lost to Follow-up|3
7084654|NCT02167035|11196756|FG000|Overall Study|Randomized to incorrect Study Medication|0
7084655|NCT02167035|11196757|FG001|Overall Study|Randomized to incorrect Study Medication|1
6804838|NCT01437111|10806884|FG000|Overall Study|Lost to Follow-up|5
6804839|NCT01437111|10806884|FG000|Overall Study|Protocol Violation|1
6804840|NCT01004263|10806921|FG000|Overall Study|Adverse Event|15
6804841|NCT01004263|10806921|FG000|Overall Study|Withdrawal by Subject|58
6804842|NCT01004263|10806921|FG000|Overall Study|Protocol Violation|10
6804843|NCT01004263|10806921|FG000|Overall Study|Lost to Follow-up|64
6804844|NCT01004263|10806921|FG000|Overall Study|Lack of Efficacy|13
6804845|NCT01004263|10806921|FG000|Overall Study|Pregnancy|2
6804846|NCT01004263|10806921|FG000|Overall Study|Physician Decision|15
6804847|NCT01004263|10806921|FG000|Overall Study|Lack of Qualifying Event|2
6804848|NCT01001234|10806930|FG000|Overall Study|Withdrawal by Subject|2
6804849|NCT01001234|10806931|FG001|Overall Study|Withdrawal by Subject|0
6804850|NCT01001234|10806932|FG002|Overall Study|Withdrawal by Subject|3
6804851|NCT01001234|10806933|FG003|Overall Study|Withdrawal by Subject|0
6804852|NCT01001234|10806934|FG004|Overall Study|Withdrawal by Subject|0
6804853|NCT01001234|10806930|FG000|Overall Study|Protocol Violation|34
6804854|NCT01001234|10806931|FG001|Overall Study|Protocol Violation|3
6804855|NCT01001234|10806932|FG002|Overall Study|Protocol Violation|19
6804856|NCT01001234|10806933|FG003|Overall Study|Protocol Violation|18
6804857|NCT01001234|10806934|FG004|Overall Study|Protocol Violation|0
6804858|NCT01001234|10806930|FG000|Overall Study|Lost to Follow-up|0
6804859|NCT01001234|10806931|FG001|Overall Study|Lost to Follow-up|0
7053253|NCT01844115|11144872|FG000|Overall Study|Lack of Efficacy|1
7053254|NCT01844115|11144873|FG001|Overall Study|Lack of Efficacy|4
7053255|NCT01844115|11144872|FG000|Overall Study|Protocol Violation|12
7053256|NCT01844115|11144873|FG001|Overall Study|Protocol Violation|10
7053257|NCT01844115|11144872|FG000|Overall Study|Withdrawal by Subject|11
7053258|NCT01844115|11144873|FG001|Overall Study|Withdrawal by Subject|11
7053259|NCT01844115|11144872|FG000|Overall Study|Lost to Follow-up|11
7053260|NCT01844115|11144873|FG001|Overall Study|Lost to Follow-up|10
7053261|NCT01844115|11144872|FG000|Overall Study|Pregnancy|0
7053262|NCT01844115|11144873|FG001|Overall Study|Pregnancy|1
6804860|NCT01001234|10806932|FG002|Overall Study|Lost to Follow-up|1
6804861|NCT01001234|10806933|FG003|Overall Study|Lost to Follow-up|2
6804862|NCT01001234|10806934|FG004|Overall Study|Lost to Follow-up|0
7053263|NCT01844284|11144890|FG000|Overall Study|Lost to Follow-up|12
7053264|NCT01844284|11144891|FG001|Overall Study|Lost to Follow-up|7
7053265|NCT01844375|11144899|FG000|Overall Study|Protocol Violation|1
7053266|NCT01844375|11144900|FG001|Overall Study|Protocol Violation|1
7053267|NCT01844531|11144927|FG000|Overall Study|Withdrawal by Subject|0
7053268|NCT01844531|11144928|FG001|Overall Study|Withdrawal by Subject|1
7053269|NCT01844531|11144929|FG002|Overall Study|Withdrawal by Subject|0
7053270|NCT01844531|11144930|FG003|Overall Study|Withdrawal by Subject|0
7053271|NCT01844583|11144942|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8
7053272|NCT01844583|11144943|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10
7053273|NCT01844687|11144954|FG000|Visit 1|Protocol Violation|3
7053274|NCT01844687|11144954|FG000|Visit 1|Lost to Follow-up|5
7053275|NCT01844687|11144954|FG000|Visit 2|Withdrawal by Subject|1
7053276|NCT01844687|11144954|FG000|Visit 2|Protocol Violation|1
6804863|NCT01001234|10806930|FG000|Overall Study|Physician Decision|1
6804864|NCT01001234|10806931|FG001|Overall Study|Physician Decision|0
6804865|NCT01001234|10806932|FG002|Overall Study|Physician Decision|0
7053277|NCT01844687|11144954|FG000|Visit 3|Lost to Follow-up|1
7053278|NCT01844687|11144954|FG000|Visit 3|Withdrawal by Subject|3
7053279|NCT01844687|11144954|FG000|Visit 3|child care problems|1
7053280|NCT01844687|11144954|FG000|Visit 4|Pregnancy|1
7053281|NCT01844687|11144954|FG000|Visit 4|Lost to Follow-up|1
7053282|NCT01844687|11144954|FG000|Visit 4|Withdrawal by Subject|2
7053283|NCT01844700|11144978|FG000|Overall Study|Lack of Efficacy|1
7053284|NCT01844700|11144979|FG001|Overall Study|Lack of Efficacy|0
7053285|NCT01844700|11144978|FG000|Overall Study|refused medication switch|1
7053286|NCT01844700|11144979|FG001|Overall Study|refused medication switch|0
7053287|NCT01844700|11144978|FG000|Overall Study|Withdrawal by Subject|1
7053288|NCT01844700|11144979|FG001|Overall Study|Withdrawal by Subject|0
7053289|NCT01844700|11144978|FG000|Overall Study|stopped taking meds|0
7053290|NCT01844700|11144979|FG001|Overall Study|stopped taking meds|1
7053291|NCT01844765|11144987|FG000|Overall Study|Adverse Event|6
7053292|NCT01844765|11144988|FG001|Overall Study|Adverse Event|8
7053293|NCT01844765|11144987|FG000|Overall Study|Withdrawal by Subject|2
7053294|NCT01844765|11144988|FG001|Overall Study|Withdrawal by Subject|3
7053295|NCT01844765|11144987|FG000|Overall Study|Disease progression|1
7053296|NCT01844765|11144988|FG001|Overall Study|Disease progression|0
7053297|NCT01844765|11144987|FG000|Overall Study|Administrative problems|3
7053298|NCT01844765|11144988|FG001|Overall Study|Administrative problems|4
7053299|NCT01844765|11144987|FG000|Overall Study|Protocol deviation|2
7053300|NCT01844765|11144988|FG001|Overall Study|Protocol deviation|0
7053301|NCT01844765|11144987|FG000|Overall Study|Untreated|1
7053302|NCT01844765|11144988|FG001|Overall Study|Untreated|0
7053303|NCT01844778|11145002|FG000|Overall Study|Protocol deviation|0
7053304|NCT01844778|11145003|FG001|Overall Study|Protocol deviation|1
7053305|NCT01844778|11145004|FG002|Overall Study|Protocol deviation|2
7053306|NCT01844778|11145002|FG000|Overall Study|Withdrawal by Subject|2
7053307|NCT01844778|11145003|FG001|Overall Study|Withdrawal by Subject|0
7053308|NCT01844778|11145004|FG002|Overall Study|Withdrawal by Subject|0
7053309|NCT01844778|11145002|FG000|Overall Study|Adverse Event|0
7053310|NCT01844778|11145003|FG001|Overall Study|Adverse Event|2
7053311|NCT01844778|11145004|FG002|Overall Study|Adverse Event|2
7053312|NCT01844817|11145018|FG000|Enrolled and Randomized|Withdrawal by Subject|2
7053313|NCT01844817|11145019|FG001|Enrolled and Randomized|Withdrawal by Subject|3
7053314|NCT01844817|11145018|FG000|Treatment|Progressive Disease|27
7053315|NCT01844817|11145019|FG001|Treatment|Progressive Disease|36
7053316|NCT01844817|11145018|FG000|Treatment|Adverse Event|17
7053317|NCT01844817|11145019|FG001|Treatment|Adverse Event|9
7053318|NCT01844817|11145018|FG000|Treatment|Withdrawal by Subject|10
7053319|NCT01844817|11145019|FG001|Treatment|Withdrawal by Subject|6
7053320|NCT01844817|11145018|FG000|Treatment|Death|10
7053321|NCT01844817|11145019|FG001|Treatment|Death|8
7053322|NCT01844817|11145018|FG000|Treatment|Lost to Follow-up|0
7053323|NCT01844817|11145019|FG001|Treatment|Lost to Follow-up|1
7053324|NCT01844817|11145018|FG000|Treatment|Other|0
7053325|NCT01844817|11145019|FG001|Treatment|Other|3
7053326|NCT01844830|11145028|FG000|Overall Study|Withdrawal by Subject|1
7053327|NCT01844830|11145029|FG001|Overall Study|Withdrawal by Subject|0
7053328|NCT01844895|11145035|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1
7053329|NCT01844895|11145035|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1
7053330|NCT01844895|11145035|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1
7053331|NCT01844895|11145035|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1
7053332|NCT01844895|11145035|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1
7053333|NCT01844895|11145035|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3
7053334|NCT01844895|11145035|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1
6804866|NCT01001234|10806933|FG003|Overall Study|Physician Decision|0
6804867|NCT01001234|10806934|FG004|Overall Study|Physician Decision|0
7053335|NCT01845025|11145050|FG000|Overall Study|Adverse Event|6
7053336|NCT01845025|11145051|FG001|Overall Study|Adverse Event|3
7053337|NCT01845025|11145050|FG000|Overall Study|Unsatisfactory therapeutic effect|4
7053338|NCT01845025|11145051|FG001|Overall Study|Unsatisfactory therapeutic effect|2
7053339|NCT01845025|11145050|FG000|Overall Study|Withdrawal by Subject|48
7053340|NCT01845025|11145051|FG001|Overall Study|Withdrawal by Subject|44
7053341|NCT01845025|11145050|FG000|Overall Study|Lost to Follow-up|13
7053342|NCT01845025|11145051|FG001|Overall Study|Lost to Follow-up|13
7053343|NCT01845025|11145050|FG000|Overall Study|Administrative problems|8
7053344|NCT01845025|11145051|FG001|Overall Study|Administrative problems|8
6804868|NCT01001234|10806930|FG000|Overall Study|Not Treated: Adverse Event|1
7053345|NCT01845025|11145050|FG000|Overall Study|Death|2
7053346|NCT01845025|11145051|FG001|Overall Study|Death|0
7053347|NCT01845025|11145050|FG000|Overall Study|Protocol deviation|3
7053348|NCT01845025|11145051|FG001|Overall Study|Protocol deviation|6
7053349|NCT01845025|11145050|FG000|Overall Study|Missing|1
7053350|NCT01845025|11145051|FG001|Overall Study|Missing|1
7053351|NCT01845077|11145060|FG000|Washout Period|Lost to Follow-up|0
7053352|NCT01845077|11145061|FG001|Washout Period|Lost to Follow-up|1
7053353|NCT01845077|11145062|FG002|Washout Period|Lost to Follow-up|0
7053354|NCT01845077|11145063|FG003|Washout Period|Lost to Follow-up|1
7053355|NCT01845077|11145064|FG004|Washout Period|Lost to Follow-up|0
7053356|NCT01845077|11145065|FG005|Washout Period|Lost to Follow-up|1
7053357|NCT01845077|11145060|FG000|Washout Period|Adverse Event|1
7053358|NCT01845077|11145061|FG001|Washout Period|Adverse Event|0
7053359|NCT01845077|11145062|FG002|Washout Period|Adverse Event|0
7053360|NCT01845077|11145063|FG003|Washout Period|Adverse Event|0
7053361|NCT01845077|11145064|FG004|Washout Period|Adverse Event|0
7053362|NCT01845077|11145065|FG005|Washout Period|Adverse Event|0
7053363|NCT01845077|11145060|FG000|Washout Period|elevated lab values (not clinic. sign.)|0
7053364|NCT01845077|11145061|FG001|Washout Period|elevated lab values (not clinic. sign.)|0
7053365|NCT01845077|11145062|FG002|Washout Period|elevated lab values (not clinic. sign.)|1
7053366|NCT01845077|11145063|FG003|Washout Period|elevated lab values (not clinic. sign.)|0
7053367|NCT01845077|11145064|FG004|Washout Period|elevated lab values (not clinic. sign.)|0
7053368|NCT01845077|11145065|FG005|Washout Period|elevated lab values (not clinic. sign.)|0
7053369|NCT01845077|11145060|FG000|Washout Period|Protocol Violation|0
7053370|NCT01845077|11145061|FG001|Washout Period|Protocol Violation|0
7053371|NCT01845077|11145062|FG002|Washout Period|Protocol Violation|0
7053372|NCT01845077|11145063|FG003|Washout Period|Protocol Violation|1
7053373|NCT01845077|11145064|FG004|Washout Period|Protocol Violation|1
7053374|NCT01845077|11145065|FG005|Washout Period|Protocol Violation|0
7053375|NCT01845818|11145115|FG000|Overall Study|Withdrawal by Subject|0
7053376|NCT01845818|11145116|FG001|Overall Study|Withdrawal by Subject|1
7053377|NCT01845818|11145115|FG000|Overall Study|Lost to Follow-up|7
7053378|NCT01845818|11145116|FG001|Overall Study|Lost to Follow-up|5
7053379|NCT01845818|11145115|FG000|Overall Study|Administrative Reasons|3
7053380|NCT01845818|11145116|FG001|Overall Study|Administrative Reasons|1
7053381|NCT01845818|11145115|FG000|Overall Study|Serious Adverse Event|1
7053382|NCT01845818|11145116|FG001|Overall Study|Serious Adverse Event|1
7053383|NCT01845818|11145115|FG000|Overall Study|Other|25
7053384|NCT01845818|11145116|FG001|Overall Study|Other|8
7053385|NCT01845818|11145115|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5
7053386|NCT01845818|11145116|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0
7053387|NCT01845818|11145115|FG000|Overall Study|No Follow-Up Data Available|4
7053388|NCT01845818|11145116|FG001|Overall Study|No Follow-Up Data Available|1
7053389|NCT01845831|11145126|FG000|Inpatient Phase|Withdrawal by Subject|1
7053390|NCT01845831|11145127|FG001|Inpatient Phase|Withdrawal by Subject|1
7053391|NCT01845831|11145128|FG002|Inpatient Phase|Withdrawal by Subject|0
7053392|NCT01845831|11145129|FG003|Inpatient Phase|Withdrawal by Subject|0
7053393|NCT01845831|11145130|FG004|Inpatient Phase|Withdrawal by Subject|0
7053394|NCT01845974|11145143|FG000|Overall Study|screen failure|1
7053395|NCT01845974|11145144|FG001|Overall Study|screen failure|0
7053396|NCT01846039|11145150|FG000|Overall Study|Protocol Violation|1
7053397|NCT01846039|11145150|FG000|Overall Study|Subject Withdrew Consent|1
7053398|NCT01846104|11145154|FG000|Overall Study|Withdrawal by Subject|1
7053399|NCT01846208|11145161|FG000|Overall Study|Withdrew prior to treatment|1
7053400|NCT01846208|11145162|FG001|Overall Study|Withdrew prior to treatment|1
7053401|NCT01846208|11145163|FG002|Overall Study|Withdrew prior to treatment|1
7053402|NCT01846208|11145161|FG000|Overall Study|Dosing Symptoms|1
7053403|NCT01846208|11145162|FG001|Overall Study|Dosing Symptoms|2
7053404|NCT01846208|11145163|FG002|Overall Study|Dosing Symptoms|6
7053405|NCT01846208|11145161|FG000|Overall Study|Withdrawal by Subject|5
7053406|NCT01846208|11145162|FG001|Overall Study|Withdrawal by Subject|0
7053407|NCT01846208|11145163|FG002|Overall Study|Withdrawal by Subject|0
7053408|NCT01846208|11145161|FG000|Overall Study|Non-compliance|1
7053409|NCT01846208|11145162|FG001|Overall Study|Non-compliance|1
7053410|NCT01846208|11145163|FG002|Overall Study|Non-compliance|0
7053411|NCT01846208|11145161|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1
7053412|NCT01846208|11145162|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0
7053413|NCT01846208|11145163|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0
7053414|NCT01846208|11145161|FG000|Overall Study|Refused SU OFC|0
7053415|NCT01846208|11145162|FG001|Overall Study|Refused SU OFC|0
7053416|NCT01846208|11145163|FG002|Overall Study|Refused SU OFC|1
7053417|NCT01846221|11145173|FG000|Overall Study|Catheter Failure|2
7053418|NCT01846221|11145174|FG001|Overall Study|Catheter Failure|0
7053419|NCT01846221|11145173|FG000|Overall Study|Age Exclusion|1
7053420|NCT01846221|11145174|FG001|Overall Study|Age Exclusion|0
7053421|NCT01846299|11145182|FG000|Overall Study|Physician Decision|4
7053422|NCT01846299|11145183|FG001|Overall Study|Physician Decision|2
7053423|NCT01846299|11145182|FG000|Overall Study|Protocol deviation|1
7053424|NCT01846299|11145183|FG001|Overall Study|Protocol deviation|0
7053425|NCT01846299|11145182|FG000|Overall Study|Death|1
7053426|NCT01846299|11145183|FG001|Overall Study|Death|2
7053427|NCT01846299|11145182|FG000|Overall Study|Lost to Follow-up|3
7053428|NCT01846299|11145183|FG001|Overall Study|Lost to Follow-up|0
7053429|NCT01846299|11145182|FG000|Overall Study|Withdrawal by Subject|1
7053430|NCT01846299|11145183|FG001|Overall Study|Withdrawal by Subject|6
7053431|NCT01846299|11145182|FG000|Overall Study|Adverse Event|2
7053432|NCT01846299|11145183|FG001|Overall Study|Adverse Event|0
7053433|NCT01846416|11145194|FG000|Treatment Phase|Death|2
7053434|NCT01846416|11145195|FG001|Treatment Phase|Death|9
7053435|NCT01846416|11145196|FG002|Treatment Phase|Death|1
7053436|NCT01846416|11145194|FG000|Treatment Phase|Withdrawal by Subject|2
7053437|NCT01846416|11145195|FG001|Treatment Phase|Withdrawal by Subject|4
7053438|NCT01846416|11145196|FG002|Treatment Phase|Withdrawal by Subject|2
7053439|NCT01846416|11145194|FG000|Treatment Phase|Other|1
7084656|NCT02167139|11196776|FG000|Randomised, Double-blind|Withdrawal by Subject|11
7053440|NCT01846416|11145195|FG001|Treatment Phase|Other|5
7053441|NCT01846416|11145196|FG002|Treatment Phase|Other|1
7053442|NCT01846416|11145194|FG000|Treatment Phase|Physician Decision|1
7053443|NCT01846416|11145195|FG001|Treatment Phase|Physician Decision|2
7053444|NCT01846416|11145196|FG002|Treatment Phase|Physician Decision|0
7053445|NCT01846416|11145194|FG000|Treatment Phase|Adverse Event|3
7053446|NCT01846416|11145195|FG001|Treatment Phase|Adverse Event|4
7053447|NCT01846416|11145196|FG002|Treatment Phase|Adverse Event|0
7053448|NCT01846416|11145194|FG000|Treatment Phase|Non-compliance|0
7053449|NCT01846416|11145195|FG001|Treatment Phase|Non-compliance|2
7053450|NCT01846416|11145196|FG002|Treatment Phase|Non-compliance|0
7053451|NCT01846416|11145194|FG000|Treatment Phase|Study Terminated by Sponsor|1
7053452|NCT01846416|11145195|FG001|Treatment Phase|Study Terminated by Sponsor|4
7053453|NCT01846416|11145196|FG002|Treatment Phase|Study Terminated by Sponsor|0
7053454|NCT01846416|11145194|FG000|Treatment Phase|Progressive Disease|21
7053455|NCT01846416|11145195|FG001|Treatment Phase|Progressive Disease|63
7053456|NCT01846416|11145196|FG002|Treatment Phase|Progressive Disease|9
7053457|NCT01846416|11145194|FG000|Survival Follow-up|Death|21
7053458|NCT01846416|11145195|FG001|Survival Follow-up|Death|62
7053459|NCT01846416|11145196|FG002|Survival Follow-up|Death|9
7053460|NCT01846416|11145194|FG000|Survival Follow-up|Lost to Follow-up|0
7053461|NCT01846416|11145195|FG001|Survival Follow-up|Lost to Follow-up|2
7053462|NCT01846416|11145196|FG002|Survival Follow-up|Lost to Follow-up|2
7053463|NCT01846416|11145194|FG000|Survival Follow-up|Withdrawal by Subject|2
7053464|NCT01846416|11145195|FG001|Survival Follow-up|Withdrawal by Subject|7
7053465|NCT01846416|11145196|FG002|Survival Follow-up|Withdrawal by Subject|0
7053466|NCT01846416|11145194|FG000|Survival Follow-up|Study Terminated by Sponsor|2
7053467|NCT01846416|11145195|FG001|Survival Follow-up|Study Terminated by Sponsor|8
7053468|NCT01846416|11145196|FG002|Survival Follow-up|Study Terminated by Sponsor|0
7053469|NCT01846416|11145194|FG000|Survival Follow-up|Other|3
7053470|NCT01846416|11145195|FG001|Survival Follow-up|Other|1
7053471|NCT01846416|11145196|FG002|Survival Follow-up|Other|1
7053472|NCT01846442|11145209|FG000|Overall Study|Adverse Event|2
7053473|NCT01846442|11145210|FG001|Overall Study|Adverse Event|4
7053474|NCT01846442|11145211|FG002|Overall Study|Adverse Event|2
7053475|NCT01846442|11145212|FG003|Overall Study|Adverse Event|1
7053476|NCT01846442|11145209|FG000|Overall Study|Lost to Follow-up|0
7053477|NCT01846442|11145210|FG001|Overall Study|Lost to Follow-up|0
7053478|NCT01846442|11145211|FG002|Overall Study|Lost to Follow-up|1
7053479|NCT01846442|11145212|FG003|Overall Study|Lost to Follow-up|0
7053480|NCT01846442|11145209|FG000|Overall Study|Withdrawal by Subject|3
7053481|NCT01846442|11145210|FG001|Overall Study|Withdrawal by Subject|2
7053482|NCT01846442|11145211|FG002|Overall Study|Withdrawal by Subject|0
6804869|NCT01001234|10806931|FG001|Overall Study|Not Treated: Adverse Event|0
6804870|NCT01001234|10806932|FG002|Overall Study|Not Treated: Adverse Event|0
6804871|NCT01001234|10806933|FG003|Overall Study|Not Treated: Adverse Event|0
6804872|NCT01001234|10806934|FG004|Overall Study|Not Treated: Adverse Event|0
6804873|NCT01001234|10806930|FG000|Overall Study|Not Treated: Withdrawal by Subject|23
6804874|NCT01001234|10806931|FG001|Overall Study|Not Treated: Withdrawal by Subject|2
6804875|NCT01001234|10806932|FG002|Overall Study|Not Treated: Withdrawal by Subject|2
6804876|NCT01001234|10806933|FG003|Overall Study|Not Treated: Withdrawal by Subject|0
6804877|NCT01001234|10806934|FG004|Overall Study|Not Treated: Withdrawal by Subject|0
6804878|NCT01001234|10806930|FG000|Overall Study|Not Treated: Protocol Violation|3
6804879|NCT01001234|10806931|FG001|Overall Study|Not Treated: Protocol Violation|0
6804880|NCT01001234|10806932|FG002|Overall Study|Not Treated: Protocol Violation|0
6804881|NCT01001234|10806933|FG003|Overall Study|Not Treated: Protocol Violation|0
6804882|NCT01001234|10806934|FG004|Overall Study|Not Treated: Protocol Violation|0
6804883|NCT01001234|10806930|FG000|Overall Study|Not Treated: Lost to Follow-up|53
6804884|NCT01001234|10806931|FG001|Overall Study|Not Treated: Lost to Follow-up|4
6804885|NCT01001234|10806932|FG002|Overall Study|Not Treated: Lost to Follow-up|7
7053483|NCT01846442|11145212|FG003|Overall Study|Withdrawal by Subject|1
7053484|NCT01846442|11145209|FG000|Overall Study|Left the city/Lost medication|1
7053485|NCT01846442|11145210|FG001|Overall Study|Left the city/Lost medication|0
7053486|NCT01846442|11145211|FG002|Overall Study|Left the city/Lost medication|1
7053487|NCT01846442|11145212|FG003|Overall Study|Left the city/Lost medication|1
7053488|NCT01846507|11145252|FG000|Overall Study|Lost to Follow-up|4
7053489|NCT01846507|11145252|FG000|Overall Study|Protocol Violation|1
7053490|NCT01846507|11145252|FG000|Overall Study|Missing data|2
7053491|NCT01846611|11145260|FG000|Overall Study|Lost to Follow-up|4
7053492|NCT01846611|11145261|FG001|Overall Study|Lost to Follow-up|6
7053493|NCT01846611|11145260|FG000|Overall Study|Withdrawal by Subject|15
7053494|NCT01846611|11145261|FG001|Overall Study|Withdrawal by Subject|19
7053495|NCT01846611|11145260|FG000|Overall Study|Other|19
7053496|NCT01846611|11145261|FG001|Overall Study|Other|18
7053497|NCT01846624|11145267|FG000|Overall Study|Died during induction, no midostaurin|1
7053498|NCT01846741|11145312|FG000|Baseline Visit|Subject did not meet entry criteria|2
7053499|NCT01847092|11145401|FG000|Overall Study|Adverse Event|12
7053500|NCT01847092|11145402|FG001|Overall Study|Adverse Event|3
7053501|NCT01847092|11145401|FG000|Overall Study|Withdrawal by Subject|5
7053502|NCT01847092|11145402|FG001|Overall Study|Withdrawal by Subject|5
7053503|NCT01847092|11145401|FG000|Overall Study|Protocol Specified|8
7053504|NCT01847092|11145402|FG001|Overall Study|Protocol Specified|0
7053505|NCT01847092|11145401|FG000|Overall Study|Physician Decision|1
7053506|NCT01847092|11145402|FG001|Overall Study|Physician Decision|1
7053507|NCT01847092|11145401|FG000|Overall Study|Protocol Violation|0
7053508|NCT01847092|11145402|FG001|Overall Study|Protocol Violation|2
7053509|NCT01847209|11145421|FG000|Overall Study|Withdrawal by Subject|1
7053510|NCT01847209|11145421|FG000|Overall Study|No lung nodule found on intraop CT scan|1
7053511|NCT01847313|11145427|FG000|Overall Study|Death|0
7053512|NCT01847313|11145428|FG001|Overall Study|Death|1
7053513|NCT01847313|11145427|FG000|Overall Study|Withdrawal by Subject|0
7053514|NCT01847313|11145428|FG001|Overall Study|Withdrawal by Subject|1
7084657|NCT02167139|11196777|FG001|Randomised, Double-blind|Withdrawal by Subject|8
7084658|NCT02167139|11196778|FG002|Randomised, Double-blind|Withdrawal by Subject|0
7084659|NCT02167139|11196779|FG003|Randomised, Double-blind|Withdrawal by Subject|0
7084660|NCT02167139|11196776|FG000|Randomised, Double-blind|Adverse Event|2
7084661|NCT02167139|11196777|FG001|Randomised, Double-blind|Adverse Event|9
7084662|NCT02167139|11196778|FG002|Randomised, Double-blind|Adverse Event|0
7084663|NCT02167139|11196779|FG003|Randomised, Double-blind|Adverse Event|0
7084664|NCT02167139|11196776|FG000|Randomised, Double-blind|Lack of Efficacy|1
7084665|NCT02167139|11196777|FG001|Randomised, Double-blind|Lack of Efficacy|2
7084666|NCT02167139|11196778|FG002|Randomised, Double-blind|Lack of Efficacy|0
7084667|NCT02167139|11196779|FG003|Randomised, Double-blind|Lack of Efficacy|0
7084668|NCT02167139|11196776|FG000|Randomised, Double-blind|Other|3
7084669|NCT02167139|11196777|FG001|Randomised, Double-blind|Other|0
7084670|NCT02167139|11196778|FG002|Randomised, Double-blind|Other|0
7084671|NCT02167139|11196779|FG003|Randomised, Double-blind|Other|0
7084672|NCT02167139|11196776|FG000|Transition-extension|Adverse Event|2
7084673|NCT02167139|11196777|FG001|Transition-extension|Adverse Event|0
7084674|NCT02167139|11196778|FG002|Transition-extension|Adverse Event|2
7084675|NCT02167139|11196779|FG003|Transition-extension|Adverse Event|3
7084676|NCT02167139|11196776|FG000|Transition-extension|Withdrawal by Subject|2
7084677|NCT02167139|11196777|FG001|Transition-extension|Withdrawal by Subject|0
7084678|NCT02167139|11196778|FG002|Transition-extension|Withdrawal by Subject|4
6804886|NCT01001234|10806933|FG003|Overall Study|Not Treated: Lost to Follow-up|5
7084679|NCT02167139|11196779|FG003|Transition-extension|Withdrawal by Subject|1
7084680|NCT02167139|11196776|FG000|Transition-extension|Lack of Efficacy|0
7084681|NCT02167139|11196777|FG001|Transition-extension|Lack of Efficacy|0
7053515|NCT01847443|11145438|FG000|Study Period 1|Withdrawal by Subject|0
7053516|NCT01847443|11145439|FG001|Study Period 1|Withdrawal by Subject|1
7053517|NCT01847443|11145440|FG002|Study Period 1|Withdrawal by Subject|0
7084682|NCT02167139|11196778|FG002|Transition-extension|Lack of Efficacy|1
7084683|NCT02167139|11196779|FG003|Transition-extension|Lack of Efficacy|1
7084684|NCT02167139|11196776|FG000|Transition-extension|Other|1
7084685|NCT02167139|11196777|FG001|Transition-extension|Other|0
7084686|NCT02167139|11196778|FG002|Transition-extension|Other|1
7084687|NCT02167139|11196779|FG003|Transition-extension|Other|0
7084688|NCT02167139|11196776|FG000|Transition-extension|Lost to Follow-up|1
7084689|NCT02167139|11196777|FG001|Transition-extension|Lost to Follow-up|0
7084690|NCT02167139|11196778|FG002|Transition-extension|Lost to Follow-up|0
7084691|NCT02167139|11196779|FG003|Transition-extension|Lost to Follow-up|0
7084692|NCT02167256|11196809|FG000|Overall Study|Adverse Event|13
7084693|NCT02167256|11196810|FG001|Overall Study|Adverse Event|6
7084694|NCT02167256|11196809|FG000|Overall Study|Withdrawal by Subject|4
7084695|NCT02167256|11196810|FG001|Overall Study|Withdrawal by Subject|4
7084696|NCT02167256|11196809|FG000|Overall Study|non-compliance|3
7084697|NCT02167256|11196810|FG001|Overall Study|non-compliance|0
7053518|NCT01847443|11145441|FG003|Study Period 1|Withdrawal by Subject|0
7053519|NCT01847443|11145438|FG000|Washout Period Before Study Period 2|Adverse Event|1
7053520|NCT01847443|11145439|FG001|Washout Period Before Study Period 2|Adverse Event|1
7053521|NCT01847443|11145440|FG002|Washout Period Before Study Period 2|Adverse Event|0
7053522|NCT01847443|11145441|FG003|Washout Period Before Study Period 2|Adverse Event|0
7053523|NCT01847443|11145438|FG000|Washout Period Before Study Period 2|Other reason|1
7053524|NCT01847443|11145439|FG001|Washout Period Before Study Period 2|Other reason|0
7053525|NCT01847443|11145440|FG002|Washout Period Before Study Period 2|Other reason|0
7053526|NCT01847443|11145441|FG003|Washout Period Before Study Period 2|Other reason|0
7053527|NCT01847443|11145438|FG000|Washout Period Before Study Period 3|Other reason|1
7084698|NCT02167256|11196809|FG000|Overall Study|Study partner unable to participate|1
7084699|NCT02167256|11196810|FG001|Overall Study|Study partner unable to participate|0
7084700|NCT02167451|11196816|FG000|Overall Study|Withdrawal by Subject|1
7084701|NCT02167594|11196823|FG000|Overall Study|Withdrawal by Subject|2
6804887|NCT01001234|10806934|FG004|Overall Study|Not Treated: Lost to Follow-up|0
6804888|NCT01001234|10806930|FG000|Overall Study|Not Treated: Pregnancy|3
6804889|NCT01001234|10806931|FG001|Overall Study|Not Treated: Pregnancy|0
6804890|NCT01001234|10806932|FG002|Overall Study|Not Treated: Pregnancy|0
6804891|NCT01001234|10806933|FG003|Overall Study|Not Treated: Pregnancy|0
6804892|NCT01001234|10806934|FG004|Overall Study|Not Treated: Pregnancy|0
7053528|NCT01847443|11145439|FG001|Washout Period Before Study Period 3|Other reason|0
7053529|NCT01847443|11145440|FG002|Washout Period Before Study Period 3|Other reason|0
7053530|NCT01847443|11145441|FG003|Washout Period Before Study Period 3|Other reason|0
7053531|NCT01847443|11145438|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1
7053532|NCT01847443|11145439|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0
7053533|NCT01847443|11145440|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0
7053534|NCT01847443|11145441|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0
7053535|NCT01847443|11145438|FG000|Washout Period Before Study Period 4|Positive alcohol test|1
7053536|NCT01847443|11145439|FG001|Washout Period Before Study Period 4|Positive alcohol test|0
7053537|NCT01847443|11145440|FG002|Washout Period Before Study Period 4|Positive alcohol test|0
7053538|NCT01847443|11145441|FG003|Washout Period Before Study Period 4|Positive alcohol test|0
7053539|NCT01847755|11145542|FG000|Overall Study|Adverse Event|2
7053540|NCT01847755|11145542|FG000|Overall Study|Withdrawal by Subject|2
7053541|NCT01847755|11145542|FG000|Overall Study|Physician Decision|1
7053542|NCT01847885|11145548|FG000|Initial Enrollment (Consented)|Protocol Violation|1
7053543|NCT01847885|11145549|FG001|Initial Enrollment (Consented)|Protocol Violation|0
7053544|NCT01847885|11145550|FG002|Initial Enrollment (Consented)|Protocol Violation|0
7053545|NCT01847885|11145548|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2
7053546|NCT01847885|11145549|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0
7053547|NCT01847885|11145550|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0
7053548|NCT01847885|11145548|FG000|Initial Enrollment (Consented)|Screen failure|39
7053549|NCT01847885|11145549|FG001|Initial Enrollment (Consented)|Screen failure|0
7053550|NCT01847885|11145550|FG002|Initial Enrollment (Consented)|Screen failure|0
7053551|NCT01847885|11145548|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6
7053552|NCT01847885|11145549|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
7053553|NCT01847885|11145550|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
7053554|NCT01847885|11145548|FG000|Randomization|Protocol Violation|0
7053555|NCT01847885|11145549|FG001|Randomization|Protocol Violation|1
7053556|NCT01847885|11145550|FG002|Randomization|Protocol Violation|0
7053557|NCT01847885|11145548|FG000|Randomization|Withdrawal by Subject|0
7053558|NCT01847885|11145549|FG001|Randomization|Withdrawal by Subject|0
7053559|NCT01847885|11145550|FG002|Randomization|Withdrawal by Subject|2
7053560|NCT01847885|11145548|FG000|Randomization|Screen Failure|0
7053561|NCT01847885|11145549|FG001|Randomization|Screen Failure|3
7053562|NCT01847885|11145550|FG002|Randomization|Screen Failure|0
7053563|NCT01848145|11145595|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1
7053564|NCT01848145|11145595|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1
7053565|NCT01848145|11145595|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1
7053566|NCT01848145|11145595|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1
7053567|NCT01848145|11145595|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6
7053568|NCT01848145|11145595|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3
7053569|NCT01848145|11145595|FG000|Subsequent Infusions: Weeks 3-8|Death|1
7053570|NCT01848210|11145620|FG000|Overall Study|Informed Consent Form Withdrawal|28
7053571|NCT01848210|11145621|FG001|Overall Study|Informed Consent Form Withdrawal|24
7053572|NCT01848210|11145620|FG000|Overall Study|Lost to Follow-up|24
7053573|NCT01848210|11145621|FG001|Overall Study|Lost to Follow-up|12
7053574|NCT01848210|11145620|FG000|Overall Study|Protocol Violation|3
7053575|NCT01848210|11145621|FG001|Overall Study|Protocol Violation|5
7053576|NCT01848210|11145620|FG000|Overall Study|Use of Forbidden Drugs|9
6804893|NCT01001234|10806930|FG000|Overall Study|Not Treated: Physician Decision|37
6804894|NCT01001234|10806931|FG001|Overall Study|Not Treated: Physician Decision|4
6804895|NCT01001234|10806932|FG002|Overall Study|Not Treated: Physician Decision|0
7053577|NCT01848210|11145621|FG001|Overall Study|Use of Forbidden Drugs|10
7053578|NCT01848210|11145620|FG000|Overall Study|Impedition Condition|5
7053579|NCT01848210|11145621|FG001|Overall Study|Impedition Condition|9
7053580|NCT01848210|11145620|FG000|Overall Study|Adverse Event|7
7053581|NCT01848210|11145621|FG001|Overall Study|Adverse Event|9
7053582|NCT01848210|11145620|FG000|Overall Study|Discontinuation Criterion|5
7053583|NCT01848210|11145621|FG001|Overall Study|Discontinuation Criterion|7
7053584|NCT01848210|11145620|FG000|Overall Study|Hypesensitivity|1
6804896|NCT01001234|10806933|FG003|Overall Study|Not Treated: Physician Decision|0
6804897|NCT01001234|10806934|FG004|Overall Study|Not Treated: Physician Decision|0
6804898|NCT01001234|10806930|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248
6804899|NCT01001234|10806931|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13
6804900|NCT01001234|10806932|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0
6804901|NCT01001234|10806933|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0
6804902|NCT01001234|10806934|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0
6804903|NCT00924170|10806942|FG000|Overall Study|Refused further treatment|0
6804904|NCT00924170|10806943|FG001|Overall Study|Refused further treatment|1
6804905|NCT00924170|10806942|FG000|Overall Study|Physician Decision|0
6804906|NCT00924170|10806943|FG001|Overall Study|Physician Decision|1
6804907|NCT00924170|10806942|FG000|Overall Study|Progressive disease|3
6804908|NCT00924170|10806943|FG001|Overall Study|Progressive disease|6
6804909|NCT00924170|10806942|FG000|Overall Study|Stopped due to neutralizing antibodies|3
6804910|NCT00924170|10806943|FG001|Overall Study|Stopped due to neutralizing antibodies|0
6804911|NCT00924170|10806942|FG000|Overall Study|Death|1
6804912|NCT00924170|10806943|FG001|Overall Study|Death|0
6804913|NCT00894556|10806958|FG000|Baseline Phase|Did not meet Randomization Criteria|0
6804914|NCT00894556|10806959|FG001|Baseline Phase|Did not meet Randomization Criteria|0
6804915|NCT00894556|10806960|FG002|Baseline Phase|Did not meet Randomization Criteria|0
6804916|NCT00894556|10806961|FG003|Baseline Phase|Did not meet Randomization Criteria|85
6804917|NCT00894556|10806958|FG000|Treatment Phase|Lost to Follow-up|2
6804918|NCT00894556|10806959|FG001|Treatment Phase|Lost to Follow-up|3
6804919|NCT00894556|10806960|FG002|Treatment Phase|Lost to Follow-up|1
6804920|NCT00894556|10806961|FG003|Treatment Phase|Lost to Follow-up|0
6804921|NCT00894556|10806958|FG000|Treatment Phase|Lack of Qualifying Event|2
6804922|NCT00894556|10806959|FG001|Treatment Phase|Lack of Qualifying Event|1
6804923|NCT00894556|10806960|FG002|Treatment Phase|Lack of Qualifying Event|0
6804924|NCT00894556|10806961|FG003|Treatment Phase|Lack of Qualifying Event|0
6804925|NCT00840177|10806971|FG000|Overall Study|Adverse Event|5
6804926|NCT00840177|10806972|FG001|Overall Study|Adverse Event|1
6804927|NCT00840177|10806973|FG002|Overall Study|Adverse Event|1
6804928|NCT00840177|10806971|FG000|Overall Study|Refusal unrelated to adverse events|1
6804929|NCT00840177|10806972|FG001|Overall Study|Refusal unrelated to adverse events|0
6804930|NCT00840177|10806973|FG002|Overall Study|Refusal unrelated to adverse events|1
6804931|NCT00840177|10806971|FG000|Overall Study|Progression/relapse|2
6804932|NCT00840177|10806972|FG001|Overall Study|Progression/relapse|0
6804933|NCT00840177|10806973|FG002|Overall Study|Progression/relapse|0
6804934|NCT00840177|10806971|FG000|Overall Study|Death|4
6804935|NCT00840177|10806972|FG001|Overall Study|Death|5
6804936|NCT00840177|10806973|FG002|Overall Study|Death|5
6804937|NCT00840177|10806971|FG000|Overall Study|not protocol specified|6
6804938|NCT00840177|10806972|FG001|Overall Study|not protocol specified|3
6804939|NCT00840177|10806973|FG002|Overall Study|not protocol specified|0
6804940|NCT00840177|10806971|FG000|Overall Study|Ineligible|0
6804941|NCT00840177|10806972|FG001|Overall Study|Ineligible|0
6804942|NCT00840177|10806973|FG002|Overall Study|Ineligible|3
6804943|NCT00840177|10806971|FG000|Overall Study|Did not start treatment|0
6804944|NCT00840177|10806972|FG001|Overall Study|Did not start treatment|0
7053585|NCT01848210|11145621|FG001|Overall Study|Hypesensitivity|0
7053586|NCT01848210|11145620|FG000|Overall Study|Hepatic Function Alteration|4
7053587|NCT01848210|11145621|FG001|Overall Study|Hepatic Function Alteration|0
7053588|NCT01848210|11145620|FG000|Overall Study|Chronic Venous Insufficiency Course|1
7053589|NCT01848210|11145621|FG001|Overall Study|Chronic Venous Insufficiency Course|2
7053590|NCT01848210|11145620|FG000|Overall Study|Administrative|1
7053591|NCT01848210|11145621|FG001|Overall Study|Administrative|0
7053592|NCT01848288|11145627|FG000|Overall Study|Death|1
7053593|NCT01848288|11145627|FG000|Overall Study|Protocol Violation|1
7053594|NCT01848288|11145627|FG000|Overall Study|Withdrawal by Subject|1
7053595|NCT01848353|11145636|FG000|Phase 1|Withdrawal by Subject|3
7053596|NCT01848353|11145637|FG001|Phase 1|Withdrawal by Subject|1
7053597|NCT01848353|11145638|FG002|Phase 1|Withdrawal by Subject|0
7053598|NCT01848353|11145639|FG003|Phase 1|Withdrawal by Subject|0
7053599|NCT01848353|11145636|FG000|Phase 2|Withdrawal by Subject|3
7053600|NCT01848353|11145637|FG001|Phase 2|Withdrawal by Subject|2
7053601|NCT01848353|11145638|FG002|Phase 2|Withdrawal by Subject|0
6804945|NCT00840177|10806973|FG002|Overall Study|Did not start treatment|1
6804946|NCT00820950|10806986|FG000|Overall Study|Scheduling Conflict|0
6804947|NCT00820950|10806987|FG001|Overall Study|Scheduling Conflict|0
6804948|NCT00820950|10806988|FG002|Overall Study|Scheduling Conflict|0
6804949|NCT00820950|10806989|FG003|Overall Study|Scheduling Conflict|0
6804950|NCT00820950|10806990|FG004|Overall Study|Scheduling Conflict|0
6804951|NCT00820950|10806991|FG005|Overall Study|Scheduling Conflict|0
6804952|NCT00820950|10806992|FG006|Overall Study|Scheduling Conflict|1
6804953|NCT00820950|10806993|FG007|Overall Study|Scheduling Conflict|1
6804954|NCT00820950|10806994|FG008|Overall Study|Scheduling Conflict|0
7053602|NCT01848353|11145639|FG003|Phase 2|Withdrawal by Subject|0
7053603|NCT01848353|11145636|FG000|Phase 3|Withdrawal by Subject|1
7053604|NCT01848353|11145637|FG001|Phase 3|Withdrawal by Subject|1
7053605|NCT01848353|11145638|FG002|Phase 3|Withdrawal by Subject|0
7053606|NCT01848353|11145639|FG003|Phase 3|Withdrawal by Subject|0
7053607|NCT01848457|11145665|FG000|Overall Study|Death|1
7053608|NCT01848457|11145666|FG001|Overall Study|Death|0
7053609|NCT01848457|11145667|FG002|Overall Study|Death|0
7053610|NCT01848457|11145668|FG003|Overall Study|Death|0
7053611|NCT01848483|11145688|FG000|Overall Study|Death|2
7053612|NCT01848483|11145689|FG001|Overall Study|Death|1
7053613|NCT01848483|11145688|FG000|Overall Study|Lost to Follow-up|6
7053614|NCT01848483|11145689|FG001|Overall Study|Lost to Follow-up|8
7053615|NCT01848483|11145688|FG000|Overall Study|Withdrawal by Subject|1
7053616|NCT01848483|11145689|FG001|Overall Study|Withdrawal by Subject|0
7053617|NCT01848483|11145688|FG000|Overall Study|Incarceration|2
7053618|NCT01848483|11145689|FG001|Overall Study|Incarceration|2
7053619|NCT01848756|11145696|FG000|Overall Study|Adverse Event|1
7053620|NCT01848756|11145696|FG000|Overall Study|Withdrawal by Subject|1
7053621|NCT01848756|11145696|FG000|Overall Study|Enrolled in Error|1
7053622|NCT01848834|11145715|FG000|Overall Study|Adverse Event|3
7053623|NCT01848834|11145716|FG001|Overall Study|Adverse Event|11
7053624|NCT01848834|11145717|FG002|Overall Study|Adverse Event|3
7053625|NCT01848834|11145718|FG003|Overall Study|Adverse Event|5
7053626|NCT01848834|11145719|FG004|Overall Study|Adverse Event|9
7053627|NCT01848834|11145715|FG000|Overall Study|Death|2
7053628|NCT01848834|11145716|FG001|Overall Study|Death|11
7053629|NCT01848834|11145717|FG002|Overall Study|Death|1
7053630|NCT01848834|11145718|FG003|Overall Study|Death|8
7053631|NCT01848834|11145719|FG004|Overall Study|Death|27
7053632|NCT01848834|11145715|FG000|Overall Study|Excluded Medication|5
7053633|NCT01848834|11145716|FG001|Overall Study|Excluded Medication|4
7053634|NCT01848834|11145717|FG002|Overall Study|Excluded Medication|3
7053635|NCT01848834|11145718|FG003|Overall Study|Excluded Medication|6
7053636|NCT01848834|11145719|FG004|Overall Study|Excluded Medication|6
7053637|NCT01848834|11145715|FG000|Overall Study|Lost to Follow-up|5
7053638|NCT01848834|11145716|FG001|Overall Study|Lost to Follow-up|5
7053639|NCT01848834|11145717|FG002|Overall Study|Lost to Follow-up|3
7053640|NCT01848834|11145718|FG003|Overall Study|Lost to Follow-up|0
7053641|NCT01848834|11145719|FG004|Overall Study|Lost to Follow-up|3
7053642|NCT01848834|11145715|FG000|Overall Study|Physician Decision|1
7053643|NCT01848834|11145716|FG001|Overall Study|Physician Decision|3
7053644|NCT01848834|11145717|FG002|Overall Study|Physician Decision|4
7053645|NCT01848834|11145718|FG003|Overall Study|Physician Decision|0
7053646|NCT01848834|11145719|FG004|Overall Study|Physician Decision|11
7053647|NCT01848834|11145715|FG000|Overall Study|Protocol Violation|0
7053648|NCT01848834|11145716|FG001|Overall Study|Protocol Violation|0
7053649|NCT01848834|11145717|FG002|Overall Study|Protocol Violation|0
7053650|NCT01848834|11145718|FG003|Overall Study|Protocol Violation|0
7053651|NCT01848834|11145719|FG004|Overall Study|Protocol Violation|1
7053652|NCT01848834|11145715|FG000|Overall Study|Sponsor Decision|1
7053653|NCT01848834|11145716|FG001|Overall Study|Sponsor Decision|1
7053654|NCT01848834|11145717|FG002|Overall Study|Sponsor Decision|0
7053655|NCT01848834|11145718|FG003|Overall Study|Sponsor Decision|1
7053656|NCT01848834|11145719|FG004|Overall Study|Sponsor Decision|1
7053657|NCT01848834|11145715|FG000|Overall Study|Withdrawal by Subject|2
7053658|NCT01848834|11145716|FG001|Overall Study|Withdrawal by Subject|13
7053659|NCT01848834|11145717|FG002|Overall Study|Withdrawal by Subject|10
7053660|NCT01848834|11145718|FG003|Overall Study|Withdrawal by Subject|6
7053661|NCT01848834|11145719|FG004|Overall Study|Withdrawal by Subject|36
7053662|NCT01848938|11145755|FG000|Overall Study|Lost to Follow-up|1
7053663|NCT01848938|11145756|FG001|Overall Study|Lost to Follow-up|1
7053664|NCT01848990|11145774|FG000|Overall Study|Adverse Event|6
7053665|NCT01848990|11145775|FG001|Overall Study|Adverse Event|2
7053666|NCT01848990|11145776|FG002|Overall Study|Adverse Event|0
7053667|NCT01848990|11145774|FG000|Overall Study|Lost to Follow-up|6
7053668|NCT01848990|11145775|FG001|Overall Study|Lost to Follow-up|2
7053669|NCT01848990|11145776|FG002|Overall Study|Lost to Follow-up|2
7053670|NCT01848990|11145774|FG000|Overall Study|Protocol Violation|1
7053671|NCT01848990|11145775|FG001|Overall Study|Protocol Violation|1
7053672|NCT01848990|11145776|FG002|Overall Study|Protocol Violation|0
7053673|NCT01848990|11145774|FG000|Overall Study|Withdrawal by Subject|29
7053674|NCT01848990|11145775|FG001|Overall Study|Withdrawal by Subject|10
7053675|NCT01848990|11145776|FG002|Overall Study|Withdrawal by Subject|11
7053676|NCT01848990|11145774|FG000|Overall Study|Physician Decision|1
7053677|NCT01848990|11145775|FG001|Overall Study|Physician Decision|1
7053678|NCT01848990|11145776|FG002|Overall Study|Physician Decision|0
7053679|NCT01848990|11145774|FG000|Overall Study|Non Compliance|1
7053680|NCT01848990|11145775|FG001|Overall Study|Non Compliance|0
7053681|NCT01848990|11145776|FG002|Overall Study|Non Compliance|0
7053682|NCT01848990|11145774|FG000|Overall Study|Death|1
7053683|NCT01848990|11145775|FG001|Overall Study|Death|0
7053684|NCT01848990|11145776|FG002|Overall Study|Death|1
7053685|NCT01848990|11145774|FG000|Overall Study|Other|1
7053686|NCT01848990|11145775|FG001|Overall Study|Other|4
7053687|NCT01848990|11145776|FG002|Overall Study|Other|2
7053688|NCT01849055|11145794|FG000|Overall Study|Withdrawal by Subject|0
6804955|NCT00820950|10806995|FG009|Overall Study|Scheduling Conflict|0
6804956|NCT00820950|10806986|FG000|Overall Study|Protocol Violation|1
6804957|NCT00820950|10806987|FG001|Overall Study|Protocol Violation|1
6804958|NCT00820950|10806988|FG002|Overall Study|Protocol Violation|0
6804959|NCT00820950|10806989|FG003|Overall Study|Protocol Violation|0
6804960|NCT00820950|10806990|FG004|Overall Study|Protocol Violation|0
6804961|NCT00820950|10806991|FG005|Overall Study|Protocol Violation|0
6804962|NCT00820950|10806992|FG006|Overall Study|Protocol Violation|0
6804963|NCT00820950|10806993|FG007|Overall Study|Protocol Violation|0
6804964|NCT00820950|10806994|FG008|Overall Study|Protocol Violation|0
6804965|NCT00820950|10806995|FG009|Overall Study|Protocol Violation|0
6804966|NCT00806416|10807037|FG000|Period 1 - Part I|Adverse Event|0
6804967|NCT00806416|10807038|FG001|Period 1 - Part I|Adverse Event|1
6804968|NCT00806416|10807039|FG002|Period 1 - Part I|Adverse Event|0
6804969|NCT00806416|10807040|FG003|Period 1 - Part I|Adverse Event|0
6804970|NCT00806416|10807037|FG000|Period 1 - Part I|Lost to Follow-up|0
6804971|NCT00806416|10807038|FG001|Period 1 - Part I|Lost to Follow-up|2
6804972|NCT00806416|10807039|FG002|Period 1 - Part I|Lost to Follow-up|0
6804973|NCT00806416|10807040|FG003|Period 1 - Part I|Lost to Follow-up|0
6804974|NCT00806416|10807037|FG000|Period 1 - Part I|Withdrawal by Subject|3
6804975|NCT00806416|10807038|FG001|Period 1 - Part I|Withdrawal by Subject|1
6804976|NCT00806416|10807039|FG002|Period 1 - Part I|Withdrawal by Subject|0
6804977|NCT00806416|10807040|FG003|Period 1 - Part I|Withdrawal by Subject|0
6804978|NCT00806416|10807037|FG000|Period 1 - Part II|Withdrawal by Subject|0
6804979|NCT00806416|10807038|FG001|Period 1 - Part II|Withdrawal by Subject|0
6804980|NCT00806416|10807039|FG002|Period 1 - Part II|Withdrawal by Subject|0
6804981|NCT00806416|10807040|FG003|Period 1 - Part II|Withdrawal by Subject|2
6804982|NCT00729651|10807050|FG000|Overall Study|Withdrawal by Subject|5
6804983|NCT00729651|10807051|FG001|Overall Study|Withdrawal by Subject|6
6804984|NCT00729651|10807050|FG000|Overall Study|Lost to Follow-up|5
6804985|NCT00729651|10807051|FG001|Overall Study|Lost to Follow-up|4
6804986|NCT00729651|10807050|FG000|Overall Study|Protocol Violation|0
6804987|NCT00729651|10807051|FG001|Overall Study|Protocol Violation|1
6804988|NCT00729651|10807050|FG000|Overall Study|Adverse Event|7
6804989|NCT00729651|10807051|FG001|Overall Study|Adverse Event|3
6804990|NCT00729651|10807050|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0
6804991|NCT00729651|10807051|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4
6804992|NCT00729651|10807050|FG000|Overall Study|Subject's private reason|2
6804993|NCT00729651|10807051|FG001|Overall Study|Subject's private reason|0
6804994|NCT00698815|10807060|FG000|Overall Study|Death|1
6804995|NCT00698815|10807061|FG001|Overall Study|Death|2
6804996|NCT00698815|10807062|FG002|Overall Study|Death|4
6804997|NCT00698815|10807060|FG000|Overall Study|Withdrawal by Subject|6
6804998|NCT00698815|10807061|FG001|Overall Study|Withdrawal by Subject|3
6804999|NCT00698815|10807062|FG002|Overall Study|Withdrawal by Subject|2
6805000|NCT00698815|10807060|FG000|Overall Study|MD discretion|2
6805001|NCT00698815|10807061|FG001|Overall Study|MD discretion|7
6805002|NCT00698815|10807062|FG002|Overall Study|MD discretion|2
6805003|NCT00698815|10807060|FG000|Overall Study|Did not receive protocol treatment|1
6805004|NCT00698815|10807061|FG001|Overall Study|Did not receive protocol treatment|2
6805005|NCT00698815|10807062|FG002|Overall Study|Did not receive protocol treatment|2
6805006|NCT00692913|10807085|FG000|Overall Study|Adverse Event|8
6805007|NCT00692913|10807086|FG001|Overall Study|Adverse Event|4
6805008|NCT00692913|10807085|FG000|Overall Study|Lost to Follow-up|3
6805009|NCT00692913|10807086|FG001|Overall Study|Lost to Follow-up|5
6805010|NCT00692913|10807085|FG000|Overall Study|Physician Decision|2
6805011|NCT00692913|10807086|FG001|Overall Study|Physician Decision|0
6805012|NCT00692913|10807085|FG000|Overall Study|Protocol Violation|1
6805013|NCT00692913|10807086|FG001|Overall Study|Protocol Violation|1
6805014|NCT00692913|10807085|FG000|Overall Study|Withdrawal by Subject|15
6805015|NCT00692913|10807086|FG001|Overall Study|Withdrawal by Subject|20
6805016|NCT00617708|10807132|FG000|Overall Study|Adverse Event|0
6805017|NCT00617708|10807133|FG001|Overall Study|Adverse Event|6
6805018|NCT00617708|10807134|FG002|Overall Study|Adverse Event|9
6805019|NCT00617708|10807132|FG000|Overall Study|Withdrawal by Subject|1
6805020|NCT00617708|10807133|FG001|Overall Study|Withdrawal by Subject|1
6805021|NCT00617708|10807134|FG002|Overall Study|Withdrawal by Subject|7
6805022|NCT00617708|10807132|FG000|Overall Study|Death|0
6805023|NCT00617708|10807133|FG001|Overall Study|Death|6
6805024|NCT00617708|10807134|FG002|Overall Study|Death|5
6805025|NCT00617708|10807132|FG000|Overall Study|Progression/Relapse|7
6805026|NCT00617708|10807133|FG001|Overall Study|Progression/Relapse|40
6805027|NCT00617708|10807134|FG002|Overall Study|Progression/Relapse|36
6805028|NCT00617708|10807132|FG000|Overall Study|Not protocol specified|1
6805029|NCT00617708|10807133|FG001|Overall Study|Not protocol specified|4
6805030|NCT00617708|10807134|FG002|Overall Study|Not protocol specified|2
6805031|NCT00617708|10807132|FG000|Overall Study|Not eligible|1
6805032|NCT00617708|10807133|FG001|Overall Study|Not eligible|3
6805033|NCT00617708|10807134|FG002|Overall Study|Not eligible|5
7053689|NCT01849055|11145795|FG001|Overall Study|Withdrawal by Subject|0
7053690|NCT01849055|11145796|FG002|Overall Study|Withdrawal by Subject|1
7053691|NCT01849055|11145797|FG003|Overall Study|Withdrawal by Subject|0
7053692|NCT01849055|11145798|FG004|Overall Study|Withdrawal by Subject|0
7053693|NCT01849055|11145799|FG005|Overall Study|Withdrawal by Subject|0
7053694|NCT01849276|11145835|FG000|Followed for Survival for 5 Years|Death|1
7053695|NCT01849276|11145835|FG000|Followed for Survival for 5 Years|Early termination of the study|1
7053696|NCT01849289|11145841|FG000|Overall Study|Adverse Event|3
7053697|NCT01849289|11145842|FG001|Overall Study|Adverse Event|3
7053698|NCT01849289|11145841|FG000|Overall Study|Protocol Violation|3
7053699|NCT01849289|11145842|FG001|Overall Study|Protocol Violation|3
7053700|NCT01849289|11145841|FG000|Overall Study|Withdrawal criteria|1
7053701|NCT01849289|11145842|FG001|Overall Study|Withdrawal criteria|0
7053702|NCT01849289|11145841|FG000|Overall Study|Unclassified|25
7053703|NCT01849289|11145842|FG001|Overall Study|Unclassified|18
7053704|NCT01849458|11145853|FG000|Overall Study|Lost to Follow-up|4
7053705|NCT01849497|11145859|FG000|Overall Study|Withdrawal by Subject|1
7053706|NCT01849497|11145860|FG001|Overall Study|Withdrawal by Subject|2
7053707|NCT01849497|11145859|FG000|Overall Study|Sponsor Decision|0
7053708|NCT01849497|11145860|FG001|Overall Study|Sponsor Decision|1
7053709|NCT01849497|11145859|FG000|Overall Study|Lost to Follow-up|0
7053710|NCT01849497|11145860|FG001|Overall Study|Lost to Follow-up|1
7053711|NCT01849562|11145869|FG000|Overall Study|Lost to Follow-up|1
7053712|NCT01849562|11145870|FG001|Overall Study|Lost to Follow-up|0
7053713|NCT01849562|11145871|FG002|Overall Study|Lost to Follow-up|0
7053714|NCT01849562|11145869|FG000|Overall Study|Non-compliance with Study Drug|1
7053715|NCT01849562|11145870|FG001|Overall Study|Non-compliance with Study Drug|0
7053716|NCT01849562|11145871|FG002|Overall Study|Non-compliance with Study Drug|0
7053717|NCT01849588|11145891|FG000|Overall Study|Lack of Efficacy|3
7053718|NCT01849848|11145944|FG000|Overall Study|Physician Decision|1
7053719|NCT01849848|11145944|FG000|Overall Study|Progression of the primary disease|3
7053720|NCT01850030|11145950|FG000|Overall Study|Adverse Event|64
7053721|NCT01850030|11145951|FG001|Overall Study|Adverse Event|82
7053722|NCT01850030|11145950|FG000|Overall Study|Lack of Efficacy|3
7053723|NCT01850030|11145951|FG001|Overall Study|Lack of Efficacy|1
7053724|NCT01850030|11145950|FG000|Overall Study|Lost to Follow-up|5
7053725|NCT01850030|11145951|FG001|Overall Study|Lost to Follow-up|5
7053726|NCT01850030|11145950|FG000|Overall Study|Withdrawal by Subject|3
7053727|NCT01850030|11145951|FG001|Overall Study|Withdrawal by Subject|4
7053728|NCT01850030|11145950|FG000|Overall Study|Protocol Violation|24
7053729|NCT01850030|11145951|FG001|Overall Study|Protocol Violation|28
7053730|NCT01850030|11145950|FG000|Overall Study|pregnancy not confirmed at visit 4|248
7053731|NCT01850030|11145951|FG001|Overall Study|pregnancy not confirmed at visit 4|249
7053732|NCT01850446|11145972|FG000|Overall Study|Lack of Efficacy|1
7053733|NCT01850446|11145973|FG001|Overall Study|Lack of Efficacy|0
7053734|NCT01850446|11145972|FG000|Overall Study|Withdrawal by Subject|4
7053735|NCT01850446|11145973|FG001|Overall Study|Withdrawal by Subject|0
7053736|NCT01850446|11145972|FG000|Overall Study|Protocol Violation|0
7053737|NCT01850446|11145973|FG001|Overall Study|Protocol Violation|2
7053738|NCT01850589|11145999|FG000|Overall Study|Withdrawal by Subject|8
7053739|NCT01850589|11146000|FG001|Overall Study|Withdrawal by Subject|0
7053740|NCT01850602|11146008|FG000|Overall Study|Adverse Event|7
7053741|NCT01850602|11146009|FG001|Overall Study|Adverse Event|10
7053742|NCT01850602|11146008|FG000|Overall Study|Physician Decision|2
7053743|NCT01850602|11146009|FG001|Overall Study|Physician Decision|1
7053744|NCT01850602|11146008|FG000|Overall Study|Withdrawal by Subject|2
7053745|NCT01850602|11146009|FG001|Overall Study|Withdrawal by Subject|4
6805034|NCT00516737|10807146|FG000|Overall Study|Lost to Follow-up|2
7053746|NCT01850602|11146008|FG000|Overall Study|Decrease in serum calcium|2
7053747|NCT01850602|11146009|FG001|Overall Study|Decrease in serum calcium|3
7053748|NCT01850602|11146008|FG000|Overall Study|Increase in serum ferritin|1
7053749|NCT01850602|11146009|FG001|Overall Study|Increase in serum ferritin|0
7053750|NCT01850615|11146017|FG000|Overall Study|Protocol Violation|4
7053751|NCT01850615|11146018|FG001|Overall Study|Protocol Violation|1
7053752|NCT01850615|11146017|FG000|Overall Study|Adverse Event|2
7053753|NCT01850615|11146018|FG001|Overall Study|Adverse Event|1
7053754|NCT01850615|11146017|FG000|Overall Study|Withdrawal by Subject|3
7053755|NCT01850615|11146018|FG001|Overall Study|Withdrawal by Subject|1
7053756|NCT01850615|11146017|FG000|Overall Study|Lost to Follow-up|0
7053757|NCT01850615|11146018|FG001|Overall Study|Lost to Follow-up|1
7053758|NCT01850615|11146017|FG000|Overall Study|Unclassified|0
7053759|NCT01850615|11146018|FG001|Overall Study|Unclassified|1
7053760|NCT01850641|11146024|FG000|Overall Study|Physician Decision|1
7053761|NCT01850641|11146024|FG000|Overall Study|Decrease in serum phosphorus|1
7053762|NCT01850641|11146024|FG000|Overall Study|Decrease in serum calcium|2
7053763|NCT01850641|11146024|FG000|Overall Study|Increase in serum ferritin|1
7053764|NCT01850823|11146044|FG000|Overall Study|Early Visit Window|0
7053765|NCT01850823|11146045|FG001|Overall Study|Early Visit Window|1
7053766|NCT01850823|11146046|FG002|Overall Study|Early Visit Window|4
7053767|NCT01850823|11146044|FG000|Overall Study|Enrolled in Error|0
7053768|NCT01850823|11146045|FG001|Overall Study|Enrolled in Error|1
7053769|NCT01850823|11146046|FG002|Overall Study|Enrolled in Error|2
7053770|NCT01850823|11146044|FG000|Overall Study|Lack of Efficacy|1
7053771|NCT01850823|11146045|FG001|Overall Study|Lack of Efficacy|0
7053772|NCT01850823|11146046|FG002|Overall Study|Lack of Efficacy|0
7053773|NCT01850823|11146044|FG000|Overall Study|Lost to Follow-up|0
7053774|NCT01850823|11146045|FG001|Overall Study|Lost to Follow-up|0
7053775|NCT01850823|11146046|FG002|Overall Study|Lost to Follow-up|1
7053776|NCT01850823|11146044|FG000|Overall Study|Restricted Medication|0
7053777|NCT01850823|11146045|FG001|Overall Study|Restricted Medication|0
7053778|NCT01850823|11146046|FG002|Overall Study|Restricted Medication|2
7053779|NCT01850823|11146044|FG000|Overall Study|Significant worstening of SAR|0
7053780|NCT01850823|11146045|FG001|Overall Study|Significant worstening of SAR|1
6805035|NCT00516737|10807147|FG001|Overall Study|Lost to Follow-up|0
6805036|NCT00516737|10807146|FG000|Overall Study|Physician Decision|0
6805037|NCT00516737|10807147|FG001|Overall Study|Physician Decision|1
6805038|NCT00516737|10807146|FG000|Overall Study|Withdrawal by Subject|0
6805039|NCT00516737|10807147|FG001|Overall Study|Withdrawal by Subject|1
6805040|NCT00516737|10807146|FG000|Overall Study|Lack of Qualifying Event|9
6805041|NCT00516737|10807147|FG001|Overall Study|Lack of Qualifying Event|6
6805042|NCT00358527|10807155|FG000|Overall Study|Adverse Event|4
6805043|NCT00358527|10807156|FG001|Overall Study|Adverse Event|0
6805044|NCT00358527|10807155|FG000|Overall Study|Withdrawal by Subject|1
6805045|NCT00358527|10807156|FG001|Overall Study|Withdrawal by Subject|1
6805046|NCT00358527|10807155|FG000|Overall Study|Non-compliance with protocol|6
6805047|NCT00358527|10807156|FG001|Overall Study|Non-compliance with protocol|1
7053781|NCT01850823|11146046|FG002|Overall Study|Significant worstening of SAR|0
7053782|NCT01850823|11146044|FG000|Overall Study|Withdrawal by Subject|2
7053783|NCT01850823|11146045|FG001|Overall Study|Withdrawal by Subject|0
7053784|NCT01850823|11146046|FG002|Overall Study|Withdrawal by Subject|1
7053785|NCT01851330|11146059|FG000|Overall Study|Lack of Efficacy|10
7053786|NCT01851330|11146060|FG001|Overall Study|Lack of Efficacy|9
7053787|NCT01851330|11146061|FG002|Overall Study|Lack of Efficacy|2
7053788|NCT01851330|11146059|FG000|Overall Study|Lost to Follow-up|1
7053789|NCT01851330|11146060|FG001|Overall Study|Lost to Follow-up|6
7053790|NCT01851330|11146061|FG002|Overall Study|Lost to Follow-up|9
7053791|NCT01851330|11146059|FG000|Overall Study|Withdrew Consent|2
7053792|NCT01851330|11146060|FG001|Overall Study|Withdrew Consent|1
7053793|NCT01851330|11146061|FG002|Overall Study|Withdrew Consent|0
7053794|NCT01851330|11146059|FG000|Overall Study|Investigator's Discretion|0
7053795|NCT01851330|11146060|FG001|Overall Study|Investigator's Discretion|0
7053796|NCT01851330|11146061|FG002|Overall Study|Investigator's Discretion|1
7053797|NCT01851590|11146072|FG000|Overall Study|Withdrawal by Subject|0
7053798|NCT01851590|11146073|FG001|Overall Study|Withdrawal by Subject|0
7053799|NCT01851590|11146074|FG002|Overall Study|Withdrawal by Subject|1
7053800|NCT01851590|11146072|FG000|Overall Study|Adverse Event|0
7053801|NCT01851590|11146073|FG001|Overall Study|Adverse Event|0
7053802|NCT01851590|11146074|FG002|Overall Study|Adverse Event|2
7053803|NCT01851590|11146072|FG000|Overall Study|Lack of Efficacy|0
7053804|NCT01851590|11146073|FG001|Overall Study|Lack of Efficacy|1
7053805|NCT01851590|11146074|FG002|Overall Study|Lack of Efficacy|0
7053806|NCT01851720|11146097|FG000|Overall Study|Lost to Follow-up|0
7053807|NCT01851720|11146098|FG001|Overall Study|Lost to Follow-up|1
7053808|NCT01851863|11146112|FG000|Overall Study|Did not receive study medication|2
7053809|NCT01851863|11146113|FG001|Overall Study|Did not receive study medication|5
7053810|NCT01851863|11146114|FG002|Overall Study|Did not receive study medication|3
7053811|NCT01851863|11146115|FG003|Overall Study|Did not receive study medication|0
7053812|NCT01851863|11146112|FG000|Overall Study|Lost to Follow-up|3
7053813|NCT01851863|11146113|FG001|Overall Study|Lost to Follow-up|4
7053814|NCT01851863|11146114|FG002|Overall Study|Lost to Follow-up|2
7053815|NCT01851863|11146115|FG003|Overall Study|Lost to Follow-up|3
7053816|NCT01852045|11146163|FG000|Overall Study|Adverse Event|1
7053817|NCT01852045|11146164|FG001|Overall Study|Adverse Event|0
7053818|NCT01852045|11146165|FG002|Overall Study|Adverse Event|0
7053819|NCT01852045|11146163|FG000|Overall Study|Lack of Efficacy|3
7053820|NCT01852045|11146164|FG001|Overall Study|Lack of Efficacy|0
7053821|NCT01852045|11146165|FG002|Overall Study|Lack of Efficacy|0
7053822|NCT01852045|11146163|FG000|Overall Study|Lost to Follow-up|0
7053823|NCT01852045|11146164|FG001|Overall Study|Lost to Follow-up|1
7053824|NCT01852045|11146165|FG002|Overall Study|Lost to Follow-up|1
7053825|NCT01852045|11146163|FG000|Overall Study|Withdrawal by Subject|1
7053826|NCT01852045|11146164|FG001|Overall Study|Withdrawal by Subject|0
7053827|NCT01852045|11146165|FG002|Overall Study|Withdrawal by Subject|1
7053828|NCT01852045|11146163|FG000|Overall Study|Other Miscellaneous Reasons|1
7053829|NCT01852045|11146164|FG001|Overall Study|Other Miscellaneous Reasons|3
7053830|NCT01852045|11146165|FG002|Overall Study|Other Miscellaneous Reasons|2
7053831|NCT01852058|11146176|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1
7053832|NCT01852058|11146177|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7053833|NCT01852058|11146178|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7053834|NCT01852058|11146179|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7053835|NCT01852058|11146180|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7053836|NCT01852058|11146181|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7053837|NCT01852058|11146182|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7053838|NCT01852058|11146183|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7053839|NCT01852058|11146184|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7053840|NCT01852058|11146185|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7053841|NCT01852058|11146186|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7053842|NCT01852058|11146187|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7053843|NCT01852058|11146176|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7053844|NCT01852058|11146177|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7053845|NCT01852058|11146178|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7053846|NCT01852058|11146179|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7053847|NCT01852058|11146180|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1
7053848|NCT01852058|11146181|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7053849|NCT01852058|11146182|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7053850|NCT01852058|11146183|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7053851|NCT01852058|11146184|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7053852|NCT01852058|11146185|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7053853|NCT01852058|11146186|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7053854|NCT01852058|11146187|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7053855|NCT01852058|11146176|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7053856|NCT01852058|11146177|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7053857|NCT01852058|11146178|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7053858|NCT01852058|11146179|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7053859|NCT01852058|11146180|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1
7053860|NCT01852058|11146181|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1
7053861|NCT01852058|11146182|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7053862|NCT01852058|11146183|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7053863|NCT01852058|11146184|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7053864|NCT01852058|11146185|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7053865|NCT01852058|11146186|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7053866|NCT01852058|11146187|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7053867|NCT01852058|11146176|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7053868|NCT01852058|11146177|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7053869|NCT01852058|11146178|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7053870|NCT01852058|11146179|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7053871|NCT01852058|11146180|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1
7053872|NCT01852058|11146181|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7053873|NCT01852058|11146182|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7053874|NCT01852058|11146183|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7053875|NCT01852058|11146184|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7053876|NCT01852058|11146185|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7053877|NCT01852058|11146186|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7053878|NCT01852058|11146187|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7053879|NCT01852058|11146176|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7053880|NCT01852058|11146177|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7053881|NCT01852058|11146178|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7053882|NCT01852058|11146179|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7053883|NCT01852058|11146180|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3
7053884|NCT01852058|11146181|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1
7053885|NCT01852058|11146182|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7053886|NCT01852058|11146183|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7053887|NCT01852058|11146184|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7053888|NCT01852058|11146185|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7053889|NCT01852058|11146186|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7053890|NCT01852058|11146187|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7053891|NCT01852058|11146176|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7053892|NCT01852058|11146177|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7053893|NCT01852058|11146178|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7053894|NCT01852058|11146179|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1
7053895|NCT01852058|11146180|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7053896|NCT01852058|11146181|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7053897|NCT01852058|11146182|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7053898|NCT01852058|11146183|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7053899|NCT01852058|11146184|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7053900|NCT01852058|11146185|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7053901|NCT01852058|11146186|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7053902|NCT01852058|11146187|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7053903|NCT01852058|11146176|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7053904|NCT01852058|11146177|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7053905|NCT01852058|11146178|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7053906|NCT01852058|11146179|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7053907|NCT01852058|11146180|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1
7053908|NCT01852058|11146181|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7
7053909|NCT01852058|11146182|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7053910|NCT01852058|11146183|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7053911|NCT01852058|11146184|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7053912|NCT01852058|11146185|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7053913|NCT01852058|11146186|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7053914|NCT01852058|11146187|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7053915|NCT01852058|11146176|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7053916|NCT01852058|11146177|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7053917|NCT01852058|11146178|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7053918|NCT01852058|11146179|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7053919|NCT01852058|11146180|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7053920|NCT01852058|11146181|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7053921|NCT01852058|11146182|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7084702|NCT02167594|11196824|FG001|Overall Study|Withdrawal by Subject|0
7084703|NCT02167594|11196825|FG002|Overall Study|Withdrawal by Subject|0
7084704|NCT02167594|11196823|FG000|Overall Study|Death|0
7084705|NCT02167594|11196824|FG001|Overall Study|Death|1
7053922|NCT01852058|11146183|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1
7053923|NCT01852058|11146184|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7053924|NCT01852058|11146185|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7053925|NCT01852058|11146186|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7053926|NCT01852058|11146187|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7053927|NCT01852058|11146176|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7053928|NCT01852058|11146177|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7053929|NCT01852058|11146178|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7053930|NCT01852058|11146179|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7053931|NCT01852058|11146180|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7053932|NCT01852058|11146181|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7053933|NCT01852058|11146182|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7053934|NCT01852058|11146183|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7053935|NCT01852058|11146184|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1
7053936|NCT01852058|11146185|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7053937|NCT01852058|11146186|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7053938|NCT01852058|11146187|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7053939|NCT01852110|11146256|FG000|Overall Study|Adverse Event|12
7053940|NCT01852110|11146257|FG001|Overall Study|Adverse Event|5
7053941|NCT01852110|11146258|FG002|Overall Study|Adverse Event|0
7053942|NCT01852110|11146259|FG003|Overall Study|Adverse Event|0
7053943|NCT01852110|11146260|FG004|Overall Study|Adverse Event|0
7053944|NCT01852110|11146261|FG005|Overall Study|Adverse Event|0
7053945|NCT01852110|11146256|FG000|Overall Study|Lost to Follow-up|1
7053946|NCT01852110|11146257|FG001|Overall Study|Lost to Follow-up|3
7053947|NCT01852110|11146258|FG002|Overall Study|Lost to Follow-up|0
7053948|NCT01852110|11146259|FG003|Overall Study|Lost to Follow-up|0
7053949|NCT01852110|11146260|FG004|Overall Study|Lost to Follow-up|0
7053950|NCT01852110|11146261|FG005|Overall Study|Lost to Follow-up|0
7053951|NCT01852110|11146256|FG000|Overall Study|Non-compliance with Study Drug|2
7053952|NCT01852110|11146257|FG001|Overall Study|Non-compliance with Study Drug|1
7053953|NCT01852110|11146258|FG002|Overall Study|Non-compliance with Study Drug|0
7053954|NCT01852110|11146259|FG003|Overall Study|Non-compliance with Study Drug|0
7053955|NCT01852110|11146260|FG004|Overall Study|Non-compliance with Study Drug|0
7053956|NCT01852110|11146261|FG005|Overall Study|Non-compliance with Study Drug|0
7053957|NCT01852110|11146256|FG000|Overall Study|Physician Decision|1
7053958|NCT01852110|11146257|FG001|Overall Study|Physician Decision|0
7053959|NCT01852110|11146258|FG002|Overall Study|Physician Decision|0
7053960|NCT01852110|11146259|FG003|Overall Study|Physician Decision|0
7053961|NCT01852110|11146260|FG004|Overall Study|Physician Decision|0
7053962|NCT01852110|11146261|FG005|Overall Study|Physician Decision|0
7053963|NCT01852110|11146256|FG000|Overall Study|Protocol Violation|0
7053964|NCT01852110|11146257|FG001|Overall Study|Protocol Violation|1
7053965|NCT01852110|11146258|FG002|Overall Study|Protocol Violation|0
7053966|NCT01852110|11146259|FG003|Overall Study|Protocol Violation|0
7053967|NCT01852110|11146260|FG004|Overall Study|Protocol Violation|0
7053968|NCT01852110|11146261|FG005|Overall Study|Protocol Violation|0
7053969|NCT01852110|11146256|FG000|Overall Study|Study Terminated by Sponsor|30
7053970|NCT01852110|11146257|FG001|Overall Study|Study Terminated by Sponsor|32
7053971|NCT01852110|11146258|FG002|Overall Study|Study Terminated by Sponsor|0
7053972|NCT01852110|11146259|FG003|Overall Study|Study Terminated by Sponsor|0
7053973|NCT01852110|11146260|FG004|Overall Study|Study Terminated by Sponsor|0
7053974|NCT01852110|11146261|FG005|Overall Study|Study Terminated by Sponsor|0
7053975|NCT01852110|11146256|FG000|Overall Study|Withdrawal by Subject|4
7053976|NCT01852110|11146257|FG001|Overall Study|Withdrawal by Subject|4
7053977|NCT01852110|11146258|FG002|Overall Study|Withdrawal by Subject|0
7053978|NCT01852110|11146259|FG003|Overall Study|Withdrawal by Subject|0
7053979|NCT01852110|11146260|FG004|Overall Study|Withdrawal by Subject|0
7053980|NCT01852110|11146261|FG005|Overall Study|Withdrawal by Subject|0
7053981|NCT01852162|11146277|FG000|Overall Study|Adverse Event|1
7053982|NCT01852162|11146278|FG001|Overall Study|Adverse Event|0
7053983|NCT01852162|11146277|FG000|Overall Study|Withdrawal by Subject|3
7053984|NCT01852162|11146278|FG001|Overall Study|Withdrawal by Subject|1
7084706|NCT02167594|11196825|FG002|Overall Study|Death|0
7053985|NCT01852214|11146303|FG000|Period 1|Adverse Event|1
7053986|NCT01852214|11146304|FG001|Period 1|Adverse Event|2
7053987|NCT01852214|11146303|FG000|Period 1|Withdrawal by Subject|0
7053988|NCT01852214|11146304|FG001|Period 1|Withdrawal by Subject|1
7053989|NCT01852214|11146303|FG000|Washout Period|Withdrawal by Subject|0
7053990|NCT01852214|11146304|FG001|Washout Period|Withdrawal by Subject|1
7053991|NCT01852292|11146313|FG000|Overall Study|Untreated - did not receive study drug|3
7053992|NCT01852292|11146314|FG001|Overall Study|Untreated - did not receive study drug|1
7053993|NCT01852292|11146313|FG000|Overall Study|Death|9
7053994|NCT01852292|11146314|FG001|Overall Study|Death|8
7053995|NCT01852292|11146313|FG000|Overall Study|Patient/guardian decision|8
7053996|NCT01852292|11146314|FG001|Overall Study|Patient/guardian decision|4
7053997|NCT01852292|11146313|FG000|Overall Study|Adverse Event|8
7053998|NCT01852292|11146314|FG001|Overall Study|Adverse Event|11
7053999|NCT01852292|11146313|FG000|Overall Study|Physician Decision|6
7054000|NCT01852292|11146314|FG001|Overall Study|Physician Decision|2
7054001|NCT01852292|11146313|FG000|Overall Study|Protocol Violation|2
7054002|NCT01852292|11146314|FG001|Overall Study|Protocol Violation|0
7054003|NCT01852292|11146313|FG000|Overall Study|Non-compliance with study treatment|1
7054004|NCT01852292|11146314|FG001|Overall Study|Non-compliance with study treatment|0
7054005|NCT01852292|11146313|FG000|Overall Study|Study terminated by Sponsor|0
7054006|NCT01852292|11146314|FG001|Overall Study|Study terminated by Sponsor|1
7054007|NCT01852292|11146313|FG000|Overall Study|Progressive disease|42
7054008|NCT01852292|11146314|FG001|Overall Study|Progressive disease|52
7054009|NCT01852591|11146352|FG000|Overall Study|Withdrawal by Subject|2
7054010|NCT01852591|11146352|FG000|Overall Study|Not Evaluable at Time of Analysis|1
7054011|NCT01852825|11146372|FG000|Overall Study|Withdrawal by Subject|2
7054012|NCT01852825|11146373|FG001|Overall Study|Withdrawal by Subject|0
7054013|NCT01852825|11146374|FG002|Overall Study|Withdrawal by Subject|0
7054014|NCT01852942|11146384|FG000|Overall Study|Physician Decision|1
7054015|NCT01852942|11146385|FG001|Overall Study|Physician Decision|0
7054016|NCT01852942|11146384|FG000|Overall Study|Death|1
7054017|NCT01852942|11146385|FG001|Overall Study|Death|1
7054018|NCT01852942|11146384|FG000|Overall Study|Withdrawal by Subject|2
7054019|NCT01852942|11146385|FG001|Overall Study|Withdrawal by Subject|3
7054020|NCT01852942|11146384|FG000|Overall Study|Lost to Follow-up|1
7054021|NCT01852942|11146385|FG001|Overall Study|Lost to Follow-up|2
7054022|NCT01853046|11146403|FG000|Overall Study|Withdrawal by Subject|1
7054023|NCT01853046|11146404|FG001|Overall Study|Withdrawal by Subject|1
7054024|NCT01853046|11146403|FG000|Overall Study|Adverse Event|4
7054025|NCT01853046|11146404|FG001|Overall Study|Adverse Event|2
7054026|NCT01853046|11146403|FG000|Overall Study|Disease progression|13
7054027|NCT01853046|11146404|FG001|Overall Study|Disease progression|3
7054028|NCT01853072|11146413|FG000|Overall Study|Adverse event prior to treatment|0
7054029|NCT01853072|11146414|FG001|Overall Study|Adverse event prior to treatment|1
7054030|NCT01853072|11146413|FG000|Overall Study|Adverse Event|0
7054031|NCT01853072|11146414|FG001|Overall Study|Adverse Event|3
7054032|NCT01853072|11146413|FG000|Overall Study|Death|1
7054033|NCT01853072|11146414|FG001|Overall Study|Death|4
7054034|NCT01853072|11146413|FG000|Overall Study|Lost to Follow-up|0
7054035|NCT01853072|11146414|FG001|Overall Study|Lost to Follow-up|3
7054036|NCT01853072|11146413|FG000|Overall Study|Non-compliance with study drug|0
7054037|NCT01853072|11146414|FG001|Overall Study|Non-compliance with study drug|1
7054038|NCT01853072|11146413|FG000|Overall Study|Physician Decision|1
7054039|NCT01853072|11146414|FG001|Overall Study|Physician Decision|1
7054040|NCT01853072|11146413|FG000|Overall Study|Withdrawal by Subject|1
7054041|NCT01853072|11146414|FG001|Overall Study|Withdrawal by Subject|2
7054042|NCT01853072|11146413|FG000|Overall Study|Reason not specified|9
7054043|NCT01853072|11146414|FG001|Overall Study|Reason not specified|6
7054044|NCT01853137|11146428|FG000|Overall Study|Lost to Follow-up|4
7054045|NCT01853137|11146429|FG001|Overall Study|Lost to Follow-up|1
7054046|NCT01853228|11146441|FG000|Phase 1|Lack of Efficacy|8
7054047|NCT01853228|11146442|FG001|Phase 1|Lack of Efficacy|0
7054048|NCT01853228|11146441|FG000|Phase 1|Other|1
7054049|NCT01853228|11146442|FG001|Phase 1|Other|0
7054050|NCT01853228|11146441|FG000|Phase 2|Physician Decision|0
7054051|NCT01853228|11146442|FG001|Phase 2|Physician Decision|1
7054052|NCT01853228|11146441|FG000|Phase 2|Proceed To Transplant|0
7054053|NCT01853228|11146442|FG001|Phase 2|Proceed To Transplant|3
7054054|NCT01853228|11146441|FG000|Phase 2|Lack of Efficacy|0
7054055|NCT01853228|11146442|FG001|Phase 2|Lack of Efficacy|4
7054056|NCT01853254|11146447|FG000|Overall Study|Abnormal Laboratory Test|1
7054057|NCT01853254|11146447|FG000|Overall Study|Adverse Event/Intercurrent Illness|3
7054058|NCT01853254|11146447|FG000|Overall Study|Death|1
7054059|NCT01853254|11146447|FG000|Overall Study|Failure to Return|43
7054060|NCT01853254|11146447|FG000|Overall Study|Insufficient Therapeutic Response|22
7054061|NCT01853254|11146447|FG000|Overall Study|Refusal of Treatment|1
7054062|NCT01853254|11146447|FG000|Overall Study|Other Protocol Violation|1
7054063|NCT01853254|11146447|FG000|Overall Study|Withdrawal of Consent|16
7054064|NCT01853254|11146447|FG000|Overall Study|Administrative/Other|16
7054065|NCT01853280|11146453|FG000|Overall Study|Lack of Efficacy|2
7054066|NCT01853280|11146454|FG001|Overall Study|Lack of Efficacy|2
7054067|NCT01853280|11146453|FG000|Overall Study|Lost to Follow-up|0
7054068|NCT01853280|11146454|FG001|Overall Study|Lost to Follow-up|1
7054069|NCT01853280|11146453|FG000|Overall Study|Physician Decision|0
7054070|NCT01853280|11146454|FG001|Overall Study|Physician Decision|1
7054071|NCT01853280|11146453|FG000|Overall Study|Withdrawal by Subject|0
7054072|NCT01853280|11146454|FG001|Overall Study|Withdrawal by Subject|1
7054073|NCT01853280|11146453|FG000|Overall Study|Ineligible|0
7054074|NCT01853280|11146454|FG001|Overall Study|Ineligible|1
7054075|NCT01853384|11146476|FG000|Randomized|Adverse Event|5
7054076|NCT01853384|11146477|FG001|Randomized|Adverse Event|3
7054077|NCT01853384|11146476|FG000|Randomized|Death|1
7054078|NCT01853384|11146477|FG001|Randomized|Death|2
7054079|NCT01853384|11146476|FG000|Randomized|Lost to Follow-up|1
7054080|NCT01853384|11146477|FG001|Randomized|Lost to Follow-up|1
7054081|NCT01853384|11146476|FG000|Randomized|Withdrawal by Subject|5
7054082|NCT01853384|11146477|FG001|Randomized|Withdrawal by Subject|3
7054083|NCT01853384|11146476|FG000|Randomized|Sponsor Decision|47
7054084|NCT01853384|11146477|FG001|Randomized|Sponsor Decision|34
7054085|NCT01853384|11146476|FG000|Randomized|Other|3
7054086|NCT01853384|11146477|FG001|Randomized|Other|3
7054087|NCT01853384|11146476|FG000|Completed Follow up Visit 1|Early Termination|13
7054088|NCT01853384|11146477|FG001|Completed Follow up Visit 1|Early Termination|9
7054089|NCT01853384|11146476|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1
7054090|NCT01853384|11146477|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0
7054091|NCT01853384|11146476|FG000|Completed Follow up Visit 2|Adverse Event|1
7054092|NCT01853384|11146477|FG001|Completed Follow up Visit 2|Adverse Event|0
7054093|NCT01853384|11146476|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1
7054094|NCT01853384|11146477|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2
7054095|NCT01853384|11146476|FG000|Completed Follow up Visit 2|Death|1
7054096|NCT01853384|11146477|FG001|Completed Follow up Visit 2|Death|0
7054097|NCT01853384|11146476|FG000|Completed Follow up Visit 2|Lost to Follow-up|0
7054098|NCT01853384|11146477|FG001|Completed Follow up Visit 2|Lost to Follow-up|1
7054099|NCT01853397|11146487|FG000|Overall Study|Withdrawal by Subject|0
7054100|NCT01853397|11146488|FG001|Overall Study|Withdrawal by Subject|0
7054101|NCT01853397|11146489|FG002|Overall Study|Withdrawal by Subject|0
7054102|NCT01853397|11146490|FG003|Overall Study|Withdrawal by Subject|1
7054103|NCT01853397|11146487|FG000|Overall Study|Subject Noncompliance|0
7054104|NCT01853397|11146488|FG001|Overall Study|Subject Noncompliance|0
7054105|NCT01853397|11146489|FG002|Overall Study|Subject Noncompliance|0
7054106|NCT01853397|11146490|FG003|Overall Study|Subject Noncompliance|1
7054107|NCT01853462|11146502|FG000|Overall Study|Withdrawal by Subject|1
7054108|NCT01853462|11146503|FG001|Overall Study|Withdrawal by Subject|1
7054109|NCT01853475|11146514|FG000|Overall Study|Withdrawal by Subject|0
7054110|NCT01853475|11146515|FG001|Overall Study|Withdrawal by Subject|1
7054111|NCT01853475|11146516|FG002|Overall Study|Withdrawal by Subject|0
7054112|NCT01853618|11146555|FG000|Overall Study|Bile duct stent blockage/progressive dis|1
7054113|NCT01853618|11146556|FG001|Overall Study|Bile duct stent blockage/progressive dis|0
7054114|NCT01853618|11146557|FG002|Overall Study|Bile duct stent blockage/progressive dis|0
6805048|NCT00358527|10807155|FG000|Overall Study|Administrative|2
6805049|NCT00358527|10807156|FG001|Overall Study|Administrative|1
6805050|NCT00326898|10807165|FG000|Overall Study|Disease progression|52
6805051|NCT00326898|10807166|FG001|Overall Study|Disease progression|54
6805052|NCT00326898|10807167|FG002|Overall Study|Disease progression|102
6805053|NCT00326898|10807165|FG000|Overall Study|Adverse Event|124
6805054|NCT00326898|10807166|FG001|Overall Study|Adverse Event|128
6805055|NCT00326898|10807167|FG002|Overall Study|Adverse Event|33
6805056|NCT00326898|10807165|FG000|Overall Study|Death|2
6805057|NCT00326898|10807166|FG001|Overall Study|Death|0
6805058|NCT00326898|10807167|FG002|Overall Study|Death|0
6805059|NCT00326898|10807165|FG000|Overall Study|Withdrawal by Subject|134
6805060|NCT00326898|10807166|FG001|Overall Study|Withdrawal by Subject|128
6805061|NCT00326898|10807167|FG002|Overall Study|Withdrawal by Subject|32
6805062|NCT00326898|10807165|FG000|Overall Study|Alternative therapy|1
6805063|NCT00326898|10807166|FG001|Overall Study|Alternative therapy|0
6805064|NCT00326898|10807167|FG002|Overall Study|Alternative therapy|0
6805065|NCT00326898|10807165|FG000|Overall Study|Other complicating disease|5
6805066|NCT00326898|10807166|FG001|Overall Study|Other complicating disease|5
6805067|NCT00326898|10807167|FG002|Overall Study|Other complicating disease|4
6805068|NCT00326898|10807165|FG000|Overall Study|Other/Missing/Unknown|33
6805069|NCT00326898|10807166|FG001|Overall Study|Other/Missing/Unknown|28
6805070|NCT00326898|10807167|FG002|Overall Study|Other/Missing/Unknown|32
6805071|NCT00156065|10807178|FG000|Overall Study|Enrolled But Never Received Treatment|1
6805072|NCT00156065|10807179|FG001|Overall Study|Enrolled But Never Received Treatment|1
6805073|NCT00156065|10807180|FG002|Overall Study|Enrolled But Never Received Treatment|0
6805074|NCT00156065|10807178|FG000|Overall Study|Adverse Event|8
6805075|NCT00156065|10807179|FG001|Overall Study|Adverse Event|11
6805076|NCT00156065|10807180|FG002|Overall Study|Adverse Event|4
6805077|NCT00156065|10807178|FG000|Overall Study|Lack of Efficacy|2
6805078|NCT00156065|10807179|FG001|Overall Study|Lack of Efficacy|9
6805079|NCT00156065|10807180|FG002|Overall Study|Lack of Efficacy|3
7054115|NCT01853618|11146558|FG003|Overall Study|Bile duct stent blockage/progressive dis|0
7054116|NCT01853618|11146559|FG004|Overall Study|Bile duct stent blockage/progressive dis|0
7054117|NCT01853618|11146555|FG000|Overall Study|Progressive disease|1
7054118|NCT01853618|11146556|FG001|Overall Study|Progressive disease|1
7054119|NCT01853618|11146557|FG002|Overall Study|Progressive disease|1
7054120|NCT01853618|11146558|FG003|Overall Study|Progressive disease|1
7054121|NCT01853618|11146559|FG004|Overall Study|Progressive disease|2
7054122|NCT01853618|11146555|FG000|Overall Study|Physician Decision|0
7054123|NCT01853618|11146556|FG001|Overall Study|Physician Decision|1
7054124|NCT01853618|11146557|FG002|Overall Study|Physician Decision|1
7054125|NCT01853618|11146558|FG003|Overall Study|Physician Decision|0
7054126|NCT01853618|11146559|FG004|Overall Study|Physician Decision|0
7054127|NCT01853618|11146555|FG000|Overall Study|Refused further treatment|0
7054128|NCT01853618|11146556|FG001|Overall Study|Refused further treatment|0
7054129|NCT01853618|11146557|FG002|Overall Study|Refused further treatment|0
7054130|NCT01853618|11146558|FG003|Overall Study|Refused further treatment|0
7054131|NCT01853618|11146559|FG004|Overall Study|Refused further treatment|1
7054132|NCT01853644|11146572|FG000|Registration and Treatment Start|Did not start treatment|1
7054133|NCT01853644|11146572|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2
7054134|NCT01853644|11146572|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1
7054135|NCT01853644|11146572|FG000|Reached First Response/Complete 2 Cycles|Other|1
7054136|NCT01853644|11146572|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2
7054137|NCT01853644|11146572|FG000|Continued Treatment After First Response|Adverse Event|2
7054138|NCT01853644|11146572|FG000|Continued Treatment After First Response|Progressive Diseaes|10
7084707|NCT02167893|11196853|FG000|Overall Study|Investigator transferred|85
7084708|NCT02167893|11196853|FG000|Overall Study|Investigator health reasons|10
7084709|NCT02167893|11196853|FG000|Overall Study|Case report forms not collected|68
7084710|NCT02168101|11196875|FG000|Overall Study|Death|2
7084711|NCT02168101|11196876|FG001|Overall Study|Death|2
7084712|NCT02168101|11196877|FG002|Overall Study|Death|1
7084713|NCT02168387|11196915|FG000|Overall Study|Planned exubation|6
7084714|NCT02168387|11196916|FG001|Overall Study|Planned exubation|3
7084715|NCT02168387|11196915|FG000|Overall Study|Death|1
7084716|NCT02168387|11196916|FG001|Overall Study|Death|0
7084717|NCT02168439|11196924|FG000|Overall Study|Protocol Violation|0
7084718|NCT02168439|11196925|FG001|Overall Study|Protocol Violation|2
7084719|NCT02168478|11196931|FG000|Overall Study|Withdrawal by Subject|1
6805080|NCT00156065|10807178|FG000|Overall Study|Withdrawal by Subject|13
6805081|NCT00156065|10807179|FG001|Overall Study|Withdrawal by Subject|26
6805082|NCT00156065|10807180|FG002|Overall Study|Withdrawal by Subject|16
7054139|NCT01853696|11146578|FG000|Overall Study|Withdrawal by Subject|1
7054140|NCT01853696|11146579|FG001|Overall Study|Withdrawal by Subject|1
7054141|NCT01853696|11146578|FG000|Overall Study|Lost to Follow-up|5
7054142|NCT01853696|11146579|FG001|Overall Study|Lost to Follow-up|4
7054143|NCT01853839|11146596|FG000|Overall Study|Violated inclusion criteria|2
7054144|NCT01853839|11146596|FG000|Overall Study|Not meet ITT population definition|58
7054145|NCT01853839|11146596|FG000|Overall Study|End of treatment visit too early|33
7054146|NCT01853839|11146596|FG000|Overall Study|Lost to follow-up or no valid BP measure|336
7054147|NCT01853878|11146606|FG000|Overall Study|Recurrence|2
7054148|NCT01853878|11146607|FG001|Overall Study|Recurrence|0
7054149|NCT01853878|11146606|FG000|Overall Study|Adverse Event|2
7054150|NCT01853878|11146607|FG001|Overall Study|Adverse Event|0
7054151|NCT01853878|11146606|FG000|Overall Study|Withdrawal by Subject|3
7054152|NCT01853878|11146607|FG001|Overall Study|Withdrawal by Subject|1
7054153|NCT01853878|11146606|FG000|Overall Study|Migrated/moved from the study area|1
7054154|NCT01853878|11146607|FG001|Overall Study|Migrated/moved from the study area|0
7054155|NCT01853878|11146606|FG000|Overall Study|Other|55
7054156|NCT01853878|11146607|FG001|Overall Study|Other|43
7054157|NCT01854047|11146631|FG000|Overall Study|Lack of Efficacy|1
7054158|NCT01854047|11146632|FG001|Overall Study|Lack of Efficacy|0
7054159|NCT01854047|11146633|FG002|Overall Study|Lack of Efficacy|0
7054160|NCT01854047|11146634|FG003|Overall Study|Lack of Efficacy|0
7054161|NCT01854047|11146635|FG004|Overall Study|Lack of Efficacy|0
7054162|NCT01854047|11146631|FG000|Overall Study|Poor compliance to protocol|3
7054163|NCT01854047|11146632|FG001|Overall Study|Poor compliance to protocol|0
7054164|NCT01854047|11146633|FG002|Overall Study|Poor compliance to protocol|2
7054165|NCT01854047|11146634|FG003|Overall Study|Poor compliance to protocol|0
7054166|NCT01854047|11146635|FG004|Overall Study|Poor compliance to protocol|0
7054167|NCT01854047|11146631|FG000|Overall Study|Adverse Event|5
7054168|NCT01854047|11146632|FG001|Overall Study|Adverse Event|4
7054169|NCT01854047|11146633|FG002|Overall Study|Adverse Event|6
7054170|NCT01854047|11146634|FG003|Overall Study|Adverse Event|10
7054171|NCT01854047|11146635|FG004|Overall Study|Adverse Event|7
7054172|NCT01854047|11146631|FG000|Overall Study|Randomized but not treated|0
7054173|NCT01854047|11146632|FG001|Overall Study|Randomized but not treated|1
7054174|NCT01854047|11146633|FG002|Overall Study|Randomized but not treated|2
7054175|NCT01854047|11146634|FG003|Overall Study|Randomized but not treated|0
7054176|NCT01854047|11146635|FG004|Overall Study|Randomized but not treated|4
7054177|NCT01854047|11146631|FG000|Overall Study|Other than specified above|3
7054178|NCT01854047|11146632|FG001|Overall Study|Other than specified above|3
7054179|NCT01854047|11146633|FG002|Overall Study|Other than specified above|3
7054180|NCT01854047|11146634|FG003|Overall Study|Other than specified above|5
7054181|NCT01854047|11146635|FG004|Overall Study|Other than specified above|8
7054182|NCT01854528|11146703|FG000|Overall Study|Adverse Event|0
7054183|NCT01854528|11146704|FG001|Overall Study|Adverse Event|4
7054184|NCT01854528|11146703|FG000|Overall Study|Withdrawal by Subject|0
7054185|NCT01854528|11146704|FG001|Overall Study|Withdrawal by Subject|2
7054186|NCT01854528|11146703|FG000|Overall Study|Virologic Failure|0
7054187|NCT01854528|11146704|FG001|Overall Study|Virologic Failure|9
7054188|NCT01854645|11146734|FG000|Overall Study|Protocol-Specified Criteria|13
7054189|NCT01854645|11146735|FG001|Overall Study|Protocol-Specified Criteria|10
7054190|NCT01854645|11146736|FG002|Overall Study|Protocol-Specified Criteria|8
7054191|NCT01854645|11146737|FG003|Overall Study|Protocol-Specified Criteria|5
7054192|NCT01854645|11146738|FG004|Overall Study|Protocol-Specified Criteria|7
7054193|NCT01854645|11146734|FG000|Overall Study|Administrative Reasons / Missing|0
7054194|NCT01854645|11146735|FG001|Overall Study|Administrative Reasons / Missing|0
7054195|NCT01854645|11146736|FG002|Overall Study|Administrative Reasons / Missing|0
7054196|NCT01854645|11146737|FG003|Overall Study|Administrative Reasons / Missing|1
7054197|NCT01854645|11146738|FG004|Overall Study|Administrative Reasons / Missing|1
7054198|NCT01854645|11146734|FG000|Overall Study|Protocol Violation|3
7054199|NCT01854645|11146735|FG001|Overall Study|Protocol Violation|0
7054200|NCT01854645|11146736|FG002|Overall Study|Protocol Violation|5
7054201|NCT01854645|11146737|FG003|Overall Study|Protocol Violation|4
7054202|NCT01854645|11146738|FG004|Overall Study|Protocol Violation|1
7054203|NCT01854645|11146734|FG000|Overall Study|Lost to Follow-up|10
7054204|NCT01854645|11146735|FG001|Overall Study|Lost to Follow-up|7
7054205|NCT01854645|11146736|FG002|Overall Study|Lost to Follow-up|8
7054206|NCT01854645|11146737|FG003|Overall Study|Lost to Follow-up|5
7054207|NCT01854645|11146738|FG004|Overall Study|Lost to Follow-up|0
7054208|NCT01854645|11146734|FG000|Overall Study|Physician Decision|1
7054209|NCT01854645|11146735|FG001|Overall Study|Physician Decision|5
7054210|NCT01854645|11146736|FG002|Overall Study|Physician Decision|3
7054211|NCT01854645|11146737|FG003|Overall Study|Physician Decision|3
7054212|NCT01854645|11146738|FG004|Overall Study|Physician Decision|7
7054213|NCT01854645|11146734|FG000|Overall Study|Withdrawal by Subject|31
7054214|NCT01854645|11146735|FG001|Overall Study|Withdrawal by Subject|41
7054215|NCT01854645|11146736|FG002|Overall Study|Withdrawal by Subject|30
7054216|NCT01854645|11146737|FG003|Overall Study|Withdrawal by Subject|21
7054217|NCT01854645|11146738|FG004|Overall Study|Withdrawal by Subject|24
7054218|NCT01854645|11146734|FG000|Overall Study|Lack of Efficacy|7
7054219|NCT01854645|11146735|FG001|Overall Study|Lack of Efficacy|12
7054220|NCT01854645|11146736|FG002|Overall Study|Lack of Efficacy|9
7054221|NCT01854645|11146737|FG003|Overall Study|Lack of Efficacy|3
7054222|NCT01854645|11146738|FG004|Overall Study|Lack of Efficacy|9
7054223|NCT01854645|11146734|FG000|Overall Study|Adverse Event|33
7054224|NCT01854645|11146735|FG001|Overall Study|Adverse Event|31
7054225|NCT01854645|11146736|FG002|Overall Study|Adverse Event|19
7054226|NCT01854645|11146737|FG003|Overall Study|Adverse Event|20
7054227|NCT01854645|11146738|FG004|Overall Study|Adverse Event|11
7054228|NCT01854658|11146754|FG000|Overall Study|Protocol Violation|6
7054229|NCT01854658|11146755|FG001|Overall Study|Protocol Violation|2
7054230|NCT01854658|11146756|FG002|Overall Study|Protocol Violation|2
7054231|NCT01854658|11146757|FG003|Overall Study|Protocol Violation|1
7054232|NCT01854658|11146754|FG000|Overall Study|Physician Decision|7
7054233|NCT01854658|11146755|FG001|Overall Study|Physician Decision|5
7054234|NCT01854658|11146756|FG002|Overall Study|Physician Decision|2
7054235|NCT01854658|11146757|FG003|Overall Study|Physician Decision|4
7054236|NCT01854658|11146754|FG000|Overall Study|Lost to Follow-up|8
7054237|NCT01854658|11146755|FG001|Overall Study|Lost to Follow-up|9
7054238|NCT01854658|11146756|FG002|Overall Study|Lost to Follow-up|8
7054239|NCT01854658|11146757|FG003|Overall Study|Lost to Follow-up|4
7054240|NCT01854658|11146754|FG000|Overall Study|Withdrawal by Subject|28
7054241|NCT01854658|11146755|FG001|Overall Study|Withdrawal by Subject|21
7054242|NCT01854658|11146756|FG002|Overall Study|Withdrawal by Subject|29
7054243|NCT01854658|11146757|FG003|Overall Study|Withdrawal by Subject|15
7054244|NCT01854658|11146754|FG000|Overall Study|Protocol-specified criteria|15
6805083|NCT00156065|10807178|FG000|Overall Study|Lost to Follow-up|5
7054245|NCT01854658|11146755|FG001|Overall Study|Protocol-specified criteria|15
7054246|NCT01854658|11146756|FG002|Overall Study|Protocol-specified criteria|10
7054247|NCT01854658|11146757|FG003|Overall Study|Protocol-specified criteria|7
7054248|NCT01854658|11146754|FG000|Overall Study|Lack of Efficacy|3
7054249|NCT01854658|11146755|FG001|Overall Study|Lack of Efficacy|8
7054250|NCT01854658|11146756|FG002|Overall Study|Lack of Efficacy|4
7054251|NCT01854658|11146757|FG003|Overall Study|Lack of Efficacy|7
7054252|NCT01854658|11146754|FG000|Overall Study|Adverse Event|21
7054253|NCT01854658|11146755|FG001|Overall Study|Adverse Event|14
7054254|NCT01854658|11146756|FG002|Overall Study|Adverse Event|23
7054255|NCT01854658|11146757|FG003|Overall Study|Adverse Event|19
7054256|NCT01854658|11146754|FG000|Overall Study|Administrative reasons|5
7054257|NCT01854658|11146755|FG001|Overall Study|Administrative reasons|1
7054258|NCT01854658|11146756|FG002|Overall Study|Administrative reasons|2
7054259|NCT01854658|11146757|FG003|Overall Study|Administrative reasons|2
7054260|NCT01854697|11146772|FG000|Overall Study|Adverse Event|1
7054261|NCT01854697|11146773|FG001|Overall Study|Adverse Event|0
7054262|NCT01854697|11146774|FG002|Overall Study|Adverse Event|0
7054263|NCT01854697|11146775|FG003|Overall Study|Adverse Event|0
7054264|NCT01854697|11146776|FG004|Overall Study|Adverse Event|1
7054265|NCT01854697|11146772|FG000|Overall Study|Lost to Follow-up|4
7054266|NCT01854697|11146773|FG001|Overall Study|Lost to Follow-up|1
7054267|NCT01854697|11146774|FG002|Overall Study|Lost to Follow-up|1
6805084|NCT00156065|10807179|FG001|Overall Study|Lost to Follow-up|7
6805085|NCT00156065|10807180|FG002|Overall Study|Lost to Follow-up|1
6805086|NCT00156065|10807178|FG000|Overall Study|Other|2
6805087|NCT00156065|10807179|FG001|Overall Study|Other|9
6805088|NCT00156065|10807180|FG002|Overall Study|Other|3
6805089|NCT00150176|10807190|FG000|Overall Study|Adverse Event|16
6805090|NCT00150176|10807191|FG001|Overall Study|Adverse Event|53
6805091|NCT00150176|10807190|FG000|Overall Study|Relapse/Impending relapse, non-AE|10
6805092|NCT00150176|10807191|FG001|Overall Study|Relapse/Impending relapse, non-AE|39
6805093|NCT00150176|10807190|FG000|Overall Study|Withdrawal by Subject|19
6805094|NCT00150176|10807191|FG001|Overall Study|Withdrawal by Subject|12
6805095|NCT00150176|10807190|FG000|Overall Study|Lost to Follow-up|3
6805096|NCT00150176|10807191|FG001|Overall Study|Lost to Follow-up|3
7054268|NCT01854697|11146775|FG003|Overall Study|Lost to Follow-up|2
7054269|NCT01854697|11146776|FG004|Overall Study|Lost to Follow-up|0
7054270|NCT01854697|11146772|FG000|Overall Study|To enter another AbbVie study|1
7054271|NCT01854697|11146773|FG001|Overall Study|To enter another AbbVie study|0
7054272|NCT01854697|11146774|FG002|Overall Study|To enter another AbbVie study|0
7054273|NCT01854697|11146775|FG003|Overall Study|To enter another AbbVie study|0
7054274|NCT01854697|11146776|FG004|Overall Study|To enter another AbbVie study|1
7054275|NCT01854697|11146772|FG000|Overall Study|Withdrew Consent|0
7054276|NCT01854697|11146773|FG001|Overall Study|Withdrew Consent|1
7054277|NCT01854697|11146774|FG002|Overall Study|Withdrew Consent|0
7054278|NCT01854697|11146775|FG003|Overall Study|Withdrew Consent|1
7054279|NCT01854697|11146776|FG004|Overall Study|Withdrew Consent|0
7054280|NCT01854697|11146772|FG000|Overall Study|Other|0
7054281|NCT01854697|11146773|FG001|Overall Study|Other|1
7054282|NCT01854697|11146774|FG002|Overall Study|Other|1
7054283|NCT01854697|11146775|FG003|Overall Study|Other|0
7054284|NCT01854697|11146776|FG004|Overall Study|Other|0
7054285|NCT01854710|11146786|FG000|Overall Study|Withdrawal by Subject|2
7054286|NCT01854710|11146787|FG001|Overall Study|Withdrawal by Subject|1
7054287|NCT01854710|11146788|FG002|Overall Study|Withdrawal by Subject|0
7054288|NCT01854710|11146789|FG003|Overall Study|Withdrawal by Subject|0
7054289|NCT01854710|11146790|FG004|Overall Study|Withdrawal by Subject|0
7054290|NCT01854710|11146791|FG005|Overall Study|Withdrawal by Subject|0
7054291|NCT01854710|11146786|FG000|Overall Study|CRI procedural error|2
7054292|NCT01854710|11146787|FG001|Overall Study|CRI procedural error|2
7054293|NCT01854710|11146788|FG002|Overall Study|CRI procedural error|2
7054294|NCT01854710|11146789|FG003|Overall Study|CRI procedural error|2
7054295|NCT01854710|11146790|FG004|Overall Study|CRI procedural error|2
7054296|NCT01854710|11146791|FG005|Overall Study|CRI procedural error|2
7054321|NCT01854827|11146814|FG000|Overall Study|Death|1
7054322|NCT01854879|11146818|FG000|Overall Study|Could not complete testing within the scheduled time.|1
7054323|NCT01854879|11146818|FG000|Overall Study|screen fail|3
7054324|NCT01854879|11146818|FG000|Overall Study|incomplete data set|1
7054325|NCT01854918|11146828|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20
7054326|NCT01854918|11146829|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49
7054327|NCT01854918|11146828|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2
7054328|NCT01854918|11146829|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1
7054329|NCT01854918|11146828|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3
7054330|NCT01854918|11146829|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8
7054331|NCT01854918|11146828|FG000|SOC-controlled Period (Year 1)|Death|5
7054332|NCT01854918|11146829|FG001|SOC-controlled Period (Year 1)|Death|5
7054333|NCT01854918|11146828|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78
7054334|NCT01854918|11146829|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117
7054335|NCT01854918|11146828|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8
7054336|NCT01854918|11146829|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11
7054337|NCT01854918|11146828|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27
7054338|NCT01854918|11146829|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51
7054339|NCT01854918|11146828|FG000|All-IP Period (Years 2 and 3)|Death|5
7054340|NCT01854918|11146829|FG001|All-IP Period (Years 2 and 3)|Death|16
7054341|NCT01854944|11146845|FG000|Overall Study|Withdrawal by Subject|0
7054342|NCT01854944|11146846|FG001|Overall Study|Withdrawal by Subject|0
6805097|NCT00150176|10807190|FG000|Overall Study|OTHER|11
6805098|NCT00150176|10807191|FG001|Overall Study|OTHER|13
6805099|NCT00145509|10807200|FG000|Overall Study|Adverse Event|10
6805100|NCT00145509|10807201|FG001|Overall Study|Adverse Event|3
6805101|NCT00145509|10807200|FG000|Overall Study|Lack of Efficacy|3
6805102|NCT00145509|10807201|FG001|Overall Study|Lack of Efficacy|1
6805103|NCT00145509|10807200|FG000|Overall Study|Lost to Follow-up|5
6805104|NCT00145509|10807201|FG001|Overall Study|Lost to Follow-up|9
6805105|NCT00145509|10807200|FG000|Overall Study|Withdrew Consent|2
6805106|NCT00145509|10807201|FG001|Overall Study|Withdrew Consent|7
6805107|NCT00145509|10807200|FG000|Overall Study|Reason not provided|2
6805108|NCT00145509|10807201|FG001|Overall Study|Reason not provided|1
6805109|NCT00145496|10807209|FG000|Overall Study|Adverse Event|42
6805110|NCT00145496|10807210|FG001|Overall Study|Adverse Event|30
6805111|NCT00145496|10807209|FG000|Overall Study|Lack of Efficacy|12
6805112|NCT00145496|10807210|FG001|Overall Study|Lack of Efficacy|7
6805113|NCT00145496|10807209|FG000|Overall Study|Withdrawal by Subject|32
6805114|NCT00145496|10807210|FG001|Overall Study|Withdrawal by Subject|26
6805115|NCT00145496|10807209|FG000|Overall Study|Lost to Follow-up|12
6805116|NCT00145496|10807210|FG001|Overall Study|Lost to Follow-up|5
6805117|NCT00145496|10807209|FG000|Overall Study|Other|25
6805118|NCT00145496|10807210|FG001|Overall Study|Other|13
6810262|NCT00943722|10814046|FG003|Base Study|Physician Decision|0
6810263|NCT00943722|10814047|FG004|Base Study|Physician Decision|1
6810264|NCT00943722|10814048|FG005|Base Study|Physician Decision|0
6810265|NCT00943722|10814049|FG006|Base Study|Physician Decision|0
6810266|NCT00943722|10814043|FG000|Base Study|Pregnancy|0
6810267|NCT00943722|10814044|FG001|Base Study|Pregnancy|0
6810268|NCT00943722|10814045|FG002|Base Study|Pregnancy|1
6810269|NCT00943722|10814046|FG003|Base Study|Pregnancy|0
6810270|NCT00943722|10814047|FG004|Base Study|Pregnancy|2
6810271|NCT00943722|10814048|FG005|Base Study|Pregnancy|0
6810272|NCT00943722|10814049|FG006|Base Study|Pregnancy|0
6810273|NCT00943722|10814043|FG000|Base Study|Protocol Violation|0
6810274|NCT00943722|10814044|FG001|Base Study|Protocol Violation|1
6810275|NCT00943722|10814045|FG002|Base Study|Protocol Violation|0
6810276|NCT00943722|10814046|FG003|Base Study|Protocol Violation|0
6810277|NCT00943722|10814047|FG004|Base Study|Protocol Violation|2
6810278|NCT00943722|10814048|FG005|Base Study|Protocol Violation|0
6810279|NCT00943722|10814049|FG006|Base Study|Protocol Violation|0
6810280|NCT00943722|10814043|FG000|Base Study|Withdrawal by Subject|12
6810281|NCT00943722|10814044|FG001|Base Study|Withdrawal by Subject|13
6810282|NCT00943722|10814045|FG002|Base Study|Withdrawal by Subject|2
6810283|NCT00943722|10814046|FG003|Base Study|Withdrawal by Subject|13
6810284|NCT00943722|10814047|FG004|Base Study|Withdrawal by Subject|8
6810285|NCT00943722|10814048|FG005|Base Study|Withdrawal by Subject|0
6810286|NCT00943722|10814049|FG006|Base Study|Withdrawal by Subject|0
6810287|NCT00943722|10814043|FG000|Base Study|Month 12 visit not completed|0
6810288|NCT00943722|10814044|FG001|Base Study|Month 12 visit not completed|0
6810289|NCT00943722|10814045|FG002|Base Study|Month 12 visit not completed|0
6810290|NCT00943722|10814046|FG003|Base Study|Month 12 visit not completed|0
6810291|NCT00943722|10814047|FG004|Base Study|Month 12 visit not completed|2
6810292|NCT00943722|10814048|FG005|Base Study|Month 12 visit not completed|0
6810293|NCT00943722|10814049|FG006|Base Study|Month 12 visit not completed|0
6810294|NCT00943722|10814043|FG000|First Extension Study: EXT 1|Adverse Event|0
6810295|NCT00943722|10814044|FG001|First Extension Study: EXT 1|Adverse Event|0
6810296|NCT00943722|10814045|FG002|First Extension Study: EXT 1|Adverse Event|0
6810297|NCT00943722|10814046|FG003|First Extension Study: EXT 1|Adverse Event|0
6810298|NCT00943722|10814047|FG004|First Extension Study: EXT 1|Adverse Event|0
7054343|NCT01854944|11146847|FG002|Overall Study|Withdrawal by Subject|1
7054344|NCT01855048|11146875|FG000|Overall Study|Withdrawal by Subject|0
7054345|NCT01855048|11146876|FG001|Overall Study|Withdrawal by Subject|1
6810299|NCT00943722|10814048|FG005|First Extension Study: EXT 1|Adverse Event|1
6810300|NCT00943722|10814049|FG006|First Extension Study: EXT 1|Adverse Event|0
6810301|NCT00943722|10814043|FG000|First Extension Study: EXT 1|Lost to Follow-up|0
6810302|NCT00943722|10814044|FG001|First Extension Study: EXT 1|Lost to Follow-up|0
7054346|NCT01855048|11146877|FG002|Overall Study|Withdrawal by Subject|0
6810303|NCT00943722|10814045|FG002|First Extension Study: EXT 1|Lost to Follow-up|0
6810304|NCT00943722|10814046|FG003|First Extension Study: EXT 1|Lost to Follow-up|0
6810305|NCT00943722|10814047|FG004|First Extension Study: EXT 1|Lost to Follow-up|0
6810306|NCT00943722|10814048|FG005|First Extension Study: EXT 1|Lost to Follow-up|38
7054347|NCT01855048|11146878|FG003|Overall Study|Withdrawal by Subject|0
6810307|NCT00943722|10814049|FG006|First Extension Study: EXT 1|Lost to Follow-up|10
7054348|NCT01855048|11146879|FG004|Overall Study|Withdrawal by Subject|1
7054349|NCT01855048|11146880|FG005|Overall Study|Withdrawal by Subject|0
7054350|NCT01855074|11146904|FG000|Overall Study|Adverse Event|1
7054351|NCT01855074|11146904|FG000|Overall Study|Lost to Follow-up|4
7054352|NCT01855074|11146904|FG000|Overall Study|Withdrawal by Subject|8
7054353|NCT01855074|11146904|FG000|Overall Study|Started but not treated|1
7054354|NCT01855126|11146910|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4
7054355|NCT01855126|11146911|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6
7054356|NCT01855126|11146910|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2
7054357|NCT01855126|11146911|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2
7054358|NCT01855243|11146924|FG000|Overall Study|develpoed diabetic ketoacidosis|1
7054359|NCT01855243|11146925|FG001|Overall Study|develpoed diabetic ketoacidosis|0
7054360|NCT01855243|11146926|FG002|Overall Study|develpoed diabetic ketoacidosis|0
7054361|NCT01855399|11146940|FG000|6 Month|Lost to Follow-up|12
7054362|NCT01855399|11146941|FG001|6 Month|Lost to Follow-up|9
7054363|NCT01855399|11146940|FG000|6 Month|Withdrawal by Subject|8
7054364|NCT01855399|11146941|FG001|6 Month|Withdrawal by Subject|6
7054365|NCT01855399|11146940|FG000|12 Month|Lost to Follow-up|7
7054366|NCT01855399|11146941|FG001|12 Month|Lost to Follow-up|11
7054367|NCT01855425|11146947|FG000|Overall Study|Physician Decision|20
7054368|NCT01855750|11146953|FG000|Overall Study|Death|78
7054369|NCT01855750|11146954|FG001|Overall Study|Death|78
7054370|NCT01855750|11146953|FG000|Overall Study|Lost to Follow-up|9
7054371|NCT01855750|11146954|FG001|Overall Study|Lost to Follow-up|23
7054372|NCT01855750|11146953|FG000|Overall Study|Withdrawal by Subject|35
7054373|NCT01855750|11146954|FG001|Overall Study|Withdrawal by Subject|28
7054374|NCT01855750|11146953|FG000|Overall Study|Sponsor ends the study|297
7054375|NCT01855750|11146954|FG001|Overall Study|Sponsor ends the study|290
7054376|NCT01855789|11146960|FG000|1) Baseline up to Week 24|Adverse Event|37
7054377|NCT01855789|11146961|FG001|1) Baseline up to Week 24|Adverse Event|0
7054378|NCT01855789|11146962|FG002|1) Baseline up to Week 24|Adverse Event|0
7054379|NCT01855789|11146963|FG003|1) Baseline up to Week 24|Adverse Event|0
7054380|NCT01855789|11146960|FG000|1) Baseline up to Week 24|Death|2
7054381|NCT01855789|11146961|FG001|1) Baseline up to Week 24|Death|0
7054382|NCT01855789|11146962|FG002|1) Baseline up to Week 24|Death|0
7054383|NCT01855789|11146963|FG003|1) Baseline up to Week 24|Death|0
7054384|NCT01855789|11146960|FG000|1) Baseline up to Week 24|Lack of Efficacy|16
7054385|NCT01855789|11146961|FG001|1) Baseline up to Week 24|Lack of Efficacy|0
7054386|NCT01855789|11146962|FG002|1) Baseline up to Week 24|Lack of Efficacy|0
7054387|NCT01855789|11146963|FG003|1) Baseline up to Week 24|Lack of Efficacy|0
7054388|NCT01855789|11146960|FG000|1) Baseline up to Week 24|Lost to Follow-up|11
7054389|NCT01855789|11146961|FG001|1) Baseline up to Week 24|Lost to Follow-up|0
7054390|NCT01855789|11146962|FG002|1) Baseline up to Week 24|Lost to Follow-up|0
7054391|NCT01855789|11146963|FG003|1) Baseline up to Week 24|Lost to Follow-up|0
7054392|NCT01855789|11146960|FG000|1) Baseline up to Week 24|Protocol Violation|4
7054393|NCT01855789|11146961|FG001|1) Baseline up to Week 24|Protocol Violation|0
7054394|NCT01855789|11146962|FG002|1) Baseline up to Week 24|Protocol Violation|0
7054395|NCT01855789|11146963|FG003|1) Baseline up to Week 24|Protocol Violation|0
7054396|NCT01855789|11146960|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31
7054397|NCT01855789|11146961|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0
7054398|NCT01855789|11146962|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0
7054399|NCT01855789|11146963|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0
7054400|NCT01855789|11146960|FG000|1) Baseline up to Week 24|Physician Decision|4
7054401|NCT01855789|11146961|FG001|1) Baseline up to Week 24|Physician Decision|0
7054402|NCT01855789|11146962|FG002|1) Baseline up to Week 24|Physician Decision|0
7054403|NCT01855789|11146963|FG003|1) Baseline up to Week 24|Physician Decision|0
7054404|NCT01855789|11146960|FG000|1) Baseline up to Week 24|Pregnancy|1
7054405|NCT01855789|11146961|FG001|1) Baseline up to Week 24|Pregnancy|0
7054406|NCT01855789|11146962|FG002|1) Baseline up to Week 24|Pregnancy|0
7054407|NCT01855789|11146963|FG003|1) Baseline up to Week 24|Pregnancy|0
7054408|NCT01855789|11146960|FG000|1) Baseline up to Week 24|Participant Non-compliance|3
7054409|NCT01855789|11146961|FG001|1) Baseline up to Week 24|Participant Non-compliance|0
7054410|NCT01855789|11146962|FG002|1) Baseline up to Week 24|Participant Non-compliance|0
7054411|NCT01855789|11146963|FG003|1) Baseline up to Week 24|Participant Non-compliance|0
7054412|NCT01855789|11146960|FG000|1) Baseline up to Week 24|Sponsor Decision|3
7054413|NCT01855789|11146961|FG001|1) Baseline up to Week 24|Sponsor Decision|0
7054414|NCT01855789|11146962|FG002|1) Baseline up to Week 24|Sponsor Decision|0
7054415|NCT01855789|11146963|FG003|1) Baseline up to Week 24|Sponsor Decision|0
7084720|NCT02168478|11196931|FG000|Overall Study|Did Not Consent to Participation|2
7084721|NCT02168478|11196931|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1
7084722|NCT02168491|11196935|FG000|Overall Study|Withdrawal by Subject|1
7084723|NCT02168777|11196958|FG000|Overall Study|Withdrawal by Subject|1
7084724|NCT02168777|11196959|FG001|Overall Study|Withdrawal by Subject|0
7084725|NCT02168777|11196960|FG002|Overall Study|Withdrawal by Subject|2
7084726|NCT02168777|11196958|FG000|Overall Study|Adverse Event|1
7084727|NCT02168777|11196959|FG001|Overall Study|Adverse Event|0
7084728|NCT02168777|11196960|FG002|Overall Study|Adverse Event|1
7084729|NCT02168777|11196958|FG000|Overall Study|Disease recurrence|0
7084730|NCT02168777|11196959|FG001|Overall Study|Disease recurrence|0
7084731|NCT02168777|11196960|FG002|Overall Study|Disease recurrence|1
7084732|NCT02168777|11196958|FG000|Overall Study|Radiological disease progression|0
7054416|NCT01855789|11146960|FG000|1) Baseline up to Week 24|Other|4
7054417|NCT01855789|11146961|FG001|1) Baseline up to Week 24|Other|0
7054418|NCT01855789|11146962|FG002|1) Baseline up to Week 24|Other|0
7054419|NCT01855789|11146963|FG003|1) Baseline up to Week 24|Other|0
7054420|NCT01855789|11146960|FG000|2) Week 24 up to End of Study|Adverse Event|0
7054421|NCT01855789|11146961|FG001|2) Week 24 up to End of Study|Adverse Event|4
7054422|NCT01855789|11146962|FG002|2) Week 24 up to End of Study|Adverse Event|5
7084733|NCT02168777|11196959|FG001|Overall Study|Radiological disease progression|5
7084734|NCT02168777|11196960|FG002|Overall Study|Radiological disease progression|5
7084735|NCT02168777|11196958|FG000|Overall Study|Clinical disease progression|0
7084736|NCT02168777|11196959|FG001|Overall Study|Clinical disease progression|1
7084737|NCT02168777|11196960|FG002|Overall Study|Clinical disease progression|2
7084738|NCT02168777|11196958|FG000|Overall Study|Other reason|0
7084739|NCT02168777|11196959|FG001|Overall Study|Other reason|1
7084740|NCT02168777|11196960|FG002|Overall Study|Other reason|0
7084741|NCT02168803|11196974|FG000|Overall Study|Lost to Follow-up|1
7084742|NCT02168803|11196975|FG001|Overall Study|Lost to Follow-up|0
7084743|NCT02168803|11196976|FG002|Overall Study|Lost to Follow-up|1
7054423|NCT01855789|11146963|FG003|2) Week 24 up to End of Study|Adverse Event|21
7054424|NCT01855789|11146960|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
7054425|NCT01855789|11146961|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
7054426|NCT01855789|11146962|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
7054427|NCT01855789|11146963|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1
7054428|NCT01855789|11146960|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0
7054429|NCT01855789|11146961|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2
7054430|NCT01855789|11146962|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5
7054431|NCT01855789|11146963|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16
7054432|NCT01855789|11146960|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0
7054433|NCT01855789|11146961|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1
7054434|NCT01855789|11146962|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1
7054435|NCT01855789|11146963|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4
7054436|NCT01855789|11146960|FG000|2) Week 24 up to End of Study|Protocol Violation|0
7054437|NCT01855789|11146961|FG001|2) Week 24 up to End of Study|Protocol Violation|0
7054438|NCT01855789|11146962|FG002|2) Week 24 up to End of Study|Protocol Violation|0
7054439|NCT01855789|11146963|FG003|2) Week 24 up to End of Study|Protocol Violation|1
7054440|NCT01855789|11146960|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0
7054441|NCT01855789|11146961|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7
7054442|NCT01855789|11146962|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5
7054443|NCT01855789|11146963|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8
7054444|NCT01855789|11146960|FG000|2) Week 24 up to End of Study|Physician Decision|0
7054445|NCT01855789|11146961|FG001|2) Week 24 up to End of Study|Physician Decision|0
7054446|NCT01855789|11146962|FG002|2) Week 24 up to End of Study|Physician Decision|2
7054447|NCT01855789|11146963|FG003|2) Week 24 up to End of Study|Physician Decision|4
7054448|NCT01855789|11146960|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0
7054449|NCT01855789|11146961|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1
7054450|NCT01855789|11146962|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0
7054451|NCT01855789|11146963|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1
7054452|NCT01855789|11146960|FG000|2) Week 24 up to End of Study|Sponsor Decision|0
7054453|NCT01855789|11146961|FG001|2) Week 24 up to End of Study|Sponsor Decision|0
7054454|NCT01855789|11146962|FG002|2) Week 24 up to End of Study|Sponsor Decision|0
7054455|NCT01855789|11146963|FG003|2) Week 24 up to End of Study|Sponsor Decision|1
7054456|NCT01855789|11146960|FG000|2) Week 24 up to End of Study|Other|0
7054457|NCT01855789|11146961|FG001|2) Week 24 up to End of Study|Other|0
7054458|NCT01855789|11146962|FG002|2) Week 24 up to End of Study|Other|0
7054459|NCT01855789|11146963|FG003|2) Week 24 up to End of Study|Other|1
7054460|NCT01855828|11146969|FG000|Overall Study|Adverse Event|1
7054461|NCT01855828|11146969|FG000|Overall Study|Withdrawal by Subject|1
7054462|NCT01855919|11146980|FG000|Overall Study|Adverse Event|16
7054463|NCT01855919|11146981|FG001|Overall Study|Adverse Event|8
7054464|NCT01855919|11146980|FG000|Overall Study|Lack of Efficacy|1
7054465|NCT01855919|11146981|FG001|Overall Study|Lack of Efficacy|3
6805119|NCT00145470|10807218|FG000|Overall Study|Adverse Event|19
6805120|NCT00145470|10807219|FG001|Overall Study|Adverse Event|25
6805121|NCT00145470|10807218|FG000|Overall Study|Lack of Efficacy|27
6805122|NCT00145470|10807219|FG001|Overall Study|Lack of Efficacy|13
6805123|NCT00145470|10807218|FG000|Overall Study|Withdrawal by Subject|36
6805124|NCT00145470|10807219|FG001|Overall Study|Withdrawal by Subject|34
6805125|NCT00145470|10807218|FG000|Overall Study|Lost to Follow-up|21
6805126|NCT00145470|10807219|FG001|Overall Study|Lost to Follow-up|17
6805127|NCT00145470|10807218|FG000|Overall Study|Reason Not Reported|9
6805128|NCT00145470|10807219|FG001|Overall Study|Reason Not Reported|9
6805129|NCT00129402|10807227|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
6805130|NCT00129402|10807228|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
6805131|NCT00129402|10807229|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
6805132|NCT00129402|10807230|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
6805133|NCT00129402|10807231|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
6805134|NCT00129402|10807232|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
6805135|NCT00129402|10807233|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
6805136|NCT00129402|10807227|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
6805137|NCT00129402|10807228|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
6805138|NCT00129402|10807229|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
6805139|NCT00129402|10807230|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
6805140|NCT00129402|10807231|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
6805141|NCT00129402|10807232|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1
6805142|NCT00129402|10807233|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
6805143|NCT00129402|10807227|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
6805144|NCT00129402|10807228|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
6805145|NCT00129402|10807229|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
6805146|NCT00129402|10807230|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1
6805147|NCT00129402|10807231|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
6805148|NCT00129402|10807232|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
7054466|NCT01855919|11146980|FG000|Overall Study|Withdrawal by Subject|4
7054467|NCT01855919|11146981|FG001|Overall Study|Withdrawal by Subject|10
7054468|NCT01855919|11146980|FG000|Overall Study|Entry Criteria Not Met|1
7054469|NCT01855919|11146981|FG001|Overall Study|Entry Criteria Not Met|1
7054470|NCT01855919|11146980|FG000|Overall Study|Protocol Violation|1
7054471|NCT01855919|11146981|FG001|Overall Study|Protocol Violation|4
7054472|NCT01855945|11147000|FG000|Overall Study|Adverse Event|0
7084744|NCT02168803|11196974|FG000|Overall Study|Withdrawal by Subject|1
7054473|NCT01855945|11147001|FG001|Overall Study|Adverse Event|0
7054474|NCT01855945|11147002|FG002|Overall Study|Adverse Event|0
7054475|NCT01855945|11147003|FG003|Overall Study|Adverse Event|0
7054476|NCT01855945|11147004|FG004|Overall Study|Adverse Event|0
7054477|NCT01855945|11147005|FG005|Overall Study|Adverse Event|0
7054478|NCT01855945|11147006|FG006|Overall Study|Adverse Event|1
7054479|NCT01855945|11147007|FG007|Overall Study|Adverse Event|0
7054480|NCT01855945|11147008|FG008|Overall Study|Adverse Event|0
7054481|NCT01855945|11147009|FG009|Overall Study|Adverse Event|0
7054482|NCT01855945|11147010|FG010|Overall Study|Adverse Event|0
7054483|NCT01855945|11147011|FG011|Overall Study|Adverse Event|0
7054484|NCT01855945|11147000|FG000|Overall Study|Death|0
6805149|NCT00129402|10807233|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
6805150|NCT00129402|10807227|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
6805151|NCT00129402|10807228|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
6805152|NCT00129402|10807229|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
6811665|NCT01244763|10815545|FG005|Overall Study|Withdrawal by Subject|2
7054485|NCT01855945|11147001|FG001|Overall Study|Death|0
7054486|NCT01855945|11147002|FG002|Overall Study|Death|0
7054487|NCT01855945|11147003|FG003|Overall Study|Death|0
7054488|NCT01855945|11147004|FG004|Overall Study|Death|0
7054489|NCT01855945|11147005|FG005|Overall Study|Death|0
7054490|NCT01855945|11147006|FG006|Overall Study|Death|2
7054491|NCT01855945|11147007|FG007|Overall Study|Death|0
7054492|NCT01855945|11147008|FG008|Overall Study|Death|0
7054493|NCT01855945|11147009|FG009|Overall Study|Death|0
7054494|NCT01855945|11147010|FG010|Overall Study|Death|0
7054495|NCT01855945|11147011|FG011|Overall Study|Death|0
7054496|NCT01855945|11147000|FG000|Overall Study|Lost to Follow-up|11
7054497|NCT01855945|11147001|FG001|Overall Study|Lost to Follow-up|10
7054498|NCT01855945|11147002|FG002|Overall Study|Lost to Follow-up|7
7054499|NCT01855945|11147003|FG003|Overall Study|Lost to Follow-up|3
7054500|NCT01855945|11147004|FG004|Overall Study|Lost to Follow-up|0
7054501|NCT01855945|11147005|FG005|Overall Study|Lost to Follow-up|3
7054502|NCT01855945|11147006|FG006|Overall Study|Lost to Follow-up|4
7054503|NCT01855945|11147007|FG007|Overall Study|Lost to Follow-up|7
7054504|NCT01855945|11147008|FG008|Overall Study|Lost to Follow-up|2
7054505|NCT01855945|11147009|FG009|Overall Study|Lost to Follow-up|0
7054506|NCT01855945|11147010|FG010|Overall Study|Lost to Follow-up|0
7054507|NCT01855945|11147011|FG011|Overall Study|Lost to Follow-up|2
7054508|NCT01855945|11147000|FG000|Overall Study|Other - Unclassified|1
7054509|NCT01855945|11147001|FG001|Overall Study|Other - Unclassified|1
7054510|NCT01855945|11147002|FG002|Overall Study|Other - Unclassified|1
7054511|NCT01855945|11147003|FG003|Overall Study|Other - Unclassified|0
7054512|NCT01855945|11147004|FG004|Overall Study|Other - Unclassified|0
7054513|NCT01855945|11147005|FG005|Overall Study|Other - Unclassified|0
7054514|NCT01855945|11147006|FG006|Overall Study|Other - Unclassified|2
7054515|NCT01855945|11147007|FG007|Overall Study|Other - Unclassified|1
7054516|NCT01855945|11147008|FG008|Overall Study|Other - Unclassified|0
7054517|NCT01855945|11147009|FG009|Overall Study|Other - Unclassified|0
7054518|NCT01855945|11147010|FG010|Overall Study|Other - Unclassified|1
7054519|NCT01855945|11147011|FG011|Overall Study|Other - Unclassified|0
7054520|NCT01855945|11147000|FG000|Overall Study|Withdrawal by Subject|4
7054521|NCT01855945|11147001|FG001|Overall Study|Withdrawal by Subject|0
7054522|NCT01855945|11147002|FG002|Overall Study|Withdrawal by Subject|4
7054523|NCT01855945|11147003|FG003|Overall Study|Withdrawal by Subject|1
7054524|NCT01855945|11147004|FG004|Overall Study|Withdrawal by Subject|1
7054525|NCT01855945|11147005|FG005|Overall Study|Withdrawal by Subject|0
7054526|NCT01855945|11147006|FG006|Overall Study|Withdrawal by Subject|1
7054527|NCT01855945|11147007|FG007|Overall Study|Withdrawal by Subject|0
7054528|NCT01855945|11147008|FG008|Overall Study|Withdrawal by Subject|0
7054529|NCT01855945|11147009|FG009|Overall Study|Withdrawal by Subject|2
7054530|NCT01855945|11147010|FG010|Overall Study|Withdrawal by Subject|4
7054531|NCT01855945|11147011|FG011|Overall Study|Withdrawal by Subject|1
7054532|NCT01855958|11147076|FG000|Overall Study|Withdrawal by Subject|1
7054533|NCT01855958|11147077|FG001|Overall Study|Withdrawal by Subject|0
7054534|NCT01856114|11147099|FG000|Overall Study|Withdrawal by Subject|1
7054535|NCT01856114|11147100|FG001|Overall Study|Withdrawal by Subject|0
7054536|NCT01856114|11147099|FG000|Overall Study|Adverse Event|1
7054537|NCT01856114|11147100|FG001|Overall Study|Adverse Event|0
7054538|NCT01856257|11147113|FG000|Overall Study|Death|2
7054539|NCT01856257|11147114|FG001|Overall Study|Death|0
7054540|NCT01856257|11147115|FG002|Overall Study|Death|0
7054541|NCT01856257|11147116|FG003|Overall Study|Death|0
7054542|NCT01856257|11147113|FG000|Overall Study|Physician Decision|0
7054543|NCT01856257|11147114|FG001|Overall Study|Physician Decision|0
7054544|NCT01856257|11147115|FG002|Overall Study|Physician Decision|0
7054545|NCT01856257|11147116|FG003|Overall Study|Physician Decision|1
7054546|NCT01856257|11147113|FG000|Overall Study|Withdrawal by Subject|1
7054547|NCT01856257|11147114|FG001|Overall Study|Withdrawal by Subject|1
7054548|NCT01856257|11147115|FG002|Overall Study|Withdrawal by Subject|0
7054549|NCT01856257|11147116|FG003|Overall Study|Withdrawal by Subject|0
7054550|NCT01856257|11147113|FG000|Overall Study|Donor complication|0
7054551|NCT01856257|11147114|FG001|Overall Study|Donor complication|0
7054552|NCT01856257|11147115|FG002|Overall Study|Donor complication|0
7054553|NCT01856257|11147116|FG003|Overall Study|Donor complication|1
7054554|NCT01856309|11147129|FG000|Overall Study|Death|4
7054555|NCT01856309|11147130|FG001|Overall Study|Death|6
7054556|NCT01856309|11147131|FG002|Overall Study|Death|11
7054557|NCT01856309|11147132|FG003|Overall Study|Death|6
7054558|NCT01856309|11147129|FG000|Overall Study|Lost to Follow-up|6
7054559|NCT01856309|11147130|FG001|Overall Study|Lost to Follow-up|2
7054560|NCT01856309|11147131|FG002|Overall Study|Lost to Follow-up|4
7054561|NCT01856309|11147132|FG003|Overall Study|Lost to Follow-up|8
7054562|NCT01856309|11147129|FG000|Overall Study|Withdrawal by Subject|11
7054563|NCT01856309|11147130|FG001|Overall Study|Withdrawal by Subject|13
7054564|NCT01856309|11147131|FG002|Overall Study|Withdrawal by Subject|28
7054565|NCT01856309|11147132|FG003|Overall Study|Withdrawal by Subject|26
7054566|NCT01856309|11147129|FG000|Overall Study|Other|227
7054567|NCT01856309|11147130|FG001|Overall Study|Other|225
7054568|NCT01856309|11147131|FG002|Overall Study|Other|447
7054569|NCT01856309|11147132|FG003|Overall Study|Other|469
7054570|NCT01856309|11147129|FG000|Overall Study|Lack of Efficacy|14
7054571|NCT01856309|11147130|FG001|Overall Study|Lack of Efficacy|9
7054572|NCT01856309|11147131|FG002|Overall Study|Lack of Efficacy|40
7054573|NCT01856309|11147132|FG003|Overall Study|Lack of Efficacy|25
7054574|NCT01856309|11147129|FG000|Overall Study|Adverse Event|31
7054575|NCT01856309|11147130|FG001|Overall Study|Adverse Event|31
7054576|NCT01856309|11147131|FG002|Overall Study|Adverse Event|55
7054577|NCT01856309|11147132|FG003|Overall Study|Adverse Event|65
7054578|NCT01856309|11147129|FG000|Overall Study|Pregnancy|0
7054579|NCT01856309|11147130|FG001|Overall Study|Pregnancy|0
7054580|NCT01856309|11147131|FG002|Overall Study|Pregnancy|0
7054581|NCT01856309|11147132|FG003|Overall Study|Pregnancy|1
7054582|NCT01856309|11147129|FG000|Overall Study|Physician Decision|6
7054583|NCT01856309|11147130|FG001|Overall Study|Physician Decision|1
7054584|NCT01856309|11147131|FG002|Overall Study|Physician Decision|6
7054585|NCT01856309|11147132|FG003|Overall Study|Physician Decision|8
7084745|NCT02168803|11196975|FG001|Overall Study|Withdrawal by Subject|1
7084746|NCT02168803|11196976|FG002|Overall Study|Withdrawal by Subject|2
7084747|NCT02168803|11196974|FG000|Overall Study|Physician Decision|0
7084748|NCT02168803|11196975|FG001|Overall Study|Physician Decision|1
7084749|NCT02168803|11196976|FG002|Overall Study|Physician Decision|0
7084750|NCT02168803|11196974|FG000|Overall Study|Adverse Event|0
7084751|NCT02168803|11196975|FG001|Overall Study|Adverse Event|1
7084752|NCT02168803|11196976|FG002|Overall Study|Adverse Event|1
7084753|NCT02168803|11196974|FG000|Overall Study|Death|0
7084754|NCT02168803|11196975|FG001|Overall Study|Death|0
7084755|NCT02168803|11196976|FG002|Overall Study|Death|1
7084756|NCT02168803|11196974|FG000|Overall Study|Sponsor Decision|0
7084757|NCT02168803|11196975|FG001|Overall Study|Sponsor Decision|0
7054586|NCT01856309|11147129|FG000|Overall Study|Noncompliance With Study Drug|0
7054587|NCT01856309|11147130|FG001|Overall Study|Noncompliance With Study Drug|1
7054588|NCT01856309|11147131|FG002|Overall Study|Noncompliance With Study Drug|4
7054589|NCT01856309|11147132|FG003|Overall Study|Noncompliance With Study Drug|1
7054590|NCT01856543|11147157|FG000|Overall Study|Treatment discontinued|6
7054591|NCT01856543|11147158|FG001|Overall Study|Treatment discontinued|3
7054592|NCT01856543|11147157|FG000|Overall Study|Withdrawn before start|7
7054593|NCT01856543|11147158|FG001|Overall Study|Withdrawn before start|3
7054594|NCT01856569|11147165|FG000|Overall Study|Other|1
7054595|NCT01856569|11147165|FG000|Overall Study|Changed Site/Structure|1
7054596|NCT01856569|11147165|FG000|Overall Study|Lost to Follow-up|3
7054597|NCT01856569|11147165|FG000|Overall Study|Did not met inclusion criteria|8
7054598|NCT01856582|11147169|FG000|Overall Study|Died prior to Boost infusion|1
7054599|NCT01856595|11147182|FG000|Overall Study|Withdrawal by Subject|0
7054600|NCT01856595|11147183|FG001|Overall Study|Withdrawal by Subject|1
7054601|NCT01856595|11147184|FG002|Overall Study|Withdrawal by Subject|0
7054602|NCT01856595|11147185|FG003|Overall Study|Withdrawal by Subject|0
7054603|NCT01856595|11147186|FG004|Overall Study|Withdrawal by Subject|0
7054604|NCT01856595|11147187|FG005|Overall Study|Withdrawal by Subject|0
7054605|NCT01856595|11147188|FG006|Overall Study|Withdrawal by Subject|1
7054606|NCT01856595|11147189|FG007|Overall Study|Withdrawal by Subject|0
7054607|NCT01856595|11147190|FG008|Overall Study|Withdrawal by Subject|0
7054608|NCT01856673|11147228|FG000|Overall Study|Withdrawal by Subject|44
7054609|NCT01856673|11147229|FG001|Overall Study|Withdrawal by Subject|50
7054610|NCT01856673|11147230|FG002|Overall Study|Withdrawal by Subject|33
7054611|NCT01856673|11147228|FG000|Overall Study|Lost to Follow-up|31
7054612|NCT01856673|11147229|FG001|Overall Study|Lost to Follow-up|34
7054613|NCT01856673|11147230|FG002|Overall Study|Lost to Follow-up|0
7054614|NCT01856673|11147228|FG000|Overall Study|Unknown reasons|9
7054615|NCT01856673|11147229|FG001|Overall Study|Unknown reasons|0
7054616|NCT01856673|11147230|FG002|Overall Study|Unknown reasons|0
7054617|NCT01856673|11147228|FG000|Overall Study|Psychologist decision|1
7054618|NCT01856673|11147229|FG001|Overall Study|Psychologist decision|0
7054619|NCT01856673|11147230|FG002|Overall Study|Psychologist decision|0
7054620|NCT01856673|11147228|FG000|Overall Study|Paperwork errors|8
7054621|NCT01856673|11147229|FG001|Overall Study|Paperwork errors|0
7054622|NCT01856673|11147230|FG002|Overall Study|Paperwork errors|0
7054623|NCT01856673|11147228|FG000|Overall Study|Death|1
7054624|NCT01856673|11147229|FG001|Overall Study|Death|1
7054625|NCT01856673|11147230|FG002|Overall Study|Death|0
7054626|NCT01856673|11147228|FG000|Overall Study|Protocol Violation|1
7054627|NCT01856673|11147229|FG001|Overall Study|Protocol Violation|0
7054628|NCT01856673|11147230|FG002|Overall Study|Protocol Violation|1
7054629|NCT01856686|11147240|FG000|Overall Study|Lost to Follow-up|5
7054630|NCT01856686|11147241|FG001|Overall Study|Lost to Follow-up|11
7054631|NCT01856790|11147269|FG000|Closed Loop Control|Withdrawal by Subject|2
7054632|NCT01856790|11147269|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2
7054633|NCT01856907|11147283|FG000|Overall Study|Pregnancy|0
7054634|NCT01856907|11147284|FG001|Overall Study|Pregnancy|1
7084758|NCT02168803|11196976|FG002|Overall Study|Sponsor Decision|1
7054635|NCT01856907|11147285|FG002|Overall Study|Pregnancy|0
7054636|NCT01856907|11147283|FG000|Overall Study|Pregnancy|0
7054637|NCT01856907|11147284|FG001|Overall Study|Pregnancy|1
7054638|NCT01856907|11147285|FG002|Overall Study|Pregnancy|0
7084759|NCT02168816|11196993|FG000|Overall Study|Lost to Follow-up|2
7084760|NCT02168816|11196994|FG001|Overall Study|Lost to Follow-up|2
7084761|NCT02168842|11197002|FG000|Overall Study|Withdrawal by Subject|5
7054639|NCT01856907|11147283|FG000|Overall Study|Withdrawal by Subject|0
7054640|NCT01856907|11147284|FG001|Overall Study|Withdrawal by Subject|1
7054641|NCT01856907|11147285|FG002|Overall Study|Withdrawal by Subject|0
7054642|NCT01857102|11147300|FG000|Period 1|No longer meets Eligibility Criteria|0
7054643|NCT01857102|11147301|FG001|Period 1|No longer meets Eligibility Criteria|2
7054644|NCT01857102|11147300|FG000|Period 1|Lost to Follow-up|0
7054645|NCT01857102|11147301|FG001|Period 1|Lost to Follow-up|3
7054646|NCT01857102|11147300|FG000|Period 1|Unsatisfactory Lens Fit|1
7054647|NCT01857102|11147301|FG001|Period 1|Unsatisfactory Lens Fit|0
7054648|NCT01857102|11147300|FG000|Period 1|Unsatisfactory Visual Response|1
7054649|NCT01857102|11147301|FG001|Period 1|Unsatisfactory Visual Response|0
7054650|NCT01857102|11147300|FG000|Period 1|Physician Decision|1
7054651|NCT01857102|11147301|FG001|Period 1|Physician Decision|0
7054652|NCT01857102|11147300|FG000|Period 2|Lens Discomfort|1
7054653|NCT01857102|11147301|FG001|Period 2|Lens Discomfort|0
7054654|NCT01857102|11147300|FG000|Period 2|Unsatisfactory Lens Fit|1
7054655|NCT01857102|11147301|FG001|Period 2|Unsatisfactory Lens Fit|0
7054656|NCT01857206|11147311|FG000|Overall Study|ADMINISTRATIVE REASON|0
7054657|NCT01857206|11147312|FG001|Overall Study|ADMINISTRATIVE REASON|1
7054658|NCT01857206|11147311|FG000|Overall Study|Lost to Follow-up|9
7054659|NCT01857206|11147312|FG001|Overall Study|Lost to Follow-up|6
7054660|NCT01857206|11147311|FG000|Overall Study|Unclassified|3
6805153|NCT00129402|10807230|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
6805154|NCT00129402|10807231|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
7054661|NCT01857206|11147312|FG001|Overall Study|Unclassified|3
7054662|NCT01857206|11147311|FG000|Overall Study|Withdrawal by Subject|1
7054663|NCT01857206|11147312|FG001|Overall Study|Withdrawal by Subject|0
7054664|NCT01857310|11147366|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315
7054665|NCT01857310|11147367|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282
7054666|NCT01857323|11147373|FG000|Overall Study|Adverse Event|1
7054667|NCT01857323|11147373|FG000|Overall Study|Withdrawal by Subject|3
7054668|NCT01857323|11147373|FG000|Overall Study|Non-compliance|1
7054669|NCT01857323|11147373|FG000|Overall Study|Protocol Violation|6
7054670|NCT01857323|11147373|FG000|Overall Study|Lost to Follow-up|1
7054671|NCT01857323|11147373|FG000|Overall Study|Other|4
6805155|NCT00129402|10807232|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
6805156|NCT00129402|10807233|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
6805157|NCT00129402|10807227|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
6805158|NCT00129402|10807228|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
6805159|NCT00129402|10807229|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2
6805160|NCT00129402|10807230|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
6805161|NCT00129402|10807231|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
6805162|NCT00129402|10807232|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
6805163|NCT00129402|10807233|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
6805164|NCT00129402|10807227|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
6805165|NCT00129402|10807228|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
6805166|NCT00129402|10807229|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3
6805167|NCT00129402|10807230|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
6805168|NCT00129402|10807231|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
6805169|NCT00129402|10807232|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1
6805170|NCT00129402|10807233|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
6805171|NCT00129402|10807227|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
6805172|NCT00129402|10807228|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
6805173|NCT00129402|10807229|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1
6805174|NCT00129402|10807230|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
6805175|NCT00129402|10807231|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
7054672|NCT01857323|11147373|FG000|Overall Study|Did not complete 180 doses|48
7054673|NCT01857531|11147384|FG000|Overall Study|Withdrawal by Subject|4
7054674|NCT01857583|11147392|FG000|Overall Study|Adverse Event|0
7054675|NCT01857583|11147393|FG001|Overall Study|Adverse Event|0
6805176|NCT00129402|10807232|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
6805177|NCT00129402|10807233|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
6805178|NCT00129402|10807227|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
6805179|NCT00129402|10807228|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
6805180|NCT00129402|10807229|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1
6805181|NCT00129402|10807230|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
6805182|NCT00129402|10807231|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
6805183|NCT00129402|10807232|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3
6805184|NCT00129402|10807233|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
6805185|NCT00129402|10807227|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
6805186|NCT00129402|10807228|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
6805187|NCT00129402|10807229|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
6811666|NCT01244763|10815540|FG000|Overall Study|Lost to Follow-up|0
6811667|NCT01244763|10815541|FG001|Overall Study|Lost to Follow-up|1
6811668|NCT01244763|10815542|FG002|Overall Study|Lost to Follow-up|0
6811669|NCT01244763|10815543|FG003|Overall Study|Lost to Follow-up|0
6811670|NCT01244763|10815544|FG004|Overall Study|Lost to Follow-up|0
6811671|NCT01244763|10815545|FG005|Overall Study|Lost to Follow-up|0
6811672|NCT01244763|10815540|FG000|Overall Study|Enrolled into the Extension Study|0
6811673|NCT01244763|10815541|FG001|Overall Study|Enrolled into the Extension Study|0
6811674|NCT01244763|10815542|FG002|Overall Study|Enrolled into the Extension Study|0
6811675|NCT01244763|10815543|FG003|Overall Study|Enrolled into the Extension Study|0
6811676|NCT01244763|10815544|FG004|Overall Study|Enrolled into the Extension Study|0
6811677|NCT01244763|10815545|FG005|Overall Study|Enrolled into the Extension Study|1
6811678|NCT01208207|10815562|FG000|Part I|Adverse Event|19
6811679|NCT01208207|10815563|FG001|Part I|Adverse Event|2
6811680|NCT01208207|10815564|FG002|Part I|Adverse Event|6
6811681|NCT01208207|10815565|FG003|Part I|Adverse Event|0
6811682|NCT01208207|10815566|FG004|Part I|Adverse Event|0
6811683|NCT01208207|10815567|FG005|Part I|Adverse Event|0
6811684|NCT01208207|10815568|FG006|Part I|Adverse Event|0
6811685|NCT01208207|10815562|FG000|Part I|Lack of Efficacy|21
6811686|NCT01208207|10815563|FG001|Part I|Lack of Efficacy|3
6811687|NCT01208207|10815564|FG002|Part I|Lack of Efficacy|2
6811688|NCT01208207|10815565|FG003|Part I|Lack of Efficacy|0
6811689|NCT01208207|10815566|FG004|Part I|Lack of Efficacy|0
6811690|NCT01208207|10815567|FG005|Part I|Lack of Efficacy|0
6811691|NCT01208207|10815568|FG006|Part I|Lack of Efficacy|0
6811692|NCT01208207|10815562|FG000|Part I|Lost to Follow-up|6
6811693|NCT01208207|10815563|FG001|Part I|Lost to Follow-up|1
6811694|NCT01208207|10815564|FG002|Part I|Lost to Follow-up|0
6811695|NCT01208207|10815565|FG003|Part I|Lost to Follow-up|0
6811696|NCT01208207|10815566|FG004|Part I|Lost to Follow-up|0
6811697|NCT01208207|10815567|FG005|Part I|Lost to Follow-up|0
6811698|NCT01208207|10815568|FG006|Part I|Lost to Follow-up|0
6811699|NCT01208207|10815562|FG000|Part I|Non-Compliance With Study Drug|1
6811700|NCT01208207|10815563|FG001|Part I|Non-Compliance With Study Drug|0
6811701|NCT01208207|10815564|FG002|Part I|Non-Compliance With Study Drug|1
6811702|NCT01208207|10815565|FG003|Part I|Non-Compliance With Study Drug|0
6811703|NCT01208207|10815566|FG004|Part I|Non-Compliance With Study Drug|0
6811704|NCT01208207|10815567|FG005|Part I|Non-Compliance With Study Drug|0
6811705|NCT01208207|10815568|FG006|Part I|Non-Compliance With Study Drug|0
6811706|NCT01208207|10815562|FG000|Part I|Physician Decision|0
6811707|NCT01208207|10815563|FG001|Part I|Physician Decision|1
6811708|NCT01208207|10815564|FG002|Part I|Physician Decision|0
6811709|NCT01208207|10815565|FG003|Part I|Physician Decision|0
6811710|NCT01208207|10815566|FG004|Part I|Physician Decision|0
6811711|NCT01208207|10815567|FG005|Part I|Physician Decision|0
6811712|NCT01208207|10815568|FG006|Part I|Physician Decision|0
6811713|NCT01208207|10815562|FG000|Part I|Progressive Disease|1
6811714|NCT01208207|10815563|FG001|Part I|Progressive Disease|0
6811715|NCT01208207|10815564|FG002|Part I|Progressive Disease|0
6811716|NCT01208207|10815565|FG003|Part I|Progressive Disease|0
6811717|NCT01208207|10815566|FG004|Part I|Progressive Disease|0
6811718|NCT01208207|10815567|FG005|Part I|Progressive Disease|0
6811719|NCT01208207|10815568|FG006|Part I|Progressive Disease|0
6811720|NCT01208207|10815562|FG000|Part I|Protocol Violation|8
6811721|NCT01208207|10815563|FG001|Part I|Protocol Violation|0
6811722|NCT01208207|10815564|FG002|Part I|Protocol Violation|2
6811723|NCT01208207|10815565|FG003|Part I|Protocol Violation|0
6811724|NCT01208207|10815566|FG004|Part I|Protocol Violation|0
6811725|NCT01208207|10815567|FG005|Part I|Protocol Violation|0
6811726|NCT01208207|10815568|FG006|Part I|Protocol Violation|0
6811727|NCT01208207|10815562|FG000|Part I|Withdrawal by Subject|14
6811728|NCT01208207|10815563|FG001|Part I|Withdrawal by Subject|4
6811729|NCT01208207|10815564|FG002|Part I|Withdrawal by Subject|4
6811730|NCT01208207|10815565|FG003|Part I|Withdrawal by Subject|0
7054676|NCT01857583|11147394|FG002|Overall Study|Adverse Event|1
7054677|NCT01857583|11147395|FG003|Overall Study|Adverse Event|1
7054678|NCT01857583|11147392|FG000|Overall Study|Death|0
7054679|NCT01857583|11147393|FG001|Overall Study|Death|1
7054680|NCT01857583|11147394|FG002|Overall Study|Death|1
7054681|NCT01857583|11147395|FG003|Overall Study|Death|0
7054682|NCT01857583|11147392|FG000|Overall Study|Physician Decision|0
7054683|NCT01857583|11147393|FG001|Overall Study|Physician Decision|0
7054684|NCT01857583|11147394|FG002|Overall Study|Physician Decision|0
7054685|NCT01857583|11147395|FG003|Overall Study|Physician Decision|1
7054686|NCT01857583|11147392|FG000|Overall Study|Withdrawal by Subject|1
7054687|NCT01857583|11147393|FG001|Overall Study|Withdrawal by Subject|0
7054688|NCT01857583|11147394|FG002|Overall Study|Withdrawal by Subject|1
7054689|NCT01857583|11147395|FG003|Overall Study|Withdrawal by Subject|2
7054690|NCT01857622|11147408|FG000|Overall Study|Adverse Event|5
7054691|NCT01857622|11147409|FG001|Overall Study|Adverse Event|0
7054692|NCT01857622|11147410|FG002|Overall Study|Adverse Event|2
7054693|NCT01857622|11147408|FG000|Overall Study|Physician Decision|1
7054694|NCT01857622|11147409|FG001|Overall Study|Physician Decision|0
7054695|NCT01857622|11147410|FG002|Overall Study|Physician Decision|0
7054696|NCT01857622|11147408|FG000|Overall Study|Protocol Violation|4
7054697|NCT01857622|11147409|FG001|Overall Study|Protocol Violation|1
7054698|NCT01857622|11147410|FG002|Overall Study|Protocol Violation|0
7054699|NCT01857622|11147408|FG000|Overall Study|Withdrawal by Subject|1
7054700|NCT01857622|11147409|FG001|Overall Study|Withdrawal by Subject|0
7054701|NCT01857622|11147410|FG002|Overall Study|Withdrawal by Subject|0
7054702|NCT01857869|11147434|FG000|Primary/Challenge Phase|Lost to Follow-up|2
7054703|NCT01857869|11147435|FG001|Primary/Challenge Phase|Lost to Follow-up|0
7054704|NCT01857869|11147436|FG002|Primary/Challenge Phase|Lost to Follow-up|0
7054705|NCT01857869|11147437|FG003|Primary/Challenge Phase|Lost to Follow-up|0
7054706|NCT01857869|11147438|FG004|Primary/Challenge Phase|Lost to Follow-up|0
7054707|NCT01857869|11147439|FG005|Primary/Challenge Phase|Lost to Follow-up|0
7054708|NCT01857869|11147440|FG006|Primary/Challenge Phase|Lost to Follow-up|0
7054709|NCT01857869|11147441|FG007|Primary/Challenge Phase|Lost to Follow-up|0
7054710|NCT01857869|11147442|FG008|Primary/Challenge Phase|Lost to Follow-up|0
7054711|NCT01857869|11147443|FG009|Primary/Challenge Phase|Lost to Follow-up|0
7054712|NCT01857869|11147434|FG000|Primary/Challenge Phase|Pregnancy|1
7054713|NCT01857869|11147435|FG001|Primary/Challenge Phase|Pregnancy|0
7054714|NCT01857869|11147436|FG002|Primary/Challenge Phase|Pregnancy|0
7054715|NCT01857869|11147437|FG003|Primary/Challenge Phase|Pregnancy|0
7054716|NCT01857869|11147438|FG004|Primary/Challenge Phase|Pregnancy|0
7054717|NCT01857869|11147439|FG005|Primary/Challenge Phase|Pregnancy|0
7054718|NCT01857869|11147440|FG006|Primary/Challenge Phase|Pregnancy|0
7054719|NCT01857869|11147441|FG007|Primary/Challenge Phase|Pregnancy|0
7054720|NCT01857869|11147442|FG008|Primary/Challenge Phase|Pregnancy|0
7054721|NCT01857869|11147443|FG009|Primary/Challenge Phase|Pregnancy|0
7054722|NCT01857869|11147434|FG000|Primary/Challenge Phase|Protocol Violation|1
7054723|NCT01857869|11147435|FG001|Primary/Challenge Phase|Protocol Violation|0
7054724|NCT01857869|11147436|FG002|Primary/Challenge Phase|Protocol Violation|0
7054725|NCT01857869|11147437|FG003|Primary/Challenge Phase|Protocol Violation|0
7054726|NCT01857869|11147438|FG004|Primary/Challenge Phase|Protocol Violation|0
7054727|NCT01857869|11147439|FG005|Primary/Challenge Phase|Protocol Violation|0
7054728|NCT01857869|11147440|FG006|Primary/Challenge Phase|Protocol Violation|0
7054729|NCT01857869|11147441|FG007|Primary/Challenge Phase|Protocol Violation|0
7054730|NCT01857869|11147442|FG008|Primary/Challenge Phase|Protocol Violation|0
7054731|NCT01857869|11147443|FG009|Primary/Challenge Phase|Protocol Violation|0
7054732|NCT01857869|11147434|FG000|Primary/Challenge Phase|Other|1
7054733|NCT01857869|11147435|FG001|Primary/Challenge Phase|Other|1
7054734|NCT01857869|11147436|FG002|Primary/Challenge Phase|Other|0
7054735|NCT01857869|11147437|FG003|Primary/Challenge Phase|Other|0
7054736|NCT01857869|11147438|FG004|Primary/Challenge Phase|Other|0
7054737|NCT01857869|11147439|FG005|Primary/Challenge Phase|Other|0
7054738|NCT01857869|11147440|FG006|Primary/Challenge Phase|Other|0
7054739|NCT01857869|11147441|FG007|Primary/Challenge Phase|Other|0
7054740|NCT01857869|11147442|FG008|Primary/Challenge Phase|Other|0
7054741|NCT01857869|11147443|FG009|Primary/Challenge Phase|Other|0
7054742|NCT01857869|11147434|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0
7054743|NCT01857869|11147435|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0
7054744|NCT01857869|11147436|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0
7054745|NCT01857869|11147437|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1
7054746|NCT01857869|11147438|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0
7054747|NCT01857869|11147439|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0
7054748|NCT01857869|11147440|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0
7054749|NCT01857869|11147441|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0
7054750|NCT01857869|11147442|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0
7054751|NCT01857869|11147443|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0
7054752|NCT01857869|11147434|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
7054753|NCT01857869|11147435|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
7054754|NCT01857869|11147436|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
7054755|NCT01857869|11147437|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1
7054756|NCT01857869|11147438|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
7054757|NCT01857869|11147439|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
7054758|NCT01857869|11147440|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
7054759|NCT01857869|11147441|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
7054760|NCT01857869|11147442|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
7054761|NCT01857869|11147443|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
7054762|NCT01857973|11147475|FG000|Overall Study|Subject did not meet required BG range|3
7054763|NCT01857973|11147475|FG000|Overall Study|drop out after 3 failed attempts|1
7054764|NCT01857973|11147475|FG000|Overall Study|Physician Decision|1
7054765|NCT01858194|11147490|FG000|Overall Study|Total Artificial Heart Implant|0
7054766|NCT01858194|11147491|FG001|Overall Study|Total Artificial Heart Implant|1
7054767|NCT01858194|11147490|FG000|Overall Study|Lost to Follow-up|0
7054768|NCT01858194|11147491|FG001|Overall Study|Lost to Follow-up|1
7054769|NCT01858363|11147501|FG000|Overall Study|Death|35
7054770|NCT01858363|11147502|FG001|Overall Study|Death|9
7054771|NCT01858363|11147501|FG000|Overall Study|Withdrawal by Subject|28
7054772|NCT01858363|11147502|FG001|Overall Study|Withdrawal by Subject|14
7054773|NCT01858363|11147501|FG000|Overall Study|Lost to Follow-up|13
7054774|NCT01858363|11147502|FG001|Overall Study|Lost to Follow-up|3
7054775|NCT01858376|11147508|FG000|Overall Study|Dropped d/t lab work not fitting criter|4
7054776|NCT01858389|11147514|FG000|Overall Study|Death|1
7054777|NCT01858389|11147515|FG001|Overall Study|Death|3
7054778|NCT01858389|11147514|FG000|Overall Study|Study terminated by sponsor|0
7054779|NCT01858389|11147515|FG001|Overall Study|Study terminated by sponsor|2
7054780|NCT01858389|11147514|FG000|Overall Study|Withdrawal by Subject|0
7054781|NCT01858389|11147515|FG001|Overall Study|Withdrawal by Subject|1
7054782|NCT01858389|11147514|FG000|Overall Study|Progressive disease|10
7054783|NCT01858389|11147515|FG001|Overall Study|Progressive disease|11
7054784|NCT01858389|11147514|FG000|Overall Study|Other|2
7054785|NCT01858389|11147515|FG001|Overall Study|Other|4
7054786|NCT01858389|11147514|FG000|Overall Study|Adverse Event|3
7054787|NCT01858389|11147515|FG001|Overall Study|Adverse Event|1
7054788|NCT01858389|11147514|FG000|Overall Study|Did not receive treatment|0
7054789|NCT01858389|11147515|FG001|Overall Study|Did not receive treatment|3
7054790|NCT01858532|11147536|FG000|Overall Study|Adverse Event|58
7054791|NCT01858532|11147537|FG001|Overall Study|Adverse Event|50
7054792|NCT01858532|11147538|FG002|Overall Study|Adverse Event|23
7054793|NCT01858532|11147539|FG003|Overall Study|Adverse Event|28
7054794|NCT01858532|11147536|FG000|Overall Study|Withdrew consent|71
7054795|NCT01858532|11147537|FG001|Overall Study|Withdrew consent|93
7054796|NCT01858532|11147538|FG002|Overall Study|Withdrew consent|46
7054797|NCT01858532|11147539|FG003|Overall Study|Withdrew consent|27
7054798|NCT01858532|11147536|FG000|Overall Study|Lost to Follow-up|17
7054799|NCT01858532|11147537|FG001|Overall Study|Lost to Follow-up|26
7054800|NCT01858532|11147538|FG002|Overall Study|Lost to Follow-up|11
7054801|NCT01858532|11147539|FG003|Overall Study|Lost to Follow-up|14
7054802|NCT01858532|11147536|FG000|Overall Study|Deterioration of medical status|3
6805188|NCT00129402|10807230|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
7054803|NCT01858532|11147537|FG001|Overall Study|Deterioration of medical status|4
7054804|NCT01858532|11147538|FG002|Overall Study|Deterioration of medical status|3
7054805|NCT01858532|11147539|FG003|Overall Study|Deterioration of medical status|7
7054806|NCT01858532|11147536|FG000|Overall Study|Investigator request|3
7054807|NCT01858532|11147537|FG001|Overall Study|Investigator request|4
7054808|NCT01858532|11147538|FG002|Overall Study|Investigator request|2
7054809|NCT01858532|11147539|FG003|Overall Study|Investigator request|6
7054810|NCT01858532|11147536|FG000|Overall Study|Other, not specified|29
7054811|NCT01858532|11147537|FG001|Overall Study|Other, not specified|15
7054812|NCT01858532|11147538|FG002|Overall Study|Other, not specified|13
7054813|NCT01858532|11147539|FG003|Overall Study|Other, not specified|11
7054814|NCT01858558|11147560|FG000|Overall Study|Death|1
7054815|NCT01858558|11147561|FG001|Overall Study|Death|1
7054816|NCT01858558|11147560|FG000|Overall Study|Lost to Follow-up|1
7054817|NCT01858558|11147561|FG001|Overall Study|Lost to Follow-up|0
7054818|NCT01858558|11147560|FG000|Overall Study|Disease progression|3
7054819|NCT01858558|11147561|FG001|Overall Study|Disease progression|1
7054820|NCT01858558|11147560|FG000|Overall Study|Product contamination|2
7054821|NCT01858558|11147561|FG001|Overall Study|Product contamination|0
7054822|NCT01858558|11147560|FG000|Overall Study|Failed expansion of cell product|2
7054823|NCT01858558|11147561|FG001|Overall Study|Failed expansion of cell product|0
7054824|NCT01858636|11147567|FG000|Overall Study|No Device Deployment Attempted|24
7054825|NCT01858636|11147567|FG000|Overall Study|Physician Decision|1
7054826|NCT01858636|11147567|FG000|Overall Study|Death|1
7054827|NCT01858636|11147567|FG000|Overall Study|Lost to Follow-up|1
7054828|NCT01858636|11147567|FG000|Overall Study|Withdrawal by Subject|1
7054829|NCT01858701|11147572|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
7054830|NCT01858701|11147573|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
7054831|NCT01858701|11147572|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1
7054832|NCT01858701|11147573|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0
7054833|NCT01858701|11147572|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1
7054834|NCT01858701|11147573|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2
7054835|NCT01858701|11147572|FG000|Period 2, Second 30 Days of Wear|Comfort|0
7054836|NCT01858701|11147573|FG001|Period 2, Second 30 Days of Wear|Comfort|1
7054837|NCT01858766|11147607|FG000|Overall Study|Randomized but Never Treated|0
7054838|NCT01858766|11147608|FG001|Overall Study|Randomized but Never Treated|0
7054839|NCT01858766|11147609|FG002|Overall Study|Randomized but Never Treated|0
7054840|NCT01858766|11147610|FG003|Overall Study|Randomized but Never Treated|0
7054841|NCT01858766|11147611|FG004|Overall Study|Randomized but Never Treated|0
7054842|NCT01858766|11147612|FG005|Overall Study|Randomized but Never Treated|1
7054843|NCT01858766|11147613|FG006|Overall Study|Randomized but Never Treated|0
7054844|NCT01858766|11147614|FG007|Overall Study|Randomized but Never Treated|0
7054845|NCT01858766|11147615|FG008|Overall Study|Randomized but Never Treated|0
7054846|NCT01858766|11147616|FG009|Overall Study|Randomized but Never Treated|0
7054847|NCT01858766|11147617|FG010|Overall Study|Randomized but Never Treated|0
7054848|NCT01858766|11147618|FG011|Overall Study|Randomized but Never Treated|0
7054849|NCT01858766|11147619|FG012|Overall Study|Randomized but Never Treated|0
7054850|NCT01858766|11147620|FG013|Overall Study|Randomized but Never Treated|0
7054851|NCT01858766|11147621|FG014|Overall Study|Randomized but Never Treated|0
7054852|NCT01858766|11147622|FG015|Overall Study|Randomized but Never Treated|0
7054853|NCT01858766|11147623|FG016|Overall Study|Randomized but Never Treated|0
7054854|NCT01858766|11147624|FG017|Overall Study|Randomized but Never Treated|1
7054855|NCT01858766|11147625|FG018|Overall Study|Randomized but Never Treated|0
7054856|NCT01858766|11147607|FG000|Overall Study|Death|0
7054857|NCT01858766|11147608|FG001|Overall Study|Death|0
7054858|NCT01858766|11147609|FG002|Overall Study|Death|1
7084762|NCT02168842|11197003|FG001|Overall Study|Withdrawal by Subject|3
7084763|NCT02168842|11197002|FG000|Overall Study|Lost to Follow-up|0
7084764|NCT02168842|11197003|FG001|Overall Study|Lost to Follow-up|2
7084765|NCT02168842|11197002|FG000|Overall Study|Death|2
7084766|NCT02168842|11197003|FG001|Overall Study|Death|1
7084767|NCT02168842|11197002|FG000|Overall Study|Physician Decision|1
7084768|NCT02168842|11197003|FG001|Overall Study|Physician Decision|2
7084769|NCT02168946|11197032|FG000|Overall Study|Adverse Event|8
7084770|NCT02168946|11197033|FG001|Overall Study|Adverse Event|5
7084771|NCT02168946|11197032|FG000|Overall Study|Lost to Follow-up|3
7084772|NCT02168946|11197033|FG001|Overall Study|Lost to Follow-up|0
7084773|NCT02168946|11197032|FG000|Overall Study|Subject unable to come back for visits|1
7084774|NCT02168946|11197033|FG001|Overall Study|Subject unable to come back for visits|0
7084775|NCT02169219|11197053|FG000|Overall Study|Lack of Efficacy|6
7084776|NCT02169271|11197064|FG000|Overall Study|Protocol Violation|1
7084777|NCT02169271|11197065|FG001|Overall Study|Protocol Violation|2
7084778|NCT02169284|11197073|FG000|Overall Study|Physician Decision|0
7084779|NCT02169284|11197074|FG001|Overall Study|Physician Decision|1
7084780|NCT02169336|11197085|FG000|Overall Study|Lack of Efficacy|1
7084781|NCT02169336|11197086|FG001|Overall Study|Lack of Efficacy|1
7084782|NCT02169336|11197087|FG002|Overall Study|Lack of Efficacy|0
7084783|NCT02169336|11197085|FG000|Overall Study|Adverse Event|2
7084784|NCT02169336|11197086|FG001|Overall Study|Adverse Event|3
7084785|NCT02169336|11197087|FG002|Overall Study|Adverse Event|1
6805189|NCT00129402|10807231|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
7054859|NCT01858766|11147610|FG003|Overall Study|Death|0
7054860|NCT01858766|11147611|FG004|Overall Study|Death|0
7054861|NCT01858766|11147612|FG005|Overall Study|Death|0
7054862|NCT01858766|11147613|FG006|Overall Study|Death|0
7054863|NCT01858766|11147614|FG007|Overall Study|Death|0
7054864|NCT01858766|11147615|FG008|Overall Study|Death|0
7054865|NCT01858766|11147616|FG009|Overall Study|Death|0
7054866|NCT01858766|11147617|FG010|Overall Study|Death|0
7054867|NCT01858766|11147618|FG011|Overall Study|Death|0
7084786|NCT02169336|11197085|FG000|Overall Study|Withdrawal by Subject|1
7084787|NCT02169336|11197086|FG001|Overall Study|Withdrawal by Subject|0
7054868|NCT01858766|11147619|FG012|Overall Study|Death|0
7054869|NCT01858766|11147620|FG013|Overall Study|Death|0
7054870|NCT01858766|11147621|FG014|Overall Study|Death|0
7054871|NCT01858766|11147622|FG015|Overall Study|Death|0
7054872|NCT01858766|11147623|FG016|Overall Study|Death|0
7054873|NCT01858766|11147624|FG017|Overall Study|Death|0
7054874|NCT01858766|11147625|FG018|Overall Study|Death|0
7054875|NCT01858766|11147607|FG000|Overall Study|Lack of Efficacy|1
7054876|NCT01858766|11147608|FG001|Overall Study|Lack of Efficacy|0
7054877|NCT01858766|11147609|FG002|Overall Study|Lack of Efficacy|0
7084788|NCT02169336|11197087|FG002|Overall Study|Withdrawal by Subject|0
7084789|NCT02169336|11197085|FG000|Overall Study|Physician Decision|0
7084790|NCT02169336|11197086|FG001|Overall Study|Physician Decision|0
7084791|NCT02169336|11197087|FG002|Overall Study|Physician Decision|1
7084792|NCT02169336|11197085|FG000|Overall Study|Subject declined to continue dosing|0
7084793|NCT02169336|11197086|FG001|Overall Study|Subject declined to continue dosing|0
7084794|NCT02169336|11197087|FG002|Overall Study|Subject declined to continue dosing|1
7084795|NCT02169414|11197099|FG000|Overall Study|Withdrawal by Subject|1
7084796|NCT02169414|11197100|FG001|Overall Study|Withdrawal by Subject|0
7084797|NCT02169414|11197101|FG002|Overall Study|Withdrawal by Subject|0
7054878|NCT01858766|11147610|FG003|Overall Study|Lack of Efficacy|0
7054879|NCT01858766|11147611|FG004|Overall Study|Lack of Efficacy|1
7054880|NCT01858766|11147612|FG005|Overall Study|Lack of Efficacy|2
7054881|NCT01858766|11147613|FG006|Overall Study|Lack of Efficacy|0
7054882|NCT01858766|11147614|FG007|Overall Study|Lack of Efficacy|0
7084798|NCT02169414|11197102|FG003|Overall Study|Withdrawal by Subject|0
7084799|NCT02169414|11197099|FG000|Overall Study|Adverse Event|0
7084800|NCT02169414|11197100|FG001|Overall Study|Adverse Event|1
7084801|NCT02169414|11197101|FG002|Overall Study|Adverse Event|0
7084802|NCT02169414|11197102|FG003|Overall Study|Adverse Event|0
7084803|NCT02169505|11197185|FG000|Overall Study|Withdrawal by Subject|1
6811731|NCT01208207|10815566|FG004|Part I|Withdrawal by Subject|0
7054883|NCT01858766|11147615|FG008|Overall Study|Lack of Efficacy|0
7054884|NCT01858766|11147616|FG009|Overall Study|Lack of Efficacy|0
7054885|NCT01858766|11147617|FG010|Overall Study|Lack of Efficacy|0
7054886|NCT01858766|11147618|FG011|Overall Study|Lack of Efficacy|3
7054887|NCT01858766|11147619|FG012|Overall Study|Lack of Efficacy|5
7054888|NCT01858766|11147620|FG013|Overall Study|Lack of Efficacy|3
7054889|NCT01858766|11147621|FG014|Overall Study|Lack of Efficacy|5
7054890|NCT01858766|11147622|FG015|Overall Study|Lack of Efficacy|5
7054891|NCT01858766|11147623|FG016|Overall Study|Lack of Efficacy|2
7054892|NCT01858766|11147624|FG017|Overall Study|Lack of Efficacy|3
7054893|NCT01858766|11147625|FG018|Overall Study|Lack of Efficacy|3
7054894|NCT01858766|11147607|FG000|Overall Study|Lost to Follow-up|0
7054895|NCT01858766|11147608|FG001|Overall Study|Lost to Follow-up|0
7054896|NCT01858766|11147609|FG002|Overall Study|Lost to Follow-up|0
7054897|NCT01858766|11147610|FG003|Overall Study|Lost to Follow-up|0
7054898|NCT01858766|11147611|FG004|Overall Study|Lost to Follow-up|0
7054899|NCT01858766|11147612|FG005|Overall Study|Lost to Follow-up|1
7054900|NCT01858766|11147613|FG006|Overall Study|Lost to Follow-up|0
7054901|NCT01858766|11147614|FG007|Overall Study|Lost to Follow-up|2
7054902|NCT01858766|11147615|FG008|Overall Study|Lost to Follow-up|0
7054903|NCT01858766|11147616|FG009|Overall Study|Lost to Follow-up|0
7054904|NCT01858766|11147617|FG010|Overall Study|Lost to Follow-up|0
7054905|NCT01858766|11147618|FG011|Overall Study|Lost to Follow-up|1
7054906|NCT01858766|11147619|FG012|Overall Study|Lost to Follow-up|0
7054907|NCT01858766|11147620|FG013|Overall Study|Lost to Follow-up|0
7054908|NCT01858766|11147621|FG014|Overall Study|Lost to Follow-up|3
7054909|NCT01858766|11147622|FG015|Overall Study|Lost to Follow-up|1
7054910|NCT01858766|11147623|FG016|Overall Study|Lost to Follow-up|1
7054911|NCT01858766|11147624|FG017|Overall Study|Lost to Follow-up|0
7054912|NCT01858766|11147625|FG018|Overall Study|Lost to Follow-up|1
7054913|NCT01858766|11147607|FG000|Overall Study|Withdrew Consent|0
7054914|NCT01858766|11147608|FG001|Overall Study|Withdrew Consent|0
7054915|NCT01858766|11147609|FG002|Overall Study|Withdrew Consent|0
7054916|NCT01858766|11147610|FG003|Overall Study|Withdrew Consent|0
7054917|NCT01858766|11147611|FG004|Overall Study|Withdrew Consent|0
7054918|NCT01858766|11147612|FG005|Overall Study|Withdrew Consent|0
7054919|NCT01858766|11147613|FG006|Overall Study|Withdrew Consent|0
7054920|NCT01858766|11147614|FG007|Overall Study|Withdrew Consent|0
7054921|NCT01858766|11147615|FG008|Overall Study|Withdrew Consent|0
7054922|NCT01858766|11147616|FG009|Overall Study|Withdrew Consent|0
7054923|NCT01858766|11147617|FG010|Overall Study|Withdrew Consent|0
7054924|NCT01858766|11147618|FG011|Overall Study|Withdrew Consent|1
7054925|NCT01858766|11147619|FG012|Overall Study|Withdrew Consent|0
7054926|NCT01858766|11147620|FG013|Overall Study|Withdrew Consent|0
7054927|NCT01858766|11147621|FG014|Overall Study|Withdrew Consent|0
7054928|NCT01858766|11147622|FG015|Overall Study|Withdrew Consent|0
7054929|NCT01858766|11147623|FG016|Overall Study|Withdrew Consent|0
7084804|NCT02169674|11197191|FG000|Overall Study|Withdrawal by Subject|2
7054930|NCT01858766|11147624|FG017|Overall Study|Withdrew Consent|0
7054931|NCT01858766|11147625|FG018|Overall Study|Withdrew Consent|0
7054932|NCT01859143|11147675|FG000|Overall Study|Lost to Follow-up|2
7054933|NCT01859143|11147676|FG001|Overall Study|Lost to Follow-up|0
7054934|NCT01859390|11147745|FG000|Overall Study|Insufficient Sputum Collected|1
7054935|NCT01859390|11147746|FG001|Overall Study|Insufficient Sputum Collected|3
7084805|NCT02169674|11197192|FG001|Overall Study|Withdrawal by Subject|1
7054936|NCT01859390|11147745|FG000|Overall Study|Sample Missing Collection Date|0
7054937|NCT01859390|11147746|FG001|Overall Study|Sample Missing Collection Date|1
7054938|NCT01859390|11147745|FG000|Overall Study|Tube Cracked|0
7054939|NCT01859390|11147746|FG001|Overall Study|Tube Cracked|2
7054940|NCT01859390|11147745|FG000|Overall Study|Shipment Error|0
7054941|NCT01859390|11147746|FG001|Overall Study|Shipment Error|1
7054942|NCT01859403|11147754|FG000|Primary Endpoint Measure|Lost to Follow-up|0
7054943|NCT01859403|11147755|FG001|Primary Endpoint Measure|Lost to Follow-up|2
7054944|NCT01859403|11147754|FG000|Primary Endpoint Measure|Withdrawal by Subject|1
7054945|NCT01859403|11147755|FG001|Primary Endpoint Measure|Withdrawal by Subject|1
7054946|NCT01859403|11147754|FG000|Primary Endpoint Measure|Physician Decision|0
7054947|NCT01859403|11147755|FG001|Primary Endpoint Measure|Physician Decision|1
7054948|NCT01859403|11147754|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6
7054949|NCT01859403|11147755|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8
7054950|NCT01859494|11147761|FG000|Overall Study|Adverse Event|1
7054951|NCT01859507|11147765|FG000|Overall Study|left the country|4
7054952|NCT01859598|11147770|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742
7054953|NCT01859702|11147784|FG000|Overall Study|Protocol deviation|3
7054954|NCT01859702|11147784|FG000|Overall Study|Adverse Event|2
7054955|NCT01859715|11147791|FG000|Overall Study|No 2nd VAS|16
7054956|NCT01859715|11147792|FG001|Overall Study|No 2nd VAS|8
7054957|NCT01859715|11147793|FG002|Overall Study|No 2nd VAS|23
7084806|NCT02169674|11197191|FG000|Overall Study|Seroprotected|30
7084807|NCT02169674|11197192|FG001|Overall Study|Seroprotected|76
7084808|NCT02169674|11197191|FG000|Overall Study|Lost to Follow-up|0
7084809|NCT02169674|11197192|FG001|Overall Study|Lost to Follow-up|1
7084810|NCT02169739|11197200|FG000|Overall Study|Lost to Follow-up|0
7084811|NCT02169739|11197201|FG001|Overall Study|Lost to Follow-up|4
7084812|NCT02169791|11197208|FG000|Overall Study|Death|6
7084813|NCT02169791|11197208|FG000|Overall Study|patient withdrew consent|1
7084814|NCT02170025|11197240|FG000|Overall Study|Adverse Event|2
7084815|NCT02170025|11197241|FG001|Overall Study|Adverse Event|0
7084816|NCT02170051|11197249|FG000|Overall Study|Withdrawal by Subject|10
7084817|NCT02170051|11197250|FG001|Overall Study|Withdrawal by Subject|10
7084818|NCT02170051|11197249|FG000|Overall Study|Lost to Follow-up|1
7084819|NCT02170051|11197250|FG001|Overall Study|Lost to Follow-up|3
7084820|NCT02170064|11197259|FG000|Overall Study|Withdrawal by Subject|5
7084821|NCT02170064|11197260|FG001|Overall Study|Withdrawal by Subject|1
7084822|NCT02170064|11197261|FG002|Overall Study|Withdrawal by Subject|1
7084823|NCT02170064|11197259|FG000|Overall Study|Physician Decision|1
7084824|NCT02170064|11197260|FG001|Overall Study|Physician Decision|1
7084825|NCT02170064|11197261|FG002|Overall Study|Physician Decision|0
7084826|NCT02170077|11197272|FG000|Overall Study|Withdrawal by Subject|3
7084827|NCT02170077|11197273|FG001|Overall Study|Withdrawal by Subject|4
7084828|NCT02170077|11197274|FG002|Overall Study|Withdrawal by Subject|2
7084829|NCT02170077|11197272|FG000|Overall Study|Adverse Event|4
7084830|NCT02170077|11197273|FG001|Overall Study|Adverse Event|4
7084831|NCT02170077|11197274|FG002|Overall Study|Adverse Event|4
7084832|NCT02170077|11197272|FG000|Overall Study|Lost to Follow-up|0
7084833|NCT02170077|11197273|FG001|Overall Study|Lost to Follow-up|1
7084834|NCT02170077|11197274|FG002|Overall Study|Lost to Follow-up|0
7084835|NCT02170077|11197272|FG000|Overall Study|Exclusion criteria|2
7084836|NCT02170077|11197273|FG001|Overall Study|Exclusion criteria|2
7084837|NCT02170077|11197274|FG002|Overall Study|Exclusion criteria|5
7084838|NCT02170077|11197272|FG000|Overall Study|Exacerbation of seizures|0
7084839|NCT02170077|11197273|FG001|Overall Study|Exacerbation of seizures|2
7084840|NCT02170077|11197274|FG002|Overall Study|Exacerbation of seizures|1
7084841|NCT02170207|11197282|FG000|Overall Study|Case report forms unavailable|5
7054958|NCT01859741|11147811|FG000|Overall Study|Death|3
7054959|NCT01859741|11147812|FG001|Overall Study|Death|2
7054960|NCT01859741|11147813|FG002|Overall Study|Death|4
7054961|NCT01859741|11147814|FG003|Overall Study|Death|3
7054962|NCT01859741|11147815|FG004|Overall Study|Death|5
7054963|NCT01859741|11147816|FG005|Overall Study|Death|4
7054964|NCT01859741|11147817|FG006|Overall Study|Death|51
7054965|NCT01859741|11147818|FG007|Overall Study|Death|51
7054966|NCT01859741|11147811|FG000|Overall Study|Lost to Follow-up|0
7054967|NCT01859741|11147812|FG001|Overall Study|Lost to Follow-up|0
7054968|NCT01859741|11147813|FG002|Overall Study|Lost to Follow-up|0
7054969|NCT01859741|11147814|FG003|Overall Study|Lost to Follow-up|0
7054970|NCT01859741|11147815|FG004|Overall Study|Lost to Follow-up|0
7054971|NCT01859741|11147816|FG005|Overall Study|Lost to Follow-up|1
7054972|NCT01859741|11147817|FG006|Overall Study|Lost to Follow-up|0
7054973|NCT01859741|11147818|FG007|Overall Study|Lost to Follow-up|4
7054974|NCT01859741|11147811|FG000|Overall Study|Withdrawal by Subject|0
7054975|NCT01859741|11147812|FG001|Overall Study|Withdrawal by Subject|1
7054976|NCT01859741|11147813|FG002|Overall Study|Withdrawal by Subject|2
7054977|NCT01859741|11147814|FG003|Overall Study|Withdrawal by Subject|0
7054978|NCT01859741|11147815|FG004|Overall Study|Withdrawal by Subject|0
7054979|NCT01859741|11147816|FG005|Overall Study|Withdrawal by Subject|1
7054980|NCT01859741|11147817|FG006|Overall Study|Withdrawal by Subject|1
7054981|NCT01859741|11147818|FG007|Overall Study|Withdrawal by Subject|1
7054982|NCT01859741|11147811|FG000|Overall Study|Study Terminated by Sponsor|0
7054983|NCT01859741|11147812|FG001|Overall Study|Study Terminated by Sponsor|0
7054984|NCT01859741|11147813|FG002|Overall Study|Study Terminated by Sponsor|0
7054985|NCT01859741|11147814|FG003|Overall Study|Study Terminated by Sponsor|0
7054986|NCT01859741|11147815|FG004|Overall Study|Study Terminated by Sponsor|1
7054987|NCT01859741|11147816|FG005|Overall Study|Study Terminated by Sponsor|0
7054988|NCT01859741|11147817|FG006|Overall Study|Study Terminated by Sponsor|16
7084842|NCT02170389|11197322|FG000|Overall Study|Study terminated prior to start of treat|1
7084843|NCT02170688|11197365|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4
7084844|NCT02170688|11197366|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2
7084845|NCT02170688|11197367|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3
7084846|NCT02170688|11197368|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2
7084847|NCT02170688|11197369|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0
7084848|NCT02170688|11197365|FG000|Overall Study|Full dose not received|0
7084849|NCT02170688|11197366|FG001|Overall Study|Full dose not received|1
7084850|NCT02170688|11197367|FG002|Overall Study|Full dose not received|0
7084851|NCT02170688|11197368|FG003|Overall Study|Full dose not received|0
7084852|NCT02170688|11197369|FG004|Overall Study|Full dose not received|0
7084853|NCT02170688|11197365|FG000|Overall Study|Physician Decision|0
7084854|NCT02170688|11197366|FG001|Overall Study|Physician Decision|0
7084855|NCT02170688|11197367|FG002|Overall Study|Physician Decision|1
7084856|NCT02170688|11197368|FG003|Overall Study|Physician Decision|0
7084857|NCT02170688|11197369|FG004|Overall Study|Physician Decision|0
7084858|NCT02170727|11197383|FG000|Overall Study|Lost to Follow-up|1
7084859|NCT02170727|11197384|FG001|Overall Study|Lost to Follow-up|0
7084860|NCT02170727|11197383|FG000|Overall Study|Withdrawal by Subject|2
7084861|NCT02170727|11197384|FG001|Overall Study|Withdrawal by Subject|0
7084862|NCT02170779|11197395|FG000|Overall Study|Withdrawal by Subject|1
7084863|NCT02170779|11197396|FG001|Overall Study|Withdrawal by Subject|0
7084864|NCT02170779|11197395|FG000|Overall Study|Lost to Follow-up|0
7084865|NCT02170779|11197396|FG001|Overall Study|Lost to Follow-up|1
7084866|NCT02171065|11197433|FG000|Overall Study|Withdrawal by Subject|1
7084867|NCT02171065|11197434|FG001|Overall Study|Withdrawal by Subject|0
7054989|NCT01859741|11147818|FG007|Overall Study|Study Terminated by Sponsor|14
7054990|NCT01859741|11147811|FG000|Overall Study|Other|0
7054991|NCT01859741|11147812|FG001|Overall Study|Other|0
7054992|NCT01859741|11147813|FG002|Overall Study|Other|0
7054993|NCT01859741|11147814|FG003|Overall Study|Other|0
7054994|NCT01859741|11147815|FG004|Overall Study|Other|0
7054995|NCT01859741|11147816|FG005|Overall Study|Other|0
7054996|NCT01859741|11147817|FG006|Overall Study|Other|2
7054997|NCT01859741|11147818|FG007|Overall Study|Other|0
7054998|NCT01859793|11147838|FG000|First Intervention (8 Weeks)|Protocol Violation|2
7054999|NCT01859793|11147839|FG001|First Intervention (8 Weeks)|Protocol Violation|0
7055000|NCT01859793|11147838|FG000|First Intervention (8 Weeks)|Adverse Event|1
7055001|NCT01859793|11147839|FG001|First Intervention (8 Weeks)|Adverse Event|0
7055002|NCT01859793|11147838|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2
7055003|NCT01859793|11147839|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1
7055004|NCT01859793|11147838|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1
7055005|NCT01859793|11147839|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1
7055006|NCT01859923|11147849|FG000|Overall Study|Adverse Event|0
7055007|NCT01859923|11147850|FG001|Overall Study|Adverse Event|0
7055008|NCT01859923|11147851|FG002|Overall Study|Adverse Event|1
7055009|NCT01859923|11147852|FG003|Overall Study|Adverse Event|1
7055010|NCT01859949|11147867|FG000|Overall Study|Family Matters|0
7055011|NCT01859949|11147868|FG001|Overall Study|Family Matters|1
7055012|NCT01859949|11147867|FG000|Overall Study|Physician Decision|2
7055013|NCT01859949|11147868|FG001|Overall Study|Physician Decision|4
7055014|NCT01859949|11147867|FG000|Overall Study|Withdrawal by Subject|11
7055015|NCT01859949|11147868|FG001|Overall Study|Withdrawal by Subject|10
7055016|NCT01859949|11147867|FG000|Overall Study|Protocol Violation|1
7055017|NCT01859949|11147868|FG001|Overall Study|Protocol Violation|1
7055018|NCT01859949|11147867|FG000|Overall Study|Adverse Event|0
7055019|NCT01859949|11147868|FG001|Overall Study|Adverse Event|1
7055020|NCT01859988|11147880|FG000|Overall Study|Withdrawal by Subject|6
7055021|NCT01859988|11147881|FG001|Overall Study|Withdrawal by Subject|3
7055022|NCT01859988|11147882|FG002|Overall Study|Withdrawal by Subject|4
7055023|NCT01859988|11147883|FG003|Overall Study|Withdrawal by Subject|3
7055024|NCT01859988|11147884|FG004|Overall Study|Withdrawal by Subject|2
7055025|NCT01859988|11147885|FG005|Overall Study|Withdrawal by Subject|2
7055026|NCT01859988|11147880|FG000|Overall Study|Lack of Efficacy|1
7055027|NCT01859988|11147881|FG001|Overall Study|Lack of Efficacy|1
7055028|NCT01859988|11147882|FG002|Overall Study|Lack of Efficacy|5
7055029|NCT01859988|11147883|FG003|Overall Study|Lack of Efficacy|0
7055030|NCT01859988|11147884|FG004|Overall Study|Lack of Efficacy|7
7055031|NCT01859988|11147885|FG005|Overall Study|Lack of Efficacy|9
7055032|NCT01859988|11147880|FG000|Overall Study|Physician Decision|1
7055033|NCT01859988|11147881|FG001|Overall Study|Physician Decision|3
7055034|NCT01859988|11147882|FG002|Overall Study|Physician Decision|1
7055035|NCT01859988|11147883|FG003|Overall Study|Physician Decision|3
7055036|NCT01859988|11147884|FG004|Overall Study|Physician Decision|4
7055037|NCT01859988|11147885|FG005|Overall Study|Physician Decision|1
7055038|NCT01859988|11147880|FG000|Overall Study|Adverse Event|2
7055039|NCT01859988|11147881|FG001|Overall Study|Adverse Event|1
7055040|NCT01859988|11147882|FG002|Overall Study|Adverse Event|3
7055041|NCT01859988|11147883|FG003|Overall Study|Adverse Event|1
7055042|NCT01859988|11147884|FG004|Overall Study|Adverse Event|2
7055043|NCT01859988|11147885|FG005|Overall Study|Adverse Event|2
7055044|NCT01859988|11147880|FG000|Overall Study|Lost to Follow-up|1
7055045|NCT01859988|11147881|FG001|Overall Study|Lost to Follow-up|2
7055046|NCT01859988|11147882|FG002|Overall Study|Lost to Follow-up|3
7055047|NCT01859988|11147883|FG003|Overall Study|Lost to Follow-up|0
7055048|NCT01859988|11147884|FG004|Overall Study|Lost to Follow-up|3
7055049|NCT01859988|11147885|FG005|Overall Study|Lost to Follow-up|2
7055050|NCT01859988|11147880|FG000|Overall Study|Protocol Violation|0
7055051|NCT01859988|11147881|FG001|Overall Study|Protocol Violation|0
7055052|NCT01859988|11147882|FG002|Overall Study|Protocol Violation|1
7055053|NCT01859988|11147883|FG003|Overall Study|Protocol Violation|0
7055054|NCT01859988|11147884|FG004|Overall Study|Protocol Violation|0
7055055|NCT01859988|11147885|FG005|Overall Study|Protocol Violation|0
7055056|NCT01859988|11147880|FG000|Overall Study|Other than specified above|0
7055057|NCT01859988|11147881|FG001|Overall Study|Other than specified above|2
7055058|NCT01859988|11147882|FG002|Overall Study|Other than specified above|11
7055059|NCT01859988|11147883|FG003|Overall Study|Other than specified above|3
7055060|NCT01859988|11147884|FG004|Overall Study|Other than specified above|5
7055061|NCT01859988|11147885|FG005|Overall Study|Other than specified above|3
7055062|NCT01860079|11147901|FG000|Overall Study|Physician Decision|14
7055063|NCT01860079|11147902|FG001|Overall Study|Physician Decision|22
7055064|NCT01860534|11147945|FG000|ROP #1|Needed treatment for ROP|0
7055065|NCT01860534|11147946|FG001|ROP #1|Needed treatment for ROP|1
7055066|NCT01860534|11147945|FG000|ROP #2|discharged prior to ROP #2|1
7055067|NCT01860534|11147946|FG001|ROP #2|discharged prior to ROP #2|0
7084868|NCT02171065|11197435|FG002|Overall Study|Withdrawal by Subject|0
7055068|NCT01860677|11147983|FG000|Second Intervention (1 Day)|Lost to Follow-up|7
7055069|NCT01860677|11147984|FG001|Second Intervention (1 Day)|Lost to Follow-up|0
7055070|NCT01860703|11147991|FG000|Overall Study|Adverse Event|1
7055071|NCT01860703|11147992|FG001|Overall Study|Adverse Event|4
7055072|NCT01860703|11147993|FG002|Overall Study|Adverse Event|0
7055073|NCT01860703|11147994|FG003|Overall Study|Adverse Event|2
7055074|NCT01860703|11147991|FG000|Overall Study|Withdrawal by Subject|0
7055075|NCT01860703|11147992|FG001|Overall Study|Withdrawal by Subject|1
7055076|NCT01860703|11147993|FG002|Overall Study|Withdrawal by Subject|0
7055077|NCT01860703|11147994|FG003|Overall Study|Withdrawal by Subject|0
7055078|NCT01860703|11147991|FG000|Overall Study|Personal reason|1
7055079|NCT01860703|11147992|FG001|Overall Study|Personal reason|0
7055080|NCT01860703|11147993|FG002|Overall Study|Personal reason|1
7055081|NCT01860703|11147994|FG003|Overall Study|Personal reason|0
7055082|NCT01860846|11148019|FG000|Overall Study|Lost to Follow-up|33
7055083|NCT01860989|11148049|FG000|Overall Study|Unsatisfactory therapeutic|5
7055084|NCT01861522|11148094|FG000|Overall Study|Adverse Event|1
7055085|NCT01861522|11148095|FG001|Overall Study|Adverse Event|0
7055086|NCT01861522|11148094|FG000|Overall Study|Withdrawal by Subject|2
7055087|NCT01861522|11148095|FG001|Overall Study|Withdrawal by Subject|0
7055088|NCT01862029|11148175|FG000|Overall Study|Physician Decision|1
7055089|NCT01862250|11148191|FG000|Overall Study|Adverse Event|4
7055090|NCT01862328|11148202|FG000|Overall Study|Progressive Disease|3
7055091|NCT01862328|11148203|FG001|Overall Study|Progressive Disease|11
7055092|NCT01862328|11148204|FG002|Overall Study|Progressive Disease|5
7055093|NCT01862328|11148205|FG003|Overall Study|Progressive Disease|6
7055094|NCT01862328|11148206|FG004|Overall Study|Progressive Disease|7
7055095|NCT01862328|11148207|FG005|Overall Study|Progressive Disease|4
7055096|NCT01862328|11148208|FG006|Overall Study|Progressive Disease|3
7055097|NCT01862328|11148202|FG000|Overall Study|Adverse Event|0
7055098|NCT01862328|11148203|FG001|Overall Study|Adverse Event|4
7055099|NCT01862328|11148204|FG002|Overall Study|Adverse Event|0
7055100|NCT01862328|11148205|FG003|Overall Study|Adverse Event|1
7055101|NCT01862328|11148206|FG004|Overall Study|Adverse Event|0
7055102|NCT01862328|11148207|FG005|Overall Study|Adverse Event|2
7055103|NCT01862328|11148208|FG006|Overall Study|Adverse Event|4
7055104|NCT01862328|11148202|FG000|Overall Study|Other|0
7055105|NCT01862328|11148203|FG001|Overall Study|Other|2
7055106|NCT01862328|11148204|FG002|Overall Study|Other|1
7055107|NCT01862328|11148205|FG003|Overall Study|Other|0
7055108|NCT01862328|11148206|FG004|Overall Study|Other|4
7055109|NCT01862328|11148207|FG005|Overall Study|Other|0
7055110|NCT01862328|11148208|FG006|Overall Study|Other|1
7055111|NCT01862328|11148202|FG000|Overall Study|Withdrawal by Subject|1
7055112|NCT01862328|11148203|FG001|Overall Study|Withdrawal by Subject|1
7055113|NCT01862328|11148204|FG002|Overall Study|Withdrawal by Subject|0
7055114|NCT01862328|11148205|FG003|Overall Study|Withdrawal by Subject|0
7055115|NCT01862328|11148206|FG004|Overall Study|Withdrawal by Subject|1
7055116|NCT01862328|11148207|FG005|Overall Study|Withdrawal by Subject|1
7055117|NCT01862328|11148208|FG006|Overall Study|Withdrawal by Subject|1
7055118|NCT01862328|11148202|FG000|Overall Study|Symptomatic Deterioration|0
7055119|NCT01862328|11148203|FG001|Overall Study|Symptomatic Deterioration|0
7055120|NCT01862328|11148204|FG002|Overall Study|Symptomatic Deterioration|0
7055121|NCT01862328|11148205|FG003|Overall Study|Symptomatic Deterioration|0
7084869|NCT02171065|11197433|FG000|Overall Study|Lost to Follow-up|0
7084870|NCT02171065|11197434|FG001|Overall Study|Lost to Follow-up|0
7084871|NCT02171065|11197435|FG002|Overall Study|Lost to Follow-up|1
7084872|NCT02171130|11197445|FG000|Overall Study|Death|1
7084873|NCT02171130|11197445|FG000|Overall Study|Discontinued; Clinical Material Issue|16
7084874|NCT02171130|11197445|FG000|Overall Study|Discontinued; Site Termination|5
7084875|NCT02171130|11197445|FG000|Overall Study|Withdrawal by Subject|3
7084876|NCT02171130|11197445|FG000|Overall Study|Physician Decision|1
7084877|NCT02171130|11197445|FG000|Overall Study|Lost to Follow-up|1
7084878|NCT02171130|11197445|FG000|Overall Study|Met Exclusion Criteria|1
7084879|NCT02171260|11197520|FG000|Overall Study|Death|0
7084880|NCT02171260|11197521|FG001|Overall Study|Death|0
7084881|NCT02171260|11197522|FG002|Overall Study|Death|0
7084882|NCT02171260|11197523|FG003|Overall Study|Death|1
7084883|NCT02171260|11197520|FG000|Overall Study|Physician Decision|1
7084884|NCT02171260|11197521|FG001|Overall Study|Physician Decision|0
7084885|NCT02171260|11197522|FG002|Overall Study|Physician Decision|1
7084886|NCT02171260|11197523|FG003|Overall Study|Physician Decision|0
7084887|NCT02171260|11197520|FG000|Overall Study|Withdrawal by Subject|1
7084888|NCT02171260|11197521|FG001|Overall Study|Withdrawal by Subject|0
7084889|NCT02171260|11197522|FG002|Overall Study|Withdrawal by Subject|0
7084890|NCT02171260|11197523|FG003|Overall Study|Withdrawal by Subject|0
7084891|NCT02171260|11197520|FG000|Overall Study|Evidence of progressive disease|4
7084892|NCT02171260|11197521|FG001|Overall Study|Evidence of progressive disease|6
7084893|NCT02171260|11197522|FG002|Overall Study|Evidence of progressive disease|4
7084894|NCT02171260|11197523|FG003|Overall Study|Evidence of progressive disease|4
7084895|NCT02171429|11197542|FG000|Overall Study|Other|0
7084896|NCT02171429|11197543|FG001|Overall Study|Other|1
7084897|NCT02171429|11197544|FG002|Overall Study|Other|1
7084898|NCT02171429|11197542|FG000|Overall Study|Non-Compliance|0
7084899|NCT02171429|11197543|FG001|Overall Study|Non-Compliance|0
7084900|NCT02171429|11197544|FG002|Overall Study|Non-Compliance|1
7084901|NCT02171429|11197542|FG000|Overall Study|Physician Decision|0
7084902|NCT02171429|11197543|FG001|Overall Study|Physician Decision|0
7084903|NCT02171429|11197544|FG002|Overall Study|Physician Decision|1
7084904|NCT02171429|11197542|FG000|Overall Study|Withdrawal by Subject|1
7084905|NCT02171429|11197543|FG001|Overall Study|Withdrawal by Subject|1
7084906|NCT02171429|11197544|FG002|Overall Study|Withdrawal by Subject|1
7084907|NCT02171429|11197542|FG000|Overall Study|Lost to Follow-up|0
7084908|NCT02171429|11197543|FG001|Overall Study|Lost to Follow-up|1
7084909|NCT02171429|11197544|FG002|Overall Study|Lost to Follow-up|0
7084910|NCT02171429|11197542|FG000|Overall Study|Death|0
7084911|NCT02171429|11197543|FG001|Overall Study|Death|0
7084912|NCT02171429|11197544|FG002|Overall Study|Death|1
7084913|NCT02172040|11197589|FG000|Overall Study|Adverse Event|0
7084914|NCT02172040|11197590|FG001|Overall Study|Adverse Event|2
6805190|NCT00129402|10807232|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
6805191|NCT00129402|10807233|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
6805192|NCT00129402|10807227|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
7084915|NCT02172040|11197591|FG002|Overall Study|Adverse Event|0
7084916|NCT02172040|11197592|FG003|Overall Study|Adverse Event|0
6805193|NCT00129402|10807228|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
6805194|NCT00129402|10807229|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
7055122|NCT01862328|11148206|FG004|Overall Study|Symptomatic Deterioration|0
7055123|NCT01862328|11148207|FG005|Overall Study|Symptomatic Deterioration|0
7055124|NCT01862328|11148208|FG006|Overall Study|Symptomatic Deterioration|1
7055125|NCT01862484|11148241|FG000|Overall Study|Lack of Efficacy|1
7055126|NCT01862484|11148242|FG001|Overall Study|Lack of Efficacy|1
6805195|NCT00129402|10807230|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
7055127|NCT01862484|11148241|FG000|Overall Study|Lost to Follow-up|1
7055128|NCT01862484|11148242|FG001|Overall Study|Lost to Follow-up|2
7055129|NCT01862484|11148241|FG000|Overall Study|Protocol Violation|0
7055130|NCT01862484|11148242|FG001|Overall Study|Protocol Violation|2
7055131|NCT01862484|11148241|FG000|Overall Study|Withdrawal by Subject|0
7084917|NCT02172040|11197589|FG000|Overall Study|Protocol Violation|0
7055132|NCT01862484|11148242|FG001|Overall Study|Withdrawal by Subject|3
7055133|NCT01862640|11148270|FG000|Overall Study|Adverse Event|4
7055134|NCT01862640|11148271|FG001|Overall Study|Adverse Event|10
7055135|NCT01862640|11148272|FG002|Overall Study|Adverse Event|6
7055136|NCT01862640|11148273|FG003|Overall Study|Adverse Event|8
7055137|NCT01862640|11148270|FG000|Overall Study|Participant Met Withdrawal Criteria|1
7055138|NCT01862640|11148271|FG001|Overall Study|Participant Met Withdrawal Criteria|1
7055139|NCT01862640|11148272|FG002|Overall Study|Participant Met Withdrawal Criteria|2
7055140|NCT01862640|11148273|FG003|Overall Study|Participant Met Withdrawal Criteria|1
7055141|NCT01862640|11148270|FG000|Overall Study|Participant Withdrawn by Investigator|0
7055142|NCT01862640|11148271|FG001|Overall Study|Participant Withdrawn by Investigator|1
7055143|NCT01862640|11148272|FG002|Overall Study|Participant Withdrawn by Investigator|1
7055144|NCT01862640|11148273|FG003|Overall Study|Participant Withdrawn by Investigator|1
7055145|NCT01862640|11148270|FG000|Overall Study|Withdrawal by Subject|2
7055146|NCT01862640|11148271|FG001|Overall Study|Withdrawal by Subject|4
7055147|NCT01862640|11148272|FG002|Overall Study|Withdrawal by Subject|8
7055148|NCT01862640|11148273|FG003|Overall Study|Withdrawal by Subject|5
7055149|NCT01862640|11148270|FG000|Overall Study|Protocol Deviation|0
7055150|NCT01862640|11148271|FG001|Overall Study|Protocol Deviation|0
7055151|NCT01862640|11148272|FG002|Overall Study|Protocol Deviation|1
7055152|NCT01862640|11148273|FG003|Overall Study|Protocol Deviation|0
7055153|NCT01862796|11148285|FG000|Overall Study|Prohibited medications|0
7055154|NCT01862796|11148286|FG001|Overall Study|Prohibited medications|0
7055155|NCT01862796|11148287|FG002|Overall Study|Prohibited medications|1
7055156|NCT01862874|11148297|FG000|Overall Study|Randomized not treated|1
7055157|NCT01862874|11148298|FG001|Overall Study|Randomized not treated|0
7055158|NCT01862874|11148297|FG000|Overall Study|Adverse Event|0
7055159|NCT01862874|11148298|FG001|Overall Study|Adverse Event|3
7055160|NCT01862874|11148297|FG000|Overall Study|Lost to Follow-up|26
7055161|NCT01862874|11148298|FG001|Overall Study|Lost to Follow-up|29
7055162|NCT01862874|11148297|FG000|Overall Study|Physician Decision|5
7055163|NCT01862874|11148298|FG001|Overall Study|Physician Decision|3
7055164|NCT01862874|11148297|FG000|Overall Study|Withdrawn by parent/guardian|1
7055165|NCT01862874|11148298|FG001|Overall Study|Withdrawn by parent/guardian|1
7055166|NCT01862874|11148297|FG000|Overall Study|Withdrawal by Subject|46
7055167|NCT01862874|11148298|FG001|Overall Study|Withdrawal by Subject|40
7055168|NCT01862874|11148297|FG000|Overall Study|Death|0
7055169|NCT01862874|11148298|FG001|Overall Study|Death|1
7055170|NCT01862991|11148307|FG000|Overall Study|Lost to Follow-up|2
7055171|NCT01862991|11148308|FG001|Overall Study|Lost to Follow-up|1
7055172|NCT01862991|11148309|FG002|Overall Study|Lost to Follow-up|1
7055173|NCT01862991|11148307|FG000|Overall Study|Protocol Violation|1
7055174|NCT01862991|11148308|FG001|Overall Study|Protocol Violation|0
7055175|NCT01862991|11148309|FG002|Overall Study|Protocol Violation|0
7055176|NCT01863368|11148342|FG000|Phase I, Day 0 to Day 35|Adverse Event|2
7055177|NCT01863368|11148343|FG001|Phase I, Day 0 to Day 35|Adverse Event|4
7055178|NCT01863368|11148342|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1
7055179|NCT01863368|11148343|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0
7055180|NCT01863368|11148342|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0
7055181|NCT01863368|11148343|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1
7055182|NCT01863368|11148342|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0
7055183|NCT01863368|11148343|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2
7055184|NCT01863368|11148342|FG000|Phase II, Day 35 to Day 90|Adverse Event|1
7055185|NCT01863368|11148343|FG001|Phase II, Day 35 to Day 90|Adverse Event|0
7055186|NCT01863368|11148342|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1
7055187|NCT01863368|11148343|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0
7055188|NCT01863433|11148350|FG000|Overall Study|Protocol Violation|1
7055189|NCT01863667|11148369|FG000|Overall Study|Adverse Event|1
7055190|NCT01863667|11148370|FG001|Overall Study|Adverse Event|0
7055191|NCT01863667|11148369|FG000|Overall Study|Study terminated by Sponsor|30
7055192|NCT01863667|11148370|FG001|Overall Study|Study terminated by Sponsor|30
7055193|NCT01863667|11148369|FG000|Overall Study|Withdrawal by Subject|2
7055194|NCT01863667|11148370|FG001|Overall Study|Withdrawal by Subject|2
7055195|NCT01863680|11148376|FG000|Overall Study|Adverse Event|17
7055196|NCT01863680|11148376|FG000|Overall Study|Risk of OHSS|17
7055197|NCT01863680|11148376|FG000|Overall Study|Spontaneous pregnancy|2
7055198|NCT01863680|11148376|FG000|Overall Study|Withdrawal by Subject|1
7055199|NCT01863680|11148376|FG000|Overall Study|Did not undergo IVF/ET|14
7055200|NCT01863680|11148376|FG000|Overall Study|Other|6
7055201|NCT01863732|11148384|FG000|Overall Study|Adverse Event|2
7055202|NCT01863732|11148385|FG001|Overall Study|Adverse Event|0
7055203|NCT01863732|11148386|FG002|Overall Study|Adverse Event|3
7055204|NCT01863732|11148387|FG003|Overall Study|Adverse Event|3
7055205|NCT01863732|11148384|FG000|Overall Study|Lack of Efficacy|1
7055206|NCT01863732|11148385|FG001|Overall Study|Lack of Efficacy|0
7055207|NCT01863732|11148386|FG002|Overall Study|Lack of Efficacy|2
7055208|NCT01863732|11148387|FG003|Overall Study|Lack of Efficacy|1
7055209|NCT01863732|11148384|FG000|Overall Study|Lost to Follow-up|2
7055210|NCT01863732|11148385|FG001|Overall Study|Lost to Follow-up|2
7055211|NCT01863732|11148386|FG002|Overall Study|Lost to Follow-up|1
7055212|NCT01863732|11148387|FG003|Overall Study|Lost to Follow-up|1
7055213|NCT01863732|11148384|FG000|Overall Study|Physician Decision|1
7055214|NCT01863732|11148385|FG001|Overall Study|Physician Decision|0
7055215|NCT01863732|11148386|FG002|Overall Study|Physician Decision|1
7055216|NCT01863732|11148387|FG003|Overall Study|Physician Decision|0
7055217|NCT01863732|11148384|FG000|Overall Study|Pregnancy|0
7055218|NCT01863732|11148385|FG001|Overall Study|Pregnancy|0
7055219|NCT01863732|11148386|FG002|Overall Study|Pregnancy|0
7055220|NCT01863732|11148387|FG003|Overall Study|Pregnancy|1
7055221|NCT01863732|11148384|FG000|Overall Study|Technical problems|0
7055222|NCT01863732|11148385|FG001|Overall Study|Technical problems|1
7055223|NCT01863732|11148386|FG002|Overall Study|Technical problems|1
7055224|NCT01863732|11148387|FG003|Overall Study|Technical problems|0
7055225|NCT01863732|11148384|FG000|Overall Study|Subject/guardian decision|6
7055226|NCT01863732|11148385|FG001|Overall Study|Subject/guardian decision|9
7055227|NCT01863732|11148386|FG002|Overall Study|Subject/guardian decision|3
7055228|NCT01863732|11148387|FG003|Overall Study|Subject/guardian decision|1
7055229|NCT01863732|11148384|FG000|Overall Study|Death|1
7055230|NCT01863732|11148385|FG001|Overall Study|Death|0
7055231|NCT01863732|11148386|FG002|Overall Study|Death|0
7055232|NCT01863732|11148387|FG003|Overall Study|Death|1
7055233|NCT01863758|11148396|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1
7055234|NCT01863758|11148396|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1
7055235|NCT01863771|11148400|FG000|Induction Phase|Adverse Event|9
7055236|NCT01863771|11148401|FG001|Induction Phase|Adverse Event|0
7055237|NCT01863771|11148402|FG002|Induction Phase|Adverse Event|0
7055238|NCT01863771|11148403|FG003|Induction Phase|Adverse Event|0
7055239|NCT01863771|11148400|FG000|Induction Phase|Lack of Efficacy|10
7055240|NCT01863771|11148401|FG001|Induction Phase|Lack of Efficacy|0
7055241|NCT01863771|11148402|FG002|Induction Phase|Lack of Efficacy|0
7055242|NCT01863771|11148403|FG003|Induction Phase|Lack of Efficacy|0
7055243|NCT01863771|11148400|FG000|Induction Phase|Withdrawal by Subject|2
7055244|NCT01863771|11148401|FG001|Induction Phase|Withdrawal by Subject|0
7055245|NCT01863771|11148402|FG002|Induction Phase|Withdrawal by Subject|0
7055246|NCT01863771|11148403|FG003|Induction Phase|Withdrawal by Subject|0
7055247|NCT01863771|11148400|FG000|Maintenance Phase|Adverse Event|0
7055248|NCT01863771|11148401|FG001|Maintenance Phase|Adverse Event|0
7055249|NCT01863771|11148402|FG002|Maintenance Phase|Adverse Event|1
7055250|NCT01863771|11148403|FG003|Maintenance Phase|Adverse Event|1
7055251|NCT01863771|11148400|FG000|Maintenance Phase|Lack of Efficacy|0
7055252|NCT01863771|11148401|FG001|Maintenance Phase|Lack of Efficacy|3
7055253|NCT01863771|11148402|FG002|Maintenance Phase|Lack of Efficacy|7
7055254|NCT01863771|11148403|FG003|Maintenance Phase|Lack of Efficacy|38
7055255|NCT01863771|11148400|FG000|Maintenance Phase|Physician Decision|0
7055256|NCT01863771|11148401|FG001|Maintenance Phase|Physician Decision|0
7055257|NCT01863771|11148402|FG002|Maintenance Phase|Physician Decision|2
7055258|NCT01863771|11148403|FG003|Maintenance Phase|Physician Decision|1
7055259|NCT01863771|11148400|FG000|Maintenance Phase|Pregnancy|0
7055260|NCT01863771|11148401|FG001|Maintenance Phase|Pregnancy|1
7055261|NCT01863771|11148402|FG002|Maintenance Phase|Pregnancy|0
7055262|NCT01863771|11148403|FG003|Maintenance Phase|Pregnancy|0
7055263|NCT01863771|11148400|FG000|Maintenance Phase|Withdrawal by Subject|0
7055264|NCT01863771|11148401|FG001|Maintenance Phase|Withdrawal by Subject|1
7055265|NCT01863771|11148402|FG002|Maintenance Phase|Withdrawal by Subject|2
7055266|NCT01863771|11148403|FG003|Maintenance Phase|Withdrawal by Subject|3
7055267|NCT01863849|11148413|FG000|Overall Study|Lost to Follow-up|1
7055268|NCT01863849|11148414|FG001|Overall Study|Lost to Follow-up|0
7055269|NCT01863953|11148424|FG000|Overall Study|Adverse Event|0
7055270|NCT01863953|11148425|FG001|Overall Study|Adverse Event|0
7055271|NCT01863953|11148426|FG002|Overall Study|Adverse Event|1
7055272|NCT01864005|11148436|FG000|Overall Study|Protocol Violation|0
7055273|NCT01864005|11148437|FG001|Overall Study|Protocol Violation|1
7055274|NCT01864005|11148436|FG000|Overall Study|Withdrawal by Subject|0
7055275|NCT01864005|11148437|FG001|Overall Study|Withdrawal by Subject|1
7055276|NCT01864005|11148436|FG000|Overall Study|Incorrect enrolment|1
7055277|NCT01864005|11148437|FG001|Overall Study|Incorrect enrolment|0
7055278|NCT01864005|11148436|FG000|Overall Study|Disease need|1
7055279|NCT01864005|11148437|FG001|Overall Study|Disease need|1
7055280|NCT01864005|11148436|FG000|Overall Study|Need GP IIb/IIIa|1
7055281|NCT01864005|11148437|FG001|Overall Study|Need GP IIb/IIIa|3
7055282|NCT01864148|11148448|FG000|Overall Study|Other|2
7055283|NCT01864148|11148449|FG001|Overall Study|Other|1
7055284|NCT01864148|11148450|FG002|Overall Study|Other|1
7055285|NCT01864148|11148451|FG003|Overall Study|Other|3
7055286|NCT01864148|11148452|FG004|Overall Study|Other|1
7055287|NCT01864148|11148448|FG000|Overall Study|Death|0
7055288|NCT01864148|11148449|FG001|Overall Study|Death|0
7055289|NCT01864148|11148450|FG002|Overall Study|Death|0
7055290|NCT01864148|11148451|FG003|Overall Study|Death|1
7055291|NCT01864148|11148452|FG004|Overall Study|Death|0
7055292|NCT01864148|11148448|FG000|Overall Study|Investigator Decision|5
7055293|NCT01864148|11148449|FG001|Overall Study|Investigator Decision|0
7055294|NCT01864148|11148450|FG002|Overall Study|Investigator Decision|0
7055295|NCT01864148|11148451|FG003|Overall Study|Investigator Decision|4
7055296|NCT01864148|11148452|FG004|Overall Study|Investigator Decision|6
7055297|NCT01864148|11148448|FG000|Overall Study|Withdrawal by Subject|9
7055298|NCT01864148|11148449|FG001|Overall Study|Withdrawal by Subject|2
7055299|NCT01864148|11148450|FG002|Overall Study|Withdrawal by Subject|6
7055300|NCT01864148|11148451|FG003|Overall Study|Withdrawal by Subject|8
7055301|NCT01864148|11148452|FG004|Overall Study|Withdrawal by Subject|8
7055302|NCT01864148|11148448|FG000|Overall Study|Lost to Follow-up|0
7055303|NCT01864148|11148449|FG001|Overall Study|Lost to Follow-up|0
7055304|NCT01864148|11148450|FG002|Overall Study|Lost to Follow-up|0
7055305|NCT01864148|11148451|FG003|Overall Study|Lost to Follow-up|2
7055306|NCT01864148|11148452|FG004|Overall Study|Lost to Follow-up|1
7055307|NCT01864148|11148448|FG000|Overall Study|Adverse Event|4
7055308|NCT01864148|11148449|FG001|Overall Study|Adverse Event|2
7055309|NCT01864148|11148450|FG002|Overall Study|Adverse Event|4
7055310|NCT01864148|11148451|FG003|Overall Study|Adverse Event|7
7055311|NCT01864148|11148452|FG004|Overall Study|Adverse Event|7
7055312|NCT01864148|11148448|FG000|Overall Study|Not Dosed|0
7055313|NCT01864148|11148449|FG001|Overall Study|Not Dosed|0
7055314|NCT01864148|11148450|FG002|Overall Study|Not Dosed|0
7055315|NCT01864148|11148451|FG003|Overall Study|Not Dosed|1
7055316|NCT01864148|11148452|FG004|Overall Study|Not Dosed|0
7055317|NCT01864174|11148471|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15
7055318|NCT01864174|11148472|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14
7055319|NCT01864174|11148471|FG000|Double Blind - Compliant Randomized|Adverse Event|6
7055320|NCT01864174|11148472|FG001|Double Blind - Compliant Randomized|Adverse Event|1
7055321|NCT01864174|11148471|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2
7055322|NCT01864174|11148472|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0
7055323|NCT01864174|11148471|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4
7055324|NCT01864174|11148472|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5
7055325|NCT01864174|11148471|FG000|Double Blind - Compliant Randomized|Death|1
7055326|NCT01864174|11148472|FG001|Double Blind - Compliant Randomized|Death|0
7055327|NCT01864174|11148471|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3
7055328|NCT01864174|11148472|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10
7055329|NCT01864174|11148471|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1
7055330|NCT01864174|11148472|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0
7055331|NCT01864174|11148471|FG000|Double Blind - Compliant Randomized|Other|6
7055332|NCT01864174|11148472|FG001|Double Blind - Compliant Randomized|Other|10
7055333|NCT01864174|11148471|FG000|Off Treatment Follow-Up|Other|2
7055334|NCT01864174|11148472|FG001|Off Treatment Follow-Up|Other|0
7055335|NCT01864174|11148471|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1
7055336|NCT01864174|11148472|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0
7055337|NCT01864200|11148480|FG000|Overall Study|Lost to Follow-up|1
7055338|NCT01864200|11148481|FG001|Overall Study|Lost to Follow-up|3
7055339|NCT01864200|11148480|FG000|Overall Study|Protocol Violation|1
7055340|NCT01864200|11148481|FG001|Overall Study|Protocol Violation|0
7055341|NCT01864291|11148487|FG000|Overall Study|need for revision surgery|2
7055342|NCT01864525|11148502|FG000|Overall Study|Adverse Event|1
7055343|NCT01864525|11148503|FG001|Overall Study|Adverse Event|0
7055344|NCT01864564|11148515|FG000|Overall Study|Lost to Follow-up|17
7055345|NCT01864564|11148516|FG001|Overall Study|Lost to Follow-up|23
7055346|NCT01864564|11148515|FG000|Overall Study|Withdrawal by Subject|20
7055347|NCT01864564|11148516|FG001|Overall Study|Withdrawal by Subject|11
7055348|NCT01864564|11148515|FG000|Overall Study|Protocol Violation|0
7055349|NCT01864564|11148516|FG001|Overall Study|Protocol Violation|27
7055350|NCT01864564|11148515|FG000|Overall Study|not reported|0
7055351|NCT01864564|11148516|FG001|Overall Study|not reported|34
7055352|NCT01865084|11148525|FG000|Double Blind Period (DB)|Adverse Event|2
7055353|NCT01865084|11148526|FG001|Double Blind Period (DB)|Adverse Event|2
7055354|NCT01865084|11148527|FG002|Double Blind Period (DB)|Adverse Event|1
7055355|NCT01865084|11148525|FG000|Double Blind Period (DB)|Protocol Violation|0
7055356|NCT01865084|11148526|FG001|Double Blind Period (DB)|Protocol Violation|0
7055357|NCT01865084|11148527|FG002|Double Blind Period (DB)|Protocol Violation|1
7055358|NCT01865084|11148525|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
7055359|NCT01865084|11148526|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
7055360|NCT01865084|11148527|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4
7055361|NCT01865084|11148525|FG000|Double Blind Period (DB)|Withdrawal by Subject|1
7055362|NCT01865084|11148526|FG001|Double Blind Period (DB)|Withdrawal by Subject|0
7055363|NCT01865084|11148527|FG002|Double Blind Period (DB)|Withdrawal by Subject|0
7055364|NCT01865084|11148525|FG000|Open Label Extension (OLE) Period|Adverse Event|0
7055365|NCT01865084|11148526|FG001|Open Label Extension (OLE) Period|Adverse Event|0
7055366|NCT01865084|11148527|FG002|Open Label Extension (OLE) Period|Adverse Event|1
7055367|NCT01865084|11148525|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0
7055368|NCT01865084|11148526|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0
7055369|NCT01865084|11148527|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2
7055370|NCT01865084|11148525|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0
7055371|NCT01865084|11148526|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1
7055372|NCT01865084|11148527|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0
7055373|NCT01865084|11148525|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0
7084918|NCT02172040|11197590|FG001|Overall Study|Protocol Violation|1
7084919|NCT02172040|11197591|FG002|Overall Study|Protocol Violation|0
6805196|NCT00129402|10807231|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
6805197|NCT00129402|10807232|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
6805198|NCT00129402|10807233|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1
6805199|NCT00129402|10807227|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
6805200|NCT00129402|10807228|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
6805201|NCT00129402|10807229|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
7055374|NCT01865084|11148526|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8
7055375|NCT01865084|11148527|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2
7055376|NCT01865084|11148525|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0
7055377|NCT01865084|11148526|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2
7055378|NCT01865084|11148527|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2
6805202|NCT00129402|10807230|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
6805203|NCT00129402|10807231|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
6805204|NCT00129402|10807232|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
6805205|NCT00129402|10807233|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3
6805206|NCT00129402|10807227|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0
6805207|NCT00129402|10807228|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0
6805208|NCT00129402|10807229|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0
6805209|NCT00129402|10807230|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0
6805210|NCT00129402|10807231|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0
6805211|NCT00129402|10807232|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0
7055379|NCT01865448|11148541|FG000|Overall Study|Adverse Event|1
7055380|NCT01865448|11148542|FG001|Overall Study|Adverse Event|1
7055381|NCT01865448|11148541|FG000|Overall Study|Pregnancy|0
7055382|NCT01865448|11148542|FG001|Overall Study|Pregnancy|1
7055383|NCT01865448|11148541|FG000|Overall Study|dropout unrelated to study|1
7055384|NCT01865448|11148542|FG001|Overall Study|dropout unrelated to study|1
7055385|NCT01865487|11148555|FG000|Overall Study|Lost to Follow-up|0
7055386|NCT01865487|11148556|FG001|Overall Study|Lost to Follow-up|0
7055387|NCT01865487|11148557|FG002|Overall Study|Lost to Follow-up|0
7055388|NCT01865487|11148558|FG003|Overall Study|Lost to Follow-up|1
7055389|NCT01865487|11148559|FG004|Overall Study|Lost to Follow-up|0
7055390|NCT01865487|11148560|FG005|Overall Study|Lost to Follow-up|0
7055391|NCT01865487|11148561|FG006|Overall Study|Lost to Follow-up|1
7055392|NCT01865487|11148562|FG007|Overall Study|Lost to Follow-up|0
7055393|NCT01865487|11148563|FG008|Overall Study|Lost to Follow-up|0
7055394|NCT01865487|11148564|FG009|Overall Study|Lost to Follow-up|0
7055395|NCT01865487|11148555|FG000|Overall Study|Withdrawal by Subject|0
7055396|NCT01865487|11148556|FG001|Overall Study|Withdrawal by Subject|0
7055397|NCT01865487|11148557|FG002|Overall Study|Withdrawal by Subject|0
7055398|NCT01865487|11148558|FG003|Overall Study|Withdrawal by Subject|0
7055399|NCT01865487|11148559|FG004|Overall Study|Withdrawal by Subject|1
7055400|NCT01865487|11148560|FG005|Overall Study|Withdrawal by Subject|0
7055401|NCT01865487|11148561|FG006|Overall Study|Withdrawal by Subject|0
7055402|NCT01865487|11148562|FG007|Overall Study|Withdrawal by Subject|0
7055403|NCT01865487|11148563|FG008|Overall Study|Withdrawal by Subject|0
7055404|NCT01865487|11148564|FG009|Overall Study|Withdrawal by Subject|0
7055405|NCT01865552|11148598|FG000|Period 1|Adverse Event|1
7055406|NCT01865552|11148599|FG001|Period 1|Adverse Event|0
7055407|NCT01865552|11148600|FG002|Period 1|Adverse Event|0
7055408|NCT01865552|11148601|FG003|Period 1|Adverse Event|1
7055409|NCT01865552|11148602|FG004|Period 1|Adverse Event|1
7055410|NCT01865552|11148603|FG005|Period 1|Adverse Event|1
7055411|NCT01865552|11148598|FG000|Period 1|Pathological lab|0
7055412|NCT01865552|11148599|FG001|Period 1|Pathological lab|0
7055413|NCT01865552|11148600|FG002|Period 1|Pathological lab|0
7055414|NCT01865552|11148601|FG003|Period 1|Pathological lab|0
7055415|NCT01865552|11148602|FG004|Period 1|Pathological lab|1
7055416|NCT01865552|11148603|FG005|Period 1|Pathological lab|0
7055417|NCT01865552|11148598|FG000|Period 1|Other|0
7055418|NCT01865552|11148599|FG001|Period 1|Other|0
7055419|NCT01865552|11148600|FG002|Period 1|Other|0
7055420|NCT01865552|11148601|FG003|Period 1|Other|0
7055421|NCT01865552|11148602|FG004|Period 1|Other|1
7055422|NCT01865552|11148603|FG005|Period 1|Other|0
7055423|NCT01865747|11148623|FG000|Overall Study (ITT)|Adverse Event|32
7055424|NCT01865747|11148624|FG001|Overall Study (ITT)|Adverse Event|31
7055425|NCT01865747|11148623|FG000|Overall Study (ITT)|Clinical Deterioration|29
7055426|NCT01865747|11148624|FG001|Overall Study (ITT)|Clinical Deterioration|50
7055427|NCT01865747|11148623|FG000|Overall Study (ITT)|Lack of Efficacy|3
7055428|NCT01865747|11148624|FG001|Overall Study (ITT)|Lack of Efficacy|0
7055429|NCT01865747|11148623|FG000|Overall Study (ITT)|Protocol Violation|1
7055430|NCT01865747|11148624|FG001|Overall Study (ITT)|Protocol Violation|1
7055431|NCT01865747|11148623|FG000|Overall Study (ITT)|Physician Decision|5
7055432|NCT01865747|11148624|FG001|Overall Study (ITT)|Physician Decision|2
7055433|NCT01865747|11148623|FG000|Overall Study (ITT)|Withdrawal by Subject|6
7055434|NCT01865747|11148624|FG001|Overall Study (ITT)|Withdrawal by Subject|11
7055435|NCT01865747|11148623|FG000|Overall Study (ITT)|Sponsor Decision|0
7055436|NCT01865747|11148624|FG001|Overall Study (ITT)|Sponsor Decision|1
7055437|NCT01865747|11148623|FG000|Overall Study (ITT)|Progressive Disease|122
7055438|NCT01865747|11148624|FG001|Overall Study (ITT)|Progressive Disease|158
7055439|NCT01865747|11148623|FG000|Overall Study (ITT)|Reason Not Provided|0
7055440|NCT01865747|11148624|FG001|Overall Study (ITT)|Reason Not Provided|1
7055441|NCT01865747|11148623|FG000|Primary Intent to Treat (PITT)|Adverse Event|21
7055442|NCT01865747|11148624|FG001|Primary Intent to Treat (PITT)|Adverse Event|20
7055443|NCT01865747|11148623|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18
7055444|NCT01865747|11148624|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29
7055445|NCT01865747|11148623|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2
7055446|NCT01865747|11148624|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0
7055447|NCT01865747|11148623|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1
7055448|NCT01865747|11148624|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1
7055449|NCT01865747|11148623|FG000|Primary Intent to Treat (PITT)|Physician Decision|4
7055450|NCT01865747|11148624|FG001|Primary Intent to Treat (PITT)|Physician Decision|2
7055451|NCT01865747|11148623|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3
7055452|NCT01865747|11148624|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7
7055453|NCT01865747|11148623|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82
7055454|NCT01865747|11148624|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92
7055455|NCT01865747|11148623|FG000|Primary Intent to Treat (PITT)|Other|0
7055456|NCT01865747|11148624|FG001|Primary Intent to Treat (PITT)|Other|1
7055457|NCT01865812|11148630|FG000|Overall Study|Adverse Event|2
7055458|NCT01866098|11148637|FG000|Overall Study|Lost to Follow-up|11
7055459|NCT01866098|11148638|FG001|Overall Study|Lost to Follow-up|18
7055460|NCT01866098|11148639|FG002|Overall Study|Lost to Follow-up|13
7055461|NCT01866098|11148637|FG000|Overall Study|Physician Decision|0
7055462|NCT01866098|11148638|FG001|Overall Study|Physician Decision|1
7055463|NCT01866098|11148639|FG002|Overall Study|Physician Decision|2
7055464|NCT01866098|11148637|FG000|Overall Study|Adverse Event|1
7055465|NCT01866098|11148638|FG001|Overall Study|Adverse Event|5
7055466|NCT01866098|11148639|FG002|Overall Study|Adverse Event|4
7055467|NCT01866098|11148637|FG000|Overall Study|Protocol Violation|1
7055468|NCT01866098|11148638|FG001|Overall Study|Protocol Violation|0
7055469|NCT01866098|11148639|FG002|Overall Study|Protocol Violation|0
7055470|NCT01866098|11148637|FG000|Overall Study|Withdrawal by Subject|1
7055471|NCT01866098|11148638|FG001|Overall Study|Withdrawal by Subject|2
7055472|NCT01866098|11148639|FG002|Overall Study|Withdrawal by Subject|0
7055473|NCT01866098|11148637|FG000|Overall Study|Unrelated Hospitalization|2
7055474|NCT01866098|11148638|FG001|Overall Study|Unrelated Hospitalization|0
7055475|NCT01866098|11148639|FG002|Overall Study|Unrelated Hospitalization|1
7055476|NCT01866098|11148637|FG000|Overall Study|Non-compliance|1
7055477|NCT01866098|11148638|FG001|Overall Study|Non-compliance|0
7055478|NCT01866098|11148639|FG002|Overall Study|Non-compliance|1
7055479|NCT01866098|11148637|FG000|Overall Study|Pregnancy|2
7055480|NCT01866098|11148638|FG001|Overall Study|Pregnancy|0
7055481|NCT01866098|11148639|FG002|Overall Study|Pregnancy|0
7055482|NCT01866098|11148637|FG000|Overall Study|Death|0
7055483|NCT01866098|11148638|FG001|Overall Study|Death|1
7055484|NCT01866098|11148639|FG002|Overall Study|Death|0
7055485|NCT01866293|11148663|FG000|Overall Study|Adverse Event|2
7055486|NCT01866319|11148699|FG000|Overall Study|Adverse Event|12
7055487|NCT01866319|11148700|FG001|Overall Study|Adverse Event|5
7055488|NCT01866319|11148701|FG002|Overall Study|Adverse Event|9
7055489|NCT01866319|11148699|FG000|Overall Study|Clinical progression|3
7055490|NCT01866319|11148700|FG001|Overall Study|Clinical progression|2
7055491|NCT01866319|11148701|FG002|Overall Study|Clinical progression|2
7055492|NCT01866319|11148699|FG000|Overall Study|Death|153
7055493|NCT01866319|11148700|FG001|Overall Study|Death|154
7055494|NCT01866319|11148701|FG002|Overall Study|Death|147
7055495|NCT01866319|11148699|FG000|Overall Study|Lost to Follow-up|6
7055496|NCT01866319|11148700|FG001|Overall Study|Lost to Follow-up|3
7084920|NCT02172040|11197592|FG003|Overall Study|Protocol Violation|0
7084921|NCT02172040|11197589|FG000|Overall Study|Withdrawal by Subject|0
7084922|NCT02172040|11197590|FG001|Overall Study|Withdrawal by Subject|0
7084923|NCT02172040|11197591|FG002|Overall Study|Withdrawal by Subject|1
7084924|NCT02172040|11197592|FG003|Overall Study|Withdrawal by Subject|0
7084925|NCT02172040|11197589|FG000|Overall Study|Not available for Day 13 & 14 visits|0
7084926|NCT02172040|11197590|FG001|Overall Study|Not available for Day 13 & 14 visits|0
7084927|NCT02172040|11197591|FG002|Overall Study|Not available for Day 13 & 14 visits|1
7084928|NCT02172040|11197592|FG003|Overall Study|Not available for Day 13 & 14 visits|0
7084929|NCT02172040|11197589|FG000|Overall Study|Family emergency abroad|0
7084930|NCT02172040|11197590|FG001|Overall Study|Family emergency abroad|0
7084931|NCT02172040|11197591|FG002|Overall Study|Family emergency abroad|0
7084932|NCT02172040|11197592|FG003|Overall Study|Family emergency abroad|1
7084933|NCT02172625|11197605|FG000|Overall Study|Adverse Event|0
7084934|NCT02172625|11197606|FG001|Overall Study|Adverse Event|1
7084935|NCT02172625|11197605|FG000|Overall Study|Pregnancy|0
7084936|NCT02172625|11197606|FG001|Overall Study|Pregnancy|1
7084937|NCT02172625|11197605|FG000|Overall Study|car accident|0
7084938|NCT02172625|11197606|FG001|Overall Study|car accident|1
7084939|NCT02172664|11197616|FG000|Overall Study|Lost to Follow-up|4
7084940|NCT02172664|11197617|FG001|Overall Study|Lost to Follow-up|4
7084941|NCT02172664|11197616|FG000|Overall Study|Death|1
7084942|NCT02172664|11197617|FG001|Overall Study|Death|1
7084943|NCT02172664|11197616|FG000|Overall Study|Moved out of area|1
7084944|NCT02172664|11197617|FG001|Overall Study|Moved out of area|1
7084945|NCT02172911|11197650|FG000|Overall Study|Serious Adverse Event|0
7084946|NCT02172911|11197651|FG001|Overall Study|Serious Adverse Event|1
7084947|NCT02172911|11197650|FG000|Overall Study|Progression of Disease|0
7084948|NCT02172911|11197651|FG001|Overall Study|Progression of Disease|1
7084949|NCT02172911|11197650|FG000|Overall Study|Loss of insurance coverage|1
7084950|NCT02172911|11197651|FG001|Overall Study|Loss of insurance coverage|0
7084951|NCT02172950|11197659|FG000|Overall Study|Physician Decision|3
7084952|NCT02172950|11197660|FG001|Overall Study|Physician Decision|3
7084953|NCT02172950|11197659|FG000|Overall Study|Lack of Efficacy|1
7084954|NCT02172950|11197660|FG001|Overall Study|Lack of Efficacy|0
7084955|NCT02172950|11197659|FG000|Overall Study|Adverse Event|4
7084956|NCT02172950|11197660|FG001|Overall Study|Adverse Event|1
7084957|NCT02172950|11197659|FG000|Overall Study|Withdrawal by Subject|10
7084958|NCT02172950|11197660|FG001|Overall Study|Withdrawal by Subject|0
7084959|NCT02172950|11197659|FG000|Overall Study|Protocol Violation|1
7084960|NCT02172950|11197660|FG001|Overall Study|Protocol Violation|0
7055497|NCT01866319|11148701|FG002|Overall Study|Lost to Follow-up|8
7084961|NCT02172950|11197659|FG000|Overall Study|Lost to Follow-up|1
7084962|NCT02172950|11197660|FG001|Overall Study|Lost to Follow-up|0
7084963|NCT02172950|11197659|FG000|Overall Study|Death|1
7084964|NCT02172950|11197660|FG001|Overall Study|Death|0
7084965|NCT02172950|11197659|FG000|Overall Study|Patient traveling|1
7084966|NCT02172950|11197660|FG001|Overall Study|Patient traveling|0
7084967|NCT02172950|11197659|FG000|Overall Study|Patient went to other country|1
7084968|NCT02172950|11197660|FG001|Overall Study|Patient went to other country|0
7055498|NCT01866319|11148699|FG000|Overall Study|Physician Decision|1
7055499|NCT01866319|11148700|FG001|Overall Study|Physician Decision|0
7055500|NCT01866319|11148701|FG002|Overall Study|Physician Decision|1
7055501|NCT01866319|11148699|FG000|Overall Study|Protocol Violation|0
7055502|NCT01866319|11148700|FG001|Overall Study|Protocol Violation|0
7055503|NCT01866319|11148701|FG002|Overall Study|Protocol Violation|1
7055504|NCT01866319|11148699|FG000|Overall Study|Withdrawal by Subject|32
7055505|NCT01866319|11148700|FG001|Overall Study|Withdrawal by Subject|14
7055506|NCT01866319|11148701|FG002|Overall Study|Withdrawal by Subject|12
7055507|NCT01866423|11148716|FG000|Overall Study|Lack of Efficacy|3
7055508|NCT01866423|11148716|FG000|Overall Study|Sponsor Decision|1
7055509|NCT01866826|11148724|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1
7055510|NCT01866826|11148725|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0
7055511|NCT01866826|11148724|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0
7055512|NCT01866826|11148725|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2
7055513|NCT01866826|11148724|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0
7055514|NCT01866826|11148725|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1
7055515|NCT01866917|11148737|FG000|Overall Study|Pharmacist stopped dispensing treatment|4
7055516|NCT01866917|11148738|FG001|Overall Study|Pharmacist stopped dispensing treatment|6
7055517|NCT01867008|11148756|FG000|Overall Study|Withdrawal by Subject|1
7055518|NCT01867021|11148762|FG000|Overall Study|Adverse Event|0
7055519|NCT01867021|11148763|FG001|Overall Study|Adverse Event|1
7055520|NCT01867021|11148762|FG000|Overall Study|Not Eligible|0
7055521|NCT01867021|11148763|FG001|Overall Study|Not Eligible|1
7055522|NCT01867021|11148762|FG000|Overall Study|Death|1
7055523|NCT01867021|11148763|FG001|Overall Study|Death|0
7055524|NCT01867021|11148762|FG000|Overall Study|Lost to Follow-up|0
7055525|NCT01867021|11148763|FG001|Overall Study|Lost to Follow-up|2
7055526|NCT01867021|11148762|FG000|Overall Study|Withdrawal by Subject|1
7055527|NCT01867021|11148763|FG001|Overall Study|Withdrawal by Subject|6
7055528|NCT01867047|11148776|FG000|Overall Study|Lost to Follow-up|3
7055529|NCT01867047|11148777|FG001|Overall Study|Lost to Follow-up|3
7055530|NCT01867047|11148776|FG000|Overall Study|Withdrawal by Subject|2
7055531|NCT01867047|11148777|FG001|Overall Study|Withdrawal by Subject|0
7055532|NCT01867047|11148776|FG000|Overall Study|Physician Decision|2
7055533|NCT01867047|11148777|FG001|Overall Study|Physician Decision|0
7055534|NCT01867047|11148776|FG000|Overall Study|surgery not indicated in protocol|1
7055535|NCT01867047|11148777|FG001|Overall Study|surgery not indicated in protocol|2
7055536|NCT01867086|11148787|FG000|Overall Study|Disease Progression|1
7055537|NCT01867216|11148807|FG000|Overall Study|Withdrawal by Subject|2
7055538|NCT01867216|11148808|FG001|Overall Study|Withdrawal by Subject|0
7055539|NCT01867216|11148809|FG002|Overall Study|Withdrawal by Subject|0
7055540|NCT01867216|11148810|FG003|Overall Study|Withdrawal by Subject|0
7055541|NCT01867216|11148811|FG004|Overall Study|Withdrawal by Subject|1
7055542|NCT01867216|11148812|FG005|Overall Study|Withdrawal by Subject|0
7055543|NCT01867216|11148813|FG006|Overall Study|Withdrawal by Subject|1
7055544|NCT01867216|11148807|FG000|Overall Study|Physician Decision|1
7055545|NCT01867216|11148808|FG001|Overall Study|Physician Decision|0
7055546|NCT01867216|11148809|FG002|Overall Study|Physician Decision|0
7055547|NCT01867216|11148810|FG003|Overall Study|Physician Decision|0
7055548|NCT01867216|11148811|FG004|Overall Study|Physician Decision|0
7055549|NCT01867216|11148812|FG005|Overall Study|Physician Decision|0
7055550|NCT01867216|11148813|FG006|Overall Study|Physician Decision|0
7055551|NCT01867216|11148807|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1
7055552|NCT01867216|11148808|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0
7055553|NCT01867216|11148809|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0
7055554|NCT01867216|11148810|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0
7055555|NCT01867216|11148811|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0
7055556|NCT01867216|11148812|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0
7055557|NCT01867216|11148813|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0
7055558|NCT01867294|11148839|FG000|Overall Study|Withdrawal by Subject|1
7055559|NCT01867294|11148840|FG001|Overall Study|Withdrawal by Subject|1
7055560|NCT01867294|11148841|FG002|Overall Study|Withdrawal by Subject|0
7055561|NCT01867294|11148842|FG003|Overall Study|Withdrawal by Subject|0
7055562|NCT01867307|11148852|FG000|Overall Study|Protocol Violation|2
7055563|NCT01867307|11148853|FG001|Overall Study|Protocol Violation|0
7055564|NCT01867307|11148852|FG000|Overall Study|Other Adverse Event|1
7055565|NCT01867307|11148853|FG001|Overall Study|Other Adverse Event|3
7084969|NCT02172950|11197659|FG000|Overall Study|Patient relocated overseas|1
7084970|NCT02172950|11197660|FG001|Overall Study|Patient relocated overseas|1
7084971|NCT02172950|11197659|FG000|Overall Study|Patient moving|1
7084972|NCT02172950|11197660|FG001|Overall Study|Patient moving|0
7084973|NCT02173054|11197670|FG000|Overall Study|lack of compliance|1
7084974|NCT02173054|11197671|FG001|Overall Study|lack of compliance|0
7084975|NCT02173054|11197672|FG002|Overall Study|lack of compliance|0
7084976|NCT02173054|11197670|FG000|Overall Study|Withdrawal by Subject|0
7084977|NCT02173054|11197671|FG001|Overall Study|Withdrawal by Subject|0
7084978|NCT02173054|11197672|FG002|Overall Study|Withdrawal by Subject|1
7084979|NCT02173158|11197680|FG000|Efficacy Phase|Adverse Event|1
7084980|NCT02173548|11197771|FG000|Overall Study|Lost to Follow-up|0
7084981|NCT02173548|11197772|FG001|Overall Study|Lost to Follow-up|2
7084982|NCT02173548|11197771|FG000|Overall Study|Withdrawal by Subject|1
7084983|NCT02173548|11197772|FG001|Overall Study|Withdrawal by Subject|0
7084984|NCT02173704|11197780|FG000|Overall Study|Adverse Event|1
7084985|NCT02173704|11197781|FG001|Overall Study|Adverse Event|0
7084986|NCT02173704|11197780|FG000|Overall Study|Lost to Follow-up|1
7084987|NCT02173704|11197781|FG001|Overall Study|Lost to Follow-up|0
7084988|NCT02173704|11197780|FG000|Overall Study|Other|1
7084989|NCT02173704|11197781|FG001|Overall Study|Other|0
7084990|NCT02173704|11197780|FG000|Overall Study|Protocol Violation|1
7055566|NCT01867424|11148861|FG000|Overall Study|Patient noncompliance|2
7055567|NCT01867424|11148862|FG001|Overall Study|Patient noncompliance|1
7055568|NCT01867580|11148883|FG000|Overall Study|Withdrawal by Subject|2
7055569|NCT01867580|11148884|FG001|Overall Study|Withdrawal by Subject|3
7055570|NCT01867580|11148883|FG000|Overall Study|Physician Decision|17
7055571|NCT01867580|11148884|FG001|Overall Study|Physician Decision|12
7055572|NCT01867580|11148883|FG000|Overall Study|Lost to Follow-up|3
7055573|NCT01867580|11148884|FG001|Overall Study|Lost to Follow-up|5
7055574|NCT01867580|11148883|FG000|Overall Study|Sponsor terminated study|1
7055575|NCT01867580|11148884|FG001|Overall Study|Sponsor terminated study|0
7055576|NCT01867580|11148883|FG000|Overall Study|Missed follow-up assessment|2
7055577|NCT01867580|11148884|FG001|Overall Study|Missed follow-up assessment|1
7055578|NCT01867580|11148883|FG000|Overall Study|Interruption to therapy|3
7055579|NCT01867580|11148884|FG001|Overall Study|Interruption to therapy|0
7055580|NCT01867580|11148883|FG000|Overall Study|Osteomyelitis|0
7055581|NCT01867580|11148884|FG001|Overall Study|Osteomyelitis|1
7055582|NCT01867580|11148883|FG000|Overall Study|Continuation of therapy|0
7055583|NCT01867580|11148884|FG001|Overall Study|Continuation of therapy|1
7055584|NCT01867580|11148883|FG000|Overall Study|Wound recurrence|0
7055585|NCT01867580|11148884|FG001|Overall Study|Wound recurrence|1
7055586|NCT01867658|11148899|FG000|Overall Study|Withdrawal by Subject|6
7055587|NCT01867658|11148899|FG000|Overall Study|Death|2
7055588|NCT01867658|11148899|FG000|Overall Study|Subject could not be contacted|1
7084991|NCT02173704|11197781|FG001|Overall Study|Protocol Violation|0
7084992|NCT02173704|11197780|FG000|Overall Study|Withdrawal by Subject|9
7084993|NCT02173704|11197781|FG001|Overall Study|Withdrawal by Subject|4
7084994|NCT02173769|11197787|FG000|Overall Study|Protocol Violation|4
7084995|NCT02174276|11197805|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1
7084996|NCT02174276|11197806|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
7084997|NCT02174276|11197807|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
7084998|NCT02174276|11197808|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
7084999|NCT02174276|11197805|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
7085000|NCT02174276|11197806|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
7085001|NCT02174276|11197807|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1
7085002|NCT02174276|11197808|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
7085003|NCT02174276|11197805|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0
7085004|NCT02174276|11197806|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1
7085005|NCT02174276|11197807|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2
7085006|NCT02174276|11197808|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0
7085007|NCT02174276|11197805|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
7085008|NCT02174276|11197806|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
7085009|NCT02174276|11197807|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1
7085010|NCT02174276|11197808|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
7085011|NCT02174276|11197805|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0
7085012|NCT02174276|11197806|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0
7085013|NCT02174276|11197807|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1
7085014|NCT02174276|11197808|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0
7085015|NCT02174276|11197805|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1
7085016|NCT02174276|11197806|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0
7085017|NCT02174276|11197807|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1
7085018|NCT02174276|11197808|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2
7085019|NCT02174523|11197853|FG000|Overall Study|Withdrawal by Subject|1
7085020|NCT02174523|11197854|FG001|Overall Study|Withdrawal by Subject|0
7085021|NCT02174562|11197861|FG000|Overall Study|Withdrawal by Subject|7
7085022|NCT02174562|11197862|FG001|Overall Study|Withdrawal by Subject|2
7085023|NCT02174562|11197861|FG000|Overall Study|Death|2
7085024|NCT02174562|11197862|FG001|Overall Study|Death|0
7085025|NCT02174562|11197861|FG000|Overall Study|Lost to Follow-up|0
7085026|NCT02174562|11197862|FG001|Overall Study|Lost to Follow-up|3
7085027|NCT02174627|11197870|FG000|Overall Study|Missing|0
7085028|NCT02174627|11197871|FG001|Overall Study|Missing|1
7085029|NCT02174627|11197870|FG000|Overall Study|Incorrect enrolment before randomization|0
7055589|NCT01867671|11148905|FG000|Overall Study|Adverse Event|5
7055590|NCT01867671|11148906|FG001|Overall Study|Adverse Event|3
7055591|NCT01867671|11148905|FG000|Overall Study|Anaphylaxis|0
7055592|NCT01867671|11148906|FG001|Overall Study|Anaphylaxis|1
7055593|NCT01867671|11148905|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2
7055594|NCT01867671|11148906|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0
7055595|NCT01867671|11148905|FG000|Overall Study|Lost to Follow-up|0
7055596|NCT01867671|11148906|FG001|Overall Study|Lost to Follow-up|1
7055597|NCT01867671|11148905|FG000|Overall Study|Non-compliance with Study Drug|1
7055598|NCT01867671|11148906|FG001|Overall Study|Non-compliance with Study Drug|2
7055599|NCT01867671|11148905|FG000|Overall Study|Withdrawal by Subject|21
7055600|NCT01867671|11148906|FG001|Overall Study|Withdrawal by Subject|21
7055601|NCT01867710|11148916|FG000|Overall Study|Death|25
7055602|NCT01867710|11148917|FG001|Overall Study|Death|15
7055603|NCT01867710|11148918|FG002|Overall Study|Death|27
7055604|NCT01867710|11148919|FG003|Overall Study|Death|20
7055605|NCT01867710|11148916|FG000|Overall Study|Lost to Follow-up|3
7055606|NCT01867710|11148917|FG001|Overall Study|Lost to Follow-up|4
7055607|NCT01867710|11148918|FG002|Overall Study|Lost to Follow-up|3
7055608|NCT01867710|11148919|FG003|Overall Study|Lost to Follow-up|2
7055609|NCT01867710|11148916|FG000|Overall Study|Withdrawal of consent|2
7055610|NCT01867710|11148917|FG001|Overall Study|Withdrawal of consent|5
7055611|NCT01867710|11148918|FG002|Overall Study|Withdrawal of consent|1
7055612|NCT01867710|11148919|FG003|Overall Study|Withdrawal of consent|2
7055613|NCT01867710|11148916|FG000|Overall Study|Study Terminated by Sponsor|9
7055614|NCT01867710|11148917|FG001|Overall Study|Study Terminated by Sponsor|13
7055615|NCT01867710|11148918|FG002|Overall Study|Study Terminated by Sponsor|8
7055616|NCT01867710|11148919|FG003|Overall Study|Study Terminated by Sponsor|16
7055617|NCT01867710|11148916|FG000|Overall Study|Biochemical progression|0
7055618|NCT01867710|11148917|FG001|Overall Study|Biochemical progression|1
7055619|NCT01867710|11148918|FG002|Overall Study|Biochemical progression|0
7055620|NCT01867710|11148919|FG003|Overall Study|Biochemical progression|0
7055621|NCT01867710|11148916|FG000|Overall Study|Clinical progression|0
7055622|NCT01867710|11148917|FG001|Overall Study|Clinical progression|0
7055623|NCT01867710|11148918|FG002|Overall Study|Clinical progression|1
7055624|NCT01867710|11148919|FG003|Overall Study|Clinical progression|0
7055625|NCT01867710|11148916|FG000|Overall Study|Disease progression|1
7055626|NCT01867710|11148917|FG001|Overall Study|Disease progression|0
7055627|NCT01867710|11148918|FG002|Overall Study|Disease progression|0
7055628|NCT01867710|11148919|FG003|Overall Study|Disease progression|0
7055629|NCT01867710|11148916|FG000|Overall Study|Patient decision|0
7055630|NCT01867710|11148917|FG001|Overall Study|Patient decision|0
7055631|NCT01867710|11148918|FG002|Overall Study|Patient decision|0
7055632|NCT01867710|11148919|FG003|Overall Study|Patient decision|1
7055633|NCT01867710|11148916|FG000|Overall Study|Patient to follow subsequent treatment|0
7055634|NCT01867710|11148917|FG001|Overall Study|Patient to follow subsequent treatment|1
7055635|NCT01867710|11148918|FG002|Overall Study|Patient to follow subsequent treatment|0
7055636|NCT01867710|11148919|FG003|Overall Study|Patient to follow subsequent treatment|0
7055637|NCT01867710|11148916|FG000|Overall Study|Progressive disease|1
7055638|NCT01867710|11148917|FG001|Overall Study|Progressive disease|0
7055639|NCT01867710|11148918|FG002|Overall Study|Progressive disease|0
7055640|NCT01867710|11148919|FG003|Overall Study|Progressive disease|0
7055641|NCT01867710|11148916|FG000|Overall Study|Protocol Violation|0
7055642|NCT01867710|11148917|FG001|Overall Study|Protocol Violation|0
7055643|NCT01867710|11148918|FG002|Overall Study|Protocol Violation|0
7055644|NCT01867710|11148919|FG003|Overall Study|Protocol Violation|1
7055645|NCT01867710|11148916|FG000|Overall Study|PSA-progression|0
7055646|NCT01867710|11148917|FG001|Overall Study|PSA-progression|1
7055647|NCT01867710|11148918|FG002|Overall Study|PSA-progression|0
7055648|NCT01867710|11148919|FG003|Overall Study|PSA-progression|0
7055649|NCT01867710|11148916|FG000|Overall Study|Study medication no longer effective|0
7055650|NCT01867710|11148917|FG001|Overall Study|Study medication no longer effective|1
7055651|NCT01867710|11148918|FG002|Overall Study|Study medication no longer effective|0
7055652|NCT01867710|11148919|FG003|Overall Study|Study medication no longer effective|0
7055653|NCT01868009|11148929|FG000|Period 1 (5-9 Days)|Adverse Event|0
7055654|NCT01868009|11148930|FG001|Period 1 (5-9 Days)|Adverse Event|2
7055655|NCT01868009|11148929|FG000|Period 2 (5-9 Days)|Adverse Event|1
7055656|NCT01868009|11148930|FG001|Period 2 (5-9 Days)|Adverse Event|0
7055657|NCT01868009|11148929|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1
7055658|NCT01868009|11148930|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0
7055659|NCT01868022|11148945|FG000|Overall Study|Withdrawal by Subject|0
7055660|NCT01868022|11148946|FG001|Overall Study|Withdrawal by Subject|0
7055661|NCT01868022|11148947|FG002|Overall Study|Withdrawal by Subject|1
7055662|NCT01868022|11148948|FG003|Overall Study|Withdrawal by Subject|1
7055663|NCT01868022|11148949|FG004|Overall Study|Withdrawal by Subject|0
7055664|NCT01868022|11148950|FG005|Overall Study|Withdrawal by Subject|0
7055665|NCT01868022|11148951|FG006|Overall Study|Withdrawal by Subject|0
7055666|NCT01868022|11148952|FG007|Overall Study|Withdrawal by Subject|1
7055667|NCT01868022|11148953|FG008|Overall Study|Withdrawal by Subject|0
7055668|NCT01868022|11148945|FG000|Overall Study|Adverse Event|0
7055669|NCT01868022|11148946|FG001|Overall Study|Adverse Event|0
7055670|NCT01868022|11148947|FG002|Overall Study|Adverse Event|0
7055671|NCT01868022|11148948|FG003|Overall Study|Adverse Event|0
7055672|NCT01868022|11148949|FG004|Overall Study|Adverse Event|2
7055673|NCT01868022|11148950|FG005|Overall Study|Adverse Event|0
7055674|NCT01868022|11148951|FG006|Overall Study|Adverse Event|0
7055675|NCT01868022|11148952|FG007|Overall Study|Adverse Event|2
7055676|NCT01868022|11148953|FG008|Overall Study|Adverse Event|2
7055677|NCT01868022|11148945|FG000|Overall Study|Physician Decision|0
7055678|NCT01868022|11148946|FG001|Overall Study|Physician Decision|0
7055679|NCT01868022|11148947|FG002|Overall Study|Physician Decision|0
7055680|NCT01868022|11148948|FG003|Overall Study|Physician Decision|0
7055681|NCT01868022|11148949|FG004|Overall Study|Physician Decision|0
7055682|NCT01868022|11148950|FG005|Overall Study|Physician Decision|1
7055683|NCT01868022|11148951|FG006|Overall Study|Physician Decision|0
7055684|NCT01868022|11148952|FG007|Overall Study|Physician Decision|2
7055685|NCT01868022|11148953|FG008|Overall Study|Physician Decision|0
7055686|NCT01868022|11148945|FG000|Overall Study|Study closed/terminated|0
7055687|NCT01868022|11148946|FG001|Overall Study|Study closed/terminated|0
7055688|NCT01868022|11148947|FG002|Overall Study|Study closed/terminated|0
7055689|NCT01868022|11148948|FG003|Overall Study|Study closed/terminated|0
7055690|NCT01868022|11148949|FG004|Overall Study|Study closed/terminated|0
7055691|NCT01868022|11148950|FG005|Overall Study|Study closed/terminated|0
7055692|NCT01868022|11148951|FG006|Overall Study|Study closed/terminated|0
7055693|NCT01868022|11148952|FG007|Overall Study|Study closed/terminated|1
7055694|NCT01868022|11148953|FG008|Overall Study|Study closed/terminated|0
7085030|NCT02174627|11197871|FG001|Overall Study|Incorrect enrolment before randomization|1
7085031|NCT02174627|11197870|FG000|Overall Study|Participant decision|84
7085032|NCT02174627|11197871|FG001|Overall Study|Participant decision|128
7085033|NCT02174731|11197879|FG000|Overall Study|Participant decision|67
7085034|NCT02174731|11197880|FG001|Overall Study|Participant decision|64
7055695|NCT01868022|11148945|FG000|Overall Study|Ongoing|0
7055696|NCT01868022|11148946|FG001|Overall Study|Ongoing|0
7055697|NCT01868022|11148947|FG002|Overall Study|Ongoing|0
7055698|NCT01868022|11148948|FG003|Overall Study|Ongoing|0
7055699|NCT01868022|11148949|FG004|Overall Study|Ongoing|0
7055700|NCT01868022|11148950|FG005|Overall Study|Ongoing|0
7055701|NCT01868022|11148951|FG006|Overall Study|Ongoing|0
7055702|NCT01868022|11148952|FG007|Overall Study|Ongoing|3
7055703|NCT01868022|11148953|FG008|Overall Study|Ongoing|0
7055704|NCT01868035|11148979|FG000|Overall Study|Lost to Follow-up|3
7055705|NCT01868035|11148979|FG000|Overall Study|Withdrawal by Subject|1
7055706|NCT01868035|11148979|FG000|Overall Study|Progressive Disease|2
7055707|NCT01868035|11148979|FG000|Overall Study|Non-compliance|1
7055708|NCT01868074|11148985|FG000|Overall Study|Lost to Follow-up|3
7055709|NCT01868074|11148986|FG001|Overall Study|Lost to Follow-up|2
7055710|NCT01868074|11148985|FG000|Overall Study|Withdrawal by Subject|4
7055711|NCT01868074|11148986|FG001|Overall Study|Withdrawal by Subject|2
7055712|NCT01868165|11148992|FG000|Overall Study|Withdrawal by Subject|36
7055713|NCT01868165|11148992|FG000|Overall Study|Physician Decision|2
7055714|NCT01868165|11148992|FG000|Overall Study|Lost to Follow-up|3
7055715|NCT01868165|11148992|FG000|Overall Study|Death|4
7055716|NCT01868243|11148998|FG000|Overall Study|Death|0
7055717|NCT01868243|11148999|FG001|Overall Study|Death|1
7055718|NCT01868477|11149061|FG000|Overall Study|Adverse Event|2
7055719|NCT01868477|11149062|FG001|Overall Study|Adverse Event|4
7055720|NCT01868477|11149061|FG000|Overall Study|Disease progression|1
7055721|NCT01868477|11149062|FG001|Overall Study|Disease progression|1
7055722|NCT01868477|11149061|FG000|Overall Study|Withdrawal by Subject|1
6805212|NCT00129402|10807233|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1
6805213|NCT00129402|10807227|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
6805214|NCT00129402|10807228|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
6805215|NCT00129402|10807229|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
6805216|NCT00129402|10807230|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
6805217|NCT00129402|10807231|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
6805218|NCT00129402|10807232|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
6805219|NCT00129402|10807233|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1
6805220|NCT00101439|10807243|FG000|Period 2|Withdrawal by Subject|0
6805221|NCT00101439|10807244|FG001|Period 2|Withdrawal by Subject|2
6805222|NCT00096200|10807253|FG000|Overall Study|Adverse Event|0
6805223|NCT00096200|10807254|FG001|Overall Study|Adverse Event|4
6805224|NCT00096200|10807255|FG002|Overall Study|Adverse Event|0
6805225|NCT00096200|10807253|FG000|Overall Study|Withdrawal by Subject|1
6805226|NCT00096200|10807254|FG001|Overall Study|Withdrawal by Subject|2
6805227|NCT00096200|10807255|FG002|Overall Study|Withdrawal by Subject|0
6805228|NCT00096200|10807253|FG000|Overall Study|Ineligible pathology|0
6805229|NCT00096200|10807254|FG001|Overall Study|Ineligible pathology|1
6805230|NCT00096200|10807255|FG002|Overall Study|Ineligible pathology|0
6810308|NCT00943722|10814043|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0
6810309|NCT00943722|10814044|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0
6810310|NCT00943722|10814045|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0
6810311|NCT00943722|10814046|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0
6810312|NCT00943722|10814047|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0
6810313|NCT00943722|10814048|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32
6810314|NCT00943722|10814049|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10
6810315|NCT00943722|10814043|FG000|First Extension Study: EXT 1|Disposition Unknown|0
6810316|NCT00943722|10814044|FG001|First Extension Study: EXT 1|Disposition Unknown|0
6810317|NCT00943722|10814045|FG002|First Extension Study: EXT 1|Disposition Unknown|0
6810318|NCT00943722|10814046|FG003|First Extension Study: EXT 1|Disposition Unknown|0
6810319|NCT00943722|10814047|FG004|First Extension Study: EXT 1|Disposition Unknown|0
6810320|NCT00943722|10814048|FG005|First Extension Study: EXT 1|Disposition Unknown|44
6810321|NCT00943722|10814049|FG006|First Extension Study: EXT 1|Disposition Unknown|21
6810322|NCT00943722|10814043|FG000|Second Extension Study: EXT 2|Adverse Event|0
6810323|NCT00943722|10814044|FG001|Second Extension Study: EXT 2|Adverse Event|0
7055723|NCT01868477|11149062|FG001|Overall Study|Withdrawal by Subject|0
7055724|NCT01868503|11149075|FG000|Overall Study|Withdrawal by Subject|1
7055725|NCT01868503|11149075|FG000|Overall Study|Protocol Violation|1
7055726|NCT01868542|11149083|FG000|Overall Study|Protocol Violation|0
7055727|NCT01868542|11149084|FG001|Overall Study|Protocol Violation|1
7055728|NCT01868542|11149083|FG000|Overall Study|Unclassified|0
7055729|NCT01868542|11149084|FG001|Overall Study|Unclassified|1
7055730|NCT01868594|11149092|FG000|Overall Study|Do not meet inclusion criteria|4
6810324|NCT00943722|10814045|FG002|Second Extension Study: EXT 2|Adverse Event|0
6810325|NCT00943722|10814046|FG003|Second Extension Study: EXT 2|Adverse Event|0
6810326|NCT00943722|10814047|FG004|Second Extension Study: EXT 2|Adverse Event|0
6810327|NCT00943722|10814048|FG005|Second Extension Study: EXT 2|Adverse Event|1
6810328|NCT00943722|10814049|FG006|Second Extension Study: EXT 2|Adverse Event|0
6810329|NCT00943722|10814043|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0
6810330|NCT00943722|10814044|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0
6810331|NCT00943722|10814045|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0
7055731|NCT01868594|11149093|FG001|Overall Study|Do not meet inclusion criteria|3
7055732|NCT01868646|11149112|FG000|Overall Study|Do not meet inclusion criteria|3
7055733|NCT01868646|11149113|FG001|Overall Study|Do not meet inclusion criteria|5
7055734|NCT01868893|11149137|FG000|Overall Study|Adverse Event|2
7055735|NCT01868893|11149137|FG000|Overall Study|Commercial availability of study drug|17
7055736|NCT01868893|11149137|FG000|Overall Study|Neutropenia|1
7055737|NCT01868997|11149145|FG000|Overall Study|Adverse Event|2
7055738|NCT01868997|11149146|FG001|Overall Study|Adverse Event|5
7055739|NCT01868997|11149145|FG000|Overall Study|Lack of Efficacy|2
7055740|NCT01868997|11149146|FG001|Overall Study|Lack of Efficacy|0
7055741|NCT01868997|11149145|FG000|Overall Study|Other|3
7055742|NCT01868997|11149146|FG001|Overall Study|Other|1
7055743|NCT01869192|11149179|FG000|Preoperative Chemotherapy to Surgery|patient choice|2
7055744|NCT01869192|11149180|FG001|Preoperative Chemotherapy to Surgery|patient choice|1
7055745|NCT01869192|11149179|FG000|Postoperative Chemotherapy|Physician Decision|0
7055746|NCT01869192|11149180|FG001|Postoperative Chemotherapy|Physician Decision|2
7055747|NCT01869348|11149188|FG000|Overall Study|Withdrawal by Subject|1
7055748|NCT01869348|11149189|FG001|Overall Study|Withdrawal by Subject|1
7055749|NCT01869699|11149236|FG000|Overall Study|Withdrawal by Subject|1
7055750|NCT01869699|11149237|FG001|Overall Study|Withdrawal by Subject|0
7055751|NCT01869725|11149243|FG000|Overall Study|ineligible after registration|1
7055752|NCT01869725|11149243|FG000|Overall Study|Death|1
7055753|NCT01869725|11149243|FG000|Overall Study|Lost to Follow-up|2
7055754|NCT01869764|11149249|FG000|Overall Study|Withdrawal by Subject|0
7055755|NCT01869764|11149250|FG001|Overall Study|Withdrawal by Subject|2
7055756|NCT01869777|11149256|FG000|Overall Study|Excluded from the analysis, ineligible|1
7055757|NCT01869959|11149264|FG000|Randomization Period|Physician Decision|0
7055758|NCT01869959|11149265|FG001|Randomization Period|Physician Decision|0
7055759|NCT01869959|11149266|FG002|Randomization Period|Physician Decision|0
7055760|NCT01869959|11149267|FG003|Randomization Period|Physician Decision|0
7055761|NCT01869959|11149268|FG004|Randomization Period|Physician Decision|1
7055762|NCT01869959|11149264|FG000|Treatment Period|Adverse Event|1
7055763|NCT01869959|11149265|FG001|Treatment Period|Adverse Event|0
7055764|NCT01869959|11149266|FG002|Treatment Period|Adverse Event|3
7055765|NCT01869959|11149267|FG003|Treatment Period|Adverse Event|1
7055766|NCT01869959|11149268|FG004|Treatment Period|Adverse Event|0
7055767|NCT01869959|11149264|FG000|Treatment Period|Sponsor decision|0
7055768|NCT01869959|11149265|FG001|Treatment Period|Sponsor decision|1
7055769|NCT01869959|11149266|FG002|Treatment Period|Sponsor decision|0
7055770|NCT01869959|11149267|FG003|Treatment Period|Sponsor decision|1
7055771|NCT01869959|11149268|FG004|Treatment Period|Sponsor decision|0
7055772|NCT01869959|11149264|FG000|Treatment Period|Withdrawal by Subject|0
7055773|NCT01869959|11149265|FG001|Treatment Period|Withdrawal by Subject|1
7055774|NCT01869959|11149266|FG002|Treatment Period|Withdrawal by Subject|0
7055775|NCT01869959|11149267|FG003|Treatment Period|Withdrawal by Subject|0
7055776|NCT01869959|11149268|FG004|Treatment Period|Withdrawal by Subject|0
7055777|NCT01870076|11149282|FG000|Overall Study|Withdrawal by Subject|1
7055778|NCT01870076|11149283|FG001|Overall Study|Withdrawal by Subject|0
7055779|NCT01870076|11149284|FG002|Overall Study|Withdrawal by Subject|1
7055780|NCT01870076|11149285|FG003|Overall Study|Withdrawal by Subject|0
7055781|NCT01870297|11149302|FG000|Overall Study|Adverse Event|0
7055782|NCT01870297|11149303|FG001|Overall Study|Adverse Event|0
7055783|NCT01870297|11149304|FG002|Overall Study|Adverse Event|0
7055784|NCT01870297|11149305|FG003|Overall Study|Adverse Event|0
7055785|NCT01870297|11149306|FG004|Overall Study|Adverse Event|2
7055786|NCT01870297|11149307|FG005|Overall Study|Adverse Event|0
7055787|NCT01870297|11149308|FG006|Overall Study|Adverse Event|0
7055788|NCT01870297|11149302|FG000|Overall Study|Lost to Follow-up|0
7055789|NCT01870297|11149303|FG001|Overall Study|Lost to Follow-up|1
7055790|NCT01870297|11149304|FG002|Overall Study|Lost to Follow-up|1
7055791|NCT01870297|11149305|FG003|Overall Study|Lost to Follow-up|0
7055792|NCT01870297|11149306|FG004|Overall Study|Lost to Follow-up|0
7055793|NCT01870297|11149307|FG005|Overall Study|Lost to Follow-up|0
7055794|NCT01870297|11149308|FG006|Overall Study|Lost to Follow-up|0
7055795|NCT01870297|11149302|FG000|Overall Study|Withdrawal by Subject|0
7085035|NCT02174731|11197879|FG000|Overall Study|Incorrect enrolment before randomization|0
7085036|NCT02174731|11197880|FG001|Overall Study|Incorrect enrolment before randomization|1
7085037|NCT02174731|11197879|FG000|Overall Study|Missing|2
7085038|NCT02174731|11197880|FG001|Overall Study|Missing|0
7085039|NCT02174848|11197888|FG000|Overall Study|Adverse Event|2
7085040|NCT02174848|11197889|FG001|Overall Study|Adverse Event|1
7085041|NCT02174848|11197888|FG000|Overall Study|Withdrawal by Subject|3
7085042|NCT02174848|11197889|FG001|Overall Study|Withdrawal by Subject|3
7085043|NCT02174848|11197888|FG000|Overall Study|Lost to Follow-up|0
7085044|NCT02174848|11197889|FG001|Overall Study|Lost to Follow-up|1
7085045|NCT02174848|11197888|FG000|Overall Study|Worsening of disease|1
7085046|NCT02174848|11197889|FG001|Overall Study|Worsening of disease|1
7085047|NCT02174848|11197888|FG000|Overall Study|Unable to comply with study requirements|1
7085048|NCT02174848|11197889|FG001|Overall Study|Unable to comply with study requirements|0
7085049|NCT02175121|11197914|FG000|Overall Study|Lack of Efficacy|1
7085050|NCT02175121|11197915|FG001|Overall Study|Lack of Efficacy|0
7085051|NCT02175121|11197916|FG002|Overall Study|Lack of Efficacy|0
7085052|NCT02175121|11197917|FG003|Overall Study|Lack of Efficacy|0
7085053|NCT02175121|11197918|FG004|Overall Study|Lack of Efficacy|0
7055796|NCT01870297|11149303|FG001|Overall Study|Withdrawal by Subject|0
7055797|NCT01870297|11149304|FG002|Overall Study|Withdrawal by Subject|0
7055798|NCT01870297|11149305|FG003|Overall Study|Withdrawal by Subject|0
7055799|NCT01870297|11149306|FG004|Overall Study|Withdrawal by Subject|1
7055800|NCT01870297|11149307|FG005|Overall Study|Withdrawal by Subject|1
7055801|NCT01870297|11149308|FG006|Overall Study|Withdrawal by Subject|1
7055802|NCT01870297|11149302|FG000|Overall Study|Sponsor Decision|0
7055803|NCT01870297|11149303|FG001|Overall Study|Sponsor Decision|6
7055804|NCT01870297|11149304|FG002|Overall Study|Sponsor Decision|0
7055805|NCT01870297|11149305|FG003|Overall Study|Sponsor Decision|0
7055806|NCT01870297|11149306|FG004|Overall Study|Sponsor Decision|0
7055807|NCT01870297|11149307|FG005|Overall Study|Sponsor Decision|0
7055808|NCT01870297|11149308|FG006|Overall Study|Sponsor Decision|1
7055809|NCT01870583|11149347|FG000|Overall Study|Protocol Violation|0
7055810|NCT01870583|11149348|FG001|Overall Study|Protocol Violation|5
7055811|NCT01870583|11149349|FG002|Overall Study|Protocol Violation|3
7055812|NCT01870583|11149347|FG000|Overall Study|Lost to Follow-up|11
7055813|NCT01870583|11149348|FG001|Overall Study|Lost to Follow-up|13
7055814|NCT01870583|11149349|FG002|Overall Study|Lost to Follow-up|5
7055815|NCT01870726|11149373|FG000|Overall Study|Withdrawal of informed consent|0
7055816|NCT01870726|11149374|FG001|Overall Study|Withdrawal of informed consent|0
7055817|NCT01870726|11149375|FG002|Overall Study|Withdrawal of informed consent|0
7055818|NCT01870726|11149376|FG003|Overall Study|Withdrawal of informed consent|1
7055819|NCT01870726|11149377|FG004|Overall Study|Withdrawal of informed consent|0
7055820|NCT01870726|11149378|FG005|Overall Study|Withdrawal of informed consent|0
7055821|NCT01870726|11149379|FG006|Overall Study|Withdrawal of informed consent|0
7055822|NCT01870726|11149373|FG000|Overall Study|Withdrawal by Subject|0
7055823|NCT01870726|11149374|FG001|Overall Study|Withdrawal by Subject|1
7055824|NCT01870726|11149375|FG002|Overall Study|Withdrawal by Subject|0
7055825|NCT01870726|11149376|FG003|Overall Study|Withdrawal by Subject|0
7055826|NCT01870726|11149377|FG004|Overall Study|Withdrawal by Subject|0
7055827|NCT01870726|11149378|FG005|Overall Study|Withdrawal by Subject|0
7055828|NCT01870726|11149379|FG006|Overall Study|Withdrawal by Subject|0
7055829|NCT01870726|11149373|FG000|Overall Study|Adverse Event|0
7055830|NCT01870726|11149374|FG001|Overall Study|Adverse Event|0
7055831|NCT01870726|11149375|FG002|Overall Study|Adverse Event|0
7055832|NCT01870726|11149376|FG003|Overall Study|Adverse Event|0
7055833|NCT01870726|11149377|FG004|Overall Study|Adverse Event|1
7055834|NCT01870726|11149378|FG005|Overall Study|Adverse Event|1
7055835|NCT01870726|11149379|FG006|Overall Study|Adverse Event|0
7055836|NCT01870726|11149373|FG000|Overall Study|Progressive disease|5
7055837|NCT01870726|11149374|FG001|Overall Study|Progressive disease|5
7055838|NCT01870726|11149375|FG002|Overall Study|Progressive disease|4
7055839|NCT01870726|11149376|FG003|Overall Study|Progressive disease|5
7055840|NCT01870726|11149377|FG004|Overall Study|Progressive disease|6
7055841|NCT01870726|11149378|FG005|Overall Study|Progressive disease|4
7085054|NCT02175121|11197914|FG000|Overall Study|Lost to Follow-up|0
7085055|NCT02175121|11197915|FG001|Overall Study|Lost to Follow-up|1
7085056|NCT02175121|11197916|FG002|Overall Study|Lost to Follow-up|0
7085057|NCT02175121|11197917|FG003|Overall Study|Lost to Follow-up|1
7085058|NCT02175121|11197918|FG004|Overall Study|Lost to Follow-up|0
7085059|NCT02175121|11197914|FG000|Overall Study|Personal emergency|0
7085060|NCT02175121|11197915|FG001|Overall Study|Personal emergency|0
7085061|NCT02175121|11197916|FG002|Overall Study|Personal emergency|0
7085062|NCT02175121|11197917|FG003|Overall Study|Personal emergency|0
7085063|NCT02175121|11197918|FG004|Overall Study|Personal emergency|1
7085064|NCT02175121|11197914|FG000|Overall Study|Schedule conflict|0
7085065|NCT02175121|11197915|FG001|Overall Study|Schedule conflict|0
7085066|NCT02175121|11197916|FG002|Overall Study|Schedule conflict|1
7085067|NCT02175121|11197917|FG003|Overall Study|Schedule conflict|0
7085068|NCT02175121|11197918|FG004|Overall Study|Schedule conflict|0
7085069|NCT02175121|11197914|FG000|Overall Study|Time issues|0
7085070|NCT02175121|11197915|FG001|Overall Study|Time issues|0
7085071|NCT02175121|11197916|FG002|Overall Study|Time issues|1
7085072|NCT02175121|11197917|FG003|Overall Study|Time issues|0
7085073|NCT02175121|11197918|FG004|Overall Study|Time issues|0
7085074|NCT02175199|11197936|FG000|Overall Study|Withdrawal by Subject|1
7085075|NCT02175199|11197937|FG001|Overall Study|Withdrawal by Subject|5
7085076|NCT02175199|11197936|FG000|Overall Study|Randomized in Error|1
7085077|NCT02175199|11197937|FG001|Overall Study|Randomized in Error|0
7085078|NCT02175199|11197936|FG000|Overall Study|Sponsor Decision|1
7085079|NCT02175199|11197937|FG001|Overall Study|Sponsor Decision|0
7085080|NCT02175225|11197955|FG000|Overall Study|Withdrawal by Subject|1
7085081|NCT02175225|11197956|FG001|Overall Study|Withdrawal by Subject|2
7085082|NCT02175225|11197955|FG000|Overall Study|Lost to Follow-up|6
7085083|NCT02175225|11197956|FG001|Overall Study|Lost to Follow-up|7
7085084|NCT02175225|11197955|FG000|Overall Study|Study drug not administered|1
7085085|NCT02175225|11197956|FG001|Overall Study|Study drug not administered|2
7055842|NCT01870726|11149379|FG006|Overall Study|Progressive disease|10
7055843|NCT01870739|11149406|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0
7055844|NCT01870739|11149407|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1
7055845|NCT01870739|11149406|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0
7055846|NCT01870739|11149407|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1
7055847|NCT01870739|11149406|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3
7055848|NCT01870739|11149407|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2
7055849|NCT01870739|11149406|FG000|Add-on Period (40 Weeks)|Adverse Event|0
7055850|NCT01870739|11149407|FG001|Add-on Period (40 Weeks)|Adverse Event|1
7055851|NCT01870739|11149406|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1
7055852|NCT01870739|11149407|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0
7055853|NCT01870739|11149406|FG000|Add-on Period (40 Weeks)|Protocol deviation|1
7055854|NCT01870739|11149407|FG001|Add-on Period (40 Weeks)|Protocol deviation|1
7055855|NCT01870739|11149406|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1
7055856|NCT01870739|11149407|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0
7055857|NCT01870778|11149425|FG000|Overall Study|Withdrawal by Subject|8
7055858|NCT01870778|11149426|FG001|Overall Study|Withdrawal by Subject|7
7055859|NCT01870778|11149425|FG000|Overall Study|Lost to Follow-up|0
7055860|NCT01870778|11149426|FG001|Overall Study|Lost to Follow-up|2
7055861|NCT01870843|11149432|FG000|Overall Study|Adverse Event|10
7055862|NCT01870843|11149432|FG000|Overall Study|Lost to Follow-up|24
7055863|NCT01870843|11149432|FG000|Overall Study|Death|1
7055864|NCT01870843|11149432|FG000|Overall Study|Withdrawal by Subject|18
7055865|NCT01870869|11149451|FG000|Overall Study|Implanted with nonstudy device|1
7055866|NCT01870869|11149452|FG001|Overall Study|Implanted with nonstudy device|3
7055867|NCT01870869|11149453|FG002|Overall Study|Implanted with nonstudy device|14
7055868|NCT01870869|11149454|FG003|Overall Study|Implanted with nonstudy device|4
7055869|NCT01870869|11149451|FG000|Overall Study|Death|0
7055870|NCT01870869|11149452|FG001|Overall Study|Death|0
7055871|NCT01870869|11149453|FG002|Overall Study|Death|7
7055872|NCT01870869|11149454|FG003|Overall Study|Death|1
7055873|NCT01870869|11149451|FG000|Overall Study|Subject choice|6
7055874|NCT01870869|11149452|FG001|Overall Study|Subject choice|2
7055875|NCT01870869|11149453|FG002|Overall Study|Subject choice|22
7055876|NCT01870869|11149454|FG003|Overall Study|Subject choice|8
7055877|NCT01870869|11149451|FG000|Overall Study|Lost to Follow-up|10
7055878|NCT01870869|11149452|FG001|Overall Study|Lost to Follow-up|2
7055879|NCT01870869|11149453|FG002|Overall Study|Lost to Follow-up|25
7055880|NCT01870869|11149454|FG003|Overall Study|Lost to Follow-up|3
7055881|NCT01870869|11149451|FG000|Overall Study|Reason not Specified|1
7055882|NCT01870869|11149452|FG001|Overall Study|Reason not Specified|2
7055883|NCT01870869|11149453|FG002|Overall Study|Reason not Specified|20
7055884|NCT01870869|11149454|FG003|Overall Study|Reason not Specified|4
7055885|NCT01870869|11149451|FG000|Overall Study|Not evaluable|10
7055886|NCT01870869|11149452|FG001|Overall Study|Not evaluable|5
7055887|NCT01870869|11149453|FG002|Overall Study|Not evaluable|42
7055888|NCT01870869|11149454|FG003|Overall Study|Not evaluable|10
7055889|NCT01870921|11149464|FG000|Overall Study|Subject decision|80
7055890|NCT01870921|11149464|FG000|Overall Study|Severe non-compliance to protocol|7
7055891|NCT01870921|11149464|FG000|Overall Study|Subject Lost to Follow up|2
7055892|NCT01870921|11149464|FG000|Overall Study|Other|1
7055893|NCT01870973|11149470|FG000|Overall Study|Lost to Follow-up|10
7055894|NCT01870973|11149471|FG001|Overall Study|Lost to Follow-up|3
7055895|NCT01870999|11149480|FG000|Overall Study|Adverse Event|0
7055896|NCT01870999|11149481|FG001|Overall Study|Adverse Event|4
7055897|NCT01870999|11149482|FG002|Overall Study|Adverse Event|1
7055898|NCT01870999|11149480|FG000|Overall Study|Subject met withdrawal criteria|3
7055899|NCT01870999|11149481|FG001|Overall Study|Subject met withdrawal criteria|2
7055900|NCT01870999|11149482|FG002|Overall Study|Subject met withdrawal criteria|0
7055901|NCT01870999|11149480|FG000|Overall Study|Subject withdrawn by Investigator|1
7055902|NCT01870999|11149481|FG001|Overall Study|Subject withdrawn by Investigator|0
7055903|NCT01870999|11149482|FG002|Overall Study|Subject withdrawn by Investigator|0
7055904|NCT01870999|11149480|FG000|Overall Study|Withdrawal by Subject|0
7055905|NCT01870999|11149481|FG001|Overall Study|Withdrawal by Subject|2
7055906|NCT01870999|11149482|FG002|Overall Study|Withdrawal by Subject|5
7055907|NCT01870999|11149480|FG000|Overall Study|Protocol Violation|0
7055908|NCT01870999|11149481|FG001|Overall Study|Protocol Violation|0
7055909|NCT01870999|11149482|FG002|Overall Study|Protocol Violation|1
7055910|NCT01871090|11149496|FG000|Overall Study|Interrogation not done in Emergency Room|1
7055911|NCT01871090|11149497|FG001|Overall Study|Interrogation not done in Emergency Room|22
7055912|NCT01871090|11149496|FG000|Overall Study|Interrogation not completed correctly|1
7055913|NCT01871090|11149497|FG001|Overall Study|Interrogation not completed correctly|0
7055914|NCT01871090|11149496|FG000|Overall Study|Subject Non-Compliance|0
7055915|NCT01871090|11149497|FG001|Overall Study|Subject Non-Compliance|1
7055916|NCT01871142|11149503|FG000|Overall Study|Adverse Event|1
7055917|NCT01871285|11149519|FG000|First Intervention (1 Day)|Adverse Event|1
7055918|NCT01871285|11149520|FG001|First Intervention (1 Day)|Adverse Event|0
7055919|NCT01871285|11149521|FG002|First Intervention (1 Day)|Adverse Event|0
7055920|NCT01871285|11149522|FG003|First Intervention (1 Day)|Adverse Event|0
7055921|NCT01871285|11149519|FG000|First Intervention (1 Day)|Lost to Follow-up|0
7055922|NCT01871285|11149520|FG001|First Intervention (1 Day)|Lost to Follow-up|1
7055923|NCT01871285|11149521|FG002|First Intervention (1 Day)|Lost to Follow-up|1
7055924|NCT01871285|11149522|FG003|First Intervention (1 Day)|Lost to Follow-up|0
7055925|NCT01871402|11149534|FG000|Overall Study|Lost to Follow-up|1
7055926|NCT01871402|11149535|FG001|Overall Study|Lost to Follow-up|0
7055927|NCT01871402|11149534|FG000|Overall Study|Withdrawal by Subject|0
7055928|NCT01871402|11149535|FG001|Overall Study|Withdrawal by Subject|2
7055929|NCT01871402|11149534|FG000|Overall Study|Non-compliance|0
7055930|NCT01871402|11149535|FG001|Overall Study|Non-compliance|1
7055931|NCT01871519|11149568|FG000|Overall Study|Death|26
7055932|NCT01871519|11149568|FG000|Overall Study|Lost to Follow-up|15
7055933|NCT01871519|11149568|FG000|Overall Study|Withdrawal by Subject|49
7055934|NCT01871532|11149575|FG000|Overall Study|Withdrawal by Subject|1
7055935|NCT01871532|11149576|FG001|Overall Study|Withdrawal by Subject|2
7055936|NCT01871545|11149584|FG000|Overall Study|Death|2
7055937|NCT01871545|11149585|FG001|Overall Study|Death|0
7055938|NCT01871545|11149584|FG000|Overall Study|Lack of Efficacy|11
7055939|NCT01871545|11149585|FG001|Overall Study|Lack of Efficacy|2
7055940|NCT01871545|11149584|FG000|Overall Study|Physician Decision|4
7055941|NCT01871545|11149585|FG001|Overall Study|Physician Decision|0
7055942|NCT01871545|11149584|FG000|Overall Study|Withdrawal by Subject|0
7055943|NCT01871545|11149585|FG001|Overall Study|Withdrawal by Subject|1
7055944|NCT01871558|11149596|FG000|Overall Study|Other reason|0
7055945|NCT01871558|11149597|FG001|Overall Study|Other reason|1
7055946|NCT01871558|11149596|FG000|Overall Study|antidiabetic drug prematurely stopped|1
7055947|NCT01871558|11149597|FG001|Overall Study|antidiabetic drug prematurely stopped|1
7055948|NCT01871558|11149596|FG000|Overall Study|Withdrawal by Subject|2
7055949|NCT01871558|11149597|FG001|Overall Study|Withdrawal by Subject|0
7055950|NCT01871805|11149609|FG000|Phase I|Death|7
7085086|NCT02175277|11197962|FG000|Overall Study|Protocol-specified Criteria|1
7085087|NCT02175368|11197966|FG000|Overall Study|Lost to Follow-up|1
7085088|NCT02175641|11197981|FG000|Overall Study|Death|3
7085089|NCT02175641|11197982|FG001|Overall Study|Death|4
7085090|NCT02175641|11197981|FG000|Overall Study|Lost to Follow-up|4
7085091|NCT02175641|11197982|FG001|Overall Study|Lost to Follow-up|4
7085092|NCT02175641|11197981|FG000|Overall Study|Withdrawal by Subject|7
7085093|NCT02175641|11197982|FG001|Overall Study|Withdrawal by Subject|4
7085094|NCT02175641|11197981|FG000|Overall Study|Discharged from Supportive Housing Agenc|13
7085095|NCT02175641|11197982|FG001|Overall Study|Discharged from Supportive Housing Agenc|15
7085096|NCT02175641|11197981|FG000|Overall Study|Developed Contraindicated Condition|8
7085097|NCT02175641|11197982|FG001|Overall Study|Developed Contraindicated Condition|0
7055951|NCT01871805|11149610|FG001|Phase I|Death|4
7055952|NCT01871805|11149611|FG002|Phase I|Death|6
7055953|NCT01871805|11149612|FG003|Phase I|Death|2
7055954|NCT01871805|11149613|FG004|Phase I|Death|9
7055955|NCT01871805|11149614|FG005|Phase I|Death|0
7055956|NCT01871805|11149609|FG000|Phase I|Alive in Survival Follow-up|0
7055957|NCT01871805|11149610|FG001|Phase I|Alive in Survival Follow-up|2
7055958|NCT01871805|11149611|FG002|Phase I|Alive in Survival Follow-up|4
7055959|NCT01871805|11149612|FG003|Phase I|Alive in Survival Follow-up|5
7055960|NCT01871805|11149613|FG004|Phase I|Alive in Survival Follow-up|4
7055961|NCT01871805|11149614|FG005|Phase I|Alive in Survival Follow-up|0
7055962|NCT01871805|11149609|FG000|Phase I|Lost to Follow-up|0
7055963|NCT01871805|11149610|FG001|Phase I|Lost to Follow-up|1
7085098|NCT02175745|11197988|FG000|Overall Study|Not Eligible|1
7085099|NCT02175758|11197998|FG000|Treatment Phase|Lost to Follow-up|0
7055964|NCT01871805|11149611|FG002|Phase I|Lost to Follow-up|3
7055965|NCT01871805|11149612|FG003|Phase I|Lost to Follow-up|0
7055966|NCT01871805|11149613|FG004|Phase I|Lost to Follow-up|0
7055967|NCT01871805|11149614|FG005|Phase I|Lost to Follow-up|0
7055968|NCT01871805|11149609|FG000|Phase II|Death|0
7055969|NCT01871805|11149610|FG001|Phase II|Death|0
7055970|NCT01871805|11149611|FG002|Phase II|Death|0
7055971|NCT01871805|11149612|FG003|Phase II|Death|0
7055972|NCT01871805|11149613|FG004|Phase II|Death|0
7055973|NCT01871805|11149614|FG005|Phase II|Death|45
7055974|NCT01871805|11149609|FG000|Phase II|Alive in Survival Follow-up|0
7055975|NCT01871805|11149610|FG001|Phase II|Alive in Survival Follow-up|0
7055976|NCT01871805|11149611|FG002|Phase II|Alive in Survival Follow-up|0
7055977|NCT01871805|11149612|FG003|Phase II|Alive in Survival Follow-up|0
7055978|NCT01871805|11149613|FG004|Phase II|Alive in Survival Follow-up|0
7055979|NCT01871805|11149614|FG005|Phase II|Alive in Survival Follow-up|29
7055980|NCT01871805|11149609|FG000|Phase II|Lost to Follow-up|0
7055981|NCT01871805|11149610|FG001|Phase II|Lost to Follow-up|0
7055982|NCT01871805|11149611|FG002|Phase II|Lost to Follow-up|0
7055983|NCT01871805|11149612|FG003|Phase II|Lost to Follow-up|0
7055984|NCT01871805|11149613|FG004|Phase II|Lost to Follow-up|0
7055985|NCT01871805|11149614|FG005|Phase II|Lost to Follow-up|13
7055986|NCT01871870|11149645|FG000|Overall Study|Hardware issues|7
7055987|NCT01871870|11149645|FG000|Overall Study|hyperglycemia|2
7055988|NCT01872078|11149653|FG000|Overall Study|Adverse Event|0
7055989|NCT01872078|11149654|FG001|Overall Study|Adverse Event|0
7055990|NCT01872078|11149655|FG002|Overall Study|Adverse Event|1
7055991|NCT01872078|11149656|FG003|Overall Study|Adverse Event|0
7055992|NCT01872078|11149653|FG000|Overall Study|Dose administration non-compliance|0
7055993|NCT01872078|11149654|FG001|Overall Study|Dose administration non-compliance|0
7055994|NCT01872078|11149655|FG002|Overall Study|Dose administration non-compliance|0
7055995|NCT01872078|11149656|FG003|Overall Study|Dose administration non-compliance|1
7055996|NCT01872078|11149653|FG000|Overall Study|Protocol Violation|0
7055997|NCT01872078|11149654|FG001|Overall Study|Protocol Violation|0
7055998|NCT01872078|11149655|FG002|Overall Study|Protocol Violation|1
7055999|NCT01872078|11149656|FG003|Overall Study|Protocol Violation|0
7056000|NCT01872078|11149653|FG000|Overall Study|Withdrawal by Subject|0
7056001|NCT01872078|11149654|FG001|Overall Study|Withdrawal by Subject|0
7056002|NCT01872078|11149655|FG002|Overall Study|Withdrawal by Subject|1
7056003|NCT01872078|11149656|FG003|Overall Study|Withdrawal by Subject|0
7056004|NCT01872078|11149653|FG000|Overall Study|Patient met exclusion criterion 16.|0
7056005|NCT01872078|11149654|FG001|Overall Study|Patient met exclusion criterion 16.|0
7056006|NCT01872078|11149655|FG002|Overall Study|Patient met exclusion criterion 16.|0
7056007|NCT01872078|11149656|FG003|Overall Study|Patient met exclusion criterion 16.|1
7056008|NCT01872611|11149686|FG000|Overall Study|Adverse Event|3
7056009|NCT01872611|11149687|FG001|Overall Study|Adverse Event|1
7056010|NCT01872611|11149686|FG000|Overall Study|Adverse Event, prior to treatment|0
7056011|NCT01872611|11149687|FG001|Overall Study|Adverse Event, prior to treatment|1
7056012|NCT01872611|11149686|FG000|Overall Study|Death|0
7056013|NCT01872611|11149687|FG001|Overall Study|Death|1
7056014|NCT01872611|11149686|FG000|Overall Study|Death, prior to treatment|0
7056015|NCT01872611|11149687|FG001|Overall Study|Death, prior to treatment|1
7056016|NCT01872611|11149686|FG000|Overall Study|Lost to Follow-up|8
7056017|NCT01872611|11149687|FG001|Overall Study|Lost to Follow-up|1
7056018|NCT01872611|11149686|FG000|Overall Study|Physician Decision|1
7056019|NCT01872611|11149687|FG001|Overall Study|Physician Decision|0
7056020|NCT01872611|11149686|FG000|Overall Study|Withdrawal by Subject|6
7056021|NCT01872611|11149687|FG001|Overall Study|Withdrawal by Subject|1
7056022|NCT01872611|11149686|FG000|Overall Study|Reason not provided|6
7056023|NCT01872611|11149687|FG001|Overall Study|Reason not provided|6
7056024|NCT01872689|11149699|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
7056025|NCT01872689|11149700|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1
7056026|NCT01872689|11149701|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
7056027|NCT01872689|11149702|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
7056028|NCT01872689|11149699|FG000|Double-Blind/Placebo-Controlled Period|Other|1
7056029|NCT01872689|11149700|FG001|Double-Blind/Placebo-Controlled Period|Other|1
7056030|NCT01872689|11149701|FG002|Double-Blind/Placebo-Controlled Period|Other|6
7056031|NCT01872689|11149702|FG003|Double-Blind/Placebo-Controlled Period|Other|3
7056032|NCT01872689|11149699|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9
7056033|NCT01872689|11149700|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8
7056034|NCT01872689|11149701|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14
7056035|NCT01872689|11149702|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16
7056036|NCT01872689|11149699|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0
7056037|NCT01872689|11149700|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0
7056038|NCT01872689|11149701|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1
7056039|NCT01872689|11149702|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1
7056040|NCT01872689|11149699|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0
7056041|NCT01872689|11149700|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3
7056042|NCT01872689|11149701|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3
7056043|NCT01872689|11149702|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1
7056044|NCT01872689|11149699|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1
7056045|NCT01872689|11149700|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0
7056046|NCT01872689|11149701|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0
7056047|NCT01872689|11149702|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1
7056048|NCT01872689|11149699|FG000|Double-Blind/Placebo-Controlled Period|Death|3
7056049|NCT01872689|11149700|FG001|Double-Blind/Placebo-Controlled Period|Death|4
7056050|NCT01872689|11149701|FG002|Double-Blind/Placebo-Controlled Period|Death|14
7056051|NCT01872689|11149702|FG003|Double-Blind/Placebo-Controlled Period|Death|9
7056052|NCT01872689|11149699|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6
7056053|NCT01872689|11149700|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3
7056054|NCT01872689|11149701|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10
7056055|NCT01872689|11149702|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7
7056056|NCT01872689|11149699|FG000|Open-Label Period (Only For Monotherapy)|Other|2
7085100|NCT02175758|11197999|FG001|Treatment Phase|Lost to Follow-up|1
7085101|NCT02175758|11198000|FG002|Treatment Phase|Lost to Follow-up|0
7085102|NCT02175758|11198001|FG003|Treatment Phase|Lost to Follow-up|0
7085103|NCT02175758|11198002|FG004|Treatment Phase|Lost to Follow-up|0
7085104|NCT02175758|11198003|FG005|Treatment Phase|Lost to Follow-up|0
7085105|NCT02175758|11197998|FG000|Treatment Phase|Adverse Event|0
7085106|NCT02175758|11197999|FG001|Treatment Phase|Adverse Event|0
7085107|NCT02175758|11198000|FG002|Treatment Phase|Adverse Event|0
7085108|NCT02175758|11198001|FG003|Treatment Phase|Adverse Event|0
7085109|NCT02175758|11198002|FG004|Treatment Phase|Adverse Event|1
7085110|NCT02175758|11198003|FG005|Treatment Phase|Adverse Event|0
7085111|NCT02175771|11198051|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23
7085112|NCT02175771|11198052|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7085113|NCT02175771|11198053|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7085114|NCT02175771|11198054|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7085115|NCT02175771|11198055|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7085116|NCT02175771|11198056|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7085117|NCT02175771|11198057|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7085118|NCT02175771|11198058|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7085119|NCT02175771|11198059|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7085120|NCT02175771|11198051|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20
7085121|NCT02175771|11198052|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7085122|NCT02175771|11198053|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7085123|NCT02175771|11198054|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7085124|NCT02175771|11198055|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7085125|NCT02175771|11198056|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7085126|NCT02175771|11198057|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7085127|NCT02175771|11198058|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7085128|NCT02175771|11198059|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7085129|NCT02175771|11198051|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11
7085130|NCT02175771|11198052|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7085131|NCT02175771|11198053|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7085132|NCT02175771|11198054|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7085133|NCT02175771|11198055|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7056057|NCT01872689|11149700|FG001|Open-Label Period (Only For Monotherapy)|Other|3
7056058|NCT01872689|11149701|FG002|Open-Label Period (Only For Monotherapy)|Other|0
7056059|NCT01872689|11149702|FG003|Open-Label Period (Only For Monotherapy)|Other|0
7085134|NCT02175771|11198056|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7085135|NCT02175771|11198057|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7085136|NCT02175771|11198058|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7085137|NCT02175771|11198059|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
6805231|NCT03257267|10807265|FG000|Overall Study|Adverse Event|9
6805232|NCT03257267|10807266|FG001|Overall Study|Adverse Event|7
6805233|NCT03257267|10807265|FG000|Overall Study|Death|92
6805234|NCT03257267|10807266|FG001|Overall Study|Death|95
6805235|NCT03257267|10807265|FG000|Overall Study|Lost to Follow-up|2
6805236|NCT03257267|10807266|FG001|Overall Study|Lost to Follow-up|2
6805237|NCT03257267|10807265|FG000|Overall Study|Non-compliance with Study Drug|0
6805238|NCT03257267|10807266|FG001|Overall Study|Non-compliance with Study Drug|1
6805239|NCT03257267|10807265|FG000|Overall Study|Participant Decision|34
6805240|NCT03257267|10807266|FG001|Overall Study|Participant Decision|42
6805241|NCT03257267|10807265|FG000|Overall Study|Physician Decision|1
6805242|NCT03257267|10807266|FG001|Overall Study|Physician Decision|3
6805243|NCT03257267|10807265|FG000|Overall Study|Disease Progression|98
6805244|NCT03257267|10807266|FG001|Overall Study|Disease Progression|117
6805245|NCT03257267|10807265|FG000|Overall Study|Withdrawal of Consent|8
6805246|NCT03257267|10807266|FG001|Overall Study|Withdrawal of Consent|26
6805247|NCT03257267|10807265|FG000|Overall Study|Study Ongoing|53
6805248|NCT03257267|10807266|FG001|Overall Study|Study Ongoing|11
6805249|NCT04223830|10807294|FG000|Overall Study|Lost to Follow-up|9
6805250|NCT04223830|10807294|FG000|Overall Study|Adverse Event|1
6805251|NCT04153188|10807310|FG000|Overall Study|Lost to Follow-up|1
6805252|NCT04153188|10807311|FG001|Overall Study|Lost to Follow-up|1
6805253|NCT04153188|10807310|FG000|Overall Study|Withdrawal by Subject|2
6805254|NCT04153188|10807311|FG001|Overall Study|Withdrawal by Subject|0
6805255|NCT04153188|10807310|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0
6805256|NCT04153188|10807311|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1
6805257|NCT04531098|10807326|FG000|Stage I|Adverse Event|0
6805258|NCT04531098|10807327|FG001|Stage I|Adverse Event|0
6805259|NCT04531098|10807328|FG002|Stage I|Adverse Event|3
6805260|NCT04531098|10807326|FG000|Stage I|Protocol Violation|0
6805261|NCT04531098|10807327|FG001|Stage I|Protocol Violation|0
6805262|NCT04531098|10807328|FG002|Stage I|Protocol Violation|5
6805263|NCT04531098|10807326|FG000|Stage I|Withdrawal by Subject|0
6805264|NCT04531098|10807327|FG001|Stage I|Withdrawal by Subject|5
6805265|NCT04531098|10807328|FG002|Stage I|Withdrawal by Subject|10
7056060|NCT01872689|11149699|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11
7056061|NCT01872689|11149700|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12
7056062|NCT01872689|11149701|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0
7056063|NCT01872689|11149702|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0
7056064|NCT01872689|11149699|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0
7056065|NCT01872689|11149700|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1
7056066|NCT01872689|11149701|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0
7056067|NCT01872689|11149702|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0
7056068|NCT01872689|11149699|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1
7056069|NCT01872689|11149700|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3
7056070|NCT01872689|11149701|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0
7056071|NCT01872689|11149702|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0
7056072|NCT01872689|11149699|FG000|Open-Label Period (Only For Monotherapy)|Death|5
6805266|NCT04531098|10807326|FG000|Stage II|Adverse Event|1
6805267|NCT04531098|10807327|FG001|Stage II|Adverse Event|2
6805268|NCT04531098|10807328|FG002|Stage II|Adverse Event|0
6805269|NCT04531098|10807326|FG000|Stage II|Protocol Violation|1
6805270|NCT04531098|10807327|FG001|Stage II|Protocol Violation|2
6805271|NCT04531098|10807328|FG002|Stage II|Protocol Violation|0
6805272|NCT04531098|10807326|FG000|Stage II|Withdrawal by Subject|3
7056073|NCT01872689|11149700|FG001|Open-Label Period (Only For Monotherapy)|Death|3
7056074|NCT01872689|11149701|FG002|Open-Label Period (Only For Monotherapy)|Death|0
7056075|NCT01872689|11149702|FG003|Open-Label Period (Only For Monotherapy)|Death|0
7056076|NCT01872689|11149699|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2
7056077|NCT01872689|11149700|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1
7056078|NCT01872689|11149701|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0
7056079|NCT01872689|11149702|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0
7056080|NCT01872715|11149715|FG000|Overall Study|Adverse Event|1
7056081|NCT01872715|11149715|FG000|Overall Study|Protocol Violation|1
7056082|NCT01872715|11149715|FG000|Overall Study|Withdrawal by Subject|2
7056083|NCT01872910|11149740|FG000|Overall Study|Lost to Follow-up|2
7056084|NCT01872910|11149741|FG001|Overall Study|Lost to Follow-up|0
7056085|NCT01872910|11149742|FG002|Overall Study|Lost to Follow-up|2
7056086|NCT01872910|11149743|FG003|Overall Study|Lost to Follow-up|0
7056087|NCT01872910|11149744|FG004|Overall Study|Lost to Follow-up|0
7056088|NCT01872910|11149745|FG005|Overall Study|Lost to Follow-up|0
7056089|NCT01873417|11149769|FG000|Overall Study|Did Not Receive Any Study Drug|4
7056090|NCT01873417|11149769|FG000|Overall Study|Adverse Event|24
7056091|NCT01873417|11149769|FG000|Overall Study|Lost to Follow-up|2
7056092|NCT01873417|11149769|FG000|Overall Study|Withdrawal by Subject|2
7056093|NCT01873417|11149769|FG000|Overall Study|Physician Decision|3
7056094|NCT01873495|11149773|FG000|Overall Study|Withdrawal by Subject|1
7056095|NCT01873495|11149773|FG000|Overall Study|Physician Decision|3
7056096|NCT01873495|11149773|FG000|Overall Study|Adverse Event|1
6805273|NCT04531098|10807327|FG001|Stage II|Withdrawal by Subject|1
6805274|NCT04531098|10807328|FG002|Stage II|Withdrawal by Subject|0
6805275|NCT04531098|10807326|FG000|Stage II|Moved from study area|8
6805276|NCT04531098|10807327|FG001|Stage II|Moved from study area|5
6805277|NCT04531098|10807328|FG002|Stage II|Moved from study area|0
6805278|NCT04179786|10807347|FG000|Overall Study|Withdrawal by Subject|8
6805279|NCT04140292|10807353|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4
6805280|NCT04140292|10807354|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16
6805281|NCT03730012|10807386|FG000|Overall Study|Adverse Event|0
6805282|NCT03730012|10807387|FG001|Overall Study|Adverse Event|1
6805283|NCT03730012|10807386|FG000|Overall Study|Lack of Efficacy|1
6805284|NCT03730012|10807387|FG001|Overall Study|Lack of Efficacy|5
6805285|NCT03730012|10807386|FG000|Overall Study|Withdrawal by Subject|0
6805286|NCT03730012|10807387|FG001|Overall Study|Withdrawal by Subject|1
6805287|NCT03730012|10807386|FG000|Overall Study|Miscellaneous|2
6805288|NCT03730012|10807387|FG001|Overall Study|Miscellaneous|1
6805289|NCT03553836|10807398|FG000|Overall Study|Ongoing in Study|460
6805290|NCT03553836|10807399|FG001|Overall Study|Ongoing in Study|459
6805291|NCT03553836|10807398|FG000|Overall Study|Withdrawal by Subject|9
6805292|NCT03553836|10807399|FG001|Overall Study|Withdrawal by Subject|10
6805293|NCT03553836|10807398|FG000|Overall Study|Lost to Follow-up|1
6805294|NCT03553836|10807399|FG001|Overall Study|Lost to Follow-up|3
6805295|NCT03553836|10807398|FG000|Overall Study|Death|17
6805296|NCT03553836|10807399|FG001|Overall Study|Death|17
6805297|NCT03474107|10807408|FG000|Overall Study|Adverse Event|42
6805298|NCT03474107|10807409|FG001|Overall Study|Adverse Event|46
6805299|NCT03474107|10807408|FG000|Overall Study|Death|2
6805300|NCT03474107|10807409|FG001|Overall Study|Death|2
6805301|NCT03474107|10807408|FG000|Overall Study|Lost to Follow-up|0
6805302|NCT03474107|10807409|FG001|Overall Study|Lost to Follow-up|1
6805303|NCT03474107|10807408|FG000|Overall Study|Progressive Disease|177
6805304|NCT03474107|10807409|FG001|Overall Study|Progressive Disease|180
6805305|NCT03474107|10807408|FG000|Overall Study|Protocol Violation|1
6805306|NCT03474107|10807409|FG001|Overall Study|Protocol Violation|1
6805307|NCT03474107|10807408|FG000|Overall Study|Withdrawal by Subject|15
6805308|NCT03474107|10807409|FG001|Overall Study|Withdrawal by Subject|27
6805309|NCT03474107|10807408|FG000|Overall Study|Physician Decision|7
6805310|NCT03474107|10807409|FG001|Overall Study|Physician Decision|22
6805311|NCT03474107|10807408|FG000|Overall Study|Miscellaneous|1
6805312|NCT03474107|10807409|FG001|Overall Study|Miscellaneous|6
6805313|NCT02954237|10807430|FG000|Overall Study|Withdrawal by Subject|25
6805314|NCT02954237|10807430|FG000|Overall Study|Missed visit|16
6805315|NCT02954237|10807430|FG000|Overall Study|Death|2
6805316|NCT02714218|10807446|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0
7056097|NCT01873495|11149773|FG000|Overall Study|Removed for Transplantation|1
7056098|NCT01873495|11149773|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1
7056099|NCT01873586|11149777|FG000|Overall Study|Lost to Follow-up|3
7056100|NCT01873729|11149784|FG000|Overall Study|Withdrawal by Subject|1
7056101|NCT01873742|11149790|FG000|Overall Study|Lost to Follow-up|68
7056102|NCT01873742|11149791|FG001|Overall Study|Lost to Follow-up|76
7056103|NCT01873859|11149803|FG000|Overall Study|Withdrawal by Subject|0
7056104|NCT01873859|11149804|FG001|Overall Study|Withdrawal by Subject|4
7056105|NCT01873950|11149811|FG000|Period 5|Withdrawal by Subject|0
7056106|NCT01873950|11149812|FG001|Period 5|Withdrawal by Subject|0
7056107|NCT01873950|11149813|FG002|Period 5|Withdrawal by Subject|0
7056108|NCT01873950|11149814|FG003|Period 5|Withdrawal by Subject|1
7056109|NCT01873950|11149815|FG004|Period 5|Withdrawal by Subject|0
7056110|NCT01874054|11149838|FG000|Overall Study|Withdrawal by Subject|3
7056111|NCT01874054|11149838|FG000|Overall Study|Study Termination by Sponsor|42
7056112|NCT01874054|11149838|FG000|Overall Study|Lost to Follow-up|5
7056113|NCT01874054|11149838|FG000|Overall Study|Death|5
7056114|NCT01874145|11149864|FG000|Core Period|Non-compliance|1
7056115|NCT01874145|11149865|FG001|Core Period|Non-compliance|0
7056116|NCT01874145|11149864|FG000|Core Period|Protocol Violation|1
7056117|NCT01874145|11149865|FG001|Core Period|Protocol Violation|1
7056118|NCT01874145|11149864|FG000|Core Period|Physician Decision|1
7056119|NCT01874145|11149865|FG001|Core Period|Physician Decision|1
7056120|NCT01874145|11149864|FG000|Core Period|Adverse Event|0
7056121|NCT01874145|11149865|FG001|Core Period|Adverse Event|1
7056122|NCT01874145|11149864|FG000|Core Period|Withdrawal by Subject|0
7056123|NCT01874145|11149865|FG001|Core Period|Withdrawal by Subject|4
7056124|NCT01874145|11149864|FG000|Extension Period|Adverse Event|3
7056125|NCT01874145|11149865|FG001|Extension Period|Adverse Event|2
7056126|NCT01874145|11149864|FG000|Extension Period|Withdrawal by Subject|2
7056127|NCT01874145|11149865|FG001|Extension Period|Withdrawal by Subject|1
7056128|NCT01874145|11149864|FG000|Extension Period|Lost to Follow-up|1
7056129|NCT01874145|11149865|FG001|Extension Period|Lost to Follow-up|1
7056130|NCT01874275|11149886|FG000|Overall Study|Lost to Follow-up|1
7056131|NCT01874275|11149887|FG001|Overall Study|Lost to Follow-up|0
7056132|NCT01874288|11149904|FG000|Overall Study|Withdrawal by Subject|1
7056133|NCT01874288|11149905|FG001|Overall Study|Withdrawal by Subject|0
7056134|NCT01874288|11149906|FG002|Overall Study|Withdrawal by Subject|2
7085138|NCT02175771|11198051|FG000|Run-In Period (Pre-assignment)|Adverse Event|9
7085139|NCT02175771|11198052|FG001|Run-In Period (Pre-assignment)|Adverse Event|0
7085140|NCT02175771|11198053|FG002|Run-In Period (Pre-assignment)|Adverse Event|0
7085141|NCT02175771|11198054|FG003|Run-In Period (Pre-assignment)|Adverse Event|0
7085142|NCT02175771|11198055|FG004|Run-In Period (Pre-assignment)|Adverse Event|0
7085143|NCT02175771|11198056|FG005|Run-In Period (Pre-assignment)|Adverse Event|0
7085144|NCT02175771|11198057|FG006|Run-In Period (Pre-assignment)|Adverse Event|0
7085145|NCT02175771|11198058|FG007|Run-In Period (Pre-assignment)|Adverse Event|0
7085146|NCT02175771|11198059|FG008|Run-In Period (Pre-assignment)|Adverse Event|0
7085147|NCT02175771|11198051|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7
7085148|NCT02175771|11198052|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7085149|NCT02175771|11198053|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7085150|NCT02175771|11198054|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7085151|NCT02175771|11198055|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7085152|NCT02175771|11198056|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7085153|NCT02175771|11198057|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7085154|NCT02175771|11198058|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7085155|NCT02175771|11198059|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7085156|NCT02175771|11198051|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6
7085157|NCT02175771|11198052|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7085158|NCT02175771|11198053|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7085159|NCT02175771|11198054|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7085160|NCT02175771|11198055|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7085161|NCT02175771|11198056|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7085162|NCT02175771|11198057|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7085163|NCT02175771|11198058|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7085164|NCT02175771|11198059|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7085165|NCT02175771|11198051|FG000|Run-In Period (Pre-assignment)|Other|8
7085166|NCT02175771|11198052|FG001|Run-In Period (Pre-assignment)|Other|0
7085167|NCT02175771|11198053|FG002|Run-In Period (Pre-assignment)|Other|0
7085168|NCT02175771|11198054|FG003|Run-In Period (Pre-assignment)|Other|0
7085169|NCT02175771|11198055|FG004|Run-In Period (Pre-assignment)|Other|0
7085170|NCT02175771|11198056|FG005|Run-In Period (Pre-assignment)|Other|0
7085171|NCT02175771|11198057|FG006|Run-In Period (Pre-assignment)|Other|0
7085172|NCT02175771|11198058|FG007|Run-In Period (Pre-assignment)|Other|0
7085173|NCT02175771|11198059|FG008|Run-In Period (Pre-assignment)|Other|0
7085174|NCT02175771|11198051|FG000|Treatment Period|Adverse Event|0
7085175|NCT02175771|11198052|FG001|Treatment Period|Adverse Event|2
6805317|NCT02714218|10807447|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1
6805318|NCT02714218|10807448|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0
6805319|NCT02714218|10807446|FG000|Pre-Treatment Period|Other reasons|0
6805320|NCT02714218|10807447|FG001|Pre-Treatment Period|Other reasons|1
6805321|NCT02714218|10807448|FG002|Pre-Treatment Period|Other reasons|0
6805322|NCT02714218|10807446|FG000|Treatment Period|Disease Progression|55
6805323|NCT02714218|10807447|FG001|Treatment Period|Disease Progression|52
6805324|NCT02714218|10807448|FG002|Treatment Period|Disease Progression|14
6805325|NCT02714218|10807446|FG000|Treatment Period|Study drug toxicity|46
6805326|NCT02714218|10807447|FG001|Treatment Period|Study drug toxicity|70
6805327|NCT02714218|10807448|FG002|Treatment Period|Study drug toxicity|6
6805328|NCT02714218|10807446|FG000|Treatment Period|Adverse event unrelated to study drug|13
6805329|NCT02714218|10807447|FG001|Treatment Period|Adverse event unrelated to study drug|6
6805330|NCT02714218|10807448|FG002|Treatment Period|Adverse event unrelated to study drug|1
6805331|NCT02714218|10807446|FG000|Treatment Period|Request to discontinue treatment|1
6805332|NCT02714218|10807447|FG001|Treatment Period|Request to discontinue treatment|4
6805333|NCT02714218|10807448|FG002|Treatment Period|Request to discontinue treatment|1
6805334|NCT02714218|10807446|FG000|Treatment Period|Participant withdrew consent|2
6805335|NCT02714218|10807447|FG001|Treatment Period|Participant withdrew consent|2
7056135|NCT01874288|11149907|FG003|Overall Study|Withdrawal by Subject|1
7056136|NCT01874288|11149908|FG004|Overall Study|Withdrawal by Subject|1
7056137|NCT01874288|11149904|FG000|Overall Study|Physician Decision|0
7056138|NCT01874288|11149905|FG001|Overall Study|Physician Decision|0
7056139|NCT01874288|11149906|FG002|Overall Study|Physician Decision|0
7056140|NCT01874288|11149907|FG003|Overall Study|Physician Decision|1
7056141|NCT01874288|11149908|FG004|Overall Study|Physician Decision|0
7056142|NCT01874288|11149904|FG000|Overall Study|Progressive disease|2
7056143|NCT01874288|11149905|FG001|Overall Study|Progressive disease|0
7056144|NCT01874288|11149906|FG002|Overall Study|Progressive disease|3
7056145|NCT01874288|11149907|FG003|Overall Study|Progressive disease|5
7056146|NCT01874288|11149908|FG004|Overall Study|Progressive disease|1
7056147|NCT01874340|11149925|FG000|Overall Study|Study terminated by Sponsor|6
7056148|NCT01874340|11149926|FG001|Overall Study|Study terminated by Sponsor|8
7056149|NCT01874340|11149927|FG002|Overall Study|Study terminated by Sponsor|8
7056150|NCT01874340|11149928|FG003|Overall Study|Study terminated by Sponsor|4
7056151|NCT01874340|11149925|FG000|Overall Study|Withdrawal by Subject|0
7056152|NCT01874340|11149926|FG001|Overall Study|Withdrawal by Subject|0
7056153|NCT01874340|11149927|FG002|Overall Study|Withdrawal by Subject|0
7056154|NCT01874340|11149928|FG003|Overall Study|Withdrawal by Subject|1
7056155|NCT01874431|11149950|FG000|Overall Study|Physician Decision|0
7056156|NCT01874431|11149951|FG001|Overall Study|Physician Decision|0
7056157|NCT01874431|11149952|FG002|Overall Study|Physician Decision|1
7056158|NCT01874431|11149953|FG003|Overall Study|Physician Decision|0
7056159|NCT01874431|11149954|FG004|Overall Study|Physician Decision|0
7056160|NCT01874431|11149955|FG005|Overall Study|Physician Decision|0
7056161|NCT01874431|11149956|FG006|Overall Study|Physician Decision|0
7056162|NCT01874431|11149957|FG007|Overall Study|Physician Decision|0
7056163|NCT01874431|11149950|FG000|Overall Study|Adverse Event|5
7056164|NCT01874431|11149951|FG001|Overall Study|Adverse Event|4
7056165|NCT01874431|11149952|FG002|Overall Study|Adverse Event|6
7056166|NCT01874431|11149953|FG003|Overall Study|Adverse Event|5
7056167|NCT01874431|11149954|FG004|Overall Study|Adverse Event|2
7056168|NCT01874431|11149955|FG005|Overall Study|Adverse Event|8
7056169|NCT01874431|11149956|FG006|Overall Study|Adverse Event|2
7056170|NCT01874431|11149957|FG007|Overall Study|Adverse Event|3
7056171|NCT01874431|11149950|FG000|Overall Study|Protocol Violation|1
7056172|NCT01874431|11149951|FG001|Overall Study|Protocol Violation|1
7056173|NCT01874431|11149952|FG002|Overall Study|Protocol Violation|1
7056174|NCT01874431|11149953|FG003|Overall Study|Protocol Violation|0
7056175|NCT01874431|11149954|FG004|Overall Study|Protocol Violation|3
7056176|NCT01874431|11149955|FG005|Overall Study|Protocol Violation|2
7056177|NCT01874431|11149956|FG006|Overall Study|Protocol Violation|1
7056178|NCT01874431|11149957|FG007|Overall Study|Protocol Violation|1
7056179|NCT01874431|11149950|FG000|Overall Study|Non-compliance|0
7056180|NCT01874431|11149951|FG001|Overall Study|Non-compliance|0
7056181|NCT01874431|11149952|FG002|Overall Study|Non-compliance|0
7056182|NCT01874431|11149953|FG003|Overall Study|Non-compliance|0
7056183|NCT01874431|11149954|FG004|Overall Study|Non-compliance|1
7056184|NCT01874431|11149955|FG005|Overall Study|Non-compliance|0
7056185|NCT01874431|11149956|FG006|Overall Study|Non-compliance|1
7056186|NCT01874431|11149957|FG007|Overall Study|Non-compliance|0
7056187|NCT01874431|11149950|FG000|Overall Study|Logistical difficulties|0
7056188|NCT01874431|11149951|FG001|Overall Study|Logistical difficulties|0
7056189|NCT01874431|11149952|FG002|Overall Study|Logistical difficulties|0
7056190|NCT01874431|11149953|FG003|Overall Study|Logistical difficulties|0
7056191|NCT01874431|11149954|FG004|Overall Study|Logistical difficulties|0
7056192|NCT01874431|11149955|FG005|Overall Study|Logistical difficulties|0
7056193|NCT01874431|11149956|FG006|Overall Study|Logistical difficulties|1
7056194|NCT01874431|11149957|FG007|Overall Study|Logistical difficulties|0
7056195|NCT01874431|11149950|FG000|Overall Study|Withdrawal by Subject|0
7056196|NCT01874431|11149951|FG001|Overall Study|Withdrawal by Subject|0
7056197|NCT01874431|11149952|FG002|Overall Study|Withdrawal by Subject|1
7056198|NCT01874431|11149953|FG003|Overall Study|Withdrawal by Subject|2
7056199|NCT01874431|11149954|FG004|Overall Study|Withdrawal by Subject|1
7056200|NCT01874431|11149955|FG005|Overall Study|Withdrawal by Subject|1
7056201|NCT01874431|11149956|FG006|Overall Study|Withdrawal by Subject|3
7056202|NCT01874431|11149957|FG007|Overall Study|Withdrawal by Subject|0
7056203|NCT01874431|11149950|FG000|Overall Study|Sponsor decision|0
7056204|NCT01874431|11149951|FG001|Overall Study|Sponsor decision|0
7056205|NCT01874431|11149952|FG002|Overall Study|Sponsor decision|0
7056206|NCT01874431|11149953|FG003|Overall Study|Sponsor decision|0
7056207|NCT01874431|11149954|FG004|Overall Study|Sponsor decision|1
7056208|NCT01874431|11149955|FG005|Overall Study|Sponsor decision|0
7056209|NCT01874431|11149956|FG006|Overall Study|Sponsor decision|0
7056210|NCT01874431|11149957|FG007|Overall Study|Sponsor decision|0
7056211|NCT01874431|11149950|FG000|Overall Study|Lost to Follow-up|0
7056212|NCT01874431|11149951|FG001|Overall Study|Lost to Follow-up|0
7056213|NCT01874431|11149952|FG002|Overall Study|Lost to Follow-up|1
7056214|NCT01874431|11149953|FG003|Overall Study|Lost to Follow-up|0
7056215|NCT01874431|11149954|FG004|Overall Study|Lost to Follow-up|0
7056216|NCT01874431|11149955|FG005|Overall Study|Lost to Follow-up|0
7056217|NCT01874431|11149956|FG006|Overall Study|Lost to Follow-up|0
7056218|NCT01874431|11149957|FG007|Overall Study|Lost to Follow-up|0
7056219|NCT01874535|11149977|FG000|Overall Study|Lost to Follow-up|10
7056220|NCT01874535|11149978|FG001|Overall Study|Lost to Follow-up|9
7056221|NCT01874535|11149977|FG000|Overall Study|incomplete symptom resolution|45
7056222|NCT01874535|11149978|FG001|Overall Study|incomplete symptom resolution|35
7056223|NCT01874665|11149986|FG000|Overall Study|Adverse Event|6
7056224|NCT01874665|11149987|FG001|Overall Study|Adverse Event|2
6805336|NCT02714218|10807448|FG002|Treatment Period|Participant withdrew consent|0
6805337|NCT02714218|10807446|FG000|Treatment Period|Maximum clinical benefit|4
6805338|NCT02714218|10807447|FG001|Treatment Period|Maximum clinical benefit|2
6805339|NCT02714218|10807448|FG002|Treatment Period|Maximum clinical benefit|0
6805340|NCT02714218|10807446|FG000|Treatment Period|Administrative reason by sponsor|2
6805341|NCT02714218|10807447|FG001|Treatment Period|Administrative reason by sponsor|1
6805342|NCT02714218|10807448|FG002|Treatment Period|Administrative reason by sponsor|0
6805343|NCT02714218|10807446|FG000|Treatment Period|Other reasons|6
6805344|NCT02714218|10807447|FG001|Treatment Period|Other reasons|6
7056225|NCT01874665|11149986|FG000|Overall Study|Withdrawal by Subject|4
7056226|NCT01874665|11149987|FG001|Overall Study|Withdrawal by Subject|1
7056227|NCT01874665|11149986|FG000|Overall Study|Physician Decision|3
7056228|NCT01874665|11149987|FG001|Overall Study|Physician Decision|0
7056229|NCT01874665|11149986|FG000|Overall Study|Clinical Progressive Disease|4
7056230|NCT01874665|11149987|FG001|Overall Study|Clinical Progressive Disease|3
7056231|NCT01874665|11149986|FG000|Overall Study|Study Terminated by Sponsor|0
7056232|NCT01874665|11149987|FG001|Overall Study|Study Terminated by Sponsor|2
7056233|NCT01874665|11149986|FG000|Overall Study|Documented Progressive Disease|11
7056234|NCT01874665|11149987|FG001|Overall Study|Documented Progressive Disease|7
7056235|NCT01874665|11149986|FG000|Overall Study|Other|2
7056236|NCT01874665|11149987|FG001|Overall Study|Other|0
7056237|NCT01875237|11150034|FG000|Overall Study|GVDH before DLI|1
7056238|NCT01875237|11150035|FG001|Overall Study|GVDH before DLI|0
7056239|NCT01875237|11150034|FG000|Overall Study|DLI cells could not be produced|1
7056240|NCT01875237|11150035|FG001|Overall Study|DLI cells could not be produced|0
7056241|NCT01875250|11150045|FG000|Overall Study|Adverse Event|2
7056242|NCT01875250|11150046|FG001|Overall Study|Adverse Event|0
7056243|NCT01875367|11150056|FG000|Overall Study|Not complete at least 2 questionaries|4
7056244|NCT01875367|11150057|FG001|Overall Study|Not complete at least 2 questionaries|2
7056245|NCT01875367|11150056|FG000|Overall Study|Not receive study treatment|1
7056246|NCT01875367|11150057|FG001|Overall Study|Not receive study treatment|0
7056247|NCT01875445|11150069|FG000|Overall Study|Lost to Follow-up|5
7056248|NCT01875445|11150070|FG001|Overall Study|Lost to Follow-up|0
7056249|NCT01875445|11150069|FG000|Overall Study|Withdrawal by Subject|2
7056250|NCT01875445|11150070|FG001|Overall Study|Withdrawal by Subject|0
7056251|NCT01875471|11150078|FG000|Overall Study|Adverse Event|0
7056252|NCT01875471|11150079|FG001|Overall Study|Adverse Event|1
7056253|NCT01875471|11150078|FG000|Overall Study|Unsatisfactory Lens Fitting|1
7056254|NCT01875471|11150079|FG001|Overall Study|Unsatisfactory Lens Fitting|0
7056255|NCT01875731|11150096|FG000|Overall Study|Fail to obtain lab sample|1
7056256|NCT01875731|11150097|FG001|Overall Study|Fail to obtain lab sample|0
7085176|NCT02175771|11198053|FG002|Treatment Period|Adverse Event|1
7085177|NCT02175771|11198054|FG003|Treatment Period|Adverse Event|1
7085178|NCT02175771|11198055|FG004|Treatment Period|Adverse Event|1
7085179|NCT02175771|11198056|FG005|Treatment Period|Adverse Event|3
7085180|NCT02175771|11198057|FG006|Treatment Period|Adverse Event|2
7085181|NCT02175771|11198058|FG007|Treatment Period|Adverse Event|0
7085182|NCT02175771|11198059|FG008|Treatment Period|Adverse Event|1
7085183|NCT02175771|11198051|FG000|Treatment Period|Withdrawal by Subject|0
7085184|NCT02175771|11198052|FG001|Treatment Period|Withdrawal by Subject|9
7085185|NCT02175771|11198053|FG002|Treatment Period|Withdrawal by Subject|3
7085186|NCT02175771|11198054|FG003|Treatment Period|Withdrawal by Subject|6
7085187|NCT02175771|11198055|FG004|Treatment Period|Withdrawal by Subject|2
7085188|NCT02175771|11198056|FG005|Treatment Period|Withdrawal by Subject|4
7085189|NCT02175771|11198057|FG006|Treatment Period|Withdrawal by Subject|2
7085190|NCT02175771|11198058|FG007|Treatment Period|Withdrawal by Subject|9
7085191|NCT02175771|11198059|FG008|Treatment Period|Withdrawal by Subject|2
7085192|NCT02175771|11198051|FG000|Treatment Period|Noncompliance|0
7085193|NCT02175771|11198052|FG001|Treatment Period|Noncompliance|1
7085194|NCT02175771|11198053|FG002|Treatment Period|Noncompliance|2
7085195|NCT02175771|11198054|FG003|Treatment Period|Noncompliance|0
7085196|NCT02175771|11198055|FG004|Treatment Period|Noncompliance|0
6805345|NCT02714218|10807448|FG002|Treatment Period|Other reasons|0
6805346|NCT02714218|10807446|FG000|Treatment Period|Completed treatment as per protocol|36
6805347|NCT02714218|10807447|FG001|Treatment Period|Completed treatment as per protocol|27
6805348|NCT02714218|10807448|FG002|Treatment Period|Completed treatment as per protocol|3
6805349|NCT02714218|10807446|FG000|Treatment Period|Not reported|9
6805350|NCT02714218|10807447|FG001|Treatment Period|Not reported|6
7085197|NCT02175771|11198056|FG005|Treatment Period|Noncompliance|0
7085198|NCT02175771|11198057|FG006|Treatment Period|Noncompliance|0
7085199|NCT02175771|11198058|FG007|Treatment Period|Noncompliance|0
7056257|NCT01875848|11150111|FG000|Overall Study|Withdrawal by Subject|2
7056258|NCT01875848|11150112|FG001|Overall Study|Withdrawal by Subject|0
7056259|NCT01875874|11150128|FG000|Overall Study|Death|3
7056260|NCT01875991|11150146|FG000|Overall Study|Withdrawal by Subject|6
7056261|NCT01875991|11150147|FG001|Overall Study|Withdrawal by Subject|6
7056262|NCT01875991|11150146|FG000|Overall Study|Sponsor Decision|1
7056263|NCT01875991|11150147|FG001|Overall Study|Sponsor Decision|0
7056264|NCT01876043|11150156|FG000|Overall Study|Death|1
7056265|NCT01876043|11150156|FG000|Overall Study|Withdrawal by Subject|1
7056266|NCT01876082|11150162|FG000|Overall Study|Withdrawal by Subject|0
7056267|NCT01876082|11150163|FG001|Overall Study|Withdrawal by Subject|2
7056268|NCT01876082|11150162|FG000|Overall Study|Protocol Violation|1
7056269|NCT01876082|11150163|FG001|Overall Study|Protocol Violation|0
7056270|NCT01876082|11150162|FG000|Overall Study|Adverse Event|1
7056271|NCT01876082|11150163|FG001|Overall Study|Adverse Event|1
7056272|NCT01876082|11150162|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0
7056273|NCT01876082|11150163|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1
7056274|NCT01876251|11150181|FG000|Overall Study|Clinical progression|1
7056275|NCT01876251|11150182|FG001|Overall Study|Clinical progression|0
7056276|NCT01876251|11150183|FG002|Overall Study|Clinical progression|0
7056277|NCT01876251|11150181|FG000|Overall Study|Death|2
7056278|NCT01876251|11150182|FG001|Overall Study|Death|0
7056279|NCT01876251|11150183|FG002|Overall Study|Death|1
7056280|NCT01876251|11150181|FG000|Overall Study|Participant started new treatment|1
7056281|NCT01876251|11150182|FG001|Overall Study|Participant started new treatment|0
7056282|NCT01876251|11150183|FG002|Overall Study|Participant started new treatment|1
7056283|NCT01876251|11150181|FG000|Overall Study|Participant refused further follow-up|0
7056284|NCT01876251|11150182|FG001|Overall Study|Participant refused further follow-up|0
7056285|NCT01876251|11150183|FG002|Overall Study|Participant refused further follow-up|1
7056286|NCT01876251|11150181|FG000|Overall Study|Study terminated|1
7056287|NCT01876251|11150182|FG001|Overall Study|Study terminated|0
7056288|NCT01876251|11150183|FG002|Overall Study|Study terminated|0
7056289|NCT01876251|11150181|FG000|Overall Study|Objective progression or relapse|10
7085200|NCT02175771|11198059|FG008|Treatment Period|Noncompliance|1
7085201|NCT02175771|11198051|FG000|Treatment Period|Protocol Violation|0
7085202|NCT02175771|11198052|FG001|Treatment Period|Protocol Violation|0
7085203|NCT02175771|11198053|FG002|Treatment Period|Protocol Violation|0
7085204|NCT02175771|11198054|FG003|Treatment Period|Protocol Violation|0
7085205|NCT02175771|11198055|FG004|Treatment Period|Protocol Violation|0
7085206|NCT02175771|11198056|FG005|Treatment Period|Protocol Violation|0
7085207|NCT02175771|11198057|FG006|Treatment Period|Protocol Violation|0
7085208|NCT02175771|11198058|FG007|Treatment Period|Protocol Violation|1
7085209|NCT02175771|11198059|FG008|Treatment Period|Protocol Violation|0
7085210|NCT02175771|11198051|FG000|Treatment Period|Disease progression|0
7085211|NCT02175771|11198052|FG001|Treatment Period|Disease progression|0
7085212|NCT02175771|11198053|FG002|Treatment Period|Disease progression|0
7085213|NCT02175771|11198054|FG003|Treatment Period|Disease progression|0
6805351|NCT02714218|10807448|FG002|Treatment Period|Not reported|0
6805352|NCT02677896|10807457|FG000|Double Blind Period (up to 35 Months)|Death|113
6805353|NCT02677896|10807458|FG001|Double Blind Period (up to 35 Months)|Death|189
6805354|NCT02677896|10807457|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12
6805355|NCT02677896|10807458|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|12
6805356|NCT02677896|10807457|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3
6805357|NCT02677896|10807458|FG001|Double Blind Period (up to 35 Months)|Progressive disease|4
6805358|NCT02677896|10807457|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41
6805359|NCT02677896|10807458|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|69
6805360|NCT02677896|10807457|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|9
6805361|NCT02677896|10807458|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|14
6805362|NCT02677896|10807457|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|365
6805363|NCT02677896|10807458|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|180
6805364|NCT02677896|10807457|FG000|Double Blind Period (up to 35 Months)|Followed-up for OS|31
6805365|NCT02677896|10807458|FG001|Double Blind Period (up to 35 Months)|Followed-up for OS|108
6805366|NCT02677896|10807457|FG000|Open-Label Extension (up to 25 Months)|Death|40
6805367|NCT02677896|10807458|FG001|Open-Label Extension (up to 25 Months)|Death|14
6805368|NCT02677896|10807457|FG000|Open-Label Extension (up to 25 Months)|Lost to Follow-up|2
6805369|NCT02677896|10807458|FG001|Open-Label Extension (up to 25 Months)|Lost to Follow-up|1
7056290|NCT01876251|11150182|FG001|Overall Study|Objective progression or relapse|3
7056291|NCT01876251|11150183|FG002|Overall Study|Objective progression or relapse|8
7056292|NCT01876368|11150207|FG000|Overall Study|Adverse Event|2
7056293|NCT01876368|11150208|FG001|Overall Study|Adverse Event|5
7056294|NCT01876368|11150207|FG000|Overall Study|Lack of Efficacy|1
7056295|NCT01876368|11150208|FG001|Overall Study|Lack of Efficacy|0
7056296|NCT01876368|11150207|FG000|Overall Study|Lost to Follow-up|0
7056297|NCT01876368|11150208|FG001|Overall Study|Lost to Follow-up|1
7056298|NCT01876368|11150207|FG000|Overall Study|Non-compliance with study treatment|0
7056299|NCT01876368|11150208|FG001|Overall Study|Non-compliance with study treatment|1
7056300|NCT01876368|11150207|FG000|Overall Study|Physician Decision|0
7056301|NCT01876368|11150208|FG001|Overall Study|Physician Decision|2
7056302|NCT01876368|11150207|FG000|Overall Study|Protocol deviation|3
7056303|NCT01876368|11150208|FG001|Overall Study|Protocol deviation|3
7056304|NCT01876368|11150207|FG000|Overall Study|Subject/guardian decision|3
7056305|NCT01876368|11150208|FG001|Overall Study|Subject/guardian decision|1
7056306|NCT01876381|11150214|FG000|Overall Study|Lack of Efficacy|5
7056307|NCT01876381|11150214|FG000|Overall Study|Physician Decision|1
7056308|NCT01876381|11150214|FG000|Overall Study|Withdrawal by Subject|1
7056309|NCT01876420|11150218|FG000|Overall Study|Missed 30 day visit|1
7056310|NCT01876446|11150224|FG000|Overall Study|Death|0
7056311|NCT01876446|11150225|FG001|Overall Study|Death|1
7056312|NCT01876446|11150224|FG000|Overall Study|Withdrawal by Subject|1
7056313|NCT01876446|11150225|FG001|Overall Study|Withdrawal by Subject|2
6805370|NCT02677896|10807457|FG000|Open-Label Extension (up to 25 Months)|Progressive disease|3
6805371|NCT02677896|10807458|FG001|Open-Label Extension (up to 25 Months)|Progressive disease|1
6805372|NCT02677896|10807457|FG000|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|10
6805373|NCT02677896|10807458|FG001|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|9
6805374|NCT02677896|10807457|FG000|Open-Label Extension (up to 25 Months)|Miscellaneous|0
6805375|NCT02677896|10807458|FG001|Open-Label Extension (up to 25 Months)|Miscellaneous|1
6805376|NCT02677896|10807457|FG000|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|261
6805377|NCT02677896|10807458|FG001|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|136
6805378|NCT02677896|10807457|FG000|Open-Label Extension (up to 25 Months)|Followed up for OS|49
6805379|NCT02677896|10807458|FG001|Open-Label Extension (up to 25 Months)|Followed up for OS|18
6805380|NCT02652949|10807465|FG000|30-Day Follow-up for Primary Endpoint|Death|1
6805381|NCT02652949|10807465|FG000|30-Day Follow-up for Secondary Endpoint|Death|1
7056314|NCT01876446|11150224|FG000|Overall Study|Physician Decision|1
7056315|NCT01876446|11150225|FG001|Overall Study|Physician Decision|3
7056316|NCT01876511|11150243|FG000|Overall Study|Disease Progression-clinical/radiologic|11
7056317|NCT01876511|11150244|FG001|Overall Study|Disease Progression-clinical/radiologic|24
7056318|NCT01876511|11150245|FG002|Overall Study|Disease Progression-clinical/radiologic|16
7056319|NCT01876511|11150243|FG000|Overall Study|Death (unrelated)|3
6805382|NCT02652949|10807465|FG000|6-Month Follow-up Secondary Endpoint|Death|5
6805383|NCT02652949|10807465|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2
7056320|NCT01876511|11150244|FG001|Overall Study|Death (unrelated)|0
7056321|NCT01876511|11150245|FG002|Overall Study|Death (unrelated)|2
7056322|NCT01876511|11150243|FG000|Overall Study|Drug-related Toxicity|5
7056323|NCT01876511|11150244|FG001|Overall Study|Drug-related Toxicity|1
7056324|NCT01876511|11150245|FG002|Overall Study|Drug-related Toxicity|6
7056325|NCT01876511|11150243|FG000|Overall Study|Patient Decision|3
7056326|NCT01876511|11150244|FG001|Overall Study|Patient Decision|0
7056327|NCT01876511|11150245|FG002|Overall Study|Patient Decision|6
7056328|NCT01876511|11150243|FG000|Overall Study|Physician Decision|1
7056329|NCT01876511|11150244|FG001|Overall Study|Physician Decision|0
7056330|NCT01876511|11150245|FG002|Overall Study|Physician Decision|1
7056331|NCT01876706|11150255|FG000|Overall Study|BPH Intervention|9
7056332|NCT01876706|11150255|FG000|Overall Study|Lost to Follow-up|7
7056333|NCT01876706|11150255|FG000|Overall Study|Withdrawals|6
7056334|NCT01876706|11150255|FG000|Overall Study|Death|3
7056335|NCT01876732|11150259|FG000|Overall Study|MMA was not over 800mg/dL|75
7056336|NCT01876784|11150266|FG000|Overall Study|Withdrawal by Subject|17
7056337|NCT01876784|11150267|FG001|Overall Study|Withdrawal by Subject|2
7056338|NCT01876784|11150266|FG000|Overall Study|Adverse Event|15
7056339|NCT01876784|11150267|FG001|Overall Study|Adverse Event|2
7056340|NCT01876784|11150266|FG000|Overall Study|Protocol Violation|1
7056341|NCT01876784|11150267|FG001|Overall Study|Protocol Violation|0
7056342|NCT01876784|11150266|FG000|Overall Study|Disease progression|37
7056343|NCT01876784|11150267|FG001|Overall Study|Disease progression|67
7056344|NCT01876784|11150266|FG000|Overall Study|Lost to Follow-up|0
7056345|NCT01876784|11150267|FG001|Overall Study|Lost to Follow-up|1
7056346|NCT01876784|11150266|FG000|Overall Study|Death|1
7056347|NCT01876784|11150267|FG001|Overall Study|Death|0
7056348|NCT01876784|11150266|FG000|Overall Study|Randomized but not treated|2
7056349|NCT01876784|11150267|FG001|Overall Study|Randomized but not treated|1
7056350|NCT01876784|11150266|FG000|Overall Study|Other than specified above|5
7056351|NCT01876784|11150267|FG001|Overall Study|Other than specified above|6
7056352|NCT01876784|11150266|FG000|Overall Study|Ongoing|41
6811732|NCT01208207|10815567|FG005|Part I|Withdrawal by Subject|0
7056353|NCT01876784|11150267|FG001|Overall Study|Ongoing|40
7056354|NCT01876810|11150273|FG000|Overall Study|Physician Decision|0
7056355|NCT01876810|11150274|FG001|Overall Study|Physician Decision|1
7056356|NCT01876823|11150283|FG000|Overall Study|Withdrawal by Subject|5
7056357|NCT01876823|11150283|FG000|Overall Study|Physician Decision|2
7056358|NCT01876823|11150283|FG000|Overall Study|Patients moved|2
7056359|NCT01876901|11150289|FG000|Overall Study|Protocol Violation|10
7056360|NCT01876901|11150290|FG001|Overall Study|Protocol Violation|2
7056361|NCT01876901|11150289|FG000|Overall Study|No or other surgical intervention|7
7056362|NCT01876901|11150290|FG001|Overall Study|No or other surgical intervention|5
7056363|NCT01876979|11150299|FG000|Overall Study|Physician Decision|2
7085214|NCT02175771|11198055|FG004|Treatment Period|Disease progression|0
7085215|NCT02175771|11198056|FG005|Treatment Period|Disease progression|0
7085216|NCT02175771|11198057|FG006|Treatment Period|Disease progression|0
7085217|NCT02175771|11198058|FG007|Treatment Period|Disease progression|2
7056364|NCT01876979|11150300|FG001|Overall Study|Physician Decision|3
7056365|NCT01877083|11150316|FG000|Treatment Phase|Disease Progression|10
7056366|NCT01877083|11150316|FG000|Treatment Phase|Clinical Progression|1
7056367|NCT01877083|11150316|FG000|Treatment Phase|Adverse Event|6
7056368|NCT01877083|11150316|FG000|Treatment Phase|Withdrawal by Subject|2
7056369|NCT01877083|11150316|FG000|Treatment Phase|Lost to Follow-up|1
7056370|NCT01877083|11150316|FG000|Extension Phase|Disease Progression|3
7056371|NCT01877083|11150316|FG000|Extension Phase|Adverse Event|2
7056372|NCT01877187|11150337|FG000|Overall Study|Death|2
7056373|NCT01877187|11150337|FG000|Overall Study|Withdrawal by Subject|4
7056374|NCT01877187|11150337|FG000|Overall Study|Lost to Follow-up|3
7056375|NCT01877187|11150337|FG000|Overall Study|Declining clinical status|11
7056376|NCT01877187|11150337|FG000|Overall Study|Liver transplant|2
7056377|NCT01877239|11150344|FG000|Overall Study|Adverse Event|4
7056378|NCT01877239|11150344|FG000|Overall Study|Disease Remission|1
7056379|NCT01877239|11150344|FG000|Overall Study|Withdrawal by Subject|4
7056380|NCT01877239|11150344|FG000|Overall Study|Other|2
7056381|NCT01877239|11150344|FG000|Overall Study|Lack of Efficacy|4
7056382|NCT01877239|11150344|FG000|Overall Study|Data not available|35
7056383|NCT01877265|11150348|FG000|Treatment Period 1|Sponsor Decision|0
7056384|NCT01877265|11150349|FG001|Treatment Period 1|Sponsor Decision|0
7056385|NCT01877265|11150350|FG002|Treatment Period 1|Sponsor Decision|1
7056386|NCT01877265|11150351|FG003|Treatment Period 1|Sponsor Decision|0
7056387|NCT01877265|11150352|FG004|Treatment Period 1|Sponsor Decision|0
7056388|NCT01877265|11150353|FG005|Treatment Period 1|Sponsor Decision|0
7056389|NCT01877265|11150348|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
7056390|NCT01877265|11150349|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
7056391|NCT01877265|11150350|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
7056392|NCT01877265|11150351|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
7056393|NCT01877265|11150352|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
7056394|NCT01877265|11150353|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1
7056395|NCT01877265|11150348|FG000|Treatment Period 3|Lost to Follow-up|1
7056396|NCT01877265|11150349|FG001|Treatment Period 3|Lost to Follow-up|0
7056397|NCT01877265|11150350|FG002|Treatment Period 3|Lost to Follow-up|0
7056398|NCT01877265|11150351|FG003|Treatment Period 3|Lost to Follow-up|0
7056399|NCT01877265|11150352|FG004|Treatment Period 3|Lost to Follow-up|0
7056400|NCT01877265|11150353|FG005|Treatment Period 3|Lost to Follow-up|0
7056401|NCT01877278|11150366|FG000|Overall Study|Lost to Follow-up|3
7056402|NCT01877278|11150367|FG001|Overall Study|Lost to Follow-up|3
7056403|NCT01877408|11150375|FG000|Overall Study|Lost to Follow-up|0
7056404|NCT01877408|11150376|FG001|Overall Study|Lost to Follow-up|2
7056405|NCT01877421|11150415|FG000|Phase 2|Lost to Follow-up|0
7056406|NCT01877421|11150416|FG001|Phase 2|Lost to Follow-up|0
7056407|NCT01877421|11150417|FG002|Phase 2|Lost to Follow-up|0
7056408|NCT01877421|11150418|FG003|Phase 2|Lost to Follow-up|0
7056409|NCT01877421|11150419|FG004|Phase 2|Lost to Follow-up|0
7056410|NCT01877421|11150420|FG005|Phase 2|Lost to Follow-up|0
7056411|NCT01877421|11150421|FG006|Phase 2|Lost to Follow-up|1
7056412|NCT01877421|11150422|FG007|Phase 2|Lost to Follow-up|0
7056413|NCT01877421|11150423|FG008|Phase 2|Lost to Follow-up|0
7056414|NCT01877421|11150424|FG009|Phase 2|Lost to Follow-up|0
7056415|NCT01877421|11150425|FG010|Phase 2|Lost to Follow-up|0
7056416|NCT01877421|11150426|FG011|Phase 2|Lost to Follow-up|0
7056417|NCT01877421|11150427|FG012|Phase 2|Lost to Follow-up|0
7056418|NCT01877421|11150428|FG013|Phase 2|Lost to Follow-up|0
7085218|NCT02175771|11198059|FG008|Treatment Period|Disease progression|0
7085219|NCT02175771|11198051|FG000|Treatment Period|Lost to Follow-up|0
7056419|NCT01877421|11150429|FG014|Phase 2|Lost to Follow-up|0
7056420|NCT01877421|11150430|FG015|Phase 2|Lost to Follow-up|0
7056421|NCT01877421|11150431|FG016|Phase 2|Lost to Follow-up|0
7056422|NCT01877421|11150432|FG017|Phase 2|Lost to Follow-up|0
7085220|NCT02175771|11198052|FG001|Treatment Period|Lost to Follow-up|3
7085221|NCT02175771|11198053|FG002|Treatment Period|Lost to Follow-up|1
7085222|NCT02175771|11198054|FG003|Treatment Period|Lost to Follow-up|3
7085223|NCT02175771|11198055|FG004|Treatment Period|Lost to Follow-up|1
7085224|NCT02175771|11198056|FG005|Treatment Period|Lost to Follow-up|2
7085225|NCT02175771|11198057|FG006|Treatment Period|Lost to Follow-up|1
7085226|NCT02175771|11198058|FG007|Treatment Period|Lost to Follow-up|2
7085227|NCT02175771|11198059|FG008|Treatment Period|Lost to Follow-up|2
7085228|NCT02175771|11198051|FG000|Treatment Period|Lack of Efficacy|0
7085229|NCT02175771|11198052|FG001|Treatment Period|Lack of Efficacy|0
7085230|NCT02175771|11198053|FG002|Treatment Period|Lack of Efficacy|0
7085231|NCT02175771|11198054|FG003|Treatment Period|Lack of Efficacy|0
7085232|NCT02175771|11198055|FG004|Treatment Period|Lack of Efficacy|0
7085233|NCT02175771|11198056|FG005|Treatment Period|Lack of Efficacy|1
7085234|NCT02175771|11198057|FG006|Treatment Period|Lack of Efficacy|0
7085235|NCT02175771|11198058|FG007|Treatment Period|Lack of Efficacy|1
7085236|NCT02175771|11198059|FG008|Treatment Period|Lack of Efficacy|0
7085237|NCT02175771|11198051|FG000|Treatment Period|Other|0
7085238|NCT02175771|11198052|FG001|Treatment Period|Other|1
7085239|NCT02175771|11198053|FG002|Treatment Period|Other|0
7085240|NCT02175771|11198054|FG003|Treatment Period|Other|3
7085241|NCT02175771|11198055|FG004|Treatment Period|Other|1
7085242|NCT02175771|11198056|FG005|Treatment Period|Other|0
7085243|NCT02175771|11198057|FG006|Treatment Period|Other|0
7085244|NCT02175771|11198058|FG007|Treatment Period|Other|2
7085245|NCT02175771|11198059|FG008|Treatment Period|Other|0
7085246|NCT02175966|11198079|FG000|Follow-up Period|Lack of Efficacy|10
7085247|NCT02175966|11198080|FG001|Follow-up Period|Lack of Efficacy|6
7085248|NCT02176018|11198114|FG000|Overall Study|Adverse Event|0
7085249|NCT02176018|11198115|FG001|Overall Study|Adverse Event|2
7085250|NCT02176018|11198114|FG000|Overall Study|Lost to Follow-up|3
7085251|NCT02176018|11198115|FG001|Overall Study|Lost to Follow-up|1
7085252|NCT02176018|11198114|FG000|Overall Study|Protocol Violation|1
7085253|NCT02176018|11198115|FG001|Overall Study|Protocol Violation|1
7085254|NCT02176018|11198114|FG000|Overall Study|Withdrawal by Subject|1
7056423|NCT01877421|11150415|FG000|Phase 2|Withdrawal by Subject|0
7056424|NCT01877421|11150416|FG001|Phase 2|Withdrawal by Subject|0
7056425|NCT01877421|11150417|FG002|Phase 2|Withdrawal by Subject|0
7056426|NCT01877421|11150418|FG003|Phase 2|Withdrawal by Subject|0
7056427|NCT01877421|11150419|FG004|Phase 2|Withdrawal by Subject|0
7056428|NCT01877421|11150420|FG005|Phase 2|Withdrawal by Subject|0
7056429|NCT01877421|11150421|FG006|Phase 2|Withdrawal by Subject|0
7056430|NCT01877421|11150422|FG007|Phase 2|Withdrawal by Subject|0
7056431|NCT01877421|11150423|FG008|Phase 2|Withdrawal by Subject|1
7056432|NCT01877421|11150424|FG009|Phase 2|Withdrawal by Subject|0
7056433|NCT01877421|11150425|FG010|Phase 2|Withdrawal by Subject|1
7056434|NCT01877421|11150426|FG011|Phase 2|Withdrawal by Subject|0
7056435|NCT01877421|11150427|FG012|Phase 2|Withdrawal by Subject|1
7056436|NCT01877421|11150428|FG013|Phase 2|Withdrawal by Subject|0
7056437|NCT01877421|11150429|FG014|Phase 2|Withdrawal by Subject|0
7056438|NCT01877421|11150430|FG015|Phase 2|Withdrawal by Subject|1
7056439|NCT01877421|11150431|FG016|Phase 2|Withdrawal by Subject|0
7056440|NCT01877421|11150432|FG017|Phase 2|Withdrawal by Subject|0
7056441|NCT01877421|11150415|FG000|Phase 2|Protocol Violation|0
7056442|NCT01877421|11150416|FG001|Phase 2|Protocol Violation|0
7056443|NCT01877421|11150417|FG002|Phase 2|Protocol Violation|0
7056444|NCT01877421|11150418|FG003|Phase 2|Protocol Violation|0
7056445|NCT01877421|11150419|FG004|Phase 2|Protocol Violation|0
7056446|NCT01877421|11150420|FG005|Phase 2|Protocol Violation|0
7056447|NCT01877421|11150421|FG006|Phase 2|Protocol Violation|0
7056448|NCT01877421|11150422|FG007|Phase 2|Protocol Violation|0
7056449|NCT01877421|11150423|FG008|Phase 2|Protocol Violation|0
7056450|NCT01877421|11150424|FG009|Phase 2|Protocol Violation|0
7056451|NCT01877421|11150425|FG010|Phase 2|Protocol Violation|1
7056452|NCT01877421|11150426|FG011|Phase 2|Protocol Violation|0
7056453|NCT01877421|11150427|FG012|Phase 2|Protocol Violation|0
7056454|NCT01877421|11150428|FG013|Phase 2|Protocol Violation|0
7056455|NCT01877421|11150429|FG014|Phase 2|Protocol Violation|0
7056456|NCT01877421|11150430|FG015|Phase 2|Protocol Violation|0
7056457|NCT01877421|11150431|FG016|Phase 2|Protocol Violation|0
7056458|NCT01877421|11150432|FG017|Phase 2|Protocol Violation|0
7056459|NCT01877551|11150518|FG000|Overall Study|Physician Decision|0
7056460|NCT01877551|11150519|FG001|Overall Study|Physician Decision|1
7056461|NCT01877668|11150547|FG000|Overall Study|Death|0
7056462|NCT01877668|11150548|FG001|Overall Study|Death|0
7056463|NCT01877668|11150549|FG002|Overall Study|Death|0
7056464|NCT01877668|11150550|FG003|Overall Study|Death|1
7056465|NCT01877668|11150551|FG004|Overall Study|Death|0
7056466|NCT01877668|11150547|FG000|Overall Study|No longer met study criteria|1
7056467|NCT01877668|11150548|FG001|Overall Study|No longer met study criteria|0
7056468|NCT01877668|11150549|FG002|Overall Study|No longer met study criteria|1
7056469|NCT01877668|11150550|FG003|Overall Study|No longer met study criteria|0
7056470|NCT01877668|11150551|FG004|Overall Study|No longer met study criteria|0
7056471|NCT01877668|11150547|FG000|Overall Study|Insufficient clinical response|0
7056472|NCT01877668|11150548|FG001|Overall Study|Insufficient clinical response|1
7056473|NCT01877668|11150549|FG002|Overall Study|Insufficient clinical response|2
7056474|NCT01877668|11150550|FG003|Overall Study|Insufficient clinical response|2
7056475|NCT01877668|11150551|FG004|Overall Study|Insufficient clinical response|0
7056476|NCT01877668|11150547|FG000|Overall Study|Lost to Follow-up|0
7056477|NCT01877668|11150548|FG001|Overall Study|Lost to Follow-up|2
7056478|NCT01877668|11150549|FG002|Overall Study|Lost to Follow-up|1
7056479|NCT01877668|11150550|FG003|Overall Study|Lost to Follow-up|0
7056480|NCT01877668|11150551|FG004|Overall Study|Lost to Follow-up|0
7056481|NCT01877668|11150547|FG000|Overall Study|Withdrawal by Subject|2
7056482|NCT01877668|11150548|FG001|Overall Study|Withdrawal by Subject|0
7056483|NCT01877668|11150549|FG002|Overall Study|Withdrawal by Subject|3
7056484|NCT01877668|11150550|FG003|Overall Study|Withdrawal by Subject|2
7056485|NCT01877668|11150551|FG004|Overall Study|Withdrawal by Subject|2
7056486|NCT01877668|11150547|FG000|Overall Study|Other|1
7056487|NCT01877668|11150548|FG001|Overall Study|Other|1
7056488|NCT01877668|11150549|FG002|Overall Study|Other|1
7056489|NCT01877668|11150550|FG003|Overall Study|Other|1
7056490|NCT01877668|11150551|FG004|Overall Study|Other|3
7056491|NCT01877668|11150547|FG000|Overall Study|Protocol Violation|1
7056492|NCT01877668|11150548|FG001|Overall Study|Protocol Violation|1
7056493|NCT01877668|11150549|FG002|Overall Study|Protocol Violation|0
7056494|NCT01877668|11150550|FG003|Overall Study|Protocol Violation|0
7085255|NCT02176018|11198115|FG001|Overall Study|Withdrawal by Subject|2
7085256|NCT02176226|11198135|FG000|Overall Study|Lost to Follow-up|3
7085257|NCT02176226|11198135|FG000|Overall Study|Withdrew prior to treatment|6
7085258|NCT02176291|11198141|FG000|Overall Study|Death|1
7085259|NCT02176291|11198142|FG001|Overall Study|Death|0
7085260|NCT02176291|11198141|FG000|Overall Study|non compliance with protocol|2
7085261|NCT02176291|11198142|FG001|Overall Study|non compliance with protocol|0
7085262|NCT02176291|11198141|FG000|Overall Study|Withdrawal by Subject|2
7085263|NCT02176291|11198142|FG001|Overall Study|Withdrawal by Subject|0
7085264|NCT02176356|11198152|FG000|Overall Study|Screen Failure|14
7085265|NCT02176356|11198152|FG000|Overall Study|Lost to Follow-up|4
7085266|NCT02176356|11198152|FG000|Overall Study|Personal Reasons|3
7085267|NCT02176356|11198152|FG000|Overall Study|Other Miscellaneous Reasons|2
7085268|NCT02176421|11198174|FG000|Overall Study|Lost to Follow-up|4
7085269|NCT02176421|11198174|FG000|Overall Study|Adverse Event|1
7085270|NCT02176525|11198201|FG000|Overall Study|Adverse Event|0
7085271|NCT02176525|11198202|FG001|Overall Study|Adverse Event|0
7085272|NCT02176525|11198203|FG002|Overall Study|Adverse Event|0
7085273|NCT02176525|11198204|FG003|Overall Study|Adverse Event|1
7085274|NCT02176525|11198205|FG004|Overall Study|Adverse Event|1
7085275|NCT02176525|11198206|FG005|Overall Study|Adverse Event|0
7085276|NCT02176525|11198207|FG006|Overall Study|Adverse Event|1
7056495|NCT01877668|11150551|FG004|Overall Study|Protocol Violation|3
7085277|NCT02176525|11198208|FG007|Overall Study|Adverse Event|0
7085278|NCT02176525|11198201|FG000|Overall Study|not treated|1
7085279|NCT02176525|11198202|FG001|Overall Study|not treated|0
7056496|NCT01877668|11150547|FG000|Overall Study|Adverse event related to study drug|2
7056497|NCT01877668|11150548|FG001|Overall Study|Adverse event related to study drug|2
7056498|NCT01877668|11150549|FG002|Overall Study|Adverse event related to study drug|2
7056499|NCT01877668|11150550|FG003|Overall Study|Adverse event related to study drug|2
7056500|NCT01877668|11150551|FG004|Overall Study|Adverse event related to study drug|1
7085280|NCT02176525|11198203|FG002|Overall Study|not treated|0
7085281|NCT02176525|11198204|FG003|Overall Study|not treated|0
7056501|NCT01877668|11150547|FG000|Overall Study|Adverse event unrelated to study drug|4
7056502|NCT01877668|11150548|FG001|Overall Study|Adverse event unrelated to study drug|1
7056503|NCT01877668|11150549|FG002|Overall Study|Adverse event unrelated to study drug|2
7056504|NCT01877668|11150550|FG003|Overall Study|Adverse event unrelated to study drug|0
7056505|NCT01877668|11150551|FG004|Overall Study|Adverse event unrelated to study drug|1
7056506|NCT01877720|11150567|FG000|Overall Study|Adverse Event|1
7056507|NCT01877720|11150568|FG001|Overall Study|Adverse Event|0
7056508|NCT01877915|11150576|FG000|Overall Study|Lost to Follow-up|10
7056509|NCT01877915|11150577|FG001|Overall Study|Lost to Follow-up|9
7056510|NCT01877915|11150576|FG000|Overall Study|Withdrawal by Subject|42
7056511|NCT01877915|11150577|FG001|Overall Study|Withdrawal by Subject|55
7056512|NCT01877915|11150576|FG000|Overall Study|Other|2
7056513|NCT01877915|11150577|FG001|Overall Study|Other|4
7056514|NCT01878084|11150595|FG000|Overall Study|Physician Decision|2
7056515|NCT01878097|11150602|FG000|Baseline|Surveys not fully completed|2497
7056516|NCT01878097|11150603|FG001|Baseline|Surveys not fully completed|1800
7056517|NCT01878097|11150602|FG000|Implementation Year 1|Surveys not fully completed|3202
7056518|NCT01878097|11150603|FG001|Implementation Year 1|Surveys not fully completed|2549
7056519|NCT01878097|11150602|FG000|Implementation Year 2|Surveys not fully completed|3281
7056520|NCT01878097|11150603|FG001|Implementation Year 2|Surveys not fully completed|2841
7056521|NCT01878097|11150602|FG000|Implementation Year 3|Surveys not fully completed|3494
7056522|NCT01878097|11150603|FG001|Implementation Year 3|Surveys not fully completed|2980
7056523|NCT01878097|11150602|FG000|Implementation Year 4|Surveys not fully completed|3604
7056524|NCT01878097|11150603|FG001|Implementation Year 4|Surveys not fully completed|3007
7056525|NCT01878149|11150611|FG000|Overall Study|Did Not Meet Eligibility Criteria|2
7056526|NCT01878149|11150612|FG001|Overall Study|Did Not Meet Eligibility Criteria|2
7056527|NCT01878175|11150618|FG000|Overall Study|Developed contraindicated health problem|2
7056528|NCT01878214|11150625|FG000|Overall Study|Withdrawal by Subject|18
7056529|NCT01878214|11150626|FG001|Overall Study|Withdrawal by Subject|7
7056530|NCT01878214|11150625|FG000|Overall Study|Death|0
7056531|NCT01878214|11150626|FG001|Overall Study|Death|1
7056532|NCT01878214|11150625|FG000|Overall Study|Lost to Follow-up|35
7056533|NCT01878214|11150626|FG001|Overall Study|Lost to Follow-up|36
7056534|NCT01878253|11150632|FG000|Overall Study|Death|1
7056535|NCT01878253|11150632|FG000|Overall Study|SIdus System Removal|3
7056536|NCT01878253|11150632|FG000|Overall Study|Withdrawal by Subject|1
7056537|NCT01878253|11150632|FG000|Overall Study|Lost to Follow-up|2
7056538|NCT01878253|11150632|FG000|Overall Study|Completed Study w/o Follow-up Data|2
7056539|NCT01878292|11150644|FG000|Randomized|Protocol Violation|1
7085282|NCT02176525|11198205|FG004|Overall Study|not treated|0
7085283|NCT02176525|11198206|FG005|Overall Study|not treated|1
7085284|NCT02176525|11198207|FG006|Overall Study|not treated|0
7085285|NCT02176525|11198208|FG007|Overall Study|not treated|0
7085286|NCT02176642|11198236|FG000|Overall Study|Withdrawal by Subject|0
7085287|NCT02176642|11198237|FG001|Overall Study|Withdrawal by Subject|1
7085288|NCT02176655|11198243|FG000|Overall Study|Subjects did not treat|6
7085289|NCT02176928|11198254|FG000|Overall Study|Lost to Follow-up|2
7085290|NCT02176928|11198255|FG001|Overall Study|Lost to Follow-up|4
7056540|NCT01878292|11150645|FG001|Randomized|Protocol Violation|0
7056541|NCT01878292|11150646|FG002|Randomized|Protocol Violation|0
7056542|NCT01878292|11150644|FG000|Randomized|Lost to Follow-up|1
7056543|NCT01878292|11150645|FG001|Randomized|Lost to Follow-up|0
7056544|NCT01878292|11150646|FG002|Randomized|Lost to Follow-up|0
7056545|NCT01878292|11150644|FG000|Randomized|Adverse Event|1
7056546|NCT01878292|11150645|FG001|Randomized|Adverse Event|0
7056547|NCT01878292|11150646|FG002|Randomized|Adverse Event|0
7056548|NCT01878292|11150644|FG000|Double-blind Treatment Period|Other Reasons|2
7056549|NCT01878292|11150645|FG001|Double-blind Treatment Period|Other Reasons|0
7056550|NCT01878292|11150646|FG002|Double-blind Treatment Period|Other Reasons|0
7056551|NCT01878292|11150644|FG000|Double-blind Treatment Period|Lost to Follow-up|6
7056552|NCT01878292|11150645|FG001|Double-blind Treatment Period|Lost to Follow-up|3
7056553|NCT01878292|11150646|FG002|Double-blind Treatment Period|Lost to Follow-up|1
7056554|NCT01878292|11150644|FG000|Double-blind Treatment Period|Withdrawal by Subject|9
7056555|NCT01878292|11150645|FG001|Double-blind Treatment Period|Withdrawal by Subject|7
7056556|NCT01878292|11150646|FG002|Double-blind Treatment Period|Withdrawal by Subject|8
7056557|NCT01878292|11150644|FG000|Double-blind Treatment Period|Protocol Violation|3
7056558|NCT01878292|11150645|FG001|Double-blind Treatment Period|Protocol Violation|4
7056559|NCT01878292|11150646|FG002|Double-blind Treatment Period|Protocol Violation|2
7056560|NCT01878292|11150644|FG000|Double-blind Treatment Period|Lack of Efficacy|5
7056561|NCT01878292|11150645|FG001|Double-blind Treatment Period|Lack of Efficacy|3
7056562|NCT01878292|11150646|FG002|Double-blind Treatment Period|Lack of Efficacy|0
7056563|NCT01878292|11150644|FG000|Double-blind Treatment Period|Adverse Event|4
7056564|NCT01878292|11150645|FG001|Double-blind Treatment Period|Adverse Event|9
7056565|NCT01878292|11150646|FG002|Double-blind Treatment Period|Adverse Event|8
7056566|NCT01878292|11150644|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5
7056567|NCT01878292|11150645|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8
7056568|NCT01878292|11150646|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4
7056569|NCT01878383|11150656|FG000|Overall Study|Lost to Follow-up|0
7056570|NCT01878383|11150657|FG001|Overall Study|Lost to Follow-up|1499
7056571|NCT01878890|11150727|FG000|Overall Study|Protocol Violation|0
7056572|NCT01878890|11150728|FG001|Overall Study|Protocol Violation|1
7056573|NCT01878890|11150729|FG002|Overall Study|Protocol Violation|0
7056574|NCT01878890|11150730|FG003|Overall Study|Protocol Violation|0
7056575|NCT01879072|11150745|FG000|Overall Study|Withdrawal by Subject|121
7056576|NCT01879072|11150745|FG000|Overall Study|Not Transplanted|30
7056577|NCT01879319|11150760|FG000|Overall Study|Withdrawal by Subject|1
7056578|NCT01879319|11150761|FG001|Overall Study|Withdrawal by Subject|0
7056579|NCT01879319|11150760|FG000|Overall Study|Lost to Follow-up|1
7056580|NCT01879319|11150761|FG001|Overall Study|Lost to Follow-up|5
7056581|NCT01879410|11150816|FG000|Overall Study|Adverse Event|9
7056582|NCT01879410|11150817|FG001|Overall Study|Adverse Event|14
7056583|NCT01879410|11150816|FG000|Overall Study|Lack of Efficacy|4
7056584|NCT01879410|11150817|FG001|Overall Study|Lack of Efficacy|6
7056585|NCT01879410|11150816|FG000|Overall Study|Protocol Violation|1
7056586|NCT01879410|11150817|FG001|Overall Study|Protocol Violation|7
7056587|NCT01879410|11150816|FG000|Overall Study|Lost to Follow-up|2
7056588|NCT01879410|11150817|FG001|Overall Study|Lost to Follow-up|1
7056589|NCT01879410|11150816|FG000|Overall Study|Withdrawal by Subject|7
7085291|NCT02177032|11198265|FG000|Overall Study|ADMINISTRATIVE REASON|2
7056590|NCT01879410|11150817|FG001|Overall Study|Withdrawal by Subject|8
7056591|NCT01879410|11150816|FG000|Overall Study|Randomised in Error|1
7056592|NCT01879410|11150817|FG001|Overall Study|Randomised in Error|2
7056593|NCT01879553|11150829|FG000|Overall Study|Withdrawal by Subject|1
7056594|NCT01879553|11150830|FG001|Overall Study|Withdrawal by Subject|0
7056595|NCT01879579|11150839|FG000|Overall Study|Phone incompatible with texting platform|3
7056596|NCT01879579|11150840|FG001|Overall Study|Phone incompatible with texting platform|0
7056597|NCT01879579|11150839|FG000|Overall Study|Did not enroll in texting platform|1
7056598|NCT01879579|11150840|FG001|Overall Study|Did not enroll in texting platform|0
7056599|NCT01879579|11150839|FG000|Overall Study|Did not initiate insulin treatment|1
7056600|NCT01879579|11150840|FG001|Overall Study|Did not initiate insulin treatment|0
7056601|NCT01879579|11150839|FG000|Overall Study|Phenotypic type 1 diabetes|0
7056602|NCT01879579|11150840|FG001|Overall Study|Phenotypic type 1 diabetes|1
7056603|NCT01879579|11150839|FG000|Overall Study|Discontinued insulin - possible allergy|0
7056604|NCT01879579|11150840|FG001|Overall Study|Discontinued insulin - possible allergy|1
7056605|NCT01879618|11150849|FG000|Overall Study|Does not meet entrance criteria|1
7056606|NCT01879618|11150849|FG000|Overall Study|Withdrawal by Subject|1
7056607|NCT01879618|11150849|FG000|Overall Study|Surgery;changed schedule; not available|8
7056608|NCT01879618|11150849|FG000|Overall Study|Protocol Violation|6
7056609|NCT01879618|11150849|FG000|Overall Study|Adverse Event|5
7056610|NCT01879683|11150853|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1
7056611|NCT01879722|11150867|FG000|Overall Study|Pretreatment Event/Adverse Event|0
7056612|NCT01879722|11150868|FG001|Overall Study|Pretreatment Event/Adverse Event|1
7056613|NCT01879722|11150869|FG002|Overall Study|Pretreatment Event/Adverse Event|0
7056614|NCT01879722|11150870|FG003|Overall Study|Pretreatment Event/Adverse Event|1
7056615|NCT01879722|11150871|FG004|Overall Study|Pretreatment Event/Adverse Event|1
7056616|NCT01879722|11150872|FG005|Overall Study|Pretreatment Event/Adverse Event|0
7056617|NCT01879722|11150873|FG006|Overall Study|Pretreatment Event/Adverse Event|0
7056618|NCT01879722|11150874|FG007|Overall Study|Pretreatment Event/Adverse Event|1
7056619|NCT01879722|11150875|FG008|Overall Study|Pretreatment Event/Adverse Event|1
7056620|NCT01879722|11150876|FG009|Overall Study|Pretreatment Event/Adverse Event|0
7056621|NCT01879722|11150867|FG000|Overall Study|Voluntary Withdrawal|0
7056622|NCT01879722|11150868|FG001|Overall Study|Voluntary Withdrawal|0
7056623|NCT01879722|11150869|FG002|Overall Study|Voluntary Withdrawal|0
7056624|NCT01879722|11150870|FG003|Overall Study|Voluntary Withdrawal|0
7056625|NCT01879722|11150871|FG004|Overall Study|Voluntary Withdrawal|0
7056626|NCT01879722|11150872|FG005|Overall Study|Voluntary Withdrawal|0
7056627|NCT01879722|11150873|FG006|Overall Study|Voluntary Withdrawal|0
7056628|NCT01879722|11150874|FG007|Overall Study|Voluntary Withdrawal|0
7056629|NCT01879722|11150875|FG008|Overall Study|Voluntary Withdrawal|1
7056630|NCT01879722|11150876|FG009|Overall Study|Voluntary Withdrawal|0
7085292|NCT02177032|11198266|FG001|Overall Study|ADMINISTRATIVE REASON|0
7085293|NCT02177032|11198267|FG002|Overall Study|ADMINISTRATIVE REASON|1
7085294|NCT02177032|11198268|FG003|Overall Study|ADMINISTRATIVE REASON|0
7085295|NCT02177032|11198265|FG000|Overall Study|Lost to Follow-up|0
7085296|NCT02177032|11198266|FG001|Overall Study|Lost to Follow-up|2
7085297|NCT02177032|11198267|FG002|Overall Study|Lost to Follow-up|0
7085298|NCT02177032|11198268|FG003|Overall Study|Lost to Follow-up|0
7085299|NCT02177032|11198265|FG000|Overall Study|OTHER|2
7085300|NCT02177032|11198266|FG001|Overall Study|OTHER|0
7085301|NCT02177032|11198267|FG002|Overall Study|OTHER|1
7085302|NCT02177032|11198268|FG003|Overall Study|OTHER|0
7085303|NCT02177032|11198265|FG000|Overall Study|Withdrawal by Subject|1
7085304|NCT02177032|11198266|FG001|Overall Study|Withdrawal by Subject|0
7085305|NCT02177032|11198267|FG002|Overall Study|Withdrawal by Subject|1
7085306|NCT02177032|11198268|FG003|Overall Study|Withdrawal by Subject|0
7085307|NCT02177123|11198289|FG000|Overall Study|Lost to Follow-up|6
7085308|NCT02177123|11198289|FG000|Overall Study|Withdrawal by Subject|4
7085309|NCT02177123|11198289|FG000|Overall Study|Adverse Event|4
7085310|NCT02177123|11198289|FG000|Overall Study|Physician Decision|3
7085311|NCT02177123|11198289|FG000|Overall Study|Excluded by Sponsor - other reason|2
7085312|NCT02177123|11198289|FG000|Overall Study|Excluded for medical reasons|2
7085313|NCT02177123|11198289|FG000|Overall Study|Death|1
7085314|NCT02177123|11198289|FG000|Overall Study|Other|1
7085315|NCT02177123|11198289|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1
7085316|NCT02177136|11198299|FG000|DB Phase|Withdrawal by Subject|2
7085317|NCT02177136|11198300|FG001|DB Phase|Withdrawal by Subject|0
7085318|NCT02177136|11198301|FG002|DB Phase|Withdrawal by Subject|0
7085319|NCT02177136|11198302|FG003|DB Phase|Withdrawal by Subject|0
7085320|NCT02177136|11198299|FG000|DB Phase|Discontinued Due to Pruritus|1
7085321|NCT02177136|11198300|FG001|DB Phase|Discontinued Due to Pruritus|3
7085322|NCT02177136|11198301|FG002|DB Phase|Discontinued Due to Pruritus|0
7056631|NCT04495829|11150910|FG000|Overall Study|Lost to Follow-up|2
7056632|NCT04495829|11150910|FG000|Overall Study|Inclusion criterion not met|3
7056633|NCT03861052|11150918|FG000|Overall Study|Adverse Event|1
7056634|NCT03861052|11150919|FG001|Overall Study|Adverse Event|1
7056635|NCT03861052|11150920|FG002|Overall Study|Adverse Event|2
7056636|NCT03861052|11150921|FG003|Overall Study|Adverse Event|4
7056637|NCT03861052|11150918|FG000|Overall Study|Lost to Follow-up|0
7056638|NCT03861052|11150919|FG001|Overall Study|Lost to Follow-up|0
7056639|NCT03861052|11150920|FG002|Overall Study|Lost to Follow-up|0
7056640|NCT03861052|11150921|FG003|Overall Study|Lost to Follow-up|1
7056641|NCT03861052|11150918|FG000|Overall Study|Physician Decision|0
7056642|NCT03861052|11150919|FG001|Overall Study|Physician Decision|1
7056643|NCT03861052|11150920|FG002|Overall Study|Physician Decision|0
7056644|NCT03861052|11150921|FG003|Overall Study|Physician Decision|0
7056645|NCT03861052|11150918|FG000|Overall Study|Withdrawal by Subject|2
7056646|NCT03861052|11150919|FG001|Overall Study|Withdrawal by Subject|5
7056647|NCT03861052|11150920|FG002|Overall Study|Withdrawal by Subject|3
7056648|NCT03861052|11150921|FG003|Overall Study|Withdrawal by Subject|0
7056649|NCT03861052|11150918|FG000|Overall Study|Relocation to other city|1
7056650|NCT03861052|11150919|FG001|Overall Study|Relocation to other city|0
7056651|NCT03861052|11150920|FG002|Overall Study|Relocation to other city|0
7056652|NCT03861052|11150921|FG003|Overall Study|Relocation to other city|0
7056653|NCT03846453|11150938|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465
7085323|NCT02177136|11198302|FG003|DB Phase|Discontinued Due to Pruritus|0
7085324|NCT02177136|11198299|FG000|DB Phase|Adverse Event|3
7085325|NCT02177136|11198300|FG001|DB Phase|Adverse Event|2
7085326|NCT02177136|11198301|FG002|DB Phase|Adverse Event|3
7085327|NCT02177136|11198302|FG003|DB Phase|Adverse Event|0
7056654|NCT03846453|11150939|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0
7056655|NCT03846453|11150940|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0
7056656|NCT03846453|11150938|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3
7056657|NCT03846453|11150939|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0
7056658|NCT03846453|11150940|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0
7056659|NCT03846453|11150938|FG000|Placebo Run-in (14 Days)|Physician Decision|1
7056660|NCT03846453|11150939|FG001|Placebo Run-in (14 Days)|Physician Decision|0
7056661|NCT03846453|11150940|FG002|Placebo Run-in (14 Days)|Physician Decision|0
7056662|NCT03846453|11150938|FG000|Placebo Run-in (14 Days)|Other|2
7056663|NCT03846453|11150939|FG001|Placebo Run-in (14 Days)|Other|0
7056664|NCT03846453|11150940|FG002|Placebo Run-in (14 Days)|Other|0
7056665|NCT03846453|11150938|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0
7056666|NCT03846453|11150939|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16
7056667|NCT03846453|11150940|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8
7056668|NCT03846453|11150938|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0
7056669|NCT03846453|11150939|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6
7056670|NCT03846453|11150940|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5
7056671|NCT03846453|11150938|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0
7056672|NCT03846453|11150939|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2
7056673|NCT03846453|11150940|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4
7056674|NCT03846453|11150938|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0
7056675|NCT03846453|11150939|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2
7056676|NCT03846453|11150940|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4
7056677|NCT03846453|11150938|FG000|Randomized Treatment Period (Days 57±3)|Other|0
7056678|NCT03846453|11150939|FG001|Randomized Treatment Period (Days 57±3)|Other|1
7056679|NCT03846453|11150940|FG002|Randomized Treatment Period (Days 57±3)|Other|4
7056680|NCT03605862|11150950|FG000|Overall Study|Withdrawal by Subject|12
7056681|NCT03605862|11150951|FG001|Overall Study|Withdrawal by Subject|9
7056682|NCT03605862|11150950|FG000|Overall Study|Adverse Event|2
7056683|NCT03605862|11150951|FG001|Overall Study|Adverse Event|1
7056684|NCT03605862|11150950|FG000|Overall Study|Physician Decision|3
7056685|NCT03605862|11150951|FG001|Overall Study|Physician Decision|1
7056686|NCT03605862|11150950|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11
7056687|NCT03605862|11150951|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15
7056688|NCT03541252|11150958|FG000|Overall Study|Withdrawal by Subject|1
7056689|NCT03401112|11150967|FG000|Overall Study|Adverse Event|1
7056690|NCT03401112|11150968|FG001|Overall Study|Adverse Event|2
7085328|NCT02177136|11198299|FG000|DB Phase|Protocol Violation|0
7085329|NCT02177136|11198300|FG001|DB Phase|Protocol Violation|0
7056691|NCT03401112|11150969|FG002|Overall Study|Adverse Event|3
7056692|NCT03401112|11150970|FG003|Overall Study|Adverse Event|2
7056693|NCT03401112|11150971|FG004|Overall Study|Adverse Event|0
7056694|NCT03401112|11150967|FG000|Overall Study|Lost to Follow-up|1
7056695|NCT03401112|11150968|FG001|Overall Study|Lost to Follow-up|0
7056696|NCT03401112|11150969|FG002|Overall Study|Lost to Follow-up|0
7056697|NCT03401112|11150970|FG003|Overall Study|Lost to Follow-up|0
7056698|NCT03401112|11150971|FG004|Overall Study|Lost to Follow-up|0
7056699|NCT03401112|11150967|FG000|Overall Study|Noncompliance|1
7056700|NCT03401112|11150968|FG001|Overall Study|Noncompliance|2
7056701|NCT03401112|11150969|FG002|Overall Study|Noncompliance|3
7056702|NCT03401112|11150970|FG003|Overall Study|Noncompliance|0
7056703|NCT03401112|11150971|FG004|Overall Study|Noncompliance|0
7056704|NCT03401112|11150967|FG000|Overall Study|Did not Meet Inclusion Criteria|1
7056705|NCT03401112|11150968|FG001|Overall Study|Did not Meet Inclusion Criteria|0
7056706|NCT03401112|11150969|FG002|Overall Study|Did not Meet Inclusion Criteria|0
7056707|NCT03401112|11150970|FG003|Overall Study|Did not Meet Inclusion Criteria|0
7056708|NCT03401112|11150971|FG004|Overall Study|Did not Meet Inclusion Criteria|0
7056709|NCT03401112|11150967|FG000|Overall Study|Withdrawal by Subject|0
7056710|NCT03401112|11150968|FG001|Overall Study|Withdrawal by Subject|3
7056711|NCT03401112|11150969|FG002|Overall Study|Withdrawal by Subject|2
7056712|NCT03401112|11150970|FG003|Overall Study|Withdrawal by Subject|1
7056713|NCT03401112|11150971|FG004|Overall Study|Withdrawal by Subject|0
7056714|NCT03401112|11150967|FG000|Overall Study|Physician Decision|0
7056715|NCT03401112|11150968|FG001|Overall Study|Physician Decision|0
7056716|NCT03401112|11150969|FG002|Overall Study|Physician Decision|0
7056717|NCT03401112|11150970|FG003|Overall Study|Physician Decision|2
7056718|NCT03401112|11150971|FG004|Overall Study|Physician Decision|0
7056719|NCT03401112|11150967|FG000|Overall Study|Study was Terminated by Sponsor|0
7056720|NCT03401112|11150968|FG001|Overall Study|Study was Terminated by Sponsor|0
7056721|NCT03401112|11150969|FG002|Overall Study|Study was Terminated by Sponsor|0
7056722|NCT03401112|11150970|FG003|Overall Study|Study was Terminated by Sponsor|1
7085330|NCT02177136|11198301|FG002|DB Phase|Protocol Violation|1
7085331|NCT02177136|11198302|FG003|DB Phase|Protocol Violation|0
7056723|NCT03401112|11150971|FG004|Overall Study|Study was Terminated by Sponsor|0
7056724|NCT03401112|11150967|FG000|Overall Study|Day 1 Assessment not Done|1
7056725|NCT03401112|11150968|FG001|Overall Study|Day 1 Assessment not Done|0
7056726|NCT03401112|11150969|FG002|Overall Study|Day 1 Assessment not Done|0
7056727|NCT03401112|11150970|FG003|Overall Study|Day 1 Assessment not Done|0
7056728|NCT03401112|11150971|FG004|Overall Study|Day 1 Assessment not Done|0
7056729|NCT03401112|11150967|FG000|Overall Study|Not Dosed|0
7056730|NCT03401112|11150968|FG001|Overall Study|Not Dosed|0
7056731|NCT03401112|11150969|FG002|Overall Study|Not Dosed|1
7056732|NCT03401112|11150970|FG003|Overall Study|Not Dosed|0
7056733|NCT03401112|11150971|FG004|Overall Study|Not Dosed|0
7056734|NCT03401112|11150967|FG000|Overall Study|Missed Clinical Visit|0
7056735|NCT03401112|11150968|FG001|Overall Study|Missed Clinical Visit|0
7056736|NCT03401112|11150969|FG002|Overall Study|Missed Clinical Visit|1
7056737|NCT03401112|11150970|FG003|Overall Study|Missed Clinical Visit|0
7056738|NCT03401112|11150971|FG004|Overall Study|Missed Clinical Visit|0
7056739|NCT03401112|11150967|FG000|Overall Study|Missed Doses|0
7056740|NCT03401112|11150968|FG001|Overall Study|Missed Doses|0
7056741|NCT03401112|11150969|FG002|Overall Study|Missed Doses|1
7056742|NCT03401112|11150970|FG003|Overall Study|Missed Doses|0
7056743|NCT03401112|11150971|FG004|Overall Study|Missed Doses|0
7056744|NCT03041701|11151009|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1
7056745|NCT03041701|11151010|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1
7056746|NCT03041701|11151011|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0
7085332|NCT02177136|11198299|FG000|DB Phase|Withdrew Consent Prior to Dosing|1
7056747|NCT03041701|11151009|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0
7056748|NCT03041701|11151010|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0
7056749|NCT03041701|11151011|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1
7056750|NCT03000179|11151022|FG000|Overall Study|Lost to Follow-up|2
7056751|NCT02876835|11151028|FG000|Treatment Period (51.1 Month)|Other|1
7056752|NCT02876835|11151029|FG001|Treatment Period (51.1 Month)|Other|0
7056753|NCT02876835|11151028|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6
7056754|NCT02876835|11151029|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13
7056755|NCT02876835|11151028|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32
7085333|NCT02177136|11198300|FG001|DB Phase|Withdrew Consent Prior to Dosing|0
7056756|NCT02876835|11151029|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23
7056757|NCT02876835|11151028|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25
7056758|NCT02876835|11151029|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29
7056759|NCT02860039|11151038|FG000|Overall Study|Death|4
7056760|NCT02860039|11151039|FG001|Overall Study|Death|0
7056761|NCT02860039|11151038|FG000|Overall Study|Lost to Follow-up|2
7056762|NCT02860039|11151039|FG001|Overall Study|Lost to Follow-up|2
7056763|NCT02860039|11151038|FG000|Overall Study|Protocol Violation|3
7056764|NCT02860039|11151039|FG001|Overall Study|Protocol Violation|1
7056765|NCT02860039|11151038|FG000|Overall Study|Withdrawal by Subject|1
7056766|NCT02860039|11151039|FG001|Overall Study|Withdrawal by Subject|0
7056767|NCT02860039|11151038|FG000|Overall Study|Not otherwise eligible|1
7056768|NCT02860039|11151039|FG001|Overall Study|Not otherwise eligible|1
7085334|NCT02177136|11198301|FG002|DB Phase|Withdrew Consent Prior to Dosing|0
7085335|NCT02177136|11198302|FG003|DB Phase|Withdrew Consent Prior to Dosing|0
7085336|NCT02177136|11198299|FG000|LTSE Phase|Withdrawal by Subject|0
7085337|NCT02177136|11198300|FG001|LTSE Phase|Withdrawal by Subject|0
7085338|NCT02177136|11198301|FG002|LTSE Phase|Withdrawal by Subject|0
7085339|NCT02177136|11198302|FG003|LTSE Phase|Withdrawal by Subject|6
7085340|NCT02177136|11198299|FG000|LTSE Phase|Adverse Event|0
7085341|NCT02177136|11198300|FG001|LTSE Phase|Adverse Event|0
7085342|NCT02177136|11198301|FG002|LTSE Phase|Adverse Event|0
7085343|NCT02177136|11198302|FG003|LTSE Phase|Adverse Event|10
7085344|NCT02177136|11198299|FG000|LTSE Phase|Discontinued Due to Pruritus|0
7085345|NCT02177136|11198300|FG001|LTSE Phase|Discontinued Due to Pruritus|0
7085346|NCT02177136|11198301|FG002|LTSE Phase|Discontinued Due to Pruritus|0
7085347|NCT02177136|11198302|FG003|LTSE Phase|Discontinued Due to Pruritus|4
7085348|NCT02177136|11198299|FG000|LTSE Phase|Physician Decision|0
7085349|NCT02177136|11198300|FG001|LTSE Phase|Physician Decision|0
7085350|NCT02177136|11198301|FG002|LTSE Phase|Physician Decision|0
7085351|NCT02177136|11198302|FG003|LTSE Phase|Physician Decision|2
7085352|NCT02177136|11198299|FG000|LTSE Phase|Lost to Follow-up|0
7085353|NCT02177136|11198300|FG001|LTSE Phase|Lost to Follow-up|0
7085354|NCT02177136|11198301|FG002|LTSE Phase|Lost to Follow-up|0
7085355|NCT02177136|11198302|FG003|LTSE Phase|Lost to Follow-up|1
7085356|NCT02177136|11198299|FG000|LTSE Phase|Participant Moved|0
7085357|NCT02177136|11198300|FG001|LTSE Phase|Participant Moved|0
7085358|NCT02177136|11198301|FG002|LTSE Phase|Participant Moved|0
7085359|NCT02177136|11198302|FG003|LTSE Phase|Participant Moved|1
7085360|NCT02177786|11198326|FG000|Overall Study|Withdrew Consent|2
7085361|NCT02177786|11198327|FG001|Overall Study|Withdrew Consent|6
7085362|NCT02177786|11198328|FG002|Overall Study|Withdrew Consent|9
7085363|NCT02177786|11198329|FG003|Overall Study|Withdrew Consent|5
7085364|NCT02177786|11198326|FG000|Overall Study|Progression to End Stage Renal Disease|2
7085365|NCT02177786|11198327|FG001|Overall Study|Progression to End Stage Renal Disease|3
7085366|NCT02177786|11198328|FG002|Overall Study|Progression to End Stage Renal Disease|2
7085367|NCT02177786|11198329|FG003|Overall Study|Progression to End Stage Renal Disease|1
7085368|NCT02177786|11198326|FG000|Overall Study|Adverse Event|1
7085369|NCT02177786|11198327|FG001|Overall Study|Adverse Event|1
7085370|NCT02177786|11198328|FG002|Overall Study|Adverse Event|2
7056769|NCT01492361|11151068|FG000|Overall Study|Withdrawal by Subject|281
7056770|NCT01492361|11151069|FG001|Overall Study|Withdrawal by Subject|297
7056771|NCT01492361|11151068|FG000|Overall Study|Physician Decision|12
7056772|NCT01492361|11151069|FG001|Overall Study|Physician Decision|12
7056773|NCT01492361|11151068|FG000|Overall Study|Lost to Follow-up|6
7056774|NCT01492361|11151069|FG001|Overall Study|Lost to Follow-up|13
7056775|NCT01492361|11151068|FG000|Overall Study|Other than specified above|106
7056776|NCT01492361|11151069|FG001|Overall Study|Other than specified above|138
7056777|NCT01296711|11151083|FG000|Overall Study|Adverse Event|3
7056778|NCT01296711|11151084|FG001|Overall Study|Adverse Event|1
7056779|NCT01296711|11151085|FG002|Overall Study|Adverse Event|4
7056780|NCT01296711|11151086|FG003|Overall Study|Adverse Event|3
7056781|NCT01296711|11151087|FG004|Overall Study|Adverse Event|1
7056782|NCT01296711|11151088|FG005|Overall Study|Adverse Event|6
7056783|NCT01296711|11151089|FG006|Overall Study|Adverse Event|11
7056784|NCT01296711|11151090|FG007|Overall Study|Adverse Event|3
7056785|NCT01296711|11151083|FG000|Overall Study|Lack of Efficacy|1
7056786|NCT01296711|11151084|FG001|Overall Study|Lack of Efficacy|4
7056787|NCT01296711|11151085|FG002|Overall Study|Lack of Efficacy|1
7056788|NCT01296711|11151086|FG003|Overall Study|Lack of Efficacy|1
7056789|NCT01296711|11151087|FG004|Overall Study|Lack of Efficacy|1
7056790|NCT01296711|11151088|FG005|Overall Study|Lack of Efficacy|0
7056791|NCT01296711|11151089|FG006|Overall Study|Lack of Efficacy|2
7056792|NCT01296711|11151090|FG007|Overall Study|Lack of Efficacy|3
7056793|NCT01296711|11151083|FG000|Overall Study|Lost to Follow-up|0
7056794|NCT01296711|11151084|FG001|Overall Study|Lost to Follow-up|0
7056795|NCT01296711|11151085|FG002|Overall Study|Lost to Follow-up|1
7085371|NCT02177786|11198329|FG003|Overall Study|Adverse Event|3
6805384|NCT02652949|10807465|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1
7056796|NCT01296711|11151086|FG003|Overall Study|Lost to Follow-up|1
6805385|NCT02652949|10807465|FG000|12-Month Follow-up Secondary Endpoint|Death|4
6805386|NCT02652949|10807465|FG000|24-Month Follow-up Secondary Endpoint|Death|2
6805387|NCT02652949|10807465|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3
6805388|NCT02652949|10807465|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2
6805389|NCT02652949|10807465|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|27
7056797|NCT01296711|11151087|FG004|Overall Study|Lost to Follow-up|2
7056798|NCT01296711|11151088|FG005|Overall Study|Lost to Follow-up|0
7056799|NCT01296711|11151089|FG006|Overall Study|Lost to Follow-up|4
7056800|NCT01296711|11151090|FG007|Overall Study|Lost to Follow-up|2
7056801|NCT01296711|11151083|FG000|Overall Study|Protocol Violation|0
7056802|NCT01296711|11151084|FG001|Overall Study|Protocol Violation|0
7056803|NCT01296711|11151085|FG002|Overall Study|Protocol Violation|0
7056804|NCT01296711|11151086|FG003|Overall Study|Protocol Violation|1
7056805|NCT01296711|11151087|FG004|Overall Study|Protocol Violation|1
7056806|NCT01296711|11151088|FG005|Overall Study|Protocol Violation|0
7056807|NCT01296711|11151089|FG006|Overall Study|Protocol Violation|0
7056808|NCT01296711|11151090|FG007|Overall Study|Protocol Violation|0
7056809|NCT01296711|11151083|FG000|Overall Study|Withdrawal by Subject|4
7056810|NCT01296711|11151084|FG001|Overall Study|Withdrawal by Subject|2
7056811|NCT01296711|11151085|FG002|Overall Study|Withdrawal by Subject|2
7056812|NCT01296711|11151086|FG003|Overall Study|Withdrawal by Subject|1
7056813|NCT01296711|11151087|FG004|Overall Study|Withdrawal by Subject|1
7056814|NCT01296711|11151088|FG005|Overall Study|Withdrawal by Subject|1
7056815|NCT01296711|11151089|FG006|Overall Study|Withdrawal by Subject|2
7056816|NCT01296711|11151090|FG007|Overall Study|Withdrawal by Subject|1
7056817|NCT01296711|11151083|FG000|Overall Study|Study termination|8
7056818|NCT01296711|11151084|FG001|Overall Study|Study termination|1
7056819|NCT01296711|11151085|FG002|Overall Study|Study termination|5
7056820|NCT01296711|11151086|FG003|Overall Study|Study termination|4
7056821|NCT01296711|11151087|FG004|Overall Study|Study termination|4
7056822|NCT01296711|11151088|FG005|Overall Study|Study termination|4
7056823|NCT01296711|11151089|FG006|Overall Study|Study termination|8
7056824|NCT01296711|11151090|FG007|Overall Study|Study termination|10
7056825|NCT01296711|11151083|FG000|Overall Study|Continued elevated liver enzymes|0
7056826|NCT01296711|11151084|FG001|Overall Study|Continued elevated liver enzymes|0
7056827|NCT01296711|11151085|FG002|Overall Study|Continued elevated liver enzymes|0
7056828|NCT01296711|11151086|FG003|Overall Study|Continued elevated liver enzymes|1
7056829|NCT01296711|11151087|FG004|Overall Study|Continued elevated liver enzymes|0
7056830|NCT01296711|11151088|FG005|Overall Study|Continued elevated liver enzymes|0
7056831|NCT01296711|11151089|FG006|Overall Study|Continued elevated liver enzymes|0
7056832|NCT01296711|11151090|FG007|Overall Study|Continued elevated liver enzymes|0
7056833|NCT01296711|11151083|FG000|Overall Study|Methotrexate discontinued|0
7056834|NCT01296711|11151084|FG001|Overall Study|Methotrexate discontinued|0
7056835|NCT01296711|11151085|FG002|Overall Study|Methotrexate discontinued|0
7056836|NCT01296711|11151086|FG003|Overall Study|Methotrexate discontinued|1
7056837|NCT01296711|11151087|FG004|Overall Study|Methotrexate discontinued|0
7056838|NCT01296711|11151088|FG005|Overall Study|Methotrexate discontinued|0
7056839|NCT01296711|11151089|FG006|Overall Study|Methotrexate discontinued|0
7056840|NCT01296711|11151090|FG007|Overall Study|Methotrexate discontinued|0
7056841|NCT01296711|11151083|FG000|Overall Study|Investigator discretion|0
7056842|NCT01296711|11151084|FG001|Overall Study|Investigator discretion|0
7056843|NCT01296711|11151085|FG002|Overall Study|Investigator discretion|0
7056844|NCT01296711|11151086|FG003|Overall Study|Investigator discretion|0
7056845|NCT01296711|11151087|FG004|Overall Study|Investigator discretion|0
7056846|NCT01296711|11151088|FG005|Overall Study|Investigator discretion|0
7056847|NCT01296711|11151089|FG006|Overall Study|Investigator discretion|1
7056848|NCT01296711|11151090|FG007|Overall Study|Investigator discretion|0
7056849|NCT01296711|11151083|FG000|Overall Study|Other|0
7056850|NCT01296711|11151084|FG001|Overall Study|Other|0
7056851|NCT01296711|11151085|FG002|Overall Study|Other|0
7056852|NCT01296711|11151086|FG003|Overall Study|Other|0
7056853|NCT01296711|11151087|FG004|Overall Study|Other|0
7056854|NCT01296711|11151088|FG005|Overall Study|Other|0
7056855|NCT01296711|11151089|FG006|Overall Study|Other|1
7056856|NCT01296711|11151090|FG007|Overall Study|Other|0
7056857|NCT01296711|11151083|FG000|Overall Study|Required restricted steroid injections|0
7056858|NCT01296711|11151084|FG001|Overall Study|Required restricted steroid injections|0
7056859|NCT01296711|11151085|FG002|Overall Study|Required restricted steroid injections|0
7056860|NCT01296711|11151086|FG003|Overall Study|Required restricted steroid injections|0
7056861|NCT01296711|11151087|FG004|Overall Study|Required restricted steroid injections|0
7056862|NCT01296711|11151088|FG005|Overall Study|Required restricted steroid injections|0
7056863|NCT01296711|11151089|FG006|Overall Study|Required restricted steroid injections|1
7056864|NCT01296711|11151090|FG007|Overall Study|Required restricted steroid injections|0
7056865|NCT01296711|11151083|FG000|Overall Study|Ongoing missed appointments|0
7056866|NCT01296711|11151084|FG001|Overall Study|Ongoing missed appointments|0
7056867|NCT01296711|11151085|FG002|Overall Study|Ongoing missed appointments|0
7056868|NCT01296711|11151086|FG003|Overall Study|Ongoing missed appointments|0
7056869|NCT01296711|11151087|FG004|Overall Study|Ongoing missed appointments|0
7056870|NCT01296711|11151088|FG005|Overall Study|Ongoing missed appointments|0
7056871|NCT01296711|11151089|FG006|Overall Study|Ongoing missed appointments|1
7056872|NCT01296711|11151090|FG007|Overall Study|Ongoing missed appointments|0
7056873|NCT01296711|11151083|FG000|Overall Study|Failure to comply with visits|0
7056874|NCT01296711|11151084|FG001|Overall Study|Failure to comply with visits|0
7056875|NCT01296711|11151085|FG002|Overall Study|Failure to comply with visits|0
7056876|NCT01296711|11151086|FG003|Overall Study|Failure to comply with visits|0
7056877|NCT01296711|11151087|FG004|Overall Study|Failure to comply with visits|0
7056878|NCT01296711|11151088|FG005|Overall Study|Failure to comply with visits|0
7056879|NCT01296711|11151089|FG006|Overall Study|Failure to comply with visits|0
7056880|NCT01296711|11151090|FG007|Overall Study|Failure to comply with visits|1
7056881|NCT01296711|11151083|FG000|Overall Study|Patient decision due to transport|0
7056882|NCT01296711|11151084|FG001|Overall Study|Patient decision due to transport|0
7056883|NCT01296711|11151085|FG002|Overall Study|Patient decision due to transport|0
7056884|NCT01296711|11151086|FG003|Overall Study|Patient decision due to transport|0
7056885|NCT01296711|11151087|FG004|Overall Study|Patient decision due to transport|0
7056886|NCT01296711|11151088|FG005|Overall Study|Patient decision due to transport|0
7056887|NCT01296711|11151089|FG006|Overall Study|Patient decision due to transport|0
7056888|NCT01296711|11151090|FG007|Overall Study|Patient decision due to transport|1
7056889|NCT00084656|11151111|FG000|Overall Study|Other reasons|0
7056890|NCT00084656|11151112|FG001|Overall Study|Other reasons|12
7056891|NCT00084656|11151113|FG002|Overall Study|Other reasons|11
7056892|NCT00084656|11151111|FG000|Overall Study|Withdrawal by Subject|15
7056893|NCT00084656|11151112|FG001|Overall Study|Withdrawal by Subject|4
7085372|NCT02177786|11198326|FG000|Overall Study|Death|1
7085373|NCT02177786|11198327|FG001|Overall Study|Death|1
7085374|NCT02177786|11198328|FG002|Overall Study|Death|1
7085375|NCT02177786|11198329|FG003|Overall Study|Death|1
7085376|NCT02177786|11198326|FG000|Overall Study|Lost to Follow-up|0
7085377|NCT02177786|11198327|FG001|Overall Study|Lost to Follow-up|0
7085378|NCT02177786|11198328|FG002|Overall Study|Lost to Follow-up|2
7085379|NCT02177786|11198329|FG003|Overall Study|Lost to Follow-up|2
7085380|NCT02177786|11198326|FG000|Overall Study|Non-Compliance with Study Drug|0
7085381|NCT02177786|11198327|FG001|Overall Study|Non-Compliance with Study Drug|1
7085382|NCT02177786|11198328|FG002|Overall Study|Non-Compliance with Study Drug|0
7085383|NCT02177786|11198329|FG003|Overall Study|Non-Compliance with Study Drug|1
7085384|NCT02177786|11198326|FG000|Overall Study|Protocol Violation|0
7085385|NCT02177786|11198327|FG001|Overall Study|Protocol Violation|0
7085386|NCT02177786|11198328|FG002|Overall Study|Protocol Violation|2
7085387|NCT02177786|11198329|FG003|Overall Study|Protocol Violation|0
7085388|NCT02177786|11198326|FG000|Overall Study|Progressive Disease|0
7085389|NCT02177786|11198327|FG001|Overall Study|Progressive Disease|1
7085390|NCT02177786|11198328|FG002|Overall Study|Progressive Disease|0
7085391|NCT02177786|11198329|FG003|Overall Study|Progressive Disease|0
7085392|NCT02177786|11198326|FG000|Overall Study|Missing study completion status|0
7085393|NCT02177786|11198327|FG001|Overall Study|Missing study completion status|1
7085394|NCT02177786|11198328|FG002|Overall Study|Missing study completion status|0
7085395|NCT02177786|11198329|FG003|Overall Study|Missing study completion status|0
7085396|NCT02177812|11198348|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
7085397|NCT02177812|11198349|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
7085398|NCT02177812|11198350|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
7085399|NCT02177812|11198351|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
7085400|NCT02177812|11198352|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
7085401|NCT02177812|11198353|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1
7085402|NCT02177812|11198354|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2
7085403|NCT02177812|11198355|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1
7085404|NCT02177812|11198356|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
7085405|NCT02177812|11198348|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0
7085406|NCT02177812|11198349|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0
7085407|NCT02177812|11198350|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0
7085408|NCT02177812|11198351|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0
7085409|NCT02177812|11198352|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0
7085410|NCT02177812|11198353|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1
7085411|NCT02177812|11198354|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1
7085412|NCT02177812|11198355|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0
7085413|NCT02177812|11198356|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0
7085414|NCT02177812|11198348|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0
7085415|NCT02177812|11198349|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0
7056894|NCT00084656|11151113|FG002|Overall Study|Withdrawal by Subject|4
7056895|NCT00084656|11151111|FG000|Overall Study|Disease relapse|0
7056896|NCT00084656|11151112|FG001|Overall Study|Disease relapse|9
7056897|NCT00084656|11151113|FG002|Overall Study|Disease relapse|10
7056898|NCT00084656|11151111|FG000|Overall Study|Disease progression|9
7056899|NCT00084656|11151112|FG001|Overall Study|Disease progression|0
7056900|NCT00084656|11151113|FG002|Overall Study|Disease progression|0
7056901|NCT00084656|11151111|FG000|Overall Study|Lost to Follow-up|1
6811733|NCT01208207|10815568|FG006|Part I|Withdrawal by Subject|0
6805390|NCT02652949|10807465|FG000|36-Month Follow-up Secondary Endpoint|Death|2
6805391|NCT02652949|10807465|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1
6805392|NCT02652949|10807465|FG000|36-Month Follow-up Secondary Endpoint|Subject declined extended follow up at 12 month timepoint. Data entry error-to be corrected by site|1
6805393|NCT02649439|10807477|FG000|Overall Study|Switched to alternative treatment|6
6805394|NCT02649439|10807478|FG001|Overall Study|Switched to alternative treatment|4
6805395|NCT02649439|10807477|FG000|Overall Study|Patient decision|1
6805396|NCT02649439|10807478|FG001|Overall Study|Patient decision|0
6805397|NCT02649439|10807477|FG000|Overall Study|Patient going out of country|1
6805398|NCT02649439|10807478|FG001|Overall Study|Patient going out of country|0
6805399|NCT02649439|10807477|FG000|Overall Study|To start finasteride|1
6805400|NCT02649439|10807478|FG001|Overall Study|To start finasteride|0
6805401|NCT02649439|10807477|FG000|Overall Study|Physician Decision|1
6805402|NCT02649439|10807478|FG001|Overall Study|Physician Decision|0
6805403|NCT02649439|10807477|FG000|Overall Study|Disease progression on study|12
6805404|NCT02649439|10807478|FG001|Overall Study|Disease progression on study|13
6805405|NCT02649439|10807477|FG000|Overall Study|Refused further treatment|1
6805406|NCT02649439|10807478|FG001|Overall Study|Refused further treatment|0
6805407|NCT02649439|10807477|FG000|Overall Study|Refused further follow up|2
6805408|NCT02649439|10807478|FG001|Overall Study|Refused further follow up|7
6805409|NCT02649439|10807477|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1
6805410|NCT02649439|10807478|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0
6805411|NCT02649439|10807477|FG000|Overall Study|No treatment, per protocol|1
6805412|NCT02649439|10807478|FG001|Overall Study|No treatment, per protocol|0
6805413|NCT02649439|10807477|FG000|Overall Study|PSA DT makes ineligible|0
6805414|NCT02649439|10807478|FG001|Overall Study|PSA DT makes ineligible|1
6805415|NCT02649439|10807477|FG000|Overall Study|Rising PSA No Mets|0
6805416|NCT02649439|10807478|FG001|Overall Study|Rising PSA No Mets|1
6805417|NCT02649439|10807477|FG000|Overall Study|Rising PSA|0
6805418|NCT02649439|10807478|FG001|Overall Study|Rising PSA|1
6805419|NCT02649439|10807477|FG000|Overall Study|Signed follow up protocol|0
6805420|NCT02649439|10807478|FG001|Overall Study|Signed follow up protocol|1
6805421|NCT02634307|10807494|FG000|Overall Study|Adverse Event|50
6805422|NCT02634307|10807495|FG001|Overall Study|Adverse Event|24
6805423|NCT02634307|10807496|FG002|Overall Study|Adverse Event|14
6805424|NCT02634307|10807494|FG000|Overall Study|Lost to Follow-up|21
6805425|NCT02634307|10807495|FG001|Overall Study|Lost to Follow-up|5
6805426|NCT02634307|10807496|FG002|Overall Study|Lost to Follow-up|6
6805427|NCT02634307|10807494|FG000|Overall Study|Pregnancy|5
6805428|NCT02634307|10807495|FG001|Overall Study|Pregnancy|1
6805429|NCT02634307|10807496|FG002|Overall Study|Pregnancy|3
6805430|NCT02634307|10807494|FG000|Overall Study|Withdrawal by Subject|38
6805431|NCT02634307|10807495|FG001|Overall Study|Withdrawal by Subject|24
6805432|NCT02634307|10807496|FG002|Overall Study|Withdrawal by Subject|18
6805433|NCT02634307|10807494|FG000|Overall Study|Non-Compliance with Study Drug|0
6805434|NCT02634307|10807495|FG001|Overall Study|Non-Compliance with Study Drug|2
6805435|NCT02634307|10807496|FG002|Overall Study|Non-Compliance with Study Drug|2
6805436|NCT02634307|10807494|FG000|Overall Study|Lack of Efficacy|1
6805437|NCT02634307|10807495|FG001|Overall Study|Lack of Efficacy|5
6805438|NCT02634307|10807496|FG002|Overall Study|Lack of Efficacy|3
6805439|NCT02634307|10807494|FG000|Overall Study|Physician Decision|7
6805440|NCT02634307|10807495|FG001|Overall Study|Physician Decision|5
6805441|NCT02634307|10807496|FG002|Overall Study|Physician Decision|5
6805442|NCT02634307|10807494|FG000|Overall Study|Reason not Specified|3
6805443|NCT02634307|10807495|FG001|Overall Study|Reason not Specified|5
7056902|NCT00084656|11151112|FG001|Overall Study|Lost to Follow-up|0
6805444|NCT02634307|10807496|FG002|Overall Study|Reason not Specified|10
6805445|NCT02447718|10807510|FG000|Overall Study|Lost to Follow-up|8
6805446|NCT02447718|10807511|FG001|Overall Study|Lost to Follow-up|0
7056903|NCT00084656|11151113|FG002|Overall Study|Lost to Follow-up|1
6805447|NCT02447718|10807510|FG000|Overall Study|Withdrawal by Subject|3
6805448|NCT02447718|10807511|FG001|Overall Study|Withdrawal by Subject|0
6805449|NCT02447718|10807510|FG000|Overall Study|Screen Failure|1
7056904|NCT01879852|11151152|FG000|Overall Study|Withdrawal by Subject|2
7056905|NCT01879852|11151153|FG001|Overall Study|Withdrawal by Subject|0
7056906|NCT01880086|11151189|FG000|Overall Study|Lost to Follow-up|1
7056907|NCT01880086|11151190|FG001|Overall Study|Lost to Follow-up|1
7056908|NCT01880424|11151224|FG000|Overall Study|Adverse Event|7
7056909|NCT01880424|11151225|FG001|Overall Study|Adverse Event|6
7056910|NCT01880424|11151224|FG000|Overall Study|Lack of Efficacy|1
7056911|NCT01880424|11151225|FG001|Overall Study|Lack of Efficacy|4
7056912|NCT01880424|11151224|FG000|Overall Study|Lost to Follow-up|3
7056913|NCT01880424|11151225|FG001|Overall Study|Lost to Follow-up|2
7056914|NCT01880424|11151224|FG000|Overall Study|Protocol Violation|11
7056915|NCT01880424|11151225|FG001|Overall Study|Protocol Violation|13
7056916|NCT01880424|11151224|FG000|Overall Study|Withdrawal by Subject|10
7056917|NCT01880424|11151225|FG001|Overall Study|Withdrawal by Subject|30
7056918|NCT01880424|11151224|FG000|Overall Study|Other|1
7056919|NCT01880424|11151225|FG001|Overall Study|Other|0
7056920|NCT01880437|11151234|FG000|Overall Study|Death|12
7056921|NCT01880437|11151235|FG001|Overall Study|Death|4
7056922|NCT01880437|11151236|FG002|Overall Study|Death|17
7056923|NCT01880437|11151234|FG000|Overall Study|Study terminated by Sponsor|3
7056924|NCT01880437|11151235|FG001|Overall Study|Study terminated by Sponsor|0
7056925|NCT01880437|11151236|FG002|Overall Study|Study terminated by Sponsor|2
7056926|NCT01880515|11151248|FG000|Overall Study|Lost to Follow-up|3
7056927|NCT01880515|11151249|FG001|Overall Study|Lost to Follow-up|2
7056928|NCT01880515|11151248|FG000|Overall Study|Disease Progression|5
7056929|NCT01880515|11151249|FG001|Overall Study|Disease Progression|7
7056930|NCT01880528|11151258|FG000|Overall Study|Other|1
7056931|NCT01880528|11151259|FG001|Overall Study|Other|1
7056932|NCT01880554|11151265|FG000|Overall Study|Protocol Violation|14
7056933|NCT01880554|11151265|FG000|Overall Study|Simon's design requirements|2
7056934|NCT01880593|11151272|FG000|Overall Study|Adverse Event|1
7056935|NCT01880593|11151273|FG001|Overall Study|Adverse Event|0
7085416|NCT02177812|11198350|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0
7085417|NCT02177812|11198351|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1
7085418|NCT02177812|11198352|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1
7085419|NCT02177812|11198353|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1
7085420|NCT02177812|11198354|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6
7085421|NCT02177812|11198355|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1
7085422|NCT02177812|11198356|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0
7085423|NCT02177838|11198385|FG000|Overall Study|Withdrawal by Subject|1
7085424|NCT02177838|11198385|FG000|Overall Study|Physician Decision|1
7085425|NCT02177838|11198385|FG000|Overall Study|Death|1
7085426|NCT02177942|11198391|FG000|Overall Study|Adverse Event|1
7085427|NCT02177942|11198392|FG001|Overall Study|Adverse Event|0
7085428|NCT02177942|11198391|FG000|Overall Study|Lost to Follow-up|1
7085429|NCT02177942|11198392|FG001|Overall Study|Lost to Follow-up|1
7085430|NCT02177942|11198391|FG000|Overall Study|Protocol Violation|4
7085431|NCT02177942|11198392|FG001|Overall Study|Protocol Violation|6
7085432|NCT02177942|11198391|FG000|Overall Study|Withdrawal by Subject|71
7085433|NCT02177942|11198392|FG001|Overall Study|Withdrawal by Subject|81
7085434|NCT02178059|11198402|FG000|Washout|Physician Decision|1
7085435|NCT02178059|11198403|FG001|Washout|Physician Decision|0
7085436|NCT02178475|11198413|FG000|Overall Study|Withdrawal by Subject|7
7085437|NCT02178475|11198413|FG000|Overall Study|Lost to Follow-up|10
7085438|NCT02178475|11198413|FG000|Overall Study|Death|13
7085439|NCT02178475|11198413|FG000|Overall Study|Protocol-specified Criteria|99
7085440|NCT02178553|11198426|FG000|Overall Study|Did not proceed to open thoracotomy|7
7085441|NCT02178553|11198427|FG001|Overall Study|Did not proceed to open thoracotomy|3
7085442|NCT02178553|11198426|FG000|Overall Study|Physician Decision|0
7085443|NCT02178553|11198427|FG001|Overall Study|Physician Decision|4
7085444|NCT02178553|11198426|FG000|Overall Study|Technical problem with injection|1
7056936|NCT01880593|11151272|FG000|Overall Study|Lack of Efficacy|1
7056937|NCT01880593|11151273|FG001|Overall Study|Lack of Efficacy|5
7056938|NCT01880593|11151272|FG000|Overall Study|Withdrawal by Subject|6
7056939|NCT01880593|11151273|FG001|Overall Study|Withdrawal by Subject|1
7085445|NCT02178553|11198427|FG001|Overall Study|Technical problem with injection|3
7056940|NCT01880736|11151301|FG000|Overall Study|Adverse Event|0
7056941|NCT01880736|11151302|FG001|Overall Study|Adverse Event|0
7056942|NCT01880736|11151303|FG002|Overall Study|Adverse Event|0
7056943|NCT01880736|11151304|FG003|Overall Study|Adverse Event|1
7056944|NCT01880736|11151301|FG000|Overall Study|Withdrawal Criteria|1
7056945|NCT01880736|11151302|FG001|Overall Study|Withdrawal Criteria|2
7056946|NCT01880736|11151303|FG002|Overall Study|Withdrawal Criteria|1
7056947|NCT01880736|11151304|FG003|Overall Study|Withdrawal Criteria|5
7056948|NCT01881009|11151325|FG000|Summer Camp Session (6 Days)|Unable to wear device|0
7056949|NCT01881009|11151326|FG001|Summer Camp Session (6 Days)|Unable to wear device|1
7056950|NCT01881126|11151357|FG000|Overall Study|Non-compliance|1
7056951|NCT01881126|11151358|FG001|Overall Study|Non-compliance|1
7056952|NCT01881126|11151357|FG000|Overall Study|Adverse Event|0
7056953|NCT01881126|11151358|FG001|Overall Study|Adverse Event|1
7056954|NCT01881230|11151367|FG000|Overall Study|Death|2
7056955|NCT01881230|11151368|FG001|Overall Study|Death|0
7056956|NCT01881230|11151369|FG002|Overall Study|Death|1
7056957|NCT01881230|11151367|FG000|Overall Study|Adverse Event|9
7056958|NCT01881230|11151368|FG001|Overall Study|Adverse Event|13
7056959|NCT01881230|11151369|FG002|Overall Study|Adverse Event|12
7056960|NCT01881230|11151367|FG000|Overall Study|Progressive Disease|31
7056961|NCT01881230|11151368|FG001|Overall Study|Progressive Disease|35
7056962|NCT01881230|11151369|FG002|Overall Study|Progressive Disease|36
7056963|NCT01881230|11151367|FG000|Overall Study|Symptomatic Deterioration|3
7056964|NCT01881230|11151368|FG001|Overall Study|Symptomatic Deterioration|3
7056965|NCT01881230|11151369|FG002|Overall Study|Symptomatic Deterioration|1
7056966|NCT01881230|11151367|FG000|Overall Study|Withdrawal by Subject|6
7056967|NCT01881230|11151368|FG001|Overall Study|Withdrawal by Subject|4
7056968|NCT01881230|11151369|FG002|Overall Study|Withdrawal by Subject|6
7056969|NCT01881230|11151367|FG000|Overall Study|Physician Decision|4
7056970|NCT01881230|11151368|FG001|Overall Study|Physician Decision|3
6805450|NCT02447718|10807511|FG001|Overall Study|Screen Failure|0
6805451|NCT02157883|10807518|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1
6805452|NCT02157883|10807518|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3
6805453|NCT02157883|10807518|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15
6805454|NCT02157883|10807518|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1
6805455|NCT02157883|10807518|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3
6805456|NCT01962948|10807529|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3
7056971|NCT01881230|11151369|FG002|Overall Study|Physician Decision|6
7056972|NCT01881230|11151367|FG000|Overall Study|Non-Compliance with Study Drug|1
7056973|NCT01881230|11151368|FG001|Overall Study|Non-Compliance with Study Drug|2
7056974|NCT01881230|11151369|FG002|Overall Study|Non-Compliance with Study Drug|0
7056975|NCT01881230|11151367|FG000|Overall Study|Given Commercially Available Drug|0
7056976|NCT01881230|11151368|FG001|Overall Study|Given Commercially Available Drug|0
7056977|NCT01881230|11151369|FG002|Overall Study|Given Commercially Available Drug|2
7056978|NCT01881230|11151367|FG000|Overall Study|Protocol Violation|1
7056979|NCT01881230|11151368|FG001|Overall Study|Protocol Violation|1
6805457|NCT01962948|10807530|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3
6805458|NCT01962948|10807531|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6
6805459|NCT01962948|10807532|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0
7056980|NCT01881230|11151369|FG002|Overall Study|Protocol Violation|0
6805460|NCT01938001|10807541|FG000|Overall Study|Withdrawal by Subject|25
7056981|NCT01881230|11151367|FG000|Overall Study|Miscellaneous|3
7056982|NCT01881230|11151368|FG001|Overall Study|Miscellaneous|3
7056983|NCT01881230|11151369|FG002|Overall Study|Miscellaneous|0
7056984|NCT01881230|11151367|FG000|Overall Study|Untreated: Other|0
7056985|NCT01881230|11151368|FG001|Overall Study|Untreated: Other|0
7056986|NCT01881230|11151369|FG002|Overall Study|Untreated: Other|1
7056987|NCT01881230|11151367|FG000|Overall Study|Untreated: Death|0
7056988|NCT01881230|11151368|FG001|Overall Study|Untreated: Death|0
7056989|NCT01881230|11151369|FG002|Overall Study|Untreated: Death|1
7056990|NCT01881230|11151367|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1
7056991|NCT01881230|11151368|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0
7056992|NCT01881230|11151369|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0
7056993|NCT01881620|11151403|FG000|Overall Study|Protocol Violation|4
7056994|NCT01881737|11151407|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3
7056995|NCT01881737|11151407|FG000|Overall Study|Withdrawal by Subject|1
7056996|NCT01881737|11151407|FG000|Overall Study|Worsening of baseline behavior|1
7056997|NCT01881750|11151415|FG000|Overall Study|Changes in concomitant therapies|2
7056998|NCT01881750|11151416|FG001|Overall Study|Changes in concomitant therapies|3
7056999|NCT01881750|11151415|FG000|Overall Study|Lost to Follow-up|0
7057000|NCT01881750|11151416|FG001|Overall Study|Lost to Follow-up|1
7057001|NCT01881776|11151427|FG000|Overall Study|Lost to Follow-up|1
7057002|NCT01881776|11151428|FG001|Overall Study|Lost to Follow-up|2
7057003|NCT01881776|11151429|FG002|Overall Study|Lost to Follow-up|1
7057004|NCT01881776|11151427|FG000|Overall Study|Protocol Violation|0
7057005|NCT01881776|11151428|FG001|Overall Study|Protocol Violation|2
7057006|NCT01881776|11151429|FG002|Overall Study|Protocol Violation|1
7057007|NCT01881789|11151443|FG000|Overall Study|Withdrawal by Subject|0
7057008|NCT01881789|11151444|FG001|Overall Study|Withdrawal by Subject|2
7057009|NCT01881789|11151445|FG002|Overall Study|Withdrawal by Subject|1
7057010|NCT01881789|11151446|FG003|Overall Study|Withdrawal by Subject|0
7057011|NCT01881789|11151447|FG004|Overall Study|Withdrawal by Subject|1
7057012|NCT01881789|11151448|FG005|Overall Study|Withdrawal by Subject|1
7057013|NCT01881789|11151443|FG000|Overall Study|Study Terminated by Sponsor|0
7057014|NCT01881789|11151444|FG001|Overall Study|Study Terminated by Sponsor|0
7057015|NCT01881789|11151445|FG002|Overall Study|Study Terminated by Sponsor|0
7057016|NCT01881789|11151446|FG003|Overall Study|Study Terminated by Sponsor|0
7057017|NCT01881789|11151447|FG004|Overall Study|Study Terminated by Sponsor|0
7057018|NCT01881789|11151448|FG005|Overall Study|Study Terminated by Sponsor|1
7057019|NCT01881789|11151443|FG000|Overall Study|Other|3
7057020|NCT01881789|11151444|FG001|Overall Study|Other|5
7057021|NCT01881789|11151445|FG002|Overall Study|Other|2
7057022|NCT01881789|11151446|FG003|Overall Study|Other|3
7057023|NCT01881789|11151447|FG004|Overall Study|Other|1
7057024|NCT01881789|11151448|FG005|Overall Study|Other|1
7057025|NCT01882088|11151487|FG000|Overall Study|Intolerance of esophageal manometry|1
7057026|NCT01882088|11151487|FG000|Overall Study|no possibility to place the catheter|1
7057027|NCT01882088|11151487|FG000|Overall Study|Protocol Violation|1
7057028|NCT01882088|11151487|FG000|Overall Study|inadequate pH-impedance tracings|2
7057029|NCT01882257|11151494|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0
7057030|NCT01882257|11151495|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2
7057031|NCT01882257|11151496|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1
7057032|NCT01882257|11151494|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0
7057033|NCT01882257|11151495|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11
7057034|NCT01882257|11151496|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4
7057035|NCT01882439|11151511|FG000|Overall Study|Adverse event related to study drug|3
7057036|NCT01882439|11151512|FG001|Overall Study|Adverse event related to study drug|8
7057037|NCT01882439|11151513|FG002|Overall Study|Adverse event related to study drug|1
7057038|NCT01882439|11151514|FG003|Overall Study|Adverse event related to study drug|2
7057039|NCT01882439|11151511|FG000|Overall Study|Pregnancy|0
7057040|NCT01882439|11151512|FG001|Overall Study|Pregnancy|1
7057041|NCT01882439|11151513|FG002|Overall Study|Pregnancy|0
7057042|NCT01882439|11151514|FG003|Overall Study|Pregnancy|0
7057043|NCT01882439|11151511|FG000|Overall Study|Protocol Violation|2
7057044|NCT01882439|11151512|FG001|Overall Study|Protocol Violation|2
7057045|NCT01882439|11151513|FG002|Overall Study|Protocol Violation|0
7057046|NCT01882439|11151514|FG003|Overall Study|Protocol Violation|1
7057047|NCT01882439|11151511|FG000|Overall Study|No longer willing to participate|1
7057048|NCT01882439|11151512|FG001|Overall Study|No longer willing to participate|4
7057049|NCT01882439|11151513|FG002|Overall Study|No longer willing to participate|2
7057050|NCT01882439|11151514|FG003|Overall Study|No longer willing to participate|3
7057051|NCT01882439|11151511|FG000|Overall Study|Medication error with no associated AE|0
7057052|NCT01882439|11151512|FG001|Overall Study|Medication error with no associated AE|0
7057053|NCT01882439|11151513|FG002|Overall Study|Medication error with no associated AE|2
7057054|NCT01882439|11151514|FG003|Overall Study|Medication error with no associated AE|0
7057055|NCT01882439|11151511|FG000|Overall Study|Insufficient clinical response|1
7057056|NCT01882439|11151512|FG001|Overall Study|Insufficient clinical response|4
7057057|NCT01882439|11151513|FG002|Overall Study|Insufficient clinical response|4
7057058|NCT01882439|11151514|FG003|Overall Study|Insufficient clinical response|2
7057059|NCT01882439|11151511|FG000|Overall Study|Adverse event unrelated to study drug|2
7057060|NCT01882439|11151512|FG001|Overall Study|Adverse event unrelated to study drug|2
7057061|NCT01882439|11151513|FG002|Overall Study|Adverse event unrelated to study drug|1
6805461|NCT01938001|10807542|FG001|Overall Study|Withdrawal by Subject|17
6805462|NCT01938001|10807541|FG000|Overall Study|Non-compliant|1
6805463|NCT01938001|10807542|FG001|Overall Study|Non-compliant|0
6805464|NCT01938001|10807541|FG000|Overall Study|Participant Moved|0
6805465|NCT01938001|10807542|FG001|Overall Study|Participant Moved|1
6805466|NCT01938001|10807541|FG000|Overall Study|Lost to Follow-up|1
7057062|NCT01882439|11151514|FG003|Overall Study|Adverse event unrelated to study drug|1
7057063|NCT01882465|11151529|FG000|Period 1|Lens Discomfort|0
7057064|NCT01882465|11151530|FG001|Period 1|Lens Discomfort|0
7057065|NCT01882465|11151531|FG002|Period 1|Lens Discomfort|0
7057066|NCT01882465|11151532|FG003|Period 1|Lens Discomfort|1
7057067|NCT01882465|11151533|FG004|Period 1|Lens Discomfort|0
7085446|NCT02178592|11198435|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0
7085447|NCT02178592|11198436|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2
7085448|NCT02178592|11198435|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1
7085449|NCT02178592|11198436|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1
7085450|NCT02178592|11198435|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3
7085451|NCT02178592|11198436|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2
7085452|NCT02178592|11198435|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3
7085453|NCT02178592|11198436|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1
7085454|NCT02178592|11198435|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11
7085455|NCT02178592|11198436|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3
7085456|NCT02178592|11198435|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1
7085457|NCT02178592|11198436|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0
7085458|NCT02178592|11198435|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1
7085459|NCT02178592|11198436|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0
7085460|NCT02178592|11198435|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0
7085461|NCT02178592|11198436|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1
7085462|NCT02178592|11198435|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2
7085463|NCT02178592|11198436|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0
7085464|NCT02178592|11198435|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4
7085465|NCT02178592|11198436|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1
7085466|NCT02178592|11198435|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2
7085467|NCT02178592|11198436|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0
7085468|NCT02178592|11198435|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3
7085469|NCT02178592|11198436|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1
7085470|NCT02178787|11198459|FG000|Overall Study|Lost to Follow-up|1
7085471|NCT02178787|11198460|FG001|Overall Study|Lost to Follow-up|0
7085472|NCT02178787|11198459|FG000|Overall Study|Withdrawal by Subject|0
7085473|NCT02178787|11198460|FG001|Overall Study|Withdrawal by Subject|2
7085474|NCT02178787|11198459|FG000|Overall Study|No TCD window|3
7085475|NCT02178787|11198460|FG001|Overall Study|No TCD window|7
6805467|NCT01938001|10807542|FG001|Overall Study|Lost to Follow-up|3
6805468|NCT01938001|10807541|FG000|Overall Study|Death|16
6805469|NCT01938001|10807542|FG001|Overall Study|Death|26
6805470|NCT01529008|10807550|FG000|Bone Marrow Harvesting|Physician Decision|1
6805471|NCT01529008|10807551|FG001|Bone Marrow Harvesting|Physician Decision|1
6805472|NCT01529008|10807550|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0
7057068|NCT01882465|11151534|FG005|Period 1|Lens Discomfort|0
7057069|NCT01882465|11151535|FG006|Period 1|Lens Discomfort|0
6805473|NCT01529008|10807551|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2
6805474|NCT01529008|10807550|FG000|Treatment|Adverse Event|6
6805475|NCT01529008|10807551|FG001|Treatment|Adverse Event|0
6805476|NCT01529008|10807550|FG000|Treatment|Other|3
6805477|NCT01529008|10807551|FG001|Treatment|Other|1
6805478|NCT01529008|10807550|FG000|Efficacy Analysis|Protocol Violation|2
6805479|NCT01529008|10807551|FG001|Efficacy Analysis|Protocol Violation|0
6805480|NCT01529008|10807550|FG000|Efficacy Analysis|Physician Decision|0
6805481|NCT01529008|10807551|FG001|Efficacy Analysis|Physician Decision|1
6805482|NCT01529008|10807550|FG000|Efficacy Analysis|Withdrawal by Subject|0
6805483|NCT01529008|10807551|FG001|Efficacy Analysis|Withdrawal by Subject|2
6805484|NCT01484691|10807560|FG000|Overall Study|Withdrawal by Subject|1
6805485|NCT01484691|10807561|FG001|Overall Study|Withdrawal by Subject|1
6805486|NCT01484691|10807562|FG002|Overall Study|Withdrawal by Subject|1
6805487|NCT01484691|10807560|FG000|Overall Study|Physician Decision|0
6805488|NCT01484691|10807561|FG001|Overall Study|Physician Decision|2
6805489|NCT01484691|10807562|FG002|Overall Study|Physician Decision|1
6805490|NCT00400946|10807589|FG000|Overall Study|Ineligible|0
6805491|NCT00400946|10807590|FG001|Overall Study|Ineligible|0
6805492|NCT00400946|10807591|FG002|Overall Study|Ineligible|0
6805493|NCT00400946|10807592|FG003|Overall Study|Ineligible|5
6805494|NCT00400946|10807593|FG004|Overall Study|Ineligible|1
6805495|NCT00400946|10807589|FG000|Overall Study|Induction Failure|0
6805496|NCT00400946|10807590|FG001|Overall Study|Induction Failure|0
6805497|NCT00400946|10807591|FG002|Overall Study|Induction Failure|0
6805498|NCT00400946|10807592|FG003|Overall Study|Induction Failure|11
6805499|NCT00400946|10807593|FG004|Overall Study|Induction Failure|8
6805500|NCT00400946|10807589|FG000|Overall Study|Induction Death|0
6805501|NCT00400946|10807590|FG001|Overall Study|Induction Death|0
6805502|NCT00400946|10807591|FG002|Overall Study|Induction Death|0
6805503|NCT00400946|10807592|FG003|Overall Study|Induction Death|13
6805504|NCT00400946|10807593|FG004|Overall Study|Induction Death|3
6805505|NCT00400946|10807589|FG000|Overall Study|Lost to Follow-up|1
6805506|NCT00400946|10807590|FG001|Overall Study|Lost to Follow-up|1
6805507|NCT00400946|10807591|FG002|Overall Study|Lost to Follow-up|0
7057070|NCT01882465|11151529|FG000|Period 1|Withdrawal by Subject|0
7057071|NCT01882465|11151530|FG001|Period 1|Withdrawal by Subject|0
7057072|NCT01882465|11151531|FG002|Period 1|Withdrawal by Subject|0
7057073|NCT01882465|11151532|FG003|Period 1|Withdrawal by Subject|0
7057074|NCT01882465|11151533|FG004|Period 1|Withdrawal by Subject|0
7057075|NCT01882465|11151534|FG005|Period 1|Withdrawal by Subject|0
7057076|NCT01882465|11151535|FG006|Period 1|Withdrawal by Subject|1
7057077|NCT01882465|11151529|FG000|Period 2|Protocol Violation|0
7057078|NCT01882465|11151530|FG001|Period 2|Protocol Violation|0
7057079|NCT01882465|11151531|FG002|Period 2|Protocol Violation|0
7057080|NCT01882465|11151532|FG003|Period 2|Protocol Violation|0
7057081|NCT01882465|11151533|FG004|Period 2|Protocol Violation|1
7057082|NCT01882465|11151534|FG005|Period 2|Protocol Violation|0
7057083|NCT01882465|11151535|FG006|Period 2|Protocol Violation|0
7057084|NCT01882647|11151555|FG000|Overall Study|Lost to Follow-up|2
7057085|NCT01882647|11151556|FG001|Overall Study|Lost to Follow-up|2
7057086|NCT01882647|11151555|FG000|Overall Study|Withdrawal by Subject|0
7057087|NCT01882647|11151556|FG001|Overall Study|Withdrawal by Subject|4
7057088|NCT01882803|11151575|FG000|Overall Study|Disease Progression|53
7057089|NCT01882803|11151575|FG000|Overall Study|Adverse Event|22
7057090|NCT01882803|11151575|FG000|Overall Study|Death|7
7057091|NCT01882803|11151575|FG000|Overall Study|Physician Decision|7
7057092|NCT01882803|11151575|FG000|Overall Study|Protocol Violation|1
6805508|NCT00400946|10807592|FG003|Overall Study|Lost to Follow-up|0
6805509|NCT00400946|10807593|FG004|Overall Study|Lost to Follow-up|1
6805510|NCT00400946|10807589|FG000|Overall Study|Remission Death|1
6805511|NCT00400946|10807590|FG001|Overall Study|Remission Death|1
6805512|NCT00400946|10807591|FG002|Overall Study|Remission Death|0
6805513|NCT00400946|10807592|FG003|Overall Study|Remission Death|0
6805514|NCT00400946|10807593|FG004|Overall Study|Remission Death|1
6805515|NCT00400946|10807589|FG000|Overall Study|Relapse|9
6805516|NCT00400946|10807590|FG001|Overall Study|Relapse|2
7057093|NCT01882803|11151575|FG000|Overall Study|Withdrawal by Subject|4
7057094|NCT01882829|11151580|FG000|Overall Study|Adverse Event|4
7057095|NCT01882829|11151580|FG000|Overall Study|Protocol Violation|1
7057096|NCT01882829|11151580|FG000|Overall Study|Withdrawal by Subject|1
7057097|NCT01882907|11151590|FG000|Overall Study|Adverse Event|3
7057098|NCT01882907|11151591|FG001|Overall Study|Adverse Event|1
7057099|NCT01882907|11151590|FG000|Overall Study|Lack of Efficacy|0
7057100|NCT01882907|11151591|FG001|Overall Study|Lack of Efficacy|3
7057101|NCT01882907|11151590|FG000|Overall Study|Lost to Follow-up|1
7057102|NCT01882907|11151591|FG001|Overall Study|Lost to Follow-up|4
7057103|NCT01882907|11151590|FG000|Overall Study|Protocol Violation|10
7057104|NCT01882907|11151591|FG001|Overall Study|Protocol Violation|14
7057105|NCT01882907|11151590|FG000|Overall Study|Withdrawal by Subject|0
7057106|NCT01882907|11151591|FG001|Overall Study|Withdrawal by Subject|6
7057107|NCT01882985|11151599|FG000|Overall Study|Lost to Follow-up|1
7057108|NCT01882985|11151599|FG000|Overall Study|Withdrawal by Subject|1
7057109|NCT01883362|11151609|FG000|Treatment|Adverse Event|1
7057110|NCT01883362|11151610|FG001|Treatment|Adverse Event|8
7057111|NCT01883362|11151609|FG000|Treatment|Withdrawal by Subject|6
7057112|NCT01883362|11151610|FG001|Treatment|Withdrawal by Subject|2
7057113|NCT01883362|11151609|FG000|Treatment|Administrative problems|4
7057114|NCT01883362|11151610|FG001|Treatment|Administrative problems|1
7057115|NCT01883362|11151609|FG000|Treatment|Relapse|4
7057116|NCT01883362|11151610|FG001|Treatment|Relapse|2
7057117|NCT01883362|11151609|FG000|Treatment|Randomized, not treated|1
7057118|NCT01883362|11151610|FG001|Treatment|Randomized, not treated|1
7057119|NCT01883362|11151609|FG000|Post Treatment Follow-up|Protocol Violation|0
7057120|NCT01883362|11151610|FG001|Post Treatment Follow-up|Protocol Violation|1
7057121|NCT01883362|11151609|FG000|Post Treatment Follow-up|Withdrawal by Subject|4
7057122|NCT01883362|11151610|FG001|Post Treatment Follow-up|Withdrawal by Subject|3
7057123|NCT01883362|11151609|FG000|Post Treatment Follow-up|Lost to Follow-up|1
7057124|NCT01883362|11151610|FG001|Post Treatment Follow-up|Lost to Follow-up|4
7057125|NCT01883362|11151609|FG000|Post Treatment Follow-up|Administrative problems|2
7057126|NCT01883362|11151610|FG001|Post Treatment Follow-up|Administrative problems|0
7057127|NCT01883362|11151609|FG000|Post Treatment Follow-up|Death|8
7057128|NCT01883362|11151610|FG001|Post Treatment Follow-up|Death|4
7085476|NCT02178787|11198459|FG000|Overall Study|Physician Decision|1
7085477|NCT02178787|11198460|FG001|Overall Study|Physician Decision|0
7085478|NCT02178995|11198487|FG000|Double Blind|Adverse Event|0
7085479|NCT02178995|11198488|FG001|Double Blind|Adverse Event|0
7085480|NCT02178995|11198489|FG002|Double Blind|Adverse Event|0
7085481|NCT02178995|11198490|FG003|Double Blind|Adverse Event|0
7085482|NCT02178995|11198491|FG004|Double Blind|Adverse Event|0
7085483|NCT02178995|11198492|FG005|Double Blind|Adverse Event|1
7085484|NCT02178995|11198493|FG006|Double Blind|Adverse Event|0
7085485|NCT02178995|11198494|FG007|Double Blind|Adverse Event|1
7085486|NCT02178995|11198495|FG008|Double Blind|Adverse Event|1
7085487|NCT02178995|11198487|FG000|Double Blind|Lost to Follow-up|0
7085488|NCT02178995|11198488|FG001|Double Blind|Lost to Follow-up|1
7085489|NCT02178995|11198489|FG002|Double Blind|Lost to Follow-up|0
7085490|NCT02178995|11198490|FG003|Double Blind|Lost to Follow-up|0
7085491|NCT02178995|11198491|FG004|Double Blind|Lost to Follow-up|0
7085492|NCT02178995|11198492|FG005|Double Blind|Lost to Follow-up|0
7085493|NCT02178995|11198493|FG006|Double Blind|Lost to Follow-up|0
7085494|NCT02178995|11198494|FG007|Double Blind|Lost to Follow-up|1
7085495|NCT02178995|11198495|FG008|Double Blind|Lost to Follow-up|0
7085496|NCT02178995|11198487|FG000|Open Label|Adverse Event|2
7085497|NCT02178995|11198488|FG001|Open Label|Adverse Event|0
7085498|NCT02178995|11198489|FG002|Open Label|Adverse Event|0
7085499|NCT02178995|11198490|FG003|Open Label|Adverse Event|0
7085500|NCT02178995|11198491|FG004|Open Label|Adverse Event|0
7085501|NCT02178995|11198492|FG005|Open Label|Adverse Event|0
7085502|NCT02178995|11198493|FG006|Open Label|Adverse Event|0
7057129|NCT01883362|11151609|FG000|Post Treatment Follow-up|Relapse|1
7057130|NCT01883362|11151610|FG001|Post Treatment Follow-up|Relapse|2
7057131|NCT01883453|11151641|FG000|Overall Study|No episode of common cold|25
7057132|NCT01883453|11151642|FG001|Overall Study|No episode of common cold|23
7057133|NCT01883492|11151650|FG000|Overall Study|Lost to Follow-up|3
7057134|NCT01883492|11151651|FG001|Overall Study|Lost to Follow-up|4
7057135|NCT01883492|11151650|FG000|Overall Study|Surgery on contra-lateral hip|0
7085503|NCT02178995|11198494|FG007|Open Label|Adverse Event|0
6805517|NCT00400946|10807591|FG002|Overall Study|Relapse|1
6805518|NCT00400946|10807592|FG003|Overall Study|Relapse|1
6805519|NCT00400946|10807593|FG004|Overall Study|Relapse|5
6805520|NCT00400946|10807589|FG000|Overall Study|Transplant in CR1|0
6805521|NCT00400946|10807590|FG001|Overall Study|Transplant in CR1|0
6805522|NCT00400946|10807591|FG002|Overall Study|Transplant in CR1|0
6805523|NCT00400946|10807592|FG003|Overall Study|Transplant in CR1|10
6805524|NCT00400946|10807593|FG004|Overall Study|Transplant in CR1|1
6805525|NCT00400946|10807589|FG000|Overall Study|Withdrawal by Subject|2
6805526|NCT00400946|10807590|FG001|Overall Study|Withdrawal by Subject|5
6805527|NCT00400946|10807591|FG002|Overall Study|Withdrawal by Subject|1
6805528|NCT00400946|10807592|FG003|Overall Study|Withdrawal by Subject|5
6805529|NCT00400946|10807593|FG004|Overall Study|Withdrawal by Subject|8
6805530|NCT00400946|10807589|FG000|Overall Study|Clinical|1
7057136|NCT01883492|11151651|FG001|Overall Study|Surgery on contra-lateral hip|1
7057137|NCT01883492|11151650|FG000|Overall Study|Poor X-ray quality|7
7057138|NCT01883492|11151651|FG001|Overall Study|Poor X-ray quality|4
7057139|NCT01883492|11151650|FG000|Overall Study|Withdrawal by Subject|1
7057140|NCT01883492|11151651|FG001|Overall Study|Withdrawal by Subject|0
7057141|NCT01883492|11151650|FG000|Overall Study|inappropriate implant used|1
7057142|NCT01883492|11151651|FG001|Overall Study|inappropriate implant used|1
7057143|NCT01883492|11151650|FG000|Overall Study|bone anatomy did not meet study criteria|1
7057144|NCT01883492|11151651|FG001|Overall Study|bone anatomy did not meet study criteria|1
7057145|NCT01883635|11151659|FG000|Overall Study|Withdrawal by Subject|4
7057146|NCT01883635|11151660|FG001|Overall Study|Withdrawal by Subject|0
7057147|NCT01883895|11151677|FG000|Overall Study|Lost to Follow-up|2
7057148|NCT01884025|11151696|FG000|Overall Study|Lost to Follow-up|3
7057149|NCT01884025|11151697|FG001|Overall Study|Lost to Follow-up|4
7057150|NCT01884311|11151712|FG000|Overall Study|Withdrawal by Subject|3
7057151|NCT01884311|11151712|FG000|Overall Study|withdrew consent due to AEs|1
7057152|NCT01884311|11151712|FG000|Overall Study|Precautionary measure|1
7085504|NCT02178995|11198495|FG008|Open Label|Adverse Event|0
7085505|NCT02179177|11198541|FG000|Overall Study|Lost to Follow-up|1
7085506|NCT02179177|11198542|FG001|Overall Study|Lost to Follow-up|1
7085507|NCT02179177|11198541|FG000|Overall Study|Withdrawal by Subject|1
7085508|NCT02179177|11198542|FG001|Overall Study|Withdrawal by Subject|1
7085509|NCT02179190|11198548|FG000|Enrollment|Exit Prior to Device Attempt|11
7085510|NCT02179190|11198548|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7
7085511|NCT02179190|11198548|FG000|Follow-Up Post Barrel VRD Implanted|Death|3
7085512|NCT02179190|11198548|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3
7085513|NCT02179190|11198548|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2
7085514|NCT02179190|11198548|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1
7085515|NCT02179398|11198554|FG000|Overall Study|Lack of obligatory data|3
7085516|NCT02179398|11198555|FG001|Overall Study|Lack of obligatory data|3
7085517|NCT02179398|11198554|FG000|Overall Study|Lost to Follow-up|0
7085518|NCT02179398|11198555|FG001|Overall Study|Lost to Follow-up|1
7085519|NCT02179515|11198586|FG000|Overall Study|switched to alternative treatment|0
7085520|NCT02179515|11198587|FG001|Overall Study|switched to alternative treatment|1
7085521|NCT02179515|11198588|FG002|Overall Study|switched to alternative treatment|1
7085522|NCT02179515|11198586|FG000|Overall Study|Death|0
7085523|NCT02179515|11198587|FG001|Overall Study|Death|1
7085524|NCT02179515|11198588|FG002|Overall Study|Death|1
7085525|NCT02179515|11198586|FG000|Overall Study|refused further treatment|0
7085526|NCT02179515|11198587|FG001|Overall Study|refused further treatment|3
7085527|NCT02179515|11198588|FG002|Overall Study|refused further treatment|4
7085528|NCT02179515|11198586|FG000|Overall Study|Disease progression on study|2
7085529|NCT02179515|11198587|FG001|Overall Study|Disease progression on study|11
7085530|NCT02179515|11198588|FG002|Overall Study|Disease progression on study|8
7085531|NCT02179918|11198644|FG000|Overall Study|Death|0
7085532|NCT02179918|11198645|FG001|Overall Study|Death|0
7085533|NCT02179918|11198646|FG002|Overall Study|Death|0
7085534|NCT02179918|11198647|FG003|Overall Study|Death|1
7085535|NCT02179918|11198648|FG004|Overall Study|Death|0
7085536|NCT02179918|11198644|FG000|Overall Study|Lost to Follow-up|0
7085537|NCT02179918|11198645|FG001|Overall Study|Lost to Follow-up|0
7085538|NCT02179918|11198646|FG002|Overall Study|Lost to Follow-up|1
7085539|NCT02179918|11198647|FG003|Overall Study|Lost to Follow-up|0
7085540|NCT02179918|11198648|FG004|Overall Study|Lost to Follow-up|0
7085541|NCT02179918|11198644|FG000|Overall Study|Progressive Disease|4
7085542|NCT02179918|11198645|FG001|Overall Study|Progressive Disease|1
7085543|NCT02179918|11198646|FG002|Overall Study|Progressive Disease|1
7085544|NCT02179918|11198647|FG003|Overall Study|Progressive Disease|2
7085545|NCT02179918|11198648|FG004|Overall Study|Progressive Disease|6
7085546|NCT02179918|11198644|FG000|Overall Study|Other|0
7085547|NCT02179918|11198645|FG001|Overall Study|Other|1
7085548|NCT02179918|11198646|FG002|Overall Study|Other|0
7085549|NCT02179918|11198647|FG003|Overall Study|Other|0
7057153|NCT01884337|11151721|FG000|Treatment|Adverse Event|2
7057154|NCT01884337|11151722|FG001|Treatment|Adverse Event|2
7057155|NCT01884337|11151721|FG000|Treatment|Subj. request to discont. treatment|2
7057156|NCT01884337|11151722|FG001|Treatment|Subj. request to discont. treatment|0
7057157|NCT01884337|11151721|FG000|Follow-up Period|Lost to Follow-up|1
7057158|NCT01884337|11151722|FG001|Follow-up Period|Lost to Follow-up|1
7057159|NCT01884350|11151730|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17
7057160|NCT01884350|11151731|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20
7057161|NCT01884350|11151732|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0
7057162|NCT01884350|11151730|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6
7057163|NCT01884350|11151731|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4
7057164|NCT01884350|11151732|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0
7057165|NCT01884350|11151730|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0
7057166|NCT01884350|11151731|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1
7057167|NCT01884350|11151732|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0
7057168|NCT01884350|11151730|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7
7057169|NCT01884350|11151731|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6
7057170|NCT01884350|11151732|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0
7057171|NCT01884350|11151730|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15
7057172|NCT01884350|11151731|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11
7057173|NCT01884350|11151732|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0
7057174|NCT01884350|11151730|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0
7057175|NCT01884350|11151731|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2
7057176|NCT01884350|11151732|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0
7057177|NCT01884350|11151730|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2
7057178|NCT01884350|11151731|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5
7057179|NCT01884350|11151732|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0
7057180|NCT01884350|11151730|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2
7057181|NCT01884350|11151731|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0
7057182|NCT01884350|11151732|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0
7057183|NCT01884350|11151730|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1
7057184|NCT01884350|11151731|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1
7057185|NCT01884350|11151732|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0
7057186|NCT01884350|11151730|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1
7057187|NCT01884350|11151731|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1
7057188|NCT01884350|11151732|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0
7057189|NCT01884350|11151730|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3
7057190|NCT01884350|11151731|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3
7057191|NCT01884350|11151732|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0
7057192|NCT01884350|11151730|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21
7057193|NCT01884350|11151731|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0
7057194|NCT01884350|11151732|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2
7057195|NCT01884350|11151730|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7
7057196|NCT01884350|11151731|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3
7057197|NCT01884350|11151732|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3
7057198|NCT01884350|11151730|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1
7057199|NCT01884350|11151731|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0
7057200|NCT01884350|11151732|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1
7057201|NCT01884350|11151730|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17
7057202|NCT01884350|11151731|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6
7085550|NCT02179918|11198648|FG004|Overall Study|Other|1
7085551|NCT02179918|11198644|FG000|Overall Study|Subject refused further follow-up|0
7057203|NCT01884350|11151732|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3
7057204|NCT01884350|11151730|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17
7057205|NCT01884350|11151731|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3
7057206|NCT01884350|11151732|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0
7057207|NCT01884350|11151730|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3
7057208|NCT01884350|11151731|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0
7057209|NCT01884350|11151732|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2
7057210|NCT01884350|11151730|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4
7057211|NCT01884350|11151731|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0
7057212|NCT01884350|11151732|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0
7057213|NCT01884350|11151730|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3
7057214|NCT01884350|11151731|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0
7057215|NCT01884350|11151732|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0
7057216|NCT01884350|11151730|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4
7057217|NCT01884350|11151731|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1
7057218|NCT01884350|11151732|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0
7057219|NCT01884350|11151730|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1
7057220|NCT01884350|11151731|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0
7057221|NCT01884350|11151732|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0
7057222|NCT01884350|11151730|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2
7057223|NCT01884350|11151731|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0
7057224|NCT01884350|11151732|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0
7057225|NCT01884545|11151763|FG000|Overall Study|Lost to Follow-up|6
7057226|NCT01884545|11151764|FG001|Overall Study|Lost to Follow-up|4
7057227|NCT01884545|11151765|FG002|Overall Study|Lost to Follow-up|9
7057228|NCT01884545|11151766|FG003|Overall Study|Lost to Follow-up|4
7057229|NCT01884545|11151763|FG000|Overall Study|Patient withdrawn|7
7057230|NCT01884545|11151764|FG001|Overall Study|Patient withdrawn|12
7057231|NCT01884545|11151765|FG002|Overall Study|Patient withdrawn|5
7057232|NCT01884545|11151766|FG003|Overall Study|Patient withdrawn|5
7057233|NCT01884545|11151763|FG000|Overall Study|Non-adherence|0
7057234|NCT01884545|11151764|FG001|Overall Study|Non-adherence|2
7057235|NCT01884545|11151765|FG002|Overall Study|Non-adherence|0
7057236|NCT01884545|11151766|FG003|Overall Study|Non-adherence|0
7057237|NCT01884571|11151776|FG000|Overall Study|Adverse Event|1
7057238|NCT01884571|11151776|FG000|Overall Study|Death|2
7057239|NCT01884571|11151776|FG000|Overall Study|Withdrawal by Subject|2
7085552|NCT02179918|11198645|FG001|Overall Study|Subject refused further follow-up|1
7085553|NCT02179918|11198646|FG002|Overall Study|Subject refused further follow-up|0
7085554|NCT02179918|11198647|FG003|Overall Study|Subject refused further follow-up|0
7085555|NCT02179918|11198648|FG004|Overall Study|Subject refused further follow-up|1
7085556|NCT02180061|11198663|FG000|Overall Study|Adverse Event|4
7085557|NCT02180061|11198664|FG001|Overall Study|Adverse Event|2
7085558|NCT02180061|11198663|FG000|Overall Study|Clinical Progression|5
7085559|NCT02180061|11198664|FG001|Overall Study|Clinical Progression|1
7085560|NCT02180061|11198663|FG000|Overall Study|Progressive Disease|15
7085561|NCT02180061|11198664|FG001|Overall Study|Progressive Disease|5
7085562|NCT02180061|11198663|FG000|Overall Study|Physician Decision|1
7085563|NCT02180061|11198664|FG001|Overall Study|Physician Decision|0
7085564|NCT02180165|11198683|FG000|Overall Study|Not Treated|0
7085565|NCT02180165|11198684|FG001|Overall Study|Not Treated|0
7085566|NCT02180165|11198685|FG002|Overall Study|Not Treated|1
7085567|NCT02180165|11198686|FG003|Overall Study|Not Treated|0
7085568|NCT02180165|11198683|FG000|Overall Study|Adverse Event|7
7085569|NCT02180165|11198684|FG001|Overall Study|Adverse Event|0
7085570|NCT02180165|11198685|FG002|Overall Study|Adverse Event|18
7085571|NCT02180165|11198686|FG003|Overall Study|Adverse Event|3
7085572|NCT02180165|11198683|FG000|Overall Study|Lack of Efficacy|0
7085573|NCT02180165|11198684|FG001|Overall Study|Lack of Efficacy|1
7085574|NCT02180165|11198685|FG002|Overall Study|Lack of Efficacy|3
7085575|NCT02180165|11198686|FG003|Overall Study|Lack of Efficacy|2
7085576|NCT02180165|11198683|FG000|Overall Study|Physician Decision|1
7085577|NCT02180165|11198684|FG001|Overall Study|Physician Decision|0
7085578|NCT02180165|11198685|FG002|Overall Study|Physician Decision|5
7085579|NCT02180165|11198686|FG003|Overall Study|Physician Decision|0
7085580|NCT02180165|11198683|FG000|Overall Study|Withdrawal by Subject|3
7085581|NCT02180165|11198684|FG001|Overall Study|Withdrawal by Subject|0
7085582|NCT02180165|11198685|FG002|Overall Study|Withdrawal by Subject|2
7085583|NCT02180165|11198686|FG003|Overall Study|Withdrawal by Subject|1
7057240|NCT01884571|11151776|FG000|Overall Study|Disease progression|3
7057241|NCT01884597|11151783|FG000|Overall Study|Adverse Event|0
7057242|NCT01884597|11151784|FG001|Overall Study|Adverse Event|0
7057243|NCT01884597|11151785|FG002|Overall Study|Adverse Event|1
7057244|NCT01884597|11151783|FG000|Overall Study|Lack of Efficacy|1
7057245|NCT01884597|11151784|FG001|Overall Study|Lack of Efficacy|0
7057246|NCT01884597|11151785|FG002|Overall Study|Lack of Efficacy|0
7057247|NCT01884597|11151783|FG000|Overall Study|Death|0
7085584|NCT02180438|11198702|FG000|Overall Study|Lost to Follow-up|1
7085585|NCT02180659|11198719|FG000|Overall Study|Adverse Event|1
7057248|NCT01884597|11151784|FG001|Overall Study|Death|1
7085586|NCT02180659|11198720|FG001|Overall Study|Adverse Event|0
7057249|NCT01884597|11151785|FG002|Overall Study|Death|0
7057250|NCT01884675|11151801|FG000|Overall Study|Study closed/terminated|3
7057251|NCT01884675|11151802|FG001|Overall Study|Study closed/terminated|2
7057252|NCT01884688|11151810|FG000|Overall Study|Screen Failure|2
7057253|NCT01885000|11151825|FG000|Overall Study|Adverse Event|1
7085587|NCT02180659|11198719|FG000|Overall Study|Lost to Follow-up|4
7085588|NCT02180659|11198720|FG001|Overall Study|Lost to Follow-up|2
7085589|NCT02180659|11198719|FG000|Overall Study|Subject incarcerated during conduct|1
7085590|NCT02180659|11198720|FG001|Overall Study|Subject incarcerated during conduct|0
7085591|NCT02180659|11198719|FG000|Overall Study|Withdrawal by Subject|0
7085592|NCT02180659|11198720|FG001|Overall Study|Withdrawal by Subject|2
7085593|NCT02180659|11198719|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0
7085594|NCT02180659|11198720|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1
7085595|NCT02180672|11198728|FG000|Overall Study|Lost to Follow-up|5
7085596|NCT02180672|11198729|FG001|Overall Study|Lost to Follow-up|7
7085597|NCT02181296|11198790|FG000|Overall Study|Lost to Follow-up|7
7085598|NCT02181296|11198791|FG001|Overall Study|Lost to Follow-up|6
7085599|NCT02181504|11198839|FG000|Overall Study|Adverse Event|1
7085600|NCT02181504|11198840|FG001|Overall Study|Adverse Event|1
7085601|NCT02181504|11198841|FG002|Overall Study|Adverse Event|1
7085602|NCT02181556|11198867|FG000|Overall Study|Withdrawal by Subject|1
7085603|NCT02181634|11198871|FG000|Overall Study|Lack of Efficacy|33
7085604|NCT02181634|11198871|FG000|Overall Study|Adverse Event|17
7085605|NCT02181634|11198871|FG000|Overall Study|Physician Decision|8
6805531|NCT00400946|10807590|FG001|Overall Study|Clinical|2
6805532|NCT00400946|10807591|FG002|Overall Study|Clinical|0
6805533|NCT00400946|10807592|FG003|Overall Study|Clinical|2
6805534|NCT00400946|10807593|FG004|Overall Study|Clinical|9
6805535|NCT00400946|10807589|FG000|Overall Study|Other|0
6805536|NCT00400946|10807590|FG001|Overall Study|Other|0
6805537|NCT00400946|10807591|FG002|Overall Study|Other|0
7057254|NCT01885000|11151826|FG001|Overall Study|Adverse Event|0
7057255|NCT01885000|11151825|FG000|Overall Study|Withdrawal by Subject|1
7057256|NCT01885000|11151826|FG001|Overall Study|Withdrawal by Subject|1
7057257|NCT01885000|11151825|FG000|Overall Study|Protocol Violation|0
7057258|NCT01885000|11151826|FG001|Overall Study|Protocol Violation|1
7057259|NCT01885104|11151834|FG000|Overall Study|Withdrawal of Consent|1
7057260|NCT01885104|11151835|FG001|Overall Study|Withdrawal of Consent|0
7057261|NCT01885104|11151834|FG000|Overall Study|Lost to Follow-up|0
7057262|NCT01885104|11151835|FG001|Overall Study|Lost to Follow-up|1
7057263|NCT01885104|11151834|FG000|Overall Study|Physician Decision|1
7057264|NCT01885104|11151835|FG001|Overall Study|Physician Decision|0
7057265|NCT01885182|11151852|FG000|Overall Study|Adverse Event|11
7057266|NCT01885182|11151853|FG001|Overall Study|Adverse Event|13
7057267|NCT01885182|11151852|FG000|Overall Study|Withdrawal by Subject|13
7057268|NCT01885182|11151853|FG001|Overall Study|Withdrawal by Subject|6
7057269|NCT01885182|11151852|FG000|Overall Study|Lost to Follow-up|2
7057270|NCT01885182|11151853|FG001|Overall Study|Lost to Follow-up|2
7057271|NCT01885182|11151852|FG000|Overall Study|Lack of Efficacy|8
7057272|NCT01885182|11151853|FG001|Overall Study|Lack of Efficacy|1
7057273|NCT01885195|11151861|FG000|Overall Study|Adverse Event|29
7057274|NCT01885195|11151861|FG000|Overall Study|Death|1
7057275|NCT01885195|11151861|FG000|Overall Study|Disease Progression|67
7057276|NCT01885195|11151861|FG000|Overall Study|Protocol Deviation|2
7057277|NCT01885195|11151861|FG000|Overall Study|Physician Decision|3
7057278|NCT01885195|11151861|FG000|Overall Study|Patient/guardian decision|8
7085606|NCT02181634|11198871|FG000|Overall Study|Withdrawal by Subject|5
7085607|NCT02181634|11198871|FG000|Overall Study|Death|2
7085608|NCT02181634|11198871|FG000|Overall Study|Treatment delayed greater than 4 weeks|3
7085609|NCT02181634|11198871|FG000|Overall Study|Ineligible|1
6805538|NCT00400946|10807592|FG003|Overall Study|Other|0
6805539|NCT00400946|10807593|FG004|Overall Study|Other|1
6805540|NCT00180414|10807613|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4
6805541|NCT00180414|10807614|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4
6810332|NCT00943722|10814046|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0
6810333|NCT00943722|10814047|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0
7057279|NCT01885208|11151867|FG000|Overall Study|Unclassified|32
7057280|NCT01885208|11151868|FG001|Overall Study|Unclassified|38
7057281|NCT01885559|11151876|FG000|Overall Study|Lost to Follow-up|15
7057282|NCT01885559|11151877|FG001|Overall Study|Lost to Follow-up|16
7085610|NCT02181634|11198871|FG000|Overall Study|Max number of dose reduction|1
7085611|NCT02181634|11198871|FG000|Overall Study|Symptomatic progression|1
7085612|NCT02181634|11198871|FG000|Overall Study|Patient opted to proceed to surgery|1
7085613|NCT02181673|11198877|FG000|Up to Week 24|Adverse Event|2
7085614|NCT02181673|11198878|FG001|Up to Week 24|Adverse Event|0
7085615|NCT02181673|11198879|FG002|Up to Week 24|Adverse Event|3
7085616|NCT02181673|11198877|FG000|Up to Week 24|Death|1
7085617|NCT02181673|11198878|FG001|Up to Week 24|Death|0
7085618|NCT02181673|11198879|FG002|Up to Week 24|Death|0
7085619|NCT02181673|11198877|FG000|Up to Week 24|Lack of Efficacy|1
7085620|NCT02181673|11198878|FG001|Up to Week 24|Lack of Efficacy|0
7085621|NCT02181673|11198879|FG002|Up to Week 24|Lack of Efficacy|0
7085622|NCT02181673|11198877|FG000|Up to Week 24|Lost to Follow-up|1
7085623|NCT02181673|11198878|FG001|Up to Week 24|Lost to Follow-up|0
7085624|NCT02181673|11198879|FG002|Up to Week 24|Lost to Follow-up|0
7085625|NCT02181673|11198877|FG000|Up to Week 24|Physician Decision|0
6805548|NCT03627091|10807674|FG000|Overall Study|Adverse Event|0
7057283|NCT01885559|11151876|FG000|Overall Study|Less than full participation|9
7057284|NCT01885559|11151877|FG001|Overall Study|Less than full participation|19
7057285|NCT01885559|11151876|FG000|Overall Study|Protocol Violation|0
7057286|NCT01885559|11151877|FG001|Overall Study|Protocol Violation|1
7057287|NCT01885936|11151920|FG000|Overall Study|Withdrawal by Subject|1
7057288|NCT01885936|11151921|FG001|Overall Study|Withdrawal by Subject|0
7057289|NCT01886105|11151927|FG000|Overall Study|Lack of Efficacy|3
7057290|NCT01886287|11151936|FG000|Overall Study|Radiographic disease progression|1
7057291|NCT01886287|11151936|FG000|Overall Study|Clinical progression due to disease|1
7057292|NCT01886300|11151940|FG000|Overall Study|Trial terminated by sponsor|16
7085626|NCT02181673|11198878|FG001|Up to Week 24|Physician Decision|0
7085627|NCT02181673|11198879|FG002|Up to Week 24|Physician Decision|3
7085628|NCT02181673|11198877|FG000|Up to Week 24|Withdrawal by Subject|10
7085629|NCT02181673|11198878|FG001|Up to Week 24|Withdrawal by Subject|0
7085630|NCT02181673|11198879|FG002|Up to Week 24|Withdrawal by Subject|1
7085631|NCT02181673|11198877|FG000|Up to Week 24|Other|2
7085632|NCT02181673|11198878|FG001|Up to Week 24|Other|0
7085633|NCT02181673|11198879|FG002|Up to Week 24|Other|3
7085634|NCT02181673|11198877|FG000|Up to Week 24|Randomized not Treated|0
7085635|NCT02181673|11198878|FG001|Up to Week 24|Randomized not Treated|0
7085636|NCT02181673|11198879|FG002|Up to Week 24|Randomized not Treated|1
7085637|NCT02181673|11198877|FG000|Week 24-Week 60|Adverse Event|0
7085638|NCT02181673|11198878|FG001|Week 24-Week 60|Adverse Event|4
7085639|NCT02181673|11198879|FG002|Week 24-Week 60|Adverse Event|10
7085640|NCT02181673|11198877|FG000|Week 24-Week 60|Other|0
7085641|NCT02181673|11198878|FG001|Week 24-Week 60|Other|2
7085642|NCT02181673|11198879|FG002|Week 24-Week 60|Other|1
7085643|NCT02181673|11198877|FG000|Week 24-Week 60|Withdrawal by Subject|0
7085644|NCT02181673|11198878|FG001|Week 24-Week 60|Withdrawal by Subject|2
7085645|NCT02181673|11198879|FG002|Week 24-Week 60|Withdrawal by Subject|2
7085646|NCT02181673|11198877|FG000|Week 24-Week 60|Pregnancy|0
7085647|NCT02181673|11198878|FG001|Week 24-Week 60|Pregnancy|0
7085648|NCT02181673|11198879|FG002|Week 24-Week 60|Pregnancy|1
7085649|NCT02181673|11198877|FG000|Week 24-Week 60|Lack of Efficacy|0
7085650|NCT02181673|11198878|FG001|Week 24-Week 60|Lack of Efficacy|0
7085651|NCT02181673|11198879|FG002|Week 24-Week 60|Lack of Efficacy|1
7085652|NCT02181673|11198877|FG000|Week 24-Week 60|Lost to Follow-up|0
7085653|NCT02181673|11198878|FG001|Week 24-Week 60|Lost to Follow-up|0
7085654|NCT02181673|11198879|FG002|Week 24-Week 60|Lost to Follow-up|1
7085655|NCT02181673|11198877|FG000|Week 24-Week 60|Physician Decision|0
7085656|NCT02181673|11198878|FG001|Week 24-Week 60|Physician Decision|0
7085657|NCT02181673|11198879|FG002|Week 24-Week 60|Physician Decision|1
7085658|NCT02181738|11198890|FG000|Overall Study|Death|1
7085659|NCT02181738|11198891|FG001|Overall Study|Death|1
7085660|NCT02181738|11198892|FG002|Overall Study|Death|6
7085661|NCT02181738|11198893|FG003|Overall Study|Death|1
7085662|NCT02181738|11198890|FG000|Overall Study|Subject Withdrew Consent|1
7085663|NCT02181738|11198891|FG001|Overall Study|Subject Withdrew Consent|3
7085664|NCT02181738|11198892|FG002|Overall Study|Subject Withdrew Consent|2
7085665|NCT02181738|11198893|FG003|Overall Study|Subject Withdrew Consent|1
7057293|NCT01886313|11151946|FG000|Overall Study|Adverse Event|1
7085666|NCT02181738|11198890|FG000|Overall Study|Lost to Follow-up|0
7085667|NCT02181738|11198891|FG001|Overall Study|Lost to Follow-up|4
7085668|NCT02181738|11198892|FG002|Overall Study|Lost to Follow-up|2
7085669|NCT02181738|11198893|FG003|Overall Study|Lost to Follow-up|0
7085670|NCT02181738|11198890|FG000|Overall Study|Patient Return to Home Country|0
7085671|NCT02181738|11198891|FG001|Overall Study|Patient Return to Home Country|1
7085672|NCT02181738|11198892|FG002|Overall Study|Patient Return to Home Country|0
7085673|NCT02181738|11198893|FG003|Overall Study|Patient Return to Home Country|0
6805542|NCT03886220|10807651|FG000|Treatment Period|Discontinued study drug during the treatment period|5
6805543|NCT03886220|10807652|FG001|Treatment Period|Discontinued study drug during the treatment period|12
6805544|NCT03886220|10807651|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1
6805545|NCT03886220|10807652|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
6805546|NCT03886220|10807651|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1
6805547|NCT03886220|10807652|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2
6805549|NCT03627091|10807675|FG001|Overall Study|Adverse Event|0
6805550|NCT03627091|10807676|FG002|Overall Study|Adverse Event|2
6805551|NCT03627091|10807674|FG000|Overall Study|Withdrawal by Subject|2
6805552|NCT03627091|10807675|FG001|Overall Study|Withdrawal by Subject|0
6805553|NCT03627091|10807676|FG002|Overall Study|Withdrawal by Subject|2
6805554|NCT03627091|10807674|FG000|Overall Study|Physician Decision|2
6805555|NCT03627091|10807675|FG001|Overall Study|Physician Decision|0
6805556|NCT03627091|10807676|FG002|Overall Study|Physician Decision|0
6805557|NCT03627091|10807674|FG000|Overall Study|Site terminated by sponsor|0
6805558|NCT03627091|10807675|FG001|Overall Study|Site terminated by sponsor|1
6805559|NCT03627091|10807676|FG002|Overall Study|Site terminated by sponsor|0
6805560|NCT03627091|10807674|FG000|Overall Study|Disease relapse|7
6805561|NCT03627091|10807675|FG001|Overall Study|Disease relapse|5
6805562|NCT03627091|10807676|FG002|Overall Study|Disease relapse|1
6805563|NCT03627091|10807674|FG000|Overall Study|Other|1
6805564|NCT03627091|10807675|FG001|Overall Study|Other|0
6805565|NCT03627091|10807676|FG002|Overall Study|Other|0
6810334|NCT00943722|10814048|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111
6810335|NCT00943722|10814049|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46
6810336|NCT00943722|10814043|FG000|Second Extension Study: EXT 2|Physician Decision|0
6810337|NCT00943722|10814044|FG001|Second Extension Study: EXT 2|Physician Decision|0
6810338|NCT00943722|10814045|FG002|Second Extension Study: EXT 2|Physician Decision|0
6810339|NCT00943722|10814046|FG003|Second Extension Study: EXT 2|Physician Decision|0
6810340|NCT00943722|10814047|FG004|Second Extension Study: EXT 2|Physician Decision|0
6810341|NCT00943722|10814048|FG005|Second Extension Study: EXT 2|Physician Decision|1
6810342|NCT00943722|10814049|FG006|Second Extension Study: EXT 2|Physician Decision|3
6810343|NCT00943722|10814043|FG000|Second Extension Study: EXT 2|Pregnancy|0
6810344|NCT00943722|10814044|FG001|Second Extension Study: EXT 2|Pregnancy|0
6810345|NCT00943722|10814045|FG002|Second Extension Study: EXT 2|Pregnancy|0
6810346|NCT00943722|10814046|FG003|Second Extension Study: EXT 2|Pregnancy|0
6810347|NCT00943722|10814047|FG004|Second Extension Study: EXT 2|Pregnancy|0
6810348|NCT00943722|10814048|FG005|Second Extension Study: EXT 2|Pregnancy|1
6810349|NCT00943722|10814049|FG006|Second Extension Study: EXT 2|Pregnancy|0
6810350|NCT00943722|10814043|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0
7057294|NCT01886313|11151947|FG001|Overall Study|Adverse Event|1
7057295|NCT01886378|11151953|FG000|Overall Study|Adverse Event|1
7057296|NCT01886378|11151953|FG000|Overall Study|Withdrawal by Subject|4
7057297|NCT01886690|11151959|FG000|Overall Study|Protocol Violation|0
7057298|NCT01886690|11151960|FG001|Overall Study|Protocol Violation|1
7057299|NCT01886690|11151959|FG000|Overall Study|Personal Reasons|0
7057300|NCT01886690|11151960|FG001|Overall Study|Personal Reasons|1
7057301|NCT01886716|11151970|FG000|Week 1|Lost to Follow-up|0
7057302|NCT01886716|11151971|FG001|Week 1|Lost to Follow-up|0
7057303|NCT01886716|11151972|FG002|Week 1|Lost to Follow-up|2
7057304|NCT01886716|11151973|FG003|Week 1|Lost to Follow-up|2
7057305|NCT01886716|11151970|FG000|Week 2|Lost to Follow-up|3
7057306|NCT01886716|11151971|FG001|Week 2|Lost to Follow-up|2
7057307|NCT01886716|11151972|FG002|Week 2|Lost to Follow-up|1
7057308|NCT01886716|11151973|FG003|Week 2|Lost to Follow-up|3
7057309|NCT01886716|11151970|FG000|Week 3|Lost to Follow-up|1
7057310|NCT01886716|11151971|FG001|Week 3|Lost to Follow-up|1
7057311|NCT01886716|11151972|FG002|Week 3|Lost to Follow-up|0
7057312|NCT01886716|11151973|FG003|Week 3|Lost to Follow-up|1
7057313|NCT01886781|11151985|FG000|Overall Study|Protocol Violation|5
7085674|NCT02181803|11198912|FG000|Overall Study|Withdrawal by Subject|0
7085675|NCT02181803|11198913|FG001|Overall Study|Withdrawal by Subject|2
7085676|NCT02181803|11198914|FG002|Overall Study|Withdrawal by Subject|0
7085677|NCT02181803|11198915|FG003|Overall Study|Withdrawal by Subject|0
7085678|NCT02181803|11198916|FG004|Overall Study|Withdrawal by Subject|0
7085679|NCT02181803|11198917|FG005|Overall Study|Withdrawal by Subject|0
7085680|NCT02181803|11198918|FG006|Overall Study|Withdrawal by Subject|0
7085681|NCT02181803|11198919|FG007|Overall Study|Withdrawal by Subject|0
7085682|NCT02181803|11198920|FG008|Overall Study|Withdrawal by Subject|0
7085683|NCT02181803|11198912|FG000|Overall Study|Physician Decision|0
7085684|NCT02181803|11198913|FG001|Overall Study|Physician Decision|0
7085685|NCT02181803|11198914|FG002|Overall Study|Physician Decision|0
6810351|NCT00943722|10814044|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0
6810352|NCT00943722|10814045|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0
7057314|NCT01886781|11151986|FG001|Overall Study|Protocol Violation|0
7057315|NCT01886781|11151985|FG000|Overall Study|Adverse Event|1
7057316|NCT01886781|11151986|FG001|Overall Study|Adverse Event|0
7057317|NCT01886781|11151985|FG000|Overall Study|Lost to Follow-up|5
7057318|NCT01886781|11151986|FG001|Overall Study|Lost to Follow-up|0
7057319|NCT01886781|11151985|FG000|Overall Study|Withdrawal by Subject|2
7085686|NCT02181803|11198915|FG003|Overall Study|Physician Decision|1
7057320|NCT01886781|11151986|FG001|Overall Study|Withdrawal by Subject|1
7057321|NCT01886781|11151985|FG000|Overall Study|Worsening of symptoms|1
7057322|NCT01886781|11151986|FG001|Overall Study|Worsening of symptoms|1
7057323|NCT01886833|11152008|FG000|Overall Study|IgA not available from both periods|204
7057324|NCT01887210|11152039|FG000|Overall Study|Withdrawal by Subject|1
7057325|NCT01887210|11152040|FG001|Overall Study|Withdrawal by Subject|3
7085687|NCT02181803|11198916|FG004|Overall Study|Physician Decision|0
7085688|NCT02181803|11198917|FG005|Overall Study|Physician Decision|0
7085689|NCT02181803|11198918|FG006|Overall Study|Physician Decision|0
7085690|NCT02181803|11198919|FG007|Overall Study|Physician Decision|1
7085691|NCT02181803|11198920|FG008|Overall Study|Physician Decision|0
7085692|NCT02181803|11198912|FG000|Overall Study|Adverse Event|0
7085693|NCT02181803|11198913|FG001|Overall Study|Adverse Event|2
7085694|NCT02181803|11198914|FG002|Overall Study|Adverse Event|0
7085695|NCT02181803|11198915|FG003|Overall Study|Adverse Event|1
7085696|NCT02181803|11198916|FG004|Overall Study|Adverse Event|0
7085697|NCT02181803|11198917|FG005|Overall Study|Adverse Event|0
7085698|NCT02181803|11198918|FG006|Overall Study|Adverse Event|1
7085699|NCT02181803|11198919|FG007|Overall Study|Adverse Event|0
7085700|NCT02181803|11198920|FG008|Overall Study|Adverse Event|0
7085701|NCT02181816|11198965|FG000|Overall Study|Case Report Forms Uncollected|38
7085702|NCT02181816|11198965|FG000|Overall Study|Protocol Deviation|21
7085703|NCT02181842|11198973|FG000|Overall Study|Case Report Forms Uncollected|2
7085704|NCT02182440|11198990|FG000|Overall Study|Adverse Event|0
7085705|NCT02182440|11198991|FG001|Overall Study|Adverse Event|1
7085706|NCT02182440|11198992|FG002|Overall Study|Adverse Event|0
7085707|NCT02182440|11198993|FG003|Overall Study|Adverse Event|0
7085708|NCT02182440|11198990|FG000|Overall Study|Death|31
7085709|NCT02182440|11198991|FG001|Overall Study|Death|8
7085710|NCT02182440|11198992|FG002|Overall Study|Death|5
7085711|NCT02182440|11198993|FG003|Overall Study|Death|16
7085712|NCT02182440|11198990|FG000|Overall Study|Protocol Violation|0
7085713|NCT02182440|11198991|FG001|Overall Study|Protocol Violation|1
7085714|NCT02182440|11198992|FG002|Overall Study|Protocol Violation|0
7085715|NCT02182440|11198993|FG003|Overall Study|Protocol Violation|0
7085716|NCT02182440|11198990|FG000|Overall Study|Physician Decision|1
7057326|NCT01887210|11152039|FG000|Overall Study|Lost to Follow-up|0
7057327|NCT01887210|11152040|FG001|Overall Study|Lost to Follow-up|1
7057328|NCT01887353|11152062|FG000|Overall Study|Study stopped early|4
7057329|NCT01887353|11152063|FG001|Overall Study|Study stopped early|3
7057330|NCT01887418|11152072|FG000|Overall Study|Travelling difficulties|0
7057331|NCT01887418|11152073|FG001|Overall Study|Travelling difficulties|0
7057332|NCT01887418|11152074|FG002|Overall Study|Travelling difficulties|1
7057333|NCT01887600|11152106|FG000|Overall Study|Death|39
7057334|NCT01887600|11152107|FG001|Overall Study|Death|16
7057335|NCT01887600|11152106|FG000|Overall Study|Lack of Efficacy|3
7057336|NCT01887600|11152107|FG001|Overall Study|Lack of Efficacy|26
7057337|NCT01887600|11152106|FG000|Overall Study|Lost to Follow-up|5
7057338|NCT01887600|11152107|FG001|Overall Study|Lost to Follow-up|1
7057339|NCT01887600|11152106|FG000|Overall Study|Physician Decision|7
7057340|NCT01887600|11152107|FG001|Overall Study|Physician Decision|8
7057341|NCT01887600|11152106|FG000|Overall Study|Protocol Deviation|3
7057342|NCT01887600|11152107|FG001|Overall Study|Protocol Deviation|0
7057343|NCT01887600|11152106|FG000|Overall Study|Withdrawal by Subject|58
7057344|NCT01887600|11152107|FG001|Overall Study|Withdrawal by Subject|52
7057345|NCT01887600|11152106|FG000|Overall Study|Adverse Event|21
7057346|NCT01887600|11152107|FG001|Overall Study|Adverse Event|9
7057347|NCT01887600|11152106|FG000|Overall Study|Non-compliance with study drug|3
7057348|NCT01887600|11152107|FG001|Overall Study|Non-compliance with study drug|0
7057349|NCT01887600|11152106|FG000|Overall Study|Miscellaneous|6
7057350|NCT01887600|11152107|FG001|Overall Study|Miscellaneous|2
7057351|NCT01887600|11152106|FG000|Overall Study|Progressive Disease|1
7057352|NCT01887600|11152107|FG001|Overall Study|Progressive Disease|0
7057353|NCT01887678|11152116|FG000|Overall Study|Adverse Event|4
7057354|NCT01887678|11152117|FG001|Overall Study|Adverse Event|6
7057355|NCT01887678|11152116|FG000|Overall Study|Exceeded rescue medication dosage|4
7057356|NCT01887678|11152117|FG001|Overall Study|Exceeded rescue medication dosage|5
7057357|NCT01887678|11152116|FG000|Overall Study|Withdrawal of consent|3
7057358|NCT01887678|11152117|FG001|Overall Study|Withdrawal of consent|4
7057359|NCT01887678|11152116|FG000|Overall Study|Lost to Follow-up|4
7057360|NCT01887678|11152117|FG001|Overall Study|Lost to Follow-up|2
7057361|NCT01887678|11152116|FG000|Overall Study|Deterioration of clinical condition|0
7085717|NCT02182440|11198991|FG001|Overall Study|Physician Decision|0
6805566|NCT03568318|10807691|FG000|Overall Study|Adverse Event|3
6805567|NCT03568318|10807692|FG001|Overall Study|Adverse Event|1
6805568|NCT03568318|10807693|FG002|Overall Study|Adverse Event|1
6805569|NCT03568318|10807694|FG003|Overall Study|Adverse Event|0
6805570|NCT03568318|10807695|FG004|Overall Study|Adverse Event|1
6805571|NCT03568318|10807696|FG005|Overall Study|Adverse Event|0
6805572|NCT03568318|10807691|FG000|Overall Study|Withdrawal by Subject|6
6805573|NCT03568318|10807692|FG001|Overall Study|Withdrawal by Subject|5
6805574|NCT03568318|10807693|FG002|Overall Study|Withdrawal by Subject|2
6805575|NCT03568318|10807694|FG003|Overall Study|Withdrawal by Subject|1
6805576|NCT03568318|10807695|FG004|Overall Study|Withdrawal by Subject|0
6805577|NCT03568318|10807696|FG005|Overall Study|Withdrawal by Subject|0
6805578|NCT03568318|10807691|FG000|Overall Study|Lost to Follow-up|3
6805579|NCT03568318|10807692|FG001|Overall Study|Lost to Follow-up|2
6805580|NCT03568318|10807693|FG002|Overall Study|Lost to Follow-up|2
6805581|NCT03568318|10807694|FG003|Overall Study|Lost to Follow-up|2
6805582|NCT03568318|10807695|FG004|Overall Study|Lost to Follow-up|1
6805583|NCT03568318|10807696|FG005|Overall Study|Lost to Follow-up|0
6805584|NCT03568318|10807691|FG000|Overall Study|Other|3
6805585|NCT03568318|10807692|FG001|Overall Study|Other|1
6805586|NCT03568318|10807693|FG002|Overall Study|Other|3
6805587|NCT03568318|10807694|FG003|Overall Study|Other|0
6805588|NCT03568318|10807695|FG004|Overall Study|Other|0
6805589|NCT03568318|10807696|FG005|Overall Study|Other|0
6805590|NCT03568318|10807691|FG000|Overall Study|Ongoing at Time of Analysis|5
6805591|NCT03568318|10807692|FG001|Overall Study|Ongoing at Time of Analysis|3
6805592|NCT03568318|10807693|FG002|Overall Study|Ongoing at Time of Analysis|2
6805593|NCT03568318|10807694|FG003|Overall Study|Ongoing at Time of Analysis|1
6805594|NCT03568318|10807695|FG004|Overall Study|Ongoing at Time of Analysis|0
6805595|NCT03568318|10807696|FG005|Overall Study|Ongoing at Time of Analysis|0
6805596|NCT03498560|10807710|FG000|Overall Study|Found Ineligible|2
6805597|NCT03498560|10807710|FG000|Overall Study|Withdrawal by Subject|14
6805598|NCT03498560|10807710|FG000|Overall Study|Lost to Follow-up|4
6805599|NCT03498560|10807710|FG000|Overall Study|Death|1
6805600|NCT03441360|10807718|FG000|Overall Study|Radiological disease progression|5
6805601|NCT03441360|10807719|FG001|Overall Study|Radiological disease progression|6
7057362|NCT01887678|11152117|FG001|Overall Study|Deterioration of clinical condition|4
7057363|NCT01887678|11152116|FG000|Overall Study|Lack of Efficacy|1
7057364|NCT01887678|11152117|FG001|Overall Study|Lack of Efficacy|2
7057365|NCT01887678|11152116|FG000|Overall Study|Non-compliance|0
7057366|NCT01887678|11152117|FG001|Overall Study|Non-compliance|3
7057367|NCT01887678|11152116|FG000|Overall Study|Specified|1
7057368|NCT01887678|11152117|FG001|Overall Study|Specified|2
7057369|NCT01887717|11152125|FG000|Overall Study|Withdrawal by Subject|1
7057370|NCT01887717|11152126|FG001|Overall Study|Withdrawal by Subject|7
7057371|NCT01887717|11152125|FG000|Overall Study|Physician Decision|0
7057372|NCT01887717|11152126|FG001|Overall Study|Physician Decision|2
7057373|NCT01887717|11152125|FG000|Overall Study|Administrative reasons|5
7057374|NCT01887717|11152126|FG001|Overall Study|Administrative reasons|2
7057375|NCT01888003|11152154|FG000|Overall Study|Study Terminated|5
7057376|NCT01888003|11152155|FG001|Overall Study|Study Terminated|6
7057377|NCT01888003|11152156|FG002|Overall Study|Study Terminated|40
7057378|NCT01888367|11152167|FG000|Overall Study|Physician Decision|3
7057379|NCT01888367|11152168|FG001|Overall Study|Physician Decision|4
7057380|NCT01888367|11152169|FG002|Overall Study|Physician Decision|2
7057381|NCT01888367|11152167|FG000|Overall Study|Death|2
7057382|NCT01888367|11152168|FG001|Overall Study|Death|0
7057383|NCT01888367|11152169|FG002|Overall Study|Death|1
7057384|NCT01888367|11152167|FG000|Overall Study|Withdrawal by Subject|1
7057385|NCT01888367|11152168|FG001|Overall Study|Withdrawal by Subject|0
7057386|NCT01888367|11152169|FG002|Overall Study|Withdrawal by Subject|1
7057387|NCT01888367|11152167|FG000|Overall Study|Lost to Follow-up|1
7057388|NCT01888367|11152168|FG001|Overall Study|Lost to Follow-up|1
7057389|NCT01888367|11152169|FG002|Overall Study|Lost to Follow-up|0
7057390|NCT01888367|11152167|FG000|Overall Study|Protocol Violation|0
7057391|NCT01888367|11152168|FG001|Overall Study|Protocol Violation|0
7057392|NCT01888367|11152169|FG002|Overall Study|Protocol Violation|1
7085718|NCT02182440|11198992|FG002|Overall Study|Physician Decision|0
7085719|NCT02182440|11198993|FG003|Overall Study|Physician Decision|0
7085720|NCT02182440|11198990|FG000|Overall Study|Withdrawal by Subject|1
7085721|NCT02182440|11198991|FG001|Overall Study|Withdrawal by Subject|1
7057393|NCT01888367|11152167|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1
7057394|NCT01888367|11152168|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0
7057395|NCT01888367|11152169|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0
7057396|NCT01888432|11152179|FG000|12-month Analysis (FAS)|Lost to Follow-up|0
7085722|NCT02182440|11198992|FG002|Overall Study|Withdrawal by Subject|3
6805602|NCT03441360|10807720|FG002|Overall Study|Radiological disease progression|4
6805603|NCT03441360|10807718|FG000|Overall Study|Clinical disease progression|2
6805604|NCT03441360|10807719|FG001|Overall Study|Clinical disease progression|2
6805605|NCT03441360|10807720|FG002|Overall Study|Clinical disease progression|0
6805606|NCT03441360|10807718|FG000|Overall Study|Adverse Event|1
6805607|NCT03441360|10807719|FG001|Overall Study|Adverse Event|0
6805608|NCT03441360|10807720|FG002|Overall Study|Adverse Event|1
7057397|NCT01888432|11152180|FG001|12-month Analysis (FAS)|Lost to Follow-up|2
7057398|NCT01888432|11152179|FG000|12-month Analysis (FAS)|Physician Decision|1
7057399|NCT01888432|11152180|FG001|12-month Analysis (FAS)|Physician Decision|1
7057400|NCT01888432|11152179|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6
7057401|NCT01888432|11152180|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3
7057402|NCT01888432|11152179|FG000|12-month Analysis (FAS)|Death|4
7057403|NCT01888432|11152180|FG001|12-month Analysis (FAS)|Death|3
7057404|NCT01888432|11152179|FG000|24-month Analysis (FAS)|Graft loss|0
7057405|NCT01888432|11152180|FG001|24-month Analysis (FAS)|Graft loss|1
7057406|NCT01888432|11152179|FG000|24-month Analysis (FAS)|Lost to Follow-up|0
7057407|NCT01888432|11152180|FG001|24-month Analysis (FAS)|Lost to Follow-up|2
7057408|NCT01888432|11152179|FG000|24-month Analysis (FAS)|Physician Decision|2
7057409|NCT01888432|11152180|FG001|24-month Analysis (FAS)|Physician Decision|4
7057410|NCT01888432|11152179|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7
7057411|NCT01888432|11152180|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6
7057412|NCT01888432|11152179|FG000|24-month Analysis (FAS)|Death|8
7057413|NCT01888432|11152180|FG001|24-month Analysis (FAS)|Death|4
7057414|NCT01888432|11152179|FG000|36-month Analysis (Extension)|Death|1
7057415|NCT01888432|11152180|FG001|36-month Analysis (Extension)|Death|0
7057416|NCT01888497|11152196|FG000|Washout Period 1|Withdrawal by Subject|0
7057417|NCT01888497|11152197|FG001|Washout Period 1|Withdrawal by Subject|0
7057418|NCT01888497|11152198|FG002|Washout Period 1|Withdrawal by Subject|1
7057419|NCT01888497|11152199|FG003|Washout Period 1|Withdrawal by Subject|1
7057420|NCT01888497|11152196|FG000|Washout Period 2|Adverse Event|0
7057421|NCT01888497|11152197|FG001|Washout Period 2|Adverse Event|0
7057422|NCT01888497|11152198|FG002|Washout Period 2|Adverse Event|0
7057423|NCT01888497|11152199|FG003|Washout Period 2|Adverse Event|1
7057424|NCT01888497|11152196|FG000|Washout Period 2|Withdrawal by Subject|0
7057425|NCT01888497|11152197|FG001|Washout Period 2|Withdrawal by Subject|0
7057426|NCT01888497|11152198|FG002|Washout Period 2|Withdrawal by Subject|0
7057427|NCT01888497|11152199|FG003|Washout Period 2|Withdrawal by Subject|1
7057428|NCT01888640|11152212|FG000|Overall Study|Lost to Follow-up|1
7057429|NCT01888640|11152213|FG001|Overall Study|Lost to Follow-up|2
7057430|NCT01888640|11152214|FG002|Overall Study|Lost to Follow-up|0
7057431|NCT01888640|11152212|FG000|Overall Study|Withdrawal by Subject|15
7057432|NCT01888640|11152213|FG001|Overall Study|Withdrawal by Subject|11
7057433|NCT01888640|11152214|FG002|Overall Study|Withdrawal by Subject|4
7057434|NCT01888640|11152212|FG000|Overall Study|Minimum dose not met|10
7057435|NCT01888640|11152213|FG001|Overall Study|Minimum dose not met|16
7057436|NCT01888640|11152214|FG002|Overall Study|Minimum dose not met|0
7057437|NCT01888640|11152212|FG000|Overall Study|Given wrong unit (placebo)|1
7057438|NCT01888640|11152213|FG001|Overall Study|Given wrong unit (placebo)|0
7057439|NCT01888640|11152214|FG002|Overall Study|Given wrong unit (placebo)|0
7057440|NCT01888640|11152212|FG000|Overall Study|Excluded for prior TENS|0
7057441|NCT01888640|11152213|FG001|Overall Study|Excluded for prior TENS|1
7057442|NCT01888640|11152214|FG002|Overall Study|Excluded for prior TENS|0
7057443|NCT01888640|11152212|FG000|Overall Study|Researcher Termination of Participant|0
7057444|NCT01888640|11152213|FG001|Overall Study|Researcher Termination of Participant|1
7057445|NCT01888640|11152214|FG002|Overall Study|Researcher Termination of Participant|1
7057446|NCT01888874|11152232|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
7057447|NCT01888874|11152233|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
7057448|NCT01888874|11152234|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3
7057449|NCT01888874|11152235|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4
7057450|NCT01888874|11152236|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3
7057451|NCT01888874|11152237|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0
7057452|NCT01888874|11152238|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0
7057453|NCT01888874|11152232|FG000|Period 1 (Baseline up to Week 12)|Other|1
7057454|NCT01888874|11152233|FG001|Period 1 (Baseline up to Week 12)|Other|0
7057455|NCT01888874|11152234|FG002|Period 1 (Baseline up to Week 12)|Other|1
7057456|NCT01888874|11152235|FG003|Period 1 (Baseline up to Week 12)|Other|1
7057457|NCT01888874|11152236|FG004|Period 1 (Baseline up to Week 12)|Other|3
7057458|NCT01888874|11152237|FG005|Period 1 (Baseline up to Week 12)|Other|3
7057459|NCT01888874|11152238|FG006|Period 1 (Baseline up to Week 12)|Other|0
7057460|NCT01888874|11152232|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0
7057461|NCT01888874|11152233|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0
7057462|NCT01888874|11152234|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0
7057463|NCT01888874|11152235|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0
7057464|NCT01888874|11152236|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0
7057465|NCT01888874|11152237|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0
7057466|NCT01888874|11152238|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1
7057467|NCT01888874|11152232|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0
7057468|NCT01888874|11152233|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2
7057469|NCT01888874|11152234|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3
7057470|NCT01888874|11152235|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1
7057471|NCT01888874|11152236|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2
7057472|NCT01888874|11152237|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1
7057473|NCT01888874|11152238|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0
7057474|NCT01888874|11152232|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
7057475|NCT01888874|11152233|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
7057476|NCT01888874|11152234|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
7057477|NCT01888874|11152235|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
7057478|NCT01888874|11152236|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1
7057479|NCT01888874|11152237|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
7057480|NCT01888874|11152238|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
7057481|NCT01888874|11152232|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
7057482|NCT01888874|11152233|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1
7057483|NCT01888874|11152234|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
7057484|NCT01888874|11152235|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
7057485|NCT01888874|11152236|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
7057486|NCT01888874|11152237|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
7057487|NCT01888874|11152238|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
7057488|NCT01888874|11152232|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
7057489|NCT01888874|11152233|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1
7057490|NCT01888874|11152234|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
7057491|NCT01888874|11152235|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
7057492|NCT01888874|11152236|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
7057493|NCT01888874|11152237|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1
7057494|NCT01888874|11152238|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
7057495|NCT01888874|11152232|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1
7057496|NCT01888874|11152233|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1
7057497|NCT01888874|11152234|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2
7057498|NCT01888874|11152235|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
7057499|NCT01888874|11152236|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1
7057500|NCT01888874|11152237|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
7057501|NCT01888874|11152238|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
7057502|NCT01888874|11152232|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
7057503|NCT01888874|11152233|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
7057504|NCT01888874|11152234|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
7057505|NCT01888874|11152235|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
7057506|NCT01888874|11152236|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1
7057507|NCT01888874|11152237|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
7057508|NCT01888874|11152238|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
7057509|NCT01888874|11152232|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
7057510|NCT01888874|11152233|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
7057511|NCT01888874|11152234|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2
7085723|NCT02182440|11198993|FG003|Overall Study|Withdrawal by Subject|4
7085724|NCT02182440|11198990|FG000|Overall Study|different, e.g adm other hospital|12
7085725|NCT02182440|11198991|FG001|Overall Study|different, e.g adm other hospital|3
7085726|NCT02182440|11198992|FG002|Overall Study|different, e.g adm other hospital|3
7085727|NCT02182440|11198993|FG003|Overall Study|different, e.g adm other hospital|10
7085728|NCT02182830|11199020|FG000|Overall Study|Not Treated|1
7085729|NCT02182830|11199021|FG001|Overall Study|Not Treated|1
7085730|NCT02182830|11199020|FG000|Overall Study|Trial stopped, reason missing|3
7085731|NCT02182830|11199021|FG001|Overall Study|Trial stopped, reason missing|3
7085732|NCT02182830|11199020|FG000|Overall Study|Consent withdrawn|8
7085733|NCT02182830|11199021|FG001|Overall Study|Consent withdrawn|8
7085734|NCT02182830|11199020|FG000|Overall Study|Lost to Follow-up|3
7085735|NCT02182830|11199021|FG001|Overall Study|Lost to Follow-up|3
7085736|NCT02182843|11199027|FG000|Overall Study|Withdrawal by Subject|7
7085737|NCT02182843|11199027|FG000|Overall Study|Lost to Follow-up|2
7085738|NCT02182843|11199027|FG000|Overall Study|Adverse Event|1
7085739|NCT02182895|11199033|FG000|Overall Study|Discharged from hospital within 24 hours|2
7085740|NCT02182895|11199034|FG001|Overall Study|Discharged from hospital within 24 hours|4
7085741|NCT02182947|11199040|FG000|Overall Study|Withdrawal by Subject|7
7085742|NCT02182947|11199040|FG000|Overall Study|Lost to Follow-up|3
7085743|NCT02182947|11199040|FG000|Overall Study|Failed screening activities|8
7085744|NCT02182973|11199046|FG000|Overall Study|Withdrawal by Subject|3
7085745|NCT02182973|11199047|FG001|Overall Study|Withdrawal by Subject|0
7085746|NCT02182999|11199056|FG000|Overall Study|Adverse Event|4
7085747|NCT02182999|11199057|FG001|Overall Study|Adverse Event|3
7085748|NCT02182999|11199056|FG000|Overall Study|Physician Decision|1
7085749|NCT02182999|11199057|FG001|Overall Study|Physician Decision|0
7085750|NCT02183519|11199065|FG000|Overall Study|computer error|3
7085751|NCT02183519|11199066|FG001|Overall Study|computer error|0
7085752|NCT02183519|11199065|FG000|Overall Study|Did not respond to cough inducter|0
7085753|NCT02183519|11199066|FG001|Overall Study|Did not respond to cough inducter|3
7085754|NCT02183675|11199078|FG000|Treatment Period 2 (10 Days)|Adverse Event|0
7057512|NCT01888874|11152235|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
7057513|NCT01888874|11152236|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
7057514|NCT01888874|11152237|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1
7057515|NCT01888874|11152238|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
7057516|NCT01888874|11152232|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0
7057517|NCT01888874|11152233|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0
7057518|NCT01888874|11152234|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1
7057519|NCT01888874|11152235|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0
7057520|NCT01888874|11152236|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0
7057521|NCT01888874|11152237|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0
7057522|NCT01888874|11152238|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0
7057523|NCT01888874|11152232|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2
7057524|NCT01888874|11152233|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0
7057525|NCT01888874|11152234|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3
7057526|NCT01888874|11152235|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2
7057527|NCT01888874|11152236|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1
7057528|NCT01888874|11152237|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1
7057529|NCT01888874|11152238|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3
7057530|NCT01888874|11152232|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
7057531|NCT01888874|11152233|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1
7057532|NCT01888874|11152234|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
7057533|NCT01888874|11152235|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
7057534|NCT01888874|11152236|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
7057535|NCT01888874|11152237|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1
7057536|NCT01888874|11152238|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
7057537|NCT01888900|11152257|FG000|Overall Study|failed treatment|0
7057538|NCT01888900|11152258|FG001|Overall Study|failed treatment|2
7057539|NCT01888965|11152270|FG000|Overall Study|Adverse Event|5
7057540|NCT01888965|11152270|FG000|Overall Study|Lack of Efficacy|4
7057541|NCT01889069|11152276|FG000|Overall Study|Death|18
7057542|NCT01889069|11152276|FG000|Overall Study|Progression of Disease|14
7057543|NCT01889069|11152276|FG000|Overall Study|Lost to Follow-up|6
7057544|NCT01889069|11152276|FG000|Overall Study|Other|4
7057545|NCT01889069|11152276|FG000|Overall Study|Consent Withdrawal|3
7057546|NCT01889251|11152288|FG000|Overall Study|Adverse Event|1
7057547|NCT01889251|11152289|FG001|Overall Study|Adverse Event|0
7057548|NCT01889602|11152311|FG000|First Intervention|Adverse Event|1
7057549|NCT01889602|11152312|FG001|First Intervention|Adverse Event|1
7057550|NCT01889602|11152313|FG002|First Intervention|Adverse Event|1
7057551|NCT01889602|11152311|FG000|First Intervention|Protocol Violation|0
7057552|NCT01889602|11152312|FG001|First Intervention|Protocol Violation|1
7057553|NCT01889602|11152313|FG002|First Intervention|Protocol Violation|1
7057554|NCT01889602|11152311|FG000|First Intervention|Study ending|0
7057555|NCT01889602|11152312|FG001|First Intervention|Study ending|1
7057556|NCT01889602|11152313|FG002|First Intervention|Study ending|0
7057557|NCT01889602|11152311|FG000|Second Intervention|Adverse Event|0
7057558|NCT01889602|11152312|FG001|Second Intervention|Adverse Event|0
7085755|NCT02183675|11199079|FG001|Treatment Period 2 (10 Days)|Adverse Event|0
7085756|NCT02183675|11199080|FG002|Treatment Period 2 (10 Days)|Adverse Event|0
7085757|NCT02183675|11199081|FG003|Treatment Period 2 (10 Days)|Adverse Event|0
7085758|NCT02183675|11199082|FG004|Treatment Period 2 (10 Days)|Adverse Event|0
7085759|NCT02183675|11199083|FG005|Treatment Period 2 (10 Days)|Adverse Event|2
7085760|NCT02184143|11199104|FG000|Overall Study|Withdrawal by Subject|4
7085761|NCT02184143|11199105|FG001|Overall Study|Withdrawal by Subject|4
7085762|NCT02184143|11199104|FG000|Overall Study|Lost to Follow-up|5
7085763|NCT02184143|11199105|FG001|Overall Study|Lost to Follow-up|3
7085764|NCT02184143|11199104|FG000|Overall Study|Death|1
7085765|NCT02184143|11199105|FG001|Overall Study|Death|0
7085766|NCT02184442|11199132|FG000|Overall Study|Death|61
7085767|NCT02184442|11199133|FG001|Overall Study|Death|65
7085768|NCT02184442|11199132|FG000|Overall Study|Withdrawal by Subject|3
7085769|NCT02184442|11199133|FG001|Overall Study|Withdrawal by Subject|11
7057559|NCT01889602|11152313|FG002|Second Intervention|Adverse Event|1
7057560|NCT01889602|11152311|FG000|Second Intervention|Study ending|1
7057561|NCT01889602|11152312|FG001|Second Intervention|Study ending|0
7057562|NCT01889602|11152313|FG002|Second Intervention|Study ending|0
7057563|NCT01889602|11152311|FG000|Second Intervention|Withdrawal by Subject|0
7057564|NCT01889602|11152312|FG001|Second Intervention|Withdrawal by Subject|0
7057565|NCT01889602|11152313|FG002|Second Intervention|Withdrawal by Subject|1
7057566|NCT01889602|11152311|FG000|Third Intervention|Protocol Violation|1
7057567|NCT01889602|11152312|FG001|Third Intervention|Protocol Violation|0
7057568|NCT01889602|11152313|FG002|Third Intervention|Protocol Violation|0
7057569|NCT01889602|11152311|FG000|Third Intervention|Withdrawal by Subject|2
7057570|NCT01889602|11152312|FG001|Third Intervention|Withdrawal by Subject|2
7057571|NCT01889602|11152313|FG002|Third Intervention|Withdrawal by Subject|0
7057572|NCT01889862|11152353|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4
7057573|NCT01889862|11152354|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0
7057574|NCT01889862|11152355|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0
7057575|NCT01889862|11152356|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0
7057576|NCT01889862|11152357|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0
7057577|NCT01889862|11152353|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2
7057578|NCT01889862|11152354|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0
7057579|NCT01889862|11152355|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0
7057580|NCT01889862|11152356|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0
7057581|NCT01889862|11152357|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0
7057582|NCT01889862|11152353|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4
7057583|NCT01889862|11152354|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0
7057584|NCT01889862|11152355|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0
7057585|NCT01889862|11152356|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0
7057586|NCT01889862|11152357|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0
7057587|NCT01889862|11152353|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2
7057588|NCT01889862|11152354|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0
7057589|NCT01889862|11152355|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0
7057590|NCT01889862|11152356|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0
7057591|NCT01889862|11152357|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0
7057592|NCT01889862|11152353|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0
7057593|NCT01889862|11152354|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0
7057594|NCT01889862|11152355|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1
7057595|NCT01889862|11152356|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0
7057596|NCT01889862|11152357|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0
7057597|NCT01889862|11152353|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0
7057598|NCT01889862|11152354|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0
7057599|NCT01889862|11152355|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0
7057600|NCT01889862|11152356|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0
7057601|NCT01889862|11152357|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5
7057602|NCT01889862|11152353|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0
7057603|NCT01889862|11152354|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0
7057604|NCT01889862|11152355|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0
7057605|NCT01889862|11152356|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0
7057606|NCT01889862|11152357|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14
7057607|NCT01889862|11152353|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0
7057608|NCT01889862|11152354|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0
7057609|NCT01889862|11152355|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0
7057610|NCT01889862|11152356|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0
7057611|NCT01889862|11152357|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4
7057612|NCT01889862|11152353|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0
7057613|NCT01889862|11152354|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0
7057614|NCT01889862|11152355|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0
7057615|NCT01889862|11152356|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0
7057616|NCT01889862|11152357|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5
7057617|NCT01889862|11152353|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0
7057618|NCT01889862|11152354|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0
7057619|NCT01889862|11152355|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0
7057620|NCT01889862|11152356|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0
7057621|NCT01889862|11152357|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2
7057622|NCT01890109|11152405|FG000|Overall Study|Withdrawal by Subject|0
7057623|NCT01890109|11152406|FG001|Overall Study|Withdrawal by Subject|3
7057624|NCT01890109|11152405|FG000|Overall Study|Lost to Follow-up|1
7057625|NCT01890109|11152406|FG001|Overall Study|Lost to Follow-up|2
7057626|NCT01890122|11152417|FG000|Overall Study|Adverse Event|1
7057627|NCT01890122|11152418|FG001|Overall Study|Adverse Event|1
7057628|NCT01890122|11152419|FG002|Overall Study|Adverse Event|1
7057629|NCT01890122|11152420|FG003|Overall Study|Adverse Event|2
7057630|NCT01890122|11152417|FG000|Overall Study|Major Protocol Deviation|3
7057631|NCT01890122|11152418|FG001|Overall Study|Major Protocol Deviation|1
7057632|NCT01890122|11152419|FG002|Overall Study|Major Protocol Deviation|0
7057633|NCT01890122|11152420|FG003|Overall Study|Major Protocol Deviation|1
7057634|NCT01890122|11152417|FG000|Overall Study|Lost to Follow-up|0
7057635|NCT01890122|11152418|FG001|Overall Study|Lost to Follow-up|1
7057636|NCT01890122|11152419|FG002|Overall Study|Lost to Follow-up|2
7057637|NCT01890122|11152420|FG003|Overall Study|Lost to Follow-up|2
7057638|NCT01890122|11152417|FG000|Overall Study|Voluntary Withdrawal|8
7057639|NCT01890122|11152418|FG001|Overall Study|Voluntary Withdrawal|8
7057640|NCT01890122|11152419|FG002|Overall Study|Voluntary Withdrawal|2
7057641|NCT01890122|11152420|FG003|Overall Study|Voluntary Withdrawal|11
7057642|NCT01890122|11152417|FG000|Overall Study|Lack of Efficacy|14
7057643|NCT01890122|11152418|FG001|Overall Study|Lack of Efficacy|24
7057644|NCT01890122|11152419|FG002|Overall Study|Lack of Efficacy|7
7057645|NCT01890122|11152420|FG003|Overall Study|Lack of Efficacy|41
7057646|NCT01890122|11152417|FG000|Overall Study|Reason not Specified|0
7057647|NCT01890122|11152418|FG001|Overall Study|Reason not Specified|1
7057648|NCT01890122|11152419|FG002|Overall Study|Reason not Specified|1
7057649|NCT01890122|11152420|FG003|Overall Study|Reason not Specified|2
7057650|NCT01890122|11152417|FG000|Overall Study|Randomized but not Treated|1
7057651|NCT01890122|11152418|FG001|Overall Study|Randomized but not Treated|1
7057652|NCT01890122|11152419|FG002|Overall Study|Randomized but not Treated|0
7057653|NCT01890122|11152420|FG003|Overall Study|Randomized but not Treated|0
7057654|NCT01890148|11152430|FG000|Overall Study|Adverse Event|1
7057655|NCT01890265|11152449|FG000|Overall Study|Other (Unspecified reason)|0
7057656|NCT01890265|11152450|FG001|Overall Study|Other (Unspecified reason)|1
7057657|NCT01890265|11152451|FG002|Overall Study|Other (Unspecified reason)|0
7057658|NCT01890265|11152452|FG003|Overall Study|Other (Unspecified reason)|0
7057659|NCT01890265|11152453|FG004|Overall Study|Other (Unspecified reason)|0
7057660|NCT01890265|11152454|FG005|Overall Study|Other (Unspecified reason)|0
7057661|NCT01890265|11152449|FG000|Overall Study|Progressive disease|6
7057662|NCT01890265|11152450|FG001|Overall Study|Progressive disease|6
7057663|NCT01890265|11152451|FG002|Overall Study|Progressive disease|0
7057664|NCT01890265|11152452|FG003|Overall Study|Progressive disease|0
7057665|NCT01890265|11152453|FG004|Overall Study|Progressive disease|0
7057666|NCT01890265|11152454|FG005|Overall Study|Progressive disease|0
7057667|NCT01890265|11152449|FG000|Overall Study|Adverse Event|2
7057668|NCT01890265|11152450|FG001|Overall Study|Adverse Event|1
7057669|NCT01890265|11152451|FG002|Overall Study|Adverse Event|0
7057670|NCT01890265|11152452|FG003|Overall Study|Adverse Event|0
7057671|NCT01890265|11152453|FG004|Overall Study|Adverse Event|0
7057672|NCT01890265|11152454|FG005|Overall Study|Adverse Event|0
7057673|NCT01890265|11152449|FG000|Overall Study|Death|2
7057674|NCT01890265|11152450|FG001|Overall Study|Death|3
7057675|NCT01890265|11152451|FG002|Overall Study|Death|1
7057676|NCT01890265|11152452|FG003|Overall Study|Death|0
7057677|NCT01890265|11152453|FG004|Overall Study|Death|0
7057678|NCT01890265|11152454|FG005|Overall Study|Death|0
7057679|NCT01890265|11152449|FG000|Overall Study|Withdrawal by Subject|0
7057680|NCT01890265|11152450|FG001|Overall Study|Withdrawal by Subject|2
7057681|NCT01890265|11152451|FG002|Overall Study|Withdrawal by Subject|3
7057682|NCT01890265|11152452|FG003|Overall Study|Withdrawal by Subject|0
7057683|NCT01890265|11152453|FG004|Overall Study|Withdrawal by Subject|2
7057684|NCT01890265|11152454|FG005|Overall Study|Withdrawal by Subject|0
7057685|NCT01890421|11152477|FG000|Overall Study|Adverse Event|1
7057686|NCT01890421|11152477|FG000|Overall Study|Other reason|10
7057687|NCT01890434|11152481|FG000|Overall Study|Adverse Event|8
7057688|NCT01890434|11152481|FG000|Overall Study|PCI at external hospital|1
7057689|NCT01890434|11152481|FG000|Overall Study|Assessment discrepancy|1
7057690|NCT01890434|11152481|FG000|Overall Study|CRC didn't contact participant for FU|1
7057691|NCT01890434|11152481|FG000|Overall Study|Could not get whole set of images|1
7057692|NCT01890434|11152481|FG000|Overall Study|Decline to return for GSPECT|1
7057693|NCT01890434|11152481|FG000|Overall Study|GSPECT at rest was not done|1
7057694|NCT01890434|11152481|FG000|Overall Study|Participant didn't complete MRI|1
7057695|NCT01890434|11152481|FG000|Overall Study|Uncontactable by phone|1
7057696|NCT01890434|11152481|FG000|Overall Study|Moved out of position|1
7057697|NCT01890434|11152481|FG000|Overall Study|Unable to contact|1
7057698|NCT01890434|11152481|FG000|Overall Study|Withdrawal by PI for ICA not performed|2
7057699|NCT01890473|11152487|FG000|Overall Study|Lost to Follow-up|1
7057700|NCT01890473|11152488|FG001|Overall Study|Lost to Follow-up|0
7057701|NCT01890473|11152487|FG000|Overall Study|Poor/non-compliance|1
7057702|NCT01890473|11152488|FG001|Overall Study|Poor/non-compliance|0
7057703|NCT01890512|11152496|FG000|Overall Study|Physician Decision|1
7057704|NCT01890512|11152496|FG000|Overall Study|Withdrawal by Subject|1
7057705|NCT01890512|11152496|FG000|Overall Study|Protocol Violation|1
7057706|NCT01890707|11152515|FG000|Overall Study|Lost to Follow-up|1
7057707|NCT01890707|11152516|FG001|Overall Study|Lost to Follow-up|1
7057708|NCT01890746|11152524|FG000|Overall Study|Death|39
7057709|NCT01890746|11152525|FG001|Overall Study|Death|30
7057710|NCT01890746|11152524|FG000|Overall Study|Adverse Event|1
7057711|NCT01890746|11152525|FG001|Overall Study|Adverse Event|0
7057712|NCT01890746|11152524|FG000|Overall Study|Lost to Follow-up|4
7057713|NCT01890746|11152525|FG001|Overall Study|Lost to Follow-up|1
7057714|NCT01890746|11152524|FG000|Overall Study|Physician Decision|3
7057715|NCT01890746|11152525|FG001|Overall Study|Physician Decision|2
7057716|NCT01890746|11152524|FG000|Overall Study|Withdrawal by Subject|5
7057717|NCT01890746|11152525|FG001|Overall Study|Withdrawal by Subject|8
7057718|NCT01890785|11152537|FG000|Third Intervention|Withdrawal by Subject|0
7057719|NCT01890785|11152538|FG001|Third Intervention|Withdrawal by Subject|1
7057720|NCT01890785|11152539|FG002|Third Intervention|Withdrawal by Subject|0
7057721|NCT01890785|11152540|FG003|Third Intervention|Withdrawal by Subject|0
7057722|NCT01890785|11152541|FG004|Third Intervention|Withdrawal by Subject|0
7057723|NCT01890785|11152542|FG005|Third Intervention|Withdrawal by Subject|0
7057724|NCT01890915|11152553|FG000|Overall Study|Adverse Event|1
7057725|NCT01890915|11152554|FG001|Overall Study|Adverse Event|0
7057726|NCT01890915|11152553|FG000|Overall Study|Protocol Violation|2
7057727|NCT01890915|11152554|FG001|Overall Study|Protocol Violation|0
7057728|NCT01890915|11152553|FG000|Overall Study|Equipment Malfunction|0
7057729|NCT01890915|11152554|FG001|Overall Study|Equipment Malfunction|1
7057730|NCT01890967|11152575|FG000|Overall Study|Adverse Event|3
7057731|NCT01890967|11152576|FG001|Overall Study|Adverse Event|3
7057732|NCT01890967|11152577|FG002|Overall Study|Adverse Event|3
7057733|NCT01890967|11152578|FG003|Overall Study|Adverse Event|2
7057734|NCT01890967|11152579|FG004|Overall Study|Adverse Event|1
7057735|NCT01890967|11152580|FG005|Overall Study|Adverse Event|7
7085770|NCT02184455|11199139|FG000|Overall Study|Lost to Follow-up|1
7085771|NCT02184572|11199158|FG000|Overall Study|Lost to Follow-up|29
7085772|NCT02184572|11199159|FG001|Overall Study|Lost to Follow-up|21
7085773|NCT02184572|11199158|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1
7085774|NCT02184572|11199159|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0
7085775|NCT02184572|11199158|FG000|Overall Study|Loss Of Kaiser Insurance|1
7085776|NCT02184572|11199159|FG001|Overall Study|Loss Of Kaiser Insurance|0
7085777|NCT02184572|11199158|FG000|Overall Study|2nd blooddraw & diary card incomplete|1
7085778|NCT02184572|11199159|FG001|Overall Study|2nd blooddraw & diary card incomplete|0
7085779|NCT02184572|11199158|FG000|Overall Study|Traveling Outside The Country|1
7085780|NCT02184572|11199159|FG001|Overall Study|Traveling Outside The Country|0
7085781|NCT02184572|11199158|FG000|Overall Study|Withdrawal by Subject|14
7085782|NCT02184572|11199159|FG001|Overall Study|Withdrawal by Subject|9
7085783|NCT02184611|11199169|FG000|Overall Study|Lack of Efficacy|11
7085784|NCT02184611|11199170|FG001|Overall Study|Lack of Efficacy|15
7085785|NCT02184611|11199169|FG000|Overall Study|Withdrawal by Subject|5
7085786|NCT02184611|11199170|FG001|Overall Study|Withdrawal by Subject|6
7085787|NCT02184611|11199169|FG000|Overall Study|Adverse Event|4
7085788|NCT02184611|11199170|FG001|Overall Study|Adverse Event|5
7085789|NCT02184611|11199169|FG000|Overall Study|Protocol Violation|1
7085790|NCT02184611|11199170|FG001|Overall Study|Protocol Violation|1
7085791|NCT02184611|11199169|FG000|Overall Study|Protocol defined stopping criteria|0
7085792|NCT02184611|11199170|FG001|Overall Study|Protocol defined stopping criteria|1
7085793|NCT02184988|11199197|FG000|Overall Study|Pregnancy|2
7057736|NCT01890967|11152575|FG000|Overall Study|Death|1
7057737|NCT01890967|11152576|FG001|Overall Study|Death|0
7057738|NCT01890967|11152577|FG002|Overall Study|Death|0
7057739|NCT01890967|11152578|FG003|Overall Study|Death|0
7057740|NCT01890967|11152579|FG004|Overall Study|Death|0
7057741|NCT01890967|11152580|FG005|Overall Study|Death|0
7057742|NCT01890967|11152575|FG000|Overall Study|Lost to Follow-up|1
7057743|NCT01890967|11152576|FG001|Overall Study|Lost to Follow-up|1
7057744|NCT01890967|11152577|FG002|Overall Study|Lost to Follow-up|1
7057745|NCT01890967|11152578|FG003|Overall Study|Lost to Follow-up|1
7057746|NCT01890967|11152579|FG004|Overall Study|Lost to Follow-up|0
7057747|NCT01890967|11152580|FG005|Overall Study|Lost to Follow-up|1
7057748|NCT01890967|11152575|FG000|Overall Study|Protocol Violation|0
7057749|NCT01890967|11152576|FG001|Overall Study|Protocol Violation|3
7057750|NCT01890967|11152577|FG002|Overall Study|Protocol Violation|3
7057751|NCT01890967|11152578|FG003|Overall Study|Protocol Violation|2
7057752|NCT01890967|11152579|FG004|Overall Study|Protocol Violation|4
7057753|NCT01890967|11152580|FG005|Overall Study|Protocol Violation|1
7057754|NCT01890967|11152575|FG000|Overall Study|Sponsor Decision|2
7057755|NCT01890967|11152576|FG001|Overall Study|Sponsor Decision|0
7057756|NCT01890967|11152577|FG002|Overall Study|Sponsor Decision|1
7057757|NCT01890967|11152578|FG003|Overall Study|Sponsor Decision|3
7057758|NCT01890967|11152579|FG004|Overall Study|Sponsor Decision|2
7057759|NCT01890967|11152580|FG005|Overall Study|Sponsor Decision|3
7057760|NCT01890967|11152575|FG000|Overall Study|Withdrawal by Subject|3
7057761|NCT01890967|11152576|FG001|Overall Study|Withdrawal by Subject|4
7057762|NCT01890967|11152577|FG002|Overall Study|Withdrawal by Subject|2
7057763|NCT01890967|11152578|FG003|Overall Study|Withdrawal by Subject|3
7057764|NCT01890967|11152579|FG004|Overall Study|Withdrawal by Subject|3
7057765|NCT01890967|11152580|FG005|Overall Study|Withdrawal by Subject|1
7057766|NCT01891357|11152633|FG000|Overall Study|Protocol Violation|3
7057767|NCT01891669|11152647|FG000|Overall Study|Death|0
7057768|NCT01891669|11152648|FG001|Overall Study|Death|0
7057769|NCT01891669|11152649|FG002|Overall Study|Death|0
7057770|NCT01891669|11152650|FG003|Overall Study|Death|0
7057771|NCT01891669|11152651|FG004|Overall Study|Death|0
7057772|NCT01891669|11152652|FG005|Overall Study|Death|0
7057773|NCT01891669|11152653|FG006|Overall Study|Death|0
7057774|NCT01891669|11152654|FG007|Overall Study|Death|1
7057775|NCT01891669|11152655|FG008|Overall Study|Death|0
7057776|NCT01891669|11152656|FG009|Overall Study|Death|1
7057777|NCT01891669|11152647|FG000|Overall Study|Withdrawal by Subject|1
7057778|NCT01891669|11152648|FG001|Overall Study|Withdrawal by Subject|1
7057779|NCT01891669|11152649|FG002|Overall Study|Withdrawal by Subject|0
7057780|NCT01891669|11152650|FG003|Overall Study|Withdrawal by Subject|0
7057781|NCT01891669|11152651|FG004|Overall Study|Withdrawal by Subject|0
7057782|NCT01891669|11152652|FG005|Overall Study|Withdrawal by Subject|0
7057783|NCT01891669|11152653|FG006|Overall Study|Withdrawal by Subject|1
7057784|NCT01891669|11152654|FG007|Overall Study|Withdrawal by Subject|2
7057785|NCT01891669|11152655|FG008|Overall Study|Withdrawal by Subject|1
7057786|NCT01891669|11152656|FG009|Overall Study|Withdrawal by Subject|1
7057787|NCT01891669|11152647|FG000|Overall Study|Other|1
7057788|NCT01891669|11152648|FG001|Overall Study|Other|0
7057789|NCT01891669|11152649|FG002|Overall Study|Other|0
7057790|NCT01891669|11152650|FG003|Overall Study|Other|0
7057791|NCT01891669|11152651|FG004|Overall Study|Other|0
7057792|NCT01891669|11152652|FG005|Overall Study|Other|0
7057793|NCT01891669|11152653|FG006|Overall Study|Other|0
7057794|NCT01891669|11152654|FG007|Overall Study|Other|1
7057795|NCT01891669|11152655|FG008|Overall Study|Other|0
7057796|NCT01891669|11152656|FG009|Overall Study|Other|0
7057797|NCT01891721|11152690|FG000|Overall Study|Lost to Follow-up|10
7057798|NCT01891721|11152691|FG001|Overall Study|Lost to Follow-up|5
7057799|NCT01891721|11152692|FG002|Overall Study|Lost to Follow-up|1
7057800|NCT01891864|11152713|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1
7057801|NCT01891864|11152714|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1
7057802|NCT01891864|11152715|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0
7057803|NCT01891864|11152716|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0
7057804|NCT01891864|11152717|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0
7057805|NCT01891864|11152718|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0
7057806|NCT01891864|11152713|FG000|Treatment Period 1|Physician Decision|0
7057807|NCT01891864|11152714|FG001|Treatment Period 1|Physician Decision|1
7057808|NCT01891864|11152715|FG002|Treatment Period 1|Physician Decision|0
7057809|NCT01891864|11152716|FG003|Treatment Period 1|Physician Decision|0
7057810|NCT01891864|11152717|FG004|Treatment Period 1|Physician Decision|0
7057811|NCT01891864|11152718|FG005|Treatment Period 1|Physician Decision|0
7057812|NCT01891864|11152713|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0
7057813|NCT01891864|11152714|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1
7057814|NCT01891864|11152715|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0
7057815|NCT01891864|11152716|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0
7057816|NCT01891864|11152717|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0
7057817|NCT01891864|11152718|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0
7057818|NCT01891864|11152713|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4
7057819|NCT01891864|11152714|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4
7057820|NCT01891864|11152715|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0
7057821|NCT01891864|11152716|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0
7057822|NCT01891864|11152717|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0
7057823|NCT01891864|11152718|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0
7057824|NCT01891864|11152713|FG000|Treatment Period 1|Withdrawal by Subject|2
7057825|NCT01891864|11152714|FG001|Treatment Period 1|Withdrawal by Subject|5
7057826|NCT01891864|11152715|FG002|Treatment Period 1|Withdrawal by Subject|0
7057827|NCT01891864|11152716|FG003|Treatment Period 1|Withdrawal by Subject|0
7057828|NCT01891864|11152717|FG004|Treatment Period 1|Withdrawal by Subject|0
7057829|NCT01891864|11152718|FG005|Treatment Period 1|Withdrawal by Subject|0
7057830|NCT01891864|11152713|FG000|Treatment Period 1|Lost to Follow-up|1
7057831|NCT01891864|11152714|FG001|Treatment Period 1|Lost to Follow-up|0
7057832|NCT01891864|11152715|FG002|Treatment Period 1|Lost to Follow-up|0
7057833|NCT01891864|11152716|FG003|Treatment Period 1|Lost to Follow-up|0
7057834|NCT01891864|11152717|FG004|Treatment Period 1|Lost to Follow-up|0
7057835|NCT01891864|11152718|FG005|Treatment Period 1|Lost to Follow-up|0
7057836|NCT01891864|11152713|FG000|Treatment Period 2|Protocol Violation|0
7057837|NCT01891864|11152714|FG001|Treatment Period 2|Protocol Violation|0
7057838|NCT01891864|11152715|FG002|Treatment Period 2|Protocol Violation|0
7057839|NCT01891864|11152716|FG003|Treatment Period 2|Protocol Violation|1
7057840|NCT01891864|11152717|FG004|Treatment Period 2|Protocol Violation|0
7057841|NCT01891864|11152718|FG005|Treatment Period 2|Protocol Violation|0
7057842|NCT01891864|11152713|FG000|Treatment Period 2|Physician Decision|0
7057843|NCT01891864|11152714|FG001|Treatment Period 2|Physician Decision|0
7057844|NCT01891864|11152715|FG002|Treatment Period 2|Physician Decision|1
7057845|NCT01891864|11152716|FG003|Treatment Period 2|Physician Decision|0
7057846|NCT01891864|11152717|FG004|Treatment Period 2|Physician Decision|0
7057847|NCT01891864|11152718|FG005|Treatment Period 2|Physician Decision|0
7057848|NCT01891864|11152713|FG000|Treatment Period 2|Site Termination|0
7057849|NCT01891864|11152714|FG001|Treatment Period 2|Site Termination|0
7057850|NCT01891864|11152715|FG002|Treatment Period 2|Site Termination|1
7057851|NCT01891864|11152716|FG003|Treatment Period 2|Site Termination|2
7057852|NCT01891864|11152717|FG004|Treatment Period 2|Site Termination|0
7057853|NCT01891864|11152718|FG005|Treatment Period 2|Site Termination|0
7057854|NCT01891864|11152713|FG000|Treatment Period 2|Lack of Efficacy|0
7057855|NCT01891864|11152714|FG001|Treatment Period 2|Lack of Efficacy|0
7057856|NCT01891864|11152715|FG002|Treatment Period 2|Lack of Efficacy|1
7057857|NCT01891864|11152716|FG003|Treatment Period 2|Lack of Efficacy|0
7057858|NCT01891864|11152717|FG004|Treatment Period 2|Lack of Efficacy|1
7057859|NCT01891864|11152718|FG005|Treatment Period 2|Lack of Efficacy|0
7057860|NCT01891864|11152713|FG000|Treatment Period 2|Adverse Event|0
7057861|NCT01891864|11152714|FG001|Treatment Period 2|Adverse Event|0
7057862|NCT01891864|11152715|FG002|Treatment Period 2|Adverse Event|1
7057863|NCT01891864|11152716|FG003|Treatment Period 2|Adverse Event|2
7057864|NCT01891864|11152717|FG004|Treatment Period 2|Adverse Event|0
7057865|NCT01891864|11152718|FG005|Treatment Period 2|Adverse Event|4
7057866|NCT01891864|11152713|FG000|Treatment Period 2|Termination of Site|0
7057867|NCT01891864|11152714|FG001|Treatment Period 2|Termination of Site|0
7057868|NCT01891864|11152715|FG002|Treatment Period 2|Termination of Site|0
7057869|NCT01891864|11152716|FG003|Treatment Period 2|Termination of Site|0
7057870|NCT01891864|11152717|FG004|Treatment Period 2|Termination of Site|2
7057871|NCT01891864|11152718|FG005|Treatment Period 2|Termination of Site|0
7057872|NCT01891864|11152713|FG000|Treatment Period 2|Withdrawal by Subject|0
7057873|NCT01891864|11152714|FG001|Treatment Period 2|Withdrawal by Subject|0
7057874|NCT01891864|11152715|FG002|Treatment Period 2|Withdrawal by Subject|3
7057875|NCT01891864|11152716|FG003|Treatment Period 2|Withdrawal by Subject|4
7057876|NCT01891864|11152717|FG004|Treatment Period 2|Withdrawal by Subject|1
7057877|NCT01891864|11152718|FG005|Treatment Period 2|Withdrawal by Subject|1
7057878|NCT01891864|11152713|FG000|Extension Period|Lack of Efficacy|0
7057879|NCT01891864|11152714|FG001|Extension Period|Lack of Efficacy|0
7057880|NCT01891864|11152715|FG002|Extension Period|Lack of Efficacy|0
7057881|NCT01891864|11152716|FG003|Extension Period|Lack of Efficacy|1
7057882|NCT01891864|11152717|FG004|Extension Period|Lack of Efficacy|1
7057883|NCT01891864|11152718|FG005|Extension Period|Lack of Efficacy|0
7057884|NCT01891864|11152713|FG000|Extension Period|Pregnancy|0
7057885|NCT01891864|11152714|FG001|Extension Period|Pregnancy|0
7057886|NCT01891864|11152715|FG002|Extension Period|Pregnancy|1
7057887|NCT01891864|11152716|FG003|Extension Period|Pregnancy|0
7057888|NCT01891864|11152717|FG004|Extension Period|Pregnancy|0
7057889|NCT01891864|11152718|FG005|Extension Period|Pregnancy|0
7057890|NCT01891864|11152713|FG000|Extension Period|Adverse Event|0
7057891|NCT01891864|11152714|FG001|Extension Period|Adverse Event|0
7057892|NCT01891864|11152715|FG002|Extension Period|Adverse Event|4
7057893|NCT01891864|11152716|FG003|Extension Period|Adverse Event|2
7057894|NCT01891864|11152717|FG004|Extension Period|Adverse Event|2
7057895|NCT01891864|11152718|FG005|Extension Period|Adverse Event|0
7057896|NCT01891864|11152713|FG000|Extension Period|Withdrawal by Subject|0
7057897|NCT01891864|11152714|FG001|Extension Period|Withdrawal by Subject|0
7057898|NCT01891864|11152715|FG002|Extension Period|Withdrawal by Subject|1
7057899|NCT01891864|11152716|FG003|Extension Period|Withdrawal by Subject|2
7057900|NCT01891864|11152717|FG004|Extension Period|Withdrawal by Subject|4
7057901|NCT01891864|11152718|FG005|Extension Period|Withdrawal by Subject|0
7057902|NCT01891864|11152713|FG000|Extension Period|Lost to Follow-up|0
7057903|NCT01891864|11152714|FG001|Extension Period|Lost to Follow-up|0
7057904|NCT01891864|11152715|FG002|Extension Period|Lost to Follow-up|2
7057905|NCT01891864|11152716|FG003|Extension Period|Lost to Follow-up|0
7057906|NCT01891864|11152717|FG004|Extension Period|Lost to Follow-up|0
7057907|NCT01891864|11152718|FG005|Extension Period|Lost to Follow-up|0
7057908|NCT01891890|11152733|FG000|Overall Study|Lost to Follow-up|0
7057909|NCT01891890|11152734|FG001|Overall Study|Lost to Follow-up|0
7057910|NCT01891890|11152735|FG002|Overall Study|Lost to Follow-up|1
7057911|NCT01891890|11152733|FG000|Overall Study|Study ended before endpoint reached|7
7057912|NCT01891890|11152734|FG001|Overall Study|Study ended before endpoint reached|3
7057913|NCT01891890|11152735|FG002|Overall Study|Study ended before endpoint reached|6
7057914|NCT01892020|11152756|FG000|Period 1|Adverse Event|1
7057915|NCT01892020|11152757|FG001|Period 1|Adverse Event|1
7057916|NCT01892020|11152756|FG000|Period 1|Protocol Violation|2
7057917|NCT01892020|11152757|FG001|Period 1|Protocol Violation|4
7057918|NCT01892020|11152756|FG000|Period 1|Unclassified|0
7057919|NCT01892020|11152757|FG001|Period 1|Unclassified|1
7057920|NCT01892020|11152756|FG000|Period 2|Protocol Violation|1
7057921|NCT01892020|11152757|FG001|Period 2|Protocol Violation|0
7057922|NCT01892163|11152765|FG000|Overall Study|Death|1
7057923|NCT01892163|11152766|FG001|Overall Study|Death|1
7057924|NCT01892163|11152765|FG000|Overall Study|Lost to Follow-up|1
7057925|NCT01892163|11152766|FG001|Overall Study|Lost to Follow-up|0
7057926|NCT01892189|11152781|FG000|Washout Period 1 (7 Days)|Adverse Event|0
7057927|NCT01892189|11152782|FG001|Washout Period 1 (7 Days)|Adverse Event|0
7057928|NCT01892189|11152783|FG002|Washout Period 1 (7 Days)|Adverse Event|0
7057929|NCT01892189|11152784|FG003|Washout Period 1 (7 Days)|Adverse Event|0
7057930|NCT01892189|11152785|FG004|Washout Period 1 (7 Days)|Adverse Event|0
7057931|NCT01892189|11152786|FG005|Washout Period 1 (7 Days)|Adverse Event|0
7057932|NCT01892189|11152787|FG006|Washout Period 1 (7 Days)|Adverse Event|0
7057933|NCT01892189|11152788|FG007|Washout Period 1 (7 Days)|Adverse Event|0
7057934|NCT01892189|11152789|FG008|Washout Period 1 (7 Days)|Adverse Event|1
7057935|NCT01892189|11152781|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7057936|NCT01892189|11152782|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7057937|NCT01892189|11152783|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2
7057938|NCT01892189|11152784|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1
7057939|NCT01892189|11152785|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7057940|NCT01892189|11152786|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7057941|NCT01892189|11152787|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1
7057942|NCT01892189|11152788|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7057943|NCT01892189|11152789|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1
7057944|NCT01892189|11152781|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
7057945|NCT01892189|11152782|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
7057946|NCT01892189|11152783|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
7057947|NCT01892189|11152784|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
7057948|NCT01892189|11152785|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
7057949|NCT01892189|11152786|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1
7057950|NCT01892189|11152787|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
7057951|NCT01892189|11152788|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
7057952|NCT01892189|11152789|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
7057953|NCT01892293|11152813|FG000|Overall Study|Apheresed but not treated|4
7057954|NCT01892345|11152828|FG000|Overall Study|Adverse Event|0
7057955|NCT01892345|11152829|FG001|Overall Study|Adverse Event|2
7057956|NCT01892345|11152828|FG000|Overall Study|Death|1
7057957|NCT01892345|11152829|FG001|Overall Study|Death|0
7057958|NCT01892345|11152828|FG000|Overall Study|Lost to Follow-up|3
7057959|NCT01892345|11152829|FG001|Overall Study|Lost to Follow-up|0
7057960|NCT01892345|11152828|FG000|Overall Study|Withdrawal by Subject|12
7057961|NCT01892345|11152829|FG001|Overall Study|Withdrawal by Subject|1
7057962|NCT01892436|11152839|FG000|Overall Study|Withdrawal by Subject|8
7057963|NCT01892436|11152840|FG001|Overall Study|Withdrawal by Subject|15
7057964|NCT01892436|11152841|FG002|Overall Study|Withdrawal by Subject|4
7057965|NCT01892436|11152842|FG003|Overall Study|Withdrawal by Subject|4
7057966|NCT01892436|11152839|FG000|Overall Study|Death|1
7057967|NCT01892436|11152840|FG001|Overall Study|Death|1
7057968|NCT01892436|11152841|FG002|Overall Study|Death|0
7057969|NCT01892436|11152842|FG003|Overall Study|Death|0
7057970|NCT01892436|11152839|FG000|Overall Study|Physician Decision|2
7057971|NCT01892436|11152840|FG001|Overall Study|Physician Decision|1
7057972|NCT01892436|11152841|FG002|Overall Study|Physician Decision|0
7057973|NCT01892436|11152842|FG003|Overall Study|Physician Decision|1
7057974|NCT01892436|11152839|FG000|Overall Study|Pregnancy|0
7057975|NCT01892436|11152840|FG001|Overall Study|Pregnancy|2
7057976|NCT01892436|11152841|FG002|Overall Study|Pregnancy|1
7057977|NCT01892436|11152842|FG003|Overall Study|Pregnancy|0
7057978|NCT01892436|11152839|FG000|Overall Study|Technical problems|2
7057979|NCT01892436|11152840|FG001|Overall Study|Technical problems|1
7057980|NCT01892436|11152841|FG002|Overall Study|Technical problems|1
7057981|NCT01892436|11152842|FG003|Overall Study|Technical problems|1
7057982|NCT01892436|11152839|FG000|Overall Study|Lack of Efficacy|1
7057983|NCT01892436|11152840|FG001|Overall Study|Lack of Efficacy|2
7057984|NCT01892436|11152841|FG002|Overall Study|Lack of Efficacy|2
7057985|NCT01892436|11152842|FG003|Overall Study|Lack of Efficacy|2
7057986|NCT01892436|11152839|FG000|Overall Study|Lost to Follow-up|1
7057987|NCT01892436|11152840|FG001|Overall Study|Lost to Follow-up|1
7057988|NCT01892436|11152841|FG002|Overall Study|Lost to Follow-up|1
7057989|NCT01892436|11152842|FG003|Overall Study|Lost to Follow-up|3
7057990|NCT01892436|11152839|FG000|Overall Study|non-compliance with treatment|1
7057991|NCT01892436|11152840|FG001|Overall Study|non-compliance with treatment|0
7057992|NCT01892436|11152841|FG002|Overall Study|non-compliance with treatment|0
7057993|NCT01892436|11152842|FG003|Overall Study|non-compliance with treatment|0
7057994|NCT01892436|11152839|FG000|Overall Study|Adverse Event|7
7057995|NCT01892436|11152840|FG001|Overall Study|Adverse Event|6
7057996|NCT01892436|11152841|FG002|Overall Study|Adverse Event|2
7057997|NCT01892436|11152842|FG003|Overall Study|Adverse Event|3
7057998|NCT01892501|11152852|FG000|Overall Study|Protocol Violation|2
7057999|NCT01892501|11152852|FG000|Overall Study|Puncture not carried out|9
7058000|NCT01892501|11152852|FG000|Overall Study|Radiological monitoring not carried out|5
7058001|NCT01892501|11152852|FG000|Overall Study|Non-contributory histological result|12
7058002|NCT01892540|11152859|FG000|Overall Study|Did not complete PET/MRI|0
7058003|NCT01892540|11152860|FG001|Overall Study|Did not complete PET/MRI|0
7058004|NCT01892540|11152861|FG002|Overall Study|Did not complete PET/MRI|2
7058005|NCT01892540|11152859|FG000|Overall Study|Did not fit in scanner|0
7058006|NCT01892540|11152860|FG001|Overall Study|Did not fit in scanner|0
7058007|NCT01892540|11152861|FG002|Overall Study|Did not fit in scanner|1
7085794|NCT02184988|11199197|FG000|Overall Study|Adverse Event|2
7085795|NCT02184988|11199197|FG000|Overall Study|moving away/travelling/unable to complet|6
7085796|NCT02184988|11199197|FG000|Overall Study|work scheduling issues|4
7085797|NCT02184988|11199197|FG000|Overall Study|various other reasons|9
7085798|NCT02184988|11199197|FG000|Overall Study|Lost to Follow-up|32
7085799|NCT02185014|11199201|FG000|Overall Study|Adverse Event|18
7085800|NCT02185014|11199201|FG000|Overall Study|Withdrew Consent|8
7085801|NCT02185014|11199201|FG000|Overall Study|Lost to Follow-up|4
7085802|NCT02185014|11199201|FG000|Overall Study|Lack of Efficacy|14
7085803|NCT02185014|11199201|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5
7085804|NCT02185014|11199201|FG000|Overall Study|Subject Noncompliance|1
7085805|NCT02185014|11199201|FG000|Overall Study|Other|4
7085806|NCT02185040|11199210|FG000|Part 1 Treatment Phase|Miscellaneous|0
7085807|NCT02185040|11199211|FG001|Part 1 Treatment Phase|Miscellaneous|0
7085808|NCT02185040|11199212|FG002|Part 1 Treatment Phase|Miscellaneous|1
7085809|NCT02185040|11199213|FG003|Part 1 Treatment Phase|Miscellaneous|0
7058008|NCT01892657|11152869|FG000|Overall Study|Withdrawal by Subject|6
7058009|NCT01892657|11152869|FG000|Overall Study|Protocol Violation|12
7058010|NCT01893203|11152902|FG000|Overall Study|Withdrawal by Subject|1
7058011|NCT01893281|11152906|FG000|Overall Study|Adverse Event|1
7058012|NCT01893281|11152906|FG000|Overall Study|Protocol Violation|1
7058013|NCT01893281|11152906|FG000|Overall Study|Withdrawal by Subject|1
7058014|NCT01893346|11152914|FG000|Overall Study|Lost to Follow-up|0
7058015|NCT01893346|11152915|FG001|Overall Study|Lost to Follow-up|1
7058016|NCT01893346|11152916|FG002|Overall Study|Lost to Follow-up|0
7058017|NCT01893346|11152917|FG003|Overall Study|Lost to Follow-up|0
7058018|NCT01893346|11152914|FG000|Overall Study|Protocol Violation|1
7058019|NCT01893346|11152915|FG001|Overall Study|Protocol Violation|0
7058020|NCT01893346|11152916|FG002|Overall Study|Protocol Violation|0
7058021|NCT01893346|11152917|FG003|Overall Study|Protocol Violation|0
7058022|NCT01893346|11152914|FG000|Overall Study|Withdrawal by Subject|2
7058023|NCT01893346|11152915|FG001|Overall Study|Withdrawal by Subject|0
7058024|NCT01893346|11152916|FG002|Overall Study|Withdrawal by Subject|0
7058025|NCT01893346|11152917|FG003|Overall Study|Withdrawal by Subject|0
7058026|NCT01893411|11152939|FG000|Overall Study|Protocol Violation|1
7058027|NCT01893411|11152940|FG001|Overall Study|Protocol Violation|0
7058028|NCT01893411|11152941|FG002|Overall Study|Protocol Violation|0
7058029|NCT01893411|11152939|FG000|Overall Study|Physician Decision|1
7058030|NCT01893411|11152940|FG001|Overall Study|Physician Decision|1
7058031|NCT01893411|11152941|FG002|Overall Study|Physician Decision|2
7058032|NCT01893411|11152939|FG000|Overall Study|Lack of Efficacy|2
7058033|NCT01893411|11152940|FG001|Overall Study|Lack of Efficacy|1
7058034|NCT01893411|11152941|FG002|Overall Study|Lack of Efficacy|0
7058035|NCT01893411|11152939|FG000|Overall Study|Other|3
7058036|NCT01893411|11152940|FG001|Overall Study|Other|1
7058037|NCT01893411|11152941|FG002|Overall Study|Other|3
7058038|NCT01893411|11152939|FG000|Overall Study|Adverse Event|1
7058039|NCT01893411|11152940|FG001|Overall Study|Adverse Event|0
7058040|NCT01893411|11152941|FG002|Overall Study|Adverse Event|0
7058041|NCT01893411|11152939|FG000|Overall Study|Withdrawal by Subject|7
7058042|NCT01893411|11152940|FG001|Overall Study|Withdrawal by Subject|4
7058043|NCT01893411|11152941|FG002|Overall Study|Withdrawal by Subject|3
7058044|NCT01893411|11152939|FG000|Overall Study|Lost to Follow-up|2
7058045|NCT01893411|11152940|FG001|Overall Study|Lost to Follow-up|0
7058046|NCT01893411|11152941|FG002|Overall Study|Lost to Follow-up|1
7058047|NCT01893827|11152970|FG000|Overall Study|Lost to Follow-up|19
7058048|NCT01893827|11152971|FG001|Overall Study|Lost to Follow-up|26
7058049|NCT01893905|11152988|FG000|Overall Study|Withdrawal by Subject|1
7058050|NCT01893905|11152989|FG001|Overall Study|Withdrawal by Subject|0
7058051|NCT01893905|11152988|FG000|Overall Study|Adverse Event|9
7058052|NCT01893905|11152989|FG001|Overall Study|Adverse Event|3
7058053|NCT01893905|11152988|FG000|Overall Study|Lack of Efficacy|5
7058054|NCT01893905|11152989|FG001|Overall Study|Lack of Efficacy|7
7058055|NCT01893905|11152988|FG000|Overall Study|Lost to Follow-up|1
7058056|NCT01893905|11152989|FG001|Overall Study|Lost to Follow-up|0
7058057|NCT01893905|11152988|FG000|Overall Study|Protocol Violation|6
7058058|NCT01893905|11152989|FG001|Overall Study|Protocol Violation|1
7058059|NCT01893905|11152988|FG000|Overall Study|Lack of adherence to treatment|2
7058060|NCT01893905|11152989|FG001|Overall Study|Lack of adherence to treatment|0
7058061|NCT01893905|11152988|FG000|Overall Study|Other reason|1
7058062|NCT01893905|11152989|FG001|Overall Study|Other reason|3
7058063|NCT01894022|11153006|FG000|Overall Study|Death|1
7058064|NCT01894022|11153007|FG001|Overall Study|Death|0
7058065|NCT01894022|11153006|FG000|Overall Study|Adverse Event, non-fatal|1
7058066|NCT01894022|11153007|FG001|Overall Study|Adverse Event, non-fatal|0
7058067|NCT01894022|11153006|FG000|Overall Study|Study Closed/terminated|7
7058068|NCT01894022|11153007|FG001|Overall Study|Study Closed/terminated|10
7058069|NCT01894100|11153025|FG000|Overall Study|Lost to Follow-up|0
7058070|NCT01894100|11153026|FG001|Overall Study|Lost to Follow-up|1
7058071|NCT01894100|11153025|FG000|Overall Study|Withdrawal by Subject|3
7058072|NCT01894100|11153026|FG001|Overall Study|Withdrawal by Subject|0
7058073|NCT01894152|11153032|FG000|Overall Study|No DMR and no Stent thrombosis|151
7058074|NCT01894230|11153047|FG000|Overall Study|Lost to Follow-up|2
7058075|NCT01894230|11153048|FG001|Overall Study|Lost to Follow-up|2
7058076|NCT01894230|11153047|FG000|Overall Study|Withdrawal by Subject|4
7058077|NCT01894230|11153048|FG001|Overall Study|Withdrawal by Subject|4
7058078|NCT01894230|11153047|FG000|Overall Study|Non-adherent|0
7058079|NCT01894230|11153048|FG001|Overall Study|Non-adherent|1
7058080|NCT01894230|11153047|FG000|Overall Study|Death|1
7058081|NCT01894230|11153048|FG001|Overall Study|Death|0
7058082|NCT01894243|11153057|FG000|Overall Study|Adverse Event|0
7058083|NCT01894243|11153058|FG001|Overall Study|Adverse Event|1
7058084|NCT01894243|11153059|FG002|Overall Study|Adverse Event|2
7058085|NCT01894243|11153057|FG000|Overall Study|Death|0
7058086|NCT01894243|11153058|FG001|Overall Study|Death|0
7058087|NCT01894243|11153059|FG002|Overall Study|Death|3
7058088|NCT01894243|11153057|FG000|Overall Study|Lack of Efficacy|3
7058089|NCT01894243|11153058|FG001|Overall Study|Lack of Efficacy|3
7058090|NCT01894243|11153059|FG002|Overall Study|Lack of Efficacy|1
7058091|NCT01894243|11153057|FG000|Overall Study|Condition under investigation worsened|8
7058092|NCT01894243|11153058|FG001|Overall Study|Condition under investigation worsened|6
7058093|NCT01894243|11153059|FG002|Overall Study|Condition under investigation worsened|2
7058094|NCT01894243|11153057|FG000|Overall Study|Subject decision|1
7058095|NCT01894243|11153058|FG001|Overall Study|Subject decision|0
7058096|NCT01894243|11153059|FG002|Overall Study|Subject decision|0
7058097|NCT01894243|11153057|FG000|Overall Study|Other|1
7058098|NCT01894243|11153058|FG001|Overall Study|Other|0
7058099|NCT01894243|11153059|FG002|Overall Study|Other|0
7058100|NCT01894256|11153077|FG000|Part A|Adverse Event|0
7058101|NCT01894256|11153078|FG001|Part A|Adverse Event|1
7058102|NCT01894256|11153079|FG002|Part A|Adverse Event|0
7058103|NCT01894256|11153077|FG000|Part B|Death|0
7058104|NCT01894256|11153078|FG001|Part B|Death|1
7058105|NCT01894256|11153079|FG002|Part B|Death|1
7058106|NCT01894256|11153077|FG000|Part B|Withdrawal by Subject|0
7058107|NCT01894256|11153078|FG001|Part B|Withdrawal by Subject|1
7058108|NCT01894256|11153079|FG002|Part B|Withdrawal by Subject|0
7058109|NCT01894256|11153077|FG000|Part B|Lack of Efficacy|15
7058110|NCT01894256|11153078|FG001|Part B|Lack of Efficacy|12
7058111|NCT01894256|11153079|FG002|Part B|Lack of Efficacy|13
7058112|NCT01894477|11153092|FG000|Overall Study|Protocol Violation|0
7058113|NCT01894477|11153093|FG001|Overall Study|Protocol Violation|1
7058114|NCT01894477|11153092|FG000|Overall Study|protocol changed due SC changed to cord|0
7058115|NCT01894477|11153093|FG001|Overall Study|protocol changed due SC changed to cord|1
7058116|NCT01894516|11153108|FG000|Period 1 (Baseline up to Week 12)|Other|0
7058117|NCT01894516|11153109|FG001|Period 1 (Baseline up to Week 12)|Other|1
7058118|NCT01894516|11153110|FG002|Period 1 (Baseline up to Week 12)|Other|1
7058119|NCT01894516|11153111|FG003|Period 1 (Baseline up to Week 12)|Other|0
7058120|NCT01894516|11153108|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2
7058121|NCT01894516|11153109|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
7058122|NCT01894516|11153110|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
7058123|NCT01894516|11153111|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
7058124|NCT01894516|11153108|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1
7058125|NCT01894516|11153109|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1
7058126|NCT01894516|11153110|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0
7058127|NCT01894516|11153111|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0
7058128|NCT01894516|11153108|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0
7058129|NCT01894516|11153109|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0
7058130|NCT01894516|11153110|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1
7058131|NCT01894516|11153111|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0
7058132|NCT01894516|11153108|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2
7058133|NCT01894516|11153109|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0
7058134|NCT01894516|11153110|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0
7058135|NCT01894516|11153111|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1
7058136|NCT01894516|11153108|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
7058137|NCT01894516|11153109|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3
7058138|NCT01894516|11153110|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1
7058139|NCT01894516|11153111|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
7058140|NCT01894516|11153108|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0
7058141|NCT01894516|11153109|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2
7058142|NCT01894516|11153110|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3
7058143|NCT01894516|11153111|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1
7058144|NCT01894516|11153108|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
7058145|NCT01894516|11153109|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
7058146|NCT01894516|11153110|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2
7058147|NCT01894516|11153111|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
7058148|NCT01894568|11153131|FG000|Overall Study|Adverse Event|2
7058149|NCT01894568|11153132|FG001|Overall Study|Adverse Event|3
7058150|NCT01894568|11153131|FG000|Overall Study|Protocol required discontinuation|2
7058151|NCT01894568|11153132|FG001|Overall Study|Protocol required discontinuation|1
7058152|NCT01894568|11153131|FG000|Overall Study|Withdrawal by Subject|5
7058153|NCT01894568|11153132|FG001|Overall Study|Withdrawal by Subject|5
7058154|NCT01894568|11153131|FG000|Overall Study|Physician Decision|1
7058155|NCT01894568|11153132|FG001|Overall Study|Physician Decision|0
7058156|NCT01894568|11153131|FG000|Overall Study|Lost to Follow-up|0
7058157|NCT01894568|11153132|FG001|Overall Study|Lost to Follow-up|1
7058158|NCT01894581|11153141|FG000|Overall Study|Withdrawal by Subject|2
7058159|NCT01894581|11153142|FG001|Overall Study|Withdrawal by Subject|3
7058160|NCT01894581|11153141|FG000|Overall Study|Screen Failure|3
7058161|NCT01894581|11153142|FG001|Overall Study|Screen Failure|4
7058162|NCT01894607|11153148|FG000|Overall Study|Ineligible|1
7058163|NCT01894620|11153154|FG000|Overall Study|Withdrawal by Subject|0
7058164|NCT01894620|11153155|FG001|Overall Study|Withdrawal by Subject|1
7058165|NCT01894776|11153168|FG000|Overall Study|Withdrawal by Subject|1
7058166|NCT01894841|11153174|FG000|Overall Study|Withdrawal by Subject|9
7058167|NCT01894841|11153175|FG001|Overall Study|Withdrawal by Subject|4
7058168|NCT01894841|11153174|FG000|Overall Study|Withdrawn by investigator|2
7058169|NCT01894841|11153175|FG001|Overall Study|Withdrawn by investigator|2
7058170|NCT01894841|11153174|FG000|Overall Study|Lost to Follow-up|7
7058171|NCT01894841|11153175|FG001|Overall Study|Lost to Follow-up|3
7058172|NCT01894919|11153219|FG000|Overall Study|Withdrawal by Subject|1
7058173|NCT01894919|11153220|FG001|Overall Study|Withdrawal by Subject|0
7058174|NCT01894919|11153221|FG002|Overall Study|Withdrawal by Subject|0
7058175|NCT01894919|11153222|FG003|Overall Study|Withdrawal by Subject|0
7058176|NCT01894919|11153223|FG004|Overall Study|Withdrawal by Subject|1
7058177|NCT01894919|11153224|FG005|Overall Study|Withdrawal by Subject|0
7058178|NCT01894919|11153225|FG006|Overall Study|Withdrawal by Subject|0
7058179|NCT01894919|11153226|FG007|Overall Study|Withdrawal by Subject|0
7058180|NCT01894919|11153227|FG008|Overall Study|Withdrawal by Subject|0
7058181|NCT01894919|11153228|FG009|Overall Study|Withdrawal by Subject|1
7058182|NCT01894919|11153229|FG010|Overall Study|Withdrawal by Subject|1
7058183|NCT01894919|11153230|FG011|Overall Study|Withdrawal by Subject|0
7058184|NCT01894919|11153231|FG012|Overall Study|Withdrawal by Subject|0
7058185|NCT01894919|11153219|FG000|Overall Study|Adverse Event|0
7058186|NCT01894919|11153220|FG001|Overall Study|Adverse Event|0
7058187|NCT01894919|11153221|FG002|Overall Study|Adverse Event|0
7058188|NCT01894919|11153222|FG003|Overall Study|Adverse Event|0
7058189|NCT01894919|11153223|FG004|Overall Study|Adverse Event|0
7058190|NCT01894919|11153224|FG005|Overall Study|Adverse Event|0
7058191|NCT01894919|11153225|FG006|Overall Study|Adverse Event|0
7058192|NCT01894919|11153226|FG007|Overall Study|Adverse Event|0
7058193|NCT01894919|11153227|FG008|Overall Study|Adverse Event|0
7058194|NCT01894919|11153228|FG009|Overall Study|Adverse Event|0
7058195|NCT01894919|11153229|FG010|Overall Study|Adverse Event|1
7058196|NCT01894919|11153230|FG011|Overall Study|Adverse Event|0
7058197|NCT01894919|11153231|FG012|Overall Study|Adverse Event|0
7058198|NCT01894919|11153219|FG000|Overall Study|Other-Unspecified|1
7058199|NCT01894919|11153220|FG001|Overall Study|Other-Unspecified|0
7058200|NCT01894919|11153221|FG002|Overall Study|Other-Unspecified|0
7058201|NCT01894919|11153222|FG003|Overall Study|Other-Unspecified|0
7058202|NCT01894919|11153223|FG004|Overall Study|Other-Unspecified|0
7058203|NCT01894919|11153224|FG005|Overall Study|Other-Unspecified|0
7058204|NCT01894919|11153225|FG006|Overall Study|Other-Unspecified|0
7058205|NCT01894919|11153226|FG007|Overall Study|Other-Unspecified|0
7058206|NCT01894919|11153227|FG008|Overall Study|Other-Unspecified|0
7058207|NCT01894919|11153228|FG009|Overall Study|Other-Unspecified|0
7058208|NCT01894919|11153229|FG010|Overall Study|Other-Unspecified|0
7058209|NCT01894919|11153230|FG011|Overall Study|Other-Unspecified|0
7058210|NCT01894919|11153231|FG012|Overall Study|Other-Unspecified|0
7058211|NCT01894919|11153219|FG000|Overall Study|Lost to Follow-up|0
7058212|NCT01894919|11153220|FG001|Overall Study|Lost to Follow-up|0
7058213|NCT01894919|11153221|FG002|Overall Study|Lost to Follow-up|0
7058214|NCT01894919|11153222|FG003|Overall Study|Lost to Follow-up|0
7058215|NCT01894919|11153223|FG004|Overall Study|Lost to Follow-up|2
7058216|NCT01894919|11153224|FG005|Overall Study|Lost to Follow-up|0
7058217|NCT01894919|11153225|FG006|Overall Study|Lost to Follow-up|0
7058218|NCT01894919|11153226|FG007|Overall Study|Lost to Follow-up|0
7058219|NCT01894919|11153227|FG008|Overall Study|Lost to Follow-up|0
7058220|NCT01894919|11153228|FG009|Overall Study|Lost to Follow-up|0
7058221|NCT01894919|11153229|FG010|Overall Study|Lost to Follow-up|0
7058222|NCT01894919|11153230|FG011|Overall Study|Lost to Follow-up|0
7058223|NCT01894919|11153231|FG012|Overall Study|Lost to Follow-up|0
7058224|NCT01894984|11153275|FG000|Overall Study|Other|314
7058225|NCT01894984|11153276|FG001|Overall Study|Other|175
7058226|NCT01895101|11153302|FG000|Overall Study|OPCAB procedure|1
7058227|NCT01895101|11153303|FG001|Overall Study|OPCAB procedure|1
7058228|NCT01895101|11153304|FG002|Overall Study|OPCAB procedure|3
7058229|NCT01895101|11153302|FG000|Overall Study|Withdrawal by Subject|0
7058230|NCT01895101|11153303|FG001|Overall Study|Withdrawal by Subject|1
7058231|NCT01895101|11153304|FG002|Overall Study|Withdrawal by Subject|2
7058232|NCT01895101|11153302|FG000|Overall Study|another study, enrolled in other study|0
7058233|NCT01895101|11153303|FG001|Overall Study|another study, enrolled in other study|1
7058234|NCT01895101|11153304|FG002|Overall Study|another study, enrolled in other study|0
7058235|NCT01895101|11153302|FG000|Overall Study|Death|0
7058236|NCT01895101|11153303|FG001|Overall Study|Death|1
7058237|NCT01895101|11153304|FG002|Overall Study|Death|0
7058238|NCT01895101|11153302|FG000|Overall Study|coagulation disorder|0
7058239|NCT01895101|11153303|FG001|Overall Study|coagulation disorder|1
7058240|NCT01895101|11153304|FG002|Overall Study|coagulation disorder|0
7058241|NCT01895270|11153324|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0
7058242|NCT01895270|11153325|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2
7058243|NCT01895270|11153324|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3
7058244|NCT01895270|11153325|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2
7058245|NCT01895270|11153324|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3
7058246|NCT01895270|11153325|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1
7058247|NCT01895270|11153324|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0
7058248|NCT01895270|11153325|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1
7058249|NCT01895270|11153324|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3
7058250|NCT01895270|11153325|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5
7058251|NCT01895270|11153324|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0
7058252|NCT01895270|11153325|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1
7058253|NCT01895270|11153324|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0
7058254|NCT01895270|11153325|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1
7058255|NCT01895309|11153333|FG000|Overall Study|Adverse Event|13
7058256|NCT01895309|11153334|FG001|Overall Study|Adverse Event|17
7058257|NCT01895309|11153333|FG000|Overall Study|Protocol Violation|1
7058258|NCT01895309|11153334|FG001|Overall Study|Protocol Violation|0
7058259|NCT01895309|11153333|FG000|Overall Study|Lack of Efficacy|1
7058260|NCT01895309|11153334|FG001|Overall Study|Lack of Efficacy|3
7058261|NCT01895309|11153333|FG000|Overall Study|Lost to Follow-up|1
7058262|NCT01895309|11153334|FG001|Overall Study|Lost to Follow-up|3
7058263|NCT01895309|11153333|FG000|Overall Study|Physician Decision|15
7058264|NCT01895309|11153334|FG001|Overall Study|Physician Decision|10
7058265|NCT01895309|11153333|FG000|Overall Study|Withdrawal by Subject|9
7058266|NCT01895309|11153334|FG001|Overall Study|Withdrawal by Subject|18
7058267|NCT01895322|11153344|FG000|Overall Study|Adverse Event|1
7058268|NCT01895322|11153344|FG000|Overall Study|Withdrawal by Subject|2
7058269|NCT01895322|11153344|FG000|Overall Study|Protocol Violation|10
7058270|NCT01895335|11153349|FG000|Overall Study|Adverse Event|106
7058271|NCT01895335|11153349|FG000|Overall Study|Lack of Efficacy|53
7058272|NCT01895335|11153349|FG000|Overall Study|Poor Compliance to Protocol|11
7058273|NCT01895335|11153349|FG000|Overall Study|Included But Not treated|1
7058274|NCT01895335|11153349|FG000|Overall Study|Other than Specified Above|44
7058275|NCT01895361|11153356|FG000|Overall Study|Adverse Event|1
7058276|NCT01895361|11153357|FG001|Overall Study|Adverse Event|1
7058277|NCT01895361|11153358|FG002|Overall Study|Adverse Event|3
7058278|NCT01895361|11153356|FG000|Overall Study|Death|2
7058279|NCT01895361|11153357|FG001|Overall Study|Death|1
7058280|NCT01895361|11153358|FG002|Overall Study|Death|2
7058281|NCT01895361|11153356|FG000|Overall Study|Lost to Follow-up|4
7058282|NCT01895361|11153357|FG001|Overall Study|Lost to Follow-up|4
7058283|NCT01895361|11153358|FG002|Overall Study|Lost to Follow-up|6
7058284|NCT01895361|11153356|FG000|Overall Study|Non-compliance with study|1
7058285|NCT01895361|11153357|FG001|Overall Study|Non-compliance with study|3
7058286|NCT01895361|11153358|FG002|Overall Study|Non-compliance with study|1
7058287|NCT01895361|11153356|FG000|Overall Study|Physician Decision|2
7058288|NCT01895361|11153357|FG001|Overall Study|Physician Decision|2
7058289|NCT01895361|11153358|FG002|Overall Study|Physician Decision|2
7058290|NCT01895361|11153356|FG000|Overall Study|Withdrawal by Subject|7
7058291|NCT01895361|11153357|FG001|Overall Study|Withdrawal by Subject|6
7058292|NCT01895361|11153358|FG002|Overall Study|Withdrawal by Subject|6
7058293|NCT01895361|11153356|FG000|Overall Study|Lack of Efficacy|0
7058294|NCT01895361|11153357|FG001|Overall Study|Lack of Efficacy|1
7058295|NCT01895361|11153358|FG002|Overall Study|Lack of Efficacy|0
7058296|NCT01895361|11153356|FG000|Overall Study|Reasons different from categories above|7
7058297|NCT01895361|11153357|FG001|Overall Study|Reasons different from categories above|3
7058298|NCT01895361|11153358|FG002|Overall Study|Reasons different from categories above|4
7058299|NCT01895452|11153368|FG000|Overall Study|Adverse Event|1
7058300|NCT01895452|11153369|FG001|Overall Study|Adverse Event|4
7058301|NCT01895452|11153368|FG000|Overall Study|Lost to Follow-up|1
7058302|NCT01895452|11153369|FG001|Overall Study|Lost to Follow-up|5
7058303|NCT01895452|11153368|FG000|Overall Study|Pregnancy|0
7058304|NCT01895452|11153369|FG001|Overall Study|Pregnancy|1
7058305|NCT01895452|11153368|FG000|Overall Study|Withdrawal by Subject|2
7058306|NCT01895452|11153369|FG001|Overall Study|Withdrawal by Subject|14
7058307|NCT01895452|11153368|FG000|Overall Study|Underlying disease|0
7058308|NCT01895452|11153369|FG001|Overall Study|Underlying disease|3
7058309|NCT01895452|11153368|FG000|Overall Study|Noncompliance with study drug|0
7058310|NCT01895452|11153369|FG001|Overall Study|Noncompliance with study drug|1
7058311|NCT01895543|11153375|FG000|Overall Study|Withdrawal by Subject|43
7058312|NCT01895543|11153375|FG000|Overall Study|Lost to Follow-up|25
7058313|NCT01895543|11153375|FG000|Overall Study|Adverse Event|28
7058314|NCT01895543|11153375|FG000|Overall Study|Subject's substantial non-compliance|6
7058315|NCT01895543|11153375|FG000|Overall Study|Protocol Violation|1
7058316|NCT01895543|11153375|FG000|Overall Study|Physician Decision|2
7058317|NCT01895543|11153375|FG000|Overall Study|Other (Not fulfilling above criteria)|24
7058318|NCT01895608|11153383|FG000|Overall Study|change in health status|0
7058319|NCT01895608|11153384|FG001|Overall Study|change in health status|1
7058320|NCT01895608|11153385|FG002|Overall Study|change in health status|1
7058321|NCT01895608|11153386|FG003|Overall Study|change in health status|0
7058322|NCT01895608|11153383|FG000|Overall Study|Withdrawal by Subject|0
7058323|NCT01895608|11153384|FG001|Overall Study|Withdrawal by Subject|0
7058324|NCT01895608|11153385|FG002|Overall Study|Withdrawal by Subject|2
7058325|NCT01895608|11153386|FG003|Overall Study|Withdrawal by Subject|0
7058326|NCT01895777|11153415|FG000|Overall Study|Adverse Event|1
7058327|NCT01895777|11153416|FG001|Overall Study|Adverse Event|2
7058328|NCT01895777|11153415|FG000|Overall Study|Lost to Follow-up|2
7058329|NCT01895777|11153416|FG001|Overall Study|Lost to Follow-up|0
7058330|NCT01895777|11153415|FG000|Overall Study|Not treated|1
7058331|NCT01895777|11153416|FG001|Overall Study|Not treated|0
7058332|NCT01895777|11153415|FG000|Overall Study|Other reasons|3
7058333|NCT01895777|11153416|FG001|Overall Study|Other reasons|2
7058334|NCT01895777|11153415|FG000|Overall Study|Non-compliance with the CTP|2
7058335|NCT01895777|11153416|FG001|Overall Study|Non-compliance with the CTP|1
7058336|NCT01896050|11153453|FG000|Overall Study|Adverse Event|37
7058337|NCT01896050|11153454|FG001|Overall Study|Adverse Event|2
7058338|NCT01896050|11153453|FG000|Overall Study|Death|1
7058339|NCT01896050|11153454|FG001|Overall Study|Death|0
7058340|NCT01896128|11153478|FG000|Overall Study|Withdrawal by Subject|3
7058341|NCT01896128|11153479|FG001|Overall Study|Withdrawal by Subject|3
7058342|NCT01896193|11153489|FG000|Overall Study|Lack of Efficacy|20
7058343|NCT01896193|11153490|FG001|Overall Study|Lack of Efficacy|11
7058344|NCT01896193|11153489|FG000|Overall Study|Protocol Violation|0
7058345|NCT01896193|11153490|FG001|Overall Study|Protocol Violation|1
7058346|NCT01896193|11153489|FG000|Overall Study|Withdrew Consent|1
7058347|NCT01896193|11153490|FG001|Overall Study|Withdrew Consent|0
7058348|NCT01896232|11153504|FG000|Overall Study|Death|6
7058349|NCT01896232|11153505|FG001|Overall Study|Death|10
7058350|NCT01896232|11153504|FG000|Overall Study|Withdrawal by Subject|32
7058351|NCT01896232|11153505|FG001|Overall Study|Withdrawal by Subject|31
7058352|NCT01896232|11153504|FG000|Overall Study|Sponsor Decision|2
7058353|NCT01896232|11153505|FG001|Overall Study|Sponsor Decision|0
7058354|NCT01896232|11153504|FG000|Overall Study|Lost to Follow-up|9
7058355|NCT01896232|11153505|FG001|Overall Study|Lost to Follow-up|12
7058356|NCT01896271|11153511|FG000|Overall Study|Physician Decision|10
7058357|NCT01896297|11153515|FG000|Overall Study|Died in post treatment phase|1
7058358|NCT01896557|11153537|FG000|Clopidogrel Alone|Adverse Event|1
7058359|NCT01896557|11153538|FG001|Clopidogrel Alone|Adverse Event|0
7058360|NCT01896557|11153537|FG000|Clopidogrel + GI Protector|low adherence|1
7058361|NCT01896557|11153538|FG001|Clopidogrel + GI Protector|low adherence|1
7058362|NCT01896557|11153537|FG000|Clopidogrel + GI Protector|Reading error|1
7058363|NCT01896557|11153538|FG001|Clopidogrel + GI Protector|Reading error|3
7058364|NCT01896700|11153555|FG000|Overall Study|Adverse Event|4
7058365|NCT01896700|11153556|FG001|Overall Study|Adverse Event|5
7058366|NCT01896700|11153555|FG000|Overall Study|Withdrawal by Subject|0
7058367|NCT01896700|11153556|FG001|Overall Study|Withdrawal by Subject|1
7058368|NCT01896726|11153562|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1
7058369|NCT01896726|11153562|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1
7058370|NCT01896856|11153575|FG000|Overall Study|Transportation issues / Non-compliance|0
7058371|NCT01896856|11153576|FG001|Overall Study|Transportation issues / Non-compliance|0
7058372|NCT01896856|11153577|FG002|Overall Study|Transportation issues / Non-compliance|1
7058373|NCT01896856|11153578|FG003|Overall Study|Transportation issues / Non-compliance|0
7058374|NCT01896856|11153579|FG004|Overall Study|Transportation issues / Non-compliance|0
7058375|NCT01896856|11153580|FG005|Overall Study|Transportation issues / Non-compliance|0
7058376|NCT01896869|11153597|FG000|Overall Study|Withdrawal by Subject|0
7058377|NCT01896869|11153598|FG001|Overall Study|Withdrawal by Subject|6
7058378|NCT01896869|11153597|FG000|Overall Study|Lost to Follow-up|1
7058379|NCT01896869|11153598|FG001|Overall Study|Lost to Follow-up|0
7058380|NCT01896895|11153609|FG000|Double-blind MP|Physician Decision|0
7058381|NCT01896895|11153610|FG001|Double-blind MP|Physician Decision|0
7058382|NCT01896895|11153611|FG002|Double-blind MP|Physician Decision|1
7058383|NCT01896895|11153612|FG003|Double-blind MP|Physician Decision|0
7058384|NCT01896895|11153609|FG000|Double-blind MP|Withdrawal by Subject|0
7058385|NCT01896895|11153610|FG001|Double-blind MP|Withdrawal by Subject|2
7058386|NCT01896895|11153611|FG002|Double-blind MP|Withdrawal by Subject|1
7058387|NCT01896895|11153612|FG003|Double-blind MP|Withdrawal by Subject|0
7058388|NCT01896895|11153609|FG000|Double-blind MP|Lost to Follow-up|1
7058389|NCT01896895|11153610|FG001|Double-blind MP|Lost to Follow-up|0
7058390|NCT01896895|11153611|FG002|Double-blind MP|Lost to Follow-up|1
7058391|NCT01896895|11153612|FG003|Double-blind MP|Lost to Follow-up|0
7058392|NCT01896934|11153625|FG000|Overall Study|Adverse Event|1
7058393|NCT01896934|11153625|FG000|Overall Study|Withdrawal by Subject|1
7058394|NCT01896986|11153631|FG000|Overall Study|samples lost|14
7058395|NCT01896986|11153632|FG001|Overall Study|samples lost|23
7058396|NCT01897233|11153656|FG000|Part B (24 Weeks)|Adverse Event|1
7058397|NCT01897233|11153656|FG000|Part B (24 Weeks)|Withdrawal by Subject|2
7058398|NCT01897233|11153656|FG000|Part B (24 Weeks)|Physician Decision|1
7058399|NCT01897493|11153685|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1
7058400|NCT01897532|11153694|FG000|Discontinuation From Treatment|Not Treated|7
7058401|NCT01897532|11153695|FG001|Discontinuation From Treatment|Not Treated|5
7058402|NCT01897532|11153694|FG000|Discontinuation From Treatment|Other reason than specified|196
7058403|NCT01897532|11153695|FG001|Discontinuation From Treatment|Other reason than specified|176
7058404|NCT01897532|11153694|FG000|Discontinuation From Treatment|Withdrawal by Subject|333
7058405|NCT01897532|11153695|FG001|Discontinuation From Treatment|Withdrawal by Subject|281
7058406|NCT01897532|11153694|FG000|Discontinuation From Treatment|Non compliance|24
7058407|NCT01897532|11153695|FG001|Discontinuation From Treatment|Non compliance|15
7058408|NCT01897532|11153694|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402
7058409|NCT01897532|11153695|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362
7058410|NCT01897532|11153694|FG000|Discontinuation From Trial|Not Treated|7
7058411|NCT01897532|11153695|FG001|Discontinuation From Trial|Not Treated|5
7058412|NCT01897532|11153694|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55
7058413|NCT01897532|11153695|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36
7058414|NCT01897714|11153707|FG000|Phase I (Dose Escalation)|Disease progression|3
7058415|NCT01897714|11153708|FG001|Phase I (Dose Escalation)|Disease progression|5
7058416|NCT01897714|11153709|FG002|Phase I (Dose Escalation)|Disease progression|1
7058417|NCT01897714|11153710|FG003|Phase I (Dose Escalation)|Disease progression|3
7058418|NCT01897714|11153711|FG004|Phase I (Dose Escalation)|Disease progression|0
7058419|NCT01897714|11153712|FG005|Phase I (Dose Escalation)|Disease progression|0
7058420|NCT01897714|11153707|FG000|Phase I (Dose Escalation)|Adverse Event|0
7058421|NCT01897714|11153708|FG001|Phase I (Dose Escalation)|Adverse Event|1
7058422|NCT01897714|11153709|FG002|Phase I (Dose Escalation)|Adverse Event|4
7058423|NCT01897714|11153710|FG003|Phase I (Dose Escalation)|Adverse Event|3
7058424|NCT01897714|11153711|FG004|Phase I (Dose Escalation)|Adverse Event|0
7058425|NCT01897714|11153712|FG005|Phase I (Dose Escalation)|Adverse Event|0
7058426|NCT01897714|11153707|FG000|Phase I (Dose Escalation)|Other|0
7058427|NCT01897714|11153708|FG001|Phase I (Dose Escalation)|Other|1
7058428|NCT01897714|11153709|FG002|Phase I (Dose Escalation)|Other|0
7058429|NCT01897714|11153710|FG003|Phase I (Dose Escalation)|Other|0
7058430|NCT01897714|11153711|FG004|Phase I (Dose Escalation)|Other|0
7058431|NCT01897714|11153712|FG005|Phase I (Dose Escalation)|Other|0
7058432|NCT01897714|11153707|FG000|Phase II (MTD)|Withdrawal by Subject|0
7058433|NCT01897714|11153708|FG001|Phase II (MTD)|Withdrawal by Subject|0
7058434|NCT01897714|11153709|FG002|Phase II (MTD)|Withdrawal by Subject|0
7058435|NCT01897714|11153710|FG003|Phase II (MTD)|Withdrawal by Subject|0
7058436|NCT01897714|11153711|FG004|Phase II (MTD)|Withdrawal by Subject|0
7058437|NCT01897714|11153712|FG005|Phase II (MTD)|Withdrawal by Subject|1
7058438|NCT01897714|11153707|FG000|Phase II (MTD)|Lost to Follow-up|0
7058439|NCT01897714|11153708|FG001|Phase II (MTD)|Lost to Follow-up|0
7058440|NCT01897714|11153709|FG002|Phase II (MTD)|Lost to Follow-up|0
7058441|NCT01897714|11153710|FG003|Phase II (MTD)|Lost to Follow-up|0
7058442|NCT01897714|11153711|FG004|Phase II (MTD)|Lost to Follow-up|1
7058443|NCT01897714|11153712|FG005|Phase II (MTD)|Lost to Follow-up|0
7058444|NCT01897714|11153707|FG000|Phase II (MTD)|Death|0
7058445|NCT01897714|11153708|FG001|Phase II (MTD)|Death|0
7058446|NCT01897714|11153709|FG002|Phase II (MTD)|Death|0
7058447|NCT01897714|11153710|FG003|Phase II (MTD)|Death|0
7058448|NCT01897714|11153711|FG004|Phase II (MTD)|Death|25
7058449|NCT01897714|11153712|FG005|Phase II (MTD)|Death|10
7058450|NCT01897714|11153707|FG000|Phase II (MTD)|Study terminated with patient alive|0
7058451|NCT01897714|11153708|FG001|Phase II (MTD)|Study terminated with patient alive|0
7058452|NCT01897714|11153709|FG002|Phase II (MTD)|Study terminated with patient alive|0
7058453|NCT01897714|11153710|FG003|Phase II (MTD)|Study terminated with patient alive|0
7058454|NCT01897714|11153711|FG004|Phase II (MTD)|Study terminated with patient alive|1
7058455|NCT01897714|11153712|FG005|Phase II (MTD)|Study terminated with patient alive|0
7058456|NCT01897714|11153707|FG000|Phase II (MTD)|Other|0
7058457|NCT01897714|11153708|FG001|Phase II (MTD)|Other|0
7058458|NCT01897714|11153709|FG002|Phase II (MTD)|Other|0
7058459|NCT01897714|11153710|FG003|Phase II (MTD)|Other|0
7058460|NCT01897714|11153711|FG004|Phase II (MTD)|Other|3
7058461|NCT01897714|11153712|FG005|Phase II (MTD)|Other|0
7058462|NCT01897727|11153730|FG000|Overall Study|Exclusion: central sleep apnea|0
7058463|NCT01897727|11153731|FG001|Overall Study|Exclusion: central sleep apnea|1
7058464|NCT01897896|11153756|FG000|Overall Study|Death|1
7058465|NCT01897896|11153757|FG001|Overall Study|Death|0
7058466|NCT01897896|11153756|FG000|Overall Study|Adverse Event|11
7058467|NCT01897896|11153757|FG001|Overall Study|Adverse Event|1
7058468|NCT01897896|11153756|FG000|Overall Study|Lost to Follow-up|1
7058469|NCT01897896|11153757|FG001|Overall Study|Lost to Follow-up|0
7058470|NCT01897896|11153756|FG000|Overall Study|Non-compliance with study drug dosing|1
7058471|NCT01897896|11153757|FG001|Overall Study|Non-compliance with study drug dosing|1
7058472|NCT01897896|11153756|FG000|Overall Study|Withdrawal by Subject|7
7058473|NCT01897896|11153757|FG001|Overall Study|Withdrawal by Subject|1
7058474|NCT01897896|11153756|FG000|Overall Study|Require drug that interfere with study|1
7058475|NCT01897896|11153757|FG001|Overall Study|Require drug that interfere with study|4
7058476|NCT01897896|11153756|FG000|Overall Study|Protocol Violation|1
7058477|NCT01897896|11153757|FG001|Overall Study|Protocol Violation|1
7058478|NCT01897896|11153756|FG000|Overall Study|Withdrawal per Investigator's judgement|1
7058479|NCT01897896|11153757|FG001|Overall Study|Withdrawal per Investigator's judgement|1
7058480|NCT01897896|11153756|FG000|Overall Study|Caregiver can no longer participate|0
7058481|NCT01897896|11153757|FG001|Overall Study|Caregiver can no longer participate|2
7058482|NCT01897896|11153756|FG000|Overall Study|Other than specified|2
7058483|NCT01897896|11153757|FG001|Overall Study|Other than specified|1
7058484|NCT01898078|11153776|FG000|Overall Study|Progressive Disease|1
7058485|NCT01898078|11153777|FG001|Overall Study|Progressive Disease|5
7058486|NCT01898078|11153776|FG000|Overall Study|Adverse Event|2
7058487|NCT01898078|11153777|FG001|Overall Study|Adverse Event|1
7058488|NCT01898078|11153776|FG000|Overall Study|Withdrawal by Subject|1
7058489|NCT01898078|11153777|FG001|Overall Study|Withdrawal by Subject|1
7058490|NCT01898078|11153776|FG000|Overall Study|Symptomatic Deterioration|2
7058491|NCT01898078|11153777|FG001|Overall Study|Symptomatic Deterioration|0
7058492|NCT01898078|11153776|FG000|Overall Study|Reason not Specified|0
7058493|NCT01898078|11153777|FG001|Overall Study|Reason not Specified|1
7058494|NCT01898091|11153787|FG000|Overall Study|Lost to Follow-up|1
7058495|NCT01898091|11153788|FG001|Overall Study|Lost to Follow-up|1
7058496|NCT01898091|11153787|FG000|Overall Study|Withdrawal by Subject|1
7058497|NCT01898091|11153788|FG001|Overall Study|Withdrawal by Subject|5
7058498|NCT01898130|11153794|FG000|Treatment|Withdrawal by Subject|2
7058499|NCT01898130|11153794|FG000|Treatment|Progressive Disease|4
7058500|NCT01898130|11153794|FG000|Follow up Until PD or Death|Lost to Follow-up|1
7058501|NCT01898195|11153801|FG000|Smoking Abstinence|Did not have good measurements|35
7058502|NCT01898195|11153802|FG001|Smoking Abstinence|Did not have good measurements|38
7058503|NCT01898195|11153803|FG002|Smoking Abstinence|Did not have good measurements|36
7058504|NCT01898208|11153814|FG000|Overall Study|Positive blood culture|17
7058505|NCT01898208|11153815|FG001|Overall Study|Positive blood culture|23
7058506|NCT01898208|11153816|FG002|Overall Study|Positive blood culture|15
7058507|NCT01898208|11153814|FG000|Overall Study|Death/comfort care within 24 hours|10
7058508|NCT01898208|11153815|FG001|Overall Study|Death/comfort care within 24 hours|9
7058509|NCT01898208|11153816|FG002|Overall Study|Death/comfort care within 24 hours|8
7058510|NCT01898208|11153814|FG000|Overall Study|Negative Gram Stain|6
7058511|NCT01898208|11153815|FG001|Overall Study|Negative Gram Stain|9
7058512|NCT01898208|11153816|FG002|Overall Study|Negative Gram Stain|6
7058513|NCT01898208|11153814|FG000|Overall Study|Non-Blood Specimens in Bottles|3
7058514|NCT01898208|11153815|FG001|Overall Study|Non-Blood Specimens in Bottles|5
7058515|NCT01898208|11153816|FG002|Overall Study|Non-Blood Specimens in Bottles|4
7058516|NCT01898208|11153814|FG000|Overall Study|System/Technical Error|1
7058517|NCT01898208|11153815|FG001|Overall Study|System/Technical Error|2
7058518|NCT01898208|11153816|FG002|Overall Study|System/Technical Error|3
7058519|NCT01898208|11153814|FG000|Overall Study|Lost to Follow-up|3
7058520|NCT01898208|11153815|FG001|Overall Study|Lost to Follow-up|1
7058521|NCT01898208|11153816|FG002|Overall Study|Lost to Follow-up|1
7058522|NCT01898286|11153824|FG000|Overall Study|Withdrawal by Subject|1
7058523|NCT01898286|11153824|FG000|Overall Study|Protocol Violation|1
7058524|NCT01898286|11153824|FG000|Overall Study|Lost to Follow-up|1
7058525|NCT01898299|11153830|FG000|Post Treatment (One Month)|Lost to Follow-up|3
7058526|NCT01898299|11153831|FG001|Post Treatment (One Month)|Lost to Follow-up|4
7058527|NCT01898442|11153852|FG000|Overall Study|Hemolysis/technical problems|1
7058528|NCT01898442|11153853|FG001|Overall Study|Hemolysis/technical problems|2
7058529|NCT01898442|11153854|FG002|Overall Study|Hemolysis/technical problems|2
7058530|NCT01898442|11153852|FG000|Overall Study|Patient vomited pills|0
7058531|NCT01898442|11153853|FG001|Overall Study|Patient vomited pills|0
7058532|NCT01898442|11153854|FG002|Overall Study|Patient vomited pills|1
7058533|NCT01898598|11153864|FG000|Overall Study|Adverse Event|1
7058534|NCT01898598|11153865|FG001|Overall Study|Adverse Event|0
7058535|NCT01898598|11153864|FG000|Overall Study|Withdrawal by Subject|3
7058536|NCT01898598|11153865|FG001|Overall Study|Withdrawal by Subject|0
7058537|NCT01898598|11153864|FG000|Overall Study|Lost to Follow-up|0
7058538|NCT01898598|11153865|FG001|Overall Study|Lost to Follow-up|1
7058539|NCT01898598|11153864|FG000|Overall Study|Other|0
7058540|NCT01898598|11153865|FG001|Overall Study|Other|1
7085810|NCT02185040|11199214|FG004|Part 1 Treatment Phase|Miscellaneous|0
7085811|NCT02185040|11199215|FG005|Part 1 Treatment Phase|Miscellaneous|0
7085812|NCT02185040|11199216|FG006|Part 1 Treatment Phase|Miscellaneous|0
7085813|NCT02185040|11199210|FG000|Part 1 Treatment Phase|Adverse Event|1
7085814|NCT02185040|11199211|FG001|Part 1 Treatment Phase|Adverse Event|0
7085815|NCT02185040|11199212|FG002|Part 1 Treatment Phase|Adverse Event|0
7085816|NCT02185040|11199213|FG003|Part 1 Treatment Phase|Adverse Event|2
7085817|NCT02185040|11199214|FG004|Part 1 Treatment Phase|Adverse Event|3
7085818|NCT02185040|11199215|FG005|Part 1 Treatment Phase|Adverse Event|0
7085819|NCT02185040|11199216|FG006|Part 1 Treatment Phase|Adverse Event|0
7085820|NCT02185040|11199210|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0
7085821|NCT02185040|11199211|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1
7085822|NCT02185040|11199212|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0
7085823|NCT02185040|11199213|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0
7085824|NCT02185040|11199214|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0
7085825|NCT02185040|11199215|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0
7085826|NCT02185040|11199216|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0
7085827|NCT02185040|11199210|FG000|Part 1 Treatment Phase|Lost to Follow-up|0
7085828|NCT02185040|11199211|FG001|Part 1 Treatment Phase|Lost to Follow-up|1
7085829|NCT02185040|11199212|FG002|Part 1 Treatment Phase|Lost to Follow-up|0
7085830|NCT02185040|11199213|FG003|Part 1 Treatment Phase|Lost to Follow-up|0
7085831|NCT02185040|11199214|FG004|Part 1 Treatment Phase|Lost to Follow-up|0
7085832|NCT02185040|11199215|FG005|Part 1 Treatment Phase|Lost to Follow-up|0
7085833|NCT02185040|11199216|FG006|Part 1 Treatment Phase|Lost to Follow-up|0
7085834|NCT02185040|11199210|FG000|Active Treatment Extension Phase|Miscellaneous|0
7085835|NCT02185040|11199211|FG001|Active Treatment Extension Phase|Miscellaneous|0
7085836|NCT02185040|11199212|FG002|Active Treatment Extension Phase|Miscellaneous|0
7085837|NCT02185040|11199213|FG003|Active Treatment Extension Phase|Miscellaneous|0
7085838|NCT02185040|11199214|FG004|Active Treatment Extension Phase|Miscellaneous|0
7085839|NCT02185040|11199215|FG005|Active Treatment Extension Phase|Miscellaneous|1
7085840|NCT02185040|11199216|FG006|Active Treatment Extension Phase|Miscellaneous|0
7085841|NCT02185040|11199210|FG000|Active Treatment Extension Phase|Adverse Event|0
7085842|NCT02185040|11199211|FG001|Active Treatment Extension Phase|Adverse Event|0
7085843|NCT02185040|11199212|FG002|Active Treatment Extension Phase|Adverse Event|0
7085844|NCT02185040|11199213|FG003|Active Treatment Extension Phase|Adverse Event|0
7085845|NCT02185040|11199214|FG004|Active Treatment Extension Phase|Adverse Event|0
7085846|NCT02185040|11199215|FG005|Active Treatment Extension Phase|Adverse Event|1
7085847|NCT02185040|11199216|FG006|Active Treatment Extension Phase|Adverse Event|4
7085848|NCT02185040|11199210|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0
7085849|NCT02185040|11199211|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0
7085850|NCT02185040|11199212|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0
7085851|NCT02185040|11199213|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0
7085852|NCT02185040|11199214|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0
7085853|NCT02185040|11199215|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1
7085854|NCT02185040|11199216|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1
7085855|NCT02185040|11199210|FG000|Active Treatment Extension Phase|Lost to Follow-up|0
7085856|NCT02185040|11199211|FG001|Active Treatment Extension Phase|Lost to Follow-up|0
7085857|NCT02185040|11199212|FG002|Active Treatment Extension Phase|Lost to Follow-up|0
7085858|NCT02185040|11199213|FG003|Active Treatment Extension Phase|Lost to Follow-up|0
7085859|NCT02185040|11199214|FG004|Active Treatment Extension Phase|Lost to Follow-up|0
6805609|NCT03434379|10807730|FG000|Global Period|Lost to Follow-up|3
6805610|NCT03434379|10807731|FG001|Global Period|Lost to Follow-up|1
6805611|NCT03434379|10807732|FG002|Global Period|Lost to Follow-up|0
6805612|NCT03434379|10807733|FG003|Global Period|Lost to Follow-up|0
6805613|NCT03434379|10807730|FG000|Global Period|Death|99
6805614|NCT03434379|10807731|FG001|Global Period|Death|179
6805615|NCT03434379|10807732|FG002|Global Period|Death|0
6805616|NCT03434379|10807733|FG003|Global Period|Death|0
7058541|NCT01898806|11153900|FG000|Overall Study|Withdrawal by Subject|2
7058542|NCT01898806|11153900|FG000|Overall Study|Physician Decision|1
7058543|NCT01898884|11153909|FG000|Multiple Dose Period|Adverse Event|0
7058544|NCT01898884|11153910|FG001|Multiple Dose Period|Adverse Event|0
7058545|NCT01898884|11153911|FG002|Multiple Dose Period|Adverse Event|0
7058546|NCT01898884|11153912|FG003|Multiple Dose Period|Adverse Event|0
7058547|NCT01898884|11153913|FG004|Multiple Dose Period|Adverse Event|0
7058548|NCT01898884|11153914|FG005|Multiple Dose Period|Adverse Event|0
7058549|NCT01898884|11153915|FG006|Multiple Dose Period|Adverse Event|1
7058550|NCT01898884|11153916|FG007|Multiple Dose Period|Adverse Event|0
7058551|NCT01898884|11153917|FG008|Multiple Dose Period|Adverse Event|0
7058552|NCT01898884|11153909|FG000|Multiple Dose Period|Randomized Not Treated|0
7058553|NCT01898884|11153910|FG001|Multiple Dose Period|Randomized Not Treated|0
7058554|NCT01898884|11153911|FG002|Multiple Dose Period|Randomized Not Treated|0
7058555|NCT01898884|11153912|FG003|Multiple Dose Period|Randomized Not Treated|0
7058556|NCT01898884|11153913|FG004|Multiple Dose Period|Randomized Not Treated|0
7058557|NCT01898884|11153914|FG005|Multiple Dose Period|Randomized Not Treated|0
7058558|NCT01898884|11153915|FG006|Multiple Dose Period|Randomized Not Treated|0
7058559|NCT01898884|11153916|FG007|Multiple Dose Period|Randomized Not Treated|0
7058560|NCT01898884|11153917|FG008|Multiple Dose Period|Randomized Not Treated|1
7058561|NCT01898923|11153955|FG000|Overall Study|Lack of Efficacy|5
7058562|NCT01898923|11153956|FG001|Overall Study|Lack of Efficacy|6
7058563|NCT01898923|11153955|FG000|Overall Study|Adverse Event|3
7058564|NCT01898923|11153956|FG001|Overall Study|Adverse Event|1
7058565|NCT01898923|11153955|FG000|Overall Study|Lost to Follow-up|0
7058566|NCT01898923|11153956|FG001|Overall Study|Lost to Follow-up|1
7058567|NCT01898923|11153955|FG000|Overall Study|Withdrawal by Subject|4
7058568|NCT01898923|11153956|FG001|Overall Study|Withdrawal by Subject|7
7058569|NCT01898923|11153955|FG000|Overall Study|Physician Decision|3
7058570|NCT01898923|11153956|FG001|Overall Study|Physician Decision|4
7058571|NCT01898923|11153955|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1
7058572|NCT01898923|11153956|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2
7058573|NCT01899053|11153976|FG000|Overall Study|Progressive Disease|4
7058574|NCT01899053|11153977|FG001|Overall Study|Progressive Disease|0
7058575|NCT01899053|11153978|FG002|Overall Study|Progressive Disease|3
7058576|NCT01899053|11153979|FG003|Overall Study|Progressive Disease|0
7058577|NCT01899053|11153980|FG004|Overall Study|Progressive Disease|3
7058578|NCT01899053|11153981|FG005|Overall Study|Progressive Disease|1
7058579|NCT01899053|11153982|FG006|Overall Study|Progressive Disease|1
7058580|NCT01899053|11153983|FG007|Overall Study|Progressive Disease|1
7058581|NCT01899053|11153984|FG008|Overall Study|Progressive Disease|4
7058582|NCT01899053|11153985|FG009|Overall Study|Progressive Disease|3
7058583|NCT01899053|11153986|FG010|Overall Study|Progressive Disease|12
7058584|NCT01899053|11153987|FG011|Overall Study|Progressive Disease|5
7058585|NCT01899053|11153988|FG012|Overall Study|Progressive Disease|8
7058586|NCT01899053|11153989|FG013|Overall Study|Progressive Disease|17
7058587|NCT01899053|11153976|FG000|Overall Study|Adverse Event|1
7058588|NCT01899053|11153977|FG001|Overall Study|Adverse Event|1
7058589|NCT01899053|11153978|FG002|Overall Study|Adverse Event|1
7058590|NCT01899053|11153979|FG003|Overall Study|Adverse Event|3
7058591|NCT01899053|11153980|FG004|Overall Study|Adverse Event|1
7058592|NCT01899053|11153981|FG005|Overall Study|Adverse Event|1
7058593|NCT01899053|11153982|FG006|Overall Study|Adverse Event|1
7058594|NCT01899053|11153983|FG007|Overall Study|Adverse Event|0
7058595|NCT01899053|11153984|FG008|Overall Study|Adverse Event|2
7058596|NCT01899053|11153985|FG009|Overall Study|Adverse Event|0
7058597|NCT01899053|11153986|FG010|Overall Study|Adverse Event|3
7058598|NCT01899053|11153987|FG011|Overall Study|Adverse Event|1
7058599|NCT01899053|11153988|FG012|Overall Study|Adverse Event|2
7058600|NCT01899053|11153989|FG013|Overall Study|Adverse Event|2
7058601|NCT01899053|11153976|FG000|Overall Study|Reason Not Specified|0
7058602|NCT01899053|11153977|FG001|Overall Study|Reason Not Specified|0
7058603|NCT01899053|11153978|FG002|Overall Study|Reason Not Specified|0
7058604|NCT01899053|11153979|FG003|Overall Study|Reason Not Specified|0
7058605|NCT01899053|11153980|FG004|Overall Study|Reason Not Specified|0
7058606|NCT01899053|11153981|FG005|Overall Study|Reason Not Specified|0
7058607|NCT01899053|11153982|FG006|Overall Study|Reason Not Specified|1
7058608|NCT01899053|11153983|FG007|Overall Study|Reason Not Specified|0
7058609|NCT01899053|11153984|FG008|Overall Study|Reason Not Specified|0
7058610|NCT01899053|11153985|FG009|Overall Study|Reason Not Specified|0
7058611|NCT01899053|11153986|FG010|Overall Study|Reason Not Specified|0
7058612|NCT01899053|11153987|FG011|Overall Study|Reason Not Specified|0
7058613|NCT01899053|11153988|FG012|Overall Study|Reason Not Specified|1
7058614|NCT01899053|11153989|FG013|Overall Study|Reason Not Specified|0
7058615|NCT01899053|11153976|FG000|Overall Study|Withdrawal by Subject|1
7058616|NCT01899053|11153977|FG001|Overall Study|Withdrawal by Subject|1
7058617|NCT01899053|11153978|FG002|Overall Study|Withdrawal by Subject|2
7058618|NCT01899053|11153979|FG003|Overall Study|Withdrawal by Subject|0
7058619|NCT01899053|11153980|FG004|Overall Study|Withdrawal by Subject|2
7058620|NCT01899053|11153981|FG005|Overall Study|Withdrawal by Subject|0
7058621|NCT01899053|11153982|FG006|Overall Study|Withdrawal by Subject|0
7058622|NCT01899053|11153983|FG007|Overall Study|Withdrawal by Subject|1
7058623|NCT01899053|11153984|FG008|Overall Study|Withdrawal by Subject|0
7058624|NCT01899053|11153985|FG009|Overall Study|Withdrawal by Subject|0
7058625|NCT01899053|11153986|FG010|Overall Study|Withdrawal by Subject|0
7058626|NCT01899053|11153987|FG011|Overall Study|Withdrawal by Subject|0
7058627|NCT01899053|11153988|FG012|Overall Study|Withdrawal by Subject|1
7058628|NCT01899053|11153989|FG013|Overall Study|Withdrawal by Subject|1
7058629|NCT01899053|11153976|FG000|Overall Study|Protocol Violation|0
7058630|NCT01899053|11153977|FG001|Overall Study|Protocol Violation|0
7058631|NCT01899053|11153978|FG002|Overall Study|Protocol Violation|1
7058632|NCT01899053|11153979|FG003|Overall Study|Protocol Violation|0
7058633|NCT01899053|11153980|FG004|Overall Study|Protocol Violation|0
7058634|NCT01899053|11153981|FG005|Overall Study|Protocol Violation|0
7058635|NCT01899053|11153982|FG006|Overall Study|Protocol Violation|0
7058636|NCT01899053|11153983|FG007|Overall Study|Protocol Violation|0
7058637|NCT01899053|11153984|FG008|Overall Study|Protocol Violation|0
7058638|NCT01899053|11153985|FG009|Overall Study|Protocol Violation|0
7058639|NCT01899053|11153986|FG010|Overall Study|Protocol Violation|0
7058640|NCT01899053|11153987|FG011|Overall Study|Protocol Violation|0
7058641|NCT01899053|11153988|FG012|Overall Study|Protocol Violation|0
7058642|NCT01899053|11153989|FG013|Overall Study|Protocol Violation|0
7058643|NCT01899053|11153976|FG000|Overall Study|Unsatisfactory Therapeutic Response|1
7058644|NCT01899053|11153977|FG001|Overall Study|Unsatisfactory Therapeutic Response|1
7058645|NCT01899053|11153978|FG002|Overall Study|Unsatisfactory Therapeutic Response|0
7058646|NCT01899053|11153979|FG003|Overall Study|Unsatisfactory Therapeutic Response|0
7058647|NCT01899053|11153980|FG004|Overall Study|Unsatisfactory Therapeutic Response|0
7058648|NCT01899053|11153981|FG005|Overall Study|Unsatisfactory Therapeutic Response|0
7058649|NCT01899053|11153982|FG006|Overall Study|Unsatisfactory Therapeutic Response|0
7058650|NCT01899053|11153983|FG007|Overall Study|Unsatisfactory Therapeutic Response|0
7058651|NCT01899053|11153984|FG008|Overall Study|Unsatisfactory Therapeutic Response|0
7058652|NCT01899053|11153985|FG009|Overall Study|Unsatisfactory Therapeutic Response|0
7058653|NCT01899053|11153986|FG010|Overall Study|Unsatisfactory Therapeutic Response|1
7058654|NCT01899053|11153987|FG011|Overall Study|Unsatisfactory Therapeutic Response|0
7058655|NCT01899053|11153988|FG012|Overall Study|Unsatisfactory Therapeutic Response|0
7058656|NCT01899053|11153989|FG013|Overall Study|Unsatisfactory Therapeutic Response|0
7058657|NCT01899053|11153976|FG000|Overall Study|Symptomatic Deterioration|0
7058658|NCT01899053|11153977|FG001|Overall Study|Symptomatic Deterioration|0
7058659|NCT01899053|11153978|FG002|Overall Study|Symptomatic Deterioration|0
7058660|NCT01899053|11153979|FG003|Overall Study|Symptomatic Deterioration|0
7058661|NCT01899053|11153980|FG004|Overall Study|Symptomatic Deterioration|0
7058662|NCT01899053|11153981|FG005|Overall Study|Symptomatic Deterioration|1
7058663|NCT01899053|11153982|FG006|Overall Study|Symptomatic Deterioration|0
7058664|NCT01899053|11153983|FG007|Overall Study|Symptomatic Deterioration|1
7058665|NCT01899053|11153984|FG008|Overall Study|Symptomatic Deterioration|0
7058666|NCT01899053|11153985|FG009|Overall Study|Symptomatic Deterioration|0
7058667|NCT01899053|11153986|FG010|Overall Study|Symptomatic Deterioration|0
7058668|NCT01899053|11153987|FG011|Overall Study|Symptomatic Deterioration|1
7058669|NCT01899053|11153988|FG012|Overall Study|Symptomatic Deterioration|2
7058670|NCT01899053|11153989|FG013|Overall Study|Symptomatic Deterioration|0
7058671|NCT01899742|11154039|FG000|Overall Study|Adverse Event|5
7058672|NCT01899742|11154040|FG001|Overall Study|Adverse Event|4
7058673|NCT01899742|11154039|FG000|Overall Study|Lack of Efficacy|1
7058674|NCT01899742|11154040|FG001|Overall Study|Lack of Efficacy|5
7058675|NCT01899742|11154039|FG000|Overall Study|Protocol Violation|2
7058676|NCT01899742|11154040|FG001|Overall Study|Protocol Violation|2
7058677|NCT01899742|11154039|FG000|Overall Study|Withdrawal by Subject|9
7058678|NCT01899742|11154040|FG001|Overall Study|Withdrawal by Subject|5
7058679|NCT01899768|11154046|FG000|Part A|Adverse Event|2
7058680|NCT01899768|11154046|FG000|Part A|Withdrawal by Subject|1
7058681|NCT01899768|11154046|FG000|Part B|Adverse Event|1
7058682|NCT01899768|11154046|FG000|Part B|Withdrawal by Subject|1
7058683|NCT01900054|11154058|FG000|Overall Study|Physician Decision|1
7058684|NCT01900054|11154058|FG000|Overall Study|Withdrawal by Subject|1
7058685|NCT01900314|11154086|FG000|Overall Study|Lost to Follow-up|1
7058686|NCT01900314|11154087|FG001|Overall Study|Lost to Follow-up|0
7058687|NCT01900314|11154086|FG000|Overall Study|Protocol Violation|0
7058688|NCT01900314|11154087|FG001|Overall Study|Protocol Violation|1
7058689|NCT01900314|11154086|FG000|Overall Study|Withdrawal by Subject|3
7058690|NCT01900314|11154087|FG001|Overall Study|Withdrawal by Subject|3
7058691|NCT01900431|11154109|FG000|Principal Treatment Period (Part A)|Adverse Event|1
7058692|NCT01900431|11154110|FG001|Principal Treatment Period (Part A)|Adverse Event|3
7058693|NCT01900431|11154111|FG002|Principal Treatment Period (Part A)|Adverse Event|0
7058694|NCT01900431|11154109|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6
7058695|NCT01900431|11154110|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6
7058696|NCT01900431|11154111|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0
7058697|NCT01900431|11154109|FG000|Principal Treatment Period (Part A)|Other than specified above|0
7058698|NCT01900431|11154110|FG001|Principal Treatment Period (Part A)|Other than specified above|1
7058699|NCT01900431|11154111|FG002|Principal Treatment Period (Part A)|Other than specified above|0
7058700|NCT01900431|11154109|FG000|Extended Treatment Period (Part B)|Adverse Event|0
7058701|NCT01900431|11154110|FG001|Extended Treatment Period (Part B)|Adverse Event|2
7058702|NCT01900431|11154111|FG002|Extended Treatment Period (Part B)|Adverse Event|0
7058703|NCT01900431|11154109|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1
7058704|NCT01900431|11154110|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7
7058705|NCT01900431|11154111|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0
7058706|NCT01900431|11154109|FG000|Extended Treatment Period (Part B)|Other than specified above|0
7058707|NCT01900431|11154110|FG001|Extended Treatment Period (Part B)|Other than specified above|1
7058708|NCT01900431|11154111|FG002|Extended Treatment Period (Part B)|Other than specified above|0
7058709|NCT01900431|11154109|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0
7058710|NCT01900431|11154110|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0
7058711|NCT01900431|11154111|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2
7058712|NCT01900431|11154109|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
7058713|NCT01900431|11154110|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
7058714|NCT01900431|11154111|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3
7058715|NCT01900431|11154109|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
7058716|NCT01900431|11154110|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
7058717|NCT01900431|11154111|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3
7058718|NCT01900652|11154130|FG000|Overall Study|Progressive Disease|1
7058719|NCT01900652|11154131|FG001|Overall Study|Progressive Disease|0
7058720|NCT01900652|11154130|FG000|Overall Study|Consent withdrawn by subject|1
7058721|NCT01900652|11154131|FG001|Overall Study|Consent withdrawn by subject|1
7058722|NCT01900652|11154130|FG000|Overall Study|Death|3
7058723|NCT01900652|11154131|FG001|Overall Study|Death|0
7058724|NCT01900652|11154130|FG000|Overall Study|Adverse Event|2
7058725|NCT01900652|11154131|FG001|Overall Study|Adverse Event|1
7058726|NCT01900652|11154130|FG000|Overall Study|Physician Decision|1
7058727|NCT01900652|11154131|FG001|Overall Study|Physician Decision|1
7058728|NCT01900665|11154144|FG000|Placebo Controlled Period|Death|9
7058729|NCT01900665|11154145|FG001|Placebo Controlled Period|Death|16
7058730|NCT01900665|11154144|FG000|Placebo Controlled Period|Adverse Event|48
7058731|NCT01900665|11154145|FG001|Placebo Controlled Period|Adverse Event|39
7058732|NCT01900665|11154144|FG000|Placebo Controlled Period|Protocol Violation|1
7058733|NCT01900665|11154145|FG001|Placebo Controlled Period|Protocol Violation|7
7058734|NCT01900665|11154144|FG000|Placebo Controlled Period|Withdrawal by Subject|33
7058735|NCT01900665|11154145|FG001|Placebo Controlled Period|Withdrawal by Subject|45
7058736|NCT01900665|11154144|FG000|Placebo Controlled Period|Physician Decision|11
7058737|NCT01900665|11154145|FG001|Placebo Controlled Period|Physician Decision|7
7058738|NCT01900665|11154144|FG000|Placebo Controlled Period|Lost to Follow-up|3
7058739|NCT01900665|11154145|FG001|Placebo Controlled Period|Lost to Follow-up|0
7058740|NCT01900665|11154144|FG000|Placebo Controlled Period|Caregiver Decision|33
7058741|NCT01900665|11154145|FG001|Placebo Controlled Period|Caregiver Decision|41
7058742|NCT01900665|11154144|FG000|Placebo Controlled Period|Entry Criteria Not Met|5
7058743|NCT01900665|11154145|FG001|Placebo Controlled Period|Entry Criteria Not Met|9
7058744|NCT01900665|11154144|FG000|Open Label Period|Adverse Event|16
7058745|NCT01900665|11154145|FG001|Open Label Period|Adverse Event|20
7058746|NCT01900665|11154144|FG000|Open Label Period|Death|5
7058747|NCT01900665|11154145|FG001|Open Label Period|Death|6
7058748|NCT01900665|11154144|FG000|Open Label Period|Lost to Follow-up|1
7058749|NCT01900665|11154145|FG001|Open Label Period|Lost to Follow-up|1
7058750|NCT01900665|11154144|FG000|Open Label Period|Parent/Caregiver Decision|33
7058751|NCT01900665|11154145|FG001|Open Label Period|Parent/Caregiver Decision|34
7058752|NCT01900665|11154144|FG000|Open Label Period|Physician Decision|4
7058753|NCT01900665|11154145|FG001|Open Label Period|Physician Decision|4
7058754|NCT01900665|11154144|FG000|Open Label Period|Protocol Violation|0
7058755|NCT01900665|11154145|FG001|Open Label Period|Protocol Violation|1
7058756|NCT01900665|11154144|FG000|Open Label Period|Sponsor Decision|802
7058757|NCT01900665|11154145|FG001|Open Label Period|Sponsor Decision|765
7058758|NCT01900665|11154144|FG000|Open Label Period|Withdrawal by Subject|20
7058759|NCT01900665|11154145|FG001|Open Label Period|Withdrawal by Subject|28
7058760|NCT01900899|11154170|FG000|Overall Study|Withdrawal by Subject|7
7058761|NCT01900899|11154171|FG001|Overall Study|Withdrawal by Subject|1
7058762|NCT01900899|11154170|FG000|Overall Study|Migrated from study area|2
7058763|NCT01900899|11154171|FG001|Overall Study|Migrated from study area|0
7058764|NCT01901055|11154179|FG000|Randomization But Not Titrated|Did not come to titration study|1
7058765|NCT01901055|11154180|FG001|Randomization But Not Titrated|Did not come to titration study|1
7058766|NCT01901055|11154179|FG000|Randomization But Not Titrated|Physician Decision|0
7058767|NCT01901055|11154180|FG001|Randomization But Not Titrated|Physician Decision|1
7058768|NCT01901055|11154179|FG000|Started Protocol to Week 6|Physician Decision|2
7058769|NCT01901055|11154180|FG001|Started Protocol to Week 6|Physician Decision|1
7058770|NCT01901055|11154179|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0
7058771|NCT01901055|11154180|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2
7058772|NCT01901055|11154179|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1
7058773|NCT01901055|11154180|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0
7058774|NCT01901055|11154179|FG000|Started Protocol to Week 6|Withdrawal by Subject|0
7058775|NCT01901055|11154180|FG001|Started Protocol to Week 6|Withdrawal by Subject|1
7058776|NCT01901055|11154179|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1
7058777|NCT01901055|11154180|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0
7058778|NCT01901055|11154179|FG000|Week 12 Assessment|Withdrawal by Subject|0
7058779|NCT01901055|11154180|FG001|Week 12 Assessment|Withdrawal by Subject|4
7058780|NCT01901055|11154179|FG000|Week 24|Withdrawal by Subject|13
7058781|NCT01901055|11154180|FG001|Week 24|Withdrawal by Subject|19
7058782|NCT01901055|11154179|FG000|Week 24|Physician Decision|1
7058783|NCT01901055|11154180|FG001|Week 24|Physician Decision|0
7058784|NCT01901055|11154179|FG000|Week 36|Withdrawal by Subject|0
7058785|NCT01901055|11154180|FG001|Week 36|Withdrawal by Subject|5
7058786|NCT01901146|11154191|FG000|Neoadjuvant Phase|Death|1
7058787|NCT01901146|11154192|FG001|Neoadjuvant Phase|Death|2
7058788|NCT01901146|11154193|FG002|Neoadjuvant Phase|Death|0
7058789|NCT01901146|11154194|FG003|Neoadjuvant Phase|Death|0
7058790|NCT01901146|11154195|FG004|Neoadjuvant Phase|Death|0
7058791|NCT01901146|11154191|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2
7058792|NCT01901146|11154192|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3
7058793|NCT01901146|11154193|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0
7058794|NCT01901146|11154194|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0
7058795|NCT01901146|11154195|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0
7058796|NCT01901146|11154191|FG000|Neoadjuvant Phase|Lost to Follow-up|0
7058797|NCT01901146|11154192|FG001|Neoadjuvant Phase|Lost to Follow-up|1
7058798|NCT01901146|11154193|FG002|Neoadjuvant Phase|Lost to Follow-up|0
7058799|NCT01901146|11154194|FG003|Neoadjuvant Phase|Lost to Follow-up|0
7058800|NCT01901146|11154195|FG004|Neoadjuvant Phase|Lost to Follow-up|0
7058801|NCT01901146|11154191|FG000|Neoadjuvant Phase|Physician Decision|1
7058802|NCT01901146|11154192|FG001|Neoadjuvant Phase|Physician Decision|2
7058803|NCT01901146|11154193|FG002|Neoadjuvant Phase|Physician Decision|0
7058804|NCT01901146|11154194|FG003|Neoadjuvant Phase|Physician Decision|0
7058805|NCT01901146|11154195|FG004|Neoadjuvant Phase|Physician Decision|0
7058806|NCT01901146|11154191|FG000|Neoadjuvant Phase|Withdrawal by Subject|2
7058807|NCT01901146|11154192|FG001|Neoadjuvant Phase|Withdrawal by Subject|5
7058808|NCT01901146|11154193|FG002|Neoadjuvant Phase|Withdrawal by Subject|0
7058809|NCT01901146|11154194|FG003|Neoadjuvant Phase|Withdrawal by Subject|0
7058810|NCT01901146|11154195|FG004|Neoadjuvant Phase|Withdrawal by Subject|0
7058811|NCT01901146|11154191|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0
7058812|NCT01901146|11154192|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1
7058813|NCT01901146|11154193|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0
7058814|NCT01901146|11154194|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0
7058815|NCT01901146|11154195|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0
7058816|NCT01901146|11154191|FG000|Adjuvant Phase|Other|0
7058817|NCT01901146|11154192|FG001|Adjuvant Phase|Other|0
7058818|NCT01901146|11154193|FG002|Adjuvant Phase|Other|1
7058819|NCT01901146|11154194|FG003|Adjuvant Phase|Other|0
7058820|NCT01901146|11154195|FG004|Adjuvant Phase|Other|0
7058821|NCT01901146|11154191|FG000|Adjuvant Phase|Death|0
7058822|NCT01901146|11154192|FG001|Adjuvant Phase|Death|0
7058823|NCT01901146|11154193|FG002|Adjuvant Phase|Death|0
7058824|NCT01901146|11154194|FG003|Adjuvant Phase|Death|0
7058825|NCT01901146|11154195|FG004|Adjuvant Phase|Death|3
7058826|NCT01901146|11154191|FG000|Adjuvant Phase|Disease Progression or Recurrence|0
7058827|NCT01901146|11154192|FG001|Adjuvant Phase|Disease Progression or Recurrence|0
7058828|NCT01901146|11154193|FG002|Adjuvant Phase|Disease Progression or Recurrence|12
7058829|NCT01901146|11154194|FG003|Adjuvant Phase|Disease Progression or Recurrence|4
7058830|NCT01901146|11154195|FG004|Adjuvant Phase|Disease Progression or Recurrence|3
7058831|NCT01901146|11154191|FG000|Adjuvant Phase|Physician Decision|0
7058832|NCT01901146|11154192|FG001|Adjuvant Phase|Physician Decision|0
7058833|NCT01901146|11154193|FG002|Adjuvant Phase|Physician Decision|9
7058834|NCT01901146|11154194|FG003|Adjuvant Phase|Physician Decision|2
7058835|NCT01901146|11154195|FG004|Adjuvant Phase|Physician Decision|4
7058836|NCT01901146|11154191|FG000|Adjuvant Phase|Withdrawal by Subject|0
7058837|NCT01901146|11154192|FG001|Adjuvant Phase|Withdrawal by Subject|0
7058838|NCT01901146|11154193|FG002|Adjuvant Phase|Withdrawal by Subject|4
7058839|NCT01901146|11154194|FG003|Adjuvant Phase|Withdrawal by Subject|1
7058840|NCT01901146|11154195|FG004|Adjuvant Phase|Withdrawal by Subject|4
7058841|NCT01901185|11154204|FG000|Overall Study|Withdrawal by Subject|2
7058842|NCT01901302|11154228|FG000|Overall Study|Adverse Event|2
7058843|NCT01901302|11154229|FG001|Overall Study|Adverse Event|1
7058844|NCT01901302|11154228|FG000|Overall Study|Lack of Efficacy|0
7058845|NCT01901302|11154229|FG001|Overall Study|Lack of Efficacy|2
7058846|NCT01901302|11154228|FG000|Overall Study|Study Terminated by Sponsor|23
7058847|NCT01901302|11154229|FG001|Overall Study|Study Terminated by Sponsor|20
7058848|NCT01901302|11154228|FG000|Overall Study|Withdrawal by Subject|2
7058849|NCT01901302|11154229|FG001|Overall Study|Withdrawal by Subject|0
7058850|NCT01901328|11154237|FG000|Overall Study|Lost to Follow-up|1
7058851|NCT01901328|11154238|FG001|Overall Study|Lost to Follow-up|0
7058852|NCT01901328|11154237|FG000|Overall Study|Physician Decision|0
7058853|NCT01901328|11154238|FG001|Overall Study|Physician Decision|1
7058854|NCT01901328|11154237|FG000|Overall Study|Protocol Violation|1
7058855|NCT01901328|11154238|FG001|Overall Study|Protocol Violation|1
7058856|NCT01901328|11154237|FG000|Overall Study|Study Terminated by Sponsor|19
7058857|NCT01901328|11154238|FG001|Overall Study|Study Terminated by Sponsor|16
7058858|NCT01901328|11154237|FG000|Overall Study|Withdrawal by Subject|1
7058859|NCT01901328|11154238|FG001|Overall Study|Withdrawal by Subject|2
7058860|NCT01901328|11154237|FG000|Overall Study|Lack of Efficacy|0
7058861|NCT01901328|11154238|FG001|Overall Study|Lack of Efficacy|1
7058862|NCT01901341|11154247|FG000|Overall Study|Adverse Event|4
7058863|NCT01901341|11154248|FG001|Overall Study|Adverse Event|2
7058864|NCT01901341|11154247|FG000|Overall Study|Lack of Efficacy|0
7058865|NCT01901341|11154248|FG001|Overall Study|Lack of Efficacy|2
7058866|NCT01901341|11154247|FG000|Overall Study|Lost to Follow-up|0
7058867|NCT01901341|11154248|FG001|Overall Study|Lost to Follow-up|1
7058868|NCT01901341|11154247|FG000|Overall Study|Protocol Violation|2
7058869|NCT01901341|11154248|FG001|Overall Study|Protocol Violation|0
7058870|NCT01901341|11154247|FG000|Overall Study|Study Terminated by Sponsor|13
7058871|NCT01901341|11154248|FG001|Overall Study|Study Terminated by Sponsor|15
7058872|NCT01901341|11154247|FG000|Overall Study|Withdrawal by Subject|1
7058873|NCT01901341|11154248|FG001|Overall Study|Withdrawal by Subject|1
7058874|NCT01901393|11154257|FG000|Overall Study|Adverse Event|1
7058875|NCT01901393|11154258|FG001|Overall Study|Adverse Event|0
7058876|NCT01901419|11154266|FG000|Overall Study|Protocol Violation|2
7058877|NCT01901419|11154267|FG001|Overall Study|Protocol Violation|6
7058878|NCT01901419|11154266|FG000|Overall Study|unavailable researchers|6
7058879|NCT01901419|11154267|FG001|Overall Study|unavailable researchers|3
7058880|NCT01901614|11154289|FG000|Overall Study|Adverse Event|0
7058881|NCT01901614|11154290|FG001|Overall Study|Adverse Event|1
7058882|NCT01901614|11154289|FG000|Overall Study|Lost to Follow-up|1
7058883|NCT01901614|11154290|FG001|Overall Study|Lost to Follow-up|0
7058884|NCT01901614|11154289|FG000|Overall Study|Screen Fail|1
7058885|NCT01901614|11154290|FG001|Overall Study|Screen Fail|0
7058886|NCT01901653|11154309|FG000|Overall Study|Death|2
7058887|NCT01901653|11154310|FG001|Overall Study|Death|1
7058888|NCT01901653|11154311|FG002|Overall Study|Death|8
7058889|NCT01901653|11154312|FG003|Overall Study|Death|3
7058890|NCT01901653|11154313|FG004|Overall Study|Death|2
7058891|NCT01901653|11154314|FG005|Overall Study|Death|2
7058892|NCT01901653|11154315|FG006|Overall Study|Death|6
7058893|NCT01901653|11154316|FG007|Overall Study|Death|9
7058894|NCT01901653|11154317|FG008|Overall Study|Death|1
7058895|NCT01901653|11154318|FG009|Overall Study|Death|16
7058896|NCT01901653|11154319|FG010|Overall Study|Death|2
7058897|NCT01901653|11154320|FG011|Overall Study|Death|15
7058898|NCT01901653|11154321|FG012|Overall Study|Death|4
7058899|NCT01901653|11154309|FG000|Overall Study|Lost to Follow-up|1
7058900|NCT01901653|11154310|FG001|Overall Study|Lost to Follow-up|0
7058901|NCT01901653|11154311|FG002|Overall Study|Lost to Follow-up|2
7058902|NCT01901653|11154312|FG003|Overall Study|Lost to Follow-up|0
7058903|NCT01901653|11154313|FG004|Overall Study|Lost to Follow-up|0
7058904|NCT01901653|11154314|FG005|Overall Study|Lost to Follow-up|1
7058905|NCT01901653|11154315|FG006|Overall Study|Lost to Follow-up|0
7058906|NCT01901653|11154316|FG007|Overall Study|Lost to Follow-up|1
7058907|NCT01901653|11154317|FG008|Overall Study|Lost to Follow-up|0
7058908|NCT01901653|11154318|FG009|Overall Study|Lost to Follow-up|0
7058909|NCT01901653|11154319|FG010|Overall Study|Lost to Follow-up|0
7058910|NCT01901653|11154320|FG011|Overall Study|Lost to Follow-up|0
7058911|NCT01901653|11154321|FG012|Overall Study|Lost to Follow-up|0
7058912|NCT01901653|11154309|FG000|Overall Study|Withdrawal by Subject|0
7058913|NCT01901653|11154310|FG001|Overall Study|Withdrawal by Subject|0
7058914|NCT01901653|11154311|FG002|Overall Study|Withdrawal by Subject|0
7058915|NCT01901653|11154312|FG003|Overall Study|Withdrawal by Subject|0
7058916|NCT01901653|11154313|FG004|Overall Study|Withdrawal by Subject|0
7058917|NCT01901653|11154314|FG005|Overall Study|Withdrawal by Subject|0
7058918|NCT01901653|11154315|FG006|Overall Study|Withdrawal by Subject|1
7058919|NCT01901653|11154316|FG007|Overall Study|Withdrawal by Subject|0
7058920|NCT01901653|11154317|FG008|Overall Study|Withdrawal by Subject|0
7058921|NCT01901653|11154318|FG009|Overall Study|Withdrawal by Subject|0
7058922|NCT01901653|11154319|FG010|Overall Study|Withdrawal by Subject|0
7058923|NCT01901653|11154320|FG011|Overall Study|Withdrawal by Subject|0
7058924|NCT01901653|11154321|FG012|Overall Study|Withdrawal by Subject|0
7058925|NCT01901653|11154309|FG000|Overall Study|Alive at Study Termination by Sponsor|0
7058926|NCT01901653|11154310|FG001|Overall Study|Alive at Study Termination by Sponsor|0
7058927|NCT01901653|11154311|FG002|Overall Study|Alive at Study Termination by Sponsor|1
7058928|NCT01901653|11154312|FG003|Overall Study|Alive at Study Termination by Sponsor|0
7058929|NCT01901653|11154313|FG004|Overall Study|Alive at Study Termination by Sponsor|0
7058930|NCT01901653|11154314|FG005|Overall Study|Alive at Study Termination by Sponsor|0
7058931|NCT01901653|11154315|FG006|Overall Study|Alive at Study Termination by Sponsor|0
7058932|NCT01901653|11154316|FG007|Overall Study|Alive at Study Termination by Sponsor|0
7058933|NCT01901653|11154317|FG008|Overall Study|Alive at Study Termination by Sponsor|0
7058934|NCT01901653|11154318|FG009|Overall Study|Alive at Study Termination by Sponsor|2
7058935|NCT01901653|11154319|FG010|Overall Study|Alive at Study Termination by Sponsor|0
7058936|NCT01901653|11154320|FG011|Overall Study|Alive at Study Termination by Sponsor|1
7058937|NCT01901653|11154321|FG012|Overall Study|Alive at Study Termination by Sponsor|1
7058938|NCT01901848|11154370|FG000|Randomized and Treated|Lost to Follow-up|3
7058939|NCT01901848|11154371|FG001|Randomized and Treated|Lost to Follow-up|6
7058940|NCT01901848|11154370|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10
7058941|NCT01901848|11154371|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0
7058942|NCT01901874|11154377|FG000|Screening Committee Retrospective Review|Protocol Violation|47
7058943|NCT01901874|11154377|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1
7058944|NCT01901874|11154377|FG000|1-Year (365-Day) MAE Evaluation|Death|7
7058945|NCT01901874|11154377|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5
7058946|NCT01901874|11154377|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2
7058947|NCT01901874|11154377|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6
7058948|NCT01902134|11154396|FG000|Overall Study|Adverse Event|3
7058949|NCT01902134|11154397|FG001|Overall Study|Adverse Event|1
7058950|NCT01902134|11154398|FG002|Overall Study|Adverse Event|2
7058951|NCT01902134|11154399|FG003|Overall Study|Adverse Event|1
7058952|NCT01902134|11154400|FG004|Overall Study|Adverse Event|1
7058953|NCT01902134|11154401|FG005|Overall Study|Adverse Event|3
7058954|NCT01902134|11154396|FG000|Overall Study|Lack of Efficacy|0
7058955|NCT01902134|11154397|FG001|Overall Study|Lack of Efficacy|0
7058956|NCT01902134|11154398|FG002|Overall Study|Lack of Efficacy|2
7058957|NCT01902134|11154399|FG003|Overall Study|Lack of Efficacy|0
7058958|NCT01902134|11154400|FG004|Overall Study|Lack of Efficacy|0
7058959|NCT01902134|11154401|FG005|Overall Study|Lack of Efficacy|1
7058960|NCT01902134|11154396|FG000|Overall Study|Physician Decision|0
7058961|NCT01902134|11154397|FG001|Overall Study|Physician Decision|1
7058962|NCT01902134|11154398|FG002|Overall Study|Physician Decision|0
7058963|NCT01902134|11154399|FG003|Overall Study|Physician Decision|0
7058964|NCT01902134|11154400|FG004|Overall Study|Physician Decision|0
7058965|NCT01902134|11154401|FG005|Overall Study|Physician Decision|0
7058966|NCT01902134|11154396|FG000|Overall Study|Protocol Violation|0
7058967|NCT01902134|11154397|FG001|Overall Study|Protocol Violation|0
7058968|NCT01902134|11154398|FG002|Overall Study|Protocol Violation|0
7058969|NCT01902134|11154399|FG003|Overall Study|Protocol Violation|0
7058970|NCT01902134|11154400|FG004|Overall Study|Protocol Violation|0
7058971|NCT01902134|11154401|FG005|Overall Study|Protocol Violation|1
7058972|NCT01902134|11154396|FG000|Overall Study|Withdrawal by Subject|4
7058973|NCT01902134|11154397|FG001|Overall Study|Withdrawal by Subject|8
7058974|NCT01902134|11154398|FG002|Overall Study|Withdrawal by Subject|9
7058975|NCT01902134|11154399|FG003|Overall Study|Withdrawal by Subject|1
7058976|NCT01902134|11154400|FG004|Overall Study|Withdrawal by Subject|5
7058977|NCT01902134|11154401|FG005|Overall Study|Withdrawal by Subject|4
7058978|NCT01902134|11154396|FG000|Overall Study|no compliance|1
7058979|NCT01902134|11154397|FG001|Overall Study|no compliance|0
7058980|NCT01902134|11154398|FG002|Overall Study|no compliance|0
7058981|NCT01902134|11154399|FG003|Overall Study|no compliance|0
7058982|NCT01902134|11154400|FG004|Overall Study|no compliance|0
7058983|NCT01902134|11154401|FG005|Overall Study|no compliance|0
7058984|NCT01902134|11154396|FG000|Overall Study|Other|0
7058985|NCT01902134|11154397|FG001|Overall Study|Other|1
7058986|NCT01902134|11154398|FG002|Overall Study|Other|2
7058987|NCT01902134|11154399|FG003|Overall Study|Other|0
7058988|NCT01902134|11154400|FG004|Overall Study|Other|1
7058989|NCT01902134|11154401|FG005|Overall Study|Other|0
7058990|NCT01902303|11154419|FG000|Overall Study|Adverse Event|0
7058991|NCT01902303|11154420|FG001|Overall Study|Adverse Event|1
7058992|NCT01902303|11154419|FG000|Overall Study|Lost to Follow-up|0
7058993|NCT01902303|11154420|FG001|Overall Study|Lost to Follow-up|1
7058994|NCT01902303|11154419|FG000|Overall Study|Protocol Violation|2
7058995|NCT01902303|11154420|FG001|Overall Study|Protocol Violation|2
7058996|NCT01902303|11154419|FG000|Overall Study|subject lost investigational product|0
7058997|NCT01902303|11154420|FG001|Overall Study|subject lost investigational product|1
7058998|NCT01902303|11154419|FG000|Overall Study|Did not develop a cold sore|21
7058999|NCT01902303|11154420|FG001|Overall Study|Did not develop a cold sore|19
7059000|NCT01902628|11154437|FG000|Overall Study|Withdrawal of participant's consent|7
7059001|NCT01902628|11154437|FG000|Overall Study|Adverse Event|41
7059002|NCT01902628|11154437|FG000|Overall Study|Lost to Follow-up|35
7059003|NCT01903031|11154473|FG000|Overall Study|Not Able to Attend Clinic|1
7059004|NCT01903031|11154474|FG001|Overall Study|Not Able to Attend Clinic|1
7059005|NCT01903031|11154475|FG002|Overall Study|Not Able to Attend Clinic|0
7059006|NCT01903031|11154473|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1
7059007|NCT01903031|11154474|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0
7059008|NCT01903031|11154475|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0
7059009|NCT01903031|11154473|FG000|Overall Study|Adverse Event|0
7059010|NCT01903031|11154474|FG001|Overall Study|Adverse Event|1
7059011|NCT01903031|11154475|FG002|Overall Study|Adverse Event|0
7059012|NCT01903031|11154473|FG000|Overall Study|Withdrawal by Subject|0
7059013|NCT01903031|11154474|FG001|Overall Study|Withdrawal by Subject|1
7059014|NCT01903031|11154475|FG002|Overall Study|Withdrawal by Subject|1
7059015|NCT01903031|11154473|FG000|Overall Study|Protocol Violation|0
7059016|NCT01903031|11154474|FG001|Overall Study|Protocol Violation|0
7059017|NCT01903031|11154475|FG002|Overall Study|Protocol Violation|2
7059018|NCT01903031|11154473|FG000|Overall Study|Lost to Follow-up|0
7059019|NCT01903031|11154474|FG001|Overall Study|Lost to Follow-up|0
7059020|NCT01903031|11154475|FG002|Overall Study|Lost to Follow-up|1
7059021|NCT01903031|11154473|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0
7059022|NCT01903031|11154474|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0
7059023|NCT01903031|11154475|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1
7059024|NCT01903252|11154506|FG000|Double-Blind Induction|Adverse Event|20
7059025|NCT01903252|11154507|FG001|Double-Blind Induction|Adverse Event|18
7059026|NCT01903252|11154508|FG002|Double-Blind Induction|Adverse Event|0
7059027|NCT01903252|11154509|FG003|Double-Blind Induction|Adverse Event|0
7059028|NCT01903252|11154510|FG004|Double-Blind Induction|Adverse Event|0
7059029|NCT01903252|11154511|FG005|Double-Blind Induction|Adverse Event|0
7059030|NCT01903252|11154506|FG000|Double-Blind Induction|Withdrawal by Subject|10
7059031|NCT01903252|11154507|FG001|Double-Blind Induction|Withdrawal by Subject|13
7059032|NCT01903252|11154508|FG002|Double-Blind Induction|Withdrawal by Subject|0
7059033|NCT01903252|11154509|FG003|Double-Blind Induction|Withdrawal by Subject|0
7059034|NCT01903252|11154510|FG004|Double-Blind Induction|Withdrawal by Subject|0
7059035|NCT01903252|11154511|FG005|Double-Blind Induction|Withdrawal by Subject|0
7059036|NCT01903252|11154506|FG000|Double-Blind Induction|Physician Decision|2
7059037|NCT01903252|11154507|FG001|Double-Blind Induction|Physician Decision|3
7059038|NCT01903252|11154508|FG002|Double-Blind Induction|Physician Decision|0
7059039|NCT01903252|11154509|FG003|Double-Blind Induction|Physician Decision|0
7059040|NCT01903252|11154510|FG004|Double-Blind Induction|Physician Decision|0
7059041|NCT01903252|11154511|FG005|Double-Blind Induction|Physician Decision|0
7059042|NCT01903252|11154506|FG000|Double-Blind Induction|non-compliance,|7
7059043|NCT01903252|11154507|FG001|Double-Blind Induction|non-compliance,|7
7059044|NCT01903252|11154508|FG002|Double-Blind Induction|non-compliance,|0
7059045|NCT01903252|11154509|FG003|Double-Blind Induction|non-compliance,|0
7059046|NCT01903252|11154510|FG004|Double-Blind Induction|non-compliance,|0
7059047|NCT01903252|11154511|FG005|Double-Blind Induction|non-compliance,|0
7059048|NCT01903252|11154506|FG000|Extended Induction, Open-Label|Adverse Event|0
7059049|NCT01903252|11154507|FG001|Extended Induction, Open-Label|Adverse Event|0
7059050|NCT01903252|11154508|FG002|Extended Induction, Open-Label|Adverse Event|17
7059051|NCT01903252|11154509|FG003|Extended Induction, Open-Label|Adverse Event|0
7059052|NCT01903252|11154510|FG004|Extended Induction, Open-Label|Adverse Event|0
7059053|NCT01903252|11154511|FG005|Extended Induction, Open-Label|Adverse Event|0
7059054|NCT01903252|11154506|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0
7059055|NCT01903252|11154507|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0
7059056|NCT01903252|11154508|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5
7059057|NCT01903252|11154509|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0
7059058|NCT01903252|11154510|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0
7059059|NCT01903252|11154511|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0
7059060|NCT01903252|11154506|FG000|Extended Induction, Open-Label|Physician Decision|0
7059061|NCT01903252|11154507|FG001|Extended Induction, Open-Label|Physician Decision|0
7059062|NCT01903252|11154508|FG002|Extended Induction, Open-Label|Physician Decision|1
7059063|NCT01903252|11154509|FG003|Extended Induction, Open-Label|Physician Decision|0
7059064|NCT01903252|11154510|FG004|Extended Induction, Open-Label|Physician Decision|0
7059065|NCT01903252|11154511|FG005|Extended Induction, Open-Label|Physician Decision|0
7059066|NCT01903252|11154506|FG000|Maintenance, Open-Label|Adverse Event|0
7059067|NCT01903252|11154507|FG001|Maintenance, Open-Label|Adverse Event|0
7059068|NCT01903252|11154508|FG002|Maintenance, Open-Label|Adverse Event|0
7059069|NCT01903252|11154509|FG003|Maintenance, Open-Label|Adverse Event|3
7059070|NCT01903252|11154510|FG004|Maintenance, Open-Label|Adverse Event|9
7059071|NCT01903252|11154511|FG005|Maintenance, Open-Label|Adverse Event|14
7059072|NCT01903252|11154506|FG000|Maintenance, Open-Label|Withdrawal by Subject|0
7059073|NCT01903252|11154507|FG001|Maintenance, Open-Label|Withdrawal by Subject|0
7059074|NCT01903252|11154508|FG002|Maintenance, Open-Label|Withdrawal by Subject|0
7059075|NCT01903252|11154509|FG003|Maintenance, Open-Label|Withdrawal by Subject|1
7059076|NCT01903252|11154510|FG004|Maintenance, Open-Label|Withdrawal by Subject|6
7059077|NCT01903252|11154511|FG005|Maintenance, Open-Label|Withdrawal by Subject|2
7059078|NCT01903252|11154506|FG000|Maintenance, Open-Label|Other|0
7059079|NCT01903252|11154507|FG001|Maintenance, Open-Label|Other|0
7059080|NCT01903252|11154508|FG002|Maintenance, Open-Label|Other|0
7059081|NCT01903252|11154509|FG003|Maintenance, Open-Label|Other|2
7059082|NCT01903252|11154510|FG004|Maintenance, Open-Label|Other|6
7059083|NCT01903252|11154511|FG005|Maintenance, Open-Label|Other|2
7059084|NCT01903356|11154538|FG000|Overall Study|Lost to Follow-up|7
7059085|NCT01903356|11154538|FG000|Overall Study|Violated inclusion/exclusion criteria|5
7059086|NCT01903356|11154538|FG000|Overall Study|Violated the dosage and administration|3
7059087|NCT01903434|11154542|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1
7059088|NCT01903434|11154543|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0
7059089|NCT01903434|11154542|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0
7059090|NCT01903434|11154543|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2
7059091|NCT01903460|11154553|FG000|Overall Study|Adverse Event|0
7059092|NCT01903460|11154554|FG001|Overall Study|Adverse Event|0
7059093|NCT01903460|11154555|FG002|Overall Study|Adverse Event|0
7059094|NCT01903460|11154556|FG003|Overall Study|Adverse Event|1
7059095|NCT01903525|11154567|FG000|Overall Study|Lost to Follow-up|5
7059096|NCT01903525|11154568|FG001|Overall Study|Lost to Follow-up|9
7059097|NCT01903525|11154567|FG000|Overall Study|Adverse Event|0
7059098|NCT01903525|11154568|FG001|Overall Study|Adverse Event|1
7059099|NCT01903720|11154583|FG000|Overall Study|Inclusion / exclusion criteria not met|6
7059100|NCT01903720|11154583|FG000|Overall Study|Adverse Event|1
7059101|NCT01903720|11154583|FG000|Overall Study|Rescinding of informed consent|2
7059102|NCT01903720|11154583|FG000|Overall Study|Lost to Follow-up|2
7059103|NCT01903720|11154583|FG000|Overall Study|Treatment with alternative drug|1
7059104|NCT01903733|11154591|FG000|Overall Study|Death|23
7059105|NCT01903733|11154592|FG001|Overall Study|Death|54
7059106|NCT01903733|11154593|FG002|Overall Study|Death|30
7059107|NCT01903733|11154594|FG003|Overall Study|Death|98
7059108|NCT01903733|11154591|FG000|Overall Study|Participant refused further follow-up|35
7059109|NCT01903733|11154592|FG001|Overall Study|Participant refused further follow-up|38
7059110|NCT01903733|11154593|FG002|Overall Study|Participant refused further follow-up|13
7059111|NCT01903733|11154594|FG003|Overall Study|Participant refused further follow-up|9
7059112|NCT01903733|11154591|FG000|Overall Study|Lost to Follow-up|18
7059113|NCT01903733|11154592|FG001|Overall Study|Lost to Follow-up|19
7059114|NCT01903733|11154593|FG002|Overall Study|Lost to Follow-up|6
7059115|NCT01903733|11154594|FG003|Overall Study|Lost to Follow-up|9
7059116|NCT01903733|11154591|FG000|Overall Study|Other|10
7059117|NCT01903733|11154592|FG001|Overall Study|Other|15
7059118|NCT01903733|11154593|FG002|Overall Study|Other|12
7059119|NCT01903733|11154594|FG003|Overall Study|Other|3
7059120|NCT01903733|11154591|FG000|Overall Study|Missing|2
7059121|NCT01903733|11154592|FG001|Overall Study|Missing|0
7059122|NCT01903733|11154593|FG002|Overall Study|Missing|0
7059123|NCT01903733|11154594|FG003|Overall Study|Missing|0
7059124|NCT01903733|11154591|FG000|Overall Study|Investigator request|18
7059125|NCT01903733|11154592|FG001|Overall Study|Investigator request|0
7059126|NCT01903733|11154593|FG002|Overall Study|Investigator request|0
7059127|NCT01903733|11154594|FG003|Overall Study|Investigator request|0
7085860|NCT02185040|11199215|FG005|Active Treatment Extension Phase|Lost to Follow-up|0
7085861|NCT02185040|11199216|FG006|Active Treatment Extension Phase|Lost to Follow-up|2
7085862|NCT02185053|11199236|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1
7085863|NCT02185053|11199237|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0
7085864|NCT02185053|11199238|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0
7085865|NCT02185053|11199236|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2
7085866|NCT02185053|11199237|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0
7085867|NCT02185053|11199238|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0
7085868|NCT02185053|11199236|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0
7085869|NCT02185053|11199237|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1
7085870|NCT02185053|11199238|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0
7085871|NCT02185053|11199236|FG000|Donepezil Dose Escalation Phase|Adverse Event|0
7085872|NCT02185053|11199237|FG001|Donepezil Dose Escalation Phase|Adverse Event|1
7085873|NCT02185053|11199238|FG002|Donepezil Dose Escalation Phase|Adverse Event|0
7085874|NCT02185053|11199236|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0
7085875|NCT02185053|11199237|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2
7085876|NCT02185053|11199238|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0
7085877|NCT02185053|11199236|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0
7085878|NCT02185053|11199237|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1
7085879|NCT02185053|11199238|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0
7085880|NCT02185053|11199236|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0
7085881|NCT02185053|11199237|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0
7085882|NCT02185053|11199238|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1
7085883|NCT02185053|11199236|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0
7085884|NCT02185053|11199237|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0
7085885|NCT02185053|11199238|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2
7085886|NCT02185521|11199284|FG000|Overall Study|Withdrawal by Subject|1
7085887|NCT02185521|11199284|FG000|Overall Study|Protocol Violation|1
7085888|NCT02185534|11199295|FG000|First Period|Withdrawal by Subject|0
7085889|NCT02185534|11199296|FG001|First Period|Withdrawal by Subject|0
7085890|NCT02185534|11199297|FG002|First Period|Withdrawal by Subject|0
7085891|NCT02185534|11199298|FG003|First Period|Withdrawal by Subject|1
7085892|NCT02185534|11199299|FG004|First Period|Withdrawal by Subject|0
7085893|NCT02185534|11199300|FG005|First Period|Withdrawal by Subject|0
7085894|NCT02185534|11199295|FG000|First Washout Period|Withdrawal by Subject|1
7085895|NCT02185534|11199296|FG001|First Washout Period|Withdrawal by Subject|0
7085896|NCT02185534|11199297|FG002|First Washout Period|Withdrawal by Subject|0
7085897|NCT02185534|11199298|FG003|First Washout Period|Withdrawal by Subject|0
7085898|NCT02185534|11199299|FG004|First Washout Period|Withdrawal by Subject|1
7085899|NCT02185534|11199300|FG005|First Washout Period|Withdrawal by Subject|0
7085900|NCT02185534|11199295|FG000|First Washout Period|Protocol Violation|0
7085901|NCT02185534|11199296|FG001|First Washout Period|Protocol Violation|0
7085902|NCT02185534|11199297|FG002|First Washout Period|Protocol Violation|0
7085903|NCT02185534|11199298|FG003|First Washout Period|Protocol Violation|0
7085904|NCT02185534|11199299|FG004|First Washout Period|Protocol Violation|0
7085905|NCT02185534|11199300|FG005|First Washout Period|Protocol Violation|1
7085906|NCT02185794|11199322|FG000|Overall Study|Enrolled but Never Dosed|1
7085907|NCT02185794|11199323|FG001|Overall Study|Enrolled but Never Dosed|6
7085908|NCT02185794|11199324|FG002|Overall Study|Enrolled but Never Dosed|3
7085909|NCT02185794|11199325|FG003|Overall Study|Enrolled but Never Dosed|1
7085910|NCT02185794|11199326|FG004|Overall Study|Enrolled but Never Dosed|1
7085911|NCT02185794|11199327|FG005|Overall Study|Enrolled but Never Dosed|0
7085912|NCT02185794|11199322|FG000|Overall Study|Investigator's Discretion|1
7085913|NCT02185794|11199323|FG001|Overall Study|Investigator's Discretion|0
7085914|NCT02185794|11199324|FG002|Overall Study|Investigator's Discretion|1
7085915|NCT02185794|11199325|FG003|Overall Study|Investigator's Discretion|2
7085916|NCT02185794|11199326|FG004|Overall Study|Investigator's Discretion|2
7085917|NCT02185794|11199327|FG005|Overall Study|Investigator's Discretion|15
7085918|NCT02185794|11199322|FG000|Overall Study|Withdrew Consent|2
7085919|NCT02185794|11199323|FG001|Overall Study|Withdrew Consent|5
7085920|NCT02185794|11199324|FG002|Overall Study|Withdrew Consent|10
7085921|NCT02185794|11199325|FG003|Overall Study|Withdrew Consent|2
7085922|NCT02185794|11199326|FG004|Overall Study|Withdrew Consent|0
7085923|NCT02185794|11199327|FG005|Overall Study|Withdrew Consent|0
7085924|NCT02185794|11199322|FG000|Overall Study|Lost to Follow-up|1
7085925|NCT02185794|11199323|FG001|Overall Study|Lost to Follow-up|2
7085926|NCT02185794|11199324|FG002|Overall Study|Lost to Follow-up|2
7085927|NCT02185794|11199325|FG003|Overall Study|Lost to Follow-up|3
7085928|NCT02185794|11199326|FG004|Overall Study|Lost to Follow-up|0
7085929|NCT02185794|11199327|FG005|Overall Study|Lost to Follow-up|1
7085930|NCT02186015|11199357|FG000|Overall Study|Physician Decision|1
7085931|NCT02186015|11199358|FG001|Overall Study|Physician Decision|0
7085932|NCT02186171|11199367|FG000|Overall Study|Withdrawal by Subject|1
7085933|NCT02186171|11199368|FG001|Overall Study|Withdrawal by Subject|9
7085934|NCT02186171|11199367|FG000|Overall Study|Lost to Follow-up|2
7085935|NCT02186171|11199368|FG001|Overall Study|Lost to Follow-up|2
7085936|NCT02186171|11199367|FG000|Overall Study|Death|1
7085937|NCT02186171|11199368|FG001|Overall Study|Death|2
7085938|NCT02186171|11199367|FG000|Overall Study|Protocol-specified Criteria|0
7085939|NCT02186171|11199368|FG001|Overall Study|Protocol-specified Criteria|2
7085940|NCT02186223|11199385|FG000|Overall Study|Not eligible for device placement|6
7085941|NCT02186223|11199385|FG000|Overall Study|Unable to obtain femoral access|3
7085942|NCT02186223|11199385|FG000|Overall Study|Death|3
7085943|NCT02186223|11199385|FG000|Overall Study|Device in place less than 48 hours|9
7085944|NCT02186301|11199393|FG000|Overall Study|Progressive Disease|7
7085945|NCT02186301|11199394|FG001|Overall Study|Progressive Disease|22
7085946|NCT02186301|11199395|FG002|Overall Study|Progressive Disease|27
7085947|NCT02186301|11199393|FG000|Overall Study|Adverse Event|5
7085948|NCT02186301|11199394|FG001|Overall Study|Adverse Event|5
7085949|NCT02186301|11199395|FG002|Overall Study|Adverse Event|5
7085950|NCT02186301|11199393|FG000|Overall Study|Death|1
7085951|NCT02186301|11199394|FG001|Overall Study|Death|0
7085952|NCT02186301|11199395|FG002|Overall Study|Death|0
7085953|NCT02186301|11199393|FG000|Overall Study|Withdrawal by Subject|5
7085954|NCT02186301|11199394|FG001|Overall Study|Withdrawal by Subject|1
7085955|NCT02186301|11199395|FG002|Overall Study|Withdrawal by Subject|3
7085956|NCT02186301|11199393|FG000|Overall Study|Physician Decision|1
7085957|NCT02186301|11199394|FG001|Overall Study|Physician Decision|0
7085958|NCT02186301|11199395|FG002|Overall Study|Physician Decision|1
7085959|NCT02186301|11199393|FG000|Overall Study|Study Terminated by Sponsor|1
7085960|NCT02186301|11199394|FG001|Overall Study|Study Terminated by Sponsor|0
7085961|NCT02186301|11199395|FG002|Overall Study|Study Terminated by Sponsor|11
7085962|NCT02186301|11199393|FG000|Overall Study|Protocol Deviation|0
7085963|NCT02186301|11199394|FG001|Overall Study|Protocol Deviation|2
7085964|NCT02186301|11199395|FG002|Overall Study|Protocol Deviation|0
7085965|NCT02186301|11199393|FG000|Overall Study|Missing|0
7085966|NCT02186301|11199394|FG001|Overall Study|Missing|0
7085967|NCT02186301|11199395|FG002|Overall Study|Missing|2
7085968|NCT02186301|11199393|FG000|Overall Study|Other|0
7085969|NCT02186301|11199394|FG001|Overall Study|Other|0
7085970|NCT02186301|11199395|FG002|Overall Study|Other|1
7085971|NCT02186561|11199409|FG000|Enrollment|Did Not Meet Inclusion Criteria|46
7085972|NCT02186561|11199409|FG000|Enrollment|Enrollment Cap Reached|5
7085973|NCT02186561|11199409|FG000|Enrollment|Insurance Denial|2
7085974|NCT02186561|11199409|FG000|Enrollment|Withdrawal by Subject|2
7085975|NCT02186561|11199409|FG000|Enrollment|Investigator Withdrew Consent|1
7085976|NCT02186561|11199409|FG000|30-Day Post Index Procedure Visit|Death|1
7085977|NCT02186561|11199409|FG000|1- Year Post Index Procedure Visit|Death|1
7085978|NCT02186561|11199409|FG000|1- Year Post Index Procedure Visit|Missed|1
7085979|NCT02186652|11199425|FG000|Overall Study|Lost to Follow-up|2
7085980|NCT02186652|11199426|FG001|Overall Study|Lost to Follow-up|0
7085981|NCT02186821|11199461|FG000|Overall Study|Adverse Event|9
7085982|NCT02186821|11199461|FG000|Overall Study|Death|2
7085983|NCT02186821|11199461|FG000|Overall Study|Disease progression|32
7085984|NCT02186821|11199461|FG000|Overall Study|Protocol Violation|1
7085985|NCT02186821|11199461|FG000|Overall Study|Physician Decision|1
7085986|NCT02186821|11199461|FG000|Overall Study|Study terminated by sponsor|2
7085987|NCT02186873|11199467|FG000|Overall Study|Adverse Event|1
7085988|NCT02186873|11199468|FG001|Overall Study|Adverse Event|3
7085989|NCT02186873|11199467|FG000|Overall Study|Lack of Efficacy|0
7085990|NCT02186873|11199468|FG001|Overall Study|Lack of Efficacy|1
7085991|NCT02186873|11199467|FG000|Overall Study|Lost to Follow-up|1
7085992|NCT02186873|11199468|FG001|Overall Study|Lost to Follow-up|2
7085993|NCT02186873|11199467|FG000|Overall Study|Withdrawal by Subject|7
7085994|NCT02186873|11199468|FG001|Overall Study|Withdrawal by Subject|2
7085995|NCT02187029|11199505|FG000|Overall Study|Adverse Event|0
7085996|NCT02187029|11199506|FG001|Overall Study|Adverse Event|1
7085997|NCT02187029|11199507|FG002|Overall Study|Adverse Event|1
7085998|NCT02187029|11199508|FG003|Overall Study|Adverse Event|0
7085999|NCT02187029|11199505|FG000|Overall Study|Study Terminated by Sponsor|0
7086000|NCT02187029|11199506|FG001|Overall Study|Study Terminated by Sponsor|0
7086001|NCT02187029|11199507|FG002|Overall Study|Study Terminated by Sponsor|10
7086002|NCT02187029|11199508|FG003|Overall Study|Study Terminated by Sponsor|3
7086003|NCT02187029|11199505|FG000|Overall Study|Withdrawal by Subject|1
7086004|NCT02187029|11199506|FG001|Overall Study|Withdrawal by Subject|0
7086005|NCT02187029|11199507|FG002|Overall Study|Withdrawal by Subject|0
7086006|NCT02187029|11199508|FG003|Overall Study|Withdrawal by Subject|0
7086007|NCT02187042|11199520|FG000|Overall Study|Death|1
7086008|NCT02187042|11199521|FG001|Overall Study|Death|1
7086009|NCT02187042|11199520|FG000|Overall Study|Toxicity|6
7086010|NCT02187042|11199521|FG001|Overall Study|Toxicity|5
7086011|NCT02187042|11199520|FG000|Overall Study|Participant choice|1
7086012|NCT02187042|11199521|FG001|Overall Study|Participant choice|0
7086013|NCT02187042|11199520|FG000|Overall Study|Doctor choice|1
7086014|NCT02187042|11199521|FG001|Overall Study|Doctor choice|0
7086015|NCT02187042|11199520|FG000|Overall Study|Progressive disease|4
7086016|NCT02187042|11199521|FG001|Overall Study|Progressive disease|8
7086017|NCT02187055|11199531|FG000|Overall Study|Lack of Efficacy|10
7086018|NCT02187055|11199532|FG001|Overall Study|Lack of Efficacy|3
7086019|NCT02187055|11199533|FG002|Overall Study|Lack of Efficacy|7
7086020|NCT02187055|11199531|FG000|Overall Study|Lost to Follow-up|2
7086021|NCT02187055|11199532|FG001|Overall Study|Lost to Follow-up|7
7086022|NCT02187055|11199533|FG002|Overall Study|Lost to Follow-up|3
7086023|NCT02187055|11199531|FG000|Overall Study|No longer meets eligibility criteria|0
7086024|NCT02187055|11199532|FG001|Overall Study|No longer meets eligibility criteria|2
7086025|NCT02187055|11199533|FG002|Overall Study|No longer meets eligibility criteria|0
7086026|NCT02187055|11199531|FG000|Overall Study|No longer willing to participate|6
7086027|NCT02187055|11199532|FG001|Overall Study|No longer willing to participate|8
7086028|NCT02187055|11199533|FG002|Overall Study|No longer willing to participate|10
7086029|NCT02187055|11199531|FG000|Overall Study|Other|5
7086030|NCT02187055|11199532|FG001|Overall Study|Other|6
7086031|NCT02187055|11199533|FG002|Overall Study|Other|3
7086032|NCT02187055|11199531|FG000|Overall Study|Protocol Violation|9
7086033|NCT02187055|11199532|FG001|Overall Study|Protocol Violation|9
7086034|NCT02187055|11199533|FG002|Overall Study|Protocol Violation|4
7086035|NCT02187055|11199531|FG000|Overall Study|Pregnancy|3
7086036|NCT02187055|11199532|FG001|Overall Study|Pregnancy|1
7086037|NCT02187055|11199533|FG002|Overall Study|Pregnancy|0
7086038|NCT02187055|11199531|FG000|Overall Study|Withdrawal by Subject|11
7086039|NCT02187055|11199532|FG001|Overall Study|Withdrawal by Subject|11
7086040|NCT02187055|11199533|FG002|Overall Study|Withdrawal by Subject|11
7086041|NCT02187055|11199531|FG000|Overall Study|Adverse Event|21
7086042|NCT02187055|11199532|FG001|Overall Study|Adverse Event|26
7086043|NCT02187055|11199533|FG002|Overall Study|Adverse Event|36
7086044|NCT02187055|11199531|FG000|Overall Study|Death|2
7086045|NCT02187055|11199532|FG001|Overall Study|Death|0
7086046|NCT02187055|11199533|FG002|Overall Study|Death|0
7086047|NCT02187159|11199545|FG000|Overall Study|Protocol Violation|4
7086048|NCT02187159|11199546|FG001|Overall Study|Protocol Violation|6
7086049|NCT02187159|11199547|FG002|Overall Study|Protocol Violation|3
7086050|NCT02187159|11199548|FG003|Overall Study|Protocol Violation|4
7086051|NCT02187159|11199545|FG000|Overall Study|Lack of Efficacy|10
7086052|NCT02187159|11199546|FG001|Overall Study|Lack of Efficacy|5
7086053|NCT02187159|11199547|FG002|Overall Study|Lack of Efficacy|4
7086054|NCT02187159|11199548|FG003|Overall Study|Lack of Efficacy|7
7086055|NCT02187159|11199545|FG000|Overall Study|Adverse Event|28
7086056|NCT02187159|11199546|FG001|Overall Study|Adverse Event|33
7086057|NCT02187159|11199547|FG002|Overall Study|Adverse Event|42
7086058|NCT02187159|11199548|FG003|Overall Study|Adverse Event|50
7086059|NCT02187159|11199545|FG000|Overall Study|Withdrawal by Subject|24
7086060|NCT02187159|11199546|FG001|Overall Study|Withdrawal by Subject|28
7086061|NCT02187159|11199547|FG002|Overall Study|Withdrawal by Subject|25
7086062|NCT02187159|11199548|FG003|Overall Study|Withdrawal by Subject|26
7086063|NCT02187159|11199545|FG000|Overall Study|Other|3
7086064|NCT02187159|11199546|FG001|Overall Study|Other|7
7086065|NCT02187159|11199547|FG002|Overall Study|Other|3
7086066|NCT02187159|11199548|FG003|Overall Study|Other|9
7086067|NCT02187172|11199560|FG000|Overall Study|Lost to Follow-up|1
7086068|NCT02187172|11199561|FG001|Overall Study|Lost to Follow-up|2
7086069|NCT02187172|11199560|FG000|Overall Study|Lack of Efficacy|1
7086070|NCT02187172|11199561|FG001|Overall Study|Lack of Efficacy|2
7086071|NCT02187172|11199560|FG000|Overall Study|Adverse Event|0
7086072|NCT02187172|11199561|FG001|Overall Study|Adverse Event|1
7086073|NCT02187172|11199560|FG000|Overall Study|Physician Decision|1
7086074|NCT02187172|11199561|FG001|Overall Study|Physician Decision|1
7086075|NCT02187471|11199573|FG000|Overall Study|Protocol Violation|4
7086076|NCT02187471|11199574|FG001|Overall Study|Protocol Violation|5
7086077|NCT02187471|11199575|FG002|Overall Study|Protocol Violation|4
7086078|NCT02187471|11199576|FG003|Overall Study|Protocol Violation|4
7086079|NCT02187471|11199573|FG000|Overall Study|Missing|0
7086080|NCT02187471|11199574|FG001|Overall Study|Missing|0
7086081|NCT02187471|11199575|FG002|Overall Study|Missing|0
7086082|NCT02187471|11199576|FG003|Overall Study|Missing|1
7086083|NCT02187471|11199573|FG000|Overall Study|Lack of Efficacy|18
7086084|NCT02187471|11199574|FG001|Overall Study|Lack of Efficacy|9
7086085|NCT02187471|11199575|FG002|Overall Study|Lack of Efficacy|13
7086086|NCT02187471|11199576|FG003|Overall Study|Lack of Efficacy|11
7086087|NCT02187471|11199573|FG000|Overall Study|Adverse Event|24
7086088|NCT02187471|11199574|FG001|Overall Study|Adverse Event|34
7086089|NCT02187471|11199575|FG002|Overall Study|Adverse Event|44
7086090|NCT02187471|11199576|FG003|Overall Study|Adverse Event|36
7086091|NCT02187471|11199573|FG000|Overall Study|Withdrawal by Subject|23
7086092|NCT02187471|11199574|FG001|Overall Study|Withdrawal by Subject|29
7086093|NCT02187471|11199575|FG002|Overall Study|Withdrawal by Subject|22
7086094|NCT02187471|11199576|FG003|Overall Study|Withdrawal by Subject|24
7086095|NCT02187471|11199573|FG000|Overall Study|Other|7
7086096|NCT02187471|11199574|FG001|Overall Study|Other|5
7086097|NCT02187471|11199575|FG002|Overall Study|Other|3
7086098|NCT02187471|11199576|FG003|Overall Study|Other|4
7086099|NCT02187744|11199589|FG000|Study|Participant refused further follow-up|1
7086100|NCT02187744|11199590|FG001|Study|Participant refused further follow-up|0
7086101|NCT02187744|11199589|FG000|Study|Other|2
7086102|NCT02187744|11199590|FG001|Study|Other|1
7086103|NCT02187744|11199589|FG000|Study|Lost to Follow-up|0
7086104|NCT02187744|11199590|FG001|Study|Lost to Follow-up|2
7086105|NCT02187744|11199589|FG000|Study|Related adverse event, not serious|0
7086106|NCT02187744|11199590|FG001|Study|Related adverse event, not serious|2
7086107|NCT02187744|11199589|FG000|Study|Death|1
7086108|NCT02187744|11199590|FG001|Study|Death|0
7086109|NCT02187744|11199589|FG000|Study|Related adverse event, serious non-fatal|0
7086110|NCT02187744|11199590|FG001|Study|Related adverse event, serious non-fatal|1
7086111|NCT02187744|11199589|FG000|Treatment|Death|1
7086112|NCT02187744|11199590|FG001|Treatment|Death|0
7086113|NCT02187744|11199589|FG000|Treatment|Related adverse event, serious non-fatal|0
7086114|NCT02187744|11199590|FG001|Treatment|Related adverse event, serious non-fatal|1
7086115|NCT02187744|11199589|FG000|Treatment|Related adverse event, not serious|0
7086116|NCT02187744|11199590|FG001|Treatment|Related adverse event, not serious|2
7086117|NCT02187744|11199589|FG000|Treatment|Lost to Follow-up|0
7086118|NCT02187744|11199590|FG001|Treatment|Lost to Follow-up|1
7086119|NCT02187744|11199589|FG000|Treatment|Other|2
7086120|NCT02187744|11199590|FG001|Treatment|Other|0
7086121|NCT02187744|11199589|FG000|Treatment|Participant refused continued treatment|1
7086122|NCT02187744|11199590|FG001|Treatment|Participant refused continued treatment|1
7086123|NCT02187783|11199596|FG000|Overall Study|Adverse Event|8
7086124|NCT02187783|11199596|FG000|Overall Study|Death|3
7086125|NCT02187783|11199596|FG000|Overall Study|Progressive disease|80
7086126|NCT02187783|11199596|FG000|Overall Study|Protocol Violation|3
7086127|NCT02187783|11199596|FG000|Overall Study|Physician Decision|2
7086128|NCT02187783|11199596|FG000|Overall Study|Withdrawal by Subject|9
7086129|NCT02187783|11199596|FG000|Overall Study|Study terminated by sponsor|1
7086130|NCT02187809|11199600|FG000|Overall Study|The study was terminated|3
7086131|NCT02187861|11199608|FG000|Overall Study|Adverse Event|2
7086132|NCT02187861|11199609|FG001|Overall Study|Adverse Event|1
7086133|NCT02187861|11199610|FG002|Overall Study|Adverse Event|2
7086134|NCT02187861|11199611|FG003|Overall Study|Adverse Event|1
7086135|NCT02187861|11199608|FG000|Overall Study|Death|0
7086136|NCT02187861|11199609|FG001|Overall Study|Death|3
7086137|NCT02187861|11199610|FG002|Overall Study|Death|1
7086138|NCT02187861|11199611|FG003|Overall Study|Death|2
7086139|NCT02187861|11199608|FG000|Overall Study|Physician Decision|0
7086140|NCT02187861|11199609|FG001|Overall Study|Physician Decision|1
7086141|NCT02187861|11199610|FG002|Overall Study|Physician Decision|0
7086142|NCT02187861|11199611|FG003|Overall Study|Physician Decision|3
7086143|NCT02187861|11199608|FG000|Overall Study|Progressive Disease|4
7086144|NCT02187861|11199609|FG001|Overall Study|Progressive Disease|42
7086145|NCT02187861|11199610|FG002|Overall Study|Progressive Disease|19
7086146|NCT02187861|11199611|FG003|Overall Study|Progressive Disease|22
7086147|NCT02187861|11199608|FG000|Overall Study|Withdrawal by Subject|0
7086148|NCT02187861|11199609|FG001|Overall Study|Withdrawal by Subject|0
7086149|NCT02187861|11199610|FG002|Overall Study|Withdrawal by Subject|3
7086150|NCT02187861|11199611|FG003|Overall Study|Withdrawal by Subject|3
7086151|NCT02187861|11199608|FG000|Overall Study|Other|0
7086152|NCT02187861|11199609|FG001|Overall Study|Other|1
7086153|NCT02187861|11199610|FG002|Overall Study|Other|7
7086154|NCT02187861|11199611|FG003|Overall Study|Other|1
7086155|NCT02188160|11199632|FG000|Overall Study|Adverse Event|1
7086156|NCT02188160|11199633|FG001|Overall Study|Adverse Event|0
7086157|NCT02188160|11199632|FG000|Overall Study|Use of an excluded medication|0
7086158|NCT02188160|11199633|FG001|Overall Study|Use of an excluded medication|1
7086159|NCT02188303|11199647|FG000|Overall Study|Adverse Event|0
7086160|NCT02188303|11199648|FG001|Overall Study|Adverse Event|0
7086161|NCT02188303|11199649|FG002|Overall Study|Adverse Event|0
7086162|NCT02188303|11199650|FG003|Overall Study|Adverse Event|0
7086163|NCT02188303|11199651|FG004|Overall Study|Adverse Event|0
7086164|NCT02188303|11199652|FG005|Overall Study|Adverse Event|2
7086165|NCT02188303|11199653|FG006|Overall Study|Adverse Event|0
7086166|NCT02188303|11199654|FG007|Overall Study|Adverse Event|2
7086167|NCT02188303|11199647|FG000|Overall Study|Dose Termination Criteria Met|0
7086168|NCT02188303|11199648|FG001|Overall Study|Dose Termination Criteria Met|0
7086169|NCT02188303|11199649|FG002|Overall Study|Dose Termination Criteria Met|0
7086170|NCT02188303|11199650|FG003|Overall Study|Dose Termination Criteria Met|0
7086171|NCT02188303|11199651|FG004|Overall Study|Dose Termination Criteria Met|0
7086172|NCT02188303|11199652|FG005|Overall Study|Dose Termination Criteria Met|0
7086173|NCT02188303|11199653|FG006|Overall Study|Dose Termination Criteria Met|2
7086174|NCT02188303|11199654|FG007|Overall Study|Dose Termination Criteria Met|4
7086175|NCT02188459|11199680|FG000|Overall Study|Lost to Follow-up|3
7086176|NCT02188459|11199681|FG001|Overall Study|Lost to Follow-up|4
7086177|NCT02188459|11199680|FG000|Overall Study|Early Termination|0
7086178|NCT02188459|11199681|FG001|Overall Study|Early Termination|3
7086179|NCT02188485|11199693|FG000|Overall Study|Withdrawal by Subject|2
7086180|NCT02188485|11199694|FG001|Overall Study|Withdrawal by Subject|1
7086181|NCT02188485|11199693|FG000|Overall Study|PI withdrew, lack of capacity|0
7086182|NCT02188485|11199694|FG001|Overall Study|PI withdrew, lack of capacity|2
7086183|NCT02188589|11199709|FG000|Overall Study|Withdrawal by Subject|5
7086184|NCT02188719|11199718|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0
7086185|NCT02188719|11199719|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1
7086186|NCT02188719|11199720|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0
7086187|NCT02188719|11199721|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0
7086188|NCT02188784|11199731|FG000|Overall Study|Death|3
7086189|NCT02188784|11199732|FG001|Overall Study|Death|1
7086190|NCT02188784|11199731|FG000|Overall Study|Lost to Follow-up|1
7086191|NCT02188784|11199732|FG001|Overall Study|Lost to Follow-up|0
7086192|NCT02188784|11199731|FG000|Overall Study|Withdrawal by Subject|3
7086193|NCT02188784|11199732|FG001|Overall Study|Withdrawal by Subject|9
7086194|NCT02188784|11199731|FG000|Overall Study|Physician Decision|2
7086195|NCT02188784|11199732|FG001|Overall Study|Physician Decision|3
7086196|NCT02188849|11199740|FG000|Overall Study|Lost to Follow-up|3
7086197|NCT02188849|11199741|FG001|Overall Study|Lost to Follow-up|8
7086198|NCT02189252|11199775|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
7086199|NCT02189252|11199776|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1
7086200|NCT02189252|11199777|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
7086201|NCT02189252|11199778|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
7086202|NCT02189252|11199775|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0
7086203|NCT02189252|11199776|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1
7086204|NCT02189252|11199777|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0
7086205|NCT02189252|11199778|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0
7086206|NCT02189473|11199809|FG000|Overall Study|Death|22
7086207|NCT02189473|11199810|FG001|Overall Study|Death|23
7086208|NCT02189473|11199809|FG000|Overall Study|Lost to Follow-up|1
7086209|NCT02189473|11199810|FG001|Overall Study|Lost to Follow-up|2
7086210|NCT02189759|11199833|FG000|Overall Study|Lost to Follow-up|0
7086211|NCT02189759|11199834|FG001|Overall Study|Lost to Follow-up|0
7086212|NCT02189759|11199835|FG002|Overall Study|Lost to Follow-up|2
7086213|NCT02189759|11199836|FG003|Overall Study|Lost to Follow-up|5
7086214|NCT02189837|11199852|FG000|Overall Study|Withdrawal by Subject|2
7086215|NCT02189837|11199853|FG001|Overall Study|Withdrawal by Subject|1
7086216|NCT02189837|11199854|FG002|Overall Study|Withdrawal by Subject|3
7086217|NCT02189837|11199855|FG003|Overall Study|Withdrawal by Subject|1
7086218|NCT02189837|11199852|FG000|Overall Study|Sponsor Decision|0
7086219|NCT02189837|11199853|FG001|Overall Study|Sponsor Decision|0
7086220|NCT02189837|11199854|FG002|Overall Study|Sponsor Decision|0
7086221|NCT02189837|11199855|FG003|Overall Study|Sponsor Decision|1
7086222|NCT02189863|11199874|FG000|First 2 Weeks|Motion Sickness|4
7086223|NCT02189863|11199875|FG001|First 2 Weeks|Motion Sickness|2
7086224|NCT02189941|11199897|FG000|Overall Study|Non-compliance|0
7086225|NCT02189941|11199898|FG001|Overall Study|Non-compliance|0
7086226|NCT02189941|11199899|FG002|Overall Study|Non-compliance|1
7086227|NCT02190279|11199928|FG000|Overall Study|Withdrawal consent|1
7086228|NCT02190279|11199929|FG001|Overall Study|Withdrawal consent|0
7086229|NCT02190279|11199930|FG002|Overall Study|Withdrawal consent|1
7086230|NCT02190279|11199928|FG000|Overall Study|Lost to Follow-up|2
7086231|NCT02190279|11199929|FG001|Overall Study|Lost to Follow-up|0
7086232|NCT02190279|11199930|FG002|Overall Study|Lost to Follow-up|0
7086233|NCT02190279|11199928|FG000|Overall Study|Refused further treatment|0
7086234|NCT02190279|11199929|FG001|Overall Study|Refused further treatment|0
7086235|NCT02190279|11199930|FG002|Overall Study|Refused further treatment|1
7086236|NCT02190279|11199928|FG000|Overall Study|Screening failure|0
7086237|NCT02190279|11199929|FG001|Overall Study|Screening failure|0
7086238|NCT02190279|11199930|FG002|Overall Study|Screening failure|1
7086239|NCT02190435|11199942|FG000|Overall Study|First 12 patients were lead-ins|12
7086240|NCT02190435|11199943|FG001|Overall Study|First 12 patients were lead-ins|0
7086241|NCT02190435|11199942|FG000|Overall Study|3 consented screen fails|3
7086242|NCT02190435|11199943|FG001|Overall Study|3 consented screen fails|0
7086243|NCT02190591|11199956|FG000|Overall Study|Withdrawal by Subject|1
7086244|NCT02190591|11199957|FG001|Overall Study|Withdrawal by Subject|8
7086245|NCT02190591|11199956|FG000|Overall Study|Protocol Violation|1
7086246|NCT02190591|11199957|FG001|Overall Study|Protocol Violation|0
7086247|NCT02190591|11199956|FG000|Overall Study|did not use peanut ball as instructed|0
7086248|NCT02190591|11199957|FG001|Overall Study|did not use peanut ball as instructed|2
7086249|NCT02190591|11199956|FG000|Overall Study|face presentation so she was ineligible|0
7086250|NCT02190591|11199957|FG001|Overall Study|face presentation so she was ineligible|1
7086251|NCT02190604|11199982|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7086252|NCT02190604|11199983|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7086253|NCT02190604|11199984|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7086254|NCT02190604|11199985|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7086255|NCT02190604|11199986|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7086256|NCT02190604|11199987|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7086257|NCT02190604|11199988|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7086258|NCT02190604|11199989|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7086259|NCT02190604|11199990|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7086260|NCT02190604|11199991|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7086261|NCT02190604|11199992|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7086262|NCT02190604|11199993|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7086263|NCT02190604|11199994|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7086264|NCT02190604|11199995|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7086265|NCT02190604|11199996|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2
7086266|NCT02190604|11199997|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7086267|NCT02190604|11199998|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7086268|NCT02190604|11199999|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7086269|NCT02190604|11200000|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7086270|NCT02190604|11199982|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7086271|NCT02190604|11199983|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7086272|NCT02190604|11199984|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7086273|NCT02190604|11199985|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7086274|NCT02190604|11199986|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7086275|NCT02190604|11199987|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7086276|NCT02190604|11199988|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7086277|NCT02190604|11199989|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7086278|NCT02190604|11199990|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7086279|NCT02190604|11199991|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7086280|NCT02190604|11199992|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7086281|NCT02190604|11199993|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7086282|NCT02190604|11199994|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7086283|NCT02190604|11199995|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1
7086284|NCT02190604|11199996|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7086285|NCT02190604|11199997|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7086286|NCT02190604|11199998|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7086287|NCT02190604|11199999|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7086288|NCT02190604|11200000|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7086289|NCT02191046|11200090|FG000|Overall Study|low compliance|5
7086290|NCT02191046|11200091|FG001|Overall Study|low compliance|1
7086291|NCT02191137|11200097|FG000|Treatment|Death|4
7086292|NCT02191137|11200097|FG000|Treatment|Withdrawal by Subject|3
7086293|NCT02191137|11200097|FG000|Treatment|Adverse Event|2
7086294|NCT02191137|11200097|FG000|Treatment|Other|1
7086295|NCT02191137|11200097|FG000|Follow-up|Lost to Follow-up|2
7086296|NCT02191137|11200097|FG000|Follow-up|Ongoing/unknown|2
7086297|NCT02191137|11200097|FG000|Follow-up|Adverse Event|1
7086298|NCT02191267|11200104|FG000|Overall Study|Withdrawal by Subject|1
7086299|NCT02191267|11200105|FG001|Overall Study|Withdrawal by Subject|0
7086300|NCT02191267|11200106|FG002|Overall Study|Withdrawal by Subject|0
7086301|NCT02191397|11200116|FG000|Overall Study|Adverse Event|28
7086302|NCT02191397|11200117|FG001|Overall Study|Adverse Event|17
7086303|NCT02191397|11200116|FG000|Overall Study|Lack of Efficacy|10
7086304|NCT02191397|11200117|FG001|Overall Study|Lack of Efficacy|5
7086305|NCT02191397|11200116|FG000|Overall Study|Protocol Violation|0
7086306|NCT02191397|11200117|FG001|Overall Study|Protocol Violation|3
7086307|NCT02191397|11200116|FG000|Overall Study|Met protocol-defined stopping criteria|5
7086308|NCT02191397|11200117|FG001|Overall Study|Met protocol-defined stopping criteria|4
7086309|NCT02191397|11200116|FG000|Overall Study|Lost to Follow-up|10
7086310|NCT02191397|11200117|FG001|Overall Study|Lost to Follow-up|11
7086311|NCT02191397|11200116|FG000|Overall Study|Physician Decision|8
7086312|NCT02191397|11200117|FG001|Overall Study|Physician Decision|3
7086313|NCT02191397|11200116|FG000|Overall Study|Withdrawal by Subject|22
7086314|NCT02191397|11200117|FG001|Overall Study|Withdrawal by Subject|27
7086315|NCT02191579|11200125|FG000|Treatment 1|Multiple Reasons Specified|27
7086316|NCT02191579|11200126|FG001|Treatment 1|Multiple Reasons Specified|58
7086317|NCT02191579|11200125|FG000|Treatment 2|Multiple Reasons Specified|0
7086318|NCT02191579|11200126|FG001|Treatment 2|Multiple Reasons Specified|25
7086319|NCT02191605|11200137|FG000|Overall Study|Lost to Follow-up|9
7086320|NCT02191605|11200138|FG001|Overall Study|Lost to Follow-up|4
7086321|NCT02191605|11200139|FG002|Overall Study|Lost to Follow-up|7
7086322|NCT02191605|11200140|FG003|Overall Study|Lost to Follow-up|3
7086323|NCT02191605|11200141|FG004|Overall Study|Lost to Follow-up|4
7086324|NCT02191618|11200153|FG000|Overall Study|Withdrawal by Subject|3
7086325|NCT02191618|11200153|FG000|Overall Study|Missed Visit|4
7086326|NCT02192099|11200173|FG000|Overall Study|Adverse Event|1
7086327|NCT02192099|11200173|FG000|Overall Study|Lost to Follow-up|2
7086328|NCT02192099|11200173|FG000|Overall Study|Physician Decision|1
7086329|NCT02192099|11200173|FG000|Overall Study|Pregnancy|1
7086330|NCT02192099|11200173|FG000|Overall Study|Protocol Violation|8
7086331|NCT02192099|11200173|FG000|Overall Study|Study Terminated by Sponsor|32
7086332|NCT02192099|11200173|FG000|Overall Study|Withdrawal by Subject|11
7086333|NCT02192099|11200173|FG000|Overall Study|Miscellaneous Reasons|5
7086334|NCT02192164|11200177|FG000|Overall Study|Other|8
7086335|NCT02192164|11200177|FG000|Overall Study|Withdrawal by Subject|1
7086336|NCT02192164|11200177|FG000|Overall Study|Physician Decision|4
7086337|NCT02192164|11200177|FG000|Overall Study|Did not meet the exclusion criteria|1
7086338|NCT02192190|11200190|FG000|Overall Study|Adverse Event|1
7086339|NCT02192190|11200191|FG001|Overall Study|Adverse Event|1
7086340|NCT02192190|11200192|FG002|Overall Study|Adverse Event|0
7086341|NCT02192190|11200193|FG003|Overall Study|Adverse Event|0
7086342|NCT02192190|11200194|FG004|Overall Study|Adverse Event|0
7086343|NCT02192190|11200195|FG005|Overall Study|Adverse Event|0
7086344|NCT02192190|11200190|FG000|Overall Study|Lost to Follow-up|3
7086345|NCT02192190|11200191|FG001|Overall Study|Lost to Follow-up|3
7086346|NCT02192190|11200192|FG002|Overall Study|Lost to Follow-up|2
7086347|NCT02192190|11200193|FG003|Overall Study|Lost to Follow-up|1
7086348|NCT02192190|11200194|FG004|Overall Study|Lost to Follow-up|4
7086349|NCT02192190|11200195|FG005|Overall Study|Lost to Follow-up|3
7086350|NCT02192190|11200190|FG000|Overall Study|Physician Decision|2
7086351|NCT02192190|11200191|FG001|Overall Study|Physician Decision|0
7086352|NCT02192190|11200192|FG002|Overall Study|Physician Decision|0
7086353|NCT02192190|11200193|FG003|Overall Study|Physician Decision|0
7086354|NCT02192190|11200194|FG004|Overall Study|Physician Decision|0
7086355|NCT02192190|11200195|FG005|Overall Study|Physician Decision|0
7086356|NCT02192190|11200190|FG000|Overall Study|Terminated by Sponsor|43
7086357|NCT02192190|11200191|FG001|Overall Study|Terminated by Sponsor|23
7086358|NCT02192190|11200192|FG002|Overall Study|Terminated by Sponsor|20
7086359|NCT02192190|11200193|FG003|Overall Study|Terminated by Sponsor|23
7086360|NCT02192190|11200194|FG004|Overall Study|Terminated by Sponsor|21
7086361|NCT02192190|11200195|FG005|Overall Study|Terminated by Sponsor|23
7086362|NCT02192190|11200190|FG000|Overall Study|Withdrawal by Subject|4
7086363|NCT02192190|11200191|FG001|Overall Study|Withdrawal by Subject|1
7086364|NCT02192190|11200192|FG002|Overall Study|Withdrawal by Subject|2
7086365|NCT02192190|11200193|FG003|Overall Study|Withdrawal by Subject|1
7086366|NCT02192190|11200194|FG004|Overall Study|Withdrawal by Subject|5
7086367|NCT02192190|11200195|FG005|Overall Study|Withdrawal by Subject|3
7086368|NCT02192190|11200190|FG000|Overall Study|Could not Keep Visit Schedule|1
7086369|NCT02192190|11200191|FG001|Overall Study|Could not Keep Visit Schedule|0
7086370|NCT02192190|11200192|FG002|Overall Study|Could not Keep Visit Schedule|0
7086371|NCT02192190|11200193|FG003|Overall Study|Could not Keep Visit Schedule|0
7086372|NCT02192190|11200194|FG004|Overall Study|Could not Keep Visit Schedule|0
7086373|NCT02192190|11200195|FG005|Overall Study|Could not Keep Visit Schedule|0
7086374|NCT02192190|11200190|FG000|Overall Study|Positive Drug Screen|0
7086375|NCT02192190|11200191|FG001|Overall Study|Positive Drug Screen|0
7086376|NCT02192190|11200192|FG002|Overall Study|Positive Drug Screen|0
7086377|NCT02192190|11200193|FG003|Overall Study|Positive Drug Screen|1
7086378|NCT02192190|11200194|FG004|Overall Study|Positive Drug Screen|0
7086379|NCT02192190|11200195|FG005|Overall Study|Positive Drug Screen|0
7086380|NCT02192190|11200190|FG000|Overall Study|Inadequate Pain Relief|0
7086381|NCT02192190|11200191|FG001|Overall Study|Inadequate Pain Relief|1
7086382|NCT02192190|11200192|FG002|Overall Study|Inadequate Pain Relief|1
7086383|NCT02192190|11200193|FG003|Overall Study|Inadequate Pain Relief|0
7086384|NCT02192190|11200194|FG004|Overall Study|Inadequate Pain Relief|0
7086385|NCT02192190|11200195|FG005|Overall Study|Inadequate Pain Relief|0
7086386|NCT02192606|11200231|FG000|Overall Study|surgery type was changed|1
7086387|NCT02192606|11200232|FG001|Overall Study|surgery type was changed|1
7086388|NCT02192606|11200231|FG000|Overall Study|Physician Decision|1
7086389|NCT02192606|11200232|FG001|Overall Study|Physician Decision|2
7086390|NCT02192606|11200231|FG000|Overall Study|3D equipment rep unable to join|0
7086391|NCT02192606|11200232|FG001|Overall Study|3D equipment rep unable to join|1
7086392|NCT02192905|11200264|FG000|Overall Study|Lost to Follow-up|1
7086393|NCT02192970|11200271|FG000|Overall Study|Lost to Follow-up|6
7086394|NCT02192970|11200272|FG001|Overall Study|Lost to Follow-up|0
7086395|NCT02193074|11200280|FG000|Overall Study|Withdrawal by Subject|1
7086396|NCT02193074|11200281|FG001|Overall Study|Withdrawal by Subject|2
7086397|NCT02193074|11200280|FG000|Overall Study|Adverse Event|16
7086398|NCT02193074|11200281|FG001|Overall Study|Adverse Event|13
7086399|NCT02193087|11200291|FG000|Overall Study|Adverse Event|2
7086400|NCT02193087|11200292|FG001|Overall Study|Adverse Event|0
7086401|NCT02193087|11200293|FG002|Overall Study|Adverse Event|0
7086402|NCT02193087|11200294|FG003|Overall Study|Adverse Event|11
7086403|NCT02193087|11200291|FG000|Overall Study|Lost to Follow-up|14
7086404|NCT02193087|11200292|FG001|Overall Study|Lost to Follow-up|6
7086405|NCT02193087|11200293|FG002|Overall Study|Lost to Follow-up|4
7086406|NCT02193087|11200294|FG003|Overall Study|Lost to Follow-up|37
7086407|NCT02193087|11200291|FG000|Overall Study|Protocol Violation|2
7086408|NCT02193087|11200292|FG001|Overall Study|Protocol Violation|0
7086409|NCT02193087|11200293|FG002|Overall Study|Protocol Violation|1
7086410|NCT02193087|11200294|FG003|Overall Study|Protocol Violation|2
7086411|NCT02193087|11200291|FG000|Overall Study|Withdrawal by Subject|10
7086412|NCT02193087|11200292|FG001|Overall Study|Withdrawal by Subject|3
7086413|NCT02193087|11200293|FG002|Overall Study|Withdrawal by Subject|1
7086414|NCT02193087|11200294|FG003|Overall Study|Withdrawal by Subject|19
7086415|NCT02193087|11200291|FG000|Overall Study|Other Reason Not Specified|7
7086416|NCT02193087|11200292|FG001|Overall Study|Other Reason Not Specified|2
7086417|NCT02193087|11200293|FG002|Overall Study|Other Reason Not Specified|1
7086418|NCT02193087|11200294|FG003|Overall Study|Other Reason Not Specified|9
7086419|NCT02193087|11200291|FG000|Overall Study|Did Not Receive Any Vaccination|2
7086420|NCT02193087|11200292|FG001|Overall Study|Did Not Receive Any Vaccination|3
7086421|NCT02193087|11200293|FG002|Overall Study|Did Not Receive Any Vaccination|0
7086422|NCT02193087|11200294|FG003|Overall Study|Did Not Receive Any Vaccination|1
7086423|NCT02193165|11200318|FG000|4 Week Product Use|Lost to Follow-up|1
7086424|NCT02193165|11200319|FG001|4 Week Product Use|Lost to Follow-up|1
7086425|NCT02193165|11200320|FG002|4 Week Product Use|Lost to Follow-up|1
7086426|NCT02193165|11200318|FG000|6 Week Product Use|Lost to Follow-up|0
7086427|NCT02193165|11200319|FG001|6 Week Product Use|Lost to Follow-up|1
7086428|NCT02193165|11200320|FG002|6 Week Product Use|Lost to Follow-up|0
7086429|NCT02193178|11200328|FG000|Overall Study|Lost to Follow-up|1
7086430|NCT02193178|11200328|FG000|Overall Study|Dry eyes|1
7086431|NCT02193776|11200363|FG000|Overall Study|Consent withdrawn|1
7086432|NCT02193776|11200364|FG001|Overall Study|Consent withdrawn|0
7086433|NCT02193776|11200365|FG002|Overall Study|Consent withdrawn|0
7086434|NCT02193776|11200366|FG003|Overall Study|Consent withdrawn|0
7086435|NCT02193776|11200363|FG000|Overall Study|Failure to comply with protocol|0
7086436|NCT02193776|11200364|FG001|Overall Study|Failure to comply with protocol|1
7086437|NCT02193776|11200365|FG002|Overall Study|Failure to comply with protocol|0
7086438|NCT02193776|11200366|FG003|Overall Study|Failure to comply with protocol|0
7086439|NCT02193776|11200363|FG000|Overall Study|Investigator/Sponsor decision|1
7086440|NCT02193776|11200364|FG001|Overall Study|Investigator/Sponsor decision|1
7086441|NCT02193776|11200365|FG002|Overall Study|Investigator/Sponsor decision|0
6805617|NCT03434379|10807730|FG000|Global Period|Withdrawal by Subject|20
6805618|NCT03434379|10807731|FG001|Global Period|Withdrawal by Subject|20
6805619|NCT03434379|10807732|FG002|Global Period|Withdrawal by Subject|0
6805620|NCT03434379|10807733|FG003|Global Period|Withdrawal by Subject|0
7086442|NCT02193776|11200366|FG003|Overall Study|Investigator/Sponsor decision|0
7086443|NCT02193776|11200363|FG000|Overall Study|Death|1
7086444|NCT02193776|11200364|FG001|Overall Study|Death|0
7086445|NCT02193776|11200365|FG002|Overall Study|Death|0
7086446|NCT02193776|11200366|FG003|Overall Study|Death|0
7086447|NCT02193776|11200363|FG000|Overall Study|Adverse event/Specific toxicity|5
7086448|NCT02193776|11200364|FG001|Overall Study|Adverse event/Specific toxicity|5
7086449|NCT02193776|11200365|FG002|Overall Study|Adverse event/Specific toxicity|2
7086450|NCT02193776|11200366|FG003|Overall Study|Adverse event/Specific toxicity|2
7086451|NCT02193828|11200394|FG000|Overall Study|Withdrawal by Subject|0
7086452|NCT02193828|11200395|FG001|Overall Study|Withdrawal by Subject|0
7086453|NCT02193828|11200396|FG002|Overall Study|Withdrawal by Subject|1
7086454|NCT02193828|11200397|FG003|Overall Study|Withdrawal by Subject|1
7086455|NCT02193880|11200407|FG000|Overall Study|patients did not collect enough HPC|3
7086456|NCT02194062|11200414|FG000|Overall Study|Lost to Follow-up|2
7086457|NCT02194062|11200415|FG001|Overall Study|Lost to Follow-up|2
7086458|NCT02194062|11200416|FG002|Overall Study|Lost to Follow-up|5
7086459|NCT02194465|11200446|FG000|Overall Study|Adverse Event|6
7086460|NCT02194465|11200447|FG001|Overall Study|Adverse Event|1
7086461|NCT02194465|11200448|FG002|Overall Study|Adverse Event|4
7086462|NCT02194465|11200449|FG003|Overall Study|Adverse Event|4
7086463|NCT02194465|11200450|FG004|Overall Study|Adverse Event|4
7086464|NCT02194465|11200451|FG005|Overall Study|Adverse Event|2
7086465|NCT02194465|11200452|FG006|Overall Study|Adverse Event|0
7086466|NCT02194465|11200446|FG000|Overall Study|Lost to Follow-up|0
7086467|NCT02194465|11200447|FG001|Overall Study|Lost to Follow-up|0
7086468|NCT02194465|11200448|FG002|Overall Study|Lost to Follow-up|0
7086469|NCT02194465|11200449|FG003|Overall Study|Lost to Follow-up|1
7086470|NCT02194465|11200450|FG004|Overall Study|Lost to Follow-up|0
6805621|NCT03434379|10807730|FG000|Global Period|On Study|43
6805622|NCT03434379|10807731|FG001|Global Period|On Study|136
7086471|NCT02194465|11200451|FG005|Overall Study|Lost to Follow-up|1
7086472|NCT02194465|11200452|FG006|Overall Study|Lost to Follow-up|0
7086473|NCT02194465|11200446|FG000|Overall Study|Physician Decision|1
7086474|NCT02194465|11200447|FG001|Overall Study|Physician Decision|0
7086475|NCT02194465|11200448|FG002|Overall Study|Physician Decision|0
7086476|NCT02194465|11200449|FG003|Overall Study|Physician Decision|0
7086477|NCT02194465|11200450|FG004|Overall Study|Physician Decision|0
7086478|NCT02194465|11200451|FG005|Overall Study|Physician Decision|0
7086479|NCT02194465|11200452|FG006|Overall Study|Physician Decision|0
7086480|NCT02194465|11200446|FG000|Overall Study|Protocol Violation|1
7086481|NCT02194465|11200447|FG001|Overall Study|Protocol Violation|1
7086482|NCT02194465|11200448|FG002|Overall Study|Protocol Violation|2
7086483|NCT02194465|11200449|FG003|Overall Study|Protocol Violation|1
7086484|NCT02194465|11200450|FG004|Overall Study|Protocol Violation|1
7086485|NCT02194465|11200451|FG005|Overall Study|Protocol Violation|0
7086486|NCT02194465|11200452|FG006|Overall Study|Protocol Violation|0
7086487|NCT02194465|11200446|FG000|Overall Study|Withdrawal by Subject|1
7086488|NCT02194465|11200447|FG001|Overall Study|Withdrawal by Subject|3
7086489|NCT02194465|11200448|FG002|Overall Study|Withdrawal by Subject|1
7086490|NCT02194465|11200449|FG003|Overall Study|Withdrawal by Subject|2
7086491|NCT02194465|11200450|FG004|Overall Study|Withdrawal by Subject|2
7086492|NCT02194465|11200451|FG005|Overall Study|Withdrawal by Subject|1
7086493|NCT02194465|11200452|FG006|Overall Study|Withdrawal by Subject|2
7086494|NCT02194465|11200446|FG000|Overall Study|Discontinued follow-up period|0
7086495|NCT02194465|11200447|FG001|Overall Study|Discontinued follow-up period|2
7086496|NCT02194465|11200448|FG002|Overall Study|Discontinued follow-up period|1
7086497|NCT02194465|11200449|FG003|Overall Study|Discontinued follow-up period|0
7086498|NCT02194465|11200450|FG004|Overall Study|Discontinued follow-up period|2
7086499|NCT02194465|11200451|FG005|Overall Study|Discontinued follow-up period|0
7086500|NCT02194465|11200452|FG006|Overall Study|Discontinued follow-up period|0
7086501|NCT02194621|11200475|FG000|Overall Study|6 withdrew prior to randomization|2
7086502|NCT02194621|11200476|FG001|Overall Study|6 withdrew prior to randomization|2
7086503|NCT02194621|11200477|FG002|Overall Study|6 withdrew prior to randomization|2
7086504|NCT02194621|11200475|FG000|Overall Study|Withdrawal by Subject|4
7086505|NCT02194621|11200476|FG001|Overall Study|Withdrawal by Subject|4
7086506|NCT02194621|11200477|FG002|Overall Study|Withdrawal by Subject|7
7086507|NCT02194699|11200487|FG000|Randomised|Did not receive treatment|1
7086508|NCT02194699|11200488|FG001|Randomised|Did not receive treatment|5
7086509|NCT02194699|11200487|FG000|Randomised|Without potential for 52 weeks of IP|5
7086510|NCT02194699|11200488|FG001|Randomised|Without potential for 52 weeks of IP|5
7086511|NCT02194699|11200487|FG000|Randomised|Duplicate patient|2
7086512|NCT02194699|11200488|FG001|Randomised|Duplicate patient|1
7086513|NCT02194699|11200487|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4
7086514|NCT02194699|11200488|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3
7086515|NCT02194699|11200487|FG000|With Potential to Receive 52 Weeks of IP|Death|1
7086516|NCT02194699|11200488|FG001|With Potential to Receive 52 Weeks of IP|Death|3
7086517|NCT02194699|11200487|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5
7086518|NCT02194699|11200488|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8
7086519|NCT02194699|11200487|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
7086520|NCT02194699|11200488|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
7086521|NCT02194699|11200487|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14
7086522|NCT02194699|11200488|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20
7086523|NCT02194699|11200487|FG000|With Potential to Receive 52 Weeks of IP|Other|24
7086524|NCT02194699|11200488|FG001|With Potential to Receive 52 Weeks of IP|Other|16
7086525|NCT02194933|11200504|FG000|Overall Study|Lost to Follow-up|1
7086526|NCT02194933|11200505|FG001|Overall Study|Lost to Follow-up|2
7086527|NCT02194933|11200504|FG000|Overall Study|Participant met withdrawal criteria|1
7086528|NCT02194933|11200505|FG001|Overall Study|Participant met withdrawal criteria|3
7086529|NCT02194933|11200504|FG000|Overall Study|Withdrawal by Subject|0
7086530|NCT02194933|11200505|FG001|Overall Study|Withdrawal by Subject|2
7086531|NCT02194933|11200504|FG000|Overall Study|Lack of Efficacy|1
7086532|NCT02194933|11200505|FG001|Overall Study|Lack of Efficacy|2
7086533|NCT02194985|11200513|FG000|Overall Study|Adverse Event|1
7086534|NCT02194985|11200513|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3
7086535|NCT02194985|11200513|FG000|Overall Study|Physician Decision|4
7086536|NCT02194985|11200513|FG000|Overall Study|Lost to Follow-up|1
7086537|NCT02194985|11200513|FG000|Overall Study|Withdrawal by Subject|2
7086538|NCT02194998|11200521|FG000|On-HCV Treatment|Did not pick up study medication|0
7086539|NCT02194998|11200522|FG001|On-HCV Treatment|Did not pick up study medication|1
7086540|NCT02194998|11200523|FG002|On-HCV Treatment|Did not pick up study medication|0
7086541|NCT02194998|11200524|FG003|On-HCV Treatment|Did not pick up study medication|0
7086542|NCT02194998|11200521|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1
7086543|NCT02194998|11200522|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0
7086544|NCT02194998|11200523|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1
7086545|NCT02194998|11200524|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0
7086546|NCT02195011|11200536|FG000|Overall Study|Adverse Event|4
7086547|NCT02195011|11200537|FG001|Overall Study|Adverse Event|0
7086548|NCT02195011|11200536|FG000|Overall Study|Progressive Disease|18
7086549|NCT02195011|11200537|FG001|Overall Study|Progressive Disease|1
7086550|NCT02195011|11200536|FG000|Overall Study|Withdrawal by Subject|3
7086551|NCT02195011|11200537|FG001|Overall Study|Withdrawal by Subject|0
7086552|NCT02195427|11200632|FG000|Overall Study|Did not consent to study extension|13
7086553|NCT02195427|11200633|FG001|Overall Study|Did not consent to study extension|9
7086554|NCT02195427|11200632|FG000|Overall Study|Withdrawal by Subject|4
7086555|NCT02195427|11200633|FG001|Overall Study|Withdrawal by Subject|2
7086556|NCT02195427|11200632|FG000|Overall Study|Lost to Follow-up|0
7086557|NCT02195427|11200633|FG001|Overall Study|Lost to Follow-up|1
7086558|NCT02195427|11200632|FG000|Overall Study|Protocol Violation|7
7086559|NCT02195427|11200633|FG001|Overall Study|Protocol Violation|14
7086560|NCT02195427|11200632|FG000|Overall Study|Conditional re-treatment at W52|2
7086561|NCT02195427|11200633|FG001|Overall Study|Conditional re-treatment at W52|1
7086562|NCT02195518|11200643|FG000|Overall Study|Adverse Event|1
7086563|NCT02195518|11200643|FG000|Overall Study|Protocol Violation|4
7086564|NCT02195518|11200643|FG000|Overall Study|Pregnancy|2
7086565|NCT02195518|11200643|FG000|Overall Study|Withdrawal by Subject|1
7086566|NCT02195518|11200643|FG000|Overall Study|Lost to Follow-up|1
7086567|NCT02195531|11200650|FG000|Overall Study|Withdrawal by Subject|1
7086568|NCT02195531|11200651|FG001|Overall Study|Withdrawal by Subject|1
7086569|NCT02195531|11200652|FG002|Overall Study|Withdrawal by Subject|1
7086570|NCT02195583|11200660|FG000|Overall Study|Lost to Follow-up|1
7086571|NCT02195583|11200660|FG000|Overall Study|Withdrawal by Subject|4
7086572|NCT02195583|11200660|FG000|Overall Study|Adverse Event|2
7086573|NCT02195583|11200660|FG000|Overall Study|Other Reason|2
7086574|NCT02195687|11200686|FG000|Overall Study|Personal Reasons|1
7086575|NCT02195687|11200687|FG001|Overall Study|Personal Reasons|1
7086576|NCT02195687|11200686|FG000|Overall Study|Lost to Follow-up|4
7086577|NCT02195687|11200687|FG001|Overall Study|Lost to Follow-up|1
7086578|NCT02195700|11200695|FG000|Overall Study|Protocol Violation|0
7086579|NCT02195700|11200696|FG001|Overall Study|Protocol Violation|2
7086580|NCT02195700|11200695|FG000|Overall Study|Noncompliance|1
7086581|NCT02195700|11200696|FG001|Overall Study|Noncompliance|0
7086582|NCT02195700|11200695|FG000|Overall Study|Adverse Event|1
7086583|NCT02195700|11200696|FG001|Overall Study|Adverse Event|2
7086584|NCT02195700|11200695|FG000|Overall Study|Withdrawal by Subject|3
7086585|NCT02195700|11200696|FG001|Overall Study|Withdrawal by Subject|2
7086586|NCT02195700|11200695|FG000|Overall Study|Lost to Follow-up|1
7086587|NCT02195700|11200696|FG001|Overall Study|Lost to Follow-up|1
7086588|NCT02195869|11200711|FG000|Overall Study|cGVHD Progression|5
7086589|NCT02195869|11200711|FG000|Overall Study|Malignancy Progression/relapse|2
7086590|NCT02195869|11200711|FG000|Overall Study|Adverse Event|15
7086591|NCT02195869|11200711|FG000|Overall Study|Withdrawal by Subject|7
7086592|NCT02195869|11200711|FG000|Overall Study|Physician Decision|4
7086593|NCT02195869|11200711|FG000|Overall Study|Study Terminated by Sponsor|7
7086594|NCT02195869|11200711|FG000|Overall Study|Noncompliance with study drug|2
7086595|NCT02196038|11200746|FG000|Overall Study|Death|16
7086596|NCT02196038|11200747|FG001|Overall Study|Death|21
7086597|NCT02196038|11200746|FG000|Overall Study|Withdrawal by Subject|0
7086598|NCT02196038|11200747|FG001|Overall Study|Withdrawal by Subject|1
7086599|NCT02196038|11200746|FG000|Overall Study|Lost to Follow-up|1
7086600|NCT02196038|11200747|FG001|Overall Study|Lost to Follow-up|0
7086601|NCT02196077|11200753|FG000|Overall Study|Adverse Event|4
7086602|NCT02196077|11200753|FG000|Overall Study|Lack of Efficacy|1
7086603|NCT02196077|11200753|FG000|Overall Study|Withdrawal by Subject|14
7086604|NCT02196077|11200753|FG000|Overall Study|Physician Decision|1
7086605|NCT02196077|11200753|FG000|Overall Study|Lost to Follow-up|3
7086606|NCT02196077|11200753|FG000|Overall Study|Protocol Violation|24
7086607|NCT02196259|11200777|FG000|Overall Study|Researcher choice|0
7086608|NCT02196259|11200778|FG001|Overall Study|Researcher choice|0
7086609|NCT02196259|11200779|FG002|Overall Study|Researcher choice|1
7086610|NCT02196259|11200777|FG000|Overall Study|Partial data analysis|0
7086611|NCT02196259|11200778|FG001|Overall Study|Partial data analysis|3
7086612|NCT02196259|11200779|FG002|Overall Study|Partial data analysis|0
7086613|NCT02196324|11200788|FG000|Overall Study|Withdrawal by Subject|8
7086614|NCT02196324|11200789|FG001|Overall Study|Withdrawal by Subject|4
7086615|NCT02196324|11200788|FG000|Overall Study|Adverse Event or Serious Adverse Event|6
7086616|NCT02196324|11200789|FG001|Overall Study|Adverse Event or Serious Adverse Event|3
7086617|NCT02196324|11200788|FG000|Overall Study|Occurrence of an Exclusion Criterion|0
7086618|NCT02196324|11200789|FG001|Overall Study|Occurrence of an Exclusion Criterion|1
7086619|NCT02196324|11200788|FG000|Overall Study|Other|1
7086620|NCT02196324|11200789|FG001|Overall Study|Other|0
7086621|NCT02196506|11200797|FG000|Phase A|Participant Met Withdrawal Criteria|34
7086622|NCT02196506|11200798|FG001|Phase A|Participant Met Withdrawal Criteria|0
7086623|NCT02196506|11200799|FG002|Phase A|Participant Met Withdrawal Criteria|0
7086624|NCT02196506|11200800|FG003|Phase A|Participant Met Withdrawal Criteria|0
7086625|NCT02196506|11200797|FG000|Phase A|Withdrawal by Subject|34
7086626|NCT02196506|11200798|FG001|Phase A|Withdrawal by Subject|0
7086627|NCT02196506|11200799|FG002|Phase A|Withdrawal by Subject|0
7086628|NCT02196506|11200800|FG003|Phase A|Withdrawal by Subject|0
7086629|NCT02196506|11200797|FG000|Phase A|Adverse Event|22
7086630|NCT02196506|11200798|FG001|Phase A|Adverse Event|0
7086631|NCT02196506|11200799|FG002|Phase A|Adverse Event|0
7086632|NCT02196506|11200800|FG003|Phase A|Adverse Event|0
7086633|NCT02196506|11200797|FG000|Phase A|Lost to Follow-up|9
7086634|NCT02196506|11200798|FG001|Phase A|Lost to Follow-up|0
7086635|NCT02196506|11200799|FG002|Phase A|Lost to Follow-up|0
7086636|NCT02196506|11200800|FG003|Phase A|Lost to Follow-up|0
7086637|NCT02196506|11200797|FG000|Phase A|Protocol deviation|12
7086638|NCT02196506|11200798|FG001|Phase A|Protocol deviation|0
7086639|NCT02196506|11200799|FG002|Phase A|Protocol deviation|0
7086640|NCT02196506|11200800|FG003|Phase A|Protocol deviation|0
7086641|NCT02196506|11200797|FG000|Phase A|Participant withdrawn by investigator|10
7086642|NCT02196506|11200798|FG001|Phase A|Participant withdrawn by investigator|0
7086643|NCT02196506|11200799|FG002|Phase A|Participant withdrawn by investigator|0
7086644|NCT02196506|11200800|FG003|Phase A|Participant withdrawn by investigator|0
7086645|NCT02196506|11200797|FG000|Phase B|Participant Met Withdrawal Criteria|0
7086646|NCT02196506|11200798|FG001|Phase B|Participant Met Withdrawal Criteria|0
7086647|NCT02196506|11200799|FG002|Phase B|Participant Met Withdrawal Criteria|1
7086648|NCT02196506|11200800|FG003|Phase B|Participant Met Withdrawal Criteria|0
7086649|NCT02196506|11200797|FG000|Phase B|Lack of Efficacy|0
7086650|NCT02196506|11200798|FG001|Phase B|Lack of Efficacy|1
7086651|NCT02196506|11200799|FG002|Phase B|Lack of Efficacy|2
7086652|NCT02196506|11200800|FG003|Phase B|Lack of Efficacy|0
7086653|NCT02196506|11200797|FG000|Phase B|Withdrawal by Participant|0
7086654|NCT02196506|11200798|FG001|Phase B|Withdrawal by Participant|8
7086655|NCT02196506|11200799|FG002|Phase B|Withdrawal by Participant|1
7086656|NCT02196506|11200800|FG003|Phase B|Withdrawal by Participant|0
7086657|NCT02196506|11200797|FG000|Phase B|Adverse Event|0
7086658|NCT02196506|11200798|FG001|Phase B|Adverse Event|4
7086659|NCT02196506|11200799|FG002|Phase B|Adverse Event|1
7086660|NCT02196506|11200800|FG003|Phase B|Adverse Event|0
7086661|NCT02196506|11200797|FG000|Phase B|Lost to Follow-up|0
7086662|NCT02196506|11200798|FG001|Phase B|Lost to Follow-up|2
7086663|NCT02196506|11200799|FG002|Phase B|Lost to Follow-up|1
7086664|NCT02196506|11200800|FG003|Phase B|Lost to Follow-up|0
7086665|NCT02196506|11200797|FG000|Phase A+|Participant Met Withdrawal Criteria|0
7086666|NCT02196506|11200798|FG001|Phase A+|Participant Met Withdrawal Criteria|0
7086667|NCT02196506|11200799|FG002|Phase A+|Participant Met Withdrawal Criteria|0
7086668|NCT02196506|11200800|FG003|Phase A+|Participant Met Withdrawal Criteria|1
7086669|NCT02196506|11200797|FG000|Phase A+|Withdrawal by Participant|0
7086670|NCT02196506|11200798|FG001|Phase A+|Withdrawal by Participant|0
7086671|NCT02196506|11200799|FG002|Phase A+|Withdrawal by Participant|0
7086672|NCT02196506|11200800|FG003|Phase A+|Withdrawal by Participant|5
7086673|NCT02196506|11200797|FG000|Phase A+|Adverse Event|0
7086674|NCT02196506|11200798|FG001|Phase A+|Adverse Event|0
7086675|NCT02196506|11200799|FG002|Phase A+|Adverse Event|0
7086676|NCT02196506|11200800|FG003|Phase A+|Adverse Event|1
7086677|NCT02196506|11200797|FG000|Phase A+|Lost to Follow-up|0
7086678|NCT02196506|11200798|FG001|Phase A+|Lost to Follow-up|0
7086679|NCT02196506|11200799|FG002|Phase A+|Lost to Follow-up|0
7086680|NCT02196506|11200800|FG003|Phase A+|Lost to Follow-up|6
7086681|NCT02196506|11200797|FG000|Phase A+|Participant withdrawn by investigator|0
7086682|NCT02196506|11200798|FG001|Phase A+|Participant withdrawn by investigator|0
7086683|NCT02196506|11200799|FG002|Phase A+|Participant withdrawn by investigator|0
7086684|NCT02196506|11200800|FG003|Phase A+|Participant withdrawn by investigator|1
7086685|NCT02196558|11200809|FG000|Treatment Phase (12 Weeks)|Adverse Event|0
7086686|NCT02196558|11200810|FG001|Treatment Phase (12 Weeks)|Adverse Event|2
7086687|NCT02196558|11200811|FG002|Treatment Phase (12 Weeks)|Adverse Event|0
7086688|NCT02196558|11200809|FG000|Treatment Phase (12 Weeks)|Participant Choice|0
7086689|NCT02196558|11200810|FG001|Treatment Phase (12 Weeks)|Participant Choice|1
7086690|NCT02196558|11200811|FG002|Treatment Phase (12 Weeks)|Participant Choice|1
7086691|NCT02196558|11200809|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0
7086692|NCT02196558|11200810|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0
7086693|NCT02196558|11200811|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1
7086694|NCT02196558|11200809|FG000|Extension Phase (40 Weeks)|Adverse Event|1
7086695|NCT02196558|11200810|FG001|Extension Phase (40 Weeks)|Adverse Event|2
7086696|NCT02196558|11200811|FG002|Extension Phase (40 Weeks)|Adverse Event|0
7086697|NCT02196558|11200809|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1
7086698|NCT02196558|11200810|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1
7086699|NCT02196558|11200811|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1
7086700|NCT02196675|11200822|FG000|Overall Study|Withdrawal by Subject|1
7086701|NCT02196675|11200823|FG001|Overall Study|Withdrawal by Subject|0
7086702|NCT02196675|11200824|FG002|Overall Study|Withdrawal by Subject|0
7086703|NCT02196675|11200822|FG000|Overall Study|Intra-operative surgical exclusion|1
7086704|NCT02196675|11200823|FG001|Overall Study|Intra-operative surgical exclusion|1
7086705|NCT02196675|11200824|FG002|Overall Study|Intra-operative surgical exclusion|0
7086706|NCT02196675|11200822|FG000|Overall Study|Protocol Violation|0
7086707|NCT02196675|11200823|FG001|Overall Study|Protocol Violation|1
7086708|NCT02196675|11200824|FG002|Overall Study|Protocol Violation|0
7086709|NCT02196675|11200822|FG000|Overall Study|Death|0
7086710|NCT02196675|11200823|FG001|Overall Study|Death|0
7086711|NCT02196675|11200824|FG002|Overall Study|Death|1
7086712|NCT02196701|11200843|FG000|Overall Study|Adverse Event|1
7086713|NCT02196701|11200843|FG000|Overall Study|Lost to Follow-up|1
7086714|NCT02196701|11200843|FG000|Overall Study|Non-adherence to Protocol|1
7086715|NCT02196714|11200850|FG000|Overall Study|Protocol Violation|0
7086716|NCT02196714|11200851|FG001|Overall Study|Protocol Violation|0
7086717|NCT02196714|11200852|FG002|Overall Study|Protocol Violation|1
7086718|NCT02196714|11200853|FG003|Overall Study|Protocol Violation|0
7086719|NCT02197130|11200961|FG000|Overall Study|Adverse Event|13
7086720|NCT02197130|11200962|FG001|Overall Study|Adverse Event|4
7086721|NCT02197130|11200963|FG002|Overall Study|Adverse Event|23
7086722|NCT02197130|11200961|FG000|Overall Study|Death|0
7086723|NCT02197130|11200962|FG001|Overall Study|Death|1
7086724|NCT02197130|11200963|FG002|Overall Study|Death|0
7086725|NCT02197130|11200961|FG000|Overall Study|Lost to Follow-up|2
7086726|NCT02197130|11200962|FG001|Overall Study|Lost to Follow-up|0
7086727|NCT02197130|11200963|FG002|Overall Study|Lost to Follow-up|1
7086728|NCT02197130|11200961|FG000|Overall Study|Does not meet entrance criteria|0
7086729|NCT02197130|11200962|FG001|Overall Study|Does not meet entrance criteria|0
7086730|NCT02197130|11200963|FG002|Overall Study|Does not meet entrance criteria|1
7086731|NCT02197130|11200961|FG000|Overall Study|Withdrawal by Subject|0
7086732|NCT02197130|11200962|FG001|Overall Study|Withdrawal by Subject|3
7086733|NCT02197130|11200963|FG002|Overall Study|Withdrawal by Subject|4
7086734|NCT02197130|11200961|FG000|Overall Study|Other|1
7086735|NCT02197130|11200962|FG001|Overall Study|Other|0
7086736|NCT02197130|11200963|FG002|Overall Study|Other|3
7086737|NCT02197247|11200971|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2
7086738|NCT02197247|11200971|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2
7086739|NCT02197247|11200971|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5
7086740|NCT02197247|11200971|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2
7086741|NCT02197247|11200971|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2
7086742|NCT02197247|11200971|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1
7086743|NCT02197247|11200971|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1
7086744|NCT02197247|11200971|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9
7086745|NCT02197377|11200992|FG000|Overall Study|Insertion Failure|0
7086746|NCT02197377|11200993|FG001|Overall Study|Insertion Failure|3
7086747|NCT02197416|11201002|FG000|Overall Study|Other reasons|0
7086748|NCT02197416|11201003|FG001|Overall Study|Other reasons|2
7086749|NCT02197416|11201004|FG002|Overall Study|Other reasons|5
7086750|NCT02197416|11201002|FG000|Overall Study|Withdrawal by Subject|0
7086751|NCT02197416|11201003|FG001|Overall Study|Withdrawal by Subject|2
7086752|NCT02197416|11201004|FG002|Overall Study|Withdrawal by Subject|1
7086753|NCT02197416|11201002|FG000|Overall Study|Protocol Violation|1
7086754|NCT02197416|11201003|FG001|Overall Study|Protocol Violation|0
7086755|NCT02197416|11201004|FG002|Overall Study|Protocol Violation|1
7086756|NCT02197416|11201002|FG000|Overall Study|Adverse Event|0
7086757|NCT02197416|11201003|FG001|Overall Study|Adverse Event|0
7086758|NCT02197416|11201004|FG002|Overall Study|Adverse Event|1
7086759|NCT02197520|11201023|FG000|Period 1|Withdrawal by Subject|1
7086760|NCT02197520|11201024|FG001|Period 1|Withdrawal by Subject|0
7086761|NCT02197520|11201023|FG000|Period 2|Adverse Event|0
7086762|NCT02197520|11201024|FG001|Period 2|Adverse Event|2
7086763|NCT02197520|11201023|FG000|Period 2|Withdrawal by Subject|1
7086764|NCT02197520|11201024|FG001|Period 2|Withdrawal by Subject|0
7086765|NCT02197572|11201032|FG000|Overall Study|Progressive Disease|28
7086766|NCT02197572|11201032|FG000|Overall Study|Withdrawal by Subject|9
7086767|NCT02197572|11201032|FG000|Overall Study|Adverse Event|3
7086768|NCT02197572|11201032|FG000|Overall Study|Reason Not Specified|4
7086769|NCT02197806|11201044|FG000|Overall Study|Adverse Event|0
7086770|NCT02197806|11201045|FG001|Overall Study|Adverse Event|1
7086771|NCT02197806|11201046|FG002|Overall Study|Adverse Event|0
7086772|NCT02197806|11201047|FG003|Overall Study|Adverse Event|1
7086773|NCT02197897|11201057|FG000|Overall Study|not eligible|1
7086774|NCT02198040|11201064|FG000|Overall Study|Work reasons|0
7086775|NCT02198040|11201065|FG001|Overall Study|Work reasons|1
7086776|NCT02198040|11201066|FG002|Overall Study|Work reasons|0
7086777|NCT02198040|11201064|FG000|Overall Study|Withdrawal by Subject|0
7086778|NCT02198040|11201065|FG001|Overall Study|Withdrawal by Subject|0
7086779|NCT02198040|11201066|FG002|Overall Study|Withdrawal by Subject|1
7086780|NCT02198235|11201079|FG000|Overall Study|Lost to Follow-up|3
7086781|NCT02198235|11201080|FG001|Overall Study|Lost to Follow-up|2
7086782|NCT02198235|11201081|FG002|Overall Study|Lost to Follow-up|2
7086783|NCT02198651|11201098|FG000|Lead-in Period|Withdrew consent|13
7086784|NCT02198651|11201099|FG001|Lead-in Period|Withdrew consent|0
7086785|NCT02198651|11201100|FG002|Lead-in Period|Withdrew consent|0
7086786|NCT02198651|11201101|FG003|Lead-in Period|Withdrew consent|0
7086787|NCT02198651|11201102|FG004|Lead-in Period|Withdrew consent|0
7086788|NCT02198651|11201098|FG000|Lead-in Period|Adverse Event|2
7086789|NCT02198651|11201099|FG001|Lead-in Period|Adverse Event|0
7086790|NCT02198651|11201100|FG002|Lead-in Period|Adverse Event|0
7086791|NCT02198651|11201101|FG003|Lead-in Period|Adverse Event|0
7086792|NCT02198651|11201102|FG004|Lead-in Period|Adverse Event|0
7086793|NCT02198651|11201098|FG000|Lead-in Period|Other, not specified|22
7086794|NCT02198651|11201099|FG001|Lead-in Period|Other, not specified|0
7086795|NCT02198651|11201100|FG002|Lead-in Period|Other, not specified|0
7086796|NCT02198651|11201101|FG003|Lead-in Period|Other, not specified|0
7086797|NCT02198651|11201102|FG004|Lead-in Period|Other, not specified|0
7086798|NCT02198651|11201098|FG000|Double-blind Period|Withdrew consent|0
7086799|NCT02198651|11201099|FG001|Double-blind Period|Withdrew consent|4
7086800|NCT02198651|11201100|FG002|Double-blind Period|Withdrew consent|0
7086801|NCT02198651|11201101|FG003|Double-blind Period|Withdrew consent|0
7086802|NCT02198651|11201102|FG004|Double-blind Period|Withdrew consent|0
7086803|NCT02198651|11201098|FG000|Double-blind Period|Adverse Event|0
7086804|NCT02198651|11201099|FG001|Double-blind Period|Adverse Event|1
7086805|NCT02198651|11201100|FG002|Double-blind Period|Adverse Event|0
7086806|NCT02198651|11201101|FG003|Double-blind Period|Adverse Event|0
7086807|NCT02198651|11201102|FG004|Double-blind Period|Adverse Event|0
7086808|NCT02198651|11201098|FG000|Double-blind Period|Other, not specified|0
7086809|NCT02198651|11201099|FG001|Double-blind Period|Other, not specified|4
7086810|NCT02198651|11201100|FG002|Double-blind Period|Other, not specified|1
7086811|NCT02198651|11201101|FG003|Double-blind Period|Other, not specified|0
7086812|NCT02198651|11201102|FG004|Double-blind Period|Other, not specified|0
7086813|NCT02198651|11201098|FG000|Open-label Rescue Period|Withdrew consent|0
7086814|NCT02198651|11201099|FG001|Open-label Rescue Period|Withdrew consent|0
7086815|NCT02198651|11201100|FG002|Open-label Rescue Period|Withdrew consent|0
7086816|NCT02198651|11201101|FG003|Open-label Rescue Period|Withdrew consent|2
7086817|NCT02198651|11201102|FG004|Open-label Rescue Period|Withdrew consent|0
7086818|NCT02198651|11201098|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
7086819|NCT02198651|11201099|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
7086820|NCT02198651|11201100|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
7086821|NCT02198651|11201101|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1
7086822|NCT02198651|11201102|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
7086823|NCT02198664|11201117|FG000|Overall Study|Adverse Event|2
7086824|NCT02198664|11201118|FG001|Overall Study|Adverse Event|0
7086825|NCT02198664|11201117|FG000|Overall Study|Withdrawal by Subject|11
7086826|NCT02198664|11201118|FG001|Overall Study|Withdrawal by Subject|8
7086827|NCT02198664|11201117|FG000|Overall Study|Failure to tolerate|2
7086828|NCT02198664|11201118|FG001|Overall Study|Failure to tolerate|0
7086829|NCT02198664|11201117|FG000|Overall Study|Not stated|1
7086830|NCT02198664|11201118|FG001|Overall Study|Not stated|0
7086831|NCT02198963|11201126|FG000|Overall Study|Adverse Event|1
7086832|NCT02198963|11201126|FG000|Overall Study|Withdrawal by Subject|6
7086833|NCT02199028|11201137|FG000|Week 1|Adverse Event|1
7086834|NCT02199028|11201138|FG001|Week 1|Adverse Event|0
7086835|NCT02199028|11201137|FG000|Week 3|Adverse Event|1
7086836|NCT02199028|11201138|FG001|Week 3|Adverse Event|0
7086837|NCT02199080|11201150|FG000|Overall Study|Protocol Violation|12
7086838|NCT02199314|11201166|FG000|Overall Study|Withdrawal by Subject|6
7086839|NCT02199314|11201166|FG000|Overall Study|Physician Decision|10
7086840|NCT02199509|11201181|FG000|Overall Study|Suicidal Ideation|0
7086841|NCT02199509|11201182|FG001|Overall Study|Suicidal Ideation|1
7086842|NCT02199509|11201181|FG000|Overall Study|Misunderstood titration schedule|1
7086843|NCT02199509|11201182|FG001|Overall Study|Misunderstood titration schedule|0
7086844|NCT02199795|11201225|FG000|Overall Study|no longer met inclusion criteria|1
7086845|NCT02199795|11201226|FG001|Overall Study|no longer met inclusion criteria|0
7086846|NCT02199795|11201225|FG000|Overall Study|withdrew due to shoulder pain|1
7086847|NCT02199795|11201226|FG001|Overall Study|withdrew due to shoulder pain|0
7086848|NCT02200211|11201251|FG000|Overall Study|Lost to Follow-up|7
7086849|NCT02200211|11201252|FG001|Overall Study|Lost to Follow-up|7
7086850|NCT02200211|11201253|FG002|Overall Study|Lost to Follow-up|1
7086851|NCT02200211|11201254|FG003|Overall Study|Lost to Follow-up|2
7086852|NCT02200211|11201251|FG000|Overall Study|Withdrawal by Subject|1
7086853|NCT02200211|11201252|FG001|Overall Study|Withdrawal by Subject|0
7086854|NCT02200211|11201253|FG002|Overall Study|Withdrawal by Subject|0
7086855|NCT02200211|11201254|FG003|Overall Study|Withdrawal by Subject|0
7086856|NCT02200445|11201275|FG000|Overall Study|Lack of Efficacy|1
7086857|NCT02200445|11201276|FG001|Overall Study|Lack of Efficacy|2
7086858|NCT02200445|11201277|FG002|Overall Study|Lack of Efficacy|2
7086859|NCT02200445|11201275|FG000|Overall Study|Adverse Event|0
7086860|NCT02200445|11201276|FG001|Overall Study|Adverse Event|2
7086861|NCT02200445|11201277|FG002|Overall Study|Adverse Event|0
7086862|NCT02200510|11201291|FG000|Overall Study|Death|1
7086863|NCT02200510|11201292|FG001|Overall Study|Death|1
7086864|NCT02200510|11201291|FG000|Overall Study|Protocol Violation|0
7086865|NCT02200510|11201292|FG001|Overall Study|Protocol Violation|1
7086866|NCT02200510|11201291|FG000|Overall Study|Lost to Follow-up|7
7086867|NCT02200510|11201292|FG001|Overall Study|Lost to Follow-up|1
7086868|NCT02200510|11201291|FG000|Overall Study|potential COI - joined study team|1
7086869|NCT02200510|11201292|FG001|Overall Study|potential COI - joined study team|0
7086900|NCT02201108|11201368|FG000|Overall Study|Adverse Event|0
7086901|NCT02201108|11201369|FG001|Overall Study|Adverse Event|6
7086902|NCT02201108|11201368|FG000|Overall Study|Lack of Efficacy|2
7086903|NCT02201108|11201369|FG001|Overall Study|Lack of Efficacy|1
7086904|NCT02201108|11201368|FG000|Overall Study|Withdrawal by Subject|2
7086905|NCT02201108|11201369|FG001|Overall Study|Withdrawal by Subject|0
7086906|NCT02201277|11201384|FG000|Overall Study|Death|3
7086907|NCT02201277|11201385|FG001|Overall Study|Death|4
7086908|NCT02201277|11201384|FG000|Overall Study|Lost to Follow-up|2
7086909|NCT02201277|11201385|FG001|Overall Study|Lost to Follow-up|1
7086910|NCT02201277|11201384|FG000|Overall Study|Failed retrieval|1
7086911|NCT02201277|11201385|FG001|Overall Study|Failed retrieval|0
7086912|NCT02201277|11201384|FG000|Overall Study|Physician Decision|1
7086913|NCT02201277|11201385|FG001|Overall Study|Physician Decision|0
7086914|NCT02201290|11201395|FG000|Overall Study|Withdrawal by Subject|2
7086915|NCT02201290|11201395|FG000|Overall Study|Lack of Efficacy|2
7086916|NCT02201290|11201395|FG000|Overall Study|Adverse Event|1
7086917|NCT02201329|11201399|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3
7086918|NCT02201329|11201399|FG000|Overall Study|Withdrawal by Subject|2
7086919|NCT02201524|11201425|FG000|Overall Study|Adverse Event|0
7086920|NCT02201524|11201426|FG001|Overall Study|Adverse Event|2
7086921|NCT02201524|11201427|FG002|Overall Study|Adverse Event|1
7086922|NCT02201524|11201428|FG003|Overall Study|Adverse Event|0
7086923|NCT02201524|11201425|FG000|Overall Study|Insufficient clinical response|1
7086924|NCT02201524|11201426|FG001|Overall Study|Insufficient clinical response|0
7086925|NCT02201524|11201427|FG002|Overall Study|Insufficient clinical response|0
7086926|NCT02201524|11201428|FG003|Overall Study|Insufficient clinical response|0
7086927|NCT02201524|11201425|FG000|Overall Study|Lost to Follow-up|0
7086928|NCT02201524|11201426|FG001|Overall Study|Lost to Follow-up|0
7086929|NCT02201524|11201427|FG002|Overall Study|Lost to Follow-up|2
7086930|NCT02201524|11201428|FG003|Overall Study|Lost to Follow-up|0
7086931|NCT02201524|11201425|FG000|Overall Study|No longer meets eligibility criteria|0
7086932|NCT02201524|11201426|FG001|Overall Study|No longer meets eligibility criteria|0
7086933|NCT02201524|11201427|FG002|Overall Study|No longer meets eligibility criteria|0
7086934|NCT02201524|11201428|FG003|Overall Study|No longer meets eligibility criteria|2
7086935|NCT02201524|11201425|FG000|Overall Study|Protocol Violation|0
7086936|NCT02201524|11201426|FG001|Overall Study|Protocol Violation|0
7086937|NCT02201524|11201427|FG002|Overall Study|Protocol Violation|0
7086938|NCT02201524|11201428|FG003|Overall Study|Protocol Violation|1
7086939|NCT02201524|11201425|FG000|Overall Study|Withdrawal by Subject|0
7086940|NCT02201524|11201426|FG001|Overall Study|Withdrawal by Subject|0
7086941|NCT02201524|11201427|FG002|Overall Study|Withdrawal by Subject|1
7086942|NCT02201524|11201428|FG003|Overall Study|Withdrawal by Subject|1
7086943|NCT02201524|11201425|FG000|Overall Study|Other|1
7086944|NCT02201524|11201426|FG001|Overall Study|Other|1
7086945|NCT02201524|11201427|FG002|Overall Study|Other|0
7086946|NCT02201524|11201428|FG003|Overall Study|Other|0
7086947|NCT02201771|11201441|FG000|Overall Study|Death|3
7086948|NCT02201771|11201442|FG001|Overall Study|Death|2
7086949|NCT02201771|11201443|FG002|Overall Study|Death|0
7086950|NCT02201771|11201441|FG000|Overall Study|Protocol Violation|10
7086951|NCT02201771|11201442|FG001|Overall Study|Protocol Violation|8
7086952|NCT02201771|11201443|FG002|Overall Study|Protocol Violation|10
7086953|NCT02201784|11201453|FG000|Overall Study|Failure to achieve adequate block|2
7086954|NCT02201784|11201454|FG001|Overall Study|Failure to achieve adequate block|0
7086955|NCT02201901|11201463|FG000|Overall Study|Randomized but never treated|0
7086956|NCT02201901|11201464|FG001|Overall Study|Randomized but never treated|1
7086957|NCT02201901|11201465|FG002|Overall Study|Randomized but never treated|0
7086958|NCT02201901|11201463|FG000|Overall Study|Lack of Efficacy|7
7086959|NCT02201901|11201464|FG001|Overall Study|Lack of Efficacy|1
7086960|NCT02201901|11201465|FG002|Overall Study|Lack of Efficacy|6
7086961|NCT02201901|11201463|FG000|Overall Study|Death|3
7086962|NCT02201901|11201464|FG001|Overall Study|Death|3
7086963|NCT02201901|11201465|FG002|Overall Study|Death|3
7086964|NCT02201901|11201463|FG000|Overall Study|Lost to Follow-up|2
7086965|NCT02201901|11201464|FG001|Overall Study|Lost to Follow-up|3
7086966|NCT02201901|11201465|FG002|Overall Study|Lost to Follow-up|2
7086967|NCT02201901|11201463|FG000|Overall Study|Withdrew Consent|2
7086968|NCT02201901|11201464|FG001|Overall Study|Withdrew Consent|0
7086969|NCT02201901|11201465|FG002|Overall Study|Withdrew Consent|2
7086970|NCT02201901|11201463|FG000|Overall Study|Adverse Event|1
7086971|NCT02201901|11201464|FG001|Overall Study|Adverse Event|1
7086972|NCT02201901|11201465|FG002|Overall Study|Adverse Event|0
7086973|NCT02201940|11201476|FG000|Overall Study|Randomized/Enrolled but Never Treated|1
7086974|NCT02201940|11201477|FG001|Overall Study|Randomized/Enrolled but Never Treated|0
7086975|NCT02201940|11201476|FG000|Overall Study|Lack of Efficacy|2
7086976|NCT02201940|11201477|FG001|Overall Study|Lack of Efficacy|113
7086977|NCT02201940|11201476|FG000|Overall Study|Lost to Follow-up|5
7086978|NCT02201940|11201477|FG001|Overall Study|Lost to Follow-up|0
7086979|NCT02201940|11201476|FG000|Overall Study|Withdrew Consent|2
7086980|NCT02201940|11201477|FG001|Overall Study|Withdrew Consent|1
7086981|NCT02201940|11201476|FG000|Overall Study|Investigator's Discretion|1
7086982|NCT02201940|11201477|FG001|Overall Study|Investigator's Discretion|1
7086983|NCT02201940|11201476|FG000|Overall Study|Death|1
7086984|NCT02201940|11201477|FG001|Overall Study|Death|0
7086985|NCT02201940|11201476|FG000|Overall Study|Adverse Event|0
7086986|NCT02201940|11201477|FG001|Overall Study|Adverse Event|1
7086987|NCT02201953|11201485|FG000|Overall Study|Randomized but Never Treated|1
7086988|NCT02201953|11201486|FG001|Overall Study|Randomized but Never Treated|5
7086989|NCT02201953|11201485|FG000|Overall Study|Lack of Efficacy|9
7086990|NCT02201953|11201486|FG001|Overall Study|Lack of Efficacy|30
7086991|NCT02201953|11201485|FG000|Overall Study|Lost to Follow-up|8
7086992|NCT02201953|11201486|FG001|Overall Study|Lost to Follow-up|8
7086993|NCT02201953|11201485|FG000|Overall Study|Withdrew Consent|2
7086994|NCT02201953|11201486|FG001|Overall Study|Withdrew Consent|5
7086995|NCT02201953|11201485|FG000|Overall Study|Adverse Event|0
7086996|NCT02201953|11201486|FG001|Overall Study|Adverse Event|5
7086997|NCT02201953|11201485|FG000|Overall Study|Death|0
7086998|NCT02201953|11201486|FG001|Overall Study|Death|3
7086999|NCT02202031|11201494|FG000|Overall Study|Lost to Follow-up|1
7087000|NCT02202031|11201495|FG001|Overall Study|Lost to Follow-up|0
7087001|NCT02202031|11201494|FG000|Overall Study|Too Busy|1
7087002|NCT02202031|11201495|FG001|Overall Study|Too Busy|3
7087003|NCT02202031|11201494|FG000|Overall Study|Illness/Medical Reason|0
7087004|NCT02202031|11201495|FG001|Overall Study|Illness/Medical Reason|2
7087005|NCT02202031|11201494|FG000|Overall Study|Intolerance/Lack of Improvement|3
7087006|NCT02202031|11201495|FG001|Overall Study|Intolerance/Lack of Improvement|0
7087007|NCT02202109|11201503|FG000|Overall Study|Lost to Follow-up|88
7087008|NCT02202109|11201504|FG001|Overall Study|Lost to Follow-up|87
7087009|NCT02202109|11201503|FG000|Overall Study|Withdrawal by Subject|2
7087010|NCT02202109|11201504|FG001|Overall Study|Withdrawal by Subject|0
7087011|NCT02202161|11201522|FG000|Overall Study|Adverse Event|1
7087012|NCT02202161|11201523|FG001|Overall Study|Adverse Event|1
7087013|NCT02202161|11201524|FG002|Overall Study|Adverse Event|0
7087014|NCT02202161|11201525|FG003|Overall Study|Adverse Event|0
7087015|NCT02202161|11201526|FG004|Overall Study|Adverse Event|0
7087016|NCT02202161|11201527|FG005|Overall Study|Adverse Event|1
7087017|NCT02202161|11201528|FG006|Overall Study|Adverse Event|0
7087018|NCT02202161|11201529|FG007|Overall Study|Adverse Event|0
7087019|NCT02202161|11201522|FG000|Overall Study|Did not meet continuation criteria|0
7087020|NCT02202161|11201523|FG001|Overall Study|Did not meet continuation criteria|0
7087021|NCT02202161|11201524|FG002|Overall Study|Did not meet continuation criteria|0
7087022|NCT02202161|11201525|FG003|Overall Study|Did not meet continuation criteria|0
7087023|NCT02202161|11201526|FG004|Overall Study|Did not meet continuation criteria|0
7087024|NCT02202161|11201527|FG005|Overall Study|Did not meet continuation criteria|0
7087025|NCT02202161|11201528|FG006|Overall Study|Did not meet continuation criteria|0
7087026|NCT02202161|11201529|FG007|Overall Study|Did not meet continuation criteria|3
7087027|NCT02202161|11201522|FG000|Overall Study|Physician Decision|0
7087028|NCT02202161|11201523|FG001|Overall Study|Physician Decision|0
7087029|NCT02202161|11201524|FG002|Overall Study|Physician Decision|0
7087030|NCT02202161|11201525|FG003|Overall Study|Physician Decision|0
7087031|NCT02202161|11201526|FG004|Overall Study|Physician Decision|0
7087032|NCT02202161|11201527|FG005|Overall Study|Physician Decision|0
7087033|NCT02202161|11201528|FG006|Overall Study|Physician Decision|0
7087034|NCT02202161|11201529|FG007|Overall Study|Physician Decision|3
7087035|NCT02202161|11201522|FG000|Overall Study|Withdrawal by Subject|0
7087036|NCT02202161|11201523|FG001|Overall Study|Withdrawal by Subject|0
7087037|NCT02202161|11201524|FG002|Overall Study|Withdrawal by Subject|0
7087038|NCT02202161|11201525|FG003|Overall Study|Withdrawal by Subject|0
7087039|NCT02202161|11201526|FG004|Overall Study|Withdrawal by Subject|1
7087040|NCT02202161|11201527|FG005|Overall Study|Withdrawal by Subject|0
7087041|NCT02202161|11201528|FG006|Overall Study|Withdrawal by Subject|0
7087042|NCT02202161|11201529|FG007|Overall Study|Withdrawal by Subject|0
7087043|NCT02202317|11201557|FG000|Overall Study|Lost to Follow-up|1
7087044|NCT02202499|11201564|FG000|Overall Study|Cancer diagnosis|0
7087045|NCT02202499|11201565|FG001|Overall Study|Cancer diagnosis|0
7087046|NCT02202499|11201566|FG002|Overall Study|Cancer diagnosis|1
7087047|NCT02202499|11201564|FG000|Overall Study|Moved from area|0
7087048|NCT02202499|11201565|FG001|Overall Study|Moved from area|0
7087049|NCT02202499|11201566|FG002|Overall Study|Moved from area|1
7087050|NCT02202499|11201564|FG000|Overall Study|Declined before randomization|1
7087051|NCT02202499|11201565|FG001|Overall Study|Declined before randomization|0
7087052|NCT02202499|11201566|FG002|Overall Study|Declined before randomization|0
7087053|NCT02202499|11201564|FG000|Overall Study|Auto accident|1
7087054|NCT02202499|11201565|FG001|Overall Study|Auto accident|0
7087055|NCT02202499|11201566|FG002|Overall Study|Auto accident|0
7087056|NCT02202538|11201579|FG000|Overall Study|Withdrawal by Subject|5
7087057|NCT02202538|11201579|FG000|Overall Study|Did not meet all inclusion criteria|2
7087058|NCT02202538|11201579|FG000|Overall Study|Investigator Decision|1
7087059|NCT02202551|11201587|FG000|Overall Study|Adverse Event|8
7087060|NCT02202551|11201588|FG001|Overall Study|Adverse Event|19
7087061|NCT02202551|11201589|FG002|Overall Study|Adverse Event|5
7087062|NCT02202551|11201590|FG003|Overall Study|Adverse Event|9
7087063|NCT02202551|11201587|FG000|Overall Study|Death|3
7087064|NCT02202551|11201588|FG001|Overall Study|Death|2
7087065|NCT02202551|11201589|FG002|Overall Study|Death|1
7087066|NCT02202551|11201590|FG003|Overall Study|Death|1
7087067|NCT02202551|11201587|FG000|Overall Study|Lost to Follow-up|0
7087068|NCT02202551|11201588|FG001|Overall Study|Lost to Follow-up|1
7087069|NCT02202551|11201589|FG002|Overall Study|Lost to Follow-up|0
7087070|NCT02202551|11201590|FG003|Overall Study|Lost to Follow-up|1
7087071|NCT02202551|11201587|FG000|Overall Study|Needed to take excluded medication|0
7087072|NCT02202551|11201588|FG001|Overall Study|Needed to take excluded medication|2
7087073|NCT02202551|11201589|FG002|Overall Study|Needed to take excluded medication|0
7087074|NCT02202551|11201590|FG003|Overall Study|Needed to take excluded medication|1
7087075|NCT02202551|11201587|FG000|Overall Study|Subject moved away|0
7087076|NCT02202551|11201588|FG001|Overall Study|Subject moved away|1
7087077|NCT02202551|11201589|FG002|Overall Study|Subject moved away|0
7087078|NCT02202551|11201590|FG003|Overall Study|Subject moved away|0
7087079|NCT02202551|11201587|FG000|Overall Study|DBS surgery|3
7087080|NCT02202551|11201588|FG001|Overall Study|DBS surgery|0
7087081|NCT02202551|11201589|FG002|Overall Study|DBS surgery|0
7087082|NCT02202551|11201590|FG003|Overall Study|DBS surgery|0
7087083|NCT02202551|11201587|FG000|Overall Study|Dyskinesia upon taper|1
7087084|NCT02202551|11201588|FG001|Overall Study|Dyskinesia upon taper|0
7087085|NCT02202551|11201589|FG002|Overall Study|Dyskinesia upon taper|0
7087086|NCT02202551|11201590|FG003|Overall Study|Dyskinesia upon taper|0
7087087|NCT02202551|11201587|FG000|Overall Study|Lack of Efficacy|0
7087088|NCT02202551|11201588|FG001|Overall Study|Lack of Efficacy|1
7087089|NCT02202551|11201589|FG002|Overall Study|Lack of Efficacy|0
7087090|NCT02202551|11201590|FG003|Overall Study|Lack of Efficacy|0
7087091|NCT02202551|11201587|FG000|Overall Study|Physician Decision|1
7087092|NCT02202551|11201588|FG001|Overall Study|Physician Decision|0
7087093|NCT02202551|11201589|FG002|Overall Study|Physician Decision|0
7087094|NCT02202551|11201590|FG003|Overall Study|Physician Decision|0
7087095|NCT02202551|11201587|FG000|Overall Study|Site closure|3
7087096|NCT02202551|11201588|FG001|Overall Study|Site closure|0
7087097|NCT02202551|11201589|FG002|Overall Study|Site closure|0
7087098|NCT02202551|11201590|FG003|Overall Study|Site closure|1
7087099|NCT02202551|11201587|FG000|Overall Study|Unable to complete visits per protocol|1
7087100|NCT02202551|11201588|FG001|Overall Study|Unable to complete visits per protocol|0
7087101|NCT02202551|11201589|FG002|Overall Study|Unable to complete visits per protocol|0
7087102|NCT02202551|11201590|FG003|Overall Study|Unable to complete visits per protocol|0
7087103|NCT02202551|11201587|FG000|Overall Study|Worsening Dyskinesia|0
7087104|NCT02202551|11201588|FG001|Overall Study|Worsening Dyskinesia|0
7087105|NCT02202551|11201589|FG002|Overall Study|Worsening Dyskinesia|0
7087106|NCT02202551|11201590|FG003|Overall Study|Worsening Dyskinesia|1
7087107|NCT02202551|11201587|FG000|Overall Study|Protocol Violation|0
7087108|NCT02202551|11201588|FG001|Overall Study|Protocol Violation|1
7087109|NCT02202551|11201589|FG002|Overall Study|Protocol Violation|0
7087110|NCT02202551|11201590|FG003|Overall Study|Protocol Violation|0
7087111|NCT02202551|11201587|FG000|Overall Study|Sponsor's decision|2
7087112|NCT02202551|11201588|FG001|Overall Study|Sponsor's decision|0
7087113|NCT02202551|11201589|FG002|Overall Study|Sponsor's decision|0
7087114|NCT02202551|11201590|FG003|Overall Study|Sponsor's decision|0
7087115|NCT02202551|11201587|FG000|Overall Study|Subject unwilling to proceed|1
7087116|NCT02202551|11201588|FG001|Overall Study|Subject unwilling to proceed|5
7087117|NCT02202551|11201589|FG002|Overall Study|Subject unwilling to proceed|3
7087118|NCT02202551|11201590|FG003|Overall Study|Subject unwilling to proceed|5
7087119|NCT02202551|11201587|FG000|Overall Study|Subject consent withdrawn|0
7087120|NCT02202551|11201588|FG001|Overall Study|Subject consent withdrawn|3
7087121|NCT02202551|11201589|FG002|Overall Study|Subject consent withdrawn|1
7087122|NCT02202551|11201590|FG003|Overall Study|Subject consent withdrawn|2
7087123|NCT02202551|11201587|FG000|Overall Study|eGFR<50mL/min/m2|2
7087124|NCT02202551|11201588|FG001|Overall Study|eGFR<50mL/min/m2|2
7087125|NCT02202551|11201589|FG002|Overall Study|eGFR<50mL/min/m2|0
7087126|NCT02202551|11201590|FG003|Overall Study|eGFR<50mL/min/m2|1
7087127|NCT02202616|11201604|FG000|Overall Study|Screen failed|24
7087128|NCT02202616|11201604|FG000|Overall Study|Adverse Event|32
7087129|NCT02202616|11201604|FG000|Overall Study|Protocol deviation|18
7087130|NCT02202616|11201604|FG000|Overall Study|Patient withdrew consent|12
7087131|NCT02202616|11201604|FG000|Overall Study|Lost to Follow-up|6
7087132|NCT02202616|11201604|FG000|Overall Study|Administrative problems|6
7087133|NCT02202616|11201604|FG000|Overall Study|Abnormal test procedure result|1
7087134|NCT02202616|11201604|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7087135|NCT02202759|11201624|FG000|Overall Study|Study Terminated by Sponsor|3
7087136|NCT02202759|11201625|FG001|Overall Study|Study Terminated by Sponsor|3
7087137|NCT02202759|11201626|FG002|Overall Study|Study Terminated by Sponsor|3
7087138|NCT02202759|11201624|FG000|Overall Study|Withdrawal by Subject|2
7087139|NCT02202759|11201625|FG001|Overall Study|Withdrawal by Subject|1
7087140|NCT02202759|11201626|FG002|Overall Study|Withdrawal by Subject|1
7087141|NCT02202759|11201624|FG000|Overall Study|Reason not Specified|4
7087142|NCT02202759|11201625|FG001|Overall Study|Reason not Specified|11
7087143|NCT02202759|11201626|FG002|Overall Study|Reason not Specified|10
7087144|NCT02202785|11201636|FG000|Overall Study|Study Terminated by Sponsor|1
7087145|NCT02202785|11201637|FG001|Overall Study|Study Terminated by Sponsor|6
7087146|NCT02202785|11201638|FG002|Overall Study|Study Terminated by Sponsor|4
7087147|NCT02202785|11201636|FG000|Overall Study|Withdrawal by Subject|0
7087148|NCT02202785|11201637|FG001|Overall Study|Withdrawal by Subject|1
7087149|NCT02202785|11201638|FG002|Overall Study|Withdrawal by Subject|0
7087150|NCT02202785|11201636|FG000|Overall Study|Lost to Follow-up|0
7087151|NCT02202785|11201637|FG001|Overall Study|Lost to Follow-up|1
7087152|NCT02202785|11201638|FG002|Overall Study|Lost to Follow-up|0
7087153|NCT02202785|11201636|FG000|Overall Study|Reason not Specified|10
7087154|NCT02202785|11201637|FG001|Overall Study|Reason not Specified|7
7087155|NCT02202785|11201638|FG002|Overall Study|Reason not Specified|13
7087156|NCT02202837|11201648|FG000|Overall Study|Enbrel treatment discontinued|36
7087157|NCT02202837|11201649|FG001|Overall Study|Enbrel treatment discontinued|4
7087158|NCT02202837|11201648|FG000|Overall Study|Other|10
7087159|NCT02202837|11201649|FG001|Overall Study|Other|0
7087160|NCT02202837|11201648|FG000|Overall Study|Lost to Follow-up|7
7087161|NCT02202837|11201649|FG001|Overall Study|Lost to Follow-up|1
7087162|NCT02202850|11201657|FG000|Overall Study|Other|2
7087163|NCT02202850|11201658|FG001|Overall Study|Other|2
7087164|NCT02202850|11201657|FG000|Overall Study|Enbrel treatment discontinued|15
7087165|NCT02202850|11201658|FG001|Overall Study|Enbrel treatment discontinued|3
7087166|NCT02202850|11201657|FG000|Overall Study|Lost to Follow-up|7
7087167|NCT02202850|11201658|FG001|Overall Study|Lost to Follow-up|1
7087168|NCT02202980|11201678|FG000|Overall Study|Lack of Efficacy|1
7087169|NCT02202980|11201679|FG001|Overall Study|Lack of Efficacy|0
7087170|NCT02202980|11201680|FG002|Overall Study|Lack of Efficacy|7
7087171|NCT02202980|11201681|FG003|Overall Study|Lack of Efficacy|0
7087172|NCT02202980|11201682|FG004|Overall Study|Lack of Efficacy|3
7087173|NCT02202980|11201683|FG005|Overall Study|Lack of Efficacy|1
7087174|NCT02202980|11201684|FG006|Overall Study|Lack of Efficacy|11
7087175|NCT02202980|11201685|FG007|Overall Study|Lack of Efficacy|2
7087176|NCT02202980|11201686|FG008|Overall Study|Lack of Efficacy|2
7087177|NCT02202980|11201687|FG009|Overall Study|Lack of Efficacy|0
7087178|NCT02202980|11201688|FG010|Overall Study|Lack of Efficacy|0
7087179|NCT02202980|11201689|FG011|Overall Study|Lack of Efficacy|3
7087180|NCT02202980|11201690|FG012|Overall Study|Lack of Efficacy|10
7087181|NCT02202980|11201691|FG013|Overall Study|Lack of Efficacy|0
7087182|NCT02202980|11201678|FG000|Overall Study|Protocol Violation|0
7087183|NCT02202980|11201679|FG001|Overall Study|Protocol Violation|0
7087184|NCT02202980|11201680|FG002|Overall Study|Protocol Violation|0
7087185|NCT02202980|11201681|FG003|Overall Study|Protocol Violation|3
7087186|NCT02202980|11201682|FG004|Overall Study|Protocol Violation|3
7087187|NCT02202980|11201683|FG005|Overall Study|Protocol Violation|0
7087188|NCT02202980|11201684|FG006|Overall Study|Protocol Violation|0
7087189|NCT02202980|11201685|FG007|Overall Study|Protocol Violation|0
7087190|NCT02202980|11201686|FG008|Overall Study|Protocol Violation|0
7087191|NCT02202980|11201687|FG009|Overall Study|Protocol Violation|0
7087192|NCT02202980|11201688|FG010|Overall Study|Protocol Violation|0
7087193|NCT02202980|11201689|FG011|Overall Study|Protocol Violation|0
7087194|NCT02202980|11201690|FG012|Overall Study|Protocol Violation|0
7087195|NCT02202980|11201691|FG013|Overall Study|Protocol Violation|0
7087196|NCT02202980|11201678|FG000|Overall Study|Lost to Follow-up|0
7087197|NCT02202980|11201679|FG001|Overall Study|Lost to Follow-up|1
7087198|NCT02202980|11201680|FG002|Overall Study|Lost to Follow-up|1
7087199|NCT02202980|11201681|FG003|Overall Study|Lost to Follow-up|1
7087200|NCT02202980|11201682|FG004|Overall Study|Lost to Follow-up|0
7087201|NCT02202980|11201683|FG005|Overall Study|Lost to Follow-up|0
7087202|NCT02202980|11201684|FG006|Overall Study|Lost to Follow-up|0
7087203|NCT02202980|11201685|FG007|Overall Study|Lost to Follow-up|1
7087204|NCT02202980|11201686|FG008|Overall Study|Lost to Follow-up|1
7087205|NCT02202980|11201687|FG009|Overall Study|Lost to Follow-up|0
7087206|NCT02202980|11201688|FG010|Overall Study|Lost to Follow-up|0
7087207|NCT02202980|11201689|FG011|Overall Study|Lost to Follow-up|0
7087208|NCT02202980|11201690|FG012|Overall Study|Lost to Follow-up|1
7087209|NCT02202980|11201691|FG013|Overall Study|Lost to Follow-up|0
7087210|NCT02202980|11201678|FG000|Overall Study|Withdrew Consent|0
7087211|NCT02202980|11201679|FG001|Overall Study|Withdrew Consent|1
7087212|NCT02202980|11201680|FG002|Overall Study|Withdrew Consent|2
7087213|NCT02202980|11201681|FG003|Overall Study|Withdrew Consent|0
7087214|NCT02202980|11201682|FG004|Overall Study|Withdrew Consent|0
7087215|NCT02202980|11201683|FG005|Overall Study|Withdrew Consent|0
7087216|NCT02202980|11201684|FG006|Overall Study|Withdrew Consent|0
7087217|NCT02202980|11201685|FG007|Overall Study|Withdrew Consent|0
7087218|NCT02202980|11201686|FG008|Overall Study|Withdrew Consent|1
7087219|NCT02202980|11201687|FG009|Overall Study|Withdrew Consent|0
7087220|NCT02202980|11201688|FG010|Overall Study|Withdrew Consent|0
7087221|NCT02202980|11201689|FG011|Overall Study|Withdrew Consent|0
7087222|NCT02202980|11201690|FG012|Overall Study|Withdrew Consent|0
7087223|NCT02202980|11201691|FG013|Overall Study|Withdrew Consent|0
7087224|NCT02203032|11201730|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2
7087225|NCT02203032|11201731|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
7087226|NCT02203032|11201732|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
7087227|NCT02203032|11201733|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
7087228|NCT02203032|11201730|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1
7087229|NCT02203032|11201731|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
7087230|NCT02203032|11201732|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
7087231|NCT02203032|11201733|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
7087232|NCT02203032|11201730|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3
7087233|NCT02203032|11201731|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
7087234|NCT02203032|11201732|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
7087235|NCT02203032|11201733|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
7087236|NCT02203032|11201730|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6
7087237|NCT02203032|11201731|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
7087238|NCT02203032|11201732|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
7087239|NCT02203032|11201733|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
7087240|NCT02203032|11201730|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4
7087241|NCT02203032|11201731|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
7087242|NCT02203032|11201732|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
7087243|NCT02203032|11201733|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
7087244|NCT02203032|11201730|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2
7087245|NCT02203032|11201731|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0
7087246|NCT02203032|11201732|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0
7087247|NCT02203032|11201733|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0
7087248|NCT02203032|11201730|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1
7087249|NCT02203032|11201731|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
7087250|NCT02203032|11201732|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
7087251|NCT02203032|11201733|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
7087252|NCT02203032|11201730|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0
7087253|NCT02203032|11201731|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2
7087254|NCT02203032|11201732|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3
7087255|NCT02203032|11201733|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8
7087256|NCT02203032|11201730|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0
7087257|NCT02203032|11201731|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8
7087258|NCT02203032|11201732|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19
7087259|NCT02203032|11201733|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20
7087260|NCT02203032|11201730|FG000|Blinded Phase (Week 16 to Week 44)|Other|0
7087261|NCT02203032|11201731|FG001|Blinded Phase (Week 16 to Week 44)|Other|4
7087262|NCT02203032|11201732|FG002|Blinded Phase (Week 16 to Week 44)|Other|1
7087263|NCT02203032|11201733|FG003|Blinded Phase (Week 16 to Week 44)|Other|15
7087264|NCT02203032|11201730|FG000|Blinded Phase (Week 16 to Week 44)|Death|0
7087265|NCT02203032|11201731|FG001|Blinded Phase (Week 16 to Week 44)|Death|0
7087266|NCT02203032|11201732|FG002|Blinded Phase (Week 16 to Week 44)|Death|0
7087267|NCT02203032|11201733|FG003|Blinded Phase (Week 16 to Week 44)|Death|1
7087268|NCT02203032|11201730|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0
7087269|NCT02203032|11201731|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1
7087270|NCT02203032|11201732|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3
7087271|NCT02203032|11201733|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2
7087272|NCT02203071|11201743|FG000|Overall Study|Lost to Follow-up|3
7087273|NCT02203071|11201744|FG001|Overall Study|Lost to Follow-up|1
7087274|NCT02203149|11201755|FG000|Part 1|Adverse Event|0
7087275|NCT02203149|11201756|FG001|Part 1|Adverse Event|1
7087276|NCT02203149|11201757|FG002|Part 1|Adverse Event|0
7087277|NCT02203149|11201758|FG003|Part 1|Adverse Event|0
7087278|NCT02203149|11201759|FG004|Part 1|Adverse Event|0
7087279|NCT02203149|11201755|FG000|Part 2|Death|0
7087280|NCT02203149|11201756|FG001|Part 2|Death|0
7087281|NCT02203149|11201757|FG002|Part 2|Death|1
7087282|NCT02203149|11201758|FG003|Part 2|Death|1
7087283|NCT02203149|11201759|FG004|Part 2|Death|0
7087284|NCT02203149|11201755|FG000|Part 2|Withdrawal by Subject|0
7087285|NCT02203149|11201756|FG001|Part 2|Withdrawal by Subject|0
7087286|NCT02203149|11201757|FG002|Part 2|Withdrawal by Subject|0
7087287|NCT02203149|11201758|FG003|Part 2|Withdrawal by Subject|1
7087288|NCT02203149|11201759|FG004|Part 2|Withdrawal by Subject|0
7087289|NCT02203149|11201755|FG000|Part 2|Adverse Event|0
7087290|NCT02203149|11201756|FG001|Part 2|Adverse Event|0
7087291|NCT02203149|11201757|FG002|Part 2|Adverse Event|0
7087292|NCT02203149|11201758|FG003|Part 2|Adverse Event|1
7087293|NCT02203149|11201759|FG004|Part 2|Adverse Event|1
7087294|NCT02203331|11201791|FG000|Overall Study|Pregnancy|1
7087295|NCT02203331|11201792|FG001|Overall Study|Pregnancy|0
7087296|NCT02203331|11201793|FG002|Overall Study|Pregnancy|0
7087297|NCT02203331|11201794|FG003|Overall Study|Pregnancy|0
7087298|NCT02203331|11201795|FG004|Overall Study|Pregnancy|2
7087299|NCT02203331|11201796|FG005|Overall Study|Pregnancy|0
7087300|NCT02203331|11201791|FG000|Overall Study|Withdrawal by Subject|1
7087301|NCT02203331|11201792|FG001|Overall Study|Withdrawal by Subject|0
7087302|NCT02203331|11201793|FG002|Overall Study|Withdrawal by Subject|1
7087303|NCT02203331|11201794|FG003|Overall Study|Withdrawal by Subject|0
7087304|NCT02203331|11201795|FG004|Overall Study|Withdrawal by Subject|0
7087305|NCT02203331|11201796|FG005|Overall Study|Withdrawal by Subject|3
7087306|NCT02203331|11201791|FG000|Overall Study|Adverse Event|4
7087307|NCT02203331|11201792|FG001|Overall Study|Adverse Event|8
7087308|NCT02203331|11201793|FG002|Overall Study|Adverse Event|3
7087309|NCT02203331|11201794|FG003|Overall Study|Adverse Event|4
7087310|NCT02203331|11201795|FG004|Overall Study|Adverse Event|3
7087311|NCT02203331|11201796|FG005|Overall Study|Adverse Event|3
7087312|NCT02203331|11201791|FG000|Overall Study|Other Reasons|1
7087313|NCT02203331|11201792|FG001|Overall Study|Other Reasons|2
7087314|NCT02203331|11201793|FG002|Overall Study|Other Reasons|0
7087315|NCT02203331|11201794|FG003|Overall Study|Other Reasons|2
7087316|NCT02203331|11201795|FG004|Overall Study|Other Reasons|0
7087317|NCT02203331|11201796|FG005|Overall Study|Other Reasons|0
7087318|NCT02203331|11201791|FG000|Overall Study|Lack of Efficacy|0
7087319|NCT02203331|11201792|FG001|Overall Study|Lack of Efficacy|2
7087320|NCT02203331|11201793|FG002|Overall Study|Lack of Efficacy|1
7087321|NCT02203331|11201794|FG003|Overall Study|Lack of Efficacy|0
7087322|NCT02203331|11201795|FG004|Overall Study|Lack of Efficacy|0
7087323|NCT02203331|11201796|FG005|Overall Study|Lack of Efficacy|1
7087324|NCT02203331|11201791|FG000|Overall Study|Protocol Violation|0
7087325|NCT02203331|11201792|FG001|Overall Study|Protocol Violation|2
7087326|NCT02203331|11201793|FG002|Overall Study|Protocol Violation|0
7087327|NCT02203331|11201794|FG003|Overall Study|Protocol Violation|1
7087328|NCT02203331|11201795|FG004|Overall Study|Protocol Violation|1
7087329|NCT02203331|11201796|FG005|Overall Study|Protocol Violation|0
7087330|NCT02203331|11201791|FG000|Overall Study|Lost to Follow-up|0
7087331|NCT02203331|11201792|FG001|Overall Study|Lost to Follow-up|0
7087332|NCT02203331|11201793|FG002|Overall Study|Lost to Follow-up|0
7087333|NCT02203331|11201794|FG003|Overall Study|Lost to Follow-up|0
7087334|NCT02203331|11201795|FG004|Overall Study|Lost to Follow-up|1
7087335|NCT02203331|11201796|FG005|Overall Study|Lost to Follow-up|0
7087336|NCT02203357|11201813|FG000|Overall Study|Lost to Follow-up|58
7087337|NCT02203357|11201814|FG001|Overall Study|Lost to Follow-up|66
7087338|NCT02203357|11201815|FG002|Overall Study|Lost to Follow-up|70
7087339|NCT02203591|11201842|FG000|Overall Study|Did not meet treatment day baseline|147
7087340|NCT02203591|11201843|FG001|Overall Study|Did not meet treatment day baseline|141
7087341|NCT02203591|11201844|FG002|Overall Study|Did not meet treatment day baseline|150
7087342|NCT02203591|11201845|FG003|Overall Study|Did not meet treatment day baseline|45
7087343|NCT02203591|11201846|FG004|Overall Study|Did not meet treatment day baseline|33
7087344|NCT02203591|11201847|FG005|Overall Study|Did not meet treatment day baseline|35
7087345|NCT02203591|11201848|FG006|Overall Study|Did not meet treatment day baseline|29
7087346|NCT02203591|11201849|FG007|Overall Study|Did not meet treatment day baseline|12
7087347|NCT02203591|11201842|FG000|Overall Study|Discontinued early due to compromised test sites|0
7087348|NCT02203591|11201843|FG001|Overall Study|Discontinued early due to compromised test sites|1
7087349|NCT02203591|11201844|FG002|Overall Study|Discontinued early due to compromised test sites|1
7087350|NCT02203591|11201845|FG003|Overall Study|Discontinued early due to compromised test sites|0
7087351|NCT02203591|11201846|FG004|Overall Study|Discontinued early due to compromised test sites|1
7087352|NCT02203591|11201847|FG005|Overall Study|Discontinued early due to compromised test sites|0
7087353|NCT02203591|11201848|FG006|Overall Study|Discontinued early due to compromised test sites|0
7087354|NCT02203591|11201849|FG007|Overall Study|Discontinued early due to compromised test sites|1
7087355|NCT02203721|11201882|FG000|Overall Study|Lost to Follow-up|1
7087356|NCT02203721|11201883|FG001|Overall Study|Lost to Follow-up|0
7087357|NCT02203721|11201882|FG000|Overall Study|Death|0
7087358|NCT02203721|11201883|FG001|Overall Study|Death|2
7087359|NCT02203721|11201882|FG000|Overall Study|Illness|0
7087360|NCT02203721|11201883|FG001|Overall Study|Illness|1
7087361|NCT02203838|11201921|FG000|Overall Study|Lack of Efficacy|7
7087362|NCT02203838|11201922|FG001|Overall Study|Lack of Efficacy|0
7087363|NCT02203838|11201923|FG002|Overall Study|Lack of Efficacy|1
7087364|NCT02203838|11201924|FG003|Overall Study|Lack of Efficacy|1
7087365|NCT02203838|11201921|FG000|Overall Study|Adverse Event|46
7087366|NCT02203838|11201922|FG001|Overall Study|Adverse Event|6
7087367|NCT02203838|11201923|FG002|Overall Study|Adverse Event|3
7087368|NCT02203838|11201924|FG003|Overall Study|Adverse Event|2
7087369|NCT02203838|11201921|FG000|Overall Study|Lost to Follow-up|39
7087370|NCT02203838|11201922|FG001|Overall Study|Lost to Follow-up|3
7087371|NCT02203838|11201923|FG002|Overall Study|Lost to Follow-up|2
7087372|NCT02203838|11201924|FG003|Overall Study|Lost to Follow-up|1
7087373|NCT02203838|11201921|FG000|Overall Study|Protocol Violation|7
7087374|NCT02203838|11201922|FG001|Overall Study|Protocol Violation|3
7087375|NCT02203838|11201923|FG002|Overall Study|Protocol Violation|0
7087376|NCT02203838|11201924|FG003|Overall Study|Protocol Violation|0
7087377|NCT02203838|11201921|FG000|Overall Study|Withdrawal by Subject|83
7087378|NCT02203838|11201922|FG001|Overall Study|Withdrawal by Subject|10
7087379|NCT02203838|11201923|FG002|Overall Study|Withdrawal by Subject|8
7087380|NCT02203838|11201924|FG003|Overall Study|Withdrawal by Subject|11
7087381|NCT02203838|11201921|FG000|Overall Study|Physician Decision|27
7087382|NCT02203838|11201922|FG001|Overall Study|Physician Decision|0
7087383|NCT02203838|11201923|FG002|Overall Study|Physician Decision|2
7087384|NCT02203838|11201924|FG003|Overall Study|Physician Decision|3
7087385|NCT02203838|11201921|FG000|Overall Study|Other|1
7087386|NCT02203838|11201922|FG001|Overall Study|Other|0
7087387|NCT02203838|11201923|FG002|Overall Study|Other|0
7087388|NCT02203838|11201924|FG003|Overall Study|Other|0
7087389|NCT02203851|11201934|FG000|Overall Study|Lost to Follow-up|4
7087390|NCT02203851|11201934|FG000|Overall Study|Withdrawal by Subject|6
7087391|NCT02203851|11201934|FG000|Overall Study|Other|1
7087392|NCT02203916|11201948|FG000|Overall Study|Pretreatment Event/Adverse Event|1
7087393|NCT02203916|11201949|FG001|Overall Study|Pretreatment Event/Adverse Event|3
7087394|NCT02203916|11201950|FG002|Overall Study|Pretreatment Event/Adverse Event|2
7087395|NCT02203916|11201948|FG000|Overall Study|Major Protocol Deviation|1
7087396|NCT02203916|11201949|FG001|Overall Study|Major Protocol Deviation|1
7087397|NCT02203916|11201950|FG002|Overall Study|Major Protocol Deviation|0
7087398|NCT02203916|11201948|FG000|Overall Study|Lost to Follow-up|0
7087399|NCT02203916|11201949|FG001|Overall Study|Lost to Follow-up|1
7087400|NCT02203916|11201950|FG002|Overall Study|Lost to Follow-up|0
7087401|NCT02203916|11201948|FG000|Overall Study|Voluntary Withdrawal|3
7087402|NCT02203916|11201949|FG001|Overall Study|Voluntary Withdrawal|3
7087403|NCT02203916|11201950|FG002|Overall Study|Voluntary Withdrawal|8
7087404|NCT02203916|11201948|FG000|Overall Study|Lack of Efficacy|3
7087405|NCT02203916|11201949|FG001|Overall Study|Lack of Efficacy|0
7087406|NCT02203916|11201950|FG002|Overall Study|Lack of Efficacy|0
7087407|NCT02203916|11201948|FG000|Overall Study|Reason Not Specified|0
7087408|NCT02203916|11201949|FG001|Overall Study|Reason Not Specified|2
7087409|NCT02203916|11201950|FG002|Overall Study|Reason Not Specified|1
7087410|NCT02204007|11201960|FG000|Overall Study|Surgery Canceled|1
7087411|NCT02204007|11201961|FG001|Overall Study|Surgery Canceled|1
7087412|NCT02204293|11201995|FG000|Core Study Part I|Met one or more exclusion criteria|1
7087413|NCT02204293|11201996|FG001|Core Study Part I|Met one or more exclusion criteria|0
7087414|NCT02204293|11201997|FG002|Core Study Part I|Met one or more exclusion criteria|0
7087415|NCT02204293|11201998|FG003|Core Study Part I|Met one or more exclusion criteria|0
7087416|NCT02204293|11201999|FG004|Core Study Part I|Met one or more exclusion criteria|0
7087417|NCT02204293|11202000|FG005|Core Study Part I|Met one or more exclusion criteria|0
7087418|NCT02204293|11201995|FG000|Core Study Part I|Adverse Event|1
7087419|NCT02204293|11201996|FG001|Core Study Part I|Adverse Event|0
7087420|NCT02204293|11201997|FG002|Core Study Part I|Adverse Event|0
7087421|NCT02204293|11201998|FG003|Core Study Part I|Adverse Event|0
7087422|NCT02204293|11201999|FG004|Core Study Part I|Adverse Event|0
7087423|NCT02204293|11202000|FG005|Core Study Part I|Adverse Event|0
7087424|NCT02204293|11201995|FG000|Core Study Part I|Physician Decision|0
7087425|NCT02204293|11201996|FG001|Core Study Part I|Physician Decision|3
7087426|NCT02204293|11201997|FG002|Core Study Part I|Physician Decision|0
7087427|NCT02204293|11201998|FG003|Core Study Part I|Physician Decision|0
7087428|NCT02204293|11201999|FG004|Core Study Part I|Physician Decision|0
7087429|NCT02204293|11202000|FG005|Core Study Part I|Physician Decision|0
7087430|NCT02204293|11201995|FG000|LTE Phase|Study Suspended|0
7087431|NCT02204293|11201996|FG001|LTE Phase|Study Suspended|0
7087432|NCT02204293|11201997|FG002|LTE Phase|Study Suspended|0
7087433|NCT02204293|11201998|FG003|LTE Phase|Study Suspended|0
7087434|NCT02204293|11201999|FG004|LTE Phase|Study Suspended|0
7087435|NCT02204293|11202000|FG005|LTE Phase|Study Suspended|7
7087436|NCT02204319|11202014|FG000|Overall Study|Pregnancy|1
7087437|NCT02204319|11202014|FG000|Overall Study|Withdrawal by Subject|2
7087438|NCT02204371|11202019|FG000|Overall Study|Adverse Event|1
7087439|NCT02204410|11202023|FG000|Overall Study|Lost to Follow-up|5
7087440|NCT02204410|11202023|FG000|Overall Study|Physician Decision|2
7087441|NCT02204410|11202023|FG000|Overall Study|Protocol Violation|1
7087442|NCT02204410|11202023|FG000|Overall Study|Withdrawal by Subject|3
7087443|NCT02204449|11202029|FG000|Overall Study|Lost to Follow-up|7
7087444|NCT02204449|11202030|FG001|Overall Study|Lost to Follow-up|9
7087445|NCT02204449|11202029|FG000|Overall Study|Death|0
7087446|NCT02204449|11202030|FG001|Overall Study|Death|1
7087447|NCT02204449|11202029|FG000|Overall Study|Withdrawal by Subject|0
7087448|NCT02204449|11202030|FG001|Overall Study|Withdrawal by Subject|1
7087449|NCT02204579|11202040|FG000|Overall Study|Screen failures|2
7087450|NCT02204917|11202066|FG000|Overall Study|Protocol Violation|1
7087451|NCT02204982|11202075|FG000|Overall Study|Patient ineligible-medical monitor|1
7087452|NCT02204982|11202076|FG001|Overall Study|Patient ineligible-medical monitor|0
7087453|NCT02204982|11202075|FG000|Overall Study|Withdrawal by Subject|1
7087454|NCT02204982|11202076|FG001|Overall Study|Withdrawal by Subject|0
7087455|NCT02204982|11202075|FG000|Overall Study|Adverse Event|1
7087456|NCT02204982|11202076|FG001|Overall Study|Adverse Event|0
7087457|NCT02204982|11202075|FG000|Overall Study|Adverse Event and Investigator decision|1
7087458|NCT02204982|11202076|FG001|Overall Study|Adverse Event and Investigator decision|0
7087459|NCT02204982|11202075|FG000|Overall Study|Physician Decision|0
7087460|NCT02204982|11202076|FG001|Overall Study|Physician Decision|2
7087461|NCT02204982|11202075|FG000|Overall Study|Protocol-Specified Disease Progression|0
7087462|NCT02204982|11202076|FG001|Overall Study|Protocol-Specified Disease Progression|4
7087463|NCT02204982|11202075|FG000|Overall Study|Termination of Study bySponsor|0
7087464|NCT02204982|11202076|FG001|Overall Study|Termination of Study bySponsor|1
7087465|NCT02205333|11202110|FG000|Overall Study|Death|5
7087466|NCT02205333|11202111|FG001|Overall Study|Death|6
7087467|NCT02205333|11202112|FG002|Overall Study|Death|2
7087468|NCT02205333|11202113|FG003|Overall Study|Death|6
7087469|NCT02205333|11202114|FG004|Overall Study|Death|5
7087470|NCT02205333|11202115|FG005|Overall Study|Death|3
7087471|NCT02205333|11202116|FG006|Overall Study|Death|3
7087472|NCT02205333|11202117|FG007|Overall Study|Death|2
7087473|NCT02205333|11202118|FG008|Overall Study|Death|0
7087474|NCT02205333|11202110|FG000|Overall Study|Withdrawal by Subject|1
7087475|NCT02205333|11202111|FG001|Overall Study|Withdrawal by Subject|0
7087476|NCT02205333|11202112|FG002|Overall Study|Withdrawal by Subject|0
7087477|NCT02205333|11202113|FG003|Overall Study|Withdrawal by Subject|1
7087478|NCT02205333|11202114|FG004|Overall Study|Withdrawal by Subject|0
7087479|NCT02205333|11202115|FG005|Overall Study|Withdrawal by Subject|0
7087480|NCT02205333|11202116|FG006|Overall Study|Withdrawal by Subject|2
7087481|NCT02205333|11202117|FG007|Overall Study|Withdrawal by Subject|0
7087482|NCT02205333|11202118|FG008|Overall Study|Withdrawal by Subject|0
7087483|NCT02205476|11202140|FG000|Overall Study|Study termination by Sponsor|7
7087484|NCT02205476|11202141|FG001|Overall Study|Study termination by Sponsor|3
7087485|NCT02205814|11202174|FG000|Overall Study|Lost to Follow-up|0
7087486|NCT02205814|11202175|FG001|Overall Study|Lost to Follow-up|0
7087487|NCT02205814|11202176|FG002|Overall Study|Lost to Follow-up|0
7087488|NCT02205814|11202177|FG003|Overall Study|Lost to Follow-up|1
7087489|NCT02205814|11202174|FG000|Overall Study|Lack of Efficacy|1
7087490|NCT02205814|11202175|FG001|Overall Study|Lack of Efficacy|0
7087491|NCT02205814|11202176|FG002|Overall Study|Lack of Efficacy|1
7087492|NCT02205814|11202177|FG003|Overall Study|Lack of Efficacy|1
7087493|NCT02205814|11202174|FG000|Overall Study|Physician Decision|0
7087494|NCT02205814|11202175|FG001|Overall Study|Physician Decision|0
7087495|NCT02205814|11202176|FG002|Overall Study|Physician Decision|1
7087496|NCT02205814|11202177|FG003|Overall Study|Physician Decision|0
7087497|NCT02205814|11202174|FG000|Overall Study|Protocol Violation|1
7087498|NCT02205814|11202175|FG001|Overall Study|Protocol Violation|0
7087499|NCT02205814|11202176|FG002|Overall Study|Protocol Violation|0
7087500|NCT02205814|11202177|FG003|Overall Study|Protocol Violation|1
7087501|NCT02205814|11202174|FG000|Overall Study|Withdrawal by Subject|0
7087502|NCT02205814|11202175|FG001|Overall Study|Withdrawal by Subject|1
7087503|NCT02205814|11202176|FG002|Overall Study|Withdrawal by Subject|2
7087504|NCT02205814|11202177|FG003|Overall Study|Withdrawal by Subject|1
7087505|NCT02205814|11202174|FG000|Overall Study|not compliant with study procedures|0
7087506|NCT02205814|11202175|FG001|Overall Study|not compliant with study procedures|0
7087507|NCT02205814|11202176|FG002|Overall Study|not compliant with study procedures|1
7087508|NCT02205814|11202177|FG003|Overall Study|not compliant with study procedures|0
7087509|NCT02206061|11202207|FG000|Overall Study|Withdrawal by Subject|4
7087510|NCT02206061|11202208|FG001|Overall Study|Withdrawal by Subject|7
7087511|NCT02206061|11202209|FG002|Overall Study|Withdrawal by Subject|1
7087512|NCT02206061|11202207|FG000|Overall Study|Lost to Follow-up|14
7087513|NCT02206061|11202208|FG001|Overall Study|Lost to Follow-up|7
7087514|NCT02206061|11202209|FG002|Overall Study|Lost to Follow-up|20
7087515|NCT02206152|11202217|FG000|Pre-Randomization|Withdrawal by Subject|2
7087516|NCT02206607|11202232|FG000|Open-Label Run-In|Withdrawal by Subject|3
7087517|NCT02206607|11202233|FG001|Open-Label Run-In|Withdrawal by Subject|0
7087518|NCT02206607|11202234|FG002|Open-Label Run-In|Withdrawal by Subject|0
7087519|NCT02206607|11202235|FG003|Open-Label Run-In|Withdrawal by Subject|0
7087520|NCT02206607|11202236|FG004|Open-Label Run-In|Withdrawal by Subject|0
7087521|NCT02206607|11202232|FG000|Second Intervention Period|Insufficient Clinical Response|0
7087522|NCT02206607|11202233|FG001|Second Intervention Period|Insufficient Clinical Response|0
7087523|NCT02206607|11202234|FG002|Second Intervention Period|Insufficient Clinical Response|0
7087524|NCT02206607|11202235|FG003|Second Intervention Period|Insufficient Clinical Response|1
7087525|NCT02206607|11202236|FG004|Second Intervention Period|Insufficient Clinical Response|0
7087526|NCT02206620|11202252|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1
7087527|NCT02206620|11202253|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1
7087528|NCT02206620|11202252|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0
7087529|NCT02206620|11202253|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2
7087530|NCT02206685|11202267|FG000|Overall Study|Surgery cancelled/changed|2
7087531|NCT02206685|11202268|FG001|Overall Study|Surgery cancelled/changed|3
7087532|NCT02206685|11202267|FG000|Overall Study|Withdrawal by Subject|1
7087533|NCT02206685|11202268|FG001|Overall Study|Withdrawal by Subject|2
7087534|NCT02206685|11202267|FG000|Overall Study|Protocol Violation|2
7087535|NCT02206685|11202268|FG001|Overall Study|Protocol Violation|2
7087536|NCT02206828|11202283|FG000|Overall Study|Lost to Follow-up|7
7087537|NCT02207088|11202310|FG000|Overall Study|Adverse Event|2
7087538|NCT02207231|11202317|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
7087539|NCT02207231|11202318|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4
7087540|NCT02207231|11202319|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
7087541|NCT02207231|11202320|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
7087542|NCT02207231|11202317|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2
7087543|NCT02207231|11202318|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
7087544|NCT02207231|11202319|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1
7087545|NCT02207231|11202320|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
7087546|NCT02207231|11202317|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
7087547|NCT02207231|11202318|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
7087548|NCT02207231|11202319|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
7087549|NCT02207231|11202320|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
7087550|NCT02207231|11202317|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2
7087551|NCT02207231|11202318|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
7087552|NCT02207231|11202319|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4
7087553|NCT02207231|11202320|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
7087554|NCT02207231|11202317|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
7087555|NCT02207231|11202318|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
7087556|NCT02207231|11202319|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
7087557|NCT02207231|11202320|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
7087558|NCT02207231|11202317|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0
7087559|NCT02207231|11202318|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2
7087560|NCT02207231|11202319|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1
7087561|NCT02207231|11202320|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0
7087562|NCT02207231|11202317|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1
7087563|NCT02207231|11202318|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6
7087564|NCT02207231|11202319|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10
7087565|NCT02207231|11202320|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0
7087566|NCT02207231|11202317|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0
7087567|NCT02207231|11202318|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0
7087568|NCT02207231|11202319|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1
7087569|NCT02207231|11202320|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0
7087570|NCT02207231|11202317|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0
7087571|NCT02207231|11202318|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3
7087572|NCT02207231|11202319|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11
7087573|NCT02207231|11202320|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0
7087574|NCT02207231|11202317|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1
7087575|NCT02207231|11202318|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2
7087576|NCT02207231|11202319|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5
7087577|NCT02207231|11202320|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0
7087578|NCT02207231|11202317|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1
7087579|NCT02207231|11202318|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4
7087580|NCT02207231|11202319|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10
7087581|NCT02207231|11202320|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0
7087582|NCT02207231|11202317|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0
7087583|NCT02207231|11202318|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1
7087584|NCT02207231|11202319|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0
7087585|NCT02207231|11202320|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0
7087586|NCT02207231|11202317|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0
7087587|NCT02207231|11202318|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3
7087588|NCT02207231|11202319|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3
7087589|NCT02207231|11202320|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0
7087590|NCT02207231|11202317|FG000|Active Controlled Period: Week 16 - 48|Other|0
7087591|NCT02207231|11202318|FG001|Active Controlled Period: Week 16 - 48|Other|2
7087592|NCT02207231|11202319|FG002|Active Controlled Period: Week 16 - 48|Other|3
7087593|NCT02207231|11202320|FG003|Active Controlled Period: Week 16 - 48|Other|0
7087594|NCT02207231|11202317|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0
7087595|NCT02207231|11202318|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0
7087596|NCT02207231|11202319|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12
7087597|NCT02207231|11202320|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19
7087598|NCT02207231|11202317|FG000|Open-label Guselkumab: Week 48 - 264|Death|0
7087599|NCT02207231|11202318|FG001|Open-label Guselkumab: Week 48 - 264|Death|0
7087600|NCT02207231|11202319|FG002|Open-label Guselkumab: Week 48 - 264|Death|1
7087601|NCT02207231|11202320|FG003|Open-label Guselkumab: Week 48 - 264|Death|3
7087602|NCT02207231|11202317|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0
7087603|NCT02207231|11202318|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0
7087604|NCT02207231|11202319|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3
7087605|NCT02207231|11202320|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7
7087606|NCT02207231|11202317|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0
7087607|NCT02207231|11202318|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0
7087608|NCT02207231|11202319|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2
7087609|NCT02207231|11202320|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4
7087610|NCT02207231|11202317|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0
7087611|NCT02207231|11202318|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0
7087612|NCT02207231|11202319|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6
7087613|NCT02207231|11202320|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11
7087614|NCT02207231|11202317|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0
7087615|NCT02207231|11202318|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0
7087616|NCT02207231|11202319|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10
7087617|NCT02207231|11202320|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28
7087618|NCT02207231|11202317|FG000|Open-label Guselkumab: Week 48 - 264|Other|0
7087619|NCT02207231|11202318|FG001|Open-label Guselkumab: Week 48 - 264|Other|0
7087620|NCT02207231|11202319|FG002|Open-label Guselkumab: Week 48 - 264|Other|4
7087621|NCT02207231|11202320|FG003|Open-label Guselkumab: Week 48 - 264|Other|11
7087622|NCT02207244|11202341|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2
7087623|NCT02207244|11202342|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9
7087624|NCT02207244|11202343|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4
7087625|NCT02207244|11202344|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0
7087626|NCT02207244|11202345|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0
7087627|NCT02207244|11202346|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0
7087628|NCT02207244|11202347|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0
7087629|NCT02207244|11202348|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0
7087630|NCT02207244|11202349|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0
7087631|NCT02207244|11202350|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0
7087632|NCT02207244|11202351|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0
7087633|NCT02207244|11202341|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4
7087634|NCT02207244|11202342|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
7087635|NCT02207244|11202343|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2
7087636|NCT02207244|11202344|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
7087637|NCT02207244|11202345|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
7087638|NCT02207244|11202346|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
7087639|NCT02207244|11202347|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
7087640|NCT02207244|11202348|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
7087641|NCT02207244|11202349|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
7087642|NCT02207244|11202350|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
7087643|NCT02207244|11202351|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
7087644|NCT02207244|11202341|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1
7087645|NCT02207244|11202342|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3
7087646|NCT02207244|11202343|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2
7087647|NCT02207244|11202344|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
7087648|NCT02207244|11202345|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
7087649|NCT02207244|11202346|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
7087650|NCT02207244|11202347|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
7087651|NCT02207244|11202348|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
7087652|NCT02207244|11202349|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
7087653|NCT02207244|11202350|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
7087654|NCT02207244|11202351|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
7087655|NCT02207244|11202341|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7
7087656|NCT02207244|11202342|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1
7087657|NCT02207244|11202343|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
7087658|NCT02207244|11202344|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
7087659|NCT02207244|11202345|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
7087660|NCT02207244|11202346|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
7087661|NCT02207244|11202347|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
7087662|NCT02207244|11202348|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
7087663|NCT02207244|11202349|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
7087664|NCT02207244|11202350|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
7087665|NCT02207244|11202351|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
7087666|NCT02207244|11202341|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1
7087667|NCT02207244|11202342|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3
7087668|NCT02207244|11202343|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1
7087669|NCT02207244|11202344|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0
7087670|NCT02207244|11202345|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0
7087671|NCT02207244|11202346|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0
7087672|NCT02207244|11202347|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0
7087673|NCT02207244|11202348|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0
7087674|NCT02207244|11202349|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0
7087675|NCT02207244|11202350|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0
7087676|NCT02207244|11202351|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0
7087677|NCT02207244|11202341|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0
7087678|NCT02207244|11202342|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1
7087679|NCT02207244|11202343|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2
7087680|NCT02207244|11202344|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0
7087681|NCT02207244|11202345|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0
7087682|NCT02207244|11202346|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0
7087683|NCT02207244|11202347|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0
7087684|NCT02207244|11202348|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0
7087685|NCT02207244|11202349|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0
7087686|NCT02207244|11202350|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0
7087687|NCT02207244|11202351|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0
7087688|NCT02207244|11202341|FG000|Placebo Controlled Period: Week 0-16|OTHER|0
7087689|NCT02207244|11202342|FG001|Placebo Controlled Period: Week 0-16|OTHER|1
7087690|NCT02207244|11202343|FG002|Placebo Controlled Period: Week 0-16|OTHER|0
7087691|NCT02207244|11202344|FG003|Placebo Controlled Period: Week 0-16|OTHER|0
7087692|NCT02207244|11202345|FG004|Placebo Controlled Period: Week 0-16|OTHER|0
7087693|NCT02207244|11202346|FG005|Placebo Controlled Period: Week 0-16|OTHER|0
7087694|NCT02207244|11202347|FG006|Placebo Controlled Period: Week 0-16|OTHER|0
7087695|NCT02207244|11202348|FG007|Placebo Controlled Period: Week 0-16|OTHER|0
7087696|NCT02207244|11202349|FG008|Placebo Controlled Period: Week 0-16|OTHER|0
7087697|NCT02207244|11202350|FG009|Placebo Controlled Period: Week 0-16|OTHER|0
7087698|NCT02207244|11202351|FG010|Placebo Controlled Period: Week 0-16|OTHER|0
7087699|NCT02207244|11202341|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
7087700|NCT02207244|11202342|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
7087701|NCT02207244|11202343|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
7087702|NCT02207244|11202344|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
7087703|NCT02207244|11202345|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3
7087704|NCT02207244|11202346|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2
7087705|NCT02207244|11202347|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
7087706|NCT02207244|11202348|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
7087707|NCT02207244|11202349|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
7087708|NCT02207244|11202350|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
7087709|NCT02207244|11202351|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
7087710|NCT02207244|11202341|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7087711|NCT02207244|11202342|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7087712|NCT02207244|11202343|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7087713|NCT02207244|11202344|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7087714|NCT02207244|11202345|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7087715|NCT02207244|11202346|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2
7087716|NCT02207244|11202347|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7087717|NCT02207244|11202348|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7087718|NCT02207244|11202349|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7087719|NCT02207244|11202350|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7087720|NCT02207244|11202351|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7087721|NCT02207244|11202341|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
7087722|NCT02207244|11202342|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
7087723|NCT02207244|11202343|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
7087724|NCT02207244|11202344|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1
7087725|NCT02207244|11202345|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2
7087726|NCT02207244|11202346|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2
7087727|NCT02207244|11202347|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
7087728|NCT02207244|11202348|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
7087729|NCT02207244|11202349|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
7087730|NCT02207244|11202350|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
7087731|NCT02207244|11202351|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
7087732|NCT02207244|11202341|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
7087733|NCT02207244|11202342|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
7087734|NCT02207244|11202343|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
7087735|NCT02207244|11202344|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3
7087736|NCT02207244|11202345|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3
7087737|NCT02207244|11202346|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2
7087738|NCT02207244|11202347|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
7087739|NCT02207244|11202348|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
7087740|NCT02207244|11202349|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
7087741|NCT02207244|11202350|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
7087742|NCT02207244|11202351|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
7087743|NCT02207244|11202341|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
7087744|NCT02207244|11202342|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
7087745|NCT02207244|11202343|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
7087746|NCT02207244|11202344|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1
7087747|NCT02207244|11202345|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
7087748|NCT02207244|11202346|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1
7087749|NCT02207244|11202347|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
7087750|NCT02207244|11202348|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
7087751|NCT02207244|11202349|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
7087752|NCT02207244|11202350|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
7087753|NCT02207244|11202351|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
7087754|NCT02207244|11202341|FG000|Placebo Crossover and ACP: Week 16-28|Other|0
7087755|NCT02207244|11202342|FG001|Placebo Crossover and ACP: Week 16-28|Other|0
7087756|NCT02207244|11202343|FG002|Placebo Crossover and ACP: Week 16-28|Other|0
7087757|NCT02207244|11202344|FG003|Placebo Crossover and ACP: Week 16-28|Other|1
7087758|NCT02207244|11202345|FG004|Placebo Crossover and ACP: Week 16-28|Other|0
7087759|NCT02207244|11202346|FG005|Placebo Crossover and ACP: Week 16-28|Other|0
7087760|NCT02207244|11202347|FG006|Placebo Crossover and ACP: Week 16-28|Other|0
7087761|NCT02207244|11202348|FG007|Placebo Crossover and ACP: Week 16-28|Other|0
7087762|NCT02207244|11202349|FG008|Placebo Crossover and ACP: Week 16-28|Other|0
7087763|NCT02207244|11202350|FG009|Placebo Crossover and ACP: Week 16-28|Other|0
7087764|NCT02207244|11202351|FG010|Placebo Crossover and ACP: Week 16-28|Other|0
7087765|NCT02207244|11202341|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
7087766|NCT02207244|11202342|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
7087767|NCT02207244|11202343|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
7087768|NCT02207244|11202344|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
7087769|NCT02207244|11202345|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
7087770|NCT02207244|11202346|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
7087771|NCT02207244|11202347|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1
7087772|NCT02207244|11202348|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5
7087773|NCT02207244|11202349|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3
7087774|NCT02207244|11202350|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2
7087775|NCT02207244|11202351|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
7087776|NCT02207244|11202341|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7087777|NCT02207244|11202342|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7087778|NCT02207244|11202343|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7087779|NCT02207244|11202344|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7087780|NCT02207244|11202345|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7087781|NCT02207244|11202346|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7087782|NCT02207244|11202347|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7087783|NCT02207244|11202348|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2
7087784|NCT02207244|11202349|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7087785|NCT02207244|11202350|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7087786|NCT02207244|11202351|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7087787|NCT02207244|11202341|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
7087788|NCT02207244|11202342|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
7087789|NCT02207244|11202343|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
7087790|NCT02207244|11202344|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
7087791|NCT02207244|11202345|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
7087792|NCT02207244|11202346|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
7087793|NCT02207244|11202347|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1
7087794|NCT02207244|11202348|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3
7087795|NCT02207244|11202349|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2
7087796|NCT02207244|11202350|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2
7087797|NCT02207244|11202351|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
7087798|NCT02207244|11202341|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
7087799|NCT02207244|11202342|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
7087800|NCT02207244|11202343|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
7087801|NCT02207244|11202344|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
7087802|NCT02207244|11202345|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
7087803|NCT02207244|11202346|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
7087804|NCT02207244|11202347|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2
7087805|NCT02207244|11202348|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7
7087806|NCT02207244|11202349|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
7087807|NCT02207244|11202350|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2
7087808|NCT02207244|11202351|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
7087809|NCT02207244|11202341|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
7087810|NCT02207244|11202342|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
7087811|NCT02207244|11202343|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
7087812|NCT02207244|11202344|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
7087813|NCT02207244|11202345|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
7087814|NCT02207244|11202346|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
7087815|NCT02207244|11202347|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2
7087816|NCT02207244|11202348|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7
7087817|NCT02207244|11202349|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2
7087818|NCT02207244|11202350|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2
7087819|NCT02207244|11202351|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
7087820|NCT02207244|11202341|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
7087821|NCT02207244|11202342|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
7087822|NCT02207244|11202343|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
7087823|NCT02207244|11202344|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
7087824|NCT02207244|11202345|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
7087825|NCT02207244|11202346|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
7087826|NCT02207244|11202347|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
7087827|NCT02207244|11202348|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1
7087828|NCT02207244|11202349|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1
7087829|NCT02207244|11202350|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
7087830|NCT02207244|11202351|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
7087831|NCT02207244|11202341|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7087832|NCT02207244|11202342|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7087833|NCT02207244|11202343|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7087834|NCT02207244|11202344|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7087835|NCT02207244|11202345|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7087836|NCT02207244|11202346|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7087837|NCT02207244|11202347|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7087838|NCT02207244|11202348|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7087839|NCT02207244|11202349|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1
7087840|NCT02207244|11202350|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7087841|NCT02207244|11202351|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7087842|NCT02207244|11202341|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0
7087843|NCT02207244|11202342|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0
7087844|NCT02207244|11202343|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0
7087845|NCT02207244|11202344|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0
7087846|NCT02207244|11202345|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0
7087847|NCT02207244|11202346|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0
7087848|NCT02207244|11202347|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0
7087849|NCT02207244|11202348|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2
7087850|NCT02207244|11202349|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0
7087851|NCT02207244|11202350|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0
7087852|NCT02207244|11202351|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0
7087853|NCT02207244|11202341|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7087854|NCT02207244|11202342|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7087855|NCT02207244|11202343|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7087856|NCT02207244|11202344|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7087857|NCT02207244|11202345|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7087858|NCT02207244|11202346|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7087859|NCT02207244|11202347|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8
7087860|NCT02207244|11202348|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7087861|NCT02207244|11202349|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7087862|NCT02207244|11202350|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7087863|NCT02207244|11202351|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7087864|NCT02207244|11202341|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
7087865|NCT02207244|11202342|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
7087866|NCT02207244|11202343|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
7087867|NCT02207244|11202344|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
7087868|NCT02207244|11202345|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
7087869|NCT02207244|11202346|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
7087870|NCT02207244|11202347|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
7087871|NCT02207244|11202348|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
7087872|NCT02207244|11202349|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10
7087873|NCT02207244|11202350|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
7087874|NCT02207244|11202351|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30
7087875|NCT02207244|11202341|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
7087876|NCT02207244|11202342|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
7087877|NCT02207244|11202343|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
7087878|NCT02207244|11202344|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
7087879|NCT02207244|11202345|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
7087880|NCT02207244|11202346|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
7087881|NCT02207244|11202347|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
7087882|NCT02207244|11202348|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
7087883|NCT02207244|11202349|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2
7087884|NCT02207244|11202350|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
7087885|NCT02207244|11202351|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3
7087886|NCT02207244|11202341|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
7087887|NCT02207244|11202342|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
7087888|NCT02207244|11202343|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
7087889|NCT02207244|11202344|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
7087890|NCT02207244|11202345|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
7087891|NCT02207244|11202346|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
7087892|NCT02207244|11202347|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
7087893|NCT02207244|11202348|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
7087894|NCT02207244|11202349|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5
7087895|NCT02207244|11202350|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
7087896|NCT02207244|11202351|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26
7087897|NCT02207244|11202341|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0
7087898|NCT02207244|11202342|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0
7087899|NCT02207244|11202343|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0
7087900|NCT02207244|11202344|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0
7087901|NCT02207244|11202345|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0
7087902|NCT02207244|11202346|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0
7087903|NCT02207244|11202347|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0
7087904|NCT02207244|11202348|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0
7087905|NCT02207244|11202349|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12
7087906|NCT02207244|11202350|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0
7087907|NCT02207244|11202351|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21
7087908|NCT02207244|11202341|FG000|Open-label Guselkumab: Week 72-264|Death|0
7087909|NCT02207244|11202342|FG001|Open-label Guselkumab: Week 72-264|Death|0
7087910|NCT02207244|11202343|FG002|Open-label Guselkumab: Week 72-264|Death|0
7087911|NCT02207244|11202344|FG003|Open-label Guselkumab: Week 72-264|Death|0
7087912|NCT02207244|11202345|FG004|Open-label Guselkumab: Week 72-264|Death|0
7087913|NCT02207244|11202346|FG005|Open-label Guselkumab: Week 72-264|Death|0
7087914|NCT02207244|11202347|FG006|Open-label Guselkumab: Week 72-264|Death|0
7087915|NCT02207244|11202348|FG007|Open-label Guselkumab: Week 72-264|Death|0
7087916|NCT02207244|11202349|FG008|Open-label Guselkumab: Week 72-264|Death|1
7087917|NCT02207244|11202350|FG009|Open-label Guselkumab: Week 72-264|Death|0
7087918|NCT02207244|11202351|FG010|Open-label Guselkumab: Week 72-264|Death|1
7087919|NCT02207244|11202341|FG000|Open-label Guselkumab: Week 72-264|Other|0
7087920|NCT02207244|11202342|FG001|Open-label Guselkumab: Week 72-264|Other|0
7087921|NCT02207244|11202343|FG002|Open-label Guselkumab: Week 72-264|Other|0
7087922|NCT02207244|11202344|FG003|Open-label Guselkumab: Week 72-264|Other|0
7087923|NCT02207244|11202345|FG004|Open-label Guselkumab: Week 72-264|Other|0
7087924|NCT02207244|11202346|FG005|Open-label Guselkumab: Week 72-264|Other|0
7087925|NCT02207244|11202347|FG006|Open-label Guselkumab: Week 72-264|Other|0
7087926|NCT02207244|11202348|FG007|Open-label Guselkumab: Week 72-264|Other|0
7087927|NCT02207244|11202349|FG008|Open-label Guselkumab: Week 72-264|Other|8
7087928|NCT02207244|11202350|FG009|Open-label Guselkumab: Week 72-264|Other|0
7087929|NCT02207244|11202351|FG010|Open-label Guselkumab: Week 72-264|Other|19
7087930|NCT02207244|11202341|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0
7087931|NCT02207244|11202342|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0
7087932|NCT02207244|11202343|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0
7087933|NCT02207244|11202344|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0
7087934|NCT02207244|11202345|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0
7087935|NCT02207244|11202346|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0
7087936|NCT02207244|11202347|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0
7087937|NCT02207244|11202348|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0
7087938|NCT02207244|11202349|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0
7087939|NCT02207244|11202350|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0
7087940|NCT02207244|11202351|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2
7087941|NCT02207374|11202392|FG000|Overall Study|Withdrawal by Subject|5
7087942|NCT02207374|11202393|FG001|Overall Study|Withdrawal by Subject|9
7087943|NCT02207374|11202394|FG002|Overall Study|Withdrawal by Subject|4
7087944|NCT02207374|11202392|FG000|Overall Study|Death|1
7087945|NCT02207374|11202393|FG001|Overall Study|Death|0
7087946|NCT02207374|11202394|FG002|Overall Study|Death|1
7087947|NCT02207374|11202392|FG000|Overall Study|Missing follow-up information|0
7087948|NCT02207374|11202393|FG001|Overall Study|Missing follow-up information|1
7087949|NCT02207374|11202394|FG002|Overall Study|Missing follow-up information|1
7087950|NCT02207400|11202404|FG000|Overall Study|Adverse Event|1
7087951|NCT02207400|11202405|FG001|Overall Study|Adverse Event|1
7087952|NCT02207400|11202404|FG000|Overall Study|Lost to Follow-up|6
7087953|NCT02207400|11202405|FG001|Overall Study|Lost to Follow-up|7
7087954|NCT02207400|11202404|FG000|Overall Study|Protocol Violation|1
7087955|NCT02207400|11202405|FG001|Overall Study|Protocol Violation|1
7087956|NCT02207400|11202404|FG000|Overall Study|Withdrawal by Subject|8
7087957|NCT02207400|11202405|FG001|Overall Study|Withdrawal by Subject|4
7087958|NCT02207400|11202404|FG000|Overall Study|Positive Urine Pregnancy Test|0
7087959|NCT02207400|11202405|FG001|Overall Study|Positive Urine Pregnancy Test|1
7087960|NCT02207413|11202420|FG000|Overall Study|Withdrawal by Subject|1
7087961|NCT02207413|11202421|FG001|Overall Study|Withdrawal by Subject|0
7087962|NCT02207413|11202422|FG002|Overall Study|Withdrawal by Subject|0
7087963|NCT02207413|11202423|FG003|Overall Study|Withdrawal by Subject|0
7087964|NCT02207413|11202424|FG004|Overall Study|Withdrawal by Subject|3
7087965|NCT02207413|11202425|FG005|Overall Study|Withdrawal by Subject|7
7087966|NCT02207413|11202420|FG000|Overall Study|Lost to Follow-up|0
7087967|NCT02207413|11202421|FG001|Overall Study|Lost to Follow-up|0
7087968|NCT02207413|11202422|FG002|Overall Study|Lost to Follow-up|0
7087969|NCT02207413|11202423|FG003|Overall Study|Lost to Follow-up|1
7087970|NCT02207413|11202424|FG004|Overall Study|Lost to Follow-up|1
7087971|NCT02207413|11202425|FG005|Overall Study|Lost to Follow-up|5
7087972|NCT02207413|11202420|FG000|Overall Study|Adverse Event|0
7087973|NCT02207413|11202421|FG001|Overall Study|Adverse Event|0
7087974|NCT02207413|11202422|FG002|Overall Study|Adverse Event|0
7087975|NCT02207413|11202423|FG003|Overall Study|Adverse Event|0
7087976|NCT02207413|11202424|FG004|Overall Study|Adverse Event|2
7087977|NCT02207413|11202425|FG005|Overall Study|Adverse Event|1
7087978|NCT02207413|11202420|FG000|Overall Study|Migrated/moved from study area|0
7087979|NCT02207413|11202421|FG001|Overall Study|Migrated/moved from study area|0
7087980|NCT02207413|11202422|FG002|Overall Study|Migrated/moved from study area|0
7087981|NCT02207413|11202423|FG003|Overall Study|Migrated/moved from study area|0
7087982|NCT02207413|11202424|FG004|Overall Study|Migrated/moved from study area|1
7087983|NCT02207413|11202425|FG005|Overall Study|Migrated/moved from study area|0
7087984|NCT02207491|11202456|FG000|Overall Study|Adverse Event|20
7087985|NCT02207491|11202457|FG001|Overall Study|Adverse Event|4
7087986|NCT02207491|11202456|FG000|Overall Study|Withdrawal by Subject|3
7087987|NCT02207491|11202457|FG001|Overall Study|Withdrawal by Subject|2
7087988|NCT02207491|11202456|FG000|Overall Study|Non-compliant|0
7087989|NCT02207491|11202457|FG001|Overall Study|Non-compliant|1
7087990|NCT02207491|11202456|FG000|Overall Study|Lost to Follow-up|0
7087991|NCT02207491|11202457|FG001|Overall Study|Lost to Follow-up|1
7087992|NCT02207491|11202456|FG000|Overall Study|Lack of Efficacy|3
7087993|NCT02207491|11202457|FG001|Overall Study|Lack of Efficacy|0
7087994|NCT02207491|11202456|FG000|Overall Study|Physician Decision|2
7087995|NCT02207491|11202457|FG001|Overall Study|Physician Decision|0
7087996|NCT02207491|11202456|FG000|Overall Study|Protocol Violation|3
7087997|NCT02207491|11202457|FG001|Overall Study|Protocol Violation|5
7087998|NCT02207530|11202463|FG000|Overall Study|Worsening condition under investigation|78
7087999|NCT02207530|11202463|FG000|Overall Study|Patient decision to stop study treatment|5
7088000|NCT02207530|11202463|FG000|Overall Study|Adverse Event|8
7088001|NCT02207556|11202469|FG000|Overall Study|Physician Decision|1
7088002|NCT02207556|11202470|FG001|Overall Study|Physician Decision|0
7088003|NCT02207556|11202469|FG000|Overall Study|Withdrawal by Subject|1
7088004|NCT02207556|11202470|FG001|Overall Study|Withdrawal by Subject|0
7088005|NCT02207556|11202469|FG000|Overall Study|Death|0
7088006|NCT02207556|11202470|FG001|Overall Study|Death|5
7088007|NCT02207569|11202479|FG000|Implant to 1-Month|Death|6
7088008|NCT02207569|11202479|FG000|Implant to 1-Month|Withdrawal by Subject|2
7088009|NCT02207569|11202479|FG000|Implant to 1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1
7088010|NCT02207569|11202479|FG000|1-Month to 6-Month|Death|8
7088011|NCT02207569|11202479|FG000|1-Month to 6-Month|Withdrawal by Subject|2
7088012|NCT02207569|11202479|FG000|12-Month|Death|8
7088013|NCT02207569|11202479|FG000|12-Month|Withdrawal by Subject|1
7088014|NCT02207569|11202479|FG000|6-Month to 12-Month|Death|14
7088015|NCT02207569|11202479|FG000|6-Month to 12-Month|Withdrawal by Subject|2
7088016|NCT02207569|11202479|FG000|12-Month to 24 Month|Death|23
7088017|NCT02207569|11202479|FG000|12-Month to 24 Month|Withdrawal by Subject|3
7088018|NCT02207569|11202479|FG000|24-Month to 36-Month|Death|23
7088019|NCT02207569|11202479|FG000|24-Month to 36-Month|Withdrawal by Subject|4
7088020|NCT02207569|11202479|FG000|36-Month to 48-Month|Death|25
7088021|NCT02207569|11202479|FG000|36-Month to 48-Month|Withdrawal by Subject|2
7088022|NCT02207569|11202479|FG000|36-Month to 48-Month|Lost to Follow-up|4
7088023|NCT02207569|11202479|FG000|48-Month to 60-Month|Death|1
7088024|NCT02207569|11202479|FG000|48-Month to 60-Month|Lost to Follow-up|1
7088025|NCT02207569|11202479|FG000|48-Month to 60-Month|pt 103 years old no longer traveling for MD visits|1
7088026|NCT02207569|11202479|FG000|48-Month to 60-Month|Covid-19 pt not willing to be seen|1
7088027|NCT02207608|11202485|FG000|Overall Study|Adverse Event|1
7088028|NCT02207608|11202486|FG001|Overall Study|Adverse Event|0
7088029|NCT02207621|11202495|FG000|Overall Study|Adverse Event|71
7088030|NCT02207621|11202496|FG001|Overall Study|Adverse Event|15
7088031|NCT02207621|11202497|FG002|Overall Study|Adverse Event|132
7088032|NCT02207621|11202495|FG000|Overall Study|Withdrawal by Subject|9
7088033|NCT02207621|11202496|FG001|Overall Study|Withdrawal by Subject|9
7088034|NCT02207621|11202497|FG002|Overall Study|Withdrawal by Subject|13
7088035|NCT02207621|11202495|FG000|Overall Study|Non-Compliant|3
7088036|NCT02207621|11202496|FG001|Overall Study|Non-Compliant|3
7088037|NCT02207621|11202497|FG002|Overall Study|Non-Compliant|1
7088038|NCT02207621|11202495|FG000|Overall Study|Lost to Follow-up|1
7088039|NCT02207621|11202496|FG001|Overall Study|Lost to Follow-up|0
7088040|NCT02207621|11202497|FG002|Overall Study|Lost to Follow-up|3
7088041|NCT02207621|11202495|FG000|Overall Study|Lack of Efficacy|10
7088042|NCT02207621|11202496|FG001|Overall Study|Lack of Efficacy|2
7088043|NCT02207621|11202497|FG002|Overall Study|Lack of Efficacy|4
7088044|NCT02207621|11202495|FG000|Overall Study|Disallowed Concurrent Medication|2
7088045|NCT02207621|11202496|FG001|Overall Study|Disallowed Concurrent Medication|5
7088046|NCT02207621|11202497|FG002|Overall Study|Disallowed Concurrent Medication|2
7088047|NCT02207621|11202495|FG000|Overall Study|Physician Decision|1
7088048|NCT02207621|11202496|FG001|Overall Study|Physician Decision|2
7088049|NCT02207621|11202497|FG002|Overall Study|Physician Decision|2
7088050|NCT02207621|11202495|FG000|Overall Study|Protocol Violation|4
7088051|NCT02207621|11202496|FG001|Overall Study|Protocol Violation|10
7088052|NCT02207621|11202497|FG002|Overall Study|Protocol Violation|6
7088053|NCT02207621|11202495|FG000|Overall Study|Death|2
7088054|NCT02207621|11202496|FG001|Overall Study|Death|0
7088055|NCT02207621|11202497|FG002|Overall Study|Death|0
7088056|NCT02207621|11202495|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2
7088057|NCT02207621|11202496|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1
7088058|NCT02207621|11202497|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5
7088059|NCT02207634|11202508|FG000|Overall Study|Withdrawal by Subject|21
7088060|NCT02207634|11202509|FG001|Overall Study|Withdrawal by Subject|31
7088061|NCT02207634|11202508|FG000|Overall Study|Lost to Follow-up|1
7088062|NCT02207634|11202509|FG001|Overall Study|Lost to Follow-up|0
7088063|NCT02207725|11202519|FG000|Overall Study|Did Not Receive Treatment|0
7088064|NCT02207725|11202520|FG001|Overall Study|Did Not Receive Treatment|1
7088065|NCT02207725|11202521|FG002|Overall Study|Did Not Receive Treatment|1
7088066|NCT02207725|11202522|FG003|Overall Study|Did Not Receive Treatment|1
7088067|NCT02207816|11202546|FG000|Overall Study|Serious Adverse Event|0
7088068|NCT02207816|11202547|FG001|Overall Study|Serious Adverse Event|5
7088069|NCT02207816|11202548|FG002|Overall Study|Serious Adverse Event|2
7088070|NCT02207816|11202546|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2
7088071|NCT02207816|11202547|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1
7088072|NCT02207816|11202548|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2
7088073|NCT02207816|11202546|FG000|Overall Study|Withdrawal by Subject|4
7088074|NCT02207816|11202547|FG001|Overall Study|Withdrawal by Subject|9
7088075|NCT02207816|11202548|FG002|Overall Study|Withdrawal by Subject|7
7088076|NCT02207816|11202546|FG000|Overall Study|Migrated/Moved From Study Area|41
7088077|NCT02207816|11202547|FG001|Overall Study|Migrated/Moved From Study Area|60
7088078|NCT02207816|11202548|FG002|Overall Study|Migrated/Moved From Study Area|51
7088079|NCT02207816|11202546|FG000|Overall Study|Lost to Follow-up|3
7088080|NCT02207816|11202547|FG001|Overall Study|Lost to Follow-up|9
7088081|NCT02207816|11202548|FG002|Overall Study|Lost to Follow-up|1
7088082|NCT02207816|11202546|FG000|Overall Study|Other|1
7088083|NCT02207816|11202547|FG001|Overall Study|Other|2
7088084|NCT02207816|11202548|FG002|Overall Study|Other|4
7088085|NCT02207829|11202561|FG000|Overall Study|Adverse Event|10
7088086|NCT02207829|11202562|FG001|Overall Study|Adverse Event|9
7088087|NCT02207829|11202561|FG000|Overall Study|Lack of Efficacy|7
7088088|NCT02207829|11202562|FG001|Overall Study|Lack of Efficacy|5
7088089|NCT02207829|11202561|FG000|Overall Study|Lost to Follow-up|2
7088090|NCT02207829|11202562|FG001|Overall Study|Lost to Follow-up|2
7088091|NCT02207829|11202561|FG000|Overall Study|Protocol deviation|5
7088092|NCT02207829|11202562|FG001|Overall Study|Protocol deviation|4
7088093|NCT02207829|11202561|FG000|Overall Study|Withdrew consent|18
7088094|NCT02207829|11202562|FG001|Overall Study|Withdrew consent|14
7088095|NCT02207907|11202570|FG000|Overall Study|Lost to Follow-up|3
7088096|NCT02207907|11202571|FG001|Overall Study|Lost to Follow-up|1
7088097|NCT02207907|11202570|FG000|Overall Study|Withdrawal by Subject|5
7088098|NCT02207907|11202571|FG001|Overall Study|Withdrawal by Subject|6
7088099|NCT02207907|11202570|FG000|Overall Study|Did not meet study criteria|3
7088100|NCT02207907|11202571|FG001|Overall Study|Did not meet study criteria|0
7088101|NCT02207907|11202570|FG000|Overall Study|Pregnancy|0
7088102|NCT02207907|11202571|FG001|Overall Study|Pregnancy|1
7088103|NCT02207946|11202580|FG000|Overall Study|Lost to Follow-up|1
7088104|NCT02207946|11202581|FG001|Overall Study|Lost to Follow-up|0
7088105|NCT02207946|11202580|FG000|Overall Study|Adverse Event|0
7088106|NCT02207946|11202581|FG001|Overall Study|Adverse Event|1
7088107|NCT02208050|11202613|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1
7088108|NCT02208050|11202614|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0
7088109|NCT02208063|11202636|FG000|Overall Study|Death|3
7088110|NCT02208063|11202637|FG001|Overall Study|Death|5
7088111|NCT02208063|11202636|FG000|Overall Study|Not Specified in report|3
7088112|NCT02208063|11202637|FG001|Overall Study|Not Specified in report|4
7088113|NCT02208063|11202636|FG000|Overall Study|Withdrawal by Subject|5
7088114|NCT02208063|11202637|FG001|Overall Study|Withdrawal by Subject|2
7088115|NCT02208063|11202636|FG000|Overall Study|Lost to Follow-up|1
7088116|NCT02208063|11202637|FG001|Overall Study|Lost to Follow-up|0
7088117|NCT02208089|11202645|FG000|Overall Study|Withdrawal by Subject|1
7088118|NCT02208089|11202646|FG001|Overall Study|Withdrawal by Subject|0
7088119|NCT02208089|11202645|FG000|Overall Study|Lost to Follow-up|6
7088120|NCT02208089|11202646|FG001|Overall Study|Lost to Follow-up|0
7088121|NCT02208843|11202695|FG000|Overall Study|Clinical symptoms of progression|2
7088122|NCT02208843|11202695|FG000|Overall Study|Progression disease according to RECIST|24
7088123|NCT02208843|11202695|FG000|Overall Study|Adverse Event|12
7088124|NCT02208843|11202695|FG000|Overall Study|Protocol Violation|1
7088125|NCT02208843|11202695|FG000|Overall Study|Withdrawal by Subject|1
7088126|NCT02208843|11202695|FG000|Overall Study|Switched to commercial afatinib|20
7088127|NCT02208999|11202701|FG000|Overall Study|Lost to Follow-up|1
7088128|NCT02209181|11202729|FG000|Overall Study|Adverse Event|1
7088129|NCT02209181|11202730|FG001|Overall Study|Adverse Event|0
7088130|NCT02209181|11202731|FG002|Overall Study|Adverse Event|1
7088131|NCT02209181|11202732|FG003|Overall Study|Adverse Event|0
7088132|NCT02209181|11202729|FG000|Overall Study|Withdrawal by Subject|0
7088133|NCT02209181|11202730|FG001|Overall Study|Withdrawal by Subject|1
7088134|NCT02209181|11202731|FG002|Overall Study|Withdrawal by Subject|0
7088135|NCT02209181|11202732|FG003|Overall Study|Withdrawal by Subject|0
7088136|NCT02209454|11202764|FG000|Second Period|Adverse Event|1
7088137|NCT02209454|11202765|FG001|Second Period|Adverse Event|0
7088138|NCT02209506|11202776|FG000|Overall Study|Withdrawal by Subject|0
7088139|NCT02209506|11202777|FG001|Overall Study|Withdrawal by Subject|0
7088140|NCT02209506|11202778|FG002|Overall Study|Withdrawal by Subject|0
7088141|NCT02209506|11202779|FG003|Overall Study|Withdrawal by Subject|0
7088142|NCT02209506|11202780|FG004|Overall Study|Withdrawal by Subject|1
7088143|NCT02209597|11202815|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2
7088144|NCT02209597|11202815|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1
7088145|NCT02209597|11202815|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3
7088146|NCT02209597|11202815|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1
7088147|NCT02209766|11202839|FG000|Overall Study|Withdrawal by Subject|0
7088148|NCT02209766|11202840|FG001|Overall Study|Withdrawal by Subject|0
7088149|NCT02209766|11202841|FG002|Overall Study|Withdrawal by Subject|0
7088150|NCT02209766|11202842|FG003|Overall Study|Withdrawal by Subject|1
7088151|NCT02209766|11202843|FG004|Overall Study|Withdrawal by Subject|0
7088152|NCT02210000|11202864|FG000|Overall Study|Study Terminated|11
7088153|NCT02210000|11202865|FG001|Overall Study|Study Terminated|12
7088154|NCT02210000|11202864|FG000|Overall Study|Withdrawal by Subject|7
7088155|NCT02210000|11202865|FG001|Overall Study|Withdrawal by Subject|1
7088156|NCT02210000|11202864|FG000|Overall Study|Adverse Event|1
7088157|NCT02210000|11202865|FG001|Overall Study|Adverse Event|5
7088158|NCT02210000|11202864|FG000|Overall Study|Lost to Follow-up|0
7088159|NCT02210000|11202865|FG001|Overall Study|Lost to Follow-up|2
7088160|NCT02210000|11202864|FG000|Overall Study|Physician Decision|0
7088161|NCT02210000|11202865|FG001|Overall Study|Physician Decision|1
7088162|NCT02210091|11202885|FG000|Overall Study|Physician Decision|0
7088163|NCT02210091|11202886|FG001|Overall Study|Physician Decision|1
7088164|NCT02210091|11202885|FG000|Overall Study|Withdrawal by Sponsor|0
7088165|NCT02210091|11202886|FG001|Overall Study|Withdrawal by Sponsor|1
7088166|NCT02210208|11202917|FG000|Period A (Graft Site)|Withdrawal by Subject|1
7088167|NCT02210208|11202917|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1
7088168|NCT02210208|11202917|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7
7088169|NCT02210221|11202923|FG000|Overall Study|Lack of Efficacy|7
7088170|NCT02210221|11202923|FG000|Overall Study|Withdrawal by Subject|43
7088171|NCT02210689|11202969|FG000|Overall Study|Withdrawal by Subject|7
7088172|NCT02210689|11202970|FG001|Overall Study|Withdrawal by Subject|4
7088173|NCT02210689|11202971|FG002|Overall Study|Withdrawal by Subject|2
7088174|NCT02210689|11202969|FG000|Overall Study|Adverse Event|0
7088175|NCT02210689|11202970|FG001|Overall Study|Adverse Event|1
7088176|NCT02210689|11202971|FG002|Overall Study|Adverse Event|0
7088177|NCT02210689|11202969|FG000|Overall Study|Protocol Violation|1
7088178|NCT02210689|11202970|FG001|Overall Study|Protocol Violation|0
7088179|NCT02210689|11202971|FG002|Overall Study|Protocol Violation|0
7088180|NCT02210689|11202969|FG000|Overall Study|Lost to Follow-up|11
7088181|NCT02210689|11202970|FG001|Overall Study|Lost to Follow-up|9
7088182|NCT02210689|11202971|FG002|Overall Study|Lost to Follow-up|5
7088183|NCT02210689|11202969|FG000|Overall Study|Pregnancy|0
7088184|NCT02210689|11202970|FG001|Overall Study|Pregnancy|1
7088185|NCT02210689|11202971|FG002|Overall Study|Pregnancy|0
7088186|NCT02210689|11202969|FG000|Overall Study|Lack of Efficacy|0
7088187|NCT02210689|11202970|FG001|Overall Study|Lack of Efficacy|1
7088188|NCT02210689|11202971|FG002|Overall Study|Lack of Efficacy|5
7088189|NCT02210689|11202969|FG000|Overall Study|Prohibited medication|2
7088190|NCT02210689|11202970|FG001|Overall Study|Prohibited medication|8
7088191|NCT02210689|11202971|FG002|Overall Study|Prohibited medication|1
7088192|NCT02210689|11202969|FG000|Overall Study|Negative Nugent score at baseline|6
7088193|NCT02210689|11202970|FG001|Overall Study|Negative Nugent score at baseline|2
7088194|NCT02210689|11202971|FG002|Overall Study|Negative Nugent score at baseline|2
7088195|NCT02210689|11202969|FG000|Overall Study|Other|25
7088196|NCT02210689|11202970|FG001|Overall Study|Other|21
7088197|NCT02210689|11202971|FG002|Overall Study|Other|8
7088198|NCT02210780|11202981|FG000|Overall Study|Adverse Event|0
7088199|NCT02210780|11202982|FG001|Overall Study|Adverse Event|5
7088200|NCT02210780|11202981|FG000|Overall Study|Lost to Follow-up|2
7088201|NCT02210780|11202982|FG001|Overall Study|Lost to Follow-up|1
7088202|NCT02210780|11202981|FG000|Overall Study|Withdrawal by Subject|1
7088203|NCT02210780|11202982|FG001|Overall Study|Withdrawal by Subject|1
7088204|NCT02210780|11202981|FG000|Overall Study|Physician Decision|1
7088205|NCT02210780|11202982|FG001|Overall Study|Physician Decision|0
7088206|NCT02210780|11202981|FG000|Overall Study|Protocol Violation|1
7088207|NCT02210780|11202982|FG001|Overall Study|Protocol Violation|0
7088208|NCT02210780|11202981|FG000|Overall Study|Other than specified above|0
7088209|NCT02210780|11202982|FG001|Overall Study|Other than specified above|1
7088210|NCT02211014|11202990|FG000|Overall Study|Adverse Event|0
7088211|NCT02211014|11202991|FG001|Overall Study|Adverse Event|2
7088212|NCT02211014|11202990|FG000|Overall Study|Physician Decision|1
7088213|NCT02211014|11202991|FG001|Overall Study|Physician Decision|2
7088214|NCT02211014|11202990|FG000|Overall Study|Started another cancer therapy|1
7088215|NCT02211014|11202991|FG001|Overall Study|Started another cancer therapy|0
7088216|NCT02211014|11202990|FG000|Overall Study|Withdrawal by Subject|0
7088217|NCT02211014|11202991|FG001|Overall Study|Withdrawal by Subject|1
7088218|NCT02211014|11202990|FG000|Overall Study|In agreement with patient, no benefit|0
7088219|NCT02211014|11202991|FG001|Overall Study|In agreement with patient, no benefit|1
7088220|NCT02211261|11203024|FG000|Overall Study|Withdrawal by Subject|0
7088221|NCT02211261|11203025|FG001|Overall Study|Withdrawal by Subject|0
7088222|NCT02211261|11203026|FG002|Overall Study|Withdrawal by Subject|1
7088223|NCT02211261|11203027|FG003|Overall Study|Withdrawal by Subject|0
7088224|NCT02211261|11203028|FG004|Overall Study|Withdrawal by Subject|2
7088225|NCT02211261|11203029|FG005|Overall Study|Withdrawal by Subject|0
7088226|NCT02211261|11203030|FG006|Overall Study|Withdrawal by Subject|0
7088227|NCT02211261|11203031|FG007|Overall Study|Withdrawal by Subject|0
7088228|NCT02211261|11203032|FG008|Overall Study|Withdrawal by Subject|0
7088229|NCT02211261|11203033|FG009|Overall Study|Withdrawal by Subject|0
7088230|NCT02211261|11203034|FG010|Overall Study|Withdrawal by Subject|0
7088231|NCT02211261|11203024|FG000|Overall Study|Other|0
7088232|NCT02211261|11203025|FG001|Overall Study|Other|0
7088233|NCT02211261|11203026|FG002|Overall Study|Other|0
7088234|NCT02211261|11203027|FG003|Overall Study|Other|0
7088235|NCT02211261|11203028|FG004|Overall Study|Other|0
7088236|NCT02211261|11203029|FG005|Overall Study|Other|1
7088237|NCT02211261|11203030|FG006|Overall Study|Other|0
7088238|NCT02211261|11203031|FG007|Overall Study|Other|0
7088239|NCT02211261|11203032|FG008|Overall Study|Other|0
7088240|NCT02211261|11203033|FG009|Overall Study|Other|2
7088241|NCT02211261|11203034|FG010|Overall Study|Other|0
7088242|NCT02211261|11203024|FG000|Overall Study|Lost to Follow-up|0
7088243|NCT02211261|11203025|FG001|Overall Study|Lost to Follow-up|0
7088244|NCT02211261|11203026|FG002|Overall Study|Lost to Follow-up|0
7088245|NCT02211261|11203027|FG003|Overall Study|Lost to Follow-up|0
7088246|NCT02211261|11203028|FG004|Overall Study|Lost to Follow-up|0
7088247|NCT02211261|11203029|FG005|Overall Study|Lost to Follow-up|0
7088248|NCT02211261|11203030|FG006|Overall Study|Lost to Follow-up|0
7088249|NCT02211261|11203031|FG007|Overall Study|Lost to Follow-up|1
7088250|NCT02211261|11203032|FG008|Overall Study|Lost to Follow-up|0
7088251|NCT02211261|11203033|FG009|Overall Study|Lost to Follow-up|0
7088252|NCT02211261|11203034|FG010|Overall Study|Lost to Follow-up|0
7088253|NCT02211313|11203069|FG000|Overall Study|Treatment Failure|5
7088254|NCT02211313|11203070|FG001|Overall Study|Treatment Failure|2
7088255|NCT02211313|11203069|FG000|Overall Study|No Follow up Questionnaires|1
7088256|NCT02211313|11203070|FG001|Overall Study|No Follow up Questionnaires|1
7088257|NCT02211638|11203102|FG000|Overall Study|Case Report Forms Uncollected|291
7088258|NCT02211638|11203102|FG000|Overall Study|Protocol Violation|692
7088259|NCT02212197|11203128|FG000|Overall Study|Need for radiotherapy|1
7088260|NCT02212197|11203129|FG001|Overall Study|Need for radiotherapy|0
7088261|NCT02212197|11203130|FG002|Overall Study|Need for radiotherapy|0
7088262|NCT02212301|11203138|FG000|Period 1|Lost to Follow-up|0
7088263|NCT02212301|11203139|FG001|Period 1|Lost to Follow-up|1
7088264|NCT02212379|11203146|FG000|From Baseline to Week 48|Lack of Efficacy|1
7088265|NCT02212379|11203146|FG000|From Baseline to Week 48|Adverse Event|7
7088266|NCT02212379|11203146|FG000|From Baseline to Week 48|Withdrawal by Subject|1
7088267|NCT02212379|11203146|FG000|From Week 48 to Week 96|Lack of Efficacy|1
7088268|NCT02212379|11203146|FG000|From Week 48 to Week 96|Adverse Event|1
7088269|NCT02212379|11203146|FG000|From Week 48 to Week 96|Withdrawal by Subject|2
7088270|NCT02212457|11203159|FG000|Overall Study|Adverse Event|1
7088271|NCT02212457|11203160|FG001|Overall Study|Adverse Event|2
7088272|NCT02212457|11203161|FG002|Overall Study|Adverse Event|2
7088273|NCT02212457|11203162|FG003|Overall Study|Adverse Event|2
7088274|NCT02212457|11203163|FG004|Overall Study|Adverse Event|0
7088275|NCT02212457|11203164|FG005|Overall Study|Adverse Event|1
7088276|NCT02212457|11203159|FG000|Overall Study|Withdrawal by Subject|8
7088277|NCT02212457|11203160|FG001|Overall Study|Withdrawal by Subject|10
7088278|NCT02212457|11203161|FG002|Overall Study|Withdrawal by Subject|8
7088279|NCT02212457|11203162|FG003|Overall Study|Withdrawal by Subject|6
7088280|NCT02212457|11203163|FG004|Overall Study|Withdrawal by Subject|5
7088281|NCT02212457|11203164|FG005|Overall Study|Withdrawal by Subject|4
7088282|NCT02212457|11203159|FG000|Overall Study|Lost to Follow-up|6
7088283|NCT02212457|11203160|FG001|Overall Study|Lost to Follow-up|7
7088284|NCT02212457|11203161|FG002|Overall Study|Lost to Follow-up|4
7088285|NCT02212457|11203162|FG003|Overall Study|Lost to Follow-up|1
7088286|NCT02212457|11203163|FG004|Overall Study|Lost to Follow-up|8
7088287|NCT02212457|11203164|FG005|Overall Study|Lost to Follow-up|4
7088288|NCT02212457|11203159|FG000|Overall Study|Protocol Violation|2
7088289|NCT02212457|11203160|FG001|Overall Study|Protocol Violation|1
7088290|NCT02212457|11203161|FG002|Overall Study|Protocol Violation|0
7088291|NCT02212457|11203162|FG003|Overall Study|Protocol Violation|1
7088292|NCT02212457|11203163|FG004|Overall Study|Protocol Violation|2
7088293|NCT02212457|11203164|FG005|Overall Study|Protocol Violation|3
7088294|NCT02212457|11203159|FG000|Overall Study|Other|2
7088295|NCT02212457|11203160|FG001|Overall Study|Other|1
7088296|NCT02212457|11203161|FG002|Overall Study|Other|2
7088297|NCT02212457|11203162|FG003|Overall Study|Other|1
7088298|NCT02212457|11203163|FG004|Overall Study|Other|0
7088299|NCT02212457|11203164|FG005|Overall Study|Other|1
7088300|NCT02212678|11203189|FG000|Overall Study|Adverse Event|1
7088301|NCT02212730|11203195|FG000|Overall Study|Tumor not of the required cell histology|1
7088302|NCT02212730|11203196|FG001|Overall Study|Tumor not of the required cell histology|0
7088303|NCT02212730|11203195|FG000|Overall Study|Withdrawal by Subject|1
7088304|NCT02212730|11203196|FG001|Overall Study|Withdrawal by Subject|0
7088305|NCT02212730|11203195|FG000|Overall Study|Disease progression prior to RCC surgery|0
7088306|NCT02212730|11203196|FG001|Overall Study|Disease progression prior to RCC surgery|1
7088307|NCT02213042|11203225|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14
7088308|NCT02213042|11203226|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13
7088309|NCT02213042|11203227|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8
7088310|NCT02213042|11203225|FG000|Overall Study|Adverse Event|2
7088311|NCT02213042|11203226|FG001|Overall Study|Adverse Event|1
7088312|NCT02213042|11203227|FG002|Overall Study|Adverse Event|0
7088313|NCT02213042|11203225|FG000|Overall Study|Withdrawal by Subject|0
7088314|NCT02213042|11203226|FG001|Overall Study|Withdrawal by Subject|1
7088315|NCT02213042|11203227|FG002|Overall Study|Withdrawal by Subject|1
7088316|NCT02213042|11203225|FG000|Overall Study|Protocol Violation|1
7088317|NCT02213042|11203226|FG001|Overall Study|Protocol Violation|0
7088318|NCT02213042|11203227|FG002|Overall Study|Protocol Violation|0
7088319|NCT02213042|11203225|FG000|Overall Study|Investigator discretion|0
7088320|NCT02213042|11203226|FG001|Overall Study|Investigator discretion|0
7088321|NCT02213042|11203227|FG002|Overall Study|Investigator discretion|1
7088322|NCT02213055|11203239|FG000|Overall Study|Protocol was not Followed at Enrollment|5
7088323|NCT02213055|11203240|FG001|Overall Study|Protocol was not Followed at Enrollment|0
7088324|NCT02213055|11203239|FG000|Overall Study|Protocol was not Followed during Study|1
7088325|NCT02213055|11203240|FG001|Overall Study|Protocol was not Followed during Study|0
7088326|NCT02213055|11203239|FG000|Overall Study|Documentation Issue at Enrollment|1
7088327|NCT02213055|11203240|FG001|Overall Study|Documentation Issue at Enrollment|0
7088328|NCT02213055|11203239|FG000|Overall Study|Documentation Issue during Study|10
7088329|NCT02213055|11203240|FG001|Overall Study|Documentation Issue during Study|0
7088330|NCT02213055|11203239|FG000|Overall Study|Did not have Live Lice|8
7088331|NCT02213055|11203240|FG001|Overall Study|Did not have Live Lice|0
7088332|NCT02213055|11203239|FG000|Overall Study|Had another Treatment during the Study|3
7088333|NCT02213055|11203240|FG001|Overall Study|Had another Treatment during the Study|0
7088334|NCT02213055|11203239|FG000|Overall Study|Did not meet Inclusion Criteria|6
7088335|NCT02213055|11203240|FG001|Overall Study|Did not meet Inclusion Criteria|0
7088336|NCT02213055|11203239|FG000|Overall Study|Did not Return to School|5
7088337|NCT02213055|11203240|FG001|Overall Study|Did not Return to School|0
7088338|NCT02213094|11203261|FG000|Overall Study|Adverse Event|1
7088339|NCT02213094|11203262|FG001|Overall Study|Adverse Event|0
7088340|NCT02213133|11203271|FG000|Overall Study|Participant discontinued study therapy|2
7088341|NCT02213133|11203272|FG001|Overall Study|Participant discontinued study therapy|0
7088342|NCT02213133|11203273|FG002|Overall Study|Participant discontinued study therapy|0
7088343|NCT02213133|11203271|FG000|Overall Study|Participant withdrew informed consent|2
7088344|NCT02213133|11203272|FG001|Overall Study|Participant withdrew informed consent|1
7088345|NCT02213133|11203273|FG002|Overall Study|Participant withdrew informed consent|2
7088346|NCT02213133|11203271|FG000|Overall Study|Disease progression|11
7088347|NCT02213133|11203272|FG001|Overall Study|Disease progression|2
7088348|NCT02213133|11203273|FG002|Overall Study|Disease progression|0
7088349|NCT02213133|11203271|FG000|Overall Study|Adverse Event (AE)|1
7088350|NCT02213133|11203272|FG001|Overall Study|Adverse Event (AE)|0
7088351|NCT02213133|11203273|FG002|Overall Study|Adverse Event (AE)|0
7088352|NCT02213133|11203271|FG000|Overall Study|Death|16
7088353|NCT02213133|11203272|FG001|Overall Study|Death|2
7088354|NCT02213133|11203273|FG002|Overall Study|Death|1
7088355|NCT02213133|11203271|FG000|Overall Study|Other|5
7088356|NCT02213133|11203272|FG001|Overall Study|Other|0
7088357|NCT02213133|11203273|FG002|Overall Study|Other|0
7088358|NCT02213198|11203284|FG000|Baseline|No show for intake|7
7088359|NCT02213198|11203285|FG001|Baseline|No show for intake|9
7088360|NCT02213198|11203284|FG000|Baseline|Withdrawal by Subject|34
7088361|NCT02213198|11203285|FG001|Baseline|Withdrawal by Subject|11
7088362|NCT02213198|11203284|FG000|Baseline|transferred out of clinic|7
7088363|NCT02213198|11203285|FG001|Baseline|transferred out of clinic|9
7088364|NCT02213198|11203284|FG000|Baseline|Lost to Follow-up|40
7088365|NCT02213198|11203285|FG001|Baseline|Lost to Follow-up|21
7088366|NCT02213198|11203284|FG000|Baseline|incarcerated,violent|0
7088367|NCT02213198|11203285|FG001|Baseline|incarcerated,violent|1
7088368|NCT02213198|11203284|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
7088369|NCT02213198|11203285|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
7088370|NCT02213198|11203284|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3
7088371|NCT02213198|11203285|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2
7088372|NCT02213198|11203284|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1
7088373|NCT02213198|11203285|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0
7088374|NCT02213198|11203284|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68
7088375|NCT02213198|11203285|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25
7088376|NCT02213198|11203284|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17
7088377|NCT02213198|11203285|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10
7088378|NCT02213198|11203284|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23
7088379|NCT02213198|11203285|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7
7088380|NCT02213263|11203301|FG000|Overall Study|Insufficient clinical response|4
7088381|NCT02213263|11203302|FG001|Overall Study|Insufficient clinical response|3
7088382|NCT02213263|11203301|FG000|Overall Study|Lost to Follow-up|0
7088383|NCT02213263|11203302|FG001|Overall Study|Lost to Follow-up|1
7088384|NCT02213263|11203301|FG000|Overall Study|No longer willing to participate|3
7088385|NCT02213263|11203302|FG001|Overall Study|No longer willing to participate|4
7088386|NCT02213263|11203301|FG000|Overall Study|Progressive disease|20
7088387|NCT02213263|11203302|FG001|Overall Study|Progressive disease|14
7088388|NCT02213263|11203301|FG000|Overall Study|Protocol Violation|0
7088389|NCT02213263|11203302|FG001|Overall Study|Protocol Violation|1
7088390|NCT02213263|11203301|FG000|Overall Study|Adverse Event|1
7088391|NCT02213263|11203302|FG001|Overall Study|Adverse Event|3
7088392|NCT02213458|11203323|FG000|Overall Study|No longer meets criteria: caregiver deceased|4
7088393|NCT02213458|11203324|FG001|Overall Study|No longer meets criteria: caregiver deceased|0
7088394|NCT02213458|11203323|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4
7088395|NCT02213458|11203324|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0
7088396|NCT02213458|11203323|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2
7088397|NCT02213458|11203324|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0
7088398|NCT02213458|11203323|FG000|Overall Study|No longer meets criteria: patient moved out of state|10
7088399|NCT02213458|11203324|FG001|Overall Study|No longer meets criteria: patient moved out of state|0
7088400|NCT02213458|11203323|FG000|Overall Study|Refused re-consent|6
7088401|NCT02213458|11203324|FG001|Overall Study|Refused re-consent|0
7088402|NCT02213458|11203323|FG000|Overall Study|Lost to Follow-up|2
7088403|NCT02213458|11203324|FG001|Overall Study|Lost to Follow-up|2
7088404|NCT02213458|11203323|FG000|Overall Study|Withdrawal by Subject|26
7088405|NCT02213458|11203324|FG001|Overall Study|Withdrawal by Subject|8
7088406|NCT02213510|11203332|FG000|Overall Study|Death|0
7088407|NCT02213510|11203333|FG001|Overall Study|Death|1
7088408|NCT02213510|11203332|FG000|Overall Study|Lost to Follow-up|1
7088409|NCT02213510|11203333|FG001|Overall Study|Lost to Follow-up|0
7088410|NCT02213666|11203339|FG000|Overall Study|Withdrawal by Subject|1
7088411|NCT02214121|11203364|FG000|Part A|Patient decision|2
7088412|NCT02214121|11203365|FG001|Part A|Patient decision|0
7088413|NCT02214121|11203366|FG002|Part A|Patient decision|0
7088414|NCT02214121|11203364|FG000|Part A|Dev. of study-specific withdrawal crit.|4
7088415|NCT02214121|11203365|FG001|Part A|Dev. of study-specific withdrawal crit.|0
7088416|NCT02214121|11203366|FG002|Part A|Dev. of study-specific withdrawal crit.|0
7088417|NCT02214121|11203364|FG000|Part A|Other|1
7088418|NCT02214121|11203365|FG001|Part A|Other|0
7088419|NCT02214121|11203366|FG002|Part A|Other|0
7088420|NCT02214121|11203364|FG000|Part B|Patient decision|0
7088421|NCT02214121|11203365|FG001|Part B|Patient decision|1
7088422|NCT02214121|11203366|FG002|Part B|Patient decision|0
7088423|NCT02214121|11203364|FG000|Part B|Dev. of study-specific withdrawal crit.|0
7088424|NCT02214121|11203365|FG001|Part B|Dev. of study-specific withdrawal crit.|2
7088425|NCT02214121|11203366|FG002|Part B|Dev. of study-specific withdrawal crit.|0
7088426|NCT02214121|11203364|FG000|Part B|Lost to Follow-up|0
7088427|NCT02214121|11203365|FG001|Part B|Lost to Follow-up|0
7088428|NCT02214121|11203366|FG002|Part B|Lost to Follow-up|1
7088429|NCT02214186|11203401|FG000|Overall Study|Lost to Follow-up|1
7088430|NCT02214186|11203402|FG001|Overall Study|Lost to Follow-up|1
7088431|NCT02214186|11203401|FG000|Overall Study|Protocol Violation|1
7088432|NCT02214186|11203402|FG001|Overall Study|Protocol Violation|1
7088433|NCT02214225|11203425|FG000|Overall Study|Lost to Follow-up|46
7088434|NCT02214225|11203426|FG001|Overall Study|Lost to Follow-up|18
7088435|NCT02214225|11203427|FG002|Overall Study|Lost to Follow-up|18
7088436|NCT02214225|11203425|FG000|Overall Study|Withdrawal by Subject|2
7088437|NCT02214225|11203426|FG001|Overall Study|Withdrawal by Subject|0
7088438|NCT02214225|11203427|FG002|Overall Study|Withdrawal by Subject|2
7088439|NCT02214225|11203425|FG000|Overall Study|Death|5
7088440|NCT02214225|11203426|FG001|Overall Study|Death|0
7088441|NCT02214225|11203427|FG002|Overall Study|Death|1
7088442|NCT02214225|11203425|FG000|Overall Study|randomized in error, not vaccinated|2
7088443|NCT02214225|11203426|FG001|Overall Study|randomized in error, not vaccinated|1
7088444|NCT02214225|11203427|FG002|Overall Study|randomized in error, not vaccinated|1
7088445|NCT02215252|11203555|FG000|Overall Study|Adverse Event|1
7088446|NCT02215252|11203556|FG001|Overall Study|Adverse Event|5
7088447|NCT02215252|11203557|FG002|Overall Study|Adverse Event|2
7088448|NCT02215252|11203555|FG000|Overall Study|Lost to Follow-up|0
7088449|NCT02215252|11203556|FG001|Overall Study|Lost to Follow-up|0
7088450|NCT02215252|11203557|FG002|Overall Study|Lost to Follow-up|1
7088451|NCT02215252|11203555|FG000|Overall Study|Does not Meet Entrance Criteria|0
7088452|NCT02215252|11203556|FG001|Overall Study|Does not Meet Entrance Criteria|1
7088453|NCT02215252|11203557|FG002|Overall Study|Does not Meet Entrance Criteria|0
7088454|NCT02215252|11203555|FG000|Overall Study|Protocol Violation|0
7088455|NCT02215252|11203556|FG001|Overall Study|Protocol Violation|1
7088456|NCT02215252|11203557|FG002|Overall Study|Protocol Violation|0
7088457|NCT02215252|11203555|FG000|Overall Study|Withdrawal by Subject|1
7088458|NCT02215252|11203556|FG001|Overall Study|Withdrawal by Subject|0
7088459|NCT02215252|11203557|FG002|Overall Study|Withdrawal by Subject|0
7088460|NCT02215252|11203555|FG000|Overall Study|Other|0
7088461|NCT02215252|11203556|FG001|Overall Study|Other|1
7088462|NCT02215252|11203557|FG002|Overall Study|Other|1
7088463|NCT02215616|11203573|FG000|Overall Study|Sponsor requested to stop study drug|0
7088464|NCT02215616|11203574|FG001|Overall Study|Sponsor requested to stop study drug|0
7088465|NCT02215616|11203575|FG002|Overall Study|Sponsor requested to stop study drug|1
7088466|NCT02215616|11203576|FG003|Overall Study|Sponsor requested to stop study drug|4
7088467|NCT02215616|11203573|FG000|Overall Study|Death|1
7088468|NCT02215616|11203574|FG001|Overall Study|Death|0
7088469|NCT02215616|11203575|FG002|Overall Study|Death|0
7088470|NCT02215616|11203576|FG003|Overall Study|Death|0
7088471|NCT02215616|11203573|FG000|Overall Study|Adverse Event|7
7088472|NCT02215616|11203574|FG001|Overall Study|Adverse Event|4
7088473|NCT02215616|11203575|FG002|Overall Study|Adverse Event|9
7088474|NCT02215616|11203576|FG003|Overall Study|Adverse Event|2
7088475|NCT02215616|11203573|FG000|Overall Study|Withdrawal by Subject|1
7088476|NCT02215616|11203574|FG001|Overall Study|Withdrawal by Subject|8
7088477|NCT02215616|11203575|FG002|Overall Study|Withdrawal by Subject|2
7088478|NCT02215616|11203576|FG003|Overall Study|Withdrawal by Subject|5
7088479|NCT02215616|11203573|FG000|Overall Study|Non-compliance|0
7088480|NCT02215616|11203574|FG001|Overall Study|Non-compliance|2
7088481|NCT02215616|11203575|FG002|Overall Study|Non-compliance|1
7088482|NCT02215616|11203576|FG003|Overall Study|Non-compliance|0
7088483|NCT02215616|11203573|FG000|Overall Study|Protocol Violation|0
7088484|NCT02215616|11203574|FG001|Overall Study|Protocol Violation|2
7088485|NCT02215616|11203575|FG002|Overall Study|Protocol Violation|0
7088486|NCT02215616|11203576|FG003|Overall Study|Protocol Violation|0
7088487|NCT02215616|11203573|FG000|Overall Study|Lost to Follow-up|1
7088488|NCT02215616|11203574|FG001|Overall Study|Lost to Follow-up|1
7088489|NCT02215616|11203575|FG002|Overall Study|Lost to Follow-up|0
7088490|NCT02215616|11203576|FG003|Overall Study|Lost to Follow-up|1
7088491|NCT02215616|11203573|FG000|Overall Study|Other than specified|1
7088492|NCT02215616|11203574|FG001|Overall Study|Other than specified|0
7088493|NCT02215616|11203575|FG002|Overall Study|Other than specified|1
7088494|NCT02215616|11203576|FG003|Overall Study|Other than specified|1
7088495|NCT02215954|11203589|FG000|Overall Study|Adverse Event|0
7088496|NCT02215954|11203590|FG001|Overall Study|Adverse Event|0
7088497|NCT02215954|11203591|FG002|Overall Study|Adverse Event|1
7088498|NCT02215954|11203589|FG000|Overall Study|Withdrawal by Subject|0
7088499|NCT02215954|11203590|FG001|Overall Study|Withdrawal by Subject|0
7088500|NCT02215954|11203591|FG002|Overall Study|Withdrawal by Subject|2
7088501|NCT02215954|11203589|FG000|Overall Study|Not exposed|1
7088502|NCT02215954|11203590|FG001|Overall Study|Not exposed|1
7088503|NCT02215954|11203591|FG002|Overall Study|Not exposed|3
7088504|NCT02215967|11203604|FG000|Overall Study|Patient became ineligible for treatment|0
7088505|NCT02215967|11203605|FG001|Overall Study|Patient became ineligible for treatment|0
7088506|NCT02215967|11203606|FG002|Overall Study|Patient became ineligible for treatment|0
7088507|NCT02215967|11203607|FG003|Overall Study|Patient became ineligible for treatment|3
7088508|NCT02215967|11203604|FG000|Overall Study|Patient did not get CAR T-Cells|0
7088509|NCT02215967|11203605|FG001|Overall Study|Patient did not get CAR T-Cells|0
7088510|NCT02215967|11203606|FG002|Overall Study|Patient did not get CAR T-Cells|1
7088511|NCT02215967|11203607|FG003|Overall Study|Patient did not get CAR T-Cells|0
7088512|NCT02216071|11203619|FG000|Overall Study|Withdrawal by Subject|7
7088513|NCT02216071|11203620|FG001|Overall Study|Withdrawal by Subject|2
7088514|NCT02216071|11203619|FG000|Overall Study|Lost to Follow-up|3
7088515|NCT02216071|11203620|FG001|Overall Study|Lost to Follow-up|3
7088516|NCT02216071|11203619|FG000|Overall Study|Protocol Violation|3
7088517|NCT02216071|11203620|FG001|Overall Study|Protocol Violation|5
7088518|NCT02216071|11203619|FG000|Overall Study|Other|2
7088519|NCT02216071|11203620|FG001|Overall Study|Other|2
7088520|NCT02216123|11203637|FG000|Overall Study|Lost to Follow-up|4
7088521|NCT02216123|11203638|FG001|Overall Study|Lost to Follow-up|2
7088522|NCT02216123|11203637|FG000|Overall Study|Withdrawal by Subject|2
7088523|NCT02216123|11203638|FG001|Overall Study|Withdrawal by Subject|0
7088524|NCT02216214|11203663|FG000|Overall Study|Randomized Never Received Study Drug|1
7088525|NCT02216214|11203664|FG001|Overall Study|Randomized Never Received Study Drug|0
7088526|NCT02216214|11203663|FG000|Overall Study|Adverse Event|10
7088527|NCT02216214|11203664|FG001|Overall Study|Adverse Event|8
7088528|NCT02216214|11203663|FG000|Overall Study|Lack of Efficacy|2
7088529|NCT02216214|11203664|FG001|Overall Study|Lack of Efficacy|2
7088530|NCT02216214|11203663|FG000|Overall Study|Lost to Follow-up|3
7088531|NCT02216214|11203664|FG001|Overall Study|Lost to Follow-up|2
7088532|NCT02216214|11203663|FG000|Overall Study|Protocol Violation|4
7088533|NCT02216214|11203664|FG001|Overall Study|Protocol Violation|2
7088534|NCT02216214|11203663|FG000|Overall Study|Withdrawal by Subject|22
7088535|NCT02216214|11203664|FG001|Overall Study|Withdrawal by Subject|20
7088536|NCT02216214|11203663|FG000|Overall Study|Study Terminated By Sponsor|0
7088537|NCT02216214|11203664|FG001|Overall Study|Study Terminated By Sponsor|1
7088538|NCT02216214|11203663|FG000|Overall Study|Miscellaneous|1
7088539|NCT02216214|11203664|FG001|Overall Study|Miscellaneous|1
7088540|NCT02216357|11203672|FG000|Overall Study|Inclusion or exclusion criteria not met|2
7088541|NCT02216357|11203673|FG001|Overall Study|Inclusion or exclusion criteria not met|1
7088542|NCT02216526|11203686|FG000|Overall Study|Adverse Event|1
7088543|NCT02216526|11203687|FG001|Overall Study|Adverse Event|1
7088544|NCT02216526|11203688|FG002|Overall Study|Adverse Event|0
7088545|NCT02216526|11203686|FG000|Overall Study|Death|0
7088546|NCT02216526|11203687|FG001|Overall Study|Death|1
7088547|NCT02216526|11203688|FG002|Overall Study|Death|3
7088548|NCT02216526|11203686|FG000|Overall Study|Protocol Violation|2
7088549|NCT02216526|11203687|FG001|Overall Study|Protocol Violation|0
7088550|NCT02216526|11203688|FG002|Overall Study|Protocol Violation|2
7088551|NCT02216526|11203686|FG000|Overall Study|Hospitalization|2
7088552|NCT02216526|11203687|FG001|Overall Study|Hospitalization|1
7088553|NCT02216526|11203688|FG002|Overall Study|Hospitalization|3
7088554|NCT02216591|11203698|FG000|Overall Study|Lost to Follow-up|0
7088555|NCT02216591|11203699|FG001|Overall Study|Lost to Follow-up|1
7088556|NCT02216773|11203716|FG000|Overall Study|Disease progression|4
7088557|NCT02216773|11203717|FG001|Overall Study|Disease progression|2
7088558|NCT02216773|11203716|FG000|Overall Study|Insufficient FLRV|4
7088559|NCT02216773|11203717|FG001|Overall Study|Insufficient FLRV|0
7088560|NCT02216773|11203716|FG000|Overall Study|Abandoned|4
7088561|NCT02216773|11203717|FG001|Overall Study|Abandoned|3
7088562|NCT02216812|11203725|FG000|Overall Study|Lost to Follow-up|10
7088563|NCT02216812|11203726|FG001|Overall Study|Lost to Follow-up|5
7088564|NCT02217280|11203741|FG000|Overall Study|Withdrawal by Subject|2
7088565|NCT02217280|11203741|FG000|Overall Study|Post-consent sceen fail|2
7088566|NCT02217332|11203746|FG000|Overall Study|Adverse Event|3
7088567|NCT02217332|11203746|FG000|Overall Study|Dose interruption >1 month|1
7088568|NCT02217332|11203746|FG000|Overall Study|Protocol Violation (eligibility)|1
7088569|NCT02217332|11203746|FG000|Overall Study|Withdrawal by Subject|1
7088570|NCT02217332|11203746|FG000|Overall Study|Lost to Follow-up|1
7088571|NCT02217410|11203753|FG000|Overall Study|Graft Loss|0
7088572|NCT02217410|11203754|FG001|Overall Study|Graft Loss|0
7088573|NCT02217410|11203755|FG002|Overall Study|Graft Loss|2
7088574|NCT02217410|11203753|FG000|Overall Study|Withdrawal by Subject|0
7088575|NCT02217410|11203754|FG001|Overall Study|Withdrawal by Subject|0
7088576|NCT02217410|11203755|FG002|Overall Study|Withdrawal by Subject|2
7088577|NCT02217410|11203753|FG000|Overall Study|Lost to Follow-up|0
7088578|NCT02217410|11203754|FG001|Overall Study|Lost to Follow-up|0
7088579|NCT02217410|11203755|FG002|Overall Study|Lost to Follow-up|1
7088580|NCT02217410|11203753|FG000|Overall Study|Lack of Efficacy|0
7088581|NCT02217410|11203754|FG001|Overall Study|Lack of Efficacy|1
7088582|NCT02217410|11203755|FG002|Overall Study|Lack of Efficacy|0
7088583|NCT02217410|11203753|FG000|Overall Study|Physician Decision|1
7088584|NCT02217410|11203754|FG001|Overall Study|Physician Decision|3
7088585|NCT02217410|11203755|FG002|Overall Study|Physician Decision|0
7088586|NCT02217436|11203770|FG000|Overall Study|Protocol Violation|1
7088587|NCT02217436|11203771|FG001|Overall Study|Protocol Violation|1
7088588|NCT02217436|11203770|FG000|Overall Study|Incomplete data|0
7088589|NCT02217436|11203771|FG001|Overall Study|Incomplete data|1
7088590|NCT02217475|11203780|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0
7088591|NCT02217475|11203781|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1
7088592|NCT02217475|11203782|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0
7088593|NCT02217475|11203780|FG000|Treatment Period 1 (Year 1)|Adverse Event|4
7088594|NCT02217475|11203781|FG001|Treatment Period 1 (Year 1)|Adverse Event|5
7088595|NCT02217475|11203782|FG002|Treatment Period 1 (Year 1)|Adverse Event|9
7088596|NCT02217475|11203780|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1
7088597|NCT02217475|11203781|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0
7088598|NCT02217475|11203782|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0
7088599|NCT02217475|11203780|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5
7088600|NCT02217475|11203781|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2
7088601|NCT02217475|11203782|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11
7088602|NCT02217475|11203780|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0
7088603|NCT02217475|11203781|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0
7088604|NCT02217475|11203782|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1
7088605|NCT02217475|11203780|FG000|Discontinued After Period 1|Adverse Event|1
7088606|NCT02217475|11203781|FG001|Discontinued After Period 1|Adverse Event|2
7088607|NCT02217475|11203782|FG002|Discontinued After Period 1|Adverse Event|0
7088608|NCT02217475|11203780|FG000|Discontinued After Period 1|Participant Withdrew Consent|1
7088609|NCT02217475|11203781|FG001|Discontinued After Period 1|Participant Withdrew Consent|1
7088610|NCT02217475|11203782|FG002|Discontinued After Period 1|Participant Withdrew Consent|2
7088611|NCT02217475|11203780|FG000|Discontinued After Period 1|Physician Decision|0
7088612|NCT02217475|11203781|FG001|Discontinued After Period 1|Physician Decision|0
7088613|NCT02217475|11203782|FG002|Discontinued After Period 1|Physician Decision|1
7088614|NCT02217475|11203780|FG000|Treatment Period 2 (Year 2)|Adverse Event|0
7088615|NCT02217475|11203781|FG001|Treatment Period 2 (Year 2)|Adverse Event|1
7088616|NCT02217475|11203782|FG002|Treatment Period 2 (Year 2)|Adverse Event|5
7088617|NCT02217475|11203780|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0
7088618|NCT02217475|11203781|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1
7088619|NCT02217475|11203782|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2
7088620|NCT02217475|11203780|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2
7088621|NCT02217475|11203781|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0
7088622|NCT02217475|11203782|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2
7088623|NCT02217475|11203780|FG000|Treatment Period 2 (Year 2)|Physician Decision|0
7088624|NCT02217475|11203781|FG001|Treatment Period 2 (Year 2)|Physician Decision|0
7088625|NCT02217475|11203782|FG002|Treatment Period 2 (Year 2)|Physician Decision|2
7088626|NCT02217475|11203780|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0
7088627|NCT02217475|11203781|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0
7088628|NCT02217475|11203782|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1
7088629|NCT02217501|11203801|FG000|Overall Study|Death|3
7088630|NCT02217501|11203802|FG001|Overall Study|Death|4
7088631|NCT02217527|11203810|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1
7088632|NCT02217527|11203811|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3
7088633|NCT02217527|11203810|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0
7088634|NCT02217527|11203811|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1
7088635|NCT02217566|11203817|FG000|Overall Study|Lost to Follow-up|2
7088636|NCT02217566|11203817|FG000|Overall Study|Death|3
7088637|NCT02217566|11203817|FG000|Overall Study|Early study termination|6
7088638|NCT02217878|11203839|FG000|Overall Study|required morphine due to chest pain|1
7088639|NCT02217878|11203840|FG001|Overall Study|required morphine due to chest pain|2
7088640|NCT02217878|11203839|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1
7088641|NCT02217878|11203840|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0
7088642|NCT02217982|11203871|FG000|Overall Study|Trial discontinued|1
7088643|NCT02217982|11203872|FG001|Overall Study|Trial discontinued|0
7088644|NCT02217982|11203871|FG000|Overall Study|Adverse Event|0
7088645|NCT02217982|11203872|FG001|Overall Study|Adverse Event|1
7088646|NCT02218008|11203881|FG000|Stage 1 (S1)|Adverse Event|6
7088647|NCT02218008|11203882|FG001|Stage 1 (S1)|Adverse Event|5
7088648|NCT02218008|11203883|FG002|Stage 1 (S1)|Adverse Event|11
7088649|NCT02218008|11203884|FG003|Stage 1 (S1)|Adverse Event|0
7088650|NCT02218008|11203885|FG004|Stage 1 (S1)|Adverse Event|0
7088651|NCT02218008|11203886|FG005|Stage 1 (S1)|Adverse Event|0
7088652|NCT02218008|11203881|FG000|Stage 1 (S1)|Withdrawal by Subject|6
7088653|NCT02218008|11203882|FG001|Stage 1 (S1)|Withdrawal by Subject|1
7088654|NCT02218008|11203883|FG002|Stage 1 (S1)|Withdrawal by Subject|1
7088655|NCT02218008|11203884|FG003|Stage 1 (S1)|Withdrawal by Subject|0
7088656|NCT02218008|11203885|FG004|Stage 1 (S1)|Withdrawal by Subject|0
7088657|NCT02218008|11203886|FG005|Stage 1 (S1)|Withdrawal by Subject|0
7088658|NCT02218008|11203881|FG000|Stage 1 (S1)|Lack of Efficacy|3
7088659|NCT02218008|11203882|FG001|Stage 1 (S1)|Lack of Efficacy|0
7088660|NCT02218008|11203883|FG002|Stage 1 (S1)|Lack of Efficacy|0
7088661|NCT02218008|11203884|FG003|Stage 1 (S1)|Lack of Efficacy|0
7088662|NCT02218008|11203885|FG004|Stage 1 (S1)|Lack of Efficacy|0
7088663|NCT02218008|11203886|FG005|Stage 1 (S1)|Lack of Efficacy|0
7088664|NCT02218008|11203881|FG000|Stage 1 (S1)|Lost to Follow-up|3
7088665|NCT02218008|11203882|FG001|Stage 1 (S1)|Lost to Follow-up|0
7088666|NCT02218008|11203883|FG002|Stage 1 (S1)|Lost to Follow-up|1
7088667|NCT02218008|11203884|FG003|Stage 1 (S1)|Lost to Follow-up|0
7088668|NCT02218008|11203885|FG004|Stage 1 (S1)|Lost to Follow-up|0
7088669|NCT02218008|11203886|FG005|Stage 1 (S1)|Lost to Follow-up|0
7088670|NCT02218008|11203881|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2
7088671|NCT02218008|11203882|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1
7088672|NCT02218008|11203883|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0
7088673|NCT02218008|11203884|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0
7088674|NCT02218008|11203885|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0
7088675|NCT02218008|11203886|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0
7088676|NCT02218008|11203881|FG000|Stage 1 (S1)|Non-compliance; drug use|1
7088677|NCT02218008|11203882|FG001|Stage 1 (S1)|Non-compliance; drug use|0
7088678|NCT02218008|11203883|FG002|Stage 1 (S1)|Non-compliance; drug use|0
7088679|NCT02218008|11203884|FG003|Stage 1 (S1)|Non-compliance; drug use|0
7088680|NCT02218008|11203885|FG004|Stage 1 (S1)|Non-compliance; drug use|0
7088681|NCT02218008|11203886|FG005|Stage 1 (S1)|Non-compliance; drug use|0
7088682|NCT02218008|11203881|FG000|Stage 1 (S1)|Pregnancy|0
7088683|NCT02218008|11203882|FG001|Stage 1 (S1)|Pregnancy|0
7088684|NCT02218008|11203883|FG002|Stage 1 (S1)|Pregnancy|1
7088685|NCT02218008|11203884|FG003|Stage 1 (S1)|Pregnancy|0
7088686|NCT02218008|11203885|FG004|Stage 1 (S1)|Pregnancy|0
7088687|NCT02218008|11203886|FG005|Stage 1 (S1)|Pregnancy|0
7088688|NCT02218008|11203881|FG000|Stage 1 (S1)|Protocol Violation|0
7088689|NCT02218008|11203882|FG001|Stage 1 (S1)|Protocol Violation|0
7088690|NCT02218008|11203883|FG002|Stage 1 (S1)|Protocol Violation|1
7088691|NCT02218008|11203884|FG003|Stage 1 (S1)|Protocol Violation|0
7088692|NCT02218008|11203885|FG004|Stage 1 (S1)|Protocol Violation|0
7088693|NCT02218008|11203886|FG005|Stage 1 (S1)|Protocol Violation|0
7088694|NCT02218008|11203881|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1
7088695|NCT02218008|11203882|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
7088696|NCT02218008|11203883|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
7088697|NCT02218008|11203884|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
7088698|NCT02218008|11203885|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
7088699|NCT02218008|11203886|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
7088700|NCT02218008|11203881|FG000|Stage 2 (S2)|Adverse Event|0
7088701|NCT02218008|11203882|FG001|Stage 2 (S2)|Adverse Event|0
7088702|NCT02218008|11203883|FG002|Stage 2 (S2)|Adverse Event|0
7088703|NCT02218008|11203884|FG003|Stage 2 (S2)|Adverse Event|2
7088704|NCT02218008|11203885|FG004|Stage 2 (S2)|Adverse Event|3
7088705|NCT02218008|11203886|FG005|Stage 2 (S2)|Adverse Event|3
7088706|NCT02218008|11203881|FG000|Stage 2 (S2)|Withdrawal by Subject|0
7088707|NCT02218008|11203882|FG001|Stage 2 (S2)|Withdrawal by Subject|0
7088708|NCT02218008|11203883|FG002|Stage 2 (S2)|Withdrawal by Subject|0
7088709|NCT02218008|11203884|FG003|Stage 2 (S2)|Withdrawal by Subject|1
7088710|NCT02218008|11203885|FG004|Stage 2 (S2)|Withdrawal by Subject|1
7088711|NCT02218008|11203886|FG005|Stage 2 (S2)|Withdrawal by Subject|0
7088712|NCT02218008|11203881|FG000|Stage 2 (S2)|Lack of Efficacy|0
7088713|NCT02218008|11203882|FG001|Stage 2 (S2)|Lack of Efficacy|0
7088714|NCT02218008|11203883|FG002|Stage 2 (S2)|Lack of Efficacy|0
7088715|NCT02218008|11203884|FG003|Stage 2 (S2)|Lack of Efficacy|0
7088716|NCT02218008|11203885|FG004|Stage 2 (S2)|Lack of Efficacy|0
7088717|NCT02218008|11203886|FG005|Stage 2 (S2)|Lack of Efficacy|2
7088718|NCT02218008|11203881|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
7088719|NCT02218008|11203882|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
7088720|NCT02218008|11203883|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
7088721|NCT02218008|11203884|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1
7088722|NCT02218008|11203885|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
7088723|NCT02218008|11203886|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
7088724|NCT02218008|11203881|FG000|Stage 2 (S2)|Lost to Follow-up|0
7088725|NCT02218008|11203882|FG001|Stage 2 (S2)|Lost to Follow-up|0
7088726|NCT02218008|11203883|FG002|Stage 2 (S2)|Lost to Follow-up|0
7088727|NCT02218008|11203884|FG003|Stage 2 (S2)|Lost to Follow-up|0
7088728|NCT02218008|11203885|FG004|Stage 2 (S2)|Lost to Follow-up|0
7088729|NCT02218008|11203886|FG005|Stage 2 (S2)|Lost to Follow-up|1
7088730|NCT02218216|11203933|FG000|Overall Study|Study terminated before completed|6
7088731|NCT02218216|11203934|FG001|Overall Study|Study terminated before completed|0
7088732|NCT02218216|11203935|FG002|Overall Study|Study terminated before completed|0
7088733|NCT02218268|11203947|FG000|24 Hour Washout|Physician Decision|11
7088734|NCT02218268|11203948|FG001|24 Hour Washout|Physician Decision|9
7088735|NCT02218372|11203974|FG000|Overall Study|Adverse Event|1
7088736|NCT02218372|11203975|FG001|Overall Study|Adverse Event|1
7088737|NCT02218372|11203974|FG000|Overall Study|Miscellaneous|2
7088738|NCT02218372|11203975|FG001|Overall Study|Miscellaneous|1
7088739|NCT02218372|11203974|FG000|Overall Study|Randomized but did not receive treatment|2
7088740|NCT02218372|11203975|FG001|Overall Study|Randomized but did not receive treatment|3
7088741|NCT02218372|11203974|FG000|Overall Study|Withdrawal by Parent/Guardian|0
7088742|NCT02218372|11203975|FG001|Overall Study|Withdrawal by Parent/Guardian|1
7088743|NCT02218489|11204006|FG000|Overall Study|Withdrawal by Subject|4
7088744|NCT02218489|11204007|FG001|Overall Study|Withdrawal by Subject|3
7088745|NCT02218489|11204006|FG000|Overall Study|Lost to Follow-up|1
7088746|NCT02218489|11204007|FG001|Overall Study|Lost to Follow-up|0
7088747|NCT02218541|11204016|FG000|Overall Study|Lost to Follow-up|2
7088748|NCT02218541|11204017|FG001|Overall Study|Lost to Follow-up|1
7088749|NCT02218541|11204016|FG000|Overall Study|Implant Failure|4
7088750|NCT02218541|11204017|FG001|Overall Study|Implant Failure|1
7088751|NCT02218736|11204026|FG000|Overall Study|Withdrawal by Subject|10
7088752|NCT02218736|11204027|FG001|Overall Study|Withdrawal by Subject|9
7088753|NCT02218736|11204026|FG000|Overall Study|Protocol Violation|2
7088754|NCT02218736|11204027|FG001|Overall Study|Protocol Violation|0
7088755|NCT02219009|11204035|FG000|Overall Study|Withdrawal by Subject|5
7088756|NCT02219009|11204036|FG001|Overall Study|Withdrawal by Subject|1
7088757|NCT02219009|11204035|FG000|Overall Study|Adverse Event|2
7088758|NCT02219009|11204036|FG001|Overall Study|Adverse Event|4
7088759|NCT02219009|11204035|FG000|Overall Study|Lost to Follow-up|2
7088760|NCT02219009|11204036|FG001|Overall Study|Lost to Follow-up|2
7088761|NCT02219009|11204035|FG000|Overall Study|Protocol deviation|1
7088762|NCT02219009|11204036|FG001|Overall Study|Protocol deviation|0
7088763|NCT02219009|11204035|FG000|Overall Study|Physician Decision|0
7088764|NCT02219009|11204036|FG001|Overall Study|Physician Decision|1
7088765|NCT02219048|11204044|FG000|Overall Study|Adverse Event|2
7088766|NCT02219048|11204045|FG001|Overall Study|Adverse Event|5
7088767|NCT02219048|11204044|FG000|Overall Study|No longer meets eligibility criteria|1
7088768|NCT02219048|11204045|FG001|Overall Study|No longer meets eligibility criteria|0
7088769|NCT02219048|11204044|FG000|Overall Study|Study terminated by sponsor|16
7088770|NCT02219048|11204045|FG001|Overall Study|Study terminated by sponsor|15
7088771|NCT02219048|11204044|FG000|Overall Study|Withdrawal by Subject|2
7088772|NCT02219048|11204045|FG001|Overall Study|Withdrawal by Subject|0
7088773|NCT02219048|11204044|FG000|Overall Study|Other|0
7088774|NCT02219048|11204045|FG001|Overall Study|Other|1
7088775|NCT02219087|11204053|FG000|Overall Study|Randomization envelope pulled out of seq|0
7088776|NCT02219087|11204054|FG001|Overall Study|Randomization envelope pulled out of seq|1
7088777|NCT02219308|11204124|FG000|Overall Study|Withdrawal by Subject|1
7088778|NCT02219308|11204125|FG001|Overall Study|Withdrawal by Subject|2
7088779|NCT02219334|11204142|FG000|Overall Study|Withdrawal by Subject|1
7088780|NCT02219334|11204143|FG001|Overall Study|Withdrawal by Subject|0
7088781|NCT02219334|11204142|FG000|Overall Study|Protocol Violation|7
7088782|NCT02219334|11204143|FG001|Overall Study|Protocol Violation|3
7088783|NCT02219464|11204162|FG000|Overall Study|Withdrawal by Subject|1
7088784|NCT02219464|11204163|FG001|Overall Study|Withdrawal by Subject|0
7088785|NCT02219464|11204162|FG000|Overall Study|case cancelled|1
7088786|NCT02219464|11204163|FG001|Overall Study|case cancelled|0
7088787|NCT02219464|11204162|FG000|Overall Study|catheter malfunction|1
7088788|NCT02219464|11204163|FG001|Overall Study|catheter malfunction|0
7088789|NCT02219477|11204172|FG000|Overall Study|Adverse Event|0
7088790|NCT02219477|11204173|FG001|Overall Study|Adverse Event|1
7088791|NCT02219477|11204174|FG002|Overall Study|Adverse Event|1
7088792|NCT02219477|11204172|FG000|Overall Study|Withdrawal by Subject|0
7088793|NCT02219477|11204173|FG001|Overall Study|Withdrawal by Subject|1
7088794|NCT02219477|11204174|FG002|Overall Study|Withdrawal by Subject|0
7088795|NCT02219685|11204206|FG000|Blinded Treatment Phase|Lost to Follow-up|1
7088796|NCT02219685|11204207|FG001|Blinded Treatment Phase|Lost to Follow-up|0
7088797|NCT02219685|11204206|FG000|Blinded Treatment Phase|Withdrew Consent|1
7088798|NCT02219685|11204207|FG001|Blinded Treatment Phase|Withdrew Consent|0
7088799|NCT02219932|11204226|FG000|Overall Study|Other|5
7088800|NCT02219932|11204227|FG001|Overall Study|Other|11
7088801|NCT02219932|11204226|FG000|Overall Study|Death|1
7088802|NCT02219932|11204227|FG001|Overall Study|Death|1
7088803|NCT02219932|11204226|FG000|Overall Study|Investigator Decision|0
7088804|NCT02219932|11204227|FG001|Overall Study|Investigator Decision|1
7088805|NCT02219932|11204226|FG000|Overall Study|Consent Withdrawn|11
7088806|NCT02219932|11204227|FG001|Overall Study|Consent Withdrawn|7
7088807|NCT02219932|11204226|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10
7088808|NCT02219932|11204227|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2
7088809|NCT02219932|11204226|FG000|Overall Study|Protocol Violation|10
7088810|NCT02219932|11204227|FG001|Overall Study|Protocol Violation|6
7088811|NCT02219932|11204226|FG000|Overall Study|Pregnancy|1
7088812|NCT02219932|11204227|FG001|Overall Study|Pregnancy|0
7088813|NCT02219932|11204226|FG000|Overall Study|Lost to Follow-up|4
7088814|NCT02219932|11204227|FG001|Overall Study|Lost to Follow-up|2
7088815|NCT02219932|11204226|FG000|Overall Study|Adverse Event|23
7088816|NCT02219932|11204227|FG001|Overall Study|Adverse Event|21
7088817|NCT02220205|11204250|FG000|Overall Study|Withdrawal by Subject|1
7088818|NCT02220205|11204251|FG001|Overall Study|Withdrawal by Subject|0
7088819|NCT02220712|11204257|FG000|Overall Study|Adverse Event|1
7088820|NCT02220712|11204257|FG000|Overall Study|Withdrawal by Subject|2
7088821|NCT02220712|11204257|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1
7088822|NCT02220725|11204269|FG000|Overall Study|Lost to Follow-up|0
7088823|NCT02220725|11204270|FG001|Overall Study|Lost to Follow-up|0
7088824|NCT02220725|11204271|FG002|Overall Study|Lost to Follow-up|0
7088825|NCT02220725|11204272|FG003|Overall Study|Lost to Follow-up|1
7088826|NCT02220725|11204269|FG000|Overall Study|Withdrawal by Subject|0
7088827|NCT02220725|11204270|FG001|Overall Study|Withdrawal by Subject|0
7088828|NCT02220725|11204271|FG002|Overall Study|Withdrawal by Subject|0
7088829|NCT02220725|11204272|FG003|Overall Study|Withdrawal by Subject|1
7088830|NCT02220764|11204287|FG000|Overall Study|Lost to Follow-up|3
7088831|NCT02220764|11204288|FG001|Overall Study|Lost to Follow-up|1
7088832|NCT02220764|11204287|FG000|Overall Study|Death|1
7088833|NCT02220764|11204288|FG001|Overall Study|Death|0
7088834|NCT02220907|11204294|FG000|Overall Study|Adverse Event|7
7088835|NCT02220907|11204294|FG000|Overall Study|Physician Decision|1
7088836|NCT02220907|11204294|FG000|Overall Study|Withdrawal by Subject|2
7088837|NCT02220907|11204294|FG000|Overall Study|Conflict with the stopping criteria|1
7088838|NCT02220920|11204300|FG000|Overall Study|Adverse Event|1
7088839|NCT02220920|11204301|FG001|Overall Study|Adverse Event|0
7088840|NCT02220920|11204300|FG000|Overall Study|Lack of Efficacy|0
7088841|NCT02220920|11204301|FG001|Overall Study|Lack of Efficacy|1
7088842|NCT02220920|11204300|FG000|Overall Study|Withdrawal by Subject|1
7088843|NCT02220920|11204301|FG001|Overall Study|Withdrawal by Subject|0
7088844|NCT02220920|11204300|FG000|Overall Study|Conflict with the stopping criteria|1
7088845|NCT02220920|11204301|FG001|Overall Study|Conflict with the stopping criteria|2
7088846|NCT02220998|11204309|FG000|Overall Study|Randomized but Never Treated|1
7088847|NCT02220998|11204310|FG001|Overall Study|Randomized but Never Treated|2
7088848|NCT02220998|11204309|FG000|Overall Study|Death|2
7088849|NCT02220998|11204310|FG001|Overall Study|Death|0
7088850|NCT02220998|11204309|FG000|Overall Study|Lack of Efficacy|0
7088851|NCT02220998|11204310|FG001|Overall Study|Lack of Efficacy|5
7088852|NCT02220998|11204309|FG000|Overall Study|Lost to Follow-up|4
7088853|NCT02220998|11204310|FG001|Overall Study|Lost to Follow-up|4
7088854|NCT02221284|11204337|FG000|Overall Study|Case Report Forms Uncollected|56
7088855|NCT02221284|11204337|FG000|Overall Study|Protocol Deviation|5
7088856|NCT02221648|11204362|FG000|Overall Study|Withdrawal by Subject|3
7088857|NCT02221648|11204363|FG001|Overall Study|Withdrawal by Subject|3
7088858|NCT02221674|11204376|FG000|Overall Study|Lost to Follow-up|1
7088859|NCT02221674|11204377|FG001|Overall Study|Lost to Follow-up|0
7088860|NCT02221674|11204378|FG002|Overall Study|Lost to Follow-up|0
7088861|NCT02221882|11204410|FG000|Overall Study|Withdrawal by Subject|0
7088862|NCT02221882|11204411|FG001|Overall Study|Withdrawal by Subject|0
7088863|NCT02221882|11204412|FG002|Overall Study|Withdrawal by Subject|4
7088864|NCT02221882|11204413|FG003|Overall Study|Withdrawal by Subject|2
7088865|NCT02221882|11204414|FG004|Overall Study|Withdrawal by Subject|2
7088866|NCT02221882|11204415|FG005|Overall Study|Withdrawal by Subject|2
7088867|NCT02221882|11204410|FG000|Overall Study|Death|0
7088868|NCT02221882|11204411|FG001|Overall Study|Death|1
7088869|NCT02221882|11204412|FG002|Overall Study|Death|0
7088870|NCT02221882|11204413|FG003|Overall Study|Death|0
7088871|NCT02221882|11204414|FG004|Overall Study|Death|0
7088872|NCT02221882|11204415|FG005|Overall Study|Death|0
7088873|NCT02222207|11204459|FG000|Overall Study|Death|1
7088874|NCT02222207|11204459|FG000|Overall Study|Other reasons|2
7088875|NCT02222207|11204459|FG000|Overall Study|Adverse Event|1
7088876|NCT02222246|11204465|FG000|Overall Study|No Emergency Department Visits|27
7088877|NCT02222246|11204466|FG001|Overall Study|No Emergency Department Visits|26
7088878|NCT02222246|11204465|FG000|Overall Study|Physician Decision|0
7088879|NCT02222246|11204466|FG001|Overall Study|Physician Decision|1
7088880|NCT02222493|11204489|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
7088881|NCT02222493|11204490|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
7088882|NCT02222493|11204489|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0
7088883|NCT02222493|11204490|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1
7088884|NCT02222493|11204489|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11
7088885|NCT02222493|11204490|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9
7088886|NCT02222493|11204489|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5
7088887|NCT02222493|11204490|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1
7088888|NCT02222493|11204489|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0
7088889|NCT02222493|11204490|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7
7088890|NCT02222493|11204489|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1
7088891|NCT02222493|11204490|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0
7088892|NCT02222493|11204489|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2
7088893|NCT02222493|11204490|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0
7088894|NCT02222493|11204489|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18
7088895|NCT02222493|11204490|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20
7088896|NCT02222493|11204489|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4
7088897|NCT02222493|11204490|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0
7088898|NCT02222493|11204489|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1
7088899|NCT02222493|11204490|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0
7088900|NCT02222493|11204489|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1
7088901|NCT02222493|11204490|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0
7088902|NCT02222493|11204489|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22
7088903|NCT02222493|11204490|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9
7088904|NCT02222493|11204489|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3
7088905|NCT02222493|11204490|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0
7088906|NCT02222493|11204489|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1
7088907|NCT02222493|11204490|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0
7088908|NCT02222493|11204489|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6
7088909|NCT02222493|11204490|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4
7088910|NCT02222493|11204489|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
7088911|NCT02222493|11204490|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
7088912|NCT02222493|11204489|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9
7088913|NCT02222493|11204490|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3
7088914|NCT02222493|11204489|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3
7088915|NCT02222493|11204490|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0
7088916|NCT02222493|11204489|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14
7088917|NCT02222493|11204490|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0
7088918|NCT02222493|11204489|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4
7088919|NCT02222493|11204490|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0
7088920|NCT02222493|11204489|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1
7088921|NCT02222493|11204490|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0
7088922|NCT02222493|11204489|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9
7088923|NCT02222493|11204490|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0
7088924|NCT02222558|11204509|FG000|Period 1: Single Dose|Withdrawal by Subject|4
7088925|NCT02222558|11204510|FG001|Period 1: Single Dose|Withdrawal by Subject|0
7088926|NCT02222558|11204511|FG002|Period 1: Single Dose|Withdrawal by Subject|0
7088927|NCT02222558|11204512|FG003|Period 1: Single Dose|Withdrawal by Subject|0
7088928|NCT02222558|11204513|FG004|Period 1: Single Dose|Withdrawal by Subject|0
7088929|NCT02222558|11204514|FG005|Period 1: Single Dose|Withdrawal by Subject|0
7088930|NCT02222558|11204509|FG000|Period 3|Withdrawal by Subject|0
7088931|NCT02222558|11204510|FG001|Period 3|Withdrawal by Subject|0
7088932|NCT02222558|11204511|FG002|Period 3|Withdrawal by Subject|0
7088933|NCT02222558|11204512|FG003|Period 3|Withdrawal by Subject|0
7088934|NCT02222558|11204513|FG004|Period 3|Withdrawal by Subject|0
7088935|NCT02222558|11204514|FG005|Period 3|Withdrawal by Subject|1
7088936|NCT02222688|11204548|FG000|Overall Study|Withdrawal by Subject|0
7088937|NCT02222688|11204549|FG001|Overall Study|Withdrawal by Subject|0
7088938|NCT02222688|11204550|FG002|Overall Study|Withdrawal by Subject|0
7088939|NCT02222688|11204551|FG003|Overall Study|Withdrawal by Subject|2
7088940|NCT02222688|11204552|FG004|Overall Study|Withdrawal by Subject|1
7088941|NCT02222688|11204553|FG005|Overall Study|Withdrawal by Subject|0
7088942|NCT02222688|11204554|FG006|Overall Study|Withdrawal by Subject|1
7088943|NCT02222688|11204548|FG000|Overall Study|Disease progression|1
7088944|NCT02222688|11204549|FG001|Overall Study|Disease progression|0
7088945|NCT02222688|11204550|FG002|Overall Study|Disease progression|0
7088946|NCT02222688|11204551|FG003|Overall Study|Disease progression|0
7088947|NCT02222688|11204552|FG004|Overall Study|Disease progression|0
7088948|NCT02222688|11204553|FG005|Overall Study|Disease progression|0
7088949|NCT02222688|11204554|FG006|Overall Study|Disease progression|0
7088950|NCT02222714|11204577|FG000|Overall Study|Death|0
7088951|NCT02222714|11204578|FG001|Overall Study|Death|2
7088952|NCT02222714|11204579|FG002|Overall Study|Death|3
7088953|NCT02222714|11204580|FG003|Overall Study|Death|4
7088954|NCT02222714|11204581|FG004|Overall Study|Death|6
7088955|NCT02222714|11204577|FG000|Overall Study|Withdrawal by Subject|0
7088956|NCT02222714|11204578|FG001|Overall Study|Withdrawal by Subject|0
7088957|NCT02222714|11204579|FG002|Overall Study|Withdrawal by Subject|1
7088958|NCT02222714|11204580|FG003|Overall Study|Withdrawal by Subject|0
7088959|NCT02222714|11204581|FG004|Overall Study|Withdrawal by Subject|1
7088960|NCT02222818|11204598|FG000|Period 1|Eligibility criteria not met|0
7088961|NCT02222818|11204599|FG001|Period 1|Eligibility criteria not met|3
7088962|NCT02222896|11204613|FG000|Abdomen|Did not qualify|34
7088963|NCT02222896|11204614|FG001|Abdomen|Did not qualify|10
7088964|NCT02222896|11204615|FG002|Abdomen|Did not qualify|32
7088965|NCT02222896|11204613|FG000|Groin|Did not qualify|43
7088966|NCT02222896|11204614|FG001|Groin|Did not qualify|9
7088967|NCT02222896|11204615|FG002|Groin|Did not qualify|40
7088968|NCT02222922|11204635|FG000|Overall Study|Death|0
7088969|NCT02222922|11204636|FG001|Overall Study|Death|0
7088970|NCT02222922|11204637|FG002|Overall Study|Death|0
7088971|NCT02222922|11204638|FG003|Overall Study|Death|0
7088972|NCT02222922|11204639|FG004|Overall Study|Death|13
7088973|NCT02222922|11204640|FG005|Overall Study|Death|0
7088974|NCT02222922|11204641|FG006|Overall Study|Death|0
7088975|NCT02222922|11204642|FG007|Overall Study|Death|0
7088976|NCT02222922|11204643|FG008|Overall Study|Death|2
7088977|NCT02222922|11204635|FG000|Overall Study|Lost to Follow-up|0
7088978|NCT02222922|11204636|FG001|Overall Study|Lost to Follow-up|0
7088979|NCT02222922|11204637|FG002|Overall Study|Lost to Follow-up|1
7088980|NCT02222922|11204638|FG003|Overall Study|Lost to Follow-up|0
7088981|NCT02222922|11204639|FG004|Overall Study|Lost to Follow-up|9
7088982|NCT02222922|11204640|FG005|Overall Study|Lost to Follow-up|1
7088983|NCT02222922|11204641|FG006|Overall Study|Lost to Follow-up|0
7088984|NCT02222922|11204642|FG007|Overall Study|Lost to Follow-up|0
7088985|NCT02222922|11204643|FG008|Overall Study|Lost to Follow-up|0
7088986|NCT02222922|11204635|FG000|Overall Study|Other|0
7088987|NCT02222922|11204636|FG001|Overall Study|Other|0
7088988|NCT02222922|11204637|FG002|Overall Study|Other|0
7088989|NCT02222922|11204638|FG003|Overall Study|Other|2
7088990|NCT02222922|11204639|FG004|Overall Study|Other|10
7088991|NCT02222922|11204640|FG005|Overall Study|Other|2
7088992|NCT02222922|11204641|FG006|Overall Study|Other|2
7088993|NCT02222922|11204642|FG007|Overall Study|Other|4
7088994|NCT02222922|11204643|FG008|Overall Study|Other|1
7088995|NCT02222922|11204635|FG000|Overall Study|Participant refused further follow-up|1
7088996|NCT02222922|11204636|FG001|Overall Study|Participant refused further follow-up|0
7088997|NCT02222922|11204637|FG002|Overall Study|Participant refused further follow-up|0
7088998|NCT02222922|11204638|FG003|Overall Study|Participant refused further follow-up|1
7088999|NCT02222922|11204639|FG004|Overall Study|Participant refused further follow-up|6
7089000|NCT02222922|11204640|FG005|Overall Study|Participant refused further follow-up|0
7089001|NCT02222922|11204641|FG006|Overall Study|Participant refused further follow-up|0
7089002|NCT02222922|11204642|FG007|Overall Study|Participant refused further follow-up|0
7089003|NCT02222922|11204643|FG008|Overall Study|Participant refused further follow-up|3
7089004|NCT02223364|11204719|FG000|Overall Study|Protocol Violation|3
7089005|NCT02223364|11204720|FG001|Overall Study|Protocol Violation|0
7089006|NCT02223364|11204721|FG002|Overall Study|Protocol Violation|3
7089007|NCT02223364|11204719|FG000|Overall Study|subject expired before surgery|1
7089008|NCT02223364|11204720|FG001|Overall Study|subject expired before surgery|0
7089009|NCT02223364|11204721|FG002|Overall Study|subject expired before surgery|0
7089010|NCT02223364|11204719|FG000|Overall Study|Physician Decision|1
7089011|NCT02223364|11204720|FG001|Overall Study|Physician Decision|0
7089012|NCT02223364|11204721|FG002|Overall Study|Physician Decision|0
7089013|NCT02223390|11204731|FG000|Overall Study|Lost to Follow-up|9
7089014|NCT02223390|11204732|FG001|Overall Study|Lost to Follow-up|4
7089015|NCT02223715|11204807|FG000|Overall Study|Death|31
7089016|NCT02223715|11204807|FG000|Overall Study|Lost to Follow-up|73
7089017|NCT02223754|11204816|FG000|Period 1|Adverse Event|1
7089018|NCT02223754|11204817|FG001|Period 1|Adverse Event|0
7089019|NCT02223754|11204816|FG000|Period 1|Lost to Follow-up|0
7089020|NCT02223754|11204817|FG001|Period 1|Lost to Follow-up|1
7089021|NCT02223754|11204816|FG000|Period 1|Protocol Violation|2
7089022|NCT02223754|11204817|FG001|Period 1|Protocol Violation|4
7089023|NCT02223754|11204816|FG000|Period 1|Withdrawal by Subject|0
7089024|NCT02223754|11204817|FG001|Period 1|Withdrawal by Subject|4
7089025|NCT02223754|11204816|FG000|Period 1|Test Article No Longer Available|1
7089026|NCT02223754|11204817|FG001|Period 1|Test Article No Longer Available|5
7089027|NCT02223754|11204816|FG000|Period 1|Unsatisfactory Visual Response|0
7089028|NCT02223754|11204817|FG001|Period 1|Unsatisfactory Visual Response|1
7089029|NCT02223754|11204816|FG000|Period 2|Adverse Event|0
7089030|NCT02223754|11204817|FG001|Period 2|Adverse Event|1
7089031|NCT02223754|11204816|FG000|Period 2|Protocol Violation|1
7089032|NCT02223754|11204817|FG001|Period 2|Protocol Violation|0
7089033|NCT02223754|11204816|FG000|Period 2|Lens Discomfort|1
7089034|NCT02223754|11204817|FG001|Period 2|Lens Discomfort|1
7089035|NCT02223754|11204816|FG000|Period 2|Lost to Follow-up|1
7089036|NCT02223754|11204817|FG001|Period 2|Lost to Follow-up|0
7089037|NCT02223754|11204816|FG000|Period 2|Test Article No Longer Available|0
7089038|NCT02223754|11204817|FG001|Period 2|Test Article No Longer Available|1
7089039|NCT02223793|11204827|FG000|Overall Study|Lost to Follow-up|10
7089040|NCT02223793|11204828|FG001|Overall Study|Lost to Follow-up|1
7089041|NCT02223793|11204829|FG002|Overall Study|Lost to Follow-up|2
7089042|NCT02223793|11204827|FG000|Overall Study|Withdrawal by Subject|3
7089043|NCT02223793|11204828|FG001|Overall Study|Withdrawal by Subject|2
7089044|NCT02223793|11204829|FG002|Overall Study|Withdrawal by Subject|3
7089045|NCT02223793|11204827|FG000|Overall Study|Moved/studycenter unable to participate|4
7089046|NCT02223793|11204828|FG001|Overall Study|Moved/studycenter unable to participate|6
7089047|NCT02223793|11204829|FG002|Overall Study|Moved/studycenter unable to participate|8
7089048|NCT02223858|11204839|FG000|Overall Study|Death|1
7089049|NCT02223858|11204840|FG001|Overall Study|Death|1
7089050|NCT02223858|11204839|FG000|Overall Study|Lost to Follow-up|6
7089051|NCT02223858|11204840|FG001|Overall Study|Lost to Follow-up|11
7089052|NCT02223858|11204839|FG000|Overall Study|Withdrawal by Subject|8
7089053|NCT02223858|11204840|FG001|Overall Study|Withdrawal by Subject|5
7089054|NCT02223858|11204839|FG000|Overall Study|Refused|9
7089055|NCT02223858|11204840|FG001|Overall Study|Refused|9
7089056|NCT02224053|11204850|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11
7089057|NCT02224053|11204850|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4
7089058|NCT02224053|11204850|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3
7089059|NCT02224053|11204850|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1
7089060|NCT02224053|11204850|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2
7089061|NCT02224157|11204858|FG000|Overall Study|Severe non-compliance to protocol|2
7089062|NCT02224157|11204859|FG001|Overall Study|Severe non-compliance to protocol|2
7089063|NCT02224157|11204858|FG000|Overall Study|Other|13
7089064|NCT02224157|11204859|FG001|Overall Study|Other|10
7089065|NCT02224157|11204858|FG000|Overall Study|Subject decision|58
7089066|NCT02224157|11204859|FG001|Overall Study|Subject decision|50
7089067|NCT02224157|11204858|FG000|Overall Study|Prematurely closed site|4
7089068|NCT02224157|11204859|FG001|Overall Study|Prematurely closed site|2
7089069|NCT02224157|11204858|FG000|Overall Study|Eligibility criteria not fulfilled|4
7089070|NCT02224157|11204859|FG001|Overall Study|Eligibility criteria not fulfilled|8
7089071|NCT02224157|11204858|FG000|Overall Study|Lost to Follow-up|27
7089072|NCT02224157|11204859|FG001|Overall Study|Lost to Follow-up|35
7089073|NCT02224157|11204858|FG000|Overall Study|Death|1
7089074|NCT02224157|11204859|FG001|Overall Study|Death|1
7089075|NCT02224157|11204858|FG000|Overall Study|Adverse Event|1
7089076|NCT02224157|11204859|FG001|Overall Study|Adverse Event|3
7089077|NCT02224274|11204867|FG000|Overall Study|Death|1
7089078|NCT02224274|11204868|FG001|Overall Study|Death|0
7089079|NCT02224560|11204909|FG000|Overall Study|Protocol Deviation|1
7089080|NCT02224560|11204910|FG001|Overall Study|Protocol Deviation|0
7089081|NCT02224560|11204911|FG002|Overall Study|Protocol Deviation|0
7089082|NCT02224560|11204909|FG000|Overall Study|Withdrawal by Subject|2
7089083|NCT02224560|11204910|FG001|Overall Study|Withdrawal by Subject|0
7089084|NCT02224560|11204911|FG002|Overall Study|Withdrawal by Subject|1
7089085|NCT02224560|11204909|FG000|Overall Study|Met Withdrawal Criteria|1
7089086|NCT02224560|11204910|FG001|Overall Study|Met Withdrawal Criteria|0
7089087|NCT02224560|11204911|FG002|Overall Study|Met Withdrawal Criteria|0
7089088|NCT02224560|11204909|FG000|Overall Study|Adverse Event|4
7089089|NCT02224560|11204910|FG001|Overall Study|Adverse Event|1
7089090|NCT02224560|11204911|FG002|Overall Study|Adverse Event|1
7089091|NCT02224560|11204909|FG000|Overall Study|Withdrawn by Investigator|1
7089092|NCT02224560|11204910|FG001|Overall Study|Withdrawn by Investigator|1
7089093|NCT02224560|11204911|FG002|Overall Study|Withdrawn by Investigator|0
7089094|NCT02224625|11204928|FG000|Irritation|Adverse Event|6
7089095|NCT02224625|11204928|FG000|Sensitization|Adverse Event|55
7089096|NCT02224638|11204942|FG000|Overall Study|Adverse Event|1
7089097|NCT02224638|11204943|FG001|Overall Study|Adverse Event|1
7089098|NCT02224664|11204951|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5
7089099|NCT02224664|11204952|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0
7089100|NCT02224664|11204953|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0
7089101|NCT02224664|11204954|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0
7089102|NCT02224664|11204955|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0
7089103|NCT02224664|11204951|FG000|Dose Escalation Period (21 Days)|Adverse Event|0
7089104|NCT02224664|11204952|FG001|Dose Escalation Period (21 Days)|Adverse Event|0
7089105|NCT02224664|11204953|FG002|Dose Escalation Period (21 Days)|Adverse Event|2
7089106|NCT02224664|11204954|FG003|Dose Escalation Period (21 Days)|Adverse Event|2
7089107|NCT02224664|11204955|FG004|Dose Escalation Period (21 Days)|Adverse Event|7
7089108|NCT02224664|11204951|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
7089109|NCT02224664|11204952|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
7089110|NCT02224664|11204953|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
7089111|NCT02224664|11204954|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1
7089112|NCT02224664|11204955|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4
7089113|NCT02224690|11204973|FG000|Overall Study|Adverse Event|8
7089114|NCT02224690|11204974|FG001|Overall Study|Adverse Event|1
7089115|NCT02224690|11204973|FG000|Overall Study|Met Withdrawal Criteria|4
7089116|NCT02224690|11204974|FG001|Overall Study|Met Withdrawal Criteria|0
7089117|NCT02224690|11204973|FG000|Overall Study|Use of G-tube|1
7089118|NCT02224690|11204974|FG001|Overall Study|Use of G-tube|0
7089119|NCT02224690|11204973|FG000|Overall Study|Did not meet eligibility criteria|1
7089120|NCT02224690|11204974|FG001|Overall Study|Did not meet eligibility criteria|0
7089121|NCT02224703|11204983|FG000|Overall Study|Adverse Event|0
7089122|NCT02224703|11204984|FG001|Overall Study|Adverse Event|5
7089123|NCT02224703|11204985|FG002|Overall Study|Adverse Event|0
7089124|NCT02224703|11204983|FG000|Overall Study|Withdrawn by investigator|1
7089125|NCT02224703|11204984|FG001|Overall Study|Withdrawn by investigator|0
7089126|NCT02224703|11204985|FG002|Overall Study|Withdrawn by investigator|0
7089127|NCT02224703|11204983|FG000|Overall Study|Advised by medical monitor|1
7089128|NCT02224703|11204984|FG001|Overall Study|Advised by medical monitor|0
7089129|NCT02224703|11204985|FG002|Overall Study|Advised by medical monitor|0
7089130|NCT02224703|11204983|FG000|Overall Study|Withdrawn by parent/guardian|0
7089131|NCT02224703|11204984|FG001|Overall Study|Withdrawn by parent/guardian|1
7089132|NCT02224703|11204985|FG002|Overall Study|Withdrawn by parent/guardian|0
7089133|NCT02224703|11204983|FG000|Overall Study|Lack of Efficacy|1
7089134|NCT02224703|11204984|FG001|Overall Study|Lack of Efficacy|0
7089135|NCT02224703|11204985|FG002|Overall Study|Lack of Efficacy|0
7089146|NCT02224846|11205017|FG000|Period 1 (Month 3)|Adverse Event|2
7089147|NCT02224846|11205018|FG001|Period 1 (Month 3)|Adverse Event|1
7089148|NCT02224846|11205017|FG000|Period 1 (Month 3)|Lost to Follow-up|3
7089149|NCT02224846|11205018|FG001|Period 1 (Month 3)|Lost to Follow-up|8
7089150|NCT02224846|11205017|FG000|Period 1 (Month 3)|Protocol Violation|4
7089151|NCT02224846|11205018|FG001|Period 1 (Month 3)|Protocol Violation|8
7089152|NCT02224846|11205017|FG000|Period 1 (Month 3)|Withdrawal by Subject|8
7089153|NCT02224846|11205018|FG001|Period 1 (Month 3)|Withdrawal by Subject|18
7089154|NCT02224846|11205017|FG000|Period 1 (Month 3)|Sponsor Decision|2
7089155|NCT02224846|11205018|FG001|Period 1 (Month 3)|Sponsor Decision|1
7089156|NCT02224846|11205017|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1
7089157|NCT02224846|11205018|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2
7089158|NCT02224846|11205017|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3
7089159|NCT02224846|11205018|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5
7089160|NCT02224846|11205017|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0
7089161|NCT02224846|11205018|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3
7089162|NCT02224846|11205017|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15
7089163|NCT02224846|11205018|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19
7089164|NCT02224846|11205017|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0
7089165|NCT02224846|11205018|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2
7089166|NCT02224846|11205017|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3
7089167|NCT02224846|11205018|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4
7089168|NCT02224846|11205017|FG000|Period 2 (Month 12 to Month 24)|Death|1
7089169|NCT02224846|11205018|FG001|Period 2 (Month 12 to Month 24)|Death|0
7089170|NCT02224846|11205017|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7
7089171|NCT02224846|11205018|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13
7089172|NCT02224846|11205017|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4
7089173|NCT02224846|11205018|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11
7089174|NCT02224846|11205017|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25
7089175|NCT02224846|11205018|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43
7089176|NCT02224846|11205017|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0
7089177|NCT02224846|11205018|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2
7089178|NCT02224846|11205017|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2
7089179|NCT02224846|11205018|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1
7089180|NCT02225223|11205038|FG000|Overall Study|Death|10
7089181|NCT02225223|11205039|FG001|Overall Study|Death|1
7089182|NCT02225223|11205038|FG000|Overall Study|Lost to Follow-up|5
7089183|NCT02225223|11205039|FG001|Overall Study|Lost to Follow-up|0
7089184|NCT02225223|11205038|FG000|Overall Study|Other|1
7089185|NCT02225223|11205039|FG001|Overall Study|Other|2
7089186|NCT02225223|11205038|FG000|Overall Study|Physician Decision|1
7089187|NCT02225223|11205039|FG001|Overall Study|Physician Decision|0
7089188|NCT02225223|11205038|FG000|Overall Study|Withdrawal by Subject|2
7089189|NCT02225223|11205039|FG001|Overall Study|Withdrawal by Subject|2
7089190|NCT02225353|11205048|FG000|Overall Study|Lost to Follow-up|0
7089191|NCT02225353|11205049|FG001|Overall Study|Lost to Follow-up|1
7089192|NCT02225353|11205050|FG002|Overall Study|Lost to Follow-up|3
7089193|NCT02225353|11205048|FG000|Overall Study|Protocol Violation|4
7089194|NCT02225353|11205049|FG001|Overall Study|Protocol Violation|5
7089195|NCT02225353|11205050|FG002|Overall Study|Protocol Violation|12
7089196|NCT02225587|11205063|FG000|Overall Study|Adverse Event|5
7089197|NCT02225587|11205064|FG001|Overall Study|Adverse Event|5
7089198|NCT02225587|11205063|FG000|Overall Study|Lost to Follow-up|5
7089199|NCT02225587|11205064|FG001|Overall Study|Lost to Follow-up|5
7089200|NCT02225587|11205063|FG000|Overall Study|Non-Compliance With Study Drug|1
7089201|NCT02225587|11205064|FG001|Overall Study|Non-Compliance With Study Drug|0
7089202|NCT02225587|11205063|FG000|Overall Study|Physician Decision|2
7089203|NCT02225587|11205064|FG001|Overall Study|Physician Decision|0
7089204|NCT02225587|11205063|FG000|Overall Study|Protocol Violation|1
7089205|NCT02225587|11205064|FG001|Overall Study|Protocol Violation|0
7089206|NCT02225587|11205063|FG000|Overall Study|Participant Moved|1
7089207|NCT02225587|11205064|FG001|Overall Study|Participant Moved|0
7089208|NCT02225587|11205063|FG000|Overall Study|Withdrawal by Subject|13
7089209|NCT02225587|11205064|FG001|Overall Study|Withdrawal by Subject|28
7089210|NCT02225665|11205072|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1
7089211|NCT02225665|11205073|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0
7089212|NCT02225665|11205072|FG000|Overall Study|Subject restarted HAART prior to month 18.|0
7089213|NCT02225665|11205073|FG001|Overall Study|Subject restarted HAART prior to month 18.|1
7089214|NCT02225743|11205079|FG000|Overall Study|Withdrawal by Subject|18
7089215|NCT02226003|11205100|FG000|Overall Study|Lost to Follow-up|2
7089216|NCT02226003|11205101|FG001|Overall Study|Lost to Follow-up|1
7089217|NCT02226003|11205102|FG002|Overall Study|Lost to Follow-up|3
7089218|NCT02226003|11205100|FG000|Overall Study|Withdrawal by Subject|0
7089219|NCT02226003|11205101|FG001|Overall Study|Withdrawal by Subject|0
7089220|NCT02226003|11205102|FG002|Overall Study|Withdrawal by Subject|3
7089221|NCT02226120|11205110|FG000|Overall Study|Adverse Event|60
7089222|NCT02226120|11205110|FG000|Overall Study|Death|172
7089223|NCT02226120|11205110|FG000|Overall Study|Study terminated by sponsor|1
7089224|NCT02226120|11205110|FG000|Overall Study|Technical problems|4
7089225|NCT02226120|11205110|FG000|Overall Study|Lost to Follow-up|13
7089226|NCT02226120|11205110|FG000|Overall Study|Physician Decision|21
7089227|NCT02226120|11205110|FG000|Overall Study|Withdrawal by parent/guardian|36
7089228|NCT02226120|11205110|FG000|Overall Study|Non-compliance with study drug|10
7089229|NCT02226120|11205110|FG000|Overall Study|Protocol deviation|1
7089230|NCT02226120|11205110|FG000|Overall Study|missing treatment disposition pages|2
7089231|NCT02226172|11205123|FG000|Overall Study|Participant refused further follow-up|4
7089232|NCT02226172|11205123|FG000|Overall Study|Other|5
7089233|NCT02226172|11205123|FG000|Overall Study|Death|1
7089234|NCT02226172|11205123|FG000|Overall Study|Study terminated by sponsor|1
7089235|NCT02226172|11205123|FG000|Overall Study|Adverse Event|6
7089236|NCT02226198|11205127|FG000|Lead-in Phase|Protocol Violation|1
7089237|NCT02226198|11205128|FG001|Lead-in Phase|Protocol Violation|0
7089238|NCT02226198|11205129|FG002|Lead-in Phase|Protocol Violation|0
7089239|NCT02226198|11205127|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
7089240|NCT02226198|11205128|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1
7089241|NCT02226198|11205129|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
7089242|NCT02226549|11205157|FG000|Overall Study|Randomized but Never Treated|1
7089243|NCT02226549|11205158|FG001|Overall Study|Randomized but Never Treated|0
7089244|NCT02226549|11205157|FG000|Overall Study|Lost to Follow-up|0
7089245|NCT02226549|11205158|FG001|Overall Study|Lost to Follow-up|1
7089246|NCT02226562|11205166|FG000|Overall Study|Lost to Follow-up|0
7089247|NCT02226562|11205167|FG001|Overall Study|Lost to Follow-up|1
7089248|NCT02226653|11205175|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1
7089249|NCT02226653|11205176|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0
7089250|NCT02226653|11205175|FG000|Treatment Period 5 Fed State|Adverse Event|0
7089251|NCT02226653|11205176|FG001|Treatment Period 5 Fed State|Adverse Event|1
7089252|NCT02227108|11205200|FG000|Overall Study|Did not receive treatment|2
7089253|NCT02227108|11205200|FG000|Overall Study|Other|3
7089254|NCT02227108|11205200|FG000|Overall Study|Progressive disease|17
7089255|NCT02227108|11205200|FG000|Overall Study|Initiation of alternative therapy|2
7089256|NCT02227108|11205200|FG000|Overall Study|Investigator discretion|1
7089257|NCT02227108|11205200|FG000|Overall Study|Adverse Event|6
7089258|NCT02227368|11205236|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0
7089259|NCT02227368|11205237|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4
7089260|NCT02227368|11205236|FG000|Overall Study|Lost to Follow-up|1
7089261|NCT02227368|11205237|FG001|Overall Study|Lost to Follow-up|0
7089262|NCT02227368|11205236|FG000|Overall Study|Adverse Event|1
7089263|NCT02227368|11205237|FG001|Overall Study|Adverse Event|0
7089264|NCT02227446|11205245|FG000|Overall Study|not eligible post randomization|18
7089265|NCT02227446|11205246|FG001|Overall Study|not eligible post randomization|29
7089266|NCT02227446|11205245|FG000|Overall Study|Withdrawal by Subject|4
7089267|NCT02227446|11205246|FG001|Overall Study|Withdrawal by Subject|5
7089268|NCT02227784|11205306|FG000|Double-Blind Phase|Adverse Event|3
7089269|NCT02227784|11205307|FG001|Double-Blind Phase|Adverse Event|2
7089270|NCT02227784|11205308|FG002|Double-Blind Phase|Adverse Event|1
7089271|NCT02227784|11205309|FG003|Double-Blind Phase|Adverse Event|3
7089272|NCT02227784|11205310|FG004|Double-Blind Phase|Adverse Event|0
7089273|NCT02227784|11205306|FG000|Double-Blind Phase|Physician Decision|1
7089274|NCT02227784|11205307|FG001|Double-Blind Phase|Physician Decision|0
7089275|NCT02227784|11205308|FG002|Double-Blind Phase|Physician Decision|0
7089276|NCT02227784|11205309|FG003|Double-Blind Phase|Physician Decision|1
7089277|NCT02227784|11205310|FG004|Double-Blind Phase|Physician Decision|0
7089278|NCT02227784|11205306|FG000|Double-Blind Phase|Protocol Violation|0
7089279|NCT02227784|11205307|FG001|Double-Blind Phase|Protocol Violation|0
7089280|NCT02227784|11205308|FG002|Double-Blind Phase|Protocol Violation|1
7089281|NCT02227784|11205309|FG003|Double-Blind Phase|Protocol Violation|1
7089282|NCT02227784|11205310|FG004|Double-Blind Phase|Protocol Violation|0
7089283|NCT02227784|11205306|FG000|Double-Blind Phase|Sponsor Decision|34
7089284|NCT02227784|11205307|FG001|Double-Blind Phase|Sponsor Decision|15
7089285|NCT02227784|11205308|FG002|Double-Blind Phase|Sponsor Decision|14
7089286|NCT02227784|11205309|FG003|Double-Blind Phase|Sponsor Decision|32
7089287|NCT02227784|11205310|FG004|Double-Blind Phase|Sponsor Decision|0
7089288|NCT02227784|11205306|FG000|Double-Blind Phase|Withdrawal by Subject|2
7089289|NCT02227784|11205307|FG001|Double-Blind Phase|Withdrawal by Subject|1
7089290|NCT02227784|11205308|FG002|Double-Blind Phase|Withdrawal by Subject|5
7089291|NCT02227784|11205309|FG003|Double-Blind Phase|Withdrawal by Subject|2
7089292|NCT02227784|11205310|FG004|Double-Blind Phase|Withdrawal by Subject|0
7089293|NCT02227784|11205306|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0
7089294|NCT02227784|11205307|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0
7089295|NCT02227784|11205308|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0
7089296|NCT02227784|11205309|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0
7089297|NCT02227784|11205310|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1
7089298|NCT02227784|11205306|FG000|Open-Label Extension Phase (OLE)|Death|0
7089299|NCT02227784|11205307|FG001|Open-Label Extension Phase (OLE)|Death|0
7089300|NCT02227784|11205308|FG002|Open-Label Extension Phase (OLE)|Death|0
7089301|NCT02227784|11205309|FG003|Open-Label Extension Phase (OLE)|Death|0
7089302|NCT02227784|11205310|FG004|Open-Label Extension Phase (OLE)|Death|1
7089303|NCT02227784|11205306|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0
7089304|NCT02227784|11205307|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0
7089305|NCT02227784|11205308|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0
7089306|NCT02227784|11205309|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0
7089307|NCT02227784|11205310|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243
7089308|NCT02227784|11205306|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
7089309|NCT02227784|11205307|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
7089310|NCT02227784|11205308|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
7089311|NCT02227784|11205309|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
7089312|NCT02227784|11205310|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3
7089313|NCT02227849|11205338|FG000|Overall Study|Adverse Event|4
7089314|NCT02227849|11205338|FG000|Overall Study|Physician Decision|1
7089315|NCT02227849|11205338|FG000|Overall Study|Withdrawal by Subject|3
7089316|NCT02228096|11205344|FG000|Overall Study|Study terminated by Sponsor|24
7089317|NCT02228096|11205344|FG000|Overall Study|Lack of Efficacy|18
7089318|NCT02228096|11205344|FG000|Overall Study|Death|12
7089319|NCT02228096|11205344|FG000|Overall Study|Physician Decision|3
7089320|NCT02228096|11205344|FG000|Overall Study|Subject/guardian decision|2
7089321|NCT02228096|11205344|FG000|Overall Study|New therapy for study indication|1
7089322|NCT02228096|11205344|FG000|Overall Study|Enrolled, not infused|11
7089323|NCT02228395|11205366|FG000|First Intervention Period|No longer willing to participate|1
7089324|NCT02228395|11205367|FG001|First Intervention Period|No longer willing to participate|0
7089325|NCT02228395|11205368|FG002|First Intervention Period|No longer willing to participate|0
7089326|NCT02228395|11205366|FG000|First Intervention Period|Unable to comply with study dates|0
7089327|NCT02228395|11205367|FG001|First Intervention Period|Unable to comply with study dates|1
7089328|NCT02228395|11205368|FG002|First Intervention Period|Unable to comply with study dates|1
7089329|NCT02228460|11205387|FG000|Overall Study|Adverse Event|1
7089330|NCT02228460|11205387|FG000|Overall Study|Lost to Follow-up|1
7089331|NCT02228564|11205401|FG000|Overall Study|Withdrawal by Subject|10
7089332|NCT02228564|11205401|FG000|Overall Study|Death|11
7089333|NCT02228564|11205401|FG000|Overall Study|Physician Decision|5
7089334|NCT02228564|11205401|FG000|Overall Study|Lost to Follow-up|17
7089335|NCT02228564|11205401|FG000|Overall Study|Other|6
7089336|NCT02228590|11205405|FG000|Overall Study|Withdrawal by Subject|1
7089337|NCT02228720|11205419|FG000|Open Label - Day 30|Lost to Follow-up|1
7089338|NCT02228967|11205434|FG000|Overall Study|Lost to Follow-up|146
7089339|NCT02228967|11205435|FG001|Overall Study|Lost to Follow-up|142
7089340|NCT02228967|11205434|FG000|Overall Study|Withdrawal by Subject|13
7089341|NCT02228967|11205435|FG001|Overall Study|Withdrawal by Subject|18
7089342|NCT02228980|11205445|FG000|Overall Study|Adverse Event|14
7089343|NCT02228980|11205446|FG001|Overall Study|Adverse Event|0
7089344|NCT02228980|11205447|FG002|Overall Study|Adverse Event|0
7089345|NCT02228980|11205448|FG003|Overall Study|Adverse Event|0
7089346|NCT02228980|11205445|FG000|Overall Study|Protocol Violation|7
7089347|NCT02228980|11205446|FG001|Overall Study|Protocol Violation|0
7089348|NCT02228980|11205447|FG002|Overall Study|Protocol Violation|0
7089349|NCT02228980|11205448|FG003|Overall Study|Protocol Violation|0
7089350|NCT02228980|11205445|FG000|Overall Study|Withdrawal by Subject|3
7089351|NCT02228980|11205446|FG001|Overall Study|Withdrawal by Subject|3
7089352|NCT02228980|11205447|FG002|Overall Study|Withdrawal by Subject|2
7089353|NCT02228980|11205448|FG003|Overall Study|Withdrawal by Subject|3
7089354|NCT02229214|11205464|FG000|Overall Study|Adverse Event|2
7089355|NCT02229214|11205465|FG001|Overall Study|Adverse Event|0
7089356|NCT02229214|11205464|FG000|Overall Study|Withdrawal by Subject|4
7089357|NCT02229214|11205465|FG001|Overall Study|Withdrawal by Subject|0
7089358|NCT02229227|11205475|FG000|Overall Study|Adverse Event|14
7089359|NCT02229227|11205476|FG001|Overall Study|Adverse Event|9
7089360|NCT02229227|11205475|FG000|Overall Study|Lack of Efficacy|3
7089361|NCT02229227|11205476|FG001|Overall Study|Lack of Efficacy|3
7089362|NCT02229227|11205475|FG000|Overall Study|Protocol Violation|6
7089363|NCT02229227|11205476|FG001|Overall Study|Protocol Violation|8
7089364|NCT02229227|11205475|FG000|Overall Study|Protocol defined stopping criteria|1
7089365|NCT02229227|11205476|FG001|Overall Study|Protocol defined stopping criteria|3
7089366|NCT02229227|11205475|FG000|Overall Study|Lost to Follow-up|3
7089367|NCT02229227|11205476|FG001|Overall Study|Lost to Follow-up|3
7089368|NCT02229227|11205475|FG000|Overall Study|Study terminated by sponsor|11
7089369|NCT02229227|11205476|FG001|Overall Study|Study terminated by sponsor|11
7089370|NCT02229227|11205475|FG000|Overall Study|Withdrawal by Subject|8
7089371|NCT02229227|11205476|FG001|Overall Study|Withdrawal by Subject|12
7089372|NCT02229227|11205475|FG000|Overall Study|Other|0
7089373|NCT02229227|11205476|FG001|Overall Study|Other|1
7089374|NCT02229227|11205475|FG000|Overall Study|Physician Decision|5
7089375|NCT02229227|11205476|FG001|Overall Study|Physician Decision|12
7089376|NCT02229383|11205489|FG000|Overall Study|Adverse Event|7
7089377|NCT02229383|11205490|FG001|Overall Study|Adverse Event|4
7089378|NCT02229383|11205489|FG000|Overall Study|Death|0
7089379|NCT02229383|11205490|FG001|Overall Study|Death|1
7089380|NCT02229383|11205489|FG000|Overall Study|Lost to Follow-up|5
7089381|NCT02229383|11205490|FG001|Overall Study|Lost to Follow-up|3
7089382|NCT02229383|11205489|FG000|Overall Study|Withdrawal by Subject|4
7089383|NCT02229383|11205490|FG001|Overall Study|Withdrawal by Subject|6
7089384|NCT02229383|11205489|FG000|Overall Study|Did not receive treatment|1
7089385|NCT02229383|11205490|FG001|Overall Study|Did not receive treatment|0
7089386|NCT02229383|11205489|FG000|Overall Study|Other|3
7089387|NCT02229383|11205490|FG001|Overall Study|Other|8
7089388|NCT02229396|11205499|FG000|Overall Study|Adverse Event|6
7089389|NCT02229396|11205500|FG001|Overall Study|Adverse Event|12
7089390|NCT02229396|11205501|FG002|Overall Study|Adverse Event|12
7089391|NCT02229396|11205499|FG000|Overall Study|Death|2
7089392|NCT02229396|11205500|FG001|Overall Study|Death|3
7089393|NCT02229396|11205501|FG002|Overall Study|Death|1
7089394|NCT02229396|11205499|FG000|Overall Study|Lost to Follow-up|14
7089395|NCT02229396|11205500|FG001|Overall Study|Lost to Follow-up|14
7089396|NCT02229396|11205501|FG002|Overall Study|Lost to Follow-up|21
7089397|NCT02229396|11205499|FG000|Overall Study|Protocol Violation|2
7089398|NCT02229396|11205500|FG001|Overall Study|Protocol Violation|1
7089399|NCT02229396|11205501|FG002|Overall Study|Protocol Violation|0
7089400|NCT02229396|11205499|FG000|Overall Study|Patient Incorrectly Randomized|0
7089401|NCT02229396|11205500|FG001|Overall Study|Patient Incorrectly Randomized|0
7089402|NCT02229396|11205501|FG002|Overall Study|Patient Incorrectly Randomized|1
7089403|NCT02229396|11205499|FG000|Overall Study|Other|10
7089404|NCT02229396|11205500|FG001|Overall Study|Other|18
7089405|NCT02229396|11205501|FG002|Overall Study|Other|15
7089406|NCT02229396|11205499|FG000|Overall Study|Withdrawal by Subject|42
7089407|NCT02229396|11205500|FG001|Overall Study|Withdrawal by Subject|28
7089408|NCT02229396|11205501|FG002|Overall Study|Withdrawal by Subject|41
7089409|NCT02229396|11205499|FG000|Overall Study|Study-Specific Withdrawal Criteria|0
7089410|NCT02229396|11205500|FG001|Overall Study|Study-Specific Withdrawal Criteria|1
7089411|NCT02229396|11205501|FG002|Overall Study|Study-Specific Withdrawal Criteria|3
7089412|NCT02229396|11205499|FG000|Overall Study|Withdrew; No Record on Termination Page|2
7089413|NCT02229396|11205500|FG001|Overall Study|Withdrew; No Record on Termination Page|0
7089414|NCT02229396|11205501|FG002|Overall Study|Withdrew; No Record on Termination Page|1
7089415|NCT02229539|11205567|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
7089416|NCT02229539|11205568|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1
7089417|NCT02229539|11205569|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
7089418|NCT02229539|11205567|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
7089419|NCT02229539|11205568|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
7089420|NCT02229539|11205569|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1
7089421|NCT02229539|11205567|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
7089422|NCT02229539|11205568|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
7089423|NCT02229539|11205569|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1
7089424|NCT02229539|11205567|FG000|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3
7089425|NCT02229539|11205568|FG001|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4
7089426|NCT02229539|11205569|FG002|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1
7089427|NCT02229539|11205567|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
7089428|NCT02229539|11205568|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
7089429|NCT02229539|11205569|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6
7089430|NCT02229539|11205567|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2
7089431|NCT02229539|11205568|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
7089432|NCT02229539|11205569|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
7089433|NCT02229539|11205567|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0
7089434|NCT02229539|11205568|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
7089435|NCT02229539|11205569|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
7089436|NCT02229539|11205567|FG000|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
7089437|NCT02229539|11205568|FG001|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
7089438|NCT02229539|11205569|FG002|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3
7089439|NCT02229539|11205567|FG000|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2
7089440|NCT02229539|11205568|FG001|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1
7089441|NCT02229539|11205569|FG002|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0
7089442|NCT02229552|11205577|FG000|Baseline|Withdrawal by Subject|6
7089443|NCT02229552|11205577|FG000|1-year Follow up|Withdrawal by Subject|7
7089444|NCT02229552|11205577|FG000|1-year Follow up|Lost to Follow-up|18
7089445|NCT02229552|11205577|FG000|2-Year Follow up|Withdrawal by Subject|9
7089446|NCT02229552|11205577|FG000|2-Year Follow up|Lost to Follow-up|17
7089447|NCT02229851|11205584|FG000|Main Phase (Double-blind Phase)|Unclassified|1
7089448|NCT02229851|11205585|FG001|Main Phase (Double-blind Phase)|Unclassified|2
7089449|NCT02229851|11205586|FG002|Main Phase (Double-blind Phase)|Unclassified|0
7089450|NCT02229851|11205587|FG003|Main Phase (Double-blind Phase)|Unclassified|0
7089451|NCT02229851|11205588|FG004|Main Phase (Double-blind Phase)|Unclassified|0
7089452|NCT02229851|11205589|FG005|Main Phase (Double-blind Phase)|Unclassified|0
7089453|NCT02229851|11205590|FG006|Main Phase (Double-blind Phase)|Unclassified|0
7089454|NCT02229851|11205584|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0
7089455|NCT02229851|11205585|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1
7089456|NCT02229851|11205586|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0
7089457|NCT02229851|11205587|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0
7089458|NCT02229851|11205588|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0
7089459|NCT02229851|11205589|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0
7089460|NCT02229851|11205590|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0
7089461|NCT02229851|11205584|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4
7089462|NCT02229851|11205585|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12
7089463|NCT02229851|11205586|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4
7089464|NCT02229851|11205587|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
7089465|NCT02229851|11205588|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
7089466|NCT02229851|11205589|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
7089467|NCT02229851|11205590|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
7089468|NCT02229851|11205584|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0
7089469|NCT02229851|11205585|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0
7089470|NCT02229851|11205586|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2
7089471|NCT02229851|11205587|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0
7089472|NCT02229851|11205588|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0
7089473|NCT02229851|11205589|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0
7089474|NCT02229851|11205590|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0
7089475|NCT02229851|11205584|FG000|Main Phase (Double-blind Phase)|Death|1
7089476|NCT02229851|11205585|FG001|Main Phase (Double-blind Phase)|Death|1
7089477|NCT02229851|11205586|FG002|Main Phase (Double-blind Phase)|Death|0
7089478|NCT02229851|11205587|FG003|Main Phase (Double-blind Phase)|Death|0
7089479|NCT02229851|11205588|FG004|Main Phase (Double-blind Phase)|Death|0
7089480|NCT02229851|11205589|FG005|Main Phase (Double-blind Phase)|Death|0
7089481|NCT02229851|11205590|FG006|Main Phase (Double-blind Phase)|Death|0
7089482|NCT02229851|11205584|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0
7089483|NCT02229851|11205585|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0
7089484|NCT02229851|11205586|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0
7089485|NCT02229851|11205587|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0
7089486|NCT02229851|11205588|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1
7089487|NCT02229851|11205589|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1
7089488|NCT02229851|11205590|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1
7089489|NCT02229851|11205584|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0
7089490|NCT02229851|11205585|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0
7089491|NCT02229851|11205586|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0
7089492|NCT02229851|11205587|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1
7089493|NCT02229851|11205588|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4
7089494|NCT02229851|11205589|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3
7089495|NCT02229851|11205590|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1
7089496|NCT02229851|11205584|FG000|Extension Phase (Open-label Phase)|Death|0
7089497|NCT02229851|11205585|FG001|Extension Phase (Open-label Phase)|Death|0
7089498|NCT02229851|11205586|FG002|Extension Phase (Open-label Phase)|Death|0
7089499|NCT02229851|11205587|FG003|Extension Phase (Open-label Phase)|Death|1
7089500|NCT02229851|11205588|FG004|Extension Phase (Open-label Phase)|Death|0
7089501|NCT02229851|11205589|FG005|Extension Phase (Open-label Phase)|Death|1
7089502|NCT02229851|11205590|FG006|Extension Phase (Open-label Phase)|Death|1
7089503|NCT02229864|11205605|FG000|Overall Study|Death|2
7089504|NCT02229864|11205605|FG000|Overall Study|Lost to Follow-up|1
7089505|NCT02230085|11205609|FG000|Overall Study|Physician Decision|1
7089506|NCT02230085|11205609|FG000|Overall Study|Withdrawal by Subject|3
7089507|NCT02230306|11205613|FG000|Overall Study|Did not receive study treatment|1
7089508|NCT02230332|11205619|FG000|Overall Study|Adverse Event|2
7089509|NCT02230332|11205620|FG001|Overall Study|Adverse Event|1
7089510|NCT02230332|11205619|FG000|Overall Study|Lost to Follow-up|1
7089511|NCT02230332|11205620|FG001|Overall Study|Lost to Follow-up|0
7089512|NCT02230332|11205619|FG000|Overall Study|Protocol Violation|1
7089513|NCT02230332|11205620|FG001|Overall Study|Protocol Violation|0
7089514|NCT02230384|11205628|FG000|Phase 1|Lost to Follow-up|1
7089515|NCT02230384|11205629|FG001|Phase 1|Lost to Follow-up|0
7089516|NCT02230384|11205628|FG000|Phase 1|Physician Decision|0
7089517|NCT02230384|11205629|FG001|Phase 1|Physician Decision|1
7089518|NCT02230384|11205628|FG000|Phase 2 - Switch|Withdrawal by Subject|0
7089519|NCT02230384|11205629|FG001|Phase 2 - Switch|Withdrawal by Subject|1
7089520|NCT02230384|11205628|FG000|Phase 2 - Switch|Lost to Follow-up|1
7089521|NCT02230384|11205629|FG001|Phase 2 - Switch|Lost to Follow-up|0
7089522|NCT02230384|11205628|FG000|Phase 2 - Switch|Adverse Event|2
7089523|NCT02230384|11205629|FG001|Phase 2 - Switch|Adverse Event|0
7089524|NCT02230527|11205645|FG000|Overall Study|Withdrawal by Subject|1
7089525|NCT02230527|11205646|FG001|Overall Study|Withdrawal by Subject|1
7089526|NCT02230527|11205645|FG000|Overall Study|Death|1
7089527|NCT02230527|11205646|FG001|Overall Study|Death|0
7089528|NCT02230527|11205645|FG000|Overall Study|Lost to Follow-up|2
7089529|NCT02230527|11205646|FG001|Overall Study|Lost to Follow-up|1
7089530|NCT02230527|11205645|FG000|Overall Study|Other|1
7089531|NCT02230527|11205646|FG001|Overall Study|Other|0
7089532|NCT02230670|11205700|FG000|Overall Study|Adverse Event|1
7089533|NCT02230670|11205701|FG001|Overall Study|Adverse Event|2
7089534|NCT02230670|11205700|FG000|Overall Study|Withdrawal by Subject|2
7089535|NCT02230670|11205701|FG001|Overall Study|Withdrawal by Subject|2
7089536|NCT02230670|11205700|FG000|Overall Study|Physician Decision|0
7089537|NCT02230670|11205701|FG001|Overall Study|Physician Decision|1
7089538|NCT02230670|11205700|FG000|Overall Study|Protocol Violation|0
7089539|NCT02230670|11205701|FG001|Overall Study|Protocol Violation|1
7089540|NCT02230670|11205700|FG000|Overall Study|Progression to Child-Pugh C|1
7089541|NCT02230670|11205701|FG001|Overall Study|Progression to Child-Pugh C|2
7089542|NCT02230683|11205707|FG000|Overall Study|Adverse Event|1
7089543|NCT02230904|11205741|FG000|Overall Study|Safety follow up could not take place|0
7089544|NCT02230904|11205742|FG001|Overall Study|Safety follow up could not take place|1
7089545|NCT02230956|11205753|FG000|Overall Study|Adverse Event|1
7089546|NCT02230956|11205754|FG001|Overall Study|Adverse Event|1
7089547|NCT02230956|11205755|FG002|Overall Study|Adverse Event|0
7089548|NCT02230956|11205753|FG000|Overall Study|Lack of Efficacy|1
7089549|NCT02230956|11205754|FG001|Overall Study|Lack of Efficacy|1
7089550|NCT02230956|11205755|FG002|Overall Study|Lack of Efficacy|1
7089551|NCT02230956|11205753|FG000|Overall Study|Lost to Follow-up|1
7089552|NCT02230956|11205754|FG001|Overall Study|Lost to Follow-up|1
7089553|NCT02230956|11205755|FG002|Overall Study|Lost to Follow-up|2
7089554|NCT02230956|11205753|FG000|Overall Study|Personal Reasons|2
7089555|NCT02230956|11205754|FG001|Overall Study|Personal Reasons|1
7089556|NCT02230956|11205755|FG002|Overall Study|Personal Reasons|1
7089557|NCT02230956|11205753|FG000|Overall Study|Protocol Violation|0
7089558|NCT02230956|11205754|FG001|Overall Study|Protocol Violation|1
7089559|NCT02230956|11205755|FG002|Overall Study|Protocol Violation|1
7089560|NCT02230956|11205753|FG000|Overall Study|Other Miscellaneous Reason|0
7089561|NCT02230956|11205754|FG001|Overall Study|Other Miscellaneous Reason|1
7089562|NCT02230956|11205755|FG002|Overall Study|Other Miscellaneous Reason|2
7089563|NCT02231164|11205783|FG000|Overall Study|Adverse Event|1
7089564|NCT02231164|11205784|FG001|Overall Study|Adverse Event|1
7089565|NCT02231164|11205783|FG000|Overall Study|Lack of Efficacy|4
7089566|NCT02231164|11205784|FG001|Overall Study|Lack of Efficacy|3
7089567|NCT02231164|11205783|FG000|Overall Study|Withdrawal by Subject|1
7089568|NCT02231164|11205784|FG001|Overall Study|Withdrawal by Subject|2
7089569|NCT02231580|11205806|FG000|Overall Study|Adverse Event|5
7089570|NCT02231580|11205807|FG001|Overall Study|Adverse Event|0
7089571|NCT02231918|11205818|FG000|Overall Study|Withdrawal by Subject|0
7089572|NCT02231918|11205819|FG001|Overall Study|Withdrawal by Subject|1
7089573|NCT02231918|11205820|FG002|Overall Study|Withdrawal by Subject|0
7089574|NCT02231918|11205818|FG000|Overall Study|Adverse Event|0
7089575|NCT02231918|11205819|FG001|Overall Study|Adverse Event|0
7089576|NCT02231918|11205820|FG002|Overall Study|Adverse Event|1
7089577|NCT02232061|11205838|FG000|Overall Study|Administrative problems|1
7089578|NCT02232061|11205838|FG000|Overall Study|Withdrawal by Subject|1
7089579|NCT02232074|11205844|FG000|Overall Study|Withdrawal by Subject|5
7089580|NCT02232074|11205845|FG001|Overall Study|Withdrawal by Subject|3
7089581|NCT02232074|11205844|FG000|Overall Study|No legal concerns at baseline|36
7089582|NCT02232074|11205845|FG001|Overall Study|No legal concerns at baseline|41
7089583|NCT02232074|11205844|FG000|Overall Study|deemed ineligible|0
7089584|NCT02232074|11205845|FG001|Overall Study|deemed ineligible|1
7089585|NCT02232178|11205871|FG000|Overall Study|Lost to Follow-up|0
7089586|NCT02232178|11205872|FG001|Overall Study|Lost to Follow-up|1
7089587|NCT02232178|11205873|FG002|Overall Study|Lost to Follow-up|0
7089588|NCT02232178|11205871|FG000|Overall Study|ineligibility|0
7089589|NCT02232178|11205872|FG001|Overall Study|ineligibility|0
7089590|NCT02232178|11205873|FG002|Overall Study|ineligibility|1
7089591|NCT02232178|11205871|FG000|Overall Study|surgical complication|1
7089592|NCT02232178|11205872|FG001|Overall Study|surgical complication|0
7089593|NCT02232178|11205873|FG002|Overall Study|surgical complication|0
7089594|NCT02232243|11205884|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0
7089595|NCT02232243|11205885|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1
7089596|NCT02232243|11205886|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0
7089597|NCT02232425|11205897|FG000|Overall Study|Lost to Follow-up|6
7089598|NCT02232425|11205898|FG001|Overall Study|Lost to Follow-up|2
7089599|NCT02232425|11205897|FG000|Overall Study|Adverse Event|2
7089600|NCT02232425|11205898|FG001|Overall Study|Adverse Event|0
7089601|NCT02232425|11205897|FG000|Overall Study|Withdrawal by Subject|5
7089602|NCT02232425|11205898|FG001|Overall Study|Withdrawal by Subject|6
7089603|NCT02232425|11205897|FG000|Overall Study|Lack of Efficacy|1
7089604|NCT02232425|11205898|FG001|Overall Study|Lack of Efficacy|0
7089605|NCT02232698|11205906|FG000|Overall Study|Pregnancy|1
7089606|NCT02232698|11205907|FG001|Overall Study|Pregnancy|1
7089607|NCT02232698|11205906|FG000|Overall Study|Met exclusion criteria|1
7089608|NCT02232698|11205907|FG001|Overall Study|Met exclusion criteria|1
7089609|NCT02232698|11205906|FG000|Overall Study|Had device-associated symptoms|7
7089610|NCT02232698|11205907|FG001|Overall Study|Had device-associated symptoms|0
7089611|NCT02232698|11205906|FG000|Overall Study|Non-compliance with study device|1
7089612|NCT02232698|11205907|FG001|Overall Study|Non-compliance with study device|4
7089613|NCT02232698|11205906|FG000|Overall Study|Allocated to control group|0
7089614|NCT02232698|11205907|FG001|Overall Study|Allocated to control group|3
7089615|NCT02232698|11205906|FG000|Overall Study|Withdrawal by Subject|0
7089616|NCT02232698|11205907|FG001|Overall Study|Withdrawal by Subject|11
7089617|NCT02232802|11205915|FG000|Period 1|Sponsor request|1
7089618|NCT02232802|11205916|FG001|Period 1|Sponsor request|0
7089619|NCT02232802|11205915|FG000|Period 1|Adverse Event|1
7089620|NCT02232802|11205916|FG001|Period 1|Adverse Event|1
7089621|NCT02232893|11205924|FG000|Overall Study|Withdrawal by Subject|4
7089622|NCT02232893|11205925|FG001|Overall Study|Withdrawal by Subject|1
7089623|NCT02232893|11205924|FG000|Overall Study|Adverse Event|0
7089624|NCT02232893|11205925|FG001|Overall Study|Adverse Event|1
7089625|NCT02232893|11205924|FG000|Overall Study|Sponsor request early termination|0
7089626|NCT02232893|11205925|FG001|Overall Study|Sponsor request early termination|1
7089627|NCT02232893|11205924|FG000|Overall Study|Developed exclusion criteria|0
7089628|NCT02232893|11205925|FG001|Overall Study|Developed exclusion criteria|1
7089629|NCT02232893|11205924|FG000|Overall Study|Other|0
7089630|NCT02232893|11205925|FG001|Overall Study|Other|3
7089631|NCT02232984|11205931|FG000|Overall Study|Withdrawal by Subject|5
7089632|NCT02232984|11205931|FG000|Overall Study|Death|1
7089633|NCT02232984|11205931|FG000|Overall Study|Investigator withdrawal|10
7089634|NCT02232984|11205931|FG000|Overall Study|Device implant unsuccessful|53
7089635|NCT02232984|11205931|FG000|Overall Study|not disclosed by site|7
7089636|NCT02232984|11205931|FG000|Overall Study|Protocol Violation|1
7089637|NCT02233309|11205960|FG000|Overall Study|Physician Decision|5
7089638|NCT02233413|11205966|FG000|Overall Study|Lost to Follow-up|7
7089639|NCT02233413|11205967|FG001|Overall Study|Lost to Follow-up|9
7089640|NCT02233413|11205966|FG000|Overall Study|Withdrawal by Subject|4
7089641|NCT02233413|11205967|FG001|Overall Study|Withdrawal by Subject|5
7089642|NCT02233543|11205999|FG000|Period 1|Withdrawal by Subject|1
7089643|NCT02233543|11206000|FG001|Period 1|Withdrawal by Subject|0
7089644|NCT02233543|11205999|FG000|Period 1|Participants required other treatment.|2
7089645|NCT02233543|11206000|FG001|Period 1|Participants required other treatment.|3
7089646|NCT02233543|11205999|FG000|Period 2|Adverse Event|1
7089647|NCT02233543|11206000|FG001|Period 2|Adverse Event|0
7089648|NCT02233543|11205999|FG000|Period 2|Participant required other treatment.|0
7089649|NCT02233543|11206000|FG001|Period 2|Participant required other treatment.|1
7089650|NCT02233543|11205999|FG000|Period 2|COPD exacerbation|1
7089651|NCT02233543|11206000|FG001|Period 2|COPD exacerbation|0
7089652|NCT02233647|11206006|FG000|Overall Study|Adverse Event|1
7089653|NCT02233738|11206012|FG000|Overall Study|Lost to Follow-up|5
7089654|NCT02233738|11206013|FG001|Overall Study|Lost to Follow-up|12
7089655|NCT02233738|11206012|FG000|Overall Study|Death|0
7089656|NCT02233738|11206013|FG001|Overall Study|Death|1
7089657|NCT02233738|11206012|FG000|Overall Study|Withdrawal by Subject|0
7089658|NCT02233738|11206013|FG001|Overall Study|Withdrawal by Subject|1
7089659|NCT02233738|11206012|FG000|Overall Study|Did not return after Baseline|3
7089660|NCT02233738|11206013|FG001|Overall Study|Did not return after Baseline|2
7089661|NCT02233803|11206190|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1
7089662|NCT02233803|11206191|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0
7089663|NCT02233803|11206190|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0
7089664|NCT02233803|11206191|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1
7089665|NCT02233803|11206190|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2
7089666|NCT02233803|11206191|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2
7089667|NCT02233803|11206190|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0
7089668|NCT02233803|11206191|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1
7089669|NCT02233803|11206190|FG000|Washout Period (4-Wks)|Lost to Follow-up|0
7089670|NCT02233803|11206191|FG001|Washout Period (4-Wks)|Lost to Follow-up|1
7089671|NCT02233803|11206190|FG000|Washout Period (4-Wks)|Physician Decision|1
7089672|NCT02233803|11206191|FG001|Washout Period (4-Wks)|Physician Decision|0
7089673|NCT02233803|11206190|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1
7089674|NCT02233803|11206191|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1
7089675|NCT02233803|11206190|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1
7089676|NCT02233803|11206191|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0
7089677|NCT02233803|11206190|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1
7089678|NCT02233803|11206191|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2
7089679|NCT02233946|11206206|FG000|Baseline|Withdrawal by Subject|2
7089680|NCT02233946|11206207|FG001|Baseline|Withdrawal by Subject|0
7089681|NCT02233946|11206206|FG000|3-months Follow-up|Lost to Follow-up|53
7089682|NCT02233946|11206207|FG001|3-months Follow-up|Lost to Follow-up|29
7089683|NCT02233946|11206206|FG000|6-months Follow-up|Lost to Follow-up|21
7089684|NCT02233946|11206207|FG001|6-months Follow-up|Lost to Follow-up|2
7089685|NCT02233946|11206206|FG000|9-month Follow-up|Lost to Follow-up|20
7089686|NCT02233946|11206207|FG001|9-month Follow-up|Lost to Follow-up|11
7089687|NCT02233946|11206206|FG000|12-month Follow-up|Lost to Follow-up|28
7089688|NCT02233946|11206207|FG001|12-month Follow-up|Lost to Follow-up|11
7089689|NCT02234063|11206239|FG000|Overall Study|Lost to Follow-up|235
7089690|NCT02234063|11206240|FG001|Overall Study|Lost to Follow-up|42
7089691|NCT02234063|11206239|FG000|Overall Study|Withdrawal by Subject|20
7089692|NCT02234063|11206240|FG001|Overall Study|Withdrawal by Subject|1
7089693|NCT02234141|11206272|FG000|Treatment Period (24 Weeks)|Protocol Violation|0
7089694|NCT02234141|11206273|FG001|Treatment Period (24 Weeks)|Protocol Violation|0
7089695|NCT02234141|11206274|FG002|Treatment Period (24 Weeks)|Protocol Violation|0
7089696|NCT02234141|11206275|FG003|Treatment Period (24 Weeks)|Protocol Violation|1
7089697|NCT02234141|11206276|FG004|Treatment Period (24 Weeks)|Protocol Violation|0
7089698|NCT02234141|11206277|FG005|Treatment Period (24 Weeks)|Protocol Violation|0
7089699|NCT02234141|11206278|FG006|Treatment Period (24 Weeks)|Protocol Violation|0
7089700|NCT02234141|11206272|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0
7089701|NCT02234141|11206273|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2
7089702|NCT02234141|11206274|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0
7089703|NCT02234141|11206275|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0
7089704|NCT02234141|11206276|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0
7089705|NCT02234141|11206277|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0
7089706|NCT02234141|11206278|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0
7089707|NCT02234141|11206272|FG000|Treatment Period (24 Weeks)|Death|1
7089708|NCT02234141|11206273|FG001|Treatment Period (24 Weeks)|Death|2
7089709|NCT02234141|11206274|FG002|Treatment Period (24 Weeks)|Death|0
7089710|NCT02234141|11206275|FG003|Treatment Period (24 Weeks)|Death|1
7089711|NCT02234141|11206276|FG004|Treatment Period (24 Weeks)|Death|0
7089712|NCT02234141|11206277|FG005|Treatment Period (24 Weeks)|Death|0
7089713|NCT02234141|11206278|FG006|Treatment Period (24 Weeks)|Death|0
7089714|NCT02234141|11206272|FG000|Treatment Period (24 Weeks)|Adverse Event|3
7089715|NCT02234141|11206273|FG001|Treatment Period (24 Weeks)|Adverse Event|1
7089716|NCT02234141|11206274|FG002|Treatment Period (24 Weeks)|Adverse Event|2
7089717|NCT02234141|11206275|FG003|Treatment Period (24 Weeks)|Adverse Event|3
7089718|NCT02234141|11206276|FG004|Treatment Period (24 Weeks)|Adverse Event|0
7089719|NCT02234141|11206277|FG005|Treatment Period (24 Weeks)|Adverse Event|0
7089720|NCT02234141|11206278|FG006|Treatment Period (24 Weeks)|Adverse Event|0
7089721|NCT02234141|11206272|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0
7089722|NCT02234141|11206273|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1
7089723|NCT02234141|11206274|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0
7089724|NCT02234141|11206275|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0
7089725|NCT02234141|11206276|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0
7089726|NCT02234141|11206277|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0
7089727|NCT02234141|11206278|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0
7089728|NCT02234141|11206272|FG000|Long-Term Treatment Period|Death|0
7089729|NCT02234141|11206273|FG001|Long-Term Treatment Period|Death|0
7089730|NCT02234141|11206274|FG002|Long-Term Treatment Period|Death|0
7089731|NCT02234141|11206275|FG003|Long-Term Treatment Period|Death|0
7089732|NCT02234141|11206276|FG004|Long-Term Treatment Period|Death|0
7089733|NCT02234141|11206277|FG005|Long-Term Treatment Period|Death|1
7089734|NCT02234141|11206278|FG006|Long-Term Treatment Period|Death|0
7089735|NCT02234141|11206272|FG000|Long-Term Treatment Period|Investigator's discretion|1
7089736|NCT02234141|11206273|FG001|Long-Term Treatment Period|Investigator's discretion|3
7089737|NCT02234141|11206274|FG002|Long-Term Treatment Period|Investigator's discretion|2
7089738|NCT02234141|11206275|FG003|Long-Term Treatment Period|Investigator's discretion|0
7089739|NCT02234141|11206276|FG004|Long-Term Treatment Period|Investigator's discretion|0
7089740|NCT02234141|11206277|FG005|Long-Term Treatment Period|Investigator's discretion|0
7089741|NCT02234141|11206278|FG006|Long-Term Treatment Period|Investigator's discretion|1
7089742|NCT02234141|11206272|FG000|Long-Term Treatment Period|Adverse Event|4
7089743|NCT02234141|11206273|FG001|Long-Term Treatment Period|Adverse Event|0
7089744|NCT02234141|11206274|FG002|Long-Term Treatment Period|Adverse Event|5
7089745|NCT02234141|11206275|FG003|Long-Term Treatment Period|Adverse Event|0
7089746|NCT02234141|11206276|FG004|Long-Term Treatment Period|Adverse Event|1
7089747|NCT02234141|11206277|FG005|Long-Term Treatment Period|Adverse Event|1
7089748|NCT02234141|11206278|FG006|Long-Term Treatment Period|Adverse Event|1
7089749|NCT02234141|11206272|FG000|Long-Term Treatment Period|Withdrew Consent|0
7089750|NCT02234141|11206273|FG001|Long-Term Treatment Period|Withdrew Consent|1
7089751|NCT02234141|11206274|FG002|Long-Term Treatment Period|Withdrew Consent|1
7089752|NCT02234141|11206275|FG003|Long-Term Treatment Period|Withdrew Consent|0
7089753|NCT02234141|11206276|FG004|Long-Term Treatment Period|Withdrew Consent|0
7089754|NCT02234141|11206277|FG005|Long-Term Treatment Period|Withdrew Consent|0
7089755|NCT02234141|11206278|FG006|Long-Term Treatment Period|Withdrew Consent|0
7089756|NCT02234141|11206272|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28
7089757|NCT02234141|11206273|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27
7089758|NCT02234141|11206274|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25
7089759|NCT02234141|11206275|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0
7089760|NCT02234141|11206276|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9
7089761|NCT02234141|11206277|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10
7089762|NCT02234141|11206278|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8
7089763|NCT02234284|11206296|FG000|Overall Study|Death|4
7089764|NCT02234284|11206297|FG001|Overall Study|Death|2
7089765|NCT02234284|11206296|FG000|Overall Study|Withdrawal by Subject|1
7089766|NCT02234284|11206297|FG001|Overall Study|Withdrawal by Subject|0
7089767|NCT02234284|11206296|FG000|Overall Study|Lost to Follow-up|20
7089768|NCT02234284|11206297|FG001|Overall Study|Lost to Follow-up|7
7089769|NCT02234362|11206307|FG000|Overall Study|Not eligible after first screening visit|17
7089770|NCT02234362|11206307|FG000|Overall Study|Lost to Follow-up|6
7089771|NCT02234362|11206307|FG000|Overall Study|Withdrawal by Subject|3
7089772|NCT02234479|11206317|FG000|Overall Study|Withdrawal by Subject|1
7089773|NCT02234479|11206318|FG001|Overall Study|Withdrawal by Subject|3
7089774|NCT02234583|11206359|FG000|Overall Study|Adverse Event|172
7089775|NCT02234583|11206360|FG001|Overall Study|Adverse Event|156
7089776|NCT02234583|11206359|FG000|Overall Study|Withdrawal by Subject|109
7089777|NCT02234583|11206360|FG001|Overall Study|Withdrawal by Subject|157
7089778|NCT02234583|11206359|FG000|Overall Study|Lost to Follow-up|0
7089779|NCT02234583|11206360|FG001|Overall Study|Lost to Follow-up|1
7089780|NCT02234583|11206359|FG000|Overall Study|Lack of Efficacy|58
7089781|NCT02234583|11206360|FG001|Overall Study|Lack of Efficacy|103
7089782|NCT02234583|11206359|FG000|Overall Study|Protocol Violation|35
7089783|NCT02234583|11206360|FG001|Overall Study|Protocol Violation|42
7089784|NCT02234583|11206359|FG000|Overall Study|Other|39
7089785|NCT02234583|11206360|FG001|Overall Study|Other|97
7089786|NCT02234596|11206372|FG000|Overall Study|Participant not treated|2
7089787|NCT02234622|11206378|FG000|Overall Study|Withdrawal by Subject|16
7089788|NCT02234622|11206379|FG001|Overall Study|Withdrawal by Subject|22
7089789|NCT02234622|11206378|FG000|Overall Study|Lost to Follow-up|27
7089790|NCT02234622|11206379|FG001|Overall Study|Lost to Follow-up|14
7089791|NCT02235077|11206415|FG000|Overall Study|Death|5
7089792|NCT02235077|11206416|FG001|Overall Study|Death|7
7089793|NCT02235077|11206415|FG000|Overall Study|Lost to Follow-up|5
7089794|NCT02235077|11206416|FG001|Overall Study|Lost to Follow-up|6
7089795|NCT02235077|11206415|FG000|Overall Study|Withdrawal by Subject|8
7089796|NCT02235077|11206416|FG001|Overall Study|Withdrawal by Subject|5
7089797|NCT02235077|11206415|FG000|Overall Study|Physician Decision|0
7089798|NCT02235077|11206416|FG001|Overall Study|Physician Decision|1
7089799|NCT02235298|11206428|FG000|Overall Study|Lost to Follow-up|6
7089800|NCT02235298|11206429|FG001|Overall Study|Lost to Follow-up|5
7089801|NCT02235298|11206428|FG000|Overall Study|Adverse Event|2
7089802|NCT02235298|11206429|FG001|Overall Study|Adverse Event|2
7089803|NCT02235298|11206428|FG000|Overall Study|Withdrawal by Subject|0
7089804|NCT02235298|11206429|FG001|Overall Study|Withdrawal by Subject|1
7089805|NCT02235311|11206437|FG000|Overall Study|Lost to Follow-up|0
7089806|NCT02235311|11206438|FG001|Overall Study|Lost to Follow-up|1
7089807|NCT02235311|11206437|FG000|Overall Study|Protocol Violation|0
7089808|NCT02235311|11206438|FG001|Overall Study|Protocol Violation|1
7089809|NCT02235454|11206444|FG000|Overall Study|Withdrawal by Subject|2
7089810|NCT02236130|11206489|FG000|Overall Study|Lost to Follow-up|7
7089811|NCT02236130|11206490|FG001|Overall Study|Lost to Follow-up|12
7089812|NCT02236520|11206509|FG000|Overall Study|Physician Decision|0
7089813|NCT02236520|11206510|FG001|Overall Study|Physician Decision|5
7089814|NCT02236520|11206511|FG002|Overall Study|Physician Decision|0
7089815|NCT02236520|11206512|FG003|Overall Study|Physician Decision|0
7089816|NCT02236520|11206509|FG000|Overall Study|Withdrawal by Subject|1
7089817|NCT02236520|11206510|FG001|Overall Study|Withdrawal by Subject|0
7089818|NCT02236520|11206511|FG002|Overall Study|Withdrawal by Subject|0
7089819|NCT02236520|11206512|FG003|Overall Study|Withdrawal by Subject|1
7089820|NCT02236520|11206509|FG000|Overall Study|Pregnancy|1
7089821|NCT02236520|11206510|FG001|Overall Study|Pregnancy|0
7089822|NCT02236520|11206511|FG002|Overall Study|Pregnancy|0
7089823|NCT02236520|11206512|FG003|Overall Study|Pregnancy|0
7089824|NCT02236559|11206524|FG000|Overall Study|Met Exclusion|3
7089825|NCT02236559|11206525|FG001|Overall Study|Met Exclusion|6
7089826|NCT02236559|11206524|FG000|Overall Study|Did not Meet Inclusion|3
7089827|NCT02236559|11206525|FG001|Overall Study|Did not Meet Inclusion|3
7089828|NCT02236559|11206524|FG000|Overall Study|Subject Did Not Consent|4
7089829|NCT02236559|11206525|FG001|Overall Study|Subject Did Not Consent|2
7089830|NCT02236559|11206524|FG000|Overall Study|Physician Decision|1
7089831|NCT02236559|11206525|FG001|Overall Study|Physician Decision|1
7089832|NCT02236559|11206524|FG000|Overall Study|Withdrawal by Subject|1
7089833|NCT02236559|11206525|FG001|Overall Study|Withdrawal by Subject|0
7089834|NCT02236598|11206533|FG000|Overall Study|Adverse Event|0
7089835|NCT02236598|11206534|FG001|Overall Study|Adverse Event|1
7089836|NCT02236598|11206533|FG000|Overall Study|Withdrawal by Subject|0
7089837|NCT02236598|11206534|FG001|Overall Study|Withdrawal by Subject|1
7089838|NCT02236611|11206542|FG000|Overall Study|Adverse Event|10
7089839|NCT02236611|11206543|FG001|Overall Study|Adverse Event|16
7089840|NCT02236611|11206542|FG000|Overall Study|Lack of Efficacy|4
7089841|NCT02236611|11206543|FG001|Overall Study|Lack of Efficacy|7
7089842|NCT02236611|11206542|FG000|Overall Study|Lost to Follow-up|0
7089843|NCT02236611|11206543|FG001|Overall Study|Lost to Follow-up|2
7089844|NCT02236611|11206542|FG000|Overall Study|Protocol deviation|3
7089845|NCT02236611|11206543|FG001|Overall Study|Protocol deviation|5
7089846|NCT02236611|11206542|FG000|Overall Study|Withdrew consent|9
7089847|NCT02236611|11206543|FG001|Overall Study|Withdrew consent|4
7089848|NCT02236988|11206557|FG000|Overall Study|Lost to Follow-up|0
7089849|NCT02236988|11206558|FG001|Overall Study|Lost to Follow-up|0
7089850|NCT02236988|11206559|FG002|Overall Study|Lost to Follow-up|0
7089851|NCT02236988|11206560|FG003|Overall Study|Lost to Follow-up|1
7089852|NCT02236988|11206557|FG000|Overall Study|Unable to Comply with Study Visits|0
7089853|NCT02236988|11206558|FG001|Overall Study|Unable to Comply with Study Visits|0
7089854|NCT02236988|11206559|FG002|Overall Study|Unable to Comply with Study Visits|0
7089855|NCT02236988|11206560|FG003|Overall Study|Unable to Comply with Study Visits|2
7089856|NCT02237001|11206611|FG000|Overall Study|Lost to Follow-up|2
7089857|NCT02237001|11206611|FG000|Overall Study|Withdrawal by Subject|1
7089858|NCT02237001|11206611|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3
7089859|NCT02237001|11206611|FG000|Overall Study|Re-operation|4
7089860|NCT02237001|11206611|FG000|Overall Study|Incarceration|1
7089861|NCT02237118|11206632|FG000|Overall Study|Protocol Violation|0
7089862|NCT02237118|11206633|FG001|Overall Study|Protocol Violation|1
7089863|NCT02237118|11206632|FG000|Overall Study|consent withdrawn|1
7089864|NCT02237118|11206633|FG001|Overall Study|consent withdrawn|0
7089865|NCT02237157|11206647|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3
7089866|NCT02237157|11206648|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0
7089867|NCT02237157|11206649|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0
7089868|NCT02237157|11206650|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0
7089869|NCT02237157|11206647|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1
7089870|NCT02237157|11206648|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0
7089871|NCT02237157|11206649|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0
7089872|NCT02237157|11206650|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0
7089873|NCT02237196|11206661|FG000|Overall Study|Adverse Event|0
7089874|NCT02237196|11206662|FG001|Overall Study|Adverse Event|1
7089875|NCT02237196|11206663|FG002|Overall Study|Adverse Event|1
7089876|NCT02237196|11206664|FG003|Overall Study|Adverse Event|0
7089877|NCT02237196|11206661|FG000|Overall Study|Lost to Follow-up|4
7089878|NCT02237196|11206662|FG001|Overall Study|Lost to Follow-up|2
7089879|NCT02237196|11206663|FG002|Overall Study|Lost to Follow-up|4
7089880|NCT02237196|11206664|FG003|Overall Study|Lost to Follow-up|6
7089881|NCT02237196|11206661|FG000|Overall Study|Physician Decision|2
7089882|NCT02237196|11206662|FG001|Overall Study|Physician Decision|0
7089883|NCT02237196|11206663|FG002|Overall Study|Physician Decision|0
7089884|NCT02237196|11206664|FG003|Overall Study|Physician Decision|1
7089885|NCT02237196|11206661|FG000|Overall Study|Pregnancy|0
7089886|NCT02237196|11206662|FG001|Overall Study|Pregnancy|0
7089887|NCT02237196|11206663|FG002|Overall Study|Pregnancy|1
7089888|NCT02237196|11206664|FG003|Overall Study|Pregnancy|1
7089889|NCT02237196|11206661|FG000|Overall Study|Withdrawal by Subject|1
7089890|NCT02237196|11206662|FG001|Overall Study|Withdrawal by Subject|1
7089891|NCT02237196|11206663|FG002|Overall Study|Withdrawal by Subject|4
7089892|NCT02237196|11206664|FG003|Overall Study|Withdrawal by Subject|1
7089893|NCT02237196|11206661|FG000|Overall Study|Site Error|1
7089894|NCT02237196|11206662|FG001|Overall Study|Site Error|2
7089895|NCT02237196|11206663|FG002|Overall Study|Site Error|0
7089896|NCT02237196|11206664|FG003|Overall Study|Site Error|2
7089897|NCT02237911|11206701|FG000|Overall Study|Withdrawal by Subject|4
7089898|NCT02237911|11206702|FG001|Overall Study|Withdrawal by Subject|7
7089899|NCT02237911|11206703|FG002|Overall Study|Withdrawal by Subject|2
7089900|NCT02237911|11206701|FG000|Overall Study|Lost to Follow-up|3
7089901|NCT02237911|11206702|FG001|Overall Study|Lost to Follow-up|1
7089902|NCT02237911|11206703|FG002|Overall Study|Lost to Follow-up|1
7089903|NCT02238067|11206741|FG000|Overall Study|Not completed survey at Month 6|45
7089904|NCT02238080|11206745|FG000|Overall Study|Death|13
7089905|NCT02238080|11206745|FG000|Overall Study|Treatment interrupted|6
7089906|NCT02238080|11206745|FG000|Overall Study|Withdrawal by Subject|2
7089907|NCT02238080|11206745|FG000|Overall Study|Other|4
7089908|NCT02238379|11206751|FG000|Overall Study|Lost to Follow-up|1
7089909|NCT02238379|11206752|FG001|Overall Study|Lost to Follow-up|0
7089910|NCT02238483|11206760|FG000|Overall Study|Withdrawal by Subject|2
7089911|NCT02238483|11206761|FG001|Overall Study|Withdrawal by Subject|7
7089912|NCT02238483|11206760|FG000|Overall Study|Lost to Follow-up|1
7089913|NCT02238483|11206761|FG001|Overall Study|Lost to Follow-up|1
7089914|NCT02238483|11206760|FG000|Overall Study|Protocol Violation|1
7089915|NCT02238483|11206761|FG001|Overall Study|Protocol Violation|2
7089916|NCT02238483|11206760|FG000|Overall Study|Death|1
7089917|NCT02238483|11206761|FG001|Overall Study|Death|0
7089918|NCT02238483|11206760|FG000|Overall Study|Adverse Event|7
7089919|NCT02238483|11206761|FG001|Overall Study|Adverse Event|3
7089920|NCT02238483|11206760|FG000|Overall Study|Withdrawn due to physician decision|1
7089921|NCT02238483|11206761|FG001|Overall Study|Withdrawn due to physician decision|0
7089922|NCT02238483|11206760|FG000|Overall Study|Completion status not recorded|1
7089923|NCT02238483|11206761|FG001|Overall Study|Completion status not recorded|1
7089924|NCT02238483|11206760|FG000|Overall Study|Illness in family member|1
7089925|NCT02238483|11206761|FG001|Overall Study|Illness in family member|0
7089926|NCT02238626|11206771|FG000|Overall Study|Adverse Event|3
7089927|NCT02238626|11206772|FG001|Overall Study|Adverse Event|5
7089928|NCT02238626|11206773|FG002|Overall Study|Adverse Event|0
7089929|NCT02238626|11206774|FG003|Overall Study|Adverse Event|3
7089930|NCT02238626|11206771|FG000|Overall Study|Lost to Follow-up|2
7089931|NCT02238626|11206772|FG001|Overall Study|Lost to Follow-up|4
7089932|NCT02238626|11206773|FG002|Overall Study|Lost to Follow-up|2
7089933|NCT02238626|11206774|FG003|Overall Study|Lost to Follow-up|2
7089934|NCT02238626|11206771|FG000|Overall Study|Withdrawal by Subject|0
7089935|NCT02238626|11206772|FG001|Overall Study|Withdrawal by Subject|3
7089936|NCT02238626|11206773|FG002|Overall Study|Withdrawal by Subject|0
7089937|NCT02238626|11206774|FG003|Overall Study|Withdrawal by Subject|1
7089938|NCT02238626|11206771|FG000|Overall Study|Death|0
7089939|NCT02238626|11206772|FG001|Overall Study|Death|0
7089940|NCT02238626|11206773|FG002|Overall Study|Death|1
7089941|NCT02238626|11206774|FG003|Overall Study|Death|1
7089942|NCT02238626|11206771|FG000|Overall Study|Other|0
7089943|NCT02238626|11206772|FG001|Overall Study|Other|2
7089944|NCT02238626|11206773|FG002|Overall Study|Other|0
7089945|NCT02238626|11206774|FG003|Overall Study|Other|0
7089946|NCT02239094|11206821|FG000|Overall Study|Withdrawal by Subject|1
7089947|NCT02239094|11206821|FG000|Overall Study|Remitted before started|1
7089948|NCT02239120|11206827|FG000|Overall Study|Death|56
7089949|NCT02239120|11206828|FG001|Overall Study|Death|58
7089950|NCT02239120|11206827|FG000|Overall Study|Lost to Follow-up|19
7089951|NCT02239120|11206828|FG001|Overall Study|Lost to Follow-up|14
7089952|NCT02239224|11206838|FG000|Overall Study|Administrative|0
7089953|NCT02239224|11206839|FG001|Overall Study|Administrative|0
7089954|NCT02239224|11206840|FG002|Overall Study|Administrative|3
7089955|NCT02239224|11206841|FG003|Overall Study|Administrative|1
7089956|NCT02239263|11206851|FG000|Overall Study|Protocol Violation|6
7089957|NCT02239328|11206861|FG000|Overall Study|Benign disease noted at time of surgery|6
7089958|NCT02239328|11206861|FG000|Overall Study|Equipment or website malfunction|2
7089959|NCT02239510|11206871|FG000|Overall Study|Lost to Follow-up|2
7089960|NCT02239510|11206872|FG001|Overall Study|Lost to Follow-up|1
7089961|NCT02239536|11206880|FG000|Overall Study|Non-neoplastic polyp|23
7089962|NCT02239536|11206881|FG001|Overall Study|Non-neoplastic polyp|17
7089963|NCT02239601|11206916|FG000|Overall Study|Withdrawal by Subject|3
7089964|NCT02239601|11206917|FG001|Overall Study|Withdrawal by Subject|4
7089965|NCT02239601|11206916|FG000|Overall Study|Protocol Violation|4
7089966|NCT02239601|11206917|FG001|Overall Study|Protocol Violation|2
7089967|NCT02239640|11206928|FG000|Overall Study|Withdrawal by Subject|3
7089968|NCT02239640|11206928|FG000|Overall Study|Lost to Follow-up|72
7089969|NCT02239640|11206928|FG000|Overall Study|Death|142
7089970|NCT02239679|11206941|FG000|Overall Study|Lost to Follow-up|1
7089971|NCT02239679|11206942|FG001|Overall Study|Lost to Follow-up|0
7089972|NCT02239679|11206943|FG002|Overall Study|Lost to Follow-up|0
7089973|NCT02239679|11206941|FG000|Overall Study|Withdrawal by Subject|2
7089974|NCT02239679|11206942|FG001|Overall Study|Withdrawal by Subject|3
7089975|NCT02239679|11206943|FG002|Overall Study|Withdrawal by Subject|1
7089976|NCT02239692|11206953|FG000|Overall Study|Incomplete colonoscopy|1
7089977|NCT02239692|11206954|FG001|Overall Study|Incomplete colonoscopy|2
7089978|NCT02239692|11206953|FG000|Overall Study|Adverse Event|0
7089979|NCT02239692|11206954|FG001|Overall Study|Adverse Event|1
7089980|NCT02239692|11206953|FG000|Overall Study|Physician Decision|0
7089981|NCT02239692|11206954|FG001|Overall Study|Physician Decision|1
7089982|NCT02239692|11206953|FG000|Overall Study|Lost to Follow-up|1
7089983|NCT02239692|11206954|FG001|Overall Study|Lost to Follow-up|4
7089984|NCT02239692|11206953|FG000|Overall Study|Withdrawal by Subject|3
7089985|NCT02239692|11206954|FG001|Overall Study|Withdrawal by Subject|5
7089986|NCT02239692|11206953|FG000|Overall Study|Other reason|1
7089987|NCT02239692|11206954|FG001|Overall Study|Other reason|0
7089988|NCT02239939|11207005|FG000|Overall Study|Adverse Event|1
7089989|NCT02239939|11207006|FG001|Overall Study|Adverse Event|0
7089990|NCT02239939|11207005|FG000|Overall Study|Withdrawal by Subject|1
7089991|NCT02239939|11207006|FG001|Overall Study|Withdrawal by Subject|1
7089992|NCT02239939|11207005|FG000|Overall Study|Lost to Follow-up|0
7089993|NCT02239939|11207006|FG001|Overall Study|Lost to Follow-up|1
7089994|NCT02239978|11207016|FG000|Overall Study|Withdrawal by Subject|2
7089995|NCT02239978|11207017|FG001|Overall Study|Withdrawal by Subject|0
7089996|NCT02240108|11207042|FG000|Overall Study|Other than specified|8
7089997|NCT02240108|11207043|FG001|Overall Study|Other than specified|6
7089998|NCT02240108|11207042|FG000|Overall Study|Adverse Event|1
7089999|NCT02240108|11207043|FG001|Overall Study|Adverse Event|9
7090000|NCT02240108|11207042|FG000|Overall Study|Pregnancy|1
7090001|NCT02240108|11207043|FG001|Overall Study|Pregnancy|0
7090002|NCT02240108|11207042|FG000|Overall Study|Withdrawal by Subject|4
7090003|NCT02240108|11207043|FG001|Overall Study|Withdrawal by Subject|9
7090004|NCT02240108|11207042|FG000|Overall Study|StudyTerminated by Sponsor|0
7090005|NCT02240108|11207043|FG001|Overall Study|StudyTerminated by Sponsor|1
7090006|NCT02240121|11207051|FG000|Overall Study|Protocol Violation|1
7090007|NCT02240121|11207052|FG001|Overall Study|Protocol Violation|2
7090008|NCT02240121|11207051|FG000|Overall Study|Physician Decision|0
7090009|NCT02240121|11207052|FG001|Overall Study|Physician Decision|1
7090010|NCT02240121|11207051|FG000|Overall Study|Change in protocol interpretation|1
7090011|NCT02240121|11207052|FG001|Overall Study|Change in protocol interpretation|0
7090012|NCT02240121|11207051|FG000|Overall Study|Lack of Efficacy|2
7090013|NCT02240121|11207052|FG001|Overall Study|Lack of Efficacy|3
7090014|NCT02240121|11207051|FG000|Overall Study|Site closed|1
7090015|NCT02240121|11207052|FG001|Overall Study|Site closed|1
7090016|NCT02240121|11207051|FG000|Overall Study|Pregnancy|1
7090017|NCT02240121|11207052|FG001|Overall Study|Pregnancy|0
7090018|NCT02240121|11207051|FG000|Overall Study|Adverse Event|2
7090019|NCT02240121|11207052|FG001|Overall Study|Adverse Event|4
7090020|NCT02240121|11207051|FG000|Overall Study|Withdrawal by Subject|6
7090021|NCT02240121|11207052|FG001|Overall Study|Withdrawal by Subject|2
7090022|NCT02240121|11207051|FG000|Overall Study|Lost to Follow-up|3
7090023|NCT02240121|11207052|FG001|Overall Study|Lost to Follow-up|4
7090024|NCT02240121|11207051|FG000|Overall Study|Other than specified|1
7090025|NCT02240121|11207052|FG001|Overall Study|Other than specified|3
7090026|NCT02240368|11207072|FG000|Overall Study|Surgery lasted less then 20 minutes|1
7090027|NCT02240368|11207073|FG001|Overall Study|Surgery lasted less then 20 minutes|0
7090028|NCT02240368|11207074|FG002|Overall Study|Surgery lasted less then 20 minutes|0
7090029|NCT02240368|11207072|FG000|Overall Study|Entropy failed to detect more than 50%|0
7090030|NCT02240368|11207073|FG001|Overall Study|Entropy failed to detect more than 50%|0
7090031|NCT02240368|11207074|FG002|Overall Study|Entropy failed to detect more than 50%|1
7090032|NCT02240628|11207093|FG000|Overall Study|Physician Decision|6
7090033|NCT02240628|11207094|FG001|Overall Study|Physician Decision|5
7090034|NCT02240680|11207132|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6
7090035|NCT02240680|11207133|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6
7090036|NCT02240680|11207134|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0
7090037|NCT02240680|11207135|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0
7090038|NCT02240680|11207132|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4
7090039|NCT02240680|11207133|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1
7090040|NCT02240680|11207134|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0
7090041|NCT02240680|11207135|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0
7090042|NCT02240680|11207132|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1
7090043|NCT02240680|11207133|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
7090044|NCT02240680|11207134|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
7090045|NCT02240680|11207135|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
7090046|NCT02240680|11207132|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3
7090047|NCT02240680|11207133|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1
7090048|NCT02240680|11207134|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0
7090049|NCT02240680|11207135|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0
7090050|NCT02240680|11207132|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1
7090051|NCT02240680|11207133|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0
7090052|NCT02240680|11207134|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0
7090053|NCT02240680|11207135|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0
7090054|NCT02240680|11207132|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0
7090055|NCT02240680|11207133|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0
7090056|NCT02240680|11207134|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6
7090057|NCT02240680|11207135|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7
7090058|NCT02240680|11207132|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
7090059|NCT02240680|11207133|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
7090060|NCT02240680|11207134|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1
7090061|NCT02240680|11207135|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
7090062|NCT02240680|11207132|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
7090063|NCT02240680|11207133|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
7090064|NCT02240680|11207134|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1
7090065|NCT02240680|11207135|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
7090066|NCT02240693|11207148|FG000|Overall Study|Adverse Event|0
7090067|NCT02240693|11207149|FG001|Overall Study|Adverse Event|0
7090068|NCT02240693|11207150|FG002|Overall Study|Adverse Event|0
7090069|NCT02240693|11207151|FG003|Overall Study|Adverse Event|0
7090070|NCT02240693|11207152|FG004|Overall Study|Adverse Event|1
7090071|NCT02240693|11207148|FG000|Overall Study|Withdrawal by Subject|0
7090072|NCT02240693|11207149|FG001|Overall Study|Withdrawal by Subject|0
7090073|NCT02240693|11207150|FG002|Overall Study|Withdrawal by Subject|2
7090074|NCT02240693|11207151|FG003|Overall Study|Withdrawal by Subject|1
7090075|NCT02240693|11207152|FG004|Overall Study|Withdrawal by Subject|0
7090076|NCT02240693|11207148|FG000|Overall Study|Other than specified|0
7090077|NCT02240693|11207149|FG001|Overall Study|Other than specified|0
7090078|NCT02240693|11207150|FG002|Overall Study|Other than specified|2
7090079|NCT02240693|11207151|FG003|Overall Study|Other than specified|0
7090080|NCT02240693|11207152|FG004|Overall Study|Other than specified|0
7090081|NCT02240706|11207171|FG000|Overall Study|Lack of Efficacy|2
7090082|NCT02240706|11207172|FG001|Overall Study|Lack of Efficacy|2
7090083|NCT02240706|11207173|FG002|Overall Study|Lack of Efficacy|2
7090084|NCT02240706|11207174|FG003|Overall Study|Lack of Efficacy|2
7090085|NCT02240706|11207175|FG004|Overall Study|Lack of Efficacy|5
7090086|NCT02240706|11207176|FG005|Overall Study|Lack of Efficacy|0
7090087|NCT02240706|11207177|FG006|Overall Study|Lack of Efficacy|0
7090088|NCT02240706|11207171|FG000|Overall Study|Adverse Event|1
7090089|NCT02240706|11207172|FG001|Overall Study|Adverse Event|0
7090090|NCT02240706|11207173|FG002|Overall Study|Adverse Event|1
7090091|NCT02240706|11207174|FG003|Overall Study|Adverse Event|0
7090092|NCT02240706|11207175|FG004|Overall Study|Adverse Event|2
7090093|NCT02240706|11207176|FG005|Overall Study|Adverse Event|0
7090094|NCT02240706|11207177|FG006|Overall Study|Adverse Event|0
7090095|NCT02240706|11207171|FG000|Overall Study|Progressive disease|0
7090096|NCT02240706|11207172|FG001|Overall Study|Progressive disease|0
7090097|NCT02240706|11207173|FG002|Overall Study|Progressive disease|0
7090098|NCT02240706|11207174|FG003|Overall Study|Progressive disease|0
7090099|NCT02240706|11207175|FG004|Overall Study|Progressive disease|1
7090100|NCT02240706|11207176|FG005|Overall Study|Progressive disease|0
7090101|NCT02240706|11207177|FG006|Overall Study|Progressive disease|0
7090102|NCT02240706|11207171|FG000|Overall Study|Dose limiting toxicity|0
7090103|NCT02240706|11207172|FG001|Overall Study|Dose limiting toxicity|0
7090104|NCT02240706|11207173|FG002|Overall Study|Dose limiting toxicity|0
7090105|NCT02240706|11207174|FG003|Overall Study|Dose limiting toxicity|0
7090106|NCT02240706|11207175|FG004|Overall Study|Dose limiting toxicity|1
7090107|NCT02240706|11207176|FG005|Overall Study|Dose limiting toxicity|0
7090108|NCT02240706|11207177|FG006|Overall Study|Dose limiting toxicity|0
7090109|NCT02240706|11207171|FG000|Overall Study|Refused to continue taking medication|0
7090110|NCT02240706|11207172|FG001|Overall Study|Refused to continue taking medication|1
7090111|NCT02240706|11207173|FG002|Overall Study|Refused to continue taking medication|3
7090112|NCT02240706|11207174|FG003|Overall Study|Refused to continue taking medication|1
7090113|NCT02240706|11207175|FG004|Overall Study|Refused to continue taking medication|2
7090114|NCT02240706|11207176|FG005|Overall Study|Refused to continue taking medication|0
7090115|NCT02240706|11207177|FG006|Overall Study|Refused to continue taking medication|0
7090116|NCT02240706|11207171|FG000|Overall Study|Insurance billing concerns|0
7090117|NCT02240706|11207172|FG001|Overall Study|Insurance billing concerns|0
7090118|NCT02240706|11207173|FG002|Overall Study|Insurance billing concerns|0
7090119|NCT02240706|11207174|FG003|Overall Study|Insurance billing concerns|1
7090120|NCT02240706|11207175|FG004|Overall Study|Insurance billing concerns|0
7090121|NCT02240706|11207176|FG005|Overall Study|Insurance billing concerns|0
7090122|NCT02240706|11207177|FG006|Overall Study|Insurance billing concerns|0
7090123|NCT02241512|11207208|FG000|Overall Study|Pump malfunction, drug not delivered|1
7090124|NCT02241512|11207209|FG001|Overall Study|Pump malfunction, drug not delivered|0
7090125|NCT02241733|11207235|FG000|Overall Study|Lost to Follow-up|9
7090126|NCT02241733|11207236|FG001|Overall Study|Lost to Follow-up|4
7090127|NCT02241733|11207235|FG000|Overall Study|Physician Decision|6
7090128|NCT02241733|11207236|FG001|Overall Study|Physician Decision|2
7090129|NCT02241733|11207235|FG000|Overall Study|Withdrawal by Subject|0
7090130|NCT02241733|11207236|FG001|Overall Study|Withdrawal by Subject|2
7090131|NCT02241733|11207235|FG000|Overall Study|Death|0
7090132|NCT02241733|11207236|FG001|Overall Study|Death|2
7090133|NCT02241785|11207242|FG000|Overall Study|Sponsor Termination|43
7090134|NCT02241785|11207242|FG000|Overall Study|Withdrawal by Subject|1
7090135|NCT02241785|11207242|FG000|Overall Study|Lost to Follow-up|2
7090136|NCT02241785|11207242|FG000|Overall Study|Adverse Event|1
7090137|NCT02241889|11207246|FG000|Overall Study|device issues|0
7090138|NCT02241889|11207247|FG001|Overall Study|device issues|0
7090139|NCT02241889|11207248|FG002|Overall Study|device issues|1
7090140|NCT02241889|11207249|FG003|Overall Study|device issues|0
7090141|NCT02241889|11207250|FG004|Overall Study|device issues|0
7090142|NCT02241889|11207251|FG005|Overall Study|device issues|0
7090143|NCT02241889|11207246|FG000|Overall Study|Withdrawal by Subject|0
7090144|NCT02241889|11207247|FG001|Overall Study|Withdrawal by Subject|0
7090145|NCT02241889|11207248|FG002|Overall Study|Withdrawal by Subject|0
7090146|NCT02241889|11207249|FG003|Overall Study|Withdrawal by Subject|0
7090147|NCT02241889|11207250|FG004|Overall Study|Withdrawal by Subject|0
7090148|NCT02241889|11207251|FG005|Overall Study|Withdrawal by Subject|1
7090149|NCT02242045|11207280|FG000|Overall Study|Investigator's Discretion|1
7090150|NCT02242045|11207280|FG000|Overall Study|Progressive Disease|2
7090151|NCT02242045|11207280|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1
7090152|NCT02242045|11207280|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2
7090153|NCT02242201|11207287|FG000|Overall Study|preoperative identified neuropathy|2
7090154|NCT02242201|11207288|FG001|Overall Study|preoperative identified neuropathy|0
7090155|NCT02242201|11207289|FG002|Overall Study|preoperative identified neuropathy|0
7090156|NCT02242201|11207287|FG000|Overall Study|planned post-op anticoagulation|1
7090157|NCT02242201|11207288|FG001|Overall Study|planned post-op anticoagulation|0
7090158|NCT02242201|11207289|FG002|Overall Study|planned post-op anticoagulation|0
7090159|NCT02242201|11207287|FG000|Overall Study|changed surgical procedure|1
7090160|NCT02242201|11207288|FG001|Overall Study|changed surgical procedure|0
7090161|NCT02242201|11207289|FG002|Overall Study|changed surgical procedure|0
7090162|NCT02242201|11207287|FG000|Overall Study|postponed surgery|0
7090163|NCT02242201|11207288|FG001|Overall Study|postponed surgery|0
7090164|NCT02242201|11207289|FG002|Overall Study|postponed surgery|1
7090165|NCT02242201|11207287|FG000|Overall Study|preoperative opioid consumption|0
7090166|NCT02242201|11207288|FG001|Overall Study|preoperative opioid consumption|1
7090167|NCT02242201|11207289|FG002|Overall Study|preoperative opioid consumption|0
7090168|NCT02242305|11207299|FG000|Overall Study|Without spasm-like pain during 3 weeks|1
7090169|NCT02242305|11207300|FG001|Overall Study|Without spasm-like pain during 3 weeks|4
7090170|NCT02242305|11207299|FG000|Overall Study|Adverse Event|1
7090171|NCT02242305|11207300|FG001|Overall Study|Adverse Event|0
7090172|NCT02242305|11207299|FG000|Overall Study|Non-compliance dosing regimen or visit|2
7090173|NCT02242305|11207300|FG001|Overall Study|Non-compliance dosing regimen or visit|2
7090174|NCT02242305|11207299|FG000|Overall Study|Subject withdraws inform consent|0
7090175|NCT02242305|11207300|FG001|Overall Study|Subject withdraws inform consent|4
7090176|NCT02242305|11207299|FG000|Overall Study|Lost to Follow-up|2
7090177|NCT02242305|11207300|FG001|Overall Study|Lost to Follow-up|0
7090178|NCT02242487|11207308|FG000|Overall Study|Adverse Event|13
7090179|NCT02242487|11207309|FG001|Overall Study|Adverse Event|15
7090180|NCT02242487|11207308|FG000|Overall Study|Lack of Efficacy|4
7090181|NCT02242487|11207309|FG001|Overall Study|Lack of Efficacy|6
7090182|NCT02242487|11207308|FG000|Overall Study|Protocol Violation|2
7090183|NCT02242487|11207309|FG001|Overall Study|Protocol Violation|0
7090184|NCT02242487|11207308|FG000|Overall Study|Lost to Follow-up|2
7090185|NCT02242487|11207309|FG001|Overall Study|Lost to Follow-up|1
7090186|NCT02242487|11207308|FG000|Overall Study|Other - Miscellaneous|4
7090187|NCT02242487|11207309|FG001|Overall Study|Other - Miscellaneous|6
7090188|NCT02242487|11207308|FG000|Overall Study|Withdrawal by Subject|37
7090189|NCT02242487|11207309|FG001|Overall Study|Withdrawal by Subject|19
7090190|NCT02242643|11207336|FG000|Overall Study|Protocol Violation|1
7090191|NCT02242643|11207337|FG001|Overall Study|Protocol Violation|2
7090192|NCT02242643|11207336|FG000|Overall Study|Withdrawal by Subject|15
7090193|NCT02242643|11207337|FG001|Overall Study|Withdrawal by Subject|10
7090194|NCT02242643|11207336|FG000|Overall Study|Migrated/moved from study area|1
7090195|NCT02242643|11207337|FG001|Overall Study|Migrated/moved from study area|3
7090196|NCT02242643|11207336|FG000|Overall Study|Lost to Follow-up|54
7090197|NCT02242643|11207337|FG001|Overall Study|Lost to Follow-up|61
7090198|NCT02242643|11207336|FG000|Overall Study|Child placed in foster care by family|0
7090199|NCT02242643|11207337|FG001|Overall Study|Child placed in foster care by family|1
7090200|NCT02242643|11207336|FG000|Overall Study|Non-compliance|1
7090201|NCT02242643|11207337|FG001|Overall Study|Non-compliance|0
7090202|NCT02242643|11207336|FG000|Overall Study|Consent withdrawal by parent|1
7090203|NCT02242643|11207337|FG001|Overall Study|Consent withdrawal by parent|0
7090204|NCT02242643|11207336|FG000|Overall Study|Protocol requirements not followed|1
7090205|NCT02242643|11207337|FG001|Overall Study|Protocol requirements not followed|0
7090206|NCT02242643|11207336|FG000|Overall Study|Language barrier|1
7090207|NCT02242643|11207337|FG001|Overall Study|Language barrier|0
7090208|NCT02242643|11207336|FG000|Overall Study|Withdrawal by subject at Visit 2|0
7090209|NCT02242643|11207337|FG001|Overall Study|Withdrawal by subject at Visit 2|1
7090210|NCT02242903|11207352|FG000|Overall Study|Withdrawal by Subject|1
7090211|NCT02242903|11207353|FG001|Overall Study|Withdrawal by Subject|0
7090212|NCT02242903|11207354|FG002|Overall Study|Withdrawal by Subject|0
7090213|NCT02242903|11207355|FG003|Overall Study|Withdrawal by Subject|0
7090214|NCT02242903|11207356|FG004|Overall Study|Withdrawal by Subject|0
7090215|NCT02242903|11207357|FG005|Overall Study|Withdrawal by Subject|0
7090216|NCT02242903|11207358|FG006|Overall Study|Withdrawal by Subject|0
7090217|NCT02242981|11207380|FG000|Overall Study|Withdrawal by Subject|1
7090218|NCT02243046|11207400|FG000|Overall Study|Lost to Follow-up|1
7090219|NCT02243046|11207401|FG001|Overall Study|Lost to Follow-up|1
7090220|NCT02243046|11207402|FG002|Overall Study|Lost to Follow-up|4
7090221|NCT02243176|11207412|FG000|Overall Study|Other reason|1
7090222|NCT02243176|11207413|FG001|Overall Study|Other reason|2
7090223|NCT02243176|11207412|FG000|Overall Study|protocol specified withdrawal critera|1
7090224|NCT02243176|11207413|FG001|Overall Study|protocol specified withdrawal critera|3
7090225|NCT02243176|11207412|FG000|Overall Study|Protocol Violation|2
7090226|NCT02243176|11207413|FG001|Overall Study|Protocol Violation|1
7090227|NCT02243176|11207412|FG000|Overall Study|Withdrawal by Subject|8
7090228|NCT02243176|11207413|FG001|Overall Study|Withdrawal by Subject|7
7090229|NCT02243176|11207412|FG000|Overall Study|Adverse Event|2
7090230|NCT02243176|11207413|FG001|Overall Study|Adverse Event|2
7090231|NCT02243202|11207423|FG000|Overall Study|Adverse Event|5
7090232|NCT02243202|11207424|FG001|Overall Study|Adverse Event|6
7090233|NCT02243202|11207425|FG002|Overall Study|Adverse Event|10
7090234|NCT02243202|11207426|FG003|Overall Study|Adverse Event|4
7090235|NCT02243202|11207423|FG000|Overall Study|Lost to Follow-up|9
7090236|NCT02243202|11207424|FG001|Overall Study|Lost to Follow-up|9
7090237|NCT02243202|11207425|FG002|Overall Study|Lost to Follow-up|14
7090238|NCT02243202|11207426|FG003|Overall Study|Lost to Follow-up|11
7090239|NCT02243202|11207423|FG000|Overall Study|Protocol Violation|3
7090240|NCT02243202|11207424|FG001|Overall Study|Protocol Violation|1
7090241|NCT02243202|11207425|FG002|Overall Study|Protocol Violation|2
7090242|NCT02243202|11207426|FG003|Overall Study|Protocol Violation|1
7090243|NCT02243202|11207423|FG000|Overall Study|Withdrawal by Subject|7
7090244|NCT02243202|11207424|FG001|Overall Study|Withdrawal by Subject|6
7090245|NCT02243202|11207425|FG002|Overall Study|Withdrawal by Subject|4
7090246|NCT02243202|11207426|FG003|Overall Study|Withdrawal by Subject|4
7090247|NCT02243202|11207423|FG000|Overall Study|Other|1
7090248|NCT02243202|11207424|FG001|Overall Study|Other|3
7090249|NCT02243202|11207425|FG002|Overall Study|Other|1
7090250|NCT02243202|11207426|FG003|Overall Study|Other|2
7090251|NCT02243202|11207423|FG000|Overall Study|Randomized but not received treatment|0
7090252|NCT02243202|11207424|FG001|Overall Study|Randomized but not received treatment|0
7090253|NCT02243202|11207425|FG002|Overall Study|Randomized but not received treatment|0
7090254|NCT02243202|11207426|FG003|Overall Study|Randomized but not received treatment|1
7090255|NCT02243280|11207447|FG000|Treated|Adverse Event|1
7090256|NCT02243280|11207448|FG001|Treated|Adverse Event|0
7090257|NCT02243280|11207449|FG002|Treated|Adverse Event|0
7090258|NCT02243280|11207450|FG003|Treated|Adverse Event|0
7090259|NCT02243280|11207451|FG004|Treated|Adverse Event|0
7090260|NCT02243280|11207452|FG005|Treated|Adverse Event|0
7090261|NCT02243280|11207453|FG006|Treated|Adverse Event|0
7090262|NCT02243280|11207454|FG007|Treated|Adverse Event|0
7090263|NCT02243280|11207455|FG008|Treated|Adverse Event|0
7090264|NCT02243280|11207456|FG009|Treated|Adverse Event|0
7090265|NCT02243280|11207457|FG010|Treated|Adverse Event|1
7090266|NCT02243280|11207447|FG000|Treated|Lost to Follow-up|0
7090267|NCT02243280|11207448|FG001|Treated|Lost to Follow-up|0
7090268|NCT02243280|11207449|FG002|Treated|Lost to Follow-up|0
7090269|NCT02243280|11207450|FG003|Treated|Lost to Follow-up|0
7090270|NCT02243280|11207451|FG004|Treated|Lost to Follow-up|0
7090271|NCT02243280|11207452|FG005|Treated|Lost to Follow-up|0
7090272|NCT02243280|11207453|FG006|Treated|Lost to Follow-up|0
7090273|NCT02243280|11207454|FG007|Treated|Lost to Follow-up|0
7090274|NCT02243280|11207455|FG008|Treated|Lost to Follow-up|1
7090275|NCT02243280|11207456|FG009|Treated|Lost to Follow-up|0
7090276|NCT02243280|11207457|FG010|Treated|Lost to Follow-up|2
7090277|NCT02243293|11207492|FG000|Overall Study|Adverse Event|1
7090278|NCT02243293|11207493|FG001|Overall Study|Adverse Event|0
7090279|NCT02243293|11207494|FG002|Overall Study|Adverse Event|0
7090280|NCT02243293|11207495|FG003|Overall Study|Adverse Event|0
7090281|NCT02243293|11207496|FG004|Overall Study|Adverse Event|0
7090282|NCT02243293|11207497|FG005|Overall Study|Adverse Event|0
7090283|NCT02243293|11207498|FG006|Overall Study|Adverse Event|0
7090284|NCT02243293|11207499|FG007|Overall Study|Adverse Event|0
7090285|NCT02243293|11207500|FG008|Overall Study|Adverse Event|0
7090286|NCT02243293|11207501|FG009|Overall Study|Adverse Event|0
7090287|NCT02243293|11207502|FG010|Overall Study|Adverse Event|0
7090288|NCT02243293|11207503|FG011|Overall Study|Adverse Event|0
7090289|NCT02243293|11207504|FG012|Overall Study|Adverse Event|0
7090290|NCT02243293|11207505|FG013|Overall Study|Adverse Event|0
7090291|NCT02243293|11207506|FG014|Overall Study|Adverse Event|0
7090292|NCT02243293|11207507|FG015|Overall Study|Adverse Event|1
7090293|NCT02243293|11207508|FG016|Overall Study|Adverse Event|0
7090294|NCT02243293|11207509|FG017|Overall Study|Adverse Event|0
7090295|NCT02243293|11207510|FG018|Overall Study|Adverse Event|0
7090296|NCT02243293|11207511|FG019|Overall Study|Adverse Event|0
7090297|NCT02243293|11207512|FG020|Overall Study|Adverse Event|1
7090298|NCT02243293|11207513|FG021|Overall Study|Adverse Event|0
7090299|NCT02243293|11207492|FG000|Overall Study|Withdrawal by Subject|1
7090300|NCT02243293|11207493|FG001|Overall Study|Withdrawal by Subject|0
7090301|NCT02243293|11207494|FG002|Overall Study|Withdrawal by Subject|0
7090302|NCT02243293|11207495|FG003|Overall Study|Withdrawal by Subject|0
7090303|NCT02243293|11207496|FG004|Overall Study|Withdrawal by Subject|0
7090304|NCT02243293|11207497|FG005|Overall Study|Withdrawal by Subject|0
7090305|NCT02243293|11207498|FG006|Overall Study|Withdrawal by Subject|0
7090306|NCT02243293|11207499|FG007|Overall Study|Withdrawal by Subject|0
7090307|NCT02243293|11207500|FG008|Overall Study|Withdrawal by Subject|0
7090308|NCT02243293|11207501|FG009|Overall Study|Withdrawal by Subject|1
7090309|NCT02243293|11207502|FG010|Overall Study|Withdrawal by Subject|0
7090310|NCT02243293|11207503|FG011|Overall Study|Withdrawal by Subject|1
7090311|NCT02243293|11207504|FG012|Overall Study|Withdrawal by Subject|0
7090312|NCT02243293|11207505|FG013|Overall Study|Withdrawal by Subject|0
7090313|NCT02243293|11207506|FG014|Overall Study|Withdrawal by Subject|0
7090314|NCT02243293|11207507|FG015|Overall Study|Withdrawal by Subject|0
7090315|NCT02243293|11207508|FG016|Overall Study|Withdrawal by Subject|0
7090316|NCT02243293|11207509|FG017|Overall Study|Withdrawal by Subject|0
7090317|NCT02243293|11207510|FG018|Overall Study|Withdrawal by Subject|0
7090318|NCT02243293|11207511|FG019|Overall Study|Withdrawal by Subject|0
7090319|NCT02243293|11207512|FG020|Overall Study|Withdrawal by Subject|0
7090320|NCT02243293|11207513|FG021|Overall Study|Withdrawal by Subject|1
7090321|NCT02243293|11207492|FG000|Overall Study|Lost to Follow-up|0
7090322|NCT02243293|11207493|FG001|Overall Study|Lost to Follow-up|1
7090323|NCT02243293|11207494|FG002|Overall Study|Lost to Follow-up|1
7090324|NCT02243293|11207495|FG003|Overall Study|Lost to Follow-up|1
7090325|NCT02243293|11207496|FG004|Overall Study|Lost to Follow-up|0
7090326|NCT02243293|11207497|FG005|Overall Study|Lost to Follow-up|0
7090327|NCT02243293|11207498|FG006|Overall Study|Lost to Follow-up|3
7090328|NCT02243293|11207499|FG007|Overall Study|Lost to Follow-up|0
7090329|NCT02243293|11207500|FG008|Overall Study|Lost to Follow-up|0
7090330|NCT02243293|11207501|FG009|Overall Study|Lost to Follow-up|0
7090331|NCT02243293|11207502|FG010|Overall Study|Lost to Follow-up|0
7090332|NCT02243293|11207503|FG011|Overall Study|Lost to Follow-up|2
7090333|NCT02243293|11207504|FG012|Overall Study|Lost to Follow-up|0
7090334|NCT02243293|11207505|FG013|Overall Study|Lost to Follow-up|0
7090335|NCT02243293|11207506|FG014|Overall Study|Lost to Follow-up|0
7090336|NCT02243293|11207507|FG015|Overall Study|Lost to Follow-up|0
7090337|NCT02243293|11207508|FG016|Overall Study|Lost to Follow-up|3
7090338|NCT02243293|11207509|FG017|Overall Study|Lost to Follow-up|1
7090339|NCT02243293|11207510|FG018|Overall Study|Lost to Follow-up|0
7090340|NCT02243293|11207511|FG019|Overall Study|Lost to Follow-up|0
7090341|NCT02243293|11207512|FG020|Overall Study|Lost to Follow-up|1
7090342|NCT02243293|11207513|FG021|Overall Study|Lost to Follow-up|2
7090343|NCT02243293|11207492|FG000|Overall Study|Enrolled into a Re-treatment Study|0
7090344|NCT02243293|11207493|FG001|Overall Study|Enrolled into a Re-treatment Study|0
7090345|NCT02243293|11207494|FG002|Overall Study|Enrolled into a Re-treatment Study|0
7090346|NCT02243293|11207495|FG003|Overall Study|Enrolled into a Re-treatment Study|0
7090347|NCT02243293|11207496|FG004|Overall Study|Enrolled into a Re-treatment Study|0
7090348|NCT02243293|11207497|FG005|Overall Study|Enrolled into a Re-treatment Study|0
7090349|NCT02243293|11207498|FG006|Overall Study|Enrolled into a Re-treatment Study|0
7090350|NCT02243293|11207499|FG007|Overall Study|Enrolled into a Re-treatment Study|0
7090351|NCT02243293|11207500|FG008|Overall Study|Enrolled into a Re-treatment Study|0
7090352|NCT02243293|11207501|FG009|Overall Study|Enrolled into a Re-treatment Study|0
7090353|NCT02243293|11207502|FG010|Overall Study|Enrolled into a Re-treatment Study|0
7090354|NCT02243293|11207503|FG011|Overall Study|Enrolled into a Re-treatment Study|0
7090355|NCT02243293|11207504|FG012|Overall Study|Enrolled into a Re-treatment Study|0
7090356|NCT02243293|11207505|FG013|Overall Study|Enrolled into a Re-treatment Study|0
7090357|NCT02243293|11207506|FG014|Overall Study|Enrolled into a Re-treatment Study|1
7090358|NCT02243293|11207507|FG015|Overall Study|Enrolled into a Re-treatment Study|0
7090359|NCT02243293|11207508|FG016|Overall Study|Enrolled into a Re-treatment Study|0
7090360|NCT02243293|11207509|FG017|Overall Study|Enrolled into a Re-treatment Study|0
7090361|NCT02243293|11207510|FG018|Overall Study|Enrolled into a Re-treatment Study|0
7090362|NCT02243293|11207511|FG019|Overall Study|Enrolled into a Re-treatment Study|0
7090363|NCT02243293|11207512|FG020|Overall Study|Enrolled into a Re-treatment Study|0
7090364|NCT02243293|11207513|FG021|Overall Study|Enrolled into a Re-treatment Study|0
7090365|NCT02243293|11207492|FG000|Overall Study|Randomized but did'nt receive study drug|0
7090366|NCT02243293|11207493|FG001|Overall Study|Randomized but did'nt receive study drug|0
7090367|NCT02243293|11207494|FG002|Overall Study|Randomized but did'nt receive study drug|0
7090368|NCT02243293|11207495|FG003|Overall Study|Randomized but did'nt receive study drug|0
7090369|NCT02243293|11207496|FG004|Overall Study|Randomized but did'nt receive study drug|1
7090370|NCT02243293|11207497|FG005|Overall Study|Randomized but did'nt receive study drug|0
7090371|NCT02243293|11207498|FG006|Overall Study|Randomized but did'nt receive study drug|0
7090372|NCT02243293|11207499|FG007|Overall Study|Randomized but did'nt receive study drug|0
7090373|NCT02243293|11207500|FG008|Overall Study|Randomized but did'nt receive study drug|0
7090374|NCT02243293|11207501|FG009|Overall Study|Randomized but did'nt receive study drug|1
7090375|NCT02243293|11207502|FG010|Overall Study|Randomized but did'nt receive study drug|0
7090376|NCT02243293|11207503|FG011|Overall Study|Randomized but did'nt receive study drug|0
7090377|NCT02243293|11207504|FG012|Overall Study|Randomized but did'nt receive study drug|0
7090378|NCT02243293|11207505|FG013|Overall Study|Randomized but did'nt receive study drug|0
7090379|NCT02243293|11207506|FG014|Overall Study|Randomized but did'nt receive study drug|0
7090380|NCT02243293|11207507|FG015|Overall Study|Randomized but did'nt receive study drug|0
7090381|NCT02243293|11207508|FG016|Overall Study|Randomized but did'nt receive study drug|0
7090382|NCT02243293|11207509|FG017|Overall Study|Randomized but did'nt receive study drug|0
7090383|NCT02243293|11207510|FG018|Overall Study|Randomized but did'nt receive study drug|0
7090384|NCT02243293|11207511|FG019|Overall Study|Randomized but did'nt receive study drug|1
7090385|NCT02243293|11207512|FG020|Overall Study|Randomized but did'nt receive study drug|0
7090386|NCT02243293|11207513|FG021|Overall Study|Randomized but did'nt receive study drug|0
7090387|NCT02243371|11207552|FG000|Overall Study|Progressive Disease (clinic & radio)|35
7090388|NCT02243371|11207553|FG001|Overall Study|Progressive Disease (clinic & radio)|24
7090389|NCT02243371|11207552|FG000|Overall Study|Death (unrelated)|2
7090390|NCT02243371|11207553|FG001|Overall Study|Death (unrelated)|4
7090391|NCT02243371|11207552|FG000|Overall Study|Adverse Event (unrelated)|0
7090392|NCT02243371|11207553|FG001|Overall Study|Adverse Event (unrelated)|1
7090393|NCT02243371|11207552|FG000|Overall Study|Lack of Clinical Benefit|0
7090394|NCT02243371|11207553|FG001|Overall Study|Lack of Clinical Benefit|1
7090395|NCT02243371|11207552|FG000|Overall Study|Withdrawal by Subject|0
7090396|NCT02243371|11207553|FG001|Overall Study|Withdrawal by Subject|2
7090397|NCT02243696|11207572|FG000|Overall Study|Death|282
7090398|NCT02243696|11207572|FG000|Overall Study|Withdrawal by Subject|79
7090399|NCT02243696|11207572|FG000|Overall Study|Lost to Follow-up|57
7090400|NCT02243696|11207572|FG000|Overall Study|Subject No Longer has Study System|42
7090401|NCT02243696|11207572|FG000|Overall Study|Subject Withdrawn by Investigator|273
7090402|NCT02243696|11207572|FG000|Overall Study|Study Terminated for EP PASSION|961
7090403|NCT02243865|11207578|FG000|Overall Study|Protocol Violation|1
7090404|NCT02243865|11207579|FG001|Overall Study|Protocol Violation|3
7090405|NCT02243865|11207578|FG000|Overall Study|Lost to Follow-up|1
7090406|NCT02243865|11207579|FG001|Overall Study|Lost to Follow-up|1
7090407|NCT02243865|11207578|FG000|Overall Study|Withdrawal by Subject|1
7090408|NCT02243865|11207579|FG001|Overall Study|Withdrawal by Subject|0
7090409|NCT02243865|11207578|FG000|Overall Study|Adverse Event|1
7090410|NCT02243865|11207579|FG001|Overall Study|Adverse Event|1
7090411|NCT02244424|11207598|FG000|Overall Study|Lost to Follow-up|20
7090412|NCT02244424|11207599|FG001|Overall Study|Lost to Follow-up|10
7090413|NCT02244580|11207605|FG000|Overall Study|No cancer tissues available|241
7090414|NCT02244619|11207615|FG000|Overall Study|Did not receive study intervention|8
7090415|NCT02244619|11207616|FG001|Overall Study|Did not receive study intervention|21
7090416|NCT02244957|11207638|FG000|Overall Study|Lack of Efficacy|1
7090417|NCT02244957|11207639|FG001|Overall Study|Lack of Efficacy|0
7090418|NCT02244996|11207649|FG000|Overall Study|Lack of Efficacy|2
7090419|NCT02244996|11207650|FG001|Overall Study|Lack of Efficacy|6
7090420|NCT02245412|11207672|FG000|Treatment Period|Death|1
7090421|NCT02245412|11207673|FG001|Treatment Period|Death|1
7090422|NCT02245412|11207674|FG002|Treatment Period|Death|0
7090423|NCT02245412|11207672|FG000|Treatment Period|Physician Decision|1
7090424|NCT02245412|11207673|FG001|Treatment Period|Physician Decision|1
7090425|NCT02245412|11207674|FG002|Treatment Period|Physician Decision|0
7090426|NCT02245412|11207672|FG000|Treatment Period|Withdrawal by Subject|2
7090427|NCT02245412|11207673|FG001|Treatment Period|Withdrawal by Subject|1
7090428|NCT02245412|11207674|FG002|Treatment Period|Withdrawal by Subject|0
7090429|NCT02245412|11207672|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1
7090430|NCT02245412|11207673|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0
7090431|NCT02245412|11207674|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0
7090432|NCT02245412|11207672|FG000|Follow-Up Period|Death|4
7090433|NCT02245412|11207673|FG001|Follow-Up Period|Death|2
7090434|NCT02245412|11207674|FG002|Follow-Up Period|Death|1
7090435|NCT02245412|11207672|FG000|Follow-Up Period|Physician Decision|1
7090436|NCT02245412|11207673|FG001|Follow-Up Period|Physician Decision|0
7090437|NCT02245412|11207674|FG002|Follow-Up Period|Physician Decision|0
7090438|NCT02245412|11207672|FG000|Follow-Up Period|Other - Terminated by Sponsor|0
7090439|NCT02245412|11207673|FG001|Follow-Up Period|Other - Terminated by Sponsor|0
7090440|NCT02245412|11207674|FG002|Follow-Up Period|Other - Terminated by Sponsor|1
7090441|NCT02245568|11207691|FG000|Overall Study|Study terminated by Sponsor|346
7090442|NCT02245568|11207691|FG000|Overall Study|Adverse Event|144
7090443|NCT02245568|11207691|FG000|Overall Study|Lack of Efficacy|98
7090444|NCT02245568|11207691|FG000|Overall Study|Withdrawal by Caregiver|85
7090445|NCT02245568|11207691|FG000|Overall Study|Withdrawal by Subject|77
7090446|NCT02245568|11207691|FG000|Overall Study|Withdrawal by Legal Representative|31
7090447|NCT02245568|11207691|FG000|Overall Study|Missing (Site closure)|16
7090448|NCT02245568|11207691|FG000|Overall Study|Physician Decision|14
7090449|NCT02245568|11207691|FG000|Overall Study|Non-compliance with study drug|11
7090450|NCT02245568|11207691|FG000|Overall Study|Death|9
7090451|NCT02245568|11207691|FG000|Overall Study|Blue staining|6
7090452|NCT02245568|11207691|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6
7090453|NCT02245568|11207691|FG000|Overall Study|Intolerance/dosing issues/interruption|5
7090454|NCT02245568|11207691|FG000|Overall Study|Lost to Follow-up|5
7090455|NCT02245620|11207697|FG000|Overall Study|Physician Decision|1
7090456|NCT02245620|11207698|FG001|Overall Study|Physician Decision|1
7090457|NCT02245737|11207707|FG000|Overall Study|Adverse Event|23
7090458|NCT02245737|11207708|FG001|Overall Study|Adverse Event|26
7090459|NCT02245737|11207709|FG002|Overall Study|Adverse Event|33
7090460|NCT02245737|11207707|FG000|Overall Study|Condition Worsened|9
7090461|NCT02245737|11207708|FG001|Overall Study|Condition Worsened|10
7090462|NCT02245737|11207709|FG002|Overall Study|Condition Worsened|9
7090463|NCT02245737|11207707|FG000|Overall Study|Death|2
7090464|NCT02245737|11207708|FG001|Overall Study|Death|4
7090465|NCT02245737|11207709|FG002|Overall Study|Death|4
7090466|NCT02245737|11207707|FG000|Overall Study|Eligibility Criteria No Longer Met|2
7090467|NCT02245737|11207708|FG001|Overall Study|Eligibility Criteria No Longer Met|4
7090468|NCT02245737|11207709|FG002|Overall Study|Eligibility Criteria No Longer Met|4
7090469|NCT02245737|11207707|FG000|Overall Study|Initiation of Symptomatic AD medication|2
7090470|NCT02245737|11207708|FG001|Overall Study|Initiation of Symptomatic AD medication|0
7090471|NCT02245737|11207709|FG002|Overall Study|Initiation of Symptomatic AD medication|0
7090472|NCT02245737|11207707|FG000|Overall Study|Lost to Follow-up|2
7090473|NCT02245737|11207708|FG001|Overall Study|Lost to Follow-up|5
7090474|NCT02245737|11207709|FG002|Overall Study|Lost to Follow-up|4
7090475|NCT02245737|11207707|FG000|Overall Study|Other-determined by Investigator|9
7090476|NCT02245737|11207708|FG001|Overall Study|Other-determined by Investigator|10
7090477|NCT02245737|11207709|FG002|Overall Study|Other-determined by Investigator|10
7090478|NCT02245737|11207707|FG000|Overall Study|Physician Decision|6
7090479|NCT02245737|11207708|FG001|Overall Study|Physician Decision|3
7090480|NCT02245737|11207709|FG002|Overall Study|Physician Decision|6
7090481|NCT02245737|11207707|FG000|Overall Study|Protocol Violation|3
7090482|NCT02245737|11207708|FG001|Overall Study|Protocol Violation|2
7090483|NCT02245737|11207709|FG002|Overall Study|Protocol Violation|3
7090484|NCT02245737|11207707|FG000|Overall Study|Withdrawal by Subject|40
7090485|NCT02245737|11207708|FG001|Overall Study|Withdrawal by Subject|41
7090486|NCT02245737|11207709|FG002|Overall Study|Withdrawal by Subject|44
7090487|NCT02245737|11207707|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10
7090488|NCT02245737|11207708|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20
7090489|NCT02245737|11207709|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22
7090490|NCT02245737|11207707|FG000|Overall Study|Sponsor Decision|445
7090491|NCT02245737|11207708|FG001|Overall Study|Sponsor Decision|430
7090492|NCT02245737|11207709|FG002|Overall Study|Sponsor Decision|432
7090493|NCT02246166|11207758|FG000|Overall Study|Protocol Violation|1
7090494|NCT02246166|11207759|FG001|Overall Study|Protocol Violation|0
7090495|NCT02246218|11207767|FG000|Overall Study|Withdrawal by Parent/Guardian|0
7090496|NCT02246218|11207768|FG001|Overall Study|Withdrawal by Parent/Guardian|1
7090497|NCT02246218|11207767|FG000|Overall Study|Stopping Rule: Liver Transplant|2
7090498|NCT02246218|11207768|FG001|Overall Study|Stopping Rule: Liver Transplant|4
7090499|NCT02246218|11207767|FG000|Overall Study|Adverse Event|1
7090500|NCT02246218|11207768|FG001|Overall Study|Adverse Event|1
7090501|NCT02246218|11207767|FG000|Overall Study|Lost to Follow-up|1
7090502|NCT02246218|11207768|FG001|Overall Study|Lost to Follow-up|0
7090503|NCT02246439|11207794|FG000|Overall Study|Adverse Event|3
7090504|NCT02246439|11207795|FG001|Overall Study|Adverse Event|0
7090505|NCT02246439|11207794|FG000|Overall Study|Lost to Follow-up|7
7090506|NCT02246439|11207795|FG001|Overall Study|Lost to Follow-up|5
7090507|NCT02246439|11207794|FG000|Overall Study|Protocol Violation|0
7090508|NCT02246439|11207795|FG001|Overall Study|Protocol Violation|2
7090509|NCT02246439|11207794|FG000|Overall Study|Physician Decision|0
7090510|NCT02246439|11207795|FG001|Overall Study|Physician Decision|1
7090511|NCT02246439|11207794|FG000|Overall Study|Unkonwn|1
7090512|NCT02246439|11207795|FG001|Overall Study|Unkonwn|3
7090513|NCT02246439|11207794|FG000|Overall Study|Withdrawal by Subject|1
7090514|NCT02246439|11207795|FG001|Overall Study|Withdrawal by Subject|0
7090515|NCT02246478|11207805|FG000|Multiple-dose Phase|Protocol Violation|1
7090516|NCT02246478|11207806|FG001|Multiple-dose Phase|Protocol Violation|0
7090517|NCT02246478|11207807|FG002|Multiple-dose Phase|Protocol Violation|0
7090518|NCT02246478|11207808|FG003|Multiple-dose Phase|Protocol Violation|1
7090519|NCT02246582|11207825|FG000|Overall Study|Withdrawal by Subject|3
7090520|NCT02246582|11207826|FG001|Overall Study|Withdrawal by Subject|4
7090521|NCT02246647|11207841|FG000|Overall Study|Withdrawal by Subject|1
7090522|NCT02246647|11207842|FG001|Overall Study|Withdrawal by Subject|1
7090523|NCT02246660|11207865|FG000|Overall Study|Withdrawal by Subject|0
7090524|NCT02246660|11207866|FG001|Overall Study|Withdrawal by Subject|1
7090525|NCT02246660|11207867|FG002|Overall Study|Withdrawal by Subject|0
7090526|NCT02246660|11207865|FG000|Overall Study|Death|0
7090527|NCT02246660|11207866|FG001|Overall Study|Death|0
7090528|NCT02246660|11207867|FG002|Overall Study|Death|1
7090529|NCT02246673|11207880|FG000|Overall Study|Sponsor Decision|1
7090530|NCT02246673|11207881|FG001|Overall Study|Sponsor Decision|0
7090531|NCT02246673|11207882|FG002|Overall Study|Sponsor Decision|0
7090532|NCT02246673|11207883|FG003|Overall Study|Sponsor Decision|0
7090533|NCT02246673|11207884|FG004|Overall Study|Sponsor Decision|0
7090534|NCT02246673|11207880|FG000|Overall Study|Withdrawal by Subject|0
7090535|NCT02246673|11207881|FG001|Overall Study|Withdrawal by Subject|0
7090536|NCT02246673|11207882|FG002|Overall Study|Withdrawal by Subject|0
7090537|NCT02246673|11207883|FG003|Overall Study|Withdrawal by Subject|0
7090538|NCT02246673|11207884|FG004|Overall Study|Withdrawal by Subject|1
7090539|NCT02246673|11207880|FG000|Overall Study|Lost to Follow-up|0
7090540|NCT02246673|11207881|FG001|Overall Study|Lost to Follow-up|0
7090541|NCT02246673|11207882|FG002|Overall Study|Lost to Follow-up|0
7090542|NCT02246673|11207883|FG003|Overall Study|Lost to Follow-up|1
7090543|NCT02246673|11207884|FG004|Overall Study|Lost to Follow-up|0
7090544|NCT02246673|11207880|FG000|Overall Study|Protocol Violation|0
7090545|NCT02246673|11207881|FG001|Overall Study|Protocol Violation|0
7090546|NCT02246673|11207882|FG002|Overall Study|Protocol Violation|0
7090547|NCT02246673|11207883|FG003|Overall Study|Protocol Violation|1
7090548|NCT02246673|11207884|FG004|Overall Study|Protocol Violation|0
7090549|NCT02246764|11207929|FG000|Overall Study|Adverse Event|15
7090550|NCT02246764|11207930|FG001|Overall Study|Adverse Event|29
7090551|NCT02246764|11207931|FG002|Overall Study|Adverse Event|1
7090552|NCT02246764|11207929|FG000|Overall Study|Withdrawal by Subject|0
7090553|NCT02246764|11207930|FG001|Overall Study|Withdrawal by Subject|0
7090554|NCT02246764|11207931|FG002|Overall Study|Withdrawal by Subject|1
7090555|NCT02246764|11207929|FG000|Overall Study|Disallowed Concomitant Medication|1
7090556|NCT02246764|11207930|FG001|Overall Study|Disallowed Concomitant Medication|0
7090557|NCT02246764|11207931|FG002|Overall Study|Disallowed Concomitant Medication|0
7090558|NCT02246764|11207929|FG000|Overall Study|Physician Decision|0
7090559|NCT02246764|11207930|FG001|Overall Study|Physician Decision|2
7090560|NCT02246764|11207931|FG002|Overall Study|Physician Decision|1
7090561|NCT02246764|11207929|FG000|Overall Study|Protocol Violation|2
7090562|NCT02246764|11207930|FG001|Overall Study|Protocol Violation|1
7090563|NCT02246764|11207931|FG002|Overall Study|Protocol Violation|1
7090564|NCT02246777|11207939|FG000|Overall Study|Adverse Event|2
7090565|NCT02246777|11207939|FG000|Overall Study|Change of residence|1
7090566|NCT02246998|11207952|FG000|Overall Study|Adverse Event|0
7090567|NCT02246998|11207953|FG001|Overall Study|Adverse Event|1
7090568|NCT02246998|11207954|FG002|Overall Study|Adverse Event|1
7090569|NCT02246998|11207955|FG003|Overall Study|Adverse Event|0
7090570|NCT02246998|11207952|FG000|Overall Study|Lost to Follow-up|1
7090571|NCT02246998|11207953|FG001|Overall Study|Lost to Follow-up|0
7090572|NCT02246998|11207954|FG002|Overall Study|Lost to Follow-up|0
7090573|NCT02246998|11207955|FG003|Overall Study|Lost to Follow-up|1
7090574|NCT02246998|11207952|FG000|Overall Study|Randomized but Never Dosed|1
7090575|NCT02246998|11207953|FG001|Overall Study|Randomized but Never Dosed|2
7090576|NCT02246998|11207954|FG002|Overall Study|Randomized but Never Dosed|2
7090577|NCT02246998|11207955|FG003|Overall Study|Randomized but Never Dosed|1
7090578|NCT02247011|11207970|FG000|Overall Study|Poor quality of radiological results|125
7090579|NCT02247401|11208024|FG000|Overall Study|Adverse Event|1
7090580|NCT02247401|11208025|FG001|Overall Study|Adverse Event|0
7090581|NCT02247401|11208026|FG002|Overall Study|Adverse Event|0
7090582|NCT02247401|11208024|FG000|Overall Study|Withdrawal by Subject|4
7090583|NCT02247401|11208025|FG001|Overall Study|Withdrawal by Subject|1
7090584|NCT02247401|11208026|FG002|Overall Study|Withdrawal by Subject|1
7090585|NCT02247401|11208024|FG000|Overall Study|Lost to Follow-up|1
7090586|NCT02247401|11208025|FG001|Overall Study|Lost to Follow-up|1
7090587|NCT02247401|11208026|FG002|Overall Study|Lost to Follow-up|1
7090588|NCT02247440|11208035|FG000|Overall Study|Withdrawal by Subject|1
7090589|NCT02247440|11208035|FG000|Overall Study|Lack of Efficacy|3
7090590|NCT02247466|11208041|FG000|Overall Study|Procedure changed to open surgery|0
7090591|NCT02247466|11208042|FG001|Overall Study|Procedure changed to open surgery|3
7090592|NCT02247479|11208051|FG000|Overall Study|Adverse Event|8
7090593|NCT02247479|11208052|FG001|Overall Study|Adverse Event|9
7090594|NCT02247479|11208053|FG002|Overall Study|Adverse Event|8
7090595|NCT02247479|11208051|FG000|Overall Study|Death|5
7090596|NCT02247479|11208052|FG001|Overall Study|Death|4
7090597|NCT02247479|11208053|FG002|Overall Study|Death|6
7090598|NCT02247479|11208051|FG000|Overall Study|Lost to Follow-up|3
7090599|NCT02247479|11208052|FG001|Overall Study|Lost to Follow-up|3
7090600|NCT02247479|11208053|FG002|Overall Study|Lost to Follow-up|1
7090601|NCT02247479|11208051|FG000|Overall Study|Non-compliance|0
7090602|NCT02247479|11208052|FG001|Overall Study|Non-compliance|0
7090603|NCT02247479|11208053|FG002|Overall Study|Non-compliance|1
7090604|NCT02247479|11208051|FG000|Overall Study|Withdrawal by Subject|25
7090605|NCT02247479|11208052|FG001|Overall Study|Withdrawal by Subject|29
7090606|NCT02247479|11208053|FG002|Overall Study|Withdrawal by Subject|24
7090607|NCT02247479|11208051|FG000|Overall Study|Study Terminated by Sponsor|98
7090608|NCT02247479|11208052|FG001|Overall Study|Study Terminated by Sponsor|88
7090609|NCT02247479|11208053|FG002|Overall Study|Study Terminated by Sponsor|94
7090610|NCT02247479|11208051|FG000|Overall Study|Physician Decision|1
7090611|NCT02247479|11208052|FG001|Overall Study|Physician Decision|0
7090612|NCT02247479|11208053|FG002|Overall Study|Physician Decision|2
7090613|NCT02247479|11208051|FG000|Overall Study|Unspecified Reason|2
7090614|NCT02247479|11208052|FG001|Overall Study|Unspecified Reason|5
7090615|NCT02247479|11208053|FG002|Overall Study|Unspecified Reason|2
7090616|NCT02247531|11208064|FG000|Overall Study|Adverse Event|3
7090617|NCT02247531|11208065|FG001|Overall Study|Adverse Event|4
7090618|NCT02247531|11208066|FG002|Overall Study|Adverse Event|9
7090619|NCT02247531|11208064|FG000|Overall Study|Death|8
7090620|NCT02247531|11208065|FG001|Overall Study|Death|9
7090621|NCT02247531|11208066|FG002|Overall Study|Death|5
7090622|NCT02247531|11208064|FG000|Overall Study|Lost to Follow-up|1
7090623|NCT02247531|11208065|FG001|Overall Study|Lost to Follow-up|8
7090624|NCT02247531|11208066|FG002|Overall Study|Lost to Follow-up|3
7090625|NCT02247531|11208064|FG000|Overall Study|Non-compliance|2
7090626|NCT02247531|11208065|FG001|Overall Study|Non-compliance|2
7090627|NCT02247531|11208066|FG002|Overall Study|Non-compliance|0
7090628|NCT02247531|11208064|FG000|Overall Study|Withdrawal by Subject|26
7090629|NCT02247531|11208065|FG001|Overall Study|Withdrawal by Subject|31
7090630|NCT02247531|11208066|FG002|Overall Study|Withdrawal by Subject|25
7090631|NCT02247531|11208064|FG000|Overall Study|Study Terminated by Sponsor|64
7090632|NCT02247531|11208065|FG001|Overall Study|Study Terminated by Sponsor|66
7090633|NCT02247531|11208066|FG002|Overall Study|Study Terminated by Sponsor|62
7090634|NCT02247531|11208064|FG000|Overall Study|Physician Decision|0
7090635|NCT02247531|11208065|FG001|Overall Study|Physician Decision|2
7090636|NCT02247531|11208066|FG002|Overall Study|Physician Decision|2
7090637|NCT02247531|11208064|FG000|Overall Study|Unspecified Reason|2
7090638|NCT02247531|11208065|FG001|Overall Study|Unspecified Reason|3
7090639|NCT02247531|11208066|FG002|Overall Study|Unspecified Reason|4
7090640|NCT02247804|11208096|FG000|Treatment Period 1|Adverse Event|9
7090641|NCT02247804|11208097|FG001|Treatment Period 1|Adverse Event|2
7090642|NCT02247804|11208098|FG002|Treatment Period 1|Adverse Event|0
7090643|NCT02247804|11208096|FG000|Treatment Period 1|Lack of Efficacy|0
7090644|NCT02247804|11208097|FG001|Treatment Period 1|Lack of Efficacy|0
7090645|NCT02247804|11208098|FG002|Treatment Period 1|Lack of Efficacy|2
7090646|NCT02247804|11208096|FG000|Treatment Period 1|Lost to Follow-up|1
7090647|NCT02247804|11208097|FG001|Treatment Period 1|Lost to Follow-up|0
7090648|NCT02247804|11208098|FG002|Treatment Period 1|Lost to Follow-up|2
7090649|NCT02247804|11208096|FG000|Treatment Period 1|Personal Reasons|7
7090650|NCT02247804|11208097|FG001|Treatment Period 1|Personal Reasons|1
7090651|NCT02247804|11208098|FG002|Treatment Period 1|Personal Reasons|2
7090652|NCT02247804|11208096|FG000|Treatment Period 1|Protocol Deviation|0
7090653|NCT02247804|11208097|FG001|Treatment Period 1|Protocol Deviation|0
7090654|NCT02247804|11208098|FG002|Treatment Period 1|Protocol Deviation|1
7090655|NCT02247804|11208096|FG000|Treatment Period 1|Randomized but not Treated|5
7090656|NCT02247804|11208097|FG001|Treatment Period 1|Randomized but not Treated|1
7090657|NCT02247804|11208098|FG002|Treatment Period 1|Randomized but not Treated|1
7090658|NCT02247804|11208096|FG000|Treatment Period 2|Adverse Event|6
7090659|NCT02247804|11208097|FG001|Treatment Period 2|Adverse Event|3
7090660|NCT02247804|11208098|FG002|Treatment Period 2|Adverse Event|3
7090661|NCT02247804|11208096|FG000|Treatment Period 2|Lack of Efficacy|0
7090662|NCT02247804|11208097|FG001|Treatment Period 2|Lack of Efficacy|0
7090663|NCT02247804|11208098|FG002|Treatment Period 2|Lack of Efficacy|1
7090664|NCT02247804|11208096|FG000|Treatment Period 2|Lost to Follow-up|0
7090665|NCT02247804|11208097|FG001|Treatment Period 2|Lost to Follow-up|1
7090666|NCT02247804|11208098|FG002|Treatment Period 2|Lost to Follow-up|1
7090667|NCT02247804|11208096|FG000|Treatment Period 2|Personal Reasons|2
7090668|NCT02247804|11208097|FG001|Treatment Period 2|Personal Reasons|1
7090669|NCT02247804|11208098|FG002|Treatment Period 2|Personal Reasons|1
7090670|NCT02247804|11208096|FG000|Treatment Period 2|Reason not Specified|0
7090671|NCT02247804|11208097|FG001|Treatment Period 2|Reason not Specified|0
7090672|NCT02247804|11208098|FG002|Treatment Period 2|Reason not Specified|2
7090673|NCT02247804|11208096|FG000|Treatment Period 3|Adverse Event|4
7090674|NCT02247804|11208097|FG001|Treatment Period 3|Adverse Event|3
7090675|NCT02247804|11208098|FG002|Treatment Period 3|Adverse Event|3
7090676|NCT02247804|11208096|FG000|Treatment Period 3|Lack of Efficacy|0
7090677|NCT02247804|11208097|FG001|Treatment Period 3|Lack of Efficacy|1
7090678|NCT02247804|11208098|FG002|Treatment Period 3|Lack of Efficacy|0
7090679|NCT02247804|11208096|FG000|Treatment Period 3|Lost to Follow-up|1
7090680|NCT02247804|11208097|FG001|Treatment Period 3|Lost to Follow-up|2
7090681|NCT02247804|11208098|FG002|Treatment Period 3|Lost to Follow-up|2
7090682|NCT02247804|11208096|FG000|Treatment Period 3|Personal Reasons|4
7090683|NCT02247804|11208097|FG001|Treatment Period 3|Personal Reasons|3
7090684|NCT02247804|11208098|FG002|Treatment Period 3|Personal Reasons|2
7090685|NCT02247804|11208096|FG000|Treatment Period 3|Reason not Specified|2
7090686|NCT02247804|11208097|FG001|Treatment Period 3|Reason not Specified|1
7090687|NCT02247804|11208098|FG002|Treatment Period 3|Reason not Specified|3
7090688|NCT02247960|11208108|FG000|Patient Consent and Randomization|Physician Decision|2
7090689|NCT02247960|11208109|FG001|Patient Consent and Randomization|Physician Decision|2
7090690|NCT02247960|11208108|FG000|Patient Consent and Randomization|Withdrawal by Subject|0
7090691|NCT02247960|11208109|FG001|Patient Consent and Randomization|Withdrawal by Subject|4
7090692|NCT02247960|11208108|FG000|Catheter Removed|Lost to Follow-up|7
7090693|NCT02247960|11208109|FG001|Catheter Removed|Lost to Follow-up|10
7090694|NCT02248480|11208139|FG000|Overall Study|Lack of Efficacy|4
7090695|NCT02248480|11208140|FG001|Overall Study|Lack of Efficacy|6
7090696|NCT02248480|11208139|FG000|Overall Study|Adverse Event|11
7090697|NCT02248480|11208140|FG001|Overall Study|Adverse Event|2
7090698|NCT02248480|11208139|FG000|Overall Study|Withdrawal by Subject|2
7090699|NCT02248480|11208140|FG001|Overall Study|Withdrawal by Subject|4
7090700|NCT02248480|11208139|FG000|Overall Study|Entry Criteria Not Met|0
7090701|NCT02248480|11208140|FG001|Overall Study|Entry Criteria Not Met|1
7090702|NCT02248480|11208139|FG000|Overall Study|Other:Physician Decision|0
7090703|NCT02248480|11208140|FG001|Overall Study|Other:Physician Decision|1
7090704|NCT02248649|11208169|FG000|Overall Study|Death|7
7090705|NCT02248649|11208170|FG001|Overall Study|Death|11
7090706|NCT02248649|11208169|FG000|Overall Study|Lost to Follow-up|14
7090707|NCT02248649|11208170|FG001|Overall Study|Lost to Follow-up|10
7090708|NCT02248675|11208191|FG000|Overall Study|Lost to Follow-up|3
7090709|NCT02248675|11208192|FG001|Overall Study|Lost to Follow-up|1
7090710|NCT02248818|11208230|FG000|Screening|Protocol Violation|0
7090711|NCT02248818|11208231|FG001|Screening|Protocol Violation|0
7090712|NCT02248818|11208232|FG002|Screening|Protocol Violation|0
7090713|NCT02248818|11208233|FG003|Screening|Protocol Violation|0
7090714|NCT02248818|11208234|FG004|Screening|Protocol Violation|0
7090715|NCT02248818|11208235|FG005|Screening|Protocol Violation|0
7090716|NCT02248818|11208236|FG006|Screening|Protocol Violation|0
7090717|NCT02248818|11208237|FG007|Screening|Protocol Violation|0
7090718|NCT02248818|11208238|FG008|Screening|Protocol Violation|7
7090719|NCT02248818|11208230|FG000|Screening|Study fully enrolled|0
7090720|NCT02248818|11208231|FG001|Screening|Study fully enrolled|0
7090721|NCT02248818|11208232|FG002|Screening|Study fully enrolled|0
7090722|NCT02248818|11208233|FG003|Screening|Study fully enrolled|0
7090723|NCT02248818|11208234|FG004|Screening|Study fully enrolled|0
7090724|NCT02248818|11208235|FG005|Screening|Study fully enrolled|0
7090725|NCT02248818|11208236|FG006|Screening|Study fully enrolled|0
7090726|NCT02248818|11208237|FG007|Screening|Study fully enrolled|0
7090727|NCT02248818|11208238|FG008|Screening|Study fully enrolled|14
7090728|NCT02248818|11208230|FG000|Screening|Physician Decision|0
7090729|NCT02248818|11208231|FG001|Screening|Physician Decision|0
7090730|NCT02248818|11208232|FG002|Screening|Physician Decision|0
7090731|NCT02248818|11208233|FG003|Screening|Physician Decision|0
7090732|NCT02248818|11208234|FG004|Screening|Physician Decision|0
7090733|NCT02248818|11208235|FG005|Screening|Physician Decision|0
7090734|NCT02248818|11208236|FG006|Screening|Physician Decision|0
7090735|NCT02248818|11208237|FG007|Screening|Physician Decision|0
7090736|NCT02248818|11208238|FG008|Screening|Physician Decision|73
7090737|NCT02248818|11208230|FG000|Screening|Withdrawal by Subject|0
7090738|NCT02248818|11208231|FG001|Screening|Withdrawal by Subject|0
7090739|NCT02248818|11208232|FG002|Screening|Withdrawal by Subject|0
7090740|NCT02248818|11208233|FG003|Screening|Withdrawal by Subject|0
7090741|NCT02248818|11208234|FG004|Screening|Withdrawal by Subject|0
7090742|NCT02248818|11208235|FG005|Screening|Withdrawal by Subject|0
7090743|NCT02248818|11208236|FG006|Screening|Withdrawal by Subject|0
7090744|NCT02248818|11208237|FG007|Screening|Withdrawal by Subject|0
7090745|NCT02248818|11208238|FG008|Screening|Withdrawal by Subject|6
7090746|NCT02248818|11208230|FG000|Screening|Lost to Follow-up|0
7090747|NCT02248818|11208231|FG001|Screening|Lost to Follow-up|0
7090748|NCT02248818|11208232|FG002|Screening|Lost to Follow-up|0
7090749|NCT02248818|11208233|FG003|Screening|Lost to Follow-up|0
7090750|NCT02248818|11208234|FG004|Screening|Lost to Follow-up|0
7090751|NCT02248818|11208235|FG005|Screening|Lost to Follow-up|0
7090752|NCT02248818|11208236|FG006|Screening|Lost to Follow-up|0
7090753|NCT02248818|11208237|FG007|Screening|Lost to Follow-up|0
7090754|NCT02248818|11208238|FG008|Screening|Lost to Follow-up|7
7090755|NCT02248818|11208230|FG000|Randomised Study|Administrative - randomization error|0
7090756|NCT02248818|11208231|FG001|Randomised Study|Administrative - randomization error|0
7090757|NCT02248818|11208232|FG002|Randomised Study|Administrative - randomization error|0
7090758|NCT02248818|11208233|FG003|Randomised Study|Administrative - randomization error|0
7090759|NCT02248818|11208234|FG004|Randomised Study|Administrative - randomization error|0
7090760|NCT02248818|11208235|FG005|Randomised Study|Administrative - randomization error|8
7090761|NCT02248818|11208236|FG006|Randomised Study|Administrative - randomization error|0
7090762|NCT02248818|11208237|FG007|Randomised Study|Administrative - randomization error|0
7090763|NCT02248818|11208238|FG008|Randomised Study|Administrative - randomization error|0
7090764|NCT02248857|11208259|FG000|3 Month|Withdrawal by Subject|9
7090765|NCT02248857|11208260|FG001|3 Month|Withdrawal by Subject|3
7090766|NCT02248857|11208261|FG002|3 Month|Withdrawal by Subject|4
7090767|NCT02248857|11208259|FG000|3 Month|Unable to reach for 3 month|35
7090768|NCT02248857|11208260|FG001|3 Month|Unable to reach for 3 month|29
7090769|NCT02248857|11208261|FG002|3 Month|Unable to reach for 3 month|26
7090770|NCT02248857|11208259|FG000|3 Month|Partially completed, unable to finish|2
7090771|NCT02248857|11208260|FG001|3 Month|Partially completed, unable to finish|2
7090772|NCT02248857|11208261|FG002|3 Month|Partially completed, unable to finish|1
7090773|NCT02248857|11208259|FG000|6 Month|Lost to Follow-up|27
7090774|NCT02248857|11208260|FG001|6 Month|Lost to Follow-up|26
7090775|NCT02248857|11208261|FG002|6 Month|Lost to Follow-up|15
7090776|NCT02248857|11208259|FG000|6 Month|Partially completed, unable to finish|0
7090777|NCT02248857|11208260|FG001|6 Month|Partially completed, unable to finish|1
7090778|NCT02248857|11208261|FG002|6 Month|Partially completed, unable to finish|0
7090779|NCT02248857|11208259|FG000|6 Month|Withdrawal by Subject|0
7090780|NCT02248857|11208260|FG001|6 Month|Withdrawal by Subject|2
7090781|NCT02248857|11208261|FG002|6 Month|Withdrawal by Subject|2
7090782|NCT02248857|11208259|FG000|6 Month|Death|1
7090783|NCT02248857|11208260|FG001|6 Month|Death|0
7090784|NCT02248857|11208261|FG002|6 Month|Death|0
7090785|NCT02248961|11208279|FG000|Overall Study|Adverse Event|1
7090786|NCT02248961|11208280|FG001|Overall Study|Adverse Event|0
7090787|NCT02248961|11208279|FG000|Overall Study|Withdrawal by Subject|1
7090788|NCT02248961|11208280|FG001|Overall Study|Withdrawal by Subject|2
7090789|NCT02248961|11208279|FG000|Overall Study|Unmet inclusion/exclusion criteria|1
7090790|NCT02248961|11208280|FG001|Overall Study|Unmet inclusion/exclusion criteria|0
7090791|NCT02248974|11208288|FG000|1-Day Follow-Up|Lost to Follow-up|4
7090792|NCT02248974|11208289|FG001|1-Day Follow-Up|Lost to Follow-up|0
7090793|NCT02248974|11208288|FG000|1-Day Follow-Up|Withdrawal by Subject|5
7090794|NCT02248974|11208289|FG001|1-Day Follow-Up|Withdrawal by Subject|0
7090795|NCT02248974|11208288|FG000|1-Day Follow-Up|Enrolled in another study|1
7090796|NCT02248974|11208289|FG001|1-Day Follow-Up|Enrolled in another study|0
7090797|NCT02248974|11208288|FG000|1-Week Follow-Up|Became ineligible for LVAD|4
7090798|NCT02248974|11208289|FG001|1-Week Follow-Up|Became ineligible for LVAD|1
7090799|NCT02248974|11208288|FG000|1-Week Follow-Up|Enrolled in another study|1
7090800|NCT02248974|11208289|FG001|1-Week Follow-Up|Enrolled in another study|1
7090801|NCT02248974|11208288|FG000|1-Week Follow-Up|Transferred to another facility|1
7090802|NCT02248974|11208289|FG001|1-Week Follow-Up|Transferred to another facility|0
7090803|NCT02248974|11208288|FG000|1-Week Follow-Up|Cognitive Difficulty|1
7090804|NCT02248974|11208289|FG001|1-Week Follow-Up|Cognitive Difficulty|0
7090805|NCT02248974|11208288|FG000|1-Week Follow-Up|Death|1
7090806|NCT02248974|11208289|FG001|1-Week Follow-Up|Death|1
7090807|NCT02248974|11208288|FG000|1-Week Follow-Up|Excluded because of age|0
7090808|NCT02248974|11208289|FG001|1-Week Follow-Up|Excluded because of age|1
7090809|NCT02248974|11208288|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0
7090810|NCT02248974|11208289|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1
7090811|NCT02248974|11208288|FG000|1-Week Follow-Up|Timing: implanted before survey|0
7090812|NCT02248974|11208289|FG001|1-Week Follow-Up|Timing: implanted before survey|2
7090813|NCT02248974|11208288|FG000|1-Week Follow-Up|Withdrawal by Subject|0
7090814|NCT02248974|11208289|FG001|1-Week Follow-Up|Withdrawal by Subject|2
7090815|NCT02248974|11208288|FG000|1-Week Follow-Up|Lost to Follow-up|0
7090816|NCT02248974|11208289|FG001|1-Week Follow-Up|Lost to Follow-up|8
7090817|NCT02248974|11208288|FG000|1-Month Follow-Up|Lost to Follow-up|2
7090818|NCT02248974|11208289|FG001|1-Month Follow-Up|Lost to Follow-up|3
7090819|NCT02249091|11208309|FG000|Overall Study|Lack of Efficacy|8
7090820|NCT02249091|11208310|FG001|Overall Study|Lack of Efficacy|3
7090821|NCT02249091|11208309|FG000|Overall Study|Physician Decision|4
7090822|NCT02249091|11208310|FG001|Overall Study|Physician Decision|1
7090823|NCT02249091|11208309|FG000|Overall Study|Withdrawal by Subject|2
7090824|NCT02249091|11208310|FG001|Overall Study|Withdrawal by Subject|2
7090825|NCT02249091|11208309|FG000|Overall Study|Death|3
7090826|NCT02249091|11208310|FG001|Overall Study|Death|4
7090827|NCT02249091|11208309|FG000|Overall Study|Adverse Event|1
7090828|NCT02249091|11208310|FG001|Overall Study|Adverse Event|0
7090829|NCT02249091|11208309|FG000|Overall Study|Stable disease with following SCT|0
7090830|NCT02249091|11208310|FG001|Overall Study|Stable disease with following SCT|1
7090831|NCT02249091|11208309|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0
7090832|NCT02249091|11208310|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1
7090833|NCT02249091|11208309|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1
7090834|NCT02249091|11208310|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0
7090835|NCT02249091|11208309|FG000|Overall Study|Refractory AML|1
7090836|NCT02249091|11208310|FG001|Overall Study|Refractory AML|1
7090837|NCT02249182|11208334|FG000|Treatment Phase|Lost to Follow-up|4
7090838|NCT02249182|11208335|FG001|Treatment Phase|Lost to Follow-up|0
7090839|NCT02249182|11208336|FG002|Treatment Phase|Lost to Follow-up|0
7090840|NCT02249182|11208337|FG003|Treatment Phase|Lost to Follow-up|0
7090841|NCT02249182|11208338|FG004|Treatment Phase|Lost to Follow-up|0
7090842|NCT02249767|11208386|FG000|Overall Study|Did not use medication|8
7090843|NCT02249767|11208387|FG001|Overall Study|Did not use medication|9
7090844|NCT02249767|11208388|FG002|Overall Study|Did not use medication|8
7090845|NCT02249832|11208408|FG000|Overall Study|Withdrawal by Subject|3
7090846|NCT02249832|11208408|FG000|Overall Study|Lost to Follow-up|10
7090847|NCT02249949|11208417|FG000|Overall Study|Cancelled prior to treatment|2
7090848|NCT02250183|11208430|FG000|Overall Study|Withdrawal by Subject|2
7090849|NCT02250183|11208430|FG000|Overall Study|Adverse Event|5
7090850|NCT02250183|11208430|FG000|Overall Study|Lost to Follow-up|1
7090851|NCT02250274|11208439|FG000|Overall Study|Insufficient blood draw amount|7
7090852|NCT02250274|11208440|FG001|Overall Study|Insufficient blood draw amount|6
7090853|NCT02250443|11208462|FG000|Overall Study|Administrative problems|7
7090854|NCT02250443|11208462|FG000|Overall Study|Adverse Event|3
7090855|NCT02250651|11208501|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0
7090856|NCT02250651|11208502|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2
7090857|NCT02250651|11208503|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2
7090858|NCT02250651|11208501|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1
7090859|NCT02250651|11208502|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0
7090860|NCT02250651|11208503|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0
7090861|NCT02250651|11208501|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2
7090862|NCT02250651|11208502|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3
7090863|NCT02250651|11208503|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5
7090864|NCT02250651|11208501|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1
7090865|NCT02250651|11208502|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0
7090866|NCT02250651|11208503|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0
7090867|NCT02250651|11208501|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0
7090868|NCT02250651|11208502|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0
7090869|NCT02250651|11208503|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1
7090870|NCT02250651|11208501|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0
7090871|NCT02250651|11208502|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1
7090872|NCT02250651|11208503|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3
7090873|NCT02250651|11208501|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4
7090874|NCT02250651|11208502|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1
7090875|NCT02250651|11208503|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0
7090876|NCT02250651|11208501|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0
7090877|NCT02250651|11208502|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0
7090878|NCT02250651|11208503|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3
7090879|NCT02250651|11208501|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2
7090880|NCT02250651|11208502|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3
7090881|NCT02250651|11208503|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2
7090882|NCT02250651|11208501|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0
7090883|NCT02250651|11208502|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1
7090884|NCT02250651|11208503|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0
7090885|NCT02250651|11208501|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0
7090886|NCT02250651|11208502|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1
7090887|NCT02250651|11208503|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0
7090888|NCT02250651|11208501|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4
7090889|NCT02250651|11208502|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1
7090890|NCT02250651|11208503|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1
7090891|NCT02250651|11208501|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1
7090892|NCT02250651|11208502|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2
7090893|NCT02250651|11208503|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1
7090894|NCT02250651|11208501|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2
7090895|NCT02250651|11208502|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0
7090896|NCT02250651|11208503|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2
7090897|NCT02250651|11208501|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2
7090898|NCT02250651|11208502|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1
7090899|NCT02250651|11208503|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1
7090900|NCT02251275|11208542|FG000|Overall Study|Adverse Event|23
7090901|NCT02251275|11208543|FG001|Overall Study|Adverse Event|60
7090902|NCT02251275|11208544|FG002|Overall Study|Adverse Event|28
7090903|NCT02251275|11208545|FG003|Overall Study|Adverse Event|0
7090904|NCT02251275|11208546|FG004|Overall Study|Adverse Event|0
7090905|NCT02251275|11208542|FG000|Overall Study|Lost to Follow-up|5
7090906|NCT02251275|11208543|FG001|Overall Study|Lost to Follow-up|6
7090907|NCT02251275|11208544|FG002|Overall Study|Lost to Follow-up|4
7090908|NCT02251275|11208545|FG003|Overall Study|Lost to Follow-up|0
7090909|NCT02251275|11208546|FG004|Overall Study|Lost to Follow-up|0
7090910|NCT02251275|11208542|FG000|Overall Study|Physician Decision|19
7090911|NCT02251275|11208543|FG001|Overall Study|Physician Decision|30
7090912|NCT02251275|11208544|FG002|Overall Study|Physician Decision|26
7090913|NCT02251275|11208545|FG003|Overall Study|Physician Decision|0
7090914|NCT02251275|11208546|FG004|Overall Study|Physician Decision|1
7090915|NCT02251275|11208542|FG000|Overall Study|Protocol Deviation|0
7090916|NCT02251275|11208543|FG001|Overall Study|Protocol Deviation|0
7090917|NCT02251275|11208544|FG002|Overall Study|Protocol Deviation|1
7090918|NCT02251275|11208545|FG003|Overall Study|Protocol Deviation|0
7090919|NCT02251275|11208546|FG004|Overall Study|Protocol Deviation|0
7090920|NCT02251275|11208542|FG000|Overall Study|Withdrawal by Subject|25
7090921|NCT02251275|11208543|FG001|Overall Study|Withdrawal by Subject|51
7090922|NCT02251275|11208544|FG002|Overall Study|Withdrawal by Subject|35
7090923|NCT02251275|11208545|FG003|Overall Study|Withdrawal by Subject|1
7090924|NCT02251275|11208546|FG004|Overall Study|Withdrawal by Subject|0
7090925|NCT02251652|11208588|FG000|Overall Study|Withdrawal by Subject|1
7090926|NCT02251717|11208596|FG000|Overall Study|Adverse Event|0
7090927|NCT02251717|11208597|FG001|Overall Study|Adverse Event|1
7090928|NCT02251717|11208596|FG000|Overall Study|Withdrew Consent|1
7090929|NCT02251717|11208597|FG001|Overall Study|Withdrew Consent|0
7090930|NCT02251743|11208605|FG000|Overall Study|Withdrawal by Subject|1
7090931|NCT02251743|11208606|FG001|Overall Study|Withdrawal by Subject|1
7090932|NCT02251912|11208631|FG000|Overall Study|Withdrawal by Subject|2
7090933|NCT02251912|11208632|FG001|Overall Study|Withdrawal by Subject|3
7090934|NCT02251912|11208631|FG000|Overall Study|Adverse Event|0
7090935|NCT02251912|11208632|FG001|Overall Study|Adverse Event|2
7090936|NCT02251990|11208644|FG000|Period 1 (Double-blind [DB])|Adverse Event|1
7090937|NCT02251990|11208645|FG001|Period 1 (Double-blind [DB])|Adverse Event|1
7090938|NCT02251990|11208644|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5
7090939|NCT02251990|11208645|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0
7090940|NCT02251990|11208644|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1
7090941|NCT02251990|11208645|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0
7090942|NCT02251990|11208644|FG000|Period 1 (Double-blind [DB])|Not Treated|1
7090943|NCT02251990|11208645|FG001|Period 1 (Double-blind [DB])|Not Treated|0
7090944|NCT02251990|11208644|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0
7090945|NCT02251990|11208645|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1
7090946|NCT02251990|11208644|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0
7090947|NCT02251990|11208645|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2
7090948|NCT02252016|11208654|FG000|Overall Study|Lost to Follow-up|2
7090949|NCT02252016|11208655|FG001|Overall Study|Lost to Follow-up|1
7090950|NCT02252016|11208654|FG000|Overall Study|Physician Decision|1
7090951|NCT02252016|11208655|FG001|Overall Study|Physician Decision|0
7090952|NCT02252016|11208654|FG000|Overall Study|Withdrawal by Subject|0
7090953|NCT02252016|11208655|FG001|Overall Study|Withdrawal by Subject|2
7090954|NCT02252042|11208663|FG000|Overall Study|Death|170
7090955|NCT02252042|11208664|FG001|Overall Study|Death|192
7090956|NCT02252042|11208663|FG000|Overall Study|Physician Decision|0
7090957|NCT02252042|11208664|FG001|Overall Study|Physician Decision|1
7090958|NCT02252042|11208663|FG000|Overall Study|Withdrawal by Subject|13
7090959|NCT02252042|11208664|FG001|Overall Study|Withdrawal by Subject|20
7090960|NCT02252042|11208663|FG000|Overall Study|Ongoing in study|64
7090961|NCT02252042|11208664|FG001|Overall Study|Ongoing in study|35
7090962|NCT02252081|11208685|FG000|Overall Study|Withdrawal by Subject|2
7090963|NCT02252081|11208686|FG001|Overall Study|Withdrawal by Subject|1
7090964|NCT02252081|11208685|FG000|Overall Study|Adverse Event|4
7090965|NCT02252081|11208686|FG001|Overall Study|Adverse Event|1
7090966|NCT02252081|11208685|FG000|Overall Study|non compliance & others|0
7090967|NCT02252081|11208686|FG001|Overall Study|non compliance & others|2
7090968|NCT02252146|11208704|FG000|Overall Study|Lack of Efficacy|4
7090969|NCT02252146|11208704|FG000|Overall Study|Entered hospice care|1
7090970|NCT02252146|11208704|FG000|Overall Study|Inability to travel to study site|1
7090971|NCT02252211|11208710|FG000|Overall Study|Adverse Event|0
7090972|NCT02252211|11208711|FG001|Overall Study|Adverse Event|1
7090973|NCT02252211|11208712|FG002|Overall Study|Adverse Event|0
7090974|NCT02252211|11208710|FG000|Overall Study|Progressive disease|3
7090975|NCT02252211|11208711|FG001|Overall Study|Progressive disease|2
7090976|NCT02252211|11208712|FG002|Overall Study|Progressive disease|0
7090977|NCT02252211|11208710|FG000|Overall Study|Withdrawal by Subject|1
7090978|NCT02252211|11208711|FG001|Overall Study|Withdrawal by Subject|0
7090979|NCT02252211|11208712|FG002|Overall Study|Withdrawal by Subject|0
7090980|NCT02252211|11208710|FG000|Overall Study|Serious Adverse Event During Screening|1
7090981|NCT02252211|11208711|FG001|Overall Study|Serious Adverse Event During Screening|0
7090982|NCT02252211|11208712|FG002|Overall Study|Serious Adverse Event During Screening|1
7090983|NCT02252406|11208730|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2
7090984|NCT02252406|11208731|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3
7090985|NCT02252406|11208730|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1
7090986|NCT02252406|11208731|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0
7090987|NCT02252406|11208730|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1
7090988|NCT02252406|11208731|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0
7090989|NCT02252406|11208730|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1
7090990|NCT02252406|11208731|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1
7090991|NCT02252406|11208730|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2
7090992|NCT02252406|11208731|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0
7090993|NCT02252536|11208748|FG000|Overall Study|Lost to Follow-up|5
7090994|NCT02252536|11208749|FG001|Overall Study|Lost to Follow-up|3
7090995|NCT02252588|11208767|FG000|Overall Study|Withdrawal by Subject|4
7090996|NCT02252588|11208768|FG001|Overall Study|Withdrawal by Subject|0
7090997|NCT02252939|11208786|FG000|Overall Study|Lost to Follow-up|3
7090998|NCT02252965|11208797|FG000|Overall Study|Adverse Event|9
7090999|NCT02252965|11208798|FG001|Overall Study|Adverse Event|14
7091000|NCT02252965|11208797|FG000|Overall Study|Lost to Follow-up|16
7091001|NCT02252965|11208798|FG001|Overall Study|Lost to Follow-up|8
7091002|NCT02252965|11208797|FG000|Overall Study|Protocol Violation|4
7091003|NCT02252965|11208798|FG001|Overall Study|Protocol Violation|5
7091004|NCT02252965|11208797|FG000|Overall Study|Lack of Efficacy|0
7091005|NCT02252965|11208798|FG001|Overall Study|Lack of Efficacy|2
7091006|NCT02252965|11208797|FG000|Overall Study|Withdrawal by Subject|7
7091007|NCT02252965|11208798|FG001|Overall Study|Withdrawal by Subject|9
7091008|NCT02252965|11208797|FG000|Overall Study|Other|4
7091009|NCT02252965|11208798|FG001|Overall Study|Other|5
7091010|NCT02253147|11208806|FG000|Overall Study|Protocol Violation|30
7091011|NCT02253147|11208806|FG000|Overall Study|Did not consent to study extension|9
7091012|NCT02253147|11208806|FG000|Overall Study|Conditional re-treatment at W52|5
7091013|NCT02253147|11208806|FG000|Overall Study|Lost to Follow-up|2
7091014|NCT02253147|11208806|FG000|Overall Study|Withdrawal by Subject|1
7091015|NCT02253433|11208850|FG000|Overall Study|Unable to Contact|9
7091016|NCT02253433|11208851|FG001|Overall Study|Unable to Contact|16
7091017|NCT02253433|11208850|FG000|Overall Study|Death|1
7091018|NCT02253433|11208851|FG001|Overall Study|Death|1
7091019|NCT02253433|11208850|FG000|Overall Study|No Longer Interested|3
7091020|NCT02253433|11208851|FG001|Overall Study|No Longer Interested|15
7091021|NCT02253433|11208850|FG000|Overall Study|Out of Study Area|2
7091022|NCT02253433|11208851|FG001|Overall Study|Out of Study Area|7
7091023|NCT02253433|11208850|FG000|Overall Study|Uncomfortable with home visitors|0
7091024|NCT02253433|11208851|FG001|Overall Study|Uncomfortable with home visitors|3
7091025|NCT02253433|11208850|FG000|Overall Study|Unstable Housing/Homeless|0
7091026|NCT02253433|11208851|FG001|Overall Study|Unstable Housing/Homeless|7
7091027|NCT02253433|11208850|FG000|Overall Study|Too Busy|0
7091028|NCT02253433|11208851|FG001|Overall Study|Too Busy|4
7091029|NCT02253433|11208850|FG000|Overall Study|Medical or Other Concerns|1
7091030|NCT02253433|11208851|FG001|Overall Study|Medical or Other Concerns|2
7091031|NCT02253654|11208864|FG000|Overall Study|Withdrawal by Subject|12
7091032|NCT02253654|11208865|FG001|Overall Study|Withdrawal by Subject|4
7091033|NCT02253654|11208864|FG000|Overall Study|Decision by Sponsor|1
7091034|NCT02253654|11208865|FG001|Overall Study|Decision by Sponsor|1
7091035|NCT02253654|11208864|FG000|Overall Study|Lost to Follow-up|2
7091036|NCT02253654|11208865|FG001|Overall Study|Lost to Follow-up|5
7091037|NCT02253654|11208864|FG000|Overall Study|Death|4
7091038|NCT02253654|11208865|FG001|Overall Study|Death|7
7091039|NCT02253654|11208864|FG000|Overall Study|Did Not Receive Study Treatment|4
7091040|NCT02253654|11208865|FG001|Overall Study|Did Not Receive Study Treatment|1
7091041|NCT02253992|11208874|FG000|Overall Study|Study drug toxicity|1
7091042|NCT02253992|11208875|FG001|Overall Study|Study drug toxicity|0
7091043|NCT02253992|11208876|FG002|Overall Study|Study drug toxicity|10
7091044|NCT02253992|11208874|FG000|Overall Study|Disease progression|4
7091045|NCT02253992|11208875|FG001|Overall Study|Disease progression|3
7091046|NCT02253992|11208876|FG002|Overall Study|Disease progression|98
7091047|NCT02253992|11208874|FG000|Overall Study|Withdrawal by Subject|0
7091048|NCT02253992|11208875|FG001|Overall Study|Withdrawal by Subject|0
7091049|NCT02253992|11208876|FG002|Overall Study|Withdrawal by Subject|3
7091050|NCT02253992|11208874|FG000|Overall Study|Adverse Event|0
7091051|NCT02253992|11208875|FG001|Overall Study|Adverse Event|0
7091052|NCT02253992|11208876|FG002|Overall Study|Adverse Event|8
7091053|NCT02253992|11208874|FG000|Overall Study|Death|0
7091054|NCT02253992|11208875|FG001|Overall Study|Death|0
7091055|NCT02253992|11208876|FG002|Overall Study|Death|1
7091056|NCT02253992|11208874|FG000|Overall Study|Subject discontinued study drug|1
7091057|NCT02253992|11208875|FG001|Overall Study|Subject discontinued study drug|0
7091058|NCT02253992|11208876|FG002|Overall Study|Subject discontinued study drug|1
7091059|NCT02253992|11208874|FG000|Overall Study|Completed treatment as per protocol|0
7091060|NCT02253992|11208875|FG001|Overall Study|Completed treatment as per protocol|1
7091061|NCT02253992|11208876|FG002|Overall Study|Completed treatment as per protocol|22
7091062|NCT02253992|11208874|FG000|Overall Study|Other|0
7091063|NCT02253992|11208875|FG001|Overall Study|Other|0
7091064|NCT02253992|11208876|FG002|Overall Study|Other|1
7091065|NCT02254291|11208923|FG000|Overall Study|Withdrawal by Subject|0
7091066|NCT02254291|11208924|FG001|Overall Study|Withdrawal by Subject|3
7091067|NCT02254291|11208925|FG002|Overall Study|Withdrawal by Subject|1
7091068|NCT02254291|11208923|FG000|Overall Study|Missing follow-up information|0
7091069|NCT02254291|11208924|FG001|Overall Study|Missing follow-up information|0
7091070|NCT02254291|11208925|FG002|Overall Study|Missing follow-up information|1
7091071|NCT02254304|11208935|FG000|Overall Study|Adverse Event|2
7091072|NCT02254304|11208936|FG001|Overall Study|Adverse Event|1
7091073|NCT02254304|11208935|FG000|Overall Study|Lost to Follow-up|2
7091074|NCT02254304|11208936|FG001|Overall Study|Lost to Follow-up|2
7091075|NCT02254304|11208935|FG000|Overall Study|Protocol Violation|1
7091076|NCT02254304|11208936|FG001|Overall Study|Protocol Violation|0
7091077|NCT02254304|11208935|FG000|Overall Study|Withdrawal by Subject|3
7091078|NCT02254304|11208936|FG001|Overall Study|Withdrawal by Subject|0
7091079|NCT02254304|11208935|FG000|Overall Study|Injection site pain and Injection fear|1
7091080|NCT02254304|11208936|FG001|Overall Study|Injection site pain and Injection fear|0
7091081|NCT02254304|11208935|FG000|Overall Study|Personal causes|4
7091082|NCT02254304|11208936|FG001|Overall Study|Personal causes|1
7091083|NCT02254304|11208935|FG000|Overall Study|Personal decision|1
7091084|NCT02254304|11208936|FG001|Overall Study|Personal decision|0
7091085|NCT02254408|11208946|FG000|Overall Study|Randomized But Not Treated|1
7091086|NCT02254408|11208947|FG001|Overall Study|Randomized But Not Treated|3
7091087|NCT02254408|11208946|FG000|Overall Study|Adverse Event|1
7091088|NCT02254408|11208947|FG001|Overall Study|Adverse Event|0
7091089|NCT02254408|11208946|FG000|Overall Study|Death|2
7091090|NCT02254408|11208947|FG001|Overall Study|Death|3
7091091|NCT02254408|11208946|FG000|Overall Study|Investigator's Discretion|0
7091092|NCT02254408|11208947|FG001|Overall Study|Investigator's Discretion|1
7091093|NCT02254408|11208946|FG000|Overall Study|Withdrawal by Subject|3
7091094|NCT02254408|11208947|FG001|Overall Study|Withdrawal by Subject|3
7091095|NCT02254408|11208946|FG000|Overall Study|Lost to Follow-up|1
7091096|NCT02254408|11208947|FG001|Overall Study|Lost to Follow-up|0
7091097|NCT02254421|11208955|FG000|Overall Study|Randomized but Not Treated|1
7091098|NCT02254421|11208956|FG001|Overall Study|Randomized but Not Treated|0
7091099|NCT02254421|11208955|FG000|Overall Study|Death|0
7091100|NCT02254421|11208956|FG001|Overall Study|Death|2
7091101|NCT02254421|11208955|FG000|Overall Study|Withdrew Consent|1
7091102|NCT02254421|11208956|FG001|Overall Study|Withdrew Consent|1
7091103|NCT02254460|11208962|FG000|Overall Study|Adverse Event|1
7091104|NCT02254460|11208963|FG001|Overall Study|Adverse Event|0
7091105|NCT02254486|11208980|FG000|Overall Study|Adverse Event|1
7091106|NCT02254486|11208981|FG001|Overall Study|Adverse Event|1
7091107|NCT02254486|11208980|FG000|Overall Study|Lack of Efficacy|1
7091108|NCT02254486|11208981|FG001|Overall Study|Lack of Efficacy|0
7091109|NCT02254486|11208980|FG000|Overall Study|Lost to Follow-up|2
7091110|NCT02254486|11208981|FG001|Overall Study|Lost to Follow-up|4
7091111|NCT02254486|11208980|FG000|Overall Study|Protocol Violation|1
7091112|NCT02254486|11208981|FG001|Overall Study|Protocol Violation|2
7091113|NCT02254486|11208980|FG000|Overall Study|Withdrawal by Subject|17
7091114|NCT02254486|11208981|FG001|Overall Study|Withdrawal by Subject|15
7091115|NCT02254486|11208980|FG000|Overall Study|GFR<60mL/min|16
7091116|NCT02254486|11208981|FG001|Overall Study|GFR<60mL/min|21
7091117|NCT02254486|11208980|FG000|Overall Study|Various|12
7091118|NCT02254486|11208981|FG001|Overall Study|Various|12
7091119|NCT02254551|11208987|FG000|Dose Escalation|Physician Decision|1
7091120|NCT02254551|11208987|FG000|Dose Escalation|Dose-limiting toxicity|2
7091121|NCT02254681|11208994|FG000|Overall Study|Lack of Efficacy|6
7091122|NCT02254772|11208999|FG000|Overall Study|Ineligible|1
7091123|NCT02254772|11208999|FG000|Overall Study|Withdrawal by Subject|1
7091135|NCT02255149|11209020|FG000|Overall Study|Lost to Follow-up|2
7091136|NCT02255149|11209020|FG000|Overall Study|Withdrawal by Subject|1
7091137|NCT02255149|11209020|FG000|Overall Study|Withdrawal by PI|1
7091138|NCT02255149|11209020|FG000|Overall Study|Implant Failure|1
7091139|NCT02255279|11209039|FG000|Overall Study|Lost to Follow-up|2
7091140|NCT02255279|11209040|FG001|Overall Study|Lost to Follow-up|2
7091141|NCT02255279|11209039|FG000|Overall Study|Protocol Violation|0
7091142|NCT02255279|11209040|FG001|Overall Study|Protocol Violation|1
7091143|NCT02255279|11209039|FG000|Overall Study|Withdrawal by Subject|3
7091144|NCT02255279|11209040|FG001|Overall Study|Withdrawal by Subject|6
7091145|NCT02255422|11209076|FG000|Overall Study|Withdrawal by Subject|0
7091146|NCT02255422|11209077|FG001|Overall Study|Withdrawal by Subject|0
7091147|NCT02255422|11209078|FG002|Overall Study|Withdrawal by Subject|0
7091148|NCT02255422|11209079|FG003|Overall Study|Withdrawal by Subject|0
7091149|NCT02255422|11209080|FG004|Overall Study|Withdrawal by Subject|0
7091150|NCT02255422|11209081|FG005|Overall Study|Withdrawal by Subject|0
7091151|NCT02255422|11209082|FG006|Overall Study|Withdrawal by Subject|2
7091152|NCT02255422|11209076|FG000|Overall Study|Lost to Follow-up|0
7091153|NCT02255422|11209077|FG001|Overall Study|Lost to Follow-up|0
7091154|NCT02255422|11209078|FG002|Overall Study|Lost to Follow-up|1
7091155|NCT02255422|11209079|FG003|Overall Study|Lost to Follow-up|0
7091156|NCT02255422|11209080|FG004|Overall Study|Lost to Follow-up|0
7091157|NCT02255422|11209081|FG005|Overall Study|Lost to Follow-up|0
7091158|NCT02255422|11209082|FG006|Overall Study|Lost to Follow-up|0
7091159|NCT02255461|11209103|FG000|Overall Study|Adverse Event|0
7091160|NCT02255461|11209104|FG001|Overall Study|Adverse Event|1
7091161|NCT02255461|11209105|FG002|Overall Study|Adverse Event|0
7091162|NCT02255461|11209106|FG003|Overall Study|Adverse Event|0
7091163|NCT02255461|11209107|FG004|Overall Study|Adverse Event|1
7091164|NCT02255461|11209103|FG000|Overall Study|Withdrawal by Subject|0
7091165|NCT02255461|11209104|FG001|Overall Study|Withdrawal by Subject|0
7091166|NCT02255461|11209105|FG002|Overall Study|Withdrawal by Subject|1
7091167|NCT02255461|11209106|FG003|Overall Study|Withdrawal by Subject|0
7091168|NCT02255461|11209107|FG004|Overall Study|Withdrawal by Subject|1
7091169|NCT02255461|11209103|FG000|Overall Study|Not meet dose reduction BSA requirement|0
7091170|NCT02255461|11209104|FG001|Overall Study|Not meet dose reduction BSA requirement|1
7091171|NCT02255461|11209105|FG002|Overall Study|Not meet dose reduction BSA requirement|0
7091172|NCT02255461|11209106|FG003|Overall Study|Not meet dose reduction BSA requirement|0
7091173|NCT02255461|11209107|FG004|Overall Study|Not meet dose reduction BSA requirement|0
7091174|NCT02255474|11209127|FG000|Overall Study|Lost to Follow-up|1
7091175|NCT02255474|11209128|FG001|Overall Study|Lost to Follow-up|1
7091176|NCT02255474|11209129|FG002|Overall Study|Lost to Follow-up|3
7091177|NCT02255474|11209127|FG000|Overall Study|Withdrawal by Subject|1
7091178|NCT02255474|11209128|FG001|Overall Study|Withdrawal by Subject|1
7091179|NCT02255474|11209129|FG002|Overall Study|Withdrawal by Subject|0
7091180|NCT02255500|11209140|FG000|Overall Study|Withdrawal by Subject|1
7091181|NCT02255500|11209141|FG001|Overall Study|Withdrawal by Subject|0
7091182|NCT02255552|11209158|FG000|Overall Study|Participants enrolled into another study|0
7091183|NCT02255552|11209159|FG001|Overall Study|Participants enrolled into another study|11
7091184|NCT02255552|11209158|FG000|Overall Study|Withdrawal by Subject|1
7091185|NCT02255552|11209159|FG001|Overall Study|Withdrawal by Subject|4
7091186|NCT02255565|11209168|FG000|Overall Study|Withdrawal by Subject|0
7091187|NCT02255565|11209169|FG001|Overall Study|Withdrawal by Subject|1
7091188|NCT02255565|11209170|FG002|Overall Study|Withdrawal by Subject|0
7091189|NCT02255760|11209229|FG000|Overall Study|Lost to Follow-up|0
7091190|NCT02255760|11209230|FG001|Overall Study|Lost to Follow-up|1
7091191|NCT02255760|11209231|FG002|Overall Study|Lost to Follow-up|0
7091192|NCT02255760|11209232|FG003|Overall Study|Lost to Follow-up|0
7091193|NCT02255760|11209233|FG004|Overall Study|Lost to Follow-up|0
7091194|NCT02255981|11209249|FG000|Overall Study|Lost to Follow-up|3
7091195|NCT02255981|11209249|FG000|Overall Study|Withdrawal by Subject|1
7091196|NCT02256267|11209290|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1
7091197|NCT02256267|11209290|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1
7091198|NCT02256384|11209315|FG000|Overall Study|Withdrawal by Subject|12
7091199|NCT02256384|11209315|FG000|Overall Study|Equipment not capturing data|2
7091200|NCT02256436|11209325|FG000|Overall Study|Adverse Event|9
7091201|NCT02256436|11209326|FG001|Overall Study|Adverse Event|14
7091202|NCT02256436|11209325|FG000|Overall Study|Death|216
7091203|NCT02256436|11209326|FG001|Overall Study|Death|208
7091204|NCT02256436|11209325|FG000|Overall Study|Lost to Follow-up|1
7091205|NCT02256436|11209326|FG001|Overall Study|Lost to Follow-up|2
7091206|NCT02256436|11209325|FG000|Overall Study|Physician Decision|1
7091207|NCT02256436|11209326|FG001|Overall Study|Physician Decision|0
7091208|NCT02256436|11209325|FG000|Overall Study|Protocol Violation|0
7091209|NCT02256436|11209326|FG001|Overall Study|Protocol Violation|1
7091210|NCT02256436|11209325|FG000|Overall Study|Withdrawal by Subject|26
7091211|NCT02256436|11209326|FG001|Overall Study|Withdrawal by Subject|10
7091212|NCT02256436|11209325|FG000|Overall Study|Transferred to Extension Study|11
7091213|NCT02256436|11209326|FG001|Overall Study|Transferred to Extension Study|23
7091214|NCT02256436|11209325|FG000|Overall Study|Did Not Continue on Extension Study|8
7091215|NCT02256436|11209326|FG001|Overall Study|Did Not Continue on Extension Study|12
7091216|NCT02256488|11209337|FG000|Overall Study|Lost to Follow-up|6
7091217|NCT02256488|11209338|FG001|Overall Study|Lost to Follow-up|6
7091218|NCT02256488|11209339|FG002|Overall Study|Lost to Follow-up|9
7091219|NCT02256488|11209340|FG003|Overall Study|Lost to Follow-up|3
7091220|NCT02256488|11209337|FG000|Overall Study|OTHER|1
7091221|NCT02256488|11209338|FG001|Overall Study|OTHER|0
7091222|NCT02256488|11209339|FG002|Overall Study|OTHER|1
7091223|NCT02256488|11209340|FG003|Overall Study|OTHER|1
7091224|NCT02256488|11209337|FG000|Overall Study|Withdrawal by Subject|1
7091225|NCT02256488|11209338|FG001|Overall Study|Withdrawal by Subject|0
7091226|NCT02256488|11209339|FG002|Overall Study|Withdrawal by Subject|0
7091227|NCT02256488|11209340|FG003|Overall Study|Withdrawal by Subject|2
7091228|NCT02256540|11209351|FG000|Overall Study|Withdrawal by Subject|0
7091229|NCT02256540|11209352|FG001|Overall Study|Withdrawal by Subject|1
7091230|NCT02256540|11209353|FG002|Overall Study|Withdrawal by Subject|1
7091231|NCT02256540|11209351|FG000|Overall Study|Back pain preventing exercise|0
7091232|NCT02256540|11209352|FG001|Overall Study|Back pain preventing exercise|0
7091233|NCT02256540|11209353|FG002|Overall Study|Back pain preventing exercise|1
7091234|NCT02256553|11209361|FG000|Period I|Adverse Event|5
7091235|NCT02256553|11209361|FG000|Period I|Protocol Violation|1
7091236|NCT02256553|11209361|FG000|Period II|Adverse Event|1
7091237|NCT02256553|11209361|FG000|Period II|Subject Moved|1
7091238|NCT02256553|11209361|FG000|Period III|Adverse Event|3
7091239|NCT02256839|11209369|FG000|Overall Study|Did not meet Eligibility Criteria|2
7091240|NCT02256839|11209370|FG001|Overall Study|Did not meet Eligibility Criteria|3
7091241|NCT02256891|11209378|FG000|Overall Study|Death|0
7091242|NCT02256891|11209379|FG001|Overall Study|Death|2
7091243|NCT02256891|11209378|FG000|Overall Study|Lost to Follow-up|0
7091244|NCT02256891|11209379|FG001|Overall Study|Lost to Follow-up|3
7091245|NCT02256891|11209378|FG000|Overall Study|Physician Decision|7
7091246|NCT02256891|11209379|FG001|Overall Study|Physician Decision|3
7091247|NCT02256891|11209378|FG000|Overall Study|Screen Fail|5
7091248|NCT02256891|11209379|FG001|Overall Study|Screen Fail|4
7091249|NCT02256891|11209378|FG000|Overall Study|Equipment Malfunction|0
7091250|NCT02256891|11209379|FG001|Overall Study|Equipment Malfunction|1
7091251|NCT02256917|11209387|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1
7091252|NCT02256917|11209387|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1
7091253|NCT02256917|11209387|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1
7091254|NCT02256917|11209387|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1
7091255|NCT02256917|11209387|FG000|Prophylactic Treatment Phase II|Discontinued medication|1
7091256|NCT02256969|11209401|FG000|Overall Study|Screenfailed or withdrew|2
7091257|NCT02256969|11209402|FG001|Overall Study|Screenfailed or withdrew|1
7091258|NCT02256969|11209403|FG002|Overall Study|Screenfailed or withdrew|1
7091259|NCT02256982|11209413|FG000|Overall Study|Disease Progression|0
7091260|NCT02256982|11209414|FG001|Overall Study|Disease Progression|1
7091261|NCT02257372|11209473|FG000|Overall Study|Adverse Event|3
7091262|NCT02257372|11209474|FG001|Overall Study|Adverse Event|7
7091263|NCT02257372|11209473|FG000|Overall Study|Lack of Efficacy|2
7091264|NCT02257372|11209474|FG001|Overall Study|Lack of Efficacy|1
7091265|NCT02257372|11209473|FG000|Overall Study|Protocol Violation|1
7091266|NCT02257372|11209474|FG001|Overall Study|Protocol Violation|1
7091267|NCT02257372|11209473|FG000|Overall Study|Lost to Follow-up|0
7091268|NCT02257372|11209474|FG001|Overall Study|Lost to Follow-up|1
7091269|NCT02257372|11209473|FG000|Overall Study|Withdrew consent|1
7091270|NCT02257372|11209474|FG001|Overall Study|Withdrew consent|0
7091271|NCT02257385|11209482|FG000|Overall Study|Adverse Event|12
7091272|NCT02257385|11209483|FG001|Overall Study|Adverse Event|8
7091273|NCT02257385|11209482|FG000|Overall Study|Lack of Efficacy|1
7091274|NCT02257385|11209483|FG001|Overall Study|Lack of Efficacy|2
7091275|NCT02257385|11209482|FG000|Overall Study|Protocol Violation|5
7091276|NCT02257385|11209483|FG001|Overall Study|Protocol Violation|7
7091277|NCT02257385|11209482|FG000|Overall Study|Lost to Follow-up|0
7091278|NCT02257385|11209483|FG001|Overall Study|Lost to Follow-up|1
7091279|NCT02257385|11209482|FG000|Overall Study|Withdrawal by Subject|4
7091280|NCT02257385|11209483|FG001|Overall Study|Withdrawal by Subject|4
7091281|NCT02257489|11209498|FG000|Overall Study|Withdrawal by Subject|0
7091282|NCT02257489|11209499|FG001|Overall Study|Withdrawal by Subject|0
7091283|NCT02257489|11209500|FG002|Overall Study|Withdrawal by Subject|0
7091284|NCT02257489|11209501|FG003|Overall Study|Withdrawal by Subject|1
7091285|NCT02257489|11209502|FG004|Overall Study|Withdrawal by Subject|0
7091286|NCT02257489|11209503|FG005|Overall Study|Withdrawal by Subject|0
7091287|NCT02257489|11209504|FG006|Overall Study|Withdrawal by Subject|0
7091288|NCT02257489|11209505|FG007|Overall Study|Withdrawal by Subject|0
7091289|NCT02257489|11209506|FG008|Overall Study|Withdrawal by Subject|0
7091290|NCT02257632|11209548|FG000|Overall Study|Withdrawal by Subject|0
7091291|NCT02257632|11209549|FG001|Overall Study|Withdrawal by Subject|1
7091292|NCT02257632|11209548|FG000|Overall Study|Adverse Event|1
7091293|NCT02257632|11209549|FG001|Overall Study|Adverse Event|2
7091294|NCT02257684|11209557|FG000|Overall Study|Adverse Event|2
7091295|NCT02257684|11209557|FG000|Overall Study|Lack of Efficacy|1
7091296|NCT02257684|11209557|FG000|Overall Study|Sponsor's Decision|1
7091297|NCT02258074|11209600|FG000|Overall Study|Withdrawal by Subject|1
7091298|NCT02258074|11209601|FG001|Overall Study|Withdrawal by Subject|0
7091299|NCT02258074|11209602|FG002|Overall Study|Withdrawal by Subject|0
7091300|NCT02258074|11209603|FG003|Overall Study|Withdrawal by Subject|0
7091301|NCT02258334|11209640|FG000|Overall Study|Adverse Event|1
7091302|NCT02258334|11209641|FG001|Overall Study|Adverse Event|0
7091303|NCT02258334|11209642|FG002|Overall Study|Adverse Event|0
7091304|NCT02258334|11209643|FG003|Overall Study|Adverse Event|0
7091305|NCT02258464|11209678|FG000|Overall Study|Progressive disease (PD)|9
7091306|NCT02258464|11209679|FG001|Overall Study|Progressive disease (PD)|17
7091307|NCT02258464|11209678|FG000|Overall Study|Study drug never administered|1
7091308|NCT02258464|11209679|FG001|Overall Study|Study drug never administered|1
7091309|NCT02258464|11209678|FG000|Overall Study|AE not related to clinical PD|1
7091310|NCT02258464|11209679|FG001|Overall Study|AE not related to clinical PD|3
7091311|NCT02258464|11209678|FG000|Overall Study|Withdrawal by Subject|5
7091312|NCT02258464|11209679|FG001|Overall Study|Withdrawal by Subject|4
7091313|NCT02258464|11209678|FG000|Overall Study|AE related to clinical PD|1
7091314|NCT02258464|11209679|FG001|Overall Study|AE related to clinical PD|0
7091315|NCT02258529|11209697|FG000|Overall Study|Study Terminated by Sponsor|9
7091316|NCT02258529|11209697|FG000|Overall Study|Adverse Event|1
7091317|NCT02259010|11209701|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5
7091318|NCT02259088|11209709|FG000|Overall Study|Adverse Event|6
7091319|NCT02259088|11209710|FG001|Overall Study|Adverse Event|4
7091320|NCT02259088|11209709|FG000|Overall Study|Lost to Follow-up|2
7091321|NCT02259088|11209710|FG001|Overall Study|Lost to Follow-up|0
7091322|NCT02259088|11209709|FG000|Overall Study|Death|2
7091323|NCT02259088|11209710|FG001|Overall Study|Death|0
7091324|NCT02259088|11209709|FG000|Overall Study|Physician Decision|5
7091325|NCT02259088|11209710|FG001|Overall Study|Physician Decision|2
7091326|NCT02259088|11209709|FG000|Overall Study|Protocol deviation|5
7091327|NCT02259088|11209710|FG001|Overall Study|Protocol deviation|0
7091328|NCT02259088|11209709|FG000|Overall Study|Subject/guardian decision|8
7091329|NCT02259088|11209710|FG001|Overall Study|Subject/guardian decision|8
7091330|NCT02259114|11209721|FG000|Overall Study|Progressive Disease|14
7091331|NCT02259114|11209722|FG001|Overall Study|Progressive Disease|2
7091332|NCT02259114|11209723|FG002|Overall Study|Progressive Disease|10
7091333|NCT02259114|11209724|FG003|Overall Study|Progressive Disease|2
7091334|NCT02259114|11209725|FG004|Overall Study|Progressive Disease|5
7091335|NCT02259114|11209721|FG000|Overall Study|Adverse Event|2
7091336|NCT02259114|11209722|FG001|Overall Study|Adverse Event|1
7091337|NCT02259114|11209723|FG002|Overall Study|Adverse Event|0
7091338|NCT02259114|11209724|FG003|Overall Study|Adverse Event|0
7091339|NCT02259114|11209725|FG004|Overall Study|Adverse Event|1
7091340|NCT02259114|11209721|FG000|Overall Study|Death|3
7091341|NCT02259114|11209722|FG001|Overall Study|Death|0
7091342|NCT02259114|11209723|FG002|Overall Study|Death|1
7091343|NCT02259114|11209724|FG003|Overall Study|Death|0
7091344|NCT02259114|11209725|FG004|Overall Study|Death|0
7091345|NCT02259114|11209721|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0
7091346|NCT02259114|11209722|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0
7091347|NCT02259114|11209723|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1
7091348|NCT02259114|11209724|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0
7091349|NCT02259114|11209725|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0
7091350|NCT02259114|11209721|FG000|Overall Study|Withdrawal by Subject|0
7091351|NCT02259114|11209722|FG001|Overall Study|Withdrawal by Subject|0
7091352|NCT02259114|11209723|FG002|Overall Study|Withdrawal by Subject|1
7091353|NCT02259114|11209724|FG003|Overall Study|Withdrawal by Subject|1
7091354|NCT02259114|11209725|FG004|Overall Study|Withdrawal by Subject|0
7091355|NCT02259114|11209721|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1
7091356|NCT02259114|11209722|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1
7091357|NCT02259114|11209723|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0
7091358|NCT02259114|11209724|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0
7091359|NCT02259114|11209725|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0
7091360|NCT02259114|11209721|FG000|Overall Study|Not Treated|1
7091361|NCT02259114|11209722|FG001|Overall Study|Not Treated|0
7091362|NCT02259114|11209723|FG002|Overall Study|Not Treated|0
7091363|NCT02259114|11209724|FG003|Overall Study|Not Treated|0
7091364|NCT02259114|11209725|FG004|Overall Study|Not Treated|0
7091365|NCT02259231|11209744|FG000|Overall Study|Adverse Event|1
7091366|NCT02259231|11209745|FG001|Overall Study|Adverse Event|1
7091367|NCT02259231|11209746|FG002|Overall Study|Adverse Event|2
7091368|NCT02259231|11209747|FG003|Overall Study|Adverse Event|0
7091369|NCT02259231|11209748|FG004|Overall Study|Adverse Event|0
7091370|NCT02259231|11209749|FG005|Overall Study|Adverse Event|0
7091371|NCT02259231|11209750|FG006|Overall Study|Adverse Event|0
7091372|NCT02259231|11209744|FG000|Overall Study|Progressive Disease|4
7091373|NCT02259231|11209745|FG001|Overall Study|Progressive Disease|5
7091374|NCT02259231|11209746|FG002|Overall Study|Progressive Disease|4
7091375|NCT02259231|11209747|FG003|Overall Study|Progressive Disease|5
7091376|NCT02259231|11209748|FG004|Overall Study|Progressive Disease|4
7091377|NCT02259231|11209749|FG005|Overall Study|Progressive Disease|5
7091378|NCT02259231|11209750|FG006|Overall Study|Progressive Disease|4
7091379|NCT02259231|11209744|FG000|Overall Study|Sponsor termination of study|1
7091380|NCT02259231|11209745|FG001|Overall Study|Sponsor termination of study|0
7091381|NCT02259231|11209746|FG002|Overall Study|Sponsor termination of study|0
7091382|NCT02259231|11209747|FG003|Overall Study|Sponsor termination of study|1
7091383|NCT02259231|11209748|FG004|Overall Study|Sponsor termination of study|2
7091384|NCT02259231|11209749|FG005|Overall Study|Sponsor termination of study|1
7091385|NCT02259231|11209750|FG006|Overall Study|Sponsor termination of study|1
7091386|NCT02259348|11209766|FG000|Overall Study|Donors|6
7091387|NCT02259348|11209766|FG000|Overall Study|Death|4
7091388|NCT02259400|11209772|FG000|Overall Study|Death|0
7091389|NCT02259400|11209773|FG001|Overall Study|Death|2
7091390|NCT02259582|11209782|FG000|Overall Study|Physician Decision|0
7091391|NCT02259582|11209783|FG001|Overall Study|Physician Decision|1
7091392|NCT02259582|11209784|FG002|Overall Study|Physician Decision|0
7091393|NCT02259582|11209782|FG000|Overall Study|Death|0
7091394|NCT02259582|11209783|FG001|Overall Study|Death|0
7091395|NCT02259582|11209784|FG002|Overall Study|Death|1
7091396|NCT02259582|11209782|FG000|Overall Study|Adverse Event|1
7091397|NCT02259582|11209783|FG001|Overall Study|Adverse Event|0
7091398|NCT02259582|11209784|FG002|Overall Study|Adverse Event|1
7091399|NCT02259582|11209782|FG000|Overall Study|Withdrawal by Subject|0
7091400|NCT02259582|11209783|FG001|Overall Study|Withdrawal by Subject|0
7091401|NCT02259582|11209784|FG002|Overall Study|Withdrawal by Subject|1
7091402|NCT02259582|11209782|FG000|Overall Study|Disease progression|14
7091403|NCT02259582|11209783|FG001|Overall Study|Disease progression|15
7091404|NCT02259582|11209784|FG002|Overall Study|Disease progression|17
7091405|NCT02259582|11209782|FG000|Overall Study|Lack of Subject Adherence to Protocol|1
7091406|NCT02259582|11209783|FG001|Overall Study|Lack of Subject Adherence to Protocol|1
7091407|NCT02259582|11209784|FG002|Overall Study|Lack of Subject Adherence to Protocol|1
7091408|NCT02260154|11209805|FG000|Overall Study|Screening failure|2
7091409|NCT02260180|11209813|FG000|Overall Study|Adverse Event|2
7091410|NCT02260180|11209814|FG001|Overall Study|Adverse Event|0
7091411|NCT02260180|11209815|FG002|Overall Study|Adverse Event|1
7091412|NCT02260258|11209825|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2
7091413|NCT02260258|11209826|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1
7091414|NCT02260388|11209837|FG000|Overall Study|Lost to Follow-up|2
7091415|NCT02260388|11209838|FG001|Overall Study|Lost to Follow-up|8
7091416|NCT02260388|11209839|FG002|Overall Study|Lost to Follow-up|3
7091417|NCT02260388|11209840|FG003|Overall Study|Lost to Follow-up|4
7091418|NCT02260492|11209866|FG000|Overall Study|Adverse Event|6
7091419|NCT02260492|11209867|FG001|Overall Study|Adverse Event|1
7091420|NCT02260492|11209868|FG002|Overall Study|Adverse Event|2
7091421|NCT02260492|11209866|FG000|Overall Study|Death|0
7091422|NCT02260492|11209867|FG001|Overall Study|Death|1
7091423|NCT02260492|11209868|FG002|Overall Study|Death|0
7091424|NCT02260492|11209866|FG000|Overall Study|Lost to Follow-up|12
7091425|NCT02260492|11209867|FG001|Overall Study|Lost to Follow-up|9
7091426|NCT02260492|11209868|FG002|Overall Study|Lost to Follow-up|0
7091427|NCT02260492|11209866|FG000|Overall Study|Physician Decision|2
7091428|NCT02260492|11209867|FG001|Overall Study|Physician Decision|0
7091429|NCT02260492|11209868|FG002|Overall Study|Physician Decision|1
7091430|NCT02260492|11209866|FG000|Overall Study|Withdrawal by Subject|3
7091431|NCT02260492|11209867|FG001|Overall Study|Withdrawal by Subject|2
7091432|NCT02260492|11209868|FG002|Overall Study|Withdrawal by Subject|2
7091433|NCT02260635|11209907|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1
7091434|NCT02260635|11209908|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2
7091435|NCT02260635|11209907|FG000|Open-Label Extension|Study Termination|25
7091436|NCT02260635|11209908|FG001|Open-Label Extension|Study Termination|25
7091437|NCT02260635|11209907|FG000|Open-Label Extension|Withdrawal by Subject|1
7091438|NCT02260635|11209908|FG001|Open-Label Extension|Withdrawal by Subject|0
7091439|NCT02260648|11209919|FG000|Overall Study|Adverse Event|3
7091440|NCT02260648|11209920|FG001|Overall Study|Adverse Event|0
7091441|NCT02260648|11209921|FG002|Overall Study|Adverse Event|1
7091442|NCT02260648|11209919|FG000|Overall Study|Withdrawal by Subject|1
7091443|NCT02260648|11209920|FG001|Overall Study|Withdrawal by Subject|1
7091444|NCT02260648|11209921|FG002|Overall Study|Withdrawal by Subject|0
7091445|NCT02260648|11209919|FG000|Overall Study|Protocol Violation|1
7091446|NCT02260648|11209920|FG001|Overall Study|Protocol Violation|0
7091447|NCT02260648|11209921|FG002|Overall Study|Protocol Violation|0
7091448|NCT02260648|11209919|FG000|Overall Study|Discontinue Due to Study Termination|13
7091449|NCT02260648|11209920|FG001|Overall Study|Discontinue Due to Study Termination|12
7091450|NCT02260648|11209921|FG002|Overall Study|Discontinue Due to Study Termination|7
7091451|NCT02260791|11209931|FG000|Overall Study|Lost to Follow-up|4
7091452|NCT02260791|11209932|FG001|Overall Study|Lost to Follow-up|4
7091453|NCT02260791|11209931|FG000|Overall Study|Lack of Efficacy|2
7091454|NCT02260791|11209932|FG001|Overall Study|Lack of Efficacy|1
7091455|NCT02260791|11209931|FG000|Overall Study|Adverse Event|13
7091456|NCT02260791|11209932|FG001|Overall Study|Adverse Event|9
7091457|NCT02260791|11209931|FG000|Overall Study|Death|1
7091458|NCT02260791|11209932|FG001|Overall Study|Death|0
7091459|NCT02260791|11209931|FG000|Overall Study|Withdrawal by Subject|11
7091460|NCT02260791|11209932|FG001|Overall Study|Withdrawal by Subject|16
7091461|NCT02260791|11209931|FG000|Overall Study|Screen failure|0
7091462|NCT02260791|11209932|FG001|Overall Study|Screen failure|1
7091463|NCT02260791|11209931|FG000|Overall Study|Protocol deviation|2
7091464|NCT02260791|11209932|FG001|Overall Study|Protocol deviation|3
7091465|NCT02260804|11209940|FG000|Induction Study Period|Protocol Violation|2
7091466|NCT02260804|11209941|FG001|Induction Study Period|Protocol Violation|0
7091467|NCT02260804|11209940|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6
7091468|NCT02260804|11209941|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9
7091469|NCT02260804|11209940|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3
7091470|NCT02260804|11209941|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1
7091471|NCT02260804|11209940|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1
7091472|NCT02260804|11209941|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3
7091473|NCT02260804|11209940|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1
7091474|NCT02260804|11209941|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0
7091475|NCT02260804|11209940|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1
7091476|NCT02260804|11209941|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0
7091477|NCT02260804|11209940|FG000|1st Year of the Maintenance Period (MP1)|Death|0
7091478|NCT02260804|11209941|FG001|1st Year of the Maintenance Period (MP1)|Death|1
7091479|NCT02260804|11209940|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0
7091480|NCT02260804|11209941|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1
7091481|NCT02260804|11209940|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6
7091482|NCT02260804|11209941|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5
7091483|NCT02260804|11209940|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3
7091484|NCT02260804|11209941|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0
7091485|NCT02260804|11209940|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0
7091486|NCT02260804|11209941|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1
7091487|NCT02260817|11209949|FG000|Overall Study|Lost to Follow-up|0
7091488|NCT02260817|11209950|FG001|Overall Study|Lost to Follow-up|14
7091489|NCT02260817|11209949|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0
7091490|NCT02260817|11209950|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7
7091491|NCT02260817|11209949|FG000|Overall Study|Observation, no biopsy|0
7091492|NCT02260817|11209950|FG001|Overall Study|Observation, no biopsy|1
7091493|NCT02260817|11209949|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0
7091494|NCT02260817|11209950|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1
7091495|NCT02260817|11209949|FG000|Overall Study|Protocol Violation|0
7091496|NCT02260817|11209950|FG001|Overall Study|Protocol Violation|14
7091497|NCT02260882|11209958|FG000|Overall Study|Protocol Violation|0
7091498|NCT02260882|11209959|FG001|Overall Study|Protocol Violation|1
7091499|NCT02260921|11209968|FG000|Overall Study|Adverse Event|1
7091500|NCT02260921|11209969|FG001|Overall Study|Adverse Event|0
7091501|NCT02260921|11209968|FG000|Overall Study|Lost to Follow-up|4
7091502|NCT02260921|11209969|FG001|Overall Study|Lost to Follow-up|3
7091503|NCT02260921|11209968|FG000|Overall Study|Withdraw Consent|4
7091504|NCT02260921|11209969|FG001|Overall Study|Withdraw Consent|1
7091505|NCT02260921|11209968|FG000|Overall Study|Death|1
7091506|NCT02260921|11209969|FG001|Overall Study|Death|0
7091507|NCT02260921|11209968|FG000|Overall Study|Prohibited Treatment for Knee Pain|4
7091508|NCT02260921|11209969|FG001|Overall Study|Prohibited Treatment for Knee Pain|0
7091509|NCT02260934|11209977|FG000|Overall Study|Lost to Follow-up|2
7091510|NCT02260934|11209978|FG001|Overall Study|Lost to Follow-up|1
7091511|NCT02260934|11209977|FG000|Overall Study|Withdrawal by Subject|0
7091512|NCT02260934|11209978|FG001|Overall Study|Withdrawal by Subject|2
7091513|NCT02260934|11209977|FG000|Overall Study|Participant Relocated|1
7091514|NCT02260934|11209978|FG001|Overall Study|Participant Relocated|0
7091515|NCT02260934|11209977|FG000|Overall Study|Site error|0
7091516|NCT02260934|11209978|FG001|Overall Study|Site error|1
7091517|NCT02260986|11209994|FG000|Overall Study|Adverse Event|24
7091518|NCT02260986|11209995|FG001|Overall Study|Adverse Event|0
7091519|NCT02260986|11209996|FG002|Overall Study|Adverse Event|11
7091520|NCT02260986|11209994|FG000|Overall Study|Lack of Efficacy|27
7091521|NCT02260986|11209995|FG001|Overall Study|Lack of Efficacy|3
7091522|NCT02260986|11209996|FG002|Overall Study|Lack of Efficacy|0
7091523|NCT02260986|11209994|FG000|Overall Study|Protocol Violation|14
7091524|NCT02260986|11209995|FG001|Overall Study|Protocol Violation|5
7091525|NCT02260986|11209996|FG002|Overall Study|Protocol Violation|16
7091526|NCT02260986|11209994|FG000|Overall Study|Car accident|0
7091527|NCT02260986|11209995|FG001|Overall Study|Car accident|0
7091528|NCT02260986|11209996|FG002|Overall Study|Car accident|1
7091529|NCT02260986|11209994|FG000|Overall Study|Withdrawal by Subject|17
7091530|NCT02260986|11209995|FG001|Overall Study|Withdrawal by Subject|4
7091531|NCT02260986|11209996|FG002|Overall Study|Withdrawal by Subject|9
7091532|NCT02260986|11209994|FG000|Overall Study|Incorrect randomization|0
7091533|NCT02260986|11209995|FG001|Overall Study|Incorrect randomization|1
7091534|NCT02260986|11209996|FG002|Overall Study|Incorrect randomization|0
7091535|NCT02260986|11209994|FG000|Overall Study|Lack of investigation product supply|2
7091536|NCT02260986|11209995|FG001|Overall Study|Lack of investigation product supply|0
7091537|NCT02260986|11209996|FG002|Overall Study|Lack of investigation product supply|1
7091538|NCT02260986|11209994|FG000|Overall Study|Lost to Follow-up|4
7091539|NCT02260986|11209995|FG001|Overall Study|Lost to Follow-up|0
7091540|NCT02260986|11209996|FG002|Overall Study|Lost to Follow-up|3
7091541|NCT02260986|11209994|FG000|Overall Study|Pregnancy|2
7091542|NCT02260986|11209995|FG001|Overall Study|Pregnancy|0
7091543|NCT02260986|11209996|FG002|Overall Study|Pregnancy|0
7091544|NCT02261467|11210032|FG000|Overall Study|Enrolled in Error|1
7091545|NCT02261467|11210033|FG001|Overall Study|Enrolled in Error|0
7091546|NCT02261467|11210032|FG000|Overall Study|Protocol Violation|0
7091547|NCT02261467|11210033|FG001|Overall Study|Protocol Violation|1
7091548|NCT02261467|11210032|FG000|Overall Study|Personal Reasons|17
7091549|NCT02261467|11210033|FG001|Overall Study|Personal Reasons|22
7091550|NCT02261467|11210032|FG000|Overall Study|Lost to Follow-up|2
7091551|NCT02261467|11210033|FG001|Overall Study|Lost to Follow-up|13
7091552|NCT02261467|11210032|FG000|Overall Study|Adverse Event|1
7091553|NCT02261467|11210033|FG001|Overall Study|Adverse Event|1
7091554|NCT02261493|11210042|FG000|Overall Study|Noncompliance|0
7091555|NCT02261493|11210043|FG001|Overall Study|Noncompliance|0
7091556|NCT02261493|11210044|FG002|Overall Study|Noncompliance|2
7091557|NCT02261493|11210042|FG000|Overall Study|Physician Decision|0
7091558|NCT02261493|11210043|FG001|Overall Study|Physician Decision|1
7091559|NCT02261493|11210044|FG002|Overall Study|Physician Decision|0
7091560|NCT02261493|11210042|FG000|Overall Study|Undisclosed alcohol abuse|0
7091561|NCT02261493|11210043|FG001|Overall Study|Undisclosed alcohol abuse|1
7091562|NCT02261493|11210044|FG002|Overall Study|Undisclosed alcohol abuse|0
7091563|NCT02261493|11210042|FG000|Overall Study|Protocol Violation|1
7091564|NCT02261493|11210043|FG001|Overall Study|Protocol Violation|0
7091565|NCT02261493|11210044|FG002|Overall Study|Protocol Violation|0
7091566|NCT02261493|11210042|FG000|Overall Study|Personal Reasons|14
7091567|NCT02261493|11210043|FG001|Overall Study|Personal Reasons|14
7091568|NCT02261493|11210044|FG002|Overall Study|Personal Reasons|16
7091569|NCT02261493|11210042|FG000|Overall Study|Lost to Follow-up|14
7091570|NCT02261493|11210043|FG001|Overall Study|Lost to Follow-up|27
7091571|NCT02261493|11210044|FG002|Overall Study|Lost to Follow-up|8
7091572|NCT02261493|11210042|FG000|Overall Study|Pregnancy|1
7091573|NCT02261493|11210043|FG001|Overall Study|Pregnancy|2
7091574|NCT02261493|11210044|FG002|Overall Study|Pregnancy|0
7091575|NCT02261493|11210042|FG000|Overall Study|Lack of Efficacy|0
7091576|NCT02261493|11210043|FG001|Overall Study|Lack of Efficacy|1
7091577|NCT02261493|11210044|FG002|Overall Study|Lack of Efficacy|0
7091578|NCT02261493|11210042|FG000|Overall Study|Adverse Event|0
7091579|NCT02261493|11210043|FG001|Overall Study|Adverse Event|1
7091580|NCT02261493|11210044|FG002|Overall Study|Adverse Event|0
7091581|NCT02261974|11210122|FG000|Overall Study|Withdrawal by Subject|3
7091582|NCT02261974|11210123|FG001|Overall Study|Withdrawal by Subject|2
7091583|NCT02261974|11210122|FG000|Overall Study|Pregnancy|0
7091584|NCT02261974|11210123|FG001|Overall Study|Pregnancy|1
7091585|NCT02261974|11210122|FG000|Overall Study|Missed treatment cut-off date|6
7091586|NCT02261974|11210123|FG001|Overall Study|Missed treatment cut-off date|3
7091587|NCT02261974|11210122|FG000|Overall Study|Received partial treatment; FU to 1 mo|3
7091588|NCT02261974|11210123|FG001|Overall Study|Received partial treatment; FU to 1 mo|1
7091589|NCT02261974|11210122|FG000|Overall Study|Lost to Follow-up|2
7091590|NCT02261974|11210123|FG001|Overall Study|Lost to Follow-up|0
7091591|NCT02261974|11210122|FG000|Overall Study|Adverse Event|1
7091592|NCT02261974|11210123|FG001|Overall Study|Adverse Event|0
7091593|NCT02262260|11210153|FG000|Overall Study|Adverse Event|4
7091594|NCT02262260|11210154|FG001|Overall Study|Adverse Event|1
7091595|NCT02262260|11210153|FG000|Overall Study|Withdrawal of consent|4
7091596|NCT02262260|11210154|FG001|Overall Study|Withdrawal of consent|2
7091597|NCT02262260|11210153|FG000|Overall Study|Lost to Follow-up|1
7091598|NCT02262260|11210154|FG001|Overall Study|Lost to Follow-up|2
7091599|NCT02262260|11210153|FG000|Overall Study|Protocol deviation|2
7091600|NCT02262260|11210154|FG001|Overall Study|Protocol deviation|5
7091601|NCT02262364|11210160|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1
7091602|NCT02262377|11210166|FG000|Overall Study|Lost to Follow-up|5
7091603|NCT02262377|11210167|FG001|Overall Study|Lost to Follow-up|6
7091604|NCT02262377|11210166|FG000|Overall Study|Found ineligible after enrollment|3
7091605|NCT02262377|11210167|FG001|Overall Study|Found ineligible after enrollment|0
7091606|NCT02262377|11210166|FG000|Overall Study|Withdrawal by Subject|4
7091607|NCT02262377|11210167|FG001|Overall Study|Withdrawal by Subject|0
7091608|NCT02262728|11210181|FG000|Follow-up Phase (3 Years)|Death|0
7091609|NCT02262728|11210182|FG001|Follow-up Phase (3 Years)|Death|1
7091610|NCT02262728|11210181|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4
7091611|NCT02262728|11210182|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1
7091612|NCT02262728|11210181|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0
7091613|NCT02262728|11210182|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1
7091614|NCT02262754|11210191|FG000|Overall Study|Adverse Event|3
7091615|NCT02262754|11210192|FG001|Overall Study|Adverse Event|4
7091616|NCT02262754|11210193|FG002|Overall Study|Adverse Event|0
7091617|NCT02262754|11210191|FG000|Overall Study|Lack of Efficacy|2
7091618|NCT02262754|11210192|FG001|Overall Study|Lack of Efficacy|0
7091619|NCT02262754|11210193|FG002|Overall Study|Lack of Efficacy|1
7091620|NCT02262754|11210191|FG000|Overall Study|Lost to Follow-up|0
7091621|NCT02262754|11210192|FG001|Overall Study|Lost to Follow-up|0
7091622|NCT02262754|11210193|FG002|Overall Study|Lost to Follow-up|1
7091623|NCT02262754|11210191|FG000|Overall Study|No longer meets eligibility criteria|0
7091624|NCT02262754|11210192|FG001|Overall Study|No longer meets eligibility criteria|1
7091625|NCT02262754|11210193|FG002|Overall Study|No longer meets eligibility criteria|0
7091626|NCT02262754|11210191|FG000|Overall Study|Study terminated by sponsor|5
7091627|NCT02262754|11210192|FG001|Overall Study|Study terminated by sponsor|4
7091628|NCT02262754|11210193|FG002|Overall Study|Study terminated by sponsor|4
7091629|NCT02262754|11210191|FG000|Overall Study|Protocol Violation|1
7091630|NCT02262754|11210192|FG001|Overall Study|Protocol Violation|0
7091631|NCT02262754|11210193|FG002|Overall Study|Protocol Violation|0
7091632|NCT02262754|11210191|FG000|Overall Study|Withdrawal by Subject|1
7091633|NCT02262754|11210192|FG001|Overall Study|Withdrawal by Subject|0
7091634|NCT02262754|11210193|FG002|Overall Study|Withdrawal by Subject|1
7091635|NCT02262754|11210191|FG000|Overall Study|Other|4
7091636|NCT02262754|11210192|FG001|Overall Study|Other|0
7091637|NCT02262754|11210193|FG002|Overall Study|Other|2
7091638|NCT02263079|11210230|FG000|Overall Study|Physician Decision|1
7091639|NCT02263079|11210231|FG001|Overall Study|Physician Decision|0
7091640|NCT02263079|11210232|FG002|Overall Study|Physician Decision|0
7091641|NCT02263079|11210230|FG000|Overall Study|Withdrawal by Subject|2
7091642|NCT02263079|11210231|FG001|Overall Study|Withdrawal by Subject|8
7091643|NCT02263079|11210232|FG002|Overall Study|Withdrawal by Subject|0
7091644|NCT02263326|11210270|FG000|Overall Study|Lost to Follow-up|1
7091645|NCT02263326|11210271|FG001|Overall Study|Lost to Follow-up|1
7091646|NCT02263547|11210277|FG000|Overall Study|Adverse Event|1
7091647|NCT02263547|11210277|FG000|Overall Study|Lost to Follow-up|2
7091648|NCT02264574|11210324|FG000|Overall Study|Death|21
7091649|NCT02264574|11210325|FG001|Overall Study|Death|21
7091650|NCT02264574|11210324|FG000|Overall Study|Withdrawal by Subject|8
7091651|NCT02264574|11210325|FG001|Overall Study|Withdrawal by Subject|6
7091652|NCT02264574|11210324|FG000|Overall Study|Other, Not Specified|0
7091653|NCT02264574|11210325|FG001|Overall Study|Other, Not Specified|3
7091654|NCT02264639|11210336|FG000|Overall Study|Death (after completing single-dose phase)|1
7091655|NCT02264639|11210337|FG001|Overall Study|Death (after completing single-dose phase)|0
7091656|NCT02264639|11210338|FG002|Overall Study|Death (after completing single-dose phase)|0
7091657|NCT02264639|11210339|FG003|Overall Study|Death (after completing single-dose phase)|0
7091658|NCT02264639|11210340|FG004|Overall Study|Death (after completing single-dose phase)|0
7091659|NCT02264639|11210336|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1
7091660|NCT02264639|11210337|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0
7091661|NCT02264639|11210338|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0
7091662|NCT02264639|11210339|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0
7091663|NCT02264639|11210340|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0
7091664|NCT02264639|11210336|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0
7091665|NCT02264639|11210337|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0
7091666|NCT02264639|11210338|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1
7091667|NCT02264639|11210339|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0
7091668|NCT02264639|11210340|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0
7091669|NCT02264639|11210336|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0
7091670|NCT02264639|11210337|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0
7091671|NCT02264639|11210338|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0
7091672|NCT02264639|11210339|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0
7091673|NCT02264639|11210340|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1
7091674|NCT02264821|11210358|FG000|Overall Study|Protocol Violation|1
7091675|NCT02264821|11210359|FG001|Overall Study|Protocol Violation|3
7091676|NCT02264821|11210360|FG002|Overall Study|Protocol Violation|6
7091677|NCT02264990|11210370|FG000|Overall Study|Death|255
7091678|NCT02264990|11210371|FG001|Overall Study|Death|250
7091679|NCT02264990|11210370|FG000|Overall Study|Withdrawal by Subject|4
7091680|NCT02264990|11210371|FG001|Overall Study|Withdrawal by Subject|5
7091681|NCT02264990|11210370|FG000|Overall Study|Lost to Follow-up|1
7091682|NCT02264990|11210371|FG001|Overall Study|Lost to Follow-up|3
7091683|NCT02264990|11210370|FG000|Overall Study|Other|0
7091684|NCT02264990|11210371|FG001|Overall Study|Other|1
7091685|NCT02265237|11210389|FG000|As Treated (Overall Study)|Adverse Event|1
7091686|NCT02265237|11210390|FG001|As Treated (Overall Study)|Adverse Event|1
7091687|NCT02265237|11210391|FG002|As Treated (Overall Study)|Adverse Event|0
7091688|NCT02265237|11210392|FG003|As Treated (Overall Study)|Adverse Event|0
7091689|NCT02265237|11210389|FG000|As Treated (Overall Study)|Withdrawal by Subject|1
7091690|NCT02265237|11210390|FG001|As Treated (Overall Study)|Withdrawal by Subject|0
7091691|NCT02265237|11210391|FG002|As Treated (Overall Study)|Withdrawal by Subject|1
7091692|NCT02265237|11210392|FG003|As Treated (Overall Study)|Withdrawal by Subject|0
7091693|NCT02265237|11210389|FG000|As Treated (Overall Study)|Lost to Follow-up|1
7091694|NCT02265237|11210390|FG001|As Treated (Overall Study)|Lost to Follow-up|2
7091695|NCT02265237|11210391|FG002|As Treated (Overall Study)|Lost to Follow-up|6
7091696|NCT02265237|11210392|FG003|As Treated (Overall Study)|Lost to Follow-up|0
7091697|NCT02265237|11210389|FG000|As Treated (Overall Study)|Other|2
7091698|NCT02265237|11210390|FG001|As Treated (Overall Study)|Other|0
7091699|NCT02265237|11210391|FG002|As Treated (Overall Study)|Other|3
7091700|NCT02265237|11210392|FG003|As Treated (Overall Study)|Other|1
7091701|NCT02265510|11210421|FG000|Overall Study|Withdrawal by Subject|1
7091702|NCT02265510|11210422|FG001|Overall Study|Withdrawal by Subject|1
7091703|NCT02265510|11210423|FG002|Overall Study|Withdrawal by Subject|2
7091704|NCT02265510|11210424|FG003|Overall Study|Withdrawal by Subject|1
7091705|NCT02265510|11210425|FG004|Overall Study|Withdrawal by Subject|0
7091706|NCT02265510|11210426|FG005|Overall Study|Withdrawal by Subject|2
7091707|NCT02265510|11210427|FG006|Overall Study|Withdrawal by Subject|0
7091708|NCT02265510|11210428|FG007|Overall Study|Withdrawal by Subject|2
7091709|NCT02265510|11210429|FG008|Overall Study|Withdrawal by Subject|0
7091710|NCT02265510|11210430|FG009|Overall Study|Withdrawal by Subject|0
7091711|NCT02265510|11210431|FG010|Overall Study|Withdrawal by Subject|0
7091712|NCT02265510|11210432|FG011|Overall Study|Withdrawal by Subject|0
7091713|NCT02265510|11210433|FG012|Overall Study|Withdrawal by Subject|1
7091714|NCT02265510|11210434|FG013|Overall Study|Withdrawal by Subject|0
7091715|NCT02265510|11210421|FG000|Overall Study|Disease Progression|0
7091716|NCT02265510|11210422|FG001|Overall Study|Disease Progression|1
7091717|NCT02265510|11210423|FG002|Overall Study|Disease Progression|2
7091718|NCT02265510|11210424|FG003|Overall Study|Disease Progression|1
7091719|NCT02265510|11210425|FG004|Overall Study|Disease Progression|1
7091720|NCT02265510|11210426|FG005|Overall Study|Disease Progression|0
7091721|NCT02265510|11210427|FG006|Overall Study|Disease Progression|0
7091722|NCT02265510|11210428|FG007|Overall Study|Disease Progression|0
7091723|NCT02265510|11210429|FG008|Overall Study|Disease Progression|0
7091724|NCT02265510|11210430|FG009|Overall Study|Disease Progression|0
7091725|NCT02265510|11210431|FG010|Overall Study|Disease Progression|0
7091726|NCT02265510|11210432|FG011|Overall Study|Disease Progression|0
7091727|NCT02265510|11210433|FG012|Overall Study|Disease Progression|0
7091728|NCT02265510|11210434|FG013|Overall Study|Disease Progression|0
7091729|NCT02265510|11210421|FG000|Overall Study|Death|2
7091730|NCT02265510|11210422|FG001|Overall Study|Death|0
7091731|NCT02265510|11210423|FG002|Overall Study|Death|2
7091732|NCT02265510|11210424|FG003|Overall Study|Death|2
7091733|NCT02265510|11210425|FG004|Overall Study|Death|1
7091734|NCT02265510|11210426|FG005|Overall Study|Death|3
7091735|NCT02265510|11210427|FG006|Overall Study|Death|2
7091736|NCT02265510|11210428|FG007|Overall Study|Death|1
7091737|NCT02265510|11210429|FG008|Overall Study|Death|3
7091738|NCT02265510|11210430|FG009|Overall Study|Death|3
7091739|NCT02265510|11210431|FG010|Overall Study|Death|4
7091740|NCT02265510|11210432|FG011|Overall Study|Death|12
7091741|NCT02265510|11210433|FG012|Overall Study|Death|7
7091742|NCT02265510|11210434|FG013|Overall Study|Death|6
7091743|NCT02265510|11210421|FG000|Overall Study|Lost to Follow-up|0
7091744|NCT02265510|11210422|FG001|Overall Study|Lost to Follow-up|0
7091745|NCT02265510|11210423|FG002|Overall Study|Lost to Follow-up|0
7091746|NCT02265510|11210424|FG003|Overall Study|Lost to Follow-up|0
7091747|NCT02265510|11210425|FG004|Overall Study|Lost to Follow-up|1
7091748|NCT02265510|11210426|FG005|Overall Study|Lost to Follow-up|0
7091749|NCT02265510|11210427|FG006|Overall Study|Lost to Follow-up|0
7091750|NCT02265510|11210428|FG007|Overall Study|Lost to Follow-up|0
7091751|NCT02265510|11210429|FG008|Overall Study|Lost to Follow-up|0
7091752|NCT02265510|11210430|FG009|Overall Study|Lost to Follow-up|2
7091753|NCT02265510|11210431|FG010|Overall Study|Lost to Follow-up|0
7091754|NCT02265510|11210432|FG011|Overall Study|Lost to Follow-up|0
7091755|NCT02265510|11210433|FG012|Overall Study|Lost to Follow-up|0
7091756|NCT02265510|11210434|FG013|Overall Study|Lost to Follow-up|2
7091757|NCT02265510|11210421|FG000|Overall Study|Other|0
7091758|NCT02265510|11210422|FG001|Overall Study|Other|1
7091759|NCT02265510|11210423|FG002|Overall Study|Other|0
7091760|NCT02265510|11210424|FG003|Overall Study|Other|0
7091761|NCT02265510|11210425|FG004|Overall Study|Other|0
7091762|NCT02265510|11210426|FG005|Overall Study|Other|0
7091763|NCT02265510|11210427|FG006|Overall Study|Other|0
7091764|NCT02265510|11210428|FG007|Overall Study|Other|0
7091765|NCT02265510|11210429|FG008|Overall Study|Other|0
7091766|NCT02265510|11210430|FG009|Overall Study|Other|0
7091767|NCT02265510|11210431|FG010|Overall Study|Other|0
7091768|NCT02265510|11210432|FG011|Overall Study|Other|0
7091769|NCT02265510|11210433|FG012|Overall Study|Other|0
7091770|NCT02265510|11210434|FG013|Overall Study|Other|0
7091771|NCT02265510|11210421|FG000|Overall Study|Study Terminated by Sponsor|0
7091772|NCT02265510|11210422|FG001|Overall Study|Study Terminated by Sponsor|0
7091773|NCT02265510|11210423|FG002|Overall Study|Study Terminated by Sponsor|0
7091774|NCT02265510|11210424|FG003|Overall Study|Study Terminated by Sponsor|0
7091775|NCT02265510|11210425|FG004|Overall Study|Study Terminated by Sponsor|0
7091776|NCT02265510|11210426|FG005|Overall Study|Study Terminated by Sponsor|1
7091777|NCT02265510|11210427|FG006|Overall Study|Study Terminated by Sponsor|1
7091778|NCT02265510|11210428|FG007|Overall Study|Study Terminated by Sponsor|1
7091779|NCT02265510|11210429|FG008|Overall Study|Study Terminated by Sponsor|1
7091780|NCT02265510|11210430|FG009|Overall Study|Study Terminated by Sponsor|2
7091781|NCT02265510|11210431|FG010|Overall Study|Study Terminated by Sponsor|1
7091782|NCT02265510|11210432|FG011|Overall Study|Study Terminated by Sponsor|4
7091783|NCT02265510|11210433|FG012|Overall Study|Study Terminated by Sponsor|1
7091784|NCT02265510|11210434|FG013|Overall Study|Study Terminated by Sponsor|2
7091785|NCT02265705|11210492|FG000|Treatment Period Week 0-24|Adverse Event|3
7091786|NCT02265705|11210493|FG001|Treatment Period Week 0-24|Adverse Event|2
7091787|NCT02265705|11210494|FG002|Treatment Period Week 0-24|Adverse Event|0
7091788|NCT02265705|11210495|FG003|Treatment Period Week 0-24|Adverse Event|0
7091789|NCT02265705|11210496|FG004|Treatment Period Week 0-24|Adverse Event|0
7091790|NCT02265705|11210497|FG005|Treatment Period Week 0-24|Adverse Event|0
7091791|NCT02265705|11210498|FG006|Treatment Period Week 0-24|Adverse Event|0
7091792|NCT02265705|11210492|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1
7091793|NCT02265705|11210493|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1
7091794|NCT02265705|11210494|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0
7091795|NCT02265705|11210495|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0
7091796|NCT02265705|11210496|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0
7091797|NCT02265705|11210497|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0
7091798|NCT02265705|11210498|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0
7091799|NCT02265705|11210492|FG000|Treatment Period Week 0-24|Physician Decision|1
7091800|NCT02265705|11210493|FG001|Treatment Period Week 0-24|Physician Decision|0
7091801|NCT02265705|11210494|FG002|Treatment Period Week 0-24|Physician Decision|0
7091802|NCT02265705|11210495|FG003|Treatment Period Week 0-24|Physician Decision|0
7091803|NCT02265705|11210496|FG004|Treatment Period Week 0-24|Physician Decision|0
7091804|NCT02265705|11210497|FG005|Treatment Period Week 0-24|Physician Decision|0
7091805|NCT02265705|11210498|FG006|Treatment Period Week 0-24|Physician Decision|0
7091806|NCT02265705|11210492|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7
7091807|NCT02265705|11210493|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5
7091808|NCT02265705|11210494|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0
7091809|NCT02265705|11210495|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0
7091810|NCT02265705|11210496|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0
7091811|NCT02265705|11210497|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0
7091812|NCT02265705|11210498|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0
7091813|NCT02265705|11210492|FG000|Treatment Period Week 0-24|Lack of Efficacy|0
7091814|NCT02265705|11210493|FG001|Treatment Period Week 0-24|Lack of Efficacy|1
7091815|NCT02265705|11210494|FG002|Treatment Period Week 0-24|Lack of Efficacy|0
7091816|NCT02265705|11210495|FG003|Treatment Period Week 0-24|Lack of Efficacy|0
7091817|NCT02265705|11210496|FG004|Treatment Period Week 0-24|Lack of Efficacy|0
7091818|NCT02265705|11210497|FG005|Treatment Period Week 0-24|Lack of Efficacy|0
7091819|NCT02265705|11210498|FG006|Treatment Period Week 0-24|Lack of Efficacy|0
7091820|NCT02265705|11210492|FG000|Rescue Period|Withdrawal by Subject|0
7091821|NCT02265705|11210493|FG001|Rescue Period|Withdrawal by Subject|0
7091822|NCT02265705|11210494|FG002|Rescue Period|Withdrawal by Subject|1
7091823|NCT02265705|11210495|FG003|Rescue Period|Withdrawal by Subject|0
7091824|NCT02265705|11210496|FG004|Rescue Period|Withdrawal by Subject|0
7091825|NCT02265705|11210497|FG005|Rescue Period|Withdrawal by Subject|0
7091826|NCT02265705|11210498|FG006|Rescue Period|Withdrawal by Subject|0
7091827|NCT02265705|11210492|FG000|Rescue Period|Death|0
7091828|NCT02265705|11210493|FG001|Rescue Period|Death|0
7091829|NCT02265705|11210494|FG002|Rescue Period|Death|1
7091830|NCT02265705|11210495|FG003|Rescue Period|Death|0
7091831|NCT02265705|11210496|FG004|Rescue Period|Death|0
7091832|NCT02265705|11210497|FG005|Rescue Period|Death|0
7091833|NCT02265705|11210498|FG006|Rescue Period|Death|0
7091834|NCT02265705|11210492|FG000|Rescue Period|Lack of Efficacy|0
7091835|NCT02265705|11210493|FG001|Rescue Period|Lack of Efficacy|0
7091836|NCT02265705|11210494|FG002|Rescue Period|Lack of Efficacy|1
7091837|NCT02265705|11210495|FG003|Rescue Period|Lack of Efficacy|0
7091838|NCT02265705|11210496|FG004|Rescue Period|Lack of Efficacy|0
7091839|NCT02265705|11210497|FG005|Rescue Period|Lack of Efficacy|0
7091840|NCT02265705|11210498|FG006|Rescue Period|Lack of Efficacy|0
7091841|NCT02265705|11210492|FG000|Open Label Period|Adverse Event|0
7091842|NCT02265705|11210493|FG001|Open Label Period|Adverse Event|0
7091843|NCT02265705|11210494|FG002|Open Label Period|Adverse Event|0
7091844|NCT02265705|11210495|FG003|Open Label Period|Adverse Event|2
7091845|NCT02265705|11210496|FG004|Open Label Period|Adverse Event|2
7091846|NCT02265705|11210497|FG005|Open Label Period|Adverse Event|0
7091847|NCT02265705|11210498|FG006|Open Label Period|Adverse Event|0
7091848|NCT02265705|11210492|FG000|Open Label Period|Physician Decision|0
7091849|NCT02265705|11210493|FG001|Open Label Period|Physician Decision|0
7091850|NCT02265705|11210494|FG002|Open Label Period|Physician Decision|0
7091851|NCT02265705|11210495|FG003|Open Label Period|Physician Decision|0
7091852|NCT02265705|11210496|FG004|Open Label Period|Physician Decision|1
7091853|NCT02265705|11210497|FG005|Open Label Period|Physician Decision|0
7091854|NCT02265705|11210498|FG006|Open Label Period|Physician Decision|0
7091855|NCT02265705|11210492|FG000|Open Label Period|Withdrawal by Subject|0
7091856|NCT02265705|11210493|FG001|Open Label Period|Withdrawal by Subject|0
7091857|NCT02265705|11210494|FG002|Open Label Period|Withdrawal by Subject|0
7091858|NCT02265705|11210495|FG003|Open Label Period|Withdrawal by Subject|0
7091859|NCT02265705|11210496|FG004|Open Label Period|Withdrawal by Subject|2
7091860|NCT02265705|11210497|FG005|Open Label Period|Withdrawal by Subject|0
7091861|NCT02265705|11210498|FG006|Open Label Period|Withdrawal by Subject|0
7091862|NCT02265705|11210492|FG000|Follow-up Period|Sponsor Decision|0
7091863|NCT02265705|11210493|FG001|Follow-up Period|Sponsor Decision|0
7091864|NCT02265705|11210494|FG002|Follow-up Period|Sponsor Decision|0
7091865|NCT02265705|11210495|FG003|Follow-up Period|Sponsor Decision|0
7091866|NCT02265705|11210496|FG004|Follow-up Period|Sponsor Decision|0
7091867|NCT02265705|11210497|FG005|Follow-up Period|Sponsor Decision|1
7091868|NCT02265705|11210498|FG006|Follow-up Period|Sponsor Decision|6
7091869|NCT02265705|11210492|FG000|Follow-up Period|Adverse Event|0
7091870|NCT02265705|11210493|FG001|Follow-up Period|Adverse Event|0
7091871|NCT02265705|11210494|FG002|Follow-up Period|Adverse Event|0
7091872|NCT02265705|11210495|FG003|Follow-up Period|Adverse Event|0
7091873|NCT02265705|11210496|FG004|Follow-up Period|Adverse Event|0
7091874|NCT02265705|11210497|FG005|Follow-up Period|Adverse Event|0
7091875|NCT02265705|11210498|FG006|Follow-up Period|Adverse Event|3
7091876|NCT02265705|11210492|FG000|Follow-up Period|Physician Decision|0
7091877|NCT02265705|11210493|FG001|Follow-up Period|Physician Decision|0
7091878|NCT02265705|11210494|FG002|Follow-up Period|Physician Decision|0
7091879|NCT02265705|11210495|FG003|Follow-up Period|Physician Decision|0
7091880|NCT02265705|11210496|FG004|Follow-up Period|Physician Decision|0
7091881|NCT02265705|11210497|FG005|Follow-up Period|Physician Decision|0
7091882|NCT02265705|11210498|FG006|Follow-up Period|Physician Decision|1
7091883|NCT02265705|11210492|FG000|Follow-up Period|Withdrawal by Subject|0
7091884|NCT02265705|11210493|FG001|Follow-up Period|Withdrawal by Subject|0
7091885|NCT02265705|11210494|FG002|Follow-up Period|Withdrawal by Subject|0
7091886|NCT02265705|11210495|FG003|Follow-up Period|Withdrawal by Subject|0
7091887|NCT02265705|11210496|FG004|Follow-up Period|Withdrawal by Subject|0
7091888|NCT02265705|11210497|FG005|Follow-up Period|Withdrawal by Subject|0
7091889|NCT02265705|11210498|FG006|Follow-up Period|Withdrawal by Subject|1
7091890|NCT02265744|11210514|FG000|Overall Study|Poor/Non-compliance|1
7091891|NCT02265744|11210515|FG001|Overall Study|Poor/Non-compliance|1
7091892|NCT02265744|11210516|FG002|Overall Study|Poor/Non-compliance|0
7091893|NCT02265744|11210517|FG003|Overall Study|Poor/Non-compliance|0
7091894|NCT02265744|11210518|FG004|Overall Study|Poor/Non-compliance|2
7091895|NCT02265744|11210514|FG000|Overall Study|Lost to Follow-up|0
7091896|NCT02265744|11210515|FG001|Overall Study|Lost to Follow-up|0
7091897|NCT02265744|11210516|FG002|Overall Study|Lost to Follow-up|0
7091898|NCT02265744|11210517|FG003|Overall Study|Lost to Follow-up|1
7091899|NCT02265744|11210518|FG004|Overall Study|Lost to Follow-up|0
7091900|NCT02265744|11210514|FG000|Overall Study|Death|0
7091901|NCT02265744|11210515|FG001|Overall Study|Death|0
7091902|NCT02265744|11210516|FG002|Overall Study|Death|0
7091903|NCT02265744|11210517|FG003|Overall Study|Death|2
7091904|NCT02265744|11210518|FG004|Overall Study|Death|0
7091905|NCT02265744|11210514|FG000|Overall Study|Withdrawal by Subject|2
7091906|NCT02265744|11210515|FG001|Overall Study|Withdrawal by Subject|0
7091907|NCT02265744|11210516|FG002|Overall Study|Withdrawal by Subject|0
7091908|NCT02265744|11210517|FG003|Overall Study|Withdrawal by Subject|2
7091909|NCT02265744|11210518|FG004|Overall Study|Withdrawal by Subject|0
7091910|NCT02265744|11210514|FG000|Overall Study|Participant request to discontinue|2
7091911|NCT02265744|11210515|FG001|Overall Study|Participant request to discontinue|2
7091912|NCT02265744|11210516|FG002|Overall Study|Participant request to discontinue|2
7091913|NCT02265744|11210517|FG003|Overall Study|Participant request to discontinue|0
7091914|NCT02265744|11210518|FG004|Overall Study|Participant request to discontinue|0
7091915|NCT02265744|11210514|FG000|Overall Study|Adverse Event|8
7091916|NCT02265744|11210515|FG001|Overall Study|Adverse Event|4
7091917|NCT02265744|11210516|FG002|Overall Study|Adverse Event|9
7091918|NCT02265744|11210517|FG003|Overall Study|Adverse Event|8
7091919|NCT02265744|11210518|FG004|Overall Study|Adverse Event|2
7091920|NCT02265744|11210514|FG000|Overall Study|Lack of Efficacy|2
7091921|NCT02265744|11210515|FG001|Overall Study|Lack of Efficacy|4
7091922|NCT02265744|11210516|FG002|Overall Study|Lack of Efficacy|3
7091923|NCT02265744|11210517|FG003|Overall Study|Lack of Efficacy|4
7091924|NCT02265744|11210518|FG004|Overall Study|Lack of Efficacy|5
7091925|NCT02265744|11210514|FG000|Overall Study|Reason not provided by Investigator|1
7091926|NCT02265744|11210515|FG001|Overall Study|Reason not provided by Investigator|0
7091927|NCT02265744|11210516|FG002|Overall Study|Reason not provided by Investigator|0
7091928|NCT02265744|11210517|FG003|Overall Study|Reason not provided by Investigator|2
7091929|NCT02265744|11210518|FG004|Overall Study|Reason not provided by Investigator|0
7091930|NCT02265744|11210514|FG000|Overall Study|Administrative reason by sponsor|3
7091931|NCT02265744|11210515|FG001|Overall Study|Administrative reason by sponsor|2
7091932|NCT02265744|11210516|FG002|Overall Study|Administrative reason by sponsor|2
7091933|NCT02265744|11210517|FG003|Overall Study|Administrative reason by sponsor|3
7091934|NCT02265744|11210518|FG004|Overall Study|Administrative reason by sponsor|3
7091935|NCT02265744|11210514|FG000|Overall Study|Subject no longer meets study criteria|0
7091936|NCT02265744|11210515|FG001|Overall Study|Subject no longer meets study criteria|0
7091937|NCT02265744|11210516|FG002|Overall Study|Subject no longer meets study criteria|0
7091938|NCT02265744|11210517|FG003|Overall Study|Subject no longer meets study criteria|0
7091939|NCT02265744|11210518|FG004|Overall Study|Subject no longer meets study criteria|1
7091940|NCT02265744|11210514|FG000|Overall Study|Pregnancy|1
7091941|NCT02265744|11210515|FG001|Overall Study|Pregnancy|2
7091942|NCT02265744|11210516|FG002|Overall Study|Pregnancy|1
7091943|NCT02265744|11210517|FG003|Overall Study|Pregnancy|1
7091944|NCT02265744|11210518|FG004|Overall Study|Pregnancy|0
7091945|NCT02265796|11210536|FG000|Overall Study|Death|1
7091946|NCT02265796|11210537|FG001|Overall Study|Death|0
7091947|NCT02265796|11210536|FG000|Overall Study|started on excluded medication|1
7091948|NCT02265796|11210537|FG001|Overall Study|started on excluded medication|0
7091949|NCT02265796|11210536|FG000|Overall Study|Withdrawal by Subject|1
7091950|NCT02265796|11210537|FG001|Overall Study|Withdrawal by Subject|1
7091951|NCT02265952|11210565|FG000|Open Label Extension (OLE) Period|Physician Decision|0
7091952|NCT02265952|11210566|FG001|Open Label Extension (OLE) Period|Physician Decision|7
7091953|NCT02265952|11210565|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0
7091954|NCT02265952|11210566|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1
7091955|NCT02266004|11210581|FG000|Overall Study|unrelated adverse event|1
7091956|NCT02266004|11210581|FG000|Overall Study|Physician Decision|1
7091957|NCT02266147|11210598|FG000|PART 1: Dose Escalation|Physician Decision|0
7091958|NCT02266147|11210599|FG001|PART 1: Dose Escalation|Physician Decision|0
7091959|NCT02266147|11210600|FG002|PART 1: Dose Escalation|Physician Decision|1
7091960|NCT02266147|11210601|FG003|PART 1: Dose Escalation|Physician Decision|0
7091961|NCT02266147|11210598|FG000|PART 1: Dose Escalation|Lack of Efficacy|0
7091962|NCT02266147|11210599|FG001|PART 1: Dose Escalation|Lack of Efficacy|2
7091963|NCT02266147|11210600|FG002|PART 1: Dose Escalation|Lack of Efficacy|1
7091964|NCT02266147|11210601|FG003|PART 1: Dose Escalation|Lack of Efficacy|1
7091965|NCT02266147|11210598|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0
7091966|NCT02266147|11210599|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0
7091967|NCT02266147|11210600|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1
7091968|NCT02266147|11210601|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3
7091969|NCT02266147|11210598|FG000|PART 1: Dose Escalation|Other|1
7091970|NCT02266147|11210599|FG001|PART 1: Dose Escalation|Other|1
7091971|NCT02266147|11210600|FG002|PART 1: Dose Escalation|Other|0
7091972|NCT02266147|11210601|FG003|PART 1: Dose Escalation|Other|0
7091973|NCT02266147|11210598|FG000|PART 2: Dose Expansion|Lack of Efficacy|1
7091974|NCT02266147|11210599|FG001|PART 2: Dose Expansion|Lack of Efficacy|0
7091975|NCT02266147|11210600|FG002|PART 2: Dose Expansion|Lack of Efficacy|0
7091976|NCT02266147|11210601|FG003|PART 2: Dose Expansion|Lack of Efficacy|1
7091977|NCT02266147|11210598|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6
7091978|NCT02266147|11210599|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0
7091979|NCT02266147|11210600|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0
7091980|NCT02266147|11210601|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8
7091981|NCT02266225|11210613|FG000|Overall Study|Lost to Follow-up|2
7091982|NCT02266225|11210613|FG000|Overall Study|Death|1
7091983|NCT02266225|11210613|FG000|Overall Study|Withdrawal by Subject|13
7091984|NCT02266381|11210648|FG000|Overall Study|Physician Decision|3
7091985|NCT02266381|11210649|FG001|Overall Study|Physician Decision|5
7091986|NCT02266381|11210650|FG002|Overall Study|Physician Decision|4
7091987|NCT02266433|11210662|FG000|Overall Study|Lost to Follow-up|54
7091988|NCT02266433|11210663|FG001|Overall Study|Lost to Follow-up|46
7091989|NCT02266433|11210662|FG000|Overall Study|Withdrawal by Subject|5
7091990|NCT02266433|11210663|FG001|Overall Study|Withdrawal by Subject|7
7091991|NCT02266706|11210697|FG000|Overall Study|Withdrawal by Subject|0
7091992|NCT02266706|11210698|FG001|Overall Study|Withdrawal by Subject|1
7091993|NCT02266706|11210699|FG002|Overall Study|Withdrawal by Subject|1
7091994|NCT02266706|11210700|FG003|Overall Study|Withdrawal by Subject|0
7091995|NCT02266706|11210701|FG004|Overall Study|Withdrawal by Subject|0
7091996|NCT02266706|11210702|FG005|Overall Study|Withdrawal by Subject|1
7091997|NCT02266706|11210703|FG006|Overall Study|Withdrawal by Subject|0
7091998|NCT02266706|11210704|FG007|Overall Study|Withdrawal by Subject|0
7091999|NCT02266706|11210705|FG008|Overall Study|Withdrawal by Subject|0
7092000|NCT02266706|11210697|FG000|Overall Study|Screen failure|0
7092001|NCT02266706|11210698|FG001|Overall Study|Screen failure|0
7092002|NCT02266706|11210699|FG002|Overall Study|Screen failure|0
7092003|NCT02266706|11210700|FG003|Overall Study|Screen failure|0
7092004|NCT02266706|11210701|FG004|Overall Study|Screen failure|0
7092005|NCT02266706|11210702|FG005|Overall Study|Screen failure|1
7092006|NCT02266706|11210703|FG006|Overall Study|Screen failure|1
7092007|NCT02266706|11210704|FG007|Overall Study|Screen failure|0
7092008|NCT02266706|11210705|FG008|Overall Study|Screen failure|0
7092009|NCT02266706|11210697|FG000|Overall Study|Enrollment in another study|0
7092010|NCT02266706|11210698|FG001|Overall Study|Enrollment in another study|0
7092011|NCT02266706|11210699|FG002|Overall Study|Enrollment in another study|0
7092012|NCT02266706|11210700|FG003|Overall Study|Enrollment in another study|1
7092013|NCT02266706|11210701|FG004|Overall Study|Enrollment in another study|0
7092014|NCT02266706|11210702|FG005|Overall Study|Enrollment in another study|0
7092015|NCT02266706|11210703|FG006|Overall Study|Enrollment in another study|0
7092016|NCT02266706|11210704|FG007|Overall Study|Enrollment in another study|0
7092017|NCT02266706|11210705|FG008|Overall Study|Enrollment in another study|0
7092018|NCT02266875|11210745|FG000|Overall Study|Withdrawal by Subject|9
7092019|NCT02266875|11210746|FG001|Overall Study|Withdrawal by Subject|0
7092020|NCT02266875|11210745|FG000|Overall Study|Lost to Follow-up|2
7092021|NCT02266875|11210746|FG001|Overall Study|Lost to Follow-up|0
7092022|NCT02266888|11210754|FG000|Overall Study|Death|2
7092023|NCT02266888|11210755|FG001|Overall Study|Death|2
7092024|NCT02266888|11210756|FG002|Overall Study|Death|4
7092025|NCT02266888|11210757|FG003|Overall Study|Death|2
7092026|NCT02266888|11210754|FG000|Overall Study|Physician Decision|0
7092027|NCT02266888|11210755|FG001|Overall Study|Physician Decision|1
7092028|NCT02266888|11210756|FG002|Overall Study|Physician Decision|2
7092029|NCT02266888|11210757|FG003|Overall Study|Physician Decision|2
7092030|NCT02266888|11210754|FG000|Overall Study|Study Terminated|5
7092031|NCT02266888|11210755|FG001|Overall Study|Study Terminated|1
7092032|NCT02266888|11210756|FG002|Overall Study|Study Terminated|0
7092033|NCT02266888|11210757|FG003|Overall Study|Study Terminated|0
7092034|NCT02266888|11210754|FG000|Overall Study|No Longer Eligible|0
7092035|NCT02266888|11210755|FG001|Overall Study|No Longer Eligible|0
7092036|NCT02266888|11210756|FG002|Overall Study|No Longer Eligible|0
7092037|NCT02266888|11210757|FG003|Overall Study|No Longer Eligible|2
7092038|NCT02266888|11210754|FG000|Overall Study|Randomization Closed|0
7092039|NCT02266888|11210755|FG001|Overall Study|Randomization Closed|0
7092040|NCT02266888|11210756|FG002|Overall Study|Randomization Closed|4
7092041|NCT02266888|11210757|FG003|Overall Study|Randomization Closed|0
7092042|NCT02266888|11210754|FG000|Overall Study|Personnel unavailable at transplant|0
7092043|NCT02266888|11210755|FG001|Overall Study|Personnel unavailable at transplant|0
7092044|NCT02266888|11210756|FG002|Overall Study|Personnel unavailable at transplant|0
7092045|NCT02266888|11210757|FG003|Overall Study|Personnel unavailable at transplant|1
7092046|NCT02266888|11210754|FG000|Overall Study|Transfer of care|0
7092047|NCT02266888|11210755|FG001|Overall Study|Transfer of care|0
7092048|NCT02266888|11210756|FG002|Overall Study|Transfer of care|1
7092049|NCT02266888|11210757|FG003|Overall Study|Transfer of care|0
7092050|NCT02267135|11210771|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1
7092051|NCT02267135|11210772|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3
7092052|NCT02267135|11210771|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0
7092053|NCT02267135|11210772|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1
7092054|NCT02267135|11210771|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1
7092055|NCT02267135|11210772|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1
7092056|NCT02267135|11210771|FG000|Period 2 (Randomized Set)|Adverse Event|2
7092057|NCT02267135|11210772|FG001|Period 2 (Randomized Set)|Adverse Event|0
7092058|NCT02267135|11210771|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1
7092059|NCT02267135|11210772|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0
7092060|NCT02267187|11210781|FG000|Overall Study|Physician Decision|2
7092061|NCT02267187|11210781|FG000|Overall Study|Screen fail|3
7092062|NCT02267278|11210804|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1
7092063|NCT02267278|11210804|FG000|Overall Study|transformation to acute leukemia (AML)|1
7092064|NCT02267278|11210804|FG000|Overall Study|Developed new cancer diagnoses|2
7092065|NCT02267278|11210804|FG000|Overall Study|prescribed prohibited medication|1
7092066|NCT02267317|11210811|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1
7092067|NCT02267317|11210812|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
7092068|NCT02267317|11210813|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
7092069|NCT02267317|11210814|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
7092070|NCT02267317|11210815|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
7092071|NCT02267317|11210816|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
7092072|NCT02267317|11210811|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1
7092073|NCT02267317|11210812|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
7092074|NCT02267317|11210813|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
7092075|NCT02267317|11210814|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
7092076|NCT02267317|11210815|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
7092077|NCT02267317|11210816|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
7092078|NCT02267746|11210903|FG000|Overall Study|Adverse Event|0
7092079|NCT02267746|11210904|FG001|Overall Study|Adverse Event|2
7092080|NCT02267746|11210905|FG002|Overall Study|Adverse Event|1
7092081|NCT02267746|11210903|FG000|Overall Study|Protocol Violation|8
7092082|NCT02267746|11210904|FG001|Overall Study|Protocol Violation|7
7092083|NCT02267746|11210905|FG002|Overall Study|Protocol Violation|3
7092084|NCT02267746|11210903|FG000|Overall Study|Lack of Efficacy|11
7092085|NCT02267746|11210904|FG001|Overall Study|Lack of Efficacy|11
7092086|NCT02267746|11210905|FG002|Overall Study|Lack of Efficacy|15
7092087|NCT02267746|11210903|FG000|Overall Study|Protocol Violation|1
7092088|NCT02267746|11210904|FG001|Overall Study|Protocol Violation|2
7092089|NCT02267746|11210905|FG002|Overall Study|Protocol Violation|1
7092090|NCT02267746|11210903|FG000|Overall Study|Miscellaneous|1
7092091|NCT02267746|11210904|FG001|Overall Study|Miscellaneous|0
7092092|NCT02267746|11210905|FG002|Overall Study|Miscellaneous|1
7092093|NCT02267824|11210937|FG000|Overall Study|Pregnancy|1
7092094|NCT02267824|11210938|FG001|Overall Study|Pregnancy|1
7092095|NCT02267824|11210937|FG000|Overall Study|Lost to Follow-up|4
7092096|NCT02267824|11210938|FG001|Overall Study|Lost to Follow-up|0
7092097|NCT02267824|11210937|FG000|Overall Study|Protocol Violation|3
7092098|NCT02267824|11210938|FG001|Overall Study|Protocol Violation|0
7092099|NCT02267824|11210937|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2
7092100|NCT02267824|11210938|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0
7092101|NCT02268045|11210964|FG000|Overall Study|Death|4
7092102|NCT02268045|11210965|FG001|Overall Study|Death|4
7092103|NCT02268045|11210964|FG000|Overall Study|Disease Progression|2
7092104|NCT02268045|11210965|FG001|Overall Study|Disease Progression|1
7092105|NCT02268045|11210964|FG000|Overall Study|Adverse Event|7
7092106|NCT02268045|11210965|FG001|Overall Study|Adverse Event|7
7092107|NCT02268045|11210964|FG000|Overall Study|Withdrawal by Subject|2
7092108|NCT02268045|11210965|FG001|Overall Study|Withdrawal by Subject|6
7092109|NCT02268045|11210964|FG000|Overall Study|Physician Decision|0
7092110|NCT02268045|11210965|FG001|Overall Study|Physician Decision|1
7092111|NCT02268045|11210964|FG000|Overall Study|Protocol Violation|1
7092112|NCT02268045|11210965|FG001|Overall Study|Protocol Violation|1
7092113|NCT02268058|11210977|FG000|Overall Study|Protocol Violation|1
7092114|NCT02268058|11210978|FG001|Overall Study|Protocol Violation|0
7092115|NCT02268058|11210979|FG002|Overall Study|Protocol Violation|0
7092116|NCT02268058|11210980|FG003|Overall Study|Protocol Violation|0
7092117|NCT02268084|11210992|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0
7092118|NCT02268084|11210993|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3
7092119|NCT02268084|11210992|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9
7092120|NCT02268084|11210993|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4
7092121|NCT02268214|11211008|FG000|Overall Study|Subject no longer meets study criteria|0
7092122|NCT02268214|11211009|FG001|Overall Study|Subject no longer meets study criteria|2
7092123|NCT02268214|11211010|FG002|Overall Study|Subject no longer meets study criteria|0
7092124|NCT02268214|11211008|FG000|Overall Study|Pregnancy|2
7092125|NCT02268214|11211009|FG001|Overall Study|Pregnancy|2
7092126|NCT02268214|11211010|FG002|Overall Study|Pregnancy|1
7092127|NCT02268214|11211008|FG000|Overall Study|Lost to Follow-up|3
7092128|NCT02268214|11211009|FG001|Overall Study|Lost to Follow-up|3
7092129|NCT02268214|11211010|FG002|Overall Study|Lost to Follow-up|4
7092130|NCT02268214|11211008|FG000|Overall Study|Lack of Efficacy|1
7092131|NCT02268214|11211009|FG001|Overall Study|Lack of Efficacy|0
7092132|NCT02268214|11211010|FG002|Overall Study|Lack of Efficacy|2
7092133|NCT02268214|11211008|FG000|Overall Study|Adverse Event|11
7092134|NCT02268214|11211009|FG001|Overall Study|Adverse Event|14
7092135|NCT02268214|11211010|FG002|Overall Study|Adverse Event|9
7092136|NCT02268214|11211008|FG000|Overall Study|Withdrawal by Subject|4
7092137|NCT02268214|11211009|FG001|Overall Study|Withdrawal by Subject|5
7092138|NCT02268214|11211010|FG002|Overall Study|Withdrawal by Subject|10
7092139|NCT02268214|11211008|FG000|Overall Study|Subject request to discontinue treatment|10
7092140|NCT02268214|11211009|FG001|Overall Study|Subject request to discontinue treatment|8
7092141|NCT02268214|11211010|FG002|Overall Study|Subject request to discontinue treatment|6
7092142|NCT02268214|11211008|FG000|Overall Study|Poor/non-compliance|2
7092143|NCT02268214|11211009|FG001|Overall Study|Poor/non-compliance|1
7092144|NCT02268214|11211010|FG002|Overall Study|Poor/non-compliance|2
7092145|NCT02268214|11211008|FG000|Overall Study|Other reasons|7
7092146|NCT02268214|11211009|FG001|Overall Study|Other reasons|3
7092147|NCT02268214|11211010|FG002|Overall Study|Other reasons|3
7092148|NCT02268214|11211008|FG000|Overall Study|Not entering long-term period|2
7092149|NCT02268214|11211009|FG001|Overall Study|Not entering long-term period|3
7092150|NCT02268214|11211010|FG002|Overall Study|Not entering long-term period|5
7092151|NCT02268396|11211018|FG000|Overall Study|Adverse Event|3
7092152|NCT02268396|11211018|FG000|Overall Study|Administrative|2
7092153|NCT02268396|11211018|FG000|Overall Study|Withdrawal by Subject|1
7092154|NCT02268396|11211018|FG000|Overall Study|Lost to Follow-up|2
7092155|NCT02268396|11211018|FG000|Overall Study|Protocol-Specified Criteria|2
7092156|NCT02268396|11211018|FG000|Overall Study|2 Subjects no Day 29 Assessment|2
7092157|NCT02268526|11211034|FG000|Overall Study|Adverse Event|0
7092158|NCT02268526|11211035|FG001|Overall Study|Adverse Event|2
7092159|NCT02268526|11211036|FG002|Overall Study|Adverse Event|1
7092160|NCT02268526|11211034|FG000|Overall Study|Death|1
7092161|NCT02268526|11211035|FG001|Overall Study|Death|11
7092162|NCT02268526|11211036|FG002|Overall Study|Death|0
7092163|NCT02268526|11211034|FG000|Overall Study|protocol deviation|0
7092164|NCT02268526|11211035|FG001|Overall Study|protocol deviation|1
7092165|NCT02268526|11211036|FG002|Overall Study|protocol deviation|0
7092166|NCT02268526|11211034|FG000|Overall Study|Physician Decision|0
7092167|NCT02268526|11211035|FG001|Overall Study|Physician Decision|0
7092168|NCT02268526|11211036|FG002|Overall Study|Physician Decision|1
7092169|NCT02268526|11211034|FG000|Overall Study|Subject/guardian decision|0
7092170|NCT02268526|11211035|FG001|Overall Study|Subject/guardian decision|7
7092171|NCT02268526|11211036|FG002|Overall Study|Subject/guardian decision|3
7092172|NCT02268786|11211048|FG000|Overall Study|No Euploid Embryos available|42
7092173|NCT02268786|11211049|FG001|Overall Study|No Euploid Embryos available|0
7092174|NCT02268786|11211048|FG000|Overall Study|Withdrawal by Subject|7
7092175|NCT02268786|11211049|FG001|Overall Study|Withdrawal by Subject|14
7092176|NCT02268786|11211048|FG000|Overall Study|Thaw Failure|6
7092177|NCT02268786|11211049|FG001|Overall Study|Thaw Failure|4
7092178|NCT02268786|11211048|FG000|Overall Study|Protocol Violation|1
7092179|NCT02268786|11211049|FG001|Overall Study|Protocol Violation|0
7092180|NCT02268812|11211059|FG000|Overall Study|Adverse Event|8
7092181|NCT02268812|11211060|FG001|Overall Study|Adverse Event|26
7092182|NCT02268812|11211061|FG002|Overall Study|Adverse Event|7
7092183|NCT02268812|11211062|FG003|Overall Study|Adverse Event|10
7092184|NCT02268812|11211059|FG000|Overall Study|Protocol deviation|0
7092185|NCT02268812|11211060|FG001|Overall Study|Protocol deviation|0
7092186|NCT02268812|11211061|FG002|Overall Study|Protocol deviation|1
7092187|NCT02268812|11211062|FG003|Overall Study|Protocol deviation|0
7092188|NCT02268812|11211059|FG000|Overall Study|Withdrawal by Subject|0
7092189|NCT02268812|11211060|FG001|Overall Study|Withdrawal by Subject|1
7092190|NCT02268812|11211061|FG002|Overall Study|Withdrawal by Subject|0
7092191|NCT02268812|11211062|FG003|Overall Study|Withdrawal by Subject|0
7092192|NCT02268812|11211059|FG000|Overall Study|Physician Decision|3
7092193|NCT02268812|11211060|FG001|Overall Study|Physician Decision|1
7092194|NCT02268812|11211061|FG002|Overall Study|Physician Decision|0
7092195|NCT02268812|11211062|FG003|Overall Study|Physician Decision|1
7092196|NCT02268812|11211059|FG000|Overall Study|Other|5
7092197|NCT02268812|11211060|FG001|Overall Study|Other|4
7092198|NCT02268812|11211061|FG002|Overall Study|Other|1
7092199|NCT02268812|11211062|FG003|Overall Study|Other|3
7092200|NCT02268851|11211078|FG000|Overall Study|Death|0
7092201|NCT02268851|11211079|FG001|Overall Study|Death|0
7092202|NCT02268851|11211080|FG002|Overall Study|Death|0
7092203|NCT02268851|11211081|FG003|Overall Study|Death|1
7092204|NCT02268851|11211082|FG004|Overall Study|Death|2
7092205|NCT02268851|11211083|FG005|Overall Study|Death|1
7092206|NCT02268851|11211078|FG000|Overall Study|Adverse Event|0
7092207|NCT02268851|11211079|FG001|Overall Study|Adverse Event|0
7092208|NCT02268851|11211080|FG002|Overall Study|Adverse Event|0
7092209|NCT02268851|11211081|FG003|Overall Study|Adverse Event|0
7092210|NCT02268851|11211082|FG004|Overall Study|Adverse Event|2
7092211|NCT02268851|11211083|FG005|Overall Study|Adverse Event|2
7092212|NCT02268851|11211078|FG000|Overall Study|Withdrawal by Subject|0
7092213|NCT02268851|11211079|FG001|Overall Study|Withdrawal by Subject|0
7092214|NCT02268851|11211080|FG002|Overall Study|Withdrawal by Subject|0
7092215|NCT02268851|11211081|FG003|Overall Study|Withdrawal by Subject|2
7092216|NCT02268851|11211082|FG004|Overall Study|Withdrawal by Subject|0
7092217|NCT02268851|11211083|FG005|Overall Study|Withdrawal by Subject|1
7092218|NCT02268851|11211078|FG000|Overall Study|Progressive Disease|1
7092219|NCT02268851|11211079|FG001|Overall Study|Progressive Disease|3
7092220|NCT02268851|11211080|FG002|Overall Study|Progressive Disease|0
7092221|NCT02268851|11211081|FG003|Overall Study|Progressive Disease|0
7092222|NCT02268851|11211082|FG004|Overall Study|Progressive Disease|1
7092223|NCT02268851|11211083|FG005|Overall Study|Progressive Disease|4
7092224|NCT02268851|11211078|FG000|Overall Study|Physician Decision|0
7092225|NCT02268851|11211079|FG001|Overall Study|Physician Decision|0
7092226|NCT02268851|11211080|FG002|Overall Study|Physician Decision|1
7092227|NCT02268851|11211081|FG003|Overall Study|Physician Decision|0
7092228|NCT02268851|11211082|FG004|Overall Study|Physician Decision|0
7092229|NCT02268851|11211083|FG005|Overall Study|Physician Decision|1
7092230|NCT02268851|11211078|FG000|Overall Study|Patient Compliance|0
7092231|NCT02268851|11211079|FG001|Overall Study|Patient Compliance|0
7092232|NCT02268851|11211080|FG002|Overall Study|Patient Compliance|0
7092233|NCT02268851|11211081|FG003|Overall Study|Patient Compliance|0
7092234|NCT02268851|11211082|FG004|Overall Study|Patient Compliance|1
7092235|NCT02268851|11211083|FG005|Overall Study|Patient Compliance|1
7092236|NCT02268851|11211078|FG000|Overall Study|Co-Morbid Condition|0
7092237|NCT02268851|11211079|FG001|Overall Study|Co-Morbid Condition|0
7092238|NCT02268851|11211080|FG002|Overall Study|Co-Morbid Condition|0
7092239|NCT02268851|11211081|FG003|Overall Study|Co-Morbid Condition|0
7092240|NCT02268851|11211082|FG004|Overall Study|Co-Morbid Condition|1
7092241|NCT02268851|11211083|FG005|Overall Study|Co-Morbid Condition|1
7092242|NCT02268864|11211100|FG000|Overall Study|Withdrawal by Subject|2
7092243|NCT02268864|11211101|FG001|Overall Study|Withdrawal by Subject|0
7092244|NCT02268864|11211102|FG002|Overall Study|Withdrawal by Subject|0
7092245|NCT02268864|11211100|FG000|Overall Study|Death|0
7092246|NCT02268864|11211101|FG001|Overall Study|Death|1
7092247|NCT02268864|11211102|FG002|Overall Study|Death|0
7092248|NCT02269098|11211148|FG000|Overall Study|Lost to Follow-up|14
7092249|NCT02269098|11211149|FG001|Overall Study|Lost to Follow-up|9
7092250|NCT02269124|11211158|FG000|Overall Study|Lost to Follow-up|1
7092251|NCT02269124|11211159|FG001|Overall Study|Lost to Follow-up|0
7092252|NCT02269124|11211158|FG000|Overall Study|Withdrawal by Subject|0
7092253|NCT02269124|11211159|FG001|Overall Study|Withdrawal by Subject|2
7092254|NCT02269163|11211168|FG000|Overall Study|Lost to Follow-up|1
7092255|NCT02269163|11211169|FG001|Overall Study|Lost to Follow-up|0
7092256|NCT02269163|11211168|FG000|Overall Study|Major protocol violation|0
7092257|NCT02269163|11211169|FG001|Overall Study|Major protocol violation|1
7092258|NCT02269163|11211168|FG000|Overall Study|Other|2
7092259|NCT02269163|11211169|FG001|Overall Study|Other|2
7092260|NCT02269163|11211168|FG000|Overall Study|Withdrawal by Subject|0
7092261|NCT02269163|11211169|FG001|Overall Study|Withdrawal by Subject|3
7092262|NCT02269163|11211168|FG000|Overall Study|Physician Decision|0
7092263|NCT02269163|11211169|FG001|Overall Study|Physician Decision|1
7092264|NCT02269241|11211177|FG000|Overall Study|Lost to Follow-up|269
7092265|NCT02269241|11211177|FG000|Overall Study|Withdrawal by Subject|155
7092266|NCT02269241|11211177|FG000|Overall Study|Protocol Violation|1
7092267|NCT02269241|11211177|FG000|Overall Study|Physician Decision|7
7092268|NCT02269241|11211177|FG000|Overall Study|Pregnancy|15
7092269|NCT02269241|11211177|FG000|Overall Study|Wish for pregnancy|5
7092270|NCT02269241|11211177|FG000|Overall Study|Development of an exclusion criteria|16
7092271|NCT02269241|11211177|FG000|Overall Study|Adverse Event|113
7092272|NCT02269241|11211177|FG000|Overall Study|At the specific request of the sponsor|20
7092273|NCT02269241|11211177|FG000|Overall Study|Several reasons not classified|53
7092274|NCT02269241|11211177|FG000|Overall Study|Screening failures|546
7092275|NCT02269423|11211186|FG000|Overall Study|Discontinued due to change in residence|0
7092276|NCT02269423|11211187|FG001|Overall Study|Discontinued due to change in residence|1
7092277|NCT02269423|11211188|FG002|Overall Study|Discontinued due to change in residence|0
7092278|NCT02269423|11211189|FG003|Overall Study|Discontinued due to change in residence|1
7092279|NCT02269475|11211201|FG000|Overall Study|Meet Exclusion Criteria No. 17|3
7092280|NCT02269475|11211202|FG001|Overall Study|Meet Exclusion Criteria No. 17|0
7092281|NCT02269475|11211201|FG000|Overall Study|Withdrawal by Subject|0
7092282|NCT02269475|11211202|FG001|Overall Study|Withdrawal by Subject|1
7092283|NCT02269657|11211222|FG000|Overall Study|Protocol Violation|3
7092284|NCT02269709|11211228|FG000|Time of Enrollment|Withdrawal by Subject|3
7092285|NCT02269709|11211228|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1
7092286|NCT02269709|11211228|FG000|Six Month Follow-up|Lost to Follow-up|12
7092287|NCT02269787|11211235|FG000|Overall Study|Lost to Follow-up|20
7092288|NCT02269787|11211236|FG001|Overall Study|Lost to Follow-up|6
7092289|NCT02269787|11211235|FG000|Overall Study|Death|2
7092290|NCT02269787|11211236|FG001|Overall Study|Death|3
7092291|NCT02269787|11211235|FG000|Overall Study|Incapacitated|0
7092292|NCT02269787|11211236|FG001|Overall Study|Incapacitated|1
7092293|NCT02269943|11211244|FG000|Treatment Period|Death|0
7092294|NCT02269943|11211245|FG001|Treatment Period|Death|1
7092295|NCT02269943|11211244|FG000|Treatment Period|Adverse Event|1
7092296|NCT02269943|11211245|FG001|Treatment Period|Adverse Event|10
7092297|NCT02269943|11211244|FG000|Treatment Period|Progressive Disease|5
7092298|NCT02269943|11211245|FG001|Treatment Period|Progressive Disease|17
7092299|NCT02269943|11211244|FG000|Treatment Period|Symptomatic Deterioration|0
7092300|NCT02269943|11211245|FG001|Treatment Period|Symptomatic Deterioration|2
7092301|NCT02269943|11211244|FG000|Follow-Up Survival Period|Death|3
7092302|NCT02269943|11211245|FG001|Follow-Up Survival Period|Death|16
7092303|NCT02269943|11211244|FG000|Follow-Up Survival Period|Lost to Follow-up|0
7092304|NCT02269943|11211245|FG001|Follow-Up Survival Period|Lost to Follow-up|2
7092305|NCT02269943|11211244|FG000|Follow-Up Survival Period|Alive|2
7092306|NCT02269943|11211245|FG001|Follow-Up Survival Period|Alive|8
7092307|NCT02270242|11211266|FG000|Overall Study|Withdrawal by Subject|18
7092308|NCT02270242|11211267|FG001|Overall Study|Withdrawal by Subject|25
7092309|NCT02270242|11211266|FG000|Overall Study|Lost to Follow-up|41
7092310|NCT02270242|11211267|FG001|Overall Study|Lost to Follow-up|27
7092311|NCT02270242|11211266|FG000|Overall Study|Physician Decision|0
7092312|NCT02270242|11211267|FG001|Overall Study|Physician Decision|1
7092313|NCT02270515|11211282|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1
7092314|NCT02270515|11211282|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5
7092315|NCT02270515|11211282|FG000|Intervention Period 1: 0-6 Months|Received transplant|3
7092316|NCT02270515|11211282|FG000|Intervention Period 1: 0-6 Months|Death|7
7092317|NCT02270515|11211282|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2
7092318|NCT02270515|11211282|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7
7092319|NCT02270515|11211282|FG000|Intervention Period 2: 6-12 Months|Received transplant|1
7092320|NCT02270515|11211282|FG000|Intervention Period 2: 6-12 Months|Death|5
7092321|NCT02270515|11211282|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17
7092322|NCT02270515|11211282|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1
7092323|NCT02270515|11211282|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2
7092324|NCT02270515|11211282|FG000|Intervention Period 3: 12-18 Months|Received transplant|2
7092325|NCT02270515|11211282|FG000|Intervention Period 3: 12-18 Months|Death|3
7092326|NCT02270515|11211282|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16
7092327|NCT02270671|11211304|FG000|Overall Study|Withdrawal by Subject|1
7092328|NCT02270671|11211305|FG001|Overall Study|Withdrawal by Subject|1
7092329|NCT02270671|11211304|FG000|Overall Study|Protocol Violation|0
7092330|NCT02270671|11211305|FG001|Overall Study|Protocol Violation|1
7092331|NCT02270671|11211304|FG000|Overall Study|Missed Post-intervention Data Collection|2
7092332|NCT02270671|11211305|FG001|Overall Study|Missed Post-intervention Data Collection|2
7092333|NCT02270671|11211304|FG000|Overall Study|Lost to Follow-up|2
7092334|NCT02270671|11211305|FG001|Overall Study|Lost to Follow-up|1
7092335|NCT02270736|11211314|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0
7092336|NCT02270736|11211315|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1
7092337|NCT02270736|11211316|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0
7092338|NCT02270736|11211317|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0
7092339|NCT02270736|11211318|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0
7092340|NCT02270736|11211314|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2
7092341|NCT02270736|11211315|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0
7092342|NCT02270736|11211316|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1
7092343|NCT02270736|11211317|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0
7092344|NCT02270736|11211318|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0
7092345|NCT02270736|11211314|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0
7092346|NCT02270736|11211315|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1
7092347|NCT02270736|11211316|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0
7092348|NCT02270736|11211317|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0
7092349|NCT02270736|11211318|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0
7092350|NCT02270736|11211314|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0
7092351|NCT02270736|11211315|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0
7092352|NCT02270736|11211316|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1
7092353|NCT02270736|11211317|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0
7092354|NCT02270736|11211318|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0
7092355|NCT02270736|11211314|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0
7092356|NCT02270736|11211315|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0
7092357|NCT02270736|11211316|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0
7092358|NCT02270736|11211317|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1
7092359|NCT02270736|11211318|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0
7092360|NCT02270736|11211314|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0
7092361|NCT02270736|11211315|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0
7092362|NCT02270736|11211316|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0
7092363|NCT02270736|11211317|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2
7092364|NCT02270736|11211318|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0
7092365|NCT02270736|11211314|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0
7092366|NCT02270736|11211315|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0
7092367|NCT02270736|11211316|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0
7092368|NCT02270736|11211317|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4
7092369|NCT02270736|11211318|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0
7092370|NCT02270736|11211314|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0
7092371|NCT02270736|11211315|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0
7092372|NCT02270736|11211316|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0
7092373|NCT02270736|11211317|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16
7092374|NCT02270736|11211318|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0
7092375|NCT02270736|11211314|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0
7092376|NCT02270736|11211315|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0
7092377|NCT02270736|11211316|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0
7092378|NCT02270736|11211317|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2
7092379|NCT02270736|11211318|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0
7092380|NCT02270944|11211333|FG000|Overall Study|Lost to Follow-up|9
7092381|NCT02270944|11211334|FG001|Overall Study|Lost to Follow-up|4
7092382|NCT02270944|11211333|FG000|Overall Study|Withdrawal by Subject|2
7092383|NCT02270944|11211334|FG001|Overall Study|Withdrawal by Subject|1
7092384|NCT02270983|11211344|FG000|Overall Study|Adverse Event|3
7092385|NCT02270983|11211345|FG001|Overall Study|Adverse Event|2
7092386|NCT02270983|11211346|FG002|Overall Study|Adverse Event|6
7092387|NCT02270983|11211344|FG000|Overall Study|Lack of Efficacy|2
7092388|NCT02270983|11211345|FG001|Overall Study|Lack of Efficacy|1
7092389|NCT02270983|11211346|FG002|Overall Study|Lack of Efficacy|1
7092390|NCT02270983|11211344|FG000|Overall Study|Withdrawal by Subject|1
7092391|NCT02270983|11211345|FG001|Overall Study|Withdrawal by Subject|0
7092392|NCT02270983|11211346|FG002|Overall Study|Withdrawal by Subject|2
7092393|NCT02270983|11211344|FG000|Overall Study|Lost to Follow-up|1
7092394|NCT02270983|11211345|FG001|Overall Study|Lost to Follow-up|1
7092395|NCT02270983|11211346|FG002|Overall Study|Lost to Follow-up|2
7092396|NCT02270983|11211344|FG000|Overall Study|Protocol Violation|1
7092397|NCT02270983|11211345|FG001|Overall Study|Protocol Violation|1
7092398|NCT02270983|11211346|FG002|Overall Study|Protocol Violation|1
7092399|NCT02270983|11211344|FG000|Overall Study|family emergency|0
7092400|NCT02270983|11211345|FG001|Overall Study|family emergency|1
7092401|NCT02270983|11211346|FG002|Overall Study|family emergency|0
7092402|NCT02270983|11211344|FG000|Overall Study|study procedure non-compliance|1
7092403|NCT02270983|11211345|FG001|Overall Study|study procedure non-compliance|0
7092404|NCT02270983|11211346|FG002|Overall Study|study procedure non-compliance|0
7092405|NCT02270983|11211344|FG000|Overall Study|moved away from study site|0
7092406|NCT02270983|11211345|FG001|Overall Study|moved away from study site|1
7092407|NCT02270983|11211346|FG002|Overall Study|moved away from study site|0
7092408|NCT02271529|11211412|FG000|Overall Study|Withdrawal by Subject|1
7092409|NCT02271854|11211433|FG000|Overall Study|Withdrawal by Subject|2
7092410|NCT02271854|11211433|FG000|Overall Study|Unable or unwilling to cooperate with st|1
7092411|NCT02271854|11211433|FG000|Overall Study|Lost to Follow-up|1
7092412|NCT02271880|11211440|FG000|Overall Study|Premature discontinuation of study|3
7092413|NCT02271880|11211441|FG001|Overall Study|Premature discontinuation of study|4
7092414|NCT02271945|11211455|FG000|Overall Study|Death|3
7092415|NCT02271945|11211456|FG001|Overall Study|Death|3
7092416|NCT02271945|11211455|FG000|Overall Study|Withdrawal by Subject|1
7092417|NCT02271945|11211456|FG001|Overall Study|Withdrawal by Subject|1
7092418|NCT02271945|11211455|FG000|Overall Study|Other|1
7092419|NCT02271945|11211456|FG001|Overall Study|Other|1
7092420|NCT02271984|11211462|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7092421|NCT02271984|11211463|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7092422|NCT02271984|11211464|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7092423|NCT02271984|11211465|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7092424|NCT02271984|11211466|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7092425|NCT02271984|11211467|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1
7092426|NCT02271984|11211468|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7092427|NCT02271984|11211469|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1
7092428|NCT02271984|11211470|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7092429|NCT02271984|11211471|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7092430|NCT02271984|11211472|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7092431|NCT02271984|11211473|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7092432|NCT02272413|11211499|FG000|Randomized Through Treatment Start|Not treated|3
7092433|NCT02272413|11211500|FG001|Randomized Through Treatment Start|Not treated|5
7092434|NCT02272413|11211499|FG000|Pre-switch Period|Adverse Event|38
7092435|NCT02272413|11211500|FG001|Pre-switch Period|Adverse Event|37
7092436|NCT02272413|11211499|FG000|Pre-switch Period|Death|26
7092437|NCT02272413|11211500|FG001|Pre-switch Period|Death|26
7092438|NCT02272413|11211499|FG000|Pre-switch Period|Withdrawal by Subject|27
7092439|NCT02272413|11211500|FG001|Pre-switch Period|Withdrawal by Subject|15
7092440|NCT02272413|11211499|FG000|Pre-switch Period|Physician Decision|6
7092441|NCT02272413|11211500|FG001|Pre-switch Period|Physician Decision|18
7092442|NCT02272413|11211499|FG000|Pre-switch Period|Progressive disease|185
7092443|NCT02272413|11211500|FG001|Pre-switch Period|Progressive disease|173
7092444|NCT02272413|11211499|FG000|Pre-switch Period|Lost to Follow-up|0
7092445|NCT02272413|11211500|FG001|Pre-switch Period|Lost to Follow-up|2
7092446|NCT02272413|11211499|FG000|Pre-switch Period|Protocol Violation|1
7092447|NCT02272413|11211500|FG001|Pre-switch Period|Protocol Violation|0
7092448|NCT02272413|11211499|FG000|Pre-switch Period|Other than listed|10
7092449|NCT02272413|11211500|FG001|Pre-switch Period|Other than listed|11
7092450|NCT02272413|11211499|FG000|Post-switch Period|Adverse Event|4
7092451|NCT02272413|11211500|FG001|Post-switch Period|Adverse Event|4
7092452|NCT02272413|11211499|FG000|Post-switch Period|Death|3
7092453|NCT02272413|11211500|FG001|Post-switch Period|Death|2
7092454|NCT02272413|11211499|FG000|Post-switch Period|Withdrawal by Subject|1
7092455|NCT02272413|11211500|FG001|Post-switch Period|Withdrawal by Subject|2
7092456|NCT02272413|11211499|FG000|Post-switch Period|Physician Decision|1
7092457|NCT02272413|11211500|FG001|Post-switch Period|Physician Decision|1
7092458|NCT02272413|11211499|FG000|Post-switch Period|Progressive disease|21
7092459|NCT02272413|11211500|FG001|Post-switch Period|Progressive disease|21
7092460|NCT02272413|11211499|FG000|Post-switch Period|Study terminated by sponsor|8
7092461|NCT02272413|11211500|FG001|Post-switch Period|Study terminated by sponsor|11
7092462|NCT02272413|11211499|FG000|Post-switch Period|Other than listed|4
7092463|NCT02272413|11211500|FG001|Post-switch Period|Other than listed|5
7092464|NCT02272634|11211511|FG000|Overall Study|Adverse Event|1
7092465|NCT02272634|11211512|FG001|Overall Study|Adverse Event|0
7092466|NCT02272634|11211513|FG002|Overall Study|Adverse Event|0
7092467|NCT02272634|11211511|FG000|Overall Study|Protocol Violation|0
7092468|NCT02272634|11211512|FG001|Overall Study|Protocol Violation|0
7092469|NCT02272634|11211513|FG002|Overall Study|Protocol Violation|1
7092470|NCT02272634|11211511|FG000|Overall Study|Withdrawal by Subject|0
7092471|NCT02272634|11211512|FG001|Overall Study|Withdrawal by Subject|1
7092472|NCT02272634|11211513|FG002|Overall Study|Withdrawal by Subject|0
7092473|NCT02272725|11211530|FG000|Overall Study|equipment malfunction|2
7092474|NCT02272725|11211531|FG001|Overall Study|equipment malfunction|0
7092475|NCT02272777|11211539|FG000|Overall Study|Adverse Event|0
7092476|NCT02272777|11211540|FG001|Overall Study|Adverse Event|1
7092477|NCT02272777|11211539|FG000|Overall Study|Withdrawal by Subject|0
7092478|NCT02272777|11211540|FG001|Overall Study|Withdrawal by Subject|3
7092479|NCT02272777|11211539|FG000|Overall Study|Lost to Follow-up|2
7092480|NCT02272777|11211540|FG001|Overall Study|Lost to Follow-up|0
7092481|NCT02272777|11211539|FG000|Overall Study|Other|2
7092482|NCT02272777|11211540|FG001|Overall Study|Other|0
7092483|NCT02272816|11211546|FG000|Overall Study|Adverse Event|1
7092484|NCT02272842|11211552|FG000|Overall Study|Lost to Follow-up|8
7092485|NCT02272842|11211553|FG001|Overall Study|Lost to Follow-up|8
7092486|NCT02272842|11211552|FG000|Overall Study|Withdrawal by Subject|8
7092487|NCT02272842|11211553|FG001|Overall Study|Withdrawal by Subject|2
7092488|NCT02272985|11211560|FG000|Overall Study|Withdrawal by Subject|1
7092489|NCT02272985|11211560|FG000|Overall Study|hip fracture|1
7092490|NCT02272985|11211560|FG000|Overall Study|kidney transplantation|1
7092491|NCT02273037|11211567|FG000|Overall Study|Lost to Follow-up|1
7092492|NCT02273037|11211568|FG001|Overall Study|Lost to Follow-up|0
7092493|NCT02273037|11211567|FG000|Overall Study|Delivered before monitoring initiated|1
7092494|NCT02273037|11211568|FG001|Overall Study|Delivered before monitoring initiated|3
7092495|NCT02273037|11211567|FG000|Overall Study|Breech delivery|2
7092496|NCT02273037|11211568|FG001|Overall Study|Breech delivery|3
7092497|NCT02273037|11211567|FG000|Overall Study|Multiple delivery|2
7092498|NCT02273037|11211568|FG001|Overall Study|Multiple delivery|2
7092499|NCT02273037|11211567|FG000|Overall Study|Other complication|2
7092500|NCT02273037|11211568|FG001|Overall Study|Other complication|0
7092501|NCT02273050|11211579|FG000|Overall Study|Adverse Event|4
7092502|NCT02273050|11211580|FG001|Overall Study|Adverse Event|3
7092503|NCT02273050|11211581|FG002|Overall Study|Adverse Event|3
7092504|NCT02273050|11211579|FG000|Overall Study|Death|0
7092505|NCT02273050|11211580|FG001|Overall Study|Death|0
7092506|NCT02273050|11211581|FG002|Overall Study|Death|1
7092507|NCT02273050|11211579|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0
7092508|NCT02273050|11211580|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1
7092509|NCT02273050|11211581|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1
7092510|NCT02273050|11211579|FG000|Overall Study|Lack of Efficacy|0
7092511|NCT02273050|11211580|FG001|Overall Study|Lack of Efficacy|1
7092512|NCT02273050|11211581|FG002|Overall Study|Lack of Efficacy|1
7092513|NCT02273050|11211579|FG000|Overall Study|Withdrawal by Subject|17
7092514|NCT02273050|11211580|FG001|Overall Study|Withdrawal by Subject|14
7092515|NCT02273050|11211581|FG002|Overall Study|Withdrawal by Subject|16
7092516|NCT02273050|11211579|FG000|Overall Study|Lost to Follow-up|0
7092517|NCT02273050|11211580|FG001|Overall Study|Lost to Follow-up|2
7092518|NCT02273050|11211581|FG002|Overall Study|Lost to Follow-up|3
7092519|NCT02273050|11211579|FG000|Overall Study|Protocol Violation|3
7092520|NCT02273050|11211580|FG001|Overall Study|Protocol Violation|1
7092521|NCT02273050|11211581|FG002|Overall Study|Protocol Violation|4
7092522|NCT02273141|11211613|FG000|Overall Study|Adverse Event|0
7092523|NCT02273141|11211614|FG001|Overall Study|Adverse Event|1
7092524|NCT02273141|11211613|FG000|Overall Study|Lost to Follow-up|1
7092525|NCT02273141|11211614|FG001|Overall Study|Lost to Follow-up|3
7092526|NCT02273141|11211613|FG000|Overall Study|Withdrawal by Subject|10
7092527|NCT02273141|11211614|FG001|Overall Study|Withdrawal by Subject|15
7092528|NCT02273141|11211613|FG000|Overall Study|Various|6
7092529|NCT02273141|11211614|FG001|Overall Study|Various|6
7092530|NCT02273167|11211623|FG000|Overall Study|Adverse Event|1
7092531|NCT02273167|11211624|FG001|Overall Study|Adverse Event|0
7092532|NCT02273167|11211625|FG002|Overall Study|Adverse Event|0
7092533|NCT02273167|11211623|FG000|Overall Study|Protocol Violation|3
7092534|NCT02273167|11211624|FG001|Overall Study|Protocol Violation|1
7092535|NCT02273167|11211625|FG002|Overall Study|Protocol Violation|1
7092536|NCT02273167|11211623|FG000|Overall Study|Lost to Follow-up|0
7092537|NCT02273167|11211624|FG001|Overall Study|Lost to Follow-up|1
7092538|NCT02273167|11211625|FG002|Overall Study|Lost to Follow-up|1
7092539|NCT02273167|11211623|FG000|Overall Study|Withdrawal by Subject|10
7092540|NCT02273167|11211624|FG001|Overall Study|Withdrawal by Subject|12
7092541|NCT02273167|11211625|FG002|Overall Study|Withdrawal by Subject|11
7092542|NCT02273167|11211623|FG000|Overall Study|Various|10
7092543|NCT02273167|11211624|FG001|Overall Study|Various|9
7092544|NCT02273167|11211625|FG002|Overall Study|Various|8
7092545|NCT02273180|11211636|FG000|Overall Study|Adverse Event|2
7092546|NCT02273180|11211637|FG001|Overall Study|Adverse Event|2
7092547|NCT02273180|11211636|FG000|Overall Study|Lack of Efficacy|1
7092548|NCT02273180|11211637|FG001|Overall Study|Lack of Efficacy|0
7092549|NCT02273180|11211636|FG000|Overall Study|Protocol Violation|1
7092550|NCT02273180|11211637|FG001|Overall Study|Protocol Violation|7
7092551|NCT02273180|11211636|FG000|Overall Study|Randomized but not treated|1
7092552|NCT02273180|11211637|FG001|Overall Study|Randomized but not treated|0
7092553|NCT02273180|11211636|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1
7092554|NCT02273180|11211637|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0
7092555|NCT02273180|11211636|FG000|Overall Study|Other than specified above|21
7092556|NCT02273180|11211637|FG001|Overall Study|Other than specified above|10
7092557|NCT02273596|11211669|FG000|24-Week Treatment Period|Adverse Event|3
7092558|NCT02273596|11211669|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1
7092559|NCT02273596|11211669|FG000|24-Week Treatment Period|Participant was unable to Come|1
7092560|NCT02273596|11211669|FG000|24-Week Treatment Period|Physician Decision|1
7092561|NCT02273596|11211669|FG000|24-Week Treatment Period|Protocol Deviation|1
7092562|NCT02273596|11211669|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19
7092563|NCT02273596|11211669|FG000|Extension Period|Participant Withdrew for Personal Reasons|1
7092564|NCT02273596|11211669|FG000|Extension Period|Lost to Follow-up|1
7092565|NCT02273596|11211669|FG000|Extension Period|Protocol Deviation|1
7092566|NCT02273726|11211681|FG000|Overall Study|Death|70
7092567|NCT02273726|11211682|FG001|Overall Study|Death|62
7092568|NCT02273726|11211681|FG000|Overall Study|Withdrawal by Subject|41
7092569|NCT02273726|11211682|FG001|Overall Study|Withdrawal by Subject|29
7092570|NCT02273726|11211681|FG000|Overall Study|Kidney transplant|31
7092571|NCT02273726|11211682|FG001|Overall Study|Kidney transplant|39
7092572|NCT02273726|11211681|FG000|Overall Study|Physician Decision|30
7092573|NCT02273726|11211682|FG001|Overall Study|Physician Decision|15
7092574|NCT02273726|11211681|FG000|Overall Study|Adverse Event|27
7092575|NCT02273726|11211682|FG001|Overall Study|Adverse Event|9
7092576|NCT02273726|11211681|FG000|Overall Study|Lost to Follow-up|6
7092577|NCT02273726|11211682|FG001|Overall Study|Lost to Follow-up|3
7092578|NCT02273726|11211681|FG000|Overall Study|Lack of Efficacy|6
7092579|NCT02273726|11211682|FG001|Overall Study|Lack of Efficacy|1
7092580|NCT02273726|11211681|FG000|Overall Study|Protocol Violation|4
7092581|NCT02273726|11211682|FG001|Overall Study|Protocol Violation|0
7092582|NCT02273726|11211681|FG000|Overall Study|Other than specified|28
7092583|NCT02273726|11211682|FG001|Overall Study|Other than specified|30
7092584|NCT02273739|11211692|FG000|Overall Study|Progression of Disease|3
7092585|NCT02273739|11211693|FG001|Overall Study|Progression of Disease|4
7092586|NCT02273739|11211694|FG002|Overall Study|Progression of Disease|5
7092587|NCT02273739|11211695|FG003|Overall Study|Progression of Disease|2
7092588|NCT02273739|11211692|FG000|Overall Study|Death|0
7092589|NCT02273739|11211693|FG001|Overall Study|Death|0
7092590|NCT02273739|11211694|FG002|Overall Study|Death|0
7092591|NCT02273739|11211695|FG003|Overall Study|Death|2
7092592|NCT02273739|11211692|FG000|Overall Study|Adverse Event|0
7092593|NCT02273739|11211693|FG001|Overall Study|Adverse Event|0
7092594|NCT02273739|11211694|FG002|Overall Study|Adverse Event|0
7092595|NCT02273739|11211695|FG003|Overall Study|Adverse Event|1
7092596|NCT02273739|11211692|FG000|Overall Study|Withdrawal by Subject|0
7092597|NCT02273739|11211693|FG001|Overall Study|Withdrawal by Subject|0
7092598|NCT02273739|11211694|FG002|Overall Study|Withdrawal by Subject|2
7092599|NCT02273739|11211695|FG003|Overall Study|Withdrawal by Subject|1
7092600|NCT02273739|11211692|FG000|Overall Study|Physician Decision|0
7092601|NCT02273739|11211693|FG001|Overall Study|Physician Decision|0
7092602|NCT02273739|11211694|FG002|Overall Study|Physician Decision|0
7092603|NCT02273739|11211695|FG003|Overall Study|Physician Decision|1
7092604|NCT02273908|11211712|FG000|Overall Study|Adverse Event|16
7092605|NCT02273908|11211713|FG001|Overall Study|Adverse Event|0
7092606|NCT02273908|11211712|FG000|Overall Study|Lost to Follow-up|10
7092607|NCT02273908|11211713|FG001|Overall Study|Lost to Follow-up|1
7092608|NCT02273908|11211712|FG000|Overall Study|Did not meet entrance criteria|3
7092609|NCT02273908|11211713|FG001|Overall Study|Did not meet entrance criteria|2
7092610|NCT02273908|11211712|FG000|Overall Study|Withdrawal by Subject|4
7092611|NCT02273908|11211713|FG001|Overall Study|Withdrawal by Subject|2
7092612|NCT02273960|11211727|FG000|Short Term Period|Lost to Follow-up|1
7092613|NCT02273960|11211728|FG001|Short Term Period|Lost to Follow-up|0
7092614|NCT02273960|11211729|FG002|Short Term Period|Lost to Follow-up|0
7092615|NCT02273960|11211730|FG003|Short Term Period|Lost to Follow-up|0
7092616|NCT02273960|11211727|FG000|Short Term Period|Lack of Efficacy|0
7092617|NCT02273960|11211728|FG001|Short Term Period|Lack of Efficacy|0
7092618|NCT02273960|11211729|FG002|Short Term Period|Lack of Efficacy|0
7092619|NCT02273960|11211730|FG003|Short Term Period|Lack of Efficacy|1
7092620|NCT02273960|11211727|FG000|Short Term Period|ST complete, not entering LTE|4
7092621|NCT02273960|11211728|FG001|Short Term Period|ST complete, not entering LTE|6
7092622|NCT02273960|11211729|FG002|Short Term Period|ST complete, not entering LTE|4
7092623|NCT02273960|11211730|FG003|Short Term Period|ST complete, not entering LTE|5
7092624|NCT02273960|11211727|FG000|Long Term Extension|Death|0
7092625|NCT02273960|11211728|FG001|Long Term Extension|Death|0
7092626|NCT02273960|11211729|FG002|Long Term Extension|Death|0
7092627|NCT02273960|11211730|FG003|Long Term Extension|Death|1
7092628|NCT02273973|11211742|FG000|Overall Study|Adverse Event|4
7092629|NCT02273973|11211743|FG001|Overall Study|Adverse Event|0
7092630|NCT02273973|11211742|FG000|Overall Study|Withdrawal by Subject|2
7092631|NCT02273973|11211743|FG001|Overall Study|Withdrawal by Subject|3
7092632|NCT02273973|11211742|FG000|Overall Study|Death|1
7092633|NCT02273973|11211743|FG001|Overall Study|Death|0
7092634|NCT02273973|11211742|FG000|Overall Study|Non-compliance|1
7092635|NCT02273973|11211743|FG001|Overall Study|Non-compliance|0
7092636|NCT02273973|11211742|FG000|Overall Study|Protocol Violation|1
7092637|NCT02273973|11211743|FG001|Overall Study|Protocol Violation|0
7092638|NCT02273973|11211742|FG000|Overall Study|Progression of disease|0
7092639|NCT02273973|11211743|FG001|Overall Study|Progression of disease|2
7092640|NCT02273973|11211742|FG000|Overall Study|Lost to Follow-up|0
7092641|NCT02273973|11211743|FG001|Overall Study|Lost to Follow-up|1
7092642|NCT02273973|11211742|FG000|Overall Study|Physician Decision|0
7092643|NCT02273973|11211743|FG001|Overall Study|Physician Decision|1
7092644|NCT02273973|11211742|FG000|Overall Study|Reason not specified|0
7092645|NCT02273973|11211743|FG001|Overall Study|Reason not specified|1
7092646|NCT02274038|11211749|FG000|Overall Study|Death|1
7092647|NCT02274311|11211755|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1
7092648|NCT02274493|11211761|FG000|Overall Study|Withdrawal by Subject|1
7092649|NCT02274558|11211768|FG000|Overall Study|Adverse Event|2
7092650|NCT02274558|11211769|FG001|Overall Study|Adverse Event|4
7092651|NCT02274558|11211770|FG002|Overall Study|Adverse Event|2
7092652|NCT02274558|11211768|FG000|Overall Study|Non-compliance|2
7092653|NCT02274558|11211769|FG001|Overall Study|Non-compliance|1
7092654|NCT02274558|11211770|FG002|Overall Study|Non-compliance|0
7092655|NCT02274558|11211768|FG000|Overall Study|Withdrawal by Subject|1
7092656|NCT02274558|11211769|FG001|Overall Study|Withdrawal by Subject|5
7092657|NCT02274558|11211770|FG002|Overall Study|Withdrawal by Subject|4
7092658|NCT02274558|11211768|FG000|Overall Study|Death|0
7092659|NCT02274558|11211769|FG001|Overall Study|Death|0
7092660|NCT02274558|11211770|FG002|Overall Study|Death|1
7092661|NCT02274558|11211768|FG000|Overall Study|Lost to Follow-up|2
7092662|NCT02274558|11211769|FG001|Overall Study|Lost to Follow-up|1
7092663|NCT02274558|11211770|FG002|Overall Study|Lost to Follow-up|1
7092664|NCT02274558|11211768|FG000|Overall Study|Physician Decision|0
7092665|NCT02274558|11211769|FG001|Overall Study|Physician Decision|2
7092666|NCT02274558|11211770|FG002|Overall Study|Physician Decision|1
7092667|NCT02274766|11211805|FG000|Overall Study|Withdrawal by Subject|3
7092668|NCT02274766|11211806|FG001|Overall Study|Withdrawal by Subject|6
7092669|NCT02274766|11211805|FG000|Overall Study|Did Not Receive Study Drug|1
7092670|NCT02274766|11211806|FG001|Overall Study|Did Not Receive Study Drug|1
7092671|NCT02274766|11211805|FG000|Overall Study|Subject Unwilling to Proceed|0
7092672|NCT02274766|11211806|FG001|Overall Study|Subject Unwilling to Proceed|1
7092673|NCT02274766|11211805|FG000|Overall Study|Adverse Event|0
7092674|NCT02274766|11211806|FG001|Overall Study|Adverse Event|1
7092675|NCT02274792|11211812|FG000|Overall Study|Withdrawal by Subject|13
7092676|NCT02274792|11211812|FG000|Overall Study|Lost to Follow-up|8
7092677|NCT02274792|11211812|FG000|Overall Study|Protocol Specified Criteria|2
7092678|NCT02274792|11211812|FG000|Overall Study|Sponsor Decision|2
7092679|NCT02274857|11211827|FG000|Overall Study|Adverse Event|1
7092680|NCT02274857|11211828|FG001|Overall Study|Adverse Event|0
7092681|NCT02274857|11211827|FG000|Overall Study|Death|1
7092682|NCT02274857|11211828|FG001|Overall Study|Death|2
7092683|NCT02274857|11211827|FG000|Overall Study|Lost to Follow-up|3
7092684|NCT02274857|11211828|FG001|Overall Study|Lost to Follow-up|0
7092685|NCT02274857|11211827|FG000|Overall Study|Physician Decision|2
7092686|NCT02274857|11211828|FG001|Overall Study|Physician Decision|0
7092687|NCT02274857|11211827|FG000|Overall Study|Trial screen failure|0
7092688|NCT02274857|11211828|FG001|Overall Study|Trial screen failure|2
7092689|NCT02274857|11211827|FG000|Overall Study|Withdrawal by Subject|11
7092690|NCT02274857|11211828|FG001|Overall Study|Withdrawal by Subject|2
7092691|NCT02274857|11211827|FG000|Overall Study|Other|2
7092692|NCT02274857|11211828|FG001|Overall Study|Other|0
7092693|NCT02274948|11211849|FG000|Overall Study|Lost to Follow-up|28
7092694|NCT02274948|11211850|FG001|Overall Study|Lost to Follow-up|25
7092695|NCT02274948|11211849|FG000|Overall Study|Withdrawal by Subject|64
7092696|NCT02274948|11211850|FG001|Overall Study|Withdrawal by Subject|58
7092697|NCT02274948|11211849|FG000|Overall Study|Stopped on family Practitioner advice|2
7092698|NCT02274948|11211850|FG001|Overall Study|Stopped on family Practitioner advice|5
7092699|NCT02274948|11211849|FG000|Overall Study|Left the area|4
7092700|NCT02274948|11211850|FG001|Overall Study|Left the area|3
7092701|NCT02275026|11211857|FG000|Overall Study|Ineligible after cognitive baseline testing|11
7092702|NCT02275026|11211857|FG000|Overall Study|Withdrawal by Subject|4
7092703|NCT02275026|11211857|FG000|Overall Study|Ineligible due to medical history|13
7092704|NCT02275026|11211857|FG000|Overall Study|MRI malfunction precluded testing|1
7092705|NCT02275026|11211857|FG000|Overall Study|Ineligible after MRI findings|1
7092706|NCT02275026|11211857|FG000|Overall Study|Lost to Follow-up|2
7092707|NCT02275026|11211857|FG000|Overall Study|Scanner failure|1
7092708|NCT02275052|11211864|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7092709|NCT02275052|11211865|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
7092710|NCT02275052|11211866|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7092711|NCT02275052|11211867|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7092712|NCT02275052|11211864|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
7092713|NCT02275052|11211865|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1
7092714|NCT02275052|11211866|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
7092715|NCT02275052|11211867|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
7092716|NCT02275052|11211864|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6
7092717|NCT02275052|11211865|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4
7092718|NCT02275052|11211866|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
7092719|NCT02275052|11211867|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
7092720|NCT02275052|11211864|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1
7092721|NCT02275052|11211865|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
7092722|NCT02275052|11211866|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
7092723|NCT02275052|11211867|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
7092724|NCT02275052|11211864|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2
7092725|NCT02275052|11211865|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
7092726|NCT02275052|11211866|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
7092727|NCT02275052|11211867|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
7092728|NCT02275052|11211864|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3
7092729|NCT02275052|11211865|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0
7092730|NCT02275052|11211866|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0
7092731|NCT02275052|11211867|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0
7092732|NCT02275052|11211864|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1
7092733|NCT02275052|11211865|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0
7092734|NCT02275052|11211866|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0
7092735|NCT02275052|11211867|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0
7092736|NCT02275052|11211864|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
7092737|NCT02275052|11211865|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
7092738|NCT02275052|11211866|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3
7092739|NCT02275052|11211867|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2
7092740|NCT02275052|11211864|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
7092741|NCT02275052|11211865|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
7092742|NCT02275052|11211866|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
7092743|NCT02275052|11211867|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4
7092744|NCT02275052|11211864|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
7092745|NCT02275052|11211865|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
7092746|NCT02275052|11211866|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
7092747|NCT02275052|11211867|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6
7092748|NCT02275052|11211864|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
7092749|NCT02275052|11211865|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
7092750|NCT02275052|11211866|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
7092751|NCT02275052|11211867|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2
7092752|NCT02275065|11211878|FG000|Overall Study|Randomized but not treated|1
7092753|NCT02275065|11211879|FG001|Overall Study|Randomized but not treated|0
7092754|NCT02275065|11211880|FG002|Overall Study|Randomized but not treated|1
7092755|NCT02275065|11211881|FG003|Overall Study|Randomized but not treated|1
7092756|NCT02275065|11211882|FG004|Overall Study|Randomized but not treated|0
7092757|NCT02275117|11211899|FG000|Overall Study|Adverse Event|0
7092758|NCT02275117|11211900|FG001|Overall Study|Adverse Event|0
7092759|NCT02275117|11211901|FG002|Overall Study|Adverse Event|0
7092760|NCT02275117|11211902|FG003|Overall Study|Adverse Event|0
7092761|NCT02275117|11211903|FG004|Overall Study|Adverse Event|1
7092762|NCT02275117|11211899|FG000|Overall Study|Lack of Efficacy|6
7092763|NCT02275117|11211900|FG001|Overall Study|Lack of Efficacy|7
7092764|NCT02275117|11211901|FG002|Overall Study|Lack of Efficacy|5
7092765|NCT02275117|11211902|FG003|Overall Study|Lack of Efficacy|2
7092766|NCT02275117|11211903|FG004|Overall Study|Lack of Efficacy|10
7092767|NCT02275117|11211899|FG000|Overall Study|Lost to Follow-up|11
7092768|NCT02275117|11211900|FG001|Overall Study|Lost to Follow-up|16
7092769|NCT02275117|11211901|FG002|Overall Study|Lost to Follow-up|15
7092770|NCT02275117|11211902|FG003|Overall Study|Lost to Follow-up|16
7092771|NCT02275117|11211903|FG004|Overall Study|Lost to Follow-up|8
7092772|NCT02275117|11211899|FG000|Overall Study|Physician Decision|0
7092773|NCT02275117|11211900|FG001|Overall Study|Physician Decision|1
7092774|NCT02275117|11211901|FG002|Overall Study|Physician Decision|1
7092775|NCT02275117|11211902|FG003|Overall Study|Physician Decision|0
7092776|NCT02275117|11211903|FG004|Overall Study|Physician Decision|1
7092777|NCT02275117|11211899|FG000|Overall Study|Protocol Violation|1
7092778|NCT02275117|11211900|FG001|Overall Study|Protocol Violation|0
7092779|NCT02275117|11211901|FG002|Overall Study|Protocol Violation|1
7092780|NCT02275117|11211902|FG003|Overall Study|Protocol Violation|1
7092781|NCT02275117|11211903|FG004|Overall Study|Protocol Violation|0
7092782|NCT02275117|11211899|FG000|Overall Study|Withdrawal by Subject|6
7092783|NCT02275117|11211900|FG001|Overall Study|Withdrawal by Subject|4
7092784|NCT02275117|11211901|FG002|Overall Study|Withdrawal by Subject|7
7092785|NCT02275117|11211902|FG003|Overall Study|Withdrawal by Subject|3
7092786|NCT02275117|11211903|FG004|Overall Study|Withdrawal by Subject|3
7092787|NCT02275117|11211899|FG000|Overall Study|Terminated by Sponsor|4
7092788|NCT02275117|11211900|FG001|Overall Study|Terminated by Sponsor|4
7092789|NCT02275117|11211901|FG002|Overall Study|Terminated by Sponsor|4
7092790|NCT02275117|11211902|FG003|Overall Study|Terminated by Sponsor|6
7092791|NCT02275117|11211903|FG004|Overall Study|Terminated by Sponsor|4
7092792|NCT02275117|11211899|FG000|Overall Study|Worsening of Study Indication|0
7092793|NCT02275117|11211900|FG001|Overall Study|Worsening of Study Indication|1
7092794|NCT02275117|11211901|FG002|Overall Study|Worsening of Study Indication|2
7092795|NCT02275117|11211902|FG003|Overall Study|Worsening of Study Indication|0
7092796|NCT02275117|11211903|FG004|Overall Study|Worsening of Study Indication|0
7092797|NCT02275117|11211899|FG000|Overall Study|Study Burden|5
7092798|NCT02275117|11211900|FG001|Overall Study|Study Burden|4
7092799|NCT02275117|11211901|FG002|Overall Study|Study Burden|7
7092800|NCT02275117|11211902|FG003|Overall Study|Study Burden|5
7092801|NCT02275117|11211903|FG004|Overall Study|Study Burden|7
7092802|NCT02275117|11211899|FG000|Overall Study|Other|1
7092803|NCT02275117|11211900|FG001|Overall Study|Other|0
7092804|NCT02275117|11211901|FG002|Overall Study|Other|0
7092805|NCT02275117|11211902|FG003|Overall Study|Other|0
7092806|NCT02275117|11211903|FG004|Overall Study|Other|2
7092807|NCT02275338|11211929|FG000|Overall Study|Adverse Event|15
7092808|NCT02275338|11211929|FG000|Overall Study|Lack of Efficacy|3
7092809|NCT02275338|11211929|FG000|Overall Study|Withdrawal by Subject|4
7092810|NCT02275338|11211929|FG000|Overall Study|Disease progression (death)|1
7092811|NCT02275338|11211929|FG000|Overall Study|Ineligible to start Phase 2|4
7092812|NCT02275338|11211929|FG000|Overall Study|Reason not specified|5
7092813|NCT02275338|11211929|FG000|Overall Study|Does not meet entry criteria|1
7092814|NCT02275364|11211934|FG000|Period 1|Withdrawal by Subject|1
7092815|NCT02275364|11211935|FG001|Period 1|Withdrawal by Subject|0
7092816|NCT02275364|11211934|FG000|Period 1|Other reason|1
7092817|NCT02275364|11211935|FG001|Period 1|Other reason|0
7092818|NCT02275611|11211956|FG000|Inpatient Withdrawal|Withdrawal by Subject|1
7092819|NCT02275611|11211957|FG001|Inpatient Withdrawal|Withdrawal by Subject|0
7092820|NCT02275611|11211958|FG002|Inpatient Withdrawal|Withdrawal by Subject|0
7092821|NCT02275611|11211959|FG003|Inpatient Withdrawal|Withdrawal by Subject|0
7092822|NCT02275780|11211986|FG000|Base Study: 96 Weeks|Adverse Event|6
7092823|NCT02275780|11211987|FG001|Base Study: 96 Weeks|Adverse Event|14
7092824|NCT02275780|11211986|FG000|Base Study: 96 Weeks|Death|3
7092825|NCT02275780|11211987|FG001|Base Study: 96 Weeks|Death|1
7092826|NCT02275780|11211986|FG000|Base Study: 96 Weeks|Lack of Efficacy|21
7092827|NCT02275780|11211987|FG001|Base Study: 96 Weeks|Lack of Efficacy|32
7092828|NCT02275780|11211986|FG000|Base Study: 96 Weeks|Lost to Follow-up|28
7092829|NCT02275780|11211987|FG001|Base Study: 96 Weeks|Lost to Follow-up|24
7092830|NCT02275780|11211986|FG000|Base Study: 96 Weeks|Protocol Violation|1
7092831|NCT02275780|11211987|FG001|Base Study: 96 Weeks|Protocol Violation|6
7092832|NCT02275780|11211986|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19
7092833|NCT02275780|11211987|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22
7092834|NCT02275780|11211986|FG000|Base Study: 96 Weeks|Noncompliance with drug|9
7092835|NCT02275780|11211987|FG001|Base Study: 96 Weeks|Noncompliance with drug|6
7092836|NCT02275780|11211986|FG000|Base Study: 96 Weeks|Physician Decision|2
7092837|NCT02275780|11211987|FG001|Base Study: 96 Weeks|Physician Decision|4
7092838|NCT02275780|11211986|FG000|Base Study: 96 Weeks|Pregnancy|2
7092839|NCT02275780|11211987|FG001|Base Study: 96 Weeks|Pregnancy|1
7092840|NCT02275780|11211986|FG000|Base Study: 96 Weeks|Randomized not treated|2
7092841|NCT02275780|11211987|FG001|Base Study: 96 Weeks|Randomized not treated|1
7092842|NCT02275780|11211986|FG000|Extension Study: up to 192 Weeks|Ongoing|260
7092843|NCT02275780|11211987|FG001|Extension Study: up to 192 Weeks|Ongoing|233
7092844|NCT02275819|11211995|FG000|Overall Study|Adverse Event|0
7092845|NCT02275819|11211996|FG001|Overall Study|Adverse Event|1
7092846|NCT02276027|11212010|FG000|Overall Study|Death|1
7092847|NCT02276027|11212011|FG001|Overall Study|Death|0
7092848|NCT02276027|11212012|FG002|Overall Study|Death|0
7092849|NCT02276027|11212013|FG003|Overall Study|Death|2
7092850|NCT02276027|11212010|FG000|Overall Study|Physician Decision|0
7092851|NCT02276027|11212011|FG001|Overall Study|Physician Decision|0
7092852|NCT02276027|11212012|FG002|Overall Study|Physician Decision|0
7092853|NCT02276027|11212013|FG003|Overall Study|Physician Decision|1
7092854|NCT02276027|11212010|FG000|Overall Study|Progressive disease|1
7092855|NCT02276027|11212011|FG001|Overall Study|Progressive disease|13
7092856|NCT02276027|11212012|FG002|Overall Study|Progressive disease|12
7092857|NCT02276027|11212013|FG003|Overall Study|Progressive disease|14
7092858|NCT02276027|11212010|FG000|Overall Study|Subject/guardian decision|0
7092859|NCT02276027|11212011|FG001|Overall Study|Subject/guardian decision|1
7092860|NCT02276027|11212012|FG002|Overall Study|Subject/guardian decision|0
7092861|NCT02276027|11212013|FG003|Overall Study|Subject/guardian decision|3
7092862|NCT02276027|11212010|FG000|Overall Study|Adverse Event|0
7092863|NCT02276027|11212011|FG001|Overall Study|Adverse Event|2
7092864|NCT02276027|11212012|FG002|Overall Study|Adverse Event|8
7092865|NCT02276027|11212013|FG003|Overall Study|Adverse Event|2
7092866|NCT02276040|11212023|FG000|Overall Study|Physician Decision|15
7092867|NCT02276053|11212027|FG000|Overall Study|Death|2
7092868|NCT02276053|11212027|FG000|Overall Study|Adverse Event|5
7092869|NCT02276053|11212027|FG000|Overall Study|Lack of Efficacy|2
7092870|NCT02276053|11212027|FG000|Overall Study|Withdrawal by Subject|1
7092871|NCT02276053|11212027|FG000|Overall Study|Patient does not meet selection criteria|3
7092872|NCT02276053|11212027|FG000|Overall Study|Patient needs to increase baseline AED|1
7092873|NCT02276222|11212034|FG000|Overall Study|Adverse Event|62
7092874|NCT02276222|11212035|FG001|Overall Study|Adverse Event|11
7092875|NCT02276222|11212034|FG000|Overall Study|Death|3
7092876|NCT02276222|11212035|FG001|Overall Study|Death|4
7092877|NCT02276222|11212034|FG000|Overall Study|Lack of Efficacy|13
7092878|NCT02276222|11212035|FG001|Overall Study|Lack of Efficacy|3
7092879|NCT02276222|11212034|FG000|Overall Study|Protocol Violation|3
7092880|NCT02276222|11212035|FG001|Overall Study|Protocol Violation|2
7092881|NCT02276222|11212034|FG000|Overall Study|Withdrawal by Subject|79
7092882|NCT02276222|11212035|FG001|Overall Study|Withdrawal by Subject|33
7092883|NCT02276222|11212034|FG000|Overall Study|non compliance with study medication|6
7092884|NCT02276222|11212035|FG001|Overall Study|non compliance with study medication|2
7092885|NCT02276222|11212034|FG000|Overall Study|sponsor decision|0
7092886|NCT02276222|11212035|FG001|Overall Study|sponsor decision|3
7092887|NCT02276222|11212034|FG000|Overall Study|Lost to Follow-up|15
7092888|NCT02276222|11212035|FG001|Overall Study|Lost to Follow-up|5
7092889|NCT02276222|11212034|FG000|Overall Study|Physician Decision|2
7092890|NCT02276222|11212035|FG001|Overall Study|Physician Decision|1
7092891|NCT02276222|11212034|FG000|Overall Study|sheduling conflict|1
7092892|NCT02276222|11212035|FG001|Overall Study|sheduling conflict|0
7092893|NCT02276222|11212034|FG000|Overall Study|subject withdrew after randomization|1
7092894|NCT02276222|11212035|FG001|Overall Study|subject withdrew after randomization|0
7092895|NCT02276482|11212052|FG000|Overall Study|Adverse Event|1
7092896|NCT02276482|11212053|FG001|Overall Study|Adverse Event|0
7092897|NCT02276482|11212052|FG000|Overall Study|Withdrawal by Subject|1
7092898|NCT02276482|11212053|FG001|Overall Study|Withdrawal by Subject|0
7092899|NCT02276482|11212052|FG000|Overall Study|Gram-negative infection|1
7092900|NCT02276482|11212053|FG001|Overall Study|Gram-negative infection|0
7092901|NCT02276482|11212052|FG000|Overall Study|Reason not specified|0
7092902|NCT02276482|11212053|FG001|Overall Study|Reason not specified|1
7092903|NCT02276612|11212061|FG000|Overall Study|Death|1
7092904|NCT02276612|11212062|FG001|Overall Study|Death|0
7092905|NCT02276612|11212061|FG000|Overall Study|Pregnancy|1
7092906|NCT02276612|11212062|FG001|Overall Study|Pregnancy|0
7092907|NCT02276612|11212061|FG000|Overall Study|Withdrew Consent|1
7092908|NCT02276612|11212062|FG001|Overall Study|Withdrew Consent|0
7092909|NCT02276612|11212061|FG000|Overall Study|Lost to Follow-up|1
7092910|NCT02276612|11212062|FG001|Overall Study|Lost to Follow-up|0
7092911|NCT02276807|11212083|FG000|Overall Study|Withdrawal by Subject|8
7092912|NCT02276807|11212084|FG001|Overall Study|Withdrawal by Subject|7
7092913|NCT02276807|11212083|FG000|Overall Study|Lost to Follow-up|10
7092914|NCT02276807|11212084|FG001|Overall Study|Lost to Follow-up|10
7092915|NCT02276872|11212093|FG000|Overall Study|Adverse Event|1
7092916|NCT02276872|11212094|FG001|Overall Study|Adverse Event|0
7092917|NCT02276872|11212095|FG002|Overall Study|Adverse Event|0
7092918|NCT02277691|11212171|FG000|Overall Study|Pretreatment Event/Adverse Event|33
7092919|NCT02277691|11212171|FG000|Overall Study|Voluntary Withdrawal|7
7092920|NCT02277691|11212171|FG000|Overall Study|Lack of Efficacy|5
7092921|NCT02277691|11212171|FG000|Overall Study|Used Other Antihypertensive Drug|1
7092922|NCT02277743|11212178|FG000|Overall Study|Protocol Violation|1
7092923|NCT02277743|11212179|FG001|Overall Study|Protocol Violation|1
7092924|NCT02277743|11212180|FG002|Overall Study|Protocol Violation|1
7092925|NCT02277743|11212178|FG000|Overall Study|Adverse Event|10
7092926|NCT02277743|11212179|FG001|Overall Study|Adverse Event|6
7092927|NCT02277743|11212180|FG002|Overall Study|Adverse Event|6
7092928|NCT02277743|11212178|FG000|Overall Study|Lack of Efficacy|11
7092929|NCT02277743|11212179|FG001|Overall Study|Lack of Efficacy|4
7092930|NCT02277743|11212180|FG002|Overall Study|Lack of Efficacy|3
7092931|NCT02277743|11212178|FG000|Overall Study|Other than specified above|18
7092932|NCT02277743|11212179|FG001|Overall Study|Other than specified above|5
7092933|NCT02277743|11212180|FG002|Overall Study|Other than specified above|16
7092934|NCT02277769|11212191|FG000|Overall Study|Protocol Violation|3
7092935|NCT02277769|11212192|FG001|Overall Study|Protocol Violation|3
7092936|NCT02277769|11212193|FG002|Overall Study|Protocol Violation|5
7092937|NCT02277769|11212191|FG000|Overall Study|Lack of Efficacy|17
7092938|NCT02277769|11212192|FG001|Overall Study|Lack of Efficacy|0
7092939|NCT02277769|11212193|FG002|Overall Study|Lack of Efficacy|4
7092940|NCT02277769|11212191|FG000|Overall Study|Adverse Event|14
7092941|NCT02277769|11212192|FG001|Overall Study|Adverse Event|2
7092942|NCT02277769|11212193|FG002|Overall Study|Adverse Event|4
7092943|NCT02277769|11212191|FG000|Overall Study|Other than specified above|12
7092944|NCT02277769|11212192|FG001|Overall Study|Other than specified above|8
7092945|NCT02277769|11212193|FG002|Overall Study|Other than specified above|5
7092946|NCT02277990|11212214|FG000|Overall Study|Death|170
7092947|NCT02277990|11212215|FG001|Overall Study|Death|188
7092948|NCT02277990|11212214|FG000|Overall Study|Withdrawal by Subject|64
7092949|NCT02277990|11212215|FG001|Overall Study|Withdrawal by Subject|53
7092950|NCT02277990|11212214|FG000|Overall Study|Physician Decision|40
7092951|NCT02277990|11212215|FG001|Overall Study|Physician Decision|34
7092952|NCT02277990|11212214|FG000|Overall Study|Lost to Follow-up|66
7092953|NCT02277990|11212215|FG001|Overall Study|Lost to Follow-up|69
7092954|NCT02277990|11212214|FG000|Overall Study|Had other reason|26
7092955|NCT02277990|11212215|FG001|Overall Study|Had other reason|32
7092956|NCT02278003|11212223|FG000|Overall Study|Withdrawal by Subject|11
7092957|NCT02278003|11212224|FG001|Overall Study|Withdrawal by Subject|0
7092958|NCT02278003|11212223|FG000|Overall Study|Not Treated|1
7092959|NCT02278003|11212224|FG001|Overall Study|Not Treated|0
7092960|NCT02278003|11212223|FG000|Overall Study|Recognition task improperly completed|7
7092961|NCT02278003|11212224|FG001|Overall Study|Recognition task improperly completed|0
7092962|NCT02278263|11212246|FG000|Overall Study|Protocol Violation|7
7092963|NCT02278263|11212247|FG001|Overall Study|Protocol Violation|0
7092964|NCT02278263|11212248|FG002|Overall Study|Protocol Violation|9
7092965|NCT02278328|11212268|FG000|Neuropsych Screening|found ineligible on neuropsych|1
7092966|NCT02278328|11212269|FG001|Neuropsych Screening|found ineligible on neuropsych|0
7092967|NCT02278328|11212270|FG002|Neuropsych Screening|found ineligible on neuropsych|0
7092968|NCT02278328|11212268|FG000|Neuropsych Screening|Withdrawal by Subject|0
7092969|NCT02278328|11212269|FG001|Neuropsych Screening|Withdrawal by Subject|1
7092970|NCT02278328|11212270|FG002|Neuropsych Screening|Withdrawal by Subject|0
7092971|NCT02278328|11212268|FG000|Neuropsych Screening|incomplete consent|0
7092972|NCT02278328|11212269|FG001|Neuropsych Screening|incomplete consent|0
7092973|NCT02278328|11212270|FG002|Neuropsych Screening|incomplete consent|2
7092974|NCT02278341|11212278|FG000|Overall Study|Randomized but never received study drug|1
7092975|NCT02278341|11212279|FG001|Overall Study|Randomized but never received study drug|1
7092976|NCT02278341|11212278|FG000|Overall Study|Adverse Event|3
7092977|NCT02278341|11212279|FG001|Overall Study|Adverse Event|0
7092978|NCT02278341|11212278|FG000|Overall Study|Death|68
7092979|NCT02278341|11212279|FG001|Overall Study|Death|56
7092980|NCT02278341|11212278|FG000|Overall Study|Withdrawal by Subject|30
7092981|NCT02278341|11212279|FG001|Overall Study|Withdrawal by Subject|19
7092982|NCT02278341|11212278|FG000|Overall Study|Lost to Follow-up|0
7092983|NCT02278341|11212279|FG001|Overall Study|Lost to Follow-up|1
7092984|NCT02278341|11212278|FG000|Overall Study|Physician Decision|1
7092985|NCT02278341|11212279|FG001|Overall Study|Physician Decision|1
7092986|NCT02278341|11212278|FG000|Overall Study|Miscellaneous|15
7092987|NCT02278341|11212279|FG001|Overall Study|Miscellaneous|14
7092988|NCT02278354|11212288|FG000|Overall Study|Lost to Follow-up|2
7092989|NCT02278354|11212289|FG001|Overall Study|Lost to Follow-up|2
7092990|NCT02278354|11212288|FG000|Overall Study|Withdrawal by Subject|0
7092991|NCT02278354|11212289|FG001|Overall Study|Withdrawal by Subject|1
7092992|NCT02278354|11212288|FG000|Overall Study|<10 professional fights|2
7092993|NCT02278354|11212289|FG001|Overall Study|<10 professional fights|0
7092994|NCT02278367|11212299|FG000|Overall Study|Physician Decision|5
7092995|NCT02278367|11212300|FG001|Overall Study|Physician Decision|0
7092996|NCT02278367|11212299|FG000|Overall Study|Withdrawal by Subject|5
7092997|NCT02278367|11212300|FG001|Overall Study|Withdrawal by Subject|0
7092998|NCT02278471|11212308|FG000|Overall Study|Lost to Follow-up|6
7092999|NCT02278471|11212309|FG001|Overall Study|Lost to Follow-up|15
7093000|NCT02278471|11212308|FG000|Overall Study|Death|2
7093001|NCT02278471|11212309|FG001|Overall Study|Death|2
7093002|NCT02278471|11212308|FG000|Overall Study|Withdrawal by Subject|0
7093003|NCT02278471|11212309|FG001|Overall Study|Withdrawal by Subject|3
7093004|NCT02278614|11212336|FG000|Overall Study|Withdrawal by Subject|3
7093005|NCT02278614|11212337|FG001|Overall Study|Withdrawal by Subject|5
7093006|NCT02278614|11212336|FG000|Overall Study|Adverse Event|1
7093007|NCT02278614|11212337|FG001|Overall Study|Adverse Event|0
7093008|NCT02278614|11212336|FG000|Overall Study|left eye was not eligible|1
7093009|NCT02278614|11212337|FG001|Overall Study|left eye was not eligible|0
7093010|NCT02278939|11212353|FG000|Overall Study|lack of time|1
7093011|NCT02278939|11212354|FG001|Overall Study|lack of time|0
7093012|NCT02278939|11212353|FG000|Overall Study|Lost to Follow-up|1
7093013|NCT02278939|11212354|FG001|Overall Study|Lost to Follow-up|1
7093014|NCT02278939|11212353|FG000|Overall Study|death in family|1
7093015|NCT02278939|11212354|FG001|Overall Study|death in family|0
7093016|NCT02278939|11212353|FG000|Overall Study|family emergency unable to commit|2
7093017|NCT02278939|11212354|FG001|Overall Study|family emergency unable to commit|0
7093018|NCT02278952|11212360|FG000|Overall Study|Insufficient Sample|6
7093019|NCT02279043|11212373|FG000|Overall Study|Post-rand. exclusion - not eligible|1
7093020|NCT02279043|11212374|FG001|Overall Study|Post-rand. exclusion - not eligible|1
7093021|NCT02279043|11212375|FG002|Overall Study|Post-rand. exclusion - not eligible|0
7093022|NCT02279043|11212373|FG000|Overall Study|Lost to Follow-up|46
7093023|NCT02279043|11212374|FG001|Overall Study|Lost to Follow-up|88
7093024|NCT02279043|11212375|FG002|Overall Study|Lost to Follow-up|0
7093025|NCT02279407|11212407|FG000|Overall Study|Couldn't swallow IP; noncompliance|0
7093026|NCT02279407|11212408|FG001|Overall Study|Couldn't swallow IP; noncompliance|0
7093027|NCT02279407|11212409|FG002|Overall Study|Couldn't swallow IP; noncompliance|2
7093028|NCT02279407|11212410|FG003|Overall Study|Couldn't swallow IP; noncompliance|0
7093029|NCT02279407|11212407|FG000|Overall Study|Withdrawal by Subject|1
7093030|NCT02279407|11212408|FG001|Overall Study|Withdrawal by Subject|0
7093031|NCT02279407|11212409|FG002|Overall Study|Withdrawal by Subject|1
7093032|NCT02279407|11212410|FG003|Overall Study|Withdrawal by Subject|1
7093033|NCT02279407|11212407|FG000|Overall Study|Adverse Event|1
7093034|NCT02279407|11212408|FG001|Overall Study|Adverse Event|1
7093035|NCT02279407|11212409|FG002|Overall Study|Adverse Event|2
7093036|NCT02279407|11212410|FG003|Overall Study|Adverse Event|0
7093037|NCT02279420|11212420|FG000|Overall Study|Lost to Follow-up|23
7093038|NCT02279498|11212426|FG000|Overall Study|Adverse Event|3
7093039|NCT02279498|11212427|FG001|Overall Study|Adverse Event|0
7093040|NCT02279498|11212426|FG000|Overall Study|Lack of Efficacy|4
7093041|NCT02279498|11212427|FG001|Overall Study|Lack of Efficacy|0
7093042|NCT02279498|11212426|FG000|Overall Study|Lost to Follow-up|0
7093043|NCT02279498|11212427|FG001|Overall Study|Lost to Follow-up|1
7093044|NCT02279498|11212426|FG000|Overall Study|Withdrawal by Subject|9
7093045|NCT02279498|11212427|FG001|Overall Study|Withdrawal by Subject|2
7093046|NCT02279498|11212426|FG000|Overall Study|Undefined|2
7093047|NCT02279498|11212427|FG001|Overall Study|Undefined|1
7093048|NCT02279524|11212437|FG000|Overall Study|Withdrawal by Subject|3
7093049|NCT02279524|11212438|FG001|Overall Study|Withdrawal by Subject|6
7093050|NCT02279524|11212439|FG002|Overall Study|Withdrawal by Subject|3
7093051|NCT02279524|11212437|FG000|Overall Study|Adverse Event|4
7093052|NCT02279524|11212438|FG001|Overall Study|Adverse Event|3
7093053|NCT02279524|11212439|FG002|Overall Study|Adverse Event|2
7093054|NCT02279524|11212437|FG000|Overall Study|Lost to Follow-up|1
7093055|NCT02279524|11212438|FG001|Overall Study|Lost to Follow-up|1
7093056|NCT02279524|11212439|FG002|Overall Study|Lost to Follow-up|0
7093057|NCT02279524|11212437|FG000|Overall Study|Disallowed medication|1
7093058|NCT02279524|11212438|FG001|Overall Study|Disallowed medication|1
7093059|NCT02279524|11212439|FG002|Overall Study|Disallowed medication|2
7093060|NCT02279524|11212437|FG000|Overall Study|Bariatric surgery|1
7093061|NCT02279524|11212438|FG001|Overall Study|Bariatric surgery|0
7093062|NCT02279524|11212439|FG002|Overall Study|Bariatric surgery|0
7093063|NCT02279732|11212482|FG000|Overall Study|Death|23
7093064|NCT02279732|11212483|FG001|Overall Study|Death|20
7093065|NCT02279732|11212482|FG000|Overall Study|Disease Progression|13
7093066|NCT02279732|11212483|FG001|Overall Study|Disease Progression|3
7093067|NCT02279732|11212482|FG000|Overall Study|Withdrawal by Subject|2
7093068|NCT02279732|11212483|FG001|Overall Study|Withdrawal by Subject|7
7093069|NCT02279732|11212482|FG000|Overall Study|Adverse Event|1
7093070|NCT02279732|11212483|FG001|Overall Study|Adverse Event|2
7093071|NCT02279732|11212482|FG000|Overall Study|Administrative Reason By Sponsor|0
7093072|NCT02279732|11212483|FG001|Overall Study|Administrative Reason By Sponsor|2
7093073|NCT02279732|11212482|FG000|Overall Study|Study Drug Toxicity|2
7093074|NCT02279732|11212483|FG001|Overall Study|Study Drug Toxicity|0
7093075|NCT02279732|11212482|FG000|Overall Study|Lost to Follow-up|0
7093076|NCT02279732|11212483|FG001|Overall Study|Lost to Follow-up|1
7093077|NCT02279732|11212482|FG000|Overall Study|Maximum Clinical Benefit|1
7093078|NCT02279732|11212483|FG001|Overall Study|Maximum Clinical Benefit|0
7093079|NCT02279732|11212482|FG000|Overall Study|Subject Requested to Discontinue|0
7093080|NCT02279732|11212483|FG001|Overall Study|Subject Requested to Discontinue|1
7093081|NCT02279732|11212482|FG000|Overall Study|Other|53
7093082|NCT02279732|11212483|FG001|Overall Study|Other|67
7093083|NCT02279732|11212482|FG000|Overall Study|Other|3
7093084|NCT02279732|11212483|FG001|Overall Study|Other|3
7093085|NCT02279862|11212491|FG000|Overall Study|Study drug toxicity|3
7093086|NCT02279862|11212492|FG001|Overall Study|Study drug toxicity|6
7093087|NCT02279862|11212491|FG000|Overall Study|No longer meets criteria|0
7093088|NCT02279862|11212492|FG001|Overall Study|No longer meets criteria|1
7093089|NCT02279862|11212491|FG000|Overall Study|Administrative reason by sponsor|0
7093090|NCT02279862|11212492|FG001|Overall Study|Administrative reason by sponsor|1
7093091|NCT02279862|11212491|FG000|Overall Study|Disease progression|5
7093092|NCT02279862|11212492|FG001|Overall Study|Disease progression|2
7093093|NCT02279862|11212491|FG000|Overall Study|Study closed by sponsor|16
7093094|NCT02279862|11212492|FG001|Overall Study|Study closed by sponsor|13
7093095|NCT02279862|11212491|FG000|Overall Study|Other|1
7093096|NCT02279862|11212492|FG001|Overall Study|Other|2
7093097|NCT02279862|11212491|FG000|Overall Study|Withdrawal by Subject|1
7093098|NCT02279862|11212492|FG001|Overall Study|Withdrawal by Subject|0
7093099|NCT02280044|11212500|FG000|Overall Study|Planned alternate|0
7093100|NCT02280044|11212501|FG001|Overall Study|Planned alternate|2
7093101|NCT02280096|11212509|FG000|Overall Study|Pregnancy|1
7093102|NCT02280096|11212510|FG001|Overall Study|Pregnancy|0
7093103|NCT02280096|11212509|FG000|Overall Study|Functional neurological disorder|1
7093104|NCT02280096|11212510|FG001|Overall Study|Functional neurological disorder|0
7093105|NCT02280096|11212509|FG000|Overall Study|Lack of attachment|0
7093106|NCT02280096|11212510|FG001|Overall Study|Lack of attachment|1
7093107|NCT02280187|11212535|FG000|Overall Study|Lost to Follow-up|218
7093108|NCT02280291|11212556|FG000|Overall Study|Lost to Follow-up|2
7093109|NCT02280291|11212557|FG001|Overall Study|Lost to Follow-up|1
7093110|NCT02280291|11212558|FG002|Overall Study|Lost to Follow-up|3
7093111|NCT02280291|11212559|FG003|Overall Study|Lost to Follow-up|8
7093112|NCT02280291|11212556|FG000|Overall Study|Protocol Violation|1
7093113|NCT02280291|11212557|FG001|Overall Study|Protocol Violation|0
7093114|NCT02280291|11212558|FG002|Overall Study|Protocol Violation|0
7093115|NCT02280291|11212559|FG003|Overall Study|Protocol Violation|0
7093116|NCT02280291|11212556|FG000|Overall Study|Other|1
7093117|NCT02280291|11212557|FG001|Overall Study|Other|1
7093118|NCT02280291|11212558|FG002|Overall Study|Other|0
7093119|NCT02280291|11212559|FG003|Overall Study|Other|0
7093120|NCT02280304|11212573|FG000|Overall Study|Lost to Follow-up|7
7093121|NCT02280304|11212574|FG001|Overall Study|Lost to Follow-up|8
7093122|NCT02280408|11212623|FG000|Overall Study|Lost to Follow-up|0
7093123|NCT02280408|11212624|FG001|Overall Study|Lost to Follow-up|2
7093124|NCT02280408|11212625|FG002|Overall Study|Lost to Follow-up|0
7093125|NCT02280408|11212626|FG003|Overall Study|Lost to Follow-up|0
7093126|NCT02280421|11212638|FG000|Washout (2 Weeks)|Adverse Event|0
7093127|NCT02280421|11212639|FG001|Washout (2 Weeks)|Adverse Event|1
7093128|NCT02280421|11212638|FG000|Washout (2 Weeks)|Withdrawal by Subject|1
7093129|NCT02280421|11212639|FG001|Washout (2 Weeks)|Withdrawal by Subject|0
7093130|NCT02280473|11212659|FG000|Overall Study|Adverse Event|1
7093131|NCT02280473|11212660|FG001|Overall Study|Adverse Event|1
7093132|NCT02280473|11212659|FG000|Overall Study|Lack of Efficacy|0
7093133|NCT02280473|11212660|FG001|Overall Study|Lack of Efficacy|1
7093134|NCT02280473|11212659|FG000|Overall Study|Lost to Follow-up|0
7093135|NCT02280473|11212660|FG001|Overall Study|Lost to Follow-up|1
7093136|NCT02280499|11212666|FG000|Overall Study|Death|14
7093137|NCT02280499|11212666|FG000|Overall Study|Lost to Follow-up|42
7093138|NCT02280499|11212666|FG000|Overall Study|Adverse Event|5
7093139|NCT02280863|11212704|FG000|Integrated Platform|Met stopping criteria|0
7093140|NCT02280863|11212705|FG001|Integrated Platform|Met stopping criteria|1
7093141|NCT02281318|11212721|FG000|Overall Study|Adverse Event|2
7093142|NCT02281318|11212722|FG001|Overall Study|Adverse Event|2
7093143|NCT02281318|11212721|FG000|Overall Study|Lack of Efficacy|2
7093144|NCT02281318|11212722|FG001|Overall Study|Lack of Efficacy|0
7093145|NCT02281318|11212721|FG000|Overall Study|Lost to Follow-up|2
7093146|NCT02281318|11212722|FG001|Overall Study|Lost to Follow-up|1
7093147|NCT02281318|11212721|FG000|Overall Study|Physician Decision|2
7093148|NCT02281318|11212722|FG001|Overall Study|Physician Decision|0
7093149|NCT02281318|11212721|FG000|Overall Study|Withdrawal by Subject|6
7093150|NCT02281318|11212722|FG001|Overall Study|Withdrawal by Subject|2
7093151|NCT02281357|11212734|FG000|Overall Study|Adverse Event|2
7093152|NCT02281357|11212735|FG001|Overall Study|Adverse Event|1
7093153|NCT02281357|11212734|FG000|Overall Study|Lost to Follow-up|1
7093154|NCT02281357|11212735|FG001|Overall Study|Lost to Follow-up|0
7093155|NCT02281357|11212734|FG000|Overall Study|Withdrawal by Subject|4
7093156|NCT02281357|11212735|FG001|Overall Study|Withdrawal by Subject|3
7093157|NCT02281552|11212800|FG000|Overall Study|Medication error|1
7093158|NCT02281552|11212801|FG001|Overall Study|Medication error|0
7093159|NCT02281552|11212800|FG000|Overall Study|Insufficient clinical response|0
7093160|NCT02281552|11212801|FG001|Overall Study|Insufficient clinical response|1
7093161|NCT02281552|11212800|FG000|Overall Study|Adverse Event|3
7093162|NCT02281552|11212801|FG001|Overall Study|Adverse Event|9
7093163|NCT02281760|11212824|FG000|Overall Study|Withdrawal by Subject|1
7093164|NCT02281773|11212833|FG000|Overall Study|Adverse Event|6
7093165|NCT02281773|11212834|FG001|Overall Study|Adverse Event|1
7093166|NCT02281773|11212835|FG002|Overall Study|Adverse Event|4
7093167|NCT02281773|11212836|FG003|Overall Study|Adverse Event|8
7093168|NCT02281773|11212837|FG004|Overall Study|Adverse Event|9
7093169|NCT02281773|11212833|FG000|Overall Study|Protocol Violation|1
7093170|NCT02281773|11212834|FG001|Overall Study|Protocol Violation|0
7093171|NCT02281773|11212835|FG002|Overall Study|Protocol Violation|0
7093172|NCT02281773|11212836|FG003|Overall Study|Protocol Violation|2
7093173|NCT02281773|11212837|FG004|Overall Study|Protocol Violation|2
7093174|NCT02281773|11212833|FG000|Overall Study|Lost to Follow-up|2
7093175|NCT02281773|11212834|FG001|Overall Study|Lost to Follow-up|2
7093176|NCT02281773|11212835|FG002|Overall Study|Lost to Follow-up|6
7093177|NCT02281773|11212836|FG003|Overall Study|Lost to Follow-up|2
7093178|NCT02281773|11212837|FG004|Overall Study|Lost to Follow-up|10
7093179|NCT02281773|11212833|FG000|Overall Study|Withdrawal by Subject|2
7093180|NCT02281773|11212834|FG001|Overall Study|Withdrawal by Subject|8
7093181|NCT02281773|11212835|FG002|Overall Study|Withdrawal by Subject|6
7093182|NCT02281773|11212836|FG003|Overall Study|Withdrawal by Subject|6
7093183|NCT02281773|11212837|FG004|Overall Study|Withdrawal by Subject|8
7093184|NCT02281773|11212833|FG000|Overall Study|Other Reason|0
7093185|NCT02281773|11212834|FG001|Overall Study|Other Reason|4
7093186|NCT02281773|11212835|FG002|Overall Study|Other Reason|2
7093187|NCT02281773|11212836|FG003|Overall Study|Other Reason|3
7093188|NCT02281773|11212837|FG004|Overall Study|Other Reason|1
7093189|NCT02282163|11212867|FG000|Overall Study|Protocol Violation|1
7093190|NCT02282293|11212882|FG000|Overall Study|Lost to Follow-up|2
7093191|NCT02282293|11212883|FG001|Overall Study|Lost to Follow-up|2
7093192|NCT02282293|11212882|FG000|Overall Study|Unable to comply with study procedures|1
7093193|NCT02282293|11212883|FG001|Overall Study|Unable to comply with study procedures|0
7093194|NCT02282293|11212882|FG000|Overall Study|Moved out of study area|0
7093195|NCT02282293|11212883|FG001|Overall Study|Moved out of study area|1
7093196|NCT02282527|11212895|FG000|Overall Study|Lost to Follow-up|0
7093197|NCT02282527|11212896|FG001|Overall Study|Lost to Follow-up|1
7093198|NCT02282527|11212895|FG000|Overall Study|Lack of home health aid|1
7093199|NCT02282527|11212896|FG001|Overall Study|Lack of home health aid|0
7093200|NCT02282605|11212908|FG000|Overall Study|negative SA result on Day -1|3
7093201|NCT02282605|11212909|FG001|Overall Study|negative SA result on Day -1|0
7093202|NCT02282605|11212910|FG002|Overall Study|negative SA result on Day -1|0
7093203|NCT02282631|11212920|FG000|Overall Study|Lost to Follow-up|2
7093204|NCT02282631|11212921|FG001|Overall Study|Lost to Follow-up|0
7093205|NCT02282813|11212945|FG000|Overall Study|Withdrawal by Subject|4
7093206|NCT02282813|11212946|FG001|Overall Study|Withdrawal by Subject|5
7093207|NCT02282813|11212947|FG002|Overall Study|Withdrawal by Subject|0
7093208|NCT02282813|11212945|FG000|Overall Study|Adverse Event|3
7093209|NCT02282813|11212946|FG001|Overall Study|Adverse Event|10
7093210|NCT02282813|11212947|FG002|Overall Study|Adverse Event|1
7093211|NCT02282813|11212945|FG000|Overall Study|Subject non-compliance|1
7093212|NCT02282813|11212946|FG001|Overall Study|Subject non-compliance|4
7093213|NCT02282813|11212947|FG002|Overall Study|Subject non-compliance|0
7093214|NCT02282813|11212945|FG000|Overall Study|Physician Decision|0
7093215|NCT02282813|11212946|FG001|Overall Study|Physician Decision|3
7093216|NCT02282813|11212947|FG002|Overall Study|Physician Decision|1
7093217|NCT02282813|11212945|FG000|Overall Study|Lost to Follow-up|2
7093218|NCT02282813|11212946|FG001|Overall Study|Lost to Follow-up|0
7093219|NCT02282813|11212947|FG002|Overall Study|Lost to Follow-up|1
7093220|NCT02282813|11212945|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1
7093221|NCT02282813|11212946|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0
7093222|NCT02282813|11212947|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0
7093223|NCT02282813|11212945|FG000|Overall Study|Lack of Efficacy|1
7093224|NCT02282813|11212946|FG001|Overall Study|Lack of Efficacy|0
7093225|NCT02282813|11212947|FG002|Overall Study|Lack of Efficacy|0
7093226|NCT02282813|11212945|FG000|Overall Study|Administrative reasons|0
7093227|NCT02282813|11212946|FG001|Overall Study|Administrative reasons|1
7093228|NCT02282813|11212947|FG002|Overall Study|Administrative reasons|0
7093229|NCT02282982|11212965|FG000|Overall Study|Lost to Follow-up|15
7093230|NCT02282982|11212965|FG000|Overall Study|Withdrew consent|2
7093231|NCT02282982|11212965|FG000|Overall Study|Death|4
7093232|NCT02282982|11212965|FG000|Overall Study|Lack of product|156
7093233|NCT02282982|11212965|FG000|Overall Study|Palivizumab is ended|11
7093234|NCT02282982|11212965|FG000|Overall Study|Other, not specified|18
7093235|NCT02283268|11212969|FG000|Overall Study|Withdrawal by Subject|1
7093236|NCT02283294|11212983|FG000|Overall Study|Lost to Follow-up|1
7093237|NCT02283294|11212984|FG001|Overall Study|Lost to Follow-up|1
7093238|NCT02283294|11212983|FG000|Overall Study|Withdrawal by Subject|1
7093239|NCT02283294|11212984|FG001|Overall Study|Withdrawal by Subject|6
7093240|NCT02283294|11212983|FG000|Overall Study|Protocol Violation|1
7093241|NCT02283294|11212984|FG001|Overall Study|Protocol Violation|0
7093242|NCT02283294|11212983|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0
7093243|NCT02283294|11212984|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1
7093244|NCT02283411|11213000|FG000|Overall Study|Withdrawal by Subject|3
7093245|NCT02283411|11213000|FG000|Overall Study|Screen Failed|28
7093246|NCT02283658|11213013|FG000|Overall Study|Withdrawal by Subject|1
7093247|NCT02283762|11213023|FG000|Main Treatment Phase (MT)|Adverse Event|9
7093248|NCT02283762|11213024|FG001|Main Treatment Phase (MT)|Adverse Event|9
7093249|NCT02283762|11213023|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1
7093250|NCT02283762|11213024|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0
7093251|NCT02283762|11213023|FG000|Main Treatment Phase (MT)|Physician Decision|1
7093252|NCT02283762|11213024|FG001|Main Treatment Phase (MT)|Physician Decision|1
7093253|NCT02283762|11213023|FG000|Main Treatment Phase (MT)|Pregnancy|0
7093254|NCT02283762|11213024|FG001|Main Treatment Phase (MT)|Pregnancy|1
7093255|NCT02283762|11213023|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7
7093256|NCT02283762|11213024|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4
7093257|NCT02283762|11213023|FG000|Long-term Extension Phase (LTE)|Adverse Event|2
7093258|NCT02283762|11213024|FG001|Long-term Extension Phase (LTE)|Adverse Event|6
7093259|NCT02283762|11213023|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1
7093260|NCT02283762|11213024|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1
7093261|NCT02283762|11213023|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1
7093262|NCT02283762|11213024|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0
7093263|NCT02283762|11213023|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4
7093264|NCT02283762|11213024|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3
7093265|NCT02283762|11213023|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1
7093266|NCT02283762|11213024|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1
7093267|NCT02283762|11213023|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0
7093268|NCT02283762|11213024|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1
7093269|NCT02283762|11213023|FG000|Long-term Extension Phase (LTE)|Physician Decision|1
7093270|NCT02283762|11213024|FG001|Long-term Extension Phase (LTE)|Physician Decision|2
7093271|NCT02283788|11213036|FG000|Overall Study|Adverse Event|1
7093272|NCT02283788|11213037|FG001|Overall Study|Adverse Event|3
7093273|NCT02283788|11213038|FG002|Overall Study|Adverse Event|5
7093274|NCT02283788|11213039|FG003|Overall Study|Adverse Event|1
7093275|NCT02283788|11213036|FG000|Overall Study|Withdrawal by Subject|0
7093276|NCT02283788|11213037|FG001|Overall Study|Withdrawal by Subject|1
7093277|NCT02283788|11213038|FG002|Overall Study|Withdrawal by Subject|0
7093278|NCT02283788|11213039|FG003|Overall Study|Withdrawal by Subject|1
7093279|NCT02284009|11213091|FG000|Overall Study|Adverse Event|3
7093280|NCT02284009|11213092|FG001|Overall Study|Adverse Event|0
7093281|NCT02284009|11213091|FG000|Overall Study|Lost to Follow-up|1
7093282|NCT02284009|11213092|FG001|Overall Study|Lost to Follow-up|3
7093283|NCT02284009|11213091|FG000|Overall Study|Physician Decision|0
7093284|NCT02284009|11213092|FG001|Overall Study|Physician Decision|2
7093285|NCT02284009|11213091|FG000|Overall Study|Withdrawal by Subject|2
7093286|NCT02284009|11213092|FG001|Overall Study|Withdrawal by Subject|5
7093287|NCT02284178|11213122|FG000|Overall Study|Met exclusion criteria|49
7093288|NCT02284178|11213123|FG001|Overall Study|Met exclusion criteria|54
7093289|NCT02284243|11213131|FG000|Overall Study|Lack of Efficacy|3
7093290|NCT02284243|11213132|FG001|Overall Study|Lack of Efficacy|3
7093291|NCT02284243|11213131|FG000|Overall Study|Adverse Event|1
7093292|NCT02284243|11213132|FG001|Overall Study|Adverse Event|0
7093293|NCT02284347|11213138|FG000|Overall Study|Lost to Follow-up|2
7093294|NCT02284347|11213138|FG000|Overall Study|Withdrawn prior to treatment|1
7093295|NCT02284893|11213228|FG000|26 Week (Short Term)|Adverse Event|1
7093296|NCT02284893|11213229|FG001|26 Week (Short Term)|Adverse Event|9
7093297|NCT02284893|11213228|FG000|26 Week (Short Term)|Discontinuation by the subject|2
7093298|NCT02284893|11213229|FG001|26 Week (Short Term)|Discontinuation by the subject|2
7093299|NCT02284893|11213228|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7
7093300|NCT02284893|11213229|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10
7093301|NCT02284893|11213228|FG000|26 Week (Short Term)|Lost to Follow-up|3
7093302|NCT02284893|11213229|FG001|26 Week (Short Term)|Lost to Follow-up|1
7093303|NCT02284893|11213228|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5
7093304|NCT02284893|11213229|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8
7093305|NCT02284893|11213228|FG000|26 Week (Short Term)|Other|1
7093306|NCT02284893|11213229|FG001|26 Week (Short Term)|Other|1
7093307|NCT02284893|11213228|FG000|52 Week (Long Term)|Adverse Event|3
7093308|NCT02284893|11213229|FG001|52 Week (Long Term)|Adverse Event|1
7093309|NCT02284893|11213228|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0
7093310|NCT02284893|11213229|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1
7093311|NCT02284893|11213228|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4
7093312|NCT02284893|11213229|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6
7093313|NCT02284893|11213228|FG000|52 Week (Long Term)|Lost to Follow-up|2
7093314|NCT02284893|11213229|FG001|52 Week (Long Term)|Lost to Follow-up|2
7093315|NCT02284893|11213228|FG000|52 Week (Long Term)|Non-Compliance|2
7093316|NCT02284893|11213229|FG001|52 Week (Long Term)|Non-Compliance|3
7093317|NCT02285010|11213237|FG000|Overall Study|not abdominal hysterectomy|2
7093318|NCT02285010|11213238|FG001|Overall Study|not abdominal hysterectomy|0
7093319|NCT02285010|11213237|FG000|Overall Study|Not spinal anesthesia|3
7093320|NCT02285010|11213238|FG001|Overall Study|Not spinal anesthesia|1
7093321|NCT02285153|11213256|FG000|Overall Study|Adverse Event|1
7093322|NCT02285153|11213257|FG001|Overall Study|Adverse Event|0
7093323|NCT02285361|11213272|FG000|Overall Study|Protocol Violation|43
7093324|NCT02285361|11213272|FG000|Overall Study|Lost to Follow-up|5
7093325|NCT02285361|11213272|FG000|Overall Study|Not taken GIOTRIF|2
7093326|NCT02285361|11213272|FG000|Overall Study|Consented prior to the contract date|1
7093327|NCT02285777|11213296|FG000|Overall Study|Withdrawal by Subject|1
7093328|NCT02285777|11213297|FG001|Overall Study|Withdrawal by Subject|1
7093329|NCT02285777|11213296|FG000|Overall Study|Lost to Follow-up|4
7093330|NCT02285777|11213297|FG001|Overall Study|Lost to Follow-up|2
7093331|NCT02285855|11213305|FG000|Overall Study|Withdrawal by Subject|2
7093332|NCT02285855|11213306|FG001|Overall Study|Withdrawal by Subject|1
7093333|NCT02285920|11213329|FG000|Overall Study|Kidney transplantation|2
7093334|NCT02285920|11213330|FG001|Overall Study|Kidney transplantation|2
7093335|NCT02285920|11213331|FG002|Overall Study|Kidney transplantation|2
7093336|NCT02285920|11213332|FG003|Overall Study|Kidney transplantation|0
7093337|NCT02285920|11213329|FG000|Overall Study|Change to peritoneal dialysis|0
7093338|NCT02285920|11213330|FG001|Overall Study|Change to peritoneal dialysis|0
7093339|NCT02285920|11213331|FG002|Overall Study|Change to peritoneal dialysis|1
7093340|NCT02285920|11213332|FG003|Overall Study|Change to peritoneal dialysis|0
7093341|NCT02285920|11213329|FG000|Overall Study|Transfer to non-participating unit|0
7093342|NCT02285920|11213330|FG001|Overall Study|Transfer to non-participating unit|1
7093343|NCT02285920|11213331|FG002|Overall Study|Transfer to non-participating unit|0
7093344|NCT02285920|11213332|FG003|Overall Study|Transfer to non-participating unit|0
7093345|NCT02285920|11213329|FG000|Overall Study|Dialysis discontinuation|0
7093346|NCT02285920|11213330|FG001|Overall Study|Dialysis discontinuation|1
7093347|NCT02285920|11213331|FG002|Overall Study|Dialysis discontinuation|0
7093348|NCT02285920|11213332|FG003|Overall Study|Dialysis discontinuation|0
7093349|NCT02285920|11213329|FG000|Overall Study|Death|2
7093350|NCT02285920|11213330|FG001|Overall Study|Death|0
7093351|NCT02285920|11213331|FG002|Overall Study|Death|2
7093352|NCT02285920|11213332|FG003|Overall Study|Death|1
7093353|NCT02285998|11213344|FG000|Overall Study|Adverse Event|9
7093354|NCT02285998|11213345|FG001|Overall Study|Adverse Event|8
7093355|NCT02285998|11213344|FG000|Overall Study|Physician Decision|1
7093356|NCT02285998|11213345|FG001|Overall Study|Physician Decision|2
7093357|NCT02285998|11213344|FG000|Overall Study|Lost to Follow-up|176
7093358|NCT02285998|11213345|FG001|Overall Study|Lost to Follow-up|172
7093359|NCT02285998|11213344|FG000|Overall Study|Withdrawal by Subject|53
7093360|NCT02285998|11213345|FG001|Overall Study|Withdrawal by Subject|61
7093361|NCT02285998|11213344|FG000|Overall Study|Other Reasons|7
7093362|NCT02285998|11213345|FG001|Overall Study|Other Reasons|10
7093363|NCT02286102|11213353|FG000|Overall Study|Screen Failure|1
7093364|NCT02286102|11213354|FG001|Overall Study|Screen Failure|1
7093365|NCT02286193|11213360|FG000|Overall Study|Referred: CRS unable to make contact|62
7093366|NCT02286193|11213360|FG000|Overall Study|Referred: unable to reach/resource sent|104
7093367|NCT02286193|11213360|FG000|Overall Study|Referred: Declined service|38
7093368|NCT02286466|11213367|FG000|Overall Study|Death|1
7093369|NCT02286466|11213368|FG001|Overall Study|Death|3
7093370|NCT02286466|11213367|FG000|Overall Study|Withdrawal by Subject|5
7093371|NCT02286466|11213368|FG001|Overall Study|Withdrawal by Subject|2
7093372|NCT02286466|11213367|FG000|Overall Study|Lost to Follow-up|1
7093373|NCT02286466|11213368|FG001|Overall Study|Lost to Follow-up|4
7093374|NCT02286466|11213367|FG000|Overall Study|Declined Clinician Assessment|0
7093375|NCT02286466|11213368|FG001|Overall Study|Declined Clinician Assessment|1
7093376|NCT02286713|11213449|FG000|One Week Follow-Up|Death|1
7093377|NCT02286713|11213450|FG001|One Week Follow-Up|Death|0
7093378|NCT02286713|11213449|FG000|One Week Follow-Up|Lost to Follow-up|17
7093379|NCT02286713|11213450|FG001|One Week Follow-Up|Lost to Follow-up|21
7093380|NCT02286713|11213449|FG000|One Week Follow-Up|Withdrawal by Subject|6
7093381|NCT02286713|11213450|FG001|One Week Follow-Up|Withdrawal by Subject|3
7093382|NCT02286713|11213449|FG000|Three Month Follow-Up|Death|1
7093383|NCT02286713|11213450|FG001|Three Month Follow-Up|Death|1
7093384|NCT02286713|11213449|FG000|Three Month Follow-Up|Lost to Follow-up|26
7093385|NCT02286713|11213450|FG001|Three Month Follow-Up|Lost to Follow-up|24
7093386|NCT02286713|11213449|FG000|Three Month Follow-Up|Withdrawal by Subject|1
7093387|NCT02286713|11213450|FG001|Three Month Follow-Up|Withdrawal by Subject|1
7093388|NCT02286713|11213449|FG000|Six Month Follow-Up|Death|2
7093389|NCT02286713|11213450|FG001|Six Month Follow-Up|Death|0
7093390|NCT02286713|11213449|FG000|Six Month Follow-Up|Lost to Follow-up|30
7093391|NCT02286713|11213450|FG001|Six Month Follow-Up|Lost to Follow-up|27
7093392|NCT02286843|11213469|FG000|Overall Study|Not Treated|4
7093393|NCT02286843|11213469|FG000|Overall Study|Protocol Violation|1
7093394|NCT02286843|11213469|FG000|Overall Study|Withdrawal by Subject|1
7093395|NCT02286895|11213475|FG000|Assessed for Measles Seroconversion|Protocol Violation|1
7093396|NCT02286895|11213476|FG001|Assessed for Measles Seroconversion|Protocol Violation|4
7093397|NCT02286895|11213475|FG000|Assessed for Measles Seroconversion|Missing measurement|6
7093398|NCT02286895|11213476|FG001|Assessed for Measles Seroconversion|Missing measurement|3
7093399|NCT02286895|11213475|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41
7093400|NCT02286895|11213476|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32
7093401|NCT02286947|11213491|FG000|Overall Study|Withdrawal by Subject|2
7093402|NCT02286960|11213499|FG000|Overall Study|Lost to Follow-up|3
7093403|NCT02286960|11213500|FG001|Overall Study|Lost to Follow-up|3
7093404|NCT02287038|11213508|FG000|Overall Study|Stopped attending appointments|3
7093405|NCT02287038|11213509|FG001|Overall Study|Stopped attending appointments|2
7093406|NCT02287038|11213508|FG000|Overall Study|Anxiety after starting medication|0
7093407|NCT02287038|11213509|FG001|Overall Study|Anxiety after starting medication|1
7093408|NCT02287038|11213508|FG000|Overall Study|Nausea after starting medication|1
7093409|NCT02287038|11213509|FG001|Overall Study|Nausea after starting medication|0
7093410|NCT02287038|11213508|FG000|Overall Study|Abnormal ECG after starting medication|1
7093411|NCT02287038|11213509|FG001|Overall Study|Abnormal ECG after starting medication|0
7093412|NCT02287402|11213525|FG000|Treatment Period|Adverse Event|17
7093413|NCT02287402|11213525|FG000|Treatment Period|Voluntary Withdrawal|10
7093414|NCT02287402|11213525|FG000|Follow-up|Lost to Follow-up|1
7093415|NCT02287402|11213525|FG000|Follow-up|Voluntary Withdrawal|2
7093416|NCT02287467|11213535|FG000|Overall Study|Protocol Violation|12
7093417|NCT02287467|11213536|FG001|Overall Study|Protocol Violation|9
7093418|NCT02287610|11213545|FG000|Overall Study|Lost to Follow-up|3
7093419|NCT02287610|11213545|FG000|Overall Study|Withdrawal by Subject|8
7093420|NCT02287610|11213545|FG000|Overall Study|Excluded-investigator non-responsiveness|5
7093421|NCT02287623|11213551|FG000|Overall Study|Protocol Violation|0
7093422|NCT02287623|11213552|FG001|Overall Study|Protocol Violation|1
7093423|NCT02287883|11213619|FG000|Overall Study|Death|8
7093424|NCT02287883|11213620|FG001|Overall Study|Death|7
7093425|NCT02287883|11213619|FG000|Overall Study|No longer eligible|222
7093426|NCT02287883|11213620|FG001|Overall Study|No longer eligible|182
7093427|NCT02287883|11213619|FG000|Overall Study|Non-response to survey|229
7093428|NCT02287883|11213620|FG001|Overall Study|Non-response to survey|237
7093429|NCT02287896|11213628|FG000|Second Injection Visit|Withdrawal by Subject|0
7093430|NCT02287896|11213629|FG001|Second Injection Visit|Withdrawal by Subject|1
7093431|NCT02287922|11213662|FG000|Overall Study|Adverse Event|1
7093432|NCT02287922|11213663|FG001|Overall Study|Adverse Event|1
7093433|NCT02287922|11213664|FG002|Overall Study|Adverse Event|3
7093434|NCT02287922|11213665|FG003|Overall Study|Adverse Event|4
7093435|NCT02287922|11213662|FG000|Overall Study|Withdrawal by Subject|1
7093436|NCT02287922|11213663|FG001|Overall Study|Withdrawal by Subject|1
7093437|NCT02287922|11213664|FG002|Overall Study|Withdrawal by Subject|1
7093438|NCT02287922|11213665|FG003|Overall Study|Withdrawal by Subject|2
7093439|NCT02287922|11213662|FG000|Overall Study|Lost to Follow-up|0
7093440|NCT02287922|11213663|FG001|Overall Study|Lost to Follow-up|0
7093441|NCT02287922|11213664|FG002|Overall Study|Lost to Follow-up|1
7093442|NCT02287922|11213665|FG003|Overall Study|Lost to Follow-up|0
7093443|NCT02287922|11213662|FG000|Overall Study|Sponsor's decision|0
7093444|NCT02287922|11213663|FG001|Overall Study|Sponsor's decision|0
7093445|NCT02287922|11213664|FG002|Overall Study|Sponsor's decision|0
7093446|NCT02287922|11213665|FG003|Overall Study|Sponsor's decision|1
7093447|NCT02287922|11213662|FG000|Overall Study|Other|1
7093448|NCT02287922|11213663|FG001|Overall Study|Other|0
7093449|NCT02287922|11213664|FG002|Overall Study|Other|2
7093450|NCT02287922|11213665|FG003|Overall Study|Other|0
7093451|NCT02288091|11213676|FG000|Overall Study|Lost to Follow-up|1
7093452|NCT02288091|11213676|FG000|Overall Study|Screen fail|7
7093453|NCT02288182|11213701|FG000|Overall Study|Adverse Event|0
7093454|NCT02288182|11213702|FG001|Overall Study|Adverse Event|1
7093455|NCT02288182|11213701|FG000|Overall Study|Lost to Follow-up|0
7093456|NCT02288182|11213702|FG001|Overall Study|Lost to Follow-up|1
7093457|NCT02288312|11213722|FG000|Overall Study|Pregnancy|1
7093458|NCT02288312|11213723|FG001|Overall Study|Pregnancy|0
7093459|NCT02288312|11213724|FG002|Overall Study|Pregnancy|0
7093460|NCT02288325|11213732|FG000|Run-in Period|Adverse Event|48
7093461|NCT02288325|11213733|FG001|Run-in Period|Adverse Event|0
7093462|NCT02288325|11213734|FG002|Run-in Period|Adverse Event|0
7093463|NCT02288325|11213732|FG000|Run-in Period|Lack of Efficacy|16
7093464|NCT02288325|11213733|FG001|Run-in Period|Lack of Efficacy|0
7093465|NCT02288325|11213734|FG002|Run-in Period|Lack of Efficacy|0
7093466|NCT02288325|11213732|FG000|Run-in Period|Withdrawal of Consent|28
7093467|NCT02288325|11213733|FG001|Run-in Period|Withdrawal of Consent|0
7093468|NCT02288325|11213734|FG002|Run-in Period|Withdrawal of Consent|0
7093469|NCT02288325|11213732|FG000|Run-in Period|Lost to Follow-up|25
7093470|NCT02288325|11213733|FG001|Run-in Period|Lost to Follow-up|0
7093471|NCT02288325|11213734|FG002|Run-in Period|Lost to Follow-up|0
7093472|NCT02288325|11213732|FG000|Run-in Period|Protocol Violation|17
7093473|NCT02288325|11213733|FG001|Run-in Period|Protocol Violation|0
7093474|NCT02288325|11213734|FG002|Run-in Period|Protocol Violation|0
7093475|NCT02288325|11213732|FG000|Run-in Period|Non-Compliance With Study Drug|3
7093476|NCT02288325|11213733|FG001|Run-in Period|Non-Compliance With Study Drug|0
7093477|NCT02288325|11213734|FG002|Run-in Period|Non-Compliance With Study Drug|0
7093478|NCT02288325|11213732|FG000|Run-in Period|Reason not Specified|8
7093479|NCT02288325|11213733|FG001|Run-in Period|Reason not Specified|0
7093480|NCT02288325|11213734|FG002|Run-in Period|Reason not Specified|0
7093481|NCT02288325|11213732|FG000|Stabilization Period|Adverse Event|13
7093482|NCT02288325|11213733|FG001|Stabilization Period|Adverse Event|0
7093483|NCT02288325|11213734|FG002|Stabilization Period|Adverse Event|0
7093484|NCT02288325|11213732|FG000|Stabilization Period|Lack of Efficacy|22
7093485|NCT02288325|11213733|FG001|Stabilization Period|Lack of Efficacy|0
7093486|NCT02288325|11213734|FG002|Stabilization Period|Lack of Efficacy|0
7093487|NCT02288325|11213732|FG000|Stabilization Period|Withdrawal of Consent|23
7093488|NCT02288325|11213733|FG001|Stabilization Period|Withdrawal of Consent|0
7093489|NCT02288325|11213734|FG002|Stabilization Period|Withdrawal of Consent|0
7093490|NCT02288325|11213732|FG000|Stabilization Period|Lost to Follow-up|12
7093491|NCT02288325|11213733|FG001|Stabilization Period|Lost to Follow-up|0
7093492|NCT02288325|11213734|FG002|Stabilization Period|Lost to Follow-up|0
7093493|NCT02288325|11213732|FG000|Stabilization Period|Protocol Violation|8
7093494|NCT02288325|11213733|FG001|Stabilization Period|Protocol Violation|0
7093495|NCT02288325|11213734|FG002|Stabilization Period|Protocol Violation|0
7093496|NCT02288325|11213732|FG000|Stabilization Period|Non-Compliance With Study Drug|5
7093497|NCT02288325|11213733|FG001|Stabilization Period|Non-Compliance With Study Drug|0
7093498|NCT02288325|11213734|FG002|Stabilization Period|Non-Compliance With Study Drug|0
7093499|NCT02288325|11213732|FG000|Stabilization Period|Reason not Specified|15
7093500|NCT02288325|11213733|FG001|Stabilization Period|Reason not Specified|0
7093501|NCT02288325|11213734|FG002|Stabilization Period|Reason not Specified|0
7093502|NCT02288325|11213732|FG000|Double-blind Treatment Period|Adverse Event|0
7093503|NCT02288325|11213733|FG001|Double-blind Treatment Period|Adverse Event|2
7093504|NCT02288325|11213734|FG002|Double-blind Treatment Period|Adverse Event|5
7093505|NCT02288325|11213732|FG000|Double-blind Treatment Period|Withdrawal of Consent|0
7093506|NCT02288325|11213733|FG001|Double-blind Treatment Period|Withdrawal of Consent|8
7093507|NCT02288325|11213734|FG002|Double-blind Treatment Period|Withdrawal of Consent|8
7093508|NCT02288325|11213732|FG000|Double-blind Treatment Period|Lost to Follow-up|0
7093509|NCT02288325|11213733|FG001|Double-blind Treatment Period|Lost to Follow-up|4
7093510|NCT02288325|11213734|FG002|Double-blind Treatment Period|Lost to Follow-up|5
7093511|NCT02288325|11213732|FG000|Double-blind Treatment Period|Protocol Violation|0
7093512|NCT02288325|11213733|FG001|Double-blind Treatment Period|Protocol Violation|1
7093513|NCT02288325|11213734|FG002|Double-blind Treatment Period|Protocol Violation|2
7093514|NCT02288325|11213732|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0
7093515|NCT02288325|11213733|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1
7093516|NCT02288325|11213734|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4
7093517|NCT02288325|11213732|FG000|Double-blind Treatment Period|Multiple Reasons|0
7093518|NCT02288325|11213733|FG001|Double-blind Treatment Period|Multiple Reasons|8
7093519|NCT02288325|11213734|FG002|Double-blind Treatment Period|Multiple Reasons|2
7093520|NCT02288559|11213763|FG000|Overall Study|Adverse Event|1
7093521|NCT02288559|11213764|FG001|Overall Study|Adverse Event|1
7093522|NCT02288559|11213765|FG002|Overall Study|Adverse Event|5
7093523|NCT02288559|11213766|FG003|Overall Study|Adverse Event|0
7093524|NCT02288559|11213763|FG000|Overall Study|Death|0
7093525|NCT02288559|11213764|FG001|Overall Study|Death|0
7093526|NCT02288559|11213765|FG002|Overall Study|Death|1
7093527|NCT02288559|11213766|FG003|Overall Study|Death|0
7093528|NCT02288559|11213763|FG000|Overall Study|Lost to Follow-up|0
7093529|NCT02288559|11213764|FG001|Overall Study|Lost to Follow-up|0
7093530|NCT02288559|11213765|FG002|Overall Study|Lost to Follow-up|0
7093531|NCT02288559|11213766|FG003|Overall Study|Lost to Follow-up|1
7093532|NCT02288559|11213763|FG000|Overall Study|Withdrawal by Subject|0
7093533|NCT02288559|11213764|FG001|Overall Study|Withdrawal by Subject|0
7093534|NCT02288559|11213765|FG002|Overall Study|Withdrawal by Subject|2
7093535|NCT02288559|11213766|FG003|Overall Study|Withdrawal by Subject|1
7093536|NCT02288559|11213763|FG000|Overall Study|Reason Not Specified|0
7093537|NCT02288559|11213764|FG001|Overall Study|Reason Not Specified|0
7093538|NCT02288559|11213765|FG002|Overall Study|Reason Not Specified|3
7093539|NCT02288559|11213766|FG003|Overall Study|Reason Not Specified|0
7093540|NCT02289079|11213784|FG000|Overall Study|Physician Decision|2
7093541|NCT02289079|11213785|FG001|Overall Study|Physician Decision|0
7093542|NCT02289079|11213784|FG000|Overall Study|Lost to Follow-up|0
7093543|NCT02289079|11213785|FG001|Overall Study|Lost to Follow-up|1
7093544|NCT02289352|11213816|FG000|Overall Study|Withdrawal by Subject|1
7093545|NCT02289352|11213817|FG001|Overall Study|Withdrawal by Subject|1
7093546|NCT02289352|11213818|FG002|Overall Study|Withdrawal by Subject|0
7093547|NCT02289417|11213830|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3
7093548|NCT02289417|11213831|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
7093549|NCT02289417|11213832|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1
7093550|NCT02289417|11213833|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
7093551|NCT02289417|11213834|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
7093552|NCT02289417|11213835|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
7093553|NCT02289417|11213836|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
7093554|NCT02289417|11213837|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
7093555|NCT02289417|11213838|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
7093556|NCT02289417|11213830|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1
7093557|NCT02289417|11213831|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3
7093558|NCT02289417|11213832|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2
7093559|NCT02289417|11213833|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
7093560|NCT02289417|11213834|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
7093561|NCT02289417|11213835|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
7093562|NCT02289417|11213836|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
7093563|NCT02289417|11213837|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
7093564|NCT02289417|11213838|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
7093565|NCT02289417|11213830|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
7093566|NCT02289417|11213831|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1
7093567|NCT02289417|11213832|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
7093568|NCT02289417|11213833|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
7093569|NCT02289417|11213834|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
7093570|NCT02289417|11213835|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
7093571|NCT02289417|11213836|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
7093572|NCT02289417|11213837|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
7093573|NCT02289417|11213838|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
7093574|NCT02289417|11213830|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3
7093575|NCT02289417|11213831|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
7093576|NCT02289417|11213832|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
7093577|NCT02289417|11213833|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
7093578|NCT02289417|11213834|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
7093579|NCT02289417|11213835|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
7093580|NCT02289417|11213836|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
7093581|NCT02289417|11213837|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
7093582|NCT02289417|11213838|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
7093583|NCT02289417|11213830|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0
7093584|NCT02289417|11213831|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1
7093585|NCT02289417|11213832|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4
7093586|NCT02289417|11213833|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2
7093587|NCT02289417|11213834|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2
7093588|NCT02289417|11213835|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1
7093589|NCT02289417|11213836|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0
7093590|NCT02289417|11213837|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0
7093591|NCT02289417|11213838|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0
7093592|NCT02289417|11213830|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0
7093593|NCT02289417|11213831|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0
7093594|NCT02289417|11213832|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1
7093595|NCT02289417|11213833|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0
7093596|NCT02289417|11213834|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0
7093597|NCT02289417|11213835|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0
7093598|NCT02289417|11213836|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0
7093599|NCT02289417|11213837|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0
7093600|NCT02289417|11213838|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0
7093601|NCT02289417|11213830|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
7093602|NCT02289417|11213831|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1
7093603|NCT02289417|11213832|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4
7093604|NCT02289417|11213833|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6
7093605|NCT02289417|11213834|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2
7093606|NCT02289417|11213835|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3
7093607|NCT02289417|11213836|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
7093608|NCT02289417|11213837|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
7093609|NCT02289417|11213838|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
7093610|NCT02289417|11213830|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
7093611|NCT02289417|11213831|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
7093612|NCT02289417|11213832|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1
7093613|NCT02289417|11213833|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
7093614|NCT02289417|11213834|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1
7093615|NCT02289417|11213835|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1
7093616|NCT02289417|11213836|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
7093617|NCT02289417|11213837|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
7093618|NCT02289417|11213838|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
7093619|NCT02289417|11213830|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
7093620|NCT02289417|11213831|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
7093621|NCT02289417|11213832|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
7093622|NCT02289417|11213833|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
7093623|NCT02289417|11213834|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
7093624|NCT02289417|11213835|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
7093625|NCT02289417|11213836|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1
7093626|NCT02289417|11213837|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
7093627|NCT02289417|11213838|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
7093628|NCT02289417|11213830|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0
7093629|NCT02289417|11213831|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0
7093630|NCT02289417|11213832|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0
7093631|NCT02289417|11213833|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1
7093632|NCT02289417|11213834|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0
7093633|NCT02289417|11213835|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0
7093634|NCT02289417|11213836|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1
7093635|NCT02289417|11213837|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0
7093636|NCT02289417|11213838|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0
7093637|NCT02289417|11213830|FG000|Extension Phase Weeks 52-104|Adverse Event|0
7093638|NCT02289417|11213831|FG001|Extension Phase Weeks 52-104|Adverse Event|0
7093639|NCT02289417|11213832|FG002|Extension Phase Weeks 52-104|Adverse Event|0
7093640|NCT02289417|11213833|FG003|Extension Phase Weeks 52-104|Adverse Event|0
7093641|NCT02289417|11213834|FG004|Extension Phase Weeks 52-104|Adverse Event|0
7093642|NCT02289417|11213835|FG005|Extension Phase Weeks 52-104|Adverse Event|0
7093643|NCT02289417|11213836|FG006|Extension Phase Weeks 52-104|Adverse Event|0
7093644|NCT02289417|11213837|FG007|Extension Phase Weeks 52-104|Adverse Event|2
7093645|NCT02289417|11213838|FG008|Extension Phase Weeks 52-104|Adverse Event|3
7093646|NCT02289417|11213830|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0
7093647|NCT02289417|11213831|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0
7093648|NCT02289417|11213832|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0
7093649|NCT02289417|11213833|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0
7093650|NCT02289417|11213834|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0
7093651|NCT02289417|11213835|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0
7093652|NCT02289417|11213836|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0
7093653|NCT02289417|11213837|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2
7093654|NCT02289417|11213838|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2
7093655|NCT02289417|11213830|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0
7093656|NCT02289417|11213831|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0
7093657|NCT02289417|11213832|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0
7093658|NCT02289417|11213833|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0
7093659|NCT02289417|11213834|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0
7093660|NCT02289417|11213835|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0
7093661|NCT02289417|11213836|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0
7093662|NCT02289417|11213837|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2
7093663|NCT02289417|11213838|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1
7093664|NCT02289417|11213830|FG000|Extension Phase Weeks 52-104|Miscellaneous|0
7093665|NCT02289417|11213831|FG001|Extension Phase Weeks 52-104|Miscellaneous|0
7093666|NCT02289417|11213832|FG002|Extension Phase Weeks 52-104|Miscellaneous|0
7093667|NCT02289417|11213833|FG003|Extension Phase Weeks 52-104|Miscellaneous|0
7093668|NCT02289417|11213834|FG004|Extension Phase Weeks 52-104|Miscellaneous|0
7093669|NCT02289417|11213835|FG005|Extension Phase Weeks 52-104|Miscellaneous|0
7093670|NCT02289417|11213836|FG006|Extension Phase Weeks 52-104|Miscellaneous|0
7093671|NCT02289417|11213837|FG007|Extension Phase Weeks 52-104|Miscellaneous|1
7093672|NCT02289417|11213838|FG008|Extension Phase Weeks 52-104|Miscellaneous|0
7093673|NCT02289456|11213854|FG000|Induction Period|Death|2
7093674|NCT02289456|11213854|FG000|Induction Period|Adverse Event|11
7093675|NCT02289456|11213854|FG000|Induction Period|Progressive Disease (PD)|4
7093676|NCT02289456|11213854|FG000|Induction Period|Symptomatic Deterioration|4
7093677|NCT02289456|11213854|FG000|Induction Period|Withdrawal by Subject|2
7093678|NCT02289456|11213854|FG000|Induction Period|Miscellaneous|1
7093679|NCT02289456|11213854|FG000|Monotherapy Period|Death|1
7093680|NCT02289456|11213854|FG000|Monotherapy Period|Adverse Event|1
7093681|NCT02289456|11213854|FG000|Monotherapy Period|Progressive Disease (PD)|8
7093682|NCT02289456|11213854|FG000|Monotherapy Period|Symptomatic Deterioration|1
7093683|NCT02289456|11213854|FG000|Monotherapy Period|Withdrawal by Subject|2
7093684|NCT02289456|11213854|FG000|Monotherapy Period|Study Terminated by Sponsor|2
7093685|NCT02289456|11213854|FG000|Monotherapy Period|Miscellaneous|1
7093686|NCT02289469|11213865|FG000|Overall Study|Unable to match a control|6
7093687|NCT02289469|11213866|FG001|Overall Study|Unable to match a control|0
7093688|NCT02289690|11213882|FG000|Overall Study|Adverse Event Related to Progression|0
7093689|NCT02289690|11213883|FG001|Overall Study|Adverse Event Related to Progression|1
7093690|NCT02289690|11213884|FG002|Overall Study|Adverse Event Related to Progression|1
7093691|NCT02289690|11213885|FG003|Overall Study|Adverse Event Related to Progression|0
7093692|NCT02289690|11213886|FG004|Overall Study|Adverse Event Related to Progression|1
7093693|NCT02289690|11213887|FG005|Overall Study|Adverse Event Related to Progression|0
7093694|NCT02289690|11213888|FG006|Overall Study|Adverse Event Related to Progression|1
7093695|NCT02289690|11213889|FG007|Overall Study|Adverse Event Related to Progression|0
7093696|NCT02289690|11213890|FG008|Overall Study|Adverse Event Related to Progression|0
7093697|NCT02289690|11213891|FG009|Overall Study|Adverse Event Related to Progression|0
7093698|NCT02289690|11213882|FG000|Overall Study|Withdrawal by Subject|1
7093699|NCT02289690|11213883|FG001|Overall Study|Withdrawal by Subject|0
7093700|NCT02289690|11213884|FG002|Overall Study|Withdrawal by Subject|0
7093701|NCT02289690|11213885|FG003|Overall Study|Withdrawal by Subject|0
7093702|NCT02289690|11213886|FG004|Overall Study|Withdrawal by Subject|1
7093703|NCT02289690|11213887|FG005|Overall Study|Withdrawal by Subject|1
7093704|NCT02289690|11213888|FG006|Overall Study|Withdrawal by Subject|0
7093705|NCT02289690|11213889|FG007|Overall Study|Withdrawal by Subject|0
7093706|NCT02289690|11213890|FG008|Overall Study|Withdrawal by Subject|4
7093707|NCT02289690|11213891|FG009|Overall Study|Withdrawal by Subject|2
7093708|NCT02289690|11213882|FG000|Overall Study|Progressive Disease, Per Protocol|3
7093709|NCT02289690|11213883|FG001|Overall Study|Progressive Disease, Per Protocol|2
7093710|NCT02289690|11213884|FG002|Overall Study|Progressive Disease, Per Protocol|3
7093711|NCT02289690|11213885|FG003|Overall Study|Progressive Disease, Per Protocol|2
7093712|NCT02289690|11213886|FG004|Overall Study|Progressive Disease, Per Protocol|5
7093713|NCT02289690|11213887|FG005|Overall Study|Progressive Disease, Per Protocol|13
7093714|NCT02289690|11213888|FG006|Overall Study|Progressive Disease, Per Protocol|2
7093715|NCT02289690|11213889|FG007|Overall Study|Progressive Disease, Per Protocol|0
7093716|NCT02289690|11213890|FG008|Overall Study|Progressive Disease, Per Protocol|0
7093717|NCT02289690|11213891|FG009|Overall Study|Progressive Disease, Per Protocol|0
7093718|NCT02289690|11213882|FG000|Overall Study|Lost to Follow-up|0
7093719|NCT02289690|11213883|FG001|Overall Study|Lost to Follow-up|0
7093720|NCT02289690|11213884|FG002|Overall Study|Lost to Follow-up|0
7093721|NCT02289690|11213885|FG003|Overall Study|Lost to Follow-up|0
7093722|NCT02289690|11213886|FG004|Overall Study|Lost to Follow-up|0
7093723|NCT02289690|11213887|FG005|Overall Study|Lost to Follow-up|0
7093724|NCT02289690|11213888|FG006|Overall Study|Lost to Follow-up|0
7093725|NCT02289690|11213889|FG007|Overall Study|Lost to Follow-up|1
7093726|NCT02289690|11213890|FG008|Overall Study|Lost to Follow-up|0
7093727|NCT02289690|11213891|FG009|Overall Study|Lost to Follow-up|2
7093728|NCT02289690|11213882|FG000|Overall Study|Death|0
7093729|NCT02289690|11213883|FG001|Overall Study|Death|0
7093730|NCT02289690|11213884|FG002|Overall Study|Death|0
7093731|NCT02289690|11213885|FG003|Overall Study|Death|0
7093732|NCT02289690|11213886|FG004|Overall Study|Death|0
7093733|NCT02289690|11213887|FG005|Overall Study|Death|0
7093734|NCT02289690|11213888|FG006|Overall Study|Death|0
7093735|NCT02289690|11213889|FG007|Overall Study|Death|49
7093736|NCT02289690|11213890|FG008|Overall Study|Death|45
7093737|NCT02289690|11213891|FG009|Overall Study|Death|41
7093738|NCT02289690|11213882|FG000|Overall Study|Sponsor Discontinued Study|0
7093739|NCT02289690|11213883|FG001|Overall Study|Sponsor Discontinued Study|0
7093740|NCT02289690|11213884|FG002|Overall Study|Sponsor Discontinued Study|0
7093741|NCT02289690|11213885|FG003|Overall Study|Sponsor Discontinued Study|0
7093742|NCT02289690|11213886|FG004|Overall Study|Sponsor Discontinued Study|0
7093743|NCT02289690|11213887|FG005|Overall Study|Sponsor Discontinued Study|0
7093744|NCT02289690|11213888|FG006|Overall Study|Sponsor Discontinued Study|0
7093745|NCT02289690|11213889|FG007|Overall Study|Sponsor Discontinued Study|9
7093746|NCT02289690|11213890|FG008|Overall Study|Sponsor Discontinued Study|7
7093747|NCT02289690|11213891|FG009|Overall Study|Sponsor Discontinued Study|15
7093748|NCT02289690|11213882|FG000|Overall Study|Other|0
7093749|NCT02289690|11213883|FG001|Overall Study|Other|0
7093750|NCT02289690|11213884|FG002|Overall Study|Other|0
7093751|NCT02289690|11213885|FG003|Overall Study|Other|1
7093752|NCT02289690|11213886|FG004|Overall Study|Other|1
7093753|NCT02289690|11213887|FG005|Overall Study|Other|0
7093754|NCT02289690|11213888|FG006|Overall Study|Other|1
7093755|NCT02289690|11213889|FG007|Overall Study|Other|2
7093756|NCT02289690|11213890|FG008|Overall Study|Other|3
7093757|NCT02289690|11213891|FG009|Overall Study|Other|1
7093758|NCT02289729|11213927|FG000|Overall Study|Lack of Efficacy|3
7093759|NCT02289729|11213927|FG000|Overall Study|Very Narrow Therapeutic Margin|1
7093760|NCT02289729|11213927|FG000|Overall Study|Withdrawal by Subject|1
7093761|NCT02289729|11213927|FG000|Overall Study|Death|1
7093762|NCT02289742|11213933|FG000|First Wear Period|Adverse event prior to treatment|0
7093763|NCT02289742|11213934|FG001|First Wear Period|Adverse event prior to treatment|1
7093764|NCT02289742|11213935|FG002|First Wear Period|Adverse event prior to treatment|0
7093765|NCT02289742|11213936|FG003|First Wear Period|Adverse event prior to treatment|0
7093766|NCT02289742|11213933|FG000|First Wear Period|Adverse Event|0
7093767|NCT02289742|11213934|FG001|First Wear Period|Adverse Event|0
7093768|NCT02289742|11213935|FG002|First Wear Period|Adverse Event|1
7093769|NCT02289742|11213936|FG003|First Wear Period|Adverse Event|0
7093770|NCT02289742|11213933|FG000|First Wear Period|Other prior to treatment|0
7093771|NCT02289742|11213934|FG001|First Wear Period|Other prior to treatment|0
7093772|NCT02289742|11213935|FG002|First Wear Period|Other prior to treatment|0
7093773|NCT02289742|11213936|FG003|First Wear Period|Other prior to treatment|1
7093774|NCT02289742|11213933|FG000|Third Wear Period|Adverse Event|0
7093775|NCT02289742|11213934|FG001|Third Wear Period|Adverse Event|1
7093776|NCT02289742|11213935|FG002|Third Wear Period|Adverse Event|0
7093777|NCT02289742|11213936|FG003|Third Wear Period|Adverse Event|0
7093778|NCT02289742|11213933|FG000|Third Wear Period|Reason not given|0
7093779|NCT02289742|11213934|FG001|Third Wear Period|Reason not given|0
7093780|NCT02289742|11213935|FG002|Third Wear Period|Reason not given|0
7093781|NCT02289742|11213936|FG003|Third Wear Period|Reason not given|1
7093782|NCT02289820|11213961|FG000|Overall Study|Withdrawal by Subject|2
7093783|NCT02289820|11213962|FG001|Overall Study|Withdrawal by Subject|1
7093784|NCT02289820|11213963|FG002|Overall Study|Withdrawal by Subject|2
7093785|NCT02289820|11213964|FG003|Overall Study|Withdrawal by Subject|1
7093786|NCT02289820|11213965|FG004|Overall Study|Withdrawal by Subject|0
7093787|NCT02289820|11213966|FG005|Overall Study|Withdrawal by Subject|0
7093788|NCT02289820|11213967|FG006|Overall Study|Withdrawal by Subject|1
7093789|NCT02289820|11213961|FG000|Overall Study|Death|0
7093790|NCT02289820|11213962|FG001|Overall Study|Death|0
7093791|NCT02289820|11213963|FG002|Overall Study|Death|1
7093792|NCT02289820|11213964|FG003|Overall Study|Death|0
7093793|NCT02289820|11213965|FG004|Overall Study|Death|0
7093794|NCT02289820|11213966|FG005|Overall Study|Death|0
7093795|NCT02289820|11213967|FG006|Overall Study|Death|0
7093796|NCT02289820|11213961|FG000|Overall Study|Lost to Follow-up|0
7093797|NCT02289820|11213962|FG001|Overall Study|Lost to Follow-up|0
7093798|NCT02289820|11213963|FG002|Overall Study|Lost to Follow-up|3
7093799|NCT02289820|11213964|FG003|Overall Study|Lost to Follow-up|1
7093800|NCT02289820|11213965|FG004|Overall Study|Lost to Follow-up|0
7093801|NCT02289820|11213966|FG005|Overall Study|Lost to Follow-up|1
7093802|NCT02289820|11213967|FG006|Overall Study|Lost to Follow-up|1
7093803|NCT02289820|11213961|FG000|Overall Study|withdrawal of consent|0
7093804|NCT02289820|11213962|FG001|Overall Study|withdrawal of consent|1
7093805|NCT02289820|11213963|FG002|Overall Study|withdrawal of consent|0
7093806|NCT02289820|11213964|FG003|Overall Study|withdrawal of consent|0
7093807|NCT02289820|11213965|FG004|Overall Study|withdrawal of consent|0
7093808|NCT02289820|11213966|FG005|Overall Study|withdrawal of consent|0
7093809|NCT02289820|11213967|FG006|Overall Study|withdrawal of consent|0
7093810|NCT02289833|11213989|FG000|Overall Study|Study discontinuation|0
7093811|NCT02289833|11213990|FG001|Overall Study|Study discontinuation|1
7093812|NCT02289833|11213989|FG000|Overall Study|Lost to Follow-up|4
7093813|NCT02289833|11213990|FG001|Overall Study|Lost to Follow-up|0
7093814|NCT02289833|11213989|FG000|Overall Study|Death|23
7093815|NCT02289833|11213990|FG001|Overall Study|Death|16
7093816|NCT02289898|11214001|FG000|Overall Study|Death|5
7093817|NCT02289898|11214002|FG001|Overall Study|Death|4
7093818|NCT02289898|11214003|FG002|Overall Study|Death|3
7093819|NCT02289898|11214001|FG000|Overall Study|Physician Decision|2
7093820|NCT02289898|11214002|FG001|Overall Study|Physician Decision|5
7093821|NCT02289898|11214003|FG002|Overall Study|Physician Decision|2
7093822|NCT02289898|11214001|FG000|Overall Study|Withdrawal by Subject|0
7093823|NCT02289898|11214002|FG001|Overall Study|Withdrawal by Subject|4
7093824|NCT02289898|11214003|FG002|Overall Study|Withdrawal by Subject|1
7093825|NCT02289898|11214001|FG000|Overall Study|Adverse Event|3
7093826|NCT02289898|11214002|FG001|Overall Study|Adverse Event|5
7093827|NCT02289898|11214003|FG002|Overall Study|Adverse Event|5
7093828|NCT02289898|11214001|FG000|Overall Study|Disease progression|34
7093829|NCT02289898|11214002|FG001|Overall Study|Disease progression|28
7093830|NCT02289898|11214003|FG002|Overall Study|Disease progression|34
7093831|NCT02289898|11214001|FG000|Overall Study|Use of another anticancer therapy|0
7093832|NCT02289898|11214002|FG001|Overall Study|Use of another anticancer therapy|0
7093833|NCT02289898|11214003|FG002|Overall Study|Use of another anticancer therapy|1
7093834|NCT02289898|11214001|FG000|Overall Study|Other|8
7093835|NCT02289898|11214002|FG001|Overall Study|Other|7
7093836|NCT02289898|11214003|FG002|Overall Study|Other|10
7093837|NCT02289950|11214012|FG000|Overall Study|Progressive disease by RECIST 1.1|99
7093838|NCT02289950|11214013|FG001|Overall Study|Progressive disease by RECIST 1.1|52
7093839|NCT02289950|11214012|FG000|Overall Study|Progressive disease by Clinical Assessment|4
7093840|NCT02289950|11214013|FG001|Overall Study|Progressive disease by Clinical Assessment|4
7093841|NCT02289950|11214012|FG000|Overall Study|Lost to Follow-up|1
7093842|NCT02289950|11214013|FG001|Overall Study|Lost to Follow-up|0
7093843|NCT02289950|11214012|FG000|Overall Study|Physician Decision|9
7093844|NCT02289950|11214013|FG001|Overall Study|Physician Decision|3
7093845|NCT02289950|11214012|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9
7093846|NCT02289950|11214013|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2
7093847|NCT02289950|11214012|FG000|Overall Study|Withdrawal by Subject|1
7093848|NCT02289950|11214013|FG001|Overall Study|Withdrawal by Subject|3
7093849|NCT02289950|11214012|FG000|Overall Study|Test article held for greater than 28 days|0
7093850|NCT02289950|11214013|FG001|Overall Study|Test article held for greater than 28 days|1
7093851|NCT02289950|11214012|FG000|Overall Study|Adverse Event|11
7093852|NCT02289950|11214013|FG001|Overall Study|Adverse Event|3
7093853|NCT02289950|11214012|FG000|Overall Study|Death|1
7093854|NCT02289950|11214013|FG001|Overall Study|Death|1
7093855|NCT02289950|11214012|FG000|Overall Study|Other|5
7093856|NCT02289950|11214013|FG001|Overall Study|Other|2
7093857|NCT02289950|11214012|FG000|Overall Study|Not Treated|2
7093858|NCT02289950|11214013|FG001|Overall Study|Not Treated|1
7093859|NCT02289963|11214021|FG000|Overall Study|Adverse Event|1
7093860|NCT02289963|11214022|FG001|Overall Study|Adverse Event|2
7093861|NCT02289963|11214021|FG000|Overall Study|Poor compliance to protocol|1
7093862|NCT02289963|11214022|FG001|Overall Study|Poor compliance to protocol|0
7093863|NCT02289963|11214021|FG000|Overall Study|Withdrawal by Subject|1
7093864|NCT02289963|11214022|FG001|Overall Study|Withdrawal by Subject|0
7093865|NCT02289963|11214021|FG000|Overall Study|Last injection missed|2
7093866|NCT02289963|11214022|FG001|Overall Study|Last injection missed|2
7093867|NCT02289963|11214021|FG000|Overall Study|End treatment visit outside visit window|0
7093868|NCT02289963|11214022|FG001|Overall Study|End treatment visit outside visit window|4
7093869|NCT02289963|11214021|FG000|Overall Study|Other than specified above|0
7093870|NCT02289963|11214022|FG001|Overall Study|Other than specified above|2
7093871|NCT02290028|11214037|FG000|Overall Study|Death|217
7093872|NCT02290028|11214037|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186
7093873|NCT02290028|11214037|FG000|Overall Study|No longer under care of study physician|76
7093874|NCT02290028|11214037|FG000|Overall Study|Sentus lead or required CRT-D explanted|55
7093875|NCT02290028|11214037|FG000|Overall Study|Withdrawal by Subject|52
7093876|NCT02290028|11214037|FG000|Overall Study|Study site closure|44
7093877|NCT02290028|11214037|FG000|Overall Study|Lost to Follow-up|34
7093878|NCT02290028|11214037|FG000|Overall Study|Miscellaneous|10
7093879|NCT02290028|11214037|FG000|Overall Study|Transition to EP PASSION|1295
7093880|NCT02290028|11214037|FG000|Overall Study|Planned study completion at 12 months|257
7093881|NCT02290223|11214070|FG000|6 Months|Lost to Follow-up|9
7093882|NCT02290223|11214071|FG001|6 Months|Lost to Follow-up|6
7093883|NCT02290223|11214070|FG000|6 Months|Withdrawal by Subject|5
7093884|NCT02290223|11214071|FG001|6 Months|Withdrawal by Subject|0
7093885|NCT02290223|11214070|FG000|6 Months|deceased (not related to study)|2
7093886|NCT02290223|11214071|FG001|6 Months|deceased (not related to study)|0
7093887|NCT02290223|11214070|FG000|12 Months|Lost to Follow-up|16
7093888|NCT02290223|11214071|FG001|12 Months|Lost to Follow-up|10
7093889|NCT02290223|11214070|FG000|12 Months|Refusal|0
7093890|NCT02290223|11214071|FG001|12 Months|Refusal|1
7093891|NCT02290340|11214081|FG000|Overall Study|Lost to Follow-up|0
7093892|NCT02290340|11214082|FG001|Overall Study|Lost to Follow-up|0
7093893|NCT02290340|11214083|FG002|Overall Study|Lost to Follow-up|0
7093894|NCT02290340|11214084|FG003|Overall Study|Lost to Follow-up|1
7093895|NCT02290340|11214081|FG000|Overall Study|Withdrawal by Subject|1
7093896|NCT02290340|11214082|FG001|Overall Study|Withdrawal by Subject|0
7093897|NCT02290340|11214083|FG002|Overall Study|Withdrawal by Subject|0
7093898|NCT02290340|11214084|FG003|Overall Study|Withdrawal by Subject|0
7093899|NCT02290340|11214081|FG000|Overall Study|Other|1
7093900|NCT02290340|11214082|FG001|Overall Study|Other|0
7093901|NCT02290340|11214083|FG002|Overall Study|Other|0
7093902|NCT02290340|11214084|FG003|Overall Study|Other|1
7093903|NCT02290405|11214099|FG000|Overall Study|Withdrawal by Subject|1
7093904|NCT02290405|11214100|FG001|Overall Study|Withdrawal by Subject|0
7093905|NCT02290691|11214140|FG000|Overall Study|Noncompliance|0
7093906|NCT02290691|11214141|FG001|Overall Study|Noncompliance|1
7093907|NCT02290691|11214140|FG000|Overall Study|Withdrawal by Subject|1
7093908|NCT02290691|11214141|FG001|Overall Study|Withdrawal by Subject|1
7093909|NCT02290691|11214140|FG000|Overall Study|Lost to Follow-up|7
7093910|NCT02290691|11214141|FG001|Overall Study|Lost to Follow-up|7
7093911|NCT02290821|11214149|FG000|Overall Study|Withdrawal by Subject|1
7093912|NCT02290821|11214150|FG001|Overall Study|Withdrawal by Subject|1
7093913|NCT02290821|11214149|FG000|Overall Study|Unable or unwilling to cooperate with|2
7093914|NCT02290821|11214150|FG001|Overall Study|Unable or unwilling to cooperate with|0
7093915|NCT02290821|11214149|FG000|Overall Study|Lost to Follow-up|3
7093916|NCT02290821|11214150|FG001|Overall Study|Lost to Follow-up|2
7093917|NCT02290873|11214159|FG000|Overall Study|Withdrawal by Subject|0
7093918|NCT02290873|11214160|FG001|Overall Study|Withdrawal by Subject|1
7093919|NCT02290873|11214161|FG002|Overall Study|Withdrawal by Subject|1
7093920|NCT02290873|11214159|FG000|Overall Study|Nellcor device error|1
7093921|NCT02290873|11214160|FG001|Overall Study|Nellcor device error|0
7093922|NCT02290873|11214161|FG002|Overall Study|Nellcor device error|0
7093923|NCT02290873|11214159|FG000|Overall Study|Esophagogastroduodenoscopy was added|1
7093924|NCT02290873|11214160|FG001|Overall Study|Esophagogastroduodenoscopy was added|0
7093925|NCT02290873|11214161|FG002|Overall Study|Esophagogastroduodenoscopy was added|0
7093926|NCT02290873|11214159|FG000|Overall Study|Protocol Violation|0
7093927|NCT02290873|11214160|FG001|Overall Study|Protocol Violation|0
7093928|NCT02290873|11214161|FG002|Overall Study|Protocol Violation|1
7093929|NCT02290925|11214172|FG000|First Period of Three Months|Lost to Follow-up|2
7093930|NCT02290925|11214173|FG001|First Period of Three Months|Lost to Follow-up|1
7093931|NCT02290925|11214172|FG000|First Period of Three Months|Death|1
7093932|NCT02290925|11214173|FG001|First Period of Three Months|Death|0
7093933|NCT02290925|11214172|FG000|First Period of Three Months|Insulin Started|1
7093934|NCT02290925|11214173|FG001|First Period of Three Months|Insulin Started|1
7093935|NCT02290925|11214172|FG000|Second Period of 3 Months|Lost to Follow-up|1
7093936|NCT02290925|11214173|FG001|Second Period of 3 Months|Lost to Follow-up|3
7093937|NCT02290925|11214172|FG000|Second Period of 3 Months|insulin started|0
7093938|NCT02290925|11214173|FG001|Second Period of 3 Months|insulin started|1
7093939|NCT02291029|11214197|FG000|Overall Study|Withdrawal by Subject|0
7093940|NCT02291029|11214198|FG001|Overall Study|Withdrawal by Subject|0
7093941|NCT02291029|11214199|FG002|Overall Study|Withdrawal by Subject|1
7093942|NCT02291029|11214200|FG003|Overall Study|Withdrawal by Subject|0
7093943|NCT02291029|11214201|FG004|Overall Study|Withdrawal by Subject|0
7093944|NCT02291029|11214202|FG005|Overall Study|Withdrawal by Subject|0
7093945|NCT02291029|11214197|FG000|Overall Study|Adverse Event|0
7093946|NCT02291029|11214198|FG001|Overall Study|Adverse Event|1
7093947|NCT02291029|11214199|FG002|Overall Study|Adverse Event|0
7093948|NCT02291029|11214200|FG003|Overall Study|Adverse Event|0
7093949|NCT02291029|11214201|FG004|Overall Study|Adverse Event|0
7093950|NCT02291029|11214202|FG005|Overall Study|Adverse Event|0
7093951|NCT02291237|11214222|FG000|Overall Study|Study Terminated by Sponsor|72
7093952|NCT02291237|11214223|FG001|Overall Study|Study Terminated by Sponsor|67
7093953|NCT02291237|11214222|FG000|Overall Study|Adverse Event|1
7093954|NCT02291237|11214223|FG001|Overall Study|Adverse Event|3
7093955|NCT02291237|11214222|FG000|Overall Study|Investigator's Discretion|0
7093956|NCT02291237|11214223|FG001|Overall Study|Investigator's Discretion|3
7093957|NCT02291237|11214222|FG000|Overall Study|Withdrew Consent|11
7093958|NCT02291237|11214223|FG001|Overall Study|Withdrew Consent|11
7093959|NCT02291237|11214222|FG000|Overall Study|Lost to Follow-up|0
7093960|NCT02291237|11214223|FG001|Overall Study|Lost to Follow-up|2
7093961|NCT02291237|11214222|FG000|Overall Study|Subject Required Prohibited Medication|2
7093962|NCT02291237|11214223|FG001|Overall Study|Subject Required Prohibited Medication|0
7093963|NCT02291289|11214233|FG000|Induction Treatment|Not Dosed|2
7093964|NCT02291289|11214234|FG001|Induction Treatment|Not Dosed|0
7093965|NCT02291289|11214235|FG002|Induction Treatment|Not Dosed|0
7093966|NCT02291289|11214236|FG003|Induction Treatment|Not Dosed|9
7093967|NCT02291289|11214237|FG004|Induction Treatment|Not Dosed|0
7093968|NCT02291289|11214238|FG005|Induction Treatment|Not Dosed|0
7093969|NCT02291289|11214239|FG006|Induction Treatment|Not Dosed|0
7093970|NCT02291289|11214240|FG007|Induction Treatment|Not Dosed|0
7093971|NCT02291289|11214241|FG008|Induction Treatment|Not Dosed|0
7093972|NCT02291289|11214242|FG009|Induction Treatment|Not Dosed|1
7093973|NCT02291289|11214243|FG010|Induction Treatment|Not Dosed|0
7093974|NCT02291289|11214244|FG011|Induction Treatment|Not Dosed|0
7093975|NCT02291289|11214233|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0
7093976|NCT02291289|11214234|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0
7093977|NCT02291289|11214235|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0
7093978|NCT02291289|11214236|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0
7093979|NCT02291289|11214237|FG004|Maintenance Treatment Phase|Withdrawal by Subject|13
7093980|NCT02291289|11214238|FG005|Maintenance Treatment Phase|Withdrawal by Subject|11
7093981|NCT02291289|11214239|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0
7093982|NCT02291289|11214240|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0
7093983|NCT02291289|11214241|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0
7093984|NCT02291289|11214242|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0
7093985|NCT02291289|11214243|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2
7093986|NCT02291289|11214244|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3
7093987|NCT02291289|11214233|FG000|Maintenance Treatment Phase|Protocol Violation|0
7093988|NCT02291289|11214234|FG001|Maintenance Treatment Phase|Protocol Violation|1
7093989|NCT02291289|11214235|FG002|Maintenance Treatment Phase|Protocol Violation|0
7093990|NCT02291289|11214236|FG003|Maintenance Treatment Phase|Protocol Violation|0
7093991|NCT02291289|11214237|FG004|Maintenance Treatment Phase|Protocol Violation|2
7093992|NCT02291289|11214238|FG005|Maintenance Treatment Phase|Protocol Violation|1
7093993|NCT02291289|11214239|FG006|Maintenance Treatment Phase|Protocol Violation|0
7093994|NCT02291289|11214240|FG007|Maintenance Treatment Phase|Protocol Violation|0
7093995|NCT02291289|11214241|FG008|Maintenance Treatment Phase|Protocol Violation|0
7093996|NCT02291289|11214242|FG009|Maintenance Treatment Phase|Protocol Violation|0
7093997|NCT02291289|11214243|FG010|Maintenance Treatment Phase|Protocol Violation|0
7093998|NCT02291289|11214244|FG011|Maintenance Treatment Phase|Protocol Violation|0
7093999|NCT02291289|11214233|FG000|Maintenance Treatment Phase|Death|0
7094000|NCT02291289|11214234|FG001|Maintenance Treatment Phase|Death|23
7094001|NCT02291289|11214235|FG002|Maintenance Treatment Phase|Death|13
7094002|NCT02291289|11214236|FG003|Maintenance Treatment Phase|Death|0
7094003|NCT02291289|11214237|FG004|Maintenance Treatment Phase|Death|185
7094004|NCT02291289|11214238|FG005|Maintenance Treatment Phase|Death|100
7094005|NCT02291289|11214239|FG006|Maintenance Treatment Phase|Death|0
7094006|NCT02291289|11214240|FG007|Maintenance Treatment Phase|Death|1
7094007|NCT02291289|11214241|FG008|Maintenance Treatment Phase|Death|1
7094008|NCT02291289|11214242|FG009|Maintenance Treatment Phase|Death|0
7094009|NCT02291289|11214243|FG010|Maintenance Treatment Phase|Death|26
7094010|NCT02291289|11214244|FG011|Maintenance Treatment Phase|Death|11
7094011|NCT02291289|11214233|FG000|Maintenance Treatment Phase|Adverse Event|0
7094012|NCT02291289|11214234|FG001|Maintenance Treatment Phase|Adverse Event|0
7094013|NCT02291289|11214235|FG002|Maintenance Treatment Phase|Adverse Event|0
7094014|NCT02291289|11214236|FG003|Maintenance Treatment Phase|Adverse Event|0
7094015|NCT02291289|11214237|FG004|Maintenance Treatment Phase|Adverse Event|1
7094016|NCT02291289|11214238|FG005|Maintenance Treatment Phase|Adverse Event|0
7094017|NCT02291289|11214239|FG006|Maintenance Treatment Phase|Adverse Event|0
7094018|NCT02291289|11214240|FG007|Maintenance Treatment Phase|Adverse Event|0
7094019|NCT02291289|11214241|FG008|Maintenance Treatment Phase|Adverse Event|0
7094020|NCT02291289|11214242|FG009|Maintenance Treatment Phase|Adverse Event|0
7094021|NCT02291289|11214243|FG010|Maintenance Treatment Phase|Adverse Event|0
7094022|NCT02291289|11214244|FG011|Maintenance Treatment Phase|Adverse Event|0
7094023|NCT02291289|11214233|FG000|Maintenance Treatment Phase|Lost to Follow-up|0
7094024|NCT02291289|11214234|FG001|Maintenance Treatment Phase|Lost to Follow-up|0
7094025|NCT02291289|11214235|FG002|Maintenance Treatment Phase|Lost to Follow-up|0
7094026|NCT02291289|11214236|FG003|Maintenance Treatment Phase|Lost to Follow-up|0
7094027|NCT02291289|11214237|FG004|Maintenance Treatment Phase|Lost to Follow-up|12
7094028|NCT02291289|11214238|FG005|Maintenance Treatment Phase|Lost to Follow-up|3
7094029|NCT02291289|11214239|FG006|Maintenance Treatment Phase|Lost to Follow-up|0
7094030|NCT02291289|11214240|FG007|Maintenance Treatment Phase|Lost to Follow-up|1
7094031|NCT02291289|11214241|FG008|Maintenance Treatment Phase|Lost to Follow-up|0
7094032|NCT02291289|11214242|FG009|Maintenance Treatment Phase|Lost to Follow-up|0
7094033|NCT02291289|11214243|FG010|Maintenance Treatment Phase|Lost to Follow-up|2
7094034|NCT02291289|11214244|FG011|Maintenance Treatment Phase|Lost to Follow-up|1
7094035|NCT02291289|11214233|FG000|Maintenance Treatment Phase|Other|0
7094036|NCT02291289|11214234|FG001|Maintenance Treatment Phase|Other|0
7094037|NCT02291289|11214235|FG002|Maintenance Treatment Phase|Other|1
7094038|NCT02291289|11214236|FG003|Maintenance Treatment Phase|Other|0
7094039|NCT02291289|11214237|FG004|Maintenance Treatment Phase|Other|29
7094040|NCT02291289|11214238|FG005|Maintenance Treatment Phase|Other|8
7094041|NCT02291289|11214239|FG006|Maintenance Treatment Phase|Other|0
7094042|NCT02291289|11214240|FG007|Maintenance Treatment Phase|Other|0
7094043|NCT02291289|11214241|FG008|Maintenance Treatment Phase|Other|1
7094044|NCT02291289|11214242|FG009|Maintenance Treatment Phase|Other|0
7094045|NCT02291289|11214243|FG010|Maintenance Treatment Phase|Other|0
7094046|NCT02291289|11214244|FG011|Maintenance Treatment Phase|Other|0
7094047|NCT02291289|11214233|FG000|Maintenance Treatment Phase|Physician Decision|0
7094048|NCT02291289|11214234|FG001|Maintenance Treatment Phase|Physician Decision|0
7094049|NCT02291289|11214235|FG002|Maintenance Treatment Phase|Physician Decision|0
7094050|NCT02291289|11214236|FG003|Maintenance Treatment Phase|Physician Decision|0
7094051|NCT02291289|11214237|FG004|Maintenance Treatment Phase|Physician Decision|2
7094052|NCT02291289|11214238|FG005|Maintenance Treatment Phase|Physician Decision|0
7094053|NCT02291289|11214239|FG006|Maintenance Treatment Phase|Physician Decision|0
7094054|NCT02291289|11214240|FG007|Maintenance Treatment Phase|Physician Decision|0
7094055|NCT02291289|11214241|FG008|Maintenance Treatment Phase|Physician Decision|0
7094056|NCT02291289|11214242|FG009|Maintenance Treatment Phase|Physician Decision|0
7094057|NCT02291289|11214243|FG010|Maintenance Treatment Phase|Physician Decision|0
7094058|NCT02291289|11214244|FG011|Maintenance Treatment Phase|Physician Decision|1
7094059|NCT02291289|11214233|FG000|Maintenance Treatment Phase|Multiple Reasons|0
7094060|NCT02291289|11214234|FG001|Maintenance Treatment Phase|Multiple Reasons|0
7094061|NCT02291289|11214235|FG002|Maintenance Treatment Phase|Multiple Reasons|0
7094062|NCT02291289|11214236|FG003|Maintenance Treatment Phase|Multiple Reasons|0
7094063|NCT02291289|11214237|FG004|Maintenance Treatment Phase|Multiple Reasons|4
7094064|NCT02291289|11214238|FG005|Maintenance Treatment Phase|Multiple Reasons|1
7094065|NCT02291289|11214239|FG006|Maintenance Treatment Phase|Multiple Reasons|0
7094066|NCT02291289|11214240|FG007|Maintenance Treatment Phase|Multiple Reasons|0
7094067|NCT02291289|11214241|FG008|Maintenance Treatment Phase|Multiple Reasons|0
7094068|NCT02291289|11214242|FG009|Maintenance Treatment Phase|Multiple Reasons|0
7094069|NCT02291289|11214243|FG010|Maintenance Treatment Phase|Multiple Reasons|0
7094070|NCT02291289|11214244|FG011|Maintenance Treatment Phase|Multiple Reasons|0
7094071|NCT02291289|11214233|FG000|Maintenance Treatment Phase|No Treatment Received|0
7094072|NCT02291289|11214234|FG001|Maintenance Treatment Phase|No Treatment Received|0
7094073|NCT02291289|11214235|FG002|Maintenance Treatment Phase|No Treatment Received|2
7094074|NCT02291289|11214236|FG003|Maintenance Treatment Phase|No Treatment Received|0
7094075|NCT02291289|11214237|FG004|Maintenance Treatment Phase|No Treatment Received|4
7094076|NCT02291289|11214238|FG005|Maintenance Treatment Phase|No Treatment Received|5
7094077|NCT02291289|11214239|FG006|Maintenance Treatment Phase|No Treatment Received|0
7094078|NCT02291289|11214240|FG007|Maintenance Treatment Phase|No Treatment Received|0
7094079|NCT02291289|11214241|FG008|Maintenance Treatment Phase|No Treatment Received|0
7094080|NCT02291289|11214242|FG009|Maintenance Treatment Phase|No Treatment Received|0
7094081|NCT02291289|11214243|FG010|Maintenance Treatment Phase|No Treatment Received|1
7094082|NCT02291289|11214244|FG011|Maintenance Treatment Phase|No Treatment Received|0
7094083|NCT02291419|11214288|FG000|Overall Study|Early study termination|1
7094084|NCT02291419|11214289|FG001|Overall Study|Early study termination|5
7094085|NCT02291432|11214295|FG000|Overall Study|Withdrawal by Subject|2
7094086|NCT02291510|11214303|FG000|Overall Study|Adverse Event|0
7094087|NCT02291510|11214304|FG001|Overall Study|Adverse Event|0
7094088|NCT02291510|11214305|FG002|Overall Study|Adverse Event|0
7094089|NCT02291510|11214306|FG003|Overall Study|Adverse Event|1
7094090|NCT02291549|11214318|FG000|Overall Study|Lost to Follow-up|1
7094091|NCT02291549|11214319|FG001|Overall Study|Lost to Follow-up|0
7094092|NCT02291549|11214318|FG000|Overall Study|Withdrawal by Subject|0
7094093|NCT02291549|11214319|FG001|Overall Study|Withdrawal by Subject|1
7094094|NCT02291601|11214327|FG000|Abdomen|Did not qualify|333
7094095|NCT02291601|11214328|FG001|Abdomen|Did not qualify|54
7094096|NCT02291601|11214329|FG002|Abdomen|Did not qualify|339
7094097|NCT02291601|11214327|FG000|Groin|Did not qualify|183
7094098|NCT02291601|11214328|FG001|Groin|Did not qualify|30
7094099|NCT02291601|11214329|FG002|Groin|Did not qualify|177
7094100|NCT02291614|11214351|FG000|Overall Study|Lost to Follow-up|0
7094101|NCT02291614|11214352|FG001|Overall Study|Lost to Follow-up|0
7094102|NCT02291614|11214353|FG002|Overall Study|Lost to Follow-up|0
7094103|NCT02291614|11214354|FG003|Overall Study|Lost to Follow-up|0
7094104|NCT02291614|11214355|FG004|Overall Study|Lost to Follow-up|0
7094105|NCT02291614|11214356|FG005|Overall Study|Lost to Follow-up|0
7094106|NCT02291614|11214357|FG006|Overall Study|Lost to Follow-up|0
7094107|NCT02291614|11214358|FG007|Overall Study|Lost to Follow-up|1
7094108|NCT02291614|11214359|FG008|Overall Study|Lost to Follow-up|0
7094109|NCT02291614|11214360|FG009|Overall Study|Lost to Follow-up|0
7094110|NCT02291614|11214361|FG010|Overall Study|Lost to Follow-up|0
7094111|NCT02291614|11214351|FG000|Overall Study|Withdrawal by Subject|0
7094112|NCT02291614|11214352|FG001|Overall Study|Withdrawal by Subject|1
7094113|NCT02291614|11214353|FG002|Overall Study|Withdrawal by Subject|0
7094114|NCT02291614|11214354|FG003|Overall Study|Withdrawal by Subject|0
7094115|NCT02291614|11214355|FG004|Overall Study|Withdrawal by Subject|0
7094116|NCT02291614|11214356|FG005|Overall Study|Withdrawal by Subject|0
7094117|NCT02291614|11214357|FG006|Overall Study|Withdrawal by Subject|0
7094118|NCT02291614|11214358|FG007|Overall Study|Withdrawal by Subject|0
7094119|NCT02291614|11214359|FG008|Overall Study|Withdrawal by Subject|0
7094120|NCT02291614|11214360|FG009|Overall Study|Withdrawal by Subject|2
7094121|NCT02291614|11214361|FG010|Overall Study|Withdrawal by Subject|2
7094122|NCT02291614|11214351|FG000|Overall Study|Decision by sponsor|0
7094123|NCT02291614|11214352|FG001|Overall Study|Decision by sponsor|0
7094124|NCT02291614|11214353|FG002|Overall Study|Decision by sponsor|0
7094125|NCT02291614|11214354|FG003|Overall Study|Decision by sponsor|1
7094126|NCT02291614|11214355|FG004|Overall Study|Decision by sponsor|0
7094127|NCT02291614|11214356|FG005|Overall Study|Decision by sponsor|0
7094128|NCT02291614|11214357|FG006|Overall Study|Decision by sponsor|0
7094129|NCT02291614|11214358|FG007|Overall Study|Decision by sponsor|0
7094130|NCT02291614|11214359|FG008|Overall Study|Decision by sponsor|0
7094131|NCT02291614|11214360|FG009|Overall Study|Decision by sponsor|0
7094132|NCT02291614|11214361|FG010|Overall Study|Decision by sponsor|0
7094133|NCT02291614|11214351|FG000|Overall Study|Death|0
7094134|NCT02291614|11214352|FG001|Overall Study|Death|0
7094135|NCT02291614|11214353|FG002|Overall Study|Death|1
7094136|NCT02291614|11214354|FG003|Overall Study|Death|0
7094137|NCT02291614|11214355|FG004|Overall Study|Death|1
7094138|NCT02291614|11214356|FG005|Overall Study|Death|1
7094139|NCT02291614|11214357|FG006|Overall Study|Death|1
7094140|NCT02291614|11214358|FG007|Overall Study|Death|0
7094141|NCT02291614|11214359|FG008|Overall Study|Death|0
7094142|NCT02291614|11214360|FG009|Overall Study|Death|0
7094143|NCT02291614|11214361|FG010|Overall Study|Death|0
7094144|NCT02291679|11214394|FG000|Overall Study|Adverse Event|2
7094145|NCT02291679|11214395|FG001|Overall Study|Adverse Event|12
7094146|NCT02291679|11214396|FG002|Overall Study|Adverse Event|19
7094147|NCT02291679|11214394|FG000|Overall Study|Protocol Violation|5
7094148|NCT02291679|11214395|FG001|Overall Study|Protocol Violation|1
7094149|NCT02291679|11214396|FG002|Overall Study|Protocol Violation|7
7094150|NCT02291679|11214394|FG000|Overall Study|Withdrew Consent|18
7094151|NCT02291679|11214395|FG001|Overall Study|Withdrew Consent|10
7094152|NCT02291679|11214396|FG002|Overall Study|Withdrew Consent|15
7094153|NCT02291679|11214394|FG000|Overall Study|Lost to Follow-up|12
7094154|NCT02291679|11214395|FG001|Overall Study|Lost to Follow-up|10
7094155|NCT02291679|11214396|FG002|Overall Study|Lost to Follow-up|9
7094156|NCT02291679|11214394|FG000|Overall Study|Insufficient Therapeutic Response|5
7094157|NCT02291679|11214395|FG001|Overall Study|Insufficient Therapeutic Response|5
7094158|NCT02291679|11214396|FG002|Overall Study|Insufficient Therapeutic Response|7
7094159|NCT02291679|11214394|FG000|Overall Study|Other|2
7094160|NCT02291679|11214395|FG001|Overall Study|Other|4
7094161|NCT02291679|11214396|FG002|Overall Study|Other|2
7094162|NCT02291861|11214420|FG000|Overall Study|Adverse Event|2
7094163|NCT02291861|11214421|FG001|Overall Study|Adverse Event|4
7094164|NCT02291861|11214422|FG002|Overall Study|Adverse Event|1
7094165|NCT02291861|11214423|FG003|Overall Study|Adverse Event|2
7094166|NCT02291861|11214420|FG000|Overall Study|Death|0
7094167|NCT02291861|11214421|FG001|Overall Study|Death|0
7094168|NCT02291861|11214422|FG002|Overall Study|Death|1
7094169|NCT02291861|11214423|FG003|Overall Study|Death|1
7094170|NCT02291861|11214420|FG000|Overall Study|Protocol Violation|1
7094171|NCT02291861|11214421|FG001|Overall Study|Protocol Violation|0
7094172|NCT02291861|11214422|FG002|Overall Study|Protocol Violation|0
7094173|NCT02291861|11214423|FG003|Overall Study|Protocol Violation|1
7094174|NCT02291861|11214420|FG000|Overall Study|Withdrawal by Subject|1
7094175|NCT02291861|11214421|FG001|Overall Study|Withdrawal by Subject|2
7094176|NCT02291861|11214422|FG002|Overall Study|Withdrawal by Subject|1
7094177|NCT02291861|11214423|FG003|Overall Study|Withdrawal by Subject|4
7094178|NCT02291861|11214420|FG000|Overall Study|Noncompliance|1
7094179|NCT02291861|11214421|FG001|Overall Study|Noncompliance|1
7094180|NCT02291861|11214422|FG002|Overall Study|Noncompliance|2
7094181|NCT02291861|11214423|FG003|Overall Study|Noncompliance|1
7094182|NCT02291861|11214420|FG000|Overall Study|Lost to Follow-up|2
7094183|NCT02291861|11214421|FG001|Overall Study|Lost to Follow-up|1
7094184|NCT02291861|11214422|FG002|Overall Study|Lost to Follow-up|4
7094185|NCT02291861|11214423|FG003|Overall Study|Lost to Follow-up|0
7094186|NCT02291861|11214420|FG000|Overall Study|Other|0
7094187|NCT02291861|11214421|FG001|Overall Study|Other|0
7094188|NCT02291861|11214422|FG002|Overall Study|Other|0
7094189|NCT02291861|11214423|FG003|Overall Study|Other|1
7094190|NCT02291913|11214433|FG000|Overall Study|Progressive Disease|32
7094191|NCT02291913|11214433|FG000|Overall Study|Adverse Event|11
7094192|NCT02291913|11214433|FG000|Overall Study|Death|2
7094193|NCT02291913|11214433|FG000|Overall Study|Physician Decision|1
7094194|NCT02291913|11214433|FG000|Overall Study|Withdrawal by Subject|1
7094195|NCT02291913|11214433|FG000|Overall Study|Protocol Violation|1
7094196|NCT02292212|11214450|FG000|ViE Phase|Withdrawal by Subject|1
7094197|NCT02292212|11214450|FG000|ViE Phase|Protocol Violation|2
7094198|NCT02292446|11214474|FG000|Overall Study|Adverse Event|12
7094199|NCT02292446|11214474|FG000|Overall Study|Death|1
7094200|NCT02292446|11214474|FG000|Overall Study|Disease progression|2
7094201|NCT02292446|11214474|FG000|Overall Study|Subject/guardian decision|2
7094202|NCT02292446|11214474|FG000|Overall Study|Withdrawal by Subject|3
7094203|NCT02292719|11214496|FG000|Overall Study|Withdrawal by Subject|0
7094204|NCT02292719|11214497|FG001|Overall Study|Withdrawal by Subject|0
7094205|NCT02292719|11214498|FG002|Overall Study|Withdrawal by Subject|0
7094206|NCT02292719|11214499|FG003|Overall Study|Withdrawal by Subject|1
7094207|NCT02292719|11214500|FG004|Overall Study|Withdrawal by Subject|1
7094208|NCT02292719|11214501|FG005|Overall Study|Withdrawal by Subject|0
7094209|NCT02292719|11214496|FG000|Overall Study|Subject enrolled in new study.|0
7094210|NCT02292719|11214497|FG001|Overall Study|Subject enrolled in new study.|0
7094211|NCT02292719|11214498|FG002|Overall Study|Subject enrolled in new study.|1
7094212|NCT02292719|11214499|FG003|Overall Study|Subject enrolled in new study.|0
7094213|NCT02292719|11214500|FG004|Overall Study|Subject enrolled in new study.|0
7094214|NCT02292719|11214501|FG005|Overall Study|Subject enrolled in new study.|0
7094215|NCT02292771|11214517|FG000|Overall Study|Withdrawal by Subject|2
7094216|NCT02292771|11214518|FG001|Overall Study|Withdrawal by Subject|1
7094217|NCT02292771|11214517|FG000|Overall Study|Lost to Follow-up|2
7094218|NCT02292771|11214518|FG001|Overall Study|Lost to Follow-up|1
7094219|NCT02292784|11214531|FG000|Overall Study|Lost to Follow-up|1
7094220|NCT02292784|11214532|FG001|Overall Study|Lost to Follow-up|17
7094221|NCT02292784|11214533|FG002|Overall Study|Lost to Follow-up|18
7094222|NCT02292784|11214531|FG000|Overall Study|Withdrawal by Subject|0
7094223|NCT02292784|11214532|FG001|Overall Study|Withdrawal by Subject|3
7094224|NCT02292784|11214533|FG002|Overall Study|Withdrawal by Subject|3
7094225|NCT02292849|11214544|FG000|Overall Study|Lost to Follow-up|0
7094226|NCT02292849|11214545|FG001|Overall Study|Lost to Follow-up|2
7094227|NCT02292849|11214546|FG002|Overall Study|Lost to Follow-up|2
7094228|NCT02292849|11214544|FG000|Overall Study|Physician Decision|4
7094229|NCT02292849|11214545|FG001|Overall Study|Physician Decision|0
7094230|NCT02292849|11214546|FG002|Overall Study|Physician Decision|0
7094231|NCT02292927|11214556|FG000|Overall Study|Protocol Violation|13
7094232|NCT02292927|11214557|FG001|Overall Study|Protocol Violation|7
7094233|NCT02293395|11214586|FG000|Overall Study|Lost to Follow-up|1
7094234|NCT02293395|11214587|FG001|Overall Study|Lost to Follow-up|0
7094235|NCT02293395|11214586|FG000|Overall Study|Withdrawal by Subject|8
7094236|NCT02293395|11214587|FG001|Overall Study|Withdrawal by Subject|7
7094237|NCT02293460|11214593|FG000|Overall Study|Protocol Violation|1
7094238|NCT02293460|11214593|FG000|Overall Study|Lack of Efficacy|2
7094239|NCT02293460|11214593|FG000|Overall Study|Adverse Event|2
7094240|NCT02293460|11214593|FG000|Overall Study|Withdrawal by Subject|1
7094241|NCT02293499|11214600|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0
7094242|NCT02293499|11214601|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0
7094243|NCT02293499|11214602|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10
7094244|NCT02293499|11214600|FG000|Intervention - Camp|Withdrawal by Subject|3
7094245|NCT02293499|11214601|FG001|Intervention - Camp|Withdrawal by Subject|6
7094246|NCT02293499|11214602|FG002|Intervention - Camp|Withdrawal by Subject|2
7094247|NCT02293499|11214600|FG000|Intervention - Camp|these are those not showing up at camp|24
7094248|NCT02293499|11214601|FG001|Intervention - Camp|these are those not showing up at camp|28
7094249|NCT02293499|11214602|FG002|Intervention - Camp|these are those not showing up at camp|4
7094250|NCT02293499|11214600|FG000|3 Month Follow Up|Withdrawal by Subject|1
7094251|NCT02293499|11214601|FG001|3 Month Follow Up|Withdrawal by Subject|0
7094252|NCT02293499|11214602|FG002|3 Month Follow Up|Withdrawal by Subject|4
7094253|NCT02293499|11214600|FG000|3 Month Follow Up|Lost to Follow-up|14
7094254|NCT02293499|11214601|FG001|3 Month Follow Up|Lost to Follow-up|15
7094255|NCT02293499|11214602|FG002|3 Month Follow Up|Lost to Follow-up|6
7094256|NCT02293499|11214600|FG000|6 Month Follow Up|Lost to Follow-up|17
7094257|NCT02293499|11214601|FG001|6 Month Follow Up|Lost to Follow-up|27
7094258|NCT02293499|11214602|FG002|6 Month Follow Up|Lost to Follow-up|6
7094259|NCT02293499|11214600|FG000|6 Month Follow Up|Withdrawal by Subject|0
7094260|NCT02293499|11214601|FG001|6 Month Follow Up|Withdrawal by Subject|0
7094261|NCT02293499|11214602|FG002|6 Month Follow Up|Withdrawal by Subject|1
7094262|NCT02293499|11214600|FG000|9 Month Follow Up|Withdrawal by Subject|2
7094263|NCT02293499|11214601|FG001|9 Month Follow Up|Withdrawal by Subject|0
7094264|NCT02293499|11214602|FG002|9 Month Follow Up|Withdrawal by Subject|0
7094265|NCT02293499|11214600|FG000|9 Month Follow Up|Lost to Follow-up|24
7094266|NCT02293499|11214601|FG001|9 Month Follow Up|Lost to Follow-up|28
7094267|NCT02293499|11214602|FG002|9 Month Follow Up|Lost to Follow-up|4
7094268|NCT02293499|11214600|FG000|12 Month Follow Up|Lost to Follow-up|26
7094269|NCT02293499|11214601|FG001|12 Month Follow Up|Lost to Follow-up|25
7094270|NCT02293499|11214602|FG002|12 Month Follow Up|Lost to Follow-up|6
7094271|NCT02293499|11214600|FG000|12 Month Follow Up|Withdrawal by Subject|0
7094272|NCT02293499|11214601|FG001|12 Month Follow Up|Withdrawal by Subject|1
7094273|NCT02293499|11214602|FG002|12 Month Follow Up|Withdrawal by Subject|0
7094274|NCT02293499|11214600|FG000|15 Month Follow Up|Lost to Follow-up|22
7094275|NCT02293499|11214601|FG001|15 Month Follow Up|Lost to Follow-up|22
7094276|NCT02293499|11214602|FG002|15 Month Follow Up|Lost to Follow-up|7
7094277|NCT02293538|11214630|FG000|Overall Study|Adverse Event|0
7094278|NCT02293538|11214631|FG001|Overall Study|Adverse Event|1
7094279|NCT02293538|11214630|FG000|Overall Study|Lost to Follow-up|1
7094280|NCT02293538|11214631|FG001|Overall Study|Lost to Follow-up|0
7094281|NCT02293538|11214630|FG000|Overall Study|Withdrawal by Subject|0
7094282|NCT02293538|11214631|FG001|Overall Study|Withdrawal by Subject|1
7094283|NCT02293837|11214646|FG000|Overall Study|Lost to Follow-up|0
7094284|NCT02293837|11214647|FG001|Overall Study|Lost to Follow-up|2
7094285|NCT02293837|11214648|FG002|Overall Study|Lost to Follow-up|1
7094286|NCT02293837|11214649|FG003|Overall Study|Lost to Follow-up|0
7094287|NCT02293837|11214646|FG000|Overall Study|Withdrawal by Subject|2
7094288|NCT02293837|11214647|FG001|Overall Study|Withdrawal by Subject|1
7094289|NCT02293837|11214648|FG002|Overall Study|Withdrawal by Subject|2
7094290|NCT02293837|11214649|FG003|Overall Study|Withdrawal by Subject|1
7094291|NCT02293837|11214646|FG000|Overall Study|COVID-19 Related|1
7094292|NCT02293837|11214647|FG001|Overall Study|COVID-19 Related|1
7094293|NCT02293837|11214648|FG002|Overall Study|COVID-19 Related|0
7094294|NCT02293837|11214649|FG003|Overall Study|COVID-19 Related|0
7094295|NCT02293837|11214646|FG000|Overall Study|Participant ill and could not be infused|0
7094296|NCT02293837|11214647|FG001|Overall Study|Participant ill and could not be infused|0
7094297|NCT02293837|11214648|FG002|Overall Study|Participant ill and could not be infused|1
7094298|NCT02293837|11214649|FG003|Overall Study|Participant ill and could not be infused|0
7094299|NCT02293863|11214666|FG000|Overall Study|Death|4
7094300|NCT02293863|11214667|FG001|Overall Study|Death|6
7094301|NCT02293863|11214668|FG002|Overall Study|Death|4
7094302|NCT02293863|11214666|FG000|Overall Study|Lost to Follow-up|2
7094303|NCT02293863|11214667|FG001|Overall Study|Lost to Follow-up|2
7094304|NCT02293863|11214668|FG002|Overall Study|Lost to Follow-up|2
7094305|NCT02293863|11214666|FG000|Overall Study|Withdrawal by Subject|3
7094306|NCT02293863|11214667|FG001|Overall Study|Withdrawal by Subject|3
7094307|NCT02293863|11214668|FG002|Overall Study|Withdrawal by Subject|1
7094308|NCT02293863|11214666|FG000|Overall Study|Reason Not Specified|0
7094309|NCT02293863|11214667|FG001|Overall Study|Reason Not Specified|2
7094310|NCT02293863|11214668|FG002|Overall Study|Reason Not Specified|2
7094311|NCT02293902|11214681|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5
7094312|NCT02293902|11214682|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6
7094313|NCT02293902|11214683|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8
7094314|NCT02293902|11214684|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0
7094315|NCT02293902|11214685|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0
7094316|NCT02293902|11214681|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5
7094317|NCT02293902|11214682|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1
7094318|NCT02293902|11214683|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2
7094319|NCT02293902|11214684|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
7094320|NCT02293902|11214685|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
7094321|NCT02293902|11214681|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1
7094322|NCT02293902|11214682|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
7094323|NCT02293902|11214683|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
7094324|NCT02293902|11214684|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
7094325|NCT02293902|11214685|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
7094326|NCT02293902|11214681|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0
7094327|NCT02293902|11214682|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7
7094328|NCT02293902|11214683|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
7094329|NCT02293902|11214684|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
7094330|NCT02293902|11214685|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6
7094331|NCT02293902|11214681|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
7094332|NCT02293902|11214682|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
7094333|NCT02293902|11214683|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
7094334|NCT02293902|11214684|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
7094335|NCT02293902|11214685|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
7094336|NCT02293993|11214707|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1
7094337|NCT02293993|11214708|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0
7094338|NCT02293993|11214709|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0
7094339|NCT02293993|11214710|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1
7094340|NCT02293993|11214707|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0
7094341|NCT02293993|11214708|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2
7094342|NCT02293993|11214709|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1
7094343|NCT02293993|11214710|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0
7094344|NCT02293993|11214707|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0
7094345|NCT02293993|11214708|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0
7094346|NCT02293993|11214709|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1
7094347|NCT02293993|11214710|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0
7094348|NCT02293993|11214707|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2
7094349|NCT02293993|11214708|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2
7094350|NCT02293993|11214709|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3
7094351|NCT02293993|11214710|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1
7094352|NCT02293993|11214707|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0
7094353|NCT02293993|11214708|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1
7094354|NCT02293993|11214709|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0
7094355|NCT02293993|11214710|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0
7094356|NCT02294019|11214728|FG000|Overall Study|Adverse Event|2
7094357|NCT02294019|11214728|FG000|Overall Study|Protocol Violation|68
7094358|NCT02294019|11214728|FG000|Overall Study|Lost to Follow-up|31
7094359|NCT02294019|11214728|FG000|Overall Study|Other|1
7094360|NCT02294019|11214728|FG000|Overall Study|Withdrawal by Subject|1
7094361|NCT02294058|11214735|FG000|Overall Study|Adverse Event|16
7094362|NCT02294058|11214736|FG001|Overall Study|Adverse Event|7
7094363|NCT02294058|11214737|FG002|Overall Study|Adverse Event|13
7094364|NCT02294058|11214735|FG000|Overall Study|Lack of Efficacy|3
7094365|NCT02294058|11214736|FG001|Overall Study|Lack of Efficacy|3
7094366|NCT02294058|11214737|FG002|Overall Study|Lack of Efficacy|0
7094367|NCT02294058|11214735|FG000|Overall Study|Lost to Follow-up|1
7094368|NCT02294058|11214736|FG001|Overall Study|Lost to Follow-up|0
7094369|NCT02294058|11214737|FG002|Overall Study|Lost to Follow-up|2
7094370|NCT02294058|11214735|FG000|Overall Study|Withdrawal by Subject|10
7094371|NCT02294058|11214736|FG001|Overall Study|Withdrawal by Subject|14
7094372|NCT02294058|11214737|FG002|Overall Study|Withdrawal by Subject|13
7094373|NCT02294058|11214735|FG000|Overall Study|Physician Decision|2
7094374|NCT02294058|11214736|FG001|Overall Study|Physician Decision|1
7094375|NCT02294058|11214737|FG002|Overall Study|Physician Decision|0
7094376|NCT02294058|11214735|FG000|Overall Study|Miscellaneous|4
7094377|NCT02294058|11214736|FG001|Overall Study|Miscellaneous|1
7094378|NCT02294058|11214737|FG002|Overall Study|Miscellaneous|1
7094379|NCT02294175|11214748|FG000|Overall Study|Withdrawal by Subject|1
7094380|NCT02294175|11214749|FG001|Overall Study|Withdrawal by Subject|2
7094381|NCT02294175|11214748|FG000|Overall Study|pt taking excluded medication|3
7094382|NCT02294175|11214749|FG001|Overall Study|pt taking excluded medication|1
7094383|NCT02294175|11214748|FG000|Overall Study|Protocol Violation|1
7094384|NCT02294175|11214749|FG001|Overall Study|Protocol Violation|0
7094385|NCT02294175|11214748|FG000|Overall Study|Lost to Follow-up|0
7094386|NCT02294175|11214749|FG001|Overall Study|Lost to Follow-up|1
7094387|NCT02294175|11214748|FG000|Overall Study|wound healed|0
7094388|NCT02294175|11214749|FG001|Overall Study|wound healed|2
7094389|NCT02294227|11214758|FG000|Overall Study|Death|0
7094390|NCT02294227|11214759|FG001|Overall Study|Death|0
7094391|NCT02294227|11214760|FG002|Overall Study|Death|1
7094392|NCT02294227|11214758|FG000|Overall Study|Subject/Guardian Decision|6
7094393|NCT02294227|11214759|FG001|Overall Study|Subject/Guardian Decision|3
7094394|NCT02294227|11214760|FG002|Overall Study|Subject/Guardian Decision|7
7094395|NCT02294227|11214758|FG000|Overall Study|Physician Decision|1
7094396|NCT02294227|11214759|FG001|Overall Study|Physician Decision|2
7094397|NCT02294227|11214760|FG002|Overall Study|Physician Decision|1
7094398|NCT02294227|11214758|FG000|Overall Study|Lost to Follow-up|1
7094399|NCT02294227|11214759|FG001|Overall Study|Lost to Follow-up|0
7094400|NCT02294227|11214760|FG002|Overall Study|Lost to Follow-up|0
7094401|NCT02294227|11214758|FG000|Overall Study|Lack of Efficacy|11
7094402|NCT02294227|11214759|FG001|Overall Study|Lack of Efficacy|12
7094403|NCT02294227|11214760|FG002|Overall Study|Lack of Efficacy|8
7094404|NCT02294227|11214758|FG000|Overall Study|Adverse Event|6
7094405|NCT02294227|11214759|FG001|Overall Study|Adverse Event|8
7094406|NCT02294227|11214760|FG002|Overall Study|Adverse Event|2
7094407|NCT02294318|11214776|FG000|Overall Study|Worsening of drinking|3
7094408|NCT02294318|11214777|FG001|Overall Study|Worsening of drinking|0
7094409|NCT02294318|11214776|FG000|Overall Study|Not exposed to intervention|0
7094410|NCT02294318|11214777|FG001|Overall Study|Not exposed to intervention|2
7094411|NCT02294396|11214787|FG000|Overall Study|Adverse Event|26
7094412|NCT02294396|11214788|FG001|Overall Study|Adverse Event|25
7094413|NCT02294396|11214789|FG002|Overall Study|Adverse Event|21
7094414|NCT02294396|11214790|FG003|Overall Study|Adverse Event|24
7094415|NCT02294396|11214787|FG000|Overall Study|Electrocardiogram adviser's judgment|1
7094416|NCT02294396|11214788|FG001|Overall Study|Electrocardiogram adviser's judgment|0
7094417|NCT02294396|11214789|FG002|Overall Study|Electrocardiogram adviser's judgment|0
7094418|NCT02294396|11214790|FG003|Overall Study|Electrocardiogram adviser's judgment|1
7094419|NCT02294396|11214787|FG000|Overall Study|Withdrawal by Subject|8
7094420|NCT02294396|11214788|FG001|Overall Study|Withdrawal by Subject|6
7094421|NCT02294396|11214789|FG002|Overall Study|Withdrawal by Subject|6
7094422|NCT02294396|11214790|FG003|Overall Study|Withdrawal by Subject|8
7094423|NCT02294396|11214787|FG000|Overall Study|Lost to Follow-up|0
7094424|NCT02294396|11214788|FG001|Overall Study|Lost to Follow-up|0
7094425|NCT02294396|11214789|FG002|Overall Study|Lost to Follow-up|1
7094426|NCT02294396|11214790|FG003|Overall Study|Lost to Follow-up|1
7094427|NCT02294396|11214787|FG000|Overall Study|Protocol Deviation|3
7094428|NCT02294396|11214788|FG001|Overall Study|Protocol Deviation|2
7094429|NCT02294396|11214789|FG002|Overall Study|Protocol Deviation|2
7094430|NCT02294396|11214790|FG003|Overall Study|Protocol Deviation|1
7094431|NCT02294396|11214787|FG000|Overall Study|Miscellaneous|2
7094432|NCT02294396|11214788|FG001|Overall Study|Miscellaneous|0
7094433|NCT02294396|11214789|FG002|Overall Study|Miscellaneous|5
7094434|NCT02294396|11214790|FG003|Overall Study|Miscellaneous|2
7094435|NCT02294474|11214802|FG000|Overall Study|Adverse Event|7
7094436|NCT02294474|11214803|FG001|Overall Study|Adverse Event|7
7094437|NCT02294474|11214802|FG000|Overall Study|Lack of Efficacy|2
7094438|NCT02294474|11214803|FG001|Overall Study|Lack of Efficacy|1
7094439|NCT02294474|11214802|FG000|Overall Study|Protocol Violation|4
7094440|NCT02294474|11214803|FG001|Overall Study|Protocol Violation|2
7094441|NCT02294474|11214802|FG000|Overall Study|Other than specified above|12
7094442|NCT02294474|11214803|FG001|Overall Study|Other than specified above|12
7094443|NCT02294604|11214813|FG000|Overall Study|Did not provide samples for culture|0
7094444|NCT02294604|11214814|FG001|Overall Study|Did not provide samples for culture|1
7094445|NCT02294604|11214815|FG002|Overall Study|Did not provide samples for culture|0
7094446|NCT02294604|11214813|FG000|Overall Study|Culture contamination|1
7094447|NCT02294604|11214814|FG001|Overall Study|Culture contamination|2
7094448|NCT02294604|11214815|FG002|Overall Study|Culture contamination|0
7094449|NCT02294682|11214842|FG000|Overall Study|Could not swallow pills|1
7094450|NCT02294682|11214843|FG001|Overall Study|Could not swallow pills|0
7094451|NCT02294734|11214851|FG000|Overall Study|Adverse Event|5
7094452|NCT02294734|11214852|FG001|Overall Study|Adverse Event|5
7094453|NCT02294734|11214851|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1
7094454|NCT02294734|11214852|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0
7094455|NCT02294734|11214851|FG000|Overall Study|Lost to Follow-up|2
7094456|NCT02294734|11214852|FG001|Overall Study|Lost to Follow-up|0
7094457|NCT02294734|11214851|FG000|Overall Study|Physician Decision|2
7094458|NCT02294734|11214852|FG001|Overall Study|Physician Decision|1
7094459|NCT02294734|11214851|FG000|Overall Study|Withdrawal by Subject|4
7094460|NCT02294734|11214852|FG001|Overall Study|Withdrawal by Subject|2
7094461|NCT02294773|11214862|FG000|Overall Study|Withdrawal by Subject|0
7094462|NCT02294773|11214863|FG001|Overall Study|Withdrawal by Subject|2
7094463|NCT02294786|11214871|FG000|Overall Study|Withdrawal by Subject|0
7094464|NCT02294786|11214872|FG001|Overall Study|Withdrawal by Subject|1
7094465|NCT02294786|11214871|FG000|Overall Study|Physician Decision|6
7094466|NCT02294786|11214872|FG001|Overall Study|Physician Decision|7
7094467|NCT02294786|11214871|FG000|Overall Study|Lost to Follow-up|1
7094468|NCT02294786|11214872|FG001|Overall Study|Lost to Follow-up|2
7094469|NCT02294786|11214871|FG000|Overall Study|Protocol Violation|1
7094470|NCT02294786|11214872|FG001|Overall Study|Protocol Violation|0
7094471|NCT02294786|11214871|FG000|Overall Study|Adverse Event|1
7094472|NCT02294786|11214872|FG001|Overall Study|Adverse Event|1
7094473|NCT02294786|11214871|FG000|Overall Study|Death|2
7094474|NCT02294786|11214872|FG001|Overall Study|Death|3
7094475|NCT02295020|11214881|FG000|Overall Study|Adverse Event|0
7094476|NCT02295020|11214882|FG001|Overall Study|Adverse Event|1
7094477|NCT02295020|11214881|FG000|Overall Study|Withdrawal by Subject|3
7094478|NCT02295020|11214882|FG001|Overall Study|Withdrawal by Subject|2
7094479|NCT02295280|11214896|FG000|Overall Study|Adverse Event|0
7094480|NCT02295280|11214897|FG001|Overall Study|Adverse Event|1
7094481|NCT02295644|11214924|FG000|Overall Study|Did not meet inclusion criterion|0
7094482|NCT02295644|11214925|FG001|Overall Study|Did not meet inclusion criterion|0
7094483|NCT02295644|11214926|FG002|Overall Study|Did not meet inclusion criterion|1
7094484|NCT02295644|11214927|FG003|Overall Study|Did not meet inclusion criterion|2
7094485|NCT02295774|11214946|FG000|Overall Study|Physician Decision|1
7094486|NCT02295774|11214946|FG000|Overall Study|Withdrawal by Subject|2
7094487|NCT02295995|11214953|FG000|Overall Study|Lost to Follow-up|5
7094488|NCT02295995|11214954|FG001|Overall Study|Lost to Follow-up|1
7094489|NCT02296112|11214970|FG000|Overall Study|Disease progression|7
7094490|NCT02296112|11214970|FG000|Overall Study|Toxicity|1
7094491|NCT02296112|11214970|FG000|Overall Study|Began an alternate therapy|1
7094492|NCT02296138|11214981|FG000|Overall Study|Adverse Event|348
7094493|NCT02296138|11214982|FG001|Overall Study|Adverse Event|259
7094494|NCT02296138|11214981|FG000|Overall Study|Lack of Efficacy|59
7094495|NCT02296138|11214982|FG001|Overall Study|Lack of Efficacy|37
7094496|NCT02296138|11214981|FG000|Overall Study|Protocol Violation|35
7094497|NCT02296138|11214982|FG001|Overall Study|Protocol Violation|36
7094498|NCT02296138|11214981|FG000|Overall Study|Lost to Follow-up|9
7094499|NCT02296138|11214982|FG001|Overall Study|Lost to Follow-up|12
7094500|NCT02296138|11214981|FG000|Overall Study|Withdrawal by Subject|184
7094501|NCT02296138|11214982|FG001|Overall Study|Withdrawal by Subject|131
7094502|NCT02296138|11214981|FG000|Overall Study|Not Treated|1
7094503|NCT02296138|11214982|FG001|Overall Study|Not Treated|1
7094504|NCT02296138|11214981|FG000|Overall Study|Patients with data irregularities|10
7094505|NCT02296138|11214982|FG001|Overall Study|Patients with data irregularities|11
7094506|NCT02296138|11214981|FG000|Overall Study|Other than specified|15
7094507|NCT02296138|11214982|FG001|Overall Study|Other than specified|13
7094508|NCT02296190|11214998|FG000|Overall Study|Lost to Follow-up|0
7094509|NCT02296190|11214999|FG001|Overall Study|Lost to Follow-up|0
7094510|NCT02296190|11215000|FG002|Overall Study|Lost to Follow-up|0
7094511|NCT02296190|11215001|FG003|Overall Study|Lost to Follow-up|0
7094512|NCT02296190|11215002|FG004|Overall Study|Lost to Follow-up|1
7094513|NCT02296190|11215003|FG005|Overall Study|Lost to Follow-up|0
7094514|NCT02296190|11214998|FG000|Overall Study|Failure to induce PSVT|6
7094515|NCT02296190|11214999|FG001|Overall Study|Failure to induce PSVT|10
7094516|NCT02296190|11215000|FG002|Overall Study|Failure to induce PSVT|5
7094517|NCT02296190|11215001|FG003|Overall Study|Failure to induce PSVT|13
7094518|NCT02296190|11215002|FG004|Overall Study|Failure to induce PSVT|8
7094519|NCT02296190|11215003|FG005|Overall Study|Failure to induce PSVT|0
7094520|NCT02296190|11214998|FG000|Overall Study|Physician Decision|1
7094521|NCT02296190|11214999|FG001|Overall Study|Physician Decision|1
7094522|NCT02296190|11215000|FG002|Overall Study|Physician Decision|0
7094523|NCT02296190|11215001|FG003|Overall Study|Physician Decision|1
7094524|NCT02296190|11215002|FG004|Overall Study|Physician Decision|2
7094525|NCT02296190|11215003|FG005|Overall Study|Physician Decision|0
7094526|NCT02296190|11214998|FG000|Overall Study|Withdrawal by Subject|0
7094527|NCT02296190|11214999|FG001|Overall Study|Withdrawal by Subject|1
7094528|NCT02296190|11215000|FG002|Overall Study|Withdrawal by Subject|0
7094529|NCT02296190|11215001|FG003|Overall Study|Withdrawal by Subject|0
7094530|NCT02296190|11215002|FG004|Overall Study|Withdrawal by Subject|0
7094531|NCT02296190|11215003|FG005|Overall Study|Withdrawal by Subject|0
7094532|NCT02296190|11214998|FG000|Overall Study|PSVT < 5 minutes|5
7094533|NCT02296190|11214999|FG001|Overall Study|PSVT < 5 minutes|6
7094534|NCT02296190|11215000|FG002|Overall Study|PSVT < 5 minutes|6
7094535|NCT02296190|11215001|FG003|Overall Study|PSVT < 5 minutes|6
7094536|NCT02296190|11215002|FG004|Overall Study|PSVT < 5 minutes|5
7094537|NCT02296190|11215003|FG005|Overall Study|PSVT < 5 minutes|0
7094538|NCT02296190|11214998|FG000|Overall Study|Patient was given Propofol|0
7094539|NCT02296190|11214999|FG001|Overall Study|Patient was given Propofol|1
7094540|NCT02296190|11215000|FG002|Overall Study|Patient was given Propofol|0
7094541|NCT02296190|11215001|FG003|Overall Study|Patient was given Propofol|1
7094542|NCT02296190|11215002|FG004|Overall Study|Patient was given Propofol|0
7094543|NCT02296190|11215003|FG005|Overall Study|Patient was given Propofol|0
7094544|NCT02296190|11214998|FG000|Overall Study|Patient with Atrial Tachycardia|0
7094545|NCT02296190|11214999|FG001|Overall Study|Patient with Atrial Tachycardia|0
7094546|NCT02296190|11215000|FG002|Overall Study|Patient with Atrial Tachycardia|0
7094547|NCT02296190|11215001|FG003|Overall Study|Patient with Atrial Tachycardia|1
7094548|NCT02296190|11215002|FG004|Overall Study|Patient with Atrial Tachycardia|0
7094549|NCT02296190|11215003|FG005|Overall Study|Patient with Atrial Tachycardia|0
7094550|NCT02296190|11214998|FG000|Overall Study|Blood pressure <100 after sedation|0
7094551|NCT02296190|11214999|FG001|Overall Study|Blood pressure <100 after sedation|0
7094552|NCT02296190|11215000|FG002|Overall Study|Blood pressure <100 after sedation|0
7094553|NCT02296190|11215001|FG003|Overall Study|Blood pressure <100 after sedation|1
7094554|NCT02296190|11215002|FG004|Overall Study|Blood pressure <100 after sedation|0
7094555|NCT02296190|11215003|FG005|Overall Study|Blood pressure <100 after sedation|0
7094556|NCT02296190|11214998|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0
7094557|NCT02296190|11214999|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1
7094558|NCT02296190|11215000|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1
7094559|NCT02296190|11215001|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0
7094560|NCT02296190|11215002|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0
7094561|NCT02296190|11215003|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0
7094562|NCT02296190|11214998|FG000|Overall Study|Patient on antiarrhythmic medication|1
7094563|NCT02296190|11214999|FG001|Overall Study|Patient on antiarrhythmic medication|0
7094564|NCT02296190|11215000|FG002|Overall Study|Patient on antiarrhythmic medication|0
7094565|NCT02296190|11215001|FG003|Overall Study|Patient on antiarrhythmic medication|0
7094566|NCT02296190|11215002|FG004|Overall Study|Patient on antiarrhythmic medication|0
7094567|NCT02296190|11215003|FG005|Overall Study|Patient on antiarrhythmic medication|0
7094568|NCT02296190|11214998|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0
7094569|NCT02296190|11214999|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1
7094570|NCT02296190|11215000|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0
7094571|NCT02296190|11215001|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0
7094572|NCT02296190|11215002|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0
7094573|NCT02296190|11215003|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0
7094574|NCT02296190|11214998|FG000|Overall Study|Lab result not available in time|1
7094575|NCT02296190|11214999|FG001|Overall Study|Lab result not available in time|0
7094576|NCT02296190|11215000|FG002|Overall Study|Lab result not available in time|0
7094577|NCT02296190|11215001|FG003|Overall Study|Lab result not available in time|0
7094578|NCT02296190|11215002|FG004|Overall Study|Lab result not available in time|0
7094579|NCT02296190|11215003|FG005|Overall Study|Lab result not available in time|0
7094580|NCT02296242|11215021|FG000|Overall Study|Death|1
7094581|NCT02296242|11215022|FG001|Overall Study|Death|1
7094582|NCT02296242|11215023|FG002|Overall Study|Death|1
7094583|NCT02296242|11215024|FG003|Overall Study|Death|1
7094584|NCT02296242|11215025|FG004|Overall Study|Death|1
7094585|NCT02296242|11215021|FG000|Overall Study|Withdrawal by Subject|0
7094586|NCT02296242|11215022|FG001|Overall Study|Withdrawal by Subject|0
7094587|NCT02296242|11215023|FG002|Overall Study|Withdrawal by Subject|1
7094588|NCT02296242|11215024|FG003|Overall Study|Withdrawal by Subject|1
7094589|NCT02296242|11215025|FG004|Overall Study|Withdrawal by Subject|3
7094590|NCT02296242|11215021|FG000|Overall Study|Disease Progression|1
7094591|NCT02296242|11215022|FG001|Overall Study|Disease Progression|3
7094592|NCT02296242|11215023|FG002|Overall Study|Disease Progression|2
7094593|NCT02296242|11215024|FG003|Overall Study|Disease Progression|8
7094594|NCT02296242|11215025|FG004|Overall Study|Disease Progression|11
7094595|NCT02296242|11215021|FG000|Overall Study|Unacceptable Toxicity|0
7094596|NCT02296242|11215022|FG001|Overall Study|Unacceptable Toxicity|0
7094597|NCT02296242|11215023|FG002|Overall Study|Unacceptable Toxicity|0
7094598|NCT02296242|11215024|FG003|Overall Study|Unacceptable Toxicity|0
7094599|NCT02296242|11215025|FG004|Overall Study|Unacceptable Toxicity|1
7094600|NCT02296242|11215021|FG000|Overall Study|Patient Condition Changed|0
7094601|NCT02296242|11215022|FG001|Overall Study|Patient Condition Changed|0
7094602|NCT02296242|11215023|FG002|Overall Study|Patient Condition Changed|2
7094603|NCT02296242|11215024|FG003|Overall Study|Patient Condition Changed|0
7094604|NCT02296242|11215025|FG004|Overall Study|Patient Condition Changed|1
7094605|NCT02296242|11215021|FG000|Overall Study|At Least 3 Drug Interruptions|0
7094606|NCT02296242|11215022|FG001|Overall Study|At Least 3 Drug Interruptions|0
7094607|NCT02296242|11215023|FG002|Overall Study|At Least 3 Drug Interruptions|1
7094608|NCT02296242|11215024|FG003|Overall Study|At Least 3 Drug Interruptions|1
7094609|NCT02296242|11215025|FG004|Overall Study|At Least 3 Drug Interruptions|1
7094610|NCT02296242|11215021|FG000|Overall Study|Lost to Follow-up|1
7094611|NCT02296242|11215022|FG001|Overall Study|Lost to Follow-up|0
7094612|NCT02296242|11215023|FG002|Overall Study|Lost to Follow-up|0
7094613|NCT02296242|11215024|FG003|Overall Study|Lost to Follow-up|0
7094614|NCT02296242|11215025|FG004|Overall Study|Lost to Follow-up|0
7094615|NCT02296242|11215021|FG000|Overall Study|Need for Hydroxyurea|2
7094616|NCT02296242|11215022|FG001|Overall Study|Need for Hydroxyurea|0
7094617|NCT02296242|11215023|FG002|Overall Study|Need for Hydroxyurea|0
7094618|NCT02296242|11215024|FG003|Overall Study|Need for Hydroxyurea|0
7094619|NCT02296242|11215025|FG004|Overall Study|Need for Hydroxyurea|0
7094620|NCT02296242|11215021|FG000|Overall Study|Screened for Other Protocol|0
7094621|NCT02296242|11215022|FG001|Overall Study|Screened for Other Protocol|1
7094622|NCT02296242|11215023|FG002|Overall Study|Screened for Other Protocol|0
7094623|NCT02296242|11215024|FG003|Overall Study|Screened for Other Protocol|0
7094624|NCT02296242|11215025|FG004|Overall Study|Screened for Other Protocol|0
7094625|NCT02296242|11215021|FG000|Overall Study|Physician Decision|0
7094626|NCT02296242|11215022|FG001|Overall Study|Physician Decision|1
7094627|NCT02296242|11215023|FG002|Overall Study|Physician Decision|0
7094628|NCT02296242|11215024|FG003|Overall Study|Physician Decision|1
7094629|NCT02296242|11215025|FG004|Overall Study|Physician Decision|0
7094630|NCT02296242|11215021|FG000|Overall Study|Alternative Treatment|0
7094631|NCT02296242|11215022|FG001|Overall Study|Alternative Treatment|0
7094632|NCT02296242|11215023|FG002|Overall Study|Alternative Treatment|0
7094633|NCT02296242|11215024|FG003|Overall Study|Alternative Treatment|1
7094634|NCT02296242|11215025|FG004|Overall Study|Alternative Treatment|0
7094635|NCT02296242|11215021|FG000|Overall Study|Adverse Event|0
7094636|NCT02296242|11215022|FG001|Overall Study|Adverse Event|0
7094637|NCT02296242|11215023|FG002|Overall Study|Adverse Event|0
7094638|NCT02296242|11215024|FG003|Overall Study|Adverse Event|1
7094639|NCT02296242|11215025|FG004|Overall Study|Adverse Event|0
7094640|NCT02296242|11215021|FG000|Overall Study|Lack of Efficacy|0
7094641|NCT02296242|11215022|FG001|Overall Study|Lack of Efficacy|0
7094642|NCT02296242|11215023|FG002|Overall Study|Lack of Efficacy|0
7094643|NCT02296242|11215024|FG003|Overall Study|Lack of Efficacy|0
7094644|NCT02296242|11215025|FG004|Overall Study|Lack of Efficacy|3
7094645|NCT02296320|11215048|FG000|Overall Study|Withdrawal by Subject|4
7094646|NCT02296320|11215049|FG001|Overall Study|Withdrawal by Subject|0
7094647|NCT02296320|11215050|FG002|Overall Study|Withdrawal by Subject|2
7094648|NCT02296320|11215048|FG000|Overall Study|Death|24
7094649|NCT02296320|11215049|FG001|Overall Study|Death|3
7094650|NCT02296320|11215050|FG002|Overall Study|Death|27
7094651|NCT02296320|11215048|FG000|Overall Study|Lost to Follow-up|5
7094652|NCT02296320|11215049|FG001|Overall Study|Lost to Follow-up|2
7094653|NCT02296320|11215050|FG002|Overall Study|Lost to Follow-up|7
7094654|NCT02296320|11215048|FG000|Overall Study|Not treated|2
7094655|NCT02296320|11215049|FG001|Overall Study|Not treated|0
7094656|NCT02296320|11215050|FG002|Overall Study|Not treated|0
7094657|NCT02296320|11215048|FG000|Overall Study|Not - specified|0
7094658|NCT02296320|11215049|FG001|Overall Study|Not - specified|0
7094659|NCT02296320|11215050|FG002|Overall Study|Not - specified|1
7094660|NCT02296424|11215073|FG000|Part 1|New therapy for study indication|0
7094661|NCT02296424|11215074|FG001|Part 1|New therapy for study indication|1
7094662|NCT02296424|11215075|FG002|Part 1|New therapy for study indication|0
7094663|NCT02296424|11215076|FG003|Part 1|New therapy for study indication|0
7094664|NCT02296424|11215073|FG000|Part 1|Protocol Violation|0
7094665|NCT02296424|11215074|FG001|Part 1|Protocol Violation|1
7094666|NCT02296424|11215075|FG002|Part 1|Protocol Violation|0
7094667|NCT02296424|11215076|FG003|Part 1|Protocol Violation|0
7094668|NCT02296424|11215073|FG000|Part 1|Withdrawal by Subject|0
7094669|NCT02296424|11215074|FG001|Part 1|Withdrawal by Subject|2
7094670|NCT02296424|11215075|FG002|Part 1|Withdrawal by Subject|0
7094671|NCT02296424|11215076|FG003|Part 1|Withdrawal by Subject|0
7094672|NCT02296424|11215073|FG000|Part 1|Study terminated by sponsor|0
7094673|NCT02296424|11215074|FG001|Part 1|Study terminated by sponsor|1
7094674|NCT02296424|11215075|FG002|Part 1|Study terminated by sponsor|0
7094675|NCT02296424|11215076|FG003|Part 1|Study terminated by sponsor|0
7094676|NCT02296424|11215073|FG000|Part 1|Adverse Event|2
7094677|NCT02296424|11215074|FG001|Part 1|Adverse Event|11
7094678|NCT02296424|11215075|FG002|Part 1|Adverse Event|0
7094679|NCT02296424|11215076|FG003|Part 1|Adverse Event|0
7094680|NCT02296424|11215073|FG000|Part 1|Lack of Efficacy|5
7094681|NCT02296424|11215074|FG001|Part 1|Lack of Efficacy|17
7094682|NCT02296424|11215075|FG002|Part 1|Lack of Efficacy|0
7094683|NCT02296424|11215076|FG003|Part 1|Lack of Efficacy|0
7094684|NCT02296424|11215073|FG000|Part 1|16 directly started part II|16
7094685|NCT02296424|11215074|FG001|Part 1|16 directly started part II|0
7094686|NCT02296424|11215075|FG002|Part 1|16 directly started part II|0
7094687|NCT02296424|11215076|FG003|Part 1|16 directly started part II|0
7094688|NCT02296424|11215073|FG000|Part 2|Lack of Efficacy|0
7094689|NCT02296424|11215074|FG001|Part 2|Lack of Efficacy|0
7094690|NCT02296424|11215075|FG002|Part 2|Lack of Efficacy|1
7094691|NCT02296424|11215076|FG003|Part 2|Lack of Efficacy|0
7094692|NCT02296424|11215073|FG000|Part 2|Adverse Event|0
7094693|NCT02296424|11215074|FG001|Part 2|Adverse Event|0
7094694|NCT02296424|11215075|FG002|Part 2|Adverse Event|1
7094695|NCT02296424|11215076|FG003|Part 2|Adverse Event|0
7094696|NCT02296424|11215073|FG000|Part 2|Lost to Follow-up|0
7094697|NCT02296424|11215074|FG001|Part 2|Lost to Follow-up|0
7094698|NCT02296424|11215075|FG002|Part 2|Lost to Follow-up|1
7094699|NCT02296424|11215076|FG003|Part 2|Lost to Follow-up|0
7094700|NCT02296476|11215087|FG000|Overall Study|Disease Progression|6
7094701|NCT02296476|11215088|FG001|Overall Study|Disease Progression|4
7094702|NCT02296476|11215089|FG002|Overall Study|Disease Progression|2
7094703|NCT02296840|11215136|FG000|Overall Study|Adverse Event|1
7094704|NCT02296840|11215137|FG001|Overall Study|Adverse Event|1
7094705|NCT02296840|11215136|FG000|Overall Study|Protocol Violation|2
7094706|NCT02296840|11215137|FG001|Overall Study|Protocol Violation|1
7094707|NCT02296840|11215136|FG000|Overall Study|Lost to Follow-up|6
7094708|NCT02296840|11215137|FG001|Overall Study|Lost to Follow-up|17
7094709|NCT02296892|11215155|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7
7094710|NCT02296892|11215156|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4
7094711|NCT02296892|11215157|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4
7094712|NCT02296892|11215155|FG000|Overall Study|Lost to Follow-up|5
7094713|NCT02296892|11215156|FG001|Overall Study|Lost to Follow-up|0
7094714|NCT02296892|11215157|FG002|Overall Study|Lost to Follow-up|1
7094715|NCT02296931|11215167|FG000|Overall Study|Protocol Violation|0
7094716|NCT02296931|11215168|FG001|Overall Study|Protocol Violation|2
7094717|NCT02297503|11215190|FG000|Overall Study|Withdrawal by Subject|1
7094718|NCT02297503|11215191|FG001|Overall Study|Withdrawal by Subject|1
7094719|NCT02297503|11215190|FG000|Overall Study|Protocol Violation|1
7094720|NCT02297503|11215191|FG001|Overall Study|Protocol Violation|0
7094721|NCT02297503|11215190|FG000|Overall Study|Pregnancy|0
7094722|NCT02297503|11215191|FG001|Overall Study|Pregnancy|1
7094723|NCT02297503|11215190|FG000|Overall Study|Lost to Follow-up|0
7094724|NCT02297503|11215191|FG001|Overall Study|Lost to Follow-up|1
7094725|NCT02297503|11215190|FG000|Overall Study|Medical reason|0
7094726|NCT02297503|11215191|FG001|Overall Study|Medical reason|1
7094727|NCT02297516|11215208|FG000|Single Treatment Phase (6 Months)|Medical reason|1
7094728|NCT02297516|11215209|FG001|Single Treatment Phase (6 Months)|Medical reason|0
7094729|NCT02297516|11215208|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0
7094730|NCT02297516|11215209|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2
7094731|NCT02297516|11215208|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0
7094732|NCT02297516|11215209|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1
7094733|NCT02297815|11215224|FG000|Overall Study|Lost to Follow-up|236
7094734|NCT02297815|11215225|FG001|Overall Study|Lost to Follow-up|140
7094735|NCT02297841|11215233|FG000|Overall Study|Withdrawal by Subject|1
7094736|NCT02297841|11215233|FG000|Overall Study|Protocol Violation|7
7094737|NCT02298023|11215240|FG000|Overall Study|Withdrawal by Subject|1
7094738|NCT02298023|11215241|FG001|Overall Study|Withdrawal by Subject|0
7094739|NCT02298023|11215242|FG002|Overall Study|Withdrawal by Subject|0
7094740|NCT02298179|11215265|FG000|Overall Study|Lost to Follow-up|0
7094741|NCT02298179|11215266|FG001|Overall Study|Lost to Follow-up|0
7094742|NCT02298179|11215267|FG002|Overall Study|Lost to Follow-up|1
7094743|NCT02298179|11215268|FG003|Overall Study|Lost to Follow-up|0
7094744|NCT02298179|11215269|FG004|Overall Study|Lost to Follow-up|0
7094745|NCT02298179|11215270|FG005|Overall Study|Lost to Follow-up|0
7094746|NCT02298179|11215271|FG006|Overall Study|Lost to Follow-up|0
7094747|NCT02298179|11215272|FG007|Overall Study|Lost to Follow-up|1
7094748|NCT02298179|11215273|FG008|Overall Study|Lost to Follow-up|0
7094749|NCT02298179|11215274|FG009|Overall Study|Lost to Follow-up|0
7094750|NCT02298179|11215275|FG010|Overall Study|Lost to Follow-up|0
7094751|NCT02298179|11215276|FG011|Overall Study|Lost to Follow-up|0
7094752|NCT02298192|11215304|FG000|Overall Study|Unclassified|3
7094753|NCT02298192|11215305|FG001|Overall Study|Unclassified|2
7094754|NCT02298192|11215304|FG000|Overall Study|Withdrawal criteria|2
7094755|NCT02298192|11215305|FG001|Overall Study|Withdrawal criteria|0
7094756|NCT02298192|11215304|FG000|Overall Study|Withdrawal by Subject|6
7094757|NCT02298192|11215305|FG001|Overall Study|Withdrawal by Subject|1
7094758|NCT02298192|11215304|FG000|Overall Study|Lost to Follow-up|2
7094759|NCT02298192|11215305|FG001|Overall Study|Lost to Follow-up|1
7094760|NCT02298192|11215304|FG000|Overall Study|Adverse Event|6
7094761|NCT02298192|11215305|FG001|Overall Study|Adverse Event|2
7094762|NCT02298868|11215357|FG000|Overall Study|Adverse Event|1
7094763|NCT02298868|11215357|FG000|Overall Study|Death|1
7094764|NCT02298868|11215357|FG000|Overall Study|Patient underwent transplant|1
7094765|NCT02298946|11215367|FG000|Overall Study|Did not receive treatment|2
7094766|NCT02298946|11215368|FG001|Overall Study|Did not receive treatment|0
7094767|NCT02298946|11215367|FG000|Overall Study|Unevaluable|2
7094768|NCT02298946|11215368|FG001|Overall Study|Unevaluable|1
7094769|NCT02299076|11215381|FG000|Overall Study|Fraudulent Entries|20
7094770|NCT02299076|11215382|FG001|Overall Study|Fraudulent Entries|14
7094771|NCT02299167|11215426|FG000|Overall Study|patients were excluded from the study|11
7094772|NCT02299336|11215443|FG000|Overall Study|Withdrawal by Subject|11
7094773|NCT02299336|11215443|FG000|Overall Study|Adverse Event|1
7094774|NCT02299336|11215443|FG000|Overall Study|Death|1
7094775|NCT02299336|11215443|FG000|Overall Study|Lost to Follow-up|1
7094776|NCT02299375|11215458|FG000|Overall Study|Adverse Event, serious fatal|1
7094777|NCT02299375|11215459|FG001|Overall Study|Adverse Event, serious fatal|3
7094778|NCT02299375|11215458|FG000|Overall Study|Adverse Event, non-fatal|8
7094779|NCT02299375|11215459|FG001|Overall Study|Adverse Event, non-fatal|9
7094780|NCT02299375|11215458|FG000|Overall Study|Lack of Efficacy|1
7094781|NCT02299375|11215459|FG001|Overall Study|Lack of Efficacy|3
7094782|NCT02299375|11215458|FG000|Overall Study|Protocol Violation|1
7094783|NCT02299375|11215459|FG001|Overall Study|Protocol Violation|3
7094784|NCT02299375|11215458|FG000|Overall Study|Other: Met stopping criteria|1
7094785|NCT02299375|11215459|FG001|Overall Study|Other: Met stopping criteria|0
7094786|NCT02299375|11215458|FG000|Overall Study|Other: Study closed/terminated|66
7094787|NCT02299375|11215459|FG001|Overall Study|Other: Study closed/terminated|55
7094788|NCT02299375|11215458|FG000|Overall Study|Lost to Follow-up|0
7094789|NCT02299375|11215459|FG001|Overall Study|Lost to Follow-up|2
7094790|NCT02299375|11215458|FG000|Overall Study|Physician Decision|1
7094791|NCT02299375|11215459|FG001|Overall Study|Physician Decision|1
7094792|NCT02299375|11215458|FG000|Overall Study|Withdrawal by Subject|1
7094793|NCT02299375|11215459|FG001|Overall Study|Withdrawal by Subject|4
7094794|NCT02299388|11215468|FG000|Overall Study|Withdrawal by Subject|0
7094795|NCT02299388|11215469|FG001|Overall Study|Withdrawal by Subject|1
7094796|NCT02299427|11215477|FG000|Overall Study|Withdrawal by Subject|1
7094797|NCT02299427|11215478|FG001|Overall Study|Withdrawal by Subject|0
7094798|NCT02299427|11215477|FG000|Overall Study|Lost to Follow-up|1
7094799|NCT02299427|11215478|FG001|Overall Study|Lost to Follow-up|3
7094800|NCT02299427|11215477|FG000|Overall Study|not adherent to dog website use|21
7094801|NCT02299427|11215478|FG001|Overall Study|not adherent to dog website use|0
7094802|NCT02299635|11215506|FG000|Overall Study|Adverse Event|2
7094803|NCT02299635|11215506|FG000|Overall Study|Death|1
7094804|NCT02299635|11215506|FG000|Overall Study|Global deterioration of health status|1
7094805|NCT02299635|11215506|FG000|Overall Study|Objective progression or relapse|10
7094806|NCT02299635|11215506|FG000|Overall Study|Withdrawal by Subject|2
7094807|NCT02299635|11215506|FG000|Overall Study|Other|3
7094808|NCT02300103|11215564|FG000|Overall Study|Lack of Efficacy|3
7094809|NCT02300103|11215564|FG000|Overall Study|Protocol Violation|1
7094810|NCT02300103|11215564|FG000|Overall Study|Withdrew Consent|2
7094811|NCT02300129|11215568|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
7094812|NCT02300129|11215569|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1
7094813|NCT02300129|11215570|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
7094814|NCT02300129|11215571|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
7094815|NCT02300129|11215568|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
7094816|NCT02300129|11215569|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
7094817|NCT02300129|11215570|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
7094818|NCT02300129|11215571|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1
7094819|NCT02300129|11215568|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1
7094820|NCT02300129|11215569|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
7094821|NCT02300129|11215570|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
7094822|NCT02300129|11215571|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
7094823|NCT02300220|11215583|FG000|Overall Study|Lost to Follow-up|1
7094824|NCT02300220|11215584|FG001|Overall Study|Lost to Follow-up|2
7094825|NCT02300220|11215583|FG000|Overall Study|Death|1
7094826|NCT02300220|11215584|FG001|Overall Study|Death|1
7094827|NCT02300220|11215583|FG000|Overall Study|Adverse Event|1
7094828|NCT02300220|11215584|FG001|Overall Study|Adverse Event|1
7094829|NCT02300220|11215583|FG000|Overall Study|Protocol Violation|1
7094830|NCT02300220|11215584|FG001|Overall Study|Protocol Violation|0
7094831|NCT02300220|11215583|FG000|Overall Study|Withdrawal by Subject|0
7094832|NCT02300220|11215584|FG001|Overall Study|Withdrawal by Subject|2
7094833|NCT02300220|11215583|FG000|Overall Study|Did not tolerate IMP|0
7094834|NCT02300220|11215584|FG001|Overall Study|Did not tolerate IMP|1
7094835|NCT02300259|11215593|FG000|Period 1|Adverse Event|0
7094836|NCT02300259|11215594|FG001|Period 1|Adverse Event|0
7094837|NCT02300259|11215595|FG002|Period 1|Adverse Event|1
7094838|NCT02300259|11215593|FG000|Period 1|Withdrawal by Subject|0
7094839|NCT02300259|11215594|FG001|Period 1|Withdrawal by Subject|0
7094840|NCT02300259|11215595|FG002|Period 1|Withdrawal by Subject|1
7094841|NCT02300259|11215593|FG000|Period 2|Adverse Event|1
7094842|NCT02300259|11215594|FG001|Period 2|Adverse Event|0
7094843|NCT02300259|11215595|FG002|Period 2|Adverse Event|0
7094844|NCT02300259|11215593|FG000|Period 2|Withdrawal by Subject|0
7094845|NCT02300259|11215594|FG001|Period 2|Withdrawal by Subject|0
7094846|NCT02300259|11215595|FG002|Period 2|Withdrawal by Subject|1
7094847|NCT02300298|11215623|FG000|Disposition for Nintedanib|Progressive disease|10
7094848|NCT02300298|11215624|FG001|Disposition for Nintedanib|Progressive disease|0
7094849|NCT02300298|11215623|FG000|Disposition for Docetaxel|Progressive disease|0
7094850|NCT02300298|11215624|FG001|Disposition for Docetaxel|Progressive disease|6
7094851|NCT02300298|11215623|FG000|Disposition for Docetaxel|other adverse event|0
7094852|NCT02300298|11215624|FG001|Disposition for Docetaxel|other adverse event|4
7094853|NCT02300311|11215630|FG000|Overall Study|Other than the reason specified|1
7094854|NCT02300311|11215631|FG001|Overall Study|Other than the reason specified|0
7094855|NCT02300311|11215630|FG000|Overall Study|Refused to continue taking medication|18
7094856|NCT02300311|11215631|FG001|Overall Study|Refused to continue taking medication|0
7094857|NCT02300558|11215641|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6
7094858|NCT02300558|11215641|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2
7094859|NCT02300558|11215641|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1
7094860|NCT02300558|11215641|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29
7094861|NCT02300610|11215652|FG000|Overall Study|Withdrawal by Subject|1
7094862|NCT02300610|11215653|FG001|Overall Study|Withdrawal by Subject|0
7094863|NCT02300610|11215654|FG002|Overall Study|Withdrawal by Subject|1
7094864|NCT02300987|11215691|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1
7094865|NCT02300987|11215692|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0
7094866|NCT02300987|11215691|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2
7094867|NCT02300987|11215692|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0
7094868|NCT02300987|11215691|FG000|Primary Phase : Prior to Cross-over|progressive disease|3
7094869|NCT02300987|11215692|FG001|Primary Phase : Prior to Cross-over|progressive disease|2
7094870|NCT02300987|11215691|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1
7094871|NCT02300987|11215692|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0
7094872|NCT02300987|11215691|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0
7094873|NCT02300987|11215692|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1
7094874|NCT02301143|11215712|FG000|Induction Period|Enrolled But Not Treated|1
7094875|NCT02301143|11215713|FG001|Induction Period|Enrolled But Not Treated|0
7094876|NCT02301143|11215712|FG000|Induction Period|Death|1
7094877|NCT02301143|11215713|FG001|Induction Period|Death|0
7094878|NCT02301143|11215712|FG000|Induction Period|Adverse Event|22
7094879|NCT02301143|11215713|FG001|Induction Period|Adverse Event|0
7094880|NCT02301143|11215712|FG000|Induction Period|Progressive Disease|8
7094881|NCT02301143|11215713|FG001|Induction Period|Progressive Disease|0
7094882|NCT02301143|11215712|FG000|Induction Period|Withdrawal by Subject|3
7094883|NCT02301143|11215713|FG001|Induction Period|Withdrawal by Subject|0
7094884|NCT02301143|11215712|FG000|Induction Period|Noncompliance with Study Drug|1
7094885|NCT02301143|11215713|FG001|Induction Period|Noncompliance with Study Drug|0
7094886|NCT02301143|11215712|FG000|Induction Period|Physician Decision|4
7094887|NCT02301143|11215713|FG001|Induction Period|Physician Decision|0
7094888|NCT02301143|11215712|FG000|Induction Period|Symptomatic Deterioration|2
7094889|NCT02301143|11215713|FG001|Induction Period|Symptomatic Deterioration|0
7094890|NCT02301143|11215712|FG000|Induction Period|Protocol Violation|2
7094891|NCT02301143|11215713|FG001|Induction Period|Protocol Violation|0
7094892|NCT02301143|11215712|FG000|Induction Period|Other|1
7094893|NCT02301143|11215713|FG001|Induction Period|Other|0
7094894|NCT02301143|11215712|FG000|Investigator's Choice|Adverse Event|0
7094895|NCT02301143|11215713|FG001|Investigator's Choice|Adverse Event|3
7094896|NCT02301143|11215712|FG000|Investigator's Choice|Progressive Disease|0
7094897|NCT02301143|11215713|FG001|Investigator's Choice|Progressive Disease|3
7094898|NCT02301143|11215712|FG000|Investigator's Choice|Noncompliance With Study Drug|0
7094899|NCT02301143|11215713|FG001|Investigator's Choice|Noncompliance With Study Drug|1
7094900|NCT02301143|11215712|FG000|Investigator's Choice|Symptomatic Deterioration|0
7094901|NCT02301143|11215713|FG001|Investigator's Choice|Symptomatic Deterioration|1
7094902|NCT02301143|11215712|FG000|Investigator's Choice|Other|0
7094903|NCT02301143|11215713|FG001|Investigator's Choice|Other|1
7094904|NCT02301143|11215712|FG000|Investigator's Choice|Unresectable Surgery|0
7094905|NCT02301143|11215713|FG001|Investigator's Choice|Unresectable Surgery|1
7094906|NCT02301169|11215726|FG000|Overall Study|Adverse Event|1
7094907|NCT02301169|11215727|FG001|Overall Study|Adverse Event|0
7094908|NCT02301390|11215755|FG000|Overall Study|Withdrawal by Subject|3
7094909|NCT02301390|11215756|FG001|Overall Study|Withdrawal by Subject|5
7094910|NCT02301390|11215755|FG000|Overall Study|Protocol Violation|1
7094911|NCT02301390|11215756|FG001|Overall Study|Protocol Violation|0
7094912|NCT02301390|11215755|FG000|Overall Study|Physician Decision|1
7094913|NCT02301390|11215756|FG001|Overall Study|Physician Decision|0
7094914|NCT02301390|11215755|FG000|Overall Study|Lost to Follow-up|0
7094915|NCT02301390|11215756|FG001|Overall Study|Lost to Follow-up|1
7094916|NCT02301390|11215755|FG000|Overall Study|Death|2
7094917|NCT02301390|11215756|FG001|Overall Study|Death|2
7094918|NCT02301390|11215755|FG000|Overall Study|Procedure not completed|0
7094919|NCT02301390|11215756|FG001|Overall Study|Procedure not completed|4
7094920|NCT02301390|11215755|FG000|Overall Study|Missed multiple visits|1
7094921|NCT02301390|11215756|FG001|Overall Study|Missed multiple visits|1
7094922|NCT02301390|11215755|FG000|Overall Study|study terminated|2
7094923|NCT02301390|11215756|FG001|Overall Study|study terminated|0
7094924|NCT02301403|11215764|FG000|Overall Study|Withdrawal by Subject|28
7094925|NCT02301403|11215765|FG001|Overall Study|Withdrawal by Subject|41
7094926|NCT02301429|11215780|FG000|Overall Study|not acceptable vascular anatomy|3
7094927|NCT02301546|11215786|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7
7094928|NCT02301546|11215787|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8
7094929|NCT02301546|11215786|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10
7094930|NCT02301546|11215787|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7
7094931|NCT02301546|11215786|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1
7094932|NCT02301546|11215787|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0
7094933|NCT02301546|11215786|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3
7094934|NCT02301546|11215787|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3
7094935|NCT02301546|11215786|FG000|Long Term Effectiveness (~1 Year)|Death|2
7094936|NCT02301546|11215787|FG001|Long Term Effectiveness (~1 Year)|Death|0
7094937|NCT02301546|11215786|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6
7094938|NCT02301546|11215787|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2
7094939|NCT02301546|11215786|FG000|Long Term Effectiveness (~1 Year)|moved away|1
7094940|NCT02301546|11215787|FG001|Long Term Effectiveness (~1 Year)|moved away|2
7094941|NCT02301624|11215795|FG000|Blind Induction Phase|Withdrawal by Subject|1
7094942|NCT02301624|11215796|FG001|Blind Induction Phase|Withdrawal by Subject|0
7094943|NCT02301624|11215795|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4
7094944|NCT02301624|11215796|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8
7094945|NCT02301624|11215795|FG000|Open-label Maintenance Phase|Adverse Event|2
7094946|NCT02301624|11215796|FG001|Open-label Maintenance Phase|Adverse Event|5
7094947|NCT02301624|11215795|FG000|Open-label Maintenance Phase|Physician Decision|3
7094948|NCT02301624|11215796|FG001|Open-label Maintenance Phase|Physician Decision|3
7094949|NCT02301624|11215795|FG000|Open-label Maintenance Phase|Death|2
7094950|NCT02301624|11215796|FG001|Open-label Maintenance Phase|Death|1
7094951|NCT02301624|11215795|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1
7094952|NCT02301624|11215796|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0
7094953|NCT02301897|11215815|FG000|Treatment Course 1|Non-Compliance|0
7094954|NCT02301897|11215816|FG001|Treatment Course 1|Non-Compliance|0
7094955|NCT02301897|11215817|FG002|Treatment Course 1|Non-Compliance|1
7094956|NCT02301897|11215815|FG000|Treatment Course 1|Adverse Event|1
7094957|NCT02301897|11215816|FG001|Treatment Course 1|Adverse Event|1
7094958|NCT02301897|11215817|FG002|Treatment Course 1|Adverse Event|0
7094959|NCT02301897|11215815|FG000|Treatment Course 1|Lost to Follow-up|1
7094960|NCT02301897|11215816|FG001|Treatment Course 1|Lost to Follow-up|2
7094961|NCT02301897|11215817|FG002|Treatment Course 1|Lost to Follow-up|1
7094962|NCT02301897|11215815|FG000|Treatment Course 1|Withdrawal by Sponsor|0
7094963|NCT02301897|11215816|FG001|Treatment Course 1|Withdrawal by Sponsor|0
7094964|NCT02301897|11215817|FG002|Treatment Course 1|Withdrawal by Sponsor|2
7094965|NCT02301897|11215815|FG000|Treatment Course 1|Withdrawal by Subject|0
7094966|NCT02301897|11215816|FG001|Treatment Course 1|Withdrawal by Subject|0
7094967|NCT02301897|11215817|FG002|Treatment Course 1|Withdrawal by Subject|2
7094968|NCT02301897|11215815|FG000|Treatment Course 1|Other Miscellaneous Reasons|1
7094969|NCT02301897|11215816|FG001|Treatment Course 1|Other Miscellaneous Reasons|0
7094970|NCT02301897|11215817|FG002|Treatment Course 1|Other Miscellaneous Reasons|0
7094971|NCT02301897|11215815|FG000|Treatment Course 2|Lost to Follow-up|0
7094972|NCT02301897|11215816|FG001|Treatment Course 2|Lost to Follow-up|2
7094973|NCT02301897|11215817|FG002|Treatment Course 2|Lost to Follow-up|0
7094974|NCT02301897|11215815|FG000|Treatment Course 2|Pregnancy|0
7094975|NCT02301897|11215816|FG001|Treatment Course 2|Pregnancy|1
7094976|NCT02301897|11215817|FG002|Treatment Course 2|Pregnancy|1
7094977|NCT02301897|11215815|FG000|Treatment Course 2|Withdrawal by Subject|0
7094978|NCT02301897|11215816|FG001|Treatment Course 2|Withdrawal by Subject|2
7094979|NCT02301897|11215817|FG002|Treatment Course 2|Withdrawal by Subject|0
7094980|NCT02301897|11215815|FG000|Treatment Course 2|Other Miscellaneous Reasons|1
7094981|NCT02301897|11215816|FG001|Treatment Course 2|Other Miscellaneous Reasons|0
7094982|NCT02301897|11215817|FG002|Treatment Course 2|Other Miscellaneous Reasons|0
7094983|NCT02301936|11215827|FG000|Overall Study|Lost to Follow-up|1
7094984|NCT02301936|11215828|FG001|Overall Study|Lost to Follow-up|0
7094985|NCT02301975|11215837|FG000|Overall Study|Adverse Event|8
7094986|NCT02301975|11215838|FG001|Overall Study|Adverse Event|3
7094987|NCT02301975|11215839|FG002|Overall Study|Adverse Event|2
7094988|NCT02301975|11215837|FG000|Overall Study|Lack of Efficacy|1
7094989|NCT02301975|11215838|FG001|Overall Study|Lack of Efficacy|1
7094990|NCT02301975|11215839|FG002|Overall Study|Lack of Efficacy|1
7094991|NCT02301975|11215837|FG000|Overall Study|Protocol Violation|3
7094992|NCT02301975|11215838|FG001|Overall Study|Protocol Violation|5
7094993|NCT02301975|11215839|FG002|Overall Study|Protocol Violation|3
7094994|NCT02301975|11215837|FG000|Overall Study|Lost to Follow-up|0
7094995|NCT02301975|11215838|FG001|Overall Study|Lost to Follow-up|2
7094996|NCT02301975|11215839|FG002|Overall Study|Lost to Follow-up|2
7094997|NCT02301975|11215837|FG000|Overall Study|Physician Decision|4
7094998|NCT02301975|11215838|FG001|Overall Study|Physician Decision|2
7094999|NCT02301975|11215839|FG002|Overall Study|Physician Decision|3
7095000|NCT02301975|11215837|FG000|Overall Study|Withdrawal by Subject|15
7095001|NCT02301975|11215838|FG001|Overall Study|Withdrawal by Subject|12
7095002|NCT02301975|11215839|FG002|Overall Study|Withdrawal by Subject|11
7095003|NCT02301988|11215849|FG000|Overall Study|Withdrawal by Subject|2
7095004|NCT02301988|11215850|FG001|Overall Study|Withdrawal by Subject|1
7095005|NCT02301988|11215849|FG000|Overall Study|Physician Decision|2
7095006|NCT02301988|11215850|FG001|Overall Study|Physician Decision|2
7095007|NCT02301988|11215849|FG000|Overall Study|Unknown Reason|1
7095008|NCT02301988|11215850|FG001|Overall Study|Unknown Reason|3
7095009|NCT02301988|11215849|FG000|Overall Study|Lack of Efficacy|3
7095010|NCT02301988|11215850|FG001|Overall Study|Lack of Efficacy|2
7095011|NCT02301988|11215849|FG000|Overall Study|Death|1
7095012|NCT02301988|11215850|FG001|Overall Study|Death|0
7095013|NCT02301988|11215849|FG000|Overall Study|Adverse Event|1
7095014|NCT02301988|11215850|FG001|Overall Study|Adverse Event|1
7095015|NCT02302066|11215860|FG000|Overall Study|Adverse Event|1
7095016|NCT02302066|11215861|FG001|Overall Study|Adverse Event|1
7095017|NCT02302066|11215862|FG002|Overall Study|Adverse Event|3
7095018|NCT02302066|11215863|FG003|Overall Study|Adverse Event|0
7095019|NCT02302066|11215860|FG000|Overall Study|Lost to Follow-up|4
7095020|NCT02302066|11215861|FG001|Overall Study|Lost to Follow-up|5
7095021|NCT02302066|11215862|FG002|Overall Study|Lost to Follow-up|24
7095022|NCT02302066|11215863|FG003|Overall Study|Lost to Follow-up|7
7095023|NCT02302066|11215860|FG000|Overall Study|Withdrawal by Subject|25
7095024|NCT02302066|11215861|FG001|Overall Study|Withdrawal by Subject|58
7095025|NCT02302066|11215862|FG002|Overall Study|Withdrawal by Subject|124
7095026|NCT02302066|11215863|FG003|Overall Study|Withdrawal by Subject|33
7095027|NCT02302066|11215860|FG000|Overall Study|Pregnancy|2
7095028|NCT02302066|11215861|FG001|Overall Study|Pregnancy|10
7095029|NCT02302066|11215862|FG002|Overall Study|Pregnancy|12
7095030|NCT02302066|11215863|FG003|Overall Study|Pregnancy|0
7095031|NCT02302066|11215860|FG000|Overall Study|Reason Not Specified|1
7095032|NCT02302066|11215861|FG001|Overall Study|Reason Not Specified|1
7095033|NCT02302066|11215862|FG002|Overall Study|Reason Not Specified|9
7095034|NCT02302066|11215863|FG003|Overall Study|Reason Not Specified|1
7095035|NCT02302222|11215920|FG000|Overall Study|Physician Decision|0
7095036|NCT02302222|11215921|FG001|Overall Study|Physician Decision|4
7095037|NCT02302222|11215920|FG000|Overall Study|Lost to Follow-up|1
7095038|NCT02302222|11215921|FG001|Overall Study|Lost to Follow-up|0
7095039|NCT02302222|11215920|FG000|Overall Study|Treatment discontinued before day 5|0
7095040|NCT02302222|11215921|FG001|Overall Study|Treatment discontinued before day 5|1
7095041|NCT02302222|11215920|FG000|Overall Study|Withdrawn prior to any treatment|0
7095042|NCT02302222|11215921|FG001|Overall Study|Withdrawn prior to any treatment|1
7095043|NCT02302339|11215931|FG000|Overall Study|Lost to Follow-up|1
7095044|NCT02302339|11215932|FG001|Overall Study|Lost to Follow-up|0
7095045|NCT02302339|11215933|FG002|Overall Study|Lost to Follow-up|0
7095046|NCT02302339|11215934|FG003|Overall Study|Lost to Follow-up|0
7095047|NCT02302339|11215931|FG000|Overall Study|Withdrawal by Subject|0
7095048|NCT02302339|11215932|FG001|Overall Study|Withdrawal by Subject|2
7095049|NCT02302339|11215933|FG002|Overall Study|Withdrawal by Subject|1
7095050|NCT02302339|11215934|FG003|Overall Study|Withdrawal by Subject|0
7095051|NCT02302716|11215955|FG000|Overall Study|Adverse Event|1
7095052|NCT02302716|11215956|FG001|Overall Study|Adverse Event|1
7095053|NCT02302716|11215955|FG000|Overall Study|Death|0
7095054|NCT02302716|11215956|FG001|Overall Study|Death|1
7095055|NCT02302716|11215955|FG000|Overall Study|Lack of Efficacy|0
7095056|NCT02302716|11215956|FG001|Overall Study|Lack of Efficacy|1
7095057|NCT02302716|11215955|FG000|Overall Study|Lost to Follow-up|2
7095058|NCT02302716|11215956|FG001|Overall Study|Lost to Follow-up|4
7095059|NCT02302716|11215955|FG000|Overall Study|Physician Decision|3
7095060|NCT02302716|11215956|FG001|Overall Study|Physician Decision|4
7095061|NCT02302716|11215955|FG000|Overall Study|Withdrawal by Subject|13
7095062|NCT02302716|11215956|FG001|Overall Study|Withdrawal by Subject|7
7095063|NCT02302716|11215955|FG000|Overall Study|Protocol Violation|0
7095064|NCT02302716|11215956|FG001|Overall Study|Protocol Violation|1
7095065|NCT02302807|11215964|FG000|Overall Study|Withdrawal by Subject|28
7095066|NCT02302807|11215965|FG001|Overall Study|Withdrawal by Subject|11
7095067|NCT02302807|11215964|FG000|Overall Study|Lost to Follow-up|4
7095068|NCT02302807|11215965|FG001|Overall Study|Lost to Follow-up|6
7095069|NCT02302807|11215964|FG000|Overall Study|Death|397
7095070|NCT02302807|11215965|FG001|Overall Study|Death|385
7095071|NCT02302807|11215964|FG000|Overall Study|Study Terminated By Sponsor|35
7095072|NCT02302807|11215965|FG001|Overall Study|Study Terminated By Sponsor|64
7095073|NCT02302807|11215964|FG000|Overall Study|Physician Decision|0
7095074|NCT02302807|11215965|FG001|Overall Study|Physician Decision|1
7095075|NCT02302846|11215984|FG000|Overall Study|Withdrawal by Subject|1
7095076|NCT02303041|11215990|FG000|Overall Study|Adverse Event|1
7095077|NCT02303041|11215991|FG001|Overall Study|Adverse Event|2
7095078|NCT02303262|11216022|FG000|Overall Study|Withdrawal by Subject|2
7095079|NCT02303574|11216038|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
7095080|NCT02303574|11216039|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
7095081|NCT02303574|11216040|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1
7095082|NCT02303574|11216041|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
7095083|NCT02303574|11216042|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
7095084|NCT02303574|11216043|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
7095085|NCT02303574|11216044|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
7095086|NCT02303574|11216045|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
7095087|NCT02303574|11216046|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
7095088|NCT02303574|11216047|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
7095089|NCT02303574|11216038|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
7095090|NCT02303574|11216039|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
7095091|NCT02303574|11216040|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
7095092|NCT02303574|11216041|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
7095093|NCT02303574|11216042|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
7095094|NCT02303574|11216043|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
7095095|NCT02303574|11216044|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
7095096|NCT02303574|11216045|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1
7095097|NCT02303574|11216046|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
7095098|NCT02303574|11216047|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
7095099|NCT02303704|11216082|FG000|Overall Study|Protocol Violation|5
7095100|NCT02303704|11216083|FG001|Overall Study|Protocol Violation|9
7095101|NCT02304380|11216122|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
7095102|NCT02304380|11216123|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
7095103|NCT02304380|11216124|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
7095104|NCT02304380|11216125|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34
7095105|NCT02304380|11216126|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
7095106|NCT02304380|11216127|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
7095107|NCT02304484|11216163|FG000|Overall Study|Death|9
7095108|NCT02304484|11216163|FG000|Overall Study|Withdrawal by Subject|14
7095109|NCT02304484|11216163|FG000|Overall Study|Lost to Follow-up|2
7095110|NCT02304705|11216169|FG000|Overall Study|Withdrawal by Subject|2
7095111|NCT02304705|11216170|FG001|Overall Study|Withdrawal by Subject|0
7095112|NCT02304705|11216169|FG000|Overall Study|Physician Decision|2
7095113|NCT02304705|11216170|FG001|Overall Study|Physician Decision|4
7095114|NCT02304705|11216169|FG000|Overall Study|Death|0
7095115|NCT02304705|11216170|FG001|Overall Study|Death|1
7095116|NCT02304705|11216169|FG000|Overall Study|Lost to Follow-up|0
7095117|NCT02304705|11216170|FG001|Overall Study|Lost to Follow-up|2
7095118|NCT02304926|11216187|FG000|Overall Study|Lost to Follow-up|2
7095119|NCT02304926|11216188|FG001|Overall Study|Lost to Follow-up|1
7095120|NCT02305238|11216212|FG000|Overall Study|Death|2
7095121|NCT02305238|11216213|FG001|Overall Study|Death|1
7095122|NCT02305238|11216214|FG002|Overall Study|Death|0
7095123|NCT02305238|11216212|FG000|Overall Study|Progressive disease|4
7095124|NCT02305238|11216213|FG001|Overall Study|Progressive disease|4
7095125|NCT02305238|11216214|FG002|Overall Study|Progressive disease|0
7095126|NCT02305238|11216212|FG000|Overall Study|Logistical difficulties|1
7095127|NCT02305238|11216213|FG001|Overall Study|Logistical difficulties|3
7095128|NCT02305238|11216214|FG002|Overall Study|Logistical difficulties|0
7095129|NCT02305238|11216212|FG000|Overall Study|Protocol Violation|0
7095130|NCT02305238|11216213|FG001|Overall Study|Protocol Violation|3
7095131|NCT02305238|11216214|FG002|Overall Study|Protocol Violation|0
7095132|NCT02305238|11216212|FG000|Overall Study|Physician Decision|2
7095133|NCT02305238|11216213|FG001|Overall Study|Physician Decision|1
7095134|NCT02305238|11216214|FG002|Overall Study|Physician Decision|0
7095135|NCT02305238|11216212|FG000|Overall Study|Adverse Event|4
7095136|NCT02305238|11216213|FG001|Overall Study|Adverse Event|2
7095137|NCT02305238|11216214|FG002|Overall Study|Adverse Event|0
7095138|NCT02305238|11216212|FG000|Overall Study|Withdrawal by Subject|3
7095139|NCT02305238|11216213|FG001|Overall Study|Withdrawal by Subject|4
7095140|NCT02305238|11216214|FG002|Overall Study|Withdrawal by Subject|0
7095141|NCT02305238|11216212|FG000|Overall Study|Randomized failure|0
7095142|NCT02305238|11216213|FG001|Overall Study|Randomized failure|0
7095143|NCT02305238|11216214|FG002|Overall Study|Randomized failure|8
7095144|NCT02305238|11216212|FG000|Overall Study|Required procedure failed|0
7095145|NCT02305238|11216213|FG001|Overall Study|Required procedure failed|1
7095146|NCT02305238|11216214|FG002|Overall Study|Required procedure failed|0
7095147|NCT02305381|11216275|FG000|Overall Study|Unclassified|5
7095148|NCT02305381|11216276|FG001|Overall Study|Unclassified|5
7095149|NCT02305381|11216277|FG002|Overall Study|Unclassified|7
7095150|NCT02305446|11216285|FG000|Overall Study|Adverse Event|1
7095151|NCT02305563|11216294|FG000|Treatment Period|Disease progression|0
7095152|NCT02305563|11216295|FG001|Treatment Period|Disease progression|0
7095153|NCT02305563|11216296|FG002|Treatment Period|Disease progression|15
7095154|NCT02305563|11216297|FG003|Treatment Period|Disease progression|6
7095155|NCT02305563|11216298|FG004|Treatment Period|Disease progression|6
7095156|NCT02305563|11216294|FG000|Treatment Period|Study drug toxicity|0
7095157|NCT02305563|11216295|FG001|Treatment Period|Study drug toxicity|0
7095158|NCT02305563|11216296|FG002|Treatment Period|Study drug toxicity|0
6805623|NCT03434379|10807732|FG002|Global Period|On Study|0
6805624|NCT03434379|10807733|FG003|Global Period|On Study|0
6805625|NCT03434379|10807730|FG000|China Extension Period|Lost to Follow-up|0
6805626|NCT03434379|10807731|FG001|China Extension Period|Lost to Follow-up|0
6805627|NCT03434379|10807732|FG002|China Extension Period|Lost to Follow-up|1
6805628|NCT03434379|10807733|FG003|China Extension Period|Lost to Follow-up|0
6805629|NCT03434379|10807730|FG000|China Extension Period|Death|0
6805630|NCT03434379|10807731|FG001|China Extension Period|Death|0
6805631|NCT03434379|10807732|FG002|China Extension Period|Death|38
6805632|NCT03434379|10807733|FG003|China Extension Period|Death|61
6805633|NCT03434379|10807730|FG000|China Extension Period|Withdrawal by Subject|0
6805634|NCT03434379|10807731|FG001|China Extension Period|Withdrawal by Subject|0
6805635|NCT03434379|10807732|FG002|China Extension Period|Withdrawal by Subject|7
6805636|NCT03434379|10807733|FG003|China Extension Period|Withdrawal by Subject|6
7095159|NCT02305563|11216297|FG003|Treatment Period|Study drug toxicity|1
7095160|NCT02305563|11216298|FG004|Treatment Period|Study drug toxicity|2
7095161|NCT02305563|11216294|FG000|Treatment Period|Death|0
7095162|NCT02305563|11216295|FG001|Treatment Period|Death|0
6805637|NCT03434379|10807730|FG000|China Extension Period|On Study|0
6805638|NCT03434379|10807731|FG001|China Extension Period|On Study|0
6805639|NCT03434379|10807732|FG002|China Extension Period|On Study|15
6805640|NCT03434379|10807733|FG003|China Extension Period|On Study|66
7095163|NCT02305563|11216296|FG002|Treatment Period|Death|1
7095164|NCT02305563|11216297|FG003|Treatment Period|Death|2
7095165|NCT02305563|11216298|FG004|Treatment Period|Death|1
7095166|NCT02305563|11216294|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0
7095167|NCT02305563|11216295|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0
7095168|NCT02305563|11216296|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7
7095169|NCT02305563|11216297|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1
7095170|NCT02305563|11216298|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2
7095171|NCT02305563|11216294|FG000|Treatment Period|Participant request to stop therapy|0
7095172|NCT02305563|11216295|FG001|Treatment Period|Participant request to stop therapy|2
7095173|NCT02305563|11216296|FG002|Treatment Period|Participant request to stop therapy|0
7095174|NCT02305563|11216297|FG003|Treatment Period|Participant request to stop therapy|1
7095175|NCT02305563|11216298|FG004|Treatment Period|Participant request to stop therapy|0
7095176|NCT02305563|11216294|FG000|Treatment Period|Participant withdrew consent|0
7095177|NCT02305563|11216295|FG001|Treatment Period|Participant withdrew consent|0
7095178|NCT02305563|11216296|FG002|Treatment Period|Participant withdrew consent|1
7095179|NCT02305563|11216297|FG003|Treatment Period|Participant withdrew consent|1
7095180|NCT02305563|11216298|FG004|Treatment Period|Participant withdrew consent|1
7095181|NCT02305563|11216294|FG000|Treatment Period|Maximum clinical benefit|0
7095182|NCT02305563|11216295|FG001|Treatment Period|Maximum clinical benefit|0
7095183|NCT02305563|11216296|FG002|Treatment Period|Maximum clinical benefit|0
7095184|NCT02305563|11216297|FG003|Treatment Period|Maximum clinical benefit|0
7095185|NCT02305563|11216298|FG004|Treatment Period|Maximum clinical benefit|1
7095186|NCT02305563|11216294|FG000|Treatment Period|Poor/non-compliance|0
7095187|NCT02305563|11216295|FG001|Treatment Period|Poor/non-compliance|0
7095188|NCT02305563|11216296|FG002|Treatment Period|Poor/non-compliance|0
7095189|NCT02305563|11216297|FG003|Treatment Period|Poor/non-compliance|0
7095190|NCT02305563|11216298|FG004|Treatment Period|Poor/non-compliance|1
7095191|NCT02305563|11216294|FG000|Treatment Period|Administrative reason by Sponsor|0
7095192|NCT02305563|11216295|FG001|Treatment Period|Administrative reason by Sponsor|0
7095193|NCT02305563|11216296|FG002|Treatment Period|Administrative reason by Sponsor|0
7095194|NCT02305563|11216297|FG003|Treatment Period|Administrative reason by Sponsor|0
7095195|NCT02305563|11216298|FG004|Treatment Period|Administrative reason by Sponsor|1
7095196|NCT02305563|11216294|FG000|Treatment Period|other reason|2
7095197|NCT02305563|11216295|FG001|Treatment Period|other reason|0
7095198|NCT02305563|11216296|FG002|Treatment Period|other reason|2
7095199|NCT02305563|11216297|FG003|Treatment Period|other reason|2
7095200|NCT02305563|11216298|FG004|Treatment Period|other reason|1
7095201|NCT02305563|11216294|FG000|Treatment Period|Randomized but not treated|0
7095202|NCT02305563|11216295|FG001|Treatment Period|Randomized but not treated|0
7095203|NCT02305563|11216296|FG002|Treatment Period|Randomized but not treated|0
7095204|NCT02305563|11216297|FG003|Treatment Period|Randomized but not treated|0
7095205|NCT02305563|11216298|FG004|Treatment Period|Randomized but not treated|2
7095206|NCT02305563|11216294|FG000|Treatment Period|added ULO, then disease progression|0
7095207|NCT02305563|11216295|FG001|Treatment Period|added ULO, then disease progression|0
7095208|NCT02305563|11216296|FG002|Treatment Period|added ULO, then disease progression|0
7095209|NCT02305563|11216297|FG003|Treatment Period|added ULO, then disease progression|0
7095210|NCT02305563|11216298|FG004|Treatment Period|added ULO, then disease progression|4
7095211|NCT02305563|11216294|FG000|Treatment Period|added ULO; then other reason|0
7095212|NCT02305563|11216295|FG001|Treatment Period|added ULO; then other reason|0
7095213|NCT02305563|11216296|FG002|Treatment Period|added ULO; then other reason|0
7095214|NCT02305563|11216297|FG003|Treatment Period|added ULO; then other reason|0
7095215|NCT02305563|11216298|FG004|Treatment Period|added ULO; then other reason|1
7095216|NCT02305563|11216294|FG000|Treatment Period|added ULO, then request to stop|0
7095217|NCT02305563|11216295|FG001|Treatment Period|added ULO, then request to stop|0
7095218|NCT02305563|11216296|FG002|Treatment Period|added ULO, then request to stop|0
7095219|NCT02305563|11216297|FG003|Treatment Period|added ULO, then request to stop|0
7095220|NCT02305563|11216298|FG004|Treatment Period|added ULO, then request to stop|1
7095221|NCT02305563|11216294|FG000|Follow-up Period|Death|0
7095222|NCT02305563|11216295|FG001|Follow-up Period|Death|0
7095223|NCT02305563|11216296|FG002|Follow-up Period|Death|5
7095224|NCT02305563|11216297|FG003|Follow-up Period|Death|4
7095225|NCT02305563|11216298|FG004|Follow-up Period|Death|7
7095226|NCT02305563|11216294|FG000|Follow-up Period|Participant withdrew consent|0
7095227|NCT02305563|11216295|FG001|Follow-up Period|Participant withdrew consent|0
7095228|NCT02305563|11216296|FG002|Follow-up Period|Participant withdrew consent|2
7095229|NCT02305563|11216297|FG003|Follow-up Period|Participant withdrew consent|1
7095230|NCT02305563|11216298|FG004|Follow-up Period|Participant withdrew consent|0
7095231|NCT02305563|11216294|FG000|Follow-up Period|other reason|0
7095232|NCT02305563|11216295|FG001|Follow-up Period|other reason|0
7095233|NCT02305563|11216296|FG002|Follow-up Period|other reason|0
7095234|NCT02305563|11216297|FG003|Follow-up Period|other reason|0
7095235|NCT02305563|11216298|FG004|Follow-up Period|other reason|1
7095236|NCT02305563|11216294|FG000|Follow-up Period|Followup no longer required per protocol|3
7095237|NCT02305563|11216295|FG001|Follow-up Period|Followup no longer required per protocol|3
7095238|NCT02305563|11216296|FG002|Follow-up Period|Followup no longer required per protocol|4
6805641|NCT03368170|10807747|FG000|Overall Study|Adverse Event|2
7095239|NCT02305563|11216297|FG003|Follow-up Period|Followup no longer required per protocol|1
7095240|NCT02305563|11216298|FG004|Follow-up Period|Followup no longer required per protocol|4
7095241|NCT02305758|11216321|FG000|Overall Study|Death|27
7095242|NCT02305758|11216322|FG001|Overall Study|Death|27
7095243|NCT02305758|11216321|FG000|Overall Study|Withdrew consent|9
7095244|NCT02305758|11216322|FG001|Overall Study|Withdrew consent|2
7095245|NCT02305758|11216321|FG000|Overall Study|Lost to Follow-up|6
7095246|NCT02305758|11216322|FG001|Overall Study|Lost to Follow-up|1
7095247|NCT02305758|11216321|FG000|Overall Study|Study Terminated by Sponsor|21
7095248|NCT02305758|11216322|FG001|Overall Study|Study Terminated by Sponsor|34
7095249|NCT02305758|11216321|FG000|Overall Study|Other, not specified|2
7095250|NCT02305758|11216322|FG001|Overall Study|Other, not specified|1
7095251|NCT02305797|11216330|FG000|Overall Study|Adverse Event|11
7095252|NCT02305797|11216331|FG001|Overall Study|Adverse Event|2
7095253|NCT02305797|11216330|FG000|Overall Study|Withdrawal by Subject|9
7095254|NCT02305797|11216331|FG001|Overall Study|Withdrawal by Subject|10
7095255|NCT02305797|11216330|FG000|Overall Study|Lack of Efficacy|6
7095256|NCT02305797|11216331|FG001|Overall Study|Lack of Efficacy|0
7095257|NCT02305797|11216330|FG000|Overall Study|Lost to Follow-up|5
7095258|NCT02305797|11216331|FG001|Overall Study|Lost to Follow-up|11
7095259|NCT02305797|11216330|FG000|Overall Study|Pregnancy|0
7095260|NCT02305797|11216331|FG001|Overall Study|Pregnancy|2
7095261|NCT02305797|11216330|FG000|Overall Study|Noncompliance|14
7095262|NCT02305797|11216331|FG001|Overall Study|Noncompliance|12
7095263|NCT02305797|11216330|FG000|Overall Study|Reason not collected|0
7095264|NCT02305797|11216331|FG001|Overall Study|Reason not collected|1
7095265|NCT02305849|11216340|FG000|Overall Study|Adverse Event|10
7095266|NCT02305849|11216341|FG001|Overall Study|Adverse Event|12
7095267|NCT02305849|11216342|FG002|Overall Study|Adverse Event|7
7095268|NCT02305849|11216343|FG003|Overall Study|Adverse Event|3
7095269|NCT02305849|11216340|FG000|Overall Study|Lack of Efficacy|10
7095270|NCT02305849|11216341|FG001|Overall Study|Lack of Efficacy|6
7095271|NCT02305849|11216342|FG002|Overall Study|Lack of Efficacy|3
7095272|NCT02305849|11216343|FG003|Overall Study|Lack of Efficacy|9
7095273|NCT02305849|11216340|FG000|Overall Study|Withdrawal by Subject|2
7095274|NCT02305849|11216341|FG001|Overall Study|Withdrawal by Subject|2
7095275|NCT02305849|11216342|FG002|Overall Study|Withdrawal by Subject|1
7095276|NCT02305849|11216343|FG003|Overall Study|Withdrawal by Subject|4
7095277|NCT02305849|11216340|FG000|Overall Study|Lost to Follow-up|0
7095278|NCT02305849|11216341|FG001|Overall Study|Lost to Follow-up|2
7095279|NCT02305849|11216342|FG002|Overall Study|Lost to Follow-up|0
7095280|NCT02305849|11216343|FG003|Overall Study|Lost to Follow-up|0
7095281|NCT02305849|11216340|FG000|Overall Study|Protocol Violation|3
7095282|NCT02305849|11216341|FG001|Overall Study|Protocol Violation|2
7095283|NCT02305849|11216342|FG002|Overall Study|Protocol Violation|1
7095284|NCT02305849|11216343|FG003|Overall Study|Protocol Violation|1
7095285|NCT02305849|11216340|FG000|Overall Study|Lab data met discontinuation criteria|0
7095286|NCT02305849|11216341|FG001|Overall Study|Lab data met discontinuation criteria|1
7095287|NCT02305849|11216342|FG002|Overall Study|Lab data met discontinuation criteria|2
7095288|NCT02305849|11216343|FG003|Overall Study|Lab data met discontinuation criteria|1
7095289|NCT02305849|11216340|FG000|Overall Study|Miscellaneous|1
7095290|NCT02305849|11216341|FG001|Overall Study|Miscellaneous|2
7095291|NCT02305849|11216342|FG002|Overall Study|Miscellaneous|4
7095292|NCT02305849|11216343|FG003|Overall Study|Miscellaneous|1
7095293|NCT02305849|11216340|FG000|Overall Study|Not fulfill eligibility criteria|1
7095294|NCT02305849|11216341|FG001|Overall Study|Not fulfill eligibility criteria|1
7095295|NCT02305849|11216342|FG002|Overall Study|Not fulfill eligibility criteria|0
7095296|NCT02305849|11216343|FG003|Overall Study|Not fulfill eligibility criteria|0
7095297|NCT02305888|11216377|FG000|Overall Study|Lost to Follow-up|0
7095298|NCT02305888|11216378|FG001|Overall Study|Lost to Follow-up|0
7095299|NCT02305888|11216379|FG002|Overall Study|Lost to Follow-up|1
7095300|NCT02305888|11216377|FG000|Overall Study|Adverse Event|0
7095301|NCT02305888|11216378|FG001|Overall Study|Adverse Event|1
7095302|NCT02305888|11216379|FG002|Overall Study|Adverse Event|0
7095303|NCT02306265|11216387|FG000|Overall Study|Withdrawal by Subject|1
7095304|NCT02306694|11216392|FG000|Overall Study|Withdrawal by Subject|3
7095305|NCT02306694|11216392|FG000|Overall Study|Lost to Follow-up|1
7095306|NCT02306850|11216407|FG000|Overall Study|Lack of Efficacy|2
7095307|NCT02307266|11216423|FG000|Overall Study|Adverse Event|3
7095308|NCT02307266|11216424|FG001|Overall Study|Adverse Event|1
7095309|NCT02307266|11216425|FG002|Overall Study|Adverse Event|5
7095310|NCT02307266|11216423|FG000|Overall Study|Withdrawal by Subject|2
7095311|NCT02307266|11216424|FG001|Overall Study|Withdrawal by Subject|0
7095312|NCT02307266|11216425|FG002|Overall Study|Withdrawal by Subject|1
7095313|NCT02307266|11216423|FG000|Overall Study|Lost to Follow-up|3
7095314|NCT02307266|11216424|FG001|Overall Study|Lost to Follow-up|0
7095315|NCT02307266|11216425|FG002|Overall Study|Lost to Follow-up|0
7095316|NCT02307370|11216437|FG000|Overall Study|Death|5
7095317|NCT02307370|11216437|FG000|Overall Study|Lost to Follow-up|1
7095318|NCT02307370|11216437|FG000|Overall Study|Withdrawal by Subject|1
7095319|NCT02307370|11216437|FG000|Overall Study|Declined Addendum ICF|6
7095320|NCT02307370|11216437|FG000|Overall Study|No response during telephone contact|5
7095321|NCT02307370|11216437|FG000|Overall Study|Protocol Violation|1
7095322|NCT02307513|11216445|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4
7095323|NCT02307513|11216446|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3
7095324|NCT02307513|11216445|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8
7095325|NCT02307513|11216446|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0
7095326|NCT02307513|11216445|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1
7095327|NCT02307513|11216446|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0
7095328|NCT02307513|11216445|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5
7095329|NCT02307513|11216446|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4
7095330|NCT02307513|11216445|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1
7095331|NCT02307513|11216446|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0
7095332|NCT02307513|11216445|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1
7095333|NCT02307513|11216446|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1
7095334|NCT02307513|11216445|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0
7095335|NCT02307513|11216446|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1
7095336|NCT02307513|11216445|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4
7095337|NCT02307513|11216446|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9
7095338|NCT02307513|11216445|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2
7095339|NCT02307513|11216446|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2
7095340|NCT02307513|11216445|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7
7095341|NCT02307513|11216446|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7
6805642|NCT03368170|10807748|FG001|Overall Study|Adverse Event|1
7095342|NCT02307513|11216445|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1
7095343|NCT02307513|11216446|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1
7095344|NCT02307513|11216445|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1
7095345|NCT02307513|11216446|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0
7095346|NCT02307513|11216445|FG000|Long-term Extension|Physician Decision|1
7095347|NCT02307513|11216446|FG001|Long-term Extension|Physician Decision|0
7095348|NCT02307682|11216469|FG000|Overall Study|Adverse Event|9
7095349|NCT02307682|11216470|FG001|Overall Study|Adverse Event|8
7095350|NCT02307682|11216471|FG002|Overall Study|Adverse Event|12
7095351|NCT02307682|11216469|FG000|Overall Study|Lack of Efficacy|1
7095352|NCT02307682|11216470|FG001|Overall Study|Lack of Efficacy|0
7095353|NCT02307682|11216471|FG002|Overall Study|Lack of Efficacy|1
7095354|NCT02307682|11216469|FG000|Overall Study|Physician Decision|2
7095355|NCT02307682|11216470|FG001|Overall Study|Physician Decision|2
7095356|NCT02307682|11216471|FG002|Overall Study|Physician Decision|8
7095357|NCT02307682|11216469|FG000|Overall Study|Progressive Disease|1
7095358|NCT02307682|11216470|FG001|Overall Study|Progressive Disease|0
7095359|NCT02307682|11216471|FG002|Overall Study|Progressive Disease|0
7095360|NCT02307682|11216469|FG000|Overall Study|Withdrawal by Subject|26
7095361|NCT02307682|11216470|FG001|Overall Study|Withdrawal by Subject|34
7095362|NCT02307682|11216471|FG002|Overall Study|Withdrawal by Subject|23
7095363|NCT02307682|11216469|FG000|Overall Study|Death|9
7095364|NCT02307682|11216470|FG001|Overall Study|Death|7
7095365|NCT02307682|11216471|FG002|Overall Study|Death|12
7095366|NCT02307682|11216469|FG000|Overall Study|Lost to Follow-up|1
7095367|NCT02307682|11216470|FG001|Overall Study|Lost to Follow-up|5
7095368|NCT02307682|11216471|FG002|Overall Study|Lost to Follow-up|6
7095369|NCT02307682|11216469|FG000|Overall Study|Protocol Deviation|0
7095370|NCT02307682|11216470|FG001|Overall Study|Protocol Deviation|0
7095371|NCT02307682|11216471|FG002|Overall Study|Protocol Deviation|2
7095372|NCT02307682|11216469|FG000|Overall Study|Other|1
7095373|NCT02307682|11216470|FG001|Overall Study|Other|1
7095374|NCT02307682|11216471|FG002|Overall Study|Other|0
7095375|NCT02308007|11216505|FG000|Overall Study|Normal Gram stain or neg yeast culture|66
7095376|NCT02308007|11216506|FG001|Overall Study|Normal Gram stain or neg yeast culture|64
7095377|NCT02308007|11216507|FG002|Overall Study|Normal Gram stain or neg yeast culture|67
7095378|NCT02308007|11216505|FG000|Overall Study|Positive for STD at Baseline|7
7095379|NCT02308007|11216506|FG001|Overall Study|Positive for STD at Baseline|11
7095380|NCT02308007|11216507|FG002|Overall Study|Positive for STD at Baseline|7
7095381|NCT02308007|11216505|FG000|Overall Study|Lost to Follow-up|3
7095382|NCT02308007|11216506|FG001|Overall Study|Lost to Follow-up|0
7095383|NCT02308007|11216507|FG002|Overall Study|Lost to Follow-up|1
7095384|NCT02308020|11216521|FG000|Overall Study|Lost to Follow-up|1
7095385|NCT02308020|11216522|FG001|Overall Study|Lost to Follow-up|7
7095386|NCT02308020|11216523|FG002|Overall Study|Lost to Follow-up|0
7095387|NCT02308020|11216524|FG003|Overall Study|Lost to Follow-up|0
7095388|NCT02308020|11216525|FG004|Overall Study|Lost to Follow-up|1
7095389|NCT02308020|11216526|FG005|Overall Study|Lost to Follow-up|2
7095390|NCT02308020|11216521|FG000|Overall Study|Sponsor Decision|0
7095391|NCT02308020|11216522|FG001|Overall Study|Sponsor Decision|8
7095392|NCT02308020|11216523|FG002|Overall Study|Sponsor Decision|0
7095393|NCT02308020|11216524|FG003|Overall Study|Sponsor Decision|2
7095394|NCT02308020|11216525|FG004|Overall Study|Sponsor Decision|2
7095395|NCT02308020|11216526|FG005|Overall Study|Sponsor Decision|1
7095396|NCT02308020|11216521|FG000|Overall Study|Withdrawal by Subject|3
7095397|NCT02308020|11216522|FG001|Overall Study|Withdrawal by Subject|5
7095398|NCT02308020|11216523|FG002|Overall Study|Withdrawal by Subject|3
7095399|NCT02308020|11216524|FG003|Overall Study|Withdrawal by Subject|2
7095400|NCT02308020|11216525|FG004|Overall Study|Withdrawal by Subject|1
7095401|NCT02308020|11216526|FG005|Overall Study|Withdrawal by Subject|2
7095402|NCT02308033|11216548|FG000|Overall Study|Normal Gram stain at Baseline|13
7095403|NCT02308033|11216549|FG001|Overall Study|Normal Gram stain at Baseline|10
7095404|NCT02308033|11216548|FG000|Overall Study|Positive for STD at Baseline|7
7095405|NCT02308033|11216549|FG001|Overall Study|Positive for STD at Baseline|4
7095406|NCT02308033|11216548|FG000|Overall Study|Lost to Follow-up|6
7095407|NCT02308033|11216549|FG001|Overall Study|Lost to Follow-up|5
7095408|NCT02308046|11216557|FG000|Overall Study|Negative yeast culture at Baseline|32
7095409|NCT02308046|11216558|FG001|Overall Study|Negative yeast culture at Baseline|33
7095410|NCT02308046|11216557|FG000|Overall Study|Positive for STD at Baseline|1
7095411|NCT02308046|11216558|FG001|Overall Study|Positive for STD at Baseline|2
7095412|NCT02308046|11216557|FG000|Overall Study|Lost to Follow-up|1
7095413|NCT02308046|11216558|FG001|Overall Study|Lost to Follow-up|3
7095414|NCT02308124|11216567|FG000|Overall Study|Lost to Follow-up|6
7095415|NCT02308124|11216568|FG001|Overall Study|Lost to Follow-up|6
7095416|NCT02308124|11216569|FG002|Overall Study|Lost to Follow-up|6
7095417|NCT02308124|11216567|FG000|Overall Study|Adverse Event|0
7095418|NCT02308124|11216568|FG001|Overall Study|Adverse Event|2
7095419|NCT02308124|11216569|FG002|Overall Study|Adverse Event|2
7095420|NCT02308163|11216581|FG000|Overall Study|Not fulfill eligible criteria|1
7095421|NCT02308163|11216582|FG001|Overall Study|Not fulfill eligible criteria|2
7095422|NCT02308163|11216583|FG002|Overall Study|Not fulfill eligible criteria|0
7095423|NCT02308163|11216584|FG003|Overall Study|Not fulfill eligible criteria|1
7095424|NCT02308163|11216585|FG004|Overall Study|Not fulfill eligible criteria|1
7095425|NCT02308163|11216581|FG000|Overall Study|Adverse Event|9
7095426|NCT02308163|11216582|FG001|Overall Study|Adverse Event|5
7095427|NCT02308163|11216583|FG002|Overall Study|Adverse Event|2
7095428|NCT02308163|11216584|FG003|Overall Study|Adverse Event|2
7095429|NCT02308163|11216585|FG004|Overall Study|Adverse Event|11
7095430|NCT02308163|11216581|FG000|Overall Study|Lack of Efficacy|11
7095431|NCT02308163|11216582|FG001|Overall Study|Lack of Efficacy|3
7095432|NCT02308163|11216583|FG002|Overall Study|Lack of Efficacy|8
7095433|NCT02308163|11216584|FG003|Overall Study|Lack of Efficacy|4
7095434|NCT02308163|11216585|FG004|Overall Study|Lack of Efficacy|6
7095435|NCT02308163|11216581|FG000|Overall Study|Withdrawal of consent|2
7095436|NCT02308163|11216582|FG001|Overall Study|Withdrawal of consent|3
7095437|NCT02308163|11216583|FG002|Overall Study|Withdrawal of consent|0
7095438|NCT02308163|11216584|FG003|Overall Study|Withdrawal of consent|2
7095439|NCT02308163|11216585|FG004|Overall Study|Withdrawal of consent|6
7095440|NCT02308163|11216581|FG000|Overall Study|Protocol Violation|3
7095441|NCT02308163|11216582|FG001|Overall Study|Protocol Violation|3
7095442|NCT02308163|11216583|FG002|Overall Study|Protocol Violation|3
7095443|NCT02308163|11216584|FG003|Overall Study|Protocol Violation|2
7095444|NCT02308163|11216585|FG004|Overall Study|Protocol Violation|5
7095445|NCT02308163|11216581|FG000|Overall Study|Lab data met discontinuation criteria|3
7095446|NCT02308163|11216582|FG001|Overall Study|Lab data met discontinuation criteria|0
7095447|NCT02308163|11216583|FG002|Overall Study|Lab data met discontinuation criteria|0
7095448|NCT02308163|11216584|FG003|Overall Study|Lab data met discontinuation criteria|2
7095449|NCT02308163|11216585|FG004|Overall Study|Lab data met discontinuation criteria|0
7095450|NCT02308163|11216581|FG000|Overall Study|Miscellaneous|2
7095451|NCT02308163|11216582|FG001|Overall Study|Miscellaneous|2
7095452|NCT02308163|11216583|FG002|Overall Study|Miscellaneous|1
7095453|NCT02308163|11216584|FG003|Overall Study|Miscellaneous|0
7095454|NCT02308163|11216585|FG004|Overall Study|Miscellaneous|5
7095455|NCT02308228|11216623|FG000|Overall Study|Adverse Event|3
7095456|NCT02308228|11216624|FG001|Overall Study|Adverse Event|4
7095457|NCT02308228|11216623|FG000|Overall Study|Withdrawal by Subject|5
7095458|NCT02308228|11216624|FG001|Overall Study|Withdrawal by Subject|3
7095459|NCT02308540|11216662|FG000|Overall Study|Lost to Follow-up|0
7095460|NCT02308540|11216663|FG001|Overall Study|Lost to Follow-up|0
7095461|NCT02308540|11216664|FG002|Overall Study|Lost to Follow-up|0
7095462|NCT02308540|11216665|FG003|Overall Study|Lost to Follow-up|0
7095463|NCT02308540|11216666|FG004|Overall Study|Lost to Follow-up|0
7095464|NCT02308540|11216667|FG005|Overall Study|Lost to Follow-up|1
7095465|NCT02308696|11216718|FG000|Overall Study|Lost to Follow-up|28
7095466|NCT02308696|11216719|FG001|Overall Study|Lost to Follow-up|21
7095467|NCT02308696|11216718|FG000|Overall Study|Death|8
7095468|NCT02308696|11216719|FG001|Overall Study|Death|4
7095469|NCT02308696|11216718|FG000|Overall Study|Moved to a Higher Level of Care|17
7095470|NCT02308696|11216719|FG001|Overall Study|Moved to a Higher Level of Care|6
7095471|NCT02308748|11216725|FG000|Period 1|Withdrawal by Subject|0
7095472|NCT02308748|11216726|FG001|Period 1|Withdrawal by Subject|0
7095473|NCT02308748|11216727|FG002|Period 1|Withdrawal by Subject|1
7095474|NCT02308748|11216728|FG003|Period 1|Withdrawal by Subject|0
7095475|NCT02308748|11216729|FG004|Period 1|Withdrawal by Subject|0
7095476|NCT02308748|11216730|FG005|Period 1|Withdrawal by Subject|0
7095477|NCT02308748|11216731|FG006|Period 1|Withdrawal by Subject|0
7095478|NCT02308748|11216732|FG007|Period 1|Withdrawal by Subject|0
7095479|NCT02308748|11216733|FG008|Period 1|Withdrawal by Subject|0
7095480|NCT02308748|11216734|FG009|Period 1|Withdrawal by Subject|0
7095481|NCT02308748|11216725|FG000|Period 2|Adverse Event|0
7095482|NCT02308748|11216726|FG001|Period 2|Adverse Event|0
7095483|NCT02308748|11216727|FG002|Period 2|Adverse Event|0
7095484|NCT02308748|11216728|FG003|Period 2|Adverse Event|0
7095485|NCT02308748|11216729|FG004|Period 2|Adverse Event|0
7095486|NCT02308748|11216730|FG005|Period 2|Adverse Event|0
7095487|NCT02308748|11216731|FG006|Period 2|Adverse Event|0
6805643|NCT03336528|10807756|FG000|Overall Study|Protocol Violation|1
7095488|NCT02308748|11216732|FG007|Period 2|Adverse Event|1
7095489|NCT02308748|11216733|FG008|Period 2|Adverse Event|0
7095490|NCT02308748|11216734|FG009|Period 2|Adverse Event|0
7095491|NCT02308748|11216725|FG000|Period 3|Protocol Violation|0
7095492|NCT02308748|11216726|FG001|Period 3|Protocol Violation|0
7095493|NCT02308748|11216727|FG002|Period 3|Protocol Violation|0
7095494|NCT02308748|11216728|FG003|Period 3|Protocol Violation|0
7095495|NCT02308748|11216729|FG004|Period 3|Protocol Violation|0
7095496|NCT02308748|11216730|FG005|Period 3|Protocol Violation|0
7095497|NCT02308748|11216731|FG006|Period 3|Protocol Violation|0
7095498|NCT02308748|11216732|FG007|Period 3|Protocol Violation|0
7095499|NCT02308748|11216733|FG008|Period 3|Protocol Violation|0
7095500|NCT02308748|11216734|FG009|Period 3|Protocol Violation|1
7095501|NCT02308748|11216725|FG000|Period 5|Adverse Event|1
7095502|NCT02308748|11216726|FG001|Period 5|Adverse Event|0
7095503|NCT02308748|11216727|FG002|Period 5|Adverse Event|0
7095504|NCT02308748|11216728|FG003|Period 5|Adverse Event|0
7095505|NCT02308748|11216729|FG004|Period 5|Adverse Event|0
7095506|NCT02308748|11216730|FG005|Period 5|Adverse Event|0
7095507|NCT02308748|11216731|FG006|Period 5|Adverse Event|0
7095508|NCT02308748|11216732|FG007|Period 5|Adverse Event|0
7095509|NCT02308748|11216733|FG008|Period 5|Adverse Event|1
7095510|NCT02308748|11216734|FG009|Period 5|Adverse Event|0
7095511|NCT02309099|11216756|FG000|Overall Study|Adverse Event|2
7095512|NCT02309099|11216757|FG001|Overall Study|Adverse Event|0
7095513|NCT02309112|11216766|FG000|Overall Study|Withdrawal by Subject|1
7095514|NCT02309112|11216767|FG001|Overall Study|Withdrawal by Subject|0
7095515|NCT02309112|11216768|FG002|Overall Study|Withdrawal by Subject|1
7095516|NCT02309112|11216766|FG000|Overall Study|Lost to Follow-up|0
7095517|NCT02309112|11216767|FG001|Overall Study|Lost to Follow-up|1
7095518|NCT02309112|11216768|FG002|Overall Study|Lost to Follow-up|0
7095519|NCT02309138|11216780|FG000|Overall Study|Withdrawal by Subject|44
7095520|NCT02309138|11216781|FG001|Overall Study|Withdrawal by Subject|15
7095521|NCT02309138|11216780|FG000|Overall Study|Protocol Violation|4
7095522|NCT02309138|11216781|FG001|Overall Study|Protocol Violation|2
7095523|NCT02309138|11216780|FG000|Overall Study|delivered before visit 2|0
7095524|NCT02309138|11216781|FG001|Overall Study|delivered before visit 2|1
7095525|NCT02309294|11216797|FG000|Overall Study|Withdrawal by Subject|2
7095526|NCT02309359|11216806|FG000|Overall Study|Adverse Event|4
7095527|NCT02309359|11216807|FG001|Overall Study|Adverse Event|5
7095528|NCT02309359|11216808|FG002|Overall Study|Adverse Event|5
7095529|NCT02309359|11216809|FG003|Overall Study|Adverse Event|4
7095530|NCT02309359|11216810|FG004|Overall Study|Adverse Event|4
7095531|NCT02309359|11216806|FG000|Overall Study|Death|1
7095532|NCT02309359|11216807|FG001|Overall Study|Death|0
7095533|NCT02309359|11216808|FG002|Overall Study|Death|0
7095534|NCT02309359|11216809|FG003|Overall Study|Death|0
7095535|NCT02309359|11216810|FG004|Overall Study|Death|0
7095536|NCT02309359|11216806|FG000|Overall Study|Withdrawal by Subject|2
7095537|NCT02309359|11216807|FG001|Overall Study|Withdrawal by Subject|2
7095538|NCT02309359|11216808|FG002|Overall Study|Withdrawal by Subject|4
7095539|NCT02309359|11216809|FG003|Overall Study|Withdrawal by Subject|4
7095540|NCT02309359|11216810|FG004|Overall Study|Withdrawal by Subject|0
7095541|NCT02309359|11216806|FG000|Overall Study|Lack of Efficacy|3
7095542|NCT02309359|11216807|FG001|Overall Study|Lack of Efficacy|1
7095543|NCT02309359|11216808|FG002|Overall Study|Lack of Efficacy|0
7095544|NCT02309359|11216809|FG003|Overall Study|Lack of Efficacy|0
7095545|NCT02309359|11216810|FG004|Overall Study|Lack of Efficacy|3
7095546|NCT02309359|11216806|FG000|Overall Study|Lost to Follow-up|0
7095547|NCT02309359|11216807|FG001|Overall Study|Lost to Follow-up|0
7095548|NCT02309359|11216808|FG002|Overall Study|Lost to Follow-up|0
7095549|NCT02309359|11216809|FG003|Overall Study|Lost to Follow-up|1
7095550|NCT02309359|11216810|FG004|Overall Study|Lost to Follow-up|0
7095551|NCT02309359|11216806|FG000|Overall Study|Other|2
7095552|NCT02309359|11216807|FG001|Overall Study|Other|0
7095553|NCT02309359|11216808|FG002|Overall Study|Other|2
7095554|NCT02309359|11216809|FG003|Overall Study|Other|3
7095555|NCT02309359|11216810|FG004|Overall Study|Other|2
7095556|NCT02309372|11216825|FG000|Overall Study|Lost to Follow-up|3
7095557|NCT02309372|11216826|FG001|Overall Study|Lost to Follow-up|2
7095558|NCT02309411|11216835|FG000|Overall Study|Physician Decision|1
7095559|NCT02309411|11216836|FG001|Overall Study|Physician Decision|0
7095560|NCT02309411|11216837|FG002|Overall Study|Physician Decision|0
7095561|NCT02309411|11216835|FG000|Overall Study|Withdrawal by Subject|1
7095562|NCT02309411|11216836|FG001|Overall Study|Withdrawal by Subject|1
7095563|NCT02309411|11216837|FG002|Overall Study|Withdrawal by Subject|0
7095564|NCT02309515|11216855|FG000|Overall Study|Withdrawal by Subject|0
7095565|NCT02309515|11216856|FG001|Overall Study|Withdrawal by Subject|1
7095566|NCT02309723|11216865|FG000|Overall Study|Withdrawal by Subject|24
7095567|NCT02309723|11216866|FG001|Overall Study|Withdrawal by Subject|23
7095568|NCT02309723|11216867|FG002|Overall Study|Withdrawal by Subject|24
7095569|NCT02310100|11216884|FG000|Overall Study|Physician Decision|3
7095570|NCT02310100|11216884|FG000|Overall Study|Withdrawal by Subject|10
7095571|NCT02310100|11216884|FG000|Overall Study|Enrollment closure|1
7095572|NCT02310100|11216884|FG000|Overall Study|Unapproved ablation operator|1
7095573|NCT02310100|11216884|FG000|Overall Study|Visit compliance|1
7095574|NCT02310100|11216884|FG000|Overall Study|Lost to Follow-up|2
7095575|NCT02310126|11216891|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0
7095576|NCT02310126|11216892|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1
7095577|NCT02310126|11216891|FG000|Period 1 (15 Minutes)|Protocol Violation|0
7095578|NCT02310126|11216892|FG001|Period 1 (15 Minutes)|Protocol Violation|1
7095579|NCT02310568|11216903|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
7095580|NCT02310568|11216904|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
7095581|NCT02310568|11216905|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
7095582|NCT02310568|11216906|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
7095583|NCT02310568|11216907|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1
7095584|NCT02310568|11216903|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1
7095585|NCT02310568|11216904|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
7095586|NCT02310568|11216905|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
7095587|NCT02310568|11216906|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
7095588|NCT02310568|11216907|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
7095589|NCT02310568|11216903|FG000|Stage 1 ( 4 Weeks)|Other|1
7095590|NCT02310568|11216904|FG001|Stage 1 ( 4 Weeks)|Other|1
7095591|NCT02310568|11216905|FG002|Stage 1 ( 4 Weeks)|Other|0
7095592|NCT02310568|11216906|FG003|Stage 1 ( 4 Weeks)|Other|0
7095593|NCT02310568|11216907|FG004|Stage 1 ( 4 Weeks)|Other|0
7095594|NCT02310568|11216903|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1
7095595|NCT02310568|11216904|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1
7095596|NCT02310568|11216905|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1
7095597|NCT02310568|11216906|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0
7095598|NCT02310568|11216907|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0
7095599|NCT02310568|11216903|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
7095600|NCT02310568|11216904|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
7095601|NCT02310568|11216905|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
7095602|NCT02310568|11216906|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1
7095603|NCT02310568|11216907|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
7095604|NCT02310568|11216903|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
7095605|NCT02310568|11216904|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
7095606|NCT02310568|11216905|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
7095607|NCT02310568|11216906|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1
7095608|NCT02310568|11216907|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
7095609|NCT02310568|11216903|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1
7095610|NCT02310568|11216904|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0
7095611|NCT02310568|11216905|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0
7095612|NCT02310568|11216906|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1
7095613|NCT02310568|11216907|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0
7095614|NCT02310568|11216903|FG000|Stage 2 (4 Weeks)|Other|0
7095615|NCT02310568|11216904|FG001|Stage 2 (4 Weeks)|Other|1
7095616|NCT02310568|11216905|FG002|Stage 2 (4 Weeks)|Other|1
7095617|NCT02310568|11216906|FG003|Stage 2 (4 Weeks)|Other|0
7095618|NCT02310568|11216907|FG004|Stage 2 (4 Weeks)|Other|0
7095619|NCT02310568|11216903|FG000|Stage 2 (4 Weeks)|Adverse Event|0
7095620|NCT02310568|11216904|FG001|Stage 2 (4 Weeks)|Adverse Event|0
7095621|NCT02310568|11216905|FG002|Stage 2 (4 Weeks)|Adverse Event|0
7095622|NCT02310568|11216906|FG003|Stage 2 (4 Weeks)|Adverse Event|1
7095623|NCT02310568|11216907|FG004|Stage 2 (4 Weeks)|Adverse Event|1
7095624|NCT02310568|11216903|FG000|Stage 2 (4 Weeks)|Protocol Violation|0
7095625|NCT02310568|11216904|FG001|Stage 2 (4 Weeks)|Protocol Violation|0
7095626|NCT02310568|11216905|FG002|Stage 2 (4 Weeks)|Protocol Violation|0
7095627|NCT02310568|11216906|FG003|Stage 2 (4 Weeks)|Protocol Violation|1
7095628|NCT02310568|11216907|FG004|Stage 2 (4 Weeks)|Protocol Violation|0
7095629|NCT02310568|11216903|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0
7095630|NCT02310568|11216904|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0
7095631|NCT02310568|11216905|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0
7095632|NCT02310568|11216906|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2
7095633|NCT02310568|11216907|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0
7095634|NCT02310581|11216929|FG000|Overall Study|Adverse Event|1
7095635|NCT02310581|11216930|FG001|Overall Study|Adverse Event|1
7095636|NCT02310581|11216931|FG002|Overall Study|Adverse Event|1
7095637|NCT02310581|11216932|FG003|Overall Study|Adverse Event|0
7095638|NCT02310581|11216929|FG000|Overall Study|Withdrawal by Subject|2
7095639|NCT02310581|11216930|FG001|Overall Study|Withdrawal by Subject|1
7095640|NCT02310581|11216931|FG002|Overall Study|Withdrawal by Subject|0
7095641|NCT02310581|11216932|FG003|Overall Study|Withdrawal by Subject|1
7095642|NCT02310646|11216944|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1
7095643|NCT02310646|11216945|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0
7095644|NCT02310646|11216944|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1
7095645|NCT02310646|11216945|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0
7095646|NCT02310672|11216967|FG000|Overall Study|Death|1
7095647|NCT02310672|11216967|FG000|Overall Study|Lost to Follow-up|1
7095648|NCT02310672|11216967|FG000|Overall Study|Withdrawal by Subject|1
7095649|NCT02310672|11216967|FG000|Overall Study|Sponsor's decision|12
7095650|NCT02310750|11216982|FG000|HP Period 1|Lost to Follow-up|0
7095651|NCT02310750|11216983|FG001|HP Period 1|Lost to Follow-up|0
7095652|NCT02310750|11216984|FG002|HP Period 1|Lost to Follow-up|0
7095653|NCT02310750|11216985|FG003|HP Period 1|Lost to Follow-up|0
7095654|NCT02310750|11216986|FG004|HP Period 1|Lost to Follow-up|0
7095655|NCT02310750|11216987|FG005|HP Period 1|Lost to Follow-up|0
7095656|NCT02310750|11216988|FG006|HP Period 1|Lost to Follow-up|1
7095657|NCT02310750|11216989|FG007|HP Period 1|Lost to Follow-up|0
7095658|NCT02310750|11216990|FG008|HP Period 1|Lost to Follow-up|0
7095659|NCT02310750|11216991|FG009|HP Period 1|Lost to Follow-up|0
7095660|NCT02310750|11216992|FG010|HP Period 1|Lost to Follow-up|0
7095661|NCT02310750|11216993|FG011|HP Period 1|Lost to Follow-up|0
7095662|NCT02310750|11216994|FG012|HP Period 1|Lost to Follow-up|0
7095663|NCT02310750|11216995|FG013|HP Period 1|Lost to Follow-up|0
7095664|NCT02310750|11216996|FG014|HP Period 1|Lost to Follow-up|0
7095665|NCT02310750|11216997|FG015|HP Period 1|Lost to Follow-up|0
7095666|NCT02310750|11216982|FG000|HP Period 1|Withdrawal by Subject|1
7095667|NCT02310750|11216983|FG001|HP Period 1|Withdrawal by Subject|0
7095668|NCT02310750|11216984|FG002|HP Period 1|Withdrawal by Subject|0
7095669|NCT02310750|11216985|FG003|HP Period 1|Withdrawal by Subject|1
7095670|NCT02310750|11216986|FG004|HP Period 1|Withdrawal by Subject|0
7095671|NCT02310750|11216987|FG005|HP Period 1|Withdrawal by Subject|0
7095672|NCT02310750|11216988|FG006|HP Period 1|Withdrawal by Subject|0
7095673|NCT02310750|11216989|FG007|HP Period 1|Withdrawal by Subject|0
7095674|NCT02310750|11216990|FG008|HP Period 1|Withdrawal by Subject|0
7095675|NCT02310750|11216991|FG009|HP Period 1|Withdrawal by Subject|0
7095676|NCT02310750|11216992|FG010|HP Period 1|Withdrawal by Subject|0
7095677|NCT02310750|11216993|FG011|HP Period 1|Withdrawal by Subject|0
7095678|NCT02310750|11216994|FG012|HP Period 1|Withdrawal by Subject|0
7095679|NCT02310750|11216995|FG013|HP Period 1|Withdrawal by Subject|0
7095680|NCT02310750|11216996|FG014|HP Period 1|Withdrawal by Subject|0
7095681|NCT02310750|11216997|FG015|HP Period 1|Withdrawal by Subject|0
7095682|NCT02310750|11216982|FG000|HP Washout 1|Lost to Follow-up|0
7095683|NCT02310750|11216983|FG001|HP Washout 1|Lost to Follow-up|0
7095684|NCT02310750|11216984|FG002|HP Washout 1|Lost to Follow-up|1
7095685|NCT02310750|11216985|FG003|HP Washout 1|Lost to Follow-up|1
7095686|NCT02310750|11216986|FG004|HP Washout 1|Lost to Follow-up|2
7095687|NCT02310750|11216987|FG005|HP Washout 1|Lost to Follow-up|2
7095688|NCT02310750|11216988|FG006|HP Washout 1|Lost to Follow-up|3
7095689|NCT02310750|11216989|FG007|HP Washout 1|Lost to Follow-up|0
7095690|NCT02310750|11216990|FG008|HP Washout 1|Lost to Follow-up|0
7095691|NCT02310750|11216991|FG009|HP Washout 1|Lost to Follow-up|0
7095692|NCT02310750|11216992|FG010|HP Washout 1|Lost to Follow-up|0
7095693|NCT02310750|11216993|FG011|HP Washout 1|Lost to Follow-up|0
7095694|NCT02310750|11216994|FG012|HP Washout 1|Lost to Follow-up|0
7095695|NCT02310750|11216995|FG013|HP Washout 1|Lost to Follow-up|0
7095696|NCT02310750|11216996|FG014|HP Washout 1|Lost to Follow-up|0
7095697|NCT02310750|11216997|FG015|HP Washout 1|Lost to Follow-up|0
7095698|NCT02310750|11216982|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7095699|NCT02310750|11216983|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7095700|NCT02310750|11216984|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7095701|NCT02310750|11216985|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
7095702|NCT02310750|11216986|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7095703|NCT02310750|11216987|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2
7095704|NCT02310750|11216988|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7095705|NCT02310750|11216989|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7095706|NCT02310750|11216990|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6
7095707|NCT02310750|11216991|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
7095708|NCT02310750|11216992|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7095709|NCT02310750|11216993|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7095710|NCT02310750|11216994|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7095711|NCT02310750|11216995|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7095712|NCT02310750|11216996|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7095713|NCT02310750|11216997|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7095714|NCT02310750|11216982|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7095715|NCT02310750|11216983|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7095716|NCT02310750|11216984|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7095717|NCT02310750|11216985|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7095718|NCT02310750|11216986|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7095719|NCT02310750|11216987|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7095720|NCT02310750|11216988|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7095721|NCT02310750|11216989|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7095722|NCT02310750|11216990|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7095723|NCT02310750|11216991|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1
7095724|NCT02310750|11216992|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7095725|NCT02310750|11216993|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7095726|NCT02310750|11216994|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7095727|NCT02310750|11216995|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7095728|NCT02310750|11216996|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7095729|NCT02310750|11216997|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7095730|NCT02310750|11216982|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7095731|NCT02310750|11216983|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7095732|NCT02310750|11216984|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7095733|NCT02310750|11216985|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7095734|NCT02310750|11216986|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7095735|NCT02310750|11216987|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7095736|NCT02310750|11216988|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7095737|NCT02310750|11216989|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
7095738|NCT02310750|11216990|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
7095739|NCT02310750|11216991|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
7095740|NCT02310750|11216992|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7095741|NCT02310750|11216993|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7095742|NCT02310750|11216994|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7095743|NCT02310750|11216995|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7095744|NCT02310750|11216996|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7095745|NCT02310750|11216997|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7095746|NCT02310750|11216982|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7095747|NCT02310750|11216983|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7095748|NCT02310750|11216984|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7095749|NCT02310750|11216985|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7095750|NCT02310750|11216986|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7095751|NCT02310750|11216987|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7095752|NCT02310750|11216988|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7095753|NCT02310750|11216989|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
7095754|NCT02310750|11216990|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
7095755|NCT02310750|11216991|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7095756|NCT02310750|11216992|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7095757|NCT02310750|11216993|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7095758|NCT02310750|11216994|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7095759|NCT02310750|11216995|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7095760|NCT02310750|11216996|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7095761|NCT02310750|11216997|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7095762|NCT02310750|11216982|FG000|HP Washout 2|Lost to Follow-up|0
7095763|NCT02310750|11216983|FG001|HP Washout 2|Lost to Follow-up|0
7095764|NCT02310750|11216984|FG002|HP Washout 2|Lost to Follow-up|0
7095765|NCT02310750|11216985|FG003|HP Washout 2|Lost to Follow-up|0
7095766|NCT02310750|11216986|FG004|HP Washout 2|Lost to Follow-up|1
7095767|NCT02310750|11216987|FG005|HP Washout 2|Lost to Follow-up|0
7095768|NCT02310750|11216988|FG006|HP Washout 2|Lost to Follow-up|7
7095769|NCT02310750|11216989|FG007|HP Washout 2|Lost to Follow-up|0
7095770|NCT02310750|11216990|FG008|HP Washout 2|Lost to Follow-up|0
7095771|NCT02310750|11216991|FG009|HP Washout 2|Lost to Follow-up|0
7095772|NCT02310750|11216992|FG010|HP Washout 2|Lost to Follow-up|0
7095773|NCT02310750|11216993|FG011|HP Washout 2|Lost to Follow-up|0
7095774|NCT02310750|11216994|FG012|HP Washout 2|Lost to Follow-up|0
7095775|NCT02310750|11216995|FG013|HP Washout 2|Lost to Follow-up|0
7095776|NCT02310750|11216996|FG014|HP Washout 2|Lost to Follow-up|0
7095777|NCT02310750|11216997|FG015|HP Washout 2|Lost to Follow-up|0
7095778|NCT02310763|11217081|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
7095779|NCT02310763|11217082|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
7095780|NCT02310763|11217083|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
7095781|NCT02310763|11217081|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0
7095782|NCT02310763|11217082|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1
7095783|NCT02310763|11217083|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1
7095784|NCT02310763|11217081|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1
7095785|NCT02310763|11217082|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0
7095786|NCT02310763|11217083|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0
7095787|NCT02310763|11217081|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1
7095788|NCT02310763|11217082|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0
7095789|NCT02310763|11217083|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0
7095790|NCT02310763|11217081|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
7095791|NCT02310763|11217082|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
7095792|NCT02310763|11217083|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
7095793|NCT02310789|11217113|FG000|Overall Study|Adverse Event|1
7095794|NCT02310906|11217121|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0
7095795|NCT02310906|11217122|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0
7095796|NCT02310906|11217123|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0
7095797|NCT02310906|11217124|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2
7095798|NCT02310906|11217121|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0
7095799|NCT02310906|11217122|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0
7095800|NCT02310906|11217123|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2
7095801|NCT02310906|11217124|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4
7095802|NCT02310906|11217121|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0
7095803|NCT02310906|11217122|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0
7095804|NCT02310906|11217123|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0
7095805|NCT02310906|11217124|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1
7095806|NCT02310906|11217121|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0
7095807|NCT02310906|11217122|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0
7095808|NCT02310906|11217123|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0
7095809|NCT02310906|11217124|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1
7095810|NCT02311153|11217147|FG000|Overall Study|Lost to Follow-up|5
7095811|NCT02311153|11217148|FG001|Overall Study|Lost to Follow-up|7
7095812|NCT02311361|11217171|FG000|Overall Study|Did not receive treatment|0
7095813|NCT02311361|11217172|FG001|Overall Study|Did not receive treatment|1
7095814|NCT02311361|11217173|FG002|Overall Study|Did not receive treatment|0
7095815|NCT02311361|11217174|FG003|Overall Study|Did not receive treatment|1
7095819|NCT02311881|11217195|FG000|Overall Study|Did not meet the study criteria|2
7095820|NCT02311881|11217196|FG001|Overall Study|Did not meet the study criteria|2
7095821|NCT02311881|11217197|FG002|Overall Study|Did not meet the study criteria|0
7095822|NCT02311881|11217195|FG000|Overall Study|Adverse Event|7
7095823|NCT02311881|11217196|FG001|Overall Study|Adverse Event|15
7095824|NCT02311881|11217197|FG002|Overall Study|Adverse Event|8
7095825|NCT02311881|11217195|FG000|Overall Study|Lost to Follow-up|3
7095826|NCT02311881|11217196|FG001|Overall Study|Lost to Follow-up|3
7095827|NCT02311881|11217197|FG002|Overall Study|Lost to Follow-up|2
7095828|NCT02311881|11217195|FG000|Overall Study|Protocol Violation|1
7095829|NCT02311881|11217196|FG001|Overall Study|Protocol Violation|2
7095830|NCT02311881|11217197|FG002|Overall Study|Protocol Violation|3
7095831|NCT02311881|11217195|FG000|Overall Study|Withdrawal of consent|14
7095832|NCT02311881|11217196|FG001|Overall Study|Withdrawal of consent|16
7095833|NCT02311881|11217197|FG002|Overall Study|Withdrawal of consent|17
7095834|NCT02311881|11217195|FG000|Overall Study|Other|0
7095835|NCT02311881|11217196|FG001|Overall Study|Other|0
7095836|NCT02311881|11217197|FG002|Overall Study|Other|1
7095837|NCT02311881|11217195|FG000|Overall Study|Lack of Efficacy|1
7095838|NCT02311881|11217196|FG001|Overall Study|Lack of Efficacy|2
7095839|NCT02311881|11217197|FG002|Overall Study|Lack of Efficacy|0
7095840|NCT02311881|11217195|FG000|Overall Study|Subject has border line pregnancy test|1
7095841|NCT02311881|11217196|FG001|Overall Study|Subject has border line pregnancy test|0
7095842|NCT02311881|11217197|FG002|Overall Study|Subject has border line pregnancy test|0
7095843|NCT02311881|11217195|FG000|Overall Study|Withdrawal by Subject|3
7095844|NCT02311881|11217196|FG001|Overall Study|Withdrawal by Subject|1
7095845|NCT02311881|11217197|FG002|Overall Study|Withdrawal by Subject|4
7095846|NCT02311881|11217195|FG000|Overall Study|Sponsor Decision|1
7095847|NCT02311881|11217196|FG001|Overall Study|Sponsor Decision|1
7095848|NCT02311881|11217197|FG002|Overall Study|Sponsor Decision|1
7095849|NCT02311881|11217195|FG000|Overall Study|Protocol Deviation|1
7095850|NCT02311881|11217196|FG001|Overall Study|Protocol Deviation|0
7095851|NCT02311881|11217197|FG002|Overall Study|Protocol Deviation|0
7095852|NCT02311881|11217195|FG000|Overall Study|Non-Compliance|1
7095853|NCT02311881|11217196|FG001|Overall Study|Non-Compliance|0
7095854|NCT02311881|11217197|FG002|Overall Study|Non-Compliance|2
7095855|NCT02311881|11217195|FG000|Overall Study|Physician Decision|0
7095856|NCT02311881|11217196|FG001|Overall Study|Physician Decision|0
7095857|NCT02311881|11217197|FG002|Overall Study|Physician Decision|1
7095858|NCT02311881|11217195|FG000|Overall Study|Medical Monitor Discretion|0
7095859|NCT02311881|11217196|FG001|Overall Study|Medical Monitor Discretion|0
7095860|NCT02311881|11217197|FG002|Overall Study|Medical Monitor Discretion|1
7095861|NCT02311881|11217195|FG000|Overall Study|Participant taking another medication|0
7095862|NCT02311881|11217196|FG001|Overall Study|Participant taking another medication|0
7095863|NCT02311881|11217197|FG002|Overall Study|Participant taking another medication|1
7095864|NCT02311881|11217195|FG000|Overall Study|Serious Adverse Event|0
7095865|NCT02311881|11217196|FG001|Overall Study|Serious Adverse Event|1
7095866|NCT02311881|11217197|FG002|Overall Study|Serious Adverse Event|0
7095867|NCT02311894|11217208|FG000|Overall Study|Discontinued in error|1
7095868|NCT02311894|11217208|FG000|Overall Study|Lost to Follow-up|1
7095869|NCT02311894|11217208|FG000|Overall Study|Adverse Event|1
7095870|NCT02311894|11217208|FG000|Overall Study|Withdrawal by Subject|1
7095871|NCT02312063|11217242|FG000|Overall Study|Withdrawal by Subject|0
7095872|NCT02312063|11217243|FG001|Overall Study|Withdrawal by Subject|1
7095873|NCT02312206|11217257|FG000|Overall Study|Adverse Event|3
7095874|NCT02312206|11217258|FG001|Overall Study|Adverse Event|6
7095875|NCT02312206|11217257|FG000|Overall Study|Withdrawal by Subject|7
7095876|NCT02312206|11217258|FG001|Overall Study|Withdrawal by Subject|6
7095877|NCT02312206|11217257|FG000|Overall Study|Physician Decision|7
7095878|NCT02312206|11217258|FG001|Overall Study|Physician Decision|6
7095879|NCT02312206|11217257|FG000|Overall Study|Death|30
7095880|NCT02312206|11217258|FG001|Overall Study|Death|36
7095881|NCT02312206|11217257|FG000|Overall Study|Study Terminated by Sponsor|81
7095882|NCT02312206|11217258|FG001|Overall Study|Study Terminated by Sponsor|74
7095883|NCT02312206|11217257|FG000|Overall Study|Disease Progression|1
7095884|NCT02312206|11217258|FG001|Overall Study|Disease Progression|0
7095885|NCT02312206|11217257|FG000|Overall Study|Patient progression and new therapy|1
7095886|NCT02312206|11217258|FG001|Overall Study|Patient progression and new therapy|0
7095887|NCT02312206|11217257|FG000|Overall Study|Patient transferred to hospice|0
7095888|NCT02312206|11217258|FG001|Overall Study|Patient transferred to hospice|1
7095889|NCT02312206|11217257|FG000|Overall Study|Subject missed 3 consecutive tx visits|0
7095890|NCT02312206|11217258|FG001|Overall Study|Subject missed 3 consecutive tx visits|1
7095891|NCT02312219|11217266|FG000|Overall Study|Withdrawal by Subject|1
7095892|NCT02312219|11217267|FG001|Overall Study|Withdrawal by Subject|2
7095893|NCT02312219|11217266|FG000|Overall Study|could not schedule imaging in time|0
7095894|NCT02312219|11217267|FG001|Overall Study|could not schedule imaging in time|2
7095895|NCT02312219|11217266|FG000|Overall Study|Other|0
7095896|NCT02312219|11217267|FG001|Overall Study|Other|1
7095897|NCT02312219|11217266|FG000|Overall Study|Not randomized. Ineligible|0
7095898|NCT02312219|11217267|FG001|Overall Study|Not randomized. Ineligible|1
7095899|NCT02312687|11217310|FG000|Overall Study|Other, Not Specified|1
7095900|NCT02312856|11217354|FG000|Overall Study|Death|1
7095901|NCT02312856|11217354|FG000|Overall Study|Lost to Follow-up|3
7095902|NCT02312934|11217364|FG000|Overall Study|Lost to Follow-up|1
7095903|NCT02312934|11217365|FG001|Overall Study|Lost to Follow-up|0
7095904|NCT02312934|11217364|FG000|Overall Study|Physician Decision|1
7095905|NCT02312934|11217365|FG001|Overall Study|Physician Decision|0
7095906|NCT02313155|11217378|FG000|Overall Study|Lost to Follow-up|0
7095907|NCT02313155|11217379|FG001|Overall Study|Lost to Follow-up|1
7095908|NCT02313233|11217387|FG000|Overall Study|Withdrawal by Subject|1
7095909|NCT02313233|11217388|FG001|Overall Study|Withdrawal by Subject|2
7095910|NCT02313233|11217387|FG000|Overall Study|Administrative reason|1
7095911|NCT02313233|11217388|FG001|Overall Study|Administrative reason|1
7095912|NCT02313558|11217415|FG000|Overall Study|Withdrawal by Subject|2
7095913|NCT02313558|11217416|FG001|Overall Study|Withdrawal by Subject|0
7095914|NCT02313558|11217415|FG000|Overall Study|Lost to Follow-up|4
7095915|NCT02313558|11217416|FG001|Overall Study|Lost to Follow-up|4
7095916|NCT02313766|11217451|FG000|Overall Study|surgery cancelled|1
7095917|NCT02313766|11217452|FG001|Overall Study|surgery cancelled|0
7095918|NCT02313766|11217453|FG002|Overall Study|surgery cancelled|0
7095919|NCT02313766|11217451|FG000|Overall Study|Lost to Follow-up|0
7095920|NCT02313766|11217452|FG001|Overall Study|Lost to Follow-up|2
7095921|NCT02313766|11217453|FG002|Overall Study|Lost to Follow-up|0
7095922|NCT02313766|11217451|FG000|Overall Study|Adverse Event|0
7095923|NCT02313766|11217452|FG001|Overall Study|Adverse Event|1
7095924|NCT02313766|11217453|FG002|Overall Study|Adverse Event|0
7095925|NCT02313909|11217463|FG000|Overall Study|Consent withdrawn by participant|33
7095926|NCT02313909|11217464|FG001|Overall Study|Consent withdrawn by participant|33
7095927|NCT02313909|11217463|FG000|Overall Study|Lost to Follow-up|24
7095928|NCT02313909|11217464|FG001|Overall Study|Lost to Follow-up|17
7095929|NCT02314026|11217480|FG000|Overall Study|Protocol Violation|28
7095930|NCT02314052|11217484|FG000|Cycle One|Adverse Event|0
7095931|NCT02314052|11217485|FG001|Cycle One|Adverse Event|0
7095932|NCT02314052|11217486|FG002|Cycle One|Adverse Event|0
7095933|NCT02314052|11217487|FG003|Cycle One|Adverse Event|1
7095934|NCT02314052|11217488|FG004|Cycle One|Adverse Event|0
7095935|NCT02314052|11217489|FG005|Cycle One|Adverse Event|0
7095936|NCT02314117|11217518|FG000|Overall Study|Lost to Follow-up|9
7095937|NCT02314117|11217519|FG001|Overall Study|Lost to Follow-up|14
7095938|NCT02314117|11217518|FG000|Overall Study|Withdrawal by Subject|3
7095939|NCT02314117|11217519|FG001|Overall Study|Withdrawal by Subject|2
7095940|NCT02314143|11217529|FG000|Overall Study|Adverse Event|0
7095941|NCT02314143|11217530|FG001|Overall Study|Adverse Event|6
7095942|NCT02314143|11217531|FG002|Overall Study|Adverse Event|4
7095943|NCT02314143|11217529|FG000|Overall Study|Other (Study Closed/Terminated)|5
7095944|NCT02314143|11217530|FG001|Overall Study|Other (Study Closed/Terminated)|3
7095945|NCT02314143|11217531|FG002|Overall Study|Other (Study Closed/Terminated)|4
7095946|NCT02314143|11217529|FG000|Overall Study|Physician Decision|2
7095947|NCT02314143|11217530|FG001|Overall Study|Physician Decision|1
7095948|NCT02314143|11217531|FG002|Overall Study|Physician Decision|0
7095949|NCT02314143|11217529|FG000|Overall Study|Withdrawal by Subject|1
7095950|NCT02314143|11217530|FG001|Overall Study|Withdrawal by Subject|0
7095951|NCT02314143|11217531|FG002|Overall Study|Withdrawal by Subject|1
7095952|NCT02314247|11217542|FG000|Overall Study|Adverse Event|2
7095953|NCT02314247|11217543|FG001|Overall Study|Adverse Event|1
7095954|NCT02314247|11217544|FG002|Overall Study|Adverse Event|0
7095955|NCT02314247|11217542|FG000|Overall Study|Withdrawal by Subject|1
7095956|NCT02314247|11217543|FG001|Overall Study|Withdrawal by Subject|3
7095957|NCT02314247|11217544|FG002|Overall Study|Withdrawal by Subject|1
7095958|NCT02314247|11217542|FG000|Overall Study|Progression of Disease|6
7095959|NCT02314247|11217543|FG001|Overall Study|Progression of Disease|2
7095960|NCT02314247|11217544|FG002|Overall Study|Progression of Disease|0
7095961|NCT02314637|11217591|FG000|Overall Study|Adverse Event|4
7095962|NCT02314637|11217592|FG001|Overall Study|Adverse Event|8
7095963|NCT02314637|11217591|FG000|Overall Study|Lack of Efficacy|1
7095964|NCT02314637|11217592|FG001|Overall Study|Lack of Efficacy|0
7095965|NCT02314637|11217591|FG000|Overall Study|Physician Decision|5
7095966|NCT02314637|11217592|FG001|Overall Study|Physician Decision|2
7095967|NCT02314637|11217591|FG000|Overall Study|Withdrawal by Subject|5
7095968|NCT02314637|11217592|FG001|Overall Study|Withdrawal by Subject|4
7095969|NCT02314637|11217591|FG000|Overall Study|Other Reason|1
7095970|NCT02314637|11217592|FG001|Overall Study|Other Reason|0
7095971|NCT02314728|11217604|FG000|Overall Study|Protocol Violation|1
7095972|NCT02314728|11217605|FG001|Overall Study|Protocol Violation|0
7095973|NCT02314728|11217604|FG000|Overall Study|Lost to Follow-up|0
7095974|NCT02314728|11217605|FG001|Overall Study|Lost to Follow-up|1
7095975|NCT02314780|11217616|FG000|Overall Study|organizational reasons|0
7095976|NCT02314780|11217617|FG001|Overall Study|organizational reasons|2
7095977|NCT02314780|11217618|FG002|Overall Study|organizational reasons|0
7095978|NCT02314780|11217616|FG000|Overall Study|Adverse Event|0
7095979|NCT02314780|11217617|FG001|Overall Study|Adverse Event|1
7095980|NCT02314780|11217618|FG002|Overall Study|Adverse Event|0
7095981|NCT02315560|11217679|FG000|Overall Study|noncompliance by subjects|3
7095982|NCT02315625|11217685|FG000|First Intervention|Disease Progression|1
7095983|NCT02315625|11217686|FG001|First Intervention|Disease Progression|0
7095984|NCT02315625|11217685|FG000|Second Intervention|Physician Decision|2
7095985|NCT02315625|11217686|FG001|Second Intervention|Physician Decision|1
7095986|NCT02315625|11217685|FG000|Second Intervention|Study closure|1
7095987|NCT02315625|11217686|FG001|Second Intervention|Study closure|0
7095988|NCT02315625|11217685|FG000|Second Intervention|Disease Progression|1
7095989|NCT02315625|11217686|FG001|Second Intervention|Disease Progression|0
7095990|NCT02315664|11217696|FG000|Overall Study|Lost to Follow-up|1
7095991|NCT02315664|11217697|FG001|Overall Study|Lost to Follow-up|1
7095992|NCT02315664|11217696|FG000|Overall Study|Withdrawal by Subject|0
7095993|NCT02315664|11217697|FG001|Overall Study|Withdrawal by Subject|3
7095994|NCT02316171|11217726|FG000|Overall Study|difficulties with urinary catheter|1
7095995|NCT02316171|11217727|FG001|Overall Study|difficulties with urinary catheter|0
7095996|NCT02316171|11217728|FG002|Overall Study|difficulties with urinary catheter|0
7095997|NCT02316171|11217729|FG003|Overall Study|difficulties with urinary catheter|0
7095998|NCT02316223|11217738|FG000|Overall Study|Lack of Efficacy|0
7095999|NCT02316223|11217739|FG001|Overall Study|Lack of Efficacy|1
7096000|NCT02316223|11217740|FG002|Overall Study|Lack of Efficacy|1
7096001|NCT02316223|11217738|FG000|Overall Study|Lost to Follow-up|27
7096002|NCT02316223|11217739|FG001|Overall Study|Lost to Follow-up|34
7096003|NCT02316223|11217740|FG002|Overall Study|Lost to Follow-up|36
7096004|NCT02316223|11217738|FG000|Overall Study|COPD Diagnosis|3
7096005|NCT02316223|11217739|FG001|Overall Study|COPD Diagnosis|2
7096006|NCT02316223|11217740|FG002|Overall Study|COPD Diagnosis|3
7096007|NCT02316223|11217738|FG000|Overall Study|Reside outside study area|1
7096008|NCT02316223|11217739|FG001|Overall Study|Reside outside study area|1
7096009|NCT02316223|11217740|FG002|Overall Study|Reside outside study area|1
7096010|NCT02316223|11217738|FG000|Overall Study|No asthma|2
7096011|NCT02316223|11217739|FG001|Overall Study|No asthma|0
7096012|NCT02316223|11217740|FG002|Overall Study|No asthma|0
7096013|NCT02316223|11217738|FG000|Overall Study|Discontinued by PI|11
7096014|NCT02316223|11217739|FG001|Overall Study|Discontinued by PI|19
7096015|NCT02316223|11217740|FG002|Overall Study|Discontinued by PI|3
7096016|NCT02316353|11217750|FG000|Overall Study|Pregnancy|1
7096017|NCT02316353|11217751|FG001|Overall Study|Pregnancy|3
7096018|NCT02316353|11217750|FG000|Overall Study|Adverse Event|1
7096019|NCT02316353|11217751|FG001|Overall Study|Adverse Event|3
7096020|NCT02316353|11217750|FG000|Overall Study|Withdrawal by Subject|6
7096021|NCT02316353|11217751|FG001|Overall Study|Withdrawal by Subject|2
7096022|NCT02316548|11217788|FG000|Overall Study|Protocol Violation|0
7096023|NCT02316548|11217789|FG001|Overall Study|Protocol Violation|1
7096024|NCT02316613|11217795|FG000|Overall Study|Death|63
7096025|NCT02316613|11217795|FG000|Overall Study|Lost to Follow-up|9
7096026|NCT02316613|11217795|FG000|Overall Study|Lymphoma transformation|2
7096027|NCT02316613|11217795|FG000|Overall Study|Participant moved/changed medical team|11
7096028|NCT02316613|11217795|FG000|Overall Study|No data and duplicate cases|5
7096029|NCT02316613|11217795|FG000|Overall Study|Did not met selection criteria|14
7096030|NCT02316717|11217822|FG000|Overall Study|Adverse Event|2
7096031|NCT02316717|11217823|FG001|Overall Study|Adverse Event|2
7096032|NCT02316717|11217824|FG002|Overall Study|Adverse Event|0
7096033|NCT02316717|11217822|FG000|Overall Study|Lost to Follow-up|1
7096034|NCT02316717|11217823|FG001|Overall Study|Lost to Follow-up|2
7096035|NCT02316717|11217824|FG002|Overall Study|Lost to Follow-up|1
7096036|NCT02316717|11217822|FG000|Overall Study|Non compliance|3
7096037|NCT02316717|11217823|FG001|Overall Study|Non compliance|1
7096038|NCT02316717|11217824|FG002|Overall Study|Non compliance|0
7096039|NCT02316717|11217822|FG000|Overall Study|Protocol Violation|2
7096040|NCT02316717|11217823|FG001|Overall Study|Protocol Violation|0
7096041|NCT02316717|11217824|FG002|Overall Study|Protocol Violation|0
7096042|NCT02316717|11217822|FG000|Overall Study|Withdrawal by Subject|2
7096043|NCT02316717|11217823|FG001|Overall Study|Withdrawal by Subject|1
7096044|NCT02316717|11217824|FG002|Overall Study|Withdrawal by Subject|1
7096045|NCT02316717|11217822|FG000|Overall Study|Death|0
7096046|NCT02316717|11217823|FG001|Overall Study|Death|0
7096047|NCT02316717|11217824|FG002|Overall Study|Death|1
7096048|NCT02316717|11217822|FG000|Overall Study|Physician Decision|0
7096049|NCT02316717|11217823|FG001|Overall Study|Physician Decision|1
7096050|NCT02316717|11217824|FG002|Overall Study|Physician Decision|0
7096051|NCT02316717|11217822|FG000|Overall Study|TBC|1
7096052|NCT02316717|11217823|FG001|Overall Study|TBC|0
7096053|NCT02316717|11217824|FG002|Overall Study|TBC|0
7096054|NCT02316769|11217837|FG000|Overall Study|Physician Decision|1
7096055|NCT02316769|11217838|FG001|Overall Study|Physician Decision|0
7096056|NCT02316769|11217837|FG000|Overall Study|Withdrawal by Subject|1
7096057|NCT02316769|11217838|FG001|Overall Study|Withdrawal by Subject|0
7096058|NCT02316847|11217846|FG000|Overall Study|Adverse Event|0
7096059|NCT02316847|11217847|FG001|Overall Study|Adverse Event|3
7096060|NCT02316847|11217846|FG000|Overall Study|Lost to Follow-up|0
7096061|NCT02316847|11217847|FG001|Overall Study|Lost to Follow-up|2
7096062|NCT02316847|11217846|FG000|Overall Study|Physician Decision|0
7096063|NCT02316847|11217847|FG001|Overall Study|Physician Decision|1
7096064|NCT02316847|11217846|FG000|Overall Study|Pregnancy|0
7096065|NCT02316847|11217847|FG001|Overall Study|Pregnancy|1
7096066|NCT02316847|11217846|FG000|Overall Study|Withdrawal by Subject|2
7096067|NCT02316847|11217847|FG001|Overall Study|Withdrawal by Subject|9
7096068|NCT02316847|11217846|FG000|Overall Study|Noncompliance with study drug|0
7096069|NCT02316847|11217847|FG001|Overall Study|Noncompliance with study drug|3
7096070|NCT02316847|11217846|FG000|Overall Study|Withdrawn due to termination by Sponsor|7
7096071|NCT02316847|11217847|FG001|Overall Study|Withdrawn due to termination by Sponsor|67
7096072|NCT02317016|11217855|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1
7096073|NCT02317016|11217855|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1
7096074|NCT02317016|11217855|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1
7096075|NCT02317016|11217855|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23
7096076|NCT02317016|11217855|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1
7096077|NCT02317016|11217855|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2
7096078|NCT02317016|11217855|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5
7096079|NCT02317432|11217874|FG000|Overall Study|Death|4
7096080|NCT02317432|11217875|FG001|Overall Study|Death|1
7096081|NCT02317432|11217874|FG000|Overall Study|Lost to Follow-up|0
7096082|NCT02317432|11217875|FG001|Overall Study|Lost to Follow-up|5
7096083|NCT02317432|11217874|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27
7096084|NCT02317432|11217875|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0
7096085|NCT02317510|11217883|FG000|Overall Study|Adverse Event|0
7096086|NCT02317510|11217884|FG001|Overall Study|Adverse Event|1
7096087|NCT02317562|11217902|FG000|Overall Study|Physician Decision|1
7096088|NCT02317562|11217902|FG000|Overall Study|early termination of the study|8
7096089|NCT02317562|11217902|FG000|Overall Study|Lack of Efficacy|4
7096090|NCT02317562|11217902|FG000|Overall Study|Withdrawal by Subject|1
7096091|NCT02317575|11217906|FG000|Period 1|Difficulty with venous cannulation|0
7096092|NCT02317575|11217907|FG001|Period 1|Difficulty with venous cannulation|1
7096093|NCT02317575|11217908|FG002|Period 1|Difficulty with venous cannulation|0
7096094|NCT02317575|11217909|FG003|Period 1|Difficulty with venous cannulation|0
7096095|NCT02317575|11217910|FG004|Period 1|Difficulty with venous cannulation|0
7096096|NCT02317575|11217906|FG000|Period 1|Withdrawal by Subject|1
7096097|NCT02317575|11217907|FG001|Period 1|Withdrawal by Subject|0
7096098|NCT02317575|11217908|FG002|Period 1|Withdrawal by Subject|0
7096099|NCT02317575|11217909|FG003|Period 1|Withdrawal by Subject|0
7096100|NCT02317575|11217910|FG004|Period 1|Withdrawal by Subject|0
7096101|NCT02317614|11217930|FG000|Overall Study|Lost to Follow-up|1
7096102|NCT02317614|11217931|FG001|Overall Study|Lost to Follow-up|1
7096103|NCT02317614|11217930|FG000|Overall Study|Withdrawal by Subject|1
7096104|NCT02317614|11217931|FG001|Overall Study|Withdrawal by Subject|0
7096105|NCT02317614|11217930|FG000|Overall Study|Death|1
7096106|NCT02317614|11217931|FG001|Overall Study|Death|1
7096107|NCT02317809|11217955|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2
7096108|NCT02317809|11217956|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0
7096109|NCT02317809|11217955|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1
7096110|NCT02317809|11217956|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0
7096111|NCT02318134|11217967|FG000|Overall Study|Withdrawal by Subject|2
7096112|NCT02318134|11217968|FG001|Overall Study|Withdrawal by Subject|1
7096113|NCT02318368|11218007|FG000|Overall Study|Withdrawal by Subject|2
7096114|NCT02318368|11218008|FG001|Overall Study|Withdrawal by Subject|0
7096115|NCT02318368|11218007|FG000|Overall Study|Study terminated by the sponsor|5
7096116|NCT02318368|11218008|FG001|Overall Study|Study terminated by the sponsor|2
7096117|NCT02318368|11218007|FG000|Overall Study|Death|0
7096118|NCT02318368|11218008|FG001|Overall Study|Death|1
7096119|NCT02318602|11218021|FG000|Overall Study|Adverse Event|0
7096120|NCT02318602|11218022|FG001|Overall Study|Adverse Event|1
7096121|NCT02318602|11218023|FG002|Overall Study|Adverse Event|1
7096122|NCT02318602|11218021|FG000|Overall Study|Withdrawal by Subject|0
7096123|NCT02318602|11218022|FG001|Overall Study|Withdrawal by Subject|3
7096124|NCT02318602|11218023|FG002|Overall Study|Withdrawal by Subject|0
7096125|NCT02318602|11218021|FG000|Overall Study|Death|1
7096126|NCT02318602|11218022|FG001|Overall Study|Death|0
7096127|NCT02318602|11218023|FG002|Overall Study|Death|0
7096128|NCT02318602|11218021|FG000|Overall Study|Guardian decision to withdraw|0
7096129|NCT02318602|11218022|FG001|Overall Study|Guardian decision to withdraw|0
7096130|NCT02318602|11218023|FG002|Overall Study|Guardian decision to withdraw|1
7096131|NCT02318667|11218037|FG000|Overall Study|Adverse Event|1
7096132|NCT02318667|11218037|FG000|Overall Study|Lack of Efficacy|6
7096133|NCT02318667|11218037|FG000|Overall Study|Protocol Violation|2
7096134|NCT02318693|11218047|FG000|Overall Study|Protocol Violation|0
7096135|NCT02318693|11218048|FG001|Overall Study|Protocol Violation|1
7096136|NCT02318706|11218058|FG000|Double-blind Phase|Adverse Event|7
7096137|NCT02318706|11218059|FG001|Double-blind Phase|Adverse Event|4
7096138|NCT02318706|11218060|FG002|Double-blind Phase|Adverse Event|3
7096139|NCT02318706|11218061|FG003|Double-blind Phase|Adverse Event|10
7096140|NCT02318706|11218062|FG004|Double-blind Phase|Adverse Event|0
7096141|NCT02318706|11218058|FG000|Double-blind Phase|Lost to Follow-up|1
7096142|NCT02318706|11218059|FG001|Double-blind Phase|Lost to Follow-up|0
7096143|NCT02318706|11218060|FG002|Double-blind Phase|Lost to Follow-up|0
7096144|NCT02318706|11218061|FG003|Double-blind Phase|Lost to Follow-up|0
7096145|NCT02318706|11218062|FG004|Double-blind Phase|Lost to Follow-up|0
7096146|NCT02318706|11218058|FG000|Double-blind Phase|Protocol Violation|4
7096147|NCT02318706|11218059|FG001|Double-blind Phase|Protocol Violation|2
7096148|NCT02318706|11218060|FG002|Double-blind Phase|Protocol Violation|4
7096149|NCT02318706|11218061|FG003|Double-blind Phase|Protocol Violation|3
7096150|NCT02318706|11218062|FG004|Double-blind Phase|Protocol Violation|0
7096151|NCT02318706|11218058|FG000|Double-blind Phase|Withdrawal by Subject|9
7096152|NCT02318706|11218059|FG001|Double-blind Phase|Withdrawal by Subject|5
7096153|NCT02318706|11218060|FG002|Double-blind Phase|Withdrawal by Subject|7
7096154|NCT02318706|11218061|FG003|Double-blind Phase|Withdrawal by Subject|10
7096155|NCT02318706|11218062|FG004|Double-blind Phase|Withdrawal by Subject|0
7096156|NCT02318706|11218058|FG000|Double-blind Phase|Other|4
7096157|NCT02318706|11218059|FG001|Double-blind Phase|Other|1
7096158|NCT02318706|11218060|FG002|Double-blind Phase|Other|2
7096159|NCT02318706|11218061|FG003|Double-blind Phase|Other|1
7096160|NCT02318706|11218062|FG004|Double-blind Phase|Other|0
7096161|NCT02318706|11218058|FG000|Double-blind Phase|Death|0
7096162|NCT02318706|11218059|FG001|Double-blind Phase|Death|0
7096163|NCT02318706|11218060|FG002|Double-blind Phase|Death|2
7096164|NCT02318706|11218061|FG003|Double-blind Phase|Death|0
7096165|NCT02318706|11218062|FG004|Double-blind Phase|Death|0
7096166|NCT02318706|11218058|FG000|Open-label Extension Phase|Adverse Event|0
7096167|NCT02318706|11218059|FG001|Open-label Extension Phase|Adverse Event|0
7096168|NCT02318706|11218060|FG002|Open-label Extension Phase|Adverse Event|0
7096169|NCT02318706|11218061|FG003|Open-label Extension Phase|Adverse Event|0
7096170|NCT02318706|11218062|FG004|Open-label Extension Phase|Adverse Event|21
7096171|NCT02318706|11218058|FG000|Open-label Extension Phase|Lack of Efficacy|0
7096172|NCT02318706|11218059|FG001|Open-label Extension Phase|Lack of Efficacy|0
7096173|NCT02318706|11218060|FG002|Open-label Extension Phase|Lack of Efficacy|0
7096174|NCT02318706|11218061|FG003|Open-label Extension Phase|Lack of Efficacy|0
7096175|NCT02318706|11218062|FG004|Open-label Extension Phase|Lack of Efficacy|1
7096176|NCT02318706|11218058|FG000|Open-label Extension Phase|Death|0
7096177|NCT02318706|11218059|FG001|Open-label Extension Phase|Death|0
7096178|NCT02318706|11218060|FG002|Open-label Extension Phase|Death|0
7096179|NCT02318706|11218061|FG003|Open-label Extension Phase|Death|0
7096180|NCT02318706|11218062|FG004|Open-label Extension Phase|Death|1
7096181|NCT02318706|11218058|FG000|Open-label Extension Phase|Withdrawal by Subject|0
7096182|NCT02318706|11218059|FG001|Open-label Extension Phase|Withdrawal by Subject|0
7096183|NCT02318706|11218060|FG002|Open-label Extension Phase|Withdrawal by Subject|0
7096184|NCT02318706|11218061|FG003|Open-label Extension Phase|Withdrawal by Subject|0
7096185|NCT02318706|11218062|FG004|Open-label Extension Phase|Withdrawal by Subject|19
7096186|NCT02318719|11218078|FG000|Double-blind Phase|Adverse Event|7
7096187|NCT02318719|11218079|FG001|Double-blind Phase|Adverse Event|6
7096188|NCT02318719|11218080|FG002|Double-blind Phase|Adverse Event|12
7096189|NCT02318719|11218081|FG003|Double-blind Phase|Adverse Event|4
7096190|NCT02318719|11218082|FG004|Double-blind Phase|Adverse Event|0
7096191|NCT02318719|11218078|FG000|Double-blind Phase|Lack of Efficacy|5
7096192|NCT02318719|11218079|FG001|Double-blind Phase|Lack of Efficacy|0
7096193|NCT02318719|11218080|FG002|Double-blind Phase|Lack of Efficacy|1
7096194|NCT02318719|11218081|FG003|Double-blind Phase|Lack of Efficacy|1
7096195|NCT02318719|11218082|FG004|Double-blind Phase|Lack of Efficacy|0
7096196|NCT02318719|11218078|FG000|Double-blind Phase|Protocol Violation|0
7096197|NCT02318719|11218079|FG001|Double-blind Phase|Protocol Violation|1
7096198|NCT02318719|11218080|FG002|Double-blind Phase|Protocol Violation|3
7096199|NCT02318719|11218081|FG003|Double-blind Phase|Protocol Violation|0
7096200|NCT02318719|11218082|FG004|Double-blind Phase|Protocol Violation|0
7096201|NCT02318719|11218078|FG000|Double-blind Phase|Withdrawal by Subject|25
7096202|NCT02318719|11218079|FG001|Double-blind Phase|Withdrawal by Subject|7
7096203|NCT02318719|11218080|FG002|Double-blind Phase|Withdrawal by Subject|9
7096204|NCT02318719|11218081|FG003|Double-blind Phase|Withdrawal by Subject|10
7096205|NCT02318719|11218082|FG004|Double-blind Phase|Withdrawal by Subject|0
7096206|NCT02318719|11218078|FG000|Double-blind Phase|Other|1
7096207|NCT02318719|11218079|FG001|Double-blind Phase|Other|2
7096208|NCT02318719|11218080|FG002|Double-blind Phase|Other|0
7096209|NCT02318719|11218081|FG003|Double-blind Phase|Other|0
7096210|NCT02318719|11218082|FG004|Double-blind Phase|Other|0
7096211|NCT02318719|11218078|FG000|Open-label Extension Phase|Adverse Event|0
7096212|NCT02318719|11218079|FG001|Open-label Extension Phase|Adverse Event|0
7096213|NCT02318719|11218080|FG002|Open-label Extension Phase|Adverse Event|0
7096214|NCT02318719|11218081|FG003|Open-label Extension Phase|Adverse Event|0
7096215|NCT02318719|11218082|FG004|Open-label Extension Phase|Adverse Event|15
7096216|NCT02318719|11218078|FG000|Open-label Extension Phase|Death|0
7096217|NCT02318719|11218079|FG001|Open-label Extension Phase|Death|0
7096218|NCT02318719|11218080|FG002|Open-label Extension Phase|Death|0
7096219|NCT02318719|11218081|FG003|Open-label Extension Phase|Death|0
7096220|NCT02318719|11218082|FG004|Open-label Extension Phase|Death|1
7096221|NCT02318719|11218078|FG000|Open-label Extension Phase|Lack of Efficacy|0
7096222|NCT02318719|11218079|FG001|Open-label Extension Phase|Lack of Efficacy|0
7096223|NCT02318719|11218080|FG002|Open-label Extension Phase|Lack of Efficacy|0
7096224|NCT02318719|11218081|FG003|Open-label Extension Phase|Lack of Efficacy|0
7096225|NCT02318719|11218082|FG004|Open-label Extension Phase|Lack of Efficacy|1
7096226|NCT02318719|11218078|FG000|Open-label Extension Phase|Withdrawal by Subject|0
7096227|NCT02318719|11218079|FG001|Open-label Extension Phase|Withdrawal by Subject|0
7096228|NCT02318719|11218080|FG002|Open-label Extension Phase|Withdrawal by Subject|0
7096229|NCT02318719|11218081|FG003|Open-label Extension Phase|Withdrawal by Subject|0
7096230|NCT02318719|11218082|FG004|Open-label Extension Phase|Withdrawal by Subject|31
7096231|NCT02318719|11218078|FG000|Open-label Extension Phase|Other|0
7096232|NCT02318719|11218079|FG001|Open-label Extension Phase|Other|0
7096233|NCT02318719|11218080|FG002|Open-label Extension Phase|Other|0
7096234|NCT02318719|11218081|FG003|Open-label Extension Phase|Other|0
7096235|NCT02318719|11218082|FG004|Open-label Extension Phase|Other|7
7096236|NCT02318797|11218096|FG000|Overall Study|Death|3
7096237|NCT02318797|11218097|FG001|Overall Study|Death|6
7096238|NCT02318797|11218096|FG000|Overall Study|Lost to Follow-up|85
7096239|NCT02318797|11218097|FG001|Overall Study|Lost to Follow-up|96
7096240|NCT02318940|11218105|FG000|Overall Study|lost the record|1
7096241|NCT02318940|11218106|FG001|Overall Study|lost the record|0
7096242|NCT02319031|11218140|FG000|Treatment Period|Death|1
7096243|NCT02319031|11218141|FG001|Treatment Period|Death|0
7096244|NCT02319044|11218150|FG000|Overall Study|Death, PI/sponsor decision, med history|0
7096245|NCT02319044|11218151|FG001|Overall Study|Death, PI/sponsor decision, med history|1
7096246|NCT02319044|11218152|FG002|Overall Study|Death, PI/sponsor decision, med history|4
7096247|NCT02319044|11218150|FG000|Overall Study|Withdrawal by Subject|3
7096248|NCT02319044|11218151|FG001|Overall Study|Withdrawal by Subject|3
7096249|NCT02319044|11218152|FG002|Overall Study|Withdrawal by Subject|6
7096250|NCT02319044|11218150|FG000|Overall Study|Condition under investigation worsened|100
7096251|NCT02319044|11218151|FG001|Overall Study|Condition under investigation worsened|50
7096252|NCT02319044|11218152|FG002|Overall Study|Condition under investigation worsened|46
7096253|NCT02319044|11218150|FG000|Overall Study|Adverse Event|17
7096254|NCT02319044|11218151|FG001|Overall Study|Adverse Event|2
7096255|NCT02319044|11218152|FG002|Overall Study|Adverse Event|8
7096256|NCT02319044|11218150|FG000|Overall Study|Study specific discontinuation criteria|2
7096257|NCT02319044|11218151|FG001|Overall Study|Study specific discontinuation criteria|2
7096258|NCT02319044|11218152|FG002|Overall Study|Study specific discontinuation criteria|1
7096259|NCT02319044|11218150|FG000|Overall Study|Not treated|0
7096260|NCT02319044|11218151|FG001|Overall Study|Not treated|2
7096261|NCT02319044|11218152|FG002|Overall Study|Not treated|2
7096262|NCT02319148|11218164|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0
7096263|NCT02319148|11218165|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0
7096264|NCT02319148|11218166|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1
7096265|NCT02319148|11218167|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1
7096266|NCT02319148|11218164|FG000|Second Intervention Period|No longer willing to participate|0
7096267|NCT02319148|11218165|FG001|Second Intervention Period|No longer willing to participate|1
7096268|NCT02319148|11218166|FG002|Second Intervention Period|No longer willing to participate|0
7096269|NCT02319148|11218167|FG003|Second Intervention Period|No longer willing to participate|0
7096270|NCT02319148|11218164|FG000|Second Intervention Period|Other|0
7096271|NCT02319148|11218165|FG001|Second Intervention Period|Other|0
7096272|NCT02319148|11218166|FG002|Second Intervention Period|Other|0
7096273|NCT02319148|11218167|FG003|Second Intervention Period|Other|1
7096274|NCT02319525|11218275|FG000|Overall Study|Withdrawal by Subject|2
7096275|NCT02319525|11218276|FG001|Overall Study|Withdrawal by Subject|1
7096276|NCT02319642|11218284|FG000|Overall Study|Adverse Event|2
7096277|NCT02319642|11218285|FG001|Overall Study|Adverse Event|4
7096278|NCT02319642|11218284|FG000|Overall Study|Lack of Efficacy|1
7096279|NCT02319642|11218285|FG001|Overall Study|Lack of Efficacy|1
7096280|NCT02319642|11218284|FG000|Overall Study|Withdrawal by Subject|1
7096281|NCT02319642|11218285|FG001|Overall Study|Withdrawal by Subject|1
7096282|NCT02319668|11218295|FG000|Overall Study|Other (Not specified)|0
7096283|NCT02319668|11218296|FG001|Overall Study|Other (Not specified)|2
7096284|NCT02319759|11218307|FG000|Week 0 - 16|Lack of Efficacy|1
7096285|NCT02319759|11218308|FG001|Week 0 - 16|Lack of Efficacy|0
7096286|NCT02319759|11218309|FG002|Week 0 - 16|Lack of Efficacy|0
7096287|NCT02319759|11218310|FG003|Week 0 - 16|Lack of Efficacy|0
7096288|NCT02319759|11218311|FG004|Week 0 - 16|Lack of Efficacy|0
7096289|NCT02319759|11218307|FG000|Week 0 - 16|Not met all Inclusion Criteria|0
7096290|NCT02319759|11218308|FG001|Week 0 - 16|Not met all Inclusion Criteria|0
7096291|NCT02319759|11218309|FG002|Week 0 - 16|Not met all Inclusion Criteria|1
7096292|NCT02319759|11218310|FG003|Week 0 - 16|Not met all Inclusion Criteria|0
7096293|NCT02319759|11218311|FG004|Week 0 - 16|Not met all Inclusion Criteria|0
7096294|NCT02319759|11218307|FG000|Week 16 - 24|Lack of Efficacy|1
7096295|NCT02319759|11218308|FG001|Week 16 - 24|Lack of Efficacy|0
7096296|NCT02319759|11218309|FG002|Week 16 - 24|Lack of Efficacy|1
7096297|NCT02319759|11218310|FG003|Week 16 - 24|Lack of Efficacy|0
7096298|NCT02319759|11218311|FG004|Week 16 - 24|Lack of Efficacy|0
7096299|NCT02319759|11218307|FG000|Week 16 - 24|Lost to Follow-up|1
7096300|NCT02319759|11218308|FG001|Week 16 - 24|Lost to Follow-up|0
7096301|NCT02319759|11218309|FG002|Week 16 - 24|Lost to Follow-up|0
7096302|NCT02319759|11218310|FG003|Week 16 - 24|Lost to Follow-up|0
7096303|NCT02319759|11218311|FG004|Week 16 - 24|Lost to Follow-up|0
7096304|NCT02319759|11218307|FG000|Week 16 - 24|Withdrawal by Subject|0
7096305|NCT02319759|11218308|FG001|Week 16 - 24|Withdrawal by Subject|0
7096306|NCT02319759|11218309|FG002|Week 16 - 24|Withdrawal by Subject|2
7096307|NCT02319759|11218310|FG003|Week 16 - 24|Withdrawal by Subject|0
7096308|NCT02319759|11218311|FG004|Week 16 - 24|Withdrawal by Subject|0
7096309|NCT02319759|11218307|FG000|Week 24 - 56|Adverse Event|0
7096310|NCT02319759|11218308|FG001|Week 24 - 56|Adverse Event|0
7096311|NCT02319759|11218309|FG002|Week 24 - 56|Adverse Event|2
7096312|NCT02319759|11218310|FG003|Week 24 - 56|Adverse Event|0
7096313|NCT02319759|11218311|FG004|Week 24 - 56|Adverse Event|0
7096314|NCT02319759|11218307|FG000|Week 24 - 56|Lack of Efficacy|0
7096315|NCT02319759|11218308|FG001|Week 24 - 56|Lack of Efficacy|0
7096316|NCT02319759|11218309|FG002|Week 24 - 56|Lack of Efficacy|0
7096317|NCT02319759|11218310|FG003|Week 24 - 56|Lack of Efficacy|2
7096318|NCT02319759|11218311|FG004|Week 24 - 56|Lack of Efficacy|1
7096319|NCT02319759|11218307|FG000|Week 24 - 56|Withdrawal by Subject|0
7096320|NCT02319759|11218308|FG001|Week 24 - 56|Withdrawal by Subject|1
7096321|NCT02319759|11218309|FG002|Week 24 - 56|Withdrawal by Subject|0
7096322|NCT02319759|11218310|FG003|Week 24 - 56|Withdrawal by Subject|0
7096323|NCT02319759|11218311|FG004|Week 24 - 56|Withdrawal by Subject|0
7096324|NCT02319759|11218307|FG000|Week 24 - 56|Lost to Follow-up|0
7096325|NCT02319759|11218308|FG001|Week 24 - 56|Lost to Follow-up|0
7096326|NCT02319759|11218309|FG002|Week 24 - 56|Lost to Follow-up|0
7096327|NCT02319759|11218310|FG003|Week 24 - 56|Lost to Follow-up|0
7096328|NCT02319759|11218311|FG004|Week 24 - 56|Lost to Follow-up|1
7096329|NCT02320058|11218344|FG000|Overall Study|Death|25
7096330|NCT02320058|11218345|FG001|Overall Study|Death|10
7096331|NCT02320058|11218344|FG000|Overall Study|Lost to Follow-up|4
7096332|NCT02320058|11218345|FG001|Overall Study|Lost to Follow-up|0
7096333|NCT02320058|11218344|FG000|Overall Study|Other reasons|4
7096334|NCT02320058|11218345|FG001|Overall Study|Other reasons|1
7096335|NCT02320058|11218344|FG000|Overall Study|Withdrawal by Subject|8
7096336|NCT02320058|11218345|FG001|Overall Study|Withdrawal by Subject|2
7096337|NCT02320058|11218344|FG000|Overall Study|Not reported|1
7096338|NCT02320058|11218345|FG001|Overall Study|Not reported|0
7096339|NCT02320123|11218353|FG000|Overall Study|Lost to Follow-up|4
7096340|NCT02320123|11218354|FG001|Overall Study|Lost to Follow-up|6
7096341|NCT02320123|11218353|FG000|Overall Study|Death|6
7096342|NCT02320123|11218354|FG001|Overall Study|Death|5
7096343|NCT02320149|11218366|FG000|Overall Study|Adverse Event|3
7096344|NCT02320149|11218367|FG001|Overall Study|Adverse Event|7
7096345|NCT02320149|11218366|FG000|Overall Study|Withdrawal of Consent|28
7096346|NCT02320149|11218367|FG001|Overall Study|Withdrawal of Consent|32
7096347|NCT02320149|11218366|FG000|Overall Study|Lost to Follow-up|21
7096348|NCT02320149|11218367|FG001|Overall Study|Lost to Follow-up|34
7096349|NCT02320149|11218366|FG000|Overall Study|Protocol Violation|2
7096350|NCT02320149|11218367|FG001|Overall Study|Protocol Violation|1
7096351|NCT02320149|11218366|FG000|Overall Study|Noncompliance with Study Treatment|7
7096352|NCT02320149|11218367|FG001|Overall Study|Noncompliance with Study Treatment|2
7096353|NCT02320149|11218366|FG000|Overall Study|Lack of Efficacy|0
7096354|NCT02320149|11218367|FG001|Overall Study|Lack of Efficacy|1
7096355|NCT02320149|11218366|FG000|Overall Study|Other Miscellaneous Reasons|2
7096356|NCT02320149|11218367|FG001|Overall Study|Other Miscellaneous Reasons|3
7096357|NCT02320253|11218397|FG000|Overall Study|Withdrawal by Subject|3
7096358|NCT02320253|11218398|FG001|Overall Study|Withdrawal by Subject|0
7096359|NCT02320253|11218399|FG002|Overall Study|Withdrawal by Subject|0
7096360|NCT02320253|11218397|FG000|Overall Study|Lost to Follow-up|2
7096361|NCT02320253|11218398|FG001|Overall Study|Lost to Follow-up|2
7096362|NCT02320253|11218399|FG002|Overall Study|Lost to Follow-up|1
7096363|NCT02320253|11218397|FG000|Overall Study|Death|1
7096364|NCT02320253|11218398|FG001|Overall Study|Death|0
7096365|NCT02320253|11218399|FG002|Overall Study|Death|1
7096366|NCT02320487|11218407|FG000|Overall Study|Reason not Specified|1
7096367|NCT02320487|11218407|FG000|Overall Study|Physician Decision|5
7096368|NCT02320487|11218407|FG000|Overall Study|Withdrawal by Subject|1
7096369|NCT02320487|11218407|FG000|Overall Study|Death|3
7096370|NCT02320487|11218407|FG000|Overall Study|Adverse Event|11
7096371|NCT02320721|11218422|FG000|Overall Study|Adverse Event|6
7096372|NCT02320721|11218423|FG001|Overall Study|Adverse Event|6
7096373|NCT02320721|11218422|FG000|Overall Study|Lack of Efficacy|2
7096374|NCT02320721|11218423|FG001|Overall Study|Lack of Efficacy|0
7096375|NCT02320721|11218422|FG000|Overall Study|Poor compliance to protocol|3
7096376|NCT02320721|11218423|FG001|Overall Study|Poor compliance to protocol|7
7096377|NCT02320721|11218422|FG000|Overall Study|Randomized but not treated|0
7096378|NCT02320721|11218423|FG001|Overall Study|Randomized but not treated|1
7096379|NCT02320721|11218422|FG000|Overall Study|Hypoglycemia|1
7096380|NCT02320721|11218423|FG001|Overall Study|Hypoglycemia|0
7096381|NCT02320721|11218422|FG000|Overall Study|Other than specified above|15
7096382|NCT02320721|11218423|FG001|Overall Study|Other than specified above|20
7096383|NCT02320903|11218452|FG000|Overall Study|Withdrawal by Subject|0
7096384|NCT02320903|11218453|FG001|Overall Study|Withdrawal by Subject|9
7096385|NCT02320903|11218454|FG002|Overall Study|Withdrawal by Subject|9
7096386|NCT02320903|11218452|FG000|Overall Study|Exited therapy; no longer eligible|8
7096387|NCT02320903|11218453|FG001|Overall Study|Exited therapy; no longer eligible|2
7096388|NCT02320903|11218454|FG002|Overall Study|Exited therapy; no longer eligible|2
7096389|NCT02320903|11218452|FG000|Overall Study|Lost to Follow-up|0
7096390|NCT02320903|11218453|FG001|Overall Study|Lost to Follow-up|5
7096391|NCT02320903|11218454|FG002|Overall Study|Lost to Follow-up|5
7096392|NCT02321098|11218466|FG000|12 Weeks Treament|Lost to Follow-up|1
7096393|NCT02321098|11218467|FG001|12 Weeks Treament|Lost to Follow-up|1
7096394|NCT02321098|11218468|FG002|12 Weeks Treament|Lost to Follow-up|0
7096395|NCT02321098|11218466|FG000|Additional 15 Months Treatment|Lack of Efficacy|0
7096396|NCT02321098|11218467|FG001|Additional 15 Months Treatment|Lack of Efficacy|0
7096397|NCT02321098|11218468|FG002|Additional 15 Months Treatment|Lack of Efficacy|6
7096398|NCT02321098|11218466|FG000|Additional 15 Months Treatment|Lost to Follow-up|0
7096399|NCT02321098|11218467|FG001|Additional 15 Months Treatment|Lost to Follow-up|0
7096400|NCT02321098|11218468|FG002|Additional 15 Months Treatment|Lost to Follow-up|1
7096401|NCT02321098|11218466|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0
7096402|NCT02321098|11218467|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0
7096403|NCT02321098|11218468|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1
7096404|NCT02321319|11218490|FG000|Overall Study|Product discontinued|5
7096405|NCT02321436|11218496|FG000|Overall Study|Withdrawal by Subject|1
7096406|NCT02321436|11218497|FG001|Overall Study|Withdrawal by Subject|0
7096407|NCT02321436|11218496|FG000|Overall Study|Lost to Follow-up|0
7096408|NCT02321436|11218497|FG001|Overall Study|Lost to Follow-up|1
7096409|NCT02321462|11218506|FG000|Overall Study|Withdrawal by Subject|5
7096410|NCT02321462|11218507|FG001|Overall Study|Withdrawal by Subject|2
7096411|NCT02321462|11218506|FG000|Overall Study|Subject withdrawn before any treatment|1
7096412|NCT02321462|11218507|FG001|Overall Study|Subject withdrawn before any treatment|1
7096413|NCT02321800|11218532|FG000|Overall Study|Withdrawal by Subject|3
7096414|NCT02321800|11218533|FG001|Overall Study|Withdrawal by Subject|3
7096415|NCT02321800|11218532|FG000|Overall Study|Death|1
7096416|NCT02321800|11218533|FG001|Overall Study|Death|0
7096417|NCT02321800|11218532|FG000|Overall Study|Protocol Violation|1
7096418|NCT02321800|11218533|FG001|Overall Study|Protocol Violation|0
7096419|NCT02321800|11218532|FG000|Overall Study|Lost to Follow-up|10
7096420|NCT02321800|11218533|FG001|Overall Study|Lost to Follow-up|4
7096421|NCT02321800|11218532|FG000|Overall Study|Adverse Event|2
7096422|NCT02321800|11218533|FG001|Overall Study|Adverse Event|3
7096423|NCT02321800|11218532|FG000|Overall Study|Other, Miscellaneous|3
7096424|NCT02321800|11218533|FG001|Overall Study|Other, Miscellaneous|1
7096425|NCT02321930|11218539|FG000|Overall Study|Lost to Follow-up|1
7096426|NCT02322021|11218547|FG000|Core Phase|Adverse Event|1
7096427|NCT02322021|11218548|FG001|Core Phase|Adverse Event|3
7096428|NCT02322021|11218549|FG002|Core Phase|Adverse Event|4
7096429|NCT02322021|11218550|FG003|Core Phase|Adverse Event|2
7096430|NCT02322021|11218551|FG004|Core Phase|Adverse Event|0
7096431|NCT02322021|11218547|FG000|Core Phase|Participant Choice|4
7096432|NCT02322021|11218548|FG001|Core Phase|Participant Choice|5
7096433|NCT02322021|11218549|FG002|Core Phase|Participant Choice|4
7096434|NCT02322021|11218550|FG003|Core Phase|Participant Choice|2
7096435|NCT02322021|11218551|FG004|Core Phase|Participant Choice|0
7096436|NCT02322021|11218547|FG000|Core Phase|Lost to Follow-up|0
7096437|NCT02322021|11218548|FG001|Core Phase|Lost to Follow-up|0
7096438|NCT02322021|11218549|FG002|Core Phase|Lost to Follow-up|0
7096439|NCT02322021|11218550|FG003|Core Phase|Lost to Follow-up|1
7096440|NCT02322021|11218551|FG004|Core Phase|Lost to Follow-up|0
7096441|NCT02322021|11218547|FG000|Core Phase|Other|0
7096442|NCT02322021|11218548|FG001|Core Phase|Other|0
7096443|NCT02322021|11218549|FG002|Core Phase|Other|1
7096444|NCT02322021|11218550|FG003|Core Phase|Other|0
7096445|NCT02322021|11218551|FG004|Core Phase|Other|0
7096446|NCT02322021|11218547|FG000|Extension Phase|Adverse Event|0
7096447|NCT02322021|11218548|FG001|Extension Phase|Adverse Event|0
7096448|NCT02322021|11218549|FG002|Extension Phase|Adverse Event|0
7096449|NCT02322021|11218550|FG003|Extension Phase|Adverse Event|0
7096450|NCT02322021|11218551|FG004|Extension Phase|Adverse Event|3
7096451|NCT02322021|11218547|FG000|Extension Phase|Participant Choice|0
7096452|NCT02322021|11218548|FG001|Extension Phase|Participant Choice|0
7096453|NCT02322021|11218549|FG002|Extension Phase|Participant Choice|0
7096454|NCT02322021|11218550|FG003|Extension Phase|Participant Choice|0
7096455|NCT02322021|11218551|FG004|Extension Phase|Participant Choice|6
7096456|NCT02322021|11218547|FG000|Extension Phase|Other|0
7096457|NCT02322021|11218548|FG001|Extension Phase|Other|0
7096458|NCT02322021|11218549|FG002|Extension Phase|Other|0
7096459|NCT02322021|11218550|FG003|Extension Phase|Other|0
7096460|NCT02322021|11218551|FG004|Extension Phase|Other|3
7096461|NCT02322021|11218547|FG000|Extension Phase|Lost to Follow-up|0
7096462|NCT02322021|11218548|FG001|Extension Phase|Lost to Follow-up|0
7096463|NCT02322021|11218549|FG002|Extension Phase|Lost to Follow-up|0
7096464|NCT02322021|11218550|FG003|Extension Phase|Lost to Follow-up|0
7096465|NCT02322021|11218551|FG004|Extension Phase|Lost to Follow-up|1
7096466|NCT02322021|11218547|FG000|Extension Phase|Study terminated by sponsor|0
7096467|NCT02322021|11218548|FG001|Extension Phase|Study terminated by sponsor|0
7096468|NCT02322021|11218549|FG002|Extension Phase|Study terminated by sponsor|0
7096469|NCT02322021|11218550|FG003|Extension Phase|Study terminated by sponsor|0
7096470|NCT02322021|11218551|FG004|Extension Phase|Study terminated by sponsor|28
7096471|NCT02322047|11218570|FG000|Overall Study|Physician Decision|1
7096472|NCT02322047|11218571|FG001|Overall Study|Physician Decision|0
7096473|NCT02322047|11218572|FG002|Overall Study|Physician Decision|0
7096474|NCT02322047|11218573|FG003|Overall Study|Physician Decision|0
7096475|NCT02322047|11218570|FG000|Overall Study|Withdrawal by Subject|1
7096476|NCT02322047|11218571|FG001|Overall Study|Withdrawal by Subject|0
7096477|NCT02322047|11218572|FG002|Overall Study|Withdrawal by Subject|0
7096478|NCT02322047|11218573|FG003|Overall Study|Withdrawal by Subject|1
7096479|NCT02322047|11218570|FG000|Overall Study|Adverse Event|0
7096480|NCT02322047|11218571|FG001|Overall Study|Adverse Event|1
7096481|NCT02322047|11218572|FG002|Overall Study|Adverse Event|0
7096482|NCT02322047|11218573|FG003|Overall Study|Adverse Event|0
7096483|NCT02322047|11218570|FG000|Overall Study|Lost to Follow-up|0
7096484|NCT02322047|11218571|FG001|Overall Study|Lost to Follow-up|0
7096485|NCT02322047|11218572|FG002|Overall Study|Lost to Follow-up|1
7096486|NCT02322047|11218573|FG003|Overall Study|Lost to Follow-up|1
7096487|NCT02322125|11218583|FG000|Overall Study|Withdrawal by Subject|2
7096488|NCT02322190|11218587|FG000|Overall Study|Death on study|1
7096489|NCT02322190|11218588|FG001|Overall Study|Death on study|0
7096490|NCT02322216|11218595|FG000|Overall Study|Adverse Event|1
7096491|NCT02322216|11218596|FG001|Overall Study|Adverse Event|0
7096492|NCT02322216|11218595|FG000|Overall Study|Withdrawal by Subject|1
7096493|NCT02322216|11218596|FG001|Overall Study|Withdrawal by Subject|4
7096494|NCT02322229|11218603|FG000|Overall Study|Physician Decision|2
7096495|NCT02322281|11218620|FG000|Overall Study|Progressive Disease|42
7096496|NCT02322281|11218621|FG001|Overall Study|Progressive Disease|14
7096497|NCT02322281|11218622|FG002|Overall Study|Progressive Disease|49
7096498|NCT02322281|11218620|FG000|Overall Study|Adverse Event|3
7096499|NCT02322281|11218621|FG001|Overall Study|Adverse Event|4
7096500|NCT02322281|11218622|FG002|Overall Study|Adverse Event|6
7096501|NCT02322281|11218620|FG000|Overall Study|Death|3
7096502|NCT02322281|11218621|FG001|Overall Study|Death|3
7096503|NCT02322281|11218622|FG002|Overall Study|Death|3
7096504|NCT02322281|11218620|FG000|Overall Study|Withdrawal by Subject|1
7096505|NCT02322281|11218621|FG001|Overall Study|Withdrawal by Subject|1
7096506|NCT02322281|11218622|FG002|Overall Study|Withdrawal by Subject|6
7096507|NCT02322281|11218620|FG000|Overall Study|Physician Decision|2
7096508|NCT02322281|11218621|FG001|Overall Study|Physician Decision|0
7096509|NCT02322281|11218622|FG002|Overall Study|Physician Decision|5
7096510|NCT02322281|11218620|FG000|Overall Study|Study Terminated by Sponsor|2
7096511|NCT02322281|11218621|FG001|Overall Study|Study Terminated by Sponsor|0
7096512|NCT02322281|11218622|FG002|Overall Study|Study Terminated by Sponsor|0
7096513|NCT02322281|11218620|FG000|Overall Study|Missing|0
7096514|NCT02322281|11218621|FG001|Overall Study|Missing|0
7096515|NCT02322281|11218622|FG002|Overall Study|Missing|1
7096516|NCT02322281|11218620|FG000|Overall Study|Miscellaneous|0
7096517|NCT02322281|11218621|FG001|Overall Study|Miscellaneous|0
7096518|NCT02322281|11218622|FG002|Overall Study|Miscellaneous|4
7096519|NCT02322411|11218656|FG000|Overall Study|Lost to Follow-up|4
7096520|NCT02322411|11218657|FG001|Overall Study|Lost to Follow-up|7
7096521|NCT02322411|11218656|FG000|Overall Study|Withdrawal by Subject|1
7096522|NCT02322411|11218657|FG001|Overall Study|Withdrawal by Subject|0
7096523|NCT02322749|11218667|FG000|Period 2|Adverse Event|0
7096524|NCT02322749|11218668|FG001|Period 2|Adverse Event|0
7096525|NCT02322749|11218669|FG002|Period 2|Adverse Event|0
7096526|NCT02322749|11218670|FG003|Period 2|Adverse Event|1
7096527|NCT02322749|11218671|FG004|Period 2|Adverse Event|0
7096528|NCT02322749|11218672|FG005|Period 2|Adverse Event|0
7096529|NCT02322749|11218667|FG000|Period 2|Withdrawal by Subject|0
7096530|NCT02322749|11218668|FG001|Period 2|Withdrawal by Subject|0
7096531|NCT02322749|11218669|FG002|Period 2|Withdrawal by Subject|0
7096532|NCT02322749|11218670|FG003|Period 2|Withdrawal by Subject|1
7096533|NCT02322749|11218671|FG004|Period 2|Withdrawal by Subject|0
7096534|NCT02322749|11218672|FG005|Period 2|Withdrawal by Subject|0
7096535|NCT02322749|11218667|FG000|Period 3|Withdrawal by Subject|0
7096536|NCT02322749|11218668|FG001|Period 3|Withdrawal by Subject|0
7096537|NCT02322749|11218669|FG002|Period 3|Withdrawal by Subject|1
7096538|NCT02322749|11218670|FG003|Period 3|Withdrawal by Subject|0
7096539|NCT02322749|11218671|FG004|Period 3|Withdrawal by Subject|0
7096540|NCT02322749|11218672|FG005|Period 3|Withdrawal by Subject|0
7096541|NCT02322775|11218683|FG000|Overall Study|Adverse Event|1
7096542|NCT02322775|11218684|FG001|Overall Study|Adverse Event|0
7096543|NCT02322775|11218683|FG000|Overall Study|Lost to Follow-up|0
7096544|NCT02322775|11218684|FG001|Overall Study|Lost to Follow-up|1
7096545|NCT02322775|11218683|FG000|Overall Study|Protocol Violation|1
7096546|NCT02322775|11218684|FG001|Overall Study|Protocol Violation|0
7096547|NCT02322775|11218683|FG000|Overall Study|Withdrawal by Subject|3
7096548|NCT02322775|11218684|FG001|Overall Study|Withdrawal by Subject|4
7096549|NCT02322775|11218683|FG000|Overall Study|Not willing to perform all FU visits|0
7096550|NCT02322775|11218684|FG001|Overall Study|Not willing to perform all FU visits|1
7096551|NCT02322814|11218708|FG000|Overall Study|Ongoing Study|0
7096552|NCT02322814|11218709|FG001|Overall Study|Ongoing Study|13
7096553|NCT02322814|11218710|FG002|Overall Study|Ongoing Study|14
7096554|NCT02322814|11218711|FG003|Overall Study|Ongoing Study|20
7096555|NCT02322814|11218712|FG004|Overall Study|Ongoing Study|22
7096556|NCT02322814|11218708|FG000|Overall Study|Progressive Disease|0
7096557|NCT02322814|11218709|FG001|Overall Study|Progressive Disease|2
7096558|NCT02322814|11218710|FG002|Overall Study|Progressive Disease|0
7096559|NCT02322814|11218711|FG003|Overall Study|Progressive Disease|1
7096560|NCT02322814|11218712|FG004|Overall Study|Progressive Disease|0
7096561|NCT02322814|11218708|FG000|Overall Study|Lost to Follow-up|1
7096562|NCT02322814|11218709|FG001|Overall Study|Lost to Follow-up|2
7096563|NCT02322814|11218710|FG002|Overall Study|Lost to Follow-up|1
7096564|NCT02322814|11218711|FG003|Overall Study|Lost to Follow-up|0
7096565|NCT02322814|11218712|FG004|Overall Study|Lost to Follow-up|0
7096566|NCT02322814|11218708|FG000|Overall Study|Other|2
7096567|NCT02322814|11218709|FG001|Overall Study|Other|0
7096568|NCT02322814|11218710|FG002|Overall Study|Other|0
7096569|NCT02322814|11218711|FG003|Overall Study|Other|0
7096570|NCT02322814|11218712|FG004|Overall Study|Other|0
7096571|NCT02322814|11218708|FG000|Overall Study|Protocol Violation|1
7096572|NCT02322814|11218709|FG001|Overall Study|Protocol Violation|0
7096573|NCT02322814|11218710|FG002|Overall Study|Protocol Violation|0
7096574|NCT02322814|11218711|FG003|Overall Study|Protocol Violation|0
7096575|NCT02322814|11218712|FG004|Overall Study|Protocol Violation|0
7096576|NCT02322814|11218708|FG000|Overall Study|Death|7
7096577|NCT02322814|11218709|FG001|Overall Study|Death|22
7096578|NCT02322814|11218710|FG002|Overall Study|Death|30
7096579|NCT02322814|11218711|FG003|Overall Study|Death|10
7096580|NCT02322814|11218712|FG004|Overall Study|Death|6
7096581|NCT02322814|11218708|FG000|Overall Study|Withdrawal by Subject|5
7096582|NCT02322814|11218709|FG001|Overall Study|Withdrawal by Subject|4
7096583|NCT02322814|11218710|FG002|Overall Study|Withdrawal by Subject|2
7096584|NCT02322814|11218711|FG003|Overall Study|Withdrawal by Subject|1
7096585|NCT02322814|11218712|FG004|Overall Study|Withdrawal by Subject|3
7096586|NCT02322866|11218725|FG000|Overall Study|Adverse Event|6
7096587|NCT02322866|11218726|FG001|Overall Study|Adverse Event|11
7096588|NCT02322866|11218725|FG000|Overall Study|Withdrawal of Consent|16
7096589|NCT02322866|11218726|FG001|Overall Study|Withdrawal of Consent|25
7096590|NCT02322866|11218725|FG000|Overall Study|Lost to Follow-up|36
7096591|NCT02322866|11218726|FG001|Overall Study|Lost to Follow-up|39
7096592|NCT02322866|11218725|FG000|Overall Study|Protocol Violation|1
7096593|NCT02322866|11218726|FG001|Overall Study|Protocol Violation|0
7096594|NCT02322866|11218725|FG000|Overall Study|Noncompliance with Treatment|3
7096595|NCT02322866|11218726|FG001|Overall Study|Noncompliance with Treatment|4
7096596|NCT02322866|11218725|FG000|Overall Study|Lack of Efficacy|3
7096597|NCT02322866|11218726|FG001|Overall Study|Lack of Efficacy|1
7096598|NCT02322866|11218725|FG000|Overall Study|Other Miscellaneous Reasons|6
7096599|NCT02322866|11218726|FG001|Overall Study|Other Miscellaneous Reasons|6
7096600|NCT02322879|11218734|FG000|First Intervention|Physician Decision|1
7096601|NCT02322879|11218735|FG001|First Intervention|Physician Decision|0
7096602|NCT02322892|11218743|FG000|Overall Study|Surgery cancelled|1
7096603|NCT02322892|11218744|FG001|Overall Study|Surgery cancelled|2
7096604|NCT02322892|11218743|FG000|Overall Study|Met exclusion criteria|0
7096605|NCT02322892|11218744|FG001|Overall Study|Met exclusion criteria|1
7096606|NCT02322892|11218743|FG000|Overall Study|Protocol Violation|1
7096607|NCT02322892|11218744|FG001|Overall Study|Protocol Violation|0
7096608|NCT02323113|11218778|FG000|Overall Study|Adverse Event|3
7096609|NCT02323113|11218779|FG001|Overall Study|Adverse Event|3
7096610|NCT02323113|11218780|FG002|Overall Study|Adverse Event|2
7096611|NCT02323113|11218781|FG003|Overall Study|Adverse Event|5
7096612|NCT02323113|11218782|FG004|Overall Study|Adverse Event|8
7096613|NCT02323113|11218783|FG005|Overall Study|Adverse Event|3
7096614|NCT02323113|11218784|FG006|Overall Study|Adverse Event|6
7096615|NCT02323113|11218785|FG007|Overall Study|Adverse Event|0
7096616|NCT02323113|11218778|FG000|Overall Study|Progressive Disease|0
7096617|NCT02323113|11218779|FG001|Overall Study|Progressive Disease|1
7096618|NCT02323113|11218780|FG002|Overall Study|Progressive Disease|1
7096619|NCT02323113|11218781|FG003|Overall Study|Progressive Disease|0
7096620|NCT02323113|11218782|FG004|Overall Study|Progressive Disease|0
7096621|NCT02323113|11218783|FG005|Overall Study|Progressive Disease|3
7096622|NCT02323113|11218784|FG006|Overall Study|Progressive Disease|0
7096623|NCT02323113|11218785|FG007|Overall Study|Progressive Disease|0
7096624|NCT02323113|11218778|FG000|Overall Study|Symptomatic Deterioration|0
7096625|NCT02323113|11218779|FG001|Overall Study|Symptomatic Deterioration|0
7096626|NCT02323113|11218780|FG002|Overall Study|Symptomatic Deterioration|1
7096627|NCT02323113|11218781|FG003|Overall Study|Symptomatic Deterioration|0
7096628|NCT02323113|11218782|FG004|Overall Study|Symptomatic Deterioration|1
7096629|NCT02323113|11218783|FG005|Overall Study|Symptomatic Deterioration|0
7096630|NCT02323113|11218784|FG006|Overall Study|Symptomatic Deterioration|0
7096631|NCT02323113|11218785|FG007|Overall Study|Symptomatic Deterioration|0
7096632|NCT02323113|11218778|FG000|Overall Study|Unsatisfactory Therapeutic Response|1
7096633|NCT02323113|11218779|FG001|Overall Study|Unsatisfactory Therapeutic Response|2
7096634|NCT02323113|11218780|FG002|Overall Study|Unsatisfactory Therapeutic Response|0
7096635|NCT02323113|11218781|FG003|Overall Study|Unsatisfactory Therapeutic Response|0
7096636|NCT02323113|11218782|FG004|Overall Study|Unsatisfactory Therapeutic Response|0
7096637|NCT02323113|11218783|FG005|Overall Study|Unsatisfactory Therapeutic Response|2
7096638|NCT02323113|11218784|FG006|Overall Study|Unsatisfactory Therapeutic Response|0
7096639|NCT02323113|11218785|FG007|Overall Study|Unsatisfactory Therapeutic Response|0
7096640|NCT02323113|11218778|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
7096641|NCT02323113|11218779|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1
7096642|NCT02323113|11218780|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
7096643|NCT02323113|11218781|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
7096644|NCT02323113|11218782|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
7096645|NCT02323113|11218783|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
7096646|NCT02323113|11218784|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
7096647|NCT02323113|11218785|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
7096648|NCT02323204|11218808|FG000|Baseline Survey Completion|Withdrawal by Subject|10
7096649|NCT02323204|11218809|FG001|Baseline Survey Completion|Withdrawal by Subject|9
7096650|NCT02323204|11218810|FG002|Baseline Survey Completion|Withdrawal by Subject|5
7096651|NCT02323204|11218811|FG003|Baseline Survey Completion|Withdrawal by Subject|3
7096652|NCT02323204|11218808|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29
7096653|NCT02323204|11218809|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28
7096654|NCT02323204|11218810|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39
7096655|NCT02323204|11218811|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35
7096656|NCT02323204|11218808|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12
7096657|NCT02323204|11218809|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8
7096658|NCT02323204|11218810|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3
7096659|NCT02323204|11218811|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2
7096660|NCT02323204|11218808|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0
7096661|NCT02323204|11218809|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35
7096662|NCT02323204|11218810|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0
7096663|NCT02323204|11218811|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34
7096664|NCT02323204|11218808|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0
7096665|NCT02323204|11218809|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8
7096666|NCT02323204|11218810|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0
7096667|NCT02323204|11218811|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2
7096668|NCT02323204|11218808|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54
7096669|NCT02323204|11218809|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45
7096670|NCT02323204|11218810|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41
7096671|NCT02323204|11218811|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42
7096672|NCT02323204|11218808|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0
7096673|NCT02323204|11218809|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2
7096674|NCT02323204|11218810|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0
7096675|NCT02323204|11218811|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2
7096676|NCT02323204|11218808|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49
7096677|NCT02323204|11218809|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50
7096678|NCT02323204|11218810|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38
7096679|NCT02323204|11218811|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43
7096680|NCT02323204|11218808|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0
7096681|NCT02323204|11218809|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0
7096682|NCT02323204|11218810|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3
7096683|NCT02323204|11218811|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1
7096684|NCT02323334|11218835|FG000|Period 3|Lost to Follow-up|0
7096685|NCT02323334|11218836|FG001|Period 3|Lost to Follow-up|0
7096686|NCT02323334|11218837|FG002|Period 3|Lost to Follow-up|1
7096687|NCT02323334|11218838|FG003|Period 3|Lost to Follow-up|0
7096688|NCT02323334|11218839|FG004|Period 3|Lost to Follow-up|0
7096689|NCT02323334|11218840|FG005|Period 3|Lost to Follow-up|0
7096690|NCT02323334|11218841|FG006|Period 3|Lost to Follow-up|0
7096691|NCT02323334|11218842|FG007|Period 3|Lost to Follow-up|0
7096692|NCT02323334|11218843|FG008|Period 3|Lost to Follow-up|0
7096693|NCT02323334|11218844|FG009|Period 3|Lost to Follow-up|0
7096694|NCT02323334|11218845|FG010|Period 3|Lost to Follow-up|0
7096695|NCT02323334|11218846|FG011|Period 3|Lost to Follow-up|0
7096696|NCT02323334|11218847|FG012|Period 3|Lost to Follow-up|0
7096697|NCT02323334|11218848|FG013|Period 3|Lost to Follow-up|0
7096698|NCT02323334|11218849|FG014|Period 3|Lost to Follow-up|0
7096699|NCT02323334|11218850|FG015|Period 3|Lost to Follow-up|0
7096700|NCT02323334|11218851|FG016|Period 3|Lost to Follow-up|0
7096701|NCT02323334|11218835|FG000|Period 3|Withdrawal by Subject|1
7096702|NCT02323334|11218836|FG001|Period 3|Withdrawal by Subject|0
7096703|NCT02323334|11218837|FG002|Period 3|Withdrawal by Subject|0
7096704|NCT02323334|11218838|FG003|Period 3|Withdrawal by Subject|0
7096705|NCT02323334|11218839|FG004|Period 3|Withdrawal by Subject|0
7096706|NCT02323334|11218840|FG005|Period 3|Withdrawal by Subject|0
7096707|NCT02323334|11218841|FG006|Period 3|Withdrawal by Subject|0
7096708|NCT02323334|11218842|FG007|Period 3|Withdrawal by Subject|0
7096709|NCT02323334|11218843|FG008|Period 3|Withdrawal by Subject|0
7096710|NCT02323334|11218844|FG009|Period 3|Withdrawal by Subject|0
7096711|NCT02323334|11218845|FG010|Period 3|Withdrawal by Subject|0
7096712|NCT02323334|11218846|FG011|Period 3|Withdrawal by Subject|0
7096713|NCT02323334|11218847|FG012|Period 3|Withdrawal by Subject|0
7096714|NCT02323334|11218848|FG013|Period 3|Withdrawal by Subject|0
7096715|NCT02323334|11218849|FG014|Period 3|Withdrawal by Subject|0
7096716|NCT02323334|11218850|FG015|Period 3|Withdrawal by Subject|0
7096717|NCT02323334|11218851|FG016|Period 3|Withdrawal by Subject|0
7096718|NCT02323646|11218916|FG000|Treatment Course 1|Adverse Event|1
7096719|NCT02323646|11218917|FG001|Treatment Course 1|Adverse Event|0
7096720|NCT02323646|11218918|FG002|Treatment Course 1|Adverse Event|1
7096721|NCT02323646|11218916|FG000|Treatment Course 1|Heavy Bleeding|1
7096722|NCT02323646|11218917|FG001|Treatment Course 1|Heavy Bleeding|1
7096723|NCT02323646|11218918|FG002|Treatment Course 1|Heavy Bleeding|0
7096724|NCT02323646|11218916|FG000|Treatment Course 1|Lost to Follow-up|1
7096725|NCT02323646|11218917|FG001|Treatment Course 1|Lost to Follow-up|0
7096726|NCT02323646|11218918|FG002|Treatment Course 1|Lost to Follow-up|2
7096727|NCT02323646|11218916|FG000|Treatment Course 1|Withdrawal by Subject|0
7096728|NCT02323646|11218917|FG001|Treatment Course 1|Withdrawal by Subject|2
7096729|NCT02323646|11218918|FG002|Treatment Course 1|Withdrawal by Subject|0
7096730|NCT02323646|11218916|FG000|Treatment Course 2|Adverse Event|1
7096731|NCT02323646|11218917|FG001|Treatment Course 2|Adverse Event|0
7096732|NCT02323646|11218918|FG002|Treatment Course 2|Adverse Event|1
7096733|NCT02323646|11218916|FG000|Treatment Course 2|Lost to Follow-up|0
7096734|NCT02323646|11218917|FG001|Treatment Course 2|Lost to Follow-up|0
7096735|NCT02323646|11218918|FG002|Treatment Course 2|Lost to Follow-up|1
7096736|NCT02323646|11218916|FG000|Treatment Course 2|Non-compliance|0
7096737|NCT02323646|11218917|FG001|Treatment Course 2|Non-compliance|1
7096738|NCT02323646|11218918|FG002|Treatment Course 2|Non-compliance|1
7096739|NCT02324049|11218930|FG000|Part C|Study terminated|11
7096740|NCT02324153|11218946|FG000|Overall Study|Withdrawal by Subject|4
7096741|NCT02324153|11218947|FG001|Overall Study|Withdrawal by Subject|1
7096742|NCT02324153|11218946|FG000|Overall Study|Surgery postponed after randomization|3
7096743|NCT02324153|11218947|FG001|Overall Study|Surgery postponed after randomization|0
7096744|NCT02324153|11218946|FG000|Overall Study|Developed delirium preoperatively|1
7096745|NCT02324153|11218947|FG001|Overall Study|Developed delirium preoperatively|0
7096746|NCT02324205|11218953|FG000|Overall Study|Withdrawal by Subject|37
7096747|NCT02324270|11218960|FG000|Overall Study|Withdrawal by Subject|0
7096748|NCT02324270|11218961|FG001|Overall Study|Withdrawal by Subject|1
7096749|NCT02324270|11218962|FG002|Overall Study|Withdrawal by Subject|0
7096750|NCT02324270|11218960|FG000|Overall Study|Lost to Follow-up|4
7096751|NCT02324270|11218961|FG001|Overall Study|Lost to Follow-up|3
7096752|NCT02324270|11218962|FG002|Overall Study|Lost to Follow-up|4
7096753|NCT02324270|11218960|FG000|Overall Study|Protocol Violation|0
7096754|NCT02324270|11218961|FG001|Overall Study|Protocol Violation|1
7096755|NCT02324270|11218962|FG002|Overall Study|Protocol Violation|1
7096756|NCT02324270|11218960|FG000|Overall Study|Non Compliance with Study Drug|1
7096757|NCT02324270|11218961|FG001|Overall Study|Non Compliance with Study Drug|2
7096758|NCT02324270|11218962|FG002|Overall Study|Non Compliance with Study Drug|0
7096759|NCT02324361|11218981|FG000|Overall Study|Lost to Follow-up|5
7096760|NCT02324361|11218982|FG001|Overall Study|Lost to Follow-up|2
7096761|NCT02324465|11218990|FG000|Overall Study|device failure|0
7096762|NCT02324465|11218991|FG001|Overall Study|device failure|1
7096763|NCT02324569|11219027|FG000|Overall Study|Pretreatment Event/Adverse Event|9
7096764|NCT02324569|11219028|FG001|Overall Study|Pretreatment Event/Adverse Event|10
7096765|NCT02324569|11219027|FG000|Overall Study|Voluntary Withdrawal|3
7096766|NCT02324569|11219028|FG001|Overall Study|Voluntary Withdrawal|6
7096767|NCT02324569|11219027|FG000|Overall Study|Lack of Efficacy|2
7096768|NCT02324569|11219028|FG001|Overall Study|Lack of Efficacy|3
7096769|NCT02324569|11219027|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0
7096770|NCT02324569|11219028|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2
7096771|NCT02324569|11219027|FG000|Overall Study|Inconvenient Schedule|2
7096772|NCT02324569|11219028|FG001|Overall Study|Inconvenient Schedule|0
7096773|NCT02324699|11219052|FG000|Overall Study|study terminated|1
7096774|NCT02324842|11219059|FG000|Overall Study|Lost to Follow-up|1
7096775|NCT02324842|11219060|FG001|Overall Study|Lost to Follow-up|1
7096776|NCT02324842|11219061|FG002|Overall Study|Lost to Follow-up|2
7096777|NCT02325219|11219090|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6
7096778|NCT02325219|11219091|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1
7096779|NCT02325219|11219092|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0
7096780|NCT02325219|11219093|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0
7096781|NCT02325219|11219094|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0
7096782|NCT02325219|11219090|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6
7096783|NCT02325219|11219091|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1
7096784|NCT02325219|11219092|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
7096785|NCT02325219|11219093|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
7096786|NCT02325219|11219094|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
7096787|NCT02325219|11219090|FG000|Controlled Period (Week 0 - 16)|Other|0
7096788|NCT02325219|11219091|FG001|Controlled Period (Week 0 - 16)|Other|0
7096789|NCT02325219|11219092|FG002|Controlled Period (Week 0 - 16)|Other|1
7096790|NCT02325219|11219093|FG003|Controlled Period (Week 0 - 16)|Other|0
7096791|NCT02325219|11219094|FG004|Controlled Period (Week 0 - 16)|Other|0
7096792|NCT02325219|11219090|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0
7096793|NCT02325219|11219091|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0
7096794|NCT02325219|11219092|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0
7096795|NCT02325219|11219093|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0
7096796|NCT02325219|11219094|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1
7096797|NCT02325219|11219090|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
7096798|NCT02325219|11219091|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2
7096799|NCT02325219|11219092|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
7096800|NCT02325219|11219093|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
7096801|NCT02325219|11219094|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
7096802|NCT02325219|11219090|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0
7096803|NCT02325219|11219091|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1
7096804|NCT02325219|11219092|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0
7096805|NCT02325219|11219093|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0
7096806|NCT02325219|11219094|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0
7096807|NCT02325401|11219110|FG000|Overall Study|Withdrawal by Subject|0
7096808|NCT02325401|11219111|FG001|Overall Study|Withdrawal by Subject|1
7096809|NCT02325401|11219112|FG002|Overall Study|Withdrawal by Subject|1
7096810|NCT02325414|11219128|FG000|Overall Study|Withdrawal by Subject|3
7096811|NCT02325414|11219129|FG001|Overall Study|Withdrawal by Subject|1
7096812|NCT02325414|11219128|FG000|Overall Study|Lost to Follow-up|5
7096813|NCT02325414|11219129|FG001|Overall Study|Lost to Follow-up|5
7096814|NCT02325518|11219139|FG000|Overall Study|Adverse Event|4
7096815|NCT02325518|11219140|FG001|Overall Study|Adverse Event|1
7096816|NCT02325518|11219139|FG000|Overall Study|Physician Decision|0
7096817|NCT02325518|11219140|FG001|Overall Study|Physician Decision|1
7096818|NCT02325518|11219139|FG000|Overall Study|Withdrawal by Subject|0
7096819|NCT02325518|11219140|FG001|Overall Study|Withdrawal by Subject|1
7096820|NCT02325713|11219176|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7096821|NCT02325713|11219177|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7096822|NCT02325713|11219178|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7096823|NCT02325713|11219179|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7096824|NCT02325713|11219180|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7096825|NCT02325713|11219181|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7096826|NCT02325713|11219182|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7096827|NCT02325713|11219183|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7096828|NCT02325713|11219184|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7096829|NCT02325713|11219185|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7096830|NCT02325713|11219186|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1
7096831|NCT02325713|11219187|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7096832|NCT02325713|11219188|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7096833|NCT02325713|11219189|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7096834|NCT02325713|11219190|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7096835|NCT02325713|11219191|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7096836|NCT02325713|11219176|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1
7096837|NCT02325713|11219177|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7096838|NCT02325713|11219178|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7096839|NCT02325713|11219179|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7096840|NCT02325713|11219180|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7096841|NCT02325713|11219181|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7096842|NCT02325713|11219182|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7096843|NCT02325713|11219183|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7096844|NCT02325713|11219184|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7096845|NCT02325713|11219185|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7096846|NCT02325713|11219186|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7096847|NCT02325713|11219187|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7096848|NCT02325713|11219188|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7096849|NCT02325713|11219189|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7096850|NCT02325713|11219190|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7096851|NCT02325713|11219191|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7096852|NCT02325713|11219176|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7096853|NCT02325713|11219177|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7096854|NCT02325713|11219178|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7096855|NCT02325713|11219179|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7096856|NCT02325713|11219180|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7096857|NCT02325713|11219181|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7096858|NCT02325713|11219182|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7096859|NCT02325713|11219183|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7096860|NCT02325713|11219184|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7096861|NCT02325713|11219185|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1
7096862|NCT02325713|11219186|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7096863|NCT02325713|11219187|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7096864|NCT02325713|11219188|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7096865|NCT02325713|11219189|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7096866|NCT02325713|11219190|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7096867|NCT02325713|11219191|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7096868|NCT02325739|11219217|FG000|Phase I Part|Adverse Event|1
7096869|NCT02325739|11219218|FG001|Phase I Part|Adverse Event|0
7096870|NCT02325739|11219219|FG002|Phase I Part|Adverse Event|1
7096871|NCT02325739|11219220|FG003|Phase I Part|Adverse Event|2
7096872|NCT02325739|11219221|FG004|Phase I Part|Adverse Event|3
7096873|NCT02325739|11219222|FG005|Phase I Part|Adverse Event|1
7096874|NCT02325739|11219223|FG006|Phase I Part|Adverse Event|0
7096875|NCT02325739|11219224|FG007|Phase I Part|Adverse Event|2
7096876|NCT02325739|11219225|FG008|Phase I Part|Adverse Event|0
7096877|NCT02325739|11219226|FG009|Phase I Part|Adverse Event|0
7096878|NCT02325739|11219227|FG010|Phase I Part|Adverse Event|0
7096879|NCT02325739|11219217|FG000|Phase I Part|Progressive disease|9
7096880|NCT02325739|11219218|FG001|Phase I Part|Progressive disease|6
7096881|NCT02325739|11219219|FG002|Phase I Part|Progressive disease|3
7096882|NCT02325739|11219220|FG003|Phase I Part|Progressive disease|23
7096883|NCT02325739|11219221|FG004|Phase I Part|Progressive disease|14
7096884|NCT02325739|11219222|FG005|Phase I Part|Progressive disease|6
7096885|NCT02325739|11219223|FG006|Phase I Part|Progressive disease|6
7096886|NCT02325739|11219224|FG007|Phase I Part|Progressive disease|3
7096887|NCT02325739|11219225|FG008|Phase I Part|Progressive disease|0
7096888|NCT02325739|11219226|FG009|Phase I Part|Progressive disease|0
7096889|NCT02325739|11219227|FG010|Phase I Part|Progressive disease|0
7096890|NCT02325739|11219217|FG000|Phase I Part|Subject/guardian decision|1
7096891|NCT02325739|11219218|FG001|Phase I Part|Subject/guardian decision|0
7096892|NCT02325739|11219219|FG002|Phase I Part|Subject/guardian decision|1
7096893|NCT02325739|11219220|FG003|Phase I Part|Subject/guardian decision|1
7096894|NCT02325739|11219221|FG004|Phase I Part|Subject/guardian decision|0
7096895|NCT02325739|11219222|FG005|Phase I Part|Subject/guardian decision|0
7096896|NCT02325739|11219223|FG006|Phase I Part|Subject/guardian decision|0
7096897|NCT02325739|11219224|FG007|Phase I Part|Subject/guardian decision|1
7096898|NCT02325739|11219225|FG008|Phase I Part|Subject/guardian decision|0
7096899|NCT02325739|11219226|FG009|Phase I Part|Subject/guardian decision|0
7096900|NCT02325739|11219227|FG010|Phase I Part|Subject/guardian decision|0
7096901|NCT02325739|11219217|FG000|Phase I Part|Death|0
7096902|NCT02325739|11219218|FG001|Phase I Part|Death|0
7096903|NCT02325739|11219219|FG002|Phase I Part|Death|0
7096904|NCT02325739|11219220|FG003|Phase I Part|Death|0
7096905|NCT02325739|11219221|FG004|Phase I Part|Death|2
7096906|NCT02325739|11219222|FG005|Phase I Part|Death|0
7096907|NCT02325739|11219223|FG006|Phase I Part|Death|0
7096908|NCT02325739|11219224|FG007|Phase I Part|Death|0
7096909|NCT02325739|11219225|FG008|Phase I Part|Death|0
7096910|NCT02325739|11219226|FG009|Phase I Part|Death|0
7096911|NCT02325739|11219227|FG010|Phase I Part|Death|0
7096912|NCT02325739|11219217|FG000|Phase II Part|Adverse Event|0
7096913|NCT02325739|11219218|FG001|Phase II Part|Adverse Event|0
7096914|NCT02325739|11219219|FG002|Phase II Part|Adverse Event|0
7096915|NCT02325739|11219220|FG003|Phase II Part|Adverse Event|0
7096916|NCT02325739|11219221|FG004|Phase II Part|Adverse Event|0
7096917|NCT02325739|11219222|FG005|Phase II Part|Adverse Event|0
7096918|NCT02325739|11219223|FG006|Phase II Part|Adverse Event|0
7096919|NCT02325739|11219224|FG007|Phase II Part|Adverse Event|0
7096920|NCT02325739|11219225|FG008|Phase II Part|Adverse Event|4
7096921|NCT02325739|11219226|FG009|Phase II Part|Adverse Event|5
7096922|NCT02325739|11219227|FG010|Phase II Part|Adverse Event|1
7096923|NCT02325739|11219217|FG000|Phase II Part|Physician Decision|0
7096924|NCT02325739|11219218|FG001|Phase II Part|Physician Decision|0
7096925|NCT02325739|11219219|FG002|Phase II Part|Physician Decision|0
7096926|NCT02325739|11219220|FG003|Phase II Part|Physician Decision|0
7096927|NCT02325739|11219221|FG004|Phase II Part|Physician Decision|0
7096928|NCT02325739|11219222|FG005|Phase II Part|Physician Decision|0
7096929|NCT02325739|11219223|FG006|Phase II Part|Physician Decision|0
7096930|NCT02325739|11219224|FG007|Phase II Part|Physician Decision|0
7096931|NCT02325739|11219225|FG008|Phase II Part|Physician Decision|0
7096932|NCT02325739|11219226|FG009|Phase II Part|Physician Decision|1
7096933|NCT02325739|11219227|FG010|Phase II Part|Physician Decision|0
7096934|NCT02325739|11219217|FG000|Phase II Part|Progressive disease|0
7096935|NCT02325739|11219218|FG001|Phase II Part|Progressive disease|0
7096936|NCT02325739|11219219|FG002|Phase II Part|Progressive disease|0
7096937|NCT02325739|11219220|FG003|Phase II Part|Progressive disease|0
7096938|NCT02325739|11219221|FG004|Phase II Part|Progressive disease|0
7096939|NCT02325739|11219222|FG005|Phase II Part|Progressive disease|0
7096940|NCT02325739|11219223|FG006|Phase II Part|Progressive disease|0
7096941|NCT02325739|11219224|FG007|Phase II Part|Progressive disease|0
7096942|NCT02325739|11219225|FG008|Phase II Part|Progressive disease|22
7096943|NCT02325739|11219226|FG009|Phase II Part|Progressive disease|29
7096944|NCT02325739|11219227|FG010|Phase II Part|Progressive disease|18
7096945|NCT02325739|11219217|FG000|Phase II Part|Subject/guardian decision|0
7096946|NCT02325739|11219218|FG001|Phase II Part|Subject/guardian decision|0
7096947|NCT02325739|11219219|FG002|Phase II Part|Subject/guardian decision|0
7096948|NCT02325739|11219220|FG003|Phase II Part|Subject/guardian decision|0
7096949|NCT02325739|11219221|FG004|Phase II Part|Subject/guardian decision|0
7096950|NCT02325739|11219222|FG005|Phase II Part|Subject/guardian decision|0
7096951|NCT02325739|11219223|FG006|Phase II Part|Subject/guardian decision|0
7096952|NCT02325739|11219224|FG007|Phase II Part|Subject/guardian decision|0
7096953|NCT02325739|11219225|FG008|Phase II Part|Subject/guardian decision|4
7096954|NCT02325739|11219226|FG009|Phase II Part|Subject/guardian decision|1
7096955|NCT02325739|11219227|FG010|Phase II Part|Subject/guardian decision|1
7096956|NCT02325791|11219276|FG000|Overall Study|Adverse Event|0
7096957|NCT02325791|11219277|FG001|Overall Study|Adverse Event|1
7096958|NCT02325791|11219278|FG002|Overall Study|Adverse Event|1
7096959|NCT02325791|11219279|FG003|Overall Study|Adverse Event|0
7096960|NCT02325791|11219276|FG000|Overall Study|Death|0
7096961|NCT02325791|11219277|FG001|Overall Study|Death|3
7096962|NCT02325791|11219278|FG002|Overall Study|Death|0
7096963|NCT02325791|11219279|FG003|Overall Study|Death|1
7096964|NCT02325791|11219276|FG000|Overall Study|Lost to Follow-up|0
7096965|NCT02325791|11219277|FG001|Overall Study|Lost to Follow-up|15
7096966|NCT02325791|11219278|FG002|Overall Study|Lost to Follow-up|14
7096967|NCT02325791|11219279|FG003|Overall Study|Lost to Follow-up|9
7096968|NCT02325791|11219276|FG000|Overall Study|Physician Decision|0
7096969|NCT02325791|11219277|FG001|Overall Study|Physician Decision|1
7096970|NCT02325791|11219278|FG002|Overall Study|Physician Decision|1
7096971|NCT02325791|11219279|FG003|Overall Study|Physician Decision|0
7096972|NCT02325791|11219276|FG000|Overall Study|Protocol Violation|0
7096973|NCT02325791|11219277|FG001|Overall Study|Protocol Violation|0
7096974|NCT02325791|11219278|FG002|Overall Study|Protocol Violation|1
7096975|NCT02325791|11219279|FG003|Overall Study|Protocol Violation|0
7096976|NCT02325791|11219276|FG000|Overall Study|Withdrawal by Subject|0
7096977|NCT02325791|11219277|FG001|Overall Study|Withdrawal by Subject|5
7096978|NCT02325791|11219278|FG002|Overall Study|Withdrawal by Subject|8
7096979|NCT02325791|11219279|FG003|Overall Study|Withdrawal by Subject|16
7096980|NCT02326025|11219303|FG000|Overall Study|Adverse Event|3
7096981|NCT02326025|11219304|FG001|Overall Study|Adverse Event|0
7096982|NCT02326025|11219303|FG000|Overall Study|Physician Decision|1
7096983|NCT02326025|11219304|FG001|Overall Study|Physician Decision|2
7096984|NCT02326025|11219303|FG000|Overall Study|Physician and Participant Decision|1
7096985|NCT02326025|11219304|FG001|Overall Study|Physician and Participant Decision|0
7096986|NCT02326025|11219303|FG000|Overall Study|Withdrawal by Subject|0
7096987|NCT02326025|11219304|FG001|Overall Study|Withdrawal by Subject|2
7096988|NCT02326025|11219303|FG000|Overall Study|Protocol Violation|0
7096989|NCT02326025|11219304|FG001|Overall Study|Protocol Violation|1
7096990|NCT02326220|11219325|FG000|Double-blind Treatment Period|Adverse Event|1
7096991|NCT02326220|11219326|FG001|Double-blind Treatment Period|Adverse Event|2
7096992|NCT02326220|11219327|FG002|Double-blind Treatment Period|Adverse Event|0
7096993|NCT02326220|11219325|FG000|Double-blind Treatment Period|Protocol Violation|0
7096994|NCT02326220|11219326|FG001|Double-blind Treatment Period|Protocol Violation|1
7096995|NCT02326220|11219327|FG002|Double-blind Treatment Period|Protocol Violation|0
7096996|NCT02326220|11219325|FG000|Double-blind Treatment Period|Withdrawal by Subject|0
7096997|NCT02326220|11219326|FG001|Double-blind Treatment Period|Withdrawal by Subject|1
7096998|NCT02326220|11219327|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
7096999|NCT02326220|11219325|FG000|Open-label Treatment Period|Withdrawal by Subject|0
7097000|NCT02326220|11219326|FG001|Open-label Treatment Period|Withdrawal by Subject|0
7097001|NCT02326220|11219327|FG002|Open-label Treatment Period|Withdrawal by Subject|1
7097002|NCT02326220|11219325|FG000|Open-label Treatment Period|Lost to Follow-up|0
7097003|NCT02326220|11219326|FG001|Open-label Treatment Period|Lost to Follow-up|0
7097004|NCT02326220|11219327|FG002|Open-label Treatment Period|Lost to Follow-up|1
7097005|NCT02326272|11219349|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0
7097006|NCT02326272|11219350|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3
7097007|NCT02326272|11219351|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1
7097008|NCT02326272|11219352|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0
7097009|NCT02326272|11219353|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0
7097010|NCT02326272|11219354|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0
7097011|NCT02326272|11219355|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0
7097012|NCT02326272|11219356|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0
7097013|NCT02326272|11219357|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0
7097014|NCT02326272|11219358|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0
7097015|NCT02326272|11219359|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0
7097016|NCT02326272|11219360|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0
7097017|NCT02326272|11219361|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0
7097018|NCT02326272|11219362|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0
7097019|NCT02326272|11219363|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0
7097020|NCT02326272|11219349|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
7097021|NCT02326272|11219350|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2
7097022|NCT02326272|11219351|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7097023|NCT02326272|11219352|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7097024|NCT02326272|11219353|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7097025|NCT02326272|11219354|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7097026|NCT02326272|11219355|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7097027|NCT02326272|11219356|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7097028|NCT02326272|11219357|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7097029|NCT02326272|11219358|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7097030|NCT02326272|11219359|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7097031|NCT02326272|11219360|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7097032|NCT02326272|11219361|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7097033|NCT02326272|11219362|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7097034|NCT02326272|11219363|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7097035|NCT02326272|11219349|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3
7097036|NCT02326272|11219350|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2
7097037|NCT02326272|11219351|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
7097038|NCT02326272|11219352|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7097039|NCT02326272|11219353|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7097040|NCT02326272|11219354|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7097041|NCT02326272|11219355|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7097042|NCT02326272|11219356|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7097043|NCT02326272|11219357|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7097044|NCT02326272|11219358|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7097045|NCT02326272|11219359|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7097046|NCT02326272|11219360|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7097047|NCT02326272|11219361|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7097048|NCT02326272|11219362|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7097049|NCT02326272|11219363|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7097050|NCT02326272|11219349|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7097051|NCT02326272|11219350|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7097052|NCT02326272|11219351|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1
7097053|NCT02326272|11219352|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7097054|NCT02326272|11219353|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7097055|NCT02326272|11219354|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7097056|NCT02326272|11219355|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7097057|NCT02326272|11219356|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7097058|NCT02326272|11219357|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7097059|NCT02326272|11219358|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7097060|NCT02326272|11219359|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7097061|NCT02326272|11219360|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7097062|NCT02326272|11219361|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7097063|NCT02326272|11219362|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7097064|NCT02326272|11219363|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7097065|NCT02326272|11219349|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0
7097066|NCT02326272|11219350|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0
7097067|NCT02326272|11219351|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1
7097068|NCT02326272|11219352|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0
7097069|NCT02326272|11219353|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0
7097070|NCT02326272|11219354|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0
7097071|NCT02326272|11219355|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0
7097072|NCT02326272|11219356|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0
7097073|NCT02326272|11219357|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0
7097074|NCT02326272|11219358|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0
7097075|NCT02326272|11219359|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0
7097076|NCT02326272|11219360|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0
7097077|NCT02326272|11219361|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0
7097078|NCT02326272|11219362|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0
7097079|NCT02326272|11219363|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0
7097080|NCT02326272|11219349|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7097081|NCT02326272|11219350|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7097082|NCT02326272|11219351|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1
7097083|NCT02326272|11219352|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7097084|NCT02326272|11219353|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7097085|NCT02326272|11219354|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7097086|NCT02326272|11219355|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7097087|NCT02326272|11219356|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7097088|NCT02326272|11219357|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7097089|NCT02326272|11219358|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7097090|NCT02326272|11219359|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7097091|NCT02326272|11219360|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7097092|NCT02326272|11219361|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7097093|NCT02326272|11219362|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7097094|NCT02326272|11219363|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7097095|NCT02326272|11219349|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7097096|NCT02326272|11219350|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7097097|NCT02326272|11219351|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1
7097098|NCT02326272|11219352|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7097099|NCT02326272|11219353|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7097100|NCT02326272|11219354|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7097101|NCT02326272|11219355|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7097102|NCT02326272|11219356|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7097103|NCT02326272|11219357|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7097104|NCT02326272|11219358|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7097105|NCT02326272|11219359|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7097106|NCT02326272|11219360|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7097107|NCT02326272|11219361|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7097108|NCT02326272|11219362|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7097109|NCT02326272|11219363|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7097110|NCT02326272|11219349|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7097111|NCT02326272|11219350|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7097112|NCT02326272|11219351|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7097113|NCT02326272|11219352|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7097114|NCT02326272|11219353|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
7097115|NCT02326272|11219354|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3
7097116|NCT02326272|11219355|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4
7097117|NCT02326272|11219356|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
7097118|NCT02326272|11219357|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
7097119|NCT02326272|11219358|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7097120|NCT02326272|11219359|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7097121|NCT02326272|11219360|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7097122|NCT02326272|11219361|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7097123|NCT02326272|11219362|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7097124|NCT02326272|11219363|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7097125|NCT02326272|11219349|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7097126|NCT02326272|11219350|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7097127|NCT02326272|11219351|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7097128|NCT02326272|11219352|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7097129|NCT02326272|11219353|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7097130|NCT02326272|11219354|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2
7097131|NCT02326272|11219355|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
7097132|NCT02326272|11219356|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7097133|NCT02326272|11219357|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
7097134|NCT02326272|11219358|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
7097135|NCT02326272|11219359|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7097136|NCT02326272|11219360|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7097137|NCT02326272|11219361|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7097138|NCT02326272|11219362|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7097139|NCT02326272|11219363|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7097140|NCT02326272|11219349|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7097141|NCT02326272|11219350|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7097142|NCT02326272|11219351|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7097143|NCT02326272|11219352|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7097144|NCT02326272|11219353|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7097145|NCT02326272|11219354|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
7097146|NCT02326272|11219355|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7097147|NCT02326272|11219356|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
7097148|NCT02326272|11219357|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7097149|NCT02326272|11219358|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7097150|NCT02326272|11219359|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7097151|NCT02326272|11219360|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7097152|NCT02326272|11219361|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7097153|NCT02326272|11219362|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7097154|NCT02326272|11219363|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7097155|NCT02326272|11219349|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7097156|NCT02326272|11219350|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7097157|NCT02326272|11219351|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7097158|NCT02326272|11219352|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7097159|NCT02326272|11219353|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7097160|NCT02326272|11219354|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3
7097161|NCT02326272|11219355|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7097162|NCT02326272|11219356|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7097163|NCT02326272|11219357|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7097164|NCT02326272|11219358|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7097165|NCT02326272|11219359|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7097166|NCT02326272|11219360|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7097167|NCT02326272|11219361|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7097168|NCT02326272|11219362|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7097169|NCT02326272|11219363|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7097170|NCT02326272|11219349|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7097171|NCT02326272|11219350|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7097172|NCT02326272|11219351|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7097173|NCT02326272|11219352|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7097174|NCT02326272|11219353|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7097175|NCT02326272|11219354|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7097176|NCT02326272|11219355|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7097177|NCT02326272|11219356|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1
7097178|NCT02326272|11219357|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7097179|NCT02326272|11219358|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7097180|NCT02326272|11219359|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7097181|NCT02326272|11219360|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7097182|NCT02326272|11219361|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7097183|NCT02326272|11219362|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7097184|NCT02326272|11219363|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7097185|NCT02326272|11219349|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7097186|NCT02326272|11219350|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7097187|NCT02326272|11219351|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7097188|NCT02326272|11219352|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7097189|NCT02326272|11219353|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7097190|NCT02326272|11219354|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7097191|NCT02326272|11219355|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1
7097192|NCT02326272|11219356|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7097193|NCT02326272|11219357|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7097194|NCT02326272|11219358|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7097195|NCT02326272|11219359|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7097196|NCT02326272|11219360|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7097197|NCT02326272|11219361|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7097198|NCT02326272|11219362|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7097199|NCT02326272|11219363|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7097200|NCT02326272|11219349|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7097201|NCT02326272|11219350|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7097202|NCT02326272|11219351|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7097203|NCT02326272|11219352|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7097204|NCT02326272|11219353|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7097205|NCT02326272|11219354|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7097206|NCT02326272|11219355|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7097207|NCT02326272|11219356|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7097208|NCT02326272|11219357|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1
7097209|NCT02326272|11219358|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7097210|NCT02326272|11219359|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7097211|NCT02326272|11219360|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7097212|NCT02326272|11219361|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7097213|NCT02326272|11219362|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7097214|NCT02326272|11219363|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7097215|NCT02326272|11219349|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7097216|NCT02326272|11219350|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7097217|NCT02326272|11219351|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7097218|NCT02326272|11219352|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7097219|NCT02326272|11219353|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7097220|NCT02326272|11219354|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2
7097221|NCT02326272|11219355|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1
7097222|NCT02326272|11219356|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1
7097223|NCT02326272|11219357|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2
7097224|NCT02326272|11219358|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7097225|NCT02326272|11219359|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7097226|NCT02326272|11219360|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7097227|NCT02326272|11219361|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7097228|NCT02326272|11219362|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7097229|NCT02326272|11219363|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7097230|NCT02326272|11219349|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7097231|NCT02326272|11219350|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7097232|NCT02326272|11219351|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7097233|NCT02326272|11219352|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7097234|NCT02326272|11219353|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7097235|NCT02326272|11219354|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1
7097236|NCT02326272|11219355|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7097237|NCT02326272|11219356|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7097238|NCT02326272|11219357|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7097239|NCT02326272|11219358|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7097240|NCT02326272|11219359|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7097241|NCT02326272|11219360|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7097242|NCT02326272|11219361|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7097243|NCT02326272|11219362|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7097244|NCT02326272|11219363|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7097245|NCT02326272|11219349|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7097246|NCT02326272|11219350|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7097247|NCT02326272|11219351|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7097248|NCT02326272|11219352|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7097249|NCT02326272|11219353|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7097250|NCT02326272|11219354|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7097251|NCT02326272|11219355|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1
7097252|NCT02326272|11219356|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7097253|NCT02326272|11219357|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7097254|NCT02326272|11219358|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7097255|NCT02326272|11219359|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7097256|NCT02326272|11219360|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7097257|NCT02326272|11219361|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7097258|NCT02326272|11219362|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7097259|NCT02326272|11219363|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7097260|NCT02326272|11219349|FG000|Open-label Period (Week 48 to Week 144)|Death|0
7097261|NCT02326272|11219350|FG001|Open-label Period (Week 48 to Week 144)|Death|0
7097262|NCT02326272|11219351|FG002|Open-label Period (Week 48 to Week 144)|Death|0
7097263|NCT02326272|11219352|FG003|Open-label Period (Week 48 to Week 144)|Death|0
7097264|NCT02326272|11219353|FG004|Open-label Period (Week 48 to Week 144)|Death|0
7097265|NCT02326272|11219354|FG005|Open-label Period (Week 48 to Week 144)|Death|0
7097266|NCT02326272|11219355|FG006|Open-label Period (Week 48 to Week 144)|Death|0
7097267|NCT02326272|11219356|FG007|Open-label Period (Week 48 to Week 144)|Death|0
7097268|NCT02326272|11219357|FG008|Open-label Period (Week 48 to Week 144)|Death|0
7097269|NCT02326272|11219358|FG009|Open-label Period (Week 48 to Week 144)|Death|0
7097270|NCT02326272|11219359|FG010|Open-label Period (Week 48 to Week 144)|Death|0
7097271|NCT02326272|11219360|FG011|Open-label Period (Week 48 to Week 144)|Death|0
7097272|NCT02326272|11219361|FG012|Open-label Period (Week 48 to Week 144)|Death|1
7097273|NCT02326272|11219362|FG013|Open-label Period (Week 48 to Week 144)|Death|0
7097274|NCT02326272|11219363|FG014|Open-label Period (Week 48 to Week 144)|Death|0
7097275|NCT02326272|11219349|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7097276|NCT02326272|11219350|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7097277|NCT02326272|11219351|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7097278|NCT02326272|11219352|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7097279|NCT02326272|11219353|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7097280|NCT02326272|11219354|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7097281|NCT02326272|11219355|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7097282|NCT02326272|11219356|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7097283|NCT02326272|11219357|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7097284|NCT02326272|11219358|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7097285|NCT02326272|11219359|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1
7097286|NCT02326272|11219360|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8
7097287|NCT02326272|11219361|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3
7097288|NCT02326272|11219362|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7097289|NCT02326272|11219363|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1
7097290|NCT02326272|11219349|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7097291|NCT02326272|11219350|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7097292|NCT02326272|11219351|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7097293|NCT02326272|11219352|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7097294|NCT02326272|11219353|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7097295|NCT02326272|11219354|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7097296|NCT02326272|11219355|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7097297|NCT02326272|11219356|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7097298|NCT02326272|11219357|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7097299|NCT02326272|11219358|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7097300|NCT02326272|11219359|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
7097301|NCT02326272|11219360|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7097302|NCT02326272|11219361|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
7097303|NCT02326272|11219362|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7097304|NCT02326272|11219363|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7097305|NCT02326272|11219349|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7097306|NCT02326272|11219350|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7097307|NCT02326272|11219351|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7097308|NCT02326272|11219352|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7097309|NCT02326272|11219353|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7097310|NCT02326272|11219354|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7097311|NCT02326272|11219355|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7097312|NCT02326272|11219356|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7097313|NCT02326272|11219357|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7097314|NCT02326272|11219358|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7097315|NCT02326272|11219359|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7097316|NCT02326272|11219360|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1
7097317|NCT02326272|11219361|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7097318|NCT02326272|11219362|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7097319|NCT02326272|11219363|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7097320|NCT02326272|11219349|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7097321|NCT02326272|11219350|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7097322|NCT02326272|11219351|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7097323|NCT02326272|11219352|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7097324|NCT02326272|11219353|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7097325|NCT02326272|11219354|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7097326|NCT02326272|11219355|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7097327|NCT02326272|11219356|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7097328|NCT02326272|11219357|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7097329|NCT02326272|11219358|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7097330|NCT02326272|11219359|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1
7097331|NCT02326272|11219360|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7097332|NCT02326272|11219361|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2
7097333|NCT02326272|11219362|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7097334|NCT02326272|11219363|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3
7097335|NCT02326272|11219349|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7097336|NCT02326272|11219350|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7097337|NCT02326272|11219351|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7097338|NCT02326272|11219352|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
6805644|NCT03336528|10807757|FG001|Overall Study|Protocol Violation|1
6805645|NCT03336528|10807756|FG000|Overall Study|Discharged within 48 hours of study medication|8
6805646|NCT03336528|10807757|FG001|Overall Study|Discharged within 48 hours of study medication|6
6805647|NCT03336528|10807756|FG000|Overall Study|Did not receive study medication|1
6805648|NCT03336528|10807757|FG001|Overall Study|Did not receive study medication|2
6805649|NCT03334409|10807767|FG000|Overall Study|Did not meet inclusion criteria|1
6805650|NCT03334409|10807768|FG001|Overall Study|Did not meet inclusion criteria|0
7097339|NCT02326272|11219353|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7097340|NCT02326272|11219354|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7097341|NCT02326272|11219355|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7097342|NCT02326272|11219356|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7097343|NCT02326272|11219357|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7097344|NCT02326272|11219358|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7097345|NCT02326272|11219359|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7097346|NCT02326272|11219360|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4
7097347|NCT02326272|11219361|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7097348|NCT02326272|11219362|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7097349|NCT02326272|11219363|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2
7097350|NCT02326272|11219349|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7097351|NCT02326272|11219350|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7097352|NCT02326272|11219351|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7097353|NCT02326272|11219352|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7097354|NCT02326272|11219353|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7097355|NCT02326272|11219354|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7097356|NCT02326272|11219355|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7097357|NCT02326272|11219356|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7097358|NCT02326272|11219357|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7097359|NCT02326272|11219358|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7097360|NCT02326272|11219359|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7097361|NCT02326272|11219360|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1
7097362|NCT02326272|11219361|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
7097363|NCT02326272|11219362|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7097364|NCT02326272|11219363|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
7097365|NCT02326272|11219349|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7097366|NCT02326272|11219350|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7097367|NCT02326272|11219351|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7097368|NCT02326272|11219352|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7097369|NCT02326272|11219353|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7097370|NCT02326272|11219354|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7097371|NCT02326272|11219355|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7097372|NCT02326272|11219356|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7097373|NCT02326272|11219357|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7097374|NCT02326272|11219358|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7097375|NCT02326272|11219359|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7097376|NCT02326272|11219360|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1
7097377|NCT02326272|11219361|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7097378|NCT02326272|11219362|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7097379|NCT02326272|11219363|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7097380|NCT02326272|11219349|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7097381|NCT02326272|11219350|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7097382|NCT02326272|11219351|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7097383|NCT02326272|11219352|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7097384|NCT02326272|11219353|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7097385|NCT02326272|11219354|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7097386|NCT02326272|11219355|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7097387|NCT02326272|11219356|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7097388|NCT02326272|11219357|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7097389|NCT02326272|11219358|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7097390|NCT02326272|11219359|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7097391|NCT02326272|11219360|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7097392|NCT02326272|11219361|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1
7097393|NCT02326272|11219362|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7097394|NCT02326272|11219363|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7097395|NCT02326298|11219375|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0
7097396|NCT02326298|11219376|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0
7097397|NCT02326298|11219377|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1
7097398|NCT02326298|11219378|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0
7097399|NCT02326298|11219379|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0
7097400|NCT02326298|11219380|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0
7097401|NCT02326298|11219381|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0
7097402|NCT02326298|11219382|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0
7097403|NCT02326298|11219383|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0
7097404|NCT02326298|11219384|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0
7097405|NCT02326298|11219385|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0
7097406|NCT02326298|11219386|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0
7097407|NCT02326298|11219387|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0
7097408|NCT02326298|11219388|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0
7097409|NCT02326298|11219375|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1
7097410|NCT02326298|11219376|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7097411|NCT02326298|11219377|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7097412|NCT02326298|11219378|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7097413|NCT02326298|11219379|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7097414|NCT02326298|11219380|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7097415|NCT02326298|11219381|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7097416|NCT02326298|11219382|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7097417|NCT02326298|11219383|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7097418|NCT02326298|11219384|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7097419|NCT02326298|11219385|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7097420|NCT02326298|11219386|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7097421|NCT02326298|11219387|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7097422|NCT02326298|11219388|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7097423|NCT02326298|11219375|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
7097424|NCT02326298|11219376|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
7097425|NCT02326298|11219377|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7097426|NCT02326298|11219378|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7097427|NCT02326298|11219379|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7097428|NCT02326298|11219380|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7097429|NCT02326298|11219381|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7097430|NCT02326298|11219382|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7097431|NCT02326298|11219383|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7097432|NCT02326298|11219384|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7097433|NCT02326298|11219385|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7097434|NCT02326298|11219386|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7097435|NCT02326298|11219387|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7097436|NCT02326298|11219388|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7097437|NCT02326298|11219375|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3
7097438|NCT02326298|11219376|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2
7097439|NCT02326298|11219377|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7097440|NCT02326298|11219378|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7097441|NCT02326298|11219379|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7097442|NCT02326298|11219380|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7097443|NCT02326298|11219381|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7097444|NCT02326298|11219382|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7097445|NCT02326298|11219383|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7097446|NCT02326298|11219384|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7097447|NCT02326298|11219385|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7097448|NCT02326298|11219386|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7097449|NCT02326298|11219387|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7097450|NCT02326298|11219388|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7097451|NCT02326298|11219375|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7097452|NCT02326298|11219376|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7097453|NCT02326298|11219377|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2
7097454|NCT02326298|11219378|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7097455|NCT02326298|11219379|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7097456|NCT02326298|11219380|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7097457|NCT02326298|11219381|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7097458|NCT02326298|11219382|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7097459|NCT02326298|11219383|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7097460|NCT02326298|11219384|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7097461|NCT02326298|11219385|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7097462|NCT02326298|11219386|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7097463|NCT02326298|11219387|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7097464|NCT02326298|11219388|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7097465|NCT02326298|11219375|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7097466|NCT02326298|11219376|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7097467|NCT02326298|11219377|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7097468|NCT02326298|11219378|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7097469|NCT02326298|11219379|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7097470|NCT02326298|11219380|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7097471|NCT02326298|11219381|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3
7097472|NCT02326298|11219382|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7097473|NCT02326298|11219383|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7097474|NCT02326298|11219384|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7097475|NCT02326298|11219385|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7097476|NCT02326298|11219386|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7097477|NCT02326298|11219387|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7097478|NCT02326298|11219388|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7097479|NCT02326298|11219375|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7097480|NCT02326298|11219376|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7097481|NCT02326298|11219377|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7097482|NCT02326298|11219378|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7097483|NCT02326298|11219379|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7097484|NCT02326298|11219380|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1
7097485|NCT02326298|11219381|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2
7097486|NCT02326298|11219382|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7097487|NCT02326298|11219383|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4
7097488|NCT02326298|11219384|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7097489|NCT02326298|11219385|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7097490|NCT02326298|11219386|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7097491|NCT02326298|11219387|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7097492|NCT02326298|11219388|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7097493|NCT02326298|11219375|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7097494|NCT02326298|11219376|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7097495|NCT02326298|11219377|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7097496|NCT02326298|11219378|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7097497|NCT02326298|11219379|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7097498|NCT02326298|11219380|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1
7097499|NCT02326298|11219381|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7097500|NCT02326298|11219382|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7097501|NCT02326298|11219383|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7097502|NCT02326298|11219384|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7097503|NCT02326298|11219385|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7097504|NCT02326298|11219386|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7097505|NCT02326298|11219387|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7097506|NCT02326298|11219388|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7097507|NCT02326298|11219375|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7097508|NCT02326298|11219376|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7097509|NCT02326298|11219377|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7097510|NCT02326298|11219378|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7097511|NCT02326298|11219379|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7097512|NCT02326298|11219380|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7097513|NCT02326298|11219381|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1
7097514|NCT02326298|11219382|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7097515|NCT02326298|11219383|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7097516|NCT02326298|11219384|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7097517|NCT02326298|11219385|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7097518|NCT02326298|11219386|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7097519|NCT02326298|11219387|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7097520|NCT02326298|11219388|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7097521|NCT02326298|11219375|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7097522|NCT02326298|11219376|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7097523|NCT02326298|11219377|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7097524|NCT02326298|11219378|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7097525|NCT02326298|11219379|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7097526|NCT02326298|11219380|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7097527|NCT02326298|11219381|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7097528|NCT02326298|11219382|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1
7097529|NCT02326298|11219383|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7097530|NCT02326298|11219384|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7097531|NCT02326298|11219385|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7097532|NCT02326298|11219386|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7097533|NCT02326298|11219387|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7097534|NCT02326298|11219388|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7097535|NCT02326298|11219375|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7097536|NCT02326298|11219376|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7097537|NCT02326298|11219377|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7097538|NCT02326298|11219378|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7097539|NCT02326298|11219379|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7097540|NCT02326298|11219380|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7097541|NCT02326298|11219381|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1
7097542|NCT02326298|11219382|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
7097543|NCT02326298|11219383|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7097544|NCT02326298|11219384|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7097545|NCT02326298|11219385|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7097546|NCT02326298|11219386|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7097547|NCT02326298|11219387|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7097548|NCT02326298|11219388|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7097549|NCT02326298|11219375|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7097550|NCT02326298|11219376|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7097551|NCT02326298|11219377|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7097552|NCT02326298|11219378|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7097553|NCT02326298|11219379|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7097554|NCT02326298|11219380|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7097555|NCT02326298|11219381|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7097556|NCT02326298|11219382|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
7097557|NCT02326298|11219383|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7097558|NCT02326298|11219384|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7097559|NCT02326298|11219385|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7097560|NCT02326298|11219386|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7097561|NCT02326298|11219387|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7097562|NCT02326298|11219388|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7097563|NCT02326298|11219375|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7097564|NCT02326298|11219376|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7097565|NCT02326298|11219377|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7097566|NCT02326298|11219378|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7097567|NCT02326298|11219379|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7097568|NCT02326298|11219380|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2
7097569|NCT02326298|11219381|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7097570|NCT02326298|11219382|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7097571|NCT02326298|11219383|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7097572|NCT02326298|11219384|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7097573|NCT02326298|11219385|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7097574|NCT02326298|11219386|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7097575|NCT02326298|11219387|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7097576|NCT02326298|11219388|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7097577|NCT02326298|11219375|FG000|Open-label Period (Week 48 to Week 144)|Death|0
7097578|NCT02326298|11219376|FG001|Open-label Period (Week 48 to Week 144)|Death|0
7097579|NCT02326298|11219377|FG002|Open-label Period (Week 48 to Week 144)|Death|0
7097580|NCT02326298|11219378|FG003|Open-label Period (Week 48 to Week 144)|Death|0
7097581|NCT02326298|11219379|FG004|Open-label Period (Week 48 to Week 144)|Death|0
7097582|NCT02326298|11219380|FG005|Open-label Period (Week 48 to Week 144)|Death|0
7097583|NCT02326298|11219381|FG006|Open-label Period (Week 48 to Week 144)|Death|0
7097584|NCT02326298|11219382|FG007|Open-label Period (Week 48 to Week 144)|Death|0
7097585|NCT02326298|11219383|FG008|Open-label Period (Week 48 to Week 144)|Death|0
7097586|NCT02326298|11219384|FG009|Open-label Period (Week 48 to Week 144)|Death|0
7097587|NCT02326298|11219385|FG010|Open-label Period (Week 48 to Week 144)|Death|0
7097588|NCT02326298|11219386|FG011|Open-label Period (Week 48 to Week 144)|Death|1
7097589|NCT02326298|11219387|FG012|Open-label Period (Week 48 to Week 144)|Death|0
7097590|NCT02326298|11219388|FG013|Open-label Period (Week 48 to Week 144)|Death|0
7097591|NCT02326298|11219375|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7097592|NCT02326298|11219376|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7097593|NCT02326298|11219377|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7097594|NCT02326298|11219378|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7097595|NCT02326298|11219379|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7097596|NCT02326298|11219380|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7097597|NCT02326298|11219381|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7097598|NCT02326298|11219382|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7097599|NCT02326298|11219383|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7097600|NCT02326298|11219384|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7097601|NCT02326298|11219385|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7097602|NCT02326298|11219386|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3
7097603|NCT02326298|11219387|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3
7097604|NCT02326298|11219388|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7097605|NCT02326298|11219375|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7097606|NCT02326298|11219376|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7097607|NCT02326298|11219377|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7097608|NCT02326298|11219378|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7097609|NCT02326298|11219379|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7097610|NCT02326298|11219380|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7097611|NCT02326298|11219381|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7097612|NCT02326298|11219382|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7097613|NCT02326298|11219383|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7097614|NCT02326298|11219384|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7097615|NCT02326298|11219385|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7097616|NCT02326298|11219386|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
7097617|NCT02326298|11219387|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
7097618|NCT02326298|11219388|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7097619|NCT02326298|11219375|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7097620|NCT02326298|11219376|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7097621|NCT02326298|11219377|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7097622|NCT02326298|11219378|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7097623|NCT02326298|11219379|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7097624|NCT02326298|11219380|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7097625|NCT02326298|11219381|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7097626|NCT02326298|11219382|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7097627|NCT02326298|11219383|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7097628|NCT02326298|11219384|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7097629|NCT02326298|11219385|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7097630|NCT02326298|11219386|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7097631|NCT02326298|11219387|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7097632|NCT02326298|11219388|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2
7097633|NCT02326298|11219375|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7097634|NCT02326298|11219376|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7097635|NCT02326298|11219377|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7097636|NCT02326298|11219378|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7097637|NCT02326298|11219379|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7097638|NCT02326298|11219380|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7097639|NCT02326298|11219381|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7097640|NCT02326298|11219382|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7097641|NCT02326298|11219383|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7097642|NCT02326298|11219384|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7097643|NCT02326298|11219385|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7097644|NCT02326298|11219386|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7
7097645|NCT02326298|11219387|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2
7097646|NCT02326298|11219388|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1
7097647|NCT02326298|11219375|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7097648|NCT02326298|11219376|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7097649|NCT02326298|11219377|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7097650|NCT02326298|11219378|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7097651|NCT02326298|11219379|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7097652|NCT02326298|11219380|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7097653|NCT02326298|11219381|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7097654|NCT02326298|11219382|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7097655|NCT02326298|11219383|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7097656|NCT02326298|11219384|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7097657|NCT02326298|11219385|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7097658|NCT02326298|11219386|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2
7097659|NCT02326298|11219387|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7
7097660|NCT02326298|11219388|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
7097661|NCT02326298|11219375|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7097662|NCT02326298|11219376|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7097663|NCT02326298|11219377|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7097664|NCT02326298|11219378|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7097665|NCT02326298|11219379|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7097666|NCT02326298|11219380|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7097667|NCT02326298|11219381|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7097668|NCT02326298|11219382|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7097669|NCT02326298|11219383|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7097670|NCT02326298|11219384|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7097671|NCT02326298|11219385|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7097672|NCT02326298|11219386|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6
7097673|NCT02326298|11219387|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6
7097674|NCT02326298|11219388|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3
7097675|NCT02326467|11219408|FG000|Overall Study|Withdrawal by Subject|1
7097676|NCT02326597|11219415|FG000|Overall Study|Lost to Follow-up|42
7097677|NCT02326597|11219416|FG001|Overall Study|Lost to Follow-up|32
7097678|NCT02326883|11219444|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84
7097679|NCT02326883|11219445|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85
7097680|NCT02326883|11219446|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69
7097681|NCT02327013|11219457|FG000|Overall Study|Adverse Event|4
7097682|NCT02327013|11219458|FG001|Overall Study|Adverse Event|4
7097683|NCT02327013|11219459|FG002|Overall Study|Adverse Event|3
7097684|NCT02327013|11219460|FG003|Overall Study|Adverse Event|0
7097685|NCT02327013|11219461|FG004|Overall Study|Adverse Event|1
7097686|NCT02327013|11219457|FG000|Overall Study|Lack of Efficacy|2
7097687|NCT02327013|11219458|FG001|Overall Study|Lack of Efficacy|0
7097688|NCT02327013|11219459|FG002|Overall Study|Lack of Efficacy|5
7097689|NCT02327013|11219460|FG003|Overall Study|Lack of Efficacy|0
7097690|NCT02327013|11219461|FG004|Overall Study|Lack of Efficacy|1
7097691|NCT02327013|11219457|FG000|Overall Study|Non-compliance with IMP|1
7097692|NCT02327013|11219458|FG001|Overall Study|Non-compliance with IMP|2
7097693|NCT02327013|11219459|FG002|Overall Study|Non-compliance with IMP|7
7097694|NCT02327013|11219460|FG003|Overall Study|Non-compliance with IMP|0
7097695|NCT02327013|11219461|FG004|Overall Study|Non-compliance with IMP|0
7097696|NCT02327013|11219457|FG000|Overall Study|Withdrawal of Consent|1
7097697|NCT02327013|11219458|FG001|Overall Study|Withdrawal of Consent|0
7097698|NCT02327013|11219459|FG002|Overall Study|Withdrawal of Consent|3
7097699|NCT02327013|11219460|FG003|Overall Study|Withdrawal of Consent|0
7097700|NCT02327013|11219461|FG004|Overall Study|Withdrawal of Consent|0
7097701|NCT02327013|11219457|FG000|Overall Study|Lost to Follow-up|2
7097702|NCT02327013|11219458|FG001|Overall Study|Lost to Follow-up|4
7097703|NCT02327013|11219459|FG002|Overall Study|Lost to Follow-up|5
7097704|NCT02327013|11219460|FG003|Overall Study|Lost to Follow-up|0
7097705|NCT02327013|11219461|FG004|Overall Study|Lost to Follow-up|0
7097706|NCT02327013|11219457|FG000|Overall Study|Administrative or other reason(s)|1
7097707|NCT02327013|11219458|FG001|Overall Study|Administrative or other reason(s)|5
7097708|NCT02327013|11219459|FG002|Overall Study|Administrative or other reason(s)|11
7097709|NCT02327013|11219460|FG003|Overall Study|Administrative or other reason(s)|1
7097710|NCT02327013|11219461|FG004|Overall Study|Administrative or other reason(s)|1
7097711|NCT02327013|11219457|FG000|Overall Study|Protocol Violation|0
7097712|NCT02327013|11219458|FG001|Overall Study|Protocol Violation|0
7097713|NCT02327013|11219459|FG002|Overall Study|Protocol Violation|3
7097714|NCT02327013|11219460|FG003|Overall Study|Protocol Violation|0
7097715|NCT02327013|11219461|FG004|Overall Study|Protocol Violation|1
7097716|NCT02327013|11219457|FG000|Overall Study|Withdrawal before treatment|2
7097717|NCT02327013|11219458|FG001|Overall Study|Withdrawal before treatment|1
7097718|NCT02327013|11219459|FG002|Overall Study|Withdrawal before treatment|5
7097719|NCT02327013|11219460|FG003|Overall Study|Withdrawal before treatment|0
7097720|NCT02327013|11219461|FG004|Overall Study|Withdrawal before treatment|0
7097721|NCT02327130|11219494|FG000|Overall Study|Discharged in less than 5 days|5
7097722|NCT02327130|11219494|FG000|Overall Study|Physician Decision|2
7097723|NCT02327130|11219494|FG000|Overall Study|Unable to provide breath sample|1
7097724|NCT02327130|11219494|FG000|Overall Study|Incorrectly place ventilator adaptor|1
7097725|NCT02327130|11219494|FG000|Overall Study|Met exclusion criteria|3
7097726|NCT02327169|11219523|FG000|Overall Study|Progressive Disease|1
7097727|NCT02327169|11219524|FG001|Overall Study|Progressive Disease|3
7097728|NCT02327169|11219525|FG002|Overall Study|Progressive Disease|4
7097729|NCT02327169|11219526|FG003|Overall Study|Progressive Disease|3
7097730|NCT02327169|11219527|FG004|Overall Study|Progressive Disease|4
7097731|NCT02327169|11219528|FG005|Overall Study|Progressive Disease|3
7097732|NCT02327169|11219529|FG006|Overall Study|Progressive Disease|3
7097733|NCT02327169|11219530|FG007|Overall Study|Progressive Disease|3
7097734|NCT02327169|11219531|FG008|Overall Study|Progressive Disease|4
7097735|NCT02327169|11219532|FG009|Overall Study|Progressive Disease|4
7097736|NCT02327169|11219533|FG010|Overall Study|Progressive Disease|4
7097737|NCT02327169|11219534|FG011|Overall Study|Progressive Disease|3
7097738|NCT02327169|11219535|FG012|Overall Study|Progressive Disease|1
7097739|NCT02327169|11219536|FG013|Overall Study|Progressive Disease|3
7097740|NCT02327169|11219537|FG014|Overall Study|Progressive Disease|3
7097741|NCT02327169|11219523|FG000|Overall Study|Adverse Event|2
7097742|NCT02327169|11219524|FG001|Overall Study|Adverse Event|0
7097743|NCT02327169|11219525|FG002|Overall Study|Adverse Event|1
7097744|NCT02327169|11219526|FG003|Overall Study|Adverse Event|0
7097745|NCT02327169|11219527|FG004|Overall Study|Adverse Event|1
7097746|NCT02327169|11219528|FG005|Overall Study|Adverse Event|0
7097747|NCT02327169|11219529|FG006|Overall Study|Adverse Event|0
7097748|NCT02327169|11219530|FG007|Overall Study|Adverse Event|0
7097749|NCT02327169|11219531|FG008|Overall Study|Adverse Event|0
7097750|NCT02327169|11219532|FG009|Overall Study|Adverse Event|2
7097751|NCT02327169|11219533|FG010|Overall Study|Adverse Event|0
7097752|NCT02327169|11219534|FG011|Overall Study|Adverse Event|3
7097753|NCT02327169|11219535|FG012|Overall Study|Adverse Event|0
7097754|NCT02327169|11219536|FG013|Overall Study|Adverse Event|2
7097755|NCT02327169|11219537|FG014|Overall Study|Adverse Event|1
7097756|NCT02327169|11219523|FG000|Overall Study|Symptomatic Deterioration|0
7097757|NCT02327169|11219524|FG001|Overall Study|Symptomatic Deterioration|0
7097758|NCT02327169|11219525|FG002|Overall Study|Symptomatic Deterioration|1
7097759|NCT02327169|11219526|FG003|Overall Study|Symptomatic Deterioration|0
7097760|NCT02327169|11219527|FG004|Overall Study|Symptomatic Deterioration|1
7097761|NCT02327169|11219528|FG005|Overall Study|Symptomatic Deterioration|1
7097762|NCT02327169|11219529|FG006|Overall Study|Symptomatic Deterioration|0
7097763|NCT02327169|11219530|FG007|Overall Study|Symptomatic Deterioration|0
7097764|NCT02327169|11219531|FG008|Overall Study|Symptomatic Deterioration|2
7097765|NCT02327169|11219532|FG009|Overall Study|Symptomatic Deterioration|1
7097766|NCT02327169|11219533|FG010|Overall Study|Symptomatic Deterioration|0
7097767|NCT02327169|11219534|FG011|Overall Study|Symptomatic Deterioration|0
7097768|NCT02327169|11219535|FG012|Overall Study|Symptomatic Deterioration|0
7097769|NCT02327169|11219536|FG013|Overall Study|Symptomatic Deterioration|2
7097770|NCT02327169|11219537|FG014|Overall Study|Symptomatic Deterioration|1
7097771|NCT02327169|11219523|FG000|Overall Study|Reason Not Specified|0
7097772|NCT02327169|11219524|FG001|Overall Study|Reason Not Specified|0
7097773|NCT02327169|11219525|FG002|Overall Study|Reason Not Specified|1
7097774|NCT02327169|11219526|FG003|Overall Study|Reason Not Specified|0
7097775|NCT02327169|11219527|FG004|Overall Study|Reason Not Specified|0
7097776|NCT02327169|11219528|FG005|Overall Study|Reason Not Specified|0
7097777|NCT02327169|11219529|FG006|Overall Study|Reason Not Specified|0
7097778|NCT02327169|11219530|FG007|Overall Study|Reason Not Specified|0
7097779|NCT02327169|11219531|FG008|Overall Study|Reason Not Specified|0
7097780|NCT02327169|11219532|FG009|Overall Study|Reason Not Specified|1
7097781|NCT02327169|11219533|FG010|Overall Study|Reason Not Specified|2
7097782|NCT02327169|11219534|FG011|Overall Study|Reason Not Specified|1
7097783|NCT02327169|11219535|FG012|Overall Study|Reason Not Specified|0
7097784|NCT02327169|11219536|FG013|Overall Study|Reason Not Specified|0
7097785|NCT02327169|11219537|FG014|Overall Study|Reason Not Specified|2
7097786|NCT02327169|11219523|FG000|Overall Study|Withdrawal by Subject|1
7097787|NCT02327169|11219524|FG001|Overall Study|Withdrawal by Subject|0
7097788|NCT02327169|11219525|FG002|Overall Study|Withdrawal by Subject|0
7097789|NCT02327169|11219526|FG003|Overall Study|Withdrawal by Subject|0
7097790|NCT02327169|11219527|FG004|Overall Study|Withdrawal by Subject|1
7097791|NCT02327169|11219528|FG005|Overall Study|Withdrawal by Subject|0
7097792|NCT02327169|11219529|FG006|Overall Study|Withdrawal by Subject|0
7097793|NCT02327169|11219530|FG007|Overall Study|Withdrawal by Subject|1
7097794|NCT02327169|11219531|FG008|Overall Study|Withdrawal by Subject|0
7097795|NCT02327169|11219532|FG009|Overall Study|Withdrawal by Subject|0
7097796|NCT02327169|11219533|FG010|Overall Study|Withdrawal by Subject|0
7097797|NCT02327169|11219534|FG011|Overall Study|Withdrawal by Subject|0
7097798|NCT02327169|11219535|FG012|Overall Study|Withdrawal by Subject|0
7097799|NCT02327169|11219536|FG013|Overall Study|Withdrawal by Subject|0
7097800|NCT02327169|11219537|FG014|Overall Study|Withdrawal by Subject|3
7097801|NCT02327169|11219523|FG000|Overall Study|Lost to Follow-up|0
7097802|NCT02327169|11219524|FG001|Overall Study|Lost to Follow-up|0
7097803|NCT02327169|11219525|FG002|Overall Study|Lost to Follow-up|0
7097804|NCT02327169|11219526|FG003|Overall Study|Lost to Follow-up|0
7097805|NCT02327169|11219527|FG004|Overall Study|Lost to Follow-up|1
7097806|NCT02327169|11219528|FG005|Overall Study|Lost to Follow-up|0
7097807|NCT02327169|11219529|FG006|Overall Study|Lost to Follow-up|0
7097808|NCT02327169|11219530|FG007|Overall Study|Lost to Follow-up|0
7097809|NCT02327169|11219531|FG008|Overall Study|Lost to Follow-up|0
7097810|NCT02327169|11219532|FG009|Overall Study|Lost to Follow-up|0
7097811|NCT02327169|11219533|FG010|Overall Study|Lost to Follow-up|0
7097812|NCT02327169|11219534|FG011|Overall Study|Lost to Follow-up|0
7097813|NCT02327169|11219535|FG012|Overall Study|Lost to Follow-up|0
7097814|NCT02327169|11219536|FG013|Overall Study|Lost to Follow-up|0
7097815|NCT02327169|11219537|FG014|Overall Study|Lost to Follow-up|0
7097816|NCT02327260|11219582|FG000|Overall Study|Lost to Follow-up|2
7097817|NCT02327260|11219583|FG001|Overall Study|Lost to Follow-up|3
7097818|NCT02327260|11219584|FG002|Overall Study|Lost to Follow-up|2
7097819|NCT02327260|11219582|FG000|Overall Study|invalid phone number|1
7097820|NCT02327260|11219583|FG001|Overall Study|invalid phone number|1
7097821|NCT02327260|11219584|FG002|Overall Study|invalid phone number|0
7097822|NCT02327260|11219582|FG000|Overall Study|non-adherence to protocol|2
7097823|NCT02327260|11219583|FG001|Overall Study|non-adherence to protocol|0
7097824|NCT02327260|11219584|FG002|Overall Study|non-adherence to protocol|0
7097825|NCT02327260|11219582|FG000|Overall Study|cognitive concerns|1
7097826|NCT02327260|11219583|FG001|Overall Study|cognitive concerns|0
7097827|NCT02327260|11219584|FG002|Overall Study|cognitive concerns|0
7097828|NCT02327325|11219596|FG000|Overall Study|Withdrawal by Subject|1
7097829|NCT02327325|11219597|FG001|Overall Study|Withdrawal by Subject|4
7097830|NCT02327325|11219598|FG002|Overall Study|Withdrawal by Subject|4
7097831|NCT02327325|11219596|FG000|Overall Study|Excluded by Study Team|0
7097832|NCT02327325|11219597|FG001|Overall Study|Excluded by Study Team|0
7097833|NCT02327325|11219598|FG002|Overall Study|Excluded by Study Team|1
7097834|NCT02328027|11219629|FG000|Overall Study|Withdrawal by Subject|0
7097835|NCT02328027|11219630|FG001|Overall Study|Withdrawal by Subject|1
6805651|NCT03230292|10807783|FG000|Overall Study|Adverse Event|1
6805652|NCT03230292|10807783|FG000|Overall Study|Protocol Violation|1
6805653|NCT03230292|10807783|FG000|Overall Study|Lost to Follow-up|1
6805654|NCT03230292|10807783|FG000|Overall Study|Withdrawal by Subject|3
6810353|NCT00943722|10814046|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0
6810354|NCT00943722|10814047|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0
6810355|NCT00943722|10814048|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137
7097836|NCT02328040|11219637|FG000|First Intervention (2 Days)|Withdrawal by Subject|1
7097837|NCT02328040|11219638|FG001|First Intervention (2 Days)|Withdrawal by Subject|1
7097838|NCT02328326|11219646|FG000|Overall Study|Withdrawal by Subject|10
7097839|NCT02328326|11219647|FG001|Overall Study|Withdrawal by Subject|3
7097840|NCT02328326|11219646|FG000|Overall Study|Death|2
7097841|NCT02328326|11219647|FG001|Overall Study|Death|1
7097842|NCT02328326|11219646|FG000|Overall Study|Lost to Follow-up|10
7097843|NCT02328326|11219647|FG001|Overall Study|Lost to Follow-up|4
7097844|NCT02328547|11219670|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1
7097845|NCT02328547|11219671|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0
7097846|NCT02328547|11219670|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2
7097847|NCT02328547|11219671|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0
7097848|NCT02328937|11219704|FG000|Period 1|Lost to Follow-up|0
7097849|NCT02328937|11219705|FG001|Period 1|Lost to Follow-up|0
7097850|NCT02328937|11219706|FG002|Period 1|Lost to Follow-up|0
7097851|NCT02328937|11219707|FG003|Period 1|Lost to Follow-up|1
6810356|NCT00943722|10814049|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50
6810357|NCT00676663|10814074|FG000|Overall Study|Death|43
7097852|NCT02328937|11219708|FG004|Period 1|Lost to Follow-up|0
7097853|NCT02328937|11219709|FG005|Period 1|Lost to Follow-up|0
7097854|NCT02328937|11219704|FG000|Period 2|Adverse Event|0
7097855|NCT02328937|11219705|FG001|Period 2|Adverse Event|0
7097856|NCT02328937|11219706|FG002|Period 2|Adverse Event|1
7097857|NCT02328937|11219707|FG003|Period 2|Adverse Event|0
7097858|NCT02328937|11219708|FG004|Period 2|Adverse Event|0
7097859|NCT02328937|11219709|FG005|Period 2|Adverse Event|0
7097860|NCT02329223|11219729|FG000|Overall Study|Withdrawal by Subject|1
7097861|NCT02329223|11219730|FG001|Overall Study|Withdrawal by Subject|2
7097862|NCT02329223|11219731|FG002|Overall Study|Withdrawal by Subject|5
7097863|NCT02329223|11219729|FG000|Overall Study|Physician Decision|0
7097864|NCT02329223|11219730|FG001|Overall Study|Physician Decision|0
7097865|NCT02329223|11219731|FG002|Overall Study|Physician Decision|1
7097866|NCT02329223|11219729|FG000|Overall Study|Adverse Event|0
7097867|NCT02329223|11219730|FG001|Overall Study|Adverse Event|1
7097868|NCT02329223|11219731|FG002|Overall Study|Adverse Event|0
7097869|NCT02329431|11219741|FG000|Overall Study|Lost to Follow-up|20
7097870|NCT02329431|11219742|FG001|Overall Study|Lost to Follow-up|13
7097871|NCT02329730|11219774|FG000|Overall Study|Protocol Violation|0
7097872|NCT02329730|11219775|FG001|Overall Study|Protocol Violation|0
7097873|NCT02329730|11219776|FG002|Overall Study|Protocol Violation|0
7097874|NCT02329730|11219777|FG003|Overall Study|Protocol Violation|0
7097875|NCT02329730|11219778|FG004|Overall Study|Protocol Violation|2
7097876|NCT02329730|11219779|FG005|Overall Study|Protocol Violation|2
7097877|NCT02329730|11219780|FG006|Overall Study|Protocol Violation|0
7097878|NCT02329730|11219781|FG007|Overall Study|Protocol Violation|0
7097879|NCT02329730|11219782|FG008|Overall Study|Protocol Violation|0
7097880|NCT02329730|11219783|FG009|Overall Study|Protocol Violation|0
7097881|NCT02329730|11219784|FG010|Overall Study|Protocol Violation|0
7097882|NCT02329730|11219785|FG011|Overall Study|Protocol Violation|0
7097883|NCT02329730|11219774|FG000|Overall Study|Withdrawal by Subject|0
7097884|NCT02329730|11219775|FG001|Overall Study|Withdrawal by Subject|0
7097885|NCT02329730|11219776|FG002|Overall Study|Withdrawal by Subject|0
7097886|NCT02329730|11219777|FG003|Overall Study|Withdrawal by Subject|0
7097887|NCT02329730|11219778|FG004|Overall Study|Withdrawal by Subject|1
7097888|NCT02329730|11219779|FG005|Overall Study|Withdrawal by Subject|0
7097889|NCT02329730|11219780|FG006|Overall Study|Withdrawal by Subject|1
7097890|NCT02329730|11219781|FG007|Overall Study|Withdrawal by Subject|1
7097891|NCT02329730|11219782|FG008|Overall Study|Withdrawal by Subject|1
7097892|NCT02329730|11219783|FG009|Overall Study|Withdrawal by Subject|1
7097893|NCT02329730|11219784|FG010|Overall Study|Withdrawal by Subject|0
7097894|NCT02329730|11219785|FG011|Overall Study|Withdrawal by Subject|0
7097895|NCT02329743|11219806|FG000|Overall Study|Adverse Event|1
7097896|NCT02329743|11219807|FG001|Overall Study|Adverse Event|1
7097897|NCT02329743|11219808|FG002|Overall Study|Adverse Event|3
7097898|NCT02329743|11219806|FG000|Overall Study|Lost to Follow-up|1
7097899|NCT02329743|11219807|FG001|Overall Study|Lost to Follow-up|0
7097900|NCT02329743|11219808|FG002|Overall Study|Lost to Follow-up|1
7097901|NCT02329743|11219806|FG000|Overall Study|Withdrawal by Subject|4
7097902|NCT02329743|11219807|FG001|Overall Study|Withdrawal by Subject|4
7097903|NCT02329743|11219808|FG002|Overall Study|Withdrawal by Subject|1
7097904|NCT02329743|11219806|FG000|Overall Study|Other|0
7097905|NCT02329743|11219807|FG001|Overall Study|Other|2
7097906|NCT02329743|11219808|FG002|Overall Study|Other|3
7097907|NCT02330055|11219827|FG000|Overall Study|technical issues|2
7097908|NCT02330055|11219828|FG001|Overall Study|technical issues|0
7097909|NCT02330055|11219827|FG000|Overall Study|participant forgot to wear device|5
7097910|NCT02330055|11219828|FG001|Overall Study|participant forgot to wear device|5
7097911|NCT02330055|11219827|FG000|Overall Study|data for less than 60 minutes|3
7097912|NCT02330055|11219828|FG001|Overall Study|data for less than 60 minutes|3
7097913|NCT02330055|11219827|FG000|Overall Study|participant did not sleep|0
7097914|NCT02330055|11219828|FG001|Overall Study|participant did not sleep|1
7097915|NCT02330081|11219834|FG000|Overall Study|Adverse Event|1
7097916|NCT02330081|11219834|FG000|Overall Study|Donation did not meet criteria|1
7097917|NCT02330081|11219834|FG000|Overall Study|Protocol Violation|6
7097918|NCT02330549|11219892|FG000|Overall Study|Adverse Event|1
7097919|NCT02330549|11219893|FG001|Overall Study|Adverse Event|0
7097920|NCT02330549|11219892|FG000|Overall Study|Subject withdrew consent|2
7097921|NCT02330549|11219893|FG001|Overall Study|Subject withdrew consent|1
7097922|NCT02330549|11219892|FG000|Overall Study|Failure to meet randomization criteria|1
7097923|NCT02330549|11219893|FG001|Overall Study|Failure to meet randomization criteria|0
7097924|NCT02331368|11219981|FG000|Overall Study|Withdrawal by Subject|3
7097925|NCT02331394|11219985|FG000|Overall Study|Disease progression|1
7097926|NCT02331446|11220004|FG000|Overall Study|Lost to Follow-up|2
7097927|NCT02331446|11220005|FG001|Overall Study|Lost to Follow-up|1
7097928|NCT02331446|11220006|FG002|Overall Study|Lost to Follow-up|0
7097929|NCT02331446|11220007|FG003|Overall Study|Lost to Follow-up|1
7097930|NCT02331446|11220004|FG000|Overall Study|Personal Problem|2
7097931|NCT02331446|11220005|FG001|Overall Study|Personal Problem|0
7097932|NCT02331446|11220006|FG002|Overall Study|Personal Problem|0
7097933|NCT02331446|11220007|FG003|Overall Study|Personal Problem|0
7097934|NCT02331446|11220004|FG000|Overall Study|Disease|0
7097935|NCT02331446|11220005|FG001|Overall Study|Disease|2
7097936|NCT02331446|11220006|FG002|Overall Study|Disease|2
7097937|NCT02331446|11220007|FG003|Overall Study|Disease|1
7097938|NCT02331446|11220004|FG000|Overall Study|Physician Decision|0
7097939|NCT02331446|11220005|FG001|Overall Study|Physician Decision|1
7097940|NCT02331446|11220006|FG002|Overall Study|Physician Decision|0
7097941|NCT02331446|11220007|FG003|Overall Study|Physician Decision|1
7097942|NCT02331446|11220004|FG000|Overall Study|Lost before baseline analysis|0
7097943|NCT02331446|11220005|FG001|Overall Study|Lost before baseline analysis|1
7097944|NCT02331446|11220006|FG002|Overall Study|Lost before baseline analysis|1
7097945|NCT02331446|11220007|FG003|Overall Study|Lost before baseline analysis|0
7097946|NCT02331680|11220029|FG000|Overall Study|Adverse Event|3
7097947|NCT02331680|11220030|FG001|Overall Study|Adverse Event|0
7097948|NCT02331680|11220031|FG002|Overall Study|Adverse Event|2
7097949|NCT02331680|11220029|FG000|Overall Study|Physician Decision|1
7097950|NCT02331680|11220030|FG001|Overall Study|Physician Decision|1
7097951|NCT02331680|11220031|FG002|Overall Study|Physician Decision|2
7097952|NCT02331680|11220029|FG000|Overall Study|Withdrawal by Subject|0
7097953|NCT02331680|11220030|FG001|Overall Study|Withdrawal by Subject|1
7097954|NCT02331680|11220031|FG002|Overall Study|Withdrawal by Subject|2
7097955|NCT02331680|11220029|FG000|Overall Study|Met withdrawal criteria|2
7097956|NCT02331680|11220030|FG001|Overall Study|Met withdrawal criteria|2
7097957|NCT02331680|11220031|FG002|Overall Study|Met withdrawal criteria|5
7097958|NCT02331680|11220029|FG000|Overall Study|Non-compliance with study drug|0
7097959|NCT02331680|11220030|FG001|Overall Study|Non-compliance with study drug|0
7097960|NCT02331680|11220031|FG002|Overall Study|Non-compliance with study drug|1
7097961|NCT02331680|11220029|FG000|Overall Study|Protocol Violation|0
7097962|NCT02331680|11220030|FG001|Overall Study|Protocol Violation|0
7097963|NCT02331680|11220031|FG002|Overall Study|Protocol Violation|3
7097964|NCT02332239|11220054|FG000|Overall Study|Lost to Follow-up|4
7097965|NCT02332239|11220055|FG001|Overall Study|Lost to Follow-up|6
7097966|NCT02332291|11220065|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3
7097967|NCT02332291|11220066|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5
7097968|NCT02332291|11220065|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0
7097969|NCT02332291|11220066|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4
7097970|NCT02332291|11220065|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1
7097971|NCT02332291|11220066|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0
7097972|NCT02332291|11220065|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2
7097973|NCT02332291|11220066|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7
7097974|NCT02332291|11220065|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0
7097975|NCT02332291|11220066|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1
7097976|NCT02332291|11220065|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1
7097977|NCT02332291|11220066|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0
7097978|NCT02332707|11220094|FG000|Overall Study|Adverse Event|0
7097979|NCT02332707|11220095|FG001|Overall Study|Adverse Event|0
7097980|NCT02332707|11220096|FG002|Overall Study|Adverse Event|0
7097981|NCT02332707|11220097|FG003|Overall Study|Adverse Event|0
7097982|NCT02332707|11220098|FG004|Overall Study|Adverse Event|0
7097983|NCT02332707|11220099|FG005|Overall Study|Adverse Event|0
7097984|NCT02332707|11220100|FG006|Overall Study|Adverse Event|0
7097985|NCT02332707|11220101|FG007|Overall Study|Adverse Event|0
7097986|NCT02332707|11220102|FG008|Overall Study|Adverse Event|0
7097987|NCT02332707|11220103|FG009|Overall Study|Adverse Event|0
7097988|NCT02332707|11220104|FG010|Overall Study|Adverse Event|0
7097989|NCT02332707|11220105|FG011|Overall Study|Adverse Event|0
7097990|NCT02332707|11220106|FG012|Overall Study|Adverse Event|1
7097991|NCT02332707|11220107|FG013|Overall Study|Adverse Event|0
7097992|NCT02332707|11220108|FG014|Overall Study|Adverse Event|0
7097993|NCT02332707|11220109|FG015|Overall Study|Adverse Event|0
7097994|NCT02332707|11220110|FG016|Overall Study|Adverse Event|0
7097995|NCT02332707|11220111|FG017|Overall Study|Adverse Event|0
7097996|NCT02332707|11220094|FG000|Overall Study|Lost to Follow-up|0
7097997|NCT02332707|11220095|FG001|Overall Study|Lost to Follow-up|0
7097998|NCT02332707|11220096|FG002|Overall Study|Lost to Follow-up|0
7097999|NCT02332707|11220097|FG003|Overall Study|Lost to Follow-up|0
7098000|NCT02332707|11220098|FG004|Overall Study|Lost to Follow-up|0
7098001|NCT02332707|11220099|FG005|Overall Study|Lost to Follow-up|1
7098002|NCT02332707|11220100|FG006|Overall Study|Lost to Follow-up|0
7098003|NCT02332707|11220101|FG007|Overall Study|Lost to Follow-up|0
7098004|NCT02332707|11220102|FG008|Overall Study|Lost to Follow-up|0
7098005|NCT02332707|11220103|FG009|Overall Study|Lost to Follow-up|0
7098006|NCT02332707|11220104|FG010|Overall Study|Lost to Follow-up|2
7098007|NCT02332707|11220105|FG011|Overall Study|Lost to Follow-up|0
7098008|NCT02332707|11220106|FG012|Overall Study|Lost to Follow-up|3
7098009|NCT02332707|11220107|FG013|Overall Study|Lost to Follow-up|0
7098010|NCT02332707|11220108|FG014|Overall Study|Lost to Follow-up|0
7098011|NCT02332707|11220109|FG015|Overall Study|Lost to Follow-up|0
7098012|NCT02332707|11220110|FG016|Overall Study|Lost to Follow-up|0
7098013|NCT02332707|11220111|FG017|Overall Study|Lost to Follow-up|0
7098014|NCT02332707|11220094|FG000|Overall Study|Physician Decision|0
7098015|NCT02332707|11220095|FG001|Overall Study|Physician Decision|0
7098016|NCT02332707|11220096|FG002|Overall Study|Physician Decision|0
7098017|NCT02332707|11220097|FG003|Overall Study|Physician Decision|1
7098018|NCT02332707|11220098|FG004|Overall Study|Physician Decision|0
7098019|NCT02332707|11220099|FG005|Overall Study|Physician Decision|0
7098020|NCT02332707|11220100|FG006|Overall Study|Physician Decision|0
7098021|NCT02332707|11220101|FG007|Overall Study|Physician Decision|0
7098022|NCT02332707|11220102|FG008|Overall Study|Physician Decision|0
7098023|NCT02332707|11220103|FG009|Overall Study|Physician Decision|0
7098024|NCT02332707|11220104|FG010|Overall Study|Physician Decision|0
7098025|NCT02332707|11220105|FG011|Overall Study|Physician Decision|0
7098026|NCT02332707|11220106|FG012|Overall Study|Physician Decision|1
7098027|NCT02332707|11220107|FG013|Overall Study|Physician Decision|0
7098028|NCT02332707|11220108|FG014|Overall Study|Physician Decision|0
7098029|NCT02332707|11220109|FG015|Overall Study|Physician Decision|0
7098030|NCT02332707|11220110|FG016|Overall Study|Physician Decision|0
7098031|NCT02332707|11220111|FG017|Overall Study|Physician Decision|0
7098032|NCT02332707|11220094|FG000|Overall Study|Withdrawal by Subject|0
7098033|NCT02332707|11220095|FG001|Overall Study|Withdrawal by Subject|0
7098034|NCT02332707|11220096|FG002|Overall Study|Withdrawal by Subject|1
7098035|NCT02332707|11220097|FG003|Overall Study|Withdrawal by Subject|0
7098036|NCT02332707|11220098|FG004|Overall Study|Withdrawal by Subject|0
7098037|NCT02332707|11220099|FG005|Overall Study|Withdrawal by Subject|0
7098038|NCT02332707|11220100|FG006|Overall Study|Withdrawal by Subject|0
7098039|NCT02332707|11220101|FG007|Overall Study|Withdrawal by Subject|0
7098040|NCT02332707|11220102|FG008|Overall Study|Withdrawal by Subject|0
7098041|NCT02332707|11220103|FG009|Overall Study|Withdrawal by Subject|3
7098042|NCT02332707|11220104|FG010|Overall Study|Withdrawal by Subject|0
7098043|NCT02332707|11220105|FG011|Overall Study|Withdrawal by Subject|0
7098044|NCT02332707|11220106|FG012|Overall Study|Withdrawal by Subject|0
7098045|NCT02332707|11220107|FG013|Overall Study|Withdrawal by Subject|0
7098046|NCT02332707|11220108|FG014|Overall Study|Withdrawal by Subject|0
7098047|NCT02332707|11220109|FG015|Overall Study|Withdrawal by Subject|0
7098048|NCT02332707|11220110|FG016|Overall Study|Withdrawal by Subject|0
7098049|NCT02332707|11220111|FG017|Overall Study|Withdrawal by Subject|0
7098050|NCT02332720|11220172|FG000|Part A and Part B|Lost to Follow-up|1
7098051|NCT02332720|11220173|FG001|Part A and Part B|Lost to Follow-up|0
7098052|NCT02332720|11220174|FG002|Part A and Part B|Lost to Follow-up|0
7098053|NCT02332720|11220175|FG003|Part A and Part B|Lost to Follow-up|0
7098054|NCT02332720|11220176|FG004|Part A and Part B|Lost to Follow-up|0
7098055|NCT02332720|11220177|FG005|Part A and Part B|Lost to Follow-up|2
7098056|NCT02332720|11220178|FG006|Part A and Part B|Lost to Follow-up|1
7098057|NCT02332720|11220179|FG007|Part A and Part B|Lost to Follow-up|1
7098058|NCT02332720|11220180|FG008|Part A and Part B|Lost to Follow-up|0
7098059|NCT02332720|11220181|FG009|Part A and Part B|Lost to Follow-up|0
7098060|NCT02332720|11220182|FG010|Part A and Part B|Lost to Follow-up|0
7098061|NCT02332720|11220183|FG011|Part A and Part B|Lost to Follow-up|0
7098062|NCT02332720|11220184|FG012|Part A and Part B|Lost to Follow-up|0
7098063|NCT02332720|11220185|FG013|Part A and Part B|Lost to Follow-up|0
7098064|NCT02332720|11220186|FG014|Part A and Part B|Lost to Follow-up|0
7098065|NCT02332720|11220187|FG015|Part A and Part B|Lost to Follow-up|1
7098066|NCT02332720|11220188|FG016|Part A and Part B|Lost to Follow-up|0
7098067|NCT02332720|11220189|FG017|Part A and Part B|Lost to Follow-up|0
7098068|NCT02332720|11220190|FG018|Part A and Part B|Lost to Follow-up|0
7098069|NCT02332720|11220191|FG019|Part A and Part B|Lost to Follow-up|0
7098070|NCT02332720|11220192|FG020|Part A and Part B|Lost to Follow-up|0
7098071|NCT02332720|11220193|FG021|Part A and Part B|Lost to Follow-up|0
7098072|NCT02332720|11220194|FG022|Part A and Part B|Lost to Follow-up|0
7098073|NCT02332720|11220172|FG000|Part A and Part B|Adverse Event|0
7098074|NCT02332720|11220173|FG001|Part A and Part B|Adverse Event|0
7098075|NCT02332720|11220174|FG002|Part A and Part B|Adverse Event|0
7098076|NCT02332720|11220175|FG003|Part A and Part B|Adverse Event|0
7098077|NCT02332720|11220176|FG004|Part A and Part B|Adverse Event|0
7098078|NCT02332720|11220177|FG005|Part A and Part B|Adverse Event|0
7098079|NCT02332720|11220178|FG006|Part A and Part B|Adverse Event|0
7098080|NCT02332720|11220179|FG007|Part A and Part B|Adverse Event|0
7098081|NCT02332720|11220180|FG008|Part A and Part B|Adverse Event|0
7098082|NCT02332720|11220181|FG009|Part A and Part B|Adverse Event|0
7098083|NCT02332720|11220182|FG010|Part A and Part B|Adverse Event|0
7098084|NCT02332720|11220183|FG011|Part A and Part B|Adverse Event|0
7098085|NCT02332720|11220184|FG012|Part A and Part B|Adverse Event|0
7098086|NCT02332720|11220185|FG013|Part A and Part B|Adverse Event|0
7098087|NCT02332720|11220186|FG014|Part A and Part B|Adverse Event|0
7098088|NCT02332720|11220187|FG015|Part A and Part B|Adverse Event|0
7098089|NCT02332720|11220188|FG016|Part A and Part B|Adverse Event|0
7098090|NCT02332720|11220189|FG017|Part A and Part B|Adverse Event|1
7098091|NCT02332720|11220190|FG018|Part A and Part B|Adverse Event|0
7098092|NCT02332720|11220191|FG019|Part A and Part B|Adverse Event|0
7098093|NCT02332720|11220192|FG020|Part A and Part B|Adverse Event|0
7098094|NCT02332720|11220193|FG021|Part A and Part B|Adverse Event|0
7098095|NCT02332720|11220194|FG022|Part A and Part B|Adverse Event|0
7098096|NCT02332720|11220172|FG000|Part A and Part B|Physician Decision|0
7098097|NCT02332720|11220173|FG001|Part A and Part B|Physician Decision|0
7098098|NCT02332720|11220174|FG002|Part A and Part B|Physician Decision|0
7098099|NCT02332720|11220175|FG003|Part A and Part B|Physician Decision|0
7098100|NCT02332720|11220176|FG004|Part A and Part B|Physician Decision|0
7098101|NCT02332720|11220177|FG005|Part A and Part B|Physician Decision|0
7098102|NCT02332720|11220178|FG006|Part A and Part B|Physician Decision|0
7098103|NCT02332720|11220179|FG007|Part A and Part B|Physician Decision|0
7098104|NCT02332720|11220180|FG008|Part A and Part B|Physician Decision|0
7098105|NCT02332720|11220181|FG009|Part A and Part B|Physician Decision|0
7098106|NCT02332720|11220182|FG010|Part A and Part B|Physician Decision|0
7098107|NCT02332720|11220183|FG011|Part A and Part B|Physician Decision|0
7098108|NCT02332720|11220184|FG012|Part A and Part B|Physician Decision|0
7098109|NCT02332720|11220185|FG013|Part A and Part B|Physician Decision|0
7098110|NCT02332720|11220186|FG014|Part A and Part B|Physician Decision|0
7098111|NCT02332720|11220187|FG015|Part A and Part B|Physician Decision|0
7098112|NCT02332720|11220188|FG016|Part A and Part B|Physician Decision|0
7098113|NCT02332720|11220189|FG017|Part A and Part B|Physician Decision|0
7098114|NCT02332720|11220190|FG018|Part A and Part B|Physician Decision|1
7098115|NCT02332720|11220191|FG019|Part A and Part B|Physician Decision|0
7098116|NCT02332720|11220192|FG020|Part A and Part B|Physician Decision|0
7098117|NCT02332720|11220193|FG021|Part A and Part B|Physician Decision|0
7098118|NCT02332720|11220194|FG022|Part A and Part B|Physician Decision|0
7098119|NCT02332720|11220172|FG000|Part A and Part B|Withdrawal by Subject|0
7098120|NCT02332720|11220173|FG001|Part A and Part B|Withdrawal by Subject|0
7098121|NCT02332720|11220174|FG002|Part A and Part B|Withdrawal by Subject|0
7098122|NCT02332720|11220175|FG003|Part A and Part B|Withdrawal by Subject|0
7098123|NCT02332720|11220176|FG004|Part A and Part B|Withdrawal by Subject|0
7098124|NCT02332720|11220177|FG005|Part A and Part B|Withdrawal by Subject|1
7098125|NCT02332720|11220178|FG006|Part A and Part B|Withdrawal by Subject|0
7098126|NCT02332720|11220179|FG007|Part A and Part B|Withdrawal by Subject|0
7098127|NCT02332720|11220180|FG008|Part A and Part B|Withdrawal by Subject|0
7098128|NCT02332720|11220181|FG009|Part A and Part B|Withdrawal by Subject|0
7098129|NCT02332720|11220182|FG010|Part A and Part B|Withdrawal by Subject|0
7098130|NCT02332720|11220183|FG011|Part A and Part B|Withdrawal by Subject|0
7098131|NCT02332720|11220184|FG012|Part A and Part B|Withdrawal by Subject|0
7098132|NCT02332720|11220185|FG013|Part A and Part B|Withdrawal by Subject|0
7098133|NCT02332720|11220186|FG014|Part A and Part B|Withdrawal by Subject|0
7098134|NCT02332720|11220187|FG015|Part A and Part B|Withdrawal by Subject|0
7098135|NCT02332720|11220188|FG016|Part A and Part B|Withdrawal by Subject|0
7098136|NCT02332720|11220189|FG017|Part A and Part B|Withdrawal by Subject|0
7098137|NCT02332720|11220190|FG018|Part A and Part B|Withdrawal by Subject|0
7098138|NCT02332720|11220191|FG019|Part A and Part B|Withdrawal by Subject|1
7098139|NCT02332720|11220192|FG020|Part A and Part B|Withdrawal by Subject|0
7098140|NCT02332720|11220193|FG021|Part A and Part B|Withdrawal by Subject|0
7098141|NCT02332720|11220194|FG022|Part A and Part B|Withdrawal by Subject|0
7098142|NCT02332798|11220259|FG000|Overall Study|Unwilling to Participate in Study|0
7098143|NCT02332798|11220260|FG001|Overall Study|Unwilling to Participate in Study|1
7098144|NCT02332798|11220261|FG002|Overall Study|Unwilling to Participate in Study|1
7098145|NCT02332798|11220259|FG000|Overall Study|Positive Urine Drug Test|0
6805655|NCT03131960|10807804|FG000|Overall Study|Adverse Event|0
6805656|NCT03131960|10807805|FG001|Overall Study|Adverse Event|1
6805657|NCT03084536|10807814|FG000|Overall Study|Determined to be ineligible|0
6805658|NCT03084536|10807815|FG001|Overall Study|Determined to be ineligible|0
6805659|NCT03084536|10807816|FG002|Overall Study|Determined to be ineligible|16
6805660|NCT03084536|10807814|FG000|Overall Study|Withdrawal by Subject|0
6805661|NCT03084536|10807815|FG001|Overall Study|Withdrawal by Subject|0
6805662|NCT03084536|10807816|FG002|Overall Study|Withdrawal by Subject|4
6805663|NCT03084536|10807814|FG000|Overall Study|Physician Decision|0
6805664|NCT03084536|10807815|FG001|Overall Study|Physician Decision|0
6805665|NCT03084536|10807816|FG002|Overall Study|Physician Decision|3
6805666|NCT03084536|10807814|FG000|Overall Study|Death|0
6805667|NCT03084536|10807815|FG001|Overall Study|Death|0
6805668|NCT03084536|10807816|FG002|Overall Study|Death|1
6805669|NCT03084536|10807814|FG000|Overall Study|Lost to Follow-up|0
6805670|NCT03084536|10807815|FG001|Overall Study|Lost to Follow-up|0
6805671|NCT03084536|10807816|FG002|Overall Study|Lost to Follow-up|1
6805672|NCT03084536|10807814|FG000|Overall Study|Protocol Violation|0
6805673|NCT03084536|10807815|FG001|Overall Study|Protocol Violation|0
6805674|NCT03084536|10807816|FG002|Overall Study|Protocol Violation|1
6805675|NCT03084536|10807814|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0
6805676|NCT03084536|10807815|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0
6805677|NCT03084536|10807816|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1
6805678|NCT02988661|10807868|FG000|Overall Study|Death|2
6805679|NCT02988661|10807869|FG001|Overall Study|Death|18
6805680|NCT02988661|10807868|FG000|Overall Study|Lost to Follow-up|0
6805681|NCT02988661|10807869|FG001|Overall Study|Lost to Follow-up|33
6805682|NCT02988661|10807868|FG000|Overall Study|Withdrawal by Subject|0
7098146|NCT02332798|11220260|FG001|Overall Study|Positive Urine Drug Test|1
7098147|NCT02332798|11220261|FG002|Overall Study|Positive Urine Drug Test|0
7098148|NCT02332798|11220259|FG000|Overall Study|Abnormal Laboratory Findings|1
7098149|NCT02332798|11220260|FG001|Overall Study|Abnormal Laboratory Findings|0
7098150|NCT02332798|11220261|FG002|Overall Study|Abnormal Laboratory Findings|0
6805683|NCT02988661|10807869|FG001|Overall Study|Withdrawal by Subject|6
6805684|NCT02988661|10807868|FG000|Overall Study|Unable to complete the 18-month survey|1
6805685|NCT02988661|10807869|FG001|Overall Study|Unable to complete the 18-month survey|27
7098151|NCT02332824|11220275|FG000|Overall Study|Pretreatment Event/Adverse Event|4
7098152|NCT02332824|11220276|FG001|Overall Study|Pretreatment Event/Adverse Event|0
7098153|NCT02332824|11220277|FG002|Overall Study|Pretreatment Event/Adverse Event|1
7098154|NCT02332824|11220278|FG003|Overall Study|Pretreatment Event/Adverse Event|1
7098155|NCT02332824|11220279|FG004|Overall Study|Pretreatment Event/Adverse Event|4
7098156|NCT02332824|11220280|FG005|Overall Study|Pretreatment Event/Adverse Event|1
7098157|NCT02332824|11220275|FG000|Overall Study|Voluntary Withdrawal|1
7098158|NCT02332824|11220276|FG001|Overall Study|Voluntary Withdrawal|0
7098159|NCT02332824|11220277|FG002|Overall Study|Voluntary Withdrawal|0
7098160|NCT02332824|11220278|FG003|Overall Study|Voluntary Withdrawal|0
7098161|NCT02332824|11220279|FG004|Overall Study|Voluntary Withdrawal|0
7098162|NCT02332824|11220280|FG005|Overall Study|Voluntary Withdrawal|0
7098163|NCT02332824|11220275|FG000|Overall Study|Inconvenient schedule|1
7098164|NCT02332824|11220276|FG001|Overall Study|Inconvenient schedule|1
7098165|NCT02332824|11220277|FG002|Overall Study|Inconvenient schedule|0
7098166|NCT02332824|11220278|FG003|Overall Study|Inconvenient schedule|0
6805690|NCT02921776|10807885|FG000|Overall Study|patient deterioration, fatigue|2
7098167|NCT02332824|11220279|FG004|Overall Study|Inconvenient schedule|0
7098168|NCT02332824|11220280|FG005|Overall Study|Inconvenient schedule|0
7098169|NCT02332824|11220275|FG000|Overall Study|Transfer|0
7098170|NCT02332824|11220276|FG001|Overall Study|Transfer|0
7098171|NCT02332824|11220277|FG002|Overall Study|Transfer|1
7098172|NCT02332824|11220278|FG003|Overall Study|Transfer|1
7098173|NCT02332824|11220279|FG004|Overall Study|Transfer|0
7098174|NCT02332824|11220280|FG005|Overall Study|Transfer|0
7098175|NCT02332876|11220305|FG000|Overall Study|Lost to Follow-up|1
7098176|NCT02332876|11220306|FG001|Overall Study|Lost to Follow-up|1
7098177|NCT02332889|11220312|FG000|Overall Study|Physician Decision|1
7098178|NCT02332915|11220322|FG000|Overall Study|Moved out of region|3
7098179|NCT02332915|11220323|FG001|Overall Study|Moved out of region|0
7098180|NCT02332915|11220322|FG000|Overall Study|Unrelated illness|1
7098181|NCT02332915|11220323|FG001|Overall Study|Unrelated illness|1
7098182|NCT02332915|11220322|FG000|Overall Study|Travel distance prohibitive|0
7098183|NCT02332915|11220323|FG001|Overall Study|Travel distance prohibitive|1
7098184|NCT02332915|11220322|FG000|Overall Study|did not meet inclusion criteria|2
7098185|NCT02332915|11220323|FG001|Overall Study|did not meet inclusion criteria|4
7098186|NCT02333331|11220358|FG000|Overall Study|Adverse Event|1
7098187|NCT02333331|11220359|FG001|Overall Study|Adverse Event|0
7098188|NCT02333331|11220360|FG002|Overall Study|Adverse Event|4
7098189|NCT02333331|11220361|FG003|Overall Study|Adverse Event|1
7098190|NCT02333331|11220358|FG000|Overall Study|Death|0
7098191|NCT02333331|11220359|FG001|Overall Study|Death|0
7098192|NCT02333331|11220360|FG002|Overall Study|Death|2
7098193|NCT02333331|11220361|FG003|Overall Study|Death|0
7098194|NCT02333331|11220358|FG000|Overall Study|Lost to Follow-up|0
7098195|NCT02333331|11220359|FG001|Overall Study|Lost to Follow-up|0
7098196|NCT02333331|11220360|FG002|Overall Study|Lost to Follow-up|1
7098197|NCT02333331|11220361|FG003|Overall Study|Lost to Follow-up|0
7098198|NCT02333331|11220358|FG000|Overall Study|Physician Decision|0
7098199|NCT02333331|11220359|FG001|Overall Study|Physician Decision|1
7098200|NCT02333331|11220360|FG002|Overall Study|Physician Decision|0
7098201|NCT02333331|11220361|FG003|Overall Study|Physician Decision|0
7098202|NCT02333331|11220358|FG000|Overall Study|Protocol Deviation|0
7098203|NCT02333331|11220359|FG001|Overall Study|Protocol Deviation|3
7098204|NCT02333331|11220360|FG002|Overall Study|Protocol Deviation|2
7098205|NCT02333331|11220361|FG003|Overall Study|Protocol Deviation|1
7098206|NCT02333331|11220358|FG000|Overall Study|Patient/Guardian Decision|1
7098207|NCT02333331|11220359|FG001|Overall Study|Patient/Guardian Decision|2
7098208|NCT02333331|11220360|FG002|Overall Study|Patient/Guardian Decision|9
7098209|NCT02333331|11220361|FG003|Overall Study|Patient/Guardian Decision|1
7098210|NCT02333383|11220371|FG000|Overall Study|Adalimumab discontinuation|21
7098211|NCT02333383|11220371|FG000|Overall Study|Lost to Follow-up|15
7098212|NCT02333383|11220371|FG000|Overall Study|Withdrawal by Subject|3
7098213|NCT02333383|11220371|FG000|Overall Study|Transfer to another hospital|2
7098214|NCT02333487|11220378|FG000|Overall Study|Adverse Event|0
7098215|NCT02333487|11220379|FG001|Overall Study|Adverse Event|2
7098216|NCT02333487|11220380|FG002|Overall Study|Adverse Event|0
7098217|NCT02333630|11220391|FG000|Overall Study|Lost to Follow-up|5
7098218|NCT02333630|11220392|FG001|Overall Study|Lost to Follow-up|2
7098219|NCT02334215|11220418|FG000|Overall Study|Death|1
7098220|NCT02334215|11220419|FG001|Overall Study|Death|1
7098221|NCT02334215|11220420|FG002|Overall Study|Death|0
7098222|NCT02334215|11220418|FG000|Overall Study|Lost to Follow-up|1
7098223|NCT02334215|11220419|FG001|Overall Study|Lost to Follow-up|0
7098224|NCT02334215|11220420|FG002|Overall Study|Lost to Follow-up|4
7098225|NCT02334215|11220418|FG000|Overall Study|Withdrawal by Subject|2
7098226|NCT02334215|11220419|FG001|Overall Study|Withdrawal by Subject|2
7098227|NCT02334215|11220420|FG002|Overall Study|Withdrawal by Subject|1
7098228|NCT02334215|11220418|FG000|Overall Study|Not released from incarceration on time|3
7098229|NCT02334215|11220419|FG001|Overall Study|Not released from incarceration on time|3
7098230|NCT02334215|11220420|FG002|Overall Study|Not released from incarceration on time|3
7098231|NCT02334215|11220418|FG000|Overall Study|Incarcerated|0
7098232|NCT02334215|11220419|FG001|Overall Study|Incarcerated|0
7098233|NCT02334215|11220420|FG002|Overall Study|Incarcerated|7
7098234|NCT02334306|11220445|FG000|Double-blind Period|Adverse Event|0
7098235|NCT02334306|11220446|FG001|Double-blind Period|Adverse Event|1
7098236|NCT02334306|11220445|FG000|Double-blind Period|Withdrawal by Subject|1
7098237|NCT02334306|11220446|FG001|Double-blind Period|Withdrawal by Subject|1
7098238|NCT02334384|11220459|FG000|Overall Study|Lost to Follow-up|1
7098239|NCT02334384|11220460|FG001|Overall Study|Lost to Follow-up|1
7098240|NCT02334423|11220468|FG000|Overall Study|Protocol Violation|10
7098241|NCT02334423|11220469|FG001|Overall Study|Protocol Violation|3
7098242|NCT02334683|11220494|FG000|First 12 Week Period|Lost to Follow-up|1
7098243|NCT02334683|11220495|FG001|First 12 Week Period|Lost to Follow-up|0
7098244|NCT02334683|11220494|FG000|Second 12 Week Period|Adverse Event|0
7098245|NCT02334683|11220495|FG001|Second 12 Week Period|Adverse Event|1
7098246|NCT02334748|11220501|FG000|Overall Study|Adverse Event|1
7098247|NCT02334748|11220501|FG000|Overall Study|Inclusion in the CACZ8852306 study|1
7098248|NCT02334748|11220501|FG000|Overall Study|Patient no longer required study drug|2
7098249|NCT02334748|11220501|FG000|Overall Study|Lack of Efficacy|4
7098250|NCT02335346|11220636|FG000|Overall Study|Adverse Event|11
7098251|NCT02335346|11220636|FG000|Overall Study|Withdrawal by Subject|1
7098252|NCT02335450|11220640|FG000|Overall Study|Pregnancy|1
7098253|NCT02335489|11220650|FG000|Overall Study|Sponsor terminated study|4
7098254|NCT02335489|11220650|FG000|Overall Study|Lost to Follow-up|1
7098255|NCT02335489|11220650|FG000|Overall Study|Withdrawal by Subject|2
7098256|NCT02335489|11220650|FG000|Overall Study|Physician Decision|2
7098257|NCT02335489|11220650|FG000|Overall Study|Lack of Efficacy|1
7098258|NCT02335983|11220677|FG000|Overall Study|Sponsor Decision|0
7098259|NCT02335983|11220678|FG001|Overall Study|Sponsor Decision|0
7098260|NCT02335983|11220679|FG002|Overall Study|Sponsor Decision|1
7098261|NCT02335983|11220680|FG003|Overall Study|Sponsor Decision|1
7098262|NCT02335983|11220681|FG004|Overall Study|Sponsor Decision|0
7098263|NCT02335983|11220682|FG005|Overall Study|Sponsor Decision|1
7098264|NCT02335983|11220677|FG000|Overall Study|Withdrawal by Subject|3
7098265|NCT02335983|11220678|FG001|Overall Study|Withdrawal by Subject|2
7098266|NCT02335983|11220679|FG002|Overall Study|Withdrawal by Subject|2
7098267|NCT02335983|11220680|FG003|Overall Study|Withdrawal by Subject|1
7098268|NCT02335983|11220681|FG004|Overall Study|Withdrawal by Subject|3
7098269|NCT02335983|11220682|FG005|Overall Study|Withdrawal by Subject|9
7098270|NCT02335983|11220677|FG000|Overall Study|Death|0
7098271|NCT02335983|11220678|FG001|Overall Study|Death|0
7098272|NCT02335983|11220679|FG002|Overall Study|Death|2
7098273|NCT02335983|11220680|FG003|Overall Study|Death|0
7098274|NCT02335983|11220681|FG004|Overall Study|Death|0
7098275|NCT02335983|11220682|FG005|Overall Study|Death|0
7098276|NCT02335983|11220677|FG000|Overall Study|Lost to Follow-up|0
7098277|NCT02335983|11220678|FG001|Overall Study|Lost to Follow-up|0
7098278|NCT02335983|11220679|FG002|Overall Study|Lost to Follow-up|0
7098279|NCT02335983|11220680|FG003|Overall Study|Lost to Follow-up|0
7098280|NCT02335983|11220681|FG004|Overall Study|Lost to Follow-up|0
7098281|NCT02335983|11220682|FG005|Overall Study|Lost to Follow-up|1
7098282|NCT02335983|11220677|FG000|Overall Study|Protocol Specified Criteria|5
7098283|NCT02335983|11220678|FG001|Overall Study|Protocol Specified Criteria|7
7098284|NCT02335983|11220679|FG002|Overall Study|Protocol Specified Criteria|27
7098285|NCT02335983|11220680|FG003|Overall Study|Protocol Specified Criteria|7
7098286|NCT02335983|11220681|FG004|Overall Study|Protocol Specified Criteria|5
7098287|NCT02335983|11220682|FG005|Overall Study|Protocol Specified Criteria|21
7098288|NCT02336074|11220707|FG000|Overall Study|Adverse Event|0
7098289|NCT02336074|11220708|FG001|Overall Study|Adverse Event|2
7098290|NCT02336165|11220724|FG000|Overall Study|Death|3
7098291|NCT02336165|11220725|FG001|Overall Study|Death|0
7098292|NCT02336165|11220726|FG002|Overall Study|Death|0
7098293|NCT02336165|11220727|FG003|Overall Study|Death|0
7098294|NCT02336165|11220728|FG004|Overall Study|Death|1
7098295|NCT02336165|11220724|FG000|Overall Study|Physician Decision|2
7098296|NCT02336165|11220725|FG001|Overall Study|Physician Decision|2
7098297|NCT02336165|11220726|FG002|Overall Study|Physician Decision|1
7098298|NCT02336165|11220727|FG003|Overall Study|Physician Decision|1
7098299|NCT02336165|11220728|FG004|Overall Study|Physician Decision|0
7098300|NCT02336165|11220724|FG000|Overall Study|Withdrawal by Subject|0
7098301|NCT02336165|11220725|FG001|Overall Study|Withdrawal by Subject|0
7098302|NCT02336165|11220726|FG002|Overall Study|Withdrawal by Subject|1
7098303|NCT02336165|11220727|FG003|Overall Study|Withdrawal by Subject|0
7098304|NCT02336165|11220728|FG004|Overall Study|Withdrawal by Subject|1
7098305|NCT02336165|11220724|FG000|Overall Study|Adverse Event|4
7098306|NCT02336165|11220725|FG001|Overall Study|Adverse Event|1
7098307|NCT02336165|11220726|FG002|Overall Study|Adverse Event|2
7098308|NCT02336165|11220727|FG003|Overall Study|Adverse Event|4
7098309|NCT02336165|11220728|FG004|Overall Study|Adverse Event|1
7098310|NCT02336165|11220724|FG000|Overall Study|Progressive disease|23
7098311|NCT02336165|11220725|FG001|Overall Study|Progressive disease|22
7098312|NCT02336165|11220726|FG002|Overall Study|Progressive disease|27
7098313|NCT02336165|11220727|FG003|Overall Study|Progressive disease|24
7098314|NCT02336165|11220728|FG004|Overall Study|Progressive disease|19
7098315|NCT02336165|11220724|FG000|Overall Study|Non-compliance|1
7098316|NCT02336165|11220725|FG001|Overall Study|Non-compliance|0
7098317|NCT02336165|11220726|FG002|Overall Study|Non-compliance|0
7098318|NCT02336165|11220727|FG003|Overall Study|Non-compliance|1
7098319|NCT02336165|11220728|FG004|Overall Study|Non-compliance|0
7098320|NCT02336165|11220724|FG000|Overall Study|Other|1
7098321|NCT02336165|11220725|FG001|Overall Study|Other|0
7098322|NCT02336165|11220726|FG002|Overall Study|Other|0
7098323|NCT02336165|11220727|FG003|Overall Study|Other|1
7098324|NCT02336165|11220728|FG004|Overall Study|Other|0
7098325|NCT02336178|11220744|FG000|Overall Study|Lost to Follow-up|1
7098326|NCT02336178|11220744|FG000|Overall Study|Protocol Violation|1
7098327|NCT02336178|11220744|FG000|Overall Study|Withdrawal by Subject|1
7098328|NCT02336178|11220744|FG000|Overall Study|Other|1
7098329|NCT02336282|11220756|FG000|Overall Study|Unrelated illness|1
7098330|NCT02336282|11220756|FG000|Overall Study|Uncomfortable with technology|1
7098331|NCT02336282|11220756|FG000|Overall Study|Lost to Follow-up|1
7098332|NCT02336282|11220756|FG000|Overall Study|Not enough time to complete sessions|2
7098333|NCT02336373|11220772|FG000|Overall Study|Protocol closed early|4
7098334|NCT02336373|11220772|FG000|Overall Study|Physician Decision|14
7098335|NCT02336451|11220787|FG000|Overall Study|Adverse Event|1
7098336|NCT02336451|11220788|FG001|Overall Study|Adverse Event|2
7098337|NCT02336451|11220789|FG002|Overall Study|Adverse Event|0
7098338|NCT02336451|11220790|FG003|Overall Study|Adverse Event|6
7098339|NCT02336451|11220791|FG004|Overall Study|Adverse Event|4
7098340|NCT02336451|11220787|FG000|Overall Study|Death|6
7098341|NCT02336451|11220788|FG001|Overall Study|Death|2
7098342|NCT02336451|11220789|FG002|Overall Study|Death|3
7098343|NCT02336451|11220790|FG003|Overall Study|Death|6
7098344|NCT02336451|11220791|FG004|Overall Study|Death|6
7098345|NCT02336451|11220787|FG000|Overall Study|Physician Decision|9
7098346|NCT02336451|11220788|FG001|Overall Study|Physician Decision|6
7098347|NCT02336451|11220789|FG002|Overall Study|Physician Decision|7
7098348|NCT02336451|11220790|FG003|Overall Study|Physician Decision|16
7098349|NCT02336451|11220791|FG004|Overall Study|Physician Decision|3
7098350|NCT02336451|11220787|FG000|Overall Study|Progressive disease|23
7098351|NCT02336451|11220788|FG001|Overall Study|Progressive disease|26
7098352|NCT02336451|11220789|FG002|Overall Study|Progressive disease|2
7098353|NCT02336451|11220790|FG003|Overall Study|Progressive disease|14
7098354|NCT02336451|11220791|FG004|Overall Study|Progressive disease|4
7098355|NCT02336451|11220787|FG000|Overall Study|Protocol Violation|1
7098356|NCT02336451|11220788|FG001|Overall Study|Protocol Violation|0
7098357|NCT02336451|11220789|FG002|Overall Study|Protocol Violation|0
7098358|NCT02336451|11220790|FG003|Overall Study|Protocol Violation|0
7098359|NCT02336451|11220791|FG004|Overall Study|Protocol Violation|0
7098360|NCT02336451|11220787|FG000|Overall Study|Patient/guardian decision|2
7098361|NCT02336451|11220788|FG001|Overall Study|Patient/guardian decision|4
7098362|NCT02336451|11220789|FG002|Overall Study|Patient/guardian decision|0
7098363|NCT02336451|11220790|FG003|Overall Study|Patient/guardian decision|2
7098364|NCT02336451|11220791|FG004|Overall Study|Patient/guardian decision|1
7098365|NCT02336555|11220807|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7098366|NCT02336555|11220808|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
7098367|NCT02336555|11220807|FG000|Treatment Period 1 (28 Days)|Physician Decision|2
7098368|NCT02336555|11220808|FG001|Treatment Period 1 (28 Days)|Physician Decision|0
7098369|NCT02336555|11220807|FG000|Treatment Period 2 (28 Days)|Adverse Event|0
7098370|NCT02336555|11220808|FG001|Treatment Period 2 (28 Days)|Adverse Event|1
7098371|NCT02336607|11220838|FG000|Overall Study|Physician Decision|1
7098372|NCT02336607|11220839|FG001|Overall Study|Physician Decision|4
7098373|NCT02336607|11220840|FG002|Overall Study|Physician Decision|3
7098374|NCT02336607|11220841|FG003|Overall Study|Physician Decision|15
7098375|NCT02336607|11220838|FG000|Overall Study|Lack of Efficacy|1
7098376|NCT02336607|11220839|FG001|Overall Study|Lack of Efficacy|0
7098377|NCT02336607|11220840|FG002|Overall Study|Lack of Efficacy|0
7098378|NCT02336607|11220841|FG003|Overall Study|Lack of Efficacy|2
7098379|NCT02336607|11220838|FG000|Overall Study|Lost to Follow-up|2
7098380|NCT02336607|11220839|FG001|Overall Study|Lost to Follow-up|1
7098381|NCT02336607|11220840|FG002|Overall Study|Lost to Follow-up|0
7098382|NCT02336607|11220841|FG003|Overall Study|Lost to Follow-up|21
7098383|NCT02336607|11220838|FG000|Overall Study|Protocol Violation|0
7098384|NCT02336607|11220839|FG001|Overall Study|Protocol Violation|1
7098385|NCT02336607|11220840|FG002|Overall Study|Protocol Violation|1
7098386|NCT02336607|11220841|FG003|Overall Study|Protocol Violation|3
7098387|NCT02336607|11220838|FG000|Overall Study|Adverse Event|0
7098388|NCT02336607|11220839|FG001|Overall Study|Adverse Event|2
7098389|NCT02336607|11220840|FG002|Overall Study|Adverse Event|2
7098390|NCT02336607|11220841|FG003|Overall Study|Adverse Event|26
7098391|NCT02336607|11220838|FG000|Overall Study|Withdrawal by Subject|0
7098392|NCT02336607|11220839|FG001|Overall Study|Withdrawal by Subject|2
7098393|NCT02336607|11220840|FG002|Overall Study|Withdrawal by Subject|0
7098394|NCT02336607|11220841|FG003|Overall Study|Withdrawal by Subject|20
7098395|NCT02336737|11220851|FG000|Overall Study|Withdrawal by Subject|5
7098396|NCT02336737|11220851|FG000|Overall Study|Physician Decision|8
7098397|NCT02336815|11220858|FG000|Overall Study|Disease Progression|45
7098398|NCT02336815|11220859|FG001|Overall Study|Disease Progression|70
7098399|NCT02336815|11220858|FG000|Overall Study|Adverse Event|18
7098400|NCT02336815|11220859|FG001|Overall Study|Adverse Event|39
7098401|NCT02336815|11220858|FG000|Overall Study|Physician Decision|11
7098402|NCT02336815|11220859|FG001|Overall Study|Physician Decision|4
7098403|NCT02336815|11220858|FG000|Overall Study|Withdrawal by Subject|3
7098404|NCT02336815|11220859|FG001|Overall Study|Withdrawal by Subject|2
7098405|NCT02336815|11220858|FG000|Overall Study|Lost to Follow-up|1
7098406|NCT02336815|11220859|FG001|Overall Study|Lost to Follow-up|3
7098407|NCT02336815|11220858|FG000|Overall Study|Other|1
7098408|NCT02336815|11220859|FG001|Overall Study|Other|5
7098409|NCT02337361|11220898|FG000|3-month Follow-up|Lost to Follow-up|19
7098410|NCT02337361|11220899|FG001|3-month Follow-up|Lost to Follow-up|14
7098411|NCT02337361|11220898|FG000|6-month Follow-up|Lost to Follow-up|2
7098412|NCT02337361|11220899|FG001|6-month Follow-up|Lost to Follow-up|4
7098413|NCT02337387|11220910|FG000|Overall Study|Adverse Event|0
7098414|NCT02337387|11220911|FG001|Overall Study|Adverse Event|1
7098415|NCT02337387|11220912|FG002|Overall Study|Adverse Event|0
7098416|NCT02337387|11220913|FG003|Overall Study|Adverse Event|0
7098417|NCT02337387|11220910|FG000|Overall Study|Sponsor Decision to Terminate Study|14
7098418|NCT02337387|11220911|FG001|Overall Study|Sponsor Decision to Terminate Study|7
7098419|NCT02337387|11220912|FG002|Overall Study|Sponsor Decision to Terminate Study|3
7098420|NCT02337387|11220913|FG003|Overall Study|Sponsor Decision to Terminate Study|3
7098421|NCT02337478|11220927|FG000|Overall Study|Lack of Efficacy|5
7098422|NCT02337491|11220933|FG000|Overall Study|Death|1
7098423|NCT02337491|11220934|FG001|Overall Study|Death|1
7098424|NCT02337491|11220933|FG000|Overall Study|Adverse Event|0
7098425|NCT02337491|11220934|FG001|Overall Study|Adverse Event|1
7098426|NCT02337491|11220933|FG000|Overall Study|Withdrawal by Subject|3
7098427|NCT02337491|11220934|FG001|Overall Study|Withdrawal by Subject|0
7098428|NCT02337491|11220933|FG000|Overall Study|Progressive Disease|44
7098429|NCT02337491|11220934|FG001|Overall Study|Progressive Disease|28
7098430|NCT02337491|11220933|FG000|Overall Study|On Treatment|2
7098431|NCT02337491|11220934|FG001|Overall Study|On Treatment|0
7098432|NCT02337907|11220964|FG000|Overall Study|Other than listed|1
7098433|NCT02337907|11220965|FG001|Overall Study|Other than listed|0
7098434|NCT02337907|11220966|FG002|Overall Study|Other than listed|0
7098435|NCT02337907|11220967|FG003|Overall Study|Other than listed|1
7098436|NCT02337907|11220968|FG004|Overall Study|Other than listed|1
7098437|NCT02337907|11220969|FG005|Overall Study|Other than listed|0
7098438|NCT02337907|11220964|FG000|Overall Study|Withdrawal by Subject|2
7098439|NCT02337907|11220965|FG001|Overall Study|Withdrawal by Subject|3
7098440|NCT02337907|11220966|FG002|Overall Study|Withdrawal by Subject|0
7098441|NCT02337907|11220967|FG003|Overall Study|Withdrawal by Subject|2
7098442|NCT02337907|11220968|FG004|Overall Study|Withdrawal by Subject|5
7098443|NCT02337907|11220969|FG005|Overall Study|Withdrawal by Subject|0
7098444|NCT02337907|11220964|FG000|Overall Study|Lost to Follow-up|0
7098445|NCT02337907|11220965|FG001|Overall Study|Lost to Follow-up|0
7098446|NCT02337907|11220966|FG002|Overall Study|Lost to Follow-up|0
7098447|NCT02337907|11220967|FG003|Overall Study|Lost to Follow-up|0
7098448|NCT02337907|11220968|FG004|Overall Study|Lost to Follow-up|0
7098449|NCT02337907|11220969|FG005|Overall Study|Lost to Follow-up|1
7098450|NCT02337907|11220964|FG000|Overall Study|Adverse Event|1
7098451|NCT02337907|11220965|FG001|Overall Study|Adverse Event|1
7098452|NCT02337907|11220966|FG002|Overall Study|Adverse Event|1
7098453|NCT02337907|11220967|FG003|Overall Study|Adverse Event|1
7098454|NCT02337907|11220968|FG004|Overall Study|Adverse Event|4
7098455|NCT02337907|11220969|FG005|Overall Study|Adverse Event|0
7098456|NCT02337946|11220993|FG000|Protocol Treatment 1 Period|Adverse Event|7
7098457|NCT02337946|11220994|FG001|Protocol Treatment 1 Period|Adverse Event|0
7098458|NCT02337946|11220995|FG002|Protocol Treatment 1 Period|Adverse Event|0
7098459|NCT02337946|11220993|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1
7098460|NCT02337946|11220994|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0
7098461|NCT02337946|11220995|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0
7098462|NCT02337946|11220993|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6
7098463|NCT02337946|11220994|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0
7098464|NCT02337946|11220995|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0
7098465|NCT02337946|11220993|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15
7098466|NCT02337946|11220994|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0
7098467|NCT02337946|11220995|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0
7098468|NCT02337946|11220993|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3
7098469|NCT02337946|11220994|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0
7098470|NCT02337946|11220995|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0
7098471|NCT02337946|11220993|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9
7098472|NCT02337946|11220994|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0
7098473|NCT02337946|11220995|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0
7098474|NCT02337946|11220993|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1
7098475|NCT02337946|11220994|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0
7098476|NCT02337946|11220995|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0
7098477|NCT02337946|11220993|FG000|Protocol Treatment 1 Period|Reason not specified|8
7098478|NCT02337946|11220994|FG001|Protocol Treatment 1 Period|Reason not specified|0
7098479|NCT02337946|11220995|FG002|Protocol Treatment 1 Period|Reason not specified|0
7098480|NCT02337946|11220993|FG000|In-between Period|Without Informed Consent|1
7098481|NCT02337946|11220994|FG001|In-between Period|Without Informed Consent|0
7098482|NCT02337946|11220995|FG002|In-between Period|Without Informed Consent|0
7098483|NCT02337946|11220993|FG000|Protocol Treatment 2 Period|Adverse Event|0
7098484|NCT02337946|11220994|FG001|Protocol Treatment 2 Period|Adverse Event|9
7098485|NCT02337946|11220995|FG002|Protocol Treatment 2 Period|Adverse Event|9
7098486|NCT02337946|11220993|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0
7098487|NCT02337946|11220994|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3
7098488|NCT02337946|11220995|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1
7098489|NCT02337946|11220993|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0
6805691|NCT02921776|10807886|FG001|Overall Study|patient deterioration, fatigue|6
7098490|NCT02337946|11220994|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29
7098491|NCT02337946|11220995|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29
7098492|NCT02337946|11220993|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0
7098493|NCT02337946|11220994|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1
7098494|NCT02337946|11220995|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0
7098495|NCT02337946|11220993|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0
7098496|NCT02337946|11220994|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5
7098497|NCT02337946|11220995|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7
7098498|NCT02337946|11220993|FG000|Protocol Treatment 2 Period|Reason not specified|0
7098499|NCT02337946|11220994|FG001|Protocol Treatment 2 Period|Reason not specified|4
7098500|NCT02337946|11220995|FG002|Protocol Treatment 2 Period|Reason not specified|4
7098501|NCT02338154|11221020|FG000|Overall Study|Death|46
7098502|NCT02338154|11221020|FG000|Overall Study|Valve Implant Failure|17
7098503|NCT02338154|11221020|FG000|Overall Study|Valve Explant|11
7098504|NCT02338154|11221020|FG000|Overall Study|Withdrawal by Subject or by Investigator|10
7098505|NCT02338154|11221020|FG000|Overall Study|Lost to Follow-up|8
7098506|NCT02338154|11221020|FG000|Overall Study|Other Reason|3
7098507|NCT02338154|11221020|FG000|Overall Study|Patients Without Exit Form|47
7098508|NCT02338154|11221020|FG000|Overall Study|Missing Exit Reason on Exit Form|1
7098509|NCT02338193|11221035|FG000|Overall Study|Withdrawal by Subject|0
7098510|NCT02338193|11221036|FG001|Overall Study|Withdrawal by Subject|0
7098511|NCT02338193|11221037|FG002|Overall Study|Withdrawal by Subject|2
7098512|NCT02338193|11221035|FG000|Overall Study|Pregnancy|0
7098513|NCT02338193|11221036|FG001|Overall Study|Pregnancy|1
7098514|NCT02338193|11221037|FG002|Overall Study|Pregnancy|1
7098515|NCT02338193|11221035|FG000|Overall Study|Noncompliant with visits|2
7098516|NCT02338193|11221036|FG001|Overall Study|Noncompliant with visits|2
7098517|NCT02338193|11221037|FG002|Overall Study|Noncompliant with visits|7
7098518|NCT02338193|11221035|FG000|Overall Study|moved out of state|0
7098519|NCT02338193|11221036|FG001|Overall Study|moved out of state|1
7098520|NCT02338193|11221037|FG002|Overall Study|moved out of state|0
7098521|NCT02338193|11221035|FG000|Overall Study|intolerant of side effects|1
7098522|NCT02338193|11221036|FG001|Overall Study|intolerant of side effects|0
7098523|NCT02338193|11221037|FG002|Overall Study|intolerant of side effects|0
7098524|NCT02338362|11221058|FG000|Overall Study|Withdrawal by Subject|1
7098525|NCT02338362|11221059|FG001|Overall Study|Withdrawal by Subject|1
7098526|NCT02338492|11221065|FG000|Overall Study|Death|32
7098527|NCT02338492|11221065|FG000|Overall Study|Adverse Event|3
7098528|NCT02338492|11221065|FG000|Overall Study|Lost to Follow-up|4
7098529|NCT02338492|11221065|FG000|Overall Study|Reason not captured above|6
7098530|NCT02338843|11221077|FG000|Overall Study|Adverse Event|2
7098531|NCT02338843|11221078|FG001|Overall Study|Adverse Event|1
7098532|NCT02338843|11221077|FG000|Overall Study|Death|40
7098533|NCT02338843|11221078|FG001|Overall Study|Death|53
7098534|NCT02338843|11221077|FG000|Overall Study|Physician Decision|1
7098535|NCT02338843|11221078|FG001|Overall Study|Physician Decision|0
7098536|NCT02338843|11221077|FG000|Overall Study|Withdrawal by Subject|0
7098537|NCT02338843|11221078|FG001|Overall Study|Withdrawal by Subject|2
7098538|NCT02338843|11221077|FG000|Overall Study|Subject Recovered|0
7098539|NCT02338843|11221078|FG001|Overall Study|Subject Recovered|2
7098540|NCT02338843|11221077|FG000|Overall Study|Discontinued prior to randomizat|1
7098541|NCT02338843|11221078|FG001|Overall Study|Discontinued prior to randomizat|0
7098542|NCT02338882|11221086|FG000|Overall Study|Death|1
7098543|NCT02338882|11221087|FG001|Overall Study|Death|0
7098544|NCT02338882|11221086|FG000|Overall Study|Lost to Follow-up|6
7098545|NCT02338882|11221087|FG001|Overall Study|Lost to Follow-up|3
7098546|NCT02338999|11221193|FG000|First Intervention|Withdrawal by Subject|3
7098547|NCT02338999|11221194|FG001|First Intervention|Withdrawal by Subject|1
7098548|NCT02338999|11221193|FG000|Washout Period|Withdrawal by Subject|0
7098549|NCT02338999|11221194|FG001|Washout Period|Withdrawal by Subject|2
7098550|NCT02338999|11221193|FG000|Second Intervention|Withdrawal by Subject|0
7098551|NCT02338999|11221194|FG001|Second Intervention|Withdrawal by Subject|2
7098552|NCT02339155|11221206|FG000|Overall Study|Adverse Event|0
7098553|NCT02339155|11221207|FG001|Overall Study|Adverse Event|6
7098554|NCT02339155|11221206|FG000|Overall Study|Death|1
7098555|NCT02339155|11221207|FG001|Overall Study|Death|1
7098556|NCT02339155|11221206|FG000|Overall Study|Lost to Follow-up|8
7098557|NCT02339155|11221207|FG001|Overall Study|Lost to Follow-up|9
7098558|NCT02339155|11221206|FG000|Overall Study|Physician Decision|2
7098559|NCT02339155|11221207|FG001|Overall Study|Physician Decision|1
7098560|NCT02339155|11221206|FG000|Overall Study|Withdrawal by Subject|4
7098561|NCT02339155|11221207|FG001|Overall Study|Withdrawal by Subject|4
7098562|NCT02339285|11221230|FG000|Overall Study|Withdrawal by Subject|0
7098563|NCT02339285|11221231|FG001|Overall Study|Withdrawal by Subject|1
7098564|NCT02339285|11221232|FG002|Overall Study|Withdrawal by Subject|1
7098565|NCT02339285|11221230|FG000|Overall Study|Lost to Follow-up|1
7098566|NCT02339285|11221231|FG001|Overall Study|Lost to Follow-up|1
7098567|NCT02339285|11221232|FG002|Overall Study|Lost to Follow-up|1
7098568|NCT02339285|11221230|FG000|Overall Study|Protocol Deviation|0
7098569|NCT02339285|11221231|FG001|Overall Study|Protocol Deviation|1
7098570|NCT02339285|11221232|FG002|Overall Study|Protocol Deviation|0
7098571|NCT02339506|11221256|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0
7098572|NCT02339506|11221257|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1
7098573|NCT02339506|11221256|FG000|Washout (Period 2)|Withdrawal by Subject|2
7098574|NCT02339506|11221257|FG001|Washout (Period 2)|Withdrawal by Subject|0
7098575|NCT02339584|11221274|FG000|Overall Study|Adverse Event|11
7098576|NCT02339584|11221275|FG001|Overall Study|Adverse Event|7
7098577|NCT02339584|11221274|FG000|Overall Study|Lack of Efficacy|0
7098578|NCT02339584|11221275|FG001|Overall Study|Lack of Efficacy|1
7098579|NCT02339584|11221274|FG000|Overall Study|Physician Decision|1
7098580|NCT02339584|11221275|FG001|Overall Study|Physician Decision|2
7098581|NCT02339584|11221274|FG000|Overall Study|Protocol Violation|1
7098582|NCT02339584|11221275|FG001|Overall Study|Protocol Violation|1
7098583|NCT02339584|11221274|FG000|Overall Study|Withdrawal by Subject|2
7098584|NCT02339584|11221275|FG001|Overall Study|Withdrawal by Subject|4
7098585|NCT02339909|11221293|FG000|Overall Study|Became ineligible after randomisation|89
7098586|NCT02339909|11221294|FG001|Overall Study|Became ineligible after randomisation|63
7098587|NCT02339909|11221295|FG002|Overall Study|Became ineligible after randomisation|71
7098588|NCT02340000|11221305|FG000|Time Period 1|Withdrawal by Subject|6
7098589|NCT02340000|11221306|FG001|Time Period 1|Withdrawal by Subject|8
7098590|NCT02340000|11221305|FG000|Time Period 1|Lost to Follow-up|6
7098591|NCT02340000|11221306|FG001|Time Period 1|Lost to Follow-up|7
7098592|NCT02340000|11221305|FG000|Time Period 2|Withdrawal by Subject|9
7098593|NCT02340000|11221306|FG001|Time Period 2|Withdrawal by Subject|7
7098594|NCT02340000|11221305|FG000|Time Period 2|Lost to Follow-up|10
7098595|NCT02340000|11221306|FG001|Time Period 2|Lost to Follow-up|8
7098596|NCT02340078|11221319|FG000|Overall Study|Protocol Violation|1
7098597|NCT02340520|11221376|FG000|Overall Study|Lost to Follow-up|1
7098598|NCT02340520|11221376|FG000|Overall Study|Patient did not take drug as specified|1
7098599|NCT02340520|11221376|FG000|Overall Study|Withdrawal by Subject|1
7098600|NCT02340663|11221382|FG000|Overall Study|Lost to Follow-up|1
7098601|NCT02340663|11221383|FG001|Overall Study|Lost to Follow-up|0
7098602|NCT02340663|11221382|FG000|Overall Study|Protocol Violation|1
7098603|NCT02340663|11221383|FG001|Overall Study|Protocol Violation|0
7098604|NCT02340663|11221382|FG000|Overall Study|Withdrawal by Subject|3
7098605|NCT02340663|11221383|FG001|Overall Study|Withdrawal by Subject|1
7098606|NCT02340780|11221425|FG000|Overall Study|Ineligible|1
7098607|NCT02340806|11221431|FG000|Overall Study|Protocol Violation|2
7098608|NCT02340806|11221432|FG001|Overall Study|Protocol Violation|0
7098609|NCT02340806|11221431|FG000|Overall Study|epidural catheter replaced|2
7098610|NCT02340806|11221432|FG001|Overall Study|epidural catheter replaced|1
7098611|NCT02340806|11221431|FG000|Overall Study|history of chronic pain medication|1
7098612|NCT02340806|11221432|FG001|Overall Study|history of chronic pain medication|0
7098613|NCT02340806|11221431|FG000|Overall Study|re-dose < 90 min of CSE|1
7098614|NCT02340806|11221432|FG001|Overall Study|re-dose < 90 min of CSE|3
7098615|NCT02340819|11221438|FG000|Overall Study|Adverse Event|1
7098616|NCT02340819|11221438|FG000|Overall Study|Withdrawal by Subject|2
7098617|NCT02340819|11221438|FG000|Overall Study|Discontinued with other reason|1
7098618|NCT02340949|11221444|FG000|Overall Study|Adverse Event|4
7098619|NCT02340949|11221445|FG001|Overall Study|Adverse Event|2
7098620|NCT02340949|11221444|FG000|Overall Study|Withdrawal by Subject|2
7098621|NCT02340949|11221445|FG001|Overall Study|Withdrawal by Subject|0
7098622|NCT02340949|11221444|FG000|Overall Study|Progression disease|6
7098623|NCT02340949|11221445|FG001|Overall Study|Progression disease|2
7098624|NCT02340949|11221444|FG000|Overall Study|Death|3
7098625|NCT02340949|11221445|FG001|Overall Study|Death|0
7098626|NCT02340949|11221444|FG000|Overall Study|Physician Decision|1
7098627|NCT02340949|11221445|FG001|Overall Study|Physician Decision|0
7098628|NCT02340962|11221453|FG000|Overall Study|Lost to Follow-up|1
7098629|NCT02340962|11221454|FG001|Overall Study|Lost to Follow-up|0
7098630|NCT02340975|11221466|FG000|Overall Study|Death|6
7098631|NCT02340975|11221467|FG001|Overall Study|Death|23
7098632|NCT02340975|11221468|FG002|Overall Study|Death|21
7098633|NCT02340975|11221469|FG003|Overall Study|Death|7
7098634|NCT02340975|11221470|FG004|Overall Study|Death|21
7098635|NCT02340975|11221471|FG005|Overall Study|Death|13
7098636|NCT02340975|11221466|FG000|Overall Study|Lost to Follow-up|0
7098637|NCT02340975|11221467|FG001|Overall Study|Lost to Follow-up|0
7098638|NCT02340975|11221468|FG002|Overall Study|Lost to Follow-up|0
7098639|NCT02340975|11221469|FG003|Overall Study|Lost to Follow-up|0
7098640|NCT02340975|11221470|FG004|Overall Study|Lost to Follow-up|2
7098641|NCT02340975|11221471|FG005|Overall Study|Lost to Follow-up|0
7098642|NCT02340975|11221466|FG000|Overall Study|Withdrawal by Subject|0
7098643|NCT02340975|11221467|FG001|Overall Study|Withdrawal by Subject|0
7098644|NCT02340975|11221468|FG002|Overall Study|Withdrawal by Subject|3
7098645|NCT02340975|11221469|FG003|Overall Study|Withdrawal by Subject|3
7098646|NCT02340975|11221470|FG004|Overall Study|Withdrawal by Subject|2
7098647|NCT02340975|11221471|FG005|Overall Study|Withdrawal by Subject|0
7098648|NCT02340975|11221466|FG000|Overall Study|Other|0
7098649|NCT02340975|11221467|FG001|Overall Study|Other|4
7098650|NCT02340975|11221468|FG002|Overall Study|Other|0
7098651|NCT02340975|11221469|FG003|Overall Study|Other|2
7098652|NCT02340975|11221470|FG004|Overall Study|Other|0
7098653|NCT02340975|11221471|FG005|Overall Study|Other|6
7098654|NCT02341417|11221498|FG000|Overall Study|Withdrawal by Subject|0
7098655|NCT02341417|11221499|FG001|Overall Study|Withdrawal by Subject|2
7098656|NCT02341417|11221500|FG002|Overall Study|Withdrawal by Subject|0
7098657|NCT02341417|11221498|FG000|Overall Study|Decision by sponsor|2
7098658|NCT02341417|11221499|FG001|Overall Study|Decision by sponsor|0
7098659|NCT02341417|11221500|FG002|Overall Study|Decision by sponsor|0
7098660|NCT02341417|11221498|FG000|Overall Study|Death|0
7098661|NCT02341417|11221499|FG001|Overall Study|Death|0
7098662|NCT02341417|11221500|FG002|Overall Study|Death|1
7098663|NCT02341456|11221512|FG000|Overall Study|Disease progression|2
7098664|NCT02341456|11221513|FG001|Overall Study|Disease progression|3
7098665|NCT02341456|11221514|FG002|Overall Study|Disease progression|1
7098666|NCT02341456|11221512|FG000|Overall Study|Death|1
7098667|NCT02341456|11221513|FG001|Overall Study|Death|1
7098668|NCT02341456|11221514|FG002|Overall Study|Death|1
7098669|NCT02341456|11221512|FG000|Overall Study|Withdrawal by Subject|0
7098670|NCT02341456|11221513|FG001|Overall Study|Withdrawal by Subject|1
7098671|NCT02341456|11221514|FG002|Overall Study|Withdrawal by Subject|1
7098672|NCT02341456|11221512|FG000|Overall Study|Moved to local access programme.|0
7098673|NCT02341456|11221513|FG001|Overall Study|Moved to local access programme.|1
7098674|NCT02341456|11221514|FG002|Overall Study|Moved to local access programme.|1
7098675|NCT02341456|11221512|FG000|Overall Study|Physician Decision|1
7098676|NCT02341456|11221513|FG001|Overall Study|Physician Decision|0
7098677|NCT02341456|11221514|FG002|Overall Study|Physician Decision|0
7098678|NCT02341482|11221522|FG000|Overall Study|Adverse Event|1
7098679|NCT02342171|11221575|FG000|Overall Study|Death|4
7098680|NCT02342171|11221576|FG001|Overall Study|Death|87
7098681|NCT02342171|11221575|FG000|Overall Study|Received favipiravir|10
7098682|NCT02342171|11221576|FG001|Overall Study|Received favipiravir|0
7098683|NCT02342171|11221575|FG000|Overall Study|Missing cycle treshold value|1
7098684|NCT02342171|11221576|FG001|Overall Study|Missing cycle treshold value|0
7098685|NCT02342171|11221575|FG000|Overall Study|Unknown outcome|0
7098686|NCT02342171|11221576|FG001|Overall Study|Unknown outcome|1
7098687|NCT02342171|11221575|FG000|Overall Study|Missing age data|0
7098688|NCT02342171|11221576|FG001|Overall Study|Missing age data|1
7098689|NCT02342223|11221590|FG000|Overall Study|Lost to Follow-up|1
7098690|NCT02342288|11221596|FG000|Overall Study|no protocol anesthesiologist available|3
7098691|NCT02342288|11221597|FG001|Overall Study|no protocol anesthesiologist available|2
7098692|NCT02342288|11221596|FG000|Overall Study|anesthesia leak in system|1
7098693|NCT02342288|11221597|FG001|Overall Study|anesthesia leak in system|0
7098694|NCT02342288|11221596|FG000|Overall Study|Withdrawal by Subject|1
7098695|NCT02342288|11221597|FG001|Overall Study|Withdrawal by Subject|0
7098696|NCT02342288|11221596|FG000|Overall Study|coordinator contaminated with blood|0
7098697|NCT02342288|11221597|FG001|Overall Study|coordinator contaminated with blood|1
7098698|NCT02342288|11221596|FG000|Overall Study|subject cannot tolerate numbing drops|0
7098699|NCT02342288|11221597|FG001|Overall Study|subject cannot tolerate numbing drops|1
7098700|NCT02342288|11221596|FG000|Overall Study|coordinator not available|0
7098701|NCT02342288|11221597|FG001|Overall Study|coordinator not available|2
7098702|NCT02342418|11221707|FG000|Overall Study|Adverse Event|0
7098703|NCT02342418|11221708|FG001|Overall Study|Adverse Event|1
7098704|NCT02342548|11221721|FG000|Overall Study|Adverse Event|12
7098705|NCT02342548|11221722|FG001|Overall Study|Adverse Event|17
7098706|NCT02342548|11221723|FG002|Overall Study|Adverse Event|13
7098707|NCT02342548|11221721|FG000|Overall Study|Lost to Follow-up|0
7098708|NCT02342548|11221722|FG001|Overall Study|Lost to Follow-up|1
7098709|NCT02342548|11221723|FG002|Overall Study|Lost to Follow-up|0
7098710|NCT02342548|11221721|FG000|Overall Study|Study terminated by sponsor|20
7098711|NCT02342548|11221722|FG001|Overall Study|Study terminated by sponsor|39
7098712|NCT02342548|11221723|FG002|Overall Study|Study terminated by sponsor|25
7098713|NCT02342548|11221721|FG000|Overall Study|Protocol Violation|0
7098714|NCT02342548|11221722|FG001|Overall Study|Protocol Violation|1
7098715|NCT02342548|11221723|FG002|Overall Study|Protocol Violation|0
7098716|NCT02342548|11221721|FG000|Overall Study|Withdrawal by Subject|1
7098717|NCT02342548|11221722|FG001|Overall Study|Withdrawal by Subject|3
7098718|NCT02342548|11221723|FG002|Overall Study|Withdrawal by Subject|4
7098719|NCT02342548|11221721|FG000|Overall Study|Other|1
7098720|NCT02342548|11221722|FG001|Overall Study|Other|1
7098721|NCT02342548|11221723|FG002|Overall Study|Other|1
7098722|NCT02342639|11221741|FG000|Overall Study|Acute illness, unrelated to study drug|2
7098723|NCT02342639|11221742|FG001|Overall Study|Acute illness, unrelated to study drug|3
7098724|NCT02342639|11221741|FG000|Overall Study|Protocol Violation|0
7098725|NCT02342639|11221742|FG001|Overall Study|Protocol Violation|2
7098726|NCT02342678|11221752|FG000|Overall Study|Lost to Follow-up|0
7098727|NCT02342678|11221753|FG001|Overall Study|Lost to Follow-up|1
7098728|NCT02342678|11221752|FG000|Overall Study|Too busy to complete study|0
7098729|NCT02342678|11221753|FG001|Overall Study|Too busy to complete study|2
7098730|NCT02342678|11221752|FG000|Overall Study|Family illness/emergency|0
7098731|NCT02342678|11221753|FG001|Overall Study|Family illness/emergency|1
7098732|NCT02342678|11221752|FG000|Overall Study|Illness/medical reason|1
7098733|NCT02342678|11221753|FG001|Overall Study|Illness/medical reason|1
7098734|NCT02342704|11221761|FG000|Overall Study|Physician Decision|0
7098735|NCT02342704|11221762|FG001|Overall Study|Physician Decision|3
7098736|NCT02342704|11221761|FG000|Overall Study|Sponsor Termination|49
7098737|NCT02342704|11221762|FG001|Overall Study|Sponsor Termination|43
7098738|NCT02342704|11221761|FG000|Overall Study|Other|0
7098739|NCT02342704|11221762|FG001|Overall Study|Other|1
7098740|NCT02342704|11221761|FG000|Overall Study|Withdrawal by Subject|1
7098741|NCT02342704|11221762|FG001|Overall Study|Withdrawal by Subject|0
7098742|NCT02342704|11221761|FG000|Overall Study|Lost to Follow-up|2
7098743|NCT02342704|11221762|FG001|Overall Study|Lost to Follow-up|1
7098744|NCT02342704|11221761|FG000|Overall Study|Adverse Event|1
7098745|NCT02342704|11221762|FG001|Overall Study|Adverse Event|3
7098746|NCT02342743|11221768|FG000|Baseline Period|Withdrawal by Subject|3
7098747|NCT02342743|11221768|FG000|Baseline Period|Lost to Follow-up|2
7098748|NCT02342743|11221768|FG000|Baseline Period|Change in prophylactic medication|3
7098749|NCT02342743|11221768|FG000|Baseline Period|Screening failure regarding baseline|7
7098750|NCT02342743|11221768|FG000|Treatment Period|Withdrawal by Subject|2
7098751|NCT02342743|11221768|FG000|Treatment Period|Lost to Follow-up|8
7098752|NCT02342743|11221768|FG000|Treatment Period|Change in prophylactic medication|1
7098753|NCT02342886|11221777|FG000|Overall Study|Treatment non-compliance|1
7098754|NCT02342886|11221778|FG001|Overall Study|Treatment non-compliance|0
7098755|NCT02342886|11221779|FG002|Overall Study|Treatment non-compliance|0
7098756|NCT02342886|11221780|FG003|Overall Study|Treatment non-compliance|1
7098757|NCT02342886|11221781|FG004|Overall Study|Treatment non-compliance|0
7098758|NCT02342886|11221777|FG000|Overall Study|Late exclusion: rifampicin resistance|1
7098759|NCT02342886|11221778|FG001|Overall Study|Late exclusion: rifampicin resistance|0
7098760|NCT02342886|11221779|FG002|Overall Study|Late exclusion: rifampicin resistance|0
7098761|NCT02342886|11221780|FG003|Overall Study|Late exclusion: rifampicin resistance|0
7098762|NCT02342886|11221781|FG004|Overall Study|Late exclusion: rifampicin resistance|0
7098763|NCT02342886|11221777|FG000|Overall Study|Adverse event/specific toxicity|4
7098764|NCT02342886|11221778|FG001|Overall Study|Adverse event/specific toxicity|3
7098765|NCT02342886|11221779|FG002|Overall Study|Adverse event/specific toxicity|11
7098766|NCT02342886|11221780|FG003|Overall Study|Adverse event/specific toxicity|2
7098767|NCT02342886|11221781|FG004|Overall Study|Adverse event/specific toxicity|1
7098768|NCT02342886|11221777|FG000|Overall Study|Lost to Follow-up|1
7098769|NCT02342886|11221778|FG001|Overall Study|Lost to Follow-up|0
7098770|NCT02342886|11221779|FG002|Overall Study|Lost to Follow-up|0
7098771|NCT02342886|11221780|FG003|Overall Study|Lost to Follow-up|0
7098772|NCT02342886|11221781|FG004|Overall Study|Lost to Follow-up|0
7098773|NCT02342886|11221777|FG000|Overall Study|Death|1
7098774|NCT02342886|11221778|FG001|Overall Study|Death|2
7098775|NCT02342886|11221779|FG002|Overall Study|Death|1
7098776|NCT02342886|11221780|FG003|Overall Study|Death|0
7098777|NCT02342886|11221781|FG004|Overall Study|Death|1
7098778|NCT02342886|11221777|FG000|Overall Study|Withdrawal by Subject|0
7098779|NCT02342886|11221778|FG001|Overall Study|Withdrawal by Subject|1
7098780|NCT02342886|11221779|FG002|Overall Study|Withdrawal by Subject|0
7098781|NCT02342886|11221780|FG003|Overall Study|Withdrawal by Subject|1
7098782|NCT02342886|11221781|FG004|Overall Study|Withdrawal by Subject|0
7098783|NCT02342886|11221777|FG000|Overall Study|Investigator/sponsor decision|0
7098784|NCT02342886|11221778|FG001|Overall Study|Investigator/sponsor decision|2
7098785|NCT02342886|11221779|FG002|Overall Study|Investigator/sponsor decision|0
7098786|NCT02342886|11221780|FG003|Overall Study|Investigator/sponsor decision|3
7098787|NCT02342886|11221781|FG004|Overall Study|Investigator/sponsor decision|1
7098788|NCT02342886|11221777|FG000|Overall Study|Pregnancy|0
7098789|NCT02342886|11221778|FG001|Overall Study|Pregnancy|0
7098790|NCT02342886|11221779|FG002|Overall Study|Pregnancy|2
7098791|NCT02342886|11221780|FG003|Overall Study|Pregnancy|0
7098792|NCT02342886|11221781|FG004|Overall Study|Pregnancy|0
7098793|NCT02342886|11221777|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0
7098794|NCT02342886|11221778|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0
7098795|NCT02342886|11221779|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1
7098796|NCT02342886|11221780|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0
7098797|NCT02342886|11221781|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0
7098798|NCT02342886|11221777|FG000|Overall Study|Protocol Violation|0
7098799|NCT02342886|11221778|FG001|Overall Study|Protocol Violation|0
7098800|NCT02342886|11221779|FG002|Overall Study|Protocol Violation|0
7098801|NCT02342886|11221780|FG003|Overall Study|Protocol Violation|2
7098802|NCT02342886|11221781|FG004|Overall Study|Protocol Violation|0
7098803|NCT02343003|11221795|FG000|Overall Study|Withdrawal by Subject|9
7098804|NCT02343003|11221796|FG001|Overall Study|Withdrawal by Subject|4
7098805|NCT02343003|11221795|FG000|Overall Study|Lost to Follow-up|5
7098806|NCT02343003|11221796|FG001|Overall Study|Lost to Follow-up|1
7098807|NCT02343003|11221795|FG000|Overall Study|Protocol Violation|1
7098808|NCT02343003|11221796|FG001|Overall Study|Protocol Violation|0
7098809|NCT02343003|11221795|FG000|Overall Study|Death|0
7098810|NCT02343003|11221796|FG001|Overall Study|Death|1
7098811|NCT02343003|11221795|FG000|Overall Study|exclusion criteria met|1
7098812|NCT02343003|11221796|FG001|Overall Study|exclusion criteria met|1
7098813|NCT02343003|11221795|FG000|Overall Study|terminated by sponsor|2
7098814|NCT02343003|11221796|FG001|Overall Study|terminated by sponsor|0
7098815|NCT02343406|11221844|FG000|Overall Study|Progressive disease|72
7098816|NCT02343406|11221845|FG001|Overall Study|Progressive disease|70
7098817|NCT02343406|11221846|FG002|Overall Study|Progressive disease|43
7098818|NCT02343406|11221847|FG003|Overall Study|Progressive disease|15
7098819|NCT02343406|11221848|FG004|Overall Study|Progressive disease|5
7098820|NCT02343406|11221844|FG000|Overall Study|Adverse Event|6
7098821|NCT02343406|11221845|FG001|Overall Study|Adverse Event|8
7098822|NCT02343406|11221846|FG002|Overall Study|Adverse Event|6
7098823|NCT02343406|11221847|FG003|Overall Study|Adverse Event|3
7098824|NCT02343406|11221848|FG004|Overall Study|Adverse Event|0
7098825|NCT02343406|11221844|FG000|Overall Study|Withdrawal by Subject|6
7098826|NCT02343406|11221845|FG001|Overall Study|Withdrawal by Subject|4
7098827|NCT02343406|11221846|FG002|Overall Study|Withdrawal by Subject|8
7098828|NCT02343406|11221847|FG003|Overall Study|Withdrawal by Subject|3
7098829|NCT02343406|11221848|FG004|Overall Study|Withdrawal by Subject|0
7098830|NCT02343406|11221844|FG000|Overall Study|Death|2
7098831|NCT02343406|11221845|FG001|Overall Study|Death|1
7098832|NCT02343406|11221846|FG002|Overall Study|Death|0
7098833|NCT02343406|11221847|FG003|Overall Study|Death|0
7098834|NCT02343406|11221848|FG004|Overall Study|Death|0
7098835|NCT02343406|11221844|FG000|Overall Study|Start of a new anti-cancer treatment|0
7098836|NCT02343406|11221845|FG001|Overall Study|Start of a new anti-cancer treatment|1
7098837|NCT02343406|11221846|FG002|Overall Study|Start of a new anti-cancer treatment|0
7098838|NCT02343406|11221847|FG003|Overall Study|Start of a new anti-cancer treatment|1
7098839|NCT02343406|11221848|FG004|Overall Study|Start of a new anti-cancer treatment|0
7098840|NCT02343406|11221844|FG000|Overall Study|Other primary malignancy|0
7098841|NCT02343406|11221845|FG001|Overall Study|Other primary malignancy|1
7098842|NCT02343406|11221846|FG002|Overall Study|Other primary malignancy|0
7098843|NCT02343406|11221847|FG003|Overall Study|Other primary malignancy|0
7098844|NCT02343406|11221848|FG004|Overall Study|Other primary malignancy|0
7098845|NCT02343406|11221844|FG000|Overall Study|Other, not specified|2
7098846|NCT02343406|11221845|FG001|Overall Study|Other, not specified|1
7098847|NCT02343406|11221846|FG002|Overall Study|Other, not specified|1
7098848|NCT02343406|11221847|FG003|Overall Study|Other, not specified|4
7098849|NCT02343406|11221848|FG004|Overall Study|Other, not specified|0
7098850|NCT02343458|11221863|FG000|Overall Study|Adverse Event|15
7098851|NCT02343458|11221864|FG001|Overall Study|Adverse Event|14
7098852|NCT02343458|11221865|FG002|Overall Study|Adverse Event|15
7098853|NCT02343458|11221866|FG003|Overall Study|Adverse Event|3
7098854|NCT02343458|11221863|FG000|Overall Study|Lack of Efficacy|3
7098855|NCT02343458|11221864|FG001|Overall Study|Lack of Efficacy|8
7098856|NCT02343458|11221865|FG002|Overall Study|Lack of Efficacy|4
7098857|NCT02343458|11221866|FG003|Overall Study|Lack of Efficacy|8
7098858|NCT02343458|11221863|FG000|Overall Study|Withdrawal by Subject|18
7098859|NCT02343458|11221864|FG001|Overall Study|Withdrawal by Subject|17
7098860|NCT02343458|11221865|FG002|Overall Study|Withdrawal by Subject|23
7098861|NCT02343458|11221866|FG003|Overall Study|Withdrawal by Subject|14
7098862|NCT02343458|11221863|FG000|Overall Study|Physician Decision|1
7098863|NCT02343458|11221864|FG001|Overall Study|Physician Decision|4
7098864|NCT02343458|11221865|FG002|Overall Study|Physician Decision|2
7098865|NCT02343458|11221866|FG003|Overall Study|Physician Decision|2
7098866|NCT02343458|11221863|FG000|Overall Study|Lost to Follow-up|5
7098867|NCT02343458|11221864|FG001|Overall Study|Lost to Follow-up|5
7098868|NCT02343458|11221865|FG002|Overall Study|Lost to Follow-up|3
7098869|NCT02343458|11221866|FG003|Overall Study|Lost to Follow-up|1
7098870|NCT02343458|11221863|FG000|Overall Study|Protocol Violation|2
7098871|NCT02343458|11221864|FG001|Overall Study|Protocol Violation|5
7098872|NCT02343458|11221865|FG002|Overall Study|Protocol Violation|2
7098873|NCT02343458|11221866|FG003|Overall Study|Protocol Violation|2
7098874|NCT02343458|11221863|FG000|Overall Study|Protocol Specified Criteria|17
7098875|NCT02343458|11221864|FG001|Overall Study|Protocol Specified Criteria|13
7098876|NCT02343458|11221865|FG002|Overall Study|Protocol Specified Criteria|14
7098877|NCT02343458|11221866|FG003|Overall Study|Protocol Specified Criteria|8
7098878|NCT02343939|11221903|FG000|Overall Study|Death|0
7098879|NCT02343939|11221904|FG001|Overall Study|Death|15
7098880|NCT02343939|11221905|FG002|Overall Study|Death|4
7098881|NCT02343939|11221906|FG003|Overall Study|Death|2
7098882|NCT02343939|11221907|FG004|Overall Study|Death|5
7098883|NCT02343939|11221908|FG005|Overall Study|Death|11
7098884|NCT02343939|11221909|FG006|Overall Study|Death|8
7098885|NCT02343939|11221910|FG007|Overall Study|Death|22
7098886|NCT02343939|11221911|FG008|Overall Study|Death|1
7098887|NCT02343939|11221903|FG000|Overall Study|Study terminated by sponsor|0
7098888|NCT02343939|11221904|FG001|Overall Study|Study terminated by sponsor|27
7098889|NCT02343939|11221905|FG002|Overall Study|Study terminated by sponsor|0
7098890|NCT02343939|11221906|FG003|Overall Study|Study terminated by sponsor|1
7098891|NCT02343939|11221907|FG004|Overall Study|Study terminated by sponsor|1
7098892|NCT02343939|11221908|FG005|Overall Study|Study terminated by sponsor|5
7098893|NCT02343939|11221909|FG006|Overall Study|Study terminated by sponsor|3
7098894|NCT02343939|11221910|FG007|Overall Study|Study terminated by sponsor|4
7098895|NCT02343939|11221911|FG008|Overall Study|Study terminated by sponsor|0
7098896|NCT02343939|11221903|FG000|Overall Study|Withdrew consent|3
7098897|NCT02343939|11221904|FG001|Overall Study|Withdrew consent|6
7098898|NCT02343939|11221905|FG002|Overall Study|Withdrew consent|1
7098899|NCT02343939|11221906|FG003|Overall Study|Withdrew consent|2
7098900|NCT02343939|11221907|FG004|Overall Study|Withdrew consent|2
7098901|NCT02343939|11221908|FG005|Overall Study|Withdrew consent|0
7098902|NCT02343939|11221909|FG006|Overall Study|Withdrew consent|0
7098903|NCT02343939|11221910|FG007|Overall Study|Withdrew consent|8
7098904|NCT02343939|11221911|FG008|Overall Study|Withdrew consent|6
7098905|NCT02343939|11221903|FG000|Overall Study|Treatment failure|0
7098906|NCT02343939|11221904|FG001|Overall Study|Treatment failure|0
7098907|NCT02343939|11221905|FG002|Overall Study|Treatment failure|0
7098908|NCT02343939|11221906|FG003|Overall Study|Treatment failure|0
7098909|NCT02343939|11221907|FG004|Overall Study|Treatment failure|0
7098910|NCT02343939|11221908|FG005|Overall Study|Treatment failure|0
7098911|NCT02343939|11221909|FG006|Overall Study|Treatment failure|2
7098912|NCT02343939|11221910|FG007|Overall Study|Treatment failure|1
7098913|NCT02343939|11221911|FG008|Overall Study|Treatment failure|0
7098914|NCT02343939|11221903|FG000|Overall Study|Investigator's discretion|0
7098915|NCT02343939|11221904|FG001|Overall Study|Investigator's discretion|0
7098916|NCT02343939|11221905|FG002|Overall Study|Investigator's discretion|0
7098917|NCT02343939|11221906|FG003|Overall Study|Investigator's discretion|1
7098918|NCT02343939|11221907|FG004|Overall Study|Investigator's discretion|0
7098919|NCT02343939|11221908|FG005|Overall Study|Investigator's discretion|0
7098920|NCT02343939|11221909|FG006|Overall Study|Investigator's discretion|1
7098921|NCT02343939|11221910|FG007|Overall Study|Investigator's discretion|0
7098922|NCT02343939|11221911|FG008|Overall Study|Investigator's discretion|0
7098923|NCT02343939|11221903|FG000|Overall Study|Adverse Event|0
7098924|NCT02343939|11221904|FG001|Overall Study|Adverse Event|0
7098925|NCT02343939|11221905|FG002|Overall Study|Adverse Event|0
7098926|NCT02343939|11221906|FG003|Overall Study|Adverse Event|0
7098927|NCT02343939|11221907|FG004|Overall Study|Adverse Event|0
7098928|NCT02343939|11221908|FG005|Overall Study|Adverse Event|1
7098929|NCT02343939|11221909|FG006|Overall Study|Adverse Event|0
7098930|NCT02343939|11221910|FG007|Overall Study|Adverse Event|0
7098931|NCT02343939|11221911|FG008|Overall Study|Adverse Event|0
7098932|NCT02343939|11221903|FG000|Overall Study|Never Treated With ENTO|0
7098933|NCT02343939|11221904|FG001|Overall Study|Never Treated With ENTO|0
7098934|NCT02343939|11221905|FG002|Overall Study|Never Treated With ENTO|0
7098935|NCT02343939|11221906|FG003|Overall Study|Never Treated With ENTO|0
7098936|NCT02343939|11221907|FG004|Overall Study|Never Treated With ENTO|0
7098937|NCT02343939|11221908|FG005|Overall Study|Never Treated With ENTO|0
7098938|NCT02343939|11221909|FG006|Overall Study|Never Treated With ENTO|1
7098939|NCT02343939|11221910|FG007|Overall Study|Never Treated With ENTO|2
7098940|NCT02343939|11221911|FG008|Overall Study|Never Treated With ENTO|0
7098941|NCT02344004|11221947|FG000|Overall Study|Adverse Event|11
7098942|NCT02344004|11221948|FG001|Overall Study|Adverse Event|1
7098943|NCT02344004|11221947|FG000|Overall Study|Death|9
7098944|NCT02344004|11221948|FG001|Overall Study|Death|7
7098945|NCT02344004|11221947|FG000|Overall Study|Physician Decision|4
7098946|NCT02344004|11221948|FG001|Overall Study|Physician Decision|1
7098947|NCT02344004|11221947|FG000|Overall Study|Withdrawal by Subject|22
7098948|NCT02344004|11221948|FG001|Overall Study|Withdrawal by Subject|5
7098949|NCT02344004|11221947|FG000|Overall Study|Rescue Medication|2
7098950|NCT02344004|11221948|FG001|Overall Study|Rescue Medication|0
7098951|NCT02344004|11221947|FG000|Overall Study|Other Not Specified|12
7098952|NCT02344004|11221948|FG001|Overall Study|Other Not Specified|0
7098953|NCT02344004|11221947|FG000|Overall Study|Protocol Violation|1
7098954|NCT02344004|11221948|FG001|Overall Study|Protocol Violation|0
7098955|NCT02344173|11221955|FG000|Procedure|Ablation Procedure Not Performed|7
7098956|NCT02344173|11221955|FG000|12-month Visit|Death|8
7098957|NCT02344173|11221955|FG000|12-month Visit|Withdrawal by Subject|30
7098958|NCT02344173|11221955|FG000|12-month Visit|Lost to Follow-up|58
7098959|NCT02344342|11222015|FG000|Overall Study|Industry partner dropped out|11
7098960|NCT02344342|11222016|FG001|Overall Study|Industry partner dropped out|9
7098961|NCT02344342|11222017|FG002|Overall Study|Industry partner dropped out|14
7098962|NCT02344342|11222018|FG003|Overall Study|Industry partner dropped out|10
7098963|NCT02344576|11222049|FG000|Enrollment|Agreed to Medical Record Review Only|7
7098964|NCT02344576|11222050|FG001|Enrollment|Agreed to Medical Record Review Only|8
7098965|NCT02344576|11222051|FG002|Enrollment|Agreed to Medical Record Review Only|0
7098966|NCT02344576|11222052|FG003|Enrollment|Agreed to Medical Record Review Only|0
7098967|NCT02344576|11222049|FG000|1-Month Follow-Up|Death|13
7098968|NCT02344576|11222050|FG001|1-Month Follow-Up|Death|8
7098969|NCT02344576|11222051|FG002|1-Month Follow-Up|Death|0
7098970|NCT02344576|11222052|FG003|1-Month Follow-Up|Death|0
7098971|NCT02344576|11222049|FG000|1-Month Follow-Up|Withdrawal by Subject|3
7098972|NCT02344576|11222050|FG001|1-Month Follow-Up|Withdrawal by Subject|14
7098973|NCT02344576|11222051|FG002|1-Month Follow-Up|Withdrawal by Subject|8
7098974|NCT02344576|11222052|FG003|1-Month Follow-Up|Withdrawal by Subject|10
7098975|NCT02344576|11222049|FG000|1-Month Follow-Up|Lost to Follow-up|2
7098976|NCT02344576|11222050|FG001|1-Month Follow-Up|Lost to Follow-up|5
7098977|NCT02344576|11222051|FG002|1-Month Follow-Up|Lost to Follow-up|11
7098978|NCT02344576|11222052|FG003|1-Month Follow-Up|Lost to Follow-up|3
7098979|NCT02344576|11222049|FG000|6-Month Follow-Up|Death|14
7098980|NCT02344576|11222050|FG001|6-Month Follow-Up|Death|14
7098981|NCT02344576|11222051|FG002|6-Month Follow-Up|Death|0
7098982|NCT02344576|11222052|FG003|6-Month Follow-Up|Death|0
7098983|NCT02344576|11222049|FG000|6-Month Follow-Up|Withdrawal by Subject|1
7098984|NCT02344576|11222050|FG001|6-Month Follow-Up|Withdrawal by Subject|0
7098985|NCT02344576|11222051|FG002|6-Month Follow-Up|Withdrawal by Subject|1
7098986|NCT02344576|11222052|FG003|6-Month Follow-Up|Withdrawal by Subject|2
7098987|NCT02344576|11222049|FG000|6-Month Follow-Up|Lost to Follow-up|4
7098988|NCT02344576|11222050|FG001|6-Month Follow-Up|Lost to Follow-up|5
7098989|NCT02344576|11222051|FG002|6-Month Follow-Up|Lost to Follow-up|13
7098990|NCT02344576|11222052|FG003|6-Month Follow-Up|Lost to Follow-up|6
7098991|NCT02344745|11222075|FG000|Overall Study|Data collection sheets were lost|2
7098992|NCT02344745|11222076|FG001|Overall Study|Data collection sheets were lost|0
7098993|NCT02345161|11222095|FG000|Overall Study|Withdrawal by Subject|25
7098994|NCT02345161|11222096|FG001|Overall Study|Withdrawal by Subject|33
7098995|NCT02345161|11222095|FG000|Overall Study|Adverse Event|16
7098996|NCT02345161|11222096|FG001|Overall Study|Adverse Event|19
7098997|NCT02345161|11222095|FG000|Overall Study|Physician Decision|4
7098998|NCT02345161|11222096|FG001|Overall Study|Physician Decision|4
7098999|NCT02345161|11222095|FG000|Overall Study|Lost to Follow-up|0
7099000|NCT02345161|11222096|FG001|Overall Study|Lost to Follow-up|1
7099001|NCT02345226|11222109|FG000|Double-Blind Phase|Adverse Event|5
7099002|NCT02345226|11222110|FG001|Double-Blind Phase|Adverse Event|6
7099003|NCT02345226|11222109|FG000|Double-Blind Phase|Death|3
7099004|NCT02345226|11222110|FG001|Double-Blind Phase|Death|0
7099005|NCT02345226|11222109|FG000|Double-Blind Phase|Pregnancy|0
7099006|NCT02345226|11222110|FG001|Double-Blind Phase|Pregnancy|1
7099007|NCT02345226|11222109|FG000|Double-Blind Phase|Lack of Efficacy|1
7099008|NCT02345226|11222110|FG001|Double-Blind Phase|Lack of Efficacy|0
7099009|NCT02345226|11222109|FG000|Double-Blind Phase|Investigator's Discretion|4
7099010|NCT02345226|11222110|FG001|Double-Blind Phase|Investigator's Discretion|3
7099011|NCT02345226|11222109|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1
7099012|NCT02345226|11222110|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2
7099013|NCT02345226|11222109|FG000|Double-Blind Phase|Withdrew Consent|41
7099014|NCT02345226|11222110|FG001|Double-Blind Phase|Withdrew Consent|39
7099015|NCT02345226|11222109|FG000|Double-Blind Phase|Lost to Follow-up|12
7099016|NCT02345226|11222110|FG001|Double-Blind Phase|Lost to Follow-up|16
7099017|NCT02345226|11222109|FG000|Double-Blind Phase|Randomized but Never Treated|2
7099018|NCT02345226|11222110|FG001|Double-Blind Phase|Randomized but Never Treated|4
7099019|NCT02345226|11222109|FG000|Open-Label Extension Phase|Lost to Follow-up|0
7099020|NCT02345226|11222110|FG001|Open-Label Extension Phase|Lost to Follow-up|1
7099021|NCT02345252|11222120|FG000|Double-Blind Phase|Adverse Event|2
7099022|NCT02345252|11222121|FG001|Double-Blind Phase|Adverse Event|3
7099023|NCT02345252|11222120|FG000|Double-Blind Phase|Death|1
7099024|NCT02345252|11222121|FG001|Double-Blind Phase|Death|2
7099025|NCT02345252|11222120|FG000|Double-Blind Phase|Lack of Efficacy|1
7099026|NCT02345252|11222121|FG001|Double-Blind Phase|Lack of Efficacy|0
7099027|NCT02345252|11222120|FG000|Double-Blind Phase|Investigator's Discretion|4
7099028|NCT02345252|11222121|FG001|Double-Blind Phase|Investigator's Discretion|6
7099029|NCT02345252|11222120|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1
7099030|NCT02345252|11222121|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2
7099031|NCT02345252|11222120|FG000|Double-Blind Phase|Protocol Violation|2
7099032|NCT02345252|11222121|FG001|Double-Blind Phase|Protocol Violation|1
7099033|NCT02345252|11222120|FG000|Double-Blind Phase|Withdrew Consent|21
7099034|NCT02345252|11222121|FG001|Double-Blind Phase|Withdrew Consent|23
7099035|NCT02345252|11222120|FG000|Double-Blind Phase|Lost to Follow-up|8
7099036|NCT02345252|11222121|FG001|Double-Blind Phase|Lost to Follow-up|10
7099037|NCT02345252|11222120|FG000|Double-Blind Phase|Randomized but Never Treated|0
7099038|NCT02345252|11222121|FG001|Double-Blind Phase|Randomized but Never Treated|2
7099039|NCT02345330|11222129|FG000|Overall Study|Death|1
7099040|NCT02345330|11222129|FG000|Overall Study|Progressive Disease|2
7099041|NCT02345434|11222135|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5
7099042|NCT02345434|11222136|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2
7099043|NCT02345512|11222151|FG000|Overall Study|Adverse Event|1
7099044|NCT02345512|11222151|FG000|Overall Study|Withdrawal by Subject|1
7099045|NCT02345811|11222173|FG000|First Intervention|Withdrawal by Subject|1
7099046|NCT02345811|11222174|FG001|First Intervention|Withdrawal by Subject|1
7099047|NCT02345889|11222186|FG000|Overall Study|Inadequate Bowel Prep|17
7099048|NCT02345889|11222187|FG001|Overall Study|Inadequate Bowel Prep|16
7099049|NCT02345889|11222188|FG002|Overall Study|Inadequate Bowel Prep|18
7099050|NCT02345889|11222189|FG003|Overall Study|Inadequate Bowel Prep|14
7099051|NCT02345889|11222186|FG000|Overall Study|Polyposis identified during procedure|1
7099052|NCT02345889|11222187|FG001|Overall Study|Polyposis identified during procedure|1
7099053|NCT02345889|11222188|FG002|Overall Study|Polyposis identified during procedure|0
7099054|NCT02345889|11222189|FG003|Overall Study|Polyposis identified during procedure|1
7099055|NCT02345889|11222186|FG000|Overall Study|Recognized ineligible post-randomization|1
7099056|NCT02345889|11222187|FG001|Overall Study|Recognized ineligible post-randomization|0
7099057|NCT02345889|11222188|FG002|Overall Study|Recognized ineligible post-randomization|2
7099058|NCT02345889|11222189|FG003|Overall Study|Recognized ineligible post-randomization|1
7099059|NCT02345889|11222186|FG000|Overall Study|Ulcerative Colitis identified|1
7099060|NCT02345889|11222187|FG001|Overall Study|Ulcerative Colitis identified|0
7099061|NCT02345889|11222188|FG002|Overall Study|Ulcerative Colitis identified|0
7099062|NCT02345889|11222189|FG003|Overall Study|Ulcerative Colitis identified|0
7099063|NCT02345889|11222186|FG000|Overall Study|Cecum not intubated|1
7099064|NCT02345889|11222187|FG001|Overall Study|Cecum not intubated|0
7099065|NCT02345889|11222188|FG002|Overall Study|Cecum not intubated|0
7099066|NCT02345889|11222189|FG003|Overall Study|Cecum not intubated|0
7099067|NCT02346136|11222201|FG000|Overall Study|Withdrawal by Subject|7
7099068|NCT02346136|11222202|FG001|Overall Study|Withdrawal by Subject|5
7099069|NCT02346136|11222201|FG000|Overall Study|Death|1
7099070|NCT02346136|11222202|FG001|Overall Study|Death|0
7099071|NCT02346136|11222201|FG000|Overall Study|Study termination|14
7099072|NCT02346136|11222202|FG001|Overall Study|Study termination|18
7099073|NCT02346240|11222212|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0
7099074|NCT02346240|11222213|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4
7099075|NCT02346240|11222214|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1
7099076|NCT02346240|11222215|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1
7099077|NCT02346240|11222216|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0
7099078|NCT02346240|11222217|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0
7099079|NCT02346240|11222218|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0
7099080|NCT02346240|11222219|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0
7099081|NCT02346240|11222220|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0
7099082|NCT02346240|11222221|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0
7099083|NCT02346240|11222222|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0
7099084|NCT02346240|11222223|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0
7099085|NCT02346240|11222224|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0
7099086|NCT02346240|11222225|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0
7099087|NCT02346240|11222226|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0
7099088|NCT02346240|11222227|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0
7099089|NCT02346240|11222228|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0
7099090|NCT02346240|11222229|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0
7099091|NCT02346240|11222230|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0
7099092|NCT02346240|11222231|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0
7099093|NCT02346240|11222232|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0
7099094|NCT02346240|11222233|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0
7099095|NCT02346240|11222234|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0
7099096|NCT02346240|11222235|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0
7099097|NCT02346240|11222212|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7099098|NCT02346240|11222213|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1
7099099|NCT02346240|11222214|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7099100|NCT02346240|11222215|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7099101|NCT02346240|11222216|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7099102|NCT02346240|11222217|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7099103|NCT02346240|11222218|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7099104|NCT02346240|11222219|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7099105|NCT02346240|11222220|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7099106|NCT02346240|11222221|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7099107|NCT02346240|11222222|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7099108|NCT02346240|11222223|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7099109|NCT02346240|11222224|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7099110|NCT02346240|11222225|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7099111|NCT02346240|11222226|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7099112|NCT02346240|11222227|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7099113|NCT02346240|11222228|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7099114|NCT02346240|11222229|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7099115|NCT02346240|11222230|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7099116|NCT02346240|11222231|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7099117|NCT02346240|11222232|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7099118|NCT02346240|11222233|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7099119|NCT02346240|11222234|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7099120|NCT02346240|11222235|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7099121|NCT02346240|11222212|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0
7099122|NCT02346240|11222213|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1
7099123|NCT02346240|11222214|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0
7099124|NCT02346240|11222215|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0
7099125|NCT02346240|11222216|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0
7099126|NCT02346240|11222217|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0
7099127|NCT02346240|11222218|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0
7099128|NCT02346240|11222219|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0
7099129|NCT02346240|11222220|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0
7099130|NCT02346240|11222221|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0
7099131|NCT02346240|11222222|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0
7099132|NCT02346240|11222223|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0
7099133|NCT02346240|11222224|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0
7099134|NCT02346240|11222225|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0
7099135|NCT02346240|11222226|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0
7099136|NCT02346240|11222227|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0
7099137|NCT02346240|11222228|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0
7099138|NCT02346240|11222229|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0
7099139|NCT02346240|11222230|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0
7099140|NCT02346240|11222231|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0
7099141|NCT02346240|11222232|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0
7099142|NCT02346240|11222233|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0
7099143|NCT02346240|11222234|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0
7099144|NCT02346240|11222235|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0
7099145|NCT02346240|11222212|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1
7099146|NCT02346240|11222213|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2
7099147|NCT02346240|11222214|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1
7099148|NCT02346240|11222215|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3
7099149|NCT02346240|11222216|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7099150|NCT02346240|11222217|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7099151|NCT02346240|11222218|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7099152|NCT02346240|11222219|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7099153|NCT02346240|11222220|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7099154|NCT02346240|11222221|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7099155|NCT02346240|11222222|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7099156|NCT02346240|11222223|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7099157|NCT02346240|11222224|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7099158|NCT02346240|11222225|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7099159|NCT02346240|11222226|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7099160|NCT02346240|11222227|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7099161|NCT02346240|11222228|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7099162|NCT02346240|11222229|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7099163|NCT02346240|11222230|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7099164|NCT02346240|11222231|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7099165|NCT02346240|11222232|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7099166|NCT02346240|11222233|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7099167|NCT02346240|11222234|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7099168|NCT02346240|11222235|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7099169|NCT02346240|11222212|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1
7099170|NCT02346240|11222213|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2
7099171|NCT02346240|11222214|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3
7099172|NCT02346240|11222215|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2
7099173|NCT02346240|11222216|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7099174|NCT02346240|11222217|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7099175|NCT02346240|11222218|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7099176|NCT02346240|11222219|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7099177|NCT02346240|11222220|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7099178|NCT02346240|11222221|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7099179|NCT02346240|11222222|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7099180|NCT02346240|11222223|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7099181|NCT02346240|11222224|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7099182|NCT02346240|11222225|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7099183|NCT02346240|11222226|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7099184|NCT02346240|11222227|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7099185|NCT02346240|11222228|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7099186|NCT02346240|11222229|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7099187|NCT02346240|11222230|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7099188|NCT02346240|11222231|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7099189|NCT02346240|11222232|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7099190|NCT02346240|11222233|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7099191|NCT02346240|11222234|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7099192|NCT02346240|11222235|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7099193|NCT02346240|11222212|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0
7099194|NCT02346240|11222213|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1
7099195|NCT02346240|11222214|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0
7099196|NCT02346240|11222215|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1
7099197|NCT02346240|11222216|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0
7099198|NCT02346240|11222217|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0
7099199|NCT02346240|11222218|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0
7099200|NCT02346240|11222219|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0
7099201|NCT02346240|11222220|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0
7099202|NCT02346240|11222221|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0
7099203|NCT02346240|11222222|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0
7099204|NCT02346240|11222223|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0
7099205|NCT02346240|11222224|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0
7099206|NCT02346240|11222225|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0
7099207|NCT02346240|11222226|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0
7099208|NCT02346240|11222227|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0
7099209|NCT02346240|11222228|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0
7099210|NCT02346240|11222229|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0
7099211|NCT02346240|11222230|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0
7099212|NCT02346240|11222231|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0
7099213|NCT02346240|11222232|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0
7099214|NCT02346240|11222233|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0
7099215|NCT02346240|11222234|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0
7099216|NCT02346240|11222235|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0
7099217|NCT02346240|11222212|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7099218|NCT02346240|11222213|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7099219|NCT02346240|11222214|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1
7099220|NCT02346240|11222215|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7099221|NCT02346240|11222216|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7099222|NCT02346240|11222217|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7099223|NCT02346240|11222218|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7099224|NCT02346240|11222219|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7099225|NCT02346240|11222220|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7099226|NCT02346240|11222221|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7099227|NCT02346240|11222222|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7099228|NCT02346240|11222223|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7099229|NCT02346240|11222224|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7099230|NCT02346240|11222225|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7099231|NCT02346240|11222226|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7099232|NCT02346240|11222227|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7099233|NCT02346240|11222228|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7099234|NCT02346240|11222229|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7099235|NCT02346240|11222230|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7099236|NCT02346240|11222231|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7099237|NCT02346240|11222232|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7099238|NCT02346240|11222233|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7099239|NCT02346240|11222234|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7099240|NCT02346240|11222235|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7099241|NCT02346240|11222212|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7099242|NCT02346240|11222213|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7099243|NCT02346240|11222214|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7099244|NCT02346240|11222215|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7099245|NCT02346240|11222216|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7099246|NCT02346240|11222217|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7099247|NCT02346240|11222218|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7099248|NCT02346240|11222219|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
7099249|NCT02346240|11222220|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
7099250|NCT02346240|11222221|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7099251|NCT02346240|11222222|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7099252|NCT02346240|11222223|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7099253|NCT02346240|11222224|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7099254|NCT02346240|11222225|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
7099255|NCT02346240|11222226|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4
7099256|NCT02346240|11222227|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
7099257|NCT02346240|11222228|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
7099258|NCT02346240|11222229|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7099259|NCT02346240|11222230|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7099260|NCT02346240|11222231|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7099261|NCT02346240|11222232|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7099262|NCT02346240|11222233|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7099263|NCT02346240|11222234|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7099264|NCT02346240|11222235|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7099265|NCT02346240|11222212|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7099266|NCT02346240|11222213|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7099267|NCT02346240|11222214|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7099268|NCT02346240|11222215|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7099269|NCT02346240|11222216|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7099270|NCT02346240|11222217|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7099271|NCT02346240|11222218|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7099272|NCT02346240|11222219|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7099273|NCT02346240|11222220|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7099274|NCT02346240|11222221|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7099275|NCT02346240|11222222|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7099276|NCT02346240|11222223|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7099277|NCT02346240|11222224|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7099278|NCT02346240|11222225|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
7099279|NCT02346240|11222226|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7099280|NCT02346240|11222227|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3
7099281|NCT02346240|11222228|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7099282|NCT02346240|11222229|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7099283|NCT02346240|11222230|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7099284|NCT02346240|11222231|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7099285|NCT02346240|11222232|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7099286|NCT02346240|11222233|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7099287|NCT02346240|11222234|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7099288|NCT02346240|11222235|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7099289|NCT02346240|11222212|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7099290|NCT02346240|11222213|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7099291|NCT02346240|11222214|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7099292|NCT02346240|11222215|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7099293|NCT02346240|11222216|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7099294|NCT02346240|11222217|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7099295|NCT02346240|11222218|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7099296|NCT02346240|11222219|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7099297|NCT02346240|11222220|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7099298|NCT02346240|11222221|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7099299|NCT02346240|11222222|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7099300|NCT02346240|11222223|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7099301|NCT02346240|11222224|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7099302|NCT02346240|11222225|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7099303|NCT02346240|11222226|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1
7099304|NCT02346240|11222227|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7099305|NCT02346240|11222228|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7099306|NCT02346240|11222229|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7099307|NCT02346240|11222230|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7099308|NCT02346240|11222231|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7099309|NCT02346240|11222232|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7099310|NCT02346240|11222233|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7099311|NCT02346240|11222234|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7099312|NCT02346240|11222235|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7099313|NCT02346240|11222212|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7099314|NCT02346240|11222213|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7099315|NCT02346240|11222214|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7099316|NCT02346240|11222215|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7099317|NCT02346240|11222216|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7099318|NCT02346240|11222217|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7099319|NCT02346240|11222218|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7099320|NCT02346240|11222219|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7099321|NCT02346240|11222220|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7099322|NCT02346240|11222221|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7099323|NCT02346240|11222222|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7099324|NCT02346240|11222223|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2
7099325|NCT02346240|11222224|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7099326|NCT02346240|11222225|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2
7099327|NCT02346240|11222226|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5
7099328|NCT02346240|11222227|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2
7099329|NCT02346240|11222228|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7099330|NCT02346240|11222229|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7099331|NCT02346240|11222230|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7099332|NCT02346240|11222231|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7099333|NCT02346240|11222232|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7099334|NCT02346240|11222233|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7099335|NCT02346240|11222234|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7099336|NCT02346240|11222235|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7099337|NCT02346240|11222212|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7099338|NCT02346240|11222213|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7099339|NCT02346240|11222214|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7099340|NCT02346240|11222215|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7099341|NCT02346240|11222216|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7099342|NCT02346240|11222217|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7099343|NCT02346240|11222218|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7099344|NCT02346240|11222219|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7099345|NCT02346240|11222220|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7099346|NCT02346240|11222221|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7099347|NCT02346240|11222222|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7099348|NCT02346240|11222223|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7099349|NCT02346240|11222224|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7099350|NCT02346240|11222225|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3
7099351|NCT02346240|11222226|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3
7099352|NCT02346240|11222227|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8
7099353|NCT02346240|11222228|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4
7099354|NCT02346240|11222229|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7099355|NCT02346240|11222230|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7099356|NCT02346240|11222231|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7099357|NCT02346240|11222232|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7099358|NCT02346240|11222233|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7099359|NCT02346240|11222234|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7099360|NCT02346240|11222235|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7099361|NCT02346240|11222212|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7099362|NCT02346240|11222213|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7099363|NCT02346240|11222214|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7099364|NCT02346240|11222215|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7099365|NCT02346240|11222216|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7099366|NCT02346240|11222217|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7099367|NCT02346240|11222218|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1
7099368|NCT02346240|11222219|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7099369|NCT02346240|11222220|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7099370|NCT02346240|11222221|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7099371|NCT02346240|11222222|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7099372|NCT02346240|11222223|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7099373|NCT02346240|11222224|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7099374|NCT02346240|11222225|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7099375|NCT02346240|11222226|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7099376|NCT02346240|11222227|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7099377|NCT02346240|11222228|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7099378|NCT02346240|11222229|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7099379|NCT02346240|11222230|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7099380|NCT02346240|11222231|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7099381|NCT02346240|11222232|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7099382|NCT02346240|11222233|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7099383|NCT02346240|11222234|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7099384|NCT02346240|11222235|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7099385|NCT02346240|11222212|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7099386|NCT02346240|11222213|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7099387|NCT02346240|11222214|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7099388|NCT02346240|11222215|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7099389|NCT02346240|11222216|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7099390|NCT02346240|11222217|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7099391|NCT02346240|11222218|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7099392|NCT02346240|11222219|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7099393|NCT02346240|11222220|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
7099394|NCT02346240|11222221|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7099395|NCT02346240|11222222|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7099396|NCT02346240|11222223|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
7099397|NCT02346240|11222224|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7099398|NCT02346240|11222225|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
7099399|NCT02346240|11222226|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
7099400|NCT02346240|11222227|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7099401|NCT02346240|11222228|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7099402|NCT02346240|11222229|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7099403|NCT02346240|11222230|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7099404|NCT02346240|11222231|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7099405|NCT02346240|11222232|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7099406|NCT02346240|11222233|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7099407|NCT02346240|11222234|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7099408|NCT02346240|11222235|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7099409|NCT02346240|11222212|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7099410|NCT02346240|11222213|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7099411|NCT02346240|11222214|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7099412|NCT02346240|11222215|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7099413|NCT02346240|11222216|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7099414|NCT02346240|11222217|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7099415|NCT02346240|11222218|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7099416|NCT02346240|11222219|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7099417|NCT02346240|11222220|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7099418|NCT02346240|11222221|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1
7099419|NCT02346240|11222222|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7099420|NCT02346240|11222223|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7099421|NCT02346240|11222224|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7099422|NCT02346240|11222225|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7099423|NCT02346240|11222226|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7099424|NCT02346240|11222227|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7099425|NCT02346240|11222228|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7099426|NCT02346240|11222229|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7099427|NCT02346240|11222230|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7099428|NCT02346240|11222231|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7099429|NCT02346240|11222232|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7099430|NCT02346240|11222233|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7099431|NCT02346240|11222234|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7099432|NCT02346240|11222235|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7099433|NCT02346240|11222212|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7099434|NCT02346240|11222213|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7099435|NCT02346240|11222214|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7099436|NCT02346240|11222215|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7099437|NCT02346240|11222216|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7099438|NCT02346240|11222217|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7099439|NCT02346240|11222218|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7099440|NCT02346240|11222219|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7099441|NCT02346240|11222220|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7099442|NCT02346240|11222221|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7099443|NCT02346240|11222222|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1
7099444|NCT02346240|11222223|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7099445|NCT02346240|11222224|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7099446|NCT02346240|11222225|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7099447|NCT02346240|11222226|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7099448|NCT02346240|11222227|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7099449|NCT02346240|11222228|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7099450|NCT02346240|11222229|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7099451|NCT02346240|11222230|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7099452|NCT02346240|11222231|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7099453|NCT02346240|11222232|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7099454|NCT02346240|11222233|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7099455|NCT02346240|11222234|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7099456|NCT02346240|11222235|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7099457|NCT02346240|11222212|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7099458|NCT02346240|11222213|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7099459|NCT02346240|11222214|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7099460|NCT02346240|11222215|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7099461|NCT02346240|11222216|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7099462|NCT02346240|11222217|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7099463|NCT02346240|11222218|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7099464|NCT02346240|11222219|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7099465|NCT02346240|11222220|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7099466|NCT02346240|11222221|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7099467|NCT02346240|11222222|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7099468|NCT02346240|11222223|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7099469|NCT02346240|11222224|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7099470|NCT02346240|11222225|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7099471|NCT02346240|11222226|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1
7099472|NCT02346240|11222227|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7099473|NCT02346240|11222228|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7099474|NCT02346240|11222229|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7099475|NCT02346240|11222230|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7099476|NCT02346240|11222231|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7099477|NCT02346240|11222232|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7099478|NCT02346240|11222233|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7099479|NCT02346240|11222234|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7099480|NCT02346240|11222235|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7099481|NCT02346240|11222212|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7099482|NCT02346240|11222213|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7099483|NCT02346240|11222214|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7099484|NCT02346240|11222215|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7099485|NCT02346240|11222216|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7099486|NCT02346240|11222217|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7099487|NCT02346240|11222218|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7099488|NCT02346240|11222219|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7099489|NCT02346240|11222220|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7099490|NCT02346240|11222221|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7099491|NCT02346240|11222222|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7099492|NCT02346240|11222223|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7099493|NCT02346240|11222224|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7099494|NCT02346240|11222225|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7099495|NCT02346240|11222226|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1
7099496|NCT02346240|11222227|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7099497|NCT02346240|11222228|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7099498|NCT02346240|11222229|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7099499|NCT02346240|11222230|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7099500|NCT02346240|11222231|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7099501|NCT02346240|11222232|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7099502|NCT02346240|11222233|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7099503|NCT02346240|11222234|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7099504|NCT02346240|11222235|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7099505|NCT02346240|11222212|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7099506|NCT02346240|11222213|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7099507|NCT02346240|11222214|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7099508|NCT02346240|11222215|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7099509|NCT02346240|11222216|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7099510|NCT02346240|11222217|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7099511|NCT02346240|11222218|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7099512|NCT02346240|11222219|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7099513|NCT02346240|11222220|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7099514|NCT02346240|11222221|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7099515|NCT02346240|11222222|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7099516|NCT02346240|11222223|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7099517|NCT02346240|11222224|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7099518|NCT02346240|11222225|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7099519|NCT02346240|11222226|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1
7099520|NCT02346240|11222227|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7099521|NCT02346240|11222228|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7099522|NCT02346240|11222229|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7099523|NCT02346240|11222230|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7099524|NCT02346240|11222231|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7099525|NCT02346240|11222232|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7099526|NCT02346240|11222233|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7099527|NCT02346240|11222234|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7099528|NCT02346240|11222235|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7099529|NCT02346240|11222212|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7099530|NCT02346240|11222213|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7099531|NCT02346240|11222214|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7099532|NCT02346240|11222215|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7099533|NCT02346240|11222216|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7099534|NCT02346240|11222217|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7099535|NCT02346240|11222218|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7099536|NCT02346240|11222219|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7099537|NCT02346240|11222220|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7099538|NCT02346240|11222221|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7099539|NCT02346240|11222222|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7099540|NCT02346240|11222223|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7099541|NCT02346240|11222224|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7099542|NCT02346240|11222225|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7099543|NCT02346240|11222226|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7099544|NCT02346240|11222227|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7099545|NCT02346240|11222228|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7099546|NCT02346240|11222229|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1
7099547|NCT02346240|11222230|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6
7099548|NCT02346240|11222231|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2
7099549|NCT02346240|11222232|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3
7099550|NCT02346240|11222233|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13
7099551|NCT02346240|11222234|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3
7099552|NCT02346240|11222235|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3
7099553|NCT02346240|11222212|FG000|Open-Label Period (Week 48 to Week 144)|Death|0
7099554|NCT02346240|11222213|FG001|Open-Label Period (Week 48 to Week 144)|Death|0
7099555|NCT02346240|11222214|FG002|Open-Label Period (Week 48 to Week 144)|Death|0
7099556|NCT02346240|11222215|FG003|Open-Label Period (Week 48 to Week 144)|Death|0
7099557|NCT02346240|11222216|FG004|Open-Label Period (Week 48 to Week 144)|Death|0
7099558|NCT02346240|11222217|FG005|Open-Label Period (Week 48 to Week 144)|Death|0
7099559|NCT02346240|11222218|FG006|Open-Label Period (Week 48 to Week 144)|Death|0
7099560|NCT02346240|11222219|FG007|Open-Label Period (Week 48 to Week 144)|Death|0
7099561|NCT02346240|11222220|FG008|Open-Label Period (Week 48 to Week 144)|Death|0
7099562|NCT02346240|11222221|FG009|Open-Label Period (Week 48 to Week 144)|Death|0
7099563|NCT02346240|11222222|FG010|Open-Label Period (Week 48 to Week 144)|Death|0
7099564|NCT02346240|11222223|FG011|Open-Label Period (Week 48 to Week 144)|Death|0
7099565|NCT02346240|11222224|FG012|Open-Label Period (Week 48 to Week 144)|Death|0
7099566|NCT02346240|11222225|FG013|Open-Label Period (Week 48 to Week 144)|Death|0
7099567|NCT02346240|11222226|FG014|Open-Label Period (Week 48 to Week 144)|Death|0
7099568|NCT02346240|11222227|FG015|Open-Label Period (Week 48 to Week 144)|Death|0
7099569|NCT02346240|11222228|FG016|Open-Label Period (Week 48 to Week 144)|Death|0
7099570|NCT02346240|11222229|FG017|Open-Label Period (Week 48 to Week 144)|Death|0
7099571|NCT02346240|11222230|FG018|Open-Label Period (Week 48 to Week 144)|Death|1
7099572|NCT02346240|11222231|FG019|Open-Label Period (Week 48 to Week 144)|Death|1
7099573|NCT02346240|11222232|FG020|Open-Label Period (Week 48 to Week 144)|Death|0
7099574|NCT02346240|11222233|FG021|Open-Label Period (Week 48 to Week 144)|Death|1
7099575|NCT02346240|11222234|FG022|Open-Label Period (Week 48 to Week 144)|Death|0
7099576|NCT02346240|11222235|FG023|Open-Label Period (Week 48 to Week 144)|Death|0
7099577|NCT02346240|11222212|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7099578|NCT02346240|11222213|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7099579|NCT02346240|11222214|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7099580|NCT02346240|11222215|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7099581|NCT02346240|11222216|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7099582|NCT02346240|11222217|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7099583|NCT02346240|11222218|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7099584|NCT02346240|11222219|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7099585|NCT02346240|11222220|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7099586|NCT02346240|11222221|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7099587|NCT02346240|11222222|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7099588|NCT02346240|11222223|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7099589|NCT02346240|11222224|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7099590|NCT02346240|11222225|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7099591|NCT02346240|11222226|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7099592|NCT02346240|11222227|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7099593|NCT02346240|11222228|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7099594|NCT02346240|11222229|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7099595|NCT02346240|11222230|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1
7099596|NCT02346240|11222231|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7099597|NCT02346240|11222232|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7099598|NCT02346240|11222233|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1
7099599|NCT02346240|11222234|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7099600|NCT02346240|11222235|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7099601|NCT02346240|11222212|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7099602|NCT02346240|11222213|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7099603|NCT02346240|11222214|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7099604|NCT02346240|11222215|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7099605|NCT02346240|11222216|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7099606|NCT02346240|11222217|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7099607|NCT02346240|11222218|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7099608|NCT02346240|11222219|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7099609|NCT02346240|11222220|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7099610|NCT02346240|11222221|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7099611|NCT02346240|11222222|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7099612|NCT02346240|11222223|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7099613|NCT02346240|11222224|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7099614|NCT02346240|11222225|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7099615|NCT02346240|11222226|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7099616|NCT02346240|11222227|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7099617|NCT02346240|11222228|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7099618|NCT02346240|11222229|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7099619|NCT02346240|11222230|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7099620|NCT02346240|11222231|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7099621|NCT02346240|11222232|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7099622|NCT02346240|11222233|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1
7099623|NCT02346240|11222234|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7099624|NCT02346240|11222235|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7099625|NCT02346240|11222212|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7099626|NCT02346240|11222213|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7099627|NCT02346240|11222214|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7099628|NCT02346240|11222215|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7099629|NCT02346240|11222216|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7099630|NCT02346240|11222217|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7099631|NCT02346240|11222218|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7099632|NCT02346240|11222219|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7099633|NCT02346240|11222220|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7099634|NCT02346240|11222221|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7099635|NCT02346240|11222222|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7099636|NCT02346240|11222223|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7099637|NCT02346240|11222224|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7099638|NCT02346240|11222225|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7099639|NCT02346240|11222226|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7099640|NCT02346240|11222227|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7099641|NCT02346240|11222228|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7099642|NCT02346240|11222229|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2
7099643|NCT02346240|11222230|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2
7099644|NCT02346240|11222231|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3
7099645|NCT02346240|11222232|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7099646|NCT02346240|11222233|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1
7099647|NCT02346240|11222234|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1
7099648|NCT02346240|11222235|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1
7099649|NCT02346240|11222212|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7099650|NCT02346240|11222213|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7099651|NCT02346240|11222214|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7099652|NCT02346240|11222215|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7099653|NCT02346240|11222216|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7099654|NCT02346240|11222217|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7099655|NCT02346240|11222218|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7099656|NCT02346240|11222219|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7099657|NCT02346240|11222220|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7099658|NCT02346240|11222221|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7099659|NCT02346240|11222222|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7099660|NCT02346240|11222223|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7099661|NCT02346240|11222224|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7099662|NCT02346240|11222225|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7099663|NCT02346240|11222226|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7099664|NCT02346240|11222227|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7099665|NCT02346240|11222228|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7099666|NCT02346240|11222229|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7099667|NCT02346240|11222230|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4
7099668|NCT02346240|11222231|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1
7099669|NCT02346240|11222232|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7099670|NCT02346240|11222233|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10
7099671|NCT02346240|11222234|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1
7099672|NCT02346240|11222235|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1
7099673|NCT02346240|11222212|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7099674|NCT02346240|11222213|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7099675|NCT02346240|11222214|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7099676|NCT02346240|11222215|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7099677|NCT02346240|11222216|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7099678|NCT02346240|11222217|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7099679|NCT02346240|11222218|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7099680|NCT02346240|11222219|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7099681|NCT02346240|11222220|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7099682|NCT02346240|11222221|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7099683|NCT02346240|11222222|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7099684|NCT02346240|11222223|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7099685|NCT02346240|11222224|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7099686|NCT02346240|11222225|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7099687|NCT02346240|11222226|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7099688|NCT02346240|11222227|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7099689|NCT02346240|11222228|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7099690|NCT02346240|11222229|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7099691|NCT02346240|11222230|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2
7099692|NCT02346240|11222231|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7099693|NCT02346240|11222232|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7099694|NCT02346240|11222233|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4
7099695|NCT02346240|11222234|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2
7099696|NCT02346240|11222235|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3
7099697|NCT02346240|11222212|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7099698|NCT02346240|11222213|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7099699|NCT02346240|11222214|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7099700|NCT02346240|11222215|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7099701|NCT02346240|11222216|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7099702|NCT02346240|11222217|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7099703|NCT02346240|11222218|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7099704|NCT02346240|11222219|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7099705|NCT02346240|11222220|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7099706|NCT02346240|11222221|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7099707|NCT02346240|11222222|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7099708|NCT02346240|11222223|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7099709|NCT02346240|11222224|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7099710|NCT02346240|11222225|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7099711|NCT02346240|11222226|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7099712|NCT02346240|11222227|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7099713|NCT02346240|11222228|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7099714|NCT02346240|11222229|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7099715|NCT02346240|11222230|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1
7099716|NCT02346240|11222231|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7099717|NCT02346240|11222232|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7099718|NCT02346240|11222233|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7099719|NCT02346240|11222234|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7099720|NCT02346240|11222235|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7099721|NCT02346370|11222260|FG000|Overall Study|Not treated|1
7099722|NCT02346370|11222261|FG001|Overall Study|Not treated|0
7099723|NCT02346370|11222262|FG002|Overall Study|Not treated|0
7099724|NCT02346370|11222260|FG000|Overall Study|Withdrawal of consent|1
7099725|NCT02346370|11222261|FG001|Overall Study|Withdrawal of consent|0
7099726|NCT02346370|11222262|FG002|Overall Study|Withdrawal of consent|0
7099727|NCT02346370|11222260|FG000|Overall Study|Death|1
7099728|NCT02346370|11222261|FG001|Overall Study|Death|3
7099729|NCT02346370|11222262|FG002|Overall Study|Death|1
7099730|NCT02346370|11222260|FG000|Overall Study|Sponsor discontinued study|5
7099731|NCT02346370|11222261|FG001|Overall Study|Sponsor discontinued study|0
7099732|NCT02346370|11222262|FG002|Overall Study|Sponsor discontinued study|2
7099733|NCT02346370|11222260|FG000|Overall Study|Radiologic progression|0
7099734|NCT02346370|11222261|FG001|Overall Study|Radiologic progression|0
7099735|NCT02346370|11222262|FG002|Overall Study|Radiologic progression|1
7099736|NCT02346370|11222260|FG000|Overall Study|Physician Decision|0
7099737|NCT02346370|11222261|FG001|Overall Study|Physician Decision|1
7099738|NCT02346370|11222262|FG002|Overall Study|Physician Decision|0
7099739|NCT02346708|11222296|FG000|Overall Study|Adverse Event|2
7099740|NCT02346708|11222297|FG001|Overall Study|Adverse Event|0
7099741|NCT02346708|11222296|FG000|Overall Study|Protocol Violation|0
7099742|NCT02346708|11222297|FG001|Overall Study|Protocol Violation|1
7099743|NCT02346721|11222304|FG000|Overall Study|Withdrew Consent|3
7099744|NCT02346721|11222304|FG000|Overall Study|Lack of Efficacy|1
7099745|NCT02347072|11222318|FG000|Overall Study|Adverse Event|2
7099746|NCT02347072|11222318|FG000|Overall Study|Withdrawal by Subject|6
7099747|NCT02347072|11222318|FG000|Overall Study|Physician Decision|1
7099748|NCT02347072|11222318|FG000|Overall Study|Lost to Follow-up|2
7099749|NCT02347072|11222318|FG000|Overall Study|Protocol Violation|1
7099750|NCT02347072|11222318|FG000|Overall Study|Disc due to Protocol-specified Criteria|6
7099751|NCT02347085|11222326|FG000|Overall Study|Adverse Event|2
7099752|NCT02347085|11222326|FG000|Overall Study|Lack of Efficacy|1
7099753|NCT02347085|11222326|FG000|Overall Study|Withdrawal by Subject|4
7099754|NCT02347085|11222326|FG000|Overall Study|Lost to Follow-up|1
7099755|NCT02347085|11222326|FG000|Overall Study|Protocol Criteria|2
7099756|NCT02347098|11222334|FG000|Overall Study|Death|1
7099757|NCT02347098|11222335|FG001|Overall Study|Death|0
7099758|NCT02347098|11222334|FG000|Overall Study|Withdrawal by Subject|1
7099759|NCT02347098|11222335|FG001|Overall Study|Withdrawal by Subject|0
7099760|NCT02347098|11222334|FG000|Overall Study|Lost to Follow-up|2
7099761|NCT02347098|11222335|FG001|Overall Study|Lost to Follow-up|2
7099762|NCT02347098|11222334|FG000|Overall Study|Refuse Follow-up Visit|1
7099763|NCT02347098|11222335|FG001|Overall Study|Refuse Follow-up Visit|5
7099764|NCT02347098|11222334|FG000|Overall Study|no visit due to illness|2
7099765|NCT02347098|11222335|FG001|Overall Study|no visit due to illness|1
7099766|NCT02347176|11222354|FG000|Overall Study|Lost to Follow-up|2
7099767|NCT02347176|11222355|FG001|Overall Study|Lost to Follow-up|3
7099768|NCT02347176|11222356|FG002|Overall Study|Lost to Follow-up|1
7099769|NCT02347176|11222357|FG003|Overall Study|Lost to Follow-up|1
7099770|NCT02347176|11222354|FG000|Overall Study|Withdrawal by Subject|9
7099771|NCT02347176|11222355|FG001|Overall Study|Withdrawal by Subject|5
7099772|NCT02347176|11222356|FG002|Overall Study|Withdrawal by Subject|5
7099773|NCT02347176|11222357|FG003|Overall Study|Withdrawal by Subject|3
7099774|NCT02347176|11222354|FG000|Overall Study|Other|1
7099775|NCT02347176|11222355|FG001|Overall Study|Other|2
7099776|NCT02347176|11222356|FG002|Overall Study|Other|2
7099777|NCT02347176|11222357|FG003|Overall Study|Other|0
7099778|NCT02347189|11222367|FG000|Overall Study|No implant attempted of study device|9
7099779|NCT02347189|11222367|FG000|Overall Study|No primary outcome data available|2
7099780|NCT02347332|11222384|FG000|Overall Study|Not treated|5
7099781|NCT02347332|11222385|FG001|Overall Study|Not treated|2
7099782|NCT02347332|11222384|FG000|Overall Study|Progressive disease|141
7099783|NCT02347332|11222385|FG001|Overall Study|Progressive disease|159
7099784|NCT02347332|11222384|FG000|Overall Study|Adverse Event|50
7099785|NCT02347332|11222385|FG001|Overall Study|Adverse Event|41
7099786|NCT02347332|11222384|FG000|Overall Study|Death (Unknown, Various reasons)|6
7099787|NCT02347332|11222385|FG001|Overall Study|Death (Unknown, Various reasons)|6
7099788|NCT02347332|11222384|FG000|Overall Study|Protocol Violation|1
7099789|NCT02347332|11222385|FG001|Overall Study|Protocol Violation|1
7099790|NCT02347332|11222384|FG000|Overall Study|Lost to Follow-up|2
7099791|NCT02347332|11222385|FG001|Overall Study|Lost to Follow-up|1
7099792|NCT02347332|11222384|FG000|Overall Study|Physician Decision|4
7099793|NCT02347332|11222385|FG001|Overall Study|Physician Decision|3
7099794|NCT02347332|11222384|FG000|Overall Study|Withdrawal by Subject|20
7099795|NCT02347332|11222385|FG001|Overall Study|Withdrawal by Subject|14
7099796|NCT02347332|11222384|FG000|Overall Study|Protocol requirement|1
7099797|NCT02347332|11222385|FG001|Overall Study|Protocol requirement|1
7099798|NCT02347332|11222384|FG000|Overall Study|Switch Post-Trial program|0
7099799|NCT02347332|11222385|FG001|Overall Study|Switch Post-Trial program|1
7099800|NCT02347631|11222444|FG000|First Intervention (2 Months)|Adverse Event|1
7099801|NCT02347631|11222445|FG001|First Intervention (2 Months)|Adverse Event|1
7099802|NCT02347631|11222444|FG000|First Intervention (2 Months)|Pregnancy|1
7099803|NCT02347631|11222445|FG001|First Intervention (2 Months)|Pregnancy|0
7099804|NCT02347631|11222444|FG000|First Intervention (2 Months)|Moved out of area|0
7099805|NCT02347631|11222445|FG001|First Intervention (2 Months)|Moved out of area|2
7099806|NCT02347631|11222444|FG000|First Intervention (2 Months)|Lost to Follow-up|5
7099807|NCT02347631|11222445|FG001|First Intervention (2 Months)|Lost to Follow-up|3
7099808|NCT02347631|11222444|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2
7099809|NCT02347631|11222445|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2
7099810|NCT02347631|11222444|FG000|Washout 2 (1 Month)|Lost to Follow-up|0
7099811|NCT02347631|11222445|FG001|Washout 2 (1 Month)|Lost to Follow-up|1
7099812|NCT02347631|11222444|FG000|Second Intervention (2 Months)|Lost to Follow-up|7
7099813|NCT02347631|11222445|FG001|Second Intervention (2 Months)|Lost to Follow-up|4
7099814|NCT02347631|11222444|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6
7099815|NCT02347631|11222445|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0
7099816|NCT02347657|11222455|FG000|Overall Study|Physician Decision|0
7099817|NCT02347657|11222456|FG001|Overall Study|Physician Decision|1
7099818|NCT02347657|11222455|FG000|Overall Study|Adverse Event|8
7099819|NCT02347657|11222456|FG001|Overall Study|Adverse Event|4
7099820|NCT02347657|11222455|FG000|Overall Study|Withdrawal by Subject|6
7099821|NCT02347657|11222456|FG001|Overall Study|Withdrawal by Subject|7
7099822|NCT02347657|11222455|FG000|Overall Study|Randomized but not treated|1
7099823|NCT02347657|11222456|FG001|Overall Study|Randomized but not treated|0
7099824|NCT02347657|11222455|FG000|Overall Study|Other|3
7099825|NCT02347657|11222456|FG001|Overall Study|Other|3
7099826|NCT02347761|11222466|FG000|All Collected|Death|1
7099827|NCT02347761|11222467|FG001|All Collected|Death|0
7099828|NCT02347761|11222468|FG002|All Collected|Death|0
7099829|NCT02347761|11222466|FG000|All Collected|Lost to Follow-up|3
7099830|NCT02347761|11222467|FG001|All Collected|Lost to Follow-up|2
7099831|NCT02347761|11222468|FG002|All Collected|Lost to Follow-up|3
7099832|NCT02347761|11222466|FG000|All Collected|Withdrawal by Subject|11
7099833|NCT02347761|11222467|FG001|All Collected|Withdrawal by Subject|11
7099834|NCT02347761|11222468|FG002|All Collected|Withdrawal by Subject|22
7099835|NCT02347761|11222466|FG000|All Collected|invetigator disretion|2
7099836|NCT02347761|11222467|FG001|All Collected|invetigator disretion|0
7099837|NCT02347761|11222468|FG002|All Collected|invetigator disretion|0
7099838|NCT02347761|11222466|FG000|All Collected|instillation site pain|0
7099839|NCT02347761|11222467|FG001|All Collected|instillation site pain|0
7099840|NCT02347761|11222468|FG002|All Collected|instillation site pain|1
7099841|NCT02347761|11222466|FG000|All Collected|exacerbation of COPD|0
7099842|NCT02347761|11222467|FG001|All Collected|exacerbation of COPD|0
7099843|NCT02347761|11222468|FG002|All Collected|exacerbation of COPD|1
7099844|NCT02347761|11222466|FG000|All Collected|moved/travel|0
7099845|NCT02347761|11222467|FG001|All Collected|moved/travel|1
7099846|NCT02347761|11222468|FG002|All Collected|moved/travel|0
7099847|NCT02347761|11222466|FG000|On Study Treatment|Lack of Efficacy|2
7099848|NCT02347761|11222467|FG001|On Study Treatment|Lack of Efficacy|3
7099849|NCT02347761|11222468|FG002|On Study Treatment|Lack of Efficacy|4
7099850|NCT02347761|11222466|FG000|On Study Treatment|non-compliance with study medication|0
7099851|NCT02347761|11222467|FG001|On Study Treatment|non-compliance with study medication|0
6805692|NCT02921776|10807887|FG002|Overall Study|patient deterioration, fatigue|0
6805693|NCT02921776|10807888|FG003|Overall Study|patient deterioration, fatigue|0
6805694|NCT02921776|10807889|FG004|Overall Study|patient deterioration, fatigue|0
6805695|NCT02921776|10807890|FG005|Overall Study|patient deterioration, fatigue|0
6805696|NCT02921776|10807891|FG006|Overall Study|patient deterioration, fatigue|0
6805697|NCT02921776|10807892|FG007|Overall Study|patient deterioration, fatigue|0
6805698|NCT02921776|10807885|FG000|Overall Study|Withdrawal by Subject|0
6805699|NCT02921776|10807886|FG001|Overall Study|Withdrawal by Subject|2
6805700|NCT02921776|10807887|FG002|Overall Study|Withdrawal by Subject|0
6805701|NCT02921776|10807888|FG003|Overall Study|Withdrawal by Subject|1
6805702|NCT02921776|10807889|FG004|Overall Study|Withdrawal by Subject|1
6805703|NCT02921776|10807890|FG005|Overall Study|Withdrawal by Subject|0
6805704|NCT02921776|10807891|FG006|Overall Study|Withdrawal by Subject|8
6805705|NCT02921776|10807892|FG007|Overall Study|Withdrawal by Subject|1
6805706|NCT02921776|10807885|FG000|Overall Study|Death|0
6805707|NCT02921776|10807886|FG001|Overall Study|Death|0
6805708|NCT02921776|10807887|FG002|Overall Study|Death|0
6805709|NCT02921776|10807888|FG003|Overall Study|Death|2
6805710|NCT02921776|10807889|FG004|Overall Study|Death|0
6805711|NCT02921776|10807890|FG005|Overall Study|Death|0
6805712|NCT02921776|10807891|FG006|Overall Study|Death|0
6805713|NCT02921776|10807892|FG007|Overall Study|Death|0
6805714|NCT02921776|10807885|FG000|Overall Study|extubation or early discharge|0
6805715|NCT02921776|10807886|FG001|Overall Study|extubation or early discharge|0
6805716|NCT02921776|10807887|FG002|Overall Study|extubation or early discharge|0
6805717|NCT02921776|10807888|FG003|Overall Study|extubation or early discharge|5
6805718|NCT02921776|10807889|FG004|Overall Study|extubation or early discharge|5
6805719|NCT02921776|10807890|FG005|Overall Study|extubation or early discharge|0
6805720|NCT02921776|10807891|FG006|Overall Study|extubation or early discharge|0
6805721|NCT02921776|10807892|FG007|Overall Study|extubation or early discharge|0
7099852|NCT02347761|11222468|FG002|On Study Treatment|non-compliance with study medication|2
6805722|NCT02921776|10807885|FG000|Overall Study|Lost to Follow-up|0
6805723|NCT02921776|10807886|FG001|Overall Study|Lost to Follow-up|0
6805724|NCT02921776|10807887|FG002|Overall Study|Lost to Follow-up|0
6805725|NCT02921776|10807888|FG003|Overall Study|Lost to Follow-up|0
6805726|NCT02921776|10807889|FG004|Overall Study|Lost to Follow-up|0
6805727|NCT02921776|10807890|FG005|Overall Study|Lost to Follow-up|2
6805728|NCT02921776|10807891|FG006|Overall Study|Lost to Follow-up|3
6805729|NCT02921776|10807892|FG007|Overall Study|Lost to Follow-up|6
7099853|NCT02347761|11222466|FG000|On Study Treatment|Withdrawal by Subject|7
7099854|NCT02347761|11222467|FG001|On Study Treatment|Withdrawal by Subject|3
7099855|NCT02347761|11222468|FG002|On Study Treatment|Withdrawal by Subject|5
7099856|NCT02347761|11222466|FG000|On Study Treatment|move/travel|2
7099857|NCT02347761|11222467|FG001|On Study Treatment|move/travel|6
7099858|NCT02347761|11222468|FG002|On Study Treatment|move/travel|5
7099859|NCT02347761|11222466|FG000|On Study Treatment|dissastisfaction with device|2
7099860|NCT02347761|11222467|FG001|On Study Treatment|dissastisfaction with device|1
7099861|NCT02347761|11222468|FG002|On Study Treatment|dissastisfaction with device|4
7099862|NCT02347761|11222466|FG000|On Study Treatment|Lost to Follow-up|2
7099863|NCT02347761|11222467|FG001|On Study Treatment|Lost to Follow-up|1
7099864|NCT02347761|11222468|FG002|On Study Treatment|Lost to Follow-up|1
7099865|NCT02347761|11222466|FG000|On Study Treatment|investigator discretion|2
7099866|NCT02347761|11222467|FG001|On Study Treatment|investigator discretion|0
7099867|NCT02347761|11222468|FG002|On Study Treatment|investigator discretion|0
7099868|NCT02347761|11222466|FG000|On Study Treatment|durg not working|0
7099869|NCT02347761|11222467|FG001|On Study Treatment|durg not working|1
7099870|NCT02347761|11222468|FG002|On Study Treatment|durg not working|1
7099871|NCT02347761|11222466|FG000|On Study Treatment|Adverse Event|10
7099872|NCT02347761|11222467|FG001|On Study Treatment|Adverse Event|8
7099873|NCT02347761|11222468|FG002|On Study Treatment|Adverse Event|20
7099874|NCT02347774|11222479|FG000|Study Participation|Lost to Follow-up|3
7099875|NCT02347774|11222480|FG001|Study Participation|Lost to Follow-up|6
7099876|NCT02347774|11222481|FG002|Study Participation|Lost to Follow-up|2
7099877|NCT02347774|11222479|FG000|Study Participation|Withdrawal by Subject|8
7099878|NCT02347774|11222480|FG001|Study Participation|Withdrawal by Subject|9
7099879|NCT02347774|11222481|FG002|Study Participation|Withdrawal by Subject|15
7099880|NCT02347774|11222479|FG000|Study Participation|Adverse Event|1
7099881|NCT02347774|11222480|FG001|Study Participation|Adverse Event|4
7099882|NCT02347774|11222481|FG002|Study Participation|Adverse Event|6
7099883|NCT02347774|11222479|FG000|Study Participation|withdrew consent|1
7099884|NCT02347774|11222480|FG001|Study Participation|withdrew consent|1
7099885|NCT02347774|11222481|FG002|Study Participation|withdrew consent|1
7099886|NCT02347774|11222479|FG000|Study Participation|Met Prolonged QT criteria|1
7099887|NCT02347774|11222480|FG001|Study Participation|Met Prolonged QT criteria|0
7099888|NCT02347774|11222481|FG002|Study Participation|Met Prolonged QT criteria|0
7099889|NCT02347774|11222479|FG000|Study Participation|non-compliance with study drug|0
7099890|NCT02347774|11222480|FG001|Study Participation|non-compliance with study drug|1
7099891|NCT02347774|11222481|FG002|Study Participation|non-compliance with study drug|0
7099892|NCT02347774|11222479|FG000|Study Participation|incarceration|1
7099893|NCT02347774|11222480|FG001|Study Participation|incarceration|0
7099894|NCT02347774|11222481|FG002|Study Participation|incarceration|0
7099895|NCT02347774|11222479|FG000|Study Participation|randomized in error|0
7099896|NCT02347774|11222480|FG001|Study Participation|randomized in error|0
7099897|NCT02347774|11222481|FG002|Study Participation|randomized in error|1
7099898|NCT02347774|11222479|FG000|On Study Treatment|Adverse Event|9
7099899|NCT02347774|11222480|FG001|On Study Treatment|Adverse Event|15
7099900|NCT02347774|11222481|FG002|On Study Treatment|Adverse Event|19
7099901|NCT02347774|11222479|FG000|On Study Treatment|Lack of Efficacy|3
7099902|NCT02347774|11222480|FG001|On Study Treatment|Lack of Efficacy|0
7099903|NCT02347774|11222481|FG002|On Study Treatment|Lack of Efficacy|2
7099904|NCT02347774|11222479|FG000|On Study Treatment|non-complicance with study medication|0
7099905|NCT02347774|11222480|FG001|On Study Treatment|non-complicance with study medication|2
7099906|NCT02347774|11222481|FG002|On Study Treatment|non-complicance with study medication|0
7099907|NCT02347774|11222479|FG000|On Study Treatment|Protocol Violation|0
7099908|NCT02347774|11222480|FG001|On Study Treatment|Protocol Violation|0
7099909|NCT02347774|11222481|FG002|On Study Treatment|Protocol Violation|1
7099910|NCT02347774|11222479|FG000|On Study Treatment|withdrew consent|9
7099911|NCT02347774|11222480|FG001|On Study Treatment|withdrew consent|8
7099912|NCT02347774|11222481|FG002|On Study Treatment|withdrew consent|12
7099913|NCT02347774|11222479|FG000|On Study Treatment|Lost to Follow-up|2
7099914|NCT02347774|11222480|FG001|On Study Treatment|Lost to Follow-up|6
7099915|NCT02347774|11222481|FG002|On Study Treatment|Lost to Follow-up|1
7099916|NCT02347774|11222479|FG000|On Study Treatment|Met Prolonged QT criteria|1
7099917|NCT02347774|11222480|FG001|On Study Treatment|Met Prolonged QT criteria|0
7099918|NCT02347774|11222481|FG002|On Study Treatment|Met Prolonged QT criteria|0
7099919|NCT02347774|11222479|FG000|On Study Treatment|ranomized in error|0
7099920|NCT02347774|11222480|FG001|On Study Treatment|ranomized in error|0
7099921|NCT02347774|11222481|FG002|On Study Treatment|ranomized in error|1
7099922|NCT02347787|11222491|FG000|6 Month Follow-Up|Lost to Follow-up|63
7099923|NCT02347787|11222492|FG001|6 Month Follow-Up|Lost to Follow-up|47
7099924|NCT02347787|11222491|FG000|6 Month Follow-Up|Withdrawal by Subject|3
7099925|NCT02347787|11222492|FG001|6 Month Follow-Up|Withdrawal by Subject|9
7099926|NCT02347787|11222491|FG000|9 Month Follow-Up|Lost to Follow-up|52
7099927|NCT02347787|11222492|FG001|9 Month Follow-Up|Lost to Follow-up|59
7099928|NCT02347787|11222491|FG000|9 Month Follow-Up|Withdrawal by Subject|9
7099929|NCT02347787|11222492|FG001|9 Month Follow-Up|Withdrawal by Subject|12
7099930|NCT02347813|11222505|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1
7099931|NCT02347813|11222506|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1
7099932|NCT02347813|11222505|FG000|First Intervention, 24 Weeks|Adverse Event|1
7099933|NCT02347813|11222506|FG001|First Intervention, 24 Weeks|Adverse Event|1
7099934|NCT02348008|11222514|FG000|Overall Study|Adverse Event|2
7099935|NCT02348008|11222515|FG001|Overall Study|Adverse Event|3
7099936|NCT02348008|11222516|FG002|Overall Study|Adverse Event|3
7099937|NCT02348008|11222514|FG000|Overall Study|Disease Progression|1
7099938|NCT02348008|11222515|FG001|Overall Study|Disease Progression|5
7099939|NCT02348008|11222516|FG002|Overall Study|Disease Progression|16
7099940|NCT02348008|11222514|FG000|Overall Study|Withdrawal by Subject|0
7099941|NCT02348008|11222515|FG001|Overall Study|Withdrawal by Subject|1
7099942|NCT02348008|11222516|FG002|Overall Study|Withdrawal by Subject|0
7099943|NCT02348008|11222514|FG000|Overall Study|Symptomatic Deterioration|0
7099944|NCT02348008|11222515|FG001|Overall Study|Symptomatic Deterioration|1
7099945|NCT02348008|11222516|FG002|Overall Study|Symptomatic Deterioration|0
7099946|NCT02348489|11222535|FG000|Overall Study|Death|336
7099947|NCT02348489|11222536|FG001|Overall Study|Death|335
7099948|NCT02348489|11222535|FG000|Overall Study|Withdrawal by Subject|14
7099949|NCT02348489|11222536|FG001|Overall Study|Withdrawal by Subject|27
7099950|NCT02348489|11222535|FG000|Overall Study|Lost to Follow-up|3
7099951|NCT02348489|11222536|FG001|Overall Study|Lost to Follow-up|5
7099952|NCT02348723|11222609|FG000|Overall Study|No ablation|21
7099953|NCT02348723|11222610|FG001|Overall Study|No ablation|20
7099954|NCT02348723|11222609|FG000|Overall Study|Non-compliant with Protocol|1
7099955|NCT02348723|11222610|FG001|Overall Study|Non-compliant with Protocol|0
7099956|NCT02348723|11222609|FG000|Overall Study|Lost to Follow-up|1
7099957|NCT02348723|11222610|FG001|Overall Study|Lost to Follow-up|1
7099958|NCT02348723|11222609|FG000|Overall Study|Consent withdrawn|1
7099959|NCT02348723|11222610|FG001|Overall Study|Consent withdrawn|3
7099960|NCT02348723|11222609|FG000|Overall Study|Reason other than specified|1
7099961|NCT02348723|11222610|FG001|Overall Study|Reason other than specified|1
7099962|NCT02348723|11222609|FG000|Overall Study|Adverse Event|3
7099963|NCT02348723|11222610|FG001|Overall Study|Adverse Event|1
7099964|NCT02348840|11222629|FG000|Overall Study|Withdrawal by Subject|2
7099965|NCT02348840|11222630|FG001|Overall Study|Withdrawal by Subject|1
7099966|NCT02348840|11222631|FG002|Overall Study|Withdrawal by Subject|0
7099967|NCT02348840|11222632|FG003|Overall Study|Withdrawal by Subject|0
7099968|NCT02349048|11222681|FG000|Overall Study|Withdrawal by Subject|4
6805750|NCT02870348|10807938|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4
6805751|NCT02841280|10807944|FG000|Overall Study|Adverse Event|2
6805752|NCT02841280|10807945|FG001|Overall Study|Adverse Event|1
6805753|NCT02841280|10807944|FG000|Overall Study|Death|1
6805754|NCT02841280|10807945|FG001|Overall Study|Death|0
6805755|NCT02841280|10807944|FG000|Overall Study|Lost to Follow-up|2
6805756|NCT02841280|10807945|FG001|Overall Study|Lost to Follow-up|2
6805757|NCT02841280|10807944|FG000|Overall Study|Withdrawal by Subject|7
6805758|NCT02841280|10807945|FG001|Overall Study|Withdrawal by Subject|3
7099969|NCT02349048|11222682|FG001|Overall Study|Withdrawal by Subject|0
7099970|NCT02349048|11222681|FG000|Overall Study|Lost to Follow-up|1
6805759|NCT02841280|10807944|FG000|Overall Study|Stop Point: BP above threshold|2
6805760|NCT02841280|10807945|FG001|Overall Study|Stop Point: BP above threshold|0
6805761|NCT02771275|10807968|FG000|Overall Study|Reoperation|2
6805762|NCT02771275|10807968|FG000|Overall Study|On Study|11
6810358|NCT00676663|10814075|FG001|Overall Study|Death|27
6810359|NCT00676663|10814074|FG000|Overall Study|Withdrew Consent|1
6810360|NCT00676663|10814075|FG001|Overall Study|Withdrew Consent|8
6810361|NCT00676663|10814074|FG000|Overall Study|Lost to Follow-up|1
6810362|NCT00676663|10814075|FG001|Overall Study|Lost to Follow-up|3
6811163|NCT02407236|10815058|FG006|Maintenance Study (44 Weeks)|Lost to Follow-up|0
6811164|NCT02407236|10815059|FG007|Maintenance Study (44 Weeks)|Lost to Follow-up|1
6811165|NCT02407236|10815052|FG000|Maintenance Study (44 Weeks)|Death|0
6811166|NCT02407236|10815053|FG001|Maintenance Study (44 Weeks)|Death|0
7099971|NCT02349048|11222682|FG001|Overall Study|Lost to Follow-up|0
7099972|NCT02349061|11222690|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4
7099973|NCT02349061|11222691|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3
7099974|NCT02349061|11222692|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0
7099975|NCT02349061|11222690|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1
7099976|NCT02349061|11222691|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0
7099977|NCT02349061|11222692|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0
7099978|NCT02349061|11222690|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1
7099979|NCT02349061|11222691|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0
7099980|NCT02349061|11222692|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0
7099981|NCT02349061|11222690|FG000|Main Study: PCP (Up to Week 24)|Other|1
7099982|NCT02349061|11222691|FG001|Main Study: PCP (Up to Week 24)|Other|1
7099983|NCT02349061|11222692|FG002|Main Study: PCP (Up to Week 24)|Other|0
7099984|NCT02349061|11222690|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2
7099985|NCT02349061|11222691|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0
7099986|NCT02349061|11222692|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0
7099987|NCT02349061|11222690|FG000|Main Study: Week 24 to 56|Adverse Event|0
7099988|NCT02349061|11222691|FG001|Main Study: Week 24 to 56|Adverse Event|2
7099989|NCT02349061|11222692|FG002|Main Study: Week 24 to 56|Adverse Event|1
7099990|NCT02349061|11222690|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0
7099991|NCT02349061|11222691|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1
7099992|NCT02349061|11222692|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0
7099993|NCT02349061|11222690|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0
7099994|NCT02349061|11222691|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0
7099995|NCT02349061|11222692|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1
7099996|NCT02349061|11222690|FG000|Main Study: Week 24 to 56|Physician Decision|0
7099997|NCT02349061|11222691|FG001|Main Study: Week 24 to 56|Physician Decision|0
7099998|NCT02349061|11222692|FG002|Main Study: Week 24 to 56|Physician Decision|1
7099999|NCT02349061|11222690|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0
7100000|NCT02349061|11222691|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3
7100001|NCT02349061|11222692|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0
7100002|NCT02349061|11222690|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0
7100003|NCT02349061|11222691|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0
7100004|NCT02349061|11222692|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1
7100005|NCT02349061|11222690|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0
7100006|NCT02349061|11222691|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2
7100007|NCT02349061|11222692|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1
7100008|NCT02349061|11222690|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0
7100009|NCT02349061|11222691|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0
7100010|NCT02349061|11222692|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1
7100011|NCT02349295|11222718|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7
7100012|NCT02349295|11222719|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5
7100013|NCT02349295|11222720|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5
7100014|NCT02349295|11222721|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0
7100015|NCT02349295|11222722|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0
7100016|NCT02349295|11222723|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0
7100017|NCT02349295|11222724|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0
7100018|NCT02349295|11222725|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0
7100019|NCT02349295|11222726|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0
7100020|NCT02349295|11222727|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0
7100021|NCT02349295|11222728|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0
7100022|NCT02349295|11222729|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0
7100023|NCT02349295|11222730|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0
7100024|NCT02349295|11222731|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0
7100025|NCT02349295|11222718|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4
7100026|NCT02349295|11222719|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2
7100027|NCT02349295|11222720|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9
7100028|NCT02349295|11222721|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7100029|NCT02349295|11222722|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7100030|NCT02349295|11222723|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7100031|NCT02349295|11222724|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7100032|NCT02349295|11222725|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7100033|NCT02349295|11222726|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7100034|NCT02349295|11222727|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7100035|NCT02349295|11222728|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7100036|NCT02349295|11222729|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7100037|NCT02349295|11222730|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7100038|NCT02349295|11222731|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7100039|NCT02349295|11222718|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
7100040|NCT02349295|11222719|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
7100041|NCT02349295|11222720|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7
7100042|NCT02349295|11222721|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7100043|NCT02349295|11222722|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7100044|NCT02349295|11222723|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7100045|NCT02349295|11222724|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7100046|NCT02349295|11222725|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7100047|NCT02349295|11222726|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7100048|NCT02349295|11222727|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7100049|NCT02349295|11222728|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7100050|NCT02349295|11222729|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7100051|NCT02349295|11222730|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7100052|NCT02349295|11222731|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7100053|NCT02349295|11222718|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
7100054|NCT02349295|11222719|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
7100055|NCT02349295|11222720|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2
7100056|NCT02349295|11222721|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7100057|NCT02349295|11222722|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7100058|NCT02349295|11222723|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7100059|NCT02349295|11222724|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7100060|NCT02349295|11222725|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7100061|NCT02349295|11222726|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7100062|NCT02349295|11222727|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7100063|NCT02349295|11222728|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7100064|NCT02349295|11222729|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7100065|NCT02349295|11222730|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7100066|NCT02349295|11222731|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7100067|NCT02349295|11222718|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7100068|NCT02349295|11222719|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
7100069|NCT02349295|11222720|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
7100070|NCT02349295|11222721|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7100071|NCT02349295|11222722|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7100072|NCT02349295|11222723|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7100073|NCT02349295|11222724|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7100074|NCT02349295|11222725|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7100075|NCT02349295|11222726|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7100076|NCT02349295|11222727|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7100077|NCT02349295|11222728|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7100078|NCT02349295|11222729|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7100079|NCT02349295|11222730|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7100080|NCT02349295|11222731|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7100081|NCT02349295|11222718|FG000|IR (Week 16-24)|Lack of Efficacy|0
7100082|NCT02349295|11222719|FG001|IR (Week 16-24)|Lack of Efficacy|0
7100083|NCT02349295|11222720|FG002|IR (Week 16-24)|Lack of Efficacy|0
7100084|NCT02349295|11222721|FG003|IR (Week 16-24)|Lack of Efficacy|1
7100085|NCT02349295|11222722|FG004|IR (Week 16-24)|Lack of Efficacy|0
7100086|NCT02349295|11222723|FG005|IR (Week 16-24)|Lack of Efficacy|0
7100087|NCT02349295|11222724|FG006|IR (Week 16-24)|Lack of Efficacy|0
7100088|NCT02349295|11222725|FG007|IR (Week 16-24)|Lack of Efficacy|0
7100089|NCT02349295|11222726|FG008|IR (Week 16-24)|Lack of Efficacy|0
7100090|NCT02349295|11222727|FG009|IR (Week 16-24)|Lack of Efficacy|0
7100091|NCT02349295|11222728|FG010|IR (Week 16-24)|Lack of Efficacy|0
7100092|NCT02349295|11222729|FG011|IR (Week 16-24)|Lack of Efficacy|0
7100093|NCT02349295|11222730|FG012|IR (Week 16-24)|Lack of Efficacy|0
7100094|NCT02349295|11222731|FG013|IR (Week 16-24)|Lack of Efficacy|0
7100095|NCT02349295|11222718|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7100096|NCT02349295|11222719|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7100097|NCT02349295|11222720|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7100098|NCT02349295|11222721|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7100099|NCT02349295|11222722|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7100100|NCT02349295|11222723|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7100101|NCT02349295|11222724|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7100102|NCT02349295|11222725|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32
7100103|NCT02349295|11222726|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25
7100104|NCT02349295|11222727|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19
7100105|NCT02349295|11222728|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18
7100106|NCT02349295|11222729|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7100107|NCT02349295|11222730|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7100108|NCT02349295|11222731|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7100109|NCT02349295|11222718|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7100110|NCT02349295|11222719|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7100111|NCT02349295|11222720|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7100112|NCT02349295|11222721|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7100113|NCT02349295|11222722|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7100114|NCT02349295|11222723|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7100115|NCT02349295|11222724|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7100116|NCT02349295|11222725|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9
7100117|NCT02349295|11222726|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9
7100118|NCT02349295|11222727|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2
7100119|NCT02349295|11222728|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2
7100120|NCT02349295|11222729|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7100121|NCT02349295|11222730|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7100122|NCT02349295|11222731|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7100123|NCT02349295|11222718|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7100124|NCT02349295|11222719|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7100125|NCT02349295|11222720|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7100126|NCT02349295|11222721|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7100127|NCT02349295|11222722|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7100128|NCT02349295|11222723|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7100129|NCT02349295|11222724|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7100130|NCT02349295|11222725|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2
7100131|NCT02349295|11222726|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7100132|NCT02349295|11222727|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3
7100133|NCT02349295|11222728|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7100134|NCT02349295|11222729|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7100135|NCT02349295|11222730|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7100136|NCT02349295|11222731|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7100137|NCT02349295|11222718|FG000|Long-Term Extension Period (Week 24-156)|Death|0
7100138|NCT02349295|11222719|FG001|Long-Term Extension Period (Week 24-156)|Death|0
7100139|NCT02349295|11222720|FG002|Long-Term Extension Period (Week 24-156)|Death|0
7100140|NCT02349295|11222721|FG003|Long-Term Extension Period (Week 24-156)|Death|0
7100141|NCT02349295|11222722|FG004|Long-Term Extension Period (Week 24-156)|Death|0
7100142|NCT02349295|11222723|FG005|Long-Term Extension Period (Week 24-156)|Death|0
7100143|NCT02349295|11222724|FG006|Long-Term Extension Period (Week 24-156)|Death|0
7100144|NCT02349295|11222725|FG007|Long-Term Extension Period (Week 24-156)|Death|1
7100145|NCT02349295|11222726|FG008|Long-Term Extension Period (Week 24-156)|Death|1
7100146|NCT02349295|11222727|FG009|Long-Term Extension Period (Week 24-156)|Death|1
7100147|NCT02349295|11222728|FG010|Long-Term Extension Period (Week 24-156)|Death|0
7100148|NCT02349295|11222729|FG011|Long-Term Extension Period (Week 24-156)|Death|0
7100149|NCT02349295|11222730|FG012|Long-Term Extension Period (Week 24-156)|Death|0
7100150|NCT02349295|11222731|FG013|Long-Term Extension Period (Week 24-156)|Death|0
7100151|NCT02349295|11222718|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7100152|NCT02349295|11222719|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7100153|NCT02349295|11222720|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7100154|NCT02349295|11222721|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7100155|NCT02349295|11222722|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7100156|NCT02349295|11222723|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7100157|NCT02349295|11222724|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7100158|NCT02349295|11222725|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4
7100159|NCT02349295|11222726|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2
7100160|NCT02349295|11222727|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1
7100161|NCT02349295|11222728|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3
7100162|NCT02349295|11222729|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7100163|NCT02349295|11222730|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7100164|NCT02349295|11222731|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7100165|NCT02349295|11222718|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7100166|NCT02349295|11222719|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7100167|NCT02349295|11222720|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7100168|NCT02349295|11222721|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7100169|NCT02349295|11222722|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7100170|NCT02349295|11222723|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7100171|NCT02349295|11222724|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7100172|NCT02349295|11222725|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2
7100173|NCT02349295|11222726|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2
7100174|NCT02349295|11222727|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7100175|NCT02349295|11222728|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7100176|NCT02349295|11222729|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7100177|NCT02349295|11222730|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7100178|NCT02349295|11222731|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7100179|NCT02349295|11222718|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7100180|NCT02349295|11222719|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7100181|NCT02349295|11222720|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7100182|NCT02349295|11222721|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7100183|NCT02349295|11222722|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7100184|NCT02349295|11222723|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7100185|NCT02349295|11222724|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7100186|NCT02349295|11222725|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2
7100187|NCT02349295|11222726|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2
7100188|NCT02349295|11222727|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7100189|NCT02349295|11222728|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7100190|NCT02349295|11222729|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7100191|NCT02349295|11222730|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7100192|NCT02349295|11222731|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7100193|NCT02349295|11222718|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7100194|NCT02349295|11222719|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7100195|NCT02349295|11222720|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7100196|NCT02349295|11222721|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7100197|NCT02349295|11222722|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7100198|NCT02349295|11222723|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7100199|NCT02349295|11222724|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7100200|NCT02349295|11222725|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7100201|NCT02349295|11222726|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7100202|NCT02349295|11222727|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7100203|NCT02349295|11222728|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7100204|NCT02349295|11222729|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1
7100205|NCT02349295|11222730|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5
7100206|NCT02349295|11222731|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1
7100207|NCT02349295|11222718|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7100208|NCT02349295|11222719|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7100209|NCT02349295|11222720|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7100210|NCT02349295|11222721|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7100211|NCT02349295|11222722|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7100212|NCT02349295|11222723|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7100213|NCT02349295|11222724|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7100214|NCT02349295|11222725|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7100215|NCT02349295|11222726|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7100216|NCT02349295|11222727|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7100217|NCT02349295|11222728|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7100218|NCT02349295|11222729|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1
7100219|NCT02349295|11222730|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2
7100220|NCT02349295|11222731|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7100221|NCT02349295|11222718|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7100222|NCT02349295|11222719|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7100223|NCT02349295|11222720|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7100224|NCT02349295|11222721|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7100225|NCT02349295|11222722|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7100226|NCT02349295|11222723|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7100227|NCT02349295|11222724|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7100228|NCT02349295|11222725|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7100229|NCT02349295|11222726|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7100230|NCT02349295|11222727|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7100231|NCT02349295|11222728|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7100232|NCT02349295|11222729|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1
7100233|NCT02349295|11222730|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1
7100234|NCT02349295|11222731|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7100235|NCT02349295|11222718|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7100236|NCT02349295|11222719|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7100237|NCT02349295|11222720|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7100238|NCT02349295|11222721|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7100239|NCT02349295|11222722|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7100240|NCT02349295|11222723|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7100241|NCT02349295|11222724|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7100242|NCT02349295|11222725|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7100243|NCT02349295|11222726|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7100244|NCT02349295|11222727|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7100245|NCT02349295|11222728|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7100246|NCT02349295|11222729|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2
7100247|NCT02349295|11222730|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7100248|NCT02349295|11222731|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7100249|NCT02349295|11222718|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7100250|NCT02349295|11222719|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7100251|NCT02349295|11222720|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7100252|NCT02349295|11222721|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7100253|NCT02349295|11222722|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7100254|NCT02349295|11222723|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7100255|NCT02349295|11222724|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7100256|NCT02349295|11222725|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7100257|NCT02349295|11222726|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7100258|NCT02349295|11222727|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7100259|NCT02349295|11222728|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7100260|NCT02349295|11222729|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4
7100261|NCT02349295|11222730|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7100262|NCT02349295|11222731|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7100263|NCT02349360|11222758|FG000|Overall Study|Withdrawal by Subject|0
7100264|NCT02349360|11222759|FG001|Overall Study|Withdrawal by Subject|1
7100265|NCT02349412|11222767|FG000|Overall Study|Withdrawal by Subject|7
7100266|NCT02349412|11222768|FG001|Overall Study|Withdrawal by Subject|7
7100267|NCT02349425|11222778|FG000|Period 1|Adverse Event|1
7100268|NCT02349425|11222779|FG001|Period 1|Adverse Event|1
7100269|NCT02349425|11222780|FG002|Period 1|Adverse Event|0
7100270|NCT02349425|11222781|FG003|Period 1|Adverse Event|0
7100271|NCT02349425|11222778|FG000|Period 2|Adverse Event|0
7100272|NCT02349425|11222779|FG001|Period 2|Adverse Event|1
7100273|NCT02349425|11222780|FG002|Period 2|Adverse Event|1
7100274|NCT02349425|11222781|FG003|Period 2|Adverse Event|0
7100275|NCT02349451|11222830|FG000|Overall Study|Withdrawal by Subject|0
7100276|NCT02349451|11222831|FG001|Overall Study|Withdrawal by Subject|1
7100277|NCT02349451|11222832|FG002|Overall Study|Withdrawal by Subject|2
7100278|NCT02349451|11222833|FG003|Overall Study|Withdrawal by Subject|1
7100279|NCT02349542|11222859|FG000|Overall Study|Withdrawal by Subject|5
7100280|NCT02349633|11222877|FG000|Overall Study|Death|0
7100281|NCT02349633|11222878|FG001|Overall Study|Death|1
7100282|NCT02349633|11222879|FG002|Overall Study|Death|0
7100283|NCT02349633|11222880|FG003|Overall Study|Death|0
7100284|NCT02349633|11222881|FG004|Overall Study|Death|0
7100285|NCT02349633|11222882|FG005|Overall Study|Death|1
7100286|NCT02349633|11222883|FG006|Overall Study|Death|1
7100287|NCT02349633|11222884|FG007|Overall Study|Death|1
7100288|NCT02349633|11222885|FG008|Overall Study|Death|0
7100289|NCT02349633|11222886|FG009|Overall Study|Death|1
7100290|NCT02349633|11222887|FG010|Overall Study|Death|0
7100291|NCT02349633|11222888|FG011|Overall Study|Death|0
7100292|NCT02349633|11222889|FG012|Overall Study|Death|0
7100293|NCT02349633|11222890|FG013|Overall Study|Death|0
7100294|NCT02349633|11222877|FG000|Overall Study|Withdrawal by Subject|0
7100295|NCT02349633|11222878|FG001|Overall Study|Withdrawal by Subject|0
7100296|NCT02349633|11222879|FG002|Overall Study|Withdrawal by Subject|0
7100297|NCT02349633|11222880|FG003|Overall Study|Withdrawal by Subject|1
7100298|NCT02349633|11222881|FG004|Overall Study|Withdrawal by Subject|0
7100299|NCT02349633|11222882|FG005|Overall Study|Withdrawal by Subject|0
7100300|NCT02349633|11222883|FG006|Overall Study|Withdrawal by Subject|0
7100301|NCT02349633|11222884|FG007|Overall Study|Withdrawal by Subject|2
7100302|NCT02349633|11222885|FG008|Overall Study|Withdrawal by Subject|2
7100303|NCT02349633|11222886|FG009|Overall Study|Withdrawal by Subject|1
7100304|NCT02349633|11222887|FG010|Overall Study|Withdrawal by Subject|0
7100305|NCT02349633|11222888|FG011|Overall Study|Withdrawal by Subject|0
7100306|NCT02349633|11222889|FG012|Overall Study|Withdrawal by Subject|0
7100307|NCT02349633|11222890|FG013|Overall Study|Withdrawal by Subject|0
7100308|NCT02349633|11222877|FG000|Overall Study|Withdrawal of informed consent|0
7100309|NCT02349633|11222878|FG001|Overall Study|Withdrawal of informed consent|0
7100310|NCT02349633|11222879|FG002|Overall Study|Withdrawal of informed consent|0
7100311|NCT02349633|11222880|FG003|Overall Study|Withdrawal of informed consent|1
7100312|NCT02349633|11222881|FG004|Overall Study|Withdrawal of informed consent|1
7100313|NCT02349633|11222882|FG005|Overall Study|Withdrawal of informed consent|0
7100314|NCT02349633|11222883|FG006|Overall Study|Withdrawal of informed consent|0
7100315|NCT02349633|11222884|FG007|Overall Study|Withdrawal of informed consent|3
7100316|NCT02349633|11222885|FG008|Overall Study|Withdrawal of informed consent|0
7100317|NCT02349633|11222886|FG009|Overall Study|Withdrawal of informed consent|0
7100318|NCT02349633|11222887|FG010|Overall Study|Withdrawal of informed consent|0
7100319|NCT02349633|11222888|FG011|Overall Study|Withdrawal of informed consent|0
7100320|NCT02349633|11222889|FG012|Overall Study|Withdrawal of informed consent|0
7100321|NCT02349633|11222890|FG013|Overall Study|Withdrawal of informed consent|0
7100322|NCT02349633|11222877|FG000|Overall Study|Transition to compassionate use|0
7100323|NCT02349633|11222878|FG001|Overall Study|Transition to compassionate use|0
7100324|NCT02349633|11222879|FG002|Overall Study|Transition to compassionate use|0
7100325|NCT02349633|11222880|FG003|Overall Study|Transition to compassionate use|0
7100326|NCT02349633|11222881|FG004|Overall Study|Transition to compassionate use|1
7100327|NCT02349633|11222882|FG005|Overall Study|Transition to compassionate use|0
7100328|NCT02349633|11222883|FG006|Overall Study|Transition to compassionate use|0
7100329|NCT02349633|11222884|FG007|Overall Study|Transition to compassionate use|3
7100330|NCT02349633|11222885|FG008|Overall Study|Transition to compassionate use|0
7100331|NCT02349633|11222886|FG009|Overall Study|Transition to compassionate use|1
7100332|NCT02349633|11222887|FG010|Overall Study|Transition to compassionate use|0
7100333|NCT02349633|11222888|FG011|Overall Study|Transition to compassionate use|0
7100334|NCT02349633|11222889|FG012|Overall Study|Transition to compassionate use|0
7100335|NCT02349633|11222890|FG013|Overall Study|Transition to compassionate use|0
7100336|NCT02349633|11222877|FG000|Overall Study|Early termination of survival follow-up|0
7100337|NCT02349633|11222878|FG001|Overall Study|Early termination of survival follow-up|0
7100338|NCT02349633|11222879|FG002|Overall Study|Early termination of survival follow-up|0
7100339|NCT02349633|11222880|FG003|Overall Study|Early termination of survival follow-up|0
7100340|NCT02349633|11222881|FG004|Overall Study|Early termination of survival follow-up|0
7100341|NCT02349633|11222882|FG005|Overall Study|Early termination of survival follow-up|0
7100342|NCT02349633|11222883|FG006|Overall Study|Early termination of survival follow-up|0
7100343|NCT02349633|11222884|FG007|Overall Study|Early termination of survival follow-up|4
7100344|NCT02349633|11222885|FG008|Overall Study|Early termination of survival follow-up|0
7100345|NCT02349633|11222886|FG009|Overall Study|Early termination of survival follow-up|0
7100346|NCT02349633|11222887|FG010|Overall Study|Early termination of survival follow-up|0
7100347|NCT02349633|11222888|FG011|Overall Study|Early termination of survival follow-up|0
7100348|NCT02349633|11222889|FG012|Overall Study|Early termination of survival follow-up|0
7100349|NCT02349633|11222890|FG013|Overall Study|Early termination of survival follow-up|0
7100350|NCT02349633|11222877|FG000|Overall Study|Termination by sponsor|0
7100351|NCT02349633|11222878|FG001|Overall Study|Termination by sponsor|0
7100352|NCT02349633|11222879|FG002|Overall Study|Termination by sponsor|0
7100353|NCT02349633|11222880|FG003|Overall Study|Termination by sponsor|0
7100354|NCT02349633|11222881|FG004|Overall Study|Termination by sponsor|0
7100355|NCT02349633|11222882|FG005|Overall Study|Termination by sponsor|0
7100356|NCT02349633|11222883|FG006|Overall Study|Termination by sponsor|0
7100357|NCT02349633|11222884|FG007|Overall Study|Termination by sponsor|1
7100358|NCT02349633|11222885|FG008|Overall Study|Termination by sponsor|0
7100359|NCT02349633|11222886|FG009|Overall Study|Termination by sponsor|2
7100360|NCT02349633|11222887|FG010|Overall Study|Termination by sponsor|0
7100361|NCT02349633|11222888|FG011|Overall Study|Termination by sponsor|0
7100362|NCT02349633|11222889|FG012|Overall Study|Termination by sponsor|0
7100363|NCT02349633|11222890|FG013|Overall Study|Termination by sponsor|0
7100364|NCT02349633|11222877|FG000|Overall Study|Other|0
7100365|NCT02349633|11222878|FG001|Overall Study|Other|0
7100366|NCT02349633|11222879|FG002|Overall Study|Other|0
7100367|NCT02349633|11222880|FG003|Overall Study|Other|0
7100368|NCT02349633|11222881|FG004|Overall Study|Other|0
7100369|NCT02349633|11222882|FG005|Overall Study|Other|0
7100370|NCT02349633|11222883|FG006|Overall Study|Other|0
7100371|NCT02349633|11222884|FG007|Overall Study|Other|2
7100372|NCT02349633|11222885|FG008|Overall Study|Other|0
7100373|NCT02349633|11222886|FG009|Overall Study|Other|0
7100374|NCT02349633|11222887|FG010|Overall Study|Other|0
7100375|NCT02349633|11222888|FG011|Overall Study|Other|0
7100376|NCT02349633|11222889|FG012|Overall Study|Other|0
7100377|NCT02349633|11222890|FG013|Overall Study|Other|0
7100378|NCT02349711|11222970|FG000|Overall Study|Withdrawal by Subject|2
7100379|NCT02349711|11222971|FG001|Overall Study|Withdrawal by Subject|1
7100380|NCT02349711|11222970|FG000|Overall Study|Lost to Follow-up|1
7100381|NCT02349711|11222971|FG001|Overall Study|Lost to Follow-up|1
7100382|NCT02349789|11222977|FG000|Overall Study|Withdrawal by Subject|2
7100383|NCT02350127|11222983|FG000|4-Month Assessment|Withdrawal by Subject|10
7100384|NCT02350127|11222984|FG001|4-Month Assessment|Withdrawal by Subject|9
7100385|NCT02350127|11222983|FG000|4-Month Assessment|Death|1
7100386|NCT02350127|11222984|FG001|4-Month Assessment|Death|0
7100387|NCT02350127|11222983|FG000|8-Month Assessment|Death|1
7100388|NCT02350127|11222984|FG001|8-Month Assessment|Death|1
7100389|NCT02350127|11222983|FG000|8-Month Assessment|Withdrawal by Subject|5
7100390|NCT02350127|11222984|FG001|8-Month Assessment|Withdrawal by Subject|8
7100391|NCT02350309|11222997|FG000|Treatment Period 1 (2 Days)|Physician Decision|0
7100392|NCT02350309|11222998|FG001|Treatment Period 1 (2 Days)|Physician Decision|0
7100393|NCT02350309|11222999|FG002|Treatment Period 1 (2 Days)|Physician Decision|1
7100394|NCT02350309|11223000|FG003|Treatment Period 1 (2 Days)|Physician Decision|0
7100395|NCT02350309|11223001|FG004|Treatment Period 1 (2 Days)|Physician Decision|0
7100396|NCT02350309|11223002|FG005|Treatment Period 1 (2 Days)|Physician Decision|0
7100397|NCT02350309|11222997|FG000|Treatment Period 4 (2 Days)|Death in the Family|0
7100398|NCT02350309|11222998|FG001|Treatment Period 4 (2 Days)|Death in the Family|0
7100399|NCT02350309|11222999|FG002|Treatment Period 4 (2 Days)|Death in the Family|0
7100400|NCT02350309|11223000|FG003|Treatment Period 4 (2 Days)|Death in the Family|0
7100401|NCT02350309|11223001|FG004|Treatment Period 4 (2 Days)|Death in the Family|0
7100402|NCT02350309|11223002|FG005|Treatment Period 4 (2 Days)|Death in the Family|1
7100403|NCT02350478|11223019|FG000|Overall Study|Lost to Follow-up|5
7100404|NCT02350478|11223020|FG001|Overall Study|Lost to Follow-up|1
7100405|NCT02351167|11223136|FG000|Overall Study|Withdrawal by Subject|19
7100406|NCT02351167|11223137|FG001|Overall Study|Withdrawal by Subject|18
7100407|NCT02351167|11223138|FG002|Overall Study|Withdrawal by Subject|21
7100408|NCT02351349|11223166|FG000|Overall Study|Withdrawal by Subject|2
7100409|NCT02351349|11223167|FG001|Overall Study|Withdrawal by Subject|3
7100410|NCT02351817|11223203|FG000|Period 1|Adverse Event|1
7100411|NCT02351817|11223204|FG001|Period 1|Adverse Event|2
7100412|NCT02351817|11223203|FG000|Period 1|Lack of Efficacy|0
7100413|NCT02351817|11223204|FG001|Period 1|Lack of Efficacy|1
7100414|NCT02351817|11223203|FG000|Period 2|Adverse Event|0
7100415|NCT02351817|11223204|FG001|Period 2|Adverse Event|2
7100416|NCT02351817|11223203|FG000|Period 2|Protocol Violation|1
7100417|NCT02351817|11223204|FG001|Period 2|Protocol Violation|0
7100418|NCT02351934|11223213|FG000|Allocation|POD weight<pre-op weight|3
7100419|NCT02351934|11223214|FG001|Allocation|POD weight<pre-op weight|0
7100420|NCT02351934|11223213|FG000|Allocation|Hypotension preventing administration|2
7100421|NCT02351934|11223214|FG001|Allocation|Hypotension preventing administration|0
7100422|NCT02351934|11223213|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1
7100423|NCT02351934|11223214|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0
7100424|NCT02351934|11223213|FG000|Follow-Up|POD weight<pre-op weight|3
7100425|NCT02351934|11223214|FG001|Follow-Up|POD weight<pre-op weight|0
7100426|NCT02351934|11223213|FG000|Follow-Up|Acute Kidney Injury|1
7100427|NCT02351934|11223214|FG001|Follow-Up|Acute Kidney Injury|0
7100428|NCT02351934|11223213|FG000|Follow-Up|Early dismissal|3
7100429|NCT02351934|11223214|FG001|Follow-Up|Early dismissal|0
7100430|NCT02351934|11223213|FG000|Follow-Up|Hypotension|3
7100431|NCT02351934|11223214|FG001|Follow-Up|Hypotension|0
7100432|NCT02351934|11223213|FG000|Follow-Up|No documentation|2
7100433|NCT02351934|11223214|FG001|Follow-Up|No documentation|0
7100434|NCT02351934|11223213|FG000|Follow-Up|1 ERAS Component Noncompliant|0
7100435|NCT02351934|11223214|FG001|Follow-Up|1 ERAS Component Noncompliant|6
7100436|NCT02351934|11223213|FG000|Follow-Up|2 ERAS Components Noncompliant|0
7100437|NCT02351934|11223214|FG001|Follow-Up|2 ERAS Components Noncompliant|4
7100438|NCT02351960|11223222|FG000|Overall Study|Pretreatment Event/Adverse Event|6
7100439|NCT02351960|11223223|FG001|Overall Study|Pretreatment Event/Adverse Event|3
7100440|NCT02351960|11223222|FG000|Overall Study|Voluntary Withdrawal|5
7100441|NCT02351960|11223223|FG001|Overall Study|Voluntary Withdrawal|4
7100442|NCT02351960|11223222|FG000|Overall Study|Significant Protocol Deviation|0
7100443|NCT02351960|11223223|FG001|Overall Study|Significant Protocol Deviation|5
7100444|NCT02352493|11223266|FG000|Overall Study|Pregnancy|0
7100445|NCT02352493|11223267|FG001|Overall Study|Pregnancy|0
7100446|NCT02352493|11223268|FG002|Overall Study|Pregnancy|0
7100447|NCT02352493|11223269|FG003|Overall Study|Pregnancy|0
7100448|NCT02352493|11223270|FG004|Overall Study|Pregnancy|0
7100449|NCT02352493|11223271|FG005|Overall Study|Pregnancy|0
7100450|NCT02352493|11223272|FG006|Overall Study|Pregnancy|1
7100451|NCT02352493|11223273|FG007|Overall Study|Pregnancy|0
7100452|NCT02352493|11223274|FG008|Overall Study|Pregnancy|1
7100453|NCT02352493|11223275|FG009|Overall Study|Pregnancy|0
7100454|NCT02352493|11223276|FG010|Overall Study|Pregnancy|0
7100455|NCT02352493|11223277|FG011|Overall Study|Pregnancy|0
7100456|NCT02352493|11223278|FG012|Overall Study|Pregnancy|0
7100457|NCT02352493|11223279|FG013|Overall Study|Pregnancy|0
7100458|NCT02352493|11223280|FG014|Overall Study|Pregnancy|0
7100459|NCT02352493|11223281|FG015|Overall Study|Pregnancy|0
7100460|NCT02352493|11223282|FG016|Overall Study|Pregnancy|0
7100461|NCT02352493|11223283|FG017|Overall Study|Pregnancy|0
7100462|NCT02352493|11223266|FG000|Overall Study|Withdrawal by Subject|0
7100463|NCT02352493|11223267|FG001|Overall Study|Withdrawal by Subject|0
7100464|NCT02352493|11223268|FG002|Overall Study|Withdrawal by Subject|0
7100465|NCT02352493|11223269|FG003|Overall Study|Withdrawal by Subject|0
7100466|NCT02352493|11223270|FG004|Overall Study|Withdrawal by Subject|0
7100467|NCT02352493|11223271|FG005|Overall Study|Withdrawal by Subject|0
7100468|NCT02352493|11223272|FG006|Overall Study|Withdrawal by Subject|0
7100469|NCT02352493|11223273|FG007|Overall Study|Withdrawal by Subject|0
7100470|NCT02352493|11223274|FG008|Overall Study|Withdrawal by Subject|1
7100471|NCT02352493|11223275|FG009|Overall Study|Withdrawal by Subject|0
7100472|NCT02352493|11223276|FG010|Overall Study|Withdrawal by Subject|0
7100473|NCT02352493|11223277|FG011|Overall Study|Withdrawal by Subject|0
7100474|NCT02352493|11223278|FG012|Overall Study|Withdrawal by Subject|0
7100475|NCT02352493|11223279|FG013|Overall Study|Withdrawal by Subject|0
7100476|NCT02352493|11223280|FG014|Overall Study|Withdrawal by Subject|1
7100477|NCT02352493|11223281|FG015|Overall Study|Withdrawal by Subject|0
7100478|NCT02352493|11223282|FG016|Overall Study|Withdrawal by Subject|0
7100479|NCT02352493|11223283|FG017|Overall Study|Withdrawal by Subject|0
7100480|NCT02352493|11223266|FG000|Overall Study|Lost to Follow-up|0
7100481|NCT02352493|11223267|FG001|Overall Study|Lost to Follow-up|0
7100482|NCT02352493|11223268|FG002|Overall Study|Lost to Follow-up|0
7100483|NCT02352493|11223269|FG003|Overall Study|Lost to Follow-up|0
7100484|NCT02352493|11223270|FG004|Overall Study|Lost to Follow-up|0
7100485|NCT02352493|11223271|FG005|Overall Study|Lost to Follow-up|0
7100486|NCT02352493|11223272|FG006|Overall Study|Lost to Follow-up|0
7100487|NCT02352493|11223273|FG007|Overall Study|Lost to Follow-up|0
7100488|NCT02352493|11223274|FG008|Overall Study|Lost to Follow-up|0
7100489|NCT02352493|11223275|FG009|Overall Study|Lost to Follow-up|1
7100490|NCT02352493|11223276|FG010|Overall Study|Lost to Follow-up|0
7100491|NCT02352493|11223277|FG011|Overall Study|Lost to Follow-up|0
7100492|NCT02352493|11223278|FG012|Overall Study|Lost to Follow-up|1
7100493|NCT02352493|11223279|FG013|Overall Study|Lost to Follow-up|2
7100494|NCT02352493|11223280|FG014|Overall Study|Lost to Follow-up|0
7100495|NCT02352493|11223281|FG015|Overall Study|Lost to Follow-up|0
7100496|NCT02352493|11223282|FG016|Overall Study|Lost to Follow-up|0
7100497|NCT02352493|11223283|FG017|Overall Study|Lost to Follow-up|0
7100498|NCT02352779|11223341|FG000|Overall Study|Personal Issues|1
7100499|NCT02352779|11223342|FG001|Overall Study|Personal Issues|1
7100500|NCT02352779|11223343|FG002|Overall Study|Personal Issues|0
7100501|NCT02352779|11223341|FG000|Overall Study|Too Many Forms|2
7100502|NCT02352779|11223342|FG001|Overall Study|Too Many Forms|0
7100503|NCT02352779|11223343|FG002|Overall Study|Too Many Forms|0
7100504|NCT02352779|11223341|FG000|Overall Study|Feeling Overwhelmed|1
7100505|NCT02352779|11223342|FG001|Overall Study|Feeling Overwhelmed|0
7100506|NCT02352779|11223343|FG002|Overall Study|Feeling Overwhelmed|0
7100507|NCT02352779|11223341|FG000|Overall Study|Disliked Intervention|1
7100508|NCT02352779|11223342|FG001|Overall Study|Disliked Intervention|0
7100509|NCT02352779|11223343|FG002|Overall Study|Disliked Intervention|0
7100510|NCT02352779|11223341|FG000|Overall Study|Changed Mind|1
7100511|NCT02352779|11223342|FG001|Overall Study|Changed Mind|0
7100512|NCT02352779|11223343|FG002|Overall Study|Changed Mind|0
7100513|NCT02352779|11223341|FG000|Overall Study|Study Related Symptoms|1
7100514|NCT02352779|11223342|FG001|Overall Study|Study Related Symptoms|0
7100515|NCT02352779|11223343|FG002|Overall Study|Study Related Symptoms|0
7100516|NCT02352779|11223341|FG000|Overall Study|Absence of Symptoms|1
7100517|NCT02352779|11223342|FG001|Overall Study|Absence of Symptoms|0
7100518|NCT02352779|11223343|FG002|Overall Study|Absence of Symptoms|0
7100519|NCT02352779|11223341|FG000|Overall Study|Other Medical Reason|0
7100520|NCT02352779|11223342|FG001|Overall Study|Other Medical Reason|0
7100521|NCT02352779|11223343|FG002|Overall Study|Other Medical Reason|1
7100522|NCT02352779|11223341|FG000|Overall Study|No Reason|0
7100523|NCT02352779|11223342|FG001|Overall Study|No Reason|0
7100524|NCT02352779|11223343|FG002|Overall Study|No Reason|1
7100525|NCT02353169|11223401|FG000|Overall Study|QTc > 450 msec|1
7100526|NCT02353169|11223402|FG001|Overall Study|QTc > 450 msec|1
7100527|NCT02353169|11223403|FG002|Overall Study|QTc > 450 msec|1
7100528|NCT02353169|11223404|FG003|Overall Study|QTc > 450 msec|1
7100529|NCT02353169|11223401|FG000|Overall Study|OR team declined|2
7100530|NCT02353169|11223402|FG001|Overall Study|OR team declined|0
7100531|NCT02353169|11223403|FG002|Overall Study|OR team declined|0
7100532|NCT02353169|11223404|FG003|Overall Study|OR team declined|0
7100533|NCT02353169|11223401|FG000|Overall Study|Inhalational induction|0
7100534|NCT02353169|11223402|FG001|Overall Study|Inhalational induction|2
7100535|NCT02353169|11223403|FG002|Overall Study|Inhalational induction|0
7100536|NCT02353169|11223404|FG003|Overall Study|Inhalational induction|0
7100537|NCT02353169|11223401|FG000|Overall Study|ECG data error|0
7100538|NCT02353169|11223402|FG001|Overall Study|ECG data error|3
7100539|NCT02353169|11223403|FG002|Overall Study|ECG data error|2
7100540|NCT02353169|11223404|FG003|Overall Study|ECG data error|2
7100541|NCT02353169|11223401|FG000|Overall Study|Pre-op medication|0
7100542|NCT02353169|11223402|FG001|Overall Study|Pre-op medication|0
7100543|NCT02353169|11223403|FG002|Overall Study|Pre-op medication|1
7100544|NCT02353169|11223404|FG003|Overall Study|Pre-op medication|0
7100545|NCT02353442|11223437|FG000|Overall Study|Withdrawal by Subject|3
7100546|NCT02353442|11223438|FG001|Overall Study|Withdrawal by Subject|4
7100547|NCT02353871|11223474|FG000|Overall Study|Protocol deviation|0
7100548|NCT02353871|11223475|FG001|Overall Study|Protocol deviation|1
7100549|NCT02353871|11223474|FG000|Overall Study|Consent withdrawn|1
7100550|NCT02353871|11223475|FG001|Overall Study|Consent withdrawn|8
7100551|NCT02353871|11223474|FG000|Overall Study|Lost to Follow-up|2
7100552|NCT02353871|11223475|FG001|Overall Study|Lost to Follow-up|0
7100553|NCT02354222|11223501|FG000|Overall Study|Adverse Event|0
7100554|NCT02354222|11223502|FG001|Overall Study|Adverse Event|3
7100555|NCT02354222|11223501|FG000|Overall Study|Physician Decision|1
7100556|NCT02354222|11223502|FG001|Overall Study|Physician Decision|1
7100557|NCT02354222|11223501|FG000|Overall Study|Pregnancy|1
7100558|NCT02354222|11223502|FG001|Overall Study|Pregnancy|0
7100559|NCT02354222|11223501|FG000|Overall Study|Withdrawal by Subject|2
7100560|NCT02354222|11223502|FG001|Overall Study|Withdrawal by Subject|3
7100561|NCT02354222|11223501|FG000|Overall Study|Conflict with the stopping criteria|0
7100562|NCT02354222|11223502|FG001|Overall Study|Conflict with the stopping criteria|4
7100563|NCT02354235|11223510|FG000|Overall Study|Adverse Event|2
7100564|NCT02354235|11223511|FG001|Overall Study|Adverse Event|2
7100565|NCT02354235|11223510|FG000|Overall Study|Physician Decision|0
7100566|NCT02354235|11223511|FG001|Overall Study|Physician Decision|1
7100567|NCT02354235|11223510|FG000|Overall Study|Withdrawal by Subject|1
7100568|NCT02354235|11223511|FG001|Overall Study|Withdrawal by Subject|3
7100569|NCT02354235|11223510|FG000|Overall Study|Conflict with the stopping criteria|0
7100570|NCT02354235|11223511|FG001|Overall Study|Conflict with the stopping criteria|1
7100571|NCT02354417|11223544|FG000|Overall Study|Physician Decision|1
7100572|NCT02354508|11223569|FG000|Period 1: Core Phase|Adverse Event|1
7100573|NCT02354508|11223570|FG001|Period 1: Core Phase|Adverse Event|1
7100574|NCT02354508|11223571|FG002|Period 1: Core Phase|Adverse Event|2
7100575|NCT02354508|11223569|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1
7100576|NCT02354508|11223570|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0
7100577|NCT02354508|11223571|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2
7100578|NCT02354508|11223569|FG000|Period 1: Core Phase|Withdrawal by Subject|0
7100579|NCT02354508|11223570|FG001|Period 1: Core Phase|Withdrawal by Subject|1
7100580|NCT02354508|11223571|FG002|Period 1: Core Phase|Withdrawal by Subject|2
7100581|NCT02354508|11223569|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1
7100582|NCT02354508|11223570|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3
7100583|NCT02354508|11223571|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2
7100584|NCT02354508|11223569|FG000|Period 2: Extension Phase|Withdrawal by Subject|0
7100585|NCT02354508|11223570|FG001|Period 2: Extension Phase|Withdrawal by Subject|1
7100586|NCT02354508|11223571|FG002|Period 2: Extension Phase|Withdrawal by Subject|0
7100587|NCT02354508|11223569|FG000|Period 2: Extension Phase|Physician Decision|5
7100588|NCT02354508|11223570|FG001|Period 2: Extension Phase|Physician Decision|0
7100589|NCT02354508|11223571|FG002|Period 2: Extension Phase|Physician Decision|1
7100590|NCT02354508|11223569|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1
7100591|NCT02354508|11223570|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2
7100592|NCT02354508|11223571|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2
7100593|NCT02354508|11223569|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0
7100594|NCT02354508|11223570|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1
7100595|NCT02354508|11223571|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0
7100596|NCT02354508|11223569|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3
7100597|NCT02354508|11223570|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0
7100598|NCT02354508|11223571|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1
7100599|NCT02354586|11223637|FG000|Overall Study|Death|168
7100600|NCT02354586|11223637|FG000|Overall Study|Withdrawal by Subject|51
7100601|NCT02354586|11223637|FG000|Overall Study|Lost to Follow-up|6
7100602|NCT02354586|11223637|FG000|Overall Study|Disease progression|116
7100603|NCT02354599|11223647|FG000|Overall Study|Pretreatment Event/Adverse Event|0
7100604|NCT02354599|11223648|FG001|Overall Study|Pretreatment Event/Adverse Event|0
7100605|NCT02354599|11223649|FG002|Overall Study|Pretreatment Event/Adverse Event|0
7100606|NCT02354599|11223650|FG003|Overall Study|Pretreatment Event/Adverse Event|0
7100607|NCT02354599|11223651|FG004|Overall Study|Pretreatment Event/Adverse Event|0
7100608|NCT02354599|11223652|FG005|Overall Study|Pretreatment Event/Adverse Event|1
7100609|NCT02354599|11223647|FG000|Overall Study|Withdrawal by Subject|1
7100610|NCT02354599|11223648|FG001|Overall Study|Withdrawal by Subject|1
7100611|NCT02354599|11223649|FG002|Overall Study|Withdrawal by Subject|0
7100612|NCT02354599|11223650|FG003|Overall Study|Withdrawal by Subject|0
7100613|NCT02354599|11223651|FG004|Overall Study|Withdrawal by Subject|0
7100614|NCT02354599|11223652|FG005|Overall Study|Withdrawal by Subject|0
7100615|NCT02354690|11223672|FG000|Overall Study|Physician Decision|1
7100616|NCT02354976|11223715|FG000|Overall Study|Other - reason not specified|1
7100617|NCT02354976|11223716|FG001|Overall Study|Other - reason not specified|0
7100618|NCT02354976|11223717|FG002|Overall Study|Other - reason not specified|1
7100619|NCT02354976|11223715|FG000|Overall Study|Study-specifc withdrawal criteria|0
7100620|NCT02354976|11223716|FG001|Overall Study|Study-specifc withdrawal criteria|1
7100621|NCT02354976|11223717|FG002|Overall Study|Study-specifc withdrawal criteria|0
7100622|NCT02354976|11223715|FG000|Overall Study|Adverse Event|1
7100623|NCT02354976|11223716|FG001|Overall Study|Adverse Event|0
7100624|NCT02354976|11223717|FG002|Overall Study|Adverse Event|2
7100625|NCT02355028|11223727|FG000|Overall Study|Adverse Event|2
7100626|NCT02355028|11223728|FG001|Overall Study|Adverse Event|0
7100627|NCT02355028|11223727|FG000|Overall Study|Withdrawal by Subject|1
7100628|NCT02355028|11223728|FG001|Overall Study|Withdrawal by Subject|1
7100629|NCT02355028|11223727|FG000|Overall Study|Deemed ineligible after randomization|8
7100630|NCT02355028|11223728|FG001|Overall Study|Deemed ineligible after randomization|4
7100631|NCT02355665|11223783|FG000|Overall Study|Adverse Event|16
7100632|NCT02355665|11223784|FG001|Overall Study|Adverse Event|24
7100633|NCT02355665|11223783|FG000|Overall Study|Protocol Violation|2
7100634|NCT02355665|11223784|FG001|Overall Study|Protocol Violation|0
7100635|NCT02355665|11223783|FG000|Overall Study|Withdrawal by Subject|90
7100636|NCT02355665|11223784|FG001|Overall Study|Withdrawal by Subject|100
7100637|NCT02355665|11223783|FG000|Overall Study|Lost to Follow-up|131
7100638|NCT02355665|11223784|FG001|Overall Study|Lost to Follow-up|103
7100639|NCT02355665|11223783|FG000|Overall Study|Death|4
7100640|NCT02355665|11223784|FG001|Overall Study|Death|2
7100641|NCT02355665|11223783|FG000|Overall Study|Compliance, PI decision, move, eligible|6
7100642|NCT02355665|11223784|FG001|Overall Study|Compliance, PI decision, move, eligible|3
7100643|NCT02355691|11223792|FG000|Overall Study|Loss of Research Personnel|7
7100644|NCT02355691|11223793|FG001|Overall Study|Loss of Research Personnel|9
7100645|NCT02355743|11223799|FG000|Overall Study|Withdrawal by Subject|1
7100646|NCT02355743|11223799|FG000|Overall Study|Lost to Follow-up|1
7100647|NCT02356211|11223854|FG000|Overall Study|Withdrawal by Subject|2
7100648|NCT02356211|11223855|FG001|Overall Study|Withdrawal by Subject|2
7100649|NCT02356211|11223854|FG000|Overall Study|ineligible|1
7100650|NCT02356211|11223855|FG001|Overall Study|ineligible|8
7100651|NCT02356562|11223871|FG000|Overall Study|Withdrawal by Subject|0
7100652|NCT02356562|11223872|FG001|Overall Study|Withdrawal by Subject|1
7100653|NCT02356562|11223871|FG000|Overall Study|Re-entered treatment in a previous study|1
7100654|NCT02356562|11223872|FG001|Overall Study|Re-entered treatment in a previous study|0
7100655|NCT02356562|11223871|FG000|Overall Study|site closure|1
7100656|NCT02356562|11223872|FG001|Overall Study|site closure|0
7100657|NCT02356588|11223881|FG000|Overall Study|Lack of Efficacy|4
7100658|NCT02356588|11223882|FG001|Overall Study|Lack of Efficacy|10
7100659|NCT02356588|11223881|FG000|Overall Study|Adverse Event|0
7100660|NCT02356588|11223882|FG001|Overall Study|Adverse Event|2
7100661|NCT02356588|11223881|FG000|Overall Study|Withdrawal by Subject|1
7100662|NCT02356588|11223882|FG001|Overall Study|Withdrawal by Subject|0
7100663|NCT02356588|11223881|FG000|Overall Study|Protocol Violation|0
7100664|NCT02356588|11223882|FG001|Overall Study|Protocol Violation|1
7100665|NCT02356783|11223899|FG000|Overall Study|Lost to Follow-up|1
7100666|NCT02356783|11223900|FG001|Overall Study|Lost to Follow-up|3
7100667|NCT02356887|11223906|FG000|Overall Study|poor compliance|2
7100668|NCT02357134|11223933|FG000|Overall Study|Lost to Follow-up|1
7100669|NCT02357134|11223934|FG001|Overall Study|Lost to Follow-up|0
7100670|NCT02357134|11223935|FG002|Overall Study|Lost to Follow-up|0
7100671|NCT02357134|11223936|FG003|Overall Study|Lost to Follow-up|0
7100672|NCT02357147|11223948|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3
7100673|NCT02357147|11223949|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3
7100674|NCT02357147|11223948|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0
7100675|NCT02357147|11223949|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1
7100676|NCT02357147|11223948|FG000|Combination Treatment Phase|Investigator Discretion|1
7100677|NCT02357147|11223949|FG001|Combination Treatment Phase|Investigator Discretion|1
7100678|NCT02357147|11223948|FG000|Combination Treatment Phase|Withdrawal by Subject|4
7100679|NCT02357147|11223949|FG001|Combination Treatment Phase|Withdrawal by Subject|2
7100680|NCT02357147|11223948|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4
7100681|NCT02357147|11223949|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1
7100682|NCT02357147|11223948|FG000|Combination Treatment Phase|Adverse Event|12
7100683|NCT02357147|11223949|FG001|Combination Treatment Phase|Adverse Event|4
7100684|NCT02357147|11223948|FG000|Combination Treatment Phase|Death|1
7100685|NCT02357147|11223949|FG001|Combination Treatment Phase|Death|1
7100686|NCT02357147|11223948|FG000|Combination Treatment Phase|Sponsor Decision|0
7100687|NCT02357147|11223949|FG001|Combination Treatment Phase|Sponsor Decision|12
7100688|NCT02357147|11223948|FG000|Combination Treatment Phase|Other|1
7100689|NCT02357147|11223949|FG001|Combination Treatment Phase|Other|0
7100690|NCT02357147|11223948|FG000|Combination Treatment Phase|Not treated|0
7100691|NCT02357147|11223949|FG001|Combination Treatment Phase|Not treated|2
7100692|NCT02357147|11223948|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15
7100693|NCT02357147|11223949|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10
7100694|NCT02357147|11223948|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0
7100695|NCT02357147|11223949|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1
7100696|NCT02357147|11223948|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10
7100697|NCT02357147|11223949|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0
7100698|NCT02357147|11223948|FG000|Maintenance Treatment Phase|Adverse Event|0
7100699|NCT02357147|11223949|FG001|Maintenance Treatment Phase|Adverse Event|3
7100700|NCT02357147|11223948|FG000|Maintenance Treatment Phase|Sponsor Decision|0
7100701|NCT02357147|11223949|FG001|Maintenance Treatment Phase|Sponsor Decision|15
7100702|NCT02357147|11223948|FG000|Maintenance Treatment Phase|Not Treated|1
7100703|NCT02357147|11223949|FG001|Maintenance Treatment Phase|Not Treated|0
7100704|NCT02357342|11223987|FG000|First 6 Months|Death|2
7100705|NCT02357342|11223988|FG001|First 6 Months|Death|0
7100706|NCT02357368|11223998|FG000|Overall Study|Lost to Follow-up|0
7100707|NCT02357368|11223999|FG001|Overall Study|Lost to Follow-up|0
7100708|NCT02357368|11224000|FG002|Overall Study|Lost to Follow-up|0
7100709|NCT02357368|11224001|FG003|Overall Study|Lost to Follow-up|1
7100710|NCT02357368|11223998|FG000|Overall Study|Pregnancy|3
7100711|NCT02357368|11223999|FG001|Overall Study|Pregnancy|2
7100712|NCT02357368|11224000|FG002|Overall Study|Pregnancy|0
7100713|NCT02357368|11224001|FG003|Overall Study|Pregnancy|0
7100714|NCT02357368|11223998|FG000|Overall Study|Withdrawal by Subject|3
7100715|NCT02357368|11223999|FG001|Overall Study|Withdrawal by Subject|1
7100716|NCT02357368|11224000|FG002|Overall Study|Withdrawal by Subject|1
7100717|NCT02357368|11224001|FG003|Overall Study|Withdrawal by Subject|2
7100718|NCT02357420|11224024|FG000|Overall Study|Adverse Event|3
7100719|NCT02357420|11224025|FG001|Overall Study|Adverse Event|3
7100720|NCT02357420|11224026|FG002|Overall Study|Adverse Event|8
7100721|NCT02357420|11224027|FG003|Overall Study|Adverse Event|9
7100722|NCT02357420|11224024|FG000|Overall Study|Investigator Decision|1
7100723|NCT02357420|11224025|FG001|Overall Study|Investigator Decision|0
7100724|NCT02357420|11224026|FG002|Overall Study|Investigator Decision|0
7100725|NCT02357420|11224027|FG003|Overall Study|Investigator Decision|0
7100726|NCT02357420|11224024|FG000|Overall Study|Prohibited Medication|1
7100727|NCT02357420|11224025|FG001|Overall Study|Prohibited Medication|1
7100728|NCT02357420|11224026|FG002|Overall Study|Prohibited Medication|0
7100729|NCT02357420|11224027|FG003|Overall Study|Prohibited Medication|0
7100730|NCT02357420|11224024|FG000|Overall Study|Protocol Non-compliance|0
7100731|NCT02357420|11224025|FG001|Overall Study|Protocol Non-compliance|0
7100732|NCT02357420|11224026|FG002|Overall Study|Protocol Non-compliance|0
7100733|NCT02357420|11224027|FG003|Overall Study|Protocol Non-compliance|1
7100734|NCT02357420|11224024|FG000|Overall Study|Withdrawn Consent|4
7100735|NCT02357420|11224025|FG001|Overall Study|Withdrawn Consent|8
7100736|NCT02357420|11224026|FG002|Overall Study|Withdrawn Consent|6
7100737|NCT02357420|11224027|FG003|Overall Study|Withdrawn Consent|6
7100738|NCT02357420|11224024|FG000|Overall Study|Lost to Follow-up|3
7100739|NCT02357420|11224025|FG001|Overall Study|Lost to Follow-up|0
7100740|NCT02357420|11224026|FG002|Overall Study|Lost to Follow-up|2
7100741|NCT02357420|11224027|FG003|Overall Study|Lost to Follow-up|3
7100742|NCT02357459|11224040|FG000|Overall Study|Adverse Event|0
7100743|NCT02357459|11224041|FG001|Overall Study|Adverse Event|1
7100744|NCT02357459|11224042|FG002|Overall Study|Adverse Event|1
7100745|NCT02357459|11224040|FG000|Overall Study|Withdrawal by Subject|5
7100746|NCT02357459|11224041|FG001|Overall Study|Withdrawal by Subject|3
7100747|NCT02357459|11224042|FG002|Overall Study|Withdrawal by Subject|3
7100748|NCT02357459|11224040|FG000|Overall Study|Physician Decision|0
7100749|NCT02357459|11224041|FG001|Overall Study|Physician Decision|2
7100750|NCT02357459|11224042|FG002|Overall Study|Physician Decision|0
7100751|NCT02357459|11224040|FG000|Overall Study|Protocol Violation|1
7100752|NCT02357459|11224041|FG001|Overall Study|Protocol Violation|1
7100753|NCT02357459|11224042|FG002|Overall Study|Protocol Violation|0
7100754|NCT02357459|11224040|FG000|Overall Study|Lost to Follow-up|1
7100755|NCT02357459|11224041|FG001|Overall Study|Lost to Follow-up|3
7100756|NCT02357459|11224042|FG002|Overall Study|Lost to Follow-up|0
7100757|NCT02357459|11224040|FG000|Overall Study|Lack of Efficacy|7
7100758|NCT02357459|11224041|FG001|Overall Study|Lack of Efficacy|4
7100759|NCT02357459|11224042|FG002|Overall Study|Lack of Efficacy|4
7100760|NCT02357459|11224040|FG000|Overall Study|Patient Relocated|2
7100761|NCT02357459|11224041|FG001|Overall Study|Patient Relocated|0
7100762|NCT02357459|11224042|FG002|Overall Study|Patient Relocated|0
7100763|NCT02357459|11224040|FG000|Overall Study|Instruction from PCP|1
7100764|NCT02357459|11224041|FG001|Overall Study|Instruction from PCP|0
7100765|NCT02357459|11224042|FG002|Overall Study|Instruction from PCP|0
7100766|NCT02357459|11224040|FG000|Overall Study|Incarceration|0
7100767|NCT02357459|11224041|FG001|Overall Study|Incarceration|0
7100768|NCT02357459|11224042|FG002|Overall Study|Incarceration|1
7100769|NCT02357459|11224040|FG000|Overall Study|Pre-planned Knee surgery|0
7100770|NCT02357459|11224041|FG001|Overall Study|Pre-planned Knee surgery|0
7100771|NCT02357459|11224042|FG002|Overall Study|Pre-planned Knee surgery|2
7100772|NCT02357459|11224040|FG000|Overall Study|Job Commitments|0
6805763|NCT02675426|10807975|FG000|Overall Study|Adverse Event|6
6805764|NCT02675426|10807976|FG001|Overall Study|Adverse Event|2
6805765|NCT02675426|10807977|FG002|Overall Study|Adverse Event|9
6805766|NCT02675426|10807975|FG000|Overall Study|Withdrawal by Subject|3
6805767|NCT02675426|10807976|FG001|Overall Study|Withdrawal by Subject|5
6805768|NCT02675426|10807977|FG002|Overall Study|Withdrawal by Subject|5
6805769|NCT02675426|10807975|FG000|Overall Study|Lost to Follow-up|1
6805770|NCT02675426|10807976|FG001|Overall Study|Lost to Follow-up|0
6805771|NCT02675426|10807977|FG002|Overall Study|Lost to Follow-up|2
6805772|NCT02675426|10807975|FG000|Overall Study|Other|3
6805773|NCT02675426|10807976|FG001|Overall Study|Other|1
6805774|NCT02675426|10807977|FG002|Overall Study|Other|2
6805775|NCT02639546|10807993|FG000|Overall Study|Death|2
6805776|NCT02639546|10807994|FG001|Overall Study|Death|2
6805777|NCT02639546|10807995|FG002|Overall Study|Death|1
6805778|NCT02639546|10807996|FG003|Overall Study|Death|2
6805779|NCT02639546|10807997|FG004|Overall Study|Death|2
6805780|NCT02639546|10807998|FG005|Overall Study|Death|2
6805781|NCT02639546|10807999|FG006|Overall Study|Death|0
7100773|NCT02357459|11224041|FG001|Overall Study|Job Commitments|0
7100774|NCT02357459|11224042|FG002|Overall Study|Job Commitments|1
6805782|NCT02639546|10808000|FG007|Overall Study|Death|0
6805783|NCT02639546|10807993|FG000|Overall Study|Lost to Follow-up|0
6805784|NCT02639546|10807994|FG001|Overall Study|Lost to Follow-up|0
6805785|NCT02639546|10807995|FG002|Overall Study|Lost to Follow-up|1
6805786|NCT02639546|10807996|FG003|Overall Study|Lost to Follow-up|0
6805787|NCT02639546|10807997|FG004|Overall Study|Lost to Follow-up|1
6805788|NCT02639546|10807998|FG005|Overall Study|Lost to Follow-up|1
6805789|NCT02639546|10807999|FG006|Overall Study|Lost to Follow-up|0
6805790|NCT02639546|10808000|FG007|Overall Study|Lost to Follow-up|1
6805791|NCT02639546|10807993|FG000|Overall Study|PI, physician decision; no response to trt.|2
6810363|NCT04617860|10814096|FG000|Overall Study|Adverse Event|0
7100775|NCT02357576|11224060|FG000|Treatment Period|Withdrawal by Subject|0
7100776|NCT02357576|11224061|FG001|Treatment Period|Withdrawal by Subject|1
7100777|NCT02357576|11224060|FG000|Treatment Period|Physician Decision|0
7100778|NCT02357576|11224061|FG001|Treatment Period|Physician Decision|1
7100779|NCT02357576|11224060|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1
7100780|NCT02357576|11224061|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1
7100781|NCT02357576|11224060|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1
7100782|NCT02357576|11224061|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0
7100783|NCT02357576|11224060|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1
7100784|NCT02357576|11224061|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4
7100785|NCT02357576|11224060|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2
7100786|NCT02357576|11224061|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0
7100787|NCT02357901|11224098|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161
7100788|NCT02357901|11224099|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0
7100789|NCT02357901|11224100|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0
7100790|NCT02357901|11224101|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0
7100791|NCT02357901|11224098|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0
7100792|NCT02357901|11224099|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26
7100793|NCT02357901|11224100|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23
7100794|NCT02357901|11224101|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12
7100795|NCT02357901|11224098|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0
7100796|NCT02357901|11224099|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20
7100797|NCT02357901|11224100|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21
7100798|NCT02357901|11224101|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18
7100799|NCT02357901|11224098|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0
7100800|NCT02357901|11224099|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3
7100801|NCT02357901|11224100|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5
7100802|NCT02357901|11224101|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18
7100803|NCT02357901|11224098|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0
7100804|NCT02357901|11224099|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6
7100805|NCT02357901|11224100|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10
7100806|NCT02357901|11224101|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2
7100807|NCT02357901|11224098|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
7100808|NCT02357901|11224099|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2
7100809|NCT02357901|11224100|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5
7100810|NCT02357901|11224101|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
7100811|NCT02357901|11224098|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0
7100812|NCT02357901|11224099|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
7100813|NCT02357901|11224100|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
7100814|NCT02357901|11224101|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3
7100815|NCT02357901|11224098|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
7100816|NCT02357901|11224099|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
7100817|NCT02357901|11224100|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
7100818|NCT02357901|11224101|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
7100819|NCT02357901|11224098|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
7100820|NCT02357901|11224099|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1
7100821|NCT02357901|11224100|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
7100822|NCT02357901|11224101|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3
7100823|NCT02357901|11224098|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0
7100824|NCT02357901|11224099|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0
7100825|NCT02357901|11224100|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1
7100826|NCT02357901|11224101|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1
7100827|NCT02357901|11224098|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0
7100828|NCT02357901|11224099|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17
7100829|NCT02357901|11224100|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6
7100830|NCT02357901|11224101|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7
7100831|NCT02357940|11224111|FG000|Overall Study|Adverse Event|0
7100832|NCT02357940|11224112|FG001|Overall Study|Adverse Event|1
7100833|NCT02357940|11224111|FG000|Overall Study|Investigator's judgement|0
7100834|NCT02357940|11224112|FG001|Overall Study|Investigator's judgement|1
7100835|NCT02357979|11224120|FG000|Overall Study|Lost to Follow-up|5
7100836|NCT02357979|11224121|FG001|Overall Study|Lost to Follow-up|5
7100837|NCT02358044|11224129|FG000|Overall Study|Adverse Event|0
7100838|NCT02358044|11224130|FG001|Overall Study|Adverse Event|1
7100839|NCT02358044|11224129|FG000|Overall Study|Lost to Follow-up|2
7100840|NCT02358044|11224130|FG001|Overall Study|Lost to Follow-up|1
7100841|NCT02358044|11224129|FG000|Overall Study|Physician Decision|0
7100842|NCT02358044|11224130|FG001|Overall Study|Physician Decision|1
7100843|NCT02358044|11224129|FG000|Overall Study|Withdrawal by Subject|0
7100844|NCT02358044|11224130|FG001|Overall Study|Withdrawal by Subject|4
7100845|NCT02358343|11224150|FG000|Screening Intervention|Death|0
7100846|NCT02358343|11224151|FG001|Screening Intervention|Death|2
7100847|NCT02358343|11224152|FG002|Screening Intervention|Death|0
7100848|NCT02358343|11224153|FG003|Screening Intervention|Death|0
7100849|NCT02358343|11224154|FG004|Screening Intervention|Death|0
7100850|NCT02358343|11224150|FG000|Screening Intervention|Withdrawal by Subject|1
7100851|NCT02358343|11224151|FG001|Screening Intervention|Withdrawal by Subject|0
7100852|NCT02358343|11224152|FG002|Screening Intervention|Withdrawal by Subject|0
7100853|NCT02358343|11224153|FG003|Screening Intervention|Withdrawal by Subject|0
7100854|NCT02358343|11224154|FG004|Screening Intervention|Withdrawal by Subject|0
7100855|NCT02358343|11224150|FG000|Screening Intervention|Determined Ineligible|5
7100856|NCT02358343|11224151|FG001|Screening Intervention|Determined Ineligible|6
7100857|NCT02358343|11224152|FG002|Screening Intervention|Determined Ineligible|0
7100858|NCT02358343|11224153|FG003|Screening Intervention|Determined Ineligible|0
7100859|NCT02358343|11224154|FG004|Screening Intervention|Determined Ineligible|0
7100860|NCT02358343|11224150|FG000|Comparative Efficacy Trial / Observation|Death|0
7100861|NCT02358343|11224151|FG001|Comparative Efficacy Trial / Observation|Death|0
7100862|NCT02358343|11224152|FG002|Comparative Efficacy Trial / Observation|Death|2
7100863|NCT02358343|11224153|FG003|Comparative Efficacy Trial / Observation|Death|0
7100864|NCT02358343|11224154|FG004|Comparative Efficacy Trial / Observation|Death|0
7100865|NCT02358343|11224150|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0
7100866|NCT02358343|11224151|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0
7100867|NCT02358343|11224152|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
7100868|NCT02358343|11224153|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
7100869|NCT02358343|11224154|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
7100870|NCT02358343|11224150|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
7100871|NCT02358343|11224151|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
7100872|NCT02358343|11224152|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1
7100873|NCT02358343|11224153|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
7100874|NCT02358343|11224154|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
7100875|NCT02358369|11224168|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35
7100876|NCT02358369|11224169|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0
7100877|NCT02358369|11224170|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0
7100878|NCT02358369|11224171|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0
7100879|NCT02358369|11224172|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0
7100880|NCT02358369|11224168|FG000|Treatment Period A/B|Adverse Event|0
7100881|NCT02358369|11224169|FG001|Treatment Period A/B|Adverse Event|0
7100882|NCT02358369|11224170|FG002|Treatment Period A/B|Adverse Event|1
7100883|NCT02358369|11224171|FG003|Treatment Period A/B|Adverse Event|2
7100884|NCT02358369|11224172|FG004|Treatment Period A/B|Adverse Event|0
7100885|NCT02358369|11224168|FG000|Treatment Period A/B|Death|0
7100886|NCT02358369|11224169|FG001|Treatment Period A/B|Death|0
7100887|NCT02358369|11224170|FG002|Treatment Period A/B|Death|1
7100888|NCT02358369|11224171|FG003|Treatment Period A/B|Death|0
7100889|NCT02358369|11224172|FG004|Treatment Period A/B|Death|0
7100890|NCT02358369|11224168|FG000|Treatment Period A/B|Withdrawal by Subject|0
7100891|NCT02358369|11224169|FG001|Treatment Period A/B|Withdrawal by Subject|2
7100892|NCT02358369|11224170|FG002|Treatment Period A/B|Withdrawal by Subject|0
7100893|NCT02358369|11224171|FG003|Treatment Period A/B|Withdrawal by Subject|2
7100894|NCT02358369|11224172|FG004|Treatment Period A/B|Withdrawal by Subject|0
7100895|NCT02358369|11224168|FG000|Treatment Period C|Adverse Event|0
7100896|NCT02358369|11224169|FG001|Treatment Period C|Adverse Event|0
7100897|NCT02358369|11224170|FG002|Treatment Period C|Adverse Event|0
7100898|NCT02358369|11224171|FG003|Treatment Period C|Adverse Event|0
7100899|NCT02358369|11224172|FG004|Treatment Period C|Adverse Event|7
7100900|NCT02358473|11224182|FG000|Overall Study|Disease Progession|6
7100901|NCT02358473|11224182|FG000|Overall Study|Adverse Event|3
7100902|NCT02358473|11224182|FG000|Overall Study|Withdrawal by Subject|2
7100903|NCT02358473|11224182|FG000|Overall Study|Physician Decision|2
7100904|NCT02358668|11224198|FG000|Overall Study|Adverse Event|2
7100905|NCT02358668|11224199|FG001|Overall Study|Adverse Event|0
7100906|NCT02358668|11224200|FG002|Overall Study|Adverse Event|0
7100907|NCT02358668|11224198|FG000|Overall Study|Withdrawal by Subject|0
7100908|NCT02358668|11224199|FG001|Overall Study|Withdrawal by Subject|1
7100909|NCT02358668|11224200|FG002|Overall Study|Withdrawal by Subject|0
7100910|NCT02358863|11224208|FG000|Overall Study|Physician Decision|3
7100911|NCT02359045|11224246|FG000|Overall Study|Eligibility criteria not fulfilled|3
7100912|NCT02359045|11224247|FG001|Overall Study|Eligibility criteria not fulfilled|1
7100913|NCT02359045|11224246|FG000|Overall Study|Lost to Follow-up|1
7100914|NCT02359045|11224247|FG001|Overall Study|Lost to Follow-up|1
7100915|NCT02359045|11224246|FG000|Overall Study|Adverse Event|0
7100916|NCT02359045|11224247|FG001|Overall Study|Adverse Event|1
7100917|NCT02359435|11224297|FG000|Overall Study|Lost to Follow-up|4
7100918|NCT02359435|11224298|FG001|Overall Study|Lost to Follow-up|4
7100919|NCT02359552|11224306|FG000|Overall Study|Lost to Follow-up|3
7100920|NCT02359552|11224307|FG001|Overall Study|Lost to Follow-up|4
7100921|NCT02359851|11224313|FG000|Overall Study|Death|1
7100922|NCT02359851|11224313|FG000|Overall Study|Disease progression|1
7100923|NCT02359877|11224321|FG000|Overall Study|Withdrawal by Subject|1
7100924|NCT02359877|11224322|FG001|Overall Study|Withdrawal by Subject|0
7100925|NCT02359877|11224323|FG002|Overall Study|Withdrawal by Subject|0
7100926|NCT02359877|11224324|FG003|Overall Study|Withdrawal by Subject|2
7100927|NCT02359877|11224321|FG000|Overall Study|Adverse Event|0
7100928|NCT02359877|11224322|FG001|Overall Study|Adverse Event|0
7100929|NCT02359877|11224323|FG002|Overall Study|Adverse Event|0
7100930|NCT02359877|11224324|FG003|Overall Study|Adverse Event|1
7100931|NCT02359890|11224352|FG000|Overall Study|Not meeting eligibility|4
7100932|NCT02359890|11224352|FG000|Overall Study|Never treated with study catheter|6
7100933|NCT02359903|11224358|FG000|Overall Study|Adverse Event|0
7100934|NCT02359903|11224359|FG001|Overall Study|Adverse Event|2
7100935|NCT02360098|11224425|FG000|Overall Study|Physician Decision|7
7100936|NCT02360228|11224458|FG000|Overall Study|Withdrawal by Subject|1
7100937|NCT02360228|11224459|FG001|Overall Study|Withdrawal by Subject|0
7100938|NCT02360228|11224460|FG002|Overall Study|Withdrawal by Subject|0
7100939|NCT02360228|11224458|FG000|Overall Study|Self-discontinued medication|0
7100940|NCT02360228|11224459|FG001|Overall Study|Self-discontinued medication|1
7100941|NCT02360228|11224460|FG002|Overall Study|Self-discontinued medication|0
7100942|NCT02360228|11224458|FG000|Overall Study|Unstable symptoms during screening|0
7100943|NCT02360228|11224459|FG001|Overall Study|Unstable symptoms during screening|0
7100944|NCT02360228|11224460|FG002|Overall Study|Unstable symptoms during screening|1
7100945|NCT02360293|11224470|FG000|Overall Study|Lost to Follow-up|73
7100946|NCT02360293|11224471|FG001|Overall Study|Lost to Follow-up|95
7100947|NCT02360293|11224470|FG000|Overall Study|Withdrawal by Subject|2
7100948|NCT02360293|11224471|FG001|Overall Study|Withdrawal by Subject|1
7100949|NCT02360293|11224470|FG000|Overall Study|Excluded|1
7100950|NCT02360293|11224471|FG001|Overall Study|Excluded|0
7100951|NCT02360397|11224499|FG000|Overall Study|Incomplete screening|3
7100952|NCT02360397|11224499|FG000|Overall Study|Adverse Event|1
7100953|NCT02360475|11224508|FG000|Overall Study|Lost to Follow-up|4
7100954|NCT02360475|11224509|FG001|Overall Study|Lost to Follow-up|12
7100955|NCT02360475|11224510|FG002|Overall Study|Lost to Follow-up|6
7100956|NCT02360475|11224511|FG003|Overall Study|Lost to Follow-up|4
7100957|NCT02360475|11224508|FG000|Overall Study|Withdrawal by Subject|0
7100958|NCT02360475|11224509|FG001|Overall Study|Withdrawal by Subject|1
7100959|NCT02360475|11224510|FG002|Overall Study|Withdrawal by Subject|2
7100960|NCT02360475|11224511|FG003|Overall Study|Withdrawal by Subject|0
7100961|NCT02360475|11224508|FG000|Overall Study|Migrated/moved from study area|0
7100962|NCT02360475|11224509|FG001|Overall Study|Migrated/moved from study area|0
7100963|NCT02360475|11224510|FG002|Overall Study|Migrated/moved from study area|0
7100964|NCT02360475|11224511|FG003|Overall Study|Migrated/moved from study area|1
7100965|NCT02360605|11224532|FG000|Overall Study|Withdrawal by Subject|4
7100966|NCT02360605|11224533|FG001|Overall Study|Withdrawal by Subject|9
7100967|NCT02360605|11224532|FG000|Overall Study|Lost to Follow-up|7
7100968|NCT02360605|11224533|FG001|Overall Study|Lost to Follow-up|8
7100969|NCT02360605|11224532|FG000|Overall Study|Death|0
7100970|NCT02360605|11224533|FG001|Overall Study|Death|1
7100971|NCT02360995|11224564|FG000|Overall Study|Lost to Follow-up|2
7100972|NCT02360995|11224565|FG001|Overall Study|Lost to Follow-up|0
7100973|NCT02360995|11224566|FG002|Overall Study|Lost to Follow-up|2
7100974|NCT02360995|11224564|FG000|Overall Study|Withdrawal by Subject|0
7100975|NCT02360995|11224565|FG001|Overall Study|Withdrawal by Subject|1
7100976|NCT02360995|11224566|FG002|Overall Study|Withdrawal by Subject|0
7100977|NCT02361216|11224576|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0
7100978|NCT02361216|11224577|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1
7100979|NCT02361216|11224576|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1
7100980|NCT02361216|11224577|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2
7100981|NCT02361216|11224576|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1
7100982|NCT02361216|11224577|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0
7100983|NCT02361216|11224576|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6
7100984|NCT02361216|11224577|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11
7100985|NCT02361216|11224576|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3
7100986|NCT02361216|11224577|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3
7100987|NCT02361216|11224576|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0
7100988|NCT02361216|11224577|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2
7100989|NCT02361307|11224588|FG000|Overall Study|Unstable medical condition.|0
7100990|NCT02361307|11224589|FG001|Overall Study|Unstable medical condition.|1
7100991|NCT02361762|11224615|FG000|Overall Study|Withdrawal by Subject|0
7100992|NCT02361762|11224616|FG001|Overall Study|Withdrawal by Subject|1
7100993|NCT02361762|11224615|FG000|Overall Study|Lost to Follow-up|0
7100994|NCT02361762|11224616|FG001|Overall Study|Lost to Follow-up|1
7100995|NCT02362269|11224637|FG000|Overall Study|Moved|1
7100996|NCT02362269|11224638|FG001|Overall Study|Moved|0
7100997|NCT02362269|11224637|FG000|Overall Study|Lost to Follow-up|0
7100998|NCT02362269|11224638|FG001|Overall Study|Lost to Follow-up|6
7100999|NCT02362282|11224646|FG000|Overall Study|Withdrawal by Subject|1
7101000|NCT02362282|11224647|FG001|Overall Study|Withdrawal by Subject|0
7101001|NCT02362360|11224662|FG000|Period 1|Lack of Efficacy|1
7101002|NCT02362360|11224663|FG001|Period 1|Lack of Efficacy|0
7101003|NCT02362360|11224662|FG000|Period 1|Withdrawal by Subject|2
7101004|NCT02362360|11224663|FG001|Period 1|Withdrawal by Subject|1
7101005|NCT02362412|11224673|FG000|Treatment Period III|Lost to Follow-up|0
7101006|NCT02362412|11224674|FG001|Treatment Period III|Lost to Follow-up|1
7101007|NCT02362425|11224690|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2
7101008|NCT02362425|11224691|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
7101009|NCT02362425|11224692|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
7101010|NCT02362425|11224693|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
7101011|NCT02362425|11224690|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1
7101012|NCT02362425|11224691|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0
7101013|NCT02362425|11224692|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0
7101014|NCT02362425|11224693|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0
7101015|NCT02362425|11224690|FG000|Phase 1 (up to 6 Months)|Screening failure|1
7101016|NCT02362425|11224691|FG001|Phase 1 (up to 6 Months)|Screening failure|0
7101017|NCT02362425|11224692|FG002|Phase 1 (up to 6 Months)|Screening failure|0
7101018|NCT02362425|11224693|FG003|Phase 1 (up to 6 Months)|Screening failure|0
7101019|NCT02362425|11224690|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3
7101020|NCT02362425|11224691|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
7101021|NCT02362425|11224692|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
7101022|NCT02362425|11224693|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
7101023|NCT02362425|11224690|FG000|Phase 1 (up to 6 Months)|Study closure|9
7101024|NCT02362425|11224691|FG001|Phase 1 (up to 6 Months)|Study closure|0
7101025|NCT02362425|11224692|FG002|Phase 1 (up to 6 Months)|Study closure|0
7101026|NCT02362425|11224693|FG003|Phase 1 (up to 6 Months)|Study closure|0
7101027|NCT02362425|11224690|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
7101028|NCT02362425|11224691|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
7101029|NCT02362425|11224692|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
7101030|NCT02362425|11224693|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2
7101031|NCT02362425|11224690|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
7101032|NCT02362425|11224691|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
7101033|NCT02362425|11224692|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
7101034|NCT02362425|11224693|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1
7101035|NCT02362425|11224690|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
7101036|NCT02362425|11224691|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
7101037|NCT02362425|11224692|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1
7101038|NCT02362425|11224693|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
7101039|NCT02362646|11224715|FG000|Overall Study|Death|15
7101040|NCT02362646|11224716|FG001|Overall Study|Death|8
7101041|NCT02362646|11224715|FG000|Overall Study|Withdrawal by Subject|2
7101042|NCT02362646|11224716|FG001|Overall Study|Withdrawal by Subject|2
7101043|NCT02362646|11224715|FG000|Overall Study|received transplant|21
7101044|NCT02362646|11224716|FG001|Overall Study|received transplant|14
7101045|NCT02362724|11224739|FG000|Overall Study|Withdrawal by Subject|3
7101046|NCT02362724|11224740|FG001|Overall Study|Withdrawal by Subject|1
7101047|NCT02362724|11224739|FG000|Overall Study|Adverse Event|3
7101048|NCT02362724|11224740|FG001|Overall Study|Adverse Event|0
7101049|NCT02362789|11224748|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1
7101050|NCT02362789|11224749|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0
7101051|NCT02362789|11224750|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0
7101052|NCT02362789|11224748|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1
7101053|NCT02362789|11224749|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0
7101054|NCT02362789|11224750|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0
7101055|NCT02362789|11224748|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0
7101056|NCT02362789|11224749|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2
7101057|NCT02362789|11224750|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6
7101058|NCT02362789|11224748|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0
7101059|NCT02362789|11224749|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1
7101060|NCT02362789|11224750|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4
7101061|NCT02362789|11224748|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0
7101062|NCT02362789|11224749|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1
7101063|NCT02362789|11224750|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2
7101064|NCT02363283|11224766|FG000|Overall Study|Withdrawal by Subject|1
7101065|NCT02363283|11224766|FG000|Overall Study|Not eligible due to transaminitis|1
7101066|NCT02363322|11224772|FG000|Overall Study|Lost to Follow-up|1
7101067|NCT02363322|11224773|FG001|Overall Study|Lost to Follow-up|0
7101068|NCT02363439|11224779|FG000|Overall Study|Lack of Efficacy|4
7101069|NCT02363478|11224783|FG000|Overall Study|Lost to Follow-up|4
7101070|NCT02363478|11224783|FG000|Overall Study|Adverse Event|4
7101071|NCT02363686|11224797|FG000|Overall Study|Withdrawal by Subject|22
7101072|NCT02363686|11224797|FG000|Overall Study|incomplete FEES examinations|13
7101073|NCT02363738|11224803|FG000|Overall Study|Adverse Event|5
7101074|NCT02363738|11224804|FG001|Overall Study|Adverse Event|2
7101075|NCT02363738|11224803|FG000|Overall Study|Lack of Efficacy|1
7101076|NCT02363738|11224804|FG001|Overall Study|Lack of Efficacy|2
7101077|NCT02363738|11224803|FG000|Overall Study|Lost to Follow-up|2
7101078|NCT02363738|11224804|FG001|Overall Study|Lost to Follow-up|1
7101079|NCT02363946|11224846|FG000|Overall Study|Lost to Follow-up|0
7101080|NCT02363946|11224847|FG001|Overall Study|Lost to Follow-up|0
7101081|NCT02363946|11224848|FG002|Overall Study|Lost to Follow-up|0
7101082|NCT02363946|11224849|FG003|Overall Study|Lost to Follow-up|0
7101083|NCT02363946|11224850|FG004|Overall Study|Lost to Follow-up|0
7101084|NCT02363946|11224851|FG005|Overall Study|Lost to Follow-up|0
7101085|NCT02363946|11224852|FG006|Overall Study|Lost to Follow-up|0
7101086|NCT02363946|11224853|FG007|Overall Study|Lost to Follow-up|1
7101087|NCT02363946|11224854|FG008|Overall Study|Lost to Follow-up|0
7101088|NCT02363946|11224855|FG009|Overall Study|Lost to Follow-up|0
7101089|NCT02363946|11224856|FG010|Overall Study|Lost to Follow-up|0
7101090|NCT02363946|11224857|FG011|Overall Study|Lost to Follow-up|0
7101091|NCT02363946|11224858|FG012|Overall Study|Lost to Follow-up|0
7101092|NCT02363959|11224888|FG000|Overall Study|Medical instability|1
7101093|NCT02363959|11224889|FG001|Overall Study|Medical instability|0
7101094|NCT02364037|11224901|FG000|Overall Study|Withdrawal by Subject|7
7101095|NCT02364037|11224902|FG001|Overall Study|Withdrawal by Subject|4
7101096|NCT02364037|11224901|FG000|Overall Study|Lost to Follow-up|37
7101097|NCT02364037|11224902|FG001|Overall Study|Lost to Follow-up|49
7101098|NCT02364180|11224912|FG000|Overall Study|Screen Fail|1
7101099|NCT02364336|11224928|FG000|Overall Study|Adverse Event|0
7101100|NCT02364336|11224929|FG001|Overall Study|Adverse Event|1
7101101|NCT02364388|11224936|FG000|Overall Study|Protocol Violation|1
7101102|NCT02364388|11224936|FG000|Overall Study|Technical Failure|3
7101103|NCT02364388|11224936|FG000|Overall Study|No OA/US data|2
7101104|NCT02364388|11224936|FG000|Overall Study|No Biopsy|2
7101105|NCT02364947|11224980|FG000|Overall Study|Withdrawal by Subject|10
7101106|NCT02364947|11224981|FG001|Overall Study|Withdrawal by Subject|8
7101107|NCT02364947|11224982|FG002|Overall Study|Withdrawal by Subject|9
7101108|NCT02364947|11224980|FG000|Overall Study|Adverse Event|45
7101109|NCT02364947|11224981|FG001|Overall Study|Adverse Event|33
7101110|NCT02364947|11224982|FG002|Overall Study|Adverse Event|11
7101111|NCT02364947|11224980|FG000|Overall Study|Protocol Violation|1
7101112|NCT02364947|11224981|FG001|Overall Study|Protocol Violation|1
7101113|NCT02364947|11224982|FG002|Overall Study|Protocol Violation|1
7101114|NCT02364947|11224980|FG000|Overall Study|Physician Decision|3
7101115|NCT02364947|11224981|FG001|Overall Study|Physician Decision|2
7101116|NCT02364947|11224982|FG002|Overall Study|Physician Decision|5
7101117|NCT02364947|11224980|FG000|Overall Study|Death|0
7101118|NCT02364947|11224981|FG001|Overall Study|Death|1
7101119|NCT02364947|11224982|FG002|Overall Study|Death|0
7101120|NCT02364999|11224992|FG000|Overall Study|Death|136
7101121|NCT02364999|11224993|FG001|Overall Study|Death|138
7101122|NCT02364999|11224992|FG000|Overall Study|Lost to Follow-up|10
7101123|NCT02364999|11224993|FG001|Overall Study|Lost to Follow-up|15
7101124|NCT02364999|11224992|FG000|Overall Study|Protocol Violation|3
7101125|NCT02364999|11224993|FG001|Overall Study|Protocol Violation|2
7101126|NCT02364999|11224992|FG000|Overall Study|Withdrawal by Subject|14
7101127|NCT02364999|11224993|FG001|Overall Study|Withdrawal by Subject|14
7101128|NCT02364999|11224992|FG000|Overall Study|Other|0
7101129|NCT02364999|11224993|FG001|Overall Study|Other|1
7101130|NCT02364999|11224992|FG000|Overall Study|Randomized but did not receive treatment|2
7101131|NCT02364999|11224993|FG001|Overall Study|Randomized but did not receive treatment|3
7101132|NCT02365064|11225002|FG000|Overall Study|Patients met baseline exclusion requirem|2
7101133|NCT02365064|11225003|FG001|Overall Study|Patients met baseline exclusion requirem|15
7101134|NCT02365064|11225002|FG000|Overall Study|Withdrawal by Subject|6
7101135|NCT02365064|11225003|FG001|Overall Study|Withdrawal by Subject|9
7101136|NCT02365064|11225002|FG000|Overall Study|Treatment intolerance|2
7101137|NCT02365064|11225003|FG001|Overall Study|Treatment intolerance|4
7101138|NCT02365285|11225013|FG000|Overall Study|Physician Decision|0
7101139|NCT02365285|11225014|FG001|Overall Study|Physician Decision|1
7101140|NCT02365285|11225015|FG002|Overall Study|Physician Decision|1
7101141|NCT02365285|11225016|FG003|Overall Study|Physician Decision|0
7101142|NCT02365285|11225013|FG000|Overall Study|Adverse Event|0
7101143|NCT02365285|11225014|FG001|Overall Study|Adverse Event|0
7101144|NCT02365285|11225015|FG002|Overall Study|Adverse Event|0
7101145|NCT02365285|11225016|FG003|Overall Study|Adverse Event|2
7101146|NCT02365298|11225028|FG000|Period 2|incorrect Rx dispensed|1
7101147|NCT02365298|11225029|FG001|Period 2|incorrect Rx dispensed|0
7101148|NCT02365298|11225028|FG000|Period 2|Discontinued at request of Sponsor|1
7101149|NCT02365298|11225029|FG001|Period 2|Discontinued at request of Sponsor|0
7101150|NCT02365298|11225028|FG000|Period 2|Test Article longer available|0
7101151|NCT02365298|11225029|FG001|Period 2|Test Article longer available|1
7101152|NCT02365298|11225028|FG000|Period 2|Protocol Violation|0
7101153|NCT02365298|11225029|FG001|Period 2|Protocol Violation|1
7101154|NCT02365480|11225037|FG000|Overall Study|Withdrawal by Subject|2
7101155|NCT02365480|11225038|FG001|Overall Study|Withdrawal by Subject|0
7101156|NCT02365506|11225047|FG000|Overall Study|Investigator's Discretion|0
7101157|NCT02365506|11225048|FG001|Overall Study|Investigator's Discretion|0
7101158|NCT02365506|11225049|FG002|Overall Study|Investigator's Discretion|1
7101159|NCT02365519|11225059|FG000|Randomized and Treated|Adverse Event|0
7101160|NCT02365519|11225060|FG001|Randomized and Treated|Adverse Event|1
7101161|NCT02365519|11225061|FG002|Randomized and Treated|Adverse Event|0
7101162|NCT02365519|11225059|FG000|Randomized and Treated|Withdrawal by Subject|0
7101163|NCT02365519|11225060|FG001|Randomized and Treated|Withdrawal by Subject|1
7101164|NCT02365519|11225061|FG002|Randomized and Treated|Withdrawal by Subject|1
7101165|NCT02365558|11225070|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1
7101166|NCT02365558|11225071|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0
7101167|NCT02365558|11225070|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0
7101168|NCT02365558|11225071|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1
7101169|NCT02365584|11225082|FG000|Overall Study|Adverse Event|2
7101170|NCT02365584|11225083|FG001|Overall Study|Adverse Event|2
7101171|NCT02365584|11225082|FG000|Overall Study|Withdrawal by Subject|1
7101172|NCT02365584|11225083|FG001|Overall Study|Withdrawal by Subject|0
7101173|NCT02365584|11225082|FG000|Overall Study|Disease Progression|9
7101174|NCT02365584|11225083|FG001|Overall Study|Disease Progression|12
7101175|NCT02365636|11225092|FG000|Overall Study|Adverse Event|3
7101176|NCT02365636|11225093|FG001|Overall Study|Adverse Event|3
7101177|NCT02365636|11225094|FG002|Overall Study|Adverse Event|2
7101178|NCT02365636|11225092|FG000|Overall Study|Protocol Violation|1
7101179|NCT02365636|11225093|FG001|Overall Study|Protocol Violation|4
7101180|NCT02365636|11225094|FG002|Overall Study|Protocol Violation|0
7101181|NCT02365636|11225092|FG000|Overall Study|Lost to Follow-up|0
7101182|NCT02365636|11225093|FG001|Overall Study|Lost to Follow-up|0
7101183|NCT02365636|11225094|FG002|Overall Study|Lost to Follow-up|1
7101184|NCT02365636|11225092|FG000|Overall Study|Other|2
7101185|NCT02365636|11225093|FG001|Overall Study|Other|0
7101186|NCT02365636|11225094|FG002|Overall Study|Other|0
7101187|NCT02366091|11225128|FG000|Overall Study|Withdrawal by Subject|3
7101188|NCT02366091|11225129|FG001|Overall Study|Withdrawal by Subject|7
7101189|NCT02366091|11225130|FG002|Overall Study|Withdrawal by Subject|3
7101190|NCT02366091|11225131|FG003|Overall Study|Withdrawal by Subject|1
7101191|NCT02366130|11225141|FG000|Overall Study|Withdrawal by Subject|3
7101192|NCT02366130|11225141|FG000|Overall Study|Ineligible|6
7101193|NCT02366143|11225148|FG000|Overall Study|Death|307
7101194|NCT02366143|11225149|FG001|Overall Study|Death|278
7101195|NCT02366143|11225150|FG002|Overall Study|Death|280
7101196|NCT02366143|11225148|FG000|Overall Study|Lost to Follow-up|2
7101197|NCT02366143|11225149|FG001|Overall Study|Lost to Follow-up|4
7101198|NCT02366143|11225150|FG002|Overall Study|Lost to Follow-up|2
7101199|NCT02366143|11225148|FG000|Overall Study|Physician Decision|1
7101200|NCT02366143|11225149|FG001|Overall Study|Physician Decision|2
7101201|NCT02366143|11225150|FG002|Overall Study|Physician Decision|1
7101202|NCT02366143|11225148|FG000|Overall Study|Protocol Violation|0
7101203|NCT02366143|11225149|FG001|Overall Study|Protocol Violation|0
7101204|NCT02366143|11225150|FG002|Overall Study|Protocol Violation|2
7101205|NCT02366143|11225148|FG000|Overall Study|Withdrawal by Subject|16
7101206|NCT02366143|11225149|FG001|Overall Study|Withdrawal by Subject|17
7101207|NCT02366143|11225150|FG002|Overall Study|Withdrawal by Subject|22
7101208|NCT02366143|11225148|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0
7101209|NCT02366143|11225149|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6
7101210|NCT02366143|11225150|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0
7101211|NCT02366143|11225148|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0
7101212|NCT02366143|11225149|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1
7101213|NCT02366143|11225150|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0
7101214|NCT02366143|11225148|FG000|Overall Study|Randomization Error|1
7101215|NCT02366143|11225149|FG001|Overall Study|Randomization Error|0
7101216|NCT02366143|11225150|FG002|Overall Study|Randomization Error|0
7101217|NCT02366143|11225148|FG000|Overall Study|PI Move and Site Closure|1
7101218|NCT02366143|11225149|FG001|Overall Study|PI Move and Site Closure|0
7101219|NCT02366143|11225150|FG002|Overall Study|PI Move and Site Closure|1
7101220|NCT02366143|11225148|FG000|Overall Study|Study Terminated By Sponsor|0
7101221|NCT02366143|11225149|FG001|Overall Study|Study Terminated By Sponsor|0
7101222|NCT02366143|11225150|FG002|Overall Study|Study Terminated By Sponsor|2
7101223|NCT02366143|11225148|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70
7101224|NCT02366143|11225149|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57
7101225|NCT02366143|11225150|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52
7101226|NCT02366143|11225148|FG000|Overall Study|Patient moved to roll-over study|1
7101227|NCT02366143|11225149|FG001|Overall Study|Patient moved to roll-over study|19
7101228|NCT02366143|11225150|FG002|Overall Study|Patient moved to roll-over study|28
7101229|NCT02366143|11225148|FG000|Overall Study|Patient moved to commercial stock|0
7101230|NCT02366143|11225149|FG001|Overall Study|Patient moved to commercial stock|0
7101231|NCT02366143|11225150|FG002|Overall Study|Patient moved to commercial stock|1
7101232|NCT02366143|11225148|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0
7101233|NCT02366143|11225149|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0
7101234|NCT02366143|11225150|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1
7101235|NCT02366143|11225148|FG000|Overall Study|Patient rolling over to patient assistance program|0
7101236|NCT02366143|11225149|FG001|Overall Study|Patient rolling over to patient assistance program|0
7101237|NCT02366143|11225150|FG002|Overall Study|Patient rolling over to patient assistance program|1
7101238|NCT02366143|11225148|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0
7101239|NCT02366143|11225149|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0
7101240|NCT02366143|11225150|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1
7101241|NCT02366143|11225148|FG000|Overall Study|Requester's instructions|1
7101242|NCT02366143|11225149|FG001|Overall Study|Requester's instructions|1
7101243|NCT02366143|11225150|FG002|Overall Study|Requester's instructions|1
7101244|NCT02366143|11225148|FG000|Overall Study|Uneligible|0
7101245|NCT02366143|11225149|FG001|Overall Study|Uneligible|1
7101246|NCT02366143|11225150|FG002|Overall Study|Uneligible|0
7101247|NCT02366143|11225148|FG000|Overall Study|Post Trial Migration|0
7101248|NCT02366143|11225149|FG001|Overall Study|Post Trial Migration|1
7101249|NCT02366143|11225150|FG002|Overall Study|Post Trial Migration|0
7101250|NCT02366143|11225148|FG000|Overall Study|Patient moving onto PTAP commercial stock|0
7101251|NCT02366143|11225149|FG001|Overall Study|Patient moving onto PTAP commercial stock|1
7101252|NCT02366143|11225150|FG002|Overall Study|Patient moving onto PTAP commercial stock|0
7101253|NCT02366143|11225148|FG000|Overall Study|Patient switched to PTAP|0
7101254|NCT02366143|11225149|FG001|Overall Study|Patient switched to PTAP|1
7101255|NCT02366143|11225150|FG002|Overall Study|Patient switched to PTAP|0
7101256|NCT02366143|11225148|FG000|Overall Study|Patient moved to commercial atezolizumab use|0
7101257|NCT02366143|11225149|FG001|Overall Study|Patient moved to commercial atezolizumab use|11
7101258|NCT02366143|11225150|FG002|Overall Study|Patient moved to commercial atezolizumab use|7
7101259|NCT02366195|11225162|FG000|Overall Study|Protocol-specified criteria|3
7101260|NCT02366195|11225162|FG000|Overall Study|Withdrawal by Subject|9
7101261|NCT02366195|11225162|FG000|Overall Study|Lost to Follow-up|1
7101262|NCT02366195|11225162|FG000|Overall Study|Death|41
7101263|NCT02366312|11225168|FG000|Overall Study|Lost to Follow-up|0
7101264|NCT02366312|11225169|FG001|Overall Study|Lost to Follow-up|1
7101265|NCT02366468|11225190|FG000|Overall Study|Adverse Event|2
7101266|NCT02366468|11225191|FG001|Overall Study|Adverse Event|0
7101267|NCT02366468|11225190|FG000|Overall Study|Withdrawal by Subject|1
7101268|NCT02366468|11225191|FG001|Overall Study|Withdrawal by Subject|5
7101269|NCT02366468|11225190|FG000|Overall Study|Lost to Follow-up|2
7101270|NCT02366468|11225191|FG001|Overall Study|Lost to Follow-up|0
7101271|NCT02366468|11225190|FG000|Overall Study|Death|1
7101272|NCT02366468|11225191|FG001|Overall Study|Death|2
7101273|NCT02366468|11225190|FG000|Overall Study|Other|0
7101274|NCT02366468|11225191|FG001|Overall Study|Other|2
7101275|NCT02366637|11225207|FG000|First Intervention Period|Adverse Event|0
7101276|NCT02366637|11225208|FG001|First Intervention Period|Adverse Event|1
7101277|NCT02366637|11225207|FG000|First Intervention Period|Study Terminated by Sponsor|6
7101278|NCT02366637|11225208|FG001|First Intervention Period|Study Terminated by Sponsor|4
7101279|NCT02366637|11225207|FG000|Second Intervention Period|Study Terminated by Sponsor|1
7101280|NCT02366637|11225208|FG001|Second Intervention Period|Study Terminated by Sponsor|1
7101281|NCT02366689|11225226|FG000|Overall Study|Withdrawal by Subject|1
7101282|NCT02366689|11225227|FG001|Overall Study|Withdrawal by Subject|0
7101283|NCT02366689|11225228|FG002|Overall Study|Withdrawal by Subject|1
7101284|NCT02366689|11225226|FG000|Overall Study|Lost to Follow-up|3
7101285|NCT02366689|11225227|FG001|Overall Study|Lost to Follow-up|2
7101286|NCT02366689|11225228|FG002|Overall Study|Lost to Follow-up|0
7101287|NCT02366689|11225226|FG000|Overall Study|Pregnancy|0
7101288|NCT02366689|11225227|FG001|Overall Study|Pregnancy|1
7101289|NCT02366689|11225228|FG002|Overall Study|Pregnancy|1
7101290|NCT02366767|11225238|FG000|Overall Study|left for home after 1 day at camp|1
7101291|NCT02366767|11225239|FG001|Overall Study|left for home after 1 day at camp|0
7101292|NCT02366910|11225263|FG000|Overall Study|Withdrawal by Subject|2
7101293|NCT02366910|11225263|FG000|Overall Study|Screen Failure|3
7101294|NCT02366923|11225269|FG000|Overall Study|Withdrawal by Subject|1
7101295|NCT02366923|11225269|FG000|Overall Study|Positive Slit Lamp Findings|2
7101296|NCT02366923|11225269|FG000|Overall Study|High Astigmatism|3
7101297|NCT02366936|11225274|FG000|Overall Study|Withdrawal by Subject|2
7101298|NCT02366936|11225274|FG000|Overall Study|Lost to Follow-up|4
7101299|NCT02366936|11225274|FG000|Overall Study|Physician Decision|2
7101300|NCT02367131|11225311|FG000|Overall Study|Adverse Event|64
7101301|NCT02367131|11225311|FG000|Overall Study|No visit since the first visit|4
7101302|NCT02367131|11225311|FG000|Overall Study|Request by patient|54
7101303|NCT02367131|11225311|FG000|Overall Study|Improvement/remission|2
7101304|NCT02367131|11225311|FG000|Overall Study|No change/progressive disease|78
7101305|NCT02367131|11225311|FG000|Overall Study|Other than stated above|20
7101306|NCT02367352|11225315|FG000|Overall Study|Progressive disease|7
7101307|NCT02367352|11225316|FG001|Overall Study|Progressive disease|0
7101308|NCT02367352|11225317|FG002|Overall Study|Progressive disease|0
7101309|NCT02367352|11225315|FG000|Overall Study|Participant Received Alternative Therapy|1
7101310|NCT02367352|11225316|FG001|Overall Study|Participant Received Alternative Therapy|0
7101311|NCT02367352|11225317|FG002|Overall Study|Participant Received Alternative Therapy|0
7101312|NCT02367352|11225315|FG000|Overall Study|Adverse Event|1
7101313|NCT02367352|11225316|FG001|Overall Study|Adverse Event|0
7101314|NCT02367352|11225317|FG002|Overall Study|Adverse Event|0
7101315|NCT02367521|11225338|FG000|Overall Study|severe headache after intervention|2
7101316|NCT02367521|11225339|FG001|Overall Study|severe headache after intervention|0
7101317|NCT02367521|11225338|FG000|Overall Study|unable to find transportation|2
7101318|NCT02367521|11225339|FG001|Overall Study|unable to find transportation|0
7101319|NCT02367716|11225354|FG000|Overall Study|Patient did not meet inclusion criteria|1
7101320|NCT02367729|11225361|FG000|Overall Study|Organic disorder diagnosed|2
7101321|NCT02367729|11225362|FG001|Overall Study|Organic disorder diagnosed|1
7101322|NCT02367729|11225361|FG000|Overall Study|Adverse Event|1
7101323|NCT02367729|11225362|FG001|Overall Study|Adverse Event|2
7101324|NCT02367729|11225361|FG000|Overall Study|Withdrawal by Subject|0
7101325|NCT02367729|11225362|FG001|Overall Study|Withdrawal by Subject|5
7101326|NCT02367781|11225371|FG000|Overall Study|Withdrawal by Subject|20
7101327|NCT02367781|11225372|FG001|Overall Study|Withdrawal by Subject|13
7101328|NCT02367781|11225371|FG000|Overall Study|Protocol Violation|0
7101329|NCT02367781|11225372|FG001|Overall Study|Protocol Violation|1
7101330|NCT02367781|11225371|FG000|Overall Study|Physician Decision|7
7101331|NCT02367781|11225372|FG001|Overall Study|Physician Decision|0
7101332|NCT02367781|11225371|FG000|Overall Study|Randomized in Error|5
7101333|NCT02367781|11225372|FG001|Overall Study|Randomized in Error|4
7101334|NCT02367781|11225371|FG000|Overall Study|Non-Compliance|1
7101335|NCT02367781|11225372|FG001|Overall Study|Non-Compliance|0
7101336|NCT02367781|11225371|FG000|Overall Study|Lost to Follow-up|1
7101337|NCT02367781|11225372|FG001|Overall Study|Lost to Follow-up|2
7101338|NCT02367781|11225371|FG000|Overall Study|Death|330
7101339|NCT02367781|11225372|FG001|Overall Study|Death|176
7101340|NCT02367781|11225371|FG000|Overall Study|Patient Moving to Roll-Over Study|17
7101341|NCT02367781|11225372|FG001|Overall Study|Patient Moving to Roll-Over Study|5
7101342|NCT02367781|11225371|FG000|Overall Study|Prolonged Hospitalization|1
7101343|NCT02367781|11225372|FG001|Overall Study|Prolonged Hospitalization|0
7101344|NCT02367781|11225371|FG000|Overall Study|Death Prior First Dose|1
7101345|NCT02367781|11225372|FG001|Overall Study|Death Prior First Dose|0
7101346|NCT02367781|11225371|FG000|Overall Study|Administrative-Change Facility|1
7101347|NCT02367781|11225372|FG001|Overall Study|Administrative-Change Facility|0
7101348|NCT02367781|11225371|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78
7101349|NCT02367781|11225372|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29
7101350|NCT02367781|11225371|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14
7101351|NCT02367781|11225372|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9
7101352|NCT02367781|11225371|FG000|Overall Study|Study Terminated by Sponsor|3
7101353|NCT02367781|11225372|FG001|Overall Study|Study Terminated by Sponsor|1
7101354|NCT02367781|11225371|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1
7101355|NCT02367781|11225372|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0
7101356|NCT02367781|11225371|FG000|Overall Study|Sponsor Decision|2
7101357|NCT02367781|11225372|FG001|Overall Study|Sponsor Decision|0
7101358|NCT02367781|11225371|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1
7101359|NCT02367781|11225372|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0
7101360|NCT02367833|11225397|FG000|Overall Study|Withdrawal by Subject|1
7101361|NCT02367833|11225398|FG001|Overall Study|Withdrawal by Subject|1
7101362|NCT02367833|11225399|FG002|Overall Study|Withdrawal by Subject|0
7101363|NCT02367885|11225456|FG000|Overall Study|Lost to Follow-up|1
7101364|NCT02367885|11225457|FG001|Overall Study|Lost to Follow-up|0
7101365|NCT02367885|11225458|FG002|Overall Study|Lost to Follow-up|0
7101366|NCT02367885|11225456|FG000|Overall Study|Withdrawal by Subject|1
7101367|NCT02367885|11225457|FG001|Overall Study|Withdrawal by Subject|0
7101368|NCT02367885|11225458|FG002|Overall Study|Withdrawal by Subject|0
7101369|NCT02367911|11225471|FG000|Overall Study|Withdrawal by Subject|3
7101370|NCT02367911|11225472|FG001|Overall Study|Withdrawal by Subject|2
7101371|NCT02367911|11225471|FG000|Overall Study|Lost to Follow-up|2
7101372|NCT02367911|11225472|FG001|Overall Study|Lost to Follow-up|2
7101373|NCT02368210|11225489|FG000|Overall Study|Withdrawal by Subject|1
7101374|NCT02368210|11225490|FG001|Overall Study|Withdrawal by Subject|0
7101375|NCT02368210|11225489|FG000|Overall Study|Adverse Event|0
7101376|NCT02368210|11225490|FG001|Overall Study|Adverse Event|1
7101377|NCT02368314|11225498|FG000|Overall Study|Withdrawal by Subject|2
7101378|NCT02368314|11225499|FG001|Overall Study|Withdrawal by Subject|1
7101379|NCT02368314|11225498|FG000|Overall Study|Adverse Event|1
7101380|NCT02368314|11225499|FG001|Overall Study|Adverse Event|2
7101381|NCT02368691|11225524|FG000|Overall Study|Death|13
7101382|NCT02368691|11225524|FG000|Overall Study|Lack of Efficacy|15
7101383|NCT02368691|11225524|FG000|Overall Study|Physician Decision|4
7101384|NCT02369159|11225539|FG000|Overall Study|Adverse Event|0
7101385|NCT02369159|11225540|FG001|Overall Study|Adverse Event|1
7101386|NCT02369159|11225539|FG000|Overall Study|Lost to Follow-up|1
7101387|NCT02369159|11225540|FG001|Overall Study|Lost to Follow-up|1
7101388|NCT02369159|11225539|FG000|Overall Study|Withdrawal by Subject|7
7101389|NCT02369159|11225540|FG001|Overall Study|Withdrawal by Subject|0
7101390|NCT02369341|11225590|FG000|Overall Study|Migrated/moved from study area|1
7101391|NCT02369341|11225591|FG001|Overall Study|Migrated/moved from study area|0
7101392|NCT02369510|11225608|FG000|Overall Study|Spilled Medication|1
7101393|NCT02369510|11225609|FG001|Overall Study|Spilled Medication|2
7101394|NCT02369510|11225610|FG002|Overall Study|Spilled Medication|1
7101395|NCT02369510|11225608|FG000|Overall Study|Epidural Activation|1
7101396|NCT02369510|11225609|FG001|Overall Study|Epidural Activation|1
7101397|NCT02369510|11225610|FG002|Overall Study|Epidural Activation|5
7101398|NCT02369848|11225648|FG000|Overall Study|Death|1
7101399|NCT02369848|11225648|FG000|Overall Study|Withdrawal by Subject|2
7101400|NCT02369848|11225648|FG000|Overall Study|Lost to Follow-up|1
7101401|NCT02369874|11225655|FG000|Overall Study|Lost to Follow-up|2
7101402|NCT02369874|11225656|FG001|Overall Study|Lost to Follow-up|2
7101403|NCT02369874|11225657|FG002|Overall Study|Lost to Follow-up|2
7101404|NCT02369874|11225655|FG000|Overall Study|Withdrawal by Subject|7
7101405|NCT02369874|11225656|FG001|Overall Study|Withdrawal by Subject|9
7101406|NCT02369874|11225657|FG002|Overall Study|Withdrawal by Subject|27
7101407|NCT02369874|11225655|FG000|Overall Study|Miscellaneous|1
7101408|NCT02369874|11225656|FG001|Overall Study|Miscellaneous|1
7101409|NCT02369874|11225657|FG002|Overall Study|Miscellaneous|0
7101410|NCT02369874|11225655|FG000|Overall Study|On Treatment/Off Study|34
7101411|NCT02369874|11225656|FG001|Overall Study|On Treatment/Off Study|45
7101412|NCT02369874|11225657|FG002|Overall Study|On Treatment/Off Study|32
7101413|NCT02370043|11225683|FG000|Overall Study|Withdrawal by Subject|0
7101414|NCT02370043|11225684|FG001|Overall Study|Withdrawal by Subject|0
7101415|NCT02370043|11225685|FG002|Overall Study|Withdrawal by Subject|0
7101416|NCT02370043|11225686|FG003|Overall Study|Withdrawal by Subject|0
7101417|NCT02370043|11225687|FG004|Overall Study|Withdrawal by Subject|1
7101418|NCT02370043|11225688|FG005|Overall Study|Withdrawal by Subject|1
7101419|NCT02370095|11225727|FG000|Overall Study|Withdrawal by Subject|0
7101420|NCT02370095|11225728|FG001|Overall Study|Withdrawal by Subject|1
7101421|NCT02370121|11225736|FG000|Overall Study|Lost to Follow-up|1
7101422|NCT02370121|11225737|FG001|Overall Study|Lost to Follow-up|1
7101423|NCT02370160|11225743|FG000|Overall Study|Death|3
7101424|NCT02370160|11225744|FG001|Overall Study|Death|4
7101425|NCT02370160|11225745|FG002|Overall Study|Death|1
7101426|NCT02370238|11225760|FG000|Overall Study|Death|42
7101427|NCT02370238|11225761|FG001|Overall Study|Death|35
7101428|NCT02370238|11225760|FG000|Overall Study|Lost to Follow-up|1
7101429|NCT02370238|11225761|FG001|Overall Study|Lost to Follow-up|3
7101430|NCT02370238|11225760|FG000|Overall Study|Withdrawal by Subject|2
7101431|NCT02370238|11225761|FG001|Overall Study|Withdrawal by Subject|6
7101432|NCT02370238|11225760|FG000|Overall Study|Other|2
7101433|NCT02370238|11225761|FG001|Overall Study|Other|1
7101434|NCT02370251|11225771|FG000|Overall Study|Received less than 8 days of Omegaven|7
7101435|NCT02370251|11225771|FG000|Overall Study|Death|4
7101436|NCT02370368|11225777|FG000|Overall Study|Adverse Event|1
7101437|NCT02370368|11225778|FG001|Overall Study|Adverse Event|2
7101438|NCT02370368|11225777|FG000|Overall Study|Withdrawal by Subject|5
7101439|NCT02370368|11225778|FG001|Overall Study|Withdrawal by Subject|4
7101440|NCT02370394|11225786|FG000|Overall Study|Lost to Follow-up|2
7101441|NCT02370394|11225787|FG001|Overall Study|Lost to Follow-up|1
7101442|NCT02370394|11225786|FG000|Overall Study|Withdrawal by Subject|0
7101443|NCT02370394|11225787|FG001|Overall Study|Withdrawal by Subject|1
7101444|NCT02370420|11225809|FG000|Overall Study|Physician Decision|3
7101445|NCT02370420|11225810|FG001|Overall Study|Physician Decision|3
7101446|NCT02370420|11225809|FG000|Overall Study|Lost to Follow-up|11
7101447|NCT02370420|11225810|FG001|Overall Study|Lost to Follow-up|9
7101448|NCT02370498|11225818|FG000|Overall Study|Adverse Event|10
7101449|NCT02370498|11225819|FG001|Overall Study|Adverse Event|8
7101450|NCT02370498|11225818|FG000|Overall Study|Death|263
7101451|NCT02370498|11225819|FG001|Overall Study|Death|265
7101452|NCT02370498|11225818|FG000|Overall Study|Protocol Violation|1
7101453|NCT02370498|11225819|FG001|Overall Study|Protocol Violation|2
7101454|NCT02370498|11225818|FG000|Overall Study|Withdrawal by Subject|7
7101455|NCT02370498|11225819|FG001|Overall Study|Withdrawal by Subject|12
7101456|NCT02370498|11225818|FG000|Overall Study|Sponsor's decision|15
7101457|NCT02370498|11225819|FG001|Overall Study|Sponsor's decision|9
7101458|NCT02370511|11225829|FG000|Overall Study|Death|10
7101459|NCT02370511|11225830|FG001|Overall Study|Death|7
7101460|NCT02370511|11225831|FG002|Overall Study|Death|1
7101461|NCT02370511|11225829|FG000|Overall Study|Withdrawal by Subject|2
7101462|NCT02370511|11225830|FG001|Overall Study|Withdrawal by Subject|0
7101463|NCT02370511|11225831|FG002|Overall Study|Withdrawal by Subject|0
7101464|NCT02370511|11225829|FG000|Overall Study|Lost to Follow-up|0
7101465|NCT02370511|11225830|FG001|Overall Study|Lost to Follow-up|4
7101466|NCT02370511|11225831|FG002|Overall Study|Lost to Follow-up|0
7101467|NCT02370537|11225842|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0
7101468|NCT02370537|11225843|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1
7101469|NCT02370537|11225844|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0
7101470|NCT02370537|11225842|FG000|Part A (Open-label Recruitment)|Adverse Event|0
7101471|NCT02370537|11225843|FG001|Part A (Open-label Recruitment)|Adverse Event|0
7101472|NCT02370537|11225844|FG002|Part A (Open-label Recruitment)|Adverse Event|1
7101473|NCT02370537|11225842|FG000|Part B|Not randomised to receive treatment|1
7101474|NCT02370537|11225843|FG001|Part B|Not randomised to receive treatment|2
7101475|NCT02370537|11225844|FG002|Part B|Not randomised to receive treatment|259
7101476|NCT02370537|11225842|FG000|Part B|Withdrawal by Subject|0
7101477|NCT02370537|11225843|FG001|Part B|Withdrawal by Subject|1
7101478|NCT02370537|11225844|FG002|Part B|Withdrawal by Subject|0
7101479|NCT02370602|11225867|FG000|Overall Study|Pretreatment Event/Adverse Event|1
7101480|NCT02370602|11225868|FG001|Overall Study|Pretreatment Event/Adverse Event|0
7101481|NCT02370602|11225869|FG002|Overall Study|Pretreatment Event/Adverse Event|0
7101482|NCT02370602|11225870|FG003|Overall Study|Pretreatment Event/Adverse Event|0
7101483|NCT02370602|11225871|FG004|Overall Study|Pretreatment Event/Adverse Event|0
7101484|NCT02370602|11225872|FG005|Overall Study|Pretreatment Event/Adverse Event|0
7101485|NCT02370615|11225891|FG000|Overall Study|Adverse Event|1
7101486|NCT02370615|11225892|FG001|Overall Study|Adverse Event|0
7101487|NCT02370641|11225907|FG000|Overall Study|dropped study|4
7101488|NCT02370641|11225908|FG001|Overall Study|dropped study|2
7101489|NCT02370667|11225917|FG000|Overall Study|Lost to Follow-up|0
7101490|NCT02370667|11225918|FG001|Overall Study|Lost to Follow-up|1
7101491|NCT02370667|11225919|FG002|Overall Study|Lost to Follow-up|0
7101492|NCT02370784|11225939|FG000|Overall Study|Patient started prohibited medication|0
7101493|NCT02370784|11225940|FG001|Overall Study|Patient started prohibited medication|1
7101494|NCT02370914|11225959|FG000|Overall Study|Protocol Violation|2
7101495|NCT02371616|11226008|FG000|Overall Study|Protocol Violation|2
7101496|NCT02371616|11226009|FG001|Overall Study|Protocol Violation|1
7101497|NCT02371616|11226008|FG000|Overall Study|Adverse Event|0
7101498|NCT02371616|11226009|FG001|Overall Study|Adverse Event|1
7101499|NCT02371616|11226008|FG000|Overall Study|Withdrawal of Consent|1
7101500|NCT02371616|11226009|FG001|Overall Study|Withdrawal of Consent|0
7101501|NCT02371616|11226008|FG000|Overall Study|Other (Not specified)|1
7101502|NCT02371616|11226009|FG001|Overall Study|Other (Not specified)|5
7101503|NCT02371629|11226017|FG000|Overall Study|Patient decision|14
7101504|NCT02371629|11226018|FG001|Overall Study|Patient decision|10
7101505|NCT02371629|11226017|FG000|Overall Study|Adverse Event|8
7101506|NCT02371629|11226018|FG001|Overall Study|Adverse Event|8
7101507|NCT02371629|11226017|FG000|Overall Study|Physician Decision|2
7101508|NCT02371629|11226018|FG001|Overall Study|Physician Decision|3
7101509|NCT02371629|11226017|FG000|Overall Study|Death|1
7101510|NCT02371629|11226018|FG001|Overall Study|Death|1
7101511|NCT02371629|11226017|FG000|Overall Study|Noncompliance with study treatment|1
7101512|NCT02371629|11226018|FG001|Overall Study|Noncompliance with study treatment|0
7101513|NCT02371629|11226017|FG000|Overall Study|Lack of Efficacy|0
7101514|NCT02371629|11226018|FG001|Overall Study|Lack of Efficacy|2
7101515|NCT02371629|11226017|FG000|Overall Study|Protocol deviation|0
7101516|NCT02371629|11226018|FG001|Overall Study|Protocol deviation|1
7101517|NCT02371746|11226040|FG000|Overall Study|Consent withdrawn|0
7101518|NCT02371746|11226041|FG001|Overall Study|Consent withdrawn|0
7101519|NCT02371746|11226042|FG002|Overall Study|Consent withdrawn|0
7101520|NCT02371746|11226043|FG003|Overall Study|Consent withdrawn|0
7101521|NCT02371746|11226044|FG004|Overall Study|Consent withdrawn|0
7101522|NCT02371746|11226045|FG005|Overall Study|Consent withdrawn|0
7101523|NCT02371746|11226046|FG006|Overall Study|Consent withdrawn|1
7101524|NCT02371759|11226070|FG000|Overall Study|Protocol Violation|3
7101525|NCT02371759|11226071|FG001|Overall Study|Protocol Violation|1
7101526|NCT02371759|11226072|FG002|Overall Study|Protocol Violation|1
7101527|NCT02371759|11226073|FG003|Overall Study|Protocol Violation|0
7101528|NCT02371759|11226074|FG004|Overall Study|Protocol Violation|3
7101529|NCT02371759|11226075|FG005|Overall Study|Protocol Violation|1
7101530|NCT02371759|11226076|FG006|Overall Study|Protocol Violation|0
7101531|NCT02371759|11226077|FG007|Overall Study|Protocol Violation|3
7101532|NCT02371759|11226070|FG000|Overall Study|Withdrawal by Subject|0
7101533|NCT02371759|11226071|FG001|Overall Study|Withdrawal by Subject|0
7101534|NCT02371759|11226072|FG002|Overall Study|Withdrawal by Subject|0
7101535|NCT02371759|11226073|FG003|Overall Study|Withdrawal by Subject|0
7101536|NCT02371759|11226074|FG004|Overall Study|Withdrawal by Subject|0
7101537|NCT02371759|11226075|FG005|Overall Study|Withdrawal by Subject|0
7101538|NCT02371759|11226076|FG006|Overall Study|Withdrawal by Subject|0
7101539|NCT02371759|11226077|FG007|Overall Study|Withdrawal by Subject|1
7101540|NCT02371980|11226124|FG000|Open-label Period|Pretreatment Event/Adverse Event|63
7101541|NCT02371980|11226125|FG001|Open-label Period|Pretreatment Event/Adverse Event|0
7101542|NCT02371980|11226126|FG002|Open-label Period|Pretreatment Event/Adverse Event|0
7101543|NCT02371980|11226127|FG003|Open-label Period|Pretreatment Event/Adverse Event|0
7101544|NCT02371980|11226128|FG004|Open-label Period|Pretreatment Event/Adverse Event|0
7101545|NCT02371980|11226124|FG000|Open-label Period|Significant Protocol Deviation|19
7101546|NCT02371980|11226125|FG001|Open-label Period|Significant Protocol Deviation|0
7101547|NCT02371980|11226126|FG002|Open-label Period|Significant Protocol Deviation|0
7101548|NCT02371980|11226127|FG003|Open-label Period|Significant Protocol Deviation|0
7101549|NCT02371980|11226128|FG004|Open-label Period|Significant Protocol Deviation|0
7101550|NCT02371980|11226124|FG000|Open-label Period|Noncompliance with Study Drug|10
7101551|NCT02371980|11226125|FG001|Open-label Period|Noncompliance with Study Drug|0
7101552|NCT02371980|11226126|FG002|Open-label Period|Noncompliance with Study Drug|0
7101553|NCT02371980|11226127|FG003|Open-label Period|Noncompliance with Study Drug|0
7101554|NCT02371980|11226128|FG004|Open-label Period|Noncompliance with Study Drug|0
7101555|NCT02371980|11226124|FG000|Open-label Period|Lost to Follow-up|55
7101556|NCT02371980|11226125|FG001|Open-label Period|Lost to Follow-up|0
7101557|NCT02371980|11226126|FG002|Open-label Period|Lost to Follow-up|0
7101558|NCT02371980|11226127|FG003|Open-label Period|Lost to Follow-up|0
7101559|NCT02371980|11226128|FG004|Open-label Period|Lost to Follow-up|0
7101560|NCT02371980|11226124|FG000|Open-label Period|Voluntary Withdrawal|91
7101561|NCT02371980|11226125|FG001|Open-label Period|Voluntary Withdrawal|0
7101562|NCT02371980|11226126|FG002|Open-label Period|Voluntary Withdrawal|0
7101563|NCT02371980|11226127|FG003|Open-label Period|Voluntary Withdrawal|0
7101564|NCT02371980|11226128|FG004|Open-label Period|Voluntary Withdrawal|0
7101565|NCT02371980|11226124|FG000|Open-label Period|Pregnancy|1
7101566|NCT02371980|11226125|FG001|Open-label Period|Pregnancy|0
7101567|NCT02371980|11226126|FG002|Open-label Period|Pregnancy|0
7101568|NCT02371980|11226127|FG003|Open-label Period|Pregnancy|0
7101569|NCT02371980|11226128|FG004|Open-label Period|Pregnancy|0
7101570|NCT02371980|11226124|FG000|Open-label Period|Lack of Efficacy|116
7101571|NCT02371980|11226125|FG001|Open-label Period|Lack of Efficacy|0
7101572|NCT02371980|11226126|FG002|Open-label Period|Lack of Efficacy|0
7101573|NCT02371980|11226127|FG003|Open-label Period|Lack of Efficacy|0
7101574|NCT02371980|11226128|FG004|Open-label Period|Lack of Efficacy|0
7101575|NCT02371980|11226124|FG000|Open-label Period|Did not Meet Randomization Criteria|162
7101576|NCT02371980|11226125|FG001|Open-label Period|Did not Meet Randomization Criteria|0
7101577|NCT02371980|11226126|FG002|Open-label Period|Did not Meet Randomization Criteria|0
7101578|NCT02371980|11226127|FG003|Open-label Period|Did not Meet Randomization Criteria|0
7101579|NCT02371980|11226128|FG004|Open-label Period|Did not Meet Randomization Criteria|0
7101580|NCT02371980|11226124|FG000|Open-label Period|Reason not Specified|9
7101581|NCT02371980|11226125|FG001|Open-label Period|Reason not Specified|0
7101582|NCT02371980|11226126|FG002|Open-label Period|Reason not Specified|0
7101583|NCT02371980|11226127|FG003|Open-label Period|Reason not Specified|0
7101584|NCT02371980|11226128|FG004|Open-label Period|Reason not Specified|0
7101585|NCT02371980|11226124|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0
7101586|NCT02371980|11226125|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4
7101587|NCT02371980|11226126|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3
7101588|NCT02371980|11226127|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2
7101589|NCT02371980|11226128|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9
7101590|NCT02371980|11226124|FG000|Double-blind Period|Significant Protocol Deviation|0
7101591|NCT02371980|11226125|FG001|Double-blind Period|Significant Protocol Deviation|2
7101592|NCT02371980|11226126|FG002|Double-blind Period|Significant Protocol Deviation|7
7101593|NCT02371980|11226127|FG003|Double-blind Period|Significant Protocol Deviation|3
7101594|NCT02371980|11226128|FG004|Double-blind Period|Significant Protocol Deviation|3
7101595|NCT02371980|11226124|FG000|Double-blind Period|Noncompliance with Study Drug|0
7101596|NCT02371980|11226125|FG001|Double-blind Period|Noncompliance with Study Drug|1
7101597|NCT02371980|11226126|FG002|Double-blind Period|Noncompliance with Study Drug|2
7101598|NCT02371980|11226127|FG003|Double-blind Period|Noncompliance with Study Drug|2
7101599|NCT02371980|11226128|FG004|Double-blind Period|Noncompliance with Study Drug|3
7101600|NCT02371980|11226124|FG000|Double-blind Period|Lost to Follow-up|0
7101601|NCT02371980|11226125|FG001|Double-blind Period|Lost to Follow-up|8
7101602|NCT02371980|11226126|FG002|Double-blind Period|Lost to Follow-up|8
7101603|NCT02371980|11226127|FG003|Double-blind Period|Lost to Follow-up|6
7101604|NCT02371980|11226128|FG004|Double-blind Period|Lost to Follow-up|5
7101605|NCT02371980|11226124|FG000|Double-blind Period|Voluntary Withdrawal|0
7101606|NCT02371980|11226125|FG001|Double-blind Period|Voluntary Withdrawal|12
7101607|NCT02371980|11226126|FG002|Double-blind Period|Voluntary Withdrawal|8
7101608|NCT02371980|11226127|FG003|Double-blind Period|Voluntary Withdrawal|9
7101609|NCT02371980|11226128|FG004|Double-blind Period|Voluntary Withdrawal|11
7101610|NCT02371980|11226124|FG000|Double-blind Period|Relapse|0
7101611|NCT02371980|11226125|FG001|Double-blind Period|Relapse|50
7101612|NCT02371980|11226126|FG002|Double-blind Period|Relapse|25
7101613|NCT02371980|11226127|FG003|Double-blind Period|Relapse|25
7101614|NCT02371980|11226128|FG004|Double-blind Period|Relapse|26
7101615|NCT02371980|11226124|FG000|Double-blind Period|Reason not Specified|0
7101616|NCT02371980|11226125|FG001|Double-blind Period|Reason not Specified|3
7101617|NCT02371980|11226126|FG002|Double-blind Period|Reason not Specified|3
7101618|NCT02371980|11226127|FG003|Double-blind Period|Reason not Specified|2
7101619|NCT02371980|11226128|FG004|Double-blind Period|Reason not Specified|1
7101620|NCT02371980|11226124|FG000|Double-blind Period|Missing|0
7101621|NCT02371980|11226125|FG001|Double-blind Period|Missing|1
7101622|NCT02371980|11226126|FG002|Double-blind Period|Missing|0
7101623|NCT02371980|11226127|FG003|Double-blind Period|Missing|0
7101624|NCT02371980|11226128|FG004|Double-blind Period|Missing|0
7101625|NCT02372006|11226142|FG000|Overall Study|Progressive disease|8
7101626|NCT02372006|11226143|FG001|Overall Study|Progressive disease|7
7101627|NCT02372006|11226144|FG002|Overall Study|Progressive disease|34
7101628|NCT02372006|11226142|FG000|Overall Study|Dose limiting toxicity|0
7101629|NCT02372006|11226143|FG001|Overall Study|Dose limiting toxicity|1
7101630|NCT02372006|11226144|FG002|Overall Study|Dose limiting toxicity|0
7101631|NCT02372006|11226142|FG000|Overall Study|Adverse Event|0
7101632|NCT02372006|11226143|FG001|Overall Study|Adverse Event|0
7101633|NCT02372006|11226144|FG002|Overall Study|Adverse Event|3
7101634|NCT02372006|11226142|FG000|Overall Study|Withdrawal by Subject|0
7101635|NCT02372006|11226143|FG001|Overall Study|Withdrawal by Subject|1
7101636|NCT02372006|11226144|FG002|Overall Study|Withdrawal by Subject|1
7101637|NCT02372006|11226142|FG000|Overall Study|Other reason for not completing|0
7101638|NCT02372006|11226143|FG001|Overall Study|Other reason for not completing|0
7101639|NCT02372006|11226144|FG002|Overall Study|Other reason for not completing|1
7101640|NCT02372058|11226153|FG000|Overall Study|Withdrawal by Subject|3
7101641|NCT02372071|11226159|FG000|Overall Study|Protocol Violation|18
7101642|NCT02372253|11226175|FG000|Overall Study|Non Compliance|2
7101643|NCT02372253|11226176|FG001|Overall Study|Non Compliance|0
7101644|NCT02372383|11226196|FG000|First Intervention (1 Day)|Unable to collect blood|0
7101645|NCT02372383|11226197|FG001|First Intervention (1 Day)|Unable to collect blood|1
7101646|NCT02372383|11226198|FG002|First Intervention (1 Day)|Unable to collect blood|0
7101647|NCT02372396|11226210|FG000|Overall Study|Lost to Follow-up|7
7101648|NCT02372396|11226211|FG001|Overall Study|Lost to Follow-up|9
7101649|NCT02372799|11226236|FG000|Treatment Period|Adverse Event|3
7101650|NCT02372799|11226237|FG001|Treatment Period|Adverse Event|10
7101651|NCT02372799|11226238|FG002|Treatment Period|Adverse Event|6
7101652|NCT02372799|11226236|FG000|Treatment Period|Insufficient therapeutic response|2
7101653|NCT02372799|11226237|FG001|Treatment Period|Insufficient therapeutic response|2
7101654|NCT02372799|11226238|FG002|Treatment Period|Insufficient therapeutic response|0
7101655|NCT02372799|11226236|FG000|Treatment Period|Withdrawal by Subject|10
7101656|NCT02372799|11226237|FG001|Treatment Period|Withdrawal by Subject|10
7101657|NCT02372799|11226238|FG002|Treatment Period|Withdrawal by Subject|2
7101658|NCT02372799|11226236|FG000|Treatment Period|Lost to Follow-up|11
7101659|NCT02372799|11226237|FG001|Treatment Period|Lost to Follow-up|5
7101660|NCT02372799|11226238|FG002|Treatment Period|Lost to Follow-up|3
7101661|NCT02372799|11226236|FG000|Treatment Period|Protocol Violation|3
7101662|NCT02372799|11226237|FG001|Treatment Period|Protocol Violation|0
7101663|NCT02372799|11226238|FG002|Treatment Period|Protocol Violation|0
7101664|NCT02372799|11226236|FG000|Treatment Period|Non-compliance with study drug|4
7101665|NCT02372799|11226237|FG001|Treatment Period|Non-compliance with study drug|4
7101666|NCT02372799|11226238|FG002|Treatment Period|Non-compliance with study drug|4
7101667|NCT02372799|11226236|FG000|Treatment Period|Miscellaneous Reasons|1
7101668|NCT02372799|11226237|FG001|Treatment Period|Miscellaneous Reasons|1
7101669|NCT02372799|11226238|FG002|Treatment Period|Miscellaneous Reasons|0
7101670|NCT02372799|11226236|FG000|Down-taper Period|Lost to Follow-up|1
7101671|NCT02372799|11226237|FG001|Down-taper Period|Lost to Follow-up|2
7101672|NCT02372799|11226238|FG002|Down-taper Period|Lost to Follow-up|2
7101673|NCT02373098|11226248|FG000|Overall Study|Lost to Follow-up|1
7101674|NCT02373098|11226249|FG001|Overall Study|Lost to Follow-up|0
7101675|NCT02373098|11226248|FG000|Overall Study|Protocol Violation|3
7101676|NCT02373098|11226249|FG001|Overall Study|Protocol Violation|0
7101677|NCT02373098|11226248|FG000|Overall Study|Withdrawal by Subject|5
7101678|NCT02373098|11226249|FG001|Overall Study|Withdrawal by Subject|0
7101679|NCT02373098|11226248|FG000|Overall Study|Adverse Event|3
7101680|NCT02373098|11226249|FG001|Overall Study|Adverse Event|0
7101681|NCT02373202|11226279|FG000|Overall Study|Adverse Event|2
7101682|NCT02373202|11226280|FG001|Overall Study|Adverse Event|5
7101683|NCT02373202|11226281|FG002|Overall Study|Adverse Event|2
7101684|NCT02373202|11226282|FG003|Overall Study|Adverse Event|1
7101685|NCT02373202|11226279|FG000|Overall Study|Lack of Efficacy|0
7101686|NCT02373202|11226280|FG001|Overall Study|Lack of Efficacy|0
7101687|NCT02373202|11226281|FG002|Overall Study|Lack of Efficacy|1
7101688|NCT02373202|11226282|FG003|Overall Study|Lack of Efficacy|0
7101689|NCT02373202|11226279|FG000|Overall Study|Other|0
7101690|NCT02373202|11226280|FG001|Overall Study|Other|1
7101691|NCT02373202|11226281|FG002|Overall Study|Other|0
7101692|NCT02373202|11226282|FG003|Overall Study|Other|0
7101693|NCT02373813|11226304|FG000|Run-In Period|Other, Not Specified|5
7101694|NCT02373813|11226305|FG001|Run-In Period|Other, Not Specified|0
7101695|NCT02373813|11226306|FG002|Run-In Period|Other, Not Specified|0
7101696|NCT02373813|11226307|FG003|Run-In Period|Other, Not Specified|0
7101697|NCT02373813|11226304|FG000|Run-In Period|Withdrawal by Subject|16
7101698|NCT02373813|11226305|FG001|Run-In Period|Withdrawal by Subject|0
7101699|NCT02373813|11226306|FG002|Run-In Period|Withdrawal by Subject|0
7101700|NCT02373813|11226307|FG003|Run-In Period|Withdrawal by Subject|0
7101701|NCT02373813|11226304|FG000|Run-In Period|Decision by Sponsor|11
7101702|NCT02373813|11226305|FG001|Run-In Period|Decision by Sponsor|0
7101703|NCT02373813|11226306|FG002|Run-In Period|Decision by Sponsor|0
7101704|NCT02373813|11226307|FG003|Run-In Period|Decision by Sponsor|0
7101705|NCT02373813|11226304|FG000|Run-In Period|Protocol Violation|75
7101706|NCT02373813|11226305|FG001|Run-In Period|Protocol Violation|0
7101707|NCT02373813|11226306|FG002|Run-In Period|Protocol Violation|0
7101708|NCT02373813|11226307|FG003|Run-In Period|Protocol Violation|0
7101709|NCT02373813|11226304|FG000|Run-In Period|Lost to Follow-up|2
7101710|NCT02373813|11226305|FG001|Run-In Period|Lost to Follow-up|0
7101711|NCT02373813|11226306|FG002|Run-In Period|Lost to Follow-up|0
7101712|NCT02373813|11226307|FG003|Run-In Period|Lost to Follow-up|0
7101713|NCT02373813|11226304|FG000|Run-In Period|Adverse Event|3
7101714|NCT02373813|11226305|FG001|Run-In Period|Adverse Event|0
7101715|NCT02373813|11226306|FG002|Run-In Period|Adverse Event|0
7101716|NCT02373813|11226307|FG003|Run-In Period|Adverse Event|0
7101717|NCT02373813|11226304|FG000|Run-In Period|Noncompliance|1
7101718|NCT02373813|11226305|FG001|Run-In Period|Noncompliance|0
7101719|NCT02373813|11226306|FG002|Run-In Period|Noncompliance|0
7101720|NCT02373813|11226307|FG003|Run-In Period|Noncompliance|0
7101721|NCT02373813|11226304|FG000|Run-In Period|Ineligibility Determined|3
7101722|NCT02373813|11226305|FG001|Run-In Period|Ineligibility Determined|0
7101723|NCT02373813|11226306|FG002|Run-In Period|Ineligibility Determined|0
7101724|NCT02373813|11226307|FG003|Run-In Period|Ineligibility Determined|0
7101725|NCT02373813|11226304|FG000|Double-Blind Treatment Period|Decision by Sponsor|0
7101726|NCT02373813|11226305|FG001|Double-Blind Treatment Period|Decision by Sponsor|1
7101727|NCT02373813|11226306|FG002|Double-Blind Treatment Period|Decision by Sponsor|2
7101728|NCT02373813|11226307|FG003|Double-Blind Treatment Period|Decision by Sponsor|0
7101729|NCT02373813|11226304|FG000|Double-Blind Treatment Period|Protocol Violation|0
7101730|NCT02373813|11226305|FG001|Double-Blind Treatment Period|Protocol Violation|2
7101731|NCT02373813|11226306|FG002|Double-Blind Treatment Period|Protocol Violation|0
7101732|NCT02373813|11226307|FG003|Double-Blind Treatment Period|Protocol Violation|0
7101733|NCT02373813|11226304|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
7101734|NCT02373813|11226305|FG001|Double-Blind Treatment Period|Lost to Follow-up|0
7101735|NCT02373813|11226306|FG002|Double-Blind Treatment Period|Lost to Follow-up|1
7101736|NCT02373813|11226307|FG003|Double-Blind Treatment Period|Lost to Follow-up|1
7101737|NCT02373813|11226304|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
7101738|NCT02373813|11226305|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10
7101739|NCT02373813|11226306|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6
7101740|NCT02373813|11226307|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3
7101741|NCT02374099|11226337|FG000|Overall Study|Adverse Event|1
7101742|NCT02374099|11226338|FG001|Overall Study|Adverse Event|0
7101743|NCT02374099|11226337|FG000|Overall Study|Progressive Disease|35
7101744|NCT02374099|11226338|FG001|Overall Study|Progressive Disease|40
7101745|NCT02374099|11226337|FG000|Overall Study|Withdrawal by Subject|5
7101746|NCT02374099|11226338|FG001|Overall Study|Withdrawal by Subject|1
7101747|NCT02374099|11226337|FG000|Overall Study|Miscellaneous|2
7101748|NCT02374099|11226338|FG001|Overall Study|Miscellaneous|3
7101749|NCT02374099|11226337|FG000|Overall Study|Randomized, but not treated|2
7101750|NCT02374099|11226338|FG001|Overall Study|Randomized, but not treated|1
7101751|NCT02374099|11226337|FG000|Overall Study|Study Terminated by Sponsor|3
7101752|NCT02374099|11226338|FG001|Overall Study|Study Terminated by Sponsor|4
7101753|NCT02374255|11226371|FG000|Overall Study|Withdrawal by Subject|2
7101754|NCT02374255|11226372|FG001|Overall Study|Withdrawal by Subject|0
7101755|NCT02374255|11226373|FG002|Overall Study|Withdrawal by Subject|0
7101756|NCT02374255|11226374|FG003|Overall Study|Withdrawal by Subject|0
7101757|NCT02374307|11226392|FG000|3-months Follow-up|Lost to Follow-up|1
7101758|NCT02374307|11226393|FG001|3-months Follow-up|Lost to Follow-up|2
7101759|NCT02374307|11226392|FG000|3-months Follow-up|Withdrawal by Subject|1
7101760|NCT02374307|11226393|FG001|3-months Follow-up|Withdrawal by Subject|4
7101761|NCT02374307|11226392|FG000|3-months Follow-up|Death|1
7101762|NCT02374307|11226393|FG001|3-months Follow-up|Death|2
7101763|NCT02374307|11226392|FG000|3-months Follow-up|Missed first follow-up|5
7101764|NCT02374307|11226393|FG001|3-months Follow-up|Missed first follow-up|1
7101765|NCT02374307|11226392|FG000|6-months Follow-up|Lost to Follow-up|1
7101766|NCT02374307|11226393|FG001|6-months Follow-up|Lost to Follow-up|2
7101767|NCT02374307|11226392|FG000|6-months Follow-up|Death|2
7101768|NCT02374307|11226393|FG001|6-months Follow-up|Death|1
7101769|NCT02374307|11226392|FG000|6-months Follow-up|Withdrawal by Subject|0
7101770|NCT02374307|11226393|FG001|6-months Follow-up|Withdrawal by Subject|3
7101771|NCT02374346|11226399|FG000|Overall Study|operated or discharged during weekend|48
7101772|NCT02374463|11226425|FG000|Overall Study|Withdrawal by Subject|3
7101773|NCT02374463|11226426|FG001|Overall Study|Withdrawal by Subject|3
7101774|NCT02374593|11226435|FG000|Overall Study|non-compliant|2
7101775|NCT02374593|11226436|FG001|Overall Study|non-compliant|0
7101776|NCT02374671|11226449|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0
7101777|NCT02374671|11226450|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0
7101778|NCT02374671|11226451|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4
7101779|NCT02374671|11226449|FG000|Observation (Deferred Implantation)|Adverse Event|0
7101780|NCT02374671|11226450|FG001|Observation (Deferred Implantation)|Adverse Event|0
7101781|NCT02374671|11226451|FG002|Observation (Deferred Implantation)|Adverse Event|1
7101782|NCT02374671|11226449|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17
7101783|NCT02374671|11226450|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1
7101784|NCT02374671|11226451|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2
7101785|NCT02374671|11226449|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7
7101786|NCT02374671|11226450|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0
7101787|NCT02374671|11226451|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1
7101788|NCT02374671|11226449|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1
7101789|NCT02374671|11226450|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
7101790|NCT02374671|11226451|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
7101791|NCT02374918|11226461|FG000|Overall Study|Protocol Violation|2
7101792|NCT02374918|11226462|FG001|Overall Study|Protocol Violation|0
7101793|NCT02374918|11226463|FG002|Overall Study|Protocol Violation|2
7101794|NCT02374918|11226464|FG003|Overall Study|Protocol Violation|1
7101795|NCT02374918|11226461|FG000|Overall Study|Withdrawal by Subject|1
7101796|NCT02374918|11226462|FG001|Overall Study|Withdrawal by Subject|1
7101797|NCT02374918|11226463|FG002|Overall Study|Withdrawal by Subject|1
7101798|NCT02374918|11226464|FG003|Overall Study|Withdrawal by Subject|0
7101799|NCT02374918|11226461|FG000|Overall Study|Lack of Efficacy|0
7101800|NCT02374918|11226462|FG001|Overall Study|Lack of Efficacy|0
7101801|NCT02374918|11226463|FG002|Overall Study|Lack of Efficacy|1
7101802|NCT02374918|11226464|FG003|Overall Study|Lack of Efficacy|1
7101803|NCT02374957|11226474|FG000|Overall Study|Patient did not complete forms correctly|1
7101804|NCT02374957|11226475|FG001|Overall Study|Patient did not complete forms correctly|0
7101805|NCT02375347|11226481|FG000|Overall Study|Protocol Violation|1
7101806|NCT02375373|11226485|FG000|Overall Study|Withdrawal by Subject|11
7101807|NCT02375698|11226491|FG000|Overall Study|Withdrawal by Subject|0
7101808|NCT02375698|11226492|FG001|Overall Study|Withdrawal by Subject|2
7101809|NCT02375698|11226491|FG000|Overall Study|Physician Decision|2
7101810|NCT02375698|11226492|FG001|Overall Study|Physician Decision|0
7101811|NCT02375724|11226500|FG000|Overall Study|Lack of Efficacy|1
7101812|NCT02375724|11226501|FG001|Overall Study|Lack of Efficacy|1
7101813|NCT02375724|11226500|FG000|Overall Study|Withdrawal by Subject|1
7101814|NCT02375724|11226501|FG001|Overall Study|Withdrawal by Subject|1
7101815|NCT02375724|11226500|FG000|Overall Study|Lost to Follow-up|1
7101816|NCT02375724|11226501|FG001|Overall Study|Lost to Follow-up|0
7101817|NCT02375724|11226500|FG000|Overall Study|Protocol Violation|1
7101818|NCT02375724|11226501|FG001|Overall Study|Protocol Violation|0
7101819|NCT02375724|11226500|FG000|Overall Study|Adverse Event|2
7101820|NCT02375724|11226501|FG001|Overall Study|Adverse Event|4
7101821|NCT02375971|11226510|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0
7101822|NCT02375971|11226511|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0
7101823|NCT02375971|11226512|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2
7101824|NCT02375971|11226510|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1
7101825|NCT02375971|11226511|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1
7101826|NCT02375971|11226512|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1
7101827|NCT02375971|11226510|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0
7101828|NCT02375971|11226511|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0
7101829|NCT02375971|11226512|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1
7101830|NCT02375971|11226510|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0
7101831|NCT02375971|11226511|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0
7101832|NCT02375971|11226512|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1
7101833|NCT02375971|11226510|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1
7101834|NCT02375971|11226511|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0
7101835|NCT02375971|11226512|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0
7101836|NCT02375971|11226510|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1
7101837|NCT02375971|11226511|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0
7101838|NCT02375971|11226512|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1
7101839|NCT02375971|11226510|FG000|Follow-Up Phase (up to Day 169)|Death|4
7101840|NCT02375971|11226511|FG001|Follow-Up Phase (up to Day 169)|Death|4
7101841|NCT02375971|11226512|FG002|Follow-Up Phase (up to Day 169)|Death|4
7101842|NCT02375971|11226510|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1
7101843|NCT02375971|11226511|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1
7101844|NCT02375971|11226512|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0
7101845|NCT02376166|11226533|FG000|Overall Study|Adverse Event|1
7101846|NCT02376166|11226533|FG000|Overall Study|Discontinued metformin early|2
7101847|NCT02376790|11226597|FG000|Overall Study|Withdrawal by Subject|43
7101848|NCT02376790|11226598|FG001|Overall Study|Withdrawal by Subject|36
7101849|NCT02376790|11226599|FG002|Overall Study|Withdrawal by Subject|37
7101850|NCT02376790|11226597|FG000|Overall Study|Decision by Sponsor|2
7101851|NCT02376790|11226598|FG001|Overall Study|Decision by Sponsor|1
7101852|NCT02376790|11226599|FG002|Overall Study|Decision by Sponsor|4
7101853|NCT02376790|11226597|FG000|Overall Study|Lost to Follow-up|15
7101854|NCT02376790|11226598|FG001|Overall Study|Lost to Follow-up|10
7101855|NCT02376790|11226599|FG002|Overall Study|Lost to Follow-up|12
7101856|NCT02377063|11226611|FG000|Overall Study|Non-compliance|5
7101857|NCT02377349|11226617|FG000|Overall Study|Serious Adverse Event|1
7101858|NCT02377349|11226618|FG001|Overall Study|Serious Adverse Event|0
7101859|NCT02377349|11226617|FG000|Overall Study|Protocol Violation|3
7101860|NCT02377349|11226618|FG001|Overall Study|Protocol Violation|2
7101861|NCT02377349|11226617|FG000|Overall Study|Withdrawal by Subject|5
7101862|NCT02377349|11226618|FG001|Overall Study|Withdrawal by Subject|3
7101863|NCT02377349|11226617|FG000|Overall Study|Lost to follow-up (partial vaccination)|1
7101864|NCT02377349|11226618|FG001|Overall Study|Lost to follow-up (partial vaccination)|0
7101865|NCT02377349|11226617|FG000|Overall Study|Lost to follow-up (complete vaccination)|6
7101866|NCT02377349|11226618|FG001|Overall Study|Lost to follow-up (complete vaccination)|5
7101867|NCT02377349|11226617|FG000|Overall Study|Other|0
7101868|NCT02377349|11226618|FG001|Overall Study|Other|1
7101869|NCT02377362|11226646|FG000|Part A Second Treatment|Protocol Violation|0
7101870|NCT02377362|11226647|FG001|Part A Second Treatment|Protocol Violation|0
7101871|NCT02377362|11226648|FG002|Part A Second Treatment|Protocol Violation|0
7101872|NCT02377362|11226649|FG003|Part A Second Treatment|Protocol Violation|0
7101873|NCT02377362|11226650|FG004|Part A Second Treatment|Protocol Violation|1
7101874|NCT02377362|11226651|FG005|Part A Second Treatment|Protocol Violation|0
7101875|NCT02377362|11226652|FG006|Part A Second Treatment|Protocol Violation|0
7101876|NCT02377362|11226653|FG007|Part A Second Treatment|Protocol Violation|0
7101877|NCT02377362|11226654|FG008|Part A Second Treatment|Protocol Violation|0
7101878|NCT02377362|11226655|FG009|Part A Second Treatment|Protocol Violation|0
7101879|NCT02377362|11226656|FG010|Part A Second Treatment|Protocol Violation|0
7101880|NCT02377362|11226657|FG011|Part A Second Treatment|Protocol Violation|0
7101881|NCT02377362|11226658|FG012|Part A Second Treatment|Protocol Violation|0
7101882|NCT02377362|11226646|FG000|Part A Third Treatment|Highest dose level 1200 not used|0
7101883|NCT02377362|11226647|FG001|Part A Third Treatment|Highest dose level 1200 not used|0
7101884|NCT02377362|11226648|FG002|Part A Third Treatment|Highest dose level 1200 not used|0
7101885|NCT02377362|11226649|FG003|Part A Third Treatment|Highest dose level 1200 not used|4
7101886|NCT02377362|11226650|FG004|Part A Third Treatment|Highest dose level 1200 not used|3
7101887|NCT02377362|11226651|FG005|Part A Third Treatment|Highest dose level 1200 not used|4
7101888|NCT02377362|11226652|FG006|Part A Third Treatment|Highest dose level 1200 not used|0
7101889|NCT02377362|11226653|FG007|Part A Third Treatment|Highest dose level 1200 not used|0
7101890|NCT02377362|11226654|FG008|Part A Third Treatment|Highest dose level 1200 not used|0
7101891|NCT02377362|11226655|FG009|Part A Third Treatment|Highest dose level 1200 not used|0
7101892|NCT02377362|11226656|FG010|Part A Third Treatment|Highest dose level 1200 not used|0
7101893|NCT02377362|11226657|FG011|Part A Third Treatment|Highest dose level 1200 not used|0
7101894|NCT02377362|11226658|FG012|Part A Third Treatment|Highest dose level 1200 not used|0
7101895|NCT02377362|11226646|FG000|Part B Overall|Protocol Violation|0
7101896|NCT02377362|11226647|FG001|Part B Overall|Protocol Violation|0
7101897|NCT02377362|11226648|FG002|Part B Overall|Protocol Violation|0
7101898|NCT02377362|11226649|FG003|Part B Overall|Protocol Violation|0
7101899|NCT02377362|11226650|FG004|Part B Overall|Protocol Violation|0
7101900|NCT02377362|11226651|FG005|Part B Overall|Protocol Violation|0
7101901|NCT02377362|11226652|FG006|Part B Overall|Protocol Violation|0
7101902|NCT02377362|11226653|FG007|Part B Overall|Protocol Violation|0
7101903|NCT02377362|11226654|FG008|Part B Overall|Protocol Violation|0
7101904|NCT02377362|11226655|FG009|Part B Overall|Protocol Violation|1
7101905|NCT02377362|11226656|FG010|Part B Overall|Protocol Violation|0
7101906|NCT02377362|11226657|FG011|Part B Overall|Protocol Violation|0
7101907|NCT02377362|11226658|FG012|Part B Overall|Protocol Violation|0
7101908|NCT02377362|11226646|FG000|Part B Overall|Adverse Event|0
7101909|NCT02377362|11226647|FG001|Part B Overall|Adverse Event|0
7101910|NCT02377362|11226648|FG002|Part B Overall|Adverse Event|0
7101911|NCT02377362|11226649|FG003|Part B Overall|Adverse Event|0
7101912|NCT02377362|11226650|FG004|Part B Overall|Adverse Event|0
7101913|NCT02377362|11226651|FG005|Part B Overall|Adverse Event|0
7101914|NCT02377362|11226652|FG006|Part B Overall|Adverse Event|1
7101915|NCT02377362|11226653|FG007|Part B Overall|Adverse Event|1
7101916|NCT02377362|11226654|FG008|Part B Overall|Adverse Event|0
7101917|NCT02377362|11226655|FG009|Part B Overall|Adverse Event|0
7101918|NCT02377362|11226656|FG010|Part B Overall|Adverse Event|0
7101919|NCT02377362|11226657|FG011|Part B Overall|Adverse Event|0
7101920|NCT02377362|11226658|FG012|Part B Overall|Adverse Event|0
7101921|NCT02377362|11226646|FG000|Part B Overall|Withdrawal by Subject|0
7101922|NCT02377362|11226647|FG001|Part B Overall|Withdrawal by Subject|0
7101923|NCT02377362|11226648|FG002|Part B Overall|Withdrawal by Subject|0
7101924|NCT02377362|11226649|FG003|Part B Overall|Withdrawal by Subject|0
7101925|NCT02377362|11226650|FG004|Part B Overall|Withdrawal by Subject|0
7101926|NCT02377362|11226651|FG005|Part B Overall|Withdrawal by Subject|0
7101927|NCT02377362|11226652|FG006|Part B Overall|Withdrawal by Subject|1
7101928|NCT02377362|11226653|FG007|Part B Overall|Withdrawal by Subject|0
7101929|NCT02377362|11226654|FG008|Part B Overall|Withdrawal by Subject|0
7101930|NCT02377362|11226655|FG009|Part B Overall|Withdrawal by Subject|0
7101931|NCT02377362|11226656|FG010|Part B Overall|Withdrawal by Subject|0
7101932|NCT02377362|11226657|FG011|Part B Overall|Withdrawal by Subject|1
7101933|NCT02377362|11226658|FG012|Part B Overall|Withdrawal by Subject|0
7101934|NCT02377427|11226698|FG000|Part A (Up to Week 20)|Physician Decision|1
7101935|NCT02377427|11226699|FG001|Part A (Up to Week 20)|Physician Decision|0
7101936|NCT02377427|11226700|FG002|Part A (Up to Week 20)|Physician Decision|0
7101937|NCT02377427|11226701|FG003|Part A (Up to Week 20)|Physician Decision|0
7101938|NCT02377427|11226702|FG004|Part A (Up to Week 20)|Physician Decision|0
7101939|NCT02377427|11226698|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1
7101940|NCT02377427|11226699|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
7101941|NCT02377427|11226700|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
7101942|NCT02377427|11226701|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
7101943|NCT02377427|11226702|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
7101944|NCT02377427|11226698|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2
7101945|NCT02377427|11226699|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0
7101946|NCT02377427|11226700|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0
7101947|NCT02377427|11226701|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0
7101948|NCT02377427|11226702|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0
7101949|NCT02377427|11226698|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
7101950|NCT02377427|11226699|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
7101951|NCT02377427|11226700|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1
7101952|NCT02377427|11226701|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
7101953|NCT02377427|11226702|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
7101954|NCT02377466|11226717|FG000|Overall Study|Other: Randomized and not treated|0
7101955|NCT02377466|11226718|FG001|Overall Study|Other: Randomized and not treated|2
7101956|NCT02377817|11226761|FG000|Overall Study|Transportation/childcare barriers.|2
7101957|NCT02377817|11226762|FG001|Overall Study|Transportation/childcare barriers.|0
7101958|NCT02377817|11226761|FG000|Overall Study|Unrelated injury prevented lateral sleep|1
7101959|NCT02377817|11226762|FG001|Overall Study|Unrelated injury prevented lateral sleep|0
7101960|NCT02377921|11226772|FG000|Overall Study|Subject non-compliance|1
7101961|NCT02377921|11226773|FG001|Overall Study|Subject non-compliance|1
7101962|NCT02378220|11226819|FG000|Overall Study|Death|6
7101963|NCT02378220|11226820|FG001|Overall Study|Death|1
7101964|NCT02378480|11226842|FG000|Overall Study|Physician Decision|1
7101965|NCT02378480|11226843|FG001|Overall Study|Physician Decision|1
7101966|NCT02378480|11226842|FG000|Overall Study|Death|1
7101967|NCT02378480|11226843|FG001|Overall Study|Death|2
7101968|NCT02378480|11226842|FG000|Overall Study|Randomized, but Not Treated|6
7101969|NCT02378480|11226843|FG001|Overall Study|Randomized, but Not Treated|4
7101970|NCT02378480|11226842|FG000|Overall Study|Adverse Event|0
7101971|NCT02378480|11226843|FG001|Overall Study|Adverse Event|1
7101972|NCT02378480|11226842|FG000|Overall Study|Missed EOT/PTE Visit|1
7101973|NCT02378480|11226843|FG001|Overall Study|Missed EOT/PTE Visit|2
7101974|NCT02378480|11226842|FG000|Overall Study|Withdrawal by Subject|9
7101975|NCT02378480|11226843|FG001|Overall Study|Withdrawal by Subject|4
7101976|NCT02378480|11226842|FG000|Overall Study|Lost to Follow-up|10
7101977|NCT02378480|11226843|FG001|Overall Study|Lost to Follow-up|18
7101978|NCT02378506|11226849|FG000|Overall Study|Lack of Efficacy|3
7101979|NCT02378506|11226849|FG000|Overall Study|Withdrawal by Subject|4
7101980|NCT02378506|11226849|FG000|Overall Study|Protocol Violation|2
7101981|NCT02378506|11226849|FG000|Overall Study|Death|1
7101982|NCT02378506|11226849|FG000|Overall Study|Adverse Event|14
7101983|NCT02378506|11226849|FG000|Overall Study|Randomized But Not Treated|1
7101984|NCT02378662|11226855|FG000|Overall Study|Early Discontinuation|2
7101985|NCT02378662|11226856|FG001|Overall Study|Early Discontinuation|0
7101986|NCT02378883|11226924|FG000|Enrollment|Subject did not meet Inclusion criteria|6
7101987|NCT02378883|11226924|FG000|Enrollment|Attempt to use Apollo was not performed|3
7101988|NCT02378883|11226924|FG000|30 Day Follow-Up|Withdrawal by Subject|1
7101989|NCT02378883|11226924|FG000|30 Day Follow-Up|Physician Decision|2
7101990|NCT02378883|11226924|FG000|30 Day Follow-Up|Missed Visit|2
7101991|NCT02378883|11226924|FG000|30 Day Follow-Up|Death|1
7101992|NCT02378883|11226924|FG000|12 Months Follow-Up|Lost to Follow-up|3
7101993|NCT02378883|11226924|FG000|12 Months Follow-Up|Death|2
7101994|NCT02378935|11226936|FG000|Overall Study|Lack of Efficacy|10
7101995|NCT02378935|11226937|FG001|Overall Study|Lack of Efficacy|0
7101996|NCT02378935|11226938|FG002|Overall Study|Lack of Efficacy|2
7101997|NCT02378935|11226939|FG003|Overall Study|Lack of Efficacy|6
7101998|NCT02378935|11226940|FG004|Overall Study|Lack of Efficacy|0
7101999|NCT02378935|11226941|FG005|Overall Study|Lack of Efficacy|0
7102000|NCT02378935|11226942|FG006|Overall Study|Lack of Efficacy|0
7102001|NCT02378935|11226936|FG000|Overall Study|Death|0
7102002|NCT02378935|11226937|FG001|Overall Study|Death|0
7102003|NCT02378935|11226938|FG002|Overall Study|Death|1
7102004|NCT02378935|11226939|FG003|Overall Study|Death|0
7102005|NCT02378935|11226940|FG004|Overall Study|Death|0
7102006|NCT02378935|11226941|FG005|Overall Study|Death|0
7102007|NCT02378935|11226942|FG006|Overall Study|Death|0
7102008|NCT02378961|11226962|FG000|Overall Study|Lack of Efficacy|4
7102009|NCT02378961|11226963|FG001|Overall Study|Lack of Efficacy|2
7102010|NCT02378961|11226964|FG002|Overall Study|Lack of Efficacy|0
7102011|NCT02378961|11226965|FG003|Overall Study|Lack of Efficacy|1
7102012|NCT02378961|11226962|FG000|Overall Study|Death|0
7102013|NCT02378961|11226963|FG001|Overall Study|Death|0
7102014|NCT02378961|11226964|FG002|Overall Study|Death|1
7102015|NCT02378961|11226965|FG003|Overall Study|Death|0
7102016|NCT02379052|11226977|FG000|Overall Study|Protocol Violation|0
7102017|NCT02379052|11226978|FG001|Overall Study|Protocol Violation|1
7102018|NCT02379052|11226977|FG000|Overall Study|Adverse Event|0
7102019|NCT02379052|11226978|FG001|Overall Study|Adverse Event|1
7102020|NCT02379052|11226977|FG000|Overall Study|Physician Decision|1
7102021|NCT02379052|11226978|FG001|Overall Study|Physician Decision|1
7102022|NCT02379052|11226977|FG000|Overall Study|Withdrawal by Subject|2
7102023|NCT02379052|11226978|FG001|Overall Study|Withdrawal by Subject|0
7102024|NCT02379052|11226977|FG000|Overall Study|Lost to Follow-up|2
7102025|NCT02379052|11226978|FG001|Overall Study|Lost to Follow-up|1
7102026|NCT02379052|11226977|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1
7102027|NCT02379052|11226978|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0
7102028|NCT02379052|11226977|FG000|Overall Study|Subject was Incarcerated|0
7102029|NCT02379052|11226978|FG001|Overall Study|Subject was Incarcerated|1
7102030|NCT02379078|11226986|FG000|Overall Study|Lost to Follow-up|33
7102031|NCT02379078|11226987|FG001|Overall Study|Lost to Follow-up|30
7102032|NCT02379078|11226986|FG000|Overall Study|Withdrawal by Subject|6
7102033|NCT02379078|11226987|FG001|Overall Study|Withdrawal by Subject|5
7102034|NCT02379091|11226997|FG000|Overall Study|Pretreatment Event/Adverse Event|0
7102035|NCT02379091|11226998|FG001|Overall Study|Pretreatment Event/Adverse Event|2
7102036|NCT02379091|11226999|FG002|Overall Study|Pretreatment Event/Adverse Event|0
7102037|NCT02379091|11227000|FG003|Overall Study|Pretreatment Event/Adverse Event|1
7102038|NCT02379091|11226997|FG000|Overall Study|Principal Investigator Discretion|0
7102039|NCT02379091|11226998|FG001|Overall Study|Principal Investigator Discretion|1
7102040|NCT02379091|11226999|FG002|Overall Study|Principal Investigator Discretion|0
7102041|NCT02379091|11227000|FG003|Overall Study|Principal Investigator Discretion|0
7102042|NCT02379091|11226997|FG000|Overall Study|Lost to Follow-up|0
7102043|NCT02379091|11226998|FG001|Overall Study|Lost to Follow-up|0
7102044|NCT02379091|11226999|FG002|Overall Study|Lost to Follow-up|0
7102045|NCT02379091|11227000|FG003|Overall Study|Lost to Follow-up|1
7102046|NCT02379091|11226997|FG000|Overall Study|Voluntary Withdrawal|2
7102047|NCT02379091|11226998|FG001|Overall Study|Voluntary Withdrawal|5
7102048|NCT02379091|11226999|FG002|Overall Study|Voluntary Withdrawal|2
7102049|NCT02379091|11227000|FG003|Overall Study|Voluntary Withdrawal|4
7102050|NCT02379091|11226997|FG000|Overall Study|Study Termination|7
7102051|NCT02379091|11226998|FG001|Overall Study|Study Termination|2
7102052|NCT02379091|11226999|FG002|Overall Study|Study Termination|5
7102053|NCT02379091|11227000|FG003|Overall Study|Study Termination|8
7102054|NCT02379091|11226997|FG000|Overall Study|Lack of Efficacy|3
7102055|NCT02379091|11226998|FG001|Overall Study|Lack of Efficacy|0
7102056|NCT02379091|11226999|FG002|Overall Study|Lack of Efficacy|0
7102057|NCT02379091|11227000|FG003|Overall Study|Lack of Efficacy|0
7102058|NCT02379221|11227025|FG000|Overall Study|Lost to Follow-up|1
7102059|NCT02379637|11227044|FG000|Overall Study|Protocol Violation|0
7102060|NCT02379637|11227045|FG001|Overall Study|Protocol Violation|1
7102061|NCT02379637|11227044|FG000|Overall Study|Adverse Event|1
7102062|NCT02379637|11227045|FG001|Overall Study|Adverse Event|0
7102063|NCT02379637|11227044|FG000|Overall Study|Withdrawal by Subject|1
7102064|NCT02379637|11227045|FG001|Overall Study|Withdrawal by Subject|0
7102065|NCT02379728|11227053|FG000|Overall Study|Lost to Follow-up|1
7102066|NCT02379728|11227054|FG001|Overall Study|Lost to Follow-up|0
7102067|NCT02379728|11227055|FG002|Overall Study|Lost to Follow-up|3
7102068|NCT02379728|11227056|FG003|Overall Study|Lost to Follow-up|0
7102069|NCT02379728|11227053|FG000|Overall Study|Withdrawal by Subject|5
7102070|NCT02379728|11227054|FG001|Overall Study|Withdrawal by Subject|0
7102071|NCT02379728|11227055|FG002|Overall Study|Withdrawal by Subject|5
7102072|NCT02379728|11227056|FG003|Overall Study|Withdrawal by Subject|3
7102073|NCT02379728|11227053|FG000|Overall Study|Protocol Violation|0
7102074|NCT02379728|11227054|FG001|Overall Study|Protocol Violation|0
7102075|NCT02379728|11227055|FG002|Overall Study|Protocol Violation|2
7102076|NCT02379728|11227056|FG003|Overall Study|Protocol Violation|0
7102077|NCT02379923|11227074|FG000|Overall Study|Death|5
7102078|NCT02380248|11227090|FG000|Overall Study|Lost to Follow-up|11
7102079|NCT02380248|11227090|FG000|Overall Study|Withdrawal by Subject|3
7102080|NCT02380287|11227107|FG000|Overall Study|Adverse Event|0
7102081|NCT02380287|11227108|FG001|Overall Study|Adverse Event|0
7102082|NCT02380287|11227109|FG002|Overall Study|Adverse Event|1
7102083|NCT02380287|11227110|FG003|Overall Study|Adverse Event|0
7102084|NCT02380287|11227111|FG004|Overall Study|Adverse Event|0
7102085|NCT02380287|11227112|FG005|Overall Study|Adverse Event|0
7102086|NCT02380287|11227113|FG006|Overall Study|Adverse Event|0
7102087|NCT02380287|11227114|FG007|Overall Study|Adverse Event|0
7102088|NCT02380677|11227158|FG000|Overall Study|Adverse Event|0
7102089|NCT02380677|11227159|FG001|Overall Study|Adverse Event|0
7102090|NCT02380677|11227160|FG002|Overall Study|Adverse Event|0
7102091|NCT02380677|11227161|FG003|Overall Study|Adverse Event|1
7102092|NCT02380677|11227162|FG004|Overall Study|Adverse Event|1
7102093|NCT02380677|11227163|FG005|Overall Study|Adverse Event|4
7102094|NCT02380677|11227164|FG006|Overall Study|Adverse Event|2
7102095|NCT02380677|11227165|FG007|Overall Study|Adverse Event|2
7102096|NCT02380677|11227166|FG008|Overall Study|Adverse Event|2
7102097|NCT02380677|11227167|FG009|Overall Study|Adverse Event|1
7102098|NCT02380677|11227168|FG010|Overall Study|Adverse Event|2
7102099|NCT02380677|11227169|FG011|Overall Study|Adverse Event|1
7102100|NCT02380677|11227158|FG000|Overall Study|Physician Decision|1
7102101|NCT02380677|11227159|FG001|Overall Study|Physician Decision|0
7102102|NCT02380677|11227160|FG002|Overall Study|Physician Decision|1
7102103|NCT02380677|11227161|FG003|Overall Study|Physician Decision|1
7102104|NCT02380677|11227162|FG004|Overall Study|Physician Decision|0
7102105|NCT02380677|11227163|FG005|Overall Study|Physician Decision|0
7102106|NCT02380677|11227164|FG006|Overall Study|Physician Decision|0
7102107|NCT02380677|11227165|FG007|Overall Study|Physician Decision|0
7102108|NCT02380677|11227166|FG008|Overall Study|Physician Decision|0
7102109|NCT02380677|11227167|FG009|Overall Study|Physician Decision|0
7102110|NCT02380677|11227168|FG010|Overall Study|Physician Decision|0
7102111|NCT02380677|11227169|FG011|Overall Study|Physician Decision|0
7102112|NCT02380677|11227158|FG000|Overall Study|Lack of Efficacy|0
7102113|NCT02380677|11227159|FG001|Overall Study|Lack of Efficacy|1
7102114|NCT02380677|11227160|FG002|Overall Study|Lack of Efficacy|2
7102115|NCT02380677|11227161|FG003|Overall Study|Lack of Efficacy|0
7102116|NCT02380677|11227162|FG004|Overall Study|Lack of Efficacy|4
7102117|NCT02380677|11227163|FG005|Overall Study|Lack of Efficacy|1
7102118|NCT02380677|11227164|FG006|Overall Study|Lack of Efficacy|1
7102119|NCT02380677|11227165|FG007|Overall Study|Lack of Efficacy|2
7102120|NCT02380677|11227166|FG008|Overall Study|Lack of Efficacy|2
7102121|NCT02380677|11227167|FG009|Overall Study|Lack of Efficacy|0
7102122|NCT02380677|11227168|FG010|Overall Study|Lack of Efficacy|2
7102123|NCT02380677|11227169|FG011|Overall Study|Lack of Efficacy|1
7102124|NCT02380677|11227158|FG000|Overall Study|Withdrawal by Subject|0
7102125|NCT02380677|11227159|FG001|Overall Study|Withdrawal by Subject|0
7102126|NCT02380677|11227160|FG002|Overall Study|Withdrawal by Subject|0
7102127|NCT02380677|11227161|FG003|Overall Study|Withdrawal by Subject|0
7102128|NCT02380677|11227162|FG004|Overall Study|Withdrawal by Subject|0
7102129|NCT02380677|11227163|FG005|Overall Study|Withdrawal by Subject|0
7102130|NCT02380677|11227164|FG006|Overall Study|Withdrawal by Subject|0
7102131|NCT02380677|11227165|FG007|Overall Study|Withdrawal by Subject|0
7102132|NCT02380677|11227166|FG008|Overall Study|Withdrawal by Subject|0
7102133|NCT02380677|11227167|FG009|Overall Study|Withdrawal by Subject|1
7102134|NCT02380677|11227168|FG010|Overall Study|Withdrawal by Subject|0
7102135|NCT02380677|11227169|FG011|Overall Study|Withdrawal by Subject|3
7102136|NCT02380677|11227158|FG000|Overall Study|Other|0
7102137|NCT02380677|11227159|FG001|Overall Study|Other|0
7102138|NCT02380677|11227160|FG002|Overall Study|Other|0
7102139|NCT02380677|11227161|FG003|Overall Study|Other|1
7102140|NCT02380677|11227162|FG004|Overall Study|Other|1
7102141|NCT02380677|11227163|FG005|Overall Study|Other|1
7102142|NCT02380677|11227164|FG006|Overall Study|Other|0
7102143|NCT02380677|11227165|FG007|Overall Study|Other|0
7102144|NCT02380677|11227166|FG008|Overall Study|Other|0
7102145|NCT02380677|11227167|FG009|Overall Study|Other|0
7102146|NCT02380677|11227168|FG010|Overall Study|Other|0
7102147|NCT02380677|11227169|FG011|Overall Study|Other|0
7102148|NCT02380690|11227199|FG000|Overall Study|Lost to Follow-up|14
7102149|NCT02380690|11227200|FG001|Overall Study|Lost to Follow-up|4
7102150|NCT02380690|11227199|FG000|Overall Study|Withdrawal by Subject|20
7102151|NCT02380690|11227200|FG001|Overall Study|Withdrawal by Subject|8
7102152|NCT02380703|11227208|FG000|Overall Study|Withdrawal by Subject|12
7102153|NCT02380703|11227209|FG001|Overall Study|Withdrawal by Subject|9
7102154|NCT02380703|11227208|FG000|Overall Study|Lost to Follow-up|12
7102155|NCT02380703|11227209|FG001|Overall Study|Lost to Follow-up|12
7102156|NCT02380703|11227208|FG000|Overall Study|Caregiver death|1
7102157|NCT02380703|11227209|FG001|Overall Study|Caregiver death|0
7102158|NCT02380703|11227208|FG000|Overall Study|Person with dementia (PWD) death|7
7102159|NCT02380703|11227209|FG001|Overall Study|Person with dementia (PWD) death|8
7102160|NCT02380703|11227208|FG000|Overall Study|Entered Long-term Care|4
7102161|NCT02380703|11227209|FG001|Overall Study|Entered Long-term Care|7
7102162|NCT02380742|11227217|FG000|Overall Study|Withdrawal by Subject|1
7102163|NCT02380742|11227218|FG001|Overall Study|Withdrawal by Subject|0
7102164|NCT02380859|11227226|FG000|Overall Study|Withdrawal by Subject|2
7102165|NCT02380859|11227227|FG001|Overall Study|Withdrawal by Subject|0
7102166|NCT02381795|11227297|FG000|Overall Study|Withdrawal by Subject|1
7102167|NCT02381795|11227297|FG000|Overall Study|Study Terminated|2
7102168|NCT02382016|11227303|FG000|Double-blind (DB) Treatment Period|Physician Decision|3
7102169|NCT02382016|11227304|FG001|Double-blind (DB) Treatment Period|Physician Decision|0
7102170|NCT02382016|11227303|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1
7102171|NCT02382016|11227304|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0
7102172|NCT02382016|11227303|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0
7102173|NCT02382016|11227304|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1
7102174|NCT02382016|11227303|FG000|Open-label (OL) Treatment Period|Physician Decision|3
7102175|NCT02382016|11227304|FG001|Open-label (OL) Treatment Period|Physician Decision|0
7102176|NCT02382016|11227303|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2
7102177|NCT02382016|11227304|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0
7102178|NCT02382016|11227303|FG000|Open-label (OL) Treatment Period|Death|4
7102179|NCT02382016|11227304|FG001|Open-label (OL) Treatment Period|Death|0
7102180|NCT02382016|11227303|FG000|OL Extension Period|Physician Decision|3
7102181|NCT02382016|11227304|FG001|OL Extension Period|Physician Decision|0
7102182|NCT02382016|11227303|FG000|OL Extension Period|Death|2
7102183|NCT02382016|11227304|FG001|OL Extension Period|Death|0
7102184|NCT02382016|11227303|FG000|OL Extension Period|Withdrawal by Subject|1
7102185|NCT02382016|11227304|FG001|OL Extension Period|Withdrawal by Subject|0
7102186|NCT02382133|11227312|FG000|Overall Study|Death|22
7102187|NCT02382133|11227312|FG000|Overall Study|transfer out of ICU|4
7102188|NCT02382133|11227312|FG000|Overall Study|Physician Decision|2
7102189|NCT02382133|11227312|FG000|Overall Study|arterial catheter loss|4
7102190|NCT02382133|11227312|FG000|Overall Study|pressure injury both sites|1
7102191|NCT02382276|11227319|FG000|Overall Study|Withdrawal by Subject|4
7102192|NCT02382276|11227320|FG001|Overall Study|Withdrawal by Subject|8
7102193|NCT02382276|11227321|FG002|Overall Study|Withdrawal by Subject|5
7102194|NCT02382276|11227319|FG000|Overall Study|Adverse Event|7
7102195|NCT02382276|11227320|FG001|Overall Study|Adverse Event|2
7102196|NCT02382276|11227321|FG002|Overall Study|Adverse Event|32
7102197|NCT02382276|11227319|FG000|Overall Study|Physician Decision|0
7102198|NCT02382276|11227320|FG001|Overall Study|Physician Decision|0
7102199|NCT02382276|11227321|FG002|Overall Study|Physician Decision|2
7102200|NCT02382640|11227331|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1
7102201|NCT02382640|11227332|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
7102202|NCT02382640|11227333|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
7102203|NCT02382640|11227334|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
7102204|NCT02382796|11227361|FG000|Overall Study|Global deterioration of health status|1
7102205|NCT02382796|11227361|FG000|Overall Study|Objective progression or relapse|3
7102206|NCT02382796|11227361|FG000|Overall Study|Commercial dacomitinib became available|3
7102207|NCT02382939|11227415|FG000|Overall Study|Adverse Event|1
7102208|NCT02382939|11227416|FG001|Overall Study|Adverse Event|1
7102209|NCT02382939|11227415|FG000|Overall Study|Withdrawal by Subject|2
7102210|NCT02382939|11227416|FG001|Overall Study|Withdrawal by Subject|2
7102211|NCT02382991|11227425|FG000|Overall Study|Adverse Event|1
7102212|NCT02382991|11227426|FG001|Overall Study|Adverse Event|2
7102213|NCT02382991|11227425|FG000|Overall Study|Lost to Follow-up|1
7102214|NCT02382991|11227426|FG001|Overall Study|Lost to Follow-up|0
7102215|NCT02382991|11227425|FG000|Overall Study|Withdrawal by Subject|0
7102216|NCT02382991|11227426|FG001|Overall Study|Withdrawal by Subject|1
7102217|NCT02383017|11227433|FG000|Overall Study|Injury Sustained Outside Study|1
7102218|NCT02383017|11227434|FG001|Overall Study|Injury Sustained Outside Study|0
7102219|NCT02383017|11227433|FG000|Overall Study|Compliance|3
7102220|NCT02383017|11227434|FG001|Overall Study|Compliance|2
7102221|NCT02383017|11227433|FG000|Overall Study|Found to be Hypogonadal|1
7102222|NCT02383017|11227434|FG001|Overall Study|Found to be Hypogonadal|0
7102223|NCT02383056|11227456|FG000|Overall Study|Adverse Event|1
7102224|NCT02383056|11227457|FG001|Overall Study|Adverse Event|0
7102225|NCT02383056|11227456|FG000|Overall Study|Lost to Follow-up|0
7102226|NCT02383056|11227457|FG001|Overall Study|Lost to Follow-up|2
7102227|NCT02383173|11227465|FG000|Overall Study|Palliative Care Team withdrew|0
7102228|NCT02383173|11227466|FG001|Overall Study|Palliative Care Team withdrew|2
7102229|NCT02383355|11227474|FG000|Overall Study|Adverse Event|2
7102230|NCT02383355|11227475|FG001|Overall Study|Adverse Event|0
7102231|NCT02383472|11227496|FG000|Overall Study|Withdrawal by Subject|1
7102232|NCT02383472|11227497|FG001|Overall Study|Withdrawal by Subject|1
7102233|NCT02383576|11227507|FG000|Overall Study|Death|53
7102234|NCT02383576|11227508|FG001|Overall Study|Death|33
7102235|NCT02383576|11227507|FG000|Overall Study|Lost to Follow-up|7
7102236|NCT02383576|11227508|FG001|Overall Study|Lost to Follow-up|1
7102237|NCT02383576|11227507|FG000|Overall Study|Withdrew Consent|1
7102238|NCT02383576|11227508|FG001|Overall Study|Withdrew Consent|6
7102239|NCT02383576|11227507|FG000|Overall Study|Investigator's Decision|0
7102240|NCT02383576|11227508|FG001|Overall Study|Investigator's Decision|1
7102241|NCT02383576|11227507|FG000|Overall Study|Administrative/Other|2
7102242|NCT02383576|11227508|FG001|Overall Study|Administrative/Other|4
7102243|NCT02383589|11227516|FG000|Treatment Period|Adverse Event|1
7102244|NCT02383589|11227517|FG001|Treatment Period|Adverse Event|3
7102245|NCT02383589|11227516|FG000|Treatment Period|Lost to Follow-up|0
7102246|NCT02383589|11227517|FG001|Treatment Period|Lost to Follow-up|1
7102247|NCT02383589|11227516|FG000|Treatment Period|Withdrawal by Subject|0
7102248|NCT02383589|11227517|FG001|Treatment Period|Withdrawal by Subject|5
7102249|NCT02383589|11227516|FG000|Treatment Period|Non-compliance with study drug|0
7102250|NCT02383589|11227517|FG001|Treatment Period|Non-compliance with study drug|1
7102251|NCT02383589|11227516|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2
7102252|NCT02383589|11227517|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4
7102253|NCT02383589|11227516|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5
7102254|NCT02383589|11227517|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0
7102255|NCT02383589|11227516|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0
7102256|NCT02383589|11227517|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1
7102257|NCT02383758|11227540|FG000|Overall Study|Withdrawal by Subject|0
7102258|NCT02383758|11227541|FG001|Overall Study|Withdrawal by Subject|2
7102259|NCT02383862|11227549|FG000|3 Month Follow up|Lost to Follow-up|23
7102260|NCT02383862|11227550|FG001|3 Month Follow up|Lost to Follow-up|21
7102261|NCT02383940|11227565|FG000|Overall Study|Adverse Event|1
7102262|NCT02383940|11227566|FG001|Overall Study|Adverse Event|0
7102263|NCT02383940|11227565|FG000|Overall Study|Lost to Follow-up|2
7102264|NCT02383940|11227566|FG001|Overall Study|Lost to Follow-up|2
7102265|NCT02383940|11227565|FG000|Overall Study|Physician Decision|2
7102266|NCT02383940|11227566|FG001|Overall Study|Physician Decision|0
7102267|NCT02383940|11227565|FG000|Overall Study|Withdrawal by Subject|1
7102268|NCT02383940|11227566|FG001|Overall Study|Withdrawal by Subject|1
7102269|NCT02383940|11227565|FG000|Overall Study|Randomized but not treated|2
7102270|NCT02383940|11227566|FG001|Overall Study|Randomized but not treated|0
7102271|NCT02383940|11227565|FG000|Overall Study|Other than specified above|1
7102272|NCT02383940|11227566|FG001|Overall Study|Other than specified above|0
7102273|NCT02384382|11227611|FG000|Overall Study|Transitioned to study-NCT02960022|5
7102274|NCT02384382|11227611|FG000|Overall Study|Death|1
7102275|NCT02384382|11227611|FG000|Overall Study|Adverse Event|1
7102276|NCT02384382|11227611|FG000|Overall Study|Disease progression|16
7102277|NCT02384395|11227615|FG000|Overall Study|Physician Decision|4
7102278|NCT02384395|11227615|FG000|Overall Study|Withdrawal by Subject|3
7102279|NCT02384395|11227615|FG000|Overall Study|Lost to Follow-up|3
7102280|NCT02384460|11227621|FG000|Overall Study|Protocol Violation|0
7102281|NCT02384460|11227622|FG001|Overall Study|Protocol Violation|1
7102282|NCT02384460|11227621|FG000|Overall Study|Returned to previous therapeutic regimen|0
7102283|NCT02384460|11227622|FG001|Overall Study|Returned to previous therapeutic regimen|1
7102284|NCT02384460|11227621|FG000|Overall Study|Adverse Event|5
7102285|NCT02384460|11227622|FG001|Overall Study|Adverse Event|2
7102286|NCT02384460|11227621|FG000|Overall Study|Withdrawal by Subject|0
7102287|NCT02384460|11227622|FG001|Overall Study|Withdrawal by Subject|3
7102288|NCT02384460|11227621|FG000|Overall Study|Elective medical treatment|1
7102289|NCT02384460|11227622|FG001|Overall Study|Elective medical treatment|0
7102290|NCT02384460|11227621|FG000|Overall Study|Non-compliance|1
7102291|NCT02384460|11227622|FG001|Overall Study|Non-compliance|0
7102292|NCT02384538|11227630|FG000|Overall Study|Adverse Event|1
7102293|NCT02384538|11227631|FG001|Overall Study|Adverse Event|4
7102294|NCT02384538|11227630|FG000|Overall Study|Lack of Efficacy|4
7102295|NCT02384538|11227631|FG001|Overall Study|Lack of Efficacy|4
7102296|NCT02384538|11227630|FG000|Overall Study|Withdrew Consent|0
7102297|NCT02384538|11227631|FG001|Overall Study|Withdrew Consent|4
7102298|NCT02384538|11227630|FG000|Overall Study|Other|1
7102299|NCT02384538|11227631|FG001|Overall Study|Other|3
7102300|NCT02384941|11227640|FG000|Overall Study|Adverse Event|11
7102301|NCT02384941|11227641|FG001|Overall Study|Adverse Event|13
7102302|NCT02384941|11227642|FG002|Overall Study|Adverse Event|17
7102303|NCT02384941|11227640|FG000|Overall Study|Lost to Follow-up|3
7102304|NCT02384941|11227641|FG001|Overall Study|Lost to Follow-up|2
7102305|NCT02384941|11227642|FG002|Overall Study|Lost to Follow-up|1
7102306|NCT02384941|11227640|FG000|Overall Study|Non-Compliance With Study Drug|2
7102307|NCT02384941|11227641|FG001|Overall Study|Non-Compliance With Study Drug|0
7102308|NCT02384941|11227642|FG002|Overall Study|Non-Compliance With Study Drug|1
7102309|NCT02384941|11227640|FG000|Overall Study|Physician Decision|1
7102310|NCT02384941|11227641|FG001|Overall Study|Physician Decision|1
7102311|NCT02384941|11227642|FG002|Overall Study|Physician Decision|0
7102312|NCT02384941|11227640|FG000|Overall Study|Protocol Violation|3
7102313|NCT02384941|11227641|FG001|Overall Study|Protocol Violation|0
7102314|NCT02384941|11227642|FG002|Overall Study|Protocol Violation|0
7102315|NCT02384941|11227640|FG000|Overall Study|Withdrawal by Subject|26
7102316|NCT02384941|11227641|FG001|Overall Study|Withdrawal by Subject|19
7102317|NCT02384941|11227642|FG002|Overall Study|Withdrawal by Subject|20
7102318|NCT02384941|11227640|FG000|Overall Study|Pregnancy|0
7102319|NCT02384941|11227641|FG001|Overall Study|Pregnancy|0
7102320|NCT02384941|11227642|FG002|Overall Study|Pregnancy|1
7102321|NCT02384941|11227640|FG000|Overall Study|Other than specified above|4
7102322|NCT02384941|11227641|FG001|Overall Study|Other than specified above|0
7102323|NCT02384941|11227642|FG002|Overall Study|Other than specified above|1
7102324|NCT02385084|11227651|FG000|Period 2|Protocol Violation|0
7102325|NCT02385084|11227652|FG001|Period 2|Protocol Violation|0
7102326|NCT02385084|11227653|FG002|Period 2|Protocol Violation|1
7102327|NCT02385084|11227654|FG003|Period 2|Protocol Violation|0
7102328|NCT02385084|11227655|FG004|Period 2|Protocol Violation|0
7102329|NCT02385084|11227656|FG005|Period 2|Protocol Violation|0
7102330|NCT02385526|11227703|FG000|Overall Study|Withdrawal by Subject|0
7102331|NCT02385526|11227704|FG001|Overall Study|Withdrawal by Subject|2
7102332|NCT02385526|11227705|FG002|Overall Study|Withdrawal by Subject|0
7102333|NCT02385526|11227703|FG000|Overall Study|Lost to Follow-up|0
7102334|NCT02385526|11227704|FG001|Overall Study|Lost to Follow-up|1
7102335|NCT02385526|11227705|FG002|Overall Study|Lost to Follow-up|0
7102336|NCT02385526|11227703|FG000|Overall Study|Physician Decision|1
7102337|NCT02385526|11227704|FG001|Overall Study|Physician Decision|0
7102338|NCT02385526|11227705|FG002|Overall Study|Physician Decision|0
7102339|NCT02385526|11227703|FG000|Overall Study|Protocol Violation|1
7102340|NCT02385526|11227704|FG001|Overall Study|Protocol Violation|0
7102341|NCT02385526|11227705|FG002|Overall Study|Protocol Violation|0
7102342|NCT02385669|11227713|FG000|Overall Study|Adverse Event|2
7102343|NCT02385708|11227719|FG000|Overall Study|Withdrawal by Subject|0
7102344|NCT02385708|11227720|FG001|Overall Study|Withdrawal by Subject|2
7102345|NCT02385708|11227719|FG000|Overall Study|Withdrawn - surgery canceled|2
7102346|NCT02385708|11227720|FG001|Overall Study|Withdrawn - surgery canceled|5
7102347|NCT02385708|11227719|FG000|Overall Study|Investigator decision|5
7102348|NCT02385708|11227720|FG001|Overall Study|Investigator decision|7
7102349|NCT02385708|11227719|FG000|Overall Study|Protocol Violation|1
7102350|NCT02385708|11227720|FG001|Overall Study|Protocol Violation|1
7102351|NCT02385799|11227732|FG000|Overall Study|Lost to Follow-up|1
7102352|NCT02385799|11227733|FG001|Overall Study|Lost to Follow-up|2
7102353|NCT02385799|11227732|FG000|Overall Study|Adverse Event|4
7102354|NCT02385799|11227733|FG001|Overall Study|Adverse Event|2
7102355|NCT02385799|11227732|FG000|Overall Study|Withdrawal by Subject|0
7102356|NCT02385799|11227733|FG001|Overall Study|Withdrawal by Subject|4
7102357|NCT02386098|11227744|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30
7102358|NCT02386098|11227745|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29
7102359|NCT02386098|11227746|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
7102360|NCT02386098|11227747|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
7102361|NCT02386098|11227748|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
7102362|NCT02386098|11227744|FG000|Stage 1 (96 Weeks)|Adverse Event|2
7102363|NCT02386098|11227745|FG001|Stage 1 (96 Weeks)|Adverse Event|1
7102364|NCT02386098|11227746|FG002|Stage 1 (96 Weeks)|Adverse Event|0
7102365|NCT02386098|11227747|FG003|Stage 1 (96 Weeks)|Adverse Event|0
7102366|NCT02386098|11227748|FG004|Stage 1 (96 Weeks)|Adverse Event|0
7102367|NCT02386098|11227744|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2
7102368|NCT02386098|11227745|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2
7102369|NCT02386098|11227746|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0
7102370|NCT02386098|11227747|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0
7102371|NCT02386098|11227748|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0
7102372|NCT02386098|11227744|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
7102373|NCT02386098|11227745|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2
7102374|NCT02386098|11227746|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
7102375|NCT02386098|11227747|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
7102376|NCT02386098|11227748|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
7102377|NCT02386098|11227744|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3
7102378|NCT02386098|11227745|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1
7102379|NCT02386098|11227746|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0
7102380|NCT02386098|11227747|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0
7102381|NCT02386098|11227748|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0
7102382|NCT02386098|11227744|FG000|Stage 1 (96 Weeks)|Other|1
7102383|NCT02386098|11227745|FG001|Stage 1 (96 Weeks)|Other|0
7102384|NCT02386098|11227746|FG002|Stage 1 (96 Weeks)|Other|0
7102385|NCT02386098|11227747|FG003|Stage 1 (96 Weeks)|Other|0
7102386|NCT02386098|11227748|FG004|Stage 1 (96 Weeks)|Other|0
7102387|NCT02386098|11227744|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5
7102388|NCT02386098|11227745|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8
7102389|NCT02386098|11227746|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
7102390|NCT02386098|11227747|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
7102391|NCT02386098|11227748|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
7102392|NCT02386189|11227762|FG000|Overall Study|Lost to Follow-up|2
7102393|NCT02386189|11227763|FG001|Overall Study|Lost to Follow-up|3
7102394|NCT02386189|11227762|FG000|Overall Study|Withdrawal by Subject|1
7102395|NCT02386189|11227763|FG001|Overall Study|Withdrawal by Subject|0
7102396|NCT02386189|11227762|FG000|Overall Study|Death|1
7102397|NCT02386189|11227763|FG001|Overall Study|Death|0
7102398|NCT02386345|11227778|FG000|Overall Study|Not treated|14
7102399|NCT02386345|11227778|FG000|Overall Study|Lost to Follow-up|1
7102400|NCT02386345|11227778|FG000|Overall Study|Adverse Event|5
7102401|NCT02386345|11227778|FG000|Overall Study|Repeat Procedure|10
7102402|NCT02386345|11227778|FG000|Overall Study|Did not complete 12-month follow-up|72
7102403|NCT02387164|11227811|FG000|Overall Study|Lost to Follow-up|2
7102404|NCT02387164|11227812|FG001|Overall Study|Lost to Follow-up|0
7102405|NCT02387164|11227811|FG000|Overall Study|Diagnosed|1
7102406|NCT02387164|11227812|FG001|Overall Study|Diagnosed|2
7102407|NCT02387216|11227820|FG000|Overall Study|Progressive disease|2
7102408|NCT02387216|11227821|FG001|Overall Study|Progressive disease|0
7102409|NCT02387216|11227820|FG000|Overall Study|Withdrawal by Subject|3
7102410|NCT02387216|11227821|FG001|Overall Study|Withdrawal by Subject|5
7102411|NCT02387216|11227820|FG000|Overall Study|Physician Decision|2
7102412|NCT02387216|11227821|FG001|Overall Study|Physician Decision|0
7102413|NCT02387216|11227820|FG000|Overall Study|Sponsor Decision|28
7102414|NCT02387216|11227821|FG001|Overall Study|Sponsor Decision|12
7102415|NCT02387216|11227820|FG000|Overall Study|Death|60
7102416|NCT02387216|11227821|FG001|Overall Study|Death|23
7102417|NCT02387216|11227820|FG000|Overall Study|Other|5
7102418|NCT02387216|11227821|FG001|Overall Study|Other|4
7102419|NCT02387216|11227820|FG000|Overall Study|Lost to Follow-up|0
7102420|NCT02387216|11227821|FG001|Overall Study|Lost to Follow-up|3
7102421|NCT02387372|11227856|FG000|Overall Study|Not Treated|1
7102422|NCT02387372|11227857|FG001|Overall Study|Not Treated|0
7102423|NCT02387580|11227918|FG000|Overall Study|Withdrawal by Subject|0
7102424|NCT02387580|11227919|FG001|Overall Study|Withdrawal by Subject|0
7102425|NCT02387580|11227920|FG002|Overall Study|Withdrawal by Subject|0
7102426|NCT02387580|11227921|FG003|Overall Study|Withdrawal by Subject|1
7102427|NCT02387580|11227922|FG004|Overall Study|Withdrawal by Subject|0
7102428|NCT02387580|11227923|FG005|Overall Study|Withdrawal by Subject|0
7102429|NCT02387762|11227959|FG000|Overall Study|Withdrawal by Subject|1
7102430|NCT02387762|11227960|FG001|Overall Study|Withdrawal by Subject|0
7102431|NCT02387840|11228000|FG000|Overall Study|Death|0
7102432|NCT02387840|11228001|FG001|Overall Study|Death|0
7102433|NCT02387840|11228002|FG002|Overall Study|Death|0
7102434|NCT02387840|11228003|FG003|Overall Study|Death|0
7102435|NCT02387840|11228004|FG004|Overall Study|Death|0
7102436|NCT02387840|11228005|FG005|Overall Study|Death|1
7102437|NCT02387957|11228032|FG000|Overall Study|The study was discontinued|21
7102438|NCT02387957|11228033|FG001|Overall Study|The study was discontinued|21
7102439|NCT02387957|11228034|FG002|Overall Study|The study was discontinued|20
7102440|NCT02387970|11228044|FG000|Overall Study|Did not complete 1-year follow up|1
7102441|NCT02387970|11228045|FG001|Overall Study|Did not complete 1-year follow up|2
7102442|NCT02387983|11228051|FG000|Overall Study|Adverse Event|4
7102443|NCT02387983|11228051|FG000|Overall Study|Protocol Violation|1
7102444|NCT02387983|11228051|FG000|Overall Study|Withdrawal by Subject|2
7102445|NCT02388074|11228055|FG000|Overall Study|Lost in Transit|2
7102446|NCT02388074|11228055|FG000|Overall Study|Sample Not Returned|1
7102447|NCT02388165|11228061|FG000|Overall Study|Study terminated by sponsor|5
7102448|NCT02388165|11228062|FG001|Overall Study|Study terminated by sponsor|5
7102449|NCT02388165|11228061|FG000|Overall Study|Other|11
7102450|NCT02388165|11228062|FG001|Overall Study|Other|13
7102451|NCT02388165|11228061|FG000|Overall Study|No longer meet eligibility criteria|40
7102452|NCT02388165|11228062|FG001|Overall Study|No longer meet eligibility criteria|43
7102453|NCT02388165|11228061|FG000|Overall Study|Withdrawal of consent|31
7102454|NCT02388165|11228062|FG001|Overall Study|Withdrawal of consent|32
7102455|NCT02388165|11228061|FG000|Overall Study|Lost to Follow-up|19
7102456|NCT02388165|11228062|FG001|Overall Study|Lost to Follow-up|20
7102457|NCT02388165|11228061|FG000|Overall Study|Death|13
7102458|NCT02388165|11228062|FG001|Overall Study|Death|10
7102459|NCT02388165|11228061|FG000|Overall Study|Adverse Event|3
7102460|NCT02388165|11228062|FG001|Overall Study|Adverse Event|5
7102461|NCT02388165|11228061|FG000|Overall Study|Did not meet entrance criteria|5
7102462|NCT02388165|11228062|FG001|Overall Study|Did not meet entrance criteria|2
7102463|NCT02388191|11228070|FG000|Overall Study|Patient did not receive IUD|1
7102464|NCT02388191|11228071|FG001|Overall Study|Patient did not receive IUD|0
7102465|NCT02388269|11228081|FG000|Overall Study|Adverse Event|2
7102466|NCT02388269|11228082|FG001|Overall Study|Adverse Event|0
7102467|NCT02388269|11228083|FG002|Overall Study|Adverse Event|0
7102468|NCT02388269|11228081|FG000|Overall Study|Withdrawal by Subject|1
7102469|NCT02388269|11228082|FG001|Overall Study|Withdrawal by Subject|2
7102470|NCT02388269|11228083|FG002|Overall Study|Withdrawal by Subject|0
7102471|NCT02388269|11228081|FG000|Overall Study|less than 50% stimulations|1
7102472|NCT02388269|11228082|FG001|Overall Study|less than 50% stimulations|0
7102473|NCT02388269|11228083|FG002|Overall Study|less than 50% stimulations|0
7102474|NCT02388269|11228081|FG000|Overall Study|no diary data|3
7102475|NCT02388269|11228082|FG001|Overall Study|no diary data|0
7102476|NCT02388269|11228083|FG002|Overall Study|no diary data|0
7102477|NCT02388269|11228081|FG000|Overall Study|Protocol Violation|2
7102478|NCT02388269|11228082|FG001|Overall Study|Protocol Violation|0
7102479|NCT02388269|11228083|FG002|Overall Study|Protocol Violation|0
7102480|NCT02388269|11228081|FG000|Overall Study|Screen Failure|0
7102481|NCT02388269|11228082|FG001|Overall Study|Screen Failure|0
7102482|NCT02388269|11228083|FG002|Overall Study|Screen Failure|10
7102483|NCT02388295|11228110|FG000|Dose Escalation Week 1|Adverse Event|1
7102484|NCT02388295|11228111|FG001|Dose Escalation Week 1|Adverse Event|2
7102485|NCT02388295|11228112|FG002|Dose Escalation Week 1|Adverse Event|1
7102486|NCT02388295|11228110|FG000|Dose Escalation Week 1|Determined not eligible|1
7102487|NCT02388295|11228111|FG001|Dose Escalation Week 1|Determined not eligible|1
7102488|NCT02388295|11228112|FG002|Dose Escalation Week 1|Determined not eligible|1
7102489|NCT02388295|11228110|FG000|Dose Escalation Week 2|Protocol Violation|0
7102490|NCT02388295|11228111|FG001|Dose Escalation Week 2|Protocol Violation|1
7102491|NCT02388295|11228112|FG002|Dose Escalation Week 2|Protocol Violation|0
7102492|NCT02388295|11228110|FG000|Dose Escalation Week 2|Determined not eligible|1
7102493|NCT02388295|11228111|FG001|Dose Escalation Week 2|Determined not eligible|1
7102494|NCT02388295|11228112|FG002|Dose Escalation Week 2|Determined not eligible|1
7102495|NCT02388295|11228110|FG000|Treatment Weeks 3 to 12|Adverse Event|1
7102496|NCT02388295|11228111|FG001|Treatment Weeks 3 to 12|Adverse Event|1
7102497|NCT02388295|11228112|FG002|Treatment Weeks 3 to 12|Adverse Event|0
7102498|NCT02388347|11228134|FG000|Overall Study|Withdrawal by Subject|0
7102499|NCT02388347|11228135|FG001|Overall Study|Withdrawal by Subject|0
7102500|NCT02388347|11228136|FG002|Overall Study|Withdrawal by Subject|1
7102501|NCT02388347|11228137|FG003|Overall Study|Withdrawal by Subject|0
7102502|NCT02388347|11228138|FG004|Overall Study|Withdrawal by Subject|0
7102503|NCT02388724|11228190|FG000|Overall Study|Reason not Specified|0
7102504|NCT02388724|11228191|FG001|Overall Study|Reason not Specified|1
7102505|NCT02388724|11228190|FG000|Overall Study|Major Protocol Deviation|3
7102506|NCT02388724|11228191|FG001|Overall Study|Major Protocol Deviation|3
7102507|NCT02388724|11228190|FG000|Overall Study|Pretreatment Event/Adverse Event|3
7102508|NCT02388724|11228191|FG001|Overall Study|Pretreatment Event/Adverse Event|2
7102509|NCT02388724|11228190|FG000|Overall Study|Voluntary Withdrawal|6
7102510|NCT02388724|11228191|FG001|Overall Study|Voluntary Withdrawal|5
7102511|NCT02388724|11228190|FG000|Overall Study|Randomized but not Treated|0
7102512|NCT02388724|11228191|FG001|Overall Study|Randomized but not Treated|2
7102513|NCT02388737|11228200|FG000|Overall Study|Pretreatment Event/Adverse Event|13
7102514|NCT02388737|11228201|FG001|Overall Study|Pretreatment Event/Adverse Event|11
7102515|NCT02388737|11228202|FG002|Overall Study|Pretreatment Event/Adverse Event|12
7102516|NCT02388737|11228200|FG000|Overall Study|Major Protocol Deviation|18
7102517|NCT02388737|11228201|FG001|Overall Study|Major Protocol Deviation|25
7102518|NCT02388737|11228202|FG002|Overall Study|Major Protocol Deviation|22
7102519|NCT02388737|11228200|FG000|Overall Study|Lost to Follow-up|5
7102520|NCT02388737|11228201|FG001|Overall Study|Lost to Follow-up|1
7102521|NCT02388737|11228202|FG002|Overall Study|Lost to Follow-up|4
7102522|NCT02388737|11228200|FG000|Overall Study|Voluntary Withdrawal|10
7102523|NCT02388737|11228201|FG001|Overall Study|Voluntary Withdrawal|18
7102524|NCT02388737|11228202|FG002|Overall Study|Voluntary Withdrawal|17
7102525|NCT02388737|11228200|FG000|Overall Study|Lack of Efficacy|3
7102526|NCT02388737|11228201|FG001|Overall Study|Lack of Efficacy|0
7102527|NCT02388737|11228202|FG002|Overall Study|Lack of Efficacy|3
7102528|NCT02388737|11228200|FG000|Overall Study|Reason Not Specified|5
7102529|NCT02388737|11228201|FG001|Overall Study|Reason Not Specified|5
7102530|NCT02388737|11228202|FG002|Overall Study|Reason Not Specified|4
7102531|NCT02388763|11228210|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1
7102532|NCT02388763|11228211|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1
7102533|NCT02388763|11228210|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1
7102534|NCT02388763|11228211|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1
7102535|NCT02388932|11228228|FG000|Overall Study|Death|1
7102536|NCT02388997|11228235|FG000|Overall Study|Adverse Event|1
7102537|NCT02388997|11228236|FG001|Overall Study|Adverse Event|2
7102538|NCT02388997|11228235|FG000|Overall Study|Withdrawal by Subject|2
7102539|NCT02388997|11228236|FG001|Overall Study|Withdrawal by Subject|1
7102540|NCT02388997|11228235|FG000|Overall Study|Lung function exclusion criteria|0
7102541|NCT02388997|11228236|FG001|Overall Study|Lung function exclusion criteria|2
7102542|NCT02388997|11228235|FG000|Overall Study|Tested positive for virus during run-in|0
7102543|NCT02388997|11228236|FG001|Overall Study|Tested positive for virus during run-in|1
7102544|NCT02389452|11228269|FG000|Overall Study|Lost to Follow-up|13
7102545|NCT02389452|11228269|FG000|Overall Study|Adverse Event|1
7102546|NCT02389452|11228269|FG000|Overall Study|Withdrawal by Subject|5
7102547|NCT02389452|11228269|FG000|Overall Study|Enrolled but Not Eligible for Study|6
7102548|NCT02389621|11228276|FG000|Treatment Period|Withdrawal by Subject|1
7102549|NCT02389621|11228277|FG001|Treatment Period|Withdrawal by Subject|1
7102550|NCT02389621|11228276|FG000|Posttreatment Period|Adverse Event|3
7102551|NCT02389621|11228277|FG001|Posttreatment Period|Adverse Event|1
7102552|NCT02389621|11228276|FG000|Posttreatment Period|Withdrawal by Subject|3
7102553|NCT02389621|11228277|FG001|Posttreatment Period|Withdrawal by Subject|2
7102554|NCT02389621|11228276|FG000|Posttreatment Period|Lost to Follow-up|1
7102555|NCT02389621|11228277|FG001|Posttreatment Period|Lost to Follow-up|1
7102556|NCT02389621|11228276|FG000|Posttreatment Period|Other - Miscellaneous|2
7102557|NCT02389621|11228277|FG001|Posttreatment Period|Other - Miscellaneous|0
7102558|NCT02389764|11228302|FG000|Overall Study|Lack of Efficacy|9
7102559|NCT02389816|11228309|FG000|Overall Study|Randomized but Not Treated|1
7102560|NCT02389816|11228310|FG001|Overall Study|Randomized but Not Treated|0
7102561|NCT02389816|11228311|FG002|Overall Study|Randomized but Not Treated|0
7102562|NCT02389816|11228309|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4
7102563|NCT02389816|11228310|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6
7102564|NCT02389816|11228311|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7
7102565|NCT02389816|11228309|FG000|Overall Study|Major Protocol Deviation|1
7102566|NCT02389816|11228310|FG001|Overall Study|Major Protocol Deviation|0
7102567|NCT02389816|11228311|FG002|Overall Study|Major Protocol Deviation|0
7102568|NCT02389816|11228309|FG000|Overall Study|Lost to Follow-up|1
7102569|NCT02389816|11228310|FG001|Overall Study|Lost to Follow-up|0
7102570|NCT02389816|11228311|FG002|Overall Study|Lost to Follow-up|0
7102571|NCT02389816|11228309|FG000|Overall Study|Withdrawal of Consent|6
7102572|NCT02389816|11228310|FG001|Overall Study|Withdrawal of Consent|4
7102573|NCT02389816|11228311|FG002|Overall Study|Withdrawal of Consent|4
7102574|NCT02389816|11228309|FG000|Overall Study|Lack of Efficacy|1
7102575|NCT02389816|11228310|FG001|Overall Study|Lack of Efficacy|0
7102576|NCT02389816|11228311|FG002|Overall Study|Lack of Efficacy|0
7102577|NCT02389816|11228309|FG000|Overall Study|Non Compliance with Study Drug|1
7102578|NCT02389816|11228310|FG001|Overall Study|Non Compliance with Study Drug|1
7102579|NCT02389816|11228311|FG002|Overall Study|Non Compliance with Study Drug|1
7102580|NCT02389816|11228309|FG000|Overall Study|Reason not Specified|0
7102581|NCT02389816|11228310|FG001|Overall Study|Reason not Specified|2
7102582|NCT02389816|11228311|FG002|Overall Study|Reason not Specified|0
7102583|NCT02389829|11228321|FG000|Overall Study|Lost to Follow-up|0
7102584|NCT02389829|11228322|FG001|Overall Study|Lost to Follow-up|1
7102585|NCT02389894|11228360|FG000|Overall Study|Death|4
7102586|NCT02389894|11228361|FG001|Overall Study|Death|5
7102587|NCT02389894|11228362|FG002|Overall Study|Death|3
7102588|NCT02389894|11228360|FG000|Overall Study|Withdrawal by Subject|2
7102589|NCT02389894|11228361|FG001|Overall Study|Withdrawal by Subject|4
7102590|NCT02389894|11228362|FG002|Overall Study|Withdrawal by Subject|5
7102591|NCT02389894|11228360|FG000|Overall Study|Lost to Follow-up|2
7102592|NCT02389894|11228361|FG001|Overall Study|Lost to Follow-up|1
7102593|NCT02389894|11228362|FG002|Overall Study|Lost to Follow-up|1
7102594|NCT02389998|11228381|FG000|Overall Study|car accident|1
7102595|NCT02389998|11228382|FG001|Overall Study|car accident|0
7102596|NCT02390076|11228410|FG000|Overall Study|Lost to Follow-up|2
7102597|NCT02390076|11228411|FG001|Overall Study|Lost to Follow-up|1
7102598|NCT02390076|11228412|FG002|Overall Study|Lost to Follow-up|4
7102599|NCT02390167|11228420|FG000|Overall Study|Lost to Follow-up|1
7102600|NCT02390219|11228428|FG000|Overall Study|Death|1
7102601|NCT02390219|11228428|FG000|Overall Study|Physician Decision|1
7102602|NCT02390219|11228428|FG000|Overall Study|Adverse Event|6
7102603|NCT02390219|11228428|FG000|Overall Study|Withdrawal by Subject|1
7102604|NCT02390219|11228428|FG000|Overall Study|Lost to Follow-up|2
7102605|NCT02390219|11228428|FG000|Overall Study|Other|2
7102606|NCT02390557|11228435|FG000|Wave 2|Survey non-respondent|72
7102607|NCT02390557|11228436|FG001|Wave 2|Survey non-respondent|41
7102608|NCT02390557|11228437|FG002|Wave 2|Survey non-respondent|23
7102609|NCT02391038|11228480|FG000|Overall Study|Progressive disease|3
7102610|NCT02391038|11228481|FG001|Overall Study|Progressive disease|3
7102611|NCT02391038|11228482|FG002|Overall Study|Progressive disease|6
7102612|NCT02391116|11228491|FG000|Treatment|Withdrawal by Subject|1
7102613|NCT02391116|11228491|FG000|Treatment|Protocol Violation|1
7102614|NCT02391116|11228491|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9
7102615|NCT02391116|11228491|FG000|Treatment|AE with Clinical PD|3
7102616|NCT02391116|11228491|FG000|Safety Follow-up|Adverse Event|1
7102617|NCT02391116|11228491|FG000|Safety Follow-up|Withdrawal by Subject|4
7102618|NCT02391116|11228491|FG000|Safety Follow-up|Switching to Other Therapy|4
7102619|NCT02391116|11228491|FG000|Safety Follow-up|No Follow Up|1
7102620|NCT02391116|11228491|FG000|Safety Follow-up|Deterioration of General Conditions|3
7102621|NCT02391116|11228491|FG000|Active Follow-up|Withdrawal by Subject|1
7102622|NCT02391116|11228491|FG000|Active Follow-up|Switching to Other Therapy|2
7102623|NCT02391116|11228491|FG000|Survival Follow-up|Withdrawal by Subject|3
7102624|NCT02391116|11228491|FG000|Survival Follow-up|Switching to Other Therapy|1
7102625|NCT02391311|11228504|FG000|Overall Study|Lost to Follow-up|2
7102626|NCT02391311|11228505|FG001|Overall Study|Lost to Follow-up|1
7102627|NCT02391311|11228504|FG000|Overall Study|deemed ineligible after baseline|1
7102628|NCT02391311|11228505|FG001|Overall Study|deemed ineligible after baseline|1
7102629|NCT02391337|11228513|FG000|6 Months Follow-up|Death|5
7102630|NCT02391337|11228514|FG001|6 Months Follow-up|Death|4
7102631|NCT02391337|11228513|FG000|6 Months Follow-up|Withdrawal by Subject|1
7102632|NCT02391337|11228514|FG001|6 Months Follow-up|Withdrawal by Subject|1
7102633|NCT02391337|11228513|FG000|12 Months Follow-up|Death|2
7102634|NCT02391337|11228514|FG001|12 Months Follow-up|Death|0
7102635|NCT02391337|11228513|FG000|12 Months Follow-up|Withdrawal by Subject|0
7102636|NCT02391337|11228514|FG001|12 Months Follow-up|Withdrawal by Subject|1
7102637|NCT02391337|11228513|FG000|12 Months Follow-up|Lost to Follow-up|0
7102638|NCT02391337|11228514|FG001|12 Months Follow-up|Lost to Follow-up|2
7102639|NCT02391363|11228531|FG000|Overall Study|Lost to Follow-up|5
7102640|NCT02391363|11228532|FG001|Overall Study|Lost to Follow-up|5
7102641|NCT02391363|11228531|FG000|Overall Study|Withdrawal by Subject|6
7102642|NCT02391363|11228532|FG001|Overall Study|Withdrawal by Subject|3
7102643|NCT02391545|11228540|FG000|Overall Study|Death|0
7102644|NCT02391545|11228541|FG001|Overall Study|Death|2
7102645|NCT02391545|11228540|FG000|Overall Study|Lost to Follow-up|0
7102646|NCT02391545|11228541|FG001|Overall Study|Lost to Follow-up|1
7102647|NCT02391545|11228540|FG000|Overall Study|Termination of study by sponsor|20
7102648|NCT02391545|11228541|FG001|Overall Study|Termination of study by sponsor|20
7102649|NCT02391545|11228540|FG000|Overall Study|Withdrawal by Subject|0
7102650|NCT02391545|11228541|FG001|Overall Study|Withdrawal by Subject|1
7102651|NCT02391545|11228540|FG000|Overall Study|Other Reasons|6
7102652|NCT02391545|11228541|FG001|Overall Study|Other Reasons|4
7102653|NCT02391584|11228550|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1
7102654|NCT02391584|11228551|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2
7102655|NCT02391584|11228550|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1
7102656|NCT02391584|11228551|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0
7102657|NCT02391584|11228550|FG000|3 Month|Lost to Follow-up|1
7102658|NCT02391584|11228551|FG001|3 Month|Lost to Follow-up|0
7102659|NCT02391584|11228550|FG000|6 Month|Withdrawal by Subject|1
7102660|NCT02391584|11228551|FG001|6 Month|Withdrawal by Subject|0
7102661|NCT02391584|11228550|FG000|12 Month (End of Study)|Lost to Follow-up|2
7102662|NCT02391584|11228551|FG001|12 Month (End of Study)|Lost to Follow-up|0
7102663|NCT02391948|11228585|FG000|6-month Assessment|Death|0
7102664|NCT02391948|11228586|FG001|6-month Assessment|Death|0
7102665|NCT02391948|11228587|FG002|6-month Assessment|Death|0
7102666|NCT02391948|11228588|FG003|6-month Assessment|Death|0
7102667|NCT02391948|11228589|FG004|6-month Assessment|Death|1
7102668|NCT02391948|11228585|FG000|6-month Assessment|Withdrawal by Subject|0
7102669|NCT02391948|11228586|FG001|6-month Assessment|Withdrawal by Subject|0
7102670|NCT02391948|11228587|FG002|6-month Assessment|Withdrawal by Subject|1
7102671|NCT02391948|11228588|FG003|6-month Assessment|Withdrawal by Subject|2
7102672|NCT02391948|11228589|FG004|6-month Assessment|Withdrawal by Subject|0
7102673|NCT02391948|11228585|FG000|6-month Assessment|Lost to Follow-up|4
7102674|NCT02391948|11228586|FG001|6-month Assessment|Lost to Follow-up|5
7102675|NCT02391948|11228587|FG002|6-month Assessment|Lost to Follow-up|2
7102676|NCT02391948|11228588|FG003|6-month Assessment|Lost to Follow-up|3
7102677|NCT02391948|11228589|FG004|6-month Assessment|Lost to Follow-up|1
7102678|NCT02391948|11228585|FG000|6-month Assessment|Medical issue/illness|1
7102679|NCT02391948|11228586|FG001|6-month Assessment|Medical issue/illness|1
7102680|NCT02391948|11228587|FG002|6-month Assessment|Medical issue/illness|0
7102681|NCT02391948|11228588|FG003|6-month Assessment|Medical issue/illness|0
7102682|NCT02391948|11228589|FG004|6-month Assessment|Medical issue/illness|0
7102683|NCT02391948|11228585|FG000|6-month Assessment|Not able to schedule visit in timeframe|6
7102684|NCT02391948|11228586|FG001|6-month Assessment|Not able to schedule visit in timeframe|8
7102685|NCT02391948|11228587|FG002|6-month Assessment|Not able to schedule visit in timeframe|4
7102686|NCT02391948|11228588|FG003|6-month Assessment|Not able to schedule visit in timeframe|5
7102687|NCT02391948|11228589|FG004|6-month Assessment|Not able to schedule visit in timeframe|0
7102688|NCT02391948|11228585|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68
7102689|NCT02391948|11228586|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42
7102690|NCT02391948|11228587|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24
7102691|NCT02391948|11228588|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35
7102692|NCT02391948|11228589|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24
7102693|NCT02391948|11228585|FG000|12-month Assessment|Death|0
7102694|NCT02391948|11228586|FG001|12-month Assessment|Death|0
7102695|NCT02391948|11228587|FG002|12-month Assessment|Death|0
7102696|NCT02391948|11228588|FG003|12-month Assessment|Death|1
7102697|NCT02391948|11228589|FG004|12-month Assessment|Death|0
7102698|NCT02391948|11228585|FG000|12-month Assessment|Withdrawal by Subject|1
7102699|NCT02391948|11228586|FG001|12-month Assessment|Withdrawal by Subject|0
7102700|NCT02391948|11228587|FG002|12-month Assessment|Withdrawal by Subject|0
7102701|NCT02391948|11228588|FG003|12-month Assessment|Withdrawal by Subject|1
7102702|NCT02391948|11228589|FG004|12-month Assessment|Withdrawal by Subject|0
7102703|NCT02391948|11228585|FG000|12-month Assessment|Lost to Follow-up|5
7102704|NCT02391948|11228586|FG001|12-month Assessment|Lost to Follow-up|4
7102705|NCT02391948|11228587|FG002|12-month Assessment|Lost to Follow-up|4
7102706|NCT02391948|11228588|FG003|12-month Assessment|Lost to Follow-up|4
7102707|NCT02391948|11228589|FG004|12-month Assessment|Lost to Follow-up|5
7102708|NCT02391948|11228585|FG000|12-month Assessment|Medical issue/illness|0
7102709|NCT02391948|11228586|FG001|12-month Assessment|Medical issue/illness|1
7102710|NCT02391948|11228587|FG002|12-month Assessment|Medical issue/illness|0
7102711|NCT02391948|11228588|FG003|12-month Assessment|Medical issue/illness|1
7102712|NCT02391948|11228589|FG004|12-month Assessment|Medical issue/illness|0
7102713|NCT02391948|11228585|FG000|12-month Assessment|Not able to schedule visit in timeframe|2
7102714|NCT02391948|11228586|FG001|12-month Assessment|Not able to schedule visit in timeframe|4
7102715|NCT02391948|11228587|FG002|12-month Assessment|Not able to schedule visit in timeframe|0
7102716|NCT02391948|11228588|FG003|12-month Assessment|Not able to schedule visit in timeframe|2
7102717|NCT02391948|11228589|FG004|12-month Assessment|Not able to schedule visit in timeframe|1
7102718|NCT02391948|11228585|FG000|18-month Assessment|Death|0
7102719|NCT02391948|11228586|FG001|18-month Assessment|Death|0
7102720|NCT02391948|11228587|FG002|18-month Assessment|Death|0
7102721|NCT02391948|11228588|FG003|18-month Assessment|Death|1
7102722|NCT02391948|11228589|FG004|18-month Assessment|Death|1
7102723|NCT02391948|11228585|FG000|18-month Assessment|Withdrawal by Subject|1
7102724|NCT02391948|11228586|FG001|18-month Assessment|Withdrawal by Subject|0
7102725|NCT02391948|11228587|FG002|18-month Assessment|Withdrawal by Subject|0
7102726|NCT02391948|11228588|FG003|18-month Assessment|Withdrawal by Subject|1
7102727|NCT02391948|11228589|FG004|18-month Assessment|Withdrawal by Subject|0
7102728|NCT02391948|11228585|FG000|18-month Assessment|Lost to Follow-up|2
7102729|NCT02391948|11228586|FG001|18-month Assessment|Lost to Follow-up|6
7102730|NCT02391948|11228587|FG002|18-month Assessment|Lost to Follow-up|2
7102731|NCT02391948|11228588|FG003|18-month Assessment|Lost to Follow-up|2
7102732|NCT02391948|11228589|FG004|18-month Assessment|Lost to Follow-up|3
7102733|NCT02391948|11228585|FG000|18-month Assessment|Not able to schedule visit in timeframe|3
7102734|NCT02391948|11228586|FG001|18-month Assessment|Not able to schedule visit in timeframe|3
7102735|NCT02391948|11228587|FG002|18-month Assessment|Not able to schedule visit in timeframe|2
7102736|NCT02391948|11228588|FG003|18-month Assessment|Not able to schedule visit in timeframe|1
7102737|NCT02391948|11228589|FG004|18-month Assessment|Not able to schedule visit in timeframe|4
7102738|NCT02391948|11228585|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66
7102739|NCT02391948|11228586|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41
7102740|NCT02391948|11228587|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22
7102741|NCT02391948|11228588|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31
7102742|NCT02391948|11228589|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22
7102743|NCT02391948|11228585|FG000|24-month Assessment|Death|0
7102744|NCT02391948|11228586|FG001|24-month Assessment|Death|0
7102745|NCT02391948|11228587|FG002|24-month Assessment|Death|0
7102746|NCT02391948|11228588|FG003|24-month Assessment|Death|0
7102747|NCT02391948|11228589|FG004|24-month Assessment|Death|1
7102748|NCT02391948|11228585|FG000|24-month Assessment|Withdrawal by Subject|1
7102749|NCT02391948|11228586|FG001|24-month Assessment|Withdrawal by Subject|1
7102750|NCT02391948|11228587|FG002|24-month Assessment|Withdrawal by Subject|0
7102751|NCT02391948|11228588|FG003|24-month Assessment|Withdrawal by Subject|0
7102752|NCT02391948|11228589|FG004|24-month Assessment|Withdrawal by Subject|1
7102753|NCT02391948|11228585|FG000|24-month Assessment|Lost to Follow-up|5
7102754|NCT02391948|11228586|FG001|24-month Assessment|Lost to Follow-up|4
7102755|NCT02391948|11228587|FG002|24-month Assessment|Lost to Follow-up|0
7102756|NCT02391948|11228588|FG003|24-month Assessment|Lost to Follow-up|0
7102757|NCT02391948|11228589|FG004|24-month Assessment|Lost to Follow-up|0
7102758|NCT02391948|11228585|FG000|24-month Assessment|Medical issue/illness|0
7102759|NCT02391948|11228586|FG001|24-month Assessment|Medical issue/illness|0
7102760|NCT02391948|11228587|FG002|24-month Assessment|Medical issue/illness|1
7102761|NCT02391948|11228588|FG003|24-month Assessment|Medical issue/illness|0
7102762|NCT02391948|11228589|FG004|24-month Assessment|Medical issue/illness|0
7102763|NCT02391948|11228585|FG000|24-month Assessment|Not able to schedule visit in timeframe|8
7102764|NCT02391948|11228586|FG001|24-month Assessment|Not able to schedule visit in timeframe|5
7102765|NCT02391948|11228587|FG002|24-month Assessment|Not able to schedule visit in timeframe|2
7102766|NCT02391948|11228588|FG003|24-month Assessment|Not able to schedule visit in timeframe|9
7102767|NCT02391948|11228589|FG004|24-month Assessment|Not able to schedule visit in timeframe|8
7102768|NCT02391961|11228606|FG000|First Intervention (4 Weeks)|Adverse Event|2
7102769|NCT02391961|11228607|FG001|First Intervention (4 Weeks)|Adverse Event|0
7102770|NCT02391961|11228606|FG000|Washout (2 Weeks)|Withdrawal by Subject|1
7102771|NCT02391961|11228607|FG001|Washout (2 Weeks)|Withdrawal by Subject|1
7102772|NCT02391961|11228606|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1
7102773|NCT02391961|11228607|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1
7102774|NCT02392000|11228622|FG000|Overall Study|Greater than mild sleep apnea exclusion|18
7102775|NCT02392000|11228622|FG000|Overall Study|Withdrawal by Subject|1
7102776|NCT02392000|11228622|FG000|Overall Study|Lost to Follow-up|8
7102777|NCT02392104|11228627|FG000|Overall Study|discontinuation of warfarin|3
7102778|NCT02392104|11228627|FG000|Overall Study|bleeding event|1
7102779|NCT02392104|11228627|FG000|Overall Study|transferred care to another doctor|2
7102780|NCT02392104|11228627|FG000|Overall Study|INR goal range changed|1
7102781|NCT02392104|11228627|FG000|Overall Study|admitted to skilled nursing facility|3
7102782|NCT02392104|11228627|FG000|Overall Study|INRs drawn by visiting nurse services|1
7102783|NCT02392195|11228631|FG000|Overall Study|Lost to Follow-up|4
7102784|NCT02392195|11228631|FG000|Overall Study|Withdrawal by Subject|4
7102785|NCT02392234|11228646|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1
7102786|NCT02392234|11228647|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0
7102787|NCT02392234|11228648|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1
7102788|NCT02392234|11228649|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0
7102789|NCT02392234|11228650|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1
7102790|NCT02392234|11228651|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1
7102791|NCT02392234|11228646|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
7102792|NCT02392234|11228647|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
7102793|NCT02392234|11228648|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
7102794|NCT02392234|11228649|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
7102795|NCT02392234|11228650|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2
7102796|NCT02392234|11228651|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
7102797|NCT02392234|11228646|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
7102798|NCT02392234|11228647|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
7102799|NCT02392234|11228648|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
7102800|NCT02392234|11228649|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
7102801|NCT02392234|11228650|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
7102802|NCT02392234|11228651|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
7102803|NCT02392234|11228646|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1
7102804|NCT02392234|11228647|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0
7102805|NCT02392234|11228648|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0
7102806|NCT02392234|11228649|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1
7102807|NCT02392234|11228650|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0
7102808|NCT02392234|11228651|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0
7102809|NCT02392234|11228646|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0
7102810|NCT02392234|11228647|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0
7102811|NCT02392234|11228648|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0
7102812|NCT02392234|11228649|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0
7102813|NCT02392234|11228650|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0
7102814|NCT02392234|11228651|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1
7102815|NCT02392234|11228646|FG000|Treatment Period 1 (8 Weeks)|Other|1
7102816|NCT02392234|11228647|FG001|Treatment Period 1 (8 Weeks)|Other|0
7102817|NCT02392234|11228648|FG002|Treatment Period 1 (8 Weeks)|Other|0
7102818|NCT02392234|11228649|FG003|Treatment Period 1 (8 Weeks)|Other|0
7102819|NCT02392234|11228650|FG004|Treatment Period 1 (8 Weeks)|Other|0
7102820|NCT02392234|11228651|FG005|Treatment Period 1 (8 Weeks)|Other|0
7102821|NCT02392234|11228646|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
7102822|NCT02392234|11228647|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
7102823|NCT02392234|11228648|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1
7102824|NCT02392234|11228649|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
7102825|NCT02392234|11228650|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1
7102826|NCT02392234|11228651|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
7102827|NCT02392234|11228646|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1
7102828|NCT02392234|11228647|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0
7102829|NCT02392234|11228648|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0
7102830|NCT02392234|11228649|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0
7102831|NCT02392234|11228650|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0
7102832|NCT02392234|11228651|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0
7102833|NCT02392247|11228662|FG000|Overall Study|Withdrawal by Subject|1
7102834|NCT02392247|11228662|FG000|Overall Study|Surgery cancelled; no data|1
7102835|NCT02392403|11228684|FG000|Overall Study|Adverse Event|1
7102836|NCT02392403|11228684|FG000|Overall Study|Death|1
7102837|NCT02392403|11228684|FG000|Overall Study|Withdrawal by Subject|1
7102838|NCT02392481|11228692|FG000|Overall Study|Adverse Event|0
7102839|NCT02392481|11228693|FG001|Overall Study|Adverse Event|0
7102840|NCT02392481|11228694|FG002|Overall Study|Adverse Event|1
7102841|NCT02392481|11228695|FG003|Overall Study|Adverse Event|2
7102842|NCT02392481|11228692|FG000|Overall Study|Withdrawal by Subject|0
7102843|NCT02392481|11228693|FG001|Overall Study|Withdrawal by Subject|0
7102844|NCT02392481|11228694|FG002|Overall Study|Withdrawal by Subject|1
7102845|NCT02392481|11228695|FG003|Overall Study|Withdrawal by Subject|0
7102846|NCT02392507|11228719|FG000|Induction Regimen|Death|3
7102847|NCT02392507|11228719|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1
7102848|NCT02392507|11228719|FG000|Induction Regimen|Physician Decision|1
7102849|NCT02392507|11228719|FG000|Induction Regimen|Withdrawal by Subject|2
7102850|NCT02392507|11228719|FG000|Maintenance Regimen|Death|1
7102851|NCT02392507|11228719|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1
7102852|NCT02392559|11228730|FG000|Overall Study|Withdrawal by Subject|0
7102853|NCT02392559|11228731|FG001|Overall Study|Withdrawal by Subject|1
7102854|NCT02392611|11228747|FG000|Overall Study|Adverse Event|0
7102855|NCT02392611|11228748|FG001|Overall Study|Adverse Event|0
7102856|NCT02392611|11228749|FG002|Overall Study|Adverse Event|0
7102857|NCT02392611|11228750|FG003|Overall Study|Adverse Event|1
7102858|NCT02392611|11228751|FG004|Overall Study|Adverse Event|0
7102859|NCT02392611|11228752|FG005|Overall Study|Adverse Event|0
7102860|NCT02392611|11228753|FG006|Overall Study|Adverse Event|0
7102861|NCT02392611|11228754|FG007|Overall Study|Adverse Event|0
7102862|NCT02392611|11228755|FG008|Overall Study|Adverse Event|0
7102863|NCT02392611|11228747|FG000|Overall Study|Progressive disease|0
7102864|NCT02392611|11228748|FG001|Overall Study|Progressive disease|0
7102865|NCT02392611|11228749|FG002|Overall Study|Progressive disease|0
7102866|NCT02392611|11228750|FG003|Overall Study|Progressive disease|2
7102867|NCT02392611|11228751|FG004|Overall Study|Progressive disease|1
7102868|NCT02392611|11228752|FG005|Overall Study|Progressive disease|0
7102869|NCT02392611|11228753|FG006|Overall Study|Progressive disease|0
7102870|NCT02392611|11228754|FG007|Overall Study|Progressive disease|0
7102871|NCT02392611|11228755|FG008|Overall Study|Progressive disease|0
7102872|NCT02392611|11228747|FG000|Overall Study|Death|1
7102873|NCT02392611|11228748|FG001|Overall Study|Death|0
7102874|NCT02392611|11228749|FG002|Overall Study|Death|0
7102875|NCT02392611|11228750|FG003|Overall Study|Death|0
7102876|NCT02392611|11228751|FG004|Overall Study|Death|0
7102877|NCT02392611|11228752|FG005|Overall Study|Death|1
7102878|NCT02392611|11228753|FG006|Overall Study|Death|0
7102879|NCT02392611|11228754|FG007|Overall Study|Death|0
7102880|NCT02392611|11228755|FG008|Overall Study|Death|0
7102881|NCT02392611|11228747|FG000|Overall Study|Withdrawal by Subject|0
7102882|NCT02392611|11228748|FG001|Overall Study|Withdrawal by Subject|0
7102883|NCT02392611|11228749|FG002|Overall Study|Withdrawal by Subject|0
7102884|NCT02392611|11228750|FG003|Overall Study|Withdrawal by Subject|1
7102885|NCT02392611|11228751|FG004|Overall Study|Withdrawal by Subject|0
7102886|NCT02392611|11228752|FG005|Overall Study|Withdrawal by Subject|0
7102887|NCT02392611|11228753|FG006|Overall Study|Withdrawal by Subject|0
7102888|NCT02392611|11228754|FG007|Overall Study|Withdrawal by Subject|0
7102889|NCT02392611|11228755|FG008|Overall Study|Withdrawal by Subject|0
7102890|NCT02392611|11228747|FG000|Overall Study|Lost to Follow-up|0
7102891|NCT02392611|11228748|FG001|Overall Study|Lost to Follow-up|0
7102892|NCT02392611|11228749|FG002|Overall Study|Lost to Follow-up|0
7102893|NCT02392611|11228750|FG003|Overall Study|Lost to Follow-up|0
7102894|NCT02392611|11228751|FG004|Overall Study|Lost to Follow-up|0
7102895|NCT02392611|11228752|FG005|Overall Study|Lost to Follow-up|0
7102896|NCT02392611|11228753|FG006|Overall Study|Lost to Follow-up|1
7102897|NCT02392611|11228754|FG007|Overall Study|Lost to Follow-up|0
7102898|NCT02392611|11228755|FG008|Overall Study|Lost to Follow-up|0
7102899|NCT02392611|11228747|FG000|Overall Study|Enrolled, not treated|0
7102900|NCT02392611|11228748|FG001|Overall Study|Enrolled, not treated|0
7102901|NCT02392611|11228749|FG002|Overall Study|Enrolled, not treated|0
7102902|NCT02392611|11228750|FG003|Overall Study|Enrolled, not treated|2
7102903|NCT02392611|11228751|FG004|Overall Study|Enrolled, not treated|0
7102904|NCT02392611|11228752|FG005|Overall Study|Enrolled, not treated|0
7102905|NCT02392611|11228753|FG006|Overall Study|Enrolled, not treated|0
7102906|NCT02392611|11228754|FG007|Overall Study|Enrolled, not treated|0
7102907|NCT02392611|11228755|FG008|Overall Study|Enrolled, not treated|0
7102908|NCT02392624|11228778|FG000|Overall Study|Withdrawal by Subject|15
6805792|NCT02639546|10807994|FG001|Overall Study|PI, physician decision; no response to trt.|0
6805793|NCT02639546|10807995|FG002|Overall Study|PI, physician decision; no response to trt.|0
6805794|NCT02639546|10807996|FG003|Overall Study|PI, physician decision; no response to trt.|0
6805795|NCT02639546|10807997|FG004|Overall Study|PI, physician decision; no response to trt.|0
6805796|NCT02639546|10807998|FG005|Overall Study|PI, physician decision; no response to trt.|1
6805797|NCT02639546|10807999|FG006|Overall Study|PI, physician decision; no response to trt.|0
6805798|NCT02639546|10808000|FG007|Overall Study|PI, physician decision; no response to trt.|1
6805799|NCT02639546|10807993|FG000|Overall Study|Study Terminated By Sponsor|0
7102909|NCT02392624|11228779|FG001|Overall Study|Withdrawal by Subject|12
7102910|NCT02392624|11228780|FG002|Overall Study|Withdrawal by Subject|9
7102911|NCT02392624|11228778|FG000|Overall Study|Adverse Event|4
7102912|NCT02392624|11228779|FG001|Overall Study|Adverse Event|1
7102913|NCT02392624|11228780|FG002|Overall Study|Adverse Event|2
7102914|NCT02392624|11228778|FG000|Overall Study|Pregnancy|1
7102915|NCT02392624|11228779|FG001|Overall Study|Pregnancy|0
7102916|NCT02392624|11228780|FG002|Overall Study|Pregnancy|0
7102917|NCT02392624|11228778|FG000|Overall Study|Protocol Violation|0
7102918|NCT02392624|11228779|FG001|Overall Study|Protocol Violation|0
6805800|NCT02639546|10807994|FG001|Overall Study|Study Terminated By Sponsor|2
6805801|NCT02639546|10807995|FG002|Overall Study|Study Terminated By Sponsor|3
6805802|NCT02639546|10807996|FG003|Overall Study|Study Terminated By Sponsor|4
7102919|NCT02392624|11228780|FG002|Overall Study|Protocol Violation|1
7102920|NCT02392624|11228778|FG000|Overall Study|Sponsor/Investigator Decision|2
7102921|NCT02392624|11228779|FG001|Overall Study|Sponsor/Investigator Decision|1
7102922|NCT02392624|11228780|FG002|Overall Study|Sponsor/Investigator Decision|0
7102923|NCT02392624|11228778|FG000|Overall Study|Other|49
7102924|NCT02392624|11228779|FG001|Overall Study|Other|1
7102925|NCT02392624|11228780|FG002|Overall Study|Other|1
7102926|NCT02393209|11228810|FG000|Overall Study|Study Terminated by Sponsor|1
7102927|NCT02393209|11228811|FG001|Overall Study|Study Terminated by Sponsor|1
7102928|NCT02393209|11228812|FG002|Overall Study|Study Terminated by Sponsor|0
7102929|NCT02393209|11228813|FG003|Overall Study|Study Terminated by Sponsor|0
7102930|NCT02393209|11228810|FG000|Overall Study|Withdrawal by Patient|1
7102931|NCT02393209|11228811|FG001|Overall Study|Withdrawal by Patient|0
7102932|NCT02393209|11228812|FG002|Overall Study|Withdrawal by Patient|0
7102933|NCT02393209|11228813|FG003|Overall Study|Withdrawal by Patient|0
7102934|NCT02393209|11228810|FG000|Overall Study|Death|2
7102935|NCT02393209|11228811|FG001|Overall Study|Death|2
7102936|NCT02393209|11228812|FG002|Overall Study|Death|0
7102937|NCT02393209|11228813|FG003|Overall Study|Death|0
7102938|NCT02393209|11228810|FG000|Overall Study|Death due to Disease Progression|2
7102939|NCT02393209|11228811|FG001|Overall Study|Death due to Disease Progression|2
7102940|NCT02393209|11228812|FG002|Overall Study|Death due to Disease Progression|0
7102941|NCT02393209|11228813|FG003|Overall Study|Death due to Disease Progression|0
7102942|NCT02393209|11228810|FG000|Overall Study|Death from Legionella Infection|0
7102943|NCT02393209|11228811|FG001|Overall Study|Death from Legionella Infection|1
7102944|NCT02393209|11228812|FG002|Overall Study|Death from Legionella Infection|0
7102945|NCT02393209|11228813|FG003|Overall Study|Death from Legionella Infection|0
7102946|NCT02393209|11228810|FG000|Overall Study|Patient Seen by Another Oncologist|0
7102947|NCT02393209|11228811|FG001|Overall Study|Patient Seen by Another Oncologist|1
7102948|NCT02393209|11228812|FG002|Overall Study|Patient Seen by Another Oncologist|0
7102949|NCT02393209|11228813|FG003|Overall Study|Patient Seen by Another Oncologist|0
7102950|NCT02393209|11228810|FG000|Overall Study|Lost to Follow-up|0
7102951|NCT02393209|11228811|FG001|Overall Study|Lost to Follow-up|1
7102952|NCT02393209|11228812|FG002|Overall Study|Lost to Follow-up|0
7102953|NCT02393209|11228813|FG003|Overall Study|Lost to Follow-up|0
7102954|NCT02393547|11228858|FG000|Overall Study|Adverse Event|2
7102955|NCT02393547|11228858|FG000|Overall Study|Withdrawal by Subject|3
7102956|NCT02393547|11228858|FG000|Overall Study|Lost to Follow-up|1
7102957|NCT02393755|11228873|FG000|Overall Study|Withdrawal by Subject|0
7102958|NCT02393755|11228874|FG001|Overall Study|Withdrawal by Subject|3
7102959|NCT02393755|11228873|FG000|Overall Study|Adverse Event|0
7102960|NCT02393755|11228874|FG001|Overall Study|Adverse Event|2
7102961|NCT02393755|11228873|FG000|Overall Study|Physician Decision|0
7102962|NCT02393755|11228874|FG001|Overall Study|Physician Decision|2
7102963|NCT02393950|11228881|FG000|Overall Study|Adverse Event|1
7102964|NCT02393950|11228882|FG001|Overall Study|Adverse Event|0
7102965|NCT02393950|11228881|FG000|Overall Study|Withdrawal by Subject|0
7102966|NCT02393950|11228882|FG001|Overall Study|Withdrawal by Subject|1
7102967|NCT02394275|11228917|FG000|Overall Study|Adverse Event|22
7102968|NCT02394275|11228917|FG000|Overall Study|Lost to Follow-up|7
7102969|NCT02394340|11228922|FG000|Overall Study|Failed drug screen test|1
7102970|NCT02394340|11228922|FG000|Overall Study|Adverse Event|1
7102971|NCT02394561|11228937|FG000|CORE Phase|Adverse Event|7
7102972|NCT02394561|11228938|FG001|CORE Phase|Adverse Event|9
7102973|NCT02394561|11228937|FG000|CORE Phase|Death|0
7102974|NCT02394561|11228938|FG001|CORE Phase|Death|1
7102975|NCT02394561|11228937|FG000|CORE Phase|Pregnancy|1
7102976|NCT02394561|11228938|FG001|CORE Phase|Pregnancy|0
7102977|NCT02394561|11228937|FG000|CORE Phase|Lost to Follow-up|1
7102978|NCT02394561|11228938|FG001|CORE Phase|Lost to Follow-up|0
7102979|NCT02394561|11228937|FG000|CORE Phase|Physician Decision|1
7102980|NCT02394561|11228938|FG001|CORE Phase|Physician Decision|1
7102981|NCT02394561|11228937|FG000|CORE Phase|Withdrawal by Subject|2
7102982|NCT02394561|11228938|FG001|CORE Phase|Withdrawal by Subject|2
7102983|NCT02394561|11228937|FG000|CORE Phase|Lack of Efficacy|1
7102984|NCT02394561|11228938|FG001|CORE Phase|Lack of Efficacy|6
7102985|NCT02394561|11228937|FG000|Extension Phase|Adverse Event|6
7102986|NCT02394561|11228938|FG001|Extension Phase|Adverse Event|1
7102987|NCT02394561|11228937|FG000|Extension Phase|Death|0
7102988|NCT02394561|11228938|FG001|Extension Phase|Death|1
7102989|NCT02394561|11228937|FG000|Extension Phase|Protocol Violation|1
7102990|NCT02394561|11228938|FG001|Extension Phase|Protocol Violation|0
7102991|NCT02394561|11228937|FG000|Extension Phase|Lost to Follow-up|1
7102992|NCT02394561|11228938|FG001|Extension Phase|Lost to Follow-up|0
7102993|NCT02394561|11228937|FG000|Extension Phase|Physician Decision|0
7102994|NCT02394561|11228938|FG001|Extension Phase|Physician Decision|2
7102995|NCT02394561|11228937|FG000|Extension Phase|Withdrawal by Subject|0
7102996|NCT02394561|11228938|FG001|Extension Phase|Withdrawal by Subject|5
7102997|NCT02394561|11228937|FG000|Extension Phase|Lack of Efficacy|3
7102998|NCT02394561|11228938|FG001|Extension Phase|Lack of Efficacy|3
7102999|NCT02394600|11228949|FG000|Overall Study|Adverse Event|3
7103000|NCT02394600|11228950|FG001|Overall Study|Adverse Event|0
7103001|NCT02394600|11228949|FG000|Overall Study|Lost to Follow-up|0
7103002|NCT02394600|11228950|FG001|Overall Study|Lost to Follow-up|1
7103003|NCT02394600|11228949|FG000|Overall Study|Withdrawal by Subject|0
7103004|NCT02394600|11228950|FG001|Overall Study|Withdrawal by Subject|1
7103005|NCT02394600|11228949|FG000|Overall Study|Protocol Violation|1
7103006|NCT02394600|11228950|FG001|Overall Study|Protocol Violation|0
7103007|NCT02394730|11228958|FG000|Overall Study|Lost to Follow-up|1
7103008|NCT02394730|11228959|FG001|Overall Study|Lost to Follow-up|0
7103009|NCT02394730|11228958|FG000|Overall Study|Withdrawal by Subject|0
7103010|NCT02394730|11228959|FG001|Overall Study|Withdrawal by Subject|1
7103011|NCT02394756|11228965|FG000|Period 1|Lens Discomfort|0
7103012|NCT02394756|11228966|FG001|Period 1|Lens Discomfort|0
7103013|NCT02394756|11228967|FG002|Period 1|Lens Discomfort|0
7103014|NCT02394756|11228968|FG003|Period 1|Lens Discomfort|0
7103015|NCT02394756|11228969|FG004|Period 1|Lens Discomfort|0
7103016|NCT02394756|11228970|FG005|Period 1|Lens Discomfort|1
7103017|NCT02394756|11228965|FG000|Period 1|Withdrawal by Subject|0
7103018|NCT02394756|11228966|FG001|Period 1|Withdrawal by Subject|1
7103019|NCT02394756|11228967|FG002|Period 1|Withdrawal by Subject|1
7103020|NCT02394756|11228968|FG003|Period 1|Withdrawal by Subject|1
7103021|NCT02394756|11228969|FG004|Period 1|Withdrawal by Subject|0
7103022|NCT02394756|11228970|FG005|Period 1|Withdrawal by Subject|0
7103023|NCT02394756|11228965|FG000|Period 2|Unsatisfactory Visual Response|0
7103024|NCT02394756|11228966|FG001|Period 2|Unsatisfactory Visual Response|0
7103025|NCT02394756|11228967|FG002|Period 2|Unsatisfactory Visual Response|0
7103026|NCT02394756|11228968|FG003|Period 2|Unsatisfactory Visual Response|0
7103027|NCT02394756|11228969|FG004|Period 2|Unsatisfactory Visual Response|1
7103028|NCT02394756|11228970|FG005|Period 2|Unsatisfactory Visual Response|0
7103029|NCT02394808|11228991|FG000|Period 1|Unsatisfactory lens fitting|0
7103030|NCT02394808|11228992|FG001|Period 1|Unsatisfactory lens fitting|1
7103031|NCT02394808|11228991|FG000|Period 2|Lost to Follow-up|1
7103032|NCT02394808|11228992|FG001|Period 2|Lost to Follow-up|0
7103033|NCT02394925|11229004|FG000|Overall Study|Adverse Event|1
7103034|NCT02394925|11229004|FG000|Overall Study|Lens Discomfort|3
7103035|NCT02394925|11229004|FG000|Overall Study|Lens handling difficulities|5
7103036|NCT02394925|11229004|FG000|Overall Study|Lost to Follow-up|9
7103037|NCT02394925|11229004|FG000|Overall Study|Protocol Violation|5
7103038|NCT02394925|11229004|FG000|Overall Study|No longer meet eligibility criteria|1
7103039|NCT02394925|11229004|FG000|Overall Study|Unsatisfactory Visual Response|5
7103040|NCT02395042|11229020|FG000|Treatment 1 Period|Adverse Event|1
7103041|NCT02395042|11229021|FG001|Treatment 1 Period|Adverse Event|3
7103042|NCT02395042|11229022|FG002|Treatment 1 Period|Adverse Event|1
7103043|NCT02395042|11229020|FG000|Treatment 1 Period|Lack of Efficacy|1
7103044|NCT02395042|11229021|FG001|Treatment 1 Period|Lack of Efficacy|1
7103045|NCT02395042|11229022|FG002|Treatment 1 Period|Lack of Efficacy|0
7103046|NCT02395042|11229020|FG000|Treatment 1 Period|Lost to Follow-up|1
7103047|NCT02395042|11229021|FG001|Treatment 1 Period|Lost to Follow-up|0
7103048|NCT02395042|11229022|FG002|Treatment 1 Period|Lost to Follow-up|0
7103049|NCT02395042|11229020|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0
7103050|NCT02395042|11229021|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2
7103051|NCT02395042|11229022|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1
7103052|NCT02395042|11229020|FG000|Treatment 2 Period|Lack of Efficacy|1
7103053|NCT02395042|11229021|FG001|Treatment 2 Period|Lack of Efficacy|1
7103054|NCT02395042|11229022|FG002|Treatment 2 Period|Lack of Efficacy|0
7103055|NCT02395055|11229035|FG000|Overall Study|Withdrawal by Subject|7
7103056|NCT02395055|11229036|FG001|Overall Study|Withdrawal by Subject|3
7103057|NCT02395081|11229045|FG000|Overall Study|Withdrawal by Subject|1
7103058|NCT02395081|11229046|FG001|Overall Study|Withdrawal by Subject|1
7103059|NCT02395081|11229047|FG002|Overall Study|Withdrawal by Subject|0
7103060|NCT02395081|11229045|FG000|Overall Study|Moved where blood couldn't be collected|4
7103061|NCT02395081|11229046|FG001|Overall Study|Moved where blood couldn't be collected|1
7103062|NCT02395081|11229047|FG002|Overall Study|Moved where blood couldn't be collected|3
7103063|NCT02395081|11229045|FG000|Overall Study|Fetal Loss|2
7103064|NCT02395081|11229046|FG001|Overall Study|Fetal Loss|3
7103065|NCT02395081|11229047|FG002|Overall Study|Fetal Loss|1
7103066|NCT02395133|11229062|FG000|Overall Study|Adverse Event|4
7103067|NCT02395133|11229063|FG001|Overall Study|Adverse Event|1
7103068|NCT02395133|11229064|FG002|Overall Study|Adverse Event|3
7103069|NCT02395133|11229065|FG003|Overall Study|Adverse Event|0
7103070|NCT02395133|11229062|FG000|Overall Study|Lack of Efficacy|1
7103071|NCT02395133|11229063|FG001|Overall Study|Lack of Efficacy|0
7103072|NCT02395133|11229064|FG002|Overall Study|Lack of Efficacy|1
7103073|NCT02395133|11229065|FG003|Overall Study|Lack of Efficacy|1
7103074|NCT02395133|11229062|FG000|Overall Study|Protocol Violation|1
7103075|NCT02395133|11229063|FG001|Overall Study|Protocol Violation|1
7103076|NCT02395133|11229064|FG002|Overall Study|Protocol Violation|0
7103077|NCT02395133|11229065|FG003|Overall Study|Protocol Violation|3
7103078|NCT02395133|11229062|FG000|Overall Study|Lost to Follow-up|0
7103079|NCT02395133|11229063|FG001|Overall Study|Lost to Follow-up|1
7103080|NCT02395133|11229064|FG002|Overall Study|Lost to Follow-up|1
7103081|NCT02395133|11229065|FG003|Overall Study|Lost to Follow-up|0
7103082|NCT02395133|11229062|FG000|Overall Study|Pregnancy|0
7103083|NCT02395133|11229063|FG001|Overall Study|Pregnancy|0
7103084|NCT02395133|11229064|FG002|Overall Study|Pregnancy|3
7103085|NCT02395133|11229065|FG003|Overall Study|Pregnancy|0
7103086|NCT02395133|11229062|FG000|Overall Study|Consent withdrawn with no reason given|1
7103087|NCT02395133|11229063|FG001|Overall Study|Consent withdrawn with no reason given|3
7103088|NCT02395133|11229064|FG002|Overall Study|Consent withdrawn with no reason given|0
7103089|NCT02395133|11229065|FG003|Overall Study|Consent withdrawn with no reason given|2
7103090|NCT02395133|11229062|FG000|Overall Study|Consent withdrawn with personal reason|0
7103091|NCT02395133|11229063|FG001|Overall Study|Consent withdrawn with personal reason|1
7103092|NCT02395133|11229064|FG002|Overall Study|Consent withdrawn with personal reason|0
7103093|NCT02395133|11229065|FG003|Overall Study|Consent withdrawn with personal reason|3
7103094|NCT02395133|11229062|FG000|Overall Study|Sponsor decision|2
7103095|NCT02395133|11229063|FG001|Overall Study|Sponsor decision|0
7103096|NCT02395133|11229064|FG002|Overall Study|Sponsor decision|0
7103097|NCT02395133|11229065|FG003|Overall Study|Sponsor decision|1
7103098|NCT02395133|11229062|FG000|Overall Study|Other than specified above|5
7103099|NCT02395133|11229063|FG001|Overall Study|Other than specified above|2
7103100|NCT02395133|11229064|FG002|Overall Study|Other than specified above|2
7103101|NCT02395133|11229065|FG003|Overall Study|Other than specified above|4
7103102|NCT02395172|11229077|FG000|Overall Study|Participants randomized but not treated|3
7103103|NCT02395172|11229078|FG001|Overall Study|Participants randomized but not treated|31
7103104|NCT02395302|11229092|FG000|Overall Study|Screen Failure|3
7103105|NCT02395302|11229092|FG000|Overall Study|Run In Failure|7
7103106|NCT02395302|11229092|FG000|Overall Study|Withdrawal by Subject|2
7103107|NCT02395302|11229092|FG000|Overall Study|Physician Decision|2
7103108|NCT02395471|11229098|FG000|Overall Study|Lost to Follow-up|2
7103109|NCT02395471|11229099|FG001|Overall Study|Lost to Follow-up|0
7103110|NCT02395471|11229098|FG000|Overall Study|Withdrawal by Subject|2
7103111|NCT02395471|11229099|FG001|Overall Study|Withdrawal by Subject|1
7103112|NCT02395471|11229098|FG000|Overall Study|Physician Decision|1
7103113|NCT02395471|11229099|FG001|Overall Study|Physician Decision|0
7103114|NCT02395471|11229098|FG000|Overall Study|Protocol Violation|0
7103115|NCT02395471|11229099|FG001|Overall Study|Protocol Violation|1
7103116|NCT02395471|11229098|FG000|Overall Study|Failure to swollow sponge twice|1
7103117|NCT02395471|11229099|FG001|Overall Study|Failure to swollow sponge twice|0
7103118|NCT02395471|11229098|FG000|Overall Study|Patient did not return for procedure|0
7103119|NCT02395471|11229099|FG001|Overall Study|Patient did not return for procedure|1
7103120|NCT02395471|11229098|FG000|Overall Study|Subject not eligible|1
7103121|NCT02395471|11229099|FG001|Overall Study|Subject not eligible|0
7103122|NCT02395536|11229116|FG000|Overall Study|Lost to Follow-up|4
7103123|NCT02395536|11229117|FG001|Overall Study|Lost to Follow-up|4
7103124|NCT02395536|11229116|FG000|Overall Study|Death|2
7103125|NCT02395536|11229117|FG001|Overall Study|Death|0
7103126|NCT02395536|11229116|FG000|Overall Study|Physician Decision|4
7103127|NCT02395536|11229117|FG001|Overall Study|Physician Decision|6
7103128|NCT02395536|11229116|FG000|Overall Study|Withdrawal by Subject|9
7103129|NCT02395536|11229117|FG001|Overall Study|Withdrawal by Subject|17
7103130|NCT02395536|11229116|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1
7103131|NCT02395536|11229117|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2
7103132|NCT02395536|11229116|FG000|Overall Study|Insurance issue|0
7103133|NCT02395536|11229117|FG001|Overall Study|Insurance issue|1
7103134|NCT02395627|11229126|FG000|Overall Study|Withdrawal by Subject|0
7103135|NCT02395627|11229127|FG001|Overall Study|Withdrawal by Subject|2
7103136|NCT02395627|11229128|FG002|Overall Study|Withdrawal by Subject|0
7103137|NCT02395627|11229126|FG000|Overall Study|Did not receive pembrolizumab|3
7103138|NCT02395627|11229127|FG001|Overall Study|Did not receive pembrolizumab|1
7103139|NCT02395627|11229128|FG002|Overall Study|Did not receive pembrolizumab|0
7103140|NCT02395653|11229138|FG000|Overall Study|Exclusion Criteria Met at Screening|4
7103141|NCT02395653|11229138|FG000|Overall Study|Consent Withdrawn at Screening|1
7103142|NCT02395653|11229138|FG000|Overall Study|SSEC Application But With 0 Dose|1
7103143|NCT02395653|11229138|FG000|Overall Study|Investigator Decision at Screening|1
7103144|NCT02395653|11229138|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3
7103145|NCT02395653|11229138|FG000|Overall Study|Withdrawal by Subject|1
7103146|NCT02395653|11229138|FG000|Overall Study|Lost to Follow-up|1
7103147|NCT02395822|11229150|FG000|Overall Study|Withdrawal by Subject|1
7103148|NCT02395822|11229150|FG000|Overall Study|Death|1
7103149|NCT02396212|11229207|FG000|Overall Study|Adverse Event|1
7103150|NCT02396212|11229207|FG000|Overall Study|Lack of Efficacy|2
7103151|NCT02396316|11229221|FG000|Overall Study|Physician Decision|1
7103152|NCT02396316|11229222|FG001|Overall Study|Physician Decision|0
7103153|NCT02396316|11229221|FG000|Overall Study|Progressive disease|6
7103154|NCT02396316|11229222|FG001|Overall Study|Progressive disease|3
7103155|NCT02396316|11229221|FG000|Overall Study|Protocol Violation|0
7103156|NCT02396316|11229222|FG001|Overall Study|Protocol Violation|1
7103157|NCT02396316|11229221|FG000|Overall Study|Treatment unblinded|0
7103158|NCT02396316|11229222|FG001|Overall Study|Treatment unblinded|1
7103159|NCT02396381|11229234|FG000|Overall Study|Adverse Event|3
7103160|NCT02396381|11229235|FG001|Overall Study|Adverse Event|2
7103161|NCT02396381|11229234|FG000|Overall Study|Withdrawal by Subject|33
7103162|NCT02396381|11229235|FG001|Overall Study|Withdrawal by Subject|24
7103163|NCT02396381|11229234|FG000|Overall Study|Lost to Follow-up|49
7103164|NCT02396381|11229235|FG001|Overall Study|Lost to Follow-up|31
7103165|NCT02396381|11229234|FG000|Overall Study|Protocol Violation|1
7103166|NCT02396381|11229235|FG001|Overall Study|Protocol Violation|0
7103167|NCT02396381|11229234|FG000|Overall Study|Site terminated by sponsor|7
7103168|NCT02396381|11229235|FG001|Overall Study|Site terminated by sponsor|8
7103169|NCT02396381|11229234|FG000|Overall Study|Physician Decision|5
7103170|NCT02396381|11229235|FG001|Overall Study|Physician Decision|5
7103171|NCT02396381|11229234|FG000|Overall Study|Pregnancy|2
7103172|NCT02396381|11229235|FG001|Overall Study|Pregnancy|0
7103173|NCT02396381|11229234|FG000|Overall Study|Non-compliance with study procedures|1
7103174|NCT02396381|11229235|FG001|Overall Study|Non-compliance with study procedures|0
7103175|NCT02396381|11229234|FG000|Overall Study|Moved out of town/state|1
7103176|NCT02396381|11229235|FG001|Overall Study|Moved out of town/state|3
7103177|NCT02396381|11229234|FG000|Overall Study|Could not complete visit|1
7103178|NCT02396381|11229235|FG001|Overall Study|Could not complete visit|0
7103179|NCT02396381|11229234|FG000|Overall Study|Possible conflict of interest|1
7103180|NCT02396381|11229235|FG001|Overall Study|Possible conflict of interest|0
7103181|NCT02396381|11229234|FG000|Overall Study|Randomization/Screening Error|3
7103182|NCT02396381|11229235|FG001|Overall Study|Randomization/Screening Error|1
7103183|NCT02396420|11229244|FG000|Overall Study|Death|1
7103184|NCT02396537|11229255|FG000|Overall Study|Protocol Violation|0
7103185|NCT02396537|11229256|FG001|Overall Study|Protocol Violation|1
7103186|NCT02396758|11229279|FG000|Overall Study|Withdrawal by Subject|2
7103187|NCT02396758|11229280|FG001|Overall Study|Withdrawal by Subject|0
7103188|NCT02396758|11229281|FG002|Overall Study|Withdrawal by Subject|0
7103189|NCT02396758|11229282|FG003|Overall Study|Withdrawal by Subject|1
7103190|NCT02396758|11229279|FG000|Overall Study|Lost to Follow-up|8
7103191|NCT02396758|11229280|FG001|Overall Study|Lost to Follow-up|5
7103192|NCT02396758|11229281|FG002|Overall Study|Lost to Follow-up|3
7103193|NCT02396758|11229282|FG003|Overall Study|Lost to Follow-up|3
7103194|NCT02396758|11229279|FG000|Overall Study|Death|1
7103195|NCT02396758|11229280|FG001|Overall Study|Death|1
7103196|NCT02396758|11229281|FG002|Overall Study|Death|0
7103197|NCT02396758|11229282|FG003|Overall Study|Death|1
7103198|NCT02396758|11229279|FG000|Overall Study|Randomized but not treated|1
7103199|NCT02396758|11229280|FG001|Overall Study|Randomized but not treated|0
7103200|NCT02396758|11229281|FG002|Overall Study|Randomized but not treated|1
7103201|NCT02396758|11229282|FG003|Overall Study|Randomized but not treated|0
7103202|NCT02396849|11229294|FG000|Overall Study|Lost to Follow-up|1
7103203|NCT02396849|11229295|FG001|Overall Study|Lost to Follow-up|1
7103204|NCT02396849|11229294|FG000|Overall Study|Did not tolerate intervention|1
7103205|NCT02396849|11229295|FG001|Overall Study|Did not tolerate intervention|1
7103206|NCT02396953|11229306|FG000|Overall Study|Withdrawal by Subject|0
7103207|NCT02396953|11229307|FG001|Overall Study|Withdrawal by Subject|0
7103208|NCT02396953|11229308|FG002|Overall Study|Withdrawal by Subject|1
7103209|NCT02396953|11229306|FG000|Overall Study|Insulin like Growth Factor-1 increased|3
7103210|NCT02396953|11229307|FG001|Overall Study|Insulin like Growth Factor-1 increased|2
7103211|NCT02396953|11229308|FG002|Overall Study|Insulin like Growth Factor-1 increased|2
7103212|NCT02396953|11229306|FG000|Overall Study|Personal Reasons|1
7103213|NCT02396953|11229307|FG001|Overall Study|Personal Reasons|1
7103214|NCT02396953|11229308|FG002|Overall Study|Personal Reasons|0
7103215|NCT02397057|11229325|FG000|Overall Study|Withdrawal by Subject|6
7103216|NCT02397057|11229326|FG001|Overall Study|Withdrawal by Subject|7
7103217|NCT02397057|11229325|FG000|Overall Study|Lost to Follow-up|4
7103218|NCT02397057|11229326|FG001|Overall Study|Lost to Follow-up|3
7103219|NCT02397057|11229325|FG000|Overall Study|Death|1
7103220|NCT02397057|11229326|FG001|Overall Study|Death|0
7103221|NCT02397057|11229325|FG000|Overall Study|Adverse Event|0
7103222|NCT02397057|11229326|FG001|Overall Study|Adverse Event|1
7103223|NCT02397057|11229325|FG000|Overall Study|Physician Decision|0
7103224|NCT02397057|11229326|FG001|Overall Study|Physician Decision|1
7103225|NCT02397057|11229325|FG000|Overall Study|Subject did not receive study drug|0
7103226|NCT02397057|11229326|FG001|Overall Study|Subject did not receive study drug|1
7103227|NCT02397096|11229334|FG000|Day 1 to Week 24|Adverse Event|7
7103228|NCT02397096|11229335|FG001|Day 1 to Week 24|Adverse Event|1
7103229|NCT02397096|11229334|FG000|Day 1 to Week 24|Death|1
7103230|NCT02397096|11229335|FG001|Day 1 to Week 24|Death|0
7103231|NCT02397096|11229334|FG000|Day 1 to Week 24|Lack of Efficacy|0
7103232|NCT02397096|11229335|FG001|Day 1 to Week 24|Lack of Efficacy|1
7103233|NCT02397096|11229334|FG000|Day 1 to Week 24|Lost to Follow-up|3
7103234|NCT02397096|11229335|FG001|Day 1 to Week 24|Lost to Follow-up|4
7103235|NCT02397096|11229334|FG000|Day 1 to Week 24|Physician Decision|2
7103236|NCT02397096|11229335|FG001|Day 1 to Week 24|Physician Decision|3
7103237|NCT02397096|11229334|FG000|Day 1 to Week 24|Protocol Violation|1
7103238|NCT02397096|11229335|FG001|Day 1 to Week 24|Protocol Violation|4
7103239|NCT02397096|11229334|FG000|Day 1 to Week 24|Withdrawal by Subject|6
7103240|NCT02397096|11229335|FG001|Day 1 to Week 24|Withdrawal by Subject|1
7103241|NCT02397096|11229334|FG000|Week 24 to Week 48|Adverse Event|6
7103242|NCT02397096|11229335|FG001|Week 24 to Week 48|Adverse Event|2
7103243|NCT02397096|11229334|FG000|Week 24 to Week 48|Lack of Efficacy|5
7103244|NCT02397096|11229335|FG001|Week 24 to Week 48|Lack of Efficacy|1
7103245|NCT02397096|11229334|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0
7103246|NCT02397096|11229335|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1
7103247|NCT02397096|11229334|FG000|Week 24 to Week 48|Physician Decision|2
7103248|NCT02397096|11229335|FG001|Week 24 to Week 48|Physician Decision|1
7103249|NCT02397096|11229334|FG000|Week 24 to Week 48|Withdrawal by Subject|5
7103250|NCT02397096|11229335|FG001|Week 24 to Week 48|Withdrawal by Subject|2
7103251|NCT02397096|11229334|FG000|Week 24 to Week 48|Lost to Follow-up|2
7103252|NCT02397096|11229335|FG001|Week 24 to Week 48|Lost to Follow-up|0
7103253|NCT02397096|11229334|FG000|Study Extensions|Ongoing|399
7103254|NCT02397096|11229335|FG001|Study Extensions|Ongoing|202
7103255|NCT02397278|11229370|FG000|Overall Study|Withdrawal by Subject|0
7103256|NCT02397278|11229371|FG001|Overall Study|Withdrawal by Subject|2
7103257|NCT02397278|11229370|FG000|Overall Study|Deemed ineligible following surgery|1
7103258|NCT02397278|11229371|FG001|Overall Study|Deemed ineligible following surgery|1
7103259|NCT02397408|11229386|FG000|Overall Study|Physician Decision|4
7103260|NCT02397408|11229386|FG000|Overall Study|Surgery not completed within protocol timeframe|2
7103261|NCT02397447|11229392|FG000|Overall Study|Lost to Follow-up|2
7103262|NCT02397447|11229393|FG001|Overall Study|Lost to Follow-up|2
7103263|NCT02397460|11229407|FG000|Treatment Period 2|Adverse Event|0
7103264|NCT02397460|11229408|FG001|Treatment Period 2|Adverse Event|0
7103265|NCT02397460|11229409|FG002|Treatment Period 2|Adverse Event|0
7103266|NCT02397460|11229410|FG003|Treatment Period 2|Adverse Event|0
7103267|NCT02397460|11229411|FG004|Treatment Period 2|Adverse Event|0
7103268|NCT02397460|11229412|FG005|Treatment Period 2|Adverse Event|0
7103269|NCT02397460|11229413|FG006|Treatment Period 2|Adverse Event|0
7103270|NCT02397460|11229414|FG007|Treatment Period 2|Adverse Event|1
7103271|NCT02397460|11229407|FG000|Treatment Period 4|Adverse Event|0
7103272|NCT02397460|11229408|FG001|Treatment Period 4|Adverse Event|1
7103273|NCT02397460|11229409|FG002|Treatment Period 4|Adverse Event|0
7103274|NCT02397460|11229410|FG003|Treatment Period 4|Adverse Event|0
7103275|NCT02397460|11229411|FG004|Treatment Period 4|Adverse Event|0
7103276|NCT02397460|11229412|FG005|Treatment Period 4|Adverse Event|0
7103277|NCT02397460|11229413|FG006|Treatment Period 4|Adverse Event|0
7103278|NCT02397460|11229414|FG007|Treatment Period 4|Adverse Event|0
7103279|NCT02397460|11229407|FG000|Treatment Period 4|Physician Decision|0
7103280|NCT02397460|11229408|FG001|Treatment Period 4|Physician Decision|0
7103281|NCT02397460|11229409|FG002|Treatment Period 4|Physician Decision|0
7103282|NCT02397460|11229410|FG003|Treatment Period 4|Physician Decision|0
7103283|NCT02397460|11229411|FG004|Treatment Period 4|Physician Decision|1
7103284|NCT02397460|11229412|FG005|Treatment Period 4|Physician Decision|0
7103285|NCT02397460|11229413|FG006|Treatment Period 4|Physician Decision|0
7103286|NCT02397460|11229414|FG007|Treatment Period 4|Physician Decision|0
7103287|NCT02397473|11229490|FG000|Treatment Phase|Adverse Event|1
7103288|NCT02397473|11229491|FG001|Treatment Phase|Adverse Event|2
7103289|NCT02397473|11229490|FG000|Treatment Phase|Lack of Efficacy|8
7103290|NCT02397473|11229491|FG001|Treatment Phase|Lack of Efficacy|1
7103291|NCT02397473|11229490|FG000|Treatment Phase|Lost to Follow-up|1
7103292|NCT02397473|11229491|FG001|Treatment Phase|Lost to Follow-up|0
7103293|NCT02397473|11229490|FG000|Treatment Phase|Withdrawal by Subject|2
7103294|NCT02397473|11229491|FG001|Treatment Phase|Withdrawal by Subject|1
7103295|NCT02397473|11229490|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0
7103296|NCT02397473|11229491|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3
7103297|NCT02397473|11229490|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1
7103298|NCT02397473|11229491|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1
7103299|NCT02397473|11229490|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1
7103300|NCT02397473|11229491|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0
7103301|NCT02397473|11229490|FG000|Post Treatment Follow-up Phase|Protocol Violation|1
7103302|NCT02397473|11229491|FG001|Post Treatment Follow-up Phase|Protocol Violation|0
7103303|NCT02397473|11229490|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0
7103304|NCT02397473|11229491|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1
7103305|NCT02397655|11229505|FG000|Overall Study|data not completed|1301
7103306|NCT02397694|11229511|FG000|Double-Blinded Phase|Adverse Event|1
7103307|NCT02397694|11229512|FG001|Double-Blinded Phase|Adverse Event|0
7103308|NCT02397694|11229511|FG000|Double-Blinded Phase|Non-compliance with study drug|0
7103309|NCT02397694|11229512|FG001|Double-Blinded Phase|Non-compliance with study drug|2
7103310|NCT02397694|11229511|FG000|Double-Blinded Phase|Withdrawal by Subject|1
7103311|NCT02397694|11229512|FG001|Double-Blinded Phase|Withdrawal by Subject|0
7103312|NCT02397694|11229511|FG000|Double-Blinded Phase|Lost to Follow-up|1
7103313|NCT02397694|11229512|FG001|Double-Blinded Phase|Lost to Follow-up|1
7103314|NCT02397694|11229511|FG000|Open Label Extension Phase|Protocol Violation|1
7103315|NCT02397694|11229512|FG001|Open Label Extension Phase|Protocol Violation|0
7103316|NCT02397694|11229511|FG000|Open Label Extension Phase|Withdrew Consent|3
7103317|NCT02397694|11229512|FG001|Open Label Extension Phase|Withdrew Consent|1
7103318|NCT02397694|11229511|FG000|Open Label Extension Phase|Lost to Follow-up|4
7103319|NCT02397694|11229512|FG001|Open Label Extension Phase|Lost to Follow-up|0
7103320|NCT02397837|11229547|FG000|Overall Study|Withdrawal by Subject|6
7103321|NCT02397837|11229548|FG001|Overall Study|Withdrawal by Subject|5
7103322|NCT02397837|11229547|FG000|Overall Study|Physician Decision|1
7103323|NCT02397837|11229548|FG001|Overall Study|Physician Decision|1
7103324|NCT02397889|11229556|FG000|Overall Study|Physician Decision|1
7103325|NCT02397889|11229557|FG001|Overall Study|Physician Decision|0
7103326|NCT02397915|11229563|FG000|Period 1|Protocol Violation|0
7103327|NCT02397915|11229564|FG001|Period 1|Protocol Violation|1
7103328|NCT02397915|11229565|FG002|Period 1|Protocol Violation|0
7103329|NCT02397915|11229566|FG003|Period 1|Protocol Violation|0
7103330|NCT02397915|11229563|FG000|Period 1|Physician Decision|1
7103331|NCT02397915|11229564|FG001|Period 1|Physician Decision|0
7103332|NCT02397915|11229565|FG002|Period 1|Physician Decision|0
7103333|NCT02397915|11229566|FG003|Period 1|Physician Decision|0
7103334|NCT02398188|11229580|FG000|Overall Study|Adverse Event|2
7103335|NCT02398188|11229581|FG001|Overall Study|Adverse Event|3
7103336|NCT02398188|11229580|FG000|Overall Study|Lost to Follow-up|5
7103337|NCT02398188|11229581|FG001|Overall Study|Lost to Follow-up|0
7103338|NCT02398188|11229580|FG000|Overall Study|Non-compliance|4
7103339|NCT02398188|11229581|FG001|Overall Study|Non-compliance|4
7103340|NCT02398188|11229580|FG000|Overall Study|Protocol Violation|6
7103341|NCT02398188|11229581|FG001|Overall Study|Protocol Violation|10
7103342|NCT02398188|11229580|FG000|Overall Study|Sponsor Decision|2
7103343|NCT02398188|11229581|FG001|Overall Study|Sponsor Decision|1
7103344|NCT02398188|11229580|FG000|Overall Study|Pregnancy|1
7103345|NCT02398188|11229581|FG001|Overall Study|Pregnancy|0
7103346|NCT02398188|11229580|FG000|Overall Study|Withdrawal by Subject|7
7103347|NCT02398188|11229581|FG001|Overall Study|Withdrawal by Subject|16
7103348|NCT02398227|11229589|FG000|Overall Study|Lost to Follow-up|21
7103349|NCT02398227|11229590|FG001|Overall Study|Lost to Follow-up|12
7103350|NCT02398227|11229589|FG000|Overall Study|Withdrawal by Subject|5
7103351|NCT02398227|11229590|FG001|Overall Study|Withdrawal by Subject|6
7103352|NCT02398227|11229589|FG000|Overall Study|Removed from treatment and dropped out|1
7103353|NCT02398227|11229590|FG001|Overall Study|Removed from treatment and dropped out|0
7103354|NCT02399163|11229609|FG000|Overall Study|Adverse Event|2
7103355|NCT02399163|11229609|FG000|Overall Study|Protocol Deviation|2
7103356|NCT02399163|11229609|FG000|Overall Study|Withdrawal by Participant|5
7103357|NCT02399254|11229625|FG000|Overall Study|Physician Decision|2
7103358|NCT02399475|11229636|FG000|Overall Study|Physician Decision|1
7103359|NCT02399475|11229637|FG001|Overall Study|Physician Decision|0
7103360|NCT02400307|11229663|FG000|Overall Study|Enrolled and Never Dosed|1
7103361|NCT02400307|11229664|FG001|Overall Study|Enrolled and Never Dosed|0
7103362|NCT02400333|11229674|FG000|Overall Study|Withdrawal by Subject|0
7103363|NCT02400333|11229675|FG001|Overall Study|Withdrawal by Subject|1
7103364|NCT02400333|11229676|FG002|Overall Study|Withdrawal by Subject|0
7103365|NCT02400333|11229677|FG003|Overall Study|Withdrawal by Subject|1
7103366|NCT02400333|11229674|FG000|Overall Study|Protocol Violation|1
7103367|NCT02400333|11229675|FG001|Overall Study|Protocol Violation|0
7103368|NCT02400333|11229676|FG002|Overall Study|Protocol Violation|2
7103369|NCT02400333|11229677|FG003|Overall Study|Protocol Violation|1
7103370|NCT02400346|11229688|FG000|Overall Study|Adverse Event|24
7103371|NCT02400346|11229688|FG000|Overall Study|Lack of Efficacy|9
7103372|NCT02400346|11229688|FG000|Overall Study|Non-compliance with IMP|1
7103373|NCT02400346|11229688|FG000|Overall Study|Withdrawal by Subject|7
7103374|NCT02400346|11229688|FG000|Overall Study|Administrative or other reason(s)|2
7103375|NCT02400346|11229688|FG000|Overall Study|Lost to Follow-up|1
7103376|NCT02400580|11229704|FG000|Overall Study|Withdrawal by Subject|1
7103377|NCT02400580|11229705|FG001|Overall Study|Withdrawal by Subject|1
7103378|NCT02400580|11229704|FG000|Overall Study|Adverse Event|1
7103379|NCT02400580|11229705|FG001|Overall Study|Adverse Event|0
7103380|NCT02400749|11229722|FG000|Week 0 -16|Withdrawal by Subject|5
7103381|NCT02400749|11229723|FG001|Week 0 -16|Withdrawal by Subject|5
7103382|NCT02400749|11229722|FG000|Week 0 -16|Adverse Event|3
7103383|NCT02400749|11229723|FG001|Week 0 -16|Adverse Event|1
7103384|NCT02400749|11229722|FG000|Week 0 -16|Lost to Follow-up|2
7103385|NCT02400749|11229723|FG001|Week 0 -16|Lost to Follow-up|0
7103386|NCT02400749|11229722|FG000|Week 0 -16|Protocol Violation|1
7103387|NCT02400749|11229723|FG001|Week 0 -16|Protocol Violation|0
7103388|NCT02400749|11229722|FG000|Week 17 - 32|Withdrawal by Subject|3
7103389|NCT02400749|11229723|FG001|Week 17 - 32|Withdrawal by Subject|2
7103390|NCT02400749|11229722|FG000|Week 17 - 32|Adverse Event|2
7103391|NCT02400749|11229723|FG001|Week 17 - 32|Adverse Event|1
7103392|NCT02400905|11229729|FG000|Overall Study|Death|24
7103393|NCT02400905|11229729|FG000|Overall Study|Lost to Follow-up|18
7103394|NCT02400905|11229729|FG000|Overall Study|Withdrawal by Subject|16
7103395|NCT02400905|11229729|FG000|Overall Study|Physician Decision|4
7103396|NCT02400905|11229729|FG000|Overall Study|Other|1
7103397|NCT02401230|11229764|FG000|Overall Study|Adverse Event|3
7103398|NCT02401230|11229765|FG001|Overall Study|Adverse Event|2
7103399|NCT02401230|11229766|FG002|Overall Study|Adverse Event|0
7103400|NCT02401230|11229764|FG000|Overall Study|Withdrawal by Subject|2
7103401|NCT02401230|11229765|FG001|Overall Study|Withdrawal by Subject|1
7103402|NCT02401230|11229766|FG002|Overall Study|Withdrawal by Subject|1
7103403|NCT02401230|11229764|FG000|Overall Study|Lost to Follow-up|1
7103404|NCT02401230|11229765|FG001|Overall Study|Lost to Follow-up|3
7103405|NCT02401230|11229766|FG002|Overall Study|Lost to Follow-up|3
7103406|NCT02401256|11229778|FG000|Overall Study|Adverse Event|5
7103407|NCT02401256|11229778|FG000|Overall Study|Withdrawal by Subject|12
7103408|NCT02401412|11229786|FG000|Overall Study|Lost to Follow-up|1
7103409|NCT02401412|11229787|FG001|Overall Study|Lost to Follow-up|0
7103410|NCT02401412|11229786|FG000|Overall Study|Discontinued Intervention|15
7103411|NCT02401412|11229787|FG001|Overall Study|Discontinued Intervention|21
7103412|NCT02401412|11229786|FG000|Overall Study|Withdrawal by Subject|4
7103413|NCT02401412|11229787|FG001|Overall Study|Withdrawal by Subject|4
6805803|NCT02639546|10807997|FG004|Overall Study|Study Terminated By Sponsor|4
6805804|NCT02639546|10807998|FG005|Overall Study|Study Terminated By Sponsor|3
6805805|NCT02639546|10807999|FG006|Overall Study|Study Terminated By Sponsor|3
6805806|NCT02639546|10808000|FG007|Overall Study|Study Terminated By Sponsor|9
7103414|NCT02401412|11229786|FG000|Overall Study|Subject withdrawal prior to intervention|0
7103415|NCT02401412|11229787|FG001|Overall Study|Subject withdrawal prior to intervention|1
7103416|NCT02401412|11229786|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10
6805807|NCT02639546|10807993|FG000|Overall Study|Withdrawal by Subject|2
7103417|NCT02401412|11229787|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6
7103418|NCT02401529|11229814|FG000|Overall Study|Lost to Follow-up|2
7103419|NCT02401529|11229815|FG001|Overall Study|Lost to Follow-up|1
7103420|NCT02401529|11229814|FG000|Overall Study|Physician Decision|2
7103421|NCT02401529|11229815|FG001|Overall Study|Physician Decision|6
7103422|NCT02401529|11229814|FG000|Overall Study|Protocol Violation|5
7103423|NCT02401529|11229815|FG001|Overall Study|Protocol Violation|0
7103424|NCT02401672|11229852|FG000|Overall Study|Withdrawal by Subject|1
7103425|NCT02401672|11229853|FG001|Overall Study|Withdrawal by Subject|3
7103426|NCT02401867|11229859|FG000|Specimen Collection|Didn't receive 1 or more tests|10
7103427|NCT02401867|11229859|FG000|Analysis|Cervical assay could not be conducted|9
7103428|NCT02402166|11229894|FG000|Overall Study|Adverse Event|2
7103429|NCT02402166|11229894|FG000|Overall Study|Withdrawal by Subject|2
7103430|NCT02402166|11229894|FG000|Overall Study|Lost to Follow-up|1
7103431|NCT02402218|11229915|FG000|Overall Study|Did not pickup study medication|12
7103432|NCT02402218|11229916|FG001|Overall Study|Did not pickup study medication|9
7103433|NCT02402218|11229917|FG002|Overall Study|Did not pickup study medication|13
7103434|NCT02402218|11229915|FG000|Overall Study|Lack of Efficacy|0
7103435|NCT02402218|11229916|FG001|Overall Study|Lack of Efficacy|1
7103436|NCT02402218|11229917|FG002|Overall Study|Lack of Efficacy|1
7103437|NCT02402218|11229915|FG000|Overall Study|Death|1
7103438|NCT02402218|11229916|FG001|Overall Study|Death|0
7103439|NCT02402218|11229917|FG002|Overall Study|Death|0
7103440|NCT02402218|11229915|FG000|Overall Study|Reinfection|0
7103441|NCT02402218|11229916|FG001|Overall Study|Reinfection|0
7103442|NCT02402218|11229917|FG002|Overall Study|Reinfection|1
7103443|NCT02402218|11229915|FG000|Overall Study|Adverse Event|0
7103444|NCT02402218|11229916|FG001|Overall Study|Adverse Event|2
7103445|NCT02402218|11229917|FG002|Overall Study|Adverse Event|1
7103446|NCT02402218|11229915|FG000|Overall Study|Withdrawal by Subject|1
7103447|NCT02402218|11229916|FG001|Overall Study|Withdrawal by Subject|1
7103448|NCT02402218|11229917|FG002|Overall Study|Withdrawal by Subject|1
7103449|NCT02402322|11229937|FG000|Pretreatment|Withdrawal by Subject|3
7103450|NCT02402322|11229938|FG001|Pretreatment|Withdrawal by Subject|1
7103451|NCT02402322|11229939|FG002|Pretreatment|Withdrawal by Subject|1
7103452|NCT02402322|11229937|FG000|Follow-up|Withdrawal by Subject|6
7103453|NCT02402322|11229938|FG001|Follow-up|Withdrawal by Subject|3
7103454|NCT02402322|11229939|FG002|Follow-up|Withdrawal by Subject|24
7103455|NCT02402907|11229971|FG000|Overall Study|Delivered vaginally|9
7103456|NCT02402907|11229972|FG001|Overall Study|Delivered vaginally|3
7103457|NCT02402907|11229971|FG000|Overall Study|Delivered outside of Sinai|1
7103458|NCT02402907|11229972|FG001|Overall Study|Delivered outside of Sinai|1
7103459|NCT02402907|11229971|FG000|Overall Study|Lost to follow up after C-Section|10
7103460|NCT02402907|11229972|FG001|Overall Study|Lost to follow up after C-Section|23
7103461|NCT02402933|11229978|FG000|Overall Study|Withdrawal by Subject|4
7103462|NCT02402933|11229978|FG000|Overall Study|Discontinued; Site Termination|10
7103463|NCT02403180|11229984|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0
7103464|NCT02403180|11229985|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1
7103465|NCT02403180|11229984|FG000|Period 2 (5 Days)|Withdrawal by Subject|0
7103466|NCT02403180|11229985|FG001|Period 2 (5 Days)|Withdrawal by Subject|1
7103467|NCT02403206|11229993|FG000|Overall Study|Lost to Follow-up|4
7103468|NCT02403206|11229994|FG001|Overall Study|Lost to Follow-up|3
7103469|NCT02403206|11229993|FG000|Overall Study|Physician Decision|2
7103470|NCT02403206|11229994|FG001|Overall Study|Physician Decision|0
7103471|NCT02403206|11229993|FG000|Overall Study|Withdrawal by Subject|3
7103472|NCT02403206|11229994|FG001|Overall Study|Withdrawal by Subject|3
7103473|NCT02403206|11229993|FG000|Overall Study|Reason not given|2
7103474|NCT02403206|11229994|FG001|Overall Study|Reason not given|4
7103475|NCT02403271|11230001|FG000|Period 1|Other varied reasons|1
7103476|NCT02403271|11230002|FG001|Period 1|Other varied reasons|0
7103477|NCT02403271|11230001|FG000|Period 2|Withdrawal by Subject|0
7103478|NCT02403271|11230002|FG001|Period 2|Withdrawal by Subject|14
7103479|NCT02403271|11230001|FG000|Period 2|Death|0
7103480|NCT02403271|11230002|FG001|Period 2|Death|84
7103481|NCT02403271|11230001|FG000|Period 2|Lost to Follow-up|0
7103482|NCT02403271|11230002|FG001|Period 2|Lost to Follow-up|2
7103483|NCT02403271|11230001|FG000|Period 2|Study Terminated by Sponsor|0
7103484|NCT02403271|11230002|FG001|Period 2|Study Terminated by Sponsor|14
7103485|NCT02403271|11230001|FG000|Period 2|Other varied reasons|0
7103486|NCT02403271|11230002|FG001|Period 2|Other varied reasons|10
7103487|NCT02403635|11230023|FG000|Overall Study|Not eligible|9
7103488|NCT02403674|11230045|FG000|Overall Study|Adverse Event|10
7103489|NCT02403674|11230046|FG001|Overall Study|Adverse Event|23
7103490|NCT02403674|11230045|FG000|Overall Study|Death|1
7103491|NCT02403674|11230046|FG001|Overall Study|Death|3
7103492|NCT02403674|11230045|FG000|Overall Study|Lack of Efficacy|18
7103493|NCT02403674|11230046|FG001|Overall Study|Lack of Efficacy|10
7103494|NCT02403674|11230045|FG000|Overall Study|Lost to Follow-up|6
7103495|NCT02403674|11230046|FG001|Overall Study|Lost to Follow-up|7
7103496|NCT02403674|11230045|FG000|Overall Study|Noncompliance with study drug|1
7103497|NCT02403674|11230046|FG001|Overall Study|Noncompliance with study drug|2
7103498|NCT02403674|11230045|FG000|Overall Study|Withdrawal by Subject|8
7103499|NCT02403674|11230046|FG001|Overall Study|Withdrawal by Subject|11
7103500|NCT02403674|11230045|FG000|Overall Study|Physician Decision|2
7103501|NCT02403674|11230046|FG001|Overall Study|Physician Decision|2
7103502|NCT02403674|11230045|FG000|Overall Study|Not treated with study drug|4
7103503|NCT02403674|11230046|FG001|Overall Study|Not treated with study drug|2
7103504|NCT02403674|11230045|FG000|Overall Study|Pregnancy|1
7103505|NCT02403674|11230046|FG001|Overall Study|Pregnancy|1
7103506|NCT02403674|11230045|FG000|Overall Study|Protocol Violation|4
7103507|NCT02403674|11230046|FG001|Overall Study|Protocol Violation|2
7103508|NCT02403817|11230063|FG000|Overall Study|Withdrawal by Subject|5
7103509|NCT02403817|11230064|FG001|Overall Study|Withdrawal by Subject|0
7103510|NCT02404025|11230103|FG000|Overall Study|Adverse Event|1
7103511|NCT02404025|11230103|FG000|Overall Study|Lack of Efficacy|3
7103512|NCT02404103|11230109|FG000|Overall Study|Adverse Event|1
7103513|NCT02404103|11230110|FG001|Overall Study|Adverse Event|0
7103514|NCT02404103|11230109|FG000|Overall Study|Lost to Follow-up|3
7103515|NCT02404103|11230110|FG001|Overall Study|Lost to Follow-up|3
7103516|NCT02404220|11230136|FG000|Overall Study|Adverse Event|0
7103517|NCT02404220|11230137|FG001|Overall Study|Adverse Event|0
7103518|NCT02404220|11230138|FG002|Overall Study|Adverse Event|1
7103519|NCT02404220|11230139|FG003|Overall Study|Adverse Event|0
7103520|NCT02404220|11230136|FG000|Overall Study|Death|5
7103521|NCT02404220|11230137|FG001|Overall Study|Death|5
7103522|NCT02404220|11230138|FG002|Overall Study|Death|3
7103523|NCT02404220|11230139|FG003|Overall Study|Death|8
7103524|NCT02404220|11230136|FG000|Overall Study|Progressive Disease|0
7103525|NCT02404220|11230137|FG001|Overall Study|Progressive Disease|0
7103526|NCT02404220|11230138|FG002|Overall Study|Progressive Disease|1
7103527|NCT02404220|11230139|FG003|Overall Study|Progressive Disease|1
7103528|NCT02404220|11230136|FG000|Overall Study|Study Terminated by Sponsor|0
7103529|NCT02404220|11230137|FG001|Overall Study|Study Terminated by Sponsor|0
7103530|NCT02404220|11230138|FG002|Overall Study|Study Terminated by Sponsor|2
7103531|NCT02404220|11230139|FG003|Overall Study|Study Terminated by Sponsor|1
7103532|NCT02404220|11230136|FG000|Overall Study|Withdrawal by Subject|0
7103533|NCT02404220|11230137|FG001|Overall Study|Withdrawal by Subject|1
7103534|NCT02404220|11230138|FG002|Overall Study|Withdrawal by Subject|0
7103535|NCT02404220|11230139|FG003|Overall Study|Withdrawal by Subject|0
7103536|NCT02404220|11230136|FG000|Overall Study|Enrolled but Never Treated|0
7103537|NCT02404220|11230137|FG001|Overall Study|Enrolled but Never Treated|2
7103538|NCT02404220|11230138|FG002|Overall Study|Enrolled but Never Treated|0
7103539|NCT02404220|11230139|FG003|Overall Study|Enrolled but Never Treated|0
7103540|NCT02404311|11230169|FG000|Part A: Month 0-18|Death|2
7103541|NCT02404311|11230170|FG001|Part A: Month 0-18|Death|0
7103542|NCT02404311|11230171|FG002|Part A: Month 0-18|Death|0
7103543|NCT02404311|11230172|FG003|Part A: Month 0-18|Death|0
7103544|NCT02404311|11230173|FG004|Part A: Month 0-18|Death|0
7103545|NCT02404311|11230169|FG000|Part A: Month 0-18|Physician Decision|1
7103546|NCT02404311|11230170|FG001|Part A: Month 0-18|Physician Decision|0
7103547|NCT02404311|11230171|FG002|Part A: Month 0-18|Physician Decision|0
7103548|NCT02404311|11230172|FG003|Part A: Month 0-18|Physician Decision|0
7103549|NCT02404311|11230173|FG004|Part A: Month 0-18|Physician Decision|0
7103550|NCT02404311|11230169|FG000|Part A: Month 0-18|Lost to Follow-up|4
7103551|NCT02404311|11230170|FG001|Part A: Month 0-18|Lost to Follow-up|2
7103552|NCT02404311|11230171|FG002|Part A: Month 0-18|Lost to Follow-up|0
7103553|NCT02404311|11230172|FG003|Part A: Month 0-18|Lost to Follow-up|0
7103554|NCT02404311|11230173|FG004|Part A: Month 0-18|Lost to Follow-up|0
7103555|NCT02404311|11230169|FG000|Part A: Month 0-18|Withdrawal by Subject|6
7103556|NCT02404311|11230170|FG001|Part A: Month 0-18|Withdrawal by Subject|2
7103557|NCT02404311|11230171|FG002|Part A: Month 0-18|Withdrawal by Subject|0
7103558|NCT02404311|11230172|FG003|Part A: Month 0-18|Withdrawal by Subject|0
7103559|NCT02404311|11230173|FG004|Part A: Month 0-18|Withdrawal by Subject|0
7103560|NCT02404311|11230169|FG000|Part A: Month 0-18|HIV Infection|6
7103561|NCT02404311|11230170|FG001|Part A: Month 0-18|HIV Infection|2
7103562|NCT02404311|11230171|FG002|Part A: Month 0-18|HIV Infection|0
7103563|NCT02404311|11230172|FG003|Part A: Month 0-18|HIV Infection|0
7103564|NCT02404311|11230173|FG004|Part A: Month 0-18|HIV Infection|0
7103565|NCT02404311|11230169|FG000|Part A: Month 0-18|Participant unable to adhere|7
7103566|NCT02404311|11230170|FG001|Part A: Month 0-18|Participant unable to adhere|0
7103567|NCT02404311|11230171|FG002|Part A: Month 0-18|Participant unable to adhere|0
7103568|NCT02404311|11230172|FG003|Part A: Month 0-18|Participant unable to adhere|0
7103569|NCT02404311|11230173|FG004|Part A: Month 0-18|Participant unable to adhere|0
7103570|NCT02404350|11230189|FG000|Overall Study|Adverse Event|2
7103571|NCT02404350|11230190|FG001|Overall Study|Adverse Event|2
7103572|NCT02404350|11230191|FG002|Overall Study|Adverse Event|3
7103573|NCT02404350|11230192|FG003|Overall Study|Adverse Event|9
7103574|NCT02404350|11230189|FG000|Overall Study|Lack of Efficacy|3
7103575|NCT02404350|11230190|FG001|Overall Study|Lack of Efficacy|1
7103576|NCT02404350|11230191|FG002|Overall Study|Lack of Efficacy|0
7103577|NCT02404350|11230192|FG003|Overall Study|Lack of Efficacy|3
7103578|NCT02404350|11230189|FG000|Overall Study|Lost to Follow-up|2
7103579|NCT02404350|11230190|FG001|Overall Study|Lost to Follow-up|0
7103580|NCT02404350|11230191|FG002|Overall Study|Lost to Follow-up|0
7103581|NCT02404350|11230192|FG003|Overall Study|Lost to Follow-up|1
7103582|NCT02404350|11230189|FG000|Overall Study|Physician Decision|1
7103583|NCT02404350|11230190|FG001|Overall Study|Physician Decision|0
7103584|NCT02404350|11230191|FG002|Overall Study|Physician Decision|0
7103585|NCT02404350|11230192|FG003|Overall Study|Physician Decision|2
7103586|NCT02404350|11230189|FG000|Overall Study|Pregnancy|0
7103587|NCT02404350|11230190|FG001|Overall Study|Pregnancy|0
7103588|NCT02404350|11230191|FG002|Overall Study|Pregnancy|0
7103589|NCT02404350|11230192|FG003|Overall Study|Pregnancy|1
7103590|NCT02404350|11230189|FG000|Overall Study|Withdrawal by Subject|7
7103591|NCT02404350|11230190|FG001|Overall Study|Withdrawal by Subject|3
7103592|NCT02404350|11230191|FG002|Overall Study|Withdrawal by Subject|3
7103593|NCT02404350|11230192|FG003|Overall Study|Withdrawal by Subject|19
7103594|NCT02404350|11230189|FG000|Overall Study|Due to Non-compliance with treatment|0
7103595|NCT02404350|11230190|FG001|Overall Study|Due to Non-compliance with treatment|0
7103596|NCT02404350|11230191|FG002|Overall Study|Due to Non-compliance with treatment|0
7103597|NCT02404350|11230192|FG003|Overall Study|Due to Non-compliance with treatment|1
7103598|NCT02404350|11230189|FG000|Overall Study|Due to Technical problems|0
7103599|NCT02404350|11230190|FG001|Overall Study|Due to Technical problems|0
7103600|NCT02404350|11230191|FG002|Overall Study|Due to Technical problems|0
7103601|NCT02404350|11230192|FG003|Overall Study|Due to Technical problems|1
7103602|NCT02404389|11230208|FG000|Overall Study|Adverse Event|1
7103603|NCT02404389|11230209|FG001|Overall Study|Adverse Event|0
7103604|NCT02404389|11230210|FG002|Overall Study|Adverse Event|1
7103605|NCT02404389|11230211|FG003|Overall Study|Adverse Event|0
7103606|NCT02404389|11230212|FG004|Overall Study|Adverse Event|2
7103607|NCT02404389|11230208|FG000|Overall Study|Subject/guardian decision|1
7103608|NCT02404389|11230209|FG001|Overall Study|Subject/guardian decision|0
7103609|NCT02404389|11230210|FG002|Overall Study|Subject/guardian decision|0
7103610|NCT02404389|11230211|FG003|Overall Study|Subject/guardian decision|1
7103611|NCT02404389|11230212|FG004|Overall Study|Subject/guardian decision|1
7103612|NCT02404441|11230236|FG000|Phase 1 Part|Adverse Event|1
7103613|NCT02404441|11230237|FG001|Phase 1 Part|Adverse Event|0
7103614|NCT02404441|11230238|FG002|Phase 1 Part|Adverse Event|0
7103615|NCT02404441|11230239|FG003|Phase 1 Part|Adverse Event|0
7103616|NCT02404441|11230240|FG004|Phase 1 Part|Adverse Event|0
7103617|NCT02404441|11230241|FG005|Phase 1 Part|Adverse Event|0
7103618|NCT02404441|11230242|FG006|Phase 1 Part|Adverse Event|0
7103619|NCT02404441|11230243|FG007|Phase 1 Part|Adverse Event|0
7103620|NCT02404441|11230244|FG008|Phase 1 Part|Adverse Event|0
7103621|NCT02404441|11230245|FG009|Phase 1 Part|Adverse Event|0
7103622|NCT02404441|11230236|FG000|Phase 1 Part|Physician Decision|0
7103623|NCT02404441|11230237|FG001|Phase 1 Part|Physician Decision|1
7103624|NCT02404441|11230238|FG002|Phase 1 Part|Physician Decision|0
7103625|NCT02404441|11230239|FG003|Phase 1 Part|Physician Decision|0
7103626|NCT02404441|11230240|FG004|Phase 1 Part|Physician Decision|0
7103627|NCT02404441|11230241|FG005|Phase 1 Part|Physician Decision|0
7103628|NCT02404441|11230242|FG006|Phase 1 Part|Physician Decision|0
7103629|NCT02404441|11230243|FG007|Phase 1 Part|Physician Decision|0
7103630|NCT02404441|11230244|FG008|Phase 1 Part|Physician Decision|0
7103631|NCT02404441|11230245|FG009|Phase 1 Part|Physician Decision|0
7103632|NCT02404441|11230236|FG000|Phase 1 Part|Progressive Disease|14
7103633|NCT02404441|11230237|FG001|Phase 1 Part|Progressive Disease|11
7103634|NCT02404441|11230238|FG002|Phase 1 Part|Progressive Disease|7
7103635|NCT02404441|11230239|FG003|Phase 1 Part|Progressive Disease|6
7103636|NCT02404441|11230240|FG004|Phase 1 Part|Progressive Disease|9
7103637|NCT02404441|11230241|FG005|Phase 1 Part|Progressive Disease|0
7103638|NCT02404441|11230242|FG006|Phase 1 Part|Progressive Disease|0
7103639|NCT02404441|11230243|FG007|Phase 1 Part|Progressive Disease|0
7103640|NCT02404441|11230244|FG008|Phase 1 Part|Progressive Disease|0
7103641|NCT02404441|11230245|FG009|Phase 1 Part|Progressive Disease|0
7103642|NCT02404441|11230236|FG000|Phase 1 Part|Subject/Guardian Decision|0
7103643|NCT02404441|11230237|FG001|Phase 1 Part|Subject/Guardian Decision|2
7103644|NCT02404441|11230238|FG002|Phase 1 Part|Subject/Guardian Decision|3
7103645|NCT02404441|11230239|FG003|Phase 1 Part|Subject/Guardian Decision|0
7103646|NCT02404441|11230240|FG004|Phase 1 Part|Subject/Guardian Decision|0
7103647|NCT02404441|11230241|FG005|Phase 1 Part|Subject/Guardian Decision|0
7103648|NCT02404441|11230242|FG006|Phase 1 Part|Subject/Guardian Decision|0
7103649|NCT02404441|11230243|FG007|Phase 1 Part|Subject/Guardian Decision|0
7103650|NCT02404441|11230244|FG008|Phase 1 Part|Subject/Guardian Decision|0
7103651|NCT02404441|11230245|FG009|Phase 1 Part|Subject/Guardian Decision|0
7103652|NCT02404441|11230236|FG000|Phase 1 Part|Death|1
7103653|NCT02404441|11230237|FG001|Phase 1 Part|Death|1
7103654|NCT02404441|11230238|FG002|Phase 1 Part|Death|1
7103655|NCT02404441|11230239|FG003|Phase 1 Part|Death|0
7103656|NCT02404441|11230240|FG004|Phase 1 Part|Death|1
7103657|NCT02404441|11230241|FG005|Phase 1 Part|Death|0
7103658|NCT02404441|11230242|FG006|Phase 1 Part|Death|0
7103659|NCT02404441|11230243|FG007|Phase 1 Part|Death|0
7103660|NCT02404441|11230244|FG008|Phase 1 Part|Death|0
7103661|NCT02404441|11230245|FG009|Phase 1 Part|Death|0
7103662|NCT02404441|11230236|FG000|Phase 2 Part|Adverse Event|0
7103663|NCT02404441|11230237|FG001|Phase 2 Part|Adverse Event|0
7103664|NCT02404441|11230238|FG002|Phase 2 Part|Adverse Event|0
7103665|NCT02404441|11230239|FG003|Phase 2 Part|Adverse Event|0
7103666|NCT02404441|11230240|FG004|Phase 2 Part|Adverse Event|0
7103667|NCT02404441|11230241|FG005|Phase 2 Part|Adverse Event|2
7103668|NCT02404441|11230242|FG006|Phase 2 Part|Adverse Event|3
7103669|NCT02404441|11230243|FG007|Phase 2 Part|Adverse Event|3
7103670|NCT02404441|11230244|FG008|Phase 2 Part|Adverse Event|6
7103671|NCT02404441|11230245|FG009|Phase 2 Part|Adverse Event|1
7103672|NCT02404441|11230236|FG000|Phase 2 Part|Physician Decision|0
7103673|NCT02404441|11230237|FG001|Phase 2 Part|Physician Decision|0
7103674|NCT02404441|11230238|FG002|Phase 2 Part|Physician Decision|0
7103675|NCT02404441|11230239|FG003|Phase 2 Part|Physician Decision|0
7103676|NCT02404441|11230240|FG004|Phase 2 Part|Physician Decision|0
7103677|NCT02404441|11230241|FG005|Phase 2 Part|Physician Decision|7
7103678|NCT02404441|11230242|FG006|Phase 2 Part|Physician Decision|9
7103679|NCT02404441|11230243|FG007|Phase 2 Part|Physician Decision|2
7103680|NCT02404441|11230244|FG008|Phase 2 Part|Physician Decision|1
7103681|NCT02404441|11230245|FG009|Phase 2 Part|Physician Decision|3
7103682|NCT02404441|11230236|FG000|Phase 2 Part|Progressive disease|0
7103683|NCT02404441|11230237|FG001|Phase 2 Part|Progressive disease|0
7103684|NCT02404441|11230238|FG002|Phase 2 Part|Progressive disease|0
7103685|NCT02404441|11230239|FG003|Phase 2 Part|Progressive disease|0
7103686|NCT02404441|11230240|FG004|Phase 2 Part|Progressive disease|0
7103687|NCT02404441|11230241|FG005|Phase 2 Part|Progressive disease|43
7103688|NCT02404441|11230242|FG006|Phase 2 Part|Progressive disease|32
7103689|NCT02404441|11230243|FG007|Phase 2 Part|Progressive disease|31
7103690|NCT02404441|11230244|FG008|Phase 2 Part|Progressive disease|39
7103691|NCT02404441|11230245|FG009|Phase 2 Part|Progressive disease|27
7103692|NCT02404441|11230236|FG000|Phase 2 Part|Subject/guardian decision|0
7103693|NCT02404441|11230237|FG001|Phase 2 Part|Subject/guardian decision|0
7103694|NCT02404441|11230238|FG002|Phase 2 Part|Subject/guardian decision|0
7103695|NCT02404441|11230239|FG003|Phase 2 Part|Subject/guardian decision|0
7103696|NCT02404441|11230240|FG004|Phase 2 Part|Subject/guardian decision|0
7103697|NCT02404441|11230241|FG005|Phase 2 Part|Subject/guardian decision|3
7103698|NCT02404441|11230242|FG006|Phase 2 Part|Subject/guardian decision|9
7103699|NCT02404441|11230243|FG007|Phase 2 Part|Subject/guardian decision|0
7103700|NCT02404441|11230244|FG008|Phase 2 Part|Subject/guardian decision|3
7103701|NCT02404441|11230245|FG009|Phase 2 Part|Subject/guardian decision|2
7103702|NCT02404441|11230236|FG000|Phase 2 Part|Death|0
7103703|NCT02404441|11230237|FG001|Phase 2 Part|Death|0
7103704|NCT02404441|11230238|FG002|Phase 2 Part|Death|0
7103705|NCT02404441|11230239|FG003|Phase 2 Part|Death|0
7103706|NCT02404441|11230240|FG004|Phase 2 Part|Death|0
7103707|NCT02404441|11230241|FG005|Phase 2 Part|Death|4
7103708|NCT02404441|11230242|FG006|Phase 2 Part|Death|8
7103709|NCT02404441|11230243|FG007|Phase 2 Part|Death|4
7103710|NCT02404441|11230244|FG008|Phase 2 Part|Death|10
7103711|NCT02404441|11230245|FG009|Phase 2 Part|Death|9
7103712|NCT02404493|11230291|FG000|Overall Study|Adverse Event|1
7103713|NCT02404493|11230292|FG001|Overall Study|Adverse Event|1
7103714|NCT02404649|11230318|FG000|Overall Study|Adverse Event|1
7103715|NCT02404649|11230319|FG001|Overall Study|Adverse Event|2
7103716|NCT02404805|11230342|FG000|Overall Study|Withdrawal by Subject|1
7103717|NCT02404805|11230343|FG001|Overall Study|Withdrawal by Subject|0
7103718|NCT02404805|11230344|FG002|Overall Study|Withdrawal by Subject|0
7103719|NCT02404805|11230345|FG003|Overall Study|Withdrawal by Subject|0
7103720|NCT02404805|11230346|FG004|Overall Study|Withdrawal by Subject|0
7103721|NCT02404805|11230347|FG005|Overall Study|Withdrawal by Subject|0
7103722|NCT02405091|11230359|FG000|Overall Study|Adverse Event|16
7103723|NCT02405091|11230360|FG001|Overall Study|Adverse Event|10
7103724|NCT02405091|11230361|FG002|Overall Study|Adverse Event|0
7103725|NCT02405091|11230359|FG000|Overall Study|Protocol Violation|1
7103726|NCT02405091|11230360|FG001|Overall Study|Protocol Violation|0
7103727|NCT02405091|11230361|FG002|Overall Study|Protocol Violation|0
7103728|NCT02405091|11230359|FG000|Overall Study|Noncompliance|1
7103729|NCT02405091|11230360|FG001|Overall Study|Noncompliance|6
7103730|NCT02405091|11230361|FG002|Overall Study|Noncompliance|2
7103731|NCT02405091|11230359|FG000|Overall Study|Withdrawal by Subject|4
7103732|NCT02405091|11230360|FG001|Overall Study|Withdrawal by Subject|8
7103733|NCT02405091|11230361|FG002|Overall Study|Withdrawal by Subject|0
7103734|NCT02405091|11230359|FG000|Overall Study|Death|0
7103735|NCT02405091|11230360|FG001|Overall Study|Death|1
7103736|NCT02405091|11230361|FG002|Overall Study|Death|0
7103737|NCT02405091|11230359|FG000|Overall Study|Lost to Follow-up|5
7103738|NCT02405091|11230360|FG001|Overall Study|Lost to Follow-up|6
7103739|NCT02405091|11230361|FG002|Overall Study|Lost to Follow-up|0
7103740|NCT02405091|11230359|FG000|Overall Study|Physician Decision|2
7103741|NCT02405091|11230360|FG001|Overall Study|Physician Decision|2
7103742|NCT02405091|11230361|FG002|Overall Study|Physician Decision|0
7103743|NCT02405442|11230402|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0
7103744|NCT02405442|11230403|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2
7103745|NCT02405442|11230404|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4
7103746|NCT02405442|11230405|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1
7103747|NCT02405442|11230402|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0
7103748|NCT02405442|11230403|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1
7103749|NCT02405442|11230404|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2
7103750|NCT02405442|11230405|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0
7103751|NCT02405442|11230402|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1
7103752|NCT02405442|11230403|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1
7103753|NCT02405442|11230404|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0
7103754|NCT02405442|11230405|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0
7103755|NCT02405442|11230402|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
7103756|NCT02405442|11230403|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1
7103757|NCT02405442|11230404|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
7103758|NCT02405442|11230405|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
7103759|NCT02405442|11230402|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27
7103760|NCT02405442|11230403|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28
7103761|NCT02405442|11230404|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28
7103762|NCT02405442|11230405|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13
7103763|NCT02405442|11230402|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14
7103764|NCT02405442|11230403|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11
7103765|NCT02405442|11230404|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11
7103766|NCT02405442|11230405|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2
7103767|NCT02405442|11230402|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6
7103768|NCT02405442|11230403|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1
7103769|NCT02405442|11230404|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2
7103770|NCT02405442|11230405|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6
7103771|NCT02405442|11230402|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0
7103772|NCT02405442|11230403|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1
7103773|NCT02405442|11230404|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3
7103774|NCT02405442|11230405|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2
7103775|NCT02405442|11230402|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1
7103776|NCT02405442|11230403|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2
7103777|NCT02405442|11230404|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1
7103778|NCT02405442|11230405|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1
7103779|NCT02405442|11230402|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
7103780|NCT02405442|11230403|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1
7103781|NCT02405442|11230404|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
7103782|NCT02405442|11230405|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
7103783|NCT02405442|11230402|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
7103784|NCT02405442|11230403|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1
7103785|NCT02405442|11230404|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
7103786|NCT02405442|11230405|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
7103787|NCT02405442|11230402|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
7103788|NCT02405442|11230403|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1
7103789|NCT02405442|11230404|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
7103790|NCT02405442|11230405|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
7103791|NCT02405442|11230402|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
7103792|NCT02405442|11230403|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1
7103793|NCT02405442|11230404|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
7103794|NCT02405442|11230405|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
7103795|NCT02405442|11230402|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1
7103796|NCT02405442|11230403|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
7103797|NCT02405442|11230404|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
7103798|NCT02405442|11230405|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
7103799|NCT02405780|11230423|FG000|Period I|Adverse Event|8
7103800|NCT02405780|11230424|FG001|Period I|Adverse Event|0
7103801|NCT02405780|11230425|FG002|Period I|Adverse Event|3
7103802|NCT02405780|11230426|FG003|Period I|Adverse Event|7
7103803|NCT02405780|11230423|FG000|Period I|Medical reasons|1
7103804|NCT02405780|11230424|FG001|Period I|Medical reasons|1
7103805|NCT02405780|11230425|FG002|Period I|Medical reasons|0
7103806|NCT02405780|11230426|FG003|Period I|Medical reasons|1
7103807|NCT02405780|11230423|FG000|Period I|Screening Failure|1
7103808|NCT02405780|11230424|FG001|Period I|Screening Failure|0
7103809|NCT02405780|11230425|FG002|Period I|Screening Failure|1
7103810|NCT02405780|11230426|FG003|Period I|Screening Failure|0
7103811|NCT02405780|11230423|FG000|Period I|Withdrawal by Subject|9
7103812|NCT02405780|11230424|FG001|Period I|Withdrawal by Subject|1
7103813|NCT02405780|11230425|FG002|Period I|Withdrawal by Subject|3
7103814|NCT02405780|11230426|FG003|Period I|Withdrawal by Subject|4
7103815|NCT02405780|11230423|FG000|Period I|Non-compliance with study procedures|8
7103816|NCT02405780|11230424|FG001|Period I|Non-compliance with study procedures|6
7103817|NCT02405780|11230425|FG002|Period I|Non-compliance with study procedures|8
7103818|NCT02405780|11230426|FG003|Period I|Non-compliance with study procedures|11
7103819|NCT02405780|11230423|FG000|Period II|Adverse Event|3
7103820|NCT02405780|11230424|FG001|Period II|Adverse Event|5
7103821|NCT02405780|11230425|FG002|Period II|Adverse Event|4
7103822|NCT02405780|11230426|FG003|Period II|Adverse Event|11
7103823|NCT02405780|11230423|FG000|Period II|Medical reason|0
7103824|NCT02405780|11230424|FG001|Period II|Medical reason|1
7103825|NCT02405780|11230425|FG002|Period II|Medical reason|0
7103826|NCT02405780|11230426|FG003|Period II|Medical reason|0
7103827|NCT02405780|11230423|FG000|Period II|Pregnancy|0
7103828|NCT02405780|11230424|FG001|Period II|Pregnancy|0
7103829|NCT02405780|11230425|FG002|Period II|Pregnancy|1
7103830|NCT02405780|11230426|FG003|Period II|Pregnancy|0
7103831|NCT02405780|11230423|FG000|Period II|Withdrawal by Subject|7
7103832|NCT02405780|11230424|FG001|Period II|Withdrawal by Subject|4
7103833|NCT02405780|11230425|FG002|Period II|Withdrawal by Subject|0
7103834|NCT02405780|11230426|FG003|Period II|Withdrawal by Subject|3
7103835|NCT02405780|11230423|FG000|Period II|Non-compliance with study procedures|5
7103836|NCT02405780|11230424|FG001|Period II|Non-compliance with study procedures|2
7103837|NCT02405780|11230425|FG002|Period II|Non-compliance with study procedures|7
7103838|NCT02405780|11230426|FG003|Period II|Non-compliance with study procedures|4
7103839|NCT02405962|11230453|FG000|Overall Study|Lost to Follow-up|1
7103840|NCT02405962|11230454|FG001|Overall Study|Lost to Follow-up|4
7103841|NCT02405962|11230453|FG000|Overall Study|A participant has moved to another place|0
7103842|NCT02405962|11230454|FG001|Overall Study|A participant has moved to another place|1
7103843|NCT02406248|11230460|FG000|Overall Study|Death|7
7103844|NCT02406248|11230460|FG000|Overall Study|Withdrawal by Subject|2
7103845|NCT02406261|11230466|FG000|Period 1|Lost to Follow-up|2
7103846|NCT02406261|11230467|FG001|Period 1|Lost to Follow-up|0
7103847|NCT02406261|11230466|FG000|Period 1|Adverse Event|1
7103848|NCT02406261|11230467|FG001|Period 1|Adverse Event|0
7103849|NCT02406261|11230466|FG000|Period 2|Physician Decision|0
7103850|NCT02406261|11230467|FG001|Period 2|Physician Decision|1
7103851|NCT02406261|11230466|FG000|Period 2|Protocol Violation|0
7103852|NCT02406261|11230467|FG001|Period 2|Protocol Violation|1
7103853|NCT02406261|11230466|FG000|Period 2|Withdrawal by Subject|0
7103854|NCT02406261|11230467|FG001|Period 2|Withdrawal by Subject|1
7103855|NCT02406586|11230503|FG000|Overall Study|Lost to Follow-up|0
7103856|NCT02406586|11230504|FG001|Overall Study|Lost to Follow-up|4
7103857|NCT02406586|11230505|FG002|Overall Study|Lost to Follow-up|2
7103858|NCT02406586|11230503|FG000|Overall Study|Withdrawal by Subject|1
7103859|NCT02406586|11230504|FG001|Overall Study|Withdrawal by Subject|0
7103860|NCT02406586|11230505|FG002|Overall Study|Withdrawal by Subject|0
7103861|NCT02406612|11230518|FG000|Overall Study|Screening Failure|3
7103862|NCT02406612|11230519|FG001|Overall Study|Screening Failure|0
7103863|NCT02406612|11230518|FG000|Overall Study|Intra-procedural Exclusion|1
7103864|NCT02406612|11230519|FG001|Overall Study|Intra-procedural Exclusion|3
7103865|NCT02406612|11230518|FG000|Overall Study|Guidewire Failure|0
7103866|NCT02406612|11230519|FG001|Overall Study|Guidewire Failure|1
7103867|NCT02406651|11230525|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3
7103868|NCT02406677|11230532|FG000|Overall Study|Death|16
7103869|NCT02406677|11230533|FG001|Overall Study|Death|8
7103870|NCT02406677|11230532|FG000|Overall Study|Discharged without P2Y12|1
7103871|NCT02406677|11230533|FG001|Overall Study|Discharged without P2Y12|3
7103872|NCT02406677|11230532|FG000|Overall Study|Discharged on prasugrel|283
7103873|NCT02406677|11230533|FG001|Overall Study|Discharged on prasugrel|587
7103874|NCT02406677|11230532|FG000|Overall Study|Withdrawal by Subject|1
7103875|NCT02406677|11230533|FG001|Overall Study|Withdrawal by Subject|0
7103876|NCT02406742|11230546|FG000|Overall Study|Progression of Disease|5
7103877|NCT02406742|11230547|FG001|Overall Study|Progression of Disease|1
7103878|NCT02406742|11230548|FG002|Overall Study|Progression of Disease|6
7103879|NCT02406742|11230546|FG000|Overall Study|Adverse Event|3
7103880|NCT02406742|11230547|FG001|Overall Study|Adverse Event|0
7103881|NCT02406742|11230548|FG002|Overall Study|Adverse Event|2
7103882|NCT02406742|11230546|FG000|Overall Study|Death|1
7103883|NCT02406742|11230547|FG001|Overall Study|Death|0
7103884|NCT02406742|11230548|FG002|Overall Study|Death|0
7103885|NCT02406742|11230546|FG000|Overall Study|Lack of Efficacy|0
7103886|NCT02406742|11230547|FG001|Overall Study|Lack of Efficacy|0
7103887|NCT02406742|11230548|FG002|Overall Study|Lack of Efficacy|1
7103888|NCT02406742|11230546|FG000|Overall Study|Withdrawal by Participant|1
7103889|NCT02406742|11230547|FG001|Overall Study|Withdrawal by Participant|2
7103890|NCT02406742|11230548|FG002|Overall Study|Withdrawal by Participant|0
7103891|NCT02406742|11230546|FG000|Overall Study|Physician Decision|1
7103892|NCT02406742|11230547|FG001|Overall Study|Physician Decision|2
7103893|NCT02406742|11230548|FG002|Overall Study|Physician Decision|1
7103894|NCT02406742|11230546|FG000|Overall Study|Transition to other treatment|2
7103895|NCT02406742|11230547|FG001|Overall Study|Transition to other treatment|0
7103896|NCT02406742|11230548|FG002|Overall Study|Transition to other treatment|1
7103897|NCT02406742|11230546|FG000|Overall Study|Other Reasons|1
7103898|NCT02406742|11230547|FG001|Overall Study|Other Reasons|11
7103899|NCT02406742|11230548|FG002|Overall Study|Other Reasons|5
7103900|NCT02407054|11230610|FG000|Overall Study|Adverse Event|1
7103901|NCT02407054|11230611|FG001|Overall Study|Adverse Event|4
7103902|NCT02407054|11230612|FG002|Overall Study|Adverse Event|1
7103903|NCT02407054|11230610|FG000|Overall Study|Non-compliance with Study|0
7103904|NCT02407054|11230611|FG001|Overall Study|Non-compliance with Study|2
7103905|NCT02407054|11230612|FG002|Overall Study|Non-compliance with Study|1
7103906|NCT02407054|11230610|FG000|Overall Study|Physician Decision|1
7103907|NCT02407054|11230611|FG001|Overall Study|Physician Decision|3
7103908|NCT02407054|11230612|FG002|Overall Study|Physician Decision|3
7103909|NCT02407054|11230610|FG000|Overall Study|Withdrawal by Subject|5
7103910|NCT02407054|11230611|FG001|Overall Study|Withdrawal by Subject|9
7103911|NCT02407054|11230612|FG002|Overall Study|Withdrawal by Subject|2
7103912|NCT02407223|11230633|FG000|Overall Study|Adverse Event|1
7103913|NCT02407223|11230634|FG001|Overall Study|Adverse Event|0
7103914|NCT02407223|11230635|FG002|Overall Study|Adverse Event|1
7103915|NCT02407223|11230633|FG000|Overall Study|Lack of Efficacy|6
7103916|NCT02407223|11230634|FG001|Overall Study|Lack of Efficacy|6
7103917|NCT02407223|11230635|FG002|Overall Study|Lack of Efficacy|4
7103918|NCT02407223|11230633|FG000|Overall Study|Lost to Follow-up|1
7103919|NCT02407223|11230634|FG001|Overall Study|Lost to Follow-up|0
7103920|NCT02407223|11230635|FG002|Overall Study|Lost to Follow-up|2
7103921|NCT02407223|11230633|FG000|Overall Study|Withdrawal by Subject|2
7103922|NCT02407223|11230634|FG001|Overall Study|Withdrawal by Subject|4
7103923|NCT02407223|11230635|FG002|Overall Study|Withdrawal by Subject|4
7103924|NCT02407223|11230633|FG000|Overall Study|Study Terminated by Sponsor|77
7103925|NCT02407223|11230634|FG001|Overall Study|Study Terminated by Sponsor|80
7103926|NCT02407223|11230635|FG002|Overall Study|Study Terminated by Sponsor|86
7103927|NCT02407223|11230633|FG000|Overall Study|Subject Refused Further Study Treatment|0
7103928|NCT02407223|11230634|FG001|Overall Study|Subject Refused Further Study Treatment|1
7103929|NCT02407223|11230635|FG002|Overall Study|Subject Refused Further Study Treatment|0
7103930|NCT02407223|11230633|FG000|Overall Study|Other|29
7103931|NCT02407223|11230634|FG001|Overall Study|Other|27
7103932|NCT02407223|11230635|FG002|Overall Study|Other|25
7103933|NCT02407249|11230645|FG000|Overall Study|Did not complete 12-month follow-up|13
7103934|NCT02407249|11230645|FG000|Overall Study|Not treated|13
7103935|NCT02407457|11230651|FG000|1 Month|Death|3
7103936|NCT02407457|11230652|FG001|1 Month|Death|0
7103937|NCT02407457|11230651|FG000|1 Month|Lost to Follow-up|1
7103938|NCT02407457|11230652|FG001|1 Month|Lost to Follow-up|1
7103939|NCT02407457|11230651|FG000|1 Month|missed visit|2
7103940|NCT02407457|11230652|FG001|1 Month|missed visit|6
7103941|NCT02407457|11230651|FG000|6-Month|Death|2
7103942|NCT02407457|11230652|FG001|6-Month|Death|8
7103943|NCT02407457|11230651|FG000|6-Month|Lost to Follow-up|2
7103944|NCT02407457|11230652|FG001|6-Month|Lost to Follow-up|2
7103945|NCT02407457|11230651|FG000|6-Month|missed visit|15
7103946|NCT02407457|11230652|FG001|6-Month|missed visit|12
7103947|NCT02407457|11230651|FG000|6-Month|Over Due|1
7103948|NCT02407457|11230652|FG001|6-Month|Over Due|2
7103949|NCT02407457|11230651|FG000|6-Month|Open Repair|0
7103950|NCT02407457|11230652|FG001|6-Month|Open Repair|1
7103951|NCT02407457|11230651|FG000|1 Year|Death|6
7103952|NCT02407457|11230652|FG001|1 Year|Death|11
7103953|NCT02407457|11230651|FG000|1 Year|Lost to Follow-up|3
7103954|NCT02407457|11230652|FG001|1 Year|Lost to Follow-up|2
7103955|NCT02407457|11230651|FG000|1 Year|Missed Visit|18
7103956|NCT02407457|11230652|FG001|1 Year|Missed Visit|10
7103957|NCT02407457|11230651|FG000|1 Year|Over Due|6
7103958|NCT02407457|11230652|FG001|1 Year|Over Due|4
7103959|NCT02407457|11230651|FG000|1 Year|Open Repair|0
7103960|NCT02407457|11230652|FG001|1 Year|Open Repair|1
7103961|NCT02407457|11230651|FG000|2-year|Death|14
7103962|NCT02407457|11230652|FG001|2-year|Death|8
7103963|NCT02407457|11230651|FG000|2-year|Lost to Follow-up|6
7103964|NCT02407457|11230652|FG001|2-year|Lost to Follow-up|9
7103965|NCT02407457|11230651|FG000|2-year|Missed Visit|13
7103966|NCT02407457|11230652|FG001|2-year|Missed Visit|11
7103967|NCT02407457|11230651|FG000|2-year|Over Due|1
7103968|NCT02407457|11230652|FG001|2-year|Over Due|5
7103969|NCT02407457|11230651|FG000|2-year|Open Repair|0
7103970|NCT02407457|11230652|FG001|2-year|Open Repair|2
7103971|NCT02407457|11230651|FG000|3-year|Death|11
7103972|NCT02407457|11230652|FG001|3-year|Death|10
7103973|NCT02407457|11230651|FG000|3-year|Lost to Follow-up|6
7103974|NCT02407457|11230652|FG001|3-year|Lost to Follow-up|9
7103975|NCT02407457|11230651|FG000|3-year|Missed Visit|21
7103976|NCT02407457|11230652|FG001|3-year|Missed Visit|16
7103977|NCT02407457|11230651|FG000|3-year|Over Due|4
7103978|NCT02407457|11230652|FG001|3-year|Over Due|3
7103979|NCT02407457|11230651|FG000|4-year|Death|14
7103980|NCT02407457|11230652|FG001|4-year|Death|7
7103981|NCT02407457|11230651|FG000|4-year|Lost to Follow-up|9
7103982|NCT02407457|11230652|FG001|4-year|Lost to Follow-up|12
7103983|NCT02407457|11230651|FG000|4-year|Over Due|10
7103984|NCT02407457|11230652|FG001|4-year|Over Due|5
7103985|NCT02407457|11230651|FG000|4-year|Missed Visit|13
7103986|NCT02407457|11230652|FG001|4-year|Missed Visit|13
7103987|NCT02407457|11230651|FG000|4-year|Pending visit|19
7103988|NCT02407457|11230652|FG001|4-year|Pending visit|14
7103989|NCT02407457|11230651|FG000|4-year|Not Due|16
7103990|NCT02407457|11230652|FG001|4-year|Not Due|10
7103991|NCT02407457|11230651|FG000|5-year|Death|6
7103992|NCT02407457|11230652|FG001|5-year|Death|1
7103993|NCT02407457|11230651|FG000|5-year|Lost to Follow-up|4
7103994|NCT02407457|11230652|FG001|5-year|Lost to Follow-up|4
7103995|NCT02407457|11230651|FG000|5-year|Missed Visit|10
7103996|NCT02407457|11230652|FG001|5-year|Missed Visit|9
7103997|NCT02407457|11230651|FG000|5-year|Pending Visit|18
7103998|NCT02407457|11230652|FG001|5-year|Pending Visit|17
7103999|NCT02407457|11230651|FG000|5-year|Not Due|54
7104000|NCT02407457|11230652|FG001|5-year|Not Due|46
7104001|NCT02407704|11230662|FG000|Overall Study|Lost to Follow-up|0
7104002|NCT02407704|11230663|FG001|Overall Study|Lost to Follow-up|0
7104003|NCT02407704|11230664|FG002|Overall Study|Lost to Follow-up|0
7104004|NCT02407704|11230665|FG003|Overall Study|Lost to Follow-up|2
7104005|NCT02407704|11230662|FG000|Overall Study|Protocol Violation|0
7104006|NCT02407704|11230663|FG001|Overall Study|Protocol Violation|0
7104007|NCT02407704|11230664|FG002|Overall Study|Protocol Violation|0
7104008|NCT02407704|11230665|FG003|Overall Study|Protocol Violation|1
7104009|NCT02407704|11230662|FG000|Overall Study|Withdrawal by Subject|0
7104010|NCT02407704|11230663|FG001|Overall Study|Withdrawal by Subject|0
7104011|NCT02407704|11230664|FG002|Overall Study|Withdrawal by Subject|1
7104012|NCT02407704|11230665|FG003|Overall Study|Withdrawal by Subject|0
7104013|NCT02407990|11230704|FG000|Overall Study|Death|2
7104014|NCT02407990|11230705|FG001|Overall Study|Death|22
7104015|NCT02407990|11230706|FG002|Overall Study|Death|23
7104016|NCT02407990|11230707|FG003|Overall Study|Death|7
7104017|NCT02407990|11230708|FG004|Overall Study|Death|17
7104018|NCT02407990|11230709|FG005|Overall Study|Death|16
7104019|NCT02407990|11230710|FG006|Overall Study|Death|10
7104020|NCT02407990|11230711|FG007|Overall Study|Death|248
7104021|NCT02407990|11230704|FG000|Overall Study|Lost to Follow-up|0
7104022|NCT02407990|11230705|FG001|Overall Study|Lost to Follow-up|1
7104023|NCT02407990|11230706|FG002|Overall Study|Lost to Follow-up|0
7104024|NCT02407990|11230707|FG003|Overall Study|Lost to Follow-up|0
7104025|NCT02407990|11230708|FG004|Overall Study|Lost to Follow-up|0
7104026|NCT02407990|11230709|FG005|Overall Study|Lost to Follow-up|0
7104027|NCT02407990|11230710|FG006|Overall Study|Lost to Follow-up|0
7104028|NCT02407990|11230711|FG007|Overall Study|Lost to Follow-up|17
7104029|NCT02407990|11230704|FG000|Overall Study|Progressive Disease|0
7104030|NCT02407990|11230705|FG001|Overall Study|Progressive Disease|0
7104031|NCT02407990|11230706|FG002|Overall Study|Progressive Disease|0
7104032|NCT02407990|11230707|FG003|Overall Study|Progressive Disease|0
7104033|NCT02407990|11230708|FG004|Overall Study|Progressive Disease|0
7104034|NCT02407990|11230709|FG005|Overall Study|Progressive Disease|0
7104035|NCT02407990|11230710|FG006|Overall Study|Progressive Disease|0
7104036|NCT02407990|11230711|FG007|Overall Study|Progressive Disease|1
7104037|NCT02407990|11230704|FG000|Overall Study|Withdrawal by Subject|0
7104038|NCT02407990|11230705|FG001|Overall Study|Withdrawal by Subject|0
7104039|NCT02407990|11230706|FG002|Overall Study|Withdrawal by Subject|0
7104040|NCT02407990|11230707|FG003|Overall Study|Withdrawal by Subject|0
7104041|NCT02407990|11230708|FG004|Overall Study|Withdrawal by Subject|1
7104042|NCT02407990|11230709|FG005|Overall Study|Withdrawal by Subject|0
7104043|NCT02407990|11230710|FG006|Overall Study|Withdrawal by Subject|0
7104044|NCT02407990|11230711|FG007|Overall Study|Withdrawal by Subject|30
7104045|NCT02407990|11230704|FG000|Overall Study|Study Terminated by Sponsor|1
7104046|NCT02407990|11230705|FG001|Overall Study|Study Terminated by Sponsor|3
7104047|NCT02407990|11230706|FG002|Overall Study|Study Terminated by Sponsor|3
7104048|NCT02407990|11230707|FG003|Overall Study|Study Terminated by Sponsor|0
7104049|NCT02407990|11230708|FG004|Overall Study|Study Terminated by Sponsor|3
7104050|NCT02407990|11230709|FG005|Overall Study|Study Terminated by Sponsor|4
7104051|NCT02407990|11230710|FG006|Overall Study|Study Terminated by Sponsor|3
7104052|NCT02407990|11230711|FG007|Overall Study|Study Terminated by Sponsor|37
7104053|NCT02407990|11230704|FG000|Overall Study|Logistics|0
7104054|NCT02407990|11230705|FG001|Overall Study|Logistics|0
7104055|NCT02407990|11230706|FG002|Overall Study|Logistics|0
7104056|NCT02407990|11230707|FG003|Overall Study|Logistics|0
7104057|NCT02407990|11230708|FG004|Overall Study|Logistics|0
7104058|NCT02407990|11230709|FG005|Overall Study|Logistics|0
7104059|NCT02407990|11230710|FG006|Overall Study|Logistics|0
7104060|NCT02407990|11230711|FG007|Overall Study|Logistics|1
7104061|NCT02407990|11230704|FG000|Overall Study|Rolled into long-term extension study|0
7104062|NCT02407990|11230705|FG001|Overall Study|Rolled into long-term extension study|0
7104063|NCT02407990|11230706|FG002|Overall Study|Rolled into long-term extension study|0
7104064|NCT02407990|11230707|FG003|Overall Study|Rolled into long-term extension study|0
7104065|NCT02407990|11230708|FG004|Overall Study|Rolled into long-term extension study|0
7104066|NCT02407990|11230709|FG005|Overall Study|Rolled into long-term extension study|0
7104067|NCT02407990|11230710|FG006|Overall Study|Rolled into long-term extension study|0
7104068|NCT02407990|11230711|FG007|Overall Study|Rolled into long-term extension study|1
7104069|NCT02408016|11230738|FG000|Overall Study|Death|6
7104070|NCT02408016|11230739|FG001|Overall Study|Death|1
7104071|NCT02408016|11230740|FG002|Overall Study|Death|0
7104072|NCT02408016|11230738|FG000|Overall Study|Physician Decision|0
7104073|NCT02408016|11230739|FG001|Overall Study|Physician Decision|2
7104074|NCT02408016|11230740|FG002|Overall Study|Physician Decision|0
7104075|NCT02408120|11230750|FG000|Overall Study|Withdrawal by Subject|0
7104076|NCT02408120|11230751|FG001|Overall Study|Withdrawal by Subject|1
7104077|NCT02408120|11230750|FG000|Overall Study|Treatment Refusal|1
7104078|NCT02408120|11230751|FG001|Overall Study|Treatment Refusal|0
7104079|NCT02408120|11230750|FG000|Overall Study|Received Steroids|1
7104080|NCT02408120|11230751|FG001|Overall Study|Received Steroids|1
7104081|NCT02408120|11230750|FG000|Overall Study|Discharged same day|1
7104082|NCT02408120|11230751|FG001|Overall Study|Discharged same day|1
7104083|NCT02408120|11230750|FG000|Overall Study|Did not receive insulin|1
7104084|NCT02408120|11230751|FG001|Overall Study|Did not receive insulin|2
7104085|NCT02408484|11230780|FG000|Overall Study|Withdrawal by Subject|3
7104086|NCT02408484|11230780|FG000|Overall Study|Not treated during study period|1
7104087|NCT02408523|11230802|FG000|Overall Study|Adverse Event|4
7104088|NCT02408523|11230803|FG001|Overall Study|Adverse Event|10
7104089|NCT02408523|11230802|FG000|Overall Study|Lack of Efficacy|0
7104090|NCT02408523|11230803|FG001|Overall Study|Lack of Efficacy|1
7104091|NCT02408523|11230802|FG000|Overall Study|Protocol Violation|1
7104092|NCT02408523|11230803|FG001|Overall Study|Protocol Violation|2
7104093|NCT02408523|11230802|FG000|Overall Study|Lost to Follow-up|2
7104094|NCT02408523|11230803|FG001|Overall Study|Lost to Follow-up|3
7104095|NCT02408523|11230802|FG000|Overall Study|Withdrawal by Subject|3
7104096|NCT02408523|11230803|FG001|Overall Study|Withdrawal by Subject|1
7104097|NCT02408523|11230802|FG000|Overall Study|Sponsor request|1
7104098|NCT02408523|11230803|FG001|Overall Study|Sponsor request|0
7104099|NCT02408523|11230802|FG000|Overall Study|Did not satisfy extension conditions|0
7104100|NCT02408523|11230803|FG001|Overall Study|Did not satisfy extension conditions|1
7104101|NCT02409667|11230896|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6
7104102|NCT02409667|11230897|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
7104103|NCT02409667|11230898|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
7104104|NCT02409667|11230899|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
7104105|NCT02409667|11230900|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
7104106|NCT02409667|11230896|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6
7104107|NCT02409667|11230897|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
7104108|NCT02409667|11230898|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
7104109|NCT02409667|11230899|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
7104110|NCT02409667|11230900|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
7104111|NCT02409667|11230896|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20
7104112|NCT02409667|11230897|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
7104113|NCT02409667|11230898|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
7104114|NCT02409667|11230899|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
7104115|NCT02409667|11230900|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
7104116|NCT02409667|11230896|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1
7104117|NCT02409667|11230897|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0
7104118|NCT02409667|11230898|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0
7104119|NCT02409667|11230899|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0
7104120|NCT02409667|11230900|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0
7104121|NCT02409667|11230896|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4
7104122|NCT02409667|11230897|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0
7104123|NCT02409667|11230898|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0
7104124|NCT02409667|11230899|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0
7104125|NCT02409667|11230900|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0
7104126|NCT02409667|11230896|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5
7104127|NCT02409667|11230897|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
7104128|NCT02409667|11230898|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
7104129|NCT02409667|11230899|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
7104130|NCT02409667|11230900|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
7104131|NCT02409667|11230896|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6
7104132|NCT02409667|11230897|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
7104133|NCT02409667|11230898|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
7104134|NCT02409667|11230899|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
7104135|NCT02409667|11230900|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
7104136|NCT02409667|11230896|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48
7104137|NCT02409667|11230897|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
7104138|NCT02409667|11230898|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
7104139|NCT02409667|11230899|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
7104140|NCT02409667|11230900|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
7104141|NCT02409667|11230896|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25
7104142|NCT02409667|11230897|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0
7104143|NCT02409667|11230898|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0
7104144|NCT02409667|11230899|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0
7104145|NCT02409667|11230900|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0
7104146|NCT02409667|11230896|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0
7104147|NCT02409667|11230897|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7
7104148|NCT02409667|11230898|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4
7104149|NCT02409667|11230899|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3
7104150|NCT02409667|11230900|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0
7104151|NCT02409667|11230896|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
7104152|NCT02409667|11230897|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
7104153|NCT02409667|11230898|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
7104154|NCT02409667|11230899|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2
7104155|NCT02409667|11230900|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
7104156|NCT02409667|11230896|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0
7104157|NCT02409667|11230897|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7
7104158|NCT02409667|11230898|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4
7104159|NCT02409667|11230899|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1
7104160|NCT02409667|11230900|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2
7104161|NCT02409667|11230896|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
7104162|NCT02409667|11230897|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5
7104163|NCT02409667|11230898|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4
7104164|NCT02409667|11230899|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
7104165|NCT02409667|11230900|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
7104166|NCT02409667|11230896|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0
7104167|NCT02409667|11230897|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4
7104168|NCT02409667|11230898|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5
7104169|NCT02409667|11230899|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2
7104170|NCT02409667|11230900|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0
7104171|NCT02409667|11230896|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
7104172|NCT02409667|11230897|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
7104173|NCT02409667|11230898|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1
7104174|NCT02409667|11230899|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
7104175|NCT02409667|11230900|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1
7104176|NCT02409667|11230896|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
7104177|NCT02409667|11230897|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
7104178|NCT02409667|11230898|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3
7104179|NCT02409667|11230899|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
7104180|NCT02409667|11230900|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
7104181|NCT02409680|11230913|FG000|Overall Study|Lost to Follow-up|15
7104182|NCT02409680|11230914|FG001|Overall Study|Lost to Follow-up|30
7104183|NCT02409719|11230922|FG000|Overall Study|Lost to Follow-up|3
7104184|NCT02409719|11230923|FG001|Overall Study|Lost to Follow-up|3
7104185|NCT02409732|11230929|FG000|Overall Study|Withdrawal by Subject|4
7104186|NCT02409732|11230929|FG000|Overall Study|Lost to Follow-up|2
7104187|NCT02410200|11230965|FG000|Overall Study|Adverse Event|2
7104188|NCT02410252|11230976|FG000|Overall Study|Withdrawal by Subject|4
7104189|NCT02410252|11230976|FG000|Overall Study|Physician Decision|2
7104190|NCT02410278|11230984|FG000|Run-in Period|Adverse Event|5
7104191|NCT02410278|11230985|FG001|Run-in Period|Adverse Event|0
7104192|NCT02410278|11230986|FG002|Run-in Period|Adverse Event|0
7104193|NCT02410278|11230984|FG000|Run-in Period|GSRS Threshold Not Met|30
7104194|NCT02410278|11230985|FG001|Run-in Period|GSRS Threshold Not Met|0
7104195|NCT02410278|11230986|FG002|Run-in Period|GSRS Threshold Not Met|0
7104196|NCT02410278|11230984|FG000|Run-in Period|Lost to Follow-up|1
7104197|NCT02410278|11230985|FG001|Run-in Period|Lost to Follow-up|0
7104198|NCT02410278|11230986|FG002|Run-in Period|Lost to Follow-up|0
7104199|NCT02410278|11230984|FG000|Run-in Period|Withdrawal by Subject|1
7104200|NCT02410278|11230985|FG001|Run-in Period|Withdrawal by Subject|0
7104201|NCT02410278|11230986|FG002|Run-in Period|Withdrawal by Subject|0
7104202|NCT02410278|11230984|FG000|Run-in Period|Pregnancy|1
7104203|NCT02410278|11230985|FG001|Run-in Period|Pregnancy|0
7104204|NCT02410278|11230986|FG002|Run-in Period|Pregnancy|0
7104205|NCT02410278|11230984|FG000|Study Treatment Period|Adverse Event|0
7104206|NCT02410278|11230985|FG001|Study Treatment Period|Adverse Event|6
7104207|NCT02410278|11230986|FG002|Study Treatment Period|Adverse Event|3
7104208|NCT02410278|11230984|FG000|Study Treatment Period|Physician Decision|0
7104209|NCT02410278|11230985|FG001|Study Treatment Period|Physician Decision|0
7104210|NCT02410278|11230986|FG002|Study Treatment Period|Physician Decision|1
7104211|NCT02410278|11230984|FG000|Study Treatment Period|Withdrawal by Subject|0
7104212|NCT02410278|11230985|FG001|Study Treatment Period|Withdrawal by Subject|1
7104213|NCT02410278|11230986|FG002|Study Treatment Period|Withdrawal by Subject|0
7104214|NCT02410278|11230984|FG000|Study Treatment Period|Other|0
7104215|NCT02410278|11230985|FG001|Study Treatment Period|Other|3
7104216|NCT02410278|11230986|FG002|Study Treatment Period|Other|0
7104217|NCT02410278|11230984|FG000|Study Treatment Period|GSRS Threshold Not Met|0
7104218|NCT02410278|11230985|FG001|Study Treatment Period|GSRS Threshold Not Met|1
7104219|NCT02410278|11230986|FG002|Study Treatment Period|GSRS Threshold Not Met|0
7104220|NCT02410629|11231013|FG000|Overall Study|Family cannot commit to the study|2
7104221|NCT02410629|11231014|FG001|Overall Study|Family cannot commit to the study|1
7104222|NCT02410629|11231013|FG000|Overall Study|Subject returned to work|1
7104223|NCT02410629|11231014|FG001|Overall Study|Subject returned to work|0
7104224|NCT02410629|11231013|FG000|Overall Study|Subject moved back to home country|0
7104225|NCT02410629|11231014|FG001|Overall Study|Subject moved back to home country|1
7104226|NCT02410629|11231013|FG000|Overall Study|Subject underwent heart surgery|0
7104227|NCT02410629|11231014|FG001|Overall Study|Subject underwent heart surgery|1
7104228|NCT02410772|11231029|FG000|Overall Study|Death|3
7104229|NCT02410772|11231030|FG001|Overall Study|Death|4
7104230|NCT02410772|11231031|FG002|Overall Study|Death|8
7104231|NCT02410772|11231029|FG000|Overall Study|Lost to Follow-up|31
7104232|NCT02410772|11231030|FG001|Overall Study|Lost to Follow-up|23
7104233|NCT02410772|11231031|FG002|Overall Study|Lost to Follow-up|22
7104234|NCT02410772|11231029|FG000|Overall Study|Pregnancy|8
7104235|NCT02410772|11231030|FG001|Overall Study|Pregnancy|4
7104236|NCT02410772|11231031|FG002|Overall Study|Pregnancy|5
7104237|NCT02410772|11231029|FG000|Overall Study|Protocol Violation|8
7104238|NCT02410772|11231030|FG001|Overall Study|Protocol Violation|8
7104239|NCT02410772|11231031|FG002|Overall Study|Protocol Violation|4
7104240|NCT02410772|11231029|FG000|Overall Study|Baseline Drug Resistance|49
7104241|NCT02410772|11231030|FG001|Overall Study|Baseline Drug Resistance|40
7104242|NCT02410772|11231031|FG002|Overall Study|Baseline Drug Resistance|51
7104243|NCT02410772|11231029|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4
7104244|NCT02410772|11231030|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6
7104245|NCT02410772|11231031|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3
7104246|NCT02410772|11231029|FG000|Overall Study|Reinfection with a new strain of MTB|0
7104247|NCT02410772|11231030|FG001|Overall Study|Reinfection with a new strain of MTB|1
7104248|NCT02410772|11231031|FG002|Overall Study|Reinfection with a new strain of MTB|0
7104249|NCT02410811|11231048|FG000|Overall Study|Withdrawal by Subject|0
7104250|NCT02410811|11231049|FG001|Overall Study|Withdrawal by Subject|0
7104251|NCT02410811|11231050|FG002|Overall Study|Withdrawal by Subject|1
7104252|NCT02410811|11231051|FG003|Overall Study|Withdrawal by Subject|0
7104253|NCT02410824|11231061|FG000|First Intervention (One Week)|Headache|0
7104254|NCT02410824|11231062|FG001|First Intervention (One Week)|Headache|1
7104255|NCT02410837|11231069|FG000|Overall Study|Death|387
7104256|NCT02410837|11231069|FG000|Overall Study|Lost to Follow-up|50
7104257|NCT02410837|11231069|FG000|Overall Study|Withdrawal by Subject|44
7104258|NCT02410837|11231069|FG000|Overall Study|Physician Decision|6
7104259|NCT02410837|11231069|FG000|Overall Study|Moved to nursing home, cannot communicat|1
7104260|NCT02411084|11231084|FG000|Overall Study|Lack of Efficacy|6
7104261|NCT02411084|11231085|FG001|Overall Study|Lack of Efficacy|3
7104262|NCT02411084|11231084|FG000|Overall Study|Death|5
7104263|NCT02411084|11231085|FG001|Overall Study|Death|4
7104264|NCT02411084|11231084|FG000|Overall Study|Adverse Event|2
7104265|NCT02411084|11231085|FG001|Overall Study|Adverse Event|1
7104266|NCT02411084|11231084|FG000|Overall Study|Other reasons|0
7104267|NCT02411084|11231085|FG001|Overall Study|Other reasons|5
7104268|NCT02411110|11231093|FG000|Treatment Period 1|Adverse Event|4
7104269|NCT02411110|11231094|FG001|Treatment Period 1|Adverse Event|2
7104270|NCT02411110|11231093|FG000|Treatment Period 1|Lost to Follow-up|1
7104271|NCT02411110|11231094|FG001|Treatment Period 1|Lost to Follow-up|0
7104272|NCT02411110|11231093|FG000|Treatment Period 1|Personal Reasons|2
7104273|NCT02411110|11231094|FG001|Treatment Period 1|Personal Reasons|5
7104274|NCT02411110|11231093|FG000|Treatment Period 1|Other Miscellaneous Reasons|2
7104275|NCT02411110|11231094|FG001|Treatment Period 1|Other Miscellaneous Reasons|0
7104276|NCT02411110|11231093|FG000|Treatment Period 2|Adverse Event|1
7104277|NCT02411110|11231094|FG001|Treatment Period 2|Adverse Event|0
7104278|NCT02411110|11231093|FG000|Treatment Period 2|Lost to Follow-up|0
7104279|NCT02411110|11231094|FG001|Treatment Period 2|Lost to Follow-up|2
7104280|NCT02411110|11231093|FG000|Treatment Period 2|Personal Reasons|0
7104281|NCT02411110|11231094|FG001|Treatment Period 2|Personal Reasons|2
7104282|NCT02411201|11231102|FG000|Overall Study|Adverse Event|2
7104283|NCT02411201|11231102|FG000|Overall Study|Withdrawal by Subject|2
7104284|NCT02411201|11231102|FG000|Overall Study|Age group completed|2
7104285|NCT02411292|11231108|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16
7104286|NCT02411292|11231108|FG000|Overall Study|Death|2
7104287|NCT02411292|11231108|FG000|Overall Study|Lost to Follow-up|3
7104288|NCT02411396|11231114|FG000|Overall Study|Lost to Follow-up|31
7104289|NCT02411396|11231114|FG000|Overall Study|Death|10
7104290|NCT02411539|11231138|FG000|Overall Study|Lost to Follow-up|2
7104291|NCT02411539|11231139|FG001|Overall Study|Lost to Follow-up|0
7104292|NCT02411539|11231138|FG000|Overall Study|Confounding medical condition|0
7104293|NCT02411539|11231139|FG001|Overall Study|Confounding medical condition|1
7104294|NCT02411578|11231159|FG000|Crossover Trial Phase|Pregnancy|0
7104295|NCT02411578|11231160|FG001|Crossover Trial Phase|Pregnancy|1
7104296|NCT02411591|11231171|FG000|Overall Study|Adverse Event|0
7104297|NCT02411591|11231172|FG001|Overall Study|Adverse Event|4
7104298|NCT02411591|11231173|FG002|Overall Study|Adverse Event|2
7104299|NCT02411591|11231171|FG000|Overall Study|Withdrawal by Subject|0
7104300|NCT02411591|11231172|FG001|Overall Study|Withdrawal by Subject|3
7104301|NCT02411591|11231173|FG002|Overall Study|Withdrawal by Subject|0
7104302|NCT02411591|11231171|FG000|Overall Study|Physician Decision|0
7104303|NCT02411591|11231172|FG001|Overall Study|Physician Decision|3
7104304|NCT02411591|11231173|FG002|Overall Study|Physician Decision|1
7104305|NCT02411747|11231191|FG000|Overall Study|Withdrawal by Subject|1
7104306|NCT02411747|11231192|FG001|Overall Study|Withdrawal by Subject|0
7104307|NCT02411747|11231191|FG000|Overall Study|Protocol Violation|2
7104308|NCT02411747|11231192|FG001|Overall Study|Protocol Violation|4
7104309|NCT02412111|11231235|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1
7104310|NCT02412111|11231236|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0
7104311|NCT02412111|11231237|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0
7104312|NCT02412111|11231235|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2
7104313|NCT02412111|11231236|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0
7104314|NCT02412111|11231237|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0
7104315|NCT02412111|11231235|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0
7104316|NCT02412111|11231236|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0
7104317|NCT02412111|11231237|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2
7104318|NCT02412111|11231235|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0
7104319|NCT02412111|11231236|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0
7104320|NCT02412111|11231237|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1
7104321|NCT02412111|11231235|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0
7104322|NCT02412111|11231236|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0
7104323|NCT02412111|11231237|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1
7104324|NCT02412111|11231235|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0
7104325|NCT02412111|11231236|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1
7104326|NCT02412111|11231237|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0
7104327|NCT02412111|11231235|FG000|Active Comparator Period (8 Weeks)|Other|0
7104328|NCT02412111|11231236|FG001|Active Comparator Period (8 Weeks)|Other|0
7104329|NCT02412111|11231237|FG002|Active Comparator Period (8 Weeks)|Other|2
7104330|NCT02412306|11231256|FG000|Overall Study|Lost to Follow-up|0
7104331|NCT02412306|11231257|FG001|Overall Study|Lost to Follow-up|1
7104332|NCT02412306|11231258|FG002|Overall Study|Lost to Follow-up|0
7104333|NCT02412306|11231259|FG003|Overall Study|Lost to Follow-up|0
7104334|NCT02412306|11231260|FG004|Overall Study|Lost to Follow-up|0
7104335|NCT02412306|11231256|FG000|Overall Study|Withdrawal by Subject|0
7104336|NCT02412306|11231257|FG001|Overall Study|Withdrawal by Subject|0
7104337|NCT02412306|11231258|FG002|Overall Study|Withdrawal by Subject|1
7104338|NCT02412306|11231259|FG003|Overall Study|Withdrawal by Subject|0
7104339|NCT02412306|11231260|FG004|Overall Study|Withdrawal by Subject|0
7104340|NCT02412306|11231256|FG000|Overall Study|Death|5
7104341|NCT02412306|11231257|FG001|Overall Study|Death|7
7104342|NCT02412306|11231258|FG002|Overall Study|Death|15
7104343|NCT02412306|11231259|FG003|Overall Study|Death|0
7104344|NCT02412306|11231260|FG004|Overall Study|Death|2
7104345|NCT02412371|11231287|FG000|Overall Study|Withdrawal by Subject|0
7104346|NCT02412371|11231288|FG001|Overall Study|Withdrawal by Subject|2
7104347|NCT02412371|11231289|FG002|Overall Study|Withdrawal by Subject|0
7104348|NCT02412371|11231290|FG003|Overall Study|Withdrawal by Subject|1
7104349|NCT02412371|11231291|FG004|Overall Study|Withdrawal by Subject|1
7104350|NCT02412371|11231292|FG005|Overall Study|Withdrawal by Subject|0
7104351|NCT02412371|11231287|FG000|Overall Study|Sponsor Discontinued Study|1
7104352|NCT02412371|11231288|FG001|Overall Study|Sponsor Discontinued Study|4
7104353|NCT02412371|11231289|FG002|Overall Study|Sponsor Discontinued Study|6
7104354|NCT02412371|11231290|FG003|Overall Study|Sponsor Discontinued Study|4
7104355|NCT02412371|11231291|FG004|Overall Study|Sponsor Discontinued Study|5
7104356|NCT02412371|11231292|FG005|Overall Study|Sponsor Discontinued Study|0
7104357|NCT02412371|11231287|FG000|Overall Study|Death|4
7104358|NCT02412371|11231288|FG001|Overall Study|Death|2
7104359|NCT02412371|11231289|FG002|Overall Study|Death|1
7104360|NCT02412371|11231290|FG003|Overall Study|Death|3
7104361|NCT02412371|11231291|FG004|Overall Study|Death|5
7104362|NCT02412371|11231292|FG005|Overall Study|Death|2
7104363|NCT02412371|11231287|FG000|Overall Study|Other|2
7104364|NCT02412371|11231288|FG001|Overall Study|Other|1
7104365|NCT02412371|11231289|FG002|Overall Study|Other|0
7104366|NCT02412371|11231290|FG003|Overall Study|Other|0
7104367|NCT02412371|11231291|FG004|Overall Study|Other|1
7104368|NCT02412371|11231292|FG005|Overall Study|Other|3
7104369|NCT02412436|11231307|FG000|Overall Study|Protocol-mandated Discontinuation|7
7104370|NCT02412436|11231307|FG000|Overall Study|Lost to Follow-up|6
7104371|NCT02412436|11231307|FG000|Overall Study|Unable to get to clinic|3
7104372|NCT02412436|11231307|FG000|Overall Study|Death|1
7104373|NCT02412436|11231307|FG000|Overall Study|Not Willing to Adhere to Requirements|1
7104374|NCT02412488|11231311|FG000|Overall Study|Lost to Follow-up|10
7104375|NCT02412488|11231311|FG000|Overall Study|Withdrawal by Subject|5
7104376|NCT02412488|11231311|FG000|Overall Study|Physician Decision|1
7104377|NCT02412488|11231311|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1
7104378|NCT02412488|11231311|FG000|Overall Study|Reveal LINQ explant|1
7104379|NCT02412631|11231322|FG000|Overall Study|Adverse Event|1
7104380|NCT02412631|11231323|FG001|Overall Study|Adverse Event|2
7104381|NCT02412631|11231322|FG000|Overall Study|Lost to Follow-up|5
7104382|NCT02412631|11231323|FG001|Overall Study|Lost to Follow-up|9
7104383|NCT02412631|11231322|FG000|Overall Study|Withdrawal by Subject|9
7104384|NCT02412631|11231323|FG001|Overall Study|Withdrawal by Subject|3
7104385|NCT02412631|11231322|FG000|Overall Study|Early stop by FDA|5
7104386|NCT02412631|11231323|FG001|Overall Study|Early stop by FDA|2
7104387|NCT02412631|11231322|FG000|Overall Study|Unspecified reason|6
7104388|NCT02412631|11231323|FG001|Overall Study|Unspecified reason|8
7104389|NCT02412657|11231345|FG000|Overall Study|Lost to Follow-up|1
7104390|NCT02412657|11231346|FG001|Overall Study|Lost to Follow-up|0
7104391|NCT02412657|11231347|FG002|Overall Study|Lost to Follow-up|0
7104392|NCT02412657|11231345|FG000|Overall Study|Protocol Violation|0
7104393|NCT02412657|11231346|FG001|Overall Study|Protocol Violation|2
7104394|NCT02412657|11231347|FG002|Overall Study|Protocol Violation|3
7104395|NCT02412722|11231361|FG000|Overall Study|Adverse Event|0
7104396|NCT02412722|11231362|FG001|Overall Study|Adverse Event|2
7104397|NCT02412722|11231363|FG002|Overall Study|Adverse Event|0
7104398|NCT02412722|11231364|FG003|Overall Study|Adverse Event|3
7104399|NCT02412722|11231365|FG004|Overall Study|Adverse Event|0
7104400|NCT02412722|11231366|FG005|Overall Study|Adverse Event|3
7104401|NCT02412722|11231361|FG000|Overall Study|Progressive Disease|6
7104402|NCT02412722|11231362|FG001|Overall Study|Progressive Disease|4
7104403|NCT02412722|11231363|FG002|Overall Study|Progressive Disease|4
7104404|NCT02412722|11231364|FG003|Overall Study|Progressive Disease|9
7104405|NCT02412722|11231365|FG004|Overall Study|Progressive Disease|3
7104406|NCT02412722|11231366|FG005|Overall Study|Progressive Disease|3
7104407|NCT02412722|11231361|FG000|Overall Study|Withdrawal by Subject|2
7104408|NCT02412722|11231362|FG001|Overall Study|Withdrawal by Subject|0
7104409|NCT02412722|11231363|FG002|Overall Study|Withdrawal by Subject|1
7104410|NCT02412722|11231364|FG003|Overall Study|Withdrawal by Subject|2
7104411|NCT02412722|11231365|FG004|Overall Study|Withdrawal by Subject|1
7104412|NCT02412722|11231366|FG005|Overall Study|Withdrawal by Subject|1
7104413|NCT02412722|11231361|FG000|Overall Study|Lost to Follow-up|0
7104414|NCT02412722|11231362|FG001|Overall Study|Lost to Follow-up|0
7104415|NCT02412722|11231363|FG002|Overall Study|Lost to Follow-up|0
7104416|NCT02412722|11231364|FG003|Overall Study|Lost to Follow-up|0
7104417|NCT02412722|11231365|FG004|Overall Study|Lost to Follow-up|1
7104418|NCT02412722|11231366|FG005|Overall Study|Lost to Follow-up|0
7104419|NCT02412722|11231361|FG000|Overall Study|Received drug in run-in and discontinued|0
7104420|NCT02412722|11231362|FG001|Overall Study|Received drug in run-in and discontinued|2
7104421|NCT02412722|11231363|FG002|Overall Study|Received drug in run-in and discontinued|0
7104422|NCT02412722|11231364|FG003|Overall Study|Received drug in run-in and discontinued|0
7104423|NCT02412722|11231365|FG004|Overall Study|Received drug in run-in and discontinued|0
7104424|NCT02412722|11231366|FG005|Overall Study|Received drug in run-in and discontinued|0
7104425|NCT02412722|11231361|FG000|Overall Study|Reason not Specified|3
7104426|NCT02412722|11231362|FG001|Overall Study|Reason not Specified|0
7104427|NCT02412722|11231363|FG002|Overall Study|Reason not Specified|2
7104428|NCT02412722|11231364|FG003|Overall Study|Reason not Specified|1
7104429|NCT02412722|11231365|FG004|Overall Study|Reason not Specified|2
7104430|NCT02412722|11231366|FG005|Overall Study|Reason not Specified|6
7104431|NCT02412761|11231400|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0
7104432|NCT02412761|11231401|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1
7104433|NCT02412761|11231402|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1
7104434|NCT02412761|11231403|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0
7104435|NCT02412761|11231404|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0
7104436|NCT02412761|11231405|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1
7104437|NCT02412852|11231417|FG000|Overall Study|Withdrawal by Subject|0
7104438|NCT02412852|11231418|FG001|Overall Study|Withdrawal by Subject|1
7104439|NCT02412852|11231419|FG002|Overall Study|Withdrawal by Subject|0
7104440|NCT02412852|11231420|FG003|Overall Study|Withdrawal by Subject|0
7104441|NCT02412852|11231417|FG000|Overall Study|Physician Decision|0
7104442|NCT02412852|11231418|FG001|Overall Study|Physician Decision|0
7104443|NCT02412852|11231419|FG002|Overall Study|Physician Decision|0
7104444|NCT02412852|11231420|FG003|Overall Study|Physician Decision|1
7104445|NCT02412878|11231430|FG000|Overall Study|Withdrawal by Subject|19
7104446|NCT02412878|11231431|FG001|Overall Study|Withdrawal by Subject|10
7104447|NCT02412878|11231430|FG000|Overall Study|Lost to Follow-up|2
7104448|NCT02412878|11231431|FG001|Overall Study|Lost to Follow-up|3
7104449|NCT02413229|11231508|FG000|Overall Study|Adverse Event|0
7104450|NCT02413229|11231509|FG001|Overall Study|Adverse Event|0
7104451|NCT02413229|11231510|FG002|Overall Study|Adverse Event|0
7104452|NCT02413229|11231511|FG003|Overall Study|Adverse Event|1
7104453|NCT02413229|11231512|FG004|Overall Study|Adverse Event|0
7104454|NCT02413229|11231513|FG005|Overall Study|Adverse Event|0
7104455|NCT02413229|11231514|FG006|Overall Study|Adverse Event|0
7104456|NCT02413229|11231515|FG007|Overall Study|Adverse Event|1
7104457|NCT02413229|11231508|FG000|Overall Study|Lost to Follow-up|0
7104458|NCT02413229|11231509|FG001|Overall Study|Lost to Follow-up|0
7104459|NCT02413229|11231510|FG002|Overall Study|Lost to Follow-up|1
7104460|NCT02413229|11231511|FG003|Overall Study|Lost to Follow-up|0
7104461|NCT02413229|11231512|FG004|Overall Study|Lost to Follow-up|2
7104462|NCT02413229|11231513|FG005|Overall Study|Lost to Follow-up|0
7104463|NCT02413229|11231514|FG006|Overall Study|Lost to Follow-up|0
7104464|NCT02413229|11231515|FG007|Overall Study|Lost to Follow-up|0
7104465|NCT02413229|11231508|FG000|Overall Study|Withdrawal by Subject|1
7104466|NCT02413229|11231509|FG001|Overall Study|Withdrawal by Subject|1
7104467|NCT02413229|11231510|FG002|Overall Study|Withdrawal by Subject|0
7104468|NCT02413229|11231511|FG003|Overall Study|Withdrawal by Subject|0
7104469|NCT02413229|11231512|FG004|Overall Study|Withdrawal by Subject|1
7104470|NCT02413229|11231513|FG005|Overall Study|Withdrawal by Subject|0
7104471|NCT02413229|11231514|FG006|Overall Study|Withdrawal by Subject|0
7104472|NCT02413229|11231515|FG007|Overall Study|Withdrawal by Subject|2
7104473|NCT02413229|11231508|FG000|Overall Study|Progressive Disease|0
7104474|NCT02413229|11231509|FG001|Overall Study|Progressive Disease|0
7104475|NCT02413229|11231510|FG002|Overall Study|Progressive Disease|0
7104476|NCT02413229|11231511|FG003|Overall Study|Progressive Disease|0
7104477|NCT02413229|11231512|FG004|Overall Study|Progressive Disease|0
7104478|NCT02413229|11231513|FG005|Overall Study|Progressive Disease|0
7104479|NCT02413229|11231514|FG006|Overall Study|Progressive Disease|0
7104480|NCT02413229|11231515|FG007|Overall Study|Progressive Disease|1
7104481|NCT02413255|11231550|FG000|Overall Study|Voluntary Withdrawal|0
7104482|NCT02413255|11231551|FG001|Overall Study|Voluntary Withdrawal|0
7104483|NCT02413255|11231552|FG002|Overall Study|Voluntary Withdrawal|0
7104484|NCT02413255|11231553|FG003|Overall Study|Voluntary Withdrawal|0
7104485|NCT02413255|11231554|FG004|Overall Study|Voluntary Withdrawal|0
7104486|NCT02413255|11231555|FG005|Overall Study|Voluntary Withdrawal|0
7104487|NCT02413255|11231556|FG006|Overall Study|Voluntary Withdrawal|0
7104488|NCT02413255|11231557|FG007|Overall Study|Voluntary Withdrawal|0
7104489|NCT02413255|11231558|FG008|Overall Study|Voluntary Withdrawal|0
7104490|NCT02413255|11231559|FG009|Overall Study|Voluntary Withdrawal|0
7104491|NCT02413255|11231560|FG010|Overall Study|Voluntary Withdrawal|0
7104492|NCT02413255|11231561|FG011|Overall Study|Voluntary Withdrawal|0
7104493|NCT02413255|11231562|FG012|Overall Study|Voluntary Withdrawal|0
7104494|NCT02413255|11231563|FG013|Overall Study|Voluntary Withdrawal|0
7104495|NCT02413255|11231564|FG014|Overall Study|Voluntary Withdrawal|1
7104496|NCT02413255|11231565|FG015|Overall Study|Voluntary Withdrawal|0
7104497|NCT02413255|11231566|FG016|Overall Study|Voluntary Withdrawal|0
7104498|NCT02413294|11231617|FG000|Overall Study|Withdrawal by Subject|1
7104499|NCT02413333|11231634|FG000|Period 1|Adverse Event|1
7104500|NCT02413333|11231635|FG001|Period 1|Adverse Event|0
7104501|NCT02413333|11231634|FG000|Period 1|Reason Not Specified|0
7104502|NCT02413333|11231635|FG001|Period 1|Reason Not Specified|1
7104503|NCT02413333|11231634|FG000|Period 2|Protocol Deviation|1
7104504|NCT02413333|11231635|FG001|Period 2|Protocol Deviation|0
7104505|NCT02413346|11231643|FG000|Overall Study|Adverse Event|6
7104506|NCT02413346|11231644|FG001|Overall Study|Adverse Event|6
7104507|NCT02413346|11231643|FG000|Overall Study|Withdrawal by Subject|30
7104508|NCT02413346|11231644|FG001|Overall Study|Withdrawal by Subject|40
7104509|NCT02413346|11231643|FG000|Overall Study|Lost to Follow-up|17
7104510|NCT02413346|11231644|FG001|Overall Study|Lost to Follow-up|21
7104511|NCT02413346|11231643|FG000|Overall Study|Protocol Violation|2
7104512|NCT02413346|11231644|FG001|Overall Study|Protocol Violation|0
7104513|NCT02413346|11231643|FG000|Overall Study|Other Miscellaneous Reasons|4
7104514|NCT02413346|11231644|FG001|Overall Study|Other Miscellaneous Reasons|3
7104515|NCT02413372|11231653|FG000|Treatment|Lost to Follow-up|0
7104516|NCT02413372|11231654|FG001|Treatment|Lost to Follow-up|2
7104517|NCT02413372|11231655|FG002|Treatment|Lost to Follow-up|1
7104518|NCT02413372|11231653|FG000|Treatment|Withdrawal by Subject|1
7104519|NCT02413372|11231654|FG001|Treatment|Withdrawal by Subject|0
7104520|NCT02413372|11231655|FG002|Treatment|Withdrawal by Subject|0
7104521|NCT02413372|11231653|FG000|Follow-up|Lost to Follow-up|1
7104522|NCT02413372|11231654|FG001|Follow-up|Lost to Follow-up|1
7104523|NCT02413372|11231655|FG002|Follow-up|Lost to Follow-up|0
7104524|NCT02413372|11231653|FG000|Follow-up|Subject Withdrew Consent|1
7104525|NCT02413372|11231654|FG001|Follow-up|Subject Withdrew Consent|0
7104526|NCT02413372|11231655|FG002|Follow-up|Subject Withdrew Consent|1
7104527|NCT02413372|11231653|FG000|Follow-up|Subject unable to return for visit|0
7104528|NCT02413372|11231654|FG001|Follow-up|Subject unable to return for visit|0
7104529|NCT02413372|11231655|FG002|Follow-up|Subject unable to return for visit|1
7104530|NCT02413398|11231665|FG000|Overall Study|Lost to Follow-up|2
7104531|NCT02413398|11231666|FG001|Overall Study|Lost to Follow-up|4
7104532|NCT02413398|11231665|FG000|Overall Study|Withdrawal by Subject|1
7104533|NCT02413398|11231666|FG001|Overall Study|Withdrawal by Subject|1
7104534|NCT02413398|11231665|FG000|Overall Study|Other Eligibility criteria|1
7104535|NCT02413398|11231666|FG001|Overall Study|Other Eligibility criteria|2
7104536|NCT02413489|11231684|FG000|Overall Study|Death|11
7104537|NCT02413489|11231685|FG001|Overall Study|Death|3
7104538|NCT02413489|11231686|FG002|Overall Study|Death|4
7104539|NCT02413489|11231684|FG000|Overall Study|Withdrawal by Subject|2
7104540|NCT02413489|11231685|FG001|Overall Study|Withdrawal by Subject|0
7104541|NCT02413489|11231686|FG002|Overall Study|Withdrawal by Subject|0
7104542|NCT02413489|11231684|FG000|Overall Study|Study Terminated By Sponsor|2
7104543|NCT02413489|11231685|FG001|Overall Study|Study Terminated By Sponsor|13
7104544|NCT02413489|11231686|FG002|Overall Study|Study Terminated By Sponsor|1
7104545|NCT02413593|11231698|FG000|Overall Study|Lost to Follow-up|3
7104546|NCT02413593|11231698|FG000|Overall Study|Adverse Event|1
7104547|NCT02413996|11231719|FG000|Overall Study|not comfortable with the intervention|9
7104548|NCT02413996|11231720|FG001|Overall Study|not comfortable with the intervention|2
7104549|NCT02414828|11231753|FG000|Overall Study|Lost to Follow-up|0
7104550|NCT02414828|11231754|FG001|Overall Study|Lost to Follow-up|1
7104551|NCT02414828|11231755|FG002|Overall Study|Lost to Follow-up|1
7104552|NCT02414828|11231756|FG003|Overall Study|Lost to Follow-up|2
7104553|NCT02414841|11231769|FG000|Overall Study|Withdrawal by Subject|7
7104554|NCT02414841|11231770|FG001|Overall Study|Withdrawal by Subject|5
7104555|NCT02414841|11231769|FG000|Overall Study|Lost to Follow-up|13
7104556|NCT02414841|11231770|FG001|Overall Study|Lost to Follow-up|6
7104557|NCT02414841|11231769|FG000|Overall Study|Death|17
7104558|NCT02414841|11231770|FG001|Overall Study|Death|14
7104559|NCT02414841|11231769|FG000|Overall Study|Received a Kidney Transplant|13
7104560|NCT02414841|11231770|FG001|Overall Study|Received a Kidney Transplant|4
7104561|NCT02414841|11231769|FG000|Overall Study|Randomized But Not Treated|6
7104562|NCT02414841|11231770|FG001|Overall Study|Randomized But Not Treated|4
7104563|NCT02414854|11231782|FG000|Overall Study|Adverse Event|9
7104564|NCT02414854|11231783|FG001|Overall Study|Adverse Event|7
7104565|NCT02414854|11231784|FG002|Overall Study|Adverse Event|1
7104566|NCT02414854|11231785|FG003|Overall Study|Adverse Event|12
7104567|NCT02414854|11231782|FG000|Overall Study|Poor compliance to protocol|1
7104568|NCT02414854|11231783|FG001|Overall Study|Poor compliance to protocol|1
7104569|NCT02414854|11231784|FG002|Overall Study|Poor compliance to protocol|2
7104570|NCT02414854|11231785|FG003|Overall Study|Poor compliance to protocol|2
7104571|NCT02414854|11231782|FG000|Overall Study|Other than specified above|12
7104572|NCT02414854|11231783|FG001|Overall Study|Other than specified above|37
7104573|NCT02414854|11231784|FG002|Overall Study|Other than specified above|17
7104574|NCT02414854|11231785|FG003|Overall Study|Other than specified above|37
7104575|NCT02414932|11231797|FG000|Overall Study|Withdrawal by Subject|2
7104576|NCT02414932|11231798|FG001|Overall Study|Withdrawal by Subject|3
7104577|NCT02414932|11231797|FG000|Overall Study|Adverse Event|1
7104578|NCT02414932|11231798|FG001|Overall Study|Adverse Event|0
7104579|NCT02414958|11231807|FG000|Overall Study|Adverse Event|6
7104580|NCT02414958|11231808|FG001|Overall Study|Adverse Event|6
7104581|NCT02414958|11231809|FG002|Overall Study|Adverse Event|3
7104582|NCT02414958|11231807|FG000|Overall Study|Protocol Violation|10
7104583|NCT02414958|11231808|FG001|Overall Study|Protocol Violation|3
7104584|NCT02414958|11231809|FG002|Overall Study|Protocol Violation|1
7104585|NCT02414958|11231807|FG000|Overall Study|Lost to Follow-up|7
7104586|NCT02414958|11231808|FG001|Overall Study|Lost to Follow-up|4
7104587|NCT02414958|11231809|FG002|Overall Study|Lost to Follow-up|0
7104588|NCT02414958|11231807|FG000|Overall Study|Withdrawal by Subject|5
7104589|NCT02414958|11231808|FG001|Overall Study|Withdrawal by Subject|3
7104590|NCT02414958|11231809|FG002|Overall Study|Withdrawal by Subject|5
7104591|NCT02414958|11231807|FG000|Overall Study|Other than specified|4
7104592|NCT02414958|11231808|FG001|Overall Study|Other than specified|4
7104593|NCT02414958|11231809|FG002|Overall Study|Other than specified|5
7104594|NCT02415127|11231819|FG000|Overall Study|Adverse Event|1
7104595|NCT02415127|11231820|FG001|Overall Study|Adverse Event|0
7104596|NCT02415400|11231839|FG000|Overall Study|Adverse Event|0
7104597|NCT02415400|11231840|FG001|Overall Study|Adverse Event|1
7104598|NCT02415400|11231841|FG002|Overall Study|Adverse Event|1
7104599|NCT02415400|11231842|FG003|Overall Study|Adverse Event|2
7104600|NCT02415400|11231839|FG000|Overall Study|Participant request to stop therapy|4
7104601|NCT02415400|11231840|FG001|Overall Study|Participant request to stop therapy|3
7104602|NCT02415400|11231841|FG002|Overall Study|Participant request to stop therapy|8
7104603|NCT02415400|11231842|FG003|Overall Study|Participant request to stop therapy|6
7104604|NCT02415400|11231839|FG000|Overall Study|Participant withdrew consent|14
7104605|NCT02415400|11231840|FG001|Overall Study|Participant withdrew consent|12
7104606|NCT02415400|11231841|FG002|Overall Study|Participant withdrew consent|30
7104607|NCT02415400|11231842|FG003|Overall Study|Participant withdrew consent|21
7104608|NCT02415400|11231839|FG000|Overall Study|Death|39
7104609|NCT02415400|11231840|FG001|Overall Study|Death|41
7104610|NCT02415400|11231841|FG002|Overall Study|Death|35
7104611|NCT02415400|11231842|FG003|Overall Study|Death|42
7104612|NCT02415400|11231839|FG000|Overall Study|Lost to Follow-up|3
7104613|NCT02415400|11231840|FG001|Overall Study|Lost to Follow-up|3
7104614|NCT02415400|11231841|FG002|Overall Study|Lost to Follow-up|2
7104615|NCT02415400|11231842|FG003|Overall Study|Lost to Follow-up|5
7104616|NCT02415400|11231839|FG000|Overall Study|Poor/Non-Compliance|0
7104617|NCT02415400|11231840|FG001|Overall Study|Poor/Non-Compliance|1
7104618|NCT02415400|11231841|FG002|Overall Study|Poor/Non-Compliance|3
7104619|NCT02415400|11231842|FG003|Overall Study|Poor/Non-Compliance|4
7104620|NCT02415400|11231839|FG000|Overall Study|Participant no longer meets criteria|2
7104621|NCT02415400|11231840|FG001|Overall Study|Participant no longer meets criteria|0
7104622|NCT02415400|11231841|FG002|Overall Study|Participant no longer meets criteria|0
7104623|NCT02415400|11231842|FG003|Overall Study|Participant no longer meets criteria|1
7104624|NCT02415400|11231839|FG000|Overall Study|Participant doesn't answer phone|1
7104625|NCT02415400|11231840|FG001|Overall Study|Participant doesn't answer phone|0
7104626|NCT02415400|11231841|FG002|Overall Study|Participant doesn't answer phone|0
7104627|NCT02415400|11231842|FG003|Overall Study|Participant doesn't answer phone|0
7104628|NCT02415400|11231839|FG000|Overall Study|Participant wanted home visits|1
7104629|NCT02415400|11231840|FG001|Overall Study|Participant wanted home visits|0
7104630|NCT02415400|11231841|FG002|Overall Study|Participant wanted home visits|0
7104631|NCT02415400|11231842|FG003|Overall Study|Participant wanted home visits|0
7104632|NCT02415400|11231839|FG000|Overall Study|Randomized in error|2
7104633|NCT02415400|11231840|FG001|Overall Study|Randomized in error|0
7104634|NCT02415400|11231841|FG002|Overall Study|Randomized in error|0
7104635|NCT02415400|11231842|FG003|Overall Study|Randomized in error|0
7104636|NCT02415400|11231839|FG000|Overall Study|No study drug on site|0
7104637|NCT02415400|11231840|FG001|Overall Study|No study drug on site|1
7104638|NCT02415400|11231841|FG002|Overall Study|No study drug on site|0
7104639|NCT02415400|11231842|FG003|Overall Study|No study drug on site|0
7104640|NCT02415400|11231839|FG000|Overall Study|Stroke and stroke rehabilitation|0
7104641|NCT02415400|11231840|FG001|Overall Study|Stroke and stroke rehabilitation|0
7104642|NCT02415400|11231841|FG002|Overall Study|Stroke and stroke rehabilitation|1
7104643|NCT02415400|11231842|FG003|Overall Study|Stroke and stroke rehabilitation|0
7104644|NCT02415400|11231839|FG000|Overall Study|Coagulation values cannot be set|0
7104645|NCT02415400|11231840|FG001|Overall Study|Coagulation values cannot be set|0
7104646|NCT02415400|11231841|FG002|Overall Study|Coagulation values cannot be set|1
7104647|NCT02415400|11231842|FG003|Overall Study|Coagulation values cannot be set|0
7104648|NCT02415400|11231839|FG000|Overall Study|State regulations prevent participation|0
7104649|NCT02415400|11231840|FG001|Overall Study|State regulations prevent participation|0
7104650|NCT02415400|11231841|FG002|Overall Study|State regulations prevent participation|1
7104651|NCT02415400|11231842|FG003|Overall Study|State regulations prevent participation|0
7104652|NCT02415400|11231839|FG000|Overall Study|Poor treatment monitoring|0
7104653|NCT02415400|11231840|FG001|Overall Study|Poor treatment monitoring|0
7104654|NCT02415400|11231841|FG002|Overall Study|Poor treatment monitoring|1
7104655|NCT02415400|11231842|FG003|Overall Study|Poor treatment monitoring|0
7104656|NCT02415400|11231839|FG000|Overall Study|Participant in jail|0
7104657|NCT02415400|11231840|FG001|Overall Study|Participant in jail|0
7104658|NCT02415400|11231841|FG002|Overall Study|Participant in jail|1
7104659|NCT02415400|11231842|FG003|Overall Study|Participant in jail|0
7104660|NCT02415400|11231839|FG000|Overall Study|Investigator decision|0
7104661|NCT02415400|11231840|FG001|Overall Study|Investigator decision|0
7104662|NCT02415400|11231841|FG002|Overall Study|Investigator decision|1
7104663|NCT02415400|11231842|FG003|Overall Study|Investigator decision|1
7104664|NCT02415400|11231839|FG000|Overall Study|Site closure; participant won't transfer|0
7104665|NCT02415400|11231840|FG001|Overall Study|Site closure; participant won't transfer|0
7104666|NCT02415400|11231841|FG002|Overall Study|Site closure; participant won't transfer|0
7104667|NCT02415400|11231842|FG003|Overall Study|Site closure; participant won't transfer|1
7104668|NCT02415595|11231915|FG000|Overall Study|Administrative reason by sponsor|39
7104669|NCT02415595|11231916|FG001|Overall Study|Administrative reason by sponsor|40
7104670|NCT02415595|11231917|FG002|Overall Study|Administrative reason by sponsor|41
7104671|NCT02415595|11231918|FG003|Overall Study|Administrative reason by sponsor|39
7104672|NCT02415595|11231915|FG000|Overall Study|Adverse Event|1
7104673|NCT02415595|11231916|FG001|Overall Study|Adverse Event|3
7104674|NCT02415595|11231917|FG002|Overall Study|Adverse Event|5
7104675|NCT02415595|11231918|FG003|Overall Study|Adverse Event|10
7104676|NCT02415595|11231915|FG000|Overall Study|Lack of Efficacy|4
7104677|NCT02415595|11231916|FG001|Overall Study|Lack of Efficacy|4
7104678|NCT02415595|11231917|FG002|Overall Study|Lack of Efficacy|0
7104679|NCT02415595|11231918|FG003|Overall Study|Lack of Efficacy|0
7104680|NCT02415595|11231915|FG000|Overall Study|Lost to Follow-up|1
7104681|NCT02415595|11231916|FG001|Overall Study|Lost to Follow-up|3
7104682|NCT02415595|11231917|FG002|Overall Study|Lost to Follow-up|1
7104683|NCT02415595|11231918|FG003|Overall Study|Lost to Follow-up|1
7104684|NCT02415595|11231915|FG000|Overall Study|Poor/Non-compliance|1
7104685|NCT02415595|11231916|FG001|Overall Study|Poor/Non-compliance|0
7104686|NCT02415595|11231917|FG002|Overall Study|Poor/Non-compliance|1
7104687|NCT02415595|11231918|FG003|Overall Study|Poor/Non-compliance|0
7104688|NCT02415595|11231915|FG000|Overall Study|Reached stopping criteria|0
7104689|NCT02415595|11231916|FG001|Overall Study|Reached stopping criteria|1
7104690|NCT02415595|11231917|FG002|Overall Study|Reached stopping criteria|1
7104691|NCT02415595|11231918|FG003|Overall Study|Reached stopping criteria|0
7104692|NCT02415595|11231915|FG000|Overall Study|Withdrawal by Subject|4
7104693|NCT02415595|11231916|FG001|Overall Study|Withdrawal by Subject|0
7104694|NCT02415595|11231917|FG002|Overall Study|Withdrawal by Subject|1
7104695|NCT02415595|11231918|FG003|Overall Study|Withdrawal by Subject|3
7104696|NCT02415595|11231915|FG000|Overall Study|Other|0
7104697|NCT02415595|11231916|FG001|Overall Study|Other|1
7104698|NCT02415595|11231917|FG002|Overall Study|Other|1
7104699|NCT02415595|11231918|FG003|Overall Study|Other|0
7104700|NCT02415959|11232022|FG000|Overall Study|Adverse Event|0
7104701|NCT02415959|11232023|FG001|Overall Study|Adverse Event|1
7104702|NCT02415959|11232024|FG002|Overall Study|Adverse Event|0
7104703|NCT02415959|11232025|FG003|Overall Study|Adverse Event|0
7104704|NCT02415959|11232026|FG004|Overall Study|Adverse Event|0
7104705|NCT02415959|11232022|FG000|Overall Study|Protocol Violation|0
7104706|NCT02415959|11232023|FG001|Overall Study|Protocol Violation|0
7104707|NCT02415959|11232024|FG002|Overall Study|Protocol Violation|0
7104708|NCT02415959|11232025|FG003|Overall Study|Protocol Violation|1
7104709|NCT02415959|11232026|FG004|Overall Study|Protocol Violation|0
7104710|NCT02416180|11232055|FG000|Overall Study|Withdrawal by Subject|1
7104711|NCT02416453|11232079|FG000|Overall Study|Adverse Event|0
7104712|NCT02416453|11232080|FG001|Overall Study|Adverse Event|0
7104713|NCT02416453|11232081|FG002|Overall Study|Adverse Event|0
7104714|NCT02416453|11232082|FG003|Overall Study|Adverse Event|2
7104715|NCT02416453|11232083|FG004|Overall Study|Adverse Event|0
7104716|NCT02416453|11232084|FG005|Overall Study|Adverse Event|1
7104717|NCT02416453|11232085|FG006|Overall Study|Adverse Event|0
7104718|NCT02416453|11232086|FG007|Overall Study|Adverse Event|0
7104719|NCT02416453|11232087|FG008|Overall Study|Adverse Event|0
7104720|NCT02416453|11232088|FG009|Overall Study|Adverse Event|0
7104721|NCT02416453|11232089|FG010|Overall Study|Adverse Event|0
7104722|NCT02416453|11232079|FG000|Overall Study|Lost to Follow-up|1
7104723|NCT02416453|11232080|FG001|Overall Study|Lost to Follow-up|3
7104724|NCT02416453|11232081|FG002|Overall Study|Lost to Follow-up|0
7104725|NCT02416453|11232082|FG003|Overall Study|Lost to Follow-up|8
7104726|NCT02416453|11232083|FG004|Overall Study|Lost to Follow-up|0
7104727|NCT02416453|11232084|FG005|Overall Study|Lost to Follow-up|5
7104728|NCT02416453|11232085|FG006|Overall Study|Lost to Follow-up|1
7104729|NCT02416453|11232086|FG007|Overall Study|Lost to Follow-up|3
7104730|NCT02416453|11232087|FG008|Overall Study|Lost to Follow-up|1
7104731|NCT02416453|11232088|FG009|Overall Study|Lost to Follow-up|0
7104732|NCT02416453|11232089|FG010|Overall Study|Lost to Follow-up|0
7104733|NCT02416453|11232079|FG000|Overall Study|Physician Decision|0
7104734|NCT02416453|11232080|FG001|Overall Study|Physician Decision|0
7104735|NCT02416453|11232081|FG002|Overall Study|Physician Decision|0
7104736|NCT02416453|11232082|FG003|Overall Study|Physician Decision|0
7104737|NCT02416453|11232083|FG004|Overall Study|Physician Decision|0
7104738|NCT02416453|11232084|FG005|Overall Study|Physician Decision|1
7104739|NCT02416453|11232085|FG006|Overall Study|Physician Decision|1
7104740|NCT02416453|11232086|FG007|Overall Study|Physician Decision|1
7104741|NCT02416453|11232087|FG008|Overall Study|Physician Decision|0
7104742|NCT02416453|11232088|FG009|Overall Study|Physician Decision|0
7104743|NCT02416453|11232089|FG010|Overall Study|Physician Decision|0
7104744|NCT02416453|11232079|FG000|Overall Study|Withdrawal by Subject|2
7104745|NCT02416453|11232080|FG001|Overall Study|Withdrawal by Subject|0
7104746|NCT02416453|11232081|FG002|Overall Study|Withdrawal by Subject|0
7104747|NCT02416453|11232082|FG003|Overall Study|Withdrawal by Subject|5
7104748|NCT02416453|11232083|FG004|Overall Study|Withdrawal by Subject|1
7104749|NCT02416453|11232084|FG005|Overall Study|Withdrawal by Subject|8
7104750|NCT02416453|11232085|FG006|Overall Study|Withdrawal by Subject|0
7104751|NCT02416453|11232086|FG007|Overall Study|Withdrawal by Subject|8
7104752|NCT02416453|11232087|FG008|Overall Study|Withdrawal by Subject|4
7104753|NCT02416453|11232088|FG009|Overall Study|Withdrawal by Subject|0
7104754|NCT02416453|11232089|FG010|Overall Study|Withdrawal by Subject|0
7104755|NCT02416453|11232079|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7104756|NCT02416453|11232080|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7104757|NCT02416453|11232081|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1
7104758|NCT02416453|11232082|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7104759|NCT02416453|11232083|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7104760|NCT02416453|11232084|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7104761|NCT02416453|11232085|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7104762|NCT02416453|11232086|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7104763|NCT02416453|11232087|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7104764|NCT02416453|11232088|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7104765|NCT02416453|11232089|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7104766|NCT02416453|11232079|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7104767|NCT02416453|11232080|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7104768|NCT02416453|11232081|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7104769|NCT02416453|11232082|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7104770|NCT02416453|11232083|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7104771|NCT02416453|11232084|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1
7104772|NCT02416453|11232085|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7104773|NCT02416453|11232086|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7104774|NCT02416453|11232087|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7104775|NCT02416453|11232088|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7104776|NCT02416453|11232089|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7104777|NCT02416791|11232152|FG000|6 Months|Lost to Follow-up|0
7104778|NCT02416791|11232153|FG001|6 Months|Lost to Follow-up|0
7104779|NCT02416791|11232154|FG002|6 Months|Lost to Follow-up|1
7104780|NCT02416908|11232165|FG000|Dose Escalation Phase|Adverse Event|0
7104781|NCT02416908|11232166|FG001|Dose Escalation Phase|Adverse Event|0
7104782|NCT02416908|11232167|FG002|Dose Escalation Phase|Adverse Event|3
7104783|NCT02416908|11232168|FG003|Dose Escalation Phase|Adverse Event|0
7104784|NCT02416908|11232165|FG000|Dose Escalation Phase|Withdrawal by Subject|0
7104785|NCT02416908|11232166|FG001|Dose Escalation Phase|Withdrawal by Subject|0
7104786|NCT02416908|11232167|FG002|Dose Escalation Phase|Withdrawal by Subject|1
7104787|NCT02416908|11232168|FG003|Dose Escalation Phase|Withdrawal by Subject|0
7104788|NCT02416934|11232177|FG000|Overall Study|given steroids|1
7104789|NCT02416934|11232178|FG001|Overall Study|given steroids|2
7104790|NCT02416934|11232177|FG000|Overall Study|Lost to Follow-up|0
7104791|NCT02416934|11232178|FG001|Overall Study|Lost to Follow-up|2
7104792|NCT02416934|11232177|FG000|Overall Study|Withdrawal by Subject|1
7104793|NCT02416934|11232178|FG001|Overall Study|Withdrawal by Subject|0
7104794|NCT02416934|11232177|FG000|Overall Study|recruited during continuing renewal proc|0
7104795|NCT02416934|11232178|FG001|Overall Study|recruited during continuing renewal proc|1
7104796|NCT02416934|11232177|FG000|Overall Study|Protocol Violation|0
7104797|NCT02416934|11232178|FG001|Overall Study|Protocol Violation|1
7104798|NCT02416934|11232177|FG000|Overall Study|surgery started late|0
7104799|NCT02416934|11232178|FG001|Overall Study|surgery started late|1
7104800|NCT02416934|11232177|FG000|Overall Study|re-operation|1
7104801|NCT02416934|11232178|FG001|Overall Study|re-operation|0
7104802|NCT02417064|11232206|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1
7104803|NCT02417064|11232207|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7
7104804|NCT02417064|11232208|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2
7104805|NCT02417064|11232206|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
7104806|NCT02417064|11232207|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
7104807|NCT02417064|11232208|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0
7104808|NCT02417064|11232206|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
7104809|NCT02417064|11232207|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1
7104810|NCT02417064|11232208|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
7104811|NCT02417064|11232206|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2
7104812|NCT02417064|11232207|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
7104813|NCT02417064|11232208|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
7104814|NCT02417064|11232206|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
7104815|NCT02417064|11232207|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5
7104816|NCT02417064|11232208|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
7104817|NCT02417064|11232206|FG000|Double-blind Induction Phase (4 Weeks)|Other|1
7104818|NCT02417064|11232207|FG001|Double-blind Induction Phase (4 Weeks)|Other|4
7104819|NCT02417064|11232208|FG002|Double-blind Induction Phase (4 Weeks)|Other|2
7104820|NCT02417064|11232206|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0
7104821|NCT02417064|11232207|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2
7104822|NCT02417064|11232208|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1
7104823|NCT02417064|11232206|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0
7104824|NCT02417064|11232207|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0
7104825|NCT02417064|11232208|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1
7104826|NCT02417064|11232206|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3
7104827|NCT02417064|11232207|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9
7104828|NCT02417064|11232208|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2
7104829|NCT02417064|11232206|FG000|Follow-up Phase (24 Weeks)|PI Decision|34
7104830|NCT02417064|11232207|FG001|Follow-up Phase (24 Weeks)|PI Decision|29
7104831|NCT02417064|11232208|FG002|Follow-up Phase (24 Weeks)|PI Decision|44
7104832|NCT02417064|11232206|FG000|Follow-up Phase (24 Weeks)|Other|2
7104833|NCT02417064|11232207|FG001|Follow-up Phase (24 Weeks)|Other|2
7104834|NCT02417064|11232208|FG002|Follow-up Phase (24 Weeks)|Other|3
7104835|NCT02417233|11232229|FG000|Overall Study|Death|4
7104836|NCT02417233|11232230|FG001|Overall Study|Death|10
7104837|NCT02417233|11232231|FG002|Overall Study|Death|14
7104838|NCT02417233|11232229|FG000|Overall Study|Lost to Follow-up|27
7104839|NCT02417233|11232230|FG001|Overall Study|Lost to Follow-up|39
7104840|NCT02417233|11232231|FG002|Overall Study|Lost to Follow-up|34
7104841|NCT02417233|11232229|FG000|Overall Study|Protocol Violation|2
7104842|NCT02417233|11232230|FG001|Overall Study|Protocol Violation|0
7104843|NCT02417233|11232231|FG002|Overall Study|Protocol Violation|2
7104844|NCT02417233|11232229|FG000|Overall Study|Withdrawal by Subject|2
7104845|NCT02417233|11232230|FG001|Overall Study|Withdrawal by Subject|1
7104846|NCT02417233|11232231|FG002|Overall Study|Withdrawal by Subject|8
7104847|NCT02417233|11232229|FG000|Overall Study|Relocation out of study area|1
7104848|NCT02417233|11232230|FG001|Overall Study|Relocation out of study area|0
7104849|NCT02417233|11232231|FG002|Overall Study|Relocation out of study area|1
7104850|NCT02417233|11232229|FG000|Overall Study|Mentally unstable|0
7104851|NCT02417233|11232230|FG001|Overall Study|Mentally unstable|1
7104852|NCT02417233|11232231|FG002|Overall Study|Mentally unstable|0
7104853|NCT02417246|11232242|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1
7104854|NCT02417246|11232243|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1
7104855|NCT02417246|11232242|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1
7104856|NCT02417246|11232243|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0
7104857|NCT02417246|11232242|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2
7104858|NCT02417246|11232243|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3
7104859|NCT02417246|11232242|FG000|Phase 2 1st Generic Administered|Physician Decision|1
7104860|NCT02417246|11232243|FG001|Phase 2 1st Generic Administered|Physician Decision|0
7104861|NCT02417441|11232262|FG000|Overall Study|Inconclusive due to missing data|52
7104862|NCT02417441|11232263|FG001|Overall Study|Inconclusive due to missing data|19
7104863|NCT02417753|11232276|FG000|Overall Study|Death|1
7104864|NCT02417935|11232296|FG000|Treatment Period|Adverse Event|12
7104865|NCT02417935|11232297|FG001|Treatment Period|Adverse Event|10
7104866|NCT02417935|11232296|FG000|Treatment Period|Lost to Follow-up|1
7104867|NCT02417935|11232297|FG001|Treatment Period|Lost to Follow-up|0
7104868|NCT02417935|11232296|FG000|Treatment Period|Entry Criteria not met|0
7104869|NCT02417935|11232297|FG001|Treatment Period|Entry Criteria not met|1
7104870|NCT02417935|11232296|FG000|Treatment Period|Protocol Violation|2
7104871|NCT02417935|11232297|FG001|Treatment Period|Protocol Violation|1
7104872|NCT02417935|11232296|FG000|Treatment Period|Withdrawal by Subject|3
7104873|NCT02417935|11232297|FG001|Treatment Period|Withdrawal by Subject|3
7104874|NCT02417935|11232296|FG000|Treatment Period|Physician Decision|3
7104875|NCT02417935|11232297|FG001|Treatment Period|Physician Decision|1
7104876|NCT02417961|11232303|FG000|Overall Study|Adverse Event|1
7104877|NCT02417961|11232303|FG000|Overall Study|Lost to Follow-up|1
7104878|NCT02417961|11232303|FG000|Overall Study|Withdrawal by Subject|2
7104879|NCT02418000|11232312|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2
7104880|NCT02418000|11232313|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
7104881|NCT02418000|11232314|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
7104882|NCT02418000|11232315|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
7104883|NCT02418000|11232316|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
7104884|NCT02418000|11232312|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4
7104885|NCT02418000|11232313|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
7104886|NCT02418000|11232314|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
7104887|NCT02418000|11232315|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
7104888|NCT02418000|11232316|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
7104889|NCT02418000|11232312|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1
7104890|NCT02418000|11232313|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
7104891|NCT02418000|11232314|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
7104892|NCT02418000|11232315|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
7104893|NCT02418000|11232316|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
7104894|NCT02418000|11232312|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
7104895|NCT02418000|11232313|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1
7104896|NCT02418000|11232314|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
7104897|NCT02418000|11232315|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
7104898|NCT02418000|11232316|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
7104899|NCT02418000|11232312|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
7104900|NCT02418000|11232313|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9
7104901|NCT02418000|11232314|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
7104902|NCT02418000|11232315|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
7104903|NCT02418000|11232316|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
7104904|NCT02418000|11232312|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
7104905|NCT02418000|11232313|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
7104906|NCT02418000|11232314|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3
7104907|NCT02418000|11232315|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
7104908|NCT02418000|11232316|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
7104909|NCT02418000|11232312|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
7104910|NCT02418000|11232313|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
7104911|NCT02418000|11232314|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
7104912|NCT02418000|11232315|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3
7104913|NCT02418000|11232316|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
7104914|NCT02418000|11232312|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
7104915|NCT02418000|11232313|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
7104916|NCT02418000|11232314|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
7104917|NCT02418000|11232315|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
7104918|NCT02418000|11232316|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1
7104919|NCT02418000|11232312|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
7104920|NCT02418000|11232313|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
7104921|NCT02418000|11232314|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
7104922|NCT02418000|11232315|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
7104923|NCT02418000|11232316|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3
7104924|NCT02418156|11232349|FG000|Overall Study|Lost to Follow-up|12
7104925|NCT02418156|11232349|FG000|Overall Study|Death|2
7104926|NCT02418156|11232349|FG000|Overall Study|Physician Decision|1
7104927|NCT02418156|11232349|FG000|Overall Study|Withdrawal by Subject|1
7104928|NCT02418156|11232349|FG000|Overall Study|Subject refused to return|1
7104929|NCT02418182|11232355|FG000|Overall Study|Unable to re-consent|18
7104930|NCT02418182|11232356|FG001|Overall Study|Unable to re-consent|15
7104931|NCT02418182|11232355|FG000|Overall Study|Lost to Follow-up|0
7104932|NCT02418182|11232356|FG001|Overall Study|Lost to Follow-up|2
7104933|NCT02418455|11232379|FG000|48-Week Treatment Period|Other- Not Specified|1
7104934|NCT02418455|11232379|FG000|Continuation Period|Sponsor Decision|7
7104935|NCT02418468|11232387|FG000|Overall Study|Adverse Event|1
7104936|NCT02418468|11232388|FG001|Overall Study|Adverse Event|0
7104937|NCT02418468|11232387|FG000|Overall Study|Withdrawal of informed consent|1
7104938|NCT02418468|11232388|FG001|Overall Study|Withdrawal of informed consent|1
7104939|NCT02418585|11232409|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1
7104940|NCT02418585|11232410|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1
7104941|NCT02418585|11232409|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2
7104942|NCT02418585|11232410|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2
7104943|NCT02418585|11232409|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4
7104944|NCT02418585|11232410|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7
7104945|NCT02418585|11232409|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2
7104946|NCT02418585|11232410|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0
7104947|NCT02418585|11232409|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9
7104948|NCT02418585|11232410|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1
7104949|NCT02418585|11232409|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0
7104950|NCT02418585|11232410|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1
7104951|NCT02418585|11232409|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3
7104952|NCT02418585|11232410|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3
7104953|NCT02418585|11232409|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6
7104954|NCT02418585|11232410|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3
7104955|NCT02418585|11232409|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6
7104956|NCT02418585|11232410|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17
7104957|NCT02418585|11232409|FG000|Follow-up Phase (24 Weeks)|Other|3
7104958|NCT02418585|11232410|FG001|Follow-up Phase (24 Weeks)|Other|2
7104959|NCT02418754|11232434|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0
7104960|NCT02418754|11232435|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2
7104961|NCT02418754|11232436|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0
7104962|NCT02418754|11232437|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0
7104963|NCT02418754|11232438|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0
7104964|NCT02418754|11232434|FG000|Period 1 (Day 1 to Week 12)|Death|1
7104965|NCT02418754|11232435|FG001|Period 1 (Day 1 to Week 12)|Death|0
7104966|NCT02418754|11232436|FG002|Period 1 (Day 1 to Week 12)|Death|0
7104967|NCT02418754|11232437|FG003|Period 1 (Day 1 to Week 12)|Death|0
7104968|NCT02418754|11232438|FG004|Period 1 (Day 1 to Week 12)|Death|0
7104969|NCT02418754|11232434|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1
7104970|NCT02418754|11232435|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0
7104971|NCT02418754|11232436|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0
7104972|NCT02418754|11232437|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0
7104973|NCT02418754|11232438|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0
7104974|NCT02418754|11232434|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0
7104975|NCT02418754|11232435|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2
7104976|NCT02418754|11232436|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1
7104977|NCT02418754|11232437|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0
7104978|NCT02418754|11232438|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0
7104979|NCT02418754|11232434|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
7104980|NCT02418754|11232435|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
7104981|NCT02418754|11232436|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1
7104982|NCT02418754|11232437|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
7104983|NCT02418754|11232438|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
7104984|NCT02418754|11232434|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3
7104985|NCT02418754|11232435|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7
7104986|NCT02418754|11232436|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6
7104987|NCT02418754|11232437|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2
7104988|NCT02418754|11232438|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2
7104989|NCT02418754|11232434|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1
7104990|NCT02418754|11232435|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0
7104991|NCT02418754|11232436|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0
7104992|NCT02418754|11232437|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0
7104993|NCT02418754|11232438|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0
7104994|NCT02418754|11232434|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26
7104995|NCT02418754|11232435|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28
7104996|NCT02418754|11232436|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26
7104997|NCT02418754|11232437|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21
7104998|NCT02418754|11232438|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24
7104999|NCT02418754|11232434|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3
7105000|NCT02418754|11232435|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4
7105001|NCT02418754|11232436|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4
7105002|NCT02418754|11232437|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1
7105003|NCT02418754|11232438|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0
7105004|NCT02418754|11232434|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0
7105005|NCT02418754|11232435|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2
7105006|NCT02418754|11232436|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1
7105007|NCT02418754|11232437|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2
7105008|NCT02418754|11232438|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1
7105009|NCT02418754|11232434|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0
7105010|NCT02418754|11232435|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1
7105011|NCT02418754|11232436|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0
7105012|NCT02418754|11232437|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1
7105013|NCT02418754|11232438|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0
7105014|NCT02418819|11232452|FG000|Overall Study|Adverse Event|0
7105015|NCT02418819|11232453|FG001|Overall Study|Adverse Event|0
7105016|NCT02418819|11232454|FG002|Overall Study|Adverse Event|1
7105017|NCT02418819|11232455|FG003|Overall Study|Adverse Event|0
7105018|NCT02418819|11232452|FG000|Overall Study|Lost to Follow-up|1
7105019|NCT02418819|11232453|FG001|Overall Study|Lost to Follow-up|0
7105020|NCT02418819|11232454|FG002|Overall Study|Lost to Follow-up|0
7105021|NCT02418819|11232455|FG003|Overall Study|Lost to Follow-up|0
7105022|NCT02418819|11232452|FG000|Overall Study|No longer meets eligibility criteria|0
7105023|NCT02418819|11232453|FG001|Overall Study|No longer meets eligibility criteria|0
7105024|NCT02418819|11232454|FG002|Overall Study|No longer meets eligibility criteria|1
7105025|NCT02418819|11232455|FG003|Overall Study|No longer meets eligibility criteria|0
7105026|NCT02418819|11232452|FG000|Overall Study|No longer willing to participate|0
7105027|NCT02418819|11232453|FG001|Overall Study|No longer willing to participate|0
7105028|NCT02418819|11232454|FG002|Overall Study|No longer willing to participate|2
7105029|NCT02418819|11232455|FG003|Overall Study|No longer willing to participate|1
7105030|NCT02418845|11232467|FG000|Overall Study|Lost to Follow-up|7
7105031|NCT02418845|11232468|FG001|Overall Study|Lost to Follow-up|2
7105032|NCT02418845|11232467|FG000|Overall Study|Lack of Efficacy|0
7105033|NCT02418845|11232468|FG001|Overall Study|Lack of Efficacy|3
7105034|NCT02418845|11232467|FG000|Overall Study|Physician Decision|5
7105035|NCT02418845|11232468|FG001|Overall Study|Physician Decision|5
7105036|NCT02418845|11232467|FG000|Overall Study|Protocol Violation|1
7105037|NCT02418845|11232468|FG001|Overall Study|Protocol Violation|0
7105038|NCT02418845|11232467|FG000|Overall Study|Withdrawal by Subject|3
7105039|NCT02418845|11232468|FG001|Overall Study|Withdrawal by Subject|2
7105040|NCT02418910|11232474|FG000|Overall Study|Lost to Follow-up|3
7105041|NCT02418910|11232474|FG000|Overall Study|Withdrawal by Subject|4
7105042|NCT02418949|11232482|FG000|Overall Study|Withdrawal by Subject|1
7105043|NCT02418949|11232483|FG001|Overall Study|Withdrawal by Subject|0
7105044|NCT02418949|11232484|FG002|Overall Study|Withdrawal by Subject|1
7105045|NCT02418949|11232485|FG003|Overall Study|Withdrawal by Subject|1
7105046|NCT02418949|11232482|FG000|Overall Study|Lost to Follow-up|1
7105047|NCT02418949|11232483|FG001|Overall Study|Lost to Follow-up|0
7105048|NCT02418949|11232484|FG002|Overall Study|Lost to Follow-up|1
7105049|NCT02418949|11232485|FG003|Overall Study|Lost to Follow-up|0
7105050|NCT02418949|11232482|FG000|Overall Study|Physician Decision|1
7105051|NCT02418949|11232483|FG001|Overall Study|Physician Decision|1
7105052|NCT02418949|11232484|FG002|Overall Study|Physician Decision|1
7105053|NCT02418949|11232485|FG003|Overall Study|Physician Decision|0
7105054|NCT02419001|11232497|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1
7105055|NCT02419001|11232498|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0
7105056|NCT02419313|11232504|FG000|First Intervention|Lost to Follow-up|2
7105057|NCT02419313|11232505|FG001|First Intervention|Lost to Follow-up|0
7105058|NCT02419313|11232504|FG000|Second Intervention|Lost to Follow-up|1
7105059|NCT02419313|11232505|FG001|Second Intervention|Lost to Follow-up|0
7105060|NCT02419469|11232511|FG000|Overall Study|Withdrawal by Subject|1
7105061|NCT02419508|11232517|FG000|Overall Study|Adverse Event|9
7105062|NCT02419508|11232518|FG001|Overall Study|Adverse Event|3
7105063|NCT02419508|11232517|FG000|Overall Study|Withdrawal by Subject|1
7105064|NCT02419508|11232518|FG001|Overall Study|Withdrawal by Subject|0
7105065|NCT02419508|11232517|FG000|Overall Study|Other - Reason not specified|0
7105066|NCT02419508|11232518|FG001|Overall Study|Other - Reason not specified|1
7105067|NCT02419573|11232534|FG000|Overall Study|Lost to Follow-up|3
7105068|NCT02419573|11232535|FG001|Overall Study|Lost to Follow-up|0
7105069|NCT02419573|11232534|FG000|Overall Study|Withdrawal by Subject|1
7105070|NCT02419573|11232535|FG001|Overall Study|Withdrawal by Subject|0
7105071|NCT02419612|11232543|FG000|Short-term Treatment Period|Adverse Event|1
7105072|NCT02419612|11232544|FG001|Short-term Treatment Period|Adverse Event|1
7105073|NCT02419612|11232543|FG000|Short-term Treatment Period|Death|0
7105074|NCT02419612|11232544|FG001|Short-term Treatment Period|Death|2
7105075|NCT02419612|11232543|FG000|Short-term Treatment Period|Lost to Follow-up|6
7105076|NCT02419612|11232544|FG001|Short-term Treatment Period|Lost to Follow-up|6
7105077|NCT02419612|11232543|FG000|Short-term Treatment Period|Withdrawal by Subject|9
7105078|NCT02419612|11232544|FG001|Short-term Treatment Period|Withdrawal by Subject|9
7105079|NCT02419612|11232543|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1
7105080|NCT02419612|11232544|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1
7105081|NCT02419612|11232543|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0
7105082|NCT02419612|11232544|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2
7105083|NCT02419612|11232543|FG000|Short-term Treatment Period|Worsening of liver function|0
7105084|NCT02419612|11232544|FG001|Short-term Treatment Period|Worsening of liver function|1
7105085|NCT02419612|11232543|FG000|Short-term Treatment Period|Subject moved out of state|0
7105086|NCT02419612|11232544|FG001|Short-term Treatment Period|Subject moved out of state|1
7105087|NCT02419612|11232543|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1
7105088|NCT02419612|11232544|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1
7105089|NCT02419612|11232543|FG000|Long-term Treatment Period|Lost to Follow-up|6
7105090|NCT02419612|11232544|FG001|Long-term Treatment Period|Lost to Follow-up|4
7105091|NCT02419612|11232543|FG000|Long-term Treatment Period|Lack of Efficacy|1
7105092|NCT02419612|11232544|FG001|Long-term Treatment Period|Lack of Efficacy|1
7105093|NCT02419612|11232543|FG000|Long-term Treatment Period|Death|0
7105094|NCT02419612|11232544|FG001|Long-term Treatment Period|Death|1
7105095|NCT02419612|11232543|FG000|Long-term Treatment Period|Adverse Event|0
7105096|NCT02419612|11232544|FG001|Long-term Treatment Period|Adverse Event|5
7105097|NCT02419612|11232543|FG000|Long-term Treatment Period|Other|4
7105098|NCT02419612|11232544|FG001|Long-term Treatment Period|Other|4
7105099|NCT02419612|11232543|FG000|Long-term Treatment Period|Subject Decision|2
7105100|NCT02419612|11232544|FG001|Long-term Treatment Period|Subject Decision|4
7105101|NCT02419612|11232543|FG000|Long-term Treatment Period|Withdrawal by Subject|8
7105102|NCT02419612|11232544|FG001|Long-term Treatment Period|Withdrawal by Subject|2
7105103|NCT02419755|11232561|FG000|Overall Study|Death|1
7105104|NCT02419755|11232562|FG001|Overall Study|Death|3
7105105|NCT02419755|11232561|FG000|Overall Study|Relapse|0
7105106|NCT02419755|11232562|FG001|Overall Study|Relapse|1
7105107|NCT02419755|11232561|FG000|Overall Study|Ineligible|1
7105108|NCT02419755|11232562|FG001|Overall Study|Ineligible|0
7105109|NCT02419755|11232561|FG000|Overall Study|Withdrawal by Subject|1
7105110|NCT02419755|11232562|FG001|Overall Study|Withdrawal by Subject|0
7105114|NCT02419937|11232578|FG000|Overall Study|Lost to Follow-up|1
7105115|NCT02419937|11232579|FG001|Overall Study|Lost to Follow-up|0
7105116|NCT02420093|11232605|FG000|Overall Study|Withdrawal by Subject|1
7105117|NCT02420093|11232606|FG001|Overall Study|Withdrawal by Subject|1
7105118|NCT02420223|11232618|FG000|Overall Study|Adverse Event|1
7105119|NCT02420223|11232619|FG001|Overall Study|Adverse Event|0
7105120|NCT02420223|11232618|FG000|Overall Study|Physician Decision|0
7105121|NCT02420223|11232619|FG001|Overall Study|Physician Decision|2
7105122|NCT02420262|11232627|FG000|Overall Study|Adverse Event|1
7105123|NCT02420262|11232628|FG001|Overall Study|Adverse Event|0
7105124|NCT02420262|11232627|FG000|Overall Study|Withdrawal by Subject|1
7105125|NCT02420262|11232628|FG001|Overall Study|Withdrawal by Subject|4
7105126|NCT02420262|11232627|FG000|Overall Study|Unclassified|0
7105127|NCT02420262|11232628|FG001|Overall Study|Unclassified|1
7105128|NCT02420327|11232634|FG000|Overall Study|Adverse Event|7
7105129|NCT02420327|11232634|FG000|Overall Study|Pregnancy|1
7105130|NCT02420327|11232634|FG000|Overall Study|Withdrawal by Subject|6
7105131|NCT02420327|11232634|FG000|Overall Study|Lost to Follow-up|1
7105132|NCT02420327|11232634|FG000|Overall Study|Protocol Violation|1
7105133|NCT02420353|11232646|FG000|Overall Study|Withdrawal by Subject|0
7105134|NCT02420353|11232647|FG001|Overall Study|Withdrawal by Subject|1
7105135|NCT02420379|11232655|FG000|Overall Study|Withdrawal by Subject|0
7105136|NCT02420379|11232656|FG001|Overall Study|Withdrawal by Subject|3
7105137|NCT02420379|11232655|FG000|Overall Study|Unable to complete due to schooling|0
7105138|NCT02420379|11232656|FG001|Overall Study|Unable to complete due to schooling|1
7105139|NCT02420379|11232655|FG000|Overall Study|Transitioned to commercial drug|1
7105140|NCT02420379|11232656|FG001|Overall Study|Transitioned to commercial drug|0
7105141|NCT02420691|11232666|FG000|Overall Study|Adverse Event|3
7105142|NCT02420691|11232666|FG000|Overall Study|Withdrawal by Subject|3
7105143|NCT02421120|11232714|FG000|Overall Study|Adverse Event|1
7105144|NCT02421172|11232737|FG000|Period 1|Adverse Event|1
7105145|NCT02421172|11232738|FG001|Period 1|Adverse Event|0
7105146|NCT02421172|11232739|FG002|Period 1|Adverse Event|0
7105147|NCT02421172|11232740|FG003|Period 1|Adverse Event|0
7105148|NCT02421172|11232741|FG004|Period 1|Adverse Event|0
7105149|NCT02421172|11232737|FG000|Period 1|Lost to Follow-up|3
7105150|NCT02421172|11232738|FG001|Period 1|Lost to Follow-up|1
7105151|NCT02421172|11232739|FG002|Period 1|Lost to Follow-up|0
7105152|NCT02421172|11232740|FG003|Period 1|Lost to Follow-up|0
7105153|NCT02421172|11232741|FG004|Period 1|Lost to Follow-up|0
7105154|NCT02421172|11232737|FG000|Period 1|Patient/guardian decision|0
7105155|NCT02421172|11232738|FG001|Period 1|Patient/guardian decision|1
7105156|NCT02421172|11232739|FG002|Period 1|Patient/guardian decision|0
7105157|NCT02421172|11232740|FG003|Period 1|Patient/guardian decision|0
7105158|NCT02421172|11232741|FG004|Period 1|Patient/guardian decision|0
7105159|NCT02421172|11232737|FG000|Period 2|Adverse Event|0
7105160|NCT02421172|11232738|FG001|Period 2|Adverse Event|0
7105161|NCT02421172|11232739|FG002|Period 2|Adverse Event|4
7105162|NCT02421172|11232740|FG003|Period 2|Adverse Event|0
7105163|NCT02421172|11232741|FG004|Period 2|Adverse Event|0
7105164|NCT02421172|11232737|FG000|Period 2|Lost to Follow-up|0
7105165|NCT02421172|11232738|FG001|Period 2|Lost to Follow-up|0
7105166|NCT02421172|11232739|FG002|Period 2|Lost to Follow-up|0
7105167|NCT02421172|11232740|FG003|Period 2|Lost to Follow-up|1
7105168|NCT02421172|11232741|FG004|Period 2|Lost to Follow-up|0
7105169|NCT02421172|11232737|FG000|Period 2|Patient/guardian decision|0
7105170|NCT02421172|11232738|FG001|Period 2|Patient/guardian decision|0
7105171|NCT02421172|11232739|FG002|Period 2|Patient/guardian decision|3
7105172|NCT02421172|11232740|FG003|Period 2|Patient/guardian decision|2
7105173|NCT02421172|11232741|FG004|Period 2|Patient/guardian decision|1
7105174|NCT02421419|11232809|FG000|Overall Study|Physician Decision|0
7105175|NCT02421419|11232810|FG001|Overall Study|Physician Decision|0
7105176|NCT02421419|11232811|FG002|Overall Study|Physician Decision|1
7105177|NCT02421510|11232822|FG000|Overall Study|Other|4
7105178|NCT02421510|11232823|FG001|Overall Study|Other|2
7105179|NCT02421510|11232824|FG002|Overall Study|Other|3
7105180|NCT02421510|11232822|FG000|Overall Study|Protocol Violation|1
7105181|NCT02421510|11232823|FG001|Overall Study|Protocol Violation|2
7105182|NCT02421510|11232824|FG002|Overall Study|Protocol Violation|0
7105183|NCT02421510|11232822|FG000|Overall Study|Death|1
7105184|NCT02421510|11232823|FG001|Overall Study|Death|0
7105185|NCT02421510|11232824|FG002|Overall Study|Death|0
7105186|NCT02421510|11232822|FG000|Overall Study|Noncompliance with study drug|1
7105187|NCT02421510|11232823|FG001|Overall Study|Noncompliance with study drug|0
7105188|NCT02421510|11232824|FG002|Overall Study|Noncompliance with study drug|0
7105189|NCT02421510|11232822|FG000|Overall Study|Physician Decision|1
7105190|NCT02421510|11232823|FG001|Overall Study|Physician Decision|1
7105191|NCT02421510|11232824|FG002|Overall Study|Physician Decision|3
7105192|NCT02421510|11232822|FG000|Overall Study|Adverse Event|9
7105193|NCT02421510|11232823|FG001|Overall Study|Adverse Event|10
7105194|NCT02421510|11232824|FG002|Overall Study|Adverse Event|18
7105195|NCT02421510|11232822|FG000|Overall Study|Pregnancy|1
7105196|NCT02421510|11232823|FG001|Overall Study|Pregnancy|1
7105197|NCT02421510|11232824|FG002|Overall Study|Pregnancy|0
7105198|NCT02421510|11232822|FG000|Overall Study|Withdrawal by Subject|14
7105199|NCT02421510|11232823|FG001|Overall Study|Withdrawal by Subject|18
7105200|NCT02421510|11232824|FG002|Overall Study|Withdrawal by Subject|12
7105201|NCT02421510|11232822|FG000|Overall Study|Lost to Follow-up|1
7105202|NCT02421510|11232823|FG001|Overall Study|Lost to Follow-up|1
7105203|NCT02421510|11232824|FG002|Overall Study|Lost to Follow-up|0
7105204|NCT02421588|11232834|FG000|Overall Study|Non-treatment-related AE|8
7105205|NCT02421588|11232835|FG001|Overall Study|Non-treatment-related AE|8
7105206|NCT02421588|11232834|FG000|Overall Study|Progressive disease|152
7105207|NCT02421588|11232835|FG001|Overall Study|Progressive disease|135
7105208|NCT02421588|11232834|FG000|Overall Study|Death|11
7105209|NCT02421588|11232835|FG001|Overall Study|Death|3
7105210|NCT02421588|11232834|FG000|Overall Study|Physician Decision|8
7105211|NCT02421588|11232835|FG001|Overall Study|Physician Decision|17
7105212|NCT02421588|11232834|FG000|Overall Study|Other reason not specified|3
7105213|NCT02421588|11232835|FG001|Overall Study|Other reason not specified|1
7105214|NCT02421588|11232834|FG000|Overall Study|Symptomatic deterioration|13
7105215|NCT02421588|11232835|FG001|Overall Study|Symptomatic deterioration|19
7105216|NCT02421588|11232834|FG000|Overall Study|Treatment-related AE|10
7105217|NCT02421588|11232835|FG001|Overall Study|Treatment-related AE|14
7105218|NCT02421588|11232834|FG000|Overall Study|Withdrawal by Subject|14
7105219|NCT02421588|11232835|FG001|Overall Study|Withdrawal by Subject|16
7105220|NCT02421588|11232834|FG000|Overall Study|Not treated|2
7105221|NCT02421588|11232835|FG001|Overall Study|Not treated|8
7105222|NCT02421601|11232841|FG000|Overall Study|Adverse Event|4
7105223|NCT02421601|11232841|FG000|Overall Study|Lack of Efficacy|5
7105224|NCT02421601|11232841|FG000|Overall Study|Physician Decision|1
7105225|NCT02421601|11232841|FG000|Overall Study|Withdrawal by Subject|31
7105226|NCT02421601|11232841|FG000|Overall Study|Others|41
7105227|NCT02421666|11232847|FG000|6-month Follow-up|Lost to Follow-up|8
7105228|NCT02421666|11232848|FG001|6-month Follow-up|Lost to Follow-up|7
7105229|NCT02421666|11232847|FG000|6-month Follow-up|Withdrawal by Subject|5
7105230|NCT02421666|11232848|FG001|6-month Follow-up|Withdrawal by Subject|6
7105231|NCT02421666|11232847|FG000|12-month Follow-up|Lost to Follow-up|5
7105232|NCT02421666|11232848|FG001|12-month Follow-up|Lost to Follow-up|5
7105233|NCT02421666|11232847|FG000|12-month Follow-up|Withdrawal by Subject|6
7105234|NCT02421666|11232848|FG001|12-month Follow-up|Withdrawal by Subject|11
7105235|NCT02421887|11232865|FG000|Overall Study|Lost to Follow-up|5
7105236|NCT02421887|11232866|FG001|Overall Study|Lost to Follow-up|0
7105237|NCT02421887|11232865|FG000|Overall Study|Withdrawal by Subject|8
7105238|NCT02421887|11232866|FG001|Overall Study|Withdrawal by Subject|5
7105239|NCT02421887|11232865|FG000|Overall Study|Physician Decision|2
7105240|NCT02421887|11232866|FG001|Overall Study|Physician Decision|4
7105241|NCT02421887|11232865|FG000|Overall Study|Adverse Event|2
7105242|NCT02421887|11232866|FG001|Overall Study|Adverse Event|0
7105243|NCT02421952|11232872|FG000|Overall Study|Diary Not Returned|93
7105244|NCT02421952|11232872|FG000|Overall Study|Failed seriation task|13
7105245|NCT02421952|11232872|FG000|Overall Study|Subject uncooperative for baseline test|2
7105246|NCT02421952|11232872|FG000|Overall Study|Surgery cancelled|1
7105247|NCT02422186|11232881|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1
7105248|NCT02422186|11232882|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
7105249|NCT02422186|11232881|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0
7105250|NCT02422186|11232882|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
7105251|NCT02422186|11232881|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
7105252|NCT02422186|11232882|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2
7105253|NCT02422186|11232881|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3
7105254|NCT02422186|11232882|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
7105255|NCT02422186|11232881|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4
7105256|NCT02422186|11232882|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2
7105257|NCT02422186|11232881|FG000|Double-blind Induction Phase (4 Weeks)|Other|1
7105258|NCT02422186|11232882|FG001|Double-blind Induction Phase (4 Weeks)|Other|0
7105259|NCT02422186|11232881|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1
7105260|NCT02422186|11232882|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0
7105261|NCT02422186|11232881|FG000|Follow-up Phase (2 Weeks)|Other|3
7105262|NCT02422186|11232882|FG001|Follow-up Phase (2 Weeks)|Other|0
7105263|NCT02422264|11232892|FG000|Overall Study|Serious Adverse Event|1
7105264|NCT02422264|11232893|FG001|Overall Study|Serious Adverse Event|0
7105265|NCT02422264|11232892|FG000|Overall Study|Withdrawal by Subject|1
7105266|NCT02422264|11232893|FG001|Overall Study|Withdrawal by Subject|2
7105267|NCT02422264|11232892|FG000|Overall Study|Migrated/moved from study area|3
7105268|NCT02422264|11232893|FG001|Overall Study|Migrated/moved from study area|1
7105269|NCT02422264|11232892|FG000|Overall Study|Subject vaccinated outside of the study|0
7105270|NCT02422264|11232893|FG001|Overall Study|Subject vaccinated outside of the study|1
7105271|NCT02423109|11232945|FG000|Lens 1|Adverse Event|1
7105272|NCT02423109|11232946|FG001|Lens 1|Adverse Event|0
7105273|NCT02423291|11232973|FG000|Overall Study|Lack of Efficacy|14
7105274|NCT02423291|11232973|FG000|Overall Study|Adverse Event|1
7105275|NCT02423343|11232992|FG000|Overall Study|Withdrawal by Subject|0
7105276|NCT02423343|11232993|FG001|Overall Study|Withdrawal by Subject|1
7105277|NCT02423343|11232994|FG002|Overall Study|Withdrawal by Subject|0
7105278|NCT02423343|11232995|FG003|Overall Study|Withdrawal by Subject|0
7105279|NCT02423343|11232996|FG004|Overall Study|Withdrawal by Subject|0
7105280|NCT02423343|11232997|FG005|Overall Study|Withdrawal by Subject|0
7105281|NCT02423343|11232992|FG000|Overall Study|Progressive Disease|0
7105282|NCT02423343|11232993|FG001|Overall Study|Progressive Disease|0
7105283|NCT02423343|11232994|FG002|Overall Study|Progressive Disease|0
7105284|NCT02423343|11232995|FG003|Overall Study|Progressive Disease|0
7105285|NCT02423343|11232996|FG004|Overall Study|Progressive Disease|2
7105286|NCT02423343|11232997|FG005|Overall Study|Progressive Disease|0
7105287|NCT02423343|11232992|FG000|Overall Study|Adverse Event|0
7105288|NCT02423343|11232993|FG001|Overall Study|Adverse Event|0
7105289|NCT02423343|11232994|FG002|Overall Study|Adverse Event|0
7105290|NCT02423343|11232995|FG003|Overall Study|Adverse Event|0
7105291|NCT02423343|11232996|FG004|Overall Study|Adverse Event|2
7105292|NCT02423343|11232997|FG005|Overall Study|Adverse Event|0
7105293|NCT02423343|11232992|FG000|Overall Study|Death|0
7105294|NCT02423343|11232993|FG001|Overall Study|Death|0
7105295|NCT02423343|11232994|FG002|Overall Study|Death|0
7105296|NCT02423343|11232995|FG003|Overall Study|Death|0
7105297|NCT02423343|11232996|FG004|Overall Study|Death|1
7105298|NCT02423343|11232997|FG005|Overall Study|Death|0
7105299|NCT02423798|11233053|FG000|Overall Study|Withdrawal by Subject|3
7105300|NCT02424097|11233083|FG000|Overall Study|Lost to Follow-up|1
7105301|NCT02424097|11233084|FG001|Overall Study|Lost to Follow-up|2
7105302|NCT02424149|11233092|FG000|Overall Study|surgery cancelled|2
7105303|NCT02424149|11233093|FG001|Overall Study|surgery cancelled|0
7105304|NCT02424149|11233092|FG000|Overall Study|Withdrawal by Subject|0
7105305|NCT02424149|11233093|FG001|Overall Study|Withdrawal by Subject|1
7105306|NCT02424253|11233105|FG000|Overall Study|Other, unspecified|1
7105307|NCT02424253|11233106|FG001|Overall Study|Other, unspecified|0
7105308|NCT02424253|11233105|FG000|Overall Study|Compliance problems|1
7105309|NCT02424253|11233106|FG001|Overall Study|Compliance problems|0
7105310|NCT02424253|11233105|FG000|Overall Study|Physician Decision|2
7105311|NCT02424253|11233106|FG001|Overall Study|Physician Decision|0
7105312|NCT02424253|11233105|FG000|Overall Study|Lack of Efficacy|0
7105313|NCT02424253|11233106|FG001|Overall Study|Lack of Efficacy|7
7105314|NCT02424253|11233105|FG000|Overall Study|Adverse Event|2
7105315|NCT02424253|11233106|FG001|Overall Study|Adverse Event|0
7105316|NCT02424253|11233105|FG000|Overall Study|Consent withdrawn by subject|4
7105317|NCT02424253|11233106|FG001|Overall Study|Consent withdrawn by subject|1
7105318|NCT02424253|11233105|FG000|Overall Study|Lost to Follow-up|1
7105319|NCT02424253|11233106|FG001|Overall Study|Lost to Follow-up|1
7105320|NCT02424344|11233114|FG000|Overall Study|Lack of Efficacy|0
7105321|NCT02424344|11233115|FG001|Overall Study|Lack of Efficacy|1
7105322|NCT02424344|11233114|FG000|Overall Study|Withdrawal by Subject|2
7105323|NCT02424344|11233115|FG001|Overall Study|Withdrawal by Subject|1
7105324|NCT02424344|11233114|FG000|Overall Study|Lost to Follow-up|1
7105325|NCT02424344|11233115|FG001|Overall Study|Lost to Follow-up|0
7105326|NCT02424344|11233114|FG000|Overall Study|Adverse Event|4
7105327|NCT02424344|11233115|FG001|Overall Study|Adverse Event|8
7105328|NCT02424383|11233132|FG000|Overall Study|Withdrawal by Subject|32
7105329|NCT02424383|11233132|FG000|Overall Study|Death|170
7105330|NCT02424383|11233132|FG000|Overall Study|Sponsor's decision|3
7105331|NCT02424383|11233132|FG000|Overall Study|Investigator's decision|44
7105332|NCT02424383|11233132|FG000|Overall Study|Lost to Follow-up|81
7105333|NCT02424383|11233132|FG000|Overall Study|Other|7
7105334|NCT02424383|11233132|FG000|Overall Study|Ineligible for Major Protocol Deviation|39
7105335|NCT02424539|11233150|FG000|Overall Study|Adverse Event|0
7105336|NCT02424539|11233151|FG001|Overall Study|Adverse Event|0
7105337|NCT02424539|11233152|FG002|Overall Study|Adverse Event|1
7105338|NCT02424539|11233150|FG000|Overall Study|Physician Decision|0
7105339|NCT02424539|11233151|FG001|Overall Study|Physician Decision|0
7105340|NCT02424539|11233152|FG002|Overall Study|Physician Decision|1
7105341|NCT02424539|11233150|FG000|Overall Study|Withdrawal by Subject|3
7105342|NCT02424539|11233151|FG001|Overall Study|Withdrawal by Subject|1
7105343|NCT02424539|11233152|FG002|Overall Study|Withdrawal by Subject|0
7105344|NCT02424539|11233150|FG000|Overall Study|Other: Reached stopping criteria|11
7105345|NCT02424539|11233151|FG001|Overall Study|Other: Reached stopping criteria|7
7105346|NCT02424539|11233152|FG002|Overall Study|Other: Reached stopping criteria|6
7105347|NCT02424578|11233162|FG000|Overall Study|Withdrawal by Subject|0
7105348|NCT02424578|11233163|FG001|Overall Study|Withdrawal by Subject|1
7105349|NCT02424591|11233171|FG000|Overall Study|Protocol Violation|2
7105350|NCT02424591|11233172|FG001|Overall Study|Protocol Violation|3
7105351|NCT02424630|11233180|FG000|Overall Study|No rotator cuff tear|1
7105352|NCT02424630|11233181|FG001|Overall Study|No rotator cuff tear|2
7105353|NCT02424630|11233180|FG000|Overall Study|Open procedure|0
7105354|NCT02424630|11233181|FG001|Overall Study|Open procedure|1
7105355|NCT02424734|11233190|FG000|Overall Study|Treatment stopped to be discharged home|2
7105356|NCT02424734|11233191|FG001|Overall Study|Treatment stopped to be discharged home|2
7105357|NCT02424734|11233192|FG002|Overall Study|Treatment stopped to be discharged home|0
7105358|NCT02425098|11233250|FG000|Overall Study|Lost to Follow-up|7
7105359|NCT02425098|11233251|FG001|Overall Study|Lost to Follow-up|7
7105360|NCT02425098|11233250|FG000|Overall Study|Withdrawal by Subject|4
7105361|NCT02425098|11233251|FG001|Overall Study|Withdrawal by Subject|8
7105362|NCT02425098|11233250|FG000|Overall Study|Pregnancy|2
7105363|NCT02425098|11233251|FG001|Overall Study|Pregnancy|0
7105364|NCT02425098|11233250|FG000|Overall Study|Reason not Specified|0
7105365|NCT02425098|11233251|FG001|Overall Study|Reason not Specified|1
7105366|NCT02425111|11233257|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2
7105367|NCT02425111|11233257|FG000|Part A: Treatment Period|Lack of Efficacy|15
7105368|NCT02425111|11233257|FG000|Part A: Treatment Period|Voluntary Withdrawal|4
7105369|NCT02425111|11233257|FG000|Part A: Treatment Period|Lost to Follow-up|2
7105370|NCT02425111|11233257|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3
7105371|NCT02425111|11233257|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7
7105372|NCT02425891|11233285|FG000|Overall Study|Death|332
7105373|NCT02425891|11233286|FG001|Overall Study|Death|314
7105374|NCT02425891|11233285|FG000|Overall Study|Lost to Follow-up|4
7105375|NCT02425891|11233286|FG001|Overall Study|Lost to Follow-up|6
7105376|NCT02425891|11233285|FG000|Overall Study|Non-Compliance|1
7105377|NCT02425891|11233286|FG001|Overall Study|Non-Compliance|0
7105378|NCT02425891|11233285|FG000|Overall Study|Accidentally randomized screen failure participant|0
7105379|NCT02425891|11233286|FG001|Overall Study|Accidentally randomized screen failure participant|1
7105380|NCT02425891|11233285|FG000|Overall Study|Physician Decision|0
7105381|NCT02425891|11233286|FG001|Overall Study|Physician Decision|1
7105382|NCT02425891|11233285|FG000|Overall Study|Protocol Violation|1
7105383|NCT02425891|11233286|FG001|Overall Study|Protocol Violation|1
7105384|NCT02425891|11233285|FG000|Overall Study|Study Terminated By Sponsor|1
7105385|NCT02425891|11233286|FG001|Overall Study|Study Terminated By Sponsor|0
7105386|NCT02425891|11233285|FG000|Overall Study|Withdrawal by Subject|27
7105387|NCT02425891|11233286|FG001|Overall Study|Withdrawal by Subject|32
7105388|NCT02425891|11233285|FG000|Overall Study|On-going in Study|79
7105389|NCT02425891|11233286|FG001|Overall Study|On-going in Study|90
7105390|NCT02425891|11233285|FG000|Overall Study|Not treated|6
7105391|NCT02425891|11233286|FG001|Overall Study|Not treated|6
7105392|NCT02426086|11233299|FG000|Overall Study|Death|33
7105393|NCT02426086|11233300|FG001|Overall Study|Death|36
7105394|NCT02426086|11233299|FG000|Overall Study|Lost to Follow-up|2
7105395|NCT02426086|11233300|FG001|Overall Study|Lost to Follow-up|0
7105396|NCT02426086|11233299|FG000|Overall Study|Study Terminated by Sponsor|5
7105397|NCT02426086|11233300|FG001|Overall Study|Study Terminated by Sponsor|14
7105398|NCT02426086|11233299|FG000|Overall Study|Withdrawal by Subject|8
7105399|NCT02426086|11233300|FG001|Overall Study|Withdrawal by Subject|9
7105400|NCT02426138|11233313|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1
7105401|NCT02426138|11233314|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1
7105402|NCT02426541|11233335|FG000|Overall Study|Protocol Violation|1
7105403|NCT02426541|11233336|FG001|Overall Study|Protocol Violation|0
7105404|NCT02426580|11233344|FG000|Overall Study|Death|2
7105405|NCT02426580|11233345|FG001|Overall Study|Death|2
7105406|NCT02426580|11233344|FG000|Overall Study|Lost to Follow-up|0
7105407|NCT02426580|11233345|FG001|Overall Study|Lost to Follow-up|9
7105408|NCT02426580|11233344|FG000|Overall Study|transfer to hemodialysis|5
7105409|NCT02426580|11233345|FG001|Overall Study|transfer to hemodialysis|5
7105410|NCT02426580|11233344|FG000|Overall Study|Kidney transplant|3
7105411|NCT02426580|11233345|FG001|Overall Study|Kidney transplant|0
7105412|NCT02426580|11233344|FG000|Overall Study|Allergic to egg white|1
7105413|NCT02426580|11233345|FG001|Overall Study|Allergic to egg white|0
7105416|NCT02426918|11233358|FG000|Overall Study|Adverse Event|2
7105417|NCT02426918|11233359|FG001|Overall Study|Adverse Event|2
7105418|NCT02426918|11233360|FG002|Overall Study|Adverse Event|0
7105419|NCT02426918|11233358|FG000|Overall Study|Physician Decision|1
7105420|NCT02426918|11233359|FG001|Overall Study|Physician Decision|1
7105421|NCT02426918|11233360|FG002|Overall Study|Physician Decision|1
7105422|NCT02426918|11233358|FG000|Overall Study|Withdrawal by Subject|5
7105423|NCT02426918|11233359|FG001|Overall Study|Withdrawal by Subject|5
7105424|NCT02426918|11233360|FG002|Overall Study|Withdrawal by Subject|4
7105425|NCT02426918|11233358|FG000|Overall Study|Other|9
7105426|NCT02426918|11233359|FG001|Overall Study|Other|11
7105427|NCT02426918|11233360|FG002|Overall Study|Other|9
7105428|NCT02427100|11233370|FG000|Overall Study|Lost to Follow-up|0
7105429|NCT02427100|11233371|FG001|Overall Study|Lost to Follow-up|2
7105430|NCT02427399|11233382|FG000|Overall Study|Protocol Violation|14
7105431|NCT02427399|11233383|FG001|Overall Study|Protocol Violation|16
7105432|NCT02427399|11233384|FG002|Overall Study|Protocol Violation|12
7105433|NCT02427399|11233385|FG003|Overall Study|Protocol Violation|18
7105434|NCT02427399|11233386|FG004|Overall Study|Protocol Violation|15
7105435|NCT02427477|11233400|FG000|Period 1|Adverse Event|1
7105436|NCT02427477|11233401|FG001|Period 1|Adverse Event|0
7105437|NCT02427607|11233407|FG000|Overall Study|Withdrawal by Subject|1
7105438|NCT02427646|11233413|FG000|Overall Study|Lack of Efficacy|2
7105439|NCT02427646|11233414|FG001|Overall Study|Lack of Efficacy|3
7105440|NCT02427646|11233413|FG000|Overall Study|Physician Decision|1
7105441|NCT02427646|11233414|FG001|Overall Study|Physician Decision|4
7105442|NCT02427646|11233413|FG000|Overall Study|Protocol Violation|3
7105443|NCT02427646|11233414|FG001|Overall Study|Protocol Violation|3
7105444|NCT02427646|11233413|FG000|Overall Study|Bothersome hand weakness|2
7105445|NCT02427646|11233414|FG001|Overall Study|Bothersome hand weakness|4
7105446|NCT02427802|11233461|FG000|Overall Study|Adverse Event|11
7105447|NCT02427802|11233462|FG001|Overall Study|Adverse Event|3
7105448|NCT02427802|11233463|FG002|Overall Study|Adverse Event|7
7105449|NCT02427802|11233461|FG000|Overall Study|Death|0
7105450|NCT02427802|11233462|FG001|Overall Study|Death|4
7105451|NCT02427802|11233463|FG002|Overall Study|Death|1
7105452|NCT02427802|11233461|FG000|Overall Study|Lost to Follow-up|13
7105453|NCT02427802|11233462|FG001|Overall Study|Lost to Follow-up|8
7105454|NCT02427802|11233463|FG002|Overall Study|Lost to Follow-up|8
7105455|NCT02427802|11233461|FG000|Overall Study|Physician Decision|4
7105456|NCT02427802|11233462|FG001|Overall Study|Physician Decision|2
7105457|NCT02427802|11233463|FG002|Overall Study|Physician Decision|4
7105458|NCT02427802|11233461|FG000|Overall Study|Withdrawal by Subject|10
7105459|NCT02427802|11233462|FG001|Overall Study|Withdrawal by Subject|5
7105460|NCT02427802|11233463|FG002|Overall Study|Withdrawal by Subject|11
7105461|NCT02427802|11233461|FG000|Overall Study|Protocol Violation|3
7105462|NCT02427802|11233462|FG001|Overall Study|Protocol Violation|1
7105463|NCT02427802|11233463|FG002|Overall Study|Protocol Violation|1
7105464|NCT02427802|11233461|FG000|Overall Study|protocol specific treatment unrelated|18
7105465|NCT02427802|11233462|FG001|Overall Study|protocol specific treatment unrelated|11
7105466|NCT02427802|11233463|FG002|Overall Study|protocol specific treatment unrelated|11
7105467|NCT02427841|11233471|FG000|Overall Study|Physician Decision|8
7105468|NCT02427984|11233478|FG000|Overall Study|Lost to Follow-up|13
7105469|NCT02427984|11233479|FG001|Overall Study|Lost to Follow-up|5
7105470|NCT02427984|11233480|FG002|Overall Study|Lost to Follow-up|18
7105471|NCT02428296|11233489|FG000|Overall Study|Adverse Event|7
7105472|NCT02428296|11233489|FG000|Overall Study|Withdrawal by Subject|2
7105473|NCT02428413|11233503|FG000|Overall Study|Device to measure WAG malfunctioned|3
7105474|NCT02428413|11233504|FG001|Overall Study|Device to measure WAG malfunctioned|5
7105475|NCT02428413|11233503|FG000|Overall Study|Protocol Violation|1
7105476|NCT02428413|11233504|FG001|Overall Study|Protocol Violation|2
7105477|NCT02428413|11233503|FG000|Overall Study|Case Cancelled|2
7105478|NCT02428413|11233504|FG001|Overall Study|Case Cancelled|0
7105479|NCT02428413|11233503|FG000|Overall Study|Missed Cases|1
7105480|NCT02428413|11233504|FG001|Overall Study|Missed Cases|2
7105481|NCT02428413|11233503|FG000|Overall Study|Nurse Refusal|1
7105482|NCT02428413|11233504|FG001|Overall Study|Nurse Refusal|0
7105483|NCT02428608|11233530|FG000|Overall Study|Pregnancy|2
7105484|NCT02428608|11233530|FG000|Overall Study|Lost to Follow-up|37
7105485|NCT02428608|11233530|FG000|Overall Study|Withdrawal by Subject|2
7105486|NCT02428608|11233530|FG000|Overall Study|scheduling conflicts|15
7105487|NCT02428608|11233530|FG000|Overall Study|moved away|10
7105488|NCT02428608|11233530|FG000|Overall Study|Death|1
7105489|NCT02428608|11233530|FG000|Overall Study|various|16
7105490|NCT02428699|11233535|FG000|Washout Period 1|Screen Failure|1
7105491|NCT02428699|11233536|FG001|Washout Period 1|Screen Failure|2
7105492|NCT02428855|11233547|FG000|Overall Study|Withdrawal by Subject|2
7105493|NCT02429258|11233578|FG000|Overall Study|Withdrawal by Subject|2
7105494|NCT02429258|11233579|FG001|Overall Study|Withdrawal by Subject|0
7105495|NCT02429258|11233578|FG000|Overall Study|Protocol Violation|0
7105496|NCT02429258|11233579|FG001|Overall Study|Protocol Violation|1
7105497|NCT02429310|11233587|FG000|Overall Study|Lost to Follow-up|1
7105498|NCT02429310|11233588|FG001|Overall Study|Lost to Follow-up|2
7105499|NCT02429310|11233587|FG000|Overall Study|Protocol Violation|1
7105500|NCT02429310|11233588|FG001|Overall Study|Protocol Violation|1
7105501|NCT02429427|11233596|FG000|Overall Study|Adverse Event|220
7105502|NCT02429427|11233597|FG001|Overall Study|Adverse Event|92
7105503|NCT02429427|11233596|FG000|Overall Study|Protocol Violation|10
7105504|NCT02429427|11233597|FG001|Overall Study|Protocol Violation|6
7105505|NCT02429427|11233596|FG000|Overall Study|Lost to Follow-up|15
7105506|NCT02429427|11233597|FG001|Overall Study|Lost to Follow-up|6
7105507|NCT02429427|11233596|FG000|Overall Study|Withdrawal by Subject|64
7105508|NCT02429427|11233597|FG001|Overall Study|Withdrawal by Subject|34
7105509|NCT02429427|11233596|FG000|Overall Study|Other|62
7105510|NCT02429427|11233597|FG001|Overall Study|Other|41
7105511|NCT02429778|11233605|FG000|Overall Study|Lost to Follow-up|2
7105512|NCT02429778|11233606|FG001|Overall Study|Lost to Follow-up|0
7105513|NCT02429778|11233605|FG000|Overall Study|Withdrawal by Subject|5
7105514|NCT02429778|11233606|FG001|Overall Study|Withdrawal by Subject|0
7105515|NCT02429856|11233614|FG000|Overall Study|Death|12
7105516|NCT02429856|11233615|FG001|Overall Study|Death|13
7105517|NCT02429856|11233614|FG000|Overall Study|Lost to Follow-up|6
7105518|NCT02429856|11233615|FG001|Overall Study|Lost to Follow-up|5
7105519|NCT02429856|11233614|FG000|Overall Study|Withdrawal by Subject|1
7105520|NCT02429856|11233615|FG001|Overall Study|Withdrawal by Subject|1
7105521|NCT02429934|11233629|FG000|Overall Study|Withdrawal by Subject|0
7105522|NCT02429934|11233630|FG001|Overall Study|Withdrawal by Subject|2
7105523|NCT02429934|11233629|FG000|Overall Study|Adverse Event|2
7105524|NCT02429934|11233630|FG001|Overall Study|Adverse Event|0
7105525|NCT02429934|11233629|FG000|Overall Study|Lost to Follow-up|1
7105526|NCT02429934|11233630|FG001|Overall Study|Lost to Follow-up|1
7105527|NCT02429934|11233629|FG000|Overall Study|Physician Decision|1
7105528|NCT02429934|11233630|FG001|Overall Study|Physician Decision|0
7105529|NCT02430311|11233653|FG000|Part A|Adverse Event|0
7105530|NCT02430311|11233654|FG001|Part A|Adverse Event|1
7105531|NCT02430311|11233653|FG000|Part A|Withdrawal by Subject|1
7105532|NCT02430311|11233654|FG001|Part A|Withdrawal by Subject|0
7105533|NCT02430311|11233653|FG000|Part B|Meet study-specific withdrawal criteria|6
7105534|NCT02430311|11233654|FG001|Part B|Meet study-specific withdrawal criteria|6
7105535|NCT02430311|11233653|FG000|Part B|Withdrawal by Subject|2
7105536|NCT02430311|11233654|FG001|Part B|Withdrawal by Subject|2
7105537|NCT02430311|11233653|FG000|Part B|Adverse Event|1
7105538|NCT02430311|11233654|FG001|Part B|Adverse Event|0
7105539|NCT02430311|11233653|FG000|Part B|Death|1
7105540|NCT02430311|11233654|FG001|Part B|Death|0
7105541|NCT02430480|11233691|FG000|Overall Study|Death|1
7105542|NCT02430480|11233691|FG000|Overall Study|Anesthesia concerns|1
7105543|NCT02430480|11233691|FG000|Overall Study|Progressed on treatment|1
7105544|NCT02430870|11233719|FG000|Part 2|Voluntary Withdrawal|0
7105545|NCT02430870|11233720|FG001|Part 2|Voluntary Withdrawal|0
7105546|NCT02430870|11233721|FG002|Part 2|Voluntary Withdrawal|0
7105547|NCT02430870|11233722|FG003|Part 2|Voluntary Withdrawal|0
7105548|NCT02430870|11233723|FG004|Part 2|Voluntary Withdrawal|0
7105549|NCT02430870|11233724|FG005|Part 2|Voluntary Withdrawal|0
7105550|NCT02430870|11233725|FG006|Part 2|Voluntary Withdrawal|1
7105551|NCT02430870|11233726|FG007|Part 2|Voluntary Withdrawal|0
7105552|NCT02430870|11233719|FG000|Part 2|Other Reason Not Specified|0
7105553|NCT02430870|11233720|FG001|Part 2|Other Reason Not Specified|0
7105554|NCT02430870|11233721|FG002|Part 2|Other Reason Not Specified|0
7105555|NCT02430870|11233722|FG003|Part 2|Other Reason Not Specified|0
7105556|NCT02430870|11233723|FG004|Part 2|Other Reason Not Specified|0
7105557|NCT02430870|11233724|FG005|Part 2|Other Reason Not Specified|0
7105558|NCT02430870|11233725|FG006|Part 2|Other Reason Not Specified|0
7105559|NCT02430870|11233726|FG007|Part 2|Other Reason Not Specified|1
7105560|NCT02431260|11233784|FG000|Overall Study|Subject Decision|0
7105561|NCT02431260|11233785|FG001|Overall Study|Subject Decision|1
7105562|NCT02431260|11233786|FG002|Overall Study|Subject Decision|1
7105563|NCT02431260|11233787|FG003|Overall Study|Subject Decision|0
7105564|NCT02431260|11233788|FG004|Overall Study|Subject Decision|0
7105565|NCT02431260|11233789|FG005|Overall Study|Subject Decision|0
7105566|NCT02431260|11233790|FG006|Overall Study|Subject Decision|0
7105567|NCT02431260|11233791|FG007|Overall Study|Subject Decision|0
7105568|NCT02431260|11233792|FG008|Overall Study|Subject Decision|1
7105569|NCT02431260|11233793|FG009|Overall Study|Subject Decision|1
7105570|NCT02431260|11233794|FG010|Overall Study|Subject Decision|0
7105571|NCT02431260|11233795|FG011|Overall Study|Subject Decision|1
7105572|NCT02431260|11233796|FG012|Overall Study|Subject Decision|0
7105573|NCT02431260|11233797|FG013|Overall Study|Subject Decision|0
7105574|NCT02431260|11233784|FG000|Overall Study|Death|4
7105575|NCT02431260|11233785|FG001|Overall Study|Death|4
7105576|NCT02431260|11233786|FG002|Overall Study|Death|3
7105577|NCT02431260|11233787|FG003|Overall Study|Death|4
7105578|NCT02431260|11233788|FG004|Overall Study|Death|2
7105579|NCT02431260|11233789|FG005|Overall Study|Death|2
7105580|NCT02431260|11233790|FG006|Overall Study|Death|3
7105581|NCT02431260|11233791|FG007|Overall Study|Death|1
7105582|NCT02431260|11233792|FG008|Overall Study|Death|6
7105583|NCT02431260|11233793|FG009|Overall Study|Death|6
7105584|NCT02431260|11233794|FG010|Overall Study|Death|3
7105585|NCT02431260|11233795|FG011|Overall Study|Death|2
7105586|NCT02431260|11233796|FG012|Overall Study|Death|5
7105587|NCT02431260|11233797|FG013|Overall Study|Death|1
7105588|NCT02431260|11233784|FG000|Overall Study|Lost to Follow-up|0
7105589|NCT02431260|11233785|FG001|Overall Study|Lost to Follow-up|0
7105590|NCT02431260|11233786|FG002|Overall Study|Lost to Follow-up|0
7105591|NCT02431260|11233787|FG003|Overall Study|Lost to Follow-up|0
7105592|NCT02431260|11233788|FG004|Overall Study|Lost to Follow-up|0
7105593|NCT02431260|11233789|FG005|Overall Study|Lost to Follow-up|1
7105594|NCT02431260|11233790|FG006|Overall Study|Lost to Follow-up|0
7105595|NCT02431260|11233791|FG007|Overall Study|Lost to Follow-up|0
7105596|NCT02431260|11233792|FG008|Overall Study|Lost to Follow-up|0
7105597|NCT02431260|11233793|FG009|Overall Study|Lost to Follow-up|0
7105598|NCT02431260|11233794|FG010|Overall Study|Lost to Follow-up|0
7105599|NCT02431260|11233795|FG011|Overall Study|Lost to Follow-up|0
7105600|NCT02431260|11233796|FG012|Overall Study|Lost to Follow-up|0
7105601|NCT02431260|11233797|FG013|Overall Study|Lost to Follow-up|0
7105602|NCT02431260|11233784|FG000|Overall Study|Study Terminated by the Sponsor|0
7105603|NCT02431260|11233785|FG001|Overall Study|Study Terminated by the Sponsor|0
7105604|NCT02431260|11233786|FG002|Overall Study|Study Terminated by the Sponsor|2
7105605|NCT02431260|11233787|FG003|Overall Study|Study Terminated by the Sponsor|1
7105606|NCT02431260|11233788|FG004|Overall Study|Study Terminated by the Sponsor|1
7105607|NCT02431260|11233789|FG005|Overall Study|Study Terminated by the Sponsor|0
7105608|NCT02431260|11233790|FG006|Overall Study|Study Terminated by the Sponsor|1
7105609|NCT02431260|11233791|FG007|Overall Study|Study Terminated by the Sponsor|2
7105610|NCT02431260|11233792|FG008|Overall Study|Study Terminated by the Sponsor|1
7105611|NCT02431260|11233793|FG009|Overall Study|Study Terminated by the Sponsor|1
7105612|NCT02431260|11233794|FG010|Overall Study|Study Terminated by the Sponsor|1
7105613|NCT02431260|11233795|FG011|Overall Study|Study Terminated by the Sponsor|0
7105614|NCT02431260|11233796|FG012|Overall Study|Study Terminated by the Sponsor|4
7105615|NCT02431260|11233797|FG013|Overall Study|Study Terminated by the Sponsor|0
7105616|NCT02431260|11233784|FG000|Overall Study|Physician Decision|0
7105617|NCT02431260|11233785|FG001|Overall Study|Physician Decision|0
7105618|NCT02431260|11233786|FG002|Overall Study|Physician Decision|0
7105619|NCT02431260|11233787|FG003|Overall Study|Physician Decision|0
7105620|NCT02431260|11233788|FG004|Overall Study|Physician Decision|0
7105621|NCT02431260|11233789|FG005|Overall Study|Physician Decision|1
7105622|NCT02431260|11233790|FG006|Overall Study|Physician Decision|0
7105623|NCT02431260|11233791|FG007|Overall Study|Physician Decision|0
7105624|NCT02431260|11233792|FG008|Overall Study|Physician Decision|0
7105625|NCT02431260|11233793|FG009|Overall Study|Physician Decision|0
7105626|NCT02431260|11233794|FG010|Overall Study|Physician Decision|0
7105627|NCT02431260|11233795|FG011|Overall Study|Physician Decision|0
7105628|NCT02431260|11233796|FG012|Overall Study|Physician Decision|0
7105629|NCT02431260|11233797|FG013|Overall Study|Physician Decision|0
7105630|NCT02431260|11233784|FG000|Overall Study|Other Unspecified|0
7105631|NCT02431260|11233785|FG001|Overall Study|Other Unspecified|0
7105632|NCT02431260|11233786|FG002|Overall Study|Other Unspecified|0
7105633|NCT02431260|11233787|FG003|Overall Study|Other Unspecified|0
7105634|NCT02431260|11233788|FG004|Overall Study|Other Unspecified|0
7105635|NCT02431260|11233789|FG005|Overall Study|Other Unspecified|0
7105636|NCT02431260|11233790|FG006|Overall Study|Other Unspecified|0
7105637|NCT02431260|11233791|FG007|Overall Study|Other Unspecified|0
7105638|NCT02431260|11233792|FG008|Overall Study|Other Unspecified|0
7105639|NCT02431260|11233793|FG009|Overall Study|Other Unspecified|0
7105640|NCT02431260|11233794|FG010|Overall Study|Other Unspecified|0
7105641|NCT02431260|11233795|FG011|Overall Study|Other Unspecified|1
7105642|NCT02431260|11233796|FG012|Overall Study|Other Unspecified|1
7105643|NCT02431260|11233797|FG013|Overall Study|Other Unspecified|0
7105644|NCT02431364|11233862|FG000|Overall Study|Adverse Event|0
7105645|NCT02431364|11233863|FG001|Overall Study|Adverse Event|1
7105646|NCT02431364|11233864|FG002|Overall Study|Adverse Event|0
7105647|NCT02431364|11233865|FG003|Overall Study|Adverse Event|0
7105648|NCT02431364|11233866|FG004|Overall Study|Adverse Event|0
7105649|NCT02431364|11233862|FG000|Overall Study|Randomized but never treated|0
7105650|NCT02431364|11233863|FG001|Overall Study|Randomized but never treated|0
7105651|NCT02431364|11233864|FG002|Overall Study|Randomized but never treated|0
7105652|NCT02431364|11233865|FG003|Overall Study|Randomized but never treated|1
7105653|NCT02431364|11233866|FG004|Overall Study|Randomized but never treated|0
7105654|NCT02431468|11233894|FG000|Overall Study|Adverse Event|2
7105655|NCT02431468|11233895|FG001|Overall Study|Adverse Event|4
7105656|NCT02431468|11233896|FG002|Overall Study|Adverse Event|5
7105657|NCT02431468|11233894|FG000|Overall Study|Withdrawal by Subject|4
7105658|NCT02431468|11233895|FG001|Overall Study|Withdrawal by Subject|12
7105659|NCT02431468|11233896|FG002|Overall Study|Withdrawal by Subject|2
7105660|NCT02431468|11233894|FG000|Overall Study|noncompliance, investigator termination,|2
7105661|NCT02431468|11233895|FG001|Overall Study|noncompliance, investigator termination,|2
7105662|NCT02431468|11233896|FG002|Overall Study|noncompliance, investigator termination,|2
7105663|NCT02431533|11233912|FG000|Overall Study|Withdrawal by Subject|1
7105664|NCT02431533|11233913|FG001|Overall Study|Withdrawal by Subject|3
7105665|NCT02431533|11233912|FG000|Overall Study|Developed Exclusionary criteria|1
7105666|NCT02431533|11233913|FG001|Overall Study|Developed Exclusionary criteria|0
7105667|NCT02431559|11233923|FG000|Overall Study|Adverse Event|0
7105668|NCT02431559|11233924|FG001|Overall Study|Adverse Event|1
7105669|NCT02431559|11233925|FG002|Overall Study|Adverse Event|0
7105670|NCT02431559|11233926|FG003|Overall Study|Adverse Event|4
7105671|NCT02431559|11233923|FG000|Overall Study|Progressive disease|2
7105672|NCT02431559|11233924|FG001|Overall Study|Progressive disease|1
7105673|NCT02431559|11233925|FG002|Overall Study|Progressive disease|4
7105674|NCT02431559|11233926|FG003|Overall Study|Progressive disease|22
7105675|NCT02431559|11233923|FG000|Overall Study|Withdrawal by Subject|0
7105676|NCT02431559|11233924|FG001|Overall Study|Withdrawal by Subject|1
7105677|NCT02431559|11233925|FG002|Overall Study|Withdrawal by Subject|0
7105678|NCT02431559|11233926|FG003|Overall Study|Withdrawal by Subject|4
7105679|NCT02431559|11233923|FG000|Overall Study|Physician Decision|0
7105680|NCT02431559|11233924|FG001|Overall Study|Physician Decision|0
7105681|NCT02431559|11233925|FG002|Overall Study|Physician Decision|0
7105682|NCT02431559|11233926|FG003|Overall Study|Physician Decision|1
7105683|NCT02431676|11233987|FG000|Overall Study|no lab obtained|0
7105684|NCT02431676|11233988|FG001|Overall Study|no lab obtained|1
7105685|NCT02431676|11233989|FG002|Overall Study|no lab obtained|2
7105686|NCT02431793|11234015|FG000|Overall Study|Ineligible doe to not filling Rx|11
7105687|NCT02431793|11234016|FG001|Overall Study|Ineligible doe to not filling Rx|7
7105688|NCT02431793|11234017|FG002|Overall Study|Ineligible doe to not filling Rx|8
7105689|NCT02431793|11234015|FG000|Overall Study|Withdrawal by Subject|7
7105690|NCT02431793|11234016|FG001|Overall Study|Withdrawal by Subject|5
7105691|NCT02431793|11234017|FG002|Overall Study|Withdrawal by Subject|5
7105692|NCT02431793|11234015|FG000|Overall Study|Lost to Follow-up|101
7105693|NCT02431793|11234016|FG001|Overall Study|Lost to Follow-up|122
7105694|NCT02431793|11234017|FG002|Overall Study|Lost to Follow-up|104
7105695|NCT02431806|11234029|FG000|Double-blind Treatment Period|Did not Receive Treatment|1
7105696|NCT02431806|11234030|FG001|Double-blind Treatment Period|Did not Receive Treatment|2
7105697|NCT02431806|11234031|FG002|Double-blind Treatment Period|Did not Receive Treatment|1
7105698|NCT02431806|11234032|FG003|Double-blind Treatment Period|Did not Receive Treatment|1
7105699|NCT02431806|11234029|FG000|Double-blind Treatment Period|Adverse Event|4
7105700|NCT02431806|11234030|FG001|Double-blind Treatment Period|Adverse Event|7
7105701|NCT02431806|11234031|FG002|Double-blind Treatment Period|Adverse Event|11
7105702|NCT02431806|11234032|FG003|Double-blind Treatment Period|Adverse Event|7
7105703|NCT02431806|11234029|FG000|Double-blind Treatment Period|Lack of Efficacy|2
7105704|NCT02431806|11234030|FG001|Double-blind Treatment Period|Lack of Efficacy|0
7105705|NCT02431806|11234031|FG002|Double-blind Treatment Period|Lack of Efficacy|2
7105706|NCT02431806|11234032|FG003|Double-blind Treatment Period|Lack of Efficacy|2
7105707|NCT02431806|11234029|FG000|Double-blind Treatment Period|Withdrawal of Consent|10
7105708|NCT02431806|11234030|FG001|Double-blind Treatment Period|Withdrawal of Consent|7
7105709|NCT02431806|11234031|FG002|Double-blind Treatment Period|Withdrawal of Consent|5
7105710|NCT02431806|11234032|FG003|Double-blind Treatment Period|Withdrawal of Consent|5
7105711|NCT02431806|11234029|FG000|Double-blind Treatment Period|Lost to Follow-up|7
7105712|NCT02431806|11234030|FG001|Double-blind Treatment Period|Lost to Follow-up|4
7105713|NCT02431806|11234031|FG002|Double-blind Treatment Period|Lost to Follow-up|5
7105714|NCT02431806|11234032|FG003|Double-blind Treatment Period|Lost to Follow-up|8
7105715|NCT02431806|11234029|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1
7105716|NCT02431806|11234030|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0
7105717|NCT02431806|11234031|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3
7105718|NCT02431806|11234032|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1
7105719|NCT02431806|11234029|FG000|Double-blind Treatment Period|Reason Not Specified|0
7105720|NCT02431806|11234030|FG001|Double-blind Treatment Period|Reason Not Specified|1
7105721|NCT02431806|11234031|FG002|Double-blind Treatment Period|Reason Not Specified|5
7105722|NCT02431806|11234032|FG003|Double-blind Treatment Period|Reason Not Specified|2
7105723|NCT02432040|11234044|FG000|Overall Study|Lack of Efficacy|3
7105724|NCT02432040|11234045|FG001|Overall Study|Lack of Efficacy|0
7105725|NCT02432040|11234044|FG000|Overall Study|Lost to Follow-up|4
7105726|NCT02432040|11234045|FG001|Overall Study|Lost to Follow-up|5
7105727|NCT02432040|11234044|FG000|Overall Study|Physician Decision|1
7105728|NCT02432040|11234045|FG001|Overall Study|Physician Decision|1
7105729|NCT02432105|11234054|FG000|Overall Study|Lost to Follow-up|1
7105730|NCT02432105|11234055|FG001|Overall Study|Lost to Follow-up|1
7105731|NCT02432105|11234056|FG002|Overall Study|Lost to Follow-up|0
7105732|NCT02432105|11234054|FG000|Overall Study|Withdrawal by Subject|1
7105733|NCT02432105|11234055|FG001|Overall Study|Withdrawal by Subject|0
7105734|NCT02432105|11234056|FG002|Overall Study|Withdrawal by Subject|1
7105735|NCT02432105|11234054|FG000|Overall Study|Culture positive for yeast|0
7105736|NCT02432105|11234055|FG001|Overall Study|Culture positive for yeast|1
7105737|NCT02432105|11234056|FG002|Overall Study|Culture positive for yeast|0
7105738|NCT02432105|11234054|FG000|Overall Study|Randomized in error|0
7105739|NCT02432105|11234055|FG001|Overall Study|Randomized in error|0
7105740|NCT02432105|11234056|FG002|Overall Study|Randomized in error|2
7105741|NCT02432144|11234065|FG000|Overall Study|Participant Non-Compliance|1
7105742|NCT02432235|11234098|FG000|Overall Study|Death|1
7105743|NCT02432235|11234099|FG001|Overall Study|Death|1
7105744|NCT02432235|11234100|FG002|Overall Study|Death|2
7105745|NCT02432235|11234101|FG003|Overall Study|Death|2
7105746|NCT02432235|11234102|FG004|Overall Study|Death|1
7105747|NCT02432235|11234103|FG005|Overall Study|Death|3
7105748|NCT02432235|11234104|FG006|Overall Study|Death|11
7105749|NCT02432235|11234105|FG007|Overall Study|Death|15
7105750|NCT02432235|11234106|FG008|Overall Study|Death|15
7105751|NCT02432235|11234107|FG009|Overall Study|Death|3
7105752|NCT02432235|11234108|FG010|Overall Study|Death|1
7105753|NCT02432235|11234109|FG011|Overall Study|Death|0
7105754|NCT02432235|11234098|FG000|Overall Study|Withdrawal by Subject|0
7105755|NCT02432235|11234099|FG001|Overall Study|Withdrawal by Subject|1
7105756|NCT02432235|11234100|FG002|Overall Study|Withdrawal by Subject|0
7105757|NCT02432235|11234101|FG003|Overall Study|Withdrawal by Subject|0
7105758|NCT02432235|11234102|FG004|Overall Study|Withdrawal by Subject|0
7105759|NCT02432235|11234103|FG005|Overall Study|Withdrawal by Subject|2
7105760|NCT02432235|11234104|FG006|Overall Study|Withdrawal by Subject|5
7105761|NCT02432235|11234105|FG007|Overall Study|Withdrawal by Subject|3
7105762|NCT02432235|11234106|FG008|Overall Study|Withdrawal by Subject|1
7105763|NCT02432235|11234107|FG009|Overall Study|Withdrawal by Subject|0
7105764|NCT02432235|11234108|FG010|Overall Study|Withdrawal by Subject|0
7105765|NCT02432235|11234109|FG011|Overall Study|Withdrawal by Subject|0
7105766|NCT02432235|11234098|FG000|Overall Study|Lost to Follow-up|0
7105767|NCT02432235|11234099|FG001|Overall Study|Lost to Follow-up|0
7105768|NCT02432235|11234100|FG002|Overall Study|Lost to Follow-up|0
7105769|NCT02432235|11234101|FG003|Overall Study|Lost to Follow-up|0
7105770|NCT02432235|11234102|FG004|Overall Study|Lost to Follow-up|0
7105771|NCT02432235|11234103|FG005|Overall Study|Lost to Follow-up|1
7105772|NCT02432235|11234104|FG006|Overall Study|Lost to Follow-up|0
7105773|NCT02432235|11234105|FG007|Overall Study|Lost to Follow-up|0
7105774|NCT02432235|11234106|FG008|Overall Study|Lost to Follow-up|1
7105775|NCT02432235|11234107|FG009|Overall Study|Lost to Follow-up|0
7105776|NCT02432235|11234108|FG010|Overall Study|Lost to Follow-up|0
7105777|NCT02432235|11234109|FG011|Overall Study|Lost to Follow-up|0
7105778|NCT02432235|11234098|FG000|Overall Study|Miscellaneous|0
7105779|NCT02432235|11234099|FG001|Overall Study|Miscellaneous|0
7105780|NCT02432235|11234100|FG002|Overall Study|Miscellaneous|0
7105781|NCT02432235|11234101|FG003|Overall Study|Miscellaneous|0
7105782|NCT02432235|11234102|FG004|Overall Study|Miscellaneous|1
7105783|NCT02432235|11234103|FG005|Overall Study|Miscellaneous|6
7105784|NCT02432235|11234104|FG006|Overall Study|Miscellaneous|2
7105785|NCT02432235|11234105|FG007|Overall Study|Miscellaneous|2
7105786|NCT02432235|11234106|FG008|Overall Study|Miscellaneous|4
7105787|NCT02432235|11234107|FG009|Overall Study|Miscellaneous|0
7105788|NCT02432235|11234108|FG010|Overall Study|Miscellaneous|0
7105789|NCT02432235|11234109|FG011|Overall Study|Miscellaneous|1
6805808|NCT02639546|10807994|FG001|Overall Study|Withdrawal by Subject|2
6805809|NCT02639546|10807995|FG002|Overall Study|Withdrawal by Subject|1
6805810|NCT02639546|10807996|FG003|Overall Study|Withdrawal by Subject|0
6805811|NCT02639546|10807997|FG004|Overall Study|Withdrawal by Subject|0
6805812|NCT02639546|10807998|FG005|Overall Study|Withdrawal by Subject|1
6805813|NCT02639546|10807999|FG006|Overall Study|Withdrawal by Subject|2
6805814|NCT02639546|10808000|FG007|Overall Study|Withdrawal by Subject|1
6805815|NCT02575339|10808035|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1
6805816|NCT02575339|10808036|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0
6805817|NCT02575339|10808037|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0
6805818|NCT02575339|10808035|FG000|Study Treatment|Disease Progression|5
6805819|NCT02575339|10808036|FG001|Study Treatment|Disease Progression|2
6805820|NCT02575339|10808037|FG002|Study Treatment|Disease Progression|0
6805821|NCT02575339|10808035|FG000|Study Treatment|Adverse Event|1
6805822|NCT02575339|10808036|FG001|Study Treatment|Adverse Event|2
6805823|NCT02575339|10808037|FG002|Study Treatment|Adverse Event|0
6805824|NCT02575339|10808035|FG000|Follow up|Death|6
7105846|NCT02432703|11234208|FG000|Overall Study|Adverse Event|1
7105847|NCT02432703|11234209|FG001|Overall Study|Adverse Event|4
7105848|NCT02432703|11234208|FG000|Overall Study|Lack of Efficacy|1
7105849|NCT02432703|11234209|FG001|Overall Study|Lack of Efficacy|0
7105850|NCT02432703|11234208|FG000|Overall Study|Lost to Follow-up|5
7105851|NCT02432703|11234209|FG001|Overall Study|Lost to Follow-up|3
7105852|NCT02432703|11234208|FG000|Overall Study|Withdrawal by Subject|9
7105853|NCT02432703|11234209|FG001|Overall Study|Withdrawal by Subject|6
7105854|NCT02432703|11234208|FG000|Overall Study|Other|6
7105855|NCT02432703|11234209|FG001|Overall Study|Other|5
7105856|NCT02433080|11234236|FG000|Overall Study|Lost to Follow-up|1
7105857|NCT02433080|11234237|FG001|Overall Study|Lost to Follow-up|2
7105858|NCT02433080|11234236|FG000|Overall Study|Withdrawal by Subject|0
7105859|NCT02433080|11234237|FG001|Overall Study|Withdrawal by Subject|2
7105860|NCT02433288|11234246|FG000|Overall Study|Severe non-compliance to protocol|13
7105861|NCT02433288|11234247|FG001|Overall Study|Severe non-compliance to protocol|7
7105862|NCT02433288|11234246|FG000|Overall Study|Eligibility criteria not fullfilled|7
7105863|NCT02433288|11234247|FG001|Overall Study|Eligibility criteria not fullfilled|3
7105864|NCT02433288|11234246|FG000|Overall Study|Withdrawal by Subject|101
7105865|NCT02433288|11234247|FG001|Overall Study|Withdrawal by Subject|99
7105866|NCT02433288|11234246|FG000|Overall Study|Lost to Follow-up|2
7105867|NCT02433288|11234247|FG001|Overall Study|Lost to Follow-up|14
7105868|NCT02433288|11234246|FG000|Overall Study|Death|0
7105869|NCT02433288|11234247|FG001|Overall Study|Death|3
7105870|NCT02433340|11234257|FG000|Overall Study|Adverse Event|0
7105871|NCT02433340|11234258|FG001|Overall Study|Adverse Event|0
7105872|NCT02433340|11234259|FG002|Overall Study|Adverse Event|1
7105873|NCT02433340|11234260|FG003|Overall Study|Adverse Event|0
7105874|NCT02433340|11234257|FG000|Overall Study|Withdrawal by Subject|1
7105875|NCT02433340|11234258|FG001|Overall Study|Withdrawal by Subject|0
7105876|NCT02433340|11234259|FG002|Overall Study|Withdrawal by Subject|1
7105877|NCT02433340|11234260|FG003|Overall Study|Withdrawal by Subject|2
7105878|NCT02433340|11234257|FG000|Overall Study|Lost to Follow-up|0
7105879|NCT02433340|11234258|FG001|Overall Study|Lost to Follow-up|1
7105880|NCT02433340|11234259|FG002|Overall Study|Lost to Follow-up|0
7105881|NCT02433340|11234260|FG003|Overall Study|Lost to Follow-up|0
7105882|NCT02433340|11234257|FG000|Overall Study|Required Alternative/Prohibited Therapy|1
7105883|NCT02433340|11234258|FG001|Overall Study|Required Alternative/Prohibited Therapy|0
7105884|NCT02433340|11234259|FG002|Overall Study|Required Alternative/Prohibited Therapy|0
7105885|NCT02433340|11234260|FG003|Overall Study|Required Alternative/Prohibited Therapy|0
7105886|NCT02433340|11234257|FG000|Overall Study|Other|0
7105887|NCT02433340|11234258|FG001|Overall Study|Other|1
7105888|NCT02433340|11234259|FG002|Overall Study|Other|0
7105889|NCT02433340|11234260|FG003|Overall Study|Other|0
7105890|NCT02433379|11234281|FG000|Overall Study|Screen Failures|55
7105891|NCT02433379|11234281|FG000|Overall Study|Death|57
7105892|NCT02433379|11234281|FG000|Overall Study|Total Withdrawals|209
7105893|NCT02433483|11234287|FG000|Overall Study|Unacceptable toxicity|1
7105894|NCT02433483|11234287|FG000|Overall Study|Other antineoplastic therapy/HSCT|1
7105895|NCT02433678|11234318|FG000|Overall Study|Lost to Follow-up|1
7105896|NCT02433678|11234319|FG001|Overall Study|Lost to Follow-up|2
7105897|NCT02433834|11234325|FG000|Overall Study|Protocol-specified criteria|7
7105898|NCT02433834|11234325|FG000|Overall Study|Protocol Violation|3
7105899|NCT02433834|11234325|FG000|Overall Study|Lost to Follow-up|6
7105900|NCT02433834|11234325|FG000|Overall Study|Withdrawal by Subject|14
7105901|NCT02433834|11234325|FG000|Overall Study|Adverse Event|6
7105902|NCT02433834|11234325|FG000|Overall Study|Physician Decision|1
7105903|NCT02434081|11234345|FG000|Overall Study|Death (never started treatment)|2
7105904|NCT02434081|11234345|FG000|Overall Study|Death|2
7105905|NCT02434081|11234345|FG000|Overall Study|Progression|20
7105906|NCT02434081|11234345|FG000|Overall Study|Adverse Event|20
7105907|NCT02434081|11234345|FG000|Overall Study|Physician Decision|2
7105908|NCT02434081|11234345|FG000|Overall Study|Withdrawal by Subject|1
7105909|NCT02434081|11234345|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1
7105910|NCT02434328|11234351|FG000|Overall Study|Adverse Event|9
7105911|NCT02434328|11234352|FG001|Overall Study|Adverse Event|4
7105912|NCT02434328|11234351|FG000|Overall Study|Lack of Efficacy|0
7105913|NCT02434328|11234352|FG001|Overall Study|Lack of Efficacy|2
7105914|NCT02434328|11234351|FG000|Overall Study|Physician Decision|0
7105915|NCT02434328|11234352|FG001|Overall Study|Physician Decision|1
7105916|NCT02434328|11234351|FG000|Overall Study|Withdrawal by Subject|12
7105917|NCT02434328|11234352|FG001|Overall Study|Withdrawal by Subject|21
7105918|NCT02434328|11234351|FG000|Overall Study|Death|4
7105919|NCT02434328|11234352|FG001|Overall Study|Death|7
7105920|NCT02434328|11234351|FG000|Overall Study|Lost to Follow-up|1
7105921|NCT02434328|11234352|FG001|Overall Study|Lost to Follow-up|6
7105922|NCT02434328|11234351|FG000|Overall Study|Other|4
7105923|NCT02434328|11234352|FG001|Overall Study|Other|1
7105924|NCT02434471|11234359|FG000|Overall Study|Physician Decision|9
7105925|NCT02434770|11234384|FG000|Week 1 to Week 18|Lost to Follow-up|0
7105926|NCT02434770|11234385|FG001|Week 1 to Week 18|Lost to Follow-up|0
7105927|NCT02434770|11234386|FG002|Week 1 to Week 18|Lost to Follow-up|2
7105928|NCT02434770|11234384|FG000|Week 1 to Week 18|Withdrawal by Subject|6
7105929|NCT02434770|11234385|FG001|Week 1 to Week 18|Withdrawal by Subject|12
7105930|NCT02434770|11234386|FG002|Week 1 to Week 18|Withdrawal by Subject|5
7105931|NCT02434770|11234384|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8
7105932|NCT02434770|11234385|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10
7105933|NCT02434770|11234386|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9
7105934|NCT02434770|11234384|FG000|Week 1 to Week 18|Relocated Out of Study Area|0
7105935|NCT02434770|11234385|FG001|Week 1 to Week 18|Relocated Out of Study Area|0
7105936|NCT02434770|11234386|FG002|Week 1 to Week 18|Relocated Out of Study Area|1
7105937|NCT02434770|11234384|FG000|Week 1 to Week 18|Death|1
7105938|NCT02434770|11234385|FG001|Week 1 to Week 18|Death|0
7105939|NCT02434770|11234386|FG002|Week 1 to Week 18|Death|0
7105940|NCT02434770|11234384|FG000|Week 18 to Week|Lost to Follow-up|2
7105941|NCT02434770|11234385|FG001|Week 18 to Week|Lost to Follow-up|2
7105942|NCT02434770|11234386|FG002|Week 18 to Week|Lost to Follow-up|1
7105943|NCT02434770|11234384|FG000|Week 18 to Week|Withdrawal by Subject|0
7105944|NCT02434770|11234385|FG001|Week 18 to Week|Withdrawal by Subject|0
7105945|NCT02434770|11234386|FG002|Week 18 to Week|Withdrawal by Subject|2
7105946|NCT02434770|11234384|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6
7105947|NCT02434770|11234385|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6
7105948|NCT02434770|11234386|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3
7105949|NCT02434939|11234398|FG000|Overall Study|Lack of Efficacy|34
7105950|NCT02434939|11234399|FG001|Overall Study|Lack of Efficacy|48
7105951|NCT02434939|11234398|FG000|Overall Study|Withdrawal by Subject|3
7105952|NCT02434939|11234399|FG001|Overall Study|Withdrawal by Subject|0
7105953|NCT02434939|11234398|FG000|Overall Study|Adverse Event|0
7105954|NCT02434939|11234399|FG001|Overall Study|Adverse Event|1
7105955|NCT02435069|11234406|FG000|Dose Response - First Intervention|Adverse Event|0
7105956|NCT02435069|11234407|FG001|Dose Response - First Intervention|Adverse Event|1
7105957|NCT02435069|11234408|FG002|Dose Response - First Intervention|Adverse Event|1
7105958|NCT02435069|11234409|FG003|Dose Response - First Intervention|Adverse Event|0
7105959|NCT02435069|11234410|FG004|Dose Response - First Intervention|Adverse Event|0
7105960|NCT02435069|11234406|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0
7105961|NCT02435069|11234407|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0
7105962|NCT02435069|11234408|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0
7105963|NCT02435069|11234409|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0
7105964|NCT02435069|11234410|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1
7105965|NCT02435147|11234430|FG000|Overall Study|non-evaluable DXA scan|11
7105966|NCT02435277|11234438|FG000|Overall Study|Adverse Event|1
7105967|NCT02435277|11234439|FG001|Overall Study|Adverse Event|1
7105968|NCT02435277|11234440|FG002|Overall Study|Adverse Event|0
7105969|NCT02435277|11234441|FG003|Overall Study|Adverse Event|0
7105970|NCT02435277|11234438|FG000|Overall Study|Withdrawal by Subject|1
7105971|NCT02435277|11234439|FG001|Overall Study|Withdrawal by Subject|0
7105972|NCT02435277|11234440|FG002|Overall Study|Withdrawal by Subject|0
7105973|NCT02435277|11234441|FG003|Overall Study|Withdrawal by Subject|0
7105974|NCT02435381|11234451|FG000|Overall Study|Lost to Follow-up|2
7105975|NCT02435381|11234452|FG001|Overall Study|Lost to Follow-up|1
7105976|NCT02435680|11234480|FG000|Overall Study|Physician Decision|3
7105977|NCT02435680|11234481|FG001|Overall Study|Physician Decision|0
7105978|NCT02435680|11234482|FG002|Overall Study|Physician Decision|0
7105979|NCT02435680|11234480|FG000|Overall Study|subject / guardian decision|0
7105980|NCT02435680|11234481|FG001|Overall Study|subject / guardian decision|3
7105981|NCT02435680|11234482|FG002|Overall Study|subject / guardian decision|2
7105982|NCT02435680|11234480|FG000|Overall Study|Adverse Event|8
7105983|NCT02435680|11234481|FG001|Overall Study|Adverse Event|3
7105984|NCT02435680|11234482|FG002|Overall Study|Adverse Event|2
7105985|NCT02435680|11234480|FG000|Overall Study|progressive disease|10
7105986|NCT02435680|11234481|FG001|Overall Study|progressive disease|7
7105987|NCT02435680|11234482|FG002|Overall Study|progressive disease|11
7105988|NCT02435680|11234480|FG000|Overall Study|not treated|0
7105989|NCT02435680|11234481|FG001|Overall Study|not treated|0
7105990|NCT02435680|11234482|FG002|Overall Study|not treated|1
7105991|NCT02435836|11234503|FG000|Overall Study|Lost to Follow-up|21
7105992|NCT02435836|11234503|FG000|Overall Study|Lack of Efficacy|1
7105993|NCT02435836|11234503|FG000|Overall Study|Withdrawal by Subject|236
7105994|NCT02435836|11234503|FG000|Overall Study|Insufficient Clinical Response|26
7105995|NCT02435836|11234503|FG000|Overall Study|Adverse Event|44
7105996|NCT02435836|11234503|FG000|Overall Study|Sponsor discontinued trial|167
7105997|NCT02435836|11234503|FG000|Overall Study|Noncompliance|27
7105998|NCT02435836|11234503|FG000|Overall Study|Protocol Violation|6
7105999|NCT02435836|11234503|FG000|Overall Study|Met Withdrawal Criteria|7
7106000|NCT02435836|11234503|FG000|Overall Study|AE of Worsening Schizophrenia|96
7106001|NCT02435914|11234516|FG000|Overall Study|Ocular Adverse Event|1
7106002|NCT02435914|11234517|FG001|Overall Study|Ocular Adverse Event|0
7106003|NCT02435914|11234518|FG002|Overall Study|Ocular Adverse Event|0
7106004|NCT02435914|11234519|FG003|Overall Study|Ocular Adverse Event|0
7106005|NCT02435914|11234516|FG000|Overall Study|Withdrawal by Subject|0
7106006|NCT02435914|11234517|FG001|Overall Study|Withdrawal by Subject|1
7106007|NCT02435914|11234518|FG002|Overall Study|Withdrawal by Subject|0
7106008|NCT02435914|11234519|FG003|Overall Study|Withdrawal by Subject|0
7106009|NCT02435914|11234516|FG000|Overall Study|Other Miscellaneous Reason|0
7106010|NCT02435914|11234517|FG001|Overall Study|Other Miscellaneous Reason|0
7106011|NCT02435914|11234518|FG002|Overall Study|Other Miscellaneous Reason|1
7106012|NCT02435914|11234519|FG003|Overall Study|Other Miscellaneous Reason|0
7106013|NCT02435966|11234532|FG000|Overall Study|Withdrawal by Subject|0
7106014|NCT02435966|11234533|FG001|Overall Study|Withdrawal by Subject|1
7106015|NCT02435966|11234534|FG002|Overall Study|Withdrawal by Subject|0
7106016|NCT02435992|11234547|FG000|Overall Study|non compliance with protocol|2
7106017|NCT02435992|11234548|FG001|Overall Study|non compliance with protocol|0
7106018|NCT02435992|11234549|FG002|Overall Study|non compliance with protocol|1
7106019|NCT02435992|11234550|FG003|Overall Study|non compliance with protocol|0
7106020|NCT02435992|11234551|FG004|Overall Study|non compliance with protocol|0
7106021|NCT02435992|11234547|FG000|Overall Study|Adverse Event|11
7106022|NCT02435992|11234548|FG001|Overall Study|Adverse Event|6
7106023|NCT02435992|11234549|FG002|Overall Study|Adverse Event|12
7106024|NCT02435992|11234550|FG003|Overall Study|Adverse Event|0
7106025|NCT02435992|11234551|FG004|Overall Study|Adverse Event|0
7106026|NCT02435992|11234547|FG000|Overall Study|Lack of Efficacy|4
7106027|NCT02435992|11234548|FG001|Overall Study|Lack of Efficacy|10
7106028|NCT02435992|11234549|FG002|Overall Study|Lack of Efficacy|9
7106029|NCT02435992|11234550|FG003|Overall Study|Lack of Efficacy|0
7106030|NCT02435992|11234551|FG004|Overall Study|Lack of Efficacy|0
7106031|NCT02435992|11234547|FG000|Overall Study|Withdrawal by Subject|10
7106032|NCT02435992|11234548|FG001|Overall Study|Withdrawal by Subject|8
7106033|NCT02435992|11234549|FG002|Overall Study|Withdrawal by Subject|20
7106034|NCT02435992|11234550|FG003|Overall Study|Withdrawal by Subject|0
7106035|NCT02435992|11234551|FG004|Overall Study|Withdrawal by Subject|0
7106036|NCT02435992|11234547|FG000|Overall Study|Other Reason|1
7106037|NCT02435992|11234548|FG001|Overall Study|Other Reason|0
7106038|NCT02435992|11234549|FG002|Overall Study|Other Reason|0
7106039|NCT02435992|11234550|FG003|Overall Study|Other Reason|0
7106040|NCT02435992|11234551|FG004|Overall Study|Other Reason|0
7106041|NCT02435992|11234547|FG000|Overall Study|Physician Decision|0
7106042|NCT02435992|11234548|FG001|Overall Study|Physician Decision|0
7106043|NCT02435992|11234549|FG002|Overall Study|Physician Decision|1
7106044|NCT02435992|11234550|FG003|Overall Study|Physician Decision|0
7106045|NCT02435992|11234551|FG004|Overall Study|Physician Decision|0
7106046|NCT02436005|11234563|FG000|Second Intervention|Adverse Event|0
7106047|NCT02436005|11234564|FG001|Second Intervention|Adverse Event|1
7106048|NCT02436135|11234579|FG000|Overall Study|Progressive Disease|3
7106049|NCT02436135|11234580|FG001|Overall Study|Progressive Disease|1
7106050|NCT02436135|11234579|FG000|Overall Study|Investigator Discretion|1
7106051|NCT02436135|11234580|FG001|Overall Study|Investigator Discretion|2
7106052|NCT02436135|11234579|FG000|Overall Study|Adverse Event|1
7106053|NCT02436135|11234580|FG001|Overall Study|Adverse Event|0
7106054|NCT02436135|11234579|FG000|Overall Study|Withdrawal by Participant|1
7106055|NCT02436135|11234580|FG001|Overall Study|Withdrawal by Participant|0
7106056|NCT02436135|11234579|FG000|Overall Study|Study Terminated By Sponsor|0
7106057|NCT02436135|11234580|FG001|Overall Study|Study Terminated By Sponsor|1
7106058|NCT02436200|11234586|FG000|Overall Study|Significant outlier|1
7106059|NCT02436239|11234594|FG000|Open-Lable Treatment Period|Adverse Event|12
7106060|NCT02436239|11234595|FG001|Open-Lable Treatment Period|Adverse Event|3
7106061|NCT02436239|11234596|FG002|Open-Lable Treatment Period|Adverse Event|4
7106062|NCT02436239|11234597|FG003|Open-Lable Treatment Period|Adverse Event|2
7106063|NCT02436239|11234594|FG000|Open-Lable Treatment Period|Lack of Efficacy|1
7106064|NCT02436239|11234595|FG001|Open-Lable Treatment Period|Lack of Efficacy|6
7106065|NCT02436239|11234596|FG002|Open-Lable Treatment Period|Lack of Efficacy|6
7106066|NCT02436239|11234597|FG003|Open-Lable Treatment Period|Lack of Efficacy|1
7106067|NCT02436239|11234594|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10
7106068|NCT02436239|11234595|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15
7106069|NCT02436239|11234596|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9
7106070|NCT02436239|11234597|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0
7106071|NCT02436239|11234594|FG000|Open-Lable Treatment Period|Lost to Follow-up|4
7106072|NCT02436239|11234595|FG001|Open-Lable Treatment Period|Lost to Follow-up|2
7106073|NCT02436239|11234596|FG002|Open-Lable Treatment Period|Lost to Follow-up|4
7106074|NCT02436239|11234597|FG003|Open-Lable Treatment Period|Lost to Follow-up|1
7106075|NCT02436239|11234594|FG000|Open-Lable Treatment Period|Protocol Violation|0
7106076|NCT02436239|11234595|FG001|Open-Lable Treatment Period|Protocol Violation|1
7106077|NCT02436239|11234596|FG002|Open-Lable Treatment Period|Protocol Violation|1
7106078|NCT02436239|11234597|FG003|Open-Lable Treatment Period|Protocol Violation|0
7106079|NCT02436239|11234594|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5
7106080|NCT02436239|11234595|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6
7106081|NCT02436239|11234596|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3
7106082|NCT02436239|11234597|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1
7106083|NCT02436239|11234594|FG000|Open-Lable Treatment Period|Other Reason|1
7106084|NCT02436239|11234595|FG001|Open-Lable Treatment Period|Other Reason|1
7106085|NCT02436239|11234596|FG002|Open-Lable Treatment Period|Other Reason|0
7106086|NCT02436239|11234597|FG003|Open-Lable Treatment Period|Other Reason|0
7106087|NCT02436239|11234594|FG000|Down-Taper Period|Withdrawal by Subject|4
7106088|NCT02436239|11234595|FG001|Down-Taper Period|Withdrawal by Subject|4
7106089|NCT02436239|11234596|FG002|Down-Taper Period|Withdrawal by Subject|1
7106090|NCT02436239|11234597|FG003|Down-Taper Period|Withdrawal by Subject|2
7106091|NCT02436304|11234610|FG000|Overall Study|Lost to Follow-up|0
7106092|NCT02436304|11234611|FG001|Overall Study|Lost to Follow-up|1
7106093|NCT02436304|11234612|FG002|Overall Study|Lost to Follow-up|0
7106094|NCT02436304|11234610|FG000|Overall Study|Withdrawal by Subject|0
7106095|NCT02436304|11234611|FG001|Overall Study|Withdrawal by Subject|1
7106096|NCT02436304|11234612|FG002|Overall Study|Withdrawal by Subject|0
7106097|NCT02436304|11234610|FG000|Overall Study|Randomized in error didn't meet I/E crit|0
7106098|NCT02436304|11234611|FG001|Overall Study|Randomized in error didn't meet I/E crit|0
7106099|NCT02436304|11234612|FG002|Overall Study|Randomized in error didn't meet I/E crit|1
7106100|NCT02436330|11234623|FG000|Cohort 1|Lost to Follow-up|5
7106101|NCT02436330|11234624|FG001|Cohort 1|Lost to Follow-up|2
7106102|NCT02436330|11234623|FG000|Cohort 1|Withdrawal by Subject|0
7106103|NCT02436330|11234624|FG001|Cohort 1|Withdrawal by Subject|1
7106104|NCT02436330|11234623|FG000|Cohort 2|Lost to Follow-up|2
7106105|NCT02436330|11234624|FG001|Cohort 2|Lost to Follow-up|0
7106106|NCT02436330|11234623|FG000|Cohort 2|Withdrawal by Subject|2
7106107|NCT02436330|11234624|FG001|Cohort 2|Withdrawal by Subject|3
7106108|NCT02436330|11234623|FG000|Cohort 3|Lost to Follow-up|1
7106109|NCT02436330|11234624|FG001|Cohort 3|Lost to Follow-up|0
7106110|NCT02436330|11234623|FG000|Cohort 3|Withdrawal by Subject|4
7106111|NCT02436330|11234624|FG001|Cohort 3|Withdrawal by Subject|0
7106112|NCT02436330|11234623|FG000|Cohort 4|Lost to Follow-up|1
7106113|NCT02436330|11234624|FG001|Cohort 4|Lost to Follow-up|0
7106114|NCT02436330|11234623|FG000|Cohort 4|Withdrawal by Subject|1
7106115|NCT02436330|11234624|FG001|Cohort 4|Withdrawal by Subject|0
7106116|NCT02436330|11234623|FG000|Cohort 5|Lost to Follow-up|3
7106117|NCT02436330|11234624|FG001|Cohort 5|Lost to Follow-up|2
7106118|NCT02436330|11234623|FG000|Cohort 5|Withdrawal by Subject|3
7106119|NCT02436330|11234624|FG001|Cohort 5|Withdrawal by Subject|2
7106120|NCT02436330|11234623|FG000|Cohort 6|Lost to Follow-up|2
7106121|NCT02436330|11234624|FG001|Cohort 6|Lost to Follow-up|0
7106122|NCT02436330|11234623|FG000|Cohort 6|Withdrawal by Subject|1
7106123|NCT02436330|11234624|FG001|Cohort 6|Withdrawal by Subject|1
7106124|NCT02436356|11234639|FG000|Overall Study|Excluded by MRI Screening|0
7106125|NCT02436356|11234640|FG001|Overall Study|Excluded by MRI Screening|0
7106126|NCT02436356|11234641|FG002|Overall Study|Excluded by MRI Screening|2
7106127|NCT02436356|11234639|FG000|Overall Study|Lost to Follow-up|0
7106128|NCT02436356|11234640|FG001|Overall Study|Lost to Follow-up|1
7106129|NCT02436356|11234641|FG002|Overall Study|Lost to Follow-up|0
7106130|NCT02436356|11234639|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1
7106131|NCT02436356|11234640|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0
7106132|NCT02436356|11234641|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0
7106133|NCT02436356|11234639|FG000|Overall Study|Excluded due to other medical conditions|3
7106134|NCT02436356|11234640|FG001|Overall Study|Excluded due to other medical conditions|0
7106135|NCT02436356|11234641|FG002|Overall Study|Excluded due to other medical conditions|0
7106136|NCT02436356|11234639|FG000|Overall Study|Withdrawal by Subject|1
7106137|NCT02436356|11234640|FG001|Overall Study|Withdrawal by Subject|0
7106138|NCT02436356|11234641|FG002|Overall Study|Withdrawal by Subject|0
7106139|NCT02436408|11234654|FG000|Overall Study|Death|1
7106140|NCT02436577|11234664|FG000|Overall Study|Protocol Deviation|0
7106141|NCT02436577|11234665|FG001|Overall Study|Protocol Deviation|1
7106142|NCT02436577|11234666|FG002|Overall Study|Protocol Deviation|0
7106143|NCT02436577|11234667|FG003|Overall Study|Protocol Deviation|0
7106144|NCT02436577|11234668|FG004|Overall Study|Protocol Deviation|0
7106145|NCT02436577|11234669|FG005|Overall Study|Protocol Deviation|0
7106146|NCT02436681|11234689|FG000|Overall Study|Lost to Follow-up|10
7106147|NCT02436681|11234689|FG000|Overall Study|Withdrawal by Subject|2
7106148|NCT02436681|11234689|FG000|Overall Study|Death|2
7106149|NCT02436759|11234695|FG000|Overall Study|Adverse Event|3
7106150|NCT02436759|11234696|FG001|Overall Study|Adverse Event|0
7106151|NCT02436759|11234695|FG000|Overall Study|Protocol Violation|1
7106152|NCT02436759|11234696|FG001|Overall Study|Protocol Violation|0
7106153|NCT02436759|11234695|FG000|Overall Study|Withdrawal by Subject|0
7106154|NCT02436759|11234696|FG001|Overall Study|Withdrawal by Subject|1
7106155|NCT02436811|11234705|FG000|Overall Study|Lost to Follow-up|2
7106156|NCT02436811|11234706|FG001|Overall Study|Lost to Follow-up|9
7106157|NCT02436811|11234707|FG002|Overall Study|Lost to Follow-up|7
7106158|NCT02436876|11234719|FG000|Overall Study|Lost to Follow-up|0
7106159|NCT02436876|11234720|FG001|Overall Study|Lost to Follow-up|1
7106160|NCT02436876|11234721|FG002|Overall Study|Lost to Follow-up|1
7106161|NCT02436876|11234722|FG003|Overall Study|Lost to Follow-up|1
7106162|NCT02436876|11234719|FG000|Overall Study|Withdrawal by Subject|1
7106163|NCT02436876|11234720|FG001|Overall Study|Withdrawal by Subject|0
7106164|NCT02436876|11234721|FG002|Overall Study|Withdrawal by Subject|0
7106165|NCT02436876|11234722|FG003|Overall Study|Withdrawal by Subject|1
7106166|NCT02436876|11234719|FG000|Overall Study|Physician Decision|0
7106167|NCT02436876|11234720|FG001|Overall Study|Physician Decision|2
7106168|NCT02436876|11234721|FG002|Overall Study|Physician Decision|1
7106169|NCT02436876|11234722|FG003|Overall Study|Physician Decision|0
7106170|NCT02436876|11234719|FG000|Overall Study|Inadequate amount of study drug available for randomization|0
7106171|NCT02436876|11234720|FG001|Overall Study|Inadequate amount of study drug available for randomization|1
7106172|NCT02436876|11234721|FG002|Overall Study|Inadequate amount of study drug available for randomization|0
7106173|NCT02436876|11234722|FG003|Overall Study|Inadequate amount of study drug available for randomization|0
7106174|NCT02436889|11234739|FG000|Overall Study|No improvement in symptoms|1
7106175|NCT02436889|11234740|FG001|Overall Study|No improvement in symptoms|0
7106176|NCT02436889|11234739|FG000|Overall Study|Does not like/could not tolerate medicat|0
7106177|NCT02436889|11234740|FG001|Overall Study|Does not like/could not tolerate medicat|1
7106178|NCT02436915|11234748|FG000|Overall Study|Withdrawal by Subject|0
7106179|NCT02436915|11234749|FG001|Overall Study|Withdrawal by Subject|1
7106180|NCT02437084|11234757|FG000|Overall Study|Withdrawal by Subject|2
7106181|NCT02437084|11234757|FG000|Overall Study|Physician Decision|1
7106182|NCT02437162|11234764|FG000|Overall Study|Protocol Violation|0
7106183|NCT02437162|11234765|FG001|Overall Study|Protocol Violation|1
7106184|NCT02437162|11234766|FG002|Overall Study|Protocol Violation|0
7106185|NCT02437162|11234764|FG000|Overall Study|Randomized but not treated|0
7106186|NCT02437162|11234765|FG001|Overall Study|Randomized but not treated|0
7106187|NCT02437162|11234766|FG002|Overall Study|Randomized but not treated|1
7106188|NCT02437162|11234764|FG000|Overall Study|Study discontinued by Sponsor|93
7106189|NCT02437162|11234765|FG001|Overall Study|Study discontinued by Sponsor|98
7106190|NCT02437162|11234766|FG002|Overall Study|Study discontinued by Sponsor|97
7106191|NCT02437162|11234764|FG000|Overall Study|Withdrawal by Subject|13
7106192|NCT02437162|11234765|FG001|Overall Study|Withdrawal by Subject|7
7106193|NCT02437162|11234766|FG002|Overall Study|Withdrawal by Subject|9
7106194|NCT02437162|11234764|FG000|Overall Study|Adverse Event|0
7106195|NCT02437162|11234765|FG001|Overall Study|Adverse Event|1
7106196|NCT02437162|11234766|FG002|Overall Study|Adverse Event|0
7106197|NCT02437162|11234764|FG000|Overall Study|Lost to Follow-up|1
7106198|NCT02437162|11234765|FG001|Overall Study|Lost to Follow-up|0
7106199|NCT02437162|11234766|FG002|Overall Study|Lost to Follow-up|1
7106200|NCT02437162|11234764|FG000|Overall Study|Death|0
7106201|NCT02437162|11234765|FG001|Overall Study|Death|1
7106202|NCT02437162|11234766|FG002|Overall Study|Death|0
7106203|NCT02437162|11234764|FG000|Overall Study|Other|0
7106204|NCT02437162|11234765|FG001|Overall Study|Other|0
7106205|NCT02437162|11234766|FG002|Overall Study|Other|1
7106206|NCT02437188|11234781|FG000|Overall Study|Randomized but did not receive surgery|4
7106207|NCT02437188|11234782|FG001|Overall Study|Randomized but did not receive surgery|8
7106208|NCT02437188|11234781|FG000|Overall Study|Adverse Event|0
7106209|NCT02437188|11234782|FG001|Overall Study|Adverse Event|1
7106210|NCT02437305|11234804|FG000|Overall Study|Lost to Follow-up|18
7106211|NCT02437305|11234805|FG001|Overall Study|Lost to Follow-up|12
7106212|NCT02437409|11234824|FG000|Overall Study|Withdrawal by Subject|3
7106213|NCT02437409|11234824|FG000|Overall Study|Screening failure|12
7106214|NCT02437513|11234838|FG000|Overall Study|Withdrawal by Subject|2
7106215|NCT02437864|11234849|FG000|Overall Study|Protocol Violation|4
7106216|NCT02437864|11234850|FG001|Overall Study|Protocol Violation|0
7106217|NCT02437890|11234861|FG000|Overall Study|Non-compliance to study drug|0
7106218|NCT02437890|11234862|FG001|Overall Study|Non-compliance to study drug|1
7106219|NCT02437890|11234863|FG002|Overall Study|Non-compliance to study drug|0
7106220|NCT02437890|11234864|FG003|Overall Study|Non-compliance to study drug|0
7106221|NCT02437890|11234865|FG004|Overall Study|Non-compliance to study drug|1
7106222|NCT02437890|11234861|FG000|Overall Study|Sponsor's decision|1
7106223|NCT02437890|11234862|FG001|Overall Study|Sponsor's decision|1
7106224|NCT02437890|11234863|FG002|Overall Study|Sponsor's decision|4
7106225|NCT02437890|11234864|FG003|Overall Study|Sponsor's decision|0
7106226|NCT02437890|11234865|FG004|Overall Study|Sponsor's decision|2
7106227|NCT02437890|11234861|FG000|Overall Study|Physician Decision|0
7106228|NCT02437890|11234862|FG001|Overall Study|Physician Decision|0
7106229|NCT02437890|11234863|FG002|Overall Study|Physician Decision|0
7106230|NCT02437890|11234864|FG003|Overall Study|Physician Decision|1
7106231|NCT02437890|11234865|FG004|Overall Study|Physician Decision|0
7106232|NCT02437890|11234861|FG000|Overall Study|Unable to attend visit(s)|1
7106233|NCT02437890|11234862|FG001|Overall Study|Unable to attend visit(s)|0
7106234|NCT02437890|11234863|FG002|Overall Study|Unable to attend visit(s)|0
7106235|NCT02437890|11234864|FG003|Overall Study|Unable to attend visit(s)|0
7106236|NCT02437890|11234865|FG004|Overall Study|Unable to attend visit(s)|0
7106237|NCT02437890|11234861|FG000|Overall Study|Lack of Efficacy|1
7106238|NCT02437890|11234862|FG001|Overall Study|Lack of Efficacy|3
7106239|NCT02437890|11234863|FG002|Overall Study|Lack of Efficacy|0
7106240|NCT02437890|11234864|FG003|Overall Study|Lack of Efficacy|3
7106241|NCT02437890|11234865|FG004|Overall Study|Lack of Efficacy|1
7106242|NCT02437890|11234861|FG000|Overall Study|Adverse Event|4
7106243|NCT02437890|11234862|FG001|Overall Study|Adverse Event|9
7106244|NCT02437890|11234863|FG002|Overall Study|Adverse Event|5
7106245|NCT02437890|11234864|FG003|Overall Study|Adverse Event|11
7106246|NCT02437890|11234865|FG004|Overall Study|Adverse Event|7
7106247|NCT02437890|11234861|FG000|Overall Study|Withdrawal by Subject|1
7106248|NCT02437890|11234862|FG001|Overall Study|Withdrawal by Subject|2
7106249|NCT02437890|11234863|FG002|Overall Study|Withdrawal by Subject|6
7106250|NCT02437890|11234864|FG003|Overall Study|Withdrawal by Subject|5
7106251|NCT02437890|11234865|FG004|Overall Study|Withdrawal by Subject|5
7106252|NCT02437890|11234861|FG000|Overall Study|Death|0
7106253|NCT02437890|11234862|FG001|Overall Study|Death|0
7106254|NCT02437890|11234863|FG002|Overall Study|Death|0
7106255|NCT02437890|11234864|FG003|Overall Study|Death|2
7106256|NCT02437890|11234865|FG004|Overall Study|Death|0
7106257|NCT02437903|11234881|FG000|Overall Study|Adverse Event|1
7106258|NCT02437903|11234881|FG000|Overall Study|Withdrawal by Subject|1
7106259|NCT02437903|11234881|FG000|Overall Study|Lost to Follow-up|3
7106260|NCT02438137|11234888|FG000|Overall Study|Lost to Follow-up|3
7106261|NCT02438137|11234889|FG001|Overall Study|Lost to Follow-up|2
7106262|NCT02438137|11234888|FG000|Overall Study|Adverse Event|1
7106263|NCT02438137|11234889|FG001|Overall Study|Adverse Event|0
7106264|NCT02438137|11234888|FG000|Overall Study|Withdrawal by Subject|4
7106265|NCT02438137|11234889|FG001|Overall Study|Withdrawal by Subject|3
7106266|NCT02438137|11234888|FG000|Overall Study|Physician Decision|0
7106267|NCT02438137|11234889|FG001|Overall Study|Physician Decision|1
7106268|NCT02438280|11234899|FG000|Overall Study|Physician Decision|1
7106269|NCT02438280|11234900|FG001|Overall Study|Physician Decision|0
7106270|NCT02438371|11234909|FG000|Overall Study|Lost to Follow-up|3
7106271|NCT02438371|11234910|FG001|Overall Study|Lost to Follow-up|2
7106272|NCT02438371|11234909|FG000|Overall Study|Withdrawal by Subject|1
7106273|NCT02438371|11234910|FG001|Overall Study|Withdrawal by Subject|1
7106274|NCT02438384|11234919|FG000|Overall Study|Lost to Follow-up|8
7106275|NCT02438384|11234920|FG001|Overall Study|Lost to Follow-up|6
7106276|NCT02438384|11234921|FG002|Overall Study|Lost to Follow-up|4
7106277|NCT02438787|11234970|FG000|Overall Study|Adverse Event|1
7106278|NCT02438787|11234971|FG001|Overall Study|Adverse Event|0
7106279|NCT02438787|11234972|FG002|Overall Study|Adverse Event|2
7106280|NCT02438787|11234970|FG000|Overall Study|Lack of Efficacy|1
7106281|NCT02438787|11234971|FG001|Overall Study|Lack of Efficacy|2
7106282|NCT02438787|11234972|FG002|Overall Study|Lack of Efficacy|0
7106283|NCT02438787|11234970|FG000|Overall Study|Lost to Follow-up|0
7106284|NCT02438787|11234971|FG001|Overall Study|Lost to Follow-up|1
7106285|NCT02438787|11234972|FG002|Overall Study|Lost to Follow-up|0
7106286|NCT02438787|11234970|FG000|Overall Study|Protocol Violation|0
7106287|NCT02438787|11234971|FG001|Overall Study|Protocol Violation|0
7106288|NCT02438787|11234972|FG002|Overall Study|Protocol Violation|1
7106289|NCT02438787|11234970|FG000|Overall Study|Withdrawal by Subject|15
7106290|NCT02438787|11234971|FG001|Overall Study|Withdrawal by Subject|7
7106291|NCT02438787|11234972|FG002|Overall Study|Withdrawal by Subject|10
7106292|NCT02438787|11234970|FG000|Overall Study|Study discontinued by sponsor|64
7106293|NCT02438787|11234971|FG001|Overall Study|Study discontinued by sponsor|72
7106294|NCT02438787|11234972|FG002|Overall Study|Study discontinued by sponsor|69
7106295|NCT02438787|11234970|FG000|Overall Study|Other|0
7106296|NCT02438787|11234971|FG001|Overall Study|Other|1
7106297|NCT02438787|11234972|FG002|Overall Study|Other|0
7106298|NCT02438787|11234970|FG000|Overall Study|Site terminated by sponsor|0
7106299|NCT02438787|11234971|FG001|Overall Study|Site terminated by sponsor|0
7106300|NCT02438787|11234972|FG002|Overall Study|Site terminated by sponsor|1
7106301|NCT02438813|11234985|FG000|Overall Study|Patient Decision|59
7106302|NCT02438813|11234985|FG000|Overall Study|Patient Lost to Follow-Up|137
7106303|NCT02438813|11234985|FG000|Overall Study|Study Ended by Sponsor|80
7106304|NCT02438813|11234985|FG000|Overall Study|Patients Not Treated/No EOT Visit|249
7106305|NCT02438826|11235001|FG000|Double-Blind Treatment Phase|Adverse Event|1
7106306|NCT02438826|11235002|FG001|Double-Blind Treatment Phase|Adverse Event|1
7106307|NCT02438826|11235003|FG002|Double-Blind Treatment Phase|Adverse Event|0
7106308|NCT02438826|11235004|FG003|Double-Blind Treatment Phase|Adverse Event|0
7106309|NCT02438826|11235001|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1
7106310|NCT02438826|11235002|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0
7106311|NCT02438826|11235003|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0
7106312|NCT02438826|11235004|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0
7106313|NCT02438826|11235001|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1
7106314|NCT02438826|11235002|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1
7106315|NCT02438826|11235003|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0
7106316|NCT02438826|11235004|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0
7106317|NCT02438826|11235001|FG000|Double-Blind Treatment Phase|Protocol Violation|1
7106318|NCT02438826|11235002|FG001|Double-Blind Treatment Phase|Protocol Violation|2
7106319|NCT02438826|11235003|FG002|Double-Blind Treatment Phase|Protocol Violation|0
7106320|NCT02438826|11235004|FG003|Double-Blind Treatment Phase|Protocol Violation|0
7106321|NCT02438826|11235001|FG000|Double-Blind Treatment Phase|Screen Failure|2
7106322|NCT02438826|11235002|FG001|Double-Blind Treatment Phase|Screen Failure|0
7106323|NCT02438826|11235003|FG002|Double-Blind Treatment Phase|Screen Failure|0
7106324|NCT02438826|11235004|FG003|Double-Blind Treatment Phase|Screen Failure|0
7106325|NCT02438826|11235001|FG000|Open-Label Treatment Phase|Adverse Event|11
7106326|NCT02438826|11235002|FG001|Open-Label Treatment Phase|Adverse Event|6
7106327|NCT02438826|11235003|FG002|Open-Label Treatment Phase|Adverse Event|0
7106328|NCT02438826|11235004|FG003|Open-Label Treatment Phase|Adverse Event|0
7106329|NCT02438826|11235001|FG000|Open-Label Treatment Phase|Lack of Efficacy|27
7106330|NCT02438826|11235002|FG001|Open-Label Treatment Phase|Lack of Efficacy|18
7106331|NCT02438826|11235003|FG002|Open-Label Treatment Phase|Lack of Efficacy|0
7106332|NCT02438826|11235004|FG003|Open-Label Treatment Phase|Lack of Efficacy|0
7106333|NCT02438826|11235001|FG000|Open-Label Treatment Phase|Lost to Follow-up|0
7106334|NCT02438826|11235002|FG001|Open-Label Treatment Phase|Lost to Follow-up|2
7106335|NCT02438826|11235003|FG002|Open-Label Treatment Phase|Lost to Follow-up|0
7106336|NCT02438826|11235004|FG003|Open-Label Treatment Phase|Lost to Follow-up|0
7106337|NCT02438826|11235001|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6
7106338|NCT02438826|11235002|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7
7106339|NCT02438826|11235003|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0
7106340|NCT02438826|11235004|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0
7106341|NCT02438826|11235001|FG000|Post-Treatment Phase|Adverse Event|3
7106342|NCT02438826|11235002|FG001|Post-Treatment Phase|Adverse Event|0
7106343|NCT02438826|11235003|FG002|Post-Treatment Phase|Adverse Event|0
7106344|NCT02438826|11235004|FG003|Post-Treatment Phase|Adverse Event|0
7106345|NCT02438826|11235001|FG000|Post-Treatment Phase|Lack of Efficacy|4
7106346|NCT02438826|11235002|FG001|Post-Treatment Phase|Lack of Efficacy|0
7106347|NCT02438826|11235003|FG002|Post-Treatment Phase|Lack of Efficacy|0
7106348|NCT02438826|11235004|FG003|Post-Treatment Phase|Lack of Efficacy|0
7106349|NCT02438826|11235001|FG000|Post-Treatment Phase|Physician Decision|1
7106350|NCT02438826|11235002|FG001|Post-Treatment Phase|Physician Decision|0
7106351|NCT02438826|11235003|FG002|Post-Treatment Phase|Physician Decision|0
7106352|NCT02438826|11235004|FG003|Post-Treatment Phase|Physician Decision|0
7106353|NCT02438826|11235001|FG000|Post-Treatment Phase|Withdrawal by Subject|1
7106354|NCT02438826|11235002|FG001|Post-Treatment Phase|Withdrawal by Subject|1
7106355|NCT02438826|11235003|FG002|Post-Treatment Phase|Withdrawal by Subject|0
7106356|NCT02438826|11235004|FG003|Post-Treatment Phase|Withdrawal by Subject|0
7106357|NCT02439138|11235019|FG000|Overall Study|Adverse Event|1
7106358|NCT02439138|11235019|FG000|Overall Study|PI decision to terminate the study|2
7106359|NCT02439320|11235047|FG000|Overall Study|Adverse Event|0
7106360|NCT02439320|11235048|FG001|Overall Study|Adverse Event|2
7106361|NCT02439320|11235049|FG002|Overall Study|Adverse Event|0
7106362|NCT02439320|11235047|FG000|Overall Study|Lost to Follow-up|37
7106363|NCT02439320|11235048|FG001|Overall Study|Lost to Follow-up|34
7106364|NCT02439320|11235049|FG002|Overall Study|Lost to Follow-up|42
7106365|NCT02439320|11235047|FG000|Overall Study|Death|0
7106366|NCT02439320|11235048|FG001|Overall Study|Death|1
7106367|NCT02439320|11235049|FG002|Overall Study|Death|0
7106368|NCT02439320|11235047|FG000|Overall Study|Noncompliance with Protocol|10
7106369|NCT02439320|11235048|FG001|Overall Study|Noncompliance with Protocol|11
7106370|NCT02439320|11235049|FG002|Overall Study|Noncompliance with Protocol|7
7106371|NCT02439320|11235047|FG000|Overall Study|Pregnancy|0
7106372|NCT02439320|11235048|FG001|Overall Study|Pregnancy|1
7106373|NCT02439320|11235049|FG002|Overall Study|Pregnancy|1
7106374|NCT02439320|11235047|FG000|Overall Study|Withdrawal by Subject|12
7106375|NCT02439320|11235048|FG001|Overall Study|Withdrawal by Subject|16
7106376|NCT02439320|11235049|FG002|Overall Study|Withdrawal by Subject|14
7106377|NCT02439320|11235047|FG000|Overall Study|Physician Decision|2
7106378|NCT02439320|11235048|FG001|Overall Study|Physician Decision|1
7106379|NCT02439320|11235049|FG002|Overall Study|Physician Decision|0
7106380|NCT02439320|11235047|FG000|Overall Study|Sponsor Request|0
7106381|NCT02439320|11235048|FG001|Overall Study|Sponsor Request|2
7106382|NCT02439320|11235049|FG002|Overall Study|Sponsor Request|1
7106383|NCT02439320|11235047|FG000|Overall Study|Randomization Failure|35
7106384|NCT02439320|11235048|FG001|Overall Study|Randomization Failure|46
7106385|NCT02439320|11235049|FG002|Overall Study|Randomization Failure|34
7106386|NCT02440568|11235137|FG000|Overall Study|Death|1
7106387|NCT02440568|11235138|FG001|Overall Study|Death|3
7106388|NCT02440568|11235139|FG002|Overall Study|Death|4
7106389|NCT02440568|11235140|FG003|Overall Study|Death|2
7106390|NCT02440568|11235137|FG000|Overall Study|Lack of Efficacy|2
7106391|NCT02440568|11235138|FG001|Overall Study|Lack of Efficacy|0
7106392|NCT02440568|11235139|FG002|Overall Study|Lack of Efficacy|1
7106393|NCT02440568|11235140|FG003|Overall Study|Lack of Efficacy|0
7106394|NCT02440568|11235137|FG000|Overall Study|Lost to Follow-up|1
7106395|NCT02440568|11235138|FG001|Overall Study|Lost to Follow-up|0
7106396|NCT02440568|11235139|FG002|Overall Study|Lost to Follow-up|0
7106397|NCT02440568|11235140|FG003|Overall Study|Lost to Follow-up|0
7106398|NCT02440594|11235159|FG000|Overall Study|Lost to Follow-up|34
7106399|NCT02440594|11235160|FG001|Overall Study|Lost to Follow-up|33
7106400|NCT02440594|11235161|FG002|Overall Study|Lost to Follow-up|54
7106401|NCT02440594|11235162|FG003|Overall Study|Lost to Follow-up|47
7106402|NCT02440594|11235163|FG004|Overall Study|Lost to Follow-up|5
7106403|NCT02440594|11235164|FG005|Overall Study|Lost to Follow-up|4
7106404|NCT02440594|11235165|FG006|Overall Study|Lost to Follow-up|28
7106405|NCT02440594|11235166|FG007|Overall Study|Lost to Follow-up|48
7106406|NCT02440594|11235159|FG000|Overall Study|Cognitive Impairment/Communication Issue|14
7106407|NCT02440594|11235160|FG001|Overall Study|Cognitive Impairment/Communication Issue|6
7106408|NCT02440594|11235161|FG002|Overall Study|Cognitive Impairment/Communication Issue|4
7106409|NCT02440594|11235162|FG003|Overall Study|Cognitive Impairment/Communication Issue|4
7106410|NCT02440594|11235163|FG004|Overall Study|Cognitive Impairment/Communication Issue|2
7106411|NCT02440594|11235164|FG005|Overall Study|Cognitive Impairment/Communication Issue|1
7106412|NCT02440594|11235165|FG006|Overall Study|Cognitive Impairment/Communication Issue|0
7106413|NCT02440594|11235166|FG007|Overall Study|Cognitive Impairment/Communication Issue|0
7106414|NCT02440594|11235159|FG000|Overall Study|Withdrawal by Subject|81
7106415|NCT02440594|11235160|FG001|Overall Study|Withdrawal by Subject|67
7106416|NCT02440594|11235161|FG002|Overall Study|Withdrawal by Subject|59
7106417|NCT02440594|11235162|FG003|Overall Study|Withdrawal by Subject|38
7106418|NCT02440594|11235163|FG004|Overall Study|Withdrawal by Subject|2
7106419|NCT02440594|11235164|FG005|Overall Study|Withdrawal by Subject|2
7106420|NCT02440594|11235165|FG006|Overall Study|Withdrawal by Subject|7
7106421|NCT02440594|11235166|FG007|Overall Study|Withdrawal by Subject|7
7106422|NCT02440594|11235159|FG000|Overall Study|Administratively w/drawn|3
7106423|NCT02440594|11235160|FG001|Overall Study|Administratively w/drawn|2
7106424|NCT02440594|11235161|FG002|Overall Study|Administratively w/drawn|0
7106425|NCT02440594|11235162|FG003|Overall Study|Administratively w/drawn|0
7106426|NCT02440594|11235163|FG004|Overall Study|Administratively w/drawn|0
7106427|NCT02440594|11235164|FG005|Overall Study|Administratively w/drawn|0
7106428|NCT02440594|11235165|FG006|Overall Study|Administratively w/drawn|2
7106429|NCT02440594|11235166|FG007|Overall Study|Administratively w/drawn|1
7106430|NCT02440789|11235208|FG000|Overall Study|Withdrawal by Subject|3
7106431|NCT02440789|11235208|FG000|Overall Study|Not willing to adhere to reqs|1
7106432|NCT02441114|11235216|FG000|Washout2|Withdrawal by Subject|4
7106433|NCT02441179|11235222|FG000|Overall Study|Withdrawal by Subject|1
7106434|NCT02441179|11235223|FG001|Overall Study|Withdrawal by Subject|1
7106435|NCT02441218|11235232|FG000|Overall Study|Death|503
7106436|NCT02441218|11235233|FG001|Overall Study|Death|553
7106437|NCT02441218|11235232|FG000|Overall Study|Withdrawal by Subject|73
7106438|NCT02441218|11235233|FG001|Overall Study|Withdrawal by Subject|58
7106439|NCT02441218|11235232|FG000|Overall Study|Lost to Follow-up|2
7106440|NCT02441218|11235233|FG001|Overall Study|Lost to Follow-up|1
7106441|NCT02441283|11235239|FG000|Overall Study|Withdrew consent|15
7106442|NCT02441283|11235239|FG000|Overall Study|Lost to Follow-up|42
7106443|NCT02441283|11235239|FG000|Overall Study|Death|1
7106444|NCT02441283|11235239|FG000|Overall Study|Other, not specified|32
7106445|NCT02441309|11235246|FG000|Overall Study|Disease progression|2
7106446|NCT02441309|11235247|FG001|Overall Study|Disease progression|1
7106447|NCT02441309|11235248|FG002|Overall Study|Disease progression|2
7106448|NCT02441309|11235246|FG000|Overall Study|Adverse Event|0
7106449|NCT02441309|11235247|FG001|Overall Study|Adverse Event|1
7106450|NCT02441309|11235248|FG002|Overall Study|Adverse Event|0
7106451|NCT02441309|11235246|FG000|Overall Study|Withdrawal by Subject|1
7106452|NCT02441309|11235247|FG001|Overall Study|Withdrawal by Subject|0
7106453|NCT02441309|11235248|FG002|Overall Study|Withdrawal by Subject|1
7106454|NCT02441517|11235259|FG000|Overall Study|Lost to Follow-up|1
7106455|NCT02441517|11235259|FG000|Overall Study|Withdrawal by Subject|2
7106456|NCT02441517|11235259|FG000|Overall Study|Study Terminated by Sponsor|1
7106457|NCT02441946|11235266|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
7106458|NCT02441946|11235267|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
7106459|NCT02441946|11235268|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0
7106460|NCT02441946|11235266|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1
7106461|NCT02441946|11235267|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
7106462|NCT02441946|11235268|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
7106463|NCT02441946|11235266|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
7106464|NCT02441946|11235267|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3
7106465|NCT02441946|11235268|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
7106466|NCT02441946|11235266|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
7106467|NCT02441946|11235267|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1
7106468|NCT02441946|11235268|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
7106469|NCT02441946|11235266|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15
7106470|NCT02441946|11235267|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
7106471|NCT02441946|11235268|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
7106472|NCT02441946|11235266|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1
7106473|NCT02441946|11235267|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
7106474|NCT02441946|11235268|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
7106475|NCT02441946|11235266|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1
7106476|NCT02441946|11235267|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
7106477|NCT02441946|11235268|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
7106478|NCT02441946|11235266|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1
7106479|NCT02441946|11235267|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
7106480|NCT02441946|11235268|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
7106481|NCT02441946|11235266|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9
7106482|NCT02441946|11235267|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
7106483|NCT02441946|11235268|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
7106484|NCT02441946|11235266|FG000|Extension Period (8 Weeks)|Adverse Event|1
7106485|NCT02441946|11235267|FG001|Extension Period (8 Weeks)|Adverse Event|0
7106486|NCT02441946|11235268|FG002|Extension Period (8 Weeks)|Adverse Event|0
7106487|NCT02441946|11235266|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1
7106488|NCT02441946|11235267|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0
7106489|NCT02441946|11235268|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0
7106490|NCT02442206|11235281|FG000|Period 1|Adverse Event|1
7106491|NCT02442206|11235282|FG001|Period 1|Adverse Event|1
7106492|NCT02442206|11235281|FG000|Period 1|withdrew consent|0
7106493|NCT02442206|11235282|FG001|Period 1|withdrew consent|1
7106494|NCT02442206|11235281|FG000|Period 1|COPD exacerbation|0
7106495|NCT02442206|11235282|FG001|Period 1|COPD exacerbation|1
7106496|NCT02442206|11235281|FG000|Period 2|Adverse Event|1
7106497|NCT02442206|11235282|FG001|Period 2|Adverse Event|0
7106498|NCT02442271|11235289|FG000|Overall Study|Adverse Event|1
7106499|NCT02442271|11235289|FG000|Overall Study|Withdrew Consent|1
7106500|NCT02442271|11235289|FG000|Overall Study|Lost to Follow-up|1
7106501|NCT02442271|11235289|FG000|Overall Study|Other|1
7106502|NCT02442284|11235307|FG000|Overall Study|Adverse Event|1
7106503|NCT02442284|11235307|FG000|Overall Study|Withdrew Consent|2
7106504|NCT02442284|11235307|FG000|Overall Study|Lost to Follow-up|3
7106505|NCT02442284|11235307|FG000|Overall Study|Other|1
7106506|NCT02442310|11235311|FG000|Overall Study|Adverse Event|2
7106507|NCT02442310|11235311|FG000|Overall Study|Withdrawal by Subject|1
7106508|NCT02442336|11235321|FG000|Overall Study|6 patients assisted with the intervention development only.|6
7106509|NCT02442336|11235321|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19
7106510|NCT02442336|11235321|FG000|Overall Study|Lost to Follow-up|11
7106511|NCT02442622|11235327|FG000|Overall Study|Withdrawal by Subject|3
7106512|NCT02442622|11235328|FG001|Overall Study|Withdrawal by Subject|1
7106513|NCT02442804|11235359|FG000|Overall Study|Withdrawal by Subject|0
7106514|NCT02442804|11235360|FG001|Overall Study|Withdrawal by Subject|1
7106515|NCT02442804|11235359|FG000|Overall Study|Adverse Event|1
7106516|NCT02442804|11235360|FG001|Overall Study|Adverse Event|0
7106517|NCT02442830|11235368|FG000|Overall Study|Technical Failure|0
7106518|NCT02442830|11235369|FG001|Overall Study|Technical Failure|1
7106519|NCT02443103|11235415|FG000|Overall Study|Adverse Event|2
7106520|NCT02443103|11235415|FG000|Overall Study|Noncompliance|1
7106521|NCT02443155|11235423|FG000|Overall Study|Adverse Event|3
7106522|NCT02443155|11235424|FG001|Overall Study|Adverse Event|4
7106523|NCT02443155|11235425|FG002|Overall Study|Adverse Event|1
7106524|NCT02443155|11235426|FG003|Overall Study|Adverse Event|2
7106525|NCT02443155|11235423|FG000|Overall Study|Unclassified|0
7106526|NCT02443155|11235424|FG001|Overall Study|Unclassified|0
7106527|NCT02443155|11235425|FG002|Overall Study|Unclassified|2
7106528|NCT02443155|11235426|FG003|Overall Study|Unclassified|1
7106529|NCT02443155|11235423|FG000|Overall Study|Withdrawal by Subject|4
7106530|NCT02443155|11235424|FG001|Overall Study|Withdrawal by Subject|7
7106531|NCT02443155|11235425|FG002|Overall Study|Withdrawal by Subject|3
7106532|NCT02443155|11235426|FG003|Overall Study|Withdrawal by Subject|9
7106533|NCT02443155|11235423|FG000|Overall Study|Pregnancy|3
7106534|NCT02443155|11235424|FG001|Overall Study|Pregnancy|1
7106535|NCT02443155|11235425|FG002|Overall Study|Pregnancy|1
7106536|NCT02443155|11235426|FG003|Overall Study|Pregnancy|2
7106537|NCT02443155|11235423|FG000|Overall Study|Lost to Follow-up|1
7106538|NCT02443155|11235424|FG001|Overall Study|Lost to Follow-up|2
7106539|NCT02443155|11235425|FG002|Overall Study|Lost to Follow-up|0
7106540|NCT02443155|11235426|FG003|Overall Study|Lost to Follow-up|1
7106541|NCT02443155|11235423|FG000|Overall Study|Protocol Violation|1
7106542|NCT02443155|11235424|FG001|Overall Study|Protocol Violation|0
7106543|NCT02443155|11235425|FG002|Overall Study|Protocol Violation|1
7106544|NCT02443155|11235426|FG003|Overall Study|Protocol Violation|1
7106545|NCT02443155|11235423|FG000|Overall Study|Death|0
7106546|NCT02443155|11235424|FG001|Overall Study|Death|0
7106547|NCT02443155|11235425|FG002|Overall Study|Death|1
7106548|NCT02443155|11235426|FG003|Overall Study|Death|0
7106549|NCT02443298|11235439|FG000|Overall Study|Adverse Event|3
7106550|NCT02443298|11235440|FG001|Overall Study|Adverse Event|3
7106551|NCT02443298|11235439|FG000|Overall Study|Withdrawal by Subject|1
7106552|NCT02443298|11235440|FG001|Overall Study|Withdrawal by Subject|2
7106553|NCT02443337|11235448|FG000|Overall Study|Adverse Event|0
7106554|NCT02443337|11235449|FG001|Overall Study|Adverse Event|1
7106555|NCT02443337|11235448|FG000|Overall Study|Clinical Progressive Disease|3
7106556|NCT02443337|11235449|FG001|Overall Study|Clinical Progressive Disease|0
7106557|NCT02443337|11235448|FG000|Overall Study|Withdrawal by Subject|2
7106558|NCT02443337|11235449|FG001|Overall Study|Withdrawal by Subject|1
7106559|NCT02443402|11235462|FG000|Overall Study|Withdrawal by Subject|3
7106560|NCT02443402|11235463|FG001|Overall Study|Withdrawal by Subject|1
7106561|NCT02443402|11235462|FG000|Overall Study|Screen Failure|1
7106562|NCT02443402|11235463|FG001|Overall Study|Screen Failure|2
7106563|NCT02443688|11235494|FG000|Overall Study|Adverse Event|2
7106564|NCT02443688|11235495|FG001|Overall Study|Adverse Event|3
7106565|NCT02443688|11235496|FG002|Overall Study|Adverse Event|2
7106566|NCT02443688|11235494|FG000|Overall Study|Lost to Follow-up|1
7106567|NCT02443688|11235495|FG001|Overall Study|Lost to Follow-up|0
7106568|NCT02443688|11235496|FG002|Overall Study|Lost to Follow-up|0
7106569|NCT02443688|11235494|FG000|Overall Study|Physician Decision|3
7106570|NCT02443688|11235495|FG001|Overall Study|Physician Decision|0
7106571|NCT02443688|11235496|FG002|Overall Study|Physician Decision|1
7106572|NCT02443688|11235494|FG000|Overall Study|Pregnancy|0
7106573|NCT02443688|11235495|FG001|Overall Study|Pregnancy|0
7106574|NCT02443688|11235496|FG002|Overall Study|Pregnancy|1
7106575|NCT02443688|11235494|FG000|Overall Study|Withdrawal by Subject|3
7106576|NCT02443688|11235495|FG001|Overall Study|Withdrawal by Subject|3
7106577|NCT02443688|11235496|FG002|Overall Study|Withdrawal by Subject|4
7106578|NCT02443688|11235494|FG000|Overall Study|Non-compliance with study drug|1
7106579|NCT02443688|11235495|FG001|Overall Study|Non-compliance with study drug|2
7106580|NCT02443688|11235496|FG002|Overall Study|Non-compliance with study drug|4
7106581|NCT02443688|11235494|FG000|Overall Study|Sponsor Request|2
7106582|NCT02443688|11235495|FG001|Overall Study|Sponsor Request|1
7106583|NCT02443688|11235496|FG002|Overall Study|Sponsor Request|0
7106584|NCT02443740|11235512|FG000|Intervention Period 1 (3 Days)|Adverse Event|0
7106585|NCT02443740|11235513|FG001|Intervention Period 1 (3 Days)|Adverse Event|0
7106586|NCT02443740|11235514|FG002|Intervention Period 1 (3 Days)|Adverse Event|0
7106587|NCT02443740|11235515|FG003|Intervention Period 1 (3 Days)|Adverse Event|0
7106588|NCT02443740|11235516|FG004|Intervention Period 1 (3 Days)|Adverse Event|0
7106589|NCT02443740|11235517|FG005|Intervention Period 1 (3 Days)|Adverse Event|1
7106590|NCT02443740|11235518|FG006|Intervention Period 1 (3 Days)|Adverse Event|0
7106591|NCT02443740|11235519|FG007|Intervention Period 1 (3 Days)|Adverse Event|0
7106592|NCT02443740|11235520|FG008|Intervention Period 1 (3 Days)|Adverse Event|0
7106593|NCT02443740|11235521|FG009|Intervention Period 1 (3 Days)|Adverse Event|0
7106594|NCT02443740|11235522|FG010|Intervention Period 1 (3 Days)|Adverse Event|0
7106595|NCT02443740|11235512|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1
7106596|NCT02443740|11235513|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0
7106597|NCT02443740|11235514|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0
7106598|NCT02443740|11235515|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0
7106599|NCT02443740|11235516|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0
7106600|NCT02443740|11235517|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0
7106601|NCT02443740|11235518|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1
7106602|NCT02443740|11235519|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0
7106603|NCT02443740|11235520|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0
7106604|NCT02443740|11235521|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0
7106605|NCT02443740|11235522|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0
7106606|NCT02443740|11235512|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7106607|NCT02443740|11235513|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7106608|NCT02443740|11235514|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7106609|NCT02443740|11235515|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7106610|NCT02443740|11235516|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7106611|NCT02443740|11235517|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1
7106612|NCT02443740|11235518|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7106613|NCT02443740|11235519|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7106614|NCT02443740|11235520|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7106615|NCT02443740|11235521|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7106616|NCT02443740|11235522|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7106617|NCT02443805|11235563|FG000|Overall Study|Adverse Event|100
7106618|NCT02443805|11235564|FG001|Overall Study|Adverse Event|18
7106619|NCT02443805|11235563|FG000|Overall Study|Withdrawal by Subject|73
7106620|NCT02443805|11235564|FG001|Overall Study|Withdrawal by Subject|74
7106621|NCT02443805|11235563|FG000|Overall Study|Lost to Follow-up|19
7106622|NCT02443805|11235564|FG001|Overall Study|Lost to Follow-up|14
7106623|NCT02443805|11235563|FG000|Overall Study|Pregnancy|6
7106624|NCT02443805|11235564|FG001|Overall Study|Pregnancy|5
7106625|NCT02443805|11235563|FG000|Overall Study|Protocol Violation|2
7106626|NCT02443805|11235564|FG001|Overall Study|Protocol Violation|4
7106627|NCT02443805|11235563|FG000|Overall Study|Lack of Efficacy|1
7106628|NCT02443805|11235564|FG001|Overall Study|Lack of Efficacy|1
7106629|NCT02443805|11235563|FG000|Overall Study|Non-compliance with study drug|6
7106630|NCT02443805|11235564|FG001|Overall Study|Non-compliance with study drug|4
7106631|NCT02443805|11235563|FG000|Overall Study|Withdrawal by parent/guardian|3
7106632|NCT02443805|11235564|FG001|Overall Study|Withdrawal by parent/guardian|5
7106633|NCT02443805|11235563|FG000|Overall Study|Any other reason not above-mentioned|3
7106634|NCT02443805|11235564|FG001|Overall Study|Any other reason not above-mentioned|2
7106635|NCT02443883|11235574|FG000|Overall Study|Adverse Event|0
7106636|NCT02443883|11235575|FG001|Overall Study|Adverse Event|1
7106637|NCT02443883|11235576|FG002|Overall Study|Adverse Event|0
7106638|NCT02443883|11235577|FG003|Overall Study|Adverse Event|0
7106639|NCT02443883|11235574|FG000|Overall Study|Lost to Follow-up|3
7106640|NCT02443883|11235575|FG001|Overall Study|Lost to Follow-up|2
7106641|NCT02443883|11235576|FG002|Overall Study|Lost to Follow-up|1
7106642|NCT02443883|11235577|FG003|Overall Study|Lost to Follow-up|0
7106643|NCT02443883|11235574|FG000|Overall Study|Physician Decision|1
7106644|NCT02443883|11235575|FG001|Overall Study|Physician Decision|1
7106645|NCT02443883|11235576|FG002|Overall Study|Physician Decision|0
7106646|NCT02443883|11235577|FG003|Overall Study|Physician Decision|3
7106647|NCT02443883|11235574|FG000|Overall Study|Withdrawal by Subject|1
7106648|NCT02443883|11235575|FG001|Overall Study|Withdrawal by Subject|0
7106649|NCT02443883|11235576|FG002|Overall Study|Withdrawal by Subject|0
7106650|NCT02443883|11235577|FG003|Overall Study|Withdrawal by Subject|2
7106651|NCT02443883|11235574|FG000|Overall Study|Randomized, but never treated|1
7106652|NCT02443883|11235575|FG001|Overall Study|Randomized, but never treated|0
7106653|NCT02443883|11235576|FG002|Overall Study|Randomized, but never treated|0
7106654|NCT02443883|11235577|FG003|Overall Study|Randomized, but never treated|0
7106655|NCT02444182|11235600|FG000|Overall Study|non-compliance|2
7106656|NCT02444182|11235601|FG001|Overall Study|non-compliance|1
7106657|NCT02444182|11235600|FG000|Overall Study|Lost to Follow-up|0
7106658|NCT02444182|11235601|FG001|Overall Study|Lost to Follow-up|4
7106659|NCT02444533|11235618|FG000|Overall Study|Not able to complete forms|0
7106660|NCT02444533|11235619|FG001|Overall Study|Not able to complete forms|2
7106661|NCT02444533|11235618|FG000|Overall Study|Only gave post-procedure complications|2
7106662|NCT02444533|11235619|FG001|Overall Study|Only gave post-procedure complications|2
7106663|NCT02444793|11235661|FG000|Overall Study|Lost to Follow-up|2
7106664|NCT02444793|11235662|FG001|Overall Study|Lost to Follow-up|2
7106665|NCT02444793|11235663|FG002|Overall Study|Lost to Follow-up|0
7106666|NCT02444793|11235664|FG003|Overall Study|Lost to Follow-up|0
7106667|NCT02444793|11235661|FG000|Overall Study|Death|0
7106668|NCT02444793|11235662|FG001|Overall Study|Death|3
7106669|NCT02444793|11235663|FG002|Overall Study|Death|0
7106670|NCT02444793|11235664|FG003|Overall Study|Death|0
7106671|NCT02444793|11235661|FG000|Overall Study|Other|0
7106672|NCT02444793|11235662|FG001|Overall Study|Other|0
7106673|NCT02444793|11235663|FG002|Overall Study|Other|2
7106674|NCT02444793|11235664|FG003|Overall Study|Other|0
7106675|NCT02444793|11235661|FG000|Overall Study|Objective progression or relapse|9
7106676|NCT02444793|11235662|FG001|Overall Study|Objective progression or relapse|1
7106677|NCT02444793|11235663|FG002|Overall Study|Objective progression or relapse|2
7106678|NCT02444793|11235664|FG003|Overall Study|Objective progression or relapse|3
7106679|NCT02445573|11235735|FG000|Overall Study|Withdrawal by Subject|1
7106680|NCT02445573|11235736|FG001|Overall Study|Withdrawal by Subject|1
7106681|NCT02445573|11235735|FG000|Overall Study|Lost to Follow-up|0
7106682|NCT02445573|11235736|FG001|Overall Study|Lost to Follow-up|1
7106683|NCT02445586|11235742|FG000|Overall Study|Death|14
7106684|NCT02445586|11235742|FG000|Overall Study|Withdrawal by Subject|13
7106685|NCT02445586|11235742|FG000|Overall Study|Disease Progression|10
7106686|NCT02445586|11235742|FG000|Overall Study|Protocol Violation|1
7106687|NCT02445586|11235742|FG000|Overall Study|Medical Condition|1
7106688|NCT02445755|11235751|FG000|Overall Study|Withdrawal by Subject|2
7106689|NCT02445755|11235751|FG000|Overall Study|Protocol Violation|6
7106690|NCT02445755|11235751|FG000|Overall Study|Screen Failure|5
7106691|NCT02445794|11235762|FG000|Overall Study|Adverse Event|0
7106692|NCT02445794|11235763|FG001|Overall Study|Adverse Event|0
7106693|NCT02445794|11235764|FG002|Overall Study|Adverse Event|2
7106694|NCT02445794|11235765|FG003|Overall Study|Adverse Event|0
7106695|NCT02445963|11235819|FG000|Overall Study|Lost to Follow-up|1
7106696|NCT02445963|11235820|FG001|Overall Study|Lost to Follow-up|0
7106697|NCT02445963|11235821|FG002|Overall Study|Lost to Follow-up|0
7106698|NCT02445963|11235822|FG003|Overall Study|Lost to Follow-up|0
7106699|NCT02445963|11235819|FG000|Overall Study|Change in employment|1
7106700|NCT02445963|11235820|FG001|Overall Study|Change in employment|0
7106701|NCT02445963|11235821|FG002|Overall Study|Change in employment|0
7106702|NCT02445963|11235822|FG003|Overall Study|Change in employment|0
7106703|NCT02445963|11235819|FG000|Overall Study|Symptoms post-vaccination|0
7106704|NCT02445963|11235820|FG001|Overall Study|Symptoms post-vaccination|0
7106705|NCT02445963|11235821|FG002|Overall Study|Symptoms post-vaccination|1
7106706|NCT02445963|11235822|FG003|Overall Study|Symptoms post-vaccination|0
7106707|NCT02446015|11235836|FG000|Overall Study|Adverse Event|0
7106708|NCT02446015|11235837|FG001|Overall Study|Adverse Event|1
7106709|NCT02446015|11235836|FG000|Overall Study|Withdrawal by Subject|1
7106710|NCT02446015|11235837|FG001|Overall Study|Withdrawal by Subject|0
7106711|NCT02446171|11235848|FG000|Overall Study|Withdrawal by Subject|0
7106712|NCT02446171|11235849|FG001|Overall Study|Withdrawal by Subject|0
7106713|NCT02446171|11235850|FG002|Overall Study|Withdrawal by Subject|2
7106714|NCT02446171|11235851|FG003|Overall Study|Withdrawal by Subject|0
7106715|NCT02446418|11235890|FG000|Overall Study|Adverse Event|4
7106716|NCT02446418|11235891|FG001|Overall Study|Adverse Event|8
7106717|NCT02446418|11235890|FG000|Overall Study|Physician Decision|5
7106718|NCT02446418|11235891|FG001|Overall Study|Physician Decision|1
7106719|NCT02446418|11235890|FG000|Overall Study|Withdrawal by Subject|3
7106720|NCT02446418|11235891|FG001|Overall Study|Withdrawal by Subject|3
7106721|NCT02446418|11235890|FG000|Overall Study|Lost to Follow-up|2
7106722|NCT02446418|11235891|FG001|Overall Study|Lost to Follow-up|2
7106723|NCT02446418|11235890|FG000|Overall Study|Protocol Violation|1
7106724|NCT02446418|11235891|FG001|Overall Study|Protocol Violation|2
7106725|NCT02446418|11235890|FG000|Overall Study|Lack of Efficacy|2
7106726|NCT02446418|11235891|FG001|Overall Study|Lack of Efficacy|0
7106727|NCT02446418|11235890|FG000|Overall Study|Protocol defined stopping criteria reach|1
7106728|NCT02446418|11235891|FG001|Overall Study|Protocol defined stopping criteria reach|0
7106729|NCT02446691|11235923|FG000|Overall Study|Withdrawal by Subject|2
7106730|NCT02446691|11235923|FG000|Overall Study|Lost to Follow-up|8
7106731|NCT02446691|11235923|FG000|Overall Study|Protocol Violation|1
7106732|NCT02446717|11235932|FG000|Overall Study|Adverse Event|0
7106733|NCT02446717|11235933|FG001|Overall Study|Adverse Event|0
7106734|NCT02446717|11235934|FG002|Overall Study|Adverse Event|1
7106735|NCT02446717|11235935|FG003|Overall Study|Adverse Event|0
7106736|NCT02446717|11235936|FG004|Overall Study|Adverse Event|0
7106737|NCT02446717|11235932|FG000|Overall Study|Lost to Follow-up|0
7106738|NCT02446717|11235933|FG001|Overall Study|Lost to Follow-up|1
7106739|NCT02446717|11235934|FG002|Overall Study|Lost to Follow-up|1
7106740|NCT02446717|11235935|FG003|Overall Study|Lost to Follow-up|0
7106741|NCT02446717|11235936|FG004|Overall Study|Lost to Follow-up|1
7106742|NCT02446717|11235932|FG000|Overall Study|Withdrew consent|0
7106743|NCT02446717|11235933|FG001|Overall Study|Withdrew consent|0
7106744|NCT02446717|11235934|FG002|Overall Study|Withdrew consent|0
7106745|NCT02446717|11235935|FG003|Overall Study|Withdrew consent|1
7106746|NCT02446717|11235936|FG004|Overall Study|Withdrew consent|0
7106747|NCT02446743|11235950|FG000|Overall Study|Withdrawal by Subject|1
7106748|NCT02446743|11235951|FG001|Overall Study|Withdrawal by Subject|1
7106749|NCT02446743|11235950|FG000|Overall Study|Lost to Follow-up|1
7106750|NCT02446743|11235951|FG001|Overall Study|Lost to Follow-up|0
7106751|NCT02446743|11235950|FG000|Overall Study|Adverse Event|1
7106752|NCT02446743|11235951|FG001|Overall Study|Adverse Event|1
7106753|NCT02446743|11235950|FG000|Overall Study|Other|2
7106754|NCT02446743|11235951|FG001|Overall Study|Other|3
7106755|NCT02446769|11235966|FG000|Screening Period|Screen Failure|11
7106756|NCT02446769|11235967|FG001|Screening Period|Screen Failure|0
7106757|NCT02446769|11235968|FG002|Screening Period|Screen Failure|0
7106758|NCT02446769|11235966|FG000|Study Period|Randomized in Error|0
7106759|NCT02446769|11235967|FG001|Study Period|Randomized in Error|2
7106760|NCT02446769|11235968|FG002|Study Period|Randomized in Error|0
7106761|NCT02446886|11235986|FG000|Overall Study|Adverse Event|1
7106762|NCT02446886|11235987|FG001|Overall Study|Adverse Event|3
7106763|NCT02446886|11235986|FG000|Overall Study|Withdrawal by Subject|1
7106764|NCT02446886|11235987|FG001|Overall Study|Withdrawal by Subject|1
7106765|NCT02446899|11235996|FG000|Overall Study|Adverse Event|4
7106766|NCT02446899|11235997|FG001|Overall Study|Adverse Event|7
7106767|NCT02446899|11235996|FG000|Overall Study|Condition Under Investigation Worsened|1
7106768|NCT02446899|11235997|FG001|Overall Study|Condition Under Investigation Worsened|4
7106769|NCT02446899|11235996|FG000|Overall Study|Study Specific Withdrawal Criteria|1
7106770|NCT02446899|11235997|FG001|Overall Study|Study Specific Withdrawal Criteria|0
7106771|NCT02446899|11235996|FG000|Overall Study|Lack of Efficacy|2
7106772|NCT02446899|11235997|FG001|Overall Study|Lack of Efficacy|8
7106773|NCT02446899|11235996|FG000|Overall Study|Lost to Follow-up|1
7106774|NCT02446899|11235997|FG001|Overall Study|Lost to Follow-up|3
7106775|NCT02446899|11235996|FG000|Overall Study|Severe Non-Compliance to Protocol|0
7106776|NCT02446899|11235997|FG001|Overall Study|Severe Non-Compliance to Protocol|1
7106777|NCT02446899|11235996|FG000|Overall Study|Withdrawal by Subject|11
7106778|NCT02446899|11235997|FG001|Overall Study|Withdrawal by Subject|19
7106779|NCT02446899|11235996|FG000|Overall Study|Miscellaneous|5
7106780|NCT02446899|11235997|FG001|Overall Study|Miscellaneous|4
7106781|NCT02446899|11235996|FG000|Overall Study|Failure to Meet Randomization Criteria|0
7106782|NCT02446899|11235997|FG001|Overall Study|Failure to Meet Randomization Criteria|2
7106783|NCT02446912|11236006|FG000|Overall Study|Adverse Event|3
7106784|NCT02446912|11236007|FG001|Overall Study|Adverse Event|13
7106785|NCT02446912|11236008|FG002|Overall Study|Adverse Event|5
7106786|NCT02446912|11236006|FG000|Overall Study|Condition under investigation worsened|0
7106787|NCT02446912|11236007|FG001|Overall Study|Condition under investigation worsened|1
7106788|NCT02446912|11236008|FG002|Overall Study|Condition under investigation worsened|1
7106789|NCT02446912|11236006|FG000|Overall Study|Study-specific withdrawal criteria|1
7106790|NCT02446912|11236007|FG001|Overall Study|Study-specific withdrawal criteria|0
7106791|NCT02446912|11236008|FG002|Overall Study|Study-specific withdrawal criteria|0
7106792|NCT02446912|11236006|FG000|Overall Study|Lack of Efficacy|1
7106793|NCT02446912|11236007|FG001|Overall Study|Lack of Efficacy|4
7106794|NCT02446912|11236008|FG002|Overall Study|Lack of Efficacy|7
7106795|NCT02446912|11236006|FG000|Overall Study|Lost to Follow-up|0
7106796|NCT02446912|11236007|FG001|Overall Study|Lost to Follow-up|0
7106797|NCT02446912|11236008|FG002|Overall Study|Lost to Follow-up|2
7106798|NCT02446912|11236006|FG000|Overall Study|Severe non-compliance to protocol|1
7106799|NCT02446912|11236007|FG001|Overall Study|Severe non-compliance to protocol|0
7106800|NCT02446912|11236008|FG002|Overall Study|Severe non-compliance to protocol|1
7106801|NCT02446912|11236006|FG000|Overall Study|Withdrawal by Subject|10
7106802|NCT02446912|11236007|FG001|Overall Study|Withdrawal by Subject|15
7106803|NCT02446912|11236008|FG002|Overall Study|Withdrawal by Subject|15
7106804|NCT02446912|11236006|FG000|Overall Study|Miscellaneous|2
7106805|NCT02446912|11236007|FG001|Overall Study|Miscellaneous|2
7106806|NCT02446912|11236008|FG002|Overall Study|Miscellaneous|4
7106807|NCT02446990|11236018|FG000|Overall Study|Death|485
7106808|NCT02446990|11236019|FG001|Overall Study|Death|458
7106809|NCT02446990|11236018|FG000|Overall Study|Lost to Follow-up|3
7106810|NCT02446990|11236019|FG001|Overall Study|Lost to Follow-up|1
7106811|NCT02446990|11236018|FG000|Overall Study|Physician Decision|1
7106812|NCT02446990|11236019|FG001|Overall Study|Physician Decision|0
7106813|NCT02446990|11236018|FG000|Overall Study|Withdrawal by Subject|231
7106814|NCT02446990|11236019|FG001|Overall Study|Withdrawal by Subject|199
7106815|NCT02447003|11236027|FG000|Overall Study|Other|0
7106816|NCT02447003|11236028|FG001|Overall Study|Other|4
7106817|NCT02447003|11236027|FG000|Overall Study|Site discontinued|0
7106818|NCT02447003|11236028|FG001|Overall Study|Site discontinued|2
7106819|NCT02447003|11236027|FG000|Overall Study|Physician Decision|0
7106820|NCT02447003|11236028|FG001|Overall Study|Physician Decision|1
7106821|NCT02447003|11236027|FG000|Overall Study|Withdrawal by Subject|4
7106822|NCT02447003|11236028|FG001|Overall Study|Withdrawal by Subject|3
7106823|NCT02447003|11236027|FG000|Overall Study|Sponsor Decision|6
7106824|NCT02447003|11236028|FG001|Overall Study|Sponsor Decision|11
7106825|NCT02447003|11236027|FG000|Overall Study|Progressive Disease|1
7106826|NCT02447003|11236028|FG001|Overall Study|Progressive Disease|0
7106827|NCT02447003|11236027|FG000|Overall Study|Lost to Follow-up|5
7106828|NCT02447003|11236028|FG001|Overall Study|Lost to Follow-up|0
7106829|NCT02447003|11236027|FG000|Overall Study|Death|154
7106830|NCT02447003|11236028|FG001|Overall Study|Death|63
7106831|NCT02447029|11236038|FG000|Overall Study|Withdrawal by Subject|3
7106832|NCT02447029|11236039|FG001|Overall Study|Withdrawal by Subject|2
7106833|NCT02447081|11236045|FG000|Overall Study|Death|161
7106834|NCT02447081|11236045|FG000|Overall Study|Lost to Follow-up|36
7106835|NCT02447081|11236045|FG000|Overall Study|Visit not completed|17
7106836|NCT02447081|11236045|FG000|Overall Study|unsuccessful implant procedure|10
7106837|NCT02447172|11236052|FG000|Overall Study|Adverse Event|11
7106838|NCT02447172|11236053|FG001|Overall Study|Adverse Event|8
7106839|NCT02447172|11236054|FG002|Overall Study|Adverse Event|7
7106840|NCT02447172|11236052|FG000|Overall Study|Death|3
7106841|NCT02447172|11236053|FG001|Overall Study|Death|1
7106842|NCT02447172|11236054|FG002|Overall Study|Death|0
7106843|NCT02447172|11236052|FG000|Overall Study|Protocol Violation|2
7106844|NCT02447172|11236053|FG001|Overall Study|Protocol Violation|1
7106845|NCT02447172|11236054|FG002|Overall Study|Protocol Violation|2
7106846|NCT02447172|11236052|FG000|Overall Study|Lost to Follow-up|7
7106847|NCT02447172|11236053|FG001|Overall Study|Lost to Follow-up|4
7106848|NCT02447172|11236054|FG002|Overall Study|Lost to Follow-up|4
7106849|NCT02447172|11236052|FG000|Overall Study|Withdrawal by Subject|5
7106850|NCT02447172|11236053|FG001|Overall Study|Withdrawal by Subject|1
7106851|NCT02447172|11236054|FG002|Overall Study|Withdrawal by Subject|3
7106852|NCT02447172|11236052|FG000|Overall Study|protocol specific treatment unrelated|3
7106853|NCT02447172|11236053|FG001|Overall Study|protocol specific treatment unrelated|0
7106854|NCT02447172|11236054|FG002|Overall Study|protocol specific treatment unrelated|2
7106855|NCT02447250|11236062|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1
7106856|NCT02447250|11236062|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1
7106857|NCT02447250|11236062|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4
7106858|NCT02447302|11236070|FG000|Overall Study|Physician Decision|1
7106859|NCT02447302|11236071|FG001|Overall Study|Physician Decision|0
7106860|NCT02447302|11236072|FG002|Overall Study|Physician Decision|0
7106861|NCT02447302|11236070|FG000|Overall Study|Adverse Event|4
7106862|NCT02447302|11236071|FG001|Overall Study|Adverse Event|3
7106863|NCT02447302|11236072|FG002|Overall Study|Adverse Event|0
7106864|NCT02447302|11236070|FG000|Overall Study|Withdrawal by Subject|0
7106865|NCT02447302|11236071|FG001|Overall Study|Withdrawal by Subject|1
7106866|NCT02447302|11236072|FG002|Overall Study|Withdrawal by Subject|5
7106867|NCT02447302|11236070|FG000|Overall Study|Sponsor Decision|0
7106868|NCT02447302|11236071|FG001|Overall Study|Sponsor Decision|0
7106869|NCT02447302|11236072|FG002|Overall Study|Sponsor Decision|1
7106870|NCT02447328|11236080|FG000|Overall Study|Withdrawal by Subject|1
7106871|NCT02447432|11236086|FG000|Epoch 001|Adverse Event|1
7106872|NCT02447432|11236087|FG001|Epoch 001|Adverse Event|1
7106873|NCT02447432|11236086|FG000|Epoch 001|Withdrawal by Subject|0
7106874|NCT02447432|11236087|FG001|Epoch 001|Withdrawal by Subject|4
7106875|NCT02447432|11236086|FG000|Epoch 001|Migrated/moved from study area|3
7106876|NCT02447432|11236087|FG001|Epoch 001|Migrated/moved from study area|5
7106877|NCT02447432|11236086|FG000|Epoch 001|Lost to Follow-up|1
7106878|NCT02447432|11236087|FG001|Epoch 001|Lost to Follow-up|3
7106879|NCT02447458|11236099|FG000|Overall Study|Other|0
7106880|NCT02447458|11236100|FG001|Overall Study|Other|0
7106881|NCT02447458|11236101|FG002|Overall Study|Other|1
7106882|NCT02447458|11236102|FG003|Overall Study|Other|0
7106883|NCT02447458|11236103|FG004|Overall Study|Other|0
7106884|NCT02447458|11236104|FG005|Overall Study|Other|0
7106885|NCT02447497|11236127|FG000|Overall Study|Did not meet treatment day baseline.|6
7106886|NCT02447497|11236128|FG001|Overall Study|Did not meet treatment day baseline.|5
7106887|NCT02447497|11236129|FG002|Overall Study|Did not meet treatment day baseline.|2
7106888|NCT02447497|11236130|FG003|Overall Study|Did not meet treatment day baseline.|2
7106889|NCT02447497|11236127|FG000|Overall Study|Dressing was compromised|0
7106890|NCT02447497|11236128|FG001|Overall Study|Dressing was compromised|1
7106891|NCT02447497|11236129|FG002|Overall Study|Dressing was compromised|0
7106892|NCT02447497|11236130|FG003|Overall Study|Dressing was compromised|0
7106893|NCT02447744|11236154|FG000|Overall Study|Withdrawal by Subject|3
7106894|NCT02447744|11236155|FG001|Overall Study|Withdrawal by Subject|1
7106895|NCT02447744|11236154|FG000|Overall Study|Data not collected b/c logistic reasons|3
7106896|NCT02447744|11236155|FG001|Overall Study|Data not collected b/c logistic reasons|0
7106897|NCT02447848|11236161|FG000|Overall Study|Patient discharged|3
7106898|NCT02447848|11236161|FG000|Overall Study|Lack of Efficacy|4
7106899|NCT02447848|11236161|FG000|Overall Study|Withdrawal by Subject|4
7106900|NCT02447952|11236169|FG000|Overall Study|Adverse Event|2
7106901|NCT02447952|11236169|FG000|Overall Study|Physician Decision|1
7106902|NCT02447952|11236169|FG000|Overall Study|Withdrawal by Subject|4
7106903|NCT02447991|11236175|FG000|Overall Study|Withdrawn by subject - no data|0
7106904|NCT02447991|11236176|FG001|Overall Study|Withdrawn by subject - no data|2
7106905|NCT02447991|11236175|FG000|Overall Study|Withdrawn by Subject - with data|4
7106906|NCT02447991|11236176|FG001|Overall Study|Withdrawn by Subject - with data|4
7106907|NCT02447991|11236175|FG000|Overall Study|Lost to Follow-up - no data|3
7106908|NCT02447991|11236176|FG001|Overall Study|Lost to Follow-up - no data|6
7106909|NCT02447991|11236175|FG000|Overall Study|Lost to follow-up - with data|0
7106910|NCT02447991|11236176|FG001|Overall Study|Lost to follow-up - with data|3
7106911|NCT02447991|11236175|FG000|Overall Study|End of study - no treatment results|3
7106912|NCT02447991|11236176|FG001|Overall Study|End of study - no treatment results|6
7106913|NCT02447991|11236175|FG000|Overall Study|End of study - partial treatment results|0
7106914|NCT02447991|11236176|FG001|Overall Study|End of study - partial treatment results|9
7106915|NCT02448043|11236188|FG000|Overall Study|Withdrawal by Subject|2
7106916|NCT02448043|11236189|FG001|Overall Study|Withdrawal by Subject|2
7106917|NCT02448043|11236188|FG000|Overall Study|Protocol Violation|1
7106918|NCT02448043|11236189|FG001|Overall Study|Protocol Violation|2
7106919|NCT02448446|11236248|FG000|Overall Study|Withdrawal by Subject|1
7106920|NCT02448446|11236249|FG001|Overall Study|Withdrawal by Subject|0
7106921|NCT02448537|11236258|FG000|Overall Study|Withdrawal by Subject|1
7106922|NCT02448537|11236259|FG001|Overall Study|Withdrawal by Subject|1
7106923|NCT02448537|11236260|FG002|Overall Study|Withdrawal by Subject|1
7106924|NCT02448563|11236272|FG000|Overall Study|Lost to Follow-up|16
7106925|NCT02448563|11236273|FG001|Overall Study|Lost to Follow-up|10
7106926|NCT02448563|11236272|FG000|Overall Study|Withdrawal by Subject|0
7106927|NCT02448563|11236273|FG001|Overall Study|Withdrawal by Subject|1
7106928|NCT02448706|11236312|FG000|Overall Study|Withdrawal by Subject|4
7106929|NCT02448706|11236313|FG001|Overall Study|Withdrawal by Subject|3
7106930|NCT02448706|11236312|FG000|Overall Study|Protocol Violation|1
7106931|NCT02448706|11236313|FG001|Overall Study|Protocol Violation|1
7106932|NCT02448719|11236332|FG000|Overall Study|Withdrawal by Subject|0
7106933|NCT02448719|11236333|FG001|Overall Study|Withdrawal by Subject|0
7106934|NCT02448719|11236334|FG002|Overall Study|Withdrawal by Subject|0
7106935|NCT02448719|11236335|FG003|Overall Study|Withdrawal by Subject|0
7106936|NCT02448719|11236336|FG004|Overall Study|Withdrawal by Subject|1
7106937|NCT02448719|11236337|FG005|Overall Study|Withdrawal by Subject|0
7106938|NCT02448719|11236338|FG006|Overall Study|Withdrawal by Subject|0
7106939|NCT02448719|11236339|FG007|Overall Study|Withdrawal by Subject|0
7106940|NCT02448719|11236340|FG008|Overall Study|Withdrawal by Subject|0
7106941|NCT02448719|11236341|FG009|Overall Study|Withdrawal by Subject|0
7106942|NCT02448719|11236342|FG010|Overall Study|Withdrawal by Subject|0
7106943|NCT02448771|11236403|FG000|Overall Study|Disease Progression|30
7106944|NCT02448771|11236403|FG000|Overall Study|Unacceptable Toxicity|1
7106945|NCT02448771|11236403|FG000|Overall Study|Physician Decision|3
7106946|NCT02448771|11236403|FG000|Overall Study|Started new therapy|2
7106947|NCT02448810|11236416|FG000|Overall Study|Adverse Event|0
7106948|NCT02448810|11236417|FG001|Overall Study|Adverse Event|0
7106949|NCT02448810|11236418|FG002|Overall Study|Adverse Event|1
7106950|NCT02448810|11236419|FG003|Overall Study|Adverse Event|0
7106951|NCT02448810|11236420|FG004|Overall Study|Adverse Event|0
7106952|NCT02448810|11236421|FG005|Overall Study|Adverse Event|0
7106953|NCT02448810|11236422|FG006|Overall Study|Adverse Event|0
7106954|NCT02448810|11236423|FG007|Overall Study|Adverse Event|0
7106955|NCT02448810|11236416|FG000|Overall Study|Withdrawal by Subject|0
7106956|NCT02448810|11236417|FG001|Overall Study|Withdrawal by Subject|0
7106957|NCT02448810|11236418|FG002|Overall Study|Withdrawal by Subject|1
7106958|NCT02448810|11236419|FG003|Overall Study|Withdrawal by Subject|0
7106959|NCT02448810|11236420|FG004|Overall Study|Withdrawal by Subject|3
7106960|NCT02448810|11236421|FG005|Overall Study|Withdrawal by Subject|5
7106961|NCT02448810|11236422|FG006|Overall Study|Withdrawal by Subject|0
7106962|NCT02448810|11236423|FG007|Overall Study|Withdrawal by Subject|2
7106963|NCT02448810|11236416|FG000|Overall Study|Other (study terminated by sponsor)|0
7106964|NCT02448810|11236417|FG001|Overall Study|Other (study terminated by sponsor)|0
7106965|NCT02448810|11236418|FG002|Overall Study|Other (study terminated by sponsor)|0
7106966|NCT02448810|11236419|FG003|Overall Study|Other (study terminated by sponsor)|0
7106967|NCT02448810|11236420|FG004|Overall Study|Other (study terminated by sponsor)|4
7106968|NCT02448810|11236421|FG005|Overall Study|Other (study terminated by sponsor)|2
7106969|NCT02448810|11236422|FG006|Overall Study|Other (study terminated by sponsor)|2
7106970|NCT02448810|11236423|FG007|Overall Study|Other (study terminated by sponsor)|1
7106971|NCT02448810|11236416|FG000|Overall Study|Death|1
7106972|NCT02448810|11236417|FG001|Overall Study|Death|0
7106973|NCT02448810|11236418|FG002|Overall Study|Death|1
7106974|NCT02448810|11236419|FG003|Overall Study|Death|0
7106975|NCT02448810|11236420|FG004|Overall Study|Death|1
7106976|NCT02448810|11236421|FG005|Overall Study|Death|0
7106977|NCT02448810|11236422|FG006|Overall Study|Death|0
7106978|NCT02448810|11236423|FG007|Overall Study|Death|0
7106979|NCT02448810|11236416|FG000|Overall Study|Other (Progressive disease)|2
7106980|NCT02448810|11236417|FG001|Overall Study|Other (Progressive disease)|2
7106981|NCT02448810|11236418|FG002|Overall Study|Other (Progressive disease)|0
7106982|NCT02448810|11236419|FG003|Overall Study|Other (Progressive disease)|3
7106983|NCT02448810|11236420|FG004|Overall Study|Other (Progressive disease)|23
7106984|NCT02448810|11236421|FG005|Overall Study|Other (Progressive disease)|9
7106985|NCT02448810|11236422|FG006|Overall Study|Other (Progressive disease)|14
7106986|NCT02448810|11236423|FG007|Overall Study|Other (Progressive disease)|5
7106987|NCT02448810|11236416|FG000|Overall Study|Lost to Follow-up|0
7106988|NCT02448810|11236417|FG001|Overall Study|Lost to Follow-up|1
7106989|NCT02448810|11236418|FG002|Overall Study|Lost to Follow-up|0
7106990|NCT02448810|11236419|FG003|Overall Study|Lost to Follow-up|0
7106991|NCT02448810|11236420|FG004|Overall Study|Lost to Follow-up|0
7106992|NCT02448810|11236421|FG005|Overall Study|Lost to Follow-up|0
7106993|NCT02448810|11236422|FG006|Overall Study|Lost to Follow-up|0
7106994|NCT02448810|11236423|FG007|Overall Study|Lost to Follow-up|0
7106995|NCT02448810|11236416|FG000|Overall Study|Other (unspecified)|0
7106996|NCT02448810|11236417|FG001|Overall Study|Other (unspecified)|0
7106997|NCT02448810|11236418|FG002|Overall Study|Other (unspecified)|0
7106998|NCT02448810|11236419|FG003|Overall Study|Other (unspecified)|0
7106999|NCT02448810|11236420|FG004|Overall Study|Other (unspecified)|0
7107000|NCT02448810|11236421|FG005|Overall Study|Other (unspecified)|0
7107001|NCT02448810|11236422|FG006|Overall Study|Other (unspecified)|2
7107002|NCT02448810|11236423|FG007|Overall Study|Other (unspecified)|0
7107003|NCT02448875|11236457|FG000|Overall Study|Adverse Event|2
7107004|NCT02448875|11236458|FG001|Overall Study|Adverse Event|1
7107005|NCT02448875|11236459|FG002|Overall Study|Adverse Event|0
7107006|NCT02448875|11236457|FG000|Overall Study|Lost to Follow-up|1
7107007|NCT02448875|11236458|FG001|Overall Study|Lost to Follow-up|0
7107008|NCT02448875|11236459|FG002|Overall Study|Lost to Follow-up|0
7107009|NCT02448875|11236457|FG000|Overall Study|Investigator Decision|3
7107010|NCT02448875|11236458|FG001|Overall Study|Investigator Decision|0
7107011|NCT02448875|11236459|FG002|Overall Study|Investigator Decision|1
7107012|NCT02448875|11236457|FG000|Overall Study|Withdrawal by Subject|1
7107013|NCT02448875|11236458|FG001|Overall Study|Withdrawal by Subject|0
7107014|NCT02448875|11236459|FG002|Overall Study|Withdrawal by Subject|0
7107015|NCT02449018|11236480|FG000|Overall Study|Abnormal laboratory value|0
7107016|NCT02449018|11236481|FG001|Overall Study|Abnormal laboratory value|1
7107017|NCT02449018|11236480|FG000|Overall Study|Administrative problems|1
7107018|NCT02449018|11236481|FG001|Overall Study|Administrative problems|0
7107019|NCT02449018|11236480|FG000|Overall Study|Adverse Event|5
7107020|NCT02449018|11236481|FG001|Overall Study|Adverse Event|1
7107021|NCT02449018|11236480|FG000|Overall Study|Protocol deviation|4
7107022|NCT02449018|11236481|FG001|Overall Study|Protocol deviation|0
7107023|NCT02449018|11236480|FG000|Overall Study|Patient decision|2
7107024|NCT02449018|11236481|FG001|Overall Study|Patient decision|0
7107025|NCT02449044|11236487|FG000|Overall Study|Lost to Follow-up|2
7107026|NCT02449044|11236487|FG000|Overall Study|Withdrawal by Subject|13
7107027|NCT02449044|11236487|FG000|Overall Study|Adverse Event|30
7107028|NCT02449044|11236487|FG000|Overall Study|Met Withdrawal Criteria|7
7107029|NCT02449044|11236487|FG000|Overall Study|Physician Decision|9
7107030|NCT02449044|11236487|FG000|Overall Study|Sponsor Discontinued Trial|3
7107031|NCT02449889|11236552|FG000|Overall Study|Adverse Event|1
7107032|NCT02449889|11236553|FG001|Overall Study|Adverse Event|2
7107033|NCT02449889|11236554|FG002|Overall Study|Adverse Event|0
7107034|NCT02449889|11236552|FG000|Overall Study|Protocol Violation|0
7107035|NCT02449889|11236553|FG001|Overall Study|Protocol Violation|4
7107036|NCT02449889|11236554|FG002|Overall Study|Protocol Violation|1
7107037|NCT02449902|11236564|FG000|Overall Study|Adverse Event|0
7107038|NCT02449902|11236565|FG001|Overall Study|Adverse Event|1
7107039|NCT02449902|11236564|FG000|Overall Study|Withdrawal by Subject|0
7107040|NCT02449902|11236565|FG001|Overall Study|Withdrawal by Subject|1
7107041|NCT02449915|11236575|FG000|Overall Study|Exclusion criteria - drug use|1
7107042|NCT02449915|11236576|FG001|Overall Study|Exclusion criteria - drug use|0
7107043|NCT02449915|11236575|FG000|Overall Study|Withdrawal by Subject|0
7107044|NCT02449915|11236576|FG001|Overall Study|Withdrawal by Subject|2
7107045|NCT02449915|11236575|FG000|Overall Study|Intraoperative surgical findings|1
7107046|NCT02449915|11236576|FG001|Overall Study|Intraoperative surgical findings|1
7107047|NCT02449915|11236575|FG000|Overall Study|Abnormal preop lab|0
7107048|NCT02449915|11236576|FG001|Overall Study|Abnormal preop lab|1
7107049|NCT02450487|11236591|FG000|Overall Study|Lost to Follow-up|3
7107050|NCT02450526|11236600|FG000|DB Period (Cycle 1)|Adverse Event|0
7107051|NCT02450526|11236601|FG001|DB Period (Cycle 1)|Adverse Event|0
7107052|NCT02450526|11236602|FG002|DB Period (Cycle 1)|Adverse Event|2
7107053|NCT02450526|11236603|FG003|DB Period (Cycle 1)|Adverse Event|0
7107054|NCT02450526|11236604|FG004|DB Period (Cycle 1)|Adverse Event|0
7107055|NCT02450526|11236600|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28
7107056|NCT02450526|11236601|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3
7107057|NCT02450526|11236602|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8
7107058|NCT02450526|11236603|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1
7107059|NCT02450526|11236604|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0
7107060|NCT02450526|11236600|FG000|DB Period (Cycle 1)|Lost to Follow-up|1
7107061|NCT02450526|11236601|FG001|DB Period (Cycle 1)|Lost to Follow-up|0
7107062|NCT02450526|11236602|FG002|DB Period (Cycle 1)|Lost to Follow-up|0
7107063|NCT02450526|11236603|FG003|DB Period (Cycle 1)|Lost to Follow-up|0
7107064|NCT02450526|11236604|FG004|DB Period (Cycle 1)|Lost to Follow-up|0
7107065|NCT02450526|11236600|FG000|DB Period (Cycle 1)|Protocol Violation|2
7107066|NCT02450526|11236601|FG001|DB Period (Cycle 1)|Protocol Violation|0
7107067|NCT02450526|11236602|FG002|DB Period (Cycle 1)|Protocol Violation|0
7107068|NCT02450526|11236603|FG003|DB Period (Cycle 1)|Protocol Violation|1
7107069|NCT02450526|11236604|FG004|DB Period (Cycle 1)|Protocol Violation|0
7107070|NCT02450526|11236600|FG000|OL Period (Cycles 2-5)|Adverse Event|0
7107071|NCT02450526|11236601|FG001|OL Period (Cycles 2-5)|Adverse Event|0
7107072|NCT02450526|11236602|FG002|OL Period (Cycles 2-5)|Adverse Event|0
7107073|NCT02450526|11236603|FG003|OL Period (Cycles 2-5)|Adverse Event|0
7107074|NCT02450526|11236604|FG004|OL Period (Cycles 2-5)|Adverse Event|2
7107075|NCT02450526|11236600|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0
7107076|NCT02450526|11236601|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0
7107077|NCT02450526|11236602|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0
7107078|NCT02450526|11236603|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0
7107079|NCT02450526|11236604|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31
7107080|NCT02450526|11236600|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0
7107081|NCT02450526|11236601|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0
7107082|NCT02450526|11236602|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0
7107083|NCT02450526|11236603|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0
7107084|NCT02450526|11236604|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1
7107085|NCT02450526|11236600|FG000|OL Period (Cycles 2-5)|Protocol Violation|0
7107086|NCT02450526|11236601|FG001|OL Period (Cycles 2-5)|Protocol Violation|0
7107087|NCT02450526|11236602|FG002|OL Period (Cycles 2-5)|Protocol Violation|0
7107088|NCT02450526|11236603|FG003|OL Period (Cycles 2-5)|Protocol Violation|0
7107089|NCT02450526|11236604|FG004|OL Period (Cycles 2-5)|Protocol Violation|7
7107090|NCT02450539|11236626|FG000|Overall Study|Withdrawal by Subject|12
7107091|NCT02450539|11236627|FG001|Overall Study|Withdrawal by Subject|6
7107092|NCT02450539|11236626|FG000|Overall Study|Lost to Follow-up|4
7107093|NCT02450539|11236627|FG001|Overall Study|Lost to Follow-up|1
7107094|NCT02450552|11236639|FG000|Overall Study|Withdrawal by Subject|4
7107095|NCT02450552|11236640|FG001|Overall Study|Withdrawal by Subject|0
7107096|NCT02450552|11236641|FG002|Overall Study|Withdrawal by Subject|4
7107097|NCT02450552|11236639|FG000|Overall Study|Physician Decision|1
7107098|NCT02450552|11236640|FG001|Overall Study|Physician Decision|0
7107099|NCT02450552|11236641|FG002|Overall Study|Physician Decision|1
7107100|NCT02450578|11236653|FG000|Overall Study|ECG abnormality so not treated|1
7107101|NCT02450578|11236654|FG001|Overall Study|ECG abnormality so not treated|0
7107102|NCT02450578|11236655|FG002|Overall Study|ECG abnormality so not treated|0
7107103|NCT02450578|11236656|FG003|Overall Study|ECG abnormality so not treated|0
7107104|NCT02450903|11236694|FG000|Overall Study|Adverse Event|3
7107105|NCT02450903|11236694|FG000|Overall Study|Progressive disease|15
7107106|NCT02450903|11236694|FG000|Overall Study|Switched to commercial drug|1
7107107|NCT02450903|11236694|FG000|Overall Study|Subject/guardian decision|1
7107108|NCT02451007|11236698|FG000|Overall Study|Withdrawal by Subject|4
7107109|NCT02451007|11236698|FG000|Overall Study|Adverse Event|1
7107110|NCT02451007|11236698|FG000|Overall Study|Disease Progression|2
7107111|NCT02451124|11236702|FG000|Overall Study|Withdrawal by Subject|1
7107112|NCT02451137|11236712|FG000|Overall Study|Randomized but not treated|19
7107113|NCT02451137|11236713|FG001|Overall Study|Randomized but not treated|27
7107114|NCT02451137|11236712|FG000|Overall Study|Adverse Event|43
7107115|NCT02451137|11236713|FG001|Overall Study|Adverse Event|42
7107116|NCT02451137|11236712|FG000|Overall Study|Lack of Efficacy|4
7107117|NCT02451137|11236713|FG001|Overall Study|Lack of Efficacy|9
7107118|NCT02451137|11236712|FG000|Overall Study|Participant decision:discontinue insulin|41
7107119|NCT02451137|11236713|FG001|Overall Study|Participant decision:discontinue insulin|43
7107120|NCT02451137|11236712|FG000|Overall Study|Hypoglycemia|2
7107121|NCT02451137|11236713|FG001|Overall Study|Hypoglycemia|1
7107122|NCT02451137|11236712|FG000|Overall Study|Investigator's decision|23
7107123|NCT02451137|11236713|FG001|Overall Study|Investigator's decision|19
7107124|NCT02451137|11236712|FG000|Overall Study|Lost to Follow-up|53
7107125|NCT02451137|11236713|FG001|Overall Study|Lost to Follow-up|61
7107126|NCT02451137|11236712|FG000|Overall Study|Physician Decision|6
7107127|NCT02451137|11236713|FG001|Overall Study|Physician Decision|5
7107128|NCT02451137|11236712|FG000|Overall Study|Sponsor decision|13
7107129|NCT02451137|11236713|FG001|Overall Study|Sponsor decision|25
7107130|NCT02451137|11236712|FG000|Overall Study|Withdrawal by Subject|40
7107131|NCT02451137|11236713|FG001|Overall Study|Withdrawal by Subject|63
7107132|NCT02451137|11236712|FG000|Overall Study|Other than specified above|2
7107133|NCT02451137|11236713|FG001|Overall Study|Other than specified above|3
7107134|NCT02451670|11236771|FG000|Overall Study|Did not have qualifying follow-up visit.|714
7107135|NCT02451670|11236772|FG001|Overall Study|Did not have qualifying follow-up visit.|696
7107136|NCT02451696|11236780|FG000|Overall Study|Surgery postponed|1
7107137|NCT02451696|11236781|FG001|Overall Study|Surgery postponed|0
7107138|NCT02451917|11236801|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2
7107139|NCT02451917|11236802|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0
7107140|NCT02451917|11236801|FG000|First Intervention (24 Weeks)|Death|0
7107141|NCT02451917|11236802|FG001|First Intervention (24 Weeks)|Death|1
7107142|NCT02451917|11236801|FG000|First Intervention (24 Weeks)|Adverse Event|0
7107143|NCT02451917|11236802|FG001|First Intervention (24 Weeks)|Adverse Event|2
7107144|NCT02451930|11236814|FG000|Overall Study|Death|0
7107145|NCT02451930|11236815|FG001|Overall Study|Death|15
7107146|NCT02451930|11236814|FG000|Overall Study|Lost to Follow-up|0
7107147|NCT02451930|11236815|FG001|Overall Study|Lost to Follow-up|3
7107148|NCT02451930|11236814|FG000|Overall Study|Sponsor Decision|2
7107149|NCT02451930|11236815|FG001|Overall Study|Sponsor Decision|10
7107150|NCT02451930|11236814|FG000|Overall Study|Withdrawal by Subject|0
7107151|NCT02451930|11236815|FG001|Overall Study|Withdrawal by Subject|1
7107152|NCT02451930|11236814|FG000|Overall Study|Other|0
7107153|NCT02451930|11236815|FG001|Overall Study|Other|1
7107154|NCT02452034|11236846|FG000|Overall Study|Adverse Event|0
7107155|NCT02452034|11236847|FG001|Overall Study|Adverse Event|0
7107156|NCT02452034|11236848|FG002|Overall Study|Adverse Event|0
7107157|NCT02452034|11236849|FG003|Overall Study|Adverse Event|0
7107158|NCT02452034|11236850|FG004|Overall Study|Adverse Event|0
7107159|NCT02452034|11236851|FG005|Overall Study|Adverse Event|1
7107160|NCT02452034|11236846|FG000|Overall Study|Death|0
7107161|NCT02452034|11236847|FG001|Overall Study|Death|0
7107162|NCT02452034|11236848|FG002|Overall Study|Death|0
7107163|NCT02452034|11236849|FG003|Overall Study|Death|0
7107164|NCT02452034|11236850|FG004|Overall Study|Death|1
7107165|NCT02452034|11236851|FG005|Overall Study|Death|1
7107166|NCT02452034|11236846|FG000|Overall Study|Physician Decision|0
7107167|NCT02452034|11236847|FG001|Overall Study|Physician Decision|1
7107168|NCT02452034|11236848|FG002|Overall Study|Physician Decision|1
7107169|NCT02452034|11236849|FG003|Overall Study|Physician Decision|0
7107170|NCT02452034|11236850|FG004|Overall Study|Physician Decision|0
7107171|NCT02452034|11236851|FG005|Overall Study|Physician Decision|0
7107172|NCT02452034|11236846|FG000|Overall Study|Protocol Violation|0
7107173|NCT02452034|11236847|FG001|Overall Study|Protocol Violation|0
7107174|NCT02452034|11236848|FG002|Overall Study|Protocol Violation|0
7107175|NCT02452034|11236849|FG003|Overall Study|Protocol Violation|0
7107176|NCT02452034|11236850|FG004|Overall Study|Protocol Violation|0
7107177|NCT02452034|11236851|FG005|Overall Study|Protocol Violation|1
7107178|NCT02452034|11236846|FG000|Overall Study|Screen Failure|1
7107179|NCT02452034|11236847|FG001|Overall Study|Screen Failure|0
7107180|NCT02452034|11236848|FG002|Overall Study|Screen Failure|0
7107181|NCT02452034|11236849|FG003|Overall Study|Screen Failure|1
7107182|NCT02452034|11236850|FG004|Overall Study|Screen Failure|0
7107183|NCT02452034|11236851|FG005|Overall Study|Screen Failure|0
7107184|NCT02452034|11236846|FG000|Overall Study|Withdrawn by Parent/Guardian|1
7107185|NCT02452034|11236847|FG001|Overall Study|Withdrawn by Parent/Guardian|0
7107186|NCT02452034|11236848|FG002|Overall Study|Withdrawn by Parent/Guardian|0
7107187|NCT02452034|11236849|FG003|Overall Study|Withdrawn by Parent/Guardian|0
7107188|NCT02452034|11236850|FG004|Overall Study|Withdrawn by Parent/Guardian|0
7107189|NCT02452034|11236851|FG005|Overall Study|Withdrawn by Parent/Guardian|0
7107190|NCT02452047|11236868|FG000|Overall Study|Adverse Event|0
7107191|NCT02452047|11236869|FG001|Overall Study|Adverse Event|1
7107192|NCT02452047|11236870|FG002|Overall Study|Adverse Event|1
7107193|NCT02452047|11236868|FG000|Overall Study|Death|1
7107194|NCT02452047|11236869|FG001|Overall Study|Death|3
7107195|NCT02452047|11236870|FG002|Overall Study|Death|1
7107196|NCT02452047|11236868|FG000|Overall Study|Physician Decision|1
7107197|NCT02452047|11236869|FG001|Overall Study|Physician Decision|0
7107198|NCT02452047|11236870|FG002|Overall Study|Physician Decision|0
7107199|NCT02452047|11236868|FG000|Overall Study|Lost to Follow-up|1
7107200|NCT02452047|11236869|FG001|Overall Study|Lost to Follow-up|1
7107201|NCT02452047|11236870|FG002|Overall Study|Lost to Follow-up|0
7107202|NCT02452047|11236868|FG000|Overall Study|Withdrawal by Subject|1
7107203|NCT02452047|11236869|FG001|Overall Study|Withdrawal by Subject|0
7107204|NCT02452047|11236870|FG002|Overall Study|Withdrawal by Subject|0
7107205|NCT02452190|11236889|FG000|Overall Study|Withdrawal by Sponsor|1
7107206|NCT02452190|11236890|FG001|Overall Study|Withdrawal by Sponsor|3
7107207|NCT02452190|11236889|FG000|Overall Study|Pregnancy|1
7107208|NCT02452190|11236890|FG001|Overall Study|Pregnancy|0
7107209|NCT02452190|11236889|FG000|Overall Study|Investigator's Decision|2
7107210|NCT02452190|11236890|FG001|Overall Study|Investigator's Decision|0
7107211|NCT02452190|11236889|FG000|Overall Study|Lack of Efficacy|3
7107212|NCT02452190|11236890|FG001|Overall Study|Lack of Efficacy|1
7107213|NCT02452190|11236889|FG000|Overall Study|Lost to Follow-up|4
7107214|NCT02452190|11236890|FG001|Overall Study|Lost to Follow-up|3
7107215|NCT02452190|11236889|FG000|Overall Study|Adverse Event|2
7107216|NCT02452190|11236890|FG001|Overall Study|Adverse Event|5
7107217|NCT02452190|11236889|FG000|Overall Study|Withdrawal by Subject|20
7107218|NCT02452190|11236890|FG001|Overall Study|Withdrawal by Subject|11
7107219|NCT02452190|11236889|FG000|Overall Study|Noncompliance with study drug|1
7107220|NCT02452190|11236890|FG001|Overall Study|Noncompliance with study drug|0
7107221|NCT02452190|11236889|FG000|Overall Study|Participant traveled abroad|1
7107222|NCT02452190|11236890|FG001|Overall Study|Participant traveled abroad|0
7107223|NCT02452190|11236889|FG000|Overall Study|Death|0
7107224|NCT02452190|11236890|FG001|Overall Study|Death|1
7107225|NCT02452320|11236898|FG000|Overall Study|Adverse Event|0
7107226|NCT02452320|11236899|FG001|Overall Study|Adverse Event|1
7107227|NCT02452424|11236920|FG000|Overall Study|Death|2
7107228|NCT02452424|11236921|FG001|Overall Study|Death|2
7107229|NCT02452424|11236922|FG002|Overall Study|Death|2
7107230|NCT02452424|11236923|FG003|Overall Study|Death|6
7107231|NCT02452424|11236924|FG004|Overall Study|Death|2
7107232|NCT02452424|11236925|FG005|Overall Study|Death|0
7107233|NCT02452424|11236926|FG006|Overall Study|Death|5
7107234|NCT02452424|11236927|FG007|Overall Study|Death|1
7107235|NCT02452424|11236928|FG008|Overall Study|Death|3
7107236|NCT02452424|11236929|FG009|Overall Study|Death|1
7107237|NCT02452424|11236930|FG010|Overall Study|Death|0
7107238|NCT02452424|11236920|FG000|Overall Study|Lost to Follow-up|0
7107239|NCT02452424|11236921|FG001|Overall Study|Lost to Follow-up|1
7107240|NCT02452424|11236922|FG002|Overall Study|Lost to Follow-up|1
7107241|NCT02452424|11236923|FG003|Overall Study|Lost to Follow-up|0
7107242|NCT02452424|11236924|FG004|Overall Study|Lost to Follow-up|0
7107243|NCT02452424|11236925|FG005|Overall Study|Lost to Follow-up|0
7107244|NCT02452424|11236926|FG006|Overall Study|Lost to Follow-up|0
7107245|NCT02452424|11236927|FG007|Overall Study|Lost to Follow-up|0
7107246|NCT02452424|11236928|FG008|Overall Study|Lost to Follow-up|0
7107247|NCT02452424|11236929|FG009|Overall Study|Lost to Follow-up|0
7107248|NCT02452424|11236930|FG010|Overall Study|Lost to Follow-up|0
7107249|NCT02452424|11236920|FG000|Overall Study|Withdrawal by Subject|0
7107250|NCT02452424|11236921|FG001|Overall Study|Withdrawal by Subject|0
7107251|NCT02452424|11236922|FG002|Overall Study|Withdrawal by Subject|3
7107252|NCT02452424|11236923|FG003|Overall Study|Withdrawal by Subject|2
7107253|NCT02452424|11236924|FG004|Overall Study|Withdrawal by Subject|0
7107254|NCT02452424|11236925|FG005|Overall Study|Withdrawal by Subject|0
7107255|NCT02452424|11236926|FG006|Overall Study|Withdrawal by Subject|1
7107256|NCT02452424|11236927|FG007|Overall Study|Withdrawal by Subject|0
7107257|NCT02452424|11236928|FG008|Overall Study|Withdrawal by Subject|1
7107258|NCT02452424|11236929|FG009|Overall Study|Withdrawal by Subject|1
7107259|NCT02452424|11236930|FG010|Overall Study|Withdrawal by Subject|0
7107260|NCT02452424|11236920|FG000|Overall Study|Other|0
7107261|NCT02452424|11236921|FG001|Overall Study|Other|0
7107262|NCT02452424|11236922|FG002|Overall Study|Other|1
7107263|NCT02452424|11236923|FG003|Overall Study|Other|0
7107264|NCT02452424|11236924|FG004|Overall Study|Other|0
7107265|NCT02452424|11236925|FG005|Overall Study|Other|1
7107266|NCT02452424|11236926|FG006|Overall Study|Other|4
7107267|NCT02452424|11236927|FG007|Overall Study|Other|3
7107268|NCT02452424|11236928|FG008|Overall Study|Other|0
7107269|NCT02452424|11236929|FG009|Overall Study|Other|0
7107270|NCT02452424|11236930|FG010|Overall Study|Other|1
7107271|NCT02452424|11236920|FG000|Overall Study|Progressive disease (per RECIST)|0
7107272|NCT02452424|11236921|FG001|Overall Study|Progressive disease (per RECIST)|0
7107273|NCT02452424|11236922|FG002|Overall Study|Progressive disease (per RECIST)|0
7107274|NCT02452424|11236923|FG003|Overall Study|Progressive disease (per RECIST)|0
7107275|NCT02452424|11236924|FG004|Overall Study|Progressive disease (per RECIST)|0
7107276|NCT02452424|11236925|FG005|Overall Study|Progressive disease (per RECIST)|0
7107277|NCT02452424|11236926|FG006|Overall Study|Progressive disease (per RECIST)|0
7107278|NCT02452424|11236927|FG007|Overall Study|Progressive disease (per RECIST)|0
7107279|NCT02452424|11236928|FG008|Overall Study|Progressive disease (per RECIST)|2
7107280|NCT02452424|11236929|FG009|Overall Study|Progressive disease (per RECIST)|0
7107281|NCT02452424|11236930|FG010|Overall Study|Progressive disease (per RECIST)|0
7107282|NCT02452424|11236920|FG000|Overall Study|Adverse Event|0
7107283|NCT02452424|11236921|FG001|Overall Study|Adverse Event|0
7107284|NCT02452424|11236922|FG002|Overall Study|Adverse Event|0
7107285|NCT02452424|11236923|FG003|Overall Study|Adverse Event|0
7107286|NCT02452424|11236924|FG004|Overall Study|Adverse Event|0
7107287|NCT02452424|11236925|FG005|Overall Study|Adverse Event|0
7107288|NCT02452424|11236926|FG006|Overall Study|Adverse Event|0
7107289|NCT02452424|11236927|FG007|Overall Study|Adverse Event|0
7107290|NCT02452424|11236928|FG008|Overall Study|Adverse Event|0
7107291|NCT02452424|11236929|FG009|Overall Study|Adverse Event|0
7107292|NCT02452424|11236930|FG010|Overall Study|Adverse Event|1
7107293|NCT02452463|11236959|FG000|Overall Study|Death|1
7107294|NCT02452463|11236960|FG001|Overall Study|Death|0
7107295|NCT02452463|11236961|FG002|Overall Study|Death|0
7107296|NCT02452463|11236959|FG000|Overall Study|Study Suspended|1
7107297|NCT02452463|11236960|FG001|Overall Study|Study Suspended|0
7107298|NCT02452463|11236961|FG002|Overall Study|Study Suspended|0
7107299|NCT02452463|11236959|FG000|Overall Study|Recommended by DSMB|0
7107300|NCT02452463|11236960|FG001|Overall Study|Recommended by DSMB|1
7107301|NCT02452463|11236961|FG002|Overall Study|Recommended by DSMB|0
7107302|NCT02452463|11236959|FG000|Overall Study|Withdrawal by Subject|0
7107303|NCT02452463|11236960|FG001|Overall Study|Withdrawal by Subject|1
7107304|NCT02452463|11236961|FG002|Overall Study|Withdrawal by Subject|0
7107305|NCT02452476|11236971|FG000|Overall Study|Death|4
7107306|NCT02452476|11236972|FG001|Overall Study|Death|7
7107307|NCT02452476|11236971|FG000|Overall Study|Lost to Follow-up|1
7107308|NCT02452476|11236972|FG001|Overall Study|Lost to Follow-up|1
7107309|NCT02452476|11236971|FG000|Overall Study|Physician Decision|1
7107310|NCT02452476|11236972|FG001|Overall Study|Physician Decision|1
7107311|NCT02452476|11236971|FG000|Overall Study|Not treated|5
7107312|NCT02452476|11236972|FG001|Overall Study|Not treated|1
7107313|NCT02452762|11236989|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4
7107314|NCT02452762|11236990|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3
7107315|NCT02452762|11236989|FG000|Overall Study|Withdrawal by Subject|1
7107316|NCT02452762|11236990|FG001|Overall Study|Withdrawal by Subject|0
7107317|NCT02452892|11237005|FG000|Week 1 Initial Randommization|Adverse Event|1
7107318|NCT02452892|11237006|FG001|Week 1 Initial Randommization|Adverse Event|0
7107319|NCT02452892|11237007|FG002|Week 1 Initial Randommization|Adverse Event|0
7107320|NCT02452892|11237008|FG003|Week 1 Initial Randommization|Adverse Event|0
7107321|NCT02452892|11237005|FG000|Week 1 Initial Randommization|Lost to Follow-up|0
7107322|NCT02452892|11237006|FG001|Week 1 Initial Randommization|Lost to Follow-up|0
7107323|NCT02452892|11237007|FG002|Week 1 Initial Randommization|Lost to Follow-up|1
7107324|NCT02452892|11237008|FG003|Week 1 Initial Randommization|Lost to Follow-up|0
7107325|NCT02452892|11237005|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
7107326|NCT02452892|11237006|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
7107327|NCT02452892|11237007|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
7107328|NCT02452892|11237008|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2
7107329|NCT02452892|11237005|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2
7107330|NCT02452892|11237006|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
7107331|NCT02452892|11237007|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
7107332|NCT02452892|11237008|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
7107333|NCT02452892|11237005|FG000|Follow-up|Withdrawal by Subject|0
7107334|NCT02452892|11237006|FG001|Follow-up|Withdrawal by Subject|0
7107335|NCT02452892|11237007|FG002|Follow-up|Withdrawal by Subject|0
7107336|NCT02452892|11237008|FG003|Follow-up|Withdrawal by Subject|1
7107337|NCT02452892|11237005|FG000|Follow-up|Subject left town on Day 42|1
7107338|NCT02452892|11237006|FG001|Follow-up|Subject left town on Day 42|0
7107339|NCT02452892|11237007|FG002|Follow-up|Subject left town on Day 42|0
7107340|NCT02452892|11237008|FG003|Follow-up|Subject left town on Day 42|0
7107341|NCT02453048|11237041|FG000|Overall Study|Only part of initial 6 mo. study|0
7107342|NCT02453048|11237042|FG001|Overall Study|Only part of initial 6 mo. study|0
7107343|NCT02453048|11237043|FG002|Overall Study|Only part of initial 6 mo. study|0
7107344|NCT02453048|11237044|FG003|Overall Study|Only part of initial 6 mo. study|0
7107345|NCT02453048|11237045|FG004|Overall Study|Only part of initial 6 mo. study|6
7107346|NCT02453048|11237041|FG000|Overall Study|Lost to Follow-up|0
7107347|NCT02453048|11237042|FG001|Overall Study|Lost to Follow-up|1
7107348|NCT02453048|11237043|FG002|Overall Study|Lost to Follow-up|2
7107349|NCT02453048|11237044|FG003|Overall Study|Lost to Follow-up|0
7107350|NCT02453048|11237045|FG004|Overall Study|Lost to Follow-up|0
7107351|NCT02453191|11237061|FG000|Overall Study|Withdrawal by Subject|1
7107352|NCT02453256|11237067|FG000|Double Blind Period|Death|1
7107353|NCT02453256|11237068|FG001|Double Blind Period|Death|1
7107354|NCT02453256|11237067|FG000|Double Blind Period|Adverse Event|3
7107355|NCT02453256|11237068|FG001|Double Blind Period|Adverse Event|2
7107356|NCT02453256|11237067|FG000|Double Blind Period|Withdrawal by Subject|9
7107357|NCT02453256|11237068|FG001|Double Blind Period|Withdrawal by Subject|5
7107358|NCT02453256|11237067|FG000|Double Blind Period|Other|0
7107359|NCT02453256|11237068|FG001|Double Blind Period|Other|1
7107360|NCT02453256|11237067|FG000|Open Label Period|Adverse Event|1
7107361|NCT02453256|11237068|FG001|Open Label Period|Adverse Event|3
7107362|NCT02453256|11237067|FG000|Open Label Period|Death|0
7107363|NCT02453256|11237068|FG001|Open Label Period|Death|1
7107364|NCT02453256|11237067|FG000|Open Label Period|Lost to Follow-up|1
7107365|NCT02453256|11237068|FG001|Open Label Period|Lost to Follow-up|0
7107366|NCT02453256|11237067|FG000|Open Label Period|Other|0
7107367|NCT02453256|11237068|FG001|Open Label Period|Other|2
7107368|NCT02453256|11237067|FG000|Open Label Period|Withdrawal by Subject|5
7107369|NCT02453256|11237068|FG001|Open Label Period|Withdrawal by Subject|1
7107370|NCT02453282|11237084|FG000|Overall Study|Death|275
7107371|NCT02453282|11237085|FG001|Overall Study|Death|277
7107372|NCT02453282|11237086|FG002|Overall Study|Death|296
7107373|NCT02453282|11237084|FG000|Overall Study|Lost to Follow-up|1
7107374|NCT02453282|11237085|FG001|Overall Study|Lost to Follow-up|0
7107375|NCT02453282|11237086|FG002|Overall Study|Lost to Follow-up|2
7107376|NCT02453282|11237084|FG000|Overall Study|Withdrawal by Subject|12
7107377|NCT02453282|11237085|FG001|Overall Study|Withdrawal by Subject|10
7107378|NCT02453282|11237086|FG002|Overall Study|Withdrawal by Subject|11
7107379|NCT02453282|11237084|FG000|Overall Study|Participants ongoing at data cut-off|85
7107380|NCT02453282|11237085|FG001|Overall Study|Participants ongoing at data cut-off|84
7107381|NCT02453282|11237086|FG002|Overall Study|Participants ongoing at data cut-off|62
7107382|NCT02453282|11237084|FG000|Overall Study|Other|1
7107383|NCT02453282|11237085|FG001|Overall Study|Other|1
7107384|NCT02453282|11237086|FG002|Overall Study|Other|1
7107385|NCT02453321|11237099|FG000|Overall Study|Weakness|1
7107386|NCT02453321|11237100|FG001|Overall Study|Weakness|1
7107387|NCT02453321|11237101|FG002|Overall Study|Weakness|2
7107388|NCT02453321|11237099|FG000|Overall Study|Deep Venous Thrombosis|0
7107389|NCT02453321|11237100|FG001|Overall Study|Deep Venous Thrombosis|1
7107390|NCT02453321|11237101|FG002|Overall Study|Deep Venous Thrombosis|0
7107391|NCT02453334|11237114|FG000|Overall Study|Death|15
7107392|NCT02453334|11237115|FG001|Overall Study|Death|13
7107393|NCT02453334|11237114|FG000|Overall Study|Adverse Event|2
7107394|NCT02453334|11237115|FG001|Overall Study|Adverse Event|1
7107395|NCT02453334|11237114|FG000|Overall Study|Lost to Follow-up|5
7107396|NCT02453334|11237115|FG001|Overall Study|Lost to Follow-up|9
7107397|NCT02453334|11237114|FG000|Overall Study|Physician Decision|1
7107398|NCT02453334|11237115|FG001|Overall Study|Physician Decision|0
7107399|NCT02453334|11237114|FG000|Overall Study|Withdrawal by Subject|17
7107400|NCT02453334|11237115|FG001|Overall Study|Withdrawal by Subject|13
7107401|NCT02453334|11237114|FG000|Overall Study|Other reason|1
7107402|NCT02453334|11237115|FG001|Overall Study|Other reason|4
7107403|NCT02453386|11237141|FG000|Overall Study|Adverse Event|22
7107404|NCT02453386|11237142|FG001|Overall Study|Adverse Event|30
7107405|NCT02453386|11237143|FG002|Overall Study|Adverse Event|15
7107406|NCT02453386|11237141|FG000|Overall Study|Protocol Violation|1
7107407|NCT02453386|11237142|FG001|Overall Study|Protocol Violation|0
7107408|NCT02453386|11237143|FG002|Overall Study|Protocol Violation|1
7107409|NCT02453386|11237141|FG000|Overall Study|Withdrawal by Subject|10
7107410|NCT02453386|11237142|FG001|Overall Study|Withdrawal by Subject|9
7107411|NCT02453386|11237143|FG002|Overall Study|Withdrawal by Subject|9
7107412|NCT02453386|11237141|FG000|Overall Study|Sponsor Terminated Study|14
7107413|NCT02453386|11237142|FG001|Overall Study|Sponsor Terminated Study|8
7107414|NCT02453386|11237143|FG002|Overall Study|Sponsor Terminated Study|11
7107415|NCT02453386|11237141|FG000|Overall Study|Subject Terminated by Sponsor|1
7107416|NCT02453386|11237142|FG001|Overall Study|Subject Terminated by Sponsor|1
7107417|NCT02453386|11237143|FG002|Overall Study|Subject Terminated by Sponsor|1
7107418|NCT02453386|11237141|FG000|Overall Study|Sponsor Terminated by Investigator|0
7107419|NCT02453386|11237142|FG001|Overall Study|Sponsor Terminated by Investigator|1
7107420|NCT02453386|11237143|FG002|Overall Study|Sponsor Terminated by Investigator|2
7107421|NCT02453386|11237141|FG000|Overall Study|Lost to Follow-up|0
7107422|NCT02453386|11237142|FG001|Overall Study|Lost to Follow-up|0
7107423|NCT02453386|11237143|FG002|Overall Study|Lost to Follow-up|1
7107424|NCT02453386|11237141|FG000|Overall Study|Other|1
7107425|NCT02453386|11237142|FG001|Overall Study|Other|0
7107426|NCT02453386|11237143|FG002|Overall Study|Other|1
7107427|NCT02453555|11237160|FG000|24-week Double-blind Treatment Period|Adverse Event|2
7107428|NCT02453555|11237161|FG001|24-week Double-blind Treatment Period|Adverse Event|0
7107429|NCT02453555|11237162|FG002|24-week Double-blind Treatment Period|Adverse Event|0
7107430|NCT02453555|11237163|FG003|24-week Double-blind Treatment Period|Adverse Event|0
7107431|NCT02453555|11237164|FG004|24-week Double-blind Treatment Period|Adverse Event|0
7107432|NCT02453555|11237165|FG005|24-week Double-blind Treatment Period|Adverse Event|0
7107433|NCT02453555|11237160|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1
7107434|NCT02453555|11237161|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0
7107435|NCT02453555|11237162|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0
7107436|NCT02453555|11237163|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0
7107437|NCT02453555|11237164|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0
7107438|NCT02453555|11237165|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0
7107439|NCT02453555|11237160|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2
7107440|NCT02453555|11237161|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4
7107441|NCT02453555|11237162|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0
7107442|NCT02453555|11237163|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0
7107443|NCT02453555|11237164|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0
7107444|NCT02453555|11237165|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0
7107445|NCT02453555|11237160|FG000|24-week Double-blind Treatment Period|Other than specified above|0
7107446|NCT02453555|11237161|FG001|24-week Double-blind Treatment Period|Other than specified above|3
7107447|NCT02453555|11237162|FG002|24-week Double-blind Treatment Period|Other than specified above|0
7107448|NCT02453555|11237163|FG003|24-week Double-blind Treatment Period|Other than specified above|0
7107449|NCT02453555|11237164|FG004|24-week Double-blind Treatment Period|Other than specified above|0
7107450|NCT02453555|11237165|FG005|24-week Double-blind Treatment Period|Other than specified above|0
7107451|NCT02453555|11237160|FG000|Extension Period|Adverse Event|0
7107452|NCT02453555|11237161|FG001|Extension Period|Adverse Event|0
7107453|NCT02453555|11237162|FG002|Extension Period|Adverse Event|1
7107454|NCT02453555|11237163|FG003|Extension Period|Adverse Event|2
7107455|NCT02453555|11237164|FG004|Extension Period|Adverse Event|1
7107456|NCT02453555|11237165|FG005|Extension Period|Adverse Event|1
7107457|NCT02453555|11237160|FG000|Extension Period|Protocol Violation|0
7107458|NCT02453555|11237161|FG001|Extension Period|Protocol Violation|0
7107459|NCT02453555|11237162|FG002|Extension Period|Protocol Violation|1
7107460|NCT02453555|11237163|FG003|Extension Period|Protocol Violation|0
7107461|NCT02453555|11237164|FG004|Extension Period|Protocol Violation|0
7107462|NCT02453555|11237165|FG005|Extension Period|Protocol Violation|0
7107463|NCT02453555|11237160|FG000|Extension Period|Withdrawal by Subject|0
7107464|NCT02453555|11237161|FG001|Extension Period|Withdrawal by Subject|0
7107465|NCT02453555|11237162|FG002|Extension Period|Withdrawal by Subject|1
7107466|NCT02453555|11237163|FG003|Extension Period|Withdrawal by Subject|0
7107467|NCT02453555|11237164|FG004|Extension Period|Withdrawal by Subject|0
7107468|NCT02453555|11237165|FG005|Extension Period|Withdrawal by Subject|0
7107469|NCT02453685|11237209|FG000|Overall Study|Adverse Event|0
7107470|NCT02453685|11237210|FG001|Overall Study|Adverse Event|1
7107471|NCT02453685|11237209|FG000|Overall Study|Protocol Violation|7
7107472|NCT02453685|11237210|FG001|Overall Study|Protocol Violation|4
7107473|NCT02453685|11237209|FG000|Overall Study|Lost to Follow-up|0
7107474|NCT02453685|11237210|FG001|Overall Study|Lost to Follow-up|1
7107475|NCT02453685|11237209|FG000|Overall Study|Withdrawal by Subject|8
7107476|NCT02453685|11237210|FG001|Overall Study|Withdrawal by Subject|4
7107477|NCT02453685|11237209|FG000|Overall Study|Unclassified|4
7107478|NCT02453685|11237210|FG001|Overall Study|Unclassified|2
7107479|NCT02453711|11237225|FG000|Overall Study|Withdrawal by Subject|5
7107480|NCT02453711|11237226|FG001|Overall Study|Withdrawal by Subject|4
7107481|NCT02453711|11237227|FG002|Overall Study|Withdrawal by Subject|6
7107482|NCT02453711|11237228|FG003|Overall Study|Withdrawal by Subject|4
7107483|NCT02453711|11237229|FG004|Overall Study|Withdrawal by Subject|1
7107484|NCT02453711|11237230|FG005|Overall Study|Withdrawal by Subject|1
7107485|NCT02453711|11237231|FG006|Overall Study|Withdrawal by Subject|0
7107486|NCT02453711|11237232|FG007|Overall Study|Withdrawal by Subject|1
7107487|NCT02453711|11237233|FG008|Overall Study|Withdrawal by Subject|7
7107488|NCT02453711|11237225|FG000|Overall Study|Lost to Follow-up|5
7107489|NCT02453711|11237226|FG001|Overall Study|Lost to Follow-up|3
7107490|NCT02453711|11237227|FG002|Overall Study|Lost to Follow-up|2
7107491|NCT02453711|11237228|FG003|Overall Study|Lost to Follow-up|3
7107492|NCT02453711|11237229|FG004|Overall Study|Lost to Follow-up|1
7107493|NCT02453711|11237230|FG005|Overall Study|Lost to Follow-up|5
7107494|NCT02453711|11237231|FG006|Overall Study|Lost to Follow-up|2
7107495|NCT02453711|11237232|FG007|Overall Study|Lost to Follow-up|6
7107496|NCT02453711|11237233|FG008|Overall Study|Lost to Follow-up|6
7107497|NCT02453711|11237225|FG000|Overall Study|Death|0
7107498|NCT02453711|11237226|FG001|Overall Study|Death|0
7107499|NCT02453711|11237227|FG002|Overall Study|Death|0
7107500|NCT02453711|11237228|FG003|Overall Study|Death|0
7107501|NCT02453711|11237229|FG004|Overall Study|Death|0
7107502|NCT02453711|11237230|FG005|Overall Study|Death|0
7107503|NCT02453711|11237231|FG006|Overall Study|Death|1
7107504|NCT02453711|11237232|FG007|Overall Study|Death|0
7107505|NCT02453711|11237233|FG008|Overall Study|Death|0
7107506|NCT02453711|11237225|FG000|Overall Study|Unclassified|1
7107507|NCT02453711|11237226|FG001|Overall Study|Unclassified|0
7107508|NCT02453711|11237227|FG002|Overall Study|Unclassified|1
7107509|NCT02453711|11237228|FG003|Overall Study|Unclassified|0
7107510|NCT02453711|11237229|FG004|Overall Study|Unclassified|0
7107511|NCT02453711|11237230|FG005|Overall Study|Unclassified|0
7107512|NCT02453711|11237231|FG006|Overall Study|Unclassified|0
7107513|NCT02453711|11237232|FG007|Overall Study|Unclassified|0
7107514|NCT02453711|11237233|FG008|Overall Study|Unclassified|0
7107515|NCT02453841|11237260|FG000|Overall Study|Protocol Violation|1
7107516|NCT02453841|11237260|FG000|Overall Study|Unable to obtain blood samples|2
7107517|NCT02454101|11237272|FG000|Overall Study|Adverse Event|2
7107518|NCT02454101|11237273|FG001|Overall Study|Adverse Event|3
7107519|NCT02454101|11237272|FG000|Overall Study|Lost to Follow-up|3
7107520|NCT02454101|11237273|FG001|Overall Study|Lost to Follow-up|4
7107521|NCT02454478|11237335|FG000|Overall Study|Incomplete DLT Evaluation|1
7107522|NCT02454530|11237341|FG000|Overall Study|Other|8
7107523|NCT02454530|11237342|FG001|Overall Study|Other|13
7107524|NCT02454530|11237341|FG000|Overall Study|Missing information|56
7107525|NCT02454530|11237342|FG001|Overall Study|Missing information|69
7107526|NCT02454530|11237341|FG000|Overall Study|Death|2
7107527|NCT02454530|11237342|FG001|Overall Study|Death|41
7107528|NCT02454530|11237341|FG000|Overall Study|Lost to Follow-up|4
7107529|NCT02454530|11237342|FG001|Overall Study|Lost to Follow-up|4
7107530|NCT02454608|11237352|FG000|Double-Blind Period|Lack of Efficacy|0
7107531|NCT02454608|11237353|FG001|Double-Blind Period|Lack of Efficacy|2
7107532|NCT02454608|11237354|FG002|Double-Blind Period|Lack of Efficacy|0
7107533|NCT02454608|11237352|FG000|Open Label Period|Lost to Follow-up|0
7107534|NCT02454608|11237353|FG001|Open Label Period|Lost to Follow-up|0
7107535|NCT02454608|11237354|FG002|Open Label Period|Lost to Follow-up|11
7107536|NCT02454608|11237352|FG000|Open Label Period|Withdrawal by Subject|0
7107537|NCT02454608|11237353|FG001|Open Label Period|Withdrawal by Subject|0
7107538|NCT02454608|11237354|FG002|Open Label Period|Withdrawal by Subject|8
7107539|NCT02454959|11237362|FG000|Overall Study|Protocol-Specified Criteria|3
7107540|NCT02454959|11237362|FG000|Overall Study|Physician Decision|1
7107541|NCT02454959|11237362|FG000|Overall Study|Withdrawal by Subject|3
7107542|NCT02454959|11237362|FG000|Overall Study|Adverse Event|2
7107543|NCT02454972|11237377|FG000|Overall Study|Progressive disease|17
7107544|NCT02454972|11237378|FG001|Overall Study|Progressive disease|16
7107545|NCT02454972|11237379|FG002|Overall Study|Progressive disease|59
7107546|NCT02454972|11237380|FG003|Overall Study|Progressive disease|23
7107547|NCT02454972|11237381|FG004|Overall Study|Progressive disease|16
7107548|NCT02454972|11237382|FG005|Overall Study|Progressive disease|12
7107549|NCT02454972|11237383|FG006|Overall Study|Progressive disease|19
7107550|NCT02454972|11237384|FG007|Overall Study|Progressive disease|27
7107551|NCT02454972|11237385|FG008|Overall Study|Progressive disease|84
7107552|NCT02454972|11237377|FG000|Overall Study|Death|0
7107553|NCT02454972|11237378|FG001|Overall Study|Death|0
7107554|NCT02454972|11237379|FG002|Overall Study|Death|5
7107555|NCT02454972|11237380|FG003|Overall Study|Death|1
7107556|NCT02454972|11237381|FG004|Overall Study|Death|0
7107557|NCT02454972|11237382|FG005|Overall Study|Death|0
7107558|NCT02454972|11237383|FG006|Overall Study|Death|0
7107559|NCT02454972|11237384|FG007|Overall Study|Death|0
7107560|NCT02454972|11237385|FG008|Overall Study|Death|2
7107561|NCT02454972|11237377|FG000|Overall Study|Physician Decision|0
7107562|NCT02454972|11237378|FG001|Overall Study|Physician Decision|1
7107563|NCT02454972|11237379|FG002|Overall Study|Physician Decision|2
7107564|NCT02454972|11237380|FG003|Overall Study|Physician Decision|1
7107565|NCT02454972|11237381|FG004|Overall Study|Physician Decision|2
7107566|NCT02454972|11237382|FG005|Overall Study|Physician Decision|0
7107567|NCT02454972|11237383|FG006|Overall Study|Physician Decision|0
7107568|NCT02454972|11237384|FG007|Overall Study|Physician Decision|1
7107569|NCT02454972|11237385|FG008|Overall Study|Physician Decision|4
7107570|NCT02454972|11237377|FG000|Overall Study|Non treatment-related adverse event|2
7107571|NCT02454972|11237378|FG001|Overall Study|Non treatment-related adverse event|0
7107572|NCT02454972|11237379|FG002|Overall Study|Non treatment-related adverse event|1
7107573|NCT02454972|11237380|FG003|Overall Study|Non treatment-related adverse event|0
7107574|NCT02454972|11237381|FG004|Overall Study|Non treatment-related adverse event|0
7107575|NCT02454972|11237382|FG005|Overall Study|Non treatment-related adverse event|1
7107576|NCT02454972|11237383|FG006|Overall Study|Non treatment-related adverse event|0
7107577|NCT02454972|11237384|FG007|Overall Study|Non treatment-related adverse event|1
7107578|NCT02454972|11237385|FG008|Overall Study|Non treatment-related adverse event|0
7107579|NCT02454972|11237377|FG000|Overall Study|Treatment-related adverse events|0
7107580|NCT02454972|11237378|FG001|Overall Study|Treatment-related adverse events|1
7107581|NCT02454972|11237379|FG002|Overall Study|Treatment-related adverse events|1
7107582|NCT02454972|11237380|FG003|Overall Study|Treatment-related adverse events|0
7107583|NCT02454972|11237381|FG004|Overall Study|Treatment-related adverse events|2
7107584|NCT02454972|11237382|FG005|Overall Study|Treatment-related adverse events|0
7107585|NCT02454972|11237383|FG006|Overall Study|Treatment-related adverse events|0
7107586|NCT02454972|11237384|FG007|Overall Study|Treatment-related adverse events|2
7107587|NCT02454972|11237385|FG008|Overall Study|Treatment-related adverse events|2
7107588|NCT02454972|11237377|FG000|Overall Study|Patient moves to compassionate use|0
7107589|NCT02454972|11237378|FG001|Overall Study|Patient moves to compassionate use|0
7107590|NCT02454972|11237379|FG002|Overall Study|Patient moves to compassionate use|0
7107591|NCT02454972|11237380|FG003|Overall Study|Patient moves to compassionate use|0
7107592|NCT02454972|11237381|FG004|Overall Study|Patient moves to compassionate use|0
7107593|NCT02454972|11237382|FG005|Overall Study|Patient moves to compassionate use|0
7107594|NCT02454972|11237383|FG006|Overall Study|Patient moves to compassionate use|2
7107595|NCT02454972|11237384|FG007|Overall Study|Patient moves to compassionate use|0
7107596|NCT02454972|11237385|FG008|Overall Study|Patient moves to compassionate use|11
7107597|NCT02454972|11237377|FG000|Overall Study|Withdrawal by Subject|0
7107598|NCT02454972|11237378|FG001|Overall Study|Withdrawal by Subject|1
7107599|NCT02454972|11237379|FG002|Overall Study|Withdrawal by Subject|5
7107600|NCT02454972|11237380|FG003|Overall Study|Withdrawal by Subject|2
7107601|NCT02454972|11237381|FG004|Overall Study|Withdrawal by Subject|3
7107602|NCT02454972|11237382|FG005|Overall Study|Withdrawal by Subject|2
7107603|NCT02454972|11237383|FG006|Overall Study|Withdrawal by Subject|0
7107604|NCT02454972|11237384|FG007|Overall Study|Withdrawal by Subject|1
7107605|NCT02454972|11237385|FG008|Overall Study|Withdrawal by Subject|2
7107606|NCT02454972|11237377|FG000|Overall Study|Multiple delay/holds on treatment|0
7107607|NCT02454972|11237378|FG001|Overall Study|Multiple delay/holds on treatment|0
7107608|NCT02454972|11237379|FG002|Overall Study|Multiple delay/holds on treatment|0
7107609|NCT02454972|11237380|FG003|Overall Study|Multiple delay/holds on treatment|1
7107610|NCT02454972|11237381|FG004|Overall Study|Multiple delay/holds on treatment|0
7107611|NCT02454972|11237382|FG005|Overall Study|Multiple delay/holds on treatment|0
7107612|NCT02454972|11237383|FG006|Overall Study|Multiple delay/holds on treatment|0
7107613|NCT02454972|11237384|FG007|Overall Study|Multiple delay/holds on treatment|0
7107614|NCT02454972|11237385|FG008|Overall Study|Multiple delay/holds on treatment|0
7107615|NCT02454972|11237377|FG000|Overall Study|Never treated|0
7107616|NCT02454972|11237378|FG001|Overall Study|Never treated|0
7107617|NCT02454972|11237379|FG002|Overall Study|Never treated|3
7107618|NCT02454972|11237380|FG003|Overall Study|Never treated|1
7107619|NCT02454972|11237381|FG004|Overall Study|Never treated|1
7107620|NCT02454972|11237382|FG005|Overall Study|Never treated|0
7107621|NCT02454972|11237383|FG006|Overall Study|Never treated|0
7107622|NCT02454972|11237384|FG007|Overall Study|Never treated|0
7107623|NCT02454972|11237385|FG008|Overall Study|Never treated|5
7107624|NCT02455050|11237401|FG000|Treatment Period 1|Lost to Follow-up|1
7107625|NCT02455050|11237402|FG001|Treatment Period 1|Lost to Follow-up|1
7107626|NCT02455050|11237403|FG002|Treatment Period 1|Lost to Follow-up|1
7107627|NCT02455050|11237404|FG003|Treatment Period 1|Lost to Follow-up|2
7107628|NCT02455050|11237401|FG000|Treatment Period 2|Lost to Follow-up|1
7107629|NCT02455050|11237402|FG001|Treatment Period 2|Lost to Follow-up|0
7107630|NCT02455050|11237403|FG002|Treatment Period 2|Lost to Follow-up|2
7107631|NCT02455050|11237404|FG003|Treatment Period 2|Lost to Follow-up|1
7107632|NCT02455076|11237429|FG000|Inpatient|Withdrawal by Subject|1
7107633|NCT02455076|11237430|FG001|Inpatient|Withdrawal by Subject|0
7107634|NCT02455076|11237431|FG002|Inpatient|Withdrawal by Subject|0
7107635|NCT02455076|11237432|FG003|Inpatient|Withdrawal by Subject|0
7107636|NCT02455076|11237433|FG004|Inpatient|Withdrawal by Subject|0
7107637|NCT02455076|11237429|FG000|Inpatient|Discharged <24 h after admission|0
7107638|NCT02455076|11237430|FG001|Inpatient|Discharged <24 h after admission|1
7107639|NCT02455076|11237431|FG002|Inpatient|Discharged <24 h after admission|0
7107640|NCT02455076|11237432|FG003|Inpatient|Discharged <24 h after admission|0
7107641|NCT02455076|11237433|FG004|Inpatient|Discharged <24 h after admission|0
7107642|NCT02455076|11237429|FG000|Inpatient|Adverse Event|3
7107643|NCT02455076|11237430|FG001|Inpatient|Adverse Event|0
7107644|NCT02455076|11237431|FG002|Inpatient|Adverse Event|0
7107645|NCT02455076|11237432|FG003|Inpatient|Adverse Event|0
7107646|NCT02455076|11237433|FG004|Inpatient|Adverse Event|0
7107647|NCT02455076|11237429|FG000|Outpatient|Adverse Event|0
7107648|NCT02455076|11237430|FG001|Outpatient|Adverse Event|0
7107649|NCT02455076|11237431|FG002|Outpatient|Adverse Event|0
7107650|NCT02455076|11237432|FG003|Outpatient|Adverse Event|5
7107651|NCT02455076|11237433|FG004|Outpatient|Adverse Event|0
7107652|NCT02455076|11237429|FG000|Outpatient|Lost to Follow-up|0
7107653|NCT02455076|11237430|FG001|Outpatient|Lost to Follow-up|0
7107654|NCT02455076|11237431|FG002|Outpatient|Lost to Follow-up|0
7107655|NCT02455076|11237432|FG003|Outpatient|Lost to Follow-up|1
7107656|NCT02455076|11237433|FG004|Outpatient|Lost to Follow-up|12
7107657|NCT02455336|11237451|FG000|Overall Study|Withdrawal by Subject|0
7107658|NCT02455336|11237452|FG001|Overall Study|Withdrawal by Subject|2
7107659|NCT02455336|11237451|FG000|Overall Study|Adverse Event|3
7107660|NCT02455336|11237452|FG001|Overall Study|Adverse Event|0
7107661|NCT02455336|11237451|FG000|Overall Study|Non-responder to treatment|2
7107662|NCT02455336|11237452|FG001|Overall Study|Non-responder to treatment|0
7107663|NCT02455388|11237460|FG000|Overall Study|Protocol Violation|1
7107664|NCT02455388|11237461|FG001|Overall Study|Protocol Violation|0
7107665|NCT02455388|11237462|FG002|Overall Study|Protocol Violation|4
7107666|NCT02455388|11237460|FG000|Overall Study|Withdrawal by Subject|0
7107667|NCT02455388|11237461|FG001|Overall Study|Withdrawal by Subject|0
7107668|NCT02455388|11237462|FG002|Overall Study|Withdrawal by Subject|7
7107669|NCT02455518|11237478|FG000|Overall Study|Protocol Violation|0
7107670|NCT02455518|11237479|FG001|Overall Study|Protocol Violation|1
7107671|NCT02455518|11237480|FG002|Overall Study|Protocol Violation|1
7107672|NCT02455518|11237481|FG003|Overall Study|Protocol Violation|3
7107673|NCT02456103|11237491|FG000|Overall Study|Study Closure|207
7107674|NCT02456103|11237491|FG000|Overall Study|Physician Decision|1
7107675|NCT02456103|11237491|FG000|Overall Study|Required prohibited medications|5
7107676|NCT02456103|11237491|FG000|Overall Study|Protocol Violation|1
7107677|NCT02456103|11237491|FG000|Overall Study|Adverse Event|5
7107678|NCT02456103|11237491|FG000|Overall Study|Abnormal Laboratory Value|2
7107679|NCT02456103|11237491|FG000|Overall Study|Lost to Follow-up|1
7107680|NCT02456103|11237491|FG000|Overall Study|Withdrawal by Subject|24
7107681|NCT02456636|11237498|FG000|Overall Study|Death|0
7107682|NCT02456636|11237499|FG001|Overall Study|Death|3
7107683|NCT02456636|11237500|FG002|Overall Study|Death|0
7107684|NCT02456636|11237498|FG000|Overall Study|Pregnancy|1
7107685|NCT02456636|11237499|FG001|Overall Study|Pregnancy|3
7107686|NCT02456636|11237500|FG002|Overall Study|Pregnancy|5
7107687|NCT02456636|11237498|FG000|Overall Study|Physician Decision|4
7107688|NCT02456636|11237499|FG001|Overall Study|Physician Decision|5
7107689|NCT02456636|11237500|FG002|Overall Study|Physician Decision|4
7107690|NCT02456636|11237498|FG000|Overall Study|Withdrawal by Subject|13
7107691|NCT02456636|11237499|FG001|Overall Study|Withdrawal by Subject|14
7107692|NCT02456636|11237500|FG002|Overall Study|Withdrawal by Subject|16
7107693|NCT02456636|11237498|FG000|Overall Study|Lost to Follow-up|50
7107694|NCT02456636|11237499|FG001|Overall Study|Lost to Follow-up|44
7107695|NCT02456636|11237500|FG002|Overall Study|Lost to Follow-up|50
7107696|NCT02456662|11237510|FG000|Overall Study|Lost to Follow-up|2
7107697|NCT02456662|11237511|FG001|Overall Study|Lost to Follow-up|1
7107698|NCT02456727|11237519|FG000|Overall Study|Lost to Follow-up|63
7107699|NCT02456727|11237520|FG001|Overall Study|Lost to Follow-up|65
7107700|NCT02456727|11237519|FG000|Overall Study|Death|2
7107701|NCT02456727|11237520|FG001|Overall Study|Death|1
7107702|NCT02456727|11237519|FG000|Overall Study|Withdrawal by Subject|1
7107703|NCT02456727|11237520|FG001|Overall Study|Withdrawal by Subject|10
7107704|NCT02456727|11237519|FG000|Overall Study|Never Initiated Treatment|43
7107705|NCT02456727|11237520|FG001|Overall Study|Never Initiated Treatment|30
7107706|NCT02456909|11237553|FG000|Overall Study|Did not receive allocated intervention|24
7107707|NCT02456909|11237554|FG001|Overall Study|Did not receive allocated intervention|26
7107708|NCT02456909|11237553|FG000|Overall Study|Did not complete the primary outcome|0
7107709|NCT02456909|11237554|FG001|Overall Study|Did not complete the primary outcome|1
7107710|NCT02457065|11237562|FG000|Overall Study|Lost to Follow-up|9
7107711|NCT02457065|11237563|FG001|Overall Study|Lost to Follow-up|11
7107712|NCT02457182|11237571|FG000|Overall Study|Lost to Follow-up|1
7107713|NCT02457182|11237572|FG001|Overall Study|Lost to Follow-up|0
7107714|NCT02457195|11237578|FG000|Overall Study|Adverse Event|3
7107715|NCT02457195|11237578|FG000|Overall Study|Protocol Violation|2
7107716|NCT02457195|11237578|FG000|Overall Study|Withdrawal by Subject|4
7107717|NCT02457247|11237586|FG000|Period 1|Pretreatment Event/Adverse Event|0
7107718|NCT02457247|11237587|FG001|Period 1|Pretreatment Event/Adverse Event|1
7107719|NCT02457247|11237588|FG002|Period 1|Pretreatment Event/Adverse Event|0
7107720|NCT02457247|11237589|FG003|Period 1|Pretreatment Event/Adverse Event|0
7107721|NCT02457247|11237586|FG000|Period 1|Significant Protocol Deviation|1
7107722|NCT02457247|11237587|FG001|Period 1|Significant Protocol Deviation|1
7107723|NCT02457247|11237588|FG002|Period 1|Significant Protocol Deviation|0
7107724|NCT02457247|11237589|FG003|Period 1|Significant Protocol Deviation|0
7107725|NCT02457247|11237586|FG000|Period 1|Voluntary Withdrawal|1
7107726|NCT02457247|11237587|FG001|Period 1|Voluntary Withdrawal|0
7107727|NCT02457247|11237588|FG002|Period 1|Voluntary Withdrawal|0
7107728|NCT02457247|11237589|FG003|Period 1|Voluntary Withdrawal|0
7107729|NCT02457247|11237586|FG000|Period 2|Pretreatment Event/Adverse Event|0
7107730|NCT02457247|11237587|FG001|Period 2|Pretreatment Event/Adverse Event|1
7107731|NCT02457247|11237588|FG002|Period 2|Pretreatment Event/Adverse Event|0
7107732|NCT02457247|11237589|FG003|Period 2|Pretreatment Event/Adverse Event|0
7107733|NCT02457247|11237586|FG000|Period 2|Significant Protocol Deviation|1
7107734|NCT02457247|11237587|FG001|Period 2|Significant Protocol Deviation|0
7107735|NCT02457247|11237588|FG002|Period 2|Significant Protocol Deviation|0
7107736|NCT02457247|11237589|FG003|Period 2|Significant Protocol Deviation|0
7107737|NCT02457247|11237586|FG000|Period 2|Lost to Follow-up|0
7107738|NCT02457247|11237587|FG001|Period 2|Lost to Follow-up|1
7107739|NCT02457247|11237588|FG002|Period 2|Lost to Follow-up|0
7107740|NCT02457247|11237589|FG003|Period 2|Lost to Follow-up|0
7107741|NCT02457247|11237586|FG000|Period 2|Voluntary Withdrawal|1
7107742|NCT02457247|11237587|FG001|Period 2|Voluntary Withdrawal|1
7107743|NCT02457247|11237588|FG002|Period 2|Voluntary Withdrawal|0
7107744|NCT02457247|11237589|FG003|Period 2|Voluntary Withdrawal|0
7107745|NCT02457325|11237621|FG000|First Intervention (1 Day)|Lost to Follow-up|2
7107746|NCT02457325|11237622|FG001|First Intervention (1 Day)|Lost to Follow-up|2
7107747|NCT02457520|11237639|FG000|Active Treatment Phase|Adverse Event|10
7107748|NCT02457520|11237639|FG000|Active Treatment Phase|Lost to Follow-up|8
7107749|NCT02457520|11237639|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3
7107750|NCT02457520|11237639|FG000|Active Treatment Phase|other|4
7107751|NCT02457520|11237639|FG000|Active Treatment Phase|Physician Decision|1
7107752|NCT02457520|11237639|FG000|Active Treatment Phase|Protocol Violation|1
7107753|NCT02457520|11237639|FG000|Active Treatment Phase|Withdrawal by Subject|7
7107754|NCT02457520|11237639|FG000|Post-treatment Period|Other: Retreatment Required|7
7107755|NCT02457520|11237639|FG000|Post-treatment Period|Lost to Follow-up|23
7107756|NCT02457520|11237639|FG000|Post-treatment Period|Other|3
7107757|NCT02457520|11237639|FG000|Post-treatment Period|Physician Decision|1
7107758|NCT02457520|11237639|FG000|Post-treatment Period|Withdrawal by Subject|14
7107759|NCT02457546|11237671|FG000|Overall Study|Other reasons|4
7107760|NCT02457546|11237672|FG001|Overall Study|Other reasons|1
7107761|NCT02457546|11237671|FG000|Overall Study|Refused to complete study/procedures|1
7107762|NCT02457546|11237672|FG001|Overall Study|Refused to complete study/procedures|1
7107763|NCT02457546|11237671|FG000|Overall Study|Lost to Follow-up|4
7107764|NCT02457546|11237672|FG001|Overall Study|Lost to Follow-up|1
7107765|NCT02457546|11237671|FG000|Overall Study|Adverse Event|0
7107766|NCT02457546|11237672|FG001|Overall Study|Adverse Event|1
7107767|NCT02457611|11237678|FG000|Overall Study|Lost to Follow-up|3
7107768|NCT02457637|11237682|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71
7107769|NCT02457793|11237697|FG000|Overall Study|Reason not specified|0
7107770|NCT02457793|11237698|FG001|Overall Study|Reason not specified|0
7107771|NCT02457793|11237699|FG002|Overall Study|Reason not specified|0
7107772|NCT02457793|11237700|FG003|Overall Study|Reason not specified|1
7107773|NCT02457793|11237701|FG004|Overall Study|Reason not specified|1
7107774|NCT02457793|11237702|FG005|Overall Study|Reason not specified|1
7107775|NCT02457793|11237697|FG000|Overall Study|Withdrawal by Subject|0
7107776|NCT02457793|11237698|FG001|Overall Study|Withdrawal by Subject|4
7107777|NCT02457793|11237699|FG002|Overall Study|Withdrawal by Subject|2
7107778|NCT02457793|11237700|FG003|Overall Study|Withdrawal by Subject|2
7107779|NCT02457793|11237701|FG004|Overall Study|Withdrawal by Subject|2
7107780|NCT02457793|11237702|FG005|Overall Study|Withdrawal by Subject|2
7107781|NCT02457793|11237697|FG000|Overall Study|Adverse Event|0
7107782|NCT02457793|11237698|FG001|Overall Study|Adverse Event|0
7107783|NCT02457793|11237699|FG002|Overall Study|Adverse Event|0
7107784|NCT02457793|11237700|FG003|Overall Study|Adverse Event|1
7107785|NCT02457793|11237701|FG004|Overall Study|Adverse Event|0
7107786|NCT02457793|11237702|FG005|Overall Study|Adverse Event|0
7107787|NCT02457793|11237697|FG000|Overall Study|Physician Decision|1
7107788|NCT02457793|11237698|FG001|Overall Study|Physician Decision|0
7107789|NCT02457793|11237699|FG002|Overall Study|Physician Decision|1
7107790|NCT02457793|11237700|FG003|Overall Study|Physician Decision|1
7107791|NCT02457793|11237701|FG004|Overall Study|Physician Decision|1
7107792|NCT02457793|11237702|FG005|Overall Study|Physician Decision|3
7107793|NCT02457819|11237717|FG000|Overall Study|reason not given|8
7107794|NCT02457819|11237717|FG000|Overall Study|Withdrawal by Subject|24
7107795|NCT02457819|11237717|FG000|Overall Study|Protocol Violation|1
7107796|NCT02457819|11237717|FG000|Overall Study|non compliance with study drug|4
7107797|NCT02457819|11237717|FG000|Overall Study|Lost to Follow-up|10
7107798|NCT02457819|11237717|FG000|Overall Study|Lack of Efficacy|19
7107799|NCT02457819|11237717|FG000|Overall Study|Adverse Event|33
7107800|NCT02458092|11237727|FG000|Overall Study|Withdrawal by Subject|1
7107801|NCT02458092|11237728|FG001|Overall Study|Withdrawal by Subject|0
7107802|NCT02458287|11237743|FG000|Overall Study|Adverse Event|0
7107803|NCT02458287|11237744|FG001|Overall Study|Adverse Event|0
7107804|NCT02458287|11237745|FG002|Overall Study|Adverse Event|0
7107805|NCT02458287|11237746|FG003|Overall Study|Adverse Event|1
7107806|NCT02458287|11237743|FG000|Overall Study|Lost to Follow-up|0
7107807|NCT02458287|11237744|FG001|Overall Study|Lost to Follow-up|1
7107808|NCT02458287|11237745|FG002|Overall Study|Lost to Follow-up|1
7107809|NCT02458287|11237746|FG003|Overall Study|Lost to Follow-up|0
7107810|NCT02458287|11237743|FG000|Overall Study|Protocol Violation|0
7107811|NCT02458287|11237744|FG001|Overall Study|Protocol Violation|1
7107812|NCT02458287|11237745|FG002|Overall Study|Protocol Violation|0
7107813|NCT02458287|11237746|FG003|Overall Study|Protocol Violation|0
7107814|NCT02458287|11237743|FG000|Overall Study|Withdrawal by Subject|0
7107815|NCT02458287|11237744|FG001|Overall Study|Withdrawal by Subject|2
7107816|NCT02458287|11237745|FG002|Overall Study|Withdrawal by Subject|2
7107817|NCT02458287|11237746|FG003|Overall Study|Withdrawal by Subject|1
7107818|NCT02458287|11237743|FG000|Overall Study|Relocated Out of State|0
7107819|NCT02458287|11237744|FG001|Overall Study|Relocated Out of State|0
7107820|NCT02458287|11237745|FG002|Overall Study|Relocated Out of State|0
7107821|NCT02458287|11237746|FG003|Overall Study|Relocated Out of State|1
7107822|NCT02458469|11237778|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0
7107823|NCT02458469|11237779|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0
7107824|NCT02458469|11237780|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1
7107825|NCT02458469|11237781|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0
7107826|NCT02458469|11237782|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0
7107827|NCT02458469|11237783|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0
7107828|NCT02458469|11237778|FG000|First Intervention (2 Weeks)|Physician Decision|1
7107829|NCT02458469|11237779|FG001|First Intervention (2 Weeks)|Physician Decision|0
7107830|NCT02458469|11237780|FG002|First Intervention (2 Weeks)|Physician Decision|0
7107831|NCT02458469|11237781|FG003|First Intervention (2 Weeks)|Physician Decision|0
7107832|NCT02458469|11237782|FG004|First Intervention (2 Weeks)|Physician Decision|0
7107833|NCT02458469|11237783|FG005|First Intervention (2 Weeks)|Physician Decision|0
7107834|NCT02458469|11237778|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0
7107835|NCT02458469|11237779|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0
7107836|NCT02458469|11237780|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0
7107837|NCT02458469|11237781|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0
7107838|NCT02458469|11237782|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0
7107839|NCT02458469|11237783|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1
7107840|NCT02458638|11237791|FG000|Overall Study|Death|309
7107841|NCT02458638|11237791|FG000|Overall Study|End of Cohort/End of Study|67
7107842|NCT02458638|11237791|FG000|Overall Study|Lost to Follow-up|31
7107843|NCT02458638|11237791|FG000|Overall Study|Other Reasons|4
7107844|NCT02458638|11237791|FG000|Overall Study|Physician Decision|1
7107845|NCT02458638|11237791|FG000|Overall Study|Withdrawal by Subject|47
7107846|NCT02459093|11237815|FG000|Overall Study|Protocol Violation|6
7107847|NCT02459093|11237816|FG001|Overall Study|Protocol Violation|11
7107848|NCT02459093|11237815|FG000|Overall Study|Lost to Follow-up|6
7107849|NCT02459093|11237816|FG001|Overall Study|Lost to Follow-up|7
7107850|NCT02459262|11237846|FG000|Overall Study|Withdrawal by Subject|0
7107851|NCT02459262|11237847|FG001|Overall Study|Withdrawal by Subject|0
7107852|NCT02459262|11237848|FG002|Overall Study|Withdrawal by Subject|0
7107853|NCT02459262|11237849|FG003|Overall Study|Withdrawal by Subject|0
7107854|NCT02459262|11237850|FG004|Overall Study|Withdrawal by Subject|0
7107855|NCT02459262|11237851|FG005|Overall Study|Withdrawal by Subject|0
7107856|NCT02459262|11237852|FG006|Overall Study|Withdrawal by Subject|0
7107857|NCT02459262|11237853|FG007|Overall Study|Withdrawal by Subject|0
7107858|NCT02459262|11237854|FG008|Overall Study|Withdrawal by Subject|0
7107859|NCT02459262|11237855|FG009|Overall Study|Withdrawal by Subject|1
7107860|NCT02459262|11237856|FG010|Overall Study|Withdrawal by Subject|0
7107861|NCT02459418|11237891|FG000|Overall Study|Exclusion Criteria|4
7107862|NCT02459418|11237892|FG001|Overall Study|Exclusion Criteria|0
7107863|NCT02459418|11237891|FG000|Overall Study|Protocol Violation|0
7107864|NCT02459418|11237892|FG001|Overall Study|Protocol Violation|2
7107865|NCT02459418|11237891|FG000|Overall Study|Physician Decision|0
7107866|NCT02459418|11237892|FG001|Overall Study|Physician Decision|2
7107867|NCT02459418|11237891|FG000|Overall Study|Endometrial thickness of >5 mm|1
7107868|NCT02459418|11237892|FG001|Overall Study|Endometrial thickness of >5 mm|0
7107869|NCT02459418|11237891|FG000|Overall Study|Adverse Event|0
7107870|NCT02459418|11237892|FG001|Overall Study|Adverse Event|1
7107871|NCT02459418|11237891|FG000|Overall Study|Withdrawal by Subject|1
7107872|NCT02459418|11237892|FG001|Overall Study|Withdrawal by Subject|1
7107873|NCT02459418|11237891|FG000|Overall Study|Elevated Creatine Kinase|1
7107874|NCT02459418|11237892|FG001|Overall Study|Elevated Creatine Kinase|0
7107875|NCT02459418|11237891|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1
7107876|NCT02459418|11237892|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0
7107877|NCT02459587|11237903|FG000|3-Month Follow-up Assessment|Death|0
7107878|NCT02459587|11237904|FG001|3-Month Follow-up Assessment|Death|2
7107879|NCT02459587|11237903|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3
7107880|NCT02459587|11237904|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3
7107881|NCT02459587|11237903|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27
7107882|NCT02459587|11237904|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22
7107883|NCT02459587|11237903|FG000|3-Month Follow-up Assessment|Researcher withdrew|2
7107884|NCT02459587|11237904|FG001|3-Month Follow-up Assessment|Researcher withdrew|4
7107885|NCT02459587|11237903|FG000|6-month Follow-up Assessment|Death|2
7107886|NCT02459587|11237904|FG001|6-month Follow-up Assessment|Death|1
7107887|NCT02459587|11237903|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1
7107888|NCT02459587|11237904|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2
7107889|NCT02459587|11237903|FG000|6-month Follow-up Assessment|Lost to Follow-up|21
7107890|NCT02459587|11237904|FG001|6-month Follow-up Assessment|Lost to Follow-up|22
7107891|NCT02459587|11237903|FG000|12-month Follow-up Assessment|Death|2
7107892|NCT02459587|11237904|FG001|12-month Follow-up Assessment|Death|0
7107893|NCT02459587|11237903|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2
7107894|NCT02459587|11237904|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4
7107895|NCT02459587|11237903|FG000|12-month Follow-up Assessment|Lost to Follow-up|18
7107896|NCT02459587|11237904|FG001|12-month Follow-up Assessment|Lost to Follow-up|22
7107897|NCT02459587|11237903|FG000|12-month Follow-up Assessment|Researcher withdrew|0
7107898|NCT02459587|11237904|FG001|12-month Follow-up Assessment|Researcher withdrew|1
7107899|NCT02459665|11237915|FG000|Overall Study|Withdrawal by Subject|0
7107900|NCT02459665|11237916|FG001|Overall Study|Withdrawal by Subject|1
7107901|NCT02459665|11237917|FG002|Overall Study|Withdrawal by Subject|1
7107902|NCT02459665|11237918|FG003|Overall Study|Withdrawal by Subject|2
7107903|NCT02459899|11237952|FG000|Overall Study|Adverse Event|1
7107904|NCT02459899|11237953|FG001|Overall Study|Adverse Event|1
7107905|NCT02459899|11237954|FG002|Overall Study|Adverse Event|0
7107906|NCT02459899|11237955|FG003|Overall Study|Adverse Event|0
7107907|NCT02459899|11237952|FG000|Overall Study|Lost to Follow-up|1
7107908|NCT02459899|11237953|FG001|Overall Study|Lost to Follow-up|2
7107909|NCT02459899|11237954|FG002|Overall Study|Lost to Follow-up|0
7107910|NCT02459899|11237955|FG003|Overall Study|Lost to Follow-up|1
7107911|NCT02459899|11237952|FG000|Overall Study|Non-compliance with the treatment|0
7107912|NCT02459899|11237953|FG001|Overall Study|Non-compliance with the treatment|0
7107913|NCT02459899|11237954|FG002|Overall Study|Non-compliance with the treatment|0
7107914|NCT02459899|11237955|FG003|Overall Study|Non-compliance with the treatment|1
7107915|NCT02459899|11237952|FG000|Overall Study|Withdrawal by Subject|1
7107916|NCT02459899|11237953|FG001|Overall Study|Withdrawal by Subject|3
7107917|NCT02459899|11237954|FG002|Overall Study|Withdrawal by Subject|0
7107918|NCT02459899|11237955|FG003|Overall Study|Withdrawal by Subject|0
7107919|NCT02459951|11237965|FG000|Overall Study|Unable to meet holding requirement|1
7107920|NCT02459964|11237973|FG000|Overall Study|Withdrawal by Subject|0
7107921|NCT02459964|11237974|FG001|Overall Study|Withdrawal by Subject|0
7107922|NCT02459964|11237975|FG002|Overall Study|Withdrawal by Subject|1
7107923|NCT02459964|11237973|FG000|Overall Study|Abnormal EKG changes|0
7107924|NCT02459964|11237974|FG001|Overall Study|Abnormal EKG changes|0
7107925|NCT02459964|11237975|FG002|Overall Study|Abnormal EKG changes|1
7107926|NCT02460263|11237988|FG000|Transition Period|Withdrawal by Subject|1
7107927|NCT02460263|11237988|FG000|Transition Period|Death|1
7107928|NCT02460380|11237998|FG000|Overall Study|Withdrawal by Subject|10
7107929|NCT02460380|11237999|FG001|Overall Study|Withdrawal by Subject|5
7107930|NCT02460562|11238008|FG000|Overall Study|Lost to Follow-up|15
7107931|NCT02460562|11238009|FG001|Overall Study|Lost to Follow-up|16
7107932|NCT02460575|11238017|FG000|Overall Study|Lost to Follow-up|1
7107933|NCT02460575|11238018|FG001|Overall Study|Lost to Follow-up|0
7107934|NCT02460679|11238033|FG000|Overall Study|Investigator Decision|1
7107935|NCT02460679|11238033|FG000|Overall Study|Withdrawal by Subject|4
7107936|NCT02460822|11238037|FG000|Overall Study|Withdrawal by Subject|1
7107937|NCT02460978|11238044|FG000|Overall Study|Adverse Event|17
7107938|NCT02460978|11238045|FG001|Overall Study|Adverse Event|11
7107939|NCT02460978|11238046|FG002|Overall Study|Adverse Event|11
7107940|NCT02460978|11238044|FG000|Overall Study|Withdrawal by Subject|5
7107941|NCT02460978|11238045|FG001|Overall Study|Withdrawal by Subject|5
7107942|NCT02460978|11238046|FG002|Overall Study|Withdrawal by Subject|14
7107943|NCT02460978|11238044|FG000|Overall Study|Lost to Follow-up|2
7107944|NCT02460978|11238045|FG001|Overall Study|Lost to Follow-up|3
7107945|NCT02460978|11238046|FG002|Overall Study|Lost to Follow-up|1
7107946|NCT02460978|11238044|FG000|Overall Study|Protocol Violation|1
7107947|NCT02460978|11238045|FG001|Overall Study|Protocol Violation|1
7107948|NCT02460978|11238046|FG002|Overall Study|Protocol Violation|1
7107949|NCT02460978|11238044|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2
7107950|NCT02460978|11238045|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5
7107951|NCT02460978|11238046|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4
7107952|NCT02460978|11238044|FG000|Overall Study|Pregnancy|0
7107953|NCT02460978|11238045|FG001|Overall Study|Pregnancy|0
7107954|NCT02460978|11238046|FG002|Overall Study|Pregnancy|2
7107955|NCT02460991|11238056|FG000|Overall Study|Withdrawal by Subject|0
7107956|NCT02460991|11238057|FG001|Overall Study|Withdrawal by Subject|2
7107957|NCT02461134|11238068|FG000|Overall Study|Adverse Event|1
7107958|NCT02461160|11238085|FG000|Overall Study|Lost to Follow-up|0
7107959|NCT02461160|11238086|FG001|Overall Study|Lost to Follow-up|0
7107960|NCT02461160|11238087|FG002|Overall Study|Lost to Follow-up|0
7107961|NCT02461160|11238088|FG003|Overall Study|Lost to Follow-up|0
7107962|NCT02461160|11238089|FG004|Overall Study|Lost to Follow-up|0
7107963|NCT02461160|11238090|FG005|Overall Study|Lost to Follow-up|0
7107964|NCT02461160|11238091|FG006|Overall Study|Lost to Follow-up|0
7107965|NCT02461160|11238092|FG007|Overall Study|Lost to Follow-up|1
7107966|NCT02461160|11238093|FG008|Overall Study|Lost to Follow-up|0
7107967|NCT02461160|11238094|FG009|Overall Study|Lost to Follow-up|0
7107968|NCT02461160|11238095|FG010|Overall Study|Lost to Follow-up|0
7107969|NCT02461160|11238096|FG011|Overall Study|Lost to Follow-up|0
7107970|NCT02461160|11238097|FG012|Overall Study|Lost to Follow-up|0
7107971|NCT02461290|11238146|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7
7107972|NCT02461290|11238146|FG000|Overall Study|Lost to Follow-up|3
7107973|NCT02461589|11238192|FG000|Overall Study|Withdrawal by Subject|5
7107974|NCT02461589|11238193|FG001|Overall Study|Withdrawal by Subject|1
7107975|NCT02461589|11238194|FG002|Overall Study|Withdrawal by Subject|3
7107976|NCT02461589|11238195|FG003|Overall Study|Withdrawal by Subject|2
7107977|NCT02461589|11238196|FG004|Overall Study|Withdrawal by Subject|1
7107978|NCT02461589|11238197|FG005|Overall Study|Withdrawal by Subject|2
7107979|NCT02461589|11238198|FG006|Overall Study|Withdrawal by Subject|1
7107980|NCT02461589|11238199|FG007|Overall Study|Withdrawal by Subject|3
7107981|NCT02461589|11238200|FG008|Overall Study|Withdrawal by Subject|3
7107982|NCT02461589|11238201|FG009|Overall Study|Withdrawal by Subject|1
7107983|NCT02461589|11238192|FG000|Overall Study|Lost to Follow-up|0
7107984|NCT02461589|11238193|FG001|Overall Study|Lost to Follow-up|0
7107985|NCT02461589|11238194|FG002|Overall Study|Lost to Follow-up|2
7107986|NCT02461589|11238195|FG003|Overall Study|Lost to Follow-up|3
7107987|NCT02461589|11238196|FG004|Overall Study|Lost to Follow-up|1
7107988|NCT02461589|11238197|FG005|Overall Study|Lost to Follow-up|1
7107989|NCT02461589|11238198|FG006|Overall Study|Lost to Follow-up|3
7107990|NCT02461589|11238199|FG007|Overall Study|Lost to Follow-up|1
7107991|NCT02461589|11238200|FG008|Overall Study|Lost to Follow-up|3
7107992|NCT02461589|11238201|FG009|Overall Study|Lost to Follow-up|1
7107993|NCT02461589|11238192|FG000|Overall Study|Death|0
7107994|NCT02461589|11238193|FG001|Overall Study|Death|0
7107995|NCT02461589|11238194|FG002|Overall Study|Death|0
7107996|NCT02461589|11238195|FG003|Overall Study|Death|0
7107997|NCT02461589|11238196|FG004|Overall Study|Death|0
7107998|NCT02461589|11238197|FG005|Overall Study|Death|0
7107999|NCT02461589|11238198|FG006|Overall Study|Death|0
7108000|NCT02461589|11238199|FG007|Overall Study|Death|1
7108001|NCT02461589|11238200|FG008|Overall Study|Death|0
7108002|NCT02461589|11238201|FG009|Overall Study|Death|0
7108003|NCT02461589|11238192|FG000|Overall Study|Unclassified|0
7108004|NCT02461589|11238193|FG001|Overall Study|Unclassified|0
7108005|NCT02461589|11238194|FG002|Overall Study|Unclassified|0
7108006|NCT02461589|11238195|FG003|Overall Study|Unclassified|0
7108007|NCT02461589|11238196|FG004|Overall Study|Unclassified|0
7108008|NCT02461589|11238197|FG005|Overall Study|Unclassified|0
7108009|NCT02461589|11238198|FG006|Overall Study|Unclassified|1
7108010|NCT02461589|11238199|FG007|Overall Study|Unclassified|0
7108011|NCT02461589|11238200|FG008|Overall Study|Unclassified|0
7108012|NCT02461589|11238201|FG009|Overall Study|Unclassified|2
7108013|NCT02461589|11238192|FG000|Overall Study|Missing follow-up information|1
7108014|NCT02461589|11238193|FG001|Overall Study|Missing follow-up information|1
7108015|NCT02461589|11238194|FG002|Overall Study|Missing follow-up information|0
7108016|NCT02461589|11238195|FG003|Overall Study|Missing follow-up information|0
7108017|NCT02461589|11238196|FG004|Overall Study|Missing follow-up information|0
7108018|NCT02461589|11238197|FG005|Overall Study|Missing follow-up information|0
7108019|NCT02461589|11238198|FG006|Overall Study|Missing follow-up information|1
7108020|NCT02461589|11238199|FG007|Overall Study|Missing follow-up information|0
7108021|NCT02461589|11238200|FG008|Overall Study|Missing follow-up information|0
7108022|NCT02461589|11238201|FG009|Overall Study|Missing follow-up information|0
7108023|NCT02461589|11238192|FG000|Overall Study|Withdrawal from trial before exposure|0
7108024|NCT02461589|11238193|FG001|Overall Study|Withdrawal from trial before exposure|0
7108025|NCT02461589|11238194|FG002|Overall Study|Withdrawal from trial before exposure|0
7108026|NCT02461589|11238195|FG003|Overall Study|Withdrawal from trial before exposure|0
7108027|NCT02461589|11238196|FG004|Overall Study|Withdrawal from trial before exposure|0
7108028|NCT02461589|11238197|FG005|Overall Study|Withdrawal from trial before exposure|0
7108029|NCT02461589|11238198|FG006|Overall Study|Withdrawal from trial before exposure|0
7108030|NCT02461589|11238199|FG007|Overall Study|Withdrawal from trial before exposure|0
7108031|NCT02461589|11238200|FG008|Overall Study|Withdrawal from trial before exposure|0
7108032|NCT02461589|11238201|FG009|Overall Study|Withdrawal from trial before exposure|1
7108033|NCT02461628|11238225|FG000|Overall Study|Refused to complete survey|4
7108034|NCT02461628|11238226|FG001|Overall Study|Refused to complete survey|7
7108035|NCT02461745|11238243|FG000|Overall Study|Lack of Efficacy|9
7108036|NCT02461745|11238244|FG001|Overall Study|Lack of Efficacy|1
7108037|NCT02461745|11238243|FG000|Overall Study|Lost to Follow-up|2
7108038|NCT02461745|11238244|FG001|Overall Study|Lost to Follow-up|2
7108039|NCT02461745|11238243|FG000|Overall Study|Withdrawal by Subject|3
7108040|NCT02461745|11238244|FG001|Overall Study|Withdrawal by Subject|1
7108041|NCT02461758|11238256|FG000|Overall Study|Lost to Follow-up|0
7108042|NCT02461758|11238257|FG001|Overall Study|Lost to Follow-up|1
7108043|NCT02461758|11238258|FG002|Overall Study|Lost to Follow-up|1
7108044|NCT02461758|11238259|FG003|Overall Study|Lost to Follow-up|0
7108045|NCT02462057|11238307|FG000|Overall Study|Left Vitality|32
7108046|NCT02462057|11238308|FG001|Overall Study|Left Vitality|27
7108047|NCT02462057|11238309|FG002|Overall Study|Left Vitality|23
7108048|NCT02462057|11238310|FG003|Overall Study|Left Vitality|35
7108049|NCT02462057|11238311|FG004|Overall Study|Left Vitality|33
7108050|NCT02462057|11238307|FG000|Overall Study|Joined HealthyFood Before Intervention|22
7108051|NCT02462057|11238308|FG001|Overall Study|Joined HealthyFood Before Intervention|13
7108052|NCT02462057|11238309|FG002|Overall Study|Joined HealthyFood Before Intervention|23
7108053|NCT02462057|11238310|FG003|Overall Study|Joined HealthyFood Before Intervention|16
7108054|NCT02462057|11238311|FG004|Overall Study|Joined HealthyFood Before Intervention|17
7108055|NCT02462083|11238332|FG000|Overall Study|Sponsor request|39
7108056|NCT02462083|11238332|FG000|Overall Study|Withdrawal by Subject|87
7108057|NCT02462083|11238332|FG000|Overall Study|Lost to Follow-up|41
7108058|NCT02462083|11238332|FG000|Overall Study|Lack of Efficacy|151
7108059|NCT02462083|11238332|FG000|Overall Study|Pregnancy|1
7108060|NCT02462083|11238332|FG000|Overall Study|Protocol Violation|6
7108061|NCT02462083|11238332|FG000|Overall Study|Adverse Event|33
7108062|NCT02462083|11238332|FG000|Overall Study|Worsening condition|16
7108063|NCT02462083|11238332|FG000|Overall Study|Other than specified|45
7108064|NCT02462473|11238381|FG000|Overall Study|Death|1
7108065|NCT02462473|11238381|FG000|Overall Study|Other|3
7108066|NCT02462486|11238388|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1
7108067|NCT02462486|11238389|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1
7108068|NCT02462486|11238390|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3
7108069|NCT02462486|11238388|FG000|Overall Study|Adverse Event|53
7108070|NCT02462486|11238389|FG001|Overall Study|Adverse Event|48
7108071|NCT02462486|11238390|FG002|Overall Study|Adverse Event|21
7108072|NCT02462486|11238388|FG000|Overall Study|Lack of Efficacy|6
7108073|NCT02462486|11238389|FG001|Overall Study|Lack of Efficacy|12
7108074|NCT02462486|11238390|FG002|Overall Study|Lack of Efficacy|3
7108075|NCT02462486|11238388|FG000|Overall Study|Lost to Follow-up|3
7108076|NCT02462486|11238389|FG001|Overall Study|Lost to Follow-up|4
7108077|NCT02462486|11238390|FG002|Overall Study|Lost to Follow-up|2
7108078|NCT02462486|11238388|FG000|Overall Study|Withdrawal by Subject|25
7108079|NCT02462486|11238389|FG001|Overall Study|Withdrawal by Subject|22
7108080|NCT02462486|11238390|FG002|Overall Study|Withdrawal by Subject|19
7108081|NCT02462486|11238388|FG000|Overall Study|Protocol Violation|3
7108082|NCT02462486|11238389|FG001|Overall Study|Protocol Violation|1
7108083|NCT02462486|11238390|FG002|Overall Study|Protocol Violation|1
7108084|NCT02462486|11238388|FG000|Overall Study|Reason not Specified|3
7108085|NCT02462486|11238389|FG001|Overall Study|Reason not Specified|4
7108086|NCT02462486|11238390|FG002|Overall Study|Reason not Specified|3
7108087|NCT02462720|11238398|FG000|Part 2|Withdrawal by Subject|1
7108088|NCT02462720|11238399|FG001|Part 2|Withdrawal by Subject|0
7108089|NCT02462720|11238398|FG000|Part 2|Protocol Violation|0
7108090|NCT02462720|11238399|FG001|Part 2|Protocol Violation|1
7108091|NCT02462759|11238409|FG000|Part 1: Double Blind|Death|1
7108092|NCT02462759|11238410|FG001|Part 1: Double Blind|Death|0
7108093|NCT02462759|11238411|FG002|Part 1: Double Blind|Death|0
7108094|NCT02462928|11238425|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1
7108095|NCT02462928|11238426|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1
7108096|NCT02462928|11238427|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2
7108097|NCT02462928|11238425|FG000|Overall Study|Adverse Event|47
7108098|NCT02462928|11238426|FG001|Overall Study|Adverse Event|51
7108099|NCT02462928|11238427|FG002|Overall Study|Adverse Event|25
7108100|NCT02462928|11238425|FG000|Overall Study|Lack of Efficacy|3
7108101|NCT02462928|11238426|FG001|Overall Study|Lack of Efficacy|8
7108102|NCT02462928|11238427|FG002|Overall Study|Lack of Efficacy|3
7108103|NCT02462928|11238425|FG000|Overall Study|Lost to Follow-up|4
7108104|NCT02462928|11238426|FG001|Overall Study|Lost to Follow-up|4
7108105|NCT02462928|11238427|FG002|Overall Study|Lost to Follow-up|1
7108106|NCT02462928|11238425|FG000|Overall Study|Withdrawal by Patient|31
7108107|NCT02462928|11238426|FG001|Overall Study|Withdrawal by Patient|21
7108108|NCT02462928|11238427|FG002|Overall Study|Withdrawal by Patient|21
7108109|NCT02462928|11238425|FG000|Overall Study|Protocol Violation|0
7108110|NCT02462928|11238426|FG001|Overall Study|Protocol Violation|1
7108111|NCT02462928|11238427|FG002|Overall Study|Protocol Violation|0
7108112|NCT02462928|11238425|FG000|Overall Study|Reason not Specified|4
7108113|NCT02462928|11238426|FG001|Overall Study|Reason not Specified|6
7108114|NCT02462928|11238427|FG002|Overall Study|Reason not Specified|5
7108115|NCT02463032|11238450|FG000|Overall Study|Lack of Efficacy|61
7108116|NCT02463032|11238451|FG001|Overall Study|Lack of Efficacy|50
7108117|NCT02463032|11238450|FG000|Overall Study|Death|8
7108118|NCT02463032|11238451|FG001|Overall Study|Death|8
7108119|NCT02463032|11238450|FG000|Overall Study|Adverse Event|2
7108120|NCT02463032|11238451|FG001|Overall Study|Adverse Event|6
7108121|NCT02463071|11238460|FG000|Overall Study|Adverse Event|3
7108122|NCT02463071|11238461|FG001|Overall Study|Adverse Event|5
7108123|NCT02463071|11238462|FG002|Overall Study|Adverse Event|1
7108124|NCT02463071|11238460|FG000|Overall Study|Death|1
7108125|NCT02463071|11238461|FG001|Overall Study|Death|0
7108126|NCT02463071|11238462|FG002|Overall Study|Death|0
7108127|NCT02463071|11238460|FG000|Overall Study|Eligibility criteria not fulfilled|1
7108128|NCT02463071|11238461|FG001|Overall Study|Eligibility criteria not fulfilled|0
7108129|NCT02463071|11238462|FG002|Overall Study|Eligibility criteria not fulfilled|0
7108130|NCT02463071|11238460|FG000|Overall Study|Reason not specified|7
7108131|NCT02463071|11238461|FG001|Overall Study|Reason not specified|9
7108132|NCT02463071|11238462|FG002|Overall Study|Reason not specified|4
7108133|NCT02463071|11238460|FG000|Overall Study|Protocol Violation|0
7108134|NCT02463071|11238461|FG001|Overall Study|Protocol Violation|2
7108135|NCT02463071|11238462|FG002|Overall Study|Protocol Violation|0
7108136|NCT02463071|11238460|FG000|Overall Study|Lost to Follow-up|0
7108137|NCT02463071|11238461|FG001|Overall Study|Lost to Follow-up|0
7108138|NCT02463071|11238462|FG002|Overall Study|Lost to Follow-up|1
7108139|NCT02463097|11238470|FG000|Overall Study|Withdrawal by Subject|1
7108140|NCT02463331|11238480|FG000|Overall Study|Adverse Event|4
7108141|NCT02463331|11238481|FG001|Overall Study|Adverse Event|2
7108142|NCT02463331|11238480|FG000|Overall Study|Lost to Follow-up|1
7108143|NCT02463331|11238481|FG001|Overall Study|Lost to Follow-up|1
7108144|NCT02463331|11238480|FG000|Overall Study|Pregnancy|2
7108145|NCT02463331|11238481|FG001|Overall Study|Pregnancy|3
7108146|NCT02463331|11238480|FG000|Overall Study|Lack of Efficacy|6
7108147|NCT02463331|11238481|FG001|Overall Study|Lack of Efficacy|0
7108148|NCT02463331|11238480|FG000|Overall Study|Physician Decision|3
7108149|NCT02463331|11238481|FG001|Overall Study|Physician Decision|0
7108150|NCT02463357|11238492|FG000|Overall Study|Withdrawal by Subject|1
7108151|NCT02463357|11238493|FG001|Overall Study|Withdrawal by Subject|0
7108152|NCT02463357|11238494|FG002|Overall Study|Withdrawal by Subject|0
7108153|NCT02463357|11238495|FG003|Overall Study|Withdrawal by Subject|0
7108154|NCT02463357|11238496|FG004|Overall Study|Withdrawal by Subject|0
7108155|NCT02463357|11238492|FG000|Overall Study|Withdrawal by Subject|0
7108156|NCT02463357|11238493|FG001|Overall Study|Withdrawal by Subject|0
7108157|NCT02463357|11238494|FG002|Overall Study|Withdrawal by Subject|0
7108158|NCT02463357|11238495|FG003|Overall Study|Withdrawal by Subject|0
7108159|NCT02463357|11238496|FG004|Overall Study|Withdrawal by Subject|1
7108160|NCT02463409|11238508|FG000|Overall Study|Withdrawal by Subject|1
7108161|NCT02463409|11238508|FG000|Overall Study|Screen failure|1
7108162|NCT02464059|11238535|FG000|Overall Study|Lost to Follow-up|6
7108163|NCT02465034|11238610|FG000|Overall Study|Withdrawal by Subject|1
7108164|NCT02465034|11238611|FG001|Overall Study|Withdrawal by Subject|1
7108165|NCT02465034|11238610|FG000|Overall Study|Screen fail|2
7108166|NCT02465034|11238611|FG001|Overall Study|Screen fail|0
7108167|NCT02465034|11238610|FG000|Overall Study|Could not be scheduled for study visit|0
7108168|NCT02465034|11238611|FG001|Overall Study|Could not be scheduled for study visit|5
7108169|NCT02465203|11238650|FG000|Overall Study|Protocol Violation|1
7108170|NCT02465203|11238651|FG001|Overall Study|Protocol Violation|1
7108171|NCT02465203|11238652|FG002|Overall Study|Protocol Violation|1
7108172|NCT02465203|11238650|FG000|Overall Study|Study terminated by sponsor|50
7108173|NCT02465203|11238651|FG001|Overall Study|Study terminated by sponsor|34
7108174|NCT02465203|11238652|FG002|Overall Study|Study terminated by sponsor|11
7108175|NCT02465203|11238650|FG000|Overall Study|New therapy for study indication|4
7108176|NCT02465203|11238651|FG001|Overall Study|New therapy for study indication|0
7108177|NCT02465203|11238652|FG002|Overall Study|New therapy for study indication|0
7108178|NCT02465203|11238650|FG000|Overall Study|Patient/guardian decision|1
7108179|NCT02465203|11238651|FG001|Overall Study|Patient/guardian decision|1
7108180|NCT02465203|11238652|FG002|Overall Study|Patient/guardian decision|1
7108181|NCT02465437|11238693|FG000|Overall Study|Physician Decision|0
7108182|NCT02465437|11238694|FG001|Overall Study|Physician Decision|0
7108183|NCT02465437|11238695|FG002|Overall Study|Physician Decision|1
7108184|NCT02465437|11238696|FG003|Overall Study|Physician Decision|0
7108185|NCT02465437|11238693|FG000|Overall Study|Withdrawal by Subject|1
7108186|NCT02465437|11238694|FG001|Overall Study|Withdrawal by Subject|0
7108187|NCT02465437|11238695|FG002|Overall Study|Withdrawal by Subject|0
7108188|NCT02465437|11238696|FG003|Overall Study|Withdrawal by Subject|1
7108189|NCT02465437|11238693|FG000|Overall Study|Adverse Event|0
7108190|NCT02465437|11238694|FG001|Overall Study|Adverse Event|1
7108191|NCT02465437|11238695|FG002|Overall Study|Adverse Event|0
7108192|NCT02465437|11238696|FG003|Overall Study|Adverse Event|0
7108193|NCT02465463|11238732|FG000|Overall Study|Lost to Follow-up|2
7108194|NCT02465463|11238733|FG001|Overall Study|Lost to Follow-up|1
7108195|NCT02465463|11238732|FG000|Overall Study|Death|1
7108196|NCT02465463|11238733|FG001|Overall Study|Death|0
7108197|NCT02465463|11238732|FG000|Overall Study|Protocol Violation|1
7108198|NCT02465463|11238733|FG001|Overall Study|Protocol Violation|0
7108199|NCT02465489|11238740|FG000|Overall Study|Adverse Event|5
7108200|NCT02465515|11238754|FG000|Overall Study|Investigator site closed|4
7108201|NCT02465515|11238755|FG001|Overall Study|Investigator site closed|5
7108202|NCT02465515|11238754|FG000|Overall Study|Withdrawal by Subject|74
7108203|NCT02465515|11238755|FG001|Overall Study|Withdrawal by Subject|43
7108204|NCT02465515|11238754|FG000|Overall Study|Physician Decision|8
7108205|NCT02465515|11238755|FG001|Overall Study|Physician Decision|12
7108206|NCT02465515|11238754|FG000|Overall Study|Lost to Follow-up|68
7108207|NCT02465515|11238755|FG001|Overall Study|Lost to Follow-up|51
7108208|NCT02465528|11238765|FG000|Overall Study|Progressive disease|0
7108209|NCT02465528|11238766|FG001|Overall Study|Progressive disease|2
7108210|NCT02465528|11238767|FG002|Overall Study|Progressive disease|9
7108211|NCT02465528|11238768|FG003|Overall Study|Progressive disease|4
7108212|NCT02465528|11238765|FG000|Overall Study|Study terminated by sponsor|1
7108213|NCT02465528|11238766|FG001|Overall Study|Study terminated by sponsor|2
7108214|NCT02465528|11238767|FG002|Overall Study|Study terminated by sponsor|0
7108215|NCT02465528|11238768|FG003|Overall Study|Study terminated by sponsor|0
7108216|NCT02465528|11238765|FG000|Overall Study|Withdrawal by Subject|0
7108217|NCT02465528|11238766|FG001|Overall Study|Withdrawal by Subject|0
7108218|NCT02465528|11238767|FG002|Overall Study|Withdrawal by Subject|2
7108219|NCT02465528|11238768|FG003|Overall Study|Withdrawal by Subject|0
7108220|NCT02465528|11238765|FG000|Overall Study|Adverse Event|0
7108221|NCT02465528|11238766|FG001|Overall Study|Adverse Event|0
7108222|NCT02465528|11238767|FG002|Overall Study|Adverse Event|0
7108223|NCT02465528|11238768|FG003|Overall Study|Adverse Event|1
7108224|NCT02465528|11238765|FG000|Overall Study|Physician Decision|0
7108225|NCT02465528|11238766|FG001|Overall Study|Physician Decision|0
7108226|NCT02465528|11238767|FG002|Overall Study|Physician Decision|1
7108227|NCT02465528|11238768|FG003|Overall Study|Physician Decision|0
7108228|NCT02465567|11238784|FG000|Overall Study|Adverse Event|118
7108229|NCT02465567|11238785|FG001|Overall Study|Adverse Event|113
7108230|NCT02465567|11238786|FG002|Overall Study|Adverse Event|147
7108231|NCT02465567|11238787|FG003|Overall Study|Adverse Event|138
7108232|NCT02465567|11238784|FG000|Overall Study|Lack of Efficacy|103
7108233|NCT02465567|11238785|FG001|Overall Study|Lack of Efficacy|102
7108234|NCT02465567|11238786|FG002|Overall Study|Lack of Efficacy|171
7108235|NCT02465567|11238787|FG003|Overall Study|Lack of Efficacy|135
7108236|NCT02465567|11238784|FG000|Overall Study|Withdrawal by Subject|104
7108237|NCT02465567|11238785|FG001|Overall Study|Withdrawal by Subject|94
7108238|NCT02465567|11238786|FG002|Overall Study|Withdrawal by Subject|123
7108239|NCT02465567|11238787|FG003|Overall Study|Withdrawal by Subject|130
7108240|NCT02465567|11238784|FG000|Overall Study|Physician Decision|23
7108241|NCT02465567|11238785|FG001|Overall Study|Physician Decision|33
7108242|NCT02465567|11238786|FG002|Overall Study|Physician Decision|38
7108243|NCT02465567|11238787|FG003|Overall Study|Physician Decision|28
7108244|NCT02465567|11238784|FG000|Overall Study|Major Protocol Deviation|24
7108245|NCT02465567|11238785|FG001|Overall Study|Major Protocol Deviation|26
7108246|NCT02465567|11238786|FG002|Overall Study|Major Protocol Deviation|22
7108247|NCT02465567|11238787|FG003|Overall Study|Major Protocol Deviation|25
7108248|NCT02465567|11238784|FG000|Overall Study|Lost to Follow-up|25
7108249|NCT02465567|11238785|FG001|Overall Study|Lost to Follow-up|21
7108250|NCT02465567|11238786|FG002|Overall Study|Lost to Follow-up|19
7108251|NCT02465567|11238787|FG003|Overall Study|Lost to Follow-up|15
7108252|NCT02465567|11238784|FG000|Overall Study|Protocol Specified Criteria|20
7108253|NCT02465567|11238785|FG001|Overall Study|Protocol Specified Criteria|10
7108254|NCT02465567|11238786|FG002|Overall Study|Protocol Specified Criteria|9
7108255|NCT02465567|11238787|FG003|Overall Study|Protocol Specified Criteria|12
7108256|NCT02465567|11238784|FG000|Overall Study|Administrative Reasons|12
7108257|NCT02465567|11238785|FG001|Overall Study|Administrative Reasons|9
7108258|NCT02465567|11238786|FG002|Overall Study|Administrative Reasons|11
7108259|NCT02465567|11238787|FG003|Overall Study|Administrative Reasons|5
7108260|NCT02465567|11238784|FG000|Overall Study|Randomized but not treated|1
7108261|NCT02465567|11238785|FG001|Overall Study|Randomized but not treated|5
7108262|NCT02465567|11238786|FG002|Overall Study|Randomized but not treated|4
7108263|NCT02465567|11238787|FG003|Overall Study|Randomized but not treated|5
7108264|NCT02465567|11238784|FG000|Overall Study|enrolled in >1 studies|18
7108265|NCT02465567|11238785|FG001|Overall Study|enrolled in >1 studies|11
7108266|NCT02465567|11238786|FG002|Overall Study|enrolled in >1 studies|19
7108267|NCT02465567|11238787|FG003|Overall Study|enrolled in >1 studies|15
7108268|NCT02465567|11238784|FG000|Overall Study|missing PI Signature|1
7108269|NCT02465567|11238785|FG001|Overall Study|missing PI Signature|0
7108270|NCT02465567|11238786|FG002|Overall Study|missing PI Signature|0
7108271|NCT02465567|11238787|FG003|Overall Study|missing PI Signature|0
7108272|NCT02465866|11238811|FG000|Period 3|Withdrawal by Subject|0
7108273|NCT02465866|11238812|FG001|Period 3|Withdrawal by Subject|1
7108274|NCT02465866|11238813|FG002|Period 3|Withdrawal by Subject|0
7108275|NCT02465866|11238814|FG003|Period 3|Withdrawal by Subject|0
7108276|NCT02465931|11238826|FG000|Overall Study|Lost to Follow-up|9
7108277|NCT02465931|11238827|FG001|Overall Study|Lost to Follow-up|11
7108278|NCT02465931|11238826|FG000|Overall Study|Protocol Violation|1
7108279|NCT02465931|11238827|FG001|Overall Study|Protocol Violation|0
7108280|NCT02465931|11238826|FG000|Overall Study|Withdrawal by Subject|1
7108281|NCT02465931|11238827|FG001|Overall Study|Withdrawal by Subject|0
7108282|NCT02466386|11238858|FG000|Overall Study|Adverse Event|5
7108283|NCT02466386|11238858|FG000|Overall Study|Protocol Violation|2
7108284|NCT02466386|11238858|FG000|Overall Study|Withdrawal by Subject|14
7108285|NCT02466386|11238858|FG000|Overall Study|Lost to Follow-up|5
7108286|NCT02466386|11238858|FG000|Overall Study|Lack of Efficacy|8
7108287|NCT02466386|11238858|FG000|Overall Study|Other|10
7108288|NCT02466399|11238864|FG000|Overall Study|Adverse Event|1
7108289|NCT02466399|11238865|FG001|Overall Study|Adverse Event|0
7108290|NCT02466399|11238864|FG000|Overall Study|Early exit due to family emergency|1
7108291|NCT02466399|11238865|FG001|Overall Study|Early exit due to family emergency|0
7108292|NCT02466425|11238883|FG000|Overall Study|Adverse Event|3
7108293|NCT02466425|11238884|FG001|Overall Study|Adverse Event|11
7108294|NCT02466425|11238883|FG000|Overall Study|Lack of Efficacy|4
7108295|NCT02466425|11238884|FG001|Overall Study|Lack of Efficacy|1
7108296|NCT02466425|11238883|FG000|Overall Study|Lost to Follow-up|3
7108297|NCT02466425|11238884|FG001|Overall Study|Lost to Follow-up|0
7108298|NCT02466425|11238883|FG000|Overall Study|Protocol Violation|1
7108299|NCT02466425|11238884|FG001|Overall Study|Protocol Violation|0
7108300|NCT02466425|11238883|FG000|Overall Study|Withdrawal by Subject|0
7108301|NCT02466425|11238884|FG001|Overall Study|Withdrawal by Subject|1
7108302|NCT02466425|11238883|FG000|Overall Study|Other|1
7108303|NCT02466425|11238884|FG001|Overall Study|Other|3
7108304|NCT02466425|11238883|FG000|Overall Study|Withdrawal by Parent/Guardian|2
7108305|NCT02466425|11238884|FG001|Overall Study|Withdrawal by Parent/Guardian|0
7108306|NCT02466516|11238895|FG000|Overall Study|Adverse Event|1
7108307|NCT02466516|11238896|FG001|Overall Study|Adverse Event|1
7108308|NCT02466516|11238897|FG002|Overall Study|Adverse Event|0
7108309|NCT02466516|11238898|FG003|Overall Study|Adverse Event|0
6805825|NCT02575339|10808036|FG001|Follow up|Death|2
7108310|NCT02466516|11238899|FG004|Overall Study|Adverse Event|0
7108311|NCT02466516|11238895|FG000|Overall Study|Withdrew Consent|1
7108312|NCT02466516|11238896|FG001|Overall Study|Withdrew Consent|0
7108313|NCT02466516|11238897|FG002|Overall Study|Withdrew Consent|0
7108314|NCT02466516|11238898|FG003|Overall Study|Withdrew Consent|0
7108315|NCT02466516|11238899|FG004|Overall Study|Withdrew Consent|0
7108316|NCT02466516|11238895|FG000|Overall Study|Lost to Follow-up|2
7108317|NCT02466516|11238896|FG001|Overall Study|Lost to Follow-up|0
7108318|NCT02466516|11238897|FG002|Overall Study|Lost to Follow-up|1
7108319|NCT02466516|11238898|FG003|Overall Study|Lost to Follow-up|0
7108320|NCT02466516|11238899|FG004|Overall Study|Lost to Follow-up|0
7108321|NCT02466555|11238911|FG000|Overall Study|Lost to Follow-up|2
7108322|NCT02466659|11238934|FG000|Overall Study|Lost to Follow-up|5
7108323|NCT02466659|11238935|FG001|Overall Study|Lost to Follow-up|2
7108324|NCT02467192|11238974|FG000|Overall Study|Death|1
7108325|NCT02467192|11238974|FG000|Overall Study|revealed to have pneumonia before|2
7108326|NCT02468193|11239057|FG000|Overall Study|Adverse Event|4
7108327|NCT02468193|11239057|FG000|Overall Study|Subject/ Guardian decision|2
7108328|NCT02468557|11239077|FG000|Overall Study|Adverse Event|1
7108329|NCT02468557|11239077|FG000|Overall Study|Death|1
7108330|NCT02468557|11239077|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10
7108331|NCT02468557|11239077|FG000|Overall Study|All Enrolled but Never Dosed|4
7108332|NCT02468648|11239094|FG000|Overall Study|Death|1
7108333|NCT02468674|11239107|FG000|Overall Study|Adverse Event|0
7108334|NCT02468674|11239108|FG001|Overall Study|Adverse Event|0
7108335|NCT02468674|11239109|FG002|Overall Study|Adverse Event|0
7108336|NCT02468674|11239110|FG003|Overall Study|Adverse Event|1
7108337|NCT02468674|11239111|FG004|Overall Study|Adverse Event|0
7108338|NCT02468674|11239112|FG005|Overall Study|Adverse Event|1
7108339|NCT02468674|11239113|FG006|Overall Study|Adverse Event|0
7108340|NCT02468674|11239114|FG007|Overall Study|Adverse Event|0
7108341|NCT02468674|11239115|FG008|Overall Study|Adverse Event|0
7108342|NCT02468674|11239107|FG000|Overall Study|Lost to Follow-up|1
7108343|NCT02468674|11239108|FG001|Overall Study|Lost to Follow-up|0
7108344|NCT02468674|11239109|FG002|Overall Study|Lost to Follow-up|0
7108345|NCT02468674|11239110|FG003|Overall Study|Lost to Follow-up|0
7108346|NCT02468674|11239111|FG004|Overall Study|Lost to Follow-up|0
7108347|NCT02468674|11239112|FG005|Overall Study|Lost to Follow-up|0
7108348|NCT02468674|11239113|FG006|Overall Study|Lost to Follow-up|0
7108349|NCT02468674|11239114|FG007|Overall Study|Lost to Follow-up|1
7108350|NCT02468674|11239115|FG008|Overall Study|Lost to Follow-up|1
7108351|NCT02468674|11239107|FG000|Overall Study|Physician Decision|0
7108352|NCT02468674|11239108|FG001|Overall Study|Physician Decision|0
7108353|NCT02468674|11239109|FG002|Overall Study|Physician Decision|0
7108354|NCT02468674|11239110|FG003|Overall Study|Physician Decision|0
7108355|NCT02468674|11239111|FG004|Overall Study|Physician Decision|0
7108356|NCT02468674|11239112|FG005|Overall Study|Physician Decision|0
7108357|NCT02468674|11239113|FG006|Overall Study|Physician Decision|1
7108358|NCT02468674|11239114|FG007|Overall Study|Physician Decision|0
7108359|NCT02468674|11239115|FG008|Overall Study|Physician Decision|0
7108360|NCT02468674|11239107|FG000|Overall Study|Patient/Guardian Decision|0
7108361|NCT02468674|11239108|FG001|Overall Study|Patient/Guardian Decision|0
7108362|NCT02468674|11239109|FG002|Overall Study|Patient/Guardian Decision|0
7108363|NCT02468674|11239110|FG003|Overall Study|Patient/Guardian Decision|0
7108364|NCT02468674|11239111|FG004|Overall Study|Patient/Guardian Decision|1
7108365|NCT02468674|11239112|FG005|Overall Study|Patient/Guardian Decision|0
7108366|NCT02468674|11239113|FG006|Overall Study|Patient/Guardian Decision|0
7108367|NCT02468674|11239114|FG007|Overall Study|Patient/Guardian Decision|2
7108368|NCT02468674|11239115|FG008|Overall Study|Patient/Guardian Decision|1
7108369|NCT02468674|11239107|FG000|Overall Study|Protocol Deviation|0
7108370|NCT02468674|11239108|FG001|Overall Study|Protocol Deviation|0
7108371|NCT02468674|11239109|FG002|Overall Study|Protocol Deviation|0
7108372|NCT02468674|11239110|FG003|Overall Study|Protocol Deviation|0
7108373|NCT02468674|11239111|FG004|Overall Study|Protocol Deviation|0
7108374|NCT02468674|11239112|FG005|Overall Study|Protocol Deviation|0
7108375|NCT02468674|11239113|FG006|Overall Study|Protocol Deviation|0
7108376|NCT02468674|11239114|FG007|Overall Study|Protocol Deviation|1
7108377|NCT02468674|11239115|FG008|Overall Study|Protocol Deviation|1
7108378|NCT02468934|11239157|FG000|Overall Study|Withdrawal by Subject|4
7108379|NCT02468934|11239157|FG000|Overall Study|Screen Failure|3
7108380|NCT02469038|11239165|FG000|Overall Study|Physician Decision|4
7108381|NCT02469038|11239166|FG001|Overall Study|Physician Decision|5
7108382|NCT02469064|11239174|FG000|Overall Study|Request not to receive intervention.|1
7108383|NCT02469064|11239175|FG001|Overall Study|Request not to receive intervention.|3
7108384|NCT02469077|11239183|FG000|Post Randomization/Intervention Period|Scheduling issues|3
7108385|NCT02469077|11239184|FG001|Post Randomization/Intervention Period|Scheduling issues|2
7108386|NCT02469077|11239183|FG000|Post Randomization/Intervention Period|Relocated|1
7108387|NCT02469077|11239184|FG001|Post Randomization/Intervention Period|Relocated|1
7108388|NCT02469077|11239183|FG000|Post Randomization/Intervention Period|Conflicting health issues|0
7108389|NCT02469077|11239184|FG001|Post Randomization/Intervention Period|Conflicting health issues|1
7108390|NCT02469077|11239183|FG000|Post Intervention /Followup|Withdrawal by Subject|2
7108391|NCT02469077|11239184|FG001|Post Intervention /Followup|Withdrawal by Subject|1
7108392|NCT02469090|11239196|FG000|Period 1: Dose Titration Phase|Adverse Event|12
7108393|NCT02469090|11239197|FG001|Period 1: Dose Titration Phase|Adverse Event|0
7108394|NCT02469090|11239198|FG002|Period 1: Dose Titration Phase|Adverse Event|0
7108395|NCT02469090|11239196|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8
7108396|NCT02469090|11239197|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0
7108397|NCT02469090|11239198|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0
7108398|NCT02469090|11239196|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1
7108399|NCT02469090|11239197|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0
7108400|NCT02469090|11239198|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0
7108401|NCT02469090|11239196|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11
7108402|NCT02469090|11239197|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0
7108403|NCT02469090|11239198|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0
7108404|NCT02469090|11239196|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0
7108405|NCT02469090|11239197|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5
7108406|NCT02469090|11239198|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15
7108407|NCT02469090|11239196|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0
7108408|NCT02469090|11239197|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3
7108409|NCT02469090|11239198|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4
7108410|NCT02469090|11239196|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0
7108411|NCT02469090|11239197|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1
7108412|NCT02469090|11239198|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0
7108413|NCT02469090|11239196|FG000|Period 2: Maintenance Treatment Phase|Death|0
7108414|NCT02469090|11239197|FG001|Period 2: Maintenance Treatment Phase|Death|0
7108415|NCT02469090|11239198|FG002|Period 2: Maintenance Treatment Phase|Death|1
7108416|NCT02469168|11239211|FG000|Overall Study|Trial closed|1
7108417|NCT02469168|11239212|FG001|Overall Study|Trial closed|0
7108418|NCT02469246|11239220|FG000|Double-Blind Phase|Randomized and Never Treated|5
7108419|NCT02469246|11239221|FG001|Double-Blind Phase|Randomized and Never Treated|6
7108420|NCT02469246|11239220|FG000|Double-Blind Phase|Adverse Event|12
7108421|NCT02469246|11239221|FG001|Double-Blind Phase|Adverse Event|9
7108422|NCT02469246|11239220|FG000|Double-Blind Phase|Death|2
7108423|NCT02469246|11239221|FG001|Double-Blind Phase|Death|0
7108424|NCT02469246|11239220|FG000|Double-Blind Phase|Lack of Efficacy|2
7108425|NCT02469246|11239221|FG001|Double-Blind Phase|Lack of Efficacy|1
7108426|NCT02469246|11239220|FG000|Double-Blind Phase|Investigator's Discretion|8
7108427|NCT02469246|11239221|FG001|Double-Blind Phase|Investigator's Discretion|8
7108428|NCT02469246|11239220|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3
7108429|NCT02469246|11239221|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1
7108430|NCT02469246|11239220|FG000|Double-Blind Phase|Protocol Violation|1
7108431|NCT02469246|11239221|FG001|Double-Blind Phase|Protocol Violation|1
7108432|NCT02469246|11239220|FG000|Double-Blind Phase|Withdrew Consent|25
7108433|NCT02469246|11239221|FG001|Double-Blind Phase|Withdrew Consent|25
7108434|NCT02469246|11239220|FG000|Double-Blind Phase|Lost to Follow-up|9
7108435|NCT02469246|11239221|FG001|Double-Blind Phase|Lost to Follow-up|5
7108436|NCT02469298|11239233|FG000|Overall Study|Protocol Violation|0
7108437|NCT02469298|11239234|FG001|Overall Study|Protocol Violation|1
7108438|NCT02469298|11239235|FG002|Overall Study|Protocol Violation|1
7108439|NCT02469298|11239236|FG003|Overall Study|Protocol Violation|0
7108440|NCT02469298|11239233|FG000|Overall Study|Lost to Follow-up|1
7108441|NCT02469298|11239234|FG001|Overall Study|Lost to Follow-up|0
7108442|NCT02469298|11239235|FG002|Overall Study|Lost to Follow-up|1
7108443|NCT02469298|11239236|FG003|Overall Study|Lost to Follow-up|0
7108444|NCT02469298|11239233|FG000|Overall Study|Physician Decision|0
7108445|NCT02469298|11239234|FG001|Overall Study|Physician Decision|0
7108446|NCT02469298|11239235|FG002|Overall Study|Physician Decision|0
7108447|NCT02469298|11239236|FG003|Overall Study|Physician Decision|1
7108448|NCT02469298|11239233|FG000|Overall Study|Withdrawal by Subject|0
7108449|NCT02469298|11239234|FG001|Overall Study|Withdrawal by Subject|0
7108450|NCT02469298|11239235|FG002|Overall Study|Withdrawal by Subject|0
7108451|NCT02469298|11239236|FG003|Overall Study|Withdrawal by Subject|1
7108452|NCT02469610|11239273|FG000|Overall Study|Death|1
7108453|NCT02469610|11239274|FG001|Overall Study|Death|0
7108454|NCT02469610|11239273|FG000|Overall Study|Lost to Follow-up|1
7108455|NCT02469610|11239274|FG001|Overall Study|Lost to Follow-up|0
7108456|NCT02469610|11239273|FG000|Overall Study|exclusion criteria|2
7108457|NCT02469610|11239274|FG001|Overall Study|exclusion criteria|1
7108458|NCT02469623|11239280|FG000|Overall Study|Not consented for long-term follow-up|4
7108459|NCT02469623|11239280|FG000|Overall Study|Lost to Follow-up|4
7108460|NCT02469623|11239280|FG000|Overall Study|Withdrawal by Subject|2
7108461|NCT02469623|11239280|FG000|Overall Study|Death|3
7108462|NCT02469857|11239300|FG000|Overall Study|Death|24
7108463|NCT02469857|11239301|FG001|Overall Study|Death|29
7108464|NCT02469857|11239300|FG000|Overall Study|Discontinuation|1
7108465|NCT02469857|11239301|FG001|Overall Study|Discontinuation|3
7108466|NCT02469896|11239323|FG000|Overall Study|Withdrawal by Subject|2
7108467|NCT02469896|11239324|FG001|Overall Study|Withdrawal by Subject|0
7108468|NCT02469961|11239336|FG000|Overall Study|Physician Decision|4
7108469|NCT02469961|11239337|FG001|Overall Study|Physician Decision|1
7108470|NCT02470403|11239391|FG000|Overall Study|Adverse Event|1
7108471|NCT02470403|11239392|FG001|Overall Study|Adverse Event|0
7108472|NCT02470403|11239393|FG002|Overall Study|Adverse Event|0
7108473|NCT02470403|11239394|FG003|Overall Study|Adverse Event|0
7108474|NCT02470403|11239395|FG004|Overall Study|Adverse Event|0
7108475|NCT02470403|11239391|FG000|Overall Study|Lost to Follow-up|0
7108476|NCT02470403|11239392|FG001|Overall Study|Lost to Follow-up|1
7108477|NCT02470403|11239393|FG002|Overall Study|Lost to Follow-up|0
7108478|NCT02470403|11239394|FG003|Overall Study|Lost to Follow-up|0
7108479|NCT02470403|11239395|FG004|Overall Study|Lost to Follow-up|0
7108480|NCT02470403|11239391|FG000|Overall Study|Subject/guardian decision|1
7108481|NCT02470403|11239392|FG001|Overall Study|Subject/guardian decision|0
7108482|NCT02470403|11239393|FG002|Overall Study|Subject/guardian decision|0
7108483|NCT02470403|11239394|FG003|Overall Study|Subject/guardian decision|4
7108484|NCT02470403|11239395|FG004|Overall Study|Subject/guardian decision|0
7108485|NCT02470429|11239412|FG000|Overall Study|Adverse Event|1
7108486|NCT02470429|11239413|FG001|Overall Study|Adverse Event|0
7108487|NCT02470429|11239412|FG000|Overall Study|Withdrawal by Subject|1
7108488|NCT02470429|11239413|FG001|Overall Study|Withdrawal by Subject|0
7108489|NCT02470806|11239442|FG000|Overall Study|Lost to Follow-up|1
7108490|NCT02470806|11239443|FG001|Overall Study|Lost to Follow-up|1
7108491|NCT02470806|11239442|FG000|Overall Study|Adverse Event|5
7108492|NCT02470806|11239443|FG001|Overall Study|Adverse Event|2
7108493|NCT02470806|11239442|FG000|Overall Study|Protocol Violation|4
7108494|NCT02470806|11239443|FG001|Overall Study|Protocol Violation|11
7108495|NCT02470806|11239442|FG000|Overall Study|Physician Decision|0
7108496|NCT02470806|11239443|FG001|Overall Study|Physician Decision|3
7108497|NCT02470806|11239442|FG000|Overall Study|Withdrawal by Subject|3
7108498|NCT02470806|11239443|FG001|Overall Study|Withdrawal by Subject|10
7108499|NCT02470806|11239442|FG000|Overall Study|Lack of Efficacy|5
7108500|NCT02470806|11239443|FG001|Overall Study|Lack of Efficacy|15
7108501|NCT02471014|11239467|FG000|Overall Study|Lost to Follow-up|2
7108502|NCT02471014|11239468|FG001|Overall Study|Lost to Follow-up|2
7108503|NCT02471183|11239474|FG000|Main Treatment Period|Adverse Event|1
7108504|NCT02471183|11239474|FG000|Main Treatment Period|Withdrawal by Subject|1
7108505|NCT02471183|11239474|FG000|Extended Treatment Period|Lack of Efficacy|1
7108506|NCT02471404|11239489|FG000|Overall Study|Adverse Event|7
7108507|NCT02471404|11239490|FG001|Overall Study|Adverse Event|1
7108508|NCT02471404|11239491|FG002|Overall Study|Adverse Event|2
7108509|NCT02471404|11239489|FG000|Overall Study|Developed Study Withdrawal Criteria|4
7108510|NCT02471404|11239490|FG001|Overall Study|Developed Study Withdrawal Criteria|1
7108511|NCT02471404|11239491|FG002|Overall Study|Developed Study Withdrawal Criteria|2
7108512|NCT02471404|11239489|FG000|Overall Study|Failure to Meet Randomization Criteria|2
7108513|NCT02471404|11239490|FG001|Overall Study|Failure to Meet Randomization Criteria|0
7108514|NCT02471404|11239491|FG002|Overall Study|Failure to Meet Randomization Criteria|1
7108515|NCT02471404|11239489|FG000|Overall Study|Lost to Follow-up|1
7108516|NCT02471404|11239490|FG001|Overall Study|Lost to Follow-up|1
7108517|NCT02471404|11239491|FG002|Overall Study|Lost to Follow-up|3
7108518|NCT02471404|11239489|FG000|Overall Study|Protocol Violation|1
7108519|NCT02471404|11239490|FG001|Overall Study|Protocol Violation|0
7108520|NCT02471404|11239491|FG002|Overall Study|Protocol Violation|0
7108521|NCT02471404|11239489|FG000|Overall Study|Withdrawal by Subject|8
7108522|NCT02471404|11239490|FG001|Overall Study|Withdrawal by Subject|4
7108523|NCT02471404|11239491|FG002|Overall Study|Withdrawal by Subject|5
7108524|NCT02471404|11239489|FG000|Overall Study|Other reasons not specified|10
7108525|NCT02471404|11239490|FG001|Overall Study|Other reasons not specified|7
7108526|NCT02471404|11239491|FG002|Overall Study|Other reasons not specified|12
7108527|NCT02471586|11239511|FG000|Overall Study|Lost to Follow-up|3
7108528|NCT02471586|11239512|FG001|Overall Study|Lost to Follow-up|8
7108529|NCT02471586|11239513|FG002|Overall Study|Lost to Follow-up|4
7108530|NCT02471586|11239511|FG000|Overall Study|Death|2
7108531|NCT02471586|11239512|FG001|Overall Study|Death|2
7108532|NCT02471586|11239513|FG002|Overall Study|Death|0
7108533|NCT02471612|11239523|FG000|Overall Study|Lost to Follow-up|2
7108534|NCT02471716|11239554|FG000|Overall Study|Withdrawal by Subject|0
7108535|NCT02471716|11239555|FG001|Overall Study|Withdrawal by Subject|1
7108536|NCT02471716|11239556|FG002|Overall Study|Withdrawal by Subject|0
7108537|NCT02471716|11239557|FG003|Overall Study|Withdrawal by Subject|2
7108538|NCT02471716|11239558|FG004|Overall Study|Withdrawal by Subject|5
7108539|NCT02471716|11239554|FG000|Overall Study|Study Terminiated by sponsor|0
7108540|NCT02471716|11239555|FG001|Overall Study|Study Terminiated by sponsor|0
7108541|NCT02471716|11239556|FG002|Overall Study|Study Terminiated by sponsor|0
7108542|NCT02471716|11239557|FG003|Overall Study|Study Terminiated by sponsor|1
7108543|NCT02471716|11239558|FG004|Overall Study|Study Terminiated by sponsor|0
7108544|NCT02471716|11239554|FG000|Overall Study|Lost to Follow-up|0
7108545|NCT02471716|11239555|FG001|Overall Study|Lost to Follow-up|0
7108546|NCT02471716|11239556|FG002|Overall Study|Lost to Follow-up|0
7108547|NCT02471716|11239557|FG003|Overall Study|Lost to Follow-up|3
7108548|NCT02471716|11239558|FG004|Overall Study|Lost to Follow-up|2
7108549|NCT02471716|11239554|FG000|Overall Study|Death|0
7108550|NCT02471716|11239555|FG001|Overall Study|Death|0
7108551|NCT02471716|11239556|FG002|Overall Study|Death|0
7108552|NCT02471716|11239557|FG003|Overall Study|Death|1
7108553|NCT02471716|11239558|FG004|Overall Study|Death|0
7108554|NCT02471716|11239554|FG000|Overall Study|Other|0
7108555|NCT02471716|11239555|FG001|Overall Study|Other|0
7108556|NCT02471716|11239556|FG002|Overall Study|Other|0
7108557|NCT02471716|11239557|FG003|Overall Study|Other|8
7108558|NCT02471716|11239558|FG004|Overall Study|Other|9
7108559|NCT02471755|11239574|FG000|Overall Study|Withdrawal by Subject|1
7108560|NCT02471755|11239575|FG001|Overall Study|Withdrawal by Subject|0
7108561|NCT02471755|11239574|FG000|Overall Study|Lost to Follow-up|0
7108562|NCT02471755|11239575|FG001|Overall Study|Lost to Follow-up|1
7108563|NCT02472145|11239584|FG000|Overall Study|Death|10
7108564|NCT02472145|11239585|FG001|Overall Study|Death|101
7108565|NCT02472145|11239586|FG002|Overall Study|Death|99
7108566|NCT02472145|11239584|FG000|Overall Study|Lost to Follow-up|0
7108567|NCT02472145|11239585|FG001|Overall Study|Lost to Follow-up|1
7108568|NCT02472145|11239586|FG002|Overall Study|Lost to Follow-up|0
7108569|NCT02472145|11239584|FG000|Overall Study|Withdrawal by Subject|0
7108570|NCT02472145|11239585|FG001|Overall Study|Withdrawal by Subject|9
7108571|NCT02472145|11239586|FG002|Overall Study|Withdrawal by Subject|13
7108572|NCT02472145|11239584|FG000|Overall Study|Sponsor decision|0
7108573|NCT02472145|11239585|FG001|Overall Study|Sponsor decision|3
7108574|NCT02472145|11239586|FG002|Overall Study|Sponsor decision|2
7108575|NCT02472145|11239584|FG000|Overall Study|Other|0
7108576|NCT02472145|11239585|FG001|Overall Study|Other|45
7108577|NCT02472145|11239586|FG002|Overall Study|Other|43
7108578|NCT02472353|11239626|FG000|Overall Study|Lost to Follow-up|1
7108579|NCT02472353|11239627|FG001|Overall Study|Lost to Follow-up|1
7108580|NCT02472353|11239626|FG000|Overall Study|Withdrawal by Subject|2
7108581|NCT02472353|11239627|FG001|Overall Study|Withdrawal by Subject|1
7108582|NCT02472353|11239626|FG000|Overall Study|Study Termination|1
7108583|NCT02472353|11239627|FG001|Overall Study|Study Termination|4
7108584|NCT02472366|11239635|FG000|Overall Study|Lost to Follow-up|1
7108585|NCT02472366|11239636|FG001|Overall Study|Lost to Follow-up|0
7108586|NCT02472405|11239642|FG000|Overall Study|Lost to Follow-up|9
7108587|NCT02472405|11239642|FG000|Overall Study|Adverse Event|1
7108588|NCT02472652|11239668|FG000|Overall Study|Lost to Follow-up|1
7108589|NCT02472756|11239681|FG000|Induction (Approximately 6 Months)|Adverse Event|1
7108590|NCT02472756|11239681|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1
7108591|NCT02472756|11239681|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7
7108592|NCT02472756|11239681|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2
7108593|NCT02472756|11239681|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1
7108594|NCT02472795|11239690|FG000|Overall Study|Adverse Event|0
7108595|NCT02472795|11239691|FG001|Overall Study|Adverse Event|1
7108596|NCT02472795|11239692|FG002|Overall Study|Adverse Event|0
7108597|NCT02472795|11239693|FG003|Overall Study|Adverse Event|0
7108598|NCT02472795|11239694|FG004|Overall Study|Adverse Event|2
7108599|NCT02472795|11239690|FG000|Overall Study|Withdrawal by Subject|0
7108600|NCT02472795|11239691|FG001|Overall Study|Withdrawal by Subject|0
7108601|NCT02472795|11239692|FG002|Overall Study|Withdrawal by Subject|0
7108602|NCT02472795|11239693|FG003|Overall Study|Withdrawal by Subject|0
7108603|NCT02472795|11239694|FG004|Overall Study|Withdrawal by Subject|1
7108604|NCT02472847|11239708|FG000|Overall Study|Withdrawal by Subject|1
7108605|NCT02472847|11239709|FG001|Overall Study|Withdrawal by Subject|5
7108606|NCT02472886|11239718|FG000|Overall Study|Lack of Efficacy|0
7108607|NCT02472886|11239719|FG001|Overall Study|Lack of Efficacy|2
7108608|NCT02472886|11239720|FG002|Overall Study|Lack of Efficacy|1
7108609|NCT02472977|11239736|FG000|Overall Study|Disease progression|4
7108610|NCT02472977|11239737|FG001|Overall Study|Disease progression|25
7108611|NCT02472977|11239738|FG002|Overall Study|Disease progression|6
7108612|NCT02472977|11239736|FG000|Overall Study|Withdrawal by Subject|0
7108613|NCT02472977|11239737|FG001|Overall Study|Withdrawal by Subject|1
7108614|NCT02472977|11239738|FG002|Overall Study|Withdrawal by Subject|0
7108615|NCT02472977|11239736|FG000|Overall Study|Study drug toxicity|2
7108616|NCT02472977|11239737|FG001|Overall Study|Study drug toxicity|0
7108617|NCT02472977|11239738|FG002|Overall Study|Study drug toxicity|2
7108618|NCT02472977|11239736|FG000|Overall Study|Subject request to discontinue treatment|0
7108619|NCT02472977|11239737|FG001|Overall Study|Subject request to discontinue treatment|1
7108620|NCT02472977|11239738|FG002|Overall Study|Subject request to discontinue treatment|0
7108621|NCT02473250|11239746|FG000|Overall Study|Lost to Follow-up|10
7108622|NCT02473250|11239746|FG000|Overall Study|Physician Decision|5
7108623|NCT02473250|11239746|FG000|Overall Study|Did not tolerate medication washout|3
7108624|NCT02473250|11239746|FG000|Overall Study|Antidepressant effect of divalproex|2
7108625|NCT02473289|11239753|FG000|Overall Study|Adverse Event|2
7108626|NCT02473289|11239754|FG001|Overall Study|Adverse Event|3
7108627|NCT02473289|11239753|FG000|Overall Study|Lost to Follow-up|1
7108628|NCT02473289|11239754|FG001|Overall Study|Lost to Follow-up|1
7108629|NCT02473289|11239753|FG000|Overall Study|Protocol Violation|0
7108630|NCT02473289|11239754|FG001|Overall Study|Protocol Violation|1
7108631|NCT02473289|11239753|FG000|Overall Study|Withdrawal of consent|6
7108632|NCT02473289|11239754|FG001|Overall Study|Withdrawal of consent|7
7108633|NCT02473289|11239753|FG000|Overall Study|Treatment Unblinded + Adverse event|0
7108634|NCT02473289|11239754|FG001|Overall Study|Treatment Unblinded + Adverse event|1
7108635|NCT02473289|11239753|FG000|Overall Study|Other|2
7108636|NCT02473289|11239754|FG001|Overall Study|Other|0
7108637|NCT02473367|11239760|FG000|Wait 1|Withdrawal by Subject|1
7108638|NCT02473367|11239760|FG000|Period 4|Lost to Follow-up|1
7108639|NCT02473393|11239774|FG000|Overall Study|Adverse Event|0
7108640|NCT02473393|11239775|FG001|Overall Study|Adverse Event|0
7108641|NCT02473393|11239776|FG002|Overall Study|Adverse Event|1
7108642|NCT02473393|11239777|FG003|Overall Study|Adverse Event|0
7108643|NCT02473393|11239774|FG000|Overall Study|Withdrawal by Subject|0
7108644|NCT02473393|11239775|FG001|Overall Study|Withdrawal by Subject|0
7108645|NCT02473393|11239776|FG002|Overall Study|Withdrawal by Subject|1
7108646|NCT02473393|11239777|FG003|Overall Study|Withdrawal by Subject|1
7108647|NCT02473471|11239787|FG000|Overall Study|poor oral hygiene|2
7108648|NCT02473471|11239787|FG000|Overall Study|Lost to Follow-up|1
7108649|NCT02473510|11239799|FG000|Overall Study|Lost to Follow-up|1
7108650|NCT02473510|11239800|FG001|Overall Study|Lost to Follow-up|2
7108651|NCT02473614|11239806|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1
7108652|NCT02473614|11239807|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0
7108653|NCT02473640|11239814|FG000|Treatment Period 1|Adverse Event|1
7108654|NCT02473913|11239842|FG000|Overall Study|Lost to Follow-up|3
7108655|NCT02473913|11239843|FG001|Overall Study|Lost to Follow-up|3
7108656|NCT02473952|11239851|FG000|Overall Study|Adverse Event|2
7108657|NCT02473952|11239852|FG001|Overall Study|Adverse Event|2
7108658|NCT02473952|11239851|FG000|Overall Study|Withdrawal by Subject|0
7108659|NCT02473952|11239852|FG001|Overall Study|Withdrawal by Subject|6
7108660|NCT02473965|11239860|FG000|Overall Study|Adverse Event|6
7108661|NCT02473965|11239861|FG001|Overall Study|Adverse Event|4
7108662|NCT02473965|11239860|FG000|Overall Study|MG worsening|4
7108663|NCT02473965|11239861|FG001|Overall Study|MG worsening|1
7108664|NCT02473965|11239860|FG000|Overall Study|Withdrawal by Subject|2
7108665|NCT02473965|11239861|FG001|Overall Study|Withdrawal by Subject|3
7108666|NCT02473965|11239860|FG000|Overall Study|Physician Decision|0
7108667|NCT02473965|11239861|FG001|Overall Study|Physician Decision|2
7108668|NCT02474069|11239871|FG000|Selection Phase (SP)|Adverse Event|8
7108669|NCT02474069|11239872|FG001|Selection Phase (SP)|Adverse Event|0
7108670|NCT02474069|11239873|FG002|Selection Phase (SP)|Adverse Event|0
7108671|NCT02474069|11239871|FG000|Selection Phase (SP)|Lack of Efficacy|1
7108672|NCT02474069|11239872|FG001|Selection Phase (SP)|Lack of Efficacy|0
7108673|NCT02474069|11239873|FG002|Selection Phase (SP)|Lack of Efficacy|0
7108674|NCT02474069|11239871|FG000|Selection Phase (SP)|Lost to Follow-up|4
7108675|NCT02474069|11239872|FG001|Selection Phase (SP)|Lost to Follow-up|0
7108676|NCT02474069|11239873|FG002|Selection Phase (SP)|Lost to Follow-up|0
7108677|NCT02474069|11239871|FG000|Selection Phase (SP)|Physician Decision|1
7108678|NCT02474069|11239872|FG001|Selection Phase (SP)|Physician Decision|0
7108679|NCT02474069|11239873|FG002|Selection Phase (SP)|Physician Decision|0
7108680|NCT02474069|11239871|FG000|Selection Phase (SP)|Protocol Violation|1
7108681|NCT02474069|11239872|FG001|Selection Phase (SP)|Protocol Violation|0
7108682|NCT02474069|11239873|FG002|Selection Phase (SP)|Protocol Violation|0
7108683|NCT02474069|11239871|FG000|Selection Phase (SP)|No longer requires treatment|1
7108684|NCT02474069|11239872|FG001|Selection Phase (SP)|No longer requires treatment|0
7108685|NCT02474069|11239873|FG002|Selection Phase (SP)|No longer requires treatment|0
7108686|NCT02474069|11239871|FG000|Selection Phase (SP)|Technical Problem|1
7108687|NCT02474069|11239872|FG001|Selection Phase (SP)|Technical Problem|0
7108688|NCT02474069|11239873|FG002|Selection Phase (SP)|Technical Problem|0
7108689|NCT02474069|11239871|FG000|Selection Phase (SP)|Withdrawal by Subject|3
7108690|NCT02474069|11239872|FG001|Selection Phase (SP)|Withdrawal by Subject|0
7108691|NCT02474069|11239873|FG002|Selection Phase (SP)|Withdrawal by Subject|0
7108692|NCT02474069|11239871|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3
7108693|NCT02474069|11239872|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0
7108694|NCT02474069|11239873|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0
7108695|NCT02474069|11239871|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0
7108696|NCT02474069|11239872|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3
7108697|NCT02474069|11239873|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2
7108698|NCT02474069|11239871|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0
7108699|NCT02474069|11239872|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4
7108700|NCT02474069|11239873|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1
7108701|NCT02474069|11239871|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0
7108702|NCT02474069|11239872|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0
7108703|NCT02474069|11239873|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1
7108704|NCT02474069|11239871|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0
7108705|NCT02474069|11239872|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2
7108706|NCT02474069|11239873|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2
7108707|NCT02474082|11239885|FG000|Overall Study|Adverse Event|2
7108708|NCT02474082|11239886|FG001|Overall Study|Adverse Event|32
7108709|NCT02474082|11239885|FG000|Overall Study|Withdrawal of informed consent|1
7108710|NCT02474082|11239886|FG001|Overall Study|Withdrawal of informed consent|11
7108711|NCT02474082|11239885|FG000|Overall Study|Lost to Follow-up|2
7108712|NCT02474082|11239886|FG001|Overall Study|Lost to Follow-up|2
7108713|NCT02474082|11239885|FG000|Overall Study|Dose tapering not achieved|0
7108714|NCT02474082|11239886|FG001|Overall Study|Dose tapering not achieved|4
7108715|NCT02474082|11239885|FG000|Overall Study|Participant/guardian decision|1
7108716|NCT02474082|11239886|FG001|Overall Study|Participant/guardian decision|2
7108717|NCT02474082|11239885|FG000|Overall Study|Non-compliance with study treatment|0
7108718|NCT02474082|11239886|FG001|Overall Study|Non-compliance with study treatment|2
7108719|NCT02474082|11239885|FG000|Overall Study|Protocol deviation|0
7108720|NCT02474082|11239886|FG001|Overall Study|Protocol deviation|1
7108721|NCT02474199|11239894|FG000|Overall Study|Lost to Follow-up|1
7108722|NCT02474199|11239895|FG001|Overall Study|Lost to Follow-up|0
7108723|NCT02474199|11239896|FG002|Overall Study|Lost to Follow-up|0
7108724|NCT02474199|11239897|FG003|Overall Study|Lost to Follow-up|0
7108725|NCT02474199|11239894|FG000|Overall Study|Withdrawal by Subject|1
7108726|NCT02474199|11239895|FG001|Overall Study|Withdrawal by Subject|2
7108727|NCT02474199|11239896|FG002|Overall Study|Withdrawal by Subject|0
7108728|NCT02474199|11239897|FG003|Overall Study|Withdrawal by Subject|1
7108729|NCT02474199|11239894|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0
7108730|NCT02474199|11239895|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1
7108731|NCT02474199|11239896|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0
7108732|NCT02474199|11239897|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0
7108733|NCT02474199|11239894|FG000|Overall Study|Did not meet eligibility criteria|0
7108734|NCT02474199|11239895|FG001|Overall Study|Did not meet eligibility criteria|0
7108735|NCT02474199|11239896|FG002|Overall Study|Did not meet eligibility criteria|2
7108736|NCT02474199|11239897|FG003|Overall Study|Did not meet eligibility criteria|2
7108737|NCT02474355|11239904|FG000|Overall Study|Other|43
7108738|NCT02474355|11239904|FG000|Overall Study|Eligibility Criteria not Fulfilled|2
7108739|NCT02474355|11239904|FG000|Overall Study|Lost to Follow-up|98
7108740|NCT02474355|11239904|FG000|Overall Study|Withdrawal by Subject|124
7108741|NCT02474355|11239904|FG000|Overall Study|Death|1361
7108742|NCT02474589|11239954|FG000|Overall Study|Adverse Event|6
7108743|NCT02474589|11239955|FG001|Overall Study|Adverse Event|2
7108744|NCT02474589|11239954|FG000|Overall Study|Lost to Follow-up|6
7108745|NCT02474589|11239955|FG001|Overall Study|Lost to Follow-up|1
7108746|NCT02474589|11239954|FG000|Overall Study|Protocol Violation|4
7108747|NCT02474589|11239955|FG001|Overall Study|Protocol Violation|1
7108748|NCT02474589|11239954|FG000|Overall Study|Withdrawal by Subject|4
7108749|NCT02474589|11239955|FG001|Overall Study|Withdrawal by Subject|0
7108750|NCT02474589|11239954|FG000|Overall Study|Inability to complete study procedures|5
7108751|NCT02474589|11239955|FG001|Overall Study|Inability to complete study procedures|1
7108752|NCT02475265|11239991|FG000|Overall Study|Physician Decision|1
7108753|NCT02475265|11239991|FG000|Overall Study|Withdrawal by Subject|2
7108754|NCT02475278|11239995|FG000|Overall Study|Lost to Follow-up|1
7108755|NCT02475278|11239995|FG000|Overall Study|Reason Not Specified|1
7108756|NCT02475369|11239999|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7
7108757|NCT02475369|11240000|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2
7108758|NCT02475395|11240013|FG000|Overall Study|Protocol Violation|30
7108759|NCT02475395|11240014|FG001|Overall Study|Protocol Violation|3
7108760|NCT02475564|11240022|FG000|Overall Study|Withdrawal by Subject|1
7108761|NCT02475564|11240023|FG001|Overall Study|Withdrawal by Subject|0
7108762|NCT02475564|11240022|FG000|Overall Study|Lost to Follow-up|2
7108763|NCT02475564|11240023|FG001|Overall Study|Lost to Follow-up|1
7108764|NCT02475564|11240022|FG000|Overall Study|Intense Menstrual bleeding|1
6805826|NCT02575339|10808037|FG002|Follow up|Death|0
7108765|NCT02475564|11240023|FG001|Overall Study|Intense Menstrual bleeding|0
7108766|NCT02475629|11240029|FG000|Overall Study|Adverse Event|1
7108767|NCT02475629|11240029|FG000|Overall Study|Death|4
7108768|NCT02475629|11240029|FG000|Overall Study|Physician Decision|1
7108769|NCT02475629|11240029|FG000|Overall Study|Withdrawal by Subject|1
7108770|NCT02475629|11240029|FG000|Overall Study|Lost to Follow-up|1
7108771|NCT02475629|11240029|FG000|Overall Study|Subject non-compliance|1
7108772|NCT02475655|11240035|FG000|Overall Study|Lost to Follow-up|0
7108773|NCT02475655|11240036|FG001|Overall Study|Lost to Follow-up|1
7108774|NCT02475733|11240044|FG000|Overall Study|Withdrawal by Subject|1
7108775|NCT02475733|11240045|FG001|Overall Study|Withdrawal by Subject|0
7108776|NCT02475733|11240044|FG000|Overall Study|Physician Decision|1
7108777|NCT02475733|11240045|FG001|Overall Study|Physician Decision|0
7108778|NCT02475850|11240062|FG000|Overall Study|Death|155
7108779|NCT02475850|11240063|FG001|Overall Study|Death|141
7108780|NCT02475850|11240062|FG000|Overall Study|Lost to Follow-up|217
7108781|NCT02475850|11240063|FG001|Overall Study|Lost to Follow-up|188
7108782|NCT02475850|11240062|FG000|Overall Study|Withdrawal by Subject|221
7108783|NCT02475850|11240063|FG001|Overall Study|Withdrawal by Subject|155
7108784|NCT02475954|11240072|FG000|Overall Study|Withdrawal by Subject|2
7108785|NCT02475954|11240073|FG001|Overall Study|Withdrawal by Subject|2
7108786|NCT02475954|11240072|FG000|Overall Study|Lost to Follow-up|11
7108787|NCT02475954|11240073|FG001|Overall Study|Lost to Follow-up|9
7108788|NCT02475954|11240072|FG000|Overall Study|Death|1
7108789|NCT02475954|11240073|FG001|Overall Study|Death|1
7108790|NCT02475980|11240080|FG000|Overall Study|Lost to Follow-up|4
7108791|NCT02475980|11240080|FG000|Overall Study|Withdrawal by Subject|1
7108792|NCT02476175|11240100|FG000|Overall Study|Adverse Event|2
7108793|NCT02476422|11240117|FG000|Overall Study|Subject/guardian decision|0
7108794|NCT02476422|11240118|FG001|Overall Study|Subject/guardian decision|1
7108795|NCT02476578|11240152|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35
7108796|NCT02476578|11240153|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43
7108797|NCT02476578|11240152|FG000|Overall Study|Lost to Follow-up|6
7108798|NCT02476578|11240153|FG001|Overall Study|Lost to Follow-up|13
7108799|NCT02476617|11240159|FG000|Overall Study|Adverse Event|1
7108800|NCT02476617|11240159|FG000|Overall Study|Lost to Follow-up|1
7108801|NCT02477020|11240184|FG000|Overall Study|Pretreatment Event/Adverse Event|6
7108802|NCT02477020|11240185|FG001|Overall Study|Pretreatment Event/Adverse Event|6
7108803|NCT02477020|11240184|FG000|Overall Study|Voluntary Withdrawal|7
7108804|NCT02477020|11240185|FG001|Overall Study|Voluntary Withdrawal|16
7108805|NCT02477020|11240184|FG000|Overall Study|Reason not Specified|3
7108806|NCT02477020|11240185|FG001|Overall Study|Reason not Specified|1
7108807|NCT02477020|11240184|FG000|Overall Study|Lack of Efficacy|14
7108808|NCT02477020|11240185|FG001|Overall Study|Lack of Efficacy|5
7108809|NCT02477111|11240191|FG000|Overall Study|Death|5
7108810|NCT02477111|11240191|FG000|Overall Study|Withdrawal by Subject|2
7108811|NCT02477111|11240191|FG000|Overall Study|missed visit|4
7108812|NCT02477215|11240201|FG000|Dose Escalation Phase|Physician Decision|1
7108813|NCT02477215|11240202|FG001|Dose Escalation Phase|Physician Decision|2
7108814|NCT02477215|11240203|FG002|Dose Escalation Phase|Physician Decision|0
7108815|NCT02477215|11240201|FG000|Fixed Dose Phase|Physician Decision|0
7108816|NCT02477215|11240202|FG001|Fixed Dose Phase|Physician Decision|7
7108817|NCT02477215|11240203|FG002|Fixed Dose Phase|Physician Decision|0
7108818|NCT02477332|11240234|FG000|Overall Study|Adverse Event|0
7108819|NCT02477332|11240235|FG001|Overall Study|Adverse Event|1
7108820|NCT02477332|11240236|FG002|Overall Study|Adverse Event|1
7108821|NCT02477332|11240237|FG003|Overall Study|Adverse Event|2
7108822|NCT02477332|11240238|FG004|Overall Study|Adverse Event|1
7108823|NCT02477332|11240239|FG005|Overall Study|Adverse Event|2
7108824|NCT02477332|11240234|FG000|Overall Study|Lack of Efficacy|1
7108825|NCT02477332|11240235|FG001|Overall Study|Lack of Efficacy|2
7108826|NCT02477332|11240236|FG002|Overall Study|Lack of Efficacy|1
7108827|NCT02477332|11240237|FG003|Overall Study|Lack of Efficacy|2
7108828|NCT02477332|11240238|FG004|Overall Study|Lack of Efficacy|1
7108829|NCT02477332|11240239|FG005|Overall Study|Lack of Efficacy|1
7108830|NCT02477332|11240234|FG000|Overall Study|Non-compliance with study treatment|0
7108831|NCT02477332|11240235|FG001|Overall Study|Non-compliance with study treatment|1
7108832|NCT02477332|11240236|FG002|Overall Study|Non-compliance with study treatment|2
7108833|NCT02477332|11240237|FG003|Overall Study|Non-compliance with study treatment|0
7108834|NCT02477332|11240238|FG004|Overall Study|Non-compliance with study treatment|0
7108835|NCT02477332|11240239|FG005|Overall Study|Non-compliance with study treatment|0
7108836|NCT02477332|11240234|FG000|Overall Study|Pregnancy|0
7108837|NCT02477332|11240235|FG001|Overall Study|Pregnancy|0
7108838|NCT02477332|11240236|FG002|Overall Study|Pregnancy|0
7108839|NCT02477332|11240237|FG003|Overall Study|Pregnancy|1
7108840|NCT02477332|11240238|FG004|Overall Study|Pregnancy|0
7108841|NCT02477332|11240239|FG005|Overall Study|Pregnancy|0
7108842|NCT02477332|11240234|FG000|Overall Study|Protocol Violation|2
7108843|NCT02477332|11240235|FG001|Overall Study|Protocol Violation|0
7108844|NCT02477332|11240236|FG002|Overall Study|Protocol Violation|3
7108845|NCT02477332|11240237|FG003|Overall Study|Protocol Violation|3
7108846|NCT02477332|11240238|FG004|Overall Study|Protocol Violation|1
7108847|NCT02477332|11240239|FG005|Overall Study|Protocol Violation|1
7108848|NCT02477332|11240234|FG000|Overall Study|Technical problems|0
7108849|NCT02477332|11240235|FG001|Overall Study|Technical problems|0
7108850|NCT02477332|11240236|FG002|Overall Study|Technical problems|1
7108851|NCT02477332|11240237|FG003|Overall Study|Technical problems|0
7108852|NCT02477332|11240238|FG004|Overall Study|Technical problems|0
7108853|NCT02477332|11240239|FG005|Overall Study|Technical problems|0
7108854|NCT02477332|11240234|FG000|Overall Study|Lost to Follow-up|0
7108855|NCT02477332|11240235|FG001|Overall Study|Lost to Follow-up|0
7108856|NCT02477332|11240236|FG002|Overall Study|Lost to Follow-up|2
7108857|NCT02477332|11240237|FG003|Overall Study|Lost to Follow-up|0
7108858|NCT02477332|11240238|FG004|Overall Study|Lost to Follow-up|0
7108859|NCT02477332|11240239|FG005|Overall Study|Lost to Follow-up|0
7108860|NCT02477332|11240234|FG000|Overall Study|Physician Decision|0
7108861|NCT02477332|11240235|FG001|Overall Study|Physician Decision|0
7108862|NCT02477332|11240236|FG002|Overall Study|Physician Decision|1
7108863|NCT02477332|11240237|FG003|Overall Study|Physician Decision|3
7108864|NCT02477332|11240238|FG004|Overall Study|Physician Decision|0
7108865|NCT02477332|11240239|FG005|Overall Study|Physician Decision|1
7108866|NCT02477332|11240234|FG000|Overall Study|Withdrawal by Subject|0
7108867|NCT02477332|11240235|FG001|Overall Study|Withdrawal by Subject|3
7108868|NCT02477332|11240236|FG002|Overall Study|Withdrawal by Subject|1
7108869|NCT02477332|11240237|FG003|Overall Study|Withdrawal by Subject|2
7108870|NCT02477332|11240238|FG004|Overall Study|Withdrawal by Subject|1
7108871|NCT02477332|11240239|FG005|Overall Study|Withdrawal by Subject|0
7108872|NCT02477527|11240264|FG000|Overall Study|Lost to Follow-up|2
7108873|NCT02477527|11240264|FG000|Overall Study|Withdrawal by Subject|1
7108874|NCT02477527|11240264|FG000|Overall Study|Screen Failure|3
7108875|NCT02477553|11240270|FG000|Overall Study|Screening up-to-date|12
7108876|NCT02477553|11240271|FG001|Overall Study|Screening up-to-date|13
7108877|NCT02477553|11240270|FG000|Overall Study|No MD visit|1
7108878|NCT02477553|11240271|FG001|Overall Study|No MD visit|1
7108879|NCT02477553|11240270|FG000|Overall Study|Workup consistent w/CRC|1
7108880|NCT02477553|11240271|FG001|Overall Study|Workup consistent w/CRC|1
7108881|NCT02477553|11240270|FG000|Overall Study|Technical issues with intervention|2
7108882|NCT02477553|11240271|FG001|Overall Study|Technical issues with intervention|0
7108883|NCT02477553|11240270|FG000|Overall Study|Elevated risk for CRC|2
7108884|NCT02477553|11240271|FG001|Overall Study|Elevated risk for CRC|2
7108885|NCT02477553|11240270|FG000|Overall Study|MD advised against screening|1
7108886|NCT02477553|11240271|FG001|Overall Study|MD advised against screening|3
7108887|NCT02477553|11240270|FG000|Overall Study|patient deceased|1
7108888|NCT02477553|11240271|FG001|Overall Study|patient deceased|0
7108889|NCT02477605|11240279|FG000|Overall Study|Discontinued prior to treatment|1
7108890|NCT02477605|11240280|FG001|Overall Study|Discontinued prior to treatment|0
7108891|NCT02477605|11240279|FG000|Overall Study|Lost to Follow-up|0
7108892|NCT02477605|11240280|FG001|Overall Study|Lost to Follow-up|2
7108893|NCT02477605|11240279|FG000|Overall Study|Withdrawal by Subject|0
7108894|NCT02477605|11240280|FG001|Overall Study|Withdrawal by Subject|1
7108895|NCT02477605|11240279|FG000|Overall Study|Administered gas during surgery|0
7108896|NCT02477605|11240280|FG001|Overall Study|Administered gas during surgery|1
7108897|NCT02477670|11240292|FG000|Stage 1|Adverse Event|2
7108898|NCT02477670|11240293|FG001|Stage 1|Adverse Event|7
7108899|NCT02477670|11240294|FG002|Stage 1|Adverse Event|0
7108900|NCT02477670|11240295|FG003|Stage 1|Adverse Event|0
7108901|NCT02477670|11240296|FG004|Stage 1|Adverse Event|0
7108902|NCT02477670|11240297|FG005|Stage 1|Adverse Event|0
7108903|NCT02477670|11240298|FG006|Stage 1|Adverse Event|0
7108904|NCT02477670|11240292|FG000|Stage 1|Lost to Follow-up|0
7108905|NCT02477670|11240293|FG001|Stage 1|Lost to Follow-up|2
7108906|NCT02477670|11240294|FG002|Stage 1|Lost to Follow-up|0
7108907|NCT02477670|11240295|FG003|Stage 1|Lost to Follow-up|0
7108908|NCT02477670|11240296|FG004|Stage 1|Lost to Follow-up|0
7108909|NCT02477670|11240297|FG005|Stage 1|Lost to Follow-up|0
7108910|NCT02477670|11240298|FG006|Stage 1|Lost to Follow-up|0
7108911|NCT02477670|11240292|FG000|Stage 1|Withdrawal by Subject|1
7108912|NCT02477670|11240293|FG001|Stage 1|Withdrawal by Subject|2
7108913|NCT02477670|11240294|FG002|Stage 1|Withdrawal by Subject|0
7108914|NCT02477670|11240295|FG003|Stage 1|Withdrawal by Subject|0
7108915|NCT02477670|11240296|FG004|Stage 1|Withdrawal by Subject|0
7108916|NCT02477670|11240297|FG005|Stage 1|Withdrawal by Subject|0
7108917|NCT02477670|11240298|FG006|Stage 1|Withdrawal by Subject|0
7108918|NCT02477670|11240292|FG000|Stage 1|Non-compliance with Study Drug|1
7108919|NCT02477670|11240293|FG001|Stage 1|Non-compliance with Study Drug|2
7108920|NCT02477670|11240294|FG002|Stage 1|Non-compliance with Study Drug|0
7108921|NCT02477670|11240295|FG003|Stage 1|Non-compliance with Study Drug|0
7108922|NCT02477670|11240296|FG004|Stage 1|Non-compliance with Study Drug|0
7108923|NCT02477670|11240297|FG005|Stage 1|Non-compliance with Study Drug|0
7108924|NCT02477670|11240298|FG006|Stage 1|Non-compliance with Study Drug|0
7108925|NCT02477670|11240292|FG000|Stage 2|Adverse Event|0
7108926|NCT02477670|11240293|FG001|Stage 2|Adverse Event|0
7108927|NCT02477670|11240294|FG002|Stage 2|Adverse Event|1
7108928|NCT02477670|11240295|FG003|Stage 2|Adverse Event|0
7108929|NCT02477670|11240296|FG004|Stage 2|Adverse Event|0
6805827|NCT02575339|10808035|FG000|Follow up|Study Terminated|0
7108930|NCT02477670|11240297|FG005|Stage 2|Adverse Event|0
7108931|NCT02477670|11240298|FG006|Stage 2|Adverse Event|0
7108932|NCT02477670|11240292|FG000|Stage 2|Antipsychotic Medication Changed|0
7108933|NCT02477670|11240293|FG001|Stage 2|Antipsychotic Medication Changed|0
7108934|NCT02477670|11240294|FG002|Stage 2|Antipsychotic Medication Changed|1
7108935|NCT02477670|11240295|FG003|Stage 2|Antipsychotic Medication Changed|0
7108936|NCT02477670|11240296|FG004|Stage 2|Antipsychotic Medication Changed|0
7108937|NCT02477670|11240297|FG005|Stage 2|Antipsychotic Medication Changed|0
7108938|NCT02477670|11240298|FG006|Stage 2|Antipsychotic Medication Changed|0
7108939|NCT02477670|11240292|FG000|Stage 2|Withdrawal by Subject|0
7108940|NCT02477670|11240293|FG001|Stage 2|Withdrawal by Subject|0
7108941|NCT02477670|11240294|FG002|Stage 2|Withdrawal by Subject|0
7108942|NCT02477670|11240295|FG003|Stage 2|Withdrawal by Subject|1
7108943|NCT02477670|11240296|FG004|Stage 2|Withdrawal by Subject|0
7108944|NCT02477670|11240297|FG005|Stage 2|Withdrawal by Subject|0
7108945|NCT02477670|11240298|FG006|Stage 2|Withdrawal by Subject|0
7108946|NCT02477800|11240316|FG000|Placebo-Controlled Period|Adverse Event|16
7108947|NCT02477800|11240317|FG001|Placebo-Controlled Period|Adverse Event|25
7108948|NCT02477800|11240318|FG002|Placebo-Controlled Period|Adverse Event|28
7108949|NCT02477800|11240319|FG003|Placebo-Controlled Period|Adverse Event|0
7108950|NCT02477800|11240320|FG004|Placebo-Controlled Period|Adverse Event|0
7108951|NCT02477800|11240321|FG005|Placebo-Controlled Period|Adverse Event|0
7108952|NCT02477800|11240322|FG006|Placebo-Controlled Period|Adverse Event|0
7108953|NCT02477800|11240316|FG000|Placebo-Controlled Period|Change of Treatment|1
7108954|NCT02477800|11240317|FG001|Placebo-Controlled Period|Change of Treatment|2
7108955|NCT02477800|11240318|FG002|Placebo-Controlled Period|Change of Treatment|1
7108956|NCT02477800|11240319|FG003|Placebo-Controlled Period|Change of Treatment|0
7108957|NCT02477800|11240320|FG004|Placebo-Controlled Period|Change of Treatment|0
7108958|NCT02477800|11240321|FG005|Placebo-Controlled Period|Change of Treatment|0
7108959|NCT02477800|11240322|FG006|Placebo-Controlled Period|Change of Treatment|0
7108960|NCT02477800|11240316|FG000|Placebo-Controlled Period|Consent Withdrawn|26
7108961|NCT02477800|11240317|FG001|Placebo-Controlled Period|Consent Withdrawn|16
7108962|NCT02477800|11240318|FG002|Placebo-Controlled Period|Consent Withdrawn|27
7108963|NCT02477800|11240319|FG003|Placebo-Controlled Period|Consent Withdrawn|0
7108964|NCT02477800|11240320|FG004|Placebo-Controlled Period|Consent Withdrawn|0
7108965|NCT02477800|11240321|FG005|Placebo-Controlled Period|Consent Withdrawn|0
7108966|NCT02477800|11240322|FG006|Placebo-Controlled Period|Consent Withdrawn|0
7108967|NCT02477800|11240316|FG000|Placebo-Controlled Period|Death|0
7108968|NCT02477800|11240317|FG001|Placebo-Controlled Period|Death|3
7108969|NCT02477800|11240318|FG002|Placebo-Controlled Period|Death|2
7108970|NCT02477800|11240319|FG003|Placebo-Controlled Period|Death|0
7108971|NCT02477800|11240320|FG004|Placebo-Controlled Period|Death|0
7108972|NCT02477800|11240321|FG005|Placebo-Controlled Period|Death|0
7108973|NCT02477800|11240322|FG006|Placebo-Controlled Period|Death|0
7108974|NCT02477800|11240316|FG000|Placebo-Controlled Period|Disease Progression|1
7108975|NCT02477800|11240317|FG001|Placebo-Controlled Period|Disease Progression|0
7108976|NCT02477800|11240318|FG002|Placebo-Controlled Period|Disease Progression|1
7108977|NCT02477800|11240319|FG003|Placebo-Controlled Period|Disease Progression|0
7108978|NCT02477800|11240320|FG004|Placebo-Controlled Period|Disease Progression|0
7108979|NCT02477800|11240321|FG005|Placebo-Controlled Period|Disease Progression|0
7108980|NCT02477800|11240322|FG006|Placebo-Controlled Period|Disease Progression|0
7108981|NCT02477800|11240316|FG000|Placebo-Controlled Period|Investigator Decision|3
7108982|NCT02477800|11240317|FG001|Placebo-Controlled Period|Investigator Decision|2
7108983|NCT02477800|11240318|FG002|Placebo-Controlled Period|Investigator Decision|1
7108984|NCT02477800|11240319|FG003|Placebo-Controlled Period|Investigator Decision|0
7108985|NCT02477800|11240320|FG004|Placebo-Controlled Period|Investigator Decision|0
7108986|NCT02477800|11240321|FG005|Placebo-Controlled Period|Investigator Decision|0
7108987|NCT02477800|11240322|FG006|Placebo-Controlled Period|Investigator Decision|0
7108988|NCT02477800|11240316|FG000|Placebo-Controlled Period|Lost to Follow-up|1
7108989|NCT02477800|11240317|FG001|Placebo-Controlled Period|Lost to Follow-up|3
7108990|NCT02477800|11240318|FG002|Placebo-Controlled Period|Lost to Follow-up|3
7108991|NCT02477800|11240319|FG003|Placebo-Controlled Period|Lost to Follow-up|0
7108992|NCT02477800|11240320|FG004|Placebo-Controlled Period|Lost to Follow-up|0
7108993|NCT02477800|11240321|FG005|Placebo-Controlled Period|Lost to Follow-up|0
7108994|NCT02477800|11240322|FG006|Placebo-Controlled Period|Lost to Follow-up|0
7108995|NCT02477800|11240316|FG000|Placebo-Controlled Period|Relocation|2
7108996|NCT02477800|11240317|FG001|Placebo-Controlled Period|Relocation|0
7108997|NCT02477800|11240318|FG002|Placebo-Controlled Period|Relocation|0
7108998|NCT02477800|11240319|FG003|Placebo-Controlled Period|Relocation|0
7108999|NCT02477800|11240320|FG004|Placebo-Controlled Period|Relocation|0
7109000|NCT02477800|11240321|FG005|Placebo-Controlled Period|Relocation|0
7109001|NCT02477800|11240322|FG006|Placebo-Controlled Period|Relocation|0
7109002|NCT02477800|11240316|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1
7109003|NCT02477800|11240317|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1
7109004|NCT02477800|11240318|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1
7109005|NCT02477800|11240319|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0
7109006|NCT02477800|11240320|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0
7109007|NCT02477800|11240321|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0
7109008|NCT02477800|11240322|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0
7109009|NCT02477800|11240316|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2
7109010|NCT02477800|11240317|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1
7109011|NCT02477800|11240318|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0
7109012|NCT02477800|11240319|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0
7109013|NCT02477800|11240320|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0
7109014|NCT02477800|11240321|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0
7109015|NCT02477800|11240322|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0
7109016|NCT02477800|11240316|FG000|Placebo-Controlled Period|Study Visit Burden|5
7109017|NCT02477800|11240317|FG001|Placebo-Controlled Period|Study Visit Burden|3
7109018|NCT02477800|11240318|FG002|Placebo-Controlled Period|Study Visit Burden|11
7109019|NCT02477800|11240319|FG003|Placebo-Controlled Period|Study Visit Burden|0
7109020|NCT02477800|11240320|FG004|Placebo-Controlled Period|Study Visit Burden|0
7109021|NCT02477800|11240321|FG005|Placebo-Controlled Period|Study Visit Burden|0
7109022|NCT02477800|11240322|FG006|Placebo-Controlled Period|Study Visit Burden|0
7109023|NCT02477800|11240316|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1
7109024|NCT02477800|11240317|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5
7109025|NCT02477800|11240318|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3
7109026|NCT02477800|11240319|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7109027|NCT02477800|11240320|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7109028|NCT02477800|11240321|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7109029|NCT02477800|11240322|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7109030|NCT02477800|11240316|FG000|Placebo-Controlled Period|Reason not Specified|161
7109031|NCT02477800|11240317|FG001|Placebo-Controlled Period|Reason not Specified|161
7109032|NCT02477800|11240318|FG002|Placebo-Controlled Period|Reason not Specified|189
7109033|NCT02477800|11240319|FG003|Placebo-Controlled Period|Reason not Specified|0
7109034|NCT02477800|11240320|FG004|Placebo-Controlled Period|Reason not Specified|0
7109035|NCT02477800|11240321|FG005|Placebo-Controlled Period|Reason not Specified|0
7109036|NCT02477800|11240322|FG006|Placebo-Controlled Period|Reason not Specified|0
7109037|NCT02477800|11240316|FG000|Long Term Extension Period|Adverse Event|0
7109038|NCT02477800|11240317|FG001|Long Term Extension Period|Adverse Event|0
7109039|NCT02477800|11240318|FG002|Long Term Extension Period|Adverse Event|0
7109040|NCT02477800|11240319|FG003|Long Term Extension Period|Adverse Event|6
7109041|NCT02477800|11240320|FG004|Long Term Extension Period|Adverse Event|2
7109042|NCT02477800|11240321|FG005|Long Term Extension Period|Adverse Event|4
7109043|NCT02477800|11240322|FG006|Long Term Extension Period|Adverse Event|3
7109044|NCT02477800|11240316|FG000|Long Term Extension Period|Death|0
7109045|NCT02477800|11240317|FG001|Long Term Extension Period|Death|0
7109046|NCT02477800|11240318|FG002|Long Term Extension Period|Death|0
7109047|NCT02477800|11240319|FG003|Long Term Extension Period|Death|1
7109048|NCT02477800|11240320|FG004|Long Term Extension Period|Death|1
7109049|NCT02477800|11240321|FG005|Long Term Extension Period|Death|1
7109050|NCT02477800|11240322|FG006|Long Term Extension Period|Death|2
7109051|NCT02477800|11240316|FG000|Long Term Extension Period|Consent Withdrawn|0
7109052|NCT02477800|11240317|FG001|Long Term Extension Period|Consent Withdrawn|0
7109053|NCT02477800|11240318|FG002|Long Term Extension Period|Consent Withdrawn|0
7109054|NCT02477800|11240319|FG003|Long Term Extension Period|Consent Withdrawn|10
7109055|NCT02477800|11240320|FG004|Long Term Extension Period|Consent Withdrawn|4
7109056|NCT02477800|11240321|FG005|Long Term Extension Period|Consent Withdrawn|13
7109057|NCT02477800|11240322|FG006|Long Term Extension Period|Consent Withdrawn|16
7109058|NCT02477800|11240316|FG000|Long Term Extension Period|Disease Progression|0
7109059|NCT02477800|11240317|FG001|Long Term Extension Period|Disease Progression|0
7109060|NCT02477800|11240318|FG002|Long Term Extension Period|Disease Progression|0
7109061|NCT02477800|11240319|FG003|Long Term Extension Period|Disease Progression|3
7109062|NCT02477800|11240320|FG004|Long Term Extension Period|Disease Progression|1
7109063|NCT02477800|11240321|FG005|Long Term Extension Period|Disease Progression|1
7109064|NCT02477800|11240322|FG006|Long Term Extension Period|Disease Progression|0
7109065|NCT02477800|11240316|FG000|Long Term Extension Period|Investigator Decision|0
7109066|NCT02477800|11240317|FG001|Long Term Extension Period|Investigator Decision|0
7109067|NCT02477800|11240318|FG002|Long Term Extension Period|Investigator Decision|0
7109068|NCT02477800|11240319|FG003|Long Term Extension Period|Investigator Decision|0
7109069|NCT02477800|11240320|FG004|Long Term Extension Period|Investigator Decision|0
7109070|NCT02477800|11240321|FG005|Long Term Extension Period|Investigator Decision|0
7109071|NCT02477800|11240322|FG006|Long Term Extension Period|Investigator Decision|2
7109072|NCT02477800|11240316|FG000|Long Term Extension Period|Lost to Follow-up|0
7109073|NCT02477800|11240317|FG001|Long Term Extension Period|Lost to Follow-up|0
7109074|NCT02477800|11240318|FG002|Long Term Extension Period|Lost to Follow-up|0
7109075|NCT02477800|11240319|FG003|Long Term Extension Period|Lost to Follow-up|0
7109076|NCT02477800|11240320|FG004|Long Term Extension Period|Lost to Follow-up|1
7109077|NCT02477800|11240321|FG005|Long Term Extension Period|Lost to Follow-up|3
7109078|NCT02477800|11240322|FG006|Long Term Extension Period|Lost to Follow-up|0
7109079|NCT02477800|11240316|FG000|Long Term Extension Period|Site Terminated By Sponsor|0
7109080|NCT02477800|11240317|FG001|Long Term Extension Period|Site Terminated By Sponsor|0
7109081|NCT02477800|11240318|FG002|Long Term Extension Period|Site Terminated By Sponsor|0
7109082|NCT02477800|11240319|FG003|Long Term Extension Period|Site Terminated By Sponsor|0
7109083|NCT02477800|11240320|FG004|Long Term Extension Period|Site Terminated By Sponsor|0
7109084|NCT02477800|11240321|FG005|Long Term Extension Period|Site Terminated By Sponsor|2
7109085|NCT02477800|11240322|FG006|Long Term Extension Period|Site Terminated By Sponsor|1
7109086|NCT02477800|11240316|FG000|Long Term Extension Period|Study Visit Burden|0
7109087|NCT02477800|11240317|FG001|Long Term Extension Period|Study Visit Burden|0
7109088|NCT02477800|11240318|FG002|Long Term Extension Period|Study Visit Burden|0
7109089|NCT02477800|11240319|FG003|Long Term Extension Period|Study Visit Burden|3
7109090|NCT02477800|11240320|FG004|Long Term Extension Period|Study Visit Burden|0
7109091|NCT02477800|11240321|FG005|Long Term Extension Period|Study Visit Burden|2
7109092|NCT02477800|11240322|FG006|Long Term Extension Period|Study Visit Burden|2
7109093|NCT02477800|11240316|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0
7109094|NCT02477800|11240317|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0
7109095|NCT02477800|11240318|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0
7109096|NCT02477800|11240319|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1
7109097|NCT02477800|11240320|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3
7109098|NCT02477800|11240321|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3
7109099|NCT02477800|11240322|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1
7109100|NCT02477800|11240316|FG000|Long Term Extension Period|Reason not Specified|0
7109101|NCT02477800|11240317|FG001|Long Term Extension Period|Reason not Specified|0
7109102|NCT02477800|11240318|FG002|Long Term Extension Period|Reason not Specified|0
7109103|NCT02477800|11240319|FG003|Long Term Extension Period|Reason not Specified|126
7109104|NCT02477800|11240320|FG004|Long Term Extension Period|Reason not Specified|140
7109105|NCT02477800|11240321|FG005|Long Term Extension Period|Reason not Specified|270
7109106|NCT02477800|11240322|FG006|Long Term Extension Period|Reason not Specified|224
7109107|NCT02477839|11240336|FG000|Overall Study|Adverse Event|0
7109108|NCT02477839|11240337|FG001|Overall Study|Adverse Event|1
7109109|NCT02477839|11240336|FG000|Overall Study|Protocol Violation|0
7109110|NCT02477839|11240337|FG001|Overall Study|Protocol Violation|2
7109111|NCT02477839|11240336|FG000|Overall Study|Withdrawal by Subject|3
7109112|NCT02477839|11240337|FG001|Overall Study|Withdrawal by Subject|3
7109113|NCT02477839|11240336|FG000|Overall Study|Participant had PGS during V6|0
7109114|NCT02477839|11240337|FG001|Overall Study|Participant had PGS during V6|1
7109115|NCT02477839|11240336|FG000|Overall Study|Parents decided to stop medication|0
7109116|NCT02477839|11240337|FG001|Overall Study|Parents decided to stop medication|1
7109117|NCT02477839|11240336|FG000|Overall Study|Lack of tolerability|0
7109118|NCT02477839|11240337|FG001|Overall Study|Lack of tolerability|1
7109119|NCT02477839|11240336|FG000|Overall Study|Exclusion criterion|0
7109120|NCT02477839|11240337|FG001|Overall Study|Exclusion criterion|1
7109121|NCT02478164|11240345|FG000|Overall Study|Lack of Efficacy|13
7109122|NCT02478164|11240345|FG000|Overall Study|Adverse Event|1
7109123|NCT02478164|11240345|FG000|Overall Study|Withdrawal by Subject|1
7109124|NCT02478359|11240351|FG000|Overall Study|Disenrolled from health plan|106
7109125|NCT02478359|11240352|FG001|Overall Study|Disenrolled from health plan|65
7109126|NCT02478372|11240362|FG000|Overall Study|Protocol Violation|12
7109127|NCT02478372|11240363|FG001|Overall Study|Protocol Violation|8
7109128|NCT02478372|11240362|FG000|Overall Study|Lost to Follow-up|1
7109129|NCT02478372|11240363|FG001|Overall Study|Lost to Follow-up|4
7109130|NCT02478372|11240362|FG000|Overall Study|Death|0
7109131|NCT02478372|11240363|FG001|Overall Study|Death|2
7109132|NCT02478398|11240371|FG000|Overall Study|Adverse Event|20
7109133|NCT02478398|11240372|FG001|Overall Study|Adverse Event|5
7109134|NCT02478398|11240371|FG000|Overall Study|Lost to Follow-up|5
7109135|NCT02478398|11240372|FG001|Overall Study|Lost to Follow-up|4
7109136|NCT02478398|11240371|FG000|Overall Study|Non-Compliance With Study Drug|5
7109137|NCT02478398|11240372|FG001|Overall Study|Non-Compliance With Study Drug|1
7109138|NCT02478398|11240371|FG000|Overall Study|Protocol Violation|3
7109139|NCT02478398|11240372|FG001|Overall Study|Protocol Violation|1
7109140|NCT02478398|11240371|FG000|Overall Study|Withdrawal By Parent/Guardian|9
7109141|NCT02478398|11240372|FG001|Overall Study|Withdrawal By Parent/Guardian|6
7109142|NCT02478398|11240371|FG000|Overall Study|Withdrawal By Participant|10
7109143|NCT02478398|11240372|FG001|Overall Study|Withdrawal By Participant|4
7109144|NCT02478463|11240379|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1
7109145|NCT02478463|11240379|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1
7109146|NCT02478463|11240379|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1
7109147|NCT02478632|11240407|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4
7109148|NCT02478632|11240408|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5
7109149|NCT02478632|11240407|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2
7109150|NCT02478632|11240408|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3
7109151|NCT02478632|11240407|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5
7109152|NCT02478632|11240408|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1
7109153|NCT02479139|11240428|FG000|Overall Study|Lost to Follow-up|2
7109154|NCT02479139|11240429|FG001|Overall Study|Lost to Follow-up|4
7109155|NCT02479139|11240430|FG002|Overall Study|Lost to Follow-up|4
7109156|NCT02479139|11240431|FG003|Overall Study|Lost to Follow-up|2
7109157|NCT02479139|11240432|FG004|Overall Study|Lost to Follow-up|3
7109158|NCT02479139|11240433|FG005|Overall Study|Lost to Follow-up|5
7109159|NCT02479139|11240428|FG000|Overall Study|Withdrew Consent|5
7109160|NCT02479139|11240429|FG001|Overall Study|Withdrew Consent|6
7109161|NCT02479139|11240430|FG002|Overall Study|Withdrew Consent|1
7109162|NCT02479139|11240431|FG003|Overall Study|Withdrew Consent|4
7109163|NCT02479139|11240432|FG004|Overall Study|Withdrew Consent|1
7109164|NCT02479139|11240433|FG005|Overall Study|Withdrew Consent|1
7109165|NCT02479139|11240428|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0
7109166|NCT02479139|11240429|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0
7109167|NCT02479139|11240430|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1
7109168|NCT02479139|11240431|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0
7109169|NCT02479139|11240432|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0
7109170|NCT02479139|11240433|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0
7109171|NCT02479139|11240428|FG000|Overall Study|Other Miscellaneous Reasons|1
7109172|NCT02479139|11240429|FG001|Overall Study|Other Miscellaneous Reasons|0
7109173|NCT02479139|11240430|FG002|Overall Study|Other Miscellaneous Reasons|1
7109174|NCT02479139|11240431|FG003|Overall Study|Other Miscellaneous Reasons|1
7109175|NCT02479139|11240432|FG004|Overall Study|Other Miscellaneous Reasons|1
7109176|NCT02479139|11240433|FG005|Overall Study|Other Miscellaneous Reasons|0
7109177|NCT02479412|11240456|FG000|Overall Study|Adverse Event|0
7109178|NCT02479412|11240457|FG001|Overall Study|Adverse Event|0
7109179|NCT02479412|11240458|FG002|Overall Study|Adverse Event|1
7109180|NCT02479412|11240459|FG003|Overall Study|Adverse Event|0
7109181|NCT02479412|11240460|FG004|Overall Study|Adverse Event|0
7109182|NCT02479412|11240461|FG005|Overall Study|Adverse Event|0
7109183|NCT02479412|11240462|FG006|Overall Study|Adverse Event|0
7109184|NCT02479412|11240463|FG007|Overall Study|Adverse Event|0
7109185|NCT02479412|11240464|FG008|Overall Study|Adverse Event|0
7109186|NCT02479412|11240456|FG000|Overall Study|Study-specific withdrawal criteria|0
7109187|NCT02479412|11240457|FG001|Overall Study|Study-specific withdrawal criteria|0
7109188|NCT02479412|11240458|FG002|Overall Study|Study-specific withdrawal criteria|1
7109189|NCT02479412|11240459|FG003|Overall Study|Study-specific withdrawal criteria|1
7109190|NCT02479412|11240460|FG004|Overall Study|Study-specific withdrawal criteria|0
7109191|NCT02479412|11240461|FG005|Overall Study|Study-specific withdrawal criteria|0
7109192|NCT02479412|11240462|FG006|Overall Study|Study-specific withdrawal criteria|0
7109193|NCT02479412|11240463|FG007|Overall Study|Study-specific withdrawal criteria|1
7109194|NCT02479412|11240464|FG008|Overall Study|Study-specific withdrawal criteria|1
7109195|NCT02479412|11240456|FG000|Overall Study|Randomization to wrong PK sampling group|0
7109196|NCT02479412|11240457|FG001|Overall Study|Randomization to wrong PK sampling group|0
7109197|NCT02479412|11240458|FG002|Overall Study|Randomization to wrong PK sampling group|0
7109198|NCT02479412|11240459|FG003|Overall Study|Randomization to wrong PK sampling group|0
7109199|NCT02479412|11240460|FG004|Overall Study|Randomization to wrong PK sampling group|1
7109200|NCT02479412|11240461|FG005|Overall Study|Randomization to wrong PK sampling group|0
7109201|NCT02479412|11240462|FG006|Overall Study|Randomization to wrong PK sampling group|0
7109202|NCT02479412|11240463|FG007|Overall Study|Randomization to wrong PK sampling group|0
7109203|NCT02479412|11240464|FG008|Overall Study|Randomization to wrong PK sampling group|0
7109204|NCT02479802|11240489|FG000|Overall Study|Lost to Follow-up|1
7109205|NCT02479802|11240489|FG000|Overall Study|Adverse Event|1
7109206|NCT02479880|11240495|FG000|Overall Study|Study Terminated by Sponsor|13
7109207|NCT02479880|11240496|FG001|Overall Study|Study Terminated by Sponsor|12
7109208|NCT02479880|11240495|FG000|Overall Study|Pregnancy|0
7109209|NCT02479880|11240496|FG001|Overall Study|Pregnancy|1
7109210|NCT02480010|11240504|FG000|Overall Study|Adverse Event|3
7109211|NCT02480010|11240505|FG001|Overall Study|Adverse Event|1
7109212|NCT02480010|11240504|FG000|Overall Study|Death|1
7109213|NCT02480010|11240505|FG001|Overall Study|Death|0
7109214|NCT02480010|11240504|FG000|Overall Study|Insufficient therapeutic response|31
7109215|NCT02480010|11240505|FG001|Overall Study|Insufficient therapeutic response|29
7109216|NCT02480010|11240504|FG000|Overall Study|Refused Treatment|0
7109217|NCT02480010|11240505|FG001|Overall Study|Refused Treatment|3
7109218|NCT02480114|11240513|FG000|Overall Study|Not completing surveys|3
7109219|NCT02480114|11240514|FG001|Overall Study|Not completing surveys|2
7109220|NCT02480114|11240513|FG000|Overall Study|Withdrawal by Subject|2
7109221|NCT02480114|11240514|FG001|Overall Study|Withdrawal by Subject|4
7109222|NCT02480114|11240513|FG000|Overall Study|Disease progression|3
7109223|NCT02480114|11240514|FG001|Overall Study|Disease progression|0
7109224|NCT02480114|11240513|FG000|Overall Study|Improper completion of survey|1
7109225|NCT02480114|11240514|FG001|Overall Study|Improper completion of survey|1
7109226|NCT02480114|11240513|FG000|Overall Study|Not eligible|0
7109227|NCT02480114|11240514|FG001|Overall Study|Not eligible|1
7109228|NCT02480153|11240522|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0
7109229|NCT02480153|11240523|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1
7109230|NCT02480153|11240524|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0
7109231|NCT02480153|11240522|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0
7109232|NCT02480153|11240523|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1
7109233|NCT02480153|11240524|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0
7109234|NCT02480153|11240522|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1
7109235|NCT02480153|11240523|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2
7109236|NCT02480153|11240524|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0
7109237|NCT02480153|11240522|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3
7109238|NCT02480153|11240523|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8
7109239|NCT02480153|11240524|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0
7109240|NCT02480153|11240522|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0
7109241|NCT02480153|11240523|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1
7109242|NCT02480153|11240524|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0
7109243|NCT02480153|11240522|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0
7109244|NCT02480153|11240523|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1
7109245|NCT02480153|11240524|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0
7109246|NCT02480153|11240522|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0
7109247|NCT02480153|11240523|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2
7109248|NCT02480153|11240524|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0
7109249|NCT02480153|11240522|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4
7109250|NCT02480153|11240523|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1
7109251|NCT02480153|11240524|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3
7109252|NCT02480153|11240522|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0
7109253|NCT02480153|11240523|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1
7109254|NCT02480153|11240524|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0
7109255|NCT02480153|11240522|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8
7109256|NCT02480153|11240523|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3
7109257|NCT02480153|11240524|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1
7109258|NCT02480153|11240522|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6
7109259|NCT02480153|11240523|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7
7109260|NCT02480153|11240524|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3
7109261|NCT02480153|11240522|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2
7109262|NCT02480153|11240523|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0
7109263|NCT02480153|11240524|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0
7109264|NCT02480153|11240522|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0
7109265|NCT02480153|11240523|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1
7109266|NCT02480153|11240524|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0
7109267|NCT02480153|11240522|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3
7109268|NCT02480153|11240523|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2
7109269|NCT02480153|11240524|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1
7109270|NCT02480153|11240522|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4
7109271|NCT02480153|11240523|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0
7109272|NCT02480153|11240524|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1
7109273|NCT02480153|11240522|FG000|Period 3: Week 52 Dosing to Week 78|Other|0
7109274|NCT02480153|11240523|FG001|Period 3: Week 52 Dosing to Week 78|Other|0
7109275|NCT02480153|11240524|FG002|Period 3: Week 52 Dosing to Week 78|Other|1
7109276|NCT02480153|11240522|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0
7109277|NCT02480153|11240523|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0
7109278|NCT02480153|11240524|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1
7109279|NCT02480153|11240522|FG000|Period 3: Week 52 Dosing to Week 78|Death|0
7109280|NCT02480153|11240523|FG001|Period 3: Week 52 Dosing to Week 78|Death|1
7109281|NCT02480153|11240524|FG002|Period 3: Week 52 Dosing to Week 78|Death|0
7109282|NCT02480621|11240594|FG000|Randomization|Withdrawal by Subject|1
7109283|NCT02480621|11240595|FG001|Randomization|Withdrawal by Subject|0
7109284|NCT02480621|11240594|FG000|Randomization|Surgeon did not give intervention|0
7109285|NCT02480621|11240595|FG001|Randomization|Surgeon did not give intervention|1
7109286|NCT02480621|11240594|FG000|Follow Up|Lost to Follow-up|4
7109287|NCT02480621|11240595|FG001|Follow Up|Lost to Follow-up|2
7109288|NCT02480712|11240601|FG000|Overall Study|Enrolled but Never Treated|1
7109289|NCT02480712|11240601|FG000|Overall Study|Lost to Follow-up|5
7109290|NCT02480712|11240601|FG000|Overall Study|Withdrew Consent|3
7109291|NCT02480712|11240601|FG000|Overall Study|Death|1
7109292|NCT02480712|11240601|FG000|Overall Study|Lack of Efficacy|1
7109293|NCT02480764|11240614|FG000|Overall Study|Pretreatment Event/Adverse Event|3
7109294|NCT02480764|11240615|FG001|Overall Study|Pretreatment Event/Adverse Event|6
7109295|NCT02480764|11240616|FG002|Overall Study|Pretreatment Event/Adverse Event|3
7109296|NCT02480764|11240614|FG000|Overall Study|Major Protocol Deviation|1
7109297|NCT02480764|11240615|FG001|Overall Study|Major Protocol Deviation|4
7109298|NCT02480764|11240616|FG002|Overall Study|Major Protocol Deviation|3
7109299|NCT02480764|11240614|FG000|Overall Study|Lost to Follow-up|0
7109300|NCT02480764|11240615|FG001|Overall Study|Lost to Follow-up|1
7109301|NCT02480764|11240616|FG002|Overall Study|Lost to Follow-up|2
7109302|NCT02480764|11240614|FG000|Overall Study|Voluntary Withdrawal|6
7109303|NCT02480764|11240615|FG001|Overall Study|Voluntary Withdrawal|5
7109304|NCT02480764|11240616|FG002|Overall Study|Voluntary Withdrawal|10
7109305|NCT02480764|11240614|FG000|Overall Study|Lack of Efficacy|0
7109306|NCT02480764|11240615|FG001|Overall Study|Lack of Efficacy|3
7109307|NCT02480764|11240616|FG002|Overall Study|Lack of Efficacy|3
7109308|NCT02480764|11240614|FG000|Overall Study|Reason not Specified|0
7109309|NCT02480764|11240615|FG001|Overall Study|Reason not Specified|1
7109310|NCT02480764|11240616|FG002|Overall Study|Reason not Specified|0
7109311|NCT02481050|11240639|FG000|Overall Study|Adverse Event|1
7109312|NCT02481050|11240639|FG000|Overall Study|Disease Progression|47
7109313|NCT02481050|11240639|FG000|Overall Study|Withdrawal by Subject|7
7109314|NCT02481050|11240639|FG000|Overall Study|Other|3
7109315|NCT02481869|11240784|FG000|Overall Study|Lost to Follow-up|3
7109316|NCT02481869|11240785|FG001|Overall Study|Lost to Follow-up|4
7109317|NCT02481869|11240784|FG000|Overall Study|Withdrawal by Subject|2
7109318|NCT02481869|11240785|FG001|Overall Study|Withdrawal by Subject|0
7109319|NCT02481934|11240792|FG000|Overall Study|Death|2
7109320|NCT02481947|11240798|FG000|Overall Study|Withdrawal by Subject|24
7109321|NCT02481947|11240799|FG001|Overall Study|Withdrawal by Subject|10
7109322|NCT02481947|11240798|FG000|Overall Study|Lost to Follow-up|11
7109323|NCT02481947|11240799|FG001|Overall Study|Lost to Follow-up|5
7109324|NCT02481947|11240798|FG000|Overall Study|Adverse Event|6
7109325|NCT02481947|11240799|FG001|Overall Study|Adverse Event|11
7109326|NCT02481947|11240798|FG000|Overall Study|Physician Decision|4
7109327|NCT02481947|11240799|FG001|Overall Study|Physician Decision|5
7109328|NCT02481947|11240798|FG000|Overall Study|Protocol Violation|1
7109329|NCT02481947|11240799|FG001|Overall Study|Protocol Violation|5
7109330|NCT02482129|11240816|FG000|Overall Study|Adverse Event-prior to treatment|0
7109331|NCT02482129|11240817|FG001|Overall Study|Adverse Event-prior to treatment|1
7109332|NCT02482129|11240816|FG000|Overall Study|Withdrawal by subject-prior to treatment|0
7109333|NCT02482129|11240817|FG001|Overall Study|Withdrawal by subject-prior to treatment|1
7109334|NCT02482129|11240816|FG000|Overall Study|Unable to draw blood-prior to treatment|1
7109335|NCT02482129|11240817|FG001|Overall Study|Unable to draw blood-prior to treatment|0
7109336|NCT02482129|11240816|FG000|Overall Study|Criteria not met-prior to treatment|1
7109337|NCT02482129|11240817|FG001|Overall Study|Criteria not met-prior to treatment|0
7109338|NCT02482129|11240816|FG000|Overall Study|Adverse Event|1
7109339|NCT02482129|11240817|FG001|Overall Study|Adverse Event|0
7109340|NCT02482129|11240816|FG000|Overall Study|Withdrawal by Subject|2
7109341|NCT02482129|11240817|FG001|Overall Study|Withdrawal by Subject|0
7109342|NCT02482129|11240816|FG000|Overall Study|Criteria not met|1
7109343|NCT02482129|11240817|FG001|Overall Study|Criteria not met|0
7109344|NCT02482298|11240828|FG000|Overall Study|Withdrawal by Subject|2
7109345|NCT02482298|11240829|FG001|Overall Study|Withdrawal by Subject|1
7109346|NCT02482298|11240830|FG002|Overall Study|Withdrawal by Subject|2
7109347|NCT02482298|11240828|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0
7109348|NCT02482298|11240829|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1
7109349|NCT02482298|11240830|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0
7109350|NCT02482298|11240828|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
7109351|NCT02482298|11240829|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
7109352|NCT02482298|11240830|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1
7109353|NCT02482298|11240828|FG000|Overall Study|Lost to Follow-up|0
7109354|NCT02482298|11240829|FG001|Overall Study|Lost to Follow-up|1
7109355|NCT02482298|11240830|FG002|Overall Study|Lost to Follow-up|0
7109356|NCT02482428|11240843|FG000|Overall Study|Lost to Follow-up|4
7109357|NCT02482428|11240844|FG001|Overall Study|Lost to Follow-up|9
7109358|NCT02482428|11240845|FG002|Overall Study|Lost to Follow-up|1
7109359|NCT02482428|11240846|FG003|Overall Study|Lost to Follow-up|2
7109360|NCT02482428|11240847|FG004|Overall Study|Lost to Follow-up|4
7109361|NCT02482428|11240843|FG000|Overall Study|Physician Decision|0
7109362|NCT02482428|11240844|FG001|Overall Study|Physician Decision|0
7109363|NCT02482428|11240845|FG002|Overall Study|Physician Decision|0
7109364|NCT02482428|11240846|FG003|Overall Study|Physician Decision|0
7109365|NCT02482428|11240847|FG004|Overall Study|Physician Decision|1
7109366|NCT02482428|11240843|FG000|Overall Study|protocol deviation|1
7109367|NCT02482428|11240844|FG001|Overall Study|protocol deviation|1
7109368|NCT02482428|11240845|FG002|Overall Study|protocol deviation|0
7109369|NCT02482428|11240846|FG003|Overall Study|protocol deviation|0
7109370|NCT02482428|11240847|FG004|Overall Study|protocol deviation|0
7109371|NCT02482428|11240843|FG000|Overall Study|subject/guardian decision|4
7109372|NCT02482428|11240844|FG001|Overall Study|subject/guardian decision|2
7109373|NCT02482428|11240845|FG002|Overall Study|subject/guardian decision|0
7109374|NCT02482428|11240846|FG003|Overall Study|subject/guardian decision|0
7109375|NCT02482428|11240847|FG004|Overall Study|subject/guardian decision|2
7109376|NCT02482571|11240861|FG000|Overall Study|Adverse Event|1
7109377|NCT02482571|11240861|FG000|Overall Study|Scanner or Respiract failure|3
7109378|NCT02482571|11240861|FG000|Overall Study|Withdrawal by Subject|4
7109379|NCT02482805|11240917|FG000|Overall Study|Lost to Follow-up|4
7109380|NCT02482805|11240918|FG001|Overall Study|Lost to Follow-up|4
7109381|NCT02482805|11240919|FG002|Overall Study|Lost to Follow-up|0
7109382|NCT02482935|11240942|FG000|Period 1|Withdrawal by Subject|1
7109383|NCT02482935|11240943|FG001|Period 1|Withdrawal by Subject|0
7109384|NCT02483416|11240958|FG000|Overall Study|Other reason|0
7109385|NCT02483416|11240959|FG001|Overall Study|Other reason|1
7109386|NCT02483416|11240958|FG000|Overall Study|Treatment stop|3
7109387|NCT02483416|11240959|FG001|Overall Study|Treatment stop|0
7109388|NCT02483520|11240968|FG000|Overall Study|Lost to Follow-up|3
7109389|NCT02483520|11240969|FG001|Overall Study|Lost to Follow-up|4
7109390|NCT02483520|11240968|FG000|Overall Study|Withdrawal by Subject|4
7109391|NCT02483520|11240969|FG001|Overall Study|Withdrawal by Subject|14
7109392|NCT02483520|11240968|FG000|Overall Study|Hospitalized|2
7109393|NCT02483520|11240969|FG001|Overall Study|Hospitalized|3
7109394|NCT02483520|11240968|FG000|Overall Study|Moved to LTC|2
7109395|NCT02483520|11240969|FG001|Overall Study|Moved to LTC|3
7109396|NCT02483572|11240977|FG000|Overall Study|Withdrawal by Subject|1
7109397|NCT02483572|11240978|FG001|Overall Study|Withdrawal by Subject|0
7109398|NCT02483572|11240977|FG000|Overall Study|Lost to Follow-up|1
7109399|NCT02483572|11240978|FG001|Overall Study|Lost to Follow-up|0
7109400|NCT02483572|11240977|FG000|Overall Study|Physician Decision|0
7109401|NCT02483572|11240978|FG001|Overall Study|Physician Decision|1
7109402|NCT02483611|11240987|FG000|Overall Study|Protocol Violation|0
7109403|NCT02483611|11240988|FG001|Overall Study|Protocol Violation|0
7109404|NCT02483611|11240989|FG002|Overall Study|Protocol Violation|1
7109405|NCT02483975|11241008|FG000|Overall Study|Adverse Event|0
7109406|NCT02483975|11241009|FG001|Overall Study|Adverse Event|1
7109407|NCT02483975|11241008|FG000|Overall Study|Lost to Follow-up|0
7109408|NCT02483975|11241009|FG001|Overall Study|Lost to Follow-up|1
7109409|NCT02483975|11241008|FG000|Overall Study|Physician Decision|2
7109410|NCT02483975|11241009|FG001|Overall Study|Physician Decision|0
7109411|NCT02484547|11241031|FG000|Placebo-Controlled Period|Adverse Event|10
7109412|NCT02484547|11241032|FG001|Placebo-Controlled Period|Adverse Event|13
7109413|NCT02484547|11241033|FG002|Placebo-Controlled Period|Adverse Event|20
7109414|NCT02484547|11241034|FG003|Placebo-Controlled Period|Adverse Event|0
7109415|NCT02484547|11241035|FG004|Placebo-Controlled Period|Adverse Event|0
7109416|NCT02484547|11241036|FG005|Placebo-Controlled Period|Adverse Event|0
7109417|NCT02484547|11241037|FG006|Placebo-Controlled Period|Adverse Event|0
7109418|NCT02484547|11241031|FG000|Placebo-Controlled Period|Change of Treatment|0
7109419|NCT02484547|11241032|FG001|Placebo-Controlled Period|Change of Treatment|0
7109420|NCT02484547|11241033|FG002|Placebo-Controlled Period|Change of Treatment|1
7109421|NCT02484547|11241034|FG003|Placebo-Controlled Period|Change of Treatment|0
7109422|NCT02484547|11241035|FG004|Placebo-Controlled Period|Change of Treatment|0
7109423|NCT02484547|11241036|FG005|Placebo-Controlled Period|Change of Treatment|0
7109424|NCT02484547|11241037|FG006|Placebo-Controlled Period|Change of Treatment|0
7109425|NCT02484547|11241031|FG000|Placebo-Controlled Period|Consent Withdrawn|15
7109426|NCT02484547|11241032|FG001|Placebo-Controlled Period|Consent Withdrawn|32
7109427|NCT02484547|11241033|FG002|Placebo-Controlled Period|Consent Withdrawn|26
7109428|NCT02484547|11241034|FG003|Placebo-Controlled Period|Consent Withdrawn|0
7109429|NCT02484547|11241035|FG004|Placebo-Controlled Period|Consent Withdrawn|0
7109430|NCT02484547|11241036|FG005|Placebo-Controlled Period|Consent Withdrawn|0
7109431|NCT02484547|11241037|FG006|Placebo-Controlled Period|Consent Withdrawn|0
7109432|NCT02484547|11241031|FG000|Placebo-Controlled Period|Death|5
7109433|NCT02484547|11241032|FG001|Placebo-Controlled Period|Death|0
7109434|NCT02484547|11241033|FG002|Placebo-Controlled Period|Death|6
7109435|NCT02484547|11241034|FG003|Placebo-Controlled Period|Death|0
7109436|NCT02484547|11241035|FG004|Placebo-Controlled Period|Death|0
7109437|NCT02484547|11241036|FG005|Placebo-Controlled Period|Death|0
7109438|NCT02484547|11241037|FG006|Placebo-Controlled Period|Death|0
7109439|NCT02484547|11241031|FG000|Placebo-Controlled Period|Disease Progression|2
7109440|NCT02484547|11241032|FG001|Placebo-Controlled Period|Disease Progression|0
7109441|NCT02484547|11241033|FG002|Placebo-Controlled Period|Disease Progression|1
7109442|NCT02484547|11241034|FG003|Placebo-Controlled Period|Disease Progression|0
7109443|NCT02484547|11241035|FG004|Placebo-Controlled Period|Disease Progression|0
7109444|NCT02484547|11241036|FG005|Placebo-Controlled Period|Disease Progression|0
7109445|NCT02484547|11241037|FG006|Placebo-Controlled Period|Disease Progression|0
7109446|NCT02484547|11241031|FG000|Placebo-Controlled Period|Investigator Decision|2
7109447|NCT02484547|11241032|FG001|Placebo-Controlled Period|Investigator Decision|2
7109448|NCT02484547|11241033|FG002|Placebo-Controlled Period|Investigator Decision|5
7109449|NCT02484547|11241034|FG003|Placebo-Controlled Period|Investigator Decision|0
7109450|NCT02484547|11241035|FG004|Placebo-Controlled Period|Investigator Decision|0
7109451|NCT02484547|11241036|FG005|Placebo-Controlled Period|Investigator Decision|0
7109452|NCT02484547|11241037|FG006|Placebo-Controlled Period|Investigator Decision|0
7109453|NCT02484547|11241031|FG000|Placebo-Controlled Period|Lost to Follow-up|3
7109454|NCT02484547|11241032|FG001|Placebo-Controlled Period|Lost to Follow-up|1
7109455|NCT02484547|11241033|FG002|Placebo-Controlled Period|Lost to Follow-up|3
7109456|NCT02484547|11241034|FG003|Placebo-Controlled Period|Lost to Follow-up|0
7109457|NCT02484547|11241035|FG004|Placebo-Controlled Period|Lost to Follow-up|0
7109458|NCT02484547|11241036|FG005|Placebo-Controlled Period|Lost to Follow-up|0
7109459|NCT02484547|11241037|FG006|Placebo-Controlled Period|Lost to Follow-up|0
7109460|NCT02484547|11241031|FG000|Placebo-Controlled Period|Relocation|1
7109461|NCT02484547|11241032|FG001|Placebo-Controlled Period|Relocation|1
7109462|NCT02484547|11241033|FG002|Placebo-Controlled Period|Relocation|1
7109463|NCT02484547|11241034|FG003|Placebo-Controlled Period|Relocation|0
7109464|NCT02484547|11241035|FG004|Placebo-Controlled Period|Relocation|0
7109465|NCT02484547|11241036|FG005|Placebo-Controlled Period|Relocation|0
7109466|NCT02484547|11241037|FG006|Placebo-Controlled Period|Relocation|0
7109467|NCT02484547|11241031|FG000|Placebo-Controlled Period|Study Visit Burden|2
7109468|NCT02484547|11241032|FG001|Placebo-Controlled Period|Study Visit Burden|8
7109469|NCT02484547|11241033|FG002|Placebo-Controlled Period|Study Visit Burden|5
7109470|NCT02484547|11241034|FG003|Placebo-Controlled Period|Study Visit Burden|0
7109471|NCT02484547|11241035|FG004|Placebo-Controlled Period|Study Visit Burden|0
7109472|NCT02484547|11241036|FG005|Placebo-Controlled Period|Study Visit Burden|0
7109473|NCT02484547|11241037|FG006|Placebo-Controlled Period|Study Visit Burden|0
7109474|NCT02484547|11241031|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4
7109475|NCT02484547|11241032|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1
7109476|NCT02484547|11241033|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1
7109477|NCT02484547|11241034|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7109478|NCT02484547|11241035|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7109479|NCT02484547|11241036|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7109480|NCT02484547|11241037|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7109481|NCT02484547|11241031|FG000|Placebo-Controlled Period|Reason not Specified|216
7109482|NCT02484547|11241032|FG001|Placebo-Controlled Period|Reason not Specified|194
7109483|NCT02484547|11241033|FG002|Placebo-Controlled Period|Reason not Specified|183
7109484|NCT02484547|11241034|FG003|Placebo-Controlled Period|Reason not Specified|0
7109485|NCT02484547|11241035|FG004|Placebo-Controlled Period|Reason not Specified|0
7109486|NCT02484547|11241036|FG005|Placebo-Controlled Period|Reason not Specified|0
7109487|NCT02484547|11241037|FG006|Placebo-Controlled Period|Reason not Specified|0
7109488|NCT02484547|11241031|FG000|Long-Term Extension Period|Adverse Event|0
7109489|NCT02484547|11241032|FG001|Long-Term Extension Period|Adverse Event|0
7109490|NCT02484547|11241033|FG002|Long-Term Extension Period|Adverse Event|0
7109491|NCT02484547|11241034|FG003|Long-Term Extension Period|Adverse Event|0
7109492|NCT02484547|11241035|FG004|Long-Term Extension Period|Adverse Event|1
7109493|NCT02484547|11241036|FG005|Long-Term Extension Period|Adverse Event|3
7109494|NCT02484547|11241037|FG006|Long-Term Extension Period|Adverse Event|2
7109495|NCT02484547|11241031|FG000|Long-Term Extension Period|Death|0
7109496|NCT02484547|11241032|FG001|Long-Term Extension Period|Death|0
7109497|NCT02484547|11241033|FG002|Long-Term Extension Period|Death|0
7109498|NCT02484547|11241034|FG003|Long-Term Extension Period|Death|0
7109499|NCT02484547|11241035|FG004|Long-Term Extension Period|Death|0
7109500|NCT02484547|11241036|FG005|Long-Term Extension Period|Death|3
7109501|NCT02484547|11241037|FG006|Long-Term Extension Period|Death|0
7109502|NCT02484547|11241031|FG000|Long-Term Extension Period|Disease Progression|0
7109503|NCT02484547|11241032|FG001|Long-Term Extension Period|Disease Progression|0
7109504|NCT02484547|11241033|FG002|Long-Term Extension Period|Disease Progression|0
7109505|NCT02484547|11241034|FG003|Long-Term Extension Period|Disease Progression|0
7109506|NCT02484547|11241035|FG004|Long-Term Extension Period|Disease Progression|2
7109507|NCT02484547|11241036|FG005|Long-Term Extension Period|Disease Progression|4
7109508|NCT02484547|11241037|FG006|Long-Term Extension Period|Disease Progression|0
7109509|NCT02484547|11241031|FG000|Long-Term Extension Period|Lost to Follow-up|0
7109510|NCT02484547|11241032|FG001|Long-Term Extension Period|Lost to Follow-up|0
7109511|NCT02484547|11241033|FG002|Long-Term Extension Period|Lost to Follow-up|0
7109512|NCT02484547|11241034|FG003|Long-Term Extension Period|Lost to Follow-up|1
7109513|NCT02484547|11241035|FG004|Long-Term Extension Period|Lost to Follow-up|1
7109514|NCT02484547|11241036|FG005|Long-Term Extension Period|Lost to Follow-up|2
7109515|NCT02484547|11241037|FG006|Long-Term Extension Period|Lost to Follow-up|0
7109516|NCT02484547|11241031|FG000|Long-Term Extension Period|Loss of Capacity|0
7109517|NCT02484547|11241032|FG001|Long-Term Extension Period|Loss of Capacity|0
7109518|NCT02484547|11241033|FG002|Long-Term Extension Period|Loss of Capacity|0
7109519|NCT02484547|11241034|FG003|Long-Term Extension Period|Loss of Capacity|0
7109520|NCT02484547|11241035|FG004|Long-Term Extension Period|Loss of Capacity|1
7109521|NCT02484547|11241036|FG005|Long-Term Extension Period|Loss of Capacity|0
7109522|NCT02484547|11241037|FG006|Long-Term Extension Period|Loss of Capacity|0
7109523|NCT02484547|11241031|FG000|Long-Term Extension Period|Change of Treatment|0
7109524|NCT02484547|11241032|FG001|Long-Term Extension Period|Change of Treatment|0
7109525|NCT02484547|11241033|FG002|Long-Term Extension Period|Change of Treatment|0
7109526|NCT02484547|11241034|FG003|Long-Term Extension Period|Change of Treatment|0
7109527|NCT02484547|11241035|FG004|Long-Term Extension Period|Change of Treatment|0
7109528|NCT02484547|11241036|FG005|Long-Term Extension Period|Change of Treatment|0
7109529|NCT02484547|11241037|FG006|Long-Term Extension Period|Change of Treatment|1
7109530|NCT02484547|11241031|FG000|Long-Term Extension Period|Consent Withdrawn|0
7109531|NCT02484547|11241032|FG001|Long-Term Extension Period|Consent Withdrawn|0
7109532|NCT02484547|11241033|FG002|Long-Term Extension Period|Consent Withdrawn|0
7109533|NCT02484547|11241034|FG003|Long-Term Extension Period|Consent Withdrawn|6
7109534|NCT02484547|11241035|FG004|Long-Term Extension Period|Consent Withdrawn|7
7109535|NCT02484547|11241036|FG005|Long-Term Extension Period|Consent Withdrawn|13
7109536|NCT02484547|11241037|FG006|Long-Term Extension Period|Consent Withdrawn|17
7109537|NCT02484547|11241031|FG000|Long-Term Extension Period|Investigator Decision|0
7109538|NCT02484547|11241032|FG001|Long-Term Extension Period|Investigator Decision|0
7109539|NCT02484547|11241033|FG002|Long-Term Extension Period|Investigator Decision|0
7109540|NCT02484547|11241034|FG003|Long-Term Extension Period|Investigator Decision|2
7109541|NCT02484547|11241035|FG004|Long-Term Extension Period|Investigator Decision|1
7109542|NCT02484547|11241036|FG005|Long-Term Extension Period|Investigator Decision|0
7109543|NCT02484547|11241037|FG006|Long-Term Extension Period|Investigator Decision|1
7109544|NCT02484547|11241031|FG000|Long-Term Extension Period|Relocation|0
7109545|NCT02484547|11241032|FG001|Long-Term Extension Period|Relocation|0
7109546|NCT02484547|11241033|FG002|Long-Term Extension Period|Relocation|0
7109547|NCT02484547|11241034|FG003|Long-Term Extension Period|Relocation|1
7109548|NCT02484547|11241035|FG004|Long-Term Extension Period|Relocation|1
7109549|NCT02484547|11241036|FG005|Long-Term Extension Period|Relocation|0
7109550|NCT02484547|11241037|FG006|Long-Term Extension Period|Relocation|0
7109551|NCT02484547|11241031|FG000|Long-Term Extension Period|Study Visit Burden|0
7109552|NCT02484547|11241032|FG001|Long-Term Extension Period|Study Visit Burden|0
7109553|NCT02484547|11241033|FG002|Long-Term Extension Period|Study Visit Burden|0
7109554|NCT02484547|11241034|FG003|Long-Term Extension Period|Study Visit Burden|2
7109555|NCT02484547|11241035|FG004|Long-Term Extension Period|Study Visit Burden|0
7109556|NCT02484547|11241036|FG005|Long-Term Extension Period|Study Visit Burden|0
7109557|NCT02484547|11241037|FG006|Long-Term Extension Period|Study Visit Burden|3
7109558|NCT02484547|11241031|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0
7109559|NCT02484547|11241032|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0
7109560|NCT02484547|11241033|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0
7109561|NCT02484547|11241034|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0
7109562|NCT02484547|11241035|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1
7109563|NCT02484547|11241036|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3
7109564|NCT02484547|11241037|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2
7109565|NCT02484547|11241031|FG000|Long-Term Extension Period|Reason not Specified|0
7109566|NCT02484547|11241032|FG001|Long-Term Extension Period|Reason not Specified|0
7109567|NCT02484547|11241033|FG002|Long-Term Extension Period|Reason not Specified|0
7109568|NCT02484547|11241034|FG003|Long-Term Extension Period|Reason not Specified|119
7109569|NCT02484547|11241035|FG004|Long-Term Extension Period|Reason not Specified|117
7109570|NCT02484547|11241036|FG005|Long-Term Extension Period|Reason not Specified|223
7109571|NCT02484547|11241037|FG006|Long-Term Extension Period|Reason not Specified|231
7109572|NCT02484651|11241051|FG000|Overall Study|Patients' data files were corrupted.|1
7109573|NCT02484651|11241052|FG001|Overall Study|Patients' data files were corrupted.|1
7109574|NCT02484651|11241051|FG000|Overall Study|BIS monitoring failed.|1
7109575|NCT02484651|11241052|FG001|Overall Study|BIS monitoring failed.|1
7109576|NCT02484651|11241051|FG000|Overall Study|Time of the procedure less than 90 min.|1
7109577|NCT02484651|11241052|FG001|Overall Study|Time of the procedure less than 90 min.|2
7109578|NCT02484690|11241064|FG000|Overall Study|Adverse Event|1
7109579|NCT02484690|11241065|FG001|Overall Study|Adverse Event|3
7109580|NCT02484690|11241066|FG002|Overall Study|Adverse Event|0
7109581|NCT02484690|11241067|FG003|Overall Study|Adverse Event|0
7109582|NCT02484690|11241068|FG004|Overall Study|Adverse Event|5
7109583|NCT02484690|11241064|FG000|Overall Study|Death|0
7109584|NCT02484690|11241065|FG001|Overall Study|Death|0
7109585|NCT02484690|11241066|FG002|Overall Study|Death|0
7109586|NCT02484690|11241067|FG003|Overall Study|Death|0
7109587|NCT02484690|11241068|FG004|Overall Study|Death|1
7109588|NCT02484690|11241064|FG000|Overall Study|Withdrawal by Subject|1
7109589|NCT02484690|11241065|FG001|Overall Study|Withdrawal by Subject|3
7109590|NCT02484690|11241066|FG002|Overall Study|Withdrawal by Subject|1
7109591|NCT02484690|11241067|FG003|Overall Study|Withdrawal by Subject|2
7109592|NCT02484690|11241068|FG004|Overall Study|Withdrawal by Subject|0
7109593|NCT02484690|11241064|FG000|Overall Study|Physician Decision|2
7109594|NCT02484690|11241065|FG001|Overall Study|Physician Decision|0
7109595|NCT02484690|11241066|FG002|Overall Study|Physician Decision|1
7109596|NCT02484690|11241067|FG003|Overall Study|Physician Decision|0
7109597|NCT02484690|11241068|FG004|Overall Study|Physician Decision|0
7109598|NCT02484690|11241064|FG000|Overall Study|Lost to Follow-up|0
7109599|NCT02484690|11241065|FG001|Overall Study|Lost to Follow-up|0
7109600|NCT02484690|11241066|FG002|Overall Study|Lost to Follow-up|1
7109601|NCT02484690|11241067|FG003|Overall Study|Lost to Follow-up|0
7109602|NCT02484690|11241068|FG004|Overall Study|Lost to Follow-up|0
7109603|NCT02484729|11241091|FG000|Overall Study|Failure of IntelliCap Error|0
7109604|NCT02484729|11241092|FG001|Overall Study|Failure of IntelliCap Error|0
7109605|NCT02484729|11241093|FG002|Overall Study|Failure of IntelliCap Error|0
7109606|NCT02484729|11241094|FG003|Overall Study|Failure of IntelliCap Error|0
7109607|NCT02484729|11241095|FG004|Overall Study|Failure of IntelliCap Error|0
7109608|NCT02484729|11241096|FG005|Overall Study|Failure of IntelliCap Error|0
7109609|NCT02484729|11241097|FG006|Overall Study|Failure of IntelliCap Error|0
7109610|NCT02484729|11241098|FG007|Overall Study|Failure of IntelliCap Error|0
7109611|NCT02484729|11241099|FG008|Overall Study|Failure of IntelliCap Error|0
7109612|NCT02484729|11241100|FG009|Overall Study|Failure of IntelliCap Error|1
7109613|NCT02484911|11241177|FG000|Overall Study|Withdrawal by Subject|2
7109614|NCT02484911|11241178|FG001|Overall Study|Withdrawal by Subject|1
7109615|NCT02484911|11241177|FG000|Overall Study|Protocol Violation|2
7109616|NCT02484911|11241178|FG001|Overall Study|Protocol Violation|1
7109617|NCT02485158|11241185|FG000|Overall Study|Withdrawal by Subject|3
7109618|NCT02485158|11241185|FG000|Overall Study|expected drug side effect|1
7109619|NCT02485301|11241196|FG000|Overall Study|Serious Adverse Events|2
7109620|NCT02485301|11241197|FG001|Overall Study|Serious Adverse Events|1
7109621|NCT02485301|11241196|FG000|Overall Study|Protocol Violation|0
7109622|NCT02485301|11241197|FG001|Overall Study|Protocol Violation|1
7109623|NCT02485301|11241196|FG000|Overall Study|Withdrawal by Subject|6
7109624|NCT02485301|11241197|FG001|Overall Study|Withdrawal by Subject|7
7109625|NCT02485301|11241196|FG000|Overall Study|Migrated/moved from study area|10
7109626|NCT02485301|11241197|FG001|Overall Study|Migrated/moved from study area|19
7109627|NCT02485301|11241196|FG000|Overall Study|Lost to Follow-up|17
7109628|NCT02485301|11241197|FG001|Overall Study|Lost to Follow-up|17
7109629|NCT02485301|11241196|FG000|Overall Study|Other|3
7109630|NCT02485301|11241197|FG001|Overall Study|Other|4
7109631|NCT02485353|11241203|FG000|Overall Study|Death|1
7109632|NCT02485353|11241203|FG000|Overall Study|Disease Progression|1
7109633|NCT02485483|11241209|FG000|Overall Study|Depression at baseline|15
7109634|NCT02485483|11241210|FG001|Overall Study|Depression at baseline|0
7109635|NCT02485483|11241209|FG000|Overall Study|Discontinued after baseline|39
7109636|NCT02485483|11241210|FG001|Overall Study|Discontinued after baseline|0
7109637|NCT02485704|11241231|FG000|Overall Study|Lost to Follow-up|4
7109638|NCT02485704|11241232|FG001|Overall Study|Lost to Follow-up|5
7109639|NCT02485704|11241231|FG000|Overall Study|Withdrawal by Subject|0
7109640|NCT02485704|11241232|FG001|Overall Study|Withdrawal by Subject|3
7109641|NCT02485704|11241231|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1
7109642|NCT02485704|11241232|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0
7109643|NCT02485717|11241241|FG000|Overall Study|Lost to Follow-up|6
7109644|NCT02485717|11241242|FG001|Overall Study|Lost to Follow-up|0
7109645|NCT02485717|11241243|FG002|Overall Study|Lost to Follow-up|0
7109646|NCT02485717|11241241|FG000|Overall Study|Withdrawal by Subject|0
7109647|NCT02485717|11241242|FG001|Overall Study|Withdrawal by Subject|0
7109648|NCT02485717|11241243|FG002|Overall Study|Withdrawal by Subject|1
7109649|NCT02485717|11241241|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0
7109650|NCT02485717|11241242|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1
7109651|NCT02485717|11241243|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0
7109652|NCT02485717|11241241|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0
7109653|NCT02485717|11241242|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1
7109654|NCT02485717|11241243|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0
7109655|NCT02485925|11241266|FG000|Overall Study|Withdrawal by Subject|3
7109656|NCT02485925|11241266|FG000|Overall Study|Death|1
7109657|NCT02485925|11241266|FG000|Overall Study|Lost to Follow-up|11
7109658|NCT02486302|11241303|FG000|Overall Study|Discontinued prematurely|410
7109659|NCT02486302|11241303|FG000|Overall Study|Documentation not completed|255
7109660|NCT02486302|11241303|FG000|Overall Study|Excluded due to legal reasons|8
7109661|NCT02486302|11241303|FG000|Overall Study|Not treated|3
7109662|NCT02486406|11241329|FG000|Overall Study|Withdrew consent|1
7109663|NCT02486406|11241330|FG001|Overall Study|Withdrew consent|0
7109664|NCT02486406|11241331|FG002|Overall Study|Withdrew consent|0
7109665|NCT02486406|11241332|FG003|Overall Study|Withdrew consent|1
7109666|NCT02486406|11241329|FG000|Overall Study|Lost to Follow-up|1
7109667|NCT02486406|11241330|FG001|Overall Study|Lost to Follow-up|3
7109668|NCT02486406|11241331|FG002|Overall Study|Lost to Follow-up|1
7109669|NCT02486406|11241332|FG003|Overall Study|Lost to Follow-up|3
7109670|NCT02486406|11241329|FG000|Overall Study|Other, not specified|0
7109671|NCT02486406|11241330|FG001|Overall Study|Other, not specified|0
7109672|NCT02486406|11241331|FG002|Overall Study|Other, not specified|1
7109673|NCT02486406|11241332|FG003|Overall Study|Other, not specified|0
7109674|NCT02486588|11241370|FG000|Overall Study|Randomized in error- ineligible|738
7109675|NCT02486588|11241371|FG001|Overall Study|Randomized in error- ineligible|750
7109676|NCT02486588|11241372|FG002|Overall Study|Randomized in error- ineligible|755
7109677|NCT02486588|11241373|FG003|Overall Study|Randomized in error- ineligible|738
7109678|NCT02486588|11241374|FG004|Overall Study|Randomized in error- ineligible|746
7109679|NCT02486588|11241375|FG005|Overall Study|Randomized in error- ineligible|746
7109680|NCT02486627|11241396|FG000|Overall Study|Death|1
7109681|NCT02486627|11241397|FG001|Overall Study|Death|0
7109682|NCT02486627|11241396|FG000|Overall Study|Other Unspecified|0
7109683|NCT02486627|11241397|FG001|Overall Study|Other Unspecified|2
7109684|NCT02486627|11241396|FG000|Overall Study|Consent Withdrawn by Participant|4
7109685|NCT02486627|11241397|FG001|Overall Study|Consent Withdrawn by Participant|3
7109686|NCT02486627|11241396|FG000|Overall Study|Significant Participant Noncompliance|1
7109687|NCT02486627|11241397|FG001|Overall Study|Significant Participant Noncompliance|1
7109688|NCT02486627|11241396|FG000|Overall Study|Lost to Follow-up|1
7109689|NCT02486627|11241397|FG001|Overall Study|Lost to Follow-up|3
7109690|NCT02486653|11241405|FG000|Overall Study|Withdrawal by Subject|1
7109691|NCT02486653|11241406|FG001|Overall Study|Withdrawal by Subject|3
7109692|NCT02486653|11241405|FG000|Overall Study|Protocol Violation|1
7109693|NCT02486653|11241406|FG001|Overall Study|Protocol Violation|0
7109694|NCT02486653|11241405|FG000|Overall Study|surgery cancelled|4
7109695|NCT02486653|11241406|FG001|Overall Study|surgery cancelled|1
7109696|NCT02486692|11241414|FG000|Overall Study|did not login for randomization|4
7109697|NCT02486692|11241415|FG001|Overall Study|did not login for randomization|7
7109698|NCT02486757|11241421|FG000|Overall Study|Lost to Follow-up|1
7109699|NCT02486796|11241427|FG000|Overall Study|Withdrawal by Subject|1
7109700|NCT02486796|11241428|FG001|Overall Study|Withdrawal by Subject|1
7109701|NCT02486796|11241427|FG000|Overall Study|Physician Decision|1
7109702|NCT02486796|11241428|FG001|Overall Study|Physician Decision|0
7109703|NCT02486952|11241443|FG000|Overall Study|Not Started Induction Therapy|3
7109704|NCT02486952|11241443|FG000|Overall Study|Adverse Event|1
7109705|NCT02486952|11241443|FG000|Overall Study|Death|15
7109706|NCT02486952|11241443|FG000|Overall Study|Lack of Efficacy|3
7109707|NCT02486952|11241443|FG000|Overall Study|Lost to Follow-up|26
7109708|NCT02486952|11241443|FG000|Overall Study|Other|2
7109709|NCT02487030|11241454|FG000|Overall Study|Lack of Efficacy|2
7109710|NCT02487030|11241455|FG001|Overall Study|Lack of Efficacy|4
7109711|NCT02487030|11241456|FG002|Overall Study|Lack of Efficacy|1
7109712|NCT02487030|11241457|FG003|Overall Study|Lack of Efficacy|0
7109713|NCT02487030|11241458|FG004|Overall Study|Lack of Efficacy|1
7109714|NCT02487030|11241459|FG005|Overall Study|Lack of Efficacy|0
7109715|NCT02487030|11241460|FG006|Overall Study|Lack of Efficacy|0
7109716|NCT02487030|11241454|FG000|Overall Study|Lost to Follow-up|0
7109717|NCT02487030|11241455|FG001|Overall Study|Lost to Follow-up|0
7109718|NCT02487030|11241456|FG002|Overall Study|Lost to Follow-up|1
7109719|NCT02487030|11241457|FG003|Overall Study|Lost to Follow-up|1
7109720|NCT02487030|11241458|FG004|Overall Study|Lost to Follow-up|0
7109721|NCT02487030|11241459|FG005|Overall Study|Lost to Follow-up|1
7109722|NCT02487030|11241460|FG006|Overall Study|Lost to Follow-up|0
7109723|NCT02487030|11241454|FG000|Overall Study|Adverse Event|0
7109724|NCT02487030|11241455|FG001|Overall Study|Adverse Event|0
7109725|NCT02487030|11241456|FG002|Overall Study|Adverse Event|0
7109726|NCT02487030|11241457|FG003|Overall Study|Adverse Event|1
7109727|NCT02487030|11241458|FG004|Overall Study|Adverse Event|0
7109728|NCT02487030|11241459|FG005|Overall Study|Adverse Event|0
7109729|NCT02487030|11241460|FG006|Overall Study|Adverse Event|0
7109730|NCT02487030|11241454|FG000|Overall Study|Death|0
7109731|NCT02487030|11241455|FG001|Overall Study|Death|0
7109732|NCT02487030|11241456|FG002|Overall Study|Death|0
7109733|NCT02487030|11241457|FG003|Overall Study|Death|0
7109734|NCT02487030|11241458|FG004|Overall Study|Death|1
7109735|NCT02487030|11241459|FG005|Overall Study|Death|0
7109736|NCT02487030|11241460|FG006|Overall Study|Death|0
7109737|NCT02487199|11241484|FG000|Overall Study|Withdrew Consent|0
7109738|NCT02487199|11241485|FG001|Overall Study|Withdrew Consent|1
7109739|NCT02487446|11241516|FG000|Period 1|Physician Decision|0
7109740|NCT02487446|11241517|FG001|Period 1|Physician Decision|1
7109741|NCT02487446|11241516|FG000|Period 1|Lack of Efficacy|1
7109742|NCT02487446|11241517|FG001|Period 1|Lack of Efficacy|0
7109743|NCT02487446|11241516|FG000|Period 1|Protocol deviation|3
7109744|NCT02487446|11241517|FG001|Period 1|Protocol deviation|2
7109745|NCT02487446|11241516|FG000|Period 1|Lost to Follow-up|2
7109746|NCT02487446|11241517|FG001|Period 1|Lost to Follow-up|0
7109747|NCT02487446|11241516|FG000|Period 1|Withdrawal by Subject|2
7109748|NCT02487446|11241517|FG001|Period 1|Withdrawal by Subject|0
7109749|NCT02487446|11241516|FG000|Period 1|Adverse Event|5
7109750|NCT02487446|11241517|FG001|Period 1|Adverse Event|5
7109751|NCT02487446|11241516|FG000|Washout|Lost to Follow-up|0
7109752|NCT02487446|11241517|FG001|Washout|Lost to Follow-up|2
7109753|NCT02487446|11241516|FG000|Washout|Withdrawal by Subject|1
7109754|NCT02487446|11241517|FG001|Washout|Withdrawal by Subject|4
7109755|NCT02487446|11241516|FG000|Washout|Adverse Event|2
7109756|NCT02487446|11241517|FG001|Washout|Adverse Event|2
7109757|NCT02487446|11241516|FG000|Period 2|Protocol deviation|0
7109758|NCT02487446|11241517|FG001|Period 2|Protocol deviation|1
7109759|NCT02487446|11241516|FG000|Period 2|Lost to Follow-up|1
7109760|NCT02487446|11241517|FG001|Period 2|Lost to Follow-up|1
7109761|NCT02487446|11241516|FG000|Period 2|Withdrawal by Subject|1
7109762|NCT02487446|11241517|FG001|Period 2|Withdrawal by Subject|1
7109763|NCT02487446|11241516|FG000|Period 2|Adverse Event|6
7109764|NCT02487446|11241517|FG001|Period 2|Adverse Event|2
7109765|NCT02487472|11241524|FG000|Overall Study|Did not complete telephonic interviews|9
7109766|NCT02487472|11241524|FG000|Overall Study|Other|2
7109767|NCT02487498|11241539|FG000|Period: Period 1|Adverse Event|2
7109768|NCT02487498|11241540|FG001|Period: Period 1|Adverse Event|4
7109769|NCT02487498|11241539|FG000|Period: Period 1|Subject/guardian decision|2
7109770|NCT02487498|11241540|FG001|Period: Period 1|Subject/guardian decision|4
7109771|NCT02487498|11241539|FG000|Period: Period 1|Lost to Follow-up|0
7109772|NCT02487498|11241540|FG001|Period: Period 1|Lost to Follow-up|2
7109773|NCT02487498|11241539|FG000|Period: Period 1|Lack of Efficacy|1
7109774|NCT02487498|11241540|FG001|Period: Period 1|Lack of Efficacy|0
7109775|NCT02487498|11241539|FG000|Period: Period 1|Physician Decision|0
7109776|NCT02487498|11241540|FG001|Period: Period 1|Physician Decision|1
7109777|NCT02487498|11241539|FG000|Period: Period 1|Protocol deviation|1
7109778|NCT02487498|11241540|FG001|Period: Period 1|Protocol deviation|0
7109779|NCT02487498|11241539|FG000|Period: Washout|Subject/guardian decision|0
7109780|NCT02487498|11241540|FG001|Period: Washout|Subject/guardian decision|5
7109781|NCT02487498|11241539|FG000|Period: Washout|Lack of Efficacy|1
7109782|NCT02487498|11241540|FG001|Period: Washout|Lack of Efficacy|1
7109783|NCT02487498|11241539|FG000|Period: Washout|Physician Decision|1
7109784|NCT02487498|11241540|FG001|Period: Washout|Physician Decision|0
7109785|NCT02487498|11241539|FG000|Period: Washout|Non-compliance with study treatment|0
7109786|NCT02487498|11241540|FG001|Period: Washout|Non-compliance with study treatment|1
7109787|NCT02487498|11241539|FG000|Period: Period 2|Adverse Event|2
7109788|NCT02487498|11241540|FG001|Period: Period 2|Adverse Event|2
7109789|NCT02487498|11241539|FG000|Period: Period 2|Subject/guardian decision|2
7109790|NCT02487498|11241540|FG001|Period: Period 2|Subject/guardian decision|1
7109791|NCT02487498|11241539|FG000|Period: Period 2|Lost to Follow-up|1
7109792|NCT02487498|11241540|FG001|Period: Period 2|Lost to Follow-up|1
7109793|NCT02487498|11241539|FG000|Period: Period 2|Death|0
7109794|NCT02487498|11241540|FG001|Period: Period 2|Death|1
7109795|NCT02487498|11241539|FG000|Period: Period 2|Physician Decision|1
7109796|NCT02487498|11241540|FG001|Period: Period 2|Physician Decision|0
7109797|NCT02487771|11241565|FG000|Overall Study|Lost to Follow-up|2
7109798|NCT02487771|11241566|FG001|Overall Study|Lost to Follow-up|3
7109799|NCT02487771|11241565|FG000|Overall Study|Moved out of area|5
7109800|NCT02487771|11241566|FG001|Overall Study|Moved out of area|6
7109801|NCT02487771|11241565|FG000|Overall Study|Withdrawal by Subject|3
7109802|NCT02487771|11241566|FG001|Overall Study|Withdrawal by Subject|5
7109803|NCT02487810|11241574|FG000|Overall Study|Withdrawal by Subject|1
7109804|NCT02487810|11241575|FG001|Overall Study|Withdrawal by Subject|0
7109805|NCT02488005|11241598|FG000|Overall Study|Lost to Follow-up|2
7109806|NCT02488109|11241613|FG000|Treatment in Hospital|Withdrawal by Subject|0
7109807|NCT02488109|11241614|FG001|Treatment in Hospital|Withdrawal by Subject|5
7109808|NCT02488109|11241613|FG000|12-month Follow-Up|Lost to Follow-up|4
7109809|NCT02488109|11241614|FG001|12-month Follow-Up|Lost to Follow-up|7
7109810|NCT02488239|11241622|FG000|Overall Study|Death|3
7109811|NCT02488239|11241622|FG000|Overall Study|Withdrawal by Subject|3
7109812|NCT02488239|11241622|FG000|Overall Study|Physician Decision|2
7109813|NCT02488239|11241622|FG000|Overall Study|Consent ineligible|1
7109814|NCT02488239|11241622|FG000|Overall Study|Did not undergo implant procedure|1
7109815|NCT02488330|11241640|FG000|Overall Study|Adverse Event|1
7109816|NCT02488330|11241640|FG000|Overall Study|Physician Decision|2
7109817|NCT02488330|11241640|FG000|Overall Study|Death|2
7109818|NCT02488330|11241640|FG000|Overall Study|Disease Progression|3
7109819|NCT02488330|11241640|FG000|Overall Study|Study Termination by Sponsor|4
7109820|NCT02488681|11241644|FG000|Overall Study|Implant unsuccessful|7
7109821|NCT02488824|11241650|FG000|Overall Study|Adverse Event|1
7109822|NCT02488824|11241651|FG001|Overall Study|Adverse Event|1
7109823|NCT02488915|11241657|FG000|Overall Study|Death|21
7109824|NCT02488915|11241657|FG000|Overall Study|Lost to Follow-up|4
7109825|NCT02488915|11241657|FG000|Overall Study|Withdrawal by Subject|1
7109826|NCT02488980|11241664|FG000|Overall Study|Protocol Violation|2
7109827|NCT02488980|11241665|FG001|Overall Study|Protocol Violation|2
7109828|NCT02488980|11241666|FG002|Overall Study|Protocol Violation|2
7109829|NCT02489045|11241674|FG000|Overall Study|unable to collect usable data|53
7109830|NCT02489045|11241674|FG000|Follow-up|Lost to Follow-up|10
7109831|NCT02489279|11241708|FG000|Overall Study|Lost to Follow-up|12
7109832|NCT02489279|11241709|FG001|Overall Study|Lost to Follow-up|10
7109833|NCT02489344|11241715|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1
7109834|NCT02489344|11241715|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1
7109835|NCT02489344|11241715|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1
7109836|NCT02489344|11241715|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2
7109837|NCT02489500|11241725|FG000|Overall Study|Death|1
7109838|NCT02489500|11241726|FG001|Overall Study|Death|1
7109839|NCT02489630|11241734|FG000|Overall Study|Oversedation|1
7109840|NCT02489630|11241735|FG001|Overall Study|Oversedation|1
7109841|NCT02489630|11241734|FG000|Overall Study|Time to med. admin. > protocol limit|1
7109842|NCT02489630|11241735|FG001|Overall Study|Time to med. admin. > protocol limit|1
7109843|NCT02489773|11241752|FG000|Overall Study|Lost to Follow-up|4
7109844|NCT02489773|11241753|FG001|Overall Study|Lost to Follow-up|1
7109845|NCT02489773|11241752|FG000|Overall Study|Physician Decision|1
7109846|NCT02489773|11241753|FG001|Overall Study|Physician Decision|0
7109847|NCT02489773|11241752|FG000|Overall Study|Withdrawal by Subject|1
7109848|NCT02489773|11241753|FG001|Overall Study|Withdrawal by Subject|0
7109849|NCT02489773|11241752|FG000|Overall Study|Leave the country or the state|1
7109850|NCT02489773|11241753|FG001|Overall Study|Leave the country or the state|1
7109851|NCT02489799|11241761|FG000|Overall Study|Lost to Follow-up|4
7109852|NCT02489799|11241762|FG001|Overall Study|Lost to Follow-up|1
7109853|NCT02489799|11241761|FG000|Overall Study|Failure to Maintain Eligibility|4
7109854|NCT02489799|11241762|FG001|Overall Study|Failure to Maintain Eligibility|6
7109855|NCT02489799|11241761|FG000|Overall Study|Withdrawal by Subject|1
7109856|NCT02489799|11241762|FG001|Overall Study|Withdrawal by Subject|1
7109857|NCT02489799|11241761|FG000|Overall Study|Death|0
7109858|NCT02489799|11241762|FG001|Overall Study|Death|1
7109859|NCT02489968|11241770|FG000|Open-label Treatment Period|Adverse Event|14
7109860|NCT02489968|11241771|FG001|Open-label Treatment Period|Adverse Event|7
7109861|NCT02489968|11241772|FG002|Open-label Treatment Period|Adverse Event|0
7109862|NCT02489968|11241773|FG003|Open-label Treatment Period|Adverse Event|0
7109863|NCT02489968|11241774|FG004|Open-label Treatment Period|Adverse Event|0
7109864|NCT02489968|11241775|FG005|Open-label Treatment Period|Adverse Event|0
7109865|NCT02489968|11241770|FG000|Open-label Treatment Period|Protocol Violation|2
7109866|NCT02489968|11241771|FG001|Open-label Treatment Period|Protocol Violation|2
7109867|NCT02489968|11241772|FG002|Open-label Treatment Period|Protocol Violation|0
7109868|NCT02489968|11241773|FG003|Open-label Treatment Period|Protocol Violation|0
7109869|NCT02489968|11241774|FG004|Open-label Treatment Period|Protocol Violation|0
7109870|NCT02489968|11241775|FG005|Open-label Treatment Period|Protocol Violation|0
7109871|NCT02489968|11241770|FG000|Open-label Treatment Period|Lost to Follow-up|0
7109872|NCT02489968|11241771|FG001|Open-label Treatment Period|Lost to Follow-up|3
7109873|NCT02489968|11241772|FG002|Open-label Treatment Period|Lost to Follow-up|0
7109874|NCT02489968|11241773|FG003|Open-label Treatment Period|Lost to Follow-up|0
7109875|NCT02489968|11241774|FG004|Open-label Treatment Period|Lost to Follow-up|0
7109876|NCT02489968|11241775|FG005|Open-label Treatment Period|Lost to Follow-up|0
7109877|NCT02489968|11241770|FG000|Open-label Treatment Period|Withdrawal by Subject|4
7109878|NCT02489968|11241771|FG001|Open-label Treatment Period|Withdrawal by Subject|7
7109879|NCT02489968|11241772|FG002|Open-label Treatment Period|Withdrawal by Subject|0
7109880|NCT02489968|11241773|FG003|Open-label Treatment Period|Withdrawal by Subject|0
7109881|NCT02489968|11241774|FG004|Open-label Treatment Period|Withdrawal by Subject|0
7109882|NCT02489968|11241775|FG005|Open-label Treatment Period|Withdrawal by Subject|0
7109883|NCT02489968|11241770|FG000|Open-label Treatment Period|Other than specified above|204
7109884|NCT02489968|11241771|FG001|Open-label Treatment Period|Other than specified above|189
7109885|NCT02489968|11241772|FG002|Open-label Treatment Period|Other than specified above|0
7109886|NCT02489968|11241773|FG003|Open-label Treatment Period|Other than specified above|0
7109887|NCT02489968|11241774|FG004|Open-label Treatment Period|Other than specified above|0
7109888|NCT02489968|11241775|FG005|Open-label Treatment Period|Other than specified above|0
7109889|NCT02489968|11241770|FG000|Double-blind Treatment Period|Adverse Event|0
7109890|NCT02489968|11241771|FG001|Double-blind Treatment Period|Adverse Event|0
7109891|NCT02489968|11241772|FG002|Double-blind Treatment Period|Adverse Event|2
7109892|NCT02489968|11241773|FG003|Double-blind Treatment Period|Adverse Event|6
7109893|NCT02489968|11241774|FG004|Double-blind Treatment Period|Adverse Event|4
7109894|NCT02489968|11241775|FG005|Double-blind Treatment Period|Adverse Event|5
7109895|NCT02489968|11241770|FG000|Double-blind Treatment Period|Protocol Violation|0
7109896|NCT02489968|11241771|FG001|Double-blind Treatment Period|Protocol Violation|0
7109897|NCT02489968|11241772|FG002|Double-blind Treatment Period|Protocol Violation|0
7109898|NCT02489968|11241773|FG003|Double-blind Treatment Period|Protocol Violation|0
7109899|NCT02489968|11241774|FG004|Double-blind Treatment Period|Protocol Violation|1
7109900|NCT02489968|11241775|FG005|Double-blind Treatment Period|Protocol Violation|1
7109901|NCT02489968|11241770|FG000|Double-blind Treatment Period|Withdrawal by Subject|0
7109902|NCT02489968|11241771|FG001|Double-blind Treatment Period|Withdrawal by Subject|0
7109903|NCT02489968|11241772|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
7109904|NCT02489968|11241773|FG003|Double-blind Treatment Period|Withdrawal by Subject|2
7109905|NCT02489968|11241774|FG004|Double-blind Treatment Period|Withdrawal by Subject|0
7109906|NCT02489968|11241775|FG005|Double-blind Treatment Period|Withdrawal by Subject|2
7109907|NCT02489968|11241770|FG000|Double-blind Treatment Period|Other than specified above|0
7109908|NCT02489968|11241771|FG001|Double-blind Treatment Period|Other than specified above|0
7109909|NCT02489968|11241772|FG002|Double-blind Treatment Period|Other than specified above|0
7109910|NCT02489968|11241773|FG003|Double-blind Treatment Period|Other than specified above|0
7109911|NCT02489968|11241774|FG004|Double-blind Treatment Period|Other than specified above|1
7109912|NCT02489968|11241775|FG005|Double-blind Treatment Period|Other than specified above|0
7109913|NCT02489981|11241787|FG000|Overall Study|Adverse Event|21
7109914|NCT02489981|11241787|FG000|Overall Study|Insufficient effectiveness|16
7109915|NCT02489981|11241787|FG000|Overall Study|Improved|31
7109916|NCT02489981|11241787|FG000|Overall Study|Lost to Follow-up|31
7109917|NCT02489981|11241787|FG000|Overall Study|Other than listed|28
7109918|NCT02490371|11241802|FG000|Overall Study|Lost to Follow-up|1
7109919|NCT02490371|11241803|FG001|Overall Study|Lost to Follow-up|1
7109920|NCT02490475|11241813|FG000|Period 1: First 6 Cycles|Adverse Event|2
7109921|NCT02490475|11241814|FG001|Period 1: First 6 Cycles|Adverse Event|1
7109922|NCT02490475|11241815|FG002|Period 1: First 6 Cycles|Adverse Event|0
7109923|NCT02490475|11241816|FG003|Period 1: First 6 Cycles|Adverse Event|1
7109924|NCT02490475|11241813|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
7109925|NCT02490475|11241814|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0
7109926|NCT02490475|11241815|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
7109927|NCT02490475|11241816|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
7109928|NCT02490475|11241813|FG000|Period 1: First 6 Cycles|Refused Treatment|1
7109929|NCT02490475|11241814|FG001|Period 1: First 6 Cycles|Refused Treatment|0
7109930|NCT02490475|11241815|FG002|Period 1: First 6 Cycles|Refused Treatment|0
7109931|NCT02490475|11241816|FG003|Period 1: First 6 Cycles|Refused Treatment|0
7109932|NCT02490475|11241813|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
7109933|NCT02490475|11241814|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
7109934|NCT02490475|11241815|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4
7109935|NCT02490475|11241816|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2
7109936|NCT02490475|11241813|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1
7109937|NCT02490475|11241814|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0
7109938|NCT02490475|11241815|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2
7109939|NCT02490475|11241816|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0
7109940|NCT02490475|11241813|FG000|Period 2: Extension Phase|Refused Treatment|0
7109941|NCT02490475|11241814|FG001|Period 2: Extension Phase|Refused Treatment|0
7109942|NCT02490475|11241815|FG002|Period 2: Extension Phase|Refused Treatment|0
7109943|NCT02490475|11241816|FG003|Period 2: Extension Phase|Refused Treatment|1
7109944|NCT02490475|11241813|FG000|Period 2: Extension Phase|Adverse Event|0
7109945|NCT02490475|11241814|FG001|Period 2: Extension Phase|Adverse Event|0
7109946|NCT02490475|11241815|FG002|Period 2: Extension Phase|Adverse Event|1
7109947|NCT02490475|11241816|FG003|Period 2: Extension Phase|Adverse Event|0
7109948|NCT02490878|11241857|FG000|Overall Study|deemed ineligible|0
7109949|NCT02490878|11241858|FG001|Overall Study|deemed ineligible|1
7109950|NCT02490878|11241857|FG000|Overall Study|progression prior to treatment|0
7109951|NCT02490878|11241858|FG001|Overall Study|progression prior to treatment|1
7109952|NCT02490878|11241857|FG000|Overall Study|only submitted baseline QOL|0
7109953|NCT02490878|11241858|FG001|Overall Study|only submitted baseline QOL|1
7109954|NCT02491073|11241866|FG000|Overall Study|screen failure|1
7109955|NCT02491073|11241867|FG001|Overall Study|screen failure|0
7109956|NCT02491463|11241910|FG000|Overall Study|Withdrawal by Subject|1
7109957|NCT02491463|11241911|FG001|Overall Study|Withdrawal by Subject|2
7109958|NCT02491463|11241912|FG002|Overall Study|Withdrawal by Subject|0
7109959|NCT02491463|11241913|FG003|Overall Study|Withdrawal by Subject|0
7109960|NCT02491463|11241910|FG000|Overall Study|Migrated/moved from study area|1
7109961|NCT02491463|11241911|FG001|Overall Study|Migrated/moved from study area|5
7109962|NCT02491463|11241912|FG002|Overall Study|Migrated/moved from study area|1
7109963|NCT02491463|11241913|FG003|Overall Study|Migrated/moved from study area|1
7109964|NCT02491463|11241910|FG000|Overall Study|Lost to Follow-up|0
7109965|NCT02491463|11241911|FG001|Overall Study|Lost to Follow-up|3
7109966|NCT02491463|11241912|FG002|Overall Study|Lost to Follow-up|3
7109967|NCT02491463|11241913|FG003|Overall Study|Lost to Follow-up|0
7109968|NCT02491671|11241925|FG000|Overall Study|Adverse Event|6
7109969|NCT02491671|11241926|FG001|Overall Study|Adverse Event|8
7109970|NCT02491671|11241925|FG000|Overall Study|Death|0
7109971|NCT02491671|11241926|FG001|Overall Study|Death|2
7109972|NCT02491671|11241925|FG000|Overall Study|Use of sealants other than Hemopatch|5
7109973|NCT02491671|11241926|FG001|Overall Study|Use of sealants other than Hemopatch|3
7109974|NCT02491684|11241934|FG000|Treatment Phase|Adverse Event|2
7109975|NCT02491684|11241935|FG001|Treatment Phase|Adverse Event|2
7109976|NCT02491684|11241934|FG000|Treatment Phase|Incorrect randomisation|1
7109977|NCT02491684|11241935|FG001|Treatment Phase|Incorrect randomisation|0
7109978|NCT02491684|11241934|FG000|Treatment Phase|Investigator and Sponsor decision|0
7109979|NCT02491684|11241935|FG001|Treatment Phase|Investigator and Sponsor decision|1
7109980|NCT02491892|11241952|FG000|Overall Study|Adverse Event|1
7109981|NCT02491892|11241953|FG001|Overall Study|Adverse Event|1
7109982|NCT02491892|11241952|FG000|Overall Study|Death|1
7109983|NCT02491892|11241953|FG001|Overall Study|Death|1
7109984|NCT02491892|11241952|FG000|Overall Study|Lack of Efficacy|37
7109985|NCT02491892|11241953|FG001|Overall Study|Lack of Efficacy|36
7109986|NCT02491892|11241952|FG000|Overall Study|Refused Treatment|1
7109987|NCT02491892|11241953|FG001|Overall Study|Refused Treatment|0
7109988|NCT02491892|11241952|FG000|Overall Study|Lost to Follow-up|1
7109989|NCT02491892|11241953|FG001|Overall Study|Lost to Follow-up|0
7109990|NCT02492100|11241963|FG000|Overall Study|Death|1
7109991|NCT02492763|11241998|FG000|Overall Study|Withdrawal by Subject|0
7109992|NCT02492763|11241999|FG001|Overall Study|Withdrawal by Subject|2
7109993|NCT02492763|11242000|FG002|Overall Study|Withdrawal by Subject|1
7109994|NCT02492763|11242001|FG003|Overall Study|Withdrawal by Subject|0
7109995|NCT02492763|11241998|FG000|Overall Study|Adverse Event|3
7109996|NCT02492763|11241999|FG001|Overall Study|Adverse Event|1
7109997|NCT02492763|11242000|FG002|Overall Study|Adverse Event|1
7109998|NCT02492763|11242001|FG003|Overall Study|Adverse Event|2
7109999|NCT02492763|11241998|FG000|Overall Study|Death|0
7110000|NCT02492763|11241999|FG001|Overall Study|Death|0
7110001|NCT02492763|11242000|FG002|Overall Study|Death|1
7110002|NCT02492763|11242001|FG003|Overall Study|Death|0
7110003|NCT02492763|11241998|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0
7110004|NCT02492763|11241999|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1
7110005|NCT02492763|11242000|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0
7110006|NCT02492763|11242001|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0
7110007|NCT02492763|11241998|FG000|Overall Study|Lost to Follow-up|0
7110008|NCT02492763|11241999|FG001|Overall Study|Lost to Follow-up|0
7110009|NCT02492763|11242000|FG002|Overall Study|Lost to Follow-up|1
7110010|NCT02492763|11242001|FG003|Overall Study|Lost to Follow-up|0
7110011|NCT02492763|11241998|FG000|Overall Study|Non-Compliance With Study Drug|0
7110012|NCT02492763|11241999|FG001|Overall Study|Non-Compliance With Study Drug|1
7110013|NCT02492763|11242000|FG002|Overall Study|Non-Compliance With Study Drug|0
7110014|NCT02492763|11242001|FG003|Overall Study|Non-Compliance With Study Drug|0
7110015|NCT02492763|11241998|FG000|Overall Study|Screen Failure|0
7110016|NCT02492763|11241999|FG001|Overall Study|Screen Failure|0
7110017|NCT02492763|11242000|FG002|Overall Study|Screen Failure|0
7110018|NCT02492763|11242001|FG003|Overall Study|Screen Failure|1
7110019|NCT02492763|11241998|FG000|Overall Study|Study Terminated by Sponsor|13
7110020|NCT02492763|11241999|FG001|Overall Study|Study Terminated by Sponsor|10
7110021|NCT02492763|11242000|FG002|Overall Study|Study Terminated by Sponsor|6
7110022|NCT02492763|11242001|FG003|Overall Study|Study Terminated by Sponsor|10
7110023|NCT02492841|11242018|FG000|Overall Study|Lost to Follow-up|34
7110024|NCT02492841|11242019|FG001|Overall Study|Lost to Follow-up|31
7110025|NCT02492841|11242020|FG002|Overall Study|Lost to Follow-up|35
7110026|NCT02492880|11242040|FG000|Overall Study|Lost to Follow-up|1
7110027|NCT02492880|11242040|FG000|Overall Study|Protocol Violation|1
7110028|NCT02492958|11242048|FG000|Overall Study|Withdrawal by Subject|0
7110029|NCT02492958|11242049|FG001|Overall Study|Withdrawal by Subject|0
7110030|NCT02492958|11242050|FG002|Overall Study|Withdrawal by Subject|1
7110031|NCT02492958|11242051|FG003|Overall Study|Withdrawal by Subject|0
7110032|NCT02492958|11242048|FG000|Overall Study|Adverse Event|1
7110033|NCT02492958|11242049|FG001|Overall Study|Adverse Event|0
7110034|NCT02492958|11242050|FG002|Overall Study|Adverse Event|1
7110035|NCT02492958|11242051|FG003|Overall Study|Adverse Event|0
7110036|NCT02492984|11242063|FG000|Overall Study|Adverse Event|1
7110037|NCT02492984|11242064|FG001|Overall Study|Adverse Event|0
7110038|NCT02492984|11242063|FG000|Overall Study|Protocol Violation|1
7110039|NCT02492984|11242064|FG001|Overall Study|Protocol Violation|0
7110040|NCT02492984|11242063|FG000|Overall Study|Withdrawal by Subject|1
7110041|NCT02492984|11242064|FG001|Overall Study|Withdrawal by Subject|0
7110042|NCT02492997|11242075|FG000|Overall Study|Withdrawal by Subject|1
7110043|NCT02492997|11242076|FG001|Overall Study|Withdrawal by Subject|0
7110044|NCT02492997|11242075|FG000|Overall Study|Gained Weight|1
7110045|NCT02492997|11242076|FG001|Overall Study|Gained Weight|0
7110046|NCT02492997|11242075|FG000|Overall Study|Lost to Follow-up|0
7110047|NCT02492997|11242076|FG001|Overall Study|Lost to Follow-up|1
7110048|NCT02493062|11242095|FG000|Overall Study|Physician Decision|12
7110049|NCT02493127|11242105|FG000|Overall Study|Lost to Follow-up|1
7110050|NCT02493127|11242106|FG001|Overall Study|Lost to Follow-up|1
7110051|NCT02493361|11242123|FG000|Overall Study|Withdrawal by Subject|3
7110052|NCT02493517|11242142|FG000|Overall Study|Protocol Violation|1
7110053|NCT02493517|11242143|FG001|Overall Study|Protocol Violation|2
7110054|NCT02493517|11242142|FG000|Overall Study|Withdrawal by Subject|1
7110055|NCT02493517|11242143|FG001|Overall Study|Withdrawal by Subject|2
7110056|NCT02493517|11242142|FG000|Overall Study|Adverse Event|0
7110057|NCT02493517|11242143|FG001|Overall Study|Adverse Event|2
7110058|NCT02493517|11242142|FG000|Overall Study|Missed study visit|0
7110059|NCT02493517|11242143|FG001|Overall Study|Missed study visit|1
7110060|NCT02493712|11242172|FG000|Overall Study|Withdrawal by Subject|1
7110061|NCT02493712|11242173|FG001|Overall Study|Withdrawal by Subject|0
7110062|NCT02493712|11242174|FG002|Overall Study|Withdrawal by Subject|2
7110063|NCT02493712|11242172|FG000|Overall Study|Protocol Violation|0
7110064|NCT02493712|11242173|FG001|Overall Study|Protocol Violation|0
7110065|NCT02493712|11242174|FG002|Overall Study|Protocol Violation|1
7110066|NCT02493712|11242172|FG000|Overall Study|Lost to Follow-up|1
7110067|NCT02493712|11242173|FG001|Overall Study|Lost to Follow-up|0
7110068|NCT02493712|11242174|FG002|Overall Study|Lost to Follow-up|0
7110069|NCT02493712|11242172|FG000|Overall Study|Physician Decision|0
7110070|NCT02493712|11242173|FG001|Overall Study|Physician Decision|1
7110071|NCT02493712|11242174|FG002|Overall Study|Physician Decision|0
7110072|NCT02493712|11242172|FG000|Overall Study|Lack of Efficacy|0
7110073|NCT02493712|11242173|FG001|Overall Study|Lack of Efficacy|5
7110074|NCT02493712|11242174|FG002|Overall Study|Lack of Efficacy|3
7110075|NCT02493764|11242184|FG000|Overall Study|Adverse Event|2
7110076|NCT02493764|11242185|FG001|Overall Study|Adverse Event|2
7110077|NCT02493764|11242184|FG000|Overall Study|Death|44
7110078|NCT02493764|11242185|FG001|Overall Study|Death|58
7110079|NCT02493764|11242184|FG000|Overall Study|Lost to Follow-up|2
7110080|NCT02493764|11242185|FG001|Overall Study|Lost to Follow-up|1
7110081|NCT02493764|11242184|FG000|Overall Study|Protocol Violation|6
7110082|NCT02493764|11242185|FG001|Overall Study|Protocol Violation|7
7110083|NCT02493764|11242184|FG000|Overall Study|Physician Decision|1
7110084|NCT02493764|11242185|FG001|Overall Study|Physician Decision|1
7110085|NCT02493764|11242184|FG000|Overall Study|Participant moved|17
7110086|NCT02493764|11242185|FG001|Overall Study|Participant moved|5
7110087|NCT02493764|11242184|FG000|Overall Study|Withdrawal parent/guardian|0
7110088|NCT02493764|11242185|FG001|Overall Study|Withdrawal parent/guardian|1
7110089|NCT02493764|11242184|FG000|Overall Study|Withdrawal by Subject|11
7110090|NCT02493764|11242185|FG001|Overall Study|Withdrawal by Subject|7
7110091|NCT02493777|11242193|FG000|Overall Study|Lost to Follow-up|0
7110092|NCT02493777|11242194|FG001|Overall Study|Lost to Follow-up|1
7110093|NCT02493855|11242203|FG000|Overall Study|Non-compliance|1
7110094|NCT02493855|11242204|FG001|Overall Study|Non-compliance|0
7110095|NCT02493855|11242205|FG002|Overall Study|Non-compliance|0
7110096|NCT02493855|11242203|FG000|Overall Study|Adverse Event|0
7110097|NCT02493855|11242204|FG001|Overall Study|Adverse Event|1
7110098|NCT02493855|11242205|FG002|Overall Study|Adverse Event|0
7110099|NCT02493855|11242203|FG000|Overall Study|Withdrawal by Subject|1
7110100|NCT02493855|11242204|FG001|Overall Study|Withdrawal by Subject|0
7110101|NCT02493855|11242205|FG002|Overall Study|Withdrawal by Subject|0
7110102|NCT02493868|11242213|FG000|Induction Phase: DE Participants|Adverse Event|22
7110103|NCT02493868|11242214|FG001|Induction Phase: DE Participants|Adverse Event|0
7110104|NCT02493868|11242213|FG000|Induction Phase: DE Participants|Lost to Follow-up|1
7110105|NCT02493868|11242214|FG001|Induction Phase: DE Participants|Lost to Follow-up|0
7110106|NCT02493868|11242213|FG000|Induction Phase: DE Participants|Lack of Efficacy|2
7110107|NCT02493868|11242214|FG001|Induction Phase: DE Participants|Lack of Efficacy|0
7110108|NCT02493868|11242213|FG000|Induction Phase: DE Participants|Protocol Violation|2
7110109|NCT02493868|11242214|FG001|Induction Phase: DE Participants|Protocol Violation|0
7110110|NCT02493868|11242213|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15
7110111|NCT02493868|11242214|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0
7110112|NCT02493868|11242213|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114
7110113|NCT02493868|11242214|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0
7110114|NCT02493868|11242213|FG000|Induction Phase: DE Participants|Other|8
7110115|NCT02493868|11242214|FG001|Induction Phase: DE Participants|Other|0
7110116|NCT02493868|11242213|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5
7110117|NCT02493868|11242214|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0
7110118|NCT02493868|11242213|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2
7110119|NCT02493868|11242214|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1
7110120|NCT02493868|11242213|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8
7110121|NCT02493868|11242214|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0
7110122|NCT02493868|11242213|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4
7110123|NCT02493868|11242214|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1
7110124|NCT02493868|11242213|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8
7110125|NCT02493868|11242214|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3
7110126|NCT02493868|11242213|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14
7110127|NCT02493868|11242214|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5
7110128|NCT02493868|11242213|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107
7110129|NCT02493868|11242214|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20
7110130|NCT02493868|11242213|FG000|Optimization Phase: DE+TE Participants|Other|10
7110131|NCT02493868|11242214|FG001|Optimization Phase: DE+TE Participants|Other|2
7110132|NCT02493868|11242213|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1
7110133|NCT02493868|11242214|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4
7110134|NCT02493868|11242213|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1
7110135|NCT02493868|11242214|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0
7110136|NCT02493868|11242213|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1
7110137|NCT02493868|11242214|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1
7110138|NCT02493868|11242213|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5
7110139|NCT02493868|11242214|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7
7110140|NCT02493868|11242213|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1
7110141|NCT02493868|11242214|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0
7110142|NCT02493868|11242213|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0
7110143|NCT02493868|11242214|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1
7110144|NCT02493868|11242213|FG000|Maintenance Phase: DE+TE Participants|Other|4
7110145|NCT02493868|11242214|FG001|Maintenance Phase: DE+TE Participants|Other|9
7110146|NCT02493868|11242213|FG000|Follow-up Phase|Lost to Follow-up|1
7110147|NCT02493868|11242214|FG001|Follow-up Phase|Lost to Follow-up|0
7110148|NCT02493868|11242213|FG000|Follow-up Phase|Withdrawal by Subject|3
7110149|NCT02493868|11242214|FG001|Follow-up Phase|Withdrawal by Subject|0
7110150|NCT02493868|11242213|FG000|Follow-up Phase|Investigator Decision|5
7110151|NCT02493868|11242214|FG001|Follow-up Phase|Investigator Decision|1
7110152|NCT02493868|11242213|FG000|Follow-up Phase|Other|2
7110153|NCT02493868|11242214|FG001|Follow-up Phase|Other|1
7110154|NCT02493946|11242229|FG000|DB Period|Withdrawal by Subject|8
7110155|NCT02493946|11242230|FG001|DB Period|Withdrawal by Subject|5
7110156|NCT02493946|11242231|FG002|DB Period|Withdrawal by Subject|0
7110157|NCT02493946|11242229|FG000|Open Label Period|Withdrawal by Subject|0
7110158|NCT02493946|11242230|FG001|Open Label Period|Withdrawal by Subject|0
7110159|NCT02493946|11242231|FG002|Open Label Period|Withdrawal by Subject|74
7110160|NCT02493946|11242229|FG000|Open Label Period|Adverse Event|0
7110161|NCT02493946|11242230|FG001|Open Label Period|Adverse Event|0
7110162|NCT02493946|11242231|FG002|Open Label Period|Adverse Event|4
7110163|NCT02493946|11242229|FG000|Open Label Period|Lost to Follow-up|0
7110164|NCT02493946|11242230|FG001|Open Label Period|Lost to Follow-up|0
7110165|NCT02493946|11242231|FG002|Open Label Period|Lost to Follow-up|1
7110166|NCT02493946|11242229|FG000|Open Label Period|Investigator decision, non-compliance|0
7110167|NCT02493946|11242230|FG001|Open Label Period|Investigator decision, non-compliance|0
7110168|NCT02493946|11242231|FG002|Open Label Period|Investigator decision, non-compliance|2
7110169|NCT02493946|11242229|FG000|Open Label Period|Investigator decision, non-availability|0
7110170|NCT02493946|11242230|FG001|Open Label Period|Investigator decision, non-availability|0
7110171|NCT02493946|11242231|FG002|Open Label Period|Investigator decision, non-availability|1
7110172|NCT02493946|11242229|FG000|Open Label Period|Pregnancy|0
7110173|NCT02493946|11242230|FG001|Open Label Period|Pregnancy|0
7110174|NCT02493946|11242231|FG002|Open Label Period|Pregnancy|3
7110175|NCT02493946|11242229|FG000|Open Label Period|Site error|0
7110176|NCT02493946|11242230|FG001|Open Label Period|Site error|0
7110177|NCT02493946|11242231|FG002|Open Label Period|Site error|1
7110178|NCT02494401|11242285|FG000|Overall Study|Lost to Follow-up|22
7110179|NCT02494401|11242286|FG001|Overall Study|Lost to Follow-up|25
7110180|NCT02494401|11242285|FG000|Overall Study|Withdrawal by Subject|3
7110181|NCT02494401|11242286|FG001|Overall Study|Withdrawal by Subject|2
7110182|NCT02494583|11242312|FG000|Overall Study|Death|195
7110183|NCT02494583|11242313|FG001|Overall Study|Death|189
7110184|NCT02494583|11242314|FG002|Overall Study|Death|201
7110185|NCT02494583|11242312|FG000|Overall Study|Lost to Follow-up|1
7110186|NCT02494583|11242313|FG001|Overall Study|Lost to Follow-up|0
7110187|NCT02494583|11242314|FG002|Overall Study|Lost to Follow-up|0
7110188|NCT02494583|11242312|FG000|Overall Study|Protocol Violation|1
7110189|NCT02494583|11242313|FG001|Overall Study|Protocol Violation|2
7110190|NCT02494583|11242314|FG002|Overall Study|Protocol Violation|0
7110191|NCT02494583|11242312|FG000|Overall Study|Withdrawal by Subject|3
7110192|NCT02494583|11242313|FG001|Overall Study|Withdrawal by Subject|15
7110193|NCT02494583|11242314|FG002|Overall Study|Withdrawal by Subject|15
7110194|NCT02494583|11242312|FG000|Overall Study|Ongoing in Study|56
7110195|NCT02494583|11242313|FG001|Overall Study|Ongoing in Study|51
7110196|NCT02494583|11242314|FG002|Overall Study|Ongoing in Study|34
7110197|NCT02494596|11242322|FG000|Overall Study|Insufficient Therapeutic Response|3
7110198|NCT02494596|11242323|FG001|Overall Study|Insufficient Therapeutic Response|3
7110199|NCT02494596|11242324|FG002|Overall Study|Insufficient Therapeutic Response|1
7110200|NCT02494596|11242322|FG000|Overall Study|Adverse Event|0
7110201|NCT02494596|11242323|FG001|Overall Study|Adverse Event|1
7110202|NCT02494596|11242324|FG002|Overall Study|Adverse Event|0
7110203|NCT02494596|11242322|FG000|Overall Study|Refused Treatment|0
7110204|NCT02494596|11242323|FG001|Overall Study|Refused Treatment|1
7110205|NCT02494596|11242324|FG002|Overall Study|Refused Treatment|0
7110206|NCT02494778|11242339|FG000|Overall Study|Death|3
7110207|NCT02494778|11242339|FG000|Overall Study|Other|173
7110208|NCT02494778|11242339|FG000|Overall Study|Lack of Efficacy|4
7110209|NCT02494778|11242339|FG000|Overall Study|Adverse Event|18
7110210|NCT02494778|11242339|FG000|Overall Study|Withdrawal by Subject|20
7110211|NCT02494778|11242339|FG000|Overall Study|Lost to Follow-up|2
7110212|NCT02494778|11242339|FG000|Overall Study|Noncompliant with study drug admin.|1
7110213|NCT02495025|11242354|FG000|Overall Study|Lost to Follow-up|21
7110214|NCT02495025|11242355|FG001|Overall Study|Lost to Follow-up|14
7110215|NCT02495025|11242354|FG000|Overall Study|Withdrawal by Subject|5
7110216|NCT02495025|11242355|FG001|Overall Study|Withdrawal by Subject|0
7110217|NCT02495168|11242388|FG000|Overall Study|Other than Specified|18
7110218|NCT02495168|11242389|FG001|Overall Study|Other than Specified|22
7110219|NCT02495168|11242390|FG002|Overall Study|Other than Specified|5
7110220|NCT02495168|11242388|FG000|Overall Study|Did not Complete Final Visit On Time|4
7110221|NCT02495168|11242389|FG001|Overall Study|Did not Complete Final Visit On Time|3
7110222|NCT02495168|11242390|FG002|Overall Study|Did not Complete Final Visit On Time|2
7110223|NCT02495168|11242388|FG000|Overall Study|Physician Decision|1
7110224|NCT02495168|11242389|FG001|Overall Study|Physician Decision|1
7110225|NCT02495168|11242390|FG002|Overall Study|Physician Decision|0
7110226|NCT02495168|11242388|FG000|Overall Study|Lost to Follow-up|10
7110227|NCT02495168|11242389|FG001|Overall Study|Lost to Follow-up|6
7110228|NCT02495168|11242390|FG002|Overall Study|Lost to Follow-up|1
7110229|NCT02495168|11242388|FG000|Overall Study|Withdrawal by Subject|1
7110230|NCT02495168|11242389|FG001|Overall Study|Withdrawal by Subject|4
7110231|NCT02495168|11242390|FG002|Overall Study|Withdrawal by Subject|2
7110232|NCT02495168|11242388|FG000|Overall Study|Protocol Violation|0
7110233|NCT02495168|11242389|FG001|Overall Study|Protocol Violation|10
7110234|NCT02495168|11242390|FG002|Overall Study|Protocol Violation|1
7110235|NCT02495168|11242388|FG000|Overall Study|Adverse Event|4
7110236|NCT02495168|11242389|FG001|Overall Study|Adverse Event|8
7110237|NCT02495168|11242390|FG002|Overall Study|Adverse Event|3
7110238|NCT02495168|11242388|FG000|Overall Study|Lack of Efficacy|0
7110239|NCT02495168|11242389|FG001|Overall Study|Lack of Efficacy|0
7110240|NCT02495168|11242390|FG002|Overall Study|Lack of Efficacy|3
7110241|NCT02495233|11242400|FG000|Overall Study|Miscellaneous|0
7110242|NCT02495233|11242401|FG001|Overall Study|Miscellaneous|1
7110243|NCT02495389|11242420|FG000|Overall Study|Withdrawal by Subject|40
7110244|NCT02495844|11242464|FG000|Overall Study|Lack of Efficacy|1
7110245|NCT02495844|11242465|FG001|Overall Study|Lack of Efficacy|2
7110246|NCT02495844|11242464|FG000|Overall Study|AE, non-fatal|0
7110247|NCT02495844|11242465|FG001|Overall Study|AE, non-fatal|1
7110248|NCT02495844|11242464|FG000|Overall Study|Hepatitis Positivity|0
7110249|NCT02495844|11242465|FG001|Overall Study|Hepatitis Positivity|1
7110250|NCT02495857|11242476|FG000|Overall Study|Adverse Event|5
7110251|NCT02495857|11242477|FG001|Overall Study|Adverse Event|0
7110252|NCT02495857|11242478|FG002|Overall Study|Adverse Event|1
7110253|NCT02495857|11242476|FG000|Overall Study|Withdrawal by Subject|9
7110254|NCT02495857|11242477|FG001|Overall Study|Withdrawal by Subject|6
7110255|NCT02495857|11242478|FG002|Overall Study|Withdrawal by Subject|10
7110256|NCT02495857|11242476|FG000|Overall Study|Physician Decision|0
7110257|NCT02495857|11242477|FG001|Overall Study|Physician Decision|1
7110258|NCT02495857|11242478|FG002|Overall Study|Physician Decision|0
7110259|NCT02495857|11242476|FG000|Overall Study|Protocol Violation|1
7110260|NCT02495857|11242477|FG001|Overall Study|Protocol Violation|1
7110261|NCT02495857|11242478|FG002|Overall Study|Protocol Violation|2
7110262|NCT02495857|11242476|FG000|Overall Study|Lost to Follow-up|4
7110263|NCT02495857|11242477|FG001|Overall Study|Lost to Follow-up|5
7110264|NCT02495857|11242478|FG002|Overall Study|Lost to Follow-up|3
7110265|NCT02495857|11242476|FG000|Overall Study|Other|3
7110266|NCT02495857|11242477|FG001|Overall Study|Other|3
7110267|NCT02495857|11242478|FG002|Overall Study|Other|2
7110268|NCT02495883|11242488|FG000|Overall Study|Excessive head motion|1
7110269|NCT02495883|11242489|FG001|Overall Study|Excessive head motion|0
7110270|NCT02495948|11242494|FG000|Period 1, First 30 Days of Wear|Adverse Event|0
7110271|NCT02495948|11242495|FG001|Period 1, First 30 Days of Wear|Adverse Event|1
7110272|NCT02495948|11242494|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
7110273|NCT02495948|11242495|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
7110274|NCT02496000|11242505|FG000|Overall Study|Withdrawal by Subject|1
7110275|NCT02496000|11242506|FG001|Overall Study|Withdrawal by Subject|2
7110276|NCT02496000|11242507|FG002|Overall Study|Withdrawal by Subject|0
7110277|NCT02496000|11242505|FG000|Overall Study|Lost to Follow-up|1
7110278|NCT02496000|11242506|FG001|Overall Study|Lost to Follow-up|0
7110279|NCT02496000|11242507|FG002|Overall Study|Lost to Follow-up|1
7110280|NCT02496000|11242505|FG000|Overall Study|Protocol Violation|0
7110281|NCT02496000|11242506|FG001|Overall Study|Protocol Violation|0
7110282|NCT02496000|11242507|FG002|Overall Study|Protocol Violation|1
7110283|NCT02496000|11242505|FG000|Overall Study|Non-compliance or lack of cooperation|0
7110284|NCT02496000|11242506|FG001|Overall Study|Non-compliance or lack of cooperation|2
7110285|NCT02496000|11242507|FG002|Overall Study|Non-compliance or lack of cooperation|0
7110286|NCT02496000|11242505|FG000|Overall Study|undetermined|0
7110287|NCT02496000|11242506|FG001|Overall Study|undetermined|1
7110288|NCT02496000|11242507|FG002|Overall Study|undetermined|0
7110289|NCT02496091|11242516|FG000|Overall Study|Eligibility criteria not fulfilled|2
7110290|NCT02496221|11242521|FG000|Treatment Period 2 - 4 Days|Adverse Event|0
7110291|NCT02496221|11242522|FG001|Treatment Period 2 - 4 Days|Adverse Event|1
7110292|NCT02496221|11242521|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1
7110293|NCT02496221|11242522|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0
7110294|NCT02496221|11242521|FG000|Treatment Period 2 - 4 Days|Physician Decision|1
7110295|NCT02496221|11242522|FG001|Treatment Period 2 - 4 Days|Physician Decision|0
7110296|NCT02496533|11242532|FG000|Overall Study|Lack of data on outcome|3
7110297|NCT02496533|11242533|FG001|Overall Study|Lack of data on outcome|0
7110298|NCT02496533|11242532|FG000|Overall Study|Patient did not complete all measures|0
7110299|NCT02496533|11242533|FG001|Overall Study|Patient did not complete all measures|4
7110300|NCT02496533|11242532|FG000|Overall Study|Late for radiologic testing|0
7110301|NCT02496533|11242533|FG001|Overall Study|Late for radiologic testing|2
7110302|NCT02496702|11242541|FG000|Overall Study|Lost to Follow-up|8
7110303|NCT02496702|11242542|FG001|Overall Study|Lost to Follow-up|6
7110304|NCT02496702|11242541|FG000|Overall Study|Only partially tested|0
7110305|NCT02496702|11242542|FG001|Overall Study|Only partially tested|2
7110306|NCT02496767|11242552|FG000|Open-label Lead-in Phase|Adverse Event|176
7110307|NCT02496767|11242553|FG001|Open-label Lead-in Phase|Adverse Event|0
7110308|NCT02496767|11242554|FG002|Open-label Lead-in Phase|Adverse Event|0
7110309|NCT02496767|11242555|FG003|Open-label Lead-in Phase|Adverse Event|0
7110310|NCT02496767|11242556|FG004|Open-label Lead-in Phase|Adverse Event|0
7110311|NCT02496767|11242557|FG005|Open-label Lead-in Phase|Adverse Event|0
7110312|NCT02496767|11242558|FG006|Open-label Lead-in Phase|Adverse Event|0
7110313|NCT02496767|11242559|FG007|Open-label Lead-in Phase|Adverse Event|0
7110314|NCT02496767|11242552|FG000|Open-label Lead-in Phase|Protocol Violation|2
7110315|NCT02496767|11242553|FG001|Open-label Lead-in Phase|Protocol Violation|0
7110316|NCT02496767|11242554|FG002|Open-label Lead-in Phase|Protocol Violation|0
7110317|NCT02496767|11242555|FG003|Open-label Lead-in Phase|Protocol Violation|0
7110318|NCT02496767|11242556|FG004|Open-label Lead-in Phase|Protocol Violation|0
7110319|NCT02496767|11242557|FG005|Open-label Lead-in Phase|Protocol Violation|0
7110320|NCT02496767|11242558|FG006|Open-label Lead-in Phase|Protocol Violation|0
7110321|NCT02496767|11242559|FG007|Open-label Lead-in Phase|Protocol Violation|0
7110322|NCT02496767|11242552|FG000|Open-label Lead-in Phase|Lost to Follow-up|1
7110323|NCT02496767|11242553|FG001|Open-label Lead-in Phase|Lost to Follow-up|0
7110324|NCT02496767|11242554|FG002|Open-label Lead-in Phase|Lost to Follow-up|0
7110325|NCT02496767|11242555|FG003|Open-label Lead-in Phase|Lost to Follow-up|0
7110326|NCT02496767|11242556|FG004|Open-label Lead-in Phase|Lost to Follow-up|0
7110327|NCT02496767|11242557|FG005|Open-label Lead-in Phase|Lost to Follow-up|0
7110328|NCT02496767|11242558|FG006|Open-label Lead-in Phase|Lost to Follow-up|0
7110329|NCT02496767|11242559|FG007|Open-label Lead-in Phase|Lost to Follow-up|0
7110330|NCT02496767|11242552|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0
7110331|NCT02496767|11242553|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13
7110332|NCT02496767|11242554|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23
7110333|NCT02496767|11242555|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43
7110334|NCT02496767|11242556|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43
7110335|NCT02496767|11242557|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0
7110336|NCT02496767|11242558|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0
7110337|NCT02496767|11242559|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0
7110338|NCT02496767|11242552|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0
7110339|NCT02496767|11242553|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13
7110340|NCT02496767|11242554|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9
7110341|NCT02496767|11242555|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8
7110342|NCT02496767|11242556|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14
7110343|NCT02496767|11242557|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0
7110344|NCT02496767|11242558|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0
7110345|NCT02496767|11242559|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0
7110346|NCT02496767|11242552|FG000|Double-blind, Placebo-controlled Phase|Death|0
7110347|NCT02496767|11242553|FG001|Double-blind, Placebo-controlled Phase|Death|10
7110348|NCT02496767|11242554|FG002|Double-blind, Placebo-controlled Phase|Death|6
7110349|NCT02496767|11242555|FG003|Double-blind, Placebo-controlled Phase|Death|2
7110350|NCT02496767|11242556|FG004|Double-blind, Placebo-controlled Phase|Death|4
7110351|NCT02496767|11242557|FG005|Double-blind, Placebo-controlled Phase|Death|0
7110352|NCT02496767|11242558|FG006|Double-blind, Placebo-controlled Phase|Death|0
7110353|NCT02496767|11242559|FG007|Double-blind, Placebo-controlled Phase|Death|0
7110354|NCT02496767|11242552|FG000|Double-blind, Placebo-controlled Phase|Various|0
7110355|NCT02496767|11242553|FG001|Double-blind, Placebo-controlled Phase|Various|9
7110356|NCT02496767|11242554|FG002|Double-blind, Placebo-controlled Phase|Various|4
7110357|NCT02496767|11242555|FG003|Double-blind, Placebo-controlled Phase|Various|5
7110358|NCT02496767|11242556|FG004|Double-blind, Placebo-controlled Phase|Various|2
7110359|NCT02496767|11242557|FG005|Double-blind, Placebo-controlled Phase|Various|0
7110360|NCT02496767|11242558|FG006|Double-blind, Placebo-controlled Phase|Various|0
7110361|NCT02496767|11242559|FG007|Double-blind, Placebo-controlled Phase|Various|0
7110362|NCT02496767|11242552|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
7110363|NCT02496767|11242553|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4
7110364|NCT02496767|11242554|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3
7110365|NCT02496767|11242555|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1
7110366|NCT02496767|11242556|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2
7110367|NCT02496767|11242557|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
7110368|NCT02496767|11242558|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
7110369|NCT02496767|11242559|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
7110370|NCT02496767|11242552|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0
7110371|NCT02496767|11242553|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4
7110372|NCT02496767|11242554|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1
7110373|NCT02496767|11242555|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0
7110374|NCT02496767|11242556|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0
7110375|NCT02496767|11242557|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0
7110376|NCT02496767|11242558|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0
7110377|NCT02496767|11242559|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0
7110378|NCT02496767|11242552|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7110379|NCT02496767|11242553|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2
7110380|NCT02496767|11242554|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7110381|NCT02496767|11242555|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2
7110382|NCT02496767|11242556|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1
7110383|NCT02496767|11242557|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7110384|NCT02496767|11242558|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7110385|NCT02496767|11242559|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7110386|NCT02496767|11242552|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0
7110387|NCT02496767|11242553|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1
7110388|NCT02496767|11242554|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0
7110389|NCT02496767|11242555|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0
7110390|NCT02496767|11242556|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0
7110391|NCT02496767|11242557|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0
7110392|NCT02496767|11242558|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0
7110393|NCT02496767|11242559|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0
7110394|NCT02496767|11242552|FG000|Double-blind, Withdrawal Phase|Progressive disease|0
7110395|NCT02496767|11242553|FG001|Double-blind, Withdrawal Phase|Progressive disease|0
7110396|NCT02496767|11242554|FG002|Double-blind, Withdrawal Phase|Progressive disease|0
7110397|NCT02496767|11242555|FG003|Double-blind, Withdrawal Phase|Progressive disease|0
7110398|NCT02496767|11242556|FG004|Double-blind, Withdrawal Phase|Progressive disease|0
7110399|NCT02496767|11242557|FG005|Double-blind, Withdrawal Phase|Progressive disease|4
7110400|NCT02496767|11242558|FG006|Double-blind, Withdrawal Phase|Progressive disease|0
7110401|NCT02496767|11242559|FG007|Double-blind, Withdrawal Phase|Progressive disease|1
7110402|NCT02496767|11242552|FG000|Double-blind, Withdrawal Phase|Adverse Event|0
7110403|NCT02496767|11242553|FG001|Double-blind, Withdrawal Phase|Adverse Event|0
7110404|NCT02496767|11242554|FG002|Double-blind, Withdrawal Phase|Adverse Event|0
7110405|NCT02496767|11242555|FG003|Double-blind, Withdrawal Phase|Adverse Event|0
7110406|NCT02496767|11242556|FG004|Double-blind, Withdrawal Phase|Adverse Event|0
7110407|NCT02496767|11242557|FG005|Double-blind, Withdrawal Phase|Adverse Event|1
7110408|NCT02496767|11242558|FG006|Double-blind, Withdrawal Phase|Adverse Event|2
7110409|NCT02496767|11242559|FG007|Double-blind, Withdrawal Phase|Adverse Event|1
7110410|NCT02496767|11242552|FG000|Double-blind, Withdrawal Phase|Death|0
7110411|NCT02496767|11242553|FG001|Double-blind, Withdrawal Phase|Death|0
7110412|NCT02496767|11242554|FG002|Double-blind, Withdrawal Phase|Death|0
7110413|NCT02496767|11242555|FG003|Double-blind, Withdrawal Phase|Death|0
7110414|NCT02496767|11242556|FG004|Double-blind, Withdrawal Phase|Death|0
7110415|NCT02496767|11242557|FG005|Double-blind, Withdrawal Phase|Death|0
7110416|NCT02496767|11242558|FG006|Double-blind, Withdrawal Phase|Death|1
7110417|NCT02496767|11242559|FG007|Double-blind, Withdrawal Phase|Death|2
7110418|NCT02496767|11242552|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
7110419|NCT02496767|11242553|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
7110420|NCT02496767|11242554|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
7110421|NCT02496767|11242555|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
7110422|NCT02496767|11242556|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
7110423|NCT02496767|11242557|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1
7110424|NCT02496767|11242558|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1
7110425|NCT02496767|11242559|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1
7110426|NCT02496884|11242577|FG000|Overall Study|Counted twice as enrolled|2
7110427|NCT02496884|11242578|FG001|Overall Study|Counted twice as enrolled|0
7110428|NCT02496884|11242579|FG002|Overall Study|Counted twice as enrolled|0
7110429|NCT02496884|11242580|FG003|Overall Study|Counted twice as enrolled|0
7110430|NCT02496884|11242577|FG000|Overall Study|Withdrawal by Subject|0
7110431|NCT02496884|11242578|FG001|Overall Study|Withdrawal by Subject|3
7110432|NCT02496884|11242579|FG002|Overall Study|Withdrawal by Subject|0
7110433|NCT02496884|11242580|FG003|Overall Study|Withdrawal by Subject|0
7110434|NCT02497001|11242594|FG000|Overall Study|Lost to Follow-up|10
7110435|NCT02497001|11242595|FG001|Overall Study|Lost to Follow-up|2
7110436|NCT02497001|11242596|FG002|Overall Study|Lost to Follow-up|0
7110437|NCT02497001|11242597|FG003|Overall Study|Lost to Follow-up|2
7110438|NCT02497001|11242594|FG000|Overall Study|Adverse Event|28
7110439|NCT02497001|11242595|FG001|Overall Study|Adverse Event|30
7110440|NCT02497001|11242596|FG002|Overall Study|Adverse Event|11
7110441|NCT02497001|11242597|FG003|Overall Study|Adverse Event|11
7110442|NCT02497001|11242594|FG000|Overall Study|Withdrawal by Subject|14
7110443|NCT02497001|11242595|FG001|Overall Study|Withdrawal by Subject|37
7110444|NCT02497001|11242596|FG002|Overall Study|Withdrawal by Subject|19
7110445|NCT02497001|11242597|FG003|Overall Study|Withdrawal by Subject|15
7110446|NCT02497001|11242594|FG000|Overall Study|Physician Decision|5
7110447|NCT02497001|11242595|FG001|Overall Study|Physician Decision|11
7110448|NCT02497001|11242596|FG002|Overall Study|Physician Decision|5
7110449|NCT02497001|11242597|FG003|Overall Study|Physician Decision|1
7110450|NCT02497001|11242594|FG000|Overall Study|subjects that were not treated|1
7110451|NCT02497001|11242595|FG001|Overall Study|subjects that were not treated|2
7110452|NCT02497001|11242596|FG002|Overall Study|subjects that were not treated|2
7110453|NCT02497001|11242597|FG003|Overall Study|subjects that were not treated|1
7110454|NCT02497001|11242594|FG000|Overall Study|Major Protocol Deviation|3
7110455|NCT02497001|11242595|FG001|Overall Study|Major Protocol Deviation|4
7110456|NCT02497001|11242596|FG002|Overall Study|Major Protocol Deviation|4
7110457|NCT02497001|11242597|FG003|Overall Study|Major Protocol Deviation|4
7110458|NCT02497001|11242594|FG000|Overall Study|Lack of Efficacy|10
7110459|NCT02497001|11242595|FG001|Overall Study|Lack of Efficacy|16
7110460|NCT02497001|11242596|FG002|Overall Study|Lack of Efficacy|6
7110461|NCT02497001|11242597|FG003|Overall Study|Lack of Efficacy|6
7110462|NCT02497001|11242594|FG000|Overall Study|Protocol Violation|3
7110463|NCT02497001|11242595|FG001|Overall Study|Protocol Violation|1
7110464|NCT02497001|11242596|FG002|Overall Study|Protocol Violation|3
7110465|NCT02497001|11242597|FG003|Overall Study|Protocol Violation|1
7110466|NCT02497287|11242647|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84
7110467|NCT02497287|11242647|FG000|Induction Phase (4 Weeks)|Adverse Event|52
7110468|NCT02497287|11242647|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22
7110469|NCT02497287|11242647|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21
7110470|NCT02497287|11242647|FG000|Induction Phase (4 Weeks)|Other|13
7110471|NCT02497287|11242647|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5
7110472|NCT02497287|11242647|FG000|Induction Phase (4 Weeks)|Protocol Violation|1
7110473|NCT02497287|11242647|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1
7110474|NCT02497287|11242647|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331
7110475|NCT02497287|11242647|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30
7110476|NCT02497287|11242647|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25
7110477|NCT02497287|11242647|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25
7110478|NCT02497287|11242647|FG000|Optimization/Maintenance (48 Weeks)|Other|21
7110479|NCT02497287|11242647|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10
7110480|NCT02497287|11242647|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3
7110481|NCT02497287|11242647|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3
7110482|NCT02497287|11242647|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2
7110483|NCT02497287|11242647|FG000|Optimization/Maintenance (48 Weeks)|Death|2
7110484|NCT02497287|11242647|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1
7110485|NCT02497287|11242647|FG000|Follow-up Phase (4 Week)|PI Decision|12
7110486|NCT02497287|11242647|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10
7110487|NCT02497287|11242647|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5
7110488|NCT02497287|11242647|FG000|Follow-up Phase (4 Week)|Adverse Event|3
7110489|NCT02497287|11242647|FG000|Follow-up Phase (4 Week)|Other|1
7110490|NCT02497391|11242653|FG000|Period 2 (14 Days)|Withdrawal by Subject|1
7110491|NCT02497391|11242654|FG001|Period 2 (14 Days)|Withdrawal by Subject|0
7110492|NCT02497391|11242655|FG002|Period 2 (14 Days)|Withdrawal by Subject|1
7110493|NCT02497391|11242656|FG003|Period 2 (14 Days)|Withdrawal by Subject|0
7110494|NCT02497391|11242657|FG004|Period 2 (14 Days)|Withdrawal by Subject|0
7110495|NCT02497391|11242658|FG005|Period 2 (14 Days)|Withdrawal by Subject|0
7110496|NCT02497391|11242653|FG000|Period 2 (14 Days)|Sponsor Decision|3
7110497|NCT02497391|11242654|FG001|Period 2 (14 Days)|Sponsor Decision|1
7110498|NCT02497391|11242655|FG002|Period 2 (14 Days)|Sponsor Decision|2
7110499|NCT02497391|11242656|FG003|Period 2 (14 Days)|Sponsor Decision|3
7110500|NCT02497391|11242657|FG004|Period 2 (14 Days)|Sponsor Decision|2
7110501|NCT02497391|11242658|FG005|Period 2 (14 Days)|Sponsor Decision|3
7110502|NCT02497391|11242653|FG000|Period 3 (14 Days)|Adverse Event|0
7110503|NCT02497391|11242654|FG001|Period 3 (14 Days)|Adverse Event|1
7110504|NCT02497391|11242655|FG002|Period 3 (14 Days)|Adverse Event|0
7110505|NCT02497391|11242656|FG003|Period 3 (14 Days)|Adverse Event|0
7110506|NCT02497391|11242657|FG004|Period 3 (14 Days)|Adverse Event|0
7110507|NCT02497391|11242658|FG005|Period 3 (14 Days)|Adverse Event|0
7110508|NCT02497391|11242653|FG000|Period 3 (14 Days)|Sponsor Decision|0
7110509|NCT02497391|11242654|FG001|Period 3 (14 Days)|Sponsor Decision|0
7110510|NCT02497391|11242655|FG002|Period 3 (14 Days)|Sponsor Decision|0
7110511|NCT02497391|11242656|FG003|Period 3 (14 Days)|Sponsor Decision|0
7110512|NCT02497391|11242657|FG004|Period 3 (14 Days)|Sponsor Decision|1
7110513|NCT02497391|11242658|FG005|Period 3 (14 Days)|Sponsor Decision|0
7110514|NCT02497391|11242653|FG000|Period 3 (14 Days)|Withdrawal by Subject|0
7110515|NCT02497391|11242654|FG001|Period 3 (14 Days)|Withdrawal by Subject|0
7110516|NCT02497391|11242655|FG002|Period 3 (14 Days)|Withdrawal by Subject|1
7110517|NCT02497391|11242656|FG003|Period 3 (14 Days)|Withdrawal by Subject|0
7110518|NCT02497391|11242657|FG004|Period 3 (14 Days)|Withdrawal by Subject|0
7110519|NCT02497391|11242658|FG005|Period 3 (14 Days)|Withdrawal by Subject|0
7110520|NCT02497404|11242666|FG000|Overall Study|Adverse Event|1
7110521|NCT02497469|11242672|FG000|Overall Study|Randomized but not Treated|0
7110522|NCT02497469|11242673|FG001|Overall Study|Randomized but not Treated|2
7110523|NCT02497469|11242672|FG000|Overall Study|Pretreatment Event/Adverse Event|18
7110524|NCT02497469|11242673|FG001|Overall Study|Pretreatment Event/Adverse Event|16
7110525|NCT02497469|11242672|FG000|Overall Study|Leukopenia or Lymphopenia|1
7110526|NCT02497469|11242673|FG001|Overall Study|Leukopenia or Lymphopenia|0
7110527|NCT02497469|11242672|FG000|Overall Study|Significant Protocol Deviation|4
7110528|NCT02497469|11242673|FG001|Overall Study|Significant Protocol Deviation|5
7110529|NCT02497469|11242672|FG000|Overall Study|Lost to Follow-up|14
7110530|NCT02497469|11242673|FG001|Overall Study|Lost to Follow-up|4
7110531|NCT02497469|11242672|FG000|Overall Study|Voluntary Withdrawal|39
7110532|NCT02497469|11242673|FG001|Overall Study|Voluntary Withdrawal|41
7110533|NCT02497469|11242672|FG000|Overall Study|Pregnancy|1
7110534|NCT02497469|11242673|FG001|Overall Study|Pregnancy|1
7110535|NCT02497469|11242672|FG000|Overall Study|Lack of Efficacy|86
7110536|NCT02497469|11242673|FG001|Overall Study|Lack of Efficacy|40
7110537|NCT02497469|11242672|FG000|Overall Study|Reason not Specified|6
7110538|NCT02497469|11242673|FG001|Overall Study|Reason not Specified|6
7110539|NCT02497755|11242681|FG000|Overall Study|Protocol Violation|1
7110540|NCT02497755|11242682|FG001|Overall Study|Protocol Violation|0
7110541|NCT02497781|11242691|FG000|Overall Study|Withdrawal by Subject|2
7110542|NCT02497781|11242692|FG001|Overall Study|Withdrawal by Subject|0
7110543|NCT02497781|11242691|FG000|Overall Study|Lack of Efficacy|0
7110544|NCT02497781|11242692|FG001|Overall Study|Lack of Efficacy|1
7110545|NCT02497781|11242691|FG000|Overall Study|Randomised but not treated|1
7110546|NCT02497781|11242692|FG001|Overall Study|Randomised but not treated|1
7110547|NCT02497781|11242691|FG000|Overall Study|Lost to Follow-up|1
7110548|NCT02497781|11242692|FG001|Overall Study|Lost to Follow-up|1
7110549|NCT02497976|11242708|FG000|Overall Study|Withdrawal by Subject|2
7110550|NCT02497976|11242709|FG001|Overall Study|Withdrawal by Subject|0
7110551|NCT02497976|11242708|FG000|Overall Study|Moved out of area|0
7110552|NCT02497976|11242709|FG001|Overall Study|Moved out of area|1
7110553|NCT02498067|11242715|FG000|Overall Study|Lost to Follow-up|22
7110554|NCT02498067|11242715|FG000|Overall Study|Did not meet inclusion criteria|11
7110555|NCT02498236|11242729|FG000|Overall Study|Did not show for testing|1
7110556|NCT02498236|11242730|FG001|Overall Study|Did not show for testing|0
7110557|NCT02498236|11242731|FG002|Overall Study|Did not show for testing|0
7110558|NCT02498236|11242732|FG003|Overall Study|Did not show for testing|0
7110559|NCT02498236|11242733|FG004|Overall Study|Did not show for testing|0
7110560|NCT02498236|11242734|FG005|Overall Study|Did not show for testing|0
7110561|NCT02498236|11242735|FG006|Overall Study|Did not show for testing|0
7110562|NCT02498236|11242736|FG007|Overall Study|Did not show for testing|1
7110563|NCT02498236|11242729|FG000|Overall Study|Equipment failure|0
7110564|NCT02498236|11242730|FG001|Overall Study|Equipment failure|0
7110565|NCT02498236|11242731|FG002|Overall Study|Equipment failure|0
7110566|NCT02498236|11242732|FG003|Overall Study|Equipment failure|0
7110567|NCT02498236|11242733|FG004|Overall Study|Equipment failure|0
7110568|NCT02498236|11242734|FG005|Overall Study|Equipment failure|0
7110569|NCT02498236|11242735|FG006|Overall Study|Equipment failure|1
7110570|NCT02498236|11242736|FG007|Overall Study|Equipment failure|0
7110571|NCT02498236|11242729|FG000|Overall Study|Withdrawal by Subject|0
7110572|NCT02498236|11242730|FG001|Overall Study|Withdrawal by Subject|0
7110573|NCT02498236|11242731|FG002|Overall Study|Withdrawal by Subject|0
7110574|NCT02498236|11242732|FG003|Overall Study|Withdrawal by Subject|0
7110575|NCT02498236|11242733|FG004|Overall Study|Withdrawal by Subject|1
7110576|NCT02498236|11242734|FG005|Overall Study|Withdrawal by Subject|0
7110577|NCT02498236|11242735|FG006|Overall Study|Withdrawal by Subject|0
7110578|NCT02498236|11242736|FG007|Overall Study|Withdrawal by Subject|0
7110579|NCT02498418|11242760|FG000|Overall Study|Lack of Efficacy|0
7110580|NCT02498418|11242761|FG001|Overall Study|Lack of Efficacy|0
7110581|NCT02498418|11242762|FG002|Overall Study|Lack of Efficacy|1
7110582|NCT02498418|11242760|FG000|Overall Study|Withdrawal by Subject|2
7110583|NCT02498418|11242761|FG001|Overall Study|Withdrawal by Subject|0
7110584|NCT02498418|11242762|FG002|Overall Study|Withdrawal by Subject|3
7110585|NCT02498418|11242760|FG000|Overall Study|Lost to Follow-up|0
7110586|NCT02498418|11242761|FG001|Overall Study|Lost to Follow-up|1
7110587|NCT02498418|11242762|FG002|Overall Study|Lost to Follow-up|1
7110588|NCT02498418|11242760|FG000|Overall Study|Participant taken prohibited medication|0
7110589|NCT02498418|11242761|FG001|Overall Study|Participant taken prohibited medication|1
7110590|NCT02498418|11242762|FG002|Overall Study|Participant taken prohibited medication|1
7110591|NCT02498652|11242790|FG000|Overall Study|Protocol Violation|0
7110592|NCT02498652|11242791|FG001|Overall Study|Protocol Violation|1
7110593|NCT02498678|11242817|FG000|Overall Study|interference from the surgical team|0
7110594|NCT02498678|11242818|FG001|Overall Study|interference from the surgical team|2
7110595|NCT02498821|11242835|FG000|Overall Study|Screen failure|3
7110596|NCT02498821|11242836|FG001|Overall Study|Screen failure|5
7110597|NCT02499029|11242853|FG000|Overall Study|Lost to Follow-up|2
7110598|NCT02499029|11242854|FG001|Overall Study|Lost to Follow-up|2
7110599|NCT02499029|11242853|FG000|Overall Study|Physician Decision|2
7110600|NCT02499029|11242854|FG001|Overall Study|Physician Decision|1
7110601|NCT02499029|11242853|FG000|Overall Study|Death|1
7110602|NCT02499029|11242854|FG001|Overall Study|Death|0
7110603|NCT02499120|11242866|FG000|Overall Study|Death|45
7110604|NCT02499120|11242867|FG001|Overall Study|Death|42
7110605|NCT02499120|11242866|FG000|Overall Study|Lost to Follow-up|1
7110606|NCT02499120|11242867|FG001|Overall Study|Lost to Follow-up|2
7110607|NCT02499120|11242866|FG000|Overall Study|Participant refused further follow-up|1
7110608|NCT02499120|11242867|FG001|Overall Study|Participant refused further follow-up|0
7110609|NCT02499120|11242866|FG000|Overall Study|Withdrawal by Subject|2
7110610|NCT02499120|11242867|FG001|Overall Study|Withdrawal by Subject|5
7110611|NCT02499120|11242866|FG000|Overall Study|Other|1
7110612|NCT02499120|11242867|FG001|Overall Study|Other|0
7110613|NCT02499120|11242866|FG000|Overall Study|Ongoing on study|15
7110614|NCT02499120|11242867|FG001|Overall Study|Ongoing on study|11
7110615|NCT02499146|11242873|FG000|Overall Study|Lost to Follow-up|1
7110616|NCT02499146|11242873|FG000|Overall Study|Withdrawal by Subject|1
7110617|NCT02499146|11242873|FG000|Overall Study|Other|2
7110618|NCT02499146|11242873|FG000|Overall Study|Ongoing at date of cut-off|9
7110619|NCT02499146|11242873|FG000|Overall Study|Began other treatment/therapy|13
7110620|NCT02499159|11242879|FG000|Randomization|Protocol Violation|1
7110621|NCT02499159|11242880|FG001|Randomization|Protocol Violation|1
7110622|NCT02499159|11242879|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1
7110623|NCT02499159|11242880|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1
7110624|NCT02499159|11242879|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3
7110625|NCT02499159|11242880|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1
7110626|NCT02499159|11242879|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2
7110627|NCT02499159|11242880|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0
7110628|NCT02499159|11242879|FG000|30-Day Follow-Up Phone Call|Other|1
7110629|NCT02499159|11242880|FG001|30-Day Follow-Up Phone Call|Other|0
7110630|NCT02499172|11242890|FG000|Overall Study|Financial reason|0
7110631|NCT02499172|11242891|FG001|Overall Study|Financial reason|0
7110632|NCT02499172|11242892|FG002|Overall Study|Financial reason|523
7110633|NCT02499172|11242893|FG003|Overall Study|Financial reason|436
7110634|NCT02499172|11242890|FG000|Overall Study|Lost to Follow-up|65
7110635|NCT02499172|11242891|FG001|Overall Study|Lost to Follow-up|64
7110636|NCT02499172|11242892|FG002|Overall Study|Lost to Follow-up|0
7110637|NCT02499172|11242893|FG003|Overall Study|Lost to Follow-up|0
7110638|NCT02499263|11242903|FG000|Overall Study|Lost to Follow-up|9
7110639|NCT02499263|11242903|FG000|Overall Study|Participant's withdrawal of consent|4
7110640|NCT02499263|11242903|FG000|Overall Study|Lack of Efficacy|22
7110641|NCT02499263|11242903|FG000|Overall Study|investigator's judgment|12
7110642|NCT02499263|11242903|FG000|Overall Study|Adverse Events/Serious Adverse Events|11
7110643|NCT02499263|11242903|FG000|Overall Study|Participant's decision|3
7110644|NCT02499263|11242903|FG000|Overall Study|Pregnancy|1
7110645|NCT02499406|11242911|FG000|Overall Study|missed 3 treatment sessions|4
7110646|NCT02499575|11242934|FG000|Overall Study|Protocol Violation|0
7110647|NCT02499575|11242935|FG001|Overall Study|Protocol Violation|1
7110648|NCT02499770|11242947|FG000|Overall Study|Death|17
7110649|NCT02499770|11242948|FG001|Overall Study|Death|56
7110650|NCT02499770|11242947|FG000|Overall Study|Study completion|1
7110651|NCT02499770|11242948|FG001|Overall Study|Study completion|10
7110652|NCT02499770|11242947|FG000|Overall Study|Withdrawal by Subject|0
7110653|NCT02499770|11242948|FG001|Overall Study|Withdrawal by Subject|7
7110654|NCT02499770|11242947|FG000|Overall Study|Lost to Follow-up|0
7110655|NCT02499770|11242948|FG001|Overall Study|Lost to Follow-up|2
7110656|NCT02499770|11242947|FG000|Overall Study|Subject declined further treatment|1
7110657|NCT02499770|11242948|FG001|Overall Study|Subject declined further treatment|0
7110658|NCT02499770|11242947|FG000|Overall Study|Withdrawn by PI for compassionate reason|0
7110659|NCT02499770|11242948|FG001|Overall Study|Withdrawn by PI for compassionate reason|1
7110660|NCT02499770|11242947|FG000|Overall Study|Randomized but not enrolled|0
7110661|NCT02499770|11242948|FG001|Overall Study|Randomized but not enrolled|1
7110662|NCT02499783|11242962|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2
7110663|NCT02499783|11242963|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4
7110664|NCT02499783|11242964|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0
7110665|NCT02499783|11242962|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1
7110666|NCT02499783|11242963|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0
7110667|NCT02499783|11242964|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0
7110668|NCT02499783|11242962|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1
7110669|NCT02499783|11242963|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1
7110670|NCT02499783|11242964|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0
7110671|NCT02499783|11242962|FG000|DB Period: Weeks 0-8|Adverse Event|8
7110672|NCT02499783|11242963|FG001|DB Period: Weeks 0-8|Adverse Event|6
7110673|NCT02499783|11242964|FG002|DB Period: Weeks 0-8|Adverse Event|0
7110674|NCT02499783|11242962|FG000|DB Period: Weeks 0-8|Withdrew Consent|1
7110675|NCT02499783|11242963|FG001|DB Period: Weeks 0-8|Withdrew Consent|0
7110676|NCT02499783|11242964|FG002|DB Period: Weeks 0-8|Withdrew Consent|0
7110677|NCT02499783|11242962|FG000|DB Period: Weeks 0-8|Other|1
7110678|NCT02499783|11242963|FG001|DB Period: Weeks 0-8|Other|1
7110679|NCT02499783|11242964|FG002|DB Period: Weeks 0-8|Other|0
7110680|NCT02499783|11242962|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0
7110681|NCT02499783|11242963|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0
7110682|NCT02499783|11242964|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16
7110683|NCT02499783|11242962|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0
7110684|NCT02499783|11242963|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0
7110685|NCT02499783|11242964|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2
7110686|NCT02499783|11242962|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0
7110687|NCT02499783|11242963|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0
7110688|NCT02499783|11242964|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9
7110689|NCT02499783|11242962|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0
7110690|NCT02499783|11242963|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0
7110691|NCT02499783|11242964|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2
7110692|NCT02499952|11242974|FG000|Overall Study|Lost to Follow-up|1
7110693|NCT02499952|11242974|FG000|Overall Study|Death|9
7110694|NCT02500043|11242980|FG000|Overall Study|Randomized, but not Treated|2
7110695|NCT02500043|11242981|FG001|Overall Study|Randomized, but not Treated|2
7110696|NCT02500043|11242980|FG000|Overall Study|Ongoing at Date of Cut-Off|19
7110697|NCT02500043|11242981|FG001|Overall Study|Ongoing at Date of Cut-Off|3
7110698|NCT02500043|11242980|FG000|Overall Study|Adverse Event|33
7110699|NCT02500043|11242981|FG001|Overall Study|Adverse Event|11
7110700|NCT02500043|11242980|FG000|Overall Study|Clinical Progression|54
7110701|NCT02500043|11242981|FG001|Overall Study|Clinical Progression|35
7110702|NCT02500043|11242980|FG000|Overall Study|Radiological Progression|192
7110703|NCT02500043|11242981|FG001|Overall Study|Radiological Progression|110
7110704|NCT02500043|11242980|FG000|Overall Study|Physician's Decision|11
7110705|NCT02500043|11242981|FG001|Overall Study|Physician's Decision|3
7110706|NCT02500043|11242980|FG000|Overall Study|Withdrawal by Subject|14
7110707|NCT02500043|11242981|FG001|Overall Study|Withdrawal by Subject|4
7110708|NCT02500043|11242980|FG000|Overall Study|Death|11
7110709|NCT02500043|11242981|FG001|Overall Study|Death|2
7110710|NCT02500043|11242980|FG000|Overall Study|Protocol Deviation|1
7110711|NCT02500043|11242981|FG001|Overall Study|Protocol Deviation|0
7110712|NCT02500056|11242989|FG000|Overall Study|Lost to Follow-up|3
7110713|NCT02500056|11242990|FG001|Overall Study|Lost to Follow-up|7
7110714|NCT02500056|11242989|FG000|Overall Study|Recurrence|1
7110715|NCT02500056|11242990|FG001|Overall Study|Recurrence|0
7110716|NCT02500056|11242989|FG000|Overall Study|Death|3
7110717|NCT02500056|11242990|FG001|Overall Study|Death|1
7110718|NCT02500537|11243005|FG000|Overall Study|Death|2
7110719|NCT02500537|11243006|FG001|Overall Study|Death|0
7110720|NCT02500537|11243005|FG000|Overall Study|Lost to Follow-up|0
7110721|NCT02500537|11243006|FG001|Overall Study|Lost to Follow-up|1
7110722|NCT02500537|11243005|FG000|Overall Study|Withdrawal by Subject|1
7110723|NCT02500537|11243006|FG001|Overall Study|Withdrawal by Subject|0
7110724|NCT02500550|11243013|FG000|Overall Study|Death|7
7110725|NCT02500641|11243041|FG000|Overall Study|Adverse Event|0
7110726|NCT02500641|11243042|FG001|Overall Study|Adverse Event|2
7110727|NCT02500641|11243041|FG000|Overall Study|Withdrawal by Subject|4
7110728|NCT02500641|11243042|FG001|Overall Study|Withdrawal by Subject|5
7110729|NCT02500641|11243041|FG000|Overall Study|Unable to follow study procedures|3
7110730|NCT02500641|11243042|FG001|Overall Study|Unable to follow study procedures|2
7110731|NCT02500641|11243041|FG000|Overall Study|Protocol Violation|1
7110732|NCT02500641|11243042|FG001|Overall Study|Protocol Violation|2
7110733|NCT02500641|11243041|FG000|Overall Study|Lost to Follow-up|1
7110734|NCT02500641|11243042|FG001|Overall Study|Lost to Follow-up|0
7110735|NCT02500641|11243041|FG000|Overall Study|Sponsor decision|1
7110736|NCT02500641|11243042|FG001|Overall Study|Sponsor decision|0
7110737|NCT02500641|11243041|FG000|Overall Study|Non compliance to study drug|0
7110738|NCT02500641|11243042|FG001|Overall Study|Non compliance to study drug|1
7110739|NCT02500706|11243051|FG000|Overall Study|Adverse Event|0
7110740|NCT02500706|11243052|FG001|Overall Study|Adverse Event|0
7110741|NCT02500706|11243053|FG002|Overall Study|Adverse Event|1
7110742|NCT02500706|11243051|FG000|Overall Study|Lost to Follow-up|0
7110743|NCT02500706|11243052|FG001|Overall Study|Lost to Follow-up|1
7110744|NCT02500706|11243053|FG002|Overall Study|Lost to Follow-up|1
7110745|NCT02500706|11243051|FG000|Overall Study|Withdrawal by Subject|4
7110746|NCT02500706|11243052|FG001|Overall Study|Withdrawal by Subject|6
7110747|NCT02500706|11243053|FG002|Overall Study|Withdrawal by Subject|4
7110748|NCT02500706|11243051|FG000|Overall Study|Unclassified|0
7110749|NCT02500706|11243052|FG001|Overall Study|Unclassified|0
7110750|NCT02500706|11243053|FG002|Overall Study|Unclassified|1
7110751|NCT02500719|11243063|FG000|Overall Study|Lost to Follow-up|2
7110752|NCT02500719|11243064|FG001|Overall Study|Lost to Follow-up|3
7110753|NCT02500719|11243063|FG000|Overall Study|Trauma history|1
7110754|NCT02500719|11243064|FG001|Overall Study|Trauma history|0
7110755|NCT02500719|11243063|FG000|Overall Study|MRI data found to be unusable during analysis|0
7110756|NCT02500719|11243064|FG001|Overall Study|MRI data found to be unusable during analysis|1
7110757|NCT02500719|11243063|FG000|Overall Study|Did not meet criteria for PTSD|0
7110758|NCT02500719|11243064|FG001|Overall Study|Did not meet criteria for PTSD|1
7110759|NCT02500719|11243063|FG000|Overall Study|Claustrophobia|0
7110760|NCT02500719|11243064|FG001|Overall Study|Claustrophobia|1
7110761|NCT02500719|11243063|FG000|Overall Study|History of head trauma|0
7110762|NCT02500719|11243064|FG001|Overall Study|History of head trauma|1
7110763|NCT02500732|11243072|FG000|Overall Study|Physician Decision|0
7110764|NCT02500732|11243073|FG001|Overall Study|Physician Decision|1
7110765|NCT02500758|11243081|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0
7110766|NCT02500758|11243082|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1
7110767|NCT02500758|11243081|FG000|Washout (1 Week)|Lost to Follow-up|2
7110768|NCT02500758|11243082|FG001|Washout (1 Week)|Lost to Follow-up|2
7110769|NCT02500758|11243081|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2
7110770|NCT02500758|11243082|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0
7110771|NCT02500758|11243081|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0
7110772|NCT02500758|11243082|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1
7110773|NCT02500758|11243081|FG000|Second Intervention (2 Minutes)|Protocol Violation|1
7110774|NCT02500758|11243082|FG001|Second Intervention (2 Minutes)|Protocol Violation|1
7110775|NCT02500979|11243104|FG000|Period 1|Hyperglycemia|1
7110776|NCT02500979|11243105|FG001|Period 1|Hyperglycemia|0
7110777|NCT02500979|11243104|FG000|Period 1|Severe non-compliance to protocol|0
7110778|NCT02500979|11243105|FG001|Period 1|Severe non-compliance to protocol|1
7110779|NCT02500979|11243104|FG000|Period 1|Adverse Event|1
7110780|NCT02500979|11243105|FG001|Period 1|Adverse Event|0
7110781|NCT02500979|11243104|FG000|Period 1|Subject decision|2
7110782|NCT02500979|11243105|FG001|Period 1|Subject decision|0
7110783|NCT02500979|11243104|FG000|Period 2|Change in risk|1
7110784|NCT02500979|11243105|FG001|Period 2|Change in risk|0
7110785|NCT02501161|11243123|FG000|Overall Study|Adverse Event|2
7110786|NCT02501161|11243124|FG001|Overall Study|Adverse Event|6
7110787|NCT02501161|11243123|FG000|Overall Study|Lost to Follow-up|7
7110788|NCT02501161|11243124|FG001|Overall Study|Lost to Follow-up|4
7110789|NCT02501161|11243123|FG000|Overall Study|Withdrawal by Subject|10
7110790|NCT02501161|11243124|FG001|Overall Study|Withdrawal by Subject|15
7110791|NCT02501161|11243123|FG000|Overall Study|Other|3
7110792|NCT02501161|11243124|FG001|Overall Study|Other|0
7110793|NCT02501473|11243154|FG000|Overall Study|Study Terminated|2
7110794|NCT02501473|11243155|FG001|Overall Study|Study Terminated|3
7110795|NCT02501473|11243156|FG002|Overall Study|Study Terminated|7
7110796|NCT02501473|11243157|FG003|Overall Study|Study Terminated|9
7110797|NCT02501473|11243158|FG004|Overall Study|Study Terminated|2
7110798|NCT02501473|11243159|FG005|Overall Study|Study Terminated|10
7110799|NCT02501473|11243160|FG006|Overall Study|Study Terminated|1
7110800|NCT02501473|11243161|FG007|Overall Study|Study Terminated|0
7110801|NCT02501473|11243154|FG000|Overall Study|Withdrawal by Subject|0
7110802|NCT02501473|11243155|FG001|Overall Study|Withdrawal by Subject|0
7110803|NCT02501473|11243156|FG002|Overall Study|Withdrawal by Subject|3
7110804|NCT02501473|11243157|FG003|Overall Study|Withdrawal by Subject|3
7110805|NCT02501473|11243158|FG004|Overall Study|Withdrawal by Subject|2
7110806|NCT02501473|11243159|FG005|Overall Study|Withdrawal by Subject|2
7110807|NCT02501473|11243160|FG006|Overall Study|Withdrawal by Subject|0
7110808|NCT02501473|11243161|FG007|Overall Study|Withdrawal by Subject|0
7110809|NCT02501473|11243154|FG000|Overall Study|Death|0
7110810|NCT02501473|11243155|FG001|Overall Study|Death|0
7110811|NCT02501473|11243156|FG002|Overall Study|Death|1
7110812|NCT02501473|11243157|FG003|Overall Study|Death|1
7110813|NCT02501473|11243158|FG004|Overall Study|Death|0
7110814|NCT02501473|11243159|FG005|Overall Study|Death|1
7110815|NCT02501473|11243160|FG006|Overall Study|Death|0
7110816|NCT02501473|11243161|FG007|Overall Study|Death|0
7110817|NCT02501473|11243154|FG000|Overall Study|Lost to Follow-up|1
7110818|NCT02501473|11243155|FG001|Overall Study|Lost to Follow-up|0
7110819|NCT02501473|11243156|FG002|Overall Study|Lost to Follow-up|1
7110820|NCT02501473|11243157|FG003|Overall Study|Lost to Follow-up|0
7110821|NCT02501473|11243158|FG004|Overall Study|Lost to Follow-up|0
7110822|NCT02501473|11243159|FG005|Overall Study|Lost to Follow-up|1
7110823|NCT02501473|11243160|FG006|Overall Study|Lost to Follow-up|0
7110824|NCT02501473|11243161|FG007|Overall Study|Lost to Follow-up|0
7110825|NCT02501473|11243154|FG000|Overall Study|Reason not specified|0
7110826|NCT02501473|11243155|FG001|Overall Study|Reason not specified|0
7110827|NCT02501473|11243156|FG002|Overall Study|Reason not specified|1
7110828|NCT02501473|11243157|FG003|Overall Study|Reason not specified|1
7110829|NCT02501473|11243158|FG004|Overall Study|Reason not specified|0
7110830|NCT02501473|11243159|FG005|Overall Study|Reason not specified|0
7110831|NCT02501473|11243160|FG006|Overall Study|Reason not specified|0
7110832|NCT02501473|11243161|FG007|Overall Study|Reason not specified|0
7110833|NCT02501629|11243195|FG000|Overall Study|Death|0
7110834|NCT02501629|11243196|FG001|Overall Study|Death|1
7110835|NCT02501629|11243195|FG000|Overall Study|Withdrawn from study by sponsor|1
7110836|NCT02501629|11243196|FG001|Overall Study|Withdrawn from study by sponsor|0
7110837|NCT02501629|11243195|FG000|Overall Study|Early termination by sponsor|1
7110838|NCT02501629|11243196|FG001|Overall Study|Early termination by sponsor|0
7110839|NCT02501629|11243195|FG000|Overall Study|Withdrawal by Subject|3
7110840|NCT02501629|11243196|FG001|Overall Study|Withdrawal by Subject|5
7110841|NCT02501629|11243195|FG000|Overall Study|Subject did not return to site|0
7110842|NCT02501629|11243196|FG001|Overall Study|Subject did not return to site|1
7110843|NCT02501642|11243204|FG000|Overall Study|Lost to Follow-up|7
7110844|NCT02501642|11243205|FG001|Overall Study|Lost to Follow-up|11
7110845|NCT02501811|11243215|FG000|Overall Study|Death|1
7110846|NCT02501811|11243216|FG001|Overall Study|Death|3
7110847|NCT02501811|11243217|FG002|Overall Study|Death|2
7110848|NCT02501811|11243218|FG003|Overall Study|Death|3
7110849|NCT02501811|11243215|FG000|Overall Study|Withdrawal by Subject|3
7110850|NCT02501811|11243216|FG001|Overall Study|Withdrawal by Subject|3
7110851|NCT02501811|11243217|FG002|Overall Study|Withdrawal by Subject|2
7110852|NCT02501811|11243218|FG003|Overall Study|Withdrawal by Subject|3
7110853|NCT02501811|11243215|FG000|Overall Study|Lost to Follow-up|0
7110854|NCT02501811|11243216|FG001|Overall Study|Lost to Follow-up|0
7110855|NCT02501811|11243217|FG002|Overall Study|Lost to Follow-up|2
7110856|NCT02501811|11243218|FG003|Overall Study|Lost to Follow-up|1
7110857|NCT02501902|11243236|FG000|Overall Study|Subject Refused Further Follow-up|0
7110858|NCT02501902|11243237|FG001|Overall Study|Subject Refused Further Follow-up|0
7110859|NCT02501902|11243238|FG002|Overall Study|Subject Refused Further Follow-up|0
7110860|NCT02501902|11243239|FG003|Overall Study|Subject Refused Further Follow-up|0
7110861|NCT02501902|11243240|FG004|Overall Study|Subject Refused Further Follow-up|0
7110862|NCT02501902|11243241|FG005|Overall Study|Subject Refused Further Follow-up|0
7110863|NCT02501902|11243242|FG006|Overall Study|Subject Refused Further Follow-up|0
7110864|NCT02501902|11243243|FG007|Overall Study|Subject Refused Further Follow-up|1
7110865|NCT02501902|11243236|FG000|Overall Study|Study Terminated by Sponsor|0
7110866|NCT02501902|11243237|FG001|Overall Study|Study Terminated by Sponsor|3
7110867|NCT02501902|11243238|FG002|Overall Study|Study Terminated by Sponsor|0
7110868|NCT02501902|11243239|FG003|Overall Study|Study Terminated by Sponsor|1
7110869|NCT02501902|11243240|FG004|Overall Study|Study Terminated by Sponsor|1
7110870|NCT02501902|11243241|FG005|Overall Study|Study Terminated by Sponsor|0
7110871|NCT02501902|11243242|FG006|Overall Study|Study Terminated by Sponsor|2
7110872|NCT02501902|11243243|FG007|Overall Study|Study Terminated by Sponsor|4
7110873|NCT02501902|11243236|FG000|Overall Study|Death|3
7110874|NCT02501902|11243237|FG001|Overall Study|Death|4
7110875|NCT02501902|11243238|FG002|Overall Study|Death|4
7110876|NCT02501902|11243239|FG003|Overall Study|Death|10
7110877|NCT02501902|11243240|FG004|Overall Study|Death|10
7110878|NCT02501902|11243241|FG005|Overall Study|Death|11
7110879|NCT02501902|11243242|FG006|Overall Study|Death|7
7110880|NCT02501902|11243243|FG007|Overall Study|Death|15
7110881|NCT02501928|11243269|FG000|Overall Study|Withdrawal By Parent/Guardian|0
7110882|NCT02501928|11243270|FG001|Overall Study|Withdrawal By Parent/Guardian|0
7110883|NCT02501928|11243271|FG002|Overall Study|Withdrawal By Parent/Guardian|0
7110884|NCT02501928|11243272|FG003|Overall Study|Withdrawal By Parent/Guardian|0
7110885|NCT02501928|11243273|FG004|Overall Study|Withdrawal By Parent/Guardian|1
7110886|NCT02501928|11243274|FG005|Overall Study|Withdrawal By Parent/Guardian|0
7110887|NCT02502097|11243299|FG000|Period 1|Adverse Event|0
7110888|NCT02502097|11243300|FG001|Period 1|Adverse Event|0
7110889|NCT02502097|11243301|FG002|Period 1|Adverse Event|1
7110890|NCT02502097|11243302|FG003|Period 1|Adverse Event|0
7110891|NCT02502097|11243299|FG000|Wash Out Period|Adverse Event|0
7110892|NCT02502097|11243300|FG001|Wash Out Period|Adverse Event|1
7110893|NCT02502097|11243301|FG002|Wash Out Period|Adverse Event|1
7110894|NCT02502097|11243302|FG003|Wash Out Period|Adverse Event|1
7110895|NCT02502097|11243299|FG000|Period 2|Adverse Event|0
7110896|NCT02502097|11243300|FG001|Period 2|Adverse Event|0
7110897|NCT02502097|11243301|FG002|Period 2|Adverse Event|1
7110898|NCT02502097|11243302|FG003|Period 2|Adverse Event|0
7110899|NCT02502149|11243309|FG000|Intermediate|Discontinued prematurely|1
7110900|NCT02502149|11243310|FG001|Intermediate|Discontinued prematurely|0
7110901|NCT02502149|11243311|FG002|Intermediate|Discontinued prematurely|0
7110902|NCT02502149|11243312|FG003|Intermediate|Discontinued prematurely|0
7110903|NCT02502149|11243313|FG004|Intermediate|Discontinued prematurely|0
7110904|NCT02502526|11243355|FG000|Overall Study|Lost to Follow-up|2
7110905|NCT02502526|11243356|FG001|Overall Study|Lost to Follow-up|2
7110906|NCT02502526|11243357|FG002|Overall Study|Lost to Follow-up|3
7110907|NCT02502526|11243355|FG000|Overall Study|Withdrawal by Subject|0
7110908|NCT02502526|11243356|FG001|Overall Study|Withdrawal by Subject|1
7110909|NCT02502526|11243357|FG002|Overall Study|Withdrawal by Subject|1
7110910|NCT02502526|11243355|FG000|Overall Study|Disqualified due to cataract grading|0
7110911|NCT02502526|11243356|FG001|Overall Study|Disqualified due to cataract grading|0
7110912|NCT02502526|11243357|FG002|Overall Study|Disqualified due to cataract grading|1
7110913|NCT02502526|11243355|FG000|Overall Study|Enrollment suspension|4
7110914|NCT02502526|11243356|FG001|Overall Study|Enrollment suspension|1
7110915|NCT02502526|11243357|FG002|Overall Study|Enrollment suspension|1
7110916|NCT02502734|11243366|FG000|Double-blind Treatment Period 1|Adverse Event|1
7110917|NCT02502734|11243367|FG001|Double-blind Treatment Period 1|Adverse Event|0
7110918|NCT02502734|11243366|FG000|Washout Period|Adverse Event|1
7110919|NCT02502734|11243367|FG001|Washout Period|Adverse Event|0
7110920|NCT02502864|11243375|FG000|Overall Study|Withdrawal by Subject|1
7110921|NCT02503085|11243379|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1
7110922|NCT02503085|11243380|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0
7110923|NCT02503085|11243381|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1
7110924|NCT02503085|11243382|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0
7110925|NCT02503202|11243394|FG000|Base Study: Up to Month 6|Death|1
7110926|NCT02503202|11243395|FG001|Base Study: Up to Month 6|Death|1
7110927|NCT02503202|11243396|FG002|Base Study: Up to Month 6|Death|0
7110928|NCT02503202|11243397|FG003|Base Study: Up to Month 6|Death|0
7110929|NCT02503202|11243398|FG004|Base Study: Up to Month 6|Death|0
7110930|NCT02503202|11243394|FG000|Base Study: Up to Month 6|Lost to Follow-up|11
7110931|NCT02503202|11243395|FG001|Base Study: Up to Month 6|Lost to Follow-up|8
7110932|NCT02503202|11243396|FG002|Base Study: Up to Month 6|Lost to Follow-up|10
7110933|NCT02503202|11243397|FG003|Base Study: Up to Month 6|Lost to Follow-up|5
7110934|NCT02503202|11243398|FG004|Base Study: Up to Month 6|Lost to Follow-up|1
7110935|NCT02503202|11243394|FG000|Base Study: Up to Month 6|Physician Decision|0
7110936|NCT02503202|11243395|FG001|Base Study: Up to Month 6|Physician Decision|0
7110937|NCT02503202|11243396|FG002|Base Study: Up to Month 6|Physician Decision|0
7110938|NCT02503202|11243397|FG003|Base Study: Up to Month 6|Physician Decision|0
7110939|NCT02503202|11243398|FG004|Base Study: Up to Month 6|Physician Decision|1
7110940|NCT02503202|11243394|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6
7110941|NCT02503202|11243395|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3
7110942|NCT02503202|11243396|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4
7110943|NCT02503202|11243397|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4
7110944|NCT02503202|11243398|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1
7110945|NCT02503202|11243394|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0
7110946|NCT02503202|11243395|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0
7110947|NCT02503202|11243396|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1
7110948|NCT02503202|11243397|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2
7110949|NCT02503202|11243398|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0
7110950|NCT02503202|11243394|FG000|Extension: Month 6 to 24|Protocol Violation|0
7110951|NCT02503202|11243395|FG001|Extension: Month 6 to 24|Protocol Violation|0
7110952|NCT02503202|11243396|FG002|Extension: Month 6 to 24|Protocol Violation|0
7110953|NCT02503202|11243397|FG003|Extension: Month 6 to 24|Protocol Violation|1
7110954|NCT02503202|11243398|FG004|Extension: Month 6 to 24|Protocol Violation|0
7110955|NCT02503202|11243394|FG000|Extension: Month 6 to 24|Death|1
7110956|NCT02503202|11243395|FG001|Extension: Month 6 to 24|Death|0
7110957|NCT02503202|11243396|FG002|Extension: Month 6 to 24|Death|0
7110958|NCT02503202|11243397|FG003|Extension: Month 6 to 24|Death|0
7110959|NCT02503202|11243398|FG004|Extension: Month 6 to 24|Death|0
7110960|NCT02503202|11243394|FG000|Extension: Month 6 to 24|Lost to Follow-up|4
7110961|NCT02503202|11243395|FG001|Extension: Month 6 to 24|Lost to Follow-up|8
7110962|NCT02503202|11243396|FG002|Extension: Month 6 to 24|Lost to Follow-up|6
7110963|NCT02503202|11243397|FG003|Extension: Month 6 to 24|Lost to Follow-up|10
7110964|NCT02503202|11243398|FG004|Extension: Month 6 to 24|Lost to Follow-up|1
7110965|NCT02503202|11243394|FG000|Extension: Month 6 to 24|Physician Decision|1
7110966|NCT02503202|11243395|FG001|Extension: Month 6 to 24|Physician Decision|0
7110967|NCT02503202|11243396|FG002|Extension: Month 6 to 24|Physician Decision|1
7110968|NCT02503202|11243397|FG003|Extension: Month 6 to 24|Physician Decision|3
7110969|NCT02503202|11243398|FG004|Extension: Month 6 to 24|Physician Decision|0
7110970|NCT02503202|11243394|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5
7110971|NCT02503202|11243395|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8
7110972|NCT02503202|11243396|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2
7110973|NCT02503202|11243397|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4
7110974|NCT02503202|11243398|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0
7110975|NCT02503215|11243410|FG000|Overall Study|Unable to wear compression stockings|1
7110976|NCT02503215|11243410|FG000|Overall Study|Unable to use positive airway pressure|2
7110977|NCT02503332|11243427|FG000|Overall Study|Adverse Event|17
7110978|NCT02503332|11243428|FG001|Overall Study|Adverse Event|5
7110979|NCT02503332|11243429|FG002|Overall Study|Adverse Event|3
7110980|NCT02503332|11243430|FG003|Overall Study|Adverse Event|1
7110981|NCT02503332|11243427|FG000|Overall Study|Investigator's Decision|5
7110982|NCT02503332|11243428|FG001|Overall Study|Investigator's Decision|1
7110983|NCT02503332|11243429|FG002|Overall Study|Investigator's Decision|0
7110984|NCT02503332|11243430|FG003|Overall Study|Investigator's Decision|0
7110985|NCT02503332|11243427|FG000|Overall Study|Sponsor's Decision|1
7110986|NCT02503332|11243428|FG001|Overall Study|Sponsor's Decision|0
7110987|NCT02503332|11243429|FG002|Overall Study|Sponsor's Decision|0
7110988|NCT02503332|11243430|FG003|Overall Study|Sponsor's Decision|1
7110989|NCT02503332|11243427|FG000|Overall Study|Subject Request|6
7110990|NCT02503332|11243428|FG001|Overall Study|Subject Request|5
7110991|NCT02503332|11243429|FG002|Overall Study|Subject Request|2
7110992|NCT02503332|11243430|FG003|Overall Study|Subject Request|1
7110993|NCT02503332|11243427|FG000|Overall Study|Death|0
7110994|NCT02503332|11243428|FG001|Overall Study|Death|2
7110995|NCT02503332|11243429|FG002|Overall Study|Death|2
7110996|NCT02503332|11243430|FG003|Overall Study|Death|0
7110997|NCT02503332|11243427|FG000|Overall Study|Other|5
7110998|NCT02503332|11243428|FG001|Overall Study|Other|6
7110999|NCT02503332|11243429|FG002|Overall Study|Other|1
7111000|NCT02503332|11243430|FG003|Overall Study|Other|1
7111001|NCT02503501|11243460|FG000|Overall Study|Physician Decision|1
7111002|NCT02503501|11243461|FG001|Overall Study|Physician Decision|0
7111003|NCT02503501|11243460|FG000|Overall Study|Protocol Violation|0
7111004|NCT02503501|11243461|FG001|Overall Study|Protocol Violation|1
7111005|NCT02503501|11243460|FG000|Overall Study|Withdrawal by Subject|0
7111006|NCT02503501|11243461|FG001|Overall Study|Withdrawal by Subject|2
7111007|NCT02503540|11243467|FG000|Overall Study|Death|2
7111008|NCT02503540|11243467|FG000|Overall Study|Withdrawal by Subject|1
7111009|NCT02503787|11243481|FG000|Enrollment|Withdrawal by Subject|6
7111010|NCT02503787|11243481|FG000|Enrollment|Inclusion/exclusion criteria not met|4
7111011|NCT02503787|11243481|FG000|Enrollment|Physician Decision|2
7111012|NCT02503787|11243481|FG000|Enrollment|Insurance issue|2
7111013|NCT02503787|11243481|FG000|Enrollment|Lost to Follow-up|1
7111014|NCT02503787|11243481|FG000|Enrollment|Study closure|1
7111015|NCT02503787|11243481|FG000|Enrollment|Adverse Event|1
7111016|NCT02503787|11243481|FG000|Enrollment|Protocol Violation|1
7111017|NCT02503787|11243481|FG000|Enrollment|Inability to implant system|1
7111018|NCT02503787|11243481|FG000|Enrollment|Unable to be programmed|1
7111019|NCT02503787|11243481|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6
7111020|NCT02503787|11243481|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1
7111021|NCT02503787|11243481|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3
7111022|NCT02503787|11243481|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2
7111023|NCT02503787|11243481|FG000|Implant to 3 Month Endpoint|Adverse Event|2
7111024|NCT02503787|11243481|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1
7111025|NCT02503865|11243505|FG000|Overall Study|Moved out of area|1
7111026|NCT02503865|11243506|FG001|Overall Study|Moved out of area|8
7111027|NCT02503865|11243507|FG002|Overall Study|Moved out of area|0
7111028|NCT02503865|11243505|FG000|Overall Study|Refused treatment|4
7111029|NCT02503865|11243506|FG001|Overall Study|Refused treatment|39
7111030|NCT02503865|11243507|FG002|Overall Study|Refused treatment|2
7111031|NCT02504216|11243527|FG000|Overall Study|Lost to Follow-up|3
7111032|NCT02504216|11243528|FG001|Overall Study|Lost to Follow-up|3
7111033|NCT02504216|11243527|FG000|Overall Study|Withdrawal by Subject|8
7111034|NCT02504216|11243528|FG001|Overall Study|Withdrawal by Subject|12
7111035|NCT02504268|11243537|FG000|Overall Study|Adverse Event|18
7111036|NCT02504268|11243538|FG001|Overall Study|Adverse Event|8
7111037|NCT02504268|11243539|FG002|Overall Study|Adverse Event|14
7111038|NCT02504268|11243540|FG003|Overall Study|Adverse Event|0
7111039|NCT02504268|11243541|FG004|Overall Study|Adverse Event|0
7111040|NCT02504268|11243542|FG005|Overall Study|Adverse Event|0
7111041|NCT02504268|11243543|FG006|Overall Study|Adverse Event|0
7111042|NCT02504268|11243544|FG007|Overall Study|Adverse Event|0
7111043|NCT02504268|11243545|FG008|Overall Study|Adverse Event|0
7111044|NCT02504268|11243537|FG000|Overall Study|Withdrawal of Consent|11
7111045|NCT02504268|11243538|FG001|Overall Study|Withdrawal of Consent|10
7111046|NCT02504268|11243539|FG002|Overall Study|Withdrawal of Consent|3
7111047|NCT02504268|11243540|FG003|Overall Study|Withdrawal of Consent|0
7111048|NCT02504268|11243541|FG004|Overall Study|Withdrawal of Consent|0
7111049|NCT02504268|11243542|FG005|Overall Study|Withdrawal of Consent|0
7111050|NCT02504268|11243543|FG006|Overall Study|Withdrawal of Consent|0
7111051|NCT02504268|11243544|FG007|Overall Study|Withdrawal of Consent|0
7111052|NCT02504268|11243545|FG008|Overall Study|Withdrawal of Consent|0
7111053|NCT02504268|11243537|FG000|Overall Study|Pregnancy|2
7111054|NCT02504268|11243538|FG001|Overall Study|Pregnancy|0
7111055|NCT02504268|11243539|FG002|Overall Study|Pregnancy|0
7111056|NCT02504268|11243540|FG003|Overall Study|Pregnancy|0
7111057|NCT02504268|11243541|FG004|Overall Study|Pregnancy|0
7111058|NCT02504268|11243542|FG005|Overall Study|Pregnancy|0
7111059|NCT02504268|11243543|FG006|Overall Study|Pregnancy|0
7111060|NCT02504268|11243544|FG007|Overall Study|Pregnancy|0
7111061|NCT02504268|11243545|FG008|Overall Study|Pregnancy|0
7111062|NCT02504268|11243537|FG000|Overall Study|Lost to Follow-up|3
7111063|NCT02504268|11243538|FG001|Overall Study|Lost to Follow-up|6
7111064|NCT02504268|11243539|FG002|Overall Study|Lost to Follow-up|4
7111065|NCT02504268|11243540|FG003|Overall Study|Lost to Follow-up|0
7111066|NCT02504268|11243541|FG004|Overall Study|Lost to Follow-up|0
7111067|NCT02504268|11243542|FG005|Overall Study|Lost to Follow-up|0
7111068|NCT02504268|11243543|FG006|Overall Study|Lost to Follow-up|0
7111069|NCT02504268|11243544|FG007|Overall Study|Lost to Follow-up|0
7111070|NCT02504268|11243545|FG008|Overall Study|Lost to Follow-up|0
7111071|NCT02504268|11243537|FG000|Overall Study|Death|1
7111072|NCT02504268|11243538|FG001|Overall Study|Death|1
7111073|NCT02504268|11243539|FG002|Overall Study|Death|0
7111074|NCT02504268|11243540|FG003|Overall Study|Death|0
7111075|NCT02504268|11243541|FG004|Overall Study|Death|0
7111076|NCT02504268|11243542|FG005|Overall Study|Death|0
7111077|NCT02504268|11243543|FG006|Overall Study|Death|0
7111078|NCT02504268|11243544|FG007|Overall Study|Death|0
7111079|NCT02504268|11243545|FG008|Overall Study|Death|0
7111080|NCT02504268|11243537|FG000|Overall Study|Subject Request to Discontinue|11
7111081|NCT02504268|11243538|FG001|Overall Study|Subject Request to Discontinue|3
7111082|NCT02504268|11243539|FG002|Overall Study|Subject Request to Discontinue|6
7111083|NCT02504268|11243540|FG003|Overall Study|Subject Request to Discontinue|0
7111084|NCT02504268|11243541|FG004|Overall Study|Subject Request to Discontinue|0
7111085|NCT02504268|11243542|FG005|Overall Study|Subject Request to Discontinue|0
7111086|NCT02504268|11243543|FG006|Overall Study|Subject Request to Discontinue|0
7111087|NCT02504268|11243544|FG007|Overall Study|Subject Request to Discontinue|0
7111088|NCT02504268|11243545|FG008|Overall Study|Subject Request to Discontinue|0
7111089|NCT02504268|11243537|FG000|Overall Study|No Longer Meets Study Criteria|2
7111090|NCT02504268|11243538|FG001|Overall Study|No Longer Meets Study Criteria|3
7111091|NCT02504268|11243539|FG002|Overall Study|No Longer Meets Study Criteria|0
7111092|NCT02504268|11243540|FG003|Overall Study|No Longer Meets Study Criteria|0
7111093|NCT02504268|11243541|FG004|Overall Study|No Longer Meets Study Criteria|0
7111094|NCT02504268|11243542|FG005|Overall Study|No Longer Meets Study Criteria|0
7111095|NCT02504268|11243543|FG006|Overall Study|No Longer Meets Study Criteria|0
7111096|NCT02504268|11243544|FG007|Overall Study|No Longer Meets Study Criteria|0
7111097|NCT02504268|11243545|FG008|Overall Study|No Longer Meets Study Criteria|0
7111098|NCT02504268|11243537|FG000|Overall Study|Lack of Efficacy|11
7111099|NCT02504268|11243538|FG001|Overall Study|Lack of Efficacy|35
7111100|NCT02504268|11243539|FG002|Overall Study|Lack of Efficacy|9
7111101|NCT02504268|11243540|FG003|Overall Study|Lack of Efficacy|0
7111102|NCT02504268|11243541|FG004|Overall Study|Lack of Efficacy|0
7111103|NCT02504268|11243542|FG005|Overall Study|Lack of Efficacy|0
7111104|NCT02504268|11243543|FG006|Overall Study|Lack of Efficacy|0
7111105|NCT02504268|11243544|FG007|Overall Study|Lack of Efficacy|0
7111106|NCT02504268|11243545|FG008|Overall Study|Lack of Efficacy|0
7111107|NCT02504268|11243537|FG000|Overall Study|Poor/Non-Compliance|3
7111108|NCT02504268|11243538|FG001|Overall Study|Poor/Non-Compliance|2
7111109|NCT02504268|11243539|FG002|Overall Study|Poor/Non-Compliance|3
7111110|NCT02504268|11243540|FG003|Overall Study|Poor/Non-Compliance|0
7111111|NCT02504268|11243541|FG004|Overall Study|Poor/Non-Compliance|0
7111112|NCT02504268|11243542|FG005|Overall Study|Poor/Non-Compliance|0
7111113|NCT02504268|11243543|FG006|Overall Study|Poor/Non-Compliance|0
7111114|NCT02504268|11243544|FG007|Overall Study|Poor/Non-Compliance|0
7111115|NCT02504268|11243545|FG008|Overall Study|Poor/Non-Compliance|0
7111116|NCT02504268|11243537|FG000|Overall Study|Not Disclosed|1
7111117|NCT02504268|11243538|FG001|Overall Study|Not Disclosed|0
7111118|NCT02504268|11243539|FG002|Overall Study|Not Disclosed|2
7111119|NCT02504268|11243540|FG003|Overall Study|Not Disclosed|0
7111120|NCT02504268|11243541|FG004|Overall Study|Not Disclosed|0
7111121|NCT02504268|11243542|FG005|Overall Study|Not Disclosed|0
7111122|NCT02504268|11243543|FG006|Overall Study|Not Disclosed|0
7111123|NCT02504268|11243544|FG007|Overall Study|Not Disclosed|0
7111124|NCT02504268|11243545|FG008|Overall Study|Not Disclosed|0
7111125|NCT02504294|11243567|FG000|Overall Study|Adverse Event|15
7111126|NCT02504294|11243568|FG001|Overall Study|Adverse Event|12
7111127|NCT02504294|11243567|FG000|Overall Study|Withdrawal by Subject|7
7111128|NCT02504294|11243568|FG001|Overall Study|Withdrawal by Subject|1
7111129|NCT02504294|11243567|FG000|Overall Study|Protocol Violation|27
7111130|NCT02504294|11243568|FG001|Overall Study|Protocol Violation|26
7111131|NCT02504294|11243567|FG000|Overall Study|Physician Decision|1
7111132|NCT02504294|11243568|FG001|Overall Study|Physician Decision|2
7111133|NCT02504294|11243567|FG000|Overall Study|Lost to Follow-up|6
7111134|NCT02504294|11243568|FG001|Overall Study|Lost to Follow-up|7
7111135|NCT02504320|11243578|FG000|Treatment Period 1|Positive Drug Screen|0
7111136|NCT02504320|11243579|FG001|Treatment Period 1|Positive Drug Screen|0
7111137|NCT02504320|11243580|FG002|Treatment Period 1|Positive Drug Screen|1
7111138|NCT02504320|11243581|FG003|Treatment Period 1|Positive Drug Screen|0
7111139|NCT02504320|11243578|FG000|Treatment Period 2|Positive Drug Screen|0
7111140|NCT02504320|11243579|FG001|Treatment Period 2|Positive Drug Screen|1
7111141|NCT02504320|11243580|FG002|Treatment Period 2|Positive Drug Screen|0
7111142|NCT02504320|11243581|FG003|Treatment Period 2|Positive Drug Screen|0
7111143|NCT02504320|11243578|FG000|Treatment Period 3|Positive Drug Screen|0
7111144|NCT02504320|11243579|FG001|Treatment Period 3|Positive Drug Screen|0
7111145|NCT02504320|11243580|FG002|Treatment Period 3|Positive Drug Screen|0
7111146|NCT02504320|11243581|FG003|Treatment Period 3|Positive Drug Screen|1
7111147|NCT02504320|11243578|FG000|Treatment Period 3|Adverse Event|0
7111148|NCT02504320|11243579|FG001|Treatment Period 3|Adverse Event|0
7111149|NCT02504320|11243580|FG002|Treatment Period 3|Adverse Event|1
7111150|NCT02504320|11243581|FG003|Treatment Period 3|Adverse Event|0
7111151|NCT02504424|11243591|FG000|Overall Study|Withdrawal by Subject|2
7111152|NCT02504502|11243598|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4
7111153|NCT02504502|11243599|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7
7111154|NCT02504502|11243598|FG000|Crossover to Enhanced Report|Lost to Follow-up|5
7111155|NCT02504502|11243599|FG001|Crossover to Enhanced Report|Lost to Follow-up|0
7111156|NCT02504541|11243605|FG000|Overall Study|Adverse Event|4
7111157|NCT02504541|11243605|FG000|Overall Study|Withdrawal by Subject|4
7111158|NCT02504541|11243605|FG000|Overall Study|Lost to Follow-up|1
7111159|NCT02504541|11243605|FG000|Overall Study|Met Stopping Criteria|1
7111160|NCT02504541|11243605|FG000|Overall Study|Protocol Violation|2
7111161|NCT02504541|11243605|FG000|Overall Study|Termination by Sponsor|1
7111162|NCT02504541|11243605|FG000|Overall Study|Other|2
7111163|NCT02504541|11243605|FG000|Overall Study|Multiple|5
7111164|NCT02504671|11243638|FG000|Overall Study|Withdrawal by Subject|1
7111165|NCT02504671|11243639|FG001|Overall Study|Withdrawal by Subject|5
7111166|NCT02504671|11243640|FG002|Overall Study|Withdrawal by Subject|4
7111167|NCT02504671|11243641|FG003|Overall Study|Withdrawal by Subject|4
7111168|NCT02504671|11243642|FG004|Overall Study|Withdrawal by Subject|5
7111169|NCT02504671|11243643|FG005|Overall Study|Withdrawal by Subject|3
7111170|NCT02504671|11243638|FG000|Overall Study|Lack of Efficacy|1
7111171|NCT02504671|11243639|FG001|Overall Study|Lack of Efficacy|3
7111172|NCT02504671|11243640|FG002|Overall Study|Lack of Efficacy|1
7111173|NCT02504671|11243641|FG003|Overall Study|Lack of Efficacy|0
7111174|NCT02504671|11243642|FG004|Overall Study|Lack of Efficacy|4
7111175|NCT02504671|11243643|FG005|Overall Study|Lack of Efficacy|4
7111176|NCT02504671|11243638|FG000|Overall Study|Adverse Event|1
7111177|NCT02504671|11243639|FG001|Overall Study|Adverse Event|1
7111178|NCT02504671|11243640|FG002|Overall Study|Adverse Event|0
7111179|NCT02504671|11243641|FG003|Overall Study|Adverse Event|1
7111180|NCT02504671|11243642|FG004|Overall Study|Adverse Event|0
7111181|NCT02504671|11243643|FG005|Overall Study|Adverse Event|2
7111182|NCT02504671|11243638|FG000|Overall Study|Protocol Violation|2
7111183|NCT02504671|11243639|FG001|Overall Study|Protocol Violation|1
7111184|NCT02504671|11243640|FG002|Overall Study|Protocol Violation|0
7111185|NCT02504671|11243641|FG003|Overall Study|Protocol Violation|0
7111186|NCT02504671|11243642|FG004|Overall Study|Protocol Violation|0
7111187|NCT02504671|11243643|FG005|Overall Study|Protocol Violation|1
7111188|NCT02504671|11243638|FG000|Overall Study|Lost to Follow-up|0
7111189|NCT02504671|11243639|FG001|Overall Study|Lost to Follow-up|0
7111190|NCT02504671|11243640|FG002|Overall Study|Lost to Follow-up|2
7111191|NCT02504671|11243641|FG003|Overall Study|Lost to Follow-up|0
7111192|NCT02504671|11243642|FG004|Overall Study|Lost to Follow-up|0
7111193|NCT02504671|11243643|FG005|Overall Study|Lost to Follow-up|1
7111194|NCT02504671|11243638|FG000|Overall Study|Protocol defined stopping criteria|7
7111195|NCT02504671|11243639|FG001|Overall Study|Protocol defined stopping criteria|4
7111196|NCT02504671|11243640|FG002|Overall Study|Protocol defined stopping criteria|3
7111197|NCT02504671|11243641|FG003|Overall Study|Protocol defined stopping criteria|5
7111198|NCT02504671|11243642|FG004|Overall Study|Protocol defined stopping criteria|3
7111199|NCT02504671|11243643|FG005|Overall Study|Protocol defined stopping criteria|3
7111200|NCT02504827|11243675|FG000|Overall Study|Could not produce sputum|1
7111201|NCT02504892|11243679|FG000|Overall Study|Adverse event-pneumonitis|2
7111202|NCT02505217|11243694|FG000|Overall Study|Withdrawal by Subject|1
7111203|NCT02505217|11243695|FG001|Overall Study|Withdrawal by Subject|2
7111204|NCT02505334|11243707|FG000|Main Treatment Period|Adverse Event|3
7111205|NCT02505334|11243708|FG001|Main Treatment Period|Adverse Event|3
7111206|NCT02505334|11243707|FG000|Main Treatment Period|Lack of Efficacy|7
7111207|NCT02505334|11243708|FG001|Main Treatment Period|Lack of Efficacy|17
7111208|NCT02505334|11243707|FG000|Main Treatment Period|Protocol Violation|0
7111209|NCT02505334|11243708|FG001|Main Treatment Period|Protocol Violation|1
7111210|NCT02505334|11243707|FG000|Main Treatment Period|Withdrawal by Subject|1
7111211|NCT02505334|11243708|FG001|Main Treatment Period|Withdrawal by Subject|8
7111212|NCT02505334|11243707|FG000|Main Treatment Period|Unclassified|4
7111213|NCT02505334|11243708|FG001|Main Treatment Period|Unclassified|10
7111214|NCT02505334|11243707|FG000|Extension Treatment Period|Adverse Event|5
7111215|NCT02505334|11243708|FG001|Extension Treatment Period|Adverse Event|0
7111216|NCT02505334|11243707|FG000|Extension Treatment Period|Lack of Efficacy|4
7111217|NCT02505334|11243708|FG001|Extension Treatment Period|Lack of Efficacy|0
7111218|NCT02505334|11243707|FG000|Extension Treatment Period|Withdrawal by Subject|6
7111219|NCT02505334|11243708|FG001|Extension Treatment Period|Withdrawal by Subject|0
7111220|NCT02505334|11243707|FG000|Extension Treatment Period|Unclassified|3
7111221|NCT02505334|11243708|FG001|Extension Treatment Period|Unclassified|0
7111222|NCT02505542|11243714|FG000|Part A: Open-Label Period|Adverse Event|31
7111223|NCT02505542|11243715|FG001|Part A: Open-Label Period|Adverse Event|0
7111224|NCT02505542|11243716|FG002|Part A: Open-Label Period|Adverse Event|0
7111225|NCT02505542|11243717|FG003|Part A: Open-Label Period|Adverse Event|0
7111226|NCT02505542|11243714|FG000|Part A: Open-Label Period|Lack of Efficacy|5
7111227|NCT02505542|11243715|FG001|Part A: Open-Label Period|Lack of Efficacy|0
7111228|NCT02505542|11243716|FG002|Part A: Open-Label Period|Lack of Efficacy|0
7111229|NCT02505542|11243717|FG003|Part A: Open-Label Period|Lack of Efficacy|0
7111230|NCT02505542|11243714|FG000|Part A: Open-Label Period|Protocol Violation|1
7111231|NCT02505542|11243715|FG001|Part A: Open-Label Period|Protocol Violation|0
7111232|NCT02505542|11243716|FG002|Part A: Open-Label Period|Protocol Violation|0
7111233|NCT02505542|11243717|FG003|Part A: Open-Label Period|Protocol Violation|0
7111234|NCT02505542|11243714|FG000|Part A: Open-Label Period|Lost to Follow-up|5
7111235|NCT02505542|11243715|FG001|Part A: Open-Label Period|Lost to Follow-up|0
7111236|NCT02505542|11243716|FG002|Part A: Open-Label Period|Lost to Follow-up|0
7111237|NCT02505542|11243717|FG003|Part A: Open-Label Period|Lost to Follow-up|0
7111238|NCT02505542|11243714|FG000|Part A: Open-Label Period|Withdrawal by Subject|27
7111239|NCT02505542|11243715|FG001|Part A: Open-Label Period|Withdrawal by Subject|0
7111240|NCT02505542|11243716|FG002|Part A: Open-Label Period|Withdrawal by Subject|0
7111241|NCT02505542|11243717|FG003|Part A: Open-Label Period|Withdrawal by Subject|0
7111242|NCT02505542|11243714|FG000|Part A: Open-Label Period|New medical history available|1
7111243|NCT02505542|11243715|FG001|Part A: Open-Label Period|New medical history available|0
7111244|NCT02505542|11243716|FG002|Part A: Open-Label Period|New medical history available|0
7111245|NCT02505542|11243717|FG003|Part A: Open-Label Period|New medical history available|0
7111246|NCT02505542|11243714|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1
7111247|NCT02505542|11243715|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0
7111248|NCT02505542|11243716|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0
7111249|NCT02505542|11243717|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0
7111250|NCT02505542|11243714|FG000|Part A: Open-Label Period|Pregnancy|2
7111251|NCT02505542|11243715|FG001|Part A: Open-Label Period|Pregnancy|0
7111252|NCT02505542|11243716|FG002|Part A: Open-Label Period|Pregnancy|0
7111253|NCT02505542|11243717|FG003|Part A: Open-Label Period|Pregnancy|0
7111254|NCT02505542|11243714|FG000|Part A: Open-Label Period|Sponsor directive|1
7111255|NCT02505542|11243715|FG001|Part A: Open-Label Period|Sponsor directive|0
7111256|NCT02505542|11243716|FG002|Part A: Open-Label Period|Sponsor directive|0
7111257|NCT02505542|11243717|FG003|Part A: Open-Label Period|Sponsor directive|0
7111258|NCT02505542|11243714|FG000|Part A: Open-Label Period|Medical monitor decision|1
7111259|NCT02505542|11243715|FG001|Part A: Open-Label Period|Medical monitor decision|0
7111260|NCT02505542|11243716|FG002|Part A: Open-Label Period|Medical monitor decision|0
7111261|NCT02505542|11243717|FG003|Part A: Open-Label Period|Medical monitor decision|0
7111262|NCT02505542|11243714|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1
7111263|NCT02505542|11243715|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0
7111264|NCT02505542|11243716|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0
7111265|NCT02505542|11243717|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0
7111266|NCT02505542|11243714|FG000|Part A: Open-Label Period|Non-compliance|1
7111267|NCT02505542|11243715|FG001|Part A: Open-Label Period|Non-compliance|0
7111268|NCT02505542|11243716|FG002|Part A: Open-Label Period|Non-compliance|0
7111269|NCT02505542|11243717|FG003|Part A: Open-Label Period|Non-compliance|0
7111270|NCT02505542|11243714|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2
7111271|NCT02505542|11243715|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0
7111272|NCT02505542|11243716|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0
7111273|NCT02505542|11243717|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0
7111274|NCT02505542|11243714|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3
7111275|NCT02505542|11243715|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0
7111276|NCT02505542|11243716|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0
7111277|NCT02505542|11243717|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0
7111278|NCT02505542|11243714|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341
7111279|NCT02505542|11243715|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0
7111280|NCT02505542|11243716|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0
7111281|NCT02505542|11243717|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0
7111282|NCT02505542|11243714|FG000|Part B: Double-Blind Period|Adverse Event|0
7111283|NCT02505542|11243715|FG001|Part B: Double-Blind Period|Adverse Event|0
7111284|NCT02505542|11243716|FG002|Part B: Double-Blind Period|Adverse Event|1
7111285|NCT02505542|11243717|FG003|Part B: Double-Blind Period|Adverse Event|3
7111286|NCT02505542|11243714|FG000|Part B: Double-Blind Period|Lost to Follow-up|0
7111287|NCT02505542|11243715|FG001|Part B: Double-Blind Period|Lost to Follow-up|0
7111288|NCT02505542|11243716|FG002|Part B: Double-Blind Period|Lost to Follow-up|0
7111289|NCT02505542|11243717|FG003|Part B: Double-Blind Period|Lost to Follow-up|1
7111290|NCT02505542|11243714|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0
7111291|NCT02505542|11243715|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8
7111292|NCT02505542|11243716|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7
7111293|NCT02505542|11243717|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2
7111294|NCT02505542|11243714|FG000|Part B: Double-Blind Period|Planning pregnancy|0
7111295|NCT02505542|11243715|FG001|Part B: Double-Blind Period|Planning pregnancy|1
7111296|NCT02505542|11243716|FG002|Part B: Double-Blind Period|Planning pregnancy|0
7111297|NCT02505542|11243717|FG003|Part B: Double-Blind Period|Planning pregnancy|0
7111298|NCT02505542|11243714|FG000|Part B: Double-Blind Period|Week 94 missed|0
7111299|NCT02505542|11243715|FG001|Part B: Double-Blind Period|Week 94 missed|0
7111300|NCT02505542|11243716|FG002|Part B: Double-Blind Period|Week 94 missed|1
7111301|NCT02505542|11243717|FG003|Part B: Double-Blind Period|Week 94 missed|0
7111302|NCT02505542|11243714|FG000|Part B: Double-Blind Period|Patient was moved from the country|0
7111303|NCT02505542|11243715|FG001|Part B: Double-Blind Period|Patient was moved from the country|0
7111304|NCT02505542|11243716|FG002|Part B: Double-Blind Period|Patient was moved from the country|0
7111305|NCT02505542|11243717|FG003|Part B: Double-Blind Period|Patient was moved from the country|1
7111306|NCT02505542|11243714|FG000|Part B: Double-Blind Period|Lack of Efficacy|0
7111307|NCT02505542|11243715|FG001|Part B: Double-Blind Period|Lack of Efficacy|1
7111308|NCT02505542|11243716|FG002|Part B: Double-Blind Period|Lack of Efficacy|0
7111309|NCT02505542|11243717|FG003|Part B: Double-Blind Period|Lack of Efficacy|0
7111310|NCT02505542|11243714|FG000|Part B: Double-Blind Period|Miscalculation|0
7111311|NCT02505542|11243715|FG001|Part B: Double-Blind Period|Miscalculation|1
7111312|NCT02505542|11243716|FG002|Part B: Double-Blind Period|Miscalculation|0
7111313|NCT02505542|11243717|FG003|Part B: Double-Blind Period|Miscalculation|0
7111314|NCT02505542|11243714|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0
7111315|NCT02505542|11243715|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1
7111316|NCT02505542|11243716|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0
7111317|NCT02505542|11243717|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0
7111318|NCT02505867|11243745|FG000|Overall Study|Lack of Efficacy|6
7111319|NCT02505867|11243746|FG001|Overall Study|Lack of Efficacy|6
7111320|NCT02505945|11243763|FG000|Overall Study|Withdrawal by Subject|13
7111321|NCT02505945|11243764|FG001|Overall Study|Withdrawal by Subject|2
7111322|NCT02505945|11243763|FG000|Overall Study|Adverse Event|1
7111323|NCT02505945|11243764|FG001|Overall Study|Adverse Event|0
7111324|NCT02505945|11243763|FG000|Overall Study|Physician Decision|2
7111325|NCT02505945|11243764|FG001|Overall Study|Physician Decision|1
7111326|NCT02505945|11243763|FG000|Overall Study|Lost to Follow-up|6
7111327|NCT02505945|11243764|FG001|Overall Study|Lost to Follow-up|1
7111328|NCT02506036|11243772|FG000|First Intervention (4-6 Weeks)|Death|1
7111329|NCT02506036|11243773|FG001|First Intervention (4-6 Weeks)|Death|0
7111330|NCT02506036|11243772|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0
7111331|NCT02506036|11243773|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1
7111332|NCT02506036|11243772|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0
7111333|NCT02506036|11243773|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1
7111334|NCT02506257|11243796|FG000|Overall Study|Adverse Event|0
7111335|NCT02506257|11243797|FG001|Overall Study|Adverse Event|2
7111336|NCT02506257|11243798|FG002|Overall Study|Adverse Event|3
7111337|NCT02506257|11243799|FG003|Overall Study|Adverse Event|0
7111338|NCT02506257|11243796|FG000|Overall Study|Protocol Violation|0
7111339|NCT02506257|11243797|FG001|Overall Study|Protocol Violation|0
7111340|NCT02506257|11243798|FG002|Overall Study|Protocol Violation|1
7111341|NCT02506257|11243799|FG003|Overall Study|Protocol Violation|0
7111342|NCT02506816|11243882|FG000|Overall Study|Adverse Event|3
7111343|NCT02506881|11243903|FG000|First Intervention (Day 1)|Protocol Violation|0
7111344|NCT02506881|11243904|FG001|First Intervention (Day 1)|Protocol Violation|0
7111345|NCT02506881|11243905|FG002|First Intervention (Day 1)|Protocol Violation|1
7111346|NCT02506881|11243906|FG003|First Intervention (Day 1)|Protocol Violation|0
7111347|NCT02506881|11243903|FG000|First Intervention (Day 1)|Withdrawal by Subject|1
7111348|NCT02506881|11243904|FG001|First Intervention (Day 1)|Withdrawal by Subject|0
7111349|NCT02506881|11243905|FG002|First Intervention (Day 1)|Withdrawal by Subject|0
7111350|NCT02506881|11243906|FG003|First Intervention (Day 1)|Withdrawal by Subject|0
7111351|NCT02506881|11243903|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0
7111352|NCT02506881|11243904|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0
7111353|NCT02506881|11243905|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12
7111354|NCT02506881|11243906|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12
7111355|NCT02507219|11243933|FG000|Overall Study|Physician Decision|1
7111356|NCT02507219|11243934|FG001|Overall Study|Physician Decision|0
7111357|NCT02507219|11243935|FG002|Overall Study|Physician Decision|0
7111358|NCT02507219|11243936|FG003|Overall Study|Physician Decision|0
7111359|NCT02507219|11243937|FG004|Overall Study|Physician Decision|0
7111360|NCT02507219|11243938|FG005|Overall Study|Physician Decision|0
7111361|NCT02507219|11243933|FG000|Overall Study|Withdrawal by Subject|0
7111362|NCT02507219|11243934|FG001|Overall Study|Withdrawal by Subject|0
7111363|NCT02507219|11243935|FG002|Overall Study|Withdrawal by Subject|0
7111364|NCT02507219|11243936|FG003|Overall Study|Withdrawal by Subject|0
7111365|NCT02507219|11243937|FG004|Overall Study|Withdrawal by Subject|1
7111366|NCT02507219|11243938|FG005|Overall Study|Withdrawal by Subject|0
7111367|NCT02507297|11243948|FG000|Overall Study|Withdrawal by Subject|1
7111368|NCT02507297|11243949|FG001|Overall Study|Withdrawal by Subject|0
7111369|NCT02507297|11243948|FG000|Overall Study|Lost to Follow-up|0
7111370|NCT02507297|11243949|FG001|Overall Study|Lost to Follow-up|1
7111371|NCT02507349|11243957|FG000|Overall Study|Death|12
7111372|NCT02507349|11243958|FG001|Overall Study|Death|16
7111373|NCT02507349|11243957|FG000|Overall Study|Withdrawal by Subject|1
7111374|NCT02507349|11243958|FG001|Overall Study|Withdrawal by Subject|1
7111375|NCT02507349|11243957|FG000|Overall Study|Lost to Follow-up|174
7111376|NCT02507349|11243958|FG001|Overall Study|Lost to Follow-up|144
7111377|NCT02507375|11243966|FG000|Overall Study|Progressive Disease|4
7111378|NCT02507375|11243967|FG001|Overall Study|Progressive Disease|5
7111379|NCT02507375|11243966|FG000|Overall Study|Death|0
7111380|NCT02507375|11243967|FG001|Overall Study|Death|1
7111381|NCT02507375|11243966|FG000|Overall Study|Refused treatment|0
7111382|NCT02507375|11243967|FG001|Overall Study|Refused treatment|1
7111383|NCT02507375|11243966|FG000|Overall Study|Adverse Event|0
7111384|NCT02507375|11243967|FG001|Overall Study|Adverse Event|1
7111385|NCT02507752|11243987|FG000|Overall Study|Adverse Event|1
7111386|NCT02507752|11243987|FG000|Overall Study|Protocol Violation|6
7111387|NCT02507752|11243987|FG000|Overall Study|Lost to Follow-up|7
7111388|NCT02507752|11243987|FG000|Overall Study|Infusion reaction at first infusion|1
7111389|NCT02507752|11243987|FG000|Overall Study|Participant didn't perform visit Week 12|1
7111390|NCT02507752|11243987|FG000|Overall Study|Participant didn't perform visit Week 24|1
7111391|NCT02508116|11244006|FG000|Overall Study|Lost to Follow-up|2
7111392|NCT02508116|11244007|FG001|Overall Study|Lost to Follow-up|3
7111393|NCT02508116|11244006|FG000|Overall Study|Withdrawal by Subject|3
7111394|NCT02508116|11244007|FG001|Overall Study|Withdrawal by Subject|2
7111395|NCT02508116|11244006|FG000|Overall Study|Protocol Violation|1
7111396|NCT02508116|11244007|FG001|Overall Study|Protocol Violation|2
7111397|NCT02508116|11244006|FG000|Overall Study|Physician Decision|2
7111398|NCT02508116|11244007|FG001|Overall Study|Physician Decision|0
7111399|NCT02508194|11244015|FG000|Overall Study|Death|5
7111400|NCT02508194|11244016|FG001|Overall Study|Death|3
7111401|NCT02508194|11244015|FG000|Overall Study|Lost to Follow-up|25
7111402|NCT02508194|11244016|FG001|Overall Study|Lost to Follow-up|18
7111403|NCT02508194|11244015|FG000|Overall Study|Withdrawal by Subject|20
7111404|NCT02508194|11244016|FG001|Overall Study|Withdrawal by Subject|18
7111405|NCT02508194|11244015|FG000|Overall Study|Error in Randomization|1
7111406|NCT02508194|11244016|FG001|Overall Study|Error in Randomization|3
7111407|NCT02508194|11244015|FG000|Overall Study|Principal Investigator Decision|1
7111408|NCT02508194|11244016|FG001|Overall Study|Principal Investigator Decision|2
7111409|NCT02508428|11244055|FG000|Overall Study|Death|32
7111410|NCT02508428|11244056|FG001|Overall Study|Death|33
7111411|NCT02508428|11244055|FG000|Overall Study|Liner revised|3
7111412|NCT02508428|11244056|FG001|Overall Study|Liner revised|19
7111413|NCT02508428|11244055|FG000|Overall Study|Incomplete follow-up|17
7111414|NCT02508428|11244056|FG001|Overall Study|Incomplete follow-up|15
7111415|NCT02508649|11244079|FG000|Overall Study|Withdrawal by Subject|4
7111416|NCT02508649|11244080|FG001|Overall Study|Withdrawal by Subject|6
7111417|NCT02508649|11244081|FG002|Overall Study|Withdrawal by Subject|5
7111418|NCT02508649|11244082|FG003|Overall Study|Withdrawal by Subject|6
7111419|NCT02508649|11244079|FG000|Overall Study|Investigator withdrew the subject|1
7111420|NCT02508649|11244080|FG001|Overall Study|Investigator withdrew the subject|2
7111421|NCT02508649|11244081|FG002|Overall Study|Investigator withdrew the subject|1
7111422|NCT02508649|11244082|FG003|Overall Study|Investigator withdrew the subject|0
7111423|NCT02508649|11244079|FG000|Overall Study|Post randomization screening failure|12
7111424|NCT02508649|11244080|FG001|Overall Study|Post randomization screening failure|4
7111425|NCT02508649|11244081|FG002|Overall Study|Post randomization screening failure|9
7111426|NCT02508649|11244082|FG003|Overall Study|Post randomization screening failure|3
7111427|NCT02508649|11244079|FG000|Overall Study|Lost to Follow-up|1
7111428|NCT02508649|11244080|FG001|Overall Study|Lost to Follow-up|1
7111429|NCT02508649|11244081|FG002|Overall Study|Lost to Follow-up|0
7111430|NCT02508649|11244082|FG003|Overall Study|Lost to Follow-up|1
7111431|NCT02508701|11244099|FG000|Overall Study|Lost to Follow-up|9
7111432|NCT02508701|11244100|FG001|Overall Study|Lost to Follow-up|5
7111433|NCT02508701|11244101|FG002|Overall Study|Lost to Follow-up|5
7111434|NCT02508701|11244102|FG003|Overall Study|Lost to Follow-up|3
7111435|NCT02508935|11244116|FG000|Overall Study|Withdrawal by Subject|1
7111436|NCT02508935|11244116|FG000|Overall Study|Withdrawal by Caregiver|8
7111437|NCT02508935|11244116|FG000|Overall Study|Pain Score <4|1
7111438|NCT02508935|11244116|FG000|Overall Study|Emesis|3
7111439|NCT02508935|11244116|FG000|Overall Study|Adverse Event|3
7111440|NCT02508935|11244116|FG000|Overall Study|Protocol Violation|1
7111441|NCT02508935|11244116|FG000|Overall Study|Physician Decision|1
7111442|NCT02508935|11244116|FG000|Overall Study|Trial terminated by sponsor|5
7111443|NCT02509026|11244122|FG000|Induction Period (24 Weeks)|Adverse Event|5
7111444|NCT02509026|11244122|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5
7111445|NCT02509026|11244122|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6
7111446|NCT02509026|11244122|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1
7111447|NCT02509026|11244122|FG000|Induction Period (24 Weeks)|Other|2
7111448|NCT02509026|11244122|FG000|Induction Period (24 Weeks)|Protocol Violation|1
7111449|NCT02509026|11244122|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1
7111450|NCT02509026|11244122|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1
7111451|NCT02509026|11244122|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2
7111452|NCT02509026|11244122|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5
7111453|NCT02509026|11244122|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1
7111454|NCT02509026|11244122|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2
7111455|NCT02509026|11244122|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1
7111456|NCT02509078|11244171|FG000|Overall Study|Protocol Violation|1
7111457|NCT02509078|11244172|FG001|Overall Study|Protocol Violation|1
7111458|NCT02509117|11244190|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
7111459|NCT02509117|11244191|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1
7111460|NCT02509117|11244192|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
7111461|NCT02509117|11244193|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
7111462|NCT02509117|11244194|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
7111463|NCT02509117|11244195|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
7111464|NCT02509117|11244196|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
7111465|NCT02509117|11244197|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
7111466|NCT02509117|11244198|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
7111467|NCT02509117|11244199|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
7111468|NCT02509117|11244190|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
7111469|NCT02509117|11244191|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
7111470|NCT02509117|11244192|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
7111471|NCT02509117|11244193|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
7111472|NCT02509117|11244194|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
7111473|NCT02509117|11244195|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
7111474|NCT02509117|11244196|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
7111475|NCT02509117|11244197|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
7111476|NCT02509117|11244198|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
7111477|NCT02509117|11244199|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1
7111478|NCT02509117|11244190|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
7111479|NCT02509117|11244191|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
7111480|NCT02509117|11244192|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
7111481|NCT02509117|11244193|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
7111482|NCT02509117|11244194|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
7111483|NCT02509117|11244195|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
7111484|NCT02509117|11244196|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
7111485|NCT02509117|11244197|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
7111486|NCT02509117|11244198|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
7111487|NCT02509117|11244199|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1
7111488|NCT02509156|11244239|FG000|Randomized Phase|Death|1
7111489|NCT02509156|11244240|FG001|Randomized Phase|Death|0
7111490|NCT02509156|11244239|FG000|Randomized Phase|Withdrawal by Subject|1
7111491|NCT02509156|11244240|FG001|Randomized Phase|Withdrawal by Subject|1
7111492|NCT02510001|11244309|FG000|Overall Study|Early disease progression|0
7111493|NCT02510001|11244310|FG001|Overall Study|Early disease progression|0
7111494|NCT02510001|11244311|FG002|Overall Study|Early disease progression|0
7111495|NCT02510001|11244312|FG003|Overall Study|Early disease progression|1
7111496|NCT02510001|11244313|FG004|Overall Study|Early disease progression|1
7111497|NCT02510001|11244314|FG005|Overall Study|Early disease progression|1
7111498|NCT02510001|11244315|FG006|Overall Study|Early disease progression|0
7111499|NCT02510001|11244316|FG007|Overall Study|Early disease progression|0
7111500|NCT02510001|11244309|FG000|Overall Study|Adverse Event|0
7111501|NCT02510001|11244310|FG001|Overall Study|Adverse Event|0
7111502|NCT02510001|11244311|FG002|Overall Study|Adverse Event|0
7111503|NCT02510001|11244312|FG003|Overall Study|Adverse Event|1
7111504|NCT02510001|11244313|FG004|Overall Study|Adverse Event|2
7111505|NCT02510001|11244314|FG005|Overall Study|Adverse Event|1
7111506|NCT02510001|11244315|FG006|Overall Study|Adverse Event|2
7111507|NCT02510001|11244316|FG007|Overall Study|Adverse Event|5
7111508|NCT02510001|11244309|FG000|Overall Study|Physician Decision|0
7111509|NCT02510001|11244310|FG001|Overall Study|Physician Decision|0
7111510|NCT02510001|11244311|FG002|Overall Study|Physician Decision|0
7111511|NCT02510001|11244312|FG003|Overall Study|Physician Decision|0
7111512|NCT02510001|11244313|FG004|Overall Study|Physician Decision|1
7111513|NCT02510001|11244314|FG005|Overall Study|Physician Decision|0
7111514|NCT02510001|11244315|FG006|Overall Study|Physician Decision|0
7111515|NCT02510001|11244316|FG007|Overall Study|Physician Decision|0
7111516|NCT02510001|11244309|FG000|Overall Study|Withdrawal by Subject|0
7111517|NCT02510001|11244310|FG001|Overall Study|Withdrawal by Subject|0
7111518|NCT02510001|11244311|FG002|Overall Study|Withdrawal by Subject|0
7111519|NCT02510001|11244312|FG003|Overall Study|Withdrawal by Subject|0
7111520|NCT02510001|11244313|FG004|Overall Study|Withdrawal by Subject|0
7111521|NCT02510001|11244314|FG005|Overall Study|Withdrawal by Subject|0
7111522|NCT02510001|11244315|FG006|Overall Study|Withdrawal by Subject|0
7111523|NCT02510001|11244316|FG007|Overall Study|Withdrawal by Subject|2
7111524|NCT02510014|11244354|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1
7111525|NCT02510014|11244355|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1
7111526|NCT02510014|11244354|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1
7111527|NCT02510014|11244355|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0
7111528|NCT02510014|11244354|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44
7111529|NCT02510014|11244355|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3
7111530|NCT02510014|11244354|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0
7111531|NCT02510014|11244355|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1
7111532|NCT02510014|11244354|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22
7111533|NCT02510014|11244355|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3
7111534|NCT02510014|11244354|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7
7111535|NCT02510014|11244355|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1
7111536|NCT02510014|11244354|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2
7111537|NCT02510014|11244355|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0
7111538|NCT02510014|11244354|FG000|Run-In Period (Days -14 to Day -1)|Other|19
7111539|NCT02510014|11244355|FG001|Run-In Period (Days -14 to Day -1)|Other|1
7111540|NCT02510014|11244354|FG000|Treatment Period|Adverse Event|11
7111541|NCT02510014|11244355|FG001|Treatment Period|Adverse Event|4
7111542|NCT02510014|11244354|FG000|Treatment Period|Withdrawal symptoms|3
7111543|NCT02510014|11244355|FG001|Treatment Period|Withdrawal symptoms|0
7111544|NCT02510014|11244354|FG000|Treatment Period|Lost to Follow-up|80
7111545|NCT02510014|11244355|FG001|Treatment Period|Lost to Follow-up|19
7111546|NCT02510014|11244354|FG000|Treatment Period|Physician Decision|5
7111547|NCT02510014|11244355|FG001|Treatment Period|Physician Decision|0
7111548|NCT02510014|11244354|FG000|Treatment Period|Withdrawal by Subject|67
7111549|NCT02510014|11244355|FG001|Treatment Period|Withdrawal by Subject|24
7111550|NCT02510014|11244354|FG000|Treatment Period|Withdrawn by the investigator|7
7111551|NCT02510014|11244355|FG001|Treatment Period|Withdrawn by the investigator|1
7111552|NCT02510014|11244354|FG000|Treatment Period|Protocol Violation|4
7111553|NCT02510014|11244355|FG001|Treatment Period|Protocol Violation|4
7111554|NCT02510014|11244354|FG000|Treatment Period|Incarceration, pregnancy, misc|29
7111555|NCT02510014|11244355|FG001|Treatment Period|Incarceration, pregnancy, misc|5
7111556|NCT02510664|11244373|FG000|Overall Study|Transferred Care|9
7111557|NCT02510664|11244374|FG001|Overall Study|Transferred Care|9
7111558|NCT02510664|11244375|FG002|Overall Study|Transferred Care|0
7111559|NCT02510664|11244373|FG000|Overall Study|Provider Retired/No Time to Reschedule|10
7111560|NCT02510664|11244374|FG001|Overall Study|Provider Retired/No Time to Reschedule|10
7111561|NCT02510664|11244375|FG002|Overall Study|Provider Retired/No Time to Reschedule|0
7111562|NCT02510664|11244373|FG000|Overall Study|Time Constraints|1
7111563|NCT02510664|11244374|FG001|Overall Study|Time Constraints|1
7111564|NCT02510664|11244375|FG002|Overall Study|Time Constraints|0
6805828|NCT02575339|10808036|FG001|Follow up|Study Terminated|2
7111565|NCT02510794|11244392|FG000|Overall Study|Adverse Event|0
7111566|NCT02510794|11244393|FG001|Overall Study|Adverse Event|1
7111567|NCT02510794|11244394|FG002|Overall Study|Adverse Event|0
7111568|NCT02510794|11244395|FG003|Overall Study|Adverse Event|0
7111569|NCT02510794|11244392|FG000|Overall Study|Death|1
7111570|NCT02510794|11244393|FG001|Overall Study|Death|2
7111571|NCT02510794|11244394|FG002|Overall Study|Death|1
7111572|NCT02510794|11244395|FG003|Overall Study|Death|1
7111573|NCT02510794|11244392|FG000|Overall Study|Lack of Efficacy|3
7111574|NCT02510794|11244393|FG001|Overall Study|Lack of Efficacy|1
7111575|NCT02510794|11244394|FG002|Overall Study|Lack of Efficacy|1
7111576|NCT02510794|11244395|FG003|Overall Study|Lack of Efficacy|0
7111577|NCT02510794|11244392|FG000|Overall Study|Participant moved out of the area|0
7111578|NCT02510794|11244393|FG001|Overall Study|Participant moved out of the area|0
7111579|NCT02510794|11244394|FG002|Overall Study|Participant moved out of the area|0
7111580|NCT02510794|11244395|FG003|Overall Study|Participant moved out of the area|1
7111581|NCT02510794|11244392|FG000|Overall Study|Physician Decision|3
7111582|NCT02510794|11244393|FG001|Overall Study|Physician Decision|0
7111583|NCT02510794|11244394|FG002|Overall Study|Physician Decision|0
7111584|NCT02510794|11244395|FG003|Overall Study|Physician Decision|0
7111585|NCT02510794|11244392|FG000|Overall Study|Protocol Violation|0
7111586|NCT02510794|11244393|FG001|Overall Study|Protocol Violation|0
7111587|NCT02510794|11244394|FG002|Overall Study|Protocol Violation|1
7111588|NCT02510794|11244395|FG003|Overall Study|Protocol Violation|0
7111589|NCT02510794|11244392|FG000|Overall Study|Withdrawal by Subject|1
7111590|NCT02510794|11244393|FG001|Overall Study|Withdrawal by Subject|2
7111591|NCT02510794|11244394|FG002|Overall Study|Withdrawal by Subject|4
7111592|NCT02510794|11244395|FG003|Overall Study|Withdrawal by Subject|3
7111593|NCT02510820|11244407|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0
7111594|NCT02510820|11244408|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1
7111595|NCT02510820|11244407|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1
7111596|NCT02510820|11244408|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0
7111597|NCT02511184|11244417|FG000|Overall Study|Death|1
7111598|NCT02511184|11244418|FG001|Overall Study|Death|0
7111599|NCT02511184|11244417|FG000|Overall Study|Lost to Follow-up|0
7111600|NCT02511184|11244418|FG001|Overall Study|Lost to Follow-up|1
7111601|NCT02511184|11244417|FG000|Overall Study|Study terminated by sponsor|1
7111602|NCT02511184|11244418|FG001|Overall Study|Study terminated by sponsor|5
7111603|NCT02511184|11244417|FG000|Overall Study|Withdrawal by Subject|0
7111604|NCT02511184|11244418|FG001|Overall Study|Withdrawal by Subject|1
7111605|NCT02511431|11244444|FG000|Treatment|Lost to Follow-up|0
7111606|NCT02511431|11244445|FG001|Treatment|Lost to Follow-up|0
7111607|NCT02511431|11244446|FG002|Treatment|Lost to Follow-up|1
7111608|NCT02511431|11244447|FG003|Treatment|Lost to Follow-up|0
7111609|NCT02511431|11244448|FG004|Treatment|Lost to Follow-up|0
7111610|NCT02511431|11244449|FG005|Treatment|Lost to Follow-up|1
7111611|NCT02511678|11244500|FG000|Overall Study|Withdrawal by Subject|2
7111612|NCT02511678|11244500|FG000|Overall Study|Lost to Follow-up|4
7111613|NCT02511678|11244500|FG000|Overall Study|Death|19
7111614|NCT02511678|11244500|FG000|Overall Study|Adverse Event|1
7111615|NCT02511678|11244500|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5
7111616|NCT02511678|11244500|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1
7111617|NCT02511678|11244500|FG000|Overall Study|Required Radiofrequency Ablation|1
7111618|NCT02511678|11244500|FG000|Overall Study|Biopsy was Negative|1
7111619|NCT02511678|11244500|FG000|Overall Study|Protocol Violation|1
7111620|NCT02511678|11244500|FG000|Overall Study|Received Radiation Treatment|1
7111621|NCT02511782|11244524|FG000|Overall Study|Withdrawal by Subject|1
7111622|NCT02511782|11244525|FG001|Overall Study|Withdrawal by Subject|0
7111623|NCT02511782|11244526|FG002|Overall Study|Withdrawal by Subject|0
7111624|NCT02512042|11244536|FG000|Overall Study|Adverse Event|0
7111625|NCT02512042|11244537|FG001|Overall Study|Adverse Event|4
7111626|NCT02512042|11244536|FG000|Overall Study|Withdrawal by Subject|6
7111627|NCT02512042|11244537|FG001|Overall Study|Withdrawal by Subject|6
7111628|NCT02512042|11244536|FG000|Overall Study|Non-compliance with study drug|1
7111629|NCT02512042|11244537|FG001|Overall Study|Non-compliance with study drug|2
7111630|NCT02512042|11244536|FG000|Overall Study|Lost to Follow-up|5
7111631|NCT02512042|11244537|FG001|Overall Study|Lost to Follow-up|2
7111632|NCT02512042|11244536|FG000|Overall Study|Other|11
7111633|NCT02512042|11244537|FG001|Overall Study|Other|11
7111634|NCT02512068|11244545|FG000|Overall Study|Pretreatment Event/Adverse Event|8
7111635|NCT02512068|11244546|FG001|Overall Study|Pretreatment Event/Adverse Event|6
7111636|NCT02512068|11244545|FG000|Overall Study|Major Protocol Deviation|1
7111637|NCT02512068|11244546|FG001|Overall Study|Major Protocol Deviation|0
7111638|NCT02512068|11244545|FG000|Overall Study|Voluntary Withdrawal|0
7111639|NCT02512068|11244546|FG001|Overall Study|Voluntary Withdrawal|1
7111640|NCT02512068|11244545|FG000|Overall Study|Lack of Efficacy|0
7111641|NCT02512068|11244546|FG001|Overall Study|Lack of Efficacy|1
7111642|NCT02512068|11244545|FG000|Overall Study|Reason Not Specified|3
7111643|NCT02512068|11244546|FG001|Overall Study|Reason Not Specified|5
7111644|NCT02512302|11244574|FG000|Period 1|Adverse Event|0
7111645|NCT02512302|11244575|FG001|Period 1|Adverse Event|1
7111646|NCT02512302|11244576|FG002|Period 1|Adverse Event|0
7111647|NCT02512302|11244577|FG003|Period 1|Adverse Event|0
7111648|NCT02512302|11244578|FG004|Period 1|Adverse Event|0
7111649|NCT02512302|11244579|FG005|Period 1|Adverse Event|0
7111650|NCT02512302|11244580|FG006|Period 1|Adverse Event|0
7111651|NCT02512302|11244581|FG007|Period 1|Adverse Event|0
7111652|NCT02512302|11244582|FG008|Period 1|Adverse Event|0
7111653|NCT02512302|11244583|FG009|Period 1|Adverse Event|0
7111654|NCT02512302|11244574|FG000|Period 2|Adverse Event|0
7111655|NCT02512302|11244575|FG001|Period 2|Adverse Event|0
7111656|NCT02512302|11244576|FG002|Period 2|Adverse Event|0
7111657|NCT02512302|11244577|FG003|Period 2|Adverse Event|0
7111658|NCT02512302|11244578|FG004|Period 2|Adverse Event|0
7111659|NCT02512302|11244579|FG005|Period 2|Adverse Event|0
7111660|NCT02512302|11244580|FG006|Period 2|Adverse Event|0
7111661|NCT02512302|11244581|FG007|Period 2|Adverse Event|0
7111662|NCT02512302|11244582|FG008|Period 2|Adverse Event|0
7111663|NCT02512302|11244583|FG009|Period 2|Adverse Event|1
7111664|NCT02512302|11244574|FG000|Period 3|Lost to Follow-up|0
7111665|NCT02512302|11244575|FG001|Period 3|Lost to Follow-up|0
7111666|NCT02512302|11244576|FG002|Period 3|Lost to Follow-up|1
7111667|NCT02512302|11244577|FG003|Period 3|Lost to Follow-up|0
7111668|NCT02512302|11244578|FG004|Period 3|Lost to Follow-up|0
7111669|NCT02512302|11244579|FG005|Period 3|Lost to Follow-up|0
7111670|NCT02512302|11244580|FG006|Period 3|Lost to Follow-up|0
7111671|NCT02512302|11244581|FG007|Period 3|Lost to Follow-up|0
7111672|NCT02512302|11244582|FG008|Period 3|Lost to Follow-up|0
7111673|NCT02512302|11244583|FG009|Period 3|Lost to Follow-up|0
7111674|NCT02512302|11244574|FG000|Period 4|Adverse Event|0
7111675|NCT02512302|11244575|FG001|Period 4|Adverse Event|0
7111676|NCT02512302|11244576|FG002|Period 4|Adverse Event|0
7111677|NCT02512302|11244577|FG003|Period 4|Adverse Event|0
7111678|NCT02512302|11244578|FG004|Period 4|Adverse Event|0
7111679|NCT02512302|11244579|FG005|Period 4|Adverse Event|0
7111680|NCT02512302|11244580|FG006|Period 4|Adverse Event|1
7111681|NCT02512302|11244581|FG007|Period 4|Adverse Event|0
7111682|NCT02512302|11244582|FG008|Period 4|Adverse Event|0
7111683|NCT02512302|11244583|FG009|Period 4|Adverse Event|0
7111684|NCT02512861|11244678|FG000|Overall Study|Protocol Violation|3
7111685|NCT02512861|11244679|FG001|Overall Study|Protocol Violation|7
7111686|NCT02512861|11244678|FG000|Overall Study|Physician Decision|3
7111687|NCT02512861|11244679|FG001|Overall Study|Physician Decision|1
7111688|NCT02512861|11244678|FG000|Overall Study|Withdrawal by Subject|0
7111689|NCT02512861|11244679|FG001|Overall Study|Withdrawal by Subject|1
7111690|NCT02512965|11244701|FG000|Overall Study|Withdrawal by Subject|0
7111691|NCT02512965|11244702|FG001|Overall Study|Withdrawal by Subject|4
7111692|NCT02513160|11244732|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33
7111693|NCT02513160|11244733|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
7111694|NCT02513160|11244734|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
7111695|NCT02513160|11244735|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
7111696|NCT02513160|11244732|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214
7111697|NCT02513160|11244733|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
7111698|NCT02513160|11244734|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
7111699|NCT02513160|11244735|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
7111700|NCT02513160|11244732|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6
7111701|NCT02513160|11244733|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
7111702|NCT02513160|11244734|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
7111703|NCT02513160|11244735|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
7111704|NCT02513160|11244732|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4
7111705|NCT02513160|11244733|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0
7111706|NCT02513160|11244734|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0
7111707|NCT02513160|11244735|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0
7111708|NCT02513160|11244732|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20
7111709|NCT02513160|11244733|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
7111710|NCT02513160|11244734|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
7111711|NCT02513160|11244735|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
7111712|NCT02513160|11244732|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1
7111713|NCT02513160|11244733|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
7111714|NCT02513160|11244734|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
7111715|NCT02513160|11244735|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
7111716|NCT02513160|11244732|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10
7111717|NCT02513160|11244733|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
7111718|NCT02513160|11244734|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
7111719|NCT02513160|11244735|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
7111720|NCT02513160|11244732|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
7111721|NCT02513160|11244733|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
7111722|NCT02513160|11244734|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0
7111723|NCT02513160|11244735|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1
7111724|NCT02513160|11244732|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1
7111725|NCT02513160|11244733|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0
7111726|NCT02513160|11244734|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0
7111727|NCT02513160|11244735|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0
7111728|NCT02513160|11244732|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2
7111729|NCT02513160|11244733|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
7111730|NCT02513160|11244734|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
7111731|NCT02513160|11244735|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
7111732|NCT02513160|11244732|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1
7111733|NCT02513160|11244733|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
7111734|NCT02513160|11244734|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
7111735|NCT02513160|11244735|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
7111736|NCT02513160|11244732|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
7111737|NCT02513160|11244733|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1
7111738|NCT02513160|11244734|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
7111739|NCT02513160|11244735|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
7111740|NCT02513459|11244765|FG000|Overall Study|Adverse Event|7
7111741|NCT02513459|11244765|FG000|Overall Study|Withdrew consent|5
7111742|NCT02513459|11244765|FG000|Overall Study|Loss of efficacy|2
7111743|NCT02513459|11244765|FG000|Overall Study|Pregnancy|2
7111744|NCT02513459|11244765|FG000|Overall Study|Subject decision|2
7111745|NCT02513459|11244765|FG000|Overall Study|Lack of response|1
7111746|NCT02513459|11244765|FG000|Overall Study|Reproductive plans|1
7111747|NCT02513459|11244765|FG000|Overall Study|Surgery planned-- not done|1
7111748|NCT02513550|11244786|FG000|Double Blind Treatment Period|Withdrawal by Subject|11
7111749|NCT02513550|11244787|FG001|Double Blind Treatment Period|Withdrawal by Subject|11
7111750|NCT02513550|11244788|FG002|Double Blind Treatment Period|Withdrawal by Subject|25
7111751|NCT02513550|11244789|FG003|Double Blind Treatment Period|Withdrawal by Subject|0
7111752|NCT02513550|11244790|FG004|Double Blind Treatment Period|Withdrawal by Subject|0
7111753|NCT02513550|11244791|FG005|Double Blind Treatment Period|Withdrawal by Subject|0
7111754|NCT02513550|11244786|FG000|Double Blind Treatment Period|Adverse Event|5
7111755|NCT02513550|11244787|FG001|Double Blind Treatment Period|Adverse Event|13
7111756|NCT02513550|11244788|FG002|Double Blind Treatment Period|Adverse Event|17
7111757|NCT02513550|11244789|FG003|Double Blind Treatment Period|Adverse Event|0
7111758|NCT02513550|11244790|FG004|Double Blind Treatment Period|Adverse Event|1
7111759|NCT02513550|11244791|FG005|Double Blind Treatment Period|Adverse Event|0
7111760|NCT02513550|11244786|FG000|Double Blind Treatment Period|Lost to Follow-up|9
7111761|NCT02513550|11244787|FG001|Double Blind Treatment Period|Lost to Follow-up|7
7111762|NCT02513550|11244788|FG002|Double Blind Treatment Period|Lost to Follow-up|11
7111763|NCT02513550|11244789|FG003|Double Blind Treatment Period|Lost to Follow-up|0
7111764|NCT02513550|11244790|FG004|Double Blind Treatment Period|Lost to Follow-up|0
7111765|NCT02513550|11244791|FG005|Double Blind Treatment Period|Lost to Follow-up|1
7111766|NCT02513550|11244786|FG000|Double Blind Treatment Period|Lack of Efficacy|4
7111767|NCT02513550|11244787|FG001|Double Blind Treatment Period|Lack of Efficacy|5
7111768|NCT02513550|11244788|FG002|Double Blind Treatment Period|Lack of Efficacy|6
7111769|NCT02513550|11244789|FG003|Double Blind Treatment Period|Lack of Efficacy|0
7111770|NCT02513550|11244790|FG004|Double Blind Treatment Period|Lack of Efficacy|0
7111771|NCT02513550|11244791|FG005|Double Blind Treatment Period|Lack of Efficacy|0
7111772|NCT02513550|11244786|FG000|Double Blind Treatment Period|Protocol Violation|1
7111773|NCT02513550|11244787|FG001|Double Blind Treatment Period|Protocol Violation|1
7111774|NCT02513550|11244788|FG002|Double Blind Treatment Period|Protocol Violation|4
7111775|NCT02513550|11244789|FG003|Double Blind Treatment Period|Protocol Violation|0
7111776|NCT02513550|11244790|FG004|Double Blind Treatment Period|Protocol Violation|0
7111777|NCT02513550|11244791|FG005|Double Blind Treatment Period|Protocol Violation|0
7111778|NCT02513550|11244786|FG000|Double Blind Treatment Period|Physician Decision|2
7111779|NCT02513550|11244787|FG001|Double Blind Treatment Period|Physician Decision|0
7111780|NCT02513550|11244788|FG002|Double Blind Treatment Period|Physician Decision|4
7111781|NCT02513550|11244789|FG003|Double Blind Treatment Period|Physician Decision|0
7111782|NCT02513550|11244790|FG004|Double Blind Treatment Period|Physician Decision|0
7111783|NCT02513550|11244791|FG005|Double Blind Treatment Period|Physician Decision|0
7111784|NCT02513550|11244786|FG000|Double Blind Treatment Period|Site terminated by sponsor|1
7111785|NCT02513550|11244787|FG001|Double Blind Treatment Period|Site terminated by sponsor|1
7111786|NCT02513550|11244788|FG002|Double Blind Treatment Period|Site terminated by sponsor|3
7111787|NCT02513550|11244789|FG003|Double Blind Treatment Period|Site terminated by sponsor|0
7111788|NCT02513550|11244790|FG004|Double Blind Treatment Period|Site terminated by sponsor|0
7111789|NCT02513550|11244791|FG005|Double Blind Treatment Period|Site terminated by sponsor|0
7111790|NCT02513550|11244786|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
7111791|NCT02513550|11244787|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
7111792|NCT02513550|11244788|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1
7111793|NCT02513550|11244789|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
7111794|NCT02513550|11244790|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
7111795|NCT02513550|11244791|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
7111796|NCT02513550|11244786|FG000|Double Blind Treatment Period|Due to personal business|2
7111797|NCT02513550|11244787|FG001|Double Blind Treatment Period|Due to personal business|0
7111798|NCT02513550|11244788|FG002|Double Blind Treatment Period|Due to personal business|1
7111799|NCT02513550|11244789|FG003|Double Blind Treatment Period|Due to personal business|0
7111800|NCT02513550|11244790|FG004|Double Blind Treatment Period|Due to personal business|0
7111801|NCT02513550|11244791|FG005|Double Blind Treatment Period|Due to personal business|0
7111802|NCT02513550|11244786|FG000|Double Blind Treatment Period|Death|1
7111803|NCT02513550|11244787|FG001|Double Blind Treatment Period|Death|0
7111804|NCT02513550|11244788|FG002|Double Blind Treatment Period|Death|2
7111805|NCT02513550|11244789|FG003|Double Blind Treatment Period|Death|0
7111806|NCT02513550|11244790|FG004|Double Blind Treatment Period|Death|0
7111807|NCT02513550|11244791|FG005|Double Blind Treatment Period|Death|0
7111808|NCT02513550|11244786|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12
7111809|NCT02513550|11244787|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20
7111810|NCT02513550|11244788|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26
7111811|NCT02513550|11244789|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0
7111812|NCT02513550|11244790|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0
7111813|NCT02513550|11244791|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0
7111814|NCT02513550|11244786|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12
7111815|NCT02513550|11244787|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16
7111816|NCT02513550|11244788|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20
7111817|NCT02513550|11244789|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
7111818|NCT02513550|11244790|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
7111819|NCT02513550|11244791|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
7111820|NCT02513550|11244786|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4
7111821|NCT02513550|11244787|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2
7111822|NCT02513550|11244788|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7
7111823|NCT02513550|11244789|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0
7111824|NCT02513550|11244790|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0
7111825|NCT02513550|11244791|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0
7111826|NCT02513550|11244786|FG000|Post-Treatment Follow-up Period|Adverse Event|1
7111827|NCT02513550|11244787|FG001|Post-Treatment Follow-up Period|Adverse Event|1
7111828|NCT02513550|11244788|FG002|Post-Treatment Follow-up Period|Adverse Event|4
7111829|NCT02513550|11244789|FG003|Post-Treatment Follow-up Period|Adverse Event|0
7111830|NCT02513550|11244790|FG004|Post-Treatment Follow-up Period|Adverse Event|0
7111831|NCT02513550|11244791|FG005|Post-Treatment Follow-up Period|Adverse Event|0
7111832|NCT02513550|11244786|FG000|Post-Treatment Follow-up Period|Physician Decision|2
7111833|NCT02513550|11244787|FG001|Post-Treatment Follow-up Period|Physician Decision|0
7111834|NCT02513550|11244788|FG002|Post-Treatment Follow-up Period|Physician Decision|0
7111835|NCT02513550|11244789|FG003|Post-Treatment Follow-up Period|Physician Decision|0
7111836|NCT02513550|11244790|FG004|Post-Treatment Follow-up Period|Physician Decision|0
7111837|NCT02513550|11244791|FG005|Post-Treatment Follow-up Period|Physician Decision|0
7111838|NCT02513550|11244786|FG000|Post-Treatment Follow-up Period|Death|0
7111839|NCT02513550|11244787|FG001|Post-Treatment Follow-up Period|Death|0
7111840|NCT02513550|11244788|FG002|Post-Treatment Follow-up Period|Death|1
7111841|NCT02513550|11244789|FG003|Post-Treatment Follow-up Period|Death|0
7111842|NCT02513550|11244790|FG004|Post-Treatment Follow-up Period|Death|0
7111843|NCT02513550|11244791|FG005|Post-Treatment Follow-up Period|Death|0
7111844|NCT02513550|11244786|FG000|Post-Treatment Follow-up Period|Subject move out of town|0
7111845|NCT02513550|11244787|FG001|Post-Treatment Follow-up Period|Subject move out of town|0
7111846|NCT02513550|11244788|FG002|Post-Treatment Follow-up Period|Subject move out of town|1
7111847|NCT02513550|11244789|FG003|Post-Treatment Follow-up Period|Subject move out of town|0
7111848|NCT02513550|11244790|FG004|Post-Treatment Follow-up Period|Subject move out of town|0
7111849|NCT02513550|11244791|FG005|Post-Treatment Follow-up Period|Subject move out of town|0
7111850|NCT02513550|11244786|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
7111851|NCT02513550|11244787|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
7111852|NCT02513550|11244788|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3
7111853|NCT02513550|11244789|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
7111854|NCT02513550|11244790|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
7111855|NCT02513550|11244791|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
7111856|NCT02513550|11244786|FG000|Post-Treatment Follow-up Period|Labor Reasons|0
7111857|NCT02513550|11244787|FG001|Post-Treatment Follow-up Period|Labor Reasons|0
7111858|NCT02513550|11244788|FG002|Post-Treatment Follow-up Period|Labor Reasons|1
7111859|NCT02513550|11244789|FG003|Post-Treatment Follow-up Period|Labor Reasons|0
7111860|NCT02513550|11244790|FG004|Post-Treatment Follow-up Period|Labor Reasons|0
7111861|NCT02513550|11244791|FG005|Post-Treatment Follow-up Period|Labor Reasons|0
7111862|NCT02513732|11244821|FG000|Overall Study|Lost to Follow-up|11
7111863|NCT02513732|11244821|FG000|Overall Study|Death|9
7111864|NCT02513732|11244821|FG000|Overall Study|Changing hospital|2
7111865|NCT02513745|11244827|FG000|Overall Study|Criteria at time of surgery not met.|3
7111866|NCT02513745|11244828|FG001|Overall Study|Criteria at time of surgery not met.|3
7111867|NCT02513771|11244836|FG000|Overall Study|Lost to Follow-up|1
7111868|NCT02513771|11244837|FG001|Overall Study|Lost to Follow-up|1
7111869|NCT02513771|11244836|FG000|Overall Study|Not being able to get to clinic|1
7111870|NCT02513771|11244837|FG001|Overall Study|Not being able to get to clinic|0
7111871|NCT02513823|11244843|FG000|Overall Study|Lost to Follow-up|4
7111872|NCT02513823|11244843|FG000|Overall Study|Physician Decision|1
7111873|NCT02514122|11244885|FG000|Overall Study|Withdrawal by Subject|2
7111874|NCT02514122|11244886|FG001|Overall Study|Withdrawal by Subject|0
7111875|NCT02514174|11244892|FG000|Overall Study|Patient refused to continue medication|1
7111876|NCT02514174|11244892|FG000|Overall Study|Adverse Event|2
7111877|NCT02514174|11244892|FG000|Overall Study|Study closed by sponsor|9
7111878|NCT02514174|11244892|FG000|Overall Study|Progressive disease|11
7111879|NCT02514174|11244892|FG000|Overall Study|Treatment change|1
7111880|NCT02514174|11244892|FG000|Overall Study|Treated off study with Afatinib.|1
7111881|NCT02514473|11244898|FG000|Overall Study|Adverse Event|0
7111882|NCT02514473|11244899|FG001|Overall Study|Adverse Event|2
7111883|NCT02514473|11244898|FG000|Overall Study|Withdrawal by Subject|2
7111884|NCT02514473|11244899|FG001|Overall Study|Withdrawal by Subject|1
7111885|NCT02514473|11244898|FG000|Overall Study|Lost to Follow-up|0
7111886|NCT02514473|11244899|FG001|Overall Study|Lost to Follow-up|1
7111887|NCT02514473|11244898|FG000|Overall Study|Other|1
7111888|NCT02514473|11244899|FG001|Overall Study|Other|1
7111889|NCT02514551|11244908|FG000|Overall Study|Lost to Follow-up|0
7111890|NCT02514551|11244909|FG001|Overall Study|Lost to Follow-up|1
7111891|NCT02514551|11244908|FG000|Overall Study|Participant Never Treated|0
7111892|NCT02514551|11244909|FG001|Overall Study|Participant Never Treated|2
7111893|NCT02514577|11244918|FG000|Overall Study|Lost to Follow-up|6
7111894|NCT02514577|11244919|FG001|Overall Study|Lost to Follow-up|6
7111895|NCT02514577|11244918|FG000|Overall Study|Protocol Violation|1
7111896|NCT02514577|11244919|FG001|Overall Study|Protocol Violation|0
7111897|NCT02514577|11244918|FG000|Overall Study|Withdrawal by Subject|6
7111898|NCT02514577|11244919|FG001|Overall Study|Withdrawal by Subject|6
7111899|NCT02514577|11244918|FG000|Overall Study|Adverse Event|1
7111900|NCT02514577|11244919|FG001|Overall Study|Adverse Event|1
7111901|NCT02514746|11244927|FG000|Overall Study|Chronically Ill|1
7111902|NCT02514746|11244928|FG001|Overall Study|Chronically Ill|2
7111903|NCT02514746|11244927|FG000|Overall Study|Physician Decision|4
7111904|NCT02514746|11244928|FG001|Overall Study|Physician Decision|2
7111905|NCT02514746|11244927|FG000|Overall Study|Withdrawal by Subject|12
7111906|NCT02514746|11244928|FG001|Overall Study|Withdrawal by Subject|10
7111907|NCT02514746|11244927|FG000|Overall Study|Other|5
7111908|NCT02514746|11244928|FG001|Overall Study|Other|1
7111909|NCT02514772|11244938|FG000|Overall Study|Adverse Event|1
7111910|NCT02514772|11244939|FG001|Overall Study|Adverse Event|0
7111911|NCT02514772|11244938|FG000|Overall Study|Death|0
7111912|NCT02514772|11244939|FG001|Overall Study|Death|1
7111913|NCT02514772|11244938|FG000|Overall Study|Withdrawal by Subject|2
7111914|NCT02514772|11244939|FG001|Overall Study|Withdrawal by Subject|1
7111915|NCT02514824|11244949|FG000|Overall Study|Withdrawal by Subject|1
7111916|NCT02514824|11244950|FG001|Overall Study|Withdrawal by Subject|0
7111917|NCT02514824|11244951|FG002|Overall Study|Withdrawal by Subject|0
7111918|NCT02514824|11244952|FG003|Overall Study|Withdrawal by Subject|0
7111919|NCT02514824|11244949|FG000|Overall Study|Dose-Limiting Toxicity|0
7111920|NCT02514824|11244950|FG001|Overall Study|Dose-Limiting Toxicity|1
7111921|NCT02514824|11244951|FG002|Overall Study|Dose-Limiting Toxicity|0
7111922|NCT02514824|11244952|FG003|Overall Study|Dose-Limiting Toxicity|0
7111923|NCT02515045|11244970|FG000|Overall Study|Adverse Event|0
7111924|NCT02515045|11244971|FG001|Overall Study|Adverse Event|3
7111925|NCT02515045|11244972|FG002|Overall Study|Adverse Event|3
7111926|NCT02515045|11244970|FG000|Overall Study|Lost to Follow-up|0
7111927|NCT02515045|11244971|FG001|Overall Study|Lost to Follow-up|1
7111928|NCT02515045|11244972|FG002|Overall Study|Lost to Follow-up|1
7111929|NCT02515097|11244991|FG000|Overall Study|Lost to Follow-up|4
7111930|NCT02515097|11244992|FG001|Overall Study|Lost to Follow-up|2
7111931|NCT02515097|11244991|FG000|Overall Study|Withdrawal by Subject|1
7111932|NCT02515097|11244992|FG001|Overall Study|Withdrawal by Subject|3
7111933|NCT02515097|11244991|FG000|Overall Study|Adverse Event|2
7111934|NCT02515097|11244992|FG001|Overall Study|Adverse Event|1
7111935|NCT02515279|11245007|FG000|Overall Study|Adverse Event|7
7111936|NCT02515279|11245007|FG000|Overall Study|Lack of Efficacy|31
7111937|NCT02515279|11245007|FG000|Overall Study|Lost to Follow-up|9
7111938|NCT02515279|11245007|FG000|Overall Study|Withdrawal by Subject|18
7111939|NCT02515279|11245007|FG000|Overall Study|End-of-treatment visit not attended|17
7111940|NCT02515279|11245007|FG000|Overall Study|Other|22
7111941|NCT02515331|11245027|FG000|Overall Study|Withdrawal by Subject|0
7111942|NCT02515331|11245028|FG001|Overall Study|Withdrawal by Subject|0
7111943|NCT02515331|11245029|FG002|Overall Study|Withdrawal by Subject|1
7111944|NCT02515331|11245027|FG000|Overall Study|Protocol deviation|0
7111945|NCT02515331|11245028|FG001|Overall Study|Protocol deviation|0
7111946|NCT02515331|11245029|FG002|Overall Study|Protocol deviation|3
7111947|NCT02515331|11245027|FG000|Overall Study|Adverse Event|2
7111948|NCT02515331|11245028|FG001|Overall Study|Adverse Event|0
7111949|NCT02515331|11245029|FG002|Overall Study|Adverse Event|0
7111950|NCT02515630|11245039|FG000|Overall Study|Withdrawal by Subject|5
7111951|NCT02515630|11245039|FG000|Overall Study|Adverse Event|4
7111952|NCT02515630|11245039|FG000|Overall Study|Physician Decision|4
7111953|NCT02515630|11245039|FG000|Overall Study|Death|2
7111954|NCT02515630|11245039|FG000|Overall Study|Disease Progression|1
7111955|NCT02515669|11245059|FG000|228 Week Open-Label Phase|Other|0
7111956|NCT02515669|11245060|FG001|228 Week Open-Label Phase|Other|0
7111957|NCT02515669|11245061|FG002|228 Week Open-Label Phase|Other|1
7111958|NCT02515669|11245062|FG003|228 Week Open-Label Phase|Other|4
7111959|NCT02515669|11245059|FG000|228 Week Open-Label Phase|Lack of Efficacy|0
7111960|NCT02515669|11245060|FG001|228 Week Open-Label Phase|Lack of Efficacy|0
7111961|NCT02515669|11245061|FG002|228 Week Open-Label Phase|Lack of Efficacy|1
7111962|NCT02515669|11245062|FG003|228 Week Open-Label Phase|Lack of Efficacy|0
7111963|NCT02515669|11245059|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0
7111964|NCT02515669|11245060|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0
7111965|NCT02515669|11245061|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2
7111966|NCT02515669|11245062|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3
7111967|NCT02515669|11245059|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0
7111968|NCT02515669|11245060|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7
7111969|NCT02515669|11245061|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2
7111970|NCT02515669|11245062|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17
7111971|NCT02515669|11245059|FG000|228 Week Open-Label Phase|Missing|0
7111972|NCT02515669|11245060|FG001|228 Week Open-Label Phase|Missing|2
7111973|NCT02515669|11245061|FG002|228 Week Open-Label Phase|Missing|2
7111974|NCT02515669|11245062|FG003|228 Week Open-Label Phase|Missing|2
7111975|NCT02515942|11245125|FG000|Overall Study|Adverse Event|5
7111976|NCT02515942|11245126|FG001|Overall Study|Adverse Event|0
7111977|NCT02515942|11245127|FG002|Overall Study|Adverse Event|0
7111978|NCT02515942|11245125|FG000|Overall Study|Death|0
7111979|NCT02515942|11245126|FG001|Overall Study|Death|0
7111980|NCT02515942|11245127|FG002|Overall Study|Death|1
7111981|NCT02515942|11245125|FG000|Overall Study|Lack of Efficacy|0
7111982|NCT02515942|11245126|FG001|Overall Study|Lack of Efficacy|0
7111983|NCT02515942|11245127|FG002|Overall Study|Lack of Efficacy|1
7111984|NCT02515942|11245125|FG000|Overall Study|Lost to Follow-up|2
7111985|NCT02515942|11245126|FG001|Overall Study|Lost to Follow-up|0
7111986|NCT02515942|11245127|FG002|Overall Study|Lost to Follow-up|0
7111987|NCT02515942|11245125|FG000|Overall Study|Withdrawal by Subject|0
7111988|NCT02515942|11245126|FG001|Overall Study|Withdrawal by Subject|3
7111989|NCT02515942|11245127|FG002|Overall Study|Withdrawal by Subject|2
7111990|NCT02515994|11245139|FG000|Overall Study|Protocol Violation|3
7111991|NCT02515994|11245140|FG001|Overall Study|Protocol Violation|5
7111992|NCT02515994|11245139|FG000|Overall Study|No Longer Meets Eligibility Criteria|2
7111993|NCT02515994|11245140|FG001|Overall Study|No Longer Meets Eligibility Criteria|1
7111994|NCT02515994|11245139|FG000|Overall Study|Adverse Event|3
7111995|NCT02515994|11245140|FG001|Overall Study|Adverse Event|1
7111996|NCT02515994|11245139|FG000|Overall Study|Withdrawal by Subject|2
7111997|NCT02515994|11245140|FG001|Overall Study|Withdrawal by Subject|0
7111998|NCT02516098|11245162|FG000|Period 1|Protocol Violation|1
7111999|NCT02516098|11245163|FG001|Period 1|Protocol Violation|0
7112000|NCT02516098|11245162|FG000|Washout After Period 1|Adverse Event|0
7112001|NCT02516098|11245163|FG001|Washout After Period 1|Adverse Event|1
7112002|NCT02516098|11245162|FG000|Period 2|Withdrawal by Subject|0
7112003|NCT02516098|11245163|FG001|Period 2|Withdrawal by Subject|1
7112004|NCT02516163|11245175|FG000|Overall Study|Withdrawal by Subject|1
7112005|NCT02516163|11245175|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11
7112006|NCT02516163|11245175|FG000|Overall Study|Unfit/delay in surgery|3
7112007|NCT02516163|11245175|FG000|Overall Study|Use of incorrect measurement technique|5
7112008|NCT02516163|11245175|FG000|Overall Study|Data not recorded|2
7112009|NCT02516163|11245175|FG000|Overall Study|MRI contraindication exclusion|6
7112010|NCT02516202|11245182|FG000|Overall Study|Withdrawal by Subject|1
7112011|NCT02516202|11245183|FG001|Overall Study|Withdrawal by Subject|0
7112012|NCT02516202|11245184|FG002|Overall Study|Withdrawal by Subject|1
7112013|NCT02516202|11245182|FG000|Overall Study|Lost to Follow-up|1
7112014|NCT02516202|11245183|FG001|Overall Study|Lost to Follow-up|1
7112015|NCT02516202|11245184|FG002|Overall Study|Lost to Follow-up|1
7112016|NCT02516202|11245182|FG000|Overall Study|Stopped Follow-up|0
7112017|NCT02516202|11245183|FG001|Overall Study|Stopped Follow-up|0
7112018|NCT02516202|11245184|FG002|Overall Study|Stopped Follow-up|1
7112019|NCT02516306|11245194|FG000|Period 2: Day 8 - 91|Protocol Violation|1
7112020|NCT02516306|11245195|FG001|Period 2: Day 8 - 91|Protocol Violation|2
7112021|NCT02516332|11245204|FG000|Overall Study|Withdrawal by Subject|2
7112022|NCT02516332|11245205|FG001|Overall Study|Withdrawal by Subject|1
7112023|NCT02516332|11245206|FG002|Overall Study|Withdrawal by Subject|2
7112024|NCT02516410|11245216|FG000|Overall Study|Adverse Event|0
7112025|NCT02516410|11245217|FG001|Overall Study|Adverse Event|1
7112026|NCT02516410|11245216|FG000|Overall Study|Withdrawal by Subject|0
7112027|NCT02516410|11245217|FG001|Overall Study|Withdrawal by Subject|1
7112028|NCT02516592|11245230|FG000|Overall Study|Patient withdrew consent|5
7112029|NCT02516592|11245231|FG001|Overall Study|Patient withdrew consent|2
7112030|NCT02516592|11245230|FG000|Overall Study|Protocol deviation|4
7112031|NCT02516592|11245231|FG001|Overall Study|Protocol deviation|4
7112032|NCT02516592|11245230|FG000|Overall Study|Lost to Follow-up|2
7112033|NCT02516592|11245231|FG001|Overall Study|Lost to Follow-up|3
7112034|NCT02516592|11245230|FG000|Overall Study|Patient/guardian decision|2
7112035|NCT02516592|11245231|FG001|Overall Study|Patient/guardian decision|1
7112036|NCT02516592|11245230|FG000|Overall Study|Adverse Event|1
7112037|NCT02516592|11245231|FG001|Overall Study|Adverse Event|2
7112038|NCT02516592|11245230|FG000|Overall Study|Abnormal test procedure result|1
7112039|NCT02516592|11245231|FG001|Overall Study|Abnormal test procedure result|0
7112040|NCT02516592|11245230|FG000|Overall Study|Death|1
7112041|NCT02516592|11245231|FG001|Overall Study|Death|1
7112042|NCT02516605|11245242|FG000|Overall Study|Protocol Violation|0
7112043|NCT02516605|11245243|FG001|Overall Study|Protocol Violation|0
7112044|NCT02516605|11245244|FG002|Overall Study|Protocol Violation|0
7112045|NCT02516605|11245245|FG003|Overall Study|Protocol Violation|0
7112046|NCT02516605|11245246|FG004|Overall Study|Protocol Violation|1
7112047|NCT02516605|11245242|FG000|Overall Study|Withdrawal by Subject|0
7112048|NCT02516605|11245243|FG001|Overall Study|Withdrawal by Subject|0
7112049|NCT02516605|11245244|FG002|Overall Study|Withdrawal by Subject|0
7112050|NCT02516605|11245245|FG003|Overall Study|Withdrawal by Subject|1
7112051|NCT02516605|11245246|FG004|Overall Study|Withdrawal by Subject|0
7112052|NCT02516982|11245266|FG000|Overall Study|Called in to antenatal appointment|32
7112053|NCT02516982|11245267|FG001|Overall Study|Called in to antenatal appointment|35
7112054|NCT02516982|11245268|FG002|Overall Study|Called in to antenatal appointment|0
7112055|NCT02516982|11245269|FG003|Overall Study|Called in to antenatal appointment|0
7112056|NCT02516982|11245266|FG000|Overall Study|Withdrawal by Subject|0
7112057|NCT02516982|11245267|FG001|Overall Study|Withdrawal by Subject|0
7112058|NCT02516982|11245268|FG002|Overall Study|Withdrawal by Subject|1
7112059|NCT02516982|11245269|FG003|Overall Study|Withdrawal by Subject|2
7112060|NCT02516982|11245266|FG000|Overall Study|Protocol Violation|0
7112061|NCT02516982|11245267|FG001|Overall Study|Protocol Violation|0
7112062|NCT02516982|11245268|FG002|Overall Study|Protocol Violation|1
7112063|NCT02516982|11245269|FG003|Overall Study|Protocol Violation|1
7112064|NCT02516982|11245266|FG000|Overall Study|Did not install the app|0
7112065|NCT02516982|11245267|FG001|Overall Study|Did not install the app|0
7112066|NCT02516982|11245268|FG002|Overall Study|Did not install the app|46
7112067|NCT02516982|11245269|FG003|Overall Study|Did not install the app|47
7112068|NCT02517268|11245295|FG000|Overall Study|Withdrawal by Subject|1
7112069|NCT02517268|11245296|FG001|Overall Study|Withdrawal by Subject|0
7112070|NCT02517463|11245304|FG000|Overall Study|Lost to Follow-up|5
7112071|NCT02517463|11245305|FG001|Overall Study|Lost to Follow-up|2
7112072|NCT02517515|11245313|FG000|Overall Study|Adverse Event|0
7112073|NCT02517515|11245314|FG001|Overall Study|Adverse Event|1
7112074|NCT02517515|11245313|FG000|Overall Study|Withdrew Consent|0
7112075|NCT02517515|11245314|FG001|Overall Study|Withdrew Consent|1
7112076|NCT02517515|11245313|FG000|Overall Study|Lost to Follow-up|1
7112077|NCT02517515|11245314|FG001|Overall Study|Lost to Follow-up|0
7112078|NCT02517515|11245313|FG000|Overall Study|Other|1
7112079|NCT02517515|11245314|FG001|Overall Study|Other|0
7112080|NCT02517528|11245321|FG000|Overall Study|Withdrawal by Subject|1
7112081|NCT02517541|11245325|FG000|Baseline Period (Own Product)|Protocol Violation|1
7112082|NCT02517541|11245325|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3
7112083|NCT02517541|11245325|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2
7112084|NCT02517541|11245325|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1
7112085|NCT02517541|11245325|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4
7112086|NCT02517541|11245325|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2
7112087|NCT02517866|11245360|FG000|Overall Study|Pretreatment Event/Adverse Event|9
7112088|NCT02517866|11245361|FG001|Overall Study|Pretreatment Event/Adverse Event|2
7112089|NCT02517866|11245362|FG002|Overall Study|Pretreatment Event/Adverse Event|0
7112090|NCT02517866|11245360|FG000|Overall Study|Significant Protocol Deviation|4
7112091|NCT02517866|11245361|FG001|Overall Study|Significant Protocol Deviation|1
7112092|NCT02517866|11245362|FG002|Overall Study|Significant Protocol Deviation|0
7112093|NCT02517866|11245360|FG000|Overall Study|Lost to Follow-up|1
7112094|NCT02517866|11245361|FG001|Overall Study|Lost to Follow-up|0
7112095|NCT02517866|11245362|FG002|Overall Study|Lost to Follow-up|0
7112096|NCT02517866|11245360|FG000|Overall Study|Voluntary Withdrawal|2
7112097|NCT02517866|11245361|FG001|Overall Study|Voluntary Withdrawal|2
7112098|NCT02517866|11245362|FG002|Overall Study|Voluntary Withdrawal|0
7112099|NCT02517866|11245360|FG000|Overall Study|Investigator Decision|2
7112100|NCT02517866|11245361|FG001|Overall Study|Investigator Decision|1
7112101|NCT02517866|11245362|FG002|Overall Study|Investigator Decision|0
7112102|NCT02517866|11245360|FG000|Overall Study|Reason not specified|2
7112103|NCT02517866|11245361|FG001|Overall Study|Reason not specified|0
7112104|NCT02517866|11245362|FG002|Overall Study|Reason not specified|0
7112105|NCT02517905|11245374|FG000|Overall Study|Lost to Follow-up|4
7112106|NCT02517905|11245375|FG001|Overall Study|Lost to Follow-up|0
7112107|NCT02517905|11245374|FG000|Overall Study|Withdrawal by Subject|4
7112108|NCT02517905|11245375|FG001|Overall Study|Withdrawal by Subject|0
7112109|NCT02517905|11245374|FG000|Overall Study|Screen failure|2
7112110|NCT02517905|11245375|FG001|Overall Study|Screen failure|2
7112111|NCT02518048|11245390|FG000|Overall Study|Withdrawal by Subject|1
7112112|NCT02518113|11245399|FG000|Overall Study|Adverse Event|1
7112113|NCT02518113|11245400|FG001|Overall Study|Adverse Event|0
7112114|NCT02518113|11245401|FG002|Overall Study|Adverse Event|1
7112115|NCT02518113|11245402|FG003|Overall Study|Adverse Event|0
7112116|NCT02518113|11245399|FG000|Overall Study|Death|1
7112117|NCT02518113|11245400|FG001|Overall Study|Death|2
7112118|NCT02518113|11245401|FG002|Overall Study|Death|0
7112119|NCT02518113|11245402|FG003|Overall Study|Death|0
7112120|NCT02518113|11245399|FG000|Overall Study|Physician Decision|0
7112121|NCT02518113|11245400|FG001|Overall Study|Physician Decision|1
7112122|NCT02518113|11245401|FG002|Overall Study|Physician Decision|0
7112123|NCT02518113|11245402|FG003|Overall Study|Physician Decision|0
7112124|NCT02518113|11245399|FG000|Overall Study|Progressive Disease|1
7112125|NCT02518113|11245400|FG001|Overall Study|Progressive Disease|2
7112126|NCT02518113|11245401|FG002|Overall Study|Progressive Disease|3
7112127|NCT02518113|11245402|FG003|Overall Study|Progressive Disease|0
7112128|NCT02518464|11245436|FG000|Overall Study|Adverse Event|2
7112129|NCT02518490|11245440|FG000|Overall Study|Withdrawal by Subject|1
7112130|NCT02518490|11245441|FG001|Overall Study|Withdrawal by Subject|1
7112131|NCT02518620|11245450|FG000|Overall Study|Adverse Event|23
7112132|NCT02518620|11245451|FG001|Overall Study|Adverse Event|11
7112133|NCT02518620|11245450|FG000|Overall Study|Lack of Efficacy|2
7112134|NCT02518620|11245451|FG001|Overall Study|Lack of Efficacy|0
7112135|NCT02518620|11245450|FG000|Overall Study|Non-Compliance with Study Drug|1
7112136|NCT02518620|11245451|FG001|Overall Study|Non-Compliance with Study Drug|0
7112137|NCT02518620|11245450|FG000|Overall Study|Physician Decision|1
7112138|NCT02518620|11245451|FG001|Overall Study|Physician Decision|1
7112139|NCT02518620|11245450|FG000|Overall Study|Sponsor's Decision|0
7112140|NCT02518620|11245451|FG001|Overall Study|Sponsor's Decision|3
7112141|NCT02518620|11245450|FG000|Overall Study|Lost to Follow-up|1
7112142|NCT02518620|11245451|FG001|Overall Study|Lost to Follow-up|1
7112143|NCT02518620|11245450|FG000|Overall Study|Withdrawal by Subject|17
7112144|NCT02518620|11245451|FG001|Overall Study|Withdrawal by Subject|9
7112145|NCT02518620|11245450|FG000|Overall Study|Death|1
7112146|NCT02518620|11245451|FG001|Overall Study|Death|0
7112147|NCT02518620|11245450|FG000|Overall Study|Pregnancy Wish|3
7112148|NCT02518620|11245451|FG001|Overall Study|Pregnancy Wish|0
7112149|NCT02518620|11245450|FG000|Overall Study|Pregnancy|1
7112150|NCT02518620|11245451|FG001|Overall Study|Pregnancy|0
7112151|NCT02518620|11245450|FG000|Overall Study|Relocation|2
7112152|NCT02518620|11245451|FG001|Overall Study|Relocation|1
7112153|NCT02518685|11245461|FG000|Overall Study|Adverse Event|29
7112154|NCT02518685|11245462|FG001|Overall Study|Adverse Event|1
7112155|NCT02518685|11245461|FG000|Overall Study|Withdrawal by Subject|10
7112156|NCT02518685|11245462|FG001|Overall Study|Withdrawal by Subject|3
7112157|NCT02518685|11245461|FG000|Overall Study|relocation, study fatigue|7
7112158|NCT02518685|11245462|FG001|Overall Study|relocation, study fatigue|2
7112159|NCT02518685|11245461|FG000|Overall Study|Pregnancy|1
7112160|NCT02518685|11245462|FG001|Overall Study|Pregnancy|0
7112161|NCT02518685|11245461|FG000|Overall Study|Physician Decision|1
7112162|NCT02518685|11245462|FG001|Overall Study|Physician Decision|0
7112163|NCT02518685|11245461|FG000|Overall Study|Lost to Follow-up|1
7112164|NCT02518685|11245462|FG001|Overall Study|Lost to Follow-up|4
7112165|NCT02518919|11245472|FG000|Overall Study|Protocol Violation|1
7112166|NCT02518919|11245473|FG001|Overall Study|Protocol Violation|1
7112167|NCT02518919|11245474|FG002|Overall Study|Protocol Violation|2
7112168|NCT02518971|11245484|FG000|Overall Study|Lost to Follow-up|0
7112169|NCT02518971|11245485|FG001|Overall Study|Lost to Follow-up|1
7112170|NCT02518971|11245484|FG000|Overall Study|Physician Decision|6
7112171|NCT02518971|11245485|FG001|Overall Study|Physician Decision|6
7112172|NCT02518971|11245484|FG000|Overall Study|Protocol Violation|6
7112173|NCT02518971|11245485|FG001|Overall Study|Protocol Violation|4
7112174|NCT02518971|11245484|FG000|Overall Study|Withdrawal by Subject|4
7112175|NCT02518971|11245485|FG001|Overall Study|Withdrawal by Subject|5
7112176|NCT02518971|11245484|FG000|Overall Study|Side effects|1
7112177|NCT02518971|11245485|FG001|Overall Study|Side effects|0
7112178|NCT02518971|11245484|FG000|Overall Study|medication lost in mail|0
7112179|NCT02518971|11245485|FG001|Overall Study|medication lost in mail|1
7112180|NCT02518971|11245484|FG000|Overall Study|eligibility criteria no longer met|6
7112181|NCT02518971|11245485|FG001|Overall Study|eligibility criteria no longer met|3
7112182|NCT02519231|11245540|FG000|Overall Study|Lost to Follow-up|2
7112183|NCT02519231|11245541|FG001|Overall Study|Lost to Follow-up|5
7112184|NCT02519231|11245540|FG000|Overall Study|Withdrawal by Subject|0
7112185|NCT02519231|11245541|FG001|Overall Study|Withdrawal by Subject|1
7112186|NCT02519504|11245568|FG000|Overall Study|Protocol Violation|6
7112187|NCT02519504|11245569|FG001|Overall Study|Protocol Violation|5
7112188|NCT02519504|11245568|FG000|Overall Study|Ineligible for direct testing|12
7112189|NCT02519504|11245569|FG001|Overall Study|Ineligible for direct testing|12
7112190|NCT02519504|11245568|FG000|Overall Study|Did not participate in direct testing|95
7112191|NCT02519504|11245569|FG001|Overall Study|Did not participate in direct testing|86
7112192|NCT02519595|11245578|FG000|Overall Study|Protocol Violation|8
7112193|NCT02519595|11245579|FG001|Overall Study|Protocol Violation|22
7112194|NCT02519595|11245580|FG002|Overall Study|Protocol Violation|16
7112195|NCT02519842|11245603|FG000|Base Study: Cycle 1|Screening Failure|1
7112196|NCT02519842|11245604|FG001|Base Study: Cycle 1|Screening Failure|1
7112197|NCT02519842|11245605|FG002|Base Study: Cycle 1|Screening Failure|0
7112198|NCT02519842|11245603|FG000|Base Study: Cycle 1|Adverse Event|1
7112199|NCT02519842|11245604|FG001|Base Study: Cycle 1|Adverse Event|0
7112200|NCT02519842|11245605|FG002|Base Study: Cycle 1|Adverse Event|0
7112201|NCT02519842|11245603|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
7112202|NCT02519842|11245604|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1
7112203|NCT02519842|11245605|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
7112204|NCT02519842|11245603|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0
7112205|NCT02519842|11245604|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1
7112206|NCT02519842|11245605|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0
7112207|NCT02519842|11245603|FG000|Optional Extension: Cycles 2-6|Physician Decision|0
7112208|NCT02519842|11245604|FG001|Optional Extension: Cycles 2-6|Physician Decision|0
7112209|NCT02519842|11245605|FG002|Optional Extension: Cycles 2-6|Physician Decision|5
7112210|NCT02519842|11245603|FG000|Optional Extension: Cycles 2-6|Adverse Event|0
7112211|NCT02519842|11245604|FG001|Optional Extension: Cycles 2-6|Adverse Event|0
7112212|NCT02519842|11245605|FG002|Optional Extension: Cycles 2-6|Adverse Event|1
7112213|NCT02519842|11245603|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
7112214|NCT02519842|11245604|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
7112215|NCT02519842|11245605|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3
7112216|NCT02519842|11245603|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
7112217|NCT02519842|11245604|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
7112218|NCT02519842|11245605|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1
7112219|NCT02519842|11245603|FG000|Optional Extension: Cycles 2-6|Death|0
7112220|NCT02519842|11245604|FG001|Optional Extension: Cycles 2-6|Death|0
7112221|NCT02519842|11245605|FG002|Optional Extension: Cycles 2-6|Death|1
7112222|NCT02519842|11245603|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
7112223|NCT02519842|11245604|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
7112224|NCT02519842|11245605|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2
7112225|NCT02519842|11245603|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
7112226|NCT02519842|11245604|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
7112227|NCT02519842|11245605|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13
7112228|NCT02519842|11245603|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
7112229|NCT02519842|11245604|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
7112230|NCT02519842|11245605|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1
7112231|NCT02519842|11245603|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
7112232|NCT02519842|11245604|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
7112233|NCT02519842|11245605|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2
7112234|NCT02519855|11245615|FG000|Overall Study|Adverse Event|0
7112235|NCT02519855|11245616|FG001|Overall Study|Adverse Event|1
7112236|NCT02519855|11245615|FG000|Overall Study|Lost to Follow-up|3
7112237|NCT02519855|11245616|FG001|Overall Study|Lost to Follow-up|3
7112238|NCT02520089|11245624|FG000|Overall Study|Lost to Follow-up|3
7112239|NCT02520089|11245625|FG001|Overall Study|Lost to Follow-up|4
7112240|NCT02520284|11245634|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1
7112241|NCT02520284|11245635|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3
7112242|NCT02520284|11245636|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0
7112243|NCT02520284|11245634|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
7112244|NCT02520284|11245635|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
7112245|NCT02520284|11245636|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
7112246|NCT02520284|11245634|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0
7112247|NCT02520284|11245635|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0
7112248|NCT02520284|11245636|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1
7112249|NCT02520284|11245634|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17
7112250|NCT02520284|11245635|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11
7112251|NCT02520284|11245636|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15
7112252|NCT02520284|11245634|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2
7112253|NCT02520284|11245635|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2
7112254|NCT02520284|11245636|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3
7112255|NCT02520284|11245634|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1
7112256|NCT02520284|11245635|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1
7112257|NCT02520284|11245636|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0
7112258|NCT02520284|11245634|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0
7112259|NCT02520284|11245635|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2
7112260|NCT02520284|11245636|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0
7112261|NCT02520284|11245634|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25
7112262|NCT02520284|11245635|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29
7112263|NCT02520284|11245636|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28
7112264|NCT02520284|11245634|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3
7112265|NCT02520284|11245635|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4
7112266|NCT02520284|11245636|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2
7112267|NCT02520284|11245634|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2
7112268|NCT02520284|11245635|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1
7112269|NCT02520284|11245636|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3
7112270|NCT02520284|11245634|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2
7112271|NCT02520284|11245635|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1
7112272|NCT02520284|11245636|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1
7112273|NCT02520310|11245650|FG000|At 6 Months Clinical Follow-up|Death|1
7112274|NCT02520310|11245650|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1
7112275|NCT02520310|11245650|FG000|AT 3 Year Clinical Follow-up|Death|2
7112276|NCT02520310|11245650|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2
7112277|NCT02520310|11245650|FG000|AT 4 Year Clinical Follow-up|Death|1
7112278|NCT02520310|11245650|FG000|AT 4 Year Clinical Follow-up|missed visit|1
7112279|NCT02520388|11245658|FG000|Overall Study|Physician Decision|1
7112280|NCT02520388|11245659|FG001|Overall Study|Physician Decision|0
7112281|NCT02520388|11245658|FG000|Overall Study|Subject or parent/guardian request|0
7112282|NCT02520388|11245659|FG001|Overall Study|Subject or parent/guardian request|6
7112283|NCT02520388|11245658|FG000|Overall Study|Adverse Event|1
7112284|NCT02520388|11245659|FG001|Overall Study|Adverse Event|4
7112285|NCT02520388|11245658|FG000|Overall Study|Lost to Follow-up|3
7112286|NCT02520388|11245659|FG001|Overall Study|Lost to Follow-up|2
7112287|NCT02520388|11245658|FG000|Overall Study|Other (reason not defined)|4
7112288|NCT02520388|11245659|FG001|Overall Study|Other (reason not defined)|4
7112289|NCT02520531|11245690|FG000|Overall Study|Revision of study device components|2
7112290|NCT02520531|11245691|FG001|Overall Study|Revision of study device components|2
7112291|NCT02520531|11245690|FG000|Overall Study|Death|1
7112292|NCT02520531|11245691|FG001|Overall Study|Death|2
7112293|NCT02520531|11245690|FG000|Overall Study|Lost to Follow-up|1
7112294|NCT02520531|11245691|FG001|Overall Study|Lost to Follow-up|1
7112295|NCT02520531|11245690|FG000|Overall Study|Meet exclusion criterion|0
7112296|NCT02520531|11245691|FG001|Overall Study|Meet exclusion criterion|1
7112297|NCT02520531|11245690|FG000|Overall Study|Withdrawal by Subject|1
7112298|NCT02520531|11245691|FG001|Overall Study|Withdrawal by Subject|0
7112299|NCT02520531|11245690|FG000|Overall Study|Not study device|1
7112300|NCT02520531|11245691|FG001|Overall Study|Not study device|0
7112301|NCT02521376|11245723|FG000|Overall Study|Enrolled, But Not Treated|1
7112302|NCT02521376|11245724|FG001|Overall Study|Enrolled, But Not Treated|0
7112303|NCT02521376|11245725|FG002|Overall Study|Enrolled, But Not Treated|0
7112304|NCT02521376|11245726|FG003|Overall Study|Enrolled, But Not Treated|0
7112305|NCT02521792|11245764|FG000|Overall Study|Study Terminated|6
7112306|NCT02521870|11245776|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0
7112307|NCT02521870|11245777|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1
7112308|NCT02521870|11245778|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0
7112309|NCT02521870|11245779|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0
7112310|NCT02521870|11245780|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0
7112311|NCT02521870|11245781|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0
7112312|NCT02521870|11245782|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0
7112313|NCT02521870|11245783|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0
7112314|NCT02521870|11245784|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0
7112315|NCT02521870|11245785|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0
7112316|NCT02521870|11245786|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0
7112317|NCT02521870|11245787|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0
7112318|NCT02521870|11245776|FG000|Phase 1: Dose Escalation|Adverse Event|2
7112319|NCT02521870|11245777|FG001|Phase 1: Dose Escalation|Adverse Event|1
7112320|NCT02521870|11245778|FG002|Phase 1: Dose Escalation|Adverse Event|0
7112321|NCT02521870|11245779|FG003|Phase 1: Dose Escalation|Adverse Event|0
7112322|NCT02521870|11245780|FG004|Phase 1: Dose Escalation|Adverse Event|0
7112323|NCT02521870|11245781|FG005|Phase 1: Dose Escalation|Adverse Event|0
7112324|NCT02521870|11245782|FG006|Phase 1: Dose Escalation|Adverse Event|0
7112325|NCT02521870|11245783|FG007|Phase 1: Dose Escalation|Adverse Event|0
7112326|NCT02521870|11245784|FG008|Phase 1: Dose Escalation|Adverse Event|0
7112327|NCT02521870|11245785|FG009|Phase 1: Dose Escalation|Adverse Event|0
7112328|NCT02521870|11245786|FG010|Phase 1: Dose Escalation|Adverse Event|0
7112329|NCT02521870|11245787|FG011|Phase 1: Dose Escalation|Adverse Event|0
7112330|NCT02521870|11245776|FG000|Phase 1: Dose Escalation|Progressive Disease|3
7112331|NCT02521870|11245777|FG001|Phase 1: Dose Escalation|Progressive Disease|2
7112332|NCT02521870|11245778|FG002|Phase 1: Dose Escalation|Progressive Disease|4
7112333|NCT02521870|11245779|FG003|Phase 1: Dose Escalation|Progressive Disease|6
7112334|NCT02521870|11245780|FG004|Phase 1: Dose Escalation|Progressive Disease|0
7112335|NCT02521870|11245781|FG005|Phase 1: Dose Escalation|Progressive Disease|0
7112336|NCT02521870|11245782|FG006|Phase 1: Dose Escalation|Progressive Disease|0
7112337|NCT02521870|11245783|FG007|Phase 1: Dose Escalation|Progressive Disease|0
7112338|NCT02521870|11245784|FG008|Phase 1: Dose Escalation|Progressive Disease|0
7112339|NCT02521870|11245785|FG009|Phase 1: Dose Escalation|Progressive Disease|0
7112340|NCT02521870|11245786|FG010|Phase 1: Dose Escalation|Progressive Disease|0
7112341|NCT02521870|11245787|FG011|Phase 1: Dose Escalation|Progressive Disease|0
7112342|NCT02521870|11245776|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0
7112343|NCT02521870|11245777|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0
7112344|NCT02521870|11245778|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0
7112345|NCT02521870|11245779|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0
7112346|NCT02521870|11245780|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5
7112347|NCT02521870|11245781|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1
7112348|NCT02521870|11245782|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1
7112349|NCT02521870|11245783|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0
7112350|NCT02521870|11245784|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1
7112351|NCT02521870|11245785|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1
7112352|NCT02521870|11245786|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2
7112353|NCT02521870|11245787|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0
7112354|NCT02521870|11245776|FG000|Phase 2: Dose Expansion|Adverse Event|0
7112355|NCT02521870|11245777|FG001|Phase 2: Dose Expansion|Adverse Event|0
7112356|NCT02521870|11245778|FG002|Phase 2: Dose Expansion|Adverse Event|0
7112357|NCT02521870|11245779|FG003|Phase 2: Dose Expansion|Adverse Event|0
7112358|NCT02521870|11245780|FG004|Phase 2: Dose Expansion|Adverse Event|11
7112359|NCT02521870|11245781|FG005|Phase 2: Dose Expansion|Adverse Event|2
7112360|NCT02521870|11245782|FG006|Phase 2: Dose Expansion|Adverse Event|0
7112361|NCT02521870|11245783|FG007|Phase 2: Dose Expansion|Adverse Event|1
7112362|NCT02521870|11245784|FG008|Phase 2: Dose Expansion|Adverse Event|5
7112363|NCT02521870|11245785|FG009|Phase 2: Dose Expansion|Adverse Event|0
7112364|NCT02521870|11245786|FG010|Phase 2: Dose Expansion|Adverse Event|1
7112365|NCT02521870|11245787|FG011|Phase 2: Dose Expansion|Adverse Event|0
7112366|NCT02521870|11245776|FG000|Phase 2: Dose Expansion|Progressive Disease|0
7112367|NCT02521870|11245777|FG001|Phase 2: Dose Expansion|Progressive Disease|0
7112368|NCT02521870|11245778|FG002|Phase 2: Dose Expansion|Progressive Disease|0
7112369|NCT02521870|11245779|FG003|Phase 2: Dose Expansion|Progressive Disease|0
7112370|NCT02521870|11245780|FG004|Phase 2: Dose Expansion|Progressive Disease|22
7112371|NCT02521870|11245781|FG005|Phase 2: Dose Expansion|Progressive Disease|18
7112372|NCT02521870|11245782|FG006|Phase 2: Dose Expansion|Progressive Disease|17
7112373|NCT02521870|11245783|FG007|Phase 2: Dose Expansion|Progressive Disease|7
7112374|NCT02521870|11245784|FG008|Phase 2: Dose Expansion|Progressive Disease|5
7112375|NCT02521870|11245785|FG009|Phase 2: Dose Expansion|Progressive Disease|17
7112376|NCT02521870|11245786|FG010|Phase 2: Dose Expansion|Progressive Disease|17
7112377|NCT02521870|11245787|FG011|Phase 2: Dose Expansion|Progressive Disease|21
7112378|NCT02521870|11245776|FG000|Phase 2: Dose Expansion|Death|0
7112379|NCT02521870|11245777|FG001|Phase 2: Dose Expansion|Death|0
7112380|NCT02521870|11245778|FG002|Phase 2: Dose Expansion|Death|0
7112381|NCT02521870|11245779|FG003|Phase 2: Dose Expansion|Death|0
7112382|NCT02521870|11245780|FG004|Phase 2: Dose Expansion|Death|1
7112383|NCT02521870|11245781|FG005|Phase 2: Dose Expansion|Death|1
7112384|NCT02521870|11245782|FG006|Phase 2: Dose Expansion|Death|3
7112385|NCT02521870|11245783|FG007|Phase 2: Dose Expansion|Death|1
7112386|NCT02521870|11245784|FG008|Phase 2: Dose Expansion|Death|1
7112387|NCT02521870|11245785|FG009|Phase 2: Dose Expansion|Death|5
7112388|NCT02521870|11245786|FG010|Phase 2: Dose Expansion|Death|2
7112389|NCT02521870|11245787|FG011|Phase 2: Dose Expansion|Death|2
7112390|NCT02521870|11245776|FG000|Phase 2: Dose Expansion|Other|0
7112391|NCT02521870|11245777|FG001|Phase 2: Dose Expansion|Other|0
7112392|NCT02521870|11245778|FG002|Phase 2: Dose Expansion|Other|0
7112393|NCT02521870|11245779|FG003|Phase 2: Dose Expansion|Other|0
7112394|NCT02521870|11245780|FG004|Phase 2: Dose Expansion|Other|10
7112395|NCT02521870|11245781|FG005|Phase 2: Dose Expansion|Other|3
7112396|NCT02521870|11245782|FG006|Phase 2: Dose Expansion|Other|2
7112397|NCT02521870|11245783|FG007|Phase 2: Dose Expansion|Other|0
7112398|NCT02521870|11245784|FG008|Phase 2: Dose Expansion|Other|10
7112399|NCT02521870|11245785|FG009|Phase 2: Dose Expansion|Other|5
7112400|NCT02521870|11245786|FG010|Phase 2: Dose Expansion|Other|1
7112401|NCT02521870|11245787|FG011|Phase 2: Dose Expansion|Other|7
7112402|NCT02521870|11245776|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0
7112403|NCT02521870|11245777|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0
7112404|NCT02521870|11245778|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0
7112405|NCT02521870|11245779|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0
7112406|NCT02521870|11245780|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1
7112407|NCT02521870|11245781|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0
7112408|NCT02521870|11245782|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0
7112409|NCT02521870|11245783|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0
7112410|NCT02521870|11245784|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0
7112411|NCT02521870|11245785|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0
7112412|NCT02521870|11245786|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0
7112413|NCT02521870|11245787|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0
7112414|NCT02521870|11245776|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7112415|NCT02521870|11245777|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7112416|NCT02521870|11245778|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7112417|NCT02521870|11245779|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7112418|NCT02521870|11245780|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2
7112419|NCT02521870|11245781|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7112420|NCT02521870|11245782|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7112421|NCT02521870|11245783|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7112422|NCT02521870|11245784|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7112423|NCT02521870|11245785|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7112424|NCT02521870|11245786|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7112425|NCT02521870|11245787|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7112426|NCT02521948|11245817|FG000|Overall Study|Adverse Event|2
7112427|NCT02521948|11245817|FG000|Overall Study|Death|4
7112428|NCT02521948|11245817|FG000|Overall Study|Lost to Follow-up|1
7112429|NCT02521948|11245817|FG000|Overall Study|Did not attend one or both follow-ups|6
7112430|NCT02522286|11245854|FG000|Overall Study|Withdrawal by Subject|3
7112431|NCT02522286|11245855|FG001|Overall Study|Withdrawal by Subject|0
7112432|NCT02522286|11245856|FG002|Overall Study|Withdrawal by Subject|0
7112433|NCT02522286|11245857|FG003|Overall Study|Withdrawal by Subject|3
7112434|NCT02522299|11245869|FG000|Overall Study|Adverse Event|2
7112435|NCT02522299|11245870|FG001|Overall Study|Adverse Event|0
7112436|NCT02522299|11245869|FG000|Overall Study|Physician Decision|0
7112437|NCT02522299|11245870|FG001|Overall Study|Physician Decision|1
7112438|NCT02522299|11245869|FG000|Overall Study|Withdrawal by Subject|2
7112439|NCT02522299|11245870|FG001|Overall Study|Withdrawal by Subject|0
7112440|NCT02522325|11245890|FG000|Overall Study|Adverse Event|0
7112441|NCT02522325|11245891|FG001|Overall Study|Adverse Event|1
7112442|NCT02522377|11245899|FG000|Overall Study|Withdrawal by Subject|1
7112443|NCT02522377|11245900|FG001|Overall Study|Withdrawal by Subject|0
7112444|NCT02522377|11245899|FG000|Overall Study|Remission Achieved|3
7112445|NCT02522377|11245900|FG001|Overall Study|Remission Achieved|0
7112446|NCT02522403|11245908|FG000|Overall Study|Lost to Follow-up|2
7112447|NCT02522403|11245909|FG001|Overall Study|Lost to Follow-up|2
7112448|NCT02522403|11245908|FG000|Overall Study|Withdrawal by Subject|2
7112449|NCT02522403|11245909|FG001|Overall Study|Withdrawal by Subject|4
7112450|NCT02522481|11245924|FG000|Overall Study|discontinued|1
7112451|NCT02522481|11245924|FG000|Overall Study|Not dosed|2
7112452|NCT02522494|11245937|FG000|Overall Study|Lost to Follow-up|6
7112453|NCT02522494|11245938|FG001|Overall Study|Lost to Follow-up|2
7112454|NCT02522494|11245937|FG000|Overall Study|Withdrawal by Subject|1
7112455|NCT02522494|11245938|FG001|Overall Study|Withdrawal by Subject|0
7112456|NCT02522494|11245937|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6
7112457|NCT02522494|11245938|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2
7112458|NCT02522494|11245937|FG000|Overall Study|Participant did not watch the video|1
7112459|NCT02522494|11245938|FG001|Overall Study|Participant did not watch the video|0
7112460|NCT02522494|11245937|FG000|Overall Study|Death|0
7112461|NCT02522494|11245938|FG001|Overall Study|Death|1
7112462|NCT02522624|11245946|FG000|Overall Study|Technical failure|1
7112463|NCT02522624|11245947|FG001|Overall Study|Technical failure|0
7112464|NCT02522728|11245955|FG000|Overall Study|Withdrawal by Subject|6
7112465|NCT02522728|11245956|FG001|Overall Study|Withdrawal by Subject|6
7112466|NCT02522728|11245955|FG000|Overall Study|Death|4
7112467|NCT02522728|11245956|FG001|Overall Study|Death|3
7112468|NCT02522728|11245955|FG000|Overall Study|Adverse Event|2
7112469|NCT02522728|11245956|FG001|Overall Study|Adverse Event|1
7112470|NCT02522728|11245955|FG000|Overall Study|Did not receive randomized study device|0
7112471|NCT02522728|11245956|FG001|Overall Study|Did not receive randomized study device|1
7112472|NCT02522767|11245964|FG000|Double-blind|Withdrawal by Subject|8
7112473|NCT02522767|11245965|FG001|Double-blind|Withdrawal by Subject|11
7112474|NCT02522767|11245964|FG000|Double-blind|Lost to Follow-up|1
7112475|NCT02522767|11245965|FG001|Double-blind|Lost to Follow-up|0
7112476|NCT02522767|11245964|FG000|Double-blind|Adverse Event|1
7112477|NCT02522767|11245965|FG001|Double-blind|Adverse Event|10
7112478|NCT02522767|11245964|FG000|Double-blind|Protocol Violation|0
7112479|NCT02522767|11245965|FG001|Double-blind|Protocol Violation|1
7112480|NCT02522767|11245964|FG000|Double-blind|Lack of Efficacy|0
7112481|NCT02522767|11245965|FG001|Double-blind|Lack of Efficacy|2
7112482|NCT02522767|11245964|FG000|Double-blind|Protocol Deviation|1
7112483|NCT02522767|11245965|FG001|Double-blind|Protocol Deviation|0
7112484|NCT02522767|11245964|FG000|Open-label|Withdrawal by Subject|2
7112485|NCT02522767|11245965|FG001|Open-label|Withdrawal by Subject|3
7112486|NCT02522767|11245964|FG000|Open-label|Lost to Follow-up|0
7112487|NCT02522767|11245965|FG001|Open-label|Lost to Follow-up|1
7112488|NCT02522767|11245964|FG000|Open-label|Adverse Event|2
7112489|NCT02522767|11245965|FG001|Open-label|Adverse Event|1
7112490|NCT02522767|11245964|FG000|Open-label|Lack of Efficacy|1
7112491|NCT02522767|11245965|FG001|Open-label|Lack of Efficacy|1
7112492|NCT02522767|11245964|FG000|Open-label|Protocol Violation|0
7112493|NCT02522767|11245965|FG001|Open-label|Protocol Violation|1
7112494|NCT02522780|11245975|FG000|Overall Study|Consent withdrawn by subject|5
7112495|NCT02522780|11245976|FG001|Overall Study|Consent withdrawn by subject|7
7112496|NCT02522780|11245975|FG000|Overall Study|Protocol deviation|1
7112497|NCT02522780|11245976|FG001|Overall Study|Protocol deviation|3
7112498|NCT02522780|11245975|FG000|Overall Study|Subject refused endoscopic procedure|0
7112499|NCT02522780|11245976|FG001|Overall Study|Subject refused endoscopic procedure|1
7112500|NCT02522780|11245975|FG000|Overall Study|Adverse event, non-fatal|11
7112501|NCT02522780|11245976|FG001|Overall Study|Adverse event, non-fatal|16
7112502|NCT02522884|11245992|FG000|Overall Study|Withdrawal by Subject|6
7112503|NCT02522884|11245992|FG000|Overall Study|Death|3
7112504|NCT02522884|11245992|FG000|Overall Study|Missed 12-month Follow-up|9
7112505|NCT02523599|11246028|FG000|Overall Study|Adverse Event|1
7112506|NCT02523599|11246029|FG001|Overall Study|Adverse Event|0
7112507|NCT02523599|11246028|FG000|Overall Study|Physician Decision|1
7112508|NCT02523599|11246029|FG001|Overall Study|Physician Decision|0
7112509|NCT02523599|11246028|FG000|Overall Study|Lost to Follow-up|4
7112510|NCT02523599|11246029|FG001|Overall Study|Lost to Follow-up|1
7112511|NCT02523599|11246028|FG000|Overall Study|Did not return for Day 30 visit|2
7112512|NCT02523599|11246029|FG001|Overall Study|Did not return for Day 30 visit|0
7112513|NCT02524145|11246078|FG000|Overall Study|Withdrawal by Subject|2
7112514|NCT02524145|11246079|FG001|Overall Study|Withdrawal by Subject|2
7112515|NCT02524145|11246080|FG002|Overall Study|Withdrawal by Subject|3
7112516|NCT02524158|11246090|FG000|12-weeks Assessment|Withdrawal by Subject|1
7112517|NCT02524158|11246091|FG001|12-weeks Assessment|Withdrawal by Subject|1
7112518|NCT02524158|11246090|FG000|12-weeks Assessment|Lost to Follow-up|18
7112519|NCT02524158|11246091|FG001|12-weeks Assessment|Lost to Follow-up|12
7112520|NCT02524158|11246090|FG000|6-month Assessment|Withdrawal by Subject|1
7112521|NCT02524158|11246091|FG001|6-month Assessment|Withdrawal by Subject|1
7112522|NCT02524158|11246090|FG000|6-month Assessment|Lost to Follow-up|21
7112523|NCT02524158|11246091|FG001|6-month Assessment|Lost to Follow-up|20
7112524|NCT02524665|11246120|FG000|Overall Study|Lost to Follow-up|1
7112525|NCT02524730|11246125|FG000|Overall Study|Lost to Follow-up|5
7112526|NCT02524730|11246125|FG000|Overall Study|Withdrawal by Subject|18
7112527|NCT02524730|11246125|FG000|Overall Study|Death|10
7112528|NCT02524730|11246125|FG000|Overall Study|Adverse Event|8
7112529|NCT02524730|11246125|FG000|Overall Study|Protocol Violation|1
7112530|NCT02524730|11246125|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4
7112531|NCT02524847|11246133|FG000|Overall Study|Adverse Event|4
7112532|NCT02524847|11246133|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4
7112533|NCT02524847|11246133|FG000|Overall Study|Condition no Longer Requires Treatment|4
7112534|NCT02524847|11246133|FG000|Overall Study|Death|1
7112535|NCT02524847|11246133|FG000|Overall Study|Reason not Specified|1
7112536|NCT02525094|11246176|FG000|Overall Study|Lost to Follow-up|2
7112537|NCT02525094|11246177|FG001|Overall Study|Lost to Follow-up|1
7112538|NCT02525094|11246176|FG000|Overall Study|Withdrawal by Subject|5
7112539|NCT02525094|11246177|FG001|Overall Study|Withdrawal by Subject|6
7112540|NCT02525094|11246176|FG000|Overall Study|Not Treated|1
7112541|NCT02525094|11246177|FG001|Overall Study|Not Treated|1
7112542|NCT02525133|11246186|FG000|Overall Study|Adverse Event|0
7112543|NCT02525133|11246187|FG001|Overall Study|Adverse Event|1
7112544|NCT02525133|11246186|FG000|Overall Study|Death|0
7112545|NCT02525133|11246187|FG001|Overall Study|Death|1
7112546|NCT02525133|11246186|FG000|Overall Study|did not meet randomization criteria|1
7112547|NCT02525133|11246187|FG001|Overall Study|did not meet randomization criteria|0
7112548|NCT02525133|11246186|FG000|Overall Study|Lost to Follow-up|5
7112549|NCT02525133|11246187|FG001|Overall Study|Lost to Follow-up|1
7112550|NCT02525133|11246186|FG000|Overall Study|randomized not enrolled|3
7112551|NCT02525133|11246187|FG001|Overall Study|randomized not enrolled|0
7112552|NCT02525133|11246186|FG000|Overall Study|Withdrawal by Subject|1
7112553|NCT02525133|11246187|FG001|Overall Study|Withdrawal by Subject|0
7112554|NCT02525471|11246199|FG000|Overall Study|Screen Failure|6
7112555|NCT02525471|11246199|FG000|Overall Study|Withdrawal by Subject|4
7112556|NCT02525471|11246199|FG000|Overall Study|Death|1
7112557|NCT02525588|11246245|FG000|Overall Study|Death|3
7112558|NCT02525588|11246246|FG001|Overall Study|Death|1
7112559|NCT02525588|11246245|FG000|Overall Study|Lost to Follow-up|2
7112560|NCT02525588|11246246|FG001|Overall Study|Lost to Follow-up|0
7112561|NCT02525588|11246245|FG000|Overall Study|Withdrawal by Subject|1
7112562|NCT02525588|11246246|FG001|Overall Study|Withdrawal by Subject|1
7112563|NCT02525588|11246245|FG000|Overall Study|Adverse Event|0
7112564|NCT02525588|11246246|FG001|Overall Study|Adverse Event|1
7112565|NCT02525627|11246254|FG000|Overall Study|Revision|1
7112566|NCT02525627|11246255|FG001|Overall Study|Revision|1
7112567|NCT02525627|11246254|FG000|Overall Study|Withdrawal by Subject|1
7112568|NCT02525627|11246255|FG001|Overall Study|Withdrawal by Subject|2
7112569|NCT02525627|11246254|FG000|Overall Study|Death|1
7112570|NCT02525627|11246255|FG001|Overall Study|Death|0
7112571|NCT02525627|11246254|FG000|Overall Study|Site terminated|11
7112572|NCT02525627|11246255|FG001|Overall Study|Site terminated|10
7112573|NCT02525744|11246274|FG000|Period 1|Physician Decision|0
7112574|NCT02525744|11246275|FG001|Period 1|Physician Decision|0
7112575|NCT02525744|11246276|FG002|Period 1|Physician Decision|1
7112576|NCT02525744|11246277|FG003|Period 1|Physician Decision|0
7112577|NCT02525744|11246274|FG000|Period 3|Adverse Event|0
7112578|NCT02525744|11246275|FG001|Period 3|Adverse Event|1
7112579|NCT02525744|11246276|FG002|Period 3|Adverse Event|0
7112580|NCT02525744|11246277|FG003|Period 3|Adverse Event|0
7112581|NCT02525744|11246274|FG000|Period 4|Withdrawal by Subject|1
7112582|NCT02525744|11246275|FG001|Period 4|Withdrawal by Subject|0
7112583|NCT02525744|11246276|FG002|Period 4|Withdrawal by Subject|0
7112584|NCT02525744|11246277|FG003|Period 4|Withdrawal by Subject|0
7112585|NCT02525744|11246274|FG000|Period 5|Physician Decision|1
7112586|NCT02525744|11246275|FG001|Period 5|Physician Decision|0
7112587|NCT02525744|11246276|FG002|Period 5|Physician Decision|0
7112588|NCT02525744|11246277|FG003|Period 5|Physician Decision|0
7112589|NCT02525861|11246289|FG000|Overall Study|Adverse Event|1
7112590|NCT02525861|11246290|FG001|Overall Study|Adverse Event|0
7112591|NCT02525861|11246289|FG000|Overall Study|Withdrawal by Subject|0
7112592|NCT02525861|11246290|FG001|Overall Study|Withdrawal by Subject|1
7112593|NCT02525861|11246289|FG000|Overall Study|Physician Decision|0
7112594|NCT02525861|11246290|FG001|Overall Study|Physician Decision|1
7112595|NCT02525874|11246298|FG000|Overall Study|Other|1
7112596|NCT02525874|11246298|FG000|Overall Study|Investigator Decision|1
7112597|NCT02525874|11246298|FG000|Overall Study|Consent withdrawn|22
7112598|NCT02525874|11246298|FG000|Overall Study|Non-compliance with study drug|3
7112599|NCT02525874|11246298|FG000|Overall Study|Adverse Event|17
7112600|NCT02525874|11246298|FG000|Overall Study|Lost to Follow-up|7
7112601|NCT02525874|11246298|FG000|Overall Study|Disease progression, defined by protocol|2
7112602|NCT02525874|11246298|FG000|Overall Study|Disease relapse|4
7112603|NCT02525874|11246298|FG000|Overall Study|Alternative Treatment for MS|2
7112604|NCT02525874|11246298|FG000|Overall Study|New lesions in Brain|1
7112605|NCT02526160|11246304|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0
7112606|NCT02526160|11246305|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1
7112607|NCT02526160|11246304|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0
7112608|NCT02526160|11246305|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1
7112609|NCT02526160|11246304|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3
7112610|NCT02526160|11246305|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3
7112611|NCT02526160|11246304|FG000|Open-Label Treatment Extension Period I|Death|0
7112612|NCT02526160|11246305|FG001|Open-Label Treatment Extension Period I|Death|1
7112613|NCT02526160|11246304|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3
7112614|NCT02526160|11246305|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1
7112615|NCT02526160|11246304|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0
7112616|NCT02526160|11246305|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1
7112617|NCT02526160|11246304|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0
7112618|NCT02526160|11246305|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1
7112619|NCT02526160|11246304|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1
7112620|NCT02526160|11246305|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0
7112621|NCT02526212|11246318|FG000|Overall Study|Incarceration|1
7112622|NCT02526212|11246319|FG001|Overall Study|Incarceration|0
7112623|NCT02526212|11246318|FG000|Overall Study|Lost to Follow-up|1
7112624|NCT02526212|11246319|FG001|Overall Study|Lost to Follow-up|0
7112625|NCT02526212|11246318|FG000|Overall Study|Death|0
7112626|NCT02526212|11246319|FG001|Overall Study|Death|1
7112627|NCT02526290|11246345|FG000|Overall Study|Adverse Event|3
7112628|NCT02526290|11246345|FG000|Overall Study|Withdrawal by Subject|4
7112629|NCT02526290|11246345|FG000|Overall Study|Physician Decision|1
7112630|NCT02526524|11246355|FG000|Overall Study|Withdrawal by Subject|3
7112631|NCT02526524|11246356|FG001|Overall Study|Withdrawal by Subject|3
7112632|NCT02526524|11246357|FG002|Overall Study|Withdrawal by Subject|6
7112633|NCT02526524|11246358|FG003|Overall Study|Withdrawal by Subject|1
7112634|NCT02526524|11246359|FG004|Overall Study|Withdrawal by Subject|9
7112635|NCT02526524|11246360|FG005|Overall Study|Withdrawal by Subject|5
7112636|NCT02526524|11246355|FG000|Overall Study|Adverse Event|3
7112637|NCT02526524|11246356|FG001|Overall Study|Adverse Event|2
7112638|NCT02526524|11246357|FG002|Overall Study|Adverse Event|4
7112639|NCT02526524|11246358|FG003|Overall Study|Adverse Event|2
7112640|NCT02526524|11246359|FG004|Overall Study|Adverse Event|6
7112641|NCT02526524|11246360|FG005|Overall Study|Adverse Event|8
7112642|NCT02526524|11246355|FG000|Overall Study|Lost to Follow-up|2
7112643|NCT02526524|11246356|FG001|Overall Study|Lost to Follow-up|3
7112644|NCT02526524|11246357|FG002|Overall Study|Lost to Follow-up|8
7112645|NCT02526524|11246358|FG003|Overall Study|Lost to Follow-up|1
7112646|NCT02526524|11246359|FG004|Overall Study|Lost to Follow-up|2
7112647|NCT02526524|11246360|FG005|Overall Study|Lost to Follow-up|5
7112648|NCT02526524|11246355|FG000|Overall Study|Protocol Violation|3
7112649|NCT02526524|11246356|FG001|Overall Study|Protocol Violation|1
7112650|NCT02526524|11246357|FG002|Overall Study|Protocol Violation|5
7112651|NCT02526524|11246358|FG003|Overall Study|Protocol Violation|3
7112652|NCT02526524|11246359|FG004|Overall Study|Protocol Violation|4
7112653|NCT02526524|11246360|FG005|Overall Study|Protocol Violation|3
7112654|NCT02526524|11246355|FG000|Overall Study|Loss of Glucose Control|0
7112655|NCT02526524|11246356|FG001|Overall Study|Loss of Glucose Control|0
7112656|NCT02526524|11246357|FG002|Overall Study|Loss of Glucose Control|3
7112657|NCT02526524|11246358|FG003|Overall Study|Loss of Glucose Control|0
7112658|NCT02526524|11246359|FG004|Overall Study|Loss of Glucose Control|2
7112659|NCT02526524|11246360|FG005|Overall Study|Loss of Glucose Control|0
7112660|NCT02526524|11246355|FG000|Overall Study|Physician Decision|0
7112661|NCT02526524|11246356|FG001|Overall Study|Physician Decision|0
7112662|NCT02526524|11246357|FG002|Overall Study|Physician Decision|0
7112663|NCT02526524|11246358|FG003|Overall Study|Physician Decision|0
7112664|NCT02526524|11246359|FG004|Overall Study|Physician Decision|1
7112665|NCT02526524|11246360|FG005|Overall Study|Physician Decision|0
7112666|NCT02526524|11246355|FG000|Overall Study|Sponsor Decision|1
7112667|NCT02526524|11246356|FG001|Overall Study|Sponsor Decision|0
7112668|NCT02526524|11246357|FG002|Overall Study|Sponsor Decision|0
7112669|NCT02526524|11246358|FG003|Overall Study|Sponsor Decision|0
7112670|NCT02526524|11246359|FG004|Overall Study|Sponsor Decision|0
7112671|NCT02526524|11246360|FG005|Overall Study|Sponsor Decision|0
7112672|NCT02526550|11246374|FG000|Overall Study|Lost to Follow-up|1
7112673|NCT02526693|11246413|FG000|Overall Study|Physician Decision|3
7112674|NCT02526693|11246414|FG001|Overall Study|Physician Decision|1
7112675|NCT02527148|11246426|FG000|Overall Study|Did not receive study intervention|1
7112676|NCT02527148|11246427|FG001|Overall Study|Did not receive study intervention|0
7112677|NCT02527161|11246435|FG000|Overall Study|Failed MRI|52
7112678|NCT02527161|11246435|FG000|Overall Study|Withdrawal by Subject|19
7112679|NCT02527161|11246435|FG000|Overall Study|Delay in or unfit for surgery|16
7112680|NCT02527161|11246435|FG000|Overall Study|MRI contraindication|6
7112681|NCT02527161|11246435|FG000|Overall Study|Consent violation|4
7112682|NCT02527161|11246435|FG000|Overall Study|Only Recruited to Part A|27
7112683|NCT02527161|11246435|FG000|Overall Study|Physician Decision|1
7112684|NCT02527161|11246435|FG000|Overall Study|Adverse Event|1
7112685|NCT02527161|11246435|FG000|Overall Study|Lost to Follow-up|6
7112686|NCT02527343|11246451|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1
7112687|NCT02527343|11246452|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0
7112688|NCT02527343|11246453|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0
7112689|NCT02527343|11246454|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0
7112690|NCT02527343|11246455|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0
7112691|NCT02527343|11246456|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0
7112692|NCT02527343|11246451|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1
7112693|NCT02527343|11246452|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0
7112694|NCT02527343|11246453|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0
7112695|NCT02527343|11246454|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0
7112696|NCT02527343|11246455|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0
7112697|NCT02527343|11246456|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0
7112698|NCT02527343|11246451|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0
7112699|NCT02527343|11246452|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4
7112700|NCT02527343|11246453|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0
7112701|NCT02527343|11246454|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0
7112702|NCT02527343|11246455|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0
7112703|NCT02527343|11246456|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0
7112704|NCT02527343|11246451|FG000|RT Period: Weeks 1 to 52|Other|4
7112705|NCT02527343|11246452|FG001|RT Period: Weeks 1 to 52|Other|3
7112706|NCT02527343|11246453|FG002|RT Period: Weeks 1 to 52|Other|0
7112707|NCT02527343|11246454|FG003|RT Period: Weeks 1 to 52|Other|0
7112708|NCT02527343|11246455|FG004|RT Period: Weeks 1 to 52|Other|0
7112709|NCT02527343|11246456|FG005|RT Period: Weeks 1 to 52|Other|0
7112710|NCT02527343|11246451|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0
7112711|NCT02527343|11246452|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0
7112712|NCT02527343|11246453|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1
7112713|NCT02527343|11246454|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0
7112714|NCT02527343|11246455|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0
7112715|NCT02527343|11246456|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0
7112716|NCT02527343|11246451|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0
7112717|NCT02527343|11246452|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0
7112718|NCT02527343|11246453|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0
7112719|NCT02527343|11246454|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2
7112720|NCT02527343|11246455|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0
7112721|NCT02527343|11246456|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0
7112722|NCT02527343|11246451|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0
7112723|NCT02527343|11246452|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0
7112724|NCT02527343|11246453|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0
7112725|NCT02527343|11246454|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0
7112726|NCT02527343|11246455|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1
7112727|NCT02527343|11246456|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0
7112728|NCT02527343|11246451|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0
7112729|NCT02527343|11246452|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0
7112730|NCT02527343|11246453|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0
7112731|NCT02527343|11246454|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0
7112732|NCT02527343|11246455|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3
7112733|NCT02527343|11246456|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1
7112734|NCT02527343|11246451|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0
7112735|NCT02527343|11246452|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0
7112736|NCT02527343|11246453|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0
7112737|NCT02527343|11246454|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0
7112738|NCT02527343|11246455|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2
7112739|NCT02527343|11246456|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1
7112740|NCT02527343|11246451|FG000|OLE Period-Year 1: Week 53 to 104|Other|0
7112741|NCT02527343|11246452|FG001|OLE Period-Year 1: Week 53 to 104|Other|0
7112742|NCT02527343|11246453|FG002|OLE Period-Year 1: Week 53 to 104|Other|0
7112743|NCT02527343|11246454|FG003|OLE Period-Year 1: Week 53 to 104|Other|0
7112744|NCT02527343|11246455|FG004|OLE Period-Year 1: Week 53 to 104|Other|5
7112745|NCT02527343|11246456|FG005|OLE Period-Year 1: Week 53 to 104|Other|7
7112746|NCT02527343|11246451|FG000|OLE Period-Year 2: Week 105 to 156|Other|0
7112747|NCT02527343|11246452|FG001|OLE Period-Year 2: Week 105 to 156|Other|0
7112748|NCT02527343|11246453|FG002|OLE Period-Year 2: Week 105 to 156|Other|0
7112749|NCT02527343|11246454|FG003|OLE Period-Year 2: Week 105 to 156|Other|0
7112750|NCT02527343|11246455|FG004|OLE Period-Year 2: Week 105 to 156|Other|1
7112751|NCT02527343|11246456|FG005|OLE Period-Year 2: Week 105 to 156|Other|2
7112752|NCT02527343|11246451|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0
7112753|NCT02527343|11246452|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0
7112754|NCT02527343|11246453|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0
7112755|NCT02527343|11246454|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0
7112756|NCT02527343|11246455|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1
7112757|NCT02527343|11246456|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0
7112758|NCT02527343|11246451|FG000|PT Follow-up: Weeks 104 to 169|Other|0
7112759|NCT02527343|11246452|FG001|PT Follow-up: Weeks 104 to 169|Other|0
7112760|NCT02527343|11246453|FG002|PT Follow-up: Weeks 104 to 169|Other|0
7112761|NCT02527343|11246454|FG003|PT Follow-up: Weeks 104 to 169|Other|0
7112762|NCT02527343|11246455|FG004|PT Follow-up: Weeks 104 to 169|Other|0
7112763|NCT02527343|11246456|FG005|PT Follow-up: Weeks 104 to 169|Other|1
7112764|NCT02527421|11246473|FG000|Overall Study|Withdrawal by Subject|1
7112765|NCT02527421|11246474|FG001|Overall Study|Withdrawal by Subject|0
7112766|NCT02528188|11246507|FG000|Overall Study|Adverse Event|23
7112767|NCT02528188|11246508|FG001|Overall Study|Adverse Event|22
7112768|NCT02528188|11246509|FG002|Overall Study|Adverse Event|8
7112769|NCT02528188|11246507|FG000|Overall Study|Protocol Violation|4
7112770|NCT02528188|11246508|FG001|Overall Study|Protocol Violation|6
7112771|NCT02528188|11246509|FG002|Overall Study|Protocol Violation|4
7112772|NCT02528188|11246507|FG000|Overall Study|Lack of Efficacy|19
7112773|NCT02528188|11246508|FG001|Overall Study|Lack of Efficacy|21
7112774|NCT02528188|11246509|FG002|Overall Study|Lack of Efficacy|22
7112775|NCT02528188|11246507|FG000|Overall Study|Withdrawal by Subject|97
7112776|NCT02528188|11246508|FG001|Overall Study|Withdrawal by Subject|104
7112777|NCT02528188|11246509|FG002|Overall Study|Withdrawal by Subject|100
7112778|NCT02528188|11246507|FG000|Overall Study|Lost to Follow-up|25
7112779|NCT02528188|11246508|FG001|Overall Study|Lost to Follow-up|21
7112780|NCT02528188|11246509|FG002|Overall Study|Lost to Follow-up|31
7112781|NCT02528188|11246507|FG000|Overall Study|Death|4
7112782|NCT02528188|11246508|FG001|Overall Study|Death|4
7112783|NCT02528188|11246509|FG002|Overall Study|Death|0
7112784|NCT02528188|11246507|FG000|Overall Study|Other|89
7112785|NCT02528188|11246508|FG001|Overall Study|Other|91
7112786|NCT02528188|11246509|FG002|Overall Study|Other|74
7112787|NCT02528188|11246507|FG000|Overall Study|Randomized but not treated|6
7112788|NCT02528188|11246508|FG001|Overall Study|Randomized but not treated|7
7112789|NCT02528188|11246509|FG002|Overall Study|Randomized but not treated|12
7112790|NCT02528214|11246519|FG000|Overall Study|Protocol Violation|0
7112791|NCT02528214|11246520|FG001|Overall Study|Protocol Violation|1
7112792|NCT02528214|11246519|FG000|Overall Study|Adverse Event|0
7112793|NCT02528214|11246520|FG001|Overall Study|Adverse Event|1
7112794|NCT02528214|11246519|FG000|Overall Study|Other than specified above|0
7112795|NCT02528214|11246520|FG001|Overall Study|Other than specified above|1
7112796|NCT02528253|11246532|FG000|Overall Study|Adverse Event|3
7112797|NCT02528253|11246533|FG001|Overall Study|Adverse Event|4
7112798|NCT02528253|11246534|FG002|Overall Study|Adverse Event|4
7112799|NCT02528253|11246535|FG003|Overall Study|Adverse Event|8
7112800|NCT02528253|11246536|FG004|Overall Study|Adverse Event|18
7112801|NCT02528253|11246532|FG000|Overall Study|Death|2
7112802|NCT02528253|11246533|FG001|Overall Study|Death|2
7112803|NCT02528253|11246534|FG002|Overall Study|Death|1
7112804|NCT02528253|11246535|FG003|Overall Study|Death|0
7112805|NCT02528253|11246536|FG004|Overall Study|Death|1
7112806|NCT02528253|11246532|FG000|Overall Study|Insufficient clinical response|7
7112807|NCT02528253|11246533|FG001|Overall Study|Insufficient clinical response|10
7112808|NCT02528253|11246534|FG002|Overall Study|Insufficient clinical response|13
7112809|NCT02528253|11246535|FG003|Overall Study|Insufficient clinical response|12
7112810|NCT02528253|11246536|FG004|Overall Study|Insufficient clinical response|16
7112811|NCT02528253|11246532|FG000|Overall Study|Lost to Follow-up|16
7112812|NCT02528253|11246533|FG001|Overall Study|Lost to Follow-up|9
7112813|NCT02528253|11246534|FG002|Overall Study|Lost to Follow-up|31
7112814|NCT02528253|11246535|FG003|Overall Study|Lost to Follow-up|16
7112815|NCT02528253|11246536|FG004|Overall Study|Lost to Follow-up|34
7112816|NCT02528253|11246532|FG000|Overall Study|Other|21
7112817|NCT02528253|11246533|FG001|Overall Study|Other|22
7112818|NCT02528253|11246534|FG002|Overall Study|Other|58
7112819|NCT02528253|11246535|FG003|Overall Study|Other|52
7112820|NCT02528253|11246536|FG004|Overall Study|Other|76
7112821|NCT02528253|11246532|FG000|Overall Study|Withdrawal by Subject|25
7112822|NCT02528253|11246533|FG001|Overall Study|Withdrawal by Subject|20
7112823|NCT02528253|11246534|FG002|Overall Study|Withdrawal by Subject|29
7112824|NCT02528253|11246535|FG003|Overall Study|Withdrawal by Subject|48
7112825|NCT02528253|11246536|FG004|Overall Study|Withdrawal by Subject|73
7112826|NCT02528253|11246532|FG000|Overall Study|Protocol Violation|1
7112827|NCT02528253|11246533|FG001|Overall Study|Protocol Violation|2
7112828|NCT02528253|11246534|FG002|Overall Study|Protocol Violation|4
7112829|NCT02528253|11246535|FG003|Overall Study|Protocol Violation|0
7112830|NCT02528253|11246536|FG004|Overall Study|Protocol Violation|4
7112831|NCT02528253|11246532|FG000|Overall Study|Withdrawn Due to Pregnancy|0
7112832|NCT02528253|11246533|FG001|Overall Study|Withdrawn Due to Pregnancy|1
7112833|NCT02528253|11246534|FG002|Overall Study|Withdrawn Due to Pregnancy|0
7112834|NCT02528253|11246535|FG003|Overall Study|Withdrawn Due to Pregnancy|0
7112835|NCT02528253|11246536|FG004|Overall Study|Withdrawn Due to Pregnancy|1
7112836|NCT02528305|11246567|FG000|Overall Study|Withdrawal by Subject|1
7112837|NCT02528305|11246567|FG000|Overall Study|Adverse Event|1
7112838|NCT02528305|11246567|FG000|Overall Study|Physician Decision|1
7112839|NCT02528331|11246594|FG000|Overall Study|Withdrawal by Subject|2
7112840|NCT02528357|11246617|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7112841|NCT02528357|11246618|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1
7112842|NCT02528357|11246619|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7112843|NCT02528357|11246620|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7112844|NCT02528357|11246621|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7112845|NCT02528357|11246622|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7112846|NCT02528357|11246623|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7112847|NCT02528357|11246624|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7112848|NCT02528357|11246625|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7112849|NCT02528357|11246626|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7112850|NCT02528357|11246627|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7112851|NCT02528357|11246628|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7112852|NCT02528357|11246629|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7112853|NCT02528357|11246630|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7112854|NCT02528357|11246631|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7112855|NCT02528357|11246632|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7112856|NCT02528357|11246633|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7112857|NCT02528357|11246634|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7112858|NCT02528357|11246635|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7112859|NCT02528357|11246617|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7112860|NCT02528357|11246618|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7112861|NCT02528357|11246619|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7112862|NCT02528357|11246620|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1
7112863|NCT02528357|11246621|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7112864|NCT02528357|11246622|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2
7112865|NCT02528357|11246623|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7112866|NCT02528357|11246624|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1
7112867|NCT02528357|11246625|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7112868|NCT02528357|11246626|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7112869|NCT02528357|11246627|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7112870|NCT02528357|11246628|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7112871|NCT02528357|11246629|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7112872|NCT02528357|11246630|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7112873|NCT02528357|11246631|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7112874|NCT02528357|11246632|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7112875|NCT02528357|11246633|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7112876|NCT02528357|11246634|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7112877|NCT02528357|11246635|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7112878|NCT02528357|11246617|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7112879|NCT02528357|11246618|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7112880|NCT02528357|11246619|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2
7112881|NCT02528357|11246620|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7112882|NCT02528357|11246621|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3
7112883|NCT02528357|11246622|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7112884|NCT02528357|11246623|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2
7112885|NCT02528357|11246624|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1
7112886|NCT02528357|11246625|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7112887|NCT02528357|11246626|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7112888|NCT02528357|11246627|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7112889|NCT02528357|11246628|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7112890|NCT02528357|11246629|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7112891|NCT02528357|11246630|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7112892|NCT02528357|11246631|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7112893|NCT02528357|11246632|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7112894|NCT02528357|11246633|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7112895|NCT02528357|11246634|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7112896|NCT02528357|11246635|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7112897|NCT02528357|11246617|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7112898|NCT02528357|11246618|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7112899|NCT02528357|11246619|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7112900|NCT02528357|11246620|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7112901|NCT02528357|11246621|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1
7112902|NCT02528357|11246622|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7112903|NCT02528357|11246623|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7112904|NCT02528357|11246624|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7112905|NCT02528357|11246625|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7112906|NCT02528357|11246626|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7112907|NCT02528357|11246627|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7112908|NCT02528357|11246628|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7112909|NCT02528357|11246629|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7112910|NCT02528357|11246630|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7112911|NCT02528357|11246631|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7112912|NCT02528357|11246632|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7112913|NCT02528357|11246633|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7112914|NCT02528357|11246634|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7112915|NCT02528357|11246635|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7112916|NCT02528357|11246617|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7112917|NCT02528357|11246618|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7112918|NCT02528357|11246619|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7112919|NCT02528357|11246620|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7112920|NCT02528357|11246621|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7112921|NCT02528357|11246622|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7112922|NCT02528357|11246623|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7112923|NCT02528357|11246624|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7112924|NCT02528357|11246625|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7112925|NCT02528357|11246626|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7112926|NCT02528357|11246627|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7112927|NCT02528357|11246628|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7112928|NCT02528357|11246629|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7112929|NCT02528357|11246630|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1
7112930|NCT02528357|11246631|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5
7112931|NCT02528357|11246632|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7112932|NCT02528357|11246633|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7112933|NCT02528357|11246634|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7112934|NCT02528357|11246635|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7112935|NCT02528357|11246617|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7112936|NCT02528357|11246618|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7112937|NCT02528357|11246619|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7112938|NCT02528357|11246620|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7112939|NCT02528357|11246621|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7112940|NCT02528357|11246622|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7112941|NCT02528357|11246623|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7112942|NCT02528357|11246624|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7112943|NCT02528357|11246625|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7112944|NCT02528357|11246626|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7112945|NCT02528357|11246627|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7112946|NCT02528357|11246628|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7112947|NCT02528357|11246629|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7112948|NCT02528357|11246630|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1
7112949|NCT02528357|11246631|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7112950|NCT02528357|11246632|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7112951|NCT02528357|11246633|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7112952|NCT02528357|11246634|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7112953|NCT02528357|11246635|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7112954|NCT02528357|11246617|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7112955|NCT02528357|11246618|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7112956|NCT02528357|11246619|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7112957|NCT02528357|11246620|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7112958|NCT02528357|11246621|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7112959|NCT02528357|11246622|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7112960|NCT02528357|11246623|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7112961|NCT02528357|11246624|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7112962|NCT02528357|11246625|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7112963|NCT02528357|11246626|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7112964|NCT02528357|11246627|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3
7112965|NCT02528357|11246628|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7112966|NCT02528357|11246629|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1
7112967|NCT02528357|11246630|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3
7112968|NCT02528357|11246631|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1
7112969|NCT02528357|11246632|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7112970|NCT02528357|11246633|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7112971|NCT02528357|11246634|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7112972|NCT02528357|11246635|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7112973|NCT02528357|11246617|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7112974|NCT02528357|11246618|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7112975|NCT02528357|11246619|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7112976|NCT02528357|11246620|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7112977|NCT02528357|11246621|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7112978|NCT02528357|11246622|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7112979|NCT02528357|11246623|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7112980|NCT02528357|11246624|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7112981|NCT02528357|11246625|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1
7112982|NCT02528357|11246626|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1
7112983|NCT02528357|11246627|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7112984|NCT02528357|11246628|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3
7112985|NCT02528357|11246629|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4
7112986|NCT02528357|11246630|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1
7112987|NCT02528357|11246631|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1
7112988|NCT02528357|11246632|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7112989|NCT02528357|11246633|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7112990|NCT02528357|11246634|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7112991|NCT02528357|11246635|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7112992|NCT02528357|11246617|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7112993|NCT02528357|11246618|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7112994|NCT02528357|11246619|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7112995|NCT02528357|11246620|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7112996|NCT02528357|11246621|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7112997|NCT02528357|11246622|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7112998|NCT02528357|11246623|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7112999|NCT02528357|11246624|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7113000|NCT02528357|11246625|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7113001|NCT02528357|11246626|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7113002|NCT02528357|11246627|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7113003|NCT02528357|11246628|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7113004|NCT02528357|11246629|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7113005|NCT02528357|11246630|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7113006|NCT02528357|11246631|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7113007|NCT02528357|11246632|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7113008|NCT02528357|11246633|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2
7113009|NCT02528357|11246634|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7113010|NCT02528357|11246635|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7113011|NCT02528357|11246617|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7113012|NCT02528357|11246618|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7113013|NCT02528357|11246619|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7113014|NCT02528357|11246620|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7113015|NCT02528357|11246621|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7113016|NCT02528357|11246622|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7113017|NCT02528357|11246623|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7113018|NCT02528357|11246624|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7113019|NCT02528357|11246625|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7113020|NCT02528357|11246626|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7113021|NCT02528357|11246627|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7113022|NCT02528357|11246628|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7113023|NCT02528357|11246629|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7113024|NCT02528357|11246630|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7113025|NCT02528357|11246631|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
6805829|NCT02575339|10808037|FG002|Follow up|Study Terminated|0
7113026|NCT02528357|11246632|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7113027|NCT02528357|11246633|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1
7113028|NCT02528357|11246634|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4
7113029|NCT02528357|11246635|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3
7113030|NCT02528942|11246706|FG000|Overall Study|Did not meet imaging criteria|9
7113031|NCT02528942|11246706|FG000|Overall Study|Lost to Follow-up|25
7113032|NCT02529137|11246719|FG000|Overall Study|Discontinuation for different reasons|8
7113033|NCT02529488|11246724|FG000|Overall Study|Adverse Event|1
7113034|NCT02529488|11246724|FG000|Overall Study|Death|3
7113035|NCT02529553|11246741|FG000|Overall Study|Progressive Disease|1
7113036|NCT02529553|11246742|FG001|Overall Study|Progressive Disease|0
7113037|NCT02529553|11246743|FG002|Overall Study|Progressive Disease|1
7113038|NCT02529553|11246744|FG003|Overall Study|Progressive Disease|3
7113039|NCT02529553|11246745|FG004|Overall Study|Progressive Disease|2
7113040|NCT02529553|11246746|FG005|Overall Study|Progressive Disease|3
7113041|NCT02529553|11246747|FG006|Overall Study|Progressive Disease|3
7113042|NCT02529553|11246748|FG007|Overall Study|Progressive Disease|5
7113043|NCT02529553|11246749|FG008|Overall Study|Progressive Disease|3
7113044|NCT02529553|11246741|FG000|Overall Study|Physician Decision|0
7113045|NCT02529553|11246742|FG001|Overall Study|Physician Decision|1
7113046|NCT02529553|11246743|FG002|Overall Study|Physician Decision|0
7113047|NCT02529553|11246744|FG003|Overall Study|Physician Decision|0
7113048|NCT02529553|11246745|FG004|Overall Study|Physician Decision|1
7113049|NCT02529553|11246746|FG005|Overall Study|Physician Decision|0
7113050|NCT02529553|11246747|FG006|Overall Study|Physician Decision|0
7113051|NCT02529553|11246748|FG007|Overall Study|Physician Decision|0
7113052|NCT02529553|11246749|FG008|Overall Study|Physician Decision|0
7113053|NCT02529553|11246741|FG000|Overall Study|Withdrawal by Subject|0
7113054|NCT02529553|11246742|FG001|Overall Study|Withdrawal by Subject|0
7113055|NCT02529553|11246743|FG002|Overall Study|Withdrawal by Subject|0
7113056|NCT02529553|11246744|FG003|Overall Study|Withdrawal by Subject|0
7113057|NCT02529553|11246745|FG004|Overall Study|Withdrawal by Subject|0
7113058|NCT02529553|11246746|FG005|Overall Study|Withdrawal by Subject|1
7113059|NCT02529553|11246747|FG006|Overall Study|Withdrawal by Subject|0
7113060|NCT02529553|11246748|FG007|Overall Study|Withdrawal by Subject|1
7113061|NCT02529553|11246749|FG008|Overall Study|Withdrawal by Subject|0
7113062|NCT02529995|11246772|FG000|Part A|Ongoing Study at Data Cut-off|14
7113063|NCT02529995|11246773|FG001|Part A|Ongoing Study at Data Cut-off|16
7113064|NCT02529995|11246772|FG000|Part A|Discontinued Study|1
7113065|NCT02529995|11246773|FG001|Part A|Discontinued Study|0
7113066|NCT02529995|11246772|FG000|Part B|Ongoing Study at Data Cut-off|0
7113067|NCT02529995|11246773|FG001|Part B|Ongoing Study at Data Cut-off|7
7113068|NCT02529995|11246772|FG000|Part B|Discontinued Study|6
7113069|NCT02529995|11246773|FG001|Part B|Discontinued Study|5
7113070|NCT02530125|11246779|FG000|Completed Treatment|Early termination of study|1
7113071|NCT02530125|11246779|FG000|Followed for Survival for 2 Years|Early termination of study|3
7113072|NCT02530242|11246794|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0
7113073|NCT02530242|11246795|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1
7113074|NCT02530385|11246823|FG000|Overall Study|Withdrawal by Subject|0
7113075|NCT02530385|11246824|FG001|Overall Study|Withdrawal by Subject|1
7113076|NCT02530619|11246914|FG000|Registered for Study|Withdrawal by Subject|2
7113077|NCT02530619|11246914|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2
7113078|NCT02530619|11246914|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2
7113079|NCT02530619|11246914|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4
7113080|NCT02530619|11246914|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2
7113081|NCT02530619|11246914|FG000|Follow-up Period (6 Months)|Death|4
7113082|NCT02530619|11246914|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2
7113083|NCT02530619|11246914|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5
7113084|NCT02530671|11246920|FG000|Overall Study|Lost to Follow-up|2
7113085|NCT02530671|11246921|FG001|Overall Study|Lost to Follow-up|0
7113086|NCT02530671|11246920|FG000|Overall Study|Withdrawal by Subject|1
7113087|NCT02530671|11246921|FG001|Overall Study|Withdrawal by Subject|0
7113088|NCT02530905|11246929|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0
7113089|NCT02530905|11246930|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0
7113090|NCT02530905|11246931|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1
7113091|NCT02530970|11246953|FG000|Overall Study|Adverse Event|8
7113092|NCT02530970|11246953|FG000|Overall Study|Lost to Follow-up|88
7113093|NCT02530970|11246953|FG000|Overall Study|Physician Decision|5
7113094|NCT02530970|11246953|FG000|Overall Study|Withdrawal by Subject|14
7113095|NCT02530970|11246953|FG000|Overall Study|Death|6
7113096|NCT02530970|11246953|FG000|Overall Study|Hospitalization|1
7113097|NCT02530970|11246953|FG000|Overall Study|Insurance|2
7113098|NCT02530970|11246953|FG000|Overall Study|Explant|2
7113099|NCT02530970|11246953|FG000|Overall Study|Change in Provider|5
7113100|NCT02530970|11246953|FG000|Overall Study|Relocation|3
7113101|NCT02531035|11246979|FG000|Overall Study|Death|0
7113102|NCT02531035|11246980|FG001|Overall Study|Death|1
7113103|NCT02531035|11246979|FG000|Overall Study|Protocol Violation|1
7113104|NCT02531035|11246980|FG001|Overall Study|Protocol Violation|1
7113105|NCT02531035|11246979|FG000|Overall Study|Noncompliance with study drug|8
7113106|NCT02531035|11246980|FG001|Overall Study|Noncompliance with study drug|3
7113107|NCT02531035|11246979|FG000|Overall Study|Physician Decision|1
7113108|NCT02531035|11246980|FG001|Overall Study|Physician Decision|0
7113109|NCT02531035|11246979|FG000|Overall Study|Adverse Event|16
7113110|NCT02531035|11246980|FG001|Overall Study|Adverse Event|45
7113111|NCT02531035|11246979|FG000|Overall Study|Other|3
7113112|NCT02531035|11246980|FG001|Overall Study|Other|2
7113113|NCT02531035|11246979|FG000|Overall Study|Withdrawal by Subject|42
7113114|NCT02531035|11246980|FG001|Overall Study|Withdrawal by Subject|32
7113115|NCT02531035|11246979|FG000|Overall Study|Lost to Follow-up|8
7113116|NCT02531035|11246980|FG001|Overall Study|Lost to Follow-up|10
7113117|NCT02531035|11246979|FG000|Overall Study|Randomized, not treated|2
7113118|NCT02531035|11246980|FG001|Overall Study|Randomized, not treated|1
7113119|NCT02531113|11246986|FG000|Induction Period: Week 0 to 12|Adverse Event|4
7113120|NCT02531113|11246986|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4
7113121|NCT02531113|11246986|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3
7113122|NCT02531113|11246986|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2
7113123|NCT02531113|11246986|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5
7113124|NCT02531113|11246986|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19
7113125|NCT02531113|11246986|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11
7113126|NCT02531113|11246986|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1
7113127|NCT02531373|11247008|FG000|Overall Study|Lack of Efficacy|0
7113128|NCT02531373|11247009|FG001|Overall Study|Lack of Efficacy|0
7113129|NCT02531373|11247010|FG002|Overall Study|Lack of Efficacy|0
7113130|NCT02531373|11247011|FG003|Overall Study|Lack of Efficacy|0
7113131|NCT02531373|11247012|FG004|Overall Study|Lack of Efficacy|3
7113132|NCT02531373|11247013|FG005|Overall Study|Lack of Efficacy|2
7113133|NCT02531373|11247014|FG006|Overall Study|Lack of Efficacy|4
7113134|NCT02531373|11247015|FG007|Overall Study|Lack of Efficacy|8
7113135|NCT02531373|11247016|FG008|Overall Study|Lack of Efficacy|5
7113136|NCT02531373|11247008|FG000|Overall Study|Lost to Follow-up|0
7113137|NCT02531373|11247009|FG001|Overall Study|Lost to Follow-up|0
7113138|NCT02531373|11247010|FG002|Overall Study|Lost to Follow-up|0
7113139|NCT02531373|11247011|FG003|Overall Study|Lost to Follow-up|0
7113140|NCT02531373|11247012|FG004|Overall Study|Lost to Follow-up|0
7113141|NCT02531373|11247013|FG005|Overall Study|Lost to Follow-up|2
7113142|NCT02531373|11247014|FG006|Overall Study|Lost to Follow-up|2
7113143|NCT02531373|11247015|FG007|Overall Study|Lost to Follow-up|0
7113144|NCT02531373|11247016|FG008|Overall Study|Lost to Follow-up|0
7113145|NCT02531373|11247008|FG000|Overall Study|Physician Decision|0
7113146|NCT02531373|11247009|FG001|Overall Study|Physician Decision|0
7113147|NCT02531373|11247010|FG002|Overall Study|Physician Decision|0
7113148|NCT02531373|11247011|FG003|Overall Study|Physician Decision|0
7113149|NCT02531373|11247012|FG004|Overall Study|Physician Decision|2
7113150|NCT02531373|11247013|FG005|Overall Study|Physician Decision|1
7113151|NCT02531373|11247014|FG006|Overall Study|Physician Decision|0
7113152|NCT02531373|11247015|FG007|Overall Study|Physician Decision|0
7113153|NCT02531373|11247016|FG008|Overall Study|Physician Decision|0
7113154|NCT02531373|11247008|FG000|Overall Study|Protocol Violation|0
7113155|NCT02531373|11247009|FG001|Overall Study|Protocol Violation|0
7113156|NCT02531373|11247010|FG002|Overall Study|Protocol Violation|0
7113157|NCT02531373|11247011|FG003|Overall Study|Protocol Violation|0
7113158|NCT02531373|11247012|FG004|Overall Study|Protocol Violation|0
7113159|NCT02531373|11247013|FG005|Overall Study|Protocol Violation|1
7113160|NCT02531373|11247014|FG006|Overall Study|Protocol Violation|1
7113161|NCT02531373|11247015|FG007|Overall Study|Protocol Violation|0
7113162|NCT02531373|11247016|FG008|Overall Study|Protocol Violation|1
7113163|NCT02531373|11247008|FG000|Overall Study|Withdrawal by Parent/Guardian|0
7113164|NCT02531373|11247009|FG001|Overall Study|Withdrawal by Parent/Guardian|0
7113165|NCT02531373|11247010|FG002|Overall Study|Withdrawal by Parent/Guardian|0
7113166|NCT02531373|11247011|FG003|Overall Study|Withdrawal by Parent/Guardian|0
7113167|NCT02531373|11247012|FG004|Overall Study|Withdrawal by Parent/Guardian|0
7113168|NCT02531373|11247013|FG005|Overall Study|Withdrawal by Parent/Guardian|3
7113169|NCT02531373|11247014|FG006|Overall Study|Withdrawal by Parent/Guardian|4
7113170|NCT02531373|11247015|FG007|Overall Study|Withdrawal by Parent/Guardian|1
7113171|NCT02531373|11247016|FG008|Overall Study|Withdrawal by Parent/Guardian|3
7113172|NCT02531373|11247008|FG000|Overall Study|Withdrawal by Subject|0
7113173|NCT02531373|11247009|FG001|Overall Study|Withdrawal by Subject|0
7113174|NCT02531373|11247010|FG002|Overall Study|Withdrawal by Subject|0
7113175|NCT02531373|11247011|FG003|Overall Study|Withdrawal by Subject|0
7113176|NCT02531373|11247012|FG004|Overall Study|Withdrawal by Subject|3
7113177|NCT02531373|11247013|FG005|Overall Study|Withdrawal by Subject|0
7113178|NCT02531373|11247014|FG006|Overall Study|Withdrawal by Subject|0
7113179|NCT02531373|11247015|FG007|Overall Study|Withdrawal by Subject|0
7113180|NCT02531373|11247016|FG008|Overall Study|Withdrawal by Subject|0
7113181|NCT02531438|11247039|FG000|Overall Study|Adverse Event|7
7113182|NCT02531438|11247040|FG001|Overall Study|Adverse Event|9
7113183|NCT02531438|11247039|FG000|Overall Study|Lost to Follow-up|0
7113184|NCT02531438|11247040|FG001|Overall Study|Lost to Follow-up|3
7113185|NCT02531438|11247039|FG000|Overall Study|Withdrawal by Subject|7
7113186|NCT02531438|11247040|FG001|Overall Study|Withdrawal by Subject|8
7113187|NCT02531438|11247039|FG000|Overall Study|Physician Decision|0
7113188|NCT02531438|11247040|FG001|Overall Study|Physician Decision|1
7113189|NCT02531438|11247039|FG000|Overall Study|Death|6
7113190|NCT02531438|11247040|FG001|Overall Study|Death|3
7113191|NCT02531438|11247039|FG000|Overall Study|Randomized, but Not Treated|4
7113192|NCT02531438|11247040|FG001|Overall Study|Randomized, but Not Treated|0
7113193|NCT02531438|11247039|FG000|Overall Study|Missed EOT/PTE Visit|5
7113194|NCT02531438|11247040|FG001|Overall Study|Missed EOT/PTE Visit|2
7113195|NCT02531438|11247039|FG000|Overall Study|Randomized with Exclusion Criteria|1
7113196|NCT02531438|11247040|FG001|Overall Study|Randomized with Exclusion Criteria|0
7113197|NCT02531633|11247051|FG000|Part A (52 Weeks)|Sponsor request|24
7113198|NCT02531633|11247052|FG001|Part A (52 Weeks)|Sponsor request|24
7113199|NCT02531633|11247053|FG002|Part A (52 Weeks)|Sponsor request|18
7113200|NCT02531633|11247054|FG003|Part A (52 Weeks)|Sponsor request|18
7113201|NCT02531633|11247055|FG004|Part A (52 Weeks)|Sponsor request|19
7113202|NCT02531633|11247056|FG005|Part A (52 Weeks)|Sponsor request|0
7113203|NCT02531633|11247057|FG006|Part A (52 Weeks)|Sponsor request|0
7113204|NCT02531633|11247058|FG007|Part A (52 Weeks)|Sponsor request|0
7113205|NCT02531633|11247059|FG008|Part A (52 Weeks)|Sponsor request|0
7113206|NCT02531633|11247060|FG009|Part A (52 Weeks)|Sponsor request|0
7113207|NCT02531633|11247051|FG000|Part A (52 Weeks)|Protocol Violation|1
7113208|NCT02531633|11247052|FG001|Part A (52 Weeks)|Protocol Violation|0
7113209|NCT02531633|11247053|FG002|Part A (52 Weeks)|Protocol Violation|0
7113210|NCT02531633|11247054|FG003|Part A (52 Weeks)|Protocol Violation|0
7113211|NCT02531633|11247055|FG004|Part A (52 Weeks)|Protocol Violation|0
7113212|NCT02531633|11247056|FG005|Part A (52 Weeks)|Protocol Violation|0
7113213|NCT02531633|11247057|FG006|Part A (52 Weeks)|Protocol Violation|0
7113214|NCT02531633|11247058|FG007|Part A (52 Weeks)|Protocol Violation|0
7113215|NCT02531633|11247059|FG008|Part A (52 Weeks)|Protocol Violation|0
7113216|NCT02531633|11247060|FG009|Part A (52 Weeks)|Protocol Violation|0
7113217|NCT02531633|11247051|FG000|Part A (52 Weeks)|Lost to Follow-up|0
7113218|NCT02531633|11247052|FG001|Part A (52 Weeks)|Lost to Follow-up|0
7113219|NCT02531633|11247053|FG002|Part A (52 Weeks)|Lost to Follow-up|0
7113220|NCT02531633|11247054|FG003|Part A (52 Weeks)|Lost to Follow-up|0
7113221|NCT02531633|11247055|FG004|Part A (52 Weeks)|Lost to Follow-up|1
7113222|NCT02531633|11247056|FG005|Part A (52 Weeks)|Lost to Follow-up|0
7113223|NCT02531633|11247057|FG006|Part A (52 Weeks)|Lost to Follow-up|0
7113224|NCT02531633|11247058|FG007|Part A (52 Weeks)|Lost to Follow-up|0
7113225|NCT02531633|11247059|FG008|Part A (52 Weeks)|Lost to Follow-up|0
7113226|NCT02531633|11247060|FG009|Part A (52 Weeks)|Lost to Follow-up|0
7113227|NCT02531633|11247051|FG000|Part A (52 Weeks)|Physician Decision|1
7113228|NCT02531633|11247052|FG001|Part A (52 Weeks)|Physician Decision|4
7113229|NCT02531633|11247053|FG002|Part A (52 Weeks)|Physician Decision|3
7113230|NCT02531633|11247054|FG003|Part A (52 Weeks)|Physician Decision|1
7113231|NCT02531633|11247055|FG004|Part A (52 Weeks)|Physician Decision|0
7113232|NCT02531633|11247056|FG005|Part A (52 Weeks)|Physician Decision|0
7113233|NCT02531633|11247057|FG006|Part A (52 Weeks)|Physician Decision|0
7113234|NCT02531633|11247058|FG007|Part A (52 Weeks)|Physician Decision|0
7113235|NCT02531633|11247059|FG008|Part A (52 Weeks)|Physician Decision|0
7113236|NCT02531633|11247060|FG009|Part A (52 Weeks)|Physician Decision|0
7113237|NCT02531633|11247051|FG000|Part A (52 Weeks)|Withdrawal by Subject|6
7113238|NCT02531633|11247052|FG001|Part A (52 Weeks)|Withdrawal by Subject|6
7113239|NCT02531633|11247053|FG002|Part A (52 Weeks)|Withdrawal by Subject|1
7113240|NCT02531633|11247054|FG003|Part A (52 Weeks)|Withdrawal by Subject|3
7113241|NCT02531633|11247055|FG004|Part A (52 Weeks)|Withdrawal by Subject|3
7113242|NCT02531633|11247056|FG005|Part A (52 Weeks)|Withdrawal by Subject|0
7113243|NCT02531633|11247057|FG006|Part A (52 Weeks)|Withdrawal by Subject|0
7113244|NCT02531633|11247058|FG007|Part A (52 Weeks)|Withdrawal by Subject|0
7113245|NCT02531633|11247059|FG008|Part A (52 Weeks)|Withdrawal by Subject|0
7113246|NCT02531633|11247060|FG009|Part A (52 Weeks)|Withdrawal by Subject|0
7113247|NCT02531633|11247051|FG000|Part A (52 Weeks)|Other|2
7113248|NCT02531633|11247052|FG001|Part A (52 Weeks)|Other|0
7113249|NCT02531633|11247053|FG002|Part A (52 Weeks)|Other|0
7113250|NCT02531633|11247054|FG003|Part A (52 Weeks)|Other|0
7113251|NCT02531633|11247055|FG004|Part A (52 Weeks)|Other|0
7113252|NCT02531633|11247056|FG005|Part A (52 Weeks)|Other|0
7113253|NCT02531633|11247057|FG006|Part A (52 Weeks)|Other|0
7113254|NCT02531633|11247058|FG007|Part A (52 Weeks)|Other|0
7113255|NCT02531633|11247059|FG008|Part A (52 Weeks)|Other|0
7113256|NCT02531633|11247060|FG009|Part A (52 Weeks)|Other|0
7113257|NCT02531633|11247051|FG000|Part B (104 Weeks)|Sponsor request|0
7113258|NCT02531633|11247052|FG001|Part B (104 Weeks)|Sponsor request|0
7113259|NCT02531633|11247053|FG002|Part B (104 Weeks)|Sponsor request|0
7113260|NCT02531633|11247054|FG003|Part B (104 Weeks)|Sponsor request|0
7113261|NCT02531633|11247055|FG004|Part B (104 Weeks)|Sponsor request|0
7113262|NCT02531633|11247056|FG005|Part B (104 Weeks)|Sponsor request|8
7113263|NCT02531633|11247057|FG006|Part B (104 Weeks)|Sponsor request|5
7113264|NCT02531633|11247058|FG007|Part B (104 Weeks)|Sponsor request|3
7113265|NCT02531633|11247059|FG008|Part B (104 Weeks)|Sponsor request|5
7113266|NCT02531633|11247060|FG009|Part B (104 Weeks)|Sponsor request|4
7113267|NCT02531633|11247051|FG000|Part B (104 Weeks)|Lost to Follow-up|0
7113268|NCT02531633|11247052|FG001|Part B (104 Weeks)|Lost to Follow-up|0
7113269|NCT02531633|11247053|FG002|Part B (104 Weeks)|Lost to Follow-up|0
7113270|NCT02531633|11247054|FG003|Part B (104 Weeks)|Lost to Follow-up|0
7113271|NCT02531633|11247055|FG004|Part B (104 Weeks)|Lost to Follow-up|0
7113272|NCT02531633|11247056|FG005|Part B (104 Weeks)|Lost to Follow-up|0
7113273|NCT02531633|11247057|FG006|Part B (104 Weeks)|Lost to Follow-up|0
7113274|NCT02531633|11247058|FG007|Part B (104 Weeks)|Lost to Follow-up|1
7113275|NCT02531633|11247059|FG008|Part B (104 Weeks)|Lost to Follow-up|0
7113276|NCT02531633|11247060|FG009|Part B (104 Weeks)|Lost to Follow-up|0
7113277|NCT02531646|11247103|FG000|Overall Study|equip. image processing issue|5
7113278|NCT02531646|11247104|FG001|Overall Study|equip. image processing issue|1
7113279|NCT02531646|11247105|FG002|Overall Study|equip. image processing issue|0
7113280|NCT02531698|11247115|FG000|Overall Study|Adverse Event|2
7113281|NCT02531698|11247116|FG001|Overall Study|Adverse Event|1
7113282|NCT02531698|11247115|FG000|Overall Study|Withdrawal by Subject|6
7113283|NCT02531698|11247116|FG001|Overall Study|Withdrawal by Subject|1
7113284|NCT02531698|11247115|FG000|Overall Study|Protocol Violation|2
7113285|NCT02531698|11247116|FG001|Overall Study|Protocol Violation|0
7113286|NCT02531698|11247115|FG000|Overall Study|Lost to Follow-up|1
7113287|NCT02531698|11247116|FG001|Overall Study|Lost to Follow-up|0
7113288|NCT02531802|11247152|FG000|Received Vaccination 2|Medication interfering with study taken|0
7113289|NCT02531802|11247153|FG001|Received Vaccination 2|Medication interfering with study taken|0
7113290|NCT02531802|11247154|FG002|Received Vaccination 2|Medication interfering with study taken|1
7113291|NCT02531802|11247155|FG003|Received Vaccination 2|Medication interfering with study taken|0
7113292|NCT02531802|11247156|FG004|Received Vaccination 2|Medication interfering with study taken|0
7113293|NCT02531802|11247157|FG005|Received Vaccination 2|Medication interfering with study taken|0
7113294|NCT02531802|11247158|FG006|Received Vaccination 2|Medication interfering with study taken|0
7113295|NCT02531802|11247159|FG007|Received Vaccination 2|Medication interfering with study taken|0
7113296|NCT02531802|11247160|FG008|Received Vaccination 2|Medication interfering with study taken|0
7113297|NCT02531802|11247161|FG009|Received Vaccination 2|Medication interfering with study taken|1
7113298|NCT02531802|11247162|FG010|Received Vaccination 2|Medication interfering with study taken|1
7113299|NCT02531802|11247163|FG011|Received Vaccination 2|Medication interfering with study taken|0
7113300|NCT02531802|11247164|FG012|Received Vaccination 2|Medication interfering with study taken|1
7113301|NCT02531802|11247165|FG013|Received Vaccination 2|Medication interfering with study taken|0
7113302|NCT02531802|11247166|FG014|Received Vaccination 2|Medication interfering with study taken|0
7113303|NCT02531802|11247167|FG015|Received Vaccination 2|Medication interfering with study taken|0
7113304|NCT02531802|11247168|FG016|Received Vaccination 2|Medication interfering with study taken|0
7113305|NCT02531802|11247169|FG017|Received Vaccination 2|Medication interfering with study taken|0
7113306|NCT02531802|11247170|FG018|Received Vaccination 2|Medication interfering with study taken|1
7113307|NCT02531802|11247171|FG019|Received Vaccination 2|Medication interfering with study taken|0
7113308|NCT02531802|11247172|FG020|Received Vaccination 2|Medication interfering with study taken|0
7113309|NCT02531802|11247152|FG000|Received Vaccination 2|Physician Decision|0
7113310|NCT02531802|11247153|FG001|Received Vaccination 2|Physician Decision|0
7113311|NCT02531802|11247154|FG002|Received Vaccination 2|Physician Decision|0
7113312|NCT02531802|11247155|FG003|Received Vaccination 2|Physician Decision|0
7113313|NCT02531802|11247156|FG004|Received Vaccination 2|Physician Decision|0
7113314|NCT02531802|11247157|FG005|Received Vaccination 2|Physician Decision|1
7113315|NCT02531802|11247158|FG006|Received Vaccination 2|Physician Decision|0
7113316|NCT02531802|11247159|FG007|Received Vaccination 2|Physician Decision|0
7113317|NCT02531802|11247160|FG008|Received Vaccination 2|Physician Decision|0
7113318|NCT02531802|11247161|FG009|Received Vaccination 2|Physician Decision|2
7113319|NCT02531802|11247162|FG010|Received Vaccination 2|Physician Decision|0
7113320|NCT02531802|11247163|FG011|Received Vaccination 2|Physician Decision|0
7113321|NCT02531802|11247164|FG012|Received Vaccination 2|Physician Decision|0
7113322|NCT02531802|11247165|FG013|Received Vaccination 2|Physician Decision|1
7113323|NCT02531802|11247166|FG014|Received Vaccination 2|Physician Decision|0
7113324|NCT02531802|11247167|FG015|Received Vaccination 2|Physician Decision|0
7113325|NCT02531802|11247168|FG016|Received Vaccination 2|Physician Decision|0
7113326|NCT02531802|11247169|FG017|Received Vaccination 2|Physician Decision|1
7113327|NCT02531802|11247170|FG018|Received Vaccination 2|Physician Decision|0
7113328|NCT02531802|11247171|FG019|Received Vaccination 2|Physician Decision|0
7113329|NCT02531802|11247172|FG020|Received Vaccination 2|Physician Decision|0
7113330|NCT02531802|11247152|FG000|Received Vaccination 2|Adverse Event|0
7113331|NCT02531802|11247153|FG001|Received Vaccination 2|Adverse Event|0
7113332|NCT02531802|11247154|FG002|Received Vaccination 2|Adverse Event|0
7113333|NCT02531802|11247155|FG003|Received Vaccination 2|Adverse Event|0
7113334|NCT02531802|11247156|FG004|Received Vaccination 2|Adverse Event|0
7113335|NCT02531802|11247157|FG005|Received Vaccination 2|Adverse Event|2
7113336|NCT02531802|11247158|FG006|Received Vaccination 2|Adverse Event|0
7113337|NCT02531802|11247159|FG007|Received Vaccination 2|Adverse Event|0
7113338|NCT02531802|11247160|FG008|Received Vaccination 2|Adverse Event|0
7113339|NCT02531802|11247161|FG009|Received Vaccination 2|Adverse Event|0
7113340|NCT02531802|11247162|FG010|Received Vaccination 2|Adverse Event|0
7113341|NCT02531802|11247163|FG011|Received Vaccination 2|Adverse Event|0
7113342|NCT02531802|11247164|FG012|Received Vaccination 2|Adverse Event|0
7113343|NCT02531802|11247165|FG013|Received Vaccination 2|Adverse Event|0
7113344|NCT02531802|11247166|FG014|Received Vaccination 2|Adverse Event|0
7113345|NCT02531802|11247167|FG015|Received Vaccination 2|Adverse Event|0
7113346|NCT02531802|11247168|FG016|Received Vaccination 2|Adverse Event|0
7113347|NCT02531802|11247169|FG017|Received Vaccination 2|Adverse Event|2
7113348|NCT02531802|11247170|FG018|Received Vaccination 2|Adverse Event|1
7113349|NCT02531802|11247171|FG019|Received Vaccination 2|Adverse Event|0
7113350|NCT02531802|11247172|FG020|Received Vaccination 2|Adverse Event|1
7113351|NCT02531802|11247152|FG000|Received Vaccination 2|Withdrawal by Subject|0
7113352|NCT02531802|11247153|FG001|Received Vaccination 2|Withdrawal by Subject|0
7113353|NCT02531802|11247154|FG002|Received Vaccination 2|Withdrawal by Subject|0
7113354|NCT02531802|11247155|FG003|Received Vaccination 2|Withdrawal by Subject|0
7113355|NCT02531802|11247156|FG004|Received Vaccination 2|Withdrawal by Subject|0
7113356|NCT02531802|11247157|FG005|Received Vaccination 2|Withdrawal by Subject|0
7113357|NCT02531802|11247158|FG006|Received Vaccination 2|Withdrawal by Subject|0
7113358|NCT02531802|11247159|FG007|Received Vaccination 2|Withdrawal by Subject|0
7113359|NCT02531802|11247160|FG008|Received Vaccination 2|Withdrawal by Subject|0
7113360|NCT02531802|11247161|FG009|Received Vaccination 2|Withdrawal by Subject|0
7113361|NCT02531802|11247162|FG010|Received Vaccination 2|Withdrawal by Subject|1
7113362|NCT02531802|11247163|FG011|Received Vaccination 2|Withdrawal by Subject|0
7113363|NCT02531802|11247164|FG012|Received Vaccination 2|Withdrawal by Subject|1
7113364|NCT02531802|11247165|FG013|Received Vaccination 2|Withdrawal by Subject|1
7113365|NCT02531802|11247166|FG014|Received Vaccination 2|Withdrawal by Subject|1
7113366|NCT02531802|11247167|FG015|Received Vaccination 2|Withdrawal by Subject|0
7113367|NCT02531802|11247168|FG016|Received Vaccination 2|Withdrawal by Subject|0
7113368|NCT02531802|11247169|FG017|Received Vaccination 2|Withdrawal by Subject|1
7113369|NCT02531802|11247170|FG018|Received Vaccination 2|Withdrawal by Subject|1
7113370|NCT02531802|11247171|FG019|Received Vaccination 2|Withdrawal by Subject|1
7113371|NCT02531802|11247172|FG020|Received Vaccination 2|Withdrawal by Subject|0
7113372|NCT02532179|11247273|FG000|Overall Study|Lost to Follow-up|1
7113373|NCT02532179|11247273|FG000|Overall Study|Pregnancy|1
7113374|NCT02532179|11247273|FG000|Overall Study|Subject received depot steroid injection|1
7113375|NCT02532283|11247279|FG000|Overall Study|Adverse Event|0
7113376|NCT02532283|11247280|FG001|Overall Study|Adverse Event|1
7113377|NCT02532283|11247279|FG000|Overall Study|Death|1
7113378|NCT02532283|11247280|FG001|Overall Study|Death|0
7113379|NCT02532283|11247279|FG000|Overall Study|Lost to Follow-up|0
7113380|NCT02532283|11247280|FG001|Overall Study|Lost to Follow-up|1
7113381|NCT02532283|11247279|FG000|Overall Study|Withdrawal by Subject|8
7113382|NCT02532283|11247280|FG001|Overall Study|Withdrawal by Subject|3
7113383|NCT02532374|11247288|FG000|Overall Study|Withdrawal by Subject|1
7113384|NCT02532374|11247288|FG000|Overall Study|Physician Decision|1
7113385|NCT02532465|11247302|FG000|Overall Study|Protocol Violation|1
7113386|NCT02532465|11247303|FG001|Overall Study|Protocol Violation|0
7113387|NCT02532465|11247302|FG000|Overall Study|Lack of Efficacy|0
7113388|NCT02532465|11247303|FG001|Overall Study|Lack of Efficacy|1
7113389|NCT02532517|11247309|FG000|Overall Study|Did not complete 24-Month visit|4
7113390|NCT02532517|11247309|FG000|Overall Study|Failed Angiographic eligibility|1
7113391|NCT02532517|11247309|FG000|Overall Study|Lost to Follow-up|4
7113392|NCT02532517|11247309|FG000|Overall Study|Withdrawal by Subject|4
7113393|NCT02532517|11247309|FG000|Overall Study|Death|4
7113394|NCT02532543|11247317|FG000|Overall Study|Lost to Follow-up|0
7113395|NCT02532543|11247318|FG001|Overall Study|Lost to Follow-up|0
7113396|NCT02532543|11247319|FG002|Overall Study|Lost to Follow-up|1
7113397|NCT02532543|11247320|FG003|Overall Study|Lost to Follow-up|0
7113398|NCT02532647|11247343|FG000|Overall Study|Did not receive trial medication|1
7113399|NCT02532647|11247344|FG001|Overall Study|Did not receive trial medication|0
7113400|NCT02532647|11247345|FG002|Overall Study|Did not receive trial medication|1
7113401|NCT02532764|11247363|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
7113402|NCT02532764|11247364|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
7113403|NCT02532764|11247365|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
7113404|NCT02532764|11247366|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
7113405|NCT02532764|11247367|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
7113406|NCT02532764|11247368|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
7113407|NCT02532764|11247369|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
7113408|NCT02532764|11247370|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
7113409|NCT02532764|11247371|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
7113410|NCT02532764|11247372|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
7113411|NCT02532855|11247401|FG000|Overall Study|Lost to Follow-up|4
7113412|NCT02532855|11247402|FG001|Overall Study|Lost to Follow-up|3
7113413|NCT02532855|11247401|FG000|Overall Study|Withdrawal by Subject|4
7113414|NCT02532855|11247402|FG001|Overall Study|Withdrawal by Subject|8
7113415|NCT02532972|11247417|FG000|Overall Study|Withdrawal by Subject|1
7113416|NCT02533180|11247461|FG000|Overall Study|Death|0
7113417|NCT02533180|11247462|FG001|Overall Study|Death|1
7113418|NCT02533180|11247461|FG000|Overall Study|Lost to Follow-up|0
7113419|NCT02533180|11247462|FG001|Overall Study|Lost to Follow-up|1
7113420|NCT02533180|11247461|FG000|Overall Study|Physician Decision|0
7113421|NCT02533180|11247462|FG001|Overall Study|Physician Decision|1
7113422|NCT02533180|11247461|FG000|Overall Study|Withdrawal by Subject|2
7113423|NCT02533180|11247462|FG001|Overall Study|Withdrawal by Subject|4
7113424|NCT02533180|11247461|FG000|Overall Study|Screen Failure|37
7113425|NCT02533180|11247462|FG001|Overall Study|Screen Failure|0
7113426|NCT02533180|11247461|FG000|Overall Study|Protocol Deviation|0
7113427|NCT02533180|11247462|FG001|Overall Study|Protocol Deviation|1
7113428|NCT02533180|11247461|FG000|Overall Study|On Study|0
7113429|NCT02533180|11247462|FG001|Overall Study|On Study|39
7113430|NCT02533258|11247467|FG000|Overall Study|Adverse Event|1
7113431|NCT02533258|11247467|FG000|Overall Study|Death|2
7113432|NCT02533258|11247467|FG000|Overall Study|Other|1
7113433|NCT02533258|11247467|FG000|Overall Study|Economic factor|1
7113434|NCT02533258|11247467|FG000|Overall Study|Progression of pleural effusion|1
7113435|NCT02533258|11247467|FG000|Overall Study|Lack of Efficacy|2
7113436|NCT02533375|11247471|FG000|Overall Study|Lack of Efficacy|3
7113437|NCT02533375|11247471|FG000|Overall Study|Adverse Event|2
7113438|NCT02533401|11247475|FG000|Overall Study|Adverse Event/Intercurrent Disease|3
7113439|NCT02533401|11247475|FG000|Overall Study|Death|5
7113440|NCT02533401|11247475|FG000|Overall Study|Insufficient Response/Progressed Disease|1
7113441|NCT02533401|11247475|FG000|Overall Study|Lost to Follow-up|1
7113442|NCT02533401|11247475|FG000|Overall Study|Violation of Selection Criteria|1
7113443|NCT02533453|11247486|FG000|Overall Study|Adverse Event|6
7113444|NCT02533453|11247486|FG000|Overall Study|Protocol Violation|1
7113445|NCT02533453|11247486|FG000|Overall Study|Withdrawal by Subject|2
7113446|NCT02533570|11247511|FG000|Overall Study|Adverse Event|0
7113447|NCT02533570|11247512|FG001|Overall Study|Adverse Event|1
7113448|NCT02533570|11247513|FG002|Overall Study|Adverse Event|1
7113449|NCT02533674|11247529|FG000|Dose Level I|Progressive disease|1
7113450|NCT02533674|11247530|FG001|Dose Level I|Progressive disease|0
7113451|NCT02533674|11247531|FG002|Dose Level I|Progressive disease|0
7113452|NCT02533674|11247532|FG003|Dose Level I|Progressive disease|0
7113453|NCT02533674|11247533|FG004|Dose Level I|Progressive disease|0
7113454|NCT02533674|11247534|FG005|Dose Level I|Progressive disease|0
7113455|NCT02533674|11247535|FG006|Dose Level I|Progressive disease|0
7113456|NCT02533674|11247536|FG007|Dose Level I|Progressive disease|0
7113457|NCT02533674|11247529|FG000|Dose Level I|Withdrawal by Subject|1
7113458|NCT02533674|11247530|FG001|Dose Level I|Withdrawal by Subject|0
7113459|NCT02533674|11247531|FG002|Dose Level I|Withdrawal by Subject|0
7113460|NCT02533674|11247532|FG003|Dose Level I|Withdrawal by Subject|0
7113461|NCT02533674|11247533|FG004|Dose Level I|Withdrawal by Subject|0
7113462|NCT02533674|11247534|FG005|Dose Level I|Withdrawal by Subject|0
7113463|NCT02533674|11247535|FG006|Dose Level I|Withdrawal by Subject|0
7113464|NCT02533674|11247536|FG007|Dose Level I|Withdrawal by Subject|0
7113465|NCT02533674|11247529|FG000|Dose Level I|Physician Decision|1
7113466|NCT02533674|11247530|FG001|Dose Level I|Physician Decision|0
7113467|NCT02533674|11247531|FG002|Dose Level I|Physician Decision|0
7113468|NCT02533674|11247532|FG003|Dose Level I|Physician Decision|0
7113469|NCT02533674|11247533|FG004|Dose Level I|Physician Decision|0
7113470|NCT02533674|11247534|FG005|Dose Level I|Physician Decision|0
7113471|NCT02533674|11247535|FG006|Dose Level I|Physician Decision|0
7113472|NCT02533674|11247536|FG007|Dose Level I|Physician Decision|0
7113473|NCT02533674|11247529|FG000|Dose Level I|Death|1
7113474|NCT02533674|11247530|FG001|Dose Level I|Death|0
7113475|NCT02533674|11247531|FG002|Dose Level I|Death|0
7113476|NCT02533674|11247532|FG003|Dose Level I|Death|0
7113477|NCT02533674|11247533|FG004|Dose Level I|Death|0
7113478|NCT02533674|11247534|FG005|Dose Level I|Death|0
7113479|NCT02533674|11247535|FG006|Dose Level I|Death|0
7113480|NCT02533674|11247536|FG007|Dose Level I|Death|0
7113481|NCT02533674|11247529|FG000|Dose Level I|Never Treated|1
7113482|NCT02533674|11247530|FG001|Dose Level I|Never Treated|0
7113483|NCT02533674|11247531|FG002|Dose Level I|Never Treated|0
7113484|NCT02533674|11247532|FG003|Dose Level I|Never Treated|0
7113485|NCT02533674|11247533|FG004|Dose Level I|Never Treated|0
7113486|NCT02533674|11247534|FG005|Dose Level I|Never Treated|0
7113487|NCT02533674|11247535|FG006|Dose Level I|Never Treated|0
7113488|NCT02533674|11247536|FG007|Dose Level I|Never Treated|0
7113489|NCT02533674|11247529|FG000|Dose Level II|Progressive disease|0
7113490|NCT02533674|11247530|FG001|Dose Level II|Progressive disease|3
7113491|NCT02533674|11247531|FG002|Dose Level II|Progressive disease|0
7113492|NCT02533674|11247532|FG003|Dose Level II|Progressive disease|0
7113493|NCT02533674|11247533|FG004|Dose Level II|Progressive disease|0
7113494|NCT02533674|11247534|FG005|Dose Level II|Progressive disease|0
7113495|NCT02533674|11247535|FG006|Dose Level II|Progressive disease|0
7113496|NCT02533674|11247536|FG007|Dose Level II|Progressive disease|0
7113497|NCT02533674|11247529|FG000|Dose Level II|Withdrawal by Subject|0
7113498|NCT02533674|11247530|FG001|Dose Level II|Withdrawal by Subject|1
7113499|NCT02533674|11247531|FG002|Dose Level II|Withdrawal by Subject|0
7113500|NCT02533674|11247532|FG003|Dose Level II|Withdrawal by Subject|0
7113501|NCT02533674|11247533|FG004|Dose Level II|Withdrawal by Subject|0
7113502|NCT02533674|11247534|FG005|Dose Level II|Withdrawal by Subject|0
7113503|NCT02533674|11247535|FG006|Dose Level II|Withdrawal by Subject|0
7113504|NCT02533674|11247536|FG007|Dose Level II|Withdrawal by Subject|0
7113505|NCT02533674|11247529|FG000|Dose Level II|Treatment-related AE|0
7113506|NCT02533674|11247530|FG001|Dose Level II|Treatment-related AE|1
7113507|NCT02533674|11247531|FG002|Dose Level II|Treatment-related AE|0
7113508|NCT02533674|11247532|FG003|Dose Level II|Treatment-related AE|0
7113509|NCT02533674|11247533|FG004|Dose Level II|Treatment-related AE|0
7113510|NCT02533674|11247534|FG005|Dose Level II|Treatment-related AE|0
7113511|NCT02533674|11247535|FG006|Dose Level II|Treatment-related AE|0
7113512|NCT02533674|11247536|FG007|Dose Level II|Treatment-related AE|0
7113513|NCT02533674|11247529|FG000|Dose Level II|Physician Decision|0
7113514|NCT02533674|11247530|FG001|Dose Level II|Physician Decision|1
7113515|NCT02533674|11247531|FG002|Dose Level II|Physician Decision|0
7113516|NCT02533674|11247532|FG003|Dose Level II|Physician Decision|0
7113517|NCT02533674|11247533|FG004|Dose Level II|Physician Decision|0
7113518|NCT02533674|11247534|FG005|Dose Level II|Physician Decision|0
7113519|NCT02533674|11247535|FG006|Dose Level II|Physician Decision|0
7113520|NCT02533674|11247536|FG007|Dose Level II|Physician Decision|0
7113521|NCT02533674|11247529|FG000|Dose Level II|Non-treatment-related AE|0
7113522|NCT02533674|11247530|FG001|Dose Level II|Non-treatment-related AE|1
7113523|NCT02533674|11247531|FG002|Dose Level II|Non-treatment-related AE|0
7113524|NCT02533674|11247532|FG003|Dose Level II|Non-treatment-related AE|0
7113525|NCT02533674|11247533|FG004|Dose Level II|Non-treatment-related AE|0
7113526|NCT02533674|11247534|FG005|Dose Level II|Non-treatment-related AE|0
7113527|NCT02533674|11247535|FG006|Dose Level II|Non-treatment-related AE|0
7113528|NCT02533674|11247536|FG007|Dose Level II|Non-treatment-related AE|0
7113529|NCT02533674|11247529|FG000|Dose Level III|Progressive disease|0
7113530|NCT02533674|11247530|FG001|Dose Level III|Progressive disease|0
7113531|NCT02533674|11247531|FG002|Dose Level III|Progressive disease|2
7113532|NCT02533674|11247532|FG003|Dose Level III|Progressive disease|0
7113533|NCT02533674|11247533|FG004|Dose Level III|Progressive disease|0
7113534|NCT02533674|11247534|FG005|Dose Level III|Progressive disease|0
7113535|NCT02533674|11247535|FG006|Dose Level III|Progressive disease|0
7113536|NCT02533674|11247536|FG007|Dose Level III|Progressive disease|0
7113537|NCT02533674|11247529|FG000|Dose Level III|Withdrawal by Subject|0
7113538|NCT02533674|11247530|FG001|Dose Level III|Withdrawal by Subject|0
7113539|NCT02533674|11247531|FG002|Dose Level III|Withdrawal by Subject|1
7113540|NCT02533674|11247532|FG003|Dose Level III|Withdrawal by Subject|0
7113541|NCT02533674|11247533|FG004|Dose Level III|Withdrawal by Subject|0
7113542|NCT02533674|11247534|FG005|Dose Level III|Withdrawal by Subject|0
7113543|NCT02533674|11247535|FG006|Dose Level III|Withdrawal by Subject|0
7113544|NCT02533674|11247536|FG007|Dose Level III|Withdrawal by Subject|0
7113545|NCT02533674|11247529|FG000|Dose Level III|Treatment-related AE|0
7113546|NCT02533674|11247530|FG001|Dose Level III|Treatment-related AE|0
7113547|NCT02533674|11247531|FG002|Dose Level III|Treatment-related AE|1
7113548|NCT02533674|11247532|FG003|Dose Level III|Treatment-related AE|0
7113549|NCT02533674|11247533|FG004|Dose Level III|Treatment-related AE|0
7113550|NCT02533674|11247534|FG005|Dose Level III|Treatment-related AE|0
7113551|NCT02533674|11247535|FG006|Dose Level III|Treatment-related AE|0
7113552|NCT02533674|11247536|FG007|Dose Level III|Treatment-related AE|0
7113553|NCT02533674|11247529|FG000|Dose Level IV|Progressive disease|0
7113554|NCT02533674|11247530|FG001|Dose Level IV|Progressive disease|0
7113555|NCT02533674|11247531|FG002|Dose Level IV|Progressive disease|0
7113556|NCT02533674|11247532|FG003|Dose Level IV|Progressive disease|3
7113557|NCT02533674|11247533|FG004|Dose Level IV|Progressive disease|0
7113558|NCT02533674|11247534|FG005|Dose Level IV|Progressive disease|0
7113559|NCT02533674|11247535|FG006|Dose Level IV|Progressive disease|0
7113560|NCT02533674|11247536|FG007|Dose Level IV|Progressive disease|0
7113561|NCT02533674|11247529|FG000|Dose Level IV|Withdrawal by Subject|0
7113562|NCT02533674|11247530|FG001|Dose Level IV|Withdrawal by Subject|0
7113563|NCT02533674|11247531|FG002|Dose Level IV|Withdrawal by Subject|0
7113564|NCT02533674|11247532|FG003|Dose Level IV|Withdrawal by Subject|1
7113565|NCT02533674|11247533|FG004|Dose Level IV|Withdrawal by Subject|0
7113566|NCT02533674|11247534|FG005|Dose Level IV|Withdrawal by Subject|0
7113567|NCT02533674|11247535|FG006|Dose Level IV|Withdrawal by Subject|0
7113568|NCT02533674|11247536|FG007|Dose Level IV|Withdrawal by Subject|0
7113569|NCT02533674|11247529|FG000|Dose Level IV|Physician Decision|0
7113570|NCT02533674|11247530|FG001|Dose Level IV|Physician Decision|0
7113571|NCT02533674|11247531|FG002|Dose Level IV|Physician Decision|0
7113572|NCT02533674|11247532|FG003|Dose Level IV|Physician Decision|1
7113573|NCT02533674|11247533|FG004|Dose Level IV|Physician Decision|0
7113574|NCT02533674|11247534|FG005|Dose Level IV|Physician Decision|0
7113575|NCT02533674|11247535|FG006|Dose Level IV|Physician Decision|0
7113576|NCT02533674|11247536|FG007|Dose Level IV|Physician Decision|0
7113577|NCT02533674|11247529|FG000|Dose Level V|Progressive disease|0
7113578|NCT02533674|11247530|FG001|Dose Level V|Progressive disease|0
7113579|NCT02533674|11247531|FG002|Dose Level V|Progressive disease|0
7113580|NCT02533674|11247532|FG003|Dose Level V|Progressive disease|0
7113581|NCT02533674|11247533|FG004|Dose Level V|Progressive disease|3
7113582|NCT02533674|11247534|FG005|Dose Level V|Progressive disease|0
7113583|NCT02533674|11247535|FG006|Dose Level V|Progressive disease|0
7113584|NCT02533674|11247536|FG007|Dose Level V|Progressive disease|0
7113585|NCT02533674|11247529|FG000|Dose Level V|Withdrawal by Subject|0
6805830|NCT02575339|10808035|FG000|Follow up|Death due to progressive disease after coming off treatment early|1
6805831|NCT02575339|10808036|FG001|Follow up|Death due to progressive disease after coming off treatment early|0
6805832|NCT02575339|10808037|FG002|Follow up|Death due to progressive disease after coming off treatment early|0
6805833|NCT02498444|10808049|FG000|Overall Study|Withdrawal by Subject|3
6805834|NCT02498444|10808050|FG001|Overall Study|Withdrawal by Subject|0
6805835|NCT02498444|10808049|FG000|Overall Study|Physician Decision|1
6805836|NCT02498444|10808050|FG001|Overall Study|Physician Decision|0
6805837|NCT02487108|10808060|FG000|Overall Study|Adverse Event|1
6805838|NCT02487108|10808061|FG001|Overall Study|Adverse Event|6
6805839|NCT02487108|10808062|FG002|Overall Study|Adverse Event|12
6805840|NCT02487108|10808063|FG003|Overall Study|Adverse Event|6
6805841|NCT02487108|10808060|FG000|Overall Study|Withdrawal by Subject|8
6805842|NCT02487108|10808061|FG001|Overall Study|Withdrawal by Subject|5
6805843|NCT02487108|10808062|FG002|Overall Study|Withdrawal by Subject|5
6805844|NCT02487108|10808063|FG003|Overall Study|Withdrawal by Subject|0
6805845|NCT02487108|10808060|FG000|Overall Study|Non-compliance to study medication|3
6805846|NCT02487108|10808061|FG001|Overall Study|Non-compliance to study medication|2
6805847|NCT02487108|10808062|FG002|Overall Study|Non-compliance to study medication|5
6805848|NCT02487108|10808063|FG003|Overall Study|Non-compliance to study medication|4
6805849|NCT02487108|10808060|FG000|Overall Study|Protocol Violation|1
6805850|NCT02487108|10808061|FG001|Overall Study|Protocol Violation|1
6805851|NCT02487108|10808062|FG002|Overall Study|Protocol Violation|2
6805852|NCT02487108|10808063|FG003|Overall Study|Protocol Violation|0
6805853|NCT02487108|10808060|FG000|Overall Study|Non-compliance to study procedures|0
6805854|NCT02487108|10808061|FG001|Overall Study|Non-compliance to study procedures|0
6805855|NCT02487108|10808062|FG002|Overall Study|Non-compliance to study procedures|0
6805856|NCT02487108|10808063|FG003|Overall Study|Non-compliance to study procedures|1
6805857|NCT02487108|10808060|FG000|Overall Study|Other than specified|3
6805858|NCT02487108|10808061|FG001|Overall Study|Other than specified|2
6805859|NCT02487108|10808062|FG002|Overall Study|Other than specified|2
7113586|NCT02533674|11247530|FG001|Dose Level V|Withdrawal by Subject|0
7113587|NCT02533674|11247531|FG002|Dose Level V|Withdrawal by Subject|0
7113588|NCT02533674|11247532|FG003|Dose Level V|Withdrawal by Subject|0
6805860|NCT02487108|10808063|FG003|Overall Study|Other than specified|0
6805861|NCT02455557|10808073|FG000|Overall Study|Withdrawal by Subject|2
7113589|NCT02533674|11247533|FG004|Dose Level V|Withdrawal by Subject|1
7113590|NCT02533674|11247534|FG005|Dose Level V|Withdrawal by Subject|0
7113591|NCT02533674|11247535|FG006|Dose Level V|Withdrawal by Subject|0
7113592|NCT02533674|11247536|FG007|Dose Level V|Withdrawal by Subject|0
7113593|NCT02533674|11247529|FG000|Dose Level V|Physician Decision|0
7113594|NCT02533674|11247530|FG001|Dose Level V|Physician Decision|0
7113595|NCT02533674|11247531|FG002|Dose Level V|Physician Decision|0
7113596|NCT02533674|11247532|FG003|Dose Level V|Physician Decision|0
7113597|NCT02533674|11247533|FG004|Dose Level V|Physician Decision|1
7113598|NCT02533674|11247534|FG005|Dose Level V|Physician Decision|0
7113599|NCT02533674|11247535|FG006|Dose Level V|Physician Decision|0
7113600|NCT02533674|11247536|FG007|Dose Level V|Physician Decision|0
7113601|NCT02533674|11247529|FG000|Dose Level VI|Progressive disease|0
7113602|NCT02533674|11247530|FG001|Dose Level VI|Progressive disease|0
7113603|NCT02533674|11247531|FG002|Dose Level VI|Progressive disease|0
7113604|NCT02533674|11247532|FG003|Dose Level VI|Progressive disease|0
7113605|NCT02533674|11247533|FG004|Dose Level VI|Progressive disease|0
7113606|NCT02533674|11247534|FG005|Dose Level VI|Progressive disease|7
7113607|NCT02533674|11247535|FG006|Dose Level VI|Progressive disease|0
7113608|NCT02533674|11247536|FG007|Dose Level VI|Progressive disease|0
7113609|NCT02533674|11247529|FG000|Dose Level VI|Withdrawal by Subject|0
7113610|NCT02533674|11247530|FG001|Dose Level VI|Withdrawal by Subject|0
7113611|NCT02533674|11247531|FG002|Dose Level VI|Withdrawal by Subject|0
7113612|NCT02533674|11247532|FG003|Dose Level VI|Withdrawal by Subject|0
7113613|NCT02533674|11247533|FG004|Dose Level VI|Withdrawal by Subject|0
7113614|NCT02533674|11247534|FG005|Dose Level VI|Withdrawal by Subject|1
7113615|NCT02533674|11247535|FG006|Dose Level VI|Withdrawal by Subject|0
7113616|NCT02533674|11247536|FG007|Dose Level VI|Withdrawal by Subject|0
7113617|NCT02533674|11247529|FG000|Dose Level VI|Treatment-related AE|0
7113618|NCT02533674|11247530|FG001|Dose Level VI|Treatment-related AE|0
7113619|NCT02533674|11247531|FG002|Dose Level VI|Treatment-related AE|0
7113620|NCT02533674|11247532|FG003|Dose Level VI|Treatment-related AE|0
7113621|NCT02533674|11247533|FG004|Dose Level VI|Treatment-related AE|0
7113622|NCT02533674|11247534|FG005|Dose Level VI|Treatment-related AE|1
7113623|NCT02533674|11247535|FG006|Dose Level VI|Treatment-related AE|0
7113624|NCT02533674|11247536|FG007|Dose Level VI|Treatment-related AE|0
7113625|NCT02533674|11247529|FG000|Dose Level VII|Progressive disease|0
7113626|NCT02533674|11247530|FG001|Dose Level VII|Progressive disease|0
7113627|NCT02533674|11247531|FG002|Dose Level VII|Progressive disease|0
7113628|NCT02533674|11247532|FG003|Dose Level VII|Progressive disease|0
7113629|NCT02533674|11247533|FG004|Dose Level VII|Progressive disease|0
7113630|NCT02533674|11247534|FG005|Dose Level VII|Progressive disease|0
7113631|NCT02533674|11247535|FG006|Dose Level VII|Progressive disease|10
7113632|NCT02533674|11247536|FG007|Dose Level VII|Progressive disease|0
7113633|NCT02533674|11247529|FG000|Dose Level VII|Withdrawal by Subject|0
7113634|NCT02533674|11247530|FG001|Dose Level VII|Withdrawal by Subject|0
7113635|NCT02533674|11247531|FG002|Dose Level VII|Withdrawal by Subject|0
7113636|NCT02533674|11247532|FG003|Dose Level VII|Withdrawal by Subject|0
7113637|NCT02533674|11247533|FG004|Dose Level VII|Withdrawal by Subject|0
7113638|NCT02533674|11247534|FG005|Dose Level VII|Withdrawal by Subject|0
7113639|NCT02533674|11247535|FG006|Dose Level VII|Withdrawal by Subject|3
7113640|NCT02533674|11247536|FG007|Dose Level VII|Withdrawal by Subject|0
7113641|NCT02533674|11247529|FG000|Dose Level VII|Treatment-related AE|0
7113642|NCT02533674|11247530|FG001|Dose Level VII|Treatment-related AE|0
7113643|NCT02533674|11247531|FG002|Dose Level VII|Treatment-related AE|0
7113644|NCT02533674|11247532|FG003|Dose Level VII|Treatment-related AE|0
7113645|NCT02533674|11247533|FG004|Dose Level VII|Treatment-related AE|0
7113646|NCT02533674|11247534|FG005|Dose Level VII|Treatment-related AE|0
7113647|NCT02533674|11247535|FG006|Dose Level VII|Treatment-related AE|1
7113648|NCT02533674|11247536|FG007|Dose Level VII|Treatment-related AE|0
7113649|NCT02533674|11247529|FG000|Dose Level VII|Death|0
7113650|NCT02533674|11247530|FG001|Dose Level VII|Death|0
7113651|NCT02533674|11247531|FG002|Dose Level VII|Death|0
7113652|NCT02533674|11247532|FG003|Dose Level VII|Death|0
7113653|NCT02533674|11247533|FG004|Dose Level VII|Death|0
7113654|NCT02533674|11247534|FG005|Dose Level VII|Death|0
7113655|NCT02533674|11247535|FG006|Dose Level VII|Death|2
7113656|NCT02533674|11247536|FG007|Dose Level VII|Death|0
7113657|NCT02533674|11247529|FG000|Dose Level VIII|Progressive disease|0
7113658|NCT02533674|11247530|FG001|Dose Level VIII|Progressive disease|0
7113659|NCT02533674|11247531|FG002|Dose Level VIII|Progressive disease|0
7113660|NCT02533674|11247532|FG003|Dose Level VIII|Progressive disease|0
7113661|NCT02533674|11247533|FG004|Dose Level VIII|Progressive disease|0
7113662|NCT02533674|11247534|FG005|Dose Level VIII|Progressive disease|0
7113663|NCT02533674|11247535|FG006|Dose Level VIII|Progressive disease|0
7113664|NCT02533674|11247536|FG007|Dose Level VIII|Progressive disease|3
7113665|NCT02533674|11247529|FG000|Dose Level VIII|Withdrawal by Subject|0
7113666|NCT02533674|11247530|FG001|Dose Level VIII|Withdrawal by Subject|0
7113667|NCT02533674|11247531|FG002|Dose Level VIII|Withdrawal by Subject|0
7113668|NCT02533674|11247532|FG003|Dose Level VIII|Withdrawal by Subject|0
7113669|NCT02533674|11247533|FG004|Dose Level VIII|Withdrawal by Subject|0
7113670|NCT02533674|11247534|FG005|Dose Level VIII|Withdrawal by Subject|0
7113671|NCT02533674|11247535|FG006|Dose Level VIII|Withdrawal by Subject|0
7113672|NCT02533674|11247536|FG007|Dose Level VIII|Withdrawal by Subject|1
7113673|NCT02533674|11247529|FG000|Dose Level VIII|Treatment-related AE|0
7113674|NCT02533674|11247530|FG001|Dose Level VIII|Treatment-related AE|0
7113675|NCT02533674|11247531|FG002|Dose Level VIII|Treatment-related AE|0
7113676|NCT02533674|11247532|FG003|Dose Level VIII|Treatment-related AE|0
7113677|NCT02533674|11247533|FG004|Dose Level VIII|Treatment-related AE|0
7113678|NCT02533674|11247534|FG005|Dose Level VIII|Treatment-related AE|0
7113679|NCT02533674|11247535|FG006|Dose Level VIII|Treatment-related AE|0
7113680|NCT02533674|11247536|FG007|Dose Level VIII|Treatment-related AE|1
7113681|NCT02533674|11247529|FG000|Dose Level VIII|Never treated|0
7113682|NCT02533674|11247530|FG001|Dose Level VIII|Never treated|0
7113683|NCT02533674|11247531|FG002|Dose Level VIII|Never treated|0
7113684|NCT02533674|11247532|FG003|Dose Level VIII|Never treated|0
7113685|NCT02533674|11247533|FG004|Dose Level VIII|Never treated|0
7113686|NCT02533674|11247534|FG005|Dose Level VIII|Never treated|0
7113687|NCT02533674|11247535|FG006|Dose Level VIII|Never treated|0
7113688|NCT02533674|11247536|FG007|Dose Level VIII|Never treated|1
7113689|NCT02533999|11247583|FG000|Overall Study|Lost to Follow-up|3
7113690|NCT02533999|11247584|FG001|Overall Study|Lost to Follow-up|5
7113691|NCT02533999|11247583|FG000|Overall Study|Protocol Violation|3
7113692|NCT02533999|11247584|FG001|Overall Study|Protocol Violation|0
7113693|NCT02533999|11247583|FG000|Overall Study|Adverse Event|0
7113694|NCT02533999|11247584|FG001|Overall Study|Adverse Event|1
7113695|NCT02533999|11247583|FG000|Overall Study|Randomized but intervention not received|0
7113696|NCT02533999|11247584|FG001|Overall Study|Randomized but intervention not received|1
7113697|NCT02534324|11247608|FG000|Overall Study|Protocol Violation|4
7113698|NCT02534324|11247609|FG001|Overall Study|Protocol Violation|1
7113699|NCT02534324|11247608|FG000|Overall Study|Lost to Follow-up|20
7113700|NCT02534324|11247609|FG001|Overall Study|Lost to Follow-up|7
7113701|NCT02534324|11247608|FG000|Overall Study|Adverse Event|1
7113702|NCT02534324|11247609|FG001|Overall Study|Adverse Event|0
7113703|NCT02534350|11247617|FG000|Overall Study|Randomized But Not Treated|1
7113704|NCT02534350|11247618|FG001|Overall Study|Randomized But Not Treated|0
7113705|NCT02534350|11247617|FG000|Overall Study|Protocol Violation|1
7113706|NCT02534350|11247618|FG001|Overall Study|Protocol Violation|0
7113707|NCT02534350|11247617|FG000|Overall Study|Withdrew Consent|2
7113708|NCT02534350|11247618|FG001|Overall Study|Withdrew Consent|0
7113709|NCT02534493|11247624|FG000|Overall Study|Lost to Follow-up|1
7113710|NCT02534493|11247624|FG000|Overall Study|Withdrawal by Subject|1
7113711|NCT02534883|11247632|FG000|Overall Study|Early Termination|8
7113712|NCT02534883|11247633|FG001|Overall Study|Early Termination|3
7113713|NCT02534896|11247642|FG000|Overall Study|Adverse Event|2
7113714|NCT02534896|11247643|FG001|Overall Study|Adverse Event|1
7113715|NCT02534896|11247644|FG002|Overall Study|Adverse Event|1
7113716|NCT02534896|11247642|FG000|Overall Study|Insufficient therapeutic response|2
7113717|NCT02534896|11247643|FG001|Overall Study|Insufficient therapeutic response|0
7113718|NCT02534896|11247644|FG002|Overall Study|Insufficient therapeutic response|0
7113719|NCT02534935|11247655|FG000|Stage 1: 24 Months|Withdrawal by Subject|0
7113720|NCT02534935|11247656|FG001|Stage 1: 24 Months|Withdrawal by Subject|3
7113721|NCT02534935|11247657|FG002|Stage 1: 24 Months|Withdrawal by Subject|3
7113722|NCT02534935|11247655|FG000|Stage 1: 24 Months|No longer willing to participate in study|0
7113723|NCT02534935|11247656|FG001|Stage 1: 24 Months|No longer willing to participate in study|1
7113724|NCT02534935|11247657|FG002|Stage 1: 24 Months|No longer willing to participate in study|1
7113725|NCT02534935|11247655|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0
7113726|NCT02534935|11247656|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3
7113727|NCT02534935|11247657|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0
7113728|NCT02534935|11247655|FG000|Stage 1: 24 Months|Lost to Follow-up|0
7113729|NCT02534935|11247656|FG001|Stage 1: 24 Months|Lost to Follow-up|1
7113730|NCT02534935|11247657|FG002|Stage 1: 24 Months|Lost to Follow-up|1
7113731|NCT02534935|11247655|FG000|Stage 1: 24 Months|Adverse Event|0
7113732|NCT02534935|11247656|FG001|Stage 1: 24 Months|Adverse Event|2
7113733|NCT02534935|11247657|FG002|Stage 1: 24 Months|Adverse Event|0
7113734|NCT02534935|11247655|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0
7113735|NCT02534935|11247656|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4
7113736|NCT02534935|11247657|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0
7113737|NCT02534935|11247655|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0
7113738|NCT02534935|11247656|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1
7113739|NCT02534935|11247657|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0
7113740|NCT02535000|11247685|FG000|Overall Study|Cancellation of surgery.|1
7113741|NCT02535000|11247686|FG001|Overall Study|Cancellation of surgery.|2
7113742|NCT02535364|11247706|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22
7113743|NCT02535364|11247706|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2
7113744|NCT02535364|11247706|FG000|Part A Screening Through Leukapheresis|Disease progression|1
7113745|NCT02535364|11247706|FG000|Part B Screening|Study placed on clinical hold by FDA|7
7113746|NCT02535364|11247706|FG000|Part B Screening|Unable to manufacture JCAR015|3
7113747|NCT02535364|11247706|FG000|Part B Screening|Death|2
7113748|NCT02535364|11247706|FG000|Part B Screening|Physician Decision|1
7113749|NCT02535364|11247706|FG000|Part B Screening|Withdrawal by Subject|1
7113750|NCT02535364|11247706|FG000|Part B Screening|Adverse Event|1
7113751|NCT02535364|11247706|FG000|Part B Screening|Change in diagnosis, no longer eligible|2
7113752|NCT02535364|11247706|FG000|Study Treatment|Death|1
7113753|NCT02535364|11247706|FG000|Study Treatment|Study placed on clinical hold by FDA|1
7113754|NCT02535364|11247706|FG000|12-Month Follow-up Period|Disease progression|22
7113755|NCT02535364|11247706|FG000|12-Month Follow-up Period|Death|5
7113756|NCT02535364|11247706|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5
7113757|NCT02535364|11247706|FG000|12-Month Follow-up Period|Subject received alternative therapy|2
7113758|NCT02535364|11247706|FG000|12-Month Follow-up Period|Subject transferred to hospice|1
7113759|NCT02535416|11247719|FG000|Overall Study|Family bereavement overseas|1
7113760|NCT02535416|11247720|FG001|Overall Study|Family bereavement overseas|0
7113761|NCT02535416|11247721|FG002|Overall Study|Family bereavement overseas|0
7113762|NCT02535416|11247722|FG003|Overall Study|Family bereavement overseas|0
7113763|NCT02535416|11247723|FG004|Overall Study|Family bereavement overseas|0
7113764|NCT02535416|11247724|FG005|Overall Study|Family bereavement overseas|0
7113765|NCT02535416|11247725|FG006|Overall Study|Family bereavement overseas|0
7113766|NCT02535416|11247726|FG007|Overall Study|Family bereavement overseas|0
7113767|NCT02535416|11247727|FG008|Overall Study|Family bereavement overseas|0
7113768|NCT02535715|11247779|FG000|Overall Study|Withdrawal by Subject|0
7113769|NCT02535715|11247780|FG001|Overall Study|Withdrawal by Subject|0
7113770|NCT02535715|11247781|FG002|Overall Study|Withdrawal by Subject|1
7113771|NCT02535741|11247792|FG000|Overall Study|Adverse Event|3
7113772|NCT02535741|11247792|FG000|Overall Study|Withdrawal by Subject|9
7113773|NCT02535741|11247792|FG000|Overall Study|Lost to Follow-up|10
7113774|NCT02535741|11247792|FG000|Overall Study|Exclusion criteria: Bilateral implant|4
7113775|NCT02535741|11247792|FG000|Overall Study|Missing data|6
7113776|NCT02536313|11247857|FG000|Overall Study|Lack of Efficacy|0
7113777|NCT02536313|11247858|FG001|Overall Study|Lack of Efficacy|1
7113778|NCT02536378|11247868|FG000|Overall Study|Physician Decision|0
7113779|NCT02536378|11247869|FG001|Overall Study|Physician Decision|2
7113780|NCT02536378|11247868|FG000|Overall Study|Withdrawal by Subject|0
7113781|NCT02536378|11247869|FG001|Overall Study|Withdrawal by Subject|1
7113782|NCT02536378|11247868|FG000|Overall Study|Death|1
7113783|NCT02536378|11247869|FG001|Overall Study|Death|2
7113784|NCT02536378|11247868|FG000|Overall Study|Patient refused further follow up|6
7113785|NCT02536378|11247869|FG001|Overall Study|Patient refused further follow up|2
7113786|NCT02536404|11247879|FG000|Overall Study|Adverse Event|5
7113787|NCT02536404|11247880|FG001|Overall Study|Adverse Event|0
7113788|NCT02536404|11247879|FG000|Overall Study|Withdrawal by Subject|4
7113789|NCT02536404|11247880|FG001|Overall Study|Withdrawal by Subject|1
7113790|NCT02536404|11247879|FG000|Overall Study|Physician Decision|10
7113791|NCT02536404|11247880|FG001|Overall Study|Physician Decision|0
7113792|NCT02536404|11247879|FG000|Overall Study|Sponsor decision|1
7113793|NCT02536404|11247880|FG001|Overall Study|Sponsor decision|0
7113794|NCT02536508|11247889|FG000|Overall Study|Withdrawal by Subject|18
7113795|NCT02536508|11247890|FG001|Overall Study|Withdrawal by Subject|13
7113796|NCT02536508|11247891|FG002|Overall Study|Withdrawal by Subject|7
7113797|NCT02536508|11247889|FG000|Overall Study|Adverse Event|14
7113798|NCT02536508|11247890|FG001|Overall Study|Adverse Event|13
7113799|NCT02536508|11247891|FG002|Overall Study|Adverse Event|6
7113800|NCT02536508|11247889|FG000|Overall Study|Lost to Follow-up|12
7113801|NCT02536508|11247890|FG001|Overall Study|Lost to Follow-up|4
7113802|NCT02536508|11247891|FG002|Overall Study|Lost to Follow-up|0
7113803|NCT02536508|11247889|FG000|Overall Study|Lack of Efficacy|3
7113804|NCT02536508|11247890|FG001|Overall Study|Lack of Efficacy|5
7113805|NCT02536508|11247891|FG002|Overall Study|Lack of Efficacy|4
7113806|NCT02536508|11247889|FG000|Overall Study|Protocol Discontinuation Criteria|3
7113807|NCT02536508|11247890|FG001|Overall Study|Protocol Discontinuation Criteria|2
7113808|NCT02536508|11247891|FG002|Overall Study|Protocol Discontinuation Criteria|2
7113809|NCT02536508|11247889|FG000|Overall Study|Physician Decision|0
7113810|NCT02536508|11247890|FG001|Overall Study|Physician Decision|4
7113811|NCT02536508|11247891|FG002|Overall Study|Physician Decision|2
7113812|NCT02536508|11247889|FG000|Overall Study|Major Protocol Deviation|2
7113813|NCT02536508|11247890|FG001|Overall Study|Major Protocol Deviation|2
7113814|NCT02536508|11247891|FG002|Overall Study|Major Protocol Deviation|2
7113815|NCT02536508|11247889|FG000|Overall Study|Administrative Reasons|0
7113816|NCT02536508|11247890|FG001|Overall Study|Administrative Reasons|1
7113817|NCT02536508|11247891|FG002|Overall Study|Administrative Reasons|0
7113818|NCT02536664|11247901|FG000|Overall Study|Inadequate completion of documentation|2
7113819|NCT02536664|11247902|FG001|Overall Study|Inadequate completion of documentation|4
7113820|NCT02536664|11247901|FG000|Overall Study|Progression|13
7113821|NCT02536664|11247902|FG001|Overall Study|Progression|18
7113822|NCT02536664|11247901|FG000|Overall Study|Death due to lymphoma|2
7113823|NCT02536664|11247902|FG001|Overall Study|Death due to lymphoma|1
7113824|NCT02536664|11247901|FG000|Overall Study|Death due to other reason|3
7113825|NCT02536664|11247902|FG001|Overall Study|Death due to other reason|2
7113826|NCT02536664|11247901|FG000|Overall Study|Intolerability|8
7113827|NCT02536664|11247902|FG001|Overall Study|Intolerability|6
7113828|NCT02536664|11247901|FG000|Overall Study|Withdrawal by Subject|8
7113829|NCT02536664|11247902|FG001|Overall Study|Withdrawal by Subject|5
7113830|NCT02536664|11247901|FG000|Overall Study|Other|18
7113831|NCT02536664|11247902|FG001|Overall Study|Other|24
7113832|NCT02536664|11247901|FG000|Overall Study|Missing|53
7113833|NCT02536664|11247902|FG001|Overall Study|Missing|20
7113834|NCT02536781|11247910|FG000|Overall Study|Lost to Follow-up|2
7113835|NCT02536781|11247911|FG001|Overall Study|Lost to Follow-up|0
7113836|NCT02536833|11247921|FG000|Overall Study|Discontinued Before Treatment|0
7113837|NCT02536833|11247922|FG001|Overall Study|Discontinued Before Treatment|0
7113838|NCT02536833|11247923|FG002|Overall Study|Discontinued Before Treatment|1
7113839|NCT02536833|11247924|FG003|Overall Study|Discontinued Before Treatment|2
7113840|NCT02536833|11247921|FG000|Overall Study|Adverse Event|1
7113841|NCT02536833|11247922|FG001|Overall Study|Adverse Event|3
7113842|NCT02536833|11247923|FG002|Overall Study|Adverse Event|4
7113843|NCT02536833|11247924|FG003|Overall Study|Adverse Event|1
7113844|NCT02536833|11247921|FG000|Overall Study|Lost to Follow-up|2
7113845|NCT02536833|11247922|FG001|Overall Study|Lost to Follow-up|1
7113846|NCT02536833|11247923|FG002|Overall Study|Lost to Follow-up|2
7113847|NCT02536833|11247924|FG003|Overall Study|Lost to Follow-up|2
7113848|NCT02536833|11247921|FG000|Overall Study|Physician Decision|0
7113849|NCT02536833|11247922|FG001|Overall Study|Physician Decision|0
7113850|NCT02536833|11247923|FG002|Overall Study|Physician Decision|0
7113851|NCT02536833|11247924|FG003|Overall Study|Physician Decision|1
7113852|NCT02536833|11247921|FG000|Overall Study|Site Terminated by Sponsor|2
7113853|NCT02536833|11247922|FG001|Overall Study|Site Terminated by Sponsor|2
7113854|NCT02536833|11247923|FG002|Overall Study|Site Terminated by Sponsor|2
7113855|NCT02536833|11247924|FG003|Overall Study|Site Terminated by Sponsor|2
7113856|NCT02536833|11247921|FG000|Overall Study|Subject Non-Compliance|0
7113857|NCT02536833|11247922|FG001|Overall Study|Subject Non-Compliance|1
7113858|NCT02536833|11247923|FG002|Overall Study|Subject Non-Compliance|1
7113859|NCT02536833|11247924|FG003|Overall Study|Subject Non-Compliance|0
7113860|NCT02536833|11247921|FG000|Overall Study|Withdrawal by Subject|4
7113861|NCT02536833|11247922|FG001|Overall Study|Withdrawal by Subject|3
7113862|NCT02536833|11247923|FG002|Overall Study|Withdrawal by Subject|5
7113863|NCT02536833|11247924|FG003|Overall Study|Withdrawal by Subject|11
7113864|NCT02536846|11247935|FG000|Overall Study|Withdrawal by Subject|1
7113865|NCT02536963|11247940|FG000|Overall Study|Withdrawal by Subject|18
7113866|NCT02536976|11247946|FG000|Overall Study|Physician Decision|0
7113867|NCT02536976|11247947|FG001|Overall Study|Physician Decision|1
7113868|NCT02537015|11247955|FG000|Overall Study|Adverse Event|3
7113869|NCT02537015|11247955|FG000|Overall Study|Withdrawal by Subject|2
7113870|NCT02537015|11247955|FG000|Overall Study|Other Miscellaneous Reasons|1
7113871|NCT02537431|11247959|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1
7113872|NCT02537522|11247972|FG000|Phase I - Contralateral|Subject no longer eligible|15
7113873|NCT02537522|11247973|FG001|Phase I - Contralateral|Subject no longer eligible|7
7113874|NCT02537522|11247974|FG002|Phase I - Contralateral|Subject no longer eligible|0
7113875|NCT02537522|11247975|FG003|Phase I - Contralateral|Subject no longer eligible|0
7113876|NCT02537522|11247972|FG000|Phase I - Contralateral|Withdrawal by Subject|0
7113877|NCT02537522|11247973|FG001|Phase I - Contralateral|Withdrawal by Subject|1
7113878|NCT02537522|11247974|FG002|Phase I - Contralateral|Withdrawal by Subject|0
7113879|NCT02537522|11247975|FG003|Phase I - Contralateral|Withdrawal by Subject|0
7113880|NCT02537522|11247972|FG000|Phase I - Contralateral|incorrect randomization|0
7113881|NCT02537522|11247973|FG001|Phase I - Contralateral|incorrect randomization|1
7113882|NCT02537522|11247974|FG002|Phase I - Contralateral|incorrect randomization|0
7113883|NCT02537522|11247975|FG003|Phase I - Contralateral|incorrect randomization|0
7113884|NCT02537522|11247972|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0
7113885|NCT02537522|11247973|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1
7113886|NCT02537522|11247974|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0
7113887|NCT02537522|11247975|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0
7113888|NCT02537522|11247972|FG000|Phase II - Period 1 Bilateral|Adverse Event|0
7113889|NCT02537522|11247973|FG001|Phase II - Period 1 Bilateral|Adverse Event|0
7113890|NCT02537522|11247974|FG002|Phase II - Period 1 Bilateral|Adverse Event|0
7113891|NCT02537522|11247975|FG003|Phase II - Period 1 Bilateral|Adverse Event|1
7113892|NCT02537574|11247984|FG000|Overall Study|Adverse Event|1
7113893|NCT02537574|11247985|FG001|Overall Study|Adverse Event|3
7113894|NCT02537574|11247986|FG002|Overall Study|Adverse Event|2
7113895|NCT02537574|11247984|FG000|Overall Study|Lost to Follow-up|40
7113896|NCT02537574|11247985|FG001|Overall Study|Lost to Follow-up|51
7113897|NCT02537574|11247986|FG002|Overall Study|Lost to Follow-up|55
7113898|NCT02537574|11247984|FG000|Overall Study|Noncompliance with study drug|0
7113899|NCT02537574|11247985|FG001|Overall Study|Noncompliance with study drug|1
7113900|NCT02537574|11247986|FG002|Overall Study|Noncompliance with study drug|1
7113901|NCT02537574|11247984|FG000|Overall Study|Physician Decision|2
7113902|NCT02537574|11247985|FG001|Overall Study|Physician Decision|0
7113903|NCT02537574|11247986|FG002|Overall Study|Physician Decision|0
7113904|NCT02537574|11247984|FG000|Overall Study|Protocol Violation|4
7113905|NCT02537574|11247985|FG001|Overall Study|Protocol Violation|2
7113906|NCT02537574|11247986|FG002|Overall Study|Protocol Violation|3
7113907|NCT02537574|11247984|FG000|Overall Study|Withdrawal by Subject|37
7113908|NCT02537574|11247985|FG001|Overall Study|Withdrawal by Subject|27
7113909|NCT02537574|11247986|FG002|Overall Study|Withdrawal by Subject|29
7113910|NCT02537574|11247984|FG000|Overall Study|Lack of Efficacy|14
7113911|NCT02537574|11247985|FG001|Overall Study|Lack of Efficacy|16
7113912|NCT02537574|11247986|FG002|Overall Study|Lack of Efficacy|15
7113913|NCT02537574|11247984|FG000|Overall Study|Duplicate Patient|1
7113914|NCT02537574|11247985|FG001|Overall Study|Duplicate Patient|0
7113915|NCT02537574|11247986|FG002|Overall Study|Duplicate Patient|0
7113916|NCT02537574|11247984|FG000|Overall Study|Patient not Stable|0
7113917|NCT02537574|11247985|FG001|Overall Study|Patient not Stable|1
7113918|NCT02537574|11247986|FG002|Overall Study|Patient not Stable|0
7113919|NCT02537574|11247984|FG000|Overall Study|Incarceration|0
7113920|NCT02537574|11247985|FG001|Overall Study|Incarceration|1
7113921|NCT02537574|11247986|FG002|Overall Study|Incarceration|0
7113922|NCT02537574|11247984|FG000|Overall Study|Failed Naloxone Challenge|0
7113923|NCT02537574|11247985|FG001|Overall Study|Failed Naloxone Challenge|1
7113924|NCT02537574|11247986|FG002|Overall Study|Failed Naloxone Challenge|0
7113925|NCT02537574|11247984|FG000|Overall Study|Transportation Issues|0
7113926|NCT02537574|11247985|FG001|Overall Study|Transportation Issues|0
7113927|NCT02537574|11247986|FG002|Overall Study|Transportation Issues|1
7113928|NCT02537574|11247984|FG000|Overall Study|Subject did not want last Vivitrol Injec|0
7113929|NCT02537574|11247985|FG001|Overall Study|Subject did not want last Vivitrol Injec|0
7113930|NCT02537574|11247986|FG002|Overall Study|Subject did not want last Vivitrol Injec|1
7113931|NCT02537574|11247984|FG000|Overall Study|Noncompliance with Protocol|0
7113932|NCT02537574|11247985|FG001|Overall Study|Noncompliance with Protocol|0
7113933|NCT02537574|11247986|FG002|Overall Study|Noncompliance with Protocol|1
7113934|NCT02538029|11248033|FG000|Overall Study|unable to complete cognitive assessments|1
7113935|NCT02538029|11248034|FG001|Overall Study|unable to complete cognitive assessments|0
7113936|NCT02538029|11248035|FG002|Overall Study|unable to complete cognitive assessments|1
7113937|NCT02538094|11248056|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0
7113938|NCT02538094|11248057|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1
7113939|NCT02538094|11248056|FG000|Washout (4 Weeks)|Withdrawal by Subject|0
7113940|NCT02538094|11248057|FG001|Washout (4 Weeks)|Withdrawal by Subject|1
7113941|NCT02538107|11248063|FG000|Overall Study|Did not receive any Mircera dose|11
7113942|NCT02538107|11248063|FG000|Overall Study|Missing|5
7113943|NCT02538107|11248063|FG000|Overall Study|Necessity of dialysis|20
7113944|NCT02538107|11248063|FG000|Overall Study|Administration of other ESA|11
7113945|NCT02538107|11248063|FG000|Overall Study|No further treatment necessary|18
7113946|NCT02538107|11248063|FG000|Overall Study|Withdrawal by Subject|17
7113947|NCT02538107|11248063|FG000|Overall Study|Death|4
7113948|NCT02538107|11248063|FG000|Overall Study|Administrative reason|5
7113949|NCT02538107|11248063|FG000|Overall Study|Adverse Event|4
7113950|NCT02538107|11248063|FG000|Overall Study|Surgery|1
7113951|NCT02538107|11248063|FG000|Overall Study|Other|7
7113952|NCT02538107|11248063|FG000|Overall Study|Not recorded|7
7113953|NCT02538341|11248079|FG000|Overall Study|Lost to Follow-up|51
7113954|NCT02538341|11248080|FG001|Overall Study|Lost to Follow-up|46
7113955|NCT02538341|11248079|FG000|Overall Study|Withdrawal by Subject|3
7113956|NCT02538341|11248080|FG001|Overall Study|Withdrawal by Subject|1
7113957|NCT02538341|11248079|FG000|Overall Study|Death|2
7113958|NCT02538341|11248080|FG001|Overall Study|Death|0
7113959|NCT02538471|11248104|FG000|Overall Study|Progression of disease|2
7113960|NCT02538614|11248117|FG000|Overall Study|Progressive Disease|2
7113961|NCT02538900|11248148|FG000|Overall Study|Death|2
7113962|NCT02538900|11248149|FG001|Overall Study|Death|2
7113963|NCT02538900|11248150|FG002|Overall Study|Death|2
7113964|NCT02538900|11248148|FG000|Overall Study|Withdrawal by Subject|18
7113965|NCT02538900|11248149|FG001|Overall Study|Withdrawal by Subject|16
7113966|NCT02538900|11248150|FG002|Overall Study|Withdrawal by Subject|15
7113967|NCT02538965|11248158|FG000|Treatment Period|Other = Death due to disease progression|1
7113968|NCT02538965|11248158|FG000|Treatment Period|Adverse Event|2
7113969|NCT02538965|11248158|FG000|Treatment Period|Withdrawal by Parent/Guardian|2
7113970|NCT02538965|11248158|FG000|Treatment Period|Treatment Failure|9
7113971|NCT02538965|11248158|FG000|Treatment Period|Disease Progression|1
7113972|NCT02538965|11248158|FG000|Treatment Period|Physician Decision|2
7113973|NCT02538965|11248158|FG000|Follow-Up Period|Other = Death due to disease progression|13
7113974|NCT02538965|11248158|FG000|Follow-Up Period|Withdrawal by Parent|4
7113975|NCT02539134|11248177|FG000|Overall Study|Lost to Follow-up|1
7113976|NCT02539134|11248178|FG001|Overall Study|Lost to Follow-up|0
7113977|NCT02539134|11248179|FG002|Overall Study|Lost to Follow-up|0
7113978|NCT02539134|11248180|FG003|Overall Study|Lost to Follow-up|0
7113979|NCT02539134|11248181|FG004|Overall Study|Lost to Follow-up|0
7113980|NCT02539134|11248182|FG005|Overall Study|Lost to Follow-up|0
7113981|NCT02539368|11248215|FG000|Overall Study|Death|4
7113982|NCT02539368|11248216|FG001|Overall Study|Death|2
7113983|NCT02539368|11248217|FG002|Overall Study|Death|1
7113984|NCT02539368|11248218|FG003|Overall Study|Death|0
7113985|NCT02539368|11248219|FG004|Overall Study|Death|0
7113986|NCT02539368|11248215|FG000|Overall Study|Withdrawal by Subject|44
7113987|NCT02539368|11248216|FG001|Overall Study|Withdrawal by Subject|35
7113988|NCT02539368|11248217|FG002|Overall Study|Withdrawal by Subject|9
7113989|NCT02539368|11248218|FG003|Overall Study|Withdrawal by Subject|1
7113990|NCT02539368|11248219|FG004|Overall Study|Withdrawal by Subject|3
7113991|NCT02539368|11248215|FG000|Overall Study|Physician Decision|49
7113992|NCT02539368|11248216|FG001|Overall Study|Physician Decision|15
7113993|NCT02539368|11248217|FG002|Overall Study|Physician Decision|7
7113994|NCT02539368|11248218|FG003|Overall Study|Physician Decision|0
7113995|NCT02539368|11248219|FG004|Overall Study|Physician Decision|2
7113996|NCT02539368|11248215|FG000|Overall Study|Lost to Follow-up|96
7113997|NCT02539368|11248216|FG001|Overall Study|Lost to Follow-up|21
7113998|NCT02539368|11248217|FG002|Overall Study|Lost to Follow-up|16
7113999|NCT02539368|11248218|FG003|Overall Study|Lost to Follow-up|4
7114000|NCT02539368|11248219|FG004|Overall Study|Lost to Follow-up|3
7114001|NCT02539368|11248215|FG000|Overall Study|Adverse Event|44
7114002|NCT02539368|11248216|FG001|Overall Study|Adverse Event|5
7114003|NCT02539368|11248217|FG002|Overall Study|Adverse Event|9
7114004|NCT02539368|11248218|FG003|Overall Study|Adverse Event|0
7114005|NCT02539368|11248219|FG004|Overall Study|Adverse Event|3
7114006|NCT02539368|11248215|FG000|Overall Study|Participant Non-compliant|13
7114007|NCT02539368|11248216|FG001|Overall Study|Participant Non-compliant|2
7114008|NCT02539368|11248217|FG002|Overall Study|Participant Non-compliant|1
7114009|NCT02539368|11248218|FG003|Overall Study|Participant Non-compliant|1
7114010|NCT02539368|11248219|FG004|Overall Study|Participant Non-compliant|0
7114011|NCT02539368|11248215|FG000|Overall Study|Other|145
7114012|NCT02539368|11248216|FG001|Overall Study|Other|18
7114013|NCT02539368|11248217|FG002|Overall Study|Other|24
7114014|NCT02539368|11248218|FG003|Overall Study|Other|1
7114015|NCT02539368|11248219|FG004|Overall Study|Other|3
7114016|NCT02539368|11248215|FG000|Overall Study|Missing|10
7114017|NCT02539368|11248216|FG001|Overall Study|Missing|3
7114018|NCT02539368|11248217|FG002|Overall Study|Missing|0
7114019|NCT02539368|11248218|FG003|Overall Study|Missing|0
7114020|NCT02539368|11248219|FG004|Overall Study|Missing|0
7114021|NCT02539797|11248252|FG000|Overall Study|Lost to Follow-up|0
7114022|NCT02539797|11248253|FG001|Overall Study|Lost to Follow-up|1
7114023|NCT02539797|11248254|FG002|Overall Study|Lost to Follow-up|0
7114024|NCT02540083|11248277|FG000|Overall Study|Withdrawal by Subject|16
7114025|NCT02540213|11248298|FG000|Overall Study|Death/adverse event|18
7114026|NCT02540213|11248298|FG000|Overall Study|Administrative reasons|3
7114027|NCT02540213|11248298|FG000|Overall Study|Kidney transplant|3
7114028|NCT02540213|11248298|FG000|Overall Study|Lack of Efficacy|6
7114029|NCT02540213|11248298|FG000|Overall Study|Consent withdrawn|7
7114030|NCT02540213|11248298|FG000|Overall Study|Enrolled but not treated|2
7114031|NCT02540265|11248314|FG000|Overall Study|Lost to Follow-up|0
7114032|NCT02540265|11248315|FG001|Overall Study|Lost to Follow-up|0
7114033|NCT02540265|11248316|FG002|Overall Study|Lost to Follow-up|1
7114034|NCT02540291|11248328|FG000|Overall Study|Death|7
7114035|NCT02540291|11248329|FG001|Overall Study|Death|7
7114036|NCT02540291|11248330|FG002|Overall Study|Death|5
7114037|NCT02540291|11248331|FG003|Overall Study|Death|7
7114038|NCT02540291|11248328|FG000|Overall Study|Lost to Follow-up|0
7114039|NCT02540291|11248329|FG001|Overall Study|Lost to Follow-up|0
7114040|NCT02540291|11248330|FG002|Overall Study|Lost to Follow-up|1
7114041|NCT02540291|11248331|FG003|Overall Study|Lost to Follow-up|0
7114042|NCT02540291|11248328|FG000|Overall Study|Withdrawal Of Consent|0
7114043|NCT02540291|11248329|FG001|Overall Study|Withdrawal Of Consent|1
7114044|NCT02540291|11248330|FG002|Overall Study|Withdrawal Of Consent|0
7114045|NCT02540291|11248331|FG003|Overall Study|Withdrawal Of Consent|0
7114046|NCT02540291|11248328|FG000|Overall Study|Study Terminated By Sponsor|1
7114047|NCT02540291|11248329|FG001|Overall Study|Study Terminated By Sponsor|0
7114048|NCT02540291|11248330|FG002|Overall Study|Study Terminated By Sponsor|0
7114049|NCT02540291|11248331|FG003|Overall Study|Study Terminated By Sponsor|0
7114050|NCT02540291|11248328|FG000|Overall Study|Other|0
7114051|NCT02540291|11248329|FG001|Overall Study|Other|0
7114052|NCT02540291|11248330|FG002|Overall Study|Other|1
7114053|NCT02540291|11248331|FG003|Overall Study|Other|0
7114054|NCT02540356|11248345|FG000|Overall Study|Terminated due to disease progression|1
7114055|NCT02540356|11248346|FG001|Overall Study|Terminated due to disease progression|0
7114056|NCT02540538|11248363|FG000|Overall Study|Pregnancy|0
7114057|NCT02540538|11248364|FG001|Overall Study|Pregnancy|1
7114058|NCT02540538|11248365|FG002|Overall Study|Pregnancy|0
7114059|NCT02540668|11248383|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0
7114060|NCT02540668|11248384|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1
7114061|NCT02540850|11248403|FG000|Overall Study|Lost to Follow-up|69
7114062|NCT02540850|11248404|FG001|Overall Study|Lost to Follow-up|66
7114063|NCT02540850|11248405|FG002|Overall Study|Lost to Follow-up|34
7114064|NCT02540954|11248415|FG000|Overall Study|Physician Decision|3
7114065|NCT02540954|11248416|FG001|Overall Study|Physician Decision|1
7114066|NCT02540954|11248415|FG000|Overall Study|Withdrawal by Subject|6
7114067|NCT02540954|11248416|FG001|Overall Study|Withdrawal by Subject|5
7114068|NCT02540954|11248415|FG000|Overall Study|Lost to Follow-up|1
7114069|NCT02540954|11248416|FG001|Overall Study|Lost to Follow-up|1
7114070|NCT02540954|11248415|FG000|Overall Study|Adverse Event|4
7114071|NCT02540954|11248416|FG001|Overall Study|Adverse Event|2
7114072|NCT02540954|11248415|FG000|Overall Study|Death|0
7114073|NCT02540954|11248416|FG001|Overall Study|Death|3
7114074|NCT02540954|11248415|FG000|Overall Study|Treatment failure|1
7114075|NCT02540954|11248416|FG001|Overall Study|Treatment failure|0
7114076|NCT02540954|11248415|FG000|Overall Study|Other reason|4
7114077|NCT02540954|11248416|FG001|Overall Study|Other reason|2
7114078|NCT02540993|11248424|FG000|Overall Study|Lost to Follow-up|5
7114079|NCT02540993|11248425|FG001|Overall Study|Lost to Follow-up|3
7114080|NCT02540993|11248424|FG000|Overall Study|Withdrawal by Subject|4
7114081|NCT02540993|11248425|FG001|Overall Study|Withdrawal by Subject|6
7114082|NCT02540993|11248424|FG000|Overall Study|GCP violations|33
7114083|NCT02540993|11248425|FG001|Overall Study|GCP violations|27
7114084|NCT02541604|11248463|FG000|Overall Study|Death|6
7114085|NCT02541604|11248464|FG001|Overall Study|Death|5
7114086|NCT02541604|11248465|FG002|Overall Study|Death|7
7114087|NCT02541604|11248466|FG003|Overall Study|Death|2
7114088|NCT02541604|11248467|FG004|Overall Study|Death|9
7114089|NCT02541604|11248468|FG005|Overall Study|Death|8
7114090|NCT02541604|11248469|FG006|Overall Study|Death|9
7114091|NCT02541604|11248470|FG007|Overall Study|Death|9
7114092|NCT02541604|11248471|FG008|Overall Study|Death|3
7114093|NCT02541604|11248472|FG009|Overall Study|Death|4
7114094|NCT02541604|11248473|FG010|Overall Study|Death|2
7114095|NCT02541604|11248474|FG011|Overall Study|Death|3
7114096|NCT02541604|11248463|FG000|Overall Study|Lost to Follow-up|2
7114097|NCT02541604|11248464|FG001|Overall Study|Lost to Follow-up|0
7114098|NCT02541604|11248465|FG002|Overall Study|Lost to Follow-up|1
7114099|NCT02541604|11248466|FG003|Overall Study|Lost to Follow-up|0
7114100|NCT02541604|11248467|FG004|Overall Study|Lost to Follow-up|0
7114101|NCT02541604|11248468|FG005|Overall Study|Lost to Follow-up|1
7114102|NCT02541604|11248469|FG006|Overall Study|Lost to Follow-up|1
7114103|NCT02541604|11248470|FG007|Overall Study|Lost to Follow-up|0
7114104|NCT02541604|11248471|FG008|Overall Study|Lost to Follow-up|0
7114105|NCT02541604|11248472|FG009|Overall Study|Lost to Follow-up|0
7114106|NCT02541604|11248473|FG010|Overall Study|Lost to Follow-up|0
7114107|NCT02541604|11248474|FG011|Overall Study|Lost to Follow-up|0
7114108|NCT02541604|11248463|FG000|Overall Study|Withdrawal by Subject|2
7114109|NCT02541604|11248464|FG001|Overall Study|Withdrawal by Subject|0
7114110|NCT02541604|11248465|FG002|Overall Study|Withdrawal by Subject|1
7114111|NCT02541604|11248466|FG003|Overall Study|Withdrawal by Subject|0
7114112|NCT02541604|11248467|FG004|Overall Study|Withdrawal by Subject|1
7114113|NCT02541604|11248468|FG005|Overall Study|Withdrawal by Subject|1
7114114|NCT02541604|11248469|FG006|Overall Study|Withdrawal by Subject|0
7114115|NCT02541604|11248470|FG007|Overall Study|Withdrawal by Subject|0
7114116|NCT02541604|11248471|FG008|Overall Study|Withdrawal by Subject|1
7114117|NCT02541604|11248472|FG009|Overall Study|Withdrawal by Subject|0
7114118|NCT02541604|11248473|FG010|Overall Study|Withdrawal by Subject|0
7114119|NCT02541604|11248474|FG011|Overall Study|Withdrawal by Subject|0
7114120|NCT02541604|11248463|FG000|Overall Study|Study Terminated by Sponsor|1
7114121|NCT02541604|11248464|FG001|Overall Study|Study Terminated by Sponsor|4
7114122|NCT02541604|11248465|FG002|Overall Study|Study Terminated by Sponsor|2
7114123|NCT02541604|11248466|FG003|Overall Study|Study Terminated by Sponsor|1
7114124|NCT02541604|11248467|FG004|Overall Study|Study Terminated by Sponsor|0
7114125|NCT02541604|11248468|FG005|Overall Study|Study Terminated by Sponsor|0
7114126|NCT02541604|11248469|FG006|Overall Study|Study Terminated by Sponsor|0
6805868|NCT02387996|10808090|FG000|Overall Study|Disease Progression|144
6805869|NCT02387996|10808090|FG000|Overall Study|Study Drug Toxicity|14
6805870|NCT02387996|10808090|FG000|Overall Study|Adverse Event Unrelated to Study Drug|34
6805871|NCT02387996|10808090|FG000|Overall Study|Subject Request to Discontinue Treatment|9
6805872|NCT02387996|10808090|FG000|Overall Study|Subject Withdrew Consent|1
6805873|NCT02387996|10808090|FG000|Overall Study|Lost to Follow-up|1
6805874|NCT02387996|10808090|FG000|Overall Study|Poor/Non-Compliance|1
6805875|NCT02351856|10808107|FG000|Overall Study|Adverse Event|2
6805876|NCT02351856|10808107|FG000|Overall Study|Physician Decision|5
6805877|NCT02351856|10808107|FG000|Overall Study|Study terminated by sponsor|1
6805878|NCT02349386|10808115|FG000|24-Week Double-Blind Main Study|Adverse Event|0
6805879|NCT02349386|10808116|FG001|24-Week Double-Blind Main Study|Adverse Event|0
6805880|NCT02349386|10808117|FG002|24-Week Double-Blind Main Study|Adverse Event|1
6805881|NCT02349386|10808118|FG003|24-Week Double-Blind Main Study|Adverse Event|1
6805882|NCT02349386|10808115|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6
6805883|NCT02349386|10808116|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6
6805884|NCT02349386|10808117|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2
6805885|NCT02349386|10808118|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7
6805886|NCT02349386|10808115|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0
6805887|NCT02349386|10808116|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0
6805888|NCT02349386|10808117|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1
6805889|NCT02349386|10808118|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0
6805890|NCT02349386|10808115|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0
6805891|NCT02349386|10808116|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0
7114127|NCT02541604|11248470|FG007|Overall Study|Study Terminated by Sponsor|0
7114128|NCT02541604|11248471|FG008|Overall Study|Study Terminated by Sponsor|0
7114129|NCT02541604|11248472|FG009|Overall Study|Study Terminated by Sponsor|0
7114130|NCT02541604|11248473|FG010|Overall Study|Study Terminated by Sponsor|0
7114131|NCT02541604|11248474|FG011|Overall Study|Study Terminated by Sponsor|0
7114132|NCT02541604|11248463|FG000|Overall Study|Medical condition may jeopardize safety|0
7114133|NCT02541604|11248464|FG001|Overall Study|Medical condition may jeopardize safety|0
7114134|NCT02541604|11248465|FG002|Overall Study|Medical condition may jeopardize safety|0
7114135|NCT02541604|11248466|FG003|Overall Study|Medical condition may jeopardize safety|0
7114136|NCT02541604|11248467|FG004|Overall Study|Medical condition may jeopardize safety|0
7114137|NCT02541604|11248468|FG005|Overall Study|Medical condition may jeopardize safety|0
7114138|NCT02541604|11248469|FG006|Overall Study|Medical condition may jeopardize safety|0
7114139|NCT02541604|11248470|FG007|Overall Study|Medical condition may jeopardize safety|1
7114140|NCT02541604|11248471|FG008|Overall Study|Medical condition may jeopardize safety|0
7114141|NCT02541604|11248472|FG009|Overall Study|Medical condition may jeopardize safety|0
7114142|NCT02541604|11248473|FG010|Overall Study|Medical condition may jeopardize safety|0
7114143|NCT02541604|11248474|FG011|Overall Study|Medical condition may jeopardize safety|0
7114144|NCT02541669|11248528|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0
7114145|NCT02541669|11248529|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0
7114146|NCT02541669|11248530|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1
7114147|NCT02541669|11248531|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0
7114148|NCT02541669|11248532|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1
7114149|NCT02541903|11248562|FG000|Overall Study|Death|1
7114150|NCT02542072|11248585|FG000|First Intervention (1 Month)|Adverse Event|1
7114151|NCT02542072|11248586|FG001|First Intervention (1 Month)|Adverse Event|1
7114152|NCT02542072|11248585|FG000|First Intervention (1 Month)|Lost to Follow-up|2
7114153|NCT02542072|11248586|FG001|First Intervention (1 Month)|Lost to Follow-up|0
7114154|NCT02542072|11248585|FG000|First Intervention (1 Month)|Lens discomfort|1
7114155|NCT02542072|11248586|FG001|First Intervention (1 Month)|Lens discomfort|2
7114156|NCT02542072|11248585|FG000|First Intervention (1 Month)|Protocol Violation|1
7114157|NCT02542072|11248586|FG001|First Intervention (1 Month)|Protocol Violation|0
7114158|NCT02542072|11248585|FG000|Second Intervention (1 Month)|Lost to Follow-up|1
7114159|NCT02542072|11248586|FG001|Second Intervention (1 Month)|Lost to Follow-up|0
7114160|NCT02542072|11248585|FG000|Second Intervention (1 Month)|Lens discomfort|1
7114161|NCT02542072|11248586|FG001|Second Intervention (1 Month)|Lens discomfort|0
7114162|NCT02542605|11248661|FG000|Part B: Challenge Phase|Sponsor decision|1
7114163|NCT02542605|11248662|FG001|Part B: Challenge Phase|Sponsor decision|0
7114164|NCT02542605|11248663|FG002|Part B: Challenge Phase|Sponsor decision|0
7114165|NCT02542605|11248661|FG000|Part B: Randomization Phase|Withdrawal by Subject|0
7114166|NCT02542605|11248662|FG001|Part B: Randomization Phase|Withdrawal by Subject|0
7114167|NCT02542605|11248663|FG002|Part B: Randomization Phase|Withdrawal by Subject|1
7114168|NCT02542631|11248674|FG000|Overall Study|Adverse Event|1
7114169|NCT02542631|11248675|FG001|Overall Study|Adverse Event|1
7114170|NCT02542631|11248674|FG000|Overall Study|Sponsor Termination|1
7114171|NCT02542631|11248675|FG001|Overall Study|Sponsor Termination|0
7114172|NCT02542631|11248674|FG000|Overall Study|Withdrawal by Subject|11
7114173|NCT02542631|11248675|FG001|Overall Study|Withdrawal by Subject|16
7114174|NCT02542631|11248674|FG000|Overall Study|Protocol Violation|1
7114175|NCT02542631|11248675|FG001|Overall Study|Protocol Violation|1
7114176|NCT02542631|11248674|FG000|Overall Study|Physician Decision|6
7114177|NCT02542631|11248675|FG001|Overall Study|Physician Decision|4
7114178|NCT02542631|11248674|FG000|Overall Study|Lost to Follow-up|6
7114179|NCT02542631|11248675|FG001|Overall Study|Lost to Follow-up|5
7114180|NCT02542631|11248674|FG000|Overall Study|Death|1
7114181|NCT02542631|11248675|FG001|Overall Study|Death|2
7114182|NCT02542631|11248674|FG000|Overall Study|Other|2
7114183|NCT02542631|11248675|FG001|Overall Study|Other|1
7114184|NCT02542631|11248674|FG000|Overall Study|Used Prohibited Medication|2
7114185|NCT02542631|11248675|FG001|Overall Study|Used Prohibited Medication|1
7114186|NCT02542865|11248690|FG000|Overall Study|Identified as screen failure|1
7114187|NCT02542865|11248691|FG001|Overall Study|Identified as screen failure|0
7114188|NCT02542865|11248690|FG000|Overall Study|Withdrawal by Subject|16
7114189|NCT02542865|11248691|FG001|Overall Study|Withdrawal by Subject|0
7114190|NCT02542943|11248700|FG000|Overall Study|Lost to Follow-up|1
7114191|NCT02542943|11248701|FG001|Overall Study|Lost to Follow-up|0
7114192|NCT02542943|11248702|FG002|Overall Study|Lost to Follow-up|0
7114193|NCT02542943|11248700|FG000|Overall Study|Withdrawal by Subject|0
7114194|NCT02542943|11248701|FG001|Overall Study|Withdrawal by Subject|1
7114195|NCT02542943|11248702|FG002|Overall Study|Withdrawal by Subject|0
7114196|NCT02543203|11248713|FG000|Overall Study|Unpalatable Fragrance|2
7114197|NCT02543203|11248714|FG001|Overall Study|Unpalatable Fragrance|2
7114198|NCT02543203|11248713|FG000|Overall Study|Lost to Follow-up|1
7114199|NCT02543203|11248714|FG001|Overall Study|Lost to Follow-up|0
7114200|NCT02543203|11248713|FG000|Overall Study|Increased Irritability|1
7114201|NCT02543203|11248714|FG001|Overall Study|Increased Irritability|0
7114202|NCT02543203|11248713|FG000|Overall Study|Family|1
7114203|NCT02543203|11248714|FG001|Overall Study|Family|2
7114204|NCT02543203|11248713|FG000|Overall Study|Negative Behavior|1
7114205|NCT02543203|11248714|FG001|Overall Study|Negative Behavior|0
7114206|NCT02543203|11248713|FG000|Overall Study|Withdrawal by Subject|0
7114207|NCT02543203|11248714|FG001|Overall Study|Withdrawal by Subject|1
7114208|NCT02543294|11248728|FG000|Overall Study|Lost to Follow-up|3
7114209|NCT02543294|11248728|FG000|Overall Study|Physician Decision|2
7114210|NCT02543294|11248728|FG000|Overall Study|Withdrawal by Subject|7
7114211|NCT02543346|11248733|FG000|Second Priming Visit|Withdrawal by Subject|0
7114212|NCT02543346|11248734|FG001|Second Priming Visit|Withdrawal by Subject|2
7114213|NCT02543346|11248735|FG002|Second Priming Visit|Withdrawal by Subject|2
7114214|NCT02543346|11248736|FG003|Second Priming Visit|Withdrawal by Subject|2
7114215|NCT02543346|11248733|FG000|Second Priming Visit|Adverse Event|1
7114216|NCT02543346|11248734|FG001|Second Priming Visit|Adverse Event|0
7114217|NCT02543346|11248735|FG002|Second Priming Visit|Adverse Event|0
7114218|NCT02543346|11248736|FG003|Second Priming Visit|Adverse Event|0
7114219|NCT02543528|11248759|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0
7114220|NCT02543528|11248760|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0
7114221|NCT02543528|11248761|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0
7114222|NCT02543528|11248762|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0
7114223|NCT02543528|11248763|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2
7114224|NCT02543528|11248759|FG000|Adaptation Period|Lens Handling Difficultes|0
6805892|NCT02349386|10808117|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1
6810364|NCT04617860|10814097|FG001|Overall Study|Adverse Event|2
7114225|NCT02543528|11248760|FG001|Adaptation Period|Lens Handling Difficultes|0
7114226|NCT02543528|11248761|FG002|Adaptation Period|Lens Handling Difficultes|0
7114227|NCT02543528|11248762|FG003|Adaptation Period|Lens Handling Difficultes|0
7114228|NCT02543528|11248763|FG004|Adaptation Period|Lens Handling Difficultes|8
7114229|NCT02543528|11248759|FG000|Adaptation Period|Lost to Follow-up|0
7114230|NCT02543528|11248760|FG001|Adaptation Period|Lost to Follow-up|0
7114231|NCT02543528|11248761|FG002|Adaptation Period|Lost to Follow-up|0
7114232|NCT02543528|11248762|FG003|Adaptation Period|Lost to Follow-up|0
7114233|NCT02543528|11248763|FG004|Adaptation Period|Lost to Follow-up|14
7114234|NCT02543528|11248759|FG000|Adaptation Period|Adverse Event|0
7114235|NCT02543528|11248760|FG001|Adaptation Period|Adverse Event|0
7114236|NCT02543528|11248761|FG002|Adaptation Period|Adverse Event|0
7114237|NCT02543528|11248762|FG003|Adaptation Period|Adverse Event|0
7114238|NCT02543528|11248763|FG004|Adaptation Period|Adverse Event|2
7114239|NCT02543528|11248759|FG000|Extended Wear Period|Adverse Event|17
7114240|NCT02543528|11248760|FG001|Extended Wear Period|Adverse Event|11
7114241|NCT02543528|11248761|FG002|Extended Wear Period|Adverse Event|16
7114242|NCT02543528|11248762|FG003|Extended Wear Period|Adverse Event|3
7114243|NCT02543528|11248763|FG004|Extended Wear Period|Adverse Event|0
7114244|NCT02543528|11248759|FG000|Extended Wear Period|Missed too many scheduled visits|0
7114245|NCT02543528|11248760|FG001|Extended Wear Period|Missed too many scheduled visits|0
7114246|NCT02543528|11248761|FG002|Extended Wear Period|Missed too many scheduled visits|1
7114247|NCT02543528|11248762|FG003|Extended Wear Period|Missed too many scheduled visits|3
7114248|NCT02543528|11248763|FG004|Extended Wear Period|Missed too many scheduled visits|0
7114249|NCT02543528|11248759|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1
7114250|NCT02543528|11248760|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0
7114251|NCT02543528|11248761|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0
7114252|NCT02543528|11248762|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0
7114253|NCT02543528|11248763|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0
7114254|NCT02543528|11248759|FG000|Extended Wear Period|Lost to Follow-up|0
7114255|NCT02543528|11248760|FG001|Extended Wear Period|Lost to Follow-up|1
7114256|NCT02543528|11248761|FG002|Extended Wear Period|Lost to Follow-up|2
7114257|NCT02543528|11248762|FG003|Extended Wear Period|Lost to Follow-up|1
7114258|NCT02543528|11248763|FG004|Extended Wear Period|Lost to Follow-up|0
7114259|NCT02543528|11248759|FG000|Extended Wear Period|Withdrawal by Subject|10
7114260|NCT02543528|11248760|FG001|Extended Wear Period|Withdrawal by Subject|9
7114261|NCT02543528|11248761|FG002|Extended Wear Period|Withdrawal by Subject|4
7114262|NCT02543528|11248762|FG003|Extended Wear Period|Withdrawal by Subject|5
7114263|NCT02543528|11248763|FG004|Extended Wear Period|Withdrawal by Subject|0
7114264|NCT02543658|11248788|FG000|Overall Study|Lack of Efficacy|0
7114265|NCT02543658|11248789|FG001|Overall Study|Lack of Efficacy|4
7114266|NCT02543801|11248811|FG000|Overall Study|Protocol Violation|1
7114267|NCT02543801|11248812|FG001|Overall Study|Protocol Violation|2
7114268|NCT02543801|11248813|FG002|Overall Study|Protocol Violation|0
7114269|NCT02543801|11248814|FG003|Overall Study|Protocol Violation|0
7114270|NCT02543892|11248842|FG000|Received Vaccination 2|Withdrawal by Subject|1
7114271|NCT02543892|11248843|FG001|Received Vaccination 2|Withdrawal by Subject|0
7114272|NCT02543892|11248844|FG002|Received Vaccination 2|Withdrawal by Subject|0
7114273|NCT02543892|11248845|FG003|Received Vaccination 2|Withdrawal by Subject|0
7114274|NCT02543892|11248846|FG004|Received Vaccination 2|Withdrawal by Subject|0
7114275|NCT02543892|11248847|FG005|Received Vaccination 2|Withdrawal by Subject|0
7114276|NCT02543892|11248848|FG006|Received Vaccination 2|Withdrawal by Subject|0
7114277|NCT02543892|11248849|FG007|Received Vaccination 2|Withdrawal by Subject|1
7114278|NCT02543892|11248842|FG000|Received Vaccination 2|Physician Decision|0
7114279|NCT02543892|11248843|FG001|Received Vaccination 2|Physician Decision|0
7114280|NCT02543892|11248844|FG002|Received Vaccination 2|Physician Decision|0
7114281|NCT02543892|11248845|FG003|Received Vaccination 2|Physician Decision|0
7114282|NCT02543892|11248846|FG004|Received Vaccination 2|Physician Decision|0
7114283|NCT02543892|11248847|FG005|Received Vaccination 2|Physician Decision|1
7114284|NCT02543892|11248848|FG006|Received Vaccination 2|Physician Decision|0
7114285|NCT02543892|11248849|FG007|Received Vaccination 2|Physician Decision|0
7114286|NCT02543892|11248842|FG000|Received Vaccination 2|Adverse Event|0
7114287|NCT02543892|11248843|FG001|Received Vaccination 2|Adverse Event|1
7114288|NCT02543892|11248844|FG002|Received Vaccination 2|Adverse Event|0
7114289|NCT02543892|11248845|FG003|Received Vaccination 2|Adverse Event|0
7114290|NCT02543892|11248846|FG004|Received Vaccination 2|Adverse Event|0
7114291|NCT02543892|11248847|FG005|Received Vaccination 2|Adverse Event|0
7114292|NCT02543892|11248848|FG006|Received Vaccination 2|Adverse Event|0
7114293|NCT02543892|11248849|FG007|Received Vaccination 2|Adverse Event|0
7114294|NCT02543892|11248842|FG000|Had Immunology Data|Withdrawal by Subject|0
7114295|NCT02543892|11248843|FG001|Had Immunology Data|Withdrawal by Subject|0
7114296|NCT02543892|11248844|FG002|Had Immunology Data|Withdrawal by Subject|0
7114297|NCT02543892|11248845|FG003|Had Immunology Data|Withdrawal by Subject|0
7114298|NCT02543892|11248846|FG004|Had Immunology Data|Withdrawal by Subject|0
7114299|NCT02543892|11248847|FG005|Had Immunology Data|Withdrawal by Subject|0
7114300|NCT02543892|11248848|FG006|Had Immunology Data|Withdrawal by Subject|1
7114301|NCT02543892|11248849|FG007|Had Immunology Data|Withdrawal by Subject|0
7114302|NCT02543918|11248874|FG000|Overall Study|Never treated|0
7114303|NCT02543918|11248875|FG001|Overall Study|Never treated|1
7114304|NCT02543918|11248874|FG000|Overall Study|Lost to Follow-up|1
7114305|NCT02543918|11248875|FG001|Overall Study|Lost to Follow-up|1
7114306|NCT02543918|11248874|FG000|Overall Study|Withdrawal by Subject|1
7114307|NCT02543918|11248875|FG001|Overall Study|Withdrawal by Subject|1
7114308|NCT02543918|11248874|FG000|Overall Study|Adverse Event|1
7114309|NCT02543918|11248875|FG001|Overall Study|Adverse Event|1
7114310|NCT02544113|11248883|FG000|Overall Study|Death|3
7114311|NCT02544113|11248884|FG001|Overall Study|Death|4
7114312|NCT02544152|11248892|FG000|Overall Study|Adverse Event|0
7114313|NCT02544152|11248893|FG001|Overall Study|Adverse Event|4
7114314|NCT02544152|11248892|FG000|Overall Study|Withdrawal by Subject|0
7114315|NCT02544152|11248893|FG001|Overall Study|Withdrawal by Subject|3
7114316|NCT02544152|11248892|FG000|Overall Study|Other|1
7114317|NCT02544152|11248893|FG001|Overall Study|Other|0
7114318|NCT02544217|11248905|FG000|Overall Study|Withdrawal by Subject|1
7114319|NCT02544217|11248906|FG001|Overall Study|Withdrawal by Subject|1
7114320|NCT02544217|11248907|FG002|Overall Study|Withdrawal by Subject|0
7114321|NCT02544217|11248908|FG003|Overall Study|Withdrawal by Subject|0
7114322|NCT02544217|11248909|FG004|Overall Study|Withdrawal by Subject|0
7114323|NCT02544217|11248910|FG005|Overall Study|Withdrawal by Subject|0
7114324|NCT02544321|11248979|FG000|Overall Study|Withdrawal by Subject|1
7114325|NCT02544321|11248980|FG001|Overall Study|Withdrawal by Subject|2
7114326|NCT02544321|11248979|FG000|Overall Study|Adverse Event|1
7114327|NCT02544321|11248980|FG001|Overall Study|Adverse Event|1
7114328|NCT02544321|11248979|FG000|Overall Study|Protocol Violation|0
7114329|NCT02544321|11248980|FG001|Overall Study|Protocol Violation|1
7114330|NCT02544451|11248998|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1
7114331|NCT02544451|11248999|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6
7114332|NCT02544451|11249000|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0
7114333|NCT02544451|11249001|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0
7114334|NCT02544451|11248998|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3
7114335|NCT02544451|11248999|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2
7114336|NCT02544451|11249000|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1
7114337|NCT02544451|11249001|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0
7114338|NCT02544451|11248998|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2
7114339|NCT02544451|11248999|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0
7114340|NCT02544451|11249000|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0
7114341|NCT02544451|11249001|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0
7114342|NCT02544451|11248998|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4
7114343|NCT02544451|11248999|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0
7114344|NCT02544451|11249000|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0
7114345|NCT02544451|11249001|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0
7114346|NCT02544451|11248998|FG000|Treatment Period 1 (96 Weeks)|Other|4
7114347|NCT02544451|11248999|FG001|Treatment Period 1 (96 Weeks)|Other|4
7114348|NCT02544451|11249000|FG002|Treatment Period 1 (96 Weeks)|Other|0
7114349|NCT02544451|11249001|FG003|Treatment Period 1 (96 Weeks)|Other|0
7114350|NCT02544451|11248998|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0
7114351|NCT02544451|11248999|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0
7114352|NCT02544451|11249000|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0
7114353|NCT02544451|11249001|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10
7114354|NCT02544633|11249028|FG000|Treatment Period|Patient Still on Treatment/Study|0
7114355|NCT02544633|11249029|FG001|Treatment Period|Patient Still on Treatment/Study|1
7114356|NCT02544633|11249030|FG002|Treatment Period|Patient Still on Treatment/Study|1
7114357|NCT02544633|11249031|FG003|Treatment Period|Patient Still on Treatment/Study|0
7114358|NCT02544633|11249028|FG000|Treatment Period|Adverse Event|7
7114359|NCT02544633|11249029|FG001|Treatment Period|Adverse Event|4
7114360|NCT02544633|11249030|FG002|Treatment Period|Adverse Event|0
7114361|NCT02544633|11249031|FG003|Treatment Period|Adverse Event|5
7114362|NCT02544633|11249028|FG000|Treatment Period|Lack of Efficacy|17
7114363|NCT02544633|11249029|FG001|Treatment Period|Lack of Efficacy|11
7114364|NCT02544633|11249030|FG002|Treatment Period|Lack of Efficacy|5
7114365|NCT02544633|11249031|FG003|Treatment Period|Lack of Efficacy|5
7114366|NCT02544633|11249028|FG000|Treatment Period|Global Deterioration of Health|3
7114367|NCT02544633|11249029|FG001|Treatment Period|Global Deterioration of Health|3
7114368|NCT02544633|11249030|FG002|Treatment Period|Global Deterioration of Health|0
7114369|NCT02544633|11249031|FG003|Treatment Period|Global Deterioration of Health|1
7114370|NCT02544633|11249028|FG000|Treatment Period|Withdrawal by Subject|1
7114371|NCT02544633|11249029|FG001|Treatment Period|Withdrawal by Subject|0
7114372|NCT02544633|11249030|FG002|Treatment Period|Withdrawal by Subject|0
7114373|NCT02544633|11249031|FG003|Treatment Period|Withdrawal by Subject|0
7114374|NCT02544633|11249028|FG000|Treatment Period|Lost to Follow-up|0
7114375|NCT02544633|11249029|FG001|Treatment Period|Lost to Follow-up|1
7114376|NCT02544633|11249030|FG002|Treatment Period|Lost to Follow-up|0
7114377|NCT02544633|11249031|FG003|Treatment Period|Lost to Follow-up|0
7114378|NCT02544633|11249028|FG000|Treatment Period|Death|0
7114379|NCT02544633|11249029|FG001|Treatment Period|Death|0
7114380|NCT02544633|11249030|FG002|Treatment Period|Death|1
7114381|NCT02544633|11249031|FG003|Treatment Period|Death|0
7114382|NCT02544633|11249028|FG000|Treatment Period|Non-compliance|0
7114383|NCT02544633|11249029|FG001|Treatment Period|Non-compliance|0
7114384|NCT02544633|11249030|FG002|Treatment Period|Non-compliance|1
7114385|NCT02544633|11249031|FG003|Treatment Period|Non-compliance|0
7114386|NCT02544633|11249028|FG000|Treatment Period|Clinical Disease Progression|0
7114387|NCT02544633|11249029|FG001|Treatment Period|Clinical Disease Progression|0
7114388|NCT02544633|11249030|FG002|Treatment Period|Clinical Disease Progression|0
7114389|NCT02544633|11249031|FG003|Treatment Period|Clinical Disease Progression|1
7114390|NCT02544633|11249028|FG000|Survival Follow-up Period|Death|12
7114391|NCT02544633|11249029|FG001|Survival Follow-up Period|Death|14
7114392|NCT02544633|11249030|FG002|Survival Follow-up Period|Death|3
7114393|NCT02544633|11249031|FG003|Survival Follow-up Period|Death|9
7114394|NCT02544633|11249028|FG000|Survival Follow-up Period|Lost to Follow-up|0
7114395|NCT02544633|11249029|FG001|Survival Follow-up Period|Lost to Follow-up|1
7114396|NCT02544633|11249030|FG002|Survival Follow-up Period|Lost to Follow-up|1
7114397|NCT02544633|11249031|FG003|Survival Follow-up Period|Lost to Follow-up|0
7114398|NCT02544633|11249028|FG000|Survival Follow-up Period|Withdrawal by Subject|4
7114399|NCT02544633|11249029|FG001|Survival Follow-up Period|Withdrawal by Subject|0
7114400|NCT02544633|11249030|FG002|Survival Follow-up Period|Withdrawal by Subject|1
7114401|NCT02544633|11249031|FG003|Survival Follow-up Period|Withdrawal by Subject|0
7114402|NCT02544633|11249028|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12
7114403|NCT02544633|11249029|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4
7114404|NCT02544633|11249030|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2
7114405|NCT02544633|11249031|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3
7114406|NCT02544763|11249056|FG000|Overall Study|Adverse Event|8
7114407|NCT02544763|11249057|FG001|Overall Study|Adverse Event|8
7114408|NCT02544763|11249058|FG002|Overall Study|Adverse Event|0
7114409|NCT02544763|11249056|FG000|Overall Study|Withdrawn by parent/guardian|1
7114410|NCT02544763|11249057|FG001|Overall Study|Withdrawn by parent/guardian|1
7114411|NCT02544763|11249058|FG002|Overall Study|Withdrawn by parent/guardian|1
7114412|NCT02544763|11249056|FG000|Overall Study|Met withdrawal criteria|0
7114413|NCT02544763|11249057|FG001|Overall Study|Met withdrawal criteria|2
7114414|NCT02544763|11249058|FG002|Overall Study|Met withdrawal criteria|0
7114415|NCT02544763|11249056|FG000|Overall Study|Physician Decision|0
7114416|NCT02544763|11249057|FG001|Overall Study|Physician Decision|1
7114417|NCT02544763|11249058|FG002|Overall Study|Physician Decision|0
7114418|NCT02544763|11249056|FG000|Overall Study|Difficulties taking IMP|1
7114419|NCT02544763|11249057|FG001|Overall Study|Difficulties taking IMP|0
7114420|NCT02544763|11249058|FG002|Overall Study|Difficulties taking IMP|0
7114421|NCT02545075|11249077|FG000|Randomization|Lost to Follow-up|0
7114422|NCT02545075|11249078|FG001|Randomization|Lost to Follow-up|1
7114423|NCT02545075|11249077|FG000|Randomization|Withdrawal by Subject|0
7114424|NCT02545075|11249078|FG001|Randomization|Withdrawal by Subject|6
7114425|NCT02545075|11249077|FG000|Treatment|Disease progression|71
7114426|NCT02545075|11249078|FG001|Treatment|Disease progression|32
7114427|NCT02545075|11249077|FG000|Treatment|Participant dicontinued study treatment|7
7114428|NCT02545075|11249078|FG001|Treatment|Participant dicontinued study treatment|9
7114429|NCT02545075|11249077|FG000|Treatment|Withdrawal by Subject|1
7114430|NCT02545075|11249078|FG001|Treatment|Withdrawal by Subject|0
7114431|NCT02545075|11249077|FG000|Treatment|Adverse event not related to study drug|1
7114432|NCT02545075|11249078|FG001|Treatment|Adverse event not related to study drug|0
7114433|NCT02545075|11249077|FG000|Treatment|Death|1
7114434|NCT02545075|11249078|FG001|Treatment|Death|0
7114435|NCT02545075|11249077|FG000|Treatment|Participant drug toxicity|1
7114436|NCT02545075|11249078|FG001|Treatment|Participant drug toxicity|0
7114437|NCT02545075|11249077|FG000|Treatment|Completed treatment|40
7114438|NCT02545075|11249078|FG001|Treatment|Completed treatment|12
7114439|NCT02545270|11249091|FG000|Overall Study|technical difficulties|0
7114440|NCT02545270|11249092|FG001|Overall Study|technical difficulties|1
7114441|NCT02545270|11249093|FG002|Overall Study|technical difficulties|0
7114442|NCT02545270|11249091|FG000|Overall Study|Videos being too similar to other|0
7114443|NCT02545270|11249092|FG001|Overall Study|Videos being too similar to other|0
7114444|NCT02545270|11249093|FG002|Overall Study|Videos being too similar to other|2
7114445|NCT02545322|11249102|FG000|Overall Study|Withdrawal by Subject|3
7114446|NCT02545504|11249108|FG000|Overall Study|Death|174
7114447|NCT02545504|11249109|FG001|Overall Study|Death|168
7114448|NCT02545504|11249108|FG000|Overall Study|Unknown reason|30
7114449|NCT02545504|11249109|FG001|Overall Study|Unknown reason|32
7114450|NCT02545504|11249108|FG000|Overall Study|Withdrew consent|9
7114451|NCT02545504|11249109|FG001|Overall Study|Withdrew consent|11
7114452|NCT02545504|11249108|FG000|Overall Study|Investigator's discretion|3
7114453|NCT02545504|11249109|FG001|Overall Study|Investigator's discretion|1
7114454|NCT02545504|11249108|FG000|Overall Study|Lost to Follow-up|2
7114455|NCT02545504|11249109|FG001|Overall Study|Lost to Follow-up|2
7114456|NCT02545543|11249121|FG000|Overall Study|Lost to Follow-up|67
7114457|NCT02545543|11249122|FG001|Overall Study|Lost to Follow-up|25
7114458|NCT02545543|11249121|FG000|Overall Study|Physician Decision|3
7114459|NCT02545543|11249122|FG001|Overall Study|Physician Decision|0
7114460|NCT02545543|11249121|FG000|Overall Study|Withdrawal by Subject|9
7114461|NCT02545543|11249122|FG001|Overall Study|Withdrawal by Subject|8
7114462|NCT02545543|11249121|FG000|Overall Study|Noncomplaince|1
7114463|NCT02545543|11249122|FG001|Overall Study|Noncomplaince|0
7114464|NCT02545543|11249121|FG000|Overall Study|Enrolment of subject at >1 study site|1
7114465|NCT02545543|11249122|FG001|Overall Study|Enrolment of subject at >1 study site|1
7114466|NCT02545933|11249156|FG000|Overall Study|Adverse Event|3
7114467|NCT02545933|11249157|FG001|Overall Study|Adverse Event|0
7114468|NCT02545933|11249158|FG002|Overall Study|Adverse Event|0
7114469|NCT02545933|11249156|FG000|Overall Study|Withdrawal by Subject|2
7114470|NCT02545933|11249157|FG001|Overall Study|Withdrawal by Subject|3
7114471|NCT02545933|11249158|FG002|Overall Study|Withdrawal by Subject|3
7114472|NCT02545933|11249156|FG000|Overall Study|Protocol Violation|1
7114473|NCT02545933|11249157|FG001|Overall Study|Protocol Violation|0
7114474|NCT02545933|11249158|FG002|Overall Study|Protocol Violation|1
7114475|NCT02546193|11249168|FG000|Overall Study|Withdrawal by Subject|2
7114476|NCT02546193|11249169|FG001|Overall Study|Withdrawal by Subject|0
7114477|NCT02546193|11249170|FG002|Overall Study|Withdrawal by Subject|1
7114478|NCT02546193|11249171|FG003|Overall Study|Withdrawal by Subject|0
7114479|NCT02546193|11249168|FG000|Overall Study|Not eligible at time of induction|4
7114480|NCT02546193|11249169|FG001|Overall Study|Not eligible at time of induction|6
7114481|NCT02546193|11249170|FG002|Overall Study|Not eligible at time of induction|1
7114482|NCT02546193|11249171|FG003|Overall Study|Not eligible at time of induction|0
7114483|NCT02546323|11249179|FG000|Overall Study|Withdrawal by Subject|36
7114484|NCT02546323|11249180|FG001|Overall Study|Withdrawal by Subject|33
7114485|NCT02546323|11249179|FG000|Overall Study|Eligibility Criteria not Fulfilled|0
7114486|NCT02546323|11249180|FG001|Overall Study|Eligibility Criteria not Fulfilled|1
7114487|NCT02546323|11249179|FG000|Overall Study|Adverse Event|17
7114488|NCT02546323|11249180|FG001|Overall Study|Adverse Event|11
7114489|NCT02546323|11249179|FG000|Overall Study|Patient Specific Reasons|1
7114490|NCT02546323|11249180|FG001|Overall Study|Patient Specific Reasons|2
7114491|NCT02546323|11249179|FG000|Overall Study|Lost to Follow-up|2
7114492|NCT02546323|11249180|FG001|Overall Study|Lost to Follow-up|3
7114493|NCT02546323|11249179|FG000|Overall Study|Non-compliance with Study Drug|2
7114494|NCT02546323|11249180|FG001|Overall Study|Non-compliance with Study Drug|2
7114495|NCT02546323|11249179|FG000|Overall Study|Met Withdrawal Criteria|2
7114496|NCT02546323|11249180|FG001|Overall Study|Met Withdrawal Criteria|14
7114497|NCT02546362|11249186|FG000|4-week Treatment Period|Lost to Follow-up|1
7114498|NCT02546362|11249186|FG000|4-week Treatment Period|Change in medication|2
7114499|NCT02546362|11249186|FG000|12-week Treatment Period|Withdrawal by Subject|6
7114500|NCT02546362|11249186|FG000|12-week Treatment Period|Lost to Follow-up|2
7114501|NCT02546362|11249186|FG000|12-week Treatment Period|Change in medication|1
7114502|NCT02546544|11249204|FG000|Overall Study|Disease Progression|14
7114503|NCT02546544|11249204|FG000|Overall Study|Adverse Event|1
7114504|NCT02546544|11249204|FG000|Overall Study|Withdrawal by Subject|1
7114505|NCT02546609|11249224|FG000|Overall Study|Withdrawal by Subject|0
7114506|NCT02546609|11249225|FG001|Overall Study|Withdrawal by Subject|1
7114507|NCT02546609|11249226|FG002|Overall Study|Withdrawal by Subject|2
7114508|NCT02546609|11249224|FG000|Overall Study|Adverse Event|0
7114509|NCT02546609|11249225|FG001|Overall Study|Adverse Event|6
7114510|NCT02546609|11249226|FG002|Overall Study|Adverse Event|1
7114511|NCT02546609|11249224|FG000|Overall Study|Protocol Violation|0
7114512|NCT02546609|11249225|FG001|Overall Study|Protocol Violation|1
7114513|NCT02546609|11249226|FG002|Overall Study|Protocol Violation|1
7114514|NCT02546609|11249224|FG000|Overall Study|Lost to Follow-up|2
7114515|NCT02546609|11249225|FG001|Overall Study|Lost to Follow-up|3
7114516|NCT02546609|11249226|FG002|Overall Study|Lost to Follow-up|1
7114517|NCT02546609|11249224|FG000|Overall Study|travel or work schedule restriction|0
7114518|NCT02546609|11249225|FG001|Overall Study|travel or work schedule restriction|0
7114519|NCT02546609|11249226|FG002|Overall Study|travel or work schedule restriction|2
7114520|NCT02546765|11249238|FG000|Overall Study|Withdrawal by Subject|0
7114521|NCT02546765|11249239|FG001|Overall Study|Withdrawal by Subject|1
7114522|NCT02546765|11249240|FG002|Overall Study|Withdrawal by Subject|0
7114523|NCT02546765|11249241|FG003|Overall Study|Withdrawal by Subject|0
7114524|NCT02546856|11249264|FG000|4 Months Evaluation|Death|2
7114525|NCT02546856|11249265|FG001|4 Months Evaluation|Death|3
7114526|NCT02546856|11249264|FG000|4 Months Evaluation|Withdrawal by Subject|2
7114527|NCT02546856|11249265|FG001|4 Months Evaluation|Withdrawal by Subject|3
7114528|NCT02546856|11249264|FG000|4 Months Evaluation|Lost to Follow-up|3
7114529|NCT02546856|11249265|FG001|4 Months Evaluation|Lost to Follow-up|3
7114530|NCT02546856|11249264|FG000|4 Months Evaluation|Physician Decision|3
7114531|NCT02546856|11249265|FG001|4 Months Evaluation|Physician Decision|0
7114532|NCT02546856|11249264|FG000|4 Months Evaluation|Working or living abroad|5
7114533|NCT02546856|11249265|FG001|4 Months Evaluation|Working or living abroad|1
7114534|NCT02546856|11249264|FG000|4 Months Evaluation|reasons not due to titration|4
7114535|NCT02546856|11249265|FG001|4 Months Evaluation|reasons not due to titration|1
7114536|NCT02546856|11249264|FG000|4 Months Evaluation|HF Unit not active in summer|1
7114537|NCT02546856|11249265|FG001|4 Months Evaluation|HF Unit not active in summer|0
7114538|NCT02546856|11249264|FG000|6 Months Evaluation|Death|1
7114539|NCT02546856|11249265|FG001|6 Months Evaluation|Death|1
7114540|NCT02546856|11249264|FG000|6 Months Evaluation|Lost to Follow-up|1
7114541|NCT02546856|11249265|FG001|6 Months Evaluation|Lost to Follow-up|1
7114542|NCT02546856|11249264|FG000|6 Months Evaluation|Working or living abroad|6
7114543|NCT02546856|11249265|FG001|6 Months Evaluation|Working or living abroad|4
7114544|NCT02546856|11249264|FG000|6 Months Evaluation|reasons not due to titration|0
7114545|NCT02546856|11249265|FG001|6 Months Evaluation|reasons not due to titration|1
7114546|NCT02547038|11249294|FG000|Overall Study|Lost to Follow-up|3
7114547|NCT02547038|11249295|FG001|Overall Study|Lost to Follow-up|2
7114548|NCT02547220|11249312|FG000|Overall Study|Withdrawal by Subject|1
7114549|NCT02547220|11249313|FG001|Overall Study|Withdrawal by Subject|0
7114550|NCT02547220|11249312|FG000|Overall Study|Study terminated by sponsor|18
7114551|NCT02547220|11249313|FG001|Overall Study|Study terminated by sponsor|20
7114552|NCT02547233|11249321|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1
7114553|NCT02547233|11249322|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0
7114554|NCT02547233|11249321|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1
7114555|NCT02547233|11249322|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0
7114556|NCT02547233|11249321|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0
7114557|NCT02547233|11249322|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9
7114558|NCT02547233|11249321|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0
7114559|NCT02547233|11249322|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
7114560|NCT02547233|11249321|FG000|12-month Follow-up|Withdrawal by Subject|10
7114561|NCT02547233|11249322|FG001|12-month Follow-up|Withdrawal by Subject|10
7114562|NCT02547233|11249321|FG000|12-month Follow-up|Lost to Follow-up|3
7114563|NCT02547233|11249322|FG001|12-month Follow-up|Lost to Follow-up|3
7114564|NCT02547233|11249321|FG000|12-month Follow-up|Lack of Efficacy|1
7114565|NCT02547233|11249322|FG001|12-month Follow-up|Lack of Efficacy|2
7114566|NCT02547233|11249321|FG000|12-month Follow-up|Protocol Violation|0
7114567|NCT02547233|11249322|FG001|12-month Follow-up|Protocol Violation|1
7114568|NCT02547233|11249321|FG000|12-month Follow-up|Other|0
7114569|NCT02547233|11249322|FG001|12-month Follow-up|Other|1
7114570|NCT02547363|11249332|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0
7114571|NCT02547363|11249333|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1
7114572|NCT02547363|11249332|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2
7114573|NCT02547363|11249333|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8
7114574|NCT02547363|11249332|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
7114575|NCT02547363|11249333|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
7114576|NCT02547363|11249332|FG000|3-day Treatment and 8-week Follow-up|Other|1
7114577|NCT02547363|11249333|FG001|3-day Treatment and 8-week Follow-up|Other|1
7114578|NCT02547363|11249332|FG000|12-month Follow-up|Withdrawal by Subject|4
7114579|NCT02547363|11249333|FG001|12-month Follow-up|Withdrawal by Subject|3
7114580|NCT02547363|11249332|FG000|12-month Follow-up|Lost to Follow-up|4
7114581|NCT02547363|11249333|FG001|12-month Follow-up|Lost to Follow-up|1
7114582|NCT02547363|11249332|FG000|12-month Follow-up|Lack of Efficacy|1
7114583|NCT02547363|11249333|FG001|12-month Follow-up|Lack of Efficacy|1
7114584|NCT02547363|11249332|FG000|12-month Follow-up|Other|1
7114585|NCT02547363|11249333|FG001|12-month Follow-up|Other|0
7114586|NCT02547428|11249343|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8
7114587|NCT02547428|11249344|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1
7114588|NCT02547428|11249343|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1
7114589|NCT02547428|11249344|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1
7114590|NCT02547428|11249343|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1
7114591|NCT02547428|11249344|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1
7114592|NCT02547428|11249343|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1
7114593|NCT02547428|11249344|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3
7114594|NCT02547428|11249343|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0
7114595|NCT02547428|11249344|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3
7114596|NCT02547428|11249343|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0
7114597|NCT02547428|11249344|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3
7114598|NCT02547428|11249343|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0
7114599|NCT02547428|11249344|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1
7114600|NCT02547428|11249343|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1
7114601|NCT02547428|11249344|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0
7114602|NCT02547454|11249357|FG000|Overall Study|Due to hemodialysis|53
7114603|NCT02547454|11249357|FG000|Overall Study|Due to transplantation|1
7114604|NCT02547454|11249357|FG000|Overall Study|Due to no further need to treat|4
7114605|NCT02547454|11249357|FG000|Overall Study|Death|38
7114606|NCT02547454|11249357|FG000|Overall Study|Lost to Follow-up|26
7114607|NCT02547454|11249357|FG000|Overall Study|Other|39
7114608|NCT02547454|11249357|FG000|Overall Study|No data|11
7114609|NCT02547649|11249373|FG000|Overall Study|Lost to Follow-up|3
7114610|NCT02547649|11249374|FG001|Overall Study|Lost to Follow-up|1
7114611|NCT02547649|11249375|FG002|Overall Study|Lost to Follow-up|1
7114612|NCT02547649|11249373|FG000|Overall Study|Not vaccinated|0
7114613|NCT02547649|11249374|FG001|Overall Study|Not vaccinated|0
7114614|NCT02547649|11249375|FG002|Overall Study|Not vaccinated|1
7114615|NCT02547649|11249373|FG000|Overall Study|Withdrawal by Subject|0
7114616|NCT02547649|11249374|FG001|Overall Study|Withdrawal by Subject|4
7114617|NCT02547649|11249375|FG002|Overall Study|Withdrawal by Subject|2
7114618|NCT02547766|11249388|FG000|Overall Study|Withdrawal by Subject|1
7114619|NCT02547922|11249404|FG000|Overall Study|Withdrawal by Subject|9
7114620|NCT02547922|11249405|FG001|Overall Study|Withdrawal by Subject|6
7114621|NCT02547922|11249406|FG002|Overall Study|Withdrawal by Subject|10
7114622|NCT02547922|11249404|FG000|Overall Study|Adverse Event|3
7114623|NCT02547922|11249405|FG001|Overall Study|Adverse Event|1
7114624|NCT02547922|11249406|FG002|Overall Study|Adverse Event|2
7114625|NCT02547922|11249404|FG000|Overall Study|Lost to Follow-up|1
7114626|NCT02547922|11249405|FG001|Overall Study|Lost to Follow-up|0
7114627|NCT02547922|11249406|FG002|Overall Study|Lost to Follow-up|0
7114628|NCT02547922|11249404|FG000|Overall Study|Lack of Efficacy|5
7114629|NCT02547922|11249405|FG001|Overall Study|Lack of Efficacy|7
7114630|NCT02547922|11249406|FG002|Overall Study|Lack of Efficacy|4
7114631|NCT02547922|11249404|FG000|Overall Study|Death|1
7114632|NCT02547922|11249405|FG001|Overall Study|Death|0
7114633|NCT02547922|11249406|FG002|Overall Study|Death|0
7114634|NCT02547922|11249404|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4
7114635|NCT02547922|11249405|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8
7114636|NCT02547922|11249406|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9
7114637|NCT02547922|11249404|FG000|Overall Study|TECHNICAL PROBLEMS|1
7114638|NCT02547922|11249405|FG001|Overall Study|TECHNICAL PROBLEMS|0
7114639|NCT02547922|11249406|FG002|Overall Study|TECHNICAL PROBLEMS|0
7114640|NCT02547922|11249404|FG000|Overall Study|PROGRESSIVE DISEASE|1
7114641|NCT02547922|11249405|FG001|Overall Study|PROGRESSIVE DISEASE|0
7114642|NCT02547922|11249406|FG002|Overall Study|PROGRESSIVE DISEASE|2
7114643|NCT02547922|11249404|FG000|Overall Study|Physician Decision|2
7114644|NCT02547922|11249405|FG001|Overall Study|Physician Decision|1
7114645|NCT02547922|11249406|FG002|Overall Study|Physician Decision|2
7114646|NCT02547922|11249404|FG000|Overall Study|Patients did not receive IP|1
7114647|NCT02547922|11249405|FG001|Overall Study|Patients did not receive IP|1
7114648|NCT02547922|11249406|FG002|Overall Study|Patients did not receive IP|0
7114649|NCT02547935|11249423|FG000|Overall Study|Other|0
7114650|NCT02547935|11249424|FG001|Overall Study|Other|1
7114651|NCT02547935|11249425|FG002|Overall Study|Other|0
7114652|NCT02547935|11249423|FG000|Overall Study|Withdrawal by Subject|2
7114653|NCT02547935|11249424|FG001|Overall Study|Withdrawal by Subject|3
7114654|NCT02547935|11249425|FG002|Overall Study|Withdrawal by Subject|4
7114655|NCT02547935|11249423|FG000|Overall Study|Screen Failure|2
7114656|NCT02547935|11249424|FG001|Overall Study|Screen Failure|0
7114657|NCT02547935|11249425|FG002|Overall Study|Screen Failure|0
7114658|NCT02547935|11249423|FG000|Overall Study|Physician Decision|0
7114659|NCT02547935|11249424|FG001|Overall Study|Physician Decision|1
7114660|NCT02547935|11249425|FG002|Overall Study|Physician Decision|0
7114661|NCT02547935|11249423|FG000|Overall Study|Lost to Follow-up|0
7114662|NCT02547935|11249424|FG001|Overall Study|Lost to Follow-up|2
7114663|NCT02547935|11249425|FG002|Overall Study|Lost to Follow-up|1
7114664|NCT02547935|11249423|FG000|Overall Study|Death|1
7114665|NCT02547935|11249424|FG001|Overall Study|Death|1
7114666|NCT02547935|11249425|FG002|Overall Study|Death|0
7114667|NCT02547974|11249439|FG000|Overall Study|Withdrawal by Subject|1
7114668|NCT02547974|11249440|FG001|Overall Study|Withdrawal by Subject|0
7114669|NCT02547974|11249441|FG002|Overall Study|Withdrawal by Subject|0
7114670|NCT02547974|11249442|FG003|Overall Study|Withdrawal by Subject|0
7114671|NCT02547987|11249455|FG000|Overall Study|Withdrawal by Subject|1
7114672|NCT02547987|11249455|FG000|Overall Study|Adverse Event|2
7114673|NCT02548078|11249461|FG000|Overall Study|Serious adverse event/Adverse event|1
7114674|NCT02548078|11249462|FG001|Overall Study|Serious adverse event/Adverse event|0
7114675|NCT02548078|11249461|FG000|Overall Study|Moved from study area|3
7114676|NCT02548078|11249462|FG001|Overall Study|Moved from study area|3
7114677|NCT02548078|11249461|FG000|Overall Study|Lost to Follow-up|1
7114678|NCT02548078|11249462|FG001|Overall Study|Lost to Follow-up|3
7114679|NCT02548156|11249475|FG000|Washout Period 1|Lost to Follow-up|0
7114680|NCT02548156|11249476|FG001|Washout Period 1|Lost to Follow-up|0
7114681|NCT02548156|11249477|FG002|Washout Period 1|Lost to Follow-up|0
7114682|NCT02548156|11249478|FG003|Washout Period 1|Lost to Follow-up|0
7114683|NCT02548156|11249479|FG004|Washout Period 1|Lost to Follow-up|1
7114684|NCT02548156|11249480|FG005|Washout Period 1|Lost to Follow-up|0
7114685|NCT02548455|11249521|FG000|Overall Study|Withdrawal by Subject|27
7114686|NCT02548455|11249521|FG000|Overall Study|Death|26
7114687|NCT02548455|11249521|FG000|Overall Study|Lost to Follow-up|14
7114688|NCT02548455|11249521|FG000|Overall Study|Visit not completed|173
7114689|NCT02548585|11249532|FG000|Overall Study|Withdrawal by Subject|0
7114690|NCT02548585|11249533|FG001|Overall Study|Withdrawal by Subject|0
7114691|NCT02548585|11249534|FG002|Overall Study|Withdrawal by Subject|0
7114692|NCT02548585|11249535|FG003|Overall Study|Withdrawal by Subject|0
7114693|NCT02548585|11249536|FG004|Overall Study|Withdrawal by Subject|0
7114694|NCT02548585|11249537|FG005|Overall Study|Withdrawal by Subject|1
7114695|NCT02548585|11249538|FG006|Overall Study|Withdrawal by Subject|0
7114696|NCT02548585|11249532|FG000|Overall Study|Lost to Follow-up|1
7114697|NCT02548585|11249533|FG001|Overall Study|Lost to Follow-up|0
7114698|NCT02548585|11249534|FG002|Overall Study|Lost to Follow-up|0
7114699|NCT02548585|11249535|FG003|Overall Study|Lost to Follow-up|0
7114700|NCT02548585|11249536|FG004|Overall Study|Lost to Follow-up|0
7114701|NCT02548585|11249537|FG005|Overall Study|Lost to Follow-up|0
7114702|NCT02548585|11249538|FG006|Overall Study|Lost to Follow-up|0
7114703|NCT02548585|11249532|FG000|Overall Study|Other|1
7114704|NCT02548585|11249533|FG001|Overall Study|Other|0
7114705|NCT02548585|11249534|FG002|Overall Study|Other|0
7114706|NCT02548585|11249535|FG003|Overall Study|Other|2
7114707|NCT02548585|11249536|FG004|Overall Study|Other|3
7114708|NCT02548585|11249537|FG005|Overall Study|Other|0
7114709|NCT02548585|11249538|FG006|Overall Study|Other|1
7114710|NCT02548585|11249532|FG000|Overall Study|Randomized but not treated|0
7114711|NCT02548585|11249533|FG001|Overall Study|Randomized but not treated|0
7114712|NCT02548585|11249534|FG002|Overall Study|Randomized but not treated|0
7114713|NCT02548585|11249535|FG003|Overall Study|Randomized but not treated|0
7114714|NCT02548585|11249536|FG004|Overall Study|Randomized but not treated|0
7114715|NCT02548585|11249537|FG005|Overall Study|Randomized but not treated|1
7114716|NCT02548585|11249538|FG006|Overall Study|Randomized but not treated|0
7114717|NCT02548650|11249581|FG000|Triple Therapy|Adverse Event|1
7114718|NCT02548650|11249582|FG001|Triple Therapy|Adverse Event|0
7114719|NCT02548650|11249581|FG000|Triple Therapy|Withdrawal by Subject|0
7114720|NCT02548650|11249582|FG001|Triple Therapy|Withdrawal by Subject|4
7114721|NCT02548650|11249581|FG000|Double Therapy|Adverse Event|1
7114722|NCT02548650|11249582|FG001|Double Therapy|Adverse Event|1
7114723|NCT02548650|11249581|FG000|Double Therapy|Withdrawal by Subject|0
7114724|NCT02548650|11249582|FG001|Double Therapy|Withdrawal by Subject|1
7114725|NCT02548962|11249621|FG000|Overall Study|Withdrawal by Subject|1
7114726|NCT02548962|11249622|FG001|Overall Study|Withdrawal by Subject|0
7114727|NCT02549027|11249657|FG000|Washout After Period 4|Withdrawal by Subject|0
7114728|NCT02549027|11249658|FG001|Washout After Period 4|Withdrawal by Subject|1
7114729|NCT02549027|11249659|FG002|Washout After Period 4|Withdrawal by Subject|1
7114730|NCT02549027|11249660|FG003|Washout After Period 4|Withdrawal by Subject|1
7114731|NCT02549027|11249661|FG004|Washout After Period 4|Withdrawal by Subject|0
7114732|NCT02549027|11249662|FG005|Washout After Period 4|Withdrawal by Subject|0
7114733|NCT02549027|11249657|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0
7114734|NCT02549027|11249658|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0
7114735|NCT02549027|11249659|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0
7114736|NCT02549027|11249660|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0
7114737|NCT02549027|11249661|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2
7114738|NCT02549027|11249662|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0
7114739|NCT02549196|11249693|FG000|Overall Study|Protocol Violation|0
7114740|NCT02549196|11249694|FG001|Overall Study|Protocol Violation|0
7114741|NCT02549196|11249695|FG002|Overall Study|Protocol Violation|0
7114742|NCT02549196|11249696|FG003|Overall Study|Protocol Violation|1
7114743|NCT02549196|11249693|FG000|Overall Study|Withdrawal by Subject|1
7114744|NCT02549196|11249694|FG001|Overall Study|Withdrawal by Subject|0
7114745|NCT02549196|11249695|FG002|Overall Study|Withdrawal by Subject|1
7114746|NCT02549196|11249696|FG003|Overall Study|Withdrawal by Subject|0
7114747|NCT02549287|11249708|FG000|Overall Study|Lost to Follow-up|65
7114748|NCT02549287|11249709|FG001|Overall Study|Lost to Follow-up|26
7114749|NCT02549287|11249708|FG000|Overall Study|Withdrawal by Subject|15
7114750|NCT02549287|11249709|FG001|Overall Study|Withdrawal by Subject|6
7114751|NCT02549339|11249717|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2
7114752|NCT02549339|11249718|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0
7114753|NCT02549339|11249717|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1
7114754|NCT02549339|11249718|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3
7114755|NCT02549339|11249717|FG000|3-day Treatment and 8-week Follow-up|Other|1
7114756|NCT02549339|11249718|FG001|3-day Treatment and 8-week Follow-up|Other|0
7114757|NCT02549339|11249717|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0
7114758|NCT02549339|11249718|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2
7114759|NCT02549339|11249717|FG000|12-month Follow-up|Lack of Efficacy|0
7114760|NCT02549339|11249718|FG001|12-month Follow-up|Lack of Efficacy|2
7114761|NCT02549339|11249717|FG000|12-month Follow-up|Withdrawal by Subject|8
7114762|NCT02549339|11249718|FG001|12-month Follow-up|Withdrawal by Subject|3
7114763|NCT02549339|11249717|FG000|12-month Follow-up|Lost to Follow-up|1
7114764|NCT02549339|11249718|FG001|12-month Follow-up|Lost to Follow-up|3
7114765|NCT02549339|11249717|FG000|12-month Follow-up|Other|0
7114766|NCT02549339|11249718|FG001|12-month Follow-up|Other|3
7114767|NCT02549352|11249728|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0
7114768|NCT02549352|11249729|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1
7114769|NCT02549352|11249728|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2
7114770|NCT02549352|11249729|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3
7114771|NCT02549352|11249728|FG000|3-day Treatment and 8-week Follow-up|Other|0
7114772|NCT02549352|11249729|FG001|3-day Treatment and 8-week Follow-up|Other|2
7114773|NCT02549352|11249728|FG000|12-month Follow-up|Withdrawal by Subject|4
7114774|NCT02549352|11249729|FG001|12-month Follow-up|Withdrawal by Subject|5
7114775|NCT02549352|11249728|FG000|12-month Follow-up|Lost to Follow-up|3
7114776|NCT02549352|11249729|FG001|12-month Follow-up|Lost to Follow-up|2
7114777|NCT02549352|11249728|FG000|12-month Follow-up|Death|0
7114778|NCT02549352|11249729|FG001|12-month Follow-up|Death|1
7114779|NCT02549352|11249728|FG000|12-month Follow-up|Protocol Violation|0
7114780|NCT02549352|11249729|FG001|12-month Follow-up|Protocol Violation|1
7114781|NCT02549352|11249728|FG000|12-month Follow-up|Other|1
7114782|NCT02549352|11249729|FG001|12-month Follow-up|Other|3
7114783|NCT02549573|11249759|FG000|Overall Study|Withdrawal by Subject|0
7114784|NCT02549573|11249760|FG001|Overall Study|Withdrawal by Subject|2
7114785|NCT02549573|11249759|FG000|Overall Study|Protocol Violation|0
7114786|NCT02549573|11249760|FG001|Overall Study|Protocol Violation|1
7114787|NCT02549859|11249766|FG000|Long-term 60 Hz DBS|Study Closed|1
7114788|NCT02550106|11249774|FG000|Overall Study|Adverse Event|1
7114789|NCT02550106|11249774|FG000|Overall Study|Lack of Efficacy|3
7114790|NCT02550106|11249774|FG000|Overall Study|Protocol Violation|6
7114791|NCT02550106|11249774|FG000|Overall Study|Withdrawal by Subject|2
7114792|NCT02550795|11249809|FG000|Overall Study|Physician Decision|0
7114793|NCT02550795|11249810|FG001|Overall Study|Physician Decision|1
7114794|NCT02550795|11249811|FG002|Overall Study|Physician Decision|0
7114795|NCT02550938|11249823|FG000|Overall Study|Lost to Follow-up|8
7114796|NCT02550938|11249824|FG001|Overall Study|Lost to Follow-up|7
7114797|NCT02550938|11249825|FG002|Overall Study|Lost to Follow-up|12
7114798|NCT02550938|11249826|FG003|Overall Study|Lost to Follow-up|11
7114799|NCT02551055|11249843|FG000|Overall Study|Death|2
7114800|NCT02551055|11249844|FG001|Overall Study|Death|4
7114801|NCT02551055|11249845|FG002|Overall Study|Death|2
7114802|NCT02551055|11249846|FG003|Overall Study|Death|2
7114803|NCT02551055|11249847|FG004|Overall Study|Death|2
7114804|NCT02551055|11249848|FG005|Overall Study|Death|1
7114805|NCT02551055|11249849|FG006|Overall Study|Death|2
7114806|NCT02551055|11249850|FG007|Overall Study|Death|0
7114807|NCT02551055|11249843|FG000|Overall Study|Study Terminated by Sponsor|1
7114808|NCT02551055|11249844|FG001|Overall Study|Study Terminated by Sponsor|1
7114809|NCT02551055|11249845|FG002|Overall Study|Study Terminated by Sponsor|0
7114810|NCT02551055|11249846|FG003|Overall Study|Study Terminated by Sponsor|2
7114811|NCT02551055|11249847|FG004|Overall Study|Study Terminated by Sponsor|2
7114812|NCT02551055|11249848|FG005|Overall Study|Study Terminated by Sponsor|0
7114813|NCT02551055|11249849|FG006|Overall Study|Study Terminated by Sponsor|0
7114814|NCT02551055|11249850|FG007|Overall Study|Study Terminated by Sponsor|0
7114815|NCT02551055|11249843|FG000|Overall Study|Withdrawal by Subject|1
7114816|NCT02551055|11249844|FG001|Overall Study|Withdrawal by Subject|1
7114817|NCT02551055|11249845|FG002|Overall Study|Withdrawal by Subject|0
7114818|NCT02551055|11249846|FG003|Overall Study|Withdrawal by Subject|1
7114819|NCT02551055|11249847|FG004|Overall Study|Withdrawal by Subject|2
7114820|NCT02551055|11249848|FG005|Overall Study|Withdrawal by Subject|0
7114821|NCT02551055|11249849|FG006|Overall Study|Withdrawal by Subject|0
7114822|NCT02551055|11249850|FG007|Overall Study|Withdrawal by Subject|0
7114823|NCT02551055|11249843|FG000|Overall Study|Reason not specified|0
7114824|NCT02551055|11249844|FG001|Overall Study|Reason not specified|0
7114825|NCT02551055|11249845|FG002|Overall Study|Reason not specified|0
7114826|NCT02551055|11249846|FG003|Overall Study|Reason not specified|0
7114827|NCT02551055|11249847|FG004|Overall Study|Reason not specified|1
7114828|NCT02551055|11249848|FG005|Overall Study|Reason not specified|0
7114829|NCT02551055|11249849|FG006|Overall Study|Reason not specified|1
7114830|NCT02551055|11249850|FG007|Overall Study|Reason not specified|0
7114831|NCT02551159|11249880|FG000|Overall Study|Death|352
7114832|NCT02551159|11249881|FG001|Overall Study|Death|174
7114833|NCT02551159|11249882|FG002|Overall Study|Death|161
7114834|NCT02551159|11249880|FG000|Overall Study|Withdrawal by Subject|8
7114835|NCT02551159|11249881|FG001|Overall Study|Withdrawal by Subject|5
7114836|NCT02551159|11249882|FG002|Overall Study|Withdrawal by Subject|16
7114837|NCT02551159|11249880|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53
7114838|NCT02551159|11249881|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25
7114839|NCT02551159|11249882|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29
7114840|NCT02551666|11249912|FG000|Overall Study|Withdrawal by Subject|1
7114841|NCT02551666|11249913|FG001|Overall Study|Withdrawal by Subject|3
7114842|NCT02551692|11249922|FG000|Overall Study|Lost to Follow-up|0
7114843|NCT02551692|11249923|FG001|Overall Study|Lost to Follow-up|1
7114844|NCT02551692|11249924|FG002|Overall Study|Lost to Follow-up|4
7114845|NCT02551692|11249922|FG000|Overall Study|Withdrawal by Subject|1
7114846|NCT02551692|11249923|FG001|Overall Study|Withdrawal by Subject|0
7114847|NCT02551692|11249924|FG002|Overall Study|Withdrawal by Subject|1
7114848|NCT02551731|11249932|FG000|Overall Study|Withdrawal by Subject|2
7114849|NCT02551874|11249988|FG000|Overall Study|Lost to Follow-up|0
7114850|NCT02551874|11249989|FG001|Overall Study|Lost to Follow-up|2
7114851|NCT02551874|11249988|FG000|Overall Study|Pregnancy|0
7114852|NCT02551874|11249989|FG001|Overall Study|Pregnancy|1
7114853|NCT02551874|11249988|FG000|Overall Study|Reason not reported|10
7114854|NCT02551874|11249989|FG001|Overall Study|Reason not reported|4
7114855|NCT02551874|11249988|FG000|Overall Study|Did not receive randomized treatment|0
7114856|NCT02551874|11249989|FG001|Overall Study|Did not receive randomized treatment|7
7114857|NCT02551874|11249988|FG000|Overall Study|Did not enter long-term study|18
7114858|NCT02551874|11249989|FG001|Overall Study|Did not enter long-term study|25
7114859|NCT02552121|11250016|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2
7114860|NCT02552121|11250017|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
7114861|NCT02552121|11250018|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
7114862|NCT02552121|11250019|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
7114863|NCT02552121|11250020|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
7114864|NCT02552121|11250021|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
7114865|NCT02552121|11250022|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
7114866|NCT02552121|11250023|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
7114867|NCT02552121|11250016|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1
7114868|NCT02552121|11250017|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
7114869|NCT02552121|11250018|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
7114870|NCT02552121|11250019|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
7114871|NCT02552121|11250020|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
7114872|NCT02552121|11250021|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
7114873|NCT02552121|11250022|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
7114874|NCT02552121|11250023|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
7114875|NCT02552121|11250016|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
7114876|NCT02552121|11250017|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1
7114877|NCT02552121|11250018|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
7114878|NCT02552121|11250019|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
7114879|NCT02552121|11250020|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
7114880|NCT02552121|11250021|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
7114881|NCT02552121|11250022|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
7114882|NCT02552121|11250023|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
7114883|NCT02552121|11250016|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
7114884|NCT02552121|11250017|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2
7114885|NCT02552121|11250018|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
7114886|NCT02552121|11250019|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
7114887|NCT02552121|11250020|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
7114888|NCT02552121|11250021|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
7114889|NCT02552121|11250022|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
7114890|NCT02552121|11250023|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
7114891|NCT02552121|11250016|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
7114892|NCT02552121|11250017|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2
7114893|NCT02552121|11250018|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
7114894|NCT02552121|11250019|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
7114895|NCT02552121|11250020|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
7114896|NCT02552121|11250021|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
7114897|NCT02552121|11250022|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
7114898|NCT02552121|11250023|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
7114899|NCT02552121|11250016|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
7114900|NCT02552121|11250017|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1
7114901|NCT02552121|11250018|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
7114902|NCT02552121|11250019|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
7114903|NCT02552121|11250020|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
7114904|NCT02552121|11250021|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
7114905|NCT02552121|11250022|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
7114906|NCT02552121|11250023|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
7114907|NCT02552121|11250016|FG000|Part 2: Cohort Expansion|Patient Choice|0
7114908|NCT02552121|11250017|FG001|Part 2: Cohort Expansion|Patient Choice|0
7114909|NCT02552121|11250018|FG002|Part 2: Cohort Expansion|Patient Choice|1
7114910|NCT02552121|11250019|FG003|Part 2: Cohort Expansion|Patient Choice|0
7114911|NCT02552121|11250020|FG004|Part 2: Cohort Expansion|Patient Choice|0
7114912|NCT02552121|11250021|FG005|Part 2: Cohort Expansion|Patient Choice|0
7114913|NCT02552121|11250022|FG006|Part 2: Cohort Expansion|Patient Choice|1
7114914|NCT02552121|11250023|FG007|Part 2: Cohort Expansion|Patient Choice|0
7114915|NCT02552121|11250016|FG000|Part 2: Cohort Expansion|Disease Progression|0
7114916|NCT02552121|11250017|FG001|Part 2: Cohort Expansion|Disease Progression|0
7114917|NCT02552121|11250018|FG002|Part 2: Cohort Expansion|Disease Progression|3
7114918|NCT02552121|11250019|FG003|Part 2: Cohort Expansion|Disease Progression|2
7114919|NCT02552121|11250020|FG004|Part 2: Cohort Expansion|Disease Progression|1
7114920|NCT02552121|11250021|FG005|Part 2: Cohort Expansion|Disease Progression|4
7114921|NCT02552121|11250022|FG006|Part 2: Cohort Expansion|Disease Progression|0
7114922|NCT02552121|11250023|FG007|Part 2: Cohort Expansion|Disease Progression|3
7114923|NCT02552121|11250016|FG000|Part 2: Cohort Expansion|Adverse Event|0
7114924|NCT02552121|11250017|FG001|Part 2: Cohort Expansion|Adverse Event|0
7114925|NCT02552121|11250018|FG002|Part 2: Cohort Expansion|Adverse Event|6
7114926|NCT02552121|11250019|FG003|Part 2: Cohort Expansion|Adverse Event|1
7114927|NCT02552121|11250020|FG004|Part 2: Cohort Expansion|Adverse Event|0
7114928|NCT02552121|11250021|FG005|Part 2: Cohort Expansion|Adverse Event|0
7114929|NCT02552121|11250022|FG006|Part 2: Cohort Expansion|Adverse Event|0
7114930|NCT02552121|11250023|FG007|Part 2: Cohort Expansion|Adverse Event|0
7114931|NCT02552121|11250016|FG000|Part 2: Cohort Expansion|Death|0
7114932|NCT02552121|11250017|FG001|Part 2: Cohort Expansion|Death|0
7114933|NCT02552121|11250018|FG002|Part 2: Cohort Expansion|Death|1
7114934|NCT02552121|11250019|FG003|Part 2: Cohort Expansion|Death|0
7114935|NCT02552121|11250020|FG004|Part 2: Cohort Expansion|Death|0
7114936|NCT02552121|11250021|FG005|Part 2: Cohort Expansion|Death|0
7114937|NCT02552121|11250022|FG006|Part 2: Cohort Expansion|Death|0
7114938|NCT02552121|11250023|FG007|Part 2: Cohort Expansion|Death|0
7114939|NCT02552147|11250055|FG000|First Intervention (7 Days)|Protocol Violation|1
7114940|NCT02552147|11250056|FG001|First Intervention (7 Days)|Protocol Violation|0
7114941|NCT02552147|11250055|FG000|Second Intervention (7 Days)|Protocol Violation|2
7114942|NCT02552147|11250056|FG001|Second Intervention (7 Days)|Protocol Violation|0
7114943|NCT02552225|11250064|FG000|Overall Study|Withdrawal by Subject|1
7114944|NCT02552225|11250065|FG001|Overall Study|Withdrawal by Subject|0
7114945|NCT02552238|11250071|FG000|Overall Study|Withdrawal by Subject|2
7114946|NCT02552238|11250071|FG000|Overall Study|Adverse Event|2
7114947|NCT02552303|11250086|FG000|Allocation|Withdrawal by Subject|2
7114948|NCT02552303|11250087|FG001|Allocation|Withdrawal by Subject|1
7114949|NCT02552303|11250088|FG002|Allocation|Withdrawal by Subject|1
7114950|NCT02552303|11250089|FG003|Allocation|Withdrawal by Subject|1
7114951|NCT02552303|11250086|FG000|Allocation|ineligible|1
7114952|NCT02552303|11250087|FG001|Allocation|ineligible|1
7114953|NCT02552303|11250088|FG002|Allocation|ineligible|0
7114954|NCT02552303|11250089|FG003|Allocation|ineligible|0
7114955|NCT02552303|11250086|FG000|Follow-Up|Lost to Follow-up|0
7114956|NCT02552303|11250087|FG001|Follow-Up|Lost to Follow-up|0
7114957|NCT02552303|11250088|FG002|Follow-Up|Lost to Follow-up|1
7114958|NCT02552303|11250089|FG003|Follow-Up|Lost to Follow-up|0
7114959|NCT02552303|11250086|FG000|Follow-Up|ineligible|0
7114960|NCT02552303|11250087|FG001|Follow-Up|ineligible|2
7114961|NCT02552303|11250088|FG002|Follow-Up|ineligible|0
7114962|NCT02552303|11250089|FG003|Follow-Up|ineligible|0
7114963|NCT02552316|11250099|FG000|Overall Study|Withdrawal by Subject|1
7114964|NCT02552316|11250099|FG000|Overall Study|Withdrawal due to non-compliance|1
7114965|NCT02552355|11250151|FG000|Overall Study|Adverse Event|0
7114966|NCT02552355|11250152|FG001|Overall Study|Adverse Event|2
7114967|NCT02552355|11250153|FG002|Overall Study|Adverse Event|2
7114968|NCT02552355|11250154|FG003|Overall Study|Adverse Event|0
7114969|NCT02552355|11250151|FG000|Overall Study|Withdrawal by Subject|0
7114970|NCT02552355|11250152|FG001|Overall Study|Withdrawal by Subject|0
7114971|NCT02552355|11250153|FG002|Overall Study|Withdrawal by Subject|0
7114972|NCT02552355|11250154|FG003|Overall Study|Withdrawal by Subject|1
7114973|NCT02552732|11250169|FG000|Overall Study|Lost to Follow-up|2
7114974|NCT02552732|11250169|FG000|Overall Study|Physician Decision|1
7114975|NCT02552732|11250169|FG000|Overall Study|Day 1 SpO2 > 96%|1
7114976|NCT02552732|11250169|FG000|Overall Study|Withdrawal by Subject|6
7114977|NCT02552888|11250185|FG000|Overall Study|Lost to Follow-up|1
7114978|NCT02552888|11250186|FG001|Overall Study|Lost to Follow-up|1
7114979|NCT02552966|11250196|FG000|Overall Study|Lost to Follow-up|2
7114980|NCT02552966|11250196|FG000|Overall Study|Withdrawal by Subject|3
7114981|NCT02553317|11250206|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0
7114982|NCT02553317|11250207|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1
7114983|NCT02553317|11250206|FG000|Overall Treatment Period + Follow-up|Physician Decision|2
7114984|NCT02553317|11250207|FG001|Overall Treatment Period + Follow-up|Physician Decision|4
7114985|NCT02553317|11250206|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0
7114986|NCT02553317|11250207|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1
7114987|NCT02553317|11250206|FG000|Overall Treatment Period + Follow-up|Death|1
7114988|NCT02553317|11250207|FG001|Overall Treatment Period + Follow-up|Death|3
7114989|NCT02553317|11250206|FG000|Overall Treatment Period + Follow-up|Adverse Event|6
7114990|NCT02553317|11250207|FG001|Overall Treatment Period + Follow-up|Adverse Event|5
7114991|NCT02553317|11250206|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4
7114992|NCT02553317|11250207|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5
7114993|NCT02553317|11250206|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0
7114994|NCT02553317|11250207|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1
7114995|NCT02553317|11250206|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1
7114996|NCT02553317|11250207|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1
7114997|NCT02553317|11250206|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0
7114998|NCT02553317|11250207|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1
7114999|NCT02553317|11250206|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0
7115000|NCT02553317|11250207|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1
7115001|NCT02553330|11250217|FG000|Overall Study|Study Terminated by Sponsor|2
7115002|NCT02553330|11250218|FG001|Overall Study|Study Terminated by Sponsor|13
7115003|NCT02553330|11250219|FG002|Overall Study|Study Terminated by Sponsor|12
7115004|NCT02553330|11250217|FG000|Overall Study|Withdrawal by Subject|3
7115005|NCT02553330|11250218|FG001|Overall Study|Withdrawal by Subject|19
7115006|NCT02553330|11250219|FG002|Overall Study|Withdrawal by Subject|21
7115007|NCT02553330|11250217|FG000|Overall Study|Other|0
7115008|NCT02553330|11250218|FG001|Overall Study|Other|1
7115009|NCT02553330|11250219|FG002|Overall Study|Other|0
7115010|NCT02553330|11250217|FG000|Overall Study|Non compliance to study treatment|0
7115011|NCT02553330|11250218|FG001|Overall Study|Non compliance to study treatment|1
7115012|NCT02553330|11250219|FG002|Overall Study|Non compliance to study treatment|0
7115013|NCT02553330|11250217|FG000|Overall Study|Adverse Event|0
7115014|NCT02553330|11250218|FG001|Overall Study|Adverse Event|1
7115015|NCT02553330|11250219|FG002|Overall Study|Adverse Event|0
7115016|NCT02553330|11250217|FG000|Overall Study|Lost to Follow-up|0
7115017|NCT02553330|11250218|FG001|Overall Study|Lost to Follow-up|4
7115018|NCT02553330|11250219|FG002|Overall Study|Lost to Follow-up|4
7115019|NCT02553421|11250240|FG000|Overall Study|Lost to Follow-up|21
7115020|NCT02553421|11250241|FG001|Overall Study|Lost to Follow-up|1
7115021|NCT02553421|11250240|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5
7115022|NCT02553421|11250241|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0
7115023|NCT02553421|11250240|FG000|Overall Study|Improper Device Placement|3
7115024|NCT02553421|11250241|FG001|Overall Study|Improper Device Placement|0
7115025|NCT02553499|11250262|FG000|Overall Study|Adverse Event|0
7115026|NCT02553499|11250263|FG001|Overall Study|Adverse Event|0
7115027|NCT02553499|11250264|FG002|Overall Study|Adverse Event|0
7115028|NCT02553499|11250265|FG003|Overall Study|Adverse Event|0
7115029|NCT02553499|11250266|FG004|Overall Study|Adverse Event|0
7115030|NCT02553499|11250267|FG005|Overall Study|Adverse Event|0
7115031|NCT02553499|11250268|FG006|Overall Study|Adverse Event|1
7115032|NCT02553499|11250269|FG007|Overall Study|Adverse Event|1
7115033|NCT02553499|11250270|FG008|Overall Study|Adverse Event|0
7115034|NCT02553499|11250271|FG009|Overall Study|Adverse Event|0
7115035|NCT02553499|11250272|FG010|Overall Study|Adverse Event|0
7115036|NCT02553499|11250273|FG011|Overall Study|Adverse Event|0
7115037|NCT02553499|11250274|FG012|Overall Study|Adverse Event|0
7115038|NCT02553499|11250275|FG013|Overall Study|Adverse Event|1
7115039|NCT02553499|11250262|FG000|Overall Study|Death|0
7115040|NCT02553499|11250263|FG001|Overall Study|Death|1
7115041|NCT02553499|11250264|FG002|Overall Study|Death|1
7115042|NCT02553499|11250265|FG003|Overall Study|Death|0
7115043|NCT02553499|11250266|FG004|Overall Study|Death|1
7115044|NCT02553499|11250267|FG005|Overall Study|Death|2
7115045|NCT02553499|11250268|FG006|Overall Study|Death|0
7115046|NCT02553499|11250269|FG007|Overall Study|Death|0
7115047|NCT02553499|11250270|FG008|Overall Study|Death|0
7115048|NCT02553499|11250271|FG009|Overall Study|Death|0
7115049|NCT02553499|11250272|FG010|Overall Study|Death|1
7115050|NCT02553499|11250273|FG011|Overall Study|Death|0
7115051|NCT02553499|11250274|FG012|Overall Study|Death|0
7115052|NCT02553499|11250275|FG013|Overall Study|Death|0
7115053|NCT02553499|11250262|FG000|Overall Study|Lost to Follow-up|0
7115054|NCT02553499|11250263|FG001|Overall Study|Lost to Follow-up|0
7115055|NCT02553499|11250264|FG002|Overall Study|Lost to Follow-up|0
7115056|NCT02553499|11250265|FG003|Overall Study|Lost to Follow-up|0
7115057|NCT02553499|11250266|FG004|Overall Study|Lost to Follow-up|0
7115058|NCT02553499|11250267|FG005|Overall Study|Lost to Follow-up|0
7115059|NCT02553499|11250268|FG006|Overall Study|Lost to Follow-up|1
7115060|NCT02553499|11250269|FG007|Overall Study|Lost to Follow-up|0
7115061|NCT02553499|11250270|FG008|Overall Study|Lost to Follow-up|0
7115062|NCT02553499|11250271|FG009|Overall Study|Lost to Follow-up|0
7115063|NCT02553499|11250272|FG010|Overall Study|Lost to Follow-up|0
7115064|NCT02553499|11250273|FG011|Overall Study|Lost to Follow-up|0
7115065|NCT02553499|11250274|FG012|Overall Study|Lost to Follow-up|0
7115066|NCT02553499|11250275|FG013|Overall Study|Lost to Follow-up|0
7115067|NCT02553499|11250262|FG000|Overall Study|Physician Decision|0
7115068|NCT02553499|11250263|FG001|Overall Study|Physician Decision|1
7115069|NCT02553499|11250264|FG002|Overall Study|Physician Decision|1
7115070|NCT02553499|11250265|FG003|Overall Study|Physician Decision|0
7115071|NCT02553499|11250266|FG004|Overall Study|Physician Decision|1
7115072|NCT02553499|11250267|FG005|Overall Study|Physician Decision|0
7115073|NCT02553499|11250268|FG006|Overall Study|Physician Decision|0
7115074|NCT02553499|11250269|FG007|Overall Study|Physician Decision|1
7115075|NCT02553499|11250270|FG008|Overall Study|Physician Decision|1
7115076|NCT02553499|11250271|FG009|Overall Study|Physician Decision|2
7115077|NCT02553499|11250272|FG010|Overall Study|Physician Decision|1
7115078|NCT02553499|11250273|FG011|Overall Study|Physician Decision|3
7115079|NCT02553499|11250274|FG012|Overall Study|Physician Decision|1
7115080|NCT02553499|11250275|FG013|Overall Study|Physician Decision|0
7115081|NCT02553499|11250262|FG000|Overall Study|Progressive Disease|0
7115082|NCT02553499|11250263|FG001|Overall Study|Progressive Disease|0
7115083|NCT02553499|11250264|FG002|Overall Study|Progressive Disease|0
7115084|NCT02553499|11250265|FG003|Overall Study|Progressive Disease|2
7115085|NCT02553499|11250266|FG004|Overall Study|Progressive Disease|1
7115086|NCT02553499|11250267|FG005|Overall Study|Progressive Disease|1
7115087|NCT02553499|11250268|FG006|Overall Study|Progressive Disease|1
7115088|NCT02553499|11250269|FG007|Overall Study|Progressive Disease|0
7115089|NCT02553499|11250270|FG008|Overall Study|Progressive Disease|0
7115090|NCT02553499|11250271|FG009|Overall Study|Progressive Disease|1
7115091|NCT02553499|11250272|FG010|Overall Study|Progressive Disease|0
7115092|NCT02553499|11250273|FG011|Overall Study|Progressive Disease|0
7115093|NCT02553499|11250274|FG012|Overall Study|Progressive Disease|2
7115094|NCT02553499|11250275|FG013|Overall Study|Progressive Disease|1
7115095|NCT02553499|11250262|FG000|Overall Study|Study Terminated by Sponsor|0
7115096|NCT02553499|11250263|FG001|Overall Study|Study Terminated by Sponsor|0
7115097|NCT02553499|11250264|FG002|Overall Study|Study Terminated by Sponsor|0
7115098|NCT02553499|11250265|FG003|Overall Study|Study Terminated by Sponsor|0
7115099|NCT02553499|11250266|FG004|Overall Study|Study Terminated by Sponsor|0
7115100|NCT02553499|11250267|FG005|Overall Study|Study Terminated by Sponsor|0
7115101|NCT02553499|11250268|FG006|Overall Study|Study Terminated by Sponsor|0
7115102|NCT02553499|11250269|FG007|Overall Study|Study Terminated by Sponsor|0
7115103|NCT02553499|11250270|FG008|Overall Study|Study Terminated by Sponsor|1
7115104|NCT02553499|11250271|FG009|Overall Study|Study Terminated by Sponsor|0
7115105|NCT02553499|11250272|FG010|Overall Study|Study Terminated by Sponsor|0
7115106|NCT02553499|11250273|FG011|Overall Study|Study Terminated by Sponsor|0
7115107|NCT02553499|11250274|FG012|Overall Study|Study Terminated by Sponsor|0
7115108|NCT02553499|11250275|FG013|Overall Study|Study Terminated by Sponsor|0
7115109|NCT02553499|11250262|FG000|Overall Study|Withdrawal by Subject|2
7115110|NCT02553499|11250263|FG001|Overall Study|Withdrawal by Subject|0
7115111|NCT02553499|11250264|FG002|Overall Study|Withdrawal by Subject|0
7115112|NCT02553499|11250265|FG003|Overall Study|Withdrawal by Subject|0
7115113|NCT02553499|11250266|FG004|Overall Study|Withdrawal by Subject|0
7115114|NCT02553499|11250267|FG005|Overall Study|Withdrawal by Subject|0
7115115|NCT02553499|11250268|FG006|Overall Study|Withdrawal by Subject|0
7115116|NCT02553499|11250269|FG007|Overall Study|Withdrawal by Subject|1
7115117|NCT02553499|11250270|FG008|Overall Study|Withdrawal by Subject|1
7115118|NCT02553499|11250271|FG009|Overall Study|Withdrawal by Subject|0
7115119|NCT02553499|11250272|FG010|Overall Study|Withdrawal by Subject|1
7115120|NCT02553499|11250273|FG011|Overall Study|Withdrawal by Subject|0
7115121|NCT02553499|11250274|FG012|Overall Study|Withdrawal by Subject|0
7115122|NCT02553499|11250275|FG013|Overall Study|Withdrawal by Subject|0
7115123|NCT02553538|11250312|FG000|Overall Study|Could Not Reach by Telephone|133
7115124|NCT02553538|11250313|FG001|Overall Study|Could Not Reach by Telephone|0
7115125|NCT02553538|11250312|FG000|Overall Study|Died or Left Network|54
7115126|NCT02553538|11250313|FG001|Overall Study|Died or Left Network|56
7115127|NCT02553629|11250321|FG000|Overall Study|Logistic reasons|3
7115128|NCT02553629|11250322|FG001|Overall Study|Logistic reasons|6
7115129|NCT02553772|11250339|FG000|Overall Study|Adverse Event|2
7115130|NCT02553772|11250340|FG001|Overall Study|Adverse Event|3
7115131|NCT02553772|11250339|FG000|Overall Study|Lost to Follow-up|2
7115132|NCT02553772|11250340|FG001|Overall Study|Lost to Follow-up|1
7115133|NCT02553772|11250339|FG000|Overall Study|Withdrawal of Consent|1
7115134|NCT02553772|11250340|FG001|Overall Study|Withdrawal of Consent|1
7115135|NCT02553772|11250339|FG000|Overall Study|Lack of Efficacy|1
7115136|NCT02553772|11250340|FG001|Overall Study|Lack of Efficacy|0
7115137|NCT02553772|11250339|FG000|Overall Study|Other Miscellaneous Reasons|0
7115138|NCT02553772|11250340|FG001|Overall Study|Other Miscellaneous Reasons|1
7115139|NCT02553928|11250352|FG000|Overall Study|Adverse Event|2
7115140|NCT02553928|11250353|FG001|Overall Study|Adverse Event|1
7115141|NCT02553928|11250352|FG000|Overall Study|Lost to Follow-up|0
7115142|NCT02553928|11250353|FG001|Overall Study|Lost to Follow-up|1
7115143|NCT02553928|11250352|FG000|Overall Study|Administrative reason(s)|0
7115144|NCT02553928|11250353|FG001|Overall Study|Administrative reason(s)|1
7115145|NCT02554019|11250363|FG000|Overall Study|Withdrawal by Subject|1
7115146|NCT02554019|11250364|FG001|Overall Study|Withdrawal by Subject|0
7115147|NCT02554019|11250365|FG002|Overall Study|Withdrawal by Subject|2
7115148|NCT02554019|11250363|FG000|Overall Study|Adverse Event|1
7115149|NCT02554019|11250364|FG001|Overall Study|Adverse Event|0
7115150|NCT02554019|11250365|FG002|Overall Study|Adverse Event|0
7115151|NCT02554279|11250375|FG000|Overall Study|Adverse Event|2
7115152|NCT02554279|11250376|FG001|Overall Study|Adverse Event|5
7115153|NCT02554279|11250375|FG000|Overall Study|Lost to Follow-up|3
7115154|NCT02554279|11250376|FG001|Overall Study|Lost to Follow-up|2
7115155|NCT02554279|11250375|FG000|Overall Study|Withdrawal by Subject|6
7115156|NCT02554279|11250376|FG001|Overall Study|Withdrawal by Subject|4
7115157|NCT02554279|11250375|FG000|Overall Study|Protocol Violation|2
7115158|NCT02554279|11250376|FG001|Overall Study|Protocol Violation|1
7115159|NCT02554279|11250375|FG000|Overall Study|Other reason|19
7115160|NCT02554279|11250376|FG001|Overall Study|Other reason|6
7115161|NCT02554513|11250399|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0
7115162|NCT02554513|11250400|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1
7115163|NCT02554656|11250412|FG000|Overall Study|Protocol Violation|3
7115164|NCT02554682|11250426|FG000|Overall Study|Lost to Follow-up|11
7115165|NCT02554682|11250427|FG001|Overall Study|Lost to Follow-up|9
7115166|NCT02554682|11250428|FG002|Overall Study|Lost to Follow-up|4
7115167|NCT02554682|11250429|FG003|Overall Study|Lost to Follow-up|3
7115168|NCT02554682|11250430|FG004|Overall Study|Lost to Follow-up|2
7115169|NCT02554682|11250431|FG005|Overall Study|Lost to Follow-up|1
7115170|NCT02554682|11250432|FG006|Overall Study|Lost to Follow-up|6
7115171|NCT02554682|11250433|FG007|Overall Study|Lost to Follow-up|6
7115172|NCT02554682|11250434|FG008|Overall Study|Lost to Follow-up|2
7115173|NCT02554682|11250435|FG009|Overall Study|Lost to Follow-up|2
7115174|NCT02554682|11250426|FG000|Overall Study|Withdrawal by Subject|2
7115175|NCT02554682|11250427|FG001|Overall Study|Withdrawal by Subject|1
7115176|NCT02554682|11250428|FG002|Overall Study|Withdrawal by Subject|0
7115177|NCT02554682|11250429|FG003|Overall Study|Withdrawal by Subject|0
7115178|NCT02554682|11250430|FG004|Overall Study|Withdrawal by Subject|0
7115179|NCT02554682|11250431|FG005|Overall Study|Withdrawal by Subject|0
7115180|NCT02554682|11250432|FG006|Overall Study|Withdrawal by Subject|0
7115181|NCT02554682|11250433|FG007|Overall Study|Withdrawal by Subject|0
7115182|NCT02554682|11250434|FG008|Overall Study|Withdrawal by Subject|0
7115183|NCT02554682|11250435|FG009|Overall Study|Withdrawal by Subject|0
7115184|NCT02554682|11250426|FG000|Overall Study|Physician Decision|2
7115185|NCT02554682|11250427|FG001|Overall Study|Physician Decision|2
7115186|NCT02554682|11250428|FG002|Overall Study|Physician Decision|0
7115187|NCT02554682|11250429|FG003|Overall Study|Physician Decision|0
7115188|NCT02554682|11250430|FG004|Overall Study|Physician Decision|0
7115189|NCT02554682|11250431|FG005|Overall Study|Physician Decision|0
7115190|NCT02554682|11250432|FG006|Overall Study|Physician Decision|0
7115191|NCT02554682|11250433|FG007|Overall Study|Physician Decision|0
7115192|NCT02554682|11250434|FG008|Overall Study|Physician Decision|0
7115193|NCT02554682|11250435|FG009|Overall Study|Physician Decision|0
7115194|NCT02554721|11250465|FG000|Overall Study|Adverse Event|1
7115195|NCT02554721|11250466|FG001|Overall Study|Adverse Event|0
7115196|NCT02554721|11250467|FG002|Overall Study|Adverse Event|0
7115197|NCT02554721|11250468|FG003|Overall Study|Adverse Event|0
7115198|NCT02554721|11250469|FG004|Overall Study|Adverse Event|1
7115199|NCT02554721|11250465|FG000|Overall Study|Noncompliance|0
7115200|NCT02554721|11250466|FG001|Overall Study|Noncompliance|0
7115201|NCT02554721|11250467|FG002|Overall Study|Noncompliance|0
7115202|NCT02554721|11250468|FG003|Overall Study|Noncompliance|0
7115203|NCT02554721|11250469|FG004|Overall Study|Noncompliance|1
7115204|NCT02554786|11250493|FG000|Overall Study|Subject/guardian decision|29
7115205|NCT02554786|11250494|FG001|Overall Study|Subject/guardian decision|17
7115206|NCT02554786|11250495|FG002|Overall Study|Subject/guardian decision|18
7115207|NCT02554786|11250496|FG003|Overall Study|Subject/guardian decision|30
7115208|NCT02554786|11250497|FG004|Overall Study|Subject/guardian decision|20
7115209|NCT02554786|11250493|FG000|Overall Study|Lost to Follow-up|4
7115210|NCT02554786|11250494|FG001|Overall Study|Lost to Follow-up|3
7115211|NCT02554786|11250495|FG002|Overall Study|Lost to Follow-up|4
7115212|NCT02554786|11250496|FG003|Overall Study|Lost to Follow-up|2
7115213|NCT02554786|11250497|FG004|Overall Study|Lost to Follow-up|2
7115214|NCT02554786|11250493|FG000|Overall Study|Protocol deviation|1
7115215|NCT02554786|11250494|FG001|Overall Study|Protocol deviation|3
7115216|NCT02554786|11250495|FG002|Overall Study|Protocol deviation|3
7115217|NCT02554786|11250496|FG003|Overall Study|Protocol deviation|4
7115218|NCT02554786|11250497|FG004|Overall Study|Protocol deviation|2
7115219|NCT02554786|11250493|FG000|Overall Study|Technical problems|1
7115220|NCT02554786|11250494|FG001|Overall Study|Technical problems|1
7115221|NCT02554786|11250495|FG002|Overall Study|Technical problems|0
7115222|NCT02554786|11250496|FG003|Overall Study|Technical problems|2
7115223|NCT02554786|11250497|FG004|Overall Study|Technical problems|1
7115224|NCT02554786|11250493|FG000|Overall Study|Adverse Event|0
7115225|NCT02554786|11250494|FG001|Overall Study|Adverse Event|0
7115226|NCT02554786|11250495|FG002|Overall Study|Adverse Event|0
7115227|NCT02554786|11250496|FG003|Overall Study|Adverse Event|0
7115228|NCT02554786|11250497|FG004|Overall Study|Adverse Event|2
7115229|NCT02554786|11250493|FG000|Overall Study|Death|0
7115230|NCT02554786|11250494|FG001|Overall Study|Death|0
7115231|NCT02554786|11250495|FG002|Overall Study|Death|0
7115232|NCT02554786|11250496|FG003|Overall Study|Death|1
7115233|NCT02554786|11250497|FG004|Overall Study|Death|0
7115234|NCT02554786|11250493|FG000|Overall Study|Non-compliance with study treatment|0
7115235|NCT02554786|11250494|FG001|Overall Study|Non-compliance with study treatment|1
7115236|NCT02554786|11250495|FG002|Overall Study|Non-compliance with study treatment|1
7115237|NCT02554786|11250496|FG003|Overall Study|Non-compliance with study treatment|0
7115238|NCT02554786|11250497|FG004|Overall Study|Non-compliance with study treatment|1
7115239|NCT02554786|11250493|FG000|Overall Study|Physician Decision|0
7115240|NCT02554786|11250494|FG001|Overall Study|Physician Decision|1
7115241|NCT02554786|11250495|FG002|Overall Study|Physician Decision|4
7115242|NCT02554786|11250496|FG003|Overall Study|Physician Decision|1
7115243|NCT02554786|11250497|FG004|Overall Study|Physician Decision|1
7115244|NCT02554786|11250493|FG000|Overall Study|Pregnancy|0
7115245|NCT02554786|11250494|FG001|Overall Study|Pregnancy|0
7115246|NCT02554786|11250495|FG002|Overall Study|Pregnancy|0
7115247|NCT02554786|11250496|FG003|Overall Study|Pregnancy|1
7115248|NCT02554786|11250497|FG004|Overall Study|Pregnancy|1
7115249|NCT02554877|11250526|FG000|Overall Study|Adverse Event|2
7115250|NCT02554877|11250527|FG001|Overall Study|Adverse Event|0
7115251|NCT02554877|11250528|FG002|Overall Study|Adverse Event|0
7115252|NCT02554877|11250529|FG003|Overall Study|Adverse Event|1
7115253|NCT02554877|11250526|FG000|Overall Study|Lost to Follow-up|1
7115254|NCT02554877|11250527|FG001|Overall Study|Lost to Follow-up|1
7115255|NCT02554877|11250528|FG002|Overall Study|Lost to Follow-up|1
7115256|NCT02554877|11250529|FG003|Overall Study|Lost to Follow-up|2
7115257|NCT02554877|11250526|FG000|Overall Study|Did not meet entrance criteria|0
7115258|NCT02554877|11250527|FG001|Overall Study|Did not meet entrance criteria|0
7115259|NCT02554877|11250528|FG002|Overall Study|Did not meet entrance criteria|1
7115260|NCT02554877|11250529|FG003|Overall Study|Did not meet entrance criteria|0
7115261|NCT02554877|11250526|FG000|Overall Study|No longer met eligibility criteria|1
7115262|NCT02554877|11250527|FG001|Overall Study|No longer met eligibility criteria|0
7115263|NCT02554877|11250528|FG002|Overall Study|No longer met eligibility criteria|1
7115264|NCT02554877|11250529|FG003|Overall Study|No longer met eligibility criteria|1
7115265|NCT02554877|11250526|FG000|Overall Study|Protocol Violation|3
7115266|NCT02554877|11250527|FG001|Overall Study|Protocol Violation|1
7115267|NCT02554877|11250528|FG002|Overall Study|Protocol Violation|1
7115268|NCT02554877|11250529|FG003|Overall Study|Protocol Violation|0
7115269|NCT02554877|11250526|FG000|Overall Study|Other|1
7115270|NCT02554877|11250527|FG001|Overall Study|Other|3
7115271|NCT02554877|11250528|FG002|Overall Study|Other|0
7115272|NCT02554877|11250529|FG003|Overall Study|Other|3
7115273|NCT02554877|11250526|FG000|Overall Study|Insufficient clinical response|4
7115274|NCT02554877|11250527|FG001|Overall Study|Insufficient clinical response|0
7115275|NCT02554877|11250528|FG002|Overall Study|Insufficient clinical response|0
7115276|NCT02554877|11250529|FG003|Overall Study|Insufficient clinical response|0
7115277|NCT02554877|11250526|FG000|Overall Study|No longer willing to participate|0
7115278|NCT02554877|11250527|FG001|Overall Study|No longer willing to participate|2
7115279|NCT02554877|11250528|FG002|Overall Study|No longer willing to participate|2
7115280|NCT02554877|11250529|FG003|Overall Study|No longer willing to participate|0
7115281|NCT02554890|11250541|FG000|Double-blind|Adverse Event|45
7115282|NCT02554890|11250542|FG001|Double-blind|Adverse Event|51
7115283|NCT02554890|11250541|FG000|Double-blind|Death|6
7115284|NCT02554890|11250542|FG001|Double-blind|Death|4
7115285|NCT02554890|11250541|FG000|Double-blind|Protocol Violation|1
7115286|NCT02554890|11250542|FG001|Double-blind|Protocol Violation|1
7115287|NCT02554890|11250541|FG000|Double-blind|Physician Decision|4
7115288|NCT02554890|11250542|FG001|Double-blind|Physician Decision|3
7115289|NCT02554890|11250541|FG000|Double-blind|Subject/Guardian decision|21
7115290|NCT02554890|11250542|FG001|Double-blind|Subject/Guardian decision|16
7115291|NCT02554890|11250541|FG000|Double-blind|Lost to Follow-up|7
7115292|NCT02554890|11250542|FG001|Double-blind|Lost to Follow-up|5
7115293|NCT02554890|11250541|FG000|Double-blind|Technical problems|1
7115294|NCT02554890|11250542|FG001|Double-blind|Technical problems|0
7115295|NCT02554890|11250541|FG000|Double-blind|Withdrawal by Subject|5
7115296|NCT02554890|11250542|FG001|Double-blind|Withdrawal by Subject|6
7115297|NCT02554890|11250541|FG000|Double-blind|Noncompliance with study treatment|6
7115298|NCT02554890|11250542|FG001|Double-blind|Noncompliance with study treatment|5
7115299|NCT02554890|11250541|FG000|Open-label|Adverse Event|0
7115300|NCT02554890|11250542|FG001|Open-label|Adverse Event|30
7115301|NCT02554890|11250541|FG000|Open-label|Death|0
7115302|NCT02554890|11250542|FG001|Open-label|Death|1
7115303|NCT02554890|11250541|FG000|Open-label|Physician Decision|0
7115304|NCT02554890|11250542|FG001|Open-label|Physician Decision|1
7115305|NCT02554890|11250541|FG000|Open-label|Subject/Guardian decision|0
7115306|NCT02554890|11250542|FG001|Open-label|Subject/Guardian decision|11
7115307|NCT02554890|11250541|FG000|Open-label|Lost to Follow-up|0
7115308|NCT02554890|11250542|FG001|Open-label|Lost to Follow-up|7
7115309|NCT02554890|11250541|FG000|Open-label|Technical problems|0
7115310|NCT02554890|11250542|FG001|Open-label|Technical problems|1
7115311|NCT02554890|11250541|FG000|Open-label|Withdrawal by Subject|0
7115312|NCT02554890|11250542|FG001|Open-label|Withdrawal by Subject|1
7115313|NCT02554903|11250552|FG000|Overall Study|Death|1
7115314|NCT02554903|11250553|FG001|Overall Study|Death|1
7115315|NCT02554903|11250552|FG000|Overall Study|Physician Decision|2
7115316|NCT02554903|11250553|FG001|Overall Study|Physician Decision|2
7115317|NCT02554903|11250552|FG000|Overall Study|Heart Transplant|1
7115318|NCT02554903|11250553|FG001|Overall Study|Heart Transplant|2
7115319|NCT02554929|11250562|FG000|Overall Study|Lost to Follow-up|4
7115320|NCT02554929|11250563|FG001|Overall Study|Lost to Follow-up|4
7115321|NCT02554929|11250562|FG000|Overall Study|Withdrawal by Subject|2
7115322|NCT02554929|11250563|FG001|Overall Study|Withdrawal by Subject|8
7115323|NCT02554981|11250569|FG000|Overall Study|Adverse Event|1
7115324|NCT02554981|11250569|FG000|Overall Study|Administrative Reasons|1
7115325|NCT02554981|11250569|FG000|Overall Study|Other Miscellaneous Reasons|3
7115326|NCT02555215|11250584|FG000|Overall Study|Other|1
7115327|NCT02555215|11250584|FG000|Overall Study|Investigator Decision|2
7115328|NCT02555371|11250614|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1
7115329|NCT02555371|11250615|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
7115330|NCT02555371|11250616|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
7115331|NCT02555371|11250617|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
7115332|NCT02555371|11250618|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
7115333|NCT02555371|11250614|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2
7115334|NCT02555371|11250615|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
7115335|NCT02555371|11250616|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
7115336|NCT02555371|11250617|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
7115337|NCT02555371|11250618|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
7115338|NCT02555371|11250614|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5
7115339|NCT02555371|11250615|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
7115340|NCT02555371|11250616|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
7115341|NCT02555371|11250617|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
7115342|NCT02555371|11250618|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
7115343|NCT02555371|11250614|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1
7115344|NCT02555371|11250615|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
7115345|NCT02555371|11250616|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
7115346|NCT02555371|11250617|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
7115347|NCT02555371|11250618|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
7115348|NCT02555371|11250614|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2
7115349|NCT02555371|11250615|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
7115350|NCT02555371|11250616|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
7115351|NCT02555371|11250617|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
7115352|NCT02555371|11250618|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
7115353|NCT02555371|11250614|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
7115354|NCT02555371|11250615|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84
7115355|NCT02555371|11250616|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45
7115356|NCT02555371|11250617|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
7115357|NCT02555371|11250618|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
7115358|NCT02555371|11250614|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
7115359|NCT02555371|11250615|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2
7115360|NCT02555371|11250616|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2
7115361|NCT02555371|11250617|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
7115362|NCT02555371|11250618|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
7115363|NCT02555371|11250614|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
7115364|NCT02555371|11250615|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1
7115365|NCT02555371|11250616|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
7115366|NCT02555371|11250617|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
7115367|NCT02555371|11250618|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
7115368|NCT02555371|11250614|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0
7115369|NCT02555371|11250615|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2
7115370|NCT02555371|11250616|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1
7115371|NCT02555371|11250617|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0
7115372|NCT02555371|11250618|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0
7115373|NCT02555371|11250614|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
7115374|NCT02555371|11250615|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
7115375|NCT02555371|11250616|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
7115376|NCT02555371|11250617|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1
7115377|NCT02555371|11250618|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
7115378|NCT02555371|11250614|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
7115379|NCT02555371|11250615|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
7115380|NCT02555371|11250616|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
7115381|NCT02555371|11250617|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2
7115382|NCT02555371|11250618|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
7115383|NCT02555371|11250614|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
7115384|NCT02555371|11250615|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
7115385|NCT02555371|11250616|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
7115386|NCT02555371|11250617|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
7115387|NCT02555371|11250618|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2
7115388|NCT02555371|11250614|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
7115389|NCT02555371|11250615|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
7115390|NCT02555371|11250616|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
7115391|NCT02555371|11250617|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
7115392|NCT02555371|11250618|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1
7115393|NCT02555371|11250614|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
7115394|NCT02555371|11250615|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
7115395|NCT02555371|11250616|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
7115396|NCT02555371|11250617|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1
7115397|NCT02555371|11250618|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
7115398|NCT02555618|11250633|FG000|Overall Study|Sponsor's Circumstances|1
7115399|NCT02555618|11250634|FG001|Overall Study|Sponsor's Circumstances|0
7115400|NCT02555683|11250647|FG000|Overall Study|Physician Decision|1
7115401|NCT02555683|11250648|FG001|Overall Study|Physician Decision|0
7115402|NCT02555683|11250649|FG002|Overall Study|Physician Decision|2
7115403|NCT02555683|11250647|FG000|Overall Study|Lost to Follow-up|2
7115404|NCT02555683|11250648|FG001|Overall Study|Lost to Follow-up|1
7115405|NCT02555683|11250649|FG002|Overall Study|Lost to Follow-up|2
7115406|NCT02555683|11250647|FG000|Overall Study|Technical Problems|1
7115407|NCT02555683|11250648|FG001|Overall Study|Technical Problems|1
7115408|NCT02555683|11250649|FG002|Overall Study|Technical Problems|0
7115409|NCT02555683|11250647|FG000|Overall Study|Protocol deviation|0
7115410|NCT02555683|11250648|FG001|Overall Study|Protocol deviation|1
7115411|NCT02555683|11250649|FG002|Overall Study|Protocol deviation|0
7115412|NCT02555683|11250647|FG000|Overall Study|Lack of Efficacy|2
7115413|NCT02555683|11250648|FG001|Overall Study|Lack of Efficacy|0
7115414|NCT02555683|11250649|FG002|Overall Study|Lack of Efficacy|0
7115415|NCT02555683|11250647|FG000|Overall Study|Death|0
7115416|NCT02555683|11250648|FG001|Overall Study|Death|1
7115417|NCT02555683|11250649|FG002|Overall Study|Death|2
7115418|NCT02555683|11250647|FG000|Overall Study|Adverse Event|1
7115419|NCT02555683|11250648|FG001|Overall Study|Adverse Event|0
7115420|NCT02555683|11250649|FG002|Overall Study|Adverse Event|1
7115421|NCT02555683|11250647|FG000|Overall Study|Subject/guardian decision|12
7115422|NCT02555683|11250648|FG001|Overall Study|Subject/guardian decision|12
7115423|NCT02555683|11250649|FG002|Overall Study|Subject/guardian decision|22
7115424|NCT02555683|11250647|FG000|Overall Study|Death post Treatment/safety period|0
7115425|NCT02555683|11250648|FG001|Overall Study|Death post Treatment/safety period|1
7115426|NCT02555683|11250649|FG002|Overall Study|Death post Treatment/safety period|0
7115427|NCT02555722|11250659|FG000|Week 2|Adverse Event|0
7115428|NCT02555722|11250660|FG001|Week 2|Adverse Event|1
7115429|NCT02555722|11250659|FG000|Week 2|Withdrawal by Subject|1
7115430|NCT02555722|11250660|FG001|Week 2|Withdrawal by Subject|0
7115431|NCT02555722|11250659|FG000|Month 1|Lens Discomfort|1
7115432|NCT02555722|11250660|FG001|Month 1|Lens Discomfort|0
7115433|NCT02555722|11250659|FG000|Month 2|Withdrawal by Subject|3
7115434|NCT02555722|11250660|FG001|Month 2|Withdrawal by Subject|0
7115435|NCT02555722|11250659|FG000|Month 2|Lost to Follow-up|1
7115436|NCT02555722|11250660|FG001|Month 2|Lost to Follow-up|0
7115437|NCT02555878|11250691|FG000|Overall Study|Lost to Follow-up|2
7115438|NCT02555878|11250692|FG001|Overall Study|Lost to Follow-up|3
7115439|NCT02555878|11250691|FG000|Overall Study|Withdrawal by Subject|48
7115440|NCT02555878|11250692|FG001|Overall Study|Withdrawal by Subject|48
7115441|NCT02555878|11250691|FG000|Overall Study|Adverse Event|12
7115442|NCT02555878|11250692|FG001|Overall Study|Adverse Event|8
7115443|NCT02555878|11250691|FG000|Overall Study|Death|74
7115444|NCT02555878|11250692|FG001|Overall Study|Death|59
7115445|NCT02555878|11250691|FG000|Overall Study|Protocol Violation|1
7115446|NCT02555878|11250692|FG001|Overall Study|Protocol Violation|2
7115447|NCT02555878|11250691|FG000|Overall Study|Physician Decision|12
7115448|NCT02555878|11250692|FG001|Overall Study|Physician Decision|13
7115449|NCT02555878|11250691|FG000|Overall Study|Other|17
7115450|NCT02555878|11250692|FG001|Overall Study|Other|17
7115451|NCT02556138|11250717|FG000|Overall Study|Withdrawal by Subject|1
7115452|NCT02556177|11250723|FG000|Overall Study|Subjects did not complete all 4 visits|283
7115453|NCT02556177|11250724|FG001|Overall Study|Subjects did not complete all 4 visits|61
7115454|NCT02556203|11250732|FG000|Overall Study|Withdrawal by Subject|21
7115455|NCT02556203|11250733|FG001|Overall Study|Withdrawal by Subject|21
7115456|NCT02556203|11250732|FG000|Overall Study|Lost to Follow-up|5
7115457|NCT02556203|11250733|FG001|Overall Study|Lost to Follow-up|5
7115458|NCT02556203|11250732|FG000|Overall Study|Adverse Event|1
7115459|NCT02556203|11250733|FG001|Overall Study|Adverse Event|0
7115460|NCT02556255|11250739|FG000|Overall Study|Lost to Follow-up|4
7115461|NCT02556307|11250743|FG000|Overall Study|Premature treatment interruption|11
7115462|NCT02556307|11250743|FG000|Overall Study|Lost to Follow-up|36
7115463|NCT02556307|11250743|FG000|Overall Study|Change to triple therapy|4
7115464|NCT02556307|11250743|FG000|Overall Study|Enrolled but not treated|2
7115465|NCT02556632|11250772|FG000|Overall Study|Lost to Follow-up|1
7115466|NCT02556632|11250773|FG001|Overall Study|Lost to Follow-up|0
7115467|NCT02556632|11250774|FG002|Overall Study|Lost to Follow-up|0
7115468|NCT02556632|11250772|FG000|Overall Study|Disliked Intervention|1
7115469|NCT02556632|11250773|FG001|Overall Study|Disliked Intervention|1
7115470|NCT02556632|11250774|FG002|Overall Study|Disliked Intervention|1
7115471|NCT02556632|11250772|FG000|Overall Study|No Reason|1
7115472|NCT02556632|11250773|FG001|Overall Study|No Reason|0
7115473|NCT02556632|11250774|FG002|Overall Study|No Reason|1
7115474|NCT02556632|11250772|FG000|Overall Study|Personal Issues|0
7115475|NCT02556632|11250773|FG001|Overall Study|Personal Issues|1
7115476|NCT02556632|11250774|FG002|Overall Study|Personal Issues|1
7115477|NCT02556632|11250772|FG000|Overall Study|Changed Mind|0
7115478|NCT02556632|11250773|FG001|Overall Study|Changed Mind|1
7115479|NCT02556632|11250774|FG002|Overall Study|Changed Mind|0
7115480|NCT02556632|11250772|FG000|Overall Study|Withdrew (Unrelated Medical)|1
7115481|NCT02556632|11250773|FG001|Overall Study|Withdrew (Unrelated Medical)|0
7115482|NCT02556632|11250774|FG002|Overall Study|Withdrew (Unrelated Medical)|0
7115483|NCT02556632|11250772|FG000|Overall Study|Unrelated Adverse Event|1
7115484|NCT02556632|11250773|FG001|Overall Study|Unrelated Adverse Event|0
7115485|NCT02556632|11250774|FG002|Overall Study|Unrelated Adverse Event|3
7115486|NCT02556632|11250772|FG000|Overall Study|Related Adverse Event|0
7115487|NCT02556632|11250773|FG001|Overall Study|Related Adverse Event|1
7115488|NCT02556632|11250774|FG002|Overall Study|Related Adverse Event|0
7115489|NCT02556632|11250772|FG000|Overall Study|Possibly Related Adverse Event|0
7115490|NCT02556632|11250773|FG001|Overall Study|Possibly Related Adverse Event|0
7115491|NCT02556632|11250774|FG002|Overall Study|Possibly Related Adverse Event|1
7115492|NCT02556632|11250772|FG000|Overall Study|Did Not Start RT|0
7115493|NCT02556632|11250773|FG001|Overall Study|Did Not Start RT|1
7115494|NCT02556632|11250774|FG002|Overall Study|Did Not Start RT|0
7115495|NCT02556632|11250772|FG000|Overall Study|Ineligible|0
7115496|NCT02556632|11250773|FG001|Overall Study|Ineligible|1
7115497|NCT02556632|11250774|FG002|Overall Study|Ineligible|0
7115498|NCT02556632|11250772|FG000|Overall Study|Disliked Study Procedures|0
7115499|NCT02556632|11250773|FG001|Overall Study|Disliked Study Procedures|0
7115500|NCT02556632|11250774|FG002|Overall Study|Disliked Study Procedures|1
7115501|NCT02556632|11250772|FG000|Overall Study|Treatment or Change Delay|0
7115502|NCT02556632|11250773|FG001|Overall Study|Treatment or Change Delay|0
7115503|NCT02556632|11250774|FG002|Overall Study|Treatment or Change Delay|1
7115504|NCT02556775|11250786|FG000|Overall Study|Withdrawal by Subject|1
7115505|NCT02556775|11250787|FG001|Overall Study|Withdrawal by Subject|0
7115506|NCT02556775|11250788|FG002|Overall Study|Withdrawal by Subject|1
7115507|NCT02556775|11250789|FG003|Overall Study|Withdrawal by Subject|0
7115508|NCT02556775|11250786|FG000|Overall Study|Lost to Follow-up|1
7115509|NCT02556775|11250787|FG001|Overall Study|Lost to Follow-up|0
7115510|NCT02556775|11250788|FG002|Overall Study|Lost to Follow-up|0
7115511|NCT02556775|11250789|FG003|Overall Study|Lost to Follow-up|0
7115512|NCT02556801|11250814|FG000|Overall Study|Lost to Follow-up|1
7115513|NCT02556801|11250815|FG001|Overall Study|Lost to Follow-up|0
7115514|NCT02556801|11250816|FG002|Overall Study|Lost to Follow-up|2
7115515|NCT02556801|11250817|FG003|Overall Study|Lost to Follow-up|0
7115516|NCT02556801|11250814|FG000|Overall Study|Withdrawal by Subject|1
7115517|NCT02556801|11250815|FG001|Overall Study|Withdrawal by Subject|1
7115518|NCT02556801|11250816|FG002|Overall Study|Withdrawal by Subject|1
7115519|NCT02556801|11250817|FG003|Overall Study|Withdrawal by Subject|0
7115520|NCT02556801|11250814|FG000|Overall Study|Protocol Violation|0
7115521|NCT02556801|11250815|FG001|Overall Study|Protocol Violation|3
7115522|NCT02556801|11250816|FG002|Overall Study|Protocol Violation|1
7115523|NCT02556801|11250817|FG003|Overall Study|Protocol Violation|1
7115524|NCT02556801|11250814|FG000|Overall Study|Adverse Event|0
7115525|NCT02556801|11250815|FG001|Overall Study|Adverse Event|2
7115526|NCT02556801|11250816|FG002|Overall Study|Adverse Event|0
7115527|NCT02556801|11250817|FG003|Overall Study|Adverse Event|3
7115528|NCT02556801|11250814|FG000|Overall Study|Pregnancy|0
7115529|NCT02556801|11250815|FG001|Overall Study|Pregnancy|1
7115530|NCT02556801|11250816|FG002|Overall Study|Pregnancy|0
7115531|NCT02556801|11250817|FG003|Overall Study|Pregnancy|0
7115532|NCT02556801|11250814|FG000|Overall Study|Personal reasons patient|0
7115533|NCT02556801|11250815|FG001|Overall Study|Personal reasons patient|0
7115534|NCT02556801|11250816|FG002|Overall Study|Personal reasons patient|0
7115535|NCT02556801|11250817|FG003|Overall Study|Personal reasons patient|1
7115536|NCT02556918|11250829|FG000|Overall Study|Protocol Violation|5
7115537|NCT02556918|11250830|FG001|Overall Study|Protocol Violation|6
7115538|NCT02556918|11250829|FG000|Overall Study|Withdrawal by Subject|4
7115539|NCT02556918|11250830|FG001|Overall Study|Withdrawal by Subject|4
7115540|NCT02557100|11250849|FG000|Single Blind Treatment Period|Lost to Follow-up|0
7115541|NCT02557100|11250850|FG001|Single Blind Treatment Period|Lost to Follow-up|1
7115542|NCT02557100|11250851|FG002|Single Blind Treatment Period|Lost to Follow-up|0
7115543|NCT02557100|11250849|FG000|Single Blind Treatment Period|Death|0
7115544|NCT02557100|11250850|FG001|Single Blind Treatment Period|Death|1
7115545|NCT02557100|11250851|FG002|Single Blind Treatment Period|Death|0
7115546|NCT02557100|11250849|FG000|Single Blind Treatment Period|Request to Discontinue|0
7115547|NCT02557100|11250850|FG001|Single Blind Treatment Period|Request to Discontinue|1
7115548|NCT02557100|11250851|FG002|Single Blind Treatment Period|Request to Discontinue|0
7115549|NCT02557100|11250849|FG000|Single Blind Treatment Period|Adverse Event|0
7115550|NCT02557100|11250850|FG001|Single Blind Treatment Period|Adverse Event|1
7115551|NCT02557100|11250851|FG002|Single Blind Treatment Period|Adverse Event|0
6805893|NCT02349386|10808118|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0
6805894|NCT02349386|10808115|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2
6805895|NCT02349386|10808116|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0
6805896|NCT02349386|10808117|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2
6805897|NCT02349386|10808118|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0
6805898|NCT02349386|10808115|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0
6805899|NCT02349386|10808116|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0
6805900|NCT02349386|10808117|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1
6805901|NCT02349386|10808118|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0
7115552|NCT02557100|11250849|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40
7115553|NCT02557100|11250850|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36
7115554|NCT02557100|11250851|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0
7115555|NCT02557100|11250849|FG000|Cumulative Abatacept Period|Other Reasons|0
7115556|NCT02557100|11250850|FG001|Cumulative Abatacept Period|Other Reasons|0
7115557|NCT02557100|11250851|FG002|Cumulative Abatacept Period|Other Reasons|1
7115558|NCT02557100|11250849|FG000|Cumulative Abatacept Period|Lost to Follow-up|0
7115559|NCT02557100|11250850|FG001|Cumulative Abatacept Period|Lost to Follow-up|0
7115560|NCT02557100|11250851|FG002|Cumulative Abatacept Period|Lost to Follow-up|2
7115561|NCT02557100|11250849|FG000|Cumulative Abatacept Period|Request to Discontinue|0
7115562|NCT02557100|11250850|FG001|Cumulative Abatacept Period|Request to Discontinue|0
7115563|NCT02557100|11250851|FG002|Cumulative Abatacept Period|Request to Discontinue|1
7115564|NCT02557399|11250870|FG000|Overall Study|Adverse Event|6
7115565|NCT02557399|11250871|FG001|Overall Study|Adverse Event|5
7115566|NCT02557399|11250870|FG000|Overall Study|Protocol Violation|0
6805902|NCT02328014|10808132|FG000|Overall Study|Adverse Event|1
6805903|NCT02328014|10808133|FG001|Overall Study|Adverse Event|0
6805904|NCT02328014|10808134|FG002|Overall Study|Adverse Event|0
6805905|NCT02328014|10808135|FG003|Overall Study|Adverse Event|1
6805906|NCT02328014|10808132|FG000|Overall Study|Death|0
7115567|NCT02557399|11250871|FG001|Overall Study|Protocol Violation|1
7115568|NCT02557399|11250870|FG000|Overall Study|Protocol-defined stopping criteria|0
7115569|NCT02557399|11250871|FG001|Overall Study|Protocol-defined stopping criteria|1
7115570|NCT02557399|11250870|FG000|Overall Study|Withdrawal by Subject|1
7115571|NCT02557399|11250871|FG001|Overall Study|Withdrawal by Subject|1
7115572|NCT02557516|11250884|FG000|Overall Study|Adverse Event|1
7115573|NCT02557516|11250885|FG001|Overall Study|Adverse Event|0
7115574|NCT02557516|11250886|FG002|Overall Study|Adverse Event|2
7115575|NCT02557516|11250887|FG003|Overall Study|Adverse Event|1
7115576|NCT02557516|11250884|FG000|Overall Study|Disease progression|0
7115577|NCT02557516|11250885|FG001|Overall Study|Disease progression|2
7115578|NCT02557516|11250886|FG002|Overall Study|Disease progression|0
7115579|NCT02557516|11250887|FG003|Overall Study|Disease progression|0
7115580|NCT02557516|11250884|FG000|Overall Study|Physician Decision|0
7115581|NCT02557516|11250885|FG001|Overall Study|Physician Decision|2
7115582|NCT02557516|11250886|FG002|Overall Study|Physician Decision|0
7115583|NCT02557516|11250887|FG003|Overall Study|Physician Decision|0
7115584|NCT02557516|11250884|FG000|Overall Study|Sponsor decision|0
7115585|NCT02557516|11250885|FG001|Overall Study|Sponsor decision|1
7115586|NCT02557516|11250886|FG002|Overall Study|Sponsor decision|2
7115587|NCT02557516|11250887|FG003|Overall Study|Sponsor decision|8
7115588|NCT02557646|11250911|FG000|Overall Study|Adverse Event|40
7115589|NCT02557646|11250911|FG000|Overall Study|Death|1
7115590|NCT02557646|11250911|FG000|Overall Study|Lack of Efficacy|186
7115591|NCT02557646|11250911|FG000|Overall Study|Withdrawal by Subject|18
7115592|NCT02557646|11250911|FG000|Overall Study|Lost to Follow-up|17
7115593|NCT02557646|11250911|FG000|Overall Study|Other|14
7115594|NCT02558231|11250926|FG000|Overall Study|Death|4
7115595|NCT02558231|11250927|FG001|Overall Study|Death|12
7115596|NCT02558231|11250926|FG000|Overall Study|Lost to Follow-up|7
7115597|NCT02558231|11250927|FG001|Overall Study|Lost to Follow-up|4
7115598|NCT02558231|11250926|FG000|Overall Study|Withdrawal by Subject|7
7115599|NCT02558231|11250927|FG001|Overall Study|Withdrawal by Subject|4
7115600|NCT02558231|11250926|FG000|Overall Study|Physician Decision|7
7115601|NCT02558231|11250927|FG001|Overall Study|Physician Decision|5
7115602|NCT02558231|11250926|FG000|Overall Study|Sponsor Decision|0
7115603|NCT02558231|11250927|FG001|Overall Study|Sponsor Decision|1
7115604|NCT02558296|11250935|FG000|Completed the Study Through Week 24|Adverse Event|9
7115605|NCT02558296|11250936|FG001|Completed the Study Through Week 24|Adverse Event|3
7115606|NCT02558296|11250935|FG000|Completed the Study Through Week 24|Death|7
7115607|NCT02558296|11250936|FG001|Completed the Study Through Week 24|Death|7
7115608|NCT02558296|11250935|FG000|Completed the Study Through Week 24|Lost to Follow-up|8
7115609|NCT02558296|11250936|FG001|Completed the Study Through Week 24|Lost to Follow-up|1
7115610|NCT02558296|11250935|FG000|Completed the Study Through Week 24|Physician Decision|1
7115611|NCT02558296|11250936|FG001|Completed the Study Through Week 24|Physician Decision|0
7115612|NCT02558296|11250935|FG000|Completed the Study Through Week 24|Protocol Violation|1
7115613|NCT02558296|11250936|FG001|Completed the Study Through Week 24|Protocol Violation|1
7115614|NCT02558296|11250935|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17
7115615|NCT02558296|11250936|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13
7115616|NCT02558296|11250935|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1
7115617|NCT02558296|11250936|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0
7115618|NCT02558296|11250935|FG000|Completed the Study|Adverse Event|14
7115619|NCT02558296|11250936|FG001|Completed the Study|Adverse Event|5
7115620|NCT02558296|11250935|FG000|Completed the Study|Death|39
7115621|NCT02558296|11250936|FG001|Completed the Study|Death|25
7115622|NCT02558296|11250935|FG000|Completed the Study|Lost to Follow-up|31
7115623|NCT02558296|11250936|FG001|Completed the Study|Lost to Follow-up|23
7115624|NCT02558296|11250935|FG000|Completed the Study|Physician Decision|6
7115625|NCT02558296|11250936|FG001|Completed the Study|Physician Decision|0
7115626|NCT02558296|11250935|FG000|Completed the Study|Protocol Violation|2
7115627|NCT02558296|11250936|FG001|Completed the Study|Protocol Violation|1
7115628|NCT02558296|11250935|FG000|Completed the Study|Withdrawal by Subject|53
7115629|NCT02558296|11250936|FG001|Completed the Study|Withdrawal by Subject|31
7115630|NCT02558296|11250935|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1
7115631|NCT02558296|11250936|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0
7115632|NCT02558400|11250958|FG000|Overall Study|Adverse Event|47
7115633|NCT02558400|11250959|FG001|Overall Study|Adverse Event|53
7115634|NCT02558400|11250960|FG002|Overall Study|Adverse Event|4
7115635|NCT02558400|11250958|FG000|Overall Study|Withdrawal by Subject|13
7115636|NCT02558400|11250959|FG001|Overall Study|Withdrawal by Subject|9
7115637|NCT02558400|11250960|FG002|Overall Study|Withdrawal by Subject|8
7115638|NCT02558400|11250958|FG000|Overall Study|Non-Compliant|0
7115639|NCT02558400|11250959|FG001|Overall Study|Non-Compliant|1
7115640|NCT02558400|11250960|FG002|Overall Study|Non-Compliant|3
7115641|NCT02558400|11250958|FG000|Overall Study|Lost to Follow-up|5
7115642|NCT02558400|11250959|FG001|Overall Study|Lost to Follow-up|5
7115643|NCT02558400|11250960|FG002|Overall Study|Lost to Follow-up|4
7115644|NCT02558400|11250958|FG000|Overall Study|Lack of Efficacy|0
7115645|NCT02558400|11250959|FG001|Overall Study|Lack of Efficacy|13
7115646|NCT02558400|11250960|FG002|Overall Study|Lack of Efficacy|1
7115647|NCT02558400|11250958|FG000|Overall Study|Disallowed Concurrent Medication|6
7115648|NCT02558400|11250959|FG001|Overall Study|Disallowed Concurrent Medication|7
7115649|NCT02558400|11250960|FG002|Overall Study|Disallowed Concurrent Medication|5
7115650|NCT02558400|11250958|FG000|Overall Study|Physician Decision|2
7115651|NCT02558400|11250959|FG001|Overall Study|Physician Decision|2
7115652|NCT02558400|11250960|FG002|Overall Study|Physician Decision|0
7115653|NCT02558400|11250958|FG000|Overall Study|Protocol Violation|6
7115654|NCT02558400|11250959|FG001|Overall Study|Protocol Violation|3
7115655|NCT02558400|11250960|FG002|Overall Study|Protocol Violation|8
7115656|NCT02558400|11250958|FG000|Overall Study|Death|0
7115657|NCT02558400|11250959|FG001|Overall Study|Death|1
7115658|NCT02558400|11250960|FG002|Overall Study|Death|0
7115659|NCT02558400|11250958|FG000|Overall Study|Ineligible for the study|0
7115660|NCT02558400|11250959|FG001|Overall Study|Ineligible for the study|2
7115661|NCT02558400|11250960|FG002|Overall Study|Ineligible for the study|0
7115662|NCT02558790|11250971|FG000|Overall Study|Lost to Follow-up|2
7115663|NCT02558790|11250971|FG000|Overall Study|Physician Decision|1
7115664|NCT02558790|11250971|FG000|Overall Study|Withdrawal by Subject|1
7115665|NCT02558790|11250971|FG000|Overall Study|Screen Fail|3
7115666|NCT02558894|11251010|FG000|Overall Study|Death; any cause, entire study duration|28
7115667|NCT02558894|11251011|FG001|Overall Study|Death; any cause, entire study duration|31
7115668|NCT02558894|11251010|FG000|Overall Study|Withdrawal by Subject|2
7115669|NCT02558894|11251011|FG001|Overall Study|Withdrawal by Subject|1
7115670|NCT02558894|11251010|FG000|Overall Study|Closure of Part A|2
7115671|NCT02558894|11251011|FG001|Overall Study|Closure of Part A|1
7115672|NCT02559115|11251017|FG000|Overall Study|Withdrawal by Subject|3
7115673|NCT02559206|11251029|FG000|Overall Study|Adverse Event|0
7115674|NCT02559206|11251030|FG001|Overall Study|Adverse Event|4
7115675|NCT02559206|11251031|FG002|Overall Study|Adverse Event|1
7115676|NCT02559206|11251032|FG003|Overall Study|Adverse Event|5
7115677|NCT02559206|11251033|FG004|Overall Study|Adverse Event|3
7115678|NCT02559206|11251034|FG005|Overall Study|Adverse Event|0
7115679|NCT02559206|11251035|FG006|Overall Study|Adverse Event|1
7115680|NCT02559206|11251036|FG007|Overall Study|Adverse Event|0
7115681|NCT02559206|11251029|FG000|Overall Study|Protocol Violation|1
7115682|NCT02559206|11251030|FG001|Overall Study|Protocol Violation|0
7115683|NCT02559206|11251031|FG002|Overall Study|Protocol Violation|1
7115684|NCT02559206|11251032|FG003|Overall Study|Protocol Violation|0
7115685|NCT02559206|11251033|FG004|Overall Study|Protocol Violation|0
7115686|NCT02559206|11251034|FG005|Overall Study|Protocol Violation|2
7115687|NCT02559206|11251035|FG006|Overall Study|Protocol Violation|0
7115688|NCT02559206|11251036|FG007|Overall Study|Protocol Violation|0
7115689|NCT02559206|11251029|FG000|Overall Study|Withdrawal by Subject|3
7115690|NCT02559206|11251030|FG001|Overall Study|Withdrawal by Subject|3
7115691|NCT02559206|11251031|FG002|Overall Study|Withdrawal by Subject|1
7115692|NCT02559206|11251032|FG003|Overall Study|Withdrawal by Subject|3
7115693|NCT02559206|11251033|FG004|Overall Study|Withdrawal by Subject|5
7115694|NCT02559206|11251034|FG005|Overall Study|Withdrawal by Subject|4
7115695|NCT02559206|11251035|FG006|Overall Study|Withdrawal by Subject|1
7115696|NCT02559206|11251036|FG007|Overall Study|Withdrawal by Subject|2
7115697|NCT02559206|11251029|FG000|Overall Study|Lost to Follow-up|3
7115698|NCT02559206|11251030|FG001|Overall Study|Lost to Follow-up|5
7115699|NCT02559206|11251031|FG002|Overall Study|Lost to Follow-up|3
7115700|NCT02559206|11251032|FG003|Overall Study|Lost to Follow-up|3
7115701|NCT02559206|11251033|FG004|Overall Study|Lost to Follow-up|2
7115702|NCT02559206|11251034|FG005|Overall Study|Lost to Follow-up|5
7115703|NCT02559206|11251035|FG006|Overall Study|Lost to Follow-up|1
7115704|NCT02559206|11251036|FG007|Overall Study|Lost to Follow-up|4
7115705|NCT02559206|11251029|FG000|Overall Study|Lack of Efficacy|1
7115706|NCT02559206|11251030|FG001|Overall Study|Lack of Efficacy|0
7115707|NCT02559206|11251031|FG002|Overall Study|Lack of Efficacy|3
7115708|NCT02559206|11251032|FG003|Overall Study|Lack of Efficacy|2
7115709|NCT02559206|11251033|FG004|Overall Study|Lack of Efficacy|2
7115710|NCT02559206|11251034|FG005|Overall Study|Lack of Efficacy|3
7115711|NCT02559206|11251035|FG006|Overall Study|Lack of Efficacy|3
7115712|NCT02559206|11251036|FG007|Overall Study|Lack of Efficacy|3
7115713|NCT02559206|11251029|FG000|Overall Study|Other Not Specified|0
7115714|NCT02559206|11251030|FG001|Overall Study|Other Not Specified|0
7115715|NCT02559206|11251031|FG002|Overall Study|Other Not Specified|0
7115716|NCT02559206|11251032|FG003|Overall Study|Other Not Specified|1
7115717|NCT02559206|11251033|FG004|Overall Study|Other Not Specified|0
7115718|NCT02559206|11251034|FG005|Overall Study|Other Not Specified|0
7115719|NCT02559206|11251035|FG006|Overall Study|Other Not Specified|0
7115720|NCT02559206|11251036|FG007|Overall Study|Other Not Specified|0
7115721|NCT02559310|11251056|FG000|Overall Study|Death|4
7115722|NCT02559310|11251057|FG001|Overall Study|Death|3
7115723|NCT02559310|11251056|FG000|Overall Study|Lost to Follow-up|5
7115724|NCT02559310|11251057|FG001|Overall Study|Lost to Follow-up|3
7115725|NCT02559310|11251056|FG000|Overall Study|Physician Decision|2
6805907|NCT02328014|10808133|FG001|Overall Study|Death|0
6805908|NCT02328014|10808134|FG002|Overall Study|Death|0
6805909|NCT02328014|10808135|FG003|Overall Study|Death|4
6805910|NCT02328014|10808132|FG000|Overall Study|Physician Decision|0
6805911|NCT02328014|10808133|FG001|Overall Study|Physician Decision|0
6805912|NCT02328014|10808134|FG002|Overall Study|Physician Decision|0
6805913|NCT02328014|10808135|FG003|Overall Study|Physician Decision|1
6805914|NCT02328014|10808132|FG000|Overall Study|Disease Progression|1
6805915|NCT02328014|10808133|FG001|Overall Study|Disease Progression|0
6805916|NCT02328014|10808134|FG002|Overall Study|Disease Progression|1
6805917|NCT02328014|10808135|FG003|Overall Study|Disease Progression|3
6805918|NCT02328014|10808132|FG000|Overall Study|Study Terminated by Sponsor|4
6805919|NCT02328014|10808133|FG001|Overall Study|Study Terminated by Sponsor|1
6805920|NCT02328014|10808134|FG002|Overall Study|Study Terminated by Sponsor|1
6805921|NCT02328014|10808135|FG003|Overall Study|Study Terminated by Sponsor|0
6805922|NCT02328014|10808132|FG000|Overall Study|Subject Started Another Cancer Therapy|0
6805923|NCT02328014|10808133|FG001|Overall Study|Subject Started Another Cancer Therapy|5
6805924|NCT02328014|10808134|FG002|Overall Study|Subject Started Another Cancer Therapy|4
6805925|NCT02328014|10808135|FG003|Overall Study|Subject Started Another Cancer Therapy|12
6805926|NCT02328014|10808132|FG000|Overall Study|Withdrawal by Subject|0
6805927|NCT02328014|10808133|FG001|Overall Study|Withdrawal by Subject|0
6805928|NCT02328014|10808134|FG002|Overall Study|Withdrawal by Subject|0
6805929|NCT02328014|10808135|FG003|Overall Study|Withdrawal by Subject|1
6805934|NCT01904032|10808173|FG000|Overall Study|Adverse Event|3
6805935|NCT01904032|10808174|FG001|Overall Study|Adverse Event|1
7115726|NCT02559310|11251057|FG001|Overall Study|Physician Decision|1
7115727|NCT02559310|11251056|FG000|Overall Study|Withdrawal by Subject|13
6805936|NCT01904032|10808173|FG000|Overall Study|Lost to Follow-up|4
6805937|NCT01904032|10808174|FG001|Overall Study|Lost to Follow-up|2
7115728|NCT02559310|11251057|FG001|Overall Study|Withdrawal by Subject|9
7115729|NCT02559310|11251056|FG000|Overall Study|Sponsor Decision|0
7115730|NCT02559310|11251057|FG001|Overall Study|Sponsor Decision|1
7115731|NCT02559310|11251056|FG000|Overall Study|Randomized but not treated|3
7115732|NCT02559310|11251057|FG001|Overall Study|Randomized but not treated|2
7115733|NCT02559414|11251066|FG000|Overall Study|Lost to Follow-up|0
7115734|NCT02559414|11251067|FG001|Overall Study|Lost to Follow-up|1
7115735|NCT02559414|11251068|FG002|Overall Study|Lost to Follow-up|0
7115736|NCT02559414|11251066|FG000|Overall Study|Withdrawal by Subject|1
7115737|NCT02559414|11251067|FG001|Overall Study|Withdrawal by Subject|0
7115738|NCT02559414|11251068|FG002|Overall Study|Withdrawal by Subject|1
7115739|NCT02559414|11251066|FG000|Overall Study|Other|0
7115740|NCT02559414|11251067|FG001|Overall Study|Other|1
7115741|NCT02559414|11251068|FG002|Overall Study|Other|1
7115742|NCT02559505|11251093|FG000|Overall Study|Lost to Follow-up|23
7115743|NCT02559505|11251094|FG001|Overall Study|Lost to Follow-up|20
7115744|NCT02559505|11251093|FG000|Overall Study|Withdrawal by Subject|4
7115745|NCT02559505|11251094|FG001|Overall Study|Withdrawal by Subject|2
7115746|NCT02559570|11251117|FG000|Overall Study|Adverse Event|0
7115747|NCT02559570|11251118|FG001|Overall Study|Adverse Event|2
7115748|NCT02559570|11251119|FG002|Overall Study|Adverse Event|0
7115749|NCT02559570|11251120|FG003|Overall Study|Adverse Event|1
7115750|NCT02559570|11251121|FG004|Overall Study|Adverse Event|0
7115751|NCT02559570|11251117|FG000|Overall Study|Withdrawal of Consent|0
7115752|NCT02559570|11251118|FG001|Overall Study|Withdrawal of Consent|0
7115753|NCT02559570|11251119|FG002|Overall Study|Withdrawal of Consent|1
7115754|NCT02559570|11251120|FG003|Overall Study|Withdrawal of Consent|2
7115755|NCT02559570|11251121|FG004|Overall Study|Withdrawal of Consent|1
7115756|NCT02559570|11251117|FG000|Overall Study|Lost to Follow-up|1
7115757|NCT02559570|11251118|FG001|Overall Study|Lost to Follow-up|0
7115758|NCT02559570|11251119|FG002|Overall Study|Lost to Follow-up|0
7115759|NCT02559570|11251120|FG003|Overall Study|Lost to Follow-up|0
7115760|NCT02559570|11251121|FG004|Overall Study|Lost to Follow-up|0
7115761|NCT02559570|11251117|FG000|Overall Study|Protocol Violation|1
7115762|NCT02559570|11251118|FG001|Overall Study|Protocol Violation|0
7115763|NCT02559570|11251119|FG002|Overall Study|Protocol Violation|0
7115764|NCT02559570|11251120|FG003|Overall Study|Protocol Violation|0
7115765|NCT02559570|11251121|FG004|Overall Study|Protocol Violation|1
7115766|NCT02559570|11251117|FG000|Overall Study|Other Miscellaneous Reasons|0
7115767|NCT02559570|11251118|FG001|Overall Study|Other Miscellaneous Reasons|0
7115768|NCT02559570|11251119|FG002|Overall Study|Other Miscellaneous Reasons|1
7115769|NCT02559570|11251120|FG003|Overall Study|Other Miscellaneous Reasons|0
7115770|NCT02559570|11251121|FG004|Overall Study|Other Miscellaneous Reasons|0
7115771|NCT02559622|11251136|FG000|Overall Study|Progressive disease|0
7115772|NCT02559622|11251137|FG001|Overall Study|Progressive disease|1
7115773|NCT02559622|11251138|FG002|Overall Study|Progressive disease|0
7115774|NCT02559622|11251139|FG003|Overall Study|Progressive disease|0
7115775|NCT02559622|11251136|FG000|Overall Study|Adverse Event|0
7115776|NCT02559622|11251137|FG001|Overall Study|Adverse Event|2
7115777|NCT02559622|11251138|FG002|Overall Study|Adverse Event|2
7115778|NCT02559622|11251139|FG003|Overall Study|Adverse Event|2
7115779|NCT02559622|11251136|FG000|Overall Study|Patient/guardian decision|1
7115780|NCT02559622|11251137|FG001|Overall Study|Patient/guardian decision|2
7115781|NCT02559622|11251138|FG002|Overall Study|Patient/guardian decision|0
7115782|NCT02559622|11251139|FG003|Overall Study|Patient/guardian decision|1
7115783|NCT02559687|11251153|FG000|Overall Study|Death|103
7115784|NCT02559687|11251153|FG000|Overall Study|Withdrawal by Subject|4
7115785|NCT02559687|11251153|FG000|Overall Study|Ongoing Follow-Up|14
7115786|NCT02559713|11251157|FG000|Overall Study|Pretreatment Event/ Adverse Event|1
7115787|NCT02559817|11251166|FG000|Treatment Period|Adverse Event|1
7115788|NCT02559817|11251167|FG001|Treatment Period|Adverse Event|0
7115789|NCT02559817|11251168|FG002|Treatment Period|Adverse Event|1
7115790|NCT02559817|11251169|FG003|Treatment Period|Adverse Event|0
7115791|NCT02559817|11251170|FG004|Treatment Period|Adverse Event|0
7115792|NCT02559817|11251166|FG000|Treatment Period|Lack of Efficacy|0
7115793|NCT02559817|11251167|FG001|Treatment Period|Lack of Efficacy|1
7115794|NCT02559817|11251168|FG002|Treatment Period|Lack of Efficacy|0
7115795|NCT02559817|11251169|FG003|Treatment Period|Lack of Efficacy|0
7115796|NCT02559817|11251170|FG004|Treatment Period|Lack of Efficacy|0
7115797|NCT02559817|11251166|FG000|Treatment Period|Lost to Follow-up|0
7115798|NCT02559817|11251167|FG001|Treatment Period|Lost to Follow-up|1
7115799|NCT02559817|11251168|FG002|Treatment Period|Lost to Follow-up|0
7115800|NCT02559817|11251169|FG003|Treatment Period|Lost to Follow-up|1
7115801|NCT02559817|11251170|FG004|Treatment Period|Lost to Follow-up|0
7115802|NCT02559817|11251166|FG000|Treatment Period|Non-Compliance With Study Drug|0
7115803|NCT02559817|11251167|FG001|Treatment Period|Non-Compliance With Study Drug|0
7115804|NCT02559817|11251168|FG002|Treatment Period|Non-Compliance With Study Drug|1
7115805|NCT02559817|11251169|FG003|Treatment Period|Non-Compliance With Study Drug|0
7115806|NCT02559817|11251170|FG004|Treatment Period|Non-Compliance With Study Drug|0
7115807|NCT02559817|11251166|FG000|Treatment Period|Protocol Violation|0
7115808|NCT02559817|11251167|FG001|Treatment Period|Protocol Violation|0
7115809|NCT02559817|11251168|FG002|Treatment Period|Protocol Violation|0
7115810|NCT02559817|11251169|FG003|Treatment Period|Protocol Violation|1
7115811|NCT02559817|11251170|FG004|Treatment Period|Protocol Violation|0
7115812|NCT02559895|11251186|FG000|Overall Study|Adverse Event|3
7115813|NCT02559895|11251187|FG001|Overall Study|Adverse Event|3
7115814|NCT02559895|11251188|FG002|Overall Study|Adverse Event|2
7115815|NCT02559895|11251189|FG003|Overall Study|Adverse Event|1
7115816|NCT02559895|11251186|FG000|Overall Study|Lack of Efficacy|2
7115817|NCT02559895|11251187|FG001|Overall Study|Lack of Efficacy|3
7115818|NCT02559895|11251188|FG002|Overall Study|Lack of Efficacy|2
7115819|NCT02559895|11251189|FG003|Overall Study|Lack of Efficacy|8
7115820|NCT02559895|11251186|FG000|Overall Study|Lost to Follow-up|22
7115821|NCT02559895|11251187|FG001|Overall Study|Lost to Follow-up|16
7115822|NCT02559895|11251188|FG002|Overall Study|Lost to Follow-up|12
7115823|NCT02559895|11251189|FG003|Overall Study|Lost to Follow-up|17
7115824|NCT02559895|11251186|FG000|Overall Study|Physician Decision|1
7115825|NCT02559895|11251187|FG001|Overall Study|Physician Decision|1
7115826|NCT02559895|11251188|FG002|Overall Study|Physician Decision|3
7115827|NCT02559895|11251189|FG003|Overall Study|Physician Decision|0
7115828|NCT02559895|11251186|FG000|Overall Study|Withdrawal by Subject|16
7115829|NCT02559895|11251187|FG001|Overall Study|Withdrawal by Subject|9
7115830|NCT02559895|11251188|FG002|Overall Study|Withdrawal by Subject|20
7115831|NCT02559895|11251189|FG003|Overall Study|Withdrawal by Subject|9
7115832|NCT02559895|11251186|FG000|Overall Study|Study Burden|10
7115833|NCT02559895|11251187|FG001|Overall Study|Study Burden|16
7115834|NCT02559895|11251188|FG002|Overall Study|Study Burden|12
7115835|NCT02559895|11251189|FG003|Overall Study|Study Burden|22
7115836|NCT02559895|11251186|FG000|Overall Study|Other|1
7115837|NCT02559895|11251187|FG001|Overall Study|Other|5
7115838|NCT02559895|11251188|FG002|Overall Study|Other|3
7115839|NCT02559895|11251189|FG003|Overall Study|Other|3
7115840|NCT02560012|11251199|FG000|Overall Study|Study Terminated|2
7115841|NCT02560025|11251203|FG000|Overall Study|Ineligible after consent/ registration|3
7115842|NCT02560389|11251240|FG000|Overall Study|Lost to Follow-up|1
7115843|NCT02560389|11251241|FG001|Overall Study|Lost to Follow-up|2
7115844|NCT02560389|11251242|FG002|Overall Study|Lost to Follow-up|2
7115845|NCT02560389|11251240|FG000|Overall Study|Tested positive for illicit substance|0
7115846|NCT02560389|11251241|FG001|Overall Study|Tested positive for illicit substance|1
7115847|NCT02560389|11251242|FG002|Overall Study|Tested positive for illicit substance|0
7115848|NCT02560558|11251261|FG000|Overall Study|Adverse Event|1
7115849|NCT02560558|11251262|FG001|Overall Study|Adverse Event|0
7115850|NCT02560558|11251261|FG000|Overall Study|Death|0
7115851|NCT02560558|11251262|FG001|Overall Study|Death|2
7115852|NCT02560558|11251261|FG000|Overall Study|Lost to Follow-up|0
7115853|NCT02560558|11251262|FG001|Overall Study|Lost to Follow-up|4
7115854|NCT02560558|11251261|FG000|Overall Study|Protocol Violation|3
7115855|NCT02560558|11251262|FG001|Overall Study|Protocol Violation|0
7115856|NCT02560558|11251261|FG000|Overall Study|Withdrawal by Subject|3
7115857|NCT02560558|11251262|FG001|Overall Study|Withdrawal by Subject|0
7115858|NCT02561000|11251321|FG000|Overall Study|Withdrawal by Subject|2
7115859|NCT02561000|11251322|FG001|Overall Study|Withdrawal by Subject|3
7115860|NCT02561000|11251323|FG002|Overall Study|Withdrawal by Subject|0
7115861|NCT02561000|11251321|FG000|Overall Study|Adverse Event|0
7115862|NCT02561000|11251322|FG001|Overall Study|Adverse Event|1
7115863|NCT02561000|11251323|FG002|Overall Study|Adverse Event|0
7115864|NCT02561078|11251333|FG000|Overall Study|Adverse Event|5
7115865|NCT02561078|11251334|FG001|Overall Study|Adverse Event|2
7115866|NCT02561078|11251333|FG000|Overall Study|Death|2
7115867|NCT02561078|11251334|FG001|Overall Study|Death|1
7115868|NCT02561078|11251333|FG000|Overall Study|Lost to Follow-up|2
7115869|NCT02561078|11251334|FG001|Overall Study|Lost to Follow-up|6
7115870|NCT02561078|11251333|FG000|Overall Study|Non-Compliance with Study Drug|6
7115871|NCT02561078|11251334|FG001|Overall Study|Non-Compliance with Study Drug|3
7115872|NCT02561078|11251333|FG000|Overall Study|Physician Decision|2
7115873|NCT02561078|11251334|FG001|Overall Study|Physician Decision|3
7115874|NCT02561078|11251333|FG000|Overall Study|Withdrawal by Subject|13
7115875|NCT02561078|11251334|FG001|Overall Study|Withdrawal by Subject|10
7115876|NCT02561156|11251362|FG000|Part 2|Adverse Event|0
7115877|NCT02561156|11251363|FG001|Part 2|Adverse Event|0
7115878|NCT02561156|11251364|FG002|Part 2|Adverse Event|0
7115879|NCT02561156|11251365|FG003|Part 2|Adverse Event|0
7115880|NCT02561156|11251366|FG004|Part 2|Adverse Event|0
7115881|NCT02561156|11251367|FG005|Part 2|Adverse Event|0
7115882|NCT02561156|11251368|FG006|Part 2|Adverse Event|0
7115883|NCT02561156|11251369|FG007|Part 2|Adverse Event|0
7115884|NCT02561156|11251370|FG008|Part 2|Adverse Event|0
7115885|NCT02561156|11251371|FG009|Part 2|Adverse Event|0
7115886|NCT02561156|11251372|FG010|Part 2|Adverse Event|0
7115887|NCT02561156|11251373|FG011|Part 2|Adverse Event|1
7115888|NCT02561156|11251374|FG012|Part 2|Adverse Event|0
7115889|NCT02561195|11251424|FG000|Vaccination 1 to 3|Adverse Event|4
7115890|NCT02561195|11251425|FG001|Vaccination 1 to 3|Adverse Event|5
7115891|NCT02561195|11251426|FG002|Vaccination 1 to 3|Adverse Event|0
7115892|NCT02561195|11251427|FG003|Vaccination 1 to 3|Adverse Event|3
7115893|NCT02561195|11251428|FG004|Vaccination 1 to 3|Adverse Event|4
7115894|NCT02561195|11251429|FG005|Vaccination 1 to 3|Adverse Event|0
7115895|NCT02561195|11251430|FG006|Vaccination 1 to 3|Adverse Event|0
7115896|NCT02561195|11251431|FG007|Vaccination 1 to 3|Adverse Event|0
7115897|NCT02561195|11251432|FG008|Vaccination 1 to 3|Adverse Event|0
7115898|NCT02561195|11251433|FG009|Vaccination 1 to 3|Adverse Event|0
7115899|NCT02561195|11251434|FG010|Vaccination 1 to 3|Adverse Event|0
7115900|NCT02561195|11251435|FG011|Vaccination 1 to 3|Adverse Event|0
7115901|NCT02561195|11251436|FG012|Vaccination 1 to 3|Adverse Event|0
7115902|NCT02561195|11251437|FG013|Vaccination 1 to 3|Adverse Event|0
7115903|NCT02561195|11251424|FG000|Vaccination 1 to 3|Lost to Follow-up|3
7115904|NCT02561195|11251425|FG001|Vaccination 1 to 3|Lost to Follow-up|4
7115905|NCT02561195|11251426|FG002|Vaccination 1 to 3|Lost to Follow-up|0
7115906|NCT02561195|11251427|FG003|Vaccination 1 to 3|Lost to Follow-up|2
7115907|NCT02561195|11251428|FG004|Vaccination 1 to 3|Lost to Follow-up|3
7115908|NCT02561195|11251429|FG005|Vaccination 1 to 3|Lost to Follow-up|3
7115909|NCT02561195|11251430|FG006|Vaccination 1 to 3|Lost to Follow-up|0
7115910|NCT02561195|11251431|FG007|Vaccination 1 to 3|Lost to Follow-up|0
7115911|NCT02561195|11251432|FG008|Vaccination 1 to 3|Lost to Follow-up|0
7115912|NCT02561195|11251433|FG009|Vaccination 1 to 3|Lost to Follow-up|0
7115913|NCT02561195|11251434|FG010|Vaccination 1 to 3|Lost to Follow-up|0
7115914|NCT02561195|11251435|FG011|Vaccination 1 to 3|Lost to Follow-up|0
7115915|NCT02561195|11251436|FG012|Vaccination 1 to 3|Lost to Follow-up|0
7115916|NCT02561195|11251437|FG013|Vaccination 1 to 3|Lost to Follow-up|0
7115917|NCT02561195|11251424|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0
7115918|NCT02561195|11251425|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1
7115919|NCT02561195|11251426|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0
7115920|NCT02561195|11251427|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4
7115921|NCT02561195|11251428|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4
7115922|NCT02561195|11251429|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1
7115923|NCT02561195|11251430|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0
7115924|NCT02561195|11251431|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0
7115925|NCT02561195|11251432|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0
7115926|NCT02561195|11251433|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0
7115927|NCT02561195|11251434|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0
7115928|NCT02561195|11251435|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0
7115929|NCT02561195|11251436|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0
7115930|NCT02561195|11251437|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0
7115931|NCT02561195|11251424|FG000|Vaccination 1 to 3|No longer willing to participate|2
7115932|NCT02561195|11251425|FG001|Vaccination 1 to 3|No longer willing to participate|4
7115933|NCT02561195|11251426|FG002|Vaccination 1 to 3|No longer willing to participate|0
7115934|NCT02561195|11251427|FG003|Vaccination 1 to 3|No longer willing to participate|4
7115935|NCT02561195|11251428|FG004|Vaccination 1 to 3|No longer willing to participate|1
7115936|NCT02561195|11251429|FG005|Vaccination 1 to 3|No longer willing to participate|3
7115937|NCT02561195|11251430|FG006|Vaccination 1 to 3|No longer willing to participate|0
7115938|NCT02561195|11251431|FG007|Vaccination 1 to 3|No longer willing to participate|0
7115939|NCT02561195|11251432|FG008|Vaccination 1 to 3|No longer willing to participate|0
7115940|NCT02561195|11251433|FG009|Vaccination 1 to 3|No longer willing to participate|0
6810365|NCT04617860|10814098|FG002|Overall Study|Adverse Event|2
6810366|NCT04617860|10814096|FG000|Overall Study|Withdrawal by Subject|0
6810367|NCT04617860|10814097|FG001|Overall Study|Withdrawal by Subject|0
6810368|NCT04617860|10814098|FG002|Overall Study|Withdrawal by Subject|2
6810369|NCT04617860|10814096|FG000|Overall Study|Physician Decision|0
6810370|NCT04617860|10814097|FG001|Overall Study|Physician Decision|1
6810371|NCT04617860|10814098|FG002|Overall Study|Physician Decision|0
6810372|NCT04617860|10814096|FG000|Overall Study|Sponsor Decision|0
6810373|NCT04617860|10814097|FG001|Overall Study|Sponsor Decision|3
6810374|NCT04617860|10814098|FG002|Overall Study|Sponsor Decision|1
6810375|NCT04617860|10814096|FG000|Overall Study|Termination of Study by Sponsor|8
6810376|NCT04617860|10814097|FG001|Overall Study|Termination of Study by Sponsor|4
6810377|NCT04617860|10814098|FG002|Overall Study|Termination of Study by Sponsor|13
6810378|NCT04617847|10814110|FG000|Overall Study|Withdrawal by Subject|1
6810379|NCT04617847|10814111|FG001|Overall Study|Withdrawal by Subject|0
6810380|NCT04617847|10814110|FG000|Overall Study|Adverse Event|0
6810381|NCT04617847|10814111|FG001|Overall Study|Adverse Event|2
6810382|NCT04617847|10814110|FG000|Overall Study|Death|0
6810383|NCT04617847|10814111|FG001|Overall Study|Death|1
6810384|NCT04617847|10814110|FG000|Overall Study|Termination of Study by Sponsor|2
6811167|NCT02407236|10815054|FG002|Maintenance Study (44 Weeks)|Death|0
7115941|NCT02561195|11251434|FG010|Vaccination 1 to 3|No longer willing to participate|0
7115942|NCT02561195|11251435|FG011|Vaccination 1 to 3|No longer willing to participate|0
7115943|NCT02561195|11251436|FG012|Vaccination 1 to 3|No longer willing to participate|0
7115944|NCT02561195|11251437|FG013|Vaccination 1 to 3|No longer willing to participate|0
7115945|NCT02561195|11251424|FG000|Vaccination 1 to 3|Other|7
7115946|NCT02561195|11251425|FG001|Vaccination 1 to 3|Other|3
7115947|NCT02561195|11251426|FG002|Vaccination 1 to 3|Other|1
7115948|NCT02561195|11251427|FG003|Vaccination 1 to 3|Other|7
7115949|NCT02561195|11251428|FG004|Vaccination 1 to 3|Other|5
7115950|NCT02561195|11251429|FG005|Vaccination 1 to 3|Other|1
7115951|NCT02561195|11251430|FG006|Vaccination 1 to 3|Other|0
7115952|NCT02561195|11251431|FG007|Vaccination 1 to 3|Other|0
7115953|NCT02561195|11251432|FG008|Vaccination 1 to 3|Other|0
7115954|NCT02561195|11251433|FG009|Vaccination 1 to 3|Other|0
7115955|NCT02561195|11251434|FG010|Vaccination 1 to 3|Other|0
7115956|NCT02561195|11251435|FG011|Vaccination 1 to 3|Other|0
7115957|NCT02561195|11251436|FG012|Vaccination 1 to 3|Other|0
7115958|NCT02561195|11251437|FG013|Vaccination 1 to 3|Other|0
7115959|NCT02561195|11251424|FG000|Vaccination 1 to 3|Protocol Violation|1
7115960|NCT02561195|11251425|FG001|Vaccination 1 to 3|Protocol Violation|0
7115961|NCT02561195|11251426|FG002|Vaccination 1 to 3|Protocol Violation|1
7115962|NCT02561195|11251427|FG003|Vaccination 1 to 3|Protocol Violation|2
7115963|NCT02561195|11251428|FG004|Vaccination 1 to 3|Protocol Violation|5
7115964|NCT02561195|11251429|FG005|Vaccination 1 to 3|Protocol Violation|2
7115965|NCT02561195|11251430|FG006|Vaccination 1 to 3|Protocol Violation|0
7115966|NCT02561195|11251431|FG007|Vaccination 1 to 3|Protocol Violation|0
7115967|NCT02561195|11251432|FG008|Vaccination 1 to 3|Protocol Violation|0
7115968|NCT02561195|11251433|FG009|Vaccination 1 to 3|Protocol Violation|0
7115969|NCT02561195|11251434|FG010|Vaccination 1 to 3|Protocol Violation|0
7115970|NCT02561195|11251435|FG011|Vaccination 1 to 3|Protocol Violation|0
7115971|NCT02561195|11251436|FG012|Vaccination 1 to 3|Protocol Violation|0
7115972|NCT02561195|11251437|FG013|Vaccination 1 to 3|Protocol Violation|0
7115973|NCT02561195|11251424|FG000|Vaccination 1 to 3|Death|2
7115974|NCT02561195|11251425|FG001|Vaccination 1 to 3|Death|1
7115975|NCT02561195|11251426|FG002|Vaccination 1 to 3|Death|0
7115976|NCT02561195|11251427|FG003|Vaccination 1 to 3|Death|2
7115977|NCT02561195|11251428|FG004|Vaccination 1 to 3|Death|0
7115978|NCT02561195|11251429|FG005|Vaccination 1 to 3|Death|0
7115979|NCT02561195|11251430|FG006|Vaccination 1 to 3|Death|0
7115980|NCT02561195|11251431|FG007|Vaccination 1 to 3|Death|0
7115981|NCT02561195|11251432|FG008|Vaccination 1 to 3|Death|0
7115982|NCT02561195|11251433|FG009|Vaccination 1 to 3|Death|0
7115983|NCT02561195|11251434|FG010|Vaccination 1 to 3|Death|0
7115984|NCT02561195|11251435|FG011|Vaccination 1 to 3|Death|0
7115985|NCT02561195|11251436|FG012|Vaccination 1 to 3|Death|0
7115986|NCT02561195|11251437|FG013|Vaccination 1 to 3|Death|0
7115987|NCT02561195|11251424|FG000|Vaccination 1 to 3|Withdrawal by Subject|3
7115988|NCT02561195|11251425|FG001|Vaccination 1 to 3|Withdrawal by Subject|4
7115989|NCT02561195|11251426|FG002|Vaccination 1 to 3|Withdrawal by Subject|4
7115990|NCT02561195|11251427|FG003|Vaccination 1 to 3|Withdrawal by Subject|2
7115991|NCT02561195|11251428|FG004|Vaccination 1 to 3|Withdrawal by Subject|6
7115992|NCT02561195|11251429|FG005|Vaccination 1 to 3|Withdrawal by Subject|0
7115993|NCT02561195|11251430|FG006|Vaccination 1 to 3|Withdrawal by Subject|0
7115994|NCT02561195|11251431|FG007|Vaccination 1 to 3|Withdrawal by Subject|0
7115995|NCT02561195|11251432|FG008|Vaccination 1 to 3|Withdrawal by Subject|0
7115996|NCT02561195|11251433|FG009|Vaccination 1 to 3|Withdrawal by Subject|0
7115997|NCT02561195|11251434|FG010|Vaccination 1 to 3|Withdrawal by Subject|0
7115998|NCT02561195|11251435|FG011|Vaccination 1 to 3|Withdrawal by Subject|0
7115999|NCT02561195|11251436|FG012|Vaccination 1 to 3|Withdrawal by Subject|0
7116000|NCT02561195|11251437|FG013|Vaccination 1 to 3|Withdrawal by Subject|0
7116001|NCT02561195|11251424|FG000|Vaccination 1 to 3|Randomized but not treated|1
7116002|NCT02561195|11251425|FG001|Vaccination 1 to 3|Randomized but not treated|0
7116003|NCT02561195|11251426|FG002|Vaccination 1 to 3|Randomized but not treated|0
7116004|NCT02561195|11251427|FG003|Vaccination 1 to 3|Randomized but not treated|0
7116005|NCT02561195|11251428|FG004|Vaccination 1 to 3|Randomized but not treated|0
7116006|NCT02561195|11251429|FG005|Vaccination 1 to 3|Randomized but not treated|0
7116007|NCT02561195|11251430|FG006|Vaccination 1 to 3|Randomized but not treated|0
7116008|NCT02561195|11251431|FG007|Vaccination 1 to 3|Randomized but not treated|0
7116009|NCT02561195|11251432|FG008|Vaccination 1 to 3|Randomized but not treated|0
7116010|NCT02561195|11251433|FG009|Vaccination 1 to 3|Randomized but not treated|0
7116011|NCT02561195|11251434|FG010|Vaccination 1 to 3|Randomized but not treated|0
7116012|NCT02561195|11251435|FG011|Vaccination 1 to 3|Randomized but not treated|0
7116013|NCT02561195|11251436|FG012|Vaccination 1 to 3|Randomized but not treated|0
7116014|NCT02561195|11251437|FG013|Vaccination 1 to 3|Randomized but not treated|0
7116015|NCT02561195|11251424|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0
7116016|NCT02561195|11251425|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0
7116017|NCT02561195|11251426|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0
7116018|NCT02561195|11251427|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0
7116019|NCT02561195|11251428|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0
7116020|NCT02561195|11251429|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0
7116021|NCT02561195|11251430|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0
7116022|NCT02561195|11251431|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0
7116023|NCT02561195|11251432|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3
7116024|NCT02561195|11251433|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1
7116025|NCT02561195|11251434|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2
7116026|NCT02561195|11251435|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2
7116027|NCT02561195|11251436|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3
7116028|NCT02561195|11251437|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0
7116029|NCT02561195|11251424|FG000|Extension Stage (Vaccination 4)|Adverse Event|0
7116030|NCT02561195|11251425|FG001|Extension Stage (Vaccination 4)|Adverse Event|0
7116031|NCT02561195|11251426|FG002|Extension Stage (Vaccination 4)|Adverse Event|0
7116032|NCT02561195|11251427|FG003|Extension Stage (Vaccination 4)|Adverse Event|0
7116033|NCT02561195|11251428|FG004|Extension Stage (Vaccination 4)|Adverse Event|0
7116034|NCT02561195|11251429|FG005|Extension Stage (Vaccination 4)|Adverse Event|0
7116035|NCT02561195|11251430|FG006|Extension Stage (Vaccination 4)|Adverse Event|0
7116036|NCT02561195|11251431|FG007|Extension Stage (Vaccination 4)|Adverse Event|0
7116037|NCT02561195|11251432|FG008|Extension Stage (Vaccination 4)|Adverse Event|0
7116038|NCT02561195|11251433|FG009|Extension Stage (Vaccination 4)|Adverse Event|0
7116039|NCT02561195|11251434|FG010|Extension Stage (Vaccination 4)|Adverse Event|0
7116040|NCT02561195|11251435|FG011|Extension Stage (Vaccination 4)|Adverse Event|0
7116041|NCT02561195|11251436|FG012|Extension Stage (Vaccination 4)|Adverse Event|0
7116042|NCT02561195|11251437|FG013|Extension Stage (Vaccination 4)|Adverse Event|2
7116043|NCT02561195|11251424|FG000|Extension Stage (Vaccination 4)|Death|0
7116044|NCT02561195|11251425|FG001|Extension Stage (Vaccination 4)|Death|0
7116045|NCT02561195|11251426|FG002|Extension Stage (Vaccination 4)|Death|0
7116046|NCT02561195|11251427|FG003|Extension Stage (Vaccination 4)|Death|0
7116047|NCT02561195|11251428|FG004|Extension Stage (Vaccination 4)|Death|0
7116048|NCT02561195|11251429|FG005|Extension Stage (Vaccination 4)|Death|0
7116049|NCT02561195|11251430|FG006|Extension Stage (Vaccination 4)|Death|0
7116050|NCT02561195|11251431|FG007|Extension Stage (Vaccination 4)|Death|0
7116051|NCT02561195|11251432|FG008|Extension Stage (Vaccination 4)|Death|0
7116052|NCT02561195|11251433|FG009|Extension Stage (Vaccination 4)|Death|1
7116053|NCT02561195|11251434|FG010|Extension Stage (Vaccination 4)|Death|0
7116054|NCT02561195|11251435|FG011|Extension Stage (Vaccination 4)|Death|0
7116055|NCT02561195|11251436|FG012|Extension Stage (Vaccination 4)|Death|0
7116056|NCT02561195|11251437|FG013|Extension Stage (Vaccination 4)|Death|0
7116057|NCT02561195|11251424|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0
7116058|NCT02561195|11251425|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0
7116059|NCT02561195|11251426|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0
7116060|NCT02561195|11251427|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0
7116061|NCT02561195|11251428|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0
7116062|NCT02561195|11251429|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0
7116063|NCT02561195|11251430|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1
7116064|NCT02561195|11251431|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1
7116065|NCT02561195|11251432|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0
7116066|NCT02561195|11251433|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0
7116067|NCT02561195|11251434|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2
7116068|NCT02561195|11251435|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1
7116069|NCT02561195|11251436|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2
7116070|NCT02561195|11251437|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1
7116071|NCT02561195|11251424|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7116072|NCT02561195|11251425|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7116073|NCT02561195|11251426|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7116074|NCT02561195|11251427|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7116075|NCT02561195|11251428|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7116076|NCT02561195|11251429|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7116077|NCT02561195|11251430|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7116078|NCT02561195|11251431|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7116079|NCT02561195|11251432|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7116080|NCT02561195|11251433|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7116081|NCT02561195|11251434|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7116082|NCT02561195|11251435|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1
7116083|NCT02561195|11251436|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1
7116084|NCT02561195|11251437|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1
7116085|NCT02561195|11251424|FG000|Extension Stage (Vaccination 4)|Other|0
7116086|NCT02561195|11251425|FG001|Extension Stage (Vaccination 4)|Other|0
7116087|NCT02561195|11251426|FG002|Extension Stage (Vaccination 4)|Other|0
7116088|NCT02561195|11251427|FG003|Extension Stage (Vaccination 4)|Other|0
7116089|NCT02561195|11251428|FG004|Extension Stage (Vaccination 4)|Other|0
7116090|NCT02561195|11251429|FG005|Extension Stage (Vaccination 4)|Other|0
7116091|NCT02561195|11251430|FG006|Extension Stage (Vaccination 4)|Other|0
7116092|NCT02561195|11251431|FG007|Extension Stage (Vaccination 4)|Other|0
7116093|NCT02561195|11251432|FG008|Extension Stage (Vaccination 4)|Other|0
7116094|NCT02561195|11251433|FG009|Extension Stage (Vaccination 4)|Other|0
7116095|NCT02561195|11251434|FG010|Extension Stage (Vaccination 4)|Other|2
7116096|NCT02561195|11251435|FG011|Extension Stage (Vaccination 4)|Other|2
7116097|NCT02561195|11251436|FG012|Extension Stage (Vaccination 4)|Other|1
7116098|NCT02561195|11251437|FG013|Extension Stage (Vaccination 4)|Other|0
7116099|NCT02561195|11251424|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0
7116100|NCT02561195|11251425|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0
7116101|NCT02561195|11251426|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0
7116102|NCT02561195|11251427|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0
7116103|NCT02561195|11251428|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0
7116104|NCT02561195|11251429|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0
7116105|NCT02561195|11251430|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1
7116106|NCT02561195|11251431|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0
7116107|NCT02561195|11251432|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0
7116108|NCT02561195|11251433|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0
7116109|NCT02561195|11251434|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2
7116110|NCT02561195|11251435|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1
7116111|NCT02561195|11251436|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0
7116112|NCT02561195|11251437|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1
7116113|NCT02561247|11251478|FG000|Overall Study|Protocol Violation|1
7116114|NCT02561247|11251478|FG000|Overall Study|Withdrawal by Subject|1
7116115|NCT02561247|11251478|FG000|Overall Study|Two filter changes required within the first 24 hours.|4
7116116|NCT02561273|11251484|FG000|Overall Study|Protocol Violation|1
7116117|NCT02561273|11251485|FG001|Overall Study|Protocol Violation|0
7116118|NCT02561455|11251520|FG000|Overall Study|Participant Transitioned to Commercial Drug|1
7116119|NCT02561455|11251521|FG001|Overall Study|Participant Transitioned to Commercial Drug|1
7116120|NCT02561455|11251522|FG002|Overall Study|Participant Transitioned to Commercial Drug|2
7116121|NCT02561455|11251523|FG003|Overall Study|Participant Transitioned to Commercial Drug|1
7116122|NCT02561455|11251520|FG000|Overall Study|Withdrawal by Subject|1
7116123|NCT02561455|11251521|FG001|Overall Study|Withdrawal by Subject|0
7116124|NCT02561455|11251522|FG002|Overall Study|Withdrawal by Subject|1
7116125|NCT02561455|11251523|FG003|Overall Study|Withdrawal by Subject|0
7116126|NCT02561455|11251520|FG000|Overall Study|Disease Progression|0
7116127|NCT02561455|11251521|FG001|Overall Study|Disease Progression|1
7116128|NCT02561455|11251522|FG002|Overall Study|Disease Progression|0
7116129|NCT02561455|11251523|FG003|Overall Study|Disease Progression|0
7116130|NCT02561572|11251547|FG000|Overall Study|Inadequate time before surgery|2
7116131|NCT02561572|11251548|FG001|Overall Study|Inadequate time before surgery|1
7116132|NCT02561572|11251547|FG000|Overall Study|Protocol Violation|0
7116133|NCT02561572|11251548|FG001|Overall Study|Protocol Violation|1
7116134|NCT02561806|11251576|FG000|Induction Period|Adverse Event|0
7116135|NCT02561806|11251577|FG001|Induction Period|Adverse Event|2
7116136|NCT02561806|11251576|FG000|Induction Period|Lack of Efficacy|1
7116137|NCT02561806|11251577|FG001|Induction Period|Lack of Efficacy|0
7116138|NCT02561806|11251576|FG000|Induction Period|Withdrawal by Subject|0
7116139|NCT02561806|11251577|FG001|Induction Period|Withdrawal by Subject|2
7116140|NCT02561806|11251576|FG000|Induction Period|Site staff became unblinded|1
7116141|NCT02561806|11251577|FG001|Induction Period|Site staff became unblinded|0
7116142|NCT02561806|11251576|FG000|Induction Period|Randomized but not treated|0
7116143|NCT02561806|11251577|FG001|Induction Period|Randomized but not treated|1
7116144|NCT02561806|11251576|FG000|Maintenance Period|Adverse Event|2
7116145|NCT02561806|11251577|FG001|Maintenance Period|Adverse Event|1
7116146|NCT02561806|11251576|FG000|Maintenance Period|Lack of Efficacy|3
7116147|NCT02561806|11251577|FG001|Maintenance Period|Lack of Efficacy|1
7116148|NCT02561806|11251576|FG000|Maintenance Period|Lost to Follow-up|2
7116149|NCT02561806|11251577|FG001|Maintenance Period|Lost to Follow-up|2
7116150|NCT02561806|11251576|FG000|Maintenance Period|Protocol Violation|1
7116151|NCT02561806|11251577|FG001|Maintenance Period|Protocol Violation|0
7116152|NCT02561806|11251576|FG000|Maintenance Period|Withdrawal by Subject|5
7116153|NCT02561806|11251577|FG001|Maintenance Period|Withdrawal by Subject|3
7116154|NCT02561806|11251576|FG000|Maintenance Period|Site staff became unblinded|0
7116155|NCT02561806|11251577|FG001|Maintenance Period|Site staff became unblinded|1
7116156|NCT02561806|11251576|FG000|Post-Treatment Follow-up|Lost to Follow-up|1
7116157|NCT02561806|11251577|FG001|Post-Treatment Follow-up|Lost to Follow-up|1
7116158|NCT02561806|11251576|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1
7116159|NCT02561806|11251577|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0
7116160|NCT02561832|11251600|FG000|Overall Study|Withdrawal by Subject|1
7116161|NCT02561832|11251601|FG001|Overall Study|Withdrawal by Subject|1
7116162|NCT02561832|11251600|FG000|Overall Study|Adverse Event|3
7116163|NCT02561832|11251601|FG001|Overall Study|Adverse Event|0
7116164|NCT02561832|11251600|FG000|Overall Study|Disease progression|3
7116165|NCT02561832|11251601|FG001|Overall Study|Disease progression|3
7116166|NCT02562482|11251630|FG000|Overall Study|Enrolled, but did not receive product|4
7116167|NCT02562482|11251631|FG001|Overall Study|Enrolled, but did not receive product|0
7116168|NCT02562482|11251630|FG000|Overall Study|Lost to Follow-up|9
7116169|NCT02562482|11251631|FG001|Overall Study|Lost to Follow-up|6
7116170|NCT02562482|11251630|FG000|Overall Study|Moved from area|2
7116171|NCT02562482|11251631|FG001|Overall Study|Moved from area|3
7116172|NCT02562482|11251630|FG000|Overall Study|Withdrawal by Subject|5
7116173|NCT02562482|11251631|FG001|Overall Study|Withdrawal by Subject|3
7116174|NCT02562482|11251630|FG000|Overall Study|Physician Decision|1
7116175|NCT02562482|11251631|FG001|Overall Study|Physician Decision|3
7116176|NCT02562482|11251630|FG000|Overall Study|Illness/Injury unrelated to product|0
7116177|NCT02562482|11251631|FG001|Overall Study|Illness/Injury unrelated to product|1
7116178|NCT02563067|11251696|FG000|Overall Study|Subject/guardian decision|14
7116179|NCT02563067|11251697|FG001|Overall Study|Subject/guardian decision|20
7116180|NCT02563067|11251698|FG002|Overall Study|Subject/guardian decision|16
7116181|NCT02563067|11251696|FG000|Overall Study|Physician Decision|0
7116182|NCT02563067|11251697|FG001|Overall Study|Physician Decision|1
7116183|NCT02563067|11251698|FG002|Overall Study|Physician Decision|3
7116184|NCT02563067|11251696|FG000|Overall Study|Lost to Follow-up|1
7116185|NCT02563067|11251697|FG001|Overall Study|Lost to Follow-up|2
7116186|NCT02563067|11251698|FG002|Overall Study|Lost to Follow-up|0
7116187|NCT02563067|11251696|FG000|Overall Study|Technical problems|0
7116188|NCT02563067|11251697|FG001|Overall Study|Technical problems|1
7116189|NCT02563067|11251698|FG002|Overall Study|Technical problems|0
7116190|NCT02563067|11251696|FG000|Overall Study|Lack of Efficacy|1
7116191|NCT02563067|11251697|FG001|Overall Study|Lack of Efficacy|0
7116192|NCT02563067|11251698|FG002|Overall Study|Lack of Efficacy|0
7116193|NCT02563067|11251696|FG000|Overall Study|Death|0
7116194|NCT02563067|11251697|FG001|Overall Study|Death|1
7116195|NCT02563067|11251698|FG002|Overall Study|Death|1
7116196|NCT02563067|11251696|FG000|Overall Study|Adverse Event|2
7116197|NCT02563067|11251697|FG001|Overall Study|Adverse Event|1
7116198|NCT02563067|11251698|FG002|Overall Study|Adverse Event|0
7116199|NCT02563067|11251696|FG000|Overall Study|Death post Treatment/safety period|1
7116200|NCT02563067|11251697|FG001|Overall Study|Death post Treatment/safety period|0
7116201|NCT02563067|11251698|FG002|Overall Study|Death post Treatment/safety period|0
7116202|NCT02563106|11251726|FG000|Overall Study|Withdrawal by Subject|7
7116203|NCT02563106|11251727|FG001|Overall Study|Withdrawal by Subject|8
7116204|NCT02563106|11251726|FG000|Overall Study|Adverse Event|17
7116205|NCT02563106|11251727|FG001|Overall Study|Adverse Event|15
7116206|NCT02563106|11251726|FG000|Overall Study|Protocol Violation|1
7116207|NCT02563106|11251727|FG001|Overall Study|Protocol Violation|0
7116208|NCT02563106|11251726|FG000|Overall Study|Use of non-permitted concurrent therapy|1
7116209|NCT02563106|11251727|FG001|Overall Study|Use of non-permitted concurrent therapy|2
7116210|NCT02563106|11251726|FG000|Overall Study|Lost to Follow-up|3
7116211|NCT02563106|11251727|FG001|Overall Study|Lost to Follow-up|2
7116212|NCT02563106|11251726|FG000|Overall Study|Physician Decision|3
7116213|NCT02563106|11251727|FG001|Overall Study|Physician Decision|1
7116214|NCT02563106|11251726|FG000|Overall Study|Other reason - not specified|2
7116215|NCT02563106|11251727|FG001|Overall Study|Other reason - not specified|1
7116216|NCT02563548|11251756|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2
7116217|NCT02563548|11251757|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
7116218|NCT02563548|11251758|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
7116219|NCT02563548|11251759|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1
7116220|NCT02563548|11251760|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
7116221|NCT02563548|11251761|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
7116222|NCT02563548|11251756|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1
7116223|NCT02563548|11251757|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2
7116224|NCT02563548|11251758|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2
7116225|NCT02563548|11251759|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
7116226|NCT02563548|11251760|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
7116227|NCT02563548|11251761|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
7116228|NCT02563548|11251756|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
7116229|NCT02563548|11251757|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
7116230|NCT02563548|11251758|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3
7116231|NCT02563548|11251759|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
7116232|NCT02563548|11251760|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
7116233|NCT02563548|11251761|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
7116234|NCT02563548|11251756|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
7116235|NCT02563548|11251757|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
7116236|NCT02563548|11251758|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2
7116237|NCT02563548|11251759|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1
7116238|NCT02563548|11251760|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
7116239|NCT02563548|11251761|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
7116240|NCT02563548|11251756|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
7116241|NCT02563548|11251757|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
7116242|NCT02563548|11251758|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
7116243|NCT02563548|11251759|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
7116244|NCT02563548|11251760|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1
7116245|NCT02563548|11251761|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8
7116246|NCT02563548|11251756|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
7116247|NCT02563548|11251757|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
7116248|NCT02563548|11251758|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
7116249|NCT02563548|11251759|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
7116250|NCT02563548|11251760|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15
7116251|NCT02563548|11251761|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3
7116252|NCT02563548|11251756|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
7116253|NCT02563548|11251757|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
7116254|NCT02563548|11251758|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
7116255|NCT02563548|11251759|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
7116256|NCT02563548|11251760|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6
7116257|NCT02563548|11251761|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
7116258|NCT02563548|11251756|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
7116259|NCT02563548|11251757|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
7116260|NCT02563548|11251758|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
7116261|NCT02563548|11251759|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
7116262|NCT02563548|11251760|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2
7116263|NCT02563548|11251761|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1
7116264|NCT02563548|11251756|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
7116265|NCT02563548|11251757|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
7116266|NCT02563548|11251758|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
7116267|NCT02563548|11251759|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
7116268|NCT02563548|11251760|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
7116269|NCT02563548|11251761|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2
7116270|NCT02563548|11251756|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
7116271|NCT02563548|11251757|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
7116272|NCT02563548|11251758|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
7116273|NCT02563548|11251759|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
7116274|NCT02563548|11251760|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
7116275|NCT02563548|11251761|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2
7116276|NCT02563548|11251756|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
7116277|NCT02563548|11251757|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
7116278|NCT02563548|11251758|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
7116279|NCT02563548|11251759|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
7116280|NCT02563548|11251760|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
7116281|NCT02563548|11251761|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1
7116282|NCT02563548|11251756|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
7116283|NCT02563548|11251757|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
7116284|NCT02563548|11251758|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
7116285|NCT02563548|11251759|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
7116286|NCT02563548|11251760|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1
7116287|NCT02563548|11251761|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
7116288|NCT02563561|11251784|FG000|Overall Study|Histology Other than Ta, G1-G2|3
7116289|NCT02563561|11251785|FG001|Overall Study|Histology Other than Ta, G1-G2|6
7116290|NCT02563561|11251786|FG002|Overall Study|Histology Other than Ta, G1-G2|6
7116291|NCT02563561|11251784|FG000|Overall Study|Withdrew of Consent|1
7116292|NCT02563561|11251785|FG001|Overall Study|Withdrew of Consent|1
7116293|NCT02563561|11251786|FG002|Overall Study|Withdrew of Consent|2
7116294|NCT02563561|11251784|FG000|Overall Study|Lost to Follow-up|1
7116295|NCT02563561|11251785|FG001|Overall Study|Lost to Follow-up|1
7116296|NCT02563561|11251786|FG002|Overall Study|Lost to Follow-up|0
7116297|NCT02563561|11251784|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4
7116298|NCT02563561|11251785|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2
7116299|NCT02563561|11251786|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1
7116300|NCT02563561|11251784|FG000|Overall Study|Investigator Decision|3
7116301|NCT02563561|11251785|FG001|Overall Study|Investigator Decision|4
7116302|NCT02563561|11251786|FG002|Overall Study|Investigator Decision|2
7116303|NCT02563561|11251784|FG000|Overall Study|Sponsor Decision|5
7116304|NCT02563561|11251785|FG001|Overall Study|Sponsor Decision|2
7116305|NCT02563561|11251786|FG002|Overall Study|Sponsor Decision|4
7116306|NCT02563561|11251784|FG000|Overall Study|Other|1
7116307|NCT02563561|11251785|FG001|Overall Study|Other|5
7116308|NCT02563561|11251786|FG002|Overall Study|Other|2
7116309|NCT02563899|11251822|FG000|Overall Study|Protocol Violation|1
7116310|NCT02563899|11251823|FG001|Overall Study|Protocol Violation|0
7116311|NCT02563899|11251824|FG002|Overall Study|Protocol Violation|0
7116312|NCT02563899|11251825|FG003|Overall Study|Protocol Violation|0
7116313|NCT02563899|11251822|FG000|Overall Study|Withdrawal by Subject|0
7116314|NCT02563899|11251823|FG001|Overall Study|Withdrawal by Subject|0
7116315|NCT02563899|11251824|FG002|Overall Study|Withdrawal by Subject|1
7116316|NCT02563899|11251825|FG003|Overall Study|Withdrawal by Subject|0
7116317|NCT02564042|11251873|FG000|Overall Study|Adverse Event|4
7116318|NCT02564042|11251874|FG001|Overall Study|Adverse Event|4
7116319|NCT02564042|11251875|FG002|Overall Study|Adverse Event|3
7116320|NCT02564042|11251876|FG003|Overall Study|Adverse Event|0
7116321|NCT02564042|11251877|FG004|Overall Study|Adverse Event|0
7116322|NCT02564042|11251878|FG005|Overall Study|Adverse Event|1
7116323|NCT02564042|11251873|FG000|Overall Study|Lost to Follow-up|1
7116324|NCT02564042|11251874|FG001|Overall Study|Lost to Follow-up|1
7116325|NCT02564042|11251875|FG002|Overall Study|Lost to Follow-up|1
7116326|NCT02564042|11251876|FG003|Overall Study|Lost to Follow-up|0
7116327|NCT02564042|11251877|FG004|Overall Study|Lost to Follow-up|1
7116328|NCT02564042|11251878|FG005|Overall Study|Lost to Follow-up|1
7116329|NCT02564042|11251873|FG000|Overall Study|Physician Decision|1
7116330|NCT02564042|11251874|FG001|Overall Study|Physician Decision|0
7116331|NCT02564042|11251875|FG002|Overall Study|Physician Decision|0
7116332|NCT02564042|11251876|FG003|Overall Study|Physician Decision|1
7116333|NCT02564042|11251877|FG004|Overall Study|Physician Decision|0
7116334|NCT02564042|11251878|FG005|Overall Study|Physician Decision|0
7116335|NCT02564042|11251873|FG000|Overall Study|Withdrawal by Subject|5
7116336|NCT02564042|11251874|FG001|Overall Study|Withdrawal by Subject|3
7116337|NCT02564042|11251875|FG002|Overall Study|Withdrawal by Subject|2
7116338|NCT02564042|11251876|FG003|Overall Study|Withdrawal by Subject|2
7116339|NCT02564042|11251877|FG004|Overall Study|Withdrawal by Subject|10
7116340|NCT02564042|11251878|FG005|Overall Study|Withdrawal by Subject|12
7116341|NCT02564055|11251898|FG000|Overall Study|Adverse Event|1
7116342|NCT02564055|11251899|FG001|Overall Study|Adverse Event|0
7116343|NCT02564055|11251900|FG002|Overall Study|Adverse Event|4
7116344|NCT02564055|11251901|FG003|Overall Study|Adverse Event|1
7116345|NCT02564055|11251902|FG004|Overall Study|Adverse Event|4
7116346|NCT02564055|11251903|FG005|Overall Study|Adverse Event|1
7116347|NCT02564055|11251898|FG000|Overall Study|Protocol Violation|1
7116348|NCT02564055|11251899|FG001|Overall Study|Protocol Violation|0
7116349|NCT02564055|11251900|FG002|Overall Study|Protocol Violation|0
7116350|NCT02564055|11251901|FG003|Overall Study|Protocol Violation|0
7116351|NCT02564055|11251902|FG004|Overall Study|Protocol Violation|0
7116352|NCT02564055|11251903|FG005|Overall Study|Protocol Violation|0
7116353|NCT02564055|11251898|FG000|Overall Study|Reached stopping criteria|0
7116354|NCT02564055|11251899|FG001|Overall Study|Reached stopping criteria|0
7116355|NCT02564055|11251900|FG002|Overall Study|Reached stopping criteria|0
7116356|NCT02564055|11251901|FG003|Overall Study|Reached stopping criteria|0
7116357|NCT02564055|11251902|FG004|Overall Study|Reached stopping criteria|0
7116358|NCT02564055|11251903|FG005|Overall Study|Reached stopping criteria|1
7116359|NCT02564055|11251898|FG000|Overall Study|Lost to Follow-up|0
7116360|NCT02564055|11251899|FG001|Overall Study|Lost to Follow-up|1
7116361|NCT02564055|11251900|FG002|Overall Study|Lost to Follow-up|4
7116362|NCT02564055|11251901|FG003|Overall Study|Lost to Follow-up|2
7116363|NCT02564055|11251902|FG004|Overall Study|Lost to Follow-up|1
7116364|NCT02564055|11251903|FG005|Overall Study|Lost to Follow-up|0
7116365|NCT02564055|11251898|FG000|Overall Study|Physician Decision|0
7116366|NCT02564055|11251899|FG001|Overall Study|Physician Decision|0
7116367|NCT02564055|11251900|FG002|Overall Study|Physician Decision|1
7116368|NCT02564055|11251901|FG003|Overall Study|Physician Decision|0
7116369|NCT02564055|11251902|FG004|Overall Study|Physician Decision|0
7116370|NCT02564055|11251903|FG005|Overall Study|Physician Decision|0
7116371|NCT02564055|11251898|FG000|Overall Study|Withdrawal by Subject|4
7116372|NCT02564055|11251899|FG001|Overall Study|Withdrawal by Subject|4
7116373|NCT02564055|11251900|FG002|Overall Study|Withdrawal by Subject|3
7116374|NCT02564055|11251901|FG003|Overall Study|Withdrawal by Subject|3
7116375|NCT02564055|11251902|FG004|Overall Study|Withdrawal by Subject|10
7116376|NCT02564055|11251903|FG005|Overall Study|Withdrawal by Subject|10
7116377|NCT02564120|11251922|FG000|Overall Study|Did not return release forms|160
7116378|NCT02564120|11251922|FG000|Overall Study|Death|58
7116379|NCT02564120|11251922|FG000|Overall Study|Withdrawal by Subject|204
7116380|NCT02564120|11251922|FG000|Overall Study|Other medical condition|24
7116381|NCT02564198|11251939|FG000|Overall Study|Withdrawal by Subject|2
7116382|NCT02564198|11251940|FG001|Overall Study|Withdrawal by Subject|4
7116383|NCT02564198|11251941|FG002|Overall Study|Withdrawal by Subject|0
7116384|NCT02564198|11251939|FG000|Overall Study|Adverse Event|0
7116385|NCT02564198|11251940|FG001|Overall Study|Adverse Event|1
7116386|NCT02564198|11251941|FG002|Overall Study|Adverse Event|0
7116387|NCT02564211|11251951|FG000|Overall Study|Adverse Event|4
7116388|NCT02564471|11251974|FG000|Overall Study|Adverse Event|1
7116389|NCT02564471|11251975|FG001|Overall Study|Adverse Event|0
7116390|NCT02564471|11251976|FG002|Overall Study|Adverse Event|0
7116391|NCT02564471|11251977|FG003|Overall Study|Adverse Event|0
7116392|NCT02564471|11251974|FG000|Overall Study|Withdrawal by Subject|2
7116393|NCT02564471|11251975|FG001|Overall Study|Withdrawal by Subject|1
7116394|NCT02564471|11251976|FG002|Overall Study|Withdrawal by Subject|3
7116395|NCT02564471|11251977|FG003|Overall Study|Withdrawal by Subject|0
7116396|NCT02564471|11251974|FG000|Overall Study|Lost to Follow-up|0
7116397|NCT02564471|11251975|FG001|Overall Study|Lost to Follow-up|2
7116398|NCT02564471|11251976|FG002|Overall Study|Lost to Follow-up|0
7116399|NCT02564471|11251977|FG003|Overall Study|Lost to Follow-up|0
7116400|NCT02564718|11251998|FG000|Overall Study|Withdrew from treatment|0
7116401|NCT02564718|11251999|FG001|Overall Study|Withdrew from treatment|1
7116402|NCT02564887|11252007|FG000|Overall Study|Lost to Follow-up|6
7116403|NCT02564887|11252008|FG001|Overall Study|Lost to Follow-up|0
7116404|NCT02564952|11252025|FG000|Overall Study|Adverse Event|6
7116405|NCT02564952|11252025|FG000|Overall Study|Lost to Follow-up|1
7116406|NCT02564952|11252025|FG000|Overall Study|Participant Withdrawn by Investigator|1
7116407|NCT02564952|11252025|FG000|Overall Study|Withdrawal by Subject|1
7116408|NCT02564952|11252025|FG000|Overall Study|Low Efficacy|1
7116409|NCT02564952|11252025|FG000|Overall Study|Participant Met Withdrawal Criteria|1
7116410|NCT02565108|11252031|FG000|Overall Study|Adverse Event|1
7116411|NCT02565108|11252032|FG001|Overall Study|Adverse Event|0
7116412|NCT02565108|11252031|FG000|Overall Study|Withdrew Consent|1
7116413|NCT02565108|11252032|FG001|Overall Study|Withdrew Consent|0
7116414|NCT02565147|11252040|FG000|Overall Study|Withdrawal by Subject|5
7116415|NCT02565147|11252041|FG001|Overall Study|Withdrawal by Subject|1
7116416|NCT02565147|11252040|FG000|Overall Study|Lost to Follow-up|0
7116417|NCT02565147|11252041|FG001|Overall Study|Lost to Follow-up|1
7116418|NCT02565147|11252040|FG000|Overall Study|Death|1
7116419|NCT02565147|11252041|FG001|Overall Study|Death|1
7116420|NCT02565186|11252049|FG000|Overall Study|Adverse Event|113
7116421|NCT02565186|11252050|FG001|Overall Study|Adverse Event|148
7116422|NCT02565186|11252049|FG000|Overall Study|Lost to Follow-up|102
7116423|NCT02565186|11252050|FG001|Overall Study|Lost to Follow-up|93
7116424|NCT02565186|11252049|FG000|Overall Study|Non-Compliance|57
7116425|NCT02565186|11252050|FG001|Overall Study|Non-Compliance|55
7116426|NCT02565186|11252049|FG000|Overall Study|Withdrawal by Subject|229
7116427|NCT02565186|11252050|FG001|Overall Study|Withdrawal by Subject|214
7116428|NCT02565186|11252049|FG000|Overall Study|Physician Decision|18
7116429|NCT02565186|11252050|FG001|Overall Study|Physician Decision|16
7116430|NCT02565186|11252049|FG000|Overall Study|Sponsor Request|5
7116431|NCT02565186|11252050|FG001|Overall Study|Sponsor Request|9
7116432|NCT02565186|11252049|FG000|Overall Study|Missing|1
7116433|NCT02565186|11252050|FG001|Overall Study|Missing|0
7116434|NCT02565186|11252049|FG000|Overall Study|Did Not Receive Study Drug|55
7116435|NCT02565186|11252050|FG001|Overall Study|Did Not Receive Study Drug|86
7116436|NCT02565381|11252059|FG000|Overall Study|Lost to Follow-up|1
7116437|NCT02565381|11252060|FG001|Overall Study|Lost to Follow-up|0
7116438|NCT02565381|11252061|FG002|Overall Study|Lost to Follow-up|1
7116439|NCT02565511|11252082|FG000|Overall Study|Study terminated by Sponsor|35
7116440|NCT02565511|11252083|FG001|Overall Study|Study terminated by Sponsor|22
7116441|NCT02565511|11252084|FG002|Overall Study|Study terminated by Sponsor|235
7116442|NCT02565511|11252085|FG003|Overall Study|Study terminated by Sponsor|156
7116443|NCT02565511|11252082|FG000|Overall Study|Withdrawal by Subject|3
7116444|NCT02565511|11252083|FG001|Overall Study|Withdrawal by Subject|0
7116445|NCT02565511|11252084|FG002|Overall Study|Withdrawal by Subject|12
7116446|NCT02565511|11252085|FG003|Overall Study|Withdrawal by Subject|5
7116447|NCT02565511|11252082|FG000|Overall Study|Adverse Event|0
7116448|NCT02565511|11252083|FG001|Overall Study|Adverse Event|0
7116449|NCT02565511|11252084|FG002|Overall Study|Adverse Event|1
7116450|NCT02565511|11252085|FG003|Overall Study|Adverse Event|1
7116451|NCT02565511|11252082|FG000|Overall Study|Lost to Follow-up|4
7116452|NCT02565511|11252083|FG001|Overall Study|Lost to Follow-up|1
7116453|NCT02565511|11252084|FG002|Overall Study|Lost to Follow-up|0
7116454|NCT02565511|11252085|FG003|Overall Study|Lost to Follow-up|1
7116455|NCT02565511|11252082|FG000|Overall Study|Physician Decision|0
7116456|NCT02565511|11252083|FG001|Overall Study|Physician Decision|0
7116457|NCT02565511|11252084|FG002|Overall Study|Physician Decision|0
7116458|NCT02565511|11252085|FG003|Overall Study|Physician Decision|1
7116459|NCT02565511|11252082|FG000|Overall Study|Protocol deviation|0
7116460|NCT02565511|11252083|FG001|Overall Study|Protocol deviation|0
7116461|NCT02565511|11252084|FG002|Overall Study|Protocol deviation|3
7116462|NCT02565511|11252085|FG003|Overall Study|Protocol deviation|0
7116463|NCT02565576|11252097|FG000|Overall Study|abnormal lab value|2
7116464|NCT02565576|11252098|FG001|Overall Study|abnormal lab value|0
7116465|NCT02565576|11252097|FG000|Overall Study|subject / guardian decision|1
7116466|NCT02565576|11252098|FG001|Overall Study|subject / guardian decision|3
7116467|NCT02565576|11252097|FG000|Overall Study|Lost to Follow-up|1
7116468|NCT02565576|11252098|FG001|Overall Study|Lost to Follow-up|0
7116469|NCT02565576|11252097|FG000|Overall Study|Death|0
7116470|NCT02565576|11252098|FG001|Overall Study|Death|2
7116471|NCT02565576|11252097|FG000|Overall Study|Adverse Event|1
7116472|NCT02565576|11252098|FG001|Overall Study|Adverse Event|0
7116473|NCT02565615|11252109|FG000|Overall Study|Death|0
7116474|NCT02565615|11252110|FG001|Overall Study|Death|1
7116475|NCT02565615|11252111|FG002|Overall Study|Death|0
7116476|NCT02565615|11252112|FG003|Overall Study|Death|0
7116477|NCT02565615|11252113|FG004|Overall Study|Death|4
7116478|NCT02565615|11252109|FG000|Overall Study|Not willing to participate in study|2
7116479|NCT02565615|11252110|FG001|Overall Study|Not willing to participate in study|21
7116480|NCT02565615|11252111|FG002|Overall Study|Not willing to participate in study|0
7116481|NCT02565615|11252112|FG003|Overall Study|Not willing to participate in study|1
7116482|NCT02565615|11252113|FG004|Overall Study|Not willing to participate in study|169
7116483|NCT02565615|11252109|FG000|Overall Study|Lost to Follow-up|0
7116484|NCT02565615|11252110|FG001|Overall Study|Lost to Follow-up|4
7116485|NCT02565615|11252111|FG002|Overall Study|Lost to Follow-up|0
7116486|NCT02565615|11252112|FG003|Overall Study|Lost to Follow-up|1
7116487|NCT02565615|11252113|FG004|Overall Study|Lost to Follow-up|765
7116488|NCT02565615|11252109|FG000|Overall Study|Not meeting eligibility criteria|0
7116489|NCT02565615|11252110|FG001|Overall Study|Not meeting eligibility criteria|7
7116490|NCT02565615|11252111|FG002|Overall Study|Not meeting eligibility criteria|0
7116491|NCT02565615|11252112|FG003|Overall Study|Not meeting eligibility criteria|0
7116492|NCT02565615|11252113|FG004|Overall Study|Not meeting eligibility criteria|25
7116493|NCT02565615|11252109|FG000|Overall Study|Reason not defined|0
7116494|NCT02565615|11252110|FG001|Overall Study|Reason not defined|2
7116495|NCT02565615|11252111|FG002|Overall Study|Reason not defined|0
7116496|NCT02565615|11252112|FG003|Overall Study|Reason not defined|1
7116497|NCT02565615|11252113|FG004|Overall Study|Reason not defined|62
7116498|NCT02565615|11252109|FG000|Overall Study|Adverse Event|1
7116499|NCT02565615|11252110|FG001|Overall Study|Adverse Event|1
7116500|NCT02565615|11252111|FG002|Overall Study|Adverse Event|0
7116501|NCT02565615|11252112|FG003|Overall Study|Adverse Event|0
7116502|NCT02565615|11252113|FG004|Overall Study|Adverse Event|9
7116503|NCT02565615|11252109|FG000|Overall Study|Untreated|0
7116504|NCT02565615|11252110|FG001|Overall Study|Untreated|0
7116505|NCT02565615|11252111|FG002|Overall Study|Untreated|0
7116506|NCT02565615|11252112|FG003|Overall Study|Untreated|0
7116507|NCT02565615|11252113|FG004|Overall Study|Untreated|567
7116508|NCT02565706|11252138|FG000|Overall Study|Withdrawal by Subject|5
7116509|NCT02565706|11252139|FG001|Overall Study|Withdrawal by Subject|7
7116510|NCT02565706|11252140|FG002|Overall Study|Withdrawal by Subject|7
7116511|NCT02565706|11252141|FG003|Overall Study|Withdrawal by Subject|11
7116512|NCT02565706|11252138|FG000|Overall Study|Lost to Follow-up|72
7116513|NCT02565706|11252139|FG001|Overall Study|Lost to Follow-up|75
7116514|NCT02565706|11252140|FG002|Overall Study|Lost to Follow-up|82
7116515|NCT02565706|11252141|FG003|Overall Study|Lost to Follow-up|74
7116516|NCT02565784|11252156|FG000|First Treatment|Adverse Event|1
7116517|NCT02565784|11252156|FG000|First Treatment|Withdrawal by Subject|1
7116518|NCT02565784|11252156|FG000|Second Treatment|Withdrawal by Subject|2
7116519|NCT02565810|11252164|FG000|Overall Study|Withdrawal by Subject|1
7116520|NCT02566005|11252189|FG000|Overall Study|vaginal bleeding|0
7116521|NCT02566005|11252190|FG001|Overall Study|vaginal bleeding|1
7116522|NCT02566005|11252189|FG000|Overall Study|received foley|8
7116523|NCT02566005|11252190|FG001|Overall Study|received foley|0
7116524|NCT02566005|11252189|FG000|Overall Study|did not receive foley|0
7116525|NCT02566005|11252190|FG001|Overall Study|did not receive foley|1
7116526|NCT02566005|11252189|FG000|Overall Study|labor after randomization|0
7116527|NCT02566005|11252190|FG001|Overall Study|labor after randomization|4
7116528|NCT02566031|11252198|FG000|Overall Study|Patient/guardian decision|14
7116529|NCT02566031|11252199|FG001|Overall Study|Patient/guardian decision|7
7116530|NCT02566031|11252198|FG000|Overall Study|Protocol deviation|2
7116531|NCT02566031|11252199|FG001|Overall Study|Protocol deviation|3
7116532|NCT02566031|11252198|FG000|Overall Study|Adverse Event|3
7116533|NCT02566031|11252199|FG001|Overall Study|Adverse Event|1
7116534|NCT02566031|11252198|FG000|Overall Study|Lost to Follow-up|1
6805950|NCT01632878|10808209|FG000|Screening|Physician Decision|268
6805951|NCT01632878|10808209|FG000|Treatment|Lost to Follow-up|41
6805952|NCT01632878|10808209|FG000|Treatment|Withdrawal by Subject|36
6805953|NCT01632878|10808209|FG000|Treatment|Physician Decision|34
6805954|NCT01632878|10808209|FG000|Treatment|missing information|4
6805955|NCT01632878|10808209|FG000|Treatment|no information on study completion|43
6805956|NCT01097005|10808217|FG000|Overall Study|Case Report Form not collected|18
6805957|NCT01097005|10808217|FG000|Overall Study|Subjects cannot visit the hospital|1
6805958|NCT01097005|10808217|FG000|Overall Study|Poor medication compliance|1
6805959|NCT01097005|10808217|FG000|Overall Study|No examination data available|244
6805960|NCT01097005|10808217|FG000|Overall Study|Deviation from exclusion criteria|37
6805961|NCT01097005|10808217|FG000|Overall Study|Adverse Event|14
6805962|NCT01097005|10808217|FG000|Overall Study|Discontinuance by complication|50
6805963|NCT00931255|10808229|FG000|Overall Study|Follow up biopsy not done|2
6805964|NCT00931255|10808230|FG001|Overall Study|Follow up biopsy not done|3
6811168|NCT02407236|10815055|FG003|Maintenance Study (44 Weeks)|Death|0
6811169|NCT02407236|10815056|FG004|Maintenance Study (44 Weeks)|Death|0
6811170|NCT02407236|10815057|FG005|Maintenance Study (44 Weeks)|Death|0
6811171|NCT02407236|10815058|FG006|Maintenance Study (44 Weeks)|Death|0
6811172|NCT02407236|10815059|FG007|Maintenance Study (44 Weeks)|Death|1
6811173|NCT02407236|10815052|FG000|Maintenance Study (44 Weeks)|Withdraw of consent|0
6811174|NCT02407236|10815053|FG001|Maintenance Study (44 Weeks)|Withdraw of consent|0
6811175|NCT02407236|10815054|FG002|Maintenance Study (44 Weeks)|Withdraw of consent|0
6811176|NCT02407236|10815055|FG003|Maintenance Study (44 Weeks)|Withdraw of consent|8
6811177|NCT02407236|10815056|FG004|Maintenance Study (44 Weeks)|Withdraw of consent|10
6811178|NCT02407236|10815057|FG005|Maintenance Study (44 Weeks)|Withdraw of consent|5
6811179|NCT02407236|10815058|FG006|Maintenance Study (44 Weeks)|Withdraw of consent|7
6811180|NCT02407236|10815059|FG007|Maintenance Study (44 Weeks)|Withdraw of consent|5
7116535|NCT02566031|11252199|FG001|Overall Study|Lost to Follow-up|1
7116536|NCT02566109|11252233|FG000|Overall Study|Withdrawal by Subject|1
7116537|NCT02566525|11252284|FG000|Overall Study|Protocol Violation|3
7116538|NCT02566525|11252285|FG001|Overall Study|Protocol Violation|5
7116539|NCT02566577|11252295|FG000|Overall Study|Withdrawal by Subject|1
7116540|NCT02566577|11252296|FG001|Overall Study|Withdrawal by Subject|1
7116541|NCT02566577|11252295|FG000|Overall Study|Equipment failure|1
7116542|NCT02566577|11252296|FG001|Overall Study|Equipment failure|1
7116543|NCT02566577|11252295|FG000|Overall Study|Physical limitation|1
7116544|NCT02566577|11252296|FG001|Overall Study|Physical limitation|0
7116545|NCT02566759|11252330|FG000|All Parts|Withdrawal by Subject|0
7116546|NCT02566759|11252331|FG001|All Parts|Withdrawal by Subject|1
7116547|NCT02566759|11252332|FG002|All Parts|Withdrawal by Subject|0
7116548|NCT02566759|11252333|FG003|All Parts|Withdrawal by Subject|0
7116549|NCT02566759|11252334|FG004|All Parts|Withdrawal by Subject|0
7116550|NCT02566759|11252335|FG005|All Parts|Withdrawal by Subject|0
7116551|NCT02566759|11252336|FG006|All Parts|Withdrawal by Subject|0
7116552|NCT02566759|11252337|FG007|All Parts|Withdrawal by Subject|0
7116553|NCT02566759|11252338|FG008|All Parts|Withdrawal by Subject|0
7116554|NCT02566759|11252339|FG009|All Parts|Withdrawal by Subject|0
7116555|NCT02566759|11252340|FG010|All Parts|Withdrawal by Subject|0
7116556|NCT02566759|11252341|FG011|All Parts|Withdrawal by Subject|0
7116557|NCT02566759|11252342|FG012|All Parts|Withdrawal by Subject|0
7116558|NCT02566759|11252343|FG013|All Parts|Withdrawal by Subject|0
7116559|NCT02566759|11252344|FG014|All Parts|Withdrawal by Subject|0
7116560|NCT02566759|11252345|FG015|All Parts|Withdrawal by Subject|0
7116561|NCT02566759|11252346|FG016|All Parts|Withdrawal by Subject|0
7116562|NCT02566759|11252330|FG000|All Parts|Adverse Event|0
7116563|NCT02566759|11252331|FG001|All Parts|Adverse Event|0
7116564|NCT02566759|11252332|FG002|All Parts|Adverse Event|0
7116565|NCT02566759|11252333|FG003|All Parts|Adverse Event|0
7116566|NCT02566759|11252334|FG004|All Parts|Adverse Event|0
7116567|NCT02566759|11252335|FG005|All Parts|Adverse Event|0
7116568|NCT02566759|11252336|FG006|All Parts|Adverse Event|0
7116569|NCT02566759|11252337|FG007|All Parts|Adverse Event|0
7116570|NCT02566759|11252338|FG008|All Parts|Adverse Event|0
7116571|NCT02566759|11252339|FG009|All Parts|Adverse Event|0
7116572|NCT02566759|11252340|FG010|All Parts|Adverse Event|0
7116573|NCT02566759|11252341|FG011|All Parts|Adverse Event|0
7116574|NCT02566759|11252342|FG012|All Parts|Adverse Event|1
7116575|NCT02566759|11252343|FG013|All Parts|Adverse Event|3
7116576|NCT02566759|11252344|FG014|All Parts|Adverse Event|0
7116577|NCT02566759|11252345|FG015|All Parts|Adverse Event|0
7116578|NCT02566759|11252346|FG016|All Parts|Adverse Event|0
7116579|NCT02566759|11252330|FG000|All Parts|Other|0
7116580|NCT02566759|11252331|FG001|All Parts|Other|0
7116581|NCT02566759|11252332|FG002|All Parts|Other|0
7116582|NCT02566759|11252333|FG003|All Parts|Other|0
7116583|NCT02566759|11252334|FG004|All Parts|Other|0
7116584|NCT02566759|11252335|FG005|All Parts|Other|0
7116585|NCT02566759|11252336|FG006|All Parts|Other|0
7116586|NCT02566759|11252337|FG007|All Parts|Other|0
7116587|NCT02566759|11252338|FG008|All Parts|Other|0
7116588|NCT02566759|11252339|FG009|All Parts|Other|0
7116589|NCT02566759|11252340|FG010|All Parts|Other|0
7116590|NCT02566759|11252341|FG011|All Parts|Other|0
7116591|NCT02566759|11252342|FG012|All Parts|Other|0
7116592|NCT02566759|11252343|FG013|All Parts|Other|2
7116593|NCT02566759|11252344|FG014|All Parts|Other|0
7116594|NCT02566759|11252345|FG015|All Parts|Other|0
7116595|NCT02566759|11252346|FG016|All Parts|Other|0
7116596|NCT02566759|11252330|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7116597|NCT02566759|11252331|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7116598|NCT02566759|11252332|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7116599|NCT02566759|11252333|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7116600|NCT02566759|11252334|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7116601|NCT02566759|11252335|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7116602|NCT02566759|11252336|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7116603|NCT02566759|11252337|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7116604|NCT02566759|11252338|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7116605|NCT02566759|11252339|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7116606|NCT02566759|11252340|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7116607|NCT02566759|11252341|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7116608|NCT02566759|11252342|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7116609|NCT02566759|11252343|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7116610|NCT02566759|11252344|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7116611|NCT02566759|11252345|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7116612|NCT02566759|11252346|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1
7116613|NCT02566785|11252407|FG000|Overall Study|Lost to Follow-up|0
7116614|NCT02566785|11252408|FG001|Overall Study|Lost to Follow-up|2
7116615|NCT02566785|11252407|FG000|Overall Study|Worsening condition|1
7116616|NCT02566785|11252408|FG001|Overall Study|Worsening condition|1
7116617|NCT02566889|11252416|FG000|Overall Study|Withdrawal by Subject|3
7116618|NCT02566889|11252417|FG001|Overall Study|Withdrawal by Subject|1
7116619|NCT02566889|11252416|FG000|Overall Study|Adverse Event|4
7116620|NCT02566889|11252417|FG001|Overall Study|Adverse Event|2
7116621|NCT02566889|11252416|FG000|Overall Study|Other|6
7116622|NCT02566889|11252417|FG001|Overall Study|Other|2
7116623|NCT02566902|11252424|FG000|Overall Study|Protocol Violation|2
7116624|NCT02566902|11252425|FG001|Overall Study|Protocol Violation|1
7116625|NCT02566993|11252433|FG000|Overall Study|Randomized but not treated|5
7116626|NCT02566993|11252434|FG001|Overall Study|Randomized but not treated|16
7116627|NCT02566993|11252433|FG000|Overall Study|Progressive disease|213
7116628|NCT02566993|11252434|FG001|Overall Study|Progressive disease|152
7116629|NCT02566993|11252433|FG000|Overall Study|Withdrawal by Subject|12
7116630|NCT02566993|11252434|FG001|Overall Study|Withdrawal by Subject|28
7116631|NCT02566993|11252433|FG000|Overall Study|Death|17
7116632|NCT02566993|11252434|FG001|Overall Study|Death|23
7116633|NCT02566993|11252433|FG000|Overall Study|Physician Decision|10
7116634|NCT02566993|11252434|FG001|Overall Study|Physician Decision|17
7116635|NCT02566993|11252433|FG000|Overall Study|Study drug-related adverse event|20
7116636|NCT02566993|11252434|FG001|Overall Study|Study drug-related adverse event|41
7116637|NCT02566993|11252433|FG000|Overall Study|Non study drug-related adverse event|9
7116638|NCT02566993|11252434|FG001|Overall Study|Non study drug-related adverse event|9
7116639|NCT02566993|11252433|FG000|Overall Study|Symptomatic deterioration|9
7116640|NCT02566993|11252434|FG001|Overall Study|Symptomatic deterioration|16
7116641|NCT02566993|11252433|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9
7116642|NCT02566993|11252434|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1
7116643|NCT02566993|11252433|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1
7116644|NCT02566993|11252434|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1
7116645|NCT02566993|11252433|FG000|Overall Study|Screening failure|2
7116646|NCT02566993|11252434|FG001|Overall Study|Screening failure|0
7116647|NCT02566993|11252433|FG000|Overall Study|Lost to Follow-up|0
7116648|NCT02566993|11252434|FG001|Overall Study|Lost to Follow-up|1
7116649|NCT02566993|11252433|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0
7116650|NCT02566993|11252434|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1
7116651|NCT02567188|11252442|FG000|Overall Study|Death|10
7116652|NCT02567188|11252442|FG000|Overall Study|Terminated Mircera Treatment|9
7116653|NCT02567188|11252442|FG000|Overall Study|Lost to Follow-up|5
7116654|NCT02567188|11252442|FG000|Overall Study|Adverse Event|1
7116655|NCT02567188|11252442|FG000|Overall Study|Withdrawal by Subject|1
7116656|NCT02567188|11252442|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1
7116657|NCT02567188|11252442|FG000|Overall Study|Moved and Changed Clinic|1
7116658|NCT02567188|11252442|FG000|Overall Study|Started Hemodialysis|2
7116659|NCT02567188|11252442|FG000|Overall Study|Protocol Violation|5
7116660|NCT02567227|11252449|FG000|9 Weeks|Adverse Event|5
7116661|NCT02567227|11252450|FG001|9 Weeks|Adverse Event|5
7116662|NCT02567227|11252449|FG000|9 Weeks|Withdrawal by Subject|18
7116663|NCT02567227|11252450|FG001|9 Weeks|Withdrawal by Subject|8
7116664|NCT02567227|11252449|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11
7116665|NCT02567227|11252450|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11
7116666|NCT02567227|11252449|FG000|6 Month|Death|2
7116667|NCT02567227|11252450|FG001|6 Month|Death|0
7116668|NCT02567227|11252449|FG000|6 Month|Lost to Follow-up|43
7116669|NCT02567227|11252450|FG001|6 Month|Lost to Follow-up|40
7116670|NCT02567227|11252449|FG000|12 Months|Lost to Follow-up|31
7116671|NCT02567227|11252450|FG001|12 Months|Lost to Follow-up|32
7116672|NCT02567227|11252449|FG000|12 Months|Death|0
7116673|NCT02567227|11252450|FG001|12 Months|Death|2
7116674|NCT02567266|11252459|FG000|Overall Study|Withdrawal by Subject|10
7116675|NCT02567266|11252460|FG001|Overall Study|Withdrawal by Subject|7
7116676|NCT02567266|11252461|FG002|Overall Study|Withdrawal by Subject|6
7116677|NCT02567266|11252459|FG000|Overall Study|Lost to Follow-up|13
7116678|NCT02567266|11252460|FG001|Overall Study|Lost to Follow-up|8
7116679|NCT02567266|11252461|FG002|Overall Study|Lost to Follow-up|10
7116680|NCT02567552|11252471|FG000|Overall Study|Adverse Event|0
7116681|NCT02567552|11252472|FG001|Overall Study|Adverse Event|1
7116682|NCT02567656|11252484|FG000|Overall Study|Premature discontinuation due to PD|1
7116683|NCT02567656|11252485|FG001|Overall Study|Premature discontinuation due to PD|1
7116684|NCT02567656|11252486|FG002|Overall Study|Premature discontinuation due to PD|2
7116685|NCT02567656|11252487|FG003|Overall Study|Premature discontinuation due to PD|0
7116686|NCT02567656|11252488|FG004|Overall Study|Premature discontinuation due to PD|0
7116687|NCT02567656|11252489|FG005|Overall Study|Premature discontinuation due to PD|0
7116688|NCT02567708|11252503|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0
7116689|NCT02567708|11252504|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2
7116690|NCT02567708|11252503|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0
7116691|NCT02567708|11252504|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1
7116692|NCT02567708|11252503|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2
7116693|NCT02567708|11252504|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0
7116694|NCT02567708|11252503|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0
7116695|NCT02567708|11252504|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3
7116696|NCT02568046|11252520|FG000|Overall Study|Adverse Event|0
7116697|NCT02568046|11252521|FG001|Overall Study|Adverse Event|1
7116698|NCT02568046|11252520|FG000|Overall Study|Death|2
7116699|NCT02568046|11252521|FG001|Overall Study|Death|0
7116700|NCT02568046|11252520|FG000|Overall Study|Progressive Disease|1
7116701|NCT02568046|11252521|FG001|Overall Study|Progressive Disease|0
7116702|NCT02568046|11252520|FG000|Overall Study|Withdrawal by Subject|2
7116703|NCT02568046|11252521|FG001|Overall Study|Withdrawal by Subject|1
7116704|NCT02568046|11252520|FG000|Overall Study|Other Events|0
7116705|NCT02568046|11252521|FG001|Overall Study|Other Events|1
7116706|NCT02568072|11252527|FG000|Overall Study|Unavailable for appointment|23
7116707|NCT02568072|11252527|FG000|Overall Study|Unable to contact|3
7116708|NCT02568072|11252527|FG000|Overall Study|Diagnosis of Long QT Syndrome|1
7116709|NCT02568072|11252527|FG000|Overall Study|Withdrawal by Subject|1
7116710|NCT02568072|11252527|FG000|Overall Study|Sustained injury, marathon not run|24
7116711|NCT02568254|11252532|FG000|Period 2|Adverse Event|0
7116712|NCT02568254|11252533|FG001|Period 2|Adverse Event|0
7116713|NCT02568254|11252534|FG002|Period 2|Adverse Event|1
7116714|NCT02568254|11252535|FG003|Period 2|Adverse Event|0
7116715|NCT02568254|11252536|FG004|Period 2|Adverse Event|0
7116716|NCT02568254|11252537|FG005|Period 2|Adverse Event|0
7116717|NCT02568254|11252532|FG000|Period 3|Unstatisfactory Lens fitting|0
7116718|NCT02568254|11252533|FG001|Period 3|Unstatisfactory Lens fitting|0
7116719|NCT02568254|11252534|FG002|Period 3|Unstatisfactory Lens fitting|0
7116720|NCT02568254|11252535|FG003|Period 3|Unstatisfactory Lens fitting|0
7116721|NCT02568254|11252536|FG004|Period 3|Unstatisfactory Lens fitting|1
7116722|NCT02568254|11252537|FG005|Period 3|Unstatisfactory Lens fitting|0
7116723|NCT02568384|11252549|FG000|Overall Study|Mobile devices incompatible with App|2
7116724|NCT02568397|11252553|FG000|Period 2|Withdrawal by Subject|0
7116725|NCT02568397|11252554|FG001|Period 2|Withdrawal by Subject|1
7116726|NCT02568397|11252553|FG000|Period 2|Physician Decision|0
7116727|NCT02568397|11252554|FG001|Period 2|Physician Decision|1
7116728|NCT02568475|11252571|FG000|Overall Study|Lost to Follow-up|40
7116729|NCT02568475|11252572|FG001|Overall Study|Lost to Follow-up|39
7116730|NCT02568475|11252571|FG000|Overall Study|Withdrawal by Subject|2
7116731|NCT02568475|11252572|FG001|Overall Study|Withdrawal by Subject|0
7116732|NCT02568475|11252571|FG000|Overall Study|Discharged home|4
7116733|NCT02568475|11252572|FG001|Overall Study|Discharged home|4
7116734|NCT02568475|11252571|FG000|Overall Study|Short-term: Discharge location unknown|4
7116735|NCT02568475|11252572|FG001|Overall Study|Short-term: Discharge location unknown|0
7116736|NCT02568475|11252571|FG000|Overall Study|Transferred to another facility|1
7116737|NCT02568475|11252572|FG001|Overall Study|Transferred to another facility|0
7116738|NCT02568683|11252591|FG000|Overall Study|Death|0
7116739|NCT02568683|11252592|FG001|Overall Study|Death|2
7116740|NCT02568683|11252591|FG000|Overall Study|Withdrew Consent|1
7116741|NCT02568683|11252592|FG001|Overall Study|Withdrew Consent|0
7116742|NCT02568683|11252591|FG000|Overall Study|Study Terminated By Sponsor|5
7116743|NCT02568683|11252592|FG001|Overall Study|Study Terminated By Sponsor|2
7116744|NCT02569398|11252620|FG000|Overall Study|Adverse Event|0
7116745|NCT02569398|11252621|FG001|Overall Study|Adverse Event|1
7116746|NCT02569398|11252622|FG002|Overall Study|Adverse Event|6
7116747|NCT02569398|11252620|FG000|Overall Study|Withdrawal by Subject|43
7116748|NCT02569398|11252621|FG001|Overall Study|Withdrawal by Subject|43
7116749|NCT02569398|11252622|FG002|Overall Study|Withdrawal by Subject|30
7116750|NCT02569398|11252620|FG000|Overall Study|Study terminated by sponsor|130
7116751|NCT02569398|11252621|FG001|Overall Study|Study terminated by sponsor|131
7116752|NCT02569398|11252622|FG002|Overall Study|Study terminated by sponsor|134
7116753|NCT02569398|11252620|FG000|Overall Study|Other|12
7116754|NCT02569398|11252621|FG001|Overall Study|Other|14
7116755|NCT02569398|11252622|FG002|Overall Study|Other|13
7116756|NCT02569437|11252641|FG000|Overall Study|Lost to Follow-up|12
7116757|NCT02569437|11252642|FG001|Overall Study|Lost to Follow-up|14
7116758|NCT02569710|11252675|FG000|Overall Study|Adverse Event|1
7116759|NCT02569710|11252676|FG001|Overall Study|Adverse Event|0
7116760|NCT02569710|11252677|FG002|Overall Study|Adverse Event|0
7116761|NCT02569710|11252678|FG003|Overall Study|Adverse Event|0
7116762|NCT02569710|11252679|FG004|Overall Study|Adverse Event|0
7116763|NCT02569710|11252680|FG005|Overall Study|Adverse Event|0
7116764|NCT02569710|11252681|FG006|Overall Study|Adverse Event|0
7116765|NCT02569710|11252682|FG007|Overall Study|Adverse Event|0
7116766|NCT02569710|11252683|FG008|Overall Study|Adverse Event|0
7116767|NCT02569710|11252684|FG009|Overall Study|Adverse Event|0
7116768|NCT02569710|11252675|FG000|Overall Study|Lost to Follow-up|0
7116769|NCT02569710|11252676|FG001|Overall Study|Lost to Follow-up|0
7116770|NCT02569710|11252677|FG002|Overall Study|Lost to Follow-up|0
7116771|NCT02569710|11252678|FG003|Overall Study|Lost to Follow-up|0
7116772|NCT02569710|11252679|FG004|Overall Study|Lost to Follow-up|0
7116773|NCT02569710|11252680|FG005|Overall Study|Lost to Follow-up|0
7116774|NCT02569710|11252681|FG006|Overall Study|Lost to Follow-up|1
7116775|NCT02569710|11252682|FG007|Overall Study|Lost to Follow-up|0
7116776|NCT02569710|11252683|FG008|Overall Study|Lost to Follow-up|1
7116777|NCT02569710|11252684|FG009|Overall Study|Lost to Follow-up|0
7116778|NCT02569710|11252675|FG000|Overall Study|Virologic failure|0
7116779|NCT02569710|11252676|FG001|Overall Study|Virologic failure|0
7116780|NCT02569710|11252677|FG002|Overall Study|Virologic failure|0
7116781|NCT02569710|11252678|FG003|Overall Study|Virologic failure|0
7116782|NCT02569710|11252679|FG004|Overall Study|Virologic failure|1
7116783|NCT02569710|11252680|FG005|Overall Study|Virologic failure|0
7116784|NCT02569710|11252681|FG006|Overall Study|Virologic failure|1
7116785|NCT02569710|11252682|FG007|Overall Study|Virologic failure|0
7116786|NCT02569710|11252683|FG008|Overall Study|Virologic failure|0
7116787|NCT02569710|11252684|FG009|Overall Study|Virologic failure|0
7116788|NCT02569710|11252675|FG000|Overall Study|Withdrawal by Subject|0
7116789|NCT02569710|11252676|FG001|Overall Study|Withdrawal by Subject|0
7116790|NCT02569710|11252677|FG002|Overall Study|Withdrawal by Subject|0
7116791|NCT02569710|11252678|FG003|Overall Study|Withdrawal by Subject|0
7116792|NCT02569710|11252679|FG004|Overall Study|Withdrawal by Subject|0
7116793|NCT02569710|11252680|FG005|Overall Study|Withdrawal by Subject|1
7116794|NCT02569710|11252681|FG006|Overall Study|Withdrawal by Subject|0
7116795|NCT02569710|11252682|FG007|Overall Study|Withdrawal by Subject|0
7116796|NCT02569710|11252683|FG008|Overall Study|Withdrawal by Subject|0
7116797|NCT02569710|11252684|FG009|Overall Study|Withdrawal by Subject|0
7116798|NCT02569801|11252723|FG000|Overall Study|Withdrawal by Subject|9
7116799|NCT02569801|11252724|FG001|Overall Study|Withdrawal by Subject|9
7116800|NCT02569801|11252723|FG000|Overall Study|Sponsor Decision|13
7116801|NCT02569801|11252724|FG001|Overall Study|Sponsor Decision|14
7116802|NCT02569801|11252723|FG000|Overall Study|Progressive Disease|2
7116803|NCT02569801|11252724|FG001|Overall Study|Progressive Disease|7
7116804|NCT02569801|11252723|FG000|Overall Study|Lost to Follow-up|0
7116805|NCT02569801|11252724|FG001|Overall Study|Lost to Follow-up|1
7116806|NCT02569801|11252723|FG000|Overall Study|Death|12
7116807|NCT02569801|11252724|FG001|Overall Study|Death|4
7116808|NCT02569853|11252732|FG000|Overall Study|Adverse Event|2
7116809|NCT02569853|11252733|FG001|Overall Study|Adverse Event|0
7116810|NCT02569853|11252732|FG000|Overall Study|Withdrawal by Subject|3
7116811|NCT02569853|11252733|FG001|Overall Study|Withdrawal by Subject|2
7116812|NCT02569853|11252732|FG000|Overall Study|Lost to Follow-up|3
7116813|NCT02569853|11252733|FG001|Overall Study|Lost to Follow-up|3
7116814|NCT02569853|11252732|FG000|Overall Study|Protocol Violation|1
7116815|NCT02569853|11252733|FG001|Overall Study|Protocol Violation|1
7116816|NCT02569853|11252732|FG000|Overall Study|Did not experience migraine attack|10
7116817|NCT02569853|11252733|FG001|Overall Study|Did not experience migraine attack|7
7116818|NCT02569853|11252732|FG000|Overall Study|Physician Decision|1
7116819|NCT02569853|11252733|FG001|Overall Study|Physician Decision|1
7116820|NCT02569996|11252748|FG000|Overall Study|Adverse Event|6
7116821|NCT02569996|11252748|FG000|Overall Study|Physician Decision|3
7116822|NCT02569996|11252748|FG000|Overall Study|Progression of the disease|18
7116823|NCT02569996|11252748|FG000|Overall Study|New anti-lymphoma treatment|1
7116824|NCT02569996|11252748|FG000|Overall Study|Non-compliance|9
7116825|NCT02569996|11252748|FG000|Overall Study|Withdrawal by Subject|5
7116826|NCT02569996|11252748|FG000|Overall Study|Lost to Follow-up|5
7116827|NCT02569996|11252748|FG000|Overall Study|Complete remission|7
7116828|NCT02569996|11252748|FG000|Overall Study|Unknown reason|1
7116829|NCT02570074|11252763|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1
7116830|NCT02570074|11252764|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0
7116831|NCT02570126|11252784|FG000|Overall Study|Lost to Follow-up|2
7116832|NCT02570126|11252785|FG001|Overall Study|Lost to Follow-up|0
7116833|NCT02570126|11252784|FG000|Overall Study|Unable To Arrange Visit 3|1
7116834|NCT02570126|11252785|FG001|Overall Study|Unable To Arrange Visit 3|0
7116835|NCT02570126|11252784|FG000|Overall Study|Violation Of Procedures GSK|0
7116836|NCT02570126|11252785|FG001|Overall Study|Violation Of Procedures GSK|1
7116837|NCT02570126|11252784|FG000|Overall Study|Protocol Violation|0
7116838|NCT02570126|11252785|FG001|Overall Study|Protocol Violation|1
7116839|NCT02570126|11252784|FG000|Overall Study|Withdrawal by Subject|3
7116840|NCT02570126|11252785|FG001|Overall Study|Withdrawal by Subject|7
7116841|NCT02570152|11252800|FG000|Overall Study|Protocol Violation|2
7116842|NCT02570152|11252800|FG000|Overall Study|Migrated/moved from study area|13
7116843|NCT02570165|11252811|FG000|Overall Study|Adverse Event|1
7116844|NCT02570165|11252812|FG001|Overall Study|Adverse Event|0
7116845|NCT02570165|11252813|FG002|Overall Study|Adverse Event|2
7116846|NCT02570165|11252814|FG003|Overall Study|Adverse Event|0
7116847|NCT02570165|11252815|FG004|Overall Study|Adverse Event|0
7116848|NCT02570165|11252816|FG005|Overall Study|Adverse Event|0
7116849|NCT02570165|11252817|FG006|Overall Study|Adverse Event|0
7116850|NCT02570165|11252811|FG000|Overall Study|Lack of Efficacy|0
7116851|NCT02570165|11252812|FG001|Overall Study|Lack of Efficacy|1
7116852|NCT02570165|11252813|FG002|Overall Study|Lack of Efficacy|0
7116853|NCT02570165|11252814|FG003|Overall Study|Lack of Efficacy|0
7116854|NCT02570165|11252815|FG004|Overall Study|Lack of Efficacy|4
7116855|NCT02570165|11252816|FG005|Overall Study|Lack of Efficacy|0
7116856|NCT02570165|11252817|FG006|Overall Study|Lack of Efficacy|0
7116857|NCT02570165|11252811|FG000|Overall Study|Par. Reached Stopping Criteria|1
7116858|NCT02570165|11252812|FG001|Overall Study|Par. Reached Stopping Criteria|1
7116859|NCT02570165|11252813|FG002|Overall Study|Par. Reached Stopping Criteria|0
7116860|NCT02570165|11252814|FG003|Overall Study|Par. Reached Stopping Criteria|2
7116861|NCT02570165|11252815|FG004|Overall Study|Par. Reached Stopping Criteria|1
7116862|NCT02570165|11252816|FG005|Overall Study|Par. Reached Stopping Criteria|1
7116863|NCT02570165|11252817|FG006|Overall Study|Par. Reached Stopping Criteria|0
7116864|NCT02570165|11252811|FG000|Overall Study|Lost to Follow-up|0
7116865|NCT02570165|11252812|FG001|Overall Study|Lost to Follow-up|0
7116866|NCT02570165|11252813|FG002|Overall Study|Lost to Follow-up|1
7116867|NCT02570165|11252814|FG003|Overall Study|Lost to Follow-up|1
7116868|NCT02570165|11252815|FG004|Overall Study|Lost to Follow-up|0
7116869|NCT02570165|11252816|FG005|Overall Study|Lost to Follow-up|0
7116870|NCT02570165|11252817|FG006|Overall Study|Lost to Follow-up|0
7116871|NCT02570165|11252811|FG000|Overall Study|Physician Decision|0
7116872|NCT02570165|11252812|FG001|Overall Study|Physician Decision|1
7116873|NCT02570165|11252813|FG002|Overall Study|Physician Decision|0
7116874|NCT02570165|11252814|FG003|Overall Study|Physician Decision|0
7116875|NCT02570165|11252815|FG004|Overall Study|Physician Decision|0
7116876|NCT02570165|11252816|FG005|Overall Study|Physician Decision|0
7116877|NCT02570165|11252817|FG006|Overall Study|Physician Decision|0
7116878|NCT02570165|11252811|FG000|Overall Study|Withdrawal by Subject|0
7116879|NCT02570165|11252812|FG001|Overall Study|Withdrawal by Subject|0
7116880|NCT02570165|11252813|FG002|Overall Study|Withdrawal by Subject|0
7116881|NCT02570165|11252814|FG003|Overall Study|Withdrawal by Subject|2
7116882|NCT02570165|11252815|FG004|Overall Study|Withdrawal by Subject|1
7116883|NCT02570165|11252816|FG005|Overall Study|Withdrawal by Subject|0
7116884|NCT02570165|11252817|FG006|Overall Study|Withdrawal by Subject|0
7116885|NCT02570165|11252811|FG000|Overall Study|Par. did not Meet Continuation Criteria|0
7116886|NCT02570165|11252812|FG001|Overall Study|Par. did not Meet Continuation Criteria|0
7116887|NCT02570165|11252813|FG002|Overall Study|Par. did not Meet Continuation Criteria|0
7116888|NCT02570165|11252814|FG003|Overall Study|Par. did not Meet Continuation Criteria|0
7116889|NCT02570165|11252815|FG004|Overall Study|Par. did not Meet Continuation Criteria|0
7116890|NCT02570165|11252816|FG005|Overall Study|Par. did not Meet Continuation Criteria|1
7116891|NCT02570165|11252817|FG006|Overall Study|Par. did not Meet Continuation Criteria|0
7116892|NCT02570165|11252811|FG000|Overall Study|Withdrawal Request by GSK|0
7116893|NCT02570165|11252812|FG001|Overall Study|Withdrawal Request by GSK|0
7116894|NCT02570165|11252813|FG002|Overall Study|Withdrawal Request by GSK|2
7116895|NCT02570165|11252814|FG003|Overall Study|Withdrawal Request by GSK|0
7116896|NCT02570165|11252815|FG004|Overall Study|Withdrawal Request by GSK|0
7116897|NCT02570165|11252816|FG005|Overall Study|Withdrawal Request by GSK|0
7116898|NCT02570165|11252817|FG006|Overall Study|Withdrawal Request by GSK|0
7116899|NCT02570711|11252856|FG000|Overall Study|Death|1
7116900|NCT02570711|11252857|FG001|Overall Study|Death|0
7116901|NCT02570711|11252856|FG000|Overall Study|Early Termination of Study by Sponsor|0
7116902|NCT02570711|11252857|FG001|Overall Study|Early Termination of Study by Sponsor|2
7116903|NCT02570750|11252865|FG000|Overall Study|Inclusion/exclusion criteria deviation|1
7116904|NCT02570750|11252866|FG001|Overall Study|Inclusion/exclusion criteria deviation|0
7116905|NCT02570750|11252865|FG000|Overall Study|Protocol deviation|4
7116906|NCT02570750|11252866|FG001|Overall Study|Protocol deviation|2
7116907|NCT02570750|11252865|FG000|Overall Study|Withdrawal by Subject|5
7116908|NCT02570750|11252866|FG001|Overall Study|Withdrawal by Subject|0
7116909|NCT02570750|11252865|FG000|Overall Study|Lost to Follow-up|2
7116910|NCT02570750|11252866|FG001|Overall Study|Lost to Follow-up|2
7116911|NCT02570750|11252865|FG000|Overall Study|Adverse Event|2
7116912|NCT02570750|11252866|FG001|Overall Study|Adverse Event|1
7116913|NCT02571049|11252872|FG000|Screening|Did not meet entry criteria|2
7116914|NCT02571049|11252873|FG001|Screening|Did not meet entry criteria|2
7116915|NCT02571049|11252872|FG000|Randomization|No migraine attack|0
7116916|NCT02571049|11252873|FG001|Randomization|No migraine attack|1
7116917|NCT02571049|11252872|FG000|Randomization|Adverse Event|0
7116918|NCT02571049|11252873|FG001|Randomization|Adverse Event|1
7116919|NCT02571075|11252881|FG000|Overall Study|Lost to Follow-up|20
7116920|NCT02571075|11252882|FG001|Overall Study|Lost to Follow-up|24
7116921|NCT02571244|11252912|FG000|Overall Study|Lost to Follow-up|0
7116922|NCT02571244|11252913|FG001|Overall Study|Lost to Follow-up|1
7116923|NCT02571244|11252912|FG000|Overall Study|Unable to reach out post discharge|3
7116924|NCT02571244|11252913|FG001|Overall Study|Unable to reach out post discharge|0
7116925|NCT02571452|11252933|FG000|Overall Study Treatment|Protocol Violation|0
7116926|NCT02571452|11252934|FG001|Overall Study Treatment|Protocol Violation|1
7116927|NCT02571452|11252933|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4
7116928|NCT02571452|11252934|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0
7116929|NCT02571452|11252933|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1
7116930|NCT02571452|11252934|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0
7116931|NCT02571777|11252950|FG000|Overall Study|Subject/guardian decision|34
7116932|NCT02571777|11252951|FG001|Overall Study|Subject/guardian decision|26
7116933|NCT02571777|11252952|FG002|Overall Study|Subject/guardian decision|26
7116934|NCT02571777|11252953|FG003|Overall Study|Subject/guardian decision|25
7116935|NCT02571777|11252954|FG004|Overall Study|Subject/guardian decision|27
7116936|NCT02571777|11252950|FG000|Overall Study|Protocol Deviation|2
7116937|NCT02571777|11252951|FG001|Overall Study|Protocol Deviation|3
7116938|NCT02571777|11252952|FG002|Overall Study|Protocol Deviation|4
7116939|NCT02571777|11252953|FG003|Overall Study|Protocol Deviation|8
7116940|NCT02571777|11252954|FG004|Overall Study|Protocol Deviation|4
7116941|NCT02571777|11252950|FG000|Overall Study|Death|1
7116942|NCT02571777|11252951|FG001|Overall Study|Death|1
7116943|NCT02571777|11252952|FG002|Overall Study|Death|4
7116944|NCT02571777|11252953|FG003|Overall Study|Death|0
7116945|NCT02571777|11252954|FG004|Overall Study|Death|0
7116946|NCT02571777|11252950|FG000|Overall Study|Lost to Follow-up|1
7116947|NCT02571777|11252951|FG001|Overall Study|Lost to Follow-up|1
7116948|NCT02571777|11252952|FG002|Overall Study|Lost to Follow-up|2
7116949|NCT02571777|11252953|FG003|Overall Study|Lost to Follow-up|0
7116950|NCT02571777|11252954|FG004|Overall Study|Lost to Follow-up|1
7116951|NCT02571777|11252950|FG000|Overall Study|Physician Decision|1
7116952|NCT02571777|11252951|FG001|Overall Study|Physician Decision|7
7116953|NCT02571777|11252952|FG002|Overall Study|Physician Decision|5
7116954|NCT02571777|11252953|FG003|Overall Study|Physician Decision|2
7116955|NCT02571777|11252954|FG004|Overall Study|Physician Decision|4
7116956|NCT02571777|11252950|FG000|Overall Study|Pregnancy|0
7116957|NCT02571777|11252951|FG001|Overall Study|Pregnancy|0
7116958|NCT02571777|11252952|FG002|Overall Study|Pregnancy|0
7116959|NCT02571777|11252953|FG003|Overall Study|Pregnancy|2
7116960|NCT02571777|11252954|FG004|Overall Study|Pregnancy|0
7116961|NCT02571972|11252966|FG000|Overall Study|Protocol Violation|2
7116962|NCT02571972|11252966|FG000|Overall Study|Withdrawal by Subject|2
7116963|NCT02572076|11252970|FG000|Overall Study|Protocol Violation|1
7116964|NCT02572167|11252977|FG000|Overall Study|In follow up|6
7116965|NCT02572167|11252978|FG001|Overall Study|In follow up|48
7116966|NCT02572167|11252979|FG002|Overall Study|In follow up|27
7116967|NCT02572167|11252977|FG000|Overall Study|Withdrawal by Subject|0
7116968|NCT02572167|11252978|FG001|Overall Study|Withdrawal by Subject|3
7116969|NCT02572167|11252979|FG002|Overall Study|Withdrawal by Subject|1
7116970|NCT02572167|11252977|FG000|Overall Study|Lost to Follow-up|0
7116971|NCT02572167|11252978|FG001|Overall Study|Lost to Follow-up|2
7116972|NCT02572167|11252979|FG002|Overall Study|Lost to Follow-up|1
7116973|NCT02572167|11252977|FG000|Overall Study|Death|0
7116974|NCT02572167|11252978|FG001|Overall Study|Death|3
7116975|NCT02572167|11252979|FG002|Overall Study|Death|1
7116976|NCT02572167|11252977|FG000|Overall Study|Did not meet inclusion criteria|0
7116977|NCT02572167|11252978|FG001|Overall Study|Did not meet inclusion criteria|0
7116978|NCT02572167|11252979|FG002|Overall Study|Did not meet inclusion criteria|1
7116979|NCT02572388|11252991|FG000|Overall Study|Withdrawal by Subject|1
7116980|NCT02572388|11252992|FG001|Overall Study|Withdrawal by Subject|1
7116981|NCT02572388|11252993|FG002|Overall Study|Withdrawal by Subject|2
7116982|NCT02572388|11252994|FG003|Overall Study|Withdrawal by Subject|2
7116983|NCT02572401|11253008|FG000|Overall Study|Lost to Follow-up|5
7116984|NCT02572401|11253009|FG001|Overall Study|Lost to Follow-up|8
7116985|NCT02572401|11253010|FG002|Overall Study|Lost to Follow-up|9
7116986|NCT02572401|11253011|FG003|Overall Study|Lost to Follow-up|9
7116987|NCT02572401|11253008|FG000|Overall Study|Death|0
7116988|NCT02572401|11253009|FG001|Overall Study|Death|0
7116989|NCT02572401|11253010|FG002|Overall Study|Death|0
7116990|NCT02572401|11253011|FG003|Overall Study|Death|1
7116991|NCT02572570|11253030|FG000|Overall Study|Study Terminated|27
7116992|NCT02572817|11253060|FG000|Overall Study|Death|6
7116993|NCT02572817|11253061|FG001|Overall Study|Death|3
7116994|NCT02572817|11253060|FG000|Overall Study|Lost to Follow-up|3
7116995|NCT02572817|11253061|FG001|Overall Study|Lost to Follow-up|3
7116996|NCT02573012|11253069|FG000|Overall Study|Adverse Event|5
7116997|NCT02573012|11253070|FG001|Overall Study|Adverse Event|5
7116998|NCT02573012|11253069|FG000|Overall Study|Lack of Efficacy|5
7116999|NCT02573012|11253070|FG001|Overall Study|Lack of Efficacy|4
7117000|NCT02573012|11253069|FG000|Overall Study|Non-compliance|1
7117001|NCT02573012|11253070|FG001|Overall Study|Non-compliance|2
7117002|NCT02573012|11253069|FG000|Overall Study|Withdrawal by Subject|2
7117003|NCT02573012|11253070|FG001|Overall Study|Withdrawal by Subject|2
7117004|NCT02573012|11253069|FG000|Overall Study|Study Ended per Protocol|1
7117005|NCT02573012|11253070|FG001|Overall Study|Study Ended per Protocol|0
7117006|NCT02573012|11253069|FG000|Overall Study|Physician Decision|1
7117007|NCT02573012|11253070|FG001|Overall Study|Physician Decision|2
7117008|NCT02573155|11253078|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0
7117009|NCT02573155|11253079|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1
7117010|NCT02573155|11253078|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0
7117011|NCT02573155|11253079|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1
7117012|NCT02573155|11253078|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0
7117013|NCT02573155|11253079|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3
7117014|NCT02573155|11253078|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1
7117015|NCT02573155|11253079|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0
7117016|NCT02573155|11253078|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0
7117017|NCT02573155|11253079|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2
7117018|NCT02573155|11253078|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0
7117019|NCT02573155|11253079|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1
7117020|NCT02573155|11253078|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0
7117021|NCT02573155|11253079|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1
7117022|NCT02573155|11253078|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0
7117023|NCT02573155|11253079|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1
7117024|NCT02573246|11253119|FG000|Overall Study|Lost to Follow-up|2
7117025|NCT02573246|11253120|FG001|Overall Study|Lost to Follow-up|0
7117026|NCT02573246|11253121|FG002|Overall Study|Lost to Follow-up|0
7117027|NCT02573246|11253122|FG003|Overall Study|Lost to Follow-up|0
7117028|NCT02573246|11253123|FG004|Overall Study|Lost to Follow-up|1
7117029|NCT02573246|11253119|FG000|Overall Study|Withdrawal by Subject|0
7117030|NCT02573246|11253120|FG001|Overall Study|Withdrawal by Subject|0
7117031|NCT02573246|11253121|FG002|Overall Study|Withdrawal by Subject|0
7117032|NCT02573246|11253122|FG003|Overall Study|Withdrawal by Subject|0
7117033|NCT02573246|11253123|FG004|Overall Study|Withdrawal by Subject|1
7117034|NCT02573246|11253119|FG000|Overall Study|Physician Decision|1
7117035|NCT02573246|11253120|FG001|Overall Study|Physician Decision|1
7117036|NCT02573246|11253121|FG002|Overall Study|Physician Decision|3
7117037|NCT02573246|11253122|FG003|Overall Study|Physician Decision|2
7117038|NCT02573246|11253123|FG004|Overall Study|Physician Decision|2
7117039|NCT02573311|11253142|FG000|Disposition for Part 1|Withdrawal by Subject|7
7117040|NCT02573311|11253143|FG001|Disposition for Part 1|Withdrawal by Subject|3
7117041|NCT02573311|11253142|FG000|Disposition for Part 2|Physician Decision|25
7117042|NCT02573311|11253143|FG001|Disposition for Part 2|Physician Decision|7
7117043|NCT02573311|11253142|FG000|Disposition for Part 2|Adverse Event|36
7117044|NCT02573311|11253143|FG001|Disposition for Part 2|Adverse Event|5
7117045|NCT02573311|11253142|FG000|Disposition for Part 2|Lost to Follow-up|76
7117046|NCT02573311|11253143|FG001|Disposition for Part 2|Lost to Follow-up|7
7117047|NCT02573311|11253142|FG000|Disposition for Part 2|Withdrawal by Subject|60
7117048|NCT02573311|11253143|FG001|Disposition for Part 2|Withdrawal by Subject|3
7117049|NCT02573311|11253142|FG000|Disposition for Part 2|Investigator decision|0
7117050|NCT02573311|11253143|FG001|Disposition for Part 2|Investigator decision|1
7117051|NCT02573311|11253142|FG000|Disposition for Part 2|Other than specified above|13
7117052|NCT02573311|11253143|FG001|Disposition for Part 2|Other than specified above|3
7117053|NCT02573350|11253151|FG000|Overall Study|Lost to Follow-up|2
7117054|NCT02573350|11253152|FG001|Overall Study|Lost to Follow-up|1
7117055|NCT02573350|11253151|FG000|Overall Study|Adverse Event|3
7117056|NCT02573350|11253152|FG001|Overall Study|Adverse Event|4
7117057|NCT02573350|11253151|FG000|Overall Study|Subject met Withdrawal Criteria|1
7117058|NCT02573350|11253152|FG001|Overall Study|Subject met Withdrawal Criteria|1
7117059|NCT02573350|11253151|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3
7117060|NCT02573350|11253152|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1
7117061|NCT02573350|11253151|FG000|Overall Study|Subject withdrew consent to participate|6
7117062|NCT02573350|11253152|FG001|Overall Study|Subject withdrew consent to participate|1
7117063|NCT02573350|11253151|FG000|Overall Study|Protocol Deviation|1
7117064|NCT02573350|11253152|FG001|Overall Study|Protocol Deviation|1
7117065|NCT02573467|11253174|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0
7117066|NCT02573467|11253175|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0
7117067|NCT02573467|11253176|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1
7117068|NCT02573467|11253177|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0
7117069|NCT02573467|11253174|FG000|Double-blind Treatment Epoch|Adverse Event|1
7117070|NCT02573467|11253175|FG001|Double-blind Treatment Epoch|Adverse Event|0
7117071|NCT02573467|11253176|FG002|Double-blind Treatment Epoch|Adverse Event|1
7117072|NCT02573467|11253177|FG003|Double-blind Treatment Epoch|Adverse Event|0
7117073|NCT02573467|11253174|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2
7117074|NCT02573467|11253175|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1
7117075|NCT02573467|11253176|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1
7117076|NCT02573467|11253177|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0
7117077|NCT02573467|11253174|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50
7117078|NCT02573467|11253175|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51
7117079|NCT02573467|11253176|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48
7117080|NCT02573467|11253177|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55
7117081|NCT02573467|11253174|FG000|Post-treatment Follow up Epoch|Death|1
7117082|NCT02573467|11253175|FG001|Post-treatment Follow up Epoch|Death|1
7117083|NCT02573467|11253176|FG002|Post-treatment Follow up Epoch|Death|0
7117084|NCT02573467|11253177|FG003|Post-treatment Follow up Epoch|Death|1
7117085|NCT02573467|11253174|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5
7117086|NCT02573467|11253175|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4
7117087|NCT02573467|11253176|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9
7117088|NCT02573467|11253177|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2
7117089|NCT02573467|11253174|FG000|Post-treatment Follow up Epoch|Technical problems|0
7117090|NCT02573467|11253175|FG001|Post-treatment Follow up Epoch|Technical problems|0
7117091|NCT02573467|11253176|FG002|Post-treatment Follow up Epoch|Technical problems|1
7117092|NCT02573467|11253177|FG003|Post-treatment Follow up Epoch|Technical problems|0
7117093|NCT02573870|11253199|FG000|Overall Study|Adverse Event|0
7117094|NCT02573870|11253200|FG001|Overall Study|Adverse Event|2
7117095|NCT02573870|11253199|FG000|Overall Study|Lack of Efficacy|0
7117096|NCT02573870|11253200|FG001|Overall Study|Lack of Efficacy|1
7117097|NCT02573870|11253199|FG000|Overall Study|Other: Reached defined stopping criteria|0
7117098|NCT02573870|11253200|FG001|Overall Study|Other: Reached defined stopping criteria|1
7117099|NCT02573870|11253199|FG000|Overall Study|Lost to Follow-up|0
7117100|NCT02573870|11253200|FG001|Overall Study|Lost to Follow-up|1
7117101|NCT02573870|11253199|FG000|Overall Study|Other: Fail to Meet Visit|0
7117102|NCT02573870|11253200|FG001|Overall Study|Other: Fail to Meet Visit|2
7117103|NCT02573883|11253208|FG000|Six Month Follow Up|Lost to Follow-up|1
7117104|NCT02573883|11253209|FG001|Six Month Follow Up|Lost to Follow-up|0
7117105|NCT02573883|11253210|FG002|Six Month Follow Up|Lost to Follow-up|0
7117106|NCT02573883|11253211|FG003|Six Month Follow Up|Lost to Follow-up|0
7117107|NCT02573883|11253208|FG000|One Year Follow Up|Lost to Follow-up|2
7117108|NCT02573883|11253209|FG001|One Year Follow Up|Lost to Follow-up|1
7117109|NCT02573883|11253210|FG002|One Year Follow Up|Lost to Follow-up|0
7117110|NCT02573883|11253211|FG003|One Year Follow Up|Lost to Follow-up|0
7117111|NCT02573948|11253226|FG000|Longitudinal Cohort|Death|9
7117112|NCT02573948|11253226|FG000|Longitudinal Cohort|Lost to Follow-up|22
7117113|NCT02573948|11253226|FG000|Longitudinal Cohort|Incarcerated|25
7117114|NCT02574078|11253246|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0
7117115|NCT02574078|11253247|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0
7117116|NCT02574078|11253248|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0
7117117|NCT02574078|11253249|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0
7117118|NCT02574078|11253250|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0
7117119|NCT02574078|11253251|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1
7117120|NCT02574078|11253252|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2
7117121|NCT02574078|11253253|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0
7117122|NCT02574078|11253254|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1
7117123|NCT02574078|11253255|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0
7117124|NCT02574078|11253256|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0
7117125|NCT02574078|11253257|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0
7117126|NCT02574078|11253258|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0
7117127|NCT02574078|11253246|FG000|Pre-Treatment Period|Participant withdrew consent|0
7117128|NCT02574078|11253247|FG001|Pre-Treatment Period|Participant withdrew consent|0
7117129|NCT02574078|11253248|FG002|Pre-Treatment Period|Participant withdrew consent|0
7117130|NCT02574078|11253249|FG003|Pre-Treatment Period|Participant withdrew consent|0
7117131|NCT02574078|11253250|FG004|Pre-Treatment Period|Participant withdrew consent|0
7117132|NCT02574078|11253251|FG005|Pre-Treatment Period|Participant withdrew consent|0
7117133|NCT02574078|11253252|FG006|Pre-Treatment Period|Participant withdrew consent|0
7117134|NCT02574078|11253253|FG007|Pre-Treatment Period|Participant withdrew consent|3
7117135|NCT02574078|11253254|FG008|Pre-Treatment Period|Participant withdrew consent|0
7117136|NCT02574078|11253255|FG009|Pre-Treatment Period|Participant withdrew consent|0
7117137|NCT02574078|11253256|FG010|Pre-Treatment Period|Participant withdrew consent|2
7117138|NCT02574078|11253257|FG011|Pre-Treatment Period|Participant withdrew consent|0
7117139|NCT02574078|11253258|FG012|Pre-Treatment Period|Participant withdrew consent|0
7117140|NCT02574078|11253246|FG000|Pre-Treatment Period|Other reasons|0
7117141|NCT02574078|11253247|FG001|Pre-Treatment Period|Other reasons|0
7117142|NCT02574078|11253248|FG002|Pre-Treatment Period|Other reasons|0
7117143|NCT02574078|11253249|FG003|Pre-Treatment Period|Other reasons|0
7117144|NCT02574078|11253250|FG004|Pre-Treatment Period|Other reasons|0
7117145|NCT02574078|11253251|FG005|Pre-Treatment Period|Other reasons|0
7117146|NCT02574078|11253252|FG006|Pre-Treatment Period|Other reasons|2
7117147|NCT02574078|11253253|FG007|Pre-Treatment Period|Other reasons|0
7117148|NCT02574078|11253254|FG008|Pre-Treatment Period|Other reasons|0
7117149|NCT02574078|11253255|FG009|Pre-Treatment Period|Other reasons|0
7117150|NCT02574078|11253256|FG010|Pre-Treatment Period|Other reasons|2
7117151|NCT02574078|11253257|FG011|Pre-Treatment Period|Other reasons|0
7117152|NCT02574078|11253258|FG012|Pre-Treatment Period|Other reasons|0
7117153|NCT02574078|11253246|FG000|Pre-Treatment Period|Poor/non-compliance|0
7117154|NCT02574078|11253247|FG001|Pre-Treatment Period|Poor/non-compliance|0
7117155|NCT02574078|11253248|FG002|Pre-Treatment Period|Poor/non-compliance|0
7117156|NCT02574078|11253249|FG003|Pre-Treatment Period|Poor/non-compliance|0
7117157|NCT02574078|11253250|FG004|Pre-Treatment Period|Poor/non-compliance|0
7117158|NCT02574078|11253251|FG005|Pre-Treatment Period|Poor/non-compliance|0
7117159|NCT02574078|11253252|FG006|Pre-Treatment Period|Poor/non-compliance|0
7117160|NCT02574078|11253253|FG007|Pre-Treatment Period|Poor/non-compliance|0
7117161|NCT02574078|11253254|FG008|Pre-Treatment Period|Poor/non-compliance|0
7117162|NCT02574078|11253255|FG009|Pre-Treatment Period|Poor/non-compliance|0
7117163|NCT02574078|11253256|FG010|Pre-Treatment Period|Poor/non-compliance|0
7117164|NCT02574078|11253257|FG011|Pre-Treatment Period|Poor/non-compliance|1
7117165|NCT02574078|11253258|FG012|Pre-Treatment Period|Poor/non-compliance|0
7117166|NCT02574078|11253246|FG000|Treatment Period|Disease progression|6
7117167|NCT02574078|11253247|FG001|Treatment Period|Disease progression|4
7117168|NCT02574078|11253248|FG002|Treatment Period|Disease progression|7
7117169|NCT02574078|11253249|FG003|Treatment Period|Disease progression|18
7117170|NCT02574078|11253250|FG004|Treatment Period|Disease progression|16
7117171|NCT02574078|11253251|FG005|Treatment Period|Disease progression|26
7117172|NCT02574078|11253252|FG006|Treatment Period|Disease progression|5
7117173|NCT02574078|11253253|FG007|Treatment Period|Disease progression|9
7117174|NCT02574078|11253254|FG008|Treatment Period|Disease progression|8
7117175|NCT02574078|11253255|FG009|Treatment Period|Disease progression|5
7117176|NCT02574078|11253256|FG010|Treatment Period|Disease progression|20
7117177|NCT02574078|11253257|FG011|Treatment Period|Disease progression|29
7117178|NCT02574078|11253258|FG012|Treatment Period|Disease progression|2
7117179|NCT02574078|11253246|FG000|Treatment Period|Study drug toxicity|1
7117180|NCT02574078|11253247|FG001|Treatment Period|Study drug toxicity|1
7117181|NCT02574078|11253248|FG002|Treatment Period|Study drug toxicity|0
7117182|NCT02574078|11253249|FG003|Treatment Period|Study drug toxicity|5
7117183|NCT02574078|11253250|FG004|Treatment Period|Study drug toxicity|3
7117184|NCT02574078|11253251|FG005|Treatment Period|Study drug toxicity|1
7117185|NCT02574078|11253252|FG006|Treatment Period|Study drug toxicity|2
7117186|NCT02574078|11253253|FG007|Treatment Period|Study drug toxicity|0
7117187|NCT02574078|11253254|FG008|Treatment Period|Study drug toxicity|2
7117188|NCT02574078|11253255|FG009|Treatment Period|Study drug toxicity|1
7117189|NCT02574078|11253256|FG010|Treatment Period|Study drug toxicity|16
7117190|NCT02574078|11253257|FG011|Treatment Period|Study drug toxicity|2
7117191|NCT02574078|11253258|FG012|Treatment Period|Study drug toxicity|4
7117192|NCT02574078|11253246|FG000|Treatment Period|Death|2
7117193|NCT02574078|11253247|FG001|Treatment Period|Death|0
7117194|NCT02574078|11253248|FG002|Treatment Period|Death|0
7117195|NCT02574078|11253249|FG003|Treatment Period|Death|0
7117196|NCT02574078|11253250|FG004|Treatment Period|Death|1
7117197|NCT02574078|11253251|FG005|Treatment Period|Death|1
7117198|NCT02574078|11253252|FG006|Treatment Period|Death|1
7117199|NCT02574078|11253253|FG007|Treatment Period|Death|1
7117200|NCT02574078|11253254|FG008|Treatment Period|Death|7
7117201|NCT02574078|11253255|FG009|Treatment Period|Death|1
7117202|NCT02574078|11253256|FG010|Treatment Period|Death|0
7117203|NCT02574078|11253257|FG011|Treatment Period|Death|2
7117204|NCT02574078|11253258|FG012|Treatment Period|Death|1
7117205|NCT02574078|11253246|FG000|Treatment Period|Adverse event unrelated to drug|0
7117206|NCT02574078|11253247|FG001|Treatment Period|Adverse event unrelated to drug|0
7117207|NCT02574078|11253248|FG002|Treatment Period|Adverse event unrelated to drug|1
7117208|NCT02574078|11253249|FG003|Treatment Period|Adverse event unrelated to drug|0
7117209|NCT02574078|11253250|FG004|Treatment Period|Adverse event unrelated to drug|2
7117210|NCT02574078|11253251|FG005|Treatment Period|Adverse event unrelated to drug|3
7117211|NCT02574078|11253252|FG006|Treatment Period|Adverse event unrelated to drug|0
7117212|NCT02574078|11253253|FG007|Treatment Period|Adverse event unrelated to drug|0
7117213|NCT02574078|11253254|FG008|Treatment Period|Adverse event unrelated to drug|1
7117214|NCT02574078|11253255|FG009|Treatment Period|Adverse event unrelated to drug|2
7117215|NCT02574078|11253256|FG010|Treatment Period|Adverse event unrelated to drug|4
7117216|NCT02574078|11253257|FG011|Treatment Period|Adverse event unrelated to drug|1
7117217|NCT02574078|11253258|FG012|Treatment Period|Adverse event unrelated to drug|0
7117218|NCT02574078|11253246|FG000|Treatment Period|Administrative reason by Sponsor|0
7117219|NCT02574078|11253247|FG001|Treatment Period|Administrative reason by Sponsor|1
7117220|NCT02574078|11253248|FG002|Treatment Period|Administrative reason by Sponsor|0
7117221|NCT02574078|11253249|FG003|Treatment Period|Administrative reason by Sponsor|0
7117222|NCT02574078|11253250|FG004|Treatment Period|Administrative reason by Sponsor|0
7117223|NCT02574078|11253251|FG005|Treatment Period|Administrative reason by Sponsor|0
7117224|NCT02574078|11253252|FG006|Treatment Period|Administrative reason by Sponsor|1
7117225|NCT02574078|11253253|FG007|Treatment Period|Administrative reason by Sponsor|0
7117226|NCT02574078|11253254|FG008|Treatment Period|Administrative reason by Sponsor|0
7117227|NCT02574078|11253255|FG009|Treatment Period|Administrative reason by Sponsor|0
7117228|NCT02574078|11253256|FG010|Treatment Period|Administrative reason by Sponsor|0
7117229|NCT02574078|11253257|FG011|Treatment Period|Administrative reason by Sponsor|0
7117230|NCT02574078|11253258|FG012|Treatment Period|Administrative reason by Sponsor|3
7117231|NCT02574078|11253246|FG000|Treatment Period|Other reasons|1
7117232|NCT02574078|11253247|FG001|Treatment Period|Other reasons|0
7117233|NCT02574078|11253248|FG002|Treatment Period|Other reasons|1
7117234|NCT02574078|11253249|FG003|Treatment Period|Other reasons|3
7117235|NCT02574078|11253250|FG004|Treatment Period|Other reasons|3
7117236|NCT02574078|11253251|FG005|Treatment Period|Other reasons|1
7117237|NCT02574078|11253252|FG006|Treatment Period|Other reasons|2
7117238|NCT02574078|11253253|FG007|Treatment Period|Other reasons|1
7117239|NCT02574078|11253254|FG008|Treatment Period|Other reasons|3
7117240|NCT02574078|11253255|FG009|Treatment Period|Other reasons|1
7117241|NCT02574078|11253256|FG010|Treatment Period|Other reasons|1
7117242|NCT02574078|11253257|FG011|Treatment Period|Other reasons|3
7117243|NCT02574078|11253258|FG012|Treatment Period|Other reasons|1
7117244|NCT02574078|11253246|FG000|Treatment Period|Participant request to stop drug|0
7117245|NCT02574078|11253247|FG001|Treatment Period|Participant request to stop drug|0
7117246|NCT02574078|11253248|FG002|Treatment Period|Participant request to stop drug|0
7117247|NCT02574078|11253249|FG003|Treatment Period|Participant request to stop drug|2
7117248|NCT02574078|11253250|FG004|Treatment Period|Participant request to stop drug|4
7117249|NCT02574078|11253251|FG005|Treatment Period|Participant request to stop drug|0
7117250|NCT02574078|11253252|FG006|Treatment Period|Participant request to stop drug|1
7117251|NCT02574078|11253253|FG007|Treatment Period|Participant request to stop drug|0
7117252|NCT02574078|11253254|FG008|Treatment Period|Participant request to stop drug|3
7117253|NCT02574078|11253255|FG009|Treatment Period|Participant request to stop drug|2
7117254|NCT02574078|11253256|FG010|Treatment Period|Participant request to stop drug|2
7117255|NCT02574078|11253257|FG011|Treatment Period|Participant request to stop drug|4
7117256|NCT02574078|11253258|FG012|Treatment Period|Participant request to stop drug|1
7117257|NCT02574078|11253246|FG000|Treatment Period|Participant withdrew consent|0
7117258|NCT02574078|11253247|FG001|Treatment Period|Participant withdrew consent|0
7117259|NCT02574078|11253248|FG002|Treatment Period|Participant withdrew consent|0
7117260|NCT02574078|11253249|FG003|Treatment Period|Participant withdrew consent|0
7117261|NCT02574078|11253250|FG004|Treatment Period|Participant withdrew consent|1
7117262|NCT02574078|11253251|FG005|Treatment Period|Participant withdrew consent|1
7117263|NCT02574078|11253252|FG006|Treatment Period|Participant withdrew consent|0
7117264|NCT02574078|11253253|FG007|Treatment Period|Participant withdrew consent|1
7117265|NCT02574078|11253254|FG008|Treatment Period|Participant withdrew consent|0
7117266|NCT02574078|11253255|FG009|Treatment Period|Participant withdrew consent|2
7117267|NCT02574078|11253256|FG010|Treatment Period|Participant withdrew consent|1
7117268|NCT02574078|11253257|FG011|Treatment Period|Participant withdrew consent|4
7117269|NCT02574078|11253258|FG012|Treatment Period|Participant withdrew consent|1
7117270|NCT02574078|11253246|FG000|Treatment Period|Participant no longer meets criteria|0
7117271|NCT02574078|11253247|FG001|Treatment Period|Participant no longer meets criteria|0
7117272|NCT02574078|11253248|FG002|Treatment Period|Participant no longer meets criteria|0
7117273|NCT02574078|11253249|FG003|Treatment Period|Participant no longer meets criteria|0
7117274|NCT02574078|11253250|FG004|Treatment Period|Participant no longer meets criteria|1
7117275|NCT02574078|11253251|FG005|Treatment Period|Participant no longer meets criteria|0
7117276|NCT02574078|11253252|FG006|Treatment Period|Participant no longer meets criteria|0
7117277|NCT02574078|11253253|FG007|Treatment Period|Participant no longer meets criteria|0
7117278|NCT02574078|11253254|FG008|Treatment Period|Participant no longer meets criteria|0
7117279|NCT02574078|11253255|FG009|Treatment Period|Participant no longer meets criteria|1
7117280|NCT02574078|11253256|FG010|Treatment Period|Participant no longer meets criteria|1
7117281|NCT02574078|11253257|FG011|Treatment Period|Participant no longer meets criteria|1
7117282|NCT02574078|11253258|FG012|Treatment Period|Participant no longer meets criteria|0
7117283|NCT02574078|11253246|FG000|Treatment Period|Lost to Follow-up|0
7117284|NCT02574078|11253247|FG001|Treatment Period|Lost to Follow-up|0
7117285|NCT02574078|11253248|FG002|Treatment Period|Lost to Follow-up|0
7117286|NCT02574078|11253249|FG003|Treatment Period|Lost to Follow-up|0
7117287|NCT02574078|11253250|FG004|Treatment Period|Lost to Follow-up|0
7117288|NCT02574078|11253251|FG005|Treatment Period|Lost to Follow-up|0
7117289|NCT02574078|11253252|FG006|Treatment Period|Lost to Follow-up|0
7117290|NCT02574078|11253253|FG007|Treatment Period|Lost to Follow-up|0
7117291|NCT02574078|11253254|FG008|Treatment Period|Lost to Follow-up|0
7117292|NCT02574078|11253255|FG009|Treatment Period|Lost to Follow-up|1
7117293|NCT02574078|11253256|FG010|Treatment Period|Lost to Follow-up|0
7117294|NCT02574078|11253257|FG011|Treatment Period|Lost to Follow-up|1
7117295|NCT02574078|11253258|FG012|Treatment Period|Lost to Follow-up|0
7117296|NCT02574078|11253246|FG000|Treatment Period|Maximum clinical benefit|0
7117297|NCT02574078|11253247|FG001|Treatment Period|Maximum clinical benefit|0
7117298|NCT02574078|11253248|FG002|Treatment Period|Maximum clinical benefit|0
7117299|NCT02574078|11253249|FG003|Treatment Period|Maximum clinical benefit|0
7117300|NCT02574078|11253250|FG004|Treatment Period|Maximum clinical benefit|0
7117301|NCT02574078|11253251|FG005|Treatment Period|Maximum clinical benefit|0
7117302|NCT02574078|11253252|FG006|Treatment Period|Maximum clinical benefit|0
7117303|NCT02574078|11253253|FG007|Treatment Period|Maximum clinical benefit|0
7117304|NCT02574078|11253254|FG008|Treatment Period|Maximum clinical benefit|0
7117305|NCT02574078|11253255|FG009|Treatment Period|Maximum clinical benefit|1
7117306|NCT02574078|11253256|FG010|Treatment Period|Maximum clinical benefit|0
7117307|NCT02574078|11253257|FG011|Treatment Period|Maximum clinical benefit|0
7117308|NCT02574078|11253258|FG012|Treatment Period|Maximum clinical benefit|0
7117309|NCT02574247|11253292|FG000|Overall Study|Withdrawal by Subject|1
7117310|NCT02574247|11253293|FG001|Overall Study|Withdrawal by Subject|0
7117311|NCT02574247|11253294|FG002|Overall Study|Withdrawal by Subject|0
7117312|NCT02574247|11253292|FG000|Overall Study|Did not meet inclusion criteria|4
7117313|NCT02574247|11253293|FG001|Overall Study|Did not meet inclusion criteria|3
7117314|NCT02574247|11253294|FG002|Overall Study|Did not meet inclusion criteria|5
7117315|NCT02574260|11253304|FG000|Overall Study|Disease Progression|1
7117316|NCT02574312|11253310|FG000|3 Months Follow-up|Withdrawal by Subject|1
7117317|NCT02574312|11253311|FG001|3 Months Follow-up|Withdrawal by Subject|0
7117318|NCT02574520|11253321|FG000|Overall Study|Not dosed|2
7117319|NCT02574520|11253322|FG001|Overall Study|Not dosed|0
7117320|NCT02574520|11253323|FG002|Overall Study|Not dosed|5
7117321|NCT02574520|11253324|FG003|Overall Study|Not dosed|4
7117322|NCT02574520|11253321|FG000|Overall Study|Adverse Event|0
7117323|NCT02574520|11253322|FG001|Overall Study|Adverse Event|0
7117324|NCT02574520|11253323|FG002|Overall Study|Adverse Event|0
7117325|NCT02574520|11253324|FG003|Overall Study|Adverse Event|1
7117326|NCT02574520|11253321|FG000|Overall Study|Withdrawal by Subject|0
7117327|NCT02574520|11253322|FG001|Overall Study|Withdrawal by Subject|0
7117328|NCT02574520|11253323|FG002|Overall Study|Withdrawal by Subject|0
7117329|NCT02574520|11253324|FG003|Overall Study|Withdrawal by Subject|1
7117330|NCT02574520|11253321|FG000|Overall Study|Other|0
7117331|NCT02574520|11253322|FG001|Overall Study|Other|0
7117332|NCT02574520|11253323|FG002|Overall Study|Other|0
7117333|NCT02574520|11253324|FG003|Overall Study|Other|2
7117334|NCT02574637|11253348|FG000|Double-blind Period|Adverse Event|1
7117335|NCT02574637|11253349|FG001|Double-blind Period|Adverse Event|0
7117336|NCT02574637|11253350|FG002|Double-blind Period|Adverse Event|0
7117337|NCT02574637|11253351|FG003|Double-blind Period|Adverse Event|0
7117338|NCT02574637|11253352|FG004|Double-blind Period|Adverse Event|0
7117339|NCT02574637|11253353|FG005|Double-blind Period|Adverse Event|0
7117340|NCT02574637|11253354|FG006|Double-blind Period|Adverse Event|0
7117341|NCT02574637|11253355|FG007|Double-blind Period|Adverse Event|0
7117342|NCT02574637|11253356|FG008|Double-blind Period|Adverse Event|0
7117343|NCT02574637|11253357|FG009|Double-blind Period|Adverse Event|0
7117344|NCT02574637|11253348|FG000|Double-blind Period|Lack of Efficacy|0
7117345|NCT02574637|11253349|FG001|Double-blind Period|Lack of Efficacy|0
7117346|NCT02574637|11253350|FG002|Double-blind Period|Lack of Efficacy|2
7117347|NCT02574637|11253351|FG003|Double-blind Period|Lack of Efficacy|0
7117348|NCT02574637|11253352|FG004|Double-blind Period|Lack of Efficacy|0
7117349|NCT02574637|11253353|FG005|Double-blind Period|Lack of Efficacy|0
7117350|NCT02574637|11253354|FG006|Double-blind Period|Lack of Efficacy|0
7117351|NCT02574637|11253355|FG007|Double-blind Period|Lack of Efficacy|0
7117352|NCT02574637|11253356|FG008|Double-blind Period|Lack of Efficacy|0
7117353|NCT02574637|11253357|FG009|Double-blind Period|Lack of Efficacy|0
7117354|NCT02574637|11253348|FG000|Double-blind Period|Protocol Deviation|1
7117355|NCT02574637|11253349|FG001|Double-blind Period|Protocol Deviation|0
7117356|NCT02574637|11253350|FG002|Double-blind Period|Protocol Deviation|0
7117357|NCT02574637|11253351|FG003|Double-blind Period|Protocol Deviation|0
7117358|NCT02574637|11253352|FG004|Double-blind Period|Protocol Deviation|0
7117359|NCT02574637|11253353|FG005|Double-blind Period|Protocol Deviation|0
7117360|NCT02574637|11253354|FG006|Double-blind Period|Protocol Deviation|0
7117361|NCT02574637|11253355|FG007|Double-blind Period|Protocol Deviation|0
7117362|NCT02574637|11253356|FG008|Double-blind Period|Protocol Deviation|0
7117363|NCT02574637|11253357|FG009|Double-blind Period|Protocol Deviation|0
7117364|NCT02574637|11253348|FG000|Double-blind Period|Non-Compliance With Study Drug|0
7117365|NCT02574637|11253349|FG001|Double-blind Period|Non-Compliance With Study Drug|0
7117366|NCT02574637|11253350|FG002|Double-blind Period|Non-Compliance With Study Drug|0
7117367|NCT02574637|11253351|FG003|Double-blind Period|Non-Compliance With Study Drug|1
7117368|NCT02574637|11253352|FG004|Double-blind Period|Non-Compliance With Study Drug|0
7117369|NCT02574637|11253353|FG005|Double-blind Period|Non-Compliance With Study Drug|0
7117370|NCT02574637|11253354|FG006|Double-blind Period|Non-Compliance With Study Drug|0
7117371|NCT02574637|11253355|FG007|Double-blind Period|Non-Compliance With Study Drug|0
7117372|NCT02574637|11253356|FG008|Double-blind Period|Non-Compliance With Study Drug|0
7117373|NCT02574637|11253357|FG009|Double-blind Period|Non-Compliance With Study Drug|0
7117374|NCT02574637|11253348|FG000|Double-blind Period|Study Terminated By Sponsor|1
7117375|NCT02574637|11253349|FG001|Double-blind Period|Study Terminated By Sponsor|1
7117376|NCT02574637|11253350|FG002|Double-blind Period|Study Terminated By Sponsor|5
7117377|NCT02574637|11253351|FG003|Double-blind Period|Study Terminated By Sponsor|2
7117378|NCT02574637|11253352|FG004|Double-blind Period|Study Terminated By Sponsor|2
7117379|NCT02574637|11253353|FG005|Double-blind Period|Study Terminated By Sponsor|0
7117380|NCT02574637|11253354|FG006|Double-blind Period|Study Terminated By Sponsor|0
7117381|NCT02574637|11253355|FG007|Double-blind Period|Study Terminated By Sponsor|0
7117382|NCT02574637|11253356|FG008|Double-blind Period|Study Terminated By Sponsor|0
7117383|NCT02574637|11253357|FG009|Double-blind Period|Study Terminated By Sponsor|0
7117384|NCT02574637|11253348|FG000|Double-blind Period|Reason Not Specified|0
7117385|NCT02574637|11253349|FG001|Double-blind Period|Reason Not Specified|0
7117386|NCT02574637|11253350|FG002|Double-blind Period|Reason Not Specified|0
7117387|NCT02574637|11253351|FG003|Double-blind Period|Reason Not Specified|1
7117388|NCT02574637|11253352|FG004|Double-blind Period|Reason Not Specified|0
7117389|NCT02574637|11253353|FG005|Double-blind Period|Reason Not Specified|0
7117390|NCT02574637|11253354|FG006|Double-blind Period|Reason Not Specified|0
7117391|NCT02574637|11253355|FG007|Double-blind Period|Reason Not Specified|0
7117392|NCT02574637|11253356|FG008|Double-blind Period|Reason Not Specified|0
7117393|NCT02574637|11253357|FG009|Double-blind Period|Reason Not Specified|0
7117394|NCT02574637|11253348|FG000|Open-label (OL) Period|Adverse Event|0
7117395|NCT02574637|11253349|FG001|Open-label (OL) Period|Adverse Event|0
7117396|NCT02574637|11253350|FG002|Open-label (OL) Period|Adverse Event|0
7117397|NCT02574637|11253351|FG003|Open-label (OL) Period|Adverse Event|0
7117398|NCT02574637|11253352|FG004|Open-label (OL) Period|Adverse Event|0
7117399|NCT02574637|11253353|FG005|Open-label (OL) Period|Adverse Event|0
7117400|NCT02574637|11253354|FG006|Open-label (OL) Period|Adverse Event|0
7117401|NCT02574637|11253355|FG007|Open-label (OL) Period|Adverse Event|0
7117402|NCT02574637|11253356|FG008|Open-label (OL) Period|Adverse Event|1
7117403|NCT02574637|11253357|FG009|Open-label (OL) Period|Adverse Event|0
7117404|NCT02574637|11253348|FG000|Open-label (OL) Period|Withdrawal by Subject|0
7117405|NCT02574637|11253349|FG001|Open-label (OL) Period|Withdrawal by Subject|0
7117406|NCT02574637|11253350|FG002|Open-label (OL) Period|Withdrawal by Subject|0
7117407|NCT02574637|11253351|FG003|Open-label (OL) Period|Withdrawal by Subject|0
7117408|NCT02574637|11253352|FG004|Open-label (OL) Period|Withdrawal by Subject|0
7117409|NCT02574637|11253353|FG005|Open-label (OL) Period|Withdrawal by Subject|1
7117410|NCT02574637|11253354|FG006|Open-label (OL) Period|Withdrawal by Subject|0
7117411|NCT02574637|11253355|FG007|Open-label (OL) Period|Withdrawal by Subject|0
7117412|NCT02574637|11253356|FG008|Open-label (OL) Period|Withdrawal by Subject|0
7117413|NCT02574637|11253357|FG009|Open-label (OL) Period|Withdrawal by Subject|1
7117414|NCT02574637|11253348|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0
7117415|NCT02574637|11253349|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0
7117416|NCT02574637|11253350|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0
7117417|NCT02574637|11253351|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0
7117418|NCT02574637|11253352|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0
7117419|NCT02574637|11253353|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1
7117420|NCT02574637|11253354|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2
7117421|NCT02574637|11253355|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1
7117422|NCT02574637|11253356|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1
7117423|NCT02574637|11253357|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0
7117424|NCT02574845|11253388|FG000|Overall Study|Consent withdrawn further participation|0
7117425|NCT02574845|11253389|FG001|Overall Study|Consent withdrawn further participation|0
7117426|NCT02574845|11253390|FG002|Overall Study|Consent withdrawn further participation|0
7117427|NCT02574845|11253391|FG003|Overall Study|Consent withdrawn further participation|0
7117428|NCT02574845|11253392|FG004|Overall Study|Consent withdrawn further participation|1
7117429|NCT02574845|11253393|FG005|Overall Study|Consent withdrawn further participation|0
7117430|NCT02574845|11253388|FG000|Overall Study|Adverse Event|0
7117431|NCT02574845|11253389|FG001|Overall Study|Adverse Event|1
7117432|NCT02574845|11253390|FG002|Overall Study|Adverse Event|0
7117433|NCT02574845|11253391|FG003|Overall Study|Adverse Event|0
7117434|NCT02574845|11253392|FG004|Overall Study|Adverse Event|0
7117435|NCT02574845|11253393|FG005|Overall Study|Adverse Event|1
7117436|NCT02575079|11253413|FG000|Overall Study|Death|3
7117437|NCT02575079|11253414|FG001|Overall Study|Death|0
7117438|NCT02575079|11253413|FG000|Overall Study|Withdrawal by Subject|3
7117439|NCT02575079|11253414|FG001|Overall Study|Withdrawal by Subject|0
7117440|NCT02575807|11253428|FG000|Overall Study|Death|8
7117441|NCT02575807|11253429|FG001|Overall Study|Death|3
7117442|NCT02575807|11253430|FG002|Overall Study|Death|7
7117443|NCT02575807|11253431|FG003|Overall Study|Death|0
7117444|NCT02575807|11253432|FG004|Overall Study|Death|1
7117445|NCT02575807|11253428|FG000|Overall Study|Study terminated by Sponsor|0
7117446|NCT02575807|11253429|FG001|Overall Study|Study terminated by Sponsor|1
7117447|NCT02575807|11253430|FG002|Overall Study|Study terminated by Sponsor|7
7117448|NCT02575807|11253431|FG003|Overall Study|Study terminated by Sponsor|0
7117449|NCT02575807|11253432|FG004|Overall Study|Study terminated by Sponsor|1
7117450|NCT02575807|11253428|FG000|Overall Study|Terminated due to FDA clinical hold|1
7117451|NCT02575807|11253429|FG001|Overall Study|Terminated due to FDA clinical hold|0
7117452|NCT02575807|11253430|FG002|Overall Study|Terminated due to FDA clinical hold|0
7117453|NCT02575807|11253431|FG003|Overall Study|Terminated due to FDA clinical hold|0
7117454|NCT02575807|11253432|FG004|Overall Study|Terminated due to FDA clinical hold|0
7117455|NCT02575807|11253428|FG000|Overall Study|Terminated due to physician decision|0
7117456|NCT02575807|11253429|FG001|Overall Study|Terminated due to physician decision|0
7117457|NCT02575807|11253430|FG002|Overall Study|Terminated due to physician decision|1
7117458|NCT02575807|11253431|FG003|Overall Study|Terminated due to physician decision|0
7117459|NCT02575807|11253432|FG004|Overall Study|Terminated due to physician decision|0
7117460|NCT02575807|11253428|FG000|Overall Study|Subject ineligible - medical implant|0
7117461|NCT02575807|11253429|FG001|Overall Study|Subject ineligible - medical implant|0
7117462|NCT02575807|11253430|FG002|Overall Study|Subject ineligible - medical implant|0
7117463|NCT02575807|11253431|FG003|Overall Study|Subject ineligible - medical implant|1
7117464|NCT02575807|11253432|FG004|Overall Study|Subject ineligible - medical implant|0
7117465|NCT02575807|11253428|FG000|Overall Study|Withdrawal by Subject|0
7117466|NCT02575807|11253429|FG001|Overall Study|Withdrawal by Subject|0
7117467|NCT02575807|11253430|FG002|Overall Study|Withdrawal by Subject|1
7117468|NCT02575807|11253431|FG003|Overall Study|Withdrawal by Subject|1
7117469|NCT02575807|11253432|FG004|Overall Study|Withdrawal by Subject|2
7117470|NCT02575833|11253448|FG000|Overall Study|Withdrawal by Subject|0
7117471|NCT02575833|11253449|FG001|Overall Study|Withdrawal by Subject|1
7117472|NCT02575833|11253448|FG000|Overall Study|Lost to Follow-up|1
7117473|NCT02575833|11253449|FG001|Overall Study|Lost to Follow-up|0
7117474|NCT02575911|11253455|FG000|Overall Study|Lost to Follow-up|1
7117475|NCT02575950|11253467|FG000|Overall Study|Withdrawal by Subject|0
7117476|NCT02575950|11253468|FG001|Overall Study|Withdrawal by Subject|0
7117477|NCT02575950|11253469|FG002|Overall Study|Withdrawal by Subject|0
7117478|NCT02575950|11253470|FG003|Overall Study|Withdrawal by Subject|2
7117479|NCT02575950|11253467|FG000|Overall Study|Lost to Follow-up|0
7117480|NCT02575950|11253468|FG001|Overall Study|Lost to Follow-up|1
7117481|NCT02575950|11253469|FG002|Overall Study|Lost to Follow-up|0
7117482|NCT02575950|11253470|FG003|Overall Study|Lost to Follow-up|3
7117483|NCT02576054|11253482|FG000|Overall Study|Withdrawal by Subject|1
7117484|NCT02576067|11253490|FG000|Overall Study|Death|0
7117485|NCT02576067|11253491|FG001|Overall Study|Death|1
7117486|NCT02576067|11253490|FG000|Overall Study|Lack of Efficacy|1
7117487|NCT02576067|11253491|FG001|Overall Study|Lack of Efficacy|0
7117488|NCT02576067|11253490|FG000|Overall Study|Lost to Follow-up|11
7117489|NCT02576067|11253491|FG001|Overall Study|Lost to Follow-up|0
7117490|NCT02576067|11253490|FG000|Overall Study|Withdrawal by Subject|11
7117491|NCT02576067|11253491|FG001|Overall Study|Withdrawal by Subject|2
7117492|NCT02576067|11253490|FG000|Overall Study|study closure of main CIRT trial)|0
7117493|NCT02576067|11253491|FG001|Overall Study|study closure of main CIRT trial)|8
7117494|NCT02576067|11253490|FG000|Overall Study|not randomized, failed run-in|7
7117495|NCT02576067|11253491|FG001|Overall Study|not randomized, failed run-in|0
7117496|NCT02576067|11253490|FG000|Overall Study|screen failure/ re-enrolled|0
7117497|NCT02576067|11253491|FG001|Overall Study|screen failure/ re-enrolled|25
7117498|NCT02576067|11253490|FG000|Overall Study|Physician Decision|4
7117499|NCT02576067|11253491|FG001|Overall Study|Physician Decision|0
7117500|NCT02576145|11253499|FG000|Overall Study|Adverse Event|1
7117501|NCT02576145|11253500|FG001|Overall Study|Adverse Event|0
7117502|NCT02576145|11253499|FG000|Overall Study|Withdrawal by Subject|1
7117503|NCT02576145|11253500|FG001|Overall Study|Withdrawal by Subject|0
7117504|NCT02576145|11253499|FG000|Overall Study|Acute rejection|1
7117505|NCT02576145|11253500|FG001|Overall Study|Acute rejection|0
7117506|NCT02576145|11253499|FG000|Overall Study|Tetanus Titers Decreased|0
7117507|NCT02576145|11253500|FG001|Overall Study|Tetanus Titers Decreased|1
7117508|NCT02576535|11253515|FG000|Overall Study|Withdrawal by Subject|2
7117509|NCT02576587|11253521|FG000|Baseline|Equipment failure|0
7117510|NCT02576587|11253522|FG001|Baseline|Equipment failure|1
7117511|NCT02576587|11253521|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25
7117512|NCT02576587|11253522|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0
7117513|NCT02576587|11253521|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92
7117514|NCT02576587|11253522|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0
7117515|NCT02576587|11253521|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0
7117516|NCT02576587|11253522|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155
7117517|NCT02576639|11253535|FG000|Overall Study|Withdrawal by Subject|1
7117518|NCT02576639|11253536|FG001|Overall Study|Withdrawal by Subject|2
7117519|NCT02576639|11253537|FG002|Overall Study|Withdrawal by Subject|1
7117520|NCT02576639|11253538|FG003|Overall Study|Withdrawal by Subject|0
7117521|NCT02576639|11253539|FG004|Overall Study|Withdrawal by Subject|1
7117522|NCT02576639|11253535|FG000|Overall Study|Adverse Event|1
7117523|NCT02576639|11253536|FG001|Overall Study|Adverse Event|0
7117524|NCT02576639|11253537|FG002|Overall Study|Adverse Event|1
7117525|NCT02576639|11253538|FG003|Overall Study|Adverse Event|1
7117526|NCT02576639|11253539|FG004|Overall Study|Adverse Event|2
7117527|NCT02576639|11253535|FG000|Overall Study|Physician Decision|0
7117528|NCT02576639|11253536|FG001|Overall Study|Physician Decision|0
7117529|NCT02576639|11253537|FG002|Overall Study|Physician Decision|0
7117530|NCT02576639|11253538|FG003|Overall Study|Physician Decision|0
7117531|NCT02576639|11253539|FG004|Overall Study|Physician Decision|1
7117532|NCT02576652|11253555|FG000|Overall Study|Withdrawal by Subject|2
7117533|NCT02576678|11253562|FG000|Overall Study|Adverse Event|0
7117534|NCT02576678|11253563|FG001|Overall Study|Adverse Event|0
7117535|NCT02576678|11253564|FG002|Overall Study|Adverse Event|2
7117536|NCT02576678|11253562|FG000|Overall Study|Withdrawal by Subject|3
7117537|NCT02576678|11253563|FG001|Overall Study|Withdrawal by Subject|1
7117538|NCT02576678|11253564|FG002|Overall Study|Withdrawal by Subject|2
7117539|NCT02576678|11253562|FG000|Overall Study|Lost to Follow-up|0
7117540|NCT02576678|11253563|FG001|Overall Study|Lost to Follow-up|0
7117541|NCT02576678|11253564|FG002|Overall Study|Lost to Follow-up|1
7117542|NCT02576678|11253562|FG000|Overall Study|Miscellaneous|2
7117543|NCT02576678|11253563|FG001|Overall Study|Miscellaneous|0
7117544|NCT02576678|11253564|FG002|Overall Study|Miscellaneous|0
7117545|NCT02576938|11253585|FG000|Overall Study|Adverse Event|5
7117546|NCT02576938|11253586|FG001|Overall Study|Adverse Event|3
7117547|NCT02576938|11253587|FG002|Overall Study|Adverse Event|6
7117548|NCT02576938|11253585|FG000|Overall Study|Protocol Violation|1
7117549|NCT02576938|11253586|FG001|Overall Study|Protocol Violation|1
7117550|NCT02576938|11253587|FG002|Overall Study|Protocol Violation|1
7117551|NCT02576938|11253585|FG000|Overall Study|Withdrawal by Subject|3
7117552|NCT02576938|11253586|FG001|Overall Study|Withdrawal by Subject|2
7117553|NCT02576938|11253587|FG002|Overall Study|Withdrawal by Subject|4
7117554|NCT02576938|11253585|FG000|Overall Study|Lack of Efficacy|9
7117555|NCT02576938|11253586|FG001|Overall Study|Lack of Efficacy|4
7117556|NCT02576938|11253587|FG002|Overall Study|Lack of Efficacy|0
7117557|NCT02576938|11253585|FG000|Overall Study|Lost to Follow-up|2
7117558|NCT02576938|11253586|FG001|Overall Study|Lost to Follow-up|0
7117559|NCT02576938|11253587|FG002|Overall Study|Lost to Follow-up|1
7117560|NCT02576938|11253585|FG000|Overall Study|Physician Decision|0
7117561|NCT02576938|11253586|FG001|Overall Study|Physician Decision|1
7117562|NCT02576938|11253587|FG002|Overall Study|Physician Decision|0
7117563|NCT02576938|11253585|FG000|Overall Study|Met Exclusion Criteria|0
7117564|NCT02576938|11253586|FG001|Overall Study|Met Exclusion Criteria|1
7117565|NCT02576938|11253587|FG002|Overall Study|Met Exclusion Criteria|0
7117566|NCT02576951|11253601|FG000|Overall Study|Lost to Follow-up|0
7117567|NCT02576951|11253602|FG001|Overall Study|Lost to Follow-up|0
7117568|NCT02576951|11253603|FG002|Overall Study|Lost to Follow-up|2
7117569|NCT02576951|11253604|FG003|Overall Study|Lost to Follow-up|2
7117570|NCT02576951|11253601|FG000|Overall Study|Withdrawal by Subject|1
7117571|NCT02576951|11253602|FG001|Overall Study|Withdrawal by Subject|0
7117572|NCT02576951|11253603|FG002|Overall Study|Withdrawal by Subject|0
7117573|NCT02576951|11253604|FG003|Overall Study|Withdrawal by Subject|2
7117574|NCT02576951|11253601|FG000|Overall Study|Protocol Violation|0
7117575|NCT02576951|11253602|FG001|Overall Study|Protocol Violation|0
7117576|NCT02576951|11253603|FG002|Overall Study|Protocol Violation|0
7117577|NCT02576951|11253604|FG003|Overall Study|Protocol Violation|1
7117578|NCT02576977|11253618|FG000|Overall Study|Adverse Event|13
7117579|NCT02576977|11253619|FG001|Overall Study|Adverse Event|2
7117580|NCT02576977|11253618|FG000|Overall Study|Death|73
7117581|NCT02576977|11253619|FG001|Overall Study|Death|60
7117582|NCT02576977|11253618|FG000|Overall Study|Screen failure|1
7117583|NCT02576977|11253619|FG001|Overall Study|Screen failure|0
7117584|NCT02576977|11253618|FG000|Overall Study|Study Terminated at Selected Sites|27
7117585|NCT02576977|11253619|FG001|Overall Study|Study Terminated at Selected Sites|50
7117586|NCT02576977|11253618|FG000|Overall Study|Withdrawal by Subject|11
7117587|NCT02576977|11253619|FG001|Overall Study|Withdrawal by Subject|11
7117588|NCT02576977|11253618|FG000|Overall Study|Final Disposition Unknown|0
7117589|NCT02576977|11253619|FG001|Overall Study|Final Disposition Unknown|1
7117590|NCT02576977|11253618|FG000|Overall Study|Lost to Follow-up|1
7117591|NCT02576977|11253619|FG001|Overall Study|Lost to Follow-up|0
7117592|NCT02576977|11253618|FG000|Overall Study|Progressive Disease|0
7117593|NCT02576977|11253619|FG001|Overall Study|Progressive Disease|1
7117594|NCT02576990|11253627|FG000|Overall Study|Death|29
7117595|NCT02576990|11253628|FG001|Overall Study|Death|18
7117596|NCT02576990|11253627|FG000|Overall Study|Physician Decision|1
7117597|NCT02576990|11253628|FG001|Overall Study|Physician Decision|0
7117598|NCT02576990|11253627|FG000|Overall Study|Screen failure|2
7117599|NCT02576990|11253628|FG001|Overall Study|Screen failure|0
7117600|NCT02576990|11253627|FG000|Overall Study|Sponsor's decision|24
7117601|NCT02576990|11253628|FG001|Overall Study|Sponsor's decision|4
7117602|NCT02576990|11253627|FG000|Overall Study|Withdrawal by Subject|0
7117603|NCT02576990|11253628|FG001|Overall Study|Withdrawal by Subject|2
7117604|NCT02577003|11253636|FG000|Overall Study|Adverse Event|2
7117605|NCT02577003|11253637|FG001|Overall Study|Adverse Event|4
7117606|NCT02577003|11253636|FG000|Overall Study|Withdrawal by Subject|0
7117607|NCT02577003|11253637|FG001|Overall Study|Withdrawal by Subject|1
7117608|NCT02577016|11253645|FG000|Overall Study|Adverse Event|2
7117609|NCT02577016|11253646|FG001|Overall Study|Adverse Event|1
7117610|NCT02577016|11253645|FG000|Overall Study|Physician Decision|0
7117611|NCT02577016|11253646|FG001|Overall Study|Physician Decision|1
7117612|NCT02577029|11253660|FG000|Overall Study|Adverse Event|1
7117613|NCT02577029|11253661|FG001|Overall Study|Adverse Event|0
7117614|NCT02577029|11253662|FG002|Overall Study|Adverse Event|2
7117615|NCT02577029|11253663|FG003|Overall Study|Adverse Event|0
7117616|NCT02577029|11253664|FG004|Overall Study|Adverse Event|1
7117617|NCT02577029|11253665|FG005|Overall Study|Adverse Event|0
7117618|NCT02577029|11253666|FG006|Overall Study|Adverse Event|0
7117619|NCT02577029|11253667|FG007|Overall Study|Adverse Event|0
7117620|NCT02577029|11253660|FG000|Overall Study|Withdrawal by Subject|0
7117621|NCT02577029|11253661|FG001|Overall Study|Withdrawal by Subject|0
7117622|NCT02577029|11253662|FG002|Overall Study|Withdrawal by Subject|0
7117623|NCT02577029|11253663|FG003|Overall Study|Withdrawal by Subject|0
7117624|NCT02577029|11253664|FG004|Overall Study|Withdrawal by Subject|0
7117625|NCT02577029|11253665|FG005|Overall Study|Withdrawal by Subject|1
7117626|NCT02577029|11253666|FG006|Overall Study|Withdrawal by Subject|0
7117627|NCT02577029|11253667|FG007|Overall Study|Withdrawal by Subject|0
7117628|NCT02577029|11253660|FG000|Overall Study|Sponsor Termination of the Study|9
7117629|NCT02577029|11253661|FG001|Overall Study|Sponsor Termination of the Study|2
7117630|NCT02577029|11253662|FG002|Overall Study|Sponsor Termination of the Study|5
7117631|NCT02577029|11253663|FG003|Overall Study|Sponsor Termination of the Study|12
7117632|NCT02577029|11253664|FG004|Overall Study|Sponsor Termination of the Study|10
7117633|NCT02577029|11253665|FG005|Overall Study|Sponsor Termination of the Study|12
7117634|NCT02577029|11253666|FG006|Overall Study|Sponsor Termination of the Study|12
7117635|NCT02577029|11253667|FG007|Overall Study|Sponsor Termination of the Study|12
7117636|NCT02577107|11253697|FG000|Overall Study|Protocol deviation|0
7117637|NCT02577107|11253698|FG001|Overall Study|Protocol deviation|1
7117638|NCT02577146|11253704|FG000|Overall Study|Lost to Follow-up|8
7117639|NCT02577146|11253704|FG000|Overall Study|Physician Decision|3
7117640|NCT02577146|11253704|FG000|Overall Study|Screen Failure|17
7117641|NCT02577315|11253710|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
7117642|NCT02577315|11253711|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
7117643|NCT02577718|11253763|FG000|Overall Study|Death|6
7117644|NCT02577718|11253763|FG000|Overall Study|Withdrawal by Subject|2
7117645|NCT02577887|11253778|FG000|Overall Study|Death|93
7117646|NCT02577887|11253778|FG000|Overall Study|Protocol Violation|125
7117647|NCT02577887|11253778|FG000|Overall Study|Withdrawal by Subject|80
7117648|NCT02578186|11253817|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
7117649|NCT02578186|11253818|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
7117650|NCT02578186|11253817|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1
7117651|NCT02578186|11253818|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1
7117652|NCT02578316|11253832|FG000|Extension Phase|Progression of disease|6
7117653|NCT02578706|11253843|FG000|Overall Study|Withdrawal by Subject|1
7117654|NCT02578706|11253844|FG001|Overall Study|Withdrawal by Subject|0
7117655|NCT02578706|11253845|FG002|Overall Study|Withdrawal by Subject|0
7117656|NCT02578706|11253843|FG000|Overall Study|Lost to Follow-up|0
7117657|NCT02578706|11253844|FG001|Overall Study|Lost to Follow-up|4
7117658|NCT02578706|11253845|FG002|Overall Study|Lost to Follow-up|0
7117659|NCT02578706|11253843|FG000|Overall Study|Physician Decision|0
7117660|NCT02578706|11253844|FG001|Overall Study|Physician Decision|1
7117661|NCT02578706|11253845|FG002|Overall Study|Physician Decision|0
7117662|NCT02578862|11253865|FG000|Overall Study|Withdrawal by Subject|0
7117663|NCT02578862|11253866|FG001|Overall Study|Withdrawal by Subject|1
7117664|NCT02578862|11253865|FG000|Overall Study|Unplanned unilateral procedure|0
7117665|NCT02578862|11253866|FG001|Overall Study|Unplanned unilateral procedure|1
7117666|NCT02578940|11253881|FG000|Overall Study|Screening failure|5
7117667|NCT02578940|11253881|FG000|Overall Study|Lost to Follow-up|1
7117668|NCT02578992|11253889|FG000|Overall Study|equipment not available or malfunction|3
7117669|NCT02578992|11253890|FG001|Overall Study|equipment not available or malfunction|3
7117670|NCT02579382|11253933|FG000|Main Study Phase|Lost to Follow-up|0
7117671|NCT02579382|11253934|FG001|Main Study Phase|Lost to Follow-up|0
7117672|NCT02579382|11253935|FG002|Main Study Phase|Lost to Follow-up|2
7117673|NCT02579382|11253936|FG003|Main Study Phase|Lost to Follow-up|0
7117674|NCT02579382|11253933|FG000|Main Study Phase|Withdrew Consent|0
7117675|NCT02579382|11253934|FG001|Main Study Phase|Withdrew Consent|0
7117676|NCT02579382|11253935|FG002|Main Study Phase|Withdrew Consent|0
7117677|NCT02579382|11253936|FG003|Main Study Phase|Withdrew Consent|2
7117678|NCT02579382|11253933|FG000|Main Study Phase|Lack of Efficacy|0
7117679|NCT02579382|11253934|FG001|Main Study Phase|Lack of Efficacy|0
7117680|NCT02579382|11253935|FG002|Main Study Phase|Lack of Efficacy|0
7117681|NCT02579382|11253936|FG003|Main Study Phase|Lack of Efficacy|1
7117682|NCT02579382|11253933|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0
7117683|NCT02579382|11253934|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3
7117684|NCT02579382|11253935|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1
7117685|NCT02579382|11253936|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4
7117686|NCT02579382|11253933|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1
7117687|NCT02579382|11253934|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0
7117688|NCT02579382|11253935|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2
7117689|NCT02579382|11253936|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0
7117690|NCT02579382|11253933|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0
7117691|NCT02579382|11253934|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1
7117692|NCT02579382|11253935|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1
7117693|NCT02579382|11253936|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1
7117694|NCT02579382|11253933|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0
7117695|NCT02579382|11253934|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1
7117696|NCT02579382|11253935|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0
7117697|NCT02579382|11253936|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0
7117698|NCT02579382|11253933|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0
7117699|NCT02579382|11253934|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1
7117700|NCT02579382|11253935|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0
7117701|NCT02579382|11253936|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0
7117702|NCT02579382|11253933|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0
6805965|NCT04537078|10808276|FG000|Overall Study|Protocol Violation|3
6805966|NCT04537078|10808277|FG001|Overall Study|Protocol Violation|2
6805967|NCT04537078|10808276|FG000|Overall Study|Lost to Follow-up|1
6805968|NCT04537078|10808277|FG001|Overall Study|Lost to Follow-up|0
6805969|NCT04537078|10808276|FG000|Overall Study|Withdrawal by Subject|0
6805970|NCT04537078|10808277|FG001|Overall Study|Withdrawal by Subject|1
6805971|NCT04425252|10808292|FG000|Overall Study|Withdrawal by Subject|2
6805972|NCT04425252|10808293|FG001|Overall Study|Withdrawal by Subject|1
6805973|NCT04425252|10808292|FG000|Overall Study|Lost to Follow-up|1
6805974|NCT04425252|10808293|FG001|Overall Study|Lost to Follow-up|0
6805975|NCT04425252|10808292|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1
6805976|NCT04425252|10808293|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1
6805977|NCT03875313|10808322|FG000|Overall Study|Withdrawal by Subject|1
6805978|NCT03875313|10808323|FG001|Overall Study|Withdrawal by Subject|3
6805979|NCT03875313|10808324|FG002|Overall Study|Withdrawal by Subject|0
6805980|NCT03875313|10808325|FG003|Overall Study|Withdrawal by Subject|0
7117703|NCT02579382|11253934|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1
7117704|NCT02579382|11253935|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0
7117705|NCT02579382|11253936|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0
7117706|NCT02579603|11253973|FG000|Overall Study|Not treated|1
7117707|NCT02579603|11253974|FG001|Overall Study|Not treated|0
7117708|NCT02579603|11253973|FG000|Overall Study|Adverse Event|2
7117709|NCT02579603|11253974|FG001|Overall Study|Adverse Event|2
7117710|NCT02579603|11253973|FG000|Overall Study|Other than stated|1
7117711|NCT02579603|11253974|FG001|Overall Study|Other than stated|0
7117712|NCT02579616|11253981|FG000|Overall Study|Participants did not receive treatment|3
7117713|NCT02579629|11253988|FG000|Overall Study|Withdrawal by Subject|0
7117714|NCT02579629|11253989|FG001|Overall Study|Withdrawal by Subject|1
7117715|NCT02579629|11253990|FG002|Overall Study|Withdrawal by Subject|0
7117716|NCT02579629|11253988|FG000|Overall Study|Screen Failure|2
7117717|NCT02579629|11253989|FG001|Overall Study|Screen Failure|0
7117718|NCT02579629|11253990|FG002|Overall Study|Screen Failure|2
7117719|NCT02579759|11254001|FG000|Overall Study|Protocol Violation|2
7117720|NCT02579759|11254002|FG001|Overall Study|Protocol Violation|0
7117721|NCT02579759|11254003|FG002|Overall Study|Protocol Violation|0
7117722|NCT02579759|11254001|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0
7117723|NCT02579759|11254002|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1
7117724|NCT02579759|11254003|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0
7117725|NCT02579759|11254001|FG000|Overall Study|BfArM hold|13
7117726|NCT02579759|11254002|FG001|Overall Study|BfArM hold|12
7117727|NCT02579759|11254003|FG002|Overall Study|BfArM hold|12
7117728|NCT02579759|11254001|FG000|Overall Study|Sponsor stopped Dose 2|0
7117729|NCT02579759|11254002|FG001|Overall Study|Sponsor stopped Dose 2|41
7117730|NCT02579759|11254003|FG002|Overall Study|Sponsor stopped Dose 2|0
7117731|NCT02579759|11254001|FG000|Overall Study|Non compliance|0
7117732|NCT02579759|11254002|FG001|Overall Study|Non compliance|1
7117733|NCT02579759|11254003|FG002|Overall Study|Non compliance|0
7117734|NCT02579759|11254001|FG000|Overall Study|Pregnancy|0
7117735|NCT02579759|11254002|FG001|Overall Study|Pregnancy|1
7117736|NCT02579759|11254003|FG002|Overall Study|Pregnancy|0
7117737|NCT02579759|11254001|FG000|Overall Study|Inclusion/exclusion criteria|0
7117738|NCT02579759|11254002|FG001|Overall Study|Inclusion/exclusion criteria|0
7117739|NCT02579759|11254003|FG002|Overall Study|Inclusion/exclusion criteria|1
7117740|NCT02579759|11254001|FG000|Overall Study|Adverse Event|4
7117741|NCT02579759|11254002|FG001|Overall Study|Adverse Event|3
7117742|NCT02579759|11254003|FG002|Overall Study|Adverse Event|1
7117743|NCT02579759|11254001|FG000|Overall Study|Withdrawal by Subject|3
7117744|NCT02579759|11254002|FG001|Overall Study|Withdrawal by Subject|3
7117745|NCT02579759|11254003|FG002|Overall Study|Withdrawal by Subject|5
7117746|NCT02579759|11254001|FG000|Overall Study|Lost to Follow-up|2
7117747|NCT02579759|11254002|FG001|Overall Study|Lost to Follow-up|2
7117748|NCT02579759|11254003|FG002|Overall Study|Lost to Follow-up|2
7117749|NCT02579772|11254013|FG000|Overall Study|Withdrawal by Subject|0
7117750|NCT02579772|11254014|FG001|Overall Study|Withdrawal by Subject|1
7117751|NCT02579772|11254013|FG000|Overall Study|Usage of additional antioxidants|1
7117752|NCT02579772|11254014|FG001|Overall Study|Usage of additional antioxidants|0
7117753|NCT02579772|11254013|FG000|Overall Study|flu-like illness, orthopedic trauma|1
7117754|NCT02579772|11254014|FG001|Overall Study|flu-like illness, orthopedic trauma|1
7117755|NCT02579863|11254022|FG000|Overall Study|Final Disposition Unknown|2
7117756|NCT02579863|11254023|FG001|Overall Study|Final Disposition Unknown|1
7117757|NCT02579863|11254022|FG000|Overall Study|Adverse Event|18
7117758|NCT02579863|11254023|FG001|Overall Study|Adverse Event|11
7117759|NCT02579863|11254022|FG000|Overall Study|Death|31
6805981|NCT03875313|10808326|FG004|Overall Study|Withdrawal by Subject|0
6805982|NCT03875313|10808322|FG000|Overall Study|Death|0
6805983|NCT03875313|10808323|FG001|Overall Study|Death|0
6805984|NCT03875313|10808324|FG002|Overall Study|Death|0
6805985|NCT03875313|10808325|FG003|Overall Study|Death|0
6805986|NCT03875313|10808326|FG004|Overall Study|Death|1
6805987|NCT03875313|10808322|FG000|Overall Study|Lost to Follow-up|0
6805988|NCT03875313|10808323|FG001|Overall Study|Lost to Follow-up|0
6805989|NCT03875313|10808324|FG002|Overall Study|Lost to Follow-up|0
6805990|NCT03875313|10808325|FG003|Overall Study|Lost to Follow-up|0
6805991|NCT03875313|10808326|FG004|Overall Study|Lost to Follow-up|1
6805992|NCT03875313|10808322|FG000|Overall Study|Study Termination by Sponsor|0
6805993|NCT03875313|10808323|FG001|Overall Study|Study Termination by Sponsor|1
6805994|NCT03875313|10808324|FG002|Overall Study|Study Termination by Sponsor|1
6805995|NCT03875313|10808325|FG003|Overall Study|Study Termination by Sponsor|0
6805996|NCT03875313|10808326|FG004|Overall Study|Study Termination by Sponsor|1
6805997|NCT03875313|10808322|FG000|Overall Study|New Anticancer Treatment|0
6805998|NCT03875313|10808323|FG001|Overall Study|New Anticancer Treatment|1
6805999|NCT03875313|10808324|FG002|Overall Study|New Anticancer Treatment|2
6806000|NCT03875313|10808325|FG003|Overall Study|New Anticancer Treatment|1
7117760|NCT02579863|11254023|FG001|Overall Study|Death|29
7117761|NCT02579863|11254022|FG000|Overall Study|Lost to Follow-up|2
7117762|NCT02579863|11254023|FG001|Overall Study|Lost to Follow-up|1
7117763|NCT02579863|11254022|FG000|Overall Study|Physician Decision|1
7117764|NCT02579863|11254023|FG001|Overall Study|Physician Decision|2
7117765|NCT02579863|11254022|FG000|Overall Study|Screen Failure|0
7117766|NCT02579863|11254023|FG001|Overall Study|Screen Failure|2
7117767|NCT02579863|11254022|FG000|Overall Study|Study Terminated at Selected Sites|82
7117768|NCT02579863|11254023|FG001|Overall Study|Study Terminated at Selected Sites|88
7117769|NCT02579863|11254022|FG000|Overall Study|Withdrawal by Subject|20
7117770|NCT02579863|11254023|FG001|Overall Study|Withdrawal by Subject|20
7117771|NCT02579928|11254049|FG000|Overall Study|Withdrawal by Subject|1
7117772|NCT02579928|11254050|FG001|Overall Study|Withdrawal by Subject|0
7117773|NCT02580240|11254078|FG000|Overall Study|Physician Decision|2
7117774|NCT02580240|11254079|FG001|Overall Study|Physician Decision|0
7117775|NCT02580357|11254092|FG000|Overall Study|Lost to Follow-up|2
7117776|NCT02580357|11254093|FG001|Overall Study|Lost to Follow-up|0
7117777|NCT02580357|11254094|FG002|Overall Study|Lost to Follow-up|0
7117778|NCT02580357|11254092|FG000|Overall Study|Protocol Violation|1
7117779|NCT02580357|11254093|FG001|Overall Study|Protocol Violation|0
7117780|NCT02580357|11254094|FG002|Overall Study|Protocol Violation|0
7117781|NCT02580591|11254106|FG000|Overall Study|Adverse Event|0
7117782|NCT02580591|11254107|FG001|Overall Study|Adverse Event|1
6806001|NCT03875313|10808326|FG004|Overall Study|New Anticancer Treatment|0
6806002|NCT03875313|10808322|FG000|Overall Study|Other, Not Specified|2
6806003|NCT03875313|10808323|FG001|Overall Study|Other, Not Specified|11
6806004|NCT03875313|10808324|FG002|Overall Study|Other, Not Specified|3
6806005|NCT03875313|10808325|FG003|Overall Study|Other, Not Specified|3
6806006|NCT03875313|10808326|FG004|Overall Study|Other, Not Specified|1
6806007|NCT03694353|10808338|FG000|Overall Study|Withdrawal by Subject|1
7117783|NCT02580591|11254108|FG002|Overall Study|Adverse Event|2
7117784|NCT02580591|11254109|FG003|Overall Study|Adverse Event|5
7117785|NCT02580591|11254106|FG000|Overall Study|Protocol Violation|3
7117786|NCT02580591|11254107|FG001|Overall Study|Protocol Violation|2
7117787|NCT02580591|11254108|FG002|Overall Study|Protocol Violation|1
7117788|NCT02580591|11254109|FG003|Overall Study|Protocol Violation|1
7117789|NCT02580591|11254106|FG000|Overall Study|Lost to Follow-up|5
7117790|NCT02580591|11254107|FG001|Overall Study|Lost to Follow-up|3
7117791|NCT02580591|11254108|FG002|Overall Study|Lost to Follow-up|3
7117792|NCT02580591|11254109|FG003|Overall Study|Lost to Follow-up|1
7117793|NCT02580591|11254106|FG000|Overall Study|Withdrawal by Subject|6
7117794|NCT02580591|11254107|FG001|Overall Study|Withdrawal by Subject|1
7117795|NCT02580591|11254108|FG002|Overall Study|Withdrawal by Subject|2
7117796|NCT02580591|11254109|FG003|Overall Study|Withdrawal by Subject|3
7117797|NCT02580591|11254106|FG000|Overall Study|Not treated|1
7117798|NCT02580591|11254107|FG001|Overall Study|Not treated|1
7117799|NCT02580591|11254108|FG002|Overall Study|Not treated|0
7117800|NCT02580591|11254109|FG003|Overall Study|Not treated|0
7117801|NCT02580591|11254106|FG000|Overall Study|Other than specified|3
7117802|NCT02580591|11254107|FG001|Overall Study|Other than specified|2
7117803|NCT02580591|11254108|FG002|Overall Study|Other than specified|5
7117804|NCT02580591|11254109|FG003|Overall Study|Other than specified|2
7117805|NCT02580877|11254125|FG000|Overall Study|Withdrawal by Subject|1
7117806|NCT02580877|11254126|FG001|Overall Study|Withdrawal by Subject|3
7117807|NCT02580877|11254125|FG000|Overall Study|Adverse Event|0
7117808|NCT02580877|11254126|FG001|Overall Study|Adverse Event|1
7117809|NCT02581163|11254142|FG000|Overall Study|Failure to return|15
7117810|NCT02581163|11254142|FG000|Overall Study|Insufficient virological response|3
7117811|NCT02581163|11254142|FG000|Overall Study|Withdrew consent|1
7117812|NCT02581163|11254142|FG000|Overall Study|Death|1
7117813|NCT02581163|11254142|FG000|Overall Study|Other, not specified|9
7117814|NCT02581189|11254149|FG000|Overall Study|Failure to return|36
7117815|NCT02581189|11254149|FG000|Overall Study|Withdrew consent|5
7117816|NCT02581189|11254149|FG000|Overall Study|Death|3
7117817|NCT02581189|11254149|FG000|Overall Study|Insufficient virological response|2
7117818|NCT02581189|11254149|FG000|Overall Study|Other, not specified|7
7117819|NCT02581202|11254156|FG000|Overall Study|Lack of Efficacy|2
7117820|NCT02581202|11254156|FG000|Overall Study|Withdrawal by Subject|4
7117821|NCT02581202|11254156|FG000|Overall Study|Lost to Follow-up|5
7117822|NCT02581202|11254156|FG000|Overall Study|Pregnancy|3
7117823|NCT02581345|11254163|FG000|Part 1: up to Week 16|Adverse Event|3
7117824|NCT02581345|11254164|FG001|Part 1: up to Week 16|Adverse Event|8
7117825|NCT02581345|11254165|FG002|Part 1: up to Week 16|Adverse Event|0
7117826|NCT02581345|11254166|FG003|Part 1: up to Week 16|Adverse Event|0
7117827|NCT02581345|11254163|FG000|Part 1: up to Week 16|Physician Decision|2
7117828|NCT02581345|11254164|FG001|Part 1: up to Week 16|Physician Decision|4
7117829|NCT02581345|11254165|FG002|Part 1: up to Week 16|Physician Decision|0
7117830|NCT02581345|11254166|FG003|Part 1: up to Week 16|Physician Decision|0
7117831|NCT02581345|11254163|FG000|Part 1: up to Week 16|Withdrawal by Subject|4
7117832|NCT02581345|11254164|FG001|Part 1: up to Week 16|Withdrawal by Subject|7
7117833|NCT02581345|11254165|FG002|Part 1: up to Week 16|Withdrawal by Subject|0
7117834|NCT02581345|11254166|FG003|Part 1: up to Week 16|Withdrawal by Subject|0
7117835|NCT02581345|11254163|FG000|Part 1: up to Week 16|Lost to Follow-up|2
7117836|NCT02581345|11254164|FG001|Part 1: up to Week 16|Lost to Follow-up|0
7117837|NCT02581345|11254165|FG002|Part 1: up to Week 16|Lost to Follow-up|0
7117838|NCT02581345|11254166|FG003|Part 1: up to Week 16|Lost to Follow-up|0
7117839|NCT02581345|11254163|FG000|Part 1: up to Week 16|Unspecified Reason|3
7117840|NCT02581345|11254164|FG001|Part 1: up to Week 16|Unspecified Reason|3
7117841|NCT02581345|11254165|FG002|Part 1: up to Week 16|Unspecified Reason|0
7117842|NCT02581345|11254166|FG003|Part 1: up to Week 16|Unspecified Reason|0
7117843|NCT02581345|11254163|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1
7117844|NCT02581345|11254164|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1
7117845|NCT02581345|11254165|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0
7117846|NCT02581345|11254166|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0
7117847|NCT02581345|11254163|FG000|Part 2: Week 17 to Week 47|Adverse Event|5
7117848|NCT02581345|11254164|FG001|Part 2: Week 17 to Week 47|Adverse Event|0
7117849|NCT02581345|11254165|FG002|Part 2: Week 17 to Week 47|Adverse Event|2
7117850|NCT02581345|11254166|FG003|Part 2: Week 17 to Week 47|Adverse Event|2
7117851|NCT02581345|11254163|FG000|Part 2: Week 17 to Week 47|Physician Decision|3
7117852|NCT02581345|11254164|FG001|Part 2: Week 17 to Week 47|Physician Decision|0
7117853|NCT02581345|11254165|FG002|Part 2: Week 17 to Week 47|Physician Decision|2
7117854|NCT02581345|11254166|FG003|Part 2: Week 17 to Week 47|Physician Decision|1
7117855|NCT02581345|11254163|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9
7117856|NCT02581345|11254164|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0
7117857|NCT02581345|11254165|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7
7117858|NCT02581345|11254166|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5
7117859|NCT02581345|11254163|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8
7117860|NCT02581345|11254164|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0
7117861|NCT02581345|11254165|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3
7117862|NCT02581345|11254166|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2
7117863|NCT02581345|11254163|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2
7117864|NCT02581345|11254164|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0
7117865|NCT02581345|11254165|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0
7117866|NCT02581345|11254166|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1
7117867|NCT02581345|11254163|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2
7117868|NCT02581345|11254164|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0
7117869|NCT02581345|11254165|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1
7117870|NCT02581345|11254166|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1
7117871|NCT02581410|11254194|FG000|Vaccination Phase|Adverse Event|2
7117872|NCT02581410|11254195|FG001|Vaccination Phase|Adverse Event|1
7117873|NCT02581410|11254194|FG000|Vaccination Phase|Withdrawal by Subject|0
7117874|NCT02581410|11254195|FG001|Vaccination Phase|Withdrawal by Subject|1
7117875|NCT02581410|11254194|FG000|Vaccination Phase|Migrated/moved from study area|0
7117876|NCT02581410|11254195|FG001|Vaccination Phase|Migrated/moved from study area|1
7117877|NCT02581410|11254194|FG000|End of Study Phase|Adverse Event|4
7117878|NCT02581410|11254195|FG001|End of Study Phase|Adverse Event|3
7117879|NCT02581410|11254194|FG000|End of Study Phase|Withdrawal by Subject|1
7117880|NCT02581410|11254195|FG001|End of Study Phase|Withdrawal by Subject|2
7117881|NCT02581410|11254194|FG000|End of Study Phase|Migrated/moved from study area|0
7117882|NCT02581410|11254195|FG001|End of Study Phase|Migrated/moved from study area|3
7117883|NCT02581410|11254194|FG000|End of Study Phase|Lost to Follow-up|0
7117884|NCT02581410|11254195|FG001|End of Study Phase|Lost to Follow-up|2
7117885|NCT02581410|11254194|FG000|End of Study Phase|Other-transfer of subject not completed|0
7117886|NCT02581410|11254195|FG001|End of Study Phase|Other-transfer of subject not completed|1
7117887|NCT02581488|11254213|FG000|Overall Study|Adverse Event|6
7117888|NCT02581488|11254214|FG001|Overall Study|Adverse Event|7
7117889|NCT02581488|11254213|FG000|Overall Study|Lost to Follow-up|1
7117890|NCT02581488|11254214|FG001|Overall Study|Lost to Follow-up|0
7117891|NCT02581488|11254213|FG000|Overall Study|Withdrawal by Subject|1
7117892|NCT02581488|11254214|FG001|Overall Study|Withdrawal by Subject|0
7117893|NCT02581488|11254213|FG000|Overall Study|Non-Compliance|1
7117894|NCT02581488|11254214|FG001|Overall Study|Non-Compliance|0
7117895|NCT02581488|11254213|FG000|Overall Study|Protocol Violation|0
7117896|NCT02581488|11254214|FG001|Overall Study|Protocol Violation|4
7117897|NCT02581891|11254242|FG000|Overall Study|Adverse Event|4
7117898|NCT02581891|11254243|FG001|Overall Study|Adverse Event|6
7117899|NCT02581891|11254242|FG000|Overall Study|Death|3
7117900|NCT02581891|11254243|FG001|Overall Study|Death|4
7117901|NCT02581891|11254242|FG000|Overall Study|Lost to Follow-up|1
7117902|NCT02581891|11254243|FG001|Overall Study|Lost to Follow-up|2
7117903|NCT02581891|11254242|FG000|Overall Study|Physician Decision|0
7117904|NCT02581891|11254243|FG001|Overall Study|Physician Decision|1
7117905|NCT02581891|11254242|FG000|Overall Study|Withdrawal by Subject|4
7117906|NCT02581891|11254243|FG001|Overall Study|Withdrawal by Subject|5
7117907|NCT02581891|11254242|FG000|Overall Study|Other Reasons|3
7117908|NCT02581891|11254243|FG001|Overall Study|Other Reasons|1
7117909|NCT02581891|11254242|FG000|Overall Study|Discontinued during followup|1
7117910|NCT02581891|11254243|FG001|Overall Study|Discontinued during followup|0
7117911|NCT02581995|11254250|FG000|Overall Study|Unspecified other|3
7117912|NCT02581995|11254250|FG000|Overall Study|Adverse Event|6
7117913|NCT02581995|11254250|FG000|Overall Study|Lost to Follow-up|5
7117914|NCT02581995|11254250|FG000|Overall Study|Withdrawal by participant|12
7117915|NCT02581995|11254250|FG000|Overall Study|Physician Decision|1
7117916|NCT02581995|11254250|FG000|Overall Study|Death|4
7117917|NCT02582242|11254270|FG000|Overall Study|Adverse Event|4
7117918|NCT02582242|11254271|FG001|Overall Study|Adverse Event|3
7117919|NCT02582242|11254270|FG000|Overall Study|Protocol Violation|3
7117920|NCT02582242|11254271|FG001|Overall Study|Protocol Violation|1
7117921|NCT02582242|11254270|FG000|Overall Study|Lost to Follow-up|0
7117922|NCT02582242|11254271|FG001|Overall Study|Lost to Follow-up|1
7117923|NCT02582242|11254270|FG000|Overall Study|Withdrawal by Subject|11
7117924|NCT02582242|11254271|FG001|Overall Study|Withdrawal by Subject|11
7117925|NCT02582242|11254270|FG000|Overall Study|Unclassified|2
7117926|NCT02582242|11254271|FG001|Overall Study|Unclassified|1
7117927|NCT02582255|11254279|FG000|Overall Study|Protocol Violation|0
7117928|NCT02582255|11254280|FG001|Overall Study|Protocol Violation|3
7117929|NCT02582515|11254289|FG000|Overall Study|Withdrawal by Subject|0
7117930|NCT02582515|11254290|FG001|Overall Study|Withdrawal by Subject|1
7117931|NCT02582632|11254296|FG000|Overall Study|Other|1
7117932|NCT02582658|11254300|FG000|Overall Study|Failure to Return|10
7117933|NCT02582658|11254300|FG000|Overall Study|Insufficient Virological Response|2
7117934|NCT02582658|11254300|FG000|Overall Study|Withdrawn Consent|1
7117935|NCT02582658|11254300|FG000|Overall Study|Death|1
7117936|NCT02582658|11254300|FG000|Overall Study|Not further specified|11
7117937|NCT02582671|11254304|FG000|Overall Study|Failure to return|1
7117938|NCT02582671|11254304|FG000|Overall Study|Other, not specified|1
7117939|NCT02582684|11254309|FG000|Overall Study|Unable to contact subject/parent|4
7117940|NCT02582684|11254309|FG000|Overall Study|Subject not able to get to clinic|10
7117941|NCT02582684|11254309|FG000|Overall Study|Subject withdrew consent|1
7117942|NCT02582684|11254309|FG000|Overall Study|Found to be ineligible after enrollment|2
7117943|NCT02582814|11254315|FG000|Overall Study|Study-specific withdrawal criteria|1
7117944|NCT02582814|11254316|FG001|Overall Study|Study-specific withdrawal criteria|0
7117945|NCT02582814|11254315|FG000|Overall Study|Withdrawal by Subject|4
7117946|NCT02582814|11254316|FG001|Overall Study|Withdrawal by Subject|3
7117947|NCT02582814|11254315|FG000|Overall Study|Adverse Event|4
7117948|NCT02582814|11254316|FG001|Overall Study|Adverse Event|4
7117949|NCT02582866|11254337|FG000|Overall Study|Death|1
7117950|NCT02582866|11254337|FG000|Overall Study|Lack of Efficacy|2
7117951|NCT02582866|11254337|FG000|Overall Study|Lost to Follow-up|2
7117952|NCT02582866|11254337|FG000|Overall Study|Withdrawal by Subject|7
7117953|NCT02582866|11254337|FG000|Overall Study|Investigator decision|5
7117954|NCT02582866|11254337|FG000|Overall Study|Participant wants to get pregnant|1
7117955|NCT02582866|11254337|FG000|Overall Study|Pregnancy|2
7117956|NCT02582866|11254337|FG000|Overall Study|Sponsor decision|1
7117957|NCT02582866|11254337|FG000|Overall Study|Withdrawal due to personal reasons|1
7117958|NCT02582983|11254345|FG000|Overall Study|Death|3
7117959|NCT02582983|11254345|FG000|Overall Study|Withdrawal by Subject|2
7117960|NCT02582983|11254345|FG000|Overall Study|Adverse Event|1
7117961|NCT02583256|11254357|FG000|Overall Study|Withdrawal by Subject|0
7117962|NCT02583256|11254358|FG001|Overall Study|Withdrawal by Subject|1
7117963|NCT02583256|11254359|FG002|Overall Study|Withdrawal by Subject|1
7117964|NCT02583256|11254360|FG003|Overall Study|Withdrawal by Subject|0
7117965|NCT02583256|11254357|FG000|Overall Study|Lost to Follow-up|1
7117966|NCT02583256|11254358|FG001|Overall Study|Lost to Follow-up|1
7117967|NCT02583256|11254359|FG002|Overall Study|Lost to Follow-up|0
7117968|NCT02583256|11254360|FG003|Overall Study|Lost to Follow-up|1
7117969|NCT02583256|11254357|FG000|Overall Study|Administrative/Other|2
7117970|NCT02583256|11254358|FG001|Overall Study|Administrative/Other|0
7117971|NCT02583256|11254359|FG002|Overall Study|Administrative/Other|1
7117972|NCT02583256|11254360|FG003|Overall Study|Administrative/Other|2
7117973|NCT02583399|11254381|FG000|Overall Study|Able to be discharged|3
7117974|NCT02583399|11254381|FG000|Overall Study|Wanted to use a restricted medication|3
7117975|NCT02583425|11254385|FG000|Screening|Did not meet entry criteria|12
7117976|NCT02583425|11254385|FG000|Baseline|Did not meet continued criteria|5
7117977|NCT02583425|11254385|FG000|Treatment Period|Adverse Event|1
7117978|NCT02583477|11254392|FG000|Overall Study|Adverse Event|0
7117979|NCT02583477|11254393|FG001|Overall Study|Adverse Event|2
7117980|NCT02583477|11254392|FG000|Overall Study|Death|1
7117981|NCT02583477|11254393|FG001|Overall Study|Death|16
7117982|NCT02583477|11254392|FG000|Overall Study|Study terminated|2
7117983|NCT02583477|11254393|FG001|Overall Study|Study terminated|2
7117984|NCT02583711|11254403|FG000|Overall Study|Withdrawal by Subject|0
7117985|NCT02583711|11254404|FG001|Overall Study|Withdrawal by Subject|10
7117986|NCT02583711|11254405|FG002|Overall Study|Withdrawal by Subject|0
7117987|NCT02584257|11254419|FG000|Period 1|Withdrawal by Subject|0
7117988|NCT02584257|11254420|FG001|Period 1|Withdrawal by Subject|0
7117989|NCT02584257|11254421|FG002|Period 1|Withdrawal by Subject|0
7117990|NCT02584257|11254422|FG003|Period 1|Withdrawal by Subject|0
7117991|NCT02584257|11254423|FG004|Period 1|Withdrawal by Subject|0
7117992|NCT02584257|11254424|FG005|Period 1|Withdrawal by Subject|0
7117993|NCT02584257|11254425|FG006|Period 1|Withdrawal by Subject|1
7117994|NCT02584257|11254426|FG007|Period 1|Withdrawal by Subject|0
7117995|NCT02584257|11254427|FG008|Period 1|Withdrawal by Subject|0
7117996|NCT02584257|11254419|FG000|Period 2|Physician Decision|1
7117997|NCT02584257|11254420|FG001|Period 2|Physician Decision|0
7117998|NCT02584257|11254421|FG002|Period 2|Physician Decision|0
7117999|NCT02584257|11254422|FG003|Period 2|Physician Decision|0
7118000|NCT02584257|11254423|FG004|Period 2|Physician Decision|0
7118001|NCT02584257|11254424|FG005|Period 2|Physician Decision|0
7118002|NCT02584257|11254425|FG006|Period 2|Physician Decision|0
7118003|NCT02584257|11254426|FG007|Period 2|Physician Decision|0
7118004|NCT02584257|11254427|FG008|Period 2|Physician Decision|0
7118005|NCT02584257|11254419|FG000|Period 2|Adverse Event|0
7118006|NCT02584257|11254420|FG001|Period 2|Adverse Event|1
7118007|NCT02584257|11254421|FG002|Period 2|Adverse Event|0
7118008|NCT02584257|11254422|FG003|Period 2|Adverse Event|0
7118009|NCT02584257|11254423|FG004|Period 2|Adverse Event|0
7118010|NCT02584257|11254424|FG005|Period 2|Adverse Event|0
7118011|NCT02584257|11254425|FG006|Period 2|Adverse Event|0
7118012|NCT02584257|11254426|FG007|Period 2|Adverse Event|0
7118013|NCT02584257|11254427|FG008|Period 2|Adverse Event|0
7118014|NCT02584452|11254441|FG000|Overall Study|Physician Decision|1
7118015|NCT02584452|11254442|FG001|Overall Study|Physician Decision|1
7118016|NCT02584452|11254441|FG000|Overall Study|Lost to Follow-up|1
7118017|NCT02584452|11254442|FG001|Overall Study|Lost to Follow-up|1
7118018|NCT02584504|11254452|FG000|Double-blind Treatment|Participant withdrew consent|0
7118019|NCT02584504|11254453|FG001|Double-blind Treatment|Participant withdrew consent|0
7118020|NCT02584504|11254454|FG002|Double-blind Treatment|Participant withdrew consent|1
7118021|NCT02584504|11254452|FG000|Double-blind Treatment|Adverse Event|0
7118022|NCT02584504|11254453|FG001|Double-blind Treatment|Adverse Event|1
7118023|NCT02584504|11254454|FG002|Double-blind Treatment|Adverse Event|0
7118024|NCT02584504|11254452|FG000|Double-blind Treatment|Family Matter|0
7118025|NCT02584504|11254453|FG001|Double-blind Treatment|Family Matter|1
7118026|NCT02584504|11254454|FG002|Double-blind Treatment|Family Matter|0
7118027|NCT02584504|11254452|FG000|Open-label Treatment|Participant withdrew consent|0
7118028|NCT02584504|11254453|FG001|Open-label Treatment|Participant withdrew consent|0
7118029|NCT02584504|11254454|FG002|Open-label Treatment|Participant withdrew consent|4
7118030|NCT02584504|11254452|FG000|Open-label Treatment|Adverse Event|2
7118031|NCT02584504|11254453|FG001|Open-label Treatment|Adverse Event|2
7118032|NCT02584504|11254454|FG002|Open-label Treatment|Adverse Event|3
7118033|NCT02584504|11254452|FG000|Open-label Treatment|Physician Decision|0
7118034|NCT02584504|11254453|FG001|Open-label Treatment|Physician Decision|1
7118035|NCT02584504|11254454|FG002|Open-label Treatment|Physician Decision|0
7118036|NCT02584504|11254452|FG000|Open-label Treatment|Entered but not treated|0
7118037|NCT02584504|11254453|FG001|Open-label Treatment|Entered but not treated|1
7118038|NCT02584504|11254454|FG002|Open-label Treatment|Entered but not treated|1
7118039|NCT02584660|11254472|FG000|Overall Study|Adverse Event|4
7118040|NCT02584660|11254473|FG001|Overall Study|Adverse Event|0
7118041|NCT02584660|11254472|FG000|Overall Study|Lost to Follow-up|3
7118042|NCT02584660|11254473|FG001|Overall Study|Lost to Follow-up|4
7118043|NCT02584660|11254472|FG000|Overall Study|Protocol Violation|0
7118044|NCT02584660|11254473|FG001|Overall Study|Protocol Violation|1
7118045|NCT02584660|11254472|FG000|Overall Study|Withdrawal by Subject|0
7118046|NCT02584660|11254473|FG001|Overall Study|Withdrawal by Subject|2
7118047|NCT02584660|11254472|FG000|Overall Study|Other|0
7118048|NCT02584660|11254473|FG001|Overall Study|Other|1
7118049|NCT02584855|11254515|FG000|Open-Label Treatment Period|Lack of Efficacy|61
7118050|NCT02584855|11254516|FG001|Open-Label Treatment Period|Lack of Efficacy|0
7118051|NCT02584855|11254517|FG002|Open-Label Treatment Period|Lack of Efficacy|0
7118052|NCT02584855|11254518|FG003|Open-Label Treatment Period|Lack of Efficacy|0
7118053|NCT02584855|11254519|FG004|Open-Label Treatment Period|Lack of Efficacy|0
7118054|NCT02584855|11254520|FG005|Open-Label Treatment Period|Lack of Efficacy|0
7118055|NCT02584855|11254515|FG000|Open-Label Treatment Period|Withdrawal by Subject|21
7118056|NCT02584855|11254516|FG001|Open-Label Treatment Period|Withdrawal by Subject|0
7118057|NCT02584855|11254517|FG002|Open-Label Treatment Period|Withdrawal by Subject|0
7118058|NCT02584855|11254518|FG003|Open-Label Treatment Period|Withdrawal by Subject|0
7118059|NCT02584855|11254519|FG004|Open-Label Treatment Period|Withdrawal by Subject|0
7118060|NCT02584855|11254520|FG005|Open-Label Treatment Period|Withdrawal by Subject|0
7118061|NCT02584855|11254515|FG000|Open-Label Treatment Period|Adverse Event|14
7118062|NCT02584855|11254516|FG001|Open-Label Treatment Period|Adverse Event|0
7118063|NCT02584855|11254517|FG002|Open-Label Treatment Period|Adverse Event|0
7118064|NCT02584855|11254518|FG003|Open-Label Treatment Period|Adverse Event|0
7118065|NCT02584855|11254519|FG004|Open-Label Treatment Period|Adverse Event|0
7118066|NCT02584855|11254520|FG005|Open-Label Treatment Period|Adverse Event|0
7118067|NCT02584855|11254515|FG000|Open-Label Treatment Period|Death|2
7118068|NCT02584855|11254516|FG001|Open-Label Treatment Period|Death|0
7118069|NCT02584855|11254517|FG002|Open-Label Treatment Period|Death|0
7118070|NCT02584855|11254518|FG003|Open-Label Treatment Period|Death|0
7118071|NCT02584855|11254519|FG004|Open-Label Treatment Period|Death|0
7118072|NCT02584855|11254520|FG005|Open-Label Treatment Period|Death|0
7118073|NCT02584855|11254515|FG000|Open-Label Treatment Period|Lost to Follow-up|1
7118074|NCT02584855|11254516|FG001|Open-Label Treatment Period|Lost to Follow-up|0
7118075|NCT02584855|11254517|FG002|Open-Label Treatment Period|Lost to Follow-up|0
7118076|NCT02584855|11254518|FG003|Open-Label Treatment Period|Lost to Follow-up|0
7118077|NCT02584855|11254519|FG004|Open-Label Treatment Period|Lost to Follow-up|0
7118078|NCT02584855|11254520|FG005|Open-Label Treatment Period|Lost to Follow-up|0
7118079|NCT02584855|11254515|FG000|Open-Label Treatment Period|Protocol Violation|1
7118080|NCT02584855|11254516|FG001|Open-Label Treatment Period|Protocol Violation|0
7118081|NCT02584855|11254517|FG002|Open-Label Treatment Period|Protocol Violation|0
7118082|NCT02584855|11254518|FG003|Open-Label Treatment Period|Protocol Violation|0
7118083|NCT02584855|11254519|FG004|Open-Label Treatment Period|Protocol Violation|0
7118084|NCT02584855|11254520|FG005|Open-Label Treatment Period|Protocol Violation|0
7118085|NCT02584855|11254515|FG000|Open-Label Treatment Period|No PI Available|2
7118086|NCT02584855|11254516|FG001|Open-Label Treatment Period|No PI Available|0
7118087|NCT02584855|11254517|FG002|Open-Label Treatment Period|No PI Available|0
7118088|NCT02584855|11254518|FG003|Open-Label Treatment Period|No PI Available|0
7118089|NCT02584855|11254519|FG004|Open-Label Treatment Period|No PI Available|0
7118090|NCT02584855|11254520|FG005|Open-Label Treatment Period|No PI Available|0
7118091|NCT02584855|11254515|FG000|Open-Label Treatment Period|Sponsor Decision|1
7118092|NCT02584855|11254516|FG001|Open-Label Treatment Period|Sponsor Decision|0
7118093|NCT02584855|11254517|FG002|Open-Label Treatment Period|Sponsor Decision|0
7118094|NCT02584855|11254518|FG003|Open-Label Treatment Period|Sponsor Decision|0
7118095|NCT02584855|11254519|FG004|Open-Label Treatment Period|Sponsor Decision|0
7118096|NCT02584855|11254520|FG005|Open-Label Treatment Period|Sponsor Decision|0
7118097|NCT02584855|11254515|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0
7118098|NCT02584855|11254516|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0
7118099|NCT02584855|11254517|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2
7118100|NCT02584855|11254518|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0
7118101|NCT02584855|11254519|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0
7118102|NCT02584855|11254520|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0
7118103|NCT02584855|11254515|FG000|Double-Blind Withdrawal Period|Adverse Event|0
7118104|NCT02584855|11254516|FG001|Double-Blind Withdrawal Period|Adverse Event|4
7118105|NCT02584855|11254517|FG002|Double-Blind Withdrawal Period|Adverse Event|0
7118106|NCT02584855|11254518|FG003|Double-Blind Withdrawal Period|Adverse Event|1
7118107|NCT02584855|11254519|FG004|Double-Blind Withdrawal Period|Adverse Event|0
7118108|NCT02584855|11254520|FG005|Double-Blind Withdrawal Period|Adverse Event|0
7118109|NCT02584855|11254515|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0
7118110|NCT02584855|11254516|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10
7118111|NCT02584855|11254517|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0
7118112|NCT02584855|11254518|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0
7118113|NCT02584855|11254519|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0
7118114|NCT02584855|11254520|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0
7118115|NCT02584855|11254515|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
7118116|NCT02584855|11254516|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1
7118117|NCT02584855|11254517|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
7118118|NCT02584855|11254518|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
7118119|NCT02584855|11254519|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
7118120|NCT02584855|11254520|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
7118121|NCT02584855|11254515|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0
7118122|NCT02584855|11254516|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0
7118123|NCT02584855|11254517|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0
7118124|NCT02584855|11254518|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0
7118125|NCT02584855|11254519|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7
7118126|NCT02584855|11254520|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0
7118127|NCT02584855|11254515|FG000|Post Treatment Follow-up Period|Protocol Violation|0
7118128|NCT02584855|11254516|FG001|Post Treatment Follow-up Period|Protocol Violation|0
7118129|NCT02584855|11254517|FG002|Post Treatment Follow-up Period|Protocol Violation|0
7118130|NCT02584855|11254518|FG003|Post Treatment Follow-up Period|Protocol Violation|0
7118131|NCT02584855|11254519|FG004|Post Treatment Follow-up Period|Protocol Violation|1
7118132|NCT02584855|11254520|FG005|Post Treatment Follow-up Period|Protocol Violation|0
7118133|NCT02584959|11254545|FG000|Period 1|Withdrawn from study|3
7118134|NCT02584959|11254546|FG001|Period 1|Withdrawn from study|4
7118135|NCT02584959|11254547|FG002|Period 1|Withdrawn from study|0
7118136|NCT02584959|11254545|FG000|Period 2|Withdrawn from study|6
7118137|NCT02584959|11254546|FG001|Period 2|Withdrawn from study|1
7118138|NCT02584959|11254547|FG002|Period 2|Withdrawn from study|2
7118139|NCT02585713|11254593|FG000|Overall Study|Withdrew prior to treatment|2
7118140|NCT02585713|11254594|FG001|Overall Study|Withdrew prior to treatment|7
7118141|NCT02585713|11254593|FG000|Overall Study|Other|3
7118142|NCT02585713|11254594|FG001|Overall Study|Other|1
7118143|NCT02585778|11254604|FG000|Overall Study|Adverse Event|17
7118144|NCT02585778|11254605|FG001|Overall Study|Adverse Event|4
7118145|NCT02585778|11254604|FG000|Overall Study|Participant did not wish to continue|9
7118146|NCT02585778|11254605|FG001|Overall Study|Participant did not wish to continue|4
7118147|NCT02585778|11254604|FG000|Overall Study|Poor compliance to study protocol|0
7118148|NCT02585778|11254605|FG001|Overall Study|Poor compliance to study protocol|2
7118149|NCT02585778|11254604|FG000|Overall Study|Death|0
7118150|NCT02585778|11254605|FG001|Overall Study|Death|1
7118151|NCT02585778|11254604|FG000|Overall Study|Randomized but not treated|1
7118152|NCT02585778|11254605|FG001|Overall Study|Randomized but not treated|2
7118153|NCT02585778|11254604|FG000|Overall Study|Other than specified above|6
7118154|NCT02585778|11254605|FG001|Overall Study|Other than specified above|2
7118155|NCT02585830|11254615|FG000|Overall Study|Withdrawal by Subject|3
7118156|NCT02585934|11254642|FG000|Overall Study|Lost to Follow-up|2
7118157|NCT02585934|11254643|FG001|Overall Study|Lost to Follow-up|2
7118158|NCT02585934|11254642|FG000|Overall Study|Protocol Violation|14
7118159|NCT02585934|11254643|FG001|Overall Study|Protocol Violation|11
7118160|NCT02585934|11254642|FG000|Overall Study|Adverse Event|21
7118161|NCT02585934|11254643|FG001|Overall Study|Adverse Event|22
7118162|NCT02585934|11254642|FG000|Overall Study|Physician Decision|3
7118163|NCT02585934|11254643|FG001|Overall Study|Physician Decision|2
7118164|NCT02585934|11254642|FG000|Overall Study|Withdrawal by Subject|7
7118165|NCT02585934|11254643|FG001|Overall Study|Withdrawal by Subject|21
7118166|NCT02585934|11254642|FG000|Overall Study|Lack of Efficacy|2
7118167|NCT02585934|11254643|FG001|Overall Study|Lack of Efficacy|1
7118168|NCT02585934|11254642|FG000|Overall Study|Death|2
7118169|NCT02585934|11254643|FG001|Overall Study|Death|0
7118170|NCT02585934|11254642|FG000|Overall Study|Caregiver Withdrew Consent|7
7118171|NCT02585934|11254643|FG001|Overall Study|Caregiver Withdrew Consent|7
7118172|NCT02585934|11254642|FG000|Overall Study|Sponsor Termination|1
7118173|NCT02585934|11254643|FG001|Overall Study|Sponsor Termination|2
7118174|NCT02585934|11254642|FG000|Overall Study|Another Reason|10
7118175|NCT02585934|11254643|FG001|Overall Study|Another Reason|5
7118176|NCT02585960|11254657|FG000|PK/Safety Assessment Period|Physician Decision|0
7118177|NCT02585960|11254658|FG001|PK/Safety Assessment Period|Physician Decision|1
7118178|NCT02585960|11254659|FG002|PK/Safety Assessment Period|Physician Decision|0
7118179|NCT02585960|11254657|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1
7118180|NCT02585960|11254658|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2
7118181|NCT02585960|11254659|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5
7118182|NCT02585960|11254657|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0
7118183|NCT02585960|11254658|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2
7118184|NCT02585960|11254659|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0
7118185|NCT02585960|11254657|FG000|PK/Safety Assessment Period|Other|4
7118186|NCT02585960|11254658|FG001|PK/Safety Assessment Period|Other|4
7118187|NCT02585960|11254659|FG002|PK/Safety Assessment Period|Other|0
7118188|NCT02585960|11254657|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0
7118189|NCT02585960|11254658|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1
7118190|NCT02585960|11254659|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0
7118191|NCT02585960|11254657|FG000|PK/Safety Assessment Period|Screen Failure|0
7118192|NCT02585960|11254658|FG001|PK/Safety Assessment Period|Screen Failure|0
7118193|NCT02585960|11254659|FG002|PK/Safety Assessment Period|Screen Failure|1
7118194|NCT02585960|11254657|FG000|Prophylactic Treatment Period|Major protocol deviation|0
7118195|NCT02585960|11254658|FG001|Prophylactic Treatment Period|Major protocol deviation|4
7118196|NCT02585960|11254659|FG002|Prophylactic Treatment Period|Major protocol deviation|0
7118197|NCT02585960|11254657|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0
7118198|NCT02585960|11254658|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1
7118199|NCT02585960|11254659|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0
7118200|NCT02585999|11254670|FG000|Overall Study|Lost to Follow-up|1
7118201|NCT02585999|11254670|FG000|Overall Study|Protocol Violation|1
7118202|NCT02586012|11254675|FG000|Overall Study|Withdrawal by Subject|1
7118203|NCT02586012|11254676|FG001|Overall Study|Withdrawal by Subject|1
7118204|NCT02586012|11254677|FG002|Overall Study|Withdrawal by Subject|0
7118205|NCT02586012|11254678|FG003|Overall Study|Withdrawal by Subject|1
7118206|NCT02586012|11254679|FG004|Overall Study|Withdrawal by Subject|0
7118207|NCT02586012|11254680|FG005|Overall Study|Withdrawal by Subject|2
7118208|NCT02586012|11254675|FG000|Overall Study|Protocol Violation|0
7118209|NCT02586012|11254676|FG001|Overall Study|Protocol Violation|0
7118210|NCT02586012|11254677|FG002|Overall Study|Protocol Violation|0
7118211|NCT02586012|11254678|FG003|Overall Study|Protocol Violation|0
7118212|NCT02586012|11254679|FG004|Overall Study|Protocol Violation|0
7118213|NCT02586012|11254680|FG005|Overall Study|Protocol Violation|1
7118214|NCT02586012|11254675|FG000|Overall Study|study terminated|0
7118215|NCT02586012|11254676|FG001|Overall Study|study terminated|2
7118216|NCT02586012|11254677|FG002|Overall Study|study terminated|1
7118217|NCT02586012|11254678|FG003|Overall Study|study terminated|1
7118218|NCT02586012|11254679|FG004|Overall Study|study terminated|1
7118219|NCT02586012|11254680|FG005|Overall Study|study terminated|0
7118220|NCT02586064|11254691|FG000|Overall Study|Other Obligations|6
7118221|NCT02586064|11254692|FG001|Overall Study|Other Obligations|6
7118222|NCT02586064|11254691|FG000|Overall Study|Other|3
7118223|NCT02586064|11254692|FG001|Overall Study|Other|7
7118224|NCT02586064|11254691|FG000|Overall Study|Never Started|3
7118225|NCT02586064|11254692|FG001|Overall Study|Never Started|3
7118226|NCT02586064|11254691|FG000|Overall Study|Lost Interest|1
7118227|NCT02586064|11254692|FG001|Overall Study|Lost Interest|4
7118228|NCT02586064|11254691|FG000|Overall Study|Miscellaneous Life Issues|0
7118229|NCT02586064|11254692|FG001|Overall Study|Miscellaneous Life Issues|5
7118230|NCT02586064|11254691|FG000|Overall Study|Infrequent Attendance|2
7118231|NCT02586064|11254692|FG001|Overall Study|Infrequent Attendance|1
7118232|NCT02586064|11254691|FG000|Overall Study|Timed Out|2
7118233|NCT02586064|11254692|FG001|Overall Study|Timed Out|0
7118234|NCT02586064|11254691|FG000|Overall Study|AUD relapse|0
7118235|NCT02586064|11254692|FG001|Overall Study|AUD relapse|2
7118236|NCT02586064|11254691|FG000|Overall Study|Legal Issue|1
7118237|NCT02586064|11254692|FG001|Overall Study|Legal Issue|0
7118238|NCT02586077|11254701|FG000|Overall Study|Withdrawal by Subject|1
7118239|NCT02586077|11254701|FG000|Overall Study|Physician Decision|4
7118240|NCT02586077|11254701|FG000|Overall Study|Lost to Follow-up|3
7118241|NCT02586155|11254708|FG000|Overall Study|Adverse Event|2
7118242|NCT02586155|11254709|FG001|Overall Study|Adverse Event|3
7118243|NCT02586155|11254708|FG000|Overall Study|Withdrawal by Subject|31
7118244|NCT02586155|11254709|FG001|Overall Study|Withdrawal by Subject|24
7118245|NCT02586155|11254708|FG000|Overall Study|Lost to Follow-up|7
7118246|NCT02586155|11254709|FG001|Overall Study|Lost to Follow-up|13
7118247|NCT02586155|11254708|FG000|Overall Study|Death|61
7118248|NCT02586155|11254709|FG001|Overall Study|Death|72
7118249|NCT02586155|11254708|FG000|Overall Study|Other reasons|26
7118250|NCT02586155|11254709|FG001|Overall Study|Other reasons|15
7118251|NCT02586233|11254722|FG000|Overall Study|Randomized but did not receive treatment|0
7118252|NCT02586233|11254723|FG001|Overall Study|Randomized but did not receive treatment|1
7118253|NCT02586233|11254724|FG002|Overall Study|Randomized but did not receive treatment|0
7118254|NCT02586233|11254725|FG003|Overall Study|Randomized but did not receive treatment|0
7118255|NCT02586233|11254726|FG004|Overall Study|Randomized but did not receive treatment|0
7118256|NCT02586233|11254727|FG005|Overall Study|Randomized but did not receive treatment|2
7118257|NCT02586233|11254728|FG006|Overall Study|Randomized but did not receive treatment|2
7118258|NCT02586233|11254722|FG000|Overall Study|Death|0
7118259|NCT02586233|11254723|FG001|Overall Study|Death|1
7118260|NCT02586233|11254724|FG002|Overall Study|Death|0
7118261|NCT02586233|11254725|FG003|Overall Study|Death|0
7118262|NCT02586233|11254726|FG004|Overall Study|Death|2
7118263|NCT02586233|11254727|FG005|Overall Study|Death|0
6811734|NCT01208207|10815562|FG000|Part II|Withdrawal by Subject|0
7118264|NCT02586233|11254728|FG006|Overall Study|Death|0
7118265|NCT02586415|11254750|FG000|Overall Study|Death|13
7118266|NCT02586415|11254751|FG001|Overall Study|Death|23
7118267|NCT02586415|11254750|FG000|Overall Study|Lost to Follow-up|1
7118268|NCT02586415|11254751|FG001|Overall Study|Lost to Follow-up|2
7118269|NCT02586493|11254758|FG000|Overall Study|Adverse Event|4
7118270|NCT02586493|11254758|FG000|Overall Study|Protocol Violation|6
7118271|NCT02586493|11254758|FG000|Overall Study|Lost to Follow-up|1
7118272|NCT02586493|11254758|FG000|Overall Study|Withdrawal by Subject|1
7118273|NCT02586506|11254762|FG000|Overall Study|Protocol Violation|6
7118274|NCT02586506|11254762|FG000|Overall Study|Lost to Follow-up|1
7118275|NCT02586506|11254762|FG000|Overall Study|Other Reason|2
7118276|NCT02586727|11254768|FG000|Overall Study|Lost to Follow-up|1
7118277|NCT02586727|11254769|FG001|Overall Study|Lost to Follow-up|0
7118278|NCT02586805|11254779|FG000|Overall Study|Withdrawal by Subject|3
7118279|NCT02586805|11254780|FG001|Overall Study|Withdrawal by Subject|1
7118280|NCT02586805|11254781|FG002|Overall Study|Withdrawal by Subject|1
7118281|NCT02586805|11254782|FG003|Overall Study|Withdrawal by Subject|2
7118282|NCT02586805|11254779|FG000|Overall Study|Adverse Event|2
7118283|NCT02586805|11254780|FG001|Overall Study|Adverse Event|0
7118284|NCT02586805|11254781|FG002|Overall Study|Adverse Event|1
7118285|NCT02586805|11254782|FG003|Overall Study|Adverse Event|0
7118286|NCT02586805|11254779|FG000|Overall Study|Lost to Follow-up|0
7118287|NCT02586805|11254780|FG001|Overall Study|Lost to Follow-up|0
7118288|NCT02586805|11254781|FG002|Overall Study|Lost to Follow-up|1
7118289|NCT02586805|11254782|FG003|Overall Study|Lost to Follow-up|0
7118290|NCT02586805|11254779|FG000|Overall Study|Physician Decision|1
7118291|NCT02586805|11254780|FG001|Overall Study|Physician Decision|0
7118292|NCT02586805|11254781|FG002|Overall Study|Physician Decision|0
7118293|NCT02586805|11254782|FG003|Overall Study|Physician Decision|0
7118294|NCT02587065|11254816|FG000|Overall Study|Adverse Event|14
7118295|NCT02587065|11254816|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5
7118296|NCT02587065|11254816|FG000|Overall Study|Non-adherence to the Protocol|3
7118297|NCT02587065|11254816|FG000|Overall Study|Discontinuation of Study Medication|2
7118298|NCT02587065|11254816|FG000|Overall Study|Reason not Specified|3
7118299|NCT02587143|11254831|FG000|Overall Study|Adverse Event|1
7118300|NCT02587143|11254832|FG001|Overall Study|Adverse Event|0
7118301|NCT02587221|11254840|FG000|Overall Study|Adverse Event|3
7118302|NCT02587221|11254841|FG001|Overall Study|Adverse Event|3
7118303|NCT02587221|11254840|FG000|Overall Study|Death|33
7118304|NCT02587221|11254841|FG001|Overall Study|Death|34
7118305|NCT02587221|11254840|FG000|Overall Study|Withdrawal by Subject|66
7118306|NCT02587221|11254841|FG001|Overall Study|Withdrawal by Subject|61
7118307|NCT02587221|11254840|FG000|Overall Study|Lost to Follow-up|21
7118308|NCT02587221|11254841|FG001|Overall Study|Lost to Follow-up|19
7118309|NCT02587221|11254840|FG000|Overall Study|Protocol Violation|6
7118310|NCT02587221|11254841|FG001|Overall Study|Protocol Violation|5
7118311|NCT02587221|11254840|FG000|Overall Study|Other Reason or Unspecified|2
7118312|NCT02587221|11254841|FG001|Overall Study|Other Reason or Unspecified|1
7118313|NCT02587234|11254849|FG000|Overall Study|Withdrawal by Subject|1
7118314|NCT02587234|11254850|FG001|Overall Study|Withdrawal by Subject|1
7118315|NCT02587234|11254849|FG000|Overall Study|Lost to Follow-up|0
7118316|NCT02587234|11254850|FG001|Overall Study|Lost to Follow-up|2
7118317|NCT02587819|11254865|FG000|Overall Study|Adverse Event|1
7118318|NCT02587819|11254865|FG000|Overall Study|Lost to Follow-up|1
7118319|NCT02587962|11254875|FG000|Overall Study|Adverse Event|0
7118320|NCT02587962|11254876|FG001|Overall Study|Adverse Event|0
7118321|NCT02587962|11254877|FG002|Overall Study|Adverse Event|1
7118322|NCT02587962|11254878|FG003|Overall Study|Adverse Event|0
7118323|NCT02587962|11254879|FG004|Overall Study|Adverse Event|0
7118324|NCT02587962|11254875|FG000|Overall Study|Withdrawal by Subject|0
7118325|NCT02587962|11254876|FG001|Overall Study|Withdrawal by Subject|0
7118326|NCT02587962|11254877|FG002|Overall Study|Withdrawal by Subject|1
7118327|NCT02587962|11254878|FG003|Overall Study|Withdrawal by Subject|1
7118328|NCT02587962|11254879|FG004|Overall Study|Withdrawal by Subject|4
7118329|NCT02587962|11254875|FG000|Overall Study|Radiological progression|2
7118330|NCT02587962|11254876|FG001|Overall Study|Radiological progression|2
7118331|NCT02587962|11254877|FG002|Overall Study|Radiological progression|2
7118332|NCT02587962|11254878|FG003|Overall Study|Radiological progression|5
7118333|NCT02587962|11254879|FG004|Overall Study|Radiological progression|10
7118334|NCT02587962|11254875|FG000|Overall Study|Clinical progression|0
7118335|NCT02587962|11254876|FG001|Overall Study|Clinical progression|1
7118336|NCT02587962|11254877|FG002|Overall Study|Clinical progression|2
7118337|NCT02587962|11254878|FG003|Overall Study|Clinical progression|0
7118338|NCT02587962|11254879|FG004|Overall Study|Clinical progression|1
7118339|NCT02588092|11254904|FG000|Overall Study|Death|4
7118340|NCT02588092|11254905|FG001|Overall Study|Death|3
7118341|NCT02588092|11254906|FG002|Overall Study|Death|3
7118342|NCT02588092|11254907|FG003|Overall Study|Death|3
7118343|NCT02588092|11254908|FG004|Overall Study|Death|2
7118344|NCT02588092|11254909|FG005|Overall Study|Death|2
7118345|NCT02588092|11254910|FG006|Overall Study|Death|2
7118346|NCT02588092|11254911|FG007|Overall Study|Death|1
7118347|NCT02588092|11254912|FG008|Overall Study|Death|5
7118348|NCT02588092|11254913|FG009|Overall Study|Death|2
7118349|NCT02588092|11254904|FG000|Overall Study|Withdrawal by Subject|0
7118350|NCT02588092|11254905|FG001|Overall Study|Withdrawal by Subject|0
7118351|NCT02588092|11254906|FG002|Overall Study|Withdrawal by Subject|0
7118352|NCT02588092|11254907|FG003|Overall Study|Withdrawal by Subject|0
7118353|NCT02588092|11254908|FG004|Overall Study|Withdrawal by Subject|0
7118354|NCT02588092|11254909|FG005|Overall Study|Withdrawal by Subject|1
7118355|NCT02588092|11254910|FG006|Overall Study|Withdrawal by Subject|1
7118356|NCT02588092|11254911|FG007|Overall Study|Withdrawal by Subject|2
7118357|NCT02588092|11254912|FG008|Overall Study|Withdrawal by Subject|0
7118358|NCT02588092|11254913|FG009|Overall Study|Withdrawal by Subject|0
7118359|NCT02588092|11254904|FG000|Overall Study|Started Another Treatment|0
7118360|NCT02588092|11254905|FG001|Overall Study|Started Another Treatment|0
7118361|NCT02588092|11254906|FG002|Overall Study|Started Another Treatment|0
7118362|NCT02588092|11254907|FG003|Overall Study|Started Another Treatment|0
7118363|NCT02588092|11254908|FG004|Overall Study|Started Another Treatment|1
7118364|NCT02588092|11254909|FG005|Overall Study|Started Another Treatment|0
7118365|NCT02588092|11254910|FG006|Overall Study|Started Another Treatment|0
7118366|NCT02588092|11254911|FG007|Overall Study|Started Another Treatment|1
7118367|NCT02588092|11254912|FG008|Overall Study|Started Another Treatment|0
7118368|NCT02588092|11254913|FG009|Overall Study|Started Another Treatment|0
7118369|NCT02588092|11254904|FG000|Overall Study|Sponsor Decision|0
7118370|NCT02588092|11254905|FG001|Overall Study|Sponsor Decision|0
7118371|NCT02588092|11254906|FG002|Overall Study|Sponsor Decision|0
7118372|NCT02588092|11254907|FG003|Overall Study|Sponsor Decision|0
7118373|NCT02588092|11254908|FG004|Overall Study|Sponsor Decision|0
7118374|NCT02588092|11254909|FG005|Overall Study|Sponsor Decision|0
7118375|NCT02588092|11254910|FG006|Overall Study|Sponsor Decision|0
7118376|NCT02588092|11254911|FG007|Overall Study|Sponsor Decision|0
7118377|NCT02588092|11254912|FG008|Overall Study|Sponsor Decision|1
7118378|NCT02588092|11254913|FG009|Overall Study|Sponsor Decision|1
7118379|NCT04960228|11254941|FG000|Overall Study|Withdrawal by Subject|216
7118380|NCT04960228|11254942|FG001|Overall Study|Withdrawal by Subject|35
7118381|NCT04960228|11254941|FG000|Overall Study|Failed attention check|69
7118382|NCT04960228|11254942|FG001|Overall Study|Failed attention check|148
7118383|NCT04960228|11254941|FG000|Overall Study|Flagged for response quality by Dynata|3
7118384|NCT04960228|11254942|FG001|Overall Study|Flagged for response quality by Dynata|3
7118385|NCT03922477|11254948|FG000|Overall Study|Death|9
7118386|NCT03922477|11254948|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1
7118387|NCT03922477|11254948|FG000|Overall Study|Physician Decision|1
7118388|NCT03922477|11254948|FG000|Overall Study|Withdrawal by Subject|2
7118469|NCT02343952|11255006|FG000|Study Treatment|Disease Progression|23
7118470|NCT02343952|11255006|FG000|Study Treatment|Death|3
7118471|NCT02343952|11255006|FG000|Study Treatment|Adverse Event|19
7118472|NCT02343952|11255006|FG000|Study Treatment|Withdrawal by Subject|7
7118473|NCT02343952|11255006|FG000|Study Treatment|other complicating Diseases|1
7118474|NCT02343952|11255006|FG000|Follow up|Withdrawal by Subject|3
7118475|NCT02343952|11255006|FG000|Follow up|Death|33
7118476|NCT02343952|11255006|FG000|Follow up|Patient does not meet eligibility for study.|1
7118477|NCT02343952|11255006|FG000|Follow up|Research department closed by the practice.|5
7118478|NCT02343952|11255006|FG000|Follow up|Patient went home to Russia|1
7118479|NCT02343952|11255006|FG000|Follow up|Disease Progression|1
7118480|NCT02343952|11255006|FG000|Follow up|study terminated|1
7118481|NCT02326155|11255012|FG000|Overall Study|Adverse Event|21
7118482|NCT02326155|11255013|FG001|Overall Study|Adverse Event|5
7118483|NCT02326155|11255012|FG000|Overall Study|Death|3
7118484|NCT02326155|11255013|FG001|Overall Study|Death|0
7118485|NCT02326155|11255012|FG000|Overall Study|Lack of Efficacy|49
7118486|NCT02326155|11255013|FG001|Overall Study|Lack of Efficacy|5
7118487|NCT02326155|11255012|FG000|Overall Study|Lost to Follow-up|14
7118488|NCT02326155|11255013|FG001|Overall Study|Lost to Follow-up|3
7118489|NCT02326155|11255012|FG000|Overall Study|Protocol Violation|2
7118490|NCT02326155|11255013|FG001|Overall Study|Protocol Violation|0
7118491|NCT02326155|11255012|FG000|Overall Study|Withdrawal by Subject|34
7118492|NCT02326155|11255013|FG001|Overall Study|Withdrawal by Subject|11
7118493|NCT02326155|11255012|FG000|Overall Study|Disease progression|37
7118494|NCT02326155|11255013|FG001|Overall Study|Disease progression|4
7118495|NCT02326155|11255012|FG000|Overall Study|Study close|188
7118496|NCT02326155|11255013|FG001|Overall Study|Study close|21
7118497|NCT02326155|11255012|FG000|Overall Study|except for study close|46
7118498|NCT02326155|11255013|FG001|Overall Study|except for study close|13
7118499|NCT02304367|11255019|FG000|Overall Study|Lack of Response to Bruosumab|1
7118500|NCT02304367|11255019|FG000|Overall Study|Sponsor Decision|3
7118501|NCT02304367|11255019|FG000|Overall Study|Death|2
7118502|NCT02304367|11255019|FG000|Overall Study|Physician Decision|1
7118503|NCT02304367|11255019|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1
7118504|NCT02588261|11255041|FG000|Overall Study|Study Terminated by Sponsor|157
7118505|NCT02588261|11255042|FG001|Overall Study|Study Terminated by Sponsor|142
7118389|NCT03688074|11254954|FG000|Overall Study|Adverse Event|0
7118390|NCT03688074|11254955|FG001|Overall Study|Adverse Event|1
7118391|NCT03688074|11254954|FG000|Overall Study|Other|1
7118392|NCT03688074|11254955|FG001|Overall Study|Other|0
7118393|NCT03342001|11254961|FG000|Overall Study|Adverse Event|1
7118394|NCT03342001|11254961|FG000|Overall Study|Lost to Follow-up|1
7118395|NCT02859558|11254979|FG000|Step 1|Not Eligible|0
7118396|NCT02859558|11254980|FG001|Step 1|Not Eligible|0
7118397|NCT02859558|11254981|FG002|Step 1|Not Eligible|0
7118398|NCT02859558|11254982|FG003|Step 1|Not Eligible|0
7118399|NCT02859558|11254983|FG004|Step 1|Not Eligible|3
7118400|NCT02859558|11254979|FG000|Step 1|Lost to Follow-up|1
7118401|NCT02859558|11254980|FG001|Step 1|Lost to Follow-up|3
7118402|NCT02859558|11254981|FG002|Step 1|Lost to Follow-up|3
7118403|NCT02859558|11254982|FG003|Step 1|Lost to Follow-up|0
7118404|NCT02859558|11254983|FG004|Step 1|Lost to Follow-up|0
7118405|NCT02859558|11254979|FG000|Step 1|Did Not Return to Clinic|2
7118406|NCT02859558|11254980|FG001|Step 1|Did Not Return to Clinic|3
7118407|NCT02859558|11254981|FG002|Step 1|Did Not Return to Clinic|4
7118408|NCT02859558|11254982|FG003|Step 1|Did Not Return to Clinic|0
7118409|NCT02859558|11254983|FG004|Step 1|Did Not Return to Clinic|0
7118410|NCT02859558|11254979|FG000|Step 1|Moved|0
7118411|NCT02859558|11254980|FG001|Step 1|Moved|1
7118412|NCT02859558|11254981|FG002|Step 1|Moved|1
7118413|NCT02859558|11254982|FG003|Step 1|Moved|0
7118414|NCT02859558|11254983|FG004|Step 1|Moved|0
7118415|NCT02859558|11254979|FG000|Step 1|Withdrawal By Participant|1
7118416|NCT02859558|11254980|FG001|Step 1|Withdrawal By Participant|2
7118417|NCT02859558|11254981|FG002|Step 1|Withdrawal By Participant|1
7118418|NCT02859558|11254982|FG003|Step 1|Withdrawal By Participant|0
7118419|NCT02859558|11254983|FG004|Step 1|Withdrawal By Participant|0
7118420|NCT02859558|11254979|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1
7118421|NCT02859558|11254980|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0
7118422|NCT02859558|11254981|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0
7118423|NCT02859558|11254982|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0
7118424|NCT02859558|11254983|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0
7118425|NCT02859558|11254979|FG000|Step 1|Incarceration|0
7118426|NCT02859558|11254980|FG001|Step 1|Incarceration|1
7118427|NCT02859558|11254981|FG002|Step 1|Incarceration|0
7118428|NCT02859558|11254982|FG003|Step 1|Incarceration|0
7118429|NCT02859558|11254983|FG004|Step 1|Incarceration|0
7118430|NCT02859558|11254979|FG000|Step 1|Non-Adherence to Study Drug|2
7118431|NCT02859558|11254980|FG001|Step 1|Non-Adherence to Study Drug|0
7118432|NCT02859558|11254981|FG002|Step 1|Non-Adherence to Study Drug|1
7118433|NCT02859558|11254982|FG003|Step 1|Non-Adherence to Study Drug|0
7118434|NCT02859558|11254983|FG004|Step 1|Non-Adherence to Study Drug|0
7118435|NCT02859558|11254979|FG000|Step 1|Non-Adherence to Study Requirements|3
7118436|NCT02859558|11254980|FG001|Step 1|Non-Adherence to Study Requirements|1
7118437|NCT02859558|11254981|FG002|Step 1|Non-Adherence to Study Requirements|0
7118438|NCT02859558|11254982|FG003|Step 1|Non-Adherence to Study Requirements|0
7118439|NCT02859558|11254983|FG004|Step 1|Non-Adherence to Study Requirements|0
7118440|NCT02859558|11254979|FG000|Step 1|Virologic Failure|2
7118441|NCT02859558|11254980|FG001|Step 1|Virologic Failure|1
7118442|NCT02859558|11254981|FG002|Step 1|Virologic Failure|1
7118443|NCT02859558|11254982|FG003|Step 1|Virologic Failure|0
7118444|NCT02859558|11254983|FG004|Step 1|Virologic Failure|0
7118445|NCT02859558|11254979|FG000|Step 2|Active On Study|23
7118446|NCT02859558|11254980|FG001|Step 2|Active On Study|38
7118447|NCT02859558|11254981|FG002|Step 2|Active On Study|20
7118448|NCT02859558|11254982|FG003|Step 2|Active On Study|0
7118449|NCT02859558|11254983|FG004|Step 2|Active On Study|0
7118450|NCT02859558|11254979|FG000|Step 2|Did Not Return to Clinic|2
7118451|NCT02859558|11254980|FG001|Step 2|Did Not Return to Clinic|0
7118452|NCT02859558|11254981|FG002|Step 2|Did Not Return to Clinic|0
7118453|NCT02859558|11254982|FG003|Step 2|Did Not Return to Clinic|0
7118454|NCT02859558|11254983|FG004|Step 2|Did Not Return to Clinic|0
7118455|NCT02859558|11254979|FG000|Step 2|Unexpected Closure of Site|0
7118456|NCT02859558|11254980|FG001|Step 2|Unexpected Closure of Site|1
7118457|NCT02859558|11254981|FG002|Step 2|Unexpected Closure of Site|1
7118458|NCT02859558|11254982|FG003|Step 2|Unexpected Closure of Site|0
7118459|NCT02859558|11254983|FG004|Step 2|Unexpected Closure of Site|0
7118460|NCT02818920|11254993|FG000|Overall Study|Unresectable|4
7118461|NCT02818920|11254993|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1
7118462|NCT02818920|11254993|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8
7118463|NCT02818920|11254993|FG000|Overall Study|Adverse Event|3
7118464|NCT02818920|11254993|FG000|Overall Study|Developed Other Disease|1
7118465|NCT02818920|11254993|FG000|Overall Study|Refused Further Treatment|1
7118466|NCT02481310|11255000|FG000|Follow up|Still in follow up|0
7118467|NCT02481310|11255001|FG001|Follow up|Still in follow up|3
7118468|NCT02481310|11255002|FG002|Follow up|Still in follow up|0
7118506|NCT02588261|11255041|FG000|Overall Study|Protocol Deviation|1
7118507|NCT02588261|11255042|FG001|Overall Study|Protocol Deviation|0
7118508|NCT02588261|11255041|FG000|Overall Study|Death|1
7118509|NCT02588261|11255042|FG001|Overall Study|Death|2
7118510|NCT02588261|11255041|FG000|Overall Study|Withdrawal by Subject|12
7118511|NCT02588261|11255042|FG001|Overall Study|Withdrawal by Subject|8
7118512|NCT02588261|11255041|FG000|Overall Study|Noncompliance with Study Drug|0
7118513|NCT02588261|11255042|FG001|Overall Study|Noncompliance with Study Drug|1
7118514|NCT02588261|11255041|FG000|Overall Study|Miscellaneous|5
7118515|NCT02588261|11255042|FG001|Overall Study|Miscellaneous|4
7118516|NCT02588261|11255041|FG000|Overall Study|Progressive Disease|61
7118517|NCT02588261|11255042|FG001|Overall Study|Progressive Disease|82
7118518|NCT02588261|11255041|FG000|Overall Study|Adverse Event|29
7118519|NCT02588261|11255042|FG001|Overall Study|Adverse Event|24
7118520|NCT02588261|11255041|FG000|Overall Study|Lost to Follow-up|1
7118521|NCT02588261|11255042|FG001|Overall Study|Lost to Follow-up|0
7118522|NCT02588339|11255048|FG000|Overall Study|Withdrawal by Subject|1
7118523|NCT02588339|11255048|FG000|Overall Study|GVHD Progression prior to treatment|2
7118524|NCT02588612|11255081|FG000|Overall Study|Physician Decision|1
7118525|NCT02588612|11255081|FG000|Overall Study|Leukapheresis did not yield enough cells|1
7118526|NCT02588612|11255081|FG000|Overall Study|Failed eligibility prior to chemotherapy|2
7118527|NCT02588612|11255081|FG000|Overall Study|Death prior to T-cell infusion|1
7118528|NCT02588664|11255087|FG000|Overall Study|Death|56
7118529|NCT02588664|11255088|FG001|Overall Study|Death|55
7118530|NCT02588664|11255087|FG000|Overall Study|Lost to Follow-up|1305
7118531|NCT02588664|11255088|FG001|Overall Study|Lost to Follow-up|990
7118532|NCT02588833|11255096|FG000|Part 1|Withdrawal by Subject|1
7118533|NCT02588833|11255097|FG001|Part 1|Withdrawal by Subject|0
7118534|NCT02588833|11255096|FG000|Part 2A|Physician Decision|0
7118535|NCT02588833|11255097|FG001|Part 2A|Physician Decision|1
7118536|NCT02588833|11255096|FG000|Part 2A|Withdrawal by Subject|0
7118537|NCT02588833|11255097|FG001|Part 2A|Withdrawal by Subject|1
7118538|NCT02588833|11255096|FG000|Part 2B|Adverse Event|0
7118539|NCT02588833|11255097|FG001|Part 2B|Adverse Event|1
7118540|NCT02588833|11255096|FG000|Part 2C|Adverse Event|0
7118541|NCT02588833|11255097|FG001|Part 2C|Adverse Event|1
7118542|NCT02588833|11255096|FG000|Part 2C|Withdrawal by Subject|0
7118543|NCT02588833|11255097|FG001|Part 2C|Withdrawal by Subject|1
7118544|NCT02588833|11255096|FG000|Part 3 (Safety Follow-up)|Other|0
7118545|NCT02588833|11255097|FG001|Part 3 (Safety Follow-up)|Other|2
7118546|NCT02589405|11255137|FG000|Overall Study|Adverse Event|3
7118547|NCT02589405|11255137|FG000|Overall Study|Withdrawal by Subject|1
7118548|NCT02589626|11255143|FG000|Overall Study|Other than the reason specified|1
6806008|NCT03694353|10808338|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1
6806009|NCT03583554|10808342|FG000|Period 2|Did not receive treatment due to loss of contact|1
6806010|NCT03583554|10808343|FG001|Period 2|Did not receive treatment due to loss of contact|0
6806011|NCT03583554|10808344|FG002|Period 2|Did not receive treatment due to loss of contact|1
6806012|NCT03408873|10808361|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3
6806013|NCT03408873|10808361|FG000|Visit 2 Assessment|Lost to Follow-up|1
6806014|NCT03408873|10808361|FG000|Visit 3 Assessment|Withdrawal by Subject|1
6806015|NCT03408873|10808361|FG000|Visit 4 Assessment|Lost to Follow-up|2
6806016|NCT03408873|10808361|FG000|Visit 5 Assessment|Lost to Follow-up|1
6806017|NCT03408873|10808361|FG000|Visit 6 Assessment|Withdrawal by Subject|1
6806018|NCT03132467|10808365|FG000|Overall Study|Adverse Event|2
6806019|NCT03132467|10808365|FG000|Overall Study|Withdrawal by Subject|2
6810385|NCT04617847|10814111|FG001|Overall Study|Termination of Study by Sponsor|21
6811181|NCT02407236|10815052|FG000|Maintenance Study (44 Weeks)|Sponsor decision|0
6811182|NCT02407236|10815053|FG001|Maintenance Study (44 Weeks)|Sponsor decision|0
7118549|NCT02589626|11255144|FG001|Overall Study|Other than the reason specified|0
7118550|NCT02589626|11255143|FG000|Overall Study|Withdrawal by Subject|1
7118551|NCT02589626|11255144|FG001|Overall Study|Withdrawal by Subject|1
7118552|NCT02589626|11255143|FG000|Overall Study|Adverse Event|1
7118553|NCT02589626|11255144|FG001|Overall Study|Adverse Event|1
7118554|NCT02589639|11255153|FG000|Overall Study|Lost to Follow-up|1
7118555|NCT02589639|11255154|FG001|Overall Study|Lost to Follow-up|0
7118556|NCT02589639|11255155|FG002|Overall Study|Lost to Follow-up|0
7118557|NCT02589639|11255153|FG000|Overall Study|Protocol Violation|1
7118558|NCT02589639|11255154|FG001|Overall Study|Protocol Violation|0
7118559|NCT02589639|11255155|FG002|Overall Study|Protocol Violation|0
7118560|NCT02589639|11255153|FG000|Overall Study|Patient withdrawal, not due to AE|3
7118561|NCT02589639|11255154|FG001|Overall Study|Patient withdrawal, not due to AE|0
7118562|NCT02589639|11255155|FG002|Overall Study|Patient withdrawal, not due to AE|0
7118563|NCT02589639|11255153|FG000|Overall Study|Adverse Event|4
7118564|NCT02589639|11255154|FG001|Overall Study|Adverse Event|5
7118565|NCT02589639|11255155|FG002|Overall Study|Adverse Event|3
7118566|NCT02589639|11255153|FG000|Overall Study|Other reason than specified above|1
7118567|NCT02589639|11255154|FG001|Overall Study|Other reason than specified above|2
7118568|NCT02589639|11255155|FG002|Overall Study|Other reason than specified above|1
7118569|NCT02589639|11255153|FG000|Overall Study|Not Treated|0
7118570|NCT02589639|11255154|FG001|Overall Study|Not Treated|3
7118571|NCT02589639|11255155|FG002|Overall Study|Not Treated|0
7118572|NCT02589665|11255167|FG000|Induction Period|Did not receive drug|0
7118573|NCT02589665|11255168|FG001|Induction Period|Did not receive drug|0
7118574|NCT02589665|11255169|FG002|Induction Period|Did not receive drug|0
7118575|NCT02589665|11255170|FG003|Induction Period|Did not receive drug|1
7118576|NCT02589665|11255171|FG004|Induction Period|Did not receive drug|0
7118577|NCT02589665|11255172|FG005|Induction Period|Did not receive drug|0
7118578|NCT02589665|11255173|FG006|Induction Period|Did not receive drug|0
7118579|NCT02589665|11255174|FG007|Induction Period|Did not receive drug|0
7118580|NCT02589665|11255175|FG008|Induction Period|Did not receive drug|0
7118581|NCT02589665|11255176|FG009|Induction Period|Did not receive drug|0
7118582|NCT02589665|11255167|FG000|Induction Period|Adverse Event|3
7118583|NCT02589665|11255168|FG001|Induction Period|Adverse Event|0
7118584|NCT02589665|11255169|FG002|Induction Period|Adverse Event|2
7118585|NCT02589665|11255170|FG003|Induction Period|Adverse Event|2
7118586|NCT02589665|11255171|FG004|Induction Period|Adverse Event|0
7118587|NCT02589665|11255172|FG005|Induction Period|Adverse Event|0
7118588|NCT02589665|11255173|FG006|Induction Period|Adverse Event|0
7118589|NCT02589665|11255174|FG007|Induction Period|Adverse Event|0
7118590|NCT02589665|11255175|FG008|Induction Period|Adverse Event|0
7118591|NCT02589665|11255176|FG009|Induction Period|Adverse Event|0
7118592|NCT02589665|11255167|FG000|Induction Period|Withdrawal by Subject|0
7118593|NCT02589665|11255168|FG001|Induction Period|Withdrawal by Subject|1
7118594|NCT02589665|11255169|FG002|Induction Period|Withdrawal by Subject|0
7118595|NCT02589665|11255170|FG003|Induction Period|Withdrawal by Subject|1
7118596|NCT02589665|11255171|FG004|Induction Period|Withdrawal by Subject|0
7118597|NCT02589665|11255172|FG005|Induction Period|Withdrawal by Subject|0
7118598|NCT02589665|11255173|FG006|Induction Period|Withdrawal by Subject|0
7118599|NCT02589665|11255174|FG007|Induction Period|Withdrawal by Subject|0
7118600|NCT02589665|11255175|FG008|Induction Period|Withdrawal by Subject|0
7118601|NCT02589665|11255176|FG009|Induction Period|Withdrawal by Subject|0
7118602|NCT02589665|11255167|FG000|Induction Period|Protocol Violation|0
7118603|NCT02589665|11255168|FG001|Induction Period|Protocol Violation|1
7118604|NCT02589665|11255169|FG002|Induction Period|Protocol Violation|0
7118605|NCT02589665|11255170|FG003|Induction Period|Protocol Violation|0
7118606|NCT02589665|11255171|FG004|Induction Period|Protocol Violation|0
7118607|NCT02589665|11255172|FG005|Induction Period|Protocol Violation|0
7118608|NCT02589665|11255173|FG006|Induction Period|Protocol Violation|0
7118609|NCT02589665|11255174|FG007|Induction Period|Protocol Violation|0
7118610|NCT02589665|11255175|FG008|Induction Period|Protocol Violation|0
7118611|NCT02589665|11255176|FG009|Induction Period|Protocol Violation|0
7118612|NCT02589665|11255167|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
7118613|NCT02589665|11255168|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
7118614|NCT02589665|11255169|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
7118615|NCT02589665|11255170|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
7118616|NCT02589665|11255171|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7
7118617|NCT02589665|11255172|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41
7118618|NCT02589665|11255173|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39
7118619|NCT02589665|11255174|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
7118620|NCT02589665|11255175|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
7118621|NCT02589665|11255176|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
7118622|NCT02589665|11255167|FG000|Maintenance Period|Withdrawal by Subject|0
7118623|NCT02589665|11255168|FG001|Maintenance Period|Withdrawal by Subject|0
7118624|NCT02589665|11255169|FG002|Maintenance Period|Withdrawal by Subject|0
7118625|NCT02589665|11255170|FG003|Maintenance Period|Withdrawal by Subject|0
7118626|NCT02589665|11255171|FG004|Maintenance Period|Withdrawal by Subject|4
7118627|NCT02589665|11255172|FG005|Maintenance Period|Withdrawal by Subject|2
7118628|NCT02589665|11255173|FG006|Maintenance Period|Withdrawal by Subject|4
7118629|NCT02589665|11255174|FG007|Maintenance Period|Withdrawal by Subject|0
7118630|NCT02589665|11255175|FG008|Maintenance Period|Withdrawal by Subject|0
7118631|NCT02589665|11255176|FG009|Maintenance Period|Withdrawal by Subject|0
7118632|NCT02589665|11255167|FG000|Maintenance Period|Lack of Efficacy|0
7118633|NCT02589665|11255168|FG001|Maintenance Period|Lack of Efficacy|0
7118634|NCT02589665|11255169|FG002|Maintenance Period|Lack of Efficacy|0
7118635|NCT02589665|11255170|FG003|Maintenance Period|Lack of Efficacy|0
7118636|NCT02589665|11255171|FG004|Maintenance Period|Lack of Efficacy|2
7118637|NCT02589665|11255172|FG005|Maintenance Period|Lack of Efficacy|1
7118638|NCT02589665|11255173|FG006|Maintenance Period|Lack of Efficacy|0
7118639|NCT02589665|11255174|FG007|Maintenance Period|Lack of Efficacy|0
7118640|NCT02589665|11255175|FG008|Maintenance Period|Lack of Efficacy|0
7118641|NCT02589665|11255176|FG009|Maintenance Period|Lack of Efficacy|0
7118642|NCT02589665|11255167|FG000|Maintenance Period|Adverse Event|0
7118643|NCT02589665|11255168|FG001|Maintenance Period|Adverse Event|0
7118644|NCT02589665|11255169|FG002|Maintenance Period|Adverse Event|0
7118645|NCT02589665|11255170|FG003|Maintenance Period|Adverse Event|0
7118646|NCT02589665|11255171|FG004|Maintenance Period|Adverse Event|0
7118647|NCT02589665|11255172|FG005|Maintenance Period|Adverse Event|0
7118648|NCT02589665|11255173|FG006|Maintenance Period|Adverse Event|2
7118649|NCT02589665|11255174|FG007|Maintenance Period|Adverse Event|0
7118650|NCT02589665|11255175|FG008|Maintenance Period|Adverse Event|0
7118651|NCT02589665|11255176|FG009|Maintenance Period|Adverse Event|0
7118652|NCT02589665|11255167|FG000|Maintenance Period|Lost to Follow-up|0
7118653|NCT02589665|11255168|FG001|Maintenance Period|Lost to Follow-up|0
7118654|NCT02589665|11255169|FG002|Maintenance Period|Lost to Follow-up|0
7118655|NCT02589665|11255170|FG003|Maintenance Period|Lost to Follow-up|0
7118656|NCT02589665|11255171|FG004|Maintenance Period|Lost to Follow-up|0
7118657|NCT02589665|11255172|FG005|Maintenance Period|Lost to Follow-up|1
7118658|NCT02589665|11255173|FG006|Maintenance Period|Lost to Follow-up|0
7118659|NCT02589665|11255174|FG007|Maintenance Period|Lost to Follow-up|0
7118660|NCT02589665|11255175|FG008|Maintenance Period|Lost to Follow-up|0
7118661|NCT02589665|11255176|FG009|Maintenance Period|Lost to Follow-up|0
7118662|NCT02589665|11255167|FG000|Maintenance Period|Physician Decision|0
7118663|NCT02589665|11255168|FG001|Maintenance Period|Physician Decision|0
7118664|NCT02589665|11255169|FG002|Maintenance Period|Physician Decision|0
7118665|NCT02589665|11255170|FG003|Maintenance Period|Physician Decision|0
7118666|NCT02589665|11255171|FG004|Maintenance Period|Physician Decision|0
7118667|NCT02589665|11255172|FG005|Maintenance Period|Physician Decision|1
7118668|NCT02589665|11255173|FG006|Maintenance Period|Physician Decision|0
7118669|NCT02589665|11255174|FG007|Maintenance Period|Physician Decision|0
7118670|NCT02589665|11255175|FG008|Maintenance Period|Physician Decision|0
7118671|NCT02589665|11255176|FG009|Maintenance Period|Physician Decision|0
7118672|NCT02589665|11255167|FG000|Maintenance Period|Reason Not Collected|0
7118673|NCT02589665|11255168|FG001|Maintenance Period|Reason Not Collected|0
7118674|NCT02589665|11255169|FG002|Maintenance Period|Reason Not Collected|0
7118675|NCT02589665|11255170|FG003|Maintenance Period|Reason Not Collected|0
7118676|NCT02589665|11255171|FG004|Maintenance Period|Reason Not Collected|0
7118677|NCT02589665|11255172|FG005|Maintenance Period|Reason Not Collected|1
7118678|NCT02589665|11255173|FG006|Maintenance Period|Reason Not Collected|1
7118679|NCT02589665|11255174|FG007|Maintenance Period|Reason Not Collected|0
7118680|NCT02589665|11255175|FG008|Maintenance Period|Reason Not Collected|0
7118681|NCT02589665|11255176|FG009|Maintenance Period|Reason Not Collected|0
7118682|NCT02589665|11255167|FG000|Induction Extension Period|Adverse Event|0
7118683|NCT02589665|11255168|FG001|Induction Extension Period|Adverse Event|0
7118684|NCT02589665|11255169|FG002|Induction Extension Period|Adverse Event|0
7118685|NCT02589665|11255170|FG003|Induction Extension Period|Adverse Event|0
7118686|NCT02589665|11255171|FG004|Induction Extension Period|Adverse Event|0
7118687|NCT02589665|11255172|FG005|Induction Extension Period|Adverse Event|0
7118688|NCT02589665|11255173|FG006|Induction Extension Period|Adverse Event|0
7118689|NCT02589665|11255174|FG007|Induction Extension Period|Adverse Event|0
7118690|NCT02589665|11255175|FG008|Induction Extension Period|Adverse Event|4
7118691|NCT02589665|11255176|FG009|Induction Extension Period|Adverse Event|0
7118692|NCT02589665|11255167|FG000|Induction Extension Period|Lack of Efficacy|0
7118693|NCT02589665|11255168|FG001|Induction Extension Period|Lack of Efficacy|0
7118694|NCT02589665|11255169|FG002|Induction Extension Period|Lack of Efficacy|0
7118695|NCT02589665|11255170|FG003|Induction Extension Period|Lack of Efficacy|0
7118696|NCT02589665|11255171|FG004|Induction Extension Period|Lack of Efficacy|0
7118697|NCT02589665|11255172|FG005|Induction Extension Period|Lack of Efficacy|0
7118698|NCT02589665|11255173|FG006|Induction Extension Period|Lack of Efficacy|0
7118699|NCT02589665|11255174|FG007|Induction Extension Period|Lack of Efficacy|0
7118700|NCT02589665|11255175|FG008|Induction Extension Period|Lack of Efficacy|3
7118701|NCT02589665|11255176|FG009|Induction Extension Period|Lack of Efficacy|0
7118702|NCT02589665|11255167|FG000|Induction Extension Period|Withdrawal by Subject|0
7118703|NCT02589665|11255168|FG001|Induction Extension Period|Withdrawal by Subject|0
7118704|NCT02589665|11255169|FG002|Induction Extension Period|Withdrawal by Subject|0
7118705|NCT02589665|11255170|FG003|Induction Extension Period|Withdrawal by Subject|0
7118706|NCT02589665|11255171|FG004|Induction Extension Period|Withdrawal by Subject|0
7118707|NCT02589665|11255172|FG005|Induction Extension Period|Withdrawal by Subject|0
7118708|NCT02589665|11255173|FG006|Induction Extension Period|Withdrawal by Subject|0
7118709|NCT02589665|11255174|FG007|Induction Extension Period|Withdrawal by Subject|2
7118710|NCT02589665|11255175|FG008|Induction Extension Period|Withdrawal by Subject|3
7118711|NCT02589665|11255176|FG009|Induction Extension Period|Withdrawal by Subject|0
7118712|NCT02589665|11255167|FG000|Induction Extension Period|Physician Decision|0
7118713|NCT02589665|11255168|FG001|Induction Extension Period|Physician Decision|0
7118714|NCT02589665|11255169|FG002|Induction Extension Period|Physician Decision|0
7118715|NCT02589665|11255170|FG003|Induction Extension Period|Physician Decision|0
7118716|NCT02589665|11255171|FG004|Induction Extension Period|Physician Decision|0
7118717|NCT02589665|11255172|FG005|Induction Extension Period|Physician Decision|0
7118718|NCT02589665|11255173|FG006|Induction Extension Period|Physician Decision|0
7118719|NCT02589665|11255174|FG007|Induction Extension Period|Physician Decision|0
7118720|NCT02589665|11255175|FG008|Induction Extension Period|Physician Decision|1
7118721|NCT02589665|11255176|FG009|Induction Extension Period|Physician Decision|0
7118722|NCT02589665|11255167|FG000|Induction Extension Period|Reason Not Collected|0
7118723|NCT02589665|11255168|FG001|Induction Extension Period|Reason Not Collected|0
7118724|NCT02589665|11255169|FG002|Induction Extension Period|Reason Not Collected|0
7118725|NCT02589665|11255170|FG003|Induction Extension Period|Reason Not Collected|0
7118726|NCT02589665|11255171|FG004|Induction Extension Period|Reason Not Collected|0
7118727|NCT02589665|11255172|FG005|Induction Extension Period|Reason Not Collected|0
7118728|NCT02589665|11255173|FG006|Induction Extension Period|Reason Not Collected|0
7118729|NCT02589665|11255174|FG007|Induction Extension Period|Reason Not Collected|0
7118730|NCT02589665|11255175|FG008|Induction Extension Period|Reason Not Collected|1
7118731|NCT02589665|11255176|FG009|Induction Extension Period|Reason Not Collected|0
7118732|NCT02589665|11255167|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
7118733|NCT02589665|11255168|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
7118734|NCT02589665|11255169|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
7118735|NCT02589665|11255170|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
7118736|NCT02589665|11255171|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
7118737|NCT02589665|11255172|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
7118738|NCT02589665|11255173|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
7118739|NCT02589665|11255174|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
7118740|NCT02589665|11255175|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
7118741|NCT02589665|11255176|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57
7118742|NCT02589665|11255167|FG000|Maintenance Extension Period|Withdrawal by Subject|0
7118743|NCT02589665|11255168|FG001|Maintenance Extension Period|Withdrawal by Subject|0
7118744|NCT02589665|11255169|FG002|Maintenance Extension Period|Withdrawal by Subject|0
7118745|NCT02589665|11255170|FG003|Maintenance Extension Period|Withdrawal by Subject|0
7118746|NCT02589665|11255171|FG004|Maintenance Extension Period|Withdrawal by Subject|0
7118747|NCT02589665|11255172|FG005|Maintenance Extension Period|Withdrawal by Subject|0
7118748|NCT02589665|11255173|FG006|Maintenance Extension Period|Withdrawal by Subject|0
7118749|NCT02589665|11255174|FG007|Maintenance Extension Period|Withdrawal by Subject|0
7118750|NCT02589665|11255175|FG008|Maintenance Extension Period|Withdrawal by Subject|0
7118751|NCT02589665|11255176|FG009|Maintenance Extension Period|Withdrawal by Subject|4
7118752|NCT02589665|11255167|FG000|Maintenance Extension Period|Lack of Efficacy|0
7118753|NCT02589665|11255168|FG001|Maintenance Extension Period|Lack of Efficacy|0
7118754|NCT02589665|11255169|FG002|Maintenance Extension Period|Lack of Efficacy|0
7118755|NCT02589665|11255170|FG003|Maintenance Extension Period|Lack of Efficacy|0
7118756|NCT02589665|11255171|FG004|Maintenance Extension Period|Lack of Efficacy|0
7118757|NCT02589665|11255172|FG005|Maintenance Extension Period|Lack of Efficacy|0
7118758|NCT02589665|11255173|FG006|Maintenance Extension Period|Lack of Efficacy|0
7118759|NCT02589665|11255174|FG007|Maintenance Extension Period|Lack of Efficacy|0
7118760|NCT02589665|11255175|FG008|Maintenance Extension Period|Lack of Efficacy|0
7118761|NCT02589665|11255176|FG009|Maintenance Extension Period|Lack of Efficacy|4
7118762|NCT02589665|11255167|FG000|Maintenance Extension Period|Adverse Event|0
7118763|NCT02589665|11255168|FG001|Maintenance Extension Period|Adverse Event|0
7118764|NCT02589665|11255169|FG002|Maintenance Extension Period|Adverse Event|0
7118765|NCT02589665|11255170|FG003|Maintenance Extension Period|Adverse Event|0
7118766|NCT02589665|11255171|FG004|Maintenance Extension Period|Adverse Event|0
7118767|NCT02589665|11255172|FG005|Maintenance Extension Period|Adverse Event|0
7118768|NCT02589665|11255173|FG006|Maintenance Extension Period|Adverse Event|0
7118769|NCT02589665|11255174|FG007|Maintenance Extension Period|Adverse Event|0
7118770|NCT02589665|11255175|FG008|Maintenance Extension Period|Adverse Event|0
7118771|NCT02589665|11255176|FG009|Maintenance Extension Period|Adverse Event|2
7118772|NCT02589665|11255167|FG000|Maintenance Extension Period|Non-responder|0
7118773|NCT02589665|11255168|FG001|Maintenance Extension Period|Non-responder|0
7118774|NCT02589665|11255169|FG002|Maintenance Extension Period|Non-responder|0
7118775|NCT02589665|11255170|FG003|Maintenance Extension Period|Non-responder|0
7118776|NCT02589665|11255171|FG004|Maintenance Extension Period|Non-responder|0
7118777|NCT02589665|11255172|FG005|Maintenance Extension Period|Non-responder|0
7118778|NCT02589665|11255173|FG006|Maintenance Extension Period|Non-responder|0
7118779|NCT02589665|11255174|FG007|Maintenance Extension Period|Non-responder|0
7118780|NCT02589665|11255175|FG008|Maintenance Extension Period|Non-responder|0
7118781|NCT02589665|11255176|FG009|Maintenance Extension Period|Non-responder|1
7118782|NCT02590003|11255229|FG000|Overall Study|Death|1
7118783|NCT02590003|11255230|FG001|Overall Study|Death|2
7118784|NCT02590354|11255236|FG000|Phase 1|Active hepatitis B or C infection|1
7118785|NCT02590354|11255236|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1
7118786|NCT02590354|11255236|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75
7118787|NCT02590354|11255236|FG000|Phase 1|Subject does not want to participate|20
7118788|NCT02590354|11255236|FG000|Phase 1|Lost to Follow-up|1
7118789|NCT02590354|11255236|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2
7118790|NCT02590406|11255243|FG000|Overall Study|Adverse Event|1
7118791|NCT02590406|11255244|FG001|Overall Study|Adverse Event|0
7118792|NCT02590406|11255243|FG000|Overall Study|Saturometer malfunction|0
7118793|NCT02590406|11255244|FG001|Overall Study|Saturometer malfunction|1
7118794|NCT02590432|11255252|FG000|Open-label Treatment Period|Adverse Event|97
7118795|NCT02590432|11255253|FG001|Open-label Treatment Period|Adverse Event|79
7118796|NCT02590432|11255254|FG002|Open-label Treatment Period|Adverse Event|0
7118797|NCT02590432|11255255|FG003|Open-label Treatment Period|Adverse Event|0
7118798|NCT02590432|11255256|FG004|Open-label Treatment Period|Adverse Event|0
7118799|NCT02590432|11255257|FG005|Open-label Treatment Period|Adverse Event|0
7118800|NCT02590432|11255258|FG006|Open-label Treatment Period|Adverse Event|0
7118801|NCT02590432|11255259|FG007|Open-label Treatment Period|Adverse Event|0
7118802|NCT02590432|11255260|FG008|Open-label Treatment Period|Adverse Event|0
7118803|NCT02590432|11255252|FG000|Open-label Treatment Period|Lack of Efficacy|14
7118804|NCT02590432|11255253|FG001|Open-label Treatment Period|Lack of Efficacy|5
7118805|NCT02590432|11255254|FG002|Open-label Treatment Period|Lack of Efficacy|0
7118806|NCT02590432|11255255|FG003|Open-label Treatment Period|Lack of Efficacy|0
7118807|NCT02590432|11255256|FG004|Open-label Treatment Period|Lack of Efficacy|0
7118808|NCT02590432|11255257|FG005|Open-label Treatment Period|Lack of Efficacy|0
7118809|NCT02590432|11255258|FG006|Open-label Treatment Period|Lack of Efficacy|0
7118810|NCT02590432|11255259|FG007|Open-label Treatment Period|Lack of Efficacy|0
7118811|NCT02590432|11255260|FG008|Open-label Treatment Period|Lack of Efficacy|0
7118812|NCT02590432|11255252|FG000|Open-label Treatment Period|Withdrawal of Consent|43
7118813|NCT02590432|11255253|FG001|Open-label Treatment Period|Withdrawal of Consent|28
7118814|NCT02590432|11255254|FG002|Open-label Treatment Period|Withdrawal of Consent|0
7118815|NCT02590432|11255255|FG003|Open-label Treatment Period|Withdrawal of Consent|0
7118816|NCT02590432|11255256|FG004|Open-label Treatment Period|Withdrawal of Consent|0
7118817|NCT02590432|11255257|FG005|Open-label Treatment Period|Withdrawal of Consent|0
7118818|NCT02590432|11255258|FG006|Open-label Treatment Period|Withdrawal of Consent|0
7118819|NCT02590432|11255259|FG007|Open-label Treatment Period|Withdrawal of Consent|0
7118820|NCT02590432|11255260|FG008|Open-label Treatment Period|Withdrawal of Consent|0
7118821|NCT02590432|11255252|FG000|Open-label Treatment Period|Lost to Follow-up|51
7118822|NCT02590432|11255253|FG001|Open-label Treatment Period|Lost to Follow-up|29
7118823|NCT02590432|11255254|FG002|Open-label Treatment Period|Lost to Follow-up|0
7118824|NCT02590432|11255255|FG003|Open-label Treatment Period|Lost to Follow-up|0
7118825|NCT02590432|11255256|FG004|Open-label Treatment Period|Lost to Follow-up|0
7118826|NCT02590432|11255257|FG005|Open-label Treatment Period|Lost to Follow-up|0
7118827|NCT02590432|11255258|FG006|Open-label Treatment Period|Lost to Follow-up|0
7118828|NCT02590432|11255259|FG007|Open-label Treatment Period|Lost to Follow-up|0
7118829|NCT02590432|11255260|FG008|Open-label Treatment Period|Lost to Follow-up|0
7118830|NCT02590432|11255252|FG000|Open-label Treatment Period|Protocol Violation|10
7118831|NCT02590432|11255253|FG001|Open-label Treatment Period|Protocol Violation|4
7118832|NCT02590432|11255254|FG002|Open-label Treatment Period|Protocol Violation|0
7118833|NCT02590432|11255255|FG003|Open-label Treatment Period|Protocol Violation|0
7118834|NCT02590432|11255256|FG004|Open-label Treatment Period|Protocol Violation|0
7118835|NCT02590432|11255257|FG005|Open-label Treatment Period|Protocol Violation|0
7118836|NCT02590432|11255258|FG006|Open-label Treatment Period|Protocol Violation|0
7118837|NCT02590432|11255259|FG007|Open-label Treatment Period|Protocol Violation|0
7118838|NCT02590432|11255260|FG008|Open-label Treatment Period|Protocol Violation|0
7118839|NCT02590432|11255252|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7
7118840|NCT02590432|11255253|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1
7118841|NCT02590432|11255254|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0
7118842|NCT02590432|11255255|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0
7118843|NCT02590432|11255256|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0
7118844|NCT02590432|11255257|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0
7118845|NCT02590432|11255258|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0
7118846|NCT02590432|11255259|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0
7118847|NCT02590432|11255260|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0
7118848|NCT02590432|11255252|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10
7118849|NCT02590432|11255253|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6
7118850|NCT02590432|11255254|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0
7118851|NCT02590432|11255255|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0
7118852|NCT02590432|11255256|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0
7118853|NCT02590432|11255257|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0
7118854|NCT02590432|11255258|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0
7118855|NCT02590432|11255259|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0
7118856|NCT02590432|11255260|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0
7118857|NCT02590432|11255252|FG000|Double-blind Treatment Period|Adverse Event|0
7118858|NCT02590432|11255253|FG001|Double-blind Treatment Period|Adverse Event|0
7118859|NCT02590432|11255254|FG002|Double-blind Treatment Period|Adverse Event|14
7118860|NCT02590432|11255255|FG003|Double-blind Treatment Period|Adverse Event|12
7118861|NCT02590432|11255256|FG004|Double-blind Treatment Period|Adverse Event|6
7118862|NCT02590432|11255257|FG005|Double-blind Treatment Period|Adverse Event|22
7118863|NCT02590432|11255258|FG006|Double-blind Treatment Period|Adverse Event|20
7118864|NCT02590432|11255259|FG007|Double-blind Treatment Period|Adverse Event|0
7118865|NCT02590432|11255260|FG008|Double-blind Treatment Period|Adverse Event|0
7118866|NCT02590432|11255252|FG000|Double-blind Treatment Period|Lack of Efficacy|0
7118867|NCT02590432|11255253|FG001|Double-blind Treatment Period|Lack of Efficacy|0
7118868|NCT02590432|11255254|FG002|Double-blind Treatment Period|Lack of Efficacy|1
7118869|NCT02590432|11255255|FG003|Double-blind Treatment Period|Lack of Efficacy|0
7118870|NCT02590432|11255256|FG004|Double-blind Treatment Period|Lack of Efficacy|0
7118871|NCT02590432|11255257|FG005|Double-blind Treatment Period|Lack of Efficacy|0
7118872|NCT02590432|11255258|FG006|Double-blind Treatment Period|Lack of Efficacy|0
7118873|NCT02590432|11255259|FG007|Double-blind Treatment Period|Lack of Efficacy|0
7118874|NCT02590432|11255260|FG008|Double-blind Treatment Period|Lack of Efficacy|0
7118875|NCT02590432|11255252|FG000|Double-blind Treatment Period|Withdrawal of Consent|0
7118876|NCT02590432|11255253|FG001|Double-blind Treatment Period|Withdrawal of Consent|0
7118877|NCT02590432|11255254|FG002|Double-blind Treatment Period|Withdrawal of Consent|1
7118878|NCT02590432|11255255|FG003|Double-blind Treatment Period|Withdrawal of Consent|3
7118879|NCT02590432|11255256|FG004|Double-blind Treatment Period|Withdrawal of Consent|3
7118880|NCT02590432|11255257|FG005|Double-blind Treatment Period|Withdrawal of Consent|1
7118881|NCT02590432|11255258|FG006|Double-blind Treatment Period|Withdrawal of Consent|1
7118882|NCT02590432|11255259|FG007|Double-blind Treatment Period|Withdrawal of Consent|0
7118883|NCT02590432|11255260|FG008|Double-blind Treatment Period|Withdrawal of Consent|0
7118884|NCT02590432|11255252|FG000|Double-blind Treatment Period|Lost to Follow-up|0
7118885|NCT02590432|11255253|FG001|Double-blind Treatment Period|Lost to Follow-up|0
7118886|NCT02590432|11255254|FG002|Double-blind Treatment Period|Lost to Follow-up|1
7118887|NCT02590432|11255255|FG003|Double-blind Treatment Period|Lost to Follow-up|0
7118888|NCT02590432|11255256|FG004|Double-blind Treatment Period|Lost to Follow-up|0
7118889|NCT02590432|11255257|FG005|Double-blind Treatment Period|Lost to Follow-up|2
7118890|NCT02590432|11255258|FG006|Double-blind Treatment Period|Lost to Follow-up|0
7118891|NCT02590432|11255259|FG007|Double-blind Treatment Period|Lost to Follow-up|0
7118892|NCT02590432|11255260|FG008|Double-blind Treatment Period|Lost to Follow-up|0
7118893|NCT02590432|11255252|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0
7118894|NCT02590432|11255253|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0
7118895|NCT02590432|11255254|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0
7118896|NCT02590432|11255255|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0
7118897|NCT02590432|11255256|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0
7118898|NCT02590432|11255257|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1
7118899|NCT02590432|11255258|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0
7118900|NCT02590432|11255259|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0
7118901|NCT02590432|11255260|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0
7118902|NCT02590432|11255252|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0
7118903|NCT02590432|11255253|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0
7118904|NCT02590432|11255254|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0
7118905|NCT02590432|11255255|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0
7118906|NCT02590432|11255256|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0
7118907|NCT02590432|11255257|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0
7118908|NCT02590432|11255258|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0
7118909|NCT02590432|11255259|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12
7118910|NCT02590432|11255260|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15
7118911|NCT02590432|11255252|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
7118912|NCT02590432|11255253|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
7118913|NCT02590432|11255254|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
7118914|NCT02590432|11255255|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
7118915|NCT02590432|11255256|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
7118916|NCT02590432|11255257|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
7118917|NCT02590432|11255258|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
7118918|NCT02590432|11255259|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1
7118919|NCT02590432|11255260|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
7118920|NCT02590432|11255252|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
7118921|NCT02590432|11255253|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
7118922|NCT02590432|11255254|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
7118923|NCT02590432|11255255|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
7118924|NCT02590432|11255256|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
7118925|NCT02590432|11255257|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
7118926|NCT02590432|11255258|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
7118927|NCT02590432|11255259|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3
7118928|NCT02590432|11255260|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1
7118929|NCT02590432|11255252|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
7118930|NCT02590432|11255253|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
7118931|NCT02590432|11255254|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
7118932|NCT02590432|11255255|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
7118933|NCT02590432|11255256|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
7118934|NCT02590432|11255257|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
7118935|NCT02590432|11255258|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
7118936|NCT02590432|11255259|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
7118937|NCT02590432|11255260|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1
7118938|NCT02590432|11255252|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0
7118939|NCT02590432|11255253|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0
7118940|NCT02590432|11255254|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0
7118941|NCT02590432|11255255|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0
7118942|NCT02590432|11255256|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0
7118943|NCT02590432|11255257|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0
7118944|NCT02590432|11255258|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0
7118945|NCT02590432|11255259|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0
7118946|NCT02590432|11255260|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1
7118947|NCT02590432|11255252|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
7118948|NCT02590432|11255253|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
7118949|NCT02590432|11255254|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
7118950|NCT02590432|11255255|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
7118951|NCT02590432|11255256|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
7118952|NCT02590432|11255257|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
7118953|NCT02590432|11255258|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
7118954|NCT02590432|11255259|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1
7118955|NCT02590432|11255260|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
7118956|NCT02590432|11255252|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
7118957|NCT02590432|11255253|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
7118958|NCT02590432|11255254|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
7118959|NCT02590432|11255255|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
7118960|NCT02590432|11255256|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
7118961|NCT02590432|11255257|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
7118962|NCT02590432|11255258|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
7118963|NCT02590432|11255259|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1
7118964|NCT02590432|11255260|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
7118965|NCT02590562|11255272|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6
7118966|NCT02590588|11255282|FG000|Overall Study|Adverse Event|1
7118967|NCT02590939|11255288|FG000|Overall Study|Withdrawal by Subject|3
7118968|NCT02590939|11255289|FG001|Overall Study|Withdrawal by Subject|1
7118969|NCT02590939|11255288|FG000|Overall Study|Failed the nociceptive test|2
7118970|NCT02590939|11255289|FG001|Overall Study|Failed the nociceptive test|1
7118971|NCT02591238|11255303|FG000|Overall Study|Pregnancy|1
7118972|NCT02591238|11255304|FG001|Overall Study|Pregnancy|0
7118973|NCT02591238|11255305|FG002|Overall Study|Pregnancy|0
7118974|NCT02591238|11255306|FG003|Overall Study|Pregnancy|0
7118975|NCT02591238|11255303|FG000|Overall Study|Withdrawal by Subject|0
7118976|NCT02591238|11255304|FG001|Overall Study|Withdrawal by Subject|0
7118977|NCT02591238|11255305|FG002|Overall Study|Withdrawal by Subject|0
7118978|NCT02591238|11255306|FG003|Overall Study|Withdrawal by Subject|1
7118979|NCT02591238|11255303|FG000|Overall Study|influenza|0
7118980|NCT02591238|11255304|FG001|Overall Study|influenza|0
7118981|NCT02591238|11255305|FG002|Overall Study|influenza|0
7118982|NCT02591238|11255306|FG003|Overall Study|influenza|1
7118983|NCT02591238|11255303|FG000|Overall Study|personal circumstances|0
7118984|NCT02591238|11255304|FG001|Overall Study|personal circumstances|0
7118985|NCT02591238|11255305|FG002|Overall Study|personal circumstances|0
7118986|NCT02591238|11255306|FG003|Overall Study|personal circumstances|1
7118987|NCT02591238|11255303|FG000|Overall Study|personal circumstances|0
7118988|NCT02591238|11255304|FG001|Overall Study|personal circumstances|1
7118989|NCT02591238|11255305|FG002|Overall Study|personal circumstances|0
7118990|NCT02591238|11255306|FG003|Overall Study|personal circumstances|0
7118991|NCT02591290|11255316|FG000|Overall Study|Withdrawal by Subject|2
7118992|NCT02592018|11255339|FG000|Overall Study|Adverse Event|1
7118993|NCT02592018|11255339|FG000|Overall Study|Lost to Follow-up|1
7118994|NCT02592434|11255352|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12
7118995|NCT02592434|11255353|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0
7118996|NCT02592434|11255354|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0
7118997|NCT02592434|11255352|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21
7118998|NCT02592434|11255353|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0
7118999|NCT02592434|11255354|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0
7119000|NCT02592434|11255352|FG000|Open-Label Phase (18 Weeks)|Other|3
7119001|NCT02592434|11255353|FG001|Open-Label Phase (18 Weeks)|Other|0
7119002|NCT02592434|11255354|FG002|Open-Label Phase (18 Weeks)|Other|0
7119003|NCT02592434|11255352|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4
7119004|NCT02592434|11255353|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0
7119005|NCT02592434|11255354|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0
7119006|NCT02592434|11255352|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0
7119007|NCT02592434|11255353|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2
7119008|NCT02592434|11255354|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2
7119009|NCT02592434|11255352|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0
7119010|NCT02592434|11255353|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22
7119011|NCT02592434|11255354|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44
7119012|NCT02592434|11255352|FG000|Double Blind Phase (26 Weeks)|Other|0
7119013|NCT02592434|11255353|FG001|Double Blind Phase (26 Weeks)|Other|1
7119014|NCT02592434|11255354|FG002|Double Blind Phase (26 Weeks)|Other|0
7119015|NCT02592434|11255352|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0
7119016|NCT02592434|11255353|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0
7119017|NCT02592434|11255354|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1
7119018|NCT02592434|11255352|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0
7119019|NCT02592434|11255353|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1
7119020|NCT02592434|11255354|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0
7119021|NCT02592434|11255352|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0
7119022|NCT02592434|11255353|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1
7119023|NCT02592434|11255354|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0
7119024|NCT02592447|11255364|FG000|Overall Study|Lost to Follow-up|1
7119025|NCT02592447|11255365|FG001|Overall Study|Lost to Follow-up|0
7119026|NCT02592447|11255364|FG000|Overall Study|Ineligible after randomization|1
7119027|NCT02592447|11255365|FG001|Overall Study|Ineligible after randomization|0
7119028|NCT02592447|11255364|FG000|Overall Study|Withdrawal by Subject|0
7119029|NCT02592447|11255365|FG001|Overall Study|Withdrawal by Subject|1
7119030|NCT02592798|11255412|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1
7119031|NCT02592798|11255413|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0
7119032|NCT02592798|11255412|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0
7119033|NCT02592798|11255413|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1
7119034|NCT02592798|11255412|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1
7119035|NCT02592798|11255413|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3
7119036|NCT02592798|11255412|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1
7119037|NCT02592798|11255413|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2
7119038|NCT02592798|11255412|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3
7119039|NCT02592798|11255413|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2
7119040|NCT02592798|11255412|FG000|Double-Blind Period 2 (DB2)|Other reasons|1
7119041|NCT02592798|11255413|FG001|Double-Blind Period 2 (DB2)|Other reasons|0
7119042|NCT02592798|11255412|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1
7119043|NCT02592798|11255413|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0
7119044|NCT02592798|11255412|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1
7119045|NCT02592798|11255413|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0
7119046|NCT02592798|11255412|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1
7119047|NCT02592798|11255413|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2
7119048|NCT02592798|11255412|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1
7119049|NCT02592798|11255413|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0
7119050|NCT02592798|11255412|FG000|Transition From DB2 to OLE|Other reasons|1
7119051|NCT02592798|11255413|FG001|Transition From DB2 to OLE|Other reasons|0
7119052|NCT02592798|11255412|FG000|Open Label Period (OLE)|Other reasons|0
7119053|NCT02592798|11255413|FG001|Open Label Period (OLE)|Other reasons|2
7119054|NCT02592798|11255412|FG000|Open Label Period (OLE)|Participant request to discontinue|1
7119055|NCT02592798|11255413|FG001|Open Label Period (OLE)|Participant request to discontinue|0
7119056|NCT02592798|11255412|FG000|Open Label Period (OLE)|Lost to Follow-up|0
7119057|NCT02592798|11255413|FG001|Open Label Period (OLE)|Lost to Follow-up|1
7119058|NCT02592798|11255412|FG000|Open Label Period (OLE)|Lack of Efficacy|3
7119059|NCT02592798|11255413|FG001|Open Label Period (OLE)|Lack of Efficacy|5
7119060|NCT02592798|11255412|FG000|Open Label Period (OLE)|Adverse Event|0
7119061|NCT02592798|11255413|FG001|Open Label Period (OLE)|Adverse Event|1
7119062|NCT02592876|11255428|FG000|Overall Study|Withdrawal by Subject|3
7119063|NCT02592876|11255429|FG001|Overall Study|Withdrawal by Subject|3
7119064|NCT02592876|11255428|FG000|Overall Study|Study Termination by Sponsor|32
7119065|NCT02592876|11255429|FG001|Overall Study|Study Termination by Sponsor|27
7119066|NCT02592876|11255428|FG000|Overall Study|Lost to Follow-up|0
7119067|NCT02592876|11255429|FG001|Overall Study|Lost to Follow-up|1
7119068|NCT02592876|11255428|FG000|Overall Study|Death|6
7119069|NCT02592876|11255429|FG001|Overall Study|Death|9
7119070|NCT02593097|11255460|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1
7119071|NCT02593097|11255461|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2
7119072|NCT02593097|11255460|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1
7119073|NCT02593097|11255461|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2
7119074|NCT02593097|11255460|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1
7119075|NCT02593097|11255461|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1
7119076|NCT02593097|11255460|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1
7119077|NCT02593097|11255461|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0
7119078|NCT02593097|11255460|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1
7119079|NCT02593097|11255461|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0
7119080|NCT02593149|11255469|FG000|Run-In|Didn't use CVC for at least 21 days|36
7119081|NCT02593149|11255470|FG001|Run-In|Didn't use CVC for at least 21 days|38
7119082|NCT02593149|11255469|FG000|Intervention|Didn't use CVC for at least 21 day|116
7119083|NCT02593149|11255470|FG001|Intervention|Didn't use CVC for at least 21 day|115
7119084|NCT02593305|11255479|FG000|Post 1|Comparison only group. No intervention.|0
7119085|NCT02593305|11255480|FG001|Post 1|Comparison only group. No intervention.|0
7119086|NCT02593305|11255481|FG002|Post 1|Comparison only group. No intervention.|10
7119087|NCT02593318|11255492|FG000|Overall Study|Withdrawal by Subject|1
7119088|NCT02593318|11255493|FG001|Overall Study|Withdrawal by Subject|1
7119089|NCT02593539|11255514|FG000|Overall Study|Adverse Event|1
7119090|NCT02593773|11255526|FG000|Overall Study|Voluntary Withdrawal|3
7119091|NCT02593773|11255526|FG000|Overall Study|Study Terminated by Sponsor|31
7119092|NCT02593773|11255526|FG000|Overall Study|Death|1
7119093|NCT02593825|11255532|FG000|Intervention|Lost to Follow-up|10
7119094|NCT02593825|11255533|FG001|Intervention|Lost to Follow-up|12
7119095|NCT02593864|11255541|FG000|Overall Study|Withdrawal by Subject|3
7119096|NCT02593864|11255541|FG000|Overall Study|Lost to Follow-up|3
7119097|NCT04142242|11255551|FG000|Overall Study|Non-compliance with the protocol|1
7119098|NCT04142242|11255552|FG001|Overall Study|Non-compliance with the protocol|0
7119099|NCT04142242|11255553|FG002|Overall Study|Non-compliance with the protocol|0
7119100|NCT04142242|11255554|FG003|Overall Study|Non-compliance with the protocol|0
7119101|NCT04142242|11255555|FG004|Overall Study|Non-compliance with the protocol|0
7119102|NCT04142242|11255556|FG005|Overall Study|Non-compliance with the protocol|1
7119103|NCT04142242|11255551|FG000|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0
7119104|NCT04142242|11255552|FG001|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|1
7119105|NCT04142242|11255553|FG002|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0
7119106|NCT04142242|11255554|FG003|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0
7119107|NCT04142242|11255555|FG004|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0
7119108|NCT04142242|11255556|FG005|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0
7119109|NCT04142242|11255551|FG000|Overall Study|Ongoing|0
7119110|NCT04142242|11255552|FG001|Overall Study|Ongoing|0
7119111|NCT04142242|11255553|FG002|Overall Study|Ongoing|31
7119112|NCT04142242|11255554|FG003|Overall Study|Ongoing|39
7119113|NCT04142242|11255555|FG004|Overall Study|Ongoing|0
7119114|NCT04142242|11255556|FG005|Overall Study|Ongoing|0
7119115|NCT03990389|11255577|FG000|Overall Study|Lost to Follow-up|3
7119116|NCT03990389|11255578|FG001|Overall Study|Lost to Follow-up|0
7119117|NCT03939312|11255584|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43
7119118|NCT03939312|11255584|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25
7119119|NCT03939312|11255584|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4
7119120|NCT03939312|11255584|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35
7119121|NCT03939312|11255584|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19
7119122|NCT03939312|11255584|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3
7119123|NCT03939312|11255584|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16
7119124|NCT03939312|11255584|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4
7119125|NCT03939312|11255584|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3
7119126|NCT03939312|11255584|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22
7119127|NCT03939312|11255584|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12
7119128|NCT03939312|11255584|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4
7119129|NCT03934541|11255594|FG000|Overall Study|Study Terminated by Sponsor|0
7119130|NCT03934541|11255595|FG001|Overall Study|Study Terminated by Sponsor|1
7119131|NCT03934541|11255596|FG002|Overall Study|Study Terminated by Sponsor|0
7119132|NCT03934541|11255597|FG003|Overall Study|Study Terminated by Sponsor|0
7119133|NCT03895034|11255607|FG000|Overall Study|Lost to Follow-up|2
7119134|NCT03870477|11255611|FG000|Overall Study|Early Study Termination|1
7119135|NCT03351244|11255618|FG000|Overall Study|Adverse Event|7
7119136|NCT03351244|11255619|FG001|Overall Study|Adverse Event|11
7119137|NCT03351244|11255620|FG002|Overall Study|Adverse Event|12
7119138|NCT03351244|11255618|FG000|Overall Study|Investigator's decision|0
7119139|NCT03351244|11255619|FG001|Overall Study|Investigator's decision|0
7119140|NCT03351244|11255620|FG002|Overall Study|Investigator's decision|2
7119141|NCT03351244|11255618|FG000|Overall Study|System error|0
7119142|NCT03351244|11255619|FG001|Overall Study|System error|0
7119143|NCT03351244|11255620|FG002|Overall Study|System error|2
7119144|NCT03351244|11255618|FG000|Overall Study|COVID-19 restrictions|3
7119145|NCT03351244|11255619|FG001|Overall Study|COVID-19 restrictions|0
7119146|NCT03351244|11255620|FG002|Overall Study|COVID-19 restrictions|1
7119147|NCT03351244|11255618|FG000|Overall Study|Non-compliance|2
7119148|NCT03351244|11255619|FG001|Overall Study|Non-compliance|5
7119149|NCT03351244|11255620|FG002|Overall Study|Non-compliance|0
7119150|NCT03351244|11255618|FG000|Overall Study|Withdrawal by Subject|11
7119151|NCT03351244|11255619|FG001|Overall Study|Withdrawal by Subject|16
7119152|NCT03351244|11255620|FG002|Overall Study|Withdrawal by Subject|13
7119153|NCT03351244|11255618|FG000|Overall Study|Lost to Follow-up|2
7119154|NCT03351244|11255619|FG001|Overall Study|Lost to Follow-up|6
7119155|NCT03351244|11255620|FG002|Overall Study|Lost to Follow-up|4
7119156|NCT03351244|11255618|FG000|Overall Study|Protocol Violation|2
7119157|NCT03351244|11255619|FG001|Overall Study|Protocol Violation|2
7119158|NCT03351244|11255620|FG002|Overall Study|Protocol Violation|0
7119159|NCT02982954|11255652|FG000|Treatment Period|Disease progression|62
7119160|NCT02982954|11255653|FG001|Treatment Period|Disease progression|26
7119161|NCT02982954|11255654|FG002|Treatment Period|Disease progression|12
7119162|NCT02982954|11255655|FG003|Treatment Period|Disease progression|10
7119163|NCT02982954|11255652|FG000|Treatment Period|study drug toxicity|20
7119164|NCT02982954|11255653|FG001|Treatment Period|study drug toxicity|10
7119165|NCT02982954|11255654|FG002|Treatment Period|study drug toxicity|8
7119166|NCT02982954|11255655|FG003|Treatment Period|study drug toxicity|0
7119167|NCT02982954|11255652|FG000|Treatment Period|Death|1
7119168|NCT02982954|11255653|FG001|Treatment Period|Death|3
7119169|NCT02982954|11255654|FG002|Treatment Period|Death|2
7119170|NCT02982954|11255655|FG003|Treatment Period|Death|4
7119171|NCT02982954|11255652|FG000|Treatment Period|Adverse events unrelated to study drug|4
7119172|NCT02982954|11255653|FG001|Treatment Period|Adverse events unrelated to study drug|1
7119173|NCT02982954|11255654|FG002|Treatment Period|Adverse events unrelated to study drug|1
7119174|NCT02982954|11255655|FG003|Treatment Period|Adverse events unrelated to study drug|3
7119175|NCT02982954|11255652|FG000|Treatment Period|participant request to discontinue|2
7119176|NCT02982954|11255653|FG001|Treatment Period|participant request to discontinue|2
7119177|NCT02982954|11255654|FG002|Treatment Period|participant request to discontinue|1
7119178|NCT02982954|11255655|FG003|Treatment Period|participant request to discontinue|2
7119179|NCT02982954|11255652|FG000|Treatment Period|participant withdrew consent|1
7119180|NCT02982954|11255653|FG001|Treatment Period|participant withdrew consent|1
7119181|NCT02982954|11255654|FG002|Treatment Period|participant withdrew consent|0
7119182|NCT02982954|11255655|FG003|Treatment Period|participant withdrew consent|1
7119183|NCT02982954|11255652|FG000|Treatment Period|maximum clinical benefit|1
7119184|NCT02982954|11255653|FG001|Treatment Period|maximum clinical benefit|0
7119185|NCT02982954|11255654|FG002|Treatment Period|maximum clinical benefit|0
7119186|NCT02982954|11255655|FG003|Treatment Period|maximum clinical benefit|0
7119187|NCT02982954|11255652|FG000|Treatment Period|no longer meets study criteria|0
7119188|NCT02982954|11255653|FG001|Treatment Period|no longer meets study criteria|1
7119189|NCT02982954|11255654|FG002|Treatment Period|no longer meets study criteria|0
7119190|NCT02982954|11255655|FG003|Treatment Period|no longer meets study criteria|0
7119191|NCT02982954|11255652|FG000|Treatment Period|Admin reason by sponsor|3
7119192|NCT02982954|11255653|FG001|Treatment Period|Admin reason by sponsor|0
7119193|NCT02982954|11255654|FG002|Treatment Period|Admin reason by sponsor|0
7119194|NCT02982954|11255655|FG003|Treatment Period|Admin reason by sponsor|0
7119195|NCT02982954|11255652|FG000|Treatment Period|other reasons|12
7119196|NCT02982954|11255653|FG001|Treatment Period|other reasons|8
7119197|NCT02982954|11255654|FG002|Treatment Period|other reasons|4
7119198|NCT02982954|11255655|FG003|Treatment Period|other reasons|5
7119199|NCT02982954|11255652|FG000|Continuing in Study|Death|44
7119200|NCT02982954|11255653|FG001|Continuing in Study|Death|27
7119201|NCT02982954|11255654|FG002|Continuing in Study|Death|10
7119202|NCT02982954|11255655|FG003|Continuing in Study|Death|17
7119203|NCT02982954|11255652|FG000|Continuing in Study|participant withdrew consent|9
7119204|NCT02982954|11255653|FG001|Continuing in Study|participant withdrew consent|5
7119205|NCT02982954|11255654|FG002|Continuing in Study|participant withdrew consent|1
7119206|NCT02982954|11255655|FG003|Continuing in Study|participant withdrew consent|1
7119207|NCT02982954|11255652|FG000|Continuing in Study|Lost to Follow-up|1
7119208|NCT02982954|11255653|FG001|Continuing in Study|Lost to Follow-up|0
7119209|NCT02982954|11255654|FG002|Continuing in Study|Lost to Follow-up|0
7119210|NCT02982954|11255655|FG003|Continuing in Study|Lost to Follow-up|0
7119211|NCT02982954|11255652|FG000|Continuing in Study|other reasons|0
7119212|NCT02982954|11255653|FG001|Continuing in Study|other reasons|1
7119213|NCT02982954|11255654|FG002|Continuing in Study|other reasons|0
7119214|NCT02982954|11255655|FG003|Continuing in Study|other reasons|0
7119215|NCT02903914|11255673|FG000|Overall Study|Adverse Event|0
7119216|NCT02903914|11255674|FG001|Overall Study|Adverse Event|0
7119217|NCT02903914|11255675|FG002|Overall Study|Adverse Event|1
7119218|NCT02903914|11255676|FG003|Overall Study|Adverse Event|0
7119219|NCT02903914|11255677|FG004|Overall Study|Adverse Event|0
7119220|NCT02903914|11255678|FG005|Overall Study|Adverse Event|1
7119221|NCT02903914|11255679|FG006|Overall Study|Adverse Event|2
7119222|NCT02903914|11255680|FG007|Overall Study|Adverse Event|1
7119223|NCT02903914|11255673|FG000|Overall Study|Withdrawal by Subject|3
7119224|NCT02903914|11255674|FG001|Overall Study|Withdrawal by Subject|1
7119225|NCT02903914|11255675|FG002|Overall Study|Withdrawal by Subject|28
7119226|NCT02903914|11255676|FG003|Overall Study|Withdrawal by Subject|0
7119227|NCT02903914|11255677|FG004|Overall Study|Withdrawal by Subject|1
7119228|NCT02903914|11255678|FG005|Overall Study|Withdrawal by Subject|1
7119229|NCT02903914|11255679|FG006|Overall Study|Withdrawal by Subject|12
7119230|NCT02903914|11255680|FG007|Overall Study|Withdrawal by Subject|0
7119231|NCT02903914|11255673|FG000|Overall Study|Progressive Disease|1
7119232|NCT02903914|11255674|FG001|Overall Study|Progressive Disease|0
7119233|NCT02903914|11255675|FG002|Overall Study|Progressive Disease|4
7119234|NCT02903914|11255676|FG003|Overall Study|Progressive Disease|0
7119235|NCT02903914|11255677|FG004|Overall Study|Progressive Disease|0
7119236|NCT02903914|11255678|FG005|Overall Study|Progressive Disease|0
7119237|NCT02903914|11255679|FG006|Overall Study|Progressive Disease|2
7119238|NCT02903914|11255680|FG007|Overall Study|Progressive Disease|4
7119239|NCT02903914|11255673|FG000|Overall Study|Death|0
7119240|NCT02903914|11255674|FG001|Overall Study|Death|0
7119241|NCT02903914|11255675|FG002|Overall Study|Death|9
7119242|NCT02903914|11255676|FG003|Overall Study|Death|0
7119243|NCT02903914|11255677|FG004|Overall Study|Death|1
7119244|NCT02903914|11255678|FG005|Overall Study|Death|3
7119245|NCT02903914|11255679|FG006|Overall Study|Death|24
7119246|NCT02903914|11255680|FG007|Overall Study|Death|0
7119247|NCT02903914|11255673|FG000|Overall Study|Lost to Follow-up|0
7119248|NCT02903914|11255674|FG001|Overall Study|Lost to Follow-up|1
7119249|NCT02903914|11255675|FG002|Overall Study|Lost to Follow-up|0
7119250|NCT02903914|11255676|FG003|Overall Study|Lost to Follow-up|0
7119251|NCT02903914|11255677|FG004|Overall Study|Lost to Follow-up|2
7119252|NCT02903914|11255678|FG005|Overall Study|Lost to Follow-up|0
7119253|NCT02903914|11255679|FG006|Overall Study|Lost to Follow-up|1
7119254|NCT02903914|11255680|FG007|Overall Study|Lost to Follow-up|0
7119255|NCT02903914|11255673|FG000|Overall Study|Physician Decision|0
7119256|NCT02903914|11255674|FG001|Overall Study|Physician Decision|0
7119257|NCT02903914|11255675|FG002|Overall Study|Physician Decision|1
7119258|NCT02903914|11255676|FG003|Overall Study|Physician Decision|0
7119259|NCT02903914|11255677|FG004|Overall Study|Physician Decision|0
7119260|NCT02903914|11255678|FG005|Overall Study|Physician Decision|0
7119261|NCT02903914|11255679|FG006|Overall Study|Physician Decision|1
7119262|NCT02903914|11255680|FG007|Overall Study|Physician Decision|0
7119263|NCT02903914|11255673|FG000|Overall Study|Symptomatic Deterioration|0
7119264|NCT02903914|11255674|FG001|Overall Study|Symptomatic Deterioration|0
7119265|NCT02903914|11255675|FG002|Overall Study|Symptomatic Deterioration|1
7119266|NCT02903914|11255676|FG003|Overall Study|Symptomatic Deterioration|0
7119267|NCT02903914|11255677|FG004|Overall Study|Symptomatic Deterioration|0
7119268|NCT02903914|11255678|FG005|Overall Study|Symptomatic Deterioration|0
7119269|NCT02903914|11255679|FG006|Overall Study|Symptomatic Deterioration|0
7119270|NCT02903914|11255680|FG007|Overall Study|Symptomatic Deterioration|0
7119271|NCT02903914|11255673|FG000|Overall Study|New Cancer Therapy|2
7119272|NCT02903914|11255674|FG001|Overall Study|New Cancer Therapy|2
7119273|NCT02903914|11255675|FG002|Overall Study|New Cancer Therapy|21
7119274|NCT02903914|11255676|FG003|Overall Study|New Cancer Therapy|4
7119275|NCT02903914|11255677|FG004|Overall Study|New Cancer Therapy|3
7119276|NCT02903914|11255678|FG005|Overall Study|New Cancer Therapy|6
7119277|NCT02903914|11255679|FG006|Overall Study|New Cancer Therapy|55
7119278|NCT02903914|11255680|FG007|Overall Study|New Cancer Therapy|0
7119279|NCT02903914|11255673|FG000|Overall Study|Reasoning not specified|2
7119280|NCT02903914|11255674|FG001|Overall Study|Reasoning not specified|3
7119281|NCT02903914|11255675|FG002|Overall Study|Reasoning not specified|20
7119282|NCT02903914|11255676|FG003|Overall Study|Reasoning not specified|3
7119283|NCT02903914|11255677|FG004|Overall Study|Reasoning not specified|3
7119284|NCT02903914|11255678|FG005|Overall Study|Reasoning not specified|3
7119285|NCT02903914|11255679|FG006|Overall Study|Reasoning not specified|20
7119286|NCT02903914|11255680|FG007|Overall Study|Reasoning not specified|0
7119287|NCT02727699|11255702|FG000|Overall Study|Adverse Event|2
7119288|NCT02727699|11255703|FG001|Overall Study|Adverse Event|0
7119289|NCT02727699|11255702|FG000|Overall Study|Withdrawal by Subject|5
7119290|NCT02727699|11255703|FG001|Overall Study|Withdrawal by Subject|3
7119291|NCT02727699|11255702|FG000|Overall Study|Protocol Violation|0
7119292|NCT02727699|11255703|FG001|Overall Study|Protocol Violation|1
7119293|NCT02727699|11255702|FG000|Overall Study|Physician Decision|0
7119294|NCT02727699|11255703|FG001|Overall Study|Physician Decision|1
7119295|NCT02727699|11255702|FG000|Overall Study|Lost to Follow-up|1
7119296|NCT02727699|11255703|FG001|Overall Study|Lost to Follow-up|0
7119297|NCT02727699|11255702|FG000|Overall Study|Sponsor Decision|1
7119298|NCT02727699|11255703|FG001|Overall Study|Sponsor Decision|0
7119299|NCT02230254|11255723|FG000|Overall Study|Lost to Follow-up|3
7119300|NCT01909453|11255732|FG000|Overall Study|Ongoing|118
7119301|NCT01909453|11255733|FG001|Overall Study|Ongoing|103
7119302|NCT01909453|11255734|FG002|Overall Study|Ongoing|83
7119303|NCT01909453|11255735|FG003|Overall Study|Ongoing|164
7119304|NCT01909453|11255736|FG004|Overall Study|Ongoing|50
7119305|NCT01909453|11255732|FG000|Overall Study|Death|69
7119306|NCT01909453|11255733|FG001|Overall Study|Death|74
7119307|NCT01909453|11255734|FG002|Overall Study|Death|88
7119308|NCT01909453|11255735|FG003|Overall Study|Death|86
7119309|NCT01909453|11255736|FG004|Overall Study|Death|29
7119310|NCT01909453|11255732|FG000|Overall Study|Lost to Follow-up|3
7119311|NCT01909453|11255733|FG001|Overall Study|Lost to Follow-up|4
7119312|NCT01909453|11255734|FG002|Overall Study|Lost to Follow-up|4
7119313|NCT01909453|11255735|FG003|Overall Study|Lost to Follow-up|3
7119314|NCT01909453|11255736|FG004|Overall Study|Lost to Follow-up|3
7119315|NCT01909453|11255732|FG000|Overall Study|Withdrawal by Subject|2
7119316|NCT01909453|11255733|FG001|Overall Study|Withdrawal by Subject|13
7119317|NCT01909453|11255734|FG002|Overall Study|Withdrawal by Subject|16
7119318|NCT01909453|11255735|FG003|Overall Study|Withdrawal by Subject|5
7119319|NCT01909453|11255736|FG004|Overall Study|Withdrawal by Subject|4
7119320|NCT01891396|11255757|FG000|Overall Study|Withdrawal by Subject|4
7119321|NCT01891396|11255758|FG001|Overall Study|Withdrawal by Subject|4
7119322|NCT01891396|11255759|FG002|Overall Study|Withdrawal by Subject|3
7119323|NCT01891396|11255757|FG000|Overall Study|Lost to Follow-up|0
7119324|NCT01891396|11255758|FG001|Overall Study|Lost to Follow-up|1
7119325|NCT01891396|11255759|FG002|Overall Study|Lost to Follow-up|0
7119326|NCT01525901|11255775|FG000|Period 2: 12 Weeks|Adverse Event|0
7119327|NCT01525901|11255776|FG001|Period 2: 12 Weeks|Adverse Event|1
7119328|NCT01525901|11255777|FG002|Period 2: 12 Weeks|Adverse Event|0
7119329|NCT01525901|11255778|FG003|Period 2: 12 Weeks|Adverse Event|0
7119330|NCT01354431|11255791|FG000|Pre-Treatment Period|Not reported|1
7119331|NCT01354431|11255792|FG001|Pre-Treatment Period|Not reported|0
7119332|NCT01354431|11255793|FG002|Pre-Treatment Period|Not reported|0
7119333|NCT01354431|11255791|FG000|Treatment Period|Disease Progression|50
7119334|NCT01354431|11255792|FG001|Treatment Period|Disease Progression|40
7119335|NCT01354431|11255793|FG002|Treatment Period|Disease Progression|44
7119336|NCT01354431|11255791|FG000|Treatment Period|Study Drug Toxicity|5
7119337|NCT01354431|11255792|FG001|Treatment Period|Study Drug Toxicity|8
7119338|NCT01354431|11255793|FG002|Treatment Period|Study Drug Toxicity|4
7119339|NCT01354431|11255791|FG000|Treatment Period|Death|0
7119340|NCT01354431|11255792|FG001|Treatment Period|Death|1
7119341|NCT01354431|11255793|FG002|Treatment Period|Death|0
7119342|NCT01354431|11255791|FG000|Treatment Period|AE unrelated to study drug|1
7119343|NCT01354431|11255792|FG001|Treatment Period|AE unrelated to study drug|2
7119344|NCT01354431|11255793|FG002|Treatment Period|AE unrelated to study drug|5
7119345|NCT01354431|11255791|FG000|Treatment Period|Participant request to discontinue|2
7119346|NCT01354431|11255792|FG001|Treatment Period|Participant request to discontinue|2
7119347|NCT01354431|11255793|FG002|Treatment Period|Participant request to discontinue|1
7119348|NCT01354431|11255791|FG000|Treatment Period|Participant withdrew consent|0
7119349|NCT01354431|11255792|FG001|Treatment Period|Participant withdrew consent|1
7119350|NCT01354431|11255793|FG002|Treatment Period|Participant withdrew consent|0
7119351|NCT01354431|11255791|FG000|Treatment Period|Participant no longer meeting study criteria|1
7119352|NCT01354431|11255792|FG001|Treatment Period|Participant no longer meeting study criteria|0
7119353|NCT01354431|11255793|FG002|Treatment Period|Participant no longer meeting study criteria|0
7119354|NCT01003691|11255805|FG000|Overall Study|Adverse Event|0
7119355|NCT01003691|11255806|FG001|Overall Study|Adverse Event|0
7119356|NCT01003691|11255807|FG002|Overall Study|Adverse Event|0
7119357|NCT01003691|11255808|FG003|Overall Study|Adverse Event|1
7119358|NCT02594098|11255830|FG000|Overall Study|Lack of Efficacy|17
7119359|NCT02594098|11255831|FG001|Overall Study|Lack of Efficacy|6
7119360|NCT02594098|11255830|FG000|Overall Study|Withdrawal by Subject|1
7119361|NCT02594098|11255831|FG001|Overall Study|Withdrawal by Subject|3
7119362|NCT02594098|11255830|FG000|Overall Study|Terminated participation|6
7119363|NCT02594098|11255831|FG001|Overall Study|Terminated participation|2
7119364|NCT02594098|11255830|FG000|Overall Study|Seek alternative treatment|2
7119365|NCT02594098|11255831|FG001|Overall Study|Seek alternative treatment|1
7119366|NCT02594098|11255830|FG000|Overall Study|Other|0
7119367|NCT02594098|11255831|FG001|Overall Study|Other|1
7119368|NCT02594163|11255850|FG000|Treatment Period|Progressive disease|2
7119369|NCT02594163|11255851|FG001|Treatment Period|Progressive disease|3
7119370|NCT02594163|11255850|FG000|Treatment Period|Adverse Event|1
7119371|NCT02594163|11255851|FG001|Treatment Period|Adverse Event|5
7119372|NCT02594163|11255850|FG000|Treatment Period|Physician Decision|1
7119373|NCT02594163|11255851|FG001|Treatment Period|Physician Decision|3
7119374|NCT02594163|11255850|FG000|Treatment Period|Study termination by sponsor|2
7119375|NCT02594163|11255851|FG001|Treatment Period|Study termination by sponsor|1
7119376|NCT02594163|11255850|FG000|Treatment Period|Other, Non-AE|1
7119377|NCT02594163|11255851|FG001|Treatment Period|Other, Non-AE|0
7119378|NCT02594163|11255850|FG000|Follow-up Period|Withdrawal by Subject|0
7119379|NCT02594163|11255851|FG001|Follow-up Period|Withdrawal by Subject|1
7119380|NCT02594163|11255850|FG000|Follow-up Period|Study Termination by Sponsor|6
7119381|NCT02594163|11255851|FG001|Follow-up Period|Study Termination by Sponsor|4
7119382|NCT02594163|11255850|FG000|Follow-up Period|Lost to Follow-up|1
7119383|NCT02594163|11255851|FG001|Follow-up Period|Lost to Follow-up|0
7119384|NCT02594163|11255850|FG000|Follow-up Period|Death|2
7119385|NCT02594163|11255851|FG001|Follow-up Period|Death|5
7119386|NCT02594163|11255850|FG000|Follow-up Period|Adverse Event|0
7119387|NCT02594163|11255851|FG001|Follow-up Period|Adverse Event|1
7119388|NCT02594163|11255850|FG000|Follow-up Period|Progressive Disease|2
7119389|NCT02594163|11255851|FG001|Follow-up Period|Progressive Disease|0
7119390|NCT02594163|11255850|FG000|Follow-up Period|Physician Decision|0
7119391|NCT02594163|11255851|FG001|Follow-up Period|Physician Decision|1
7119392|NCT02595008|11255887|FG000|Overall Study|Enrolled In Error|1
7119393|NCT02595008|11255888|FG001|Overall Study|Enrolled In Error|0
7119394|NCT02595073|11255896|FG000|Overall Study|Progressive Disease|0
7119395|NCT02595073|11255897|FG001|Overall Study|Progressive Disease|1
7119396|NCT02595073|11255896|FG000|Overall Study|Protocol Violation|2
7119397|NCT02595073|11255897|FG001|Overall Study|Protocol Violation|0
7119398|NCT02595398|11255905|FG000|Overall Study|Non-compliance|1
7119399|NCT02595398|11255906|FG001|Overall Study|Non-compliance|0
7119400|NCT02595398|11255905|FG000|Overall Study|Withdrawal by Subject|2
7119401|NCT02595398|11255906|FG001|Overall Study|Withdrawal by Subject|1
7119402|NCT02595398|11255905|FG000|Overall Study|Lost to Follow-up|1
7119403|NCT02595398|11255906|FG001|Overall Study|Lost to Follow-up|0
7119404|NCT02595437|11255912|FG000|Triferic Via IV|Withdrawal by Subject|1
7119405|NCT02595450|11255924|FG000|Overall Study|Unspecified (only completed 1 cycle)|73
7119406|NCT02595450|11255924|FG000|Overall Study|Enrolled, but not treated|8
7119407|NCT02595502|11255928|FG000|Period 1|Adverse Event|0
7119408|NCT02595502|11255929|FG001|Period 1|Adverse Event|1
7119409|NCT02595502|11255928|FG000|Period 1|Withdrawal by Subject|1
7119410|NCT02595502|11255929|FG001|Period 1|Withdrawal by Subject|0
7119411|NCT02595502|11255928|FG000|Period 1|Lost to Follow-up|0
7119412|NCT02595502|11255929|FG001|Period 1|Lost to Follow-up|1
7119413|NCT02595502|11255928|FG000|Period 2|Adverse Event|1
7119414|NCT02595502|11255929|FG001|Period 2|Adverse Event|1
7119415|NCT02595502|11255928|FG000|Period 2|Received incorrect lens at Period 1|0
7119416|NCT02595502|11255929|FG001|Period 2|Received incorrect lens at Period 1|1
7119417|NCT02595502|11255928|FG000|Period 3|Protocol Violation|0
7119418|NCT02595502|11255929|FG001|Period 3|Protocol Violation|1
7119419|NCT02595502|11255928|FG000|Period 3|Lost to Follow-up|1
7119420|NCT02595502|11255929|FG001|Period 3|Lost to Follow-up|0
7119421|NCT02595502|11255928|FG000|Period 3|Received Incorrect Treatment at period 3|0
7119422|NCT02595502|11255929|FG001|Period 3|Received Incorrect Treatment at period 3|1
7119423|NCT02595528|11255939|FG000|Overall Study|Withdrawal by Subject|1
7119424|NCT02595528|11255940|FG001|Overall Study|Withdrawal by Subject|2
7119425|NCT02595528|11255941|FG002|Overall Study|Withdrawal by Subject|1
7119426|NCT02595528|11255942|FG003|Overall Study|Withdrawal by Subject|3
7119427|NCT02595528|11255939|FG000|Overall Study|Lost to Follow-up|1
7119428|NCT02595528|11255940|FG001|Overall Study|Lost to Follow-up|1
7119429|NCT02595528|11255941|FG002|Overall Study|Lost to Follow-up|0
7119430|NCT02595528|11255942|FG003|Overall Study|Lost to Follow-up|1
7119431|NCT02595723|11255968|FG000|First Washout (21 Days)|Withdrawal by Subject|1
7119432|NCT02595723|11255969|FG001|First Washout (21 Days)|Withdrawal by Subject|0
7119433|NCT02595723|11255970|FG002|First Washout (21 Days)|Withdrawal by Subject|0
7119434|NCT02595723|11255968|FG000|First Washout (21 Days)|Lost to Follow-up|1
7119435|NCT02595723|11255969|FG001|First Washout (21 Days)|Lost to Follow-up|0
7119436|NCT02595723|11255970|FG002|First Washout (21 Days)|Lost to Follow-up|0
7119437|NCT02595749|11255980|FG000|Overall Study|Withdrawal by Subject|12
7119438|NCT02595749|11255981|FG001|Overall Study|Withdrawal by Subject|7
7119439|NCT02595970|11255987|FG000|Overall Study|Withdrawal by Subject|2
7119440|NCT02595970|11255987|FG000|Overall Study|Physician Decision|2
7119441|NCT02595970|11255987|FG000|Overall Study|Protocol Violation|4
7119442|NCT02595970|11255987|FG000|Overall Study|Adverse Event|5
7119443|NCT02595970|11255987|FG000|Overall Study|Lack of Efficacy|7
7119444|NCT02596009|11255996|FG000|Overall Study|Administrative problems|0
7119445|NCT02596009|11255997|FG001|Overall Study|Administrative problems|1
7119446|NCT02596009|11255998|FG002|Overall Study|Administrative problems|0
7119447|NCT02596009|11255999|FG003|Overall Study|Administrative problems|0
7119448|NCT02596009|11256000|FG004|Overall Study|Administrative problems|0
7119449|NCT02596009|11256001|FG005|Overall Study|Administrative problems|0
7119450|NCT02596230|11256021|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714
7119451|NCT02596230|11256022|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228
7119452|NCT02596230|11256023|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0
7119453|NCT02596230|11256024|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846
7119454|NCT02596230|11256025|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0
7119455|NCT02596230|11256021|FG000|Objective 2, One Year|Lost to Follow-up|0
7119456|NCT02596230|11256022|FG001|Objective 2, One Year|Lost to Follow-up|41
7119457|NCT02596230|11256023|FG002|Objective 2, One Year|Lost to Follow-up|41
7119458|NCT02596230|11256024|FG003|Objective 2, One Year|Lost to Follow-up|32
7119459|NCT02596230|11256025|FG004|Objective 2, One Year|Lost to Follow-up|46
7119460|NCT02596230|11256021|FG000|Objective 2, One Year|Withdrawal by Subject|0
7119461|NCT02596230|11256022|FG001|Objective 2, One Year|Withdrawal by Subject|11
7119462|NCT02596230|11256023|FG002|Objective 2, One Year|Withdrawal by Subject|14
7119463|NCT02596230|11256024|FG003|Objective 2, One Year|Withdrawal by Subject|5
7119464|NCT02596230|11256025|FG004|Objective 2, One Year|Withdrawal by Subject|2
7119465|NCT02596230|11256021|FG000|Objective 2, One Year|Adverse drug reaction|0
7119466|NCT02596230|11256022|FG001|Objective 2, One Year|Adverse drug reaction|1
7119467|NCT02596230|11256023|FG002|Objective 2, One Year|Adverse drug reaction|0
7119468|NCT02596230|11256024|FG003|Objective 2, One Year|Adverse drug reaction|0
7119469|NCT02596230|11256025|FG004|Objective 2, One Year|Adverse drug reaction|0
7119470|NCT02596230|11256021|FG000|Objective 2, One Year|Death|0
7119471|NCT02596230|11256022|FG001|Objective 2, One Year|Death|12
7119472|NCT02596230|11256023|FG002|Objective 2, One Year|Death|41
7119473|NCT02596230|11256024|FG003|Objective 2, One Year|Death|21
7119474|NCT02596230|11256025|FG004|Objective 2, One Year|Death|30
7119475|NCT02596230|11256021|FG000|Objective 2, One Year|Other|0
7119476|NCT02596230|11256022|FG001|Objective 2, One Year|Other|3
7119477|NCT02596230|11256023|FG002|Objective 2, One Year|Other|2
7119478|NCT02596230|11256024|FG003|Objective 2, One Year|Other|0
7119479|NCT02596230|11256025|FG004|Objective 2, One Year|Other|0
7119480|NCT02596620|11256058|FG000|Overall Study|Lost to Follow-up|1
7119481|NCT02596620|11256059|FG001|Overall Study|Lost to Follow-up|1
7119482|NCT02596711|11256068|FG000|Overall Study|Lost to Follow-up|1
7119483|NCT02596711|11256069|FG001|Overall Study|Lost to Follow-up|2
7119484|NCT02596711|11256070|FG002|Overall Study|Lost to Follow-up|3
7119485|NCT02596854|11256088|FG000|Overall Study|Withdrawn|8
7119486|NCT02596893|11256101|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61
7119487|NCT02596893|11256102|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56
7119488|NCT02596893|11256103|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48
7119489|NCT02596893|11256104|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58
7119490|NCT02596893|11256101|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11
7119491|NCT02596893|11256102|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15
7119492|NCT02596893|11256103|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15
7119493|NCT02596893|11256104|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12
7119494|NCT02596893|11256101|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
7119495|NCT02596893|11256102|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
7119496|NCT02596893|11256103|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
7119497|NCT02596893|11256104|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1
7119498|NCT02596893|11256101|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15
7119499|NCT02596893|11256102|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14
7119500|NCT02596893|11256103|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14
7119501|NCT02596893|11256104|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13
7119502|NCT02596893|11256101|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10
7119503|NCT02596893|11256102|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4
7119504|NCT02596893|11256103|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13
7119505|NCT02596893|11256104|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5
7119506|NCT02596893|11256101|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1
7119507|NCT02596893|11256102|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2
7119508|NCT02596893|11256103|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0
7119509|NCT02596893|11256104|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2
7119510|NCT02596893|11256101|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0
7119511|NCT02596893|11256102|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
7119512|NCT02596893|11256103|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
7119513|NCT02596893|11256104|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
7119514|NCT02596893|11256101|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0
7119515|NCT02596893|11256102|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0
7119516|NCT02596893|11256103|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1
7119517|NCT02596893|11256104|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2
7119518|NCT02596893|11256101|FG000|Overall Double-Blind Period Weeks 0-52|Death|0
7119519|NCT02596893|11256102|FG001|Overall Double-Blind Period Weeks 0-52|Death|0
7119520|NCT02596893|11256103|FG002|Overall Double-Blind Period Weeks 0-52|Death|1
7119521|NCT02596893|11256104|FG003|Overall Double-Blind Period Weeks 0-52|Death|0
7119522|NCT02596893|11256101|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
7119523|NCT02596893|11256102|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
7119524|NCT02596893|11256103|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
7119525|NCT02596893|11256104|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2
7119526|NCT02596893|11256101|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66
7119527|NCT02596893|11256102|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76
7119528|NCT02596893|11256103|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69
7119529|NCT02596893|11256104|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70
7119530|NCT02596945|11256123|FG000|Overall Study|No documentation of study drug dosing|3
7119531|NCT02596945|11256123|FG000|Overall Study|Other|32
7119532|NCT02596945|11256123|FG000|Overall Study|Change to hemodialysis|15
7119533|NCT02596945|11256123|FG000|Overall Study|Other Erythropoietin stimulating agent|4
7119534|NCT02596945|11256123|FG000|Overall Study|Withdrawal by Subject|1
7119535|NCT02596945|11256123|FG000|Overall Study|Missing|1
7119536|NCT02596958|11256127|FG000|Overall Study|Serious Adverse Drug Reactions|44
7119537|NCT02596958|11256127|FG000|Overall Study|Cancer Progression|441
7119538|NCT02596958|11256127|FG000|Overall Study|Death From Cancer|112
7119539|NCT02596958|11256127|FG000|Overall Study|Death From Other Cause|33
7119540|NCT02596958|11256127|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61
7119541|NCT02596958|11256127|FG000|Overall Study|Administrative Reasons/Other|231
7119542|NCT02596958|11256127|FG000|Overall Study|Lost to Follow-up|33
7119543|NCT02596958|11256127|FG000|Overall Study|Missing|32
7119544|NCT02596958|11256127|FG000|Overall Study|Excluded Due to Second Line Treatment|9
7119545|NCT02596971|11256134|FG000|Overall Study|Death|5
7119546|NCT02596971|11256135|FG001|Overall Study|Death|1
7119547|NCT02596971|11256136|FG002|Overall Study|Death|5
7119548|NCT02596971|11256134|FG000|Overall Study|Withdrawal by Subject|5
7119549|NCT02596971|11256135|FG001|Overall Study|Withdrawal by Subject|1
7119550|NCT02596971|11256136|FG002|Overall Study|Withdrawal by Subject|4
7119551|NCT02597049|11256150|FG000|Overall Study|Lost to Follow-up|0
7119552|NCT02597049|11256151|FG001|Overall Study|Lost to Follow-up|3
7119553|NCT02597049|11256152|FG002|Overall Study|Lost to Follow-up|2
7119554|NCT02597049|11256150|FG000|Overall Study|Withdrawal by Subject|2
7119555|NCT02597049|11256151|FG001|Overall Study|Withdrawal by Subject|2
7119556|NCT02597049|11256152|FG002|Overall Study|Withdrawal by Subject|1
7119557|NCT02597049|11256150|FG000|Overall Study|Adverse Event|2
7119558|NCT02597049|11256151|FG001|Overall Study|Adverse Event|0
7119559|NCT02597049|11256152|FG002|Overall Study|Adverse Event|0
7119560|NCT02597049|11256150|FG000|Overall Study|Death|2
7119561|NCT02597049|11256151|FG001|Overall Study|Death|0
7119562|NCT02597049|11256152|FG002|Overall Study|Death|0
7119563|NCT02597049|11256150|FG000|Overall Study|Noncompliant with Study Visits|1
7119564|NCT02597049|11256151|FG001|Overall Study|Noncompliant with Study Visits|0
7119565|NCT02597049|11256152|FG002|Overall Study|Noncompliant with Study Visits|0
7119566|NCT02597452|11256223|FG000|Overall Study|testing incomplete|30
7119567|NCT02597478|11256229|FG000|Overall Study|Withdrawal by Subject|2
7119568|NCT02597478|11256230|FG001|Overall Study|Withdrawal by Subject|0
7119569|NCT02597478|11256229|FG000|Overall Study|Change of opioid dose|1
7119570|NCT02597478|11256230|FG001|Overall Study|Change of opioid dose|0
6806020|NCT03096288|10808374|FG000|Overall Study|Withdrawal by Subject|0
6806021|NCT03096288|10808375|FG001|Overall Study|Withdrawal by Subject|1
6806022|NCT03096288|10808376|FG002|Overall Study|Withdrawal by Subject|0
6806023|NCT03096288|10808377|FG003|Overall Study|Withdrawal by Subject|1
6806024|NCT02919436|10808389|FG000|Overall Study|Did not undergo surgery|16
6806025|NCT02919436|10808390|FG001|Overall Study|Did not undergo surgery|20
6806026|NCT02919436|10808389|FG000|Overall Study|Enrolled before trial registration|44
7119571|NCT02597478|11256229|FG000|Overall Study|Insufficient exertional dyspnea|0
7119572|NCT02597478|11256230|FG001|Overall Study|Insufficient exertional dyspnea|1
6806027|NCT02919436|10808390|FG001|Overall Study|Enrolled before trial registration|33
7119573|NCT02597712|11256276|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2
7119574|NCT02597712|11256277|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0
7119575|NCT02597712|11256276|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1
7119576|NCT02597712|11256277|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0
7119577|NCT02597712|11256276|FG000|Overall Study|Recurrent metastatic prostate cancer|0
7119578|NCT02597712|11256277|FG001|Overall Study|Recurrent metastatic prostate cancer|1
7119579|NCT02597855|11256285|FG000|Overall Study|Lost to Follow-up|2
7119580|NCT02597855|11256286|FG001|Overall Study|Lost to Follow-up|1
7119581|NCT02597920|11256304|FG000|Overall Study|Worsening of other pre-existing disease|0
6806028|NCT02028884|10808404|FG000|Double-blind Period|Adverse Event|5
6806029|NCT02028884|10808405|FG001|Double-blind Period|Adverse Event|3
6806030|NCT02028884|10808404|FG000|Double-blind Period|Eligibility Violation|1
7119582|NCT02597920|11256305|FG001|Overall Study|Worsening of other pre-existing disease|1
7119583|NCT02597920|11256306|FG002|Overall Study|Worsening of other pre-existing disease|0
7119584|NCT02597920|11256304|FG000|Overall Study|Other adverse event|20
7119585|NCT02597920|11256305|FG001|Overall Study|Other adverse event|30
7119586|NCT02597920|11256306|FG002|Overall Study|Other adverse event|0
7119587|NCT02597920|11256304|FG000|Overall Study|Lost to Follow-up|7
7119588|NCT02597920|11256305|FG001|Overall Study|Lost to Follow-up|9
7119589|NCT02597920|11256306|FG002|Overall Study|Lost to Follow-up|0
7119590|NCT02597920|11256304|FG000|Overall Study|Refuse to continue in the study|3
7119591|NCT02597920|11256305|FG001|Overall Study|Refuse to continue in the study|13
7119592|NCT02597920|11256306|FG002|Overall Study|Refuse to continue in the study|1
7119593|NCT02597920|11256304|FG000|Overall Study|Other than specified|10
7119594|NCT02597920|11256305|FG001|Overall Study|Other than specified|31
6806031|NCT02028884|10808405|FG001|Double-blind Period|Eligibility Violation|0
6806032|NCT02028884|10808404|FG000|Double-blind Period|Non-Compliance With Study Drug|2
6806033|NCT02028884|10808405|FG001|Double-blind Period|Non-Compliance With Study Drug|0
7119595|NCT02597920|11256306|FG002|Overall Study|Other than specified|5
7119596|NCT02597920|11256304|FG000|Overall Study|Other|1
7119597|NCT02597920|11256305|FG001|Overall Study|Other|0
7119598|NCT02597920|11256306|FG002|Overall Study|Other|0
7119599|NCT02597933|11256318|FG000|Overall Study|Withdrawal by Subject|7
7119600|NCT02597933|11256319|FG001|Overall Study|Withdrawal by Subject|5
7119601|NCT02597933|11256318|FG000|Overall Study|Protocol Violation|2
7119602|NCT02597933|11256319|FG001|Overall Study|Protocol Violation|2
7119603|NCT02597933|11256318|FG000|Overall Study|Adverse Event|20
7119604|NCT02597933|11256319|FG001|Overall Study|Adverse Event|28
7119605|NCT02597933|11256318|FG000|Overall Study|Not treated|2
7119606|NCT02597933|11256319|FG001|Overall Study|Not treated|2
7119607|NCT02597933|11256318|FG000|Overall Study|Other than stated above|7
7119608|NCT02597933|11256319|FG001|Overall Study|Other than stated above|14
7119609|NCT02597946|11256325|FG000|Overall Study|Withdrawal by Subject|1
7119610|NCT02597946|11256325|FG000|Overall Study|Progressive disease|16
7119611|NCT02597946|11256325|FG000|Overall Study|Other than above|1
7119612|NCT02598076|11256331|FG000|Overall Study|Lost to Follow-up|2
7119613|NCT02598076|11256332|FG001|Overall Study|Lost to Follow-up|3
7119614|NCT02598128|11256354|FG000|Period A: Days -7 to -1|Adverse Event|1
7119615|NCT02598128|11256355|FG001|Period A: Days -7 to -1|Adverse Event|0
7119616|NCT02598128|11256356|FG002|Period A: Days -7 to -1|Adverse Event|0
7119617|NCT02598128|11256357|FG003|Period A: Days -7 to -1|Adverse Event|0
7119618|NCT02598193|11256369|FG000|Overall Study|Adverse Event|13
7119619|NCT02598193|11256369|FG000|Overall Study|Withdrawal by Subject|1
7119620|NCT02598193|11256369|FG000|Overall Study|Listed in active lung transplant list|1
7119621|NCT02598193|11256369|FG000|Overall Study|Does not want to take Nintedanib|1
7119622|NCT02598297|11256375|FG000|Overall Study|Study terminated by Sponsor|21
7119623|NCT02598297|11256376|FG001|Overall Study|Study terminated by Sponsor|23
7119624|NCT02598297|11256375|FG000|Overall Study|Adverse Event|1
7119625|NCT02598297|11256376|FG001|Overall Study|Adverse Event|1
7119626|NCT02598297|11256375|FG000|Overall Study|Physician Decision|1
7119627|NCT02598297|11256376|FG001|Overall Study|Physician Decision|0
7119628|NCT02598297|11256375|FG000|Overall Study|Subject/guardian decision|1
7119629|NCT02598297|11256376|FG001|Overall Study|Subject/guardian decision|0
7119630|NCT02598297|11256375|FG000|Overall Study|Followed for survival|1
7119631|NCT02598297|11256376|FG001|Overall Study|Followed for survival|0
7119632|NCT02598934|11256384|FG000|Overall Study|Adverse Event|11
7119633|NCT02598934|11256385|FG001|Overall Study|Adverse Event|13
7119634|NCT02598934|11256384|FG000|Overall Study|Failure to Return|3
7119635|NCT02598934|11256385|FG001|Overall Study|Failure to Return|3
7119636|NCT02598934|11256384|FG000|Overall Study|Withdrawal by Subject|2
7119637|NCT02598934|11256385|FG001|Overall Study|Withdrawal by Subject|3
7119638|NCT02598934|11256384|FG000|Overall Study|Administrative|2
7119639|NCT02598934|11256385|FG001|Overall Study|Administrative|1
7119640|NCT02598934|11256384|FG000|Overall Study|Protocol Violation|1
7119641|NCT02598934|11256385|FG001|Overall Study|Protocol Violation|2
7119642|NCT02599129|11256393|FG000|Overall Study|Lack of Efficacy|2
7119643|NCT02599129|11256394|FG001|Overall Study|Lack of Efficacy|2
7119644|NCT02599129|11256393|FG000|Overall Study|Lost to Follow-up|1
7119645|NCT02599129|11256394|FG001|Overall Study|Lost to Follow-up|0
7119646|NCT02599129|11256393|FG000|Overall Study|Withdrawal by Subject|2
7119647|NCT02599129|11256394|FG001|Overall Study|Withdrawal by Subject|1
7119648|NCT02599402|11256406|FG000|Overall Study|Disease progression|153
7119649|NCT02599402|11256406|FG000|Overall Study|Study drug toxicity|201
7119650|NCT02599402|11256406|FG000|Overall Study|Death|26
7119651|NCT02599402|11256406|FG000|Overall Study|Adverse Event unrelated to study drug|23
7119652|NCT02599402|11256406|FG000|Overall Study|Participant request to discontinue study treatment|13
7119653|NCT02599402|11256406|FG000|Overall Study|Participant withdrew consent|5
7119654|NCT02599402|11256406|FG000|Overall Study|Lost to Follow-up|1
7119655|NCT02599402|11256406|FG000|Overall Study|Maximum Clinical Benefit|7
7119656|NCT02599402|11256406|FG000|Overall Study|Poor/non-compliance|1
7119657|NCT02599402|11256406|FG000|Overall Study|Pregnancy|1
7119658|NCT02599402|11256406|FG000|Overall Study|Participant no longer met study criteria|7
7119659|NCT02599402|11256406|FG000|Overall Study|Other Reasons|95
7119660|NCT02599688|11256457|FG000|Overall Study|Lack of Efficacy|1
7119661|NCT02599688|11256457|FG000|Overall Study|Withdrawal by Subject|1
7119662|NCT02599688|11256457|FG000|Overall Study|Termination by Sponsor|2
7119663|NCT02599961|11256469|FG000|Overall Study|Withdrawal by Subject|1
7119664|NCT02599961|11256469|FG000|Overall Study|Subject Non-Compliance|2
7119665|NCT02599961|11256469|FG000|Overall Study|Discontinuation of Study by Sponsor|9
7119666|NCT02599961|11256469|FG000|Overall Study|Other, Not Specified|3
7119667|NCT02600351|11256481|FG000|Overall Study|Lack of Efficacy|3
7119668|NCT02600351|11256482|FG001|Overall Study|Lack of Efficacy|0
7119669|NCT02600351|11256483|FG002|Overall Study|Lack of Efficacy|5
7119670|NCT02600351|11256484|FG003|Overall Study|Lack of Efficacy|2
7119671|NCT02600351|11256481|FG000|Overall Study|Lost to Follow-up|1
7119672|NCT02600351|11256482|FG001|Overall Study|Lost to Follow-up|0
7119673|NCT02600351|11256483|FG002|Overall Study|Lost to Follow-up|0
7119674|NCT02600351|11256484|FG003|Overall Study|Lost to Follow-up|0
7119675|NCT02600351|11256481|FG000|Overall Study|Randomized but Not Treated|1
7119676|NCT02600351|11256482|FG001|Overall Study|Randomized but Not Treated|0
7119677|NCT02600351|11256483|FG002|Overall Study|Randomized but Not Treated|1
7119678|NCT02600351|11256484|FG003|Overall Study|Randomized but Not Treated|3
7119679|NCT02600559|11256512|FG000|Overall Study|Withdrawal by Subject|3
7119680|NCT02600559|11256512|FG000|Overall Study|Lost to Follow-up|20
7119681|NCT02600819|11256550|FG000|GEN Phase|Adverse Event|2
7119682|NCT02600819|11256551|FG001|GEN Phase|Adverse Event|0
7119683|NCT02600819|11256550|FG000|GEN Phase|Death|2
7119684|NCT02600819|11256551|FG001|GEN Phase|Death|0
7119685|NCT02600819|11256550|FG000|GEN Phase|Investigator's Discretion|4
7119686|NCT02600819|11256551|FG001|GEN Phase|Investigator's Discretion|0
7119687|NCT02600819|11256550|FG000|GEN Phase|Non-Compliance with Study Drug|1
7119688|NCT02600819|11256551|FG001|GEN Phase|Non-Compliance with Study Drug|0
7119689|NCT02600819|11256550|FG000|GEN Phase|Withdrew Consent|5
7119690|NCT02600819|11256551|FG001|GEN Phase|Withdrew Consent|0
7119691|NCT02600819|11256550|FG000|GEN Phase|Lost to Follow-up|2
7119692|NCT02600819|11256551|FG001|GEN Phase|Lost to Follow-up|0
7119693|NCT02600845|11256557|FG000|Overall Study|Reason Not Specified|3
7119694|NCT02600845|11256557|FG000|Overall Study|Non-compliance with Study Procedures|10
7119695|NCT02600845|11256557|FG000|Overall Study|Consent Withdrawal|5
7119696|NCT02600871|11256563|FG000|Overall Study|Lost to Follow-up|13
7119697|NCT02600871|11256564|FG001|Overall Study|Lost to Follow-up|10
7119698|NCT02601001|11256574|FG000|Dosing Period 2|Adverse Event|0
7119699|NCT02601001|11256575|FG001|Dosing Period 2|Adverse Event|0
7119700|NCT02601001|11256576|FG002|Dosing Period 2|Adverse Event|0
7119701|NCT02601001|11256577|FG003|Dosing Period 2|Adverse Event|0
7119702|NCT02601001|11256578|FG004|Dosing Period 2|Adverse Event|0
7119703|NCT02601001|11256579|FG005|Dosing Period 2|Adverse Event|0
7119704|NCT02601001|11256580|FG006|Dosing Period 2|Adverse Event|1
7119705|NCT02601027|11256603|FG000|Registration to Surgery|Withdrawal by Subject|20
7119706|NCT02601027|11256604|FG001|Registration to Surgery|Withdrawal by Subject|10
7119707|NCT02601300|11256625|FG000|Induction Phase|Lack of Efficacy|2
7119708|NCT02601300|11256625|FG000|Induction Phase|Protocol Violation|1
7119709|NCT02601300|11256625|FG000|Extension Phase|Withdrawal by Subject|3
7119710|NCT02601300|11256625|FG000|Extension Phase|Adverse Event|4
7119711|NCT02601300|11256625|FG000|Extension Phase|Lack of Efficacy|10
7119712|NCT02601469|11256633|FG000|Overall Study|Enrolled in Error|1
7119713|NCT02601469|11256634|FG001|Overall Study|Enrolled in Error|0
7119714|NCT02601560|11256648|FG000|Overall Study|Other|0
7119715|NCT02601560|11256649|FG001|Overall Study|Other|0
7119716|NCT02601560|11256650|FG002|Overall Study|Other|0
7119717|NCT02601560|11256651|FG003|Overall Study|Other|0
7119718|NCT02601560|11256652|FG004|Overall Study|Other|0
7119719|NCT02601560|11256653|FG005|Overall Study|Other|0
7119720|NCT02601560|11256654|FG006|Overall Study|Other|1
7119721|NCT02601560|11256655|FG007|Overall Study|Other|0
7119722|NCT02601573|11256685|FG000|Overall Study|Lost to Follow-up|0
7119723|NCT02601573|11256686|FG001|Overall Study|Lost to Follow-up|3
7119724|NCT02601573|11256687|FG002|Overall Study|Lost to Follow-up|1
7119725|NCT02601573|11256688|FG003|Overall Study|Lost to Follow-up|0
7119726|NCT02601573|11256689|FG004|Overall Study|Lost to Follow-up|2
7119727|NCT02601573|11256685|FG000|Overall Study|Withdrawal by Subject|0
7119728|NCT02601573|11256686|FG001|Overall Study|Withdrawal by Subject|1
7119729|NCT02601573|11256687|FG002|Overall Study|Withdrawal by Subject|0
7119730|NCT02601573|11256688|FG003|Overall Study|Withdrawal by Subject|1
7119731|NCT02601573|11256689|FG004|Overall Study|Withdrawal by Subject|0
7119732|NCT02601625|11256705|FG000|Overall Study|Lost to Follow-up|0
7119733|NCT02601625|11256706|FG001|Overall Study|Lost to Follow-up|0
7119734|NCT02601625|11256707|FG002|Overall Study|Lost to Follow-up|1
7119735|NCT02601625|11256708|FG003|Overall Study|Lost to Follow-up|1
7119736|NCT02601820|11256732|FG000|Early On-Treatment (T2)|Missing T2 Record|51
7119737|NCT02601820|11256732|FG000|Late On-Treatment (T3)|missing T3 Record|49
7119738|NCT02601820|11256732|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3
7119739|NCT02601820|11256732|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88
7119740|NCT02602080|11256768|FG000|Overall Study|Protocol Violation|6
7119741|NCT02602080|11256769|FG001|Overall Study|Protocol Violation|1
7119742|NCT02602080|11256770|FG002|Overall Study|Protocol Violation|3
6806034|NCT02028884|10808404|FG000|Double-blind Period|Withdrawal by Subject|2
6806035|NCT02028884|10808405|FG001|Double-blind Period|Withdrawal by Subject|0
6806036|NCT02028884|10808404|FG000|Double-blind Period|On-going in Study|8
6806037|NCT02028884|10808405|FG001|Double-blind Period|On-going in Study|20
6806038|NCT02028884|10808404|FG000|Open-label Extension Period|Adverse Event|2
6806039|NCT02028884|10808405|FG001|Open-label Extension Period|Adverse Event|1
6806040|NCT02028884|10808404|FG000|Open-label Extension Period|Lack of Efficacy|3
6806041|NCT02028884|10808405|FG001|Open-label Extension Period|Lack of Efficacy|0
6806042|NCT02028884|10808404|FG000|Open-label Extension Period|Non-Compliance With Study Drug|0
6806043|NCT02028884|10808405|FG001|Open-label Extension Period|Non-Compliance With Study Drug|1
6806044|NCT02028884|10808404|FG000|Open-label Extension Period|Withdrawal by Subject|0
6806045|NCT02028884|10808405|FG001|Open-label Extension Period|Withdrawal by Subject|2
6806046|NCT02028884|10808404|FG000|Open-label Extension Period|On-going in Study|19
6806047|NCT02028884|10808405|FG001|Open-label Extension Period|On-going in Study|14
6806048|NCT01983774|10808416|FG000|Overall Study|Lung Transplant|0
6806049|NCT01983774|10808417|FG001|Overall Study|Lung Transplant|1
6806050|NCT01983774|10808416|FG000|Overall Study|Lost to Follow-up|1
6806051|NCT01983774|10808417|FG001|Overall Study|Lost to Follow-up|0
6806052|NCT01974206|10808427|FG000|Overall Study|Did Not Take Study Drug|0
6806053|NCT01974206|10808428|FG001|Overall Study|Did Not Take Study Drug|1
6806054|NCT01974206|10808427|FG000|Overall Study|Physician Decision|1
6806055|NCT01974206|10808428|FG001|Overall Study|Physician Decision|0
6806056|NCT01974206|10808427|FG000|Overall Study|Withdrawal by Subject|3
6806057|NCT01974206|10808428|FG001|Overall Study|Withdrawal by Subject|0
6806058|NCT01974206|10808427|FG000|Overall Study|Lost to Follow-up|1
6806059|NCT01974206|10808428|FG001|Overall Study|Lost to Follow-up|0
6806060|NCT01974206|10808427|FG000|Overall Study|Death|1
6806061|NCT01974206|10808428|FG001|Overall Study|Death|0
6806062|NCT01970865|10808451|FG000|Overall Study|Death|3
6806063|NCT01970865|10808452|FG001|Overall Study|Death|1
6806064|NCT01970865|10808453|FG002|Overall Study|Death|3
7119743|NCT02603107|11256799|FG000|Randomized Phase|Withdrew consent|8
7119744|NCT02603107|11256800|FG001|Randomized Phase|Withdrew consent|15
7119745|NCT02603107|11256799|FG000|Randomized Phase|Lost to Follow-up|1
7119746|NCT02603107|11256800|FG001|Randomized Phase|Lost to Follow-up|3
7119747|NCT02603107|11256799|FG000|Randomized Phase|Adverse Event|2
7119748|NCT02603107|11256800|FG001|Randomized Phase|Adverse Event|0
7119749|NCT02603107|11256799|FG000|Randomized Phase|Death|1
7119750|NCT02603107|11256800|FG001|Randomized Phase|Death|1
7119751|NCT02603107|11256799|FG000|Randomized Phase|Non-compliance with study drug|1
7119752|NCT02603107|11256800|FG001|Randomized Phase|Non-compliance with study drug|1
7119753|NCT02603107|11256799|FG000|Randomized Phase|Investigator's discretion|0
7119754|NCT02603107|11256800|FG001|Randomized Phase|Investigator's discretion|1
7119755|NCT02603107|11256799|FG000|Randomized Phase|Lack of Efficacy|1
7119756|NCT02603107|11256800|FG001|Randomized Phase|Lack of Efficacy|0
7119757|NCT02603107|11256799|FG000|Randomized Phase|Protocol Violation|1
7119758|NCT02603107|11256800|FG001|Randomized Phase|Protocol Violation|0
7119759|NCT02603107|11256799|FG000|Optional Extension Phase|Lost to Follow-up|3
7119760|NCT02603107|11256800|FG001|Optional Extension Phase|Lost to Follow-up|3
7119761|NCT02603107|11256799|FG000|Optional Extension Phase|Withdrew consent|3
7119762|NCT02603107|11256800|FG001|Optional Extension Phase|Withdrew consent|2
7119763|NCT02603107|11256799|FG000|Optional Extension Phase|Investigator's discretion|2
7119764|NCT02603107|11256800|FG001|Optional Extension Phase|Investigator's discretion|2
7119765|NCT02603107|11256799|FG000|Optional Extension Phase|Pregnancy|0
7119766|NCT02603107|11256800|FG001|Optional Extension Phase|Pregnancy|3
7119767|NCT02603107|11256799|FG000|Optional Extension Phase|Adverse Event|0
7119768|NCT02603107|11256800|FG001|Optional Extension Phase|Adverse Event|2
7119769|NCT02603107|11256799|FG000|Optional Extension Phase|Not treated in extension phase|0
7119770|NCT02603107|11256800|FG001|Optional Extension Phase|Not treated in extension phase|1
7119771|NCT02603107|11256799|FG000|Optional Extension Phase|Protocol Violation|1
7119772|NCT02603107|11256800|FG001|Optional Extension Phase|Protocol Violation|0
7119773|NCT02603120|11256810|FG000|Double-Blind Treatment Phase|Withdrew consent|4
7119774|NCT02603120|11256811|FG001|Double-Blind Treatment Phase|Withdrew consent|8
7119775|NCT02603120|11256810|FG000|Double-Blind Treatment Phase|Adverse Event|3
7119776|NCT02603120|11256811|FG001|Double-Blind Treatment Phase|Adverse Event|3
7119777|NCT02603120|11256810|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4
7119778|NCT02603120|11256811|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2
7119779|NCT02603120|11256810|FG000|Double-Blind Treatment Phase|Death|2
7119780|NCT02603120|11256811|FG001|Double-Blind Treatment Phase|Death|0
7119781|NCT02603120|11256810|FG000|Double-Blind Treatment Phase|Investigator's discretion|2
7119782|NCT02603120|11256811|FG001|Double-Blind Treatment Phase|Investigator's discretion|0
7119783|NCT02603120|11256810|FG000|Double-Blind Treatment Phase|Pregnancy|1
7119784|NCT02603120|11256811|FG001|Double-Blind Treatment Phase|Pregnancy|1
7119785|NCT02603120|11256810|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1
7119786|NCT02603120|11256811|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0
7119787|NCT02603120|11256810|FG000|Double-Blind Treatment Phase|Did not receive study drug|2
7119788|NCT02603120|11256811|FG001|Double-Blind Treatment Phase|Did not receive study drug|2
7119789|NCT02603120|11256810|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3
7119790|NCT02603120|11256811|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4
7119791|NCT02603120|11256810|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1
7119792|NCT02603120|11256811|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2
7119793|NCT02603120|11256810|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1
7119794|NCT02603120|11256811|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2
7119795|NCT02603120|11256810|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0
7119796|NCT02603120|11256811|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1
7119797|NCT02603120|11256810|FG000|OL Extension B/F/TAF Treatment Phase|Death|0
7119798|NCT02603120|11256811|FG001|OL Extension B/F/TAF Treatment Phase|Death|1
7119799|NCT02603120|11256810|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0
7119800|NCT02603120|11256811|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1
7119801|NCT02603172|11256827|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0
7119802|NCT02603172|11256828|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0
7119803|NCT02603172|11256829|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1
7119804|NCT02603172|11256830|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0
7119805|NCT02603172|11256831|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0
7119806|NCT02603172|11256832|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0
7119807|NCT02603172|11256833|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0
7119808|NCT02603172|11256834|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0
7119809|NCT02603393|11256857|FG000|Overall Study|Patient/guardian decision|32
7119810|NCT02603393|11256858|FG001|Overall Study|Patient/guardian decision|18
7119811|NCT02603393|11256857|FG000|Overall Study|Adverse Event|17
7119812|NCT02603393|11256858|FG001|Overall Study|Adverse Event|15
7119813|NCT02603393|11256857|FG000|Overall Study|Technical problems|4
7119814|NCT02603393|11256858|FG001|Overall Study|Technical problems|7
7119815|NCT02603393|11256857|FG000|Overall Study|Lack of Efficacy|7
7119816|NCT02603393|11256858|FG001|Overall Study|Lack of Efficacy|2
7119817|NCT02603393|11256857|FG000|Overall Study|Death|3
7119818|NCT02603393|11256858|FG001|Overall Study|Death|4
7119819|NCT02603393|11256857|FG000|Overall Study|Physician Decision|3
7119820|NCT02603393|11256858|FG001|Overall Study|Physician Decision|3
7119821|NCT02603393|11256857|FG000|Overall Study|Protocol deviation|2
7119822|NCT02603393|11256858|FG001|Overall Study|Protocol deviation|3
7119823|NCT02603393|11256857|FG000|Overall Study|Lost to Follow-up|1
7119824|NCT02603393|11256858|FG001|Overall Study|Lost to Follow-up|2
7119825|NCT02603393|11256857|FG000|Overall Study|Non-compliance with study treatment|1
7119826|NCT02603393|11256858|FG001|Overall Study|Non-compliance with study treatment|0
7119827|NCT02603393|11256857|FG000|Overall Study|Sponsor decision|1
7119828|NCT02603393|11256858|FG001|Overall Study|Sponsor decision|0
7119829|NCT02603419|11256870|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
7119830|NCT02603419|11256871|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1
7119831|NCT02603419|11256872|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
7119832|NCT02603419|11256873|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
7119833|NCT02603419|11256874|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
7119834|NCT02603419|11256875|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
7119835|NCT02603419|11256870|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2
7119836|NCT02603419|11256871|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4
7119837|NCT02603419|11256872|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2
7119838|NCT02603419|11256873|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4
7119839|NCT02603419|11256874|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3
7119840|NCT02603419|11256875|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0
7119841|NCT02603419|11256870|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2
7119842|NCT02603419|11256871|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0
7119843|NCT02603419|11256872|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3
7119844|NCT02603419|11256873|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0
7119845|NCT02603419|11256874|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1
7119846|NCT02603419|11256875|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0
7119847|NCT02603419|11256870|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
7119848|NCT02603419|11256871|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
7119849|NCT02603419|11256872|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
7119850|NCT02603419|11256873|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
7119851|NCT02603419|11256874|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1
7119852|NCT02603419|11256875|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
7119853|NCT02603419|11256870|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
7119854|NCT02603419|11256871|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1
7119855|NCT02603419|11256872|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
7119856|NCT02603419|11256873|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
7119857|NCT02603419|11256874|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
7119858|NCT02603419|11256875|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
7119859|NCT02603419|11256870|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2
7119860|NCT02603419|11256871|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1
7119861|NCT02603419|11256872|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1
7119862|NCT02603419|11256873|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0
7119863|NCT02603419|11256874|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1
7119864|NCT02603419|11256875|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0
7119865|NCT02603419|11256870|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
7119866|NCT02603419|11256871|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
7119867|NCT02603419|11256872|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
7119868|NCT02603419|11256873|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2
7119869|NCT02603419|11256874|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
7119870|NCT02603419|11256875|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
7119871|NCT02603419|11256870|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
7119872|NCT02603419|11256871|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
7119873|NCT02603419|11256872|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
7119874|NCT02603419|11256873|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
7119875|NCT02603419|11256874|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
7119876|NCT02603419|11256875|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1
7119877|NCT02603419|11256870|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0
7119878|NCT02603419|11256871|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0
7119879|NCT02603419|11256872|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0
7119880|NCT02603419|11256873|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0
7119881|NCT02603419|11256874|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0
7119882|NCT02603419|11256875|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1
7119883|NCT02603419|11256870|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
7119884|NCT02603419|11256871|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
7119885|NCT02603419|11256872|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
7119886|NCT02603419|11256873|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
7119887|NCT02603419|11256874|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
7119888|NCT02603419|11256875|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1
7119889|NCT02603809|11256900|FG000|Overall Study|Withdrawal by Subject|4
7119890|NCT02603809|11256901|FG001|Overall Study|Withdrawal by Subject|1
7119891|NCT02603809|11256902|FG002|Overall Study|Withdrawal by Subject|2
7119892|NCT02603809|11256903|FG003|Overall Study|Withdrawal by Subject|3
7119893|NCT02603809|11256904|FG004|Overall Study|Withdrawal by Subject|3
7119894|NCT02603809|11256905|FG005|Overall Study|Withdrawal by Subject|4
7119895|NCT02603809|11256900|FG000|Overall Study|Lost to Follow-up|2
7119896|NCT02603809|11256901|FG001|Overall Study|Lost to Follow-up|3
7119897|NCT02603809|11256902|FG002|Overall Study|Lost to Follow-up|1
7119898|NCT02603809|11256903|FG003|Overall Study|Lost to Follow-up|4
7119899|NCT02603809|11256904|FG004|Overall Study|Lost to Follow-up|2
7119900|NCT02603809|11256905|FG005|Overall Study|Lost to Follow-up|2
7119901|NCT02603809|11256900|FG000|Overall Study|Pre-specified discontinuation criteria|3
7119902|NCT02603809|11256901|FG001|Overall Study|Pre-specified discontinuation criteria|3
7119903|NCT02603809|11256902|FG002|Overall Study|Pre-specified discontinuation criteria|2
7119904|NCT02603809|11256903|FG003|Overall Study|Pre-specified discontinuation criteria|2
7119905|NCT02603809|11256904|FG004|Overall Study|Pre-specified discontinuation criteria|3
7119906|NCT02603809|11256905|FG005|Overall Study|Pre-specified discontinuation criteria|1
7119907|NCT02603809|11256900|FG000|Overall Study|Physician Decision|0
7119908|NCT02603809|11256901|FG001|Overall Study|Physician Decision|0
7119909|NCT02603809|11256902|FG002|Overall Study|Physician Decision|0
7119910|NCT02603809|11256903|FG003|Overall Study|Physician Decision|1
7119911|NCT02603809|11256904|FG004|Overall Study|Physician Decision|2
7119912|NCT02603809|11256905|FG005|Overall Study|Physician Decision|1
7119913|NCT02603809|11256900|FG000|Overall Study|Adverse Event|3
7119914|NCT02603809|11256901|FG001|Overall Study|Adverse Event|0
7119915|NCT02603809|11256902|FG002|Overall Study|Adverse Event|2
7119916|NCT02603809|11256903|FG003|Overall Study|Adverse Event|2
7119917|NCT02603809|11256904|FG004|Overall Study|Adverse Event|1
7119918|NCT02603809|11256905|FG005|Overall Study|Adverse Event|1
7119919|NCT02603809|11256900|FG000|Overall Study|Lack of Efficacy|0
7119920|NCT02603809|11256901|FG001|Overall Study|Lack of Efficacy|1
7119921|NCT02603809|11256902|FG002|Overall Study|Lack of Efficacy|0
7119922|NCT02603809|11256903|FG003|Overall Study|Lack of Efficacy|0
7119923|NCT02603809|11256904|FG004|Overall Study|Lack of Efficacy|0
7119924|NCT02603809|11256905|FG005|Overall Study|Lack of Efficacy|1
7119925|NCT02603952|11256930|FG000|Overall Study|Withdrawal by Subject|1
7119926|NCT02603952|11256931|FG001|Overall Study|Withdrawal by Subject|0
7119927|NCT02603952|11256932|FG002|Overall Study|Withdrawal by Subject|0
7119928|NCT02603952|11256933|FG003|Overall Study|Withdrawal by Subject|0
7119929|NCT02603952|11256930|FG000|Overall Study|Received oseltamivir by error|0
7119930|NCT02603952|11256931|FG001|Overall Study|Received oseltamivir by error|0
7119931|NCT02603952|11256932|FG002|Overall Study|Received oseltamivir by error|0
7119932|NCT02603952|11256933|FG003|Overall Study|Received oseltamivir by error|1
7119933|NCT02604017|11256948|FG000|Overall Study|Withdrew Consent|0
7119934|NCT02604017|11256949|FG001|Overall Study|Withdrew Consent|2
7119935|NCT02604017|11256948|FG000|Overall Study|Lost to Follow-up|5
7119936|NCT02604017|11256949|FG001|Overall Study|Lost to Follow-up|6
7119937|NCT02604017|11256948|FG000|Overall Study|Other|1
7119938|NCT02604017|11256949|FG001|Overall Study|Other|0
7119939|NCT02604160|11256957|FG000|Overall Study|Protocol Violation|0
7119940|NCT02604160|11256958|FG001|Overall Study|Protocol Violation|1
7119941|NCT02604160|11256957|FG000|Overall Study|Physician Decision|0
7119942|NCT02604160|11256958|FG001|Overall Study|Physician Decision|1
7119943|NCT02604199|11256983|FG000|Overall Study|Pregnancy|0
7119944|NCT02604199|11256984|FG001|Overall Study|Pregnancy|0
7119945|NCT02604199|11256985|FG002|Overall Study|Pregnancy|0
7119946|NCT02604199|11256986|FG003|Overall Study|Pregnancy|1
7119947|NCT02604199|11256983|FG000|Overall Study|Study terminated by sponsor|0
7119948|NCT02604199|11256984|FG001|Overall Study|Study terminated by sponsor|2
7119949|NCT02604199|11256985|FG002|Overall Study|Study terminated by sponsor|0
7119950|NCT02604199|11256986|FG003|Overall Study|Study terminated by sponsor|2
7119951|NCT02604199|11256983|FG000|Overall Study|Withdrawal by Subject|0
7119952|NCT02604199|11256984|FG001|Overall Study|Withdrawal by Subject|1
7119953|NCT02604199|11256985|FG002|Overall Study|Withdrawal by Subject|0
7119954|NCT02604199|11256986|FG003|Overall Study|Withdrawal by Subject|0
7119955|NCT02604212|11257003|FG000|Overall Study|Study Terminated by Sponsor|2
7119956|NCT02604212|11257004|FG001|Overall Study|Study Terminated by Sponsor|1
7119957|NCT02604212|11257005|FG002|Overall Study|Study Terminated by Sponsor|3
7119958|NCT02604212|11257006|FG003|Overall Study|Study Terminated by Sponsor|3
7119959|NCT02604212|11257003|FG000|Overall Study|Withdrawal by Subject|0
7119960|NCT02604212|11257004|FG001|Overall Study|Withdrawal by Subject|0
7119961|NCT02604212|11257005|FG002|Overall Study|Withdrawal by Subject|1
7119962|NCT02604212|11257006|FG003|Overall Study|Withdrawal by Subject|0
7119963|NCT02604264|11257023|FG000|Intervention|Didn't use CVC for at least 21 days|200
7119964|NCT02604264|11257024|FG001|Intervention|Didn't use CVC for at least 21 days|242
7119965|NCT02604342|11257032|FG000|Overall Study|Death|32
7119966|NCT02604342|11257033|FG001|Overall Study|Death|16
7119967|NCT02604342|11257032|FG000|Overall Study|Progression of disease|1
7119968|NCT02604342|11257033|FG001|Overall Study|Progression of disease|0
7119969|NCT02604342|11257032|FG000|Overall Study|Withdrawal by Subject|5
7119970|NCT02604342|11257033|FG001|Overall Study|Withdrawal by Subject|6
7119971|NCT02604342|11257032|FG000|Overall Study|Other|1
7119972|NCT02604342|11257033|FG001|Overall Study|Other|0
7119973|NCT02604342|11257032|FG000|Overall Study|Study Termination by Sponsor|1
7119974|NCT02604342|11257033|FG001|Overall Study|Study Termination by Sponsor|0
7119975|NCT02604342|11257032|FG000|Overall Study|Lost to Follow-up|1
7119976|NCT02604342|11257033|FG001|Overall Study|Lost to Follow-up|1
7119977|NCT02604342|11257032|FG000|Overall Study|Physician Decision|2
7119978|NCT02604342|11257033|FG001|Overall Study|Physician Decision|0
7119979|NCT02604407|11257042|FG000|Overall Study|Adverse Event|0
7119980|NCT02604407|11257043|FG001|Overall Study|Adverse Event|7
7119981|NCT02604407|11257044|FG002|Overall Study|Adverse Event|5
7119982|NCT02604407|11257042|FG000|Overall Study|Protocol Violation|2
7119983|NCT02604407|11257043|FG001|Overall Study|Protocol Violation|0
7119984|NCT02604407|11257044|FG002|Overall Study|Protocol Violation|0
7119985|NCT02604407|11257042|FG000|Overall Study|Withdrawal by Subject|3
7119986|NCT02604407|11257043|FG001|Overall Study|Withdrawal by Subject|3
7119987|NCT02604407|11257044|FG002|Overall Study|Withdrawal by Subject|5
7119988|NCT02604407|11257042|FG000|Overall Study|Lost to Follow-up|2
7119989|NCT02604407|11257043|FG001|Overall Study|Lost to Follow-up|1
7119990|NCT02604407|11257044|FG002|Overall Study|Lost to Follow-up|2
7119991|NCT02604407|11257042|FG000|Overall Study|Lack of Efficacy|1
7119992|NCT02604407|11257043|FG001|Overall Study|Lack of Efficacy|0
7119993|NCT02604407|11257044|FG002|Overall Study|Lack of Efficacy|0
7119994|NCT02604407|11257042|FG000|Overall Study|Other|3
7119995|NCT02604407|11257043|FG001|Overall Study|Other|1
7119996|NCT02604407|11257044|FG002|Overall Study|Other|4
7119997|NCT02604550|11257054|FG000|Overall Study|Lost to Follow-up|7
7119998|NCT02604550|11257055|FG001|Overall Study|Lost to Follow-up|6
7119999|NCT02604550|11257054|FG000|Overall Study|Withdrawal by Subject|0
7120000|NCT02604550|11257055|FG001|Overall Study|Withdrawal by Subject|1
7120001|NCT02604550|11257054|FG000|Overall Study|Incomplete data using paper journal|18
7120002|NCT02604550|11257055|FG001|Overall Study|Incomplete data using paper journal|19
7120003|NCT02604589|11257064|FG000|Overall Study|catheter dislodgement|0
7120004|NCT02604589|11257065|FG001|Overall Study|catheter dislodgement|0
7120005|NCT02604589|11257066|FG002|Overall Study|catheter dislodgement|1
7120006|NCT02605122|11257082|FG000|Overall Study|Withdrawal by Subject|4
7120007|NCT02605122|11257083|FG001|Overall Study|Withdrawal by Subject|1
7120008|NCT02605122|11257082|FG000|Overall Study|Lost to Follow-up|1
7120009|NCT02605122|11257083|FG001|Overall Study|Lost to Follow-up|1
7120010|NCT02605174|11257093|FG000|Overall Study|Adverse Event|0
7120011|NCT02605174|11257094|FG001|Overall Study|Adverse Event|0
7120012|NCT02605174|11257095|FG002|Overall Study|Adverse Event|1
7120013|NCT02605174|11257096|FG003|Overall Study|Adverse Event|0
7120014|NCT02605174|11257097|FG004|Overall Study|Adverse Event|4
7120015|NCT02605174|11257098|FG005|Overall Study|Adverse Event|0
7120016|NCT02605174|11257099|FG006|Overall Study|Adverse Event|0
7120017|NCT02605174|11257093|FG000|Overall Study|Lost to Follow-up|20
7120018|NCT02605174|11257094|FG001|Overall Study|Lost to Follow-up|7
7120019|NCT02605174|11257095|FG002|Overall Study|Lost to Follow-up|27
7120020|NCT02605174|11257096|FG003|Overall Study|Lost to Follow-up|10
7120021|NCT02605174|11257097|FG004|Overall Study|Lost to Follow-up|20
7120022|NCT02605174|11257098|FG005|Overall Study|Lost to Follow-up|10
7120023|NCT02605174|11257099|FG006|Overall Study|Lost to Follow-up|29
7120024|NCT02605174|11257093|FG000|Overall Study|Protocol Violation|10
7120025|NCT02605174|11257094|FG001|Overall Study|Protocol Violation|4
7120026|NCT02605174|11257095|FG002|Overall Study|Protocol Violation|14
7120027|NCT02605174|11257096|FG003|Overall Study|Protocol Violation|6
7120028|NCT02605174|11257097|FG004|Overall Study|Protocol Violation|7
7120029|NCT02605174|11257098|FG005|Overall Study|Protocol Violation|7
7120030|NCT02605174|11257099|FG006|Overall Study|Protocol Violation|12
7120031|NCT02605174|11257093|FG000|Overall Study|Pregnancy|1
7120032|NCT02605174|11257094|FG001|Overall Study|Pregnancy|0
7120033|NCT02605174|11257095|FG002|Overall Study|Pregnancy|0
7120034|NCT02605174|11257096|FG003|Overall Study|Pregnancy|2
7120035|NCT02605174|11257097|FG004|Overall Study|Pregnancy|0
7120036|NCT02605174|11257098|FG005|Overall Study|Pregnancy|0
7120037|NCT02605174|11257099|FG006|Overall Study|Pregnancy|0
7120038|NCT02605174|11257093|FG000|Overall Study|Withdrawal by Subject|9
7120039|NCT02605174|11257094|FG001|Overall Study|Withdrawal by Subject|6
7120040|NCT02605174|11257095|FG002|Overall Study|Withdrawal by Subject|14
7120041|NCT02605174|11257096|FG003|Overall Study|Withdrawal by Subject|11
7120042|NCT02605174|11257097|FG004|Overall Study|Withdrawal by Subject|6
7120043|NCT02605174|11257098|FG005|Overall Study|Withdrawal by Subject|4
7120044|NCT02605174|11257099|FG006|Overall Study|Withdrawal by Subject|15
7120045|NCT02605174|11257093|FG000|Overall Study|Physician Decision|2
7120046|NCT02605174|11257094|FG001|Overall Study|Physician Decision|0
7120047|NCT02605174|11257095|FG002|Overall Study|Physician Decision|0
7120048|NCT02605174|11257096|FG003|Overall Study|Physician Decision|0
7120049|NCT02605174|11257097|FG004|Overall Study|Physician Decision|0
7120050|NCT02605174|11257098|FG005|Overall Study|Physician Decision|0
7120051|NCT02605174|11257099|FG006|Overall Study|Physician Decision|3
7120052|NCT02605174|11257093|FG000|Overall Study|Randomization Failure|22
7120053|NCT02605174|11257094|FG001|Overall Study|Randomization Failure|6
7120054|NCT02605174|11257095|FG002|Overall Study|Randomization Failure|20
7120055|NCT02605174|11257096|FG003|Overall Study|Randomization Failure|7
7120056|NCT02605174|11257097|FG004|Overall Study|Randomization Failure|16
7120057|NCT02605174|11257098|FG005|Overall Study|Randomization Failure|11
7120058|NCT02605174|11257099|FG006|Overall Study|Randomization Failure|30
7120059|NCT02605447|11257158|FG000|Overall Study|Death|66
7120060|NCT02605447|11257158|FG000|Overall Study|Physician Decision|1
7120061|NCT02605447|11257158|FG000|Overall Study|Lost to Follow-up|24
7120062|NCT02605447|11257158|FG000|Overall Study|Withdrawal by Subject|10
7120063|NCT02605447|11257158|FG000|Overall Study|Not disclosed|1
7120064|NCT02605642|11257165|FG000|Overall Study|Other|11
7120065|NCT02605642|11257166|FG001|Overall Study|Other|1
7120066|NCT02605642|11257165|FG000|Overall Study|Participant non-compliance|2
7120067|NCT02605642|11257166|FG001|Overall Study|Participant non-compliance|4
7120068|NCT02605642|11257165|FG000|Overall Study|Physician Decision|10
7120069|NCT02605642|11257166|FG001|Overall Study|Physician Decision|0
7120070|NCT02605642|11257165|FG000|Overall Study|Lost to Follow-up|12
7120071|NCT02605642|11257166|FG001|Overall Study|Lost to Follow-up|1
7120072|NCT02605642|11257165|FG000|Overall Study|Adverse Event|14
7120073|NCT02605642|11257166|FG001|Overall Study|Adverse Event|2
7120074|NCT02605642|11257165|FG000|Overall Study|Withdrawal by Subject|23
7120075|NCT02605642|11257166|FG001|Overall Study|Withdrawal by Subject|2
7120076|NCT02605642|11257165|FG000|Overall Study|Lack of response|24
7120077|NCT02605642|11257166|FG001|Overall Study|Lack of response|11
7120078|NCT02605837|11257174|FG000|Overall Study|Adverse Event|3
7120079|NCT02605837|11257175|FG001|Overall Study|Adverse Event|1
7120080|NCT02605837|11257174|FG000|Overall Study|Non-Compliance with Study Drug|0
7120081|NCT02605837|11257175|FG001|Overall Study|Non-Compliance with Study Drug|1
7120082|NCT02605837|11257174|FG000|Overall Study|Withdrawal by Subject|8
7120083|NCT02605837|11257175|FG001|Overall Study|Withdrawal by Subject|8
7120084|NCT02605837|11257174|FG000|Overall Study|Physician Decision|0
7120085|NCT02605837|11257175|FG001|Overall Study|Physician Decision|1
7120086|NCT02605928|11257204|FG000|Overall Study|Model tuning phase|28
7120087|NCT02605928|11257204|FG000|Overall Study|Lack of Efficacy|5
7120088|NCT02605954|11257210|FG000|Overall Study|Adverse Event|5
7120089|NCT02605954|11257211|FG001|Overall Study|Adverse Event|1
7120090|NCT02605954|11257210|FG000|Overall Study|Investigator's Discretion|1
7120091|NCT02605954|11257211|FG001|Overall Study|Investigator's Discretion|0
7120092|NCT02605954|11257210|FG000|Overall Study|Non-Compliance with Study Drug|1
7120093|NCT02605954|11257211|FG001|Overall Study|Non-Compliance with Study Drug|0
7120094|NCT02605954|11257210|FG000|Overall Study|Withdrew Consent|2
7120095|NCT02605954|11257211|FG001|Overall Study|Withdrew Consent|2
7120096|NCT02605954|11257210|FG000|Overall Study|Lost to Follow-up|3
7120097|NCT02605954|11257211|FG001|Overall Study|Lost to Follow-up|0
7120098|NCT02605954|11257210|FG000|Overall Study|Randomized but not treated|0
7120099|NCT02605954|11257211|FG001|Overall Study|Randomized but not treated|1
7120100|NCT02606253|11257223|FG000|Overall Study|Adverse Event|2
7120101|NCT02606253|11257224|FG001|Overall Study|Adverse Event|0
7120102|NCT02606253|11257225|FG002|Overall Study|Adverse Event|0
7120103|NCT02606253|11257223|FG000|Overall Study|Protocol Violation|2
7120104|NCT02606253|11257224|FG001|Overall Study|Protocol Violation|1
7120105|NCT02606253|11257225|FG002|Overall Study|Protocol Violation|0
7120106|NCT02606253|11257223|FG000|Overall Study|Physician Decision|1
7120107|NCT02606253|11257224|FG001|Overall Study|Physician Decision|1
7120108|NCT02606253|11257225|FG002|Overall Study|Physician Decision|0
7120109|NCT02606643|11257255|FG000|Overall Study|did not meet inclusion criteria|1
7120110|NCT02606643|11257256|FG001|Overall Study|did not meet inclusion criteria|3
7120111|NCT02606877|11257284|FG000|Overall Study|Adverse Event|3
7120112|NCT02606877|11257285|FG001|Overall Study|Adverse Event|0
7120113|NCT02606877|11257284|FG000|Overall Study|Non-compliance with protocol|0
7120114|NCT02606877|11257285|FG001|Overall Study|Non-compliance with protocol|1
7120115|NCT02606877|11257284|FG000|Overall Study|Other than listed above|1
7120116|NCT02606877|11257285|FG001|Overall Study|Other than listed above|0
7120117|NCT02607228|11257314|FG000|Overall Study|Progressive Disease|4
7120118|NCT02607228|11257315|FG001|Overall Study|Progressive Disease|3
7120119|NCT02607228|11257316|FG002|Overall Study|Progressive Disease|1
7120120|NCT02607228|11257317|FG003|Overall Study|Progressive Disease|5
7120121|NCT02607228|11257318|FG004|Overall Study|Progressive Disease|4
7120122|NCT02607228|11257319|FG005|Overall Study|Progressive Disease|3
7120123|NCT02607228|11257320|FG006|Overall Study|Progressive Disease|1
7120124|NCT02607228|11257314|FG000|Overall Study|Adverse Event|1
7120125|NCT02607228|11257315|FG001|Overall Study|Adverse Event|0
7120126|NCT02607228|11257316|FG002|Overall Study|Adverse Event|1
7120127|NCT02607228|11257317|FG003|Overall Study|Adverse Event|0
7120128|NCT02607228|11257318|FG004|Overall Study|Adverse Event|1
7120129|NCT02607228|11257319|FG005|Overall Study|Adverse Event|1
7120130|NCT02607228|11257320|FG006|Overall Study|Adverse Event|1
7120131|NCT02607228|11257314|FG000|Overall Study|Investigator's Discretion|0
7120132|NCT02607228|11257315|FG001|Overall Study|Investigator's Discretion|0
7120133|NCT02607228|11257316|FG002|Overall Study|Investigator's Discretion|1
7120134|NCT02607228|11257317|FG003|Overall Study|Investigator's Discretion|0
7120135|NCT02607228|11257318|FG004|Overall Study|Investigator's Discretion|0
7120136|NCT02607228|11257319|FG005|Overall Study|Investigator's Discretion|1
7120137|NCT02607228|11257320|FG006|Overall Study|Investigator's Discretion|0
7120138|NCT02607228|11257314|FG000|Overall Study|Withdrew Consent|0
7120139|NCT02607228|11257315|FG001|Overall Study|Withdrew Consent|1
7120140|NCT02607228|11257316|FG002|Overall Study|Withdrew Consent|0
7120141|NCT02607228|11257317|FG003|Overall Study|Withdrew Consent|0
7120142|NCT02607228|11257318|FG004|Overall Study|Withdrew Consent|0
7120143|NCT02607228|11257319|FG005|Overall Study|Withdrew Consent|1
7120144|NCT02607228|11257320|FG006|Overall Study|Withdrew Consent|0
7120145|NCT02607228|11257314|FG000|Overall Study|Study Terminated by Sponsor|0
7120146|NCT02607228|11257315|FG001|Overall Study|Study Terminated by Sponsor|0
7120147|NCT02607228|11257316|FG002|Overall Study|Study Terminated by Sponsor|0
7120148|NCT02607228|11257317|FG003|Overall Study|Study Terminated by Sponsor|1
7120149|NCT02607228|11257318|FG004|Overall Study|Study Terminated by Sponsor|0
7120150|NCT02607228|11257319|FG005|Overall Study|Study Terminated by Sponsor|0
7120151|NCT02607228|11257320|FG006|Overall Study|Study Terminated by Sponsor|0
7120152|NCT02607280|11257358|FG000|Overall Study|Adverse Event|4
7120153|NCT02607280|11257359|FG001|Overall Study|Adverse Event|0
7120154|NCT02607280|11257358|FG000|Overall Study|Decrease in CrCl <15|0
7120155|NCT02607280|11257359|FG001|Overall Study|Decrease in CrCl <15|1
7120156|NCT02607306|11257368|FG000|Overall Study|Adverse Event|8
7120157|NCT02607306|11257369|FG001|Overall Study|Adverse Event|6
7120158|NCT02607306|11257370|FG002|Overall Study|Adverse Event|6
7120159|NCT02607306|11257368|FG000|Overall Study|Unclassified|1
7120160|NCT02607306|11257369|FG001|Overall Study|Unclassified|4
7120161|NCT02607306|11257370|FG002|Overall Study|Unclassified|0
7120162|NCT02607306|11257368|FG000|Overall Study|Withdrawal by Subject|8
7120163|NCT02607306|11257369|FG001|Overall Study|Withdrawal by Subject|10
7120164|NCT02607306|11257370|FG002|Overall Study|Withdrawal by Subject|2
7120165|NCT02607306|11257368|FG000|Overall Study|Lack of Efficacy|0
7120166|NCT02607306|11257369|FG001|Overall Study|Lack of Efficacy|1
7120167|NCT02607306|11257370|FG002|Overall Study|Lack of Efficacy|1
7120168|NCT02607306|11257368|FG000|Overall Study|Protocol Violation|4
7120169|NCT02607306|11257369|FG001|Overall Study|Protocol Violation|2
7120170|NCT02607306|11257370|FG002|Overall Study|Protocol Violation|1
7120171|NCT02607735|11257390|FG000|Primary Study|Randomized but Never Treated|1
7120172|NCT02607735|11257391|FG001|Primary Study|Randomized but Never Treated|0
7120173|NCT02607735|11257392|FG002|Primary Study|Randomized but Never Treated|0
7120174|NCT02607735|11257390|FG000|Primary Study|Lost to Follow-up|4
7120175|NCT02607735|11257391|FG001|Primary Study|Lost to Follow-up|0
7120176|NCT02607735|11257392|FG002|Primary Study|Lost to Follow-up|0
7120177|NCT02607735|11257390|FG000|Primary Study|Withdrew Consent|2
7120178|NCT02607735|11257391|FG001|Primary Study|Withdrew Consent|0
7120179|NCT02607735|11257392|FG002|Primary Study|Withdrew Consent|0
7120180|NCT02607735|11257390|FG000|Deferred Treatment Substudy|Lost to Follow-up|0
7120181|NCT02607735|11257391|FG001|Deferred Treatment Substudy|Lost to Follow-up|0
7120182|NCT02607735|11257392|FG002|Deferred Treatment Substudy|Lost to Follow-up|4
7120183|NCT02607735|11257390|FG000|Deferred Treatment Substudy|Withdrew Consent|0
7120184|NCT02607735|11257391|FG001|Deferred Treatment Substudy|Withdrew Consent|0
7120185|NCT02607735|11257392|FG002|Deferred Treatment Substudy|Withdrew Consent|1
7120186|NCT02607800|11257402|FG000|Overall Study|Lost to Follow-up|7
7120187|NCT02607800|11257403|FG001|Overall Study|Lost to Follow-up|10
7120188|NCT02607800|11257402|FG000|Overall Study|Withdrew Consent|2
7120189|NCT02607800|11257403|FG001|Overall Study|Withdrew Consent|0
7120190|NCT02607800|11257402|FG000|Overall Study|Randomized/Enrolled but Not Treated|1
7120191|NCT02607800|11257403|FG001|Overall Study|Randomized/Enrolled but Not Treated|1
7120192|NCT02607865|11257414|FG000|Overall Study|Lost to Follow-up|9
7120193|NCT02607865|11257415|FG001|Overall Study|Lost to Follow-up|7
7120194|NCT02607865|11257416|FG002|Overall Study|Lost to Follow-up|7
7120195|NCT02607865|11257417|FG003|Overall Study|Lost to Follow-up|5
7120196|NCT02607865|11257414|FG000|Overall Study|Withdrawal by Subject|18
7120197|NCT02607865|11257415|FG001|Overall Study|Withdrawal by Subject|18
7120198|NCT02607865|11257416|FG002|Overall Study|Withdrawal by Subject|17
7120199|NCT02607865|11257417|FG003|Overall Study|Withdrawal by Subject|8
7120200|NCT02607865|11257414|FG000|Overall Study|Death|5
7120201|NCT02607865|11257415|FG001|Overall Study|Death|4
7120202|NCT02607865|11257416|FG002|Overall Study|Death|1
7120203|NCT02607865|11257417|FG003|Overall Study|Death|3
7120204|NCT02607865|11257414|FG000|Overall Study|Unclassified|1
7120205|NCT02607865|11257415|FG001|Overall Study|Unclassified|1
7120206|NCT02607865|11257416|FG002|Overall Study|Unclassified|2
7120207|NCT02607865|11257417|FG003|Overall Study|Unclassified|0
7120208|NCT02608099|11257429|FG000|Overall Study|Ablation procedure not initiated|3
7120209|NCT02608099|11257430|FG001|Overall Study|Ablation procedure not initiated|2
7120210|NCT02608450|11257460|FG000|Overall Study|Lost to Follow-up|39
7120211|NCT02608450|11257461|FG001|Overall Study|Lost to Follow-up|32
7120212|NCT02608450|11257460|FG000|Overall Study|Withdrawal by Subject|21
7120213|NCT02608450|11257461|FG001|Overall Study|Withdrawal by Subject|15
7120214|NCT02608450|11257460|FG000|Overall Study|Adverse Event|3
7120215|NCT02608450|11257461|FG001|Overall Study|Adverse Event|6
7120216|NCT02608450|11257460|FG000|Overall Study|Withdrawal by parent|2
7120217|NCT02608450|11257461|FG001|Overall Study|Withdrawal by parent|3
7120218|NCT02608450|11257460|FG000|Overall Study|Lack of Efficacy|0
7120219|NCT02608450|11257461|FG001|Overall Study|Lack of Efficacy|3
7120220|NCT02608450|11257460|FG000|Overall Study|Noncompliance with study drug|0
7120221|NCT02608450|11257461|FG001|Overall Study|Noncompliance with study drug|2
7120222|NCT02608450|11257460|FG000|Overall Study|Physician Decision|0
7120223|NCT02608450|11257461|FG001|Overall Study|Physician Decision|1
7120224|NCT02608450|11257460|FG000|Overall Study|Pregnancy|0
7120225|NCT02608450|11257461|FG001|Overall Study|Pregnancy|1
7120226|NCT02608450|11257460|FG000|Overall Study|Progressive disease|1
7120227|NCT02608450|11257461|FG001|Overall Study|Progressive disease|0
7120228|NCT02608450|11257460|FG000|Overall Study|Multiple reasons|0
7120229|NCT02608450|11257461|FG001|Overall Study|Multiple reasons|2
7120230|NCT02608476|11257483|FG000|Overall Study|Withdrawal by Subject|30
7120231|NCT02608476|11257484|FG001|Overall Study|Withdrawal by Subject|37
7120232|NCT02608476|11257483|FG000|Overall Study|Lost to Follow-up|24
7120233|NCT02608476|11257484|FG001|Overall Study|Lost to Follow-up|24
7120234|NCT02608476|11257483|FG000|Overall Study|Adverse Event|2
7120235|NCT02608476|11257484|FG001|Overall Study|Adverse Event|8
7120236|NCT02608476|11257483|FG000|Overall Study|Withdrawal by Parent/Guardian|5
7120237|NCT02608476|11257484|FG001|Overall Study|Withdrawal by Parent/Guardian|4
7120238|NCT02608476|11257483|FG000|Overall Study|Noncompliance with treatment|1
7120239|NCT02608476|11257484|FG001|Overall Study|Noncompliance with treatment|5
7120240|NCT02608476|11257483|FG000|Overall Study|Lack of Efficacy|3
7120241|NCT02608476|11257484|FG001|Overall Study|Lack of Efficacy|1
7120242|NCT02608476|11257483|FG000|Overall Study|Other|0
7120243|NCT02608476|11257484|FG001|Overall Study|Other|1
7120244|NCT02608476|11257483|FG000|Overall Study|Physician Decision|1
7120245|NCT02608476|11257484|FG001|Overall Study|Physician Decision|0
7120246|NCT02608476|11257483|FG000|Overall Study|Pregnancy|0
7120247|NCT02608476|11257484|FG001|Overall Study|Pregnancy|1
7120248|NCT02608476|11257483|FG000|Overall Study|Progressive disease|1
7120249|NCT02608476|11257484|FG001|Overall Study|Progressive disease|0
7120250|NCT02608879|11257502|FG000|Overall Study|Lost to Follow-up|1
7120251|NCT02608879|11257503|FG001|Overall Study|Lost to Follow-up|0
7120252|NCT02608879|11257504|FG002|Overall Study|Lost to Follow-up|0
7120253|NCT02608879|11257502|FG000|Overall Study|Did not meet continuation criteria|0
7120254|NCT02608879|11257503|FG001|Overall Study|Did not meet continuation criteria|0
7120255|NCT02608879|11257504|FG002|Overall Study|Did not meet continuation criteria|3
7120256|NCT02608892|11257514|FG000|Overall Study|Lost to Follow-up|1
7120257|NCT02608892|11257515|FG001|Overall Study|Lost to Follow-up|0
7120258|NCT02609178|11257542|FG000|First Crown|Withdrawal by Subject|0
7120259|NCT02609178|11257543|FG001|First Crown|Withdrawal by Subject|0
7120260|NCT02609178|11257544|FG002|First Crown|Withdrawal by Subject|1
7120261|NCT02609178|11257545|FG003|First Crown|Withdrawal by Subject|1
7120262|NCT02609178|11257546|FG004|First Crown|Withdrawal by Subject|0
7120263|NCT02609178|11257547|FG005|First Crown|Withdrawal by Subject|0
7120264|NCT02609399|11257569|FG000|Influenza Season 2015-2016|Lost to Follow-up|3
7120265|NCT02609399|11257570|FG001|Influenza Season 2015-2016|Lost to Follow-up|2
7120266|NCT02609399|11257569|FG000|Influenza Season 2016-2017|Lost to Follow-up|8
7120267|NCT02609399|11257570|FG001|Influenza Season 2016-2017|Lost to Follow-up|5
7120268|NCT02609399|11257569|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1
7120269|NCT02609399|11257570|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0
7120270|NCT02609607|11257580|FG000|Overall Study|Lost to Follow-up|0
7120271|NCT02609607|11257581|FG001|Overall Study|Lost to Follow-up|1
7120272|NCT02609633|11257589|FG000|Overall Study|Consent Withdrawn|0
7120273|NCT02609633|11257590|FG001|Overall Study|Consent Withdrawn|1
7120274|NCT02609633|11257589|FG000|Overall Study|Protocol Deviation|1
7120275|NCT02609633|11257590|FG001|Overall Study|Protocol Deviation|0
7120276|NCT02609633|11257589|FG000|Overall Study|Non-Compliant with Study Procedures|2
7120277|NCT02609633|11257590|FG001|Overall Study|Non-Compliant with Study Procedures|0
7120278|NCT02609633|11257589|FG000|Overall Study|Reason not Specified|2
7120279|NCT02609633|11257590|FG001|Overall Study|Reason not Specified|1
7120280|NCT02609659|11257597|FG000|Overall Study|Adverse Event|1
7120281|NCT02609659|11257597|FG000|Overall Study|Lost to Follow-up|6
7120282|NCT02609659|11257597|FG000|Overall Study|Other|1
7120283|NCT02609672|11257603|FG000|Overall Study|Lost to Follow-up|3
7120284|NCT02609672|11257604|FG001|Overall Study|Lost to Follow-up|1
7120285|NCT02609984|11257620|FG000|Overall Study|Death|29
7120286|NCT02609984|11257621|FG001|Overall Study|Death|26
7120287|NCT02609984|11257620|FG000|Overall Study|Participation Discontinued by Sponsor|12
7120288|NCT02609984|11257621|FG001|Overall Study|Participation Discontinued by Sponsor|10
7120289|NCT02609984|11257620|FG000|Overall Study|Lost to Follow-up|1
7120290|NCT02609984|11257621|FG001|Overall Study|Lost to Follow-up|2
7120291|NCT02609984|11257620|FG000|Overall Study|Withdrawal by Subject|0
7120292|NCT02609984|11257621|FG001|Overall Study|Withdrawal by Subject|1
7120293|NCT02609984|11257620|FG000|Overall Study|Disease Progression|2
7120294|NCT02609984|11257621|FG001|Overall Study|Disease Progression|0
7120295|NCT02610140|11257629|FG000|Randomization and Treatment Period|Radiological progression|23
7120296|NCT02610140|11257630|FG001|Randomization and Treatment Period|Radiological progression|15
7120297|NCT02610140|11257629|FG000|Randomization and Treatment Period|Progressive disease - radiological|54
7120298|NCT02610140|11257630|FG001|Randomization and Treatment Period|Progressive disease - radiological|23
7120299|NCT02610140|11257629|FG000|Randomization and Treatment Period|Protocol Violation|1
7120300|NCT02610140|11257630|FG001|Randomization and Treatment Period|Protocol Violation|0
7120301|NCT02610140|11257629|FG000|Randomization and Treatment Period|Physician Decision|0
7120302|NCT02610140|11257630|FG001|Randomization and Treatment Period|Physician Decision|1
7120303|NCT02610140|11257629|FG000|Randomization and Treatment Period|Lack of Efficacy|1
7120304|NCT02610140|11257630|FG001|Randomization and Treatment Period|Lack of Efficacy|0
7120305|NCT02610140|11257629|FG000|Randomization and Treatment Period|Death|7
7120306|NCT02610140|11257630|FG001|Randomization and Treatment Period|Death|1
7120307|NCT02610140|11257629|FG000|Randomization and Treatment Period|Withdrawal by Subject|12
7120308|NCT02610140|11257630|FG001|Randomization and Treatment Period|Withdrawal by Subject|12
7120309|NCT02610140|11257629|FG000|Randomization and Treatment Period|Adverse Event|44
7120310|NCT02610140|11257630|FG001|Randomization and Treatment Period|Adverse Event|13
7120311|NCT02610140|11257629|FG000|Randomization and Treatment Period|Progressive disease - clinical|12
7120312|NCT02610140|11257630|FG001|Randomization and Treatment Period|Progressive disease - clinical|5
7120313|NCT02610140|11257629|FG000|Randomization and Treatment Period|Ongoing but not completed|9
7120314|NCT02610140|11257630|FG001|Randomization and Treatment Period|Ongoing but not completed|2
7120315|NCT02610140|11257629|FG000|Randomization and Treatment Period|Not treated|3
7120316|NCT02610140|11257630|FG001|Randomization and Treatment Period|Not treated|10
7120317|NCT02610140|11257629|FG000|Safety Follow-up|Other|0
7120318|NCT02610140|11257630|FG001|Safety Follow-up|Other|2
7120319|NCT02610140|11257629|FG000|Safety Follow-up|Lost to Follow-up|1
7120320|NCT02610140|11257630|FG001|Safety Follow-up|Lost to Follow-up|0
7120321|NCT02610140|11257629|FG000|Safety Follow-up|No follow-up|5
7120322|NCT02610140|11257630|FG001|Safety Follow-up|No follow-up|3
7120323|NCT02610140|11257629|FG000|Safety Follow-up|Death|12
7120324|NCT02610140|11257630|FG001|Safety Follow-up|Death|2
7120325|NCT02610140|11257629|FG000|Safety Follow-up|Deterioration of general conditions|15
7120326|NCT02610140|11257630|FG001|Safety Follow-up|Deterioration of general conditions|5
7120327|NCT02610140|11257629|FG000|Safety Follow-up|Withdrawal by Subject|12
7120328|NCT02610140|11257630|FG001|Safety Follow-up|Withdrawal by Subject|12
7120329|NCT02610140|11257629|FG000|Active Follow-up|Progressive disease - radiological|30
7120330|NCT02610140|11257630|FG001|Active Follow-up|Progressive disease - radiological|22
7120331|NCT02610140|11257629|FG000|Active Follow-up|Death|8
7120332|NCT02610140|11257630|FG001|Active Follow-up|Death|1
7120333|NCT02610140|11257629|FG000|Active Follow-up|Withdrawal by Subject|4
7120334|NCT02610140|11257630|FG001|Active Follow-up|Withdrawal by Subject|0
7120335|NCT02610140|11257629|FG000|Active Follow-up|Progressive disease - clinical|1
7120336|NCT02610140|11257630|FG001|Active Follow-up|Progressive disease - clinical|2
7120337|NCT02610140|11257629|FG000|Active Follow-up|Deterioration of general conditions|1
7120338|NCT02610140|11257630|FG001|Active Follow-up|Deterioration of general conditions|0
7120339|NCT02610140|11257629|FG000|Active Follow-up|Ongoing but not completed|4
7120340|NCT02610140|11257630|FG001|Active Follow-up|Ongoing but not completed|1
7120341|NCT02610140|11257629|FG000|Long-term Follow-up|Death|86
7120342|NCT02610140|11257630|FG001|Long-term Follow-up|Death|44
7120343|NCT02610140|11257629|FG000|Long-term Follow-up|Withdrawal by Subject|6
7120344|NCT02610140|11257630|FG001|Long-term Follow-up|Withdrawal by Subject|3
7120345|NCT02610140|11257629|FG000|Long-term Follow-up|Lost to Follow-up|1
7120346|NCT02610140|11257630|FG001|Long-term Follow-up|Lost to Follow-up|2
7120347|NCT02610140|11257629|FG000|Long-term Follow-up|Ongoing but not completed|30
7120348|NCT02610140|11257630|FG001|Long-term Follow-up|Ongoing but not completed|17
7120349|NCT02610192|11257636|FG000|Overall Study|Received other treatment|8
7120350|NCT02610192|11257636|FG000|Overall Study|Physician Decision|1
7120351|NCT02610231|11257640|FG000|Overall Study|Withdrawal by Subject|27
7120352|NCT02610231|11257640|FG000|Overall Study|Adverse Event|20
7120353|NCT02610231|11257640|FG000|Overall Study|Death|5
7120354|NCT02610231|11257640|FG000|Overall Study|Surgery|2
7120355|NCT02610231|11257640|FG000|Overall Study|Physician Decision|1
7120356|NCT02610231|11257640|FG000|Overall Study|Non Compliance|2
7120357|NCT02610231|11257640|FG000|Overall Study|Other|3
7120358|NCT02610725|11257656|FG000|Overall Study|Lost to Follow-up|197
7120359|NCT02610725|11257656|FG000|Overall Study|self-reported contraindication|9
7120360|NCT02610816|11257662|FG000|Phase 1|Withdrawal by Subject|2
7120361|NCT02610816|11257663|FG001|Phase 1|Withdrawal by Subject|6
7120362|NCT02610816|11257664|FG002|Phase 1|Withdrawal by Subject|0
7120363|NCT02610816|11257665|FG003|Phase 1|Withdrawal by Subject|0
7120364|NCT02610816|11257662|FG000|Phase 1|Lost to Follow-up|2
7120365|NCT02610816|11257663|FG001|Phase 1|Lost to Follow-up|1
7120366|NCT02610816|11257664|FG002|Phase 1|Lost to Follow-up|0
7120367|NCT02610816|11257665|FG003|Phase 1|Lost to Follow-up|0
7120368|NCT02610816|11257662|FG000|Phase 1|Physician Decision|0
7120369|NCT02610816|11257663|FG001|Phase 1|Physician Decision|1
7120370|NCT02610816|11257664|FG002|Phase 1|Physician Decision|0
7120371|NCT02610816|11257665|FG003|Phase 1|Physician Decision|0
7120372|NCT02610816|11257662|FG000|Phase 2|Withdrawal by Subject|0
7120373|NCT02610816|11257663|FG001|Phase 2|Withdrawal by Subject|0
7120374|NCT02610816|11257664|FG002|Phase 2|Withdrawal by Subject|9
7120375|NCT02610816|11257665|FG003|Phase 2|Withdrawal by Subject|3
7120376|NCT02610816|11257662|FG000|Phase 2|Lost to Follow-up|0
7120377|NCT02610816|11257663|FG001|Phase 2|Lost to Follow-up|0
7120378|NCT02610816|11257664|FG002|Phase 2|Lost to Follow-up|2
7120379|NCT02610816|11257665|FG003|Phase 2|Lost to Follow-up|0
7120380|NCT02610816|11257662|FG000|Phase 2|Physician Decision|0
7120381|NCT02610816|11257663|FG001|Phase 2|Physician Decision|0
7120382|NCT02610816|11257664|FG002|Phase 2|Physician Decision|0
7120383|NCT02610816|11257665|FG003|Phase 2|Physician Decision|2
7120384|NCT02610816|11257662|FG000|Phase 2|Pregnancy|0
7120385|NCT02610816|11257663|FG001|Phase 2|Pregnancy|0
7120386|NCT02610816|11257664|FG002|Phase 2|Pregnancy|0
7120387|NCT02610816|11257665|FG003|Phase 2|Pregnancy|1
7120388|NCT02610842|11257675|FG000|Overall Study|Lost to Follow-up|5
7120389|NCT02611362|11257731|FG000|Overall Study|Withdrawal by Subject|7
7120390|NCT02611362|11257732|FG001|Overall Study|Withdrawal by Subject|2
7120391|NCT02611362|11257731|FG000|Overall Study|Lost to Follow-up|2
7120392|NCT02611362|11257732|FG001|Overall Study|Lost to Follow-up|4
7120393|NCT02611479|11257739|FG000|Baseline Enrollment|Exited study|13
7120394|NCT02611479|11257739|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2
7120395|NCT02611479|11257739|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18
7120396|NCT02611479|11257739|FG000|Data Cleaning|No baseline function or pain metrics|2
7120397|NCT02611752|11257745|FG000|Overall Study|Adverse Event|0
7120398|NCT02611752|11257746|FG001|Overall Study|Adverse Event|1
7120399|NCT02611778|11257776|FG000|Overall Study|Withdrawal by Subject|2
7120400|NCT02611778|11257777|FG001|Overall Study|Withdrawal by Subject|8
7120401|NCT02611778|11257776|FG000|Overall Study|Adverse Event|1
7120402|NCT02611778|11257777|FG001|Overall Study|Adverse Event|2
7120403|NCT02611778|11257776|FG000|Overall Study|Death|2
7120404|NCT02611778|11257777|FG001|Overall Study|Death|1
7120405|NCT02611778|11257776|FG000|Overall Study|Protocol Violation|1
7120406|NCT02611778|11257777|FG001|Overall Study|Protocol Violation|0
7120407|NCT02611778|11257776|FG000|Overall Study|Lost to Follow-up|3
7120408|NCT02611778|11257777|FG001|Overall Study|Lost to Follow-up|1
7120409|NCT02611778|11257776|FG000|Overall Study|Need for alternative treatment|1
7120410|NCT02611778|11257777|FG001|Overall Study|Need for alternative treatment|0
7120411|NCT02611778|11257776|FG000|Overall Study|Other Reason|2
7120412|NCT02611778|11257777|FG001|Overall Study|Other Reason|1
7120413|NCT02611882|11257787|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33
7120414|NCT02611882|11257788|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0
7120415|NCT02611882|11257789|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0
7120416|NCT02612064|11257798|FG000|Overall Study|Withdrawal by Subject|1
7120417|NCT02612064|11257799|FG001|Overall Study|Withdrawal by Subject|1
7120418|NCT02612064|11257798|FG000|Overall Study|Other|0
7120419|NCT02612064|11257799|FG001|Overall Study|Other|2
7120420|NCT02612077|11257805|FG000|Overall Study|Adverse Event|3
7120421|NCT02612077|11257805|FG000|Overall Study|Withdrawal by Subject|9
7120422|NCT02612077|11257805|FG000|Overall Study|Protocol Violation|28
7120423|NCT02612077|11257805|FG000|Overall Study|Lost to Follow-up|20
7120424|NCT02612077|11257805|FG000|Overall Study|Death|377
7120425|NCT02612077|11257805|FG000|Overall Study|Moved or Changed Medical Team|23
7120426|NCT02612077|11257805|FG000|Overall Study|Enrollment in a Clinical Trial|1
7120427|NCT02612077|11257805|FG000|Overall Study|Disease Progression|3
7120428|NCT02612077|11257805|FG000|Overall Study|Unknown reason|2
7120429|NCT02612155|11257814|FG000|Overall Study|Death|1
7120430|NCT02612155|11257815|FG001|Overall Study|Death|1
7120431|NCT02612155|11257814|FG000|Overall Study|Lost to Follow-up|2
7120432|NCT02612155|11257815|FG001|Overall Study|Lost to Follow-up|2
7120433|NCT02612428|11257823|FG000|VTL-308|Death|14
7120434|NCT02612428|11257824|FG001|VTL-308|Death|16
7120435|NCT02612428|11257823|FG000|VTL-308|Withdrawal by Subject|0
7120436|NCT02612428|11257824|FG001|VTL-308|Withdrawal by Subject|1
7120437|NCT02612428|11257823|FG000|VTL-308E|Death|9
7120438|NCT02612428|11257824|FG001|VTL-308E|Death|7
7120439|NCT02612428|11257823|FG000|VTL-308E|Lost to Follow-up|2
7120440|NCT02612428|11257824|FG001|VTL-308E|Lost to Follow-up|0
7120441|NCT02612610|11257834|FG000|Overall Study|Withdrawal by Subject|1
7120442|NCT02612610|11257835|FG001|Overall Study|Withdrawal by Subject|1
7120443|NCT02612610|11257836|FG002|Overall Study|Withdrawal by Subject|0
7120444|NCT02612610|11257837|FG003|Overall Study|Withdrawal by Subject|2
7120445|NCT02612610|11257834|FG000|Overall Study|Adverse Event|2
7120446|NCT02612610|11257835|FG001|Overall Study|Adverse Event|2
7120447|NCT02612610|11257836|FG002|Overall Study|Adverse Event|3
7120448|NCT02612610|11257837|FG003|Overall Study|Adverse Event|10
7120449|NCT02612610|11257834|FG000|Overall Study|Lost to Follow-up|0
7120450|NCT02612610|11257835|FG001|Overall Study|Lost to Follow-up|1
7120451|NCT02612610|11257836|FG002|Overall Study|Lost to Follow-up|0
7120452|NCT02612610|11257837|FG003|Overall Study|Lost to Follow-up|0
7120453|NCT02612610|11257834|FG000|Overall Study|Protocol Violation|0
7120454|NCT02612610|11257835|FG001|Overall Study|Protocol Violation|1
7120455|NCT02612610|11257836|FG002|Overall Study|Protocol Violation|1
7120456|NCT02612610|11257837|FG003|Overall Study|Protocol Violation|0
7120457|NCT02612610|11257834|FG000|Overall Study|Lack of Efficacy|1
7120458|NCT02612610|11257835|FG001|Overall Study|Lack of Efficacy|2
7120459|NCT02612610|11257836|FG002|Overall Study|Lack of Efficacy|0
7120460|NCT02612610|11257837|FG003|Overall Study|Lack of Efficacy|1
7120461|NCT02612610|11257834|FG000|Overall Study|Physician Decision|0
7120462|NCT02612610|11257835|FG001|Overall Study|Physician Decision|1
7120463|NCT02612610|11257836|FG002|Overall Study|Physician Decision|0
7120464|NCT02612610|11257837|FG003|Overall Study|Physician Decision|0
7120465|NCT02612610|11257834|FG000|Overall Study|Noncompliance|1
7120466|NCT02612610|11257835|FG001|Overall Study|Noncompliance|0
7120467|NCT02612610|11257836|FG002|Overall Study|Noncompliance|0
7120468|NCT02612610|11257837|FG003|Overall Study|Noncompliance|0
7120469|NCT02612610|11257834|FG000|Overall Study|Cough Improvement|0
7120470|NCT02612610|11257835|FG001|Overall Study|Cough Improvement|0
7120471|NCT02612610|11257836|FG002|Overall Study|Cough Improvement|1
7120472|NCT02612610|11257837|FG003|Overall Study|Cough Improvement|0
7120473|NCT02612623|11257851|FG000|Overall Study|Withdrawal by Subject|0
7120474|NCT02612623|11257852|FG001|Overall Study|Withdrawal by Subject|1
7120475|NCT02612623|11257853|FG002|Overall Study|Withdrawal by Subject|0
7120476|NCT02612623|11257854|FG003|Overall Study|Withdrawal by Subject|0
7120477|NCT02612623|11257851|FG000|Overall Study|Adverse Event|1
7120478|NCT02612623|11257852|FG001|Overall Study|Adverse Event|0
7120479|NCT02612623|11257853|FG002|Overall Study|Adverse Event|1
7120480|NCT02612623|11257854|FG003|Overall Study|Adverse Event|0
7120481|NCT02612727|11257877|FG000|Overall Study|Parent request|4
7120482|NCT02612727|11257878|FG001|Overall Study|Parent request|1
7120483|NCT02612727|11257877|FG000|Overall Study|Needed treatment incompatible with PT|1
7120484|NCT02612727|11257878|FG001|Overall Study|Needed treatment incompatible with PT|1
7120485|NCT02612727|11257877|FG000|Overall Study|Direct hyperbilirubinemia|0
7120486|NCT02612727|11257878|FG001|Overall Study|Direct hyperbilirubinemia|2
7120487|NCT02612779|11257886|FG000|Overall Study|Administrative reason by sponsor|4
7120488|NCT02612779|11257887|FG001|Overall Study|Administrative reason by sponsor|1
7120489|NCT02612779|11257886|FG000|Overall Study|No longer meet study criteria|0
7120490|NCT02612779|11257887|FG001|Overall Study|No longer meet study criteria|1
7120491|NCT02612779|11257886|FG000|Overall Study|Disease progression|29
7120492|NCT02612779|11257887|FG001|Overall Study|Disease progression|2
7120493|NCT02612779|11257886|FG000|Overall Study|Study drug toxicity|10
7120494|NCT02612779|11257887|FG001|Overall Study|Study drug toxicity|1
7120495|NCT02612779|11257886|FG000|Overall Study|Death|1
7120496|NCT02612779|11257887|FG001|Overall Study|Death|0
7120497|NCT02612779|11257886|FG000|Overall Study|Adverse event unrelated to study drug|5
7120498|NCT02612779|11257887|FG001|Overall Study|Adverse event unrelated to study drug|0
7120499|NCT02612779|11257886|FG000|Overall Study|Participant withdrew consent|4
7120500|NCT02612779|11257887|FG001|Overall Study|Participant withdrew consent|0
7120501|NCT02612779|11257886|FG000|Overall Study|Lost to Follow-up|1
7120502|NCT02612779|11257887|FG001|Overall Study|Lost to Follow-up|0
7120503|NCT02612779|11257886|FG000|Overall Study|Maximum clinical benefit|10
7120504|NCT02612779|11257887|FG001|Overall Study|Maximum clinical benefit|1
7120505|NCT02612779|11257886|FG000|Overall Study|Other reasons|4
7120506|NCT02612779|11257887|FG001|Overall Study|Other reasons|0
7120507|NCT02612909|11257912|FG000|Phase 2|Withdrawal by Subject|2
7120508|NCT02612909|11257913|FG001|Phase 2|Withdrawal by Subject|5
7120509|NCT02612909|11257914|FG002|Phase 2|Withdrawal by Subject|0
7120510|NCT02612909|11257915|FG003|Phase 2|Withdrawal by Subject|0
7120511|NCT02612909|11257916|FG004|Phase 2|Withdrawal by Subject|0
7120512|NCT02612909|11257912|FG000|Phase 2|Pregnancy|0
7120513|NCT02612909|11257913|FG001|Phase 2|Pregnancy|0
7120514|NCT02612909|11257914|FG002|Phase 2|Pregnancy|1
7120515|NCT02612909|11257915|FG003|Phase 2|Pregnancy|0
7120516|NCT02612909|11257916|FG004|Phase 2|Pregnancy|0
7120517|NCT02612909|11257912|FG000|Phase 3|Withdrawal by Subject|0
7120518|NCT02612909|11257913|FG001|Phase 3|Withdrawal by Subject|0
7120519|NCT02612909|11257914|FG002|Phase 3|Withdrawal by Subject|0
7120520|NCT02612909|11257915|FG003|Phase 3|Withdrawal by Subject|1
7120521|NCT02612909|11257916|FG004|Phase 3|Withdrawal by Subject|0
7120522|NCT02613169|11257941|FG000|Overall Study|Withdrawal by Subject|4
7120523|NCT02613169|11257942|FG001|Overall Study|Withdrawal by Subject|1
7120524|NCT02613169|11257941|FG000|Overall Study|Lost to Follow-up|0
7120525|NCT02613169|11257942|FG001|Overall Study|Lost to Follow-up|5
7120526|NCT02613169|11257941|FG000|Overall Study|HIV|0
7120527|NCT02613169|11257942|FG001|Overall Study|HIV|2
7120528|NCT02613169|11257941|FG000|Overall Study|No TB infection endpoint|14
7120529|NCT02613169|11257942|FG001|Overall Study|No TB infection endpoint|9
7120530|NCT02613182|11257948|FG000|Overall Study|Death|6
7120531|NCT02613182|11257948|FG000|Overall Study|Physician Decision|1
7120532|NCT02613182|11257948|FG000|Overall Study|Study Terminated by Sponsor|21
7120533|NCT02613182|11257948|FG000|Overall Study|Withdrawal by Subject|6
7120534|NCT02613208|11257952|FG000|Overall Study|Withdrawal by Subject|1
7120535|NCT02613208|11257952|FG000|Overall Study|Change of address|2
7120536|NCT02613208|11257952|FG000|Overall Study|Physician Decision|2
7120537|NCT02613208|11257952|FG000|Overall Study|Lost to Follow-up|5
7120538|NCT02613208|11257952|FG000|Overall Study|Death|37
7120539|NCT02613221|11257956|FG000|Overall Study|Lack of efficacy (exacerbation)|50
7120540|NCT02613221|11257956|FG000|Overall Study|Adverse Event|2
7120541|NCT02613221|11257956|FG000|Overall Study|Voluntary Discontinuation|1
7120542|NCT02613221|11257956|FG000|Overall Study|Delayed Treatment|1
7120543|NCT02613221|11257956|FG000|Overall Study|Enrolled but Not Treated|1
7120544|NCT02613364|11257967|FG000|Overall Study|Other|19
7120545|NCT02613364|11257968|FG001|Overall Study|Other|29
7120546|NCT02613364|11257969|FG002|Overall Study|Other|17
7120547|NCT02613364|11257967|FG000|Overall Study|Too time consuming|21
7120548|NCT02613364|11257968|FG001|Overall Study|Too time consuming|26
7120549|NCT02613364|11257969|FG002|Overall Study|Too time consuming|26
7120550|NCT02613364|11257967|FG000|Overall Study|Withdrawal by Subject|13
7120551|NCT02613364|11257968|FG001|Overall Study|Withdrawal by Subject|18
7120552|NCT02613364|11257969|FG002|Overall Study|Withdrawal by Subject|17
7120553|NCT02613364|11257967|FG000|Overall Study|Medical|12
7120554|NCT02613364|11257968|FG001|Overall Study|Medical|13
7120555|NCT02613364|11257969|FG002|Overall Study|Medical|9
7120556|NCT02613364|11257967|FG000|Overall Study|Disliked Study Procedure|1
7120557|NCT02613364|11257968|FG001|Overall Study|Disliked Study Procedure|1
7120558|NCT02613364|11257969|FG002|Overall Study|Disliked Study Procedure|4
7120559|NCT02613364|11257967|FG000|Overall Study|Disliked Intervention|0
7120560|NCT02613364|11257968|FG001|Overall Study|Disliked Intervention|3
7120561|NCT02613364|11257969|FG002|Overall Study|Disliked Intervention|3
7120562|NCT02613403|11257981|FG000|Overall Study|Lost to Follow-up|0
7120563|NCT02613403|11257982|FG001|Overall Study|Lost to Follow-up|1
7120564|NCT02613403|11257983|FG002|Overall Study|Lost to Follow-up|0
7120565|NCT02613403|11257984|FG003|Overall Study|Lost to Follow-up|0
7120566|NCT02613403|11257985|FG004|Overall Study|Lost to Follow-up|0
7120567|NCT02613403|11257981|FG000|Overall Study|Withdrawal by Subject|2
7120568|NCT02613403|11257982|FG001|Overall Study|Withdrawal by Subject|0
7120569|NCT02613403|11257983|FG002|Overall Study|Withdrawal by Subject|0
7120570|NCT02613403|11257984|FG003|Overall Study|Withdrawal by Subject|0
7120571|NCT02613403|11257985|FG004|Overall Study|Withdrawal by Subject|0
7120572|NCT02613481|11257995|FG000|Overall Study|Lost to Follow-up|7
7120573|NCT02613481|11257995|FG000|Overall Study|Withdrawal by Subject|2
7120574|NCT02613572|11258002|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1
7120575|NCT02613572|11258003|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0
7120576|NCT02613572|11258004|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0
7120577|NCT02613572|11258002|FG000|Phase II: Double-Blind Rand Plac Control|Death|0
7120578|NCT02613572|11258003|FG001|Phase II: Double-Blind Rand Plac Control|Death|1
7120579|NCT02613572|11258004|FG002|Phase II: Double-Blind Rand Plac Control|Death|0
7120580|NCT02613871|11258016|FG000|Overall Study|Death|2
7120581|NCT02613871|11258016|FG000|Overall Study|Withdrew Consent|1
7120582|NCT02613884|11258020|FG000|Overall Study|Death|1
7120583|NCT02613884|11258020|FG000|Overall Study|Lost to Follow-up|1
7120584|NCT02613910|11258039|FG000|Overall Study|Termination of study|1
7120585|NCT02614079|11258043|FG000|Overall Study|Withdrawal by Subject|1
7120586|NCT02614131|11258054|FG000|Overall Study|Withdrawal by Subject|1
7120587|NCT02614131|11258055|FG001|Overall Study|Withdrawal by Subject|0
7120588|NCT02614131|11258056|FG002|Overall Study|Withdrawal by Subject|0
7120589|NCT02614131|11258057|FG003|Overall Study|Withdrawal by Subject|0
7120590|NCT02614131|11258058|FG004|Overall Study|Withdrawal by Subject|0
7120591|NCT02614131|11258059|FG005|Overall Study|Withdrawal by Subject|0
7120592|NCT02614131|11258060|FG006|Overall Study|Withdrawal by Subject|0
7120593|NCT02614131|11258054|FG000|Overall Study|Adverse Event|0
7120594|NCT02614131|11258055|FG001|Overall Study|Adverse Event|0
7120595|NCT02614131|11258056|FG002|Overall Study|Adverse Event|0
7120596|NCT02614131|11258057|FG003|Overall Study|Adverse Event|0
7120597|NCT02614131|11258058|FG004|Overall Study|Adverse Event|0
7120598|NCT02614131|11258059|FG005|Overall Study|Adverse Event|0
7120599|NCT02614131|11258060|FG006|Overall Study|Adverse Event|1
7120600|NCT02614183|11258085|FG000|Double Blind Treatment Phase|Adverse Event|10
7120601|NCT02614183|11258086|FG001|Double Blind Treatment Phase|Adverse Event|9
7120602|NCT02614183|11258087|FG002|Double Blind Treatment Phase|Adverse Event|7
7120603|NCT02614183|11258085|FG000|Double Blind Treatment Phase|Lack of Efficacy|10
7120604|NCT02614183|11258086|FG001|Double Blind Treatment Phase|Lack of Efficacy|1
7120605|NCT02614183|11258087|FG002|Double Blind Treatment Phase|Lack of Efficacy|2
7120606|NCT02614183|11258085|FG000|Double Blind Treatment Phase|Lost to Follow-up|18
7120607|NCT02614183|11258086|FG001|Double Blind Treatment Phase|Lost to Follow-up|9
7120608|NCT02614183|11258087|FG002|Double Blind Treatment Phase|Lost to Follow-up|5
7120609|NCT02614183|11258085|FG000|Double Blind Treatment Phase|Physician Decision|7
7120610|NCT02614183|11258086|FG001|Double Blind Treatment Phase|Physician Decision|3
7120611|NCT02614183|11258087|FG002|Double Blind Treatment Phase|Physician Decision|2
7120612|NCT02614183|11258085|FG000|Double Blind Treatment Phase|Pregnancy|2
7120613|NCT02614183|11258086|FG001|Double Blind Treatment Phase|Pregnancy|1
7120614|NCT02614183|11258087|FG002|Double Blind Treatment Phase|Pregnancy|3
7120615|NCT02614183|11258085|FG000|Double Blind Treatment Phase|Protocol Violation|2
7120616|NCT02614183|11258086|FG001|Double Blind Treatment Phase|Protocol Violation|2
7120617|NCT02614183|11258087|FG002|Double Blind Treatment Phase|Protocol Violation|2
7120618|NCT02614183|11258085|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33
7120619|NCT02614183|11258086|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11
7120620|NCT02614183|11258087|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16
7120621|NCT02614183|11258085|FG000|Double Blind Treatment Phase|Did not receive study drug|1
7120622|NCT02614183|11258086|FG001|Double Blind Treatment Phase|Did not receive study drug|1
7120623|NCT02614183|11258087|FG002|Double Blind Treatment Phase|Did not receive study drug|2
7120624|NCT02614183|11258085|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5
7120625|NCT02614183|11258086|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3
7120626|NCT02614183|11258087|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5
7120627|NCT02614183|11258085|FG000|Post Treatment Follow-up Phase|Physician Decision|5
7120628|NCT02614183|11258086|FG001|Post Treatment Follow-up Phase|Physician Decision|1
7120629|NCT02614183|11258087|FG002|Post Treatment Follow-up Phase|Physician Decision|2
7120630|NCT02614183|11258085|FG000|Post Treatment Follow-up Phase|Protocol Violation|1
7120631|NCT02614183|11258086|FG001|Post Treatment Follow-up Phase|Protocol Violation|0
7120632|NCT02614183|11258087|FG002|Post Treatment Follow-up Phase|Protocol Violation|0
7120633|NCT02614183|11258085|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7
7120634|NCT02614183|11258086|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2
7120635|NCT02614183|11258087|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5
7120636|NCT02614196|11258107|FG000|Double Blind Treatment Phase|Adverse Event|8
7120637|NCT02614196|11258108|FG001|Double Blind Treatment Phase|Adverse Event|5
7120638|NCT02614196|11258109|FG002|Double Blind Treatment Phase|Adverse Event|9
7120639|NCT02614196|11258110|FG003|Double Blind Treatment Phase|Adverse Event|0
7120640|NCT02614196|11258111|FG004|Double Blind Treatment Phase|Adverse Event|0
7120641|NCT02614196|11258112|FG005|Double Blind Treatment Phase|Adverse Event|0
7120642|NCT02614196|11258107|FG000|Double Blind Treatment Phase|Lack of Efficacy|6
7120643|NCT02614196|11258108|FG001|Double Blind Treatment Phase|Lack of Efficacy|1
7120644|NCT02614196|11258109|FG002|Double Blind Treatment Phase|Lack of Efficacy|1
7120645|NCT02614196|11258110|FG003|Double Blind Treatment Phase|Lack of Efficacy|0
7120646|NCT02614196|11258111|FG004|Double Blind Treatment Phase|Lack of Efficacy|0
7120647|NCT02614196|11258112|FG005|Double Blind Treatment Phase|Lack of Efficacy|0
7120648|NCT02614196|11258107|FG000|Double Blind Treatment Phase|Lost to Follow-up|10
7120649|NCT02614196|11258108|FG001|Double Blind Treatment Phase|Lost to Follow-up|7
7120650|NCT02614196|11258109|FG002|Double Blind Treatment Phase|Lost to Follow-up|1
7120651|NCT02614196|11258110|FG003|Double Blind Treatment Phase|Lost to Follow-up|0
7120652|NCT02614196|11258111|FG004|Double Blind Treatment Phase|Lost to Follow-up|0
7120653|NCT02614196|11258112|FG005|Double Blind Treatment Phase|Lost to Follow-up|0
7120654|NCT02614196|11258107|FG000|Double Blind Treatment Phase|Physician Decision|4
7120655|NCT02614196|11258108|FG001|Double Blind Treatment Phase|Physician Decision|0
7120656|NCT02614196|11258109|FG002|Double Blind Treatment Phase|Physician Decision|2
7120657|NCT02614196|11258110|FG003|Double Blind Treatment Phase|Physician Decision|0
7120658|NCT02614196|11258111|FG004|Double Blind Treatment Phase|Physician Decision|0
7120659|NCT02614196|11258112|FG005|Double Blind Treatment Phase|Physician Decision|0
7120660|NCT02614196|11258107|FG000|Double Blind Treatment Phase|Pregnancy|1
7120661|NCT02614196|11258108|FG001|Double Blind Treatment Phase|Pregnancy|2
7120662|NCT02614196|11258109|FG002|Double Blind Treatment Phase|Pregnancy|0
7120663|NCT02614196|11258110|FG003|Double Blind Treatment Phase|Pregnancy|0
7120664|NCT02614196|11258111|FG004|Double Blind Treatment Phase|Pregnancy|0
7120665|NCT02614196|11258112|FG005|Double Blind Treatment Phase|Pregnancy|0
7120666|NCT02614196|11258107|FG000|Double Blind Treatment Phase|Protocol Violation|5
7120667|NCT02614196|11258108|FG001|Double Blind Treatment Phase|Protocol Violation|2
7120668|NCT02614196|11258109|FG002|Double Blind Treatment Phase|Protocol Violation|1
7120669|NCT02614196|11258110|FG003|Double Blind Treatment Phase|Protocol Violation|0
7120670|NCT02614196|11258111|FG004|Double Blind Treatment Phase|Protocol Violation|1
7120671|NCT02614196|11258112|FG005|Double Blind Treatment Phase|Protocol Violation|0
7120672|NCT02614196|11258107|FG000|Double Blind Treatment Phase|Terminated by sponsor|1
7120673|NCT02614196|11258108|FG001|Double Blind Treatment Phase|Terminated by sponsor|0
7120674|NCT02614196|11258109|FG002|Double Blind Treatment Phase|Terminated by sponsor|0
7120675|NCT02614196|11258110|FG003|Double Blind Treatment Phase|Terminated by sponsor|0
7120676|NCT02614196|11258111|FG004|Double Blind Treatment Phase|Terminated by sponsor|0
7120677|NCT02614196|11258112|FG005|Double Blind Treatment Phase|Terminated by sponsor|0
7120678|NCT02614196|11258107|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39
7120679|NCT02614196|11258108|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11
7120680|NCT02614196|11258109|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14
7120681|NCT02614196|11258110|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4
7120682|NCT02614196|11258111|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0
7120683|NCT02614196|11258112|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0
7120684|NCT02614196|11258107|FG000|Double Blind Treatment Phase|Did not receive study drug|2
7120685|NCT02614196|11258108|FG001|Double Blind Treatment Phase|Did not receive study drug|2
7120686|NCT02614196|11258109|FG002|Double Blind Treatment Phase|Did not receive study drug|3
7120687|NCT02614196|11258110|FG003|Double Blind Treatment Phase|Did not receive study drug|0
7120688|NCT02614196|11258111|FG004|Double Blind Treatment Phase|Did not receive study drug|0
7120689|NCT02614196|11258112|FG005|Double Blind Treatment Phase|Did not receive study drug|0
7120690|NCT02614196|11258107|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8
7120691|NCT02614196|11258108|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3
7120692|NCT02614196|11258109|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3
7120693|NCT02614196|11258110|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0
7120694|NCT02614196|11258111|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1
7120695|NCT02614196|11258112|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0
7120696|NCT02614196|11258107|FG000|Post Treatment Follow-up Phase|Pregnancy|2
7120697|NCT02614196|11258108|FG001|Post Treatment Follow-up Phase|Pregnancy|0
7120698|NCT02614196|11258109|FG002|Post Treatment Follow-up Phase|Pregnancy|0
7120699|NCT02614196|11258110|FG003|Post Treatment Follow-up Phase|Pregnancy|0
7120700|NCT02614196|11258111|FG004|Post Treatment Follow-up Phase|Pregnancy|0
7120701|NCT02614196|11258112|FG005|Post Treatment Follow-up Phase|Pregnancy|0
7120702|NCT02614196|11258107|FG000|Post Treatment Follow-up Phase|Protocol Violation|0
7120703|NCT02614196|11258108|FG001|Post Treatment Follow-up Phase|Protocol Violation|1
7120704|NCT02614196|11258109|FG002|Post Treatment Follow-up Phase|Protocol Violation|0
7120705|NCT02614196|11258110|FG003|Post Treatment Follow-up Phase|Protocol Violation|0
7120706|NCT02614196|11258111|FG004|Post Treatment Follow-up Phase|Protocol Violation|1
7120707|NCT02614196|11258112|FG005|Post Treatment Follow-up Phase|Protocol Violation|0
7120708|NCT02614196|11258107|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10
7120709|NCT02614196|11258108|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1
7120710|NCT02614196|11258109|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5
7120711|NCT02614196|11258110|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1
7120712|NCT02614196|11258111|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0
7120713|NCT02614196|11258112|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0
7120714|NCT02614287|11258155|FG000|Open Label (OL) Treatment Phase|Adverse Event|7
7120715|NCT02614287|11258156|FG001|Open Label (OL) Treatment Phase|Adverse Event|6
7120716|NCT02614287|11258155|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13
7120717|NCT02614287|11258156|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5
7120718|NCT02614287|11258155|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7
7120719|NCT02614287|11258156|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4
7120720|NCT02614287|11258155|FG000|Open Label (OL) Treatment Phase|Physician Decision|1
7120721|NCT02614287|11258156|FG001|Open Label (OL) Treatment Phase|Physician Decision|0
7120722|NCT02614287|11258155|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10
7120723|NCT02614287|11258156|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7
7120724|NCT02614287|11258155|FG000|Post Treatment Follow-up Phase|Adverse Event|1
7120725|NCT02614287|11258156|FG001|Post Treatment Follow-up Phase|Adverse Event|0
7120726|NCT02614287|11258155|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2
7120727|NCT02614287|11258156|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2
7120728|NCT02614287|11258155|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6
7120729|NCT02614287|11258156|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3
7120730|NCT02614560|11258178|FG000|Overall Study|Death|6
7120731|NCT02614560|11258179|FG001|Overall Study|Death|2
7120732|NCT02614703|11258187|FG000|Overall Study|Withdrawal by Subject|7
7120733|NCT02614703|11258188|FG001|Overall Study|Withdrawal by Subject|1
7120734|NCT02614729|11258196|FG000|Overall Study|Withdrawal by Subject|1
7120735|NCT02614729|11258197|FG001|Overall Study|Withdrawal by Subject|0
7120736|NCT02615145|11258218|FG000|Overall Study|Did Not Start Treatment|0
7120737|NCT02615145|11258219|FG001|Overall Study|Did Not Start Treatment|0
7120738|NCT02615145|11258220|FG002|Overall Study|Did Not Start Treatment|1
7120739|NCT02615145|11258221|FG003|Overall Study|Did Not Start Treatment|1
7120740|NCT02615145|11258218|FG000|Overall Study|Failure to Return|20
7120741|NCT02615145|11258219|FG001|Overall Study|Failure to Return|10
7120742|NCT02615145|11258220|FG002|Overall Study|Failure to Return|7
7120743|NCT02615145|11258221|FG003|Overall Study|Failure to Return|0
7120744|NCT02615145|11258218|FG000|Overall Study|Death|2
7120745|NCT02615145|11258219|FG001|Overall Study|Death|3
7120746|NCT02615145|11258220|FG002|Overall Study|Death|0
7120747|NCT02615145|11258221|FG003|Overall Study|Death|0
7120748|NCT02615145|11258218|FG000|Overall Study|Other, Not Specified|5
7120749|NCT02615145|11258219|FG001|Overall Study|Other, Not Specified|2
7120750|NCT02615145|11258220|FG002|Overall Study|Other, Not Specified|0
7120751|NCT02615145|11258221|FG003|Overall Study|Other, Not Specified|0
7120752|NCT02615171|11258262|FG000|Overall Study|Lost to Follow-up|2
7120753|NCT02615171|11258263|FG001|Overall Study|Lost to Follow-up|1
7120754|NCT02615249|11258269|FG000|Overall Study|Withdrawal by Subject|1
7120755|NCT02615470|11258276|FG000|Overall Study|Lost to Follow-up|21
7120756|NCT02615470|11258277|FG001|Overall Study|Lost to Follow-up|32
7120757|NCT02615509|11258283|FG000|Overall Study|Lost to Follow-up|134
7120758|NCT02615509|11258283|FG000|Overall Study|Death|4
7120759|NCT02615509|11258283|FG000|Overall Study|Withdrawal by Subject|8
7120760|NCT02616029|11258316|FG000|Overall Study|Adverse Event|1
7120761|NCT02616029|11258317|FG001|Overall Study|Adverse Event|0
7120762|NCT02616029|11258316|FG000|Overall Study|Death|0
7120763|NCT02616029|11258317|FG001|Overall Study|Death|1
7120764|NCT02616029|11258316|FG000|Overall Study|Protocol Violation|1
7120765|NCT02616029|11258317|FG001|Overall Study|Protocol Violation|0
7120766|NCT02616029|11258316|FG000|Overall Study|Withdrew Consent|1
7120767|NCT02616029|11258317|FG001|Overall Study|Withdrew Consent|0
7120768|NCT02616029|11258316|FG000|Overall Study|Enrolled and Never Treated|1
7120769|NCT02616029|11258317|FG001|Overall Study|Enrolled and Never Treated|1
7120770|NCT02616380|11258332|FG000|Overall Study|Lost to Follow-up|1
7120771|NCT02616380|11258332|FG000|Overall Study|Other|2
7120772|NCT02616601|11258355|FG000|Overall Study|Withdrawal by Subject|4
7120773|NCT02616601|11258356|FG001|Overall Study|Withdrawal by Subject|4
7120774|NCT02616601|11258357|FG002|Overall Study|Withdrawal by Subject|3
7120775|NCT02616601|11258355|FG000|Overall Study|Adverse Event|2
7120776|NCT02616601|11258356|FG001|Overall Study|Adverse Event|0
7120777|NCT02616601|11258357|FG002|Overall Study|Adverse Event|2
7120778|NCT02616601|11258355|FG000|Overall Study|Death|1
7120779|NCT02616601|11258356|FG001|Overall Study|Death|0
7120780|NCT02616601|11258357|FG002|Overall Study|Death|0
7120781|NCT02616601|11258355|FG000|Overall Study|Lost to Follow-up|1
7120782|NCT02616601|11258356|FG001|Overall Study|Lost to Follow-up|0
7120783|NCT02616601|11258357|FG002|Overall Study|Lost to Follow-up|1
7120784|NCT02616601|11258355|FG000|Overall Study|Non-Compliance with Test Article|1
7120785|NCT02616601|11258356|FG001|Overall Study|Non-Compliance with Test Article|0
7120786|NCT02616601|11258357|FG002|Overall Study|Non-Compliance with Test Article|1
7120787|NCT02616614|11258368|FG000|Overall Study|Withdrawal by Subject|10
7120788|NCT02616614|11258369|FG001|Overall Study|Withdrawal by Subject|5
7120789|NCT02616614|11258370|FG002|Overall Study|Withdrawal by Subject|6
7120790|NCT02616614|11258368|FG000|Overall Study|Physician Decision|2
7120791|NCT02616614|11258369|FG001|Overall Study|Physician Decision|1
7120792|NCT02616614|11258370|FG002|Overall Study|Physician Decision|0
7120793|NCT02616614|11258368|FG000|Overall Study|Adverse Event|1
7120794|NCT02616614|11258369|FG001|Overall Study|Adverse Event|4
7120795|NCT02616614|11258370|FG002|Overall Study|Adverse Event|1
7120796|NCT02616614|11258368|FG000|Overall Study|Protocol Violation|0
7120797|NCT02616614|11258369|FG001|Overall Study|Protocol Violation|3
7120798|NCT02616614|11258370|FG002|Overall Study|Protocol Violation|1
7120799|NCT02616614|11258368|FG000|Overall Study|Prohibited Medication|12
7120800|NCT02616614|11258369|FG001|Overall Study|Prohibited Medication|9
7120801|NCT02616614|11258370|FG002|Overall Study|Prohibited Medication|5
7120802|NCT02616614|11258368|FG000|Overall Study|More than 3 applications missed|6
7120803|NCT02616614|11258369|FG001|Overall Study|More than 3 applications missed|8
7120804|NCT02616614|11258370|FG002|Overall Study|More than 3 applications missed|1
7120805|NCT02616614|11258368|FG000|Overall Study|Lost to Follow-up|31
7120806|NCT02616614|11258369|FG001|Overall Study|Lost to Follow-up|28
7120807|NCT02616614|11258370|FG002|Overall Study|Lost to Follow-up|13
7120808|NCT02616614|11258368|FG000|Overall Study|Pregnancy|2
7120809|NCT02616614|11258369|FG001|Overall Study|Pregnancy|0
7120810|NCT02616614|11258370|FG002|Overall Study|Pregnancy|1
7120811|NCT02616614|11258368|FG000|Overall Study|Other|1
7120812|NCT02616614|11258369|FG001|Overall Study|Other|2
7120813|NCT02616614|11258370|FG002|Overall Study|Other|1
7120814|NCT02616783|11258381|FG000|Overall Study|Randomized but Not Treated|1
7120815|NCT02616783|11258382|FG001|Overall Study|Randomized but Not Treated|0
7120816|NCT02616783|11258381|FG000|Overall Study|Adverse Event|1
7120817|NCT02616783|11258382|FG001|Overall Study|Adverse Event|0
7120818|NCT02616783|11258381|FG000|Overall Study|Death|1
7120819|NCT02616783|11258382|FG001|Overall Study|Death|0
7120820|NCT02616783|11258381|FG000|Overall Study|Non-Compliance with Study Drug|1
7120821|NCT02616783|11258382|FG001|Overall Study|Non-Compliance with Study Drug|0
7120822|NCT02616783|11258381|FG000|Overall Study|Protocol Violation|1
7120823|NCT02616783|11258382|FG001|Overall Study|Protocol Violation|1
7120824|NCT02616783|11258381|FG000|Overall Study|Withdrew Consent|1
7120825|NCT02616783|11258382|FG001|Overall Study|Withdrew Consent|1
7120826|NCT02616900|11258388|FG000|Overall Study|Lack of Efficacy|7
7120827|NCT02616900|11258388|FG000|Overall Study|Lost to Follow-up|2
7120828|NCT02616900|11258388|FG000|Overall Study|Protocol Violation|5
7120829|NCT02616900|11258388|FG000|Overall Study|Withdrawal by Subject|3
7120830|NCT02616900|11258388|FG000|Overall Study|Incomplete data|6
7120831|NCT02617628|11258394|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62
7120832|NCT02617628|11258395|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61
7120833|NCT02618382|11258483|FG000|Overall Study|Physician Decision|1
7120834|NCT02618382|11258483|FG000|Overall Study|Withdrawal by Subject|1
7120835|NCT02618382|11258483|FG000|Overall Study|Protocol Violation|1
7120836|NCT02618616|11258493|FG000|Overall Study|Lack of Efficacy|4
7120837|NCT02618616|11258494|FG001|Overall Study|Lack of Efficacy|0
7120838|NCT02618616|11258493|FG000|Overall Study|Pregnancy|0
7120839|NCT02618616|11258494|FG001|Overall Study|Pregnancy|1
7120840|NCT02618616|11258493|FG000|Overall Study|Adverse Event|8
7120841|NCT02618616|11258494|FG001|Overall Study|Adverse Event|0
7120842|NCT02618616|11258493|FG000|Overall Study|Failure to comply with dosing/evaluation|1
7120843|NCT02618616|11258494|FG001|Overall Study|Failure to comply with dosing/evaluation|0
7120844|NCT02618616|11258493|FG000|Overall Study|Consent withdrawn by subject|8
7120845|NCT02618616|11258494|FG001|Overall Study|Consent withdrawn by subject|5
7120846|NCT02618616|11258493|FG000|Overall Study|Lost to Follow-up|0
7120847|NCT02618616|11258494|FG001|Overall Study|Lost to Follow-up|1
7120848|NCT02618759|11258527|FG000|Overall Study|Lost to Follow-up|0
7120849|NCT02618759|11258528|FG001|Overall Study|Lost to Follow-up|1
7120850|NCT02618759|11258527|FG000|Overall Study|Withdrawal by Subject|1
7120851|NCT02618759|11258528|FG001|Overall Study|Withdrawal by Subject|0
7120852|NCT02618759|11258527|FG000|Overall Study|Other Reasons|1
7120853|NCT02618759|11258528|FG001|Overall Study|Other Reasons|4
7120854|NCT02618928|11258554|FG000|Overall Study|Failure to Return|28
7120855|NCT02618928|11258554|FG000|Overall Study|Insufficient Virological Response|1
7120856|NCT02618928|11258554|FG000|Overall Study|Withdrawal by Subject|2
7120857|NCT02618928|11258554|FG000|Overall Study|Death|3
7120858|NCT02618928|11258554|FG000|Overall Study|Other|11
7120859|NCT02618928|11258554|FG000|Overall Study|Missing|6
7120860|NCT02618928|11258554|FG000|Overall Study|Treatment Never Started|7
7120861|NCT02618967|11258569|FG000|Overall Study|Lost to Follow-up|0
7120862|NCT02618967|11258570|FG001|Overall Study|Lost to Follow-up|0
7120863|NCT02618967|11258571|FG002|Overall Study|Lost to Follow-up|1
7120864|NCT02618967|11258572|FG003|Overall Study|Lost to Follow-up|0
7120865|NCT02618967|11258573|FG004|Overall Study|Lost to Follow-up|2
7120866|NCT02618967|11258574|FG005|Overall Study|Lost to Follow-up|0
7120867|NCT02618967|11258575|FG006|Overall Study|Lost to Follow-up|0
7120868|NCT02618967|11258576|FG007|Overall Study|Lost to Follow-up|0
7120869|NCT02618967|11258569|FG000|Overall Study|Withdrawal by Subject|1
7120870|NCT02618967|11258570|FG001|Overall Study|Withdrawal by Subject|0
7120871|NCT02618967|11258571|FG002|Overall Study|Withdrawal by Subject|0
7120872|NCT02618967|11258572|FG003|Overall Study|Withdrawal by Subject|0
7120873|NCT02618967|11258573|FG004|Overall Study|Withdrawal by Subject|0
7120874|NCT02618967|11258574|FG005|Overall Study|Withdrawal by Subject|0
7120875|NCT02618967|11258575|FG006|Overall Study|Withdrawal by Subject|0
7120876|NCT02618967|11258576|FG007|Overall Study|Withdrawal by Subject|0
7120877|NCT02619175|11258596|FG000|Overall Study|Withdrawal by Subject|1
7120878|NCT02619175|11258597|FG001|Overall Study|Withdrawal by Subject|0
7120879|NCT02619175|11258596|FG000|Overall Study|foot pain|1
7120880|NCT02619175|11258597|FG001|Overall Study|foot pain|0
7120881|NCT02619617|11258655|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0
7120882|NCT02619617|11258656|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1
7120883|NCT02619617|11258655|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0
7120884|NCT02619617|11258656|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3
7120885|NCT02620020|11258677|FG000|Overall Study|Adverse Event|8
7120886|NCT02620020|11258678|FG001|Overall Study|Adverse Event|4
7120887|NCT02620020|11258679|FG002|Overall Study|Adverse Event|3
7120888|NCT02620020|11258680|FG003|Overall Study|Adverse Event|5
7120889|NCT02620020|11258677|FG000|Overall Study|Lost to Follow-up|4
7120890|NCT02620020|11258678|FG001|Overall Study|Lost to Follow-up|8
7120891|NCT02620020|11258679|FG002|Overall Study|Lost to Follow-up|1
7120892|NCT02620020|11258680|FG003|Overall Study|Lost to Follow-up|4
7120893|NCT02620020|11258677|FG000|Overall Study|Physician Decision|7
7120894|NCT02620020|11258678|FG001|Overall Study|Physician Decision|4
7120895|NCT02620020|11258679|FG002|Overall Study|Physician Decision|3
7120896|NCT02620020|11258680|FG003|Overall Study|Physician Decision|4
7120897|NCT02620020|11258677|FG000|Overall Study|Protocol Violation|5
7120898|NCT02620020|11258678|FG001|Overall Study|Protocol Violation|2
7120899|NCT02620020|11258679|FG002|Overall Study|Protocol Violation|1
7120900|NCT02620020|11258680|FG003|Overall Study|Protocol Violation|1
7120901|NCT02620020|11258677|FG000|Overall Study|Withdrawal by Subject|20
7120902|NCT02620020|11258678|FG001|Overall Study|Withdrawal by Subject|16
7120903|NCT02620020|11258679|FG002|Overall Study|Withdrawal by Subject|17
7120904|NCT02620020|11258680|FG003|Overall Study|Withdrawal by Subject|12
7120905|NCT02620020|11258677|FG000|Overall Study|Death|0
7120906|NCT02620020|11258678|FG001|Overall Study|Death|1
7120907|NCT02620020|11258679|FG002|Overall Study|Death|0
7120908|NCT02620020|11258680|FG003|Overall Study|Death|0
7120909|NCT02620384|11258692|FG000|Overall Study|Adverse Event|2
7120910|NCT02620384|11258693|FG001|Overall Study|Adverse Event|1
7120911|NCT02620384|11258692|FG000|Overall Study|Discharged prior to 2nd dose|2
7120912|NCT02620384|11258693|FG001|Overall Study|Discharged prior to 2nd dose|5
7120913|NCT02620384|11258692|FG000|Overall Study|Drug shortage prevented 2nd dose|0
7120914|NCT02620384|11258693|FG001|Overall Study|Drug shortage prevented 2nd dose|1
7120915|NCT02620787|11258716|FG000|Overall Study|Adverse Event|1
7120916|NCT02620787|11258717|FG001|Overall Study|Adverse Event|0
7120917|NCT02620787|11258716|FG000|Overall Study|Eligibility Criteria Not Met|1
7120918|NCT02620787|11258717|FG001|Overall Study|Eligibility Criteria Not Met|0
7120919|NCT02621034|11258748|FG000|Overall Study|Lost to Follow-up|3
7120920|NCT02621034|11258749|FG001|Overall Study|Lost to Follow-up|2
7120921|NCT02621034|11258750|FG002|Overall Study|Lost to Follow-up|5
7120922|NCT02621047|11258763|FG000|Overall Study|Adverse Event|0
7120923|NCT02621047|11258764|FG001|Overall Study|Adverse Event|0
7120924|NCT02621047|11258765|FG002|Overall Study|Adverse Event|1
7120925|NCT02621073|11258785|FG000|Overall Study|Lost to Follow-up|0
7120926|NCT02621073|11258786|FG001|Overall Study|Lost to Follow-up|1
7120927|NCT02621073|11258785|FG000|Overall Study|Physician Decision|3
7120928|NCT02621073|11258786|FG001|Overall Study|Physician Decision|2
7120929|NCT02621931|11258817|FG000|Overall Study|Death|0
7120930|NCT02621931|11258818|FG001|Overall Study|Death|1
7120931|NCT02621931|11258819|FG002|Overall Study|Death|0
7120932|NCT02621931|11258817|FG000|Overall Study|Adverse Event|8
7120933|NCT02621931|11258818|FG001|Overall Study|Adverse Event|5
7120934|NCT02621931|11258819|FG002|Overall Study|Adverse Event|7
7120935|NCT02621931|11258817|FG000|Overall Study|Withdrawal by Subject|12
7120936|NCT02621931|11258818|FG001|Overall Study|Withdrawal by Subject|10
7120937|NCT02621931|11258819|FG002|Overall Study|Withdrawal by Subject|11
7120938|NCT02621931|11258817|FG000|Overall Study|Protocol Violation|2
7120939|NCT02621931|11258818|FG001|Overall Study|Protocol Violation|2
7120940|NCT02621931|11258819|FG002|Overall Study|Protocol Violation|2
7120941|NCT02621931|11258817|FG000|Overall Study|Pregnancy|2
7120942|NCT02621931|11258818|FG001|Overall Study|Pregnancy|0
7120943|NCT02621931|11258819|FG002|Overall Study|Pregnancy|0
7120944|NCT02621931|11258817|FG000|Overall Study|Noncompliance to study procedures|0
7120945|NCT02621931|11258818|FG001|Overall Study|Noncompliance to study procedures|1
7120946|NCT02621931|11258819|FG002|Overall Study|Noncompliance to study procedures|2
7120947|NCT02621931|11258817|FG000|Overall Study|Lost to Follow-up|8
7120948|NCT02621931|11258818|FG001|Overall Study|Lost to Follow-up|7
7120949|NCT02621931|11258819|FG002|Overall Study|Lost to Follow-up|10
7120950|NCT02621931|11258817|FG000|Overall Study|Lack of Efficacy|0
7120951|NCT02621931|11258818|FG001|Overall Study|Lack of Efficacy|0
7120952|NCT02621931|11258819|FG002|Overall Study|Lack of Efficacy|1
7120953|NCT02621931|11258817|FG000|Overall Study|Other|1
7120954|NCT02621931|11258818|FG001|Overall Study|Other|1
7120955|NCT02621931|11258819|FG002|Overall Study|Other|3
7120956|NCT02622074|11258844|FG000|Overall Study|Death|4
7120957|NCT02622074|11258845|FG001|Overall Study|Death|0
7120958|NCT02622074|11258846|FG002|Overall Study|Death|0
7120959|NCT02622074|11258847|FG003|Overall Study|Death|1
7120960|NCT02622074|11258848|FG004|Overall Study|Death|1
7120961|NCT02622074|11258849|FG005|Overall Study|Death|0
7120962|NCT02622074|11258844|FG000|Overall Study|Withdrawal by Subject|0
7120963|NCT02622074|11258845|FG001|Overall Study|Withdrawal by Subject|1
7120964|NCT02622074|11258846|FG002|Overall Study|Withdrawal by Subject|0
7120965|NCT02622074|11258847|FG003|Overall Study|Withdrawal by Subject|0
7120966|NCT02622074|11258848|FG004|Overall Study|Withdrawal by Subject|0
7120967|NCT02622074|11258849|FG005|Overall Study|Withdrawal by Subject|0
7120968|NCT02622113|11258865|FG000|Overall Study|Adverse Event|4
7120969|NCT02622113|11258866|FG001|Overall Study|Adverse Event|4
7120970|NCT02622113|11258865|FG000|Overall Study|Physician Decision|0
7120971|NCT02622113|11258866|FG001|Overall Study|Physician Decision|1
7120972|NCT02622113|11258865|FG000|Overall Study|Withdrawal by Subject|0
7120973|NCT02622113|11258866|FG001|Overall Study|Withdrawal by Subject|2
7120974|NCT02622113|11258865|FG000|Overall Study|Stopping Criteria|1
7120975|NCT02622113|11258866|FG001|Overall Study|Stopping Criteria|3
7120976|NCT02622321|11258900|FG000|Overall Study|Withdrawal by Subject|2
7120977|NCT02622321|11258901|FG001|Overall Study|Withdrawal by Subject|0
7120978|NCT02622321|11258902|FG002|Overall Study|Withdrawal by Subject|0
7120979|NCT02622321|11258903|FG003|Overall Study|Withdrawal by Subject|0
7120980|NCT02622321|11258900|FG000|Overall Study|Death|0
7120981|NCT02622321|11258901|FG001|Overall Study|Death|0
7120982|NCT02622321|11258902|FG002|Overall Study|Death|1
7120983|NCT02622321|11258903|FG003|Overall Study|Death|0
7120984|NCT02622321|11258900|FG000|Overall Study|Physician Decision|1
7120985|NCT02622321|11258901|FG001|Overall Study|Physician Decision|0
7120986|NCT02622321|11258902|FG002|Overall Study|Physician Decision|0
7120987|NCT02622321|11258903|FG003|Overall Study|Physician Decision|0
7120988|NCT02622568|11258929|FG000|Overall Study|Lost to Follow-up|5
7120989|NCT02622568|11258930|FG001|Overall Study|Lost to Follow-up|5
7120990|NCT02622724|11258938|FG000|Overall Study|Death|51
7120991|NCT02622724|11258939|FG001|Overall Study|Death|53
7120992|NCT02622724|11258938|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4
7120993|NCT02622724|11258939|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7
7120994|NCT02622724|11258938|FG000|Overall Study|Early termination of study|38
7120995|NCT02622724|11258939|FG001|Overall Study|Early termination of study|43
7120996|NCT02623218|11258956|FG000|Overall Study|Lost to Follow-up|0
7120997|NCT02623218|11258957|FG001|Overall Study|Lost to Follow-up|1
7120998|NCT02623218|11258958|FG002|Overall Study|Lost to Follow-up|0
7120999|NCT02623218|11258959|FG003|Overall Study|Lost to Follow-up|0
7121000|NCT02623218|11258960|FG004|Overall Study|Lost to Follow-up|0
7121001|NCT02623322|11258975|FG000|Overall Study|Lost to Follow-up|2
7121002|NCT02623322|11258976|FG001|Overall Study|Lost to Follow-up|1
7121003|NCT02623322|11258977|FG002|Overall Study|Lost to Follow-up|0
7121004|NCT02623335|11258989|FG000|Overall Study|Death|8
7121005|NCT02623335|11258990|FG001|Overall Study|Death|7
7121006|NCT02623335|11258989|FG000|Overall Study|Lost to Follow-up|15
7121007|NCT02623335|11258990|FG001|Overall Study|Lost to Follow-up|23
7121008|NCT02623335|11258989|FG000|Overall Study|Withdrawal by Subject|2
7121009|NCT02623335|11258990|FG001|Overall Study|Withdrawal by Subject|5
7121010|NCT02623335|11258989|FG000|Overall Study|Protocol Violation|2
7121011|NCT02623335|11258990|FG001|Overall Study|Protocol Violation|1
7121012|NCT02623361|11259007|FG000|Overall Study|Protocol Violation|0
7121013|NCT02623361|11259008|FG001|Overall Study|Protocol Violation|1
7121014|NCT02623361|11259007|FG000|Overall Study|Withdrawal by Subject|0
7121015|NCT02623361|11259008|FG001|Overall Study|Withdrawal by Subject|1
7121016|NCT02623829|11259025|FG000|Overall Study|Lost to Follow-up|1
7121017|NCT02623829|11259026|FG001|Overall Study|Lost to Follow-up|1
7121018|NCT02624050|11259043|FG000|Overall Study|Physician Decision|4
7121019|NCT02624050|11259044|FG001|Overall Study|Physician Decision|0
7121020|NCT02624050|11259043|FG000|Overall Study|Protocol Violation|2
7121021|NCT02624050|11259044|FG001|Overall Study|Protocol Violation|0
7121022|NCT02624284|11259062|FG000|Overall Study|Withdrawal by Subject|3
7121023|NCT02624284|11259063|FG001|Overall Study|Withdrawal by Subject|6
7121024|NCT02624284|11259064|FG002|Overall Study|Withdrawal by Subject|3
7121025|NCT02624284|11259062|FG000|Overall Study|Protocol Violation|9
7121026|NCT02624284|11259063|FG001|Overall Study|Protocol Violation|10
7121027|NCT02624284|11259064|FG002|Overall Study|Protocol Violation|7
7121028|NCT02624284|11259062|FG000|Overall Study|Revealed exclusionary condition|2
7121029|NCT02624284|11259063|FG001|Overall Study|Revealed exclusionary condition|2
7121030|NCT02624284|11259064|FG002|Overall Study|Revealed exclusionary condition|0
7121031|NCT02624284|11259062|FG000|Overall Study|Adverse Event|0
7121032|NCT02624284|11259063|FG001|Overall Study|Adverse Event|0
7121033|NCT02624284|11259064|FG002|Overall Study|Adverse Event|1
7121034|NCT02624492|11259079|FG000|Overall Study|Adverse Event|2
7121035|NCT02624492|11259080|FG001|Overall Study|Adverse Event|2
7121036|NCT02624492|11259081|FG002|Overall Study|Adverse Event|2
7121037|NCT02624492|11259079|FG000|Overall Study|Progressive disease|0
7121038|NCT02624492|11259080|FG001|Overall Study|Progressive disease|2
7121039|NCT02624492|11259081|FG002|Overall Study|Progressive disease|3
7121040|NCT02624687|11259091|FG000|Overall Study|Withdrawal by Subject|1
7121041|NCT02624687|11259092|FG001|Overall Study|Withdrawal by Subject|1
7121042|NCT02624687|11259091|FG000|Overall Study|medical leave from work|0
7121043|NCT02624687|11259092|FG001|Overall Study|medical leave from work|1
7121044|NCT02624713|11259111|FG000|Overall Study|Lost to Follow-up|14
7121045|NCT02624713|11259112|FG001|Overall Study|Lost to Follow-up|0
7121046|NCT02624791|11259119|FG000|Overall Study|Withdrawal by Subject|2
7121047|NCT02624791|11259120|FG001|Overall Study|Withdrawal by Subject|0
7121048|NCT02624791|11259121|FG002|Overall Study|Withdrawal by Subject|0
7121049|NCT02624791|11259122|FG003|Overall Study|Withdrawal by Subject|0
7121050|NCT02624791|11259123|FG004|Overall Study|Withdrawal by Subject|0
7121051|NCT02624791|11259124|FG005|Overall Study|Withdrawal by Subject|0
7121052|NCT02624986|11259149|FG000|Overall Study|Death|0
7121053|NCT02624986|11259150|FG001|Overall Study|Death|1
7121054|NCT02624986|11259151|FG002|Overall Study|Death|2
7121055|NCT02624986|11259152|FG003|Overall Study|Death|2
7121056|NCT02624986|11259153|FG004|Overall Study|Death|2
7121057|NCT02624986|11259154|FG005|Overall Study|Death|0
7121058|NCT02624986|11259155|FG006|Overall Study|Death|0
7121059|NCT02624986|11259156|FG007|Overall Study|Death|1
7121060|NCT02624986|11259149|FG000|Overall Study|Study Terminated by Sponsor|1
7121061|NCT02624986|11259150|FG001|Overall Study|Study Terminated by Sponsor|1
7121062|NCT02624986|11259151|FG002|Overall Study|Study Terminated by Sponsor|0
7121063|NCT02624986|11259152|FG003|Overall Study|Study Terminated by Sponsor|1
7121064|NCT02624986|11259153|FG004|Overall Study|Study Terminated by Sponsor|2
7121065|NCT02624986|11259154|FG005|Overall Study|Study Terminated by Sponsor|2
7121066|NCT02624986|11259155|FG006|Overall Study|Study Terminated by Sponsor|4
7121067|NCT02624986|11259156|FG007|Overall Study|Study Terminated by Sponsor|3
7121068|NCT02624986|11259149|FG000|Overall Study|Progressive Disease|0
7121069|NCT02624986|11259150|FG001|Overall Study|Progressive Disease|1
7121070|NCT02624986|11259151|FG002|Overall Study|Progressive Disease|0
7121071|NCT02624986|11259152|FG003|Overall Study|Progressive Disease|0
7121072|NCT02624986|11259153|FG004|Overall Study|Progressive Disease|0
7121073|NCT02624986|11259154|FG005|Overall Study|Progressive Disease|0
7121074|NCT02624986|11259155|FG006|Overall Study|Progressive Disease|0
7121075|NCT02624986|11259156|FG007|Overall Study|Progressive Disease|0
7121076|NCT02624986|11259149|FG000|Overall Study|Protocol Violation|1
7121077|NCT02624986|11259150|FG001|Overall Study|Protocol Violation|0
7121078|NCT02624986|11259151|FG002|Overall Study|Protocol Violation|0
7121079|NCT02624986|11259152|FG003|Overall Study|Protocol Violation|0
7121080|NCT02624986|11259153|FG004|Overall Study|Protocol Violation|0
7121081|NCT02624986|11259154|FG005|Overall Study|Protocol Violation|0
7121082|NCT02624986|11259155|FG006|Overall Study|Protocol Violation|0
7121083|NCT02624986|11259156|FG007|Overall Study|Protocol Violation|0
7121084|NCT02624986|11259149|FG000|Overall Study|Withdrawal by Subject|0
7121085|NCT02624986|11259150|FG001|Overall Study|Withdrawal by Subject|0
7121086|NCT02624986|11259151|FG002|Overall Study|Withdrawal by Subject|0
7121087|NCT02624986|11259152|FG003|Overall Study|Withdrawal by Subject|0
7121088|NCT02624986|11259153|FG004|Overall Study|Withdrawal by Subject|0
7121089|NCT02624986|11259154|FG005|Overall Study|Withdrawal by Subject|0
7121090|NCT02624986|11259155|FG006|Overall Study|Withdrawal by Subject|0
7121091|NCT02624986|11259156|FG007|Overall Study|Withdrawal by Subject|1
7121092|NCT02625220|11259212|FG000|Overall Study|Adverse Event|2
7121093|NCT02625220|11259212|FG000|Overall Study|Lost to Follow-up|2
7121094|NCT02625220|11259212|FG000|Overall Study|Protocol Violation|1
7121095|NCT02625220|11259212|FG000|Overall Study|Study discontinued at site|2
7121096|NCT02625233|11259218|FG000|Overall Study|Adverse Event|2
7121097|NCT02625233|11259219|FG001|Overall Study|Adverse Event|0
7121098|NCT02625259|11259230|FG000|First Intervention (Day 1)|Other|0
7121099|NCT02625259|11259231|FG001|First Intervention (Day 1)|Other|0
7121100|NCT02625259|11259232|FG002|First Intervention (Day 1)|Other|1
7121101|NCT02625259|11259233|FG003|First Intervention (Day 1)|Other|0
7121102|NCT02625259|11259234|FG004|First Intervention (Day 1)|Other|0
7121103|NCT02625259|11259230|FG000|First Intervention (Day 1)|Adverse Event|2
7121104|NCT02625259|11259231|FG001|First Intervention (Day 1)|Adverse Event|1
7121105|NCT02625259|11259232|FG002|First Intervention (Day 1)|Adverse Event|0
7121106|NCT02625259|11259233|FG003|First Intervention (Day 1)|Adverse Event|0
7121107|NCT02625259|11259234|FG004|First Intervention (Day 1)|Adverse Event|0
7121108|NCT02625259|11259230|FG000|First Intervention (Day 1)|Withdrawal by Subject|0
7121109|NCT02625259|11259231|FG001|First Intervention (Day 1)|Withdrawal by Subject|0
7121110|NCT02625259|11259232|FG002|First Intervention (Day 1)|Withdrawal by Subject|0
7121111|NCT02625259|11259233|FG003|First Intervention (Day 1)|Withdrawal by Subject|1
7121112|NCT02625259|11259234|FG004|First Intervention (Day 1)|Withdrawal by Subject|0
7121113|NCT02625623|11259288|FG000|Overall Study|Participants randomized but not treated|9
7121114|NCT02625623|11259289|FG001|Overall Study|Participants randomized but not treated|1
7121115|NCT02625909|11259303|FG000|Overall Study|Death|2
7121116|NCT02625909|11259304|FG001|Overall Study|Death|0
7121117|NCT02625909|11259303|FG000|Overall Study|Lost to Follow-up|3
7121118|NCT02625909|11259304|FG001|Overall Study|Lost to Follow-up|5
7121119|NCT02625909|11259303|FG000|Overall Study|Lack of Efficacy|9
7121120|NCT02625909|11259304|FG001|Overall Study|Lack of Efficacy|2
7121121|NCT02625909|11259303|FG000|Overall Study|Reinfection|3
7121122|NCT02625909|11259304|FG001|Overall Study|Reinfection|2
7121123|NCT02625922|11259312|FG000|Overall Study|Non-availability of IMP|1
7121124|NCT02625922|11259313|FG001|Overall Study|Non-availability of IMP|1
7121125|NCT02625922|11259312|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1
7121126|NCT02625922|11259313|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1
7121127|NCT02625974|11259324|FG000|Overall Study|Adverse Event|12
7121128|NCT02625974|11259325|FG001|Overall Study|Adverse Event|2
7121129|NCT02625974|11259324|FG000|Overall Study|Withdrawal by Subject|3
7121130|NCT02625974|11259325|FG001|Overall Study|Withdrawal by Subject|1
7121131|NCT02625974|11259324|FG000|Overall Study|positive parasitemia|1
7121132|NCT02625974|11259325|FG001|Overall Study|positive parasitemia|0
7121133|NCT02625974|11259324|FG000|Overall Study|non-compliance with study drug|0
7121134|NCT02625974|11259325|FG001|Overall Study|non-compliance with study drug|2
7121135|NCT02625974|11259324|FG000|Overall Study|Protocol Violation|0
7121136|NCT02625974|11259325|FG001|Overall Study|Protocol Violation|1
7121137|NCT02626000|11259367|FG000|Overall Study|Decision by Sponsor|1
7121138|NCT02626000|11259367|FG000|Overall Study|Death|29
7121139|NCT02626026|11259378|FG000|Overall Study|Randomized but Never Treated|0
7121140|NCT02626026|11259379|FG001|Overall Study|Randomized but Never Treated|0
7121141|NCT02626026|11259380|FG002|Overall Study|Randomized but Never Treated|0
7121142|NCT02626026|11259381|FG003|Overall Study|Randomized but Never Treated|0
7121143|NCT02626026|11259382|FG004|Overall Study|Randomized but Never Treated|1
7121144|NCT02626026|11259383|FG005|Overall Study|Randomized but Never Treated|0
7121145|NCT02626182|11259424|FG000|Overall Study|Adverse Event|2
7121146|NCT02626182|11259425|FG001|Overall Study|Adverse Event|0
7121147|NCT02626780|11259451|FG000|Overall Study|Withdrawal by Subject|3
7121148|NCT02626819|11259457|FG000|Overall Study|Lost to Follow-up|3
7121149|NCT02626819|11259458|FG001|Overall Study|Lost to Follow-up|2
7121150|NCT02626819|11259457|FG000|Overall Study|Withdrawal by Subject|1
7121151|NCT02626819|11259458|FG001|Overall Study|Withdrawal by Subject|0
7121152|NCT02626819|11259457|FG000|Overall Study|Diagnosed w/ catastrophic illness|0
7121153|NCT02626819|11259458|FG001|Overall Study|Diagnosed w/ catastrophic illness|1
7121154|NCT02627144|11259495|FG000|Overall Study|Serious adverse event|32
7121155|NCT02627144|11259495|FG000|Overall Study|Cancer progression|171
7121156|NCT02627144|11259495|FG000|Overall Study|Death from cancer|20
7121157|NCT02627144|11259495|FG000|Overall Study|Death from other cause|8
7121158|NCT02627144|11259495|FG000|Overall Study|Refusal of treatment / poor cooperation|38
7121159|NCT02627144|11259495|FG000|Overall Study|Administrative reasons|65
7121160|NCT02627144|11259495|FG000|Overall Study|Lost to Follow-up|8
7121161|NCT02627144|11259495|FG000|Overall Study|Enrolled, not treated|6
7121162|NCT02627144|11259495|FG000|Overall Study|Other|17
7121163|NCT02627495|11259499|FG000|Overall Study|Withdrawal by Subject|4
7121164|NCT02627677|11259506|FG000|Overall Study|Adverse event (not progressive disease)|1
7121165|NCT02627677|11259507|FG001|Overall Study|Adverse event (not progressive disease)|4
7121166|NCT02627677|11259508|FG002|Overall Study|Adverse event (not progressive disease)|1
7121167|NCT02627677|11259506|FG000|Overall Study|Progressive disease|1
7121168|NCT02627677|11259507|FG001|Overall Study|Progressive disease|3
7121169|NCT02627677|11259508|FG002|Overall Study|Progressive disease|0
7121170|NCT02627677|11259506|FG000|Overall Study|Lack of Efficacy|1
7121171|NCT02627677|11259507|FG001|Overall Study|Lack of Efficacy|2
7121172|NCT02627677|11259508|FG002|Overall Study|Lack of Efficacy|0
7121173|NCT02627677|11259506|FG000|Overall Study|Lost to Follow-up|0
7121174|NCT02627677|11259507|FG001|Overall Study|Lost to Follow-up|0
7121175|NCT02627677|11259508|FG002|Overall Study|Lost to Follow-up|1
7121176|NCT02627677|11259506|FG000|Overall Study|Pregnancy|0
7121177|NCT02627677|11259507|FG001|Overall Study|Pregnancy|1
7121178|NCT02627677|11259508|FG002|Overall Study|Pregnancy|0
7121179|NCT02627677|11259506|FG000|Overall Study|Study Terminated by Sponsor|5
7121180|NCT02627677|11259507|FG001|Overall Study|Study Terminated by Sponsor|10
7121181|NCT02627677|11259508|FG002|Overall Study|Study Terminated by Sponsor|6
7121182|NCT02627677|11259506|FG000|Overall Study|Physician Decision|0
7121183|NCT02627677|11259507|FG001|Overall Study|Physician Decision|0
7121184|NCT02627677|11259508|FG002|Overall Study|Physician Decision|2
7121185|NCT02627677|11259506|FG000|Overall Study|Withdrawal by Subject|2
7121186|NCT02627677|11259507|FG001|Overall Study|Withdrawal by Subject|1
7121187|NCT02627677|11259508|FG002|Overall Study|Withdrawal by Subject|1
7121188|NCT02627677|11259506|FG000|Overall Study|Reason not Specified|0
7121189|NCT02627677|11259507|FG001|Overall Study|Reason not Specified|0
7121190|NCT02627677|11259508|FG002|Overall Study|Reason not Specified|1
7121191|NCT02627677|11259506|FG000|Overall Study|Randomized but not Treated|1
7121192|NCT02627677|11259507|FG001|Overall Study|Randomized but not Treated|0
7121193|NCT02627677|11259508|FG002|Overall Study|Randomized but not Treated|0
7121194|NCT02628028|11259539|FG000|Dosing Period|Withdrawal by Subject|0
7121195|NCT02628028|11259540|FG001|Dosing Period|Withdrawal by Subject|0
7121196|NCT02628028|11259541|FG002|Dosing Period|Withdrawal by Subject|1
7121197|NCT02628028|11259542|FG003|Dosing Period|Withdrawal by Subject|0
7121198|NCT02628028|11259543|FG004|Dosing Period|Withdrawal by Subject|2
7121199|NCT02628028|11259544|FG005|Dosing Period|Withdrawal by Subject|4
7121200|NCT02628028|11259545|FG006|Dosing Period|Withdrawal by Subject|1
7121201|NCT02628028|11259546|FG007|Dosing Period|Withdrawal by Subject|1
7121202|NCT02628028|11259539|FG000|Dosing Period|Adverse Event|0
7121203|NCT02628028|11259540|FG001|Dosing Period|Adverse Event|0
7121204|NCT02628028|11259541|FG002|Dosing Period|Adverse Event|0
7121205|NCT02628028|11259542|FG003|Dosing Period|Adverse Event|0
7121206|NCT02628028|11259543|FG004|Dosing Period|Adverse Event|2
7121207|NCT02628028|11259544|FG005|Dosing Period|Adverse Event|1
7121208|NCT02628028|11259545|FG006|Dosing Period|Adverse Event|3
7121209|NCT02628028|11259546|FG007|Dosing Period|Adverse Event|2
7121210|NCT02628028|11259539|FG000|Dosing Period|Death|0
7121211|NCT02628028|11259540|FG001|Dosing Period|Death|0
7121212|NCT02628028|11259541|FG002|Dosing Period|Death|0
7121213|NCT02628028|11259542|FG003|Dosing Period|Death|0
7121214|NCT02628028|11259543|FG004|Dosing Period|Death|0
7121215|NCT02628028|11259544|FG005|Dosing Period|Death|0
7121216|NCT02628028|11259545|FG006|Dosing Period|Death|0
7121217|NCT02628028|11259546|FG007|Dosing Period|Death|1
7121218|NCT02628028|11259539|FG000|Dosing Period|Lack of Efficacy|0
7121219|NCT02628028|11259540|FG001|Dosing Period|Lack of Efficacy|0
7121220|NCT02628028|11259541|FG002|Dosing Period|Lack of Efficacy|0
7121221|NCT02628028|11259542|FG003|Dosing Period|Lack of Efficacy|0
7121222|NCT02628028|11259543|FG004|Dosing Period|Lack of Efficacy|3
7121223|NCT02628028|11259544|FG005|Dosing Period|Lack of Efficacy|0
7121224|NCT02628028|11259545|FG006|Dosing Period|Lack of Efficacy|1
7121225|NCT02628028|11259546|FG007|Dosing Period|Lack of Efficacy|0
7121226|NCT02628028|11259539|FG000|Dosing Period|Study Terminated by Sponsor|0
7121227|NCT02628028|11259540|FG001|Dosing Period|Study Terminated by Sponsor|0
7121228|NCT02628028|11259541|FG002|Dosing Period|Study Terminated by Sponsor|0
7121229|NCT02628028|11259542|FG003|Dosing Period|Study Terminated by Sponsor|0
7121230|NCT02628028|11259543|FG004|Dosing Period|Study Terminated by Sponsor|7
7121231|NCT02628028|11259544|FG005|Dosing Period|Study Terminated by Sponsor|6
7121232|NCT02628028|11259545|FG006|Dosing Period|Study Terminated by Sponsor|7
7121233|NCT02628028|11259546|FG007|Dosing Period|Study Terminated by Sponsor|7
7121234|NCT02628028|11259539|FG000|Dosing Period|Physician Decision|0
7121235|NCT02628028|11259540|FG001|Dosing Period|Physician Decision|0
7121236|NCT02628028|11259541|FG002|Dosing Period|Physician Decision|0
7121237|NCT02628028|11259542|FG003|Dosing Period|Physician Decision|0
7121238|NCT02628028|11259543|FG004|Dosing Period|Physician Decision|0
7121239|NCT02628028|11259544|FG005|Dosing Period|Physician Decision|1
7121240|NCT02628028|11259545|FG006|Dosing Period|Physician Decision|0
7121241|NCT02628028|11259546|FG007|Dosing Period|Physician Decision|0
7121242|NCT02628028|11259539|FG000|Dosing Period|Site Terminated by Sponsor|0
7121243|NCT02628028|11259540|FG001|Dosing Period|Site Terminated by Sponsor|0
7121244|NCT02628028|11259541|FG002|Dosing Period|Site Terminated by Sponsor|0
7121245|NCT02628028|11259542|FG003|Dosing Period|Site Terminated by Sponsor|0
7121246|NCT02628028|11259543|FG004|Dosing Period|Site Terminated by Sponsor|0
7121247|NCT02628028|11259544|FG005|Dosing Period|Site Terminated by Sponsor|1
7121248|NCT02628028|11259545|FG006|Dosing Period|Site Terminated by Sponsor|1
7121249|NCT02628028|11259546|FG007|Dosing Period|Site Terminated by Sponsor|0
7121250|NCT02628028|11259539|FG000|Dosing Period|Lost to Follow-up|0
7121251|NCT02628028|11259540|FG001|Dosing Period|Lost to Follow-up|0
7121252|NCT02628028|11259541|FG002|Dosing Period|Lost to Follow-up|0
7121253|NCT02628028|11259542|FG003|Dosing Period|Lost to Follow-up|0
7121254|NCT02628028|11259543|FG004|Dosing Period|Lost to Follow-up|0
7121255|NCT02628028|11259544|FG005|Dosing Period|Lost to Follow-up|0
7121256|NCT02628028|11259545|FG006|Dosing Period|Lost to Follow-up|1
7121257|NCT02628028|11259546|FG007|Dosing Period|Lost to Follow-up|0
7121258|NCT02628028|11259539|FG000|Dosing Period|Other|0
7121259|NCT02628028|11259540|FG001|Dosing Period|Other|0
7121260|NCT02628028|11259541|FG002|Dosing Period|Other|0
7121261|NCT02628028|11259542|FG003|Dosing Period|Other|0
7121262|NCT02628028|11259543|FG004|Dosing Period|Other|2
7121263|NCT02628028|11259544|FG005|Dosing Period|Other|1
7121264|NCT02628028|11259545|FG006|Dosing Period|Other|2
7121265|NCT02628028|11259546|FG007|Dosing Period|Other|4
7121266|NCT02628028|11259539|FG000|Long-term Extension (LTE) Period|Adverse Event|0
7121267|NCT02628028|11259540|FG001|Long-term Extension (LTE) Period|Adverse Event|0
7121268|NCT02628028|11259541|FG002|Long-term Extension (LTE) Period|Adverse Event|0
7121269|NCT02628028|11259542|FG003|Long-term Extension (LTE) Period|Adverse Event|0
7121270|NCT02628028|11259543|FG004|Long-term Extension (LTE) Period|Adverse Event|0
7121271|NCT02628028|11259544|FG005|Long-term Extension (LTE) Period|Adverse Event|1
7121272|NCT02628028|11259545|FG006|Long-term Extension (LTE) Period|Adverse Event|0
7121273|NCT02628028|11259546|FG007|Long-term Extension (LTE) Period|Adverse Event|3
7121274|NCT02628028|11259539|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0
7121275|NCT02628028|11259540|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0
7121276|NCT02628028|11259541|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0
7121277|NCT02628028|11259542|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0
7121278|NCT02628028|11259543|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0
7121279|NCT02628028|11259544|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2
7121280|NCT02628028|11259545|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0
7121281|NCT02628028|11259546|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1
7121282|NCT02628028|11259539|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
7121283|NCT02628028|11259540|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
7121284|NCT02628028|11259541|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
7121285|NCT02628028|11259542|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
7121286|NCT02628028|11259543|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
7121287|NCT02628028|11259544|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52
7121288|NCT02628028|11259545|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51
7121289|NCT02628028|11259546|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51
7121290|NCT02628028|11259539|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0
7121291|NCT02628028|11259540|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0
7121292|NCT02628028|11259541|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0
7121293|NCT02628028|11259542|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0
7121294|NCT02628028|11259543|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0
7121295|NCT02628028|11259544|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2
7121296|NCT02628028|11259545|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3
7121297|NCT02628028|11259546|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3
7121298|NCT02628028|11259539|FG000|Long-term Extension (LTE) Period|Other|0
7121299|NCT02628028|11259540|FG001|Long-term Extension (LTE) Period|Other|0
7121300|NCT02628028|11259541|FG002|Long-term Extension (LTE) Period|Other|0
7121301|NCT02628028|11259542|FG003|Long-term Extension (LTE) Period|Other|0
7121302|NCT02628028|11259543|FG004|Long-term Extension (LTE) Period|Other|0
7121303|NCT02628028|11259544|FG005|Long-term Extension (LTE) Period|Other|3
7121304|NCT02628028|11259545|FG006|Long-term Extension (LTE) Period|Other|4
7121305|NCT02628028|11259546|FG007|Long-term Extension (LTE) Period|Other|3
7121306|NCT02628418|11259596|FG000|Overall Study|Lost to Follow-up|1
7121307|NCT02628418|11259597|FG001|Overall Study|Lost to Follow-up|2
7121308|NCT02628600|11259611|FG000|Overall Study|Death|2
7121309|NCT02628600|11259612|FG001|Overall Study|Death|1
7121310|NCT02628600|11259611|FG000|Overall Study|Adverse Event|3
7121311|NCT02628600|11259612|FG001|Overall Study|Adverse Event|20
7121312|NCT02628600|11259611|FG000|Overall Study|Protocol Violation|0
7121313|NCT02628600|11259612|FG001|Overall Study|Protocol Violation|1
7121314|NCT02628600|11259611|FG000|Overall Study|Lack of Efficacy|2
7121315|NCT02628600|11259612|FG001|Overall Study|Lack of Efficacy|0
7121316|NCT02628600|11259611|FG000|Overall Study|Withdrawal by Subject|13
7121317|NCT02628600|11259612|FG001|Overall Study|Withdrawal by Subject|8
7121318|NCT02628600|11259611|FG000|Overall Study|Lost to Follow-up|1
7121319|NCT02628600|11259612|FG001|Overall Study|Lost to Follow-up|0
7121320|NCT02628600|11259611|FG000|Overall Study|Physician Decision|2
7121321|NCT02628600|11259612|FG001|Overall Study|Physician Decision|2
7121322|NCT02628600|11259611|FG000|Overall Study|Other not specified|1
7121323|NCT02628600|11259612|FG001|Overall Study|Other not specified|0
7121324|NCT02628743|11259618|FG000|Overall Study|Other|3
7121325|NCT02628743|11259618|FG000|Overall Study|Withdrawal by Subject|50
7121326|NCT02628743|11259618|FG000|Overall Study|Study Terminated by Sponsor|76
7121327|NCT02628743|11259618|FG000|Overall Study|Physician Decision|2
7121328|NCT02628769|11259622|FG000|First Intervention|Adverse Event|1
7121329|NCT02628769|11259623|FG001|First Intervention|Adverse Event|0
7121330|NCT02628769|11259622|FG000|First Intervention|Withdrawal by Subject|0
7121331|NCT02628769|11259623|FG001|First Intervention|Withdrawal by Subject|1
7121332|NCT02628769|11259622|FG000|Second Intervention|Adverse Event|2
7121333|NCT02628769|11259623|FG001|Second Intervention|Adverse Event|0
7121334|NCT02628769|11259622|FG000|Second Intervention|Physician Decision|0
7121335|NCT02628769|11259623|FG001|Second Intervention|Physician Decision|1
7121336|NCT02628873|11259631|FG000|Break (1 Hour)|Withdrawal by Subject|0
7121337|NCT02628873|11259632|FG001|Break (1 Hour)|Withdrawal by Subject|1
7121338|NCT02628873|11259631|FG000|Second Test (1 Hour)|Physician Decision|1
7121339|NCT02628873|11259632|FG001|Second Test (1 Hour)|Physician Decision|0
7121340|NCT02628938|11259641|FG000|Overall Study|Did not attend the follow up recall|2
7121341|NCT02628938|11259642|FG001|Overall Study|Did not attend the follow up recall|2
7121342|NCT02628938|11259643|FG002|Overall Study|Did not attend the follow up recall|1
7121343|NCT02628938|11259641|FG000|Overall Study|Failure to comply with the instructions|3
7121344|NCT02628938|11259642|FG001|Overall Study|Failure to comply with the instructions|0
7121345|NCT02628938|11259643|FG002|Overall Study|Failure to comply with the instructions|3
7121346|NCT02629133|11259666|FG000|Overall Study|Lost to Follow-up|3
7121347|NCT02629133|11259667|FG001|Overall Study|Lost to Follow-up|1
7121348|NCT02629133|11259666|FG000|Overall Study|Withdrawal by Subject|1
7121349|NCT02629133|11259667|FG001|Overall Study|Withdrawal by Subject|1
7121350|NCT02629822|11259682|FG000|Base Study|Lost to Follow-up|2
7121351|NCT02629822|11259682|FG000|Base Study|Non-Compliance With Study Drug|1
7121352|NCT02629822|11259682|FG000|Extension Study|Adverse Event|1
7121353|NCT02629822|11259682|FG000|Extension Study|Lost to Follow-up|1
7121354|NCT02629861|11259690|FG000|Overall Study|Adverse Event|7
7121355|NCT02629861|11259691|FG001|Overall Study|Adverse Event|5
7121356|NCT02629861|11259692|FG002|Overall Study|Adverse Event|4
7121357|NCT02629861|11259690|FG000|Overall Study|Withdrawal by Subject|5
7121358|NCT02629861|11259691|FG001|Overall Study|Withdrawal by Subject|8
7121359|NCT02629861|11259692|FG002|Overall Study|Withdrawal by Subject|13
7121360|NCT02629861|11259690|FG000|Overall Study|Protocol Violation|2
7121361|NCT02629861|11259691|FG001|Overall Study|Protocol Violation|3
7121362|NCT02629861|11259692|FG002|Overall Study|Protocol Violation|7
7121363|NCT02629861|11259690|FG000|Overall Study|Lost to Follow-up|12
7121364|NCT02629861|11259691|FG001|Overall Study|Lost to Follow-up|9
7121365|NCT02629861|11259692|FG002|Overall Study|Lost to Follow-up|4
7121366|NCT02629861|11259690|FG000|Overall Study|Other|1
7121367|NCT02629861|11259691|FG001|Overall Study|Other|1
7121368|NCT02629861|11259692|FG002|Overall Study|Other|0
7121369|NCT02629861|11259690|FG000|Overall Study|Pregnancy|2
7121370|NCT02629861|11259691|FG001|Overall Study|Pregnancy|1
7121371|NCT02629861|11259692|FG002|Overall Study|Pregnancy|0
7121372|NCT02629965|11259700|FG000|Period 1|Adverse Event|1
7121373|NCT02629965|11259701|FG001|Period 1|Adverse Event|0
7121374|NCT02629965|11259700|FG000|Period 1|Unexpected worsening of disease|2
7121375|NCT02629965|11259701|FG001|Period 1|Unexpected worsening of disease|0
7121376|NCT02629965|11259700|FG000|Period 1|Other than listed above|1
7121377|NCT02629965|11259701|FG001|Period 1|Other than listed above|2
7121378|NCT02629965|11259700|FG000|Period 2|Adverse Event|1
7121379|NCT02629965|11259701|FG001|Period 2|Adverse Event|0
7121380|NCT02630186|11259738|FG000|Overall Study|Withdrawal by Subject|1
7121381|NCT02630251|11259746|FG000|Overall Study|Physician Decision|0
7121382|NCT02630251|11259747|FG001|Overall Study|Physician Decision|0
7121383|NCT02630251|11259748|FG002|Overall Study|Physician Decision|1
7121384|NCT02630251|11259749|FG003|Overall Study|Physician Decision|0
7121385|NCT02630563|11259768|FG000|Overall Study|Administrative|1
7121386|NCT02630693|11259775|FG000|Overall Study|No receive treatment|0
7121387|NCT02630693|11259776|FG001|Overall Study|No receive treatment|1
7121388|NCT02630706|11259785|FG000|Overall Study|Adverse Event|2
7121389|NCT02630706|11259786|FG001|Overall Study|Adverse Event|1
7121390|NCT02630706|11259787|FG002|Overall Study|Adverse Event|1
7121391|NCT02630706|11259785|FG000|Overall Study|Lost to Follow-up|0
7121392|NCT02630706|11259786|FG001|Overall Study|Lost to Follow-up|1
7121393|NCT02630706|11259787|FG002|Overall Study|Lost to Follow-up|2
7121394|NCT02630706|11259785|FG000|Overall Study|Physician Decision|1
7121395|NCT02630706|11259786|FG001|Overall Study|Physician Decision|1
7121396|NCT02630706|11259787|FG002|Overall Study|Physician Decision|0
7121397|NCT02630706|11259785|FG000|Overall Study|Pregnancy|0
7121398|NCT02630706|11259786|FG001|Overall Study|Pregnancy|1
7121399|NCT02630706|11259787|FG002|Overall Study|Pregnancy|0
7121400|NCT02630706|11259785|FG000|Overall Study|Withdrawal by Subject|4
7121401|NCT02630706|11259786|FG001|Overall Study|Withdrawal by Subject|5
7121402|NCT02630706|11259787|FG002|Overall Study|Withdrawal by Subject|7
7121403|NCT02630966|11259815|FG000|Overall Study|Adverse Event|1
7121404|NCT02630966|11259816|FG001|Overall Study|Adverse Event|3
7121405|NCT02630966|11259815|FG000|Overall Study|Significant Protocol Deviation|0
7121406|NCT02630966|11259816|FG001|Overall Study|Significant Protocol Deviation|2
7121407|NCT02630966|11259815|FG000|Overall Study|Voluntary Withdrawal|1
7121408|NCT02630966|11259816|FG001|Overall Study|Voluntary Withdrawal|1
7121409|NCT02630966|11259815|FG000|Overall Study|Lack of Efficacy|0
7121410|NCT02630966|11259816|FG001|Overall Study|Lack of Efficacy|2
7121411|NCT02631538|11259848|FG000|Treatment Period (Up to Week 52)|Adverse Event|1
7121412|NCT02631538|11259849|FG001|Treatment Period (Up to Week 52)|Adverse Event|5
7121413|NCT02631538|11259850|FG002|Treatment Period (Up to Week 52)|Adverse Event|2
7121414|NCT02631538|11259851|FG003|Treatment Period (Up to Week 52)|Adverse Event|2
7121415|NCT02631538|11259848|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1
7121416|NCT02631538|11259849|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1
7121417|NCT02631538|11259850|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2
7121418|NCT02631538|11259851|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5
7121419|NCT02631538|11259848|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1
7121420|NCT02631538|11259849|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1
7121421|NCT02631538|11259850|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0
7121422|NCT02631538|11259851|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0
7121423|NCT02631538|11259848|FG000|Treatment Period (Up to Week 52)|Physician Decision|1
7121424|NCT02631538|11259849|FG001|Treatment Period (Up to Week 52)|Physician Decision|0
7121425|NCT02631538|11259850|FG002|Treatment Period (Up to Week 52)|Physician Decision|0
7121426|NCT02631538|11259851|FG003|Treatment Period (Up to Week 52)|Physician Decision|1
7121427|NCT02631538|11259848|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0
7121428|NCT02631538|11259849|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0
7121429|NCT02631538|11259850|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1
7121430|NCT02631538|11259851|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0
7121431|NCT02631538|11259848|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1
7121432|NCT02631538|11259849|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0
7121433|NCT02631538|11259850|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0
7121434|NCT02631538|11259851|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1
7121435|NCT02631551|11259865|FG000|Overall Study|Adverse Event|1
7121436|NCT02631551|11259866|FG001|Overall Study|Adverse Event|2
7121437|NCT02631551|11259867|FG002|Overall Study|Adverse Event|4
7121438|NCT02631551|11259868|FG003|Overall Study|Adverse Event|0
7121439|NCT02631551|11259865|FG000|Overall Study|Lack of Efficacy|0
7121440|NCT02631551|11259866|FG001|Overall Study|Lack of Efficacy|0
7121441|NCT02631551|11259867|FG002|Overall Study|Lack of Efficacy|1
7121442|NCT02631551|11259868|FG003|Overall Study|Lack of Efficacy|0
7121443|NCT02631551|11259865|FG000|Overall Study|Lost to Follow-up|1
7121444|NCT02631551|11259866|FG001|Overall Study|Lost to Follow-up|2
7121445|NCT02631551|11259867|FG002|Overall Study|Lost to Follow-up|0
7121446|NCT02631551|11259868|FG003|Overall Study|Lost to Follow-up|3
7121447|NCT02631551|11259865|FG000|Overall Study|Withdrawal by Subject|2
7121448|NCT02631551|11259866|FG001|Overall Study|Withdrawal by Subject|2
7121449|NCT02631551|11259867|FG002|Overall Study|Withdrawal by Subject|0
7121450|NCT02631551|11259868|FG003|Overall Study|Withdrawal by Subject|5
7121451|NCT02631551|11259865|FG000|Overall Study|Protocol deviation|3
7121452|NCT02631551|11259866|FG001|Overall Study|Protocol deviation|6
7121453|NCT02631551|11259867|FG002|Overall Study|Protocol deviation|3
7121454|NCT02631551|11259868|FG003|Overall Study|Protocol deviation|0
7121455|NCT02631551|11259865|FG000|Overall Study|Non-compliance with study procedures|0
7121456|NCT02631551|11259866|FG001|Overall Study|Non-compliance with study procedures|0
7121457|NCT02631551|11259867|FG002|Overall Study|Non-compliance with study procedures|1
7121458|NCT02631551|11259868|FG003|Overall Study|Non-compliance with study procedures|1
7121459|NCT02631551|11259865|FG000|Overall Study|Non-compliance with study drug|1
7121460|NCT02631551|11259866|FG001|Overall Study|Non-compliance with study drug|0
7121461|NCT02631551|11259867|FG002|Overall Study|Non-compliance with study drug|0
7121462|NCT02631551|11259868|FG003|Overall Study|Non-compliance with study drug|0
7121463|NCT02631551|11259865|FG000|Overall Study|Other, specific reasons not collected|5
7121464|NCT02631551|11259866|FG001|Overall Study|Other, specific reasons not collected|7
7121465|NCT02631551|11259867|FG002|Overall Study|Other, specific reasons not collected|2
7121466|NCT02631551|11259868|FG003|Overall Study|Other, specific reasons not collected|2
7121467|NCT02631746|11259882|FG000|Overall Study|Lack of Efficacy|3
7121468|NCT02631850|11259899|FG000|Treatment Period|Lost to Follow-up|0
7121469|NCT02631850|11259900|FG001|Treatment Period|Lost to Follow-up|1
7121470|NCT02631850|11259901|FG002|Treatment Period|Lost to Follow-up|0
7121471|NCT02631850|11259902|FG003|Treatment Period|Lost to Follow-up|0
7121472|NCT02631850|11259899|FG000|Treatment Period|Protocol Violation|1
7121473|NCT02631850|11259900|FG001|Treatment Period|Protocol Violation|0
7121474|NCT02631850|11259901|FG002|Treatment Period|Protocol Violation|0
7121475|NCT02631850|11259902|FG003|Treatment Period|Protocol Violation|0
7121476|NCT02631850|11259899|FG000|Treatment Period|Withdrawal by Subject|0
7121477|NCT02631850|11259900|FG001|Treatment Period|Withdrawal by Subject|5
7121478|NCT02631850|11259901|FG002|Treatment Period|Withdrawal by Subject|2
7121479|NCT02631850|11259902|FG003|Treatment Period|Withdrawal by Subject|2
7121480|NCT02631850|11259899|FG000|Treatment Period|Adverse Event|1
7121481|NCT02631850|11259900|FG001|Treatment Period|Adverse Event|0
7121482|NCT02631850|11259901|FG002|Treatment Period|Adverse Event|2
7121483|NCT02631850|11259902|FG003|Treatment Period|Adverse Event|3
7121484|NCT02631850|11259899|FG000|Treatment Period|Family medical issue|1
7121485|NCT02631850|11259900|FG001|Treatment Period|Family medical issue|0
7121486|NCT02631850|11259901|FG002|Treatment Period|Family medical issue|0
7121487|NCT02631850|11259902|FG003|Treatment Period|Family medical issue|0
7121488|NCT02631850|11259899|FG000|6 Month Follow up|Lost to Follow-up|5
7121489|NCT02631850|11259900|FG001|6 Month Follow up|Lost to Follow-up|8
7121490|NCT02631850|11259901|FG002|6 Month Follow up|Lost to Follow-up|3
7121491|NCT02631850|11259902|FG003|6 Month Follow up|Lost to Follow-up|5
7121492|NCT02631850|11259899|FG000|6 Month Follow up|Withdrawal by Subject|1
7121493|NCT02631850|11259900|FG001|6 Month Follow up|Withdrawal by Subject|0
7121494|NCT02631850|11259901|FG002|6 Month Follow up|Withdrawal by Subject|0
7121495|NCT02631850|11259902|FG003|6 Month Follow up|Withdrawal by Subject|2
7121496|NCT02631850|11259899|FG000|6 Month Follow up|Adverse Event|1
7121497|NCT02631850|11259900|FG001|6 Month Follow up|Adverse Event|4
7121498|NCT02631850|11259901|FG002|6 Month Follow up|Adverse Event|1
7121499|NCT02631850|11259902|FG003|6 Month Follow up|Adverse Event|3
7121500|NCT02631850|11259899|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0
7121501|NCT02631850|11259900|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1
7121502|NCT02631850|11259901|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2
7121503|NCT02631850|11259902|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1
7121504|NCT02631876|11259915|FG000|Overall Study|Death|96
7121505|NCT02631876|11259916|FG001|Overall Study|Death|50
7121506|NCT02631876|11259915|FG000|Overall Study|Investigator's discretion|1
7121507|NCT02631876|11259916|FG001|Overall Study|Investigator's discretion|0
7121508|NCT02631876|11259915|FG000|Overall Study|Lost to Follow-up|2
7121509|NCT02631876|11259916|FG001|Overall Study|Lost to Follow-up|0
7121510|NCT02631876|11259915|FG000|Overall Study|Withdrawal by Subject|16
7121511|NCT02631876|11259916|FG001|Overall Study|Withdrawal by Subject|9
7121512|NCT02631876|11259915|FG000|Overall Study|Other than specified|4
7121513|NCT02631876|11259916|FG001|Overall Study|Other than specified|4
7121514|NCT02632110|11259937|FG000|Overall Study|Withdrawal by Subject|1
7121515|NCT02632110|11259938|FG001|Overall Study|Withdrawal by Subject|1
7121516|NCT02632110|11259939|FG002|Overall Study|Withdrawal by Subject|0
7121517|NCT02632110|11259940|FG003|Overall Study|Withdrawal by Subject|0
7121518|NCT02632110|11259941|FG004|Overall Study|Withdrawal by Subject|1
7121519|NCT02632110|11259942|FG005|Overall Study|Withdrawal by Subject|1
7121520|NCT02632110|11259943|FG006|Overall Study|Withdrawal by Subject|3
7121521|NCT02632110|11259944|FG007|Overall Study|Withdrawal by Subject|3
7121522|NCT02632110|11259945|FG008|Overall Study|Withdrawal by Subject|1
7121523|NCT02632110|11259946|FG009|Overall Study|Withdrawal by Subject|1
7121524|NCT02632552|11260021|FG000|Overall Study|Lost to Follow-up|14
7121525|NCT02632552|11260022|FG001|Overall Study|Lost to Follow-up|8
7121526|NCT02632552|11260021|FG000|Overall Study|Withdrawal by Subject|2
7121527|NCT02632552|11260022|FG001|Overall Study|Withdrawal by Subject|0
7121528|NCT02632552|11260021|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7
7121529|NCT02632552|11260022|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2
7121530|NCT02632747|11260031|FG000|Wash-out Period|Adverse Event|1
7121531|NCT02632747|11260032|FG001|Wash-out Period|Adverse Event|0
7121532|NCT02632786|11260040|FG000|Overall Study|Adverse Event|2
7121533|NCT02632786|11260041|FG001|Overall Study|Adverse Event|1
7121534|NCT02632786|11260040|FG000|Overall Study|Death|3
7121535|NCT02632786|11260041|FG001|Overall Study|Death|2
7121536|NCT02632786|11260040|FG000|Overall Study|Physician Decision|5
7121537|NCT02632786|11260041|FG001|Overall Study|Physician Decision|4
7121538|NCT02632786|11260040|FG000|Overall Study|Withdrawal by Subject|1
7121539|NCT02632786|11260041|FG001|Overall Study|Withdrawal by Subject|0
7121540|NCT02632838|11260059|FG000|Overall Study|Withdrawal by Subject|3
7121541|NCT02632838|11260060|FG001|Overall Study|Withdrawal by Subject|0
7121542|NCT02632838|11260059|FG000|Overall Study|Lost to Follow-up|0
7121543|NCT02632838|11260060|FG001|Overall Study|Lost to Follow-up|2
7121544|NCT02633020|11260072|FG000|Overall Study|Adverse Event|1
7121545|NCT02633020|11260073|FG001|Overall Study|Adverse Event|0
7121546|NCT02633046|11260079|FG000|Overall Study|Adverse Event|8
7121547|NCT02633046|11260079|FG000|Overall Study|Physician Decision|7
7121548|NCT02633046|11260079|FG000|Overall Study|Withdrawal by Subject|8
7121549|NCT02633046|11260079|FG000|Overall Study|Increased proteinuria|2
7121550|NCT02633046|11260079|FG000|Overall Study|Participant decided not to continue with open label extension|1
7121551|NCT02633046|11260079|FG000|Overall Study|Mutual decision patient and physician|1
7121552|NCT02633215|11260085|FG000|Overall Study|Lost to Follow-up|2
7121553|NCT02633215|11260086|FG001|Overall Study|Lost to Follow-up|3
7121554|NCT02633306|11260092|FG000|Overall Study|Withdrawal by Subject|3
7121555|NCT02633501|11260126|FG000|Overall Study|Adverse Event|0
7121556|NCT02633501|11260127|FG001|Overall Study|Adverse Event|0
7121557|NCT02633501|11260128|FG002|Overall Study|Adverse Event|1
7121558|NCT02633501|11260129|FG003|Overall Study|Adverse Event|0
7121559|NCT02633501|11260130|FG004|Overall Study|Adverse Event|1
7121560|NCT02633501|11260131|FG005|Overall Study|Adverse Event|1
7121561|NCT02633501|11260126|FG000|Overall Study|Withdrawal by Subject|2
7121562|NCT02633501|11260127|FG001|Overall Study|Withdrawal by Subject|1
7121563|NCT02633501|11260128|FG002|Overall Study|Withdrawal by Subject|2
7121564|NCT02633501|11260129|FG003|Overall Study|Withdrawal by Subject|2
7121565|NCT02633501|11260130|FG004|Overall Study|Withdrawal by Subject|1
7121566|NCT02633501|11260131|FG005|Overall Study|Withdrawal by Subject|3
7121567|NCT02633501|11260126|FG000|Overall Study|Various other reasons|0
7121568|NCT02633501|11260127|FG001|Overall Study|Various other reasons|2
7121569|NCT02633501|11260128|FG002|Overall Study|Various other reasons|4
7121570|NCT02633501|11260129|FG003|Overall Study|Various other reasons|1
7121571|NCT02633501|11260130|FG004|Overall Study|Various other reasons|7
7121572|NCT02633501|11260131|FG005|Overall Study|Various other reasons|11
7121573|NCT02633501|11260126|FG000|Overall Study|Lost to Follow-up|0
7121574|NCT02633501|11260127|FG001|Overall Study|Lost to Follow-up|0
7121575|NCT02633501|11260128|FG002|Overall Study|Lost to Follow-up|0
7121576|NCT02633501|11260129|FG003|Overall Study|Lost to Follow-up|1
7121577|NCT02633501|11260130|FG004|Overall Study|Lost to Follow-up|2
7121578|NCT02633501|11260131|FG005|Overall Study|Lost to Follow-up|0
7121579|NCT02633527|11260155|FG000|Overall Study|Failed to meet eligibility|0
7121580|NCT02633527|11260156|FG001|Overall Study|Failed to meet eligibility|1
7121581|NCT02633527|11260157|FG002|Overall Study|Failed to meet eligibility|1
7121582|NCT02633527|11260158|FG003|Overall Study|Failed to meet eligibility|0
7121583|NCT02633527|11260159|FG004|Overall Study|Failed to meet eligibility|1
7121584|NCT02633527|11260155|FG000|Overall Study|Adverse Event|0
7121585|NCT02633527|11260156|FG001|Overall Study|Adverse Event|4
7121586|NCT02633527|11260157|FG002|Overall Study|Adverse Event|3
7121587|NCT02633527|11260158|FG003|Overall Study|Adverse Event|1
7121588|NCT02633527|11260159|FG004|Overall Study|Adverse Event|5
7121589|NCT02633527|11260155|FG000|Overall Study|Lost to Follow-up|1
7121590|NCT02633527|11260156|FG001|Overall Study|Lost to Follow-up|2
7121591|NCT02633527|11260157|FG002|Overall Study|Lost to Follow-up|5
7121592|NCT02633527|11260158|FG003|Overall Study|Lost to Follow-up|5
7121593|NCT02633527|11260159|FG004|Overall Study|Lost to Follow-up|4
7121594|NCT02633527|11260155|FG000|Overall Study|Withdrawal by Subject|0
7121595|NCT02633527|11260156|FG001|Overall Study|Withdrawal by Subject|3
7121596|NCT02633527|11260157|FG002|Overall Study|Withdrawal by Subject|5
7121597|NCT02633527|11260158|FG003|Overall Study|Withdrawal by Subject|4
7121598|NCT02633527|11260159|FG004|Overall Study|Withdrawal by Subject|4
7121599|NCT02633527|11260155|FG000|Overall Study|Protocol Violation|0
7121600|NCT02633527|11260156|FG001|Overall Study|Protocol Violation|1
7121601|NCT02633527|11260157|FG002|Overall Study|Protocol Violation|1
7121602|NCT02633527|11260158|FG003|Overall Study|Protocol Violation|1
7121603|NCT02633527|11260159|FG004|Overall Study|Protocol Violation|1
7121604|NCT02633527|11260155|FG000|Overall Study|Physician Decision|0
7121605|NCT02633527|11260156|FG001|Overall Study|Physician Decision|0
7121606|NCT02633527|11260157|FG002|Overall Study|Physician Decision|0
7121607|NCT02633527|11260158|FG003|Overall Study|Physician Decision|0
7121608|NCT02633527|11260159|FG004|Overall Study|Physician Decision|1
7121609|NCT02633527|11260155|FG000|Overall Study|Administrative reason|1
7121610|NCT02633527|11260156|FG001|Overall Study|Administrative reason|0
7121611|NCT02633527|11260157|FG002|Overall Study|Administrative reason|0
7121612|NCT02633527|11260158|FG003|Overall Study|Administrative reason|1
7121613|NCT02633527|11260159|FG004|Overall Study|Administrative reason|0
7121614|NCT02633527|11260155|FG000|Overall Study|Multiple reasons|1
7121615|NCT02633527|11260156|FG001|Overall Study|Multiple reasons|0
7121616|NCT02633527|11260157|FG002|Overall Study|Multiple reasons|2
7121617|NCT02633527|11260158|FG003|Overall Study|Multiple reasons|2
7121618|NCT02633527|11260159|FG004|Overall Study|Multiple reasons|1
7121619|NCT02633787|11260180|FG000|Overall Study|Withdrawal by Subject|1
7121620|NCT02633800|11260186|FG000|Overall Study|Death|3
7121621|NCT02633800|11260187|FG001|Overall Study|Death|3
7121622|NCT02633800|11260186|FG000|Overall Study|Reason not provided|1
7121623|NCT02633800|11260187|FG001|Overall Study|Reason not provided|0
7121624|NCT02633800|11260186|FG000|Overall Study|Radiologic(al) progression|23
7121625|NCT02633800|11260187|FG001|Overall Study|Radiologic(al) progression|23
7121626|NCT02633800|11260186|FG000|Overall Study|Clinical progression|3
7121627|NCT02633800|11260187|FG001|Overall Study|Clinical progression|6
7121628|NCT02633800|11260186|FG000|Overall Study|Study terminated by sponsor|6
7121629|NCT02633800|11260187|FG001|Overall Study|Study terminated by sponsor|5
7121630|NCT02633800|11260186|FG000|Overall Study|Adverse event, non-fatal|7
7121631|NCT02633800|11260187|FG001|Overall Study|Adverse event, non-fatal|2
7121632|NCT02633800|11260186|FG000|Overall Study|Withdrawal by Subject|0
7121633|NCT02633800|11260187|FG001|Overall Study|Withdrawal by Subject|3
7121634|NCT02633800|11260186|FG000|Overall Study|Patient Request|1
7121635|NCT02633800|11260187|FG001|Overall Study|Patient Request|1
7121636|NCT02634151|11260229|FG000|Overall Study|Withdrawal by Subject|1
7121637|NCT02634151|11260230|FG001|Overall Study|Withdrawal by Subject|0
7121638|NCT02634151|11260229|FG000|Overall Study|Non-Compliance|0
7121639|NCT02634151|11260230|FG001|Overall Study|Non-Compliance|1
7121640|NCT02634151|11260229|FG000|Overall Study|Other|0
7121641|NCT02634151|11260230|FG001|Overall Study|Other|1
7121642|NCT02634320|11260245|FG000|Overall Study|Adverse Event|2
7121643|NCT02634320|11260245|FG000|Overall Study|Lost to Follow-up|3
7121644|NCT02634320|11260245|FG000|Overall Study|Moved out of area|2
7121645|NCT02634320|11260245|FG000|Overall Study|Out of window for study visits|1
7121646|NCT02634320|11260245|FG000|Overall Study|Protocol Violation|1
7121647|NCT02634320|11260245|FG000|Overall Study|Withdrawal by Subject|5
7121648|NCT02634320|11260245|FG000|Overall Study|Lack of Efficacy|2
7121649|NCT02634333|11260251|FG000|Overall Study|Completed out of Window|3
7121650|NCT02634333|11260252|FG001|Overall Study|Completed out of Window|2
7121651|NCT02634333|11260251|FG000|Overall Study|Missed Visit|5
7121652|NCT02634333|11260252|FG001|Overall Study|Missed Visit|2
7121653|NCT02634333|11260251|FG000|Overall Study|Lost to Follow-up|12
7121654|NCT02634333|11260252|FG001|Overall Study|Lost to Follow-up|7
7121655|NCT02634333|11260251|FG000|Overall Study|Withdrawal by Subject|9
7121656|NCT02634333|11260252|FG001|Overall Study|Withdrawal by Subject|13
7121657|NCT02634333|11260251|FG000|Overall Study|Death|11
7121658|NCT02634333|11260252|FG001|Overall Study|Death|8
7121659|NCT02634346|11260262|FG000|Overall Study|Withdrawal by Subject|8
7121660|NCT02634346|11260263|FG001|Overall Study|Withdrawal by Subject|9
7121661|NCT02634346|11260264|FG002|Overall Study|Withdrawal by Subject|8
7121662|NCT02634346|11260262|FG000|Overall Study|Adverse Event|2
7121663|NCT02634346|11260263|FG001|Overall Study|Adverse Event|2
7121664|NCT02634346|11260264|FG002|Overall Study|Adverse Event|7
7121665|NCT02634346|11260262|FG000|Overall Study|Lack of Efficacy|1
7121666|NCT02634346|11260263|FG001|Overall Study|Lack of Efficacy|2
7121667|NCT02634346|11260264|FG002|Overall Study|Lack of Efficacy|8
7121668|NCT02634346|11260262|FG000|Overall Study|Lost to Follow-up|1
7121669|NCT02634346|11260263|FG001|Overall Study|Lost to Follow-up|0
7121670|NCT02634346|11260264|FG002|Overall Study|Lost to Follow-up|0
7121671|NCT02634346|11260262|FG000|Overall Study|Protocol Violation|0
7121672|NCT02634346|11260263|FG001|Overall Study|Protocol Violation|1
7121673|NCT02634346|11260264|FG002|Overall Study|Protocol Violation|0
7121674|NCT02634580|11260276|FG000|Double-blind Treatment Period|Subject Request|1
7121675|NCT02634580|11260277|FG001|Double-blind Treatment Period|Subject Request|0
7121676|NCT02634580|11260278|FG002|Double-blind Treatment Period|Subject Request|1
7121677|NCT02634580|11260279|FG003|Double-blind Treatment Period|Subject Request|1
7121678|NCT02634580|11260276|FG000|Open-label Extension Period|Withdrawal by Subject|0
7121679|NCT02634580|11260277|FG001|Open-label Extension Period|Withdrawal by Subject|1
7121680|NCT02634580|11260278|FG002|Open-label Extension Period|Withdrawal by Subject|0
7121681|NCT02634580|11260279|FG003|Open-label Extension Period|Withdrawal by Subject|1
7121682|NCT02634788|11260309|FG000|Overall Study|Adverse Event|0
7121683|NCT02634788|11260310|FG001|Overall Study|Adverse Event|8
7121684|NCT02634788|11260311|FG002|Overall Study|Adverse Event|3
7121685|NCT02634788|11260312|FG003|Overall Study|Adverse Event|1
7121686|NCT02634788|11260309|FG000|Overall Study|Lack of Efficacy|4
7121687|NCT02634788|11260310|FG001|Overall Study|Lack of Efficacy|0
7121688|NCT02634788|11260311|FG002|Overall Study|Lack of Efficacy|1
7121689|NCT02634788|11260312|FG003|Overall Study|Lack of Efficacy|4
7121690|NCT02634788|11260309|FG000|Overall Study|Lost to Follow-up|0
7121691|NCT02634788|11260310|FG001|Overall Study|Lost to Follow-up|1
7121692|NCT02634788|11260311|FG002|Overall Study|Lost to Follow-up|0
7121693|NCT02634788|11260312|FG003|Overall Study|Lost to Follow-up|0
7121694|NCT02634788|11260309|FG000|Overall Study|Withdrawal by Subject|0
7121695|NCT02634788|11260310|FG001|Overall Study|Withdrawal by Subject|1
7121696|NCT02634788|11260311|FG002|Overall Study|Withdrawal by Subject|1
7121697|NCT02634788|11260312|FG003|Overall Study|Withdrawal by Subject|0
7121698|NCT02634801|11260325|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2
7121699|NCT02634801|11260326|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20
7121700|NCT02634801|11260327|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0
7121701|NCT02634801|11260325|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0
7121702|NCT02634801|11260326|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2
7121703|NCT02634801|11260327|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0
7121704|NCT02634801|11260325|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2
7121705|NCT02634801|11260326|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1
7121706|NCT02634801|11260327|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1
7121707|NCT02634801|11260325|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0
7121708|NCT02634801|11260326|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0
7121709|NCT02634801|11260327|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1
7121710|NCT02634801|11260325|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0
7121711|NCT02634801|11260326|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8
7121712|NCT02634801|11260327|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3
7121713|NCT02634801|11260325|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0
7121714|NCT02634801|11260326|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0
7121715|NCT02634801|11260327|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1
7121716|NCT02634801|11260325|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1
7121717|NCT02634801|11260326|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0
7121718|NCT02634801|11260327|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0
7121719|NCT02634801|11260325|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
7121720|NCT02634801|11260326|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
7121721|NCT02634801|11260327|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
7121722|NCT02634801|11260325|FG000|Extension Period (Weeks 24 to 36)|Missing|1
7121723|NCT02634801|11260326|FG001|Extension Period (Weeks 24 to 36)|Missing|0
7121724|NCT02634801|11260327|FG002|Extension Period (Weeks 24 to 36)|Missing|0
7121725|NCT02634801|11260325|FG000|Follow-up Period|Lost to Follow-up|3
7121726|NCT02634801|11260326|FG001|Follow-up Period|Lost to Follow-up|1
7121727|NCT02634801|11260327|FG002|Follow-up Period|Lost to Follow-up|2
7121728|NCT02634801|11260325|FG000|Follow-up Period|Physician Decision|0
7121729|NCT02634801|11260326|FG001|Follow-up Period|Physician Decision|0
7121730|NCT02634801|11260327|FG002|Follow-up Period|Physician Decision|1
7121731|NCT02634801|11260325|FG000|Follow-up Period|Withdrawal by Subject|1
7121732|NCT02634801|11260326|FG001|Follow-up Period|Withdrawal by Subject|2
7121733|NCT02634801|11260327|FG002|Follow-up Period|Withdrawal by Subject|5
7121734|NCT02634801|11260325|FG000|Follow-up Period|Adverse Event|1
7121735|NCT02634801|11260326|FG001|Follow-up Period|Adverse Event|5
7121736|NCT02634801|11260327|FG002|Follow-up Period|Adverse Event|0
7121737|NCT02634983|11260352|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2
7121738|NCT02634983|11260353|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0
7121739|NCT02635204|11260370|FG000|Overall Study|Adverse Event|1
7121740|NCT02635204|11260371|FG001|Overall Study|Adverse Event|0
7121741|NCT02635204|11260370|FG000|Overall Study|Lost to Follow-up|1
7121742|NCT02635204|11260371|FG001|Overall Study|Lost to Follow-up|1
7121743|NCT02635347|11260379|FG000|Overall Study|Failed screening|20
7121744|NCT02635347|11260380|FG001|Overall Study|Failed screening|7
7121745|NCT02635386|11260392|FG000|Overall Study|Pregnancy|2
7121746|NCT02635386|11260393|FG001|Overall Study|Pregnancy|0
7121747|NCT02635386|11260394|FG002|Overall Study|Pregnancy|0
7121748|NCT02635386|11260395|FG003|Overall Study|Pregnancy|0
7121749|NCT02635386|11260396|FG004|Overall Study|Pregnancy|2
7121750|NCT02635386|11260392|FG000|Overall Study|Withdrawal by Subject|1
7121751|NCT02635386|11260393|FG001|Overall Study|Withdrawal by Subject|1
7121752|NCT02635386|11260394|FG002|Overall Study|Withdrawal by Subject|0
7121753|NCT02635386|11260395|FG003|Overall Study|Withdrawal by Subject|1
7121754|NCT02635386|11260396|FG004|Overall Study|Withdrawal by Subject|0
7121755|NCT02635386|11260392|FG000|Overall Study|Physician Decision|0
7121756|NCT02635386|11260393|FG001|Overall Study|Physician Decision|1
7121757|NCT02635386|11260394|FG002|Overall Study|Physician Decision|0
7121758|NCT02635386|11260395|FG003|Overall Study|Physician Decision|0
7121759|NCT02635386|11260396|FG004|Overall Study|Physician Decision|0
7121760|NCT02635386|11260392|FG000|Overall Study|Moved Out of State|0
7121761|NCT02635386|11260393|FG001|Overall Study|Moved Out of State|1
7121762|NCT02635386|11260394|FG002|Overall Study|Moved Out of State|0
7121763|NCT02635386|11260395|FG003|Overall Study|Moved Out of State|0
7121764|NCT02635386|11260396|FG004|Overall Study|Moved Out of State|0
7121765|NCT02635386|11260392|FG000|Overall Study|Noncompliant|0
7121766|NCT02635386|11260393|FG001|Overall Study|Noncompliant|2
7121767|NCT02635386|11260394|FG002|Overall Study|Noncompliant|1
7121768|NCT02635386|11260395|FG003|Overall Study|Noncompliant|1
7121769|NCT02635386|11260396|FG004|Overall Study|Noncompliant|1
7121770|NCT02635386|11260392|FG000|Overall Study|side effects|0
7121771|NCT02635386|11260393|FG001|Overall Study|side effects|0
7121772|NCT02635386|11260394|FG002|Overall Study|side effects|1
7121773|NCT02635386|11260395|FG003|Overall Study|side effects|4
7121774|NCT02635386|11260396|FG004|Overall Study|side effects|6
7121775|NCT02635386|11260392|FG000|Overall Study|needed other major surgery|0
7121776|NCT02635386|11260393|FG001|Overall Study|needed other major surgery|1
7121777|NCT02635386|11260394|FG002|Overall Study|needed other major surgery|0
7121778|NCT02635386|11260395|FG003|Overall Study|needed other major surgery|0
7121779|NCT02635386|11260396|FG004|Overall Study|needed other major surgery|0
7121780|NCT02635386|11260392|FG000|Overall Study|Other medical problems not drug related|0
7121781|NCT02635386|11260393|FG001|Overall Study|Other medical problems not drug related|0
7121782|NCT02635386|11260394|FG002|Overall Study|Other medical problems not drug related|0
7121783|NCT02635386|11260395|FG003|Overall Study|Other medical problems not drug related|1
7121784|NCT02635386|11260396|FG004|Overall Study|Other medical problems not drug related|0
7121785|NCT02635646|11260433|FG000|Overall Study|Lost to Follow-up|24
7121786|NCT02635646|11260434|FG001|Overall Study|Lost to Follow-up|25
7121787|NCT02635646|11260433|FG000|Overall Study|Pregnancy|1
7121788|NCT02635646|11260434|FG001|Overall Study|Pregnancy|1
7121789|NCT02635724|11260449|FG000|Overall Study|Withdrawal by Subject|0
7121790|NCT02635724|11260450|FG001|Overall Study|Withdrawal by Subject|1
7121791|NCT02635724|11260451|FG002|Overall Study|Withdrawal by Subject|0
7121792|NCT02635737|11260459|FG000|Overall Study|Protocol Violation|1
7121793|NCT02635984|11260473|FG000|Overall Study|Lost to Follow-up|2
7121794|NCT02635984|11260474|FG001|Overall Study|Lost to Follow-up|4
7121795|NCT02635984|11260473|FG000|Overall Study|Study Arm Closed|1
7121796|NCT02635984|11260474|FG001|Overall Study|Study Arm Closed|0
7121797|NCT02636361|11260486|FG000|Period 4|Physician Decision|0
7121798|NCT02636361|11260487|FG001|Period 4|Physician Decision|0
7121799|NCT02636361|11260488|FG002|Period 4|Physician Decision|0
7121800|NCT02636361|11260489|FG003|Period 4|Physician Decision|1
7121801|NCT02636361|11260490|FG004|Period 4|Physician Decision|0
7121802|NCT02636595|11260504|FG000|Overall Study|Lost to Follow-up|1
7121803|NCT02636595|11260504|FG000|Overall Study|Other|1
7121804|NCT02636608|11260508|FG000|Overall Study|Failure to Return|4
7121805|NCT02636608|11260508|FG000|Overall Study|Insufficient Virological Response|1
7121806|NCT02636608|11260508|FG000|Overall Study|Death|3
7121807|NCT02636608|11260508|FG000|Overall Study|Other|2
7121808|NCT02636608|11260508|FG000|Overall Study|Did Not Receive Treatment|1
7121809|NCT02636699|11260517|FG000|Overall Study|Adverse Event|4
7121810|NCT02636699|11260518|FG001|Overall Study|Adverse Event|0
7121811|NCT02636699|11260517|FG000|Overall Study|Lost to Follow-up|3
7121812|NCT02636699|11260518|FG001|Overall Study|Lost to Follow-up|3
7121813|NCT02636699|11260517|FG000|Overall Study|Non-compliance with the investigational product (IP)|2
7121814|NCT02636699|11260518|FG001|Overall Study|Non-compliance with the investigational product (IP)|0
7121815|NCT02636699|11260517|FG000|Overall Study|Physician Decision|0
7121816|NCT02636699|11260518|FG001|Overall Study|Physician Decision|1
7121817|NCT02636699|11260517|FG000|Overall Study|Withdrawal by Subject|13
7121818|NCT02636699|11260518|FG001|Overall Study|Withdrawal by Subject|6
7121819|NCT02636699|11260517|FG000|Overall Study|Other|3
7121820|NCT02636699|11260518|FG001|Overall Study|Other|1
7121821|NCT02636725|11260529|FG000|Baseline|Adverse Event|1
7121822|NCT02636725|11260529|FG000|Baseline|Lack of Efficacy|2
7121823|NCT02636868|11260536|FG000|Overall Study|Death|0
7121824|NCT02636868|11260537|FG001|Overall Study|Death|1
7121825|NCT02636868|11260538|FG002|Overall Study|Death|2
7121826|NCT02636907|11260546|FG000|Autoinjector Assessment Period|Adverse Event|2
7121827|NCT02636907|11260546|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2
7121828|NCT02636907|11260546|FG000|Extension Phase|Adverse Event|2
7121829|NCT02636907|11260546|FG000|Extension Phase|Withdrawal by Subject|4
7121830|NCT02636907|11260546|FG000|Extension Phase|Physician Decision|1
7121831|NCT02636907|11260546|FG000|Extension Phase|Lost to Follow-up|2
7121832|NCT02636907|11260546|FG000|Extension Phase|Lack of Efficacy|1
7121833|NCT02637037|11260552|FG000|Overall Study|Positive drug screen at admission|1
7121834|NCT02637037|11260553|FG001|Overall Study|Positive drug screen at admission|0
7121835|NCT02637037|11260552|FG000|Overall Study|Withdrawal by Subject|2
7121836|NCT02637037|11260553|FG001|Overall Study|Withdrawal by Subject|1
7121837|NCT02637037|11260552|FG000|Overall Study|Adverse Event|1
7121838|NCT02637037|11260553|FG001|Overall Study|Adverse Event|0
7121839|NCT02637063|11260574|FG000|Overall Study|Lost to Follow-up|3
7121840|NCT02637063|11260575|FG001|Overall Study|Lost to Follow-up|2
7121841|NCT02637063|11260576|FG002|Overall Study|Lost to Follow-up|3
7121842|NCT02637063|11260574|FG000|Overall Study|Withdrawal by Subject|2
7121843|NCT02637063|11260575|FG001|Overall Study|Withdrawal by Subject|2
7121844|NCT02637063|11260576|FG002|Overall Study|Withdrawal by Subject|3
7121845|NCT02637076|11260586|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1
7121846|NCT02637076|11260587|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1
7121847|NCT02637076|11260586|FG000|Overall Study|Withdrawal by Subject|0
7121848|NCT02637076|11260587|FG001|Overall Study|Withdrawal by Subject|4
7121849|NCT02637141|11260596|FG000|Overall Study|Adverse Event|1
7121850|NCT02637141|11260597|FG001|Overall Study|Adverse Event|1
7121851|NCT02637141|11260598|FG002|Overall Study|Adverse Event|0
7121852|NCT02637141|11260596|FG000|Overall Study|Withdrawal by Subject|1
7121853|NCT02637141|11260597|FG001|Overall Study|Withdrawal by Subject|1
7121854|NCT02637141|11260598|FG002|Overall Study|Withdrawal by Subject|1
7121855|NCT02637232|11260606|FG000|Overall Study|Lost to Follow-up|42
7121856|NCT02637232|11260606|FG000|Overall Study|Adverse Event|11
7121857|NCT02637232|11260606|FG000|Overall Study|patient 's decision|2
7121858|NCT02637323|11260612|FG000|Overall Study|Lost to Follow-up|2
7121859|NCT02637323|11260613|FG001|Overall Study|Lost to Follow-up|0
7121860|NCT02637323|11260612|FG000|Overall Study|Protocol Violation|0
7121861|NCT02637323|11260613|FG001|Overall Study|Protocol Violation|1
7121862|NCT02637557|11260633|FG000|Overall Study|Adverse Event|3
7121863|NCT02637557|11260634|FG001|Overall Study|Adverse Event|1
7121864|NCT02637557|11260635|FG002|Overall Study|Adverse Event|3
7121865|NCT02637557|11260636|FG003|Overall Study|Adverse Event|3
7121866|NCT02637557|11260633|FG000|Overall Study|Lost to Follow-up|1
7121867|NCT02637557|11260634|FG001|Overall Study|Lost to Follow-up|1
7121868|NCT02637557|11260635|FG002|Overall Study|Lost to Follow-up|0
7121869|NCT02637557|11260636|FG003|Overall Study|Lost to Follow-up|1
7121870|NCT02637557|11260633|FG000|Overall Study|Physician Decision|1
7121871|NCT02637557|11260634|FG001|Overall Study|Physician Decision|0
7121872|NCT02637557|11260635|FG002|Overall Study|Physician Decision|0
7121873|NCT02637557|11260636|FG003|Overall Study|Physician Decision|0
7121874|NCT02637557|11260633|FG000|Overall Study|Protocol Violation|2
7121875|NCT02637557|11260634|FG001|Overall Study|Protocol Violation|0
7121876|NCT02637557|11260635|FG002|Overall Study|Protocol Violation|2
7121877|NCT02637557|11260636|FG003|Overall Study|Protocol Violation|1
7121878|NCT02637557|11260633|FG000|Overall Study|Withdrawal by Subject|1
7121879|NCT02637557|11260634|FG001|Overall Study|Withdrawal by Subject|3
7121880|NCT02637557|11260635|FG002|Overall Study|Withdrawal by Subject|4
7121881|NCT02637557|11260636|FG003|Overall Study|Withdrawal by Subject|2
6806065|NCT01970865|10808454|FG003|Overall Study|Death|4
6806066|NCT01970865|10808455|FG004|Overall Study|Death|6
6806067|NCT01970865|10808456|FG005|Overall Study|Death|3
6806068|NCT01970865|10808457|FG006|Overall Study|Death|1
6806069|NCT01970865|10808458|FG007|Overall Study|Death|3
6806070|NCT01970865|10808459|FG008|Overall Study|Death|2
6806071|NCT01970865|10808460|FG009|Overall Study|Death|1
6806072|NCT01970865|10808461|FG010|Overall Study|Death|1
6806073|NCT01970865|10808462|FG011|Overall Study|Death|4
6806074|NCT01970865|10808463|FG012|Overall Study|Death|14
6806075|NCT01970865|10808464|FG013|Overall Study|Death|19
6806076|NCT01970865|10808465|FG014|Overall Study|Death|15
6806077|NCT01970865|10808466|FG015|Overall Study|Death|10
6806078|NCT01970865|10808467|FG016|Overall Study|Death|1
6806079|NCT01970865|10808451|FG000|Overall Study|Lost to Follow-up|0
6806080|NCT01970865|10808452|FG001|Overall Study|Lost to Follow-up|0
6806081|NCT01970865|10808453|FG002|Overall Study|Lost to Follow-up|0
6806082|NCT01970865|10808454|FG003|Overall Study|Lost to Follow-up|1
6806083|NCT01970865|10808455|FG004|Overall Study|Lost to Follow-up|1
6806084|NCT01970865|10808456|FG005|Overall Study|Lost to Follow-up|0
6806085|NCT01970865|10808457|FG006|Overall Study|Lost to Follow-up|0
6806086|NCT01970865|10808458|FG007|Overall Study|Lost to Follow-up|0
6806087|NCT01970865|10808459|FG008|Overall Study|Lost to Follow-up|0
6806088|NCT01970865|10808460|FG009|Overall Study|Lost to Follow-up|0
6806089|NCT01970865|10808461|FG010|Overall Study|Lost to Follow-up|0
6806090|NCT01970865|10808462|FG011|Overall Study|Lost to Follow-up|0
6806091|NCT01970865|10808463|FG012|Overall Study|Lost to Follow-up|1
7121882|NCT02637856|11260668|FG000|Main Study (Baseline to Week 100)|Adverse Event|9
7121883|NCT02637856|11260669|FG001|Main Study (Baseline to Week 100)|Adverse Event|0
7121884|NCT02637856|11260668|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5
7121885|NCT02637856|11260669|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0
7121886|NCT02637856|11260668|FG000|Main Study (Baseline to Week 100)|Physician Decision|2
7121887|NCT02637856|11260669|FG001|Main Study (Baseline to Week 100)|Physician Decision|0
7121888|NCT02637856|11260668|FG000|Main Study (Baseline to Week 100)|Pregnancy|7
7121889|NCT02637856|11260669|FG001|Main Study (Baseline to Week 100)|Pregnancy|0
7121890|NCT02637856|11260668|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20
7121891|NCT02637856|11260669|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0
7121892|NCT02637856|11260668|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2
6806092|NCT01970865|10808464|FG013|Overall Study|Lost to Follow-up|0
6806093|NCT01970865|10808465|FG014|Overall Study|Lost to Follow-up|0
6806094|NCT01970865|10808466|FG015|Overall Study|Lost to Follow-up|0
6806095|NCT01970865|10808467|FG016|Overall Study|Lost to Follow-up|0
6806096|NCT01970865|10808451|FG000|Overall Study|Withdrawal by Subject|0
7121893|NCT02637856|11260669|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0
7121894|NCT02637856|11260668|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164
7121895|NCT02637856|11260669|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0
7121896|NCT02637856|11260668|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1
7121897|NCT02637856|11260669|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0
7121898|NCT02637856|11260668|FG000|Main Study (Baseline to Week 100)|Incarceration|1
7121899|NCT02637856|11260669|FG001|Main Study (Baseline to Week 100)|Incarceration|0
7121900|NCT02637856|11260668|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2
7121901|NCT02637856|11260669|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0
7121902|NCT02637856|11260668|FG000|Main Study (Baseline to Week 100)|Site Closing|6
7121903|NCT02637856|11260669|FG001|Main Study (Baseline to Week 100)|Site Closing|0
6806097|NCT01970865|10808452|FG001|Overall Study|Withdrawal by Subject|0
6806098|NCT01970865|10808453|FG002|Overall Study|Withdrawal by Subject|0
6806099|NCT01970865|10808454|FG003|Overall Study|Withdrawal by Subject|1
6806100|NCT01970865|10808455|FG004|Overall Study|Withdrawal by Subject|2
7121904|NCT02637856|11260668|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0
7121905|NCT02637856|11260669|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1
7121906|NCT02637856|11260668|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0
7121907|NCT02637856|11260669|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3
7121908|NCT02637895|11260677|FG000|Overall Study|Lost to Follow-up|4
7121909|NCT02637895|11260678|FG001|Overall Study|Lost to Follow-up|0
7121910|NCT02637895|11260677|FG000|Overall Study|Protocol Violation|0
7121911|NCT02637895|11260678|FG001|Overall Study|Protocol Violation|1
7121912|NCT02637895|11260677|FG000|Overall Study|Lack of Efficacy|1
7121913|NCT02637895|11260678|FG001|Overall Study|Lack of Efficacy|0
7121914|NCT02637895|11260677|FG000|Overall Study|Withdrawal by Subject|1
7121915|NCT02637895|11260678|FG001|Overall Study|Withdrawal by Subject|1
7121916|NCT02637895|11260677|FG000|Overall Study|Abnormal baseline lab|0
7121917|NCT02637895|11260678|FG001|Overall Study|Abnormal baseline lab|1
7121918|NCT02638012|11260698|FG000|Overall Study|Lost to Follow-up|1
7121919|NCT02638103|11260715|FG000|Overall Study|Adverse Event|13
7121920|NCT02638103|11260716|FG001|Overall Study|Adverse Event|12
7121921|NCT02638103|11260717|FG002|Overall Study|Adverse Event|19
7121922|NCT02638103|11260718|FG003|Overall Study|Adverse Event|12
7121923|NCT02638103|11260715|FG000|Overall Study|Withdrawal by Subject|43
7121924|NCT02638103|11260716|FG001|Overall Study|Withdrawal by Subject|53
7121925|NCT02638103|11260717|FG002|Overall Study|Withdrawal by Subject|30
7121926|NCT02638103|11260718|FG003|Overall Study|Withdrawal by Subject|61
7121927|NCT02638103|11260715|FG000|Overall Study|Protocol Violation|1
7121928|NCT02638103|11260716|FG001|Overall Study|Protocol Violation|2
7121929|NCT02638103|11260717|FG002|Overall Study|Protocol Violation|1
7121930|NCT02638103|11260718|FG003|Overall Study|Protocol Violation|4
7121931|NCT02638103|11260715|FG000|Overall Study|Pregnancy|2
7121932|NCT02638103|11260716|FG001|Overall Study|Pregnancy|3
7121933|NCT02638103|11260717|FG002|Overall Study|Pregnancy|0
7121934|NCT02638103|11260718|FG003|Overall Study|Pregnancy|1
7121935|NCT02638103|11260715|FG000|Overall Study|Non-compliance to Study Procedures|2
7121936|NCT02638103|11260716|FG001|Overall Study|Non-compliance to Study Procedures|1
7121937|NCT02638103|11260717|FG002|Overall Study|Non-compliance to Study Procedures|1
7121938|NCT02638103|11260718|FG003|Overall Study|Non-compliance to Study Procedures|1
7121939|NCT02638103|11260715|FG000|Overall Study|Lost to Follow-up|26
7121940|NCT02638103|11260716|FG001|Overall Study|Lost to Follow-up|33
7121941|NCT02638103|11260717|FG002|Overall Study|Lost to Follow-up|20
7121942|NCT02638103|11260718|FG003|Overall Study|Lost to Follow-up|37
7121943|NCT02638103|11260715|FG000|Overall Study|Lack of Efficacy|14
7121944|NCT02638103|11260716|FG001|Overall Study|Lack of Efficacy|10
7121945|NCT02638103|11260717|FG002|Overall Study|Lack of Efficacy|12
7121946|NCT02638103|11260718|FG003|Overall Study|Lack of Efficacy|22
7121947|NCT02638103|11260715|FG000|Overall Study|Other than specified|5
7121948|NCT02638103|11260716|FG001|Overall Study|Other than specified|4
7121949|NCT02638103|11260717|FG002|Overall Study|Other than specified|2
7121950|NCT02638103|11260718|FG003|Overall Study|Other than specified|4
7121951|NCT02638259|11260758|FG000|Treatment Period 1|Adverse Event|1
7121952|NCT02638259|11260759|FG001|Treatment Period 1|Adverse Event|5
7121953|NCT02638259|11260758|FG000|Treatment Period 1|Death|0
7121954|NCT02638259|11260759|FG001|Treatment Period 1|Death|1
7121955|NCT02638259|11260758|FG000|Treatment Period 1|Lack of Efficacy|0
7121956|NCT02638259|11260759|FG001|Treatment Period 1|Lack of Efficacy|1
7121957|NCT02638259|11260758|FG000|Treatment Period 1|Protocol Violation|0
7121958|NCT02638259|11260759|FG001|Treatment Period 1|Protocol Violation|3
7121959|NCT02638259|11260758|FG000|Treatment Period 1|Withdrawal by Subject|4
7121960|NCT02638259|11260759|FG001|Treatment Period 1|Withdrawal by Subject|6
7121961|NCT02638259|11260758|FG000|Treatment Period 1|Withdrawn per sponsor decision|0
7121962|NCT02638259|11260759|FG001|Treatment Period 1|Withdrawn per sponsor decision|2
7121963|NCT02638259|11260758|FG000|Treatment Period 2|Adverse Event|5
7121964|NCT02638259|11260759|FG001|Treatment Period 2|Adverse Event|4
7121965|NCT02638259|11260758|FG000|Treatment Period 2|Withdrawal by Subject|1
7121966|NCT02638259|11260759|FG001|Treatment Period 2|Withdrawal by Subject|7
7121967|NCT02638337|11260771|FG000|Overall Study|Adverse Event|6
7121968|NCT02638337|11260772|FG001|Overall Study|Adverse Event|10
7121969|NCT02638337|11260771|FG000|Overall Study|Protocol Violation|3
7121970|NCT02638337|11260772|FG001|Overall Study|Protocol Violation|0
7121971|NCT02638337|11260771|FG000|Overall Study|Withdrawal by Subject|13
7121972|NCT02638337|11260772|FG001|Overall Study|Withdrawal by Subject|16
7121973|NCT02638337|11260771|FG000|Overall Study|Lost to Follow-up|7
7121974|NCT02638337|11260772|FG001|Overall Study|Lost to Follow-up|7
7121975|NCT02638337|11260771|FG000|Overall Study|Other - Miscellaneous|4
7121976|NCT02638337|11260772|FG001|Overall Study|Other - Miscellaneous|3
7121977|NCT02638493|11260781|FG000|Overall Study|Inability to provide semen samples|2
7121978|NCT02638493|11260782|FG001|Overall Study|Inability to provide semen samples|0
7121979|NCT02638493|11260783|FG002|Overall Study|Inability to provide semen samples|0
7121980|NCT02638623|11260804|FG000|Overall Study|Surgery timing|5
7121981|NCT02638623|11260805|FG001|Overall Study|Surgery timing|6
7121982|NCT02638623|11260804|FG000|Overall Study|Not given intervention|2
7121983|NCT02638623|11260805|FG001|Overall Study|Not given intervention|0
7121984|NCT02638948|11260815|FG000|Overall Study|Withdrawal by Subject|4
7121985|NCT02638948|11260816|FG001|Overall Study|Withdrawal by Subject|5
7121986|NCT02638948|11260817|FG002|Overall Study|Withdrawal by Subject|3
7121987|NCT02638948|11260818|FG003|Overall Study|Withdrawal by Subject|1
7121988|NCT02638948|11260815|FG000|Overall Study|Administrative Reason by Sponsor|0
7121989|NCT02638948|11260816|FG001|Overall Study|Administrative Reason by Sponsor|1
7121990|NCT02638948|11260817|FG002|Overall Study|Administrative Reason by Sponsor|0
7121991|NCT02638948|11260818|FG003|Overall Study|Administrative Reason by Sponsor|4
7121992|NCT02638948|11260815|FG000|Overall Study|Adverse Event|0
7121993|NCT02638948|11260816|FG001|Overall Study|Adverse Event|0
7121994|NCT02638948|11260817|FG002|Overall Study|Adverse Event|1
7121995|NCT02638948|11260818|FG003|Overall Study|Adverse Event|1
7121996|NCT02638948|11260815|FG000|Overall Study|Lack of Efficacy|1
7121997|NCT02638948|11260816|FG001|Overall Study|Lack of Efficacy|1
7121998|NCT02638948|11260817|FG002|Overall Study|Lack of Efficacy|0
7121999|NCT02638948|11260818|FG003|Overall Study|Lack of Efficacy|0
7122000|NCT02638948|11260815|FG000|Overall Study|Lost to Follow-up|0
7122001|NCT02638948|11260816|FG001|Overall Study|Lost to Follow-up|0
7122002|NCT02638948|11260817|FG002|Overall Study|Lost to Follow-up|1
7122003|NCT02638948|11260818|FG003|Overall Study|Lost to Follow-up|1
7122004|NCT02638948|11260815|FG000|Overall Study|Poor/Non-Compliance|0
7122005|NCT02638948|11260816|FG001|Overall Study|Poor/Non-Compliance|2
7122006|NCT02638948|11260817|FG002|Overall Study|Poor/Non-Compliance|1
7122007|NCT02638948|11260818|FG003|Overall Study|Poor/Non-Compliance|0
7122008|NCT02638948|11260815|FG000|Overall Study|Participant no longer met study criteria|0
7122009|NCT02638948|11260816|FG001|Overall Study|Participant no longer met study criteria|1
7122010|NCT02638948|11260817|FG002|Overall Study|Participant no longer met study criteria|0
7122011|NCT02638948|11260818|FG003|Overall Study|Participant no longer met study criteria|0
7122012|NCT02638948|11260815|FG000|Overall Study|Other than specified above|4
7122013|NCT02638948|11260816|FG001|Overall Study|Other than specified above|1
7122014|NCT02638948|11260817|FG002|Overall Study|Other than specified above|1
7122015|NCT02638948|11260818|FG003|Overall Study|Other than specified above|1
7122016|NCT02639052|11260840|FG000|Overall Study|Lost to Follow-up|1
7122017|NCT02639182|11260848|FG000|Overall Study|Disease Progression|50
7122018|NCT02639182|11260849|FG001|Overall Study|Disease Progression|49
7122019|NCT02639182|11260848|FG000|Overall Study|Adverse Event|7
7122020|NCT02639182|11260849|FG001|Overall Study|Adverse Event|5
7122021|NCT02639182|11260848|FG000|Overall Study|Physician Decision|3
7122022|NCT02639182|11260849|FG001|Overall Study|Physician Decision|3
7122023|NCT02639182|11260848|FG000|Overall Study|Withdrew Consent|5
7122024|NCT02639182|11260849|FG001|Overall Study|Withdrew Consent|4
7122025|NCT02639182|11260848|FG000|Overall Study|Lost to Follow-up|0
7122026|NCT02639182|11260849|FG001|Overall Study|Lost to Follow-up|1
7122027|NCT02639182|11260848|FG000|Overall Study|Study Closure|1
7122028|NCT02639182|11260849|FG001|Overall Study|Study Closure|2
7122029|NCT02639182|11260848|FG000|Overall Study|Sponsor Ended Study|0
7122030|NCT02639182|11260849|FG001|Overall Study|Sponsor Ended Study|1
7122031|NCT02639182|11260848|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1
7122032|NCT02639182|11260849|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1
7122033|NCT02639247|11260857|FG000|Overall Study|Lost to Follow-up|2
7122034|NCT02639247|11260858|FG001|Overall Study|Lost to Follow-up|1
7122035|NCT02639247|11260857|FG000|Overall Study|Death|2
7122036|NCT02639247|11260858|FG001|Overall Study|Death|0
7122037|NCT02639247|11260857|FG000|Overall Study|Withdrew Consent|0
7122038|NCT02639247|11260858|FG001|Overall Study|Withdrew Consent|1
7122039|NCT02639247|11260857|FG000|Overall Study|Protocol Violation|1
7122040|NCT02639247|11260858|FG001|Overall Study|Protocol Violation|0
7122041|NCT02639338|11260875|FG000|Overall Study|Lost to Follow-up|2
7122042|NCT02639338|11260876|FG001|Overall Study|Lost to Follow-up|2
7122043|NCT02639338|11260875|FG000|Overall Study|Withdrew Consent|1
7122044|NCT02639338|11260876|FG001|Overall Study|Withdrew Consent|2
7122045|NCT02639338|11260875|FG000|Overall Study|Death|1
7122046|NCT02639338|11260876|FG001|Overall Study|Death|0
7122047|NCT02639338|11260875|FG000|Overall Study|Randomized but Not Treated|0
7122048|NCT02639338|11260876|FG001|Overall Study|Randomized but Not Treated|1
7122049|NCT02640053|11260947|FG000|Overall Study|Withdrawal by Subject|2
7122050|NCT02640053|11260948|FG001|Overall Study|Withdrawal by Subject|1
7122051|NCT02640053|11260947|FG000|Overall Study|Adverse Event|1
7122052|NCT02640053|11260948|FG001|Overall Study|Adverse Event|1
7122053|NCT02640053|11260947|FG000|Overall Study|Alternative Therapy|1
7122054|NCT02640053|11260948|FG001|Overall Study|Alternative Therapy|1
7122055|NCT02640053|11260947|FG000|Overall Study|Chemo regimen changed after 1st Rx|0
7122056|NCT02640053|11260948|FG001|Overall Study|Chemo regimen changed after 1st Rx|1
7122057|NCT02640157|11260957|FG000|Overall Study|Adverse Event|2
7122058|NCT02640157|11260958|FG001|Overall Study|Adverse Event|2
7122059|NCT02640157|11260959|FG002|Overall Study|Adverse Event|1
7122060|NCT02640157|11260957|FG000|Overall Study|Withdrew consent|2
7122061|NCT02640157|11260958|FG001|Overall Study|Withdrew consent|0
7122062|NCT02640157|11260959|FG002|Overall Study|Withdrew consent|2
7122063|NCT02640157|11260957|FG000|Overall Study|Lost to Follow-up|9
7122064|NCT02640157|11260958|FG001|Overall Study|Lost to Follow-up|2
7122065|NCT02640157|11260959|FG002|Overall Study|Lost to Follow-up|7
7122066|NCT02640157|11260957|FG000|Overall Study|Randomized in error; did not receive Tx|0
7122067|NCT02640157|11260958|FG001|Overall Study|Randomized in error; did not receive Tx|1
7122068|NCT02640157|11260959|FG002|Overall Study|Randomized in error; did not receive Tx|0
7122069|NCT02640235|11260970|FG000|Overall Study|Withdrawal by Subject|7
7122070|NCT02640235|11260971|FG001|Overall Study|Withdrawal by Subject|6
7122071|NCT02640235|11260970|FG000|Overall Study|Lost to Follow-up|4
7122072|NCT02640235|11260971|FG001|Overall Study|Lost to Follow-up|3
7122073|NCT02640235|11260970|FG000|Overall Study|Death|2
7122074|NCT02640235|11260971|FG001|Overall Study|Death|3
7122075|NCT02640235|11260970|FG000|Overall Study|Other|1
7122076|NCT02640235|11260971|FG001|Overall Study|Other|2
7122077|NCT02640404|11260979|FG000|Overall Study|Protocol Violation|1
7122078|NCT02640404|11260980|FG001|Overall Study|Protocol Violation|0
7122079|NCT02640404|11260979|FG000|Overall Study|Withdrawal by Subject|1
7122080|NCT02640404|11260980|FG001|Overall Study|Withdrawal by Subject|0
7122081|NCT02640482|11260988|FG000|Overall Study|Lost to Follow-up|3
7122082|NCT02640482|11260989|FG001|Overall Study|Lost to Follow-up|0
7122083|NCT02640547|11260995|FG000|Overall Study|Failure to Return|1
7122084|NCT02640547|11260995|FG000|Overall Study|Withdrawal by Subject|1
7122085|NCT02640547|11260995|FG000|Overall Study|Death|6
7122086|NCT02640547|11260995|FG000|Overall Study|Miscellaneous|3
7122087|NCT02640612|11261010|FG000|Overall Study|Adverse Event|6
7122088|NCT02640612|11261011|FG001|Overall Study|Adverse Event|7
7122089|NCT02640612|11261012|FG002|Overall Study|Adverse Event|2
7122090|NCT02640612|11261010|FG000|Overall Study|Death|1
7122091|NCT02640612|11261011|FG001|Overall Study|Death|0
7122092|NCT02640612|11261012|FG002|Overall Study|Death|0
7122093|NCT02640612|11261010|FG000|Overall Study|Withdrawal by Subject|10
7122094|NCT02640612|11261011|FG001|Overall Study|Withdrawal by Subject|3
7122095|NCT02640612|11261012|FG002|Overall Study|Withdrawal by Subject|3
7122096|NCT02640612|11261010|FG000|Overall Study|Lost to Follow-up|4
7122097|NCT02640612|11261011|FG001|Overall Study|Lost to Follow-up|1
7122098|NCT02640612|11261012|FG002|Overall Study|Lost to Follow-up|1
7122099|NCT02640612|11261010|FG000|Overall Study|Protocol Violation|0
7122100|NCT02640612|11261011|FG001|Overall Study|Protocol Violation|2
7122101|NCT02640612|11261012|FG002|Overall Study|Protocol Violation|0
7122102|NCT02640612|11261010|FG000|Overall Study|Lack of Efficacy|1
7122103|NCT02640612|11261011|FG001|Overall Study|Lack of Efficacy|1
7122104|NCT02640612|11261012|FG002|Overall Study|Lack of Efficacy|0
7122105|NCT02640755|11261031|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0
7122106|NCT02640755|11261032|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1
7122107|NCT02640755|11261031|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1
7122108|NCT02640755|11261032|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0
7122109|NCT02640755|11261031|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1
7122110|NCT02640755|11261032|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0
7122111|NCT02641080|11261063|FG000|Overall Study|Physician Decision|2
7122112|NCT02641080|11261064|FG001|Overall Study|Physician Decision|0
7122113|NCT02641080|11261063|FG000|Overall Study|Withdrawal by Subject|0
7122114|NCT02641080|11261064|FG001|Overall Study|Withdrawal by Subject|1
7122115|NCT02641080|11261063|FG000|Overall Study|Rehab Center denied use of pumps|0
7122116|NCT02641080|11261064|FG001|Overall Study|Rehab Center denied use of pumps|3
7122117|NCT02641080|11261063|FG000|Overall Study|Lost to Follow-up|0
7122118|NCT02641080|11261064|FG001|Overall Study|Lost to Follow-up|3
7122119|NCT02641379|11261102|FG000|Overall Study|Exclusion criterion during screening|1
7122120|NCT02641379|11261103|FG001|Overall Study|Exclusion criterion during screening|0
7122121|NCT02641379|11261104|FG002|Overall Study|Exclusion criterion during screening|0
7122122|NCT02641379|11261105|FG003|Overall Study|Exclusion criterion during screening|1
7122123|NCT02641379|11261106|FG004|Overall Study|Exclusion criterion during screening|2
7122124|NCT02641379|11261107|FG005|Overall Study|Exclusion criterion during screening|0
7122125|NCT02641379|11261108|FG006|Overall Study|Exclusion criterion during screening|0
7122126|NCT02641379|11261109|FG007|Overall Study|Exclusion criterion during screening|0
7122127|NCT02641379|11261110|FG008|Overall Study|Exclusion criterion during screening|0
7122128|NCT02641379|11261111|FG009|Overall Study|Exclusion criterion during screening|0
7122129|NCT02641379|11261112|FG010|Overall Study|Exclusion criterion during screening|0
7122130|NCT02641379|11261102|FG000|Overall Study|Withdrawal of informed consent|0
7122131|NCT02641379|11261103|FG001|Overall Study|Withdrawal of informed consent|1
7122132|NCT02641379|11261104|FG002|Overall Study|Withdrawal of informed consent|0
7122133|NCT02641379|11261105|FG003|Overall Study|Withdrawal of informed consent|0
7122134|NCT02641379|11261106|FG004|Overall Study|Withdrawal of informed consent|0
7122135|NCT02641379|11261107|FG005|Overall Study|Withdrawal of informed consent|0
7122136|NCT02641379|11261108|FG006|Overall Study|Withdrawal of informed consent|0
7122137|NCT02641379|11261109|FG007|Overall Study|Withdrawal of informed consent|1
7122138|NCT02641379|11261110|FG008|Overall Study|Withdrawal of informed consent|0
7122139|NCT02641379|11261111|FG009|Overall Study|Withdrawal of informed consent|0
7122140|NCT02641379|11261112|FG010|Overall Study|Withdrawal of informed consent|0
7122141|NCT02641379|11261102|FG000|Overall Study|Adverse Event|7
7122142|NCT02641379|11261103|FG001|Overall Study|Adverse Event|8
7122143|NCT02641379|11261104|FG002|Overall Study|Adverse Event|2
7122144|NCT02641379|11261105|FG003|Overall Study|Adverse Event|2
7122145|NCT02641379|11261106|FG004|Overall Study|Adverse Event|5
7122146|NCT02641379|11261107|FG005|Overall Study|Adverse Event|1
7122147|NCT02641379|11261108|FG006|Overall Study|Adverse Event|5
7122148|NCT02641379|11261109|FG007|Overall Study|Adverse Event|0
7122149|NCT02641379|11261110|FG008|Overall Study|Adverse Event|1
7122150|NCT02641379|11261111|FG009|Overall Study|Adverse Event|1
7122151|NCT02641379|11261112|FG010|Overall Study|Adverse Event|5
7122152|NCT02641379|11261102|FG000|Overall Study|Lack of Efficacy|0
7122153|NCT02641379|11261103|FG001|Overall Study|Lack of Efficacy|0
7122154|NCT02641379|11261104|FG002|Overall Study|Lack of Efficacy|2
7122155|NCT02641379|11261105|FG003|Overall Study|Lack of Efficacy|0
7122156|NCT02641379|11261106|FG004|Overall Study|Lack of Efficacy|0
7122157|NCT02641379|11261107|FG005|Overall Study|Lack of Efficacy|2
7122158|NCT02641379|11261108|FG006|Overall Study|Lack of Efficacy|0
7122159|NCT02641379|11261109|FG007|Overall Study|Lack of Efficacy|5
7122160|NCT02641379|11261110|FG008|Overall Study|Lack of Efficacy|0
7122161|NCT02641379|11261111|FG009|Overall Study|Lack of Efficacy|0
7122162|NCT02641379|11261112|FG010|Overall Study|Lack of Efficacy|0
7122163|NCT02641379|11261102|FG000|Overall Study|Participant unable to attend study visit|4
7122164|NCT02641379|11261103|FG001|Overall Study|Participant unable to attend study visit|10
7122165|NCT02641379|11261104|FG002|Overall Study|Participant unable to attend study visit|1
7122166|NCT02641379|11261105|FG003|Overall Study|Participant unable to attend study visit|2
7122167|NCT02641379|11261106|FG004|Overall Study|Participant unable to attend study visit|5
7122168|NCT02641379|11261107|FG005|Overall Study|Participant unable to attend study visit|1
7122169|NCT02641379|11261108|FG006|Overall Study|Participant unable to attend study visit|1
7122170|NCT02641379|11261109|FG007|Overall Study|Participant unable to attend study visit|1
7122171|NCT02641379|11261110|FG008|Overall Study|Participant unable to attend study visit|0
7122172|NCT02641379|11261111|FG009|Overall Study|Participant unable to attend study visit|2
7122173|NCT02641379|11261112|FG010|Overall Study|Participant unable to attend study visit|0
7122174|NCT02641379|11261102|FG000|Overall Study|Participant's compliance|0
7122175|NCT02641379|11261103|FG001|Overall Study|Participant's compliance|1
7122176|NCT02641379|11261104|FG002|Overall Study|Participant's compliance|0
7122177|NCT02641379|11261105|FG003|Overall Study|Participant's compliance|1
7122178|NCT02641379|11261106|FG004|Overall Study|Participant's compliance|0
7122179|NCT02641379|11261107|FG005|Overall Study|Participant's compliance|2
7122180|NCT02641379|11261108|FG006|Overall Study|Participant's compliance|0
7122181|NCT02641379|11261109|FG007|Overall Study|Participant's compliance|0
7122182|NCT02641379|11261110|FG008|Overall Study|Participant's compliance|1
7122183|NCT02641379|11261111|FG009|Overall Study|Participant's compliance|1
7122184|NCT02641379|11261112|FG010|Overall Study|Participant's compliance|1
7122185|NCT02641379|11261102|FG000|Overall Study|Participant cannot be reached|4
7122186|NCT02641379|11261103|FG001|Overall Study|Participant cannot be reached|4
7122187|NCT02641379|11261104|FG002|Overall Study|Participant cannot be reached|0
7122188|NCT02641379|11261105|FG003|Overall Study|Participant cannot be reached|8
7122189|NCT02641379|11261106|FG004|Overall Study|Participant cannot be reached|2
7122190|NCT02641379|11261107|FG005|Overall Study|Participant cannot be reached|1
7122191|NCT02641379|11261108|FG006|Overall Study|Participant cannot be reached|0
7122192|NCT02641379|11261109|FG007|Overall Study|Participant cannot be reached|1
7122193|NCT02641379|11261110|FG008|Overall Study|Participant cannot be reached|0
7122194|NCT02641379|11261111|FG009|Overall Study|Participant cannot be reached|2
7122195|NCT02641379|11261112|FG010|Overall Study|Participant cannot be reached|1
7122196|NCT02641379|11261102|FG000|Overall Study|PCR positive at Week 24|15
7122197|NCT02641379|11261103|FG001|Overall Study|PCR positive at Week 24|21
7122198|NCT02641379|11261104|FG002|Overall Study|PCR positive at Week 24|62
7122199|NCT02641379|11261105|FG003|Overall Study|PCR positive at Week 24|0
7122200|NCT02641379|11261106|FG004|Overall Study|PCR positive at Week 24|0
7122201|NCT02641379|11261107|FG005|Overall Study|PCR positive at Week 24|6
7122202|NCT02641379|11261108|FG006|Overall Study|PCR positive at Week 24|3
7122203|NCT02641379|11261109|FG007|Overall Study|PCR positive at Week 24|8
7122204|NCT02641379|11261110|FG008|Overall Study|PCR positive at Week 24|0
7122205|NCT02641379|11261111|FG009|Overall Study|PCR positive at Week 24|1
7122206|NCT02641379|11261112|FG010|Overall Study|PCR positive at Week 24|0
7122207|NCT02641379|11261102|FG000|Overall Study|PCR positive at follow up 2|1
7122208|NCT02641379|11261103|FG001|Overall Study|PCR positive at follow up 2|0
7122209|NCT02641379|11261104|FG002|Overall Study|PCR positive at follow up 2|0
7122210|NCT02641379|11261105|FG003|Overall Study|PCR positive at follow up 2|0
7122211|NCT02641379|11261106|FG004|Overall Study|PCR positive at follow up 2|0
7122212|NCT02641379|11261107|FG005|Overall Study|PCR positive at follow up 2|0
7122213|NCT02641379|11261108|FG006|Overall Study|PCR positive at follow up 2|0
7122214|NCT02641379|11261109|FG007|Overall Study|PCR positive at follow up 2|0
7122215|NCT02641379|11261110|FG008|Overall Study|PCR positive at follow up 2|0
7122216|NCT02641379|11261111|FG009|Overall Study|PCR positive at follow up 2|0
7122217|NCT02641379|11261112|FG010|Overall Study|PCR positive at follow up 2|0
7122218|NCT02641379|11261102|FG000|Overall Study|Participant showed relapse|1
7122219|NCT02641379|11261103|FG001|Overall Study|Participant showed relapse|0
7122220|NCT02641379|11261104|FG002|Overall Study|Participant showed relapse|0
7122221|NCT02641379|11261105|FG003|Overall Study|Participant showed relapse|0
7122222|NCT02641379|11261106|FG004|Overall Study|Participant showed relapse|0
6806101|NCT01970865|10808456|FG005|Overall Study|Withdrawal by Subject|0
7122223|NCT02641379|11261107|FG005|Overall Study|Participant showed relapse|0
7122224|NCT02641379|11261108|FG006|Overall Study|Participant showed relapse|1
7122225|NCT02641379|11261109|FG007|Overall Study|Participant showed relapse|0
7122226|NCT02641379|11261110|FG008|Overall Study|Participant showed relapse|0
7122227|NCT02641379|11261111|FG009|Overall Study|Participant showed relapse|0
7122228|NCT02641379|11261112|FG010|Overall Study|Participant showed relapse|0
7122229|NCT02641379|11261102|FG000|Overall Study|Participant stopped study/treatment|1
7122230|NCT02641379|11261103|FG001|Overall Study|Participant stopped study/treatment|3
7122231|NCT02641379|11261104|FG002|Overall Study|Participant stopped study/treatment|1
7122232|NCT02641379|11261105|FG003|Overall Study|Participant stopped study/treatment|0
7122233|NCT02641379|11261106|FG004|Overall Study|Participant stopped study/treatment|0
7122234|NCT02641379|11261107|FG005|Overall Study|Participant stopped study/treatment|1
7122235|NCT02641379|11261108|FG006|Overall Study|Participant stopped study/treatment|2
7122236|NCT02641379|11261109|FG007|Overall Study|Participant stopped study/treatment|0
7122237|NCT02641379|11261110|FG008|Overall Study|Participant stopped study/treatment|1
7122238|NCT02641379|11261111|FG009|Overall Study|Participant stopped study/treatment|0
7122239|NCT02641379|11261112|FG010|Overall Study|Participant stopped study/treatment|0
7122240|NCT02641379|11261102|FG000|Overall Study|Therapy stopped due to misunderstanding|1
7122241|NCT02641379|11261103|FG001|Overall Study|Therapy stopped due to misunderstanding|0
7122242|NCT02641379|11261104|FG002|Overall Study|Therapy stopped due to misunderstanding|0
7122243|NCT02641379|11261105|FG003|Overall Study|Therapy stopped due to misunderstanding|0
7122244|NCT02641379|11261106|FG004|Overall Study|Therapy stopped due to misunderstanding|0
7122245|NCT02641379|11261107|FG005|Overall Study|Therapy stopped due to misunderstanding|0
7122246|NCT02641379|11261108|FG006|Overall Study|Therapy stopped due to misunderstanding|0
7122247|NCT02641379|11261109|FG007|Overall Study|Therapy stopped due to misunderstanding|0
7122248|NCT02641379|11261110|FG008|Overall Study|Therapy stopped due to misunderstanding|0
7122249|NCT02641379|11261111|FG009|Overall Study|Therapy stopped due to misunderstanding|0
7122250|NCT02641379|11261112|FG010|Overall Study|Therapy stopped due to misunderstanding|0
7122251|NCT02641379|11261102|FG000|Overall Study|Financial problems|0
7122252|NCT02641379|11261103|FG001|Overall Study|Financial problems|1
7122253|NCT02641379|11261104|FG002|Overall Study|Financial problems|0
7122254|NCT02641379|11261105|FG003|Overall Study|Financial problems|0
7122255|NCT02641379|11261106|FG004|Overall Study|Financial problems|0
7122256|NCT02641379|11261107|FG005|Overall Study|Financial problems|0
7122257|NCT02641379|11261108|FG006|Overall Study|Financial problems|0
7122258|NCT02641379|11261109|FG007|Overall Study|Financial problems|0
7122259|NCT02641379|11261110|FG008|Overall Study|Financial problems|0
7122260|NCT02641379|11261111|FG009|Overall Study|Financial problems|0
7122261|NCT02641379|11261112|FG010|Overall Study|Financial problems|0
7122262|NCT02641379|11261102|FG000|Overall Study|PCR positive at Week 68|0
7122263|NCT02641379|11261103|FG001|Overall Study|PCR positive at Week 68|1
7122264|NCT02641379|11261104|FG002|Overall Study|PCR positive at Week 68|0
7122265|NCT02641379|11261105|FG003|Overall Study|PCR positive at Week 68|0
7122266|NCT02641379|11261106|FG004|Overall Study|PCR positive at Week 68|0
7122267|NCT02641379|11261107|FG005|Overall Study|PCR positive at Week 68|0
7122268|NCT02641379|11261108|FG006|Overall Study|PCR positive at Week 68|0
7122269|NCT02641379|11261109|FG007|Overall Study|PCR positive at Week 68|0
7122270|NCT02641379|11261110|FG008|Overall Study|PCR positive at Week 68|0
7122271|NCT02641379|11261111|FG009|Overall Study|PCR positive at Week 68|0
7122272|NCT02641379|11261112|FG010|Overall Study|PCR positive at Week 68|0
7122273|NCT02641379|11261102|FG000|Overall Study|PCR positive at Week 48|0
7122274|NCT02641379|11261103|FG001|Overall Study|PCR positive at Week 48|1
7122275|NCT02641379|11261104|FG002|Overall Study|PCR positive at Week 48|0
7122276|NCT02641379|11261105|FG003|Overall Study|PCR positive at Week 48|0
7122277|NCT02641379|11261106|FG004|Overall Study|PCR positive at Week 48|0
7122278|NCT02641379|11261107|FG005|Overall Study|PCR positive at Week 48|0
7122279|NCT02641379|11261108|FG006|Overall Study|PCR positive at Week 48|0
7122280|NCT02641379|11261109|FG007|Overall Study|PCR positive at Week 48|0
7122281|NCT02641379|11261110|FG008|Overall Study|PCR positive at Week 48|0
7122282|NCT02641379|11261111|FG009|Overall Study|PCR positive at Week 48|0
7122283|NCT02641379|11261112|FG010|Overall Study|PCR positive at Week 48|0
7122284|NCT02641379|11261102|FG000|Overall Study|PCR not performed at Week 12|0
7122285|NCT02641379|11261103|FG001|Overall Study|PCR not performed at Week 12|0
7122286|NCT02641379|11261104|FG002|Overall Study|PCR not performed at Week 12|1
7122287|NCT02641379|11261105|FG003|Overall Study|PCR not performed at Week 12|0
7122288|NCT02641379|11261106|FG004|Overall Study|PCR not performed at Week 12|0
7122289|NCT02641379|11261107|FG005|Overall Study|PCR not performed at Week 12|0
7122290|NCT02641379|11261108|FG006|Overall Study|PCR not performed at Week 12|0
7122291|NCT02641379|11261109|FG007|Overall Study|PCR not performed at Week 12|0
7122292|NCT02641379|11261110|FG008|Overall Study|PCR not performed at Week 12|0
7122293|NCT02641379|11261111|FG009|Overall Study|PCR not performed at Week 12|0
7122294|NCT02641379|11261112|FG010|Overall Study|PCR not performed at Week 12|0
7122295|NCT02641379|11261102|FG000|Overall Study|No PCR at baseline|0
7122296|NCT02641379|11261103|FG001|Overall Study|No PCR at baseline|0
7122297|NCT02641379|11261104|FG002|Overall Study|No PCR at baseline|1
7122298|NCT02641379|11261105|FG003|Overall Study|No PCR at baseline|0
7122299|NCT02641379|11261106|FG004|Overall Study|No PCR at baseline|0
7122300|NCT02641379|11261107|FG005|Overall Study|No PCR at baseline|0
7122301|NCT02641379|11261108|FG006|Overall Study|No PCR at baseline|0
7122302|NCT02641379|11261109|FG007|Overall Study|No PCR at baseline|0
7122303|NCT02641379|11261110|FG008|Overall Study|No PCR at baseline|0
7122304|NCT02641379|11261111|FG009|Overall Study|No PCR at baseline|0
7122305|NCT02641379|11261112|FG010|Overall Study|No PCR at baseline|0
7122306|NCT02641379|11261102|FG000|Overall Study|PCR positive at Week 28|0
7122307|NCT02641379|11261103|FG001|Overall Study|PCR positive at Week 28|0
7122308|NCT02641379|11261104|FG002|Overall Study|PCR positive at Week 28|1
7122309|NCT02641379|11261105|FG003|Overall Study|PCR positive at Week 28|0
7122310|NCT02641379|11261106|FG004|Overall Study|PCR positive at Week 28|0
7122311|NCT02641379|11261107|FG005|Overall Study|PCR positive at Week 28|0
7122312|NCT02641379|11261108|FG006|Overall Study|PCR positive at Week 28|0
7122313|NCT02641379|11261109|FG007|Overall Study|PCR positive at Week 28|0
7122314|NCT02641379|11261110|FG008|Overall Study|PCR positive at Week 28|0
7122315|NCT02641379|11261111|FG009|Overall Study|PCR positive at Week 28|0
7122316|NCT02641379|11261112|FG010|Overall Study|PCR positive at Week 28|0
7122317|NCT02641379|11261102|FG000|Overall Study|PCR sample for Week 4 not drawn|0
7122318|NCT02641379|11261103|FG001|Overall Study|PCR sample for Week 4 not drawn|0
7122319|NCT02641379|11261104|FG002|Overall Study|PCR sample for Week 4 not drawn|0
7122320|NCT02641379|11261105|FG003|Overall Study|PCR sample for Week 4 not drawn|1
7122321|NCT02641379|11261106|FG004|Overall Study|PCR sample for Week 4 not drawn|0
7122322|NCT02641379|11261107|FG005|Overall Study|PCR sample for Week 4 not drawn|0
7122323|NCT02641379|11261108|FG006|Overall Study|PCR sample for Week 4 not drawn|0
7122324|NCT02641379|11261109|FG007|Overall Study|PCR sample for Week 4 not drawn|0
7122325|NCT02641379|11261110|FG008|Overall Study|PCR sample for Week 4 not drawn|0
7122326|NCT02641379|11261111|FG009|Overall Study|PCR sample for Week 4 not drawn|0
7122327|NCT02641379|11261112|FG010|Overall Study|PCR sample for Week 4 not drawn|0
7122328|NCT02641379|11261102|FG000|Overall Study|Inclusion criteria not fulfilled|0
7122329|NCT02641379|11261103|FG001|Overall Study|Inclusion criteria not fulfilled|0
7122330|NCT02641379|11261104|FG002|Overall Study|Inclusion criteria not fulfilled|0
7122331|NCT02641379|11261105|FG003|Overall Study|Inclusion criteria not fulfilled|1
7122332|NCT02641379|11261106|FG004|Overall Study|Inclusion criteria not fulfilled|0
7122333|NCT02641379|11261107|FG005|Overall Study|Inclusion criteria not fulfilled|0
7122334|NCT02641379|11261108|FG006|Overall Study|Inclusion criteria not fulfilled|0
7122335|NCT02641379|11261109|FG007|Overall Study|Inclusion criteria not fulfilled|0
7122336|NCT02641379|11261110|FG008|Overall Study|Inclusion criteria not fulfilled|0
7122337|NCT02641379|11261111|FG009|Overall Study|Inclusion criteria not fulfilled|0
7122338|NCT02641379|11261112|FG010|Overall Study|Inclusion criteria not fulfilled|0
7122339|NCT02641379|11261102|FG000|Overall Study|Baseline viral load unavailable|0
7122340|NCT02641379|11261103|FG001|Overall Study|Baseline viral load unavailable|0
7122341|NCT02641379|11261104|FG002|Overall Study|Baseline viral load unavailable|0
7122342|NCT02641379|11261105|FG003|Overall Study|Baseline viral load unavailable|1
7122343|NCT02641379|11261106|FG004|Overall Study|Baseline viral load unavailable|0
7122344|NCT02641379|11261107|FG005|Overall Study|Baseline viral load unavailable|0
7122345|NCT02641379|11261108|FG006|Overall Study|Baseline viral load unavailable|0
7122346|NCT02641379|11261109|FG007|Overall Study|Baseline viral load unavailable|0
7122347|NCT02641379|11261110|FG008|Overall Study|Baseline viral load unavailable|0
7122348|NCT02641379|11261111|FG009|Overall Study|Baseline viral load unavailable|0
7122349|NCT02641379|11261112|FG010|Overall Study|Baseline viral load unavailable|0
7122350|NCT02641379|11261102|FG000|Overall Study|Blood could not be drawn|0
7122351|NCT02641379|11261103|FG001|Overall Study|Blood could not be drawn|0
7122352|NCT02641379|11261104|FG002|Overall Study|Blood could not be drawn|0
7122353|NCT02641379|11261105|FG003|Overall Study|Blood could not be drawn|0
7122354|NCT02641379|11261106|FG004|Overall Study|Blood could not be drawn|1
7122355|NCT02641379|11261107|FG005|Overall Study|Blood could not be drawn|0
7122356|NCT02641379|11261108|FG006|Overall Study|Blood could not be drawn|0
7122357|NCT02641379|11261109|FG007|Overall Study|Blood could not be drawn|0
7122358|NCT02641379|11261110|FG008|Overall Study|Blood could not be drawn|0
7122359|NCT02641379|11261111|FG009|Overall Study|Blood could not be drawn|0
7122360|NCT02641379|11261112|FG010|Overall Study|Blood could not be drawn|0
7122361|NCT02641379|11261102|FG000|Overall Study|Protocol Violation|0
7122362|NCT02641379|11261103|FG001|Overall Study|Protocol Violation|0
7122363|NCT02641379|11261104|FG002|Overall Study|Protocol Violation|0
7122364|NCT02641379|11261105|FG003|Overall Study|Protocol Violation|0
7122365|NCT02641379|11261106|FG004|Overall Study|Protocol Violation|2
7122366|NCT02641379|11261107|FG005|Overall Study|Protocol Violation|0
7122367|NCT02641379|11261108|FG006|Overall Study|Protocol Violation|0
7122368|NCT02641379|11261109|FG007|Overall Study|Protocol Violation|0
7122369|NCT02641379|11261110|FG008|Overall Study|Protocol Violation|1
7122370|NCT02641379|11261111|FG009|Overall Study|Protocol Violation|0
7122371|NCT02641379|11261112|FG010|Overall Study|Protocol Violation|0
7122372|NCT02641379|11261102|FG000|Overall Study|Participation in sili rescue study|0
7122373|NCT02641379|11261103|FG001|Overall Study|Participation in sili rescue study|0
7122374|NCT02641379|11261104|FG002|Overall Study|Participation in sili rescue study|0
7122375|NCT02641379|11261105|FG003|Overall Study|Participation in sili rescue study|0
7122376|NCT02641379|11261106|FG004|Overall Study|Participation in sili rescue study|0
7122377|NCT02641379|11261107|FG005|Overall Study|Participation in sili rescue study|1
7122378|NCT02641379|11261108|FG006|Overall Study|Participation in sili rescue study|0
7122379|NCT02641379|11261109|FG007|Overall Study|Participation in sili rescue study|0
7122380|NCT02641379|11261110|FG008|Overall Study|Participation in sili rescue study|0
7122381|NCT02641379|11261111|FG009|Overall Study|Participation in sili rescue study|0
7122382|NCT02641379|11261112|FG010|Overall Study|Participation in sili rescue study|0
7122383|NCT02641379|11261102|FG000|Overall Study|Lost to Follow-up|0
7122384|NCT02641379|11261103|FG001|Overall Study|Lost to Follow-up|0
7122385|NCT02641379|11261104|FG002|Overall Study|Lost to Follow-up|0
7122386|NCT02641379|11261105|FG003|Overall Study|Lost to Follow-up|0
7122387|NCT02641379|11261106|FG004|Overall Study|Lost to Follow-up|0
7122388|NCT02641379|11261107|FG005|Overall Study|Lost to Follow-up|0
7122389|NCT02641379|11261108|FG006|Overall Study|Lost to Follow-up|0
7122390|NCT02641379|11261109|FG007|Overall Study|Lost to Follow-up|0
7122391|NCT02641379|11261110|FG008|Overall Study|Lost to Follow-up|1
7122392|NCT02641379|11261111|FG009|Overall Study|Lost to Follow-up|0
7122393|NCT02641379|11261112|FG010|Overall Study|Lost to Follow-up|0
7122394|NCT02641379|11261102|FG000|Overall Study|Source data not found|0
7122395|NCT02641379|11261103|FG001|Overall Study|Source data not found|0
7122396|NCT02641379|11261104|FG002|Overall Study|Source data not found|0
7122397|NCT02641379|11261105|FG003|Overall Study|Source data not found|0
7122398|NCT02641379|11261106|FG004|Overall Study|Source data not found|0
7122399|NCT02641379|11261107|FG005|Overall Study|Source data not found|1
7122400|NCT02641379|11261108|FG006|Overall Study|Source data not found|0
7122401|NCT02641379|11261109|FG007|Overall Study|Source data not found|0
7122402|NCT02641379|11261110|FG008|Overall Study|Source data not found|0
7122403|NCT02641379|11261111|FG009|Overall Study|Source data not found|0
7122404|NCT02641379|11261112|FG010|Overall Study|Source data not found|0
7122405|NCT02641379|11261102|FG000|Overall Study|Participant showed weight reduction|0
7122406|NCT02641379|11261103|FG001|Overall Study|Participant showed weight reduction|0
7122407|NCT02641379|11261104|FG002|Overall Study|Participant showed weight reduction|0
7122408|NCT02641379|11261105|FG003|Overall Study|Participant showed weight reduction|0
7122409|NCT02641379|11261106|FG004|Overall Study|Participant showed weight reduction|0
7122410|NCT02641379|11261107|FG005|Overall Study|Participant showed weight reduction|0
7122411|NCT02641379|11261108|FG006|Overall Study|Participant showed weight reduction|0
7122412|NCT02641379|11261109|FG007|Overall Study|Participant showed weight reduction|1
7122413|NCT02641379|11261110|FG008|Overall Study|Participant showed weight reduction|0
7122414|NCT02641379|11261111|FG009|Overall Study|Participant showed weight reduction|0
7122415|NCT02641379|11261112|FG010|Overall Study|Participant showed weight reduction|0
7122416|NCT02641379|11261102|FG000|Overall Study|Non-response Week 12|0
7122417|NCT02641379|11261103|FG001|Overall Study|Non-response Week 12|0
7122418|NCT02641379|11261104|FG002|Overall Study|Non-response Week 12|0
7122419|NCT02641379|11261105|FG003|Overall Study|Non-response Week 12|0
7122420|NCT02641379|11261106|FG004|Overall Study|Non-response Week 12|0
7122421|NCT02641379|11261107|FG005|Overall Study|Non-response Week 12|0
7122422|NCT02641379|11261108|FG006|Overall Study|Non-response Week 12|0
7122423|NCT02641379|11261109|FG007|Overall Study|Non-response Week 12|1
7122424|NCT02641379|11261110|FG008|Overall Study|Non-response Week 12|0
7122425|NCT02641379|11261111|FG009|Overall Study|Non-response Week 12|0
7122426|NCT02641379|11261112|FG010|Overall Study|Non-response Week 12|0
7122427|NCT02641379|11261102|FG000|Overall Study|No 2 Log drop at Week 12|0
7122428|NCT02641379|11261103|FG001|Overall Study|No 2 Log drop at Week 12|0
7122429|NCT02641379|11261104|FG002|Overall Study|No 2 Log drop at Week 12|0
7122430|NCT02641379|11261105|FG003|Overall Study|No 2 Log drop at Week 12|0
7122431|NCT02641379|11261106|FG004|Overall Study|No 2 Log drop at Week 12|0
7122432|NCT02641379|11261107|FG005|Overall Study|No 2 Log drop at Week 12|0
7122433|NCT02641379|11261108|FG006|Overall Study|No 2 Log drop at Week 12|0
7122434|NCT02641379|11261109|FG007|Overall Study|No 2 Log drop at Week 12|0
7122435|NCT02641379|11261110|FG008|Overall Study|No 2 Log drop at Week 12|0
7122436|NCT02641379|11261111|FG009|Overall Study|No 2 Log drop at Week 12|0
7122437|NCT02641379|11261112|FG010|Overall Study|No 2 Log drop at Week 12|1
7122438|NCT02641379|11261102|FG000|Overall Study|Negative PCR result|0
7122439|NCT02641379|11261103|FG001|Overall Study|Negative PCR result|0
7122440|NCT02641379|11261104|FG002|Overall Study|Negative PCR result|0
7122441|NCT02641379|11261105|FG003|Overall Study|Negative PCR result|0
7122442|NCT02641379|11261106|FG004|Overall Study|Negative PCR result|0
7122443|NCT02641379|11261107|FG005|Overall Study|Negative PCR result|0
7122444|NCT02641379|11261108|FG006|Overall Study|Negative PCR result|0
7122445|NCT02641379|11261109|FG007|Overall Study|Negative PCR result|0
7122446|NCT02641379|11261110|FG008|Overall Study|Negative PCR result|0
7122447|NCT02641379|11261111|FG009|Overall Study|Negative PCR result|1
7122448|NCT02641379|11261112|FG010|Overall Study|Negative PCR result|0
7122449|NCT02641379|11261102|FG000|Overall Study|Participant's PCR high|0
7122450|NCT02641379|11261103|FG001|Overall Study|Participant's PCR high|0
7122451|NCT02641379|11261104|FG002|Overall Study|Participant's PCR high|0
7122452|NCT02641379|11261105|FG003|Overall Study|Participant's PCR high|0
7122453|NCT02641379|11261106|FG004|Overall Study|Participant's PCR high|0
7122454|NCT02641379|11261107|FG005|Overall Study|Participant's PCR high|0
7122455|NCT02641379|11261108|FG006|Overall Study|Participant's PCR high|0
7122456|NCT02641379|11261109|FG007|Overall Study|Participant's PCR high|1
7122457|NCT02641379|11261110|FG008|Overall Study|Participant's PCR high|0
7122458|NCT02641379|11261111|FG009|Overall Study|Participant's PCR high|0
7122459|NCT02641379|11261112|FG010|Overall Study|Participant's PCR high|0
7122460|NCT02641379|11261102|FG000|Overall Study|Participant treated after Week 24|0
7122461|NCT02641379|11261103|FG001|Overall Study|Participant treated after Week 24|0
7122462|NCT02641379|11261104|FG002|Overall Study|Participant treated after Week 24|0
7122463|NCT02641379|11261105|FG003|Overall Study|Participant treated after Week 24|0
7122464|NCT02641379|11261106|FG004|Overall Study|Participant treated after Week 24|0
7122465|NCT02641379|11261107|FG005|Overall Study|Participant treated after Week 24|0
7122466|NCT02641379|11261108|FG006|Overall Study|Participant treated after Week 24|0
7122467|NCT02641379|11261109|FG007|Overall Study|Participant treated after Week 24|0
7122468|NCT02641379|11261110|FG008|Overall Study|Participant treated after Week 24|1
7122469|NCT02641379|11261111|FG009|Overall Study|Participant treated after Week 24|0
7122470|NCT02641379|11261112|FG010|Overall Study|Participant treated after Week 24|0
7122471|NCT02641379|11261102|FG000|Overall Study|Missing PCR result at Week 8|0
7122472|NCT02641379|11261103|FG001|Overall Study|Missing PCR result at Week 8|0
7122473|NCT02641379|11261104|FG002|Overall Study|Missing PCR result at Week 8|0
7122474|NCT02641379|11261105|FG003|Overall Study|Missing PCR result at Week 8|0
7122475|NCT02641379|11261106|FG004|Overall Study|Missing PCR result at Week 8|0
7122476|NCT02641379|11261107|FG005|Overall Study|Missing PCR result at Week 8|0
7122477|NCT02641379|11261108|FG006|Overall Study|Missing PCR result at Week 8|0
7122478|NCT02641379|11261109|FG007|Overall Study|Missing PCR result at Week 8|0
7122479|NCT02641379|11261110|FG008|Overall Study|Missing PCR result at Week 8|0
7122480|NCT02641379|11261111|FG009|Overall Study|Missing PCR result at Week 8|1
7122481|NCT02641379|11261112|FG010|Overall Study|Missing PCR result at Week 8|0
7122482|NCT02641379|11261102|FG000|Overall Study|PCR positive|0
7122483|NCT02641379|11261103|FG001|Overall Study|PCR positive|0
7122484|NCT02641379|11261104|FG002|Overall Study|PCR positive|0
7122485|NCT02641379|11261105|FG003|Overall Study|PCR positive|0
7122486|NCT02641379|11261106|FG004|Overall Study|PCR positive|0
7122487|NCT02641379|11261107|FG005|Overall Study|PCR positive|0
7122488|NCT02641379|11261108|FG006|Overall Study|PCR positive|1
7122489|NCT02641379|11261109|FG007|Overall Study|PCR positive|0
7122490|NCT02641379|11261110|FG008|Overall Study|PCR positive|0
7122491|NCT02641379|11261111|FG009|Overall Study|PCR positive|0
7122492|NCT02641379|11261112|FG010|Overall Study|PCR positive|0
7122493|NCT02641392|11261144|FG000|Overall Study|Lost to Follow-up|0
7122494|NCT02641392|11261145|FG001|Overall Study|Lost to Follow-up|0
7122495|NCT02641392|11261146|FG002|Overall Study|Lost to Follow-up|2
7122496|NCT02641392|11261144|FG000|Overall Study|Withdrawal by Subject|0
7122497|NCT02641392|11261145|FG001|Overall Study|Withdrawal by Subject|0
7122498|NCT02641392|11261146|FG002|Overall Study|Withdrawal by Subject|17
7122499|NCT02641392|11261144|FG000|Overall Study|Adverse Event|0
7122500|NCT02641392|11261145|FG001|Overall Study|Adverse Event|1
7122501|NCT02641392|11261146|FG002|Overall Study|Adverse Event|25
7122502|NCT02641392|11261144|FG000|Overall Study|Study Terminated by Sponsor|4
7122503|NCT02641392|11261145|FG001|Overall Study|Study Terminated by Sponsor|12
7122504|NCT02641392|11261146|FG002|Overall Study|Study Terminated by Sponsor|144
7122505|NCT02641392|11261144|FG000|Overall Study|Lack of Efficacy|0
7122506|NCT02641392|11261145|FG001|Overall Study|Lack of Efficacy|0
7122507|NCT02641392|11261146|FG002|Overall Study|Lack of Efficacy|101
7122508|NCT02641392|11261144|FG000|Overall Study|Miscellaneous|0
7122509|NCT02641392|11261145|FG001|Overall Study|Miscellaneous|0
7122510|NCT02641392|11261146|FG002|Overall Study|Miscellaneous|3
7122511|NCT02641392|11261144|FG000|Overall Study|Death|0
7122512|NCT02641392|11261145|FG001|Overall Study|Death|0
7122513|NCT02641392|11261146|FG002|Overall Study|Death|1
7122514|NCT02641587|11261178|FG000|Confinement Period|Adverse Event|1
7122515|NCT02641587|11261179|FG001|Confinement Period|Adverse Event|0
7122516|NCT02641587|11261178|FG000|Confinement Period|Withdrawal by Subject|2
7122517|NCT02641587|11261179|FG001|Confinement Period|Withdrawal by Subject|1
7122518|NCT02641587|11261178|FG000|Ambulatory Period|Withdrawal by Subject|1
7122519|NCT02641587|11261179|FG001|Ambulatory Period|Withdrawal by Subject|0
7122520|NCT02641730|11261205|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2
7122521|NCT02641730|11261206|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
7122522|NCT02641730|11261207|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
7122523|NCT02641730|11261208|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1
7122524|NCT02641730|11261209|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2
7122525|NCT02641730|11261205|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0
7122526|NCT02641730|11261206|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1
7122527|NCT02641730|11261207|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1
7122528|NCT02641730|11261208|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5
7122529|NCT02641730|11261209|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4
7122530|NCT02641730|11261205|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0
7122531|NCT02641730|11261206|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2
7122532|NCT02641730|11261207|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0
7122533|NCT02641730|11261208|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2
7122534|NCT02641730|11261209|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0
7122535|NCT02641730|11261205|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0
7122536|NCT02641730|11261206|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0
7122537|NCT02641730|11261207|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0
7122538|NCT02641730|11261208|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1
7122539|NCT02641730|11261209|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1
7122540|NCT02641730|11261205|FG000|After Controlled Period (Week 16 - 52)|Other|0
7122541|NCT02641730|11261206|FG001|After Controlled Period (Week 16 - 52)|Other|1
7122542|NCT02641730|11261207|FG002|After Controlled Period (Week 16 - 52)|Other|1
7122543|NCT02641730|11261208|FG003|After Controlled Period (Week 16 - 52)|Other|0
7122544|NCT02641730|11261209|FG004|After Controlled Period (Week 16 - 52)|Other|1
7122545|NCT02641730|11261205|FG000|Observational Period (Week 60 - Week 84)|Other|0
7122546|NCT02641730|11261206|FG001|Observational Period (Week 60 - Week 84)|Other|0
7122547|NCT02641730|11261207|FG002|Observational Period (Week 60 - Week 84)|Other|0
7122548|NCT02641730|11261208|FG003|Observational Period (Week 60 - Week 84)|Other|0
7122549|NCT02641730|11261209|FG004|Observational Period (Week 60 - Week 84)|Other|1
7122550|NCT02642159|11261248|FG000|Overall Study|Randomized but not treated|1
7122551|NCT02642159|11261249|FG001|Overall Study|Randomized but not treated|0
7122552|NCT02642159|11261248|FG000|Overall Study|Adverse Event|10
7122553|NCT02642159|11261249|FG001|Overall Study|Adverse Event|4
7122554|NCT02642159|11261248|FG000|Overall Study|Withdrawal by Subject|9
7122555|NCT02642159|11261249|FG001|Overall Study|Withdrawal by Subject|1
7122556|NCT02642159|11261248|FG000|Overall Study|Poor compliance to study protocol|1
7122557|NCT02642159|11261249|FG001|Overall Study|Poor compliance to study protocol|0
7122558|NCT02642159|11261248|FG000|Overall Study|Other than specified above|10
7122559|NCT02642159|11261249|FG001|Overall Study|Other than specified above|3
7122560|NCT02642432|11261274|FG000|Overall Study|Adverse Event|2
7122561|NCT02642432|11261274|FG000|Overall Study|Withdrew Consent|1
7122562|NCT02642432|11261274|FG000|Overall Study|Lost to Follow-up|2
7122563|NCT02642432|11261274|FG000|Overall Study|Other|3
7122564|NCT02642614|11261295|FG000|Overall Study|Adverse Event|1
7122565|NCT02642614|11261296|FG001|Overall Study|Adverse Event|1
7122566|NCT02642614|11261297|FG002|Overall Study|Adverse Event|2
7122567|NCT02642614|11261298|FG003|Overall Study|Adverse Event|2
7122568|NCT02642614|11261295|FG000|Overall Study|Lost to Follow-up|1
7122569|NCT02642614|11261296|FG001|Overall Study|Lost to Follow-up|0
7122570|NCT02642614|11261297|FG002|Overall Study|Lost to Follow-up|0
7122571|NCT02642614|11261298|FG003|Overall Study|Lost to Follow-up|0
7122572|NCT02642614|11261295|FG000|Overall Study|Withdrawal by Subject|1
7122573|NCT02642614|11261296|FG001|Overall Study|Withdrawal by Subject|1
7122574|NCT02642614|11261297|FG002|Overall Study|Withdrawal by Subject|0
7122575|NCT02642614|11261298|FG003|Overall Study|Withdrawal by Subject|0
7122576|NCT02642653|11261318|FG000|Overall Study|Adverse Event|2
7122577|NCT02642653|11261319|FG001|Overall Study|Adverse Event|0
7122578|NCT02642679|11261325|FG000|Overall Study|Withdrawal by Subject|1
7122579|NCT02642679|11261325|FG000|Overall Study|Physician Decision|1
7122580|NCT02642679|11261325|FG000|Overall Study|Physician Decision|1
7122581|NCT02643082|11261359|FG000|Period 1|Adverse Event|1
7122582|NCT02643082|11261360|FG001|Period 1|Adverse Event|0
7122583|NCT02643251|11261387|FG000|Overall Study|Adverse Event|3
7122584|NCT02643251|11261388|FG001|Overall Study|Adverse Event|1
7122585|NCT02643251|11261387|FG000|Overall Study|Withdrawal by Subject|2
7122586|NCT02643251|11261388|FG001|Overall Study|Withdrawal by Subject|0
7122587|NCT02643251|11261387|FG000|Overall Study|Lost to Follow-up|4
7122588|NCT02643251|11261388|FG001|Overall Study|Lost to Follow-up|1
7122589|NCT02643251|11261387|FG000|Overall Study|Protocol Violation|1
7122590|NCT02643251|11261388|FG001|Overall Study|Protocol Violation|0
7122591|NCT02643251|11261387|FG000|Overall Study|PI Decision to terminate patient|1
7122592|NCT02643251|11261388|FG001|Overall Study|PI Decision to terminate patient|0
7122593|NCT02643355|11261396|FG000|Overall Study|Withdrawal by Subject|1
7122594|NCT02643355|11261397|FG001|Overall Study|Withdrawal by Subject|3
7122595|NCT02643355|11261396|FG000|Overall Study|Protocol Violation|0
7122596|NCT02643355|11261397|FG001|Overall Study|Protocol Violation|2
7122597|NCT02643394|11261405|FG000|Overall Study|Protocol Violation|4
7122598|NCT02643394|11261406|FG001|Overall Study|Protocol Violation|5
7122599|NCT02643472|11261424|FG000|Overall Study|Death|2
7122600|NCT02643472|11261425|FG001|Overall Study|Death|5
7122601|NCT02643472|11261424|FG000|Overall Study|Withdrawal by Subject|3
7122602|NCT02643472|11261425|FG001|Overall Study|Withdrawal by Subject|2
7122603|NCT02643472|11261424|FG000|Overall Study|Protocol Violation|0
7122604|NCT02643472|11261425|FG001|Overall Study|Protocol Violation|1
7122605|NCT02643472|11261424|FG000|Overall Study|Lost to Follow-up|22
7122606|NCT02643472|11261425|FG001|Overall Study|Lost to Follow-up|26
7122607|NCT02643628|11261445|FG000|Overall Study|Lost to Follow-up|1
7122608|NCT02643628|11261446|FG001|Overall Study|Lost to Follow-up|4
7122609|NCT02643628|11261445|FG000|Overall Study|Withdrawal by Subject|0
7122610|NCT02643628|11261446|FG001|Overall Study|Withdrawal by Subject|1
7122611|NCT02643628|11261445|FG000|Overall Study|Relocated out of state|0
7122612|NCT02643628|11261446|FG001|Overall Study|Relocated out of state|1
7122613|NCT02643693|11261454|FG000|Overall Study|Physician Decision|0
7122614|NCT02643693|11261455|FG001|Overall Study|Physician Decision|1
7122615|NCT02643693|11261456|FG002|Overall Study|Physician Decision|0
7122616|NCT02643693|11261457|FG003|Overall Study|Physician Decision|0
7122617|NCT02643693|11261458|FG004|Overall Study|Physician Decision|0
7122618|NCT02643693|11261459|FG005|Overall Study|Physician Decision|0
7122619|NCT02643693|11261454|FG000|Overall Study|Withdrawal by Subject|0
7122620|NCT02643693|11261455|FG001|Overall Study|Withdrawal by Subject|1
7122621|NCT02643693|11261456|FG002|Overall Study|Withdrawal by Subject|0
7122622|NCT02643693|11261457|FG003|Overall Study|Withdrawal by Subject|0
7122623|NCT02643693|11261458|FG004|Overall Study|Withdrawal by Subject|0
7122624|NCT02643693|11261459|FG005|Overall Study|Withdrawal by Subject|0
7122625|NCT02643693|11261454|FG000|Overall Study|Protocol Adherence Issues|2
7122626|NCT02643693|11261455|FG001|Overall Study|Protocol Adherence Issues|0
7122627|NCT02643693|11261456|FG002|Overall Study|Protocol Adherence Issues|1
7122628|NCT02643693|11261457|FG003|Overall Study|Protocol Adherence Issues|0
7122629|NCT02643693|11261458|FG004|Overall Study|Protocol Adherence Issues|0
7122630|NCT02643693|11261459|FG005|Overall Study|Protocol Adherence Issues|1
7122631|NCT02644096|11261496|FG000|Overall Study|Withdrawal by Subject|28
7122632|NCT02644096|11261497|FG001|Overall Study|Withdrawal by Subject|25
7122633|NCT02644109|11261505|FG000|Overall Study|Adverse Event|0
7122634|NCT02644109|11261506|FG001|Overall Study|Adverse Event|4
7122635|NCT02644122|11261512|FG000|Overall Study|Withdrawal by Subject|1
7122636|NCT02644343|11261534|FG000|Overall Study|Withdrawal by Subject|1
7122637|NCT02644356|11261538|FG000|Overall Study|Withdrawal by Subject|2
7122638|NCT02644668|11261545|FG000|Overall Study|Adverse Event|2
7122639|NCT02644668|11261546|FG001|Overall Study|Adverse Event|0
7122640|NCT02644668|11261547|FG002|Overall Study|Adverse Event|1
7122641|NCT02644668|11261545|FG000|Overall Study|Protocol Violation|0
7122642|NCT02644668|11261546|FG001|Overall Study|Protocol Violation|0
7122643|NCT02644668|11261547|FG002|Overall Study|Protocol Violation|1
7122644|NCT02644668|11261545|FG000|Overall Study|Withdrawal by Subject|0
7122645|NCT02644668|11261546|FG001|Overall Study|Withdrawal by Subject|0
7122646|NCT02644668|11261547|FG002|Overall Study|Withdrawal by Subject|1
7122647|NCT02645409|11261615|FG000|Overall Study|Withdrawal by Subject|3
7122648|NCT02645409|11261616|FG001|Overall Study|Withdrawal by Subject|0
7122649|NCT02645409|11261615|FG000|Overall Study|Physician Decision|1
7122650|NCT02645409|11261616|FG001|Overall Study|Physician Decision|0
7122651|NCT02646124|11261637|FG000|Overall Study|Lost to Follow-up|0
7122652|NCT02646124|11261638|FG001|Overall Study|Lost to Follow-up|2
7122653|NCT02646332|11261646|FG000|Overall Study|Lost to Follow-up|0
7122654|NCT02646332|11261647|FG001|Overall Study|Lost to Follow-up|3
7122655|NCT02646423|11261664|FG000|Overall Study|Adverse Event|5
7122656|NCT02646423|11261665|FG001|Overall Study|Adverse Event|7
7122657|NCT02646423|11261664|FG000|Overall Study|Ineligible|2
7122658|NCT02646423|11261665|FG001|Overall Study|Ineligible|1
7122659|NCT02646566|11261683|FG000|Overall Study|Lost to Follow-up|5
7122660|NCT02646566|11261684|FG001|Overall Study|Lost to Follow-up|4
7122661|NCT02646566|11261685|FG002|Overall Study|Lost to Follow-up|5
7122662|NCT02646566|11261683|FG000|Overall Study|Treatment failure|1
7122663|NCT02646566|11261684|FG001|Overall Study|Treatment failure|0
7122664|NCT02646566|11261685|FG002|Overall Study|Treatment failure|0
7122665|NCT02646618|11261695|FG000|Overall Study|Lost to Follow-up|10
7122666|NCT02646618|11261696|FG001|Overall Study|Lost to Follow-up|14
7122667|NCT02646891|11261740|FG000|Overall Study|Adverse Event|0
7122668|NCT02646891|11261741|FG001|Overall Study|Adverse Event|1
7122669|NCT02646891|11261742|FG002|Overall Study|Adverse Event|0
7122670|NCT02646891|11261743|FG003|Overall Study|Adverse Event|0
7122671|NCT02646891|11261744|FG004|Overall Study|Adverse Event|0
7122672|NCT02646891|11261745|FG005|Overall Study|Adverse Event|0
7122673|NCT02646891|11261746|FG006|Overall Study|Adverse Event|0
7122674|NCT02646891|11261747|FG007|Overall Study|Adverse Event|0
7122675|NCT02646891|11261748|FG008|Overall Study|Adverse Event|0
7122676|NCT02646891|11261749|FG009|Overall Study|Adverse Event|0
7122677|NCT02646891|11261740|FG000|Overall Study|Lost to Follow-up|0
7122678|NCT02646891|11261741|FG001|Overall Study|Lost to Follow-up|0
7122679|NCT02646891|11261742|FG002|Overall Study|Lost to Follow-up|0
7122680|NCT02646891|11261743|FG003|Overall Study|Lost to Follow-up|0
7122681|NCT02646891|11261744|FG004|Overall Study|Lost to Follow-up|0
7122682|NCT02646891|11261745|FG005|Overall Study|Lost to Follow-up|0
7122683|NCT02646891|11261746|FG006|Overall Study|Lost to Follow-up|2
7122684|NCT02646891|11261747|FG007|Overall Study|Lost to Follow-up|2
7122685|NCT02646891|11261748|FG008|Overall Study|Lost to Follow-up|2
7122686|NCT02646891|11261749|FG009|Overall Study|Lost to Follow-up|2
7122687|NCT02646891|11261740|FG000|Overall Study|Protocol Violation|0
7122688|NCT02646891|11261741|FG001|Overall Study|Protocol Violation|0
7122689|NCT02646891|11261742|FG002|Overall Study|Protocol Violation|0
7122690|NCT02646891|11261743|FG003|Overall Study|Protocol Violation|0
7122691|NCT02646891|11261744|FG004|Overall Study|Protocol Violation|0
7122692|NCT02646891|11261745|FG005|Overall Study|Protocol Violation|0
7122693|NCT02646891|11261746|FG006|Overall Study|Protocol Violation|1
7122694|NCT02646891|11261747|FG007|Overall Study|Protocol Violation|1
7122695|NCT02646891|11261748|FG008|Overall Study|Protocol Violation|0
7122696|NCT02646891|11261749|FG009|Overall Study|Protocol Violation|0
7122697|NCT02646891|11261740|FG000|Overall Study|Withdrawal by Subject|2
7122698|NCT02646891|11261741|FG001|Overall Study|Withdrawal by Subject|0
7122699|NCT02646891|11261742|FG002|Overall Study|Withdrawal by Subject|1
7122700|NCT02646891|11261743|FG003|Overall Study|Withdrawal by Subject|0
7122701|NCT02646891|11261744|FG004|Overall Study|Withdrawal by Subject|0
7122702|NCT02646891|11261745|FG005|Overall Study|Withdrawal by Subject|0
7122703|NCT02646891|11261746|FG006|Overall Study|Withdrawal by Subject|5
7122704|NCT02646891|11261747|FG007|Overall Study|Withdrawal by Subject|9
7122705|NCT02646891|11261748|FG008|Overall Study|Withdrawal by Subject|7
7122706|NCT02646891|11261749|FG009|Overall Study|Withdrawal by Subject|3
7122707|NCT02646891|11261740|FG000|Overall Study|Death|0
7122708|NCT02646891|11261741|FG001|Overall Study|Death|0
7122709|NCT02646891|11261742|FG002|Overall Study|Death|0
7122710|NCT02646891|11261743|FG003|Overall Study|Death|0
7122711|NCT02646891|11261744|FG004|Overall Study|Death|0
7122712|NCT02646891|11261745|FG005|Overall Study|Death|0
7122713|NCT02646891|11261746|FG006|Overall Study|Death|1
7122714|NCT02646891|11261747|FG007|Overall Study|Death|1
7122715|NCT02646891|11261748|FG008|Overall Study|Death|1
7122716|NCT02646891|11261749|FG009|Overall Study|Death|0
7122717|NCT02647281|11261815|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
7122718|NCT02647281|11261816|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
7122719|NCT02647281|11261817|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
7122720|NCT02647281|11261818|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
7122721|NCT02647281|11261819|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
7122722|NCT02647281|11261820|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
7122723|NCT02647281|11261821|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
7122724|NCT02647281|11261822|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
7122725|NCT02647281|11261823|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1
7122726|NCT02647320|11261857|FG000|Overall Study|Adverse Event|0
7122727|NCT02647320|11261858|FG001|Overall Study|Adverse Event|1
7122728|NCT02647320|11261859|FG002|Overall Study|Adverse Event|3
7122729|NCT02647320|11261860|FG003|Overall Study|Adverse Event|2
7122730|NCT02647320|11261861|FG004|Overall Study|Adverse Event|1
7122731|NCT02647320|11261857|FG000|Overall Study|Protocol Violation|0
7122732|NCT02647320|11261858|FG001|Overall Study|Protocol Violation|0
7122733|NCT02647320|11261859|FG002|Overall Study|Protocol Violation|3
7122734|NCT02647320|11261860|FG003|Overall Study|Protocol Violation|0
7122735|NCT02647320|11261861|FG004|Overall Study|Protocol Violation|0
7122736|NCT02647320|11261857|FG000|Overall Study|Withdrawal by Subject|7
7122737|NCT02647320|11261858|FG001|Overall Study|Withdrawal by Subject|4
7122738|NCT02647320|11261859|FG002|Overall Study|Withdrawal by Subject|2
7122739|NCT02647320|11261860|FG003|Overall Study|Withdrawal by Subject|2
7122740|NCT02647320|11261861|FG004|Overall Study|Withdrawal by Subject|7
7122741|NCT02647320|11261857|FG000|Overall Study|Persistent hyperglycemia|0
7122742|NCT02647320|11261858|FG001|Overall Study|Persistent hyperglycemia|1
7122743|NCT02647320|11261859|FG002|Overall Study|Persistent hyperglycemia|1
7122744|NCT02647320|11261860|FG003|Overall Study|Persistent hyperglycemia|1
7122745|NCT02647320|11261861|FG004|Overall Study|Persistent hyperglycemia|1
7122746|NCT02647320|11261857|FG000|Overall Study|Study terminated by sponsor|1
7122747|NCT02647320|11261858|FG001|Overall Study|Study terminated by sponsor|1
7122748|NCT02647320|11261859|FG002|Overall Study|Study terminated by sponsor|1
7122749|NCT02647320|11261860|FG003|Overall Study|Study terminated by sponsor|1
7122750|NCT02647320|11261861|FG004|Overall Study|Study terminated by sponsor|2
7122751|NCT02647320|11261857|FG000|Overall Study|Reason not provided|0
7122752|NCT02647320|11261858|FG001|Overall Study|Reason not provided|0
7122753|NCT02647320|11261859|FG002|Overall Study|Reason not provided|1
7122754|NCT02647320|11261860|FG003|Overall Study|Reason not provided|0
7122755|NCT02647320|11261861|FG004|Overall Study|Reason not provided|2
7122756|NCT02647320|11261857|FG000|Overall Study|Lost to Follow-up|1
7122757|NCT02647320|11261858|FG001|Overall Study|Lost to Follow-up|1
7122758|NCT02647320|11261859|FG002|Overall Study|Lost to Follow-up|0
7122759|NCT02647320|11261860|FG003|Overall Study|Lost to Follow-up|0
7122760|NCT02647320|11261861|FG004|Overall Study|Lost to Follow-up|0
7122761|NCT02647320|11261857|FG000|Overall Study|Develop anemia|1
7122762|NCT02647320|11261858|FG001|Overall Study|Develop anemia|0
7122763|NCT02647320|11261859|FG002|Overall Study|Develop anemia|0
7122764|NCT02647320|11261860|FG003|Overall Study|Develop anemia|0
7122765|NCT02647320|11261861|FG004|Overall Study|Develop anemia|0
7122766|NCT02647320|11261857|FG000|Overall Study|Lack of Efficacy|0
7122767|NCT02647320|11261858|FG001|Overall Study|Lack of Efficacy|0
7122768|NCT02647320|11261859|FG002|Overall Study|Lack of Efficacy|0
7122769|NCT02647320|11261860|FG003|Overall Study|Lack of Efficacy|1
7122770|NCT02647320|11261861|FG004|Overall Study|Lack of Efficacy|0
7122771|NCT02647320|11261857|FG000|Overall Study|Disposition Missing Due to Fire at Site|2
7122772|NCT02647320|11261858|FG001|Overall Study|Disposition Missing Due to Fire at Site|3
7122773|NCT02647320|11261859|FG002|Overall Study|Disposition Missing Due to Fire at Site|4
7122774|NCT02647320|11261860|FG003|Overall Study|Disposition Missing Due to Fire at Site|3
7122775|NCT02647320|11261861|FG004|Overall Study|Disposition Missing Due to Fire at Site|4
7122776|NCT02647645|11261881|FG000|Overall Study|Lost to Follow-up|2
7122777|NCT02647645|11261882|FG001|Overall Study|Lost to Follow-up|1
7122778|NCT02647658|11261890|FG000|Overall Study|Consent refusal|15
7122779|NCT02647658|11261891|FG001|Overall Study|Consent refusal|24
7122780|NCT02647788|11261899|FG000|Overall Study|Lost to Follow-up|13
7122781|NCT02647788|11261900|FG001|Overall Study|Lost to Follow-up|11
7122782|NCT02647788|11261899|FG000|Overall Study|Did not want opiate|0
7122783|NCT02647788|11261900|FG001|Overall Study|Did not want opiate|1
7122784|NCT02647788|11261899|FG000|Overall Study|Withdrawal by Subject|1
7122785|NCT02647788|11261900|FG001|Overall Study|Withdrawal by Subject|0
7122786|NCT02647788|11261899|FG000|Overall Study|Felt itchy with assigned medication|1
7122787|NCT02647788|11261900|FG001|Overall Study|Felt itchy with assigned medication|0
7122788|NCT02647788|11261899|FG000|Overall Study|Felt nauseous with assigned medication|1
7122789|NCT02647788|11261900|FG001|Overall Study|Felt nauseous with assigned medication|1
7122790|NCT02647866|11261911|FG000|Overall Study|Adverse Event|0
7122791|NCT02647866|11261912|FG001|Overall Study|Adverse Event|0
7122792|NCT02647866|11261913|FG002|Overall Study|Adverse Event|2
7122793|NCT02647866|11261914|FG003|Overall Study|Adverse Event|2
7122794|NCT02647866|11261915|FG004|Overall Study|Adverse Event|1
7122795|NCT02647866|11261911|FG000|Overall Study|Disease Worsening|3
7122796|NCT02647866|11261912|FG001|Overall Study|Disease Worsening|1
7122797|NCT02647866|11261913|FG002|Overall Study|Disease Worsening|0
7122798|NCT02647866|11261914|FG003|Overall Study|Disease Worsening|0
7122799|NCT02647866|11261915|FG004|Overall Study|Disease Worsening|1
7122800|NCT02647866|11261911|FG000|Overall Study|Withdrawal by Subject|1
7122801|NCT02647866|11261912|FG001|Overall Study|Withdrawal by Subject|1
7122802|NCT02647866|11261913|FG002|Overall Study|Withdrawal by Subject|2
7122803|NCT02647866|11261914|FG003|Overall Study|Withdrawal by Subject|4
7122804|NCT02647866|11261915|FG004|Overall Study|Withdrawal by Subject|4
7122805|NCT02647866|11261911|FG000|Overall Study|Physician Decision|0
7122806|NCT02647866|11261912|FG001|Overall Study|Physician Decision|1
7122807|NCT02647866|11261913|FG002|Overall Study|Physician Decision|1
7122808|NCT02647866|11261914|FG003|Overall Study|Physician Decision|0
7122809|NCT02647866|11261915|FG004|Overall Study|Physician Decision|2
7122810|NCT02647866|11261911|FG000|Overall Study|Death|0
7122811|NCT02647866|11261912|FG001|Overall Study|Death|1
7122812|NCT02647866|11261913|FG002|Overall Study|Death|0
7122813|NCT02647866|11261914|FG003|Overall Study|Death|0
7122814|NCT02647866|11261915|FG004|Overall Study|Death|0
7122815|NCT02647866|11261911|FG000|Overall Study|Subject moved to different country|1
7122816|NCT02647866|11261912|FG001|Overall Study|Subject moved to different country|0
7122817|NCT02647866|11261913|FG002|Overall Study|Subject moved to different country|0
7122818|NCT02647866|11261914|FG003|Overall Study|Subject moved to different country|0
7122819|NCT02647866|11261915|FG004|Overall Study|Subject moved to different country|0
7122820|NCT02647905|11261935|FG000|Overall Study|Lost to Follow-up|1
7122821|NCT02647905|11261935|FG000|Overall Study|Withdrawal by Subject|2
7122822|NCT02647944|11261941|FG000|Overall Study|Withdrawal by Subject|0
7122823|NCT02647944|11261942|FG001|Overall Study|Withdrawal by Subject|3
7122824|NCT02647944|11261941|FG000|Overall Study|Adverse Event|2
7122825|NCT02647944|11261942|FG001|Overall Study|Adverse Event|0
7122826|NCT02648204|11261965|FG000|Overall Study|Withdrawal by Subject|12
7122827|NCT02648204|11261966|FG001|Overall Study|Withdrawal by Subject|8
7122828|NCT02648204|11261967|FG002|Overall Study|Withdrawal by Subject|2
7122829|NCT02648204|11261968|FG003|Overall Study|Withdrawal by Subject|6
7122830|NCT02648204|11261965|FG000|Overall Study|Lost to Follow-up|5
7122831|NCT02648204|11261966|FG001|Overall Study|Lost to Follow-up|8
7122832|NCT02648204|11261967|FG002|Overall Study|Lost to Follow-up|4
7122833|NCT02648204|11261968|FG003|Overall Study|Lost to Follow-up|6
7122834|NCT02648204|11261965|FG000|Overall Study|Missing follow-up information|4
7122835|NCT02648204|11261966|FG001|Overall Study|Missing follow-up information|4
7122836|NCT02648204|11261967|FG002|Overall Study|Missing follow-up information|4
7122837|NCT02648204|11261968|FG003|Overall Study|Missing follow-up information|2
7122838|NCT02648204|11261965|FG000|Overall Study|Death|1
7122839|NCT02648204|11261966|FG001|Overall Study|Death|1
7122840|NCT02648204|11261967|FG002|Overall Study|Death|2
7122841|NCT02648204|11261968|FG003|Overall Study|Death|2
7122842|NCT02648204|11261965|FG000|Overall Study|Adverse Event|0
7122843|NCT02648204|11261966|FG001|Overall Study|Adverse Event|0
7122844|NCT02648204|11261967|FG002|Overall Study|Adverse Event|1
7122845|NCT02648204|11261968|FG003|Overall Study|Adverse Event|0
7122846|NCT02648217|11261980|FG000|Overall Study|Adverse Event|0
7122847|NCT02648217|11261981|FG001|Overall Study|Adverse Event|1
7122848|NCT02648217|11261980|FG000|Overall Study|Lost to Follow-up|1
7122849|NCT02648217|11261981|FG001|Overall Study|Lost to Follow-up|1
7122850|NCT02648217|11261980|FG000|Overall Study|Withdrawal by Subject|4
7122851|NCT02648217|11261981|FG001|Overall Study|Withdrawal by Subject|3
7122852|NCT02648217|11261980|FG000|Overall Study|Unclassified|5
7122853|NCT02648217|11261981|FG001|Overall Study|Unclassified|0
7122854|NCT02648438|11261994|FG000|Overall Study|Eligibility criteria not fulfilled|0
7122855|NCT02648438|11261995|FG001|Overall Study|Eligibility criteria not fulfilled|2
7122856|NCT02648438|11261996|FG002|Overall Study|Eligibility criteria not fulfilled|0
7122857|NCT02648438|11261994|FG000|Overall Study|Protocol Violation|2
7122858|NCT02648438|11261995|FG001|Overall Study|Protocol Violation|0
7122859|NCT02648438|11261996|FG002|Overall Study|Protocol Violation|0
7122860|NCT02648438|11261994|FG000|Overall Study|Withdrawal by Subject|1
7122861|NCT02648438|11261995|FG001|Overall Study|Withdrawal by Subject|1
7122862|NCT02648438|11261996|FG002|Overall Study|Withdrawal by Subject|0
7122863|NCT02648932|11262027|FG000|Overall Study|No transplant|3
7122864|NCT02648932|11262028|FG001|Overall Study|No transplant|1
7122865|NCT02649218|11262081|FG000|Overall Study|Adverse Event|8
7122866|NCT02649218|11262081|FG000|Overall Study|Lack of Efficacy|8
7122867|NCT02649218|11262081|FG000|Overall Study|Pregnancy|3
7122868|NCT02649218|11262081|FG000|Overall Study|Protocol Violation|3
7122869|NCT02649218|11262081|FG000|Overall Study|Physician Decision|1
7122870|NCT02649218|11262081|FG000|Overall Study|Withdrawal by Subject|2
7122871|NCT02649231|11262090|FG000|Overall Study|Adverse Event|0
7122872|NCT02649231|11262091|FG001|Overall Study|Adverse Event|0
7122873|NCT02649231|11262092|FG002|Overall Study|Adverse Event|0
7122874|NCT02649231|11262093|FG003|Overall Study|Adverse Event|1
7122875|NCT02649231|11262090|FG000|Overall Study|Lost to Follow-up|2
7122876|NCT02649231|11262091|FG001|Overall Study|Lost to Follow-up|1
7122877|NCT02649231|11262092|FG002|Overall Study|Lost to Follow-up|1
7122878|NCT02649231|11262093|FG003|Overall Study|Lost to Follow-up|0
7122879|NCT02649231|11262090|FG000|Overall Study|Withdrawal by Subject|0
7122880|NCT02649231|11262091|FG001|Overall Study|Withdrawal by Subject|1
7122881|NCT02649231|11262092|FG002|Overall Study|Withdrawal by Subject|0
7122882|NCT02649231|11262093|FG003|Overall Study|Withdrawal by Subject|1
7122883|NCT02649231|11262090|FG000|Overall Study|Protocol Violation|2
7122884|NCT02649231|11262091|FG001|Overall Study|Protocol Violation|1
7122885|NCT02649231|11262092|FG002|Overall Study|Protocol Violation|1
7122886|NCT02649231|11262093|FG003|Overall Study|Protocol Violation|0
7122887|NCT02649634|11262166|FG000|Overall Study|Withdrawal by Subject|3
7122888|NCT02649634|11262167|FG001|Overall Study|Withdrawal by Subject|5
7122889|NCT02649634|11262166|FG000|Overall Study|Lost to Follow-up|0
7122890|NCT02649634|11262167|FG001|Overall Study|Lost to Follow-up|1
7122891|NCT02649894|11262181|FG000|Overall Study|Adverse Event|1
7122892|NCT02649894|11262182|FG001|Overall Study|Adverse Event|0
7122893|NCT02649894|11262181|FG000|Overall Study|Physician Decision|0
7122894|NCT02649894|11262182|FG001|Overall Study|Physician Decision|1
7122895|NCT02649894|11262181|FG000|Overall Study|Withdrawal by Subject|5
7122896|NCT02649894|11262182|FG001|Overall Study|Withdrawal by Subject|2
7122897|NCT02649894|11262181|FG000|Overall Study|Lost to Follow-up|2
7122898|NCT02649894|11262182|FG001|Overall Study|Lost to Follow-up|1
7122899|NCT02649894|11262181|FG000|Overall Study|Death|30
7122900|NCT02649894|11262182|FG001|Overall Study|Death|7
7122901|NCT02649894|11262181|FG000|Overall Study|Other, not specified|6
7122902|NCT02649894|11262182|FG001|Overall Study|Other, not specified|0
7122903|NCT02650128|11262188|FG000|Overall Study|Death|2
7122904|NCT02650466|11262225|FG000|Overall Study|Physician Decision|1
7122905|NCT02650466|11262225|FG000|Overall Study|Withdrawal by Subject|5
7122906|NCT02650466|11262225|FG000|Overall Study|Lost to Follow-up|1
7122907|NCT02650895|11262246|FG000|Overall Study|Withdrawal by Subject|0
7122908|NCT02650895|11262247|FG001|Overall Study|Withdrawal by Subject|1
7122909|NCT02650895|11262248|FG002|Overall Study|Withdrawal by Subject|0
7122910|NCT02650895|11262249|FG003|Overall Study|Withdrawal by Subject|0
7122911|NCT02650895|11262250|FG004|Overall Study|Withdrawal by Subject|0
7122912|NCT02650895|11262251|FG005|Overall Study|Withdrawal by Subject|0
7122913|NCT02650921|11262270|FG000|Overall Study|Withdrawal by Subject|4
7122914|NCT02650921|11262270|FG000|Overall Study|Lost to Follow-up|2
7122915|NCT02650921|11262270|FG000|Overall Study|Adverse Event|1
7122916|NCT02650921|11262270|FG000|Overall Study|Due to Medical Condition|1
7122917|NCT02651116|11262286|FG000|Overall Study|Adverse Event|0
7122918|NCT02651116|11262287|FG001|Overall Study|Adverse Event|1
7122919|NCT02651116|11262286|FG000|Overall Study|No Longer Willing To Participate In Study|1
7122920|NCT02651116|11262287|FG001|Overall Study|No Longer Willing To Participate In Study|0
7122921|NCT02651155|11262295|FG000|Overall Study|Pretreatment Event/Adverse Event|1
7122922|NCT02651155|11262296|FG001|Overall Study|Pretreatment Event/Adverse Event|2
7122923|NCT02651155|11262295|FG000|Overall Study|Voluntary Withdrawal|5
7122924|NCT02651155|11262296|FG001|Overall Study|Voluntary Withdrawal|0
7122925|NCT02651194|11262302|FG000|Overall Study|Lost to Follow-up|3
7122926|NCT02651194|11262302|FG000|Overall Study|Other|2
7122927|NCT02651220|11262309|FG000|Overall Study|Adverse Event|1
7122928|NCT02651220|11262310|FG001|Overall Study|Adverse Event|5
7122929|NCT02651220|11262311|FG002|Overall Study|Adverse Event|1
7122930|NCT02651220|11262309|FG000|Overall Study|Lost to Follow-up|8
7122931|NCT02651220|11262310|FG001|Overall Study|Lost to Follow-up|14
7122932|NCT02651220|11262311|FG002|Overall Study|Lost to Follow-up|14
7122933|NCT02651220|11262309|FG000|Overall Study|Non-Compliance with Study Drug|4
7122934|NCT02651220|11262310|FG001|Overall Study|Non-Compliance with Study Drug|0
7122935|NCT02651220|11262311|FG002|Overall Study|Non-Compliance with Study Drug|1
7122936|NCT02651220|11262309|FG000|Overall Study|Pregnancy|1
7122937|NCT02651220|11262310|FG001|Overall Study|Pregnancy|0
7122938|NCT02651220|11262311|FG002|Overall Study|Pregnancy|1
7122939|NCT02651220|11262309|FG000|Overall Study|Protocol Violation|0
7122940|NCT02651220|11262310|FG001|Overall Study|Protocol Violation|0
7122941|NCT02651220|11262311|FG002|Overall Study|Protocol Violation|1
7122942|NCT02651220|11262309|FG000|Overall Study|Withdrawal by Subject|5
7122943|NCT02651220|11262310|FG001|Overall Study|Withdrawal by Subject|6
7122944|NCT02651220|11262311|FG002|Overall Study|Withdrawal by Subject|8
7122945|NCT02651220|11262309|FG000|Overall Study|Miscellaneous|4
7122946|NCT02651220|11262310|FG001|Overall Study|Miscellaneous|1
7122947|NCT02651220|11262311|FG002|Overall Study|Miscellaneous|2
7122948|NCT02651220|11262309|FG000|Overall Study|Withdrawal by Parent/Guardian|0
7122949|NCT02651220|11262310|FG001|Overall Study|Withdrawal by Parent/Guardian|1
7122950|NCT02651220|11262311|FG002|Overall Study|Withdrawal by Parent/Guardian|1
7122951|NCT02651467|11262360|FG000|Overall Study|Withdrawal by Subject|0
7122952|NCT02651467|11262361|FG001|Overall Study|Withdrawal by Subject|0
7122953|NCT02651467|11262362|FG002|Overall Study|Withdrawal by Subject|2
7122954|NCT02651467|11262360|FG000|Overall Study|Other (Not specified)|1
7122955|NCT02651467|11262361|FG001|Overall Study|Other (Not specified)|0
7122956|NCT02651467|11262362|FG002|Overall Study|Other (Not specified)|2
7122957|NCT02651688|11262395|FG000|Overall Study|Non-compliance|0
7122958|NCT02651688|11262396|FG001|Overall Study|Non-compliance|0
7122959|NCT02651688|11262397|FG002|Overall Study|Non-compliance|1
7122960|NCT02651688|11262395|FG000|Overall Study|Principal Investigator (PI) decision|0
7122961|NCT02651688|11262396|FG001|Overall Study|Principal Investigator (PI) decision|2
7122962|NCT02651688|11262397|FG002|Overall Study|Principal Investigator (PI) decision|0
7122963|NCT02651688|11262395|FG000|Overall Study|Lost to Follow-up|1
7122964|NCT02651688|11262396|FG001|Overall Study|Lost to Follow-up|3
7122965|NCT02651688|11262397|FG002|Overall Study|Lost to Follow-up|0
7122966|NCT02651688|11262395|FG000|Overall Study|Withdrawal by Subject|1
7122967|NCT02651688|11262396|FG001|Overall Study|Withdrawal by Subject|0
7122968|NCT02651688|11262397|FG002|Overall Study|Withdrawal by Subject|2
7122969|NCT02651922|11262405|FG000|Overall Study|due to exclusion criteria|2
7122970|NCT02651987|11262411|FG000|Overall Study|Adverse Event|2
7122971|NCT02651987|11262412|FG001|Overall Study|Adverse Event|2
7122972|NCT02651987|11262411|FG000|Overall Study|Consent Withdrawn|2
7122973|NCT02651987|11262412|FG001|Overall Study|Consent Withdrawn|0
7122974|NCT02651987|11262411|FG000|Overall Study|Local PD|0
7122975|NCT02651987|11262412|FG001|Overall Study|Local PD|2
7122976|NCT02651987|11262411|FG000|Overall Study|Investigator Decision|1
7122977|NCT02651987|11262412|FG001|Overall Study|Investigator Decision|1
7122978|NCT02652156|11262424|FG000|Overall Study|Physician Decision|1
7122979|NCT02652156|11262425|FG001|Overall Study|Physician Decision|0
7122980|NCT02652156|11262426|FG002|Overall Study|Physician Decision|0
7122981|NCT02652260|11262450|FG000|Overall Study|Pregnancy|0
7122982|NCT02652260|11262451|FG001|Overall Study|Pregnancy|1
7122983|NCT02652260|11262450|FG000|Overall Study|Withdrawal by Subject|0
7122984|NCT02652260|11262451|FG001|Overall Study|Withdrawal by Subject|1
7122985|NCT02652442|11262496|FG000|Centrifugation - Distance|Lost to Follow-up|1
7122986|NCT02652624|11262514|FG000|Randomized Phase|Pregnancy|3
7122987|NCT02652624|11262515|FG001|Randomized Phase|Pregnancy|1
7122988|NCT02652624|11262514|FG000|Randomized Phase|Investigator's Discretion|0
7122989|NCT02652624|11262515|FG001|Randomized Phase|Investigator's Discretion|2
7122990|NCT02652624|11262514|FG000|Randomized Phase|Death|0
7122991|NCT02652624|11262515|FG001|Randomized Phase|Death|1
7122992|NCT02652624|11262514|FG000|Randomized Phase|Lost to Follow-up|0
7122993|NCT02652624|11262515|FG001|Randomized Phase|Lost to Follow-up|1
7122994|NCT02652624|11262514|FG000|Extension Phase|Lost to Follow-up|3
7122995|NCT02652624|11262515|FG001|Extension Phase|Lost to Follow-up|1
7122996|NCT02652624|11262514|FG000|Extension Phase|Pregnancy|1
7122997|NCT02652624|11262515|FG001|Extension Phase|Pregnancy|1
7122998|NCT02652624|11262514|FG000|Extension Phase|Adverse Event|0
7122999|NCT02652624|11262515|FG001|Extension Phase|Adverse Event|1
7123000|NCT02652624|11262514|FG000|Extension Phase|Withdrew Consent|0
7123001|NCT02652624|11262515|FG001|Extension Phase|Withdrew Consent|1
7123002|NCT02652767|11262523|FG000|Overall Study|Death|2
7123003|NCT02652767|11262523|FG000|Overall Study|Lost to Follow-up|1
7123004|NCT02652767|11262523|FG000|Overall Study|Withdrawal by Subject|1
7123005|NCT02653170|11262552|FG000|Overall Study|Withdrawal by Subject|3
7123006|NCT02653170|11262553|FG001|Overall Study|Withdrawal by Subject|8
7123007|NCT02653170|11262554|FG002|Overall Study|Withdrawal by Subject|3
7123008|NCT02653170|11262552|FG000|Overall Study|withdrawn by study team|2
7123009|NCT02653170|11262553|FG001|Overall Study|withdrawn by study team|4
7123010|NCT02653170|11262554|FG002|Overall Study|withdrawn by study team|5
7123011|NCT02653170|11262552|FG000|Overall Study|Lost to Follow-up|12
7123012|NCT02653170|11262553|FG001|Overall Study|Lost to Follow-up|4
7123013|NCT02653170|11262554|FG002|Overall Study|Lost to Follow-up|10
7123014|NCT02653300|11262571|FG000|Overall Study|Withdrawal by Subject|2
7123015|NCT02653326|11262577|FG000|Overall Study|Lost to Follow-up|10
7123016|NCT02653326|11262578|FG001|Overall Study|Lost to Follow-up|7
7123017|NCT02653625|11262672|FG000|Overall Study|Adverse Event|1
7123018|NCT02653625|11262672|FG000|Overall Study|Non-compliance with Study Drug|1
7123019|NCT02653625|11262672|FG000|Overall Study|Protocol Violation|1
7123020|NCT02653625|11262672|FG000|Overall Study|Suspected Drug Induced Liver Injury|1
7123021|NCT02653664|11262679|FG000|Post-Treatment|Withdrawal by Subject|6
7123022|NCT02653664|11262680|FG001|Post-Treatment|Withdrawal by Subject|5
7123023|NCT02653664|11262681|FG002|Post-Treatment|Withdrawal by Subject|7
7123024|NCT02653664|11262679|FG000|Post-Treatment|Lost to Follow-up|8
7123025|NCT02653664|11262680|FG001|Post-Treatment|Lost to Follow-up|1
7123026|NCT02653664|11262681|FG002|Post-Treatment|Lost to Follow-up|7
7123027|NCT02653664|11262679|FG000|3 Month Follow-Up|Withdrawal by Subject|9
7123028|NCT02653664|11262680|FG001|3 Month Follow-Up|Withdrawal by Subject|5
7123029|NCT02653664|11262681|FG002|3 Month Follow-Up|Withdrawal by Subject|9
7123030|NCT02653664|11262679|FG000|3 Month Follow-Up|Lost to Follow-up|9
7123031|NCT02653664|11262680|FG001|3 Month Follow-Up|Lost to Follow-up|8
7123032|NCT02653664|11262681|FG002|3 Month Follow-Up|Lost to Follow-up|16
7123033|NCT02653664|11262679|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0
7123034|NCT02653664|11262680|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2
7123035|NCT02653664|11262681|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0
7123036|NCT02653664|11262679|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3
7123037|NCT02653664|11262680|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0
7123038|NCT02653664|11262681|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0
7123039|NCT02653664|11262679|FG000|6 Month Follow-Up|Withdrawal by Subject|13
7123040|NCT02653664|11262680|FG001|6 Month Follow-Up|Withdrawal by Subject|7
7123041|NCT02653664|11262681|FG002|6 Month Follow-Up|Withdrawal by Subject|14
7123042|NCT02653664|11262679|FG000|6 Month Follow-Up|Lost to Follow-up|10
7123043|NCT02653664|11262680|FG001|6 Month Follow-Up|Lost to Follow-up|11
7123044|NCT02653664|11262681|FG002|6 Month Follow-Up|Lost to Follow-up|9
7123045|NCT02653664|11262679|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0
7123046|NCT02653664|11262680|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2
7123047|NCT02653664|11262681|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0
7123048|NCT02653664|11262679|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0
7123049|NCT02653664|11262680|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1
7123050|NCT02653664|11262681|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0
7123051|NCT02654002|11262724|FG000|Overall Study|Adverse Event|0
7123052|NCT02654002|11262725|FG001|Overall Study|Adverse Event|0
7123053|NCT02654002|11262726|FG002|Overall Study|Adverse Event|0
7123054|NCT02654002|11262727|FG003|Overall Study|Adverse Event|0
7123055|NCT02654002|11262728|FG004|Overall Study|Adverse Event|0
7123056|NCT02654002|11262729|FG005|Overall Study|Adverse Event|0
7123057|NCT02654002|11262730|FG006|Overall Study|Adverse Event|1
7123058|NCT02654002|11262731|FG007|Overall Study|Adverse Event|0
7123059|NCT02654002|11262732|FG008|Overall Study|Adverse Event|0
7123060|NCT02654002|11262724|FG000|Overall Study|Withdrew Consent|0
7123061|NCT02654002|11262725|FG001|Overall Study|Withdrew Consent|0
7123062|NCT02654002|11262726|FG002|Overall Study|Withdrew Consent|0
7123063|NCT02654002|11262727|FG003|Overall Study|Withdrew Consent|0
7123064|NCT02654002|11262728|FG004|Overall Study|Withdrew Consent|0
7123065|NCT02654002|11262729|FG005|Overall Study|Withdrew Consent|1
7123066|NCT02654002|11262730|FG006|Overall Study|Withdrew Consent|0
7123067|NCT02654002|11262731|FG007|Overall Study|Withdrew Consent|1
7123068|NCT02654002|11262732|FG008|Overall Study|Withdrew Consent|0
7123069|NCT02654054|11262770|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2
7123070|NCT02654054|11262771|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6
7123071|NCT02654054|11262772|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7
7123072|NCT02654054|11262770|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3
7123073|NCT02654054|11262771|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7123074|NCT02654054|11262772|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13
7123075|NCT02654054|11262770|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2
7123076|NCT02654054|11262771|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2
7123077|NCT02654054|11262772|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2
7123078|NCT02654054|11262770|FG000|Post-Treatment Follow-Up Period|Other|1
7123079|NCT02654054|11262771|FG001|Post-Treatment Follow-Up Period|Other|0
7123080|NCT02654054|11262772|FG002|Post-Treatment Follow-Up Period|Other|4
7123081|NCT02654054|11262770|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0
7123082|NCT02654054|11262771|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0
7123083|NCT02654054|11262772|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4
7123084|NCT02654145|11262781|FG000|Overall Study|Lack of Efficacy|1
7123085|NCT02654145|11262781|FG000|Overall Study|Protocol Violation|1
7123086|NCT02654145|11262781|FG000|Overall Study|Withdrawal by Subject|5
7123087|NCT02654717|11262815|FG000|Overall Study|Adverse Event|2
7123088|NCT02654717|11262816|FG001|Overall Study|Adverse Event|2
7123089|NCT02654717|11262815|FG000|Overall Study|Protocol Violation|1
7123090|NCT02654717|11262816|FG001|Overall Study|Protocol Violation|2
7123091|NCT02654717|11262815|FG000|Overall Study|Withdrawal by Subject|0
7123092|NCT02654717|11262816|FG001|Overall Study|Withdrawal by Subject|1
7123093|NCT02654717|11262815|FG000|Overall Study|Non-permitted medication|3
7123094|NCT02654717|11262816|FG001|Overall Study|Non-permitted medication|0
7123095|NCT02654977|11262873|FG000|Overall Study|Death|1
7123096|NCT02654977|11262873|FG000|Overall Study|Lost to Follow-up|1
7123097|NCT02654977|11262873|FG000|Overall Study|Adverse Event|1
7123098|NCT02654977|11262873|FG000|Overall Study|Withdrawal by Subject|1
7123099|NCT02654977|11262873|FG000|Overall Study|Lack of Efficacy|3
7123100|NCT02655224|11262879|FG000|Overall Study|Adverse Event|1
7123101|NCT02655224|11262880|FG001|Overall Study|Adverse Event|1
7123102|NCT02655237|11262888|FG000|Overall Study|Adverse Event|10
7123103|NCT02655237|11262889|FG001|Overall Study|Adverse Event|7
7123104|NCT02655237|11262888|FG000|Overall Study|Protocol Deviation|2
7123105|NCT02655237|11262889|FG001|Overall Study|Protocol Deviation|0
7123106|NCT02655237|11262888|FG000|Overall Study|Withdrawal by Participant|1
7123107|NCT02655237|11262889|FG001|Overall Study|Withdrawal by Participant|2
7123108|NCT02655237|11262888|FG000|Overall Study|Lack of Efficacy|0
7123109|NCT02655237|11262889|FG001|Overall Study|Lack of Efficacy|1
7123110|NCT02655237|11262888|FG000|Overall Study|Recovery Leading to Surgery|2
7123111|NCT02655237|11262889|FG001|Overall Study|Recovery Leading to Surgery|1
7123112|NCT02655237|11262888|FG000|Overall Study|Reduction of Hemoglobin Concentration|1
7123113|NCT02655237|11262889|FG001|Overall Study|Reduction of Hemoglobin Concentration|0
7123114|NCT02655237|11262888|FG000|Overall Study|Randomized but Not Treated|1
7123115|NCT02655237|11262889|FG001|Overall Study|Randomized but Not Treated|0
7123116|NCT02655419|11262906|FG000|Overall Study|Enrolled but not treated|1
7123117|NCT02655419|11262907|FG001|Overall Study|Enrolled but not treated|5
7123118|NCT02655419|11262906|FG000|Overall Study|Withdrawal by Subject|4
7123119|NCT02655419|11262907|FG001|Overall Study|Withdrawal by Subject|1
7123120|NCT02655419|11262906|FG000|Overall Study|Other|0
7123121|NCT02655419|11262907|FG001|Overall Study|Other|1
7123122|NCT02655666|11262945|FG000|Overall Study|Sponsor stopped this clinical research.|12
7123123|NCT02655679|11262954|FG000|Overall Study|Adverse Event|0
7123124|NCT02655679|11262955|FG001|Overall Study|Adverse Event|1
7123125|NCT02655679|11262956|FG002|Overall Study|Adverse Event|0
7123126|NCT02655679|11262957|FG003|Overall Study|Adverse Event|0
7123127|NCT02655679|11262958|FG004|Overall Study|Adverse Event|0
7123128|NCT02655679|11262954|FG000|Overall Study|Withdrawal by Subject|1
7123129|NCT02655679|11262955|FG001|Overall Study|Withdrawal by Subject|1
7123130|NCT02655679|11262956|FG002|Overall Study|Withdrawal by Subject|0
7123131|NCT02655679|11262957|FG003|Overall Study|Withdrawal by Subject|3
7123132|NCT02655679|11262958|FG004|Overall Study|Withdrawal by Subject|1
7123133|NCT02655679|11262954|FG000|Overall Study|Inability to Comply with the Protocol|1
7123134|NCT02655679|11262955|FG001|Overall Study|Inability to Comply with the Protocol|0
7123135|NCT02655679|11262956|FG002|Overall Study|Inability to Comply with the Protocol|0
7123136|NCT02655679|11262957|FG003|Overall Study|Inability to Comply with the Protocol|0
7123137|NCT02655679|11262958|FG004|Overall Study|Inability to Comply with the Protocol|0
7123138|NCT02655679|11262954|FG000|Overall Study|Lost to Follow-up|0
7123139|NCT02655679|11262955|FG001|Overall Study|Lost to Follow-up|1
7123140|NCT02655679|11262956|FG002|Overall Study|Lost to Follow-up|1
7123141|NCT02655679|11262957|FG003|Overall Study|Lost to Follow-up|1
7123142|NCT02655679|11262958|FG004|Overall Study|Lost to Follow-up|0
7123143|NCT02655679|11262954|FG000|Overall Study|Other Miscellaneous Reasons|1
7123144|NCT02655679|11262955|FG001|Overall Study|Other Miscellaneous Reasons|0
7123145|NCT02655679|11262956|FG002|Overall Study|Other Miscellaneous Reasons|0
7123146|NCT02655679|11262957|FG003|Overall Study|Other Miscellaneous Reasons|0
7123147|NCT02655679|11262958|FG004|Overall Study|Other Miscellaneous Reasons|0
7123148|NCT02655887|11262971|FG000|Overall Study|Lost to Follow-up|3
7123149|NCT02655887|11262971|FG000|Overall Study|Death|4
7123150|NCT02655887|11262971|FG000|Overall Study|Withdrawal by Subject|3
7123151|NCT02655887|11262971|FG000|Overall Study|Missed 12-month follow-up visit|4
7123152|NCT02656173|11262993|FG000|Overall Study|Deviation from the Eligible Criteria|3
7123153|NCT02656173|11262994|FG001|Overall Study|Deviation from the Eligible Criteria|2
7123154|NCT02656173|11262993|FG000|Overall Study|Adverse Event|7
7123155|NCT02656173|11262994|FG001|Overall Study|Adverse Event|5
7123156|NCT02656173|11262993|FG000|Overall Study|Withdrawal by Subject|1
7123157|NCT02656173|11262994|FG001|Overall Study|Withdrawal by Subject|3
7123158|NCT02656173|11262993|FG000|Overall Study|Protocol Violation|0
7123159|NCT02656173|11262994|FG001|Overall Study|Protocol Violation|1
7123160|NCT02656173|11262993|FG000|Overall Study|Miscellaneous|2
7123161|NCT02656173|11262994|FG001|Overall Study|Miscellaneous|0
7123162|NCT02656329|11263004|FG000|Overall Study|Lost to Follow-up|2
7123163|NCT02656329|11263005|FG001|Overall Study|Lost to Follow-up|3
7123164|NCT02656329|11263004|FG000|Overall Study|Withdrawal by Subject|7
7123165|NCT02656329|11263005|FG001|Overall Study|Withdrawal by Subject|6
7123166|NCT02656329|11263004|FG000|Overall Study|Study termination by Sponsor|150
7123167|NCT02656329|11263005|FG001|Overall Study|Study termination by Sponsor|142
7123168|NCT02656329|11263004|FG000|Overall Study|Other than specified above|5
7123169|NCT02656329|11263005|FG001|Overall Study|Other than specified above|6
7123170|NCT02656680|11263052|FG000|Overall Study|Lost to Follow-up|0
7123171|NCT02656680|11263053|FG001|Overall Study|Lost to Follow-up|1
7123172|NCT02656693|11263064|FG000|Overall Study|Pregnancy|1
7123173|NCT02656693|11263065|FG001|Overall Study|Pregnancy|1
7123174|NCT02656693|11263066|FG002|Overall Study|Pregnancy|1
7123175|NCT02656693|11263064|FG000|Overall Study|Bariatric surgery|0
7123176|NCT02656693|11263065|FG001|Overall Study|Bariatric surgery|1
7123177|NCT02656693|11263066|FG002|Overall Study|Bariatric surgery|2
7123178|NCT02657031|11263091|FG000|Overall Study|Adverse Event|1
7123179|NCT02657031|11263092|FG001|Overall Study|Adverse Event|2
7123180|NCT02657369|11263114|FG000|Overall Study|Death|27
7123181|NCT02657369|11263114|FG000|Overall Study|Study terminated by sponsor|7
7123182|NCT02657408|11263120|FG000|Overall Study|Adverse Event|3
7123183|NCT02657408|11263121|FG001|Overall Study|Adverse Event|7
7123184|NCT02657889|11263152|FG000|Overall Study|Death|5
7123185|NCT02657889|11263153|FG001|Overall Study|Death|2
7123186|NCT02657889|11263154|FG002|Overall Study|Death|20
7123187|NCT02657889|11263155|FG003|Overall Study|Death|34
7123188|NCT02657889|11263152|FG000|Overall Study|Lost to Follow-up|2
7123189|NCT02657889|11263153|FG001|Overall Study|Lost to Follow-up|0
7123190|NCT02657889|11263154|FG002|Overall Study|Lost to Follow-up|1
7123191|NCT02657889|11263155|FG003|Overall Study|Lost to Follow-up|2
7123192|NCT02657889|11263152|FG000|Overall Study|Withdrawal by Subject|0
7123193|NCT02657889|11263153|FG001|Overall Study|Withdrawal by Subject|0
7123194|NCT02657889|11263154|FG002|Overall Study|Withdrawal by Subject|8
7123195|NCT02657889|11263155|FG003|Overall Study|Withdrawal by Subject|0
7123196|NCT02657889|11263152|FG000|Overall Study|Ongoing in Study|0
7123197|NCT02657889|11263153|FG001|Overall Study|Ongoing in Study|5
7123198|NCT02657889|11263154|FG002|Overall Study|Ongoing in Study|24
7123199|NCT02657889|11263155|FG003|Overall Study|Ongoing in Study|19
7123200|NCT02658019|11263186|FG000|Overall Study|Adverse Event|1
7123201|NCT02658084|11263192|FG000|Overall Study|Withdrawal by Subject|1
7123202|NCT02658084|11263193|FG001|Overall Study|Withdrawal by Subject|0
7123203|NCT02658084|11263192|FG000|Overall Study|Study Termination|1
7123204|NCT02658084|11263193|FG001|Overall Study|Study Termination|0
7123205|NCT02658149|11263200|FG000|Overall Study|Physician Decision|1
7123206|NCT02658149|11263201|FG001|Overall Study|Physician Decision|0
7123207|NCT02658175|11263210|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1
7123208|NCT02658175|11263211|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0
7123209|NCT02658175|11263212|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0
7123210|NCT02658175|11263210|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6
7123211|NCT02658175|11263211|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2
7123212|NCT02658175|11263212|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0
7123213|NCT02658175|11263210|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8
7123214|NCT02658175|11263211|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5
7123215|NCT02658175|11263212|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0
7123216|NCT02658175|11263210|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1
7123217|NCT02658175|11263211|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0
7123218|NCT02658175|11263212|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0
7123219|NCT02658175|11263210|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4
7123220|NCT02658175|11263211|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0
7123221|NCT02658175|11263212|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1
7123222|NCT02658175|11263210|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7
7123223|NCT02658175|11263211|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0
7123224|NCT02658175|11263212|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0
7123225|NCT02658175|11263210|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1
7123226|NCT02658175|11263211|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0
7123227|NCT02658175|11263212|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1
7123228|NCT02658175|11263210|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8
7123229|NCT02658175|11263211|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2
7123230|NCT02658175|11263212|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0
7123231|NCT02658175|11263210|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0
7123232|NCT02658175|11263211|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0
7123233|NCT02658175|11263212|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1
7123234|NCT02658175|11263210|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1
7123235|NCT02658175|11263211|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0
7123236|NCT02658175|11263212|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0
7123237|NCT02658448|11263229|FG000|Overall Study|Lost to Follow-up|1
7123238|NCT02658487|11263248|FG000|Overall Study|Death|2
7123239|NCT02658487|11263248|FG000|Overall Study|Disease progression|10
7123240|NCT02658487|11263248|FG000|Overall Study|Alternative therapy|1
7123241|NCT02658487|11263248|FG000|Overall Study|Adverse Event|1
7123242|NCT02658487|11263248|FG000|Overall Study|Treatment Failure, circulating blasts|1
7123243|NCT02658487|11263248|FG000|Overall Study|Refractory AML|1
7123244|NCT02658630|11263253|FG000|Overall Study|Withdrawal by Subject|4
7123245|NCT02658734|11263257|FG000|Overall Study|Adverse Event|2
7123246|NCT02658734|11263257|FG000|Overall Study|Death|4
7123247|NCT02658734|11263257|FG000|Overall Study|Lost to Follow-up|7
7123248|NCT02658734|11263257|FG000|Overall Study|Withdrawal of Consent|16
7123249|NCT02658734|11263257|FG000|Overall Study|Disease Progression|28
7123250|NCT02659098|11263279|FG000|Overall Study|Withdrawal by Subject|7
7123251|NCT02659150|11263283|FG000|Subject Enrollment|Physician Decision|3
7123252|NCT02659150|11263283|FG000|Subject Enrollment|Withdrawal by Subject|2
7123253|NCT02659150|11263283|FG000|Baseline Imaging|Withdrawal by Subject|1
7123254|NCT02659150|11263283|FG000|Baseline Imaging|Physician Decision|1
7123255|NCT02659150|11263283|FG000|Study Drug Dosing|Adverse Event|1
7123256|NCT02659540|11263299|FG000|Overall Study|Adverse Event|3
7123257|NCT02659540|11263300|FG001|Overall Study|Adverse Event|2
7123258|NCT02659540|11263299|FG000|Overall Study|Death|1
7123259|NCT02659540|11263300|FG001|Overall Study|Death|0
7123260|NCT02659540|11263299|FG000|Overall Study|Progressive disease|2
7123261|NCT02659540|11263300|FG001|Overall Study|Progressive disease|6
7123262|NCT02659631|11263316|FG000|Overall Study|Lost to Follow-up|0
7123263|NCT02659631|11263317|FG001|Overall Study|Lost to Follow-up|0
7123264|NCT02659631|11263318|FG002|Overall Study|Lost to Follow-up|2
7123265|NCT02659631|11263319|FG003|Overall Study|Lost to Follow-up|0
7123266|NCT02659631|11263320|FG004|Overall Study|Lost to Follow-up|0
7123267|NCT02659631|11263321|FG005|Overall Study|Lost to Follow-up|1
7123268|NCT02659631|11263322|FG006|Overall Study|Lost to Follow-up|0
7123269|NCT02659631|11263323|FG007|Overall Study|Lost to Follow-up|0
7123270|NCT02659631|11263324|FG008|Overall Study|Lost to Follow-up|0
7123271|NCT02659631|11263325|FG009|Overall Study|Lost to Follow-up|0
7123272|NCT02659631|11263316|FG000|Overall Study|Withdrawal prior to treatment|0
7123273|NCT02659631|11263317|FG001|Overall Study|Withdrawal prior to treatment|0
7123274|NCT02659631|11263318|FG002|Overall Study|Withdrawal prior to treatment|0
7123275|NCT02659631|11263319|FG003|Overall Study|Withdrawal prior to treatment|0
7123276|NCT02659631|11263320|FG004|Overall Study|Withdrawal prior to treatment|1
7123277|NCT02659631|11263321|FG005|Overall Study|Withdrawal prior to treatment|0
7123278|NCT02659631|11263322|FG006|Overall Study|Withdrawal prior to treatment|0
7123279|NCT02659631|11263323|FG007|Overall Study|Withdrawal prior to treatment|0
7123280|NCT02659631|11263324|FG008|Overall Study|Withdrawal prior to treatment|0
7123281|NCT02659631|11263325|FG009|Overall Study|Withdrawal prior to treatment|0
7123282|NCT02659631|11263316|FG000|Overall Study|Participant refused further follow-up|0
7123283|NCT02659631|11263317|FG001|Overall Study|Participant refused further follow-up|0
7123284|NCT02659631|11263318|FG002|Overall Study|Participant refused further follow-up|0
7123285|NCT02659631|11263319|FG003|Overall Study|Participant refused further follow-up|1
7123286|NCT02659631|11263320|FG004|Overall Study|Participant refused further follow-up|0
7123287|NCT02659631|11263321|FG005|Overall Study|Participant refused further follow-up|0
7123288|NCT02659631|11263322|FG006|Overall Study|Participant refused further follow-up|0
7123289|NCT02659631|11263323|FG007|Overall Study|Participant refused further follow-up|0
7123290|NCT02659631|11263324|FG008|Overall Study|Participant refused further follow-up|1
7123291|NCT02659631|11263325|FG009|Overall Study|Participant refused further follow-up|0
7123292|NCT02659631|11263316|FG000|Overall Study|Death (follow-up phase)|1
7123293|NCT02659631|11263317|FG001|Overall Study|Death (follow-up phase)|2
7123294|NCT02659631|11263318|FG002|Overall Study|Death (follow-up phase)|1
7123295|NCT02659631|11263319|FG003|Overall Study|Death (follow-up phase)|1
7123296|NCT02659631|11263320|FG004|Overall Study|Death (follow-up phase)|3
7123297|NCT02659631|11263321|FG005|Overall Study|Death (follow-up phase)|2
7123298|NCT02659631|11263322|FG006|Overall Study|Death (follow-up phase)|0
7123299|NCT02659631|11263323|FG007|Overall Study|Death (follow-up phase)|3
7123300|NCT02659631|11263324|FG008|Overall Study|Death (follow-up phase)|1
7123301|NCT02659631|11263325|FG009|Overall Study|Death (follow-up phase)|0
7123302|NCT02659631|11263316|FG000|Overall Study|Death (treatment phase)|0
7123303|NCT02659631|11263317|FG001|Overall Study|Death (treatment phase)|0
7123304|NCT02659631|11263318|FG002|Overall Study|Death (treatment phase)|0
7123305|NCT02659631|11263319|FG003|Overall Study|Death (treatment phase)|0
7123306|NCT02659631|11263320|FG004|Overall Study|Death (treatment phase)|1
7123307|NCT02659631|11263321|FG005|Overall Study|Death (treatment phase)|0
7123308|NCT02659631|11263322|FG006|Overall Study|Death (treatment phase)|1
7123309|NCT02659631|11263323|FG007|Overall Study|Death (treatment phase)|0
7123310|NCT02659631|11263324|FG008|Overall Study|Death (treatment phase)|0
7123311|NCT02659631|11263325|FG009|Overall Study|Death (treatment phase)|0
7123312|NCT02659943|11263367|FG000|Overall Study|Switched to alternative treatment|1
7123313|NCT02659943|11263368|FG001|Overall Study|Switched to alternative treatment|1
7123314|NCT02659943|11263369|FG002|Overall Study|Switched to alternative treatment|0
7123315|NCT02659943|11263370|FG003|Overall Study|Switched to alternative treatment|2
7123316|NCT02659943|11263371|FG004|Overall Study|Switched to alternative treatment|1
7123317|NCT02659943|11263372|FG005|Overall Study|Switched to alternative treatment|0
7123318|NCT02659943|11263373|FG006|Overall Study|Switched to alternative treatment|1
7123319|NCT02659943|11263367|FG000|Overall Study|Disease progression on study|0
7123320|NCT02659943|11263368|FG001|Overall Study|Disease progression on study|1
7123321|NCT02659943|11263369|FG002|Overall Study|Disease progression on study|1
7123322|NCT02659943|11263370|FG003|Overall Study|Disease progression on study|1
7123323|NCT02659943|11263371|FG004|Overall Study|Disease progression on study|1
7123324|NCT02659943|11263372|FG005|Overall Study|Disease progression on study|4
7123325|NCT02659943|11263373|FG006|Overall Study|Disease progression on study|0
7123326|NCT02659943|11263367|FG000|Overall Study|Patient's condition per principal investigator|0
7123327|NCT02659943|11263368|FG001|Overall Study|Patient's condition per principal investigator|0
7123328|NCT02659943|11263369|FG002|Overall Study|Patient's condition per principal investigator|0
7123329|NCT02659943|11263370|FG003|Overall Study|Patient's condition per principal investigator|0
7123330|NCT02659943|11263371|FG004|Overall Study|Patient's condition per principal investigator|0
7123331|NCT02659943|11263372|FG005|Overall Study|Patient's condition per principal investigator|1
7123332|NCT02659943|11263373|FG006|Overall Study|Patient's condition per principal investigator|0
7123333|NCT02659943|11263367|FG000|Overall Study|Ineligible|0
7123334|NCT02659943|11263368|FG001|Overall Study|Ineligible|0
7123335|NCT02659943|11263369|FG002|Overall Study|Ineligible|0
7123336|NCT02659943|11263370|FG003|Overall Study|Ineligible|0
7123337|NCT02659943|11263371|FG004|Overall Study|Ineligible|0
7123338|NCT02659943|11263372|FG005|Overall Study|Ineligible|0
7123339|NCT02659943|11263373|FG006|Overall Study|Ineligible|1
7123340|NCT02659943|11263367|FG000|Overall Study|No longer meets eligibility|0
7123341|NCT02659943|11263368|FG001|Overall Study|No longer meets eligibility|0
7123342|NCT02659943|11263369|FG002|Overall Study|No longer meets eligibility|0
7123343|NCT02659943|11263370|FG003|Overall Study|No longer meets eligibility|0
7123344|NCT02659943|11263371|FG004|Overall Study|No longer meets eligibility|0
7123345|NCT02659943|11263372|FG005|Overall Study|No longer meets eligibility|0
7123346|NCT02659943|11263373|FG006|Overall Study|No longer meets eligibility|1
7123347|NCT02659943|11263367|FG000|Overall Study|No treatment, per protocol|0
7123348|NCT02659943|11263368|FG001|Overall Study|No treatment, per protocol|0
7123349|NCT02659943|11263369|FG002|Overall Study|No treatment, per protocol|0
7123350|NCT02659943|11263370|FG003|Overall Study|No treatment, per protocol|0
7123351|NCT02659943|11263371|FG004|Overall Study|No treatment, per protocol|0
7123352|NCT02659943|11263372|FG005|Overall Study|No treatment, per protocol|0
7123353|NCT02659943|11263373|FG006|Overall Study|No treatment, per protocol|3
7123354|NCT02660138|11263401|FG000|Overall Study|Adverse Event|0
7123355|NCT02660138|11263402|FG001|Overall Study|Adverse Event|3
7123356|NCT02660138|11263403|FG002|Overall Study|Adverse Event|2
7123357|NCT02660138|11263401|FG000|Overall Study|Lack of Efficacy|1
7123358|NCT02660138|11263402|FG001|Overall Study|Lack of Efficacy|2
7123359|NCT02660138|11263403|FG002|Overall Study|Lack of Efficacy|1
7123360|NCT02660138|11263401|FG000|Overall Study|Withdrawal by Subject|7
7123361|NCT02660138|11263402|FG001|Overall Study|Withdrawal by Subject|6
7123362|NCT02660138|11263403|FG002|Overall Study|Withdrawal by Subject|6
7123363|NCT02660138|11263401|FG000|Overall Study|Lost to Follow-up|4
7123364|NCT02660138|11263402|FG001|Overall Study|Lost to Follow-up|4
7123365|NCT02660138|11263403|FG002|Overall Study|Lost to Follow-up|1
7123366|NCT02660138|11263401|FG000|Overall Study|Sponsor Decision to Terminate Study|57
7123367|NCT02660138|11263402|FG001|Overall Study|Sponsor Decision to Terminate Study|57
7123368|NCT02660138|11263403|FG002|Overall Study|Sponsor Decision to Terminate Study|62
7123369|NCT02660138|11263401|FG000|Overall Study|Other|1
7123370|NCT02660138|11263402|FG001|Overall Study|Other|1
7123371|NCT02660138|11263403|FG002|Overall Study|Other|0
7123372|NCT02660138|11263401|FG000|Overall Study|Not treated|0
7123373|NCT02660138|11263402|FG001|Overall Study|Not treated|1
7123374|NCT02660138|11263403|FG002|Overall Study|Not treated|0
7123375|NCT02660229|11263416|FG000|Overall Study|Adverse Event|2
7123376|NCT02660229|11263417|FG001|Overall Study|Adverse Event|0
7123377|NCT02660229|11263416|FG000|Overall Study|Withdrawal by Subject|0
7123378|NCT02660229|11263417|FG001|Overall Study|Withdrawal by Subject|1
7123379|NCT02660242|11263423|FG000|Glucose Tabs|Lost to Follow-up|1
7123380|NCT02660242|11263423|FG000|Glucagon Injection|Lost to Follow-up|1
7123381|NCT02660359|11263439|FG000|Overall Study|Protocol Deviation|0
7123382|NCT02660359|11263440|FG001|Overall Study|Protocol Deviation|0
7123383|NCT02660359|11263441|FG002|Overall Study|Protocol Deviation|1
7123384|NCT02660359|11263439|FG000|Overall Study|Sponsor Decision to Terminate Study|73
7123385|NCT02660359|11263440|FG001|Overall Study|Sponsor Decision to Terminate Study|75
7123386|NCT02660359|11263441|FG002|Overall Study|Sponsor Decision to Terminate Study|71
7123387|NCT02660359|11263439|FG000|Overall Study|Lack of Efficacy|1
7123388|NCT02660359|11263440|FG001|Overall Study|Lack of Efficacy|1
7123389|NCT02660359|11263441|FG002|Overall Study|Lack of Efficacy|1
7123390|NCT02660359|11263439|FG000|Overall Study|Adverse Event|0
7123391|NCT02660359|11263440|FG001|Overall Study|Adverse Event|1
7123392|NCT02660359|11263441|FG002|Overall Study|Adverse Event|0
7123393|NCT02660359|11263439|FG000|Overall Study|Other|2
7123394|NCT02660359|11263440|FG001|Overall Study|Other|1
7123395|NCT02660359|11263441|FG002|Overall Study|Other|3
7123396|NCT02660359|11263439|FG000|Overall Study|Withdrawal by Subject|7
7123397|NCT02660359|11263440|FG001|Overall Study|Withdrawal by Subject|5
7123398|NCT02660359|11263441|FG002|Overall Study|Withdrawal by Subject|8
7123399|NCT02660359|11263439|FG000|Overall Study|Lost to Follow-up|3
7123400|NCT02660359|11263440|FG001|Overall Study|Lost to Follow-up|3
7123401|NCT02660359|11263441|FG002|Overall Study|Lost to Follow-up|0
7123402|NCT02660489|11263451|FG000|Overall Study|Lost to Follow-up|1
7123403|NCT02660489|11263452|FG001|Overall Study|Lost to Follow-up|1
7123404|NCT02660489|11263451|FG000|Overall Study|Adverse Event|1
7123405|NCT02660489|11263452|FG001|Overall Study|Adverse Event|3
7123406|NCT02660489|11263451|FG000|Overall Study|no rhinovirus infection|4
7123407|NCT02660489|11263452|FG001|Overall Study|no rhinovirus infection|4
7123408|NCT02660580|11263460|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1
7123409|NCT02660580|11263461|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1
7123410|NCT02660580|11263462|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
7123411|NCT02660580|11263463|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
7123412|NCT02660580|11263464|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
7123413|NCT02660580|11263460|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3
7123414|NCT02660580|11263461|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1
7123415|NCT02660580|11263462|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
7123416|NCT02660580|11263463|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
7123417|NCT02660580|11263464|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
7123418|NCT02660580|11263460|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1
7123419|NCT02660580|11263461|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0
7123420|NCT02660580|11263462|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0
7123421|NCT02660580|11263463|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0
7123422|NCT02660580|11263464|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0
7123423|NCT02660580|11263460|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
7123424|NCT02660580|11263461|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2
7123425|NCT02660580|11263462|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
7123426|NCT02660580|11263463|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
7123427|NCT02660580|11263464|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
7123428|NCT02660580|11263460|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2
7123429|NCT02660580|11263461|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9
7123430|NCT02660580|11263462|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0
7123431|NCT02660580|11263463|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0
7123432|NCT02660580|11263464|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0
7123433|NCT02660580|11263460|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1
7123434|NCT02660580|11263461|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4
7123435|NCT02660580|11263462|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
7123436|NCT02660580|11263463|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
7123437|NCT02660580|11263464|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
7123438|NCT02660580|11263460|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1
7123439|NCT02660580|11263461|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2
7123440|NCT02660580|11263462|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
7123441|NCT02660580|11263463|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
7123442|NCT02660580|11263464|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
7123443|NCT02660580|11263460|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
7123444|NCT02660580|11263461|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
7123445|NCT02660580|11263462|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2
7123446|NCT02660580|11263463|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
7123447|NCT02660580|11263464|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1
7123448|NCT02660580|11263460|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
7123449|NCT02660580|11263461|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
7123450|NCT02660580|11263462|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1
7123451|NCT02660580|11263463|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
7123452|NCT02660580|11263464|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1
7123453|NCT02660580|11263460|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0
7123454|NCT02660580|11263461|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0
7123455|NCT02660580|11263462|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4
7123456|NCT02660580|11263463|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2
7123457|NCT02660580|11263464|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2
7123458|NCT02660580|11263460|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0
7123459|NCT02660580|11263461|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0
7123460|NCT02660580|11263462|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8
7123461|NCT02660580|11263463|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6
7123462|NCT02660580|11263464|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4
7123463|NCT02660580|11263460|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0
7123464|NCT02660580|11263461|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0
7123465|NCT02660580|11263462|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3
7123466|NCT02660580|11263463|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2
7123467|NCT02660580|11263464|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2
7123468|NCT02660580|11263460|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
7123469|NCT02660580|11263461|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
7123470|NCT02660580|11263462|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
7123471|NCT02660580|11263463|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1
7123472|NCT02660580|11263464|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1
7123473|NCT02660944|11263515|FG000|Overall Study|Adverse Event|3
7123474|NCT02660944|11263516|FG001|Overall Study|Adverse Event|4
7123475|NCT02660944|11263515|FG000|Overall Study|Physician Decision|3
7123476|NCT02660944|11263516|FG001|Overall Study|Physician Decision|1
7123477|NCT02660944|11263515|FG000|Overall Study|Withdrawal by Subject|5
7123478|NCT02660944|11263516|FG001|Overall Study|Withdrawal by Subject|3
7123479|NCT02660944|11263515|FG000|Overall Study|Lost to Follow-up|4
7123480|NCT02660944|11263516|FG001|Overall Study|Lost to Follow-up|1
7123481|NCT02660944|11263515|FG000|Overall Study|Subject schedule|0
7123482|NCT02660944|11263516|FG001|Overall Study|Subject schedule|1
7123483|NCT02660944|11263515|FG000|Overall Study|Exclusion criteria met|2
7123484|NCT02660944|11263516|FG001|Overall Study|Exclusion criteria met|0
7123485|NCT02660983|11263524|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1
7123486|NCT02660983|11263525|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5
7123487|NCT02660983|11263524|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15
7123488|NCT02660983|11263525|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12
7123489|NCT02660983|11263524|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8
7123490|NCT02660983|11263525|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9
7123491|NCT02660983|11263524|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1
7123492|NCT02660983|11263525|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1
7123493|NCT02660983|11263524|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1
7123494|NCT02660983|11263525|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4
7123495|NCT02660983|11263524|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1
7123496|NCT02660983|11263525|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3
7123497|NCT02660983|11263524|FG000|Open Label Extension Phase (24 Weeks)|Other|0
7123498|NCT02660983|11263525|FG001|Open Label Extension Phase (24 Weeks)|Other|1
7123499|NCT02661061|11263534|FG000|Overall Study|Lack of Efficacy|1
7123500|NCT02661061|11263535|FG001|Overall Study|Lack of Efficacy|1
7123501|NCT02661061|11263534|FG000|Overall Study|Withdrawal by Subject|1
7123502|NCT02661061|11263535|FG001|Overall Study|Withdrawal by Subject|1
7123503|NCT02661178|11263565|FG000|Part 1|Protocol Violation|1
7123504|NCT02661178|11263566|FG001|Part 1|Protocol Violation|0
7123505|NCT02661178|11263567|FG002|Part 1|Protocol Violation|0
7123506|NCT02661178|11263568|FG003|Part 1|Protocol Violation|0
7123507|NCT02661178|11263569|FG004|Part 1|Protocol Violation|0
7123508|NCT02661178|11263570|FG005|Part 1|Protocol Violation|0
7123509|NCT02661178|11263571|FG006|Part 1|Protocol Violation|0
7123510|NCT02661178|11263572|FG007|Part 1|Protocol Violation|0
7123511|NCT02661178|11263573|FG008|Part 1|Protocol Violation|0
7123512|NCT02661178|11263574|FG009|Part 1|Protocol Violation|0
7123513|NCT02661178|11263575|FG010|Part 1|Protocol Violation|0
7123514|NCT02661178|11263576|FG011|Part 1|Protocol Violation|0
7123515|NCT02661178|11263577|FG012|Part 1|Protocol Violation|0
7123516|NCT02661178|11263578|FG013|Part 1|Protocol Violation|0
7123517|NCT02661178|11263579|FG014|Part 1|Protocol Violation|0
7123518|NCT02661217|11263631|FG000|Overall Study|Physician Decision|12
7123519|NCT02661217|11263632|FG001|Overall Study|Physician Decision|15
7123520|NCT02661217|11263631|FG000|Overall Study|Lost to Follow-up|1
7123521|NCT02661217|11263632|FG001|Overall Study|Lost to Follow-up|4
7123522|NCT02661217|11263631|FG000|Overall Study|Protocol Deviation|0
7123523|NCT02661217|11263632|FG001|Overall Study|Protocol Deviation|4
7123524|NCT02661217|11263631|FG000|Overall Study|Non-compliance with study treatment|5
7123525|NCT02661217|11263632|FG001|Overall Study|Non-compliance with study treatment|5
7123526|NCT02661217|11263631|FG000|Overall Study|Death|21
7123527|NCT02661217|11263632|FG001|Overall Study|Death|15
7123528|NCT02661217|11263631|FG000|Overall Study|Adverse Event|10
7123529|NCT02661217|11263632|FG001|Overall Study|Adverse Event|8
7123530|NCT02661217|11263631|FG000|Overall Study|Withdrawal by Subject|15
7123531|NCT02661217|11263632|FG001|Overall Study|Withdrawal by Subject|19
7123532|NCT02661217|11263631|FG000|Overall Study|Did not enter follow-up epoch|7
7123533|NCT02661217|11263632|FG001|Overall Study|Did not enter follow-up epoch|10
7123534|NCT02661217|11263631|FG000|Overall Study|Death - no study drug received|1
7123535|NCT02661217|11263632|FG001|Overall Study|Death - no study drug received|2
7123536|NCT02661217|11263631|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3
7123537|NCT02661217|11263632|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1
7123538|NCT02661490|11263650|FG000|Overall Study|Lost to Follow-up|0
7123539|NCT02661490|11263651|FG001|Overall Study|Lost to Follow-up|1
7123540|NCT02661490|11263652|FG002|Overall Study|Lost to Follow-up|0
7123541|NCT02661490|11263653|FG003|Overall Study|Lost to Follow-up|0
7123542|NCT02661490|11263654|FG004|Overall Study|Lost to Follow-up|2
7123543|NCT02661490|11263650|FG000|Overall Study|Withdrawal by Subject|2
7123544|NCT02661490|11263651|FG001|Overall Study|Withdrawal by Subject|0
7123545|NCT02661490|11263652|FG002|Overall Study|Withdrawal by Subject|2
7123546|NCT02661490|11263653|FG003|Overall Study|Withdrawal by Subject|0
7123547|NCT02661490|11263654|FG004|Overall Study|Withdrawal by Subject|0
7123548|NCT02661490|11263650|FG000|Overall Study|Death|1
7123549|NCT02661490|11263651|FG001|Overall Study|Death|1
7123550|NCT02661490|11263652|FG002|Overall Study|Death|0
7123551|NCT02661490|11263653|FG003|Overall Study|Death|1
7123552|NCT02661490|11263654|FG004|Overall Study|Death|0
7123553|NCT02661490|11263650|FG000|Overall Study|Reason not Specified|0
7123554|NCT02661490|11263651|FG001|Overall Study|Reason not Specified|0
7123555|NCT02661490|11263652|FG002|Overall Study|Reason not Specified|0
7123556|NCT02661490|11263653|FG003|Overall Study|Reason not Specified|0
7123557|NCT02661490|11263654|FG004|Overall Study|Reason not Specified|1
7123558|NCT02661594|11263670|FG000|Overall Study|Protocol Violation|1
7123559|NCT02661594|11263671|FG001|Overall Study|Protocol Violation|0
7123560|NCT02661594|11263672|FG002|Overall Study|Protocol Violation|1
7123561|NCT02661594|11263673|FG003|Overall Study|Protocol Violation|0
7123562|NCT02661815|11263691|FG000|Overall Study|Withdrawal by Subject|1
7123563|NCT02661815|11263692|FG001|Overall Study|Withdrawal by Subject|0
7123564|NCT02661815|11263693|FG002|Overall Study|Withdrawal by Subject|0
7123565|NCT02661815|11263694|FG003|Overall Study|Withdrawal by Subject|0
7123566|NCT02662556|11263751|FG000|Overall Study|Adverse Event|4
7123567|NCT02662556|11263751|FG000|Overall Study|Lack of Efficacy|4
7123568|NCT02662569|11263760|FG000|Overall Study|Withdrawal by Subject|6
7123569|NCT02662569|11263761|FG001|Overall Study|Withdrawal by Subject|1
7123570|NCT02662569|11263762|FG002|Overall Study|Withdrawal by Subject|6
7123571|NCT02662569|11263763|FG003|Overall Study|Withdrawal by Subject|4
7123572|NCT02662569|11263760|FG000|Overall Study|Lost to Follow-up|1
7123573|NCT02662569|11263761|FG001|Overall Study|Lost to Follow-up|0
7123574|NCT02662569|11263762|FG002|Overall Study|Lost to Follow-up|0
7123575|NCT02662569|11263763|FG003|Overall Study|Lost to Follow-up|0
6806102|NCT01970865|10808457|FG006|Overall Study|Withdrawal by Subject|0
6806103|NCT01970865|10808458|FG007|Overall Study|Withdrawal by Subject|0
6806104|NCT01970865|10808459|FG008|Overall Study|Withdrawal by Subject|0
7123576|NCT02662582|11263775|FG000|Treatment Period 1 (14 Days)|Adverse Event|3
7123577|NCT02662582|11263776|FG001|Treatment Period 1 (14 Days)|Adverse Event|2
7123578|NCT02662582|11263775|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0
7123579|NCT02662582|11263776|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1
7123580|NCT02662582|11263775|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1
7123581|NCT02662582|11263776|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0
7123582|NCT02662582|11263775|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
7123583|NCT02662582|11263776|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
7123584|NCT02662764|11263787|FG000|Overall Study|Adverse Event|6
7123585|NCT02662764|11263787|FG000|Overall Study|Lack of Efficacy|8
7123586|NCT02662764|11263787|FG000|Overall Study|Protocol Violation|1
7123587|NCT02662764|11263787|FG000|Overall Study|Withdrawal by Subject|5
7123588|NCT02662764|11263787|FG000|Overall Study|Device failure|4
7123589|NCT02662764|11263787|FG000|Overall Study|Patient changed treatment|1
7123590|NCT02662764|11263787|FG000|Overall Study|Patient discharged prior to 24 hrs|5
7123591|NCT02663128|11263798|FG000|Period 2|Physician Decision|0
7123592|NCT02663128|11263799|FG001|Period 2|Physician Decision|0
7123593|NCT02663128|11263800|FG002|Period 2|Physician Decision|0
7123594|NCT02663128|11263801|FG003|Period 2|Physician Decision|0
7123595|NCT02663128|11263802|FG004|Period 2|Physician Decision|1
7123596|NCT02663128|11263803|FG005|Period 2|Physician Decision|0
7123597|NCT02663453|11263818|FG000|Overall Study|Death|4
7123598|NCT02663453|11263819|FG001|Overall Study|Death|4
7123599|NCT02663453|11263818|FG000|Overall Study|Withdrawal by Subject|1
7123600|NCT02663453|11263819|FG001|Overall Study|Withdrawal by Subject|0
7123601|NCT02663674|11263827|FG000|Overall Study|Lost to Follow-up|5
7123602|NCT02663674|11263828|FG001|Overall Study|Lost to Follow-up|4
7123603|NCT02663674|11263827|FG000|Overall Study|Withdrawal by Subject|1
7123604|NCT02663674|11263828|FG001|Overall Study|Withdrawal by Subject|4
7123605|NCT02663674|11263827|FG000|Overall Study|Physician Decision|1
7123606|NCT02663674|11263828|FG001|Overall Study|Physician Decision|1
7123607|NCT02663674|11263827|FG000|Overall Study|Other Event (Health Related)|0
7123608|NCT02663674|11263828|FG001|Overall Study|Other Event (Health Related)|1
7123609|NCT02663687|11263839|FG000|Overall Study|Adverse Event|1
7123610|NCT02663687|11263840|FG001|Overall Study|Adverse Event|0
7123611|NCT02663687|11263841|FG002|Overall Study|Adverse Event|0
7123612|NCT02663687|11263842|FG003|Overall Study|Adverse Event|0
7123613|NCT02663687|11263843|FG004|Overall Study|Adverse Event|0
7123614|NCT02663687|11263839|FG000|Overall Study|Other|1
7123615|NCT02663687|11263840|FG001|Overall Study|Other|0
7123616|NCT02663687|11263841|FG002|Overall Study|Other|1
7123617|NCT02663687|11263842|FG003|Overall Study|Other|0
7123618|NCT02663687|11263843|FG004|Overall Study|Other|0
7123619|NCT02663817|11263868|FG000|Overall Study|Screen failure|2
7123620|NCT02663882|11263876|FG000|Overall Study|Lost to Follow-up|4
7123621|NCT02663882|11263877|FG001|Overall Study|Lost to Follow-up|2
7123622|NCT02663895|11263883|FG000|Overall Study|Adverse Event|3
7123623|NCT02663895|11263883|FG000|Overall Study|Physician Decision|2
7123624|NCT02663895|11263883|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1
7123625|NCT02663895|11263883|FG000|Overall Study|Withdrawal by Subject|1
7123626|NCT02664272|11263897|FG000|Overall Study|Fluoroscopic images not made available|2
7123627|NCT02664415|11263916|FG000|Overall Study|Adverse Event|1
7123628|NCT02664415|11263917|FG001|Overall Study|Adverse Event|0
7123629|NCT02665052|11263979|FG000|Overall Study|Lost to Follow-up|1
7123630|NCT02665052|11263980|FG001|Overall Study|Lost to Follow-up|0
7123631|NCT02665052|11263981|FG002|Overall Study|Lost to Follow-up|0
7123632|NCT02665052|11263982|FG003|Overall Study|Lost to Follow-up|0
7123633|NCT02665052|11263979|FG000|Overall Study|Withdrawal by Subject|1
7123634|NCT02665052|11263980|FG001|Overall Study|Withdrawal by Subject|1
7123635|NCT02665052|11263981|FG002|Overall Study|Withdrawal by Subject|0
7123636|NCT02665052|11263982|FG003|Overall Study|Withdrawal by Subject|5
7123637|NCT02665052|11263979|FG000|Overall Study|Adverse Event|1
7123638|NCT02665052|11263980|FG001|Overall Study|Adverse Event|1
7123639|NCT02665052|11263981|FG002|Overall Study|Adverse Event|0
7123640|NCT02665052|11263982|FG003|Overall Study|Adverse Event|0
7123641|NCT02665286|11264026|FG000|Overall Study|Lost to Follow-up|3
7123642|NCT02665286|11264027|FG001|Overall Study|Lost to Follow-up|2
7123643|NCT02665286|11264028|FG002|Overall Study|Lost to Follow-up|1
7123644|NCT02665455|11264045|FG000|Overall Study|Withdrawal by Subject|6
7123645|NCT02665455|11264045|FG000|Overall Study|Lost to Follow-up|1
7123646|NCT02665455|11264045|FG000|Overall Study|Adverse Event|1
7123647|NCT02665455|11264045|FG000|Overall Study|Protocol Violation|1
7123648|NCT02665689|11264060|FG000|Overall Study|Adverse Event|1
7123649|NCT02665689|11264061|FG001|Overall Study|Adverse Event|0
7123650|NCT02665689|11264060|FG000|Overall Study|Trial termination|1
7123651|NCT02665689|11264061|FG001|Overall Study|Trial termination|1
7123652|NCT02665689|11264060|FG000|Overall Study|Lost to Follow-up|0
7123653|NCT02665689|11264061|FG001|Overall Study|Lost to Follow-up|1
7123654|NCT02666222|11264093|FG000|Overall Study|Death|2
7123655|NCT02666664|11264133|FG000|Overall Study|Physician Decision|0
7123656|NCT02666664|11264134|FG001|Overall Study|Physician Decision|1
7123657|NCT02666664|11264133|FG000|Overall Study|Protocol Violation|0
7123658|NCT02666664|11264134|FG001|Overall Study|Protocol Violation|2
7123659|NCT02666664|11264133|FG000|Overall Study|Other|0
7123660|NCT02666664|11264134|FG001|Overall Study|Other|1
7123661|NCT02666664|11264133|FG000|Overall Study|Adverse Event|12
7123662|NCT02666664|11264134|FG001|Overall Study|Adverse Event|37
7123663|NCT02666664|11264133|FG000|Overall Study|Withdrawal by participant|23
7123664|NCT02666664|11264134|FG001|Overall Study|Withdrawal by participant|40
7123665|NCT02666664|11264133|FG000|Overall Study|Sponsor decision|0
7123666|NCT02666664|11264134|FG001|Overall Study|Sponsor decision|1
7123667|NCT02666664|11264133|FG000|Overall Study|Lost to Follow-up|1
7123668|NCT02666664|11264134|FG001|Overall Study|Lost to Follow-up|2
7123669|NCT02667236|11264192|FG000|Overall Study|Adverse Event|1
7123670|NCT02667236|11264193|FG001|Overall Study|Adverse Event|1
7123671|NCT02667236|11264192|FG000|Overall Study|Withdrawal by Subject|2
7123672|NCT02667236|11264193|FG001|Overall Study|Withdrawal by Subject|0
7123673|NCT02667275|11264201|FG000|Overall Study|Protocol Violation|11
7123674|NCT02667275|11264202|FG001|Overall Study|Protocol Violation|7
7123675|NCT02667275|11264201|FG000|Overall Study|Lost to Follow-up|0
7123676|NCT02667275|11264202|FG001|Overall Study|Lost to Follow-up|2
7123677|NCT02667275|11264201|FG000|Overall Study|Withdrawal by Subject|0
7123678|NCT02667275|11264202|FG001|Overall Study|Withdrawal by Subject|5
7123679|NCT02667275|11264201|FG000|Overall Study|Discontinued early without completing|0
7123680|NCT02667275|11264202|FG001|Overall Study|Discontinued early without completing|1
7123681|NCT02667288|11264208|FG000|Overall Study|Protocol Violation|5
7123682|NCT02667288|11264208|FG000|Overall Study|Lost to Follow-up|3
7123683|NCT02667288|11264208|FG000|Overall Study|Withdrawal by Subject|5
7123684|NCT02667301|11264212|FG000|Overall Study|Adverse Event|1
7123685|NCT02667301|11264212|FG000|Overall Study|Lack of Efficacy|1
7123686|NCT02667457|11264224|FG000|Overall Study|Withdrawal by Subject|1
7123687|NCT02667457|11264225|FG001|Overall Study|Withdrawal by Subject|0
7123688|NCT02667457|11264224|FG000|Overall Study|Other Reason|0
7123689|NCT02667457|11264225|FG001|Overall Study|Other Reason|2
7123690|NCT02667626|11264234|FG000|Overall Study|Withdrawal by Subject|0
7123691|NCT02667626|11264235|FG001|Overall Study|Withdrawal by Subject|1
7123692|NCT02667912|11264258|FG000|Overall Study|Death|3
7123693|NCT02667912|11264259|FG001|Overall Study|Death|1
7123694|NCT02667912|11264258|FG000|Overall Study|Withdrawal by Subject|1
7123695|NCT02667912|11264259|FG001|Overall Study|Withdrawal by Subject|2
7123696|NCT02667912|11264258|FG000|Overall Study|Withdrawal by Subject|1
7123697|NCT02667912|11264259|FG001|Overall Study|Withdrawal by Subject|0
7123698|NCT02668185|11264283|FG000|First Intervention (4 Weeks)|Physician Decision|2
7123699|NCT02668185|11264284|FG001|First Intervention (4 Weeks)|Physician Decision|0
7123700|NCT02668185|11264283|FG000|Washout Period (2 Weeks)|Adverse Event|1
7123701|NCT02668185|11264284|FG001|Washout Period (2 Weeks)|Adverse Event|0
7123702|NCT02668185|11264283|FG000|Washout Period (2 Weeks)|Physician Decision|0
7123703|NCT02668185|11264284|FG001|Washout Period (2 Weeks)|Physician Decision|2
7123704|NCT02668185|11264283|FG000|Second Intervention (4 Weeks)|Physician Decision|1
7123705|NCT02668185|11264284|FG001|Second Intervention (4 Weeks)|Physician Decision|3
7123706|NCT02668302|11264297|FG000|Overall Study|Withdrawal by Subject|1
7123707|NCT02668302|11264298|FG001|Overall Study|Withdrawal by Subject|0
7123708|NCT02668393|11264306|FG000|Overall Study|Progressive disease|6
7123709|NCT02668393|11264307|FG001|Overall Study|Progressive disease|3
7123710|NCT02668393|11264306|FG000|Overall Study|Adverse Event|0
7123711|NCT02668393|11264307|FG001|Overall Study|Adverse Event|2
7123712|NCT02668393|11264306|FG000|Overall Study|Withdrawal from the trial|0
7123713|NCT02668393|11264307|FG001|Overall Study|Withdrawal from the trial|1
7123714|NCT02668393|11264306|FG000|Overall Study|Lack of benefit and side effects|1
7123715|NCT02668393|11264307|FG001|Overall Study|Lack of benefit and side effects|0
7123716|NCT02668640|11264323|FG000|Overall Study|Lost to Follow-up|13
7123717|NCT02668640|11264323|FG000|Overall Study|Other, not specified|1
7123718|NCT02668692|11264329|FG000|Overall Study|Adverse Event|1
7123719|NCT02668692|11264330|FG001|Overall Study|Adverse Event|0
7123720|NCT02669017|11264354|FG000|Overall Study|Death|1
7123721|NCT02669017|11264355|FG001|Overall Study|Death|2
7123722|NCT02669017|11264356|FG002|Overall Study|Death|2
7123723|NCT02669017|11264357|FG003|Overall Study|Death|3
7123724|NCT02669017|11264358|FG004|Overall Study|Death|8
7123725|NCT02669017|11264359|FG005|Overall Study|Death|18
7123726|NCT02669017|11264360|FG006|Overall Study|Death|10
7123727|NCT02669017|11264361|FG007|Overall Study|Death|47
7123728|NCT02669017|11264362|FG008|Overall Study|Death|20
7123729|NCT02669017|11264354|FG000|Overall Study|Withdrawal by Subject|0
7123730|NCT02669017|11264355|FG001|Overall Study|Withdrawal by Subject|0
7123731|NCT02669017|11264356|FG002|Overall Study|Withdrawal by Subject|0
7123732|NCT02669017|11264357|FG003|Overall Study|Withdrawal by Subject|1
7123733|NCT02669017|11264358|FG004|Overall Study|Withdrawal by Subject|2
7123734|NCT02669017|11264359|FG005|Overall Study|Withdrawal by Subject|0
7123735|NCT02669017|11264360|FG006|Overall Study|Withdrawal by Subject|0
7123736|NCT02669017|11264361|FG007|Overall Study|Withdrawal by Subject|2
7123737|NCT02669017|11264362|FG008|Overall Study|Withdrawal by Subject|2
7123738|NCT02669017|11264354|FG000|Overall Study|Lost to Follow-up|0
7123739|NCT02669017|11264355|FG001|Overall Study|Lost to Follow-up|0
7123740|NCT02669017|11264356|FG002|Overall Study|Lost to Follow-up|0
7123741|NCT02669017|11264357|FG003|Overall Study|Lost to Follow-up|0
7123742|NCT02669017|11264358|FG004|Overall Study|Lost to Follow-up|0
7123743|NCT02669017|11264359|FG005|Overall Study|Lost to Follow-up|0
7123744|NCT02669017|11264360|FG006|Overall Study|Lost to Follow-up|0
7123745|NCT02669017|11264361|FG007|Overall Study|Lost to Follow-up|0
7123746|NCT02669017|11264362|FG008|Overall Study|Lost to Follow-up|1
7123747|NCT02669017|11264354|FG000|Overall Study|Miscellaneous|0
7123748|NCT02669017|11264355|FG001|Overall Study|Miscellaneous|0
7123749|NCT02669017|11264356|FG002|Overall Study|Miscellaneous|0
7123750|NCT02669017|11264357|FG003|Overall Study|Miscellaneous|0
7123751|NCT02669017|11264358|FG004|Overall Study|Miscellaneous|2
7123752|NCT02669017|11264359|FG005|Overall Study|Miscellaneous|1
7123753|NCT02669017|11264360|FG006|Overall Study|Miscellaneous|1
7123754|NCT02669017|11264361|FG007|Overall Study|Miscellaneous|13
7123755|NCT02669017|11264362|FG008|Overall Study|Miscellaneous|2
7123756|NCT02669043|11264390|FG000|Overall Study|Didn't meet I/E criteria|4
7123757|NCT02669082|11264394|FG000|Overall Study|Adverse Event|1
7123758|NCT02669095|11264400|FG000|Overall Study|Adverse Event|1
7123759|NCT02669095|11264401|FG001|Overall Study|Adverse Event|0
7123760|NCT02669095|11264400|FG000|Overall Study|Unsatisfactory Lens Fitting|0
7123761|NCT02669095|11264401|FG001|Overall Study|Unsatisfactory Lens Fitting|1
7123762|NCT02669095|11264400|FG000|Overall Study|Torn Lens|0
7123763|NCT02669095|11264401|FG001|Overall Study|Torn Lens|1
7123764|NCT02669095|11264400|FG000|Overall Study|Visit 5 assessments not completed|0
7123765|NCT02669095|11264401|FG001|Overall Study|Visit 5 assessments not completed|1
7123766|NCT02669121|11264409|FG000|Overall Study|Adverse Event|4
7123767|NCT02669121|11264410|FG001|Overall Study|Adverse Event|5
7123768|NCT02669121|11264409|FG000|Overall Study|Lost to Follow-up|15
7123769|NCT02669121|11264410|FG001|Overall Study|Lost to Follow-up|27
7123770|NCT02669121|11264409|FG000|Overall Study|Withdrawal by Subject|132
7123771|NCT02669121|11264410|FG001|Overall Study|Withdrawal by Subject|140
7123772|NCT02669121|11264409|FG000|Overall Study|Pregnancy|0
7123773|NCT02669121|11264410|FG001|Overall Study|Pregnancy|1
7123774|NCT02669121|11264409|FG000|Overall Study|Discharged from US Military Active Service|117
7123775|NCT02669121|11264410|FG001|Overall Study|Discharged from US Military Active Service|91
7123776|NCT02669121|11264409|FG000|Overall Study|Reason not Specified|22
7123777|NCT02669121|11264410|FG001|Overall Study|Reason not Specified|18
7123778|NCT02669264|11264423|FG000|Overall Study|Death|5
7123779|NCT02669264|11264424|FG001|Overall Study|Death|5
7123780|NCT02669264|11264425|FG002|Overall Study|Death|3
7123781|NCT02669264|11264426|FG003|Overall Study|Death|3
7123782|NCT02669264|11264427|FG004|Overall Study|Death|3
7123783|NCT02669264|11264428|FG005|Overall Study|Death|6
7123784|NCT02669264|11264429|FG006|Overall Study|Death|3
7123785|NCT02669264|11264423|FG000|Overall Study|Withdrawal by Subject|0
7123786|NCT02669264|11264424|FG001|Overall Study|Withdrawal by Subject|1
7123787|NCT02669264|11264425|FG002|Overall Study|Withdrawal by Subject|0
7123788|NCT02669264|11264426|FG003|Overall Study|Withdrawal by Subject|0
7123789|NCT02669264|11264427|FG004|Overall Study|Withdrawal by Subject|1
7123790|NCT02669264|11264428|FG005|Overall Study|Withdrawal by Subject|0
7123791|NCT02669264|11264429|FG006|Overall Study|Withdrawal by Subject|0
7123792|NCT02669264|11264423|FG000|Overall Study|Lost to Follow-up|0
7123793|NCT02669264|11264424|FG001|Overall Study|Lost to Follow-up|0
7123794|NCT02669264|11264425|FG002|Overall Study|Lost to Follow-up|0
7123795|NCT02669264|11264426|FG003|Overall Study|Lost to Follow-up|0
7123796|NCT02669264|11264427|FG004|Overall Study|Lost to Follow-up|1
7123797|NCT02669264|11264428|FG005|Overall Study|Lost to Follow-up|0
7123798|NCT02669264|11264429|FG006|Overall Study|Lost to Follow-up|0
7123799|NCT02669264|11264423|FG000|Overall Study|Miscellaneous|0
7123800|NCT02669264|11264424|FG001|Overall Study|Miscellaneous|0
7123801|NCT02669264|11264425|FG002|Overall Study|Miscellaneous|0
7123802|NCT02669264|11264426|FG003|Overall Study|Miscellaneous|0
7123803|NCT02669264|11264427|FG004|Overall Study|Miscellaneous|0
7123804|NCT02669264|11264428|FG005|Overall Study|Miscellaneous|0
7123805|NCT02669264|11264429|FG006|Overall Study|Miscellaneous|2
7123806|NCT02669407|11264451|FG000|Overall Study|Physician Decision|3
7123807|NCT02669433|11264458|FG000|Overall Study|Protocol Violation|0
7123808|NCT02669433|11264459|FG001|Overall Study|Protocol Violation|4
7123809|NCT02669433|11264460|FG002|Overall Study|Protocol Violation|1
7123810|NCT02669433|11264458|FG000|Overall Study|Disease Progression|1
7123811|NCT02669433|11264459|FG001|Overall Study|Disease Progression|0
7123812|NCT02669433|11264460|FG002|Overall Study|Disease Progression|0
7123813|NCT02669433|11264458|FG000|Overall Study|Physician Decision|1
7123814|NCT02669433|11264459|FG001|Overall Study|Physician Decision|1
7123815|NCT02669433|11264460|FG002|Overall Study|Physician Decision|0
7123816|NCT02669433|11264458|FG000|Overall Study|Adverse Event|6
7123817|NCT02669433|11264459|FG001|Overall Study|Adverse Event|7
7123818|NCT02669433|11264460|FG002|Overall Study|Adverse Event|10
7123819|NCT02669433|11264458|FG000|Overall Study|Sponsor Termination|1
7123820|NCT02669433|11264459|FG001|Overall Study|Sponsor Termination|0
7123821|NCT02669433|11264460|FG002|Overall Study|Sponsor Termination|1
7123822|NCT02669433|11264458|FG000|Overall Study|Withdrawal by Subject|5
7123823|NCT02669433|11264459|FG001|Overall Study|Withdrawal by Subject|1
7123824|NCT02669433|11264460|FG002|Overall Study|Withdrawal by Subject|0
7123825|NCT02669433|11264458|FG000|Overall Study|Withdrawal by Caregiver|1
7123826|NCT02669433|11264459|FG001|Overall Study|Withdrawal by Caregiver|0
7123827|NCT02669433|11264460|FG002|Overall Study|Withdrawal by Caregiver|2
7123828|NCT02669433|11264458|FG000|Overall Study|Death|0
7123829|NCT02669433|11264459|FG001|Overall Study|Death|1
7123830|NCT02669433|11264460|FG002|Overall Study|Death|1
7123831|NCT02669667|11264479|FG000|Overall Study|Lost to Follow-up|0
7123832|NCT02669667|11264480|FG001|Overall Study|Lost to Follow-up|0
7123833|NCT02669667|11264481|FG002|Overall Study|Lost to Follow-up|0
7123834|NCT02669667|11264482|FG003|Overall Study|Lost to Follow-up|0
7123835|NCT02669667|11264483|FG004|Overall Study|Lost to Follow-up|0
7123836|NCT02669667|11264484|FG005|Overall Study|Lost to Follow-up|1
7123837|NCT02669667|11264485|FG006|Overall Study|Lost to Follow-up|0
7123838|NCT02669758|11264507|FG000|Overall Study|Withdrawal by Subject|43
7123839|NCT02669758|11264507|FG000|Overall Study|Lost to Follow-up|19
7123840|NCT02669758|11264507|FG000|Overall Study|Adverse Event|16
7123841|NCT02669758|11264507|FG000|Overall Study|Non-Compliance with Study Drug|8
7123842|NCT02669758|11264507|FG000|Overall Study|Lack of Efficacy|5
7123843|NCT02669758|11264507|FG000|Overall Study|Pregnancy|1
7123844|NCT02669758|11264507|FG000|Overall Study|Study noncompliance|1
7123845|NCT02669758|11264507|FG000|Overall Study|Protocol Violation|1
7123846|NCT02669849|11264523|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0
7123847|NCT02669849|11264524|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0
7123848|NCT02669849|11264525|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3
7123849|NCT02669849|11264523|FG000|Overall Study|Lost to Follow-up|1
7123850|NCT02669849|11264524|FG001|Overall Study|Lost to Follow-up|0
7123851|NCT02669849|11264525|FG002|Overall Study|Lost to Follow-up|3
7123852|NCT02669849|11264523|FG000|Overall Study|Death|1
7123853|NCT02669849|11264524|FG001|Overall Study|Death|1
7123854|NCT02669849|11264525|FG002|Overall Study|Death|2
7123855|NCT02669849|11264523|FG000|Overall Study|Study terminated by sponsor|16
7123856|NCT02669849|11264524|FG001|Overall Study|Study terminated by sponsor|1
7123857|NCT02669849|11264525|FG002|Overall Study|Study terminated by sponsor|14
7123858|NCT02669849|11264523|FG000|Overall Study|Other|0
7123859|NCT02669849|11264524|FG001|Overall Study|Other|0
7123860|NCT02669849|11264525|FG002|Overall Study|Other|2
7123861|NCT02669862|11264536|FG000|Overall Study|Lost to Follow-up|0
7123862|NCT02669862|11264537|FG001|Overall Study|Lost to Follow-up|2
7123863|NCT02669862|11264538|FG002|Overall Study|Lost to Follow-up|1
7123864|NCT02669862|11264536|FG000|Overall Study|Withdrawal by Subject|2
7123865|NCT02669862|11264537|FG001|Overall Study|Withdrawal by Subject|2
7123866|NCT02669862|11264538|FG002|Overall Study|Withdrawal by Subject|3
7123867|NCT02669862|11264536|FG000|Overall Study|moved|0
7123868|NCT02669862|11264537|FG001|Overall Study|moved|1
7123869|NCT02669862|11264538|FG002|Overall Study|moved|0
7123870|NCT02669862|11264536|FG000|Overall Study|Protocol Violation|0
7123871|NCT02669862|11264537|FG001|Overall Study|Protocol Violation|0
7123872|NCT02669862|11264538|FG002|Overall Study|Protocol Violation|1
7123873|NCT02669940|11264564|FG000|Overall Study|Failure to return|0
7123874|NCT02669940|11264565|FG001|Overall Study|Failure to return|3
7123875|NCT02669940|11264564|FG000|Overall Study|Insufficient follow-up data|1
7123876|NCT02669940|11264565|FG001|Overall Study|Insufficient follow-up data|0
7123877|NCT02670083|11264580|FG000|Overall Study|Adverse Event|16
7123878|NCT02670083|11264581|FG001|Overall Study|Adverse Event|13
7123879|NCT02670083|11264580|FG000|Overall Study|Death|4
7123880|NCT02670083|11264581|FG001|Overall Study|Death|6
7123881|NCT02670083|11264580|FG000|Overall Study|Lost to Follow-up|2
7123882|NCT02670083|11264581|FG001|Overall Study|Lost to Follow-up|2
7123883|NCT02670083|11264580|FG000|Overall Study|Multiple Reasons|9
7123884|NCT02670083|11264581|FG001|Overall Study|Multiple Reasons|9
7123885|NCT02670083|11264580|FG000|Overall Study|Physician Decision|0
7123886|NCT02670083|11264581|FG001|Overall Study|Physician Decision|2
7123887|NCT02670083|11264580|FG000|Overall Study|Study Terminated By Sponsor|257
7123888|NCT02670083|11264581|FG001|Overall Study|Study Terminated By Sponsor|254
7123889|NCT02670083|11264580|FG000|Overall Study|Symptomatic Deterioration|0
7123890|NCT02670083|11264581|FG001|Overall Study|Symptomatic Deterioration|2
7123891|NCT02670083|11264580|FG000|Overall Study|Withdrawal by Subject|32
7123892|NCT02670083|11264581|FG001|Overall Study|Withdrawal by Subject|31
7123893|NCT02670083|11264580|FG000|Overall Study|Non-Compliance With Study Drug|1
7123894|NCT02670083|11264581|FG001|Overall Study|Non-Compliance With Study Drug|0
7123895|NCT02670122|11264588|FG000|Overall Study|Lost to Follow-up|4
7123896|NCT02670330|11264601|FG000|Overall Study|Protocol Deviation|1
7123897|NCT02670330|11264602|FG001|Overall Study|Protocol Deviation|0
7123898|NCT02670330|11264601|FG000|Overall Study|Study Terminated By Sponsor|36
7123899|NCT02670330|11264602|FG001|Overall Study|Study Terminated By Sponsor|43
7123900|NCT02670330|11264601|FG000|Overall Study|Adverse Event|1
7123901|NCT02670330|11264602|FG001|Overall Study|Adverse Event|3
7123902|NCT02670330|11264601|FG000|Overall Study|Withdrawal by Subject|34
7123903|NCT02670330|11264602|FG001|Overall Study|Withdrawal by Subject|29
7123904|NCT02670330|11264601|FG000|Overall Study|Lost to Follow-up|3
7123905|NCT02670330|11264602|FG001|Overall Study|Lost to Follow-up|2
7123906|NCT02670382|11264612|FG000|Placebo lead-in Phase|Withdrawal by Subject|2
7123907|NCT02670382|11264613|FG001|Placebo lead-in Phase|Withdrawal by Subject|1
7123908|NCT02670473|11264621|FG000|Overall Study|Withdrawal by Subject|1
7123909|NCT02670538|11264637|FG000|Overall Study|Withdrawal of Consent|8
7123910|NCT02670538|11264638|FG001|Overall Study|Withdrawal of Consent|6
7123911|NCT02670538|11264639|FG002|Overall Study|Withdrawal of Consent|5
7123912|NCT02670538|11264637|FG000|Overall Study|Lost to Follow-up|8
7123913|NCT02670538|11264638|FG001|Overall Study|Lost to Follow-up|12
7123914|NCT02670538|11264639|FG002|Overall Study|Lost to Follow-up|7
7123915|NCT02670538|11264637|FG000|Overall Study|Adverse Event|5
7123916|NCT02670538|11264638|FG001|Overall Study|Adverse Event|5
7123917|NCT02670538|11264639|FG002|Overall Study|Adverse Event|11
7123918|NCT02670538|11264637|FG000|Overall Study|Lack of Efficacy|7
7123919|NCT02670538|11264638|FG001|Overall Study|Lack of Efficacy|1
7123920|NCT02670538|11264639|FG002|Overall Study|Lack of Efficacy|2
7123921|NCT02670538|11264637|FG000|Overall Study|Protocol Violation|3
7123922|NCT02670538|11264638|FG001|Overall Study|Protocol Violation|4
7123923|NCT02670538|11264639|FG002|Overall Study|Protocol Violation|1
7123924|NCT02670538|11264637|FG000|Overall Study|Noncompliance with Study Drug|1
7123925|NCT02670538|11264638|FG001|Overall Study|Noncompliance with Study Drug|3
7123926|NCT02670538|11264639|FG002|Overall Study|Noncompliance with Study Drug|2
7123927|NCT02670538|11264637|FG000|Overall Study|Other Miscellaneous Reasons|0
7123928|NCT02670538|11264638|FG001|Overall Study|Other Miscellaneous Reasons|1
7123929|NCT02670538|11264639|FG002|Overall Study|Other Miscellaneous Reasons|2
7123930|NCT02670551|11264650|FG000|Overall Study|Adverse Event|4
7123931|NCT02670551|11264651|FG001|Overall Study|Adverse Event|7
7123932|NCT02670551|11264652|FG002|Overall Study|Adverse Event|9
7123933|NCT02670551|11264650|FG000|Overall Study|Lack of Efficacy|2
7123934|NCT02670551|11264651|FG001|Overall Study|Lack of Efficacy|0
7123935|NCT02670551|11264652|FG002|Overall Study|Lack of Efficacy|3
7123936|NCT02670551|11264650|FG000|Overall Study|Withdrawal of Consent|6
7123937|NCT02670551|11264651|FG001|Overall Study|Withdrawal of Consent|3
7123938|NCT02670551|11264652|FG002|Overall Study|Withdrawal of Consent|8
7123939|NCT02670551|11264650|FG000|Overall Study|Lost to Follow-up|5
7123940|NCT02670551|11264651|FG001|Overall Study|Lost to Follow-up|7
7123941|NCT02670551|11264652|FG002|Overall Study|Lost to Follow-up|6
7123942|NCT02670551|11264650|FG000|Overall Study|Protocol Violation|1
7123943|NCT02670551|11264651|FG001|Overall Study|Protocol Violation|0
7123944|NCT02670551|11264652|FG002|Overall Study|Protocol Violation|0
7123945|NCT02670551|11264650|FG000|Overall Study|Noncompliance with study drug|3
7123946|NCT02670551|11264651|FG001|Overall Study|Noncompliance with study drug|3
7123947|NCT02670551|11264652|FG002|Overall Study|Noncompliance with study drug|2
7123948|NCT02670551|11264650|FG000|Overall Study|Other Miscellaneous Reasons|2
7123949|NCT02670551|11264651|FG001|Overall Study|Other Miscellaneous Reasons|3
7123950|NCT02670551|11264652|FG002|Overall Study|Other Miscellaneous Reasons|3
7123951|NCT02670551|11264650|FG000|Overall Study|Did Not Receive Treatment|5
7123952|NCT02670551|11264651|FG001|Overall Study|Did Not Receive Treatment|3
7123953|NCT02670551|11264652|FG002|Overall Study|Did Not Receive Treatment|0
7123954|NCT02670915|11264681|FG000|Overall Study|Withdrawal by Subject|0
7123955|NCT02670915|11264682|FG001|Overall Study|Withdrawal by Subject|1
7123956|NCT02670915|11264683|FG002|Overall Study|Withdrawal by Subject|4
7123957|NCT02670915|11264681|FG000|Overall Study|Withdrawal by parent/guardian|4
7123958|NCT02670915|11264682|FG001|Overall Study|Withdrawal by parent/guardian|4
7123959|NCT02670915|11264683|FG002|Overall Study|Withdrawal by parent/guardian|1
7123960|NCT02670915|11264681|FG000|Overall Study|Unclassified|0
7123961|NCT02670915|11264682|FG001|Overall Study|Unclassified|3
7123962|NCT02670915|11264683|FG002|Overall Study|Unclassified|0
7123963|NCT02670928|11264693|FG000|Overall Study|Adverse Event|3
7123964|NCT02670928|11264694|FG001|Overall Study|Adverse Event|1
7123965|NCT02670928|11264693|FG000|Overall Study|Withdrawal by Subject|4
7123966|NCT02670928|11264694|FG001|Overall Study|Withdrawal by Subject|0
7123967|NCT02670928|11264693|FG000|Overall Study|Lost to Follow-up|1
7123968|NCT02670928|11264694|FG001|Overall Study|Lost to Follow-up|0
7123969|NCT02670928|11264693|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2
7123970|NCT02670928|11264694|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0
7123971|NCT02671266|11264706|FG000|Overall Study|Withdrawal by Subject|1
7123972|NCT02671266|11264707|FG001|Overall Study|Withdrawal by Subject|1
7123973|NCT02671422|11264713|FG000|Overall Study|Lost to Follow-up|1
7123974|NCT02671422|11264713|FG000|Overall Study|Adverse Event|68
7123975|NCT02671422|11264713|FG000|Overall Study|Lack of Efficacy|1
7123976|NCT02671422|11264713|FG000|Overall Study|Lost to Follow-up|4
7123977|NCT02671422|11264713|FG000|Overall Study|Withdrawal by Subject|7
7123978|NCT02671422|11264713|FG000|Overall Study|Progressive Disease|156
7123979|NCT02671422|11264713|FG000|Overall Study|Worsening of Disease|4
7123980|NCT02671422|11264713|FG000|Overall Study|Sponsor decision|5
7123981|NCT02671422|11264713|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8
7123982|NCT02671422|11264713|FG000|Overall Study|Not treated with Vargatef®|3
7123983|NCT02671422|11264713|FG000|Overall Study|Other not defined above|3
7123984|NCT02671500|11264717|FG000|Overall Study|Lack of Efficacy|12
7123985|NCT02671500|11264717|FG000|Overall Study|Lost to Follow-up|2
7123986|NCT02671760|11264725|FG000|Overall Study|Lost to Follow-up|0
7123987|NCT02671760|11264726|FG001|Overall Study|Lost to Follow-up|1
7123988|NCT02671760|11264727|FG002|Overall Study|Lost to Follow-up|0
7123989|NCT02672423|11264760|FG000|Period 1|Adverse Event|0
7123990|NCT02672423|11264761|FG001|Period 1|Adverse Event|0
7123991|NCT02672423|11264762|FG002|Period 1|Adverse Event|0
7123992|NCT02672423|11264763|FG003|Period 1|Adverse Event|0
7123993|NCT02672423|11264764|FG004|Period 1|Adverse Event|1
7123994|NCT02672423|11264765|FG005|Period 1|Adverse Event|0
7123995|NCT02672423|11264766|FG006|Period 1|Adverse Event|0
7123996|NCT02672423|11264767|FG007|Period 1|Adverse Event|0
7123997|NCT02672423|11264768|FG008|Period 1|Adverse Event|0
7123998|NCT02672423|11264769|FG009|Period 1|Adverse Event|0
7123999|NCT02672423|11264760|FG000|Period 2|Withdrawal by Subject|0
7124000|NCT02672423|11264761|FG001|Period 2|Withdrawal by Subject|0
7124001|NCT02672423|11264762|FG002|Period 2|Withdrawal by Subject|1
7124002|NCT02672423|11264763|FG003|Period 2|Withdrawal by Subject|0
7124003|NCT02672423|11264764|FG004|Period 2|Withdrawal by Subject|0
7124004|NCT02672423|11264765|FG005|Period 2|Withdrawal by Subject|0
7124005|NCT02672423|11264766|FG006|Period 2|Withdrawal by Subject|0
7124006|NCT02672423|11264767|FG007|Period 2|Withdrawal by Subject|0
7124007|NCT02672423|11264768|FG008|Period 2|Withdrawal by Subject|0
7124008|NCT02672423|11264769|FG009|Period 2|Withdrawal by Subject|0
7124009|NCT02672423|11264760|FG000|Period 3|Withdrawal by Subject|0
7124010|NCT02672423|11264761|FG001|Period 3|Withdrawal by Subject|0
7124011|NCT02672423|11264762|FG002|Period 3|Withdrawal by Subject|0
7124012|NCT02672423|11264763|FG003|Period 3|Withdrawal by Subject|0
7124013|NCT02672423|11264764|FG004|Period 3|Withdrawal by Subject|0
7124014|NCT02672423|11264765|FG005|Period 3|Withdrawal by Subject|0
7124015|NCT02672423|11264766|FG006|Period 3|Withdrawal by Subject|0
7124016|NCT02672423|11264767|FG007|Period 3|Withdrawal by Subject|1
7124017|NCT02672423|11264768|FG008|Period 3|Withdrawal by Subject|0
7124018|NCT02672423|11264769|FG009|Period 3|Withdrawal by Subject|0
7124019|NCT02672423|11264760|FG000|Period 3|Physician Decision|0
7124020|NCT02672423|11264761|FG001|Period 3|Physician Decision|0
7124021|NCT02672423|11264762|FG002|Period 3|Physician Decision|0
7124022|NCT02672423|11264763|FG003|Period 3|Physician Decision|0
7124023|NCT02672423|11264764|FG004|Period 3|Physician Decision|0
7124024|NCT02672423|11264765|FG005|Period 3|Physician Decision|1
7124025|NCT02672423|11264766|FG006|Period 3|Physician Decision|0
7124026|NCT02672423|11264767|FG007|Period 3|Physician Decision|0
7124027|NCT02672423|11264768|FG008|Period 3|Physician Decision|0
7124028|NCT02672423|11264769|FG009|Period 3|Physician Decision|0
7124029|NCT02672553|11264801|FG000|Overall Study|Death|3
7124030|NCT02672553|11264802|FG001|Overall Study|Death|5
7124031|NCT02672553|11264801|FG000|Overall Study|Valve Explant|1
7124032|NCT02672553|11264802|FG001|Overall Study|Valve Explant|0
7124033|NCT02672553|11264801|FG000|Overall Study|Conversion to Commercial Valve|3
7124034|NCT02672553|11264802|FG001|Overall Study|Conversion to Commercial Valve|0
7124035|NCT02672553|11264801|FG000|Overall Study|Withdrawal by Subject|3
7124036|NCT02672553|11264802|FG001|Overall Study|Withdrawal by Subject|3
7124037|NCT02672553|11264801|FG000|Overall Study|Intraoperative screen failure|2
7124038|NCT02672553|11264802|FG001|Overall Study|Intraoperative screen failure|0
7124039|NCT02672852|11264811|FG000|Part A1|Disease Worsening|1
7124040|NCT02672852|11264812|FG001|Part A1|Disease Worsening|0
7124041|NCT02672852|11264813|FG002|Part A1|Disease Worsening|0
7124042|NCT02672852|11264814|FG003|Part A1|Disease Worsening|0
7124043|NCT02672852|11264815|FG004|Part A1|Disease Worsening|0
7124044|NCT02672852|11264816|FG005|Part A1|Disease Worsening|0
7124045|NCT02672852|11264817|FG006|Part A1|Disease Worsening|0
7124046|NCT02672852|11264811|FG000|Part A1|Adverse Event|0
7124047|NCT02672852|11264812|FG001|Part A1|Adverse Event|1
7124048|NCT02672852|11264813|FG002|Part A1|Adverse Event|0
7124049|NCT02672852|11264814|FG003|Part A1|Adverse Event|0
7124050|NCT02672852|11264815|FG004|Part A1|Adverse Event|0
7124051|NCT02672852|11264816|FG005|Part A1|Adverse Event|0
7124052|NCT02672852|11264817|FG006|Part A1|Adverse Event|0
7124053|NCT02672852|11264811|FG000|Part A1|Lost to Follow-up|1
7124054|NCT02672852|11264812|FG001|Part A1|Lost to Follow-up|2
7124055|NCT02672852|11264813|FG002|Part A1|Lost to Follow-up|0
7124056|NCT02672852|11264814|FG003|Part A1|Lost to Follow-up|0
7124057|NCT02672852|11264815|FG004|Part A1|Lost to Follow-up|0
7124058|NCT02672852|11264816|FG005|Part A1|Lost to Follow-up|0
7124059|NCT02672852|11264817|FG006|Part A1|Lost to Follow-up|0
7124060|NCT02672852|11264811|FG000|Part A1|Withdrawal by Subject|1
7124061|NCT02672852|11264812|FG001|Part A1|Withdrawal by Subject|1
7124062|NCT02672852|11264813|FG002|Part A1|Withdrawal by Subject|0
7124063|NCT02672852|11264814|FG003|Part A1|Withdrawal by Subject|0
7124064|NCT02672852|11264815|FG004|Part A1|Withdrawal by Subject|0
7124065|NCT02672852|11264816|FG005|Part A1|Withdrawal by Subject|0
7124066|NCT02672852|11264817|FG006|Part A1|Withdrawal by Subject|0
7124067|NCT02672852|11264811|FG000|Part A2|Disease worsening|0
7124068|NCT02672852|11264812|FG001|Part A2|Disease worsening|0
7124069|NCT02672852|11264813|FG002|Part A2|Disease worsening|1
7124070|NCT02672852|11264814|FG003|Part A2|Disease worsening|0
7124071|NCT02672852|11264815|FG004|Part A2|Disease worsening|0
7124072|NCT02672852|11264816|FG005|Part A2|Disease worsening|0
7124073|NCT02672852|11264817|FG006|Part A2|Disease worsening|0
7124074|NCT02672852|11264811|FG000|Part A2|Adverse Event|0
7124075|NCT02672852|11264812|FG001|Part A2|Adverse Event|0
7124076|NCT02672852|11264813|FG002|Part A2|Adverse Event|3
7124077|NCT02672852|11264814|FG003|Part A2|Adverse Event|0
7124078|NCT02672852|11264815|FG004|Part A2|Adverse Event|0
7124079|NCT02672852|11264816|FG005|Part A2|Adverse Event|0
7124080|NCT02672852|11264817|FG006|Part A2|Adverse Event|0
7124081|NCT02672852|11264811|FG000|Part A2|Lost to Follow-up|0
7124082|NCT02672852|11264812|FG001|Part A2|Lost to Follow-up|0
7124083|NCT02672852|11264813|FG002|Part A2|Lost to Follow-up|2
7124084|NCT02672852|11264814|FG003|Part A2|Lost to Follow-up|0
7124085|NCT02672852|11264815|FG004|Part A2|Lost to Follow-up|0
7124086|NCT02672852|11264816|FG005|Part A2|Lost to Follow-up|0
7124087|NCT02672852|11264817|FG006|Part A2|Lost to Follow-up|0
7124088|NCT02672852|11264811|FG000|Part A2|Withdrawal by Subject|0
7124089|NCT02672852|11264812|FG001|Part A2|Withdrawal by Subject|0
7124090|NCT02672852|11264813|FG002|Part A2|Withdrawal by Subject|1
7124091|NCT02672852|11264814|FG003|Part A2|Withdrawal by Subject|0
7124092|NCT02672852|11264815|FG004|Part A2|Withdrawal by Subject|0
7124093|NCT02672852|11264816|FG005|Part A2|Withdrawal by Subject|0
7124094|NCT02672852|11264817|FG006|Part A2|Withdrawal by Subject|0
7124095|NCT02672852|11264811|FG000|Part A2|Other|0
7124096|NCT02672852|11264812|FG001|Part A2|Other|0
7124097|NCT02672852|11264813|FG002|Part A2|Other|3
7124098|NCT02672852|11264814|FG003|Part A2|Other|0
7124099|NCT02672852|11264815|FG004|Part A2|Other|0
7124100|NCT02672852|11264816|FG005|Part A2|Other|0
7124101|NCT02672852|11264817|FG006|Part A2|Other|0
7124102|NCT02672852|11264811|FG000|Part A2|Not entered in Part B|0
7124103|NCT02672852|11264812|FG001|Part A2|Not entered in Part B|0
7124104|NCT02672852|11264813|FG002|Part A2|Not entered in Part B|0
7124105|NCT02672852|11264814|FG003|Part A2|Not entered in Part B|4
7124106|NCT02672852|11264815|FG004|Part A2|Not entered in Part B|0
7124107|NCT02672852|11264816|FG005|Part A2|Not entered in Part B|0
7124108|NCT02672852|11264817|FG006|Part A2|Not entered in Part B|0
7124109|NCT02672852|11264811|FG000|Part B|Disease worsening|0
7124110|NCT02672852|11264812|FG001|Part B|Disease worsening|0
7124111|NCT02672852|11264813|FG002|Part B|Disease worsening|0
7124112|NCT02672852|11264814|FG003|Part B|Disease worsening|0
7124113|NCT02672852|11264815|FG004|Part B|Disease worsening|1
7124114|NCT02672852|11264816|FG005|Part B|Disease worsening|0
7124115|NCT02672852|11264817|FG006|Part B|Disease worsening|1
7124116|NCT02672852|11264811|FG000|Part B|Worsening pre-existing condition|0
7124117|NCT02672852|11264812|FG001|Part B|Worsening pre-existing condition|0
7124118|NCT02672852|11264813|FG002|Part B|Worsening pre-existing condition|0
7124119|NCT02672852|11264814|FG003|Part B|Worsening pre-existing condition|0
7124120|NCT02672852|11264815|FG004|Part B|Worsening pre-existing condition|0
7124121|NCT02672852|11264816|FG005|Part B|Worsening pre-existing condition|1
7124122|NCT02672852|11264817|FG006|Part B|Worsening pre-existing condition|0
7124123|NCT02672852|11264811|FG000|Part B|Other adverse event|0
7124124|NCT02672852|11264812|FG001|Part B|Other adverse event|0
7124125|NCT02672852|11264813|FG002|Part B|Other adverse event|0
7124126|NCT02672852|11264814|FG003|Part B|Other adverse event|0
7124127|NCT02672852|11264815|FG004|Part B|Other adverse event|3
7124128|NCT02672852|11264816|FG005|Part B|Other adverse event|5
7124129|NCT02672852|11264817|FG006|Part B|Other adverse event|1
7124130|NCT02672852|11264811|FG000|Part B|Lost to Follow-up|0
7124131|NCT02672852|11264812|FG001|Part B|Lost to Follow-up|0
7124132|NCT02672852|11264813|FG002|Part B|Lost to Follow-up|0
7124133|NCT02672852|11264814|FG003|Part B|Lost to Follow-up|0
7124134|NCT02672852|11264815|FG004|Part B|Lost to Follow-up|3
7124135|NCT02672852|11264816|FG005|Part B|Lost to Follow-up|4
7124136|NCT02672852|11264817|FG006|Part B|Lost to Follow-up|1
7124137|NCT02672852|11264811|FG000|Part B|Withdrawal by Subject|0
7124138|NCT02672852|11264812|FG001|Part B|Withdrawal by Subject|0
7124139|NCT02672852|11264813|FG002|Part B|Withdrawal by Subject|0
7124140|NCT02672852|11264814|FG003|Part B|Withdrawal by Subject|0
7124141|NCT02672852|11264815|FG004|Part B|Withdrawal by Subject|5
7124142|NCT02672852|11264816|FG005|Part B|Withdrawal by Subject|0
7124143|NCT02672852|11264817|FG006|Part B|Withdrawal by Subject|7
7124144|NCT02672852|11264811|FG000|Part B|Other|0
7124145|NCT02672852|11264812|FG001|Part B|Other|0
7124146|NCT02672852|11264813|FG002|Part B|Other|0
7124147|NCT02672852|11264814|FG003|Part B|Other|0
7124148|NCT02672852|11264815|FG004|Part B|Other|4
7124149|NCT02672852|11264816|FG005|Part B|Other|1
7124150|NCT02672852|11264817|FG006|Part B|Other|2
7124151|NCT02673489|11264845|FG000|Treatment Period|Lost to Follow-up|3
7124152|NCT02673489|11264846|FG001|Treatment Period|Lost to Follow-up|0
7124153|NCT02673489|11264845|FG000|Treatment Period|Participant request to discontinue|1
7124154|NCT02673489|11264846|FG001|Treatment Period|Participant request to discontinue|1
7124155|NCT02673489|11264845|FG000|Treatment Period|Participant moved to another province|1
7124156|NCT02673489|11264846|FG001|Treatment Period|Participant moved to another province|0
7124157|NCT02673489|11264845|FG000|Treatment Period|Participant was incarcerated|0
7124158|NCT02673489|11264846|FG001|Treatment Period|Participant was incarcerated|1
7124159|NCT02673489|11264845|FG000|Treatment Period|Adverse Event|0
7124160|NCT02673489|11264846|FG001|Treatment Period|Adverse Event|1
7124161|NCT02673489|11264845|FG000|Follow Up Period|Unable to return for week 24 follow-up|0
7124162|NCT02673489|11264846|FG001|Follow Up Period|Unable to return for week 24 follow-up|1
7124163|NCT02673489|11264845|FG000|Follow Up Period|Unable to return for follow-up|0
7124164|NCT02673489|11264846|FG001|Follow Up Period|Unable to return for follow-up|1
7124165|NCT02673515|11264855|FG000|Overall Study|Lack of motivation|2
7124166|NCT02673515|11264856|FG001|Overall Study|Lack of motivation|1
7124167|NCT02673619|11264875|FG000|Overall Study|Lost to Follow-up|1
7124168|NCT02673619|11264876|FG001|Overall Study|Lost to Follow-up|0
7124169|NCT02673619|11264877|FG002|Overall Study|Lost to Follow-up|0
7124170|NCT02673619|11264878|FG003|Overall Study|Lost to Follow-up|0
7124171|NCT02673619|11264875|FG000|Overall Study|Withdrawal by Subject|1
7124172|NCT02673619|11264876|FG001|Overall Study|Withdrawal by Subject|1
7124173|NCT02673619|11264877|FG002|Overall Study|Withdrawal by Subject|1
7124174|NCT02673619|11264878|FG003|Overall Study|Withdrawal by Subject|0
7124175|NCT02673619|11264875|FG000|Overall Study|Adverse Event|0
7124176|NCT02673619|11264876|FG001|Overall Study|Adverse Event|0
7124177|NCT02673619|11264877|FG002|Overall Study|Adverse Event|1
7124178|NCT02673619|11264878|FG003|Overall Study|Adverse Event|0
7124179|NCT02673619|11264875|FG000|Overall Study|Lack of Efficacy|0
7124180|NCT02673619|11264876|FG001|Overall Study|Lack of Efficacy|0
7124181|NCT02673619|11264877|FG002|Overall Study|Lack of Efficacy|1
7124182|NCT02673619|11264878|FG003|Overall Study|Lack of Efficacy|0
7124183|NCT02674334|11264907|FG000|Overall Study|Lost to Follow-up|5
7124184|NCT02674334|11264908|FG001|Overall Study|Lost to Follow-up|3
7124185|NCT02674334|11264907|FG000|Overall Study|participant difficulty breathing|1
7124186|NCT02674334|11264908|FG001|Overall Study|participant difficulty breathing|0
7124187|NCT02674334|11264907|FG000|Overall Study|NIRS not recording|1
7124188|NCT02674334|11264908|FG001|Overall Study|NIRS not recording|0
7124189|NCT02674386|11264917|FG000|Overall Study|Lost to Follow-up|0
7124190|NCT02674386|11264918|FG001|Overall Study|Lost to Follow-up|1
7124191|NCT02674386|11264919|FG002|Overall Study|Lost to Follow-up|1
7124192|NCT02674386|11264917|FG000|Overall Study|Withdrawal by Subject|0
7124193|NCT02674386|11264918|FG001|Overall Study|Withdrawal by Subject|4
7124194|NCT02674386|11264919|FG002|Overall Study|Withdrawal by Subject|0
7124195|NCT02674386|11264917|FG000|Overall Study|Other|0
7124196|NCT02674386|11264918|FG001|Overall Study|Other|1
7124197|NCT02674386|11264919|FG002|Overall Study|Other|0
7124198|NCT02674386|11264917|FG000|Overall Study|Enrolled but not evaluated|0
7124199|NCT02674386|11264918|FG001|Overall Study|Enrolled but not evaluated|4
7124200|NCT02674386|11264919|FG002|Overall Study|Enrolled but not evaluated|0
7124201|NCT02674399|11264934|FG000|Overall Study|Lost to Follow-up|2
7124202|NCT02674399|11264935|FG001|Overall Study|Lost to Follow-up|0
7124203|NCT02674477|11264951|FG000|Overall Study|Protocol Violation|8
7124204|NCT02674477|11264952|FG001|Overall Study|Protocol Violation|2
7124205|NCT02674568|11264958|FG000|Overall Study|Withdrawal by Subject|5
7124206|NCT02674568|11264958|FG000|Overall Study|Death|303
7124207|NCT02674568|11264958|FG000|Overall Study|Physician Decision|2
7124208|NCT02674568|11264958|FG000|Overall Study|Lost to Follow-up|9
7124209|NCT02674568|11264958|FG000|Overall Study|Other, Not Specified|20
7124210|NCT02674633|11264969|FG000|Overall Study|Lost to Follow-up|3
7124211|NCT02674633|11264970|FG001|Overall Study|Lost to Follow-up|2
7124212|NCT02674633|11264969|FG000|Overall Study|Physician Decision|1
7124213|NCT02674633|11264970|FG001|Overall Study|Physician Decision|0
7124214|NCT02674633|11264969|FG000|Overall Study|Withdrawal by Parent/Guardian|1
7124215|NCT02674633|11264970|FG001|Overall Study|Withdrawal by Parent/Guardian|2
7124216|NCT02674685|11264985|FG000|Overall Study|Protocol Violation|4
7124217|NCT02674854|11264992|FG000|Overall Study|Adverse Event|17
7124218|NCT02674854|11264993|FG001|Overall Study|Adverse Event|15
7124219|NCT02674854|11264994|FG002|Overall Study|Adverse Event|5
7124220|NCT02674854|11264992|FG000|Overall Study|Withdrawal by Subject|1
7124221|NCT02674854|11264993|FG001|Overall Study|Withdrawal by Subject|5
7124222|NCT02674854|11264994|FG002|Overall Study|Withdrawal by Subject|4
7124223|NCT02674854|11264992|FG000|Overall Study|No-compliant subject|1
7124224|NCT02674854|11264993|FG001|Overall Study|No-compliant subject|0
7124225|NCT02674854|11264994|FG002|Overall Study|No-compliant subject|1
7124226|NCT02674854|11264992|FG000|Overall Study|Lost to Follow-up|1
7124227|NCT02674854|11264993|FG001|Overall Study|Lost to Follow-up|0
7124228|NCT02674854|11264994|FG002|Overall Study|Lost to Follow-up|2
7124229|NCT02674854|11264992|FG000|Overall Study|Lack of Efficacy|0
7124230|NCT02674854|11264993|FG001|Overall Study|Lack of Efficacy|3
7124231|NCT02674854|11264994|FG002|Overall Study|Lack of Efficacy|0
7124232|NCT02674854|11264992|FG000|Overall Study|Disallowed Concurrent Medication|2
7124233|NCT02674854|11264993|FG001|Overall Study|Disallowed Concurrent Medication|2
7124234|NCT02674854|11264994|FG002|Overall Study|Disallowed Concurrent Medication|0
7124235|NCT02674854|11264992|FG000|Overall Study|Protocol Violation|1
7124236|NCT02674854|11264993|FG001|Overall Study|Protocol Violation|1
7124237|NCT02674854|11264994|FG002|Overall Study|Protocol Violation|2
7124238|NCT02674854|11264992|FG000|Overall Study|Death|0
7124239|NCT02674854|11264993|FG001|Overall Study|Death|1
7124240|NCT02674854|11264994|FG002|Overall Study|Death|0
7124241|NCT02674854|11264992|FG000|Overall Study|Subject missed V6.2|1
7124242|NCT02674854|11264993|FG001|Overall Study|Subject missed V6.2|0
7124243|NCT02674854|11264994|FG002|Overall Study|Subject missed V6.2|0
7124244|NCT02675075|11265004|FG000|Overall Study|Lost to Follow-up|3
7124245|NCT02675075|11265005|FG001|Overall Study|Lost to Follow-up|0
7124246|NCT02675517|11265013|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8
7124247|NCT02675517|11265013|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151
7124248|NCT02675634|11265026|FG000|Test Period 1|Adverse Event|0
7124249|NCT02675634|11265027|FG001|Test Period 1|Adverse Event|1
7124250|NCT02675634|11265028|FG002|Test Period 1|Adverse Event|0
7124251|NCT02675634|11265029|FG003|Test Period 1|Adverse Event|1
7124252|NCT02675634|11265030|FG004|Test Period 1|Adverse Event|0
7124253|NCT02675634|11265031|FG005|Test Period 1|Adverse Event|0
7124254|NCT02675634|11265026|FG000|Test Period 1|Device deficiency that did not lead to A|0
7124255|NCT02675634|11265027|FG001|Test Period 1|Device deficiency that did not lead to A|0
7124256|NCT02675634|11265028|FG002|Test Period 1|Device deficiency that did not lead to A|1
7124257|NCT02675634|11265029|FG003|Test Period 1|Device deficiency that did not lead to A|0
7124258|NCT02675634|11265030|FG004|Test Period 1|Device deficiency that did not lead to A|0
7124259|NCT02675634|11265031|FG005|Test Period 1|Device deficiency that did not lead to A|0
7124260|NCT02675634|11265026|FG000|Test Period 2|Lack of Efficacy|1
7124261|NCT02675634|11265027|FG001|Test Period 2|Lack of Efficacy|0
7124262|NCT02675634|11265028|FG002|Test Period 2|Lack of Efficacy|0
7124263|NCT02675634|11265029|FG003|Test Period 2|Lack of Efficacy|0
7124264|NCT02675634|11265030|FG004|Test Period 2|Lack of Efficacy|0
7124265|NCT02675634|11265031|FG005|Test Period 2|Lack of Efficacy|0
7124266|NCT02675634|11265026|FG000|Test Period 2|Adverse Event|0
7124267|NCT02675634|11265027|FG001|Test Period 2|Adverse Event|0
7124268|NCT02675634|11265028|FG002|Test Period 2|Adverse Event|0
7124269|NCT02675634|11265029|FG003|Test Period 2|Adverse Event|0
7124270|NCT02675634|11265030|FG004|Test Period 2|Adverse Event|0
7124271|NCT02675634|11265031|FG005|Test Period 2|Adverse Event|1
7124272|NCT02675907|11265050|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
7124273|NCT02675907|11265051|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
7124274|NCT02675907|11265050|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
7124275|NCT02675907|11265051|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
7124276|NCT02675907|11265050|FG000|Study Overall|Lack of Efficacy|1
7124277|NCT02675907|11265051|FG001|Study Overall|Lack of Efficacy|0
7124278|NCT02675907|11265050|FG000|Study Overall|Withdrawal by Subject|2
7124279|NCT02675907|11265051|FG001|Study Overall|Withdrawal by Subject|2
7124280|NCT02675907|11265050|FG000|Study Overall|Lost to Follow-up|0
7124281|NCT02675907|11265051|FG001|Study Overall|Lost to Follow-up|2
7124282|NCT02675998|11265061|FG000|8-Week Treatment Period|Adverse Event|6
7124283|NCT02675998|11265062|FG001|8-Week Treatment Period|Adverse Event|5
7124284|NCT02675998|11265063|FG002|8-Week Treatment Period|Adverse Event|6
7124285|NCT02675998|11265064|FG003|8-Week Treatment Period|Adverse Event|0
7124286|NCT02675998|11265061|FG000|8-Week Treatment Period|Withdrawal by Subject|3
7124287|NCT02675998|11265062|FG001|8-Week Treatment Period|Withdrawal by Subject|3
7124288|NCT02675998|11265063|FG002|8-Week Treatment Period|Withdrawal by Subject|3
7124289|NCT02675998|11265064|FG003|8-Week Treatment Period|Withdrawal by Subject|0
7124290|NCT02675998|11265061|FG000|8-Week Treatment Period|Lack of Efficacy|2
7124291|NCT02675998|11265062|FG001|8-Week Treatment Period|Lack of Efficacy|5
7124292|NCT02675998|11265063|FG002|8-Week Treatment Period|Lack of Efficacy|3
7124293|NCT02675998|11265064|FG003|8-Week Treatment Period|Lack of Efficacy|0
7124294|NCT02675998|11265061|FG000|8-Week Treatment Period|Physician Decision|1
7124295|NCT02675998|11265062|FG001|8-Week Treatment Period|Physician Decision|0
7124296|NCT02675998|11265063|FG002|8-Week Treatment Period|Physician Decision|2
7124297|NCT02675998|11265064|FG003|8-Week Treatment Period|Physician Decision|0
7124298|NCT02675998|11265061|FG000|8-Week Treatment Period|GI side Effects|1
7124299|NCT02675998|11265062|FG001|8-Week Treatment Period|GI side Effects|4
7124300|NCT02675998|11265063|FG002|8-Week Treatment Period|GI side Effects|2
7124301|NCT02675998|11265064|FG003|8-Week Treatment Period|GI side Effects|0
7124302|NCT02675998|11265061|FG000|8-Week Treatment Period|Protocol Violation|1
7124303|NCT02675998|11265062|FG001|8-Week Treatment Period|Protocol Violation|1
7124304|NCT02675998|11265063|FG002|8-Week Treatment Period|Protocol Violation|1
7124305|NCT02675998|11265064|FG003|8-Week Treatment Period|Protocol Violation|0
7124306|NCT02675998|11265061|FG000|8-Week Treatment Period|Other|3
7124307|NCT02675998|11265062|FG001|8-Week Treatment Period|Other|1
7124308|NCT02675998|11265063|FG002|8-Week Treatment Period|Other|2
7124309|NCT02675998|11265064|FG003|8-Week Treatment Period|Other|0
7124310|NCT02675998|11265061|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0
7124311|NCT02675998|11265062|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1
7124312|NCT02675998|11265063|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1
7124313|NCT02675998|11265064|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3
7124314|NCT02675998|11265061|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0
7124315|NCT02675998|11265062|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0
7124316|NCT02675998|11265063|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1
7124317|NCT02675998|11265064|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3
7124318|NCT02675998|11265061|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0
7124319|NCT02675998|11265062|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0
7124320|NCT02675998|11265063|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0
7124321|NCT02675998|11265064|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1
7124322|NCT02675998|11265061|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1
7124323|NCT02675998|11265062|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0
7124324|NCT02675998|11265063|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0
7124325|NCT02675998|11265064|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0
7124326|NCT02675998|11265061|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0
7124327|NCT02675998|11265062|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0
7124328|NCT02675998|11265063|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0
7124329|NCT02675998|11265064|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1
7124330|NCT02676466|11265095|FG000|Overall Study|Death|0
7124331|NCT02676466|11265096|FG001|Overall Study|Death|2
7124332|NCT02676466|11265097|FG002|Overall Study|Death|1
7124333|NCT02676466|11265098|FG003|Overall Study|Death|0
7124334|NCT02676466|11265099|FG004|Overall Study|Death|0
7124335|NCT02676466|11265100|FG005|Overall Study|Death|0
7124336|NCT02676466|11265101|FG006|Overall Study|Death|0
7124337|NCT02676466|11265102|FG007|Overall Study|Death|0
7124338|NCT02676466|11265095|FG000|Overall Study|Withdrawal by Subject|4
7124339|NCT02676466|11265096|FG001|Overall Study|Withdrawal by Subject|3
7124340|NCT02676466|11265097|FG002|Overall Study|Withdrawal by Subject|1
7124341|NCT02676466|11265098|FG003|Overall Study|Withdrawal by Subject|0
7124342|NCT02676466|11265099|FG004|Overall Study|Withdrawal by Subject|3
7124343|NCT02676466|11265100|FG005|Overall Study|Withdrawal by Subject|1
7124344|NCT02676466|11265101|FG006|Overall Study|Withdrawal by Subject|1
6806105|NCT01970865|10808460|FG009|Overall Study|Withdrawal by Subject|0
7124345|NCT02676466|11265102|FG007|Overall Study|Withdrawal by Subject|1
7124346|NCT02676778|11265127|FG000|Overall Study|Disease Progression|7
7124347|NCT02676778|11265128|FG001|Overall Study|Disease Progression|3
7124348|NCT02676778|11265129|FG002|Overall Study|Disease Progression|1
7124349|NCT02676778|11265127|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1
7124350|NCT02676778|11265128|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1
7124351|NCT02676778|11265129|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0
7124352|NCT02676778|11265127|FG000|Overall Study|Withdrawal by Subject|3
7124353|NCT02676778|11265128|FG001|Overall Study|Withdrawal by Subject|2
7124354|NCT02676778|11265129|FG002|Overall Study|Withdrawal by Subject|0
7124355|NCT02676778|11265127|FG000|Overall Study|Other|4
7124356|NCT02676778|11265128|FG001|Overall Study|Other|3
7124357|NCT02676778|11265129|FG002|Overall Study|Other|0
7124358|NCT02676778|11265127|FG000|Overall Study|Adverse Event|2
7124359|NCT02676778|11265128|FG001|Overall Study|Adverse Event|3
7124360|NCT02676778|11265129|FG002|Overall Study|Adverse Event|0
7124361|NCT02676882|11265145|FG000|Overall Study|Adverse Event|1
7124362|NCT02676882|11265146|FG001|Overall Study|Adverse Event|0
7124363|NCT02676882|11265145|FG000|Overall Study|Lost to Follow-up|1
7124364|NCT02676882|11265146|FG001|Overall Study|Lost to Follow-up|0
7124365|NCT02676882|11265145|FG000|Overall Study|Withdrawal by Subject|1
7124366|NCT02676882|11265146|FG001|Overall Study|Withdrawal by Subject|2
7124367|NCT02676895|11265155|FG000|Overall Study|Administrative reason|1
7124368|NCT02676895|11265156|FG001|Overall Study|Administrative reason|0
7124369|NCT02676895|11265157|FG002|Overall Study|Administrative reason|0
7124370|NCT02676895|11265155|FG000|Overall Study|Protocol Violation|1
7124371|NCT02676895|11265156|FG001|Overall Study|Protocol Violation|0
7124372|NCT02676895|11265157|FG002|Overall Study|Protocol Violation|0
7124373|NCT02676895|11265155|FG000|Overall Study|Adverse Event|0
7124374|NCT02676895|11265156|FG001|Overall Study|Adverse Event|3
7124375|NCT02676895|11265157|FG002|Overall Study|Adverse Event|1
7124376|NCT02676895|11265155|FG000|Overall Study|Lost to Follow-up|0
7124377|NCT02676895|11265156|FG001|Overall Study|Lost to Follow-up|0
7124378|NCT02676895|11265157|FG002|Overall Study|Lost to Follow-up|1
7124379|NCT02676895|11265155|FG000|Overall Study|Withdrawal by Subject|0
7124380|NCT02676895|11265156|FG001|Overall Study|Withdrawal by Subject|0
7124381|NCT02676895|11265157|FG002|Overall Study|Withdrawal by Subject|1
7124382|NCT02677116|11265175|FG000|Overall Study|Adverse Event|0
7124383|NCT02677116|11265176|FG001|Overall Study|Adverse Event|1
7124384|NCT02677116|11265177|FG002|Overall Study|Adverse Event|0
7124385|NCT02677116|11265178|FG003|Overall Study|Adverse Event|0
7124386|NCT02677116|11265179|FG004|Overall Study|Adverse Event|0
7124387|NCT02677116|11265180|FG005|Overall Study|Adverse Event|1
7124388|NCT02677116|11265181|FG006|Overall Study|Adverse Event|1
7124389|NCT02677116|11265182|FG007|Overall Study|Adverse Event|0
7124390|NCT02677116|11265183|FG008|Overall Study|Adverse Event|0
7124391|NCT02677116|11265175|FG000|Overall Study|Physician Decision|0
7124392|NCT02677116|11265176|FG001|Overall Study|Physician Decision|2
7124393|NCT02677116|11265177|FG002|Overall Study|Physician Decision|3
7124394|NCT02677116|11265178|FG003|Overall Study|Physician Decision|2
7124395|NCT02677116|11265179|FG004|Overall Study|Physician Decision|1
7124396|NCT02677116|11265180|FG005|Overall Study|Physician Decision|3
7124397|NCT02677116|11265181|FG006|Overall Study|Physician Decision|1
7124398|NCT02677116|11265182|FG007|Overall Study|Physician Decision|1
7124399|NCT02677116|11265183|FG008|Overall Study|Physician Decision|2
7124400|NCT02677116|11265175|FG000|Overall Study|Withdrawal by parent or guardian|2
7124401|NCT02677116|11265176|FG001|Overall Study|Withdrawal by parent or guardian|1
7124402|NCT02677116|11265177|FG002|Overall Study|Withdrawal by parent or guardian|0
7124403|NCT02677116|11265178|FG003|Overall Study|Withdrawal by parent or guardian|1
7124404|NCT02677116|11265179|FG004|Overall Study|Withdrawal by parent or guardian|0
7124405|NCT02677116|11265180|FG005|Overall Study|Withdrawal by parent or guardian|0
7124406|NCT02677116|11265181|FG006|Overall Study|Withdrawal by parent or guardian|2
7124407|NCT02677116|11265182|FG007|Overall Study|Withdrawal by parent or guardian|1
7124408|NCT02677116|11265183|FG008|Overall Study|Withdrawal by parent or guardian|0
7124409|NCT02677116|11265175|FG000|Overall Study|Withdrawal by Subject|1
7124410|NCT02677116|11265176|FG001|Overall Study|Withdrawal by Subject|0
7124411|NCT02677116|11265177|FG002|Overall Study|Withdrawal by Subject|0
7124412|NCT02677116|11265178|FG003|Overall Study|Withdrawal by Subject|0
7124413|NCT02677116|11265179|FG004|Overall Study|Withdrawal by Subject|0
7124414|NCT02677116|11265180|FG005|Overall Study|Withdrawal by Subject|0
7124415|NCT02677116|11265181|FG006|Overall Study|Withdrawal by Subject|0
7124416|NCT02677116|11265182|FG007|Overall Study|Withdrawal by Subject|0
7124417|NCT02677116|11265183|FG008|Overall Study|Withdrawal by Subject|0
7124418|NCT02677220|11265226|FG000|Overall Study|Adverse Event|1
7124419|NCT02677714|11265284|FG000|Overall Study|Withdrawal by Subject|2
7124420|NCT02677714|11265285|FG001|Overall Study|Withdrawal by Subject|0
7124421|NCT02677844|11265329|FG000|Period 3|Withdrawal by Subject|0
6806106|NCT01970865|10808461|FG010|Overall Study|Withdrawal by Subject|0
7124422|NCT02677844|11265330|FG001|Period 3|Withdrawal by Subject|0
7124423|NCT02677844|11265331|FG002|Period 3|Withdrawal by Subject|0
7124424|NCT02677844|11265332|FG003|Period 3|Withdrawal by Subject|1
7124425|NCT02677844|11265333|FG004|Period 3|Withdrawal by Subject|0
7124426|NCT02677844|11265334|FG005|Period 3|Withdrawal by Subject|0
7124427|NCT02677844|11265335|FG006|Period 3|Withdrawal by Subject|0
7124428|NCT02678000|11265359|FG000|PART 2|Adverse Event|0
7124429|NCT02678000|11265360|FG001|PART 2|Adverse Event|0
7124430|NCT02678000|11265361|FG002|PART 2|Adverse Event|2
7124431|NCT02678000|11265362|FG003|PART 2|Adverse Event|1
7124432|NCT02678000|11265363|FG004|PART 2|Adverse Event|0
7124433|NCT02678000|11265359|FG000|PART 2|Withdrawal by Subject|0
7124434|NCT02678000|11265360|FG001|PART 2|Withdrawal by Subject|0
7124435|NCT02678000|11265361|FG002|PART 2|Withdrawal by Subject|1
7124436|NCT02678000|11265362|FG003|PART 2|Withdrawal by Subject|0
7124437|NCT02678000|11265363|FG004|PART 2|Withdrawal by Subject|0
7124438|NCT02678247|11265399|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0
7124439|NCT02678247|11265400|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2
7124440|NCT02678247|11265399|FG000|First Intervention (7 Weeks)|Adverse Event|1
7124441|NCT02678247|11265400|FG001|First Intervention (7 Weeks)|Adverse Event|2
7124442|NCT02678247|11265399|FG000|First Intervention (7 Weeks)|Physician Decision|1
7124443|NCT02678247|11265400|FG001|First Intervention (7 Weeks)|Physician Decision|0
7124444|NCT02678247|11265399|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1
7124445|NCT02678247|11265400|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1
7124446|NCT02678247|11265399|FG000|Second Intervention (7 Weeks)|Adverse Event|2
7124447|NCT02678247|11265400|FG001|Second Intervention (7 Weeks)|Adverse Event|1
7124448|NCT02678247|11265399|FG000|Second Intervention (7 Weeks)|Physician Decision|1
7124449|NCT02678247|11265400|FG001|Second Intervention (7 Weeks)|Physician Decision|0
7124450|NCT02678286|11265413|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2
7124451|NCT02678286|11265414|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1
7124452|NCT02678286|11265413|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0
7124453|NCT02678286|11265414|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1
7124454|NCT02678286|11265413|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1
7124455|NCT02678286|11265414|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0
7124456|NCT02678286|11265413|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3
7124457|NCT02678286|11265414|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2
7124458|NCT02678286|11265413|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
7124459|NCT02678286|11265414|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
7124460|NCT02678390|11265422|FG000|AE (1 Day)|Withdrawal by Subject|0
7124461|NCT02678390|11265423|FG001|AE (1 Day)|Withdrawal by Subject|1
7124462|NCT02678416|11265431|FG000|Part 1|Withdrawal by Subject|1
7124463|NCT02678416|11265431|FG000|Part 2|Adverse Event|2
7124464|NCT02678416|11265431|FG000|Part 2|Withdrawal by Subject|1
7124465|NCT02678676|11265460|FG000|Overall Study|Death|619
7124466|NCT02678676|11265461|FG001|Overall Study|Death|649
7124467|NCT02678676|11265460|FG000|Overall Study|Withdrawal by Subject|13
7124468|NCT02678676|11265461|FG001|Overall Study|Withdrawal by Subject|5
7124469|NCT02678676|11265460|FG000|Overall Study|Lost to Follow-up|171
7124470|NCT02678676|11265461|FG001|Overall Study|Lost to Follow-up|151
7124471|NCT02678676|11265460|FG000|Overall Study|Unconfirmed for lost to follow-up|85
7124472|NCT02678676|11265461|FG001|Overall Study|Unconfirmed for lost to follow-up|67
7124473|NCT02678923|11265469|FG000|Overall Study|Protocol Deviation (Not Dosed)|1
7124474|NCT02678923|11265470|FG001|Overall Study|Protocol Deviation (Not Dosed)|3
7124475|NCT02678923|11265469|FG000|Overall Study|Withdrawal by Subject|3
7124476|NCT02678923|11265470|FG001|Overall Study|Withdrawal by Subject|2
7124477|NCT02678923|11265469|FG000|Overall Study|Lost to Follow-up|1
7124478|NCT02678923|11265470|FG001|Overall Study|Lost to Follow-up|0
7124479|NCT02678923|11265469|FG000|Overall Study|Did Not Return for Study Visits|1
7124480|NCT02678923|11265470|FG001|Overall Study|Did Not Return for Study Visits|0
7124481|NCT02679079|11265479|FG000|Overall Study|Adverse Event|2
7124482|NCT02679079|11265480|FG001|Overall Study|Adverse Event|0
7124483|NCT02679079|11265481|FG002|Overall Study|Adverse Event|2
7124484|NCT02679079|11265479|FG000|Overall Study|Protocol Violation|0
7124485|NCT02679079|11265480|FG001|Overall Study|Protocol Violation|1
7124486|NCT02679079|11265481|FG002|Overall Study|Protocol Violation|0
7124487|NCT02679079|11265479|FG000|Overall Study|Withdrawal by Subject|2
7124488|NCT02679079|11265480|FG001|Overall Study|Withdrawal by Subject|1
7124489|NCT02679079|11265481|FG002|Overall Study|Withdrawal by Subject|0
7124490|NCT02679222|11265489|FG000|Overall Study|No time for project|1
7124491|NCT02679235|11265501|FG000|Overall Study|Withdrawal by Subject|3
7124492|NCT02679235|11265501|FG000|Overall Study|Adverse Event|1
7124493|NCT02679274|11265507|FG000|Overall Study|Withdrawal by Subject|1
7124494|NCT02679274|11265508|FG001|Overall Study|Withdrawal by Subject|0
7124495|NCT02679287|11265516|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2
7124496|NCT02679287|11265517|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1
7124497|NCT02679287|11265516|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2
7124498|NCT02679287|11265517|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3
7124499|NCT02679287|11265516|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0
7124500|NCT02679287|11265517|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1
7124501|NCT02679287|11265516|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0
7124502|NCT02679287|11265517|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1
7124503|NCT02679287|11265516|FG000|Period 2|Work/Scheduling Conflict|1
7124504|NCT02679287|11265517|FG001|Period 2|Work/Scheduling Conflict|0
7124505|NCT02679287|11265516|FG000|Period 2|Disliked Mobile System|2
7124506|NCT02679287|11265517|FG001|Period 2|Disliked Mobile System|0
7124507|NCT02679287|11265516|FG000|Period 3|Work/Scheduling Conflict|0
7124508|NCT02679287|11265517|FG001|Period 3|Work/Scheduling Conflict|1
7124509|NCT02679573|11265535|FG000|Overall Study|Adverse Event|13
7124510|NCT02679573|11265536|FG001|Overall Study|Adverse Event|6
7124511|NCT02679573|11265535|FG000|Overall Study|Lack of Efficacy|12
7124512|NCT02679573|11265536|FG001|Overall Study|Lack of Efficacy|15
7124513|NCT02679573|11265535|FG000|Overall Study|Could not complete required study visits|6
7124514|NCT02679573|11265536|FG001|Overall Study|Could not complete required study visits|2
7124515|NCT02679573|11265535|FG000|Overall Study|Withdrawal by Subject|2
7124516|NCT02679573|11265536|FG001|Overall Study|Withdrawal by Subject|9
7124517|NCT02679573|11265535|FG000|Overall Study|Death|2
7124518|NCT02679573|11265536|FG001|Overall Study|Death|0
7124519|NCT02679573|11265535|FG000|Overall Study|Physician Decision|2
7124520|NCT02679573|11265536|FG001|Overall Study|Physician Decision|4
7124521|NCT02679573|11265535|FG000|Overall Study|Lost to Follow-up|0
7124522|NCT02679573|11265536|FG001|Overall Study|Lost to Follow-up|3
7124523|NCT02679729|11265557|FG000|Overall Study|Lost to Follow-up|0
7124524|NCT02679729|11265558|FG001|Overall Study|Lost to Follow-up|1
7124525|NCT02679729|11265559|FG002|Overall Study|Lost to Follow-up|0
7124526|NCT02679729|11265560|FG003|Overall Study|Lost to Follow-up|0
7124527|NCT02679729|11265561|FG004|Overall Study|Lost to Follow-up|1
7124528|NCT02679729|11265562|FG005|Overall Study|Lost to Follow-up|0
7124529|NCT02679729|11265563|FG006|Overall Study|Lost to Follow-up|0
7124530|NCT02679729|11265564|FG007|Overall Study|Lost to Follow-up|0
7124531|NCT02679729|11265565|FG008|Overall Study|Lost to Follow-up|0
7124532|NCT02679729|11265557|FG000|Overall Study|Participant decision|0
7124533|NCT02679729|11265558|FG001|Overall Study|Participant decision|1
7124534|NCT02679729|11265559|FG002|Overall Study|Participant decision|0
7124535|NCT02679729|11265560|FG003|Overall Study|Participant decision|0
7124536|NCT02679729|11265561|FG004|Overall Study|Participant decision|0
7124537|NCT02679729|11265562|FG005|Overall Study|Participant decision|0
7124538|NCT02679729|11265563|FG006|Overall Study|Participant decision|1
7124539|NCT02679729|11265564|FG007|Overall Study|Participant decision|0
7124540|NCT02679729|11265565|FG008|Overall Study|Participant decision|0
7124541|NCT02679755|11265599|FG000|Overall Study|Death|0
7124542|NCT02679755|11265600|FG001|Overall Study|Death|3
7124543|NCT02679755|11265599|FG000|Overall Study|Global deterioration of health status|1
7124544|NCT02679755|11265600|FG001|Overall Study|Global deterioration of health status|8
7124545|NCT02679755|11265599|FG000|Overall Study|Lost to Follow-up|1
7124546|NCT02679755|11265600|FG001|Overall Study|Lost to Follow-up|0
7124547|NCT02679755|11265599|FG000|Overall Study|Objective progression or relapse|24
7124548|NCT02679755|11265600|FG001|Overall Study|Objective progression or relapse|83
7124549|NCT02679755|11265599|FG000|Overall Study|Not defined|0
7124550|NCT02679755|11265600|FG001|Overall Study|Not defined|2
7124551|NCT02679755|11265599|FG000|Overall Study|Withdrawal by participant|6
7124552|NCT02679755|11265600|FG001|Overall Study|Withdrawal by participant|3
7124553|NCT02679755|11265599|FG000|Overall Study|Adverse Event|1
7124554|NCT02679755|11265600|FG001|Overall Study|Adverse Event|4
7124555|NCT02679755|11265599|FG000|Overall Study|Adverse events not related to study drug|1
7124556|NCT02679755|11265600|FG001|Overall Study|Adverse events not related to study drug|2
7124557|NCT02680002|11265634|FG000|Overall Study|Lost to Follow-up|5
7124558|NCT02680002|11265635|FG001|Overall Study|Lost to Follow-up|1
7124559|NCT02680002|11265636|FG002|Overall Study|Lost to Follow-up|4
7124560|NCT02680002|11265637|FG003|Overall Study|Lost to Follow-up|2
7124561|NCT02680002|11265638|FG004|Overall Study|Lost to Follow-up|0
7124562|NCT02680002|11265639|FG005|Overall Study|Lost to Follow-up|2
7124563|NCT02680002|11265634|FG000|Overall Study|Physician Decision|5
7124564|NCT02680002|11265635|FG001|Overall Study|Physician Decision|1
7124565|NCT02680002|11265636|FG002|Overall Study|Physician Decision|1
7124566|NCT02680002|11265637|FG003|Overall Study|Physician Decision|1
7124567|NCT02680002|11265638|FG004|Overall Study|Physician Decision|1
7124568|NCT02680002|11265639|FG005|Overall Study|Physician Decision|1
7124569|NCT02680002|11265634|FG000|Overall Study|Protocol Violation|1
7124570|NCT02680002|11265635|FG001|Overall Study|Protocol Violation|0
7124571|NCT02680002|11265636|FG002|Overall Study|Protocol Violation|1
7124572|NCT02680002|11265637|FG003|Overall Study|Protocol Violation|0
7124573|NCT02680002|11265638|FG004|Overall Study|Protocol Violation|1
7124574|NCT02680002|11265639|FG005|Overall Study|Protocol Violation|2
7124575|NCT02680002|11265634|FG000|Overall Study|Withdrawal by Subject|0
7124576|NCT02680002|11265635|FG001|Overall Study|Withdrawal by Subject|0
7124577|NCT02680002|11265636|FG002|Overall Study|Withdrawal by Subject|1
7124578|NCT02680002|11265637|FG003|Overall Study|Withdrawal by Subject|0
7124579|NCT02680002|11265638|FG004|Overall Study|Withdrawal by Subject|2
7124580|NCT02680002|11265639|FG005|Overall Study|Withdrawal by Subject|2
7124581|NCT02680002|11265634|FG000|Overall Study|Missed Visit 8 (Day 201)|2
7124582|NCT02680002|11265635|FG001|Overall Study|Missed Visit 8 (Day 201)|1
7124583|NCT02680002|11265636|FG002|Overall Study|Missed Visit 8 (Day 201)|3
7124584|NCT02680002|11265637|FG003|Overall Study|Missed Visit 8 (Day 201)|1
7124585|NCT02680002|11265638|FG004|Overall Study|Missed Visit 8 (Day 201)|5
7124586|NCT02680002|11265639|FG005|Overall Study|Missed Visit 8 (Day 201)|0
7124587|NCT02680002|11265634|FG000|Overall Study|Other|0
7124588|NCT02680002|11265635|FG001|Overall Study|Other|1
7124589|NCT02680002|11265636|FG002|Overall Study|Other|0
7124590|NCT02680002|11265637|FG003|Overall Study|Other|0
7124591|NCT02680002|11265638|FG004|Overall Study|Other|1
7124592|NCT02680002|11265639|FG005|Overall Study|Other|0
7124593|NCT02680002|11265634|FG000|Overall Study|Adverse Event|0
7124594|NCT02680002|11265635|FG001|Overall Study|Adverse Event|0
7124595|NCT02680002|11265636|FG002|Overall Study|Adverse Event|0
7124596|NCT02680002|11265637|FG003|Overall Study|Adverse Event|0
7124597|NCT02680002|11265638|FG004|Overall Study|Adverse Event|1
7124598|NCT02680002|11265639|FG005|Overall Study|Adverse Event|2
7124599|NCT02680041|11265656|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8
7124600|NCT02680041|11265656|FG000|Overall Study|Lost to Follow-up|2
7124601|NCT02680639|11265713|FG000|Screening Period|Screen Failure|7
7124602|NCT02680639|11265714|FG001|Screening Period|Screen Failure|0
7124603|NCT02680639|11265715|FG002|Screening Period|Screen Failure|0
7124604|NCT02680665|11265725|FG000|Overall Study|No visit after the first prescription|5
7124605|NCT02680756|11265731|FG000|Overall Study|Adverse Event|10
7124606|NCT02680756|11265732|FG001|Overall Study|Adverse Event|2
7124607|NCT02680756|11265731|FG000|Overall Study|Lost to Follow-up|7
7124608|NCT02680756|11265732|FG001|Overall Study|Lost to Follow-up|6
7124609|NCT02680756|11265731|FG000|Overall Study|Withdrawal by Subject|5
7124610|NCT02680756|11265732|FG001|Overall Study|Withdrawal by Subject|5
7124611|NCT02680756|11265731|FG000|Overall Study|Physician Decision|4
7124612|NCT02680756|11265732|FG001|Overall Study|Physician Decision|1
7124613|NCT02680756|11265731|FG000|Overall Study|Hb ≤7.5 g/dL|0
7124614|NCT02680756|11265732|FG001|Overall Study|Hb ≤7.5 g/dL|2
7124615|NCT02680756|11265731|FG000|Overall Study|Blood transfusion for any reason|0
7124616|NCT02680756|11265732|FG001|Overall Study|Blood transfusion for any reason|1
7124617|NCT02680756|11265731|FG000|Overall Study|Death|1
7124618|NCT02680756|11265732|FG001|Overall Study|Death|0
7124619|NCT02680756|11265731|FG000|Overall Study|Protocol Violation|1
7124620|NCT02680756|11265732|FG001|Overall Study|Protocol Violation|0
7124621|NCT02680756|11265731|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1
7124622|NCT02680756|11265732|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0
7124623|NCT02680756|11265731|FG000|Overall Study|None of above or not recorded|3
7124624|NCT02680756|11265732|FG001|Overall Study|None of above or not recorded|2
7124625|NCT02680834|11265740|FG000|Overall Study|Physician Decision|5
7124626|NCT02680834|11265741|FG001|Overall Study|Physician Decision|2
7124627|NCT02680834|11265740|FG000|Overall Study|Withdrawal by Subject|6
7124628|NCT02680834|11265741|FG001|Overall Study|Withdrawal by Subject|0
7124629|NCT02680834|11265740|FG000|Overall Study|Lost to Follow-up|0
7124630|NCT02680834|11265741|FG001|Overall Study|Lost to Follow-up|1
7124631|NCT02680847|11265750|FG000|Overall Study|Other|2
7124632|NCT02680847|11265751|FG001|Overall Study|Other|0
7124633|NCT02680847|11265752|FG002|Overall Study|Other|0
7124634|NCT02680847|11265750|FG000|Overall Study|No longer met eligibility criteria|2
7124635|NCT02680847|11265751|FG001|Overall Study|No longer met eligibility criteria|2
7124636|NCT02680847|11265752|FG002|Overall Study|No longer met eligibility criteria|0
7124637|NCT02680847|11265750|FG000|Overall Study|Unwilling to participate in study|1
7124638|NCT02680847|11265751|FG001|Overall Study|Unwilling to participate in study|1
7124639|NCT02680847|11265752|FG002|Overall Study|Unwilling to participate in study|0
7124640|NCT02680847|11265750|FG000|Overall Study|Lack of Efficacy|0
7124641|NCT02680847|11265751|FG001|Overall Study|Lack of Efficacy|0
7124642|NCT02680847|11265752|FG002|Overall Study|Lack of Efficacy|2
7124643|NCT02680847|11265750|FG000|Overall Study|Adverse Event|0
7124644|NCT02680847|11265751|FG001|Overall Study|Adverse Event|0
7124645|NCT02680847|11265752|FG002|Overall Study|Adverse Event|1
7124646|NCT02681094|11265763|FG000|1 -Modified Enrolled Participants Set|Participant decision|7
7124647|NCT02681094|11265764|FG001|1 -Modified Enrolled Participants Set|Participant decision|10
7124648|NCT02681094|11265765|FG002|1 -Modified Enrolled Participants Set|Participant decision|9
7124649|NCT02681094|11265763|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10
7124650|NCT02681094|11265764|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4
7124651|NCT02681094|11265765|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1
7124652|NCT02681094|11265763|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2
7124653|NCT02681094|11265764|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0
7124654|NCT02681094|11265765|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1
7124655|NCT02681094|11265763|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1
7124656|NCT02681094|11265764|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5
7124657|NCT02681094|11265765|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14
7124658|NCT02681094|11265763|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11
7124659|NCT02681094|11265764|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13
7124660|NCT02681094|11265765|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20
7124661|NCT02681094|11265763|FG000|1 -Modified Enrolled Participants Set|Other|6
7124662|NCT02681094|11265764|FG001|1 -Modified Enrolled Participants Set|Other|6
7124663|NCT02681094|11265765|FG002|1 -Modified Enrolled Participants Set|Other|7
7124664|NCT02681094|11265763|FG000|1 -Modified Enrolled Participants Set|No treatment given|0
7124665|NCT02681094|11265764|FG001|1 -Modified Enrolled Participants Set|No treatment given|1
7124666|NCT02681094|11265765|FG002|1 -Modified Enrolled Participants Set|No treatment given|1
7124667|NCT02681094|11265763|FG000|2 - Enrolled Participants Set|Participant decision|7
7124668|NCT02681094|11265764|FG001|2 - Enrolled Participants Set|Participant decision|10
7124669|NCT02681094|11265765|FG002|2 - Enrolled Participants Set|Participant decision|9
7124670|NCT02681094|11265763|FG000|2 - Enrolled Participants Set|Adverse Event|10
7124671|NCT02681094|11265764|FG001|2 - Enrolled Participants Set|Adverse Event|4
7124672|NCT02681094|11265765|FG002|2 - Enrolled Participants Set|Adverse Event|1
7124673|NCT02681094|11265763|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2
7124674|NCT02681094|11265764|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0
7124675|NCT02681094|11265765|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1
7124676|NCT02681094|11265763|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1
7124677|NCT02681094|11265764|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5
7124678|NCT02681094|11265765|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14
7124679|NCT02681094|11265763|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14
7124680|NCT02681094|11265764|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15
7124681|NCT02681094|11265765|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21
7124682|NCT02681094|11265763|FG000|2 - Enrolled Participants Set|Other|6
7124683|NCT02681094|11265764|FG001|2 - Enrolled Participants Set|Other|6
7124684|NCT02681094|11265765|FG002|2 - Enrolled Participants Set|Other|7
7124685|NCT02681094|11265763|FG000|2 - Enrolled Participants Set|No treatment given|0
7124686|NCT02681094|11265764|FG001|2 - Enrolled Participants Set|No treatment given|1
7124687|NCT02681094|11265765|FG002|2 - Enrolled Participants Set|No treatment given|1
7124688|NCT02681510|11265787|FG000|Overall Study|Withdrawal by Subject|1
7124689|NCT02681510|11265787|FG000|Overall Study|Lost to Follow-up|9
7124690|NCT02681523|11265791|FG000|Overall Study|Adverse Event|1
7124691|NCT02681523|11265791|FG000|Overall Study|Patient Non-compliance|1
7124692|NCT02682264|11265846|FG000|Overall Study|Withdrawal by Subject|56
7124693|NCT02682264|11265847|FG001|Overall Study|Withdrawal by Subject|45
7124694|NCT02682264|11265846|FG000|Overall Study|Lost to Follow-up|49
7124695|NCT02682264|11265847|FG001|Overall Study|Lost to Follow-up|41
7124696|NCT02682264|11265846|FG000|Overall Study|Lack of Efficacy|14
7124697|NCT02682264|11265847|FG001|Overall Study|Lack of Efficacy|16
7124698|NCT02682264|11265846|FG000|Overall Study|Withdrawal by Parent|6
7124699|NCT02682264|11265847|FG001|Overall Study|Withdrawal by Parent|7
7124700|NCT02682264|11265846|FG000|Overall Study|Adverse Event|9
7124701|NCT02682264|11265847|FG001|Overall Study|Adverse Event|0
7124702|NCT02682264|11265846|FG000|Overall Study|Noncompliance with study drug|1
7124703|NCT02682264|11265847|FG001|Overall Study|Noncompliance with study drug|4
7124704|NCT02682264|11265846|FG000|Overall Study|Pregnancy|1
7124705|NCT02682264|11265847|FG001|Overall Study|Pregnancy|2
7124706|NCT02682264|11265846|FG000|Overall Study|Recovery|1
7124707|NCT02682264|11265847|FG001|Overall Study|Recovery|2
7124708|NCT02682264|11265846|FG000|Overall Study|Progressive Disease|1
7124709|NCT02682264|11265847|FG001|Overall Study|Progressive Disease|0
7124710|NCT02682264|11265846|FG000|Overall Study|Technical Problems|0
7124711|NCT02682264|11265847|FG001|Overall Study|Technical Problems|1
7124712|NCT02682264|11265846|FG000|Overall Study|Moved abroad and unable to continue|0
7124713|NCT02682264|11265847|FG001|Overall Study|Moved abroad and unable to continue|3
7124714|NCT02682264|11265846|FG000|Overall Study|Stopped test article application|0
7124715|NCT02682264|11265847|FG001|Overall Study|Stopped test article application|1
7124716|NCT02682602|11265898|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1
7124717|NCT02682602|11265899|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0
7124718|NCT02682602|11265898|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3
7124719|NCT02682602|11265899|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0
7124720|NCT02682784|11265913|FG000|Overall Study|Withdrawal by Subject|0
7124721|NCT02682784|11265914|FG001|Overall Study|Withdrawal by Subject|2
7124722|NCT02682784|11265915|FG002|Overall Study|Withdrawal by Subject|1
7124723|NCT02682784|11265916|FG003|Overall Study|Withdrawal by Subject|2
7124724|NCT02682784|11265913|FG000|Overall Study|Physician Decision|1
7124725|NCT02682784|11265914|FG001|Overall Study|Physician Decision|0
7124726|NCT02682784|11265915|FG002|Overall Study|Physician Decision|1
7124727|NCT02682784|11265916|FG003|Overall Study|Physician Decision|1
7124728|NCT02682823|11265931|FG000|Overall Study|Withdrawal by Subject|0
7124729|NCT02682823|11265932|FG001|Overall Study|Withdrawal by Subject|0
7124730|NCT02682823|11265933|FG002|Overall Study|Withdrawal by Subject|1
7124731|NCT02682823|11265934|FG003|Overall Study|Withdrawal by Subject|0
7124732|NCT02682823|11265935|FG004|Overall Study|Withdrawal by Subject|1
7124733|NCT02682823|11265931|FG000|Overall Study|Protocol Deviation|0
7124734|NCT02682823|11265932|FG001|Overall Study|Protocol Deviation|1
7124735|NCT02682823|11265933|FG002|Overall Study|Protocol Deviation|0
7124736|NCT02682823|11265934|FG003|Overall Study|Protocol Deviation|0
7124737|NCT02682823|11265935|FG004|Overall Study|Protocol Deviation|0
7124738|NCT02682823|11265931|FG000|Overall Study|Adverse Event|0
7124739|NCT02682823|11265932|FG001|Overall Study|Adverse Event|0
7124740|NCT02682823|11265933|FG002|Overall Study|Adverse Event|0
7124741|NCT02682823|11265934|FG003|Overall Study|Adverse Event|1
7124742|NCT02682823|11265935|FG004|Overall Study|Adverse Event|0
7124743|NCT02683109|11265953|FG000|Overall Study|Adverse Event|1
7124744|NCT02683109|11265954|FG001|Overall Study|Adverse Event|0
7124745|NCT02683187|11265970|FG000|Overall Study|Failed IV access|3
7124746|NCT02683187|11265970|FG000|Overall Study|Withdrawal by Subject|5
7124747|NCT02683525|11265995|FG000|Overall Study|Lost to Follow-up|1
7124748|NCT02683525|11265995|FG000|Overall Study|Physician Decision|1
7124749|NCT02683525|11265995|FG000|Overall Study|Disease Progression|6
7124750|NCT02683668|11266014|FG000|Period 2|Withdrawal by Subject|0
7124751|NCT02683668|11266015|FG001|Period 2|Withdrawal by Subject|1
7124752|NCT02683668|11266016|FG002|Period 2|Withdrawal by Subject|0
7124753|NCT02683746|11266033|FG000|Overall Study|Adverse Event|3
7124754|NCT02683746|11266034|FG001|Overall Study|Adverse Event|2
7124755|NCT02683746|11266033|FG000|Overall Study|Lost to Follow-up|5
7124756|NCT02683746|11266034|FG001|Overall Study|Lost to Follow-up|6
7124757|NCT02683746|11266033|FG000|Overall Study|Withdrawal by Subject|6
7124758|NCT02683746|11266034|FG001|Overall Study|Withdrawal by Subject|5
7124759|NCT02683746|11266033|FG000|Overall Study|Physician Decision|2
7124760|NCT02683746|11266034|FG001|Overall Study|Physician Decision|1
7124761|NCT02683785|11266053|FG000|Overall Study|Withdrawal by Subject|1
7124762|NCT02683785|11266054|FG001|Overall Study|Withdrawal by Subject|1
7124763|NCT02683785|11266053|FG000|Overall Study|Lost to Follow-up|0
7124764|NCT02683785|11266054|FG001|Overall Study|Lost to Follow-up|1
7124765|NCT02683785|11266053|FG000|Overall Study|Adverse Event|0
7124766|NCT02683785|11266054|FG001|Overall Study|Adverse Event|2
7124767|NCT02683876|11266064|FG000|Overall Study|samples damaged during shipping|2
7124768|NCT02683876|11266065|FG001|Overall Study|samples damaged during shipping|0
7124769|NCT02683941|11266084|FG000|Double-blind Phase|Adverse Event|0
7124770|NCT02683941|11266085|FG001|Double-blind Phase|Adverse Event|1
7124771|NCT02683941|11266084|FG000|Double-blind Phase|Withdrawal by Subject|4
7124772|NCT02683941|11266085|FG001|Double-blind Phase|Withdrawal by Subject|2
7124773|NCT02683941|11266084|FG000|Double-blind Phase|Lost to Follow-up|1
7124774|NCT02683941|11266085|FG001|Double-blind Phase|Lost to Follow-up|0
7124775|NCT02683941|11266084|FG000|Double-blind Phase|Disease Progression|5
7124776|NCT02683941|11266085|FG001|Double-blind Phase|Disease Progression|2
7124777|NCT02683941|11266084|FG000|Open-label Treatment Phase|Withdrawal by Subject|0
7124778|NCT02683941|11266085|FG001|Open-label Treatment Phase|Withdrawal by Subject|2
7124779|NCT02683941|11266084|FG000|Open-label Treatment Phase|Disease Progression|1
7124780|NCT02683941|11266085|FG001|Open-label Treatment Phase|Disease Progression|2
7124781|NCT02683941|11266084|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18
7124782|NCT02683941|11266085|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9
7124783|NCT02683941|11266084|FG000|Open-label Treatment Phase|Other|1
7124784|NCT02683941|11266085|FG001|Open-label Treatment Phase|Other|0
7124785|NCT02683941|11266084|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3
7124786|NCT02683941|11266085|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3
7124787|NCT02683941|11266084|FG000|Open-label Follow-up Phase|Lost to Follow-up|1
7124788|NCT02683941|11266085|FG001|Open-label Follow-up Phase|Lost to Follow-up|0
7124789|NCT02683941|11266084|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6
7124790|NCT02683941|11266085|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4
7124791|NCT02683941|11266084|FG000|Open-label Follow-up Phase|Other|8
7124792|NCT02683941|11266085|FG001|Open-label Follow-up Phase|Other|1
7124793|NCT02684097|11266106|FG000|Overall Study|Lack of Efficacy|13
7124794|NCT02684097|11266107|FG001|Overall Study|Lack of Efficacy|6
7124795|NCT02684279|11266132|FG000|Overall Study|Adverse Event|87
7124796|NCT02684279|11266132|FG000|Overall Study|Lack of Efficacy|4
7124797|NCT02684279|11266132|FG000|Overall Study|Lost to Follow-up|61
7124798|NCT02684279|11266132|FG000|Overall Study|Protocol Violation|6
7124799|NCT02684279|11266132|FG000|Overall Study|Pregnancy|8
7124800|NCT02684279|11266132|FG000|Overall Study|Withdrawal by Subject|92
7124801|NCT02684279|11266132|FG000|Overall Study|non-compliance with study drug|9
7124802|NCT02684279|11266132|FG000|Overall Study|non compliance with study visits|2
7124803|NCT02684279|11266132|FG000|Overall Study|subject to have surgery|1
7124804|NCT02684279|11266132|FG000|Overall Study|family emergency|1
7124805|NCT02684279|11266132|FG000|Overall Study|Site closures|7
7124806|NCT02684279|11266132|FG000|Overall Study|Physician Decision|1
7124807|NCT02684344|11266138|FG000|Overall Study|Withdrawal by Subject|0
7124808|NCT02684344|11266139|FG001|Overall Study|Withdrawal by Subject|1
7124809|NCT02684357|11266148|FG000|Part A|Adverse Event (Worsening of Disease)|1
7124810|NCT02684357|11266149|FG001|Part A|Adverse Event (Worsening of Disease)|0
7124811|NCT02684357|11266150|FG002|Part A|Adverse Event (Worsening of Disease)|0
7124812|NCT02684357|11266151|FG003|Part A|Adverse Event (Worsening of Disease)|0
7124813|NCT02684357|11266152|FG004|Part A|Adverse Event (Worsening of Disease)|0
7124814|NCT02684357|11266153|FG005|Part A|Adverse Event (Worsening of Disease)|0
7124815|NCT02684357|11266148|FG000|Part A|Lost to Follow-up|0
7124816|NCT02684357|11266149|FG001|Part A|Lost to Follow-up|2
7124817|NCT02684357|11266150|FG002|Part A|Lost to Follow-up|2
7124818|NCT02684357|11266151|FG003|Part A|Lost to Follow-up|0
7124819|NCT02684357|11266152|FG004|Part A|Lost to Follow-up|0
7124820|NCT02684357|11266153|FG005|Part A|Lost to Follow-up|0
7124821|NCT02684357|11266148|FG000|Part A|Withdrawal by Subject|3
7124822|NCT02684357|11266149|FG001|Part A|Withdrawal by Subject|0
7124823|NCT02684357|11266150|FG002|Part A|Withdrawal by Subject|0
7124824|NCT02684357|11266151|FG003|Part A|Withdrawal by Subject|0
7124825|NCT02684357|11266152|FG004|Part A|Withdrawal by Subject|0
7124826|NCT02684357|11266153|FG005|Part A|Withdrawal by Subject|0
7124827|NCT02684357|11266148|FG000|Part A|Other|0
7124828|NCT02684357|11266149|FG001|Part A|Other|1
7124829|NCT02684357|11266150|FG002|Part A|Other|0
7124830|NCT02684357|11266151|FG003|Part A|Other|0
7124831|NCT02684357|11266152|FG004|Part A|Other|0
7124832|NCT02684357|11266153|FG005|Part A|Other|0
7124833|NCT02684357|11266148|FG000|Part B|Adverse Event (Other)|0
7124834|NCT02684357|11266149|FG001|Part B|Adverse Event (Other)|0
7124835|NCT02684357|11266150|FG002|Part B|Adverse Event (Other)|0
7124836|NCT02684357|11266151|FG003|Part B|Adverse Event (Other)|1
7124837|NCT02684357|11266152|FG004|Part B|Adverse Event (Other)|1
7124838|NCT02684357|11266153|FG005|Part B|Adverse Event (Other)|1
7124839|NCT02684357|11266148|FG000|Part B|Lost to Follow-up|0
7124840|NCT02684357|11266149|FG001|Part B|Lost to Follow-up|0
7124841|NCT02684357|11266150|FG002|Part B|Lost to Follow-up|0
7124842|NCT02684357|11266151|FG003|Part B|Lost to Follow-up|1
7124843|NCT02684357|11266152|FG004|Part B|Lost to Follow-up|1
7124844|NCT02684357|11266153|FG005|Part B|Lost to Follow-up|7
7124845|NCT02684357|11266148|FG000|Part B|Withdrawal by Subject|0
7124846|NCT02684357|11266149|FG001|Part B|Withdrawal by Subject|0
7124847|NCT02684357|11266150|FG002|Part B|Withdrawal by Subject|0
7124848|NCT02684357|11266151|FG003|Part B|Withdrawal by Subject|0
7124849|NCT02684357|11266152|FG004|Part B|Withdrawal by Subject|2
7124850|NCT02684357|11266153|FG005|Part B|Withdrawal by Subject|4
7124851|NCT02684357|11266148|FG000|Part B|Other|0
7124852|NCT02684357|11266149|FG001|Part B|Other|0
7124853|NCT02684357|11266150|FG002|Part B|Other|0
7124854|NCT02684357|11266151|FG003|Part B|Other|1
7124855|NCT02684357|11266152|FG004|Part B|Other|0
7124856|NCT02684357|11266153|FG005|Part B|Other|1
7124857|NCT02684370|11266169|FG000|Part A|Adverse Event|2
7124858|NCT02684370|11266170|FG001|Part A|Adverse Event|0
7124859|NCT02684370|11266171|FG002|Part A|Adverse Event|1
7124860|NCT02684370|11266172|FG003|Part A|Adverse Event|0
7124861|NCT02684370|11266173|FG004|Part A|Adverse Event|0
7124862|NCT02684370|11266174|FG005|Part A|Adverse Event|0
7124863|NCT02684370|11266169|FG000|Part A|Lost to Follow-up|1
7124864|NCT02684370|11266170|FG001|Part A|Lost to Follow-up|1
7124865|NCT02684370|11266171|FG002|Part A|Lost to Follow-up|0
7124866|NCT02684370|11266172|FG003|Part A|Lost to Follow-up|0
7124867|NCT02684370|11266173|FG004|Part A|Lost to Follow-up|0
7124868|NCT02684370|11266174|FG005|Part A|Lost to Follow-up|0
7124869|NCT02684370|11266169|FG000|Part A|Subject Withdrawal|1
7124870|NCT02684370|11266170|FG001|Part A|Subject Withdrawal|0
7124871|NCT02684370|11266171|FG002|Part A|Subject Withdrawal|3
7124872|NCT02684370|11266172|FG003|Part A|Subject Withdrawal|0
7124873|NCT02684370|11266173|FG004|Part A|Subject Withdrawal|0
7124874|NCT02684370|11266174|FG005|Part A|Subject Withdrawal|0
7124875|NCT02684370|11266169|FG000|Part A|Other|0
7124876|NCT02684370|11266170|FG001|Part A|Other|0
7124877|NCT02684370|11266171|FG002|Part A|Other|1
7124878|NCT02684370|11266172|FG003|Part A|Other|0
7124879|NCT02684370|11266173|FG004|Part A|Other|0
7124880|NCT02684370|11266174|FG005|Part A|Other|0
7124881|NCT02684370|11266169|FG000|Part B|Adverse Event|0
7124882|NCT02684370|11266170|FG001|Part B|Adverse Event|0
7124883|NCT02684370|11266171|FG002|Part B|Adverse Event|0
7124884|NCT02684370|11266172|FG003|Part B|Adverse Event|0
7124885|NCT02684370|11266173|FG004|Part B|Adverse Event|2
7124886|NCT02684370|11266174|FG005|Part B|Adverse Event|1
7124887|NCT02684370|11266169|FG000|Part B|Lost to Follow-up|0
7124888|NCT02684370|11266170|FG001|Part B|Lost to Follow-up|0
7124889|NCT02684370|11266171|FG002|Part B|Lost to Follow-up|0
7124890|NCT02684370|11266172|FG003|Part B|Lost to Follow-up|1
7124891|NCT02684370|11266173|FG004|Part B|Lost to Follow-up|2
7124892|NCT02684370|11266174|FG005|Part B|Lost to Follow-up|5
7124893|NCT02684370|11266169|FG000|Part B|Subject Withdrawal|0
7124894|NCT02684370|11266170|FG001|Part B|Subject Withdrawal|0
7124895|NCT02684370|11266171|FG002|Part B|Subject Withdrawal|0
7124896|NCT02684370|11266172|FG003|Part B|Subject Withdrawal|1
7124897|NCT02684370|11266173|FG004|Part B|Subject Withdrawal|1
7124898|NCT02684370|11266174|FG005|Part B|Subject Withdrawal|2
7124899|NCT02684617|11266238|FG000|Overall Study|Adverse Event|1
7124900|NCT02684617|11266239|FG001|Overall Study|Adverse Event|0
7124901|NCT02684617|11266240|FG002|Overall Study|Adverse Event|1
7124902|NCT02684617|11266238|FG000|Overall Study|Death|8
7124903|NCT02684617|11266239|FG001|Overall Study|Death|16
7124904|NCT02684617|11266240|FG002|Overall Study|Death|28
7124905|NCT02684617|11266238|FG000|Overall Study|Withdrawal by Subject|2
7124906|NCT02684617|11266239|FG001|Overall Study|Withdrawal by Subject|0
7124907|NCT02684617|11266240|FG002|Overall Study|Withdrawal by Subject|4
7124908|NCT02684617|11266238|FG000|Overall Study|Screen Failure|1
7124909|NCT02684617|11266239|FG001|Overall Study|Screen Failure|0
7124910|NCT02684617|11266240|FG002|Overall Study|Screen Failure|2
7124911|NCT02684617|11266238|FG000|Overall Study|Study Terminated by Sponsor|6
7124912|NCT02684617|11266239|FG001|Overall Study|Study Terminated by Sponsor|1
7124913|NCT02684617|11266240|FG002|Overall Study|Study Terminated by Sponsor|5
7124914|NCT02684981|11266278|FG000|Overall Study|Permanently discontinued the treatment|157
7124915|NCT02684981|11266279|FG001|Overall Study|Permanently discontinued the treatment|161
7124916|NCT02684981|11266280|FG002|Overall Study|Permanently discontinued the treatment|110
7124917|NCT02684981|11266278|FG000|Overall Study|Other|83
7124918|NCT02684981|11266279|FG001|Overall Study|Other|49
7124919|NCT02684981|11266280|FG002|Overall Study|Other|17
7124920|NCT02685033|11266300|FG000|Overall Study|Withdrawal of Consent|0
7124921|NCT02685033|11266301|FG001|Overall Study|Withdrawal of Consent|1
7124922|NCT02685033|11266300|FG000|Overall Study|Lost to Follow-up|2
7124923|NCT02685033|11266301|FG001|Overall Study|Lost to Follow-up|1
7124924|NCT02685033|11266300|FG000|Overall Study|Adverse Event|1
7124925|NCT02685033|11266301|FG001|Overall Study|Adverse Event|0
7124926|NCT02685072|11266309|FG000|Treatment Period|Lost to Follow-up|12
7124927|NCT02685072|11266310|FG001|Treatment Period|Lost to Follow-up|6
7124928|NCT02685072|11266309|FG000|Treatment Period|Withdrawal by Subject|1
7124929|NCT02685072|11266310|FG001|Treatment Period|Withdrawal by Subject|3
7124930|NCT02685072|11266309|FG000|1-Month Follow-Up|Withdrawal by Subject|1
7124931|NCT02685072|11266310|FG001|1-Month Follow-Up|Withdrawal by Subject|0
7124932|NCT02685488|11266339|FG000|Overall Study|Withdrawal by Subject|0
7124933|NCT02685488|11266340|FG001|Overall Study|Withdrawal by Subject|1
7124934|NCT02685995|11266368|FG000|Overall Study|Insertion of immediately puncturable graft.|1
7124935|NCT02685995|11266369|FG001|Overall Study|Insertion of immediately puncturable graft.|1
7124936|NCT02686034|11266377|FG000|Run-In Period 1|Eligibility|12
7124937|NCT02686034|11266378|FG001|Run-In Period 1|Eligibility|10
7124938|NCT02686034|11266377|FG000|Run-In Period 1|Withdrawal by Subject|4
7124939|NCT02686034|11266378|FG001|Run-In Period 1|Withdrawal by Subject|3
7124940|NCT02686034|11266377|FG000|Run-In Period 1|Lost to Follow-up|4
7124941|NCT02686034|11266378|FG001|Run-In Period 1|Lost to Follow-up|4
7124942|NCT02686034|11266377|FG000|Randomized Controlled Period 2|Lost to Follow-up|1
7124943|NCT02686034|11266378|FG001|Randomized Controlled Period 2|Lost to Follow-up|2
7124944|NCT02686034|11266377|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3
7124945|NCT02686034|11266378|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0
7124946|NCT02686034|11266377|FG000|Randomized Controlled Period 2|Adverse Event|0
7124947|NCT02686034|11266378|FG001|Randomized Controlled Period 2|Adverse Event|2
7124948|NCT02686034|11266377|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1
7124949|NCT02686034|11266378|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0
7124950|NCT02686034|11266377|FG000|Open Label Period 3|Lost to Follow-up|0
7124951|NCT02686034|11266378|FG001|Open Label Period 3|Lost to Follow-up|1
7124952|NCT02686164|11266393|FG000|Overall Study|Adverse Event|1
7124953|NCT02686164|11266393|FG000|Overall Study|Withdrawal of consent|1
7124954|NCT02686164|11266393|FG000|Overall Study|Clinical progression|1
7124955|NCT02687035|11266409|FG000|Overall Study|Withdrawal by Subject|1
7124956|NCT02687035|11266409|FG000|Overall Study|Death|87
7124957|NCT02687035|11266409|FG000|Overall Study|Lost to Follow-up|1
7124958|NCT02687035|11266409|FG000|Overall Study|Missed Visit|87
7124959|NCT02687035|11266409|FG000|Overall Study|Did not receive Study Device|8
7124960|NCT02687191|11266430|FG000|Overall Study|Death|0
7124961|NCT02687191|11266431|FG001|Overall Study|Death|1
7124962|NCT02687191|11266432|FG002|Overall Study|Death|1
7124963|NCT02687191|11266433|FG003|Overall Study|Death|0
7124964|NCT02687191|11266434|FG004|Overall Study|Death|1
7124965|NCT02687191|11266435|FG005|Overall Study|Death|1
7124966|NCT02687191|11266430|FG000|Overall Study|Withdrawal by Subject|0
7124967|NCT02687191|11266431|FG001|Overall Study|Withdrawal by Subject|0
7124968|NCT02687191|11266432|FG002|Overall Study|Withdrawal by Subject|0
7124969|NCT02687191|11266433|FG003|Overall Study|Withdrawal by Subject|1
7124970|NCT02687191|11266434|FG004|Overall Study|Withdrawal by Subject|0
7124971|NCT02687191|11266435|FG005|Overall Study|Withdrawal by Subject|0
7124972|NCT02687451|11266473|FG000|Overall Study|Withdrawal by Subject|1
7124973|NCT02687451|11266474|FG001|Overall Study|Withdrawal by Subject|0
7124974|NCT02687451|11266475|FG002|Overall Study|Withdrawal by Subject|0
7124975|NCT02687451|11266476|FG003|Overall Study|Withdrawal by Subject|0
7124976|NCT02687451|11266477|FG004|Overall Study|Withdrawal by Subject|0
7124977|NCT02687451|11266478|FG005|Overall Study|Withdrawal by Subject|1
7124978|NCT02687542|11266508|FG000|Overall Study|Medication error without associated AEs|0
7124979|NCT02687542|11266509|FG001|Overall Study|Medication error without associated AEs|0
7124980|NCT02687542|11266510|FG002|Overall Study|Medication error without associated AEs|0
7124981|NCT02687542|11266511|FG003|Overall Study|Medication error without associated AEs|0
7124982|NCT02687542|11266512|FG004|Overall Study|Medication error without associated AEs|1
7124983|NCT02687542|11266508|FG000|Overall Study|Lost to Follow-up|0
7124984|NCT02687542|11266509|FG001|Overall Study|Lost to Follow-up|0
7124985|NCT02687542|11266510|FG002|Overall Study|Lost to Follow-up|0
7124986|NCT02687542|11266511|FG003|Overall Study|Lost to Follow-up|0
7124987|NCT02687542|11266512|FG004|Overall Study|Lost to Follow-up|1
7124988|NCT02687542|11266508|FG000|Overall Study|Protocol Violation|0
7124989|NCT02687542|11266509|FG001|Overall Study|Protocol Violation|1
7124990|NCT02687542|11266510|FG002|Overall Study|Protocol Violation|0
7124991|NCT02687542|11266511|FG003|Overall Study|Protocol Violation|0
7124992|NCT02687542|11266512|FG004|Overall Study|Protocol Violation|0
7124993|NCT02687542|11266508|FG000|Overall Study|Other|5
7124994|NCT02687542|11266509|FG001|Overall Study|Other|9
7124995|NCT02687542|11266510|FG002|Overall Study|Other|10
7124996|NCT02687542|11266511|FG003|Overall Study|Other|6
7124997|NCT02687542|11266512|FG004|Overall Study|Other|5
7124998|NCT02687542|11266508|FG000|Overall Study|Adverse Event|3
7124999|NCT02687542|11266509|FG001|Overall Study|Adverse Event|1
7125000|NCT02687542|11266510|FG002|Overall Study|Adverse Event|3
7125001|NCT02687542|11266511|FG003|Overall Study|Adverse Event|2
7125002|NCT02687542|11266512|FG004|Overall Study|Adverse Event|9
7125003|NCT02687542|11266508|FG000|Overall Study|Withdrawal by Subject|0
7125004|NCT02687542|11266509|FG001|Overall Study|Withdrawal by Subject|1
7125005|NCT02687542|11266510|FG002|Overall Study|Withdrawal by Subject|1
7125006|NCT02687542|11266511|FG003|Overall Study|Withdrawal by Subject|2
7125007|NCT02687542|11266512|FG004|Overall Study|Withdrawal by Subject|4
7125008|NCT02687711|11266524|FG000|Overall Study|Adverse Event|89
7125009|NCT02687711|11266524|FG000|Overall Study|Lack of Efficacy|70
7125010|NCT02687711|11266524|FG000|Overall Study|Lost to Follow-up|20
7125011|NCT02687711|11266524|FG000|Overall Study|Consent withdrawn|15
7125012|NCT02687711|11266524|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1
7125013|NCT02687711|11266524|FG000|Overall Study|Too expensive|4
7125014|NCT02687711|11266524|FG000|Overall Study|Participant moved abroad|1
7125015|NCT02687711|11266524|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1
7125016|NCT02687711|11266524|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1
7125017|NCT02687711|11266524|FG000|Overall Study|Disliked taste|1
7125018|NCT02687711|11266524|FG000|Overall Study|Low mood|1
7125019|NCT02687711|11266524|FG000|Overall Study|Side effects|1
7125020|NCT02687711|11266524|FG000|Overall Study|Change of Hospital|1
7125021|NCT02687711|11266524|FG000|Overall Study|Liver Encephalopathy|1
7125022|NCT02687711|11266524|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1
7125023|NCT02687711|11266524|FG000|Overall Study|Withdrawn due to intake interruption|1
7125024|NCT02687711|11266524|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1
7125025|NCT02687711|11266524|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1
7125026|NCT02687711|11266524|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1
7125027|NCT02687815|11266530|FG000|Overall Study|Lost to Follow-up|2
7125028|NCT02687815|11266531|FG001|Overall Study|Lost to Follow-up|4
7125029|NCT02687815|11266530|FG000|Overall Study|Withdrawal by Subject|2
7125030|NCT02687815|11266531|FG001|Overall Study|Withdrawal by Subject|4
7125031|NCT02687919|11266539|FG000|Overall Study|Withdrawal by Subject|6
7125032|NCT02687919|11266540|FG001|Overall Study|Withdrawal by Subject|6
7125033|NCT02687919|11266539|FG000|Overall Study|Protocol Violation|2
7125034|NCT02687919|11266540|FG001|Overall Study|Protocol Violation|0
7125035|NCT02688153|11266548|FG000|Overall Study|Death|7
7125036|NCT02688153|11266549|FG001|Overall Study|Death|5
7125037|NCT02688153|11266548|FG000|Overall Study|Withdrawal by Subject|4
7125038|NCT02688153|11266549|FG001|Overall Study|Withdrawal by Subject|2
7125039|NCT02688153|11266548|FG000|Overall Study|Valve Explant|1
7125040|NCT02688153|11266549|FG001|Overall Study|Valve Explant|0
7125041|NCT02688153|11266548|FG000|Overall Study|Conversion to Commercial Valve|3
7125042|NCT02688153|11266549|FG001|Overall Study|Conversion to Commercial Valve|0
7125043|NCT02688192|11266558|FG000|Overall Study|Lost to Follow-up|11
7125044|NCT02688192|11266559|FG001|Overall Study|Lost to Follow-up|5
7125045|NCT02688192|11266558|FG000|Overall Study|Physician Decision|1
7125046|NCT02688192|11266559|FG001|Overall Study|Physician Decision|0
7125047|NCT02688387|11266579|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7125048|NCT02688387|11266580|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7125049|NCT02688387|11266581|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1
7125050|NCT02688387|11266582|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7125051|NCT02688387|11266583|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7125052|NCT02688387|11266584|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7125053|NCT02688387|11266585|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7125054|NCT02688387|11266586|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7125055|NCT02688387|11266587|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7125056|NCT02688387|11266588|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7125057|NCT02688387|11266589|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7125058|NCT02688387|11266590|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7125059|NCT02688387|11266591|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7125060|NCT02688387|11266592|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7125061|NCT02688387|11266593|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7125062|NCT02688387|11266594|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7125063|NCT02688387|11266595|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7125064|NCT02688387|11266596|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7125065|NCT02688387|11266597|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7125066|NCT02688387|11266598|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7125067|NCT02688387|11266599|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7125068|NCT02688387|11266600|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7125069|NCT02688387|11266579|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125070|NCT02688387|11266580|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125071|NCT02688387|11266581|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125072|NCT02688387|11266582|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1
7125073|NCT02688387|11266583|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125074|NCT02688387|11266584|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125075|NCT02688387|11266585|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125076|NCT02688387|11266586|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125077|NCT02688387|11266587|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125078|NCT02688387|11266588|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125079|NCT02688387|11266589|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125080|NCT02688387|11266590|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125081|NCT02688387|11266591|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125082|NCT02688387|11266592|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125083|NCT02688387|11266593|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125084|NCT02688387|11266594|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125085|NCT02688387|11266595|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125086|NCT02688387|11266596|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125087|NCT02688387|11266597|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125088|NCT02688387|11266598|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125089|NCT02688387|11266599|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125090|NCT02688387|11266600|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125091|NCT02688387|11266579|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7125092|NCT02688387|11266580|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1
7125093|NCT02688387|11266581|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7125094|NCT02688387|11266582|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7125095|NCT02688387|11266583|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7125096|NCT02688387|11266584|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7125097|NCT02688387|11266585|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7125098|NCT02688387|11266586|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7125099|NCT02688387|11266587|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7125100|NCT02688387|11266588|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7125101|NCT02688387|11266589|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7125102|NCT02688387|11266590|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7125103|NCT02688387|11266591|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7125104|NCT02688387|11266592|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7125105|NCT02688387|11266593|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7125106|NCT02688387|11266594|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7125107|NCT02688387|11266595|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7125108|NCT02688387|11266596|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7125109|NCT02688387|11266597|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7125110|NCT02688387|11266598|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7125111|NCT02688387|11266599|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7125112|NCT02688387|11266600|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
6806107|NCT01970865|10808462|FG011|Overall Study|Withdrawal by Subject|1
7125113|NCT02688387|11266579|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7125114|NCT02688387|11266580|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7125115|NCT02688387|11266581|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1
7125116|NCT02688387|11266582|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7125117|NCT02688387|11266583|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1
7125118|NCT02688387|11266584|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7125119|NCT02688387|11266585|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7125120|NCT02688387|11266586|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7125121|NCT02688387|11266587|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7125122|NCT02688387|11266588|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7125123|NCT02688387|11266589|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7125124|NCT02688387|11266590|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7125125|NCT02688387|11266591|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7125126|NCT02688387|11266592|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7125127|NCT02688387|11266593|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7125128|NCT02688387|11266594|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7125129|NCT02688387|11266595|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7125130|NCT02688387|11266596|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7125131|NCT02688387|11266597|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7125132|NCT02688387|11266598|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7125133|NCT02688387|11266599|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7125134|NCT02688387|11266600|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7125135|NCT02688387|11266579|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1
7125136|NCT02688387|11266580|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7125137|NCT02688387|11266581|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7125138|NCT02688387|11266582|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7125139|NCT02688387|11266583|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7125140|NCT02688387|11266584|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7125141|NCT02688387|11266585|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7125142|NCT02688387|11266586|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7125143|NCT02688387|11266587|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7125144|NCT02688387|11266588|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7125145|NCT02688387|11266589|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7125146|NCT02688387|11266590|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7125147|NCT02688387|11266591|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7125148|NCT02688387|11266592|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7125149|NCT02688387|11266593|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7125150|NCT02688387|11266594|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7125151|NCT02688387|11266595|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7125152|NCT02688387|11266596|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7125153|NCT02688387|11266597|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7125154|NCT02688387|11266598|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7125155|NCT02688387|11266599|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7125156|NCT02688387|11266600|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7125157|NCT02688387|11266579|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7125158|NCT02688387|11266580|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7125159|NCT02688387|11266581|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7125160|NCT02688387|11266582|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7125161|NCT02688387|11266583|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7125162|NCT02688387|11266584|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7125163|NCT02688387|11266585|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7125164|NCT02688387|11266586|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7125165|NCT02688387|11266587|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7125166|NCT02688387|11266588|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7125167|NCT02688387|11266589|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1
7125168|NCT02688387|11266590|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7125169|NCT02688387|11266591|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7125170|NCT02688387|11266592|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7125171|NCT02688387|11266593|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7125172|NCT02688387|11266594|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7125173|NCT02688387|11266595|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7125174|NCT02688387|11266596|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7125175|NCT02688387|11266597|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7125176|NCT02688387|11266598|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7125177|NCT02688387|11266599|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7125178|NCT02688387|11266600|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7125179|NCT02688387|11266579|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125180|NCT02688387|11266580|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125181|NCT02688387|11266581|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125182|NCT02688387|11266582|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125183|NCT02688387|11266583|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125184|NCT02688387|11266584|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125185|NCT02688387|11266585|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125186|NCT02688387|11266586|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125187|NCT02688387|11266587|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125188|NCT02688387|11266588|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125189|NCT02688387|11266589|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125190|NCT02688387|11266590|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125191|NCT02688387|11266591|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125192|NCT02688387|11266592|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125193|NCT02688387|11266593|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1
7125194|NCT02688387|11266594|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125195|NCT02688387|11266595|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125196|NCT02688387|11266596|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125197|NCT02688387|11266597|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125198|NCT02688387|11266598|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125199|NCT02688387|11266599|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125200|NCT02688387|11266600|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7125201|NCT02688387|11266579|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7125202|NCT02688387|11266580|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7125203|NCT02688387|11266581|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7125204|NCT02688387|11266582|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7125205|NCT02688387|11266583|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7125206|NCT02688387|11266584|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7125207|NCT02688387|11266585|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7125208|NCT02688387|11266586|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7125209|NCT02688387|11266587|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7125210|NCT02688387|11266588|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7125211|NCT02688387|11266589|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7125212|NCT02688387|11266590|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7125213|NCT02688387|11266591|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7125214|NCT02688387|11266592|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7125215|NCT02688387|11266593|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7125216|NCT02688387|11266594|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7125217|NCT02688387|11266595|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7125218|NCT02688387|11266596|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7125219|NCT02688387|11266597|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7125220|NCT02688387|11266598|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7125221|NCT02688387|11266599|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1
7125222|NCT02688387|11266600|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7125223|NCT02688387|11266579|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7125224|NCT02688387|11266580|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7125225|NCT02688387|11266581|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7125226|NCT02688387|11266582|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7125227|NCT02688387|11266583|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7125228|NCT02688387|11266584|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7125229|NCT02688387|11266585|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7125230|NCT02688387|11266586|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7125231|NCT02688387|11266587|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7125232|NCT02688387|11266588|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7125233|NCT02688387|11266589|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7125234|NCT02688387|11266590|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7125235|NCT02688387|11266591|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7125236|NCT02688387|11266592|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7125237|NCT02688387|11266593|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7125238|NCT02688387|11266594|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7125239|NCT02688387|11266595|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7125240|NCT02688387|11266596|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7125241|NCT02688387|11266597|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1
7125242|NCT02688387|11266598|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7125243|NCT02688387|11266599|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1
7125244|NCT02688387|11266600|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7125245|NCT02688387|11266579|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7125246|NCT02688387|11266580|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7125247|NCT02688387|11266581|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7125248|NCT02688387|11266582|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7125249|NCT02688387|11266583|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7125250|NCT02688387|11266584|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7125251|NCT02688387|11266585|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7125252|NCT02688387|11266586|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7125253|NCT02688387|11266587|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7125254|NCT02688387|11266588|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7125255|NCT02688387|11266589|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7125256|NCT02688387|11266590|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7125257|NCT02688387|11266591|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7125258|NCT02688387|11266592|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7125259|NCT02688387|11266593|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7125260|NCT02688387|11266594|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7125261|NCT02688387|11266595|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7125262|NCT02688387|11266596|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7125263|NCT02688387|11266597|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7125264|NCT02688387|11266598|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1
7125265|NCT02688387|11266599|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7125266|NCT02688387|11266600|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7125267|NCT02688621|11266657|FG000|Overall Study|Pregnancy|1
7125268|NCT02688621|11266658|FG001|Overall Study|Pregnancy|3
7125269|NCT02688621|11266657|FG000|Overall Study|Lost to Follow-up|38
7125270|NCT02688621|11266658|FG001|Overall Study|Lost to Follow-up|15
7125271|NCT02688621|11266657|FG000|Overall Study|Withdrawal by Subject|1
7125272|NCT02688621|11266658|FG001|Overall Study|Withdrawal by Subject|0
7125273|NCT02688764|11266669|FG000|Overall Study|Adverse Event|3
7125274|NCT02688764|11266670|FG001|Overall Study|Adverse Event|3
7125275|NCT02688764|11266669|FG000|Overall Study|AE/Kidney transplant|1
7125276|NCT02688764|11266670|FG001|Overall Study|AE/Kidney transplant|0
7125277|NCT02688764|11266669|FG000|Overall Study|AE/Lack of efficacy|1
7125278|NCT02688764|11266670|FG001|Overall Study|AE/Lack of efficacy|0
7125279|NCT02688764|11266669|FG000|Overall Study|AE/Non-compl.|1
7125280|NCT02688764|11266670|FG001|Overall Study|AE/Non-compl.|0
7125281|NCT02688764|11266669|FG000|Overall Study|AE/Non-compl./Withd. parent|0
7125282|NCT02688764|11266670|FG001|Overall Study|AE/Non-compl./Withd. parent|1
7125283|NCT02688764|11266669|FG000|Overall Study|AE/Other|0
7125284|NCT02688764|11266670|FG001|Overall Study|AE/Other|1
7125285|NCT02688764|11266669|FG000|Overall Study|AE/Physician decision|1
7125286|NCT02688764|11266670|FG001|Overall Study|AE/Physician decision|0
7125287|NCT02688764|11266669|FG000|Overall Study|AE/Withd. parent|3
7125288|NCT02688764|11266670|FG001|Overall Study|AE/Withd. parent|0
7125289|NCT02688764|11266669|FG000|Overall Study|AE/Withd. parent/Withd. subject|1
7125290|NCT02688764|11266670|FG001|Overall Study|AE/Withd. parent/Withd. subject|1
7125291|NCT02688764|11266669|FG000|Overall Study|AE/Withd. subject|1
7125292|NCT02688764|11266670|FG001|Overall Study|AE/Withd. subject|0
7125293|NCT02688764|11266669|FG000|Overall Study|Kidney transplant|10
7125294|NCT02688764|11266670|FG001|Overall Study|Kidney transplant|4
7125295|NCT02688764|11266669|FG000|Overall Study|Lack of Efficacy|3
7125296|NCT02688764|11266670|FG001|Overall Study|Lack of Efficacy|2
7125297|NCT02688764|11266669|FG000|Overall Study|Lack of efficacy/Physician decision|0
7125298|NCT02688764|11266670|FG001|Overall Study|Lack of efficacy/Physician decision|1
7125299|NCT02688764|11266669|FG000|Overall Study|Non-compliance with study drug|4
7125300|NCT02688764|11266670|FG001|Overall Study|Non-compliance with study drug|0
7125301|NCT02688764|11266669|FG000|Overall Study|Non-compl./Physician decision|2
7125302|NCT02688764|11266670|FG001|Overall Study|Non-compl./Physician decision|0
7125303|NCT02688764|11266669|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1
7125304|NCT02688764|11266670|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1
7125305|NCT02688764|11266669|FG000|Overall Study|Non-compl./Withd. subject|0
7125306|NCT02688764|11266670|FG001|Overall Study|Non-compl./Withd. subject|2
7125307|NCT02688764|11266669|FG000|Overall Study|Phosphorus level outside safe range|0
7125308|NCT02688764|11266670|FG001|Overall Study|Phosphorus level outside safe range|1
7125309|NCT02688764|11266669|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1
7125310|NCT02688764|11266670|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0
7125311|NCT02688764|11266669|FG000|Overall Study|Study drug taste/Withd. parent|1
7125312|NCT02688764|11266670|FG001|Overall Study|Study drug taste/Withd. parent|0
7125313|NCT02688764|11266669|FG000|Overall Study|Subject moving out|2
7125314|NCT02688764|11266670|FG001|Overall Study|Subject moving out|0
7125315|NCT02688764|11266669|FG000|Overall Study|Subject taken off dialysis|1
7125316|NCT02688764|11266670|FG001|Overall Study|Subject taken off dialysis|0
7125317|NCT02688764|11266669|FG000|Overall Study|Withdrawal by parent|3
7125318|NCT02688764|11266670|FG001|Overall Study|Withdrawal by parent|0
7125319|NCT02689076|11266711|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172
7125320|NCT02689076|11266712|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213
7125321|NCT02689076|11266713|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0
7125322|NCT02689076|11266711|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3
7125323|NCT02689076|11266712|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1
7125324|NCT02689076|11266713|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0
7125325|NCT02689076|11266711|FG000|Overall Study|Did not have an HIE match|2
7125326|NCT02689076|11266712|FG001|Overall Study|Did not have an HIE match|0
7125327|NCT02689076|11266713|FG002|Overall Study|Did not have an HIE match|0
7125328|NCT02689076|11266711|FG000|Overall Study|Death during non-VA encounter|2
7125329|NCT02689076|11266712|FG001|Overall Study|Death during non-VA encounter|5
7125330|NCT02689076|11266713|FG002|Overall Study|Death during non-VA encounter|0
7125331|NCT02689076|11266711|FG000|Overall Study|Provider declined to participate after participant assignment|1
7125332|NCT02689076|11266712|FG001|Overall Study|Provider declined to participate after participant assignment|1
7125333|NCT02689076|11266713|FG002|Overall Study|Provider declined to participate after participant assignment|0
7125334|NCT02689076|11266711|FG000|Overall Study|Participant no longer active in VA system|1
7125335|NCT02689076|11266712|FG001|Overall Study|Participant no longer active in VA system|0
7125336|NCT02689076|11266713|FG002|Overall Study|Participant no longer active in VA system|0
7125337|NCT02689076|11266711|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0
7125338|NCT02689076|11266712|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2
7125339|NCT02689076|11266713|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0
7125340|NCT02689206|11266730|FG000|Overall Study|Adverse Event|0
7125341|NCT02689206|11266731|FG001|Overall Study|Adverse Event|0
7125342|NCT02689206|11266732|FG002|Overall Study|Adverse Event|1
7125343|NCT02689206|11266733|FG003|Overall Study|Adverse Event|0
7125344|NCT02689206|11266734|FG004|Overall Study|Adverse Event|2
7125345|NCT02689206|11266730|FG000|Overall Study|Protocol Violation|1
7125346|NCT02689206|11266731|FG001|Overall Study|Protocol Violation|0
7125347|NCT02689206|11266732|FG002|Overall Study|Protocol Violation|0
7125348|NCT02689206|11266733|FG003|Overall Study|Protocol Violation|1
7125349|NCT02689206|11266734|FG004|Overall Study|Protocol Violation|2
7125350|NCT02689206|11266730|FG000|Overall Study|Other: Reached stopping criteria|0
7125351|NCT02689206|11266731|FG001|Overall Study|Other: Reached stopping criteria|1
7125352|NCT02689206|11266732|FG002|Overall Study|Other: Reached stopping criteria|2
7125353|NCT02689206|11266733|FG003|Overall Study|Other: Reached stopping criteria|3
7125354|NCT02689206|11266734|FG004|Overall Study|Other: Reached stopping criteria|4
7125355|NCT02689206|11266730|FG000|Overall Study|Physician Decision|1
7125356|NCT02689206|11266731|FG001|Overall Study|Physician Decision|0
7125357|NCT02689206|11266732|FG002|Overall Study|Physician Decision|0
7125358|NCT02689206|11266733|FG003|Overall Study|Physician Decision|0
7125359|NCT02689206|11266734|FG004|Overall Study|Physician Decision|0
7125360|NCT02689206|11266730|FG000|Overall Study|Withdrawal by Subject|1
7125361|NCT02689206|11266731|FG001|Overall Study|Withdrawal by Subject|0
7125362|NCT02689206|11266732|FG002|Overall Study|Withdrawal by Subject|1
7125363|NCT02689206|11266733|FG003|Overall Study|Withdrawal by Subject|0
7125364|NCT02689206|11266734|FG004|Overall Study|Withdrawal by Subject|0
7125365|NCT02689219|11266752|FG000|Overall Study|Death|1
7125366|NCT02689219|11266753|FG001|Overall Study|Death|1
7125367|NCT02689219|11266752|FG000|Overall Study|Disease Progression|10
7125368|NCT02689219|11266753|FG001|Overall Study|Disease Progression|6
7125369|NCT02689492|11266759|FG000|Overall Study|Lost to Follow-up|61
7125370|NCT02689492|11266759|FG000|Overall Study|Withdrawal by Subject|11
7125371|NCT02689492|11266759|FG000|Overall Study|Death|9
7125372|NCT02689492|11266759|FG000|Overall Study|Physician Decision|2
7125373|NCT02689492|11266759|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1
7125374|NCT02689492|11266759|FG000|Overall Study|Withdrawal/ Physician's Decision|1
7125375|NCT02689492|11266759|FG000|Overall Study|Other than listed|1
7125376|NCT02689804|11266768|FG000|Overall Study|Withdrawal by Subject|2
7125377|NCT02689804|11266769|FG001|Overall Study|Withdrawal by Subject|0
7125378|NCT02690194|11266829|FG000|Overall Study|Withdrawal by Subject|1
7125379|NCT02690194|11266830|FG001|Overall Study|Withdrawal by Subject|4
7125380|NCT02690194|11266831|FG002|Overall Study|Withdrawal by Subject|0
7125381|NCT02690207|11266839|FG000|Overall Study|Lost to Follow-up|48
7125382|NCT02690207|11266839|FG000|Overall Study|Withdrawal by Subject|46
7125383|NCT02690207|11266839|FG000|Overall Study|Protocol Violation|2
7125384|NCT02690207|11266839|FG000|Overall Study|Serious adverse event|110
7125385|NCT02690207|11266839|FG000|Overall Study|Non-serious Adverse Event|18
7125386|NCT02690207|11266839|FG000|Overall Study|Migrated/moved from study area|5
7125387|NCT02690207|11266839|FG000|Overall Study|Suspected HZ Episode|1
7125388|NCT02690207|11266839|FG000|Overall Study|Other reasons for withdrawal|23
7125389|NCT02690649|11266849|FG000|Overall Study|Withdrawal by Subject|1
7125390|NCT02690649|11266850|FG001|Overall Study|Withdrawal by Subject|1
7125391|NCT02690649|11266849|FG000|Overall Study|Protocol Violation|0
7125392|NCT02690649|11266850|FG001|Overall Study|Protocol Violation|3
7125393|NCT02690701|11266860|FG000|Treatment Period 1|Adverse Event|2
7125394|NCT02690701|11266861|FG001|Treatment Period 1|Adverse Event|2
7125395|NCT02690701|11266860|FG000|Treatment Period 1|Withdrawal by Subject|0
7125396|NCT02690701|11266861|FG001|Treatment Period 1|Withdrawal by Subject|1
7125397|NCT02690701|11266860|FG000|Treatment Period 2|Adverse Event|2
7125398|NCT02690701|11266861|FG001|Treatment Period 2|Adverse Event|0
7125399|NCT02690701|11266860|FG000|Treatment Period 2|Lack of Efficacy|1
7125400|NCT02690701|11266861|FG001|Treatment Period 2|Lack of Efficacy|0
7125401|NCT02690701|11266860|FG000|Treatment Period 2|Lost to Follow-up|0
7125402|NCT02690701|11266861|FG001|Treatment Period 2|Lost to Follow-up|2
7125403|NCT02690701|11266860|FG000|Treatment Period 2|Withdrawal by Subject|0
7125404|NCT02690701|11266861|FG001|Treatment Period 2|Withdrawal by Subject|2
7125405|NCT02690701|11266860|FG000|Treatment Period 2|Protocol Violation|0
7125406|NCT02690701|11266861|FG001|Treatment Period 2|Protocol Violation|1
7125407|NCT02690714|11266868|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1
7125408|NCT02690714|11266868|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1
7125409|NCT02690727|11266876|FG000|Overall Study|Adverse Event|2
7125410|NCT02690727|11266877|FG001|Overall Study|Adverse Event|2
7125411|NCT02690974|11266903|FG000|Overall Study|Adverse Event|16
7125412|NCT02690974|11266903|FG000|Overall Study|Death|9
7125413|NCT02690974|11266903|FG000|Overall Study|Subject/guardian decision|4
7125414|NCT02690974|11266903|FG000|Overall Study|Lost to Follow-up|3
7125415|NCT02690974|11266903|FG000|Overall Study|Withdrawal of Informed Consent|3
7125416|NCT02690974|11266903|FG000|Overall Study|Physician Decision|2
7125417|NCT02690974|11266903|FG000|Overall Study|Non-compliance with study treatment|1
7125418|NCT02690974|11266903|FG000|Overall Study|Protocol-defined stopping criteria|1
7125419|NCT02690974|11266903|FG000|Overall Study|Protocol Deviation|1
7125420|NCT02691247|11266919|FG000|Overall Study|Withdrawal by Subject|1
7125421|NCT02691247|11266920|FG001|Overall Study|Withdrawal by Subject|2
7125422|NCT02691247|11266921|FG002|Overall Study|Withdrawal by Subject|2
7125423|NCT02691247|11266919|FG000|Overall Study|Lost to Follow-up|2
7125424|NCT02691247|11266920|FG001|Overall Study|Lost to Follow-up|0
7125425|NCT02691247|11266921|FG002|Overall Study|Lost to Follow-up|1
7125426|NCT02691455|11266961|FG000|Overall Study|Withdrawal by Subject|1
7125427|NCT02691455|11266962|FG001|Overall Study|Withdrawal by Subject|2
7125428|NCT02691455|11266961|FG000|Overall Study|Lost to Follow-up|15
7125429|NCT02691455|11266962|FG001|Overall Study|Lost to Follow-up|15
7125430|NCT02691468|11266970|FG000|Overall Study|Bronchial blocker use|2
7125431|NCT02691468|11266971|FG001|Overall Study|Bronchial blocker use|1
7125432|NCT02691468|11266970|FG000|Overall Study|Lost to Follow-up|2
7125433|NCT02691468|11266971|FG001|Overall Study|Lost to Follow-up|1
7125434|NCT02691468|11266970|FG000|Overall Study|Failure to advance FOB|2
7125435|NCT02691468|11266971|FG001|Overall Study|Failure to advance FOB|0
7125436|NCT02691494|11266980|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1
7125437|NCT02691494|11266981|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2
7125438|NCT02691494|11266982|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8
7125439|NCT02691494|11266980|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2
7125440|NCT02691494|11266981|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3
7125441|NCT02691494|11266982|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4
7125442|NCT02691494|11266980|FG000|Post-Treatment Follow-Up Period|Other|2
7125443|NCT02691494|11266981|FG001|Post-Treatment Follow-Up Period|Other|1
7125444|NCT02691494|11266982|FG002|Post-Treatment Follow-Up Period|Other|1
7125445|NCT02691494|11266980|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0
7125446|NCT02691494|11266981|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0
7125447|NCT02691494|11266982|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3
7125448|NCT02691494|11266980|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0
7125449|NCT02691494|11266981|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1
7125450|NCT02691494|11266982|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1
7125451|NCT02691507|11266992|FG000|Overall Study|Missed Visit 3|0
7125452|NCT02691507|11266993|FG001|Overall Study|Missed Visit 3|1
7125453|NCT02691572|11267001|FG000|Overall Study|Withdrawal by Subject|1
7125454|NCT02691572|11267002|FG001|Overall Study|Withdrawal by Subject|0
7125455|NCT02691572|11267001|FG000|Overall Study|Protocol Violation|0
7125456|NCT02691572|11267002|FG001|Overall Study|Protocol Violation|1
7125457|NCT02691702|11267019|FG000|Overall Study|Adverse Event|1
7125458|NCT02691702|11267020|FG001|Overall Study|Adverse Event|0
7125459|NCT02691702|11267021|FG002|Overall Study|Adverse Event|0
7125460|NCT02691702|11267022|FG003|Overall Study|Adverse Event|0
7125461|NCT02691702|11267023|FG004|Overall Study|Adverse Event|0
7125462|NCT02691702|11267024|FG005|Overall Study|Adverse Event|0
7125463|NCT02691702|11267025|FG006|Overall Study|Adverse Event|0
7125464|NCT02691702|11267026|FG007|Overall Study|Adverse Event|0
7125465|NCT02691702|11267027|FG008|Overall Study|Adverse Event|1
7125466|NCT02691702|11267028|FG009|Overall Study|Adverse Event|0
7125467|NCT02691702|11267029|FG010|Overall Study|Adverse Event|1
7125468|NCT02691702|11267019|FG000|Overall Study|Lost to Follow-up|0
7125469|NCT02691702|11267020|FG001|Overall Study|Lost to Follow-up|0
7125470|NCT02691702|11267021|FG002|Overall Study|Lost to Follow-up|1
7125471|NCT02691702|11267022|FG003|Overall Study|Lost to Follow-up|0
7125472|NCT02691702|11267023|FG004|Overall Study|Lost to Follow-up|0
7125473|NCT02691702|11267024|FG005|Overall Study|Lost to Follow-up|2
7125474|NCT02691702|11267025|FG006|Overall Study|Lost to Follow-up|0
7125475|NCT02691702|11267026|FG007|Overall Study|Lost to Follow-up|0
7125476|NCT02691702|11267027|FG008|Overall Study|Lost to Follow-up|0
7125477|NCT02691702|11267028|FG009|Overall Study|Lost to Follow-up|0
7125478|NCT02691702|11267029|FG010|Overall Study|Lost to Follow-up|1
7125479|NCT02691702|11267019|FG000|Overall Study|Withdrawal by Subject|1
7125480|NCT02691702|11267020|FG001|Overall Study|Withdrawal by Subject|1
7125481|NCT02691702|11267021|FG002|Overall Study|Withdrawal by Subject|0
7125482|NCT02691702|11267022|FG003|Overall Study|Withdrawal by Subject|0
7125483|NCT02691702|11267023|FG004|Overall Study|Withdrawal by Subject|0
7125484|NCT02691702|11267024|FG005|Overall Study|Withdrawal by Subject|1
7125485|NCT02691702|11267025|FG006|Overall Study|Withdrawal by Subject|2
7125486|NCT02691702|11267026|FG007|Overall Study|Withdrawal by Subject|0
7125487|NCT02691702|11267027|FG008|Overall Study|Withdrawal by Subject|0
7125488|NCT02691702|11267028|FG009|Overall Study|Withdrawal by Subject|0
7125489|NCT02691702|11267029|FG010|Overall Study|Withdrawal by Subject|0
7125490|NCT02691702|11267019|FG000|Overall Study|Other|0
7125491|NCT02691702|11267020|FG001|Overall Study|Other|0
7125492|NCT02691702|11267021|FG002|Overall Study|Other|0
7125493|NCT02691702|11267022|FG003|Overall Study|Other|0
7125494|NCT02691702|11267023|FG004|Overall Study|Other|0
7125495|NCT02691702|11267024|FG005|Overall Study|Other|0
7125496|NCT02691702|11267025|FG006|Overall Study|Other|1
7125497|NCT02691702|11267026|FG007|Overall Study|Other|0
7125498|NCT02691702|11267027|FG008|Overall Study|Other|1
7125499|NCT02691702|11267028|FG009|Overall Study|Other|0
7125500|NCT02691702|11267029|FG010|Overall Study|Other|0
7125501|NCT02691702|11267019|FG000|Overall Study|Protocol Violation|0
7125502|NCT02691702|11267020|FG001|Overall Study|Protocol Violation|0
7125503|NCT02691702|11267021|FG002|Overall Study|Protocol Violation|0
7125504|NCT02691702|11267022|FG003|Overall Study|Protocol Violation|0
7125505|NCT02691702|11267023|FG004|Overall Study|Protocol Violation|0
7125506|NCT02691702|11267024|FG005|Overall Study|Protocol Violation|0
7125507|NCT02691702|11267025|FG006|Overall Study|Protocol Violation|0
7125508|NCT02691702|11267026|FG007|Overall Study|Protocol Violation|0
7125509|NCT02691702|11267027|FG008|Overall Study|Protocol Violation|0
7125510|NCT02691702|11267028|FG009|Overall Study|Protocol Violation|2
7125511|NCT02691702|11267029|FG010|Overall Study|Protocol Violation|0
7125512|NCT02691741|11267063|FG000|Overall Study|Adverse Event|0
7125513|NCT02691741|11267064|FG001|Overall Study|Adverse Event|2
7125514|NCT02691741|11267063|FG000|Overall Study|Lost to Follow-up|1
7125515|NCT02691741|11267064|FG001|Overall Study|Lost to Follow-up|0
7125516|NCT02691741|11267063|FG000|Overall Study|Physician Decision|0
7125517|NCT02691741|11267064|FG001|Overall Study|Physician Decision|1
7125518|NCT02691741|11267063|FG000|Overall Study|Withdrawal by Subject|0
7125519|NCT02691741|11267064|FG001|Overall Study|Withdrawal by Subject|4
7125520|NCT02691936|11267077|FG000|Overall Study|Withdrawal by Subject|2
7125521|NCT02691936|11267078|FG001|Overall Study|Withdrawal by Subject|5
7125522|NCT02692040|11267106|FG000|Overall Study|Protocol Violation|0
7125523|NCT02692040|11267107|FG001|Overall Study|Protocol Violation|0
7125524|NCT02692040|11267108|FG002|Overall Study|Protocol Violation|0
7125525|NCT02692040|11267109|FG003|Overall Study|Protocol Violation|0
7125526|NCT02692040|11267110|FG004|Overall Study|Protocol Violation|0
7125527|NCT02692040|11267111|FG005|Overall Study|Protocol Violation|0
7125528|NCT02692040|11267112|FG006|Overall Study|Protocol Violation|0
7125529|NCT02692040|11267113|FG007|Overall Study|Protocol Violation|0
7125530|NCT02692040|11267114|FG008|Overall Study|Protocol Violation|0
7125531|NCT02692040|11267115|FG009|Overall Study|Protocol Violation|0
7125532|NCT02692040|11267116|FG010|Overall Study|Protocol Violation|0
7125533|NCT02692040|11267117|FG011|Overall Study|Protocol Violation|0
7125534|NCT02692040|11267118|FG012|Overall Study|Protocol Violation|1
7125535|NCT02692040|11267119|FG013|Overall Study|Protocol Violation|0
7125536|NCT02692040|11267120|FG014|Overall Study|Protocol Violation|0
7125537|NCT02692040|11267121|FG015|Overall Study|Protocol Violation|0
7125538|NCT02692040|11267122|FG016|Overall Study|Protocol Violation|0
7125539|NCT02692040|11267106|FG000|Overall Study|Adverse Event|0
7125540|NCT02692040|11267107|FG001|Overall Study|Adverse Event|0
7125541|NCT02692040|11267108|FG002|Overall Study|Adverse Event|0
7125542|NCT02692040|11267109|FG003|Overall Study|Adverse Event|0
7125543|NCT02692040|11267110|FG004|Overall Study|Adverse Event|0
7125544|NCT02692040|11267111|FG005|Overall Study|Adverse Event|0
7125545|NCT02692040|11267112|FG006|Overall Study|Adverse Event|0
7125546|NCT02692040|11267113|FG007|Overall Study|Adverse Event|0
7125547|NCT02692040|11267114|FG008|Overall Study|Adverse Event|0
7125548|NCT02692040|11267115|FG009|Overall Study|Adverse Event|0
7125549|NCT02692040|11267116|FG010|Overall Study|Adverse Event|0
7125550|NCT02692040|11267117|FG011|Overall Study|Adverse Event|0
7125551|NCT02692040|11267118|FG012|Overall Study|Adverse Event|0
7125552|NCT02692040|11267119|FG013|Overall Study|Adverse Event|3
7125553|NCT02692040|11267120|FG014|Overall Study|Adverse Event|1
7125554|NCT02692040|11267121|FG015|Overall Study|Adverse Event|1
7125555|NCT02692040|11267122|FG016|Overall Study|Adverse Event|0
7125556|NCT02692235|11267207|FG000|Overall Study|Withdrawal by Subject|2
7125557|NCT02692235|11267208|FG001|Overall Study|Withdrawal by Subject|1
7125558|NCT02692235|11267207|FG000|Overall Study|Adverse Event|1
7125559|NCT02692235|11267208|FG001|Overall Study|Adverse Event|2
7125560|NCT02692417|11267225|FG000|Overall Study|Withdrawal by Subject|5
7125561|NCT02692417|11267226|FG001|Overall Study|Withdrawal by Subject|1
7125562|NCT02692417|11267225|FG000|Overall Study|Adverse Event|1
7125563|NCT02692417|11267226|FG001|Overall Study|Adverse Event|0
7125564|NCT02692482|11267234|FG000|Overall Study|Death|2
7125565|NCT02692482|11267235|FG001|Overall Study|Death|2
7125566|NCT02692482|11267234|FG000|Overall Study|Withdrawal by Subject|1
7125567|NCT02692482|11267235|FG001|Overall Study|Withdrawal by Subject|2
7125568|NCT02692560|11267257|FG000|Overall Study|Withdrawal by Subject|0
7125569|NCT02692560|11267258|FG001|Overall Study|Withdrawal by Subject|6
7125570|NCT02692586|11267264|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1
7125571|NCT02692586|11267264|FG000|Overall Study|Received adjunctive thrombolytics|2
7125572|NCT02692703|11267268|FG000|Overall Study|Lost to Follow-up|1
7125573|NCT02692703|11267268|FG000|Overall Study|Other|1
7125574|NCT02692716|11267274|FG000|Overall Study|Lost to Follow-up|2
7125575|NCT02692716|11267275|FG001|Overall Study|Lost to Follow-up|5
7125576|NCT02692716|11267274|FG000|Overall Study|Withdrawal by Subject|3
7125577|NCT02692716|11267275|FG001|Overall Study|Withdrawal by Subject|1
7125578|NCT02693106|11267295|FG000|Overall Study|No time|3
7125579|NCT02693119|11267307|FG000|Open-Label Period|Withdrawal by Subject|0
7125580|NCT02693119|11267308|FG001|Open-Label Period|Withdrawal by Subject|1
7125581|NCT02693418|11267369|FG000|Overall Study|Lost to Follow-up|1
7125582|NCT02693418|11267370|FG001|Overall Study|Lost to Follow-up|2
7125583|NCT02693418|11267371|FG002|Overall Study|Lost to Follow-up|0
7125584|NCT02693418|11267372|FG003|Overall Study|Lost to Follow-up|0
7125585|NCT02693418|11267373|FG004|Overall Study|Lost to Follow-up|0
7125586|NCT02693418|11267369|FG000|Overall Study|Menses during study period|0
7125587|NCT02693418|11267370|FG001|Overall Study|Menses during study period|0
7125588|NCT02693418|11267371|FG002|Overall Study|Menses during study period|2
7125589|NCT02693418|11267372|FG003|Overall Study|Menses during study period|0
7125590|NCT02693418|11267373|FG004|Overall Study|Menses during study period|0
7125591|NCT02693834|11267402|FG000|Baseline Measurement|Withdrawal by Subject|1
7125592|NCT02693834|11267403|FG001|Baseline Measurement|Withdrawal by Subject|0
7125593|NCT02693834|11267402|FG000|Baseline Measurement|Adverse Event|1
7125594|NCT02693834|11267403|FG001|Baseline Measurement|Adverse Event|0
7125595|NCT02693834|11267402|FG000|Week 2 Practice|Adverse Event|0
7125596|NCT02693834|11267403|FG001|Week 2 Practice|Adverse Event|1
7125597|NCT02694328|11267432|FG000|Overall Study|Adverse Event|27
7125598|NCT02694328|11267433|FG001|Overall Study|Adverse Event|33
7125599|NCT02694328|11267432|FG000|Overall Study|Withdrawal by Subject|27
7125600|NCT02694328|11267433|FG001|Overall Study|Withdrawal by Subject|23
7125601|NCT02694328|11267432|FG000|Overall Study|Lost to Follow-up|26
7125602|NCT02694328|11267433|FG001|Overall Study|Lost to Follow-up|22
7125603|NCT02694328|11267432|FG000|Overall Study|Noncompliant with study drug|11
7125604|NCT02694328|11267433|FG001|Overall Study|Noncompliant with study drug|8
7125605|NCT02694328|11267432|FG000|Overall Study|Incarceration|1
7125606|NCT02694328|11267433|FG001|Overall Study|Incarceration|1
7125607|NCT02694328|11267432|FG000|Overall Study|Lack of Efficacy|1
7125608|NCT02694328|11267433|FG001|Overall Study|Lack of Efficacy|2
7125609|NCT02694328|11267432|FG000|Overall Study|Pregnancy|1
7125610|NCT02694328|11267433|FG001|Overall Study|Pregnancy|1
7125611|NCT02694328|11267432|FG000|Overall Study|Protocol Violation|6
7125612|NCT02694328|11267433|FG001|Overall Study|Protocol Violation|5
7125613|NCT02694328|11267432|FG000|Overall Study|Abnormal Laboratory Value|0
7125614|NCT02694328|11267433|FG001|Overall Study|Abnormal Laboratory Value|3
7125615|NCT02694523|11267445|FG000|Part A|Adverse Event|7
7125616|NCT02694523|11267446|FG001|Part A|Adverse Event|3
7125617|NCT02694523|11267447|FG002|Part A|Adverse Event|0
7125618|NCT02694523|11267448|FG003|Part A|Adverse Event|0
7125619|NCT02694523|11267449|FG004|Part A|Adverse Event|0
7125620|NCT02694523|11267450|FG005|Part A|Adverse Event|0
7125621|NCT02694523|11267451|FG006|Part A|Adverse Event|0
7125622|NCT02694523|11267445|FG000|Part A|Protocol Violation|1
7125623|NCT02694523|11267446|FG001|Part A|Protocol Violation|0
7125624|NCT02694523|11267447|FG002|Part A|Protocol Violation|0
7125625|NCT02694523|11267448|FG003|Part A|Protocol Violation|0
7125626|NCT02694523|11267449|FG004|Part A|Protocol Violation|0
7125627|NCT02694523|11267450|FG005|Part A|Protocol Violation|0
7125628|NCT02694523|11267451|FG006|Part A|Protocol Violation|0
7125629|NCT02694523|11267445|FG000|Part A|Lost to Follow-up|1
7125630|NCT02694523|11267446|FG001|Part A|Lost to Follow-up|2
7125631|NCT02694523|11267447|FG002|Part A|Lost to Follow-up|0
7125632|NCT02694523|11267448|FG003|Part A|Lost to Follow-up|0
7125633|NCT02694523|11267449|FG004|Part A|Lost to Follow-up|0
7125634|NCT02694523|11267450|FG005|Part A|Lost to Follow-up|0
7125635|NCT02694523|11267451|FG006|Part A|Lost to Follow-up|0
7125636|NCT02694523|11267445|FG000|Part A|Withdrawal by Subject|3
7125637|NCT02694523|11267446|FG001|Part A|Withdrawal by Subject|1
7125638|NCT02694523|11267447|FG002|Part A|Withdrawal by Subject|0
7125639|NCT02694523|11267448|FG003|Part A|Withdrawal by Subject|0
7125640|NCT02694523|11267449|FG004|Part A|Withdrawal by Subject|0
7125641|NCT02694523|11267450|FG005|Part A|Withdrawal by Subject|0
7125642|NCT02694523|11267451|FG006|Part A|Withdrawal by Subject|0
7125643|NCT02694523|11267445|FG000|Part A|Other|1
7125644|NCT02694523|11267446|FG001|Part A|Other|1
7125645|NCT02694523|11267447|FG002|Part A|Other|0
7125646|NCT02694523|11267448|FG003|Part A|Other|0
7125647|NCT02694523|11267449|FG004|Part A|Other|0
7125648|NCT02694523|11267450|FG005|Part A|Other|0
7125649|NCT02694523|11267451|FG006|Part A|Other|0
7125650|NCT02694523|11267445|FG000|Part B|Adverse Event|0
7125651|NCT02694523|11267446|FG001|Part B|Adverse Event|0
7125652|NCT02694523|11267447|FG002|Part B|Adverse Event|7
7125653|NCT02694523|11267448|FG003|Part B|Adverse Event|1
7125654|NCT02694523|11267449|FG004|Part B|Adverse Event|1
7125655|NCT02694523|11267450|FG005|Part B|Adverse Event|2
7125656|NCT02694523|11267451|FG006|Part B|Adverse Event|0
7125657|NCT02694523|11267445|FG000|Part B|Protocol Violation|0
7125658|NCT02694523|11267446|FG001|Part B|Protocol Violation|0
7125659|NCT02694523|11267447|FG002|Part B|Protocol Violation|1
7125660|NCT02694523|11267448|FG003|Part B|Protocol Violation|0
7125661|NCT02694523|11267449|FG004|Part B|Protocol Violation|0
7125662|NCT02694523|11267450|FG005|Part B|Protocol Violation|0
7125663|NCT02694523|11267451|FG006|Part B|Protocol Violation|0
7125664|NCT02694523|11267445|FG000|Part B|Lost to Follow-up|0
7125665|NCT02694523|11267446|FG001|Part B|Lost to Follow-up|0
7125666|NCT02694523|11267447|FG002|Part B|Lost to Follow-up|2
7125667|NCT02694523|11267448|FG003|Part B|Lost to Follow-up|3
7125668|NCT02694523|11267449|FG004|Part B|Lost to Follow-up|2
7125669|NCT02694523|11267450|FG005|Part B|Lost to Follow-up|0
7125670|NCT02694523|11267451|FG006|Part B|Lost to Follow-up|1
7125671|NCT02694523|11267445|FG000|Part B|Withdrawal by Subject|0
7125672|NCT02694523|11267446|FG001|Part B|Withdrawal by Subject|0
7125673|NCT02694523|11267447|FG002|Part B|Withdrawal by Subject|9
7125674|NCT02694523|11267448|FG003|Part B|Withdrawal by Subject|0
7125675|NCT02694523|11267449|FG004|Part B|Withdrawal by Subject|1
7125676|NCT02694523|11267450|FG005|Part B|Withdrawal by Subject|3
7125677|NCT02694523|11267451|FG006|Part B|Withdrawal by Subject|0
7125678|NCT02694523|11267445|FG000|Part B|Other|0
7125679|NCT02694523|11267446|FG001|Part B|Other|0
7125680|NCT02694523|11267447|FG002|Part B|Other|1
7125681|NCT02694523|11267448|FG003|Part B|Other|0
7125682|NCT02694523|11267449|FG004|Part B|Other|0
7125683|NCT02694523|11267450|FG005|Part B|Other|0
7125684|NCT02694523|11267451|FG006|Part B|Other|1
7125685|NCT02694536|11267463|FG000|Overall Study|Progressive Disease|40
7125686|NCT02694536|11267463|FG000|Overall Study|Lost to Follow-up|1
7125687|NCT02694536|11267463|FG000|Overall Study|Study Drug-Related Adverse Event|1
7125688|NCT02694536|11267463|FG000|Overall Study|Withdrawal by Subject|8
7125689|NCT02694536|11267463|FG000|Overall Study|Death|8
7125690|NCT02694536|11267463|FG000|Overall Study|Other|22
7125691|NCT02694549|11267467|FG000|Overall Study|screen failures|2
7125692|NCT02694562|11267471|FG000|Overall Study|Death|8
7125693|NCT02694562|11267471|FG000|Overall Study|Protocol Violation|4
7125694|NCT02694562|11267471|FG000|Overall Study|Lost to Follow-up|3
7125695|NCT02694562|11267471|FG000|Overall Study|Screen Failure|2
7125696|NCT02694562|11267471|FG000|Overall Study|Physician Decision|1
7125697|NCT02694718|11267479|FG000|Overall Study|Death|1
7125698|NCT02694718|11267479|FG000|Overall Study|Withdrawal by Subject|1
7125699|NCT02694744|11267485|FG000|Overall Study|Adverse Event|2
7125700|NCT02694744|11267486|FG001|Overall Study|Adverse Event|1
7125701|NCT02694744|11267485|FG000|Overall Study|Withdrawal by Subject|2
7125702|NCT02694744|11267486|FG001|Overall Study|Withdrawal by Subject|1
7125703|NCT02694744|11267485|FG000|Overall Study|Physician Decision|1
7125704|NCT02694744|11267486|FG001|Overall Study|Physician Decision|2
7125705|NCT02694744|11267485|FG000|Overall Study|Lost to Follow-up|1
7125706|NCT02694744|11267486|FG001|Overall Study|Lost to Follow-up|0
7125707|NCT02694744|11267485|FG000|Overall Study|Taking potassium supplement: exclusion 6|0
7125708|NCT02694744|11267486|FG001|Overall Study|Taking potassium supplement: exclusion 6|1
7125709|NCT02694978|11267505|FG000|Overall Study|Adverse Event|10
7125710|NCT02694978|11267506|FG001|Overall Study|Adverse Event|9
7125711|NCT02694978|11267505|FG000|Overall Study|Withdrawal by Subject|22
7125712|NCT02694978|11267506|FG001|Overall Study|Withdrawal by Subject|19
7125713|NCT02694978|11267505|FG000|Overall Study|Lost to Follow-up|14
7125714|NCT02694978|11267506|FG001|Overall Study|Lost to Follow-up|17
7125715|NCT02694978|11267505|FG000|Overall Study|Death|4
7125716|NCT02694978|11267506|FG001|Overall Study|Death|1
7125717|NCT02694978|11267505|FG000|Overall Study|Other-Decision of Participant|6
7125718|NCT02694978|11267506|FG001|Overall Study|Other-Decision of Participant|1
7125719|NCT02694978|11267505|FG000|Overall Study|Other-Investigator's decision|1
7125720|NCT02694978|11267506|FG001|Overall Study|Other-Investigator's decision|0
7125721|NCT02694978|11267505|FG000|Overall Study|Other-Unable to be reached|0
7125722|NCT02694978|11267506|FG001|Overall Study|Other-Unable to be reached|1
7125723|NCT02694978|11267505|FG000|Overall Study|Other-Protocol noncompliant|2
7125724|NCT02694978|11267506|FG001|Overall Study|Other-Protocol noncompliant|1
7125725|NCT02694978|11267505|FG000|Overall Study|Other-Personal reasons|3
7125726|NCT02694978|11267506|FG001|Overall Study|Other-Personal reasons|3
7125727|NCT02694978|11267505|FG000|Overall Study|Other-Withdrew prior to dosing|9
7125728|NCT02694978|11267506|FG001|Overall Study|Other-Withdrew prior to dosing|8
7125729|NCT02695329|11267518|FG000|Overall Study|Adverse Event|1
7125730|NCT02695329|11267519|FG001|Overall Study|Adverse Event|0
7125731|NCT02695329|11267518|FG000|Overall Study|Poor X-ray quality for measurement|4
7125732|NCT02695329|11267519|FG001|Overall Study|Poor X-ray quality for measurement|5
7125733|NCT02695420|11267529|FG000|Overall Study|Death|0
7125734|NCT02695420|11267530|FG001|Overall Study|Death|1
7125735|NCT02695420|11267531|FG002|Overall Study|Death|0
7125736|NCT02695420|11267532|FG003|Overall Study|Death|0
7125737|NCT02695524|11267551|FG000|Overall Study|Lost to Follow-up|3
7125738|NCT02695524|11267552|FG001|Overall Study|Lost to Follow-up|2
7125739|NCT02695524|11267551|FG000|Overall Study|Death|0
7125740|NCT02695524|11267552|FG001|Overall Study|Death|1
7125741|NCT02695537|11267558|FG000|Overall Study|Adverse Event|3
7125742|NCT02695537|11267558|FG000|Overall Study|Lack of Efficacy|28
7125743|NCT02695537|11267558|FG000|Overall Study|Withdrawal by Subject|4
7125744|NCT02695537|11267558|FG000|Overall Study|Protocol Violation|3
7125745|NCT02695628|11267562|FG000|Overall Study|Withdrawal by Subject|1
7125746|NCT02695719|11267568|FG000|Overall Study|Pretreatment Event/Adverse Event|2
7125747|NCT02695719|11267569|FG001|Overall Study|Pretreatment Event/Adverse Event|9
7125748|NCT02695719|11267568|FG000|Overall Study|Significant Protocol Deviation|0
7125749|NCT02695719|11267569|FG001|Overall Study|Significant Protocol Deviation|1
7125750|NCT02695719|11267568|FG000|Overall Study|Voluntary Withdrawal|1
7125751|NCT02695719|11267569|FG001|Overall Study|Voluntary Withdrawal|0
7125752|NCT02696317|11267611|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2
7125753|NCT02696317|11267612|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4
7125754|NCT02696317|11267611|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1
7125755|NCT02696317|11267612|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0
7125756|NCT02696434|11267622|FG000|Overall Study|Adverse Event|3
7125757|NCT02696434|11267623|FG001|Overall Study|Adverse Event|1
7125758|NCT02696434|11267622|FG000|Overall Study|Lost to Follow-up|5
7125759|NCT02696434|11267623|FG001|Overall Study|Lost to Follow-up|4
7125760|NCT02696434|11267622|FG000|Overall Study|Withdrawal by Subject|14
7125761|NCT02696434|11267623|FG001|Overall Study|Withdrawal by Subject|12
7125762|NCT02696434|11267622|FG000|Overall Study|Physician Decision|0
7125763|NCT02696434|11267623|FG001|Overall Study|Physician Decision|1
7125764|NCT02696785|11267633|FG000|Blinded Treatment Period|Adverse Event|0
7125765|NCT02696785|11267634|FG001|Blinded Treatment Period|Adverse Event|1
7125766|NCT02696785|11267635|FG002|Blinded Treatment Period|Adverse Event|3
7125767|NCT02696785|11267636|FG003|Blinded Treatment Period|Adverse Event|0
7125768|NCT02696785|11267633|FG000|Blinded Treatment Period|Withdrawal by Subject|0
7125769|NCT02696785|11267634|FG001|Blinded Treatment Period|Withdrawal by Subject|1
7125770|NCT02696785|11267635|FG002|Blinded Treatment Period|Withdrawal by Subject|1
7125771|NCT02696785|11267636|FG003|Blinded Treatment Period|Withdrawal by Subject|2
7125772|NCT02696785|11267633|FG000|Blinded Treatment Period|Lack of Efficacy|0
7125773|NCT02696785|11267634|FG001|Blinded Treatment Period|Lack of Efficacy|0
7125774|NCT02696785|11267635|FG002|Blinded Treatment Period|Lack of Efficacy|0
7125775|NCT02696785|11267636|FG003|Blinded Treatment Period|Lack of Efficacy|1
7125776|NCT02696785|11267633|FG000|Blinded Treatment Period|Screen Failure|1
7125777|NCT02696785|11267634|FG001|Blinded Treatment Period|Screen Failure|0
7125778|NCT02696785|11267635|FG002|Blinded Treatment Period|Screen Failure|0
7125779|NCT02696785|11267636|FG003|Blinded Treatment Period|Screen Failure|0
7125780|NCT02696785|11267633|FG000|Washout Period|Withdrawal by Subject|0
7125781|NCT02696785|11267634|FG001|Washout Period|Withdrawal by Subject|1
7125782|NCT02696785|11267635|FG002|Washout Period|Withdrawal by Subject|0
7125783|NCT02696785|11267636|FG003|Washout Period|Withdrawal by Subject|0
7125784|NCT02696785|11267633|FG000|Washout Period|Lack of Efficacy|0
7125785|NCT02696785|11267634|FG001|Washout Period|Lack of Efficacy|1
7125786|NCT02696785|11267635|FG002|Washout Period|Lack of Efficacy|0
7125787|NCT02696785|11267636|FG003|Washout Period|Lack of Efficacy|0
7125788|NCT02696785|11267633|FG000|Extended Treatment Period|Adverse Event|2
7125789|NCT02696785|11267634|FG001|Extended Treatment Period|Adverse Event|3
7125790|NCT02696785|11267635|FG002|Extended Treatment Period|Adverse Event|2
7125791|NCT02696785|11267636|FG003|Extended Treatment Period|Adverse Event|1
7125792|NCT02696785|11267633|FG000|Extended Treatment Period|Lack of Efficacy|0
7125793|NCT02696785|11267634|FG001|Extended Treatment Period|Lack of Efficacy|1
7125794|NCT02696785|11267635|FG002|Extended Treatment Period|Lack of Efficacy|0
7125795|NCT02696785|11267636|FG003|Extended Treatment Period|Lack of Efficacy|0
7125796|NCT02696785|11267633|FG000|Extended Treatment Period|Withdrawal by Subject|1
7125797|NCT02696785|11267634|FG001|Extended Treatment Period|Withdrawal by Subject|2
7125798|NCT02696785|11267635|FG002|Extended Treatment Period|Withdrawal by Subject|3
7125799|NCT02696785|11267636|FG003|Extended Treatment Period|Withdrawal by Subject|5
7125800|NCT02696785|11267633|FG000|Follow-up Period|Adverse Event|0
7125801|NCT02696785|11267634|FG001|Follow-up Period|Adverse Event|0
7125802|NCT02696785|11267635|FG002|Follow-up Period|Adverse Event|8
7125803|NCT02696785|11267636|FG003|Follow-up Period|Adverse Event|2
7125804|NCT02696785|11267633|FG000|Follow-up Period|Lost to Follow-up|0
7125805|NCT02696785|11267634|FG001|Follow-up Period|Lost to Follow-up|0
7125806|NCT02696785|11267635|FG002|Follow-up Period|Lost to Follow-up|0
7125807|NCT02696785|11267636|FG003|Follow-up Period|Lost to Follow-up|1
7125808|NCT02696785|11267633|FG000|Follow-up Period|Lack of Efficacy|0
7125809|NCT02696785|11267634|FG001|Follow-up Period|Lack of Efficacy|0
7125810|NCT02696785|11267635|FG002|Follow-up Period|Lack of Efficacy|0
7125811|NCT02696785|11267636|FG003|Follow-up Period|Lack of Efficacy|1
7125812|NCT02696785|11267633|FG000|Follow-up Period|Withdrawal by Subject|1
7125813|NCT02696785|11267634|FG001|Follow-up Period|Withdrawal by Subject|0
7125814|NCT02696785|11267635|FG002|Follow-up Period|Withdrawal by Subject|5
7125815|NCT02696785|11267636|FG003|Follow-up Period|Withdrawal by Subject|4
7125816|NCT02696798|11267667|FG000|Blinded Treatment Dosing Period|Adverse Event|2
7125817|NCT02696798|11267668|FG001|Blinded Treatment Dosing Period|Adverse Event|9
7125818|NCT02696798|11267669|FG002|Blinded Treatment Dosing Period|Adverse Event|2
7125819|NCT02696798|11267667|FG000|Blinded Treatment Dosing Period|Death|0
7125820|NCT02696798|11267668|FG001|Blinded Treatment Dosing Period|Death|0
7125821|NCT02696798|11267669|FG002|Blinded Treatment Dosing Period|Death|1
7125822|NCT02696798|11267667|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2
7125823|NCT02696798|11267668|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1
7125824|NCT02696798|11267669|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1
7125825|NCT02696798|11267667|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0
7125826|NCT02696798|11267668|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1
7125827|NCT02696798|11267669|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0
7125828|NCT02696798|11267667|FG000|Blinded Treatment Dosing Period|Physician Decision|0
7125829|NCT02696798|11267668|FG001|Blinded Treatment Dosing Period|Physician Decision|1
7125830|NCT02696798|11267669|FG002|Blinded Treatment Dosing Period|Physician Decision|0
7125831|NCT02696798|11267667|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7
7125832|NCT02696798|11267668|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3
7125833|NCT02696798|11267669|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4
7125834|NCT02696798|11267667|FG000|Extended Treatment Period|Adverse Event|1
7125835|NCT02696798|11267668|FG001|Extended Treatment Period|Adverse Event|4
7125836|NCT02696798|11267669|FG002|Extended Treatment Period|Adverse Event|5
7125837|NCT02696798|11267667|FG000|Extended Treatment Period|Lack of Efficacy|7
7125838|NCT02696798|11267668|FG001|Extended Treatment Period|Lack of Efficacy|2
7125839|NCT02696798|11267669|FG002|Extended Treatment Period|Lack of Efficacy|2
7125840|NCT02696798|11267667|FG000|Extended Treatment Period|Lost to Follow-up|1
7125841|NCT02696798|11267668|FG001|Extended Treatment Period|Lost to Follow-up|0
7125842|NCT02696798|11267669|FG002|Extended Treatment Period|Lost to Follow-up|0
7125843|NCT02696798|11267667|FG000|Extended Treatment Period|Physician Decision|0
7125844|NCT02696798|11267668|FG001|Extended Treatment Period|Physician Decision|1
7125845|NCT02696798|11267669|FG002|Extended Treatment Period|Physician Decision|0
7125846|NCT02696798|11267667|FG000|Extended Treatment Period|Withdrawal by Subject|3
7125847|NCT02696798|11267668|FG001|Extended Treatment Period|Withdrawal by Subject|2
7125848|NCT02696798|11267669|FG002|Extended Treatment Period|Withdrawal by Subject|3
7125849|NCT02696798|11267667|FG000|Post-treatment Follow-up Period|Adverse Event|2
7125850|NCT02696798|11267668|FG001|Post-treatment Follow-up Period|Adverse Event|12
7125851|NCT02696798|11267669|FG002|Post-treatment Follow-up Period|Adverse Event|6
7125852|NCT02696798|11267667|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0
7125853|NCT02696798|11267668|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1
7125854|NCT02696798|11267669|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1
7125855|NCT02696798|11267667|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1
7125856|NCT02696798|11267668|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2
7125857|NCT02696798|11267669|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0
7125858|NCT02696798|11267667|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2
7125859|NCT02696798|11267668|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8
7125860|NCT02696798|11267669|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12
7125861|NCT02696798|11267667|FG000|Post-treatment Follow-up Period|Physician Decision|0
7125862|NCT02696798|11267668|FG001|Post-treatment Follow-up Period|Physician Decision|2
7125863|NCT02696798|11267669|FG002|Post-treatment Follow-up Period|Physician Decision|0
7125864|NCT02696798|11267667|FG000|Post-treatment Follow-up Period|No progressive improvement|0
7125865|NCT02696798|11267668|FG001|Post-treatment Follow-up Period|No progressive improvement|1
7125866|NCT02696798|11267669|FG002|Post-treatment Follow-up Period|No progressive improvement|0
7125867|NCT02696850|11267693|FG000|Overall Study|Withdrawal by Subject|3
7125868|NCT02696850|11267694|FG001|Overall Study|Withdrawal by Subject|3
7125869|NCT02696850|11267693|FG000|Overall Study|Lost to Follow-up|8
7125870|NCT02696850|11267694|FG001|Overall Study|Lost to Follow-up|5
7125871|NCT02696902|11267703|FG000|Overall Study|Lost to Follow-up|0
7125872|NCT02696902|11267704|FG001|Overall Study|Lost to Follow-up|1
7125873|NCT02696902|11267705|FG002|Overall Study|Lost to Follow-up|1
7125874|NCT02696902|11267703|FG000|Overall Study|Withdrawal by Subject|0
7125875|NCT02696902|11267704|FG001|Overall Study|Withdrawal by Subject|0
7125876|NCT02696902|11267705|FG002|Overall Study|Withdrawal by Subject|1
7125877|NCT02696902|11267703|FG000|Overall Study|Death|19
7125878|NCT02696902|11267704|FG001|Overall Study|Death|3
7125879|NCT02696902|11267705|FG002|Overall Study|Death|24
7125880|NCT02696902|11267703|FG000|Overall Study|Participant not fit post-randomization|0
7125881|NCT02696902|11267704|FG001|Overall Study|Participant not fit post-randomization|0
7125882|NCT02696902|11267705|FG002|Overall Study|Participant not fit post-randomization|1
7125883|NCT02696902|11267703|FG000|Overall Study|Participant not eligible (negative PCR)|0
7125884|NCT02696902|11267704|FG001|Overall Study|Participant not eligible (negative PCR)|0
7125885|NCT02696902|11267705|FG002|Overall Study|Participant not eligible (negative PCR)|1
7125886|NCT02696902|11267703|FG000|Overall Study|Principal investigator's decision|1
7125887|NCT02696902|11267704|FG001|Overall Study|Principal investigator's decision|0
7125888|NCT02696902|11267705|FG002|Overall Study|Principal investigator's decision|0
7125889|NCT02696902|11267703|FG000|Overall Study|Sponsor's decision|1
7125890|NCT02696902|11267704|FG001|Overall Study|Sponsor's decision|0
7125891|NCT02696902|11267705|FG002|Overall Study|Sponsor's decision|0
7125892|NCT02696902|11267703|FG000|Overall Study|Transferred to other hospital|1
7125893|NCT02696902|11267704|FG001|Overall Study|Transferred to other hospital|0
7125894|NCT02696902|11267705|FG002|Overall Study|Transferred to other hospital|0
7125895|NCT02697435|11267784|FG000|Overall Study|Withdrawal by Subject|1
7125896|NCT02697435|11267785|FG001|Overall Study|Withdrawal by Subject|0
7125897|NCT02697435|11267784|FG000|Overall Study|Physician Decision|0
7125898|NCT02697435|11267785|FG001|Overall Study|Physician Decision|4
7125899|NCT02697591|11267802|FG000|Overall Study|Lost to Follow-up|0
7125900|NCT02697591|11267803|FG001|Overall Study|Lost to Follow-up|0
7125901|NCT02697591|11267804|FG002|Overall Study|Lost to Follow-up|0
7125902|NCT02697591|11267805|FG003|Overall Study|Lost to Follow-up|0
7125903|NCT02697591|11267806|FG004|Overall Study|Lost to Follow-up|0
7125904|NCT02697591|11267807|FG005|Overall Study|Lost to Follow-up|1
7125905|NCT02697591|11267808|FG006|Overall Study|Lost to Follow-up|1
7125906|NCT02697591|11267809|FG007|Overall Study|Lost to Follow-up|0
7125907|NCT02697591|11267810|FG008|Overall Study|Lost to Follow-up|0
7125908|NCT02697591|11267811|FG009|Overall Study|Lost to Follow-up|1
7125909|NCT02697591|11267802|FG000|Overall Study|Withdrawal by Subject|1
7125910|NCT02697591|11267803|FG001|Overall Study|Withdrawal by Subject|1
7125911|NCT02697591|11267804|FG002|Overall Study|Withdrawal by Subject|2
7125912|NCT02697591|11267805|FG003|Overall Study|Withdrawal by Subject|1
7125913|NCT02697591|11267806|FG004|Overall Study|Withdrawal by Subject|7
7125914|NCT02697591|11267807|FG005|Overall Study|Withdrawal by Subject|6
7125915|NCT02697591|11267808|FG006|Overall Study|Withdrawal by Subject|9
7125916|NCT02697591|11267809|FG007|Overall Study|Withdrawal by Subject|1
7125917|NCT02697591|11267810|FG008|Overall Study|Withdrawal by Subject|6
7125918|NCT02697591|11267811|FG009|Overall Study|Withdrawal by Subject|10
7125919|NCT02697591|11267802|FG000|Overall Study|Physician Decision|1
7125920|NCT02697591|11267803|FG001|Overall Study|Physician Decision|0
7125921|NCT02697591|11267804|FG002|Overall Study|Physician Decision|0
7125922|NCT02697591|11267805|FG003|Overall Study|Physician Decision|0
7125923|NCT02697591|11267806|FG004|Overall Study|Physician Decision|1
7125924|NCT02697591|11267807|FG005|Overall Study|Physician Decision|2
7125925|NCT02697591|11267808|FG006|Overall Study|Physician Decision|0
7125926|NCT02697591|11267809|FG007|Overall Study|Physician Decision|0
7125927|NCT02697591|11267810|FG008|Overall Study|Physician Decision|1
7125928|NCT02697591|11267811|FG009|Overall Study|Physician Decision|1
7125929|NCT02697591|11267802|FG000|Overall Study|Death|2
7125930|NCT02697591|11267803|FG001|Overall Study|Death|3
7125931|NCT02697591|11267804|FG002|Overall Study|Death|1
7125932|NCT02697591|11267805|FG003|Overall Study|Death|1
7125933|NCT02697591|11267806|FG004|Overall Study|Death|4
7125934|NCT02697591|11267807|FG005|Overall Study|Death|5
7125935|NCT02697591|11267808|FG006|Overall Study|Death|3
7125936|NCT02697591|11267809|FG007|Overall Study|Death|1
7125937|NCT02697591|11267810|FG008|Overall Study|Death|1
7125938|NCT02697591|11267811|FG009|Overall Study|Death|5
7125939|NCT02697591|11267802|FG000|Overall Study|Reason not Specified|0
7125940|NCT02697591|11267803|FG001|Overall Study|Reason not Specified|0
7125941|NCT02697591|11267804|FG002|Overall Study|Reason not Specified|0
7125942|NCT02697591|11267805|FG003|Overall Study|Reason not Specified|1
7125943|NCT02697591|11267806|FG004|Overall Study|Reason not Specified|1
7125944|NCT02697591|11267807|FG005|Overall Study|Reason not Specified|2
7125945|NCT02697591|11267808|FG006|Overall Study|Reason not Specified|3
7125946|NCT02697591|11267809|FG007|Overall Study|Reason not Specified|1
7125947|NCT02697591|11267810|FG008|Overall Study|Reason not Specified|1
7125948|NCT02697591|11267811|FG009|Overall Study|Reason not Specified|3
7125949|NCT02697617|11267834|FG000|Overall Study|Withdrawal by Subject|0
7125950|NCT02697617|11267835|FG001|Overall Study|Withdrawal by Subject|2
7125951|NCT02697617|11267834|FG000|Overall Study|Pregnancy|1
7125952|NCT02697617|11267835|FG001|Overall Study|Pregnancy|0
7125953|NCT02697734|11267847|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4
7125954|NCT02697734|11267848|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0
7125955|NCT02697734|11267847|FG000|Core Phase - up to Week 48|Adverse Event|1
7125956|NCT02697734|11267848|FG001|Core Phase - up to Week 48|Adverse Event|2
7125957|NCT02697734|11267847|FG000|Core Phase - up to Week 48|Physician Decision|1
7125958|NCT02697734|11267848|FG001|Core Phase - up to Week 48|Physician Decision|0
7125959|NCT02697734|11267847|FG000|Optional Extension Phase|Adverse Event|5
7125960|NCT02697734|11267848|FG001|Optional Extension Phase|Adverse Event|1
7125961|NCT02697734|11267847|FG000|Optional Extension Phase|Physician Decision|0
7125962|NCT02697734|11267848|FG001|Optional Extension Phase|Physician Decision|1
7125963|NCT02697773|11267865|FG000|Overall Study|Adverse Event|2
7125964|NCT02697773|11267866|FG001|Overall Study|Adverse Event|1
7125965|NCT02697773|11267867|FG002|Overall Study|Adverse Event|2
7125966|NCT02697773|11267865|FG000|Overall Study|Death|0
7125967|NCT02697773|11267866|FG001|Overall Study|Death|0
7125968|NCT02697773|11267867|FG002|Overall Study|Death|2
7125969|NCT02697773|11267865|FG000|Overall Study|Lack of Efficacy|4
7125970|NCT02697773|11267866|FG001|Overall Study|Lack of Efficacy|6
7125971|NCT02697773|11267867|FG002|Overall Study|Lack of Efficacy|6
7125972|NCT02697773|11267865|FG000|Overall Study|Lost to Follow-up|5
7125973|NCT02697773|11267866|FG001|Overall Study|Lost to Follow-up|5
7125974|NCT02697773|11267867|FG002|Overall Study|Lost to Follow-up|7
7125975|NCT02697773|11267865|FG000|Overall Study|Other|15
7125976|NCT02697773|11267866|FG001|Overall Study|Other|11
7125977|NCT02697773|11267867|FG002|Overall Study|Other|10
7125978|NCT02697773|11267865|FG000|Overall Study|Protocol Violation|1
7125979|NCT02697773|11267866|FG001|Overall Study|Protocol Violation|1
7125980|NCT02697773|11267867|FG002|Overall Study|Protocol Violation|0
7125981|NCT02697773|11267865|FG000|Overall Study|Withdrawal by Subject|10
7125982|NCT02697773|11267866|FG001|Overall Study|Withdrawal by Subject|13
7125983|NCT02697773|11267867|FG002|Overall Study|Withdrawal by Subject|13
7125984|NCT02697773|11267865|FG000|Overall Study|Randomized but not treated|1
7125985|NCT02697773|11267866|FG001|Overall Study|Randomized but not treated|1
7125986|NCT02697773|11267867|FG002|Overall Study|Randomized but not treated|0
7125987|NCT02697916|11267886|FG000|Overall Study|Death|357
7125988|NCT02697916|11267887|FG001|Overall Study|Death|315
7125989|NCT02697916|11267886|FG000|Overall Study|Withdrawal by Subject|221
7125990|NCT02697916|11267887|FG001|Overall Study|Withdrawal by Subject|393
7125991|NCT02698176|11267900|FG000|Overall Study|Progressive disease|4
7125992|NCT02698176|11267901|FG001|Overall Study|Progressive disease|3
7125993|NCT02698176|11267902|FG002|Overall Study|Progressive disease|1
7125994|NCT02698176|11267903|FG003|Overall Study|Progressive disease|0
7125995|NCT02698176|11267900|FG000|Overall Study|Adverse Event|2
7125996|NCT02698176|11267901|FG001|Overall Study|Adverse Event|0
7125997|NCT02698176|11267902|FG002|Overall Study|Adverse Event|0
7125998|NCT02698176|11267903|FG003|Overall Study|Adverse Event|0
7125999|NCT02698176|11267900|FG000|Overall Study|Clinical progression|3
7126000|NCT02698176|11267901|FG001|Overall Study|Clinical progression|0
7126001|NCT02698176|11267902|FG002|Overall Study|Clinical progression|0
7126002|NCT02698176|11267903|FG003|Overall Study|Clinical progression|0
7126003|NCT02698189|11267916|FG000|Overall Study|Progressive disease|3
7126004|NCT02698189|11267917|FG001|Overall Study|Progressive disease|5
7126005|NCT02698189|11267916|FG000|Overall Study|Still ongoing in the study|0
7126006|NCT02698189|11267917|FG001|Overall Study|Still ongoing in the study|1
7126007|NCT02698241|11267934|FG000|Overall Study|Inclusion/exclusion criteria not met|4
7126008|NCT02698241|11267934|FG000|Overall Study|Screening not met|7
7126009|NCT02698241|11267934|FG000|Overall Study|Withdrawal by Subject|7
7126010|NCT02698241|11267934|FG000|Overall Study|Physician Decision|2
7126011|NCT02698241|11267934|FG000|Overall Study|Subject underwent system modification|2
7126012|NCT02698241|11267934|FG000|Overall Study|Lost to Follow-up|3
7126013|NCT02698241|11267934|FG000|Overall Study|Subject on inodrip not safe to continue|6
7126014|NCT02698241|11267934|FG000|Overall Study|geographic and licensing issue|1
7126015|NCT02698241|11267934|FG000|Overall Study|Death|2
7126016|NCT02698371|11267938|FG000|All Participants Flow|Lost to Follow-up|3
7126017|NCT02698371|11267938|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3
7126018|NCT02698371|11267938|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3
7126019|NCT02698371|11267938|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3
7126020|NCT02698371|11267938|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3
7126021|NCT02698371|11267938|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3
7126022|NCT02698371|11267938|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2
7126023|NCT02698410|11267954|FG000|Overall Study|Adverse Event|2
7126024|NCT02698410|11267954|FG000|Overall Study|Withdrawal by Subject|1
7126025|NCT02698410|11267954|FG000|Overall Study|Other|1
7126026|NCT02698423|11267960|FG000|Overall Study|Lost to Follow-up|19
7126027|NCT02698423|11267961|FG001|Overall Study|Lost to Follow-up|24
7126028|NCT02698436|11267971|FG000|Overall Study|Adverse Event|1
7126029|NCT02698436|11267972|FG001|Overall Study|Adverse Event|0
7126030|NCT02698436|11267971|FG000|Overall Study|Withdrawal by Subject|3
7126031|NCT02698436|11267972|FG001|Overall Study|Withdrawal by Subject|3
7126032|NCT02698436|11267971|FG000|Overall Study|Lost to Follow-up|2
7126033|NCT02698436|11267972|FG001|Overall Study|Lost to Follow-up|4
7126034|NCT02698436|11267971|FG000|Overall Study|Non-compliance with study regimen|1
7126035|NCT02698436|11267972|FG001|Overall Study|Non-compliance with study regimen|0
7126036|NCT02698475|11267978|FG000|Main Study Period|Lack of Efficacy|1
7126037|NCT02698475|11267978|FG000|Main Study Period|Protocol Violation|2
7126038|NCT02698475|11267978|FG000|Long-Term Extension Period|Lost to Follow-up|1
7126039|NCT02698475|11267978|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1
7126040|NCT02698475|11267978|FG000|Long-Term Extension Period|Withdrawal by Subject|3
7126041|NCT02698475|11267978|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22
7126042|NCT02698475|11267978|FG000|Long-Term Extension Period|Other|1
7126043|NCT02698787|11268002|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0
7126044|NCT02698787|11268003|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1
7126045|NCT02699099|11268020|FG000|Overall Study|Adverse Event|1
7126046|NCT02699099|11268021|FG001|Overall Study|Adverse Event|0
7126047|NCT02699099|11268022|FG002|Overall Study|Adverse Event|2
7126048|NCT02699099|11268020|FG000|Overall Study|Lost to Follow-up|0
7126049|NCT02699099|11268021|FG001|Overall Study|Lost to Follow-up|1
7126050|NCT02699099|11268022|FG002|Overall Study|Lost to Follow-up|0
7126051|NCT02699099|11268020|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7
7126052|NCT02699099|11268021|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2
7126053|NCT02699099|11268022|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4
7126054|NCT02699125|11268032|FG000|Placebo|Lost to Follow-up|2
7126055|NCT02699125|11268033|FG001|Placebo|Lost to Follow-up|0
7126056|NCT02699125|11268032|FG000|Placebo|Protocol Violation|1
7126057|NCT02699125|11268033|FG001|Placebo|Protocol Violation|0
7126058|NCT02699125|11268032|FG000|Placebo|Withdrawal by Subject|0
7126059|NCT02699125|11268033|FG001|Placebo|Withdrawal by Subject|4
7126060|NCT02699125|11268032|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7
7126061|NCT02699125|11268033|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2
7126062|NCT02699450|11268046|FG000|Overall Study|Death|2
7126063|NCT02699450|11268047|FG001|Overall Study|Death|1
7126064|NCT02699450|11268048|FG002|Overall Study|Death|2
7126065|NCT02699450|11268046|FG000|Overall Study|Met Criteria for Study Exit|0
7126066|NCT02699450|11268047|FG001|Overall Study|Met Criteria for Study Exit|0
7126067|NCT02699450|11268048|FG002|Overall Study|Met Criteria for Study Exit|1
7126068|NCT02699450|11268046|FG000|Overall Study|Protocol Violation|4
7126069|NCT02699450|11268047|FG001|Overall Study|Protocol Violation|3
7126070|NCT02699450|11268048|FG002|Overall Study|Protocol Violation|5
7126071|NCT02699450|11268046|FG000|Overall Study|Lost to Follow-up|3
7126072|NCT02699450|11268047|FG001|Overall Study|Lost to Follow-up|0
7126073|NCT02699450|11268048|FG002|Overall Study|Lost to Follow-up|5
7126074|NCT02699450|11268046|FG000|Overall Study|Physician Decision|2
7126075|NCT02699450|11268047|FG001|Overall Study|Physician Decision|0
7126076|NCT02699450|11268048|FG002|Overall Study|Physician Decision|0
7126077|NCT02699450|11268046|FG000|Overall Study|Withdrawal by Subject|3
7126078|NCT02699450|11268047|FG001|Overall Study|Withdrawal by Subject|1
7126079|NCT02699450|11268048|FG002|Overall Study|Withdrawal by Subject|2
7126080|NCT02699450|11268046|FG000|Overall Study|Adverse Event|1
6806108|NCT01970865|10808463|FG012|Overall Study|Withdrawal by Subject|2
6806109|NCT01970865|10808464|FG013|Overall Study|Withdrawal by Subject|5
6806110|NCT01970865|10808465|FG014|Overall Study|Withdrawal by Subject|2
6806111|NCT01970865|10808466|FG015|Overall Study|Withdrawal by Subject|7
6806112|NCT01970865|10808467|FG016|Overall Study|Withdrawal by Subject|0
6806113|NCT01970865|10808451|FG000|Overall Study|Other|0
6806114|NCT01970865|10808452|FG001|Overall Study|Other|0
6806115|NCT01970865|10808453|FG002|Overall Study|Other|0
6806116|NCT01970865|10808454|FG003|Overall Study|Other|1
6806117|NCT01970865|10808455|FG004|Overall Study|Other|0
6806118|NCT01970865|10808456|FG005|Overall Study|Other|0
6806119|NCT01970865|10808457|FG006|Overall Study|Other|0
6806120|NCT01970865|10808458|FG007|Overall Study|Other|0
6806121|NCT01970865|10808459|FG008|Overall Study|Other|0
6806122|NCT01970865|10808460|FG009|Overall Study|Other|0
6806123|NCT01970865|10808461|FG010|Overall Study|Other|0
6806124|NCT01970865|10808462|FG011|Overall Study|Other|0
6806125|NCT01970865|10808463|FG012|Overall Study|Other|0
6806126|NCT01970865|10808464|FG013|Overall Study|Other|1
6806127|NCT01970865|10808465|FG014|Overall Study|Other|0
6806128|NCT01970865|10808466|FG015|Overall Study|Other|1
6806129|NCT01970865|10808467|FG016|Overall Study|Other|0
6806130|NCT01970865|10808451|FG000|Overall Study|Study ongoing|0
6806131|NCT01970865|10808452|FG001|Overall Study|Study ongoing|2
6806132|NCT01970865|10808453|FG002|Overall Study|Study ongoing|0
6806133|NCT01970865|10808454|FG003|Overall Study|Study ongoing|6
6806134|NCT01970865|10808455|FG004|Overall Study|Study ongoing|8
7126081|NCT02699450|11268047|FG001|Overall Study|Adverse Event|0
6806135|NCT01970865|10808456|FG005|Overall Study|Study ongoing|0
7126082|NCT02699450|11268048|FG002|Overall Study|Adverse Event|0
7126083|NCT02699463|11268059|FG000|Overall Study|Lost to Follow-up|11
7126084|NCT02699463|11268060|FG001|Overall Study|Lost to Follow-up|8
7126085|NCT02699463|11268059|FG000|Overall Study|Withdrawal by Subject|4
7126086|NCT02699463|11268060|FG001|Overall Study|Withdrawal by Subject|1
7126087|NCT02699593|11268066|FG000|Period 1|Unsatisfactory Visual Response|0
7126088|NCT02699593|11268067|FG001|Period 1|Unsatisfactory Visual Response|1
7126089|NCT02699593|11268066|FG000|Period 1|Torn Contact Len|4
7126090|NCT02699593|11268067|FG001|Period 1|Torn Contact Len|3
7126091|NCT02699593|11268066|FG000|Period 1|Protocol Violation|0
7126092|NCT02699593|11268067|FG001|Period 1|Protocol Violation|1
7126093|NCT02699593|11268066|FG000|Period 1|Withdrawal by Subject|0
7126094|NCT02699593|11268067|FG001|Period 1|Withdrawal by Subject|1
7126095|NCT02699593|11268066|FG000|Period 1|Adverse Event|1
7126096|NCT02699593|11268067|FG001|Period 1|Adverse Event|1
7126097|NCT02699593|11268066|FG000|Period 2|Adverse Event|1
7126098|NCT02699593|11268067|FG001|Period 2|Adverse Event|1
7126099|NCT02699593|11268066|FG000|Period 2|Lost Contact Lens|0
7126100|NCT02699593|11268067|FG001|Period 2|Lost Contact Lens|1
7126101|NCT02699593|11268066|FG000|Period 2|Torn Contact Lens|1
7126102|NCT02699593|11268067|FG001|Period 2|Torn Contact Lens|0
7126103|NCT02699684|11268080|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1
7126104|NCT02699684|11268081|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0
7126105|NCT02699749|11268102|FG000|Overall Study|Other|0
7126106|NCT02699749|11268103|FG001|Overall Study|Other|0
7126107|NCT02699749|11268104|FG002|Overall Study|Other|2
7126108|NCT02699749|11268105|FG003|Overall Study|Other|0
7126109|NCT02699749|11268106|FG004|Overall Study|Other|0
7126110|NCT02699749|11268107|FG005|Overall Study|Other|1
7126111|NCT02699749|11268108|FG006|Overall Study|Other|1
7126112|NCT02699749|11268109|FG007|Overall Study|Other|0
7126113|NCT02699749|11268110|FG008|Overall Study|Other|0
7126114|NCT02699749|11268111|FG009|Overall Study|Other|0
7126115|NCT02699749|11268112|FG010|Overall Study|Other|1
7126116|NCT02699749|11268113|FG011|Overall Study|Other|0
7126117|NCT02699749|11268114|FG012|Overall Study|Other|0
7126118|NCT02699749|11268115|FG013|Overall Study|Other|0
7126119|NCT02699749|11268102|FG000|Overall Study|Progressive Disease|3
7126120|NCT02699749|11268103|FG001|Overall Study|Progressive Disease|3
7126121|NCT02699749|11268104|FG002|Overall Study|Progressive Disease|14
7126122|NCT02699749|11268105|FG003|Overall Study|Progressive Disease|3
7126123|NCT02699749|11268106|FG004|Overall Study|Progressive Disease|3
7126124|NCT02699749|11268107|FG005|Overall Study|Progressive Disease|7
7126125|NCT02699749|11268108|FG006|Overall Study|Progressive Disease|5
7126126|NCT02699749|11268109|FG007|Overall Study|Progressive Disease|5
7126127|NCT02699749|11268110|FG008|Overall Study|Progressive Disease|6
7126128|NCT02699749|11268111|FG009|Overall Study|Progressive Disease|6
7126129|NCT02699749|11268112|FG010|Overall Study|Progressive Disease|5
7126130|NCT02699749|11268113|FG011|Overall Study|Progressive Disease|4
7126131|NCT02699749|11268114|FG012|Overall Study|Progressive Disease|3
7126132|NCT02699749|11268115|FG013|Overall Study|Progressive Disease|5
7126133|NCT02699749|11268102|FG000|Overall Study|Death|0
7126134|NCT02699749|11268103|FG001|Overall Study|Death|0
7126135|NCT02699749|11268104|FG002|Overall Study|Death|0
7126136|NCT02699749|11268105|FG003|Overall Study|Death|0
7126137|NCT02699749|11268106|FG004|Overall Study|Death|0
7126138|NCT02699749|11268107|FG005|Overall Study|Death|0
7126139|NCT02699749|11268108|FG006|Overall Study|Death|0
7126140|NCT02699749|11268109|FG007|Overall Study|Death|0
7126141|NCT02699749|11268110|FG008|Overall Study|Death|0
7126142|NCT02699749|11268111|FG009|Overall Study|Death|0
7126143|NCT02699749|11268112|FG010|Overall Study|Death|0
7126144|NCT02699749|11268113|FG011|Overall Study|Death|0
7126145|NCT02699749|11268114|FG012|Overall Study|Death|0
7126146|NCT02699749|11268115|FG013|Overall Study|Death|1
7126147|NCT02699749|11268102|FG000|Overall Study|Lost to Follow-up|0
7126148|NCT02699749|11268103|FG001|Overall Study|Lost to Follow-up|0
7126149|NCT02699749|11268104|FG002|Overall Study|Lost to Follow-up|0
7126150|NCT02699749|11268105|FG003|Overall Study|Lost to Follow-up|0
7126151|NCT02699749|11268106|FG004|Overall Study|Lost to Follow-up|0
7126152|NCT02699749|11268107|FG005|Overall Study|Lost to Follow-up|1
7126153|NCT02699749|11268108|FG006|Overall Study|Lost to Follow-up|0
7126154|NCT02699749|11268109|FG007|Overall Study|Lost to Follow-up|1
7126155|NCT02699749|11268110|FG008|Overall Study|Lost to Follow-up|0
7126156|NCT02699749|11268111|FG009|Overall Study|Lost to Follow-up|0
7126157|NCT02699749|11268112|FG010|Overall Study|Lost to Follow-up|0
7126158|NCT02699749|11268113|FG011|Overall Study|Lost to Follow-up|0
7126159|NCT02699749|11268114|FG012|Overall Study|Lost to Follow-up|0
7126160|NCT02699749|11268115|FG013|Overall Study|Lost to Follow-up|0
7126161|NCT02699866|11268145|FG000|Overall Study|Withdrawal by Subject|3
7126162|NCT02699866|11268145|FG000|Overall Study|Physician Decision|2
7126163|NCT02699866|11268145|FG000|Overall Study|Adverse Event|3
7126164|NCT02699892|11268149|FG000|Overall Study|Other|36
7126165|NCT02699983|11268160|FG000|Overall Study|Withdrawal by Subject|1
7126166|NCT02699983|11268161|FG001|Overall Study|Withdrawal by Subject|0
7126167|NCT02699996|11268173|FG000|Overall Study|Withdrawal by Subject|5
7126168|NCT02699996|11268174|FG001|Overall Study|Withdrawal by Subject|2
7126169|NCT02700412|11268195|FG000|Overall Study|Adverse Event|6
7126170|NCT02700412|11268195|FG000|Overall Study|Death|1
7126171|NCT02700412|11268195|FG000|Overall Study|Lack of Efficacy|19
7126172|NCT02700412|11268195|FG000|Overall Study|Protocol Violation|5
7126173|NCT02700412|11268195|FG000|Overall Study|Withdrawal by Subject|2
7126174|NCT02700815|11268212|FG000|Overall Study|Adverse Event|0
7126175|NCT02700815|11268213|FG001|Overall Study|Adverse Event|6
7126176|NCT02700815|11268214|FG002|Overall Study|Adverse Event|2
7126177|NCT02700815|11268215|FG003|Overall Study|Adverse Event|3
7126178|NCT02700815|11268212|FG000|Overall Study|Lack of Efficacy|0
7126179|NCT02700815|11268213|FG001|Overall Study|Lack of Efficacy|0
7126180|NCT02700815|11268214|FG002|Overall Study|Lack of Efficacy|1
7126181|NCT02700815|11268215|FG003|Overall Study|Lack of Efficacy|2
7126182|NCT02700815|11268212|FG000|Overall Study|Lost to Follow-up|1
7126183|NCT02700815|11268213|FG001|Overall Study|Lost to Follow-up|0
7126184|NCT02700815|11268214|FG002|Overall Study|Lost to Follow-up|0
7126185|NCT02700815|11268215|FG003|Overall Study|Lost to Follow-up|1
7126186|NCT02700815|11268212|FG000|Overall Study|Refusal to continue medication|0
7126187|NCT02700815|11268213|FG001|Overall Study|Refusal to continue medication|1
7126188|NCT02700815|11268214|FG002|Overall Study|Refusal to continue medication|0
7126189|NCT02700815|11268215|FG003|Overall Study|Refusal to continue medication|1
7126190|NCT02700815|11268212|FG000|Overall Study|Withdrawal by Subject|0
7126191|NCT02700815|11268213|FG001|Overall Study|Withdrawal by Subject|0
7126192|NCT02700815|11268214|FG002|Overall Study|Withdrawal by Subject|1
7126193|NCT02700815|11268215|FG003|Overall Study|Withdrawal by Subject|0
7126194|NCT02700919|11268228|FG000|Overall Study|Physician Decision|1
7126195|NCT02700919|11268229|FG001|Overall Study|Physician Decision|0
7126196|NCT02700919|11268230|FG002|Overall Study|Physician Decision|0
7126197|NCT02700919|11268228|FG000|Overall Study|Protocol Violation|1
7126198|NCT02700919|11268229|FG001|Overall Study|Protocol Violation|0
7126199|NCT02700919|11268230|FG002|Overall Study|Protocol Violation|0
7126200|NCT02700919|11268228|FG000|Overall Study|Adverse Event|1
7126201|NCT02700919|11268229|FG001|Overall Study|Adverse Event|3
7126202|NCT02700919|11268230|FG002|Overall Study|Adverse Event|1
7126203|NCT02700919|11268228|FG000|Overall Study|Withdrawal by Subject|5
7126204|NCT02700919|11268229|FG001|Overall Study|Withdrawal by Subject|8
7126205|NCT02700919|11268230|FG002|Overall Study|Withdrawal by Subject|2
7126206|NCT02700919|11268228|FG000|Overall Study|Lost to Follow-up|2
7126207|NCT02700919|11268229|FG001|Overall Study|Lost to Follow-up|0
7126208|NCT02700919|11268230|FG002|Overall Study|Lost to Follow-up|0
7126209|NCT02700919|11268228|FG000|Overall Study|Other|2
7126210|NCT02700919|11268229|FG001|Overall Study|Other|1
7126211|NCT02700919|11268230|FG002|Overall Study|Other|1
7126212|NCT02700984|11268240|FG000|Overall Study|Death|2
7126213|NCT02700984|11268241|FG001|Overall Study|Death|1
7126214|NCT02700984|11268240|FG000|Overall Study|Lost to Follow-up|2
7126215|NCT02700984|11268241|FG001|Overall Study|Lost to Follow-up|1
7126216|NCT02700984|11268240|FG000|Overall Study|Physician Decision|0
7126217|NCT02700984|11268241|FG001|Overall Study|Physician Decision|1
7126218|NCT02700984|11268240|FG000|Overall Study|Withdrawal by Subject|8
7126219|NCT02700984|11268241|FG001|Overall Study|Withdrawal by Subject|9
7126220|NCT02700984|11268240|FG000|Overall Study|Reason not specified|3
7126221|NCT02700984|11268241|FG001|Overall Study|Reason not specified|2
7126222|NCT02700997|11268257|FG000|Overall Study|Did not undergo CT imaging|1
7126223|NCT02700997|11268257|FG000|Overall Study|No CT measurement - pelvic calcification|1
7126224|NCT02701296|11268341|FG000|Overall Study|Incomplete Data|0
7126225|NCT02701296|11268342|FG001|Overall Study|Incomplete Data|2
7126226|NCT02701361|11268351|FG000|Overall Study|Lost to Follow-up|5
7126227|NCT02701361|11268352|FG001|Overall Study|Lost to Follow-up|2
7126228|NCT02701361|11268353|FG002|Overall Study|Lost to Follow-up|1
7126229|NCT02701361|11268351|FG000|Overall Study|Withdrawal by Subject|4
7126230|NCT02701361|11268352|FG001|Overall Study|Withdrawal by Subject|0
7126231|NCT02701361|11268353|FG002|Overall Study|Withdrawal by Subject|0
7126232|NCT02701361|11268351|FG000|Overall Study|timed out in rehab center|0
7126233|NCT02701361|11268352|FG001|Overall Study|timed out in rehab center|1
7126234|NCT02701361|11268353|FG002|Overall Study|timed out in rehab center|0
7126235|NCT02701361|11268351|FG000|Overall Study|incarceration|0
7126236|NCT02701361|11268352|FG001|Overall Study|incarceration|0
7126237|NCT02701361|11268353|FG002|Overall Study|incarceration|1
7126238|NCT02701413|11268380|FG000|Overall Study|Withdrawal by Subject|7
7126239|NCT02701413|11268381|FG001|Overall Study|Withdrawal by Subject|11
7126240|NCT02701634|11268400|FG000|Overall Study|Adverse Event|2
7126241|NCT02701634|11268401|FG001|Overall Study|Adverse Event|3
7126242|NCT02701634|11268400|FG000|Overall Study|Death|1
7126243|NCT02701634|11268401|FG001|Overall Study|Death|0
7126244|NCT02701634|11268400|FG000|Overall Study|Investigator's Discretion|7
7126245|NCT02701634|11268401|FG001|Overall Study|Investigator's Discretion|4
7126246|NCT02701634|11268400|FG000|Overall Study|Study terminated by Sponsor|15
7126247|NCT02701634|11268401|FG001|Overall Study|Study terminated by Sponsor|17
7126248|NCT02701634|11268400|FG000|Overall Study|Withdrew Consent|6
7126249|NCT02701634|11268401|FG001|Overall Study|Withdrew Consent|7
7126250|NCT02701634|11268400|FG000|Overall Study|Randomized but not treated|1
7126251|NCT02701634|11268401|FG001|Overall Study|Randomized but not treated|0
7126252|NCT02701764|11268429|FG000|Overall Study|Lost to Follow-up|0
7126253|NCT02701764|11268430|FG001|Overall Study|Lost to Follow-up|1
7126254|NCT02701985|11268452|FG000|Overall Study|Withdrawal by Subject|1
7126255|NCT02701985|11268453|FG001|Overall Study|Withdrawal by Subject|1
7126256|NCT02701985|11268452|FG000|Overall Study|Lost to Follow-up|1
7126257|NCT02701985|11268453|FG001|Overall Study|Lost to Follow-up|0
7126258|NCT02701985|11268452|FG000|Overall Study|Death|1
7126259|NCT02701985|11268453|FG001|Overall Study|Death|0
7126260|NCT02701985|11268452|FG000|Overall Study|Adverse Event|0
7126261|NCT02701985|11268453|FG001|Overall Study|Adverse Event|5
7126262|NCT02702011|11268464|FG000|Overall Study|Withdrawal by Subject|0
7126263|NCT02702011|11268465|FG001|Overall Study|Withdrawal by Subject|1
7126264|NCT02702011|11268466|FG002|Overall Study|Withdrawal by Subject|0
7126265|NCT02702011|11268467|FG003|Overall Study|Withdrawal by Subject|0
7126266|NCT02702193|11268479|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1
7126267|NCT02702193|11268480|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0
7126268|NCT02702193|11268479|FG000|4 Month Follow up|Withdrawal by Subject|1
7126269|NCT02702193|11268480|FG001|4 Month Follow up|Withdrawal by Subject|0
7126270|NCT02702193|11268479|FG000|4 Month Follow up|Lost to Follow-up|17
7126271|NCT02702193|11268480|FG001|4 Month Follow up|Lost to Follow-up|18
7126272|NCT02702193|11268479|FG000|8 Month Follow up|Withdrawal by Subject|1
7126273|NCT02702193|11268480|FG001|8 Month Follow up|Withdrawal by Subject|0
7126274|NCT02702193|11268479|FG000|8 Month Follow up|Lost to Follow-up|14
7126275|NCT02702193|11268480|FG001|8 Month Follow up|Lost to Follow-up|18
7126276|NCT02702193|11268479|FG000|12 Month Follow up|Withdrawal by Subject|1
7126277|NCT02702193|11268480|FG001|12 Month Follow up|Withdrawal by Subject|0
7126278|NCT02702193|11268479|FG000|12 Month Follow up|Lost to Follow-up|16
7126279|NCT02702193|11268480|FG001|12 Month Follow up|Lost to Follow-up|18
7126280|NCT02702388|11268488|FG000|Overall Study|Disease Progression|18
7126281|NCT02702388|11268489|FG001|Overall Study|Disease Progression|25
7126282|NCT02702388|11268488|FG000|Overall Study|Withdrawal by Subject|9
7126283|NCT02702388|11268489|FG001|Overall Study|Withdrawal by Subject|7
7126284|NCT02702388|11268488|FG000|Overall Study|Adverse Event|11
7126285|NCT02702388|11268489|FG001|Overall Study|Adverse Event|15
7126286|NCT02702388|11268488|FG000|Overall Study|Other|2
7126287|NCT02702388|11268489|FG001|Overall Study|Other|4
7126288|NCT02702401|11268506|FG000|Overall Study|Death|180
7126289|NCT02702401|11268507|FG001|Overall Study|Death|101
7126290|NCT02702401|11268506|FG000|Overall Study|Withdrawal by Subject|4
7126291|NCT02702401|11268507|FG001|Overall Study|Withdrawal by Subject|0
7126292|NCT02702401|11268506|FG000|Overall Study|Ongoing in study|94
7126293|NCT02702401|11268507|FG001|Overall Study|Ongoing in study|34
7126294|NCT02702518|11268515|FG000|Overall Study|Lost to Follow-up|3
7126295|NCT02702518|11268516|FG001|Overall Study|Lost to Follow-up|4
7126296|NCT02702609|11268524|FG000|Overall Study|Lost to Follow-up|8
7126297|NCT02702609|11268525|FG001|Overall Study|Lost to Follow-up|4
7126298|NCT02702609|11268524|FG000|Overall Study|Physician Decision|1
7126299|NCT02702609|11268525|FG001|Overall Study|Physician Decision|0
7126300|NCT02703259|11268551|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1
7126301|NCT02703259|11268552|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4
7126302|NCT02703259|11268551|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1
7126303|NCT02703259|11268552|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2
7126304|NCT02703259|11268551|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10
7126305|NCT02703259|11268552|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10
7126306|NCT02703311|11268558|FG000|Overall Study|Death|5
7126307|NCT02703311|11268558|FG000|Overall Study|Withdrawal by Subject|3
7126308|NCT02703324|11268562|FG000|Period Two|Withdrawal by Subject|0
7126309|NCT02703324|11268563|FG001|Period Two|Withdrawal by Subject|0
7126310|NCT02703324|11268564|FG002|Period Two|Withdrawal by Subject|1
7126311|NCT02703324|11268565|FG003|Period Two|Withdrawal by Subject|0
7126312|NCT02703324|11268566|FG004|Period Two|Withdrawal by Subject|0
7126313|NCT02703324|11268567|FG005|Period Two|Withdrawal by Subject|0
7126314|NCT02703337|11268576|FG000|Period One (Part A)|Withdrawal by Subject|0
7126315|NCT02703337|11268577|FG001|Period One (Part A)|Withdrawal by Subject|0
7126316|NCT02703337|11268578|FG002|Period One (Part A)|Withdrawal by Subject|0
7126317|NCT02703337|11268579|FG003|Period One (Part A)|Withdrawal by Subject|0
7126318|NCT02703337|11268580|FG004|Period One (Part A)|Withdrawal by Subject|1
7126319|NCT02703337|11268581|FG005|Period One (Part A)|Withdrawal by Subject|0
7126320|NCT02703337|11268582|FG006|Period One (Part A)|Withdrawal by Subject|0
7126321|NCT02703337|11268583|FG007|Period One (Part A)|Withdrawal by Subject|0
7126322|NCT02703454|11268628|FG000|Overall Study|Not treated|1
7126323|NCT02703454|11268629|FG001|Overall Study|Not treated|3
7126324|NCT02703454|11268628|FG000|Overall Study|Withdrawal by Subject|4
7126325|NCT02703454|11268629|FG001|Overall Study|Withdrawal by Subject|3
7126326|NCT02703454|11268628|FG000|Overall Study|Lost to Follow-up|1
7126327|NCT02703454|11268629|FG001|Overall Study|Lost to Follow-up|2
7126328|NCT02703454|11268628|FG000|Overall Study|Study discontinuation|5
7126329|NCT02703454|11268629|FG001|Overall Study|Study discontinuation|8
7126330|NCT02703532|11268656|FG000|Overall Study|Withdrawal by Subject|0
7126331|NCT02703532|11268657|FG001|Overall Study|Withdrawal by Subject|1
7126332|NCT02703532|11268658|FG002|Overall Study|Withdrawal by Subject|0
7126333|NCT02703532|11268659|FG003|Overall Study|Withdrawal by Subject|1
7126334|NCT02703532|11268656|FG000|Overall Study|Lost to Follow-up|2
7126335|NCT02703532|11268657|FG001|Overall Study|Lost to Follow-up|0
7126336|NCT02703532|11268658|FG002|Overall Study|Lost to Follow-up|2
7126337|NCT02703532|11268659|FG003|Overall Study|Lost to Follow-up|0
7126338|NCT02703636|11268669|FG000|Overall Study|Adverse Event|14
7126339|NCT02703636|11268669|FG000|Overall Study|Study stopped by sponsor|1
7126340|NCT02703636|11268669|FG000|Overall Study|Withdrawal by Subject|1
7126341|NCT02704091|11268716|FG000|Overall Study|Adverse Event|4
7126342|NCT02704091|11268717|FG001|Overall Study|Adverse Event|3
7126343|NCT02704091|11268716|FG000|Overall Study|Protocol Violation|5
7126344|NCT02704091|11268717|FG001|Overall Study|Protocol Violation|3
7126345|NCT02704091|11268716|FG000|Overall Study|Consent withdrawn|4
7126346|NCT02704091|11268717|FG001|Overall Study|Consent withdrawn|4
7126347|NCT02704091|11268716|FG000|Overall Study|Lost to Follow-up|13
7126348|NCT02704091|11268717|FG001|Overall Study|Lost to Follow-up|5
7126349|NCT02704091|11268716|FG000|Overall Study|Other|2
7126350|NCT02704091|11268717|FG001|Overall Study|Other|8
7126351|NCT02704143|11268731|FG000|Overall Study|disease progression|10
7126352|NCT02704689|11268735|FG000|Overall Study|Physician Decision|1
7126353|NCT02704689|11268735|FG000|Overall Study|Study device not implanted|2
7126354|NCT02705105|11268776|FG000|Treatment|Objective Disease Progression|1
7126355|NCT02705105|11268777|FG001|Treatment|Objective Disease Progression|50
7126356|NCT02705105|11268776|FG000|Treatment|Withdrawal by Subject|3
7126357|NCT02705105|11268777|FG001|Treatment|Withdrawal by Subject|5
7126358|NCT02705105|11268776|FG000|Treatment|Adverse Event|0
7126359|NCT02705105|11268777|FG001|Treatment|Adverse Event|17
7126360|NCT02705105|11268776|FG000|Treatment|Clinical Disease Progression|0
7126361|NCT02705105|11268777|FG001|Treatment|Clinical Disease Progression|32
7126362|NCT02705105|11268776|FG000|Treatment|Physician Decision|0
7126363|NCT02705105|11268777|FG001|Treatment|Physician Decision|3
7126364|NCT02705105|11268776|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0
7126365|NCT02705105|11268777|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2
7126366|NCT02705105|11268776|FG000|Follow-Up|Death|3
7126367|NCT02705105|11268777|FG001|Follow-Up|Death|68
7126368|NCT02705105|11268776|FG000|Follow-Up|Withdrawal by Subject|1
7126369|NCT02705105|11268777|FG001|Follow-Up|Withdrawal by Subject|14
7126370|NCT02705105|11268776|FG000|Follow-Up|Study Terminated|0
7126371|NCT02705105|11268777|FG001|Follow-Up|Study Terminated|26
7126372|NCT02705105|11268776|FG000|Follow-Up|Discontinued per Amendment 3|0
7126373|NCT02705105|11268777|FG001|Follow-Up|Discontinued per Amendment 3|2
7126374|NCT02705586|11268813|FG000|Overall Study|Health Issues|2
7126375|NCT02705586|11268813|FG000|Overall Study|Transportation Difficulties|5
7126376|NCT02705586|11268813|FG000|Overall Study|Vacation/Planned Absence|1
7126377|NCT02705625|11268820|FG000|Overall Study|Protocol Violation|1
7126378|NCT02705625|11268821|FG001|Overall Study|Protocol Violation|0
7126379|NCT02705625|11268822|FG002|Overall Study|Protocol Violation|0
7126380|NCT02705625|11268820|FG000|Overall Study|Adverse Event|6
7126381|NCT02705625|11268821|FG001|Overall Study|Adverse Event|5
7126382|NCT02705625|11268822|FG002|Overall Study|Adverse Event|2
7126383|NCT02705625|11268820|FG000|Overall Study|Death|0
7126384|NCT02705625|11268821|FG001|Overall Study|Death|0
7126385|NCT02705625|11268822|FG002|Overall Study|Death|1
7126386|NCT02705625|11268820|FG000|Overall Study|Withdrawal by Subject|1
7126387|NCT02705625|11268821|FG001|Overall Study|Withdrawal by Subject|4
7126388|NCT02705625|11268822|FG002|Overall Study|Withdrawal by Subject|5
7126389|NCT02705625|11268820|FG000|Overall Study|Lost to Follow-up|0
7126390|NCT02705625|11268821|FG001|Overall Study|Lost to Follow-up|0
7126391|NCT02705625|11268822|FG002|Overall Study|Lost to Follow-up|1
7126392|NCT02705625|11268820|FG000|Overall Study|Non-compliance|0
7126393|NCT02705625|11268821|FG001|Overall Study|Non-compliance|1
7126394|NCT02705625|11268822|FG002|Overall Study|Non-compliance|1
7126395|NCT02705625|11268820|FG000|Overall Study|Overdosing|0
7126396|NCT02705625|11268821|FG001|Overall Study|Overdosing|0
7126397|NCT02705625|11268822|FG002|Overall Study|Overdosing|1
7126398|NCT02705716|11268832|FG000|Overall Study|Adverse Event|0
7126399|NCT02705716|11268833|FG001|Overall Study|Adverse Event|1
7126400|NCT02705716|11268832|FG000|Overall Study|Protocol Violation|3
7126401|NCT02705716|11268833|FG001|Overall Study|Protocol Violation|0
7126402|NCT02705716|11268832|FG000|Overall Study|Withdrawal of Consent|1
7126403|NCT02705716|11268833|FG001|Overall Study|Withdrawal of Consent|1
7126404|NCT02706327|11268866|FG000|Overall Study|Lost to Follow-up|1
7126405|NCT02706327|11268867|FG001|Overall Study|Lost to Follow-up|1
7126406|NCT02706327|11268868|FG002|Overall Study|Lost to Follow-up|2
7126407|NCT02706483|11268876|FG000|Overall Study|Adverse Event|97
7126408|NCT02706483|11268876|FG000|Overall Study|Death|1
7126409|NCT02706483|11268876|FG000|Overall Study|Lack of Efficacy|39
7126410|NCT02706483|11268876|FG000|Overall Study|Lost to Follow-up|101
7126411|NCT02706483|11268876|FG000|Overall Study|Non-compliance with study drug|15
7126412|NCT02706483|11268876|FG000|Overall Study|Physician Decision|6
7126413|NCT02706483|11268876|FG000|Overall Study|Pregnancy|6
7126414|NCT02706483|11268876|FG000|Overall Study|Protocol Violation|18
7126415|NCT02706483|11268876|FG000|Overall Study|Withdrawal by Subject|136
7126416|NCT02706483|11268876|FG000|Overall Study|Non-compliance with visits|6
7126417|NCT02706483|11268876|FG000|Overall Study|Site closure|4
7126418|NCT02706483|11268876|FG000|Overall Study|Subject moved|1
7126419|NCT02706717|11268882|FG000|Overall Study|Withdrawal by Subject|1
7126420|NCT02706717|11268883|FG001|Overall Study|Withdrawal by Subject|8
7126421|NCT02706717|11268882|FG000|Overall Study|Lost to Follow-up|0
7126422|NCT02706717|11268883|FG001|Overall Study|Lost to Follow-up|1
7126423|NCT02706717|11268882|FG000|Overall Study|Physician Decision|0
7126424|NCT02706717|11268883|FG001|Overall Study|Physician Decision|1
7126425|NCT02706717|11268882|FG000|Overall Study|Death|0
7126426|NCT02706717|11268883|FG001|Overall Study|Death|1
7126427|NCT02706834|11268900|FG000|Overall Study|Pretreatment Event/Adverse Event|0
7126428|NCT02706834|11268901|FG001|Overall Study|Pretreatment Event/Adverse Event|1
7126429|NCT02706834|11268902|FG002|Overall Study|Pretreatment Event/Adverse Event|0
7126430|NCT02706834|11268903|FG003|Overall Study|Pretreatment Event/Adverse Event|0
7126431|NCT02706834|11268904|FG004|Overall Study|Pretreatment Event/Adverse Event|0
7126432|NCT02706834|11268905|FG005|Overall Study|Pretreatment Event/Adverse Event|0
7126433|NCT02706834|11268906|FG006|Overall Study|Pretreatment Event/Adverse Event|0
7126434|NCT02706834|11268907|FG007|Overall Study|Pretreatment Event/Adverse Event|0
7126435|NCT02706834|11268908|FG008|Overall Study|Pretreatment Event/Adverse Event|0
7126436|NCT02706834|11268909|FG009|Overall Study|Pretreatment Event/Adverse Event|0
7126437|NCT02706834|11268910|FG010|Overall Study|Pretreatment Event/Adverse Event|1
7126438|NCT02706834|11268900|FG000|Overall Study|Lost to Follow-up|0
7126439|NCT02706834|11268901|FG001|Overall Study|Lost to Follow-up|0
7126440|NCT02706834|11268902|FG002|Overall Study|Lost to Follow-up|1
7126441|NCT02706834|11268903|FG003|Overall Study|Lost to Follow-up|0
7126442|NCT02706834|11268904|FG004|Overall Study|Lost to Follow-up|0
7126443|NCT02706834|11268905|FG005|Overall Study|Lost to Follow-up|0
7126444|NCT02706834|11268906|FG006|Overall Study|Lost to Follow-up|0
7126445|NCT02706834|11268907|FG007|Overall Study|Lost to Follow-up|0
7126446|NCT02706834|11268908|FG008|Overall Study|Lost to Follow-up|0
7126447|NCT02706834|11268909|FG009|Overall Study|Lost to Follow-up|0
7126448|NCT02706834|11268910|FG010|Overall Study|Lost to Follow-up|0
7126449|NCT02706834|11268900|FG000|Overall Study|Voluntary Withdrawal|1
7126450|NCT02706834|11268901|FG001|Overall Study|Voluntary Withdrawal|0
7126451|NCT02706834|11268902|FG002|Overall Study|Voluntary Withdrawal|0
7126452|NCT02706834|11268903|FG003|Overall Study|Voluntary Withdrawal|0
7126453|NCT02706834|11268904|FG004|Overall Study|Voluntary Withdrawal|0
7126454|NCT02706834|11268905|FG005|Overall Study|Voluntary Withdrawal|0
7126455|NCT02706834|11268906|FG006|Overall Study|Voluntary Withdrawal|0
7126456|NCT02706834|11268907|FG007|Overall Study|Voluntary Withdrawal|0
7126457|NCT02706834|11268908|FG008|Overall Study|Voluntary Withdrawal|0
7126458|NCT02706834|11268909|FG009|Overall Study|Voluntary Withdrawal|1
7126459|NCT02706834|11268910|FG010|Overall Study|Voluntary Withdrawal|0
7126460|NCT02706834|11268900|FG000|Overall Study|Other Reason Not Specified|1
7126461|NCT02706834|11268901|FG001|Overall Study|Other Reason Not Specified|0
7126462|NCT02706834|11268902|FG002|Overall Study|Other Reason Not Specified|0
7126463|NCT02706834|11268903|FG003|Overall Study|Other Reason Not Specified|0
7126464|NCT02706834|11268904|FG004|Overall Study|Other Reason Not Specified|1
7126465|NCT02706834|11268905|FG005|Overall Study|Other Reason Not Specified|0
7126466|NCT02706834|11268906|FG006|Overall Study|Other Reason Not Specified|0
7126467|NCT02706834|11268907|FG007|Overall Study|Other Reason Not Specified|0
7126468|NCT02706834|11268908|FG008|Overall Study|Other Reason Not Specified|0
7126469|NCT02706834|11268909|FG009|Overall Study|Other Reason Not Specified|0
7126470|NCT02706834|11268910|FG010|Overall Study|Other Reason Not Specified|0
7126471|NCT02706873|11268959|FG000|Overall Study|Adverse Event|13
7126472|NCT02706873|11268960|FG001|Overall Study|Adverse Event|3
7126473|NCT02706873|11268961|FG002|Overall Study|Adverse Event|13
7126474|NCT02706873|11268962|FG003|Overall Study|Adverse Event|12
7126475|NCT02706873|11268959|FG000|Overall Study|Withdrawal by Subject|15
7126476|NCT02706873|11268960|FG001|Overall Study|Withdrawal by Subject|0
7126477|NCT02706873|11268961|FG002|Overall Study|Withdrawal by Subject|8
7126478|NCT02706873|11268962|FG003|Overall Study|Withdrawal by Subject|11
7126479|NCT02706873|11268959|FG000|Overall Study|Lost to Follow-up|3
7126480|NCT02706873|11268960|FG001|Overall Study|Lost to Follow-up|0
7126481|NCT02706873|11268961|FG002|Overall Study|Lost to Follow-up|4
7126482|NCT02706873|11268962|FG003|Overall Study|Lost to Follow-up|2
7126483|NCT02706873|11268959|FG000|Overall Study|Lack of Efficacy|10
7126484|NCT02706873|11268960|FG001|Overall Study|Lack of Efficacy|0
7126485|NCT02706873|11268961|FG002|Overall Study|Lack of Efficacy|0
7126486|NCT02706873|11268962|FG003|Overall Study|Lack of Efficacy|3
7126487|NCT02706873|11268959|FG000|Overall Study|Other|5
7126488|NCT02706873|11268960|FG001|Overall Study|Other|1
7126489|NCT02706873|11268961|FG002|Overall Study|Other|2
7126490|NCT02706873|11268962|FG003|Overall Study|Other|3
7126491|NCT02706873|11268959|FG000|Overall Study|Not Dosed|1
7126492|NCT02706873|11268960|FG001|Overall Study|Not Dosed|0
7126493|NCT02706873|11268961|FG002|Overall Study|Not Dosed|0
7126494|NCT02706873|11268962|FG003|Overall Study|Not Dosed|1
7126495|NCT02706873|11268959|FG000|Overall Study|Ongoing|0
7126496|NCT02706873|11268960|FG001|Overall Study|Ongoing|0
7126497|NCT02706873|11268961|FG002|Overall Study|Ongoing|0
7126498|NCT02706873|11268962|FG003|Overall Study|Ongoing|1
7126499|NCT02706886|11268983|FG000|Part A: SAD Period|Withdrawal by Subject|0
7126500|NCT02706886|11268984|FG001|Part A: SAD Period|Withdrawal by Subject|0
7126501|NCT02706886|11268985|FG002|Part A: SAD Period|Withdrawal by Subject|0
7126502|NCT02706886|11268986|FG003|Part A: SAD Period|Withdrawal by Subject|2
7126503|NCT02706886|11268987|FG004|Part A: SAD Period|Withdrawal by Subject|0
7126504|NCT02706886|11268988|FG005|Part A: SAD Period|Withdrawal by Subject|0
7126505|NCT02706886|11268989|FG006|Part A: SAD Period|Withdrawal by Subject|0
7126506|NCT02706886|11268990|FG007|Part A: SAD Period|Withdrawal by Subject|0
7126507|NCT02706886|11268991|FG008|Part A: SAD Period|Withdrawal by Subject|0
7126508|NCT02706899|11269036|FG000|Overall Study|Withdrawal by Subject|1
7126509|NCT02706899|11269037|FG001|Overall Study|Withdrawal by Subject|0
7126510|NCT02706899|11269036|FG000|Overall Study|Death|8
7126511|NCT02706899|11269037|FG001|Overall Study|Death|0
7126512|NCT02706899|11269036|FG000|Overall Study|Study Termination by Sponsor|4
7126513|NCT02706899|11269037|FG001|Overall Study|Study Termination by Sponsor|6
7126514|NCT02706938|11269090|FG000|First Period, 6 Weeks|Adverse Event|8
7126515|NCT02706938|11269091|FG001|First Period, 6 Weeks|Adverse Event|0
7126516|NCT02706938|11269090|FG000|First Period, 6 Weeks|Lost to Follow-up|2
7126517|NCT02706938|11269091|FG001|First Period, 6 Weeks|Lost to Follow-up|2
7126518|NCT02706938|11269090|FG000|First Period, 6 Weeks|Withdrawal by Subject|1
7126519|NCT02706938|11269091|FG001|First Period, 6 Weeks|Withdrawal by Subject|0
7126520|NCT02706938|11269090|FG000|Second Period, 6 Weeks|Adverse Event|0
7126521|NCT02706938|11269091|FG001|Second Period, 6 Weeks|Adverse Event|7
7126522|NCT02706938|11269090|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0
7126523|NCT02706938|11269091|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3
7126524|NCT02706951|11269101|FG000|Overall Study|Adverse Event|1
7126525|NCT02706951|11269102|FG001|Overall Study|Adverse Event|5
7126526|NCT02706951|11269103|FG002|Overall Study|Adverse Event|3
7126527|NCT02706951|11269101|FG000|Overall Study|Withdrawal by Subject|11
7126528|NCT02706951|11269102|FG001|Overall Study|Withdrawal by Subject|6
7126529|NCT02706951|11269103|FG002|Overall Study|Withdrawal by Subject|6
7126530|NCT02706951|11269101|FG000|Overall Study|Lost to Follow-up|0
7126531|NCT02706951|11269102|FG001|Overall Study|Lost to Follow-up|4
7126532|NCT02706951|11269103|FG002|Overall Study|Lost to Follow-up|1
7126533|NCT02706951|11269101|FG000|Overall Study|Other|2
7126534|NCT02706951|11269102|FG001|Overall Study|Other|1
7126535|NCT02706951|11269103|FG002|Overall Study|Other|0
7126536|NCT02707601|11269149|FG000|Overall Study|Death|0
7126537|NCT02707601|11269150|FG001|Overall Study|Death|1
7126538|NCT02707601|11269149|FG000|Overall Study|Lack of Efficacy|0
7126539|NCT02707601|11269150|FG001|Overall Study|Lack of Efficacy|1
7126540|NCT02707601|11269149|FG000|Overall Study|Investigator's Discretion|1
7126541|NCT02707601|11269150|FG001|Overall Study|Investigator's Discretion|0
7126542|NCT02707601|11269149|FG000|Overall Study|Withdrew Consent|0
7126543|NCT02707601|11269150|FG001|Overall Study|Withdrew Consent|1
7126544|NCT02707601|11269149|FG000|Overall Study|Lost to Follow-up|1
7126545|NCT02707601|11269150|FG001|Overall Study|Lost to Follow-up|1
7126546|NCT02707601|11269149|FG000|Overall Study|Participants Randomized but Not Treated|2
7126547|NCT02707601|11269150|FG001|Overall Study|Participants Randomized but Not Treated|0
7126548|NCT02707640|11269162|FG000|Overall Study|Adverse Event|4
7126549|NCT02707640|11269163|FG001|Overall Study|Adverse Event|2
7126550|NCT02707640|11269162|FG000|Overall Study|Death|1
7126551|NCT02707640|11269163|FG001|Overall Study|Death|2
7126552|NCT02707640|11269162|FG000|Overall Study|Physician Decision|2
7126553|NCT02707640|11269163|FG001|Overall Study|Physician Decision|0
7126554|NCT02707640|11269162|FG000|Overall Study|Withdrawal by Subject|0
7126555|NCT02707640|11269163|FG001|Overall Study|Withdrawal by Subject|1
7126556|NCT02707640|11269162|FG000|Overall Study|Participant's Personal Decision|1
7126557|NCT02707640|11269163|FG001|Overall Study|Participant's Personal Decision|2
7126558|NCT02707640|11269162|FG000|Overall Study|Sponsor Discretion|1
7126559|NCT02707640|11269163|FG001|Overall Study|Sponsor Discretion|0
7126560|NCT02707757|11269171|FG000|Overall Study|Protocol Violation|3
7126561|NCT02707757|11269172|FG001|Overall Study|Protocol Violation|2
7126562|NCT02707757|11269171|FG000|Overall Study|Withdrawal by Subject|2
7126563|NCT02707757|11269172|FG001|Overall Study|Withdrawal by Subject|0
7126564|NCT02707757|11269171|FG000|Overall Study|Death|0
7126565|NCT02707757|11269172|FG001|Overall Study|Death|1
7126566|NCT02707757|11269171|FG000|Overall Study|Adverse Event|6
7126567|NCT02707757|11269172|FG001|Overall Study|Adverse Event|4
7126568|NCT02707757|11269171|FG000|Overall Study|Renal transplant/elective operation|1
7126569|NCT02707757|11269172|FG001|Overall Study|Renal transplant/elective operation|5
7126570|NCT02707861|11269191|FG000|Overall Study|Went onto commercial drug|30
7126571|NCT02707861|11269192|FG001|Overall Study|Went onto commercial drug|23
7126572|NCT02707861|11269191|FG000|Overall Study|Adverse Event|2
7126573|NCT02707861|11269192|FG001|Overall Study|Adverse Event|3
7126574|NCT02707861|11269191|FG000|Overall Study|Death|5
7126575|NCT02707861|11269192|FG001|Overall Study|Death|2
7126576|NCT02707861|11269191|FG000|Overall Study|Lack of Efficacy|0
7126577|NCT02707861|11269192|FG001|Overall Study|Lack of Efficacy|2
7126578|NCT02707861|11269191|FG000|Overall Study|Physician Decision|1
7126579|NCT02707861|11269192|FG001|Overall Study|Physician Decision|4
7126580|NCT02707861|11269191|FG000|Overall Study|Withdrawal by Subject|2
7126581|NCT02707861|11269192|FG001|Overall Study|Withdrawal by Subject|1
7126582|NCT02707861|11269191|FG000|Overall Study|Lost to Follow-up|1
7126583|NCT02707861|11269192|FG001|Overall Study|Lost to Follow-up|3
7126584|NCT02707952|11269202|FG000|Overall Study|Adverse Event|1
7126585|NCT02707952|11269203|FG001|Overall Study|Adverse Event|0
7126586|NCT02707952|11269204|FG002|Overall Study|Adverse Event|0
7126587|NCT02707952|11269205|FG003|Overall Study|Adverse Event|0
7126588|NCT02707952|11269202|FG000|Overall Study|Lost to Follow-up|1
7126589|NCT02707952|11269203|FG001|Overall Study|Lost to Follow-up|0
7126590|NCT02707952|11269204|FG002|Overall Study|Lost to Follow-up|0
7126591|NCT02707952|11269205|FG003|Overall Study|Lost to Follow-up|0
7126592|NCT02707952|11269202|FG000|Overall Study|Withdrawal by Subject|0
7126593|NCT02707952|11269203|FG001|Overall Study|Withdrawal by Subject|1
7126594|NCT02707952|11269204|FG002|Overall Study|Withdrawal by Subject|2
7126595|NCT02707952|11269205|FG003|Overall Study|Withdrawal by Subject|0
7126596|NCT02707965|11269226|FG000|Overall Study|Withdrawal by Subject|0
7126597|NCT02707965|11269227|FG001|Overall Study|Withdrawal by Subject|0
7126598|NCT02707965|11269228|FG002|Overall Study|Withdrawal by Subject|1
7126599|NCT02707965|11269229|FG003|Overall Study|Withdrawal by Subject|0
7126600|NCT02707965|11269230|FG004|Overall Study|Withdrawal by Subject|0
7126601|NCT02707965|11269231|FG005|Overall Study|Withdrawal by Subject|0
7126602|NCT02707965|11269232|FG006|Overall Study|Withdrawal by Subject|0
7126603|NCT02707965|11269233|FG007|Overall Study|Withdrawal by Subject|2
7126604|NCT02707965|11269234|FG008|Overall Study|Withdrawal by Subject|0
7126605|NCT02707965|11269235|FG009|Overall Study|Withdrawal by Subject|0
7126606|NCT02707965|11269236|FG010|Overall Study|Withdrawal by Subject|0
7126607|NCT02707965|11269237|FG011|Overall Study|Withdrawal by Subject|0
7126608|NCT02707965|11269238|FG012|Overall Study|Withdrawal by Subject|0
7126609|NCT02707965|11269239|FG013|Overall Study|Withdrawal by Subject|0
7126610|NCT02707965|11269240|FG014|Overall Study|Withdrawal by Subject|0
7126611|NCT02707965|11269241|FG015|Overall Study|Withdrawal by Subject|0
7126612|NCT02707965|11269226|FG000|Overall Study|PI decisions|0
7126613|NCT02707965|11269227|FG001|Overall Study|PI decisions|0
7126614|NCT02707965|11269228|FG002|Overall Study|PI decisions|0
7126615|NCT02707965|11269229|FG003|Overall Study|PI decisions|0
7126616|NCT02707965|11269230|FG004|Overall Study|PI decisions|0
7126617|NCT02707965|11269231|FG005|Overall Study|PI decisions|0
7126618|NCT02707965|11269232|FG006|Overall Study|PI decisions|0
7126619|NCT02707965|11269233|FG007|Overall Study|PI decisions|0
7126620|NCT02707965|11269234|FG008|Overall Study|PI decisions|0
7126621|NCT02707965|11269235|FG009|Overall Study|PI decisions|0
7126622|NCT02707965|11269236|FG010|Overall Study|PI decisions|0
7126623|NCT02707965|11269237|FG011|Overall Study|PI decisions|0
7126624|NCT02707965|11269238|FG012|Overall Study|PI decisions|0
7126625|NCT02707965|11269239|FG013|Overall Study|PI decisions|0
7126626|NCT02707965|11269240|FG014|Overall Study|PI decisions|2
7126627|NCT02707965|11269241|FG015|Overall Study|PI decisions|0
7126628|NCT02707965|11269226|FG000|Overall Study|Protocol deviation|1
7126629|NCT02707965|11269227|FG001|Overall Study|Protocol deviation|1
7126630|NCT02707965|11269228|FG002|Overall Study|Protocol deviation|0
7126631|NCT02707965|11269229|FG003|Overall Study|Protocol deviation|0
7126632|NCT02707965|11269230|FG004|Overall Study|Protocol deviation|0
7126633|NCT02707965|11269231|FG005|Overall Study|Protocol deviation|0
7126634|NCT02707965|11269232|FG006|Overall Study|Protocol deviation|0
7126635|NCT02707965|11269233|FG007|Overall Study|Protocol deviation|1
7126636|NCT02707965|11269234|FG008|Overall Study|Protocol deviation|0
7126637|NCT02707965|11269235|FG009|Overall Study|Protocol deviation|0
7126638|NCT02707965|11269236|FG010|Overall Study|Protocol deviation|0
7126639|NCT02707965|11269237|FG011|Overall Study|Protocol deviation|0
7126640|NCT02707965|11269238|FG012|Overall Study|Protocol deviation|0
7126641|NCT02707965|11269239|FG013|Overall Study|Protocol deviation|0
7126642|NCT02707965|11269240|FG014|Overall Study|Protocol deviation|0
7126643|NCT02707965|11269241|FG015|Overall Study|Protocol deviation|0
7126644|NCT02707991|11269276|FG000|Overall Study|Protocol Violation|1
7126645|NCT02707991|11269277|FG001|Overall Study|Protocol Violation|0
7126646|NCT02707991|11269276|FG000|Overall Study|Became ineligible|0
7126647|NCT02707991|11269277|FG001|Overall Study|Became ineligible|1
7126648|NCT02708095|11269286|FG000|Overall Study|Adverse Event|4
7126649|NCT02708095|11269287|FG001|Overall Study|Adverse Event|10
7126650|NCT02708095|11269288|FG002|Overall Study|Adverse Event|11
7126651|NCT02708095|11269286|FG000|Overall Study|Lack of Efficacy|9
7126652|NCT02708095|11269287|FG001|Overall Study|Lack of Efficacy|3
7126653|NCT02708095|11269288|FG002|Overall Study|Lack of Efficacy|0
7126654|NCT02708095|11269286|FG000|Overall Study|Lost to Follow-up|2
7126655|NCT02708095|11269287|FG001|Overall Study|Lost to Follow-up|0
7126656|NCT02708095|11269288|FG002|Overall Study|Lost to Follow-up|0
7126657|NCT02708095|11269286|FG000|Overall Study|Physician Decision|2
7126658|NCT02708095|11269287|FG001|Overall Study|Physician Decision|3
7126659|NCT02708095|11269288|FG002|Overall Study|Physician Decision|2
7126660|NCT02708095|11269286|FG000|Overall Study|Protocol Violation|0
7126661|NCT02708095|11269287|FG001|Overall Study|Protocol Violation|0
7126662|NCT02708095|11269288|FG002|Overall Study|Protocol Violation|1
7126663|NCT02708095|11269286|FG000|Overall Study|Withdrawal by Subject|5
7126664|NCT02708095|11269287|FG001|Overall Study|Withdrawal by Subject|3
7126665|NCT02708095|11269288|FG002|Overall Study|Withdrawal by Subject|4
7126666|NCT02708121|11269300|FG000|Overall Study|Withdrawn by Study Team|1
7126667|NCT02708121|11269301|FG001|Overall Study|Withdrawn by Study Team|1
7126668|NCT02708121|11269300|FG000|Overall Study|Withdrawal by Subject|0
7126669|NCT02708121|11269301|FG001|Overall Study|Withdrawal by Subject|4
7126670|NCT02708277|11269344|FG000|Overall Study|Lost to Follow-up|7
7126671|NCT02708277|11269345|FG001|Overall Study|Lost to Follow-up|4
7126672|NCT02708355|11269363|FG000|Overall Study|Adverse Event|1
7126673|NCT02708355|11269364|FG001|Overall Study|Adverse Event|0
7126674|NCT02708355|11269365|FG002|Overall Study|Adverse Event|0
7126675|NCT02708485|11269382|FG000|Overall Study|Withdrawal by Subject|3
7126676|NCT02708485|11269383|FG001|Overall Study|Withdrawal by Subject|2
7126677|NCT02708498|11269397|FG000|Overall Study|Death|20
7126678|NCT02708498|11269398|FG001|Overall Study|Death|19
7126679|NCT02708498|11269399|FG002|Overall Study|Death|0
7126680|NCT02708498|11269400|FG003|Overall Study|Death|0
7126681|NCT02708498|11269401|FG004|Overall Study|Death|1
7126682|NCT02708498|11269402|FG005|Overall Study|Death|0
7126683|NCT02708498|11269403|FG006|Overall Study|Death|0
7126684|NCT02708498|11269404|FG007|Overall Study|Death|0
7126685|NCT02708498|11269397|FG000|Overall Study|Unknown reason, missing data|0
7126686|NCT02708498|11269398|FG001|Overall Study|Unknown reason, missing data|0
7126687|NCT02708498|11269399|FG002|Overall Study|Unknown reason, missing data|62
7126688|NCT02708498|11269400|FG003|Overall Study|Unknown reason, missing data|51
7126689|NCT02708498|11269401|FG004|Overall Study|Unknown reason, missing data|195
7126690|NCT02708498|11269402|FG005|Overall Study|Unknown reason, missing data|132
7126691|NCT02708498|11269403|FG006|Overall Study|Unknown reason, missing data|0
7126692|NCT02708498|11269404|FG007|Overall Study|Unknown reason, missing data|0
7126693|NCT02708524|11269424|FG000|Overall Study|Adverse Event|0
7126694|NCT02708524|11269425|FG001|Overall Study|Adverse Event|1
7126695|NCT02708524|11269426|FG002|Overall Study|Adverse Event|0
7126696|NCT02708524|11269427|FG003|Overall Study|Adverse Event|0
7126697|NCT02708524|11269424|FG000|Overall Study|Lens Discomfort|1
7126698|NCT02708524|11269425|FG001|Overall Study|Lens Discomfort|0
7126699|NCT02708524|11269426|FG002|Overall Study|Lens Discomfort|1
7126700|NCT02708524|11269427|FG003|Overall Study|Lens Discomfort|0
7126701|NCT02708524|11269424|FG000|Overall Study|Lost to Follow-up|1
7126702|NCT02708524|11269425|FG001|Overall Study|Lost to Follow-up|1
7126703|NCT02708524|11269426|FG002|Overall Study|Lost to Follow-up|1
7126704|NCT02708524|11269427|FG003|Overall Study|Lost to Follow-up|0
7126705|NCT02708524|11269424|FG000|Overall Study|Protocol Violation|0
7126706|NCT02708524|11269425|FG001|Overall Study|Protocol Violation|1
7126707|NCT02708524|11269426|FG002|Overall Study|Protocol Violation|0
7126708|NCT02708524|11269427|FG003|Overall Study|Protocol Violation|0
7126709|NCT02708524|11269424|FG000|Overall Study|Withdrawal by Subject|1
7126710|NCT02708524|11269425|FG001|Overall Study|Withdrawal by Subject|1
7126711|NCT02708524|11269426|FG002|Overall Study|Withdrawal by Subject|0
7126712|NCT02708524|11269427|FG003|Overall Study|Withdrawal by Subject|0
7126713|NCT02708524|11269424|FG000|Overall Study|Dispensed incorrect study lens|0
7126714|NCT02708524|11269425|FG001|Overall Study|Dispensed incorrect study lens|1
7126715|NCT02708524|11269426|FG002|Overall Study|Dispensed incorrect study lens|1
7126716|NCT02708524|11269427|FG003|Overall Study|Dispensed incorrect study lens|0
7126717|NCT02708524|11269424|FG000|Overall Study|Did not wear lens at final visit|0
7126718|NCT02708524|11269425|FG001|Overall Study|Did not wear lens at final visit|1
7126719|NCT02708524|11269426|FG002|Overall Study|Did not wear lens at final visit|0
7126720|NCT02708524|11269427|FG003|Overall Study|Did not wear lens at final visit|0
7126721|NCT02708524|11269424|FG000|Overall Study|Subject lost study lens|1
7126722|NCT02708524|11269425|FG001|Overall Study|Subject lost study lens|0
7126723|NCT02708524|11269426|FG002|Overall Study|Subject lost study lens|0
7126724|NCT02708524|11269427|FG003|Overall Study|Subject lost study lens|0
7126725|NCT02708966|11269469|FG000|Overall Study|Lost to Follow-up|2
7126726|NCT02708966|11269470|FG001|Overall Study|Lost to Follow-up|2
7126727|NCT02709005|11269478|FG000|Overall Study|Lost to Follow-up|1
7126728|NCT02709005|11269479|FG001|Overall Study|Lost to Follow-up|1
7126729|NCT02709005|11269478|FG000|Overall Study|Withdrawal by Subject|3
7126730|NCT02709005|11269479|FG001|Overall Study|Withdrawal by Subject|0
7126731|NCT02709096|11269498|FG000|Overall Study|non-compliance|1
7126732|NCT02709096|11269499|FG001|Overall Study|non-compliance|1
7126733|NCT02709109|11269509|FG000|Treatment Period 1 (28 Days)|Adverse Event|3
7126734|NCT02709109|11269510|FG001|Treatment Period 1 (28 Days)|Adverse Event|3
7126735|NCT02709109|11269511|FG002|Treatment Period 1 (28 Days)|Adverse Event|1
7126736|NCT02709109|11269512|FG003|Treatment Period 1 (28 Days)|Adverse Event|0
7126737|NCT02709109|11269509|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0
7126738|NCT02709109|11269510|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2
7126739|NCT02709109|11269511|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0
7126740|NCT02709109|11269512|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0
7126741|NCT02709109|11269509|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1
7126742|NCT02709109|11269510|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0
7126743|NCT02709109|11269511|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0
7126744|NCT02709109|11269512|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0
7126745|NCT02709109|11269509|FG000|Washout Period (28 Days)|Other|2
7126746|NCT02709109|11269510|FG001|Washout Period (28 Days)|Other|2
7126747|NCT02709109|11269511|FG002|Washout Period (28 Days)|Other|3
7126748|NCT02709109|11269512|FG003|Washout Period (28 Days)|Other|0
7126749|NCT02709109|11269509|FG000|Treatment Period 2 (28 Days)|Adverse Event|2
7126750|NCT02709109|11269510|FG001|Treatment Period 2 (28 Days)|Adverse Event|3
7126751|NCT02709109|11269511|FG002|Treatment Period 2 (28 Days)|Adverse Event|0
7126752|NCT02709109|11269512|FG003|Treatment Period 2 (28 Days)|Adverse Event|0
7126753|NCT02709109|11269509|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0
7126754|NCT02709109|11269510|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1
7126755|NCT02709109|11269511|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1
7126756|NCT02709109|11269512|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0
7126757|NCT02709109|11269509|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0
7126758|NCT02709109|11269510|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0
7126759|NCT02709109|11269511|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1
7126760|NCT02709109|11269512|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0
7126761|NCT02709109|11269509|FG000|Treatment Period 2 (28 Days)|Other|0
7126762|NCT02709109|11269510|FG001|Treatment Period 2 (28 Days)|Other|0
7126763|NCT02709109|11269511|FG002|Treatment Period 2 (28 Days)|Other|1
7126764|NCT02709109|11269512|FG003|Treatment Period 2 (28 Days)|Other|0
7126765|NCT02709330|11269523|FG000|Overall Study|Death|5
7126766|NCT02709330|11269524|FG001|Overall Study|Death|0
7126767|NCT02709330|11269523|FG000|Overall Study|Lost to Follow-up|2
7126768|NCT02709330|11269524|FG001|Overall Study|Lost to Follow-up|0
7126769|NCT02709330|11269523|FG000|Overall Study|Physician Decision|2
7126770|NCT02709330|11269524|FG001|Overall Study|Physician Decision|0
7126771|NCT02709330|11269523|FG000|Overall Study|Withdrawal by Subject|4
7126772|NCT02709330|11269524|FG001|Overall Study|Withdrawal by Subject|0
7126773|NCT02709369|11269530|FG000|Overall Study|Lost to Follow-up|15
7126774|NCT02709369|11269530|FG000|Overall Study|Withdrawal by Subject|10
7126775|NCT02709369|11269530|FG000|Overall Study|Did not received intervention|2
7126776|NCT02709486|11269537|FG000|Overall Study|Adverse Event|2
7126777|NCT02709486|11269538|FG001|Overall Study|Adverse Event|5
7126778|NCT02709486|11269539|FG002|Overall Study|Adverse Event|3
7126779|NCT02709486|11269537|FG000|Overall Study|Death|0
7126780|NCT02709486|11269538|FG001|Overall Study|Death|0
7126781|NCT02709486|11269539|FG002|Overall Study|Death|2
7126782|NCT02709486|11269537|FG000|Overall Study|Insufficient clinical response|7
7126783|NCT02709486|11269538|FG001|Overall Study|Insufficient clinical response|3
7126784|NCT02709486|11269539|FG002|Overall Study|Insufficient clinical response|3
7126785|NCT02709486|11269537|FG000|Overall Study|Lost to Follow-up|3
7126786|NCT02709486|11269538|FG001|Overall Study|Lost to Follow-up|2
7126787|NCT02709486|11269539|FG002|Overall Study|Lost to Follow-up|2
7126788|NCT02709486|11269537|FG000|Overall Study|Other|0
7126789|NCT02709486|11269538|FG001|Overall Study|Other|2
7126790|NCT02709486|11269539|FG002|Overall Study|Other|3
7126791|NCT02709486|11269537|FG000|Overall Study|Withdrawal by Subject|32
7126792|NCT02709486|11269538|FG001|Overall Study|Withdrawal by Subject|22
7126793|NCT02709486|11269539|FG002|Overall Study|Withdrawal by Subject|32
7126794|NCT02709538|11269550|FG000|Overall Study|Adverse Event|13
7126795|NCT02709538|11269551|FG001|Overall Study|Adverse Event|2
7126796|NCT02709538|11269552|FG002|Overall Study|Adverse Event|3
7126797|NCT02709538|11269550|FG000|Overall Study|Lack of Efficacy|1
7126798|NCT02709538|11269551|FG001|Overall Study|Lack of Efficacy|0
7126799|NCT02709538|11269552|FG002|Overall Study|Lack of Efficacy|0
7126800|NCT02709538|11269550|FG000|Overall Study|Lost to Follow-up|24
7126801|NCT02709538|11269551|FG001|Overall Study|Lost to Follow-up|8
7126802|NCT02709538|11269552|FG002|Overall Study|Lost to Follow-up|4
7126803|NCT02709538|11269550|FG000|Overall Study|Physician Decision|1
7126804|NCT02709538|11269551|FG001|Overall Study|Physician Decision|0
7126805|NCT02709538|11269552|FG002|Overall Study|Physician Decision|0
7126806|NCT02709538|11269550|FG000|Overall Study|Withdrawal by Subject|40
7126807|NCT02709538|11269551|FG001|Overall Study|Withdrawal by Subject|7
7126808|NCT02709538|11269552|FG002|Overall Study|Withdrawal by Subject|4
7126809|NCT02709538|11269550|FG000|Overall Study|Non-compliance with study procedures|5
7126810|NCT02709538|11269551|FG001|Overall Study|Non-compliance with study procedures|0
7126811|NCT02709538|11269552|FG002|Overall Study|Non-compliance with study procedures|0
7126812|NCT02709538|11269550|FG000|Overall Study|Non-compliance with study drug|2
7126813|NCT02709538|11269551|FG001|Overall Study|Non-compliance with study drug|0
7126814|NCT02709538|11269552|FG002|Overall Study|Non-compliance with study drug|0
7126815|NCT02709538|11269550|FG000|Overall Study|Protocol deviation|10
7126816|NCT02709538|11269551|FG001|Overall Study|Protocol deviation|4
7126817|NCT02709538|11269552|FG002|Overall Study|Protocol deviation|4
7126818|NCT02709538|11269550|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1
7126819|NCT02709538|11269551|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0
7126820|NCT02709538|11269552|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0
7126821|NCT02709538|11269550|FG000|Overall Study|Other|16
7126822|NCT02709538|11269551|FG001|Overall Study|Other|7
7126823|NCT02709538|11269552|FG002|Overall Study|Other|5
7126824|NCT02709577|11269562|FG000|Overall Study|non-accommodating anatomy|0
7126825|NCT02709577|11269563|FG001|Overall Study|non-accommodating anatomy|1
7126826|NCT02709577|11269564|FG002|Overall Study|non-accommodating anatomy|0
7126827|NCT02709577|11269565|FG003|Overall Study|non-accommodating anatomy|0
7126828|NCT02709577|11269562|FG000|Overall Study|procedural complication|0
7126829|NCT02709577|11269563|FG001|Overall Study|procedural complication|1
7126830|NCT02709577|11269564|FG002|Overall Study|procedural complication|0
7126831|NCT02709577|11269565|FG003|Overall Study|procedural complication|0
7126832|NCT02709577|11269562|FG000|Overall Study|Withdrawal by Subject|2
7126833|NCT02709577|11269563|FG001|Overall Study|Withdrawal by Subject|3
7126834|NCT02709577|11269564|FG002|Overall Study|Withdrawal by Subject|2
7126835|NCT02709577|11269565|FG003|Overall Study|Withdrawal by Subject|0
7126836|NCT02709746|11269595|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4
7126837|NCT02709746|11269596|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0
7126838|NCT02709746|11269597|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0
7126839|NCT02709746|11269598|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0
7126840|NCT02709746|11269599|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0
7126841|NCT02709746|11269595|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14
7126842|NCT02709746|11269596|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0
7126843|NCT02709746|11269597|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0
7126844|NCT02709746|11269598|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0
7126845|NCT02709746|11269599|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0
7126846|NCT02709746|11269595|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12
7126847|NCT02709746|11269596|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
7126848|NCT02709746|11269597|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
7126849|NCT02709746|11269598|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
7126850|NCT02709746|11269599|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
7126851|NCT02709746|11269595|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7
7126852|NCT02709746|11269596|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
7126853|NCT02709746|11269597|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
7126854|NCT02709746|11269598|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
7126855|NCT02709746|11269599|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
7126856|NCT02709746|11269595|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2
7126857|NCT02709746|11269596|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0
7126858|NCT02709746|11269597|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0
7126859|NCT02709746|11269598|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0
7126860|NCT02709746|11269599|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0
7126861|NCT02709746|11269595|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12
7126862|NCT02709746|11269596|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
7126863|NCT02709746|11269597|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
7126864|NCT02709746|11269598|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
7126865|NCT02709746|11269599|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
7126866|NCT02709746|11269595|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7
7126867|NCT02709746|11269596|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
7126868|NCT02709746|11269597|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
7126869|NCT02709746|11269598|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
7126870|NCT02709746|11269599|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
7126871|NCT02709746|11269595|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7
7126872|NCT02709746|11269596|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
7126873|NCT02709746|11269597|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
7126874|NCT02709746|11269598|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
7126875|NCT02709746|11269599|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
7126876|NCT02709746|11269595|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103
7126877|NCT02709746|11269596|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
7126878|NCT02709746|11269597|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
7126879|NCT02709746|11269598|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
7126880|NCT02709746|11269599|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
7126881|NCT02709746|11269595|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0
7126882|NCT02709746|11269596|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1
7126883|NCT02709746|11269597|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0
7126884|NCT02709746|11269598|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0
7126885|NCT02709746|11269599|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2
7126886|NCT02709746|11269595|FG000|Phase B (Double-blind Treatment Period)|Other|0
7126887|NCT02709746|11269596|FG001|Phase B (Double-blind Treatment Period)|Other|6
7126888|NCT02709746|11269597|FG002|Phase B (Double-blind Treatment Period)|Other|5
7126889|NCT02709746|11269598|FG003|Phase B (Double-blind Treatment Period)|Other|6
7126890|NCT02709746|11269599|FG004|Phase B (Double-blind Treatment Period)|Other|7
7126891|NCT02709746|11269595|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0
7126892|NCT02709746|11269596|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1
7126893|NCT02709746|11269597|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4
7126894|NCT02709746|11269598|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1
7126895|NCT02709746|11269599|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0
7126896|NCT02709746|11269595|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0
7126897|NCT02709746|11269596|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3
7126898|NCT02709746|11269597|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0
7126899|NCT02709746|11269598|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1
7126900|NCT02709746|11269599|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2
7126901|NCT02709746|11269595|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0
7126902|NCT02709746|11269596|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4
7126903|NCT02709746|11269597|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8
7126904|NCT02709746|11269598|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5
7126905|NCT02709746|11269599|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2
7126906|NCT02709746|11269595|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0
7126907|NCT02709746|11269596|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2
7126908|NCT02709746|11269597|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2
7126909|NCT02709746|11269598|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2
7126910|NCT02709746|11269599|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1
7126911|NCT02709746|11269595|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0
7126912|NCT02709746|11269596|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0
7126913|NCT02709746|11269597|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1
7126914|NCT02709746|11269598|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0
7126915|NCT02709746|11269599|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0
7126916|NCT02709746|11269595|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0
7126917|NCT02709746|11269596|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4
7126918|NCT02709746|11269597|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2
7126919|NCT02709746|11269598|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0
7126920|NCT02709746|11269599|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2
7126921|NCT02709785|11269614|FG000|Overall Study|Withdrawal by Subject|1
7126922|NCT02709785|11269615|FG001|Overall Study|Withdrawal by Subject|2
7126923|NCT02709785|11269616|FG002|Overall Study|Withdrawal by Subject|1
7126924|NCT02709889|11269632|FG000|Overall Study|Withdrawal by Subject|11
7126925|NCT02709889|11269633|FG001|Overall Study|Withdrawal by Subject|10
7126926|NCT02709889|11269634|FG002|Overall Study|Withdrawal by Subject|2
7126927|NCT02709889|11269635|FG003|Overall Study|Withdrawal by Subject|12
7126928|NCT02709889|11269632|FG000|Overall Study|Death|25
7126929|NCT02709889|11269633|FG001|Overall Study|Death|38
7126930|NCT02709889|11269634|FG002|Overall Study|Death|4
7126931|NCT02709889|11269635|FG003|Overall Study|Death|44
7126932|NCT02709889|11269632|FG000|Overall Study|Physician Decision|1
7126933|NCT02709889|11269633|FG001|Overall Study|Physician Decision|2
7126934|NCT02709889|11269634|FG002|Overall Study|Physician Decision|3
7126935|NCT02709889|11269635|FG003|Overall Study|Physician Decision|5
7126936|NCT02709889|11269632|FG000|Overall Study|Lost to Follow-up|2
7126937|NCT02709889|11269633|FG001|Overall Study|Lost to Follow-up|0
7126938|NCT02709889|11269634|FG002|Overall Study|Lost to Follow-up|0
7126939|NCT02709889|11269635|FG003|Overall Study|Lost to Follow-up|4
7126940|NCT02709889|11269632|FG000|Overall Study|Study Terminated by Sponsor|4
7126941|NCT02709889|11269633|FG001|Overall Study|Study Terminated by Sponsor|6
7126942|NCT02709889|11269634|FG002|Overall Study|Study Terminated by Sponsor|2
7126943|NCT02709889|11269635|FG003|Overall Study|Study Terminated by Sponsor|17
7126944|NCT02709889|11269632|FG000|Overall Study|Other, Not Specified|0
7126945|NCT02709889|11269633|FG001|Overall Study|Other, Not Specified|1
7126946|NCT02709889|11269634|FG002|Overall Study|Other, Not Specified|1
7126947|NCT02709889|11269635|FG003|Overall Study|Other, Not Specified|6
7126948|NCT02710045|11269683|FG000|Overall Study|Death|1
7126949|NCT02710045|11269684|FG001|Overall Study|Death|2
7126950|NCT02710045|11269685|FG002|Overall Study|Death|0
7126951|NCT02710045|11269683|FG000|Overall Study|Withdrawal by Subject|6
7126952|NCT02710045|11269684|FG001|Overall Study|Withdrawal by Subject|6
7126953|NCT02710045|11269685|FG002|Overall Study|Withdrawal by Subject|2
7126954|NCT02710045|11269683|FG000|Overall Study|Protocol Violation|1
7126955|NCT02710045|11269684|FG001|Overall Study|Protocol Violation|2
7126956|NCT02710045|11269685|FG002|Overall Study|Protocol Violation|3
7126957|NCT02710045|11269683|FG000|Overall Study|Lost to Follow-up|3
7126958|NCT02710045|11269684|FG001|Overall Study|Lost to Follow-up|6
7126959|NCT02710045|11269685|FG002|Overall Study|Lost to Follow-up|7
7126960|NCT02710045|11269683|FG000|Overall Study|Physician Decision|0
7126961|NCT02710045|11269684|FG001|Overall Study|Physician Decision|0
7126962|NCT02710045|11269685|FG002|Overall Study|Physician Decision|1
7126963|NCT02710045|11269683|FG000|Overall Study|Poor Attendance|0
7126964|NCT02710045|11269684|FG001|Overall Study|Poor Attendance|1
7126965|NCT02710045|11269685|FG002|Overall Study|Poor Attendance|0
7126966|NCT02710071|11269695|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3
7126967|NCT02710071|11269696|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4
7126968|NCT02710071|11269695|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1
7126969|NCT02710071|11269696|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2
7126970|NCT02710136|11269705|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1
7126971|NCT02710136|11269706|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0
7126972|NCT02710214|11269715|FG000|Overall Study|Lost to Follow-up|1
7126973|NCT02710214|11269716|FG001|Overall Study|Lost to Follow-up|0
7126974|NCT02710214|11269715|FG000|Overall Study|Lack of Efficacy|0
7126975|NCT02710214|11269716|FG001|Overall Study|Lack of Efficacy|1
7126976|NCT02710214|11269715|FG000|Overall Study|Death|0
7126977|NCT02710214|11269716|FG001|Overall Study|Death|1
7126978|NCT02710292|11269726|FG000|Period 1, First 10 Days of Wear|Adverse Event|0
7126979|NCT02710292|11269727|FG001|Period 1, First 10 Days of Wear|Adverse Event|1
7126980|NCT02710292|11269726|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1
7126981|NCT02710292|11269727|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2
7126982|NCT02710422|11269736|FG000|Overall Study|Termination of study|9
7126983|NCT02710422|11269737|FG001|Overall Study|Termination of study|9
7126984|NCT02711306|11269828|FG000|Overall Study|Withdrawal by Subject|2
7126985|NCT02711306|11269829|FG001|Overall Study|Withdrawal by Subject|2
7126986|NCT02711345|11269845|FG000|Overall Study|Adverse Event|0
7126987|NCT02711345|11269846|FG001|Overall Study|Adverse Event|0
7126988|NCT02711345|11269847|FG002|Overall Study|Adverse Event|0
7126989|NCT02711345|11269848|FG003|Overall Study|Adverse Event|1
7126990|NCT02711345|11269849|FG004|Overall Study|Adverse Event|1
7126991|NCT02711345|11269850|FG005|Overall Study|Adverse Event|2
7126992|NCT02711345|11269851|FG006|Overall Study|Adverse Event|1
7126993|NCT02711345|11269852|FG007|Overall Study|Adverse Event|0
7126994|NCT02711345|11269853|FG008|Overall Study|Adverse Event|0
7126995|NCT02711345|11269854|FG009|Overall Study|Adverse Event|2
7126996|NCT02711345|11269845|FG000|Overall Study|Physician Decision|0
7126997|NCT02711345|11269846|FG001|Overall Study|Physician Decision|0
7126998|NCT02711345|11269847|FG002|Overall Study|Physician Decision|1
7126999|NCT02711345|11269848|FG003|Overall Study|Physician Decision|0
7127000|NCT02711345|11269849|FG004|Overall Study|Physician Decision|0
7127001|NCT02711345|11269850|FG005|Overall Study|Physician Decision|0
7127002|NCT02711345|11269851|FG006|Overall Study|Physician Decision|0
7127003|NCT02711345|11269852|FG007|Overall Study|Physician Decision|0
7127004|NCT02711345|11269853|FG008|Overall Study|Physician Decision|1
7127005|NCT02711345|11269854|FG009|Overall Study|Physician Decision|0
7127006|NCT02711345|11269845|FG000|Overall Study|Progressive disease|1
7127007|NCT02711345|11269846|FG001|Overall Study|Progressive disease|3
7127008|NCT02711345|11269847|FG002|Overall Study|Progressive disease|5
7127009|NCT02711345|11269848|FG003|Overall Study|Progressive disease|3
7127010|NCT02711345|11269849|FG004|Overall Study|Progressive disease|7
7127011|NCT02711345|11269850|FG005|Overall Study|Progressive disease|2
7127012|NCT02711345|11269851|FG006|Overall Study|Progressive disease|8
7127013|NCT02711345|11269852|FG007|Overall Study|Progressive disease|4
7127014|NCT02711345|11269853|FG008|Overall Study|Progressive disease|5
7127015|NCT02711345|11269854|FG009|Overall Study|Progressive disease|6
7127016|NCT02711345|11269845|FG000|Overall Study|Subject/guardian decision|0
7127017|NCT02711345|11269846|FG001|Overall Study|Subject/guardian decision|0
7127018|NCT02711345|11269847|FG002|Overall Study|Subject/guardian decision|0
7127019|NCT02711345|11269848|FG003|Overall Study|Subject/guardian decision|0
7127020|NCT02711345|11269849|FG004|Overall Study|Subject/guardian decision|0
7127021|NCT02711345|11269850|FG005|Overall Study|Subject/guardian decision|2
7127022|NCT02711345|11269851|FG006|Overall Study|Subject/guardian decision|3
7127023|NCT02711345|11269852|FG007|Overall Study|Subject/guardian decision|1
7127024|NCT02711345|11269853|FG008|Overall Study|Subject/guardian decision|0
7127025|NCT02711345|11269854|FG009|Overall Study|Subject/guardian decision|4
7127026|NCT02711345|11269845|FG000|Overall Study|Death|1
7127027|NCT02711345|11269846|FG001|Overall Study|Death|0
7127028|NCT02711345|11269847|FG002|Overall Study|Death|0
7127029|NCT02711345|11269848|FG003|Overall Study|Death|0
7127030|NCT02711345|11269849|FG004|Overall Study|Death|0
7127031|NCT02711345|11269850|FG005|Overall Study|Death|0
7127032|NCT02711345|11269851|FG006|Overall Study|Death|0
7127033|NCT02711345|11269852|FG007|Overall Study|Death|1
7127034|NCT02711345|11269853|FG008|Overall Study|Death|0
7127035|NCT02711345|11269854|FG009|Overall Study|Death|0
7127036|NCT02711553|11269885|FG000|Overall Study|Withdrawal by Subject|2
7127037|NCT02711553|11269886|FG001|Overall Study|Withdrawal by Subject|1
7127038|NCT02711553|11269887|FG002|Overall Study|Withdrawal by Subject|1
7127039|NCT02711553|11269888|FG003|Overall Study|Withdrawal by Subject|0
7127040|NCT02711553|11269885|FG000|Overall Study|Lost to Follow-up|3
7127041|NCT02711553|11269886|FG001|Overall Study|Lost to Follow-up|3
7127042|NCT02711553|11269887|FG002|Overall Study|Lost to Follow-up|6
7127043|NCT02711553|11269888|FG003|Overall Study|Lost to Follow-up|3
7127044|NCT02711553|11269885|FG000|Overall Study|On Study Treatment at Study Conclusion|1
7127045|NCT02711553|11269886|FG001|Overall Study|On Study Treatment at Study Conclusion|1
7127046|NCT02711553|11269887|FG002|Overall Study|On Study Treatment at Study Conclusion|3
7127047|NCT02711553|11269888|FG003|Overall Study|On Study Treatment at Study Conclusion|1
7127048|NCT02711800|11269900|FG000|Overall Study|Lost to Follow-up|1
7127049|NCT02711800|11269900|FG000|Overall Study|Withdrawal by Subject|1
7127050|NCT02711956|11269928|FG000|Overall Study|Adverse Event|0
7127051|NCT02711956|11269929|FG001|Overall Study|Adverse Event|0
7127052|NCT02711956|11269930|FG002|Overall Study|Adverse Event|0
7127053|NCT02711956|11269931|FG003|Overall Study|Adverse Event|1
7127054|NCT02711956|11269932|FG004|Overall Study|Adverse Event|2
7127055|NCT02711956|11269933|FG005|Overall Study|Adverse Event|0
7127056|NCT02711956|11269934|FG006|Overall Study|Adverse Event|0
7127057|NCT02711956|11269935|FG007|Overall Study|Adverse Event|1
7127058|NCT02711956|11269936|FG008|Overall Study|Adverse Event|1
7127059|NCT02711956|11269937|FG009|Overall Study|Adverse Event|1
7127060|NCT02711956|11269938|FG010|Overall Study|Adverse Event|1
7127061|NCT02711956|11269939|FG011|Overall Study|Adverse Event|0
7127062|NCT02711956|11269940|FG012|Overall Study|Adverse Event|0
7127063|NCT02711956|11269941|FG013|Overall Study|Adverse Event|0
7127064|NCT02711956|11269942|FG014|Overall Study|Adverse Event|2
7127065|NCT02711956|11269928|FG000|Overall Study|Physician Decision|0
7127066|NCT02711956|11269929|FG001|Overall Study|Physician Decision|0
7127067|NCT02711956|11269930|FG002|Overall Study|Physician Decision|0
7127068|NCT02711956|11269931|FG003|Overall Study|Physician Decision|2
7127069|NCT02711956|11269932|FG004|Overall Study|Physician Decision|0
7127070|NCT02711956|11269933|FG005|Overall Study|Physician Decision|0
7127071|NCT02711956|11269934|FG006|Overall Study|Physician Decision|0
7127072|NCT02711956|11269935|FG007|Overall Study|Physician Decision|0
7127073|NCT02711956|11269936|FG008|Overall Study|Physician Decision|0
7127074|NCT02711956|11269937|FG009|Overall Study|Physician Decision|0
7127075|NCT02711956|11269938|FG010|Overall Study|Physician Decision|0
7127076|NCT02711956|11269939|FG011|Overall Study|Physician Decision|0
7127077|NCT02711956|11269940|FG012|Overall Study|Physician Decision|0
7127078|NCT02711956|11269941|FG013|Overall Study|Physician Decision|0
7127079|NCT02711956|11269942|FG014|Overall Study|Physician Decision|0
7127080|NCT02711956|11269928|FG000|Overall Study|Withdrawal by Subject|0
7127081|NCT02711956|11269929|FG001|Overall Study|Withdrawal by Subject|0
7127082|NCT02711956|11269930|FG002|Overall Study|Withdrawal by Subject|0
7127083|NCT02711956|11269931|FG003|Overall Study|Withdrawal by Subject|0
7127084|NCT02711956|11269932|FG004|Overall Study|Withdrawal by Subject|0
7127085|NCT02711956|11269933|FG005|Overall Study|Withdrawal by Subject|0
7127086|NCT02711956|11269934|FG006|Overall Study|Withdrawal by Subject|1
7127087|NCT02711956|11269935|FG007|Overall Study|Withdrawal by Subject|0
7127088|NCT02711956|11269936|FG008|Overall Study|Withdrawal by Subject|0
7127089|NCT02711956|11269937|FG009|Overall Study|Withdrawal by Subject|0
7127090|NCT02711956|11269938|FG010|Overall Study|Withdrawal by Subject|0
7127091|NCT02711956|11269939|FG011|Overall Study|Withdrawal by Subject|1
7127092|NCT02711956|11269940|FG012|Overall Study|Withdrawal by Subject|6
7127093|NCT02711956|11269941|FG013|Overall Study|Withdrawal by Subject|0
7127094|NCT02711956|11269942|FG014|Overall Study|Withdrawal by Subject|1
7127095|NCT02711956|11269928|FG000|Overall Study|Clinical progression|1
7127096|NCT02711956|11269929|FG001|Overall Study|Clinical progression|0
7127097|NCT02711956|11269930|FG002|Overall Study|Clinical progression|0
7127098|NCT02711956|11269931|FG003|Overall Study|Clinical progression|0
7127099|NCT02711956|11269932|FG004|Overall Study|Clinical progression|0
7127100|NCT02711956|11269933|FG005|Overall Study|Clinical progression|0
7127101|NCT02711956|11269934|FG006|Overall Study|Clinical progression|1
7127102|NCT02711956|11269935|FG007|Overall Study|Clinical progression|0
7127103|NCT02711956|11269936|FG008|Overall Study|Clinical progression|1
7127104|NCT02711956|11269937|FG009|Overall Study|Clinical progression|0
7127105|NCT02711956|11269938|FG010|Overall Study|Clinical progression|0
7127106|NCT02711956|11269939|FG011|Overall Study|Clinical progression|2
7127107|NCT02711956|11269940|FG012|Overall Study|Clinical progression|4
7127108|NCT02711956|11269941|FG013|Overall Study|Clinical progression|1
7127109|NCT02711956|11269942|FG014|Overall Study|Clinical progression|1
7127110|NCT02711956|11269928|FG000|Overall Study|Radiographic progression|1
7127111|NCT02711956|11269929|FG001|Overall Study|Radiographic progression|1
7127112|NCT02711956|11269930|FG002|Overall Study|Radiographic progression|2
7127113|NCT02711956|11269931|FG003|Overall Study|Radiographic progression|0
7127114|NCT02711956|11269932|FG004|Overall Study|Radiographic progression|1
7127115|NCT02711956|11269933|FG005|Overall Study|Radiographic progression|0
7127116|NCT02711956|11269934|FG006|Overall Study|Radiographic progression|0
7127117|NCT02711956|11269935|FG007|Overall Study|Radiographic progression|0
7127118|NCT02711956|11269936|FG008|Overall Study|Radiographic progression|2
7127119|NCT02711956|11269937|FG009|Overall Study|Radiographic progression|1
7127120|NCT02711956|11269938|FG010|Overall Study|Radiographic progression|0
7127121|NCT02711956|11269939|FG011|Overall Study|Radiographic progression|5
7127122|NCT02711956|11269940|FG012|Overall Study|Radiographic progression|3
7127123|NCT02711956|11269941|FG013|Overall Study|Radiographic progression|0
7127124|NCT02711956|11269942|FG014|Overall Study|Radiographic progression|1
7127125|NCT02711956|11269928|FG000|Overall Study|PSA progression with clinical progression|0
7127126|NCT02711956|11269929|FG001|Overall Study|PSA progression with clinical progression|0
7127127|NCT02711956|11269930|FG002|Overall Study|PSA progression with clinical progression|0
7127128|NCT02711956|11269931|FG003|Overall Study|PSA progression with clinical progression|0
7127129|NCT02711956|11269932|FG004|Overall Study|PSA progression with clinical progression|1
7127130|NCT02711956|11269933|FG005|Overall Study|PSA progression with clinical progression|0
7127131|NCT02711956|11269934|FG006|Overall Study|PSA progression with clinical progression|0
7127132|NCT02711956|11269935|FG007|Overall Study|PSA progression with clinical progression|0
7127133|NCT02711956|11269936|FG008|Overall Study|PSA progression with clinical progression|0
7127134|NCT02711956|11269937|FG009|Overall Study|PSA progression with clinical progression|0
7127135|NCT02711956|11269938|FG010|Overall Study|PSA progression with clinical progression|0
7127136|NCT02711956|11269939|FG011|Overall Study|PSA progression with clinical progression|0
7127137|NCT02711956|11269940|FG012|Overall Study|PSA progression with clinical progression|1
7127138|NCT02711956|11269941|FG013|Overall Study|PSA progression with clinical progression|1
7127139|NCT02711956|11269942|FG014|Overall Study|PSA progression with clinical progression|0
7127140|NCT02711956|11269928|FG000|Overall Study|PSA progression with radiographic progression|0
7127141|NCT02711956|11269929|FG001|Overall Study|PSA progression with radiographic progression|1
7127142|NCT02711956|11269930|FG002|Overall Study|PSA progression with radiographic progression|0
7127143|NCT02711956|11269931|FG003|Overall Study|PSA progression with radiographic progression|0
7127144|NCT02711956|11269932|FG004|Overall Study|PSA progression with radiographic progression|0
7127145|NCT02711956|11269933|FG005|Overall Study|PSA progression with radiographic progression|2
7127146|NCT02711956|11269934|FG006|Overall Study|PSA progression with radiographic progression|2
7127147|NCT02711956|11269935|FG007|Overall Study|PSA progression with radiographic progression|1
7127148|NCT02711956|11269936|FG008|Overall Study|PSA progression with radiographic progression|0
7127149|NCT02711956|11269937|FG009|Overall Study|PSA progression with radiographic progression|1
7127150|NCT02711956|11269938|FG010|Overall Study|PSA progression with radiographic progression|0
7127151|NCT02711956|11269939|FG011|Overall Study|PSA progression with radiographic progression|1
7127152|NCT02711956|11269940|FG012|Overall Study|PSA progression with radiographic progression|2
7127153|NCT02711956|11269941|FG013|Overall Study|PSA progression with radiographic progression|3
7127154|NCT02711956|11269942|FG014|Overall Study|PSA progression with radiographic progression|3
7127155|NCT02711995|11269983|FG000|Washout (90 Days)|Conflicting medication|1
7127156|NCT02712008|11269992|FG000|Baseline (Day 1) up to Week 12|Death|3
7127157|NCT02712008|11269993|FG001|Baseline (Day 1) up to Week 12|Death|0
7127158|NCT02712008|11269994|FG002|Baseline (Day 1) up to Week 12|Death|0
7127159|NCT02712008|11269995|FG003|Baseline (Day 1) up to Week 12|Death|0
7127160|NCT02712008|11269996|FG004|Baseline (Day 1) up to Week 12|Death|0
7127161|NCT02712008|11269997|FG005|Baseline (Day 1) up to Week 12|Death|0
7127162|NCT02712008|11269998|FG006|Baseline (Day 1) up to Week 12|Death|0
7127163|NCT02712008|11269999|FG007|Baseline (Day 1) up to Week 12|Death|0
7127164|NCT02712008|11269992|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7127165|NCT02712008|11269993|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2
7127166|NCT02712008|11269994|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1
7127167|NCT02712008|11269995|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7127168|NCT02712008|11269996|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7127169|NCT02712008|11269997|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7127170|NCT02712008|11269998|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7127171|NCT02712008|11269999|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7127172|NCT02712008|11269992|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1
7127173|NCT02712008|11269993|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7127174|NCT02712008|11269994|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2
7127175|NCT02712008|11269995|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7127176|NCT02712008|11269996|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7127177|NCT02712008|11269997|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7127178|NCT02712008|11269998|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7127179|NCT02712008|11269999|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7127180|NCT02712008|11269992|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0
7127181|NCT02712008|11269993|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0
7127182|NCT02712008|11269994|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1
7127183|NCT02712008|11269995|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0
7127184|NCT02712008|11269996|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0
7127185|NCT02712008|11269997|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0
7127186|NCT02712008|11269998|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0
7127187|NCT02712008|11269999|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0
7127188|NCT02712008|11269992|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0
7127189|NCT02712008|11269993|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1
7127190|NCT02712008|11269994|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0
7127191|NCT02712008|11269995|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0
7127192|NCT02712008|11269996|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0
7127193|NCT02712008|11269997|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0
7127194|NCT02712008|11269998|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0
7127195|NCT02712008|11269999|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0
7127196|NCT02712008|11269992|FG000|From Week 12 up to Week 36|Adverse Event|0
7127197|NCT02712008|11269993|FG001|From Week 12 up to Week 36|Adverse Event|0
7127198|NCT02712008|11269994|FG002|From Week 12 up to Week 36|Adverse Event|0
7127199|NCT02712008|11269995|FG003|From Week 12 up to Week 36|Adverse Event|0
7127200|NCT02712008|11269996|FG004|From Week 12 up to Week 36|Adverse Event|1
7127201|NCT02712008|11269997|FG005|From Week 12 up to Week 36|Adverse Event|0
7127202|NCT02712008|11269998|FG006|From Week 12 up to Week 36|Adverse Event|0
7127203|NCT02712008|11269999|FG007|From Week 12 up to Week 36|Adverse Event|2
7127204|NCT02712008|11269992|FG000|From Week 12 up to Week 36|Death|1
7127205|NCT02712008|11269993|FG001|From Week 12 up to Week 36|Death|0
7127206|NCT02712008|11269994|FG002|From Week 12 up to Week 36|Death|0
7127207|NCT02712008|11269995|FG003|From Week 12 up to Week 36|Death|0
7127208|NCT02712008|11269996|FG004|From Week 12 up to Week 36|Death|0
7127209|NCT02712008|11269997|FG005|From Week 12 up to Week 36|Death|0
7127210|NCT02712008|11269998|FG006|From Week 12 up to Week 36|Death|1
7127211|NCT02712008|11269999|FG007|From Week 12 up to Week 36|Death|0
7127212|NCT02712008|11269992|FG000|From Week 12 up to Week 36|Lost to Follow-up|0
7127213|NCT02712008|11269993|FG001|From Week 12 up to Week 36|Lost to Follow-up|0
7127214|NCT02712008|11269994|FG002|From Week 12 up to Week 36|Lost to Follow-up|0
7127215|NCT02712008|11269995|FG003|From Week 12 up to Week 36|Lost to Follow-up|1
7127216|NCT02712008|11269996|FG004|From Week 12 up to Week 36|Lost to Follow-up|0
7127217|NCT02712008|11269997|FG005|From Week 12 up to Week 36|Lost to Follow-up|0
7127218|NCT02712008|11269998|FG006|From Week 12 up to Week 36|Lost to Follow-up|1
7127219|NCT02712008|11269999|FG007|From Week 12 up to Week 36|Lost to Follow-up|0
7127220|NCT02712008|11269992|FG000|From Week 12 up to Week 36|Physician Decision|0
7127221|NCT02712008|11269993|FG001|From Week 12 up to Week 36|Physician Decision|0
6806136|NCT01970865|10808457|FG006|Overall Study|Study ongoing|2
7127222|NCT02712008|11269994|FG002|From Week 12 up to Week 36|Physician Decision|0
7127223|NCT02712008|11269995|FG003|From Week 12 up to Week 36|Physician Decision|1
7127224|NCT02712008|11269996|FG004|From Week 12 up to Week 36|Physician Decision|1
7127225|NCT02712008|11269997|FG005|From Week 12 up to Week 36|Physician Decision|0
7127226|NCT02712008|11269998|FG006|From Week 12 up to Week 36|Physician Decision|0
7127227|NCT02712008|11269999|FG007|From Week 12 up to Week 36|Physician Decision|0
7127228|NCT02712008|11269992|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0
7127229|NCT02712008|11269993|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0
7127230|NCT02712008|11269994|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0
7127231|NCT02712008|11269995|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0
7127232|NCT02712008|11269996|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0
6806137|NCT01970865|10808458|FG007|Overall Study|Study ongoing|0
6806138|NCT01970865|10808459|FG008|Overall Study|Study ongoing|1
6806139|NCT01970865|10808460|FG009|Overall Study|Study ongoing|3
6806140|NCT01970865|10808461|FG010|Overall Study|Study ongoing|29
6806141|NCT01970865|10808462|FG011|Overall Study|Study ongoing|22
6806142|NCT01970865|10808463|FG012|Overall Study|Study ongoing|43
6806143|NCT01970865|10808464|FG013|Overall Study|Study ongoing|41
7127233|NCT02712008|11269997|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0
7127234|NCT02712008|11269998|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3
7127235|NCT02712008|11269999|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2
7127236|NCT02712320|11270029|FG000|Overall Study|Lost to Follow-up|1
7127237|NCT02712320|11270029|FG000|Overall Study|Withdrawal by Subject|1
7127238|NCT02712320|11270029|FG000|Overall Study|Transferred to another facility|1
7127239|NCT02712320|11270029|FG000|Overall Study|Treating with the prohibited medications|2
7127240|NCT02712333|11270035|FG000|First Period|Withdrawal by Subject|3
7127241|NCT02712333|11270036|FG001|First Period|Withdrawal by Subject|2
7127242|NCT02712398|11270064|FG000|Overall Study|Withdrawal by Subject|6
7127243|NCT02712398|11270064|FG000|Overall Study|Lost to Follow-up|6
7127244|NCT02712398|11270064|FG000|Overall Study|Sponsor Decision|1
7127245|NCT02712398|11270064|FG000|Overall Study|Physician Decision|1
7127246|NCT02712398|11270064|FG000|Overall Study|Death|2
7127247|NCT02712398|11270064|FG000|Overall Study|Re-operation|21
7127248|NCT02712424|11270070|FG000|Overall Study|Lost to Follow-up|34
7127249|NCT02712424|11270071|FG001|Overall Study|Lost to Follow-up|32
7127250|NCT02712554|11270079|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0
7127251|NCT02712554|11270080|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13
7127252|NCT02712554|11270079|FG000|Part B: Qualification Phase|Sponsor Decision|0
7127253|NCT02712554|11270080|FG001|Part B: Qualification Phase|Sponsor Decision|4
7127254|NCT02712554|11270079|FG000|Part B: Qualification Phase|Withdrawal by Subject|0
7127255|NCT02712554|11270080|FG001|Part B: Qualification Phase|Withdrawal by Subject|3
7127256|NCT02712554|11270079|FG000|Part B: Qualification Phase|Adverse Event|0
7127257|NCT02712554|11270080|FG001|Part B: Qualification Phase|Adverse Event|1
7127258|NCT02712554|11270079|FG000|Part B: Treatment Phase|Adverse Event|0
7127259|NCT02712554|11270080|FG001|Part B: Treatment Phase|Adverse Event|1
7127260|NCT02712554|11270079|FG000|Part B: Treatment Phase|Withdrawal by Subject|0
7127261|NCT02712554|11270080|FG001|Part B: Treatment Phase|Withdrawal by Subject|1
7127262|NCT02712554|11270079|FG000|Part B: Treatment Phase|Other|0
7127263|NCT02712554|11270080|FG001|Part B: Treatment Phase|Other|1
7127264|NCT02712788|11270105|FG000|Overall Study|Physician Decision|1
7127265|NCT02712788|11270106|FG001|Overall Study|Physician Decision|0
7127266|NCT02712788|11270105|FG000|Overall Study|Protocol Violation|1
7127267|NCT02712788|11270106|FG001|Overall Study|Protocol Violation|0
7127268|NCT02712983|11270121|FG000|Treatment Phase|Adverse Event|3
7127269|NCT02712983|11270122|FG001|Treatment Phase|Adverse Event|1
7127270|NCT02712983|11270123|FG002|Treatment Phase|Adverse Event|1
7127271|NCT02712983|11270124|FG003|Treatment Phase|Adverse Event|4
7127272|NCT02712983|11270125|FG004|Treatment Phase|Adverse Event|3
7127273|NCT02712983|11270126|FG005|Treatment Phase|Adverse Event|0
7127274|NCT02712983|11270127|FG006|Treatment Phase|Adverse Event|6
7127275|NCT02712983|11270128|FG007|Treatment Phase|Adverse Event|6
7127276|NCT02712983|11270129|FG008|Treatment Phase|Adverse Event|1
7127277|NCT02712983|11270121|FG000|Treatment Phase|Protocol Deviation|0
7127278|NCT02712983|11270122|FG001|Treatment Phase|Protocol Deviation|0
7127279|NCT02712983|11270123|FG002|Treatment Phase|Protocol Deviation|0
7127280|NCT02712983|11270124|FG003|Treatment Phase|Protocol Deviation|2
7127281|NCT02712983|11270125|FG004|Treatment Phase|Protocol Deviation|0
7127282|NCT02712983|11270126|FG005|Treatment Phase|Protocol Deviation|0
7127283|NCT02712983|11270127|FG006|Treatment Phase|Protocol Deviation|1
7127284|NCT02712983|11270128|FG007|Treatment Phase|Protocol Deviation|0
7127285|NCT02712983|11270129|FG008|Treatment Phase|Protocol Deviation|0
7127286|NCT02712983|11270121|FG000|Treatment Phase|Technical Problems|0
7127287|NCT02712983|11270122|FG001|Treatment Phase|Technical Problems|0
7127288|NCT02712983|11270123|FG002|Treatment Phase|Technical Problems|0
7127289|NCT02712983|11270124|FG003|Treatment Phase|Technical Problems|0
7127290|NCT02712983|11270125|FG004|Treatment Phase|Technical Problems|0
7127291|NCT02712983|11270126|FG005|Treatment Phase|Technical Problems|0
7127292|NCT02712983|11270127|FG006|Treatment Phase|Technical Problems|1
7127293|NCT02712983|11270128|FG007|Treatment Phase|Technical Problems|0
7127294|NCT02712983|11270129|FG008|Treatment Phase|Technical Problems|0
7127295|NCT02712983|11270121|FG000|Treatment Phase|Physician Decision|0
7127296|NCT02712983|11270122|FG001|Treatment Phase|Physician Decision|0
7127297|NCT02712983|11270123|FG002|Treatment Phase|Physician Decision|0
7127298|NCT02712983|11270124|FG003|Treatment Phase|Physician Decision|0
7127299|NCT02712983|11270125|FG004|Treatment Phase|Physician Decision|0
7127300|NCT02712983|11270126|FG005|Treatment Phase|Physician Decision|0
7127301|NCT02712983|11270127|FG006|Treatment Phase|Physician Decision|0
7127302|NCT02712983|11270128|FG007|Treatment Phase|Physician Decision|1
7127303|NCT02712983|11270129|FG008|Treatment Phase|Physician Decision|1
7127304|NCT02712983|11270121|FG000|Treatment Phase|Subject Decision|2
7127305|NCT02712983|11270122|FG001|Treatment Phase|Subject Decision|0
7127306|NCT02712983|11270123|FG002|Treatment Phase|Subject Decision|0
7127307|NCT02712983|11270124|FG003|Treatment Phase|Subject Decision|2
7127308|NCT02712983|11270125|FG004|Treatment Phase|Subject Decision|1
7127309|NCT02712983|11270126|FG005|Treatment Phase|Subject Decision|0
7127310|NCT02712983|11270127|FG006|Treatment Phase|Subject Decision|1
7127311|NCT02712983|11270128|FG007|Treatment Phase|Subject Decision|2
7127312|NCT02712983|11270129|FG008|Treatment Phase|Subject Decision|0
7127313|NCT02712983|11270121|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
7127314|NCT02712983|11270122|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1
7127315|NCT02712983|11270123|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
7127316|NCT02712983|11270124|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
7127317|NCT02712983|11270125|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
7127318|NCT02712983|11270126|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
7127319|NCT02712983|11270127|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1
7127320|NCT02712983|11270128|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1
7127321|NCT02712983|11270129|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
7127322|NCT02712983|11270121|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
7127323|NCT02712983|11270122|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
7127324|NCT02712983|11270123|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
7127325|NCT02712983|11270124|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1
7127326|NCT02712983|11270125|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
7127327|NCT02712983|11270126|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
7127328|NCT02712983|11270127|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
7127329|NCT02712983|11270128|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
7127330|NCT02712983|11270129|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
7127331|NCT02712983|11270121|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
7127332|NCT02712983|11270122|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
7127333|NCT02712983|11270123|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
7127334|NCT02712983|11270124|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
7127335|NCT02712983|11270125|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2
7127336|NCT02712983|11270126|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1
7127337|NCT02712983|11270127|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1
7127338|NCT02712983|11270128|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2
7127339|NCT02712983|11270129|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
7127340|NCT02712996|11270151|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0
7127341|NCT02712996|11270152|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1
7127342|NCT02713204|11270176|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1
7127343|NCT02713204|11270177|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0
7127344|NCT02713204|11270178|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1
7127345|NCT02713204|11270179|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0
7127346|NCT02713204|11270180|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0
7127347|NCT02713204|11270181|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0
7127348|NCT02713204|11270182|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0
7127349|NCT02713204|11270183|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0
7127350|NCT02713204|11270176|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7127351|NCT02713204|11270177|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7127352|NCT02713204|11270178|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1
7127353|NCT02713204|11270179|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7127354|NCT02713204|11270180|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7127355|NCT02713204|11270181|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7127356|NCT02713204|11270182|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7127357|NCT02713204|11270183|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7127358|NCT02713204|11270176|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7127359|NCT02713204|11270177|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1
7127360|NCT02713204|11270178|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7127361|NCT02713204|11270179|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7127362|NCT02713204|11270180|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7127363|NCT02713204|11270181|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7127364|NCT02713204|11270182|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7127365|NCT02713204|11270183|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7127366|NCT02713204|11270176|FG000|From Week 12 up to Week 36|Adverse Event|1
6806144|NCT01970865|10808465|FG014|Overall Study|Study ongoing|29
6806145|NCT01970865|10808466|FG015|Overall Study|Study ongoing|29
6806146|NCT01970865|10808467|FG016|Overall Study|Study ongoing|2
6806147|NCT00589420|10808528|FG000|Overall Study|screen failure|1
6810386|NCT04426318|10814121|FG000|Overall Study|failed attention checks and had their data removed from analyses|2
6810387|NCT04426318|10814122|FG001|Overall Study|failed attention checks and had their data removed from analyses|2
6811183|NCT02407236|10815054|FG002|Maintenance Study (44 Weeks)|Sponsor decision|0
7127367|NCT02713204|11270177|FG001|From Week 12 up to Week 36|Adverse Event|0
7127368|NCT02713204|11270178|FG002|From Week 12 up to Week 36|Adverse Event|0
7127369|NCT02713204|11270179|FG003|From Week 12 up to Week 36|Adverse Event|1
7127370|NCT02713204|11270180|FG004|From Week 12 up to Week 36|Adverse Event|1
7127371|NCT02713204|11270181|FG005|From Week 12 up to Week 36|Adverse Event|0
7127372|NCT02713204|11270182|FG006|From Week 12 up to Week 36|Adverse Event|2
7127373|NCT02713204|11270183|FG007|From Week 12 up to Week 36|Adverse Event|1
7127374|NCT02713204|11270176|FG000|From Week 12 up to Week 36|Death|0
7127375|NCT02713204|11270177|FG001|From Week 12 up to Week 36|Death|0
7127376|NCT02713204|11270178|FG002|From Week 12 up to Week 36|Death|0
7127377|NCT02713204|11270179|FG003|From Week 12 up to Week 36|Death|1
7127378|NCT02713204|11270180|FG004|From Week 12 up to Week 36|Death|0
7127379|NCT02713204|11270181|FG005|From Week 12 up to Week 36|Death|1
7127380|NCT02713204|11270182|FG006|From Week 12 up to Week 36|Death|0
7127381|NCT02713204|11270183|FG007|From Week 12 up to Week 36|Death|3
7127382|NCT02713204|11270176|FG000|From Week 12 up to Week 36|Lost to Follow-up|0
7127383|NCT02713204|11270177|FG001|From Week 12 up to Week 36|Lost to Follow-up|0
7127384|NCT02713204|11270178|FG002|From Week 12 up to Week 36|Lost to Follow-up|0
7127385|NCT02713204|11270179|FG003|From Week 12 up to Week 36|Lost to Follow-up|2
7127386|NCT02713204|11270180|FG004|From Week 12 up to Week 36|Lost to Follow-up|0
7127387|NCT02713204|11270181|FG005|From Week 12 up to Week 36|Lost to Follow-up|0
7127388|NCT02713204|11270182|FG006|From Week 12 up to Week 36|Lost to Follow-up|0
7127389|NCT02713204|11270183|FG007|From Week 12 up to Week 36|Lost to Follow-up|0
7127390|NCT02713204|11270176|FG000|From Week 12 up to Week 36|Participant Re-located|0
7127391|NCT02713204|11270177|FG001|From Week 12 up to Week 36|Participant Re-located|0
7127392|NCT02713204|11270178|FG002|From Week 12 up to Week 36|Participant Re-located|0
7127393|NCT02713204|11270179|FG003|From Week 12 up to Week 36|Participant Re-located|0
7127394|NCT02713204|11270180|FG004|From Week 12 up to Week 36|Participant Re-located|1
7127395|NCT02713204|11270181|FG005|From Week 12 up to Week 36|Participant Re-located|0
7127396|NCT02713204|11270182|FG006|From Week 12 up to Week 36|Participant Re-located|0
7127397|NCT02713204|11270183|FG007|From Week 12 up to Week 36|Participant Re-located|0
7127398|NCT02713243|11270214|FG000|Overall Study|Abnormal laboratory value(s)#|1
7127399|NCT02713243|11270215|FG001|Overall Study|Abnormal laboratory value(s)#|0
7127400|NCT02713243|11270214|FG000|Overall Study|Administrative problems|0
7127401|NCT02713243|11270215|FG001|Overall Study|Administrative problems|1
7127402|NCT02713243|11270214|FG000|Overall Study|Protocol deviation|0
7127403|NCT02713243|11270215|FG001|Overall Study|Protocol deviation|1
7127404|NCT02713490|11270231|FG000|Overall Study|Withdrawal by Subject|2
7127405|NCT02713490|11270232|FG001|Overall Study|Withdrawal by Subject|1
7127406|NCT02713490|11270231|FG000|Overall Study|Did not receive study drug|1
7127407|NCT02713490|11270232|FG001|Overall Study|Did not receive study drug|0
7127408|NCT02713490|11270231|FG000|Overall Study|Met exclusion criteria|0
7127409|NCT02713490|11270232|FG001|Overall Study|Met exclusion criteria|1
7127410|NCT02713529|11270245|FG000|Overall Study|Withdrawal by Subject|3
7127411|NCT02713529|11270246|FG001|Overall Study|Withdrawal by Subject|1
7127412|NCT02713529|11270247|FG002|Overall Study|Withdrawal by Subject|4
7127413|NCT02713529|11270248|FG003|Overall Study|Withdrawal by Subject|2
7127414|NCT02713529|11270249|FG004|Overall Study|Withdrawal by Subject|0
7127415|NCT02713529|11270250|FG005|Overall Study|Withdrawal by Subject|1
7127416|NCT02713529|11270251|FG006|Overall Study|Withdrawal by Subject|1
7127417|NCT02713529|11270245|FG000|Overall Study|Lost to Follow-up|1
7127418|NCT02713529|11270246|FG001|Overall Study|Lost to Follow-up|0
7127419|NCT02713529|11270247|FG002|Overall Study|Lost to Follow-up|1
7127420|NCT02713529|11270248|FG003|Overall Study|Lost to Follow-up|0
7127421|NCT02713529|11270249|FG004|Overall Study|Lost to Follow-up|0
7127422|NCT02713529|11270250|FG005|Overall Study|Lost to Follow-up|0
7127423|NCT02713529|11270251|FG006|Overall Study|Lost to Follow-up|0
7127424|NCT02713529|11270245|FG000|Overall Study|Death|3
7127425|NCT02713529|11270246|FG001|Overall Study|Death|3
7127426|NCT02713529|11270247|FG002|Overall Study|Death|26
7127427|NCT02713529|11270248|FG003|Overall Study|Death|27
7127428|NCT02713529|11270249|FG004|Overall Study|Death|3
7127429|NCT02713529|11270250|FG005|Overall Study|Death|13
7127430|NCT02713529|11270251|FG006|Overall Study|Death|3
7127431|NCT02713542|11270273|FG000|Overall Study|Use of prohibited medication|14
7127432|NCT02713542|11270274|FG001|Overall Study|Use of prohibited medication|5
7127433|NCT02713542|11270273|FG000|Overall Study|Withdrawal by Subject|4
7127434|NCT02713542|11270274|FG001|Overall Study|Withdrawal by Subject|1
7127435|NCT02713594|11270282|FG000|Overall Study|Withdrawal by Subject|32
7127436|NCT02713594|11270283|FG001|Overall Study|Withdrawal by Subject|22
7127437|NCT02713594|11270282|FG000|Overall Study|Lost to Follow-up|358
7127438|NCT02713594|11270283|FG001|Overall Study|Lost to Follow-up|374
7127439|NCT02713789|11270332|FG000|Overall Study|Lost to Follow-up|0
7127440|NCT02713789|11270333|FG001|Overall Study|Lost to Follow-up|1
7127441|NCT02713789|11270334|FG002|Overall Study|Lost to Follow-up|1
7127442|NCT02713828|11270344|FG000|Overall Study|Death|2
7127443|NCT02713828|11270345|FG001|Overall Study|Death|0
7127444|NCT02713828|11270344|FG000|Overall Study|Withdrawal by Subject|1
7127445|NCT02713828|11270345|FG001|Overall Study|Withdrawal by Subject|0
7127446|NCT02713828|11270344|FG000|Overall Study|study terminated but patient allowed to|2
7127447|NCT02713828|11270345|FG001|Overall Study|study terminated but patient allowed to|0
7127448|NCT02714153|11270350|FG000|Overall Study|Death|1
7127449|NCT02714426|11270376|FG000|Overall Study|Withdrawal by Subject|2
7127450|NCT02714426|11270377|FG001|Overall Study|Withdrawal by Subject|2
7127451|NCT02714569|11270403|FG000|Part A Second Intervention|Withdrawal by Subject|0
7127452|NCT02714569|11270404|FG001|Part A Second Intervention|Withdrawal by Subject|1
7127453|NCT02714569|11270405|FG002|Part A Second Intervention|Withdrawal by Subject|0
7127454|NCT02714569|11270406|FG003|Part A Second Intervention|Withdrawal by Subject|0
7127455|NCT02714569|11270407|FG004|Part A Second Intervention|Withdrawal by Subject|0
7127456|NCT02714569|11270408|FG005|Part A Second Intervention|Withdrawal by Subject|0
7127457|NCT02714569|11270409|FG006|Part A Second Intervention|Withdrawal by Subject|0
7127458|NCT02714569|11270410|FG007|Part A Second Intervention|Withdrawal by Subject|0
7127459|NCT02714569|11270411|FG008|Part A Second Intervention|Withdrawal by Subject|0
7127460|NCT02714569|11270412|FG009|Part A Second Intervention|Withdrawal by Subject|0
7127461|NCT02714569|11270413|FG010|Part A Second Intervention|Withdrawal by Subject|0
7127462|NCT02714569|11270403|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7127463|NCT02714569|11270404|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7127464|NCT02714569|11270405|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7127465|NCT02714569|11270406|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1
7127466|NCT02714569|11270407|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7127467|NCT02714569|11270408|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7127468|NCT02714569|11270409|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7127469|NCT02714569|11270410|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7127470|NCT02714569|11270411|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7127471|NCT02714569|11270412|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7127472|NCT02714569|11270413|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7127473|NCT02714569|11270403|FG000|Part A Third Intervention|Adverse Event|0
7127474|NCT02714569|11270404|FG001|Part A Third Intervention|Adverse Event|0
7127475|NCT02714569|11270405|FG002|Part A Third Intervention|Adverse Event|1
7127476|NCT02714569|11270406|FG003|Part A Third Intervention|Adverse Event|0
7127477|NCT02714569|11270407|FG004|Part A Third Intervention|Adverse Event|0
7127478|NCT02714569|11270408|FG005|Part A Third Intervention|Adverse Event|0
7127479|NCT02714569|11270409|FG006|Part A Third Intervention|Adverse Event|0
7127480|NCT02714569|11270410|FG007|Part A Third Intervention|Adverse Event|0
7127481|NCT02714569|11270411|FG008|Part A Third Intervention|Adverse Event|0
7127482|NCT02714569|11270412|FG009|Part A Third Intervention|Adverse Event|0
7127483|NCT02714569|11270413|FG010|Part A Third Intervention|Adverse Event|0
7127484|NCT02714569|11270403|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1
7127485|NCT02714569|11270404|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
7127486|NCT02714569|11270405|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
7127487|NCT02714569|11270406|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
7127488|NCT02714569|11270407|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
7127489|NCT02714569|11270408|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1
7127490|NCT02714569|11270409|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
7127491|NCT02714569|11270410|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
7127492|NCT02714569|11270411|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
7127493|NCT02714569|11270412|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
7127494|NCT02714569|11270413|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
7127495|NCT02714569|11270403|FG000|Part B (Overall)|Lost to Follow-up|0
7127496|NCT02714569|11270404|FG001|Part B (Overall)|Lost to Follow-up|0
7127497|NCT02714569|11270405|FG002|Part B (Overall)|Lost to Follow-up|0
7127498|NCT02714569|11270406|FG003|Part B (Overall)|Lost to Follow-up|0
7127499|NCT02714569|11270407|FG004|Part B (Overall)|Lost to Follow-up|0
7127500|NCT02714569|11270408|FG005|Part B (Overall)|Lost to Follow-up|0
7127501|NCT02714569|11270409|FG006|Part B (Overall)|Lost to Follow-up|1
7127502|NCT02714569|11270410|FG007|Part B (Overall)|Lost to Follow-up|0
7127503|NCT02714569|11270411|FG008|Part B (Overall)|Lost to Follow-up|0
7127504|NCT02714569|11270412|FG009|Part B (Overall)|Lost to Follow-up|0
7127505|NCT02714569|11270413|FG010|Part B (Overall)|Lost to Follow-up|0
7127506|NCT02714569|11270403|FG000|Part B (Overall)|Withdrawal by Subject|0
7127507|NCT02714569|11270404|FG001|Part B (Overall)|Withdrawal by Subject|0
7127508|NCT02714569|11270405|FG002|Part B (Overall)|Withdrawal by Subject|0
7127509|NCT02714569|11270406|FG003|Part B (Overall)|Withdrawal by Subject|0
7127510|NCT02714569|11270407|FG004|Part B (Overall)|Withdrawal by Subject|0
7127511|NCT02714569|11270408|FG005|Part B (Overall)|Withdrawal by Subject|0
7127512|NCT02714569|11270409|FG006|Part B (Overall)|Withdrawal by Subject|0
7127513|NCT02714569|11270410|FG007|Part B (Overall)|Withdrawal by Subject|1
7127514|NCT02714569|11270411|FG008|Part B (Overall)|Withdrawal by Subject|0
7127515|NCT02714569|11270412|FG009|Part B (Overall)|Withdrawal by Subject|1
7127516|NCT02714569|11270413|FG010|Part B (Overall)|Withdrawal by Subject|0
7127517|NCT02714569|11270403|FG000|Part B (Overall)|Adverse Event|0
7127518|NCT02714569|11270404|FG001|Part B (Overall)|Adverse Event|0
7127519|NCT02714569|11270405|FG002|Part B (Overall)|Adverse Event|0
7127520|NCT02714569|11270406|FG003|Part B (Overall)|Adverse Event|0
7127521|NCT02714569|11270407|FG004|Part B (Overall)|Adverse Event|0
7127522|NCT02714569|11270408|FG005|Part B (Overall)|Adverse Event|0
7127523|NCT02714569|11270409|FG006|Part B (Overall)|Adverse Event|0
7127524|NCT02714569|11270410|FG007|Part B (Overall)|Adverse Event|0
7127525|NCT02714569|11270411|FG008|Part B (Overall)|Adverse Event|0
7127526|NCT02714569|11270412|FG009|Part B (Overall)|Adverse Event|1
7127527|NCT02714569|11270413|FG010|Part B (Overall)|Adverse Event|0
7127528|NCT02714595|11270475|FG000|Overall Study|Lost to Follow-up|1
7127529|NCT02714595|11270476|FG001|Overall Study|Lost to Follow-up|0
7127530|NCT02714595|11270475|FG000|Overall Study|Withdrawal by Subject|1
7127531|NCT02714595|11270476|FG001|Overall Study|Withdrawal by Subject|2
7127532|NCT02714595|11270475|FG000|Overall Study|Lack of Efficacy|0
7127533|NCT02714595|11270476|FG001|Overall Study|Lack of Efficacy|1
7127534|NCT02714595|11270475|FG000|Overall Study|Death|30
7127535|NCT02714595|11270476|FG001|Overall Study|Death|9
7127536|NCT02714595|11270475|FG000|Overall Study|Other-Miscellaneous|0
7127537|NCT02714595|11270476|FG001|Overall Study|Other-Miscellaneous|1
7127538|NCT02714868|11270502|FG000|Overall Study|Withdrawal by Subject|3
7127539|NCT02714868|11270503|FG001|Overall Study|Withdrawal by Subject|0
7127540|NCT02714868|11270502|FG000|Overall Study|PI withdrawal safety risk self/others|1
7127541|NCT02714868|11270503|FG001|Overall Study|PI withdrawal safety risk self/others|0
7127542|NCT02714868|11270502|FG000|Overall Study|PI withdraw did not meet inclusion|1
7127543|NCT02714868|11270503|FG001|Overall Study|PI withdraw did not meet inclusion|0
7127544|NCT02715258|11270537|FG000|Overall Study|Withdrawal by Subject|6
7127545|NCT02715258|11270538|FG001|Overall Study|Withdrawal by Subject|1
6806148|NCT04993339|10808538|FG000|Overall Study|Lost to Follow-up|0
7127546|NCT02715258|11270537|FG000|Overall Study|Lost to Follow-up|7
7127547|NCT02715258|11270538|FG001|Overall Study|Lost to Follow-up|1
7127548|NCT02715258|11270537|FG000|Overall Study|Terminated by Sponsor|0
7127549|NCT02715258|11270538|FG001|Overall Study|Terminated by Sponsor|1
7127550|NCT02715258|11270537|FG000|Overall Study|Death|0
7127551|NCT02715258|11270538|FG001|Overall Study|Death|1
7127552|NCT02715258|11270537|FG000|Overall Study|Subject non-compliant|1
7127553|NCT02715258|11270538|FG001|Overall Study|Subject non-compliant|1
7127554|NCT02715258|11270537|FG000|Overall Study|GCP violation|2
7127555|NCT02715258|11270538|FG001|Overall Study|GCP violation|1
7127556|NCT02715726|11270554|FG000|Overall Study|Adverse Event|2
7127557|NCT02715726|11270555|FG001|Overall Study|Adverse Event|6
7127558|NCT02715726|11270554|FG000|Overall Study|Protocol Violation|1
7127559|NCT02715726|11270555|FG001|Overall Study|Protocol Violation|0
7127560|NCT02715726|11270554|FG000|Overall Study|Death|2
7127561|NCT02715726|11270555|FG001|Overall Study|Death|1
7127562|NCT02715726|11270554|FG000|Overall Study|Participant moved|1
7127563|NCT02715726|11270555|FG001|Overall Study|Participant moved|3
7127564|NCT02715726|11270554|FG000|Overall Study|Other than specified above|11
7127565|NCT02715726|11270555|FG001|Overall Study|Other than specified above|15
7127566|NCT02715726|11270554|FG000|Overall Study|Randomized but not treated|1
7127567|NCT02715726|11270555|FG001|Overall Study|Randomized but not treated|2
7127568|NCT02715804|11270563|FG000|Overall Study|Death|222
7127569|NCT02715804|11270564|FG001|Overall Study|Death|106
7127570|NCT02715804|11270563|FG000|Overall Study|Withdrawal by Subject|5
7127571|NCT02715804|11270564|FG001|Overall Study|Withdrawal by Subject|4
7127572|NCT02715804|11270563|FG000|Overall Study|Other than specified|2
7127573|NCT02715804|11270564|FG001|Overall Study|Other than specified|3
7127574|NCT02716194|11270573|FG000|Period 1 - ADVATE|Withdrawal by Subject|1
7127575|NCT02716194|11270574|FG001|Period 1 - ADVATE|Withdrawal by Subject|1
7127576|NCT02716194|11270575|FG002|Period 1 - ADVATE|Withdrawal by Subject|0
7127577|NCT02716298|11270596|FG000|First Intervention (1 Month)|Lens discomfort|1
7127578|NCT02716298|11270597|FG001|First Intervention (1 Month)|Lens discomfort|1
7127579|NCT02716584|11270623|FG000|Overall Study|Lost to Follow-up|8
7127580|NCT02716584|11270624|FG001|Overall Study|Lost to Follow-up|5
7127581|NCT02716779|11270655|FG000|Monotherapy|Adverse Event|0
7127582|NCT02716779|11270656|FG001|Monotherapy|Adverse Event|1
7127583|NCT02716779|11270657|FG002|Monotherapy|Adverse Event|1
7127584|NCT02716779|11270655|FG000|Combination Therapy|Adverse Event|0
7127585|NCT02716779|11270656|FG001|Combination Therapy|Adverse Event|2
7127586|NCT02716779|11270657|FG002|Combination Therapy|Adverse Event|1
7127587|NCT02716805|11270671|FG000|Overall Study|Progressive disease|2
7127588|NCT02716805|11270672|FG001|Overall Study|Progressive disease|0
7127589|NCT02716805|11270673|FG002|Overall Study|Progressive disease|0
7127590|NCT02716805|11270674|FG003|Overall Study|Progressive disease|0
7127591|NCT02716896|11270711|FG000|Overall Study|Physician Decision|0
7127592|NCT02716896|11270712|FG001|Overall Study|Physician Decision|1
7127593|NCT02716987|11270724|FG000|Overall Study|Ligand synthesis failure|0
7127594|NCT02716987|11270725|FG001|Overall Study|Ligand synthesis failure|0
7127595|NCT02716987|11270726|FG002|Overall Study|Ligand synthesis failure|1
7127596|NCT02716987|11270727|FG003|Overall Study|Ligand synthesis failure|0
7127597|NCT02716987|11270728|FG004|Overall Study|Ligand synthesis failure|0
7127598|NCT02716987|11270729|FG005|Overall Study|Ligand synthesis failure|0
7127599|NCT02716987|11270724|FG000|Overall Study|Withdrawal by Subject|0
7127600|NCT02716987|11270725|FG001|Overall Study|Withdrawal by Subject|0
7127601|NCT02716987|11270726|FG002|Overall Study|Withdrawal by Subject|0
7127602|NCT02716987|11270727|FG003|Overall Study|Withdrawal by Subject|0
7127603|NCT02716987|11270728|FG004|Overall Study|Withdrawal by Subject|1
7127604|NCT02716987|11270729|FG005|Overall Study|Withdrawal by Subject|1
7127605|NCT02717195|11270758|FG000|Prospective Confirmation (PC) Period|Adverse Event|19
7127606|NCT02717195|11270759|FG001|Prospective Confirmation (PC) Period|Adverse Event|7
7127607|NCT02717195|11270760|FG002|Prospective Confirmation (PC) Period|Adverse Event|0
7127608|NCT02717195|11270761|FG003|Prospective Confirmation (PC) Period|Adverse Event|0
7127609|NCT02717195|11270762|FG004|Prospective Confirmation (PC) Period|Adverse Event|0
7127610|NCT02717195|11270758|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2
7127611|NCT02717195|11270759|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1
7127612|NCT02717195|11270760|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0
7127613|NCT02717195|11270761|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0
7127614|NCT02717195|11270762|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0
7127615|NCT02717195|11270758|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7
7127616|NCT02717195|11270759|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1
7127617|NCT02717195|11270760|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
7127618|NCT02717195|11270761|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
7127619|NCT02717195|11270762|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
7127620|NCT02717195|11270758|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3
7127621|NCT02717195|11270759|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1
7127622|NCT02717195|11270760|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0
7127623|NCT02717195|11270761|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0
7127624|NCT02717195|11270762|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0
7127625|NCT02717195|11270758|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43
7127626|NCT02717195|11270759|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12
7127627|NCT02717195|11270760|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
7127628|NCT02717195|11270761|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
7127629|NCT02717195|11270762|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
7127630|NCT02717195|11270758|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9
7127631|NCT02717195|11270759|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4
7127632|NCT02717195|11270760|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0
7127633|NCT02717195|11270761|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0
7127634|NCT02717195|11270762|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0
7127635|NCT02717195|11270758|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189
7127636|NCT02717195|11270759|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75
7127637|NCT02717195|11270760|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
7127638|NCT02717195|11270761|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
7127639|NCT02717195|11270762|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
7127640|NCT02717195|11270758|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3
7127641|NCT02717195|11270759|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3
7127642|NCT02717195|11270760|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0
7127643|NCT02717195|11270761|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0
7127644|NCT02717195|11270762|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0
7127645|NCT02717195|11270758|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1
7127646|NCT02717195|11270759|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
7127647|NCT02717195|11270760|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
7127648|NCT02717195|11270761|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
7127649|NCT02717195|11270762|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
7127650|NCT02717195|11270758|FG000|Prospective Confirmation (PC) Period|Technical error|1
7127651|NCT02717195|11270759|FG001|Prospective Confirmation (PC) Period|Technical error|0
7127652|NCT02717195|11270760|FG002|Prospective Confirmation (PC) Period|Technical error|0
7127653|NCT02717195|11270761|FG003|Prospective Confirmation (PC) Period|Technical error|0
7127654|NCT02717195|11270762|FG004|Prospective Confirmation (PC) Period|Technical error|0
7127655|NCT02717195|11270758|FG000|Prospective Confirmation (PC) Period|Patient decision|5
7127656|NCT02717195|11270759|FG001|Prospective Confirmation (PC) Period|Patient decision|2
7127657|NCT02717195|11270760|FG002|Prospective Confirmation (PC) Period|Patient decision|0
7127658|NCT02717195|11270761|FG003|Prospective Confirmation (PC) Period|Patient decision|0
7127659|NCT02717195|11270762|FG004|Prospective Confirmation (PC) Period|Patient decision|0
7127660|NCT02717195|11270758|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1
7127661|NCT02717195|11270759|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
7127662|NCT02717195|11270760|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
7127663|NCT02717195|11270761|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
7127664|NCT02717195|11270762|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
7127665|NCT02717195|11270758|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1
7127666|NCT02717195|11270759|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0
7127667|NCT02717195|11270760|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0
7127668|NCT02717195|11270761|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0
7127669|NCT02717195|11270762|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0
7127670|NCT02717195|11270758|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
7127671|NCT02717195|11270759|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1
7127672|NCT02717195|11270760|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
7127673|NCT02717195|11270761|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
7127674|NCT02717195|11270762|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
7127675|NCT02717195|11270758|FG000|Prospective Confirmation (PC) Period|Investigator decision|2
7127676|NCT02717195|11270759|FG001|Prospective Confirmation (PC) Period|Investigator decision|1
7127677|NCT02717195|11270760|FG002|Prospective Confirmation (PC) Period|Investigator decision|0
7127678|NCT02717195|11270761|FG003|Prospective Confirmation (PC) Period|Investigator decision|0
7127679|NCT02717195|11270762|FG004|Prospective Confirmation (PC) Period|Investigator decision|0
7127680|NCT02717195|11270758|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
7127681|NCT02717195|11270759|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1
7127682|NCT02717195|11270760|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
7127683|NCT02717195|11270761|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
7127684|NCT02717195|11270762|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
7127685|NCT02717195|11270758|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1
7127686|NCT02717195|11270759|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
7127687|NCT02717195|11270760|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
7127688|NCT02717195|11270761|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
7127689|NCT02717195|11270762|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
7127690|NCT02717195|11270758|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
7127691|NCT02717195|11270759|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1
7127692|NCT02717195|11270760|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
7127693|NCT02717195|11270761|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
7127694|NCT02717195|11270762|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
7127695|NCT02717195|11270758|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1
7127696|NCT02717195|11270759|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0
7127697|NCT02717195|11270760|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0
7127698|NCT02717195|11270761|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0
7127699|NCT02717195|11270762|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0
7127700|NCT02717195|11270758|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0
7127701|NCT02717195|11270759|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1
7127702|NCT02717195|11270760|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0
7127703|NCT02717195|11270761|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0
7127704|NCT02717195|11270762|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0
7127705|NCT02717195|11270758|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1
7127706|NCT02717195|11270759|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0
7127707|NCT02717195|11270760|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0
7127708|NCT02717195|11270761|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0
7127709|NCT02717195|11270762|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0
7127710|NCT02717195|11270758|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1
7127711|NCT02717195|11270759|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
7127712|NCT02717195|11270760|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
7127713|NCT02717195|11270761|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
7127714|NCT02717195|11270762|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
7127715|NCT02717195|11270758|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0
7127716|NCT02717195|11270759|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0
7127717|NCT02717195|11270760|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10
7127718|NCT02717195|11270761|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11
7127719|NCT02717195|11270762|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8
7127720|NCT02717195|11270758|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0
7127721|NCT02717195|11270759|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0
7127722|NCT02717195|11270760|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6
7127723|NCT02717195|11270761|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9
7127724|NCT02717195|11270762|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2
7127725|NCT02717195|11270758|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0
7127726|NCT02717195|11270759|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0
7127727|NCT02717195|11270760|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4
7127728|NCT02717195|11270761|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3
7127729|NCT02717195|11270762|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2
6806149|NCT04993339|10808539|FG001|Overall Study|Lost to Follow-up|1
6806150|NCT04993339|10808538|FG000|Overall Study|no MRI scan|3
6806151|NCT04993339|10808539|FG001|Overall Study|no MRI scan|1
6810388|NCT04063657|10814130|FG000|Overall Study|Lost to Follow-up|1
6810389|NCT04063657|10814131|FG001|Overall Study|Lost to Follow-up|0
6810390|NCT03882047|10814144|FG000|Overall Study|Adverse Event|0
6810391|NCT03882047|10814145|FG001|Overall Study|Adverse Event|2
6810392|NCT03882047|10814146|FG002|Overall Study|Adverse Event|2
6810393|NCT03882047|10814144|FG000|Overall Study|Treatment Failure|3
7127730|NCT02717195|11270758|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0
7127731|NCT02717195|11270759|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0
7127732|NCT02717195|11270760|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1
7127733|NCT02717195|11270761|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0
7127734|NCT02717195|11270762|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1
7127735|NCT02717195|11270758|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0
7127736|NCT02717195|11270759|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0
7127737|NCT02717195|11270760|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14
7127738|NCT02717195|11270761|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13
7127739|NCT02717195|11270762|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8
7127740|NCT02717195|11270758|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
7127741|NCT02717195|11270759|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
7127742|NCT02717195|11270760|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
7127743|NCT02717195|11270761|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3
7127744|NCT02717195|11270762|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2
7127745|NCT02717195|11270758|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
7127746|NCT02717195|11270759|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
7127747|NCT02717195|11270760|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1
7127748|NCT02717195|11270761|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
7127749|NCT02717195|11270762|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
7127750|NCT02717195|11270758|FG000|Double-blind Treatment (DBT) Period|Patient decision|0
7127751|NCT02717195|11270759|FG001|Double-blind Treatment (DBT) Period|Patient decision|0
7127752|NCT02717195|11270760|FG002|Double-blind Treatment (DBT) Period|Patient decision|0
7127753|NCT02717195|11270761|FG003|Double-blind Treatment (DBT) Period|Patient decision|2
7127754|NCT02717195|11270762|FG004|Double-blind Treatment (DBT) Period|Patient decision|2
7127755|NCT02717195|11270758|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0
7127756|NCT02717195|11270759|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0
7127757|NCT02717195|11270760|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0
7127758|NCT02717195|11270761|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1
7127759|NCT02717195|11270762|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1
7127760|NCT02717195|11270758|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0
7127761|NCT02717195|11270759|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0
7127762|NCT02717195|11270760|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0
7127763|NCT02717195|11270761|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0
7127764|NCT02717195|11270762|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1
7127765|NCT02717195|11270758|FG000|Double-blind Treatment (DBT) Period|Change of residence|0
7127766|NCT02717195|11270759|FG001|Double-blind Treatment (DBT) Period|Change of residence|0
7127767|NCT02717195|11270760|FG002|Double-blind Treatment (DBT) Period|Change of residence|0
7127768|NCT02717195|11270761|FG003|Double-blind Treatment (DBT) Period|Change of residence|1
7127769|NCT02717195|11270762|FG004|Double-blind Treatment (DBT) Period|Change of residence|1
7127770|NCT02717195|11270758|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
7127771|NCT02717195|11270759|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
7127772|NCT02717195|11270760|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
7127773|NCT02717195|11270761|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
7127774|NCT02717195|11270762|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1
7127775|NCT02717195|11270758|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0
7127776|NCT02717195|11270759|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0
7127777|NCT02717195|11270760|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1
7127778|NCT02717195|11270761|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0
7127779|NCT02717195|11270762|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0
7127780|NCT02717195|11270758|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0
7127781|NCT02717195|11270759|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0
7127782|NCT02717195|11270760|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0
7127783|NCT02717195|11270761|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1
7127784|NCT02717195|11270762|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1
7127785|NCT02717494|11270787|FG000|First Intervention (Step 1)|Lost to Follow-up|4
7127786|NCT02717494|11270788|FG001|First Intervention (Step 1)|Lost to Follow-up|7
7127787|NCT02717494|11270789|FG002|First Intervention (Step 1)|Lost to Follow-up|3
7127788|NCT02717494|11270787|FG000|First Intervention (Step 1)|Withdrawal by Subject|2
7127789|NCT02717494|11270788|FG001|First Intervention (Step 1)|Withdrawal by Subject|0
7127790|NCT02717494|11270789|FG002|First Intervention (Step 1)|Withdrawal by Subject|1
7127791|NCT02717494|11270787|FG000|First Intervention (Step 1)|Death|0
7127792|NCT02717494|11270788|FG001|First Intervention (Step 1)|Death|0
7127793|NCT02717494|11270789|FG002|First Intervention (Step 1)|Death|1
7127794|NCT02717494|11270787|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0
7127795|NCT02717494|11270788|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0
7127796|NCT02717494|11270789|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4
7127797|NCT02717546|11270815|FG000|Overall Study|Lost to Follow-up|12
7127798|NCT02717754|11270825|FG000|Overall Study|Incorrect Infusion Duration|0
7127799|NCT02717754|11270826|FG001|Overall Study|Incorrect Infusion Duration|0
7127800|NCT02717754|11270827|FG002|Overall Study|Incorrect Infusion Duration|0
7127801|NCT02717754|11270828|FG003|Overall Study|Incorrect Infusion Duration|10
7127802|NCT02717754|11270829|FG004|Overall Study|Incorrect Infusion Duration|20
7127803|NCT02717754|11270830|FG005|Overall Study|Incorrect Infusion Duration|20
7127804|NCT02718131|11270855|FG000|Overall Study|Withdrawal by Subject|1
7127805|NCT02718131|11270856|FG001|Overall Study|Withdrawal by Subject|0
7127806|NCT02718131|11270855|FG000|Overall Study|Adverse Event|1
7127807|NCT02718131|11270856|FG001|Overall Study|Adverse Event|0
7127808|NCT02718131|11270855|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1
7127809|NCT02718131|11270856|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0
7127810|NCT02718326|11270875|FG000|Overall Study|Adverse Event|4
7127811|NCT02718326|11270876|FG001|Overall Study|Adverse Event|9
7127812|NCT02718326|11270877|FG002|Overall Study|Adverse Event|0
7127813|NCT02718326|11270875|FG000|Overall Study|Death|8
7127814|NCT02718326|11270876|FG001|Overall Study|Death|1
7127815|NCT02718326|11270877|FG002|Overall Study|Death|2
7127816|NCT02718326|11270875|FG000|Overall Study|Withdrawal by Subject|4
7127817|NCT02718326|11270876|FG001|Overall Study|Withdrawal by Subject|9
7127818|NCT02718326|11270877|FG002|Overall Study|Withdrawal by Subject|6
7127819|NCT02718326|11270875|FG000|Overall Study|Lost to Follow-up|18
7127820|NCT02718326|11270876|FG001|Overall Study|Lost to Follow-up|5
7127821|NCT02718326|11270877|FG002|Overall Study|Lost to Follow-up|14
7127822|NCT02718326|11270875|FG000|Overall Study|Protocol Deviation|1
7127823|NCT02718326|11270876|FG001|Overall Study|Protocol Deviation|0
7127824|NCT02718326|11270877|FG002|Overall Study|Protocol Deviation|0
7127825|NCT02718326|11270875|FG000|Overall Study|Pregnancy|1
7127826|NCT02718326|11270876|FG001|Overall Study|Pregnancy|0
7127827|NCT02718326|11270877|FG002|Overall Study|Pregnancy|0
7127828|NCT02718417|11270890|FG000|Chemotherapy Phase (CP)|Adverse Event|9
7127829|NCT02718417|11270891|FG001|Chemotherapy Phase (CP)|Adverse Event|14
7127830|NCT02718417|11270892|FG002|Chemotherapy Phase (CP)|Adverse Event|13
6806152|NCT04919161|10808581|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1
6806153|NCT04919161|10808582|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0
6806154|NCT04919161|10808581|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0
6806155|NCT04919161|10808582|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1
6806156|NCT04919161|10808581|FG000|Overall Study|Acute ankle sprain after session 1|0
6806157|NCT04919161|10808582|FG001|Overall Study|Acute ankle sprain after session 1|1
6806158|NCT04883541|10808673|FG000|Overall Study|Not attending regular yoga class|16
6806159|NCT04883541|10808674|FG001|Overall Study|Not attending regular yoga class|0
6806160|NCT04883541|10808673|FG000|Overall Study|Not attending the pregnancy school|0
6806161|NCT04883541|10808674|FG001|Overall Study|Not attending the pregnancy school|9
6806162|NCT04357782|10808690|FG000|Overall Study|Discharged from hospital|1
6806163|NCT04357782|10808691|FG001|Overall Study|Discharged from hospital|0
6806164|NCT04357782|10808690|FG000|Overall Study|Death|0
6806165|NCT04357782|10808691|FG001|Overall Study|Death|2
6806166|NCT03760068|10808718|FG000|Overall Study|Withdrawal by Subject|7
6806167|NCT03760068|10808719|FG001|Overall Study|Withdrawal by Subject|8
6806168|NCT03760068|10808718|FG000|Overall Study|Adverse Event|1
7127831|NCT02718417|11270890|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5
7127832|NCT02718417|11270891|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4
6806169|NCT03760068|10808719|FG001|Overall Study|Adverse Event|2
6806170|NCT03760068|10808718|FG000|Overall Study|Administrative Decision by Sponsor|0
7127833|NCT02718417|11270892|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1
7127834|NCT02718417|11270890|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3
7127835|NCT02718417|11270891|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2
7127836|NCT02718417|11270892|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1
7127837|NCT02718417|11270890|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4
7127838|NCT02718417|11270891|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2
7127839|NCT02718417|11270892|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1
7127840|NCT02718417|11270890|FG000|Chemotherapy Phase (CP)|Physician's decision|5
7127841|NCT02718417|11270891|FG001|Chemotherapy Phase (CP)|Physician's decision|0
7127842|NCT02718417|11270892|FG002|Chemotherapy Phase (CP)|Physician's decision|4
7127843|NCT02718417|11270890|FG000|Chemotherapy Phase (CP)|Progressive disease|11
7127844|NCT02718417|11270891|FG001|Chemotherapy Phase (CP)|Progressive disease|7
7127845|NCT02718417|11270892|FG002|Chemotherapy Phase (CP)|Progressive disease|10
7127846|NCT02718417|11270890|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13
7127847|NCT02718417|11270891|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8
7127848|NCT02718417|11270892|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15
7127849|NCT02718417|11270890|FG000|Chemotherapy Phase (CP)|Other|2
7127850|NCT02718417|11270891|FG001|Chemotherapy Phase (CP)|Other|0
7127851|NCT02718417|11270892|FG002|Chemotherapy Phase (CP)|Other|1
7127852|NCT02718417|11270890|FG000|Maintenance Phase (MP)|Adverse Event|21
7127853|NCT02718417|11270891|FG001|Maintenance Phase (MP)|Adverse Event|26
7127854|NCT02718417|11270892|FG002|Maintenance Phase (MP)|Adverse Event|0
7127855|NCT02718417|11270890|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1
7127856|NCT02718417|11270891|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1
7127857|NCT02718417|11270892|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0
7127858|NCT02718417|11270890|FG000|Maintenance Phase (MP)|Global deterioration of health status|5
7127859|NCT02718417|11270891|FG001|Maintenance Phase (MP)|Global deterioration of health status|3
7127860|NCT02718417|11270892|FG002|Maintenance Phase (MP)|Global deterioration of health status|0
7127861|NCT02718417|11270890|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0
7127862|NCT02718417|11270891|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1
7127863|NCT02718417|11270892|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0
7127864|NCT02718417|11270890|FG000|Maintenance Phase (MP)|Physician's decision|6
7127865|NCT02718417|11270891|FG001|Maintenance Phase (MP)|Physician's decision|7
7127866|NCT02718417|11270892|FG002|Maintenance Phase (MP)|Physician's decision|0
7127867|NCT02718417|11270890|FG000|Maintenance Phase (MP)|Progressive disease|100
7127868|NCT02718417|11270891|FG001|Maintenance Phase (MP)|Progressive disease|88
7127869|NCT02718417|11270892|FG002|Maintenance Phase (MP)|Progressive disease|0
7127870|NCT02718417|11270890|FG000|Maintenance Phase (MP)|Other|2
7127871|NCT02718417|11270891|FG001|Maintenance Phase (MP)|Other|1
7127872|NCT02718417|11270892|FG002|Maintenance Phase (MP)|Other|0
7127873|NCT02718417|11270890|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17
7127874|NCT02718417|11270891|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20
7127875|NCT02718417|11270892|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0
7127876|NCT02718417|11270890|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114
7127877|NCT02718417|11270891|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140
7127878|NCT02718417|11270892|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0
7127879|NCT02718417|11270890|FG000|Observation Phase (OP)|Adverse Event|0
7127880|NCT02718417|11270891|FG001|Observation Phase (OP)|Adverse Event|0
7127881|NCT02718417|11270892|FG002|Observation Phase (OP)|Adverse Event|1
7127882|NCT02718417|11270890|FG000|Observation Phase (OP)|Death leading to discontinuation|0
7127883|NCT02718417|11270891|FG001|Observation Phase (OP)|Death leading to discontinuation|0
7127884|NCT02718417|11270892|FG002|Observation Phase (OP)|Death leading to discontinuation|2
7127885|NCT02718417|11270890|FG000|Observation Phase (OP)|Lost to Follow-up|0
7127886|NCT02718417|11270891|FG001|Observation Phase (OP)|Lost to Follow-up|0
7127887|NCT02718417|11270892|FG002|Observation Phase (OP)|Lost to Follow-up|1
7127888|NCT02718417|11270890|FG000|Observation Phase (OP)|Physician Decision|0
7127889|NCT02718417|11270891|FG001|Observation Phase (OP)|Physician Decision|0
7127890|NCT02718417|11270892|FG002|Observation Phase (OP)|Physician Decision|9
7127891|NCT02718417|11270890|FG000|Observation Phase (OP)|Progressive disease|0
7127892|NCT02718417|11270891|FG001|Observation Phase (OP)|Progressive disease|0
7127893|NCT02718417|11270892|FG002|Observation Phase (OP)|Progressive disease|92
7127894|NCT02718417|11270890|FG000|Observation Phase (OP)|Study terminated by sponsor|0
7127895|NCT02718417|11270891|FG001|Observation Phase (OP)|Study terminated by sponsor|0
7127896|NCT02718417|11270892|FG002|Observation Phase (OP)|Study terminated by sponsor|135
7127897|NCT02718417|11270890|FG000|Observation Phase (OP)|Withdrawal by Subject|0
7127898|NCT02718417|11270891|FG001|Observation Phase (OP)|Withdrawal by Subject|0
7127899|NCT02718417|11270892|FG002|Observation Phase (OP)|Withdrawal by Subject|34
7127900|NCT02718417|11270890|FG000|Observation Phase (OP)|Global deterioration of health status|0
7127901|NCT02718417|11270891|FG001|Observation Phase (OP)|Global deterioration of health status|0
7127902|NCT02718417|11270892|FG002|Observation Phase (OP)|Global deterioration of health status|1
7127903|NCT02718417|11270890|FG000|Observation Phase (OP)|Other|0
7127904|NCT02718417|11270891|FG001|Observation Phase (OP)|Other|0
7127905|NCT02718417|11270892|FG002|Observation Phase (OP)|Other|7
7127906|NCT02718417|11270890|FG000|Follow-up Phase|Adverse Event|3
7127907|NCT02718417|11270891|FG001|Follow-up Phase|Adverse Event|1
7127908|NCT02718417|11270892|FG002|Follow-up Phase|Adverse Event|1
7127909|NCT02718417|11270890|FG000|Follow-up Phase|Other|4
7127910|NCT02718417|11270891|FG001|Follow-up Phase|Other|6
7127911|NCT02718417|11270892|FG002|Follow-up Phase|Other|4
7127912|NCT02718417|11270890|FG000|Follow-up Phase|Withdrawal by Subject|19
7127913|NCT02718417|11270891|FG001|Follow-up Phase|Withdrawal by Subject|17
7127914|NCT02718417|11270892|FG002|Follow-up Phase|Withdrawal by Subject|5
7127915|NCT02718417|11270890|FG000|Follow-up Phase|Study terminated by sponsor|100
7127916|NCT02718417|11270891|FG001|Follow-up Phase|Study terminated by sponsor|138
7127917|NCT02718417|11270892|FG002|Follow-up Phase|Study terminated by sponsor|6
7127918|NCT02718417|11270890|FG000|Follow-up Phase|Lost to Follow-up|2
7127919|NCT02718417|11270891|FG001|Follow-up Phase|Lost to Follow-up|3
7127920|NCT02718417|11270892|FG002|Follow-up Phase|Lost to Follow-up|0
7127921|NCT02718417|11270890|FG000|Follow-up Phase|Death leading to discontinuation|7
7127922|NCT02718417|11270891|FG001|Follow-up Phase|Death leading to discontinuation|7
7127923|NCT02718417|11270892|FG002|Follow-up Phase|Death leading to discontinuation|3
7127924|NCT02718417|11270890|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20
7127925|NCT02718417|11270891|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17
7127926|NCT02718417|11270892|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11
7127927|NCT02718417|11270890|FG000|Long-term Follow-up Phase|Lost to Follow-up|8
7127928|NCT02718417|11270891|FG001|Long-term Follow-up Phase|Lost to Follow-up|4
7127929|NCT02718417|11270892|FG002|Long-term Follow-up Phase|Lost to Follow-up|3
7127930|NCT02718417|11270890|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105
7127931|NCT02718417|11270891|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80
7127932|NCT02718417|11270892|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112
7127933|NCT02718417|11270890|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6
7127934|NCT02718417|11270891|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9
7127935|NCT02718417|11270892|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9
7127936|NCT02718417|11270890|FG000|Long-term Follow-up Phase|Other|0
7127937|NCT02718417|11270891|FG001|Long-term Follow-up Phase|Other|2
7127938|NCT02718417|11270892|FG002|Long-term Follow-up Phase|Other|0
7127939|NCT02718625|11270909|FG000|Overall Study|Adverse Event|0
7127940|NCT02718625|11270910|FG001|Overall Study|Adverse Event|1
7127941|NCT02718625|11270909|FG000|Overall Study|Termination of Study by Sponsor|0
7127942|NCT02718625|11270910|FG001|Overall Study|Termination of Study by Sponsor|1
7127943|NCT02718898|11270918|FG000|Blinded Treatment Period|Adverse Event|5
7127944|NCT02718898|11270919|FG001|Blinded Treatment Period|Adverse Event|1
7127945|NCT02718898|11270920|FG002|Blinded Treatment Period|Adverse Event|0
7127946|NCT02718898|11270921|FG003|Blinded Treatment Period|Adverse Event|0
7127947|NCT02718898|11270922|FG004|Blinded Treatment Period|Adverse Event|0
7127948|NCT02718898|11270923|FG005|Blinded Treatment Period|Adverse Event|0
7127949|NCT02718898|11270924|FG006|Blinded Treatment Period|Adverse Event|0
7127950|NCT02718898|11270918|FG000|Blinded Treatment Period|Physician Decision|1
7127951|NCT02718898|11270919|FG001|Blinded Treatment Period|Physician Decision|0
7127952|NCT02718898|11270920|FG002|Blinded Treatment Period|Physician Decision|0
7127953|NCT02718898|11270921|FG003|Blinded Treatment Period|Physician Decision|0
7127954|NCT02718898|11270922|FG004|Blinded Treatment Period|Physician Decision|0
7127955|NCT02718898|11270923|FG005|Blinded Treatment Period|Physician Decision|0
7127956|NCT02718898|11270924|FG006|Blinded Treatment Period|Physician Decision|0
7127957|NCT02718898|11270918|FG000|Blinded Treatment Period|Lack of Efficacy|1
7127958|NCT02718898|11270919|FG001|Blinded Treatment Period|Lack of Efficacy|0
7127959|NCT02718898|11270920|FG002|Blinded Treatment Period|Lack of Efficacy|0
7127960|NCT02718898|11270921|FG003|Blinded Treatment Period|Lack of Efficacy|0
7127961|NCT02718898|11270922|FG004|Blinded Treatment Period|Lack of Efficacy|0
7127962|NCT02718898|11270923|FG005|Blinded Treatment Period|Lack of Efficacy|0
7127963|NCT02718898|11270924|FG006|Blinded Treatment Period|Lack of Efficacy|0
7127964|NCT02718898|11270918|FG000|Blinded Treatment Period|Lost to Follow-up|2
7127965|NCT02718898|11270919|FG001|Blinded Treatment Period|Lost to Follow-up|0
7127966|NCT02718898|11270920|FG002|Blinded Treatment Period|Lost to Follow-up|0
7127967|NCT02718898|11270921|FG003|Blinded Treatment Period|Lost to Follow-up|0
7127968|NCT02718898|11270922|FG004|Blinded Treatment Period|Lost to Follow-up|0
7127969|NCT02718898|11270923|FG005|Blinded Treatment Period|Lost to Follow-up|0
7127970|NCT02718898|11270924|FG006|Blinded Treatment Period|Lost to Follow-up|0
7127971|NCT02718898|11270918|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0
7127972|NCT02718898|11270919|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0
7127973|NCT02718898|11270920|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1
7127974|NCT02718898|11270921|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1
7127975|NCT02718898|11270922|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0
7127976|NCT02718898|11270923|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0
7127977|NCT02718898|11270924|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0
7127978|NCT02718898|11270918|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
7127979|NCT02718898|11270919|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
7127980|NCT02718898|11270920|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
7127981|NCT02718898|11270921|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2
7127982|NCT02718898|11270922|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
7127983|NCT02718898|11270923|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
7127984|NCT02718898|11270924|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
7127985|NCT02718898|11270918|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
7127986|NCT02718898|11270919|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
7127987|NCT02718898|11270920|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1
7127988|NCT02718898|11270921|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3
7127989|NCT02718898|11270922|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
7127990|NCT02718898|11270923|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
7127991|NCT02718898|11270924|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
7127992|NCT02718898|11270918|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
7127993|NCT02718898|11270919|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
7127994|NCT02718898|11270920|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1
7127995|NCT02718898|11270921|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2
7127996|NCT02718898|11270922|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
7127997|NCT02718898|11270923|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
7127998|NCT02718898|11270924|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
7127999|NCT02718898|11270918|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
7128000|NCT02718898|11270919|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
7128001|NCT02718898|11270920|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
7128002|NCT02718898|11270921|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1
7128003|NCT02718898|11270922|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
7128004|NCT02718898|11270923|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
7128005|NCT02718898|11270924|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
7128006|NCT02718898|11270918|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
7128007|NCT02718898|11270919|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
7128008|NCT02718898|11270920|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
7128009|NCT02718898|11270921|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1
7128010|NCT02718898|11270922|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
7128011|NCT02718898|11270923|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
7128012|NCT02718898|11270924|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
7128013|NCT02718898|11270918|FG000|Post Treatment Follow-up Period|Adverse Event|0
7128014|NCT02718898|11270919|FG001|Post Treatment Follow-up Period|Adverse Event|0
7128015|NCT02718898|11270920|FG002|Post Treatment Follow-up Period|Adverse Event|0
7128016|NCT02718898|11270921|FG003|Post Treatment Follow-up Period|Adverse Event|0
7128017|NCT02718898|11270922|FG004|Post Treatment Follow-up Period|Adverse Event|0
7128018|NCT02718898|11270923|FG005|Post Treatment Follow-up Period|Adverse Event|1
7128019|NCT02718898|11270924|FG006|Post Treatment Follow-up Period|Adverse Event|1
7128020|NCT02718898|11270918|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0
7128021|NCT02718898|11270919|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0
7128022|NCT02718898|11270920|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0
7128023|NCT02718898|11270921|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0
7128024|NCT02718898|11270922|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1
7128025|NCT02718898|11270923|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5
7128026|NCT02718898|11270924|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1
7128027|NCT02718898|11270918|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0
7128028|NCT02718898|11270919|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0
7128029|NCT02718898|11270920|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0
7128030|NCT02718898|11270921|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0
7128031|NCT02718898|11270922|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0
7128032|NCT02718898|11270923|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5
7128033|NCT02718898|11270924|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3
7128034|NCT02719028|11270950|FG000|Overall Study|Adverse Event|2
7128035|NCT02719028|11270951|FG001|Overall Study|Adverse Event|1
7128036|NCT02719028|11270952|FG002|Overall Study|Adverse Event|4
7128037|NCT02719028|11270953|FG003|Overall Study|Adverse Event|8
7128038|NCT02719028|11270950|FG000|Overall Study|Physician Decision|0
7128039|NCT02719028|11270951|FG001|Overall Study|Physician Decision|1
7128040|NCT02719028|11270952|FG002|Overall Study|Physician Decision|1
7128041|NCT02719028|11270953|FG003|Overall Study|Physician Decision|1
7128042|NCT02719028|11270950|FG000|Overall Study|Use of prohibited medication|0
7128043|NCT02719028|11270951|FG001|Overall Study|Use of prohibited medication|0
7128044|NCT02719028|11270952|FG002|Overall Study|Use of prohibited medication|1
7128045|NCT02719028|11270953|FG003|Overall Study|Use of prohibited medication|0
7128046|NCT02719028|11270950|FG000|Overall Study|Protocol Violation|0
7128047|NCT02719028|11270951|FG001|Overall Study|Protocol Violation|0
7128048|NCT02719028|11270952|FG002|Overall Study|Protocol Violation|0
7128049|NCT02719028|11270953|FG003|Overall Study|Protocol Violation|1
7128050|NCT02719171|11270981|FG000|Overall Study|Adverse Event|1
7128051|NCT02719171|11270982|FG001|Overall Study|Adverse Event|2
7128052|NCT02719171|11270983|FG002|Overall Study|Adverse Event|0
7128053|NCT02719171|11270984|FG003|Overall Study|Adverse Event|0
7128054|NCT02719171|11270985|FG004|Overall Study|Adverse Event|2
7128055|NCT02719171|11270981|FG000|Overall Study|Lost to Follow-up|0
7128056|NCT02719171|11270982|FG001|Overall Study|Lost to Follow-up|0
7128057|NCT02719171|11270983|FG002|Overall Study|Lost to Follow-up|1
7128058|NCT02719171|11270984|FG003|Overall Study|Lost to Follow-up|0
7128059|NCT02719171|11270985|FG004|Overall Study|Lost to Follow-up|0
7128060|NCT02719171|11270981|FG000|Overall Study|Subject Withdrawal|0
7128061|NCT02719171|11270982|FG001|Overall Study|Subject Withdrawal|2
7128062|NCT02719171|11270983|FG002|Overall Study|Subject Withdrawal|2
7128063|NCT02719171|11270984|FG003|Overall Study|Subject Withdrawal|1
7128064|NCT02719171|11270985|FG004|Overall Study|Subject Withdrawal|0
7128065|NCT02719171|11270981|FG000|Overall Study|Other|0
7128066|NCT02719171|11270982|FG001|Overall Study|Other|0
7128067|NCT02719171|11270983|FG002|Overall Study|Other|0
7128068|NCT02719171|11270984|FG003|Overall Study|Other|1
7128069|NCT02719171|11270985|FG004|Overall Study|Other|0
7128070|NCT02719353|11271000|FG000|First Intervention|Physician Decision|0
7128071|NCT02719353|11271001|FG001|First Intervention|Physician Decision|1
7128072|NCT02719743|11271029|FG000|Overall Study|Consent withdrawal|0
7128073|NCT02719743|11271030|FG001|Overall Study|Consent withdrawal|2
7128074|NCT02719743|11271031|FG002|Overall Study|Consent withdrawal|0
7128075|NCT02719743|11271032|FG003|Overall Study|Consent withdrawal|1
7128076|NCT02719743|11271033|FG004|Overall Study|Consent withdrawal|0
7128077|NCT02719743|11271029|FG000|Overall Study|Migrated/moved from study area|0
7128078|NCT02719743|11271030|FG001|Overall Study|Migrated/moved from study area|0
7128079|NCT02719743|11271031|FG002|Overall Study|Migrated/moved from study area|0
7128080|NCT02719743|11271032|FG003|Overall Study|Migrated/moved from study area|0
7128081|NCT02719743|11271033|FG004|Overall Study|Migrated/moved from study area|2
7128082|NCT02719743|11271029|FG000|Overall Study|Lost to Follow-up|1
7128083|NCT02719743|11271030|FG001|Overall Study|Lost to Follow-up|1
7128084|NCT02719743|11271031|FG002|Overall Study|Lost to Follow-up|0
7128085|NCT02719743|11271032|FG003|Overall Study|Lost to Follow-up|0
7128086|NCT02719743|11271033|FG004|Overall Study|Lost to Follow-up|0
7128087|NCT02720042|11271054|FG000|Overall Study|Death|3
7128088|NCT02720042|11271054|FG000|Overall Study|Lost to Follow-up|4
7128089|NCT02720042|11271054|FG000|Overall Study|Withdrawal by Subject|1
7128090|NCT02720042|11271054|FG000|Overall Study|Physician Decision|3
7128091|NCT02720042|11271054|FG000|Overall Study|Phasix Mesh explanted|1
7128092|NCT02720042|11271054|FG000|Overall Study|unable due to non-study-related illness|3
7128093|NCT02720081|11271060|FG000|Overall Study|Adverse Event|0
7128094|NCT02720081|11271061|FG001|Overall Study|Adverse Event|3
7128095|NCT02720081|11271060|FG000|Overall Study|Protocol Violation|4
7128096|NCT02720081|11271061|FG001|Overall Study|Protocol Violation|1
7128097|NCT02720198|11271073|FG000|Overall Study|Withdrawal by Subject|0
7128098|NCT02720198|11271074|FG001|Overall Study|Withdrawal by Subject|1
7128099|NCT02720484|11271084|FG000|Treatment on Study|Adverse Event|1
7128100|NCT02720484|11271084|FG000|Treatment on Study|Withdrawal by Subject|1
7128101|NCT02720484|11271084|FG000|Treatment on Study|Progressive Disease|4
7128102|NCT02720484|11271084|FG000|Follow Up for 2 Years|Withdrawal by Subject|1
7128103|NCT02720484|11271084|FG000|Follow Up for 2 Years|Death|3
7128104|NCT02720484|11271084|FG000|Follow Up for 2 Years|Lost to Follow-up|2
7128161|NCT02720536|11271111|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11
7128162|NCT02720536|11271111|FG000|Overall Study|PR - pregnancy|2
7128163|NCT02720536|11271111|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2
7128164|NCT02720536|11271111|FG000|Overall Study|PR - death|1
7128165|NCT02720536|11271111|FG000|Overall Study|PR - adverse event|1
7128166|NCT02720536|11271111|FG000|Overall Study|PR - abnormal lab value(s)|1
7128167|NCT02720536|11271111|FG000|Overall Study|PR- unwilling to comply with procedures|1
7128168|NCT02720757|11271125|FG000|Overall Study|Other reason|5
7128169|NCT02720757|11271125|FG000|Overall Study|Loss of contact|4
7128170|NCT02720757|11271125|FG000|Overall Study|Informed consent withdrawal|1
7128171|NCT02720757|11271125|FG000|Overall Study|Patients wish to withdraw|2
7128172|NCT02720757|11271125|FG000|Overall Study|Missing|3
7128173|NCT02720757|11271125|FG000|Overall Study|General exclusion|3
7128174|NCT02721147|11271143|FG000|Overall Study|Lost to Follow-up|2
7128175|NCT02721147|11271144|FG001|Overall Study|Lost to Follow-up|0
7128176|NCT02721147|11271145|FG002|Overall Study|Lost to Follow-up|0
7128177|NCT02721251|11271156|FG000|Overall Study|Withdrawal by Subject|8
7128178|NCT02721251|11271157|FG001|Overall Study|Withdrawal by Subject|7
7128179|NCT02721251|11271158|FG002|Overall Study|Withdrawal by Subject|9
7128180|NCT02721251|11271156|FG000|Overall Study|poor adherence|2
7128181|NCT02721251|11271157|FG001|Overall Study|poor adherence|2
7128182|NCT02721251|11271158|FG002|Overall Study|poor adherence|2
7128183|NCT02721355|11271169|FG000|Overall Study|Lost to Follow-up|6
7128184|NCT02721355|11271170|FG001|Overall Study|Lost to Follow-up|1
7128185|NCT02721875|11271182|FG000|Overall Study|Progressive disease/relapse|1
7128186|NCT02721875|11271183|FG001|Overall Study|Progressive disease/relapse|0
7128187|NCT02721966|11271192|FG000|Overall Study|Protocol Violation|1
7128188|NCT02721966|11271193|FG001|Overall Study|Protocol Violation|0
7128189|NCT02721966|11271194|FG002|Overall Study|Protocol Violation|0
7128190|NCT02721966|11271195|FG003|Overall Study|Protocol Violation|0
7128191|NCT02721966|11271196|FG004|Overall Study|Protocol Violation|0
7128192|NCT02721966|11271192|FG000|Overall Study|Withdrawal by Subject|9
7128193|NCT02721966|11271193|FG001|Overall Study|Withdrawal by Subject|2
7128194|NCT02721966|11271194|FG002|Overall Study|Withdrawal by Subject|3
7128195|NCT02721966|11271195|FG003|Overall Study|Withdrawal by Subject|7
7128196|NCT02721966|11271196|FG004|Overall Study|Withdrawal by Subject|0
7128197|NCT02721966|11271192|FG000|Overall Study|Adverse Event|4
7128198|NCT02721966|11271193|FG001|Overall Study|Adverse Event|4
7128199|NCT02721966|11271194|FG002|Overall Study|Adverse Event|3
7128200|NCT02721966|11271195|FG003|Overall Study|Adverse Event|0
7128201|NCT02721966|11271196|FG004|Overall Study|Adverse Event|0
6810394|NCT03882047|10814145|FG001|Overall Study|Treatment Failure|3
7128202|NCT02721966|11271192|FG000|Overall Study|Death|1
7128203|NCT02721966|11271193|FG001|Overall Study|Death|0
7128204|NCT02721966|11271194|FG002|Overall Study|Death|0
7128205|NCT02721966|11271195|FG003|Overall Study|Death|0
7128206|NCT02721966|11271196|FG004|Overall Study|Death|0
7128207|NCT02721966|11271192|FG000|Overall Study|Lack of Efficacy|7
7128208|NCT02721966|11271193|FG001|Overall Study|Lack of Efficacy|4
7128209|NCT02721966|11271194|FG002|Overall Study|Lack of Efficacy|0
7128210|NCT02721966|11271195|FG003|Overall Study|Lack of Efficacy|0
7128211|NCT02721966|11271196|FG004|Overall Study|Lack of Efficacy|0
7128212|NCT02721966|11271192|FG000|Overall Study|Lost to Follow-up|0
7128213|NCT02721966|11271193|FG001|Overall Study|Lost to Follow-up|0
7128214|NCT02721966|11271194|FG002|Overall Study|Lost to Follow-up|3
7128215|NCT02721966|11271195|FG003|Overall Study|Lost to Follow-up|0
7128216|NCT02721966|11271196|FG004|Overall Study|Lost to Follow-up|0
7128217|NCT02721966|11271192|FG000|Overall Study|Physician Decision|1
7128218|NCT02721966|11271193|FG001|Overall Study|Physician Decision|1
7128219|NCT02721966|11271194|FG002|Overall Study|Physician Decision|0
7128220|NCT02721966|11271195|FG003|Overall Study|Physician Decision|0
7128221|NCT02721966|11271196|FG004|Overall Study|Physician Decision|0
7128222|NCT02721966|11271192|FG000|Overall Study|Pregnancy|1
7128223|NCT02721966|11271193|FG001|Overall Study|Pregnancy|0
7128224|NCT02721966|11271194|FG002|Overall Study|Pregnancy|0
7128225|NCT02721966|11271195|FG003|Overall Study|Pregnancy|0
7128226|NCT02721966|11271196|FG004|Overall Study|Pregnancy|0
7128227|NCT02721966|11271192|FG000|Overall Study|Did not continue to period 2|5
7128228|NCT02721966|11271193|FG001|Overall Study|Did not continue to period 2|12
7128229|NCT02721966|11271194|FG002|Overall Study|Did not continue to period 2|0
7128230|NCT02721966|11271195|FG003|Overall Study|Did not continue to period 2|0
7128231|NCT02721966|11271196|FG004|Overall Study|Did not continue to period 2|5
7128232|NCT02722044|11271204|FG000|Overall Study|Adverse Event|2
7128233|NCT02722044|11271204|FG000|Overall Study|Physician Decision|1
7128234|NCT02722044|11271204|FG000|Overall Study|Withdrawal by Subject|1
7128235|NCT02722044|11271204|FG000|Overall Study|Did Not Meet Criteria at Week 14|1
7128236|NCT02722148|11271209|FG000|Overall Study|Lost to Follow-up|2
7128237|NCT02722148|11271209|FG000|Overall Study|Non compliant with treatment regimen|3
7128238|NCT02722278|11271225|FG000|Overall Study|Withdrawal by Subject|5
7128239|NCT02722278|11271226|FG001|Overall Study|Withdrawal by Subject|3
7128240|NCT02722278|11271225|FG000|Overall Study|Adverse Event|4
7128241|NCT02722278|11271226|FG001|Overall Study|Adverse Event|1
7128242|NCT02722278|11271225|FG000|Overall Study|Lost to Follow-up|2
7128243|NCT02722278|11271226|FG001|Overall Study|Lost to Follow-up|0
7128244|NCT02722278|11271225|FG000|Overall Study|Protocol Violation|1
7128245|NCT02722278|11271226|FG001|Overall Study|Protocol Violation|0
7128246|NCT02722278|11271225|FG000|Overall Study|High PSA pre-study/ not eligible|0
7128247|NCT02722278|11271226|FG001|Overall Study|High PSA pre-study/ not eligible|1
7128248|NCT02722278|11271225|FG000|Overall Study|Subject declined after tx assignment|0
7128249|NCT02722278|11271226|FG001|Overall Study|Subject declined after tx assignment|1
7128250|NCT02722278|11271225|FG000|Overall Study|Site closure not study related|0
7128251|NCT02722278|11271226|FG001|Overall Study|Site closure not study related|1
7128252|NCT02722304|11271239|FG000|Overall Study|Study Terminated by Sponsor|1
7128253|NCT02722304|11271240|FG001|Overall Study|Study Terminated by Sponsor|0
7128254|NCT02722304|11271241|FG002|Overall Study|Study Terminated by Sponsor|2
7128255|NCT02722304|11271242|FG003|Overall Study|Study Terminated by Sponsor|1
7128256|NCT02722304|11271243|FG004|Overall Study|Study Terminated by Sponsor|1
7128257|NCT02722304|11271239|FG000|Overall Study|Other|0
7128258|NCT02722304|11271240|FG001|Overall Study|Other|0
7128259|NCT02722304|11271241|FG002|Overall Study|Other|0
7128260|NCT02722304|11271242|FG003|Overall Study|Other|1
7128261|NCT02722304|11271243|FG004|Overall Study|Other|1
7128262|NCT02722499|11271270|FG000|Overall Study|Lost to Follow-up|2
7128263|NCT02722499|11271271|FG001|Overall Study|Lost to Follow-up|0
7128264|NCT02722499|11271272|FG002|Overall Study|Lost to Follow-up|1
7128265|NCT02722928|11271299|FG000|Overall Study|Standard CT was not as required per prot|5
7128266|NCT02722928|11271300|FG001|Overall Study|Standard CT was not as required per prot|13
7128267|NCT02722928|11271299|FG000|Overall Study|Required Intraoperative MRI|5
7128268|NCT02722928|11271300|FG001|Overall Study|Required Intraoperative MRI|7
7128269|NCT02722967|11271313|FG000|Overall Study|Adverse Event|1
7128270|NCT02722967|11271314|FG001|Overall Study|Adverse Event|0
7128271|NCT02722967|11271315|FG002|Overall Study|Adverse Event|0
7128272|NCT02722967|11271313|FG000|Overall Study|Lost to Follow-up|0
7128273|NCT02722967|11271314|FG001|Overall Study|Lost to Follow-up|1
7128274|NCT02722967|11271315|FG002|Overall Study|Lost to Follow-up|0
7128275|NCT02722967|11271313|FG000|Overall Study|Non-compliance with patch wearing|2
7128276|NCT02722967|11271314|FG001|Overall Study|Non-compliance with patch wearing|1
7128277|NCT02722967|11271315|FG002|Overall Study|Non-compliance with patch wearing|1
7128278|NCT02722967|11271313|FG000|Overall Study|Withdrawal by Subject|1
7128279|NCT02722967|11271314|FG001|Overall Study|Withdrawal by Subject|0
7128280|NCT02722967|11271315|FG002|Overall Study|Withdrawal by Subject|1
7128281|NCT02722967|11271313|FG000|Overall Study|Physician Decision|1
6810395|NCT03882047|10814146|FG002|Overall Study|Treatment Failure|12
7128282|NCT02722967|11271314|FG001|Overall Study|Physician Decision|0
7128283|NCT02722967|11271315|FG002|Overall Study|Physician Decision|0
7128284|NCT02722967|11271313|FG000|Overall Study|Non-adherence of the patch to the skin|0
7128285|NCT02722967|11271314|FG001|Overall Study|Non-adherence of the patch to the skin|0
7128286|NCT02722967|11271315|FG002|Overall Study|Non-adherence of the patch to the skin|2
7128287|NCT02723006|11271326|FG000|Overall Study|Withdrawal by Subject|0
7128288|NCT02723006|11271327|FG001|Overall Study|Withdrawal by Subject|1
7128289|NCT02723006|11271328|FG002|Overall Study|Withdrawal by Subject|1
7128290|NCT02723006|11271326|FG000|Overall Study|Study Terminated by Sponsor|1
7128291|NCT02723006|11271327|FG001|Overall Study|Study Terminated by Sponsor|6
7128292|NCT02723006|11271328|FG002|Overall Study|Study Terminated by Sponsor|6
7128293|NCT02723084|11271338|FG000|Overall Study|Withdrawal by Subject|1
7128294|NCT02723084|11271339|FG001|Overall Study|Withdrawal by Subject|1
7128295|NCT02723084|11271338|FG000|Overall Study|Lost to Follow-up|3
7128296|NCT02723084|11271339|FG001|Overall Study|Lost to Follow-up|0
7128297|NCT02723175|11271347|FG000|Overall Study|Lost to 1 Month Follow Up|3
7128298|NCT02723175|11271348|FG001|Overall Study|Lost to 1 Month Follow Up|2
7128299|NCT02723175|11271347|FG000|Overall Study|Lost to 3 Month Follow Up|1
7128300|NCT02723175|11271348|FG001|Overall Study|Lost to 3 Month Follow Up|1
7128301|NCT02723188|11271357|FG000|Overall Study|Withdrawal by Subject|1
7128302|NCT02723188|11271358|FG001|Overall Study|Withdrawal by Subject|0
7128303|NCT02723188|11271359|FG002|Overall Study|Withdrawal by Subject|0
7128304|NCT02723201|11271370|FG000|Second Intervention Period|Protocol Violation|1
7128305|NCT02723201|11271371|FG001|Second Intervention Period|Protocol Violation|0
7128306|NCT02723201|11271372|FG002|Second Intervention Period|Protocol Violation|0
7128307|NCT02723201|11271370|FG000|Second Intervention Period|Adverse Event|1
7128308|NCT02723201|11271371|FG001|Second Intervention Period|Adverse Event|0
7128309|NCT02723201|11271372|FG002|Second Intervention Period|Adverse Event|0
7128310|NCT02723344|11271388|FG000|Overall Study|Lost to Follow-up|0
7128311|NCT02723344|11271389|FG001|Overall Study|Lost to Follow-up|4
7128312|NCT02723591|11271397|FG000|Overall Study|Adverse Event|48
7128313|NCT02723591|11271398|FG001|Overall Study|Adverse Event|40
7128314|NCT02723591|11271397|FG000|Overall Study|Death|2
7128315|NCT02723591|11271398|FG001|Overall Study|Death|2
7128316|NCT02723591|11271397|FG000|Overall Study|Lack of Efficacy|4
7128317|NCT02723591|11271398|FG001|Overall Study|Lack of Efficacy|3
7128318|NCT02723591|11271397|FG000|Overall Study|Lost to Follow-up|1
7128319|NCT02723591|11271398|FG001|Overall Study|Lost to Follow-up|7
7128320|NCT02723591|11271397|FG000|Overall Study|Protocol Violation|20
7128321|NCT02723591|11271398|FG001|Overall Study|Protocol Violation|23
7128322|NCT02723591|11271397|FG000|Overall Study|Withdrawal by Subject|4
7128323|NCT02723591|11271398|FG001|Overall Study|Withdrawal by Subject|8
7128324|NCT02723591|11271397|FG000|Overall Study|Randomized but Never Received StudyDrug|12
7128325|NCT02723591|11271398|FG001|Overall Study|Randomized but Never Received StudyDrug|12
7128326|NCT02723591|11271397|FG000|Overall Study|Miscellaneous|5
7128327|NCT02723591|11271398|FG001|Overall Study|Miscellaneous|6
7128328|NCT02723630|11271410|FG000|Intervention Period 1|Adverse Event|1
7128329|NCT02723630|11271411|FG001|Intervention Period 1|Adverse Event|0
7128330|NCT02723630|11271412|FG002|Intervention Period 1|Adverse Event|0
7128331|NCT02723630|11271413|FG003|Intervention Period 1|Adverse Event|0
7128332|NCT02723630|11271414|FG004|Intervention Period 1|Adverse Event|0
7128333|NCT02723630|11271415|FG005|Intervention Period 1|Adverse Event|0
7128334|NCT02723630|11271410|FG000|Intervention Period 3|consumption of restricted item|0
7128335|NCT02723630|11271411|FG001|Intervention Period 3|consumption of restricted item|1
7128336|NCT02723630|11271412|FG002|Intervention Period 3|consumption of restricted item|0
7128337|NCT02723630|11271413|FG003|Intervention Period 3|consumption of restricted item|0
7128338|NCT02723630|11271414|FG004|Intervention Period 3|consumption of restricted item|0
7128339|NCT02723630|11271415|FG005|Intervention Period 3|consumption of restricted item|0
7128340|NCT02723786|11271428|FG000|Overall Study|Lost to Follow-up|1
7128341|NCT02724020|11271455|FG000|Overall Study|Death|16
7128342|NCT02724020|11271456|FG001|Overall Study|Death|18
7128343|NCT02724020|11271457|FG002|Overall Study|Death|19
7128344|NCT02724020|11271455|FG000|Overall Study|Lost to Follow-up|0
7128345|NCT02724020|11271456|FG001|Overall Study|Lost to Follow-up|3
7128346|NCT02724020|11271457|FG002|Overall Study|Lost to Follow-up|0
7128347|NCT02724020|11271455|FG000|Overall Study|Site Terminated by Sponsor|15
7128348|NCT02724020|11271456|FG001|Overall Study|Site Terminated by Sponsor|8
7128349|NCT02724020|11271457|FG002|Overall Study|Site Terminated by Sponsor|8
7128350|NCT02724020|11271455|FG000|Overall Study|Withdrawal by Subject|1
7128351|NCT02724020|11271456|FG001|Overall Study|Withdrawal by Subject|3
7128352|NCT02724020|11271457|FG002|Overall Study|Withdrawal by Subject|5
7128353|NCT02724111|11271480|FG000|Overall Study|Protocol Violation|2
7128354|NCT02724111|11271481|FG001|Overall Study|Protocol Violation|5
7128355|NCT02724462|11271498|FG000|3 Month Follow-up Survey|Lost to Follow-up|171
7128356|NCT02724462|11271499|FG001|3 Month Follow-up Survey|Lost to Follow-up|151
7128357|NCT02724462|11271498|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40
7128358|NCT02724462|11271499|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48
7128359|NCT02724462|11271498|FG000|6 Month Follow-up Survey|Lost to Follow-up|156
7128360|NCT02724462|11271499|FG001|6 Month Follow-up Survey|Lost to Follow-up|123
7128361|NCT02724462|11271498|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40
7128362|NCT02724462|11271499|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48
7128363|NCT02724462|11271498|FG000|12 Month Follow-up Survey|Lost to Follow-up|174
7128364|NCT02724462|11271499|FG001|12 Month Follow-up Survey|Lost to Follow-up|134
7128365|NCT02724462|11271498|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40
7128366|NCT02724462|11271499|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48
7128367|NCT02724592|11271507|FG000|Overall Study|Lost to Follow-up|4
7128368|NCT02724592|11271508|FG001|Overall Study|Lost to Follow-up|1
7128369|NCT02724644|11271516|FG000|Overall Study|Adverse Event|7
7128370|NCT02724644|11271517|FG001|Overall Study|Adverse Event|1
7128371|NCT02724644|11271516|FG000|Overall Study|Lost to Follow-up|6
7128372|NCT02724644|11271517|FG001|Overall Study|Lost to Follow-up|2
7128373|NCT02724644|11271516|FG000|Overall Study|Withdrawal by Subject|7
7128374|NCT02724644|11271517|FG001|Overall Study|Withdrawal by Subject|1
7128375|NCT02724644|11271516|FG000|Overall Study|Administrative|1
7128376|NCT02724644|11271517|FG001|Overall Study|Administrative|0
7128377|NCT02724839|11271539|FG000|Overall Study|Withdrawal by Subject|1
7128378|NCT02724839|11271540|FG001|Overall Study|Withdrawal by Subject|1
7128379|NCT02724839|11271541|FG002|Overall Study|Withdrawal by Subject|0
7128380|NCT02724839|11271539|FG000|Overall Study|Lost to Follow-up|0
7128381|NCT02724839|11271540|FG001|Overall Study|Lost to Follow-up|3
7128382|NCT02724839|11271541|FG002|Overall Study|Lost to Follow-up|2
7128383|NCT02724839|11271539|FG000|Overall Study|Physician Decision|0
7128384|NCT02724839|11271540|FG001|Overall Study|Physician Decision|0
7128385|NCT02724839|11271541|FG002|Overall Study|Physician Decision|3
7128386|NCT02724956|11271558|FG000|Overall Study|Physician Decision|1
7128387|NCT02724956|11271559|FG001|Overall Study|Physician Decision|0
7128388|NCT02724956|11271558|FG000|Overall Study|Lack of Efficacy|0
7128389|NCT02724956|11271559|FG001|Overall Study|Lack of Efficacy|1
7128390|NCT02724956|11271558|FG000|Overall Study|Withdrawal by Subject|0
7128391|NCT02724956|11271559|FG001|Overall Study|Withdrawal by Subject|1
7128392|NCT02725008|11271567|FG000|Overall Study|Lost to Follow-up|7
7128393|NCT02725008|11271568|FG001|Overall Study|Lost to Follow-up|9
7128394|NCT02725008|11271567|FG000|Overall Study|Withdrawal by Subject|2
7128395|NCT02725008|11271568|FG001|Overall Study|Withdrawal by Subject|2
7128396|NCT02725008|11271567|FG000|Overall Study|Admitted to hospital|0
7128397|NCT02725008|11271568|FG001|Overall Study|Admitted to hospital|1
7128398|NCT02725268|11271578|FG000|Overall Study|Death|58
7128399|NCT02725268|11271579|FG001|Overall Study|Death|59
7128400|NCT02725268|11271580|FG002|Overall Study|Death|30
7128401|NCT02725268|11271581|FG003|Overall Study|Death|16
7128402|NCT02725268|11271578|FG000|Overall Study|Lost to Follow-up|4
7128403|NCT02725268|11271579|FG001|Overall Study|Lost to Follow-up|3
7128404|NCT02725268|11271580|FG002|Overall Study|Lost to Follow-up|0
7128405|NCT02725268|11271581|FG003|Overall Study|Lost to Follow-up|1
7128406|NCT02725268|11271578|FG000|Overall Study|Site Terminated by Sponsor|0
7128407|NCT02725268|11271579|FG001|Overall Study|Site Terminated by Sponsor|1
7128408|NCT02725268|11271580|FG002|Overall Study|Site Terminated by Sponsor|0
7128409|NCT02725268|11271581|FG003|Overall Study|Site Terminated by Sponsor|0
7128410|NCT02725268|11271578|FG000|Overall Study|Withdrawal by Subject|8
7128411|NCT02725268|11271579|FG001|Overall Study|Withdrawal by Subject|6
7128412|NCT02725268|11271580|FG002|Overall Study|Withdrawal by Subject|8
7128413|NCT02725268|11271581|FG003|Overall Study|Withdrawal by Subject|1
7128414|NCT02725268|11271578|FG000|Overall Study|Reason not Specified|2
7128415|NCT02725268|11271579|FG001|Overall Study|Reason not Specified|1
7128416|NCT02725268|11271580|FG002|Overall Study|Reason not Specified|0
7128417|NCT02725268|11271581|FG003|Overall Study|Reason not Specified|0
7128418|NCT02725411|11271594|FG000|Treatment Period (56 Weeks)|Adverse Event|3
7128419|NCT02725411|11271595|FG001|Treatment Period (56 Weeks)|Adverse Event|5
7128420|NCT02725411|11271596|FG002|Treatment Period (56 Weeks)|Adverse Event|4
7128421|NCT02725411|11271594|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1
7128422|NCT02725411|11271595|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4
7128423|NCT02725411|11271596|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1
7128424|NCT02725411|11271594|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0
7128425|NCT02725411|11271595|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1
7128426|NCT02725411|11271596|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0
7128427|NCT02725411|11271594|FG000|Treatment Period (56 Weeks)|Other|1
7128428|NCT02725411|11271595|FG001|Treatment Period (56 Weeks)|Other|4
7128429|NCT02725411|11271596|FG002|Treatment Period (56 Weeks)|Other|5
7128430|NCT02725411|11271594|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0
7128431|NCT02725411|11271595|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1
7128432|NCT02725411|11271596|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4
7128433|NCT02725411|11271594|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25
7128434|NCT02725411|11271595|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35
7128435|NCT02725411|11271596|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35
7128436|NCT02725411|11271594|FG000|Follow-up Period (24 Weeks)|Adverse Event|1
7128437|NCT02725411|11271595|FG001|Follow-up Period (24 Weeks)|Adverse Event|1
7128438|NCT02725411|11271596|FG002|Follow-up Period (24 Weeks)|Adverse Event|0
7128439|NCT02725411|11271594|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0
7128440|NCT02725411|11271595|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2
7128441|NCT02725411|11271596|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0
7128442|NCT02725411|11271594|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1
7128443|NCT02725411|11271595|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1
7128444|NCT02725411|11271596|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0
7128445|NCT02725411|11271594|FG000|Follow-up Period (24 Weeks)|Other|1
7128446|NCT02725411|11271595|FG001|Follow-up Period (24 Weeks)|Other|4
7128447|NCT02725411|11271596|FG002|Follow-up Period (24 Weeks)|Other|2
7128448|NCT02725411|11271594|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
7128449|NCT02725411|11271595|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3
7128450|NCT02725411|11271596|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3
7128451|NCT02725476|11271606|FG000|Overall Study|Physician Decision|2
7128452|NCT02725476|11271607|FG001|Overall Study|Physician Decision|0
7128453|NCT02725476|11271606|FG000|Overall Study|Adverse Event|1
7128454|NCT02725476|11271607|FG001|Overall Study|Adverse Event|1
7128455|NCT02725515|11271615|FG000|Overall Study|Refused infusion (no study treatment)|1
7128456|NCT02725515|11271616|FG001|Overall Study|Refused infusion (no study treatment)|0
7128457|NCT02725515|11271615|FG000|Overall Study|Loss of Improvement per Protocol|14
7128458|NCT02725515|11271616|FG001|Overall Study|Loss of Improvement per Protocol|25
7128459|NCT02725515|11271615|FG000|Overall Study|Withdrawal by Subject|2
7128460|NCT02725515|11271616|FG001|Overall Study|Withdrawal by Subject|1
7128461|NCT02725515|11271615|FG000|Overall Study|Non-Compliance With Study Drug|0
7128462|NCT02725515|11271616|FG001|Overall Study|Non-Compliance With Study Drug|3
7128463|NCT02725515|11271615|FG000|Overall Study|Lost to Follow-up|1
7128464|NCT02725515|11271616|FG001|Overall Study|Lost to Follow-up|1
7128465|NCT02725515|11271615|FG000|Overall Study|Adverse Event|7
7128466|NCT02725515|11271616|FG001|Overall Study|Adverse Event|2
7128467|NCT02725515|11271615|FG000|Overall Study|No Documented Disease Improvement|0
7128468|NCT02725515|11271616|FG001|Overall Study|No Documented Disease Improvement|1
7128469|NCT02725515|11271615|FG000|Overall Study|Completed Study Under Original Protocol|0
7128470|NCT02725515|11271616|FG001|Overall Study|Completed Study Under Original Protocol|1
7128471|NCT02725515|11271615|FG000|Overall Study|Lack of Response|0
7128472|NCT02725515|11271616|FG001|Overall Study|Lack of Response|1
7128473|NCT02725710|11271628|FG000|Overall Study|Lost to Follow-up|1
7128474|NCT02725710|11271629|FG001|Overall Study|Lost to Follow-up|0
7128475|NCT02725788|11271637|FG000|Overall Study|Lost to Follow-up|1
7128476|NCT02725788|11271638|FG001|Overall Study|Lost to Follow-up|1
7128477|NCT02725788|11271637|FG000|Overall Study|Protocol Violation|0
7128478|NCT02725788|11271638|FG001|Overall Study|Protocol Violation|1
7128479|NCT02725866|11271653|FG000|Overall Study|Failure to return|6
7128480|NCT02725866|11271653|FG000|Overall Study|Withdrew consent|3
7128481|NCT02725866|11271653|FG000|Overall Study|Insufficient virological response|1
7128482|NCT02725866|11271653|FG000|Overall Study|Other, not specified|4
7128483|NCT02726022|11271657|FG000|Overall Study|Adverse Event|14
7128484|NCT02726022|11271657|FG000|Overall Study|Treatment Failure|8
7128485|NCT02726022|11271657|FG000|Overall Study|Poor Compliance|13
7128486|NCT02726022|11271657|FG000|Overall Study|Treatment Failure and Poor Compliance|1
7128487|NCT02726074|11271661|FG000|Overall Study|Withdrawal by Subject|4
7128488|NCT02726074|11271661|FG000|Overall Study|Adverse Event|14
7128489|NCT02726074|11271661|FG000|Overall Study|Protocol Violation|3
7128490|NCT02726074|11271661|FG000|Overall Study|Lost to Follow-up|2
7128491|NCT02726074|11271661|FG000|Overall Study|Others|3
7128492|NCT02726113|11271667|FG000|Total Enrollment|Physician Decision|0
7128493|NCT02726113|11271668|FG001|Total Enrollment|Physician Decision|1
7128494|NCT02726113|11271667|FG000|Total Enrollment|Protocol Violation|1
7128495|NCT02726113|11271668|FG001|Total Enrollment|Protocol Violation|0
7128496|NCT02726113|11271667|FG000|Total Enrollment|Withdrawal by Subject|2
7128497|NCT02726113|11271668|FG001|Total Enrollment|Withdrawal by Subject|1
7128498|NCT02726113|11271667|FG000|Total Enrollment|Insurance non-coverage for surgery|1
7128499|NCT02726113|11271668|FG001|Total Enrollment|Insurance non-coverage for surgery|1
7128500|NCT02726113|11271667|FG000|Genomic Analysis|Protocol Violation|1
7128501|NCT02726113|11271668|FG001|Genomic Analysis|Protocol Violation|0
7128502|NCT02726113|11271667|FG000|Genomic Analysis|Withdrawal by Subject|2
7128503|NCT02726113|11271668|FG001|Genomic Analysis|Withdrawal by Subject|1
7128504|NCT02726113|11271667|FG000|Genomic Analysis|Insurance non-coverage for surgery|1
7128505|NCT02726113|11271668|FG001|Genomic Analysis|Insurance non-coverage for surgery|1
7128506|NCT02726945|11271721|FG000|Overall Study|Withdrawal by Subject|0
7128507|NCT02726945|11271722|FG001|Overall Study|Withdrawal by Subject|0
7128508|NCT02726945|11271723|FG002|Overall Study|Withdrawal by Subject|1
7128509|NCT02726945|11271721|FG000|Overall Study|Elected to have total knee replacement|0
7128510|NCT02726945|11271722|FG001|Overall Study|Elected to have total knee replacement|1
7128511|NCT02726945|11271723|FG002|Overall Study|Elected to have total knee replacement|0
7128512|NCT02727192|11271742|FG000|Overall Study|Lost to Follow-up|1
7128513|NCT02727192|11271743|FG001|Overall Study|Lost to Follow-up|0
7128514|NCT02727192|11271744|FG002|Overall Study|Lost to Follow-up|0
7128515|NCT02727322|11271753|FG000|Overall Study|Withdrawal by Subject|1
7128516|NCT02727322|11271754|FG001|Overall Study|Withdrawal by Subject|1
7128517|NCT02727322|11271753|FG000|Overall Study|Protocol Violation|1
7128518|NCT02727322|11271754|FG001|Overall Study|Protocol Violation|0
7128519|NCT02727660|11271767|FG000|Overall Study|Lack of Efficacy|40
7128520|NCT02727660|11271768|FG001|Overall Study|Lack of Efficacy|40
7128521|NCT02727660|11271769|FG002|Overall Study|Lack of Efficacy|70
7128522|NCT02727660|11271767|FG000|Overall Study|Adverse Event|28
7128523|NCT02727660|11271768|FG001|Overall Study|Adverse Event|21
7128524|NCT02727660|11271769|FG002|Overall Study|Adverse Event|32
7128525|NCT02727660|11271767|FG000|Overall Study|Withdrawal by Subject|26
7128526|NCT02727660|11271768|FG001|Overall Study|Withdrawal by Subject|25
7128527|NCT02727660|11271769|FG002|Overall Study|Withdrawal by Subject|30
7128528|NCT02727660|11271767|FG000|Overall Study|Physician Decision|3
7128529|NCT02727660|11271768|FG001|Overall Study|Physician Decision|8
7128530|NCT02727660|11271769|FG002|Overall Study|Physician Decision|14
7128531|NCT02727660|11271767|FG000|Overall Study|Lost to Follow-up|5
7128532|NCT02727660|11271768|FG001|Overall Study|Lost to Follow-up|9
7128533|NCT02727660|11271769|FG002|Overall Study|Lost to Follow-up|8
7128534|NCT02727660|11271767|FG000|Overall Study|Protocol Violation|7
7128535|NCT02727660|11271768|FG001|Overall Study|Protocol Violation|5
7128536|NCT02727660|11271769|FG002|Overall Study|Protocol Violation|5
7128537|NCT02727660|11271767|FG000|Overall Study|Protocol Specified Disc. Criteria|5
7128538|NCT02727660|11271768|FG001|Overall Study|Protocol Specified Disc. Criteria|5
7128539|NCT02727660|11271769|FG002|Overall Study|Protocol Specified Disc. Criteria|2
7128540|NCT02727660|11271767|FG000|Overall Study|Administrative Reasons|2
7128541|NCT02727660|11271768|FG001|Overall Study|Administrative Reasons|3
7128542|NCT02727660|11271769|FG002|Overall Study|Administrative Reasons|4
7128543|NCT02727777|11271784|FG000|Overall Study|Screen Failure|2
7128544|NCT02727777|11271785|FG001|Overall Study|Screen Failure|0
7128545|NCT02727777|11271786|FG002|Overall Study|Screen Failure|0
7128546|NCT02727777|11271784|FG000|Overall Study|Progressive disease|2
7128547|NCT02727777|11271785|FG001|Overall Study|Progressive disease|0
7128548|NCT02727777|11271786|FG002|Overall Study|Progressive disease|0
7128549|NCT02728089|11271830|FG000|Overall Study|Physician Decision|2
7128550|NCT02728089|11271830|FG000|Overall Study|Withdrawal by Subject|1
7128551|NCT02728102|11271837|FG000|Overall Study|Death|1
7128552|NCT02728102|11271838|FG001|Overall Study|Death|0
7128553|NCT02728102|11271839|FG002|Overall Study|Death|0
7128554|NCT02728102|11271837|FG000|Overall Study|Withdrawal by Subject|0
7128555|NCT02728102|11271838|FG001|Overall Study|Withdrawal by Subject|2
7128556|NCT02728102|11271839|FG002|Overall Study|Withdrawal by Subject|2
7128557|NCT02728206|11271846|FG000|Overall Study|Death|1
7128558|NCT02728830|11271850|FG000|Overall Study|Exclusionary Surgery|9
7128559|NCT02728830|11271850|FG000|Overall Study|Exclusionary Pathology|6
7128560|NCT02728830|11271850|FG000|Overall Study|Physician Decision|3
7128561|NCT02728830|11271850|FG000|Overall Study|Withdrawal by Subject|2
7128562|NCT02728830|11271850|FG000|Overall Study|Lost to Follow-up|1
7128563|NCT02728830|11271850|FG000|Overall Study|Exclusionary Lab Values|1
7128564|NCT02728830|11271850|FG000|Overall Study|Contraindicated Illness|1
7128565|NCT02728830|11271850|FG000|Overall Study|Language Barrier|1
7128566|NCT02728895|11271856|FG000|Overall Study|Other|1
7128567|NCT02728895|11271857|FG001|Overall Study|Other|2
7128568|NCT02728895|11271856|FG000|Overall Study|Withdrawal by Subject|0
7128569|NCT02728895|11271857|FG001|Overall Study|Withdrawal by Subject|3
7128570|NCT02729025|11271865|FG000|Overall Study|Sponsor Decision|0
7128571|NCT02729025|11271866|FG001|Overall Study|Sponsor Decision|1
7128572|NCT02729051|11271898|FG000|Overall Study|Adverse Event|21
7128573|NCT02729051|11271899|FG001|Overall Study|Adverse Event|11
7128574|NCT02729051|11271898|FG000|Overall Study|Lack of Efficacy|1
7128575|NCT02729051|11271899|FG001|Overall Study|Lack of Efficacy|1
7128576|NCT02729051|11271898|FG000|Overall Study|Lost to Follow-up|1
7128577|NCT02729051|11271899|FG001|Overall Study|Lost to Follow-up|2
7128578|NCT02729051|11271898|FG000|Overall Study|Physician Decision|1
7128579|NCT02729051|11271899|FG001|Overall Study|Physician Decision|1
7128580|NCT02729051|11271898|FG000|Overall Study|Withdrawal by Subject|6
7128581|NCT02729051|11271899|FG001|Overall Study|Withdrawal by Subject|17
7128582|NCT02729194|11271905|FG000|Overall Study|Withdrawal by Subject|3
7128583|NCT02729545|11271911|FG000|Overall Study|Pregnancy|1
7128584|NCT02729545|11271912|FG001|Overall Study|Pregnancy|1
7128585|NCT02729545|11271911|FG000|Overall Study|Lost to Follow-up|0
7128586|NCT02729545|11271912|FG001|Overall Study|Lost to Follow-up|1
7128587|NCT02729545|11271911|FG000|Overall Study|Withdrawal by Subject|2
7128588|NCT02729545|11271912|FG001|Overall Study|Withdrawal by Subject|3
7128589|NCT02729740|11271918|FG000|Overall Study|Early Termination|130
7128590|NCT02729740|11271918|FG000|Overall Study|Other|1
7128591|NCT02729831|11271926|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38
7128592|NCT02729831|11271927|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23
7128593|NCT02729831|11271928|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18
7128594|NCT02729831|11271929|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17
7128595|NCT02729831|11271926|FG000|1 Week Post-visit|Lost to Follow-up|43
7128596|NCT02729831|11271927|FG001|1 Week Post-visit|Lost to Follow-up|40
7128597|NCT02729831|11271928|FG002|1 Week Post-visit|Lost to Follow-up|38
7128598|NCT02729831|11271929|FG003|1 Week Post-visit|Lost to Follow-up|36
7128599|NCT02729831|11271926|FG000|6 Month Follow-up|Lost to Follow-up|54
7128600|NCT02729831|11271927|FG001|6 Month Follow-up|Lost to Follow-up|51
7128601|NCT02729831|11271928|FG002|6 Month Follow-up|Lost to Follow-up|48
7128602|NCT02729831|11271929|FG003|6 Month Follow-up|Lost to Follow-up|42
7128603|NCT02729831|11271926|FG000|6 Month Follow-up|Death|1
7128604|NCT02729831|11271927|FG001|6 Month Follow-up|Death|3
7128605|NCT02729831|11271928|FG002|6 Month Follow-up|Death|0
7128606|NCT02729831|11271929|FG003|6 Month Follow-up|Death|1
7128607|NCT02729896|11271942|FG000|Overall Study|Death|0
7128608|NCT02729896|11271943|FG001|Overall Study|Death|2
7128609|NCT02729896|11271944|FG002|Overall Study|Death|13
7128610|NCT02729896|11271942|FG000|Overall Study|Lost to Follow-up|0
7128611|NCT02729896|11271943|FG001|Overall Study|Lost to Follow-up|2
7128612|NCT02729896|11271944|FG002|Overall Study|Lost to Follow-up|3
7128613|NCT02729896|11271942|FG000|Overall Study|Other|0
7128614|NCT02729896|11271943|FG001|Overall Study|Other|2
7128615|NCT02729896|11271944|FG002|Overall Study|Other|0
7128616|NCT02729896|11271942|FG000|Overall Study|Physician Decision|1
7128617|NCT02729896|11271943|FG001|Overall Study|Physician Decision|2
7128618|NCT02729896|11271944|FG002|Overall Study|Physician Decision|3
7128619|NCT02729896|11271942|FG000|Overall Study|Progressive Disease|0
7128620|NCT02729896|11271943|FG001|Overall Study|Progressive Disease|1
7128621|NCT02729896|11271944|FG002|Overall Study|Progressive Disease|0
7128622|NCT02729896|11271942|FG000|Overall Study|Withdrawal by Subject|1
7128623|NCT02729896|11271943|FG001|Overall Study|Withdrawal by Subject|0
7128624|NCT02729896|11271944|FG002|Overall Study|Withdrawal by Subject|3
7128625|NCT02729909|11271955|FG000|Overall Study|Lost to Follow-up|0
7128626|NCT02729909|11271956|FG001|Overall Study|Lost to Follow-up|1
7128627|NCT02729909|11271955|FG000|Overall Study|Lack of Efficacy|0
7128628|NCT02729909|11271956|FG001|Overall Study|Lack of Efficacy|2
7128629|NCT02729909|11271955|FG000|Overall Study|Significant Protocol Deviation|0
7128630|NCT02729909|11271956|FG001|Overall Study|Significant Protocol Deviation|2
7128631|NCT02729909|11271955|FG000|Overall Study|Voluntary Withdrawal|1
7128632|NCT02729909|11271956|FG001|Overall Study|Voluntary Withdrawal|0
7128633|NCT02730169|11271966|FG000|Overall Study|Protocol Violation|1
7128634|NCT02730169|11271967|FG001|Overall Study|Protocol Violation|0
7128635|NCT02730169|11271968|FG002|Overall Study|Protocol Violation|0
7128636|NCT02730169|11271969|FG003|Overall Study|Protocol Violation|1
7128637|NCT02730169|11271966|FG000|Overall Study|Adverse Event|2
7128638|NCT02730169|11271967|FG001|Overall Study|Adverse Event|3
7128639|NCT02730169|11271968|FG002|Overall Study|Adverse Event|3
7128640|NCT02730169|11271969|FG003|Overall Study|Adverse Event|0
7128641|NCT02730169|11271966|FG000|Overall Study|Adverse Event of Special Interest|0
7128642|NCT02730169|11271967|FG001|Overall Study|Adverse Event of Special Interest|1
7128643|NCT02730169|11271968|FG002|Overall Study|Adverse Event of Special Interest|2
7128644|NCT02730169|11271969|FG003|Overall Study|Adverse Event of Special Interest|0
7128645|NCT02730169|11271966|FG000|Overall Study|Withdrawal by Subject|6
7128646|NCT02730169|11271967|FG001|Overall Study|Withdrawal by Subject|11
7128647|NCT02730169|11271968|FG002|Overall Study|Withdrawal by Subject|6
7128648|NCT02730169|11271969|FG003|Overall Study|Withdrawal by Subject|8
7128649|NCT02730169|11271966|FG000|Overall Study|Lost to Follow-up|5
7128650|NCT02730169|11271967|FG001|Overall Study|Lost to Follow-up|6
7128651|NCT02730169|11271968|FG002|Overall Study|Lost to Follow-up|5
7128652|NCT02730169|11271969|FG003|Overall Study|Lost to Follow-up|6
7128653|NCT02730169|11271966|FG000|Overall Study|Other|0
7128654|NCT02730169|11271967|FG001|Overall Study|Other|0
7128655|NCT02730169|11271968|FG002|Overall Study|Other|1
7128656|NCT02730169|11271969|FG003|Overall Study|Other|1
7128657|NCT02730195|11271979|FG000|Overall Study|Withdrawal by Subject|1
7128658|NCT02730208|11271985|FG000|Overall Study|Withdrawal of consent (not due to AE)|0
7128659|NCT02730208|11271986|FG001|Overall Study|Withdrawal of consent (not due to AE)|1
7128660|NCT02730351|11272009|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1
7128661|NCT02730351|11272010|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0
7128662|NCT02730351|11272009|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0
7128663|NCT02730351|11272010|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1
7128664|NCT02730351|11272009|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1
7128665|NCT02730351|11272010|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0
7128666|NCT02730351|11272009|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1
7128667|NCT02730351|11272010|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0
7128668|NCT02730351|11272009|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1
7128669|NCT02730351|11272010|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0
7128670|NCT02730377|11272018|FG000|Overall Study|Other|5
7128671|NCT02730377|11272019|FG001|Overall Study|Other|4
7128672|NCT02730377|11272018|FG000|Overall Study|Death|1
7128673|NCT02730377|11272019|FG001|Overall Study|Death|8
7128674|NCT02730377|11272018|FG000|Overall Study|Inadequate glycaemic control|368
7128675|NCT02730377|11272019|FG001|Overall Study|Inadequate glycaemic control|473
7128676|NCT02730377|11272018|FG000|Overall Study|Adverse Event|79
7128677|NCT02730377|11272019|FG001|Overall Study|Adverse Event|41
7128678|NCT02730377|11272018|FG000|Overall Study|Protocol Violation|23
7128679|NCT02730377|11272019|FG001|Overall Study|Protocol Violation|30
7128680|NCT02730377|11272018|FG000|Overall Study|Lack of Efficacy|4
7128681|NCT02730377|11272019|FG001|Overall Study|Lack of Efficacy|13
7128682|NCT02730377|11272018|FG000|Overall Study|Pregnancy|0
7128683|NCT02730377|11272019|FG001|Overall Study|Pregnancy|1
7128684|NCT02730377|11272018|FG000|Overall Study|Withdrawal by Subject|45
7128685|NCT02730377|11272019|FG001|Overall Study|Withdrawal by Subject|42
7128686|NCT02730377|11272018|FG000|Overall Study|Lost to Follow-up|25
7128687|NCT02730377|11272019|FG001|Overall Study|Lost to Follow-up|21
7128688|NCT02730455|11272033|FG000|Overall Study|Death|5
7128689|NCT02730455|11272034|FG001|Overall Study|Death|6
7128690|NCT02730455|11272035|FG002|Overall Study|Death|4
7128691|NCT02730455|11272033|FG000|Overall Study|Consent withdrawn|2
7128692|NCT02730455|11272034|FG001|Overall Study|Consent withdrawn|4
7128693|NCT02730455|11272035|FG002|Overall Study|Consent withdrawn|1
7128694|NCT02730455|11272033|FG000|Overall Study|Lost to Follow-up|3
7128695|NCT02730455|11272034|FG001|Overall Study|Lost to Follow-up|1
7128696|NCT02730455|11272035|FG002|Overall Study|Lost to Follow-up|4
7128697|NCT02730455|11272033|FG000|Overall Study|Other|1
7128698|NCT02730455|11272034|FG001|Overall Study|Other|1
7128699|NCT02730455|11272035|FG002|Overall Study|Other|2
7128700|NCT02730455|11272033|FG000|Overall Study|Other|2
7128701|NCT02730455|11272034|FG001|Overall Study|Other|2
7128702|NCT02730455|11272035|FG002|Overall Study|Other|0
7128703|NCT02730598|11272045|FG000|Overall Study|Withdrawal by Subject|3
7128704|NCT02730598|11272046|FG001|Overall Study|Withdrawal by Subject|3
7128705|NCT02730598|11272045|FG000|Overall Study|Protocol Violation|0
7128706|NCT02730598|11272046|FG001|Overall Study|Protocol Violation|1
7128707|NCT02730598|11272045|FG000|Overall Study|Unrelated Injury affecting outcomes.|1
7128708|NCT02730598|11272046|FG001|Overall Study|Unrelated Injury affecting outcomes.|0
7128709|NCT02730728|11272059|FG000|Overall Study|Withdrawal by Subject|0
7128710|NCT02730728|11272060|FG001|Overall Study|Withdrawal by Subject|1
7128711|NCT02730728|11272061|FG002|Overall Study|Withdrawal by Subject|0
7128712|NCT02730728|11272059|FG000|Overall Study|Lack of Efficacy|0
7128713|NCT02730728|11272060|FG001|Overall Study|Lack of Efficacy|1
7128714|NCT02730728|11272061|FG002|Overall Study|Lack of Efficacy|1
7128715|NCT02730819|11272069|FG000|Overall Study|Lost to Follow-up|9
7128716|NCT02730871|11272075|FG000|Overall Study|Adverse Event|6
7128717|NCT02730871|11272076|FG001|Overall Study|Adverse Event|0
7128718|NCT02731131|11272106|FG000|Overall Study|Psychiatric Disorder|0
7128719|NCT02731131|11272107|FG001|Overall Study|Psychiatric Disorder|1
7128720|NCT02731131|11272106|FG000|Overall Study|Refused Therapy|0
7128721|NCT02731131|11272107|FG001|Overall Study|Refused Therapy|1
7128722|NCT02731157|11272113|FG000|First Rejuvenated RCE|Withdrawal by Subject|1
7128723|NCT02731638|11272179|FG000|Overall Study|Lost to Follow-up|6
7128724|NCT02731638|11272180|FG001|Overall Study|Lost to Follow-up|9
7128725|NCT02731690|11272186|FG000|Overall Study|Adverse Event|1
7128726|NCT02731690|11272186|FG000|Overall Study|Withdrawal by Subject|3
7128727|NCT02731690|11272186|FG000|Overall Study|Discontinuation of Study by Sponsor|26
7128728|NCT02731729|11272192|FG000|Overall Study|Death|2
7128729|NCT02731729|11272193|FG001|Overall Study|Death|2
7128730|NCT02731729|11272192|FG000|Overall Study|Study terminated by Sponsor|6
7128731|NCT02731729|11272193|FG001|Overall Study|Study terminated by Sponsor|6
7128732|NCT02731729|11272192|FG000|Overall Study|Withdrawal by Subject|1
7128733|NCT02731729|11272193|FG001|Overall Study|Withdrawal by Subject|0
7128734|NCT02731742|11272203|FG000|Overall Study|Death|1
7128735|NCT02731742|11272204|FG001|Overall Study|Death|2
7128736|NCT02731742|11272205|FG002|Overall Study|Death|5
7128737|NCT02731742|11272206|FG003|Overall Study|Death|0
7128738|NCT02731742|11272203|FG000|Overall Study|Physician Decision|0
7128739|NCT02731742|11272204|FG001|Overall Study|Physician Decision|0
7128740|NCT02731742|11272205|FG002|Overall Study|Physician Decision|0
7128741|NCT02731742|11272206|FG003|Overall Study|Physician Decision|1
7128742|NCT02731742|11272203|FG000|Overall Study|Study Terminated by Sponsor|2
7128743|NCT02731742|11272204|FG001|Overall Study|Study Terminated by Sponsor|1
7128744|NCT02731742|11272205|FG002|Overall Study|Study Terminated by Sponsor|1
7128745|NCT02731742|11272206|FG003|Overall Study|Study Terminated by Sponsor|1
7128746|NCT02731755|11272216|FG000|First Intervention|Withdrawal by Subject|0
7128747|NCT02731755|11272217|FG001|First Intervention|Withdrawal by Subject|2
7128748|NCT02732015|11272243|FG000|Overall Study|Lost to Follow-up|0
7128749|NCT02732015|11272244|FG001|Overall Study|Lost to Follow-up|1
7128750|NCT02732119|11272255|FG000|Phase I|Adverse Event|1
7128751|NCT02732119|11272256|FG001|Phase I|Adverse Event|3
7128752|NCT02732119|11272257|FG002|Phase I|Adverse Event|1
7128753|NCT02732119|11272258|FG003|Phase I|Adverse Event|0
7128754|NCT02732119|11272259|FG004|Phase I|Adverse Event|0
7128755|NCT02732119|11272255|FG000|Phase I|Progressive disease|7
7128756|NCT02732119|11272256|FG001|Phase I|Progressive disease|3
7128757|NCT02732119|11272257|FG002|Phase I|Progressive disease|2
7128758|NCT02732119|11272258|FG003|Phase I|Progressive disease|0
7128759|NCT02732119|11272259|FG004|Phase I|Progressive disease|0
7128760|NCT02732119|11272255|FG000|Phase I|Protocol deviation|0
7128761|NCT02732119|11272256|FG001|Phase I|Protocol deviation|1
7128762|NCT02732119|11272257|FG002|Phase I|Protocol deviation|0
7128763|NCT02732119|11272258|FG003|Phase I|Protocol deviation|0
7128764|NCT02732119|11272259|FG004|Phase I|Protocol deviation|0
7128765|NCT02732119|11272255|FG000|Phase I|Physician Decision|0
7128766|NCT02732119|11272256|FG001|Phase I|Physician Decision|3
7128767|NCT02732119|11272257|FG002|Phase I|Physician Decision|4
7128768|NCT02732119|11272258|FG003|Phase I|Physician Decision|0
7128769|NCT02732119|11272259|FG004|Phase I|Physician Decision|0
7128770|NCT02732119|11272255|FG000|Phase II|Adverse Event|0
7128771|NCT02732119|11272256|FG001|Phase II|Adverse Event|0
7128772|NCT02732119|11272257|FG002|Phase II|Adverse Event|0
7128773|NCT02732119|11272258|FG003|Phase II|Adverse Event|3
7128774|NCT02732119|11272259|FG004|Phase II|Adverse Event|3
7128775|NCT02732119|11272255|FG000|Phase II|Death|0
7128776|NCT02732119|11272256|FG001|Phase II|Death|0
7128777|NCT02732119|11272257|FG002|Phase II|Death|0
7128778|NCT02732119|11272258|FG003|Phase II|Death|1
7128779|NCT02732119|11272259|FG004|Phase II|Death|0
7128780|NCT02732119|11272255|FG000|Phase II|Progressive dissease|0
7128781|NCT02732119|11272256|FG001|Phase II|Progressive dissease|0
7128782|NCT02732119|11272257|FG002|Phase II|Progressive dissease|0
7128783|NCT02732119|11272258|FG003|Phase II|Progressive dissease|30
7128784|NCT02732119|11272259|FG004|Phase II|Progressive dissease|23
7128785|NCT02732119|11272255|FG000|Phase II|Study terminated by sponsor|0
7128786|NCT02732119|11272256|FG001|Phase II|Study terminated by sponsor|0
7128787|NCT02732119|11272257|FG002|Phase II|Study terminated by sponsor|0
7128788|NCT02732119|11272258|FG003|Phase II|Study terminated by sponsor|2
7128789|NCT02732119|11272259|FG004|Phase II|Study terminated by sponsor|2
7128790|NCT02732119|11272255|FG000|Phase II|Other|0
7128791|NCT02732119|11272256|FG001|Phase II|Other|0
7128792|NCT02732119|11272257|FG002|Phase II|Other|0
7128793|NCT02732119|11272258|FG003|Phase II|Other|2
7128794|NCT02732119|11272259|FG004|Phase II|Other|0
7128795|NCT02732119|11272255|FG000|Phase II|Physician Decision|0
7128796|NCT02732119|11272256|FG001|Phase II|Physician Decision|0
7128797|NCT02732119|11272257|FG002|Phase II|Physician Decision|0
7128798|NCT02732119|11272258|FG003|Phase II|Physician Decision|8
7128799|NCT02732119|11272259|FG004|Phase II|Physician Decision|5
7128800|NCT02732210|11272310|FG000|Overall Study|Site Closed|0
7128801|NCT02732210|11272311|FG001|Overall Study|Site Closed|11
7128802|NCT02732210|11272310|FG000|Overall Study|Study Ended|13
7128803|NCT02732210|11272311|FG001|Overall Study|Study Ended|13
7128804|NCT02732210|11272310|FG000|Overall Study|Withdrawal by Subject|28
7128805|NCT02732210|11272311|FG001|Overall Study|Withdrawal by Subject|87
7128806|NCT02732210|11272310|FG000|Overall Study|Lost to Follow-up|5
7128807|NCT02732210|11272311|FG001|Overall Study|Lost to Follow-up|57
7128808|NCT02732210|11272310|FG000|Overall Study|Death|4
7128809|NCT02732210|11272311|FG001|Overall Study|Death|15
7128810|NCT02732210|11272310|FG000|Overall Study|Other|35
7128811|NCT02732210|11272311|FG001|Overall Study|Other|103
7128812|NCT02732210|11272310|FG000|Overall Study|Missing|0
7128813|NCT02732210|11272311|FG001|Overall Study|Missing|8
7128814|NCT02732561|11272331|FG000|Overall Study|Lost to Follow-up|1
7128815|NCT02732561|11272332|FG001|Overall Study|Lost to Follow-up|1
7128816|NCT02732561|11272331|FG000|Overall Study|Withdrawal by Subject|1
7128817|NCT02732561|11272332|FG001|Overall Study|Withdrawal by Subject|0
7128818|NCT02732639|11272352|FG000|Overall Study|Lost to Follow-up|1
7128819|NCT02732847|11272358|FG000|Overall Study|some filled early|42
7128820|NCT02732847|11272359|FG001|Overall Study|some filled early|42
7128821|NCT02732912|11272376|FG000|Overall Study|Discharged before night|2
7128822|NCT02732912|11272377|FG001|Overall Study|Discharged before night|6
7128823|NCT02732912|11272376|FG000|Overall Study|Incomplete completion of questionnaire|2
7128824|NCT02732912|11272377|FG001|Overall Study|Incomplete completion of questionnaire|3
7128825|NCT02732912|11272376|FG000|Overall Study|No outcome; discharged or refused|6
7128826|NCT02732912|11272377|FG001|Overall Study|No outcome; discharged or refused|9
7128827|NCT02732938|11272385|FG000|Overall Study|Death|0
7128828|NCT02732938|11272386|FG001|Overall Study|Death|11
7128829|NCT02732938|11272387|FG002|Overall Study|Death|0
7128830|NCT02732938|11272385|FG000|Overall Study|Randomized but did not receive treatment|0
7128831|NCT02732938|11272386|FG001|Overall Study|Randomized but did not receive treatment|1
7128832|NCT02732938|11272387|FG002|Overall Study|Randomized but did not receive treatment|0
7128833|NCT02732938|11272385|FG000|Overall Study|Refused further follow-up|1
7128834|NCT02732938|11272386|FG001|Overall Study|Refused further follow-up|0
7128835|NCT02732938|11272387|FG002|Overall Study|Refused further follow-up|0
7128836|NCT02732938|11272385|FG000|Overall Study|Study terminated by sponsor|3
7128837|NCT02732938|11272386|FG001|Overall Study|Study terminated by sponsor|6
7128838|NCT02732938|11272387|FG002|Overall Study|Study terminated by sponsor|0
7128839|NCT02732951|11272397|FG000|Overall Study|Other than listed|1
7128840|NCT02732951|11272398|FG001|Overall Study|Other than listed|0
7128841|NCT02732951|11272397|FG000|Overall Study|Lost to Follow-up|0
7128842|NCT02732951|11272398|FG001|Overall Study|Lost to Follow-up|1
7128843|NCT02732951|11272397|FG000|Overall Study|Adverse Event|4
7128844|NCT02732951|11272398|FG001|Overall Study|Adverse Event|4
7128845|NCT02732951|11272397|FG000|Overall Study|Protocol Violation|0
7128846|NCT02732951|11272398|FG001|Overall Study|Protocol Violation|1
7128847|NCT02733367|11272404|FG000|Overall Study|Withdrawal by Subject|6
7128848|NCT02733627|11272417|FG000|Overall Study|Adverse Event|0
7128849|NCT02733627|11272418|FG001|Overall Study|Adverse Event|1
7128850|NCT02733627|11272419|FG002|Overall Study|Adverse Event|1
7128851|NCT02733627|11272420|FG003|Overall Study|Adverse Event|0
7128852|NCT02733627|11272417|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0
7128853|NCT02733627|11272418|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0
7128854|NCT02733627|11272419|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1
7128855|NCT02733627|11272420|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0
7128856|NCT02733991|11272453|FG000|Overall Study|Adverse Event|1
7128857|NCT02733991|11272454|FG001|Overall Study|Adverse Event|0
7128858|NCT02733991|11272453|FG000|Overall Study|Withdrawal by Subject|0
7128859|NCT02733991|11272454|FG001|Overall Study|Withdrawal by Subject|5
7128860|NCT02734212|11272480|FG000|Overall Study|Lost to Follow-up|5
7128861|NCT02734212|11272481|FG001|Overall Study|Lost to Follow-up|10
7128862|NCT02734693|11272526|FG000|Overall Study|Adverse Event|1
7128863|NCT02734693|11272527|FG001|Overall Study|Adverse Event|3
7128864|NCT02734693|11272528|FG002|Overall Study|Adverse Event|3
7128865|NCT02734693|11272526|FG000|Overall Study|Lack of Efficacy|1
7128866|NCT02734693|11272527|FG001|Overall Study|Lack of Efficacy|0
7128867|NCT02734693|11272528|FG002|Overall Study|Lack of Efficacy|0
7128868|NCT02734693|11272526|FG000|Overall Study|Lost to Follow-up|2
7128869|NCT02734693|11272527|FG001|Overall Study|Lost to Follow-up|0
7128870|NCT02734693|11272528|FG002|Overall Study|Lost to Follow-up|0
7128871|NCT02734693|11272526|FG000|Overall Study|Protocol Violation|1
7128872|NCT02734693|11272527|FG001|Overall Study|Protocol Violation|0
7128873|NCT02734693|11272528|FG002|Overall Study|Protocol Violation|0
7128874|NCT02734693|11272526|FG000|Overall Study|Withdrawal by Subject|1
7128875|NCT02734693|11272527|FG001|Overall Study|Withdrawal by Subject|0
7128876|NCT02734693|11272528|FG002|Overall Study|Withdrawal by Subject|0
7128877|NCT02734810|11272538|FG000|Overall Study|Adverse Event|1
7128878|NCT02734810|11272539|FG001|Overall Study|Adverse Event|0
7128879|NCT02734810|11272538|FG000|Overall Study|Lack of Efficacy|1
7128880|NCT02734810|11272539|FG001|Overall Study|Lack of Efficacy|0
7128881|NCT02734862|11272561|FG000|Part A|Death|3
7128882|NCT02734862|11272562|FG001|Part A|Death|4
7128883|NCT02734862|11272563|FG002|Part A|Death|6
7128884|NCT02734862|11272561|FG000|Part A|Lost to Follow-up|2
7128885|NCT02734862|11272562|FG001|Part A|Lost to Follow-up|1
7128886|NCT02734862|11272563|FG002|Part A|Lost to Follow-up|1
6806171|NCT03760068|10808719|FG001|Overall Study|Administrative Decision by Sponsor|2
6806172|NCT03760068|10808718|FG000|Overall Study|Physician Decision|1
6806173|NCT03760068|10808719|FG001|Overall Study|Physician Decision|2
6806174|NCT03760068|10808718|FG000|Overall Study|Lost to Follow-up|4
6806175|NCT03760068|10808719|FG001|Overall Study|Lost to Follow-up|9
6806176|NCT03760068|10808718|FG000|Overall Study|Subject Moved Out of State|1
6806177|NCT03760068|10808719|FG001|Overall Study|Subject Moved Out of State|0
6806178|NCT03628781|10808737|FG000|Overall Study|Lost to Follow-up|16
6806179|NCT03628781|10808738|FG001|Overall Study|Lost to Follow-up|8
6806180|NCT03628781|10808737|FG000|Overall Study|Withdrawal by Subject|16
6806181|NCT03628781|10808738|FG001|Overall Study|Withdrawal by Subject|1
6806182|NCT03560206|10808746|FG000|Overall Study|Lost to Follow-up|19
6806183|NCT03560206|10808747|FG001|Overall Study|Lost to Follow-up|11
6806184|NCT03560206|10808746|FG000|Overall Study|Withdrawal by Subject|2
6806185|NCT03560206|10808747|FG001|Overall Study|Withdrawal by Subject|4
6806186|NCT03560206|10808746|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5
6806187|NCT03560206|10808747|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0
6806188|NCT03560206|10808746|FG000|Overall Study|Busy schedule|14
6806189|NCT03560206|10808747|FG001|Overall Study|Busy schedule|2
6806190|NCT03560206|10808746|FG000|Overall Study|patients' new health condition such as cancer|10
6806191|NCT03560206|10808747|FG001|Overall Study|patients' new health condition such as cancer|1
6806192|NCT03340766|10808756|FG000|Overall Study|Death|6
6806193|NCT03340766|10808757|FG001|Overall Study|Death|6
6806194|NCT03340766|10808758|FG002|Overall Study|Death|2
6806195|NCT03340766|10808756|FG000|Overall Study|Withdrawal by Subject|2
6806196|NCT03340766|10808757|FG001|Overall Study|Withdrawal by Subject|1
6806197|NCT03340766|10808758|FG002|Overall Study|Withdrawal by Subject|2
6806198|NCT03340766|10808756|FG000|Overall Study|Continuing Study|3
6806199|NCT03340766|10808757|FG001|Overall Study|Continuing Study|3
6806200|NCT03340766|10808758|FG002|Overall Study|Continuing Study|5
6806201|NCT02706847|10808779|FG000|Day 1 to Week 12|Adverse Event|2
6806202|NCT02706847|10808780|FG001|Day 1 to Week 12|Adverse Event|2
6806203|NCT02706847|10808781|FG002|Day 1 to Week 12|Adverse Event|1
6806204|NCT02706847|10808782|FG003|Day 1 to Week 12|Adverse Event|12
6806205|NCT02706847|10808779|FG000|Day 1 to Week 12|Withdrawal by Subject|2
6806206|NCT02706847|10808780|FG001|Day 1 to Week 12|Withdrawal by Subject|1
6806207|NCT02706847|10808781|FG002|Day 1 to Week 12|Withdrawal by Subject|4
6806208|NCT02706847|10808782|FG003|Day 1 to Week 12|Withdrawal by Subject|2
6806209|NCT02706847|10808779|FG000|Day 1 to Week 12|Lost to Follow-up|2
6806210|NCT02706847|10808780|FG001|Day 1 to Week 12|Lost to Follow-up|1
6806211|NCT02706847|10808781|FG002|Day 1 to Week 12|Lost to Follow-up|0
6806212|NCT02706847|10808782|FG003|Day 1 to Week 12|Lost to Follow-up|0
6806213|NCT02706847|10808779|FG000|Day 1 to Week 12|Other|4
6806214|NCT02706847|10808780|FG001|Day 1 to Week 12|Other|4
7128887|NCT02734862|11272561|FG000|Part A|Withdrawal by Subject|1
7128888|NCT02734862|11272562|FG001|Part A|Withdrawal by Subject|1
7128889|NCT02734862|11272563|FG002|Part A|Withdrawal by Subject|2
7128890|NCT02734862|11272561|FG000|Part A|Physician Decision|2
7128891|NCT02734862|11272562|FG001|Part A|Physician Decision|0
7128892|NCT02734862|11272563|FG002|Part A|Physician Decision|1
7128893|NCT02734862|11272561|FG000|Part A|Adverse Event|2
7128894|NCT02734862|11272562|FG001|Part A|Adverse Event|0
7128895|NCT02734862|11272563|FG002|Part A|Adverse Event|1
7128896|NCT02734862|11272561|FG000|Part A|Noncompliance|1
7128897|NCT02734862|11272562|FG001|Part A|Noncompliance|1
7128898|NCT02734862|11272563|FG002|Part A|Noncompliance|0
7128899|NCT02734862|11272561|FG000|Part A|Other|1
7128900|NCT02734862|11272562|FG001|Part A|Other|1
7128901|NCT02734862|11272563|FG002|Part A|Other|3
7128902|NCT02734862|11272561|FG000|Part B|Death|8
7128903|NCT02734862|11272562|FG001|Part B|Death|3
7128904|NCT02734862|11272563|FG002|Part B|Death|5
7128905|NCT02734862|11272561|FG000|Part B|Lost to Follow-up|2
7128906|NCT02734862|11272562|FG001|Part B|Lost to Follow-up|2
7128907|NCT02734862|11272563|FG002|Part B|Lost to Follow-up|0
7128908|NCT02734862|11272561|FG000|Part B|Withdrawal by Subject|3
7128909|NCT02734862|11272562|FG001|Part B|Withdrawal by Subject|1
7128910|NCT02734862|11272563|FG002|Part B|Withdrawal by Subject|0
7128911|NCT02734862|11272561|FG000|Part B|Other|0
7128912|NCT02734862|11272562|FG001|Part B|Other|1
7128913|NCT02734862|11272563|FG002|Part B|Other|0
7128914|NCT02735096|11272588|FG000|Overall Study|No symptoms in clinic/personal leave|1
7128915|NCT02735200|11272613|FG000|Overall Study|Lost to Follow-up|0
7128916|NCT02735200|11272614|FG001|Overall Study|Lost to Follow-up|5
7128917|NCT02735200|11272613|FG000|Overall Study|Withdrawal by Subject|8
7128918|NCT02735200|11272614|FG001|Overall Study|Withdrawal by Subject|0
7128919|NCT02735421|11272637|FG000|Overall Study|Adverse Event|2
7128920|NCT02735421|11272637|FG000|Overall Study|Withdrawal by Subject|6
7128921|NCT02735421|11272637|FG000|Overall Study|Lost to Follow-up|3
7128922|NCT02735421|11272637|FG000|Overall Study|Inadequate compliance to treatment|1
7128923|NCT02735421|11272637|FG000|Overall Study|Pregnancy|1
7128924|NCT02735577|11272657|FG000|Disulfiram Treatment|Lost to Follow-up|1
7128925|NCT02735577|11272657|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2
7128926|NCT02735915|11272674|FG000|Overall Study|Not vaccinated but subject ID assigned|8
7128927|NCT02735915|11272674|FG000|Overall Study|Withdrawal following SAE|2
7128928|NCT02735915|11272674|FG000|Overall Study|Withdrawal by Subject|1
7128929|NCT02735980|11272683|FG000|Overall Study|Adverse Event|0
7128930|NCT02735980|11272684|FG001|Overall Study|Adverse Event|4
7128931|NCT02735980|11272685|FG002|Overall Study|Adverse Event|1
7128932|NCT02735980|11272683|FG000|Overall Study|Death|5
7128933|NCT02735980|11272684|FG001|Overall Study|Death|4
7128934|NCT02735980|11272685|FG002|Overall Study|Death|0
7128935|NCT02735980|11272683|FG000|Overall Study|Physician Decision|3
7128936|NCT02735980|11272684|FG001|Overall Study|Physician Decision|1
7128937|NCT02735980|11272685|FG002|Overall Study|Physician Decision|0
7128938|NCT02735980|11272683|FG000|Overall Study|Screen failure|1
7128939|NCT02735980|11272684|FG001|Overall Study|Screen failure|0
7128940|NCT02735980|11272685|FG002|Overall Study|Screen failure|0
7128941|NCT02735980|11272683|FG000|Overall Study|Withdrawal by Subject|1
7128942|NCT02735980|11272684|FG001|Overall Study|Withdrawal by Subject|2
7128943|NCT02735980|11272685|FG002|Overall Study|Withdrawal by Subject|0
7128944|NCT02736188|11272707|FG000|Overall Study|Discontinuation of Study by Sponsor|134
7128945|NCT02736188|11272707|FG000|Overall Study|Adverse Event|1
7128946|NCT02736188|11272707|FG000|Overall Study|Withdrawal by Subject|1
7128947|NCT02736188|11272707|FG000|Overall Study|Other|6
7128948|NCT02736409|11272717|FG000|Overall Study|Withdrawal by Subject|4
7128949|NCT02736409|11272718|FG001|Overall Study|Withdrawal by Subject|2
7128950|NCT02736409|11272719|FG002|Overall Study|Withdrawal by Subject|17
7128951|NCT02736409|11272720|FG003|Overall Study|Withdrawal by Subject|3
7128952|NCT02736409|11272717|FG000|Overall Study|Non-Compliance with Study Drug|0
7128953|NCT02736409|11272718|FG001|Overall Study|Non-Compliance with Study Drug|0
7128954|NCT02736409|11272719|FG002|Overall Study|Non-Compliance with Study Drug|0
7128955|NCT02736409|11272720|FG003|Overall Study|Non-Compliance with Study Drug|1
7128956|NCT02736409|11272717|FG000|Overall Study|Adverse Event|0
7128957|NCT02736409|11272718|FG001|Overall Study|Adverse Event|1
7128958|NCT02736409|11272719|FG002|Overall Study|Adverse Event|5
7128959|NCT02736409|11272720|FG003|Overall Study|Adverse Event|4
7128960|NCT02736409|11272717|FG000|Overall Study|Other|0
7128961|NCT02736409|11272718|FG001|Overall Study|Other|0
7128962|NCT02736409|11272719|FG002|Overall Study|Other|1
7128963|NCT02736409|11272720|FG003|Overall Study|Other|1
7128964|NCT02736409|11272717|FG000|Overall Study|Pregnancy|0
7128965|NCT02736409|11272718|FG001|Overall Study|Pregnancy|0
7128966|NCT02736409|11272719|FG002|Overall Study|Pregnancy|1
7128967|NCT02736409|11272720|FG003|Overall Study|Pregnancy|0
7128968|NCT02736409|11272717|FG000|Overall Study|Lost to Follow-up|0
7128969|NCT02736409|11272718|FG001|Overall Study|Lost to Follow-up|0
7128970|NCT02736409|11272719|FG002|Overall Study|Lost to Follow-up|2
7128971|NCT02736409|11272720|FG003|Overall Study|Lost to Follow-up|1
7128972|NCT02736409|11272717|FG000|Overall Study|Physician Decision|0
7128973|NCT02736409|11272718|FG001|Overall Study|Physician Decision|0
7128974|NCT02736409|11272719|FG002|Overall Study|Physician Decision|0
7128975|NCT02736409|11272720|FG003|Overall Study|Physician Decision|2
7128976|NCT02736474|11272733|FG000|Overall Study|Lost to Follow-up|0
7128977|NCT02736474|11272734|FG001|Overall Study|Lost to Follow-up|1
7128978|NCT02736578|11272742|FG000|Overall Study|Adverse Event|1
7128979|NCT02736578|11272743|FG001|Overall Study|Adverse Event|0
7128980|NCT02736721|11272753|FG000|Overall Study|Adverse Event|8
7128981|NCT02736721|11272753|FG000|Overall Study|Lost to Follow-up|3
7128982|NCT02736721|11272753|FG000|Overall Study|Other|5
7128983|NCT02736825|11272759|FG000|Overall Study|Lost to Follow-up|10
7128984|NCT02736825|11272760|FG001|Overall Study|Lost to Follow-up|11
7128985|NCT02736825|11272759|FG000|Overall Study|Early Termination|0
7128986|NCT02736825|11272760|FG001|Overall Study|Early Termination|1
7128987|NCT02736890|11272769|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1
7128988|NCT02736890|11272770|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2
7128989|NCT02736890|11272769|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1
7128990|NCT02736890|11272770|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0
7128991|NCT02737358|11272824|FG000|Overall Study|Withdrawal by Subject|7
7128992|NCT02737358|11272825|FG001|Overall Study|Withdrawal by Subject|12
7128993|NCT02737358|11272824|FG000|Overall Study|Lost to Follow-up|2
7128994|NCT02737358|11272825|FG001|Overall Study|Lost to Follow-up|3
7128995|NCT02737501|11272843|FG000|Randomized Phase|Died|41
7128996|NCT02737501|11272844|FG001|Randomized Phase|Died|29
7128997|NCT02737501|11272845|FG002|Randomized Phase|Died|0
7128998|NCT02737501|11272843|FG000|Randomized Phase|Withdrawal by Subject|16
7128999|NCT02737501|11272844|FG001|Randomized Phase|Withdrawal by Subject|6
7129000|NCT02737501|11272845|FG002|Randomized Phase|Withdrawal by Subject|0
7129001|NCT02737501|11272843|FG000|Randomized Phase|Lost to Follow-up|0
7129002|NCT02737501|11272844|FG001|Randomized Phase|Lost to Follow-up|1
7129003|NCT02737501|11272845|FG002|Randomized Phase|Lost to Follow-up|0
7129004|NCT02737501|11272843|FG000|Randomized Phase|Site Terminated by Sponsor|58
7129005|NCT02737501|11272844|FG001|Randomized Phase|Site Terminated by Sponsor|16
7129006|NCT02737501|11272845|FG002|Randomized Phase|Site Terminated by Sponsor|0
7129007|NCT02737501|11272843|FG000|Randomized Phase|Reason not Specified|1
7129008|NCT02737501|11272844|FG001|Randomized Phase|Reason not Specified|1
7129009|NCT02737501|11272845|FG002|Randomized Phase|Reason not Specified|0
7129010|NCT02737501|11272843|FG000|Randomized Phase|Never Treated|1
7129011|NCT02737501|11272844|FG001|Randomized Phase|Never Treated|1
7129012|NCT02737501|11272845|FG002|Randomized Phase|Never Treated|0
7129013|NCT02737501|11272843|FG000|Crossover Phase|Died|0
7129014|NCT02737501|11272844|FG001|Crossover Phase|Died|0
7129015|NCT02737501|11272845|FG002|Crossover Phase|Died|22
7129016|NCT02737501|11272843|FG000|Crossover Phase|Withdrew Consent|0
7129017|NCT02737501|11272844|FG001|Crossover Phase|Withdrew Consent|0
7129018|NCT02737501|11272845|FG002|Crossover Phase|Withdrew Consent|9
7129019|NCT02737501|11272843|FG000|Crossover Phase|Physician Decision|0
7129020|NCT02737501|11272844|FG001|Crossover Phase|Physician Decision|0
7129021|NCT02737501|11272845|FG002|Crossover Phase|Physician Decision|1
7129022|NCT02737501|11272843|FG000|Crossover Phase|Site Terminated by Sponsor|0
7129023|NCT02737501|11272844|FG001|Crossover Phase|Site Terminated by Sponsor|0
7129024|NCT02737501|11272845|FG002|Crossover Phase|Site Terminated by Sponsor|23
7129025|NCT02737592|11272853|FG000|Overall Study|Withdrawal by Subject|1
7129026|NCT02737618|11272857|FG000|Overall Study|Withdrawal by Subject|9
7129027|NCT02737722|11272869|FG000|Overall Study|Physician Decision|0
7129028|NCT02737722|11272870|FG001|Overall Study|Physician Decision|0
7129029|NCT02737722|11272871|FG002|Overall Study|Physician Decision|1
7129030|NCT02737722|11272872|FG003|Overall Study|Physician Decision|0
7129031|NCT02737826|11272882|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0
7129032|NCT02737826|11272883|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12
7129033|NCT02737826|11272884|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14
7129034|NCT02737852|11272893|FG000|Overall Study|Withdrawal by Subject|2
7129035|NCT02737930|11272917|FG000|Overall Study|Withdrawal by Subject|0
7129036|NCT02737930|11272918|FG001|Overall Study|Withdrawal by Subject|1
7129037|NCT02738008|11272927|FG000|Overall Study|Study Terminated by Sponsor|1
7129038|NCT02738008|11272928|FG001|Overall Study|Study Terminated by Sponsor|5
7129039|NCT02738008|11272929|FG002|Overall Study|Study Terminated by Sponsor|3
7129040|NCT02738008|11272927|FG000|Overall Study|Adverse Event|0
7129041|NCT02738008|11272928|FG001|Overall Study|Adverse Event|1
7129042|NCT02738008|11272929|FG002|Overall Study|Adverse Event|2
7129043|NCT02738138|11272951|FG000|Overall Study|Adverse Event|0
7129044|NCT02738138|11272952|FG001|Overall Study|Adverse Event|1
7129045|NCT02738138|11272951|FG000|Overall Study|Lost to Follow-up|2
7129046|NCT02738138|11272952|FG001|Overall Study|Lost to Follow-up|0
7129047|NCT02738138|11272951|FG000|Overall Study|Other - not further specified|1
7129048|NCT02738138|11272952|FG001|Overall Study|Other - not further specified|0
7129049|NCT02738151|11272959|FG000|Overall Study|Randomized but not treated|4
7129050|NCT02738151|11272960|FG001|Overall Study|Randomized but not treated|1
7129051|NCT02738151|11272959|FG000|Overall Study|Adverse Event|4
7129052|NCT02738151|11272960|FG001|Overall Study|Adverse Event|5
7129053|NCT02738151|11272959|FG000|Overall Study|Hypoglycemia|0
7129054|NCT02738151|11272960|FG001|Overall Study|Hypoglycemia|1
7129055|NCT02738151|11272959|FG000|Overall Study|Poor Compliance to Protocol|4
7129056|NCT02738151|11272960|FG001|Overall Study|Poor Compliance to Protocol|3
7129057|NCT02738151|11272959|FG000|Overall Study|Other than specified above|11
7129058|NCT02738151|11272960|FG001|Overall Study|Other than specified above|21
7129059|NCT02738203|11272968|FG000|Overall Study|Failed IUD Insertion|2
7129060|NCT02738203|11272969|FG001|Overall Study|Failed IUD Insertion|2
7129061|NCT02738203|11272968|FG000|Overall Study|Protocol Violation|0
7129062|NCT02738203|11272969|FG001|Overall Study|Protocol Violation|1
7129063|NCT02738333|11272978|FG000|Overall Study|Death|1
7129064|NCT02738333|11272979|FG001|Overall Study|Death|0
7129065|NCT02738333|11272980|FG002|Overall Study|Death|0
7129066|NCT02738333|11272978|FG000|Overall Study|Lost to Follow-up|1
7129067|NCT02738333|11272979|FG001|Overall Study|Lost to Follow-up|0
7129068|NCT02738333|11272980|FG002|Overall Study|Lost to Follow-up|0
7129069|NCT02738450|11272992|FG000|Overall Study|Withdrawal by Subject|0
7129070|NCT02738450|11272993|FG001|Overall Study|Withdrawal by Subject|2
7129071|NCT02738450|11272994|FG002|Overall Study|Withdrawal by Subject|0
7129072|NCT02738580|11273005|FG000|Overall Study|Adverse Event|1
7129073|NCT02738580|11273006|FG001|Overall Study|Adverse Event|0
7129074|NCT02738580|11273005|FG000|Overall Study|Lack of Efficacy|3
7129075|NCT02738580|11273006|FG001|Overall Study|Lack of Efficacy|2
7129076|NCT02738580|11273005|FG000|Overall Study|Withdrawal by Subject|0
7129077|NCT02738580|11273006|FG001|Overall Study|Withdrawal by Subject|1
7129078|NCT02738580|11273005|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0
6806215|NCT02706847|10808781|FG002|Day 1 to Week 12|Other|2
6806216|NCT02706847|10808782|FG003|Day 1 to Week 12|Other|2
6806217|NCT02706847|10808779|FG000|Day 1 to Week 12|Randomized in Error|0
6806218|NCT02706847|10808780|FG001|Day 1 to Week 12|Randomized in Error|0
6806219|NCT02706847|10808781|FG002|Day 1 to Week 12|Randomized in Error|1
6806220|NCT02706847|10808782|FG003|Day 1 to Week 12|Randomized in Error|0
6806221|NCT02706847|10808779|FG000|Week 12 to Week 24|Adverse Event|1
6806222|NCT02706847|10808780|FG001|Week 12 to Week 24|Adverse Event|2
6806223|NCT02706847|10808781|FG002|Week 12 to Week 24|Adverse Event|2
6806224|NCT02706847|10808782|FG003|Week 12 to Week 24|Adverse Event|5
6806225|NCT02706847|10808779|FG000|Week 12 to Week 24|Withdrawal by Subject|1
6806226|NCT02706847|10808780|FG001|Week 12 to Week 24|Withdrawal by Subject|0
6806227|NCT02706847|10808781|FG002|Week 12 to Week 24|Withdrawal by Subject|1
6806228|NCT02706847|10808782|FG003|Week 12 to Week 24|Withdrawal by Subject|4
6806229|NCT02706847|10808779|FG000|Week 12 to Week 24|Lost to Follow-up|0
7129079|NCT02738580|11273006|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1
7129080|NCT02738775|11273018|FG000|Overall Study|Withdrawal by Subject|0
7129081|NCT02738775|11273019|FG001|Overall Study|Withdrawal by Subject|1
7129082|NCT02738775|11273020|FG002|Overall Study|Withdrawal by Subject|0
7129083|NCT02738775|11273021|FG003|Overall Study|Withdrawal by Subject|0
7129084|NCT02738775|11273022|FG004|Overall Study|Withdrawal by Subject|0
7129085|NCT02738775|11273023|FG005|Overall Study|Withdrawal by Subject|0
7129086|NCT02738775|11273018|FG000|Overall Study|Adverse Event|0
7129087|NCT02738775|11273019|FG001|Overall Study|Adverse Event|0
7129088|NCT02738775|11273020|FG002|Overall Study|Adverse Event|0
7129089|NCT02738775|11273021|FG003|Overall Study|Adverse Event|1
7129090|NCT02738775|11273022|FG004|Overall Study|Adverse Event|0
7129091|NCT02738775|11273023|FG005|Overall Study|Adverse Event|0
7129092|NCT02738775|11273018|FG000|Overall Study|Pregnancy|0
7129093|NCT02738775|11273019|FG001|Overall Study|Pregnancy|1
7129094|NCT02738775|11273020|FG002|Overall Study|Pregnancy|0
7129095|NCT02738775|11273021|FG003|Overall Study|Pregnancy|0
7129096|NCT02738775|11273022|FG004|Overall Study|Pregnancy|0
7129097|NCT02738775|11273023|FG005|Overall Study|Pregnancy|0
7129098|NCT02738775|11273018|FG000|Overall Study|Missing|0
7129099|NCT02738775|11273019|FG001|Overall Study|Missing|0
7129100|NCT02738775|11273020|FG002|Overall Study|Missing|0
7129101|NCT02738775|11273021|FG003|Overall Study|Missing|0
7129102|NCT02738775|11273022|FG004|Overall Study|Missing|0
7129103|NCT02738775|11273023|FG005|Overall Study|Missing|1
7129104|NCT02738801|11273043|FG000|Overall Study|Adverse Event|1
7129105|NCT02738801|11273044|FG001|Overall Study|Adverse Event|1
7129106|NCT02738801|11273043|FG000|Overall Study|Withdrawal by Subject|0
7129107|NCT02738801|11273044|FG001|Overall Study|Withdrawal by Subject|1
7129108|NCT02738840|11273051|FG000|Overall Study|MRI Scan not Performed|5
7129109|NCT02738840|11273051|FG000|Overall Study|Lost to Follow-up|1
7129110|NCT02738840|11273051|FG000|Overall Study|Subject Participation Terminated by Investigator|1
7129111|NCT02738840|11273051|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1
7129112|NCT02738879|11273057|FG000|Overall Study|Adverse Event|1
7129113|NCT02738879|11273058|FG001|Overall Study|Adverse Event|1
7129114|NCT02738879|11273057|FG000|Overall Study|Death|0
7129115|NCT02738879|11273058|FG001|Overall Study|Death|2
7129116|NCT02738879|11273057|FG000|Overall Study|Lost to Follow-up|1
7129117|NCT02738879|11273058|FG001|Overall Study|Lost to Follow-up|5
7129118|NCT02738879|11273057|FG000|Overall Study|Protocol Violation|1
7129119|NCT02738879|11273058|FG001|Overall Study|Protocol Violation|3
7129120|NCT02738879|11273057|FG000|Overall Study|Physician Decision|3
7129121|NCT02738879|11273058|FG001|Overall Study|Physician Decision|4
7129122|NCT02738879|11273057|FG000|Overall Study|Pregnancy|0
7129123|NCT02738879|11273058|FG001|Overall Study|Pregnancy|1
7129124|NCT02738879|11273057|FG000|Overall Study|Screen Failure|1
7129125|NCT02738879|11273058|FG001|Overall Study|Screen Failure|2
7129126|NCT02738879|11273057|FG000|Overall Study|Site Discontinued Study Participation|1
7129127|NCT02738879|11273058|FG001|Overall Study|Site Discontinued Study Participation|0
7129128|NCT02738879|11273057|FG000|Overall Study|Withdrawal by Subject|5
7129129|NCT02738879|11273058|FG001|Overall Study|Withdrawal by Subject|7
7129130|NCT02739269|11273074|FG000|Overall Study|Protocol Violation|5
7129131|NCT02739269|11273075|FG001|Overall Study|Protocol Violation|0
7129132|NCT02739269|11273074|FG000|Overall Study|Cycle cancellation|2
7129133|NCT02739269|11273075|FG001|Overall Study|Cycle cancellation|2
7129134|NCT02739269|11273074|FG000|Overall Study|Withdrawal by Subject|0
7129135|NCT02739269|11273075|FG001|Overall Study|Withdrawal by Subject|2
7129136|NCT02739321|11273083|FG000|Overall Study|Lack of Efficacy|1
7129137|NCT02739321|11273084|FG001|Overall Study|Lack of Efficacy|1
7129138|NCT02739321|11273083|FG000|Overall Study|Lost to Follow-up|1
7129139|NCT02739321|11273084|FG001|Overall Study|Lost to Follow-up|1
7129140|NCT02739321|11273083|FG000|Overall Study|Withdrawal by Subject|1
7129141|NCT02739321|11273084|FG001|Overall Study|Withdrawal by Subject|2
7129142|NCT02739360|11273099|FG000|Overall Study|Adverse Event|1
7129143|NCT02739360|11273099|FG000|Overall Study|Study terminated by Sponsor|2
7129144|NCT02739594|11273105|FG000|Overall Study|Undesired Event|3
7129145|NCT02739594|11273106|FG001|Overall Study|Undesired Event|4
7129146|NCT02739594|11273105|FG000|Overall Study|Violation of Eligibility Criteria|1
7129147|NCT02739594|11273106|FG001|Overall Study|Violation of Eligibility Criteria|2
7129148|NCT02739594|11273105|FG000|Overall Study|Protocol Violation|5
7129149|NCT02739594|11273106|FG001|Overall Study|Protocol Violation|6
7129150|NCT02739594|11273105|FG000|Overall Study|Death|4
7129151|NCT02739594|11273106|FG001|Overall Study|Death|2
7129152|NCT02739594|11273105|FG000|Overall Study|Renal Insufficiency|4
7129153|NCT02739594|11273106|FG001|Overall Study|Renal Insufficiency|6
7129154|NCT02739594|11273105|FG000|Overall Study|Administrative Reasons|1
7129155|NCT02739594|11273106|FG001|Overall Study|Administrative Reasons|3
7129156|NCT02739594|11273105|FG000|Overall Study|Withdrawal by Subject|1
7129157|NCT02739594|11273106|FG001|Overall Study|Withdrawal by Subject|1
7129158|NCT02739594|11273105|FG000|Overall Study|Lost to Follow-up|0
7129159|NCT02739594|11273106|FG001|Overall Study|Lost to Follow-up|1
7129160|NCT02739594|11273105|FG000|Overall Study|Elevated Serum Creatinine|0
7129161|NCT02739594|11273106|FG001|Overall Study|Elevated Serum Creatinine|1
7129162|NCT02739594|11273105|FG000|Overall Study|Other|6
7129163|NCT02739594|11273106|FG001|Overall Study|Other|2
7129164|NCT02739828|11273131|FG000|Overall Study|Adverse Event|1
7129165|NCT02739828|11273131|FG000|Overall Study|Lost to Follow-up|4
7129166|NCT02739984|11273137|FG000|Overall Study|Sponsor Decision|1
7129167|NCT02739984|11273138|FG001|Overall Study|Sponsor Decision|0
7129168|NCT02739984|11273137|FG000|Overall Study|Withdrawal by Subject|1
7129169|NCT02739984|11273138|FG001|Overall Study|Withdrawal by Subject|1
7129170|NCT02739984|11273137|FG000|Overall Study|Death|0
7129171|NCT02739984|11273138|FG001|Overall Study|Death|1
7129172|NCT02739984|11273137|FG000|Overall Study|Lost to Follow-up|3
7129173|NCT02739984|11273138|FG001|Overall Study|Lost to Follow-up|0
7129174|NCT02739997|11273144|FG000|Overall Study|Death|1
7129175|NCT02739997|11273144|FG000|Overall Study|Withdrawal by Subject|1
7129176|NCT02740049|11273148|FG000|Overall Study|Isolated cells did not grow sufficiently|1
7129177|NCT02740478|11273180|FG000|Overall Study|Withdrawal by Subject|1
7129178|NCT02741076|11273236|FG000|Overall Study|Adverse Event|0
7129179|NCT02741076|11273237|FG001|Overall Study|Adverse Event|1
7129180|NCT02741076|11273238|FG002|Overall Study|Adverse Event|1
7129181|NCT02741076|11273239|FG003|Overall Study|Adverse Event|0
7129182|NCT02741076|11273236|FG000|Overall Study|Lack of Efficacy|1
7129183|NCT02741076|11273237|FG001|Overall Study|Lack of Efficacy|0
7129184|NCT02741076|11273238|FG002|Overall Study|Lack of Efficacy|0
7129185|NCT02741076|11273239|FG003|Overall Study|Lack of Efficacy|0
7129186|NCT02741076|11273236|FG000|Overall Study|Withdrawal by Subject|0
7129187|NCT02741076|11273237|FG001|Overall Study|Withdrawal by Subject|1
7129188|NCT02741076|11273238|FG002|Overall Study|Withdrawal by Subject|0
7129189|NCT02741076|11273239|FG003|Overall Study|Withdrawal by Subject|0
7129190|NCT02741076|11273236|FG000|Overall Study|Sponsor Request|2
7129191|NCT02741076|11273237|FG001|Overall Study|Sponsor Request|3
7129192|NCT02741076|11273238|FG002|Overall Study|Sponsor Request|0
7129193|NCT02741076|11273239|FG003|Overall Study|Sponsor Request|1
7129194|NCT02741076|11273236|FG000|Overall Study|No additional information available|0
7129195|NCT02741076|11273237|FG001|Overall Study|No additional information available|0
7129196|NCT02741076|11273238|FG002|Overall Study|No additional information available|1
7129197|NCT02741076|11273239|FG003|Overall Study|No additional information available|1
7129198|NCT02741310|11273267|FG000|Overall Study|Sponsor Decision|2
7129199|NCT02741310|11273268|FG001|Overall Study|Sponsor Decision|2
7129200|NCT02741518|11273284|FG000|Overall Study|Withdrawal by Subject|1
7129201|NCT02741518|11273285|FG001|Overall Study|Withdrawal by Subject|1
7129202|NCT02741596|11273293|FG000|Overall Study|Adverse Event|1
7129203|NCT02741596|11273294|FG001|Overall Study|Adverse Event|5
7129204|NCT02741596|11273293|FG000|Overall Study|Lost to Follow-up|1
7129205|NCT02741596|11273294|FG001|Overall Study|Lost to Follow-up|1
7129206|NCT02741596|11273293|FG000|Overall Study|Physician Decision|2
7129207|NCT02741596|11273294|FG001|Overall Study|Physician Decision|1
7129208|NCT02741596|11273293|FG000|Overall Study|Pregnancy|3
7129209|NCT02741596|11273294|FG001|Overall Study|Pregnancy|1
7129210|NCT02741596|11273293|FG000|Overall Study|Other (Unspecified)|0
7129211|NCT02741596|11273294|FG001|Overall Study|Other (Unspecified)|3
7129212|NCT02741596|11273293|FG000|Overall Study|Subject withdrawn-Other|17
7129213|NCT02741596|11273294|FG001|Overall Study|Subject withdrawn-Other|4
7129214|NCT02741596|11273293|FG000|Overall Study|Subject withdrawn-to commercial product|54
7129215|NCT02741596|11273294|FG001|Overall Study|Subject withdrawn-to commercial product|63
7129216|NCT02741635|11273300|FG000|Overall Study|Withdrawal by Subject|1
7129217|NCT02741713|11273316|FG000|Overall Study|Surgery type changed intra-operatively|2
7129218|NCT02741713|11273317|FG001|Overall Study|Surgery type changed intra-operatively|1
7129219|NCT02742103|11273330|FG000|Overall Study|Protocol Violation|1
7129220|NCT02742103|11273331|FG001|Overall Study|Protocol Violation|0
7129221|NCT02742103|11273330|FG000|Overall Study|Death|2
7129222|NCT02742103|11273331|FG001|Overall Study|Death|2
7129223|NCT02742103|11273330|FG000|Overall Study|Adverse Event|1
7129224|NCT02742103|11273331|FG001|Overall Study|Adverse Event|0
7129225|NCT02742103|11273330|FG000|Overall Study|Moved to another town|0
7129226|NCT02742103|11273331|FG001|Overall Study|Moved to another town|1
7129227|NCT02742103|11273330|FG000|Overall Study|Withdrawal by Subject|5
7129228|NCT02742103|11273331|FG001|Overall Study|Withdrawal by Subject|2
7129229|NCT02742441|11273351|FG000|Overall Study|Lost to Follow-up|4
7129230|NCT02742441|11273352|FG001|Overall Study|Lost to Follow-up|4
7129231|NCT02742441|11273351|FG000|Overall Study|Withdrawal by Subject|2
7129232|NCT02742441|11273352|FG001|Overall Study|Withdrawal by Subject|2
7129233|NCT02742441|11273351|FG000|Overall Study|Adverse Event|0
7129234|NCT02742441|11273352|FG001|Overall Study|Adverse Event|2
7129235|NCT02742519|11273360|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1
7129236|NCT02742519|11273361|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1
7129237|NCT02742519|11273362|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0
7129238|NCT02742519|11273360|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0
7129239|NCT02742519|11273361|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0
7129240|NCT02742519|11273362|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9
7129241|NCT02742519|11273360|FG000|Part 2 Open Label Period (32 Weeks)|Other|0
7129242|NCT02742519|11273361|FG001|Part 2 Open Label Period (32 Weeks)|Other|0
7129243|NCT02742519|11273362|FG002|Part 2 Open Label Period (32 Weeks)|Other|1
7129244|NCT02742649|11273382|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5
7129245|NCT02742649|11273383|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0
7129246|NCT02742649|11273384|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0
7129247|NCT02742649|11273385|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0
7129248|NCT02742649|11273386|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0
7129249|NCT02742649|11273382|FG000|Double-Blind Treatment Period|Adverse Event|0
7129250|NCT02742649|11273383|FG001|Double-Blind Treatment Period|Adverse Event|1
7129251|NCT02742649|11273384|FG002|Double-Blind Treatment Period|Adverse Event|0
7129252|NCT02742649|11273385|FG003|Double-Blind Treatment Period|Adverse Event|0
7129253|NCT02742649|11273386|FG004|Double-Blind Treatment Period|Adverse Event|0
7129254|NCT02742649|11273382|FG000|Open-Label Period|Lost to Follow-up|0
7129255|NCT02742649|11273383|FG001|Open-Label Period|Lost to Follow-up|0
7129256|NCT02742649|11273384|FG002|Open-Label Period|Lost to Follow-up|0
7129257|NCT02742649|11273385|FG003|Open-Label Period|Lost to Follow-up|0
7129258|NCT02742649|11273386|FG004|Open-Label Period|Lost to Follow-up|1
7129259|NCT02742766|11273416|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7129260|NCT02742766|11273417|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7129261|NCT02742766|11273418|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7129262|NCT02742766|11273419|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7129263|NCT02742766|11273420|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7129264|NCT02742766|11273421|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7129265|NCT02742766|11273422|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7129266|NCT02742766|11273423|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7129267|NCT02742766|11273424|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7129268|NCT02742766|11273425|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7129269|NCT02742766|11273426|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7129270|NCT02742766|11273427|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7129271|NCT02742766|11273428|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7129272|NCT02742766|11273429|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1
7129273|NCT02742766|11273430|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7129274|NCT02742766|11273431|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7129275|NCT02742766|11273432|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7129276|NCT02742766|11273433|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7129277|NCT02742766|11273434|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7129278|NCT02742766|11273416|FG000|Part 2 (Up to 22 Days)|Physician Decision|0
7129279|NCT02742766|11273417|FG001|Part 2 (Up to 22 Days)|Physician Decision|0
7129280|NCT02742766|11273418|FG002|Part 2 (Up to 22 Days)|Physician Decision|0
7129281|NCT02742766|11273419|FG003|Part 2 (Up to 22 Days)|Physician Decision|0
7129282|NCT02742766|11273420|FG004|Part 2 (Up to 22 Days)|Physician Decision|0
7129283|NCT02742766|11273421|FG005|Part 2 (Up to 22 Days)|Physician Decision|0
7129284|NCT02742766|11273422|FG006|Part 2 (Up to 22 Days)|Physician Decision|0
7129285|NCT02742766|11273423|FG007|Part 2 (Up to 22 Days)|Physician Decision|0
7129286|NCT02742766|11273424|FG008|Part 2 (Up to 22 Days)|Physician Decision|0
7129287|NCT02742766|11273425|FG009|Part 2 (Up to 22 Days)|Physician Decision|0
7129288|NCT02742766|11273426|FG010|Part 2 (Up to 22 Days)|Physician Decision|0
7129289|NCT02742766|11273427|FG011|Part 2 (Up to 22 Days)|Physician Decision|0
7129290|NCT02742766|11273428|FG012|Part 2 (Up to 22 Days)|Physician Decision|2
7129291|NCT02742766|11273429|FG013|Part 2 (Up to 22 Days)|Physician Decision|5
7129292|NCT02742766|11273430|FG014|Part 2 (Up to 22 Days)|Physician Decision|0
7129293|NCT02742766|11273431|FG015|Part 2 (Up to 22 Days)|Physician Decision|1
7129294|NCT02742766|11273432|FG016|Part 2 (Up to 22 Days)|Physician Decision|0
7129295|NCT02742766|11273433|FG017|Part 2 (Up to 22 Days)|Physician Decision|0
7129296|NCT02742766|11273434|FG018|Part 2 (Up to 22 Days)|Physician Decision|0
7129297|NCT02742818|11273496|FG000|Overall Study|Adverse Event|0
7129298|NCT02742818|11273497|FG001|Overall Study|Adverse Event|1
7129299|NCT02742818|11273496|FG000|Overall Study|Protocol Violation|0
7129300|NCT02742818|11273497|FG001|Overall Study|Protocol Violation|1
7129301|NCT02743117|11273520|FG000|Overall Study|Lost to Follow-up|0
7129302|NCT02743117|11273521|FG001|Overall Study|Lost to Follow-up|1
7129303|NCT02743117|11273520|FG000|Overall Study|Other|1
7129304|NCT02743117|11273521|FG001|Overall Study|Other|0
7129305|NCT02743221|11273529|FG000|Overall Study|Progressive disease|29
7129306|NCT02743221|11273530|FG001|Overall Study|Progressive disease|38
7129307|NCT02743221|11273529|FG000|Overall Study|Adverse Event|17
7129308|NCT02743221|11273530|FG001|Overall Study|Adverse Event|14
7129309|NCT02743221|11273529|FG000|Overall Study|non medical reason|8
7129310|NCT02743221|11273530|FG001|Overall Study|non medical reason|2
7129311|NCT02743221|11273529|FG000|Overall Study|Physician Decision|2
7129312|NCT02743221|11273530|FG001|Overall Study|Physician Decision|5
7129313|NCT02743221|11273529|FG000|Overall Study|Patient not eligible, not treated|0
7129314|NCT02743221|11273530|FG001|Overall Study|Patient not eligible, not treated|1
7129315|NCT02743520|11273568|FG000|Overall Study|Withdrawal by Subject|1
7129316|NCT02743780|11273586|FG000|Part 3 (7 Days)|Adverse Event|0
7129317|NCT02743780|11273587|FG001|Part 3 (7 Days)|Adverse Event|0
7129318|NCT02743780|11273588|FG002|Part 3 (7 Days)|Adverse Event|1
7129319|NCT02743780|11273589|FG003|Part 3 (7 Days)|Adverse Event|0
7129320|NCT02743780|11273590|FG004|Part 3 (7 Days)|Adverse Event|0
7129321|NCT02743793|11273612|FG000|Overall Study|Death|1
7129322|NCT02743793|11273613|FG001|Overall Study|Death|1
7129323|NCT02743793|11273612|FG000|Overall Study|Withdrawal by Subject|0
7129324|NCT02743793|11273613|FG001|Overall Study|Withdrawal by Subject|1
7129325|NCT02743793|11273612|FG000|Overall Study|Screen Failure|4
7129326|NCT02743793|11273613|FG001|Overall Study|Screen Failure|0
7129327|NCT02743793|11273612|FG000|Overall Study|No Primary Care Physician|0
7129328|NCT02743793|11273613|FG001|Overall Study|No Primary Care Physician|1
7129329|NCT02743793|11273612|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0
7129330|NCT02743793|11273613|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1
7129331|NCT02743793|11273612|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0
7129332|NCT02743793|11273613|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32
7129333|NCT02743949|11273630|FG000|Overall Study|Adverse Event|0
7129334|NCT02743949|11273631|FG001|Overall Study|Adverse Event|0
7129335|NCT02743949|11273632|FG002|Overall Study|Adverse Event|2
7129336|NCT02743949|11273630|FG000|Overall Study|Significant Protocol Deviation|2
7129337|NCT02743949|11273631|FG001|Overall Study|Significant Protocol Deviation|0
7129338|NCT02743949|11273632|FG002|Overall Study|Significant Protocol Deviation|1
7129339|NCT02743949|11273630|FG000|Overall Study|Voluntary Withdrawal|2
7129340|NCT02743949|11273631|FG001|Overall Study|Voluntary Withdrawal|1
7129341|NCT02743949|11273632|FG002|Overall Study|Voluntary Withdrawal|0
7129342|NCT02743962|11273642|FG000|Overall Study|Atrophic vaginitis diagnosed|1
7129343|NCT02743962|11273643|FG001|Overall Study|Atrophic vaginitis diagnosed|0
7129344|NCT02744066|11273654|FG000|Overall Study|Withdrawal by parent|0
7129345|NCT02744066|11273655|FG001|Overall Study|Withdrawal by parent|1
7129346|NCT02744066|11273654|FG000|Overall Study|Discharged from NICU prior to completion|0
7129347|NCT02744066|11273655|FG001|Overall Study|Discharged from NICU prior to completion|4
7129348|NCT02744391|11273663|FG000|Overall Study|Lost to Follow-up|9
7129349|NCT02744391|11273663|FG000|Overall Study|Physician Decision|2
7129350|NCT02744391|11273663|FG000|Overall Study|Withdrawal by Subject|3
7129351|NCT02744755|11273675|FG000|Study Period 1|Protocol Violation|2
7129352|NCT02744755|11273676|FG001|Study Period 1|Protocol Violation|1
7129353|NCT02744755|11273675|FG000|Study Period 1|not defined|0
7129354|NCT02744755|11273676|FG001|Study Period 1|not defined|1
7129355|NCT02744755|11273675|FG000|Study Period 1|Pregnancy|1
7129356|NCT02744755|11273676|FG001|Study Period 1|Pregnancy|0
7129357|NCT02744755|11273675|FG000|Study Period 1|Adverse Event|1
7129358|NCT02744755|11273676|FG001|Study Period 1|Adverse Event|1
7129359|NCT02744755|11273675|FG000|Study Period 1|Lost to Follow-up|1
7129360|NCT02744755|11273676|FG001|Study Period 1|Lost to Follow-up|1
7129361|NCT02744755|11273675|FG000|Study Period 1|Lack of Efficacy|1
7129362|NCT02744755|11273676|FG001|Study Period 1|Lack of Efficacy|0
7129363|NCT02744755|11273675|FG000|Study Period 1|Withdrawal by Subject|8
7129364|NCT02744755|11273676|FG001|Study Period 1|Withdrawal by Subject|4
7129365|NCT02744755|11273675|FG000|Study Period 2|Adverse Event|5
7129366|NCT02744755|11273676|FG001|Study Period 2|Adverse Event|0
7129367|NCT02744755|11273675|FG000|Study Period 2|Protocol Violation|1
7129368|NCT02744755|11273676|FG001|Study Period 2|Protocol Violation|0
7129369|NCT02744755|11273675|FG000|Study Period 2|not defined|3
7129370|NCT02744755|11273676|FG001|Study Period 2|not defined|2
7129371|NCT02744755|11273675|FG000|Study Period 2|Lost to Follow-up|0
7129372|NCT02744755|11273676|FG001|Study Period 2|Lost to Follow-up|2
7129373|NCT02744755|11273675|FG000|Study Period 2|Withdrawal by Subject|2
7129374|NCT02744755|11273676|FG001|Study Period 2|Withdrawal by Subject|2
7129375|NCT02744755|11273675|FG000|Study Period 2|Lack of Efficacy|3
7129376|NCT02744755|11273676|FG001|Study Period 2|Lack of Efficacy|2
7129377|NCT02744898|11273694|FG000|Overall Study|Progressive Disease|2
7129378|NCT02744898|11273694|FG000|Overall Study|Physician Decision|1
7129379|NCT02744898|11273694|FG000|Overall Study|Toxicity|1
7129380|NCT02745080|11273700|FG000|Overall Study|Adverse Event|13
7129381|NCT02745080|11273701|FG001|Overall Study|Adverse Event|21
7129382|NCT02745080|11273700|FG000|Overall Study|Lack of Efficacy|11
7129383|NCT02745080|11273701|FG001|Overall Study|Lack of Efficacy|23
7129384|NCT02745080|11273700|FG000|Overall Study|Lost to Follow-up|3
7129385|NCT02745080|11273701|FG001|Overall Study|Lost to Follow-up|3
7129386|NCT02745080|11273700|FG000|Overall Study|Physician Decision|3
7129387|NCT02745080|11273701|FG001|Overall Study|Physician Decision|0
7129388|NCT02745080|11273700|FG000|Overall Study|Protocol Violation|3
7129389|NCT02745080|11273701|FG001|Overall Study|Protocol Violation|1
7129390|NCT02745080|11273700|FG000|Overall Study|Withdrawal by Subject|22
7129391|NCT02745080|11273701|FG001|Overall Study|Withdrawal by Subject|41
7129392|NCT02745119|11273712|FG000|Overall Study|Adverse Event|1
7129393|NCT02745119|11273713|FG001|Overall Study|Adverse Event|0
7129394|NCT02745119|11273714|FG002|Overall Study|Adverse Event|1
7129395|NCT02745119|11273715|FG003|Overall Study|Adverse Event|3
7129396|NCT02745119|11273712|FG000|Overall Study|Death|3
7129397|NCT02745119|11273713|FG001|Overall Study|Death|3
7129398|NCT02745119|11273714|FG002|Overall Study|Death|0
7129399|NCT02745119|11273715|FG003|Overall Study|Death|4
7129400|NCT02745119|11273712|FG000|Overall Study|Lost to Follow-up|0
7129401|NCT02745119|11273713|FG001|Overall Study|Lost to Follow-up|0
7129402|NCT02745119|11273714|FG002|Overall Study|Lost to Follow-up|0
7129403|NCT02745119|11273715|FG003|Overall Study|Lost to Follow-up|1
7129404|NCT02745119|11273712|FG000|Overall Study|Protocol Deviation|0
7129405|NCT02745119|11273713|FG001|Overall Study|Protocol Deviation|0
7129406|NCT02745119|11273714|FG002|Overall Study|Protocol Deviation|0
7129407|NCT02745119|11273715|FG003|Overall Study|Protocol Deviation|1
7129408|NCT02745119|11273712|FG000|Overall Study|Withdrawal by Subject|7
7129409|NCT02745119|11273713|FG001|Overall Study|Withdrawal by Subject|15
7129410|NCT02745119|11273714|FG002|Overall Study|Withdrawal by Subject|8
7129411|NCT02745119|11273715|FG003|Overall Study|Withdrawal by Subject|14
7129412|NCT02745119|11273712|FG000|Overall Study|Study Terminated by Sponsor|134
7129413|NCT02745119|11273713|FG001|Overall Study|Study Terminated by Sponsor|252
7129414|NCT02745119|11273714|FG002|Overall Study|Study Terminated by Sponsor|135
7129415|NCT02745119|11273715|FG003|Overall Study|Study Terminated by Sponsor|251
7129416|NCT02745119|11273712|FG000|Overall Study|Physician Decision|0
7129417|NCT02745119|11273713|FG001|Overall Study|Physician Decision|2
7129418|NCT02745119|11273714|FG002|Overall Study|Physician Decision|2
7129419|NCT02745119|11273715|FG003|Overall Study|Physician Decision|2
7129420|NCT02745119|11273712|FG000|Overall Study|Reason Not Specified|0
7129421|NCT02745119|11273713|FG001|Overall Study|Reason Not Specified|2
7129422|NCT02745119|11273714|FG002|Overall Study|Reason Not Specified|0
7129423|NCT02745119|11273715|FG003|Overall Study|Reason Not Specified|1
7129424|NCT02745145|11273730|FG000|Overall Study|Adverse Event|1
7129425|NCT02745145|11273731|FG001|Overall Study|Adverse Event|0
7129426|NCT02745145|11273732|FG002|Overall Study|Adverse Event|0
7129427|NCT02745145|11273730|FG000|Overall Study|Death|0
7129428|NCT02745145|11273731|FG001|Overall Study|Death|1
7129429|NCT02745145|11273732|FG002|Overall Study|Death|0
7129430|NCT02745145|11273730|FG000|Overall Study|Progressive disease|0
7129431|NCT02745145|11273731|FG001|Overall Study|Progressive disease|0
7129432|NCT02745145|11273732|FG002|Overall Study|Progressive disease|1
7129433|NCT02745145|11273730|FG000|Overall Study|Withdrew consent|1
7129434|NCT02745145|11273731|FG001|Overall Study|Withdrew consent|1
7129435|NCT02745145|11273732|FG002|Overall Study|Withdrew consent|1
7129436|NCT02745145|11273730|FG000|Overall Study|Study Termination|8
7129437|NCT02745145|11273731|FG001|Overall Study|Study Termination|3
7129438|NCT02745145|11273732|FG002|Overall Study|Study Termination|7
7129439|NCT02745392|11273753|FG000|Overall Study|Lost to Follow-up|0
7129440|NCT02745392|11273754|FG001|Overall Study|Lost to Follow-up|1
7129441|NCT02745392|11273755|FG002|Overall Study|Lost to Follow-up|0
7129442|NCT02745392|11273756|FG003|Overall Study|Lost to Follow-up|0
7129443|NCT02746575|11273798|FG000|Overall Study|Surgery cancelled or time chaned|13
7129444|NCT02746575|11273798|FG000|Overall Study|Received epidural|10
7129445|NCT02746575|11273798|FG000|Overall Study|Withdrawal by Subject|3
7129446|NCT02746575|11273798|FG000|Overall Study|Bradycardia/hypotension|9
7129447|NCT02746575|11273798|FG000|Overall Study|Study paused|8
7129448|NCT02746575|11273798|FG000|Overall Study|put on beta-blocker|3
7129449|NCT02746575|11273798|FG000|Overall Study|type of surgery|1
7129450|NCT02746575|11273798|FG000|Overall Study|typ of surgery|1
7129451|NCT02746575|11273798|FG000|Overall Study|PI unavailable|1
7129452|NCT02746575|11273798|FG000|Overall Study|Unknown history of CVA|1
7129453|NCT02746627|11273805|FG000|Overall Study|Withdrawal by Subject|1
7129454|NCT02746627|11273806|FG001|Overall Study|Withdrawal by Subject|1
7129455|NCT02746627|11273807|FG002|Overall Study|Withdrawal by Subject|1
7129456|NCT02746679|11273817|FG000|Overall Study|Lost to Follow-up|4
7129457|NCT02746679|11273818|FG001|Overall Study|Lost to Follow-up|6
7129458|NCT02746705|11273826|FG000|Overall Study|Physician Decision|1
7129459|NCT02746705|11273827|FG001|Overall Study|Physician Decision|1
7129460|NCT02746705|11273826|FG000|Overall Study|Lost to Follow-up|1
7129461|NCT02746705|11273827|FG001|Overall Study|Lost to Follow-up|0
7129462|NCT02746705|11273826|FG000|Overall Study|outlier scores deemed not valid|0
7129463|NCT02746705|11273827|FG001|Overall Study|outlier scores deemed not valid|1
7129464|NCT02746874|11273835|FG000|Overall Study|Withdrawal by Subject|0
7129465|NCT02746874|11273836|FG001|Overall Study|Withdrawal by Subject|1
7129466|NCT02746874|11273835|FG000|Overall Study|Surgery Date Changed|0
7129467|NCT02746874|11273836|FG001|Overall Study|Surgery Date Changed|2
7129468|NCT02747004|11273856|FG000|Overall Study|Withdrawal by Subject|8
7129469|NCT02747004|11273857|FG001|Overall Study|Withdrawal by Subject|5
7129470|NCT02747004|11273858|FG002|Overall Study|Withdrawal by Subject|4
7129471|NCT02747004|11273856|FG000|Overall Study|Lost to Follow-up|1
7129472|NCT02747004|11273857|FG001|Overall Study|Lost to Follow-up|2
7129473|NCT02747004|11273858|FG002|Overall Study|Lost to Follow-up|2
7129474|NCT02747004|11273856|FG000|Overall Study|on study treatment/follow-up|48
7129475|NCT02747004|11273857|FG001|Overall Study|on study treatment/follow-up|42
7129476|NCT02747004|11273858|FG002|Overall Study|on study treatment/follow-up|41
7129477|NCT02747043|11273868|FG000|Overall Study|Other|1
7129478|NCT02747043|11273869|FG001|Overall Study|Other|1
7129479|NCT02747043|11273868|FG000|Overall Study|Adverse Event|3
7129480|NCT02747043|11273869|FG001|Overall Study|Adverse Event|1
7129481|NCT02747043|11273868|FG000|Overall Study|Withdrawal by Subject|1
7129482|NCT02747043|11273869|FG001|Overall Study|Withdrawal by Subject|1
7129483|NCT02747043|11273868|FG000|Overall Study|Physician Decision|1
7129484|NCT02747043|11273869|FG001|Overall Study|Physician Decision|1
7129485|NCT02747043|11273868|FG000|Overall Study|Protocol Violation|0
7129486|NCT02747043|11273869|FG001|Overall Study|Protocol Violation|1
7129487|NCT02747043|11273868|FG000|Overall Study|Disease progression|4
7129488|NCT02747043|11273869|FG001|Overall Study|Disease progression|0
7129489|NCT02747108|11273877|FG000|Overall Study|Death|2
7129490|NCT02747108|11273878|FG001|Overall Study|Death|2
7129491|NCT02747108|11273877|FG000|Overall Study|Withdrawal by Subject|1
7129492|NCT02747108|11273878|FG001|Overall Study|Withdrawal by Subject|0
7129493|NCT02747108|11273877|FG000|Overall Study|Protocol Violation|2
7129494|NCT02747108|11273878|FG001|Overall Study|Protocol Violation|0
7129495|NCT02747238|11273900|FG000|Overall Study|Lack of Efficacy|0
7129496|NCT02747238|11273901|FG001|Overall Study|Lack of Efficacy|1
7129497|NCT02747238|11273900|FG000|Overall Study|Data lost|3
7129498|NCT02747238|11273901|FG001|Overall Study|Data lost|5
7129499|NCT02747420|11273909|FG000|Overall Study|Lost to Follow-up|4
7129500|NCT02747420|11273910|FG001|Overall Study|Lost to Follow-up|2
7129501|NCT02747420|11273909|FG000|Overall Study|Withdrawal by Subject|3
7129502|NCT02747420|11273910|FG001|Overall Study|Withdrawal by Subject|2
7129503|NCT02747875|11273940|FG000|Overall Study|Physician Decision|1
7129504|NCT02747875|11273941|FG001|Overall Study|Physician Decision|0
7129505|NCT02747875|11273940|FG000|Overall Study|Adverse Event|0
7129506|NCT02747875|11273941|FG001|Overall Study|Adverse Event|1
7129507|NCT02747927|11273949|FG000|Overall Study|Adverse Event|5
7129508|NCT02747927|11273950|FG001|Overall Study|Adverse Event|14
7129509|NCT02747927|11273949|FG000|Overall Study|Lost to Follow-up|22
7129510|NCT02747927|11273950|FG001|Overall Study|Lost to Follow-up|43
7129511|NCT02747927|11273949|FG000|Overall Study|Pregnancy|34
7129512|NCT02747927|11273950|FG001|Overall Study|Pregnancy|66
7129513|NCT02747927|11273949|FG000|Overall Study|Protocol Violation|2
7129514|NCT02747927|11273950|FG001|Overall Study|Protocol Violation|4
7129515|NCT02747927|11273949|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147
7129516|NCT02747927|11273950|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304
7129517|NCT02747927|11273949|FG000|Overall Study|Reason not Specified|11
7129518|NCT02747927|11273950|FG001|Overall Study|Reason not Specified|27
7129519|NCT02748213|11273976|FG000|Overall Study|Withdrawal Prior to Treatment|1
7129520|NCT02748213|11273977|FG001|Overall Study|Withdrawal Prior to Treatment|2
7129521|NCT02748213|11273976|FG000|Overall Study|Abnormal Laboratory Test|1
7129522|NCT02748213|11273977|FG001|Overall Study|Abnormal Laboratory Test|0
7129523|NCT02748213|11273976|FG000|Overall Study|Adverse Event or Intercurrent Illness|5
7129524|NCT02748213|11273977|FG001|Overall Study|Adverse Event or Intercurrent Illness|11
7129525|NCT02748213|11273976|FG000|Overall Study|Death|5
7129526|NCT02748213|11273977|FG001|Overall Study|Death|3
7129527|NCT02748213|11273976|FG000|Overall Study|Insufficient Therapeutic Response|56
7129528|NCT02748213|11273977|FG001|Overall Study|Insufficient Therapeutic Response|57
7129529|NCT02748213|11273976|FG000|Overall Study|Violation of Selection Criteria|2
7129530|NCT02748213|11273977|FG001|Overall Study|Violation of Selection Criteria|0
7129531|NCT02748213|11273976|FG000|Overall Study|Protocol Violation|6
7129532|NCT02748213|11273977|FG001|Overall Study|Protocol Violation|4
7129533|NCT02748213|11273976|FG000|Overall Study|Refused Treatment*|6
7129534|NCT02748213|11273977|FG001|Overall Study|Refused Treatment*|6
7129535|NCT02748213|11273976|FG000|Overall Study|Failure to Return|1
7129536|NCT02748213|11273977|FG001|Overall Study|Failure to Return|0
7129537|NCT02748213|11273976|FG000|Overall Study|Other|30
7129538|NCT02748213|11273977|FG001|Overall Study|Other|29
7129539|NCT02748317|11273983|FG000|Overall Study|Withdrawal by Subject|14
7129540|NCT02748317|11273983|FG000|Overall Study|Lost to Follow-up|8
7129541|NCT02748317|11273983|FG000|Overall Study|Death|1
7129542|NCT02748356|11273987|FG000|Overall Study|Withdrawal by Subject|1
7129543|NCT02748512|11273993|FG000|Overall Study|Lost to Follow-up|1
7129544|NCT02748512|11273994|FG001|Overall Study|Lost to Follow-up|1
7129545|NCT02748694|11274019|FG000|Overall Study|Voluntary Withdrawal|0
7129546|NCT02748694|11274020|FG001|Overall Study|Voluntary Withdrawal|0
7129547|NCT02748694|11274021|FG002|Overall Study|Voluntary Withdrawal|0
7129548|NCT02748694|11274022|FG003|Overall Study|Voluntary Withdrawal|0
7129549|NCT02748694|11274023|FG004|Overall Study|Voluntary Withdrawal|0
7129550|NCT02748694|11274024|FG005|Overall Study|Voluntary Withdrawal|0
7129551|NCT02748694|11274025|FG006|Overall Study|Voluntary Withdrawal|0
7129552|NCT02748694|11274026|FG007|Overall Study|Voluntary Withdrawal|0
7129553|NCT02748694|11274027|FG008|Overall Study|Voluntary Withdrawal|0
7129554|NCT02748694|11274028|FG009|Overall Study|Voluntary Withdrawal|0
7129555|NCT02748694|11274029|FG010|Overall Study|Voluntary Withdrawal|0
7129556|NCT02748694|11274030|FG011|Overall Study|Voluntary Withdrawal|0
7129557|NCT02748694|11274031|FG012|Overall Study|Voluntary Withdrawal|0
7129558|NCT02748694|11274032|FG013|Overall Study|Voluntary Withdrawal|0
7129559|NCT02748694|11274033|FG014|Overall Study|Voluntary Withdrawal|2
7129560|NCT02748863|11274109|FG000|Treatment Period 1|Adverse Event|0
7129561|NCT02748863|11274110|FG001|Treatment Period 1|Adverse Event|1
7129562|NCT02748863|11274111|FG002|Treatment Period 1|Adverse Event|0
7129563|NCT02748863|11274112|FG003|Treatment Period 1|Adverse Event|0
7129564|NCT02748863|11274113|FG004|Treatment Period 1|Adverse Event|0
7129565|NCT02748863|11274109|FG000|Treatment Period 1|Lack of Efficacy|0
7129566|NCT02748863|11274110|FG001|Treatment Period 1|Lack of Efficacy|0
7129567|NCT02748863|11274111|FG002|Treatment Period 1|Lack of Efficacy|1
7129568|NCT02748863|11274112|FG003|Treatment Period 1|Lack of Efficacy|0
7129569|NCT02748863|11274113|FG004|Treatment Period 1|Lack of Efficacy|0
7129570|NCT02748863|11274109|FG000|Treatment Period 1|Withdrawal by Subject|0
7129571|NCT02748863|11274110|FG001|Treatment Period 1|Withdrawal by Subject|1
7129572|NCT02748863|11274111|FG002|Treatment Period 1|Withdrawal by Subject|1
7129573|NCT02748863|11274112|FG003|Treatment Period 1|Withdrawal by Subject|0
7129574|NCT02748863|11274113|FG004|Treatment Period 1|Withdrawal by Subject|0
7129575|NCT02748863|11274109|FG000|Treatment Period 2|Lost to Follow-up|2
7129576|NCT02748863|11274110|FG001|Treatment Period 2|Lost to Follow-up|0
7129577|NCT02748863|11274111|FG002|Treatment Period 2|Lost to Follow-up|0
7129578|NCT02748863|11274112|FG003|Treatment Period 2|Lost to Follow-up|0
7129579|NCT02748863|11274113|FG004|Treatment Period 2|Lost to Follow-up|0
7129580|NCT02748863|11274109|FG000|Treatment Period 2|Adverse Event|3
7129581|NCT02748863|11274110|FG001|Treatment Period 2|Adverse Event|2
7129582|NCT02748863|11274111|FG002|Treatment Period 2|Adverse Event|0
7129583|NCT02748863|11274112|FG003|Treatment Period 2|Adverse Event|2
7129584|NCT02748863|11274113|FG004|Treatment Period 2|Adverse Event|0
7129585|NCT02748863|11274109|FG000|Treatment Period 2|Lack of Efficacy|0
7129586|NCT02748863|11274110|FG001|Treatment Period 2|Lack of Efficacy|1
7129587|NCT02748863|11274111|FG002|Treatment Period 2|Lack of Efficacy|0
7129588|NCT02748863|11274112|FG003|Treatment Period 2|Lack of Efficacy|0
7129589|NCT02748863|11274113|FG004|Treatment Period 2|Lack of Efficacy|0
7129590|NCT02748863|11274109|FG000|Treatment Period 2|Pregnancy|0
7129591|NCT02748863|11274110|FG001|Treatment Period 2|Pregnancy|0
7129592|NCT02748863|11274111|FG002|Treatment Period 2|Pregnancy|0
7129593|NCT02748863|11274112|FG003|Treatment Period 2|Pregnancy|0
7129594|NCT02748863|11274113|FG004|Treatment Period 2|Pregnancy|1
7129595|NCT02749370|11274144|FG000|Overall Study|Withdrawal by Subject|11
7129596|NCT02749370|11274144|FG000|Overall Study|Lost to Follow-up|3
7129597|NCT02749721|11274148|FG000|Screening|Withdrawal by Subject|1
7129598|NCT02749721|11274148|FG000|Screening|Lost to Follow-up|2
7129599|NCT02749721|11274148|FG000|Screening|Protocol Violation|3
7129600|NCT02749721|11274148|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2
7129601|NCT02749721|11274148|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1
7129602|NCT02749799|11274154|FG000|Overall Study|Adverse Event|2
7129603|NCT02749799|11274154|FG000|Overall Study|Lost to Follow-up|4
7129604|NCT02749799|11274154|FG000|Overall Study|Protocol Violation|1
7129605|NCT02749799|11274154|FG000|Overall Study|Withdrawal by Subject|1
7129606|NCT02750306|11274175|FG000|Overall Study|Withdrawal by Subject|5
7129607|NCT02750306|11274176|FG001|Overall Study|Withdrawal by Subject|2
7129608|NCT02750306|11274175|FG000|Overall Study|Protocol Violation|1
7129609|NCT02750306|11274176|FG001|Overall Study|Protocol Violation|0
7129610|NCT02750332|11274182|FG000|Treatment Period 1|Withdrawal by Subject|0
7129611|NCT02750332|11274183|FG001|Treatment Period 1|Withdrawal by Subject|1
7129612|NCT02750345|11274189|FG000|Intervention 1|Adverse Event|0
7129613|NCT02750345|11274190|FG001|Intervention 1|Adverse Event|0
7129614|NCT02750345|11274191|FG002|Intervention 1|Adverse Event|0
7129615|NCT02750345|11274192|FG003|Intervention 1|Adverse Event|0
7129616|NCT02750345|11274193|FG004|Intervention 1|Adverse Event|1
7129617|NCT02750345|11274194|FG005|Intervention 1|Adverse Event|0
7129618|NCT02750410|11274206|FG000|Double-Blind Treatment Period|Adverse Event|2
7129619|NCT02750410|11274207|FG001|Double-Blind Treatment Period|Adverse Event|2
6806230|NCT02706847|10808780|FG001|Week 12 to Week 24|Lost to Follow-up|0
7129620|NCT02750410|11274206|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
7129621|NCT02750410|11274207|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1
7129622|NCT02750410|11274206|FG000|Open-Label Extension Period|Adverse Event|5
7129623|NCT02750410|11274207|FG001|Open-Label Extension Period|Adverse Event|3
7129624|NCT02750410|11274206|FG000|Open-Label Extension Period|Protocol Violation|0
7129625|NCT02750410|11274207|FG001|Open-Label Extension Period|Protocol Violation|1
7129626|NCT02750410|11274206|FG000|Open-Label Extension Period|Withdrawal by Subject|1
7129627|NCT02750410|11274207|FG001|Open-Label Extension Period|Withdrawal by Subject|2
7129628|NCT02750501|11274217|FG000|Overall Study|Adverse Event|4
7129629|NCT02750501|11274217|FG000|Overall Study|Physician Decision|1
7129630|NCT02750501|11274217|FG000|Overall Study|Protocol Violation|1
7129631|NCT02750501|11274217|FG000|Overall Study|G-tube came out|1
7129632|NCT02750501|11274217|FG000|Overall Study|Non-compliant use of PERT|1
7129633|NCT02750514|11274230|FG000|Track 1|Disease progression|20
7129634|NCT02750514|11274231|FG001|Track 1|Disease progression|1
7129635|NCT02750514|11274232|FG002|Track 1|Disease progression|0
7129636|NCT02750514|11274233|FG003|Track 1|Disease progression|1
7129637|NCT02750514|11274234|FG004|Track 1|Disease progression|0
7129638|NCT02750514|11274230|FG000|Track 1|Adverse event unrelated to study drug|1
7129639|NCT02750514|11274231|FG001|Track 1|Adverse event unrelated to study drug|0
7129640|NCT02750514|11274232|FG002|Track 1|Adverse event unrelated to study drug|0
7129641|NCT02750514|11274233|FG003|Track 1|Adverse event unrelated to study drug|0
7129642|NCT02750514|11274234|FG004|Track 1|Adverse event unrelated to study drug|0
7129643|NCT02750514|11274230|FG000|Track 1|Study drug toxicity|4
7129644|NCT02750514|11274231|FG001|Track 1|Study drug toxicity|1
7129645|NCT02750514|11274232|FG002|Track 1|Study drug toxicity|0
7129646|NCT02750514|11274233|FG003|Track 1|Study drug toxicity|1
7129647|NCT02750514|11274234|FG004|Track 1|Study drug toxicity|0
7129648|NCT02750514|11274230|FG000|Track 1|Participant request to discontinue|1
7129649|NCT02750514|11274231|FG001|Track 1|Participant request to discontinue|0
7129650|NCT02750514|11274232|FG002|Track 1|Participant request to discontinue|0
7129651|NCT02750514|11274233|FG003|Track 1|Participant request to discontinue|0
7129652|NCT02750514|11274234|FG004|Track 1|Participant request to discontinue|0
7129653|NCT02750514|11274230|FG000|Track 1|Other reasons|1
7129654|NCT02750514|11274231|FG001|Track 1|Other reasons|0
7129655|NCT02750514|11274232|FG002|Track 1|Other reasons|0
7129656|NCT02750514|11274233|FG003|Track 1|Other reasons|0
7129657|NCT02750514|11274234|FG004|Track 1|Other reasons|0
7129658|NCT02750514|11274230|FG000|Track 2|Disease progression|4
7129659|NCT02750514|11274231|FG001|Track 2|Disease progression|5
7129660|NCT02750514|11274232|FG002|Track 2|Disease progression|2
7129661|NCT02750514|11274233|FG003|Track 2|Disease progression|5
7129662|NCT02750514|11274234|FG004|Track 2|Disease progression|0
7129663|NCT02750514|11274230|FG000|Track 2|Adverse event unrelated to study drug|1
7129664|NCT02750514|11274231|FG001|Track 2|Adverse event unrelated to study drug|0
7129665|NCT02750514|11274232|FG002|Track 2|Adverse event unrelated to study drug|0
7129666|NCT02750514|11274233|FG003|Track 2|Adverse event unrelated to study drug|0
7129667|NCT02750514|11274234|FG004|Track 2|Adverse event unrelated to study drug|0
7129668|NCT02750514|11274230|FG000|Track 2|Study drug toxicity|1
7129669|NCT02750514|11274231|FG001|Track 2|Study drug toxicity|2
7129670|NCT02750514|11274232|FG002|Track 2|Study drug toxicity|0
7129671|NCT02750514|11274233|FG003|Track 2|Study drug toxicity|2
7129672|NCT02750514|11274234|FG004|Track 2|Study drug toxicity|0
7129673|NCT02750514|11274230|FG000|Track 2|Participant withdrew consent|0
7129674|NCT02750514|11274231|FG001|Track 2|Participant withdrew consent|1
7129675|NCT02750514|11274232|FG002|Track 2|Participant withdrew consent|0
7129676|NCT02750514|11274233|FG003|Track 2|Participant withdrew consent|0
7129677|NCT02750514|11274234|FG004|Track 2|Participant withdrew consent|0
7129678|NCT02750514|11274230|FG000|Track 3|Disease progression|0
7129679|NCT02750514|11274231|FG001|Track 3|Disease progression|24
7129680|NCT02750514|11274232|FG002|Track 3|Disease progression|13
7129681|NCT02750514|11274233|FG003|Track 3|Disease progression|14
7129682|NCT02750514|11274234|FG004|Track 3|Disease progression|0
7129683|NCT02750514|11274230|FG000|Track 3|Adverse event unrelated to study drug|0
7129684|NCT02750514|11274231|FG001|Track 3|Adverse event unrelated to study drug|1
7129685|NCT02750514|11274232|FG002|Track 3|Adverse event unrelated to study drug|1
7129686|NCT02750514|11274233|FG003|Track 3|Adverse event unrelated to study drug|1
7129687|NCT02750514|11274234|FG004|Track 3|Adverse event unrelated to study drug|0
7129688|NCT02750514|11274230|FG000|Track 3|Study drug toxicity|0
7129689|NCT02750514|11274231|FG001|Track 3|Study drug toxicity|3
7129690|NCT02750514|11274232|FG002|Track 3|Study drug toxicity|0
7129691|NCT02750514|11274233|FG003|Track 3|Study drug toxicity|1
7129692|NCT02750514|11274234|FG004|Track 3|Study drug toxicity|0
7129693|NCT02750514|11274230|FG000|Track 3|Participant request to discontinue|0
7129694|NCT02750514|11274231|FG001|Track 3|Participant request to discontinue|2
7129695|NCT02750514|11274232|FG002|Track 3|Participant request to discontinue|0
7129696|NCT02750514|11274233|FG003|Track 3|Participant request to discontinue|0
7129697|NCT02750514|11274234|FG004|Track 3|Participant request to discontinue|0
7129698|NCT02750514|11274230|FG000|Track 3|Participant withdrew consent|0
7129699|NCT02750514|11274231|FG001|Track 3|Participant withdrew consent|3
7129700|NCT02750514|11274232|FG002|Track 3|Participant withdrew consent|1
7129701|NCT02750514|11274233|FG003|Track 3|Participant withdrew consent|0
7129702|NCT02750514|11274234|FG004|Track 3|Participant withdrew consent|0
7129703|NCT02750514|11274230|FG000|Track 3|Other reasons|0
7129704|NCT02750514|11274231|FG001|Track 3|Other reasons|3
7129705|NCT02750514|11274232|FG002|Track 3|Other reasons|0
7129706|NCT02750514|11274233|FG003|Track 3|Other reasons|0
7129707|NCT02750514|11274234|FG004|Track 3|Other reasons|0
7129708|NCT02750514|11274230|FG000|Track 4|Study drug toxicity|0
7129709|NCT02750514|11274231|FG001|Track 4|Study drug toxicity|6
7129710|NCT02750514|11274232|FG002|Track 4|Study drug toxicity|0
7129711|NCT02750514|11274233|FG003|Track 4|Study drug toxicity|5
7129712|NCT02750514|11274234|FG004|Track 4|Study drug toxicity|0
7129713|NCT02750514|11274230|FG000|Track 4|Participant request to discontinue|0
7129714|NCT02750514|11274231|FG001|Track 4|Participant request to discontinue|1
7129715|NCT02750514|11274232|FG002|Track 4|Participant request to discontinue|0
7129716|NCT02750514|11274233|FG003|Track 4|Participant request to discontinue|1
7129717|NCT02750514|11274234|FG004|Track 4|Participant request to discontinue|0
7129718|NCT02750514|11274230|FG000|Track 4|Participant withdrew consent|0
7129719|NCT02750514|11274231|FG001|Track 4|Participant withdrew consent|1
7129720|NCT02750514|11274232|FG002|Track 4|Participant withdrew consent|0
7129721|NCT02750514|11274233|FG003|Track 4|Participant withdrew consent|0
7129722|NCT02750514|11274234|FG004|Track 4|Participant withdrew consent|0
7129723|NCT02750514|11274230|FG000|Track 4|Other reasons|0
7129724|NCT02750514|11274231|FG001|Track 4|Other reasons|5
7129725|NCT02750514|11274232|FG002|Track 4|Other reasons|0
7129726|NCT02750514|11274233|FG003|Track 4|Other reasons|3
7129727|NCT02750514|11274234|FG004|Track 4|Other reasons|0
7129728|NCT02750514|11274230|FG000|Track 4|Disease progression|0
7129729|NCT02750514|11274231|FG001|Track 4|Disease progression|33
7129730|NCT02750514|11274232|FG002|Track 4|Disease progression|0
7129731|NCT02750514|11274233|FG003|Track 4|Disease progression|32
7129732|NCT02750514|11274234|FG004|Track 4|Disease progression|0
7129733|NCT02750514|11274230|FG000|Track 4|Adverse event unrelated to study drug|0
7129734|NCT02750514|11274231|FG001|Track 4|Adverse event unrelated to study drug|5
7129735|NCT02750514|11274232|FG002|Track 4|Adverse event unrelated to study drug|0
7129736|NCT02750514|11274233|FG003|Track 4|Adverse event unrelated to study drug|0
7129737|NCT02750514|11274234|FG004|Track 4|Adverse event unrelated to study drug|0
7129738|NCT02750514|11274230|FG000|Track 4|Death|0
7129739|NCT02750514|11274231|FG001|Track 4|Death|0
7129740|NCT02750514|11274232|FG002|Track 4|Death|0
7129741|NCT02750514|11274233|FG003|Track 4|Death|1
7129742|NCT02750514|11274234|FG004|Track 4|Death|0
7129743|NCT02750514|11274230|FG000|Track 5|Disease progression|0
7129744|NCT02750514|11274231|FG001|Track 5|Disease progression|0
7129745|NCT02750514|11274232|FG002|Track 5|Disease progression|0
7129746|NCT02750514|11274233|FG003|Track 5|Disease progression|0
7129747|NCT02750514|11274234|FG004|Track 5|Disease progression|34
7129748|NCT02750514|11274230|FG000|Track 5|Adverse event unrelated to study drug|0
7129749|NCT02750514|11274231|FG001|Track 5|Adverse event unrelated to study drug|0
7129750|NCT02750514|11274232|FG002|Track 5|Adverse event unrelated to study drug|0
7129751|NCT02750514|11274233|FG003|Track 5|Adverse event unrelated to study drug|0
7129752|NCT02750514|11274234|FG004|Track 5|Adverse event unrelated to study drug|2
7129753|NCT02750514|11274230|FG000|Track 5|Study drug toxicity|0
7129754|NCT02750514|11274231|FG001|Track 5|Study drug toxicity|0
7129755|NCT02750514|11274232|FG002|Track 5|Study drug toxicity|0
7129756|NCT02750514|11274233|FG003|Track 5|Study drug toxicity|0
7129757|NCT02750514|11274234|FG004|Track 5|Study drug toxicity|2
7129758|NCT02750514|11274230|FG000|Track 5|Participant request to discontinue|0
7129759|NCT02750514|11274231|FG001|Track 5|Participant request to discontinue|0
7129760|NCT02750514|11274232|FG002|Track 5|Participant request to discontinue|0
7129761|NCT02750514|11274233|FG003|Track 5|Participant request to discontinue|0
7129762|NCT02750514|11274234|FG004|Track 5|Participant request to discontinue|3
7129763|NCT02750514|11274230|FG000|Track 5|Other reasons|0
7129764|NCT02750514|11274231|FG001|Track 5|Other reasons|0
7129765|NCT02750514|11274232|FG002|Track 5|Other reasons|0
7129766|NCT02750514|11274233|FG003|Track 5|Other reasons|0
7129767|NCT02750514|11274234|FG004|Track 5|Other reasons|2
7129768|NCT02750592|11274254|FG000|Overall Study|Adverse Event|3
7129769|NCT02750592|11274254|FG000|Overall Study|Lack of Efficacy|2
7129770|NCT02750618|11274258|FG000|Overall Study|Withdrawal by Subject|1
7129771|NCT02750709|11274262|FG000|Treatment Period 1|Adverse Event|0
7129772|NCT02750709|11274263|FG001|Treatment Period 1|Adverse Event|0
7129773|NCT02750709|11274264|FG002|Treatment Period 1|Adverse Event|0
7129774|NCT02750709|11274265|FG003|Treatment Period 1|Adverse Event|0
7129775|NCT02750709|11274266|FG004|Treatment Period 1|Adverse Event|0
7129776|NCT02750709|11274267|FG005|Treatment Period 1|Adverse Event|1
7129777|NCT02750761|11274281|FG000|Overall Study|Lost to Follow-up|0
7129778|NCT02750761|11274282|FG001|Overall Study|Lost to Follow-up|0
7129779|NCT02750761|11274283|FG002|Overall Study|Lost to Follow-up|1
7129780|NCT02750761|11274284|FG003|Overall Study|Lost to Follow-up|0
7129781|NCT02750761|11274285|FG004|Overall Study|Lost to Follow-up|0
7129782|NCT02750761|11274286|FG005|Overall Study|Lost to Follow-up|0
7129783|NCT02750800|11274310|FG000|Overall Study|Adverse Event|18
7129784|NCT02750800|11274310|FG000|Overall Study|Lost to Follow-up|12
7129785|NCT02750800|11274310|FG000|Overall Study|Investigator decision|53
7129786|NCT02750800|11274310|FG000|Overall Study|Patient request|12
7129787|NCT02750800|11274310|FG000|Overall Study|Other, not specified|3
7129788|NCT02750813|11274328|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1
7129789|NCT02750813|11274329|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0
7129790|NCT02750813|11274328|FG000|Period 1, First 14 Days of Wear|Reason not given|0
7129791|NCT02750813|11274329|FG001|Period 1, First 14 Days of Wear|Reason not given|1
7129792|NCT02750930|11274336|FG000|Overall Study|Study closed/terminated|8
7129793|NCT02750943|11274342|FG000|Overall Study|Lost to Follow-up|1
7129794|NCT02750943|11274343|FG001|Overall Study|Lost to Follow-up|2
7129795|NCT02750943|11274342|FG000|Overall Study|Withdrawal by Subject|5
7129796|NCT02750943|11274343|FG001|Overall Study|Withdrawal by Subject|7
7129797|NCT02751320|11274349|FG000|Overall Study|Adverse Event|2
7129798|NCT02751320|11274349|FG000|Overall Study|Withdrawal by Subject|1
7129799|NCT02751359|11274374|FG000|Overall Study|Lost to Follow-up|1
7129800|NCT02751424|11274402|FG000|Part 2|Adverse Event|0
7129801|NCT02751424|11274403|FG001|Part 2|Adverse Event|0
7129802|NCT02751424|11274404|FG002|Part 2|Adverse Event|0
7129803|NCT02751424|11274405|FG003|Part 2|Adverse Event|0
7129804|NCT02751424|11274406|FG004|Part 2|Adverse Event|0
7129805|NCT02751424|11274407|FG005|Part 2|Adverse Event|0
7129806|NCT02751424|11274408|FG006|Part 2|Adverse Event|0
7129807|NCT02751424|11274409|FG007|Part 2|Adverse Event|5
7129808|NCT02751424|11274410|FG008|Part 2|Adverse Event|0
7129809|NCT02751450|11274435|FG000|Overall Study|Adverse Event|1
7129810|NCT02751450|11274436|FG001|Overall Study|Adverse Event|0
7129811|NCT02751580|11274444|FG000|Overall Study|Lost to Follow-up|4
7129812|NCT02751580|11274444|FG000|Overall Study|Death|2
7129813|NCT02751827|11274451|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0
7129814|NCT02751827|11274452|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0
7129815|NCT02751827|11274453|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1
7129816|NCT02751931|11274475|FG000|Overall Study|Adverse Event|3
7129817|NCT02751931|11274476|FG001|Overall Study|Adverse Event|0
7129818|NCT02751931|11274475|FG000|Overall Study|Other: Miscelleneous|10
7129819|NCT02751931|11274476|FG001|Overall Study|Other: Miscelleneous|8
7129820|NCT02751983|11274490|FG000|Treatment|Stopped ACT, but Remained in study|2
7129821|NCT02751983|11274491|FG001|Treatment|Stopped ACT, but Remained in study|0
7129822|NCT02751983|11274490|FG000|Treatment|Discharged prior to beginning ACT|2
7129823|NCT02751983|11274491|FG001|Treatment|Discharged prior to beginning ACT|0
7129824|NCT02751983|11274490|FG000|Post-Treatment Assessment|Lost to Follow-up|5
7129825|NCT02751983|11274491|FG001|Post-Treatment Assessment|Lost to Follow-up|0
7129826|NCT02751983|11274490|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14
7129827|NCT02751983|11274491|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12
7129828|NCT02751983|11274490|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12
7129829|NCT02751983|11274491|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16
7129830|NCT02752048|11274500|FG000|Overall Study|Withdrawal by Subject|0
7129831|NCT02752048|11274501|FG001|Overall Study|Withdrawal by Subject|0
7129832|NCT02752048|11274502|FG002|Overall Study|Withdrawal by Subject|3
7129833|NCT02752074|11274512|FG000|Overall Study|Lost to Follow-up|1
7129834|NCT02752074|11274513|FG001|Overall Study|Lost to Follow-up|4
7129835|NCT02752074|11274512|FG000|Overall Study|Death|146
7129836|NCT02752074|11274513|FG001|Overall Study|Death|129
7129837|NCT02752074|11274512|FG000|Overall Study|Withdrawal by Subject|9
7129838|NCT02752074|11274513|FG001|Overall Study|Withdrawal by Subject|10
7129839|NCT02752087|11274519|FG000|Washout|Physician Decision|1
7129840|NCT02752087|11274520|FG001|Washout|Physician Decision|0
7129841|NCT02752633|11274544|FG000|Overall Study|Withdrawal by Subject|1
7129842|NCT02752776|11274551|FG000|Overall Study|Adverse Event|15
7129843|NCT02752776|11274552|FG001|Overall Study|Adverse Event|23
7129844|NCT02752776|11274553|FG002|Overall Study|Adverse Event|11
7129845|NCT02752776|11274551|FG000|Overall Study|Lack of Efficacy|2
7129846|NCT02752776|11274552|FG001|Overall Study|Lack of Efficacy|6
7129847|NCT02752776|11274553|FG002|Overall Study|Lack of Efficacy|14
7129848|NCT02752776|11274551|FG000|Overall Study|Lost to Follow-up|11
7129849|NCT02752776|11274552|FG001|Overall Study|Lost to Follow-up|12
7129850|NCT02752776|11274553|FG002|Overall Study|Lost to Follow-up|4
7129851|NCT02752776|11274551|FG000|Overall Study|Non-compliance with study treatment|0
7129852|NCT02752776|11274552|FG001|Overall Study|Non-compliance with study treatment|0
7129853|NCT02752776|11274553|FG002|Overall Study|Non-compliance with study treatment|1
7129854|NCT02752776|11274551|FG000|Overall Study|Physician Decision|2
7129855|NCT02752776|11274552|FG001|Overall Study|Physician Decision|6
7129856|NCT02752776|11274553|FG002|Overall Study|Physician Decision|2
7129857|NCT02752776|11274551|FG000|Overall Study|Pregnancy|1
7129858|NCT02752776|11274552|FG001|Overall Study|Pregnancy|6
7129859|NCT02752776|11274553|FG002|Overall Study|Pregnancy|3
7129860|NCT02752776|11274551|FG000|Overall Study|Protocol Violation|10
7129861|NCT02752776|11274552|FG001|Overall Study|Protocol Violation|13
7129862|NCT02752776|11274553|FG002|Overall Study|Protocol Violation|6
7129863|NCT02752776|11274551|FG000|Overall Study|Subject/guardian decision|8
7129864|NCT02752776|11274552|FG001|Overall Study|Subject/guardian decision|6
7129865|NCT02752776|11274553|FG002|Overall Study|Subject/guardian decision|4
7129866|NCT02752776|11274551|FG000|Overall Study|Death|0
7129867|NCT02752776|11274552|FG001|Overall Study|Death|0
7129868|NCT02752776|11274553|FG002|Overall Study|Death|1
7129869|NCT02752776|11274551|FG000|Overall Study|Withdrawal by Subject|3
7129870|NCT02752776|11274552|FG001|Overall Study|Withdrawal by Subject|4
7129871|NCT02752776|11274553|FG002|Overall Study|Withdrawal by Subject|2
7129872|NCT02752802|11274565|FG000|Overall Study|Contrast Volume Not Collected|1
7129873|NCT02752802|11274566|FG001|Overall Study|Contrast Volume Not Collected|0
7129874|NCT02752958|11274584|FG000|Overall Study|Adverse Event|3
7129875|NCT02752958|11274584|FG000|Overall Study|Lost to Follow-up|1
7129876|NCT02752958|11274584|FG000|Overall Study|Protocol Violation|1
7129877|NCT02752958|11274584|FG000|Overall Study|Withdrawal by Subject|2
7129878|NCT02752958|11274584|FG000|Overall Study|Other (Reason not specified)|2
7129879|NCT02753075|11274593|FG000|Overall Study|Adverse Event|2
7129880|NCT02753075|11274594|FG001|Overall Study|Adverse Event|1
7129881|NCT02753075|11274595|FG002|Overall Study|Adverse Event|0
7129882|NCT02753075|11274593|FG000|Overall Study|Lost to Follow-up|2
7129883|NCT02753075|11274594|FG001|Overall Study|Lost to Follow-up|0
7129884|NCT02753075|11274595|FG002|Overall Study|Lost to Follow-up|0
7129885|NCT02753075|11274593|FG000|Overall Study|Withdrawal of Consent|1
7129886|NCT02753075|11274594|FG001|Overall Study|Withdrawal of Consent|1
7129887|NCT02753075|11274595|FG002|Overall Study|Withdrawal of Consent|3
7129888|NCT02753075|11274593|FG000|Overall Study|Physician Decision|3
7129889|NCT02753075|11274594|FG001|Overall Study|Physician Decision|1
7129890|NCT02753075|11274595|FG002|Overall Study|Physician Decision|0
7129891|NCT02753400|11274606|FG000|Overall Study|Adverse Event|3
7129892|NCT02753400|11274607|FG001|Overall Study|Adverse Event|0
7129893|NCT02753400|11274606|FG000|Overall Study|Withdrawal by Subject|2
7129894|NCT02753400|11274607|FG001|Overall Study|Withdrawal by Subject|1
7129895|NCT02753595|11274624|FG000|Overall Study|Sponsor termination|2
7129896|NCT02753595|11274625|FG001|Overall Study|Sponsor termination|2
7129897|NCT02753816|11274648|FG000|Overall Study|Protocol Violation|0
7129898|NCT02753816|11274649|FG001|Overall Study|Protocol Violation|1
7129899|NCT02753816|11274650|FG002|Overall Study|Protocol Violation|0
7129900|NCT02753946|11274709|FG000|Overall Study|Adverse Event|7
7129901|NCT02753946|11274710|FG001|Overall Study|Adverse Event|6
7129902|NCT02753946|11274709|FG000|Overall Study|Withdrawal by Subject|6
7129903|NCT02753946|11274710|FG001|Overall Study|Withdrawal by Subject|1
7129904|NCT02753946|11274709|FG000|Overall Study|Lack of Efficacy|1
7129905|NCT02753946|11274710|FG001|Overall Study|Lack of Efficacy|0
7129906|NCT02753946|11274709|FG000|Overall Study|Physician Decision|0
7129907|NCT02753946|11274710|FG001|Overall Study|Physician Decision|2
7129908|NCT02754440|11274738|FG000|Overall Study|Protocol Violation|3
7129909|NCT02754440|11274739|FG001|Overall Study|Protocol Violation|2
7129910|NCT02754440|11274740|FG002|Overall Study|Protocol Violation|2
7129911|NCT02754440|11274741|FG003|Overall Study|Protocol Violation|6
7129912|NCT02754440|11274738|FG000|Overall Study|Adverse Event|3
7129913|NCT02754440|11274739|FG001|Overall Study|Adverse Event|1
7129914|NCT02754440|11274740|FG002|Overall Study|Adverse Event|0
7129915|NCT02754440|11274741|FG003|Overall Study|Adverse Event|9
7129916|NCT02754440|11274738|FG000|Overall Study|Withdrawal by Subject|0
7129917|NCT02754440|11274739|FG001|Overall Study|Withdrawal by Subject|0
7129918|NCT02754440|11274740|FG002|Overall Study|Withdrawal by Subject|0
7129919|NCT02754440|11274741|FG003|Overall Study|Withdrawal by Subject|1
7129920|NCT02754440|11274738|FG000|Overall Study|Equipment failure|0
7129921|NCT02754440|11274739|FG001|Overall Study|Equipment failure|5
7129922|NCT02754440|11274740|FG002|Overall Study|Equipment failure|5
7129923|NCT02754440|11274741|FG003|Overall Study|Equipment failure|7
7129924|NCT02754440|11274738|FG000|Overall Study|Subject issues not resulting in AE|0
7129925|NCT02754440|11274739|FG001|Overall Study|Subject issues not resulting in AE|0
7129926|NCT02754440|11274740|FG002|Overall Study|Subject issues not resulting in AE|0
7129927|NCT02754440|11274741|FG003|Overall Study|Subject issues not resulting in AE|12
7129928|NCT02754492|11274754|FG000|Overall Study|Protocol Violation|2
7129929|NCT02754492|11274755|FG001|Overall Study|Protocol Violation|2
7129930|NCT02754492|11274756|FG002|Overall Study|Protocol Violation|0
7129931|NCT02754492|11274757|FG003|Overall Study|Protocol Violation|1
7129932|NCT02754492|11274754|FG000|Overall Study|Withdrawal by Subject|2
7129933|NCT02754492|11274755|FG001|Overall Study|Withdrawal by Subject|0
7129934|NCT02754492|11274756|FG002|Overall Study|Withdrawal by Subject|0
7129935|NCT02754492|11274757|FG003|Overall Study|Withdrawal by Subject|0
7129936|NCT02754492|11274754|FG000|Overall Study|Equipment malfuntion|0
7129937|NCT02754492|11274755|FG001|Overall Study|Equipment malfuntion|0
7129938|NCT02754492|11274756|FG002|Overall Study|Equipment malfuntion|2
7129939|NCT02754492|11274757|FG003|Overall Study|Equipment malfuntion|5
7129940|NCT02754492|11274754|FG000|Overall Study|Adverse Event|0
7129941|NCT02754492|11274755|FG001|Overall Study|Adverse Event|0
7129942|NCT02754492|11274756|FG002|Overall Study|Adverse Event|0
7129943|NCT02754492|11274757|FG003|Overall Study|Adverse Event|13
7129944|NCT02754492|11274754|FG000|Overall Study|Venous access issues not resulting in AE|0
7129945|NCT02754492|11274755|FG001|Overall Study|Venous access issues not resulting in AE|0
7129946|NCT02754492|11274756|FG002|Overall Study|Venous access issues not resulting in AE|0
7129947|NCT02754492|11274757|FG003|Overall Study|Venous access issues not resulting in AE|4
7129948|NCT02755090|11274798|FG000|Overall Study|equipment malfunction|1
7129949|NCT02755090|11274799|FG001|Overall Study|equipment malfunction|0
7129950|NCT02755116|11274807|FG000|Overall Study|surgery converted to open, pt admitted|3
7129951|NCT02755116|11274808|FG001|Overall Study|surgery converted to open, pt admitted|1
7129952|NCT02755649|11274828|FG000|Overall Study|Transitioned into OLE study|99
7129953|NCT02755649|11274829|FG001|Overall Study|Transitioned into OLE study|98
7129954|NCT02755649|11274830|FG002|Overall Study|Transitioned into OLE study|100
7129955|NCT02755649|11274828|FG000|Overall Study|Did Not Complete Follow-up Visits|1
7129956|NCT02755649|11274829|FG001|Overall Study|Did Not Complete Follow-up Visits|0
7129957|NCT02755649|11274830|FG002|Overall Study|Did Not Complete Follow-up Visits|0
7129958|NCT02755649|11274828|FG000|Overall Study|Physician Decision|0
7129959|NCT02755649|11274829|FG001|Overall Study|Physician Decision|0
7129960|NCT02755649|11274830|FG002|Overall Study|Physician Decision|2
7129961|NCT02755649|11274828|FG000|Overall Study|Withdrawal by Subject|0
7129962|NCT02755649|11274829|FG001|Overall Study|Withdrawal by Subject|1
7129963|NCT02755649|11274830|FG002|Overall Study|Withdrawal by Subject|0
7129964|NCT02755649|11274828|FG000|Overall Study|Undecided|1
7129965|NCT02755649|11274829|FG001|Overall Study|Undecided|0
7129966|NCT02755649|11274830|FG002|Overall Study|Undecided|0
7129967|NCT02755805|11274840|FG000|Overall Study|Lost to Follow-up|1
7129968|NCT02755805|11274841|FG001|Overall Study|Lost to Follow-up|2
7129969|NCT02755805|11274840|FG000|Overall Study|Refused assessments|1
7129970|NCT02755805|11274841|FG001|Overall Study|Refused assessments|0
7129971|NCT02755805|11274840|FG000|Overall Study|Withdrawal by Subject|0
7129972|NCT02755805|11274841|FG001|Overall Study|Withdrawal by Subject|2
7129973|NCT02755818|11274851|FG000|Overall Study|Withdrawal by Subject|0
7129974|NCT02755818|11274852|FG001|Overall Study|Withdrawal by Subject|0
7129975|NCT02755818|11274853|FG002|Overall Study|Withdrawal by Subject|0
7129976|NCT02755818|11274854|FG003|Overall Study|Withdrawal by Subject|2
7129977|NCT02755818|11274851|FG000|Overall Study|withdrawal by PI|0
7129978|NCT02755818|11274852|FG001|Overall Study|withdrawal by PI|0
7129979|NCT02755818|11274853|FG002|Overall Study|withdrawal by PI|1
7129980|NCT02755818|11274854|FG003|Overall Study|withdrawal by PI|1
7129981|NCT02755831|11274868|FG000|Overall Study|Lost to Follow-up|3
7129982|NCT02755831|11274869|FG001|Overall Study|Lost to Follow-up|3
7129985|NCT02756078|11274883|FG000|Period 1|Unsatisfactory Lens Fitting|0
7129986|NCT02756078|11274884|FG001|Period 1|Unsatisfactory Lens Fitting|1
7129987|NCT02756078|11274883|FG000|Period 1|Lost to Follow-up|0
7129988|NCT02756078|11274884|FG001|Period 1|Lost to Follow-up|2
7129989|NCT02756078|11274883|FG000|Period 1|Protocol Violation|0
7129990|NCT02756078|11274884|FG001|Period 1|Protocol Violation|1
7129991|NCT02756078|11274883|FG000|Period 1|Adverse Event|1
7129992|NCT02756078|11274884|FG001|Period 1|Adverse Event|10
7129993|NCT02756078|11274883|FG000|Period 1|Withdrawal by Subject|6
7129994|NCT02756078|11274884|FG001|Period 1|Withdrawal by Subject|6
7129995|NCT02756078|11274883|FG000|Period 1|Lens Discomfort|2
7129996|NCT02756078|11274884|FG001|Period 1|Lens Discomfort|2
7129997|NCT02756078|11274883|FG000|Period 2|Adverse Event|3
7129998|NCT02756078|11274884|FG001|Period 2|Adverse Event|5
7129999|NCT02756078|11274883|FG000|Period 2|Unsatisfactory Lens Fitting|0
7130000|NCT02756078|11274884|FG001|Period 2|Unsatisfactory Lens Fitting|1
7130001|NCT02756078|11274883|FG000|Period 2|Withdrawal by Subject|3
7130002|NCT02756078|11274884|FG001|Period 2|Withdrawal by Subject|1
7130003|NCT02756182|11274890|FG000|Overall Study|StudyTechnical Difficulties|4
7130004|NCT02756338|11274896|FG000|Overall Study|Withdrawn by Investigator|1
7130005|NCT02756338|11274896|FG000|Overall Study|Device Replaced with Pacemaker|4
7130006|NCT02756364|11274912|FG000|Overall Study|Site Terminated by Sponsor|24
7130007|NCT02756364|11274913|FG001|Overall Study|Site Terminated by Sponsor|30
7130008|NCT02756364|11274914|FG002|Overall Study|Site Terminated by Sponsor|21
7130009|NCT02756364|11274912|FG000|Overall Study|Death|20
7130010|NCT02756364|11274913|FG001|Overall Study|Death|15
7130011|NCT02756364|11274914|FG002|Overall Study|Death|18
6806231|NCT02706847|10808781|FG002|Week 12 to Week 24|Lost to Follow-up|0
6806232|NCT02706847|10808782|FG003|Week 12 to Week 24|Lost to Follow-up|1
6806233|NCT02706847|10808779|FG000|Week 12 to Week 24|Other|1
6806234|NCT02706847|10808780|FG001|Week 12 to Week 24|Other|0
6806235|NCT02706847|10808781|FG002|Week 12 to Week 24|Other|1
6806236|NCT02706847|10808782|FG003|Week 12 to Week 24|Other|4
6806237|NCT02701777|10808796|FG000|Overall Study|Some subjects did not like the stimulation.|4
6806238|NCT02701777|10808797|FG001|Overall Study|Some subjects did not like the stimulation.|0
6806239|NCT02701777|10808798|FG002|Overall Study|Some subjects did not like the stimulation.|0
6806240|NCT02701777|10808799|FG003|Overall Study|Some subjects did not like the stimulation.|2
6806241|NCT02701777|10808796|FG000|Overall Study|Some subjects were unable to commit to the training study.|0
6806242|NCT02701777|10808797|FG001|Overall Study|Some subjects were unable to commit to the training study.|3
6806243|NCT02701777|10808798|FG002|Overall Study|Some subjects were unable to commit to the training study.|4
6806244|NCT02701777|10808799|FG003|Overall Study|Some subjects were unable to commit to the training study.|0
6810396|NCT03882047|10814144|FG000|Overall Study|Lost to Follow-up|0
6810397|NCT03882047|10814145|FG001|Overall Study|Lost to Follow-up|1
6810398|NCT03882047|10814146|FG002|Overall Study|Lost to Follow-up|0
6810399|NCT03882047|10814144|FG000|Overall Study|Did Not Wish to Continue|1
6810400|NCT03882047|10814145|FG001|Overall Study|Did Not Wish to Continue|4
6810401|NCT03882047|10814146|FG002|Overall Study|Did Not Wish to Continue|1
7130012|NCT02756364|11274912|FG000|Overall Study|Withdrawal by Patient|2
7130013|NCT02756364|11274913|FG001|Overall Study|Withdrawal by Patient|1
7130014|NCT02756364|11274914|FG002|Overall Study|Withdrawal by Patient|8
7130015|NCT02756364|11274912|FG000|Overall Study|Lost to Follow-up|0
7130016|NCT02756364|11274913|FG001|Overall Study|Lost to Follow-up|1
7130017|NCT02756364|11274914|FG002|Overall Study|Lost to Follow-up|1
7130018|NCT02756637|11274942|FG000|Overall Study|Not eligible for initial SWOG study|10
7130019|NCT02756637|11274943|FG001|Overall Study|Not eligible for initial SWOG study|10
7130020|NCT02756637|11274942|FG000|Overall Study|No available NLR value|44
7130021|NCT02756637|11274943|FG001|Overall Study|No available NLR value|44
7130022|NCT02756637|11274942|FG000|Overall Study|Did not complete curative therapy|33
7130023|NCT02756637|11274943|FG001|Overall Study|Did not complete curative therapy|0
7130024|NCT02756650|11274949|FG000|Overall Study|Physician Decision|1
7130025|NCT02756650|11274949|FG000|Overall Study|Adverse Event|1
7130026|NCT02756819|11274996|FG000|Overall Study|Lost for observation|23
7130027|NCT02756819|11274996|FG000|Overall Study|Patient's unwillingness|16
7130028|NCT02756819|11274996|FG000|Overall Study|Insufficient efficacy|2
7130029|NCT02756819|11274996|FG000|Overall Study|Adverse Event|2
7130030|NCT02756819|11274996|FG000|Overall Study|Reason not Specified|9
7130031|NCT02756832|11275000|FG000|Overall Study|Lost for Observation after Baseline|6
7130032|NCT02756832|11275000|FG000|Overall Study|Lost for Observation|13
7130033|NCT02756832|11275000|FG000|Overall Study|Patient's Unwillingness|12
7130034|NCT02756832|11275000|FG000|Overall Study|Insufficient Efficacy|2
7130035|NCT02756832|11275000|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1
7130036|NCT02756832|11275000|FG000|Overall Study|Reason not Specified|9
7130037|NCT02756832|11275000|FG000|Overall Study|Protocol Deviation|10
7130038|NCT02757352|11275114|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2
7130039|NCT02757352|11275115|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
7130040|NCT02757352|11275116|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1
7130041|NCT02757352|11275117|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
7130042|NCT02757352|11275118|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
7130043|NCT02757352|11275119|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
7130044|NCT02757352|11275120|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
7130045|NCT02757352|11275121|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
7130046|NCT02757352|11275122|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
7130047|NCT02757352|11275123|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
7130048|NCT02757352|11275114|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
7130049|NCT02757352|11275115|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
7130050|NCT02757352|11275116|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1
7130051|NCT02757352|11275117|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
7130052|NCT02757352|11275118|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
7130053|NCT02757352|11275119|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
7130054|NCT02757352|11275120|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
7130055|NCT02757352|11275121|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
7130056|NCT02757352|11275122|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
7130057|NCT02757352|11275123|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
7130058|NCT02757352|11275114|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6
7130059|NCT02757352|11275115|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1
7130060|NCT02757352|11275116|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2
7130061|NCT02757352|11275117|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
7130062|NCT02757352|11275118|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
7130063|NCT02757352|11275119|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
7130064|NCT02757352|11275120|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
7130065|NCT02757352|11275121|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
7130066|NCT02757352|11275122|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
7130067|NCT02757352|11275123|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
7130068|NCT02757352|11275114|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
7130069|NCT02757352|11275115|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1
7130070|NCT02757352|11275116|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
7130071|NCT02757352|11275117|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
7130072|NCT02757352|11275118|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
7130073|NCT02757352|11275119|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
7130074|NCT02757352|11275120|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
7130075|NCT02757352|11275121|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
7130076|NCT02757352|11275122|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
7130077|NCT02757352|11275123|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
7130078|NCT02757352|11275114|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
7130079|NCT02757352|11275115|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1
7130080|NCT02757352|11275116|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
7130081|NCT02757352|11275117|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
7130082|NCT02757352|11275118|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
7130083|NCT02757352|11275119|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
7130084|NCT02757352|11275120|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
7130085|NCT02757352|11275121|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
7130086|NCT02757352|11275122|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
7130087|NCT02757352|11275123|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
7130088|NCT02757352|11275114|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1
7130089|NCT02757352|11275115|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1
7130090|NCT02757352|11275116|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4
7130091|NCT02757352|11275117|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
7130092|NCT02757352|11275118|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
7130093|NCT02757352|11275119|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
7130094|NCT02757352|11275120|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
7130095|NCT02757352|11275121|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
7130096|NCT02757352|11275122|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
7130097|NCT02757352|11275123|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
7130098|NCT02757352|11275114|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62
7130099|NCT02757352|11275115|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40
7130100|NCT02757352|11275116|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42
7130101|NCT02757352|11275117|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
7130102|NCT02757352|11275118|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
7130103|NCT02757352|11275119|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
7130104|NCT02757352|11275120|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
7130105|NCT02757352|11275121|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
7130106|NCT02757352|11275122|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
7130107|NCT02757352|11275123|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
7130108|NCT02757352|11275114|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
7130109|NCT02757352|11275115|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
7130110|NCT02757352|11275116|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
7130111|NCT02757352|11275117|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3
7130112|NCT02757352|11275118|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
7130113|NCT02757352|11275119|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1
7130114|NCT02757352|11275120|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
7130115|NCT02757352|11275121|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
7130116|NCT02757352|11275122|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
7130117|NCT02757352|11275123|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
7130118|NCT02757352|11275114|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
7130119|NCT02757352|11275115|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
7130120|NCT02757352|11275116|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
7130121|NCT02757352|11275117|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2
7130122|NCT02757352|11275118|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1
7130123|NCT02757352|11275119|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4
7130124|NCT02757352|11275120|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
7130125|NCT02757352|11275121|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
7130126|NCT02757352|11275122|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
7130127|NCT02757352|11275123|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
7130128|NCT02757352|11275114|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
7130129|NCT02757352|11275115|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
7130130|NCT02757352|11275116|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
7130131|NCT02757352|11275117|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
7130132|NCT02757352|11275118|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1
7130133|NCT02757352|11275119|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
7130134|NCT02757352|11275120|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
7130135|NCT02757352|11275121|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
7130136|NCT02757352|11275122|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
7130137|NCT02757352|11275123|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
7130138|NCT02757352|11275114|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
7130139|NCT02757352|11275115|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
7130140|NCT02757352|11275116|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
7130141|NCT02757352|11275117|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
7130142|NCT02757352|11275118|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
7130143|NCT02757352|11275119|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1
7130144|NCT02757352|11275120|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
7130145|NCT02757352|11275121|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
7130146|NCT02757352|11275122|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
7130147|NCT02757352|11275123|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
7130148|NCT02757352|11275114|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
7130149|NCT02757352|11275115|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
7130150|NCT02757352|11275116|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
7130151|NCT02757352|11275117|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2
7130152|NCT02757352|11275118|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1
7130153|NCT02757352|11275119|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1
7130154|NCT02757352|11275120|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
7130155|NCT02757352|11275121|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
7130156|NCT02757352|11275122|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
7130157|NCT02757352|11275123|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
7130158|NCT02757352|11275114|FG000|Follow-Up Period|Adverse Event|0
7130159|NCT02757352|11275115|FG001|Follow-Up Period|Adverse Event|0
7130160|NCT02757352|11275116|FG002|Follow-Up Period|Adverse Event|0
7130161|NCT02757352|11275117|FG003|Follow-Up Period|Adverse Event|0
7130162|NCT02757352|11275118|FG004|Follow-Up Period|Adverse Event|0
7130163|NCT02757352|11275119|FG005|Follow-Up Period|Adverse Event|0
7130164|NCT02757352|11275120|FG006|Follow-Up Period|Adverse Event|1
7130165|NCT02757352|11275121|FG007|Follow-Up Period|Adverse Event|0
7130166|NCT02757352|11275122|FG008|Follow-Up Period|Adverse Event|2
7130167|NCT02757352|11275123|FG009|Follow-Up Period|Adverse Event|0
7130168|NCT02757352|11275114|FG000|Follow-Up Period|Lost to Follow-up|0
7130169|NCT02757352|11275115|FG001|Follow-Up Period|Lost to Follow-up|0
7130170|NCT02757352|11275116|FG002|Follow-Up Period|Lost to Follow-up|0
7130171|NCT02757352|11275117|FG003|Follow-Up Period|Lost to Follow-up|0
7130172|NCT02757352|11275118|FG004|Follow-Up Period|Lost to Follow-up|0
7130173|NCT02757352|11275119|FG005|Follow-Up Period|Lost to Follow-up|0
7130174|NCT02757352|11275120|FG006|Follow-Up Period|Lost to Follow-up|0
7130175|NCT02757352|11275121|FG007|Follow-Up Period|Lost to Follow-up|0
7130176|NCT02757352|11275122|FG008|Follow-Up Period|Lost to Follow-up|1
7130177|NCT02757352|11275123|FG009|Follow-Up Period|Lost to Follow-up|0
7130178|NCT02757352|11275114|FG000|Follow-Up Period|Lack of Efficacy|0
7130179|NCT02757352|11275115|FG001|Follow-Up Period|Lack of Efficacy|0
7130180|NCT02757352|11275116|FG002|Follow-Up Period|Lack of Efficacy|0
7130181|NCT02757352|11275117|FG003|Follow-Up Period|Lack of Efficacy|0
7130182|NCT02757352|11275118|FG004|Follow-Up Period|Lack of Efficacy|0
7130183|NCT02757352|11275119|FG005|Follow-Up Period|Lack of Efficacy|0
7130184|NCT02757352|11275120|FG006|Follow-Up Period|Lack of Efficacy|0
7130185|NCT02757352|11275121|FG007|Follow-Up Period|Lack of Efficacy|0
7130186|NCT02757352|11275122|FG008|Follow-Up Period|Lack of Efficacy|1
7130187|NCT02757352|11275123|FG009|Follow-Up Period|Lack of Efficacy|1
7130188|NCT02757352|11275114|FG000|Follow-Up Period|Withdrawal by Subject|0
7130189|NCT02757352|11275115|FG001|Follow-Up Period|Withdrawal by Subject|0
7130190|NCT02757352|11275116|FG002|Follow-Up Period|Withdrawal by Subject|0
7130191|NCT02757352|11275117|FG003|Follow-Up Period|Withdrawal by Subject|0
7130192|NCT02757352|11275118|FG004|Follow-Up Period|Withdrawal by Subject|0
7130193|NCT02757352|11275119|FG005|Follow-Up Period|Withdrawal by Subject|0
7130194|NCT02757352|11275120|FG006|Follow-Up Period|Withdrawal by Subject|0
7130195|NCT02757352|11275121|FG007|Follow-Up Period|Withdrawal by Subject|1
7130196|NCT02757352|11275122|FG008|Follow-Up Period|Withdrawal by Subject|6
7130197|NCT02757352|11275123|FG009|Follow-Up Period|Withdrawal by Subject|2
7130198|NCT02757430|11275154|FG000|Overall Study|Physician Decision|6
7130199|NCT02757430|11275154|FG000|Overall Study|Inclusion/Exclusion criteria not met|3
7130200|NCT02757430|11275154|FG000|Overall Study|No informed consent|1
7130201|NCT02757430|11275154|FG000|Overall Study|No procedure performed|2
7130202|NCT02757625|11275171|FG000|Overall Study|Investigator's discretion|0
7130203|NCT02757625|11275172|FG001|Overall Study|Investigator's discretion|0
7130204|NCT02757625|11275173|FG002|Overall Study|Investigator's discretion|1
7130205|NCT02757625|11275174|FG003|Overall Study|Investigator's discretion|0
7130206|NCT02757625|11275171|FG000|Overall Study|Adverse Event|0
7130207|NCT02757625|11275172|FG001|Overall Study|Adverse Event|0
7130208|NCT02757625|11275173|FG002|Overall Study|Adverse Event|1
7130209|NCT02757625|11275174|FG003|Overall Study|Adverse Event|0
7130210|NCT02757768|11275188|FG000|Overall Study|Randomized Never Received Study Drug|3
7130211|NCT02757768|11275189|FG001|Overall Study|Randomized Never Received Study Drug|4
7130212|NCT02757768|11275188|FG000|Overall Study|Adverse Event|5
7130213|NCT02757768|11275189|FG001|Overall Study|Adverse Event|3
7130214|NCT02757768|11275188|FG000|Overall Study|Lack of Efficacy|2
7130215|NCT02757768|11275189|FG001|Overall Study|Lack of Efficacy|1
7130216|NCT02757768|11275188|FG000|Overall Study|Lost to Follow-up|1
7130217|NCT02757768|11275189|FG001|Overall Study|Lost to Follow-up|0
7130218|NCT02757768|11275188|FG000|Overall Study|Protocol Deviation|2
7130219|NCT02757768|11275189|FG001|Overall Study|Protocol Deviation|9
7130220|NCT02757768|11275188|FG000|Overall Study|Withdrawal by Subject|16
7130221|NCT02757768|11275189|FG001|Overall Study|Withdrawal by Subject|9
7130222|NCT02757768|11275188|FG000|Overall Study|Miscellaneous|4
7130223|NCT02757768|11275189|FG001|Overall Study|Miscellaneous|2
7130224|NCT02757963|11275207|FG000|Overall Study|Adverse Event|3
7130225|NCT02757963|11275207|FG000|Overall Study|Reached Stopping Criteria|1054
7130226|NCT02757963|11275207|FG000|Overall Study|Lost to Follow-up|5
7130227|NCT02757963|11275207|FG000|Overall Study|Physician Decision|1
7130228|NCT02757963|11275207|FG000|Overall Study|Withdrawal by Subject|34
7130229|NCT02758171|11275235|FG000|Wash-out|Withdrawal by Subject|1
7130230|NCT02758171|11275236|FG001|Wash-out|Withdrawal by Subject|0
7130231|NCT02758171|11275235|FG000|Wash-out|Other reason|1
7130232|NCT02758171|11275236|FG001|Wash-out|Other reason|0
7130233|NCT02758301|11275248|FG000|Overall Study|Death|12
7130234|NCT02758301|11275249|FG001|Overall Study|Death|0
7130235|NCT02758301|11275248|FG000|Overall Study|Physician Decision|10
7130236|NCT02758301|11275249|FG001|Overall Study|Physician Decision|1
7130237|NCT02758301|11275248|FG000|Overall Study|Withdrawal by Subject|5
7130238|NCT02758301|11275249|FG001|Overall Study|Withdrawal by Subject|6
7130239|NCT02758301|11275248|FG000|Overall Study|Lost to Follow-up|7
7130240|NCT02758301|11275249|FG001|Overall Study|Lost to Follow-up|0
7130241|NCT02758301|11275248|FG000|Overall Study|Protocol Violation|0
7130242|NCT02758301|11275249|FG001|Overall Study|Protocol Violation|1
7130243|NCT02758613|11275259|FG000|Treatment|Physician and Sponsor Decision|1
7130244|NCT02758613|11275260|FG001|Treatment|Physician and Sponsor Decision|0
7130245|NCT02758613|11275261|FG002|Treatment|Physician and Sponsor Decision|0
7130246|NCT02758613|11275262|FG003|Treatment|Physician and Sponsor Decision|0
7130247|NCT02758613|11275259|FG000|Treatment|Withdrawal by Subject|1
7130248|NCT02758613|11275260|FG001|Treatment|Withdrawal by Subject|0
7130249|NCT02758613|11275261|FG002|Treatment|Withdrawal by Subject|1
7130250|NCT02758613|11275262|FG003|Treatment|Withdrawal by Subject|0
7130251|NCT02759016|11275286|FG000|Overall Study|Not treated with BI 836826|1
7130252|NCT02759016|11275287|FG001|Overall Study|Not treated with BI 836826|0
7130253|NCT02759016|11275286|FG000|Overall Study|Progressive disease|1
7130254|NCT02759016|11275287|FG001|Overall Study|Progressive disease|0
7130255|NCT02759016|11275286|FG000|Overall Study|SD, PR-MRDpos or PR-L|0
7130256|NCT02759016|11275287|FG001|Overall Study|SD, PR-MRDpos or PR-L|2
7130257|NCT02759016|11275286|FG000|Overall Study|Other not defined above|2
7130258|NCT02759016|11275287|FG001|Overall Study|Other not defined above|1
7130259|NCT02759055|11275296|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927
7130260|NCT02759055|11275297|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508
7130261|NCT02759120|11275305|FG000|Overall Study|Death|34
7130262|NCT02759120|11275306|FG001|Overall Study|Death|36
7130263|NCT02759120|11275305|FG000|Overall Study|Lost to Follow-up|4
7130264|NCT02759120|11275306|FG001|Overall Study|Lost to Follow-up|7
7130265|NCT02759120|11275305|FG000|Overall Study|Physician Decision|3
7130266|NCT02759120|11275306|FG001|Overall Study|Physician Decision|0
7130267|NCT02759120|11275305|FG000|Overall Study|Withdrawal by Subject|28
7130268|NCT02759120|11275306|FG001|Overall Study|Withdrawal by Subject|15
7130269|NCT02759120|11275305|FG000|Overall Study|Moved out of area|3
7130270|NCT02759120|11275306|FG001|Overall Study|Moved out of area|4
7130271|NCT02759120|11275305|FG000|Overall Study|Lung transplant|3
7130272|NCT02759120|11275306|FG001|Overall Study|Lung transplant|5
7130273|NCT02759120|11275305|FG000|Overall Study|Other reason not completed|10
7130274|NCT02759120|11275306|FG001|Overall Study|Other reason not completed|12
7130275|NCT02759315|11275345|FG000|Overall Study|Adverse Event|0
7130276|NCT02759315|11275346|FG001|Overall Study|Adverse Event|0
7130277|NCT02759315|11275347|FG002|Overall Study|Adverse Event|0
7130278|NCT02759315|11275348|FG003|Overall Study|Adverse Event|1
7130279|NCT02759315|11275349|FG004|Overall Study|Adverse Event|0
7130280|NCT02759315|11275345|FG000|Overall Study|Death|0
7130281|NCT02759315|11275346|FG001|Overall Study|Death|0
7130282|NCT02759315|11275347|FG002|Overall Study|Death|1
7130283|NCT02759315|11275348|FG003|Overall Study|Death|0
7130284|NCT02759315|11275349|FG004|Overall Study|Death|0
7130285|NCT02759315|11275345|FG000|Overall Study|Lost to Follow-up|2
7130286|NCT02759315|11275346|FG001|Overall Study|Lost to Follow-up|0
7130287|NCT02759315|11275347|FG002|Overall Study|Lost to Follow-up|4
7130288|NCT02759315|11275348|FG003|Overall Study|Lost to Follow-up|0
7130289|NCT02759315|11275349|FG004|Overall Study|Lost to Follow-up|0
7130290|NCT02759315|11275345|FG000|Overall Study|Protocol Violation|0
7130291|NCT02759315|11275346|FG001|Overall Study|Protocol Violation|1
7130292|NCT02759315|11275347|FG002|Overall Study|Protocol Violation|0
7130293|NCT02759315|11275348|FG003|Overall Study|Protocol Violation|0
7130294|NCT02759315|11275349|FG004|Overall Study|Protocol Violation|0
7130295|NCT02759315|11275345|FG000|Overall Study|Study terminated prior to completion|2
7130296|NCT02759315|11275346|FG001|Overall Study|Study terminated prior to completion|0
7130297|NCT02759315|11275347|FG002|Overall Study|Study terminated prior to completion|5
7130298|NCT02759315|11275348|FG003|Overall Study|Study terminated prior to completion|0
7130299|NCT02759315|11275349|FG004|Overall Study|Study terminated prior to completion|1
7130300|NCT02759471|11275382|FG000|Overall Study|discomfort|2
7130301|NCT02759562|11275390|FG000|Open-Label Treatment Period|Withdrew Consent|1
7130302|NCT02759562|11275391|FG001|Open-Label Treatment Period|Withdrew Consent|0
7130303|NCT02759562|11275390|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1
7130304|NCT02759562|11275391|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2
7130305|NCT02759692|11275402|FG000|Period 1|Test article no longer available|1
7130306|NCT02759692|11275403|FG001|Period 1|Test article no longer available|1
7130307|NCT02759692|11275402|FG000|Period 1|No longer meets eligibility criteria.|1
7130308|NCT02759692|11275403|FG001|Period 1|No longer meets eligibility criteria.|0
7130309|NCT02759692|11275402|FG000|Period 1|Miss-Randomized|1
7130310|NCT02759692|11275403|FG001|Period 1|Miss-Randomized|1
7130311|NCT02759692|11275402|FG000|Period 2|Lost to Follow-up|1
7130312|NCT02759692|11275403|FG001|Period 2|Lost to Follow-up|0
7130313|NCT02759692|11275402|FG000|Period 2|Test article no longer available|0
7130314|NCT02759692|11275403|FG001|Period 2|Test article no longer available|1
7130315|NCT02759939|11275413|FG000|Overall Study|Missing data on first outcome assessed|11
7130316|NCT02759939|11275414|FG001|Overall Study|Missing data on first outcome assessed|2
7130317|NCT02759939|11275415|FG002|Overall Study|Missing data on first outcome assessed|5
7130318|NCT02759939|11275416|FG003|Overall Study|Missing data on first outcome assessed|2
7130319|NCT02759939|11275413|FG000|Overall Study|Ineligible for T2 and T3|310
7130320|NCT02759939|11275414|FG001|Overall Study|Ineligible for T2 and T3|179
7130321|NCT02759939|11275415|FG002|Overall Study|Ineligible for T2 and T3|366
7130322|NCT02759939|11275416|FG003|Overall Study|Ineligible for T2 and T3|391
7130323|NCT02759939|11275413|FG000|Overall Study|Lost to Follow-up|735
7130324|NCT02759939|11275414|FG001|Overall Study|Lost to Follow-up|791
7130325|NCT02759939|11275415|FG002|Overall Study|Lost to Follow-up|783
7130326|NCT02759939|11275416|FG003|Overall Study|Lost to Follow-up|650
7130327|NCT02760069|11275439|FG000|Overall Study|Withdrawal by Subject|0
7130328|NCT02760069|11275440|FG001|Overall Study|Withdrawal by Subject|1
7130329|NCT02760069|11275441|FG002|Overall Study|Withdrawal by Subject|1
7130330|NCT02760368|11275487|FG000|Overall Study|Withdrawal by Subject|12
7130331|NCT02760368|11275488|FG001|Overall Study|Withdrawal by Subject|8
7130332|NCT02760368|11275489|FG002|Overall Study|Withdrawal by Subject|9
7130333|NCT02760368|11275487|FG000|Overall Study|Screen Failure|0
7130334|NCT02760368|11275488|FG001|Overall Study|Screen Failure|0
7130335|NCT02760368|11275489|FG002|Overall Study|Screen Failure|1
7130336|NCT02760368|11275487|FG000|Overall Study|Death|1
7130337|NCT02760368|11275488|FG001|Overall Study|Death|0
7130338|NCT02760368|11275489|FG002|Overall Study|Death|0
7130339|NCT02760368|11275487|FG000|Overall Study|Withdrawal by Sponsor|0
7130340|NCT02760368|11275488|FG001|Overall Study|Withdrawal by Sponsor|0
7130341|NCT02760368|11275489|FG002|Overall Study|Withdrawal by Sponsor|1
7130342|NCT02760407|11275501|FG000|Overall Study|Death|2
7130343|NCT02760407|11275502|FG001|Overall Study|Death|3
7130344|NCT02760407|11275503|FG002|Overall Study|Death|1
7130345|NCT02760407|11275504|FG003|Overall Study|Death|1
7130346|NCT02760407|11275501|FG000|Overall Study|Lost to Follow-up|1
7130347|NCT02760407|11275502|FG001|Overall Study|Lost to Follow-up|7
7130348|NCT02760407|11275503|FG002|Overall Study|Lost to Follow-up|4
7130349|NCT02760407|11275504|FG003|Overall Study|Lost to Follow-up|6
7130350|NCT02760407|11275501|FG000|Overall Study|Withdrawal by Subject|25
7130351|NCT02760407|11275502|FG001|Overall Study|Withdrawal by Subject|31
7130352|NCT02760407|11275503|FG002|Overall Study|Withdrawal by Subject|37
7130353|NCT02760407|11275504|FG003|Overall Study|Withdrawal by Subject|25
7130354|NCT02760407|11275501|FG000|Overall Study|Violation of Eligibility criteria|0
7130355|NCT02760407|11275502|FG001|Overall Study|Violation of Eligibility criteria|0
7130356|NCT02760407|11275503|FG002|Overall Study|Violation of Eligibility criteria|1
7130357|NCT02760407|11275504|FG003|Overall Study|Violation of Eligibility criteria|1
7130358|NCT02760407|11275501|FG000|Overall Study|Personal reasons|0
7130359|NCT02760407|11275502|FG001|Overall Study|Personal reasons|0
7130360|NCT02760407|11275503|FG002|Overall Study|Personal reasons|0
7130361|NCT02760407|11275504|FG003|Overall Study|Personal reasons|1
7130362|NCT02760407|11275501|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1
7130363|NCT02760407|11275502|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0
7130364|NCT02760407|11275503|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0
7130365|NCT02760407|11275504|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0
7130366|NCT02760407|11275501|FG000|Overall Study|Use of prohibited Medication|0
7130367|NCT02760407|11275502|FG001|Overall Study|Use of prohibited Medication|0
7130368|NCT02760407|11275503|FG002|Overall Study|Use of prohibited Medication|1
7130369|NCT02760407|11275504|FG003|Overall Study|Use of prohibited Medication|0
7130370|NCT02760407|11275501|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0
7130371|NCT02760407|11275502|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0
7130372|NCT02760407|11275503|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1
7130373|NCT02760407|11275504|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0
7130374|NCT02760407|11275501|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1
7130375|NCT02760407|11275502|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0
7130376|NCT02760407|11275503|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0
7130377|NCT02760407|11275504|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0
7130378|NCT02760407|11275501|FG000|Overall Study|Investigator's Decision (Adverse Event)|0
7130379|NCT02760407|11275502|FG001|Overall Study|Investigator's Decision (Adverse Event)|1
7130380|NCT02760407|11275503|FG002|Overall Study|Investigator's Decision (Adverse Event)|0
7130381|NCT02760407|11275504|FG003|Overall Study|Investigator's Decision (Adverse Event)|0
7130382|NCT02760407|11275501|FG000|Overall Study|Inadequately Enrolled|0
7130383|NCT02760407|11275502|FG001|Overall Study|Inadequately Enrolled|0
7130384|NCT02760407|11275503|FG002|Overall Study|Inadequately Enrolled|0
7130385|NCT02760407|11275504|FG003|Overall Study|Inadequately Enrolled|1
7130386|NCT02760407|11275501|FG000|Overall Study|Withdrawal By PI's Decision|0
7130387|NCT02760407|11275502|FG001|Overall Study|Withdrawal By PI's Decision|1
7130388|NCT02760407|11275503|FG002|Overall Study|Withdrawal By PI's Decision|0
7130389|NCT02760407|11275504|FG003|Overall Study|Withdrawal By PI's Decision|0
7130390|NCT02760407|11275501|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1
7130391|NCT02760407|11275502|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0
7130392|NCT02760407|11275503|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1
7130393|NCT02760407|11275504|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0
7130394|NCT02760407|11275501|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0
7130395|NCT02760407|11275502|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0
7130396|NCT02760407|11275503|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1
7130397|NCT02760407|11275504|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0
7130398|NCT02760407|11275501|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1
7130399|NCT02760407|11275502|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0
7130400|NCT02760407|11275503|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0
7130401|NCT02760407|11275504|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0
7130402|NCT02760407|11275501|FG000|Overall Study|Study Treatment Was Terminated At The Site|0
7130403|NCT02760407|11275502|FG001|Overall Study|Study Treatment Was Terminated At The Site|0
7130404|NCT02760407|11275503|FG002|Overall Study|Study Treatment Was Terminated At The Site|1
7130405|NCT02760407|11275504|FG003|Overall Study|Study Treatment Was Terminated At The Site|0
7130406|NCT02760407|11275501|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1
7130407|NCT02760407|11275502|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0
7130408|NCT02760407|11275503|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0
7130409|NCT02760407|11275504|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0
7130410|NCT02760407|11275501|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1
7130411|NCT02760407|11275502|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0
7130412|NCT02760407|11275503|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0
7130413|NCT02760407|11275504|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0
7130414|NCT02760407|11275501|FG000|Overall Study|Lack Of Efficacy Per PI|0
7130415|NCT02760407|11275502|FG001|Overall Study|Lack Of Efficacy Per PI|0
7130416|NCT02760407|11275503|FG002|Overall Study|Lack Of Efficacy Per PI|0
7130417|NCT02760407|11275504|FG003|Overall Study|Lack Of Efficacy Per PI|1
7130418|NCT02760407|11275501|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1
7130419|NCT02760407|11275502|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0
7130420|NCT02760407|11275503|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0
7130421|NCT02760407|11275504|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0
7130422|NCT02760407|11275501|FG000|Overall Study|Investigator recorded as Adverse Event|1
7130423|NCT02760407|11275502|FG001|Overall Study|Investigator recorded as Adverse Event|0
7130424|NCT02760407|11275503|FG002|Overall Study|Investigator recorded as Adverse Event|2
7130425|NCT02760407|11275504|FG003|Overall Study|Investigator recorded as Adverse Event|0
7130426|NCT02760433|11275520|FG000|Overall Study|Lost to Follow-up|1
7130427|NCT02760433|11275521|FG001|Overall Study|Lost to Follow-up|0
7130428|NCT02760433|11275522|FG002|Overall Study|Lost to Follow-up|1
7130429|NCT02760433|11275523|FG003|Overall Study|Lost to Follow-up|0
7130430|NCT02760433|11275524|FG004|Overall Study|Lost to Follow-up|0
7130431|NCT02760433|11275520|FG000|Overall Study|Withdrawal by Subject|23
7130432|NCT02760433|11275521|FG001|Overall Study|Withdrawal by Subject|9
7130433|NCT02760433|11275522|FG002|Overall Study|Withdrawal by Subject|0
7130434|NCT02760433|11275523|FG003|Overall Study|Withdrawal by Subject|2
7130435|NCT02760433|11275524|FG004|Overall Study|Withdrawal by Subject|9
7130436|NCT02760433|11275520|FG000|Overall Study|Lack of Response At Week 14|0
7130437|NCT02760433|11275521|FG001|Overall Study|Lack of Response At Week 14|0
7130438|NCT02760433|11275522|FG002|Overall Study|Lack of Response At Week 14|0
7130439|NCT02760433|11275523|FG003|Overall Study|Lack of Response At Week 14|0
7130440|NCT02760433|11275524|FG004|Overall Study|Lack of Response At Week 14|1
7130441|NCT02760433|11275520|FG000|Overall Study|Subject refused to continue the study|1
7130442|NCT02760433|11275521|FG001|Overall Study|Subject refused to continue the study|0
7130443|NCT02760433|11275522|FG002|Overall Study|Subject refused to continue the study|0
7130444|NCT02760433|11275523|FG003|Overall Study|Subject refused to continue the study|0
7130445|NCT02760433|11275524|FG004|Overall Study|Subject refused to continue the study|0
7130446|NCT02760433|11275520|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2
7130447|NCT02760433|11275521|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0
7130448|NCT02760433|11275522|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0
7130449|NCT02760433|11275523|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0
7130450|NCT02760433|11275524|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0
7130451|NCT02760433|11275520|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0
7130452|NCT02760433|11275521|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1
7130453|NCT02760433|11275522|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0
7130454|NCT02760433|11275523|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0
7130455|NCT02760433|11275524|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0
7130456|NCT02760654|11275543|FG000|Overall Study|Lost to Follow-up|3
7130457|NCT02760654|11275544|FG001|Overall Study|Lost to Follow-up|3
7130458|NCT02760654|11275543|FG000|Overall Study|Withdrawal by Subject|4
7130459|NCT02760654|11275544|FG001|Overall Study|Withdrawal by Subject|3
7130460|NCT02760810|11275550|FG000|Overall Study|Protocol Violation|1
7130461|NCT02760927|11275563|FG000|Overall Study|Tube Slippage from Device|1
7130462|NCT02761330|11275582|FG000|Treatment Week 1|Withdrawal by Subject|0
7130463|NCT02761330|11275583|FG001|Treatment Week 1|Withdrawal by Subject|0
7130464|NCT02761330|11275584|FG002|Treatment Week 1|Withdrawal by Subject|0
7130465|NCT02761330|11275585|FG003|Treatment Week 1|Withdrawal by Subject|1
7130466|NCT02761330|11275586|FG004|Treatment Week 1|Withdrawal by Subject|0
7130467|NCT02761330|11275587|FG005|Treatment Week 1|Withdrawal by Subject|1
7130468|NCT02761629|11275603|FG000|Overall Study|Adverse Event/Intercurrent Illness|7
7130469|NCT02761629|11275604|FG001|Overall Study|Adverse Event/Intercurrent Illness|5
7130470|NCT02761629|11275603|FG000|Overall Study|Insufficient Therapeutic Response|2
7130471|NCT02761629|11275604|FG001|Overall Study|Insufficient Therapeutic Response|7
7130472|NCT02761629|11275603|FG000|Overall Study|Failure to Return|2
7130473|NCT02761629|11275604|FG001|Overall Study|Failure to Return|4
7130474|NCT02761629|11275603|FG000|Overall Study|Did not Cooperate/Refused Treatment|2
7130475|NCT02761629|11275604|FG001|Overall Study|Did not Cooperate/Refused Treatment|4
7130476|NCT02761629|11275603|FG000|Overall Study|Protocol Violation|2
7130477|NCT02761629|11275604|FG001|Overall Study|Protocol Violation|2
7130478|NCT02761629|11275603|FG000|Overall Study|Withdrawal by Subject|0
7130479|NCT02761629|11275604|FG001|Overall Study|Withdrawal by Subject|3
7130480|NCT02761629|11275603|FG000|Overall Study|Other|0
7130481|NCT02761629|11275604|FG001|Overall Study|Other|2
7130482|NCT02761629|11275603|FG000|Overall Study|Lost to Follow-up|4
7130483|NCT02761629|11275604|FG001|Overall Study|Lost to Follow-up|1
7130484|NCT02761629|11275603|FG000|Overall Study|Randomized But Not Treated|8
7130485|NCT02761629|11275604|FG001|Overall Study|Randomized But Not Treated|4
7130486|NCT02761642|11275610|FG000|Overall Study|Did not Receive Study Treatment|3
7130487|NCT02761642|11275610|FG000|Overall Study|Adverse Event|13
7130488|NCT02761642|11275610|FG000|Overall Study|Withdrawal by Subject|2
7130489|NCT02761642|11275610|FG000|Overall Study|Non-compliant|7
7130490|NCT02761642|11275610|FG000|Overall Study|Death|3
7130491|NCT02761642|11275610|FG000|Overall Study|Lack of Efficacy|20
7130492|NCT02761642|11275610|FG000|Overall Study|Physician Decision|1
7130493|NCT02761642|11275610|FG000|Overall Study|Reason Unspecified|21
7130494|NCT02761733|11275618|FG000|Overall Study|Death|3
7130495|NCT02761733|11275619|FG001|Overall Study|Death|5
7130496|NCT02761733|11275620|FG002|Overall Study|Death|1
7130497|NCT02761733|11275621|FG003|Overall Study|Death|1
7130498|NCT02761733|11275618|FG000|Overall Study|Lost to Follow-up|6
7130499|NCT02761733|11275619|FG001|Overall Study|Lost to Follow-up|7
7130500|NCT02761733|11275620|FG002|Overall Study|Lost to Follow-up|0
7130501|NCT02761733|11275621|FG003|Overall Study|Lost to Follow-up|3
7130502|NCT02761733|11275618|FG000|Overall Study|Physician Decision|4
7130503|NCT02761733|11275619|FG001|Overall Study|Physician Decision|0
7130504|NCT02761733|11275620|FG002|Overall Study|Physician Decision|0
7130505|NCT02761733|11275621|FG003|Overall Study|Physician Decision|0
7130506|NCT02761733|11275618|FG000|Overall Study|Withdrawal by Subject|2
7130507|NCT02761733|11275619|FG001|Overall Study|Withdrawal by Subject|0
7130508|NCT02761733|11275620|FG002|Overall Study|Withdrawal by Subject|0
7130509|NCT02761733|11275621|FG003|Overall Study|Withdrawal by Subject|0
7130510|NCT02761733|11275618|FG000|Overall Study|Discharged from Study Site|10
7130511|NCT02761733|11275619|FG001|Overall Study|Discharged from Study Site|9
7130512|NCT02761733|11275620|FG002|Overall Study|Discharged from Study Site|25
7130513|NCT02761733|11275621|FG003|Overall Study|Discharged from Study Site|11
7130514|NCT02761733|11275618|FG000|Overall Study|Cognitive Impairment|5
7130515|NCT02761733|11275619|FG001|Overall Study|Cognitive Impairment|0
7130516|NCT02761733|11275620|FG002|Overall Study|Cognitive Impairment|1
7130517|NCT02761733|11275621|FG003|Overall Study|Cognitive Impairment|0
7130518|NCT02761915|11275637|FG000|Overall Study|Death|3
7130519|NCT02761915|11275638|FG001|Overall Study|Death|1
7130520|NCT02761915|11275639|FG002|Overall Study|Death|1
7130521|NCT02761915|11275640|FG003|Overall Study|Death|1
7130522|NCT02761915|11275641|FG004|Overall Study|Death|0
7130523|NCT02761915|11275642|FG005|Overall Study|Death|1
7130524|NCT02761915|11275637|FG000|Overall Study|Withdrawal by Subject|1
7130525|NCT02761915|11275638|FG001|Overall Study|Withdrawal by Subject|0
7130526|NCT02761915|11275639|FG002|Overall Study|Withdrawal by Subject|0
7130527|NCT02761915|11275640|FG003|Overall Study|Withdrawal by Subject|0
7130528|NCT02761915|11275641|FG004|Overall Study|Withdrawal by Subject|1
7130529|NCT02761915|11275642|FG005|Overall Study|Withdrawal by Subject|2
7130530|NCT02761915|11275637|FG000|Overall Study|Disease Progression|0
7130531|NCT02761915|11275638|FG001|Overall Study|Disease Progression|0
7130532|NCT02761915|11275639|FG002|Overall Study|Disease Progression|0
7130533|NCT02761915|11275640|FG003|Overall Study|Disease Progression|2
7130534|NCT02761915|11275641|FG004|Overall Study|Disease Progression|2
7130535|NCT02761915|11275642|FG005|Overall Study|Disease Progression|2
7130536|NCT02761980|11275676|FG000|Overall Study|Adverse Event|4
7130537|NCT02761980|11275677|FG001|Overall Study|Adverse Event|6
7130538|NCT02761980|11275678|FG002|Overall Study|Adverse Event|5
7130539|NCT02761980|11275679|FG003|Overall Study|Adverse Event|6
7130540|NCT02761980|11275676|FG000|Overall Study|Withdrawal by Subject|0
7130541|NCT02761980|11275677|FG001|Overall Study|Withdrawal by Subject|1
7130542|NCT02761980|11275678|FG002|Overall Study|Withdrawal by Subject|0
7130543|NCT02761980|11275679|FG003|Overall Study|Withdrawal by Subject|0
7130544|NCT02761980|11275676|FG000|Overall Study|Other|0
7130545|NCT02761980|11275677|FG001|Overall Study|Other|0
7130546|NCT02761980|11275678|FG002|Overall Study|Other|1
7130547|NCT02761980|11275679|FG003|Overall Study|Other|0
7130548|NCT02761993|11275692|FG000|Overall Study|Adverse Event|0
7130549|NCT02761993|11275693|FG001|Overall Study|Adverse Event|2
7130550|NCT02761993|11275694|FG002|Overall Study|Adverse Event|0
7130551|NCT02761993|11275692|FG000|Overall Study|Lost to Follow-up|1
7130552|NCT02761993|11275693|FG001|Overall Study|Lost to Follow-up|3
7130553|NCT02761993|11275694|FG002|Overall Study|Lost to Follow-up|2
7130554|NCT02761993|11275692|FG000|Overall Study|Withdrawal by Subject|1
7130555|NCT02761993|11275693|FG001|Overall Study|Withdrawal by Subject|1
7130556|NCT02761993|11275694|FG002|Overall Study|Withdrawal by Subject|2
7130557|NCT02762084|11275715|FG000|Overall Study|Withdrawal by Subject|1
7130558|NCT02762084|11275716|FG001|Overall Study|Withdrawal by Subject|0
7130559|NCT02762084|11275717|FG002|Overall Study|Withdrawal by Subject|0
7130560|NCT02762084|11275715|FG000|Overall Study|Adverse Event|0
7130561|NCT02762084|11275716|FG001|Overall Study|Adverse Event|0
7130562|NCT02762084|11275717|FG002|Overall Study|Adverse Event|1
7130563|NCT02762370|11275738|FG000|Overall Study|Protocol Violation|1
7130564|NCT02762370|11275739|FG001|Overall Study|Protocol Violation|0
7130565|NCT02762500|11275749|FG000|Overall Study|Lack of Efficacy|1
7130566|NCT02762500|11275750|FG001|Overall Study|Lack of Efficacy|0
7130567|NCT02762500|11275749|FG000|Overall Study|Withdrawal by Subject|1
7130568|NCT02762500|11275750|FG001|Overall Study|Withdrawal by Subject|1
7130569|NCT02762500|11275749|FG000|Overall Study|Adverse Event|0
7130570|NCT02762500|11275750|FG001|Overall Study|Adverse Event|2
7130571|NCT02762565|11275760|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11
7130572|NCT02762578|11275766|FG000|Overall Study|Adverse Event|1
7130573|NCT02762578|11275767|FG001|Overall Study|Adverse Event|6
7130574|NCT02762578|11275766|FG000|Overall Study|Protocol Violation|4
7130575|NCT02762578|11275767|FG001|Overall Study|Protocol Violation|2
7130576|NCT02762578|11275766|FG000|Overall Study|Withdrawal by Subject|4
7130577|NCT02762578|11275767|FG001|Overall Study|Withdrawal by Subject|2
7130578|NCT02762578|11275766|FG000|Overall Study|Unclassified|6
7130579|NCT02762578|11275767|FG001|Overall Study|Unclassified|0
7130580|NCT02762994|11275806|FG000|Overall Study|Withdrawal by Subject|0
7130581|NCT02762994|11275807|FG001|Overall Study|Withdrawal by Subject|1
7130582|NCT02762994|11275808|FG002|Overall Study|Withdrawal by Subject|2
7130583|NCT02762994|11275809|FG003|Overall Study|Withdrawal by Subject|0
7130584|NCT02762994|11275806|FG000|Overall Study|Protocol Violation|1
7130585|NCT02762994|11275807|FG001|Overall Study|Protocol Violation|0
7130586|NCT02762994|11275808|FG002|Overall Study|Protocol Violation|0
7130587|NCT02762994|11275809|FG003|Overall Study|Protocol Violation|2
7130588|NCT02763046|11275826|FG000|Overall Study|Adverse Event|5
7130589|NCT02763046|11275827|FG001|Overall Study|Adverse Event|4
7130590|NCT02763046|11275828|FG002|Overall Study|Adverse Event|0
7130591|NCT02763046|11275826|FG000|Overall Study|Lack of Efficacy|1
7130592|NCT02763046|11275827|FG001|Overall Study|Lack of Efficacy|1
7130593|NCT02763046|11275828|FG002|Overall Study|Lack of Efficacy|3
7130594|NCT02763046|11275826|FG000|Overall Study|Physician Decision|1
7130595|NCT02763046|11275827|FG001|Overall Study|Physician Decision|0
7130596|NCT02763046|11275828|FG002|Overall Study|Physician Decision|1
7130597|NCT02763046|11275826|FG000|Overall Study|Subject/guardian decision|2
7130598|NCT02763046|11275827|FG001|Overall Study|Subject/guardian decision|0
7130599|NCT02763046|11275828|FG002|Overall Study|Subject/guardian decision|4
7130600|NCT02763215|11275846|FG000|Overall Study|Participants withdrew from study|3
7130601|NCT02763215|11275846|FG000|Overall Study|Missed visit|1
7130602|NCT02763215|11275846|FG000|Overall Study|Visit outside visit-window|1
7130603|NCT02763215|11275846|FG000|Overall Study|Death|1
7130604|NCT02763215|11275846|FG000|Overall Study|Lost to Follow-up|1
7130605|NCT02763254|11275850|FG000|Overall Study|Adverse Event|1
7130606|NCT02763566|11275858|FG000|Overall Study|Lost to Follow-up|1
7130607|NCT02763566|11275859|FG001|Overall Study|Lost to Follow-up|4
7130608|NCT02763566|11275860|FG002|Overall Study|Lost to Follow-up|0
7130609|NCT02763566|11275861|FG003|Overall Study|Lost to Follow-up|1
7130610|NCT02763566|11275858|FG000|Overall Study|On study treatment at study conclusion|114
7130611|NCT02763566|11275859|FG001|Overall Study|On study treatment at study conclusion|34
7130612|NCT02763566|11275860|FG002|Overall Study|On study treatment at study conclusion|54
7130613|NCT02763566|11275861|FG003|Overall Study|On study treatment at study conclusion|13
7130614|NCT02763566|11275858|FG000|Overall Study|Withdrawal by Subject|3
7130615|NCT02763566|11275859|FG001|Overall Study|Withdrawal by Subject|1
7130616|NCT02763566|11275860|FG002|Overall Study|Withdrawal by Subject|0
7130617|NCT02763566|11275861|FG003|Overall Study|Withdrawal by Subject|0
7130618|NCT02763644|11275877|FG000|Overall Study|Patient/guardian decision|1
7130619|NCT02763644|11275878|FG001|Overall Study|Patient/guardian decision|0
7130620|NCT02763644|11275877|FG000|Overall Study|Death|1
7130621|NCT02763644|11275878|FG001|Overall Study|Death|1
7130622|NCT02763644|11275877|FG000|Overall Study|Adverse Event|1
7130623|NCT02763644|11275878|FG001|Overall Study|Adverse Event|1
7130624|NCT02764151|11275933|FG000|Overall Study|Subject refused further follow-up|0
7130625|NCT02764151|11275934|FG001|Overall Study|Subject refused further follow-up|0
7130626|NCT02764151|11275935|FG002|Overall Study|Subject refused further follow-up|0
7130627|NCT02764151|11275936|FG003|Overall Study|Subject refused further follow-up|1
7130628|NCT02764151|11275933|FG000|Overall Study|Other|0
7130629|NCT02764151|11275934|FG001|Overall Study|Other|0
7130630|NCT02764151|11275935|FG002|Overall Study|Other|0
7130631|NCT02764151|11275936|FG003|Overall Study|Other|2
7130632|NCT02764190|11275952|FG000|Overall Study|Lost to Follow-up|17
7130633|NCT02764190|11275953|FG001|Overall Study|Lost to Follow-up|13
7130634|NCT02764229|11275959|FG000|Overall Study|Withdrawal by Subject|15
7130635|NCT02764229|11275959|FG000|Overall Study|Adverse Event|9
7130636|NCT02764229|11275959|FG000|Overall Study|Physician Decision|5
7130637|NCT02764229|11275959|FG000|Overall Study|Lost to Follow-up|3
7130638|NCT02764229|11275959|FG000|Overall Study|Lack of Efficacy|1
7130639|NCT02764229|11275959|FG000|Overall Study|Study Stopped by Sponsor|69
7130640|NCT02764320|11275965|FG000|Overall Study|Withdrawal by Subject|35
7130641|NCT02764320|11275966|FG001|Overall Study|Withdrawal by Subject|38
7130642|NCT02764320|11275965|FG000|Overall Study|Protocol Violation|11
7130643|NCT02764320|11275966|FG001|Overall Study|Protocol Violation|6
7130644|NCT02764320|11275965|FG000|Overall Study|Adverse Event|2
7130645|NCT02764320|11275966|FG001|Overall Study|Adverse Event|0
7130646|NCT02764320|11275965|FG000|Overall Study|Health Issues unable to continue|2
7130647|NCT02764320|11275966|FG001|Overall Study|Health Issues unable to continue|0
7130648|NCT02764320|11275965|FG000|Overall Study|Did not meet inclusion criteria|1
7130649|NCT02764320|11275966|FG001|Overall Study|Did not meet inclusion criteria|0
7130650|NCT02764320|11275965|FG000|Overall Study|Subject moved|0
7130651|NCT02764320|11275966|FG001|Overall Study|Subject moved|2
7130652|NCT02764320|11275965|FG000|Overall Study|Overused medication unavailable|0
7130653|NCT02764320|11275966|FG001|Overall Study|Overused medication unavailable|1
7130654|NCT02764320|11275965|FG000|Overall Study|Seeking care outside site|0
7130655|NCT02764320|11275966|FG001|Overall Study|Seeking care outside site|1
7130656|NCT02764320|11275965|FG000|Overall Study|Technology barriers|0
7130657|NCT02764320|11275966|FG001|Overall Study|Technology barriers|1
7130658|NCT02764333|11275972|FG000|Overall Study|Ineligible|1
7130659|NCT02764697|11275985|FG000|Overall Study|Lack of Efficacy|3
7130660|NCT02764762|11275989|FG000|Overall Study|Adverse Event|5
7130661|NCT02764762|11275989|FG000|Overall Study|Voluntary Withdrawal|3
7130662|NCT02764762|11275989|FG000|Overall Study|Significant Deviation|1
7130663|NCT02764775|11275993|FG000|Overall Study|Death|1
7130664|NCT02764775|11275993|FG000|Overall Study|Lost to Follow-up|2
7130665|NCT02764775|11275993|FG000|Overall Study|Withdrawal by Subject|3
7130666|NCT02765035|11276008|FG000|First Intervention (90 Days)|Adverse Event|1
7130667|NCT02765035|11276009|FG001|First Intervention (90 Days)|Adverse Event|1
7130668|NCT02765035|11276008|FG000|Second Intervention (30 Days)|Protocol Violation|2
7130669|NCT02765035|11276009|FG001|Second Intervention (30 Days)|Protocol Violation|2
7130670|NCT02765100|11276018|FG000|Overall Study|subject found ineligible after baseline|1
7130671|NCT02765100|11276019|FG001|Overall Study|subject found ineligible after baseline|1
7130672|NCT02765100|11276018|FG000|Overall Study|Lost to Follow-up|0
7130673|NCT02765100|11276019|FG001|Overall Study|Lost to Follow-up|1
7130674|NCT02765165|11276032|FG000|Treatment Period|Progressive disease|3
7130675|NCT02765165|11276033|FG001|Treatment Period|Progressive disease|2
7130676|NCT02765165|11276034|FG002|Treatment Period|Progressive disease|3
7130677|NCT02765165|11276035|FG003|Treatment Period|Progressive disease|3
7130678|NCT02765165|11276036|FG004|Treatment Period|Progressive disease|4
7130679|NCT02765165|11276037|FG005|Treatment Period|Progressive disease|2
7130680|NCT02765165|11276038|FG006|Treatment Period|Progressive disease|2
7130681|NCT02765165|11276032|FG000|Treatment Period|Physician Decision|0
7130682|NCT02765165|11276033|FG001|Treatment Period|Physician Decision|1
7130683|NCT02765165|11276034|FG002|Treatment Period|Physician Decision|0
7130684|NCT02765165|11276035|FG003|Treatment Period|Physician Decision|0
7130685|NCT02765165|11276036|FG004|Treatment Period|Physician Decision|0
7130686|NCT02765165|11276037|FG005|Treatment Period|Physician Decision|0
7130687|NCT02765165|11276038|FG006|Treatment Period|Physician Decision|0
7130688|NCT02765165|11276032|FG000|Treatment Period|Adverse Event|0
7130689|NCT02765165|11276033|FG001|Treatment Period|Adverse Event|1
7130690|NCT02765165|11276034|FG002|Treatment Period|Adverse Event|0
7130691|NCT02765165|11276035|FG003|Treatment Period|Adverse Event|0
7130692|NCT02765165|11276036|FG004|Treatment Period|Adverse Event|0
7130693|NCT02765165|11276037|FG005|Treatment Period|Adverse Event|0
7130694|NCT02765165|11276038|FG006|Treatment Period|Adverse Event|0
7130695|NCT02765165|11276032|FG000|Treatment Period|Withdrawal by Subject|0
7130696|NCT02765165|11276033|FG001|Treatment Period|Withdrawal by Subject|0
7130697|NCT02765165|11276034|FG002|Treatment Period|Withdrawal by Subject|0
7130698|NCT02765165|11276035|FG003|Treatment Period|Withdrawal by Subject|0
7130699|NCT02765165|11276036|FG004|Treatment Period|Withdrawal by Subject|2
7130700|NCT02765165|11276037|FG005|Treatment Period|Withdrawal by Subject|0
7130701|NCT02765165|11276038|FG006|Treatment Period|Withdrawal by Subject|0
7130702|NCT02765165|11276032|FG000|Treatment Period|Study terminated|0
7130703|NCT02765165|11276033|FG001|Treatment Period|Study terminated|0
7130704|NCT02765165|11276034|FG002|Treatment Period|Study terminated|0
7130705|NCT02765165|11276035|FG003|Treatment Period|Study terminated|0
7130706|NCT02765165|11276036|FG004|Treatment Period|Study terminated|0
7130707|NCT02765165|11276037|FG005|Treatment Period|Study terminated|1
7130708|NCT02765165|11276038|FG006|Treatment Period|Study terminated|2
7130709|NCT02765165|11276032|FG000|Post-treatment Follow-up|Death|1
7130710|NCT02765165|11276033|FG001|Post-treatment Follow-up|Death|2
7130711|NCT02765165|11276034|FG002|Post-treatment Follow-up|Death|1
7130712|NCT02765165|11276035|FG003|Post-treatment Follow-up|Death|1
7130713|NCT02765165|11276036|FG004|Post-treatment Follow-up|Death|1
7130714|NCT02765165|11276037|FG005|Post-treatment Follow-up|Death|1
7130715|NCT02765165|11276038|FG006|Post-treatment Follow-up|Death|0
7130716|NCT02765165|11276032|FG000|Post-treatment Follow-up|Lost to Follow-up|0
7130717|NCT02765165|11276033|FG001|Post-treatment Follow-up|Lost to Follow-up|0
7130718|NCT02765165|11276034|FG002|Post-treatment Follow-up|Lost to Follow-up|0
7130719|NCT02765165|11276035|FG003|Post-treatment Follow-up|Lost to Follow-up|1
7130720|NCT02765165|11276036|FG004|Post-treatment Follow-up|Lost to Follow-up|0
7130721|NCT02765165|11276037|FG005|Post-treatment Follow-up|Lost to Follow-up|0
7130722|NCT02765165|11276038|FG006|Post-treatment Follow-up|Lost to Follow-up|0
7130723|NCT02765165|11276032|FG000|Post-treatment Follow-up|Site terminated by sponsor|0
7130724|NCT02765165|11276033|FG001|Post-treatment Follow-up|Site terminated by sponsor|0
7130725|NCT02765165|11276034|FG002|Post-treatment Follow-up|Site terminated by sponsor|1
7130726|NCT02765165|11276035|FG003|Post-treatment Follow-up|Site terminated by sponsor|0
7130727|NCT02765165|11276036|FG004|Post-treatment Follow-up|Site terminated by sponsor|0
7130728|NCT02765165|11276037|FG005|Post-treatment Follow-up|Site terminated by sponsor|0
7130729|NCT02765165|11276038|FG006|Post-treatment Follow-up|Site terminated by sponsor|0
7130730|NCT02765165|11276032|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0
7130731|NCT02765165|11276033|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0
7130732|NCT02765165|11276034|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1
7130733|NCT02765165|11276035|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1
7130734|NCT02765165|11276036|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0
7130735|NCT02765165|11276037|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0
7130736|NCT02765165|11276038|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0
7130737|NCT02765165|11276032|FG000|Post-treatment Follow-up|Withdrawal by Subject|0
7130738|NCT02765165|11276033|FG001|Post-treatment Follow-up|Withdrawal by Subject|1
7130739|NCT02765165|11276034|FG002|Post-treatment Follow-up|Withdrawal by Subject|0
7130740|NCT02765165|11276035|FG003|Post-treatment Follow-up|Withdrawal by Subject|0
7130741|NCT02765165|11276036|FG004|Post-treatment Follow-up|Withdrawal by Subject|0
7130742|NCT02765165|11276037|FG005|Post-treatment Follow-up|Withdrawal by Subject|0
7130743|NCT02765165|11276038|FG006|Post-treatment Follow-up|Withdrawal by Subject|0
7130744|NCT02765165|11276032|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0
7130745|NCT02765165|11276033|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0
7130746|NCT02765165|11276034|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0
7130747|NCT02765165|11276035|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0
7130748|NCT02765165|11276036|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2
7130749|NCT02765165|11276037|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2
7130750|NCT02765165|11276038|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1
7130751|NCT02765490|11276078|FG000|Overall Study|Lost to Follow-up|1
7130752|NCT02765490|11276079|FG001|Overall Study|Lost to Follow-up|1
7130753|NCT02765490|11276078|FG000|Overall Study|Other|0
7130754|NCT02765490|11276079|FG001|Overall Study|Other|1
7130755|NCT02765490|11276078|FG000|Overall Study|Death|0
7130756|NCT02765490|11276079|FG001|Overall Study|Death|1
7130757|NCT02766023|11276087|FG000|Overall Study|Lost to Follow-up|23
7130758|NCT02766023|11276088|FG001|Overall Study|Lost to Follow-up|11
7130759|NCT02766023|11276087|FG000|Overall Study|Pregnancy|1
7130760|NCT02766023|11276088|FG001|Overall Study|Pregnancy|0
7130761|NCT02766023|11276087|FG000|Overall Study|Adverse Event|1
7130762|NCT02766023|11276088|FG001|Overall Study|Adverse Event|0
7130763|NCT02766023|11276087|FG000|Overall Study|Withdrawal by Subject|4
7130764|NCT02766023|11276088|FG001|Overall Study|Withdrawal by Subject|5
7130765|NCT02766023|11276087|FG000|Overall Study|Physician Decision|1
7130766|NCT02766023|11276088|FG001|Overall Study|Physician Decision|0
7130767|NCT02766023|11276087|FG000|Overall Study|Not Eligible at Enrollment|0
7130768|NCT02766023|11276088|FG001|Overall Study|Not Eligible at Enrollment|1
7130769|NCT02766088|11276094|FG000|Overall Study|Sponsor study termination|498
7130770|NCT02766088|11276094|FG000|Overall Study|Migrated/moved from the study area|1
7130771|NCT02766088|11276094|FG000|Overall Study|Lost to Follow-up|5
7130772|NCT02766088|11276094|FG000|Overall Study|Other|1
7130773|NCT02766088|11276094|FG000|Overall Study|Death|1
7130774|NCT02766283|11276107|FG000|Overall Study|Lost to Follow-up|27
7130775|NCT02766400|11276126|FG000|Overall Study|Death|1
7130776|NCT02766400|11276127|FG001|Overall Study|Death|2
7130777|NCT02766400|11276126|FG000|Overall Study|Withdrawal by Subject|1
7130778|NCT02766400|11276127|FG001|Overall Study|Withdrawal by Subject|0
6806245|NCT02564900|10808828|FG000|Dose Escalation|Progressive disease per RECIST|2
6806246|NCT02564900|10808829|FG001|Dose Escalation|Progressive disease per RECIST|3
6806247|NCT02564900|10808830|FG002|Dose Escalation|Progressive disease per RECIST|3
6806248|NCT02564900|10808831|FG003|Dose Escalation|Progressive disease per RECIST|3
6806249|NCT02564900|10808832|FG004|Dose Escalation|Progressive disease per RECIST|3
6806250|NCT02564900|10808833|FG005|Dose Escalation|Progressive disease per RECIST|1
6806251|NCT02564900|10808834|FG006|Dose Escalation|Progressive disease per RECIST|0
6806252|NCT02564900|10808835|FG007|Dose Escalation|Progressive disease per RECIST|0
6806253|NCT02564900|10808836|FG008|Dose Escalation|Progressive disease per RECIST|0
6806254|NCT02564900|10808837|FG009|Dose Escalation|Progressive disease per RECIST|0
7130779|NCT02766608|11276151|FG000|Overall Study|Adverse Event|27
7130780|NCT02766608|11276152|FG001|Overall Study|Adverse Event|22
7130781|NCT02766608|11276153|FG002|Overall Study|Adverse Event|17
7130782|NCT02766608|11276154|FG003|Overall Study|Adverse Event|13
7130783|NCT02766608|11276155|FG004|Overall Study|Adverse Event|12
7130784|NCT02766608|11276151|FG000|Overall Study|Withdrawal by Subject|21
7130785|NCT02766608|11276152|FG001|Overall Study|Withdrawal by Subject|20
7130786|NCT02766608|11276153|FG002|Overall Study|Withdrawal by Subject|24
7130787|NCT02766608|11276154|FG003|Overall Study|Withdrawal by Subject|13
7130788|NCT02766608|11276155|FG004|Overall Study|Withdrawal by Subject|10
7130789|NCT02766608|11276151|FG000|Overall Study|Lack of Efficacy|16
7130790|NCT02766608|11276152|FG001|Overall Study|Lack of Efficacy|15
7130791|NCT02766608|11276153|FG002|Overall Study|Lack of Efficacy|32
7130792|NCT02766608|11276154|FG003|Overall Study|Lack of Efficacy|8
7130793|NCT02766608|11276155|FG004|Overall Study|Lack of Efficacy|2
7130794|NCT02766608|11276151|FG000|Overall Study|Lost to Follow-up|6
7130795|NCT02766608|11276152|FG001|Overall Study|Lost to Follow-up|3
7130796|NCT02766608|11276153|FG002|Overall Study|Lost to Follow-up|5
7130797|NCT02766608|11276154|FG003|Overall Study|Lost to Follow-up|2
7130798|NCT02766608|11276155|FG004|Overall Study|Lost to Follow-up|2
7130799|NCT02766608|11276151|FG000|Overall Study|Physician Decision|3
7130800|NCT02766608|11276152|FG001|Overall Study|Physician Decision|2
7130801|NCT02766608|11276153|FG002|Overall Study|Physician Decision|3
7130802|NCT02766608|11276154|FG003|Overall Study|Physician Decision|1
7130803|NCT02766608|11276155|FG004|Overall Study|Physician Decision|2
7130804|NCT02766608|11276151|FG000|Overall Study|Protocol disc criteria|3
7130805|NCT02766608|11276152|FG001|Overall Study|Protocol disc criteria|3
7130806|NCT02766608|11276153|FG002|Overall Study|Protocol disc criteria|4
7130807|NCT02766608|11276154|FG003|Overall Study|Protocol disc criteria|0
7130808|NCT02766608|11276155|FG004|Overall Study|Protocol disc criteria|0
7130809|NCT02766608|11276151|FG000|Overall Study|Protocol Violation|0
7130810|NCT02766608|11276152|FG001|Overall Study|Protocol Violation|4
7130811|NCT02766608|11276153|FG002|Overall Study|Protocol Violation|4
7130812|NCT02766608|11276154|FG003|Overall Study|Protocol Violation|0
6806255|NCT02564900|10808838|FG010|Dose Escalation|Progressive disease per RECIST|0
6806256|NCT02564900|10808839|FG011|Dose Escalation|Progressive disease per RECIST|0
6806257|NCT02564900|10808840|FG012|Dose Escalation|Progressive disease per RECIST|0
6806258|NCT02564900|10808841|FG013|Dose Escalation|Progressive disease per RECIST|0
6806259|NCT02564900|10808842|FG014|Dose Escalation|Progressive disease per RECIST|0
6806260|NCT02564900|10808828|FG000|Dose Escalation|Ongoing|1
6806261|NCT02564900|10808829|FG001|Dose Escalation|Ongoing|0
6806262|NCT02564900|10808830|FG002|Dose Escalation|Ongoing|0
6806263|NCT02564900|10808831|FG003|Dose Escalation|Ongoing|2
6806264|NCT02564900|10808832|FG004|Dose Escalation|Ongoing|2
6806265|NCT02564900|10808833|FG005|Dose Escalation|Ongoing|2
6806266|NCT02564900|10808834|FG006|Dose Escalation|Ongoing|0
6806267|NCT02564900|10808835|FG007|Dose Escalation|Ongoing|0
6806268|NCT02564900|10808836|FG008|Dose Escalation|Ongoing|0
6806269|NCT02564900|10808837|FG009|Dose Escalation|Ongoing|0
6806270|NCT02564900|10808838|FG010|Dose Escalation|Ongoing|0
6806271|NCT02564900|10808839|FG011|Dose Escalation|Ongoing|0
6806272|NCT02564900|10808840|FG012|Dose Escalation|Ongoing|0
6806273|NCT02564900|10808841|FG013|Dose Escalation|Ongoing|0
6806274|NCT02564900|10808842|FG014|Dose Escalation|Ongoing|0
6806275|NCT02564900|10808828|FG000|Dose Escalation|Adverse Event|0
6806276|NCT02564900|10808829|FG001|Dose Escalation|Adverse Event|0
6806277|NCT02564900|10808830|FG002|Dose Escalation|Adverse Event|0
6806278|NCT02564900|10808831|FG003|Dose Escalation|Adverse Event|1
6806279|NCT02564900|10808832|FG004|Dose Escalation|Adverse Event|1
6806280|NCT02564900|10808833|FG005|Dose Escalation|Adverse Event|3
6806281|NCT02564900|10808834|FG006|Dose Escalation|Adverse Event|0
6806282|NCT02564900|10808835|FG007|Dose Escalation|Adverse Event|0
7130813|NCT02766608|11276155|FG004|Overall Study|Protocol Violation|1
7130814|NCT02766608|11276151|FG000|Overall Study|Administrative Reasons|3
7130815|NCT02766608|11276152|FG001|Overall Study|Administrative Reasons|1
7130816|NCT02766608|11276153|FG002|Overall Study|Administrative Reasons|1
7130817|NCT02766608|11276154|FG003|Overall Study|Administrative Reasons|0
7130818|NCT02766608|11276155|FG004|Overall Study|Administrative Reasons|0
7130819|NCT02766777|11276183|FG000|Overall Study|Adverse Event|12
7130820|NCT02766777|11276183|FG000|Overall Study|Lost to Follow-up|16
7130821|NCT02766777|11276183|FG000|Overall Study|Non-Compliance With Study Drug|1
7130822|NCT02766777|11276183|FG000|Overall Study|Protocol Violation|1
7130823|NCT02766777|11276183|FG000|Overall Study|Withdrawal by Subject|4
7130824|NCT02767323|11276232|FG000|Overall Study|Withdrawal by Subject|17
7130825|NCT02767323|11276233|FG001|Overall Study|Withdrawal by Subject|5
7130826|NCT02767323|11276234|FG002|Overall Study|Withdrawal by Subject|13
7130827|NCT02767323|11276235|FG003|Overall Study|Withdrawal by Subject|0
7130828|NCT02767323|11276232|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17
7130829|NCT02767323|11276233|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20
7130830|NCT02767323|11276234|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17
7130831|NCT02767323|11276235|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0
7130832|NCT02767765|11276283|FG000|Overall Study|Adverse Event|4
7130833|NCT02767765|11276283|FG000|Overall Study|Death|1
7130834|NCT02767765|11276283|FG000|Overall Study|Insufficient response|1
7130835|NCT02767765|11276283|FG000|Overall Study|Lost to Follow-up|2
7130836|NCT02767765|11276283|FG000|Overall Study|Investigator decision|1
7130837|NCT02767765|11276283|FG000|Overall Study|Non-Compliance|1
7130838|NCT02767765|11276283|FG000|Overall Study|Withdrawal by Subject|1
7130839|NCT02768103|11276316|FG000|Overall Study|1 participant did not fit in the fMRI|1
7130840|NCT02768194|11276329|FG000|Period 1|Adverse Event|0
7130841|NCT02768194|11276330|FG001|Period 1|Adverse Event|0
7130842|NCT02768194|11276331|FG002|Period 1|Adverse Event|0
7130843|NCT02768194|11276332|FG003|Period 1|Adverse Event|1
7130844|NCT02768194|11276333|FG004|Period 1|Adverse Event|0
7130845|NCT02768194|11276334|FG005|Period 1|Adverse Event|0
7130846|NCT02768194|11276329|FG000|Period 2|Other (Reason not specified)|1
7130847|NCT02768194|11276330|FG001|Period 2|Other (Reason not specified)|0
7130848|NCT02768194|11276331|FG002|Period 2|Other (Reason not specified)|0
7130849|NCT02768194|11276332|FG003|Period 2|Other (Reason not specified)|0
7130850|NCT02768194|11276333|FG004|Period 2|Other (Reason not specified)|0
7130851|NCT02768194|11276334|FG005|Period 2|Other (Reason not specified)|0
7130852|NCT02768194|11276329|FG000|Period 3|Other (Reason not specified)|0
7130853|NCT02768194|11276330|FG001|Period 3|Other (Reason not specified)|1
7130854|NCT02768194|11276331|FG002|Period 3|Other (Reason not specified)|0
7130855|NCT02768194|11276332|FG003|Period 3|Other (Reason not specified)|0
7130856|NCT02768194|11276333|FG004|Period 3|Other (Reason not specified)|0
7130857|NCT02768194|11276334|FG005|Period 3|Other (Reason not specified)|0
7130858|NCT02768298|11276344|FG000|Overall Study|Adverse Event|1
7130859|NCT02768298|11276345|FG001|Overall Study|Adverse Event|4
7130860|NCT02768298|11276344|FG000|Overall Study|Death|2
7130861|NCT02768298|11276345|FG001|Overall Study|Death|1
7130862|NCT02768298|11276344|FG000|Overall Study|Non-compliance with study treatment|0
7130863|NCT02768298|11276345|FG001|Overall Study|Non-compliance with study treatment|1
7130864|NCT02768298|11276344|FG000|Overall Study|Subject/guardian decision|1
7130865|NCT02768298|11276345|FG001|Overall Study|Subject/guardian decision|0
7130866|NCT02768298|11276344|FG000|Overall Study|Withdrawal of informed consent|0
7130867|NCT02768298|11276345|FG001|Overall Study|Withdrawal of informed consent|1
7130868|NCT02768792|11276369|FG000|Overall Study|Adverse Event|1
7130869|NCT02769065|11276403|FG000|Overall Study|Voluntary Withdrawal|1
7130870|NCT02769065|11276404|FG001|Overall Study|Voluntary Withdrawal|0
7130871|NCT02769065|11276405|FG002|Overall Study|Voluntary Withdrawal|0
7130872|NCT02769065|11276406|FG003|Overall Study|Voluntary Withdrawal|0
7130873|NCT02769065|11276407|FG004|Overall Study|Voluntary Withdrawal|0
7130874|NCT02769065|11276408|FG005|Overall Study|Voluntary Withdrawal|0
7130875|NCT02769065|11276409|FG006|Overall Study|Voluntary Withdrawal|0
7130876|NCT02769065|11276410|FG007|Overall Study|Voluntary Withdrawal|0
7130877|NCT02769065|11276411|FG008|Overall Study|Voluntary Withdrawal|0
7130878|NCT02769065|11276412|FG009|Overall Study|Voluntary Withdrawal|0
7130879|NCT02769065|11276413|FG010|Overall Study|Voluntary Withdrawal|0
7130880|NCT02769065|11276414|FG011|Overall Study|Voluntary Withdrawal|0
7130881|NCT02769065|11276415|FG012|Overall Study|Voluntary Withdrawal|0
7130882|NCT02769065|11276416|FG013|Overall Study|Voluntary Withdrawal|0
7130883|NCT02769065|11276417|FG014|Overall Study|Voluntary Withdrawal|0
7130884|NCT02769065|11276418|FG015|Overall Study|Voluntary Withdrawal|0
7130885|NCT02769065|11276419|FG016|Overall Study|Voluntary Withdrawal|0
7130886|NCT02769065|11276420|FG017|Overall Study|Voluntary Withdrawal|0
7130887|NCT02769065|11276421|FG018|Overall Study|Voluntary Withdrawal|0
7130888|NCT02769065|11276422|FG019|Overall Study|Voluntary Withdrawal|0
7130889|NCT02769065|11276423|FG020|Overall Study|Voluntary Withdrawal|0
7130890|NCT02769065|11276424|FG021|Overall Study|Voluntary Withdrawal|0
7130891|NCT02769065|11276425|FG022|Overall Study|Voluntary Withdrawal|0
7130892|NCT02769065|11276426|FG023|Overall Study|Voluntary Withdrawal|0
7130893|NCT02769065|11276427|FG024|Overall Study|Voluntary Withdrawal|0
7130894|NCT02769065|11276428|FG025|Overall Study|Voluntary Withdrawal|0
7130895|NCT02769065|11276429|FG026|Overall Study|Voluntary Withdrawal|0
7130896|NCT02769065|11276430|FG027|Overall Study|Voluntary Withdrawal|0
7130897|NCT02769065|11276431|FG028|Overall Study|Voluntary Withdrawal|0
7130898|NCT02769065|11276432|FG029|Overall Study|Voluntary Withdrawal|0
7130899|NCT02769065|11276403|FG000|Overall Study|Reason Not Specified|0
7130900|NCT02769065|11276404|FG001|Overall Study|Reason Not Specified|0
7130901|NCT02769065|11276405|FG002|Overall Study|Reason Not Specified|0
7130902|NCT02769065|11276406|FG003|Overall Study|Reason Not Specified|0
7130903|NCT02769065|11276407|FG004|Overall Study|Reason Not Specified|0
7130904|NCT02769065|11276408|FG005|Overall Study|Reason Not Specified|0
7130905|NCT02769065|11276409|FG006|Overall Study|Reason Not Specified|1
7130906|NCT02769065|11276410|FG007|Overall Study|Reason Not Specified|0
7130907|NCT02769065|11276411|FG008|Overall Study|Reason Not Specified|0
7130908|NCT02769065|11276412|FG009|Overall Study|Reason Not Specified|0
7130909|NCT02769065|11276413|FG010|Overall Study|Reason Not Specified|0
7130910|NCT02769065|11276414|FG011|Overall Study|Reason Not Specified|0
7130911|NCT02769065|11276415|FG012|Overall Study|Reason Not Specified|0
7130912|NCT02769065|11276416|FG013|Overall Study|Reason Not Specified|0
7130913|NCT02769065|11276417|FG014|Overall Study|Reason Not Specified|0
7130914|NCT02769065|11276418|FG015|Overall Study|Reason Not Specified|0
7130915|NCT02769065|11276419|FG016|Overall Study|Reason Not Specified|0
7130916|NCT02769065|11276420|FG017|Overall Study|Reason Not Specified|0
7130917|NCT02769065|11276421|FG018|Overall Study|Reason Not Specified|0
7130918|NCT02769065|11276422|FG019|Overall Study|Reason Not Specified|0
7130919|NCT02769065|11276423|FG020|Overall Study|Reason Not Specified|0
7130920|NCT02769065|11276424|FG021|Overall Study|Reason Not Specified|0
7130921|NCT02769065|11276425|FG022|Overall Study|Reason Not Specified|0
7130922|NCT02769065|11276426|FG023|Overall Study|Reason Not Specified|0
7130923|NCT02769065|11276427|FG024|Overall Study|Reason Not Specified|0
7130924|NCT02769065|11276428|FG025|Overall Study|Reason Not Specified|0
7130925|NCT02769065|11276429|FG026|Overall Study|Reason Not Specified|0
7130926|NCT02769065|11276430|FG027|Overall Study|Reason Not Specified|0
7130927|NCT02769065|11276431|FG028|Overall Study|Reason Not Specified|0
7130928|NCT02769065|11276432|FG029|Overall Study|Reason Not Specified|0
7130929|NCT02769065|11276403|FG000|Overall Study|Pre-treatment Event/Adverse Event|0
7130930|NCT02769065|11276404|FG001|Overall Study|Pre-treatment Event/Adverse Event|0
7130931|NCT02769065|11276405|FG002|Overall Study|Pre-treatment Event/Adverse Event|0
7130932|NCT02769065|11276406|FG003|Overall Study|Pre-treatment Event/Adverse Event|0
7130933|NCT02769065|11276407|FG004|Overall Study|Pre-treatment Event/Adverse Event|0
7130934|NCT02769065|11276408|FG005|Overall Study|Pre-treatment Event/Adverse Event|0
7130935|NCT02769065|11276409|FG006|Overall Study|Pre-treatment Event/Adverse Event|0
7130936|NCT02769065|11276410|FG007|Overall Study|Pre-treatment Event/Adverse Event|0
7130937|NCT02769065|11276411|FG008|Overall Study|Pre-treatment Event/Adverse Event|0
7130938|NCT02769065|11276412|FG009|Overall Study|Pre-treatment Event/Adverse Event|0
7130939|NCT02769065|11276413|FG010|Overall Study|Pre-treatment Event/Adverse Event|1
7130940|NCT02769065|11276414|FG011|Overall Study|Pre-treatment Event/Adverse Event|0
7130941|NCT02769065|11276415|FG012|Overall Study|Pre-treatment Event/Adverse Event|0
7130942|NCT02769065|11276416|FG013|Overall Study|Pre-treatment Event/Adverse Event|0
7130943|NCT02769065|11276417|FG014|Overall Study|Pre-treatment Event/Adverse Event|0
7130944|NCT02769065|11276418|FG015|Overall Study|Pre-treatment Event/Adverse Event|0
7130945|NCT02769065|11276419|FG016|Overall Study|Pre-treatment Event/Adverse Event|0
7130946|NCT02769065|11276420|FG017|Overall Study|Pre-treatment Event/Adverse Event|0
7130947|NCT02769065|11276421|FG018|Overall Study|Pre-treatment Event/Adverse Event|0
7130948|NCT02769065|11276422|FG019|Overall Study|Pre-treatment Event/Adverse Event|0
7130949|NCT02769065|11276423|FG020|Overall Study|Pre-treatment Event/Adverse Event|0
7130950|NCT02769065|11276424|FG021|Overall Study|Pre-treatment Event/Adverse Event|0
7130951|NCT02769065|11276425|FG022|Overall Study|Pre-treatment Event/Adverse Event|0
7130952|NCT02769065|11276426|FG023|Overall Study|Pre-treatment Event/Adverse Event|0
7130953|NCT02769065|11276427|FG024|Overall Study|Pre-treatment Event/Adverse Event|0
7130954|NCT02769065|11276428|FG025|Overall Study|Pre-treatment Event/Adverse Event|0
7130955|NCT02769065|11276429|FG026|Overall Study|Pre-treatment Event/Adverse Event|0
7130956|NCT02769065|11276430|FG027|Overall Study|Pre-treatment Event/Adverse Event|0
7130957|NCT02769065|11276431|FG028|Overall Study|Pre-treatment Event/Adverse Event|0
7130958|NCT02769065|11276432|FG029|Overall Study|Pre-treatment Event/Adverse Event|0
7130959|NCT02769247|11276529|FG000|Overall Study|Withdrawal by Subject|1
7130960|NCT02769247|11276530|FG001|Overall Study|Withdrawal by Subject|0
7130961|NCT02769247|11276531|FG002|Overall Study|Withdrawal by Subject|0
7130962|NCT02769247|11276532|FG003|Overall Study|Withdrawal by Subject|1
7130963|NCT02769247|11276529|FG000|Overall Study|Protocol Violation|0
7130964|NCT02769247|11276530|FG001|Overall Study|Protocol Violation|0
7130965|NCT02769247|11276531|FG002|Overall Study|Protocol Violation|1
7130966|NCT02769247|11276532|FG003|Overall Study|Protocol Violation|0
7130967|NCT02769247|11276529|FG000|Overall Study|Physician Decision|1
7130968|NCT02769247|11276530|FG001|Overall Study|Physician Decision|0
7130969|NCT02769247|11276531|FG002|Overall Study|Physician Decision|0
7130970|NCT02769247|11276532|FG003|Overall Study|Physician Decision|0
7130971|NCT02769312|11276548|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1
7130972|NCT02769312|11276549|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1
7130973|NCT02769312|11276548|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1
7130974|NCT02769312|11276549|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0
7130975|NCT02769312|11276548|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1
7130976|NCT02769312|11276549|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0
7130977|NCT02769312|11276548|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0
7130978|NCT02769312|11276549|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1
7130979|NCT02769312|11276548|FG000|Follow-up|Lost to Follow-up|1
7130980|NCT02769312|11276549|FG001|Follow-up|Lost to Follow-up|1
7130981|NCT02769481|11276572|FG000|Overall Study|Protocol Violation|1
7130982|NCT02769481|11276573|FG001|Overall Study|Protocol Violation|0
7130983|NCT02769481|11276572|FG000|Overall Study|Adverse Event|3
7130984|NCT02769481|11276573|FG001|Overall Study|Adverse Event|6
7130985|NCT02769481|11276572|FG000|Overall Study|Entry Criteria Not Met|1
7130986|NCT02769481|11276573|FG001|Overall Study|Entry Criteria Not Met|2
7130987|NCT02769481|11276572|FG000|Overall Study|Withdrawal by Subject|14
7130988|NCT02769481|11276573|FG001|Overall Study|Withdrawal by Subject|16
7130989|NCT02769481|11276572|FG000|Overall Study|Lost to Follow-up|9
7130990|NCT02769481|11276573|FG001|Overall Study|Lost to Follow-up|9
7130991|NCT02769481|11276572|FG000|Overall Study|Physician Decision|0
7130992|NCT02769481|11276573|FG001|Overall Study|Physician Decision|1
7130993|NCT02769481|11276572|FG000|Overall Study|Terminated by Sponsor|1
7130994|NCT02769481|11276573|FG001|Overall Study|Terminated by Sponsor|0
7130995|NCT02769481|11276572|FG000|Overall Study|Death|0
7130996|NCT02769481|11276573|FG001|Overall Study|Death|1
7130997|NCT02769481|11276572|FG000|Overall Study|Undefined|4
7130998|NCT02769481|11276573|FG001|Overall Study|Undefined|1
7130999|NCT02769624|11276579|FG000|Overall Study|Lost to Follow-up|0
7131000|NCT02769624|11276580|FG001|Overall Study|Lost to Follow-up|1
7131001|NCT02769858|11276590|FG000|Overall Study|Withdrawal by Subject|2
7131002|NCT02770170|11276603|FG000|Overall Study|Withdrawal by Subject|0
7131003|NCT02770170|11276604|FG001|Overall Study|Withdrawal by Subject|0
7131004|NCT02770170|11276605|FG002|Overall Study|Withdrawal by Subject|0
7131005|NCT02770170|11276606|FG003|Overall Study|Withdrawal by Subject|2
7131006|NCT02770170|11276603|FG000|Overall Study|due to pregnancy|1
7131007|NCT02770170|11276604|FG001|Overall Study|due to pregnancy|0
7131008|NCT02770170|11276605|FG002|Overall Study|due to pregnancy|0
7131009|NCT02770170|11276606|FG003|Overall Study|due to pregnancy|0
7131010|NCT02770170|11276603|FG000|Overall Study|Lack of Efficacy|2
7131011|NCT02770170|11276604|FG001|Overall Study|Lack of Efficacy|0
7131012|NCT02770170|11276605|FG002|Overall Study|Lack of Efficacy|0
7131013|NCT02770170|11276606|FG003|Overall Study|Lack of Efficacy|1
7131014|NCT02770170|11276603|FG000|Overall Study|Adverse Event|4
7131015|NCT02770170|11276604|FG001|Overall Study|Adverse Event|3
7131016|NCT02770170|11276605|FG002|Overall Study|Adverse Event|5
7131017|NCT02770170|11276606|FG003|Overall Study|Adverse Event|3
7131018|NCT02770170|11276603|FG000|Overall Study|due to disease worsening|0
7131019|NCT02770170|11276604|FG001|Overall Study|due to disease worsening|0
7131020|NCT02770170|11276605|FG002|Overall Study|due to disease worsening|0
7131021|NCT02770170|11276606|FG003|Overall Study|due to disease worsening|1
7131022|NCT02770248|11276618|FG000|Overall Study|Adverse Event|0
7131023|NCT02770248|11276619|FG001|Overall Study|Adverse Event|1
7131024|NCT02770248|11276618|FG000|Overall Study|Randomized in error, prior to treatment|0
7131025|NCT02770248|11276619|FG001|Overall Study|Randomized in error, prior to treatment|1
7131026|NCT02770547|11276672|FG000|Overall Study|Patient non-compliant|1
7131027|NCT02770547|11276673|FG001|Overall Study|Patient non-compliant|0
7131028|NCT02770547|11276672|FG000|Overall Study|Adverse Event|0
7131029|NCT02770547|11276673|FG001|Overall Study|Adverse Event|1
7131030|NCT02770612|11276679|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1
7131031|NCT02770820|11276687|FG000|Overall Study|Death|1
7131032|NCT02770820|11276687|FG000|Overall Study|Physician Decision|2
7131033|NCT02771145|11276711|FG000|Overall Study|Adverse Event|3
7131034|NCT02771145|11276711|FG000|Overall Study|Lost to Follow-up|1
7131035|NCT02771210|11276733|FG000|Period 1|Adverse Event|5
7131036|NCT02771210|11276734|FG001|Period 1|Adverse Event|3
7131037|NCT02771210|11276733|FG000|Period 1|Lack of Efficacy|3
7131038|NCT02771210|11276734|FG001|Period 1|Lack of Efficacy|6
7131039|NCT02771210|11276733|FG000|Period 1|Lost to Follow-up|2
7131040|NCT02771210|11276734|FG001|Period 1|Lost to Follow-up|0
7131041|NCT02771210|11276733|FG000|Period 1|Physician Decision|0
7131042|NCT02771210|11276734|FG001|Period 1|Physician Decision|1
7131043|NCT02771210|11276733|FG000|Period 1|Withdrawal by Subject|0
7131044|NCT02771210|11276734|FG001|Period 1|Withdrawal by Subject|3
7131045|NCT02771210|11276733|FG000|Period 1|Withdrawal of informed consent|1
7131046|NCT02771210|11276734|FG001|Period 1|Withdrawal of informed consent|5
7131047|NCT02771210|11276733|FG000|Period 2|Adverse Event|1
7131048|NCT02771210|11276734|FG001|Period 2|Adverse Event|0
7131049|NCT02771210|11276733|FG000|Period 2|Lack of Efficacy|0
7131050|NCT02771210|11276734|FG001|Period 2|Lack of Efficacy|1
7131051|NCT02771210|11276733|FG000|Period 2|Withdrawal by Subject|1
7131052|NCT02771210|11276734|FG001|Period 2|Withdrawal by Subject|0
7131053|NCT02771210|11276733|FG000|Period 2|Withdrawal of informed consent|0
7131054|NCT02771210|11276734|FG001|Period 2|Withdrawal of informed consent|2
7131055|NCT02771366|11276755|FG000|Period 1|Withdrawal by Subject|0
7131056|NCT02771366|11276756|FG001|Period 1|Withdrawal by Subject|2
7131057|NCT02771366|11276755|FG000|Period 2 (Crossover)|Withdrawal by Subject|2
7131058|NCT02771366|11276756|FG001|Period 2 (Crossover)|Withdrawal by Subject|0
7131059|NCT02771522|11276763|FG000|Overall Study|Lost to Follow-up|3
7131060|NCT02771522|11276763|FG000|Overall Study|Withdrawal by Subject|2
7131061|NCT02771522|11276763|FG000|Overall Study|No white spot lesions|3
7131062|NCT02772757|11276822|FG000|Overall Study|Withdrawal by Subject|1
7131063|NCT02772757|11276823|FG001|Overall Study|Withdrawal by Subject|0
7131064|NCT02772757|11276824|FG002|Overall Study|Withdrawal by Subject|1
7131065|NCT02772757|11276822|FG000|Overall Study|Protocol Violation|0
7131066|NCT02772757|11276823|FG001|Overall Study|Protocol Violation|0
7131067|NCT02772757|11276824|FG002|Overall Study|Protocol Violation|1
7131068|NCT02772757|11276822|FG000|Overall Study|Physician Decision|0
7131069|NCT02772757|11276823|FG001|Overall Study|Physician Decision|3
7131070|NCT02772757|11276824|FG002|Overall Study|Physician Decision|3
7131071|NCT02772809|11276842|FG000|Overall Study|not completed some tasks|6
7131072|NCT02772978|11276851|FG000|Overall Study|Withdrawal by Subject|1
7131073|NCT02772978|11276852|FG001|Overall Study|Withdrawal by Subject|1
7131074|NCT02773368|11276859|FG000|Overall Study|Lost to Follow-up|4
7131075|NCT02773368|11276860|FG001|Overall Study|Lost to Follow-up|1
7131076|NCT02773368|11276859|FG000|Overall Study|Withdrawal by Subject|5
7131077|NCT02773368|11276860|FG001|Overall Study|Withdrawal by Subject|1
7131078|NCT02773368|11276859|FG000|Overall Study|Unclassified|1
7131079|NCT02773368|11276860|FG001|Overall Study|Unclassified|1
7131080|NCT02773368|11276859|FG000|Overall Study|Missing|0
7131081|NCT02773368|11276860|FG001|Overall Study|Missing|1
7131082|NCT02773446|11276872|FG000|First Admission|Withdrawal by Subject|0
7131083|NCT02773446|11276873|FG001|First Admission|Withdrawal by Subject|0
7131084|NCT02773446|11276874|FG002|First Admission|Withdrawal by Subject|0
7131085|NCT02773446|11276875|FG003|First Admission|Withdrawal by Subject|1
7131086|NCT02773446|11276876|FG004|First Admission|Withdrawal by Subject|0
7131087|NCT02773446|11276877|FG005|First Admission|Withdrawal by Subject|0
7131088|NCT02773446|11276872|FG000|First Admission|Lost to Follow-up|1
7131089|NCT02773446|11276873|FG001|First Admission|Lost to Follow-up|0
7131090|NCT02773446|11276874|FG002|First Admission|Lost to Follow-up|0
7131091|NCT02773446|11276875|FG003|First Admission|Lost to Follow-up|0
7131092|NCT02773446|11276876|FG004|First Admission|Lost to Follow-up|0
7131093|NCT02773446|11276877|FG005|First Admission|Lost to Follow-up|0
7131094|NCT02773537|11276897|FG000|Overall Study|Lost to Follow-up|0
7131095|NCT02773537|11276898|FG001|Overall Study|Lost to Follow-up|1
7131096|NCT02773537|11276899|FG002|Overall Study|Lost to Follow-up|4
7131097|NCT02774278|11276960|FG000|Overall Study|Lack of Efficacy|199
7131098|NCT02774278|11276960|FG000|Overall Study|Death|29
7131099|NCT02774278|11276960|FG000|Overall Study|Adverse event/intercurrent illness|16
7131100|NCT02774278|11276960|FG000|Overall Study|Refused treatment/did not cooperate|9
7131101|NCT02774278|11276960|FG000|Overall Study|Administrative reasons|6
7131102|NCT02774278|11276960|FG000|Overall Study|Withdrawal by Subject|3
7131103|NCT02774278|11276960|FG000|Overall Study|Protocol Violation|2
7131104|NCT02774681|11276988|FG000|Treatment on Study|Progressive Disease|7
7131105|NCT02774681|11276988|FG000|Follow-Up for 3 Years|Death|11
7131106|NCT02774681|11276988|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1
7131107|NCT02775344|11277031|FG000|Overall Study|No ovarian cyst identified|3
7131108|NCT02775344|11277032|FG001|Overall Study|No ovarian cyst identified|2
7131109|NCT02775864|11277051|FG000|Overall Study|Data ended end of 2010|1764
7131110|NCT02775864|11277052|FG001|Overall Study|Data ended end of 2010|2880
7131111|NCT02775864|11277053|FG002|Overall Study|Data ended end of 2010|1140
7131112|NCT02775864|11277054|FG003|Overall Study|Data ended end of 2010|1194
7131113|NCT02775864|11277051|FG000|Overall Study|Medicaid eligibility discontinued|1478
7131114|NCT02775864|11277052|FG001|Overall Study|Medicaid eligibility discontinued|2019
7131115|NCT02775864|11277053|FG002|Overall Study|Medicaid eligibility discontinued|720
7131116|NCT02775864|11277054|FG003|Overall Study|Medicaid eligibility discontinued|890
7131117|NCT02775916|11277067|FG000|Overall Study|Adverse Event|1
7131118|NCT02775916|11277068|FG001|Overall Study|Adverse Event|0
7131119|NCT02775916|11277067|FG000|Overall Study|Subject/Guardian Decision|2
7131120|NCT02775916|11277068|FG001|Overall Study|Subject/Guardian Decision|0
7131121|NCT02776033|11277077|FG000|Overall Study|Withdrawal by Subject|0
7131122|NCT02776033|11277078|FG001|Overall Study|Withdrawal by Subject|0
7131123|NCT02776033|11277079|FG002|Overall Study|Withdrawal by Subject|2
7131124|NCT02776033|11277077|FG000|Overall Study|Physician Decision|2
7131125|NCT02776033|11277078|FG001|Overall Study|Physician Decision|0
7131126|NCT02776033|11277079|FG002|Overall Study|Physician Decision|0
7131127|NCT02776033|11277077|FG000|Overall Study|Lost to Follow-up|1
7131128|NCT02776033|11277078|FG001|Overall Study|Lost to Follow-up|0
7131129|NCT02776033|11277079|FG002|Overall Study|Lost to Follow-up|0
7131130|NCT02776033|11277077|FG000|Overall Study|Adverse Event|1
7131131|NCT02776033|11277078|FG001|Overall Study|Adverse Event|2
7131132|NCT02776033|11277079|FG002|Overall Study|Adverse Event|0
7131133|NCT02776553|11277095|FG000|Overall Study|Lost to Follow-up|1
7131134|NCT02776553|11277096|FG001|Overall Study|Lost to Follow-up|0
7131135|NCT02776553|11277095|FG000|Overall Study|got liver transplant|1
7131136|NCT02776553|11277096|FG001|Overall Study|got liver transplant|2
7131137|NCT02776553|11277095|FG000|Overall Study|had other surgery|1
7131138|NCT02776553|11277096|FG001|Overall Study|had other surgery|0
7131139|NCT02776553|11277095|FG000|Overall Study|Protocol Violation|0
7131140|NCT02776553|11277096|FG001|Overall Study|Protocol Violation|1
7131141|NCT02776670|11277113|FG000|Overall Study|Adverse Event|0
7131142|NCT02776670|11277114|FG001|Overall Study|Adverse Event|2
7131143|NCT02776670|11277113|FG000|Overall Study|Protocol Violation|0
7131144|NCT02776670|11277114|FG001|Overall Study|Protocol Violation|2
7131145|NCT02776670|11277113|FG000|Overall Study|Withdrawal by Subject|0
7131146|NCT02776670|11277114|FG001|Overall Study|Withdrawal by Subject|1
7131147|NCT02776670|11277113|FG000|Overall Study|Other - Reason not given|0
7131148|NCT02776670|11277114|FG001|Overall Study|Other - Reason not given|1
7131149|NCT02776683|11277120|FG000|Pre-switch Period|Protocol Violation|1
7131150|NCT02776683|11277121|FG001|Pre-switch Period|Protocol Violation|0
7131151|NCT02776683|11277120|FG000|Pre-switch Period|Adverse Event|21
7131152|NCT02776683|11277121|FG001|Pre-switch Period|Adverse Event|0
7131153|NCT02776683|11277120|FG000|Pre-switch Period|Withdrawal by Subject|9
7131154|NCT02776683|11277121|FG001|Pre-switch Period|Withdrawal by Subject|0
7131155|NCT02776683|11277120|FG000|Pre-switch Period|Physician Decision|7
7131156|NCT02776683|11277121|FG001|Pre-switch Period|Physician Decision|0
7131157|NCT02776683|11277120|FG000|Pre-switch Period|Progressive disease|39
7131158|NCT02776683|11277121|FG001|Pre-switch Period|Progressive disease|0
7131159|NCT02776683|11277120|FG000|Pre-switch Period|Other than listed|3
7131160|NCT02776683|11277121|FG001|Pre-switch Period|Other than listed|0
7131161|NCT02776683|11277120|FG000|Post-switch Period|Adverse Event|0
7131162|NCT02776683|11277121|FG001|Post-switch Period|Adverse Event|3
7131163|NCT02776683|11277120|FG000|Post-switch Period|Withdrawal by Subject|0
7131164|NCT02776683|11277121|FG001|Post-switch Period|Withdrawal by Subject|2
7131165|NCT02776683|11277120|FG000|Post-switch Period|Physician Decision|0
7131166|NCT02776683|11277121|FG001|Post-switch Period|Physician Decision|3
7131167|NCT02776683|11277120|FG000|Post-switch Period|Progressive disease|0
7131168|NCT02776683|11277121|FG001|Post-switch Period|Progressive disease|20
7131169|NCT02776683|11277120|FG000|Post-switch Period|Other than listed|0
7131170|NCT02776683|11277121|FG001|Post-switch Period|Other than listed|15
7131171|NCT02777086|11277156|FG000|Overall Study|Lost to Follow-up|96
7131172|NCT02777086|11277157|FG001|Overall Study|Lost to Follow-up|99
7131173|NCT02777125|11277165|FG000|Overall Study|Consent form violation|14
7131174|NCT02777125|11277166|FG001|Overall Study|Consent form violation|12
7131175|NCT02777125|11277165|FG000|Overall Study|Assent form violation|21
7131176|NCT02777125|11277166|FG001|Overall Study|Assent form violation|23
7131177|NCT02777125|11277165|FG000|Overall Study|Protocol Violation|8
7131178|NCT02777125|11277166|FG001|Overall Study|Protocol Violation|12
7131179|NCT02777242|11277173|FG000|Overall Study|Other|2
7131180|NCT02777242|11277173|FG000|Overall Study|Lost to Follow-up|1
7131181|NCT02777242|11277173|FG000|Overall Study|Multiple|1
7131182|NCT02777242|11277173|FG000|Overall Study|Sponsor's request|1
7131183|NCT02777242|11277173|FG000|Overall Study|Withdrawal by Subject|1
7131184|NCT02777333|11277201|FG000|Overall Study|Withdrawal by Subject|0
7131185|NCT02777333|11277202|FG001|Overall Study|Withdrawal by Subject|1
7131186|NCT02777333|11277201|FG000|Overall Study|Lost to Follow-up|0
7131187|NCT02777333|11277202|FG001|Overall Study|Lost to Follow-up|1
7131188|NCT04952701|11277208|FG000|Control Lens|Physician Decision|4
7131189|NCT04952701|11277208|FG000|Test Lens|Physician Decision|1
7131190|NCT04074161|11277221|FG000|Overall Study|Withdrawal by Subject|2
7131191|NCT04074161|11277222|FG001|Overall Study|Withdrawal by Subject|4
7131192|NCT04074161|11277223|FG002|Overall Study|Withdrawal by Subject|1
7131193|NCT04074161|11277221|FG000|Overall Study|Lost to Follow-up|4
7131194|NCT04074161|11277222|FG001|Overall Study|Lost to Follow-up|5
7131195|NCT04074161|11277223|FG002|Overall Study|Lost to Follow-up|3
7131196|NCT04033432|11277231|FG000|Overall Study|Progressive Disease|8
7131197|NCT04033432|11277231|FG000|Overall Study|Adverse Event|4
7131198|NCT04033432|11277231|FG000|Overall Study|Death|1
7131199|NCT04030247|11277236|FG000|Overall Study|Withdrawal by Subject|4
7131200|NCT04030247|11277236|FG000|Overall Study|Lost to Follow-up|13
7131201|NCT03893565|11277245|FG000|Double-blind Induction Phase (10 Weeks)|Other|1
7131202|NCT03893565|11277246|FG001|Double-blind Induction Phase (10 Weeks)|Other|3
7131203|NCT03893565|11277247|FG002|Double-blind Induction Phase (10 Weeks)|Other|0
7131204|NCT03893565|11277248|FG003|Double-blind Induction Phase (10 Weeks)|Other|0
7131205|NCT03893565|11277249|FG004|Double-blind Induction Phase (10 Weeks)|Other|1
7131206|NCT03893565|11277250|FG005|Double-blind Induction Phase (10 Weeks)|Other|0
7131207|NCT03893565|11277251|FG006|Double-blind Induction Phase (10 Weeks)|Other|0
7131208|NCT03893565|11277252|FG007|Double-blind Induction Phase (10 Weeks)|Other|0
7131209|NCT03893565|11277253|FG008|Double-blind Induction Phase (10 Weeks)|Other|0
7131210|NCT03893565|11277245|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0
7131211|NCT03893565|11277246|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1
7131212|NCT03893565|11277247|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0
7131213|NCT03893565|11277248|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0
7131214|NCT03893565|11277249|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0
7131215|NCT03893565|11277250|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0
7131216|NCT03893565|11277251|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0
7131217|NCT03893565|11277252|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0
7131218|NCT03893565|11277253|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0
7131219|NCT03893565|11277245|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0
7131220|NCT03893565|11277246|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2
7131221|NCT03893565|11277247|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0
7131222|NCT03893565|11277248|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1
7131223|NCT03893565|11277249|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0
7131224|NCT03893565|11277250|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0
7131225|NCT03893565|11277251|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0
7131226|NCT03893565|11277252|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0
7131227|NCT03893565|11277253|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0
7131228|NCT03893565|11277245|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0
7131229|NCT03893565|11277246|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1
7131230|NCT03893565|11277247|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0
7131231|NCT03893565|11277248|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6
7131232|NCT03893565|11277249|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0
7131233|NCT03893565|11277250|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0
7131234|NCT03893565|11277251|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0
7131235|NCT03893565|11277252|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0
7131236|NCT03893565|11277253|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0
7131237|NCT03893565|11277245|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5
7131238|NCT03893565|11277246|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5
7131239|NCT03893565|11277247|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9
7131240|NCT03893565|11277248|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0
7131241|NCT03893565|11277249|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6
6806283|NCT02564900|10808836|FG008|Dose Escalation|Adverse Event|0
6806284|NCT02564900|10808837|FG009|Dose Escalation|Adverse Event|0
6806285|NCT02564900|10808838|FG010|Dose Escalation|Adverse Event|0
6806286|NCT02564900|10808839|FG011|Dose Escalation|Adverse Event|0
6806287|NCT02564900|10808840|FG012|Dose Escalation|Adverse Event|0
6806288|NCT02564900|10808841|FG013|Dose Escalation|Adverse Event|0
6806289|NCT02564900|10808842|FG014|Dose Escalation|Adverse Event|0
6806290|NCT02564900|10808828|FG000|Dose Expansion|Progressive disease per RECIST|0
6806291|NCT02564900|10808829|FG001|Dose Expansion|Progressive disease per RECIST|0
7131242|NCT03893565|11277250|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0
7131243|NCT03893565|11277251|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0
7131244|NCT03893565|11277252|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0
7131245|NCT03893565|11277253|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0
7131246|NCT03893565|11277245|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0
7131247|NCT03893565|11277246|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2
7131248|NCT03893565|11277247|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0
7131249|NCT03893565|11277248|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0
7131250|NCT03893565|11277249|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0
7131251|NCT03893565|11277250|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0
7131252|NCT03893565|11277251|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0
7131253|NCT03893565|11277252|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0
7131254|NCT03893565|11277253|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0
7131255|NCT03893565|11277245|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0
7131256|NCT03893565|11277246|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0
7131257|NCT03893565|11277247|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0
7131258|NCT03893565|11277248|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1
7131259|NCT03893565|11277249|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0
7131260|NCT03893565|11277250|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0
7131261|NCT03893565|11277251|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0
7131262|NCT03893565|11277252|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0
7131263|NCT03893565|11277253|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0
7131264|NCT03893565|11277245|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0
7131265|NCT03893565|11277246|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2
7131266|NCT03893565|11277247|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1
7131267|NCT03893565|11277248|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1
7131268|NCT03893565|11277249|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0
7131269|NCT03893565|11277250|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0
7131270|NCT03893565|11277251|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0
7131271|NCT03893565|11277252|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0
7131272|NCT03893565|11277253|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0
7131273|NCT03893565|11277245|FG000|Double-blind Extended Treatment(20weeks)|Other|0
7131274|NCT03893565|11277246|FG001|Double-blind Extended Treatment(20weeks)|Other|0
7131275|NCT03893565|11277247|FG002|Double-blind Extended Treatment(20weeks)|Other|0
7131276|NCT03893565|11277248|FG003|Double-blind Extended Treatment(20weeks)|Other|0
7131277|NCT03893565|11277249|FG004|Double-blind Extended Treatment(20weeks)|Other|0
7131278|NCT03893565|11277250|FG005|Double-blind Extended Treatment(20weeks)|Other|1
7131279|NCT03893565|11277251|FG006|Double-blind Extended Treatment(20weeks)|Other|1
7131280|NCT03893565|11277252|FG007|Double-blind Extended Treatment(20weeks)|Other|0
7131281|NCT03893565|11277253|FG008|Double-blind Extended Treatment(20weeks)|Other|0
7131282|NCT03893565|11277245|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0
7131283|NCT03893565|11277246|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0
7131284|NCT03893565|11277247|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0
7131285|NCT03893565|11277248|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0
7131286|NCT03893565|11277249|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0
7131287|NCT03893565|11277250|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0
7131288|NCT03893565|11277251|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1
7131289|NCT03893565|11277252|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0
7131290|NCT03893565|11277253|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0
7131291|NCT03893565|11277245|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0
7131292|NCT03893565|11277246|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0
7131293|NCT03893565|11277247|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0
7131294|NCT03893565|11277248|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0
7131295|NCT03893565|11277249|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0
7131296|NCT03893565|11277250|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2
7131297|NCT03893565|11277251|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2
7131298|NCT03893565|11277252|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0
7131299|NCT03893565|11277253|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0
7131300|NCT03893565|11277245|FG000|Open-label Induction Phase (10 Weeks)|Other|0
7131301|NCT03893565|11277246|FG001|Open-label Induction Phase (10 Weeks)|Other|0
7131302|NCT03893565|11277247|FG002|Open-label Induction Phase (10 Weeks)|Other|0
7131303|NCT03893565|11277248|FG003|Open-label Induction Phase (10 Weeks)|Other|0
7131304|NCT03893565|11277249|FG004|Open-label Induction Phase (10 Weeks)|Other|0
7131305|NCT03893565|11277250|FG005|Open-label Induction Phase (10 Weeks)|Other|0
7131306|NCT03893565|11277251|FG006|Open-label Induction Phase (10 Weeks)|Other|0
7131307|NCT03893565|11277252|FG007|Open-label Induction Phase (10 Weeks)|Other|3
7131308|NCT03893565|11277253|FG008|Open-label Induction Phase (10 Weeks)|Other|0
7131309|NCT03893565|11277245|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0
7131310|NCT03893565|11277246|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0
7131311|NCT03893565|11277247|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0
7131312|NCT03893565|11277248|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0
7131313|NCT03893565|11277249|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0
7131314|NCT03893565|11277250|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0
7131315|NCT03893565|11277251|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0
7131316|NCT03893565|11277252|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5
7131317|NCT03893565|11277253|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0
7131318|NCT03893565|11277245|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0
7131319|NCT03893565|11277246|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0
7131320|NCT03893565|11277247|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0
7131321|NCT03893565|11277248|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0
7131322|NCT03893565|11277249|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0
7131323|NCT03893565|11277250|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0
7131324|NCT03893565|11277251|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0
7131325|NCT03893565|11277252|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15
7131326|NCT03893565|11277253|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0
7131327|NCT03893565|11277245|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0
7131328|NCT03893565|11277246|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0
7131329|NCT03893565|11277247|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0
7131330|NCT03893565|11277248|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0
7131331|NCT03893565|11277249|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0
7131332|NCT03893565|11277250|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0
7131333|NCT03893565|11277251|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0
7131334|NCT03893565|11277252|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7
7131335|NCT03893565|11277253|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0
7131336|NCT03893565|11277245|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0
7131337|NCT03893565|11277246|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0
7131338|NCT03893565|11277247|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0
7131339|NCT03893565|11277248|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0
7131340|NCT03893565|11277249|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0
7131341|NCT03893565|11277250|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0
7131342|NCT03893565|11277251|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0
7131343|NCT03893565|11277252|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0
7131344|NCT03893565|11277253|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4
7131345|NCT03701516|11277272|FG000|Period 1|Lost to Follow-up|0
7131346|NCT03701516|11277273|FG001|Period 1|Lost to Follow-up|1
7131347|NCT03701516|11277272|FG000|Period 1|Adverse Event|0
7131348|NCT03701516|11277273|FG001|Period 1|Adverse Event|2
7131349|NCT03701516|11277272|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2
7131350|NCT03701516|11277273|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0
7131351|NCT03701516|11277272|FG000|Period 1|Non Compliance to Protocol|2
7131352|NCT03701516|11277273|FG001|Period 1|Non Compliance to Protocol|1
7131353|NCT03701516|11277272|FG000|Period 1|Withdrawal by Subject|0
7131354|NCT03701516|11277273|FG001|Period 1|Withdrawal by Subject|1
7131355|NCT03701516|11277272|FG000|Period 2|failed to meet all eligibility creiteria|1
7131356|NCT03701516|11277273|FG001|Period 2|failed to meet all eligibility creiteria|0
7131357|NCT03701516|11277272|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0
7131358|NCT03701516|11277273|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1
7131359|NCT03650556|11277279|FG000|Overall Study|Death|2
7131360|NCT03650556|11277279|FG000|Overall Study|Withdrawal by Subject|20
7131361|NCT03650556|11277279|FG000|Overall Study|Physician Decision|2
7131362|NCT03650556|11277279|FG000|Overall Study|Lost to Follow-up|8
7131363|NCT03650556|11277279|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4
7131364|NCT03650556|11277279|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1
7131365|NCT03639311|11277286|FG000|Overall Study|Ongoing at the time of analysis|88
7131366|NCT03639311|11277287|FG001|Overall Study|Ongoing at the time of analysis|0
7131367|NCT03639311|11277286|FG000|Overall Study|Lost to Follow-up|1
7131368|NCT03639311|11277287|FG001|Overall Study|Lost to Follow-up|0
7131369|NCT03639311|11277286|FG000|Overall Study|Adverse Event|1
7131370|NCT03639311|11277287|FG001|Overall Study|Adverse Event|0
7131371|NCT03628716|11277298|FG000|Overall Study|Adverse Event|1
7131372|NCT03628716|11277299|FG001|Overall Study|Adverse Event|1
7131373|NCT03628716|11277298|FG000|Overall Study|Death|1
7131374|NCT03628716|11277299|FG001|Overall Study|Death|0
7131375|NCT03628716|11277298|FG000|Overall Study|Lack of Efficacy|15
7131376|NCT03628716|11277299|FG001|Overall Study|Lack of Efficacy|20
7131377|NCT03628716|11277298|FG000|Overall Study|Withdrawal by Subject|1
7131378|NCT03628716|11277299|FG001|Overall Study|Withdrawal by Subject|2
7131379|NCT03628716|11277298|FG000|Overall Study|Study Terminated by Sponsor|1
7131380|NCT03628716|11277299|FG001|Overall Study|Study Terminated by Sponsor|0
7131381|NCT03377699|11277309|FG000|Overall Study|Withdrawal by Subject|2
7131382|NCT03377699|11277310|FG001|Overall Study|Withdrawal by Subject|9
7131383|NCT03377699|11277309|FG000|Overall Study|Lost to Follow-up|1
7131384|NCT03377699|11277310|FG001|Overall Study|Lost to Follow-up|1
7131385|NCT03377699|11277309|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1
7131386|NCT03377699|11277310|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0
7131387|NCT03377699|11277309|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1
7131388|NCT03377699|11277310|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1
7131389|NCT03377699|11277309|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11
7131390|NCT03377699|11277310|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8
7131391|NCT03377699|11277309|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6
7131392|NCT03377699|11277310|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6
7131393|NCT03275350|11277320|FG000|Overall Study|Lost to Follow-up|4
7131394|NCT03275350|11277321|FG001|Overall Study|Lost to Follow-up|6
7131395|NCT03275350|11277320|FG000|Overall Study|Death|2
7131396|NCT03275350|11277321|FG001|Overall Study|Death|1
7131397|NCT03275350|11277320|FG000|Overall Study|Physician Decision|1
7131398|NCT03275350|11277321|FG001|Overall Study|Physician Decision|0
7131399|NCT03275350|11277320|FG000|Overall Study|Incarcerated|1
7131400|NCT03275350|11277321|FG001|Overall Study|Incarcerated|1
7131401|NCT03272347|11277332|FG000|Overall Study|Death|0
7131402|NCT03272347|11277333|FG001|Overall Study|Death|0
7131403|NCT03272347|11277334|FG002|Overall Study|Death|0
7131404|NCT03272347|11277335|FG003|Overall Study|Death|1
7131405|NCT03272347|11277332|FG000|Overall Study|Lost to Follow-up|1
7131406|NCT03272347|11277333|FG001|Overall Study|Lost to Follow-up|0
7131407|NCT03272347|11277334|FG002|Overall Study|Lost to Follow-up|5
7131408|NCT03272347|11277335|FG003|Overall Study|Lost to Follow-up|1
7131409|NCT03272347|11277332|FG000|Overall Study|Physician Decision|4
7131410|NCT03272347|11277333|FG001|Overall Study|Physician Decision|2
7131411|NCT03272347|11277334|FG002|Overall Study|Physician Decision|5
7131412|NCT03272347|11277335|FG003|Overall Study|Physician Decision|4
7131413|NCT03272347|11277332|FG000|Overall Study|Screen Failure|1
7131414|NCT03272347|11277333|FG001|Overall Study|Screen Failure|0
7131415|NCT03272347|11277334|FG002|Overall Study|Screen Failure|0
7131416|NCT03272347|11277335|FG003|Overall Study|Screen Failure|0
7131417|NCT03272347|11277332|FG000|Overall Study|Withdrawal by Subject|3
7131418|NCT03272347|11277333|FG001|Overall Study|Withdrawal by Subject|1
7131419|NCT03272347|11277334|FG002|Overall Study|Withdrawal by Subject|2
7131420|NCT03272347|11277335|FG003|Overall Study|Withdrawal by Subject|1
7131421|NCT03272347|11277332|FG000|Overall Study|Status Not Recorded|22
7131422|NCT03272347|11277333|FG001|Overall Study|Status Not Recorded|26
7131423|NCT03272347|11277334|FG002|Overall Study|Status Not Recorded|19
7131424|NCT03272347|11277335|FG003|Overall Study|Status Not Recorded|22
7131434|NCT02674750|11277389|FG000|Overall Study|Death|4
7131435|NCT02674750|11277390|FG001|Overall Study|Death|5
7131436|NCT02674750|11277391|FG002|Overall Study|Death|8
7131437|NCT02674750|11277389|FG000|Overall Study|Lost to Follow-up|0
7131438|NCT02674750|11277390|FG001|Overall Study|Lost to Follow-up|8
7131439|NCT02674750|11277391|FG002|Overall Study|Lost to Follow-up|0
7131440|NCT02674750|11277389|FG000|Overall Study|Lack of Efficacy|1
7131441|NCT02674750|11277390|FG001|Overall Study|Lack of Efficacy|17
7131442|NCT02674750|11277391|FG002|Overall Study|Lack of Efficacy|3
7131443|NCT02674750|11277389|FG000|Overall Study|Withdrawal by Subject|0
7131444|NCT02674750|11277390|FG001|Overall Study|Withdrawal by Subject|7
7131445|NCT02674750|11277391|FG002|Overall Study|Withdrawal by Subject|1
7131446|NCT02674750|11277389|FG000|Overall Study|Other|0
7131447|NCT02674750|11277390|FG001|Overall Study|Other|8
7131448|NCT02674750|11277391|FG002|Overall Study|Other|0
7131449|NCT02440854|11277398|FG000|Overall Study|Relocation of patient|1
7131450|NCT02440854|11277398|FG000|Overall Study|Death|6
7131451|NCT02440854|11277398|FG000|Overall Study|Lost to Follow-up|10
7131452|NCT02440854|11277398|FG000|Overall Study|Afatinib discontinuation|46
7131453|NCT02440854|11277398|FG000|Overall Study|stopped study at earlier timepoint|14
7131454|NCT02440854|11277398|FG000|Overall Study|Study medication not received|1
7131455|NCT02440854|11277398|FG000|Overall Study|Violation of inclusion criteria|2
7131456|NCT02154529|11277417|FG000|Overall Study|Death|1
7131457|NCT02154529|11277418|FG001|Overall Study|Death|1
7131458|NCT02154529|11277419|FG002|Overall Study|Death|5
6806292|NCT02564900|10808830|FG002|Dose Expansion|Progressive disease per RECIST|0
6806293|NCT02564900|10808831|FG003|Dose Expansion|Progressive disease per RECIST|0
6806294|NCT02564900|10808832|FG004|Dose Expansion|Progressive disease per RECIST|0
6806295|NCT02564900|10808833|FG005|Dose Expansion|Progressive disease per RECIST|0
6806296|NCT02564900|10808834|FG006|Dose Expansion|Progressive disease per RECIST|19
6806297|NCT02564900|10808835|FG007|Dose Expansion|Progressive disease per RECIST|17
6806298|NCT02564900|10808836|FG008|Dose Expansion|Progressive disease per RECIST|8
6806299|NCT02564900|10808837|FG009|Dose Expansion|Progressive disease per RECIST|16
6806300|NCT02564900|10808838|FG010|Dose Expansion|Progressive disease per RECIST|13
6806301|NCT02564900|10808839|FG011|Dose Expansion|Progressive disease per RECIST|19
6806302|NCT02564900|10808840|FG012|Dose Expansion|Progressive disease per RECIST|10
6806303|NCT02564900|10808841|FG013|Dose Expansion|Progressive disease per RECIST|13
6806304|NCT02564900|10808842|FG014|Dose Expansion|Progressive disease per RECIST|11
6806305|NCT02564900|10808828|FG000|Dose Expansion|Clinical progression|0
6806306|NCT02564900|10808829|FG001|Dose Expansion|Clinical progression|0
6806307|NCT02564900|10808830|FG002|Dose Expansion|Clinical progression|0
6806308|NCT02564900|10808831|FG003|Dose Expansion|Clinical progression|0
6806309|NCT02564900|10808832|FG004|Dose Expansion|Clinical progression|0
6806310|NCT02564900|10808833|FG005|Dose Expansion|Clinical progression|0
6806311|NCT02564900|10808834|FG006|Dose Expansion|Clinical progression|5
6806312|NCT02564900|10808835|FG007|Dose Expansion|Clinical progression|12
6806313|NCT02564900|10808836|FG008|Dose Expansion|Clinical progression|0
6806314|NCT02564900|10808837|FG009|Dose Expansion|Clinical progression|3
6806315|NCT02564900|10808838|FG010|Dose Expansion|Clinical progression|2
6806316|NCT02564900|10808839|FG011|Dose Expansion|Clinical progression|0
6806317|NCT02564900|10808840|FG012|Dose Expansion|Clinical progression|1
7131459|NCT02154529|11277420|FG003|Overall Study|Death|1
7131460|NCT02154529|11277417|FG000|Overall Study|Termination of study by sponsor|2
7131461|NCT02154529|11277418|FG001|Overall Study|Termination of study by sponsor|2
7131462|NCT02154529|11277419|FG002|Overall Study|Termination of study by sponsor|3
7131463|NCT02154529|11277420|FG003|Overall Study|Termination of study by sponsor|1
7131464|NCT02154529|11277417|FG000|Overall Study|Lost to Follow-up|1
7131465|NCT02154529|11277418|FG001|Overall Study|Lost to Follow-up|0
7131466|NCT02154529|11277419|FG002|Overall Study|Lost to Follow-up|0
7131467|NCT02154529|11277420|FG003|Overall Study|Lost to Follow-up|0
7131468|NCT00788125|11277432|FG000|Overall Study|Death|6
7131469|NCT02777554|11277438|FG000|Overall Study|Adverse Event|4
7131470|NCT02777554|11277439|FG001|Overall Study|Adverse Event|4
7131471|NCT02777554|11277440|FG002|Overall Study|Adverse Event|0
7131472|NCT02777554|11277441|FG003|Overall Study|Adverse Event|1
7131473|NCT02777554|11277442|FG004|Overall Study|Adverse Event|0
7131474|NCT02777554|11277443|FG005|Overall Study|Adverse Event|0
7131475|NCT02777554|11277438|FG000|Overall Study|Withdrawal by Subject|3
7131476|NCT02777554|11277439|FG001|Overall Study|Withdrawal by Subject|1
7131477|NCT02777554|11277440|FG002|Overall Study|Withdrawal by Subject|1
7131478|NCT02777554|11277441|FG003|Overall Study|Withdrawal by Subject|0
7131479|NCT02777554|11277442|FG004|Overall Study|Withdrawal by Subject|0
7131480|NCT02777554|11277443|FG005|Overall Study|Withdrawal by Subject|0
7131481|NCT02777554|11277438|FG000|Overall Study|Discharged early due to hurricane|22
7131482|NCT02777554|11277439|FG001|Overall Study|Discharged early due to hurricane|20
7131483|NCT02777554|11277440|FG002|Overall Study|Discharged early due to hurricane|0
7131484|NCT02777554|11277441|FG003|Overall Study|Discharged early due to hurricane|0
7131485|NCT02777554|11277442|FG004|Overall Study|Discharged early due to hurricane|0
7131486|NCT02777554|11277443|FG005|Overall Study|Discharged early due to hurricane|0
7131487|NCT02777554|11277438|FG000|Overall Study|Other - Miscellaneous|1
7131488|NCT02777554|11277439|FG001|Overall Study|Other - Miscellaneous|0
7131489|NCT02777554|11277440|FG002|Overall Study|Other - Miscellaneous|0
7131490|NCT02777554|11277441|FG003|Overall Study|Other - Miscellaneous|0
7131491|NCT02777554|11277442|FG004|Overall Study|Other - Miscellaneous|0
7131492|NCT02777554|11277443|FG005|Overall Study|Other - Miscellaneous|0
7131493|NCT02777827|11277480|FG000|Washout Between Periods 3 and 4|Protocol Violation|0
7131494|NCT02777827|11277481|FG001|Washout Between Periods 3 and 4|Protocol Violation|0
7131495|NCT02777827|11277482|FG002|Washout Between Periods 3 and 4|Protocol Violation|1
7131496|NCT02777827|11277483|FG003|Washout Between Periods 3 and 4|Protocol Violation|0
7131497|NCT02777827|11277484|FG004|Washout Between Periods 3 and 4|Protocol Violation|0
7131498|NCT02777827|11277485|FG005|Washout Between Periods 3 and 4|Protocol Violation|0
7131499|NCT02777918|11277501|FG000|Overall Study|Medical reasons|1
7131500|NCT02777918|11277502|FG001|Overall Study|Medical reasons|2
7131501|NCT02777918|11277501|FG000|Overall Study|Too busy / stressed|1
7131502|NCT02777918|11277502|FG001|Overall Study|Too busy / stressed|1
7131503|NCT02777918|11277501|FG000|Overall Study|Withdrawal by Subject|1
7131504|NCT02777918|11277502|FG001|Overall Study|Withdrawal by Subject|1
7131505|NCT02777970|11277529|FG000|Overall Study|Lost to Follow-up|0
7131506|NCT02777970|11277530|FG001|Overall Study|Lost to Follow-up|1
7131507|NCT02777970|11277531|FG002|Overall Study|Lost to Follow-up|0
7131508|NCT02777970|11277529|FG000|Overall Study|Protocol Violation|1
7131509|NCT02777970|11277530|FG001|Overall Study|Protocol Violation|0
7131510|NCT02777970|11277531|FG002|Overall Study|Protocol Violation|0
7131511|NCT02778074|11277543|FG000|Overall Study|Lost to Follow-up|7
7131512|NCT02778074|11277544|FG001|Overall Study|Lost to Follow-up|10
7131513|NCT02778100|11277552|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1
7131514|NCT02778100|11277553|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0
7131515|NCT02778555|11277583|FG000|Overall Study|Withdrawal by Subject|55
7131516|NCT02778555|11277584|FG001|Overall Study|Withdrawal by Subject|32
7131517|NCT02778555|11277585|FG002|Overall Study|Withdrawal by Subject|107
7131518|NCT02778867|11277595|FG000|Phase 1|Withdrawal by Subject|2
7131519|NCT02778867|11277596|FG001|Phase 1|Withdrawal by Subject|3
7131520|NCT02778867|11277597|FG002|Phase 1|Withdrawal by Subject|0
7131521|NCT02778867|11277598|FG003|Phase 1|Withdrawal by Subject|0
7131522|NCT02778867|11277595|FG000|Phase 2|Withdrawal by Subject|0
7131523|NCT02778867|11277596|FG001|Phase 2|Withdrawal by Subject|0
7131524|NCT02778867|11277597|FG002|Phase 2|Withdrawal by Subject|1
7131525|NCT02778867|11277598|FG003|Phase 2|Withdrawal by Subject|0
7131526|NCT02778867|11277595|FG000|Phase 2|Physician Decision|0
7131527|NCT02778867|11277596|FG001|Phase 2|Physician Decision|0
7131528|NCT02778867|11277597|FG002|Phase 2|Physician Decision|0
7131529|NCT02778867|11277598|FG003|Phase 2|Physician Decision|1
7131530|NCT02778867|11277595|FG000|Phase 2|Adverse Event|0
7131531|NCT02778867|11277596|FG001|Phase 2|Adverse Event|0
7131532|NCT02778867|11277597|FG002|Phase 2|Adverse Event|0
7131533|NCT02778867|11277598|FG003|Phase 2|Adverse Event|1
7131534|NCT02779075|11277628|FG000|Overall Study|Withdrawal by Subject|1
7131535|NCT02779075|11277629|FG001|Overall Study|Withdrawal by Subject|3
7131536|NCT02779075|11277628|FG000|Overall Study|IV lost during 2nd study|1
7131537|NCT02779075|11277629|FG001|Overall Study|IV lost during 2nd study|0
7131538|NCT02780115|11277676|FG000|Overall Study|Withdrawal by Subject|0
7131539|NCT02780115|11277677|FG001|Overall Study|Withdrawal by Subject|1
7131540|NCT02780115|11277678|FG002|Overall Study|Withdrawal by Subject|1
7131541|NCT02780115|11277679|FG003|Overall Study|Withdrawal by Subject|0
7131542|NCT02780115|11277680|FG004|Overall Study|Withdrawal by Subject|0
7131543|NCT02780115|11277676|FG000|Overall Study|Adverse Event|0
7131544|NCT02780115|11277677|FG001|Overall Study|Adverse Event|0
7131545|NCT02780115|11277678|FG002|Overall Study|Adverse Event|0
7131546|NCT02780115|11277679|FG003|Overall Study|Adverse Event|1
7131547|NCT02780115|11277680|FG004|Overall Study|Adverse Event|1
7131548|NCT02780167|11277697|FG000|Overall Study|Adverse Event|9
7131549|NCT02780167|11277698|FG001|Overall Study|Adverse Event|8
7131550|NCT02780167|11277699|FG002|Overall Study|Adverse Event|8
7131551|NCT02780167|11277700|FG003|Overall Study|Adverse Event|12
7131552|NCT02780167|11277701|FG004|Overall Study|Adverse Event|8
7131553|NCT02780167|11277697|FG000|Overall Study|Lack of Efficacy|6
7131554|NCT02780167|11277698|FG001|Overall Study|Lack of Efficacy|5
7131555|NCT02780167|11277699|FG002|Overall Study|Lack of Efficacy|6
7131556|NCT02780167|11277700|FG003|Overall Study|Lack of Efficacy|1
7131557|NCT02780167|11277701|FG004|Overall Study|Lack of Efficacy|0
7131558|NCT02780167|11277697|FG000|Overall Study|Lost to Follow-up|2
7131559|NCT02780167|11277698|FG001|Overall Study|Lost to Follow-up|0
7131560|NCT02780167|11277699|FG002|Overall Study|Lost to Follow-up|1
7131561|NCT02780167|11277700|FG003|Overall Study|Lost to Follow-up|0
7131562|NCT02780167|11277701|FG004|Overall Study|Lost to Follow-up|0
7131563|NCT02780167|11277697|FG000|Overall Study|Does not meet entrance criteria|0
7131564|NCT02780167|11277698|FG001|Overall Study|Does not meet entrance criteria|0
7131565|NCT02780167|11277699|FG002|Overall Study|Does not meet entrance criteria|1
7131566|NCT02780167|11277700|FG003|Overall Study|Does not meet entrance criteria|0
7131567|NCT02780167|11277701|FG004|Overall Study|Does not meet entrance criteria|0
7131568|NCT02780167|11277697|FG000|Overall Study|No longer meets eligibility criteria|0
7131569|NCT02780167|11277698|FG001|Overall Study|No longer meets eligibility criteria|0
7131570|NCT02780167|11277699|FG002|Overall Study|No longer meets eligibility criteria|0
7131571|NCT02780167|11277700|FG003|Overall Study|No longer meets eligibility criteria|1
7131572|NCT02780167|11277701|FG004|Overall Study|No longer meets eligibility criteria|1
7131573|NCT02780167|11277697|FG000|Overall Study|Protocol Violation|5
7131574|NCT02780167|11277698|FG001|Overall Study|Protocol Violation|5
7131575|NCT02780167|11277699|FG002|Overall Study|Protocol Violation|1
7131576|NCT02780167|11277700|FG003|Overall Study|Protocol Violation|1
7131577|NCT02780167|11277701|FG004|Overall Study|Protocol Violation|2
7131578|NCT02780167|11277697|FG000|Overall Study|Withdrawal by Subject|6
7131579|NCT02780167|11277698|FG001|Overall Study|Withdrawal by Subject|4
7131580|NCT02780167|11277699|FG002|Overall Study|Withdrawal by Subject|4
7131581|NCT02780167|11277700|FG003|Overall Study|Withdrawal by Subject|3
7131582|NCT02780167|11277701|FG004|Overall Study|Withdrawal by Subject|4
7131583|NCT02780167|11277697|FG000|Overall Study|Other|0
7131584|NCT02780167|11277698|FG001|Overall Study|Other|0
7131585|NCT02780167|11277699|FG002|Overall Study|Other|3
7131586|NCT02780167|11277700|FG003|Overall Study|Other|1
7131587|NCT02780167|11277701|FG004|Overall Study|Other|2
7131588|NCT02780388|11277722|FG000|Overall Study|Lost to Follow-up|0
7131589|NCT02780388|11277723|FG001|Overall Study|Lost to Follow-up|1
7131590|NCT02780388|11277724|FG002|Overall Study|Lost to Follow-up|0
7131591|NCT02780388|11277725|FG003|Overall Study|Lost to Follow-up|0
7131592|NCT02780388|11277726|FG004|Overall Study|Lost to Follow-up|0
7131593|NCT02780388|11277722|FG000|Overall Study|Withdrawal by Subject|1
7131594|NCT02780388|11277723|FG001|Overall Study|Withdrawal by Subject|1
7131595|NCT02780388|11277724|FG002|Overall Study|Withdrawal by Subject|0
7131596|NCT02780388|11277725|FG003|Overall Study|Withdrawal by Subject|0
7131597|NCT02780388|11277726|FG004|Overall Study|Withdrawal by Subject|0
7131598|NCT02780687|11277760|FG000|Overall Study|Adverse Event|1
7131599|NCT02780687|11277761|FG001|Overall Study|Adverse Event|1
7131600|NCT02780687|11277760|FG000|Overall Study|Withdrawal by Subject|2
7131601|NCT02780687|11277761|FG001|Overall Study|Withdrawal by Subject|1
7131602|NCT02780687|11277760|FG000|Overall Study|Switched to commercial program (in CTP)|2
7131603|NCT02780687|11277761|FG001|Overall Study|Switched to commercial program (in CTP)|0
7131604|NCT02780687|11277760|FG000|Overall Study|progressive disease|29
7131605|NCT02780687|11277761|FG001|Overall Study|progressive disease|6
7131606|NCT02780700|11277766|FG000|Overall Study|Progressive disease|1
7131607|NCT02780713|11277770|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0
7131608|NCT02780713|11277771|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0
7131609|NCT02780713|11277772|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2
7131610|NCT02780713|11277773|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0
7131611|NCT02780713|11277774|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0
7131612|NCT02780856|11277802|FG000|Overall Study|Lost to Follow-up|1
7131613|NCT02781311|11277826|FG000|Overall Study|Adverse Event|2
7131614|NCT02781311|11277827|FG001|Overall Study|Adverse Event|6
7131615|NCT02781311|11277828|FG002|Overall Study|Adverse Event|1
7131616|NCT02781311|11277826|FG000|Overall Study|Withdrawal of Consent|11
7131617|NCT02781311|11277827|FG001|Overall Study|Withdrawal of Consent|12
7131618|NCT02781311|11277828|FG002|Overall Study|Withdrawal of Consent|2
7131619|NCT02781311|11277826|FG000|Overall Study|Lost to Follow-up|11
7131620|NCT02781311|11277827|FG001|Overall Study|Lost to Follow-up|8
7131621|NCT02781311|11277828|FG002|Overall Study|Lost to Follow-up|1
7131622|NCT02781311|11277826|FG000|Overall Study|Non-Compliance with Study Drug|2
7131623|NCT02781311|11277827|FG001|Overall Study|Non-Compliance with Study Drug|0
7131624|NCT02781311|11277828|FG002|Overall Study|Non-Compliance with Study Drug|0
7131625|NCT02781324|11277837|FG000|Overall Study|Withdrawal by Subject|1
7131626|NCT02781324|11277838|FG001|Overall Study|Withdrawal by Subject|0
7131627|NCT02781324|11277837|FG000|Overall Study|Physician Decision|1
7131628|NCT02781324|11277838|FG001|Overall Study|Physician Decision|2
7131629|NCT02781558|11277874|FG000|Overall Study|Lost to Follow-up|2
7131630|NCT02781558|11277875|FG001|Overall Study|Lost to Follow-up|2
7131631|NCT02781558|11277874|FG000|Overall Study|Adverse Event|1
7131632|NCT02781558|11277875|FG001|Overall Study|Adverse Event|0
7131633|NCT02781818|11277919|FG000|Overall Study|Lost to Follow-up|4
7131634|NCT02781818|11277920|FG001|Overall Study|Lost to Follow-up|2
7131635|NCT02781818|11277921|FG002|Overall Study|Lost to Follow-up|1
7131636|NCT02781844|11277933|FG000|Treatment Period 1|Adverse Event|0
7131637|NCT02781844|11277934|FG001|Treatment Period 1|Adverse Event|0
7131638|NCT02781844|11277935|FG002|Treatment Period 1|Adverse Event|0
7131639|NCT02781844|11277936|FG003|Treatment Period 1|Adverse Event|0
7131640|NCT02781844|11277937|FG004|Treatment Period 1|Adverse Event|0
7131641|NCT02781844|11277938|FG005|Treatment Period 1|Adverse Event|1
7131642|NCT02781844|11277939|FG006|Treatment Period 1|Adverse Event|0
7131643|NCT02781844|11277940|FG007|Treatment Period 1|Adverse Event|0
7131644|NCT02782169|11277963|FG000|Overall Study|Lost to Follow-up|1
7131645|NCT02782169|11277964|FG001|Overall Study|Lost to Follow-up|2
7131646|NCT02782325|11277972|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4
7131647|NCT02782325|11277973|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2
7131648|NCT02782325|11277974|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0
7131649|NCT02782325|11277972|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0
7131650|NCT02782325|11277973|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0
7131651|NCT02782325|11277974|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4
7131652|NCT02782377|11277990|FG000|Overall Study|Physician Decision|5
7131653|NCT02782676|11277995|FG000|Overall Study|Lost to Follow-up|0
7131654|NCT02782676|11277996|FG001|Overall Study|Lost to Follow-up|1
7131655|NCT02782780|11278004|FG000|Overall Study|dropped out after randomization.|7
7131656|NCT02782780|11278005|FG001|Overall Study|dropped out after randomization.|5
7131657|NCT02782780|11278004|FG000|Overall Study|Protocol Violation|0
7131658|NCT02782780|11278005|FG001|Overall Study|Protocol Violation|2
7131659|NCT02782923|11278011|FG000|Overall Study|Lost to Follow-up|15
7131660|NCT02783066|11278024|FG000|Overall Study|Withdrawal by Subject|13
7131661|NCT02783170|11278031|FG000|Overall Study|Randomized but not Vaccinated|1
7131662|NCT02783170|11278032|FG001|Overall Study|Randomized but not Vaccinated|0
7131663|NCT02783573|11278055|FG000|Placebo-Controlled Treatment Period|Adverse Event|13
7131664|NCT02783573|11278056|FG001|Placebo-Controlled Treatment Period|Adverse Event|17
7131665|NCT02783573|11278057|FG002|Placebo-Controlled Treatment Period|Adverse Event|13
7131666|NCT02783573|11278055|FG000|Placebo-Controlled Treatment Period|Death|4
7131667|NCT02783573|11278056|FG001|Placebo-Controlled Treatment Period|Death|2
7131668|NCT02783573|11278057|FG002|Placebo-Controlled Treatment Period|Death|3
7131669|NCT02783573|11278055|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0
7131670|NCT02783573|11278056|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0
7131671|NCT02783573|11278057|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2
7131672|NCT02783573|11278055|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3
7131673|NCT02783573|11278056|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3
7131674|NCT02783573|11278057|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1
7131675|NCT02783573|11278055|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0
7131676|NCT02783573|11278056|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1
7131677|NCT02783573|11278057|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0
7131678|NCT02783573|11278055|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0
7131679|NCT02783573|11278056|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1
7131680|NCT02783573|11278057|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2
7131681|NCT02783573|11278055|FG000|Placebo-Controlled Treatment Period|Physician Decision|3
7131682|NCT02783573|11278056|FG001|Placebo-Controlled Treatment Period|Physician Decision|1
7131683|NCT02783573|11278057|FG002|Placebo-Controlled Treatment Period|Physician Decision|3
7131684|NCT02783573|11278055|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1
7131685|NCT02783573|11278056|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2
7131686|NCT02783573|11278057|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0
7131687|NCT02783573|11278055|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15
7131688|NCT02783573|11278056|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20
7131689|NCT02783573|11278057|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23
7131690|NCT02783573|11278055|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3
7131691|NCT02783573|11278056|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3
7131692|NCT02783573|11278057|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9
7131693|NCT02783573|11278055|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494
7131694|NCT02783573|11278056|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512
7131695|NCT02783573|11278057|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492
7131696|NCT02783573|11278055|FG000|Delayed-Start Period|Sponsor Decision|0
7131697|NCT02783573|11278056|FG001|Delayed-Start Period|Sponsor Decision|17
7131698|NCT02783573|11278057|FG002|Delayed-Start Period|Sponsor Decision|12
7131699|NCT02783599|11278068|FG000|Overall Study|Progressive disease|23
7131700|NCT02783599|11278068|FG000|Overall Study|Surgical Resection|10
7131701|NCT02783599|11278068|FG000|Overall Study|Adverse Event|4
7131702|NCT02783599|11278068|FG000|Overall Study|Physician Decision|2
7131703|NCT02783599|11278068|FG000|Overall Study|Death|1
7131704|NCT02783729|11278083|FG000|Overall Study|Lack of Efficacy|1
7131705|NCT02783729|11278084|FG001|Overall Study|Lack of Efficacy|0
7131706|NCT02783729|11278085|FG002|Overall Study|Lack of Efficacy|0
7131707|NCT02783729|11278086|FG003|Overall Study|Lack of Efficacy|0
7131708|NCT02783729|11278083|FG000|Overall Study|Adverse Event|2
7131709|NCT02783729|11278084|FG001|Overall Study|Adverse Event|6
7131710|NCT02783729|11278085|FG002|Overall Study|Adverse Event|2
7131711|NCT02783729|11278086|FG003|Overall Study|Adverse Event|3
7131712|NCT02783729|11278083|FG000|Overall Study|Other|1
7131713|NCT02783729|11278084|FG001|Overall Study|Other|6
7131714|NCT02783729|11278085|FG002|Overall Study|Other|2
7131715|NCT02783729|11278086|FG003|Overall Study|Other|3
7131716|NCT02783729|11278083|FG000|Overall Study|Withdrawal by Subject|2
7131717|NCT02783729|11278084|FG001|Overall Study|Withdrawal by Subject|3
7131718|NCT02783729|11278085|FG002|Overall Study|Withdrawal by Subject|1
7131719|NCT02783729|11278086|FG003|Overall Study|Withdrawal by Subject|2
7131720|NCT02783729|11278083|FG000|Overall Study|Participant's choice|2
7131721|NCT02783729|11278084|FG001|Overall Study|Participant's choice|1
7131722|NCT02783729|11278085|FG002|Overall Study|Participant's choice|2
7131723|NCT02783729|11278086|FG003|Overall Study|Participant's choice|1
7131724|NCT02783729|11278083|FG000|Overall Study|Lost to Follow-up|2
7131725|NCT02783729|11278084|FG001|Overall Study|Lost to Follow-up|1
7131726|NCT02783729|11278085|FG002|Overall Study|Lost to Follow-up|1
7131727|NCT02783729|11278086|FG003|Overall Study|Lost to Follow-up|0
7131728|NCT02783768|11278101|FG000|Overall Study|Lost to Follow-up|1
7131729|NCT02783768|11278102|FG001|Overall Study|Lost to Follow-up|0
7131730|NCT02783911|11278138|FG000|Overall Study|Lost to Follow-up|3
7131731|NCT02783911|11278139|FG001|Overall Study|Lost to Follow-up|32
7131732|NCT02784106|11278156|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3
7131733|NCT02784106|11278157|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5
7131734|NCT02784106|11278158|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
7131735|NCT02784106|11278159|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
7131736|NCT02784106|11278156|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2
7131737|NCT02784106|11278157|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1
7131738|NCT02784106|11278158|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
7131739|NCT02784106|11278159|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
7131740|NCT02784106|11278156|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2
7131741|NCT02784106|11278157|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0
7131742|NCT02784106|11278158|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0
7131743|NCT02784106|11278159|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0
7131744|NCT02784106|11278156|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1
7131745|NCT02784106|11278157|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
7131746|NCT02784106|11278158|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
7131747|NCT02784106|11278159|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
7131748|NCT02784106|11278156|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0
7131749|NCT02784106|11278157|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0
7131750|NCT02784106|11278158|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2
7131751|NCT02784106|11278159|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1
7131752|NCT02784106|11278156|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
7131753|NCT02784106|11278157|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
7131754|NCT02784106|11278158|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
7131755|NCT02784106|11278159|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
7131756|NCT02784431|11278185|FG000|Overall Study|Unsuccessful Implant Attempt|1
7131757|NCT02784431|11278185|FG000|Overall Study|Early Study Termination|19
7131758|NCT02784834|11278219|FG000|Overall Study|Lack of Efficacy|1
7131759|NCT02785458|11278312|FG000|1 Month|Withdrawal by Subject|2
7131760|NCT02785458|11278313|FG001|1 Month|Withdrawal by Subject|1
7131761|NCT02785458|11278312|FG000|1 Month|Lost to Follow-up|38
7131762|NCT02785458|11278313|FG001|1 Month|Lost to Follow-up|31
7131763|NCT02785458|11278312|FG000|1 Month|Deemed Ineligible|1
7131764|NCT02785458|11278313|FG001|1 Month|Deemed Ineligible|0
7131765|NCT02785458|11278312|FG000|1 Month|Completed Evaluation by Baseline|42
7131766|NCT02785458|11278313|FG001|1 Month|Completed Evaluation by Baseline|39
7131767|NCT02785458|11278312|FG000|1 Month|Partial Interview|0
7131768|NCT02785458|11278313|FG001|1 Month|Partial Interview|4
7131769|NCT02785458|11278312|FG000|3 Months|Withdrawal by Subject|3
7131770|NCT02785458|11278313|FG001|3 Months|Withdrawal by Subject|1
7131771|NCT02785458|11278312|FG000|3 Months|Lost to Follow-up|25
7131772|NCT02785458|11278313|FG001|3 Months|Lost to Follow-up|21
7131773|NCT02785458|11278312|FG000|3 Months|Completed Evaluation at 1 Month|100
7131774|NCT02785458|11278313|FG001|3 Months|Completed Evaluation at 1 Month|89
7131775|NCT02785588|11278319|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1
7131776|NCT02785588|11278319|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1
7131777|NCT02785770|11278323|FG000|Intervention Period 2 (1 Day)|Adverse Event|0
7131778|NCT02785770|11278324|FG001|Intervention Period 2 (1 Day)|Adverse Event|1
7131779|NCT02785770|11278325|FG002|Intervention Period 2 (1 Day)|Adverse Event|0
7131780|NCT02785770|11278326|FG003|Intervention Period 2 (1 Day)|Adverse Event|0
7131781|NCT02785770|11278323|FG000|Intervention Period 2 (1 Day)|Family related obligations|0
7131782|NCT02785770|11278324|FG001|Intervention Period 2 (1 Day)|Family related obligations|0
7131783|NCT02785770|11278325|FG002|Intervention Period 2 (1 Day)|Family related obligations|1
7131784|NCT02785770|11278326|FG003|Intervention Period 2 (1 Day)|Family related obligations|0
7131785|NCT02785770|11278323|FG000|Intervention Period 3 (1 Day)|Adverse Event|0
7131786|NCT02785770|11278324|FG001|Intervention Period 3 (1 Day)|Adverse Event|0
7131787|NCT02785770|11278325|FG002|Intervention Period 3 (1 Day)|Adverse Event|0
7131788|NCT02785770|11278326|FG003|Intervention Period 3 (1 Day)|Adverse Event|1
7131789|NCT02785900|11278341|FG000|Overall Study|Study Termination by Sponsor|64
7131790|NCT02785900|11278342|FG001|Overall Study|Study Termination by Sponsor|81
7131791|NCT02785900|11278341|FG000|Overall Study|Death|46
7131792|NCT02785900|11278342|FG001|Overall Study|Death|32
7131793|NCT02785900|11278341|FG000|Overall Study|Withdrawal by Subject|4
7131794|NCT02785900|11278342|FG001|Overall Study|Withdrawal by Subject|8
7131795|NCT02785900|11278341|FG000|Overall Study|Physician Decision|3
7131796|NCT02785900|11278342|FG001|Overall Study|Physician Decision|2
7131797|NCT02785913|11278348|FG000|Overall Study|Adverse Event|5
7131798|NCT02785913|11278348|FG000|Overall Study|Death|2
7131799|NCT02785913|11278348|FG000|Overall Study|Progression|18
7131800|NCT02785913|11278348|FG000|Overall Study|Not protocol specified|1
7131801|NCT02785939|11278355|FG000|Overall Study|Progression|25
7131802|NCT02785939|11278356|FG001|Overall Study|Progression|8
7131803|NCT02785939|11278355|FG000|Overall Study|Adverse Event|3
7131804|NCT02785939|11278356|FG001|Overall Study|Adverse Event|1
7131805|NCT02785939|11278355|FG000|Overall Study|Death|1
7131806|NCT02785939|11278356|FG001|Overall Study|Death|0
7131807|NCT02785939|11278355|FG000|Overall Study|Refusal|1
7131808|NCT02785939|11278356|FG001|Overall Study|Refusal|0
7131809|NCT02785939|11278355|FG000|Overall Study|Deteriorating health|1
7131810|NCT02785939|11278356|FG001|Overall Study|Deteriorating health|0
7131811|NCT02785939|11278355|FG000|Overall Study|Not protocol specified|0
7131812|NCT02785939|11278356|FG001|Overall Study|Not protocol specified|1
7131813|NCT02786004|11278364|FG000|Overall Study|Withdrawal by Subject|0
7131814|NCT02786004|11278365|FG001|Overall Study|Withdrawal by Subject|1
7131815|NCT02786836|11278406|FG000|Overall Study|Death|1
7131816|NCT02786836|11278406|FG000|Overall Study|Lack of Efficacy|2
7131817|NCT02786836|11278406|FG000|Overall Study|Protocol Violation|3
7131818|NCT02786836|11278406|FG000|Overall Study|Withdrawal by Subject|3
7131819|NCT02786836|11278406|FG000|Overall Study|Liver Transplantation|2
7131820|NCT02786836|11278406|FG000|Overall Study|Device or Pharmacy Issues|3
7131821|NCT02786901|11278414|FG000|Overall Study|Adverse Event|1
7131822|NCT02786901|11278415|FG001|Overall Study|Adverse Event|1
7131823|NCT02786901|11278416|FG002|Overall Study|Adverse Event|2
7131824|NCT02786901|11278414|FG000|Overall Study|Physician Decision|1
7131825|NCT02786901|11278415|FG001|Overall Study|Physician Decision|0
7131826|NCT02786901|11278416|FG002|Overall Study|Physician Decision|0
7131827|NCT02786901|11278414|FG000|Overall Study|Rescue Therapy Use|71
7131828|NCT02786901|11278415|FG001|Overall Study|Rescue Therapy Use|49
7131829|NCT02786901|11278416|FG002|Overall Study|Rescue Therapy Use|33
7131830|NCT02786901|11278414|FG000|Overall Study|Subject Request/Lost to Follow up|1
7131831|NCT02786901|11278415|FG001|Overall Study|Subject Request/Lost to Follow up|5
7131832|NCT02786901|11278416|FG002|Overall Study|Subject Request/Lost to Follow up|5
7131833|NCT02786901|11278414|FG000|Overall Study|Disallowed medication|1
7131834|NCT02786901|11278415|FG001|Overall Study|Disallowed medication|1
7131835|NCT02786901|11278416|FG002|Overall Study|Disallowed medication|0
7131836|NCT02786901|11278414|FG000|Overall Study|Randomized in error|2
7131837|NCT02786901|11278415|FG001|Overall Study|Randomized in error|0
7131838|NCT02786901|11278416|FG002|Overall Study|Randomized in error|1
7131839|NCT02786927|11278424|FG000|Overall Study|Adverse Event|1
7131840|NCT02786927|11278424|FG000|Overall Study|Protocol Violation|4
7131841|NCT02786953|11278431|FG000|Overall Study|Withdrawal by Subject|3
7131842|NCT02786953|11278432|FG001|Overall Study|Withdrawal by Subject|0
7131843|NCT02786953|11278431|FG000|Overall Study|Physician Decision|0
7131844|NCT02786953|11278432|FG001|Overall Study|Physician Decision|1
7131845|NCT02787083|11278449|FG000|Overall Study|Adverse Event|1
7131846|NCT02787083|11278450|FG001|Overall Study|Adverse Event|0
7131847|NCT02787083|11278449|FG000|Overall Study|Withdrawal by Subject|2
7131848|NCT02787083|11278450|FG001|Overall Study|Withdrawal by Subject|2
7131849|NCT02787304|11278464|FG000|Overall Study|Adverse Event|9
7131850|NCT02787304|11278465|FG001|Overall Study|Adverse Event|3
7131851|NCT02787304|11278466|FG002|Overall Study|Adverse Event|8
7131852|NCT02787304|11278467|FG003|Overall Study|Adverse Event|1
7131853|NCT02787304|11278464|FG000|Overall Study|Withdrawal by Subject|1
7131854|NCT02787304|11278465|FG001|Overall Study|Withdrawal by Subject|4
7131855|NCT02787304|11278466|FG002|Overall Study|Withdrawal by Subject|0
7131856|NCT02787304|11278467|FG003|Overall Study|Withdrawal by Subject|0
7131857|NCT02787304|11278464|FG000|Overall Study|Lost to Follow-up|1
7131858|NCT02787304|11278465|FG001|Overall Study|Lost to Follow-up|0
7131859|NCT02787304|11278466|FG002|Overall Study|Lost to Follow-up|0
7131860|NCT02787304|11278467|FG003|Overall Study|Lost to Follow-up|1
7131861|NCT02787304|11278464|FG000|Overall Study|Noncompliance with study drug|0
7131862|NCT02787304|11278465|FG001|Overall Study|Noncompliance with study drug|0
7131863|NCT02787304|11278466|FG002|Overall Study|Noncompliance with study drug|1
7131864|NCT02787304|11278467|FG003|Overall Study|Noncompliance with study drug|0
7131865|NCT02787304|11278464|FG000|Overall Study|Physician Decision|0
7131866|NCT02787304|11278465|FG001|Overall Study|Physician Decision|0
7131867|NCT02787304|11278466|FG002|Overall Study|Physician Decision|1
7131868|NCT02787304|11278467|FG003|Overall Study|Physician Decision|0
7131869|NCT02787304|11278464|FG000|Overall Study|Study terminated by sponsor|25
7131870|NCT02787304|11278465|FG001|Overall Study|Study terminated by sponsor|31
7131871|NCT02787304|11278466|FG002|Overall Study|Study terminated by sponsor|31
7131872|NCT02787304|11278467|FG003|Overall Study|Study terminated by sponsor|32
7131873|NCT02787863|11278511|FG000|Overall Study|Death|1
7131874|NCT02787863|11278512|FG001|Overall Study|Death|0
7131875|NCT02787863|11278513|FG002|Overall Study|Death|1
7131876|NCT02787863|11278514|FG003|Overall Study|Death|0
7131877|NCT02787863|11278515|FG004|Overall Study|Death|0
7131878|NCT02787863|11278516|FG005|Overall Study|Death|0
7131879|NCT02787863|11278517|FG006|Overall Study|Death|0
7131880|NCT02787863|11278518|FG007|Overall Study|Death|0
7131881|NCT02787863|11278511|FG000|Overall Study|Withdrawal by Subject|0
7131882|NCT02787863|11278512|FG001|Overall Study|Withdrawal by Subject|1
7131883|NCT02787863|11278513|FG002|Overall Study|Withdrawal by Subject|1
7131884|NCT02787863|11278514|FG003|Overall Study|Withdrawal by Subject|0
7131885|NCT02787863|11278515|FG004|Overall Study|Withdrawal by Subject|0
7131886|NCT02787863|11278516|FG005|Overall Study|Withdrawal by Subject|0
7131887|NCT02787863|11278517|FG006|Overall Study|Withdrawal by Subject|0
7131888|NCT02787863|11278518|FG007|Overall Study|Withdrawal by Subject|0
7131889|NCT02788175|11278577|FG000|Overall Study|Protocol Violation|3
7131890|NCT02788175|11278577|FG000|Overall Study|Withdrawal by Subject|4
7131891|NCT02788175|11278577|FG000|Overall Study|Ineligible prior to study agent|6
7131892|NCT02788201|11278616|FG000|Overall Study|Death|1
7131893|NCT02788201|11278617|FG001|Overall Study|Death|1
7131894|NCT02788201|11278618|FG002|Overall Study|Death|1
7131895|NCT02788201|11278619|FG003|Overall Study|Death|1
7131896|NCT02788201|11278620|FG004|Overall Study|Death|0
7131897|NCT02788201|11278621|FG005|Overall Study|Death|1
7131898|NCT02788201|11278616|FG000|Overall Study|Ineligible|0
7131899|NCT02788201|11278617|FG001|Overall Study|Ineligible|0
7131900|NCT02788201|11278618|FG002|Overall Study|Ineligible|0
7131901|NCT02788201|11278619|FG003|Overall Study|Ineligible|0
7131902|NCT02788201|11278620|FG004|Overall Study|Ineligible|0
7131903|NCT02788201|11278621|FG005|Overall Study|Ineligible|1
7131904|NCT02788201|11278616|FG000|Overall Study|Withdrawal by Subject|0
7131905|NCT02788201|11278617|FG001|Overall Study|Withdrawal by Subject|0
7131906|NCT02788201|11278618|FG002|Overall Study|Withdrawal by Subject|0
7131907|NCT02788201|11278619|FG003|Overall Study|Withdrawal by Subject|0
7131908|NCT02788201|11278620|FG004|Overall Study|Withdrawal by Subject|0
7131909|NCT02788201|11278621|FG005|Overall Study|Withdrawal by Subject|1
7131910|NCT02788279|11278640|FG000|Overall Study|Death|62
7131911|NCT02788279|11278641|FG001|Overall Study|Death|136
7131912|NCT02788279|11278642|FG002|Overall Study|Death|72
7131913|NCT02788279|11278640|FG000|Overall Study|Withdrawal by Subject|10
7131914|NCT02788279|11278641|FG001|Overall Study|Withdrawal by Subject|15
7131915|NCT02788279|11278642|FG002|Overall Study|Withdrawal by Subject|5
7131916|NCT02788279|11278640|FG000|Overall Study|Lost to Follow-up|0
7131917|NCT02788279|11278641|FG001|Overall Study|Lost to Follow-up|3
7131918|NCT02788279|11278642|FG002|Overall Study|Lost to Follow-up|2
7131919|NCT02788279|11278640|FG000|Overall Study|Sponsor decision|18
7131920|NCT02788279|11278641|FG001|Overall Study|Sponsor decision|29
7131921|NCT02788279|11278642|FG002|Overall Study|Sponsor decision|11
7131922|NCT02788357|11278655|FG000|Overall Study|Lost to Follow-up|3
7131923|NCT02788357|11278656|FG001|Overall Study|Lost to Follow-up|0
7131924|NCT02788474|11278664|FG000|Double Blind Treatment Period|Not treated|1
7131925|NCT02788474|11278665|FG001|Double Blind Treatment Period|Not treated|0
7131926|NCT02788474|11278664|FG000|Double Blind Treatment Period|Patient's refusal|3
7131927|NCT02788474|11278665|FG001|Double Blind Treatment Period|Patient's refusal|0
7131928|NCT02788474|11278664|FG000|Double Blind Treatment Period|Adverse Event|6
7131929|NCT02788474|11278665|FG001|Double Blind Treatment Period|Adverse Event|4
7131930|NCT02788474|11278664|FG000|Open Label Treatment Period|Adverse Event|29
7131931|NCT02788474|11278665|FG001|Open Label Treatment Period|Adverse Event|9
7131932|NCT02788474|11278664|FG000|Open Label Treatment Period|Other than reason specified|1
7131933|NCT02788474|11278665|FG001|Open Label Treatment Period|Other than reason specified|0
7131934|NCT02788474|11278664|FG000|Open Label Treatment Period|Patient's refusal|1
7131935|NCT02788474|11278665|FG001|Open Label Treatment Period|Patient's refusal|3
7131936|NCT02788474|11278664|FG000|Open Label Treatment Period|Non-compliance|1
7131937|NCT02788474|11278665|FG001|Open Label Treatment Period|Non-compliance|0
7131938|NCT02788513|11278677|FG000|Overall Study|Withdrawal by Subject|3
7131939|NCT02788513|11278678|FG001|Overall Study|Withdrawal by Subject|0
7131940|NCT02788513|11278679|FG002|Overall Study|Withdrawal by Subject|2
7131941|NCT02788513|11278680|FG003|Overall Study|Withdrawal by Subject|3
7131942|NCT02788513|11278681|FG004|Overall Study|Withdrawal by Subject|1
7131943|NCT02788513|11278677|FG000|Overall Study|Lost to Follow-up|1
7131944|NCT02788513|11278678|FG001|Overall Study|Lost to Follow-up|0
7131945|NCT02788513|11278679|FG002|Overall Study|Lost to Follow-up|0
7131946|NCT02788513|11278680|FG003|Overall Study|Lost to Follow-up|0
7131947|NCT02788513|11278681|FG004|Overall Study|Lost to Follow-up|1
7131948|NCT02788513|11278677|FG000|Overall Study|Adverse Event|5
7131949|NCT02788513|11278678|FG001|Overall Study|Adverse Event|8
7131950|NCT02788513|11278679|FG002|Overall Study|Adverse Event|4
7131951|NCT02788513|11278680|FG003|Overall Study|Adverse Event|2
7131952|NCT02788513|11278681|FG004|Overall Study|Adverse Event|2
7131953|NCT02788513|11278677|FG000|Overall Study|Protocol Violation|0
7131954|NCT02788513|11278678|FG001|Overall Study|Protocol Violation|0
7131955|NCT02788513|11278679|FG002|Overall Study|Protocol Violation|1
7131956|NCT02788513|11278680|FG003|Overall Study|Protocol Violation|1
7131957|NCT02788513|11278681|FG004|Overall Study|Protocol Violation|0
7131958|NCT02788513|11278677|FG000|Overall Study|Subject decided to stop taking treatment|0
7131959|NCT02788513|11278678|FG001|Overall Study|Subject decided to stop taking treatment|0
7131960|NCT02788513|11278679|FG002|Overall Study|Subject decided to stop taking treatment|1
7131961|NCT02788513|11278680|FG003|Overall Study|Subject decided to stop taking treatment|0
7131962|NCT02788513|11278681|FG004|Overall Study|Subject decided to stop taking treatment|0
7131963|NCT02788513|11278677|FG000|Overall Study|Decision by the study team|0
7131964|NCT02788513|11278678|FG001|Overall Study|Decision by the study team|0
7131965|NCT02788513|11278679|FG002|Overall Study|Decision by the study team|0
7131966|NCT02788513|11278680|FG003|Overall Study|Decision by the study team|0
7131967|NCT02788513|11278681|FG004|Overall Study|Decision by the study team|1
7131968|NCT02788656|11278695|FG000|Overall Study|Withdrawal by Subject|1
7131969|NCT02788656|11278696|FG001|Overall Study|Withdrawal by Subject|0
7131970|NCT02788747|11278705|FG000|Overall Study|Adverse Event|1
7131971|NCT02788747|11278706|FG001|Overall Study|Adverse Event|0
7131972|NCT02788747|11278707|FG002|Overall Study|Adverse Event|0
7131973|NCT02789111|11278748|FG000|Overall Study|Withdrawal by Subject|1
7131974|NCT02789111|11278749|FG001|Overall Study|Withdrawal by Subject|4
7131975|NCT02789137|11278757|FG000|Overall Study|Dropped out/Died|58
7131976|NCT02789176|11278766|FG000|Overall Study|Death|0
7131977|NCT02789176|11278767|FG001|Overall Study|Death|0
7131978|NCT02789176|11278768|FG002|Overall Study|Death|3
7131979|NCT02789176|11278769|FG003|Overall Study|Death|0
7131980|NCT02789176|11278766|FG000|Overall Study|Withdrawal by Subject|0
7131981|NCT02789176|11278767|FG001|Overall Study|Withdrawal by Subject|0
7131982|NCT02789176|11278768|FG002|Overall Study|Withdrawal by Subject|1
7131983|NCT02789176|11278769|FG003|Overall Study|Withdrawal by Subject|0
7131984|NCT02789176|11278766|FG000|Overall Study|Lost to Follow-up|8
7131985|NCT02789176|11278767|FG001|Overall Study|Lost to Follow-up|2
7131986|NCT02789176|11278768|FG002|Overall Study|Lost to Follow-up|6
7131987|NCT02789176|11278769|FG003|Overall Study|Lost to Follow-up|1
6806318|NCT02564900|10808841|FG013|Dose Expansion|Clinical progression|3
6806319|NCT02564900|10808842|FG014|Dose Expansion|Clinical progression|1
6806320|NCT02564900|10808828|FG000|Dose Expansion|Adverse Event|0
6806321|NCT02564900|10808829|FG001|Dose Expansion|Adverse Event|0
6806322|NCT02564900|10808830|FG002|Dose Expansion|Adverse Event|0
6806323|NCT02564900|10808831|FG003|Dose Expansion|Adverse Event|0
6806324|NCT02564900|10808832|FG004|Dose Expansion|Adverse Event|0
6806325|NCT02564900|10808833|FG005|Dose Expansion|Adverse Event|0
6806326|NCT02564900|10808834|FG006|Dose Expansion|Adverse Event|9
6806327|NCT02564900|10808835|FG007|Dose Expansion|Adverse Event|22
6806328|NCT02564900|10808836|FG008|Dose Expansion|Adverse Event|0
6806329|NCT02564900|10808837|FG009|Dose Expansion|Adverse Event|11
6806330|NCT02564900|10808838|FG010|Dose Expansion|Adverse Event|0
6806331|NCT02564900|10808839|FG011|Dose Expansion|Adverse Event|5
6806332|NCT02564900|10808840|FG012|Dose Expansion|Adverse Event|2
7131988|NCT02790073|11278788|FG000|Overall Study|Death|1
7131989|NCT02790073|11278788|FG000|Overall Study|Withdrawal from HD|1
7131990|NCT02790073|11278788|FG000|Overall Study|Withdrawal by Subject|1
7131991|NCT02790437|11278798|FG000|Overall Study|Patient graft failure - nephrectomy|1
7131992|NCT02790437|11278799|FG001|Overall Study|Patient graft failure - nephrectomy|0
7131993|NCT02790437|11278798|FG000|Overall Study|Adverse Event|1
7131994|NCT02790437|11278799|FG001|Overall Study|Adverse Event|0
7131995|NCT02790437|11278798|FG000|Overall Study|Withdrawal by Subject|1
7131996|NCT02790437|11278799|FG001|Overall Study|Withdrawal by Subject|0
7131997|NCT02790606|11278821|FG000|Overall Study|Death|27
7131998|NCT02790606|11278821|FG000|Overall Study|Lost to Follow-up|4
7131999|NCT02790606|11278821|FG000|Overall Study|Physician Decision|3
7132000|NCT02790606|11278821|FG000|Overall Study|Withdrawal by Subject|1
7132001|NCT02791191|11278848|FG000|Overall Study|Adverse Event|2
7132002|NCT02791191|11278849|FG001|Overall Study|Adverse Event|4
7132003|NCT02791191|11278850|FG002|Overall Study|Adverse Event|5
7132004|NCT02791191|11278848|FG000|Overall Study|Lack of Efficacy|0
7132005|NCT02791191|11278849|FG001|Overall Study|Lack of Efficacy|1
7132006|NCT02791191|11278850|FG002|Overall Study|Lack of Efficacy|0
7132007|NCT02791191|11278848|FG000|Overall Study|Study Drug Non-Compliance|0
7132008|NCT02791191|11278849|FG001|Overall Study|Study Drug Non-Compliance|2
7132009|NCT02791191|11278850|FG002|Overall Study|Study Drug Non-Compliance|0
7132010|NCT02791191|11278848|FG000|Overall Study|Site Closed by Sponsor|1
7132011|NCT02791191|11278849|FG001|Overall Study|Site Closed by Sponsor|1
7132012|NCT02791191|11278850|FG002|Overall Study|Site Closed by Sponsor|3
7132013|NCT02791191|11278848|FG000|Overall Study|Progressive Disease|1
7132014|NCT02791191|11278849|FG001|Overall Study|Progressive Disease|0
7132015|NCT02791191|11278850|FG002|Overall Study|Progressive Disease|0
7132016|NCT02791191|11278848|FG000|Overall Study|Study Terminated by Sponsor|29
7132017|NCT02791191|11278849|FG001|Overall Study|Study Terminated by Sponsor|101
7132018|NCT02791191|11278850|FG002|Overall Study|Study Terminated by Sponsor|109
7132019|NCT02791191|11278848|FG000|Overall Study|Withdrawal by Subject|3
7132020|NCT02791191|11278849|FG001|Overall Study|Withdrawal by Subject|1
7132021|NCT02791191|11278850|FG002|Overall Study|Withdrawal by Subject|3
7132022|NCT02791191|11278848|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2
7132023|NCT02791191|11278849|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1
7132024|NCT02791191|11278850|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0
7132025|NCT02791269|11278860|FG000|Overall Study|Lost to Follow-up|0
7132026|NCT02791269|11278861|FG001|Overall Study|Lost to Follow-up|1
7132027|NCT02791438|11278893|FG000|Treatment Period|Adverse Event|1
7132028|NCT02791438|11278894|FG001|Treatment Period|Adverse Event|0
7132029|NCT02791438|11278893|FG000|Treatment Period|Withdrawal by Subject|0
7132030|NCT02791438|11278894|FG001|Treatment Period|Withdrawal by Subject|1
7132031|NCT02791438|11278893|FG000|Treatment Period|Withdrawal by Parent/Guardian|2
7132032|NCT02791438|11278894|FG001|Treatment Period|Withdrawal by Parent/Guardian|0
7132033|NCT02791490|11278902|FG000|Overall Study|Lost to Follow-up|1
7132034|NCT02791490|11278903|FG001|Overall Study|Lost to Follow-up|2
7132035|NCT02791490|11278902|FG000|Overall Study|Withdrawal by Subject|2
7132036|NCT02791490|11278903|FG001|Overall Study|Withdrawal by Subject|6
7132037|NCT02791516|11278911|FG000|Overall Study|Withdrawal by Subject|1
7132038|NCT02791516|11278912|FG001|Overall Study|Withdrawal by Subject|1
7132039|NCT02791659|11278920|FG000|Overall Study|Protocol Violation|0
7132040|NCT02791659|11278921|FG001|Overall Study|Protocol Violation|1
7132041|NCT02791763|11278930|FG000|Overall Study|Protocol Violation|0
7132042|NCT02791763|11278931|FG001|Overall Study|Protocol Violation|0
7132043|NCT02791763|11278932|FG002|Overall Study|Protocol Violation|1
7132044|NCT02791763|11278930|FG000|Overall Study|Withdrawal by Subject|5
7132045|NCT02791763|11278931|FG001|Overall Study|Withdrawal by Subject|1
7132046|NCT02791763|11278932|FG002|Overall Study|Withdrawal by Subject|0
7132047|NCT02791763|11278930|FG000|Overall Study|Physician Decision|0
7132048|NCT02791763|11278931|FG001|Overall Study|Physician Decision|1
7132049|NCT02791763|11278932|FG002|Overall Study|Physician Decision|0
7132050|NCT02791763|11278930|FG000|Overall Study|Needs maintenance/changes in dialysis|16
7132051|NCT02791763|11278931|FG001|Overall Study|Needs maintenance/changes in dialysis|19
7132052|NCT02791763|11278932|FG002|Overall Study|Needs maintenance/changes in dialysis|5
7132053|NCT02791763|11278930|FG000|Overall Study|Cancer event|1
7132054|NCT02791763|11278931|FG001|Overall Study|Cancer event|3
7132055|NCT02791763|11278932|FG002|Overall Study|Cancer event|0
7132056|NCT02791763|11278930|FG000|Overall Study|Participant had renal transplant|3
7132057|NCT02791763|11278931|FG001|Overall Study|Participant had renal transplant|0
7132058|NCT02791763|11278932|FG002|Overall Study|Participant had renal transplant|0
7132059|NCT02791763|11278930|FG000|Overall Study|Met hemoglobin stopping criteria|1
7132060|NCT02791763|11278931|FG001|Overall Study|Met hemoglobin stopping criteria|0
7132061|NCT02791763|11278932|FG002|Overall Study|Met hemoglobin stopping criteria|0
7132062|NCT02791763|11278930|FG000|Overall Study|Adverse Event|12
7132063|NCT02791763|11278931|FG001|Overall Study|Adverse Event|13
7132064|NCT02791763|11278932|FG002|Overall Study|Adverse Event|7
7132065|NCT02791893|11278951|FG000|Blinded Phase|Lost to Follow-up|2
7132066|NCT02791893|11278952|FG001|Blinded Phase|Lost to Follow-up|2
7132067|NCT02791893|11278951|FG000|Blinded Phase|Withdrawal by Subject|1
7132068|NCT02791893|11278952|FG001|Blinded Phase|Withdrawal by Subject|2
7132069|NCT02791893|11278951|FG000|Open Label Phase|Lost to Follow-up|3
7132070|NCT02791893|11278952|FG001|Open Label Phase|Lost to Follow-up|0
7132071|NCT02791893|11278951|FG000|Open Label Phase|Withdrawal by Subject|0
7132072|NCT02791893|11278952|FG001|Open Label Phase|Withdrawal by Subject|2
7132073|NCT02792062|11278995|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1
7132074|NCT02792062|11278996|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
7132075|NCT02792062|11278997|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
7132076|NCT02792062|11278998|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
7132077|NCT02792062|11278999|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
7132078|NCT02792062|11279000|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
7132079|NCT02792192|11279012|FG000|Overall Study|Death|1
7132080|NCT02792192|11279013|FG001|Overall Study|Death|0
7132081|NCT02792192|11279014|FG002|Overall Study|Death|0
7132082|NCT02792192|11279015|FG003|Overall Study|Death|0
7132083|NCT02792192|11279012|FG000|Overall Study|Informed Consent Withdrawn|4
7132084|NCT02792192|11279013|FG001|Overall Study|Informed Consent Withdrawn|0
7132085|NCT02792192|11279014|FG002|Overall Study|Informed Consent Withdrawn|0
7132086|NCT02792192|11279015|FG003|Overall Study|Informed Consent Withdrawn|0
7132087|NCT02792192|11279012|FG000|Overall Study|Physician Decision|1
7132088|NCT02792192|11279013|FG001|Overall Study|Physician Decision|0
7132089|NCT02792192|11279014|FG002|Overall Study|Physician Decision|0
7132090|NCT02792192|11279015|FG003|Overall Study|Physician Decision|0
7132091|NCT02792192|11279012|FG000|Overall Study|Progressive Disease|0
7132092|NCT02792192|11279013|FG001|Overall Study|Progressive Disease|1
7132093|NCT02792192|11279014|FG002|Overall Study|Progressive Disease|0
7132094|NCT02792192|11279015|FG003|Overall Study|Progressive Disease|0
7132095|NCT02792192|11279012|FG000|Overall Study|Study Terminated By Sponsor|6
7132096|NCT02792192|11279013|FG001|Overall Study|Study Terminated By Sponsor|10
7132097|NCT02792192|11279014|FG002|Overall Study|Study Terminated By Sponsor|0
7132098|NCT02792192|11279015|FG003|Overall Study|Study Terminated By Sponsor|0
7132099|NCT02792218|11279028|FG000|Overall Study|Patient/guardian decision|15
7132100|NCT02792218|11279029|FG001|Overall Study|Patient/guardian decision|42
7132101|NCT02792218|11279028|FG000|Overall Study|Adverse Event|15
7132102|NCT02792218|11279029|FG001|Overall Study|Adverse Event|14
7132103|NCT02792218|11279028|FG000|Overall Study|Lost to Follow-up|10
7132104|NCT02792218|11279029|FG001|Overall Study|Lost to Follow-up|5
7132105|NCT02792218|11279028|FG000|Overall Study|Lack of Efficacy|1
7132106|NCT02792218|11279029|FG001|Overall Study|Lack of Efficacy|12
7132107|NCT02792218|11279028|FG000|Overall Study|Physician Decision|4
7132108|NCT02792218|11279029|FG001|Overall Study|Physician Decision|4
7132109|NCT02792218|11279028|FG000|Overall Study|Protocol deviation|3
7132110|NCT02792218|11279029|FG001|Overall Study|Protocol deviation|2
7132111|NCT02792218|11279028|FG000|Overall Study|New therapy for study indication|0
7132112|NCT02792218|11279029|FG001|Overall Study|New therapy for study indication|1
7132113|NCT02792218|11279028|FG000|Overall Study|Non-compliance with study treatment|0
7132114|NCT02792218|11279029|FG001|Overall Study|Non-compliance with study treatment|1
7132115|NCT02792218|11279028|FG000|Overall Study|Pregnancy|1
7132116|NCT02792218|11279029|FG001|Overall Study|Pregnancy|0
7132117|NCT02792231|11279037|FG000|Overall Study|Patient/guardian decision|32
7132118|NCT02792231|11279038|FG001|Overall Study|Patient/guardian decision|42
7132119|NCT02792231|11279037|FG000|Overall Study|Adverse Event|15
7132120|NCT02792231|11279038|FG001|Overall Study|Adverse Event|11
7132121|NCT02792231|11279037|FG000|Overall Study|Physician Decision|14
7132122|NCT02792231|11279038|FG001|Overall Study|Physician Decision|12
7132123|NCT02792231|11279037|FG000|Overall Study|Lack of Efficacy|7
7132124|NCT02792231|11279038|FG001|Overall Study|Lack of Efficacy|9
7132125|NCT02792231|11279037|FG000|Overall Study|Lost to Follow-up|9
7132126|NCT02792231|11279038|FG001|Overall Study|Lost to Follow-up|5
7132127|NCT02792231|11279037|FG000|Overall Study|Pregnancy|1
7132128|NCT02792231|11279038|FG001|Overall Study|Pregnancy|3
7132129|NCT02792231|11279037|FG000|Overall Study|Non-compliance with study treatment|2
7132130|NCT02792231|11279038|FG001|Overall Study|Non-compliance with study treatment|1
7132131|NCT02792231|11279037|FG000|Overall Study|Protocol deviation|2
7132132|NCT02792231|11279038|FG001|Overall Study|Protocol deviation|0
7132133|NCT02792231|11279037|FG000|Overall Study|Technical problems|0
7132134|NCT02792231|11279038|FG001|Overall Study|Technical problems|1
7132135|NCT02792504|11279044|FG000|Overall Study|Lost to Follow-up|24
7132136|NCT02792504|11279044|FG000|Overall Study|Violated inclusion/exclusion criteria|6
7132137|NCT02792517|11279048|FG000|Overall Study|Withdrawal by Subject|10
7132138|NCT02792517|11279048|FG000|Overall Study|Decision by Sponsor|7
7132139|NCT02792517|11279048|FG000|Overall Study|Lost to Follow-up|3
7132140|NCT02792699|11279055|FG000|Overall Study|Adverse Event|1
7132141|NCT02792699|11279056|FG001|Overall Study|Adverse Event|2
7132142|NCT02792699|11279057|FG002|Overall Study|Adverse Event|4
7132143|NCT02792699|11279055|FG000|Overall Study|Withdrawal by Subject|4
7132144|NCT02792699|11279056|FG001|Overall Study|Withdrawal by Subject|4
7132145|NCT02792699|11279057|FG002|Overall Study|Withdrawal by Subject|3
7132146|NCT02792699|11279055|FG000|Overall Study|Lost to Follow-up|0
7132147|NCT02792699|11279056|FG001|Overall Study|Lost to Follow-up|1
7132148|NCT02792699|11279057|FG002|Overall Study|Lost to Follow-up|2
7132149|NCT02792699|11279055|FG000|Overall Study|Physician Decision|2
7132150|NCT02792699|11279056|FG001|Overall Study|Physician Decision|0
7132151|NCT02792699|11279057|FG002|Overall Study|Physician Decision|0
7132152|NCT02792699|11279055|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1
7132153|NCT02792699|11279056|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3
7132154|NCT02792699|11279057|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1
7132155|NCT02792699|11279055|FG000|Overall Study|Other|1
7132156|NCT02792699|11279056|FG001|Overall Study|Other|0
7132157|NCT02792699|11279057|FG002|Overall Study|Other|0
7132158|NCT02792777|11279074|FG000|Overall Study|Withdrawal by Subject|2
7132159|NCT02792777|11279075|FG001|Overall Study|Withdrawal by Subject|0
7132160|NCT02792777|11279074|FG000|Overall Study|Recording malfunction|2
7132161|NCT02792777|11279075|FG001|Overall Study|Recording malfunction|0
7132162|NCT02792777|11279074|FG000|Overall Study|Later determined to be ineligible|2
7132163|NCT02792777|11279075|FG001|Overall Study|Later determined to be ineligible|0
7132164|NCT02792777|11279074|FG000|Overall Study|Participant interviewed twice|1
7132165|NCT02792777|11279075|FG001|Overall Study|Participant interviewed twice|0
7132166|NCT02792829|11279090|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0
7132167|NCT02792829|11279091|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1
7132168|NCT02792829|11279092|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0
7132169|NCT02792829|11279093|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0
7132170|NCT02792829|11279094|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0
7132171|NCT02792829|11279095|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0
7132172|NCT02792829|11279096|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0
7132173|NCT02792829|11279097|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0
7132174|NCT02792829|11279090|FG000|Treatment Period 2|Adverse Event|0
7132175|NCT02792829|11279091|FG001|Treatment Period 2|Adverse Event|0
7132176|NCT02792829|11279092|FG002|Treatment Period 2|Adverse Event|0
7132177|NCT02792829|11279093|FG003|Treatment Period 2|Adverse Event|0
7132178|NCT02792829|11279094|FG004|Treatment Period 2|Adverse Event|1
7132179|NCT02792829|11279095|FG005|Treatment Period 2|Adverse Event|0
7132180|NCT02792829|11279096|FG006|Treatment Period 2|Adverse Event|1
7132181|NCT02792829|11279097|FG007|Treatment Period 2|Adverse Event|1
7132182|NCT02792829|11279090|FG000|Treatment Period 2|Use of proscribed medications|0
7132183|NCT02792829|11279091|FG001|Treatment Period 2|Use of proscribed medications|0
7132184|NCT02792829|11279092|FG002|Treatment Period 2|Use of proscribed medications|0
7132185|NCT02792829|11279093|FG003|Treatment Period 2|Use of proscribed medications|0
7132186|NCT02792829|11279094|FG004|Treatment Period 2|Use of proscribed medications|0
7132187|NCT02792829|11279095|FG005|Treatment Period 2|Use of proscribed medications|0
7132188|NCT02792829|11279096|FG006|Treatment Period 2|Use of proscribed medications|0
7132189|NCT02792829|11279097|FG007|Treatment Period 2|Use of proscribed medications|1
7132190|NCT02792959|11279123|FG000|Overall Study|Protocol Violation|1
7132191|NCT02793128|11279127|FG000|Overall Study|Death|4
7132192|NCT02793128|11279127|FG000|Overall Study|Withdrawal by Subject|2
7132193|NCT02793128|11279127|FG000|Overall Study|Physician Decision|1
7132194|NCT02793128|11279127|FG000|Overall Study|Comorbid conditions and noncompliance|1
7132195|NCT02793128|11279127|FG000|Overall Study|Patient elected nephroureterectomy|1
7132196|NCT02793232|11279161|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
7132197|NCT02793232|11279162|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
7132198|NCT02793232|11279163|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
7132199|NCT02793232|11279164|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
7132200|NCT02793232|11279165|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1
7132201|NCT02793232|11279166|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
7132202|NCT02793232|11279167|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1
7132203|NCT02793232|11279168|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
7132204|NCT02793232|11279169|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
7132205|NCT02793622|11279205|FG000|Overall Study|Lost to Follow-up|31
7132206|NCT02793622|11279206|FG001|Overall Study|Lost to Follow-up|19
7132207|NCT02793622|11279205|FG000|Overall Study|Withdrawal by Subject|21
7132208|NCT02793622|11279206|FG001|Overall Study|Withdrawal by Subject|17
7132209|NCT02793622|11279205|FG000|Overall Study|Adverse Event|0
7132210|NCT02793622|11279206|FG001|Overall Study|Adverse Event|1
7132211|NCT02793622|11279205|FG000|Overall Study|Protocol Violation|1
7132212|NCT02793622|11279206|FG001|Overall Study|Protocol Violation|5
7132213|NCT02793947|11279283|FG000|Overall Study|Death|1
7132214|NCT02793947|11279284|FG001|Overall Study|Death|0
7132215|NCT02793947|11279283|FG000|Overall Study|Physician Decision|1
7132216|NCT02793947|11279284|FG001|Overall Study|Physician Decision|5
7132217|NCT02794103|11279290|FG000|Overall Study|Loss to follow up due to high sedation|3
7132218|NCT02794246|11279302|FG000|Overall Study|Withdrawal by Subject|2
7132219|NCT02794246|11279302|FG000|Overall Study|Physician Decision|4
7132220|NCT02794480|11279317|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
7132221|NCT02794480|11279318|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
7132222|NCT02794480|11279319|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1
7132223|NCT02794480|11279320|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
7132224|NCT02794480|11279317|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
7132225|NCT02794480|11279318|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
7132226|NCT02794480|11279319|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1
7132227|NCT02794480|11279320|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
7132228|NCT02794480|11279317|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
7132229|NCT02794480|11279318|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
7132230|NCT02794480|11279319|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
7132231|NCT02794480|11279320|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2
7132232|NCT02794480|11279317|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7132233|NCT02794480|11279318|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2
7132234|NCT02794480|11279319|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7132235|NCT02794480|11279320|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1
7132236|NCT02794480|11279317|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
7132237|NCT02794480|11279318|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7132238|NCT02794480|11279319|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7132239|NCT02794480|11279320|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
7132240|NCT02794870|11279368|FG000|Overall Study|Withdrawal by Subject|2
7132241|NCT02794870|11279369|FG001|Overall Study|Withdrawal by Subject|0
7132242|NCT02794974|11279377|FG000|Overall Study|Physician Decision|0
7132243|NCT02794974|11279378|FG001|Overall Study|Physician Decision|1
7132244|NCT02795767|11279400|FG000|Overall Study|Received Commercial Emicizumab|1
7132245|NCT02795767|11279401|FG001|Overall Study|Received Commercial Emicizumab|0
7132246|NCT02795767|11279402|FG002|Overall Study|Received Commercial Emicizumab|0
7132247|NCT02795832|11279447|FG000|Overall Study|Adverse Event|0
7132248|NCT02795832|11279448|FG001|Overall Study|Adverse Event|0
6806333|NCT02564900|10808841|FG013|Dose Expansion|Adverse Event|2
7132249|NCT02795832|11279449|FG002|Overall Study|Adverse Event|0
7132250|NCT02795832|11279450|FG003|Overall Study|Adverse Event|0
7132251|NCT02795832|11279451|FG004|Overall Study|Adverse Event|0
7132252|NCT02795832|11279452|FG005|Overall Study|Adverse Event|3
7132253|NCT02796560|11279517|FG000|Overall Study|Adverse Event|2
7132254|NCT02796560|11279518|FG001|Overall Study|Adverse Event|0
7132255|NCT02796560|11279517|FG000|Overall Study|Withdrawal by Subject|2
7132256|NCT02796560|11279518|FG001|Overall Study|Withdrawal by Subject|2
7132257|NCT02796651|11279528|FG000|Overall Study|Adverse Event|6
7132258|NCT02796651|11279528|FG000|Overall Study|Lost to Follow-up|1
7132259|NCT02796651|11279528|FG000|Overall Study|Withdrawal by Subject|4
7132260|NCT02796651|11279528|FG000|Overall Study|Protocol Violation|4
7132261|NCT02796651|11279528|FG000|Overall Study|Lack of Efficacy|1
7132262|NCT02796651|11279528|FG000|Overall Study|Other|10
7132263|NCT02796664|11279545|FG000|Overall Study|Withdrawal by Subject|0
7132264|NCT02796664|11279546|FG001|Overall Study|Withdrawal by Subject|3
7132265|NCT02796664|11279545|FG000|Overall Study|Noncompliance|1
7132266|NCT02796664|11279546|FG001|Overall Study|Noncompliance|1
7132267|NCT02796664|11279545|FG000|Overall Study|Death|0
7132268|NCT02796664|11279546|FG001|Overall Study|Death|1
7132269|NCT02796677|11279558|FG000|Overall Study|Adverse Event|11
7132270|NCT02796677|11279559|FG001|Overall Study|Adverse Event|22
7132271|NCT02796677|11279560|FG002|Overall Study|Adverse Event|14
7132272|NCT02796677|11279561|FG003|Overall Study|Adverse Event|14
7132273|NCT02796677|11279558|FG000|Overall Study|Protocol Violation|7
7132274|NCT02796677|11279559|FG001|Overall Study|Protocol Violation|5
7132275|NCT02796677|11279560|FG002|Overall Study|Protocol Violation|4
7132276|NCT02796677|11279561|FG003|Overall Study|Protocol Violation|8
7132277|NCT02796677|11279558|FG000|Overall Study|Lost to Follow-up|1
7132278|NCT02796677|11279559|FG001|Overall Study|Lost to Follow-up|5
7132279|NCT02796677|11279560|FG002|Overall Study|Lost to Follow-up|2
7132280|NCT02796677|11279561|FG003|Overall Study|Lost to Follow-up|2
7132281|NCT02796677|11279558|FG000|Overall Study|Lack of Efficacy|7
7132282|NCT02796677|11279559|FG001|Overall Study|Lack of Efficacy|9
7132283|NCT02796677|11279560|FG002|Overall Study|Lack of Efficacy|14
7132284|NCT02796677|11279561|FG003|Overall Study|Lack of Efficacy|20
7132285|NCT02796677|11279558|FG000|Overall Study|Withdrawal by Subject|4
7132286|NCT02796677|11279559|FG001|Overall Study|Withdrawal by Subject|14
7132287|NCT02796677|11279560|FG002|Overall Study|Withdrawal by Subject|6
7132288|NCT02796677|11279561|FG003|Overall Study|Withdrawal by Subject|7
7132289|NCT02796677|11279558|FG000|Overall Study|Progressive disease|6
7132290|NCT02796677|11279559|FG001|Overall Study|Progressive disease|15
7132291|NCT02796677|11279560|FG002|Overall Study|Progressive disease|13
7132292|NCT02796677|11279561|FG003|Overall Study|Progressive disease|18
7132293|NCT02796677|11279558|FG000|Overall Study|Reason not mentioned|2
7132294|NCT02796677|11279559|FG001|Overall Study|Reason not mentioned|3
7132295|NCT02796677|11279560|FG002|Overall Study|Reason not mentioned|0
7132296|NCT02796677|11279561|FG003|Overall Study|Reason not mentioned|5
7132297|NCT02796755|11279575|FG000|Overall Study|Adverse Event|2
7132298|NCT02796755|11279576|FG001|Overall Study|Adverse Event|0
7132299|NCT02796963|11279590|FG000|Overall Study|Lost to Follow-up|89
7132300|NCT02796963|11279591|FG001|Overall Study|Lost to Follow-up|76
7132301|NCT02796963|11279592|FG002|Overall Study|Lost to Follow-up|69
7132302|NCT02796963|11279593|FG003|Overall Study|Lost to Follow-up|72
7132303|NCT02797080|11279616|FG000|Overall Study|Lost to Follow-up|1
7132304|NCT02797080|11279616|FG000|Overall Study|Withdrawal by Subject|1
7132305|NCT02797132|11279620|FG000|Part A (15 Days)|Adverse Event|1
7132306|NCT02797132|11279620|FG000|Part B (24 Weeks)|Adverse Event|3
7132307|NCT02797171|11279639|FG000|Overall Study|Lost to Follow-up|2
7132308|NCT02797171|11279640|FG001|Overall Study|Lost to Follow-up|0
7132309|NCT02797171|11279641|FG002|Overall Study|Lost to Follow-up|2
7132310|NCT02797171|11279642|FG003|Overall Study|Lost to Follow-up|1
7132311|NCT02797171|11279643|FG004|Overall Study|Lost to Follow-up|2
7132312|NCT02797171|11279644|FG005|Overall Study|Lost to Follow-up|0
7132313|NCT02797171|11279639|FG000|Overall Study|Withdrawal by Subject|1
7132314|NCT02797171|11279640|FG001|Overall Study|Withdrawal by Subject|1
7132315|NCT02797171|11279641|FG002|Overall Study|Withdrawal by Subject|0
7132316|NCT02797171|11279642|FG003|Overall Study|Withdrawal by Subject|0
7132317|NCT02797171|11279643|FG004|Overall Study|Withdrawal by Subject|0
7132318|NCT02797171|11279644|FG005|Overall Study|Withdrawal by Subject|0
7132319|NCT02797171|11279639|FG000|Overall Study|Protocol Violation|1
7132320|NCT02797171|11279640|FG001|Overall Study|Protocol Violation|0
7132321|NCT02797171|11279641|FG002|Overall Study|Protocol Violation|0
7132322|NCT02797171|11279642|FG003|Overall Study|Protocol Violation|0
7132323|NCT02797171|11279643|FG004|Overall Study|Protocol Violation|0
7132324|NCT02797171|11279644|FG005|Overall Study|Protocol Violation|0
7132325|NCT02797171|11279639|FG000|Overall Study|Participant unable to adhere|0
7132326|NCT02797171|11279640|FG001|Overall Study|Participant unable to adhere|1
7132327|NCT02797171|11279641|FG002|Overall Study|Participant unable to adhere|0
7132328|NCT02797171|11279642|FG003|Overall Study|Participant unable to adhere|0
7132329|NCT02797171|11279643|FG004|Overall Study|Participant unable to adhere|0
7132330|NCT02797171|11279644|FG005|Overall Study|Participant unable to adhere|0
7132331|NCT02797171|11279639|FG000|Overall Study|Not Randomized|0
7132332|NCT02797171|11279640|FG001|Overall Study|Not Randomized|0
7132333|NCT02797171|11279641|FG002|Overall Study|Not Randomized|0
7132334|NCT02797171|11279642|FG003|Overall Study|Not Randomized|0
7132335|NCT02797171|11279643|FG004|Overall Study|Not Randomized|0
7132336|NCT02797171|11279644|FG005|Overall Study|Not Randomized|1
7132337|NCT02797522|11279669|FG000|Overall Study|Study Terminated by Sponsor|0
7132338|NCT02797522|11279670|FG001|Overall Study|Study Terminated by Sponsor|0
7132339|NCT02797522|11279671|FG002|Overall Study|Study Terminated by Sponsor|0
7132340|NCT02797522|11279672|FG003|Overall Study|Study Terminated by Sponsor|0
7132341|NCT02797522|11279673|FG004|Overall Study|Study Terminated by Sponsor|0
7132342|NCT02797522|11279674|FG005|Overall Study|Study Terminated by Sponsor|0
7132343|NCT02797522|11279675|FG006|Overall Study|Study Terminated by Sponsor|0
7132344|NCT02797522|11279676|FG007|Overall Study|Study Terminated by Sponsor|4
7132345|NCT02797522|11279677|FG008|Overall Study|Study Terminated by Sponsor|2
7132346|NCT02797522|11279678|FG009|Overall Study|Study Terminated by Sponsor|4
7132347|NCT02797522|11279679|FG010|Overall Study|Study Terminated by Sponsor|1
7132348|NCT02797678|11279716|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25
7132349|NCT02797678|11279717|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0
7132350|NCT02797678|11279718|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0
7132351|NCT02797678|11279719|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0
7132352|NCT02797678|11279716|FG000|First Intervention (5 Nights)|study/device use non-compliance|0
6806334|NCT02564900|10808842|FG014|Dose Expansion|Adverse Event|1
6806335|NCT02564900|10808828|FG000|Dose Expansion|Ongoing|0
6806336|NCT02564900|10808829|FG001|Dose Expansion|Ongoing|0
6806337|NCT02564900|10808830|FG002|Dose Expansion|Ongoing|0
6806338|NCT02564900|10808831|FG003|Dose Expansion|Ongoing|0
6806339|NCT02564900|10808832|FG004|Dose Expansion|Ongoing|0
6806340|NCT02564900|10808833|FG005|Dose Expansion|Ongoing|0
6806341|NCT02564900|10808834|FG006|Dose Expansion|Ongoing|9
6806342|NCT02564900|10808835|FG007|Dose Expansion|Ongoing|10
6806343|NCT02564900|10808836|FG008|Dose Expansion|Ongoing|11
6806344|NCT02564900|10808837|FG009|Dose Expansion|Ongoing|3
6806345|NCT02564900|10808838|FG010|Dose Expansion|Ongoing|0
6806346|NCT02564900|10808839|FG011|Dose Expansion|Ongoing|0
6806347|NCT02564900|10808840|FG012|Dose Expansion|Ongoing|4
6806348|NCT02564900|10808841|FG013|Dose Expansion|Ongoing|0
6806349|NCT02564900|10808842|FG014|Dose Expansion|Ongoing|6
6806350|NCT02564900|10808828|FG000|Dose Expansion|Death|0
6806351|NCT02564900|10808829|FG001|Dose Expansion|Death|0
6806352|NCT02564900|10808830|FG002|Dose Expansion|Death|0
6806353|NCT02564900|10808831|FG003|Dose Expansion|Death|0
6806354|NCT02564900|10808832|FG004|Dose Expansion|Death|0
6806355|NCT02564900|10808833|FG005|Dose Expansion|Death|0
6806356|NCT02564900|10808834|FG006|Dose Expansion|Death|1
6806357|NCT02564900|10808835|FG007|Dose Expansion|Death|0
6806358|NCT02564900|10808836|FG008|Dose Expansion|Death|0
6806359|NCT02564900|10808837|FG009|Dose Expansion|Death|0
6806360|NCT02564900|10808838|FG010|Dose Expansion|Death|1
7132353|NCT02797678|11279717|FG001|First Intervention (5 Nights)|study/device use non-compliance|1
7132354|NCT02797678|11279718|FG002|First Intervention (5 Nights)|study/device use non-compliance|0
7132355|NCT02797678|11279719|FG003|First Intervention (5 Nights)|study/device use non-compliance|0
7132356|NCT02797678|11279716|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0
7132357|NCT02797678|11279717|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0
7132358|NCT02797678|11279718|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1
7132359|NCT02797678|11279719|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0
7132360|NCT02797808|11279734|FG000|Overall Study|Withdrawal by Subject|1
7132361|NCT02797808|11279735|FG001|Overall Study|Withdrawal by Subject|1
7132362|NCT02797808|11279734|FG000|Overall Study|Physician Decision|6
7132363|NCT02797808|11279735|FG001|Overall Study|Physician Decision|2
7132364|NCT02798211|11279757|FG000|Period 1|Adverse Event|1
7132365|NCT02798211|11279758|FG001|Period 1|Adverse Event|1
7132366|NCT02798211|11279759|FG002|Period 1|Adverse Event|0
7132367|NCT02798211|11279760|FG003|Period 1|Adverse Event|0
7132368|NCT02798211|11279761|FG004|Period 1|Adverse Event|0
7132369|NCT02798211|11279762|FG005|Period 1|Adverse Event|0
7132370|NCT02798211|11279757|FG000|Period 1|Lost to Follow-up|2
7132371|NCT02798211|11279758|FG001|Period 1|Lost to Follow-up|1
7132372|NCT02798211|11279759|FG002|Period 1|Lost to Follow-up|0
7132373|NCT02798211|11279760|FG003|Period 1|Lost to Follow-up|0
7132374|NCT02798211|11279761|FG004|Period 1|Lost to Follow-up|0
7132375|NCT02798211|11279762|FG005|Period 1|Lost to Follow-up|0
7132376|NCT02798211|11279757|FG000|Period 1|Protocol Violation|0
7132377|NCT02798211|11279758|FG001|Period 1|Protocol Violation|0
7132378|NCT02798211|11279759|FG002|Period 1|Protocol Violation|2
7132379|NCT02798211|11279760|FG003|Period 1|Protocol Violation|0
7132380|NCT02798211|11279761|FG004|Period 1|Protocol Violation|0
7132381|NCT02798211|11279762|FG005|Period 1|Protocol Violation|0
7132382|NCT02798211|11279757|FG000|Period 1|Withdrawal by Subject|1
7132383|NCT02798211|11279758|FG001|Period 1|Withdrawal by Subject|1
7132384|NCT02798211|11279759|FG002|Period 1|Withdrawal by Subject|0
7132385|NCT02798211|11279760|FG003|Period 1|Withdrawal by Subject|0
7132386|NCT02798211|11279761|FG004|Period 1|Withdrawal by Subject|0
7132387|NCT02798211|11279762|FG005|Period 1|Withdrawal by Subject|0
7132388|NCT02798211|11279757|FG000|Period 1|Death|0
7132389|NCT02798211|11279758|FG001|Period 1|Death|0
7132390|NCT02798211|11279759|FG002|Period 1|Death|1
7132391|NCT02798211|11279760|FG003|Period 1|Death|0
7132392|NCT02798211|11279761|FG004|Period 1|Death|0
7132393|NCT02798211|11279762|FG005|Period 1|Death|0
7132394|NCT02798211|11279757|FG000|Period 1|Withdrawal of Informed Consent|2
7132395|NCT02798211|11279758|FG001|Period 1|Withdrawal of Informed Consent|7
7132396|NCT02798211|11279759|FG002|Period 1|Withdrawal of Informed Consent|3
7132397|NCT02798211|11279760|FG003|Period 1|Withdrawal of Informed Consent|0
7132398|NCT02798211|11279761|FG004|Period 1|Withdrawal of Informed Consent|0
7132399|NCT02798211|11279762|FG005|Period 1|Withdrawal of Informed Consent|0
7132400|NCT02798211|11279757|FG000|Period 2|Withdrawal by Subject|2
7132401|NCT02798211|11279758|FG001|Period 2|Withdrawal by Subject|0
7132402|NCT02798211|11279759|FG002|Period 2|Withdrawal by Subject|0
7132403|NCT02798211|11279760|FG003|Period 2|Withdrawal by Subject|0
7132404|NCT02798211|11279761|FG004|Period 2|Withdrawal by Subject|2
7132405|NCT02798211|11279762|FG005|Period 2|Withdrawal by Subject|2
7132406|NCT02798211|11279757|FG000|Period 2|Adverse Event|5
7132407|NCT02798211|11279758|FG001|Period 2|Adverse Event|0
7132408|NCT02798211|11279759|FG002|Period 2|Adverse Event|0
7132409|NCT02798211|11279760|FG003|Period 2|Adverse Event|0
7132410|NCT02798211|11279761|FG004|Period 2|Adverse Event|1
7132411|NCT02798211|11279762|FG005|Period 2|Adverse Event|0
7132412|NCT02798211|11279757|FG000|Period 2|Lack of Efficacy|1
7132413|NCT02798211|11279758|FG001|Period 2|Lack of Efficacy|0
7132414|NCT02798211|11279759|FG002|Period 2|Lack of Efficacy|0
7132415|NCT02798211|11279760|FG003|Period 2|Lack of Efficacy|1
7132416|NCT02798211|11279761|FG004|Period 2|Lack of Efficacy|0
7132417|NCT02798211|11279762|FG005|Period 2|Lack of Efficacy|1
7132418|NCT02798211|11279757|FG000|Period 2|Lost to Follow-up|3
7132419|NCT02798211|11279758|FG001|Period 2|Lost to Follow-up|0
7132420|NCT02798211|11279759|FG002|Period 2|Lost to Follow-up|0
7132421|NCT02798211|11279760|FG003|Period 2|Lost to Follow-up|0
7132422|NCT02798211|11279761|FG004|Period 2|Lost to Follow-up|2
7132423|NCT02798211|11279762|FG005|Period 2|Lost to Follow-up|0
7132424|NCT02798211|11279757|FG000|Period 2|Physician Decision|1
7132425|NCT02798211|11279758|FG001|Period 2|Physician Decision|0
7132426|NCT02798211|11279759|FG002|Period 2|Physician Decision|0
7132427|NCT02798211|11279760|FG003|Period 2|Physician Decision|1
7132428|NCT02798211|11279761|FG004|Period 2|Physician Decision|1
7132429|NCT02798211|11279762|FG005|Period 2|Physician Decision|0
7132430|NCT02798211|11279757|FG000|Period 2|Pregnancy|0
7132431|NCT02798211|11279758|FG001|Period 2|Pregnancy|0
7132432|NCT02798211|11279759|FG002|Period 2|Pregnancy|0
7132433|NCT02798211|11279760|FG003|Period 2|Pregnancy|2
7132434|NCT02798211|11279761|FG004|Period 2|Pregnancy|0
7132435|NCT02798211|11279762|FG005|Period 2|Pregnancy|0
7132436|NCT02798211|11279757|FG000|Period 2|Technical problems|1
7132437|NCT02798211|11279758|FG001|Period 2|Technical problems|0
7132438|NCT02798211|11279759|FG002|Period 2|Technical problems|0
7132439|NCT02798211|11279760|FG003|Period 2|Technical problems|1
7132440|NCT02798211|11279761|FG004|Period 2|Technical problems|0
7132441|NCT02798211|11279762|FG005|Period 2|Technical problems|0
7132442|NCT02798211|11279757|FG000|Period 2|Withdrawal of Informed Consent|1
7132443|NCT02798211|11279758|FG001|Period 2|Withdrawal of Informed Consent|0
7132444|NCT02798211|11279759|FG002|Period 2|Withdrawal of Informed Consent|0
7132445|NCT02798211|11279760|FG003|Period 2|Withdrawal of Informed Consent|2
7132446|NCT02798211|11279761|FG004|Period 2|Withdrawal of Informed Consent|2
7132447|NCT02798211|11279762|FG005|Period 2|Withdrawal of Informed Consent|3
7132448|NCT02798315|11279778|FG000|Overall Study|Failure to return|1
7132449|NCT02798835|11279817|FG000|Overall Study|Protocol Violation|0
7132450|NCT02798835|11279818|FG001|Overall Study|Protocol Violation|0
7132451|NCT02798835|11279819|FG002|Overall Study|Protocol Violation|3
7132452|NCT02798861|11279827|FG000|Overall Study|Lost to Follow-up|22
7132453|NCT02798861|11279827|FG000|Overall Study|Withdrawal by Subject|1
7132454|NCT02799069|11279873|FG000|Overall Study|Adverse Event|0
7132455|NCT02799069|11279874|FG001|Overall Study|Adverse Event|2
7132456|NCT02799069|11279875|FG002|Overall Study|Adverse Event|2
7132457|NCT02799069|11279873|FG000|Overall Study|Lack of Efficacy|2
7132458|NCT02799069|11279874|FG001|Overall Study|Lack of Efficacy|0
7132459|NCT02799069|11279875|FG002|Overall Study|Lack of Efficacy|0
7132460|NCT02799069|11279873|FG000|Overall Study|Lost to Follow-up|1
7132461|NCT02799069|11279874|FG001|Overall Study|Lost to Follow-up|1
7132462|NCT02799069|11279875|FG002|Overall Study|Lost to Follow-up|0
7132463|NCT02799069|11279873|FG000|Overall Study|Withdrawal by Subject|4
7132464|NCT02799069|11279874|FG001|Overall Study|Withdrawal by Subject|4
7132465|NCT02799069|11279875|FG002|Overall Study|Withdrawal by Subject|3
7132466|NCT02799069|11279873|FG000|Overall Study|Protocol Violation|1
7132467|NCT02799069|11279874|FG001|Overall Study|Protocol Violation|0
7132468|NCT02799069|11279875|FG002|Overall Study|Protocol Violation|2
7132469|NCT02799082|11279885|FG000|Overall Study|Refused second PDT or withdraw consent|4
7132470|NCT02799082|11279886|FG001|Overall Study|Refused second PDT or withdraw consent|3
7132471|NCT02799082|11279885|FG000|Overall Study|Protocol Violation|0
7132472|NCT02799082|11279886|FG001|Overall Study|Protocol Violation|1
7132473|NCT02799381|11279911|FG000|Overall Study|Withdrew consent|3
7132474|NCT02799381|11279912|FG001|Overall Study|Withdrew consent|2
7132475|NCT02799381|11279911|FG000|Overall Study|Adverse Event|0
7132476|NCT02799381|11279912|FG001|Overall Study|Adverse Event|1
7132477|NCT02799381|11279911|FG000|Overall Study|Participant did not take any study drug|1
7132478|NCT02799381|11279912|FG001|Overall Study|Participant did not take any study drug|0
7132479|NCT02799472|11279920|FG000|Overall Study|Withdrawal by Subject|2
7132480|NCT02799472|11279921|FG001|Overall Study|Withdrawal by Subject|4
7132481|NCT02799472|11279920|FG000|Overall Study|Lack of Efficacy|2
7132482|NCT02799472|11279921|FG001|Overall Study|Lack of Efficacy|0
7132483|NCT02799472|11279920|FG000|Overall Study|Lost to Follow-up|0
7132484|NCT02799472|11279921|FG001|Overall Study|Lost to Follow-up|1
7132485|NCT02799745|11279938|FG000|Overall Study|Participant moved out of state|1
7132486|NCT02799745|11279939|FG001|Overall Study|Participant moved out of state|0
7132487|NCT02799745|11279938|FG000|Overall Study|Discontinued due to planned surgery|1
7132488|NCT02799745|11279939|FG001|Overall Study|Discontinued due to planned surgery|0
7132489|NCT02799745|11279938|FG000|Overall Study|Withdrawal by Subject|16
7132490|NCT02799745|11279939|FG001|Overall Study|Withdrawal by Subject|25
7132491|NCT02799745|11279938|FG000|Overall Study|Protocol Deviation|4
7132492|NCT02799745|11279939|FG001|Overall Study|Protocol Deviation|5
7132493|NCT02799745|11279938|FG000|Overall Study|Progressive Disease|28
7132494|NCT02799745|11279939|FG001|Overall Study|Progressive Disease|38
7132495|NCT02799745|11279938|FG000|Overall Study|Lost to Follow-up|3
7132496|NCT02799745|11279939|FG001|Overall Study|Lost to Follow-up|2
7132497|NCT02799745|11279938|FG000|Overall Study|Death|3
7132498|NCT02799745|11279939|FG001|Overall Study|Death|0
7132499|NCT02799745|11279938|FG000|Overall Study|Adverse Event|0
7132500|NCT02799745|11279939|FG001|Overall Study|Adverse Event|1
7132501|NCT02799784|11279945|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1
7132502|NCT02799784|11279946|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1
7132503|NCT02799784|11279945|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5
7132504|NCT02799784|11279946|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0
7132505|NCT02799784|11279945|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0
7132506|NCT02799784|11279946|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1
7132507|NCT02799784|11279945|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1
7132508|NCT02799784|11279946|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0
7132509|NCT02799784|11279945|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0
7132510|NCT02799784|11279946|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1
7132511|NCT02799784|11279945|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0
7132512|NCT02799784|11279946|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1
7132513|NCT02800642|11279978|FG000|Overall Study|Death|3
7132514|NCT02800642|11279978|FG000|Overall Study|Other|10
7132515|NCT02800642|11279978|FG000|Overall Study|Physician Decision|2
7132516|NCT02800642|11279978|FG000|Overall Study|Adverse Event|6
7132517|NCT02800642|11279978|FG000|Overall Study|Withdrawal by Subject|3
7132518|NCT02800642|11279978|FG000|Overall Study|Lost to Follow-up|1
7132519|NCT02800928|11279982|FG000|Overall Study|Withdrawal by Subject|1
7132520|NCT02800928|11279983|FG001|Overall Study|Withdrawal by Subject|1
7132521|NCT02800928|11279982|FG000|Overall Study|Protocol Violation|1
7132522|NCT02800928|11279983|FG001|Overall Study|Protocol Violation|1
7132523|NCT02801396|11280008|FG000|Period 1|Withdrawal by Subject|0
7132524|NCT02801396|11280009|FG001|Period 1|Withdrawal by Subject|0
7132525|NCT02801396|11280010|FG002|Period 1|Withdrawal by Subject|0
7132526|NCT02801396|11280011|FG003|Period 1|Withdrawal by Subject|0
7132527|NCT02801396|11280012|FG004|Period 1|Withdrawal by Subject|1
7132528|NCT02801396|11280013|FG005|Period 1|Withdrawal by Subject|0
7132529|NCT02801578|11280021|FG000|Overall Study|Adverse Event|2
7132530|NCT02801617|11280027|FG000|Overall Study|Protocol Violation|2
7132531|NCT02801617|11280028|FG001|Overall Study|Protocol Violation|6
7132532|NCT02801669|11280040|FG000|Overall Study|Death|66
7132533|NCT02801669|11280041|FG001|Overall Study|Death|69
7132534|NCT02801669|11280040|FG000|Overall Study|Withdrawal by Subject|81
7132535|NCT02801669|11280041|FG001|Overall Study|Withdrawal by Subject|77
7132536|NCT02801669|11280040|FG000|Overall Study|Other|4
7132537|NCT02801669|11280041|FG001|Overall Study|Other|6
7132538|NCT02801877|11280051|FG000|Overall Study|Lost to Follow-up|1
7132539|NCT02801877|11280052|FG001|Overall Study|Lost to Follow-up|1
7132540|NCT02801877|11280053|FG002|Overall Study|Lost to Follow-up|2
7132541|NCT02801877|11280054|FG003|Overall Study|Lost to Follow-up|0
7132542|NCT02801877|11280051|FG000|Overall Study|Never Started Treatment|2
7132543|NCT02801877|11280052|FG001|Overall Study|Never Started Treatment|0
7132544|NCT02801877|11280053|FG002|Overall Study|Never Started Treatment|4
7132545|NCT02801877|11280054|FG003|Overall Study|Never Started Treatment|0
7132546|NCT02802319|11280101|FG000|Overall Study|Physician Decision|2
7132547|NCT02802319|11280102|FG001|Overall Study|Physician Decision|1
7132548|NCT02802319|11280101|FG000|Overall Study|Lost to Follow-up|0
7132549|NCT02802319|11280102|FG001|Overall Study|Lost to Follow-up|4
7132550|NCT02802345|11280110|FG000|Overall Study|Not Treated|0
7132551|NCT02802345|11280111|FG001|Overall Study|Not Treated|1
7132552|NCT02802345|11280110|FG000|Overall Study|Adverse Event|28
7132553|NCT02802345|11280111|FG001|Overall Study|Adverse Event|20
7132554|NCT02802345|11280110|FG000|Overall Study|Withdrawal by Subject|3
7132555|NCT02802345|11280111|FG001|Overall Study|Withdrawal by Subject|3
7132556|NCT02802345|11280110|FG000|Overall Study|Protocol Violation|0
7132557|NCT02802345|11280111|FG001|Overall Study|Protocol Violation|1
7132558|NCT02802345|11280110|FG000|Overall Study|Other than listed|1
7132559|NCT02802345|11280111|FG001|Overall Study|Other than listed|5
7132560|NCT02802735|11280163|FG000|Overall Study|Withdrawal by Subject|0
7132561|NCT02802735|11280164|FG001|Overall Study|Withdrawal by Subject|1
7132562|NCT02802735|11280165|FG002|Overall Study|Withdrawal by Subject|0
7132563|NCT02802735|11280166|FG003|Overall Study|Withdrawal by Subject|0
7132564|NCT02802735|11280167|FG004|Overall Study|Withdrawal by Subject|0
7132565|NCT02802865|11280184|FG000|Overall Study|Pregnancy|1
7132566|NCT02802865|11280185|FG001|Overall Study|Pregnancy|1
7132567|NCT02802865|11280184|FG000|Overall Study|Ineliegible due to tuberculosis|0
7132568|NCT02802865|11280185|FG001|Overall Study|Ineliegible due to tuberculosis|1
7132569|NCT02802878|11280193|FG000|Overall Study|Withdrawal by Subject|3
7132570|NCT02802878|11280194|FG001|Overall Study|Withdrawal by Subject|3
7132571|NCT02802878|11280193|FG000|Overall Study|Protocol Violation|1
7132572|NCT02802878|11280194|FG001|Overall Study|Protocol Violation|0
7132573|NCT02803138|11280200|FG000|Overall Study|Failure to return|38
7132574|NCT02803138|11280200|FG000|Overall Study|Insufficient virological response|2
7132575|NCT02803138|11280200|FG000|Overall Study|Withdrawn consent|1
7132576|NCT02803138|11280200|FG000|Overall Study|Death|1
7132577|NCT02803138|11280200|FG000|Overall Study|Other, not specified|28
7132578|NCT02803580|11280226|FG000|Overall Study|Death|13
7132579|NCT02803580|11280226|FG000|Overall Study|Lost to Follow-up|19
7132580|NCT02803580|11280226|FG000|Overall Study|Withdrawal by Subject|3
7132581|NCT02803580|11280226|FG000|Overall Study|Inclusion in clinical trial|1
7132582|NCT02804178|11280239|FG000|Overall Study|Adverse Event|1
7132583|NCT02804399|11280243|FG000|Period 2|Adverse Event|0
7132584|NCT02804399|11280244|FG001|Period 2|Adverse Event|1
7132585|NCT02804750|11280264|FG000|Period 1|Adverse Event|0
7132586|NCT02804750|11280265|FG001|Period 1|Adverse Event|2
7132587|NCT02804750|11280264|FG000|Period 1|Withdrawal by Subject|0
7132588|NCT02804750|11280265|FG001|Period 1|Withdrawal by Subject|1
7132589|NCT02804750|11280264|FG000|Period 2|Adverse Event|1
7132590|NCT02804750|11280265|FG001|Period 2|Adverse Event|0
7132591|NCT02804750|11280264|FG000|Period 3|Adverse Event|0
7132592|NCT02804750|11280265|FG001|Period 3|Adverse Event|2
7132593|NCT02804750|11280264|FG000|Period 4|Adverse Event|0
7132594|NCT02804750|11280265|FG001|Period 4|Adverse Event|5
7132595|NCT02804763|11280277|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1
7132596|NCT02804763|11280278|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0
7132597|NCT02804763|11280279|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0
7132598|NCT02804763|11280280|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0
7132599|NCT02804763|11280277|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0
7132600|NCT02804763|11280278|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0
7132601|NCT02804763|11280279|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1
7132602|NCT02804763|11280280|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2
7132603|NCT02804763|11280277|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0
7132604|NCT02804763|11280278|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1
7132605|NCT02804763|11280279|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0
7132606|NCT02804763|11280280|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0
7132607|NCT02804763|11280277|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2
7132608|NCT02804763|11280278|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0
7132609|NCT02804763|11280279|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1
7132610|NCT02804763|11280280|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1
7132611|NCT02804763|11280277|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4
7132612|NCT02804763|11280278|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0
7132613|NCT02804763|11280279|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2
7132614|NCT02804763|11280280|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2
7132615|NCT02804763|11280277|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0
7132616|NCT02804763|11280278|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1
7132617|NCT02804763|11280279|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0
7132618|NCT02804763|11280280|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0
7132619|NCT02805309|11280301|FG000|Overall Study|Lost to Follow-up|2
7132620|NCT02805309|11280302|FG001|Overall Study|Lost to Follow-up|2
7132621|NCT02805309|11280303|FG002|Overall Study|Lost to Follow-up|2
7132622|NCT02805309|11280301|FG000|Overall Study|Post-Randomization Exclusion|0
7132623|NCT02805309|11280302|FG001|Overall Study|Post-Randomization Exclusion|2
7132624|NCT02805309|11280303|FG002|Overall Study|Post-Randomization Exclusion|1
7132625|NCT02805660|11280327|FG000|Overall Study|Death|5
7132626|NCT02805660|11280328|FG001|Overall Study|Death|2
7132627|NCT02805660|11280329|FG002|Overall Study|Death|9
7132628|NCT02805660|11280330|FG003|Overall Study|Death|5
7132629|NCT02805660|11280331|FG004|Overall Study|Death|0
7132630|NCT02805660|11280332|FG005|Overall Study|Death|14
7132631|NCT02805660|11280333|FG006|Overall Study|Death|12
7132632|NCT02805660|11280327|FG000|Overall Study|Lost to Follow-up|0
7132633|NCT02805660|11280328|FG001|Overall Study|Lost to Follow-up|1
7132634|NCT02805660|11280329|FG002|Overall Study|Lost to Follow-up|1
7132635|NCT02805660|11280330|FG003|Overall Study|Lost to Follow-up|2
7132636|NCT02805660|11280331|FG004|Overall Study|Lost to Follow-up|0
7132637|NCT02805660|11280332|FG005|Overall Study|Lost to Follow-up|0
7132638|NCT02805660|11280333|FG006|Overall Study|Lost to Follow-up|0
7132639|NCT02805660|11280327|FG000|Overall Study|Withdrawal by Subject|0
7132640|NCT02805660|11280328|FG001|Overall Study|Withdrawal by Subject|0
7132641|NCT02805660|11280329|FG002|Overall Study|Withdrawal by Subject|0
7132642|NCT02805660|11280330|FG003|Overall Study|Withdrawal by Subject|3
7132643|NCT02805660|11280331|FG004|Overall Study|Withdrawal by Subject|1
7132644|NCT02805660|11280332|FG005|Overall Study|Withdrawal by Subject|0
7132645|NCT02805660|11280333|FG006|Overall Study|Withdrawal by Subject|2
7132646|NCT02805660|11280327|FG000|Overall Study|Study terminated by Sponsor|0
7132647|NCT02805660|11280328|FG001|Overall Study|Study terminated by Sponsor|0
7132648|NCT02805660|11280329|FG002|Overall Study|Study terminated by Sponsor|1
7132649|NCT02805660|11280330|FG003|Overall Study|Study terminated by Sponsor|4
7132650|NCT02805660|11280331|FG004|Overall Study|Study terminated by Sponsor|2
7132651|NCT02805660|11280332|FG005|Overall Study|Study terminated by Sponsor|3
7132652|NCT02805660|11280333|FG006|Overall Study|Study terminated by Sponsor|1
7132653|NCT02805660|11280327|FG000|Overall Study|Miscellaneous|0
7132654|NCT02805660|11280328|FG001|Overall Study|Miscellaneous|1
7132655|NCT02805660|11280329|FG002|Overall Study|Miscellaneous|0
7132656|NCT02805660|11280330|FG003|Overall Study|Miscellaneous|4
7132657|NCT02805660|11280331|FG004|Overall Study|Miscellaneous|0
7132658|NCT02805660|11280332|FG005|Overall Study|Miscellaneous|6
7132659|NCT02805660|11280333|FG006|Overall Study|Miscellaneous|4
7132660|NCT02805790|11280364|FG000|Second Intervention (4 Weeks)|Physician Decision|0
7132661|NCT02805790|11280365|FG001|Second Intervention (4 Weeks)|Physician Decision|1
7132662|NCT02805907|11280373|FG000|Overall Study|Lost to Follow-up|3
7132663|NCT02805907|11280374|FG001|Overall Study|Lost to Follow-up|3
7132664|NCT02805972|11280382|FG000|Washout Period|Lost to Follow-up|3
7132665|NCT02805972|11280383|FG001|Washout Period|Lost to Follow-up|0
7132666|NCT02806024|11280401|FG000|Overall Study|Night Delivery|1
7132667|NCT02806024|11280402|FG001|Overall Study|Night Delivery|1
7132668|NCT02806024|11280401|FG000|Overall Study|DVT during antepartum admission|0
7132669|NCT02806024|11280402|FG001|Overall Study|DVT during antepartum admission|1
7132670|NCT02806232|11280417|FG000|Overall Study|Lost to Follow-up|1
7132671|NCT02806232|11280418|FG001|Overall Study|Lost to Follow-up|2
7132672|NCT02806232|11280419|FG002|Overall Study|Lost to Follow-up|1
7132673|NCT02806232|11280420|FG003|Overall Study|Lost to Follow-up|0
7132674|NCT02806232|11280421|FG004|Overall Study|Lost to Follow-up|0
7132675|NCT02806232|11280422|FG005|Overall Study|Lost to Follow-up|1
7132676|NCT02806232|11280423|FG006|Overall Study|Lost to Follow-up|0
7132677|NCT02806232|11280424|FG007|Overall Study|Lost to Follow-up|0
7132678|NCT02806232|11280425|FG008|Overall Study|Lost to Follow-up|0
7132679|NCT02806232|11280417|FG000|Overall Study|Withdrawal by Subject|0
7132680|NCT02806232|11280418|FG001|Overall Study|Withdrawal by Subject|2
7132681|NCT02806232|11280419|FG002|Overall Study|Withdrawal by Subject|0
7132682|NCT02806232|11280420|FG003|Overall Study|Withdrawal by Subject|0
7132683|NCT02806232|11280421|FG004|Overall Study|Withdrawal by Subject|2
7132684|NCT02806232|11280422|FG005|Overall Study|Withdrawal by Subject|1
7132685|NCT02806232|11280423|FG006|Overall Study|Withdrawal by Subject|0
7132686|NCT02806232|11280424|FG007|Overall Study|Withdrawal by Subject|0
7132687|NCT02806232|11280425|FG008|Overall Study|Withdrawal by Subject|0
7132688|NCT02806414|11280445|FG000|Overall Study|Lost to Follow-up|2
7132689|NCT02806505|11280451|FG000|Overall Study|Adverse event/intercurrent illness|1
7132690|NCT02806505|11280452|FG001|Overall Study|Adverse event/intercurrent illness|3
7132691|NCT02806505|11280451|FG000|Overall Study|Death|4
7132692|NCT02806505|11280452|FG001|Overall Study|Death|0
7132693|NCT02806505|11280451|FG000|Overall Study|Did not cooperate/refused treatment|3
7132694|NCT02806505|11280452|FG001|Overall Study|Did not cooperate/refused treatment|3
7132695|NCT02806505|11280451|FG000|Overall Study|Failure to return|0
7132696|NCT02806505|11280452|FG001|Overall Study|Failure to return|1
7132697|NCT02806505|11280451|FG000|Overall Study|Insufficient therapeutic response|2
7132698|NCT02806505|11280452|FG001|Overall Study|Insufficient therapeutic response|4
7132699|NCT02806713|11280464|FG000|Overall Study|Urethral injury during procedure|1
7132700|NCT02806713|11280465|FG001|Overall Study|Urethral injury during procedure|0
7132701|NCT02806713|11280464|FG000|Overall Study|cancelled surgery|1
7132702|NCT02806713|11280465|FG001|Overall Study|cancelled surgery|2
7132703|NCT02806726|11280471|FG000|Overall Study|Lost to Follow-up|1
7132704|NCT02806947|11280507|FG000|Overall Study|Withdrawal by Subject|5
7132705|NCT02806947|11280508|FG001|Overall Study|Withdrawal by Subject|1
7132706|NCT02806973|11280514|FG000|Period 1|Withdrawal by Subject|0
7132707|NCT02806973|11280515|FG001|Period 1|Withdrawal by Subject|2
7132708|NCT02806973|11280516|FG002|Period 1|Withdrawal by Subject|1
7132709|NCT02806973|11280517|FG003|Period 1|Withdrawal by Subject|1
7132710|NCT02806973|11280514|FG000|Period 1|Adverse Event|0
7132711|NCT02806973|11280515|FG001|Period 1|Adverse Event|0
7132712|NCT02806973|11280516|FG002|Period 1|Adverse Event|0
7132713|NCT02806973|11280517|FG003|Period 1|Adverse Event|1
7132714|NCT02806973|11280514|FG000|Period 3|Withdrawal by Subject|0
7132715|NCT02806973|11280515|FG001|Period 3|Withdrawal by Subject|0
7132716|NCT02806973|11280516|FG002|Period 3|Withdrawal by Subject|0
7132717|NCT02806973|11280517|FG003|Period 3|Withdrawal by Subject|3
7132718|NCT02806973|11280514|FG000|Period 3|Adverse Event|0
7132719|NCT02806973|11280515|FG001|Period 3|Adverse Event|0
7132720|NCT02806973|11280516|FG002|Period 3|Adverse Event|1
7132721|NCT02806973|11280517|FG003|Period 3|Adverse Event|0
7132722|NCT02806986|11280527|FG000|Treatment Stage 1|Adverse Event|1
7132723|NCT02806986|11280527|FG000|Treatment Stage 2|Adverse Event|3
7132724|NCT02806986|11280527|FG000|Treatment Stage 2|Withdrawal by Subject|2
7132725|NCT02807259|11280537|FG000|Baseline (3 Months)|migration, refusal, not available|77
7132726|NCT02807259|11280538|FG001|Baseline (3 Months)|migration, refusal, not available|112
7132727|NCT02807259|11280537|FG000|Midline (3 Months)|migration, refusal, not available|30
7132728|NCT02807259|11280538|FG001|Midline (3 Months)|migration, refusal, not available|34
7132729|NCT02807259|11280537|FG000|Endline (3 Months)|migration, refusal, not available|35
7132730|NCT02807259|11280538|FG001|Endline (3 Months)|migration, refusal, not available|87
7132731|NCT02807376|11280548|FG000|Overall Study|Intra-operative exclusion criteria|3
7132732|NCT02807376|11280549|FG001|Overall Study|Intra-operative exclusion criteria|0
7132733|NCT02807376|11280548|FG000|Overall Study|Lost to Follow-up|0
7132734|NCT02807376|11280549|FG001|Overall Study|Lost to Follow-up|1
7132735|NCT02807402|11280555|FG000|Overall Study|Failure to Return|1
7132736|NCT02807402|11280555|FG000|Overall Study|Death|3
7132737|NCT02807402|11280555|FG000|Overall Study|Other|2
7132738|NCT02807623|11280570|FG000|Overall Study|Lost to Follow-up|23
7132739|NCT02807623|11280571|FG001|Overall Study|Lost to Follow-up|18
7132740|NCT02807623|11280572|FG002|Overall Study|Lost to Follow-up|22
7132741|NCT02807623|11280570|FG000|Overall Study|Drug intolerance|0
7132742|NCT02807623|11280571|FG001|Overall Study|Drug intolerance|1
7132743|NCT02807623|11280572|FG002|Overall Study|Drug intolerance|0
7132744|NCT02807623|11280570|FG000|Overall Study|incomplete blood draw|0
7132745|NCT02807623|11280571|FG001|Overall Study|incomplete blood draw|2
7132746|NCT02807623|11280572|FG002|Overall Study|incomplete blood draw|1
7132747|NCT02807844|11280599|FG000|Overall Study|Physician Decision|0
7132748|NCT02807844|11280600|FG001|Overall Study|Physician Decision|0
7132749|NCT02807844|11280601|FG002|Overall Study|Physician Decision|0
7132750|NCT02807844|11280602|FG003|Overall Study|Physician Decision|0
7132751|NCT02807844|11280603|FG004|Overall Study|Physician Decision|0
7132752|NCT02807844|11280604|FG005|Overall Study|Physician Decision|0
7132753|NCT02807844|11280605|FG006|Overall Study|Physician Decision|3
7132754|NCT02807844|11280606|FG007|Overall Study|Physician Decision|0
7132755|NCT02807844|11280607|FG008|Overall Study|Physician Decision|1
7132756|NCT02807844|11280608|FG009|Overall Study|Physician Decision|2
7132757|NCT02807844|11280599|FG000|Overall Study|Death|0
7132758|NCT02807844|11280600|FG001|Overall Study|Death|0
7132759|NCT02807844|11280601|FG002|Overall Study|Death|2
7132760|NCT02807844|11280602|FG003|Overall Study|Death|4
7132761|NCT02807844|11280603|FG004|Overall Study|Death|1
7132762|NCT02807844|11280604|FG005|Overall Study|Death|2
7132763|NCT02807844|11280605|FG006|Overall Study|Death|1
7132764|NCT02807844|11280606|FG007|Overall Study|Death|2
7132765|NCT02807844|11280607|FG008|Overall Study|Death|0
7132766|NCT02807844|11280608|FG009|Overall Study|Death|1
7132767|NCT02807844|11280599|FG000|Overall Study|Withdrawal by Subject|0
7132768|NCT02807844|11280600|FG001|Overall Study|Withdrawal by Subject|0
7132769|NCT02807844|11280601|FG002|Overall Study|Withdrawal by Subject|2
7132770|NCT02807844|11280602|FG003|Overall Study|Withdrawal by Subject|1
7132771|NCT02807844|11280603|FG004|Overall Study|Withdrawal by Subject|1
7132772|NCT02807844|11280604|FG005|Overall Study|Withdrawal by Subject|0
7132773|NCT02807844|11280605|FG006|Overall Study|Withdrawal by Subject|1
7132774|NCT02807844|11280606|FG007|Overall Study|Withdrawal by Subject|0
7132775|NCT02807844|11280607|FG008|Overall Study|Withdrawal by Subject|0
7132776|NCT02807844|11280608|FG009|Overall Study|Withdrawal by Subject|0
7132777|NCT02807844|11280599|FG000|Overall Study|Progressive disease|5
7132778|NCT02807844|11280600|FG001|Overall Study|Progressive disease|12
7132779|NCT02807844|11280601|FG002|Overall Study|Progressive disease|8
7132780|NCT02807844|11280602|FG003|Overall Study|Progressive disease|8
7132781|NCT02807844|11280603|FG004|Overall Study|Progressive disease|3
7132782|NCT02807844|11280604|FG005|Overall Study|Progressive disease|8
7132783|NCT02807844|11280605|FG006|Overall Study|Progressive disease|14
7132784|NCT02807844|11280606|FG007|Overall Study|Progressive disease|17
7132785|NCT02807844|11280607|FG008|Overall Study|Progressive disease|19
7132786|NCT02807844|11280608|FG009|Overall Study|Progressive disease|15
7132787|NCT02807844|11280599|FG000|Overall Study|Adverse Event|1
7132788|NCT02807844|11280600|FG001|Overall Study|Adverse Event|0
7132789|NCT02807844|11280601|FG002|Overall Study|Adverse Event|0
7132790|NCT02807844|11280602|FG003|Overall Study|Adverse Event|0
7132791|NCT02807844|11280603|FG004|Overall Study|Adverse Event|1
7132792|NCT02807844|11280604|FG005|Overall Study|Adverse Event|1
7132793|NCT02807844|11280605|FG006|Overall Study|Adverse Event|1
7132794|NCT02807844|11280606|FG007|Overall Study|Adverse Event|1
7132795|NCT02807844|11280607|FG008|Overall Study|Adverse Event|1
7132796|NCT02807844|11280608|FG009|Overall Study|Adverse Event|2
7132797|NCT02807857|11280634|FG000|Enrolled Set|Patients not suitable for follow-up.|551
7132798|NCT02807857|11280634|FG000|Follow-Up Set|Study Terminated By Sponsor|131
7132799|NCT02807857|11280634|FG000|Follow-Up Set|Withdrawal by Subject|8
7132800|NCT02807857|11280634|FG000|Follow-Up Set|Lost to Follow-up|7
7132801|NCT02807857|11280634|FG000|Follow-Up Set|Physician Decision|6
7132802|NCT02807857|11280634|FG000|Follow-Up Set|Adverse Event|3
7132803|NCT02807857|11280634|FG000|Follow-Up Set|Death|27
7132804|NCT02807857|11280634|FG000|Follow-Up Set|Relocation|2
7132805|NCT02807948|11280644|FG000|Overall Study|Physician Decision|1
7132806|NCT02807948|11280645|FG001|Overall Study|Physician Decision|0
7132807|NCT02808312|11280696|FG000|Overall Study|Enrolled but Never Treated|0
7132808|NCT02808312|11280697|FG001|Overall Study|Enrolled but Never Treated|0
7132809|NCT02808312|11280698|FG002|Overall Study|Enrolled but Never Treated|1
7132810|NCT02808312|11280699|FG003|Overall Study|Enrolled but Never Treated|0
7132811|NCT02808312|11280700|FG004|Overall Study|Enrolled but Never Treated|0
7132812|NCT02808338|11280717|FG000|Screening|Screen Failure|10
7132813|NCT02808338|11280717|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1
7132814|NCT02808338|11280717|FG000|Overnight In-lab Polysomonography|Reason not given|1
7132815|NCT02808429|11280731|FG000|Overall Study|Lost to Follow-up|1
7132816|NCT02808429|11280732|FG001|Overall Study|Lost to Follow-up|0
7132817|NCT02808429|11280733|FG002|Overall Study|Lost to Follow-up|0
7132818|NCT02808429|11280731|FG000|Overall Study|Protocol Violation|0
7132819|NCT02808429|11280732|FG001|Overall Study|Protocol Violation|1
7132820|NCT02808429|11280733|FG002|Overall Study|Protocol Violation|0
7132821|NCT02808429|11280731|FG000|Overall Study|Premature study termination by sponsor|2
7132822|NCT02808429|11280732|FG001|Overall Study|Premature study termination by sponsor|0
7132823|NCT02808429|11280733|FG002|Overall Study|Premature study termination by sponsor|1
7132824|NCT02808429|11280731|FG000|Overall Study|Relocation|0
7132825|NCT02808429|11280732|FG001|Overall Study|Relocation|0
7132826|NCT02808429|11280733|FG002|Overall Study|Relocation|1
7132827|NCT02808819|11280743|FG000|Overall Study|eg. no treatment efficacy on asthma|5
7132828|NCT02808819|11280744|FG001|Overall Study|eg. no treatment efficacy on asthma|4
7132829|NCT02808819|11280743|FG000|Overall Study|Withdrawal by Subject|10
7132830|NCT02808819|11280744|FG001|Overall Study|Withdrawal by Subject|13
7132831|NCT02808819|11280743|FG000|Overall Study|Site terminated by sponsor|2
7132832|NCT02808819|11280744|FG001|Overall Study|Site terminated by sponsor|0
7132833|NCT02808819|11280743|FG000|Overall Study|Pregnancy|1
7132834|NCT02808819|11280744|FG001|Overall Study|Pregnancy|0
7132835|NCT02808819|11280743|FG000|Overall Study|Lost to Follow-up|1
7132836|NCT02808819|11280744|FG001|Overall Study|Lost to Follow-up|6
7132837|NCT02808819|11280743|FG000|Overall Study|Protocol Violation|0
7132838|NCT02808819|11280744|FG001|Overall Study|Protocol Violation|1
7132839|NCT02808819|11280743|FG000|Overall Study|Development of study-specific withdrawal criteria|8
7132840|NCT02808819|11280744|FG001|Overall Study|Development of study-specific withdrawal criteria|3
7132841|NCT02808819|11280743|FG000|Overall Study|Death|1
7132842|NCT02808819|11280744|FG001|Overall Study|Death|0
7132843|NCT02808819|11280743|FG000|Overall Study|Adverse Event|3
7132844|NCT02808819|11280744|FG001|Overall Study|Adverse Event|4
7132845|NCT02808975|11280753|FG000|Overall Study|Adverse Event|3
7132846|NCT02808975|11280754|FG001|Overall Study|Adverse Event|4
7132847|NCT02808975|11280753|FG000|Overall Study|Withdrew consent|9
7132848|NCT02808975|11280754|FG001|Overall Study|Withdrew consent|8
7132849|NCT02808975|11280753|FG000|Overall Study|Lost to Follow-up|4
7132850|NCT02808975|11280754|FG001|Overall Study|Lost to Follow-up|6
7132851|NCT02808975|11280753|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1
7132852|NCT02808975|11280754|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0
7132853|NCT02808975|11280753|FG000|Overall Study|Other, not specified|5
7132854|NCT02808975|11280754|FG001|Overall Study|Other, not specified|1
7132855|NCT02809053|11280762|FG000|Overall Study|Death|0
7132856|NCT02809053|11280763|FG001|Overall Study|Death|1
7132857|NCT02809053|11280762|FG000|Overall Study|Lost to Follow-up|3
7132858|NCT02809053|11280763|FG001|Overall Study|Lost to Follow-up|1
6806361|NCT02564900|10808839|FG011|Dose Expansion|Death|0
6806362|NCT02564900|10808840|FG012|Dose Expansion|Death|1
6806363|NCT02564900|10808841|FG013|Dose Expansion|Death|1
6806364|NCT02564900|10808842|FG014|Dose Expansion|Death|0
6806365|NCT02564900|10808828|FG000|Dose Expansion|Withdrawal by Subject|0
6806366|NCT02564900|10808829|FG001|Dose Expansion|Withdrawal by Subject|0
6806367|NCT02564900|10808830|FG002|Dose Expansion|Withdrawal by Subject|0
6806368|NCT02564900|10808831|FG003|Dose Expansion|Withdrawal by Subject|0
6806369|NCT02564900|10808832|FG004|Dose Expansion|Withdrawal by Subject|0
6806370|NCT02564900|10808833|FG005|Dose Expansion|Withdrawal by Subject|0
6806371|NCT02564900|10808834|FG006|Dose Expansion|Withdrawal by Subject|4
6806372|NCT02564900|10808835|FG007|Dose Expansion|Withdrawal by Subject|0
6806373|NCT02564900|10808836|FG008|Dose Expansion|Withdrawal by Subject|0
6806374|NCT02564900|10808837|FG009|Dose Expansion|Withdrawal by Subject|0
6806375|NCT02564900|10808838|FG010|Dose Expansion|Withdrawal by Subject|1
6806376|NCT02564900|10808839|FG011|Dose Expansion|Withdrawal by Subject|0
6806377|NCT02564900|10808840|FG012|Dose Expansion|Withdrawal by Subject|0
6806378|NCT02564900|10808841|FG013|Dose Expansion|Withdrawal by Subject|1
6806379|NCT02564900|10808842|FG014|Dose Expansion|Withdrawal by Subject|1
6806380|NCT02564900|10808828|FG000|Dose Expansion|Other|0
7132859|NCT02809053|11280762|FG000|Overall Study|Withdrawal by Subject|2
7132860|NCT02809053|11280763|FG001|Overall Study|Withdrawal by Subject|3
7132861|NCT02809053|11280762|FG000|Overall Study|Disease Progression|2
7132862|NCT02809053|11280763|FG001|Overall Study|Disease Progression|1
7132863|NCT02809833|11280803|FG000|Overall Study|Death|3
7132864|NCT02809833|11280803|FG000|Overall Study|Intolerance|54
7132865|NCT02809833|11280803|FG000|Overall Study|Lack of Efficacy|89
7132866|NCT02809833|11280803|FG000|Overall Study|Remission/Treatment No Longer Needed|3
6806381|NCT02564900|10808829|FG001|Dose Expansion|Other|0
6806382|NCT02564900|10808830|FG002|Dose Expansion|Other|0
7132867|NCT02809833|11280803|FG000|Overall Study|Noncompliance|1
7132868|NCT02809833|11280803|FG000|Overall Study|Withdrawal by Subject|34
7132869|NCT02809833|11280803|FG000|Overall Study|Lost to Follow-up|35
7132870|NCT02809833|11280803|FG000|Overall Study|Adverse Event (AE)|24
7132871|NCT02809833|11280803|FG000|Overall Study|Other|5
7132872|NCT02809833|11280803|FG000|Overall Study|Missing Information|52
7132873|NCT02809976|11280829|FG000|Overall Study|Lost to Follow-up|1
7132874|NCT02809976|11280829|FG000|Overall Study|Withdrawal by Subject|1
7132875|NCT02810340|11280845|FG000|Overall Study|Withdrawal by Subject|1
7132876|NCT02810340|11280846|FG001|Overall Study|Withdrawal by Subject|0
7132877|NCT02810340|11280847|FG002|Overall Study|Withdrawal by Subject|0
7132878|NCT02810340|11280845|FG000|Overall Study|Incarceration|0
7132879|NCT02810340|11280846|FG001|Overall Study|Incarceration|1
7132880|NCT02810340|11280847|FG002|Overall Study|Incarceration|0
7132881|NCT02810340|11280845|FG000|Overall Study|Lost to Follow-up|0
7132882|NCT02810340|11280846|FG001|Overall Study|Lost to Follow-up|0
7132883|NCT02810340|11280847|FG002|Overall Study|Lost to Follow-up|1
7132884|NCT02810392|11280857|FG000|Overall Study|Subject too ill to continue|1
7132885|NCT02810392|11280858|FG001|Overall Study|Subject too ill to continue|0
7132886|NCT02810392|11280857|FG000|Overall Study|COVID 19 research restrictions|0
7132887|NCT02810392|11280858|FG001|Overall Study|COVID 19 research restrictions|1
7132888|NCT02810951|11280885|FG000|Overall Study|Adverse Event|1
7132889|NCT02810964|11280893|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1
7132890|NCT02810964|11280894|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2
7132891|NCT02810964|11280893|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1
7132892|NCT02810964|11280894|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0
7132893|NCT02810964|11280893|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0
7132894|NCT02810964|11280894|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1
7132895|NCT02810964|11280893|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1
7132896|NCT02810964|11280894|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0
7132897|NCT02811159|11280900|FG000|Treatment Course 1|Lost to Follow-up|1
7132898|NCT02811640|11280927|FG000|Overall Study|Technology malfunction|2
7132899|NCT02812186|11280958|FG000|Period 1|Post randomization screen failure|5
7132900|NCT02812186|11280959|FG001|Period 1|Post randomization screen failure|9
7132901|NCT02812186|11280958|FG000|Period 1|nonevaluable data sets|6
7132902|NCT02812186|11280959|FG001|Period 1|nonevaluable data sets|6
7132903|NCT02813421|11281006|FG000|Overall Study|Withdrawal by Subject|1
7132904|NCT02813421|11281007|FG001|Overall Study|Withdrawal by Subject|2
7132905|NCT02813421|11281006|FG000|Overall Study|Lost to Follow-up|1
7132906|NCT02813421|11281007|FG001|Overall Study|Lost to Follow-up|1
7132907|NCT02813577|11281026|FG000|Overall Study|Study terminated|4
7132908|NCT02813681|11281033|FG000|Overall Study|Physician Decision|5
7132909|NCT02813681|11281034|FG001|Overall Study|Physician Decision|5
7132910|NCT02813681|11281035|FG002|Overall Study|Physician Decision|0
7132911|NCT02813681|11281033|FG000|Overall Study|Lost to Follow-up|0
7132912|NCT02813681|11281034|FG001|Overall Study|Lost to Follow-up|1
7132913|NCT02813681|11281035|FG002|Overall Study|Lost to Follow-up|0
7132914|NCT02813694|11281047|FG000|Overall Study|Physician Decision|0
7132915|NCT02813694|11281048|FG001|Overall Study|Physician Decision|1
7132916|NCT02813694|11281047|FG000|Overall Study|Withdrawal by Subject|10
7132917|NCT02813694|11281048|FG001|Overall Study|Withdrawal by Subject|9
7132918|NCT02813694|11281047|FG000|Overall Study|Lost to Follow-up|1
7132919|NCT02813694|11281048|FG001|Overall Study|Lost to Follow-up|1
7132920|NCT02813694|11281047|FG000|Overall Study|Death|3
7132921|NCT02813694|11281048|FG001|Overall Study|Death|3
7132922|NCT02813694|11281047|FG000|Overall Study|Randomized- did not receive study drug|2
7132923|NCT02813694|11281048|FG001|Overall Study|Randomized- did not receive study drug|0
7132924|NCT02813694|11281047|FG000|Overall Study|Patient hospitalized|1
7132925|NCT02813694|11281048|FG001|Overall Study|Patient hospitalized|0
7132926|NCT02814175|11281056|FG000|Part 1|Adverse Event|2
7132927|NCT02814175|11281057|FG001|Part 1|Adverse Event|3
7132928|NCT02814175|11281058|FG002|Part 1|Adverse Event|0
7132929|NCT02814175|11281059|FG003|Part 1|Adverse Event|0
7132930|NCT02814175|11281060|FG004|Part 1|Adverse Event|0
7132931|NCT02814175|11281061|FG005|Part 1|Adverse Event|0
7132932|NCT02814175|11281056|FG000|Part 1|Withdrawal Consent|8
7132933|NCT02814175|11281057|FG001|Part 1|Withdrawal Consent|1
7132934|NCT02814175|11281058|FG002|Part 1|Withdrawal Consent|0
7132935|NCT02814175|11281059|FG003|Part 1|Withdrawal Consent|0
7132936|NCT02814175|11281060|FG004|Part 1|Withdrawal Consent|0
7132937|NCT02814175|11281061|FG005|Part 1|Withdrawal Consent|0
7132938|NCT02814175|11281056|FG000|Part 1|Lost to Follow-up|1
7132939|NCT02814175|11281057|FG001|Part 1|Lost to Follow-up|0
7132940|NCT02814175|11281058|FG002|Part 1|Lost to Follow-up|0
7132941|NCT02814175|11281059|FG003|Part 1|Lost to Follow-up|0
7132942|NCT02814175|11281060|FG004|Part 1|Lost to Follow-up|0
7132943|NCT02814175|11281061|FG005|Part 1|Lost to Follow-up|0
7132944|NCT02814175|11281056|FG000|Part 1|Lack of Efficacy|1
7132945|NCT02814175|11281057|FG001|Part 1|Lack of Efficacy|2
7132946|NCT02814175|11281058|FG002|Part 1|Lack of Efficacy|0
7132947|NCT02814175|11281059|FG003|Part 1|Lack of Efficacy|0
7132948|NCT02814175|11281060|FG004|Part 1|Lack of Efficacy|0
7132949|NCT02814175|11281061|FG005|Part 1|Lack of Efficacy|0
7132950|NCT02814175|11281056|FG000|Part 2|Adverse Event|0
7132951|NCT02814175|11281057|FG001|Part 2|Adverse Event|0
7132952|NCT02814175|11281058|FG002|Part 2|Adverse Event|0
7132953|NCT02814175|11281059|FG003|Part 2|Adverse Event|1
7132954|NCT02814175|11281060|FG004|Part 2|Adverse Event|1
7132955|NCT02814175|11281061|FG005|Part 2|Adverse Event|2
7132956|NCT02814175|11281056|FG000|Part 2|Withdrawal Consent|0
7132957|NCT02814175|11281057|FG001|Part 2|Withdrawal Consent|0
7132958|NCT02814175|11281058|FG002|Part 2|Withdrawal Consent|0
7132959|NCT02814175|11281059|FG003|Part 2|Withdrawal Consent|2
7132960|NCT02814175|11281060|FG004|Part 2|Withdrawal Consent|1
7132961|NCT02814175|11281061|FG005|Part 2|Withdrawal Consent|1
7132962|NCT02814175|11281056|FG000|Part 2|Lost to Follow-up|0
7132963|NCT02814175|11281057|FG001|Part 2|Lost to Follow-up|0
7132964|NCT02814175|11281058|FG002|Part 2|Lost to Follow-up|0
7132965|NCT02814175|11281059|FG003|Part 2|Lost to Follow-up|1
7132966|NCT02814175|11281060|FG004|Part 2|Lost to Follow-up|0
7132967|NCT02814175|11281061|FG005|Part 2|Lost to Follow-up|0
7132968|NCT02814175|11281056|FG000|Part 2|Lack of Efficacy|0
7132969|NCT02814175|11281057|FG001|Part 2|Lack of Efficacy|0
7132970|NCT02814175|11281058|FG002|Part 2|Lack of Efficacy|0
7132971|NCT02814175|11281059|FG003|Part 2|Lack of Efficacy|0
7132972|NCT02814175|11281060|FG004|Part 2|Lack of Efficacy|0
7132973|NCT02814175|11281061|FG005|Part 2|Lack of Efficacy|3
7132974|NCT02814565|11281111|FG000|Overall Study|Lack of Efficacy|0
7132975|NCT02814565|11281112|FG001|Overall Study|Lack of Efficacy|1
7132976|NCT02814565|11281111|FG000|Overall Study|Subject decision, caused by AE Influenza|1
7132977|NCT02814565|11281112|FG001|Overall Study|Subject decision, caused by AE Influenza|1
7132978|NCT02814643|11281120|FG000|Overall Study|Lost to Follow-up|0
7132979|NCT02814643|11281121|FG001|Overall Study|Lost to Follow-up|1
7132980|NCT02814643|11281120|FG000|Overall Study|Withdrawal by Subject|1
7132981|NCT02814643|11281121|FG001|Overall Study|Withdrawal by Subject|2
7132982|NCT02814838|11281146|FG000|Overall Study|3 agreed dates for the final visit missed|1
7132983|NCT02814838|11281147|FG001|Overall Study|3 agreed dates for the final visit missed|0
7132984|NCT02814838|11281146|FG000|Overall Study|Consent withdrawal|1
7132985|NCT02814838|11281147|FG001|Overall Study|Consent withdrawal|1
7132986|NCT02815293|11281171|FG000|Overall Study|Study termination by sponsor|10
7132987|NCT02815293|11281172|FG001|Overall Study|Study termination by sponsor|7
7132988|NCT02815293|11281173|FG002|Overall Study|Study termination by sponsor|0
7132989|NCT02815293|11281171|FG000|Overall Study|Participants not randomized|0
7132990|NCT02815293|11281172|FG001|Overall Study|Participants not randomized|0
7132991|NCT02815293|11281173|FG002|Overall Study|Participants not randomized|18
7132992|NCT02815293|11281171|FG000|Overall Study|Adverse Event|0
7132993|NCT02815293|11281172|FG001|Overall Study|Adverse Event|1
7132994|NCT02815293|11281173|FG002|Overall Study|Adverse Event|0
7132995|NCT02815670|11281188|FG000|Overall Study|Prematurely discontinued of the trial|1
7132996|NCT02815735|11281214|FG000|First Intervention (4 Weeks)|Discomfort|1
7132997|NCT02815735|11281215|FG001|First Intervention (4 Weeks)|Discomfort|0
7132998|NCT02815735|11281214|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1
7132999|NCT02815735|11281215|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0
7133000|NCT02815735|11281214|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0
7133001|NCT02815735|11281215|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1
7133002|NCT02815735|11281214|FG000|Second Intervention (4 Weeks)|Protocol Violation|1
7133003|NCT02815735|11281215|FG001|Second Intervention (4 Weeks)|Protocol Violation|0
7133004|NCT02816138|11281249|FG000|Overall Study|Adverse Event|1
7133005|NCT02816398|11281274|FG000|Overall Study|Death|5
7133006|NCT02816398|11281274|FG000|Overall Study|Lack of Efficacy|8
7133007|NCT02816398|11281274|FG000|Overall Study|Lost to Follow-up|1
7133008|NCT02817087|11281305|FG000|Overall Study|Withdrawal by Subject|2
7133009|NCT02817087|11281306|FG001|Overall Study|Withdrawal by Subject|0
7133010|NCT02817516|11281316|FG000|Overall Study|Other|0
7133011|NCT02817516|11281317|FG001|Overall Study|Other|0
7133012|NCT02817516|11281318|FG002|Overall Study|Other|1
7133013|NCT02817516|11281319|FG003|Overall Study|Other|0
7133014|NCT02817555|11281334|FG000|Overall Study|Death|1
7133015|NCT02817555|11281335|FG001|Overall Study|Death|3
7133016|NCT02817555|11281334|FG000|Overall Study|moved away|1
7133017|NCT02817555|11281335|FG001|Overall Study|moved away|0
7133018|NCT02817555|11281334|FG000|Overall Study|transplant|1
7133019|NCT02817555|11281335|FG001|Overall Study|transplant|1
7133020|NCT02817555|11281334|FG000|Overall Study|changed to Peritoneal Dialysis|0
7133021|NCT02817555|11281335|FG001|Overall Study|changed to Peritoneal Dialysis|1
7133022|NCT02817594|11281341|FG000|Overall Study|Withdrawal by Subject|1
7133023|NCT02817594|11281341|FG000|Overall Study|Other|1
7133024|NCT02817594|11281341|FG000|Overall Study|Did Not Receive Treatment|1
7133025|NCT02817776|11281358|FG000|Overall Study|Excluded|33
7133026|NCT02817776|11281358|FG000|Overall Study|Lost to Follow-up|20
7133027|NCT02817776|11281358|FG000|Overall Study|Withdrawal by Subject|33
7133028|NCT02817776|11281358|FG000|Overall Study|Death|2
7133029|NCT02817828|11281362|FG000|Overall Study|Lost to Follow-up|41
7133030|NCT02817828|11281362|FG000|Overall Study|Adverse event not related to bleeding|104
7133031|NCT02817828|11281362|FG000|Overall Study|Adverse event related to bleeding|53
7133032|NCT02817828|11281362|FG000|Overall Study|Protocol Violation|11
7133033|NCT02817828|11281362|FG000|Overall Study|Pregnancy|7
7133034|NCT02817828|11281362|FG000|Overall Study|Pregnancy wish|15
7133035|NCT02817828|11281362|FG000|Overall Study|Withdrawal by Subject|78
7133036|NCT02817828|11281362|FG000|Overall Study|Other|26
7133037|NCT02817841|11281371|FG000|Overall Study|Lost to Follow-up|287
7133038|NCT02817841|11281371|FG000|Overall Study|Withdrawal by Subject|183
7133039|NCT02817841|11281371|FG000|Overall Study|Adverse event not related to bleeding|131
7133040|NCT02817841|11281371|FG000|Overall Study|Adverse event related to bleeding|51
7133041|NCT02817841|11281371|FG000|Overall Study|Pregnancy|32
7133042|NCT02817841|11281371|FG000|Overall Study|Pregnancy wish|17
7133043|NCT02817841|11281371|FG000|Overall Study|Other reasons|53
7133044|NCT02817841|11281371|FG000|Overall Study|Protocol Violation|94
7133045|NCT02817906|11281381|FG000|Overall Study|Adverse Event|3
7133046|NCT02817906|11281382|FG001|Overall Study|Adverse Event|0
7133047|NCT02817906|11281381|FG000|Overall Study|Lack of Efficacy|1
7133048|NCT02817906|11281382|FG001|Overall Study|Lack of Efficacy|0
7133049|NCT02817906|11281381|FG000|Overall Study|Protocol Violation|1
7133050|NCT02817906|11281382|FG001|Overall Study|Protocol Violation|1
7133051|NCT02817906|11281381|FG000|Overall Study|Study Terminated by Sponsor|2
7133052|NCT02817906|11281382|FG001|Overall Study|Study Terminated by Sponsor|2
7133053|NCT02817906|11281381|FG000|Overall Study|Withdrawal by Subject|7
7133054|NCT02817906|11281382|FG001|Overall Study|Withdrawal by Subject|0
7133055|NCT02817906|11281381|FG000|Overall Study|Other|2
7133056|NCT02817906|11281382|FG001|Overall Study|Other|2
7133057|NCT02818036|11281390|FG000|Overall Study|head did not fit in fMRI scanner headres|1
7133058|NCT02818036|11281391|FG001|Overall Study|head did not fit in fMRI scanner headres|0
7133059|NCT02818036|11281390|FG000|Overall Study|Withdrawal by Subject|1
7133060|NCT02818036|11281391|FG001|Overall Study|Withdrawal by Subject|0
7133061|NCT02818777|11281429|FG000|Overall Study|Adverse Event|3
7133062|NCT02818998|11281442|FG000|Overall Study|Adverse Event|3
7133063|NCT02818998|11281443|FG001|Overall Study|Adverse Event|2
7133064|NCT02818998|11281444|FG002|Overall Study|Adverse Event|1
7133065|NCT02818998|11281442|FG000|Overall Study|Lost to Follow-up|4
7133066|NCT02818998|11281443|FG001|Overall Study|Lost to Follow-up|1
7133067|NCT02818998|11281444|FG002|Overall Study|Lost to Follow-up|2
7133068|NCT02818998|11281442|FG000|Overall Study|Withdrawal by sponsor|0
7133069|NCT02818998|11281443|FG001|Overall Study|Withdrawal by sponsor|1
7133070|NCT02818998|11281444|FG002|Overall Study|Withdrawal by sponsor|1
7133071|NCT02818998|11281442|FG000|Overall Study|Death|3
7133072|NCT02818998|11281443|FG001|Overall Study|Death|6
7133073|NCT02818998|11281444|FG002|Overall Study|Death|8
7133074|NCT02818998|11281442|FG000|Overall Study|Withdrawal by Subject|7
7133075|NCT02818998|11281443|FG001|Overall Study|Withdrawal by Subject|6
7133076|NCT02818998|11281444|FG002|Overall Study|Withdrawal by Subject|6
7133077|NCT02818998|11281442|FG000|Overall Study|Physician Decision|1
7133078|NCT02818998|11281443|FG001|Overall Study|Physician Decision|0
7133079|NCT02818998|11281444|FG002|Overall Study|Physician Decision|0
7133080|NCT02819297|11281473|FG000|Overall Study|Withdrawal by Subject|25
7133081|NCT02819297|11281474|FG001|Overall Study|Withdrawal by Subject|13
7133082|NCT02819297|11281473|FG000|Overall Study|Lost to Follow-up|12
7133083|NCT02819297|11281474|FG001|Overall Study|Lost to Follow-up|14
7133084|NCT02819297|11281473|FG000|Overall Study|Adverse Event|12
7133085|NCT02819297|11281474|FG001|Overall Study|Adverse Event|10
7133086|NCT02819297|11281473|FG000|Overall Study|Physician Decision|5
7133087|NCT02819297|11281474|FG001|Overall Study|Physician Decision|5
7133088|NCT02819297|11281473|FG000|Overall Study|Lack of Efficacy|5
7133089|NCT02819297|11281474|FG001|Overall Study|Lack of Efficacy|8
7133090|NCT02819297|11281473|FG000|Overall Study|Protocol Violation|1
7133091|NCT02819297|11281474|FG001|Overall Study|Protocol Violation|2
7133092|NCT02819310|11281480|FG000|Overall Study|Withdrawal by Subject|37
7133093|NCT02819310|11281480|FG000|Overall Study|Lost to Follow-up|16
7133094|NCT02819310|11281480|FG000|Overall Study|Adverse Event|13
7133095|NCT02819310|11281480|FG000|Overall Study|Lack of Efficacy|5
7133096|NCT02819310|11281480|FG000|Overall Study|Physician Decision|8
7133097|NCT02819310|11281480|FG000|Overall Study|Protocol Violation|30
7133098|NCT02819726|11281504|FG000|Part A (All Participants)|Lost to Follow-up|0
7133099|NCT02819726|11281505|FG001|Part A (All Participants)|Lost to Follow-up|1
7133100|NCT02819726|11281506|FG002|Part A (All Participants)|Lost to Follow-up|0
7133101|NCT02819726|11281507|FG003|Part A (All Participants)|Lost to Follow-up|0
7133102|NCT02819726|11281504|FG000|Part A (All Participants)|Withdrawal by Subject|3
7133103|NCT02819726|11281505|FG001|Part A (All Participants)|Withdrawal by Subject|5
7133104|NCT02819726|11281506|FG002|Part A (All Participants)|Withdrawal by Subject|6
7133105|NCT02819726|11281507|FG003|Part A (All Participants)|Withdrawal by Subject|0
7133106|NCT02819726|11281504|FG000|Part A (All Participants)|Protocol non-compliance|3
7133107|NCT02819726|11281505|FG001|Part A (All Participants)|Protocol non-compliance|4
7133108|NCT02819726|11281506|FG002|Part A (All Participants)|Protocol non-compliance|5
7133109|NCT02819726|11281507|FG003|Part A (All Participants)|Protocol non-compliance|0
7133110|NCT02819726|11281504|FG000|Part B (All Participants)|Lost to Follow-up|1
7133111|NCT02819726|11281505|FG001|Part B (All Participants)|Lost to Follow-up|1
7133112|NCT02819726|11281506|FG002|Part B (All Participants)|Lost to Follow-up|2
7133113|NCT02819726|11281507|FG003|Part B (All Participants)|Lost to Follow-up|2
7133114|NCT02819726|11281504|FG000|Part B (All Participants)|Withdrawal by Subject|2
7133115|NCT02819726|11281505|FG001|Part B (All Participants)|Withdrawal by Subject|1
7133116|NCT02819726|11281506|FG002|Part B (All Participants)|Withdrawal by Subject|1
7133117|NCT02819726|11281507|FG003|Part B (All Participants)|Withdrawal by Subject|0
7133118|NCT02819726|11281504|FG000|Part B (All Participants)|Protocol non-compliance|0
7133119|NCT02819726|11281505|FG001|Part B (All Participants)|Protocol non-compliance|0
7133120|NCT02819726|11281506|FG002|Part B (All Participants)|Protocol non-compliance|1
7133121|NCT02819726|11281507|FG003|Part B (All Participants)|Protocol non-compliance|0
7133122|NCT02820038|11281538|FG000|Overall Study|Lost to Follow-up|7
7133123|NCT02820038|11281539|FG001|Overall Study|Lost to Follow-up|11
7133124|NCT02820038|11281540|FG002|Overall Study|Lost to Follow-up|2
7133125|NCT02820038|11281541|FG003|Overall Study|Lost to Follow-up|9
7133126|NCT02820038|11281538|FG000|Overall Study|Withdrawal by Subject|3
7133127|NCT02820038|11281539|FG001|Overall Study|Withdrawal by Subject|14
7133128|NCT02820038|11281540|FG002|Overall Study|Withdrawal by Subject|3
7133129|NCT02820038|11281541|FG003|Overall Study|Withdrawal by Subject|13
7133130|NCT02820298|11281563|FG000|Overall Study|Withdrawal by Subject|0
7133131|NCT02820298|11281564|FG001|Overall Study|Withdrawal by Subject|1
7133132|NCT02820298|11281563|FG000|Overall Study|Physician Decision|1
7133133|NCT02820298|11281564|FG001|Overall Study|Physician Decision|0
7133134|NCT02820298|11281563|FG000|Overall Study|Protocol Violation|0
7133135|NCT02820298|11281564|FG001|Overall Study|Protocol Violation|1
7133136|NCT02820597|11281597|FG000|Overall Study|Lost to Follow-up|12
7133137|NCT02820844|11281603|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1
7133138|NCT02820844|11281604|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3
7133139|NCT02820844|11281605|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
7133140|NCT02820844|11281606|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
7133141|NCT02820844|11281607|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
7133142|NCT02820844|11281608|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
7133143|NCT02820844|11281603|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1
7133144|NCT02820844|11281604|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2
7133145|NCT02820844|11281605|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
7133146|NCT02820844|11281606|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
7133147|NCT02820844|11281607|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
7133148|NCT02820844|11281608|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
7133149|NCT02820844|11281603|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
7133150|NCT02820844|11281604|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3
7133151|NCT02820844|11281605|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
7133152|NCT02820844|11281606|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
7133153|NCT02820844|11281607|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
7133154|NCT02820844|11281608|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
7133155|NCT02820844|11281603|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2
7133156|NCT02820844|11281604|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1
7133157|NCT02820844|11281605|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0
7133158|NCT02820844|11281606|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0
7133159|NCT02820844|11281607|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0
7133160|NCT02820844|11281608|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0
7133161|NCT02820844|11281603|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1
7133162|NCT02820844|11281604|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
7133163|NCT02820844|11281605|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
7133164|NCT02820844|11281606|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
7133165|NCT02820844|11281607|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
7133166|NCT02820844|11281608|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
7133167|NCT02820844|11281603|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
7133168|NCT02820844|11281604|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
7133169|NCT02820844|11281605|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1
7133170|NCT02820844|11281606|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2
7133171|NCT02820844|11281607|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
7133172|NCT02820844|11281608|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
7133173|NCT02820844|11281603|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
7133174|NCT02820844|11281604|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
7133175|NCT02820844|11281605|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1
7133176|NCT02820844|11281606|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
7133177|NCT02820844|11281607|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
7133178|NCT02820844|11281608|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
7133179|NCT02820844|11281603|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7133180|NCT02820844|11281604|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7133181|NCT02820844|11281605|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7
7133182|NCT02820844|11281606|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2
7133183|NCT02820844|11281607|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7133184|NCT02820844|11281608|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7133185|NCT02820844|11281603|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
7133186|NCT02820844|11281604|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
7133187|NCT02820844|11281605|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
7133188|NCT02820844|11281606|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
7133189|NCT02820844|11281607|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2
7133190|NCT02820844|11281608|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
7133191|NCT02820844|11281603|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7133192|NCT02820844|11281604|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7133193|NCT02820844|11281605|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7133194|NCT02820844|11281606|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7133195|NCT02820844|11281607|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7133196|NCT02820844|11281608|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1
7133197|NCT02821416|11281667|FG000|Overall Study|Adverse Event|0
7133198|NCT02821416|11281668|FG001|Overall Study|Adverse Event|1
7133199|NCT02821416|11281667|FG000|Overall Study|Withdrawal by Subject|2
7133200|NCT02821416|11281668|FG001|Overall Study|Withdrawal by Subject|0
7133201|NCT02821416|11281667|FG000|Overall Study|Lost to Follow-up|1
7133202|NCT02821416|11281668|FG001|Overall Study|Lost to Follow-up|0
7133203|NCT02821715|11281679|FG000|Overall Study|Protocol Violation|1
7133204|NCT02821715|11281680|FG001|Overall Study|Protocol Violation|0
7133205|NCT02821715|11281681|FG002|Overall Study|Protocol Violation|0
7133206|NCT02821715|11281682|FG003|Overall Study|Protocol Violation|0
7133207|NCT02821715|11281683|FG004|Overall Study|Protocol Violation|0
7133208|NCT02821715|11281684|FG005|Overall Study|Protocol Violation|0
7133209|NCT02821819|11281692|FG000|Overall Study|Protocol Violation|1
7133210|NCT02821910|11281702|FG000|Overall Study|Withdrawal by Subject|0
7133211|NCT02821910|11281703|FG001|Overall Study|Withdrawal by Subject|0
7133212|NCT02821910|11281704|FG002|Overall Study|Withdrawal by Subject|1
7133213|NCT02821910|11281705|FG003|Overall Study|Withdrawal by Subject|0
7133214|NCT02821910|11281706|FG004|Overall Study|Withdrawal by Subject|0
7133215|NCT02821910|11281707|FG005|Overall Study|Withdrawal by Subject|1
7133216|NCT02821910|11281702|FG000|Overall Study|Other than specified|1
7133217|NCT02821910|11281703|FG001|Overall Study|Other than specified|0
7133218|NCT02821910|11281704|FG002|Overall Study|Other than specified|1
7133219|NCT02821910|11281705|FG003|Overall Study|Other than specified|0
7133220|NCT02821910|11281706|FG004|Overall Study|Other than specified|0
7133221|NCT02821910|11281707|FG005|Overall Study|Other than specified|0
7133222|NCT02821962|11281723|FG000|Overall Study|Lost to Follow-up|2
7133223|NCT02821962|11281724|FG001|Overall Study|Lost to Follow-up|0
7133224|NCT02822222|11281732|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1
7133225|NCT02822222|11281733|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0
7133226|NCT02822235|11281741|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144
7133227|NCT02822235|11281742|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107
7133228|NCT02822235|11281741|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2
7133229|NCT02822235|11281742|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0
7133230|NCT02822235|11281741|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0
7133231|NCT02822235|11281742|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1
7133232|NCT02822235|11281741|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4
7133233|NCT02822235|11281742|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0
7133234|NCT02822235|11281741|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1
7133235|NCT02822235|11281742|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0
7133236|NCT02822235|11281741|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6
7133237|NCT02822235|11281742|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1
7133238|NCT02822794|11281793|FG000|Overall Study|Withdrew Consent|1
7133239|NCT02822794|11281794|FG001|Overall Study|Withdrew Consent|0
7133240|NCT02823470|11281836|FG000|Overall Study|Adverse Event|1
7133241|NCT02823470|11281837|FG001|Overall Study|Adverse Event|0
7133242|NCT02823470|11281836|FG000|Overall Study|Study terminated by sponsor|8
7133243|NCT02823470|11281837|FG001|Overall Study|Study terminated by sponsor|15
7133244|NCT02823964|11281852|FG000|Overall Study|Adverse Event|2
7133245|NCT02823964|11281852|FG000|Overall Study|Physician Decision|1
7133246|NCT02823964|11281852|FG000|Overall Study|Lack of Efficacy|1
7133247|NCT02823964|11281852|FG000|Overall Study|Withdrawal by Subject|1
7133248|NCT02824224|11281858|FG000|Overall Study|Discontinued, IUS expulsion|0
7133249|NCT02824224|11281859|FG001|Overall Study|Discontinued, IUS expulsion|1
7133250|NCT02824224|11281858|FG000|Overall Study|Did not show up for allocation visit|2
7133251|NCT02824224|11281859|FG001|Overall Study|Did not show up for allocation visit|0
7133252|NCT02824432|11281867|FG000|Overall Study|Major Protocol Deviation|1
7133253|NCT02824432|11281868|FG001|Overall Study|Major Protocol Deviation|0
7133254|NCT02824562|11281876|FG000|Overall Study|Lost to Follow-up|3
7133255|NCT02824562|11281877|FG001|Overall Study|Lost to Follow-up|4
7133256|NCT02824562|11281876|FG000|Overall Study|Death|0
7133257|NCT02824562|11281877|FG001|Overall Study|Death|1
7133258|NCT02825251|11281900|FG000|Overall Study|Adverse Event|0
7133259|NCT02825251|11281901|FG001|Overall Study|Adverse Event|1
7133260|NCT02825251|11281900|FG000|Overall Study|Lost to Follow-up|0
7133261|NCT02825251|11281901|FG001|Overall Study|Lost to Follow-up|1
7133262|NCT02825251|11281900|FG000|Overall Study|Withdrawal by Subject|1
7133263|NCT02825251|11281901|FG001|Overall Study|Withdrawal by Subject|4
7133264|NCT02825251|11281900|FG000|Overall Study|Unclassified|2
7133265|NCT02825251|11281901|FG001|Overall Study|Unclassified|0
7133266|NCT02825420|11281909|FG000|Overall Study|Death|30
7133267|NCT02825420|11281910|FG001|Overall Study|Death|12
7133268|NCT02825420|11281909|FG000|Overall Study|Progressive disease|6
7133269|NCT02825420|11281910|FG001|Overall Study|Progressive disease|1
7133270|NCT02825420|11281909|FG000|Overall Study|Lost to Follow-up|2
7133271|NCT02825420|11281910|FG001|Overall Study|Lost to Follow-up|2
7133272|NCT02825420|11281909|FG000|Overall Study|Withdrawal by Subject|1
7133273|NCT02825420|11281910|FG001|Overall Study|Withdrawal by Subject|1
7133274|NCT02825420|11281909|FG000|Overall Study|Protocol amendment not signed|1
7133275|NCT02825420|11281910|FG001|Overall Study|Protocol amendment not signed|1
7133276|NCT02825420|11281909|FG000|Overall Study|Physician Decision|1
7133277|NCT02825420|11281910|FG001|Overall Study|Physician Decision|0
7133278|NCT02825420|11281909|FG000|Overall Study|Did not receive PLD|2
7133279|NCT02825420|11281910|FG001|Overall Study|Did not receive PLD|0
7133280|NCT02825550|11281921|FG000|Overall Study|Physician Decision|1
7133281|NCT02825992|11281952|FG000|Overall Study|Withdrawal by Subject|4
7133282|NCT02825992|11281952|FG000|Overall Study|Lost to Follow-up|2
7133283|NCT02825992|11281952|FG000|Overall Study|Procedure terminated|2
7133284|NCT02826421|11281966|FG000|Overall Study|Adverse Event|1
7133285|NCT02826421|11281967|FG001|Overall Study|Adverse Event|0
7133286|NCT02826421|11281968|FG002|Overall Study|Adverse Event|0
7133287|NCT02826421|11281969|FG003|Overall Study|Adverse Event|1
7133288|NCT02826421|11281966|FG000|Overall Study|Withdrawal by Subject|1
7133289|NCT02826421|11281967|FG001|Overall Study|Withdrawal by Subject|3
7133290|NCT02826421|11281968|FG002|Overall Study|Withdrawal by Subject|1
7133291|NCT02826421|11281969|FG003|Overall Study|Withdrawal by Subject|1
7133292|NCT02826421|11281966|FG000|Overall Study|Reason not given|1
7133293|NCT02826421|11281967|FG001|Overall Study|Reason not given|0
7133294|NCT02826421|11281968|FG002|Overall Study|Reason not given|1
7133295|NCT02826421|11281969|FG003|Overall Study|Reason not given|0
7133296|NCT02826603|11281982|FG000|Overall Study|Adverse Event|17
7133297|NCT02826603|11281983|FG001|Overall Study|Adverse Event|9
7133298|NCT02826603|11281982|FG000|Overall Study|Lack of Efficacy|4
7133299|NCT02826603|11281983|FG001|Overall Study|Lack of Efficacy|9
7133300|NCT02826603|11281982|FG000|Overall Study|Lost to Follow-up|13
7133301|NCT02826603|11281983|FG001|Overall Study|Lost to Follow-up|12
7133302|NCT02826603|11281982|FG000|Overall Study|Noncompliance with treatment|0
7133303|NCT02826603|11281983|FG001|Overall Study|Noncompliance with treatment|2
7133304|NCT02826603|11281982|FG000|Overall Study|Physician Decision|1
7133305|NCT02826603|11281983|FG001|Overall Study|Physician Decision|7
7133306|NCT02826603|11281982|FG000|Overall Study|Pregnancy|1
7133307|NCT02826603|11281983|FG001|Overall Study|Pregnancy|2
7133308|NCT02826603|11281982|FG000|Overall Study|Protocol Violation|3
7133309|NCT02826603|11281983|FG001|Overall Study|Protocol Violation|3
7133310|NCT02826603|11281982|FG000|Overall Study|Withdrawal by Subject|20
7133311|NCT02826603|11281983|FG001|Overall Study|Withdrawal by Subject|19
7133312|NCT02826603|11281982|FG000|Overall Study|Death|2
7133313|NCT02826603|11281983|FG001|Overall Study|Death|0
7133314|NCT02826603|11281982|FG000|Overall Study|New therapy for study indication|0
7133315|NCT02826603|11281983|FG001|Overall Study|New therapy for study indication|1
7133316|NCT02826798|11282006|FG000|Overall Study|Withdrawal by Subject|0
7133317|NCT02826798|11282007|FG001|Overall Study|Withdrawal by Subject|1
7133318|NCT02826798|11282008|FG002|Overall Study|Withdrawal by Subject|0
7133319|NCT02826798|11282009|FG003|Overall Study|Withdrawal by Subject|1
7133320|NCT02826798|11282010|FG004|Overall Study|Withdrawal by Subject|0
7133321|NCT02827500|11282024|FG000|Overall Study|Death|7
7133322|NCT02827500|11282025|FG001|Overall Study|Death|3
7133323|NCT02827500|11282024|FG000|Overall Study|Lost to Follow-up|1
7133324|NCT02827500|11282025|FG001|Overall Study|Lost to Follow-up|1
7133325|NCT02827500|11282024|FG000|Overall Study|Withdrawal by Subject|3
7133326|NCT02827500|11282025|FG001|Overall Study|Withdrawal by Subject|1
7133327|NCT02827500|11282024|FG000|Overall Study|Missing primary endpoint data|3
7133328|NCT02827500|11282025|FG001|Overall Study|Missing primary endpoint data|1
7133329|NCT02827500|11282024|FG000|Overall Study|Other|5
7133330|NCT02827500|11282025|FG001|Overall Study|Other|1
7133331|NCT02827708|11282033|FG000|Overall Study|Lost to Follow-up|3
7133332|NCT02827708|11282034|FG001|Overall Study|Lost to Follow-up|1
7133333|NCT02827708|11282033|FG000|Overall Study|Withdrawal by Subject|1
7133334|NCT02827708|11282034|FG001|Overall Study|Withdrawal by Subject|2
7133335|NCT02827708|11282033|FG000|Overall Study|Death|1
7133336|NCT02827708|11282034|FG001|Overall Study|Death|2
7133337|NCT02828020|11282043|FG000|Treatment Period|Adverse Event|3
7133338|NCT02828020|11282044|FG001|Treatment Period|Adverse Event|1
7133339|NCT02828020|11282045|FG002|Treatment Period|Adverse Event|1
7133340|NCT02828020|11282043|FG000|Treatment Period|Withdrawal of Consent|10
7133341|NCT02828020|11282044|FG001|Treatment Period|Withdrawal of Consent|14
7133342|NCT02828020|11282045|FG002|Treatment Period|Withdrawal of Consent|9
7133343|NCT02828020|11282043|FG000|Treatment Period|Lost to Follow-up|21
7133344|NCT02828020|11282044|FG001|Treatment Period|Lost to Follow-up|24
7133345|NCT02828020|11282045|FG002|Treatment Period|Lost to Follow-up|18
7133346|NCT02828020|11282043|FG000|Treatment Period|Lack of Qualifying Event|44
7133347|NCT02828020|11282044|FG001|Treatment Period|Lack of Qualifying Event|53
7133348|NCT02828020|11282045|FG002|Treatment Period|Lack of Qualifying Event|43
7133349|NCT02828020|11282043|FG000|Treatment Period|Pregnancy|0
7133350|NCT02828020|11282044|FG001|Treatment Period|Pregnancy|2
7133351|NCT02828020|11282045|FG002|Treatment Period|Pregnancy|0
7133352|NCT02828020|11282043|FG000|Treatment Period|Protocol Violation|2
7133353|NCT02828020|11282044|FG001|Treatment Period|Protocol Violation|4
7133354|NCT02828020|11282045|FG002|Treatment Period|Protocol Violation|7
7133355|NCT02828020|11282043|FG000|Treatment Period|Other Miscellaneous Reasons|0
7133356|NCT02828020|11282044|FG001|Treatment Period|Other Miscellaneous Reasons|1
7133357|NCT02828020|11282045|FG002|Treatment Period|Other Miscellaneous Reasons|0
7133358|NCT02828020|11282043|FG000|Safety Follow-up Period|Withdrawal of Consent|10
7133359|NCT02828020|11282044|FG001|Safety Follow-up Period|Withdrawal of Consent|8
7133360|NCT02828020|11282045|FG002|Safety Follow-up Period|Withdrawal of Consent|7
7133361|NCT02828020|11282043|FG000|Safety Follow-up Period|Lost to Follow-up|9
7133362|NCT02828020|11282044|FG001|Safety Follow-up Period|Lost to Follow-up|8
7133363|NCT02828020|11282045|FG002|Safety Follow-up Period|Lost to Follow-up|11
7133364|NCT02828020|11282043|FG000|Safety Follow-up Period|Protocol Violation|0
7133365|NCT02828020|11282044|FG001|Safety Follow-up Period|Protocol Violation|2
7133366|NCT02828020|11282045|FG002|Safety Follow-up Period|Protocol Violation|1
7133367|NCT02828020|11282043|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1
7133368|NCT02828020|11282044|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0
7133369|NCT02828020|11282045|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0
7133370|NCT02828111|11282058|FG000|Overall Study|Withdrawal by Subject|0
7133371|NCT02828111|11282059|FG001|Overall Study|Withdrawal by Subject|0
7133372|NCT02828111|11282060|FG002|Overall Study|Withdrawal by Subject|2
7133373|NCT02828111|11282061|FG003|Overall Study|Withdrawal by Subject|0
7133374|NCT02828111|11282062|FG004|Overall Study|Withdrawal by Subject|0
7133375|NCT02828111|11282058|FG000|Overall Study|Lost to Follow-up|0
7133376|NCT02828111|11282059|FG001|Overall Study|Lost to Follow-up|0
7133377|NCT02828111|11282060|FG002|Overall Study|Lost to Follow-up|0
7133378|NCT02828111|11282061|FG003|Overall Study|Lost to Follow-up|1
7133379|NCT02828111|11282062|FG004|Overall Study|Lost to Follow-up|1
7133380|NCT02828241|11282098|FG000|Overall Study|Adverse Event|7
7133381|NCT02828241|11282099|FG001|Overall Study|Adverse Event|2
7133382|NCT02828241|11282098|FG000|Overall Study|Protocol Violation|1
7133383|NCT02828241|11282099|FG001|Overall Study|Protocol Violation|0
7133384|NCT02828358|11282127|FG000|Overall Study|Physician Decision|7
7133385|NCT02828358|11282128|FG001|Overall Study|Physician Decision|1
7133386|NCT02828358|11282127|FG000|Overall Study|Treatment Failure|6
7133387|NCT02828358|11282128|FG001|Overall Study|Treatment Failure|0
7133388|NCT02828358|11282127|FG000|Overall Study|Patients without KMT2A rearrangement|0
7133389|NCT02828358|11282128|FG001|Overall Study|Patients without KMT2A rearrangement|21
7133390|NCT02828358|11282127|FG000|Overall Study|Refusal of further protocol therapy|2
7133391|NCT02828358|11282128|FG001|Overall Study|Refusal of further protocol therapy|0
7133392|NCT02828358|11282127|FG000|Overall Study|Relapse|25
7133393|NCT02828358|11282128|FG001|Overall Study|Relapse|0
7133394|NCT02828358|11282127|FG000|Overall Study|Still on therapy|5
7133395|NCT02828358|11282128|FG001|Overall Study|Still on therapy|0
7133396|NCT02828436|11282133|FG000|Period 1|Did Not Meet Inclusion Criteria|0
7133397|NCT02828436|11282134|FG001|Period 1|Did Not Meet Inclusion Criteria|3
7133398|NCT02828436|11282133|FG000|Period 1|Lost to Follow-up|0
7133399|NCT02828436|11282134|FG001|Period 1|Lost to Follow-up|1
7133400|NCT02828436|11282133|FG000|Period 2|Withdrawal by Subject|4
7133401|NCT02828436|11282134|FG001|Period 2|Withdrawal by Subject|0
7133402|NCT02828436|11282133|FG000|Period 2|Did Not Meet Inclusion Criteria|3
7133403|NCT02828436|11282134|FG001|Period 2|Did Not Meet Inclusion Criteria|0
7133404|NCT02828436|11282133|FG000|Period 2|Lost to Follow-up|1
7133405|NCT02828436|11282134|FG001|Period 2|Lost to Follow-up|0
7133406|NCT02828644|11282142|FG000|Overall Study|Lost to Follow-up|23
7133407|NCT02828644|11282143|FG001|Overall Study|Lost to Follow-up|22
7133408|NCT02829138|11282161|FG000|Overall Study|Withdrawal by Subject|1
7133409|NCT02829138|11282162|FG001|Overall Study|Withdrawal by Subject|0
7133410|NCT02829775|11282198|FG000|Overall Study|Death|1
7133411|NCT02829775|11282198|FG000|Overall Study|Withdrawal by Subject|3
7133412|NCT02829775|11282198|FG000|Overall Study|Disease remission|1
7133413|NCT02829944|11282205|FG000|Overall Study|Physician Decision|0
7133414|NCT02829944|11282206|FG001|Overall Study|Physician Decision|1
7133415|NCT02829944|11282205|FG000|Overall Study|Screen Failure|2
7133416|NCT02829944|11282206|FG001|Overall Study|Screen Failure|2
7133417|NCT02829944|11282205|FG000|Overall Study|Inadequate Neuraxial Block|1
7133418|NCT02829944|11282206|FG001|Overall Study|Inadequate Neuraxial Block|1
7133419|NCT02829944|11282205|FG000|Overall Study|Withdrawal by Subject|2
7133420|NCT02829944|11282206|FG001|Overall Study|Withdrawal by Subject|1
7133421|NCT02829944|11282205|FG000|Overall Study|Catheter Displacement|1
7133422|NCT02829944|11282206|FG001|Overall Study|Catheter Displacement|0
7133423|NCT02829944|11282205|FG000|Overall Study|Catheter broke|0
7133424|NCT02829944|11282206|FG001|Overall Study|Catheter broke|1
7133425|NCT02829944|11282205|FG000|Overall Study|Staff unavailable|0
7133426|NCT02829944|11282206|FG001|Overall Study|Staff unavailable|1
7133427|NCT02829996|11282226|FG000|Overall Study|Withdrawal by Subject|1
7133428|NCT02829996|11282227|FG001|Overall Study|Withdrawal by Subject|0
7133429|NCT02829996|11282228|FG002|Overall Study|Withdrawal by Subject|0
7133430|NCT02829996|11282229|FG003|Overall Study|Withdrawal by Subject|0
7133431|NCT02829996|11282230|FG004|Overall Study|Withdrawal by Subject|0
7133432|NCT02830087|11282258|FG000|Overall Study|No study staff to follow-up patients|4
7133433|NCT02830087|11282259|FG001|Overall Study|No study staff to follow-up patients|4
7133434|NCT02830087|11282260|FG002|Overall Study|No study staff to follow-up patients|4
7133435|NCT02830087|11282261|FG003|Overall Study|No study staff to follow-up patients|3
7133436|NCT02830087|11282262|FG004|Overall Study|No study staff to follow-up patients|3
7133437|NCT02830087|11282263|FG005|Overall Study|No study staff to follow-up patients|3
7133438|NCT02830776|11282281|FG000|Overall Study|Lost to Follow-up|1
7133439|NCT02830880|11282286|FG000|Overall Study|Adverse reaction to chemotherapy|1
7133440|NCT02830880|11282286|FG000|Overall Study|Death|1
7133441|NCT02830880|11282286|FG000|Overall Study|Physician Decision|1
7133442|NCT02830893|11282292|FG000|Overall Study|Relocation to out of the country|1
7133443|NCT02830893|11282293|FG001|Overall Study|Relocation to out of the country|0
7133444|NCT02830893|11282292|FG000|Overall Study|Lost to Follow-up|0
7133445|NCT02830893|11282293|FG001|Overall Study|Lost to Follow-up|2
7133446|NCT02830893|11282292|FG000|Overall Study|Discharged to SNF, no transportation.|0
7133447|NCT02830893|11282293|FG001|Overall Study|Discharged to SNF, no transportation.|1
7133448|NCT02831387|11282301|FG000|Overall Study|Withdrawal by Subject|1
7133449|NCT02831387|11282302|FG001|Overall Study|Withdrawal by Subject|1
7133450|NCT02831387|11282301|FG000|Overall Study|Discontinued due to stock recovery|0
7133451|NCT02831387|11282302|FG001|Overall Study|Discontinued due to stock recovery|1
7133452|NCT02831855|11282327|FG000|Open Label Phase (24 Weeks)|Adverse Event|39
7133453|NCT02831855|11282328|FG001|Open Label Phase (24 Weeks)|Adverse Event|0
7133454|NCT02831855|11282329|FG002|Open Label Phase (24 Weeks)|Adverse Event|0
7133455|NCT02831855|11282327|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8
7133456|NCT02831855|11282328|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0
7133457|NCT02831855|11282329|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0
7133458|NCT02831855|11282327|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7
7133459|NCT02831855|11282328|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0
7133460|NCT02831855|11282329|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0
7133461|NCT02831855|11282327|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2
7133462|NCT02831855|11282328|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0
7133463|NCT02831855|11282329|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0
7133464|NCT02831855|11282327|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5
7133465|NCT02831855|11282328|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0
7133466|NCT02831855|11282329|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0
7133467|NCT02831855|11282327|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6
7133468|NCT02831855|11282328|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0
7133469|NCT02831855|11282329|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0
7133470|NCT02831855|11282327|FG000|Open Label Phase (24 Weeks)|Other|4
7133471|NCT02831855|11282328|FG001|Open Label Phase (24 Weeks)|Other|0
7133472|NCT02831855|11282329|FG002|Open Label Phase (24 Weeks)|Other|0
7133473|NCT02831855|11282327|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0
7133474|NCT02831855|11282328|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6
7133475|NCT02831855|11282329|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6
7133476|NCT02831855|11282327|FG000|Double Blind Phase (24 Weeks)|Death|0
7133477|NCT02831855|11282328|FG001|Double Blind Phase (24 Weeks)|Death|0
7133478|NCT02831855|11282329|FG002|Double Blind Phase (24 Weeks)|Death|2
7133479|NCT02831855|11282327|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0
7133480|NCT02831855|11282328|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1
7133481|NCT02831855|11282329|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1
7133482|NCT02831855|11282327|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0
7133483|NCT02831855|11282328|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1
6806383|NCT02564900|10808831|FG003|Dose Expansion|Other|0
6806384|NCT02564900|10808832|FG004|Dose Expansion|Other|0
6806385|NCT02564900|10808833|FG005|Dose Expansion|Other|0
6806386|NCT02564900|10808834|FG006|Dose Expansion|Other|1
6806387|NCT02564900|10808835|FG007|Dose Expansion|Other|0
6806388|NCT02564900|10808836|FG008|Dose Expansion|Other|1
6806389|NCT02564900|10808837|FG009|Dose Expansion|Other|0
7133484|NCT02831855|11282329|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0
7133485|NCT02831855|11282327|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0
7133486|NCT02831855|11282328|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5
7133487|NCT02831855|11282329|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2
7133488|NCT02831855|11282327|FG000|Double Blind Phase (24 Weeks)|Other|0
7133489|NCT02831855|11282328|FG001|Double Blind Phase (24 Weeks)|Other|2
7133490|NCT02831855|11282329|FG002|Double Blind Phase (24 Weeks)|Other|5
7133491|NCT02831855|11282327|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0
7133492|NCT02831855|11282328|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6
6806390|NCT02564900|10808838|FG010|Dose Expansion|Other|0
6806391|NCT02564900|10808839|FG011|Dose Expansion|Other|0
6806392|NCT02564900|10808840|FG012|Dose Expansion|Other|0
6806393|NCT02564900|10808841|FG013|Dose Expansion|Other|0
6806394|NCT02564900|10808842|FG014|Dose Expansion|Other|1
6806395|NCT02564900|10808828|FG000|Dose Expansion|Did not receive treatment|0
6806396|NCT02564900|10808829|FG001|Dose Expansion|Did not receive treatment|0
7133493|NCT02831855|11282329|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1
7133494|NCT02831855|11282327|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0
7133495|NCT02831855|11282328|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5
7133496|NCT02831855|11282329|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2
7133497|NCT02831855|11282327|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0
7133498|NCT02831855|11282328|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3
7133499|NCT02831855|11282329|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0
7133500|NCT02832037|11282355|FG000|Overall Study|Administrative reasons|0
7133501|NCT02832037|11282356|FG001|Overall Study|Administrative reasons|0
7133502|NCT02832037|11282357|FG002|Overall Study|Administrative reasons|1
7133503|NCT02832037|11282358|FG003|Overall Study|Administrative reasons|0
7133504|NCT02832037|11282359|FG004|Overall Study|Administrative reasons|0
7133505|NCT02832037|11282355|FG000|Overall Study|Protocol Violation|3
7133506|NCT02832037|11282356|FG001|Overall Study|Protocol Violation|0
7133507|NCT02832037|11282357|FG002|Overall Study|Protocol Violation|4
7133508|NCT02832037|11282358|FG003|Overall Study|Protocol Violation|1
7133509|NCT02832037|11282359|FG004|Overall Study|Protocol Violation|2
7133510|NCT02832037|11282355|FG000|Overall Study|Lost to Follow-up|2
7133511|NCT02832037|11282356|FG001|Overall Study|Lost to Follow-up|0
7133512|NCT02832037|11282357|FG002|Overall Study|Lost to Follow-up|3
7133513|NCT02832037|11282358|FG003|Overall Study|Lost to Follow-up|0
7133514|NCT02832037|11282359|FG004|Overall Study|Lost to Follow-up|5
7133515|NCT02832037|11282355|FG000|Overall Study|Withdrawal by Subject|9
7133516|NCT02832037|11282356|FG001|Overall Study|Withdrawal by Subject|8
7133517|NCT02832037|11282357|FG002|Overall Study|Withdrawal by Subject|0
7133518|NCT02832037|11282358|FG003|Overall Study|Withdrawal by Subject|4
7133519|NCT02832037|11282359|FG004|Overall Study|Withdrawal by Subject|8
7133520|NCT02832037|11282355|FG000|Overall Study|Adverse Event|5
7133521|NCT02832037|11282356|FG001|Overall Study|Adverse Event|4
7133522|NCT02832037|11282357|FG002|Overall Study|Adverse Event|0
7133523|NCT02832037|11282358|FG003|Overall Study|Adverse Event|2
7133524|NCT02832037|11282359|FG004|Overall Study|Adverse Event|4
7133525|NCT02832375|11282390|FG000|Overall Study|Lost to Follow-up|1
7133526|NCT02832375|11282391|FG001|Overall Study|Lost to Follow-up|0
7133527|NCT02832375|11282390|FG000|Overall Study|Withdrawal of Consent|1
7133528|NCT02832375|11282391|FG001|Overall Study|Withdrawal of Consent|0
7133529|NCT02832622|11282398|FG000|Overall Study|MPP not programmed|1259
7133530|NCT02832622|11282398|FG000|Overall Study|Withdrawal by Subject|123
7133531|NCT02832622|11282398|FG000|Overall Study|Death|119
7133532|NCT02832622|11282398|FG000|Overall Study|Unsuccessful CRT implant|93
7133533|NCT02832622|11282398|FG000|Overall Study|Lost to Follow-up|45
7133534|NCT02832622|11282398|FG000|Overall Study|Patient non-compliance|42
7133535|NCT02832622|11282398|FG000|Overall Study|Withdrawal by other reasons|25
7133536|NCT02832622|11282398|FG000|Overall Study|System explant|24
7133537|NCT02832622|11282398|FG000|Overall Study|Physician Decision|6
7133538|NCT02833077|11282409|FG000|Overall Study|Adverse Event|1
7133539|NCT02833077|11282410|FG001|Overall Study|Adverse Event|2
7133540|NCT02833077|11282409|FG000|Overall Study|Lost to Follow-up|10
7133541|NCT02833077|11282410|FG001|Overall Study|Lost to Follow-up|1
7133542|NCT02833077|11282409|FG000|Overall Study|Personal Reasons|6
7133543|NCT02833077|11282410|FG001|Overall Study|Personal Reasons|4
7133544|NCT02833077|11282409|FG000|Overall Study|Protocol Deviation|0
7133545|NCT02833077|11282410|FG001|Overall Study|Protocol Deviation|1
7133546|NCT02833350|11282428|FG000|Overall Study|Adverse Event|0
7133547|NCT02833350|11282429|FG001|Overall Study|Adverse Event|3
7133548|NCT02833350|11282430|FG002|Overall Study|Adverse Event|4
7133549|NCT02833350|11282431|FG003|Overall Study|Adverse Event|4
7133550|NCT02833350|11282432|FG004|Overall Study|Adverse Event|1
7133551|NCT02833350|11282433|FG005|Overall Study|Adverse Event|0
7133552|NCT02833350|11282434|FG006|Overall Study|Adverse Event|1
7133553|NCT02833350|11282428|FG000|Overall Study|Death|0
7133554|NCT02833350|11282429|FG001|Overall Study|Death|0
7133555|NCT02833350|11282430|FG002|Overall Study|Death|1
7133556|NCT02833350|11282431|FG003|Overall Study|Death|0
7133557|NCT02833350|11282432|FG004|Overall Study|Death|0
7133558|NCT02833350|11282433|FG005|Overall Study|Death|0
7133559|NCT02833350|11282434|FG006|Overall Study|Death|0
7133560|NCT02833350|11282428|FG000|Overall Study|Lack of Efficacy|0
7133561|NCT02833350|11282429|FG001|Overall Study|Lack of Efficacy|2
7133562|NCT02833350|11282430|FG002|Overall Study|Lack of Efficacy|1
7133563|NCT02833350|11282431|FG003|Overall Study|Lack of Efficacy|4
7133564|NCT02833350|11282432|FG004|Overall Study|Lack of Efficacy|0
7133565|NCT02833350|11282433|FG005|Overall Study|Lack of Efficacy|1
7133566|NCT02833350|11282434|FG006|Overall Study|Lack of Efficacy|1
7133567|NCT02833350|11282428|FG000|Overall Study|Lost to Follow-up|0
7133568|NCT02833350|11282429|FG001|Overall Study|Lost to Follow-up|1
7133569|NCT02833350|11282430|FG002|Overall Study|Lost to Follow-up|0
7133570|NCT02833350|11282431|FG003|Overall Study|Lost to Follow-up|0
7133571|NCT02833350|11282432|FG004|Overall Study|Lost to Follow-up|0
7133572|NCT02833350|11282433|FG005|Overall Study|Lost to Follow-up|0
7133573|NCT02833350|11282434|FG006|Overall Study|Lost to Follow-up|1
7133574|NCT02833350|11282428|FG000|Overall Study|Withdrawal by Subject|3
7133575|NCT02833350|11282429|FG001|Overall Study|Withdrawal by Subject|3
7133576|NCT02833350|11282430|FG002|Overall Study|Withdrawal by Subject|2
7133577|NCT02833350|11282431|FG003|Overall Study|Withdrawal by Subject|0
7133578|NCT02833350|11282432|FG004|Overall Study|Withdrawal by Subject|2
7133579|NCT02833350|11282433|FG005|Overall Study|Withdrawal by Subject|0
7133580|NCT02833350|11282434|FG006|Overall Study|Withdrawal by Subject|2
7133581|NCT02833948|11282472|FG000|Overall Study|Death|2
7133582|NCT02833948|11282473|FG001|Overall Study|Death|3
7133583|NCT02833948|11282472|FG000|Overall Study|were not scanned|8
7133584|NCT02833948|11282473|FG001|Overall Study|were not scanned|13
7133585|NCT02833948|11282472|FG000|Overall Study|scans could not be evaluated|5
7133586|NCT02833948|11282473|FG001|Overall Study|scans could not be evaluated|2
7133587|NCT02833974|11282485|FG000|Overall Study|Lost to Follow-up|1
7133588|NCT02833974|11282486|FG001|Overall Study|Lost to Follow-up|0
7133589|NCT02833974|11282485|FG000|Overall Study|Adverse Event|0
7133590|NCT02833974|11282486|FG001|Overall Study|Adverse Event|3
7133591|NCT02834247|11282496|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1
7133592|NCT02834247|11282497|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2
7133593|NCT02834247|11282498|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0
7133594|NCT02834247|11282499|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0
7133595|NCT02834247|11282496|FG000|Dose Escalation Phase|Death|5
7133596|NCT02834247|11282497|FG001|Dose Escalation Phase|Death|6
7133597|NCT02834247|11282498|FG002|Dose Escalation Phase|Death|5
7133598|NCT02834247|11282499|FG003|Dose Escalation Phase|Death|0
7133599|NCT02834247|11282496|FG000|Dose Escalation Phase|Lost to Follow-up|0
7133600|NCT02834247|11282497|FG001|Dose Escalation Phase|Lost to Follow-up|1
7133601|NCT02834247|11282498|FG002|Dose Escalation Phase|Lost to Follow-up|0
7133602|NCT02834247|11282499|FG003|Dose Escalation Phase|Lost to Follow-up|0
7133603|NCT02834247|11282496|FG000|Dose Escalation Phase|Withdrawal by Subject|2
7133604|NCT02834247|11282497|FG001|Dose Escalation Phase|Withdrawal by Subject|2
7133605|NCT02834247|11282498|FG002|Dose Escalation Phase|Withdrawal by Subject|0
7133606|NCT02834247|11282499|FG003|Dose Escalation Phase|Withdrawal by Subject|0
7133607|NCT02834247|11282496|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0
7133608|NCT02834247|11282497|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0
7133609|NCT02834247|11282498|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0
7133610|NCT02834247|11282499|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7
7133611|NCT02834247|11282496|FG000|Dose Expansion Phase|Death|0
7133612|NCT02834247|11282497|FG001|Dose Expansion Phase|Death|0
7133613|NCT02834247|11282498|FG002|Dose Expansion Phase|Death|0
7133614|NCT02834247|11282499|FG003|Dose Expansion Phase|Death|8
7133615|NCT02834247|11282496|FG000|Dose Expansion Phase|Lost to Follow-up|0
7133616|NCT02834247|11282497|FG001|Dose Expansion Phase|Lost to Follow-up|0
7133617|NCT02834247|11282498|FG002|Dose Expansion Phase|Lost to Follow-up|0
7133618|NCT02834247|11282499|FG003|Dose Expansion Phase|Lost to Follow-up|1
7133619|NCT02834247|11282496|FG000|Dose Expansion Phase|Withdrawal by Subject|0
7133620|NCT02834247|11282497|FG001|Dose Expansion Phase|Withdrawal by Subject|0
7133621|NCT02834247|11282498|FG002|Dose Expansion Phase|Withdrawal by Subject|0
7133622|NCT02834247|11282499|FG003|Dose Expansion Phase|Withdrawal by Subject|1
7133623|NCT02834390|11282513|FG000|Induction Phase|Progressive disease|0
7133624|NCT02834390|11282514|FG001|Induction Phase|Progressive disease|1
7133625|NCT02834390|11282513|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2
7133626|NCT02834390|11282514|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0
7133627|NCT02834390|11282513|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0
7133628|NCT02834390|11282514|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1
7133629|NCT02834390|11282513|FG000|Consolidation Phase|Physician Decision|1
7133630|NCT02834390|11282514|FG001|Consolidation Phase|Physician Decision|1
7133631|NCT02834819|11282554|FG000|Overall Study|Did not complete 7 day follow up call.|5
7133632|NCT02834819|11282555|FG001|Overall Study|Did not complete 7 day follow up call.|0
7133633|NCT02835092|11282564|FG000|Overall Study|Withdrawal by Subject|3
7133634|NCT02835092|11282565|FG001|Overall Study|Withdrawal by Subject|6
7133635|NCT02835092|11282566|FG002|Overall Study|Withdrawal by Subject|3
7133636|NCT02835092|11282564|FG000|Overall Study|Lost to Follow-up|0
7133637|NCT02835092|11282565|FG001|Overall Study|Lost to Follow-up|2
7133638|NCT02835092|11282566|FG002|Overall Study|Lost to Follow-up|0
7133639|NCT02835339|11282585|FG000|Overall Study|Did not receive allocated intervention|13
7133640|NCT02835339|11282586|FG001|Overall Study|Did not receive allocated intervention|16
7133641|NCT02835495|11282594|FG000|Overall Study|Cancer diagnosis prior intervention|1
7133642|NCT02835495|11282595|FG001|Overall Study|Cancer diagnosis prior intervention|0
7133643|NCT02835495|11282594|FG000|Overall Study|Declined in-person follow-up visit|4
7133644|NCT02835495|11282595|FG001|Overall Study|Declined in-person follow-up visit|2
7133645|NCT02835820|11282619|FG000|Overall Study|Baseline Screen Failure|0
7133646|NCT02835820|11282620|FG001|Overall Study|Baseline Screen Failure|3
7133647|NCT02836496|11282632|FG000|Overall Study|Adverse Event|2
7133648|NCT02836496|11282633|FG001|Overall Study|Adverse Event|1
7133649|NCT02836496|11282632|FG000|Overall Study|Withdrawal by Subject|0
7133650|NCT02836496|11282633|FG001|Overall Study|Withdrawal by Subject|1
7133651|NCT02836613|11282641|FG000|Overall Study|Accidental drowning|1
7133652|NCT02836613|11282642|FG001|Overall Study|Accidental drowning|0
7133653|NCT02836613|11282641|FG000|Overall Study|Lost to Follow-up|0
7133654|NCT02836613|11282642|FG001|Overall Study|Lost to Follow-up|1
7133655|NCT02836613|11282641|FG000|Overall Study|Withdrawal by Subject|0
7133656|NCT02836613|11282642|FG001|Overall Study|Withdrawal by Subject|2
7133657|NCT02836652|11282650|FG000|Overall Study|Death|3
7133658|NCT02836652|11282651|FG001|Overall Study|Death|3
7133659|NCT02836652|11282650|FG000|Overall Study|Transplant/Explant|3
7133660|NCT02836652|11282651|FG001|Overall Study|Transplant/Explant|4
7133661|NCT02836652|11282650|FG000|Overall Study|Withdrawn|9
7133662|NCT02836652|11282651|FG001|Overall Study|Withdrawn|9
7133663|NCT02836652|11282650|FG000|Overall Study|Not on treatment regimen post-op day 15|3
7133664|NCT02836652|11282651|FG001|Overall Study|Not on treatment regimen post-op day 15|3
7133665|NCT02836769|11282657|FG000|Overall Study|Lost to Follow-up|10
7133666|NCT02836769|11282657|FG000|Overall Study|Medical withdrawal|2
7133667|NCT02836769|11282657|FG000|Overall Study|Withdrawal by Subject|3
7133668|NCT02836873|11282663|FG000|Overall Study|Protocol Violation|0
7133669|NCT02836873|11282664|FG001|Overall Study|Protocol Violation|1
7133670|NCT02836873|11282663|FG000|Overall Study|Adverse Event|1
7133671|NCT02836873|11282664|FG001|Overall Study|Adverse Event|4
7133672|NCT02836873|11282663|FG000|Overall Study|Withdrawal by Subject|2
7133673|NCT02836873|11282664|FG001|Overall Study|Withdrawal by Subject|2
7133674|NCT02836873|11282663|FG000|Overall Study|Lost to Follow-up|1
7133675|NCT02836873|11282664|FG001|Overall Study|Lost to Follow-up|3
7133676|NCT02836873|11282663|FG000|Overall Study|Physician Decision|0
7133677|NCT02836873|11282664|FG001|Overall Study|Physician Decision|1
7133678|NCT02836873|11282663|FG000|Overall Study|Other|1
7133679|NCT02836873|11282664|FG001|Overall Study|Other|0
7133680|NCT02837731|11282696|FG000|Allocation|Admitted to General Floor|3
7133681|NCT02837731|11282697|FG001|Allocation|Admitted to General Floor|4
7133682|NCT02837731|11282696|FG000|Allocation|Immediate surgery/withdrew|2
7133683|NCT02837731|11282697|FG001|Allocation|Immediate surgery/withdrew|0
7133684|NCT02837731|11282696|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1
7133685|NCT02837731|11282697|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0
7133686|NCT02837731|11282696|FG000|Allocation|Withdrawal by Subject|2
7133687|NCT02837731|11282697|FG001|Allocation|Withdrawal by Subject|0
7133688|NCT02837731|11282696|FG000|Allocation|Device not available|1
7133689|NCT02837731|11282697|FG001|Allocation|Device not available|0
7133690|NCT02837731|11282696|FG000|Allocation|Protocol not implemented|7
7133691|NCT02837731|11282697|FG001|Allocation|Protocol not implemented|0
7133692|NCT02837731|11282696|FG000|Allocation|Moribund/Do not resuscitate|2
7133693|NCT02837731|11282697|FG001|Allocation|Moribund/Do not resuscitate|0
7133694|NCT02837731|11282696|FG000|Allocation|Did not meet sepsis criteria|1
7133695|NCT02837731|11282697|FG001|Allocation|Did not meet sepsis criteria|2
7133696|NCT02837731|11282696|FG000|Allocation|Known aortic abnormalities|0
7133697|NCT02837731|11282697|FG001|Allocation|Known aortic abnormalities|1
7133698|NCT02837952|11282718|FG000|Overall Study|Adverse Event|0
7133699|NCT02837952|11282719|FG001|Overall Study|Adverse Event|1
7133700|NCT02837952|11282718|FG000|Overall Study|Withdrawal by Subject|4
7133701|NCT02837952|11282719|FG001|Overall Study|Withdrawal by Subject|5
7133702|NCT02837952|11282718|FG000|Overall Study|Medication Error|1
7133703|NCT02837952|11282719|FG001|Overall Study|Medication Error|0
7133704|NCT02838017|11282727|FG000|Overall Study|Lost to Follow-up|14
7133705|NCT02838017|11282728|FG001|Overall Study|Lost to Follow-up|11
7133706|NCT02838134|11282736|FG000|Overall Study|Lost to Follow-up|1
7133707|NCT02838134|11282737|FG001|Overall Study|Lost to Follow-up|2
7133708|NCT02838134|11282736|FG000|Overall Study|logistic problems|1
7133709|NCT02838134|11282737|FG001|Overall Study|logistic problems|1
7133710|NCT02838420|11282749|FG000|Overall Study|Ongoing in Study|113
7133711|NCT02838420|11282750|FG001|Overall Study|Ongoing in Study|45
7133712|NCT02838420|11282749|FG000|Overall Study|Lost to Follow-up|1
7133713|NCT02838420|11282750|FG001|Overall Study|Lost to Follow-up|0
7133714|NCT02838420|11282749|FG000|Overall Study|Withdrawal by Subject|3
7133715|NCT02838420|11282750|FG001|Overall Study|Withdrawal by Subject|4
7133716|NCT02838420|11282749|FG000|Overall Study|Death|8
7133717|NCT02838420|11282750|FG001|Overall Study|Death|13
7133718|NCT02838628|11282758|FG000|Recurrence Follow-up Period|AK Recurrence|18
7133719|NCT02838628|11282759|FG001|Recurrence Follow-up Period|AK Recurrence|13
7133720|NCT02838628|11282758|FG000|Recurrence Follow-up Period|Adverse Event|1
7133721|NCT02838628|11282759|FG001|Recurrence Follow-up Period|Adverse Event|0
7133722|NCT02838628|11282758|FG000|Recurrence Follow-up Period|Non-compliance|0
7133723|NCT02838628|11282759|FG001|Recurrence Follow-up Period|Non-compliance|1
7133724|NCT02838628|11282758|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0
7133725|NCT02838628|11282759|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2
7133726|NCT02838628|11282758|FG000|Recurrence Follow-up Period|Other un-specified|1
7133727|NCT02838628|11282759|FG001|Recurrence Follow-up Period|Other un-specified|1
7133728|NCT02838901|11282768|FG000|Overall Study|Withdrawal by Subject|1
7133729|NCT02838901|11282769|FG001|Overall Study|Withdrawal by Subject|1
7133730|NCT02838901|11282768|FG000|Overall Study|Lost to Follow-up|1
7133731|NCT02838901|11282769|FG001|Overall Study|Lost to Follow-up|1
7133732|NCT02839200|11282783|FG000|Overall Study|Withdrawal by Subject|2
7133733|NCT02839200|11282784|FG001|Overall Study|Withdrawal by Subject|0
7133734|NCT02839200|11282785|FG002|Overall Study|Withdrawal by Subject|1
7133735|NCT02839200|11282786|FG003|Overall Study|Withdrawal by Subject|0
7133736|NCT02839200|11282787|FG004|Overall Study|Withdrawal by Subject|0
7133737|NCT02839200|11282788|FG005|Overall Study|Withdrawal by Subject|1
7133738|NCT02839200|11282783|FG000|Overall Study|Lost to Follow-up|2
7133739|NCT02839200|11282784|FG001|Overall Study|Lost to Follow-up|0
7133740|NCT02839200|11282785|FG002|Overall Study|Lost to Follow-up|0
7133741|NCT02839200|11282786|FG003|Overall Study|Lost to Follow-up|0
7133742|NCT02839200|11282787|FG004|Overall Study|Lost to Follow-up|1
7133743|NCT02839200|11282788|FG005|Overall Study|Lost to Follow-up|0
7133744|NCT02839200|11282783|FG000|Overall Study|Adverse Event|0
7133745|NCT02839200|11282784|FG001|Overall Study|Adverse Event|0
7133746|NCT02839200|11282785|FG002|Overall Study|Adverse Event|0
7133747|NCT02839200|11282786|FG003|Overall Study|Adverse Event|0
7133748|NCT02839200|11282787|FG004|Overall Study|Adverse Event|1
7133749|NCT02839200|11282788|FG005|Overall Study|Adverse Event|0
7133750|NCT02839200|11282783|FG000|Overall Study|Randomized in error|0
7133751|NCT02839200|11282784|FG001|Overall Study|Randomized in error|1
7133752|NCT02839200|11282785|FG002|Overall Study|Randomized in error|0
7133753|NCT02839200|11282786|FG003|Overall Study|Randomized in error|0
7133754|NCT02839200|11282787|FG004|Overall Study|Randomized in error|0
7133755|NCT02839200|11282788|FG005|Overall Study|Randomized in error|0
7133756|NCT02839330|11282806|FG000|Overall Study|Adverse Event|0
7133757|NCT02839330|11282807|FG001|Overall Study|Adverse Event|1
7133758|NCT02839330|11282808|FG002|Overall Study|Adverse Event|2
7133759|NCT02839330|11282809|FG003|Overall Study|Adverse Event|2
7133760|NCT02839330|11282806|FG000|Overall Study|Death|4
7133761|NCT02839330|11282807|FG001|Overall Study|Death|6
7133762|NCT02839330|11282808|FG002|Overall Study|Death|1
7133763|NCT02839330|11282809|FG003|Overall Study|Death|1
7133764|NCT02839330|11282806|FG000|Overall Study|Withdrawal by Subject|27
7133765|NCT02839330|11282807|FG001|Overall Study|Withdrawal by Subject|19
7133766|NCT02839330|11282808|FG002|Overall Study|Withdrawal by Subject|11
7133767|NCT02839330|11282809|FG003|Overall Study|Withdrawal by Subject|13
7133768|NCT02839330|11282806|FG000|Overall Study|Lost to Follow-up|22
7133769|NCT02839330|11282807|FG001|Overall Study|Lost to Follow-up|27
7133770|NCT02839330|11282808|FG002|Overall Study|Lost to Follow-up|29
7133771|NCT02839330|11282809|FG003|Overall Study|Lost to Follow-up|25
7133772|NCT02839330|11282806|FG000|Overall Study|Administrative Reason|0
7133773|NCT02839330|11282807|FG001|Overall Study|Administrative Reason|0
7133774|NCT02839330|11282808|FG002|Overall Study|Administrative Reason|0
7133775|NCT02839330|11282809|FG003|Overall Study|Administrative Reason|1
7133776|NCT02839330|11282806|FG000|Overall Study|Protocol Violation|1
7133777|NCT02839330|11282807|FG001|Overall Study|Protocol Violation|2
7133778|NCT02839330|11282808|FG002|Overall Study|Protocol Violation|2
7133779|NCT02839330|11282809|FG003|Overall Study|Protocol Violation|3
7133780|NCT02839330|11282806|FG000|Overall Study|Other reason, not specified|4
7133781|NCT02839330|11282807|FG001|Overall Study|Other reason, not specified|3
7133782|NCT02839330|11282808|FG002|Overall Study|Other reason, not specified|3
7133783|NCT02839330|11282809|FG003|Overall Study|Other reason, not specified|6
7133784|NCT02839681|11282820|FG000|Overall Study|Death|2
7133785|NCT02839746|11282824|FG000|Overall Study|Not met selection criteria|12
7133786|NCT02839798|11282851|FG000|Overall Study|Withdrawal by Subject|2
7133787|NCT02839876|11282857|FG000|Overall Study|Protocol Violation|10
7133788|NCT02839876|11282858|FG001|Overall Study|Protocol Violation|11
7133789|NCT02840253|11282898|FG000|Overall Study|Unsuccessful block|4
7133790|NCT02840461|11282905|FG000|Overall Study|Adverse Event|1
7133791|NCT02840461|11282906|FG001|Overall Study|Adverse Event|5
7133792|NCT02840461|11282907|FG002|Overall Study|Adverse Event|3
7133793|NCT02840461|11282905|FG000|Overall Study|Lost to Follow-up|10
7133794|NCT02840461|11282906|FG001|Overall Study|Lost to Follow-up|7
7133795|NCT02840461|11282907|FG002|Overall Study|Lost to Follow-up|6
7133796|NCT02840461|11282905|FG000|Overall Study|Non-Comliance with Dosing Requirements|0
7133797|NCT02840461|11282906|FG001|Overall Study|Non-Comliance with Dosing Requirements|1
7133798|NCT02840461|11282907|FG002|Overall Study|Non-Comliance with Dosing Requirements|0
7133799|NCT02840461|11282905|FG000|Overall Study|Protocol Violation|2
7133800|NCT02840461|11282906|FG001|Overall Study|Protocol Violation|3
7133801|NCT02840461|11282907|FG002|Overall Study|Protocol Violation|1
7133802|NCT02840461|11282905|FG000|Overall Study|Withdrawal by Subject|10
7133803|NCT02840461|11282906|FG001|Overall Study|Withdrawal by Subject|6
7133804|NCT02840461|11282907|FG002|Overall Study|Withdrawal by Subject|2
7133805|NCT02840461|11282905|FG000|Overall Study|Worsening of Symptom & Kit Error|0
7133806|NCT02840461|11282906|FG001|Overall Study|Worsening of Symptom & Kit Error|0
7133807|NCT02840461|11282907|FG002|Overall Study|Worsening of Symptom & Kit Error|2
7133808|NCT02840474|11282918|FG000|Overall Study|Lost to Follow-up|1
7133809|NCT02840474|11282919|FG001|Overall Study|Lost to Follow-up|0
7133810|NCT02840721|11282925|FG000|Treatment Period|Adverse Event|1
7133811|NCT02840721|11282925|FG000|Follow-Up|Lack of Efficacy|1
7133812|NCT02840721|11282925|FG000|Follow-Up|Withdrawal by Subject|4
7133813|NCT02840721|11282925|FG000|Follow-Up|Withdrawal of Consent|2
7133814|NCT02841709|11282993|FG000|5th Intervention|Adverse Event|2
7133815|NCT02841709|11282994|FG001|5th Intervention|Adverse Event|0
7133816|NCT02841709|11282995|FG002|5th Intervention|Adverse Event|0
7133817|NCT02841709|11282996|FG003|5th Intervention|Adverse Event|0
7133818|NCT02841709|11282997|FG004|5th Intervention|Adverse Event|2
7133819|NCT02841787|11283013|FG000|Overall Study|Lost to Follow-up|1
7133820|NCT02841787|11283014|FG001|Overall Study|Lost to Follow-up|0
7133821|NCT02841787|11283015|FG002|Overall Study|Lost to Follow-up|0
7133822|NCT02841787|11283013|FG000|Overall Study|Symptoms dropped below threshold|1
7133823|NCT02841787|11283014|FG001|Overall Study|Symptoms dropped below threshold|0
7133824|NCT02841787|11283015|FG002|Overall Study|Symptoms dropped below threshold|0
7133825|NCT02841787|11283013|FG000|Overall Study|Withdrawal by Subject|1
7133826|NCT02841787|11283014|FG001|Overall Study|Withdrawal by Subject|4
7133827|NCT02841787|11283015|FG002|Overall Study|Withdrawal by Subject|0
7133828|NCT02842073|11283032|FG000|Overall Study|Withdrawal by Subject|1
7133829|NCT02842086|11283038|FG000|Overall Study|Randomized but Never Treated|6
7133830|NCT02842086|11283039|FG001|Overall Study|Randomized but Never Treated|6
7133831|NCT02842086|11283038|FG000|Overall Study|Still in Double-Blind Phase|7
7133832|NCT02842086|11283039|FG001|Overall Study|Still in Double-Blind Phase|3
7133833|NCT02842086|11283038|FG000|Overall Study|Adverse Event|18
7133834|NCT02842086|11283039|FG001|Overall Study|Adverse Event|20
7133835|NCT02842086|11283038|FG000|Overall Study|Death|3
7133836|NCT02842086|11283039|FG001|Overall Study|Death|3
7133837|NCT02842086|11283038|FG000|Overall Study|Investigator's Discretion|9
7133838|NCT02842086|11283039|FG001|Overall Study|Investigator's Discretion|13
7133839|NCT02842086|11283038|FG000|Overall Study|Non-Compliance with Study Drug|9
7133840|NCT02842086|11283039|FG001|Overall Study|Non-Compliance with Study Drug|8
7133841|NCT02842086|11283038|FG000|Overall Study|Protocol Violation|8
7133842|NCT02842086|11283039|FG001|Overall Study|Protocol Violation|4
7133843|NCT02842086|11283038|FG000|Overall Study|Withdrew Consent|205
7133844|NCT02842086|11283039|FG001|Overall Study|Withdrew Consent|194
7133845|NCT02842086|11283038|FG000|Overall Study|Lost to Follow-up|274
7133846|NCT02842086|11283039|FG001|Overall Study|Lost to Follow-up|236
7133847|NCT02842086|11283038|FG000|Overall Study|HIV-1 Infection|5
7133848|NCT02842086|11283039|FG001|Overall Study|HIV-1 Infection|6
7133849|NCT02842151|11283045|FG000|Overall Study|Adverse Event|1
7133850|NCT02842151|11283045|FG000|Overall Study|Subject moved too far away|1
7133851|NCT02842736|11283060|FG000|Overall Study|Lost to Follow-up|13
7133852|NCT02842736|11283060|FG000|Overall Study|Intervention for menstrual bleeding|17
7133853|NCT02842736|11283060|FG000|Overall Study|Withdrawal by Subject|4
7133854|NCT02842736|11283060|FG000|Overall Study|Pregnancy|3
7133855|NCT02842736|11283060|FG000|Overall Study|Hysterectomy for fibroids|2
7133856|NCT02842736|11283060|FG000|Overall Study|Hysterectomy for uterine prolapse|1
7133857|NCT02842736|11283060|FG000|Overall Study|IUD: Mirena|1
7133858|NCT02843178|11283068|FG000|Overall Study|Lost to Follow-up|8
7133859|NCT02843178|11283069|FG001|Overall Study|Lost to Follow-up|8
7133860|NCT02843178|11283070|FG002|Overall Study|Lost to Follow-up|6
7133861|NCT02843178|11283071|FG003|Overall Study|Lost to Follow-up|3
7133862|NCT02843178|11283068|FG000|Overall Study|Withdrawal by Subject|0
7133863|NCT02843178|11283069|FG001|Overall Study|Withdrawal by Subject|0
7133864|NCT02843178|11283070|FG002|Overall Study|Withdrawal by Subject|1
7133865|NCT02843178|11283071|FG003|Overall Study|Withdrawal by Subject|1
7133866|NCT02843659|11283093|FG000|Overall Study|Subject Withdrew Consent|0
7133867|NCT02843659|11283094|FG001|Overall Study|Subject Withdrew Consent|0
7133868|NCT02843659|11283095|FG002|Overall Study|Subject Withdrew Consent|1
7133869|NCT02843659|11283093|FG000|Overall Study|Administrative Reason by Sponsor|4
6806397|NCT02564900|10808830|FG002|Dose Expansion|Did not receive treatment|0
6806398|NCT02564900|10808831|FG003|Dose Expansion|Did not receive treatment|0
6806399|NCT02564900|10808832|FG004|Dose Expansion|Did not receive treatment|0
6806400|NCT02564900|10808833|FG005|Dose Expansion|Did not receive treatment|0
6806401|NCT02564900|10808834|FG006|Dose Expansion|Did not receive treatment|1
6806402|NCT02564900|10808835|FG007|Dose Expansion|Did not receive treatment|1
6806403|NCT02564900|10808836|FG008|Dose Expansion|Did not receive treatment|0
6806404|NCT02564900|10808837|FG009|Dose Expansion|Did not receive treatment|0
6806405|NCT02564900|10808838|FG010|Dose Expansion|Did not receive treatment|0
6806406|NCT02564900|10808839|FG011|Dose Expansion|Did not receive treatment|0
6806407|NCT02564900|10808840|FG012|Dose Expansion|Did not receive treatment|0
6806408|NCT02564900|10808841|FG013|Dose Expansion|Did not receive treatment|0
6806409|NCT02564900|10808842|FG014|Dose Expansion|Did not receive treatment|1
6806410|NCT02561299|10808885|FG000|Overall Study|Death|2
6806411|NCT02561299|10808886|FG001|Overall Study|Death|4
6806412|NCT02561299|10808885|FG000|Overall Study|Lost to Follow-up|1
6806413|NCT02561299|10808886|FG001|Overall Study|Lost to Follow-up|0
6806414|NCT02561299|10808885|FG000|Overall Study|Withdrawal by Subject|2
6806415|NCT02561299|10808886|FG001|Overall Study|Withdrawal by Subject|2
6806416|NCT02548143|10808894|FG000|Overall Study|Adverse Event|1
6806417|NCT02548143|10808895|FG001|Overall Study|Adverse Event|0
6806418|NCT02548143|10808894|FG000|Overall Study|Withdrawal by Subject|0
6806419|NCT02548143|10808895|FG001|Overall Study|Withdrawal by Subject|1
6806420|NCT02448680|10808903|FG000|Overall Study|Physician Decision|1
6806421|NCT02448680|10808904|FG001|Overall Study|Physician Decision|1
6806422|NCT02448680|10808903|FG000|Overall Study|Withdrawal by Subject|0
6806423|NCT02448680|10808904|FG001|Overall Study|Withdrawal by Subject|2
6806424|NCT02393859|10808914|FG000|Overall Study|Decision by Sponsor|1
6806425|NCT02393859|10808915|FG001|Overall Study|Decision by Sponsor|1
6806426|NCT02393859|10808914|FG000|Overall Study|Withdrawal by Subject|5
6806427|NCT02393859|10808915|FG001|Overall Study|Withdrawal by Subject|2
6806428|NCT02393859|10808914|FG000|Overall Study|Death|16
6806429|NCT02393859|10808915|FG001|Overall Study|Death|8
6806430|NCT02393859|10808914|FG000|Overall Study|Continuing Study|32
6806431|NCT02393859|10808915|FG001|Overall Study|Continuing Study|43
6806432|NCT02178358|10808947|FG000|Overall Study|Withdrawal by Subject|0
7133870|NCT02843659|11283094|FG001|Overall Study|Administrative Reason by Sponsor|5
6806433|NCT02178358|10808948|FG001|Overall Study|Withdrawal by Subject|2
6806434|NCT02178358|10808949|FG002|Overall Study|Withdrawal by Subject|2
6806435|NCT02178358|10808947|FG000|Overall Study|Lost to Follow-up|1
6806436|NCT02178358|10808948|FG001|Overall Study|Lost to Follow-up|0
7133871|NCT02843659|11283095|FG002|Overall Study|Administrative Reason by Sponsor|4
7133872|NCT02843659|11283093|FG000|Overall Study|Adverse Event|0
7133873|NCT02843659|11283094|FG001|Overall Study|Adverse Event|1
7133874|NCT02843659|11283095|FG002|Overall Study|Adverse Event|0
7133875|NCT02844439|11283103|FG000|Overall Study|Withdrawal by Subject|1
7133876|NCT02844439|11283103|FG000|Overall Study|Lost to Follow-up|2
7133877|NCT02844439|11283103|FG000|Overall Study|Termination by Sponsor|4
7133878|NCT02844439|11283103|FG000|Overall Study|Death|28
7133879|NCT02844439|11283103|FG000|Overall Study|Other|5
7133880|NCT02844543|11283114|FG000|Overall Study|Withdrawal by Subject|4
7133881|NCT02844543|11283114|FG000|Overall Study|Did not meet eligibility criteria|1
7133882|NCT02844920|11283131|FG000|Overall Study|Lost to Follow-up|2
7133883|NCT02845336|11283150|FG000|Overall Study|Lost to Follow-up|3
7133884|NCT02845336|11283151|FG001|Overall Study|Lost to Follow-up|1
7133885|NCT02845336|11283150|FG000|Overall Study|Inability to get medication|2
7133886|NCT02845336|11283151|FG001|Overall Study|Inability to get medication|0
7133887|NCT02845375|11283160|FG000|Overall Study|upper airway obstruction|1
7133888|NCT02845375|11283161|FG001|Overall Study|upper airway obstruction|2
7133889|NCT02845375|11283162|FG002|Overall Study|upper airway obstruction|1
7133890|NCT02846324|11283210|FG000|Overall Study|Other|1
7133891|NCT02846324|11283211|FG001|Overall Study|Other|0
7133892|NCT02846324|11283212|FG002|Overall Study|Other|0
7133893|NCT02846324|11283213|FG003|Overall Study|Other|0
7133894|NCT02846324|11283210|FG000|Overall Study|Withdrawal by Subject|1
7133895|NCT02846324|11283211|FG001|Overall Study|Withdrawal by Subject|0
7133896|NCT02846324|11283212|FG002|Overall Study|Withdrawal by Subject|4
7133897|NCT02846324|11283213|FG003|Overall Study|Withdrawal by Subject|0
7133898|NCT02846415|11283234|FG000|Overall Study|Lost to Follow-up|2
7133899|NCT02846415|11283235|FG001|Overall Study|Lost to Follow-up|0
7133900|NCT02846415|11283234|FG000|Overall Study|Withdrawal by Subject|1
7133901|NCT02846415|11283235|FG001|Overall Study|Withdrawal by Subject|1
7133902|NCT02846558|11283245|FG000|Overall Study|Adverse Event|1
7133903|NCT02846558|11283246|FG001|Overall Study|Adverse Event|0
7133904|NCT02846558|11283247|FG002|Overall Study|Adverse Event|0
7133905|NCT02846558|11283248|FG003|Overall Study|Adverse Event|0
7133906|NCT02846558|11283245|FG000|Overall Study|Withdrawal by Subject|5
7133907|NCT02846558|11283246|FG001|Overall Study|Withdrawal by Subject|4
7133908|NCT02846558|11283247|FG002|Overall Study|Withdrawal by Subject|2
7133909|NCT02846558|11283248|FG003|Overall Study|Withdrawal by Subject|2
7133910|NCT02846558|11283245|FG000|Overall Study|Lost to Follow-up|2
7133911|NCT02846558|11283246|FG001|Overall Study|Lost to Follow-up|0
7133912|NCT02846558|11283247|FG002|Overall Study|Lost to Follow-up|0
7133913|NCT02846558|11283248|FG003|Overall Study|Lost to Follow-up|0
7133914|NCT02846779|11283281|FG000|Overall Study|Lost Enrollment|83
7133915|NCT02846779|11283282|FG001|Overall Study|Lost Enrollment|82
7133916|NCT02846779|11283283|FG002|Overall Study|Lost Enrollment|86
7133917|NCT02846779|11283281|FG000|Overall Study|Less than 31 days of follow-up|56
7133918|NCT02846779|11283282|FG001|Overall Study|Less than 31 days of follow-up|45
7133919|NCT02846779|11283283|FG002|Overall Study|Less than 31 days of follow-up|52
7133920|NCT02847182|11283319|FG000|Overall Study|Withdrawal by Subject|0
7133921|NCT02847182|11283320|FG001|Overall Study|Withdrawal by Subject|1
7133922|NCT02847260|11283332|FG000|Overall Study|Adverse Event|3
7133923|NCT02847260|11283332|FG000|Overall Study|Withdrawal by Subject|2
7133924|NCT02847260|11283332|FG000|Overall Study|Clinical Deterioration|1
7133925|NCT02847260|11283332|FG000|Overall Study|Physician Decision|1
7133926|NCT02847494|11283338|FG000|Overall Study|Lost to Follow-up|8
7133927|NCT02847494|11283339|FG001|Overall Study|Lost to Follow-up|5
7133928|NCT02847650|11283347|FG000|Overall Study|Adverse Event|2
7133929|NCT02847650|11283348|FG001|Overall Study|Adverse Event|4
7133930|NCT02847650|11283347|FG000|Overall Study|Lost to Follow-up|1
7133931|NCT02847650|11283348|FG001|Overall Study|Lost to Follow-up|0
7133932|NCT02847650|11283347|FG000|Overall Study|Protocol Violation|0
7133933|NCT02847650|11283348|FG001|Overall Study|Protocol Violation|1
7133934|NCT02847650|11283347|FG000|Overall Study|Withdrawal by Subject|1
7133935|NCT02847650|11283348|FG001|Overall Study|Withdrawal by Subject|1
7133936|NCT02847858|11283356|FG000|Overall Study|Lost to Follow-up|401
7133937|NCT02847858|11283357|FG001|Overall Study|Lost to Follow-up|269
7133938|NCT02848313|11283387|FG000|Overall Study|Adverse Event|1
7133939|NCT02848313|11283388|FG001|Overall Study|Adverse Event|2
7133940|NCT02848313|11283387|FG000|Overall Study|Lack of Efficacy|0
7133941|NCT02848313|11283388|FG001|Overall Study|Lack of Efficacy|1
7133942|NCT02848313|11283387|FG000|Overall Study|Withdrawal by Subject|1
7133943|NCT02848313|11283388|FG001|Overall Study|Withdrawal by Subject|1
7133944|NCT02848313|11283387|FG000|Overall Study|Lost to follow up|1
7133945|NCT02848313|11283388|FG001|Overall Study|Lost to follow up|0
7133946|NCT02848326|11283400|FG000|Treatment Period|Adverse Event|5
7133947|NCT02848326|11283401|FG001|Treatment Period|Adverse Event|4
7133948|NCT02848326|11283402|FG002|Treatment Period|Adverse Event|11
7133949|NCT02848326|11283403|FG003|Treatment Period|Adverse Event|6
7133950|NCT02848326|11283404|FG004|Treatment Period|Adverse Event|5
7133951|NCT02848326|11283405|FG005|Treatment Period|Adverse Event|7
7133952|NCT02848326|11283400|FG000|Treatment Period|Withdrawal of Consent|20
7133953|NCT02848326|11283401|FG001|Treatment Period|Withdrawal of Consent|6
7133954|NCT02848326|11283402|FG002|Treatment Period|Withdrawal of Consent|9
7133955|NCT02848326|11283403|FG003|Treatment Period|Withdrawal of Consent|6
7133956|NCT02848326|11283404|FG004|Treatment Period|Withdrawal of Consent|9
7133957|NCT02848326|11283405|FG005|Treatment Period|Withdrawal of Consent|6
7133958|NCT02848326|11283400|FG000|Treatment Period|Lost to Follow-up|5
7133959|NCT02848326|11283401|FG001|Treatment Period|Lost to Follow-up|1
7133960|NCT02848326|11283402|FG002|Treatment Period|Lost to Follow-up|11
7133961|NCT02848326|11283403|FG003|Treatment Period|Lost to Follow-up|7
7133962|NCT02848326|11283404|FG004|Treatment Period|Lost to Follow-up|2
7133963|NCT02848326|11283405|FG005|Treatment Period|Lost to Follow-up|3
7133964|NCT02848326|11283400|FG000|Treatment Period|Pregnancy|0
7133965|NCT02848326|11283401|FG001|Treatment Period|Pregnancy|0
7133966|NCT02848326|11283402|FG002|Treatment Period|Pregnancy|1
7133967|NCT02848326|11283403|FG003|Treatment Period|Pregnancy|1
7133968|NCT02848326|11283404|FG004|Treatment Period|Pregnancy|0
7133969|NCT02848326|11283405|FG005|Treatment Period|Pregnancy|1
7133970|NCT02848326|11283400|FG000|Treatment Period|Protocol Violation|4
7133971|NCT02848326|11283401|FG001|Treatment Period|Protocol Violation|3
7133972|NCT02848326|11283402|FG002|Treatment Period|Protocol Violation|4
7133973|NCT02848326|11283403|FG003|Treatment Period|Protocol Violation|2
7133974|NCT02848326|11283404|FG004|Treatment Period|Protocol Violation|3
7133975|NCT02848326|11283405|FG005|Treatment Period|Protocol Violation|3
7133976|NCT02848326|11283400|FG000|Treatment Period|Non-compliance with Study Drug|4
7133977|NCT02848326|11283401|FG001|Treatment Period|Non-compliance with Study Drug|0
7133978|NCT02848326|11283402|FG002|Treatment Period|Non-compliance with Study Drug|0
7133979|NCT02848326|11283403|FG003|Treatment Period|Non-compliance with Study Drug|1
7133980|NCT02848326|11283404|FG004|Treatment Period|Non-compliance with Study Drug|0
7133981|NCT02848326|11283405|FG005|Treatment Period|Non-compliance with Study Drug|0
7133982|NCT02848326|11283400|FG000|Safety Follow-up Period|Withdrawal of Consent|0
7133983|NCT02848326|11283401|FG001|Safety Follow-up Period|Withdrawal of Consent|1
7133984|NCT02848326|11283402|FG002|Safety Follow-up Period|Withdrawal of Consent|1
7133985|NCT02848326|11283403|FG003|Safety Follow-up Period|Withdrawal of Consent|0
7133986|NCT02848326|11283404|FG004|Safety Follow-up Period|Withdrawal of Consent|0
7133987|NCT02848326|11283405|FG005|Safety Follow-up Period|Withdrawal of Consent|2
7133988|NCT02848326|11283400|FG000|Safety Follow-up Period|Lost to Follow-up|4
7133989|NCT02848326|11283401|FG001|Safety Follow-up Period|Lost to Follow-up|0
7133990|NCT02848326|11283402|FG002|Safety Follow-up Period|Lost to Follow-up|2
7133991|NCT02848326|11283403|FG003|Safety Follow-up Period|Lost to Follow-up|0
7133992|NCT02848326|11283404|FG004|Safety Follow-up Period|Lost to Follow-up|1
7133993|NCT02848326|11283405|FG005|Safety Follow-up Period|Lost to Follow-up|3
7133994|NCT02848599|11283421|FG000|Overall Study|Protocol Violation|7
7133995|NCT02848599|11283422|FG001|Overall Study|Protocol Violation|9
7133996|NCT02848651|11283430|FG000|Overall Study|Death|85
7133997|NCT02848651|11283430|FG000|Overall Study|Lost to Follow-up|1
7133998|NCT02848651|11283430|FG000|Overall Study|Non-Compliance|1
7133999|NCT02848651|11283430|FG000|Overall Study|Symptomatic Deterioration|1
7134000|NCT02848651|11283430|FG000|Overall Study|Physician Decision|4
7134001|NCT02848651|11283430|FG000|Overall Study|Withdrawal by Subject|14
7134002|NCT02848664|11283450|FG000|Overall Study|Withdrawal by Subject|2
7134003|NCT02848664|11283450|FG000|Overall Study|Adverse Event|1
7134004|NCT02848664|11283450|FG000|Overall Study|no assistance for device training|1
7134005|NCT02848729|11283460|FG000|Overall Study|Withdrawal by Subject|1
7134006|NCT02848729|11283461|FG001|Overall Study|Withdrawal by Subject|0
7134007|NCT02848729|11283460|FG000|Overall Study|Emesis|15
7134008|NCT02848729|11283461|FG001|Overall Study|Emesis|11
7134009|NCT02848833|11283474|FG000|Overall Study|subject who are duplicated|1
7134010|NCT02848833|11283474|FG000|Overall Study|have not taken the study drug|11
7134011|NCT02848833|11283474|FG000|Overall Study|follow-up failure|6
7134012|NCT02848833|11283474|FG000|Overall Study|Protocol Violation|119
7134013|NCT02849080|11283480|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7
7134014|NCT02849080|11283481|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4
7134015|NCT02849080|11283482|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0
7134016|NCT02849080|11283483|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0
7134017|NCT02849080|11283480|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5
7134018|NCT02849080|11283481|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1
7134019|NCT02849080|11283482|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0
7134020|NCT02849080|11283483|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0
7134021|NCT02849080|11283480|FG000|Main Phase: 0 - 52 Weeks|Death|0
7134022|NCT02849080|11283481|FG001|Main Phase: 0 - 52 Weeks|Death|2
7134023|NCT02849080|11283482|FG002|Main Phase: 0 - 52 Weeks|Death|0
7134024|NCT02849080|11283483|FG003|Main Phase: 0 - 52 Weeks|Death|0
7134025|NCT02849080|11283480|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2
7134026|NCT02849080|11283481|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0
7134027|NCT02849080|11283482|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0
7134028|NCT02849080|11283483|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0
7134029|NCT02849080|11283480|FG000|Extension Phase: 53 - 104 Weeks|Other|0
7134030|NCT02849080|11283481|FG001|Extension Phase: 53 - 104 Weeks|Other|0
7134031|NCT02849080|11283482|FG002|Extension Phase: 53 - 104 Weeks|Other|1
7134032|NCT02849080|11283483|FG003|Extension Phase: 53 - 104 Weeks|Other|0
7134033|NCT02849080|11283480|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1
7134034|NCT02849080|11283481|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0
7134035|NCT02849080|11283482|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0
7134036|NCT02849080|11283483|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0
7134037|NCT02849509|11283530|FG000|Overall Study|Worsening of disease under study|1
7134038|NCT02849509|11283531|FG001|Overall Study|Worsening of disease under study|1
7134039|NCT02849509|11283532|FG002|Overall Study|Worsening of disease under study|1
7134040|NCT02849509|11283530|FG000|Overall Study|Worsening of other pre-existing disease|0
7134041|NCT02849509|11283531|FG001|Overall Study|Worsening of other pre-existing disease|1
7134042|NCT02849509|11283532|FG002|Overall Study|Worsening of other pre-existing disease|2
7134043|NCT02849509|11283530|FG000|Overall Study|Other adverse event|36
7134044|NCT02849509|11283531|FG001|Overall Study|Other adverse event|41
7134045|NCT02849509|11283532|FG002|Overall Study|Other adverse event|8
7134046|NCT02849509|11283530|FG000|Overall Study|Withdrawal by Subject|6
7134047|NCT02849509|11283531|FG001|Overall Study|Withdrawal by Subject|17
7134048|NCT02849509|11283532|FG002|Overall Study|Withdrawal by Subject|12
7134049|NCT02849509|11283530|FG000|Overall Study|Lost to Follow-up|27
7134050|NCT02849509|11283531|FG001|Overall Study|Lost to Follow-up|67
7134051|NCT02849509|11283532|FG002|Overall Study|Lost to Follow-up|36
7134052|NCT02849509|11283530|FG000|Overall Study|Other, reason not specified|14
7134053|NCT02849509|11283531|FG001|Overall Study|Other, reason not specified|29
7134054|NCT02849509|11283532|FG002|Overall Study|Other, reason not specified|25
7134055|NCT02849509|11283530|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6
7134056|NCT02849509|11283531|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10
7134057|NCT02849509|11283532|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1
7134058|NCT02849678|11283544|FG000|Overall Study|Protocol Violation|3
7134059|NCT02849678|11283545|FG001|Overall Study|Protocol Violation|6
7134060|NCT02849704|11283553|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1
7134061|NCT02849704|11283554|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0
7134062|NCT02849704|11283553|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1
7134063|NCT02849704|11283554|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0
7134064|NCT02849704|11283553|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1
7134065|NCT02849704|11283554|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0
7134066|NCT02850276|11283586|FG000|Overall Study|screen failure|43
7134067|NCT02850276|11283586|FG000|Overall Study|Withdrawal by Subject|14
7134068|NCT02850276|11283586|FG000|Overall Study|Physician Decision|2
7134069|NCT02850276|11283586|FG000|Overall Study|Lost to Follow-up|2
7134070|NCT02850965|11283602|FG000|Overall Study|Other than listed|3
7134071|NCT02850965|11283603|FG001|Overall Study|Other than listed|4
7134072|NCT02850965|11283602|FG000|Overall Study|Protocol Violation|0
7134073|NCT02850965|11283603|FG001|Overall Study|Protocol Violation|2
7134074|NCT02850965|11283602|FG000|Overall Study|Lost to Follow-up|5
7134075|NCT02850965|11283603|FG001|Overall Study|Lost to Follow-up|3
7134076|NCT02850965|11283602|FG000|Overall Study|Lack of Efficacy|4
7134077|NCT02850965|11283603|FG001|Overall Study|Lack of Efficacy|8
7134078|NCT02850965|11283602|FG000|Overall Study|Adverse Event|3
7134079|NCT02850965|11283603|FG001|Overall Study|Adverse Event|2
7134080|NCT02850965|11283602|FG000|Overall Study|Withdrawal by Subject|3
7134081|NCT02850965|11283603|FG001|Overall Study|Withdrawal by Subject|4
7134082|NCT02850965|11283602|FG000|Overall Study|Physician Decision|0
7134083|NCT02850965|11283603|FG001|Overall Study|Physician Decision|1
7134084|NCT02850965|11283602|FG000|Overall Study|Randomized but not treated|0
7134085|NCT02850965|11283603|FG001|Overall Study|Randomized but not treated|1
7134086|NCT02850978|11283609|FG000|Overall Study|Uncollectable CRF|27
7134087|NCT02850978|11283609|FG000|Overall Study|No visit since the first visit|35
7134088|NCT02850978|11283609|FG000|Overall Study|Adverse Event|81
7134089|NCT02850978|11283609|FG000|Overall Study|Lack of Efficacy|40
7134090|NCT02850978|11283609|FG000|Overall Study|Improvement in condition|34
7134091|NCT02850978|11283609|FG000|Overall Study|Lost to Follow-up|121
7134092|NCT02850978|11283609|FG000|Overall Study|Reason not listed|88
7134093|NCT02851069|11283613|FG000|Overall Study|Failure to Return|3
7134094|NCT02851069|11283613|FG000|Overall Study|Other|3
7134095|NCT02851615|11283629|FG000|Overall Study|Cognitive Issue|1
7134096|NCT02851615|11283630|FG001|Overall Study|Cognitive Issue|0
7134097|NCT02851615|11283629|FG000|Overall Study|Lost to Follow-up|0
7134098|NCT02851615|11283630|FG001|Overall Study|Lost to Follow-up|4
7134099|NCT02852005|11283648|FG000|Overall Study|Lost to Follow-up|0
7134100|NCT02852005|11283649|FG001|Overall Study|Lost to Follow-up|0
7134101|NCT02852005|11283650|FG002|Overall Study|Lost to Follow-up|0
7134102|NCT02852005|11283651|FG003|Overall Study|Lost to Follow-up|0
7134103|NCT02852005|11283652|FG004|Overall Study|Lost to Follow-up|1
7134104|NCT02852005|11283648|FG000|Overall Study|Withdrawal by Subject|1
7134105|NCT02852005|11283649|FG001|Overall Study|Withdrawal by Subject|0
7134106|NCT02852005|11283650|FG002|Overall Study|Withdrawal by Subject|0
7134107|NCT02852005|11283651|FG003|Overall Study|Withdrawal by Subject|0
7134108|NCT02852005|11283652|FG004|Overall Study|Withdrawal by Subject|0
7134109|NCT02852265|11283668|FG000|3-month Follow-up|Lost to Follow-up|1
7134110|NCT02852265|11283669|FG001|3-month Follow-up|Lost to Follow-up|1
7134111|NCT02852434|11283685|FG000|Overall Study|Withdrawal by Subject|0
7134112|NCT02852434|11283686|FG001|Overall Study|Withdrawal by Subject|1
7134113|NCT02852434|11283685|FG000|Overall Study|Unsuccessful Dilator Procedure|2
7134114|NCT02852434|11283686|FG001|Overall Study|Unsuccessful Dilator Procedure|0
7134115|NCT02853032|11283694|FG000|Overall Study|Adverse Event|4
7134116|NCT02853032|11283695|FG001|Overall Study|Adverse Event|0
7134117|NCT02853032|11283694|FG000|Overall Study|Withdrawal by Subject|3
7134118|NCT02853032|11283695|FG001|Overall Study|Withdrawal by Subject|1
7134119|NCT02853032|11283694|FG000|Overall Study|Requested to withdraw from all treatment|2
7134120|NCT02853032|11283695|FG001|Overall Study|Requested to withdraw from all treatment|2
7134121|NCT02853123|11283703|FG000|Treatment Period 1|Adverse Event|0
7134122|NCT02853123|11283704|FG001|Treatment Period 1|Adverse Event|3
7134123|NCT02853123|11283703|FG000|Washout Period|Worsening of COPD|0
7134124|NCT02853123|11283704|FG001|Washout Period|Worsening of COPD|3
7134125|NCT02853123|11283703|FG000|Washout Period|Adverse Event|1
7134126|NCT02853123|11283704|FG001|Washout Period|Adverse Event|0
7134127|NCT02853318|11283711|FG000|Overall Study|Withdrawal by Subject|1
7134128|NCT02853435|11283718|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
7134129|NCT02853435|11283719|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
7134130|NCT02853435|11283720|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
7134131|NCT02853435|11283721|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
7134132|NCT02853435|11283722|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1
7134133|NCT02853435|11283723|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
7134134|NCT02853929|11283755|FG000|Overall Study|Lost to Follow-up|3
7134135|NCT02853929|11283756|FG001|Overall Study|Lost to Follow-up|0
7134136|NCT02853929|11283755|FG000|Overall Study|Withdrawal by Subject|1
7134137|NCT02853929|11283756|FG001|Overall Study|Withdrawal by Subject|0
7134138|NCT02853929|11283755|FG000|Overall Study|Subjects enrolled but not vaccinated|7
7134139|NCT02853929|11283756|FG001|Overall Study|Subjects enrolled but not vaccinated|4
7134140|NCT02854527|11283781|FG000|Overall Study|Adverse Event|0
7134141|NCT02854527|11283782|FG001|Overall Study|Adverse Event|0
7134142|NCT02854527|11283783|FG002|Overall Study|Adverse Event|0
7134143|NCT02854527|11283784|FG003|Overall Study|Adverse Event|0
7134144|NCT02854527|11283785|FG004|Overall Study|Adverse Event|1
7134145|NCT02854527|11283786|FG005|Overall Study|Adverse Event|0
7134146|NCT02854527|11283787|FG006|Overall Study|Adverse Event|0
7134147|NCT02854527|11283788|FG007|Overall Study|Adverse Event|0
7134148|NCT02854527|11283789|FG008|Overall Study|Adverse Event|0
7134149|NCT02854527|11283790|FG009|Overall Study|Adverse Event|0
7134150|NCT02854527|11283781|FG000|Overall Study|Lost to Follow-up|0
7134151|NCT02854527|11283782|FG001|Overall Study|Lost to Follow-up|0
7134152|NCT02854527|11283783|FG002|Overall Study|Lost to Follow-up|0
7134153|NCT02854527|11283784|FG003|Overall Study|Lost to Follow-up|1
7134154|NCT02854527|11283785|FG004|Overall Study|Lost to Follow-up|0
7134155|NCT02854527|11283786|FG005|Overall Study|Lost to Follow-up|0
7134156|NCT02854527|11283787|FG006|Overall Study|Lost to Follow-up|0
7134157|NCT02854527|11283788|FG007|Overall Study|Lost to Follow-up|0
7134158|NCT02854527|11283789|FG008|Overall Study|Lost to Follow-up|0
7134159|NCT02854527|11283790|FG009|Overall Study|Lost to Follow-up|0
7134160|NCT02854605|11283811|FG000|Overall Study|Adverse Event|1
7134161|NCT02854605|11283812|FG001|Overall Study|Adverse Event|5
7134162|NCT02854605|11283813|FG002|Overall Study|Adverse Event|2
7134163|NCT02854605|11283811|FG000|Overall Study|Lost to Follow-up|0
7134164|NCT02854605|11283812|FG001|Overall Study|Lost to Follow-up|2
7134165|NCT02854605|11283813|FG002|Overall Study|Lost to Follow-up|0
7134166|NCT02854605|11283811|FG000|Overall Study|Withdrew Consent|1
7134167|NCT02854605|11283812|FG001|Overall Study|Withdrew Consent|0
7134168|NCT02854605|11283813|FG002|Overall Study|Withdrew Consent|1
7134169|NCT02854605|11283811|FG000|Overall Study|Investigator's Discretion|1
7134170|NCT02854605|11283812|FG001|Overall Study|Investigator's Discretion|0
7134171|NCT02854605|11283813|FG002|Overall Study|Investigator's Discretion|0
7134172|NCT02854605|11283811|FG000|Overall Study|Protocol Violation|0
7134173|NCT02854605|11283812|FG001|Overall Study|Protocol Violation|0
7134174|NCT02854605|11283813|FG002|Overall Study|Protocol Violation|1
7134175|NCT02854631|11283823|FG000|Overall Study|Adverse Event|1
7134176|NCT02854631|11283824|FG001|Overall Study|Adverse Event|2
7134177|NCT02854631|11283823|FG000|Overall Study|Withdrew Consent|3
7134178|NCT02854631|11283824|FG001|Overall Study|Withdrew Consent|2
7134179|NCT02854631|11283823|FG000|Overall Study|Investigator's Discretion|2
7134180|NCT02854631|11283824|FG001|Overall Study|Investigator's Discretion|0
7134181|NCT02854631|11283823|FG000|Overall Study|Death|12
7134182|NCT02854631|11283824|FG001|Overall Study|Death|8
7134183|NCT02854631|11283823|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2
7134184|NCT02854631|11283824|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0
7134185|NCT02854631|11283823|FG000|Overall Study|Protocol Violation|0
7134186|NCT02854631|11283824|FG001|Overall Study|Protocol Violation|1
7134187|NCT02854631|11283823|FG000|Overall Study|Subjects Randomized but Never Treated|2
7134188|NCT02854631|11283824|FG001|Overall Study|Subjects Randomized but Never Treated|0
7134189|NCT02854631|11283823|FG000|Overall Study|Lost to Follow-up|4
7134190|NCT02854631|11283824|FG001|Overall Study|Lost to Follow-up|2
7134191|NCT02854800|11283833|FG000|Overall Study|Protocol Violation|16
7134192|NCT02854800|11283834|FG001|Overall Study|Protocol Violation|11
7134193|NCT02854800|11283835|FG002|Overall Study|Protocol Violation|3
7134194|NCT02854800|11283833|FG000|Overall Study|Withdrawal by Subject|4
7134195|NCT02854800|11283834|FG001|Overall Study|Withdrawal by Subject|2
7134196|NCT02854800|11283835|FG002|Overall Study|Withdrawal by Subject|3
7134197|NCT02855164|11283863|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0
7134198|NCT02855164|11283864|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0
7134199|NCT02855164|11283865|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1
7134200|NCT02855164|11283866|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2
7134201|NCT02855164|11283867|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1
7134202|NCT02855164|11283868|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0
7134203|NCT02855164|11283869|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0
7134204|NCT02855164|11283870|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0
7134205|NCT02855164|11283863|FG000|Parts A + B (Randomized Set)|Physician Decision|0
7134206|NCT02855164|11283864|FG001|Parts A + B (Randomized Set)|Physician Decision|0
7134207|NCT02855164|11283865|FG002|Parts A + B (Randomized Set)|Physician Decision|0
7134208|NCT02855164|11283866|FG003|Parts A + B (Randomized Set)|Physician Decision|2
7134209|NCT02855164|11283867|FG004|Parts A + B (Randomized Set)|Physician Decision|0
7134210|NCT02855164|11283868|FG005|Parts A + B (Randomized Set)|Physician Decision|0
7134211|NCT02855164|11283869|FG006|Parts A + B (Randomized Set)|Physician Decision|0
7134212|NCT02855164|11283870|FG007|Parts A + B (Randomized Set)|Physician Decision|0
7134213|NCT02855164|11283863|FG000|Parts A + B (Randomized Set)|Adverse Event|0
7134214|NCT02855164|11283864|FG001|Parts A + B (Randomized Set)|Adverse Event|0
7134215|NCT02855164|11283865|FG002|Parts A + B (Randomized Set)|Adverse Event|0
7134216|NCT02855164|11283866|FG003|Parts A + B (Randomized Set)|Adverse Event|4
7134217|NCT02855164|11283867|FG004|Parts A + B (Randomized Set)|Adverse Event|0
7134218|NCT02855164|11283868|FG005|Parts A + B (Randomized Set)|Adverse Event|0
7134219|NCT02855164|11283869|FG006|Parts A + B (Randomized Set)|Adverse Event|0
7134220|NCT02855164|11283870|FG007|Parts A + B (Randomized Set)|Adverse Event|0
7134221|NCT02855164|11283863|FG000|Part C (Randomized Set)|Adverse Event|0
7134222|NCT02855164|11283864|FG001|Part C (Randomized Set)|Adverse Event|0
7134223|NCT02855164|11283865|FG002|Part C (Randomized Set)|Adverse Event|0
7134224|NCT02855164|11283866|FG003|Part C (Randomized Set)|Adverse Event|0
7134225|NCT02855164|11283867|FG004|Part C (Randomized Set)|Adverse Event|0
7134226|NCT02855164|11283868|FG005|Part C (Randomized Set)|Adverse Event|5
7134227|NCT02855164|11283869|FG006|Part C (Randomized Set)|Adverse Event|9
7134228|NCT02855164|11283870|FG007|Part C (Randomized Set)|Adverse Event|2
7134229|NCT02855164|11283863|FG000|Part C (Randomized Set)|Lost to Follow-up|0
7134230|NCT02855164|11283864|FG001|Part C (Randomized Set)|Lost to Follow-up|0
7134231|NCT02855164|11283865|FG002|Part C (Randomized Set)|Lost to Follow-up|0
7134232|NCT02855164|11283866|FG003|Part C (Randomized Set)|Lost to Follow-up|0
7134233|NCT02855164|11283867|FG004|Part C (Randomized Set)|Lost to Follow-up|0
7134234|NCT02855164|11283868|FG005|Part C (Randomized Set)|Lost to Follow-up|1
7134235|NCT02855164|11283869|FG006|Part C (Randomized Set)|Lost to Follow-up|1
7134236|NCT02855164|11283870|FG007|Part C (Randomized Set)|Lost to Follow-up|1
7134237|NCT02855164|11283863|FG000|Part C (Randomized Set)|Physician Decision|0
7134238|NCT02855164|11283864|FG001|Part C (Randomized Set)|Physician Decision|0
7134239|NCT02855164|11283865|FG002|Part C (Randomized Set)|Physician Decision|0
7134240|NCT02855164|11283866|FG003|Part C (Randomized Set)|Physician Decision|0
7134241|NCT02855164|11283867|FG004|Part C (Randomized Set)|Physician Decision|0
7134242|NCT02855164|11283868|FG005|Part C (Randomized Set)|Physician Decision|1
7134243|NCT02855164|11283869|FG006|Part C (Randomized Set)|Physician Decision|0
7134244|NCT02855164|11283870|FG007|Part C (Randomized Set)|Physician Decision|1
7134245|NCT02855164|11283863|FG000|Part C (Randomized Set)|Withdrawal by Subject|0
7134246|NCT02855164|11283864|FG001|Part C (Randomized Set)|Withdrawal by Subject|0
7134247|NCT02855164|11283865|FG002|Part C (Randomized Set)|Withdrawal by Subject|0
7134248|NCT02855164|11283866|FG003|Part C (Randomized Set)|Withdrawal by Subject|0
7134249|NCT02855164|11283867|FG004|Part C (Randomized Set)|Withdrawal by Subject|0
7134250|NCT02855164|11283868|FG005|Part C (Randomized Set)|Withdrawal by Subject|5
7134251|NCT02855164|11283869|FG006|Part C (Randomized Set)|Withdrawal by Subject|4
7134252|NCT02855164|11283870|FG007|Part C (Randomized Set)|Withdrawal by Subject|3
7134253|NCT02855359|11283918|FG000|Overall Study|Death|2
7134254|NCT02855359|11283919|FG001|Overall Study|Death|2
7134255|NCT02855359|11283920|FG002|Overall Study|Death|0
7134256|NCT02855359|11283921|FG003|Overall Study|Death|0
7134257|NCT02855359|11283918|FG000|Overall Study|Study Termination by Sponsor|9
7134258|NCT02855359|11283919|FG001|Overall Study|Study Termination by Sponsor|11
7134259|NCT02855359|11283920|FG002|Overall Study|Study Termination by Sponsor|0
7134260|NCT02855359|11283921|FG003|Overall Study|Study Termination by Sponsor|0
7134261|NCT02855450|11283939|FG000|Overall Study|Adverse Event|1
7134262|NCT02855450|11283940|FG001|Overall Study|Adverse Event|0
7134263|NCT02855450|11283939|FG000|Overall Study|Lost to Follow-up|4
7134264|NCT02855450|11283940|FG001|Overall Study|Lost to Follow-up|0
7134265|NCT02855541|11283946|FG000|Overall Study|Change in health status|2
7134266|NCT02855541|11283946|FG000|Overall Study|Withdrawal by Subject|2
7134267|NCT02856282|11283963|FG000|Overall Study|Withdrawal by Subject|1
7134268|NCT02856555|11283983|FG000|Overall Study|Adverse Event|1
7134269|NCT02856555|11283984|FG001|Overall Study|Adverse Event|0
7134270|NCT02856555|11283985|FG002|Overall Study|Adverse Event|0
7134271|NCT02856555|11283983|FG000|Overall Study|Lost to Follow-up|1
7134272|NCT02856555|11283984|FG001|Overall Study|Lost to Follow-up|3
7134273|NCT02856555|11283985|FG002|Overall Study|Lost to Follow-up|0
7134274|NCT02856555|11283983|FG000|Overall Study|Withdrawal by Subject|3
7134275|NCT02856555|11283984|FG001|Overall Study|Withdrawal by Subject|0
7134276|NCT02856555|11283985|FG002|Overall Study|Withdrawal by Subject|0
7134277|NCT02856555|11283983|FG000|Overall Study|Randomized but Never Treated|0
7134278|NCT02856555|11283984|FG001|Overall Study|Randomized but Never Treated|1
7134279|NCT02856555|11283985|FG002|Overall Study|Randomized but Never Treated|0
7134280|NCT02856802|11283995|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0
7134281|NCT02856802|11283996|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2
7134282|NCT02856802|11283995|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1
7134283|NCT02856802|11283996|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0
7134284|NCT02856802|11283995|FG000|Double-Blind Treatment Period 1|Protocol Violation|0
7134285|NCT02856802|11283996|FG001|Double-Blind Treatment Period 1|Protocol Violation|1
7134286|NCT02856802|11283995|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1
7134287|NCT02856802|11283996|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0
7134288|NCT02856802|11283995|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0
7134289|NCT02856802|11283996|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2
7134290|NCT02856802|11283995|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1
7134291|NCT02856802|11283996|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0
7134292|NCT02856880|11284023|FG000|Overall Study|Withdrawal of consent|1
7134293|NCT02857283|11284044|FG000|First Exposure|Withdrawal by Subject|1
7134294|NCT02857283|11284045|FG001|First Exposure|Withdrawal by Subject|0
7134295|NCT02857816|11284052|FG000|Overall Study|Screen Failure|33
7134296|NCT02857816|11284052|FG000|Overall Study|Withdrawal by Subject|4
7134297|NCT02857816|11284052|FG000|Overall Study|Lost to Follow-up|1
7134298|NCT02858076|11284068|FG000|Overall Study|Death|6
7134299|NCT02858076|11284069|FG001|Overall Study|Death|3
7134300|NCT02858076|11284068|FG000|Overall Study|Withdrawal by Subject|1
7134301|NCT02858076|11284069|FG001|Overall Study|Withdrawal by Subject|5
7134302|NCT02858076|11284068|FG000|Overall Study|Lost to Follow-up|2
7134303|NCT02858076|11284069|FG001|Overall Study|Lost to Follow-up|7
7134304|NCT02858076|11284068|FG000|Overall Study|Completed Out of Window|1
7134305|NCT02858076|11284069|FG001|Overall Study|Completed Out of Window|3
7134306|NCT02858180|11284079|FG000|Overall Study|Lost to Follow-up|0
7134307|NCT02858180|11284080|FG001|Overall Study|Lost to Follow-up|2
7134308|NCT02858362|11284093|FG000|Overall Study|Protocol Violation|0
7134309|NCT02858362|11284094|FG001|Overall Study|Protocol Violation|1
7134310|NCT02858362|11284095|FG002|Overall Study|Protocol Violation|0
7134311|NCT02858362|11284093|FG000|Overall Study|Withdrawal by Subject|1
7134312|NCT02858362|11284094|FG001|Overall Study|Withdrawal by Subject|0
7134313|NCT02858362|11284095|FG002|Overall Study|Withdrawal by Subject|0
7134314|NCT02858362|11284093|FG000|Overall Study|Early Study Termination|0
7134315|NCT02858362|11284094|FG001|Overall Study|Early Study Termination|0
7134316|NCT02858362|11284095|FG002|Overall Study|Early Study Termination|3
6806437|NCT02178358|10808949|FG002|Overall Study|Lost to Follow-up|0
6806438|NCT02073279|10808960|FG000|Double-blind Period|Adverse Event|1
6806439|NCT02073279|10808961|FG001|Double-blind Period|Adverse Event|1
6806440|NCT02073279|10808960|FG000|Double-blind Period|Protocol Deviation|0
6806441|NCT02073279|10808961|FG001|Double-blind Period|Protocol Deviation|1
6806442|NCT02073279|10808960|FG000|Double-blind Period|Withdrawal by Subject|2
6806443|NCT02073279|10808961|FG001|Double-blind Period|Withdrawal by Subject|2
6806444|NCT02073279|10808960|FG000|Double-blind Period|Reason Not Specified|1
6806445|NCT02073279|10808961|FG001|Double-blind Period|Reason Not Specified|2
7134317|NCT02858362|11284093|FG000|Overall Study|Lost to Follow-up|1
7134318|NCT02858362|11284094|FG001|Overall Study|Lost to Follow-up|0
7134319|NCT02858362|11284095|FG002|Overall Study|Lost to Follow-up|0
7134320|NCT02858401|11284115|FG000|Overall Study|Withdrew Consent|0
7134321|NCT02858401|11284116|FG001|Overall Study|Withdrew Consent|0
7134322|NCT02858401|11284117|FG002|Overall Study|Withdrew Consent|0
7134323|NCT02858401|11284118|FG003|Overall Study|Withdrew Consent|0
7134324|NCT02858401|11284119|FG004|Overall Study|Withdrew Consent|0
7134325|NCT02858401|11284120|FG005|Overall Study|Withdrew Consent|1
7134326|NCT02858401|11284121|FG006|Overall Study|Withdrew Consent|0
7134327|NCT02858401|11284115|FG000|Overall Study|Lost to Follow-up|0
7134328|NCT02858401|11284116|FG001|Overall Study|Lost to Follow-up|1
7134329|NCT02858401|11284117|FG002|Overall Study|Lost to Follow-up|0
7134330|NCT02858401|11284118|FG003|Overall Study|Lost to Follow-up|0
7134331|NCT02858401|11284119|FG004|Overall Study|Lost to Follow-up|0
7134332|NCT02858401|11284120|FG005|Overall Study|Lost to Follow-up|0
7134333|NCT02858401|11284121|FG006|Overall Study|Lost to Follow-up|0
7134334|NCT02858440|11284146|FG000|Overall Study|Lost to Follow-up|3
7134335|NCT02858440|11284146|FG000|Overall Study|Protocol Violation|2
7134336|NCT02858440|11284146|FG000|Overall Study|Consent withdrawal|3
7134337|NCT02858440|11284146|FG000|Overall Study|Migrated/moved from study area|4
7134338|NCT02858492|11284154|FG000|Overall Study|Withdrawal by Subject|0
7134339|NCT02858492|11284155|FG001|Overall Study|Withdrawal by Subject|1
7134340|NCT02858492|11284156|FG002|Overall Study|Withdrawal by Subject|0
7134341|NCT02858492|11284157|FG003|Overall Study|Withdrawal by Subject|1
7134342|NCT02858492|11284154|FG000|Overall Study|Adverse Event|0
7134343|NCT02858492|11284155|FG001|Overall Study|Adverse Event|0
7134344|NCT02858492|11284156|FG002|Overall Study|Adverse Event|0
7134345|NCT02858492|11284157|FG003|Overall Study|Adverse Event|3
7134346|NCT02858492|11284154|FG000|Overall Study|Lack of Efficacy|0
7134347|NCT02858492|11284155|FG001|Overall Study|Lack of Efficacy|0
7134348|NCT02858492|11284156|FG002|Overall Study|Lack of Efficacy|0
7134349|NCT02858492|11284157|FG003|Overall Study|Lack of Efficacy|1
7134350|NCT02858492|11284154|FG000|Overall Study|Protocol defined stopping criteria|0
7134351|NCT02858492|11284155|FG001|Overall Study|Protocol defined stopping criteria|0
7134352|NCT02858492|11284156|FG002|Overall Study|Protocol defined stopping criteria|0
7134353|NCT02858492|11284157|FG003|Overall Study|Protocol defined stopping criteria|1
7134354|NCT02858726|11284186|FG000|Overall Study|Adverse Event|4
7134355|NCT02858726|11284187|FG001|Overall Study|Adverse Event|4
7134356|NCT02858726|11284188|FG002|Overall Study|Adverse Event|9
7134357|NCT02858726|11284189|FG003|Overall Study|Adverse Event|1
7134358|NCT02858726|11284186|FG000|Overall Study|Physician Decision|0
7134359|NCT02858726|11284187|FG001|Overall Study|Physician Decision|0
7134360|NCT02858726|11284188|FG002|Overall Study|Physician Decision|1
7134361|NCT02858726|11284189|FG003|Overall Study|Physician Decision|0
7134362|NCT02858726|11284186|FG000|Overall Study|Protocol Violation|0
7134363|NCT02858726|11284187|FG001|Overall Study|Protocol Violation|0
7134364|NCT02858726|11284188|FG002|Overall Study|Protocol Violation|0
7134365|NCT02858726|11284189|FG003|Overall Study|Protocol Violation|1
7134366|NCT02858726|11284186|FG000|Overall Study|Study Terminated by Sponsor|0
7134367|NCT02858726|11284187|FG001|Overall Study|Study Terminated by Sponsor|0
7134368|NCT02858726|11284188|FG002|Overall Study|Study Terminated by Sponsor|0
7134369|NCT02858726|11284189|FG003|Overall Study|Study Terminated by Sponsor|1
7134370|NCT02858726|11284186|FG000|Overall Study|Withdrawal by Subject|1
7134371|NCT02858726|11284187|FG001|Overall Study|Withdrawal by Subject|2
7134372|NCT02858726|11284188|FG002|Overall Study|Withdrawal by Subject|1
7134373|NCT02858726|11284189|FG003|Overall Study|Withdrawal by Subject|0
7134374|NCT02858726|11284186|FG000|Overall Study|Noncompliance|0
7134375|NCT02858726|11284187|FG001|Overall Study|Noncompliance|1
7134376|NCT02858726|11284188|FG002|Overall Study|Noncompliance|0
7134377|NCT02858726|11284189|FG003|Overall Study|Noncompliance|0
7134378|NCT02859142|11284205|FG000|Overall Study|Adverse Event|1
7134379|NCT02859142|11284206|FG001|Overall Study|Adverse Event|2
7134380|NCT02859142|11284205|FG000|Overall Study|Lost to Follow-up|1
7134381|NCT02859142|11284206|FG001|Overall Study|Lost to Follow-up|4
7134382|NCT02859142|11284205|FG000|Overall Study|Withdrawal by Subject|2
7134383|NCT02859142|11284206|FG001|Overall Study|Withdrawal by Subject|0
7134384|NCT02859142|11284205|FG000|Overall Study|Scheduling difficulties|0
7134385|NCT02859142|11284206|FG001|Overall Study|Scheduling difficulties|3
7134386|NCT02859246|11284212|FG000|Overall Study|Screen fails|3
7134387|NCT02859246|11284212|FG000|Overall Study|Adverse Event|1
7134388|NCT02859246|11284212|FG000|Overall Study|Withdrawal by Subject|1
7134389|NCT02859324|11284220|FG000|Overall Study|Death|4
7134390|NCT02859324|11284221|FG001|Overall Study|Death|6
7134391|NCT02859324|11284222|FG002|Overall Study|Death|5
7134392|NCT02859324|11284220|FG000|Overall Study|Other reasons|3
7134393|NCT02859324|11284221|FG001|Overall Study|Other reasons|3
7134394|NCT02859324|11284222|FG002|Overall Study|Other reasons|0
7134395|NCT02859454|11284251|FG000|Overall Study|PI discretion/off study prior to trtmt|1
7134396|NCT02860130|11284271|FG000|Overall Study|Adverse Event|2
7134397|NCT02860130|11284272|FG001|Overall Study|Adverse Event|3
7134398|NCT02860130|11284271|FG000|Overall Study|Protocol Violation|1
7134399|NCT02860130|11284272|FG001|Overall Study|Protocol Violation|1
7134400|NCT02860130|11284271|FG000|Overall Study|Withdrawal by Subject|0
7134401|NCT02860130|11284272|FG001|Overall Study|Withdrawal by Subject|2
7134402|NCT02860130|11284271|FG000|Overall Study|Physician Decision|2
7134403|NCT02860130|11284272|FG001|Overall Study|Physician Decision|2
7134404|NCT02860130|11284271|FG000|Overall Study|Other|2
7134405|NCT02860130|11284272|FG001|Overall Study|Other|1
7134406|NCT02860546|11284305|FG000|Overall Study|Clinical Progression|6
7134407|NCT02860546|11284305|FG000|Overall Study|Radiological Progression|12
7134408|NCT02861534|11284353|FG000|Overall Study|Death|541
7134409|NCT02861534|11284354|FG001|Overall Study|Death|552
7134410|NCT02861534|11284353|FG000|Overall Study|Lost to Follow-up|14
7134411|NCT02861534|11284354|FG001|Overall Study|Lost to Follow-up|14
7134412|NCT02861534|11284353|FG000|Overall Study|Site Terminated by Sponsor|4
7134413|NCT02861534|11284354|FG001|Overall Study|Site Terminated by Sponsor|3
7134414|NCT02861534|11284353|FG000|Overall Study|Withdrawal by Subject|15
7134415|NCT02861534|11284354|FG001|Overall Study|Withdrawal by Subject|18
7134416|NCT02861586|11284368|FG000|Overall Study|Withdrawal by Subject|1
7134417|NCT02861586|11284369|FG001|Overall Study|Withdrawal by Subject|2
7134418|NCT02861586|11284370|FG002|Overall Study|Withdrawal by Subject|0
7134419|NCT02861586|11284371|FG003|Overall Study|Withdrawal by Subject|0
7134420|NCT02861586|11284372|FG004|Overall Study|Withdrawal by Subject|0
7134421|NCT02861586|11284373|FG005|Overall Study|Withdrawal by Subject|1
7134422|NCT02861586|11284374|FG006|Overall Study|Withdrawal by Subject|1
7134423|NCT02861586|11284375|FG007|Overall Study|Withdrawal by Subject|0
7134424|NCT02861586|11284368|FG000|Overall Study|Lost to Follow-up|3
7134425|NCT02861586|11284369|FG001|Overall Study|Lost to Follow-up|1
7134426|NCT02861586|11284370|FG002|Overall Study|Lost to Follow-up|1
7134427|NCT02861586|11284371|FG003|Overall Study|Lost to Follow-up|0
7134428|NCT02861586|11284372|FG004|Overall Study|Lost to Follow-up|0
7134429|NCT02861586|11284373|FG005|Overall Study|Lost to Follow-up|3
7134430|NCT02861586|11284374|FG006|Overall Study|Lost to Follow-up|0
7134431|NCT02861586|11284375|FG007|Overall Study|Lost to Follow-up|0
7134432|NCT02861586|11284368|FG000|Overall Study|Adverse Event|0
7134433|NCT02861586|11284369|FG001|Overall Study|Adverse Event|0
7134434|NCT02861586|11284370|FG002|Overall Study|Adverse Event|0
7134435|NCT02861586|11284371|FG003|Overall Study|Adverse Event|0
7134436|NCT02861586|11284372|FG004|Overall Study|Adverse Event|0
7134437|NCT02861586|11284373|FG005|Overall Study|Adverse Event|1
7134438|NCT02861586|11284374|FG006|Overall Study|Adverse Event|0
7134439|NCT02861586|11284375|FG007|Overall Study|Adverse Event|0
7134440|NCT02861664|11284400|FG000|Overall Study|Withdrawal of Consent|0
7134441|NCT02861664|11284401|FG001|Overall Study|Withdrawal of Consent|1
7134442|NCT02861807|11284409|FG000|Overall Study|Lost to Follow-up|7
7134443|NCT02861807|11284410|FG001|Overall Study|Lost to Follow-up|6
7134444|NCT02861807|11284409|FG000|Overall Study|Withdrawal by Subject|5
7134445|NCT02861807|11284410|FG001|Overall Study|Withdrawal by Subject|8
7134446|NCT02862106|11284451|FG000|Overall Study|Adverse Event|4
7134447|NCT02862106|11284452|FG001|Overall Study|Adverse Event|0
7134448|NCT02862106|11284451|FG000|Overall Study|Protocol Violation|16
7134449|NCT02862106|11284452|FG001|Overall Study|Protocol Violation|1
7134450|NCT02862106|11284451|FG000|Overall Study|Lost to Follow-up|15
7134451|NCT02862106|11284452|FG001|Overall Study|Lost to Follow-up|5
7134452|NCT02862106|11284451|FG000|Overall Study|Withdrawal by Subject|2
7134453|NCT02862106|11284452|FG001|Overall Study|Withdrawal by Subject|0
7134454|NCT02862106|11284451|FG000|Overall Study|Subjects moved to other city|1
7134455|NCT02862106|11284452|FG001|Overall Study|Subjects moved to other city|0
7134456|NCT02862535|11284468|FG000|Overall Study|Death|7
7134457|NCT02862535|11284469|FG001|Overall Study|Death|3
7134458|NCT02862535|11284470|FG002|Overall Study|Death|2
7134459|NCT02862535|11284471|FG003|Overall Study|Death|5
7134460|NCT02862535|11284468|FG000|Overall Study|Study Terminated by Sponsor|1
7134461|NCT02862535|11284469|FG001|Overall Study|Study Terminated by Sponsor|3
7134462|NCT02862535|11284470|FG002|Overall Study|Study Terminated by Sponsor|8
7134463|NCT02862535|11284471|FG003|Overall Study|Study Terminated by Sponsor|5
7134464|NCT02862535|11284468|FG000|Overall Study|Enrolled, not Treated|1
7134465|NCT02862535|11284469|FG001|Overall Study|Enrolled, not Treated|0
7134466|NCT02862535|11284470|FG002|Overall Study|Enrolled, not Treated|0
7134467|NCT02862535|11284471|FG003|Overall Study|Enrolled, not Treated|1
7134468|NCT02862574|11284484|FG000|Double-Blind Treatment Period|Adverse Event|0
7134469|NCT02862574|11284485|FG001|Double-Blind Treatment Period|Adverse Event|1
7134470|NCT02862574|11284486|FG002|Double-Blind Treatment Period|Adverse Event|0
7134471|NCT02862574|11284484|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3
7134472|NCT02862574|11284485|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1
7134473|NCT02862574|11284486|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4
7134474|NCT02862574|11284484|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2
7134475|NCT02862574|11284485|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3
7134476|NCT02862574|11284486|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1
7134477|NCT02862600|11284495|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9
7134478|NCT02862600|11284495|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3
7134479|NCT02862600|11284495|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1
7134480|NCT02862600|11284495|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7
7134481|NCT02862730|11284501|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
7134482|NCT02862730|11284502|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
7134483|NCT02862730|11284503|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1
7134484|NCT02862730|11284504|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
7134485|NCT02862730|11284505|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
7134486|NCT02862730|11284506|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
7134487|NCT02862730|11284507|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
7134488|NCT02862730|11284501|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1
7134489|NCT02862730|11284502|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0
7134490|NCT02862730|11284503|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0
7134491|NCT02862730|11284504|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0
7134492|NCT02862730|11284505|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0
7134493|NCT02862730|11284506|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0
7134494|NCT02862730|11284507|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0
7134495|NCT02862730|11284501|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
7134496|NCT02862730|11284502|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
7134497|NCT02862730|11284503|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
7134498|NCT02862730|11284504|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
7134499|NCT02862730|11284505|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
7134500|NCT02862730|11284506|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
7134501|NCT02862730|11284507|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
7134502|NCT02862730|11284501|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
7134503|NCT02862730|11284502|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
7134504|NCT02862730|11284503|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
7134505|NCT02862730|11284504|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1
7134506|NCT02862730|11284505|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
7134507|NCT02862730|11284506|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
7134508|NCT02862730|11284507|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
7134509|NCT02863328|11284558|FG000|Overall Study|Lost to Follow-up|4
7134510|NCT02863328|11284559|FG001|Overall Study|Lost to Follow-up|10
7134511|NCT02863328|11284558|FG000|Overall Study|Withdrawal by Subject|7
7134512|NCT02863328|11284559|FG001|Overall Study|Withdrawal by Subject|12
7134513|NCT02863328|11284558|FG000|Overall Study|Died|0
7134514|NCT02863328|11284559|FG001|Overall Study|Died|1
7134515|NCT02863354|11284567|FG000|Year 1|Lost to Follow-up|1
7134516|NCT02863354|11284568|FG001|Year 1|Lost to Follow-up|1
7134517|NCT02863354|11284567|FG000|Year 1|Withdrawal by Subject|3
7134518|NCT02863354|11284568|FG001|Year 1|Withdrawal by Subject|0
7134519|NCT02863354|11284567|FG000|Year 1|Death|0
7134520|NCT02863354|11284568|FG001|Year 1|Death|1
7134521|NCT02863354|11284567|FG000|Year 2|Lost to Follow-up|2
7134522|NCT02863354|11284568|FG001|Year 2|Lost to Follow-up|2
7134523|NCT02863419|11284577|FG000|Overall Study|Lost to Follow-up|0
7134524|NCT02863419|11284578|FG001|Overall Study|Lost to Follow-up|1
7134525|NCT02863419|11284579|FG002|Overall Study|Lost to Follow-up|4
7134526|NCT02863419|11284577|FG000|Overall Study|Withdrawal by Subject|5
7134527|NCT02863419|11284578|FG001|Overall Study|Withdrawal by Subject|5
7134528|NCT02863419|11284579|FG002|Overall Study|Withdrawal by Subject|3
7134529|NCT02863419|11284577|FG000|Overall Study|Died|3
7134530|NCT02863419|11284578|FG001|Overall Study|Died|4
7134531|NCT02863419|11284579|FG002|Overall Study|Died|1
7134532|NCT02863575|11284590|FG000|Overall Study|Participants Unable To Swallow Capsule|1
7134533|NCT02863575|11284591|FG001|Overall Study|Participants Unable To Swallow Capsule|0
7134534|NCT02863575|11284592|FG002|Overall Study|Participants Unable To Swallow Capsule|0
7134535|NCT02863575|11284590|FG000|Overall Study|Withdrawal by Subject|0
7134536|NCT02863575|11284591|FG001|Overall Study|Withdrawal by Subject|1
7134537|NCT02863575|11284592|FG002|Overall Study|Withdrawal by Subject|1
7134538|NCT02863575|11284590|FG000|Overall Study|Adverse Event|0
7134539|NCT02863575|11284591|FG001|Overall Study|Adverse Event|1
7134540|NCT02863575|11284592|FG002|Overall Study|Adverse Event|0
7134541|NCT02864082|11284615|FG000|Overall Study|Adverse Event|1
7134542|NCT02864082|11284616|FG001|Overall Study|Adverse Event|1
7134543|NCT02864082|11284615|FG000|Overall Study|Lost to Follow-up|0
7134544|NCT02864082|11284616|FG001|Overall Study|Lost to Follow-up|1
7134545|NCT02864082|11284615|FG000|Overall Study|Withdrawal by Subject|2
7134546|NCT02864082|11284616|FG001|Overall Study|Withdrawal by Subject|2
7134547|NCT02864316|11284638|FG000|Overall Study|Progressive Disease|2
7134548|NCT02864316|11284639|FG001|Overall Study|Progressive Disease|1
7134549|NCT02864316|11284638|FG000|Overall Study|Adverse Event|0
7134550|NCT02864316|11284639|FG001|Overall Study|Adverse Event|1
7134551|NCT02864342|11284647|FG000|Overall Study|Eligibility Criteria Deviation|2
7134552|NCT02864342|11284648|FG001|Overall Study|Eligibility Criteria Deviation|3
7134553|NCT02864342|11284647|FG000|Overall Study|Withdrawal by Subject|4
7134554|NCT02864342|11284648|FG001|Overall Study|Withdrawal by Subject|2
7134555|NCT02864342|11284647|FG000|Overall Study|Device Technology Issue|6
7134556|NCT02864342|11284648|FG001|Overall Study|Device Technology Issue|7
7134557|NCT02864342|11284647|FG000|Overall Study|Death|0
7134558|NCT02864342|11284648|FG001|Overall Study|Death|1
7134559|NCT02864342|11284647|FG000|Overall Study|Did Not Start Treatment with Symbicort|0
7134560|NCT02864342|11284648|FG001|Overall Study|Did Not Start Treatment with Symbicort|1
7134561|NCT02864342|11284647|FG000|Overall Study|Lost to Follow-up|1
7134562|NCT02864342|11284648|FG001|Overall Study|Lost to Follow-up|5
7134563|NCT02864342|11284647|FG000|Overall Study|Lost Device|1
7134564|NCT02864342|11284648|FG001|Overall Study|Lost Device|0
7134565|NCT02864342|11284647|FG000|Overall Study|Adverse Event|1
7134566|NCT02864342|11284648|FG001|Overall Study|Adverse Event|0
7134567|NCT02864381|11284666|FG000|Overall Study|Death|58
7134568|NCT02864381|11284667|FG001|Overall Study|Death|61
7134569|NCT02864381|11284666|FG000|Overall Study|Withdrew Consent|5
7134570|NCT02864381|11284667|FG001|Overall Study|Withdrew Consent|6
7134571|NCT02864381|11284666|FG000|Overall Study|Reason Unknown|7
7134572|NCT02864381|11284667|FG001|Overall Study|Reason Unknown|3
7134573|NCT02864381|11284666|FG000|Overall Study|Lost to Follow-up|1
7134574|NCT02864381|11284667|FG001|Overall Study|Lost to Follow-up|1
7134575|NCT02864381|11284666|FG000|Overall Study|Investigator's Discretion|1
7134576|NCT02864381|11284667|FG001|Overall Study|Investigator's Discretion|0
7134577|NCT02864381|11284666|FG000|Overall Study|Protocol Violation|0
7134578|NCT02864381|11284667|FG001|Overall Study|Protocol Violation|1
7134579|NCT02864394|11284675|FG000|Overall Study|Death|135
7134580|NCT02864394|11284676|FG001|Overall Study|Death|150
7134581|NCT02864394|11284675|FG000|Overall Study|Withdrawal by Subject|1
7134582|NCT02864394|11284676|FG001|Overall Study|Withdrawal by Subject|9
7134583|NCT02864394|11284675|FG000|Overall Study|Ongoing In Study|77
7134584|NCT02864394|11284676|FG001|Overall Study|Ongoing In Study|53
7134585|NCT02865499|11284763|FG000|Baseline|Adverse Event|1
7134586|NCT02865499|11284763|FG000|Baseline|Withdrawal by Subject|1
7134587|NCT02865538|11284772|FG000|Overall Study|Withdrawal by Subject|0
7134588|NCT02865538|11284773|FG001|Overall Study|Withdrawal by Subject|0
7134589|NCT02865538|11284774|FG002|Overall Study|Withdrawal by Subject|1
7134590|NCT02865538|11284775|FG003|Overall Study|Withdrawal by Subject|0
7134591|NCT02865538|11284776|FG004|Overall Study|Withdrawal by Subject|0
7134592|NCT02865538|11284772|FG000|Overall Study|Lost to Follow-up|1
7134593|NCT02865538|11284773|FG001|Overall Study|Lost to Follow-up|0
7134594|NCT02865538|11284774|FG002|Overall Study|Lost to Follow-up|0
7134595|NCT02865538|11284775|FG003|Overall Study|Lost to Follow-up|0
7134596|NCT02865538|11284776|FG004|Overall Study|Lost to Follow-up|0
7134597|NCT02866175|11284812|FG000|Overall Study|Adverse Event|56
7134598|NCT02866175|11284813|FG001|Overall Study|Adverse Event|54
7134599|NCT02866175|11284812|FG000|Overall Study|Withdrawal by Subject|31
7134600|NCT02866175|11284813|FG001|Overall Study|Withdrawal by Subject|52
7134601|NCT02866175|11284812|FG000|Overall Study|Death|30
7134602|NCT02866175|11284813|FG001|Overall Study|Death|23
7134603|NCT02866175|11284812|FG000|Overall Study|Other|7
7134604|NCT02866175|11284813|FG001|Overall Study|Other|14
7134605|NCT02866175|11284812|FG000|Overall Study|Progressive disease|1
7134606|NCT02866175|11284813|FG001|Overall Study|Progressive disease|1
7134607|NCT02866175|11284812|FG000|Overall Study|Lost to Follow-up|2
6806446|NCT02073279|10808960|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0
6806447|NCT02073279|10808961|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1
6806448|NCT02073279|10808960|FG000|Double-blind Period|On-going in Study|11
6806449|NCT02073279|10808961|FG001|Double-blind Period|On-going in Study|40
6806450|NCT02073279|10808960|FG000|Open-label Extension Period|Lack of Efficacy|1
6806451|NCT02073279|10808961|FG001|Open-label Extension Period|Lack of Efficacy|0
6806452|NCT02073279|10808960|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0
6806453|NCT02073279|10808961|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1
6806454|NCT02073279|10808960|FG000|Open-label Extension Period|Withdrawal by Subject|1
6806455|NCT02073279|10808961|FG001|Open-label Extension Period|Withdrawal by Subject|1
6806456|NCT02073279|10808960|FG000|Open-label Extension Period|Reason Not Specified|1
6806457|NCT02073279|10808961|FG001|Open-label Extension Period|Reason Not Specified|1
6806458|NCT02073279|10808960|FG000|Open-label Extension Period|On-going in Study|14
6806459|NCT02073279|10808961|FG001|Open-label Extension Period|On-going in Study|13
6806460|NCT01544127|10808973|FG000|Overall Study|Lost to Follow-up|4
6806461|NCT01544127|10808974|FG001|Overall Study|Lost to Follow-up|2
6806462|NCT01544127|10808975|FG002|Overall Study|Lost to Follow-up|9
6806463|NCT01544127|10808973|FG000|Overall Study|Withdrawal by Subject|2
6806464|NCT01544127|10808974|FG001|Overall Study|Withdrawal by Subject|2
6806465|NCT01544127|10808975|FG002|Overall Study|Withdrawal by Subject|1
6806466|NCT01544127|10808973|FG000|Overall Study|Discharged out of catchment area|1
6806467|NCT01544127|10808974|FG001|Overall Study|Discharged out of catchment area|1
6806468|NCT01544127|10808975|FG002|Overall Study|Discharged out of catchment area|1
6806469|NCT01544127|10808973|FG000|Overall Study|Death|1
6806470|NCT01544127|10808974|FG001|Overall Study|Death|0
6806471|NCT01544127|10808975|FG002|Overall Study|Death|0
6806472|NCT01544127|10808973|FG000|Overall Study|Jail or Prison|1
6806473|NCT01544127|10808974|FG001|Overall Study|Jail or Prison|1
6806474|NCT01544127|10808975|FG002|Overall Study|Jail or Prison|2
6806475|NCT01544127|10808973|FG000|Overall Study|Became Psychotic|1
6806476|NCT01544127|10808974|FG001|Overall Study|Became Psychotic|0
6806477|NCT01544127|10808975|FG002|Overall Study|Became Psychotic|0
6806478|NCT01544127|10808973|FG000|Overall Study|Researcher withdrew|1
6806479|NCT01544127|10808974|FG001|Overall Study|Researcher withdrew|0
6806480|NCT01544127|10808975|FG002|Overall Study|Researcher withdrew|0
6806481|NCT01544127|10808973|FG000|Overall Study|Went active duty|0
6806482|NCT01544127|10808974|FG001|Overall Study|Went active duty|0
6806483|NCT01544127|10808975|FG002|Overall Study|Went active duty|1
6806484|NCT00442559|10809002|FG000|Overall Study|Lost to Follow-up|32
6806485|NCT00442559|10809003|FG001|Overall Study|Lost to Follow-up|34
7134608|NCT02866175|11284813|FG001|Overall Study|Lost to Follow-up|0
7134609|NCT02866175|11284812|FG000|Overall Study|Lack of Efficacy|0
7134610|NCT02866175|11284813|FG001|Overall Study|Lack of Efficacy|1
7134611|NCT02866175|11284812|FG000|Overall Study|Physician Decision|3
6806486|NCT00442559|10809002|FG000|Overall Study|Protocol Violation|1
6806487|NCT00442559|10809003|FG001|Overall Study|Protocol Violation|1
6806488|NCT00442559|10809002|FG000|Overall Study|Withdrawal by Subject|1
7134612|NCT02866175|11284813|FG001|Overall Study|Physician Decision|15
7134613|NCT02866175|11284812|FG000|Overall Study|Did not receive treatment|5
7134614|NCT02866175|11284813|FG001|Overall Study|Did not receive treatment|15
7134615|NCT02866942|11284829|FG000|Overall Study|Invalid consent|1
7134616|NCT02867709|11284883|FG000|Treatment Period|Adverse Event|1
7134617|NCT02867709|11284884|FG001|Treatment Period|Adverse Event|1
7134618|NCT02867709|11284885|FG002|Treatment Period|Adverse Event|2
7134619|NCT02867709|11284883|FG000|Treatment Period|Withdrawal of Consent|7
7134620|NCT02867709|11284884|FG001|Treatment Period|Withdrawal of Consent|9
7134621|NCT02867709|11284885|FG002|Treatment Period|Withdrawal of Consent|8
7134622|NCT02867709|11284883|FG000|Treatment Period|Lost to Follow-up|17
7134623|NCT02867709|11284884|FG001|Treatment Period|Lost to Follow-up|20
7134624|NCT02867709|11284885|FG002|Treatment Period|Lost to Follow-up|20
7134625|NCT02867709|11284883|FG000|Treatment Period|Lack of Qualifying Event|42
7134626|NCT02867709|11284884|FG001|Treatment Period|Lack of Qualifying Event|55
7134627|NCT02867709|11284885|FG002|Treatment Period|Lack of Qualifying Event|42
7134628|NCT02867709|11284883|FG000|Treatment Period|Protocol Violation|3
7134629|NCT02867709|11284884|FG001|Treatment Period|Protocol Violation|2
7134630|NCT02867709|11284885|FG002|Treatment Period|Protocol Violation|3
7134631|NCT02867709|11284883|FG000|Safety Follow-up Period|Withdrawal of Consent|1
7134632|NCT02867709|11284884|FG001|Safety Follow-up Period|Withdrawal of Consent|8
7134633|NCT02867709|11284885|FG002|Safety Follow-up Period|Withdrawal of Consent|6
7134634|NCT02867709|11284883|FG000|Safety Follow-up Period|Lost to Follow-up|10
7134635|NCT02867709|11284884|FG001|Safety Follow-up Period|Lost to Follow-up|5
7134636|NCT02867709|11284885|FG002|Safety Follow-up Period|Lost to Follow-up|7
7134637|NCT02867709|11284883|FG000|Safety Follow-up Period|Pregnancy|0
7134638|NCT02867709|11284884|FG001|Safety Follow-up Period|Pregnancy|1
7134639|NCT02867709|11284885|FG002|Safety Follow-up Period|Pregnancy|0
7134640|NCT02867709|11284883|FG000|Safety Follow-up Period|Protocol Violation|0
7134641|NCT02867709|11284884|FG001|Safety Follow-up Period|Protocol Violation|1
7134642|NCT02867709|11284885|FG002|Safety Follow-up Period|Protocol Violation|1
7134643|NCT02867995|11284895|FG000|Overall Study|Withdrawal by Subject|0
7134644|NCT02867995|11284896|FG001|Overall Study|Withdrawal by Subject|1
7134645|NCT02867995|11284895|FG000|Overall Study|Lost to Follow-up|0
7134646|NCT02867995|11284896|FG001|Overall Study|Lost to Follow-up|2
7134647|NCT02868216|11284908|FG000|Overall Study|Death|0
7134648|NCT02868216|11284909|FG001|Overall Study|Death|1
7134649|NCT02868216|11284908|FG000|Overall Study|coronary artery bypass|1
7134650|NCT02868216|11284909|FG001|Overall Study|coronary artery bypass|0
7134651|NCT02868216|11284908|FG000|Overall Study|Withdrawal by Subject|7
7134652|NCT02868216|11284909|FG001|Overall Study|Withdrawal by Subject|5
7134653|NCT02868229|11284919|FG000|Overall Study|Adverse Event|1
7134654|NCT02868229|11284920|FG001|Overall Study|Adverse Event|0
7134655|NCT02868229|11284921|FG002|Overall Study|Adverse Event|0
7134656|NCT02868229|11284922|FG003|Overall Study|Adverse Event|1
7134657|NCT02868229|11284919|FG000|Overall Study|Death|0
7134658|NCT02868229|11284920|FG001|Overall Study|Death|0
7134659|NCT02868229|11284921|FG002|Overall Study|Death|1
7134660|NCT02868229|11284922|FG003|Overall Study|Death|1
7134661|NCT02868229|11284919|FG000|Overall Study|Missed dose|0
7134662|NCT02868229|11284920|FG001|Overall Study|Missed dose|0
7134663|NCT02868229|11284921|FG002|Overall Study|Missed dose|0
7134664|NCT02868229|11284922|FG003|Overall Study|Missed dose|3
7134665|NCT02868281|11284945|FG000|Overall Study|Adverse Event|2
7134666|NCT02868281|11284946|FG001|Overall Study|Adverse Event|2
7134667|NCT02868281|11284945|FG000|Overall Study|Protocol Violation|13
7134668|NCT02868281|11284946|FG001|Overall Study|Protocol Violation|10
6780804|NCT04600076|10776557|FG000|Overall Study|Lost to Follow-up|3
6780805|NCT04375397|10776563|FG000|Overall Study|Death|1
6780806|NCT04375397|10776564|FG001|Overall Study|Death|1
6780807|NCT04375397|10776563|FG000|Overall Study|Withdrew consent|2
7134669|NCT02868281|11284945|FG000|Overall Study|Lost to Follow-up|3
7134670|NCT02868281|11284946|FG001|Overall Study|Lost to Follow-up|6
7134671|NCT02868281|11284945|FG000|Overall Study|Withdrawal by Subject|11
7134672|NCT02868281|11284946|FG001|Overall Study|Withdrawal by Subject|15
7134673|NCT02868281|11284945|FG000|Overall Study|Physician Decision|2
7134674|NCT02868281|11284946|FG001|Overall Study|Physician Decision|0
7134675|NCT02868281|11284945|FG000|Overall Study|Had protocol-defined asthma exacerbation|8
7134676|NCT02868281|11284946|FG001|Overall Study|Had protocol-defined asthma exacerbation|8
7134677|NCT02868281|11284945|FG000|Overall Study|Inclusion/exclusion criteria violation|3
6780808|NCT04375397|10776564|FG001|Overall Study|Withdrew consent|0
7134678|NCT02868281|11284946|FG001|Overall Study|Inclusion/exclusion criteria violation|2
7134679|NCT02868281|11284945|FG000|Overall Study|Long journey/moving away|1
7134680|NCT02868281|11284946|FG001|Overall Study|Long journey/moving away|1
7134681|NCT02868554|11284955|FG000|Overall Study|Lost to Follow-up|3
7134682|NCT02868554|11284956|FG001|Overall Study|Lost to Follow-up|0
7134683|NCT02868554|11284957|FG002|Overall Study|Lost to Follow-up|1
7134684|NCT02869438|11284997|FG000|Overall Study|Lost to Follow-up|1
7134685|NCT02869438|11284998|FG001|Overall Study|Lost to Follow-up|0
7134686|NCT02869438|11284997|FG000|Overall Study|Adverse Event|1
7134687|NCT02869438|11284998|FG001|Overall Study|Adverse Event|0
7134688|NCT02869438|11284997|FG000|Overall Study|Withdrawal by Subject|1
7134689|NCT02869438|11284998|FG001|Overall Study|Withdrawal by Subject|2
7134690|NCT02869893|11285008|FG000|Overall Study|participant aversion to IV|5
7134691|NCT02869893|11285008|FG000|Overall Study|participant fear of MRI scanner|2
7134692|NCT02870933|11285064|FG000|Overall Study|Death|2
7134693|NCT02870933|11285065|FG001|Overall Study|Death|1
7134694|NCT02870933|11285064|FG000|Overall Study|Withdrawal by Subject|0
7134695|NCT02870933|11285065|FG001|Overall Study|Withdrawal by Subject|1
7134696|NCT02870972|11285077|FG000|Overall Study|Adverse Event|1
7134697|NCT02870972|11285078|FG001|Overall Study|Adverse Event|0
7134698|NCT02870972|11285079|FG002|Overall Study|Adverse Event|0
7134699|NCT02870972|11285080|FG003|Overall Study|Adverse Event|0
7134700|NCT02870972|11285081|FG004|Overall Study|Adverse Event|0
7134701|NCT02871375|11285117|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0
7134702|NCT02871375|11285118|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1
7134703|NCT02871492|11285158|FG000|Overall Study|Lost to Follow-up|6
7134704|NCT02871492|11285159|FG001|Overall Study|Lost to Follow-up|3
7134705|NCT02871492|11285160|FG002|Overall Study|Lost to Follow-up|5
7134706|NCT02871492|11285158|FG000|Overall Study|Withdrawal by Subject|0
7134707|NCT02871492|11285159|FG001|Overall Study|Withdrawal by Subject|0
7134708|NCT02871492|11285160|FG002|Overall Study|Withdrawal by Subject|1
7134709|NCT02871635|11285179|FG000|Overall Study|Primary lack of efficacy|4
7134710|NCT02871635|11285180|FG001|Overall Study|Primary lack of efficacy|4
7134711|NCT02871635|11285179|FG000|Overall Study|Protocol Violation|3
7134712|NCT02871635|11285180|FG001|Overall Study|Protocol Violation|1
7134713|NCT02871635|11285179|FG000|Overall Study|Lost to Follow-up|1
7134714|NCT02871635|11285180|FG001|Overall Study|Lost to Follow-up|2
7134715|NCT02871635|11285179|FG000|Overall Study|Pregnancy|0
7134716|NCT02871635|11285180|FG001|Overall Study|Pregnancy|2
7134717|NCT02871635|11285179|FG000|Overall Study|Physician Decision|1
7134718|NCT02871635|11285180|FG001|Overall Study|Physician Decision|1
7134719|NCT02871635|11285179|FG000|Overall Study|Withdrawal by Subject|3
7134720|NCT02871635|11285180|FG001|Overall Study|Withdrawal by Subject|4
7134721|NCT02871635|11285179|FG000|Overall Study|Adverse Event|4
7134722|NCT02871635|11285180|FG001|Overall Study|Adverse Event|4
7134723|NCT02871635|11285179|FG000|Overall Study|Secondary lack of efficacy|2
7134724|NCT02871635|11285180|FG001|Overall Study|Secondary lack of efficacy|1
7134725|NCT02871739|11285192|FG000|Overall Study|Lost to Follow-up|3
7134726|NCT02871739|11285193|FG001|Overall Study|Lost to Follow-up|2
7134727|NCT02871739|11285194|FG002|Overall Study|Lost to Follow-up|0
7134728|NCT02871739|11285195|FG003|Overall Study|Lost to Follow-up|2
7134729|NCT02872012|11285210|FG000|Overall Study|Withdrawal by Subject|1
7134730|NCT02872012|11285211|FG001|Overall Study|Withdrawal by Subject|0
7134731|NCT02872012|11285212|FG002|Overall Study|Withdrawal by Subject|0
7134732|NCT02872012|11285213|FG003|Overall Study|Withdrawal by Subject|0
7134733|NCT02872012|11285214|FG004|Overall Study|Withdrawal by Subject|0
7134734|NCT02872142|11285239|FG000|Overall Study|Adverse Event|2
7134735|NCT02872142|11285239|FG000|Overall Study|Death|1
7134736|NCT02872142|11285239|FG000|Overall Study|Participant Decision|3
7134737|NCT02872285|11285245|FG000|Overall Study|Withdrawal by Subject|2
7134738|NCT02872285|11285246|FG001|Overall Study|Withdrawal by Subject|0
7134739|NCT02872285|11285245|FG000|Overall Study|Lost to Follow-up|2
7134740|NCT02872285|11285246|FG001|Overall Study|Lost to Follow-up|2
7134741|NCT02872285|11285245|FG000|Overall Study|Discontinued due to back surgery|1
7134742|NCT02872285|11285246|FG001|Overall Study|Discontinued due to back surgery|0
7134743|NCT02872311|11285257|FG000|Overall Study|Death|2
7134744|NCT02872311|11285258|FG001|Overall Study|Death|0
7134745|NCT02872311|11285259|FG002|Overall Study|Death|0
7134746|NCT02872311|11285260|FG003|Overall Study|Death|0
7134747|NCT02872311|11285261|FG004|Overall Study|Death|0
7134748|NCT02872311|11285257|FG000|Overall Study|Lost to Follow-up|2
7134749|NCT02872311|11285258|FG001|Overall Study|Lost to Follow-up|0
7134750|NCT02872311|11285259|FG002|Overall Study|Lost to Follow-up|0
7134751|NCT02872311|11285260|FG003|Overall Study|Lost to Follow-up|0
7134752|NCT02872311|11285261|FG004|Overall Study|Lost to Follow-up|0
7134753|NCT02872311|11285257|FG000|Overall Study|Protocol Violation|0
7134754|NCT02872311|11285258|FG001|Overall Study|Protocol Violation|2
7134755|NCT02872311|11285259|FG002|Overall Study|Protocol Violation|1
7134756|NCT02872311|11285260|FG003|Overall Study|Protocol Violation|0
7134757|NCT02872311|11285261|FG004|Overall Study|Protocol Violation|0
7134758|NCT02872935|11285311|FG000|Overall Study|Other|0
7134759|NCT02872935|11285312|FG001|Overall Study|Other|1
7134760|NCT02873208|11285327|FG000|Overall Study|Withdrawal by Subject|36
7134761|NCT02873208|11285327|FG000|Overall Study|Lost to Follow-up|22
7134762|NCT02873208|11285327|FG000|Overall Study|Adverse Event|15
7134763|NCT02873208|11285327|FG000|Overall Study|Non-compliance with study drug|12
7134764|NCT02873208|11285327|FG000|Overall Study|Protocol Violation|8
7134765|NCT02873208|11285327|FG000|Overall Study|Pregnancy|2
7134766|NCT02873208|11285327|FG000|Overall Study|Incarceration|1
7134767|NCT02873208|11285327|FG000|Overall Study|Lack of Efficacy|1
7134768|NCT02873208|11285327|FG000|Overall Study|Physician Decision|1
7134769|NCT02873221|11285334|FG000|Treatment Period|Other Miscellaneous Reasons|0
7134770|NCT02873221|11285335|FG001|Treatment Period|Other Miscellaneous Reasons|2
7134771|NCT02873221|11285336|FG002|Treatment Period|Other Miscellaneous Reasons|1
7134772|NCT02873221|11285334|FG000|Treatment Period|Non-Compliance with Study Drug|0
7134773|NCT02873221|11285335|FG001|Treatment Period|Non-Compliance with Study Drug|3
7134774|NCT02873221|11285336|FG002|Treatment Period|Non-Compliance with Study Drug|2
7134775|NCT02873221|11285334|FG000|Treatment Period|Protocol Violation|2
7134776|NCT02873221|11285335|FG001|Treatment Period|Protocol Violation|5
7134777|NCT02873221|11285336|FG002|Treatment Period|Protocol Violation|8
7134778|NCT02873221|11285334|FG000|Treatment Period|Pregnancy|4
7134779|NCT02873221|11285335|FG001|Treatment Period|Pregnancy|6
7134780|NCT02873221|11285336|FG002|Treatment Period|Pregnancy|3
7134781|NCT02873221|11285334|FG000|Treatment Period|Lack of Qualifying Event|0
7134782|NCT02873221|11285335|FG001|Treatment Period|Lack of Qualifying Event|3
7134783|NCT02873221|11285336|FG002|Treatment Period|Lack of Qualifying Event|1
7134784|NCT02873221|11285334|FG000|Treatment Period|Withdrawal of Consent|52
7134785|NCT02873221|11285335|FG001|Treatment Period|Withdrawal of Consent|51
7134786|NCT02873221|11285336|FG002|Treatment Period|Withdrawal of Consent|41
7134787|NCT02873221|11285334|FG000|Treatment Period|Lack of Efficacy|0
7134788|NCT02873221|11285335|FG001|Treatment Period|Lack of Efficacy|17
7134789|NCT02873221|11285336|FG002|Treatment Period|Lack of Efficacy|12
7134790|NCT02873221|11285334|FG000|Treatment Period|Adverse Event|4
7134791|NCT02873221|11285335|FG001|Treatment Period|Adverse Event|9
7134792|NCT02873221|11285336|FG002|Treatment Period|Adverse Event|11
7134793|NCT02873221|11285334|FG000|Treatment Period|Lost to Follow-up|26
7134794|NCT02873221|11285335|FG001|Treatment Period|Lost to Follow-up|30
7134795|NCT02873221|11285336|FG002|Treatment Period|Lost to Follow-up|26
7134796|NCT02873221|11285334|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0
7134797|NCT02873221|11285335|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2
7134798|NCT02873221|11285336|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0
7134799|NCT02873221|11285334|FG000|Safety Follow-up Period|Protocol Violation|0
7134800|NCT02873221|11285335|FG001|Safety Follow-up Period|Protocol Violation|0
7134801|NCT02873221|11285336|FG002|Safety Follow-up Period|Protocol Violation|1
7134802|NCT02873221|11285334|FG000|Safety Follow-up Period|Lost to Follow-up|3
7134803|NCT02873221|11285335|FG001|Safety Follow-up Period|Lost to Follow-up|5
7134804|NCT02873221|11285336|FG002|Safety Follow-up Period|Lost to Follow-up|5
7134805|NCT02873221|11285334|FG000|Safety Follow-up Period|Withdrawal of Consent|4
7134806|NCT02873221|11285335|FG001|Safety Follow-up Period|Withdrawal of Consent|10
7134807|NCT02873221|11285336|FG002|Safety Follow-up Period|Withdrawal of Consent|8
7134808|NCT02873338|11285368|FG000|Overall Study|Adverse Event|0
7134809|NCT02873338|11285369|FG001|Overall Study|Adverse Event|2
7134810|NCT02873338|11285370|FG002|Overall Study|Adverse Event|1
7134811|NCT02873338|11285368|FG000|Overall Study|Death|2
7134812|NCT02873338|11285369|FG001|Overall Study|Death|1
7134813|NCT02873338|11285370|FG002|Overall Study|Death|1
7134814|NCT02873338|11285368|FG000|Overall Study|Withdrawal by Subject|2
7134815|NCT02873338|11285369|FG001|Overall Study|Withdrawal by Subject|1
7134816|NCT02873338|11285370|FG002|Overall Study|Withdrawal by Subject|3
7134817|NCT02873338|11285368|FG000|Overall Study|Lack of Efficacy|0
7134818|NCT02873338|11285369|FG001|Overall Study|Lack of Efficacy|2
7134819|NCT02873338|11285370|FG002|Overall Study|Lack of Efficacy|0
7134820|NCT02873338|11285368|FG000|Overall Study|Other or Missing|14
7134821|NCT02873338|11285369|FG001|Overall Study|Other or Missing|15
7134822|NCT02873338|11285370|FG002|Overall Study|Other or Missing|13
7134823|NCT02873377|11285380|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22
7134824|NCT02873377|11285381|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22
7134825|NCT02873377|11285380|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15
7134826|NCT02873377|11285381|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23
7134827|NCT02873429|11285390|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10
7134828|NCT02873429|11285391|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1
7134829|NCT02873429|11285390|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2
7134830|NCT02873429|11285391|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2
7134831|NCT02873429|11285390|FG000|16 Weeks|Lost to Follow-up|3
7134832|NCT02873429|11285391|FG001|16 Weeks|Lost to Follow-up|0
7134833|NCT02873689|11285416|FG000|Overall Study|Lack of Efficacy|1
7134834|NCT02873689|11285417|FG001|Overall Study|Lack of Efficacy|0
7134835|NCT02873689|11285416|FG000|Overall Study|Withdrawal by Subject|2
7134836|NCT02873689|11285417|FG001|Overall Study|Withdrawal by Subject|2
7134837|NCT02873689|11285416|FG000|Overall Study|Protocol Violation|1
7134838|NCT02873689|11285417|FG001|Overall Study|Protocol Violation|0
7134839|NCT02873689|11285416|FG000|Overall Study|Adverse Event|2
7134840|NCT02873689|11285417|FG001|Overall Study|Adverse Event|2
7134841|NCT02873689|11285416|FG000|Overall Study|Randomized but not Treated|1
7134842|NCT02873689|11285417|FG001|Overall Study|Randomized but not Treated|1
7134843|NCT02873702|11285425|FG000|Healing Period (up to Week 8)|Adverse Event|1
7134844|NCT02873702|11285426|FG001|Healing Period (up to Week 8)|Adverse Event|0
7134845|NCT02873702|11285427|FG002|Healing Period (up to Week 8)|Adverse Event|0
7134846|NCT02873702|11285428|FG003|Healing Period (up to Week 8)|Adverse Event|0
7134847|NCT02873702|11285425|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0
7134848|NCT02873702|11285426|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1
7134849|NCT02873702|11285427|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0
7134850|NCT02873702|11285428|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0
7134851|NCT02873702|11285425|FG000|Maintenance Period (up to Month 6)|Adverse Event|0
7134852|NCT02873702|11285426|FG001|Maintenance Period (up to Month 6)|Adverse Event|0
7134853|NCT02873702|11285427|FG002|Maintenance Period (up to Month 6)|Adverse Event|1
7134854|NCT02873702|11285428|FG003|Maintenance Period (up to Month 6)|Adverse Event|0
7134855|NCT02873702|11285425|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0
7134856|NCT02873702|11285426|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0
7134857|NCT02873702|11285427|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4
7134858|NCT02873702|11285428|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1
7134859|NCT02873702|11285425|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0
7134860|NCT02873702|11285426|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0
7134861|NCT02873702|11285427|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2
7134862|NCT02873702|11285428|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1
7134863|NCT02873754|11285438|FG000|Overall Study|Lost to Follow-up|5
7134864|NCT02873754|11285438|FG000|Overall Study|Couldn't complete study procedures|1
7134865|NCT02873936|11285449|FG000|Overall Study|Withdrew Consent|4
7134866|NCT02873936|11285450|FG001|Overall Study|Withdrew Consent|11
7134867|NCT02873936|11285451|FG002|Overall Study|Withdrew Consent|20
7134868|NCT02873936|11285449|FG000|Overall Study|Investigator's Discretion|3
7134869|NCT02873936|11285450|FG001|Overall Study|Investigator's Discretion|5
7134870|NCT02873936|11285451|FG002|Overall Study|Investigator's Discretion|4
7134871|NCT02873936|11285449|FG000|Overall Study|Adverse Event|3
7134872|NCT02873936|11285450|FG001|Overall Study|Adverse Event|5
7134873|NCT02873936|11285451|FG002|Overall Study|Adverse Event|3
7134874|NCT02873936|11285449|FG000|Overall Study|Protocol Violation|0
7134875|NCT02873936|11285450|FG001|Overall Study|Protocol Violation|1
7134876|NCT02873936|11285451|FG002|Overall Study|Protocol Violation|3
7134877|NCT02873936|11285449|FG000|Overall Study|Lost to Follow-up|1
7134878|NCT02873936|11285450|FG001|Overall Study|Lost to Follow-up|1
7134879|NCT02873936|11285451|FG002|Overall Study|Lost to Follow-up|1
7134880|NCT02873936|11285449|FG000|Overall Study|Non-compliance With Study Drug|1
7134881|NCT02873936|11285450|FG001|Overall Study|Non-compliance With Study Drug|0
7134882|NCT02873936|11285451|FG002|Overall Study|Non-compliance With Study Drug|1
7134883|NCT02873936|11285449|FG000|Overall Study|Randomized but not Dosed|1
7134884|NCT02873936|11285450|FG001|Overall Study|Randomized but not Dosed|0
7134885|NCT02873936|11285451|FG002|Overall Study|Randomized but not Dosed|0
7134886|NCT02874534|11285478|FG000|Overall Study|Withdrawal by Subject|5
7134887|NCT02874534|11285479|FG001|Overall Study|Withdrawal by Subject|8
7134888|NCT02874534|11285478|FG000|Overall Study|Lost to Follow-up|2
7134889|NCT02874534|11285479|FG001|Overall Study|Lost to Follow-up|2
7134890|NCT02874534|11285478|FG000|Overall Study|Ongoing in study|1
7134891|NCT02874534|11285479|FG001|Overall Study|Ongoing in study|1
7134892|NCT02874794|11285487|FG000|Overall Study|Physician Decision|3
7134893|NCT02874794|11285488|FG001|Overall Study|Physician Decision|2
7134894|NCT02874794|11285487|FG000|Overall Study|Withdrawal by Subject|2
7134895|NCT02874794|11285488|FG001|Overall Study|Withdrawal by Subject|8
7134896|NCT02874794|11285487|FG000|Overall Study|Death|2
7134897|NCT02874794|11285488|FG001|Overall Study|Death|1
7134898|NCT02874924|11285510|FG000|Overall Study|Adverse Event|2
7134899|NCT02874924|11285511|FG001|Overall Study|Adverse Event|0
7134900|NCT02874924|11285512|FG002|Overall Study|Adverse Event|0
7134901|NCT02874924|11285510|FG000|Overall Study|Withdrawal by Subject|1
7134902|NCT02874924|11285511|FG001|Overall Study|Withdrawal by Subject|0
7134903|NCT02874924|11285512|FG002|Overall Study|Withdrawal by Subject|0
7134904|NCT02875028|11285522|FG000|Washout Period|Withdrawal by Subject|0
7134905|NCT02875028|11285523|FG001|Washout Period|Withdrawal by Subject|1
7134906|NCT02875080|11285534|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2
7134907|NCT02875080|11285535|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0
7134908|NCT02875080|11285536|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0
7134909|NCT02875340|11285544|FG000|Overall Study|Death|2
7134910|NCT02875340|11285544|FG000|Overall Study|Withdrawal by Subject|2
7134911|NCT02875340|11285544|FG000|Overall Study|Physician Decision|3
7134912|NCT02875340|11285544|FG000|Overall Study|Adverse Event|1
7134913|NCT02875366|11285556|FG000|Overall Study|Adverse Event|0
7134914|NCT02875366|11285557|FG001|Overall Study|Adverse Event|2
7134915|NCT02875366|11285556|FG000|Overall Study|Noncompliance|0
7134916|NCT02875366|11285557|FG001|Overall Study|Noncompliance|1
7134917|NCT02875392|11285565|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7
7134918|NCT02875392|11285566|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8
7134919|NCT02875613|11285572|FG000|Overall Study|Withdrawal by Subject|1
7134920|NCT02875834|11285580|FG000|Open-label Phase|Withdrawal by Subject|3
7134921|NCT02875834|11285581|FG001|Open-label Phase|Withdrawal by Subject|0
7134922|NCT02875834|11285582|FG002|Open-label Phase|Withdrawal by Subject|0
7134923|NCT02875834|11285583|FG003|Open-label Phase|Withdrawal by Subject|0
7134924|NCT02875834|11285580|FG000|Open-label Phase|(Not collected)|4
7134925|NCT02875834|11285581|FG001|Open-label Phase|(Not collected)|0
7134926|NCT02875834|11285582|FG002|Open-label Phase|(Not collected)|0
7134927|NCT02875834|11285583|FG003|Open-label Phase|(Not collected)|0
7134928|NCT02875834|11285580|FG000|Randomized Treatment Phase|Withdrawal by Subject|0
7134929|NCT02875834|11285581|FG001|Randomized Treatment Phase|Withdrawal by Subject|3
7134930|NCT02875834|11285582|FG002|Randomized Treatment Phase|Withdrawal by Subject|1
7134931|NCT02875834|11285583|FG003|Randomized Treatment Phase|Withdrawal by Subject|0
7134932|NCT02875834|11285580|FG000|Randomized Treatment Phase|Protocol Violation|0
7134933|NCT02875834|11285581|FG001|Randomized Treatment Phase|Protocol Violation|2
7134934|NCT02875834|11285582|FG002|Randomized Treatment Phase|Protocol Violation|0
7134935|NCT02875834|11285583|FG003|Randomized Treatment Phase|Protocol Violation|0
7134936|NCT02875834|11285580|FG000|Randomized Treatment Phase|(Not collected)|0
7134937|NCT02875834|11285581|FG001|Randomized Treatment Phase|(Not collected)|9
7134938|NCT02875834|11285582|FG002|Randomized Treatment Phase|(Not collected)|10
7134939|NCT02875834|11285583|FG003|Randomized Treatment Phase|(Not collected)|9
7134940|NCT02875977|11285595|FG000|Overall Study|Lost to Follow-up|42
7134941|NCT02875977|11285596|FG001|Overall Study|Lost to Follow-up|29
6780809|NCT04375397|10776563|FG000|Overall Study|Lost to Follow-up|6
6780810|NCT04375397|10776564|FG001|Overall Study|Lost to Follow-up|4
6780811|NCT04375397|10776563|FG000|Overall Study|Other, not specified|0
6780812|NCT04375397|10776564|FG001|Overall Study|Other, not specified|1
6806489|NCT00442559|10809003|FG001|Overall Study|Withdrawal by Subject|0
6806490|NCT00117338|10809017|FG000|Overall Study|Adverse Event|0
6806491|NCT00117338|10809018|FG001|Overall Study|Adverse Event|1
6806492|NCT00117338|10809017|FG000|Overall Study|Protocol Violation|3
7134942|NCT02876601|11285636|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
7134943|NCT02876601|11285637|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
7134944|NCT02876601|11285638|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1
7134945|NCT02876601|11285639|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
7134946|NCT02877004|11285731|FG000|Overall Study|Pregnancy|0
7134947|NCT02877004|11285732|FG001|Overall Study|Pregnancy|0
7134948|NCT02877004|11285733|FG002|Overall Study|Pregnancy|1
7134949|NCT02877082|11285741|FG000|Overall Study|Trial was closed early|5
7134950|NCT02877680|11285766|FG000|Overall Study|Lost to Follow-up|1
7134951|NCT02877680|11285767|FG001|Overall Study|Lost to Follow-up|1
6780813|NCT04075734|10776593|FG000|Overall Study|Lost to Follow-up|1
6780814|NCT04075734|10776594|FG001|Overall Study|Lost to Follow-up|1
6780815|NCT04075734|10776595|FG002|Overall Study|Lost to Follow-up|0
6780816|NCT04075734|10776593|FG000|Overall Study|Withdrawal by Subject|3
6780817|NCT04075734|10776594|FG001|Overall Study|Withdrawal by Subject|0
6780818|NCT04075734|10776595|FG002|Overall Study|Withdrawal by Subject|0
6780819|NCT03915470|10776632|FG000|Overall Study|Death|3
6780820|NCT03915470|10776633|FG001|Overall Study|Death|1
6780821|NCT03915470|10776632|FG000|Overall Study|Adverse Event|1
6780822|NCT03915470|10776633|FG001|Overall Study|Adverse Event|0
6780823|NCT03915470|10776632|FG000|Overall Study|Physician Decision|1
6780824|NCT03915470|10776633|FG001|Overall Study|Physician Decision|0
6780825|NCT03915470|10776632|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1
6780826|NCT03915470|10776633|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1
6780827|NCT03881553|10776646|FG000|Overall Study|Discharged prior to participation|1
6780828|NCT03881553|10776647|FG001|Overall Study|Discharged prior to participation|1
6780829|NCT03881553|10776648|FG002|Overall Study|Discharged prior to participation|0
6780830|NCT03881553|10776646|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0
6780831|NCT03881553|10776647|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0
6780832|NCT03881553|10776648|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1
6780833|NCT03718000|10776737|FG000|Overall Study|Relocation|2
6780834|NCT03718000|10776738|FG001|Overall Study|Relocation|4
6780835|NCT03718000|10776737|FG000|Overall Study|Pregnancy|0
6780836|NCT03718000|10776738|FG001|Overall Study|Pregnancy|1
6780837|NCT03703466|10776748|FG000|Overall Study|Death|2
6780838|NCT03703466|10776749|FG001|Overall Study|Death|1
6780839|NCT03703466|10776750|FG002|Overall Study|Death|0
6780840|NCT03703466|10776748|FG000|Overall Study|Protocol Violation|1
6780841|NCT03703466|10776749|FG001|Overall Study|Protocol Violation|0
6780842|NCT03703466|10776750|FG002|Overall Study|Protocol Violation|0
6780843|NCT03703466|10776748|FG000|Overall Study|Withdrawal by Subject|0
6780844|NCT03703466|10776749|FG001|Overall Study|Withdrawal by Subject|3
6780845|NCT03703466|10776750|FG002|Overall Study|Withdrawal by Subject|0
6780846|NCT03703466|10776748|FG000|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|1
6780847|NCT03703466|10776749|FG001|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2
6780848|NCT03703466|10776750|FG002|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2
6780849|NCT03654651|10776783|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1
7134952|NCT02877927|11285779|FG000|Overall Study|Adverse Event|1
6780850|NCT03654651|10776784|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0
6780851|NCT03633396|10776793|FG000|Overall Study|Withdrawal by Subject|4
6780852|NCT03633396|10776794|FG001|Overall Study|Withdrawal by Subject|4
7134953|NCT02877927|11285780|FG001|Overall Study|Adverse Event|0
7134954|NCT02877927|11285779|FG000|Overall Study|Lost to Follow-up|37
7134955|NCT02877927|11285780|FG001|Overall Study|Lost to Follow-up|38
7134956|NCT02877927|11285779|FG000|Overall Study|Withdrawal by Subject|11
7134957|NCT02877927|11285780|FG001|Overall Study|Withdrawal by Subject|12
7134958|NCT02877927|11285779|FG000|Overall Study|Physician Decision|0
7134959|NCT02877927|11285780|FG001|Overall Study|Physician Decision|1
7134960|NCT02877927|11285779|FG000|Overall Study|Missed EOT/PTE Visit|5
7134961|NCT02877927|11285780|FG001|Overall Study|Missed EOT/PTE Visit|6
7134962|NCT02878213|11285790|FG000|Overall Study|Withdrawal by Subject|2
7134963|NCT02878213|11285790|FG000|Overall Study|Adverse Event|1
7134964|NCT02878330|11285797|FG000|Overall Study|Death|3
7134965|NCT02878330|11285798|FG001|Overall Study|Death|2
7134966|NCT02878330|11285797|FG000|Overall Study|Lost to Follow-up|11
7134967|NCT02878330|11285798|FG001|Overall Study|Lost to Follow-up|26
7134968|NCT02878330|11285797|FG000|Overall Study|Withdrawal by Subject|11
7134969|NCT02878330|11285798|FG001|Overall Study|Withdrawal by Subject|21
7134970|NCT02878330|11285797|FG000|Overall Study|Other|4
7134971|NCT02878330|11285798|FG001|Overall Study|Other|7
7134972|NCT02878590|11285823|FG000|Overall Study|Withdrawal by Subject|2
7134973|NCT02879383|11285837|FG000|First 24 Weeks|Physician Decision|0
7134974|NCT02879383|11285838|FG001|First 24 Weeks|Physician Decision|1
7134975|NCT02879383|11285839|FG002|First 24 Weeks|Physician Decision|0
7134976|NCT02879383|11285840|FG003|First 24 Weeks|Physician Decision|0
7134977|NCT02879578|11285855|FG000|Overall Study|Adverse Event|1
7134978|NCT02879578|11285856|FG001|Overall Study|Adverse Event|2
7134979|NCT02879578|11285857|FG002|Overall Study|Adverse Event|14
7134980|NCT02879578|11285855|FG000|Overall Study|Protocol Violation|0
7134981|NCT02879578|11285856|FG001|Overall Study|Protocol Violation|1
7134982|NCT02879578|11285857|FG002|Overall Study|Protocol Violation|1
7134983|NCT02879578|11285855|FG000|Overall Study|Withdrawal by Subject|8
7134984|NCT02879578|11285856|FG001|Overall Study|Withdrawal by Subject|6
7134985|NCT02879578|11285857|FG002|Overall Study|Withdrawal by Subject|9
7134986|NCT02879578|11285855|FG000|Overall Study|Lost to Follow-up|1
7134987|NCT02879578|11285856|FG001|Overall Study|Lost to Follow-up|0
7134988|NCT02879578|11285857|FG002|Overall Study|Lost to Follow-up|4
7134989|NCT02879578|11285855|FG000|Overall Study|Physician Decision|0
7134990|NCT02879578|11285856|FG001|Overall Study|Physician Decision|0
7134991|NCT02879578|11285857|FG002|Overall Study|Physician Decision|4
7134992|NCT02879994|11285896|FG000|Overall Study|off treatment early|7
7134993|NCT02879994|11285896|FG000|Overall Study|Adverse Event|2
7134994|NCT02879994|11285896|FG000|Overall Study|Death|2
7134995|NCT02880761|11285947|FG000|Overall Study|Death|6
7134996|NCT02880761|11285948|FG001|Overall Study|Death|8
7134997|NCT02880761|11285947|FG000|Overall Study|Withdrawal by Subject|3
7134998|NCT02880761|11285948|FG001|Overall Study|Withdrawal by Subject|6
7134999|NCT02880761|11285947|FG000|Overall Study|Protocol Violation|4
7135000|NCT02880761|11285948|FG001|Overall Study|Protocol Violation|3
7135001|NCT02880761|11285947|FG000|Overall Study|Lost to Follow-up|3
7135002|NCT02880761|11285948|FG001|Overall Study|Lost to Follow-up|4
7135003|NCT02880865|11285960|FG000|Overall Study|Adverse Event|1
7135004|NCT02880865|11285961|FG001|Overall Study|Adverse Event|0
7135005|NCT02880865|11285960|FG000|Overall Study|Withdrawal by Subject|0
7135006|NCT02880865|11285961|FG001|Overall Study|Withdrawal by Subject|2
7135007|NCT02880865|11285960|FG000|Overall Study|Physician Decision|0
7135008|NCT02880865|11285961|FG001|Overall Study|Physician Decision|1
7135009|NCT02881047|11286016|FG000|Overall Study|Adverse Event|1
7135010|NCT02881047|11286016|FG000|Overall Study|Withdrawal by Subject|1
7135011|NCT02881567|11286024|FG000|Overall Study|Adverse Event|1
7135012|NCT02881567|11286024|FG000|Overall Study|Lost to Follow-up|3
7135013|NCT02881567|11286024|FG000|Overall Study|Consent withdrawn|1
7135014|NCT02881567|11286024|FG000|Overall Study|Investigator decision|1
7135015|NCT02881567|11286024|FG000|Overall Study|Study terminated by sponsor|9
7135016|NCT02881567|11286024|FG000|Overall Study|Reason not Specified|3
7135017|NCT02882152|11286061|FG000|Overall Study|Lost to Follow-up|1
7135018|NCT02882152|11286062|FG001|Overall Study|Lost to Follow-up|0
7135019|NCT02882854|11286087|FG000|Overall Study|Lost to Follow-up|1
7135020|NCT02882854|11286088|FG001|Overall Study|Lost to Follow-up|2
7135021|NCT02882854|11286087|FG000|Overall Study|Physician Decision|0
7135022|NCT02882854|11286088|FG001|Overall Study|Physician Decision|1
7135023|NCT02883244|11286096|FG000|Overall Study|Lost to Follow-up|0
7135024|NCT02883244|11286097|FG001|Overall Study|Lost to Follow-up|1
7135025|NCT02883452|11286109|FG000|Overall Study|Withdrawal by Subject|1
7135026|NCT02883452|11286110|FG001|Overall Study|Withdrawal by Subject|1
7135027|NCT02883452|11286111|FG002|Overall Study|Withdrawal by Subject|3
7135028|NCT02883452|11286112|FG003|Overall Study|Withdrawal by Subject|0
7135029|NCT02883452|11286113|FG004|Overall Study|Withdrawal by Subject|2
7135030|NCT02883452|11286114|FG005|Overall Study|Withdrawal by Subject|5
7135031|NCT02883452|11286109|FG000|Overall Study|Disease progression|1
7135032|NCT02883452|11286110|FG001|Overall Study|Disease progression|0
7135033|NCT02883452|11286111|FG002|Overall Study|Disease progression|0
7135034|NCT02883452|11286112|FG003|Overall Study|Disease progression|1
7135035|NCT02883452|11286113|FG004|Overall Study|Disease progression|4
7135036|NCT02883452|11286114|FG005|Overall Study|Disease progression|5
7135037|NCT02883452|11286109|FG000|Overall Study|Adverse Event|2
7135038|NCT02883452|11286110|FG001|Overall Study|Adverse Event|1
7135039|NCT02883452|11286111|FG002|Overall Study|Adverse Event|1
7135040|NCT02883452|11286112|FG003|Overall Study|Adverse Event|1
7135041|NCT02883452|11286113|FG004|Overall Study|Adverse Event|1
7135042|NCT02883452|11286114|FG005|Overall Study|Adverse Event|3
7135043|NCT02883452|11286109|FG000|Overall Study|Physician Decision|0
7135044|NCT02883452|11286110|FG001|Overall Study|Physician Decision|0
7135045|NCT02883452|11286111|FG002|Overall Study|Physician Decision|0
7135046|NCT02883452|11286112|FG003|Overall Study|Physician Decision|0
7135047|NCT02883452|11286113|FG004|Overall Study|Physician Decision|4
7135048|NCT02883452|11286114|FG005|Overall Study|Physician Decision|1
7135049|NCT02883452|11286109|FG000|Overall Study|Death|1
7135050|NCT02883452|11286110|FG001|Overall Study|Death|0
7135051|NCT02883452|11286111|FG002|Overall Study|Death|1
7135052|NCT02883452|11286112|FG003|Overall Study|Death|0
7135053|NCT02883452|11286113|FG004|Overall Study|Death|0
7135054|NCT02883452|11286114|FG005|Overall Study|Death|0
7135055|NCT02883452|11286109|FG000|Overall Study|Other|0
7135056|NCT02883452|11286110|FG001|Overall Study|Other|0
7135057|NCT02883452|11286111|FG002|Overall Study|Other|0
7135058|NCT02883452|11286112|FG003|Overall Study|Other|0
7135059|NCT02883452|11286113|FG004|Overall Study|Other|0
7135060|NCT02883452|11286114|FG005|Overall Study|Other|1
7135061|NCT02884089|11286129|FG000|Period 1|Dosing error|2
7135062|NCT02884089|11286130|FG001|Period 1|Dosing error|2
7135063|NCT02884089|11286131|FG002|Period 1|Dosing error|0
7135064|NCT02884089|11286132|FG003|Period 1|Dosing error|0
7135065|NCT02884089|11286129|FG000|Washout Period 1|Lost to Follow-up|0
7135066|NCT02884089|11286130|FG001|Washout Period 1|Lost to Follow-up|1
7135067|NCT02884089|11286131|FG002|Washout Period 1|Lost to Follow-up|0
7135068|NCT02884089|11286132|FG003|Washout Period 1|Lost to Follow-up|1
7135069|NCT02884089|11286129|FG000|Washout Period 1|Withdrawal by Subject|0
7135070|NCT02884089|11286130|FG001|Washout Period 1|Withdrawal by Subject|1
7135071|NCT02884089|11286131|FG002|Washout Period 1|Withdrawal by Subject|0
7135072|NCT02884089|11286132|FG003|Washout Period 1|Withdrawal by Subject|0
6780853|NCT03633396|10776793|FG000|Overall Study|Adverse Event|1
6780854|NCT03633396|10776794|FG001|Overall Study|Adverse Event|1
6780855|NCT03633396|10776793|FG000|Overall Study|Lack of Efficacy|1
7135073|NCT02884089|11286129|FG000|Period 2|Adverse Event|1
7135074|NCT02884089|11286130|FG001|Period 2|Adverse Event|0
7135075|NCT02884089|11286131|FG002|Period 2|Adverse Event|0
7135076|NCT02884089|11286132|FG003|Period 2|Adverse Event|0
6780856|NCT03633396|10776794|FG001|Overall Study|Lack of Efficacy|0
7135077|NCT02884089|11286129|FG000|Period 3|Withdrawal by Subject|0
7135078|NCT02884089|11286130|FG001|Period 3|Withdrawal by Subject|0
7135079|NCT02884089|11286131|FG002|Period 3|Withdrawal by Subject|1
7135080|NCT02884089|11286132|FG003|Period 3|Withdrawal by Subject|0
7135081|NCT02884089|11286129|FG000|Washout Period 3|Withdrawal by Subject|0
7135082|NCT02884089|11286130|FG001|Washout Period 3|Withdrawal by Subject|0
7135083|NCT02884089|11286131|FG002|Washout Period 3|Withdrawal by Subject|1
7135084|NCT02884089|11286132|FG003|Washout Period 3|Withdrawal by Subject|0
7135085|NCT02884089|11286129|FG000|Washout Period 3|Lost to Follow-up|0
7135086|NCT02884089|11286130|FG001|Washout Period 3|Lost to Follow-up|0
7135087|NCT02884089|11286131|FG002|Washout Period 3|Lost to Follow-up|0
7135088|NCT02884089|11286132|FG003|Washout Period 3|Lost to Follow-up|1
7135089|NCT02884089|11286129|FG000|Period 4|Withdrawal by Subject|0
7135090|NCT02884089|11286130|FG001|Period 4|Withdrawal by Subject|1
7135091|NCT02884089|11286131|FG002|Period 4|Withdrawal by Subject|0
7135092|NCT02884089|11286132|FG003|Period 4|Withdrawal by Subject|0
7135093|NCT02884089|11286129|FG000|Period 4|Lost to Follow-up|1
7135094|NCT02884089|11286130|FG001|Period 4|Lost to Follow-up|0
7135095|NCT02884089|11286131|FG002|Period 4|Lost to Follow-up|0
7135096|NCT02884089|11286132|FG003|Period 4|Lost to Follow-up|0
7135097|NCT02884089|11286129|FG000|Follow-up Visit|Withdrawal by Subject|1
7135098|NCT02884089|11286130|FG001|Follow-up Visit|Withdrawal by Subject|0
7135099|NCT02884089|11286131|FG002|Follow-up Visit|Withdrawal by Subject|0
7135100|NCT02884089|11286132|FG003|Follow-up Visit|Withdrawal by Subject|1
7135101|NCT02885181|11286202|FG000|Overall Study|Investigator's Discretion|0
7135102|NCT02885181|11286203|FG001|Overall Study|Investigator's Discretion|1
7135103|NCT02885181|11286204|FG002|Overall Study|Investigator's Discretion|0
7135104|NCT02885181|11286205|FG003|Overall Study|Investigator's Discretion|1
7135105|NCT02885181|11286202|FG000|Overall Study|Adverse Event|0
7135106|NCT02885181|11286203|FG001|Overall Study|Adverse Event|0
7135107|NCT02885181|11286204|FG002|Overall Study|Adverse Event|0
7135108|NCT02885181|11286205|FG003|Overall Study|Adverse Event|1
7135109|NCT02885181|11286202|FG000|Overall Study|Withdrawal by Subject|0
7135110|NCT02885181|11286203|FG001|Overall Study|Withdrawal by Subject|0
7135111|NCT02885181|11286204|FG002|Overall Study|Withdrawal by Subject|0
7135112|NCT02885181|11286205|FG003|Overall Study|Withdrawal by Subject|1
7135113|NCT02886338|11286301|FG000|Overall Study|Withdrawal by Subject|1
7135114|NCT02886494|11286307|FG000|Overall Study|Adverse Event|1
7135115|NCT02886494|11286308|FG001|Overall Study|Adverse Event|0
7135116|NCT02886494|11286307|FG000|Overall Study|Withdrawal by Subject|12
7135117|NCT02886494|11286308|FG001|Overall Study|Withdrawal by Subject|3
7135118|NCT02886494|11286307|FG000|Overall Study|Protocol Violation|4
7135119|NCT02886494|11286308|FG001|Overall Study|Protocol Violation|1
7135120|NCT02886624|11286317|FG000|12-week Post Treatment Follow-up|Death|1
7135121|NCT02886624|11286317|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1
7135122|NCT02886702|11286324|FG000|Overall Study|Other|4
7135123|NCT02886702|11286325|FG001|Overall Study|Other|3
7135124|NCT02886702|11286326|FG002|Overall Study|Other|9
7135125|NCT02886702|11286324|FG000|Overall Study|Withdrawal by Subject|24
7135126|NCT02886702|11286325|FG001|Overall Study|Withdrawal by Subject|18
7135127|NCT02886702|11286326|FG002|Overall Study|Withdrawal by Subject|22
7135128|NCT02886702|11286324|FG000|Overall Study|Significant Worsening of Condition|0
7135129|NCT02886702|11286325|FG001|Overall Study|Significant Worsening of Condition|1
7135130|NCT02886702|11286326|FG002|Overall Study|Significant Worsening of Condition|0
7135131|NCT02886702|11286324|FG000|Overall Study|Protocol Violation|2
7135132|NCT02886702|11286325|FG001|Overall Study|Protocol Violation|2
7135133|NCT02886702|11286326|FG002|Overall Study|Protocol Violation|1
7135134|NCT02886702|11286324|FG000|Overall Study|Non-Compliance With Study Drug|0
7135135|NCT02886702|11286325|FG001|Overall Study|Non-Compliance With Study Drug|1
7135136|NCT02886702|11286326|FG002|Overall Study|Non-Compliance With Study Drug|4
7135137|NCT02886702|11286324|FG000|Overall Study|Lost to Follow-up|11
7135138|NCT02886702|11286325|FG001|Overall Study|Lost to Follow-up|13
7135139|NCT02886702|11286326|FG002|Overall Study|Lost to Follow-up|8
7135140|NCT02886702|11286324|FG000|Overall Study|Lack of Efficacy|3
7135141|NCT02886702|11286325|FG001|Overall Study|Lack of Efficacy|4
7135142|NCT02886702|11286326|FG002|Overall Study|Lack of Efficacy|5
7135143|NCT02886702|11286324|FG000|Overall Study|Adverse Event|4
7135144|NCT02886702|11286325|FG001|Overall Study|Adverse Event|9
7135145|NCT02886702|11286326|FG002|Overall Study|Adverse Event|3
7135146|NCT02886702|11286324|FG000|Overall Study|Administrative Reasons|0
7135147|NCT02886702|11286325|FG001|Overall Study|Administrative Reasons|0
7135148|NCT02886702|11286326|FG002|Overall Study|Administrative Reasons|1
7135149|NCT02886715|11286337|FG000|Overall Study|Non-Compliance With Study Drug|0
7135150|NCT02886715|11286338|FG001|Overall Study|Non-Compliance With Study Drug|2
7135151|NCT02886715|11286339|FG002|Overall Study|Non-Compliance With Study Drug|0
6806493|NCT00117338|10809018|FG001|Overall Study|Protocol Violation|2
7135152|NCT02886715|11286337|FG000|Overall Study|Adverse Event|4
7135153|NCT02886715|11286338|FG001|Overall Study|Adverse Event|2
7135154|NCT02886715|11286339|FG002|Overall Study|Adverse Event|0
7135155|NCT02886715|11286337|FG000|Overall Study|Lack of Efficacy|0
7135156|NCT02886715|11286338|FG001|Overall Study|Lack of Efficacy|2
7135157|NCT02886715|11286339|FG002|Overall Study|Lack of Efficacy|1
7135158|NCT02886715|11286337|FG000|Overall Study|Lost to Follow-up|29
7135159|NCT02886715|11286338|FG001|Overall Study|Lost to Follow-up|26
7135160|NCT02886715|11286339|FG002|Overall Study|Lost to Follow-up|10
7135161|NCT02886715|11286337|FG000|Overall Study|Pregnancy|1
7135162|NCT02886715|11286338|FG001|Overall Study|Pregnancy|1
7135163|NCT02886715|11286339|FG002|Overall Study|Pregnancy|1
7135164|NCT02886715|11286337|FG000|Overall Study|Protocol Violation|3
7135165|NCT02886715|11286338|FG001|Overall Study|Protocol Violation|2
7135166|NCT02886715|11286339|FG002|Overall Study|Protocol Violation|1
7135167|NCT02886715|11286337|FG000|Overall Study|Withdrawal by Subject|20
7135168|NCT02886715|11286338|FG001|Overall Study|Withdrawal by Subject|18
7135169|NCT02886715|11286339|FG002|Overall Study|Withdrawal by Subject|5
7135170|NCT02886715|11286337|FG000|Overall Study|missing|7
7135171|NCT02886715|11286338|FG001|Overall Study|missing|2
7135172|NCT02886715|11286339|FG002|Overall Study|missing|2
7135173|NCT02886728|11286351|FG000|Overall Study|Withdrew Consent|31
7135174|NCT02886728|11286352|FG001|Overall Study|Withdrew Consent|13
7135175|NCT02886728|11286353|FG002|Overall Study|Withdrew Consent|11
7135176|NCT02886728|11286354|FG003|Overall Study|Withdrew Consent|47
7135177|NCT02886728|11286351|FG000|Overall Study|Lost to Follow-up|12
7135178|NCT02886728|11286352|FG001|Overall Study|Lost to Follow-up|6
7135179|NCT02886728|11286353|FG002|Overall Study|Lost to Follow-up|13
7135180|NCT02886728|11286354|FG003|Overall Study|Lost to Follow-up|12
7135181|NCT02886728|11286351|FG000|Overall Study|Adverse Event|13
7135182|NCT02886728|11286352|FG001|Overall Study|Adverse Event|5
7135183|NCT02886728|11286353|FG002|Overall Study|Adverse Event|5
7135184|NCT02886728|11286354|FG003|Overall Study|Adverse Event|11
7135185|NCT02886728|11286351|FG000|Overall Study|Investigator's Discretion|11
7135186|NCT02886728|11286352|FG001|Overall Study|Investigator's Discretion|7
7135187|NCT02886728|11286353|FG002|Overall Study|Investigator's Discretion|5
7135188|NCT02886728|11286354|FG003|Overall Study|Investigator's Discretion|11
7135189|NCT02886728|11286351|FG000|Overall Study|Death|3
7135190|NCT02886728|11286352|FG001|Overall Study|Death|1
7135191|NCT02886728|11286353|FG002|Overall Study|Death|0
7135192|NCT02886728|11286354|FG003|Overall Study|Death|0
7135193|NCT02886728|11286351|FG000|Overall Study|Protocol Violation|0
7135194|NCT02886728|11286352|FG001|Overall Study|Protocol Violation|0
7135195|NCT02886728|11286353|FG002|Overall Study|Protocol Violation|0
7135196|NCT02886728|11286354|FG003|Overall Study|Protocol Violation|4
7135197|NCT02886728|11286351|FG000|Overall Study|Non-Compliance with Study Drug|1
7135198|NCT02886728|11286352|FG001|Overall Study|Non-Compliance with Study Drug|0
7135199|NCT02886728|11286353|FG002|Overall Study|Non-Compliance with Study Drug|1
7135200|NCT02886728|11286354|FG003|Overall Study|Non-Compliance with Study Drug|0
7135201|NCT02886728|11286351|FG000|Overall Study|Pregnancy|0
7135202|NCT02886728|11286352|FG001|Overall Study|Pregnancy|0
7135203|NCT02886728|11286353|FG002|Overall Study|Pregnancy|1
7135204|NCT02886728|11286354|FG003|Overall Study|Pregnancy|0
7135205|NCT02886728|11286351|FG000|Overall Study|Randomized but Not Dosed|1
7135206|NCT02886728|11286352|FG001|Overall Study|Randomized but Not Dosed|0
7135207|NCT02886728|11286353|FG002|Overall Study|Randomized but Not Dosed|0
7135208|NCT02886728|11286354|FG003|Overall Study|Randomized but Not Dosed|2
7135209|NCT02887183|11286371|FG000|Overall Study|Adverse Event|44
7135210|NCT02887183|11286371|FG000|Overall Study|Death|30
7135211|NCT02887183|11286371|FG000|Overall Study|Pregnancy|1
7135212|NCT02887183|11286371|FG000|Overall Study|Protocol Violation|6
7135213|NCT02887183|11286371|FG000|Overall Study|Technical Problems|2
7135214|NCT02887183|11286371|FG000|Overall Study|Lost to Follow-up|13
7135215|NCT02887183|11286371|FG000|Overall Study|Physician Decision|10
7135216|NCT02887183|11286371|FG000|Overall Study|Withdrawal by Subject|35
7135217|NCT02887521|11286387|FG000|Overall Study|Withdrawal by Subject|0
7135218|NCT02887521|11286388|FG001|Overall Study|Withdrawal by Subject|3
7135219|NCT02887989|11286396|FG000|Overall Study|Withdrawal by Subject|8
7135220|NCT02887989|11286397|FG001|Overall Study|Withdrawal by Subject|11
7135221|NCT02887989|11286396|FG000|Overall Study|Death|1
7135222|NCT02887989|11286397|FG001|Overall Study|Death|0
7135223|NCT02888080|11286405|FG000|Overall Study|Subject / Guardian decision|1
7135224|NCT02888080|11286406|FG001|Overall Study|Subject / Guardian decision|3
7135225|NCT02888080|11286405|FG000|Overall Study|New Therapy for study indication|1
7135226|NCT02888080|11286406|FG001|Overall Study|New Therapy for study indication|0
7135227|NCT02888080|11286405|FG000|Overall Study|Lack of Efficacy|0
7135228|NCT02888080|11286406|FG001|Overall Study|Lack of Efficacy|1
7135229|NCT02888080|11286405|FG000|Overall Study|Adverse Event|0
7135230|NCT02888080|11286406|FG001|Overall Study|Adverse Event|1
7135231|NCT02888106|11286429|FG000|Overall Study|Withdrawal by Subject|1
7135232|NCT02888106|11286430|FG001|Overall Study|Withdrawal by Subject|2
6806494|NCT00117338|10809017|FG000|Overall Study|Withdrawal by Subject|1
7135233|NCT02888106|11286431|FG002|Overall Study|Withdrawal by Subject|0
7135234|NCT02888106|11286432|FG003|Overall Study|Withdrawal by Subject|1
7135235|NCT02888106|11286433|FG004|Overall Study|Withdrawal by Subject|0
7135236|NCT02888106|11286434|FG005|Overall Study|Withdrawal by Subject|0
7135237|NCT02888106|11286429|FG000|Overall Study|Lost to Follow-up|1
7135238|NCT02888106|11286430|FG001|Overall Study|Lost to Follow-up|0
7135239|NCT02888106|11286431|FG002|Overall Study|Lost to Follow-up|0
7135240|NCT02888106|11286432|FG003|Overall Study|Lost to Follow-up|1
7135241|NCT02888106|11286433|FG004|Overall Study|Lost to Follow-up|0
7135242|NCT02888106|11286434|FG005|Overall Study|Lost to Follow-up|1
7135243|NCT02888106|11286429|FG000|Overall Study|Adverse Event|2
7135244|NCT02888106|11286430|FG001|Overall Study|Adverse Event|0
7135245|NCT02888106|11286431|FG002|Overall Study|Adverse Event|0
7135246|NCT02888106|11286432|FG003|Overall Study|Adverse Event|0
7135247|NCT02888106|11286433|FG004|Overall Study|Adverse Event|0
7135248|NCT02888106|11286434|FG005|Overall Study|Adverse Event|0
7135249|NCT02888106|11286429|FG000|Overall Study|Withdrawal of consent|0
7135250|NCT02888106|11286430|FG001|Overall Study|Withdrawal of consent|0
7135251|NCT02888106|11286431|FG002|Overall Study|Withdrawal of consent|0
7135252|NCT02888106|11286432|FG003|Overall Study|Withdrawal of consent|0
7135253|NCT02888106|11286433|FG004|Overall Study|Withdrawal of consent|1
7135254|NCT02888106|11286434|FG005|Overall Study|Withdrawal of consent|0
7135255|NCT02888106|11286429|FG000|Overall Study|Pregnancy|1
7135256|NCT02888106|11286430|FG001|Overall Study|Pregnancy|0
7135257|NCT02888106|11286431|FG002|Overall Study|Pregnancy|0
7135258|NCT02888106|11286432|FG003|Overall Study|Pregnancy|0
7135259|NCT02888106|11286433|FG004|Overall Study|Pregnancy|0
7135260|NCT02888106|11286434|FG005|Overall Study|Pregnancy|0
7135261|NCT02888171|11286456|FG000|Overall Study|Lost to Follow-up|2
7135262|NCT02888171|11286457|FG001|Overall Study|Lost to Follow-up|1
7135263|NCT02888171|11286456|FG000|Overall Study|Withdrawal by Subject|3
7135264|NCT02888171|11286457|FG001|Overall Study|Withdrawal by Subject|2
7135265|NCT02888171|11286456|FG000|Overall Study|Adverse Event|0
7135266|NCT02888171|11286457|FG001|Overall Study|Adverse Event|1
6780857|NCT03633396|10776793|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0
6780858|NCT03633396|10776794|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1
6780859|NCT03612856|10776803|FG000|Pre-dose Period|Physician Decision|0
6780860|NCT03612856|10776804|FG001|Pre-dose Period|Physician Decision|1
6780861|NCT03612856|10776805|FG002|Pre-dose Period|Physician Decision|1
6780862|NCT03612856|10776803|FG000|Pre-dose Period|Withdrawal by Subject|0
6780863|NCT03612856|10776804|FG001|Pre-dose Period|Withdrawal by Subject|1
6780864|NCT03612856|10776805|FG002|Pre-dose Period|Withdrawal by Subject|0
6780865|NCT03607994|10776815|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1
6780866|NCT03607994|10776816|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1
6780867|NCT03589469|10776835|FG000|Overall Study|Ongoing in study|58
6780868|NCT03589469|10776835|FG000|Overall Study|Withdrawal by Subject|6
6780869|NCT03589469|10776835|FG000|Overall Study|Physician Decision|1
7135267|NCT02888756|11286487|FG000|Analytical Treatment Interruption|Physician Decision|10
7135268|NCT02888756|11286488|FG001|Analytical Treatment Interruption|Physician Decision|6
7135269|NCT02888756|11286489|FG002|Analytical Treatment Interruption|Physician Decision|5
7135270|NCT02889562|11286520|FG000|Overall Study|Physician Decision|0
7135271|NCT02889562|11286521|FG001|Overall Study|Physician Decision|1
7135272|NCT02889562|11286520|FG000|Overall Study|Withdrawal by Subject|0
7135273|NCT02889562|11286521|FG001|Overall Study|Withdrawal by Subject|1
7135274|NCT02889796|11286531|FG000|Overall Study|Withdrew Consent|18
7135275|NCT02889796|11286532|FG001|Overall Study|Withdrew Consent|29
7135276|NCT02889796|11286533|FG002|Overall Study|Withdrew Consent|20
7135277|NCT02889796|11286534|FG003|Overall Study|Withdrew Consent|1
7135278|NCT02889796|11286535|FG004|Overall Study|Withdrew Consent|2
7135279|NCT02889796|11286536|FG005|Overall Study|Withdrew Consent|35
6780870|NCT03589469|10776835|FG000|Overall Study|Death|77
6780871|NCT03589469|10776835|FG000|Overall Study|Lost to Follow-up|3
6806495|NCT00117338|10809018|FG001|Overall Study|Withdrawal by Subject|0
6806496|NCT00117338|10809017|FG000|Overall Study|Did not meet Inclusion Criteria|1
6806497|NCT00117338|10809018|FG001|Overall Study|Did not meet Inclusion Criteria|0
7135280|NCT02889796|11286531|FG000|Overall Study|Investigator's Discretion|10
7135281|NCT02889796|11286532|FG001|Overall Study|Investigator's Discretion|9
7135282|NCT02889796|11286533|FG002|Overall Study|Investigator's Discretion|10
7135283|NCT02889796|11286534|FG003|Overall Study|Investigator's Discretion|3
7135284|NCT02889796|11286535|FG004|Overall Study|Investigator's Discretion|0
7135285|NCT02889796|11286536|FG005|Overall Study|Investigator's Discretion|15
6806498|NCT00117338|10809017|FG000|Overall Study|Lack of Efficacy|0
6806499|NCT00117338|10809018|FG001|Overall Study|Lack of Efficacy|1
6810402|NCT03882047|10814144|FG000|Overall Study|Noncompliance With Protocol|2
7135286|NCT02889796|11286531|FG000|Overall Study|Adverse Event|17
7135287|NCT02889796|11286532|FG001|Overall Study|Adverse Event|8
7135288|NCT02889796|11286533|FG002|Overall Study|Adverse Event|8
7135289|NCT02889796|11286534|FG003|Overall Study|Adverse Event|4
7135290|NCT02889796|11286535|FG004|Overall Study|Adverse Event|1
7135291|NCT02889796|11286536|FG005|Overall Study|Adverse Event|7
7135292|NCT02889796|11286531|FG000|Overall Study|Lost to Follow-up|5
7135293|NCT02889796|11286532|FG001|Overall Study|Lost to Follow-up|7
7135294|NCT02889796|11286533|FG002|Overall Study|Lost to Follow-up|2
7135295|NCT02889796|11286534|FG003|Overall Study|Lost to Follow-up|0
7135296|NCT02889796|11286535|FG004|Overall Study|Lost to Follow-up|2
7135297|NCT02889796|11286536|FG005|Overall Study|Lost to Follow-up|6
7135298|NCT02889796|11286531|FG000|Overall Study|Protocol Violation|0
7135299|NCT02889796|11286532|FG001|Overall Study|Protocol Violation|1
7135300|NCT02889796|11286533|FG002|Overall Study|Protocol Violation|3
7135301|NCT02889796|11286534|FG003|Overall Study|Protocol Violation|0
6780872|NCT03563716|10776841|FG000|Overall Study|Death|20
6780873|NCT03563716|10776842|FG001|Overall Study|Death|14
6780874|NCT03563716|10776841|FG000|Overall Study|Withdrawal by Subject|3
6780875|NCT03563716|10776842|FG001|Overall Study|Withdrawal by Subject|3
6780876|NCT03563716|10776841|FG000|Overall Study|Still on Study|45
6780877|NCT03563716|10776842|FG001|Overall Study|Still on Study|50
6780878|NCT03505671|10776850|FG000|Overall Study|Withdrawal by Subject|2
6780879|NCT03505671|10776851|FG001|Overall Study|Withdrawal by Subject|1
6780880|NCT03505671|10776850|FG000|Overall Study|Lost to Follow-up|1
6780881|NCT03505671|10776851|FG001|Overall Study|Lost to Follow-up|0
6780882|NCT03469999|10776857|FG000|Overall Study|Lost to Follow-up|2
6780883|NCT03463993|10776864|FG000|Overall Study|Lost to Follow-up|7
6780884|NCT03463993|10776865|FG001|Overall Study|Lost to Follow-up|8
6780885|NCT03463993|10776864|FG000|Overall Study|Withdrawal by Subject|2
6780886|NCT03463993|10776865|FG001|Overall Study|Withdrawal by Subject|0
6780887|NCT03463993|10776864|FG000|Overall Study|Protocol Violation|4
6780888|NCT03463993|10776865|FG001|Overall Study|Protocol Violation|1
6780889|NCT03463993|10776864|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9
6780890|NCT03463993|10776865|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11
6780891|NCT03463993|10776864|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7
6780892|NCT03463993|10776865|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6
6780893|NCT03390101|10776874|FG000|Weeks 0-12|Withdrawal by Subject|0
6780894|NCT03390101|10776875|FG001|Weeks 0-12|Withdrawal by Subject|1
6780895|NCT03390101|10776876|FG002|Weeks 0-12|Withdrawal by Subject|1
6780896|NCT03390101|10776874|FG000|Weeks 0-12|Lost to Follow-up|0
6780897|NCT03390101|10776875|FG001|Weeks 0-12|Lost to Follow-up|1
6780898|NCT03390101|10776876|FG002|Weeks 0-12|Lost to Follow-up|0
6780899|NCT03390101|10776874|FG000|Weeks 12-54|Withdrawal by Subject|0
6780900|NCT03390101|10776875|FG001|Weeks 12-54|Withdrawal by Subject|3
6780901|NCT03390101|10776876|FG002|Weeks 12-54|Withdrawal by Subject|1
6780902|NCT03390101|10776874|FG000|Weeks 12-54|Pregnancy|1
6780903|NCT03390101|10776875|FG001|Weeks 12-54|Pregnancy|0
6780904|NCT03390101|10776876|FG002|Weeks 12-54|Pregnancy|0
6780905|NCT03390101|10776874|FG000|Weeks 12-54|Adverse Event|2
6780906|NCT03390101|10776875|FG001|Weeks 12-54|Adverse Event|1
6780907|NCT03390101|10776876|FG002|Weeks 12-54|Adverse Event|1
7135302|NCT02889796|11286535|FG004|Overall Study|Protocol Violation|0
7135303|NCT02889796|11286536|FG005|Overall Study|Protocol Violation|4
7135304|NCT02889796|11286531|FG000|Overall Study|Non-compliance With Study Drug|0
7135305|NCT02889796|11286532|FG001|Overall Study|Non-compliance With Study Drug|2
7135306|NCT02889796|11286533|FG002|Overall Study|Non-compliance With Study Drug|0
7135307|NCT02889796|11286534|FG003|Overall Study|Non-compliance With Study Drug|0
7135308|NCT02889796|11286535|FG004|Overall Study|Non-compliance With Study Drug|1
7135309|NCT02889796|11286536|FG005|Overall Study|Non-compliance With Study Drug|2
7135310|NCT02889796|11286531|FG000|Overall Study|Death|1
7135311|NCT02889796|11286532|FG001|Overall Study|Death|1
7135312|NCT02889796|11286533|FG002|Overall Study|Death|0
7135313|NCT02889796|11286534|FG003|Overall Study|Death|1
7135314|NCT02889796|11286535|FG004|Overall Study|Death|0
7135315|NCT02889796|11286536|FG005|Overall Study|Death|1
7135316|NCT02889796|11286531|FG000|Overall Study|Pregnancy|0
7135317|NCT02889796|11286532|FG001|Overall Study|Pregnancy|1
7135318|NCT02889796|11286533|FG002|Overall Study|Pregnancy|1
7135319|NCT02889796|11286534|FG003|Overall Study|Pregnancy|0
7135320|NCT02889796|11286535|FG004|Overall Study|Pregnancy|0
7135321|NCT02889796|11286536|FG005|Overall Study|Pregnancy|0
7135322|NCT02889796|11286531|FG000|Overall Study|Randomized but not Dosed|2
7135323|NCT02889796|11286532|FG001|Overall Study|Randomized but not Dosed|0
7135324|NCT02889796|11286533|FG002|Overall Study|Randomized but not Dosed|0
7135325|NCT02889796|11286534|FG003|Overall Study|Randomized but not Dosed|0
7135326|NCT02889796|11286535|FG004|Overall Study|Randomized but not Dosed|0
7135327|NCT02889796|11286536|FG005|Overall Study|Randomized but not Dosed|2
7135328|NCT02889861|11286559|FG000|Overall Study|Ongoing in Survival Follow-up|2
7135329|NCT02890992|11286589|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0
7135330|NCT02890992|11286590|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1
7135331|NCT02890992|11286591|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0
7135332|NCT02890992|11286592|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0
7135333|NCT02890992|11286593|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0
7135334|NCT02890992|11286594|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0
7135335|NCT02890992|11286595|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0
7135336|NCT02890992|11286596|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0
7135337|NCT02890992|11286589|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0
7135338|NCT02890992|11286590|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0
7135339|NCT02890992|11286591|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0
7135340|NCT02890992|11286592|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0
7135341|NCT02890992|11286593|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0
7135342|NCT02890992|11286594|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0
7135343|NCT02890992|11286595|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1
7135344|NCT02890992|11286596|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1
7135345|NCT02890992|11286589|FG000|130 Weeks Open-Label Extension Period|Other than specified|0
7135346|NCT02890992|11286590|FG001|130 Weeks Open-Label Extension Period|Other than specified|2
7135347|NCT02890992|11286591|FG002|130 Weeks Open-Label Extension Period|Other than specified|0
7135348|NCT02890992|11286592|FG003|130 Weeks Open-Label Extension Period|Other than specified|0
7135349|NCT02890992|11286593|FG004|130 Weeks Open-Label Extension Period|Other than specified|0
7135350|NCT02890992|11286594|FG005|130 Weeks Open-Label Extension Period|Other than specified|0
7135351|NCT02890992|11286595|FG006|130 Weeks Open-Label Extension Period|Other than specified|0
7135352|NCT02890992|11286596|FG007|130 Weeks Open-Label Extension Period|Other than specified|0
7135353|NCT02891070|11286623|FG000|Overall Study|Adverse Event|1
7135354|NCT02891070|11286624|FG001|Overall Study|Adverse Event|0
7135355|NCT02891070|11286623|FG000|Overall Study|Physician Decision|0
7135356|NCT02891070|11286624|FG001|Overall Study|Physician Decision|1
7135357|NCT02891070|11286623|FG000|Overall Study|Lost to Follow-up|4
7135358|NCT02891070|11286624|FG001|Overall Study|Lost to Follow-up|4
7135359|NCT02891070|11286623|FG000|Overall Study|Other|1
7135360|NCT02891070|11286624|FG001|Overall Study|Other|0
7135361|NCT02891070|11286623|FG000|Overall Study|Protocol Violation|0
7135362|NCT02891070|11286624|FG001|Overall Study|Protocol Violation|1
7135363|NCT02891070|11286623|FG000|Overall Study|Withdrawal by Subject|1
7135364|NCT02891070|11286624|FG001|Overall Study|Withdrawal by Subject|2
7135365|NCT02891070|11286623|FG000|Overall Study|Death|3
6780916|NCT03213158|10776893|FG000|Overall Study|Withdrawal by Subject|1
6780917|NCT03213158|10776893|FG000|Overall Study|Physician Decision|2
6780918|NCT03194646|10776901|FG000|Overall Study|Adverse Event|24
6780919|NCT03194646|10776902|FG001|Overall Study|Adverse Event|25
6780920|NCT03194646|10776903|FG002|Overall Study|Adverse Event|14
6780921|NCT03194646|10776904|FG003|Overall Study|Adverse Event|17
6780922|NCT03194646|10776901|FG000|Overall Study|Lack of Efficacy|4
6780923|NCT03194646|10776902|FG001|Overall Study|Lack of Efficacy|2
6780924|NCT03194646|10776903|FG002|Overall Study|Lack of Efficacy|2
6780925|NCT03194646|10776904|FG003|Overall Study|Lack of Efficacy|12
6780926|NCT03194646|10776901|FG000|Overall Study|Lost to Follow-up|30
6780927|NCT03194646|10776902|FG001|Overall Study|Lost to Follow-up|22
6780928|NCT03194646|10776903|FG002|Overall Study|Lost to Follow-up|12
6780929|NCT03194646|10776904|FG003|Overall Study|Lost to Follow-up|35
6780930|NCT03194646|10776901|FG000|Overall Study|Non-compliance with study drug|4
6780931|NCT03194646|10776902|FG001|Overall Study|Non-compliance with study drug|0
7135366|NCT02891070|11286624|FG001|Overall Study|Death|0
7135367|NCT02891174|11286632|FG000|First Intervention (24 Hours)|Declined any study medication|1
6780932|NCT03194646|10776903|FG002|Overall Study|Non-compliance with study drug|1
6780933|NCT03194646|10776904|FG003|Overall Study|Non-compliance with study drug|1
7135368|NCT02891174|11286633|FG001|First Intervention (24 Hours)|Declined any study medication|5
7135369|NCT02891174|11286632|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0
7135370|NCT02891174|11286633|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2
7135371|NCT02891174|11286632|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2
7135372|NCT02891174|11286633|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6
7135373|NCT02891174|11286632|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1
7135374|NCT02891174|11286633|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0
7135375|NCT02891174|11286632|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3
7135376|NCT02891174|11286633|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5
7135377|NCT02891174|11286632|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2
7135378|NCT02891174|11286633|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1
7135379|NCT02891174|11286632|FG000|Second Intervention (24 Hours)|Protocol Violation|0
7135380|NCT02891174|11286633|FG001|Second Intervention (24 Hours)|Protocol Violation|1
7135381|NCT02891200|11286645|FG000|Overall Study|Lost to Follow-up|31
7135382|NCT02891200|11286646|FG001|Overall Study|Lost to Follow-up|36
7135383|NCT02891200|11286645|FG000|Overall Study|Death|10
7135384|NCT02891200|11286646|FG001|Overall Study|Death|9
7135385|NCT02891200|11286645|FG000|Overall Study|Withdrawal by Subject|1
7135386|NCT02891200|11286646|FG001|Overall Study|Withdrawal by Subject|4
7135387|NCT02891408|11286659|FG000|Overall Study|Lost to Follow-up|0
7135388|NCT02891408|11286660|FG001|Overall Study|Lost to Follow-up|0
7135389|NCT02891408|11286661|FG002|Overall Study|Lost to Follow-up|1
7135390|NCT02891408|11286662|FG003|Overall Study|Lost to Follow-up|0
7135391|NCT02891408|11286663|FG004|Overall Study|Lost to Follow-up|0
7135392|NCT02891408|11286664|FG005|Overall Study|Lost to Follow-up|0
7135393|NCT02891408|11286665|FG006|Overall Study|Lost to Follow-up|0
7135394|NCT02891681|11286703|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0
6780934|NCT03194646|10776901|FG000|Overall Study|Other|87
6780935|NCT03194646|10776902|FG001|Overall Study|Other|67
6780936|NCT03194646|10776903|FG002|Overall Study|Other|34
6780937|NCT03194646|10776904|FG003|Overall Study|Other|31
6780938|NCT03194646|10776901|FG000|Overall Study|Physician Decision|7
6780939|NCT03194646|10776902|FG001|Overall Study|Physician Decision|9
6780940|NCT03194646|10776903|FG002|Overall Study|Physician Decision|5
6780941|NCT03194646|10776904|FG003|Overall Study|Physician Decision|4
6780942|NCT03194646|10776901|FG000|Overall Study|Pregnancy|4
6780943|NCT03194646|10776902|FG001|Overall Study|Pregnancy|5
6780944|NCT03194646|10776903|FG002|Overall Study|Pregnancy|1
6780945|NCT03194646|10776904|FG003|Overall Study|Pregnancy|2
6780946|NCT03194646|10776901|FG000|Overall Study|Protocol Violation|4
6780947|NCT03194646|10776902|FG001|Overall Study|Protocol Violation|2
6780948|NCT03194646|10776903|FG002|Overall Study|Protocol Violation|1
6780949|NCT03194646|10776904|FG003|Overall Study|Protocol Violation|1
6780950|NCT03194646|10776901|FG000|Overall Study|Site terminated by sponsor|0
6780951|NCT03194646|10776902|FG001|Overall Study|Site terminated by sponsor|0
6780952|NCT03194646|10776903|FG002|Overall Study|Site terminated by sponsor|2
6780953|NCT03194646|10776904|FG003|Overall Study|Site terminated by sponsor|0
6780954|NCT03194646|10776901|FG000|Overall Study|Study terminated by sponsor|60
6780955|NCT03194646|10776902|FG001|Overall Study|Study terminated by sponsor|61
6780956|NCT03194646|10776903|FG002|Overall Study|Study terminated by sponsor|30
6780957|NCT03194646|10776904|FG003|Overall Study|Study terminated by sponsor|34
6780958|NCT03194646|10776901|FG000|Overall Study|Withdrawal by Subject|74
6780959|NCT03194646|10776902|FG001|Overall Study|Withdrawal by Subject|75
6780960|NCT03194646|10776903|FG002|Overall Study|Withdrawal by Subject|36
7135395|NCT02891681|11286704|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0
7135396|NCT02891681|11286705|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1
7135397|NCT02891681|11286703|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2
7135398|NCT02891681|11286704|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0
7135399|NCT02891681|11286705|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0
7135400|NCT02891681|11286703|FG000|Overall Study|Taken off study after first imaging appointment|1
6780961|NCT03194646|10776904|FG003|Overall Study|Withdrawal by Subject|131
6780962|NCT03194646|10776901|FG000|Overall Study|Missing|4
6780963|NCT03194646|10776902|FG001|Overall Study|Missing|0
6780964|NCT03194646|10776903|FG002|Overall Study|Missing|1
6780965|NCT03194646|10776904|FG003|Overall Study|Missing|12
6780966|NCT03179605|10776919|FG000|Overall Study|Withdrawal by Subject|1
6806500|NCT04851314|10809026|FG000|Overall Study|Unable to complete research set-up procedures|0
6806501|NCT04851314|10809027|FG001|Overall Study|Unable to complete research set-up procedures|2
6806502|NCT04851314|10809026|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3
6806503|NCT04851314|10809027|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2
6806504|NCT04823494|10809054|FG000|Overall Study|Programming software malfunction.|1
6806505|NCT04823494|10809055|FG001|Overall Study|Programming software malfunction.|0
6806506|NCT04823494|10809054|FG000|Overall Study|Withdrawal by Subject|1
6806507|NCT04823494|10809055|FG001|Overall Study|Withdrawal by Subject|0
6806508|NCT04823494|10809054|FG000|Overall Study|Devices lost|0
6806509|NCT04823494|10809055|FG001|Overall Study|Devices lost|1
6810403|NCT03882047|10814145|FG001|Overall Study|Noncompliance With Protocol|0
6810404|NCT03882047|10814146|FG002|Overall Study|Noncompliance With Protocol|0
6810405|NCT03882047|10814144|FG000|Overall Study|Did Not Meet Eligibility|0
6810406|NCT03882047|10814145|FG001|Overall Study|Did Not Meet Eligibility|0
6810407|NCT03882047|10814146|FG002|Overall Study|Did Not Meet Eligibility|1
6810408|NCT03879772|10814159|FG000|Overall Study|Adverse Event|2
6810409|NCT03879772|10814160|FG001|Overall Study|Adverse Event|2
6810410|NCT03879772|10814161|FG002|Overall Study|Adverse Event|3
6810411|NCT03879772|10814162|FG003|Overall Study|Adverse Event|4
6810412|NCT03879772|10814163|FG004|Overall Study|Adverse Event|3
6810413|NCT03879772|10814159|FG000|Overall Study|Treatment Failure|1
6810414|NCT03879772|10814160|FG001|Overall Study|Treatment Failure|0
6810415|NCT03879772|10814161|FG002|Overall Study|Treatment Failure|0
6810416|NCT03879772|10814162|FG003|Overall Study|Treatment Failure|2
6810417|NCT03879772|10814163|FG004|Overall Study|Treatment Failure|1
6810418|NCT03879772|10814159|FG000|Overall Study|Lost to Follow-up|0
6810419|NCT03879772|10814160|FG001|Overall Study|Lost to Follow-up|0
6810420|NCT03879772|10814161|FG002|Overall Study|Lost to Follow-up|0
6810421|NCT03879772|10814162|FG003|Overall Study|Lost to Follow-up|0
6810422|NCT03879772|10814163|FG004|Overall Study|Lost to Follow-up|1
6810423|NCT03879772|10814159|FG000|Overall Study|Withdrawal by Subject|0
6810424|NCT03879772|10814160|FG001|Overall Study|Withdrawal by Subject|1
6810425|NCT03879772|10814161|FG002|Overall Study|Withdrawal by Subject|3
6810426|NCT03879772|10814162|FG003|Overall Study|Withdrawal by Subject|1
6810427|NCT03879772|10814163|FG004|Overall Study|Withdrawal by Subject|1
6810428|NCT03879772|10814159|FG000|Overall Study|Protocol Violation|0
6810429|NCT03879772|10814160|FG001|Overall Study|Protocol Violation|0
6810430|NCT03879772|10814161|FG002|Overall Study|Protocol Violation|3
6810431|NCT03879772|10814162|FG003|Overall Study|Protocol Violation|1
6810432|NCT03879772|10814163|FG004|Overall Study|Protocol Violation|2
6810433|NCT03879772|10814159|FG000|Overall Study|Did Not Meet Entry Requirements|1
6810434|NCT03879772|10814160|FG001|Overall Study|Did Not Meet Entry Requirements|0
7135401|NCT02891681|11286704|FG001|Overall Study|Taken off study after first imaging appointment|0
7135402|NCT02891681|11286705|FG002|Overall Study|Taken off study after first imaging appointment|0
7135403|NCT02891850|11286715|FG000|Overall Study|Adverse Event|3
7135404|NCT02891850|11286716|FG001|Overall Study|Adverse Event|0
7135405|NCT02891850|11286715|FG000|Overall Study|Death|0
7135406|NCT02891850|11286716|FG001|Overall Study|Death|4
7135407|NCT02891850|11286715|FG000|Overall Study|Physician Decision|1
7135408|NCT02891850|11286716|FG001|Overall Study|Physician Decision|0
7135409|NCT02891850|11286715|FG000|Overall Study|Pregnancy|1
7135410|NCT02891850|11286716|FG001|Overall Study|Pregnancy|0
7135411|NCT02891850|11286715|FG000|Overall Study|Withdrawal by Subject|2
7135412|NCT02891850|11286716|FG001|Overall Study|Withdrawal by Subject|3
7135413|NCT02891915|11286728|FG000|Overall Study|Enrolled but Treatment Not Administered|6
7135414|NCT02891915|11286729|FG001|Overall Study|Enrolled but Treatment Not Administered|4
7135415|NCT02891915|11286728|FG000|Overall Study|Withdrawal by Subject|3
7135416|NCT02891915|11286729|FG001|Overall Study|Withdrawal by Subject|3
7135417|NCT02891915|11286728|FG000|Overall Study|Became Ineligible After Enrollment|2
7135418|NCT02891915|11286729|FG001|Overall Study|Became Ineligible After Enrollment|1
7135419|NCT02891915|11286728|FG000|Overall Study|Lost to Follow-up|1
7135420|NCT02891915|11286729|FG001|Overall Study|Lost to Follow-up|4
7135421|NCT02891915|11286728|FG000|Overall Study|Physician Decision|1
7135422|NCT02891915|11286729|FG001|Overall Study|Physician Decision|0
7135423|NCT02892019|11286737|FG000|Overall Study|randomized but not treated|0
7135424|NCT02892019|11286738|FG001|Overall Study|randomized but not treated|1
7135425|NCT02892019|11286737|FG000|Overall Study|Withdrawal by Subject|0
7135426|NCT02892019|11286738|FG001|Overall Study|Withdrawal by Subject|1
7135427|NCT02892019|11286737|FG000|Overall Study|Adverse Event|1
7135428|NCT02892019|11286738|FG001|Overall Study|Adverse Event|1
7135429|NCT02892344|11286755|FG000|Overall Study|Protocol deviation|3
7135430|NCT02892344|11286756|FG001|Overall Study|Protocol deviation|4
7135431|NCT02892344|11286755|FG000|Overall Study|Adverse Event|1
7135432|NCT02892344|11286756|FG001|Overall Study|Adverse Event|8
7135433|NCT02892344|11286755|FG000|Overall Study|Lost to Follow-up|0
7135434|NCT02892344|11286756|FG001|Overall Study|Lost to Follow-up|1
7135435|NCT02892344|11286755|FG000|Overall Study|Non-compliance with study treatment|0
7135436|NCT02892344|11286756|FG001|Overall Study|Non-compliance with study treatment|1
7135437|NCT02892344|11286755|FG000|Overall Study|Physician Decision|0
7135438|NCT02892344|11286756|FG001|Overall Study|Physician Decision|2
7135439|NCT02892344|11286755|FG000|Overall Study|Subject/guardian decision|0
6780967|NCT03150862|10776940|FG000|Overall Study|Death|2
6780968|NCT03150862|10776941|FG001|Overall Study|Death|7
6780969|NCT03150862|10776942|FG002|Overall Study|Death|8
6780970|NCT03150862|10776943|FG003|Overall Study|Death|27
6780971|NCT03150862|10776944|FG004|Overall Study|Death|4
6780972|NCT03150862|10776945|FG005|Overall Study|Death|8
7135440|NCT02892344|11286756|FG001|Overall Study|Subject/guardian decision|4
7135441|NCT02892344|11286755|FG000|Overall Study|Technical problems|0
7135442|NCT02892344|11286756|FG001|Overall Study|Technical problems|1
7135443|NCT02892409|11286764|FG000|Overall Study|Adverse Event|1
7135444|NCT02892409|11286765|FG001|Overall Study|Adverse Event|0
7135445|NCT02892409|11286764|FG000|Overall Study|Withdrawal by Subject|2
7135446|NCT02892409|11286765|FG001|Overall Study|Withdrawal by Subject|1
7135447|NCT02892422|11286771|FG000|Overall Study|Enrolled not treated|4
7135448|NCT02892422|11286771|FG000|Overall Study|Adverse Event|38
7135449|NCT02892422|11286771|FG000|Overall Study|Lack of Efficacy|32
6780973|NCT03150862|10776946|FG006|Overall Study|Death|6
7135450|NCT02892422|11286771|FG000|Overall Study|Non-compliance with study drug|11
7135451|NCT02892422|11286771|FG000|Overall Study|Protocol Violation|4
7135452|NCT02892422|11286771|FG000|Overall Study|Withdrawal by Subject|56
6780974|NCT03150862|10776947|FG007|Overall Study|Death|21
7135453|NCT02892422|11286771|FG000|Overall Study|Lost to Follow-up|5
7135454|NCT02892422|11286771|FG000|Overall Study|sponsor information 16159A results|21
7135455|NCT02892422|11286771|FG000|Overall Study|withdrawal of consent|13
7135456|NCT02892422|11286771|FG000|Overall Study|exclusion criteria met|3
7135457|NCT02892422|11286771|FG000|Overall Study|moving elsewhere|4
7135458|NCT02892422|11286771|FG000|Overall Study|non-compliance|10
7135459|NCT02892422|11286771|FG000|Overall Study|patient legally incapable|1
7135460|NCT02892422|11286771|FG000|Overall Study|patient decision|7
7135461|NCT02892422|11286771|FG000|Overall Study|Investigator decision|1
7135462|NCT02892448|11286778|FG000|Overall Study|Screening failure|2
7135463|NCT02892448|11286779|FG001|Overall Study|Screening failure|2
7135464|NCT02892448|11286780|FG002|Overall Study|Screening failure|1
7135465|NCT02892513|11286790|FG000|Overall Study|Withdrawal by Subject|0
7135466|NCT02892513|11286791|FG001|Overall Study|Withdrawal by Subject|1
7135467|NCT02892734|11286797|FG000|Treatment on Study|Progressive Disease|2
7135468|NCT02892734|11286797|FG000|Follow up for 2 Years|Death|2
6780975|NCT03150862|10776940|FG000|Overall Study|Withdrawal by Subject|1
6780976|NCT03150862|10776941|FG001|Overall Study|Withdrawal by Subject|1
6780977|NCT03150862|10776942|FG002|Overall Study|Withdrawal by Subject|0
6780978|NCT03150862|10776943|FG003|Overall Study|Withdrawal by Subject|3
6780979|NCT03150862|10776944|FG004|Overall Study|Withdrawal by Subject|1
6780980|NCT03150862|10776945|FG005|Overall Study|Withdrawal by Subject|1
6780981|NCT03150862|10776946|FG006|Overall Study|Withdrawal by Subject|1
6780982|NCT03150862|10776947|FG007|Overall Study|Withdrawal by Subject|3
6780983|NCT03150862|10776940|FG000|Overall Study|Lost to Follow-up|0
6780984|NCT03150862|10776941|FG001|Overall Study|Lost to Follow-up|0
6780985|NCT03150862|10776942|FG002|Overall Study|Lost to Follow-up|1
6780986|NCT03150862|10776943|FG003|Overall Study|Lost to Follow-up|0
6780987|NCT03150862|10776944|FG004|Overall Study|Lost to Follow-up|0
6780988|NCT03150862|10776945|FG005|Overall Study|Lost to Follow-up|0
6780989|NCT03150862|10776946|FG006|Overall Study|Lost to Follow-up|0
6780990|NCT03150862|10776947|FG007|Overall Study|Lost to Follow-up|2
6780991|NCT03150862|10776940|FG000|Overall Study|Sponsor's decision|0
6780992|NCT03150862|10776941|FG001|Overall Study|Sponsor's decision|0
6780993|NCT03150862|10776942|FG002|Overall Study|Sponsor's decision|0
6780994|NCT03150862|10776943|FG003|Overall Study|Sponsor's decision|10
6780995|NCT03150862|10776944|FG004|Overall Study|Sponsor's decision|3
6780996|NCT03150862|10776945|FG005|Overall Study|Sponsor's decision|0
6780997|NCT03150862|10776946|FG006|Overall Study|Sponsor's decision|1
6780998|NCT03150862|10776947|FG007|Overall Study|Sponsor's decision|1
6780999|NCT03150862|10776940|FG000|Overall Study|Change in Methylation status|0
6781000|NCT03150862|10776941|FG001|Overall Study|Change in Methylation status|0
6781001|NCT03150862|10776942|FG002|Overall Study|Change in Methylation status|0
6781002|NCT03150862|10776943|FG003|Overall Study|Change in Methylation status|0
7135469|NCT02892734|11286797|FG000|Follow up for 2 Years|Study closed early|1
7135470|NCT02892760|11286801|FG000|Overall Study|Withdrawal by Subject|3
7135471|NCT02894502|11286824|FG000|Baseline|Withdrawal by Subject|24
7135472|NCT02894502|11286825|FG001|Baseline|Withdrawal by Subject|31
7135473|NCT02894502|11286826|FG002|Baseline|Withdrawal by Subject|36
7135474|NCT02894502|11286824|FG000|Baseline|Death|3
7135475|NCT02894502|11286825|FG001|Baseline|Death|1
7135476|NCT02894502|11286826|FG002|Baseline|Death|9
7135477|NCT02894502|11286824|FG000|First Follow up|Withdrawal by Subject|32
7135478|NCT02894502|11286825|FG001|First Follow up|Withdrawal by Subject|29
7135479|NCT02894502|11286826|FG002|First Follow up|Withdrawal by Subject|37
7135480|NCT02894502|11286824|FG000|First Follow up|Death|2
7135481|NCT02894502|11286825|FG001|First Follow up|Death|2
7135482|NCT02894502|11286826|FG002|First Follow up|Death|3
7135483|NCT02894502|11286824|FG000|Second Follow up|Withdrawal by Subject|13
7135484|NCT02894502|11286825|FG001|Second Follow up|Withdrawal by Subject|15
7135485|NCT02894502|11286826|FG002|Second Follow up|Withdrawal by Subject|13
7135486|NCT02894502|11286824|FG000|Second Follow up|Death|2
6781003|NCT03150862|10776944|FG004|Overall Study|Change in Methylation status|1
6781004|NCT03150862|10776945|FG005|Overall Study|Change in Methylation status|0
6781005|NCT03150862|10776946|FG006|Overall Study|Change in Methylation status|0
6781006|NCT03150862|10776947|FG007|Overall Study|Change in Methylation status|0
6781007|NCT03150862|10776940|FG000|Overall Study|Roll over in to Long Term Extension|0
7135487|NCT02894502|11286825|FG001|Second Follow up|Death|3
7135488|NCT02894502|11286826|FG002|Second Follow up|Death|1
7135489|NCT02894502|11286824|FG000|Third Follow up|Withdrawal by Subject|5
7135490|NCT02894502|11286825|FG001|Third Follow up|Withdrawal by Subject|6
7135491|NCT02894502|11286826|FG002|Third Follow up|Withdrawal by Subject|3
7135492|NCT02894502|11286824|FG000|Third Follow up|Death|1
7135493|NCT02894502|11286825|FG001|Third Follow up|Death|1
7135494|NCT02894502|11286826|FG002|Third Follow up|Death|0
7135495|NCT02894840|11286841|FG000|Overall Study|Lost to Follow-up|1
7135496|NCT02894840|11286842|FG001|Overall Study|Lost to Follow-up|0
7135497|NCT02894840|11286843|FG002|Overall Study|Lost to Follow-up|3
7135498|NCT02894840|11286844|FG003|Overall Study|Lost to Follow-up|0
7135499|NCT02895295|11286886|FG000|Overall Study|Survey Non-response|71
7135500|NCT02895295|11286887|FG001|Overall Study|Survey Non-response|94
7135501|NCT02895295|11286888|FG002|Overall Study|Survey Non-response|92
7135502|NCT02895347|11286898|FG000|Overall Study|Withdrawal by Subject|3
7135503|NCT02895347|11286899|FG001|Overall Study|Withdrawal by Subject|1
7135504|NCT02895360|11286912|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4
7135505|NCT02895360|11286913|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0
7135506|NCT02895360|11286914|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0
7135507|NCT02895360|11286915|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0
7135508|NCT02895360|11286916|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0
7135509|NCT02895360|11286917|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0
7135510|NCT02895360|11286912|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0
7135511|NCT02895360|11286913|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3
7135512|NCT02895360|11286914|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0
7135513|NCT02895360|11286915|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0
7135514|NCT02895360|11286916|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0
7135515|NCT02895360|11286917|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0
7135516|NCT02895360|11286912|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0
7135517|NCT02895360|11286913|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0
7135518|NCT02895360|11286914|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2
7135519|NCT02895360|11286915|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0
7135520|NCT02895360|11286916|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0
7135521|NCT02895360|11286917|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0
7135522|NCT02895360|11286912|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0
7135523|NCT02895360|11286913|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0
7135524|NCT02895360|11286914|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7
7135525|NCT02895360|11286915|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0
7135526|NCT02895360|11286916|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0
7135527|NCT02895360|11286917|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0
7135528|NCT02895360|11286912|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0
7135529|NCT02895360|11286913|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0
7135530|NCT02895360|11286914|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0
7135531|NCT02895360|11286915|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4
7135532|NCT02895360|11286916|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0
7135533|NCT02895360|11286917|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0
7135534|NCT02895360|11286912|FG000|Phase 2a|Adverse Event|0
7135535|NCT02895360|11286913|FG001|Phase 2a|Adverse Event|0
7135536|NCT02895360|11286914|FG002|Phase 2a|Adverse Event|0
7135537|NCT02895360|11286915|FG003|Phase 2a|Adverse Event|0
7135538|NCT02895360|11286916|FG004|Phase 2a|Adverse Event|0
7135539|NCT02895360|11286917|FG005|Phase 2a|Adverse Event|1
7135540|NCT02895360|11286912|FG000|Phase 2a|Progressive disease|0
7135541|NCT02895360|11286913|FG001|Phase 2a|Progressive disease|0
7135542|NCT02895360|11286914|FG002|Phase 2a|Progressive disease|0
7135543|NCT02895360|11286915|FG003|Phase 2a|Progressive disease|0
7135544|NCT02895360|11286916|FG004|Phase 2a|Progressive disease|11
7135545|NCT02895360|11286917|FG005|Phase 2a|Progressive disease|11
7135546|NCT02895945|11286951|FG000|Overall Study|Physician Decision|2
7135547|NCT02895945|11286952|FG001|Overall Study|Physician Decision|1
7135548|NCT02896127|11286967|FG000|COMPLETED WEEK 52|Adverse Event|9
7135549|NCT02896127|11286968|FG001|COMPLETED WEEK 52|Adverse Event|2
7135550|NCT02896127|11286967|FG000|COMPLETED WEEK 52|Lack of Efficacy|2
7135551|NCT02896127|11286968|FG001|COMPLETED WEEK 52|Lack of Efficacy|3
7135552|NCT02896127|11286967|FG000|COMPLETED WEEK 52|Lost to Follow-up|0
7135553|NCT02896127|11286968|FG001|COMPLETED WEEK 52|Lost to Follow-up|1
7135554|NCT02896127|11286967|FG000|COMPLETED WEEK 52|Physician Decision|1
7135555|NCT02896127|11286968|FG001|COMPLETED WEEK 52|Physician Decision|1
7135556|NCT02896127|11286967|FG000|COMPLETED WEEK 52|Pregnancy|2
7135557|NCT02896127|11286968|FG001|COMPLETED WEEK 52|Pregnancy|0
7135558|NCT02896127|11286967|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12
7135559|NCT02896127|11286968|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4
7135560|NCT02896127|11286967|FG000|COMPLETED WEEK 52|Technical problems|1
7135561|NCT02896127|11286968|FG001|COMPLETED WEEK 52|Technical problems|0
7135562|NCT02896127|11286967|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2
7135563|NCT02896127|11286968|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3
7135564|NCT02896127|11286967|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0
7135565|NCT02896127|11286968|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1
7135566|NCT02896127|11286967|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1
7135567|NCT02896127|11286968|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0
7135568|NCT02896127|11286967|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1
7135569|NCT02896127|11286968|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0
7135570|NCT02896127|11286967|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0
7135571|NCT02896127|11286968|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1
7135572|NCT02896296|11286974|FG000|Overall Study|Adverse Event|1
7135573|NCT02896296|11286974|FG000|Overall Study|Lost to Follow-up|19
7135574|NCT02896296|11286974|FG000|Overall Study|Pregnancy|1
7135575|NCT02896296|11286974|FG000|Overall Study|Physician Decision|2
7135576|NCT02896296|11286974|FG000|Overall Study|Withdrawal by Subject|10
7135577|NCT02896296|11286974|FG000|Overall Study|Site closing|7
7135578|NCT02896296|11286974|FG000|Overall Study|Incarceration|1
7135579|NCT02896296|11286974|FG000|Overall Study|Relocation|1
7135580|NCT02896361|11286978|FG000|Third Intervention (2 Weeks)|Protocol Violation|1
7135581|NCT02896361|11286979|FG001|Third Intervention (2 Weeks)|Protocol Violation|0
7135582|NCT02896361|11286980|FG002|Third Intervention (2 Weeks)|Protocol Violation|0
7135583|NCT02896361|11286978|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0
7135584|NCT02896361|11286979|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1
7135585|NCT02896361|11286980|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0
7135586|NCT02896400|11287008|FG000|1 Month Follow-up|Lost to Follow-up|7
7135587|NCT02896400|11287009|FG001|1 Month Follow-up|Lost to Follow-up|7
7135588|NCT02896400|11287010|FG002|1 Month Follow-up|Lost to Follow-up|5
7135589|NCT02896400|11287011|FG003|1 Month Follow-up|Lost to Follow-up|8
7135590|NCT02896400|11287012|FG004|1 Month Follow-up|Lost to Follow-up|9
7135591|NCT02896400|11287013|FG005|1 Month Follow-up|Lost to Follow-up|6
7135592|NCT02896400|11287014|FG006|1 Month Follow-up|Lost to Follow-up|5
7135593|NCT02896400|11287015|FG007|1 Month Follow-up|Lost to Follow-up|6
7135594|NCT02896400|11287016|FG008|1 Month Follow-up|Lost to Follow-up|4
7135595|NCT02896400|11287017|FG009|1 Month Follow-up|Lost to Follow-up|7
7135596|NCT02896400|11287018|FG010|1 Month Follow-up|Lost to Follow-up|5
7135597|NCT02896400|11287019|FG011|1 Month Follow-up|Lost to Follow-up|5
7135598|NCT02896400|11287020|FG012|1 Month Follow-up|Lost to Follow-up|3
7135599|NCT02896400|11287021|FG013|1 Month Follow-up|Lost to Follow-up|4
7135600|NCT02896400|11287022|FG014|1 Month Follow-up|Lost to Follow-up|1
7135601|NCT02896400|11287023|FG015|1 Month Follow-up|Lost to Follow-up|2
7135602|NCT02896400|11287008|FG000|1 Month Follow-up|Death|0
7135603|NCT02896400|11287009|FG001|1 Month Follow-up|Death|0
7135604|NCT02896400|11287010|FG002|1 Month Follow-up|Death|0
7135605|NCT02896400|11287011|FG003|1 Month Follow-up|Death|0
7135606|NCT02896400|11287012|FG004|1 Month Follow-up|Death|0
7135607|NCT02896400|11287013|FG005|1 Month Follow-up|Death|0
7135608|NCT02896400|11287014|FG006|1 Month Follow-up|Death|0
7135609|NCT02896400|11287015|FG007|1 Month Follow-up|Death|0
7135610|NCT02896400|11287016|FG008|1 Month Follow-up|Death|0
7135611|NCT02896400|11287017|FG009|1 Month Follow-up|Death|0
7135612|NCT02896400|11287018|FG010|1 Month Follow-up|Death|0
7135613|NCT02896400|11287019|FG011|1 Month Follow-up|Death|0
7135614|NCT02896400|11287020|FG012|1 Month Follow-up|Death|0
7135615|NCT02896400|11287021|FG013|1 Month Follow-up|Death|0
7135616|NCT02896400|11287022|FG014|1 Month Follow-up|Death|0
7135617|NCT02896400|11287023|FG015|1 Month Follow-up|Death|1
7135618|NCT02896400|11287008|FG000|3 Month Follow-up|Lost to Follow-up|6
7135619|NCT02896400|11287009|FG001|3 Month Follow-up|Lost to Follow-up|3
7135620|NCT02896400|11287010|FG002|3 Month Follow-up|Lost to Follow-up|6
7135621|NCT02896400|11287011|FG003|3 Month Follow-up|Lost to Follow-up|11
7135622|NCT02896400|11287012|FG004|3 Month Follow-up|Lost to Follow-up|12
7135623|NCT02896400|11287013|FG005|3 Month Follow-up|Lost to Follow-up|6
7135624|NCT02896400|11287014|FG006|3 Month Follow-up|Lost to Follow-up|4
7135625|NCT02896400|11287015|FG007|3 Month Follow-up|Lost to Follow-up|3
6806510|NCT04821245|10809063|FG000|Overall Study|Withdrawal by Subject|3
7135626|NCT02896400|11287016|FG008|3 Month Follow-up|Lost to Follow-up|6
7135627|NCT02896400|11287017|FG009|3 Month Follow-up|Lost to Follow-up|5
7135628|NCT02896400|11287018|FG010|3 Month Follow-up|Lost to Follow-up|6
7135629|NCT02896400|11287019|FG011|3 Month Follow-up|Lost to Follow-up|6
7135630|NCT02896400|11287020|FG012|3 Month Follow-up|Lost to Follow-up|3
7135631|NCT02896400|11287021|FG013|3 Month Follow-up|Lost to Follow-up|5
7135632|NCT02896400|11287022|FG014|3 Month Follow-up|Lost to Follow-up|3
7135633|NCT02896400|11287023|FG015|3 Month Follow-up|Lost to Follow-up|2
7135634|NCT02896400|11287008|FG000|3 Month Follow-up|Death|0
7135635|NCT02896400|11287009|FG001|3 Month Follow-up|Death|0
7135636|NCT02896400|11287010|FG002|3 Month Follow-up|Death|0
7135637|NCT02896400|11287011|FG003|3 Month Follow-up|Death|0
7135638|NCT02896400|11287012|FG004|3 Month Follow-up|Death|0
7135639|NCT02896400|11287013|FG005|3 Month Follow-up|Death|0
7135640|NCT02896400|11287014|FG006|3 Month Follow-up|Death|0
7135641|NCT02896400|11287015|FG007|3 Month Follow-up|Death|0
7135642|NCT02896400|11287016|FG008|3 Month Follow-up|Death|0
7135643|NCT02896400|11287017|FG009|3 Month Follow-up|Death|0
7135644|NCT02896400|11287018|FG010|3 Month Follow-up|Death|0
7135645|NCT02896400|11287019|FG011|3 Month Follow-up|Death|0
7135646|NCT02896400|11287020|FG012|3 Month Follow-up|Death|0
7135647|NCT02896400|11287021|FG013|3 Month Follow-up|Death|1
7135648|NCT02896400|11287022|FG014|3 Month Follow-up|Death|1
7135649|NCT02896400|11287023|FG015|3 Month Follow-up|Death|0
7135650|NCT02896400|11287008|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1
7135651|NCT02896400|11287009|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0
7135652|NCT02896400|11287010|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1
7135653|NCT02896400|11287011|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1
7135654|NCT02896400|11287012|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0
7135655|NCT02896400|11287013|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1
7135656|NCT02896400|11287014|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3
7135657|NCT02896400|11287015|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2
7135658|NCT02896400|11287016|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1
7135659|NCT02896400|11287017|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1
7135660|NCT02896400|11287018|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0
7135661|NCT02896400|11287019|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0
7135662|NCT02896400|11287020|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1
7135663|NCT02896400|11287021|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0
7135664|NCT02896400|11287022|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3
7135665|NCT02896400|11287023|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1
7135666|NCT02896400|11287008|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45
7135667|NCT02896400|11287009|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
7135668|NCT02896400|11287010|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46
7135669|NCT02896400|11287011|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40
7135670|NCT02896400|11287012|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45
7135671|NCT02896400|11287013|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
7135672|NCT02896400|11287014|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
7135673|NCT02896400|11287015|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47
7135674|NCT02896400|11287016|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44
7135675|NCT02896400|11287017|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52
7135676|NCT02896400|11287018|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55
7135677|NCT02896400|11287019|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41
7135678|NCT02896400|11287020|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52
7135679|NCT02896400|11287021|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
7135680|NCT02896400|11287022|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52
7135681|NCT02896400|11287023|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56
7135682|NCT02896569|11287051|FG000|Overall Study|Lost to Follow-up|2
7135683|NCT02896569|11287052|FG001|Overall Study|Lost to Follow-up|1
7135684|NCT02896569|11287051|FG000|Overall Study|Physician Decision|1
7135685|NCT02896569|11287052|FG001|Overall Study|Physician Decision|3
7135686|NCT02896569|11287051|FG000|Overall Study|Adverse Event|0
7135687|NCT02896569|11287052|FG001|Overall Study|Adverse Event|1
7135688|NCT02896569|11287051|FG000|Overall Study|Withdrawal by Subject|1
7135689|NCT02896569|11287052|FG001|Overall Study|Withdrawal by Subject|0
7135690|NCT02897115|11287073|FG000|Overall Study|Early termination of study by sponsor|11
7135691|NCT02897115|11287074|FG001|Overall Study|Early termination of study by sponsor|8
7135692|NCT02897349|11287102|FG000|Overall Study|Lost to Follow-up|2
7135693|NCT02897349|11287103|FG001|Overall Study|Lost to Follow-up|2
7135694|NCT02897349|11287102|FG000|Overall Study|Adverse Event|3
7135695|NCT02897349|11287103|FG001|Overall Study|Adverse Event|3
7135696|NCT02897349|11287102|FG000|Overall Study|Other than listed above|0
7135697|NCT02897349|11287103|FG001|Overall Study|Other than listed above|1
7135698|NCT02898116|11287122|FG000|Overall Study|Adverse Event|1
7135699|NCT02898116|11287122|FG000|Overall Study|Progressive disease|1
7135700|NCT02898454|11287129|FG000|Overall Study|Adverse Event|4
7135701|NCT02898454|11287130|FG001|Overall Study|Adverse Event|1
7135702|NCT02898454|11287131|FG002|Overall Study|Adverse Event|2
7135703|NCT02898454|11287129|FG000|Overall Study|Protocol Violation|1
7135704|NCT02898454|11287130|FG001|Overall Study|Protocol Violation|0
7135705|NCT02898454|11287131|FG002|Overall Study|Protocol Violation|1
7135706|NCT02898454|11287129|FG000|Overall Study|Lack of Efficacy|4
7135707|NCT02898454|11287130|FG001|Overall Study|Lack of Efficacy|1
7135708|NCT02898454|11287131|FG002|Overall Study|Lack of Efficacy|0
7135709|NCT02898454|11287129|FG000|Overall Study|Withdrawal by Subject|6
7135710|NCT02898454|11287130|FG001|Overall Study|Withdrawal by Subject|3
7135711|NCT02898454|11287131|FG002|Overall Study|Withdrawal by Subject|3
7135712|NCT02898454|11287129|FG000|Overall Study|Lost to Follow-up|1
7135713|NCT02898454|11287130|FG001|Overall Study|Lost to Follow-up|0
7135714|NCT02898454|11287131|FG002|Overall Study|Lost to Follow-up|0
7135715|NCT02898454|11287129|FG000|Overall Study|Did Not Met Eligibility Criteria|1
7135716|NCT02898454|11287130|FG001|Overall Study|Did Not Met Eligibility Criteria|0
7135717|NCT02898454|11287131|FG002|Overall Study|Did Not Met Eligibility Criteria|0
7135718|NCT02898597|11287146|FG000|Overall Study|Protocol Violation|4
7135719|NCT02898597|11287147|FG001|Overall Study|Protocol Violation|2
7135720|NCT02898597|11287146|FG000|Overall Study|Lost to Follow-up|0
7135721|NCT02898597|11287147|FG001|Overall Study|Lost to Follow-up|9
7135722|NCT02898597|11287146|FG000|Overall Study|Death|0
7135723|NCT02898597|11287147|FG001|Overall Study|Death|1
7135724|NCT02898662|11287155|FG000|Overall Study|Adverse Event|1
6781008|NCT03150862|10776941|FG001|Overall Study|Roll over in to Long Term Extension|0
6781009|NCT03150862|10776942|FG002|Overall Study|Roll over in to Long Term Extension|0
6781010|NCT03150862|10776943|FG003|Overall Study|Roll over in to Long Term Extension|0
6781011|NCT03150862|10776944|FG004|Overall Study|Roll over in to Long Term Extension|0
6781012|NCT03150862|10776945|FG005|Overall Study|Roll over in to Long Term Extension|0
6781013|NCT03150862|10776946|FG006|Overall Study|Roll over in to Long Term Extension|0
6781014|NCT03150862|10776947|FG007|Overall Study|Roll over in to Long Term Extension|1
7135725|NCT02898662|11287156|FG001|Overall Study|Adverse Event|0
7135726|NCT02898662|11287155|FG000|Overall Study|Loss of asthma control|23
7135727|NCT02898662|11287156|FG001|Overall Study|Loss of asthma control|24
7135728|NCT02898662|11287155|FG000|Overall Study|Withdrawal by Subject|4
7135729|NCT02898662|11287156|FG001|Overall Study|Withdrawal by Subject|1
7135730|NCT02898662|11287155|FG000|Overall Study|Technical issue|0
7135731|NCT02898662|11287156|FG001|Overall Study|Technical issue|1
7135732|NCT02898662|11287155|FG000|Overall Study|Randomized in error|0
7135733|NCT02898662|11287156|FG001|Overall Study|Randomized in error|1
7135734|NCT02898662|11287155|FG000|Overall Study|Subject decision|1
7135735|NCT02898662|11287156|FG001|Overall Study|Subject decision|0
7135736|NCT02898662|11287155|FG000|Overall Study|Other|0
7135737|NCT02898662|11287156|FG001|Overall Study|Other|1
7135738|NCT02899156|11287182|FG000|Overall Study|Death|1
7135739|NCT02899156|11287183|FG001|Overall Study|Death|0
7135740|NCT02899156|11287182|FG000|Overall Study|Physician Decision|0
7135741|NCT02899156|11287183|FG001|Overall Study|Physician Decision|1
7135742|NCT02899195|11287189|FG000|Concurrent Durvalumab|Adverse Event|4
7135743|NCT02899195|11287189|FG000|Concurrent Durvalumab|Physician Decision|1
7135744|NCT02899195|11287189|FG000|Concurrent Durvalumab|Withdrawal by Subject|1
7135745|NCT02899195|11287189|FG000|Concurrent Durvalumab|Progressive Disease|5
7135746|NCT02899195|11287189|FG000|Maintenance Durvalumab|Adverse Event|1
7135747|NCT02899195|11287189|FG000|Maintenance Durvalumab|Physician Decision|1
7135748|NCT02899195|11287189|FG000|Maintenance Durvalumab|Withdrawal by Subject|1
7135749|NCT02899195|11287189|FG000|Maintenance Durvalumab|Progressive Disease|31
7135750|NCT02899338|11287195|FG000|Overall Study|Adverse Event|1
7135751|NCT02899338|11287196|FG001|Overall Study|Adverse Event|2
7135752|NCT02899338|11287195|FG000|Overall Study|Withdrawal by Subject|2
7135753|NCT02899338|11287196|FG001|Overall Study|Withdrawal by Subject|0
7135754|NCT02899377|11287204|FG000|Overall Study|Adverse Event|1
7135755|NCT02899377|11287205|FG001|Overall Study|Adverse Event|0
7135756|NCT02899962|11287241|FG000|Open-label Phase|Adverse Event|2
7135757|NCT02899962|11287242|FG001|Open-label Phase|Adverse Event|0
7135758|NCT02899962|11287243|FG002|Open-label Phase|Adverse Event|0
6781015|NCT03150862|10776940|FG000|Overall Study|Progressive Disease|0
6781016|NCT03150862|10776941|FG001|Overall Study|Progressive Disease|0
6781017|NCT03150862|10776942|FG002|Overall Study|Progressive Disease|0
6781018|NCT03150862|10776943|FG003|Overall Study|Progressive Disease|0
6781019|NCT03150862|10776944|FG004|Overall Study|Progressive Disease|0
6781020|NCT03150862|10776945|FG005|Overall Study|Progressive Disease|0
6781021|NCT03150862|10776946|FG006|Overall Study|Progressive Disease|0
7135759|NCT02899962|11287241|FG000|Open-label Phase|Lost to Follow-up|9
7135760|NCT02899962|11287242|FG001|Open-label Phase|Lost to Follow-up|0
7135761|NCT02899962|11287243|FG002|Open-label Phase|Lost to Follow-up|0
7135762|NCT02899962|11287241|FG000|Open-label Phase|Other reasons|9
6781022|NCT03150862|10776947|FG007|Overall Study|Progressive Disease|2
6781023|NCT03074695|10776976|FG000|Overall Study|Delivered with caesarean before request for analgesia|1
6781024|NCT03074695|10776977|FG001|Overall Study|Delivered with caesarean before request for analgesia|1
6781025|NCT03074695|10776976|FG000|Overall Study|Research staff not available|1
6781026|NCT03074695|10776977|FG001|Overall Study|Research staff not available|2
6781027|NCT03074695|10776976|FG000|Overall Study|Did not receive neuraxial block|2
6781028|NCT03074695|10776977|FG001|Overall Study|Did not receive neuraxial block|2
6781029|NCT03052608|10776985|FG000|Treatment Phase|Adverse Event|10
6781030|NCT03052608|10776986|FG001|Treatment Phase|Adverse Event|12
6781031|NCT03052608|10776985|FG000|Treatment Phase|Death|6
6781032|NCT03052608|10776986|FG001|Treatment Phase|Death|4
6781033|NCT03052608|10776985|FG000|Treatment Phase|Withdrawal by Subject|4
6781034|NCT03052608|10776986|FG001|Treatment Phase|Withdrawal by Subject|12
6781035|NCT03052608|10776985|FG000|Treatment Phase|Global Deterioration of Health Status|0
6781036|NCT03052608|10776986|FG001|Treatment Phase|Global Deterioration of Health Status|3
6781037|NCT03052608|10776985|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0
7135763|NCT02899962|11287242|FG001|Open-label Phase|Other reasons|0
7135764|NCT02899962|11287243|FG002|Open-label Phase|Other reasons|0
7135765|NCT02899962|11287241|FG000|Open-label Phase|Withdrawal by Subject|7
7135766|NCT02899962|11287242|FG001|Open-label Phase|Withdrawal by Subject|0
7135767|NCT02899962|11287243|FG002|Open-label Phase|Withdrawal by Subject|0
7135768|NCT02899962|11287241|FG000|Maintenance Phase|Adverse Event|0
7135769|NCT02899962|11287242|FG001|Maintenance Phase|Adverse Event|2
7135770|NCT02899962|11287243|FG002|Maintenance Phase|Adverse Event|1
7135771|NCT02899962|11287241|FG000|Maintenance Phase|Death|0
7135772|NCT02899962|11287242|FG001|Maintenance Phase|Death|0
7135773|NCT02899962|11287243|FG002|Maintenance Phase|Death|1
7135774|NCT02899962|11287241|FG000|Maintenance Phase|Lack of Efficacy|0
7135775|NCT02899962|11287242|FG001|Maintenance Phase|Lack of Efficacy|20
7135776|NCT02899962|11287243|FG002|Maintenance Phase|Lack of Efficacy|16
7135777|NCT02899962|11287241|FG000|Maintenance Phase|Lost to Follow-up|0
7135778|NCT02899962|11287242|FG001|Maintenance Phase|Lost to Follow-up|12
7135779|NCT02899962|11287243|FG002|Maintenance Phase|Lost to Follow-up|14
7135780|NCT02899962|11287241|FG000|Maintenance Phase|Other reasons|0
7135781|NCT02899962|11287242|FG001|Maintenance Phase|Other reasons|9
7135782|NCT02899962|11287243|FG002|Maintenance Phase|Other reasons|13
7135783|NCT02899962|11287241|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0
7135784|NCT02899962|11287242|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3
7135785|NCT02899962|11287243|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2
7135786|NCT02899962|11287241|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0
7135787|NCT02899962|11287242|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65
7135788|NCT02899962|11287243|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70
7135789|NCT02899962|11287241|FG000|Maintenance Phase|Withdrawal by Subject|0
7135790|NCT02899962|11287242|FG001|Maintenance Phase|Withdrawal by Subject|30
7135791|NCT02899962|11287243|FG002|Maintenance Phase|Withdrawal by Subject|36
7135792|NCT02899988|11287254|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2
7135793|NCT02899988|11287255|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1
7135794|NCT02899988|11287256|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0
7135795|NCT02899988|11287257|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0
7135796|NCT02899988|11287258|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0
7135797|NCT02899988|11287259|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0
7135798|NCT02899988|11287260|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0
7135799|NCT02899988|11287261|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0
7135800|NCT02899988|11287262|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0
7135801|NCT02899988|11287263|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0
7135802|NCT02899988|11287264|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0
7135803|NCT02899988|11287254|FG000|Induction Period (16 Weeks)|Adverse Event|0
7135804|NCT02899988|11287255|FG001|Induction Period (16 Weeks)|Adverse Event|0
7135805|NCT02899988|11287256|FG002|Induction Period (16 Weeks)|Adverse Event|0
6781038|NCT03052608|10776986|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1
6781039|NCT03052608|10776985|FG000|Treatment Phase|Subject didn't receive study treatment.|0
6781040|NCT03052608|10776986|FG001|Treatment Phase|Subject didn't receive study treatment.|1
7135806|NCT02899988|11287257|FG003|Induction Period (16 Weeks)|Adverse Event|2
7135807|NCT02899988|11287258|FG004|Induction Period (16 Weeks)|Adverse Event|0
7135808|NCT02899988|11287259|FG005|Induction Period (16 Weeks)|Adverse Event|0
7135809|NCT02899988|11287260|FG006|Induction Period (16 Weeks)|Adverse Event|0
7135810|NCT02899988|11287261|FG007|Induction Period (16 Weeks)|Adverse Event|0
7135811|NCT02899988|11287262|FG008|Induction Period (16 Weeks)|Adverse Event|0
7135812|NCT02899988|11287263|FG009|Induction Period (16 Weeks)|Adverse Event|0
7135813|NCT02899988|11287264|FG010|Induction Period (16 Weeks)|Adverse Event|0
7135814|NCT02899988|11287254|FG000|Induction Period (16 Weeks)|Physician Decision|0
7135815|NCT02899988|11287255|FG001|Induction Period (16 Weeks)|Physician Decision|1
7135816|NCT02899988|11287256|FG002|Induction Period (16 Weeks)|Physician Decision|0
7135817|NCT02899988|11287257|FG003|Induction Period (16 Weeks)|Physician Decision|0
7135818|NCT02899988|11287258|FG004|Induction Period (16 Weeks)|Physician Decision|0
7135819|NCT02899988|11287259|FG005|Induction Period (16 Weeks)|Physician Decision|0
7135820|NCT02899988|11287260|FG006|Induction Period (16 Weeks)|Physician Decision|0
7135821|NCT02899988|11287261|FG007|Induction Period (16 Weeks)|Physician Decision|0
7135822|NCT02899988|11287262|FG008|Induction Period (16 Weeks)|Physician Decision|0
7135823|NCT02899988|11287263|FG009|Induction Period (16 Weeks)|Physician Decision|0
7135824|NCT02899988|11287264|FG010|Induction Period (16 Weeks)|Physician Decision|0
7135825|NCT02899988|11287254|FG000|Maintenance Period (88 Weeks)|Adverse Event|0
7135826|NCT02899988|11287255|FG001|Maintenance Period (88 Weeks)|Adverse Event|0
7135827|NCT02899988|11287256|FG002|Maintenance Period (88 Weeks)|Adverse Event|0
7135828|NCT02899988|11287257|FG003|Maintenance Period (88 Weeks)|Adverse Event|0
7135829|NCT02899988|11287258|FG004|Maintenance Period (88 Weeks)|Adverse Event|1
7135830|NCT02899988|11287259|FG005|Maintenance Period (88 Weeks)|Adverse Event|2
7135831|NCT02899988|11287260|FG006|Maintenance Period (88 Weeks)|Adverse Event|1
7135832|NCT02899988|11287261|FG007|Maintenance Period (88 Weeks)|Adverse Event|2
7135833|NCT02899988|11287262|FG008|Maintenance Period (88 Weeks)|Adverse Event|2
7135834|NCT02899988|11287263|FG009|Maintenance Period (88 Weeks)|Adverse Event|2
7135835|NCT02899988|11287264|FG010|Maintenance Period (88 Weeks)|Adverse Event|1
7135836|NCT02899988|11287254|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0
7135837|NCT02899988|11287255|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0
7135838|NCT02899988|11287256|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0
7135839|NCT02899988|11287257|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0
7135840|NCT02899988|11287258|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0
7135841|NCT02899988|11287259|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1
7135842|NCT02899988|11287260|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0
7135843|NCT02899988|11287261|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1
7135844|NCT02899988|11287262|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0
7135845|NCT02899988|11287263|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0
7135846|NCT02899988|11287264|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0
7135847|NCT02899988|11287254|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
7135848|NCT02899988|11287255|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
7135849|NCT02899988|11287256|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
7135850|NCT02899988|11287257|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
7135851|NCT02899988|11287258|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1
7135852|NCT02899988|11287259|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
7135853|NCT02899988|11287260|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3
7135854|NCT02899988|11287261|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2
7135855|NCT02899988|11287262|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2
7135856|NCT02899988|11287263|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
7135857|NCT02899988|11287264|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1
7135858|NCT02900092|11287296|FG000|Overall Study|Adverse Event|1
7135859|NCT02900170|11287300|FG000|Overall Study|Lost to Follow-up|8
7135860|NCT02900378|11287306|FG000|Randomization (Visit 2)|Adverse Event|14
7135861|NCT02900378|11287307|FG001|Randomization (Visit 2)|Adverse Event|11
7135862|NCT02900378|11287306|FG000|Randomization (Visit 2)|Death|1
7135863|NCT02900378|11287307|FG001|Randomization (Visit 2)|Death|4
7135864|NCT02900378|11287306|FG000|Randomization (Visit 2)|Lost to Follow-up|1
7135865|NCT02900378|11287307|FG001|Randomization (Visit 2)|Lost to Follow-up|0
7135866|NCT02900378|11287306|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1
7135867|NCT02900378|11287307|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1
7135868|NCT02900378|11287306|FG000|Randomization (Visit 2)|Protocol Deviation|1
7135869|NCT02900378|11287307|FG001|Randomization (Visit 2)|Protocol Deviation|7
7135870|NCT02900378|11287306|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5
7135871|NCT02900378|11287307|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3
7135872|NCT02900378|11287306|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0
7135873|NCT02900378|11287307|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2
7135874|NCT02901054|11287313|FG000|Overall Study|Physician Decision|1
7135875|NCT02901054|11287313|FG000|Overall Study|Withdrawal by Subject|3
7135876|NCT02901431|11287347|FG000|PK Part|Adverse Event|0
7135877|NCT02901431|11287348|FG001|PK Part|Adverse Event|1
6781041|NCT03052608|10776985|FG000|Treatment Phase|Ongoing|103
6781042|NCT03052608|10776986|FG001|Treatment Phase|Ongoing|31
7135878|NCT02901431|11287349|FG002|PK Part|Adverse Event|0
7135879|NCT02901431|11287350|FG003|PK Part|Adverse Event|0
7135880|NCT02901431|11287351|FG004|PK Part|Adverse Event|0
7135881|NCT02901431|11287352|FG005|PK Part|Adverse Event|0
7135882|NCT02901431|11287353|FG006|PK Part|Adverse Event|0
7135883|NCT02901431|11287354|FG007|PK Part|Adverse Event|0
7135884|NCT02901431|11287355|FG008|PK Part|Adverse Event|0
7135885|NCT02901431|11287356|FG009|PK Part|Adverse Event|0
7135886|NCT02901431|11287357|FG010|PK Part|Adverse Event|0
7135887|NCT02901431|11287358|FG011|PK Part|Adverse Event|0
7135888|NCT02901431|11287359|FG012|PK Part|Adverse Event|0
7135889|NCT02901431|11287347|FG000|PK Part|Lost to Follow-up|0
7135890|NCT02901431|11287348|FG001|PK Part|Lost to Follow-up|0
7135891|NCT02901431|11287349|FG002|PK Part|Lost to Follow-up|1
7135892|NCT02901431|11287350|FG003|PK Part|Lost to Follow-up|0
7135893|NCT02901431|11287351|FG004|PK Part|Lost to Follow-up|0
7135894|NCT02901431|11287352|FG005|PK Part|Lost to Follow-up|0
7135895|NCT02901431|11287353|FG006|PK Part|Lost to Follow-up|0
7135896|NCT02901431|11287354|FG007|PK Part|Lost to Follow-up|0
7135897|NCT02901431|11287355|FG008|PK Part|Lost to Follow-up|0
7135898|NCT02901431|11287356|FG009|PK Part|Lost to Follow-up|0
7135899|NCT02901431|11287357|FG010|PK Part|Lost to Follow-up|0
7135900|NCT02901431|11287358|FG011|PK Part|Lost to Follow-up|0
7135901|NCT02901431|11287359|FG012|PK Part|Lost to Follow-up|0
7135902|NCT02901431|11287347|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2
7135903|NCT02901431|11287348|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0
7135904|NCT02901431|11287349|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0
7135905|NCT02901431|11287350|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0
7135906|NCT02901431|11287351|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0
7135907|NCT02901431|11287352|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0
7135908|NCT02901431|11287353|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0
7135909|NCT02901431|11287354|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0
7135910|NCT02901431|11287355|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0
7135911|NCT02901431|11287356|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0
7135912|NCT02901431|11287357|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0
7135913|NCT02901431|11287358|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0
7135914|NCT02901431|11287359|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0
7135915|NCT02901431|11287347|FG000|PK Part|Pending dose confirmation|0
7135916|NCT02901431|11287348|FG001|PK Part|Pending dose confirmation|1
7135917|NCT02901431|11287349|FG002|PK Part|Pending dose confirmation|0
7135918|NCT02901431|11287350|FG003|PK Part|Pending dose confirmation|0
7135919|NCT02901431|11287351|FG004|PK Part|Pending dose confirmation|0
7135920|NCT02901431|11287352|FG005|PK Part|Pending dose confirmation|0
7135921|NCT02901431|11287353|FG006|PK Part|Pending dose confirmation|0
7135922|NCT02901431|11287354|FG007|PK Part|Pending dose confirmation|0
7135923|NCT02901431|11287355|FG008|PK Part|Pending dose confirmation|0
7135924|NCT02901431|11287356|FG009|PK Part|Pending dose confirmation|0
7135925|NCT02901431|11287357|FG010|PK Part|Pending dose confirmation|0
7135926|NCT02901431|11287358|FG011|PK Part|Pending dose confirmation|0
7135927|NCT02901431|11287359|FG012|PK Part|Pending dose confirmation|0
7135928|NCT02901431|11287347|FG000|PK Part|8 weeks of treatment ran out|2
7135929|NCT02901431|11287348|FG001|PK Part|8 weeks of treatment ran out|0
7135930|NCT02901431|11287349|FG002|PK Part|8 weeks of treatment ran out|0
7135931|NCT02901431|11287350|FG003|PK Part|8 weeks of treatment ran out|0
7135932|NCT02901431|11287351|FG004|PK Part|8 weeks of treatment ran out|0
7135933|NCT02901431|11287352|FG005|PK Part|8 weeks of treatment ran out|0
7135934|NCT02901431|11287353|FG006|PK Part|8 weeks of treatment ran out|0
7135935|NCT02901431|11287354|FG007|PK Part|8 weeks of treatment ran out|0
7135936|NCT02901431|11287355|FG008|PK Part|8 weeks of treatment ran out|0
7135937|NCT02901431|11287356|FG009|PK Part|8 weeks of treatment ran out|0
7135938|NCT02901431|11287357|FG010|PK Part|8 weeks of treatment ran out|0
7135939|NCT02901431|11287358|FG011|PK Part|8 weeks of treatment ran out|0
7135940|NCT02901431|11287359|FG012|PK Part|8 weeks of treatment ran out|0
7135941|NCT02901431|11287347|FG000|PK Part|Stopped treatment after 8 weeks|1
7135942|NCT02901431|11287348|FG001|PK Part|Stopped treatment after 8 weeks|0
7135943|NCT02901431|11287349|FG002|PK Part|Stopped treatment after 8 weeks|1
7135944|NCT02901431|11287350|FG003|PK Part|Stopped treatment after 8 weeks|0
7135945|NCT02901431|11287351|FG004|PK Part|Stopped treatment after 8 weeks|0
7135946|NCT02901431|11287352|FG005|PK Part|Stopped treatment after 8 weeks|0
7135947|NCT02901431|11287353|FG006|PK Part|Stopped treatment after 8 weeks|0
7135948|NCT02901431|11287354|FG007|PK Part|Stopped treatment after 8 weeks|0
7135949|NCT02901431|11287355|FG008|PK Part|Stopped treatment after 8 weeks|0
7135950|NCT02901431|11287356|FG009|PK Part|Stopped treatment after 8 weeks|0
7135951|NCT02901431|11287357|FG010|PK Part|Stopped treatment after 8 weeks|0
7135952|NCT02901431|11287358|FG011|PK Part|Stopped treatment after 8 weeks|0
6781043|NCT03052608|10776985|FG000|Long-Term Follow-up Phase|Death|23
7135953|NCT02901431|11287359|FG012|PK Part|Stopped treatment after 8 weeks|0
7135954|NCT02901431|11287347|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1
7135955|NCT02901431|11287348|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7135956|NCT02901431|11287349|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4
7135957|NCT02901431|11287350|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7135958|NCT02901431|11287351|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7135959|NCT02901431|11287352|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7135960|NCT02901431|11287353|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7135961|NCT02901431|11287354|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7135962|NCT02901431|11287355|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7135963|NCT02901431|11287356|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7135964|NCT02901431|11287357|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7135965|NCT02901431|11287358|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7135966|NCT02901431|11287359|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7135967|NCT02901431|11287347|FG000|PK Part|Discontinued per Sponsor|0
7135968|NCT02901431|11287348|FG001|PK Part|Discontinued per Sponsor|3
7135969|NCT02901431|11287349|FG002|PK Part|Discontinued per Sponsor|0
7135970|NCT02901431|11287350|FG003|PK Part|Discontinued per Sponsor|0
7135971|NCT02901431|11287351|FG004|PK Part|Discontinued per Sponsor|0
7135972|NCT02901431|11287352|FG005|PK Part|Discontinued per Sponsor|0
7135973|NCT02901431|11287353|FG006|PK Part|Discontinued per Sponsor|0
7135974|NCT02901431|11287354|FG007|PK Part|Discontinued per Sponsor|0
7135975|NCT02901431|11287355|FG008|PK Part|Discontinued per Sponsor|0
7135976|NCT02901431|11287356|FG009|PK Part|Discontinued per Sponsor|0
7135977|NCT02901431|11287357|FG010|PK Part|Discontinued per Sponsor|0
7135978|NCT02901431|11287358|FG011|PK Part|Discontinued per Sponsor|0
7135979|NCT02901431|11287359|FG012|PK Part|Discontinued per Sponsor|0
7135980|NCT02901431|11287347|FG000|PK Part|Withdrawal by Subject|1
7135981|NCT02901431|11287348|FG001|PK Part|Withdrawal by Subject|1
7135982|NCT02901431|11287349|FG002|PK Part|Withdrawal by Subject|3
7135983|NCT02901431|11287350|FG003|PK Part|Withdrawal by Subject|0
7135984|NCT02901431|11287351|FG004|PK Part|Withdrawal by Subject|0
7135985|NCT02901431|11287352|FG005|PK Part|Withdrawal by Subject|0
7135986|NCT02901431|11287353|FG006|PK Part|Withdrawal by Subject|0
7135987|NCT02901431|11287354|FG007|PK Part|Withdrawal by Subject|0
7135988|NCT02901431|11287355|FG008|PK Part|Withdrawal by Subject|0
7135989|NCT02901431|11287356|FG009|PK Part|Withdrawal by Subject|0
7135990|NCT02901431|11287357|FG010|PK Part|Withdrawal by Subject|0
7135991|NCT02901431|11287358|FG011|PK Part|Withdrawal by Subject|0
7135992|NCT02901431|11287359|FG012|PK Part|Withdrawal by Subject|0
7135993|NCT02901431|11287347|FG000|Main Treatment Part|Adverse Event|0
7135994|NCT02901431|11287348|FG001|Main Treatment Part|Adverse Event|0
7135995|NCT02901431|11287349|FG002|Main Treatment Part|Adverse Event|0
7135996|NCT02901431|11287350|FG003|Main Treatment Part|Adverse Event|3
7135997|NCT02901431|11287351|FG004|Main Treatment Part|Adverse Event|3
7135998|NCT02901431|11287352|FG005|Main Treatment Part|Adverse Event|4
7135999|NCT02901431|11287353|FG006|Main Treatment Part|Adverse Event|1
7136000|NCT02901431|11287354|FG007|Main Treatment Part|Adverse Event|0
7136001|NCT02901431|11287355|FG008|Main Treatment Part|Adverse Event|0
7136002|NCT02901431|11287356|FG009|Main Treatment Part|Adverse Event|0
7136003|NCT02901431|11287357|FG010|Main Treatment Part|Adverse Event|0
7136004|NCT02901431|11287358|FG011|Main Treatment Part|Adverse Event|0
7136005|NCT02901431|11287359|FG012|Main Treatment Part|Adverse Event|0
7136006|NCT02901431|11287347|FG000|Main Treatment Part|Lack of Efficacy|0
7136007|NCT02901431|11287348|FG001|Main Treatment Part|Lack of Efficacy|0
7136008|NCT02901431|11287349|FG002|Main Treatment Part|Lack of Efficacy|0
7136009|NCT02901431|11287350|FG003|Main Treatment Part|Lack of Efficacy|1
7136010|NCT02901431|11287351|FG004|Main Treatment Part|Lack of Efficacy|0
7136011|NCT02901431|11287352|FG005|Main Treatment Part|Lack of Efficacy|0
7136012|NCT02901431|11287353|FG006|Main Treatment Part|Lack of Efficacy|0
7136013|NCT02901431|11287354|FG007|Main Treatment Part|Lack of Efficacy|0
7136014|NCT02901431|11287355|FG008|Main Treatment Part|Lack of Efficacy|0
7136015|NCT02901431|11287356|FG009|Main Treatment Part|Lack of Efficacy|0
7136016|NCT02901431|11287357|FG010|Main Treatment Part|Lack of Efficacy|0
7136017|NCT02901431|11287358|FG011|Main Treatment Part|Lack of Efficacy|0
7136018|NCT02901431|11287359|FG012|Main Treatment Part|Lack of Efficacy|0
7136019|NCT02901431|11287347|FG000|Main Treatment Part|Lost to Follow-up|0
7136020|NCT02901431|11287348|FG001|Main Treatment Part|Lost to Follow-up|0
7136021|NCT02901431|11287349|FG002|Main Treatment Part|Lost to Follow-up|0
7136022|NCT02901431|11287350|FG003|Main Treatment Part|Lost to Follow-up|3
7136023|NCT02901431|11287351|FG004|Main Treatment Part|Lost to Follow-up|1
7136024|NCT02901431|11287352|FG005|Main Treatment Part|Lost to Follow-up|2
7136025|NCT02901431|11287353|FG006|Main Treatment Part|Lost to Follow-up|3
7136026|NCT02901431|11287354|FG007|Main Treatment Part|Lost to Follow-up|0
7136027|NCT02901431|11287355|FG008|Main Treatment Part|Lost to Follow-up|0
7136028|NCT02901431|11287356|FG009|Main Treatment Part|Lost to Follow-up|0
7136029|NCT02901431|11287357|FG010|Main Treatment Part|Lost to Follow-up|0
7136030|NCT02901431|11287358|FG011|Main Treatment Part|Lost to Follow-up|0
7136031|NCT02901431|11287359|FG012|Main Treatment Part|Lost to Follow-up|0
7136032|NCT02901431|11287347|FG000|Main Treatment Part|Withdrawal by Caregiver|0
7136033|NCT02901431|11287348|FG001|Main Treatment Part|Withdrawal by Caregiver|0
7136034|NCT02901431|11287349|FG002|Main Treatment Part|Withdrawal by Caregiver|0
7136035|NCT02901431|11287350|FG003|Main Treatment Part|Withdrawal by Caregiver|0
7136036|NCT02901431|11287351|FG004|Main Treatment Part|Withdrawal by Caregiver|0
7136037|NCT02901431|11287352|FG005|Main Treatment Part|Withdrawal by Caregiver|1
7136038|NCT02901431|11287353|FG006|Main Treatment Part|Withdrawal by Caregiver|0
7136039|NCT02901431|11287354|FG007|Main Treatment Part|Withdrawal by Caregiver|0
7136040|NCT02901431|11287355|FG008|Main Treatment Part|Withdrawal by Caregiver|0
7136041|NCT02901431|11287356|FG009|Main Treatment Part|Withdrawal by Caregiver|0
7136042|NCT02901431|11287357|FG010|Main Treatment Part|Withdrawal by Caregiver|0
7136043|NCT02901431|11287358|FG011|Main Treatment Part|Withdrawal by Caregiver|0
7136044|NCT02901431|11287359|FG012|Main Treatment Part|Withdrawal by Caregiver|0
7136045|NCT02901431|11287347|FG000|Main Treatment Part|Physician Decision|0
7136046|NCT02901431|11287348|FG001|Main Treatment Part|Physician Decision|0
7136047|NCT02901431|11287349|FG002|Main Treatment Part|Physician Decision|0
7136048|NCT02901431|11287350|FG003|Main Treatment Part|Physician Decision|1
7136049|NCT02901431|11287351|FG004|Main Treatment Part|Physician Decision|0
7136050|NCT02901431|11287352|FG005|Main Treatment Part|Physician Decision|0
7136051|NCT02901431|11287353|FG006|Main Treatment Part|Physician Decision|1
7136052|NCT02901431|11287354|FG007|Main Treatment Part|Physician Decision|0
7136053|NCT02901431|11287355|FG008|Main Treatment Part|Physician Decision|0
7136054|NCT02901431|11287356|FG009|Main Treatment Part|Physician Decision|0
7136055|NCT02901431|11287357|FG010|Main Treatment Part|Physician Decision|0
7136056|NCT02901431|11287358|FG011|Main Treatment Part|Physician Decision|0
7136057|NCT02901431|11287359|FG012|Main Treatment Part|Physician Decision|0
7136058|NCT02901431|11287347|FG000|Main Treatment Part|Withdrawal by Subject|0
7136059|NCT02901431|11287348|FG001|Main Treatment Part|Withdrawal by Subject|0
7136060|NCT02901431|11287349|FG002|Main Treatment Part|Withdrawal by Subject|0
7136061|NCT02901431|11287350|FG003|Main Treatment Part|Withdrawal by Subject|18
7136062|NCT02901431|11287351|FG004|Main Treatment Part|Withdrawal by Subject|3
7136063|NCT02901431|11287352|FG005|Main Treatment Part|Withdrawal by Subject|5
7136064|NCT02901431|11287353|FG006|Main Treatment Part|Withdrawal by Subject|6
7136065|NCT02901431|11287354|FG007|Main Treatment Part|Withdrawal by Subject|0
7136066|NCT02901431|11287355|FG008|Main Treatment Part|Withdrawal by Subject|0
7136067|NCT02901431|11287356|FG009|Main Treatment Part|Withdrawal by Subject|0
7136068|NCT02901431|11287357|FG010|Main Treatment Part|Withdrawal by Subject|0
7136069|NCT02901431|11287358|FG011|Main Treatment Part|Withdrawal by Subject|0
7136070|NCT02901431|11287359|FG012|Main Treatment Part|Withdrawal by Subject|0
7136071|NCT02901431|11287347|FG000|Open Label Part|Adverse Event|0
7136072|NCT02901431|11287348|FG001|Open Label Part|Adverse Event|0
7136073|NCT02901431|11287349|FG002|Open Label Part|Adverse Event|0
7136074|NCT02901431|11287350|FG003|Open Label Part|Adverse Event|0
7136075|NCT02901431|11287351|FG004|Open Label Part|Adverse Event|0
7136076|NCT02901431|11287352|FG005|Open Label Part|Adverse Event|0
7136077|NCT02901431|11287353|FG006|Open Label Part|Adverse Event|0
7136078|NCT02901431|11287354|FG007|Open Label Part|Adverse Event|0
7136079|NCT02901431|11287355|FG008|Open Label Part|Adverse Event|4
7136080|NCT02901431|11287356|FG009|Open Label Part|Adverse Event|4
7136081|NCT02901431|11287357|FG010|Open Label Part|Adverse Event|0
7136082|NCT02901431|11287358|FG011|Open Label Part|Adverse Event|4
7136083|NCT02901431|11287359|FG012|Open Label Part|Adverse Event|1
7136084|NCT02901431|11287347|FG000|Open Label Part|Lost to Follow-up|0
7136085|NCT02901431|11287348|FG001|Open Label Part|Lost to Follow-up|0
7136086|NCT02901431|11287349|FG002|Open Label Part|Lost to Follow-up|0
7136087|NCT02901431|11287350|FG003|Open Label Part|Lost to Follow-up|0
7136088|NCT02901431|11287351|FG004|Open Label Part|Lost to Follow-up|0
7136089|NCT02901431|11287352|FG005|Open Label Part|Lost to Follow-up|0
7136090|NCT02901431|11287353|FG006|Open Label Part|Lost to Follow-up|0
7136091|NCT02901431|11287354|FG007|Open Label Part|Lost to Follow-up|0
7136092|NCT02901431|11287355|FG008|Open Label Part|Lost to Follow-up|2
7136093|NCT02901431|11287356|FG009|Open Label Part|Lost to Follow-up|2
7136094|NCT02901431|11287357|FG010|Open Label Part|Lost to Follow-up|1
7136095|NCT02901431|11287358|FG011|Open Label Part|Lost to Follow-up|1
7136096|NCT02901431|11287359|FG012|Open Label Part|Lost to Follow-up|1
7136097|NCT02901431|11287347|FG000|Open Label Part|Physician Decision|0
7136098|NCT02901431|11287348|FG001|Open Label Part|Physician Decision|0
7136099|NCT02901431|11287349|FG002|Open Label Part|Physician Decision|0
7136100|NCT02901431|11287350|FG003|Open Label Part|Physician Decision|0
7136101|NCT02901431|11287351|FG004|Open Label Part|Physician Decision|0
7136102|NCT02901431|11287352|FG005|Open Label Part|Physician Decision|0
7136103|NCT02901431|11287353|FG006|Open Label Part|Physician Decision|0
7136104|NCT02901431|11287354|FG007|Open Label Part|Physician Decision|0
7136105|NCT02901431|11287355|FG008|Open Label Part|Physician Decision|1
7136106|NCT02901431|11287356|FG009|Open Label Part|Physician Decision|1
7136107|NCT02901431|11287357|FG010|Open Label Part|Physician Decision|0
7136108|NCT02901431|11287358|FG011|Open Label Part|Physician Decision|0
7136109|NCT02901431|11287359|FG012|Open Label Part|Physician Decision|0
7136110|NCT02901431|11287347|FG000|Open Label Part|Study Terminated By Sponsor|0
7136111|NCT02901431|11287348|FG001|Open Label Part|Study Terminated By Sponsor|0
7136112|NCT02901431|11287349|FG002|Open Label Part|Study Terminated By Sponsor|0
7136113|NCT02901431|11287350|FG003|Open Label Part|Study Terminated By Sponsor|0
7136114|NCT02901431|11287351|FG004|Open Label Part|Study Terminated By Sponsor|0
7136115|NCT02901431|11287352|FG005|Open Label Part|Study Terminated By Sponsor|0
7136116|NCT02901431|11287353|FG006|Open Label Part|Study Terminated By Sponsor|0
7136117|NCT02901431|11287354|FG007|Open Label Part|Study Terminated By Sponsor|0
7136118|NCT02901431|11287355|FG008|Open Label Part|Study Terminated By Sponsor|35
7136119|NCT02901431|11287356|FG009|Open Label Part|Study Terminated By Sponsor|12
7136120|NCT02901431|11287357|FG010|Open Label Part|Study Terminated By Sponsor|21
7136121|NCT02901431|11287358|FG011|Open Label Part|Study Terminated By Sponsor|31
7136122|NCT02901431|11287359|FG012|Open Label Part|Study Terminated By Sponsor|0
7136123|NCT02901431|11287347|FG000|Open Label Part|Withdrawal by Subject|0
7136124|NCT02901431|11287348|FG001|Open Label Part|Withdrawal by Subject|0
7136125|NCT02901431|11287349|FG002|Open Label Part|Withdrawal by Subject|0
7136126|NCT02901431|11287350|FG003|Open Label Part|Withdrawal by Subject|0
7136127|NCT02901431|11287351|FG004|Open Label Part|Withdrawal by Subject|0
7136128|NCT02901431|11287352|FG005|Open Label Part|Withdrawal by Subject|0
7136129|NCT02901431|11287353|FG006|Open Label Part|Withdrawal by Subject|0
7136130|NCT02901431|11287354|FG007|Open Label Part|Withdrawal by Subject|0
7136131|NCT02901431|11287355|FG008|Open Label Part|Withdrawal by Subject|6
7136132|NCT02901431|11287356|FG009|Open Label Part|Withdrawal by Subject|5
7136133|NCT02901431|11287357|FG010|Open Label Part|Withdrawal by Subject|7
7136134|NCT02901431|11287358|FG011|Open Label Part|Withdrawal by Subject|3
7136135|NCT02901431|11287359|FG012|Open Label Part|Withdrawal by Subject|1
7136136|NCT02902809|11287443|FG000|Overall Study|Discontinuation of asthma program|28
7136137|NCT02902965|11287455|FG000|Overall Study|Withdrawal by Subject|10
7136138|NCT02903030|11287462|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2
7136139|NCT02903030|11287463|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1
7136140|NCT02903238|11287481|FG000|Overall Study|Lost to Follow-up|4
7136141|NCT02903368|11287488|FG000|Overall Study|Not sprcified|4
7136142|NCT02903368|11287489|FG001|Overall Study|Not sprcified|0
7136143|NCT02903420|11287517|FG000|Overall Study|Death|3
7136144|NCT02903511|11287532|FG000|Overall Study|Withdrawal by Subject|1
7136145|NCT02903511|11287533|FG001|Overall Study|Withdrawal by Subject|0
7136146|NCT02903511|11287532|FG000|Overall Study|Lost to Follow-up|3
7136147|NCT02903511|11287533|FG001|Overall Study|Lost to Follow-up|2
7136148|NCT02903966|11287554|FG000|Part A (Day 1 to 43)|Adverse Event|1
7136149|NCT02903966|11287555|FG001|Part A (Day 1 to 43)|Adverse Event|0
7136150|NCT02903966|11287554|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0
7136151|NCT02903966|11287555|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1
7136152|NCT02903966|11287554|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0
7136153|NCT02903966|11287555|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1
7136154|NCT02904096|11287578|FG000|Overall Study|Adverse Event|1
7136155|NCT02904096|11287579|FG001|Overall Study|Adverse Event|0
7136156|NCT02904096|11287578|FG000|Overall Study|Withdrawal by Subject|4
7136157|NCT02904096|11287579|FG001|Overall Study|Withdrawal by Subject|3
7136158|NCT02904096|11287578|FG000|Overall Study|Lost to Follow-up|10
7136159|NCT02904096|11287579|FG001|Overall Study|Lost to Follow-up|17
7136160|NCT02904096|11287578|FG000|Overall Study|Non-compliant|3
7136161|NCT02904096|11287579|FG001|Overall Study|Non-compliant|1
6781044|NCT03052608|10776986|FG001|Long-Term Follow-up Phase|Death|28
6781045|NCT03052608|10776985|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0
6781046|NCT03052608|10776986|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2
6781047|NCT03052608|10776985|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4
6781048|NCT03052608|10776986|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18
6781049|NCT03052608|10776985|FG000|Long-Term Follow-up Phase|Ongoing|122
6781050|NCT03052608|10776986|FG001|Long-Term Follow-up Phase|Ongoing|99
6781051|NCT02938520|10776998|FG000|Overall Study|On-going at the time of analysis|258
6781052|NCT02938520|10776999|FG001|Overall Study|On-going at the time of analysis|261
6781053|NCT02938520|10776998|FG000|Overall Study|Physician Decision|2
6781054|NCT02938520|10776999|FG001|Overall Study|Physician Decision|5
6781055|NCT02938520|10776998|FG000|Overall Study|Lost to Follow-up|2
6781056|NCT02938520|10776999|FG001|Overall Study|Lost to Follow-up|2
6781057|NCT02938520|10776998|FG000|Overall Study|Withdrawal by Subject|7
6781058|NCT02938520|10776999|FG001|Overall Study|Withdrawal by Subject|7
7136162|NCT02904096|11287578|FG000|Overall Study|Sponsor instructed|1
7136163|NCT02904096|11287579|FG001|Overall Study|Sponsor instructed|0
7136164|NCT02904200|11287585|FG000|Overall Study|Withdrawal by Subject|1
7136165|NCT02904200|11287586|FG001|Overall Study|Withdrawal by Subject|0
7136166|NCT02904265|11287623|FG000|Overall Study|Physician Decision|1
7136167|NCT02904265|11287624|FG001|Overall Study|Physician Decision|2
7136168|NCT02904512|11287632|FG000|Overall Study|Withdrawal by Subject|1
7136169|NCT02904512|11287633|FG001|Overall Study|Withdrawal by Subject|0
7136170|NCT02904512|11287632|FG000|Overall Study|Transferred to ICU|1
7136171|NCT02904512|11287633|FG001|Overall Study|Transferred to ICU|0
7136172|NCT02904512|11287632|FG000|Overall Study|Minor Bleeding at site of device insertion|1
7136173|NCT02904512|11287633|FG001|Overall Study|Minor Bleeding at site of device insertion|0
7136174|NCT02904902|11287639|FG000|Overall Study|Withdrawal by Subject|1
7136175|NCT02904954|11287654|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1
7136176|NCT02904954|11287655|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1
7136177|NCT02904954|11287654|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1
7136178|NCT02904954|11287655|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0
7136179|NCT02904954|11287654|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2
7136180|NCT02904954|11287655|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3
7136181|NCT02904954|11287654|FG000|Adjuvant Durvalumab|Recurrence|2
7136182|NCT02904954|11287655|FG001|Adjuvant Durvalumab|Recurrence|0
7136183|NCT02904954|11287654|FG000|Adjuvant Durvalumab|Adverse Event|2
7136184|NCT02904954|11287655|FG001|Adjuvant Durvalumab|Adverse Event|6
7136185|NCT02904954|11287654|FG000|Adjuvant Durvalumab|Participant wishes|12
7136186|NCT02904954|11287655|FG001|Adjuvant Durvalumab|Participant wishes|5
7136187|NCT02904954|11287654|FG000|Adjuvant Durvalumab|Physician Decision|2
7136188|NCT02904954|11287655|FG001|Adjuvant Durvalumab|Physician Decision|1
7136189|NCT02904954|11287654|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1
7136190|NCT02904954|11287655|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0
7136191|NCT02904954|11287654|FG000|Adjuvant Durvalumab|Death|0
7136192|NCT02904954|11287655|FG001|Adjuvant Durvalumab|Death|1
7136193|NCT02904954|11287654|FG000|Adjuvant Durvalumab|Prostate cancer|1
7136194|NCT02904954|11287655|FG001|Adjuvant Durvalumab|Prostate cancer|0
7136195|NCT02904954|11287654|FG000|Adjuvant Durvalumab|Currently on treatment|1
7136196|NCT02904954|11287655|FG001|Adjuvant Durvalumab|Currently on treatment|3
7136197|NCT02905006|11287669|FG000|Overall Study|Adverse Event|1
7136198|NCT02905006|11287670|FG001|Overall Study|Adverse Event|1
7136199|NCT02905006|11287671|FG002|Overall Study|Adverse Event|1
7136200|NCT02905006|11287672|FG003|Overall Study|Adverse Event|1
7136201|NCT02905006|11287673|FG004|Overall Study|Adverse Event|0
7136202|NCT02905006|11287674|FG005|Overall Study|Adverse Event|1
7136203|NCT02905006|11287669|FG000|Overall Study|Lack of Efficacy|1
7136204|NCT02905006|11287670|FG001|Overall Study|Lack of Efficacy|0
7136205|NCT02905006|11287671|FG002|Overall Study|Lack of Efficacy|0
7136206|NCT02905006|11287672|FG003|Overall Study|Lack of Efficacy|0
7136207|NCT02905006|11287673|FG004|Overall Study|Lack of Efficacy|0
7136208|NCT02905006|11287674|FG005|Overall Study|Lack of Efficacy|0
7136209|NCT02905006|11287669|FG000|Overall Study|Protocol Violation|2
7136210|NCT02905006|11287670|FG001|Overall Study|Protocol Violation|0
7136211|NCT02905006|11287671|FG002|Overall Study|Protocol Violation|0
7136212|NCT02905006|11287672|FG003|Overall Study|Protocol Violation|0
7136213|NCT02905006|11287673|FG004|Overall Study|Protocol Violation|0
7136214|NCT02905006|11287674|FG005|Overall Study|Protocol Violation|0
7136215|NCT02905006|11287669|FG000|Overall Study|Lost to Follow-up|0
7136216|NCT02905006|11287670|FG001|Overall Study|Lost to Follow-up|0
7136217|NCT02905006|11287671|FG002|Overall Study|Lost to Follow-up|0
7136218|NCT02905006|11287672|FG003|Overall Study|Lost to Follow-up|1
7136219|NCT02905006|11287673|FG004|Overall Study|Lost to Follow-up|1
7136220|NCT02905006|11287674|FG005|Overall Study|Lost to Follow-up|0
7136221|NCT02905006|11287669|FG000|Overall Study|Withdrawal by Subject|0
7136222|NCT02905006|11287670|FG001|Overall Study|Withdrawal by Subject|0
7136223|NCT02905006|11287671|FG002|Overall Study|Withdrawal by Subject|1
7136224|NCT02905006|11287672|FG003|Overall Study|Withdrawal by Subject|1
7136225|NCT02905006|11287673|FG004|Overall Study|Withdrawal by Subject|0
7136226|NCT02905006|11287674|FG005|Overall Study|Withdrawal by Subject|1
7136227|NCT02905006|11287669|FG000|Overall Study|Screening exclusion criteria met|1
7136228|NCT02905006|11287670|FG001|Overall Study|Screening exclusion criteria met|0
7136229|NCT02905006|11287671|FG002|Overall Study|Screening exclusion criteria met|0
7136230|NCT02905006|11287672|FG003|Overall Study|Screening exclusion criteria met|0
7136231|NCT02905006|11287673|FG004|Overall Study|Screening exclusion criteria met|0
7136232|NCT02905006|11287674|FG005|Overall Study|Screening exclusion criteria met|0
7136233|NCT02905006|11287669|FG000|Overall Study|Lab withdrawal criterion met|0
7136234|NCT02905006|11287670|FG001|Overall Study|Lab withdrawal criterion met|1
7136235|NCT02905006|11287671|FG002|Overall Study|Lab withdrawal criterion met|2
6781059|NCT02938520|10776998|FG000|Overall Study|Protocol Violation|0
6781060|NCT02938520|10776999|FG001|Overall Study|Protocol Violation|1
6781061|NCT02938520|10776998|FG000|Overall Study|Lack of Efficacy|5
6781062|NCT02938520|10776999|FG001|Overall Study|Lack of Efficacy|3
6781063|NCT02938520|10776998|FG000|Overall Study|Adverse Event|9
6781064|NCT02938520|10776999|FG001|Overall Study|Adverse Event|4
6781065|NCT02922725|10777011|FG000|Overall Study|Withdrawal by Subject|1
6781066|NCT02922725|10777012|FG001|Overall Study|Withdrawal by Subject|0
6781067|NCT02922725|10777013|FG002|Overall Study|Withdrawal by Subject|0
6781068|NCT02886572|10777020|FG000|Overall Study|Death|8
6781069|NCT02831673|10777026|FG000|Overall Study|Adverse Event|6
6781070|NCT02831673|10777027|FG001|Overall Study|Adverse Event|4
6781071|NCT02831673|10777026|FG000|Overall Study|Lack of Efficacy|3
6781072|NCT02831673|10777027|FG001|Overall Study|Lack of Efficacy|1
6781073|NCT02831673|10777026|FG000|Overall Study|Protocol Violation|5
6781074|NCT02831673|10777027|FG001|Overall Study|Protocol Violation|4
6781075|NCT02831673|10777026|FG000|Overall Study|Protocol Withdrawal Criterion Met|1
6781076|NCT02831673|10777027|FG001|Overall Study|Protocol Withdrawal Criterion Met|6
6781077|NCT02831673|10777026|FG000|Overall Study|Lost to Follow-up|9
6781078|NCT02831673|10777027|FG001|Overall Study|Lost to Follow-up|6
6781079|NCT02831673|10777026|FG000|Overall Study|Physician Decision|6
6781080|NCT02831673|10777027|FG001|Overall Study|Physician Decision|3
6781081|NCT02831673|10777026|FG000|Overall Study|Withdrawal by Subject|6
6781082|NCT02831673|10777027|FG001|Overall Study|Withdrawal by Subject|4
6781083|NCT02831673|10777026|FG000|Overall Study|Ongoing at Week 48 primary analysis.|320
6781084|NCT02831673|10777027|FG001|Overall Study|Ongoing at Week 48 primary analysis.|330
6781085|NCT02805257|10777035|FG000|Overall Study|Lost to Follow-up|7
6781086|NCT02805257|10777036|FG001|Overall Study|Lost to Follow-up|6
6781087|NCT02805257|10777035|FG000|Overall Study|Death|0
6781088|NCT02805257|10777036|FG001|Overall Study|Death|1
7136236|NCT02905006|11287672|FG003|Overall Study|Lab withdrawal criterion met|2
7136237|NCT02905006|11287673|FG004|Overall Study|Lab withdrawal criterion met|2
7136238|NCT02905006|11287674|FG005|Overall Study|Lab withdrawal criterion met|1
7136239|NCT02905006|11287669|FG000|Overall Study|Positive for Tuberculosis|0
7136240|NCT02905006|11287670|FG001|Overall Study|Positive for Tuberculosis|1
7136241|NCT02905006|11287671|FG002|Overall Study|Positive for Tuberculosis|0
7136242|NCT02905006|11287672|FG003|Overall Study|Positive for Tuberculosis|0
7136243|NCT02905006|11287673|FG004|Overall Study|Positive for Tuberculosis|0
7136244|NCT02905006|11287674|FG005|Overall Study|Positive for Tuberculosis|0
7136245|NCT02905006|11287669|FG000|Overall Study|Subject positive for Hep B|0
7136246|NCT02905006|11287670|FG001|Overall Study|Subject positive for Hep B|0
7136247|NCT02905006|11287671|FG002|Overall Study|Subject positive for Hep B|1
7136248|NCT02905006|11287672|FG003|Overall Study|Subject positive for Hep B|0
7136249|NCT02905006|11287673|FG004|Overall Study|Subject positive for Hep B|0
6781089|NCT02696564|10777075|FG000|Overall Study|Death|1
6781090|NCT02696564|10777076|FG001|Overall Study|Death|2
6781091|NCT02696564|10777075|FG000|Overall Study|Withdrawal by Subject|3
6781092|NCT02696564|10777076|FG001|Overall Study|Withdrawal by Subject|2
7136250|NCT02905006|11287674|FG005|Overall Study|Subject positive for Hep B|0
7136251|NCT02905006|11287669|FG000|Overall Study|Patient moved abroad|0
7136252|NCT02905006|11287670|FG001|Overall Study|Patient moved abroad|0
7136253|NCT02905006|11287671|FG002|Overall Study|Patient moved abroad|0
7136254|NCT02905006|11287672|FG003|Overall Study|Patient moved abroad|1
7136255|NCT02905006|11287673|FG004|Overall Study|Patient moved abroad|0
7136256|NCT02905006|11287674|FG005|Overall Study|Patient moved abroad|0
7136257|NCT02905006|11287669|FG000|Overall Study|Patient randomized by mistake|0
7136258|NCT02905006|11287670|FG001|Overall Study|Patient randomized by mistake|0
7136259|NCT02905006|11287671|FG002|Overall Study|Patient randomized by mistake|0
7136260|NCT02905006|11287672|FG003|Overall Study|Patient randomized by mistake|0
7136261|NCT02905006|11287673|FG004|Overall Study|Patient randomized by mistake|0
7136262|NCT02905006|11287674|FG005|Overall Study|Patient randomized by mistake|1
7136263|NCT02905149|11287714|FG000|Overall Study|Lost to Follow-up|2
7136264|NCT02905149|11287715|FG001|Overall Study|Lost to Follow-up|0
7136265|NCT02905266|11287723|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1
7136266|NCT02905266|11287724|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0
7136267|NCT02905266|11287723|FG000|Treatment Phase Part 1|Disease Progression|6
7136268|NCT02905266|11287724|FG001|Treatment Phase Part 1|Disease Progression|7
7136269|NCT02905266|11287723|FG000|Treatment Phase Part 1|Study Drug Toxicity|22
7136270|NCT02905266|11287724|FG001|Treatment Phase Part 1|Study Drug Toxicity|16
7136271|NCT02905266|11287723|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1
7136272|NCT02905266|11287724|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0
7136273|NCT02905266|11287723|FG000|Transition From Part 1 to Part 2|Disease progression|2
7136274|NCT02905266|11287724|FG001|Transition From Part 1 to Part 2|Disease progression|1
6781093|NCT02696564|10777075|FG000|Overall Study|Lost to Follow-up|3
6781094|NCT02696564|10777076|FG001|Overall Study|Lost to Follow-up|3
6781095|NCT02696564|10777075|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3
6781096|NCT02696564|10777076|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1
6781097|NCT02696564|10777075|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2
6781098|NCT02696564|10777076|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2
6781099|NCT02696564|10777075|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1
6781100|NCT02696564|10777076|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1
7136275|NCT02905266|11287723|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0
7136276|NCT02905266|11287724|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4
7136277|NCT02905266|11287723|FG000|Transition From Part 1 to Part 2|Death|0
7136278|NCT02905266|11287724|FG001|Transition From Part 1 to Part 2|Death|1
7136279|NCT02905266|11287723|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0
7136280|NCT02905266|11287724|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1
7136281|NCT02905266|11287723|FG000|Transition From Part 1 to Part 2|Adverse Event|1
7136282|NCT02905266|11287724|FG001|Transition From Part 1 to Part 2|Adverse Event|1
7136283|NCT02905266|11287723|FG000|Maintenance Phase Part 2|Disease Progression|9
7136284|NCT02905266|11287724|FG001|Maintenance Phase Part 2|Disease Progression|2
7136285|NCT02905266|11287723|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3
7136286|NCT02905266|11287724|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4
7136287|NCT02905266|11287723|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0
7136288|NCT02905266|11287724|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2
7136289|NCT02905331|11287732|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1
7136290|NCT02905331|11287733|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0
7136291|NCT02905331|11287734|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0
7136292|NCT02905331|11287732|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2
7136293|NCT02905331|11287733|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0
7136294|NCT02905331|11287734|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0
7136295|NCT02905331|11287732|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0
7136296|NCT02905331|11287733|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1
7136297|NCT02905331|11287734|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0
7136298|NCT02905331|11287732|FG000|Active Treatment and Follow up (wk16-40)|Other|0
7136299|NCT02905331|11287733|FG001|Active Treatment and Follow up (wk16-40)|Other|6
7136300|NCT02905331|11287734|FG002|Active Treatment and Follow up (wk16-40)|Other|0
7136301|NCT02905331|11287732|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0
7136302|NCT02905331|11287733|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2
7136303|NCT02905331|11287734|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0
7136304|NCT02905435|11287742|FG000|Overall Study|Death|2
7136305|NCT02905435|11287742|FG000|Overall Study|Physician Decision|1
7136306|NCT02905435|11287742|FG000|Overall Study|Lost to Follow-up|4
7136307|NCT02905825|11287747|FG000|Overall Study|Protocol Violation|11
7136308|NCT02905825|11287747|FG000|Overall Study|Device Malfunction|1
7136309|NCT02906358|11287757|FG000|Overall Study|Withdrawal by Subject|10
7136310|NCT02906358|11287758|FG001|Overall Study|Withdrawal by Subject|7
7136311|NCT02906358|11287757|FG000|Overall Study|Lost to Follow-up|12
7136312|NCT02906358|11287758|FG001|Overall Study|Lost to Follow-up|15
7136313|NCT02906579|11287775|FG000|Overall Study|Adverse Event|1
7136314|NCT02906579|11287775|FG000|Overall Study|Physician Decision|1
7136315|NCT02906644|11287797|FG000|First 2 Weeks|Withdrawal by Subject|0
7136316|NCT02906644|11287798|FG001|First 2 Weeks|Withdrawal by Subject|2
7136317|NCT02906644|11287797|FG000|First 2 Weeks|Physician Decision|1
7136318|NCT02906644|11287798|FG001|First 2 Weeks|Physician Decision|1
7136319|NCT02906644|11287797|FG000|Weeks 3 to 14|Withdrawal by Subject|13
7136320|NCT02906644|11287798|FG001|Weeks 3 to 14|Withdrawal by Subject|7
7136321|NCT02906644|11287797|FG000|Weeks 3 to 14|Lost to Follow-up|3
7136322|NCT02906644|11287798|FG001|Weeks 3 to 14|Lost to Follow-up|4
7136323|NCT02906670|11287815|FG000|Cohort 1, QW|Radiological Progression|1
7136324|NCT02906670|11287816|FG001|Cohort 1, QW|Radiological Progression|0
7136325|NCT02906670|11287817|FG002|Cohort 1, QW|Radiological Progression|0
7136326|NCT02906670|11287818|FG003|Cohort 1, QW|Radiological Progression|0
7136327|NCT02906670|11287819|FG004|Cohort 1, QW|Radiological Progression|0
7136328|NCT02906670|11287820|FG005|Cohort 1, QW|Radiological Progression|0
7136329|NCT02906670|11287821|FG006|Cohort 1, QW|Radiological Progression|0
7136330|NCT02906670|11287822|FG007|Cohort 1, QW|Radiological Progression|0
7136331|NCT02906670|11287823|FG008|Cohort 1, QW|Radiological Progression|0
7136332|NCT02906670|11287824|FG009|Cohort 1, QW|Radiological Progression|0
7136333|NCT02906670|11287815|FG000|Cohort 2, QW|Radiological Progression|0
7136334|NCT02906670|11287816|FG001|Cohort 2, QW|Radiological Progression|1
7136335|NCT02906670|11287817|FG002|Cohort 2, QW|Radiological Progression|0
7136336|NCT02906670|11287818|FG003|Cohort 2, QW|Radiological Progression|0
7136337|NCT02906670|11287819|FG004|Cohort 2, QW|Radiological Progression|0
7136338|NCT02906670|11287820|FG005|Cohort 2, QW|Radiological Progression|0
7136339|NCT02906670|11287821|FG006|Cohort 2, QW|Radiological Progression|0
7136340|NCT02906670|11287822|FG007|Cohort 2, QW|Radiological Progression|0
7136341|NCT02906670|11287823|FG008|Cohort 2, QW|Radiological Progression|0
7136342|NCT02906670|11287824|FG009|Cohort 2, QW|Radiological Progression|0
7136343|NCT02906670|11287815|FG000|Cohort 3, QW|Radiological Progression|0
7136344|NCT02906670|11287816|FG001|Cohort 3, QW|Radiological Progression|0
7136345|NCT02906670|11287817|FG002|Cohort 3, QW|Radiological Progression|2
7136346|NCT02906670|11287818|FG003|Cohort 3, QW|Radiological Progression|0
7136347|NCT02906670|11287819|FG004|Cohort 3, QW|Radiological Progression|0
7136348|NCT02906670|11287820|FG005|Cohort 3, QW|Radiological Progression|0
7136349|NCT02906670|11287821|FG006|Cohort 3, QW|Radiological Progression|0
7136350|NCT02906670|11287822|FG007|Cohort 3, QW|Radiological Progression|0
7136351|NCT02906670|11287823|FG008|Cohort 3, QW|Radiological Progression|0
7136352|NCT02906670|11287824|FG009|Cohort 3, QW|Radiological Progression|0
7136353|NCT02906670|11287815|FG000|Cohort 3, QW|Lack of Clinical Benefit|0
7136354|NCT02906670|11287816|FG001|Cohort 3, QW|Lack of Clinical Benefit|0
7136355|NCT02906670|11287817|FG002|Cohort 3, QW|Lack of Clinical Benefit|2
7136356|NCT02906670|11287818|FG003|Cohort 3, QW|Lack of Clinical Benefit|0
7136357|NCT02906670|11287819|FG004|Cohort 3, QW|Lack of Clinical Benefit|0
7136358|NCT02906670|11287820|FG005|Cohort 3, QW|Lack of Clinical Benefit|0
7136359|NCT02906670|11287821|FG006|Cohort 3, QW|Lack of Clinical Benefit|0
7136360|NCT02906670|11287822|FG007|Cohort 3, QW|Lack of Clinical Benefit|0
7136361|NCT02906670|11287823|FG008|Cohort 3, QW|Lack of Clinical Benefit|0
7136362|NCT02906670|11287824|FG009|Cohort 3, QW|Lack of Clinical Benefit|0
7136363|NCT02906670|11287815|FG000|Cohort 4, Q2W|Radiological Progression|0
7136364|NCT02906670|11287816|FG001|Cohort 4, Q2W|Radiological Progression|0
7136365|NCT02906670|11287817|FG002|Cohort 4, Q2W|Radiological Progression|0
7136366|NCT02906670|11287818|FG003|Cohort 4, Q2W|Radiological Progression|0
7136367|NCT02906670|11287819|FG004|Cohort 4, Q2W|Radiological Progression|0
7136368|NCT02906670|11287820|FG005|Cohort 4, Q2W|Radiological Progression|1
7136369|NCT02906670|11287821|FG006|Cohort 4, Q2W|Radiological Progression|0
7136370|NCT02906670|11287822|FG007|Cohort 4, Q2W|Radiological Progression|0
7136371|NCT02906670|11287823|FG008|Cohort 4, Q2W|Radiological Progression|0
7136372|NCT02906670|11287824|FG009|Cohort 4, Q2W|Radiological Progression|0
7136373|NCT02906670|11287815|FG000|Cohort 4, Q2W|Clinical Progression|0
7136374|NCT02906670|11287816|FG001|Cohort 4, Q2W|Clinical Progression|0
7136375|NCT02906670|11287817|FG002|Cohort 4, Q2W|Clinical Progression|0
7136376|NCT02906670|11287818|FG003|Cohort 4, Q2W|Clinical Progression|0
7136377|NCT02906670|11287819|FG004|Cohort 4, Q2W|Clinical Progression|0
7136378|NCT02906670|11287820|FG005|Cohort 4, Q2W|Clinical Progression|2
7136379|NCT02906670|11287821|FG006|Cohort 4, Q2W|Clinical Progression|0
7136380|NCT02906670|11287822|FG007|Cohort 4, Q2W|Clinical Progression|0
7136381|NCT02906670|11287823|FG008|Cohort 4, Q2W|Clinical Progression|0
7136382|NCT02906670|11287824|FG009|Cohort 4, Q2W|Clinical Progression|0
7136383|NCT02906670|11287815|FG000|Cohort 5, Q2W|Radiological Progression|0
7136384|NCT02906670|11287816|FG001|Cohort 5, Q2W|Radiological Progression|0
7136385|NCT02906670|11287817|FG002|Cohort 5, Q2W|Radiological Progression|0
7136386|NCT02906670|11287818|FG003|Cohort 5, Q2W|Radiological Progression|0
7136387|NCT02906670|11287819|FG004|Cohort 5, Q2W|Radiological Progression|0
7136388|NCT02906670|11287820|FG005|Cohort 5, Q2W|Radiological Progression|0
7136389|NCT02906670|11287821|FG006|Cohort 5, Q2W|Radiological Progression|4
7136390|NCT02906670|11287822|FG007|Cohort 5, Q2W|Radiological Progression|0
7136391|NCT02906670|11287823|FG008|Cohort 5, Q2W|Radiological Progression|0
7136392|NCT02906670|11287824|FG009|Cohort 5, Q2W|Radiological Progression|0
7136393|NCT02906670|11287815|FG000|Cohort 5, Q2W|Clinical Progression|0
7136394|NCT02906670|11287816|FG001|Cohort 5, Q2W|Clinical Progression|0
7136395|NCT02906670|11287817|FG002|Cohort 5, Q2W|Clinical Progression|0
7136396|NCT02906670|11287818|FG003|Cohort 5, Q2W|Clinical Progression|0
7136397|NCT02906670|11287819|FG004|Cohort 5, Q2W|Clinical Progression|0
7136398|NCT02906670|11287820|FG005|Cohort 5, Q2W|Clinical Progression|0
7136399|NCT02906670|11287821|FG006|Cohort 5, Q2W|Clinical Progression|1
7136400|NCT02906670|11287822|FG007|Cohort 5, Q2W|Clinical Progression|0
7136401|NCT02906670|11287823|FG008|Cohort 5, Q2W|Clinical Progression|0
7136402|NCT02906670|11287824|FG009|Cohort 5, Q2W|Clinical Progression|0
7136403|NCT02906670|11287815|FG000|Cohort 5, Q2W|Adverse Event|0
7136404|NCT02906670|11287816|FG001|Cohort 5, Q2W|Adverse Event|0
7136405|NCT02906670|11287817|FG002|Cohort 5, Q2W|Adverse Event|0
7136406|NCT02906670|11287818|FG003|Cohort 5, Q2W|Adverse Event|0
7136407|NCT02906670|11287819|FG004|Cohort 5, Q2W|Adverse Event|0
7136408|NCT02906670|11287820|FG005|Cohort 5, Q2W|Adverse Event|0
7136409|NCT02906670|11287821|FG006|Cohort 5, Q2W|Adverse Event|1
7136410|NCT02906670|11287822|FG007|Cohort 5, Q2W|Adverse Event|0
7136411|NCT02906670|11287823|FG008|Cohort 5, Q2W|Adverse Event|0
7136412|NCT02906670|11287824|FG009|Cohort 5, Q2W|Adverse Event|0
7136413|NCT02906670|11287815|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0
7136414|NCT02906670|11287816|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0
7136415|NCT02906670|11287817|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0
7136416|NCT02906670|11287818|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0
7136417|NCT02906670|11287819|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0
7136418|NCT02906670|11287820|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0
7136419|NCT02906670|11287821|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1
7136420|NCT02906670|11287822|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0
7136421|NCT02906670|11287823|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0
7136422|NCT02906670|11287824|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0
7136423|NCT02906670|11287815|FG000|Cohort 5P, Q2W|Radiological Progression|0
7136424|NCT02906670|11287816|FG001|Cohort 5P, Q2W|Radiological Progression|0
7136425|NCT02906670|11287817|FG002|Cohort 5P, Q2W|Radiological Progression|0
7136426|NCT02906670|11287818|FG003|Cohort 5P, Q2W|Radiological Progression|0
7136427|NCT02906670|11287819|FG004|Cohort 5P, Q2W|Radiological Progression|0
7136428|NCT02906670|11287820|FG005|Cohort 5P, Q2W|Radiological Progression|0
7136429|NCT02906670|11287821|FG006|Cohort 5P, Q2W|Radiological Progression|0
7136430|NCT02906670|11287822|FG007|Cohort 5P, Q2W|Radiological Progression|2
7136431|NCT02906670|11287823|FG008|Cohort 5P, Q2W|Radiological Progression|0
7136432|NCT02906670|11287824|FG009|Cohort 5P, Q2W|Radiological Progression|0
7136433|NCT02906670|11287815|FG000|Cohort 5P, Q2W|Adverse Event|0
7136434|NCT02906670|11287816|FG001|Cohort 5P, Q2W|Adverse Event|0
7136435|NCT02906670|11287817|FG002|Cohort 5P, Q2W|Adverse Event|0
7136436|NCT02906670|11287818|FG003|Cohort 5P, Q2W|Adverse Event|0
7136437|NCT02906670|11287819|FG004|Cohort 5P, Q2W|Adverse Event|0
7136438|NCT02906670|11287820|FG005|Cohort 5P, Q2W|Adverse Event|0
7136439|NCT02906670|11287821|FG006|Cohort 5P, Q2W|Adverse Event|0
7136440|NCT02906670|11287822|FG007|Cohort 5P, Q2W|Adverse Event|1
7136441|NCT02906670|11287823|FG008|Cohort 5P, Q2W|Adverse Event|0
7136442|NCT02906670|11287824|FG009|Cohort 5P, Q2W|Adverse Event|0
7136443|NCT02906670|11287815|FG000|Cohort 6P, Q2W|Radiological Progression|0
7136444|NCT02906670|11287816|FG001|Cohort 6P, Q2W|Radiological Progression|0
7136445|NCT02906670|11287817|FG002|Cohort 6P, Q2W|Radiological Progression|0
7136446|NCT02906670|11287818|FG003|Cohort 6P, Q2W|Radiological Progression|0
7136447|NCT02906670|11287819|FG004|Cohort 6P, Q2W|Radiological Progression|0
7136448|NCT02906670|11287820|FG005|Cohort 6P, Q2W|Radiological Progression|0
7136449|NCT02906670|11287821|FG006|Cohort 6P, Q2W|Radiological Progression|0
7136450|NCT02906670|11287822|FG007|Cohort 6P, Q2W|Radiological Progression|0
7136451|NCT02906670|11287823|FG008|Cohort 6P, Q2W|Radiological Progression|1
7136452|NCT02906670|11287824|FG009|Cohort 6P, Q2W|Radiological Progression|0
7136453|NCT02906670|11287815|FG000|Cohort 6P, Q2W|Clinical Progression|0
7136454|NCT02906670|11287816|FG001|Cohort 6P, Q2W|Clinical Progression|0
7136455|NCT02906670|11287817|FG002|Cohort 6P, Q2W|Clinical Progression|0
7136456|NCT02906670|11287818|FG003|Cohort 6P, Q2W|Clinical Progression|0
7136457|NCT02906670|11287819|FG004|Cohort 6P, Q2W|Clinical Progression|0
7136458|NCT02906670|11287820|FG005|Cohort 6P, Q2W|Clinical Progression|0
7136459|NCT02906670|11287821|FG006|Cohort 6P, Q2W|Clinical Progression|0
7136460|NCT02906670|11287822|FG007|Cohort 6P, Q2W|Clinical Progression|0
7136461|NCT02906670|11287823|FG008|Cohort 6P, Q2W|Clinical Progression|3
7136462|NCT02906670|11287824|FG009|Cohort 6P, Q2W|Clinical Progression|0
6781101|NCT02696564|10777075|FG000|Overall Study|Participant diagnosed with lung cancer|1
6781102|NCT02696564|10777076|FG001|Overall Study|Participant diagnosed with lung cancer|0
6781103|NCT02696564|10777075|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0
6781104|NCT02696564|10777076|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2
7136463|NCT02906670|11287815|FG000|Cohort 4P, QW|Radiological Progression|0
6781109|NCT02685826|10777097|FG000|Overall Study|Adverse Event|2
6781110|NCT02685826|10777098|FG001|Overall Study|Adverse Event|0
6781111|NCT02685826|10777099|FG002|Overall Study|Adverse Event|1
6781112|NCT02685826|10777097|FG000|Overall Study|Progressive Disease|2
6781113|NCT02685826|10777098|FG001|Overall Study|Progressive Disease|1
6781114|NCT02685826|10777099|FG002|Overall Study|Progressive Disease|0
6781115|NCT02685826|10777097|FG000|Overall Study|Withdrawal by Subject|2
6781116|NCT02685826|10777098|FG001|Overall Study|Withdrawal by Subject|0
6781117|NCT02685826|10777099|FG002|Overall Study|Withdrawal by Subject|0
6781118|NCT02685826|10777097|FG000|Overall Study|Full Clinical Hold by FDA|19
6781119|NCT02685826|10777098|FG001|Overall Study|Full Clinical Hold by FDA|9
7136464|NCT02906670|11287816|FG001|Cohort 4P, QW|Radiological Progression|0
7136465|NCT02906670|11287817|FG002|Cohort 4P, QW|Radiological Progression|0
7136466|NCT02906670|11287818|FG003|Cohort 4P, QW|Radiological Progression|3
7136467|NCT02906670|11287819|FG004|Cohort 4P, QW|Radiological Progression|0
7136468|NCT02906670|11287820|FG005|Cohort 4P, QW|Radiological Progression|0
7136469|NCT02906670|11287821|FG006|Cohort 4P, QW|Radiological Progression|0
7136470|NCT02906670|11287822|FG007|Cohort 4P, QW|Radiological Progression|0
7136471|NCT02906670|11287823|FG008|Cohort 4P, QW|Radiological Progression|0
7136472|NCT02906670|11287824|FG009|Cohort 4P, QW|Radiological Progression|0
7136473|NCT02906670|11287815|FG000|Cohort 7P, Q2W|Adverse Event|0
7136474|NCT02906670|11287816|FG001|Cohort 7P, Q2W|Adverse Event|0
7136475|NCT02906670|11287817|FG002|Cohort 7P, Q2W|Adverse Event|0
7136476|NCT02906670|11287818|FG003|Cohort 7P, Q2W|Adverse Event|0
7136477|NCT02906670|11287819|FG004|Cohort 7P, Q2W|Adverse Event|0
7136478|NCT02906670|11287820|FG005|Cohort 7P, Q2W|Adverse Event|0
7136479|NCT02906670|11287821|FG006|Cohort 7P, Q2W|Adverse Event|0
7136480|NCT02906670|11287822|FG007|Cohort 7P, Q2W|Adverse Event|0
7136481|NCT02906670|11287823|FG008|Cohort 7P, Q2W|Adverse Event|0
7136482|NCT02906670|11287824|FG009|Cohort 7P, Q2W|Adverse Event|1
7136483|NCT02906670|11287815|FG000|Cohort 7P, Q2W|Physician Decision|0
7136484|NCT02906670|11287816|FG001|Cohort 7P, Q2W|Physician Decision|0
7136485|NCT02906670|11287817|FG002|Cohort 7P, Q2W|Physician Decision|0
7136486|NCT02906670|11287818|FG003|Cohort 7P, Q2W|Physician Decision|0
7136487|NCT02906670|11287819|FG004|Cohort 7P, Q2W|Physician Decision|0
7136488|NCT02906670|11287820|FG005|Cohort 7P, Q2W|Physician Decision|0
7136489|NCT02906670|11287821|FG006|Cohort 7P, Q2W|Physician Decision|0
7136490|NCT02906670|11287822|FG007|Cohort 7P, Q2W|Physician Decision|0
7136491|NCT02906670|11287823|FG008|Cohort 7P, Q2W|Physician Decision|0
7136492|NCT02906670|11287824|FG009|Cohort 7P, Q2W|Physician Decision|1
7136493|NCT02906670|11287815|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
7136494|NCT02906670|11287816|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
7136495|NCT02906670|11287817|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
7136496|NCT02906670|11287818|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
7136497|NCT02906670|11287819|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
7136498|NCT02906670|11287820|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
7136499|NCT02906670|11287821|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
7136500|NCT02906670|11287822|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
7136501|NCT02906670|11287823|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
7136502|NCT02906670|11287824|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1
7136503|NCT02906670|11287815|FG000|Cohort 5P, QW|Radiological Progression|0
7136504|NCT02906670|11287816|FG001|Cohort 5P, QW|Radiological Progression|0
7136505|NCT02906670|11287817|FG002|Cohort 5P, QW|Radiological Progression|0
7136506|NCT02906670|11287818|FG003|Cohort 5P, QW|Radiological Progression|0
7136507|NCT02906670|11287819|FG004|Cohort 5P, QW|Radiological Progression|3
7136508|NCT02906670|11287820|FG005|Cohort 5P, QW|Radiological Progression|0
7136509|NCT02906670|11287821|FG006|Cohort 5P, QW|Radiological Progression|0
7136510|NCT02906670|11287822|FG007|Cohort 5P, QW|Radiological Progression|0
7136511|NCT02906670|11287823|FG008|Cohort 5P, QW|Radiological Progression|0
7136512|NCT02906670|11287824|FG009|Cohort 5P, QW|Radiological Progression|0
7136513|NCT02906709|11287880|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1
7136514|NCT02906709|11287881|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2
7136515|NCT02906709|11287880|FG000|Phase A (Week 0 to Week 16)|Death|0
7136516|NCT02906709|11287881|FG001|Phase A (Week 0 to Week 16)|Death|1
7136517|NCT02906709|11287880|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3
7136518|NCT02906709|11287881|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0
7136519|NCT02906709|11287880|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2
7136520|NCT02906709|11287881|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0
7136521|NCT02906917|11287908|FG000|Initiation Period (Week 0-26)|Unclassified|1
7136522|NCT02906917|11287909|FG001|Initiation Period (Week 0-26)|Unclassified|3
7136523|NCT02906917|11287908|FG000|Initiation Period (Week 0-26)|Adverse Event|1
7136524|NCT02906917|11287909|FG001|Initiation Period (Week 0-26)|Adverse Event|0
7136525|NCT02906917|11287908|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1
7136526|NCT02906917|11287909|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4
7136527|NCT02906917|11287908|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3
7136528|NCT02906917|11287909|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4
7136529|NCT02906917|11287908|FG000|Intensification Period (Week 26-38)|Unclassified|3
7136530|NCT02906917|11287909|FG001|Intensification Period (Week 26-38)|Unclassified|2
7136531|NCT02906917|11287908|FG000|Intensification Period (Week 26-38)|Adverse Event|0
7136532|NCT02906917|11287909|FG001|Intensification Period (Week 26-38)|Adverse Event|2
7136533|NCT02906917|11287908|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3
7136534|NCT02906917|11287909|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1
7136535|NCT02906917|11287908|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3
7136536|NCT02906917|11287909|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2
7136537|NCT02906930|11287919|FG000|Overall Study|Withdrawal by Subject|0
7136538|NCT02906930|11287920|FG001|Overall Study|Withdrawal by Subject|5
7136539|NCT02906930|11287921|FG002|Overall Study|Withdrawal by Subject|5
7136540|NCT02906930|11287922|FG003|Overall Study|Withdrawal by Subject|4
7136541|NCT02906930|11287919|FG000|Overall Study|Lost to Follow-up|5
7136542|NCT02906930|11287920|FG001|Overall Study|Lost to Follow-up|7
7136543|NCT02906930|11287921|FG002|Overall Study|Lost to Follow-up|5
7136544|NCT02906930|11287922|FG003|Overall Study|Lost to Follow-up|2
7136545|NCT02906930|11287919|FG000|Overall Study|Death|0
7136546|NCT02906930|11287920|FG001|Overall Study|Death|0
7136547|NCT02906930|11287921|FG002|Overall Study|Death|1
7136548|NCT02906930|11287922|FG003|Overall Study|Death|0
7136549|NCT02906930|11287919|FG000|Overall Study|Other|1
7136550|NCT02906930|11287920|FG001|Overall Study|Other|2
7136551|NCT02906930|11287921|FG002|Overall Study|Other|1
7136552|NCT02906930|11287922|FG003|Overall Study|Other|2
7136553|NCT02907177|11287947|FG000|Overall Study|Death|0
7136554|NCT02907177|11287948|FG001|Overall Study|Death|1
7136555|NCT02907177|11287947|FG000|Overall Study|Physician Decision|3
7136556|NCT02907177|11287948|FG001|Overall Study|Physician Decision|3
7136557|NCT02907177|11287947|FG000|Overall Study|Withdrawal by Subject|15
7136558|NCT02907177|11287948|FG001|Overall Study|Withdrawal by Subject|7
7136559|NCT02907177|11287947|FG000|Overall Study|Sponsor's Decision|50
7136560|NCT02907177|11287948|FG001|Overall Study|Sponsor's Decision|57
6781120|NCT02685826|10777099|FG002|Overall Study|Full Clinical Hold by FDA|20
7136561|NCT02907216|11287956|FG000|Overall Study|No benefit to be obtained by continuing|0
7136562|NCT02907216|11287957|FG001|Overall Study|No benefit to be obtained by continuing|1
7136563|NCT02907216|11287956|FG000|Overall Study|Withdrawal by Subject|1
7136564|NCT02907216|11287957|FG001|Overall Study|Withdrawal by Subject|0
7136565|NCT02907463|11287971|FG000|Overall Study|Lost to Follow-up|17
7136566|NCT02907463|11287971|FG000|Overall Study|Death|10
7136567|NCT02907463|11287971|FG000|Overall Study|Withdrawal by Subject|4
7136568|NCT02907463|11287971|FG000|Overall Study|MIS Approach was not used|2
6806511|NCT04821245|10809063|FG000|Overall Study|Physician Decision|1
7136569|NCT02907463|11287971|FG000|Overall Study|Not Implanted with Study Device|2
7136570|NCT02907463|11287971|FG000|Overall Study|Device Explanted|1
7136571|NCT02907463|11287971|FG000|Overall Study|Missing Exit Form|1
7136572|NCT02907619|11287995|FG000|Overall Study|Study terminated by sponsor|18
7136573|NCT02907619|11287996|FG001|Overall Study|Study terminated by sponsor|18
7136574|NCT02907619|11287997|FG002|Overall Study|Study terminated by sponsor|19
7136575|NCT02907619|11287995|FG000|Overall Study|Death|0
7136576|NCT02907619|11287996|FG001|Overall Study|Death|0
7136577|NCT02907619|11287997|FG002|Overall Study|Death|1
7136578|NCT02907619|11287995|FG000|Overall Study|Withdrawal by Subject|1
7136579|NCT02907619|11287996|FG001|Overall Study|Withdrawal by Subject|1
7136580|NCT02907619|11287997|FG002|Overall Study|Withdrawal by Subject|0
7136581|NCT02907619|11287995|FG000|Overall Study|Other|0
7136582|NCT02907619|11287996|FG001|Overall Study|Other|1
7136583|NCT02907619|11287997|FG002|Overall Study|Other|0
7136584|NCT02907892|11288018|FG000|Overall Study|Lost to Follow-up|27
7136585|NCT02907892|11288019|FG001|Overall Study|Lost to Follow-up|40
7136586|NCT02908100|11288035|FG000|Overall Study|Adverse Event|7
7136587|NCT02908100|11288036|FG001|Overall Study|Adverse Event|6
7136588|NCT02908100|11288037|FG002|Overall Study|Adverse Event|9
7136589|NCT02908100|11288035|FG000|Overall Study|Death|2
7136590|NCT02908100|11288036|FG001|Overall Study|Death|0
7136591|NCT02908100|11288037|FG002|Overall Study|Death|0
7136592|NCT02908100|11288035|FG000|Overall Study|Lack of Efficacy|2
7136593|NCT02908100|11288036|FG001|Overall Study|Lack of Efficacy|3
7136594|NCT02908100|11288037|FG002|Overall Study|Lack of Efficacy|3
7136595|NCT02908100|11288035|FG000|Overall Study|Lost to Follow-up|0
7136596|NCT02908100|11288036|FG001|Overall Study|Lost to Follow-up|1
7136597|NCT02908100|11288037|FG002|Overall Study|Lost to Follow-up|2
7136598|NCT02908100|11288035|FG000|Overall Study|Non-Compliance With Study Drug|1
7136599|NCT02908100|11288036|FG001|Overall Study|Non-Compliance With Study Drug|1
7136600|NCT02908100|11288037|FG002|Overall Study|Non-Compliance With Study Drug|2
7136601|NCT02908100|11288035|FG000|Overall Study|Non-Compliance With Contraceptive Method|1
7136602|NCT02908100|11288036|FG001|Overall Study|Non-Compliance With Contraceptive Method|0
7136603|NCT02908100|11288037|FG002|Overall Study|Non-Compliance With Contraceptive Method|0
7136604|NCT02908100|11288035|FG000|Overall Study|Physician Decision|0
7136605|NCT02908100|11288036|FG001|Overall Study|Physician Decision|1
7136606|NCT02908100|11288037|FG002|Overall Study|Physician Decision|0
7136607|NCT02908100|11288035|FG000|Overall Study|Pregnancy|1
7136608|NCT02908100|11288036|FG001|Overall Study|Pregnancy|2
7136609|NCT02908100|11288037|FG002|Overall Study|Pregnancy|0
7136610|NCT02908100|11288035|FG000|Overall Study|Withdrawal by Subject|8
7136611|NCT02908100|11288036|FG001|Overall Study|Withdrawal by Subject|7
7136612|NCT02908100|11288037|FG002|Overall Study|Withdrawal by Subject|5
7136613|NCT02908100|11288035|FG000|Overall Study|Randomised in Error|1
7136614|NCT02908100|11288036|FG001|Overall Study|Randomised in Error|0
7136615|NCT02908100|11288037|FG002|Overall Study|Randomised in Error|0
7136616|NCT02908347|11288065|FG000|Overall Study|Adverse Event|0
7136617|NCT02908347|11288066|FG001|Overall Study|Adverse Event|1
7136618|NCT02908347|11288065|FG000|Overall Study|Lost to Follow-up|1
7136619|NCT02908347|11288066|FG001|Overall Study|Lost to Follow-up|0
7136620|NCT02908464|11288088|FG000|Overall Study|Withdrawal by Subject|2
7136621|NCT02908464|11288089|FG001|Overall Study|Withdrawal by Subject|1
7136622|NCT02908464|11288088|FG000|Overall Study|Found ineligible after randomization|0
7136623|NCT02908464|11288089|FG001|Overall Study|Found ineligible after randomization|2
7136624|NCT02908529|11288105|FG000|Overall Study|Lost to Follow-up|0
7136625|NCT02908529|11288106|FG001|Overall Study|Lost to Follow-up|2
7136626|NCT02908841|11288137|FG000|Overall Study|Physician Decision|4
7136627|NCT02908841|11288138|FG001|Overall Study|Physician Decision|0
7136628|NCT02908880|11288144|FG000|Overall Study|Lost to Follow-up|4
7136629|NCT02908880|11288144|FG000|Overall Study|Explantation of the device|1
7136630|NCT02908880|11288144|FG000|Overall Study|Withdrawal by Subject|17
7136631|NCT02908880|11288144|FG000|Overall Study|Death|5
7136632|NCT02909101|11288150|FG000|Overall Study|Lost to Follow-up|1
7136633|NCT02909101|11288151|FG001|Overall Study|Lost to Follow-up|1
7136634|NCT02909153|11288175|FG000|Overall Study|Withdrawal by Subject|0
7136635|NCT02909153|11288176|FG001|Overall Study|Withdrawal by Subject|1
7136636|NCT02909153|11288177|FG002|Overall Study|Withdrawal by Subject|0
7136637|NCT02909153|11288178|FG003|Overall Study|Withdrawal by Subject|0
7136638|NCT02909153|11288179|FG004|Overall Study|Withdrawal by Subject|0
7136639|NCT02909504|11288200|FG000|Overall Study|Adverse Event|2
7136640|NCT02909504|11288200|FG000|Overall Study|Lack of Efficacy|3
7136641|NCT02909504|11288200|FG000|Overall Study|Withdrawal by Subject|4
7136642|NCT02909504|11288200|FG000|Overall Study|Pregnancy|1
7136643|NCT02909504|11288200|FG000|Overall Study|Subject moved|1
7136644|NCT02909504|11288200|FG000|Overall Study|Lost to Follow-up|1
7136645|NCT02909907|11288219|FG000|Overall Study|Withdrawal by Subject|0
7136646|NCT02909907|11288220|FG001|Overall Study|Withdrawal by Subject|1
7136647|NCT02910011|11288235|FG000|Overall Study|Physician Decision|2
7136648|NCT02910037|11288241|FG000|Overall Study|Withdrawal by Subject|4
7136649|NCT02910037|11288241|FG000|Overall Study|Lost to Follow-up|6
7136650|NCT02910063|11288261|FG000|Phase 2|Withdrawal by Subject|3
7136651|NCT02910063|11288262|FG001|Phase 2|Withdrawal by Subject|0
7136652|NCT02910063|11288263|FG002|Phase 2|Withdrawal by Subject|0
7136653|NCT02910063|11288261|FG000|Phase 2|Lost to Follow-up|1
7136654|NCT02910063|11288262|FG001|Phase 2|Lost to Follow-up|0
7136655|NCT02910063|11288263|FG002|Phase 2|Lost to Follow-up|0
7136656|NCT02910063|11288261|FG000|Phase 2|Death|24
7136657|NCT02910063|11288262|FG001|Phase 2|Death|0
7136658|NCT02910063|11288263|FG002|Phase 2|Death|0
7136659|NCT02910089|11288274|FG000|Overall Study|Lost insurance eligibility|22
7136660|NCT02910089|11288275|FG001|Overall Study|Lost insurance eligibility|16
7136661|NCT02910167|11288295|FG000|Overall Study|Adverse Event|1
7136662|NCT02910167|11288295|FG000|Overall Study|Lost to Follow-up|18
7136663|NCT02910466|11288308|FG000|Overall Study|Adverse Event|1
7136664|NCT02910466|11288308|FG000|Overall Study|Withdrawal by Subject|3
7136665|NCT02910466|11288308|FG000|Overall Study|Lost to Follow-up|5
7136666|NCT02910466|11288308|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29
7136667|NCT02910466|11288308|FG000|Overall Study|Participant didn't meet inclusion criteria|1
7136668|NCT02910713|11288317|FG000|Overall Study|Protocol Violation|2
7136669|NCT02910713|11288317|FG000|Overall Study|Subject Choice|4
7136670|NCT02910713|11288317|FG000|Overall Study|Received One Application|10
7136671|NCT02910713|11288317|FG000|Overall Study|Received Neither Application|18
7136672|NCT02910713|11288317|FG000|Overall Study|Enrollment cap|7
7136673|NCT02910713|11288317|FG000|Overall Study|Investigator Discretion|1
7136674|NCT02910739|11288324|FG000|Overall Study|Adverse Event|1
7136675|NCT02910739|11288325|FG001|Overall Study|Adverse Event|0
7136676|NCT02910739|11288326|FG002|Overall Study|Adverse Event|0
7136677|NCT02910739|11288327|FG003|Overall Study|Adverse Event|0
7136678|NCT02911025|11288333|FG000|Overall Study|Lost to Follow-up|3
7136679|NCT02911116|11288339|FG000|Overall Study|Insufficient Therapeutic Response|1
7136680|NCT02911116|11288340|FG001|Overall Study|Insufficient Therapeutic Response|0
7136681|NCT02911116|11288339|FG000|Overall Study|Lost to Follow-up|0
7136682|NCT02911116|11288340|FG001|Overall Study|Lost to Follow-up|1
7136683|NCT02911285|11288348|FG000|Overall Study|Lost to Follow-up|8
7136684|NCT02911285|11288349|FG001|Overall Study|Lost to Follow-up|5
7136685|NCT02911285|11288348|FG000|Overall Study|Participant got a job and no longer had time to participate.|1
7136686|NCT02911285|11288349|FG001|Overall Study|Participant got a job and no longer had time to participate.|0
7136687|NCT02911519|11288371|FG000|Overall Study|Lost to Follow-up|2
7136688|NCT02911519|11288372|FG001|Overall Study|Lost to Follow-up|2
7136689|NCT02911519|11288371|FG000|Overall Study|Death|0
7136690|NCT02911519|11288372|FG001|Overall Study|Death|2
7136691|NCT02911688|11288380|FG000|Washout|Lost to Follow-up|1
7136692|NCT02911688|11288381|FG001|Washout|Lost to Follow-up|1
7136693|NCT02911688|11288380|FG000|Washout|Withdrawal by Subject|0
7136694|NCT02911688|11288381|FG001|Washout|Withdrawal by Subject|1
7136695|NCT02911948|11288480|FG000|Overall Study|Protocol Violation|0
7136696|NCT02911948|11288481|FG001|Overall Study|Protocol Violation|1
7136697|NCT02911948|11288480|FG000|Overall Study|Withdrawal by Subject|0
7136698|NCT02911948|11288481|FG001|Overall Study|Withdrawal by Subject|2
7136699|NCT02911948|11288480|FG000|Overall Study|Lack of Efficacy|0
7136700|NCT02911948|11288481|FG001|Overall Study|Lack of Efficacy|1
7136701|NCT02911948|11288480|FG000|Overall Study|Unclassified|0
7136702|NCT02911948|11288481|FG001|Overall Study|Unclassified|3
7136703|NCT02912455|11288508|FG000|Overall Study|Withdrawal by Subject|0
7136704|NCT02912455|11288509|FG001|Overall Study|Withdrawal by Subject|1
7136705|NCT02912455|11288508|FG000|Overall Study|Lack of Efficacy|0
7136706|NCT02912455|11288509|FG001|Overall Study|Lack of Efficacy|1
7136707|NCT02912455|11288508|FG000|Overall Study|Lost to Follow-up|2
7136708|NCT02912455|11288509|FG001|Overall Study|Lost to Follow-up|1
7136709|NCT02912468|11288517|FG000|Overall Study|Adverse Event|3
7136710|NCT02912468|11288518|FG001|Overall Study|Adverse Event|2
7136711|NCT02912468|11288517|FG000|Overall Study|Withdrawal by Subject|6
7136712|NCT02912468|11288518|FG001|Overall Study|Withdrawal by Subject|2
7136713|NCT02912468|11288517|FG000|Overall Study|Randomized and not treated|0
7136714|NCT02912468|11288518|FG001|Overall Study|Randomized and not treated|1
7136715|NCT02912650|11288529|FG000|Overall Study|Withdrawal by Subject|1
7136716|NCT02912650|11288530|FG001|Overall Study|Withdrawal by Subject|0
7136717|NCT02912650|11288531|FG002|Overall Study|Withdrawal by Subject|1
7136718|NCT02912650|11288532|FG003|Overall Study|Withdrawal by Subject|5
7136719|NCT02912650|11288529|FG000|Overall Study|Adverse Event|0
7136720|NCT02912650|11288530|FG001|Overall Study|Adverse Event|0
7136721|NCT02912650|11288531|FG002|Overall Study|Adverse Event|1
7136722|NCT02912650|11288532|FG003|Overall Study|Adverse Event|0
7136723|NCT02913105|11288545|FG000|Overall Study|Adverse Event|11
7136724|NCT02913105|11288546|FG001|Overall Study|Adverse Event|0
7136725|NCT02913105|11288547|FG002|Overall Study|Adverse Event|4
7136726|NCT02913105|11288545|FG000|Overall Study|Non-Compliance With Study Drug|0
7136727|NCT02913105|11288546|FG001|Overall Study|Non-Compliance With Study Drug|0
7136728|NCT02913105|11288547|FG002|Overall Study|Non-Compliance With Study Drug|1
7136729|NCT02913105|11288545|FG000|Overall Study|Reason Not Specified|3
7136730|NCT02913105|11288546|FG001|Overall Study|Reason Not Specified|1
7136731|NCT02913105|11288547|FG002|Overall Study|Reason Not Specified|1
7136732|NCT02913105|11288545|FG000|Overall Study|Physician Decision|1
7136733|NCT02913105|11288546|FG001|Overall Study|Physician Decision|1
7136734|NCT02913105|11288547|FG002|Overall Study|Physician Decision|0
7136735|NCT02913105|11288545|FG000|Overall Study|Withdrawal by Subject|0
7136736|NCT02913105|11288546|FG001|Overall Study|Withdrawal by Subject|3
7136737|NCT02913105|11288547|FG002|Overall Study|Withdrawal by Subject|1
7136738|NCT02913326|11288558|FG000|Overall Study|Reason not listed|0
7136739|NCT02913326|11288559|FG001|Overall Study|Reason not listed|1
7136740|NCT02913326|11288558|FG000|Overall Study|Lost to Follow-up|0
7136741|NCT02913326|11288559|FG001|Overall Study|Lost to Follow-up|1
7136742|NCT02913326|11288558|FG000|Overall Study|Adverse Event|1
7136743|NCT02913326|11288559|FG001|Overall Study|Adverse Event|0
7136744|NCT02914184|11288599|FG000|Overall Study|Lost to Follow-up|7
7136745|NCT02914184|11288600|FG001|Overall Study|Lost to Follow-up|10
7136746|NCT02914184|11288601|FG002|Overall Study|Lost to Follow-up|8
7136747|NCT02914184|11288602|FG003|Overall Study|Lost to Follow-up|7
7136748|NCT02914184|11288599|FG000|Overall Study|Withdrawal by Subject|4
7136749|NCT02914184|11288600|FG001|Overall Study|Withdrawal by Subject|2
7136750|NCT02914184|11288601|FG002|Overall Study|Withdrawal by Subject|7
7136751|NCT02914184|11288602|FG003|Overall Study|Withdrawal by Subject|3
7136752|NCT02914184|11288599|FG000|Overall Study|Other|1
7136753|NCT02914184|11288600|FG001|Overall Study|Other|0
7136754|NCT02914184|11288601|FG002|Overall Study|Other|0
7136755|NCT02914184|11288602|FG003|Overall Study|Other|0
7136756|NCT02914184|11288599|FG000|Overall Study|Migrated/moved from the study area|2
7136757|NCT02914184|11288600|FG001|Overall Study|Migrated/moved from the study area|1
7136758|NCT02914184|11288601|FG002|Overall Study|Migrated/moved from the study area|2
7136759|NCT02914184|11288602|FG003|Overall Study|Migrated/moved from the study area|1
7136760|NCT02914236|11288623|FG000|Overall Study|Lost to Follow-up|1
7136761|NCT02914275|11288629|FG000|Overall Study|Lost to Follow-up|84
7136762|NCT02914275|11288630|FG001|Overall Study|Lost to Follow-up|29
7136763|NCT02914275|11288629|FG000|Overall Study|Withdrawal by Subject|26
7136764|NCT02914275|11288630|FG001|Overall Study|Withdrawal by Subject|10
7136765|NCT02914275|11288629|FG000|Overall Study|Protocol Violation|1
7136766|NCT02914275|11288630|FG001|Overall Study|Protocol Violation|1
7136767|NCT02914275|11288629|FG000|Overall Study|Physician Decision|3
7136768|NCT02914275|11288630|FG001|Overall Study|Physician Decision|1
7136769|NCT02914275|11288629|FG000|Overall Study|Other|4
7136770|NCT02914275|11288630|FG001|Overall Study|Other|1
7136771|NCT02914275|11288629|FG000|Overall Study|Excluded due to invalid informed consent|3
7136772|NCT02914275|11288630|FG001|Overall Study|Excluded due to invalid informed consent|0
7136773|NCT02914457|11288640|FG000|Overall Study|Withdrawal by Subject|1
7136774|NCT02914457|11288640|FG000|Overall Study|Physician Decision|1
7136775|NCT02914457|11288640|FG000|Overall Study|No veins available for lead placement|1
7136776|NCT02914457|11288640|FG000|Overall Study|Electrical instability of patient|1
7136777|NCT02914457|11288640|FG000|Overall Study|ECG acquisition error due to sweating|1
7136778|NCT02914457|11288640|FG000|Overall Study|Protocol Violation|1
7136779|NCT02914522|11288661|FG000|Induction Study: Up to Week 11|Adverse Event|5
7136780|NCT02914522|11288662|FG001|Induction Study: Up to Week 11|Adverse Event|6
7136781|NCT02914522|11288663|FG002|Induction Study: Up to Week 11|Adverse Event|4
7136782|NCT02914522|11288664|FG003|Induction Study: Up to Week 11|Adverse Event|18
7136783|NCT02914522|11288665|FG004|Induction Study: Up to Week 11|Adverse Event|14
7136784|NCT02914522|11288666|FG005|Induction Study: Up to Week 11|Adverse Event|10
7136785|NCT02914522|11288667|FG006|Induction Study: Up to Week 11|Adverse Event|0
7136786|NCT02914522|11288668|FG007|Induction Study: Up to Week 11|Adverse Event|0
7136787|NCT02914522|11288669|FG008|Induction Study: Up to Week 11|Adverse Event|0
7136788|NCT02914522|11288670|FG009|Induction Study: Up to Week 11|Adverse Event|0
7136789|NCT02914522|11288671|FG010|Induction Study: Up to Week 11|Adverse Event|0
7136790|NCT02914522|11288661|FG000|Induction Study: Up to Week 11|Withdrew Consent|4
7136791|NCT02914522|11288662|FG001|Induction Study: Up to Week 11|Withdrew Consent|11
7136792|NCT02914522|11288663|FG002|Induction Study: Up to Week 11|Withdrew Consent|4
7136793|NCT02914522|11288664|FG003|Induction Study: Up to Week 11|Withdrew Consent|6
7136794|NCT02914522|11288665|FG004|Induction Study: Up to Week 11|Withdrew Consent|3
7136795|NCT02914522|11288666|FG005|Induction Study: Up to Week 11|Withdrew Consent|3
7136796|NCT02914522|11288667|FG006|Induction Study: Up to Week 11|Withdrew Consent|0
7136797|NCT02914522|11288668|FG007|Induction Study: Up to Week 11|Withdrew Consent|0
7136798|NCT02914522|11288669|FG008|Induction Study: Up to Week 11|Withdrew Consent|0
7136799|NCT02914522|11288670|FG009|Induction Study: Up to Week 11|Withdrew Consent|0
7136800|NCT02914522|11288671|FG010|Induction Study: Up to Week 11|Withdrew Consent|0
7136801|NCT02914522|11288661|FG000|Induction Study: Up to Week 11|Protocol Violation|0
7136802|NCT02914522|11288662|FG001|Induction Study: Up to Week 11|Protocol Violation|2
7136803|NCT02914522|11288663|FG002|Induction Study: Up to Week 11|Protocol Violation|1
7136804|NCT02914522|11288664|FG003|Induction Study: Up to Week 11|Protocol Violation|3
7136805|NCT02914522|11288665|FG004|Induction Study: Up to Week 11|Protocol Violation|4
7136806|NCT02914522|11288666|FG005|Induction Study: Up to Week 11|Protocol Violation|2
7136807|NCT02914522|11288667|FG006|Induction Study: Up to Week 11|Protocol Violation|0
7136808|NCT02914522|11288668|FG007|Induction Study: Up to Week 11|Protocol Violation|0
7136809|NCT02914522|11288669|FG008|Induction Study: Up to Week 11|Protocol Violation|0
7136810|NCT02914522|11288670|FG009|Induction Study: Up to Week 11|Protocol Violation|0
7136811|NCT02914522|11288671|FG010|Induction Study: Up to Week 11|Protocol Violation|0
7136812|NCT02914522|11288661|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0
7136813|NCT02914522|11288662|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2
7136814|NCT02914522|11288663|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1
7136815|NCT02914522|11288664|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1
7136816|NCT02914522|11288665|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0
7136817|NCT02914522|11288666|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0
7136818|NCT02914522|11288667|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0
7136819|NCT02914522|11288668|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0
7136820|NCT02914522|11288669|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0
7136821|NCT02914522|11288670|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0
7136822|NCT02914522|11288671|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0
7136823|NCT02914522|11288661|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0
7136824|NCT02914522|11288662|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0
7136825|NCT02914522|11288663|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0
7136826|NCT02914522|11288664|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0
7136827|NCT02914522|11288665|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1
7136828|NCT02914522|11288666|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0
7136829|NCT02914522|11288667|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0
7136830|NCT02914522|11288668|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0
7136831|NCT02914522|11288669|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0
7136832|NCT02914522|11288670|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0
7136833|NCT02914522|11288671|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0
7136834|NCT02914522|11288661|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1
7136835|NCT02914522|11288662|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7136836|NCT02914522|11288663|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7136837|NCT02914522|11288664|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7136838|NCT02914522|11288665|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7136839|NCT02914522|11288666|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7136840|NCT02914522|11288667|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7136841|NCT02914522|11288668|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7136842|NCT02914522|11288669|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7136843|NCT02914522|11288670|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7136844|NCT02914522|11288671|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7136845|NCT02914522|11288661|FG000|Induction Study: Up to Week 11|Pregnancy|0
7136846|NCT02914522|11288662|FG001|Induction Study: Up to Week 11|Pregnancy|0
7136847|NCT02914522|11288663|FG002|Induction Study: Up to Week 11|Pregnancy|0
7136848|NCT02914522|11288664|FG003|Induction Study: Up to Week 11|Pregnancy|0
7136849|NCT02914522|11288665|FG004|Induction Study: Up to Week 11|Pregnancy|1
7136850|NCT02914522|11288666|FG005|Induction Study: Up to Week 11|Pregnancy|0
7136851|NCT02914522|11288667|FG006|Induction Study: Up to Week 11|Pregnancy|0
7136852|NCT02914522|11288668|FG007|Induction Study: Up to Week 11|Pregnancy|0
7136853|NCT02914522|11288669|FG008|Induction Study: Up to Week 11|Pregnancy|0
7136854|NCT02914522|11288670|FG009|Induction Study: Up to Week 11|Pregnancy|0
7136855|NCT02914522|11288671|FG010|Induction Study: Up to Week 11|Pregnancy|0
7136856|NCT02914522|11288661|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0
7136857|NCT02914522|11288662|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1
7136858|NCT02914522|11288663|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0
7136859|NCT02914522|11288664|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0
7136860|NCT02914522|11288665|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1
7136861|NCT02914522|11288666|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1
7136862|NCT02914522|11288667|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0
7136863|NCT02914522|11288668|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0
7136864|NCT02914522|11288669|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0
7136865|NCT02914522|11288670|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0
7136866|NCT02914522|11288671|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0
7136867|NCT02914522|11288661|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
7136868|NCT02914522|11288662|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
7136869|NCT02914522|11288663|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
7136870|NCT02914522|11288664|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
7136871|NCT02914522|11288665|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
7136872|NCT02914522|11288666|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
7136873|NCT02914522|11288667|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34
7136874|NCT02914522|11288668|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49
7136875|NCT02914522|11288669|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53
7136876|NCT02914522|11288670|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39
7136877|NCT02914522|11288671|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21
7136878|NCT02914522|11288661|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0
7136879|NCT02914522|11288662|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0
6781149|NCT02663622|10777121|FG000|Overall Study|Death|3
6781150|NCT02663622|10777122|FG001|Overall Study|Death|1
6781151|NCT02663622|10777123|FG002|Overall Study|Death|1
6781152|NCT02663622|10777124|FG003|Overall Study|Death|8
6781153|NCT02663622|10777121|FG000|Overall Study|Protocol Violation|0
6781154|NCT02663622|10777122|FG001|Overall Study|Protocol Violation|0
6781155|NCT02663622|10777123|FG002|Overall Study|Protocol Violation|0
6781156|NCT02663622|10777124|FG003|Overall Study|Protocol Violation|1
6781157|NCT02640950|10777152|FG000|Overall Study|Adverse Event|1
7136880|NCT02914522|11288663|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0
7136881|NCT02914522|11288664|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0
7136882|NCT02914522|11288665|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0
7136883|NCT02914522|11288666|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0
7136884|NCT02914522|11288667|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7
7136885|NCT02914522|11288668|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2
7136886|NCT02914522|11288669|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10
7136887|NCT02914522|11288670|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4
7136888|NCT02914522|11288671|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3
7136889|NCT02914522|11288661|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
7136890|NCT02914522|11288662|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
7136891|NCT02914522|11288663|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
7136892|NCT02914522|11288664|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
7136893|NCT02914522|11288665|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
7136894|NCT02914522|11288666|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
7136895|NCT02914522|11288667|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5
7136896|NCT02914522|11288668|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5
7136897|NCT02914522|11288669|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3
7136898|NCT02914522|11288670|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
7136899|NCT02914522|11288671|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1
7136900|NCT02914522|11288661|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
7136901|NCT02914522|11288662|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
7136902|NCT02914522|11288663|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
7136903|NCT02914522|11288664|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
7136904|NCT02914522|11288665|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
7136905|NCT02914522|11288666|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
7136906|NCT02914522|11288667|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4
7136907|NCT02914522|11288668|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1
7136908|NCT02914522|11288669|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6
7136909|NCT02914522|11288670|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3
7136910|NCT02914522|11288671|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4
7136911|NCT02914522|11288661|FG000|Maintenance Study: Week 11 to Week 58|Death|0
7136912|NCT02914522|11288662|FG001|Maintenance Study: Week 11 to Week 58|Death|0
7136913|NCT02914522|11288663|FG002|Maintenance Study: Week 11 to Week 58|Death|0
7136914|NCT02914522|11288664|FG003|Maintenance Study: Week 11 to Week 58|Death|0
7136915|NCT02914522|11288665|FG004|Maintenance Study: Week 11 to Week 58|Death|0
7136916|NCT02914522|11288666|FG005|Maintenance Study: Week 11 to Week 58|Death|0
7136917|NCT02914522|11288667|FG006|Maintenance Study: Week 11 to Week 58|Death|2
7136918|NCT02914522|11288668|FG007|Maintenance Study: Week 11 to Week 58|Death|0
7136919|NCT02914522|11288669|FG008|Maintenance Study: Week 11 to Week 58|Death|0
7136920|NCT02914522|11288670|FG009|Maintenance Study: Week 11 to Week 58|Death|0
7136921|NCT02914522|11288671|FG010|Maintenance Study: Week 11 to Week 58|Death|0
7136922|NCT02914522|11288661|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
7136923|NCT02914522|11288662|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
7136924|NCT02914522|11288663|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
7136925|NCT02914522|11288664|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
7136926|NCT02914522|11288665|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
6781158|NCT02640950|10777152|FG000|Overall Study|Withdrawal by Subject|1
6781159|NCT02639065|10777156|FG000|Study Treatment|Disease Progression|11
6781160|NCT02639065|10777156|FG000|Study Treatment|Adverse Event|8
6781161|NCT02639065|10777156|FG000|Study Treatment|Withdrawal by Subject|1
6781162|NCT02639065|10777156|FG000|Follow up|Withdrawal by Subject|1
6781163|NCT02639065|10777156|FG000|Follow up|Symptomatic Deterioration|2
6781164|NCT02639065|10777156|FG000|Follow up|Death|2
6781165|NCT02639065|10777156|FG000|Follow up|Study Terminated|1
6781166|NCT02639065|10777156|FG000|Follow up|Disease Progression|3
6806512|NCT04821245|10809063|FG000|Overall Study|Protocol Violation|5
6810435|NCT03879772|10814161|FG002|Overall Study|Did Not Meet Entry Requirements|1
6810436|NCT03879772|10814162|FG003|Overall Study|Did Not Meet Entry Requirements|0
6810437|NCT03879772|10814163|FG004|Overall Study|Did Not Meet Entry Requirements|0
6810438|NCT03861559|10814177|FG000|Overall Study|Adverse Event|0
6810439|NCT03861559|10814178|FG001|Overall Study|Adverse Event|2
7136927|NCT02914522|11288666|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
7136928|NCT02914522|11288667|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
7136929|NCT02914522|11288668|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1
7136930|NCT02914522|11288669|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2
7136931|NCT02914522|11288670|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
7136932|NCT02914522|11288671|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
6810440|NCT03861559|10814177|FG000|Overall Study|Treatment failure|0
6810441|NCT03861559|10814178|FG001|Overall Study|Treatment failure|2
6810442|NCT03861559|10814177|FG000|Overall Study|Noncompliance|1
6810443|NCT03861559|10814178|FG001|Overall Study|Noncompliance|1
7136933|NCT02914522|11288661|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0
7136934|NCT02914522|11288662|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0
7136935|NCT02914522|11288663|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0
7136936|NCT02914522|11288664|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0
7136937|NCT02914522|11288665|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0
7136938|NCT02914522|11288666|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0
7136939|NCT02914522|11288667|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0
7136940|NCT02914522|11288668|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0
7136941|NCT02914522|11288669|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1
7136942|NCT02914522|11288670|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2
7136943|NCT02914522|11288671|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0
7136944|NCT02914522|11288661|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7136945|NCT02914522|11288662|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7136946|NCT02914522|11288663|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7136947|NCT02914522|11288664|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7136948|NCT02914522|11288665|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7136949|NCT02914522|11288666|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7136950|NCT02914522|11288667|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7136951|NCT02914522|11288668|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7136952|NCT02914522|11288669|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7136953|NCT02914522|11288670|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1
7136954|NCT02914522|11288671|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7136955|NCT02914548|11288701|FG000|Overall Study|Adverse Event|15
7136956|NCT02914548|11288702|FG001|Overall Study|Adverse Event|7
7136957|NCT02914548|11288703|FG002|Overall Study|Adverse Event|15
7136958|NCT02914548|11288701|FG000|Overall Study|Physician Decision|2
7136959|NCT02914548|11288702|FG001|Overall Study|Physician Decision|2
7136960|NCT02914548|11288703|FG002|Overall Study|Physician Decision|0
7136961|NCT02914548|11288701|FG000|Overall Study|Protocol Violation|1
7136962|NCT02914548|11288702|FG001|Overall Study|Protocol Violation|0
7136963|NCT02914548|11288703|FG002|Overall Study|Protocol Violation|0
7136964|NCT02914548|11288701|FG000|Overall Study|Withdrawal by Subject|3
7136965|NCT02914548|11288702|FG001|Overall Study|Withdrawal by Subject|4
7136966|NCT02914548|11288703|FG002|Overall Study|Withdrawal by Subject|4
7136967|NCT02914548|11288701|FG000|Overall Study|>40% of body surface area|0
7136968|NCT02914548|11288702|FG001|Overall Study|>40% of body surface area|1
7136969|NCT02914548|11288703|FG002|Overall Study|>40% of body surface area|1
7136970|NCT02914834|11288724|FG000|Overall Study|Study halted due to COVID|1
7136971|NCT02914834|11288725|FG001|Overall Study|Study halted due to COVID|1
6781167|NCT02564263|10777162|FG000|Overall Study|Adverse Event|31
6781168|NCT02564263|10777163|FG001|Overall Study|Adverse Event|29
6781169|NCT02564263|10777162|FG000|Overall Study|Death|236
6781170|NCT02564263|10777163|FG001|Overall Study|Death|242
6781171|NCT02564263|10777162|FG000|Overall Study|Withdrawal by Subject|5
6781172|NCT02564263|10777163|FG001|Overall Study|Withdrawal by Subject|18
6781173|NCT02564263|10777162|FG000|Overall Study|Ongoing in Study|42
6781174|NCT02564263|10777163|FG001|Overall Study|Ongoing in Study|25
6781175|NCT02422615|10777171|FG000|Overall Study|Progressive disease|193
6781176|NCT02422615|10777172|FG001|Overall Study|Progressive disease|142
6781177|NCT02422615|10777171|FG000|Overall Study|Adverse Event|41
6781178|NCT02422615|10777172|FG001|Overall Study|Adverse Event|10
6781179|NCT02422615|10777171|FG000|Overall Study|Physician Decision|22
6781180|NCT02422615|10777172|FG001|Overall Study|Physician Decision|7
6781181|NCT02422615|10777171|FG000|Overall Study|Subject/guardian decision|21
6781182|NCT02422615|10777172|FG001|Overall Study|Subject/guardian decision|5
6781183|NCT02422615|10777171|FG000|Overall Study|Death|2
6781184|NCT02422615|10777172|FG001|Overall Study|Death|0
6781185|NCT02422615|10777171|FG000|Overall Study|Protocol Violation|1
6781186|NCT02422615|10777172|FG001|Overall Study|Protocol Violation|1
6781187|NCT02422615|10777171|FG000|Overall Study|Technical problems|0
6781188|NCT02422615|10777172|FG001|Overall Study|Technical problems|1
6781189|NCT02372136|10777180|FG000|Overall Study|Death|3
6781190|NCT02372136|10777181|FG001|Overall Study|Death|1
6781191|NCT02367456|10777192|FG000|Overall Study|Death|8
6781192|NCT02367456|10777193|FG001|Overall Study|Death|21
6781193|NCT02367456|10777194|FG002|Overall Study|Death|14
6781194|NCT02367456|10777192|FG000|Overall Study|Lost to Follow-up|1
6781195|NCT02367456|10777193|FG001|Overall Study|Lost to Follow-up|3
6781196|NCT02367456|10777194|FG002|Overall Study|Lost to Follow-up|1
6781197|NCT02367456|10777192|FG000|Overall Study|Ongoing|0
6781198|NCT02367456|10777193|FG001|Overall Study|Ongoing|6
6781199|NCT02367456|10777194|FG002|Overall Study|Ongoing|15
6781200|NCT02367456|10777192|FG000|Overall Study|Other reason|3
6781201|NCT02367456|10777193|FG001|Overall Study|Other reason|0
6781202|NCT02367456|10777194|FG002|Overall Study|Other reason|0
6781203|NCT02091960|10777207|FG000|Overall Study|Death|7
6781204|NCT02091960|10777207|FG000|Overall Study|Withdrawal by Subject|1
6781205|NCT02091960|10777207|FG000|Overall Study|Miscellaneous Reasons|31
6781206|NCT02091960|10777207|FG000|Overall Study|On Study at Data Cut-off|12
6781207|NCT02022033|10777211|FG000|Overall Study|Physician Decision|1
6781208|NCT01942135|10777217|FG000|Overall Study|Adverse Event|9
7136972|NCT02914834|11288724|FG000|Overall Study|1 subject withdrew|0
7136973|NCT02914834|11288725|FG001|Overall Study|1 subject withdrew|1
7136974|NCT02915159|11288742|FG000|Overall Study|Participant no longer meets criteria|2
7136975|NCT02915159|11288743|FG001|Overall Study|Participant no longer meets criteria|0
7136976|NCT02915159|11288742|FG000|Overall Study|poor/non-compliance|1
7136977|NCT02915159|11288743|FG001|Overall Study|poor/non-compliance|0
7136978|NCT02915159|11288742|FG000|Overall Study|Participant withdrew consent|5
7136979|NCT02915159|11288743|FG001|Overall Study|Participant withdrew consent|1
7136980|NCT02915159|11288742|FG000|Overall Study|Request to discontinue treatment|1
7136981|NCT02915159|11288743|FG001|Overall Study|Request to discontinue treatment|2
7136982|NCT02915159|11288742|FG000|Overall Study|Adverse Event|2
7136983|NCT02915159|11288743|FG001|Overall Study|Adverse Event|2
7136984|NCT02915159|11288742|FG000|Overall Study|Lack of Efficacy|0
7136985|NCT02915159|11288743|FG001|Overall Study|Lack of Efficacy|3
7136986|NCT02915835|11288778|FG000|Overall Study|Physician Decision|1
7136987|NCT02915835|11288779|FG001|Overall Study|Physician Decision|0
7136988|NCT02915835|11288778|FG000|Overall Study|Withdrawal by Subject|0
7136989|NCT02915835|11288779|FG001|Overall Study|Withdrawal by Subject|1
7136990|NCT02915874|11288787|FG000|Overall Study|Lost to Follow-up|5
7136991|NCT02915874|11288788|FG001|Overall Study|Lost to Follow-up|4
7136992|NCT02915874|11288787|FG000|Overall Study|Withdrawal by Subject|1
7136993|NCT02915874|11288788|FG001|Overall Study|Withdrawal by Subject|1
7136994|NCT02915874|11288787|FG000|Overall Study|Started New Anxiety Medication|0
7136995|NCT02915874|11288788|FG001|Overall Study|Started New Anxiety Medication|1
7136996|NCT02915978|11288797|FG000|Overall Study|Adverse Event|2
7136997|NCT02915978|11288798|FG001|Overall Study|Adverse Event|1
7136998|NCT02915978|11288799|FG002|Overall Study|Adverse Event|0
7136999|NCT02916056|11288807|FG000|Overall Study|Adverse Event|6
7137000|NCT02916056|11288807|FG000|Overall Study|Lost to Follow-up|1
7137001|NCT02916056|11288807|FG000|Overall Study|Other|12
7137002|NCT02916056|11288807|FG000|Overall Study|Protocol Violation|1
7137003|NCT02916056|11288807|FG000|Overall Study|Withdrawal by Subject|8
7137004|NCT02916056|11288807|FG000|Overall Study|Study Terminated by Sponsor|269
7137005|NCT02916433|11288822|FG000|Overall Study|Withdrawal by Subject|1
7137006|NCT02916433|11288823|FG001|Overall Study|Withdrawal by Subject|0
7137007|NCT02916433|11288822|FG000|Overall Study|Physician Decision|1
7137008|NCT02916433|11288823|FG001|Overall Study|Physician Decision|0
7137009|NCT02916693|11288845|FG000|Overall Study|Lost to Follow-up|7
7137010|NCT02916927|11288859|FG000|Overall Study|Discharged prior to study drug receipt|0
7137011|NCT02916927|11288860|FG001|Overall Study|Discharged prior to study drug receipt|2
7137012|NCT02916927|11288859|FG000|Overall Study|At radiology for 45 & 60 min time points|0
7137013|NCT02916927|11288860|FG001|Overall Study|At radiology for 45 & 60 min time points|1
7137014|NCT02916927|11288859|FG000|Overall Study|Withdrawal before first time point|1
7137015|NCT02916927|11288860|FG001|Overall Study|Withdrawal before first time point|0
7137016|NCT02917031|11288869|FG000|Overall Study|Reason not specified|7
7137017|NCT02917031|11288870|FG001|Overall Study|Reason not specified|5
7137018|NCT02917031|11288871|FG002|Overall Study|Reason not specified|6
7137019|NCT02917031|11288869|FG000|Overall Study|Development of study-specific withdrawal criteria|1
7137020|NCT02917031|11288870|FG001|Overall Study|Development of study-specific withdrawal criteria|1
7137021|NCT02917031|11288871|FG002|Overall Study|Development of study-specific withdrawal criteria|0
7137022|NCT02917031|11288869|FG000|Overall Study|Withdrawal by Subject|3
7137023|NCT02917031|11288870|FG001|Overall Study|Withdrawal by Subject|3
7137024|NCT02917031|11288871|FG002|Overall Study|Withdrawal by Subject|0
7137025|NCT02917031|11288869|FG000|Overall Study|Physician Decision|1
7137026|NCT02917031|11288870|FG001|Overall Study|Physician Decision|0
7137027|NCT02917031|11288871|FG002|Overall Study|Physician Decision|0
7137028|NCT02917031|11288869|FG000|Overall Study|Adverse Event|4
7137029|NCT02917031|11288870|FG001|Overall Study|Adverse Event|1
7137030|NCT02917031|11288871|FG002|Overall Study|Adverse Event|5
7137031|NCT02917031|11288869|FG000|Overall Study|Death|2
7137032|NCT02917031|11288870|FG001|Overall Study|Death|3
7137033|NCT02917031|11288871|FG002|Overall Study|Death|4
7137034|NCT02917265|11288891|FG000|Overall Study|Physician Decision|1
7137035|NCT02917265|11288892|FG001|Overall Study|Physician Decision|0
7137036|NCT02917265|11288891|FG000|Overall Study|Withdrawal by Subject|1
7137037|NCT02917265|11288892|FG001|Overall Study|Withdrawal by Subject|0
7137038|NCT02917941|11288937|FG000|Treatment Period|Adverse Event|11
7137039|NCT02917941|11288937|FG000|Treatment Period|Progressive Disease|11
7137040|NCT02917941|11288937|FG000|Treatment Period|Reason not Specified|2
7137041|NCT02917941|11288937|FG000|Survival Follow-up Period|Lost to Follow-up|1
7137042|NCT02917941|11288937|FG000|Survival Follow-up Period|Withdrawal by Subject|4
7137043|NCT02918071|11288941|FG000|Overall Study|Withdrawal by Subject|2
7137044|NCT02918071|11288941|FG000|Overall Study|Lost to Follow-up|1
7137045|NCT02918266|11288960|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0
7137046|NCT02918266|11288961|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1
6781209|NCT01942135|10777218|FG001|Overall Study|Adverse Event|3
7137047|NCT02918266|11288962|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1
7137048|NCT02918266|11288963|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1
7137049|NCT02918266|11288964|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1
7137050|NCT02918266|11288965|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1
7137051|NCT02918266|11288966|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2
7137052|NCT02918266|11288967|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1
7137053|NCT02918266|11288968|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2
7137054|NCT02918266|11288969|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1
6781210|NCT01942135|10777217|FG000|Overall Study|Global deterioration of health status|8
6781211|NCT01942135|10777218|FG001|Overall Study|Global deterioration of health status|3
6781212|NCT01942135|10777217|FG000|Overall Study|Randomized Not Treated|2
6781213|NCT01942135|10777218|FG001|Overall Study|Randomized Not Treated|2
6781214|NCT01942135|10777217|FG000|Overall Study|Death|0
6781215|NCT01942135|10777218|FG001|Overall Study|Death|1
6781216|NCT01942135|10777217|FG000|Overall Study|ObjectiveProgression+Progressive Disease|85
6781217|NCT01942135|10777218|FG001|Overall Study|ObjectiveProgression+Progressive Disease|87
6781218|NCT01942135|10777217|FG000|Overall Study|Participant Refused toContinue Treatment|1
6781219|NCT01942135|10777218|FG001|Overall Study|Participant Refused toContinue Treatment|1
6781220|NCT01942135|10777217|FG000|Overall Study|Withdrawal by Subject|4
6781221|NCT01942135|10777218|FG001|Overall Study|Withdrawal by Subject|2
6781222|NCT01942135|10777217|FG000|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|238
6781223|NCT01942135|10777218|FG001|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|75
6781224|NCT01434602|10777229|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0
6781225|NCT01434602|10777230|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1
6781226|NCT01434602|10777231|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0
6781227|NCT01434602|10777232|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0
6781228|NCT01434602|10777233|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0
6781229|NCT01434602|10777229|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0
6781230|NCT01434602|10777230|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0
6781231|NCT01434602|10777231|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0
6781232|NCT01434602|10777232|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1
6781233|NCT01434602|10777233|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0
6781234|NCT01434602|10777229|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0
6781235|NCT01434602|10777230|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0
6781236|NCT01434602|10777231|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0
6781237|NCT01434602|10777232|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1
6781238|NCT01434602|10777233|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0
6781239|NCT01434602|10777229|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0
6781240|NCT01434602|10777230|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0
6781241|NCT01434602|10777231|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0
6781242|NCT01434602|10777232|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1
6781243|NCT01434602|10777233|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0
6781244|NCT01434602|10777229|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0
6781245|NCT01434602|10777230|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0
6781246|NCT01434602|10777231|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0
6781247|NCT01434602|10777232|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1
6781248|NCT01434602|10777233|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0
6781249|NCT01434602|10777229|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0
6781250|NCT01434602|10777230|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0
6781251|NCT01434602|10777231|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0
6781252|NCT01434602|10777232|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1
6781253|NCT01434602|10777233|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0
6781254|NCT01434602|10777229|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0
6781255|NCT01434602|10777230|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0
6781256|NCT01434602|10777231|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0
6781257|NCT01434602|10777232|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0
6781258|NCT01434602|10777233|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1
6781259|NCT01434602|10777229|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0
6781260|NCT01434602|10777230|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0
6781261|NCT01434602|10777231|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0
6781262|NCT01434602|10777232|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1
6781263|NCT01434602|10777233|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1
6781264|NCT01434602|10777229|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0
6806513|NCT04799782|10809078|FG000|Washout|Physician Decision|2
7137055|NCT02918266|11288970|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1
7137056|NCT02918279|11288992|FG000|Overall Study|Lost to Follow-up|3
7137057|NCT02918279|11288993|FG001|Overall Study|Lost to Follow-up|6
7137058|NCT02918279|11288992|FG000|Overall Study|Withdrawal by Subject|5
7137059|NCT02918279|11288993|FG001|Overall Study|Withdrawal by Subject|15
7137060|NCT02918279|11288992|FG000|Overall Study|Withdrawal by parent/guardian|2
7137061|NCT02918279|11288993|FG001|Overall Study|Withdrawal by parent/guardian|1
7137062|NCT02918279|11288992|FG000|Overall Study|Other|3
7137063|NCT02918279|11288993|FG001|Overall Study|Other|1
7137064|NCT02918318|11289003|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1
7137065|NCT02918318|11289004|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4
7137066|NCT02918318|11289005|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2
7137067|NCT02918318|11289006|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3
7137068|NCT02918318|11289007|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0
7137069|NCT02918318|11289003|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
7137070|NCT02918318|11289004|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
7137071|NCT02918318|11289005|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
7137072|NCT02918318|11289006|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2
7137073|NCT02918318|11289007|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
7137074|NCT02918318|11289003|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
6781265|NCT01434602|10777230|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0
6781266|NCT01434602|10777231|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0
6781267|NCT01434602|10777232|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1
6781268|NCT01434602|10777233|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0
6781269|NCT01434602|10777229|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0
6781270|NCT01434602|10777230|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0
6781271|NCT01434602|10777231|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0
6781272|NCT01434602|10777232|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2
6781273|NCT01434602|10777233|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0
6781274|NCT01358877|10777257|FG000|Overall Study|Death|80
6781275|NCT01358877|10777258|FG001|Overall Study|Death|89
6781276|NCT01358877|10777257|FG000|Overall Study|Ongoing follow-up for post-recurrence|87
6781277|NCT01358877|10777258|FG001|Overall Study|Ongoing follow-up for post-recurrence|108
6781278|NCT01358877|10777257|FG000|Overall Study|Ongoing follow-up for IDFS event|2084
6781279|NCT01358877|10777258|FG001|Overall Study|Ongoing follow-up for IDFS event|2073
6781280|NCT01358877|10777257|FG000|Overall Study|Ongoing follow-up for overall survival|7
6781281|NCT01358877|10777258|FG001|Overall Study|Ongoing follow-up for overall survival|5
6781282|NCT01358877|10777257|FG000|Overall Study|Other|142
6781283|NCT01358877|10777258|FG001|Overall Study|Other|129
6781290|NCT01239797|10777275|FG000|Randomized Participants|Participant no longer meets study criteria|1
6781291|NCT01239797|10777276|FG001|Randomized Participants|Participant no longer meets study criteria|1
6781292|NCT01239797|10777275|FG000|Randomized Participants|Participant withdrew consent|1
6781293|NCT01239797|10777276|FG001|Randomized Participants|Participant withdrew consent|7
6781294|NCT01239797|10777275|FG000|Randomized Participants|Adverse event unrelated to study drug|0
6781295|NCT01239797|10777276|FG001|Randomized Participants|Adverse event unrelated to study drug|1
6781296|NCT01239797|10777275|FG000|Treated Participants|Disease progression|185
6781297|NCT01239797|10777276|FG001|Treated Participants|Disease progression|185
6781298|NCT01239797|10777275|FG000|Treated Participants|Study drug toxicity|39
6781299|NCT01239797|10777276|FG001|Treated Participants|Study drug toxicity|45
6781300|NCT01239797|10777275|FG000|Treated Participants|Adverse event unrelated to study drug|31
6781301|NCT01239797|10777276|FG001|Treated Participants|Adverse event unrelated to study drug|37
6781302|NCT01239797|10777275|FG000|Treated Participants|Participants request to discontinue study treatment|28
6781303|NCT01239797|10777276|FG001|Treated Participants|Participants request to discontinue study treatment|18
6781304|NCT01239797|10777275|FG000|Treated Participants|Administrative reason by sponsor|13
6781305|NCT01239797|10777276|FG001|Treated Participants|Administrative reason by sponsor|4
6781306|NCT01239797|10777275|FG000|Treated Participants|Other reasons|14
6781307|NCT01239797|10777276|FG001|Treated Participants|Other reasons|14
6781308|NCT01239797|10777275|FG000|Treated Participants|Participant withdrew consent|6
6781309|NCT01239797|10777276|FG001|Treated Participants|Participant withdrew consent|11
6781310|NCT01239797|10777275|FG000|Treated Participants|Death|1
7137075|NCT02918318|11289004|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
7137076|NCT02918318|11289005|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
6781311|NCT01239797|10777276|FG001|Treated Participants|Death|1
6781312|NCT01239797|10777275|FG000|Treated Participants|Participant no longer meets study criteria|1
6781313|NCT01239797|10777276|FG001|Treated Participants|Participant no longer meets study criteria|1
6781314|NCT01239797|10777275|FG000|Treated Participants|Poor/non-compliance|0
6781315|NCT01239797|10777276|FG001|Treated Participants|Poor/non-compliance|1
6781316|NCT01236521|10777284|FG000|Overall Study|Withdrawal by Subject|12
6781317|NCT01236521|10777285|FG001|Overall Study|Withdrawal by Subject|17
6781318|NCT01236521|10777284|FG000|Overall Study|Death|2
6781319|NCT01236521|10777285|FG001|Overall Study|Death|1
6781320|NCT01236521|10777284|FG000|Overall Study|Lost to Follow-up|9
7137077|NCT02918318|11289006|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1
7137078|NCT02918318|11289007|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
7137079|NCT02918318|11289003|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1
7137080|NCT02918318|11289004|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1
7137081|NCT02918318|11289005|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0
7137082|NCT02918318|11289006|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0
7137083|NCT02918318|11289007|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0
7137084|NCT02918318|11289003|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
7137085|NCT02918318|11289004|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
7137086|NCT02918318|11289005|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
7137087|NCT02918318|11289006|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1
7137088|NCT02918318|11289007|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
7137089|NCT02918318|11289003|FG000|Double-blind Induction Phase: 4 Weeks|Other|0
7137090|NCT02918318|11289004|FG001|Double-blind Induction Phase: 4 Weeks|Other|2
7137091|NCT02918318|11289005|FG002|Double-blind Induction Phase: 4 Weeks|Other|0
7137092|NCT02918318|11289006|FG003|Double-blind Induction Phase: 4 Weeks|Other|1
7137093|NCT02918318|11289007|FG004|Double-blind Induction Phase: 4 Weeks|Other|0
7137094|NCT02918318|11289003|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
7137095|NCT02918318|11289004|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
7137096|NCT02918318|11289005|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
7137097|NCT02918318|11289006|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2
7137098|NCT02918318|11289007|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
7137099|NCT02918318|11289003|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1
7137100|NCT02918318|11289004|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0
7137101|NCT02918318|11289005|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1
7137102|NCT02918318|11289006|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1
7137103|NCT02918318|11289007|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0
7137104|NCT02918318|11289003|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1
7137105|NCT02918318|11289004|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0
7137106|NCT02918318|11289005|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0
7137107|NCT02918318|11289006|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1
7137108|NCT02918318|11289007|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0
7137109|NCT02918318|11289003|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0
7137110|NCT02918318|11289004|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3
7137111|NCT02918318|11289005|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1
7137112|NCT02918318|11289006|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1
7137113|NCT02918318|11289007|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0
7137114|NCT02918318|11289003|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
7137115|NCT02918318|11289004|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
7137116|NCT02918318|11289005|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
7137117|NCT02918318|11289006|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
7137118|NCT02918318|11289007|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1
7137119|NCT02918318|11289003|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
7137120|NCT02918318|11289004|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
7137121|NCT02918318|11289005|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
7137122|NCT02918318|11289006|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
7137123|NCT02918318|11289007|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1
6781321|NCT01236521|10777285|FG001|Overall Study|Lost to Follow-up|7
6781322|NCT01103349|10777294|FG000|Overall Study|Adverse Event|8
6781323|NCT01103349|10777295|FG001|Overall Study|Adverse Event|5
6781324|NCT01103349|10777296|FG002|Overall Study|Adverse Event|3
6781325|NCT01103349|10777294|FG000|Overall Study|Consent withdrawn|1
6781326|NCT01103349|10777295|FG001|Overall Study|Consent withdrawn|0
6781327|NCT01103349|10777296|FG002|Overall Study|Consent withdrawn|0
6781328|NCT01103349|10777294|FG000|Overall Study|Incorrectly included in the trial|1
6781329|NCT01103349|10777295|FG001|Overall Study|Incorrectly included in the trial|0
6781330|NCT01103349|10777296|FG002|Overall Study|Incorrectly included in the trial|0
6781331|NCT01103349|10777294|FG000|Overall Study|Withdrawal by Subject|1
6781332|NCT01103349|10777295|FG001|Overall Study|Withdrawal by Subject|1
6781333|NCT01103349|10777296|FG002|Overall Study|Withdrawal by Subject|0
6781334|NCT01103349|10777294|FG000|Overall Study|did not want to take trial medication|0
7137124|NCT02918552|11289065|FG000|Overall Study|Failed Pharmacokinetics|1
7137125|NCT02918552|11289066|FG001|Overall Study|Failed Pharmacokinetics|0
7137126|NCT02918552|11289065|FG000|Overall Study|Withdrawal by Subject|0
7137127|NCT02918552|11289066|FG001|Overall Study|Withdrawal by Subject|1
7137128|NCT02918552|11289065|FG000|Overall Study|Lost to Follow-up|0
7137129|NCT02918552|11289066|FG001|Overall Study|Lost to Follow-up|1
7137130|NCT02918877|11289165|FG000|Overall Study|Withdrawal by Subject|2
7137131|NCT02918877|11289166|FG001|Overall Study|Withdrawal by Subject|2
7137132|NCT02918877|11289165|FG000|Overall Study|Surgery cancelled|1
7137133|NCT02918877|11289166|FG001|Overall Study|Surgery cancelled|0
7137134|NCT02918877|11289165|FG000|Overall Study|Physician Decision|1
7137135|NCT02918877|11289166|FG001|Overall Study|Physician Decision|0
7137136|NCT02918877|11289165|FG000|Overall Study|Received intraoperative steroids|1
7137137|NCT02918877|11289166|FG001|Overall Study|Received intraoperative steroids|0
7137138|NCT02918877|11289165|FG000|Overall Study|Unable to obtain lab samples|1
7137139|NCT02918877|11289166|FG001|Overall Study|Unable to obtain lab samples|0
7137140|NCT02918877|11289165|FG000|Overall Study|Unsafe to perform BAL|0
7137141|NCT02918877|11289166|FG001|Overall Study|Unsafe to perform BAL|1
7137142|NCT02918968|11289174|FG000|1st Line AAT|Progressive disease|9
7137143|NCT02918968|11289175|FG001|1st Line AAT|Progressive disease|4
7137144|NCT02918968|11289174|FG000|1st Line AAT|Adverse Event|12
7137145|NCT02918968|11289175|FG001|1st Line AAT|Adverse Event|3
7137146|NCT02918968|11289174|FG000|1st Line AAT|Physician Decision|4
7137147|NCT02918968|11289175|FG001|1st Line AAT|Physician Decision|2
7137148|NCT02918968|11289174|FG000|1st Line AAT|Withdrawal by Subject|2
7137149|NCT02918968|11289175|FG001|1st Line AAT|Withdrawal by Subject|1
7137150|NCT02918968|11289174|FG000|1st Line AAT|Lost to Follow-up|0
7137151|NCT02918968|11289175|FG001|1st Line AAT|Lost to Follow-up|1
7137152|NCT02918968|11289174|FG000|1st Line AAT|Death|1
7137153|NCT02918968|11289175|FG001|1st Line AAT|Death|0
7137154|NCT02918968|11289174|FG000|1st Line AAT|Miscellaneous|1
7137155|NCT02918968|11289175|FG001|1st Line AAT|Miscellaneous|0
7137156|NCT02918968|11289174|FG000|2nd Line AAT|Progressive disease|21
7137157|NCT02918968|11289175|FG001|2nd Line AAT|Progressive disease|3
7137158|NCT02918968|11289174|FG000|2nd Line AAT|Adverse Event|2
7137159|NCT02918968|11289175|FG001|2nd Line AAT|Adverse Event|5
7137160|NCT02918968|11289174|FG000|2nd Line AAT|Physician Decision|0
7137161|NCT02918968|11289175|FG001|2nd Line AAT|Physician Decision|1
7137162|NCT02918968|11289174|FG000|2nd Line AAT|Withdrawal by Subject|2
7137163|NCT02918968|11289175|FG001|2nd Line AAT|Withdrawal by Subject|2
7137164|NCT02918968|11289174|FG000|2nd Line AAT|Death|0
7137165|NCT02918968|11289175|FG001|2nd Line AAT|Death|1
7137166|NCT02919267|11289195|FG000|Overall Study|Protocol Violation|0
7137167|NCT02919267|11289196|FG001|Overall Study|Protocol Violation|3
7137168|NCT02919267|11289197|FG002|Overall Study|Protocol Violation|3
7137169|NCT02919267|11289198|FG003|Overall Study|Protocol Violation|4
7137170|NCT02919475|11289222|FG000|Overall Study|Adverse Event|3
7137171|NCT02919475|11289223|FG001|Overall Study|Adverse Event|3
7137172|NCT02919475|11289224|FG002|Overall Study|Adverse Event|3
7137173|NCT02919475|11289225|FG003|Overall Study|Adverse Event|9
7137174|NCT02919475|11289226|FG004|Overall Study|Adverse Event|2
7137175|NCT02919475|11289222|FG000|Overall Study|Death|0
7137176|NCT02919475|11289223|FG001|Overall Study|Death|1
7137177|NCT02919475|11289224|FG002|Overall Study|Death|0
7137178|NCT02919475|11289225|FG003|Overall Study|Death|0
7137179|NCT02919475|11289226|FG004|Overall Study|Death|0
7137180|NCT02919475|11289222|FG000|Overall Study|Lost to Follow-up|0
7137181|NCT02919475|11289223|FG001|Overall Study|Lost to Follow-up|0
7137182|NCT02919475|11289224|FG002|Overall Study|Lost to Follow-up|0
7137183|NCT02919475|11289225|FG003|Overall Study|Lost to Follow-up|1
7137184|NCT02919475|11289226|FG004|Overall Study|Lost to Follow-up|0
7137185|NCT02919475|11289222|FG000|Overall Study|Withdrawal by Subject|2
7137186|NCT02919475|11289223|FG001|Overall Study|Withdrawal by Subject|3
7137187|NCT02919475|11289224|FG002|Overall Study|Withdrawal by Subject|1
7137188|NCT02919475|11289225|FG003|Overall Study|Withdrawal by Subject|2
7137189|NCT02919475|11289226|FG004|Overall Study|Withdrawal by Subject|2
7137190|NCT02919475|11289222|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1
7137191|NCT02919475|11289223|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1
7137192|NCT02919475|11289224|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1
7137193|NCT02919475|11289225|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1
7137194|NCT02919475|11289226|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7137195|NCT02919696|11289247|FG000|Overall Study|Adverse Event|1
7137196|NCT02919696|11289248|FG001|Overall Study|Adverse Event|2
7137197|NCT02919696|11289247|FG000|Overall Study|Withdrawal by Subject|2
7137198|NCT02919696|11289248|FG001|Overall Study|Withdrawal by Subject|1
7137199|NCT02919696|11289247|FG000|Overall Study|Sponsor Decision|1
7137200|NCT02919696|11289248|FG001|Overall Study|Sponsor Decision|1
7137201|NCT02919696|11289247|FG000|Overall Study|Never Treated|0
7137202|NCT02919696|11289248|FG001|Overall Study|Never Treated|1
7137203|NCT02919761|11289260|FG000|Part 1: Open Label|Withdrawal by Subject|12
7137204|NCT02919761|11289261|FG001|Part 1: Open Label|Withdrawal by Subject|0
7137205|NCT02919761|11289262|FG002|Part 1: Open Label|Withdrawal by Subject|0
7137206|NCT02919761|11289260|FG000|Part 1: Open Label|Adverse Event|1
7137207|NCT02919761|11289261|FG001|Part 1: Open Label|Adverse Event|0
7137208|NCT02919761|11289262|FG002|Part 1: Open Label|Adverse Event|0
7137209|NCT02919761|11289260|FG000|Part 1: Open Label|Lost to Follow-up|1
7137210|NCT02919761|11289261|FG001|Part 1: Open Label|Lost to Follow-up|0
7137211|NCT02919761|11289262|FG002|Part 1: Open Label|Lost to Follow-up|0
7137212|NCT02919761|11289260|FG000|Part 1: Open Label|Met withdrawal criteria|5
7137213|NCT02919761|11289261|FG001|Part 1: Open Label|Met withdrawal criteria|0
7137214|NCT02919761|11289262|FG002|Part 1: Open Label|Met withdrawal criteria|0
7137215|NCT02919761|11289260|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2
7137216|NCT02919761|11289261|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0
7137217|NCT02919761|11289262|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0
7137218|NCT02919761|11289260|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1
7137219|NCT02919761|11289261|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0
7137220|NCT02919761|11289262|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0
7137221|NCT02919761|11289260|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1
7137222|NCT02919761|11289261|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0
7137223|NCT02919761|11289262|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0
7137224|NCT02919761|11289260|FG000|Part 1: Open Label|Termination by Sponsor|1
6781335|NCT01103349|10777295|FG001|Overall Study|did not want to take trial medication|1
6781336|NCT01103349|10777296|FG002|Overall Study|did not want to take trial medication|0
6781337|NCT01103349|10777294|FG000|Overall Study|forgot to take medication|0
6781338|NCT01103349|10777295|FG001|Overall Study|forgot to take medication|0
7137225|NCT02919761|11289261|FG001|Part 1: Open Label|Termination by Sponsor|0
7137226|NCT02919761|11289262|FG002|Part 1: Open Label|Termination by Sponsor|0
7137227|NCT02919761|11289260|FG000|Part 2: Double-blind|Withdrawal by Subject|0
7137228|NCT02919761|11289261|FG001|Part 2: Double-blind|Withdrawal by Subject|0
7137229|NCT02919761|11289262|FG002|Part 2: Double-blind|Withdrawal by Subject|2
7137230|NCT02919761|11289260|FG000|Part 2: Double-blind|Adverse Event|0
7137231|NCT02919761|11289261|FG001|Part 2: Double-blind|Adverse Event|1
7137232|NCT02919761|11289262|FG002|Part 2: Double-blind|Adverse Event|0
7137233|NCT02919761|11289260|FG000|Part 2: Double-blind|Lost to Follow-up|0
7137234|NCT02919761|11289261|FG001|Part 2: Double-blind|Lost to Follow-up|0
7137235|NCT02919761|11289262|FG002|Part 2: Double-blind|Lost to Follow-up|3
7137236|NCT02919761|11289260|FG000|Part 2: Double-blind|Met withdrawal criteria|0
7137237|NCT02919761|11289261|FG001|Part 2: Double-blind|Met withdrawal criteria|1
7137238|NCT02919761|11289262|FG002|Part 2: Double-blind|Met withdrawal criteria|2
7137239|NCT02919761|11289260|FG000|Part 2: Double-blind|Worsening of disease activity|0
7137240|NCT02919761|11289261|FG001|Part 2: Double-blind|Worsening of disease activity|4
7137241|NCT02919761|11289262|FG002|Part 2: Double-blind|Worsening of disease activity|10
7137242|NCT02919761|11289260|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0
6781339|NCT01103349|10777296|FG002|Overall Study|forgot to take medication|1
6781340|NCT01092143|10777309|FG000|Overall Study|Adverse Event|10
6781341|NCT01092143|10777310|FG001|Overall Study|Adverse Event|5
6781342|NCT01092143|10777311|FG002|Overall Study|Adverse Event|1
6781343|NCT01092143|10777312|FG003|Overall Study|Adverse Event|4
6781344|NCT01092143|10777313|FG004|Overall Study|Adverse Event|3
6781345|NCT01092143|10777309|FG000|Overall Study|Lost to Follow-up|1
6781346|NCT01092143|10777310|FG001|Overall Study|Lost to Follow-up|0
6781347|NCT01092143|10777311|FG002|Overall Study|Lost to Follow-up|1
6781348|NCT01092143|10777312|FG003|Overall Study|Lost to Follow-up|0
6781349|NCT01092143|10777313|FG004|Overall Study|Lost to Follow-up|0
6781350|NCT01092143|10777309|FG000|Overall Study|Consent withdrawn|2
6781351|NCT01092143|10777310|FG001|Overall Study|Consent withdrawn|1
6781352|NCT01092143|10777311|FG002|Overall Study|Consent withdrawn|0
6781353|NCT01092143|10777312|FG003|Overall Study|Consent withdrawn|1
6781354|NCT01092143|10777313|FG004|Overall Study|Consent withdrawn|3
6781355|NCT01092143|10777309|FG000|Overall Study|Not treated|0
6781356|NCT01092143|10777310|FG001|Overall Study|Not treated|0
6781357|NCT01092143|10777311|FG002|Overall Study|Not treated|1
6781358|NCT01092143|10777312|FG003|Overall Study|Not treated|0
6781359|NCT01092143|10777313|FG004|Overall Study|Not treated|0
6781360|NCT01092143|10777309|FG000|Overall Study|did not reversibility criteria|0
6781361|NCT01092143|10777310|FG001|Overall Study|did not reversibility criteria|0
6781362|NCT01092143|10777311|FG002|Overall Study|did not reversibility criteria|1
6781363|NCT01092143|10777312|FG003|Overall Study|did not reversibility criteria|0
6781364|NCT01092143|10777313|FG004|Overall Study|did not reversibility criteria|0
6781365|NCT01092143|10777309|FG000|Overall Study|Increased Albuterol use for >2 days|0
6781366|NCT01092143|10777310|FG001|Overall Study|Increased Albuterol use for >2 days|1
6781367|NCT01092143|10777311|FG002|Overall Study|Increased Albuterol use for >2 days|0
6781368|NCT01092143|10777312|FG003|Overall Study|Increased Albuterol use for >2 days|0
6781369|NCT01092143|10777313|FG004|Overall Study|Increased Albuterol use for >2 days|0
6781370|NCT01092143|10777309|FG000|Overall Study|Ineligible patient|1
6781371|NCT01092143|10777310|FG001|Overall Study|Ineligible patient|0
6781372|NCT01092143|10777311|FG002|Overall Study|Ineligible patient|0
6781373|NCT01092143|10777312|FG003|Overall Study|Ineligible patient|0
6781374|NCT01092143|10777313|FG004|Overall Study|Ineligible patient|0
6781375|NCT01092143|10777309|FG000|Overall Study|Drop in FEV1 at visit 9|1
6781376|NCT01092143|10777310|FG001|Overall Study|Drop in FEV1 at visit 9|0
6781377|NCT01092143|10777311|FG002|Overall Study|Drop in FEV1 at visit 9|0
6781378|NCT01092143|10777312|FG003|Overall Study|Drop in FEV1 at visit 9|0
6781379|NCT01092143|10777313|FG004|Overall Study|Drop in FEV1 at visit 9|0
6781380|NCT01092143|10777309|FG000|Overall Study|Patient travel|0
7137243|NCT02919761|11289261|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0
7137244|NCT02919761|11289262|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1
7137245|NCT02919761|11289260|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0
7137246|NCT02919761|11289261|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0
7137247|NCT02919761|11289262|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1
7137248|NCT02919761|11289260|FG000|Part 2: Double-blind|Discontinued exclusion 16|0
7137249|NCT02919761|11289261|FG001|Part 2: Double-blind|Discontinued exclusion 16|0
7137250|NCT02919761|11289262|FG002|Part 2: Double-blind|Discontinued exclusion 16|2
7137251|NCT02919995|11289299|FG000|Overall Study|Adverse Event|0
7137252|NCT02919995|11289300|FG001|Overall Study|Adverse Event|0
7137253|NCT02919995|11289301|FG002|Overall Study|Adverse Event|0
7137254|NCT02919995|11289302|FG003|Overall Study|Adverse Event|0
7137255|NCT02919995|11289303|FG004|Overall Study|Adverse Event|0
7137256|NCT02919995|11289304|FG005|Overall Study|Adverse Event|1
7137257|NCT02920528|11289315|FG000|Overall Study|Incomplete Data|1
7137258|NCT02920528|11289316|FG001|Overall Study|Incomplete Data|1
7137259|NCT02920528|11289317|FG002|Overall Study|Incomplete Data|1
7137260|NCT02920528|11289315|FG000|Overall Study|Adverse Event|0
7137261|NCT02920528|11289316|FG001|Overall Study|Adverse Event|0
7137262|NCT02920528|11289317|FG002|Overall Study|Adverse Event|3
7137263|NCT02920528|11289315|FG000|Overall Study|Did not meet inclusion criteria|2
7137264|NCT02920528|11289316|FG001|Overall Study|Did not meet inclusion criteria|0
7137265|NCT02920528|11289317|FG002|Overall Study|Did not meet inclusion criteria|1
7137266|NCT02920957|11289355|FG000|First Intervention : 1 Month|Withdrawal by Subject|2
7137267|NCT02920957|11289356|FG001|First Intervention : 1 Month|Withdrawal by Subject|0
7137268|NCT02920957|11289355|FG000|First Intervention : 1 Month|Lost to Follow-up|1
7137269|NCT02920957|11289356|FG001|First Intervention : 1 Month|Lost to Follow-up|0
7137270|NCT02920957|11289355|FG000|First Intervention : 1 Month|Adverse Event|1
7137271|NCT02920957|11289356|FG001|First Intervention : 1 Month|Adverse Event|0
7137272|NCT02920957|11289355|FG000|Second Intervention: 1 Month|Lost to Follow-up|0
7137273|NCT02920957|11289356|FG001|Second Intervention: 1 Month|Lost to Follow-up|1
7137274|NCT02920970|11289373|FG000|First Intervention|Protocol Violation|0
7137275|NCT02920970|11289374|FG001|First Intervention|Protocol Violation|1
7137276|NCT02920970|11289373|FG000|First Intervention|Adverse Event|0
7137277|NCT02920970|11289374|FG001|First Intervention|Adverse Event|1
7137278|NCT02920970|11289373|FG000|Second Intervention|Poor Lens Fit|1
7137279|NCT02920970|11289374|FG001|Second Intervention|Poor Lens Fit|0
7137280|NCT02920983|11289382|FG000|Dispense 1|Unacceptable Lens Fit|0
7137281|NCT02920983|11289383|FG001|Dispense 1|Unacceptable Lens Fit|0
7137282|NCT02920983|11289384|FG002|Dispense 1|Unacceptable Lens Fit|0
7137283|NCT02920983|11289385|FG003|Dispense 1|Unacceptable Lens Fit|0
7137284|NCT02920983|11289386|FG004|Dispense 1|Unacceptable Lens Fit|1
7137285|NCT02920983|11289387|FG005|Dispense 1|Unacceptable Lens Fit|0
7137286|NCT02920983|11289382|FG000|Dispense 2|Unscceptable lens fit|1
6781381|NCT01092143|10777310|FG001|Overall Study|Patient travel|0
6781382|NCT01092143|10777311|FG002|Overall Study|Patient travel|0
6781383|NCT01092143|10777312|FG003|Overall Study|Patient travel|0
6781384|NCT01092143|10777313|FG004|Overall Study|Patient travel|1
6781385|NCT01092143|10777309|FG000|Overall Study|Non compliance with study medication|0
6781386|NCT01092143|10777310|FG001|Overall Study|Non compliance with study medication|0
6781387|NCT01092143|10777311|FG002|Overall Study|Non compliance with study medication|0
6781388|NCT01092143|10777312|FG003|Overall Study|Non compliance with study medication|0
6781389|NCT01092143|10777313|FG004|Overall Study|Non compliance with study medication|1
6781390|NCT01092143|10777309|FG000|Overall Study|Randomized by mistake|0
6781391|NCT01092143|10777310|FG001|Overall Study|Randomized by mistake|0
6781392|NCT01092143|10777311|FG002|Overall Study|Randomized by mistake|0
6781393|NCT01092143|10777312|FG003|Overall Study|Randomized by mistake|1
6781394|NCT01092143|10777313|FG004|Overall Study|Randomized by mistake|0
6781395|NCT01092143|10777309|FG000|Overall Study|Pregnancy|0
6781396|NCT01092143|10777310|FG001|Overall Study|Pregnancy|0
6781397|NCT01092143|10777311|FG002|Overall Study|Pregnancy|0
6781398|NCT01092143|10777312|FG003|Overall Study|Pregnancy|1
6781399|NCT01092143|10777313|FG004|Overall Study|Pregnancy|0
7137287|NCT02920983|11289383|FG001|Dispense 2|Unscceptable lens fit|0
7137288|NCT02920983|11289384|FG002|Dispense 2|Unscceptable lens fit|0
7137289|NCT02920983|11289385|FG003|Dispense 2|Unscceptable lens fit|0
7137290|NCT02920983|11289386|FG004|Dispense 2|Unscceptable lens fit|1
7137291|NCT02920983|11289387|FG005|Dispense 2|Unscceptable lens fit|0
7137292|NCT02920983|11289382|FG000|Dispense 3|Unacceptable Lens Fit|1
7137293|NCT02920983|11289383|FG001|Dispense 3|Unacceptable Lens Fit|1
7137294|NCT02920983|11289384|FG002|Dispense 3|Unacceptable Lens Fit|0
7137295|NCT02920983|11289385|FG003|Dispense 3|Unacceptable Lens Fit|0
7137296|NCT02920983|11289386|FG004|Dispense 3|Unacceptable Lens Fit|1
7137297|NCT02920983|11289387|FG005|Dispense 3|Unacceptable Lens Fit|0
7137298|NCT02921087|11289401|FG000|Overall Study|Withdrawal by Subject|0
7137299|NCT02921087|11289402|FG001|Overall Study|Withdrawal by Subject|1
7137300|NCT02921425|11289446|FG000|Overall Study|Protocol Violation|9
6806514|NCT04799782|10809079|FG001|Washout|Physician Decision|0
6806515|NCT04799782|10809078|FG000|Washout|Withdrawal by Subject|0
6806516|NCT04799782|10809079|FG001|Washout|Withdrawal by Subject|2
6806517|NCT04799782|10809078|FG000|Washout|Lost to Follow-up|0
6806518|NCT04799782|10809079|FG001|Washout|Lost to Follow-up|1
6810444|NCT03861559|10814177|FG000|Overall Study|Did not meet eligibility requirements|1
6810445|NCT03861559|10814178|FG001|Overall Study|Did not meet eligibility requirements|0
6810446|NCT03855228|10814188|FG000|Overall Study|Adverse Event|2
6810447|NCT03855228|10814189|FG001|Overall Study|Adverse Event|4
6810448|NCT03855228|10814190|FG002|Overall Study|Adverse Event|4
6810449|NCT03855228|10814191|FG003|Overall Study|Adverse Event|8
6810450|NCT03855228|10814188|FG000|Overall Study|Treatment Failure|1
6810451|NCT03855228|10814189|FG001|Overall Study|Treatment Failure|2
6810452|NCT03855228|10814190|FG002|Overall Study|Treatment Failure|1
6810453|NCT03855228|10814191|FG003|Overall Study|Treatment Failure|8
6810454|NCT03855228|10814188|FG000|Overall Study|Lost to Follow-up|0
6810455|NCT03855228|10814189|FG001|Overall Study|Lost to Follow-up|0
6810456|NCT03855228|10814190|FG002|Overall Study|Lost to Follow-up|0
6810457|NCT03855228|10814191|FG003|Overall Study|Lost to Follow-up|1
6810458|NCT03855228|10814188|FG000|Overall Study|Protocol Violation|0
6810459|NCT03855228|10814189|FG001|Overall Study|Protocol Violation|1
6810460|NCT03855228|10814190|FG002|Overall Study|Protocol Violation|2
6810461|NCT03855228|10814191|FG003|Overall Study|Protocol Violation|1
6810462|NCT03855228|10814188|FG000|Overall Study|Did Not Meet Entry Requirements|0
6810463|NCT03855228|10814189|FG001|Overall Study|Did Not Meet Entry Requirements|2
6810464|NCT03855228|10814190|FG002|Overall Study|Did Not Meet Entry Requirements|1
6810465|NCT03855228|10814191|FG003|Overall Study|Did Not Meet Entry Requirements|1
6810466|NCT03855189|10814204|FG000|Overall Study|Adverse Event|5
6810467|NCT03855189|10814205|FG001|Overall Study|Adverse Event|2
6810468|NCT03855189|10814206|FG002|Overall Study|Adverse Event|4
6810469|NCT03855189|10814204|FG000|Overall Study|Treatment Failure|1
6810470|NCT03855189|10814205|FG001|Overall Study|Treatment Failure|1
6810471|NCT03855189|10814206|FG002|Overall Study|Treatment Failure|2
7137301|NCT02921750|11289460|FG000|Overall Study|Adverse Event|1
6810472|NCT03855189|10814204|FG000|Overall Study|Noncompliance with Protocol|0
6810473|NCT03855189|10814205|FG001|Overall Study|Noncompliance with Protocol|1
6810474|NCT03855189|10814206|FG002|Overall Study|Noncompliance with Protocol|0
6810475|NCT03855189|10814204|FG000|Overall Study|Did Not Return|4
6810476|NCT03855189|10814205|FG001|Overall Study|Did Not Return|3
6810477|NCT03855189|10814206|FG002|Overall Study|Did Not Return|0
6810478|NCT03764631|10814216|FG000|Overall Study|Personal Reasons|3
6810479|NCT03764631|10814217|FG001|Overall Study|Personal Reasons|2
7137302|NCT02921750|11289461|FG001|Overall Study|Adverse Event|2
7137303|NCT02921750|11289460|FG000|Overall Study|Withdrawal by Subject|1
7137304|NCT02921750|11289461|FG001|Overall Study|Withdrawal by Subject|1
7137305|NCT02921750|11289460|FG000|Overall Study|Lost to Follow-up|3
7137306|NCT02921750|11289461|FG001|Overall Study|Lost to Follow-up|3
7137307|NCT02921750|11289460|FG000|Overall Study|Wound healed|3
7137308|NCT02921750|11289461|FG001|Overall Study|Wound healed|3
7137309|NCT02921750|11289460|FG000|Overall Study|Serious Adverse Event|1
7137310|NCT02921750|11289461|FG001|Overall Study|Serious Adverse Event|2
7137311|NCT02922153|11289481|FG000|Overall Study|Death|8
7137312|NCT02922153|11289482|FG001|Overall Study|Death|1
7137313|NCT02922153|11289481|FG000|Overall Study|Lost to Follow-up|1
7137314|NCT02922153|11289482|FG001|Overall Study|Lost to Follow-up|0
7137315|NCT02922153|11289481|FG000|Overall Study|Physician Decision|1
7137316|NCT02922153|11289482|FG001|Overall Study|Physician Decision|1
7137317|NCT02922634|11289505|FG000|Overall Study|Withdrawal by Subject|5
7137318|NCT02922634|11289505|FG000|Overall Study|Did not have their surgery|5
7137319|NCT02923115|11289551|FG000|Overall Study|Lost to Follow-up|0
7137320|NCT02923115|11289552|FG001|Overall Study|Lost to Follow-up|0
7137321|NCT02923115|11289553|FG002|Overall Study|Lost to Follow-up|0
7137322|NCT02923115|11289554|FG003|Overall Study|Lost to Follow-up|1
7137323|NCT02923115|11289555|FG004|Overall Study|Lost to Follow-up|0
7137324|NCT02923115|11289556|FG005|Overall Study|Lost to Follow-up|0
7137325|NCT02923115|11289551|FG000|Overall Study|Withdrawal by Subject|0
7137326|NCT02923115|11289552|FG001|Overall Study|Withdrawal by Subject|1
7137327|NCT02923115|11289553|FG002|Overall Study|Withdrawal by Subject|0
7137328|NCT02923115|11289554|FG003|Overall Study|Withdrawal by Subject|0
7137329|NCT02923115|11289555|FG004|Overall Study|Withdrawal by Subject|0
7137330|NCT02923115|11289556|FG005|Overall Study|Withdrawal by Subject|0
7137331|NCT02923115|11289551|FG000|Overall Study|Randomized, but not dosed|0
7137332|NCT02923115|11289552|FG001|Overall Study|Randomized, but not dosed|0
7137333|NCT02923115|11289553|FG002|Overall Study|Randomized, but not dosed|3
7137334|NCT02923115|11289554|FG003|Overall Study|Randomized, but not dosed|1
7137335|NCT02923115|11289555|FG004|Overall Study|Randomized, but not dosed|5
7137336|NCT02923115|11289556|FG005|Overall Study|Randomized, but not dosed|0
7137337|NCT02923180|11289575|FG000|Overall Study|Off Study Due to Detectable PSA|13
7137338|NCT02923180|11289575|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13
7137339|NCT02923245|11289581|FG000|Overall Study|ultrasound order was cancelled|2
7137340|NCT02923245|11289582|FG001|Overall Study|ultrasound order was cancelled|1
7137341|NCT02923349|11289605|FG000|Overall Study|Other|1
6781448|NCT00640133|10777356|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1
6781449|NCT00640133|10777357|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0
6781450|NCT00640133|10777356|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1
6781451|NCT00640133|10777357|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0
6781452|NCT00640133|10777356|FG000|Open Label Phase (Month 4-12)|Adverse Event|1
6781453|NCT00640133|10777357|FG001|Open Label Phase (Month 4-12)|Adverse Event|0
6781454|NCT00593567|10777367|FG000|Overall Study|Adverse Event|2
6781455|NCT00593567|10777368|FG001|Overall Study|Adverse Event|0
6781456|NCT00593567|10777367|FG000|Overall Study|Physician Decision|2
6781457|NCT00593567|10777368|FG001|Overall Study|Physician Decision|0
6781458|NCT00593567|10777367|FG000|Overall Study|Protocol Violation|13
6781459|NCT00593567|10777368|FG001|Overall Study|Protocol Violation|7
6781460|NCT00593567|10777367|FG000|Overall Study|Lack of Efficacy|2
6781461|NCT00593567|10777368|FG001|Overall Study|Lack of Efficacy|1
6781462|NCT00593567|10777367|FG000|Overall Study|Withdrawal by Subject|1
6781463|NCT00593567|10777368|FG001|Overall Study|Withdrawal by Subject|2
6781464|NCT00588770|10777376|FG000|Overall Study|Disease progression|85
6781465|NCT00588770|10777377|FG001|Overall Study|Disease progression|68
6781466|NCT00588770|10777376|FG000|Overall Study|Adverse Event|29
6781467|NCT00588770|10777377|FG001|Overall Study|Adverse Event|58
6781468|NCT00588770|10777376|FG000|Overall Study|Death|13
6781469|NCT00588770|10777377|FG001|Overall Study|Death|22
6781470|NCT00588770|10777376|FG000|Overall Study|Withdrawal by Subject|15
6781471|NCT00588770|10777377|FG001|Overall Study|Withdrawal by Subject|25
6781472|NCT00588770|10777376|FG000|Overall Study|Alternative therapy|2
6781473|NCT00588770|10777377|FG001|Overall Study|Alternative therapy|4
6781474|NCT00588770|10777376|FG000|Overall Study|Other complicating disease|3
6781475|NCT00588770|10777377|FG001|Overall Study|Other complicating disease|2
6781476|NCT00588770|10777376|FG000|Overall Study|Not start protocol therapy|0
6781477|NCT00588770|10777377|FG001|Overall Study|Not start protocol therapy|9
6781478|NCT00588770|10777376|FG000|Overall Study|Lack of Efficacy|8
6781479|NCT00588770|10777377|FG001|Overall Study|Lack of Efficacy|10
6781480|NCT00588770|10777376|FG000|Overall Study|Physician discretion|2
6781481|NCT00588770|10777377|FG001|Overall Study|Physician discretion|0
7137342|NCT02923349|11289606|FG001|Overall Study|Other|2
7137343|NCT02923349|11289607|FG002|Overall Study|Other|4
6781482|NCT00588770|10777376|FG000|Overall Study|Patient non-compliance|2
6781483|NCT00588770|10777377|FG001|Overall Study|Patient non-compliance|2
7137344|NCT02923349|11289608|FG003|Overall Study|Other|1
7137345|NCT02923349|11289609|FG004|Overall Study|Other|3
7137346|NCT02923349|11289610|FG005|Overall Study|Other|0
7137347|NCT02923349|11289611|FG006|Overall Study|Other|1
7137348|NCT02923349|11289605|FG000|Overall Study|Withdrawal by Subject|2
7137349|NCT02923349|11289606|FG001|Overall Study|Withdrawal by Subject|2
7137350|NCT02923349|11289607|FG002|Overall Study|Withdrawal by Subject|8
7137351|NCT02923349|11289608|FG003|Overall Study|Withdrawal by Subject|10
7137352|NCT02923349|11289609|FG004|Overall Study|Withdrawal by Subject|12
7137353|NCT02923349|11289610|FG005|Overall Study|Withdrawal by Subject|3
7137354|NCT02923349|11289611|FG006|Overall Study|Withdrawal by Subject|0
7137355|NCT02923349|11289605|FG000|Overall Study|Physician Decision|0
7137356|NCT02923349|11289606|FG001|Overall Study|Physician Decision|0
7137357|NCT02923349|11289607|FG002|Overall Study|Physician Decision|0
7137358|NCT02923349|11289608|FG003|Overall Study|Physician Decision|1
7137359|NCT02923349|11289609|FG004|Overall Study|Physician Decision|1
7137360|NCT02923349|11289610|FG005|Overall Study|Physician Decision|0
7137361|NCT02923349|11289611|FG006|Overall Study|Physician Decision|2
7137362|NCT02923349|11289605|FG000|Overall Study|Lost to Follow-up|0
7137363|NCT02923349|11289606|FG001|Overall Study|Lost to Follow-up|0
7137364|NCT02923349|11289607|FG002|Overall Study|Lost to Follow-up|3
7137365|NCT02923349|11289608|FG003|Overall Study|Lost to Follow-up|0
7137366|NCT02923349|11289609|FG004|Overall Study|Lost to Follow-up|1
7137367|NCT02923349|11289610|FG005|Overall Study|Lost to Follow-up|1
7137368|NCT02923349|11289611|FG006|Overall Study|Lost to Follow-up|0
7137369|NCT02923349|11289605|FG000|Overall Study|Death|1
7137370|NCT02923349|11289606|FG001|Overall Study|Death|0
7137371|NCT02923349|11289607|FG002|Overall Study|Death|2
7137372|NCT02923349|11289608|FG003|Overall Study|Death|4
7137373|NCT02923349|11289609|FG004|Overall Study|Death|2
7137374|NCT02923349|11289610|FG005|Overall Study|Death|3
7137375|NCT02923349|11289611|FG006|Overall Study|Death|0
7137376|NCT02923427|11289629|FG000|Overall Study|convert to laparatomy|2
7137377|NCT02923427|11289630|FG001|Overall Study|convert to laparatomy|2
7137378|NCT02923427|11289629|FG000|Overall Study|destaturation|1
7137379|NCT02923427|11289630|FG001|Overall Study|destaturation|0
7137380|NCT02923427|11289629|FG000|Overall Study|can not replace LMA|1
7137381|NCT02923427|11289630|FG001|Overall Study|can not replace LMA|0
7137382|NCT02923921|11289647|FG000|Overall Study|Sponsor Decision|39
7137383|NCT02923921|11289648|FG001|Overall Study|Sponsor Decision|38
7137384|NCT02923921|11289647|FG000|Overall Study|Lost to Follow-up|1
7137385|NCT02923921|11289648|FG001|Overall Study|Lost to Follow-up|0
7137386|NCT02923921|11289647|FG000|Overall Study|Withdrawal by Subject|6
7137387|NCT02923921|11289648|FG001|Overall Study|Withdrawal by Subject|13
7137388|NCT02923921|11289647|FG000|Overall Study|Unknown, Not Collected|7
7137389|NCT02923921|11289648|FG001|Overall Study|Unknown, Not Collected|6
7137390|NCT02924051|11289656|FG000|Overall Study|Withdrawal by Subject|1
7137391|NCT02924051|11289657|FG001|Overall Study|Withdrawal by Subject|9
7137392|NCT02924428|11289676|FG000|Overall Study|Adverse Event|1
7137393|NCT02924428|11289677|FG001|Overall Study|Adverse Event|0
7137394|NCT02924428|11289676|FG000|Overall Study|Physician Decision|1
7137395|NCT02924428|11289677|FG001|Overall Study|Physician Decision|0
7137396|NCT02924428|11289676|FG000|Overall Study|Lost to Follow-up|2
7137397|NCT02924428|11289677|FG001|Overall Study|Lost to Follow-up|4
7137398|NCT02924428|11289676|FG000|Overall Study|Pregnancy|0
7137399|NCT02924428|11289677|FG001|Overall Study|Pregnancy|1
7137400|NCT02924688|11289689|FG000|Overall Study|Adverse Event|9
7137401|NCT02924688|11289690|FG001|Overall Study|Adverse Event|3
7137402|NCT02924688|11289691|FG002|Overall Study|Adverse Event|2
7137403|NCT02924688|11289692|FG003|Overall Study|Adverse Event|2
7137404|NCT02924688|11289693|FG004|Overall Study|Adverse Event|3
7137405|NCT02924688|11289694|FG005|Overall Study|Adverse Event|2
7137406|NCT02924688|11289689|FG000|Overall Study|Lack of Efficacy|2
7137407|NCT02924688|11289690|FG001|Overall Study|Lack of Efficacy|3
7137408|NCT02924688|11289691|FG002|Overall Study|Lack of Efficacy|4
7137409|NCT02924688|11289692|FG003|Overall Study|Lack of Efficacy|2
7137410|NCT02924688|11289693|FG004|Overall Study|Lack of Efficacy|1
7137411|NCT02924688|11289694|FG005|Overall Study|Lack of Efficacy|1
7137412|NCT02924688|11289689|FG000|Overall Study|Protocol Violation|3
7137413|NCT02924688|11289690|FG001|Overall Study|Protocol Violation|7
7137414|NCT02924688|11289691|FG002|Overall Study|Protocol Violation|5
7137415|NCT02924688|11289692|FG003|Overall Study|Protocol Violation|6
7137416|NCT02924688|11289693|FG004|Overall Study|Protocol Violation|2
7137417|NCT02924688|11289694|FG005|Overall Study|Protocol Violation|2
7137418|NCT02924688|11289689|FG000|Overall Study|Protocol defined withdrawal criteria met|1
7137419|NCT02924688|11289690|FG001|Overall Study|Protocol defined withdrawal criteria met|0
7137420|NCT02924688|11289691|FG002|Overall Study|Protocol defined withdrawal criteria met|1
7137421|NCT02924688|11289692|FG003|Overall Study|Protocol defined withdrawal criteria met|1
7137422|NCT02924688|11289693|FG004|Overall Study|Protocol defined withdrawal criteria met|1
7137423|NCT02924688|11289694|FG005|Overall Study|Protocol defined withdrawal criteria met|0
7137424|NCT02924688|11289689|FG000|Overall Study|Lost to Follow-up|2
7137425|NCT02924688|11289690|FG001|Overall Study|Lost to Follow-up|4
7137426|NCT02924688|11289691|FG002|Overall Study|Lost to Follow-up|2
7137427|NCT02924688|11289692|FG003|Overall Study|Lost to Follow-up|4
7137428|NCT02924688|11289693|FG004|Overall Study|Lost to Follow-up|2
7137429|NCT02924688|11289694|FG005|Overall Study|Lost to Follow-up|4
7137430|NCT02924688|11289689|FG000|Overall Study|Physician Decision|2
7137431|NCT02924688|11289690|FG001|Overall Study|Physician Decision|1
7137432|NCT02924688|11289691|FG002|Overall Study|Physician Decision|0
7137433|NCT02924688|11289692|FG003|Overall Study|Physician Decision|1
7137434|NCT02924688|11289693|FG004|Overall Study|Physician Decision|1
7137435|NCT02924688|11289694|FG005|Overall Study|Physician Decision|1
7137436|NCT02924688|11289689|FG000|Overall Study|Withdrawal by Subject|14
7137437|NCT02924688|11289690|FG001|Overall Study|Withdrawal by Subject|13
7137438|NCT02924688|11289691|FG002|Overall Study|Withdrawal by Subject|9
7137439|NCT02924688|11289692|FG003|Overall Study|Withdrawal by Subject|12
7137440|NCT02924688|11289693|FG004|Overall Study|Withdrawal by Subject|13
7137441|NCT02924688|11289694|FG005|Overall Study|Withdrawal by Subject|14
7137442|NCT02924883|11289713|FG000|Overall Study|Death|39
7137443|NCT02924883|11289714|FG001|Overall Study|Death|20
7137444|NCT02924883|11289713|FG000|Overall Study|Lost to Follow-up|1
7137445|NCT02924883|11289714|FG001|Overall Study|Lost to Follow-up|0
7137446|NCT02924883|11289713|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0
7137447|NCT02924883|11289714|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1
7137448|NCT02924883|11289713|FG000|Overall Study|Protocol Violation|1
7137449|NCT02924883|11289714|FG001|Overall Study|Protocol Violation|0
7137450|NCT02924883|11289713|FG000|Overall Study|Withdrawal by Subject|22
7137451|NCT02924883|11289714|FG001|Overall Study|Withdrawal by Subject|16
7137452|NCT02924883|11289713|FG000|Overall Study|Progressive Disease|1
7137453|NCT02924883|11289714|FG001|Overall Study|Progressive Disease|0
7137454|NCT02924883|11289713|FG000|Overall Study|Study Terminated by Sponsor|69
7137455|NCT02924883|11289714|FG001|Overall Study|Study Terminated by Sponsor|32
7137456|NCT02925117|11289735|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1
7137457|NCT02925117|11289736|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3
7137458|NCT02925117|11289737|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1
7137459|NCT02925117|11289738|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2
7137460|NCT02925117|11289739|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0
7137461|NCT02925117|11289740|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0
7137462|NCT02925117|11289741|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0
7137463|NCT02925117|11289742|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0
7137464|NCT02925117|11289743|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0
7137465|NCT02925117|11289744|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0
7137466|NCT02925117|11289745|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0
7137467|NCT02925117|11289746|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0
7137468|NCT02925117|11289735|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10
7137469|NCT02925117|11289736|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3
7137470|NCT02925117|11289737|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3
7137471|NCT02925117|11289738|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
7137472|NCT02925117|11289739|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
7137473|NCT02925117|11289740|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
7137474|NCT02925117|11289741|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
7137475|NCT02925117|11289742|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
7137476|NCT02925117|11289743|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
7137477|NCT02925117|11289744|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
7137478|NCT02925117|11289745|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
7137479|NCT02925117|11289746|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
7137480|NCT02925117|11289735|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2
7137481|NCT02925117|11289736|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1
7137482|NCT02925117|11289737|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7137483|NCT02925117|11289738|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7137484|NCT02925117|11289739|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7137485|NCT02925117|11289740|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7137486|NCT02925117|11289741|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7137487|NCT02925117|11289742|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7137488|NCT02925117|11289743|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7137489|NCT02925117|11289744|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7137490|NCT02925117|11289745|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7137491|NCT02925117|11289746|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7137492|NCT02925117|11289735|FG000|Period 1 (Weeks 0 - 16)|Other|5
6781488|NCT02983617|10777389|FG000|Overall Study|Adverse Event|0
6781489|NCT02983617|10777390|FG001|Overall Study|Adverse Event|7
6781490|NCT02983617|10777389|FG000|Overall Study|Death|0
6781491|NCT02983617|10777390|FG001|Overall Study|Death|1
6781492|NCT02983617|10777389|FG000|Overall Study|Investigator's Discretion|0
6781493|NCT02983617|10777390|FG001|Overall Study|Investigator's Discretion|1
6781494|NCT02649946|10777424|FG000|Overall Study|Withdrawal by Subject|1
6781495|NCT02649946|10777425|FG001|Overall Study|Withdrawal by Subject|1
6781496|NCT02649946|10777424|FG000|Overall Study|Death|7
6781497|NCT02649946|10777425|FG001|Overall Study|Death|9
6781498|NCT02649946|10777424|FG000|Overall Study|Physician Decision|1
6781499|NCT02649946|10777425|FG001|Overall Study|Physician Decision|0
6781500|NCT02649946|10777424|FG000|Overall Study|Lost to Follow-up|2
6781501|NCT02649946|10777425|FG001|Overall Study|Lost to Follow-up|1
6781502|NCT02649946|10777424|FG000|Overall Study|Erroneously enrolled|1
6781503|NCT02649946|10777425|FG001|Overall Study|Erroneously enrolled|0
6781504|NCT02649946|10777424|FG000|Overall Study|Missed 6-month follow-up visit|0
7137493|NCT02925117|11289736|FG001|Period 1 (Weeks 0 - 16)|Other|4
7137494|NCT02925117|11289737|FG002|Period 1 (Weeks 0 - 16)|Other|1
7137495|NCT02925117|11289738|FG003|Period 1 (Weeks 0 - 16)|Other|1
6781505|NCT02649946|10777425|FG001|Overall Study|Missed 6-month follow-up visit|4
6806519|NCT04755595|10809114|FG000|Overall Study|Lost to Follow-up|1
6806520|NCT04749745|10809119|FG000|Overall Study|Withdrawal by Subject|1
7137496|NCT02925117|11289739|FG004|Period 1 (Weeks 0 - 16)|Other|0
7137497|NCT02925117|11289740|FG005|Period 1 (Weeks 0 - 16)|Other|0
7137498|NCT02925117|11289741|FG006|Period 1 (Weeks 0 - 16)|Other|0
7137499|NCT02925117|11289742|FG007|Period 1 (Weeks 0 - 16)|Other|0
7137500|NCT02925117|11289743|FG008|Period 1 (Weeks 0 - 16)|Other|0
7137501|NCT02925117|11289744|FG009|Period 1 (Weeks 0 - 16)|Other|0
7137502|NCT02925117|11289745|FG010|Period 1 (Weeks 0 - 16)|Other|0
7137503|NCT02925117|11289746|FG011|Period 1 (Weeks 0 - 16)|Other|0
7137504|NCT02925117|11289735|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0
7137505|NCT02925117|11289736|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0
7137506|NCT02925117|11289737|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0
7137507|NCT02925117|11289738|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0
7137508|NCT02925117|11289739|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0
7137509|NCT02925117|11289740|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1
7137510|NCT02925117|11289741|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0
7137511|NCT02925117|11289742|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0
7137512|NCT02925117|11289743|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0
7137513|NCT02925117|11289744|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0
7137514|NCT02925117|11289745|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3
7137515|NCT02925117|11289746|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2
7137516|NCT02925117|11289735|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
7137517|NCT02925117|11289736|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
7137518|NCT02925117|11289737|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
7137519|NCT02925117|11289738|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
7137520|NCT02925117|11289739|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
7137521|NCT02925117|11289740|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1
7137522|NCT02925117|11289741|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4
7137523|NCT02925117|11289742|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3
7137524|NCT02925117|11289743|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
7137525|NCT02925117|11289744|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
7137526|NCT02925117|11289745|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
7137527|NCT02925117|11289746|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
7137528|NCT02925117|11289735|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
7137529|NCT02925117|11289736|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
7137530|NCT02925117|11289737|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
7137531|NCT02925117|11289738|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
7137532|NCT02925117|11289739|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
7137533|NCT02925117|11289740|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2
7137534|NCT02925117|11289741|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
7137535|NCT02925117|11289742|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
7137536|NCT02925117|11289743|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
7137537|NCT02925117|11289744|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
7137538|NCT02925117|11289745|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
7137539|NCT02925117|11289746|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
7137540|NCT02925117|11289735|FG000|Period 2 (Weeks 16 - 88)|Other|0
7137541|NCT02925117|11289736|FG001|Period 2 (Weeks 16 - 88)|Other|0
7137542|NCT02925117|11289737|FG002|Period 2 (Weeks 16 - 88)|Other|0
7137543|NCT02925117|11289738|FG003|Period 2 (Weeks 16 - 88)|Other|0
7137544|NCT02925117|11289739|FG004|Period 2 (Weeks 16 - 88)|Other|1
7137545|NCT02925117|11289740|FG005|Period 2 (Weeks 16 - 88)|Other|1
6781506|NCT02431247|10777433|FG000|BL to EOE-Test and BL to Switch- Control|Other|11
6781507|NCT02431247|10777434|FG001|BL to EOE-Test and BL to Switch- Control|Other|2
6781508|NCT02431247|10777435|FG002|BL to EOE-Test and BL to Switch- Control|Other|0
6781509|NCT02431247|10777433|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17
6781510|NCT02431247|10777434|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8
6781511|NCT02431247|10777435|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0
6781512|NCT02431247|10777433|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9
6781513|NCT02431247|10777434|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4
6781514|NCT02431247|10777435|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0
6781515|NCT02431247|10777433|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1
6781516|NCT02431247|10777434|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1
6781517|NCT02431247|10777435|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0
6781518|NCT02431247|10777433|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12
6781519|NCT02431247|10777434|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16
6781520|NCT02431247|10777435|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0
6781521|NCT02431247|10777433|FG000|BL to EOE-Test and BL to Switch- Control|Death|0
6781522|NCT02431247|10777434|FG001|BL to EOE-Test and BL to Switch- Control|Death|1
6781523|NCT02431247|10777435|FG002|BL to EOE-Test and BL to Switch- Control|Death|0
6781524|NCT02431247|10777433|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14
6781525|NCT02431247|10777434|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9
6781526|NCT02431247|10777435|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0
6781527|NCT02431247|10777433|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2
7137546|NCT02925117|11289741|FG006|Period 2 (Weeks 16 - 88)|Other|1
7137547|NCT02925117|11289742|FG007|Period 2 (Weeks 16 - 88)|Other|1
7137548|NCT02925117|11289743|FG008|Period 2 (Weeks 16 - 88)|Other|3
7137549|NCT02925117|11289744|FG009|Period 2 (Weeks 16 - 88)|Other|4
7137550|NCT02925117|11289745|FG010|Period 2 (Weeks 16 - 88)|Other|3
7137551|NCT02925117|11289746|FG011|Period 2 (Weeks 16 - 88)|Other|0
7137552|NCT02925312|11289774|FG000|Overall Study|Lost to Follow-up|25
7137553|NCT02925312|11289775|FG001|Overall Study|Lost to Follow-up|0
7137554|NCT02925312|11289774|FG000|Overall Study|Adverse Event|2
7137555|NCT02925312|11289775|FG001|Overall Study|Adverse Event|0
7137556|NCT02925403|11289783|FG000|Overall Study|Lost to Follow-up|0
7137557|NCT02925403|11289784|FG001|Overall Study|Lost to Follow-up|1
6781528|NCT02431247|10777434|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0
6781529|NCT02431247|10777435|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0
6781530|NCT02431247|10777433|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0
6781531|NCT02431247|10777434|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0
6781532|NCT02431247|10777435|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4
6781533|NCT02431247|10777433|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0
6781534|NCT02431247|10777434|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0
6781535|NCT02431247|10777435|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12
6781536|NCT02431247|10777433|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0
6781537|NCT02431247|10777434|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0
6781538|NCT02431247|10777435|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1
6781539|NCT02431247|10777433|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0
6781540|NCT02431247|10777434|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0
6781541|NCT02431247|10777435|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5
6781542|NCT02431247|10777433|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0
6781543|NCT02431247|10777434|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0
6781544|NCT02431247|10777435|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1
6781545|NCT02431247|10777433|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0
6781546|NCT02431247|10777434|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0
6781547|NCT02431247|10777435|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10
6781548|NCT02345850|10777450|FG000|Overall Study|Not transplanted|10
6781549|NCT02345850|10777451|FG001|Overall Study|Not transplanted|5
6781550|NCT02345850|10777452|FG002|Overall Study|Not transplanted|4
6781551|NCT02345850|10777450|FG000|Overall Study|Lost to Follow-up|2
6781552|NCT02345850|10777451|FG001|Overall Study|Lost to Follow-up|3
6781553|NCT02345850|10777452|FG002|Overall Study|Lost to Follow-up|2
6781554|NCT02345850|10777450|FG000|Overall Study|Withdrawal by Subject|1
6781555|NCT02345850|10777451|FG001|Overall Study|Withdrawal by Subject|0
6781556|NCT02345850|10777452|FG002|Overall Study|Withdrawal by Subject|0
6781557|NCT02343302|10777462|FG000|Overall Study|Physician Decision|1
6781558|NCT02343302|10777463|FG001|Overall Study|Physician Decision|1
6781575|NCT01464164|10777522|FG000|Overall Study|Screen failure|0
6781576|NCT01464164|10777523|FG001|Overall Study|Screen failure|1
6781577|NCT01464164|10777524|FG002|Overall Study|Screen failure|2
6781578|NCT01464164|10777525|FG003|Overall Study|Screen failure|0
6781579|NCT01464164|10777526|FG004|Overall Study|Screen failure|0
6781580|NCT01464164|10777527|FG005|Overall Study|Screen failure|0
6781581|NCT01464164|10777528|FG006|Overall Study|Screen failure|0
6781582|NCT01464164|10777522|FG000|Overall Study|Physician Decision|0
6781583|NCT01464164|10777523|FG001|Overall Study|Physician Decision|0
6781584|NCT01464164|10777524|FG002|Overall Study|Physician Decision|0
6781585|NCT01464164|10777525|FG003|Overall Study|Physician Decision|0
6781586|NCT01464164|10777526|FG004|Overall Study|Physician Decision|0
6781587|NCT01464164|10777527|FG005|Overall Study|Physician Decision|0
6781588|NCT01464164|10777528|FG006|Overall Study|Physician Decision|2
6781589|NCT01111565|10777558|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3
6781590|NCT01111565|10777559|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0
6781591|NCT01111565|10777560|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0
6781592|NCT01111565|10777561|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0
6781593|NCT01111565|10777562|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0
6781594|NCT01111565|10777558|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1
6781595|NCT01111565|10777559|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0
6781596|NCT01111565|10777560|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0
6781597|NCT01111565|10777561|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0
6781598|NCT01111565|10777562|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0
6781599|NCT01111565|10777558|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58
6781600|NCT01111565|10777559|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0
6781601|NCT01111565|10777560|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0
7137558|NCT02925455|11289792|FG000|Overall Study|Withdrawal by Subject|2
6781602|NCT01111565|10777561|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0
7137559|NCT02925455|11289793|FG001|Overall Study|Withdrawal by Subject|0
7137560|NCT02925494|11289803|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8
7137561|NCT02925494|11289804|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2
7137562|NCT02925494|11289805|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8
7137563|NCT02925494|11289806|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23
7137564|NCT02925494|11289803|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3
7137565|NCT02925494|11289804|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2
7137566|NCT02925494|11289805|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9
7137567|NCT02925494|11289806|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10
7137568|NCT02925494|11289803|FG000|Post-Treatment Follow-Up Period|Other|1
7137569|NCT02925494|11289804|FG001|Post-Treatment Follow-Up Period|Other|4
7137570|NCT02925494|11289805|FG002|Post-Treatment Follow-Up Period|Other|3
7137571|NCT02925494|11289806|FG003|Post-Treatment Follow-Up Period|Other|6
7137572|NCT02925494|11289803|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1
7137573|NCT02925494|11289804|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2
7137574|NCT02925494|11289805|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2
7137575|NCT02925494|11289806|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6
7137576|NCT02925494|11289803|FG000|Post-Treatment Follow-Up Period|Pregnancy|1
7137577|NCT02925494|11289804|FG001|Post-Treatment Follow-Up Period|Pregnancy|0
7137578|NCT02925494|11289805|FG002|Post-Treatment Follow-Up Period|Pregnancy|1
7137579|NCT02925494|11289806|FG003|Post-Treatment Follow-Up Period|Pregnancy|2
7137580|NCT02925494|11289803|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0
7137581|NCT02925494|11289804|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0
7137582|NCT02925494|11289805|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1
7137583|NCT02925494|11289806|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2
7137584|NCT02925494|11289803|FG000|Post-Treatment Follow-Up Period|Adverse Event|0
7137585|NCT02925494|11289804|FG001|Post-Treatment Follow-Up Period|Adverse Event|0
7137586|NCT02925494|11289805|FG002|Post-Treatment Follow-Up Period|Adverse Event|0
7137587|NCT02925494|11289806|FG003|Post-Treatment Follow-Up Period|Adverse Event|1
7137588|NCT02925741|11289828|FG000|Overall Study|Withdrawal by Subject|11
7137589|NCT02925741|11289829|FG001|Overall Study|Withdrawal by Subject|0
7137590|NCT02925923|11289849|FG000|Overall Study|blood samples hemolyzed|0
7137591|NCT02925923|11289850|FG001|Overall Study|blood samples hemolyzed|2
7137592|NCT02926209|11289865|FG000|Study Cohort|Poor Bowel Preparation|1
7137593|NCT02926209|11289866|FG001|Study Cohort|Poor Bowel Preparation|0
7137594|NCT02926573|11289875|FG000|Overall Study|Nausea|1
7137595|NCT02926573|11289876|FG001|Overall Study|Nausea|0
7137596|NCT02926573|11289875|FG000|Overall Study|Remain intubated|2
7137597|NCT02926573|11289876|FG001|Overall Study|Remain intubated|2
7137598|NCT02926573|11289875|FG000|Overall Study|Change in surgery plan|3
7137599|NCT02926573|11289876|FG001|Overall Study|Change in surgery plan|1
7137600|NCT02926573|11289875|FG000|Overall Study|Change to outpatient status|5
7137601|NCT02926573|11289876|FG001|Overall Study|Change to outpatient status|1
7137602|NCT02926573|11289875|FG000|Overall Study|Withdrawal by Subject|0
7137603|NCT02926573|11289876|FG001|Overall Study|Withdrawal by Subject|2
7137604|NCT02926573|11289875|FG000|Overall Study|Return to operating room|0
7137605|NCT02926573|11289876|FG001|Overall Study|Return to operating room|2
7137606|NCT02926573|11289875|FG000|Overall Study|Delirium|0
7137607|NCT02926573|11289876|FG001|Overall Study|Delirium|1
7137608|NCT02926937|11289899|FG000|Overall Study|Adverse Event|0
7137609|NCT02926937|11289900|FG001|Overall Study|Adverse Event|1
7137610|NCT02926937|11289901|FG002|Overall Study|Adverse Event|1
7137611|NCT02926937|11289899|FG000|Overall Study|Poor Compliance to Protocol|1
7137612|NCT02926937|11289900|FG001|Overall Study|Poor Compliance to Protocol|0
7137613|NCT02926937|11289901|FG002|Overall Study|Poor Compliance to Protocol|0
7137614|NCT02926937|11289899|FG000|Overall Study|Lost to Follow-up|4
7137615|NCT02926937|11289900|FG001|Overall Study|Lost to Follow-up|5
7137616|NCT02926937|11289901|FG002|Overall Study|Lost to Follow-up|0
7137617|NCT02926937|11289899|FG000|Overall Study|At the Participant's own Request|11
7137618|NCT02926937|11289900|FG001|Overall Study|At the Participant's own Request|5
7137619|NCT02926937|11289901|FG002|Overall Study|At the Participant's own Request|8
7137620|NCT02926937|11289899|FG000|Overall Study|Reason not Specified|3
7137621|NCT02926937|11289900|FG001|Overall Study|Reason not Specified|4
7137622|NCT02926937|11289901|FG002|Overall Study|Reason not Specified|2
6781603|NCT01111565|10777562|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0
6781604|NCT01111565|10777558|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1
6781605|NCT01111565|10777559|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0
6781606|NCT01111565|10777560|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0
6781607|NCT01111565|10777561|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0
6781608|NCT01111565|10777562|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0
6781609|NCT01111565|10777558|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1
6781610|NCT01111565|10777559|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0
6781611|NCT01111565|10777560|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0
7137623|NCT02926950|11289912|FG000|Overall Study|Adverse Event|4
7137624|NCT02926950|11289913|FG001|Overall Study|Adverse Event|6
7137625|NCT02926950|11289912|FG000|Overall Study|At the participant's own request|21
7137626|NCT02926950|11289913|FG001|Overall Study|At the participant's own request|25
7137627|NCT02926950|11289912|FG000|Overall Study|Reason not Specified|17
7137628|NCT02926950|11289913|FG001|Overall Study|Reason not Specified|9
7137629|NCT02926950|11289912|FG000|Overall Study|Lost to Follow-up|7
7137630|NCT02926950|11289913|FG001|Overall Study|Lost to Follow-up|8
7137631|NCT02927080|11289930|FG000|Overall Study|Withdrawal by Subject|0
7137632|NCT02927080|11289931|FG001|Overall Study|Withdrawal by Subject|0
7137633|NCT02927080|11289932|FG002|Overall Study|Withdrawal by Subject|0
7137634|NCT02927080|11289933|FG003|Overall Study|Withdrawal by Subject|0
7137635|NCT02927080|11289934|FG004|Overall Study|Withdrawal by Subject|1
7137636|NCT02927080|11289935|FG005|Overall Study|Withdrawal by Subject|0
7137637|NCT02927080|11289936|FG006|Overall Study|Withdrawal by Subject|1
7137638|NCT02927080|11289937|FG007|Overall Study|Withdrawal by Subject|1
7137639|NCT02927080|11289938|FG008|Overall Study|Withdrawal by Subject|0
6781612|NCT01111565|10777561|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0
6781613|NCT01111565|10777562|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0
6781614|NCT01111565|10777558|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1
6781615|NCT01111565|10777559|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0
6781616|NCT01111565|10777560|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0
6781617|NCT01111565|10777561|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0
6781618|NCT01111565|10777562|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0
7137640|NCT02927080|11289939|FG009|Overall Study|Withdrawal by Subject|2
7137641|NCT02927080|11289930|FG000|Overall Study|Willingness to comply with protocol|0
7137642|NCT02927080|11289931|FG001|Overall Study|Willingness to comply with protocol|0
7137643|NCT02927080|11289932|FG002|Overall Study|Willingness to comply with protocol|0
7137644|NCT02927080|11289933|FG003|Overall Study|Willingness to comply with protocol|0
7137645|NCT02927080|11289934|FG004|Overall Study|Willingness to comply with protocol|0
7137646|NCT02927080|11289935|FG005|Overall Study|Willingness to comply with protocol|0
7137647|NCT02927080|11289936|FG006|Overall Study|Willingness to comply with protocol|0
7137648|NCT02927080|11289937|FG007|Overall Study|Willingness to comply with protocol|0
7137649|NCT02927080|11289938|FG008|Overall Study|Willingness to comply with protocol|0
7137650|NCT02927080|11289939|FG009|Overall Study|Willingness to comply with protocol|1
6781619|NCT01111565|10777558|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1
6781620|NCT01111565|10777559|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0
6781621|NCT01111565|10777560|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0
6781622|NCT01111565|10777561|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0
6781623|NCT01111565|10777562|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0
6781624|NCT01111565|10777558|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
6781625|NCT01111565|10777559|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
6781626|NCT01111565|10777560|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
6781627|NCT01111565|10777561|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1
6781628|NCT01111565|10777562|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
6781629|NCT01111565|10777558|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0
6781630|NCT01111565|10777559|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0
6781631|NCT01111565|10777560|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2
6781632|NCT01111565|10777561|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0
6781633|NCT01111565|10777562|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0
6781634|NCT01111565|10777558|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0
6781635|NCT01111565|10777559|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7
6781636|NCT01111565|10777560|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3
6781637|NCT01111565|10777561|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2
6781638|NCT01111565|10777562|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3
6781639|NCT01111565|10777558|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0
6781640|NCT01111565|10777559|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0
6781641|NCT01111565|10777560|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0
6781642|NCT01111565|10777561|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1
6781643|NCT01111565|10777562|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0
6781644|NCT01111565|10777558|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0
6781645|NCT01111565|10777559|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0
6781646|NCT01111565|10777560|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0
6781647|NCT01111565|10777561|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0
6781648|NCT01111565|10777562|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1
6781649|NCT01092117|10777572|FG000|Index Procedure to 1 Month|Death|1
6781650|NCT01092117|10777572|FG000|1 Month|Death|1
6781651|NCT01092117|10777572|FG000|1 Month|Withdrawal by Subject|1
6781652|NCT01092117|10777572|FG000|1 Month|Lost to Follow-up|1
6781653|NCT01092117|10777572|FG000|6 Months|Death|2
6781654|NCT01092117|10777572|FG000|6 Months|Withdrawal by Subject|3
6781655|NCT01092117|10777572|FG000|12 Month|Death|11
6781656|NCT01092117|10777572|FG000|12 Month|Withdrawal by Subject|2
6781657|NCT01092117|10777572|FG000|12 Month|Lost to Follow-up|1
6781658|NCT01092117|10777572|FG000|Year 2|Death|5
6781659|NCT01092117|10777572|FG000|Year 2|Withdrawal by Subject|4
6781660|NCT01092117|10777572|FG000|Year 2|Lost to Follow-up|1
6781661|NCT01092117|10777572|FG000|Year 3|Death|7
6781662|NCT01092117|10777572|FG000|Year 3|Withdrawal by Subject|9
6781663|NCT01092117|10777572|FG000|Year 3|Lost to Follow-up|3
7137651|NCT02927080|11289930|FG000|Overall Study|Study terminated by Sponsor|0
7137652|NCT02927080|11289931|FG001|Overall Study|Study terminated by Sponsor|0
7137653|NCT02927080|11289932|FG002|Overall Study|Study terminated by Sponsor|0
7137654|NCT02927080|11289933|FG003|Overall Study|Study terminated by Sponsor|0
7137655|NCT02927080|11289934|FG004|Overall Study|Study terminated by Sponsor|0
7137656|NCT02927080|11289935|FG005|Overall Study|Study terminated by Sponsor|0
7137657|NCT02927080|11289936|FG006|Overall Study|Study terminated by Sponsor|6
7137658|NCT02927080|11289937|FG007|Overall Study|Study terminated by Sponsor|7
7137659|NCT02927080|11289938|FG008|Overall Study|Study terminated by Sponsor|2
7137660|NCT02927080|11289939|FG009|Overall Study|Study terminated by Sponsor|3
6781664|NCT01092117|10777572|FG000|Year 4|Death|8
7137661|NCT02927080|11289930|FG000|Overall Study|Adverse Event|0
7137662|NCT02927080|11289931|FG001|Overall Study|Adverse Event|1
7137663|NCT02927080|11289932|FG002|Overall Study|Adverse Event|0
7137664|NCT02927080|11289933|FG003|Overall Study|Adverse Event|0
7137665|NCT02927080|11289934|FG004|Overall Study|Adverse Event|0
7137666|NCT02927080|11289935|FG005|Overall Study|Adverse Event|0
7137667|NCT02927080|11289936|FG006|Overall Study|Adverse Event|0
7137668|NCT02927080|11289937|FG007|Overall Study|Adverse Event|1
7137669|NCT02927080|11289938|FG008|Overall Study|Adverse Event|0
7137670|NCT02927080|11289939|FG009|Overall Study|Adverse Event|1
7137671|NCT02927080|11289930|FG000|Overall Study|Other|0
7137672|NCT02927080|11289931|FG001|Overall Study|Other|0
7137673|NCT02927080|11289932|FG002|Overall Study|Other|0
6781665|NCT01092117|10777572|FG000|Year 4|Withdrawal by Subject|4
6781666|NCT01092117|10777572|FG000|Year 4|Lost to Follow-up|4
6781667|NCT00950989|10777580|FG000|Overall Study|Death|0
6781668|NCT00950989|10777581|FG001|Overall Study|Death|0
6781669|NCT00950989|10777582|FG002|Overall Study|Death|1
6781670|NCT00950989|10777583|FG003|Overall Study|Death|0
6781671|NCT00950989|10777580|FG000|Overall Study|Administrative Decision|0
6781672|NCT00950989|10777581|FG001|Overall Study|Administrative Decision|1
6781673|NCT00950989|10777582|FG002|Overall Study|Administrative Decision|0
7137674|NCT02927080|11289933|FG003|Overall Study|Other|0
7137675|NCT02927080|11289934|FG004|Overall Study|Other|0
7137676|NCT02927080|11289935|FG005|Overall Study|Other|0
7137677|NCT02927080|11289936|FG006|Overall Study|Other|1
7137678|NCT02927080|11289937|FG007|Overall Study|Other|0
7137679|NCT02927080|11289938|FG008|Overall Study|Other|1
7137680|NCT02927080|11289939|FG009|Overall Study|Other|0
7137681|NCT02927171|11289986|FG000|Overall Study|Lost to Follow-up|0
6781674|NCT00950989|10777583|FG003|Overall Study|Administrative Decision|0
6781675|NCT00950989|10777580|FG000|Overall Study|Disease Progression|0
6781676|NCT00950989|10777581|FG001|Overall Study|Disease Progression|0
6781677|NCT00950989|10777582|FG002|Overall Study|Disease Progression|1
6781678|NCT00950989|10777583|FG003|Overall Study|Disease Progression|0
6781679|NCT00950989|10777580|FG000|Overall Study|Withdrawal by Subject|2
6781680|NCT00950989|10777581|FG001|Overall Study|Withdrawal by Subject|1
6781681|NCT00950989|10777582|FG002|Overall Study|Withdrawal by Subject|0
6781682|NCT00950989|10777583|FG003|Overall Study|Withdrawal by Subject|0
6781683|NCT00950989|10777580|FG000|Overall Study|Adverse Event|2
6781684|NCT00950989|10777581|FG001|Overall Study|Adverse Event|1
6781685|NCT00950989|10777582|FG002|Overall Study|Adverse Event|1
6781686|NCT00950989|10777583|FG003|Overall Study|Adverse Event|0
6781687|NCT00489307|10777598|FG000|Overall Study|Death|1
6781688|NCT00489307|10777599|FG001|Overall Study|Death|1
6781689|NCT00489307|10777598|FG000|Overall Study|Lost to Follow-up|2
6781690|NCT00489307|10777599|FG001|Overall Study|Lost to Follow-up|2
6781691|NCT00489307|10777598|FG000|Overall Study|Physician Decision|1
6781692|NCT00489307|10777599|FG001|Overall Study|Physician Decision|0
6781693|NCT00489307|10777598|FG000|Overall Study|Withdrawal by Subject|2
6781694|NCT00489307|10777599|FG001|Overall Study|Withdrawal by Subject|4
6781695|NCT00489307|10777598|FG000|Overall Study|Hospitalization unrelated to treatment|10
6781696|NCT00489307|10777599|FG001|Overall Study|Hospitalization unrelated to treatment|7
6781697|NCT00489307|10777598|FG000|Overall Study|Surgery after assignment|1
6781698|NCT00489307|10777599|FG001|Overall Study|Surgery after assignment|0
6781699|NCT00489307|10777598|FG000|Overall Study|Did not fill up the forms|2
6781700|NCT00489307|10777599|FG001|Overall Study|Did not fill up the forms|1
6781701|NCT00489307|10777598|FG000|Overall Study|Patient or family refusal|5
6781702|NCT00489307|10777599|FG001|Overall Study|Patient or family refusal|9
6781703|NCT00072410|10777607|FG000|Overall Study|Progressive disease|0
6781704|NCT00072410|10777608|FG001|Overall Study|Progressive disease|3
6806521|NCT04749745|10809120|FG001|Overall Study|Withdrawal by Subject|0
6806522|NCT04748341|10809128|FG000|Overall Study|Lost to Follow-up|1
6806523|NCT04748341|10809129|FG001|Overall Study|Lost to Follow-up|1
6810480|NCT03764631|10814216|FG000|Overall Study|Switching Therapy|3
6810481|NCT03764631|10814217|FG001|Overall Study|Switching Therapy|3
6810482|NCT03764631|10814216|FG000|Overall Study|Adverse Event|0
6810483|NCT03764631|10814217|FG001|Overall Study|Adverse Event|1
6810484|NCT03764631|10814216|FG000|Overall Study|Lost to Follow-up|33
6810485|NCT03764631|10814217|FG001|Overall Study|Lost to Follow-up|41
6811735|NCT01208207|10815563|FG001|Part II|Withdrawal by Subject|0
7137682|NCT02927171|11289987|FG001|Overall Study|Lost to Follow-up|1
7137683|NCT02927301|11289999|FG000|Overall Study|Adverse Event|7
7137684|NCT02927301|11289999|FG000|Overall Study|Withdrawal by Subject|1
7137685|NCT02927301|11289999|FG000|Overall Study|Physician Decision|2
7137686|NCT02927366|11290014|FG000|Overall Study|Adverse Event|1
7137687|NCT02927366|11290015|FG001|Overall Study|Adverse Event|0
7137688|NCT02927366|11290014|FG000|Overall Study|Patient schedule|1
7137689|NCT02927366|11290015|FG001|Overall Study|Patient schedule|0
7137690|NCT02927431|11290024|FG000|Overall Study|Withdrawal by Subject|0
7137691|NCT02927431|11290025|FG001|Overall Study|Withdrawal by Subject|0
7137692|NCT02927431|11290026|FG002|Overall Study|Withdrawal by Subject|1
7137693|NCT02927795|11290058|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19
7137694|NCT02927795|11290058|FG000|Overall Study|Not Treated|4
7137695|NCT02927834|11290065|FG000|Overall Study|Lost to Follow-up|1
7137696|NCT02927834|11290066|FG001|Overall Study|Lost to Follow-up|2
7137697|NCT02927834|11290067|FG002|Overall Study|Lost to Follow-up|2
7137698|NCT02927873|11290081|FG000|Overall Study|Lost to Follow-up|0
6781705|NCT04498247|10777655|FG000|Overall Study|Lost to Follow-up|0
6781706|NCT04498247|10777656|FG001|Overall Study|Lost to Follow-up|0
6781707|NCT04498247|10777657|FG002|Overall Study|Lost to Follow-up|0
6781708|NCT04498247|10777658|FG003|Overall Study|Lost to Follow-up|1
7137699|NCT02927873|11290082|FG001|Overall Study|Lost to Follow-up|1
7137700|NCT02927873|11290083|FG002|Overall Study|Lost to Follow-up|0
7137701|NCT02927873|11290084|FG003|Overall Study|Lost to Follow-up|0
7137702|NCT02927873|11290085|FG004|Overall Study|Lost to Follow-up|0
7137703|NCT02927873|11290086|FG005|Overall Study|Lost to Follow-up|0
7137704|NCT02927873|11290081|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
7137705|NCT02927873|11290082|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1
7137706|NCT02927873|11290083|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
6781709|NCT04498247|10777659|FG004|Overall Study|Lost to Follow-up|0
6781710|NCT04498247|10777660|FG005|Overall Study|Lost to Follow-up|0
6781711|NCT04498247|10777661|FG006|Overall Study|Lost to Follow-up|0
6781712|NCT04498247|10777662|FG007|Overall Study|Lost to Follow-up|0
6781713|NCT04498247|10777655|FG000|Overall Study|Mistakenly Randomized; Not Treated|1
6781714|NCT04498247|10777656|FG001|Overall Study|Mistakenly Randomized; Not Treated|0
6781715|NCT04498247|10777657|FG002|Overall Study|Mistakenly Randomized; Not Treated|0
6781716|NCT04498247|10777658|FG003|Overall Study|Mistakenly Randomized; Not Treated|0
7137707|NCT02927873|11290084|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
7137708|NCT02927873|11290085|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
6781717|NCT04498247|10777659|FG004|Overall Study|Mistakenly Randomized; Not Treated|0
6781718|NCT04498247|10777660|FG005|Overall Study|Mistakenly Randomized; Not Treated|0
6781719|NCT04498247|10777661|FG006|Overall Study|Mistakenly Randomized; Not Treated|0
6781720|NCT04498247|10777662|FG007|Overall Study|Mistakenly Randomized; Not Treated|0
6781721|NCT04498247|10777655|FG000|Overall Study|Withdrawal by Subject|0
6781722|NCT04498247|10777656|FG001|Overall Study|Withdrawal by Subject|8
6781723|NCT04498247|10777657|FG002|Overall Study|Withdrawal by Subject|0
6781724|NCT04498247|10777658|FG003|Overall Study|Withdrawal by Subject|7
6781725|NCT04498247|10777659|FG004|Overall Study|Withdrawal by Subject|0
6781726|NCT04498247|10777660|FG005|Overall Study|Withdrawal by Subject|0
6781727|NCT04498247|10777661|FG006|Overall Study|Withdrawal by Subject|1
6781728|NCT04498247|10777662|FG007|Overall Study|Withdrawal by Subject|0
6781729|NCT04498247|10777655|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0
6781730|NCT04498247|10777656|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4
6781731|NCT04498247|10777657|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0
6781732|NCT04498247|10777658|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3
6781733|NCT04498247|10777659|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0
6781734|NCT04498247|10777660|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0
6781735|NCT04498247|10777661|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7
6781736|NCT04498247|10777662|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0
6781737|NCT04472650|10777679|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1
6781738|NCT04472650|10777680|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0
6781739|NCT04151290|10777697|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286
6781740|NCT04038385|10777703|FG000|Overall Study|Completed baseline assessment only|7
6781741|NCT04038385|10777704|FG001|Overall Study|Completed baseline assessment only|4
6781742|NCT04038385|10777703|FG000|Overall Study|Moved out of area|4
6781743|NCT04038385|10777704|FG001|Overall Study|Moved out of area|2
6781744|NCT04038385|10777703|FG000|Overall Study|Discontinued study involvement|6
6781745|NCT04038385|10777704|FG001|Overall Study|Discontinued study involvement|1
6781746|NCT03923738|10777710|FG000|Period 1|Adverse Event|1
6781747|NCT03923738|10777710|FG000|Period 1|Withdrawal by Subject|1
6781748|NCT03887117|10777720|FG000|Overall Study|Discontinued prematurely|0
6781749|NCT03887117|10777721|FG001|Overall Study|Discontinued prematurely|1
6781750|NCT03887117|10777722|FG002|Overall Study|Discontinued prematurely|1
6781751|NCT03887117|10777723|FG003|Overall Study|Discontinued prematurely|2
6781752|NCT03858634|10777744|FG000|Overall Study|Withdrawal by Subject|1
6781753|NCT03858634|10777745|FG001|Overall Study|Withdrawal by Subject|0
6781754|NCT03858634|10777744|FG000|Overall Study|Adverse Event|1
6781755|NCT03858634|10777745|FG001|Overall Study|Adverse Event|0
6781756|NCT03858634|10777744|FG000|Overall Study|Lost to Follow-up|0
6781757|NCT03858634|10777745|FG001|Overall Study|Lost to Follow-up|1
6781758|NCT03858634|10777744|FG000|Overall Study|Other, Not Specified|1
6781759|NCT03858634|10777745|FG001|Overall Study|Other, Not Specified|1
7137709|NCT02927873|11290086|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
7137710|NCT02927873|11290081|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7137711|NCT02927873|11290082|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7137712|NCT02927873|11290083|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7137713|NCT02927873|11290084|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7137714|NCT02927873|11290085|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7137715|NCT02927873|11290086|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
7137716|NCT02927873|11290081|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0
7137717|NCT02927873|11290082|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1
7137718|NCT02927873|11290083|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0
7137719|NCT02927873|11290084|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0
7137720|NCT02927873|11290085|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0
7137721|NCT02927873|11290086|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0
7137722|NCT02927873|11290081|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1
7137723|NCT02927873|11290082|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0
7137724|NCT02927873|11290083|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0
7137725|NCT02927873|11290084|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0
7137726|NCT02927873|11290085|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0
7137727|NCT02927873|11290086|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0
7137728|NCT02927873|11290081|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1
7137729|NCT02927873|11290082|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0
6781760|NCT03819114|10777763|FG000|Overall Study|Protocol Violation|0
6781761|NCT03819114|10777764|FG001|Overall Study|Protocol Violation|1
6781762|NCT03819114|10777765|FG002|Overall Study|Protocol Violation|1
6781763|NCT03819114|10777766|FG003|Overall Study|Protocol Violation|0
6781764|NCT03819114|10777763|FG000|Overall Study|Lost to Follow-up|0
6781765|NCT03819114|10777764|FG001|Overall Study|Lost to Follow-up|0
6781766|NCT03819114|10777765|FG002|Overall Study|Lost to Follow-up|1
6781767|NCT03819114|10777766|FG003|Overall Study|Lost to Follow-up|0
6781768|NCT03804268|10777780|FG000|Overall Study|Adverse Event|2
6781769|NCT03804268|10777781|FG001|Overall Study|Adverse Event|2
6781770|NCT03804268|10777780|FG000|Overall Study|Withdrawal by Subject|2
6781771|NCT03804268|10777781|FG001|Overall Study|Withdrawal by Subject|0
6781772|NCT03804268|10777780|FG000|Overall Study|Lost to Follow-up|1
6781773|NCT03804268|10777781|FG001|Overall Study|Lost to Follow-up|0
6781774|NCT03804268|10777780|FG000|Overall Study|Physician Decision|2
6781775|NCT03804268|10777781|FG001|Overall Study|Physician Decision|0
6806524|NCT04737278|10809137|FG000|Overall Study|Lost to Follow-up|1
6806525|NCT04737278|10809138|FG001|Overall Study|Lost to Follow-up|1
6806526|NCT04737278|10809137|FG000|Overall Study|Withdrawal by Subject|1
6806527|NCT04737278|10809138|FG001|Overall Study|Withdrawal by Subject|0
6806528|NCT04737278|10809137|FG000|Overall Study|Protocol Violation|1
6806529|NCT04737278|10809138|FG001|Overall Study|Protocol Violation|1
6806530|NCT04737278|10809137|FG000|Overall Study|failure to complete questionnaire|1
6806531|NCT04737278|10809138|FG001|Overall Study|failure to complete questionnaire|1
7137730|NCT02927873|11290083|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0
7137731|NCT02927873|11290084|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0
7137732|NCT02927873|11290085|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0
7137733|NCT02927873|11290086|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0
7137734|NCT02927925|11290100|FG000|Overall Study|Death|16
7137735|NCT02927925|11290100|FG000|Overall Study|Physician Decision|1
7137736|NCT02927925|11290100|FG000|Overall Study|Withdrawal by Subject|11
7137737|NCT02927925|11290100|FG000|Overall Study|Other|3
7137738|NCT02927925|11290100|FG000|Overall Study|Disease progression at clinical cutoff|1
7137739|NCT02928029|11290106|FG000|Overall Study|Withdrawal by Subject|0
7137740|NCT02928029|11290107|FG001|Overall Study|Withdrawal by Subject|1
7137741|NCT02928029|11290106|FG000|Overall Study|Radiological progression|1
7137742|NCT02928029|11290107|FG001|Overall Study|Radiological progression|0
7137743|NCT02928029|11290106|FG000|Overall Study|Clinical progression|1
6806532|NCT04524598|10809172|FG000|Phase I - Feasibility|Lost to Follow-up|2
6806533|NCT04524598|10809173|FG001|Phase I - Feasibility|Lost to Follow-up|4
6806534|NCT04524598|10809174|FG002|Phase I - Feasibility|Lost to Follow-up|0
6806535|NCT04524598|10809175|FG003|Phase I - Feasibility|Lost to Follow-up|0
6806536|NCT04524598|10809176|FG004|Phase I - Feasibility|Lost to Follow-up|0
6806537|NCT04524598|10809172|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2
6806538|NCT04524598|10809173|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1
6806539|NCT04524598|10809174|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0
6806540|NCT04524598|10809175|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0
6806541|NCT04524598|10809176|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0
6806542|NCT04524598|10809172|FG000|Phase II - Outcomes|Lost to Follow-up|0
6806543|NCT04524598|10809173|FG001|Phase II - Outcomes|Lost to Follow-up|0
6806544|NCT04524598|10809174|FG002|Phase II - Outcomes|Lost to Follow-up|16
6806545|NCT04524598|10809175|FG003|Phase II - Outcomes|Lost to Follow-up|8
6806546|NCT04524598|10809176|FG004|Phase II - Outcomes|Lost to Follow-up|0
7137744|NCT02928029|11290107|FG001|Overall Study|Clinical progression|2
7137745|NCT02928029|11290106|FG000|Overall Study|AE not related to clinical progression|1
7137746|NCT02928029|11290107|FG001|Overall Study|AE not related to clinical progression|1
7137747|NCT02928770|11290146|FG000|Overall Study|Withdrawal by Subject|2
7137748|NCT02928848|11290152|FG000|Arm 2|Withdrawal by Subject|1
7137749|NCT02928848|11290153|FG001|Arm 2|Withdrawal by Subject|0
7137750|NCT02928952|11290163|FG000|Overall Study|Lost to Follow-up|5
7137751|NCT02928952|11290164|FG001|Overall Study|Lost to Follow-up|5
7137752|NCT02928952|11290163|FG000|Overall Study|Withdrawal by Subject|5
7137753|NCT02928952|11290164|FG001|Overall Study|Withdrawal by Subject|1
7137754|NCT02928952|11290163|FG000|Overall Study|Physician Decision|0
7137755|NCT02928952|11290164|FG001|Overall Study|Physician Decision|1
7137756|NCT02929329|11290172|FG000|Overall Study|Withdrawal by Subject|24
7137757|NCT02929329|11290173|FG001|Overall Study|Withdrawal by Subject|21
7137758|NCT02929329|11290172|FG000|Overall Study|Lost to Follow-up|26
7137759|NCT02929329|11290173|FG001|Overall Study|Lost to Follow-up|20
7137760|NCT02929329|11290172|FG000|Overall Study|Death|1054
7137761|NCT02929329|11290173|FG001|Overall Study|Death|1051
7137762|NCT02929407|11290183|FG000|Overall Study|Adverse Event|1
7137763|NCT02929498|11290190|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3
7137764|NCT02929498|11290191|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0
7137765|NCT02929498|11290192|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0
7137766|NCT02929498|11290190|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2
7137767|NCT02929498|11290191|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0
7137768|NCT02929498|11290192|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0
6781776|NCT04435808|10777790|FG000|Overall Study|Study stopped by DSMB|0
6781777|NCT04435808|10777791|FG001|Overall Study|Study stopped by DSMB|1
6781778|NCT04409262|10777799|FG000|Overall Study|Adverse Event|0
6781779|NCT04409262|10777800|FG001|Overall Study|Adverse Event|2
6781780|NCT04409262|10777799|FG000|Overall Study|Death|55
6781781|NCT04409262|10777800|FG001|Overall Study|Death|97
6781782|NCT04409262|10777799|FG000|Overall Study|Lost to Follow-up|12
7137769|NCT02930005|11290234|FG000|Overall Study|Lost to Follow-up|1
7137770|NCT02930005|11290235|FG001|Overall Study|Lost to Follow-up|5
7137771|NCT02930018|11290243|FG000|Overall Study|Lost to Follow-up|1
7137772|NCT02930018|11290244|FG001|Overall Study|Lost to Follow-up|1
7137773|NCT02930018|11290243|FG000|Overall Study|Withdrawal by Subject|5
7137774|NCT02930018|11290244|FG001|Overall Study|Withdrawal by Subject|2
7137775|NCT02930226|11290267|FG000|Overall Study|Technical Problems: Leak in plasma bag|0
7137776|NCT02930226|11290268|FG001|Overall Study|Technical Problems: Leak in plasma bag|0
7137777|NCT02930226|11290269|FG002|Overall Study|Technical Problems: Leak in plasma bag|0
7137778|NCT02930226|11290270|FG003|Overall Study|Technical Problems: Leak in plasma bag|0
7137779|NCT02930226|11290271|FG004|Overall Study|Technical Problems: Leak in plasma bag|1
7137780|NCT02930226|11290272|FG005|Overall Study|Technical Problems: Leak in plasma bag|0
7137781|NCT02930343|11290290|FG000|Overall Study|Lost to Follow-up|9
7137782|NCT02930343|11290291|FG001|Overall Study|Lost to Follow-up|7
7137783|NCT02930837|11290320|FG000|Overall Study|Adverse Event|6
7137784|NCT02930837|11290320|FG000|Overall Study|Lost to Follow-up|5
7137785|NCT02930837|11290320|FG000|Overall Study|Withdrawal by Subject|1
7137786|NCT02930941|11290326|FG000|Overall Study|Lost to Follow-up|1
6781783|NCT04409262|10777800|FG001|Overall Study|Lost to Follow-up|23
6781784|NCT04409262|10777799|FG000|Overall Study|Lack of Staff|0
6781785|NCT04409262|10777800|FG001|Overall Study|Lack of Staff|1
6781786|NCT04409262|10777799|FG000|Overall Study|Protocol Violation|3
6781787|NCT04409262|10777800|FG001|Overall Study|Protocol Violation|1
6781788|NCT04409262|10777799|FG000|Overall Study|Withdrawal by Subject|5
6781789|NCT04409262|10777800|FG001|Overall Study|Withdrawal by Subject|10
6781790|NCT04305912|10777809|FG000|First Intervention|COVID-19 Suspension|2
6781791|NCT04305912|10777810|FG001|First Intervention|COVID-19 Suspension|0
6781792|NCT04305912|10777809|FG000|First Intervention|Withdrawal by Subject|0
6781793|NCT04305912|10777810|FG001|First Intervention|Withdrawal by Subject|1
6781794|NCT04305912|10777809|FG000|Second Intervention|Adverse Event|0
6781795|NCT04305912|10777810|FG001|Second Intervention|Adverse Event|1
6806547|NCT04524598|10809172|FG000|Phase II - Outcomes|Withdrawal by Subject|0
6806548|NCT04524598|10809173|FG001|Phase II - Outcomes|Withdrawal by Subject|0
6806549|NCT04524598|10809174|FG002|Phase II - Outcomes|Withdrawal by Subject|2
6806550|NCT04524598|10809175|FG003|Phase II - Outcomes|Withdrawal by Subject|0
6806551|NCT04524598|10809176|FG004|Phase II - Outcomes|Withdrawal by Subject|0
6806552|NCT04524598|10809172|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0
6806553|NCT04524598|10809173|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0
6806554|NCT04524598|10809174|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8
6806555|NCT04524598|10809175|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5
6806556|NCT04524598|10809176|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0
6806557|NCT04524598|10809172|FG000|Phase II - Control Extension|Lost to Follow-up|0
6806558|NCT04524598|10809173|FG001|Phase II - Control Extension|Lost to Follow-up|0
6806559|NCT04524598|10809174|FG002|Phase II - Control Extension|Lost to Follow-up|0
6806560|NCT04524598|10809175|FG003|Phase II - Control Extension|Lost to Follow-up|0
6806561|NCT04524598|10809176|FG004|Phase II - Control Extension|Lost to Follow-up|6
6806562|NCT04524598|10809172|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0
6806563|NCT04524598|10809173|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0
6806564|NCT04524598|10809174|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0
6806565|NCT04524598|10809175|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0
6806566|NCT04524598|10809176|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6
6806567|NCT04334460|10809192|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4
6806568|NCT04334460|10809193|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1
6806569|NCT04334460|10809192|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4
6806570|NCT04334460|10809193|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1
6810486|NCT03764631|10814216|FG000|Overall Study|No data as study site was closed|2
6810487|NCT03764631|10814217|FG001|Overall Study|No data as study site was closed|6
6810488|NCT03764072|10814229|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0
6810489|NCT03764072|10814230|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0
6810490|NCT03764072|10814231|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1
6810491|NCT03764072|10814232|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0
6810492|NCT03764072|10814233|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0
6810493|NCT03764072|10814234|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0
6810494|NCT03764072|10814229|FG000|Overall Study|Withdrawal of consent (for other reason)|0
6810495|NCT03764072|10814230|FG001|Overall Study|Withdrawal of consent (for other reason)|0
6810496|NCT03764072|10814231|FG002|Overall Study|Withdrawal of consent (for other reason)|0
6810497|NCT03764072|10814232|FG003|Overall Study|Withdrawal of consent (for other reason)|0
6810498|NCT03764072|10814233|FG004|Overall Study|Withdrawal of consent (for other reason)|0
6810499|NCT03764072|10814234|FG005|Overall Study|Withdrawal of consent (for other reason)|1
6810500|NCT03764072|10814229|FG000|Overall Study|Lost to Follow-up|0
6810501|NCT03764072|10814230|FG001|Overall Study|Lost to Follow-up|0
7137787|NCT02930941|11290327|FG001|Overall Study|Lost to Follow-up|2
7137788|NCT02931396|11290361|FG000|Overall Study|Lost to Follow-up|3
7137789|NCT02931396|11290362|FG001|Overall Study|Lost to Follow-up|0
7137790|NCT02931396|11290361|FG000|Overall Study|Withdrawal by Subject|2
7137791|NCT02931396|11290362|FG001|Overall Study|Withdrawal by Subject|0
7137792|NCT02931539|11290370|FG000|Period 1: Treatment Phase|Investigator discretion|1
7137793|NCT02931539|11290371|FG001|Period 1: Treatment Phase|Investigator discretion|1
7137794|NCT02931539|11290372|FG002|Period 1: Treatment Phase|Investigator discretion|0
7137795|NCT02931539|11290370|FG000|Period 1: Treatment Phase|Adverse Event|5
7137796|NCT02931539|11290371|FG001|Period 1: Treatment Phase|Adverse Event|1
7137797|NCT02931539|11290372|FG002|Period 1: Treatment Phase|Adverse Event|0
7137798|NCT02931539|11290370|FG000|Period 1: Treatment Phase|Lost to Follow-up|1
6781796|NCT03987919|10777829|FG000|Overall Study|Adverse Event|1
6781797|NCT03987919|10777830|FG001|Overall Study|Adverse Event|4
6781798|NCT03987919|10777831|FG002|Overall Study|Adverse Event|1
6781799|NCT03987919|10777832|FG003|Overall Study|Adverse Event|3
6781800|NCT03987919|10777829|FG000|Overall Study|Death|4
6781801|NCT03987919|10777830|FG001|Overall Study|Death|4
6781802|NCT03987919|10777831|FG002|Overall Study|Death|4
6781803|NCT03987919|10777832|FG003|Overall Study|Death|1
6781804|NCT03987919|10777829|FG000|Overall Study|Lost to Follow-up|5
6781805|NCT03987919|10777830|FG001|Overall Study|Lost to Follow-up|6
6781806|NCT03987919|10777831|FG002|Overall Study|Lost to Follow-up|8
6781807|NCT03987919|10777832|FG003|Overall Study|Lost to Follow-up|12
6781808|NCT03987919|10777829|FG000|Overall Study|Physician Decision|0
6781809|NCT03987919|10777830|FG001|Overall Study|Physician Decision|2
6781810|NCT03987919|10777831|FG002|Overall Study|Physician Decision|0
6781811|NCT03987919|10777832|FG003|Overall Study|Physician Decision|4
6781812|NCT03987919|10777829|FG000|Overall Study|Pregnancy|1
6781813|NCT03987919|10777830|FG001|Overall Study|Pregnancy|0
6781814|NCT03987919|10777831|FG002|Overall Study|Pregnancy|1
6781815|NCT03987919|10777832|FG003|Overall Study|Pregnancy|1
6781816|NCT03987919|10777829|FG000|Overall Study|Protocol Violation|0
6781817|NCT03987919|10777830|FG001|Overall Study|Protocol Violation|1
6781818|NCT03987919|10777831|FG002|Overall Study|Protocol Violation|0
6781819|NCT03987919|10777832|FG003|Overall Study|Protocol Violation|0
6781820|NCT03987919|10777829|FG000|Overall Study|Site terminated by Sponsor|0
6781821|NCT03987919|10777830|FG001|Overall Study|Site terminated by Sponsor|0
6781822|NCT03987919|10777831|FG002|Overall Study|Site terminated by Sponsor|0
7137799|NCT02931539|11290371|FG001|Period 1: Treatment Phase|Lost to Follow-up|2
7137800|NCT02931539|11290372|FG002|Period 1: Treatment Phase|Lost to Follow-up|0
7137801|NCT02931539|11290370|FG000|Period 1: Treatment Phase|Death|8
7137802|NCT02931539|11290371|FG001|Period 1: Treatment Phase|Death|24
7137803|NCT02931539|11290372|FG002|Period 1: Treatment Phase|Death|0
7137804|NCT02931539|11290370|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16
7137805|NCT02931539|11290371|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8
7137806|NCT02931539|11290372|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0
7137807|NCT02931539|11290370|FG000|Period 1: Treatment Phase|Protocol Violation|6
7137808|NCT02931539|11290371|FG001|Period 1: Treatment Phase|Protocol Violation|0
7137809|NCT02931539|11290372|FG002|Period 1: Treatment Phase|Protocol Violation|0
7137810|NCT02931539|11290370|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22
7137811|NCT02931539|11290371|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0
7137812|NCT02931539|11290372|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0
6781823|NCT03987919|10777832|FG003|Overall Study|Site terminated by Sponsor|1
6781824|NCT03987919|10777829|FG000|Overall Study|Withdrawal by Subject|7
6781825|NCT03987919|10777830|FG001|Overall Study|Withdrawal by Subject|7
6781826|NCT03987919|10777831|FG002|Overall Study|Withdrawal by Subject|8
6781827|NCT03987919|10777832|FG003|Overall Study|Withdrawal by Subject|4
6781828|NCT03987919|10777829|FG000|Overall Study|Other - as reported by the investigator|1
6781829|NCT03987919|10777830|FG001|Overall Study|Other - as reported by the investigator|3
6781830|NCT03987919|10777831|FG002|Overall Study|Other - as reported by the investigator|2
6781831|NCT03987919|10777832|FG003|Overall Study|Other - as reported by the investigator|0
6781832|NCT03861039|10777861|FG000|Overall Study|Adverse Event|2
6781833|NCT03861039|10777862|FG001|Overall Study|Adverse Event|5
6781834|NCT03861039|10777863|FG002|Overall Study|Adverse Event|11
6781835|NCT03861039|10777861|FG000|Overall Study|Withdrawal by Subject|1
6781836|NCT03861039|10777862|FG001|Overall Study|Withdrawal by Subject|3
6781837|NCT03861039|10777863|FG002|Overall Study|Withdrawal by Subject|4
6781838|NCT03759587|10777873|FG000|Overall Study|Ongoing|19
6781839|NCT03730662|10777881|FG000|Treatment Period (52 Weeks)|Adverse Event|3
6781840|NCT03730662|10777882|FG001|Treatment Period (52 Weeks)|Adverse Event|2
6781841|NCT03730662|10777883|FG002|Treatment Period (52 Weeks)|Adverse Event|0
6781842|NCT03730662|10777884|FG003|Treatment Period (52 Weeks)|Adverse Event|3
6781843|NCT03730662|10777881|FG000|Treatment Period (52 Weeks)|Screen Failure|0
6781844|NCT03730662|10777882|FG001|Treatment Period (52 Weeks)|Screen Failure|1
6781845|NCT03730662|10777883|FG002|Treatment Period (52 Weeks)|Screen Failure|0
6781846|NCT03730662|10777884|FG003|Treatment Period (52 Weeks)|Screen Failure|0
6781847|NCT03730662|10777881|FG000|Treatment Period (52 Weeks)|Death|6
6781848|NCT03730662|10777882|FG001|Treatment Period (52 Weeks)|Death|2
6781849|NCT03730662|10777883|FG002|Treatment Period (52 Weeks)|Death|2
6781850|NCT03730662|10777884|FG003|Treatment Period (52 Weeks)|Death|9
6810502|NCT03764072|10814231|FG002|Overall Study|Lost to Follow-up|0
7137813|NCT02931539|11290370|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0
7137814|NCT02931539|11290371|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0
7137815|NCT02931539|11290372|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2
7137816|NCT02931838|11290401|FG000|Overall Study|Reason not provided by investigator|1
7137817|NCT02931838|11290402|FG001|Overall Study|Reason not provided by investigator|0
7137818|NCT02931838|11290403|FG002|Overall Study|Reason not provided by investigator|1
7137819|NCT02931838|11290404|FG003|Overall Study|Reason not provided by investigator|0
7137820|NCT02931838|11290405|FG004|Overall Study|Reason not provided by investigator|0
7137821|NCT02931838|11290406|FG005|Overall Study|Reason not provided by investigator|0
7137822|NCT02931838|11290401|FG000|Overall Study|Poor/non-compliance|0
7137823|NCT02931838|11290402|FG001|Overall Study|Poor/non-compliance|0
7137824|NCT02931838|11290403|FG002|Overall Study|Poor/non-compliance|1
7137825|NCT02931838|11290404|FG003|Overall Study|Poor/non-compliance|0
7137826|NCT02931838|11290405|FG004|Overall Study|Poor/non-compliance|0
7137827|NCT02931838|11290406|FG005|Overall Study|Poor/non-compliance|0
7137828|NCT02931838|11290401|FG000|Overall Study|Lack of Efficacy|5
7137829|NCT02931838|11290402|FG001|Overall Study|Lack of Efficacy|4
7137830|NCT02931838|11290403|FG002|Overall Study|Lack of Efficacy|0
7137831|NCT02931838|11290404|FG003|Overall Study|Lack of Efficacy|0
7137832|NCT02931838|11290405|FG004|Overall Study|Lack of Efficacy|0
7137833|NCT02931838|11290406|FG005|Overall Study|Lack of Efficacy|1
7137834|NCT02931838|11290401|FG000|Overall Study|Lost to Follow-up|1
7137835|NCT02931838|11290402|FG001|Overall Study|Lost to Follow-up|0
7137836|NCT02931838|11290403|FG002|Overall Study|Lost to Follow-up|1
7137837|NCT02931838|11290404|FG003|Overall Study|Lost to Follow-up|1
7137838|NCT02931838|11290405|FG004|Overall Study|Lost to Follow-up|2
7137839|NCT02931838|11290406|FG005|Overall Study|Lost to Follow-up|0
7137840|NCT02931838|11290401|FG000|Overall Study|Subject request to discontinue treatment|4
7137841|NCT02931838|11290402|FG001|Overall Study|Subject request to discontinue treatment|3
7137842|NCT02931838|11290403|FG002|Overall Study|Subject request to discontinue treatment|3
7137843|NCT02931838|11290404|FG003|Overall Study|Subject request to discontinue treatment|0
7137844|NCT02931838|11290405|FG004|Overall Study|Subject request to discontinue treatment|1
7137845|NCT02931838|11290406|FG005|Overall Study|Subject request to discontinue treatment|0
7137846|NCT02931838|11290401|FG000|Overall Study|Withdrawal by Subject|1
7137847|NCT02931838|11290402|FG001|Overall Study|Withdrawal by Subject|2
7137848|NCT02931838|11290403|FG002|Overall Study|Withdrawal by Subject|0
7137849|NCT02931838|11290404|FG003|Overall Study|Withdrawal by Subject|1
7137850|NCT02931838|11290405|FG004|Overall Study|Withdrawal by Subject|0
7137851|NCT02931838|11290406|FG005|Overall Study|Withdrawal by Subject|0
7137852|NCT02931838|11290401|FG000|Overall Study|Adverse Event|2
6781851|NCT03730662|10777881|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4
6781852|NCT03730662|10777882|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2
6781853|NCT03730662|10777883|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2
6781854|NCT03730662|10777884|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11
6781855|NCT03730662|10777881|FG000|Treatment Period (52 Weeks)|Physician Decision|1
6781856|NCT03730662|10777882|FG001|Treatment Period (52 Weeks)|Physician Decision|1
6781857|NCT03730662|10777883|FG002|Treatment Period (52 Weeks)|Physician Decision|0
6781858|NCT03730662|10777884|FG003|Treatment Period (52 Weeks)|Physician Decision|3
6781859|NCT03730662|10777881|FG000|Treatment Period (52 Weeks)|Protocol Violation|0
6781860|NCT03730662|10777882|FG001|Treatment Period (52 Weeks)|Protocol Violation|1
6781861|NCT03730662|10777883|FG002|Treatment Period (52 Weeks)|Protocol Violation|0
6781862|NCT03730662|10777884|FG003|Treatment Period (52 Weeks)|Protocol Violation|1
6781863|NCT03730662|10777881|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5
6781864|NCT03730662|10777882|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0
6781865|NCT03730662|10777883|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5
6781866|NCT03730662|10777884|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23
6781867|NCT03730662|10777881|FG000|Treatment Period (52 Weeks)|Personal Reason|2
6781868|NCT03730662|10777882|FG001|Treatment Period (52 Weeks)|Personal Reason|2
6781869|NCT03730662|10777883|FG002|Treatment Period (52 Weeks)|Personal Reason|0
6781870|NCT03730662|10777884|FG003|Treatment Period (52 Weeks)|Personal Reason|2
6781871|NCT03730662|10777881|FG000|Variable Treatment Period|Adverse Event|1
6781872|NCT03730662|10777882|FG001|Variable Treatment Period|Adverse Event|2
6781873|NCT03730662|10777883|FG002|Variable Treatment Period|Adverse Event|0
6781874|NCT03730662|10777884|FG003|Variable Treatment Period|Adverse Event|7
6781875|NCT03730662|10777881|FG000|Variable Treatment Period|Death|9
6781876|NCT03730662|10777882|FG001|Variable Treatment Period|Death|0
6781877|NCT03730662|10777883|FG002|Variable Treatment Period|Death|6
6781878|NCT03730662|10777884|FG003|Variable Treatment Period|Death|26
6781879|NCT03730662|10777881|FG000|Variable Treatment Period|Lost to Follow-up|2
6781880|NCT03730662|10777882|FG001|Variable Treatment Period|Lost to Follow-up|1
6781881|NCT03730662|10777883|FG002|Variable Treatment Period|Lost to Follow-up|4
6781882|NCT03730662|10777884|FG003|Variable Treatment Period|Lost to Follow-up|11
6781883|NCT03730662|10777881|FG000|Variable Treatment Period|Personal Reason|0
6781884|NCT03730662|10777882|FG001|Variable Treatment Period|Personal Reason|2
6781885|NCT03730662|10777883|FG002|Variable Treatment Period|Personal Reason|1
6781886|NCT03730662|10777884|FG003|Variable Treatment Period|Personal Reason|6
6781887|NCT03730662|10777881|FG000|Variable Treatment Period|Physician Decision|0
6781888|NCT03730662|10777882|FG001|Variable Treatment Period|Physician Decision|0
6781889|NCT03730662|10777883|FG002|Variable Treatment Period|Physician Decision|0
7137853|NCT02931838|11290402|FG001|Overall Study|Adverse Event|1
7137854|NCT02931838|11290403|FG002|Overall Study|Adverse Event|2
7137855|NCT02931838|11290404|FG003|Overall Study|Adverse Event|1
7137856|NCT02931838|11290405|FG004|Overall Study|Adverse Event|3
7137857|NCT02931838|11290406|FG005|Overall Study|Adverse Event|1
7137858|NCT02932228|11290427|FG000|Overall Study|Death|8
7137859|NCT02932228|11290428|FG001|Overall Study|Death|23
7137860|NCT02932228|11290427|FG000|Overall Study|not eligible upon chart review|2
7137861|NCT02932228|11290428|FG001|Overall Study|not eligible upon chart review|5
7137862|NCT02932267|11290436|FG000|Overall Study|Withdrawal by Subject|3
6781890|NCT03730662|10777884|FG003|Variable Treatment Period|Physician Decision|3
6781891|NCT03730662|10777881|FG000|Variable Treatment Period|Protocol Violation|0
6781892|NCT03730662|10777882|FG001|Variable Treatment Period|Protocol Violation|1
6781893|NCT03730662|10777883|FG002|Variable Treatment Period|Protocol Violation|1
6781894|NCT03730662|10777884|FG003|Variable Treatment Period|Protocol Violation|1
6781895|NCT03730662|10777881|FG000|Variable Treatment Period|Withdrawal by Subject|2
6781896|NCT03730662|10777882|FG001|Variable Treatment Period|Withdrawal by Subject|1
6781897|NCT03730662|10777883|FG002|Variable Treatment Period|Withdrawal by Subject|4
6781898|NCT03730662|10777884|FG003|Variable Treatment Period|Withdrawal by Subject|17
6781899|NCT03538444|10777900|FG000|Overall Study|opioid withdrawal|1
6781900|NCT03538444|10777901|FG001|Overall Study|opioid withdrawal|0
6781901|NCT03410693|10777909|FG000|Overall Study|Disc trt: Withdrawal by participant|6
6781902|NCT03410693|10777910|FG001|Overall Study|Disc trt: Withdrawal by participant|4
6781903|NCT03410693|10777909|FG000|Overall Study|Disc trt: Lost to follow up|0
6781904|NCT03410693|10777910|FG001|Overall Study|Disc trt: Lost to follow up|1
6781905|NCT03410693|10777909|FG000|Overall Study|Disc trt: radiological progression|58
6781906|NCT03410693|10777910|FG001|Overall Study|Disc trt: radiological progression|50
6781907|NCT03410693|10777909|FG000|Overall Study|Disc trt: Other|1
6781908|NCT03410693|10777910|FG001|Overall Study|Disc trt: Other|0
6781909|NCT03410693|10777909|FG000|Overall Study|Study drug never administered|1
6781910|NCT03410693|10777910|FG001|Overall Study|Study drug never administered|6
6781911|NCT03410693|10777909|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6
6781912|NCT03410693|10777910|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4
6781913|NCT03410693|10777909|FG000|Overall Study|Disc trt: Adverse Event (AE)|13
6781914|NCT03410693|10777910|FG001|Overall Study|Disc trt: Adverse Event (AE)|9
6781915|NCT03410693|10777909|FG000|Overall Study|Disc trt: Physician decision|0
6781916|NCT03410693|10777910|FG001|Overall Study|Disc trt: Physician decision|5
6781917|NCT03410693|10777909|FG000|Overall Study|Disc trt: clinical progression|1
6781918|NCT03410693|10777910|FG001|Overall Study|Disc trt: clinical progression|5
6781919|NCT03410693|10777909|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1
6781920|NCT03410693|10777910|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4
6781921|NCT03252925|10777937|FG000|Overall Study|Withdrawal by Subject|1
6781922|NCT03252925|10777938|FG001|Overall Study|Withdrawal by Subject|0
6781923|NCT03252925|10777937|FG000|Overall Study|Protocol Violation|6
6781924|NCT03252925|10777938|FG001|Overall Study|Protocol Violation|0
6781925|NCT03252925|10777937|FG000|Overall Study|Adverse Event|1
6781926|NCT03252925|10777938|FG001|Overall Study|Adverse Event|0
6781927|NCT03252925|10777937|FG000|Overall Study|Lost to Follow-up|6
6781928|NCT03252925|10777938|FG001|Overall Study|Lost to Follow-up|6
6781929|NCT03185832|10777948|FG000|Overall Study|Death|9
6781930|NCT03185832|10777949|FG001|Overall Study|Death|14
6781931|NCT03185832|10777950|FG002|Overall Study|Death|9
6781932|NCT03185832|10777951|FG003|Overall Study|Death|7
6781933|NCT03185832|10777948|FG000|Overall Study|Withdrawn - vital status available|0
6781934|NCT03185832|10777949|FG001|Overall Study|Withdrawn - vital status available|1
6781935|NCT03185832|10777950|FG002|Overall Study|Withdrawn - vital status available|1
7137863|NCT02932267|11290436|FG000|Overall Study|Lost to Follow-up|4
7137864|NCT02932267|11290436|FG000|Overall Study|Pregnancy|1
7137865|NCT02932306|11290442|FG000|Overall Study|Withdrawal by Subject|16
7137866|NCT02932306|11290443|FG001|Overall Study|Withdrawal by Subject|25
7137867|NCT02932306|11290442|FG000|Overall Study|Adverse Event|3
7137868|NCT02932306|11290443|FG001|Overall Study|Adverse Event|0
7137869|NCT02932306|11290442|FG000|Overall Study|Pregnancy|2
7137870|NCT02932306|11290443|FG001|Overall Study|Pregnancy|0
7137871|NCT02932306|11290442|FG000|Overall Study|Protocol Violation|1
7137872|NCT02932306|11290443|FG001|Overall Study|Protocol Violation|1
7137873|NCT02932306|11290442|FG000|Overall Study|Noncompliance with Study Drug|1
7137874|NCT02932306|11290443|FG001|Overall Study|Noncompliance with Study Drug|1
7137875|NCT02932306|11290442|FG000|Overall Study|Lost to Follow-up|36
7137876|NCT02932306|11290443|FG001|Overall Study|Lost to Follow-up|40
6781936|NCT03185832|10777951|FG003|Overall Study|Withdrawn - vital status available|4
6806571|NCT04247828|10809200|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9
6806572|NCT04084769|10809208|FG000|Overall Study|Protocol Violation|1
6806573|NCT04084769|10809209|FG001|Overall Study|Protocol Violation|3
6806574|NCT04084769|10809210|FG002|Overall Study|Protocol Violation|0
6806575|NCT04084769|10809211|FG003|Overall Study|Protocol Violation|1
6806576|NCT04084769|10809208|FG000|Overall Study|Withdrawal by Subject|0
6806577|NCT04084769|10809209|FG001|Overall Study|Withdrawal by Subject|1
6806578|NCT04084769|10809210|FG002|Overall Study|Withdrawal by Subject|0
6806579|NCT04084769|10809211|FG003|Overall Study|Withdrawal by Subject|0
6810503|NCT03764072|10814232|FG003|Overall Study|Lost to Follow-up|0
7137877|NCT02932306|11290442|FG000|Overall Study|Withdrawal by Parent or Guardian|6
6781937|NCT02959918|10777982|FG000|Overall Study|Adverse Event|1
6781938|NCT02959918|10777983|FG001|Overall Study|Adverse Event|1
6781939|NCT02959918|10777984|FG002|Overall Study|Adverse Event|2
6781940|NCT02959918|10777985|FG003|Overall Study|Adverse Event|0
6781941|NCT02959918|10777986|FG004|Overall Study|Adverse Event|0
6781942|NCT02959918|10777987|FG005|Overall Study|Adverse Event|2
6781943|NCT02959918|10777988|FG006|Overall Study|Adverse Event|2
6781944|NCT02959918|10777989|FG007|Overall Study|Adverse Event|1
6781945|NCT02959918|10777990|FG008|Overall Study|Adverse Event|2
6781946|NCT02959918|10777991|FG009|Overall Study|Adverse Event|1
6781947|NCT02959918|10777992|FG010|Overall Study|Adverse Event|1
6781948|NCT02959918|10777993|FG011|Overall Study|Adverse Event|3
6781949|NCT02959918|10777994|FG012|Overall Study|Adverse Event|2
6781950|NCT02959918|10777995|FG013|Overall Study|Adverse Event|4
6781951|NCT02959918|10777982|FG000|Overall Study|Lost to Follow-up|0
6781952|NCT02959918|10777983|FG001|Overall Study|Lost to Follow-up|0
6781953|NCT02959918|10777984|FG002|Overall Study|Lost to Follow-up|0
6781954|NCT02959918|10777985|FG003|Overall Study|Lost to Follow-up|0
6781955|NCT02959918|10777986|FG004|Overall Study|Lost to Follow-up|0
6781956|NCT02959918|10777987|FG005|Overall Study|Lost to Follow-up|0
6781957|NCT02959918|10777988|FG006|Overall Study|Lost to Follow-up|0
6781958|NCT02959918|10777989|FG007|Overall Study|Lost to Follow-up|0
6781959|NCT02959918|10777990|FG008|Overall Study|Lost to Follow-up|0
6781960|NCT02959918|10777991|FG009|Overall Study|Lost to Follow-up|1
6781961|NCT02959918|10777992|FG010|Overall Study|Lost to Follow-up|0
6781962|NCT02959918|10777993|FG011|Overall Study|Lost to Follow-up|0
6781963|NCT02959918|10777994|FG012|Overall Study|Lost to Follow-up|1
6781964|NCT02959918|10777995|FG013|Overall Study|Lost to Follow-up|0
6781965|NCT02959918|10777982|FG000|Overall Study|Withdrawal by Subject|0
6781966|NCT02959918|10777983|FG001|Overall Study|Withdrawal by Subject|0
6781967|NCT02959918|10777984|FG002|Overall Study|Withdrawal by Subject|1
6781968|NCT02959918|10777985|FG003|Overall Study|Withdrawal by Subject|2
6781969|NCT02959918|10777986|FG004|Overall Study|Withdrawal by Subject|0
6781970|NCT02959918|10777987|FG005|Overall Study|Withdrawal by Subject|0
6781971|NCT02959918|10777988|FG006|Overall Study|Withdrawal by Subject|1
6781972|NCT02959918|10777989|FG007|Overall Study|Withdrawal by Subject|0
6781973|NCT02959918|10777990|FG008|Overall Study|Withdrawal by Subject|1
6781974|NCT02959918|10777991|FG009|Overall Study|Withdrawal by Subject|1
6781975|NCT02959918|10777992|FG010|Overall Study|Withdrawal by Subject|2
6781976|NCT02959918|10777993|FG011|Overall Study|Withdrawal by Subject|3
6781977|NCT02959918|10777994|FG012|Overall Study|Withdrawal by Subject|1
6781978|NCT02959918|10777995|FG013|Overall Study|Withdrawal by Subject|1
6781979|NCT02959918|10777982|FG000|Overall Study|Protocol Violation|0
6781980|NCT02959918|10777983|FG001|Overall Study|Protocol Violation|0
6781981|NCT02959918|10777984|FG002|Overall Study|Protocol Violation|1
6781982|NCT02959918|10777985|FG003|Overall Study|Protocol Violation|0
6781983|NCT02959918|10777986|FG004|Overall Study|Protocol Violation|0
6781984|NCT02959918|10777987|FG005|Overall Study|Protocol Violation|1
6781985|NCT02959918|10777988|FG006|Overall Study|Protocol Violation|0
6781986|NCT02959918|10777989|FG007|Overall Study|Protocol Violation|0
6781987|NCT02959918|10777990|FG008|Overall Study|Protocol Violation|2
6781988|NCT02959918|10777991|FG009|Overall Study|Protocol Violation|1
6781989|NCT02959918|10777992|FG010|Overall Study|Protocol Violation|0
6781990|NCT02959918|10777993|FG011|Overall Study|Protocol Violation|1
6781991|NCT02959918|10777994|FG012|Overall Study|Protocol Violation|1
6781992|NCT02959918|10777995|FG013|Overall Study|Protocol Violation|0
6781993|NCT02959918|10777982|FG000|Overall Study|Stopping Rule Met|1
6781994|NCT02959918|10777983|FG001|Overall Study|Stopping Rule Met|0
6781995|NCT02959918|10777984|FG002|Overall Study|Stopping Rule Met|3
6781996|NCT02959918|10777985|FG003|Overall Study|Stopping Rule Met|4
6781997|NCT02959918|10777986|FG004|Overall Study|Stopping Rule Met|5
6781998|NCT02959918|10777987|FG005|Overall Study|Stopping Rule Met|3
6781999|NCT02959918|10777988|FG006|Overall Study|Stopping Rule Met|2
6782000|NCT02959918|10777989|FG007|Overall Study|Stopping Rule Met|4
6782001|NCT02959918|10777990|FG008|Overall Study|Stopping Rule Met|1
6782002|NCT02959918|10777991|FG009|Overall Study|Stopping Rule Met|1
6782003|NCT02959918|10777992|FG010|Overall Study|Stopping Rule Met|3
6782004|NCT02959918|10777993|FG011|Overall Study|Stopping Rule Met|5
6782005|NCT02959918|10777994|FG012|Overall Study|Stopping Rule Met|2
6782006|NCT02959918|10777995|FG013|Overall Study|Stopping Rule Met|1
6782007|NCT02959918|10777982|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1
6782008|NCT02959918|10777983|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2
6782009|NCT02959918|10777984|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1
6782010|NCT02959918|10777985|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3
6782011|NCT02959918|10777986|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
6782012|NCT02959918|10777987|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
6782013|NCT02959918|10777988|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
6782014|NCT02959918|10777989|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
6782015|NCT02959918|10777990|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
6782016|NCT02959918|10777991|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
6782017|NCT02959918|10777992|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
6782018|NCT02959918|10777993|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
7137878|NCT02932306|11290443|FG001|Overall Study|Withdrawal by Parent or Guardian|8
7137879|NCT02932306|11290442|FG000|Overall Study|Lack of Efficacy|0
7137880|NCT02932306|11290443|FG001|Overall Study|Lack of Efficacy|2
7137881|NCT02932306|11290442|FG000|Overall Study|Worsening condition|2
7137882|NCT02932306|11290443|FG001|Overall Study|Worsening condition|0
7137883|NCT02932306|11290442|FG000|Overall Study|Withdrew due to burning,itching,stinging|1
7137884|NCT02932306|11290443|FG001|Overall Study|Withdrew due to burning,itching,stinging|0
7137885|NCT02932462|11290451|FG000|Overall Study|Adverse Event|1
7137886|NCT02932462|11290452|FG001|Overall Study|Adverse Event|2
7137887|NCT02932462|11290451|FG000|Overall Study|Lost to Follow-up|4
7137888|NCT02932462|11290452|FG001|Overall Study|Lost to Follow-up|1
7137889|NCT02932462|11290451|FG000|Overall Study|Protocol Violation|0
7137890|NCT02932462|11290452|FG001|Overall Study|Protocol Violation|5
7137891|NCT02932462|11290451|FG000|Overall Study|Withdrawal by Subject|1
7137892|NCT02932462|11290452|FG001|Overall Study|Withdrawal by Subject|4
7137893|NCT02932462|11290451|FG000|Overall Study|Non-Compliance With Study Drug|0
7137894|NCT02932462|11290452|FG001|Overall Study|Non-Compliance With Study Drug|1
7137895|NCT02932462|11290451|FG000|Overall Study|Progressive Disease|1
7137896|NCT02932462|11290452|FG001|Overall Study|Progressive Disease|0
7137897|NCT02932878|11290472|FG000|Overall Study|Due to Lab Results|2
6782019|NCT02959918|10777994|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
6782020|NCT02959918|10777995|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
6782021|NCT02959918|10777982|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0
6782022|NCT02959918|10777983|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0
6782023|NCT02959918|10777984|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0
6782024|NCT02959918|10777985|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0
6782025|NCT02959918|10777986|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0
6782026|NCT02959918|10777987|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0
6782027|NCT02959918|10777988|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0
6782028|NCT02959918|10777989|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1
6782029|NCT02959918|10777990|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0
6782030|NCT02959918|10777991|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0
6782031|NCT02959918|10777992|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0
6782032|NCT02959918|10777993|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0
6782033|NCT02959918|10777994|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0
6782034|NCT02959918|10777995|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0
6782035|NCT02959918|10777982|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0
6782036|NCT02959918|10777983|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0
6782037|NCT02959918|10777984|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0
6782038|NCT02959918|10777985|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0
6782039|NCT02959918|10777986|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0
6782040|NCT02959918|10777987|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0
6782041|NCT02959918|10777988|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0
6782042|NCT02959918|10777989|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0
6782043|NCT02959918|10777990|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1
6782044|NCT02959918|10777991|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0
6782045|NCT02959918|10777992|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0
6782046|NCT02959918|10777993|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0
6782047|NCT02959918|10777994|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0
6782048|NCT02959918|10777995|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0
6782049|NCT02959918|10777982|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
6782050|NCT02959918|10777983|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
6782051|NCT02959918|10777984|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
6782052|NCT02959918|10777985|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
6782053|NCT02959918|10777986|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
6782054|NCT02959918|10777987|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
6782055|NCT02959918|10777988|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
6782056|NCT02959918|10777989|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
6782057|NCT02959918|10777990|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
6782058|NCT02959918|10777991|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1
6782059|NCT02959918|10777992|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
6782060|NCT02959918|10777993|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
6782061|NCT02959918|10777994|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
6782062|NCT02959918|10777995|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
6782063|NCT02472964|10778030|FG000|Part 1 (up to Week 24)|Adverse Event|2
6782064|NCT02472964|10778031|FG001|Part 1 (up to Week 24)|Adverse Event|4
6782065|NCT02472964|10778030|FG000|Part 1 (up to Week 24)|disease progression|58
6782066|NCT02472964|10778031|FG001|Part 1 (up to Week 24)|disease progression|47
7137898|NCT02932878|11290473|FG001|Overall Study|Due to Lab Results|1
7137899|NCT02932891|11290479|FG000|Overall Study|Lost to Follow-up|2
7137900|NCT02932891|11290479|FG000|Overall Study|HPA Suppress|2
7137901|NCT02932904|11290487|FG000|Overall Study|Reason not Specified|1
7137902|NCT02932904|11290488|FG001|Overall Study|Reason not Specified|0
7137903|NCT02932904|11290489|FG002|Overall Study|Reason not Specified|2
7137904|NCT02932904|11290490|FG003|Overall Study|Reason not Specified|2
7137905|NCT02932904|11290487|FG000|Overall Study|Noncompliance with Study Drug|2
7137906|NCT02932904|11290488|FG001|Overall Study|Noncompliance with Study Drug|3
7137907|NCT02932904|11290489|FG002|Overall Study|Noncompliance with Study Drug|3
7137908|NCT02932904|11290490|FG003|Overall Study|Noncompliance with Study Drug|4
7137909|NCT02932904|11290487|FG000|Overall Study|Pregnancy|0
7137910|NCT02932904|11290488|FG001|Overall Study|Pregnancy|1
7137911|NCT02932904|11290489|FG002|Overall Study|Pregnancy|1
7137912|NCT02932904|11290490|FG003|Overall Study|Pregnancy|0
7137913|NCT02932904|11290487|FG000|Overall Study|Study Termination|0
7137914|NCT02932904|11290488|FG001|Overall Study|Study Termination|1
7137915|NCT02932904|11290489|FG002|Overall Study|Study Termination|0
7137916|NCT02932904|11290490|FG003|Overall Study|Study Termination|0
7137917|NCT02932904|11290487|FG000|Overall Study|Voluntary Withdrawal|2
7137918|NCT02932904|11290488|FG001|Overall Study|Voluntary Withdrawal|1
7137919|NCT02932904|11290489|FG002|Overall Study|Voluntary Withdrawal|4
7137920|NCT02932904|11290490|FG003|Overall Study|Voluntary Withdrawal|2
7137921|NCT02932904|11290487|FG000|Overall Study|Lost to Follow-up|5
7137922|NCT02932904|11290488|FG001|Overall Study|Lost to Follow-up|3
7137923|NCT02932904|11290489|FG002|Overall Study|Lost to Follow-up|6
7137924|NCT02932904|11290490|FG003|Overall Study|Lost to Follow-up|0
7137925|NCT02932904|11290487|FG000|Overall Study|Significant Protocol Deviation|2
7137926|NCT02932904|11290488|FG001|Overall Study|Significant Protocol Deviation|3
7137927|NCT02932904|11290489|FG002|Overall Study|Significant Protocol Deviation|6
7137928|NCT02932904|11290490|FG003|Overall Study|Significant Protocol Deviation|1
7137929|NCT02932904|11290487|FG000|Overall Study|Pretreatment Event/Adverse Event|3
7137930|NCT02932904|11290488|FG001|Overall Study|Pretreatment Event/Adverse Event|5
7137931|NCT02932904|11290489|FG002|Overall Study|Pretreatment Event/Adverse Event|1
7137932|NCT02932904|11290490|FG003|Overall Study|Pretreatment Event/Adverse Event|3
7137933|NCT02932904|11290487|FG000|Overall Study|Randomized But Not Treated|1
7137934|NCT02932904|11290488|FG001|Overall Study|Randomized But Not Treated|1
7137935|NCT02932904|11290489|FG002|Overall Study|Randomized But Not Treated|0
7137936|NCT02932904|11290490|FG003|Overall Study|Randomized But Not Treated|2
7137937|NCT02932943|11290505|FG000|Overall Study|Lost to Follow-up|0
7137938|NCT02932943|11290506|FG001|Overall Study|Lost to Follow-up|2
6782067|NCT02472964|10778030|FG000|Part 1 (up to Week 24)|Death|3
6782068|NCT02472964|10778031|FG001|Part 1 (up to Week 24)|Death|6
7137939|NCT02932943|11290505|FG000|Overall Study|Adverse Event|2
7137940|NCT02932943|11290506|FG001|Overall Study|Adverse Event|2
7137941|NCT02932943|11290505|FG000|Overall Study|Withdrawal by Subject|3
7137942|NCT02932943|11290506|FG001|Overall Study|Withdrawal by Subject|3
7137943|NCT02933060|11290518|FG000|Overall Study|Withdrawal by Subject|0
7137944|NCT02933060|11290519|FG001|Overall Study|Withdrawal by Subject|1
7137945|NCT02933489|11290566|FG000|Overall Study|Ineligible|3
7137946|NCT02933489|11290567|FG001|Overall Study|Ineligible|3
7137947|NCT02933489|11290566|FG000|Overall Study|Withdrawal by Subject|27
7137948|NCT02933489|11290567|FG001|Overall Study|Withdrawal by Subject|18
7137949|NCT02933489|11290566|FG000|Overall Study|Unable to complete exams (other)|14
7137950|NCT02933489|11290567|FG001|Overall Study|Unable to complete exams (other)|7
7137951|NCT02933528|11290582|FG000|Overall Study|Lost to Follow-up|2
7137952|NCT02934178|11290612|FG000|Received Vaccination 2|Death|0
7137953|NCT02934178|11290613|FG001|Received Vaccination 2|Death|1
7137954|NCT02934178|11290612|FG000|Received Vaccination 3|Withdrawal by Subject|1
7137955|NCT02934178|11290613|FG001|Received Vaccination 3|Withdrawal by Subject|0
7137956|NCT02935192|11290695|FG000|Overall Study|Withdrawal by Subject|8
7137957|NCT02935192|11290696|FG001|Overall Study|Withdrawal by Subject|4
7137958|NCT02935452|11290704|FG000|Overall Study|work and life commintment|3
7137959|NCT02935452|11290705|FG001|Overall Study|work and life commintment|1
7137960|NCT02935673|11290718|FG000|Overall Study|Adverse Event|0
7137961|NCT02935673|11290719|FG001|Overall Study|Adverse Event|1
7137962|NCT02935673|11290720|FG002|Overall Study|Adverse Event|0
7137963|NCT02935673|11290718|FG000|Overall Study|Withdrawal by Subject|1
7137964|NCT02935673|11290719|FG001|Overall Study|Withdrawal by Subject|2
7137965|NCT02935673|11290720|FG002|Overall Study|Withdrawal by Subject|0
7137966|NCT02935842|11290760|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2
7137967|NCT02935842|11290761|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0
7137968|NCT02935842|11290762|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0
7137969|NCT02935842|11290763|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0
7137970|NCT02935842|11290760|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1
7137971|NCT02935842|11290761|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2
7137972|NCT02935842|11290762|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2
7137973|NCT02935842|11290763|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0
6782069|NCT02472964|10778030|FG000|Part 1 (up to Week 24)|Physician Decision|3
7137974|NCT02935842|11290760|FG000|Testing and Therapy Period 3|Accident prior to treatment|2
7137975|NCT02935842|11290761|FG001|Testing and Therapy Period 3|Accident prior to treatment|2
7137976|NCT02935842|11290762|FG002|Testing and Therapy Period 3|Accident prior to treatment|0
7137977|NCT02935842|11290763|FG003|Testing and Therapy Period 3|Accident prior to treatment|0
7137978|NCT02935842|11290760|FG000|Testing and Therapy Period 3|Lost to Follow-up|0
7137979|NCT02935842|11290761|FG001|Testing and Therapy Period 3|Lost to Follow-up|0
7137980|NCT02935842|11290762|FG002|Testing and Therapy Period 3|Lost to Follow-up|0
7137981|NCT02935842|11290763|FG003|Testing and Therapy Period 3|Lost to Follow-up|1
7137982|NCT02935842|11290760|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0
7137983|NCT02935842|11290761|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0
7137984|NCT02935842|11290762|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3
6782070|NCT02472964|10778031|FG001|Part 1 (up to Week 24)|Physician Decision|1
6782071|NCT02472964|10778030|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0
6782072|NCT02472964|10778031|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1
6782073|NCT02472964|10778030|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7
6782074|NCT02472964|10778031|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2
6782075|NCT02472964|10778030|FG000|Part 1 (up to Week 24)|Other|2
6782076|NCT02472964|10778031|FG001|Part 1 (up to Week 24)|Other|1
6782077|NCT02472964|10778030|FG000|Part 2 (Week 24-week 48)|Adverse Event|4
6782078|NCT02472964|10778031|FG001|Part 2 (Week 24-week 48)|Adverse Event|2
6782079|NCT02472964|10778030|FG000|Part 2 (Week 24-week 48)|Disease Progression|52
6782080|NCT02472964|10778031|FG001|Part 2 (Week 24-week 48)|Disease Progression|56
6782081|NCT02472964|10778030|FG000|Part 2 (Week 24-week 48)|Death|0
6782082|NCT02472964|10778031|FG001|Part 2 (Week 24-week 48)|Death|1
6782083|NCT02472964|10778030|FG000|Part 2 (Week 24-week 48)|Physician Decision|1
6782084|NCT02472964|10778031|FG001|Part 2 (Week 24-week 48)|Physician Decision|1
6782085|NCT02472964|10778030|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2
6782086|NCT02472964|10778031|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1
6782087|NCT02472964|10778030|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3
6782088|NCT02472964|10778031|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1
6782089|NCT02472964|10778030|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3
6782090|NCT02472964|10778031|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1
6782091|NCT02178722|10778042|FG000|Overall Study|Withdrawal by Subject|0
6782092|NCT02178722|10778043|FG001|Overall Study|Withdrawal by Subject|0
6782093|NCT02178722|10778044|FG002|Overall Study|Withdrawal by Subject|0
6782094|NCT02178722|10778045|FG003|Overall Study|Withdrawal by Subject|2
6782095|NCT02178722|10778046|FG004|Overall Study|Withdrawal by Subject|33
6782096|NCT02178722|10778042|FG000|Overall Study|Death|2
6782097|NCT02178722|10778043|FG001|Overall Study|Death|13
6782098|NCT02178722|10778044|FG002|Overall Study|Death|12
6782099|NCT02178722|10778045|FG003|Overall Study|Death|12
6782100|NCT02178722|10778046|FG004|Overall Study|Death|205
6782101|NCT02178722|10778042|FG000|Overall Study|Lost to Follow-up|0
6782102|NCT02178722|10778043|FG001|Overall Study|Lost to Follow-up|0
6782103|NCT02178722|10778044|FG002|Overall Study|Lost to Follow-up|0
6782104|NCT02178722|10778045|FG003|Overall Study|Lost to Follow-up|2
6782105|NCT02178722|10778046|FG004|Overall Study|Lost to Follow-up|11
6782106|NCT02178722|10778042|FG000|Overall Study|Study terminated by Sponsor|2
6782107|NCT02178722|10778043|FG001|Overall Study|Study terminated by Sponsor|7
6782108|NCT02178722|10778044|FG002|Overall Study|Study terminated by Sponsor|6
6782109|NCT02178722|10778045|FG003|Overall Study|Study terminated by Sponsor|4
6782110|NCT02178722|10778046|FG004|Overall Study|Study terminated by Sponsor|128
6782111|NCT02178722|10778042|FG000|Overall Study|Physician Decision|0
6782112|NCT02178722|10778043|FG001|Overall Study|Physician Decision|0
6782113|NCT02178722|10778044|FG002|Overall Study|Physician Decision|0
6782114|NCT02178722|10778045|FG003|Overall Study|Physician Decision|0
6782115|NCT02178722|10778046|FG004|Overall Study|Physician Decision|3
6782116|NCT02178722|10778042|FG000|Overall Study|Other|0
6782117|NCT02178722|10778043|FG001|Overall Study|Other|0
6782118|NCT02178722|10778044|FG002|Overall Study|Other|0
6782119|NCT02178722|10778045|FG003|Overall Study|Other|0
6782120|NCT02178722|10778046|FG004|Overall Study|Other|2
6782121|NCT01258803|10778061|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1
6782122|NCT01258803|10778062|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1
6782123|NCT01258803|10778063|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0
6782124|NCT01258803|10778064|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0
6782125|NCT01258803|10778065|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0
6782126|NCT01258803|10778066|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1
6782127|NCT01258803|10778061|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
6782128|NCT01258803|10778062|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1
6782129|NCT01258803|10778063|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
6782130|NCT01258803|10778064|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
6782131|NCT01258803|10778065|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
6782132|NCT01258803|10778066|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
6782133|NCT01258803|10778061|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0
6782134|NCT01258803|10778062|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0
6782135|NCT01258803|10778063|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1
6782136|NCT01258803|10778064|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0
6782137|NCT01258803|10778065|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0
6782138|NCT01258803|10778066|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0
6782139|NCT00862251|10778087|FG000|Overall Study|Adverse Event|8
6782140|NCT00862251|10778088|FG001|Overall Study|Adverse Event|3
7137985|NCT02935842|11290763|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0
7137986|NCT02935894|11290780|FG000|Overall Study|Subject dismissed|1
7137987|NCT02936037|11290786|FG000|Double-Blind Treatment Period|Protocol Violation|1
7137988|NCT02936037|11290787|FG001|Double-Blind Treatment Period|Protocol Violation|4
7137989|NCT02936037|11290786|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2
7137990|NCT02936037|11290787|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8
7137991|NCT02936037|11290786|FG000|Double-Blind Treatment Period|Lack of Efficacy|4
7137992|NCT02936037|11290787|FG001|Double-Blind Treatment Period|Lack of Efficacy|12
7137993|NCT02936037|11290786|FG000|Double-Blind Treatment Period|Death|0
7137994|NCT02936037|11290787|FG001|Double-Blind Treatment Period|Death|1
7137995|NCT02936037|11290786|FG000|Double-Blind Treatment Period|Adverse Event|11
7137996|NCT02936037|11290787|FG001|Double-Blind Treatment Period|Adverse Event|11
7137997|NCT02936037|11290786|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31
7137998|NCT02936037|11290787|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28
7137999|NCT02936037|11290786|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
7138000|NCT02936037|11290787|FG001|Double-Blind Treatment Period|Lost to Follow-up|1
7138001|NCT02936037|11290786|FG000|Open Label Extension|Adverse Event|0
7138002|NCT02936037|11290787|FG001|Open Label Extension|Adverse Event|3
7138003|NCT02936037|11290786|FG000|Open Label Extension|Other|0
7138004|NCT02936037|11290787|FG001|Open Label Extension|Other|3
7138005|NCT02936037|11290786|FG000|Open Label Extension|Withdrawal by Subject|0
7138006|NCT02936037|11290787|FG001|Open Label Extension|Withdrawal by Subject|4
7138007|NCT02936635|11290808|FG000|Overall Study|Adverse Event|43
7138008|NCT02936635|11290809|FG001|Overall Study|Adverse Event|25
7138009|NCT02936635|11290808|FG000|Overall Study|Progressive Disease|10
7138010|NCT02936635|11290809|FG001|Overall Study|Progressive Disease|18
7138011|NCT02936635|11290808|FG000|Overall Study|Sponsor Discretion|10
7138012|NCT02936635|11290809|FG001|Overall Study|Sponsor Discretion|16
7138013|NCT02936635|11290808|FG000|Overall Study|Death|9
7138014|NCT02936635|11290809|FG001|Overall Study|Death|15
7138015|NCT02936635|11290808|FG000|Overall Study|Withdrawal by Subject|8
7138016|NCT02936635|11290809|FG001|Overall Study|Withdrawal by Subject|15
7138017|NCT02936635|11290808|FG000|Overall Study|Physician Decision|2
7138018|NCT02936635|11290809|FG001|Overall Study|Physician Decision|9
7138019|NCT02936635|11290808|FG000|Overall Study|Lost to Follow-up|1
7138020|NCT02936635|11290809|FG001|Overall Study|Lost to Follow-up|2
7138021|NCT02936635|11290808|FG000|Overall Study|Protocol Violation|1
7138022|NCT02936635|11290809|FG001|Overall Study|Protocol Violation|0
7138023|NCT02936635|11290808|FG000|Overall Study|Lack of effect/Entry into other study|31
7138024|NCT02936635|11290809|FG001|Overall Study|Lack of effect/Entry into other study|65
7138025|NCT02936869|11290821|FG000|Overall Study|Lost to Follow-up|1
7138026|NCT02936869|11290822|FG001|Overall Study|Lost to Follow-up|3
7138027|NCT02936869|11290821|FG000|Overall Study|Death|0
7138028|NCT02936869|11290822|FG001|Overall Study|Death|1
7138029|NCT02936869|11290821|FG000|Overall Study|Legal Case|0
7138030|NCT02936869|11290822|FG001|Overall Study|Legal Case|1
7138031|NCT02936869|11290821|FG000|Overall Study|Protocol Violation|1
7138032|NCT02936869|11290822|FG001|Overall Study|Protocol Violation|0
7138033|NCT02937350|11290898|FG000|Overall Study|Withdrawal by Subject|0
7138034|NCT02937350|11290899|FG001|Overall Study|Withdrawal by Subject|1
7138035|NCT02937350|11290900|FG002|Overall Study|Withdrawal by Subject|0
7138036|NCT02937454|11290908|FG000|Overall Study|Adverse Event|0
7138037|NCT02937454|11290909|FG001|Overall Study|Adverse Event|1
7138038|NCT02937454|11290908|FG000|Overall Study|Death|98
7138039|NCT02937454|11290909|FG001|Overall Study|Death|95
7138040|NCT02937454|11290908|FG000|Overall Study|Lost to Follow-up|1
7138041|NCT02937454|11290909|FG001|Overall Study|Lost to Follow-up|1
7138042|NCT02937454|11290908|FG000|Overall Study|Physician Decision|0
7138043|NCT02937454|11290909|FG001|Overall Study|Physician Decision|1
7138044|NCT02937454|11290908|FG000|Overall Study|Protocol Violation|6
7138045|NCT02937454|11290909|FG001|Overall Study|Protocol Violation|10
7138046|NCT02937454|11290908|FG000|Overall Study|Withdrawal by Subject|27
7138047|NCT02937454|11290909|FG001|Overall Study|Withdrawal by Subject|15
6782141|NCT00862251|10778089|FG002|Overall Study|Adverse Event|1
6782142|NCT00862251|10778087|FG000|Overall Study|Lost to Follow-up|0
6782143|NCT00862251|10778088|FG001|Overall Study|Lost to Follow-up|0
6782144|NCT00862251|10778089|FG002|Overall Study|Lost to Follow-up|1
6782145|NCT00862251|10778087|FG000|Overall Study|Protocol Violation|2
6782146|NCT00862251|10778088|FG001|Overall Study|Protocol Violation|0
6782147|NCT00862251|10778089|FG002|Overall Study|Protocol Violation|1
6782148|NCT00862251|10778087|FG000|Overall Study|Withdrawal by Subject|9
7138048|NCT02937454|11290908|FG000|Overall Study|Other|8
7138049|NCT02937454|11290909|FG001|Overall Study|Other|5
7138050|NCT02937545|11290927|FG000|Overall Study|Withdrawal by Subject|1
7138051|NCT02937545|11290928|FG001|Overall Study|Withdrawal by Subject|2
7138052|NCT02937545|11290929|FG002|Overall Study|Withdrawal by Subject|6
7138053|NCT02937545|11290930|FG003|Overall Study|Withdrawal by Subject|7
7138054|NCT02937545|11290927|FG000|Overall Study|Lost to Follow-up|1
7138055|NCT02937545|11290928|FG001|Overall Study|Lost to Follow-up|0
7138056|NCT02937545|11290929|FG002|Overall Study|Lost to Follow-up|0
6782149|NCT00862251|10778088|FG001|Overall Study|Withdrawal by Subject|2
6782150|NCT00862251|10778089|FG002|Overall Study|Withdrawal by Subject|6
6782151|NCT00783263|10778104|FG000|Overall Study|Adverse Event|3
7138057|NCT02937545|11290930|FG003|Overall Study|Lost to Follow-up|0
7138058|NCT02937584|11290951|FG000|Period 1|Adverse Event|1
7138059|NCT02937584|11290952|FG001|Period 1|Adverse Event|2
7138060|NCT02937584|11290951|FG000|Washout|Adverse Event|0
7138061|NCT02937584|11290952|FG001|Washout|Adverse Event|1
7138062|NCT02937636|11290969|FG000|Overall Study|Other (Not specified)|3
7138063|NCT02937636|11290970|FG001|Overall Study|Other (Not specified)|2
7138064|NCT02937701|11290979|FG000|Day 1 to Week 22|Adverse Event|11
7138065|NCT02937701|11290980|FG001|Day 1 to Week 22|Adverse Event|14
7138066|NCT02937701|11290981|FG002|Day 1 to Week 22|Adverse Event|0
7138067|NCT02937701|11290982|FG003|Day 1 to Week 22|Adverse Event|0
7138068|NCT02937701|11290983|FG004|Day 1 to Week 22|Adverse Event|0
7138069|NCT02937701|11290979|FG000|Day 1 to Week 22|Protocol Specified Criteria|7
7138070|NCT02937701|11290980|FG001|Day 1 to Week 22|Protocol Specified Criteria|7
7138071|NCT02937701|11290981|FG002|Day 1 to Week 22|Protocol Specified Criteria|0
7138072|NCT02937701|11290982|FG003|Day 1 to Week 22|Protocol Specified Criteria|0
7138073|NCT02937701|11290983|FG004|Day 1 to Week 22|Protocol Specified Criteria|0
7138074|NCT02937701|11290979|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5
7138075|NCT02937701|11290980|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9
7138076|NCT02937701|11290981|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
7138077|NCT02937701|11290982|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
7138078|NCT02937701|11290983|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
7138079|NCT02937701|11290979|FG000|Day 1 to Week 22|Withdrawal by Subject|6
7138080|NCT02937701|11290980|FG001|Day 1 to Week 22|Withdrawal by Subject|6
7138081|NCT02937701|11290981|FG002|Day 1 to Week 22|Withdrawal by Subject|0
7138082|NCT02937701|11290982|FG003|Day 1 to Week 22|Withdrawal by Subject|0
7138083|NCT02937701|11290983|FG004|Day 1 to Week 22|Withdrawal by Subject|0
7138084|NCT02937701|11290979|FG000|Day 1 to Week 22|Death|1
7138085|NCT02937701|11290980|FG001|Day 1 to Week 22|Death|1
7138086|NCT02937701|11290981|FG002|Day 1 to Week 22|Death|0
7138087|NCT02937701|11290982|FG003|Day 1 to Week 22|Death|0
7138088|NCT02937701|11290983|FG004|Day 1 to Week 22|Death|0
7138089|NCT02937701|11290979|FG000|Day 1 to Week 22|Protocol Violation|1
7138090|NCT02937701|11290980|FG001|Day 1 to Week 22|Protocol Violation|1
7138091|NCT02937701|11290981|FG002|Day 1 to Week 22|Protocol Violation|0
7138092|NCT02937701|11290982|FG003|Day 1 to Week 22|Protocol Violation|0
7138093|NCT02937701|11290983|FG004|Day 1 to Week 22|Protocol Violation|0
7138094|NCT02937701|11290979|FG000|Day 1 to Week 22|Lost to Follow-up|1
7138095|NCT02937701|11290980|FG001|Day 1 to Week 22|Lost to Follow-up|1
7138096|NCT02937701|11290981|FG002|Day 1 to Week 22|Lost to Follow-up|0
7138097|NCT02937701|11290982|FG003|Day 1 to Week 22|Lost to Follow-up|0
7138098|NCT02937701|11290983|FG004|Day 1 to Week 22|Lost to Follow-up|0
7138099|NCT02937701|11290979|FG000|Day 1 to Week 22|Physician Decision|2
7138100|NCT02937701|11290980|FG001|Day 1 to Week 22|Physician Decision|0
7138101|NCT02937701|11290981|FG002|Day 1 to Week 22|Physician Decision|0
7138102|NCT02937701|11290982|FG003|Day 1 to Week 22|Physician Decision|0
7138103|NCT02937701|11290983|FG004|Day 1 to Week 22|Physician Decision|0
7138104|NCT02937701|11290979|FG000|Day 1 to Week 22|Other|1
7138105|NCT02937701|11290980|FG001|Day 1 to Week 22|Other|0
7138106|NCT02937701|11290981|FG002|Day 1 to Week 22|Other|0
6782152|NCT00783263|10778105|FG001|Overall Study|Adverse Event|0
6782153|NCT00783263|10778106|FG002|Overall Study|Adverse Event|2
6782154|NCT00783263|10778107|FG003|Overall Study|Adverse Event|1
6782155|NCT00783263|10778104|FG000|Overall Study|Lost to Follow-up|1
6782156|NCT00783263|10778105|FG001|Overall Study|Lost to Follow-up|1
6782157|NCT00783263|10778106|FG002|Overall Study|Lost to Follow-up|0
6782158|NCT00783263|10778107|FG003|Overall Study|Lost to Follow-up|0
6782159|NCT00783263|10778104|FG000|Overall Study|Withdrawal by Subject|0
6782160|NCT00783263|10778105|FG001|Overall Study|Withdrawal by Subject|1
6782161|NCT00783263|10778106|FG002|Overall Study|Withdrawal by Subject|1
6782162|NCT00783263|10778107|FG003|Overall Study|Withdrawal by Subject|2
6782163|NCT00782184|10778132|FG000|Overall Study|Adverse Event|1
6782164|NCT00782184|10778133|FG001|Overall Study|Adverse Event|2
6782165|NCT00782184|10778132|FG000|Overall Study|Protocol Violation|0
6782166|NCT00782184|10778133|FG001|Overall Study|Protocol Violation|1
6782167|NCT00782184|10778132|FG000|Overall Study|Withdrawal by Subject|3
6782168|NCT00782184|10778133|FG001|Overall Study|Withdrawal by Subject|2
6782169|NCT00635882|10778146|FG000|Overall Study|Protocol Violation|1
6782170|NCT00635882|10778147|FG001|Overall Study|Protocol Violation|0
6782171|NCT00635882|10778148|FG002|Overall Study|Protocol Violation|0
6782172|NCT00635882|10778149|FG003|Overall Study|Protocol Violation|0
6782173|NCT00635882|10778150|FG004|Overall Study|Protocol Violation|0
6782174|NCT00635882|10778151|FG005|Overall Study|Protocol Violation|0
6782175|NCT00535405|10778179|FG000|Overall Study|Adverse Event|6
6782176|NCT00535405|10778180|FG001|Overall Study|Adverse Event|8
6782177|NCT00535405|10778181|FG002|Overall Study|Adverse Event|3
6782178|NCT00535405|10778182|FG003|Overall Study|Adverse Event|8
7138107|NCT02937701|11290982|FG003|Day 1 to Week 22|Other|0
7138108|NCT02937701|11290983|FG004|Day 1 to Week 22|Other|0
7138109|NCT02937701|11290979|FG000|Week 22 to Week 50|Adverse Event|0
7138110|NCT02937701|11290980|FG001|Week 22 to Week 50|Adverse Event|0
7138111|NCT02937701|11290981|FG002|Week 22 to Week 50|Adverse Event|10
7138112|NCT02937701|11290982|FG003|Week 22 to Week 50|Adverse Event|3
6782179|NCT00535405|10778183|FG004|Overall Study|Adverse Event|6
7138113|NCT02937701|11290983|FG004|Week 22 to Week 50|Adverse Event|3
7138114|NCT02937701|11290979|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0
7138115|NCT02937701|11290980|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0
7138116|NCT02937701|11290981|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10
7138117|NCT02937701|11290982|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3
7138118|NCT02937701|11290983|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2
7138119|NCT02937701|11290979|FG000|Week 22 to Week 50|Withdrawal by Subject|0
7138120|NCT02937701|11290980|FG001|Week 22 to Week 50|Withdrawal by Subject|0
7138121|NCT02937701|11290981|FG002|Week 22 to Week 50|Withdrawal by Subject|8
7138122|NCT02937701|11290982|FG003|Week 22 to Week 50|Withdrawal by Subject|2
7138123|NCT02937701|11290983|FG004|Week 22 to Week 50|Withdrawal by Subject|1
7138124|NCT02937701|11290979|FG000|Week 22 to Week 50|Lost to Follow-up|0
7138125|NCT02937701|11290980|FG001|Week 22 to Week 50|Lost to Follow-up|0
7138126|NCT02937701|11290981|FG002|Week 22 to Week 50|Lost to Follow-up|2
7138127|NCT02937701|11290982|FG003|Week 22 to Week 50|Lost to Follow-up|0
7138128|NCT02937701|11290983|FG004|Week 22 to Week 50|Lost to Follow-up|1
7138129|NCT02937701|11290979|FG000|Week 22 to Week 50|Physician Decision|0
7138130|NCT02937701|11290980|FG001|Week 22 to Week 50|Physician Decision|0
7138131|NCT02937701|11290981|FG002|Week 22 to Week 50|Physician Decision|2
7138132|NCT02937701|11290982|FG003|Week 22 to Week 50|Physician Decision|0
7138133|NCT02937701|11290983|FG004|Week 22 to Week 50|Physician Decision|1
7138134|NCT02937701|11290979|FG000|Week 22 to Week 50|Other|0
7138135|NCT02937701|11290980|FG001|Week 22 to Week 50|Other|0
7138136|NCT02937701|11290981|FG002|Week 22 to Week 50|Other|0
7138137|NCT02937701|11290982|FG003|Week 22 to Week 50|Other|0
7138138|NCT02937701|11290983|FG004|Week 22 to Week 50|Other|1
7138139|NCT02937740|11290997|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3
7138140|NCT02937740|11290998|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14
7138141|NCT02937740|11290997|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0
7138142|NCT02937740|11290998|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10
7138143|NCT02937740|11290997|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2
7138144|NCT02937740|11290998|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7
7138145|NCT02937740|11290997|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1
7138146|NCT02937740|11290998|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0
7138147|NCT02937740|11290997|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0
7138148|NCT02937740|11290998|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1
7138149|NCT02937740|11290997|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0
7138150|NCT02937740|11290998|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1
7138151|NCT02937870|11291010|FG000|Overall Study|Adverse Event|1
7138152|NCT02937870|11291010|FG000|Overall Study|Protocol Deviation|2
7138153|NCT02938585|11291073|FG000|Overall Study|Withdrawal by parent or guardian|0
7138154|NCT02938585|11291074|FG001|Overall Study|Withdrawal by parent or guardian|1
7138155|NCT02938585|11291075|FG002|Overall Study|Withdrawal by parent or guardian|0
6782180|NCT00535405|10778179|FG000|Overall Study|Lost to Follow-up|1
6782181|NCT00535405|10778180|FG001|Overall Study|Lost to Follow-up|3
6782182|NCT00535405|10778181|FG002|Overall Study|Lost to Follow-up|3
6782183|NCT00535405|10778182|FG003|Overall Study|Lost to Follow-up|2
6782184|NCT00535405|10778183|FG004|Overall Study|Lost to Follow-up|1
6782185|NCT00535405|10778179|FG000|Overall Study|Physician Decision|3
6782186|NCT00535405|10778180|FG001|Overall Study|Physician Decision|2
6782187|NCT00535405|10778181|FG002|Overall Study|Physician Decision|0
6782188|NCT00535405|10778182|FG003|Overall Study|Physician Decision|1
6782189|NCT00535405|10778183|FG004|Overall Study|Physician Decision|1
6782190|NCT00535405|10778179|FG000|Overall Study|Protocol Violation|2
6782191|NCT00535405|10778180|FG001|Overall Study|Protocol Violation|2
6782192|NCT00535405|10778181|FG002|Overall Study|Protocol Violation|2
6782193|NCT00535405|10778182|FG003|Overall Study|Protocol Violation|1
6782194|NCT00535405|10778183|FG004|Overall Study|Protocol Violation|0
6782195|NCT00535405|10778179|FG000|Overall Study|Withdrawal by Subject|5
6782196|NCT00535405|10778180|FG001|Overall Study|Withdrawal by Subject|11
6782197|NCT00535405|10778181|FG002|Overall Study|Withdrawal by Subject|10
6782198|NCT00535405|10778182|FG003|Overall Study|Withdrawal by Subject|10
6782199|NCT00535405|10778183|FG004|Overall Study|Withdrawal by Subject|8
6782200|NCT00496730|10778197|FG000|Overall Study|Lost to Follow-up|4
6782201|NCT00496730|10778198|FG001|Overall Study|Lost to Follow-up|3
6782202|NCT00496730|10778197|FG000|Overall Study|Withdrawal by Subject|2
6782203|NCT00496730|10778198|FG001|Overall Study|Withdrawal by Subject|2
6782204|NCT00462748|10778207|FG000|Overall Study|Adverse Event|7
6782205|NCT00462748|10778208|FG001|Overall Study|Adverse Event|5
6782206|NCT00462748|10778209|FG002|Overall Study|Adverse Event|9
6782207|NCT00462748|10778207|FG000|Overall Study|Protocol Violation|0
6782208|NCT00462748|10778208|FG001|Overall Study|Protocol Violation|2
6782209|NCT00462748|10778209|FG002|Overall Study|Protocol Violation|1
6782210|NCT00462748|10778207|FG000|Overall Study|Withdrew consent|3
6782211|NCT00462748|10778208|FG001|Overall Study|Withdrew consent|3
6782212|NCT00462748|10778209|FG002|Overall Study|Withdrew consent|0
6782213|NCT00462748|10778207|FG000|Overall Study|Lost to Follow-up|1
6782214|NCT00462748|10778208|FG001|Overall Study|Lost to Follow-up|1
6782215|NCT00462748|10778209|FG002|Overall Study|Lost to Follow-up|1
7138156|NCT02938585|11291076|FG003|Overall Study|Withdrawal by parent or guardian|0
7138157|NCT02938585|11291073|FG000|Overall Study|Withdrawal by Subject|0
7138158|NCT02938585|11291074|FG001|Overall Study|Withdrawal by Subject|0
6782216|NCT00462748|10778207|FG000|Overall Study|Discontinued after 41 days Rx|1
7138159|NCT02938585|11291075|FG002|Overall Study|Withdrawal by Subject|0
7138160|NCT02938585|11291076|FG003|Overall Study|Withdrawal by Subject|5
7138161|NCT02939014|11291111|FG000|Overall Study|Lost to Follow-up|1
7138162|NCT02939014|11291112|FG001|Overall Study|Lost to Follow-up|0
7138163|NCT02939014|11291111|FG000|Overall Study|Death|4
7138164|NCT02939014|11291112|FG001|Overall Study|Death|3
7138165|NCT02939079|11291121|FG000|Overall Study|Adverse Event|2
7138166|NCT02939079|11291122|FG001|Overall Study|Adverse Event|1
7138167|NCT02939079|11291121|FG000|Overall Study|Lost to Follow-up|0
7138168|NCT02939079|11291122|FG001|Overall Study|Lost to Follow-up|2
7138169|NCT02939079|11291121|FG000|Overall Study|Protocol Violation|1
7138170|NCT02939079|11291122|FG001|Overall Study|Protocol Violation|0
7138171|NCT02939079|11291121|FG000|Overall Study|Withdrawal by Subject|0
7138172|NCT02939079|11291122|FG001|Overall Study|Withdrawal by Subject|1
7138173|NCT02939079|11291121|FG000|Overall Study|relapse during the study|1
7138174|NCT02939079|11291122|FG001|Overall Study|relapse during the study|1
7138175|NCT02939131|11291135|FG000|Overall Study|Unable to get to clinic|6
7138176|NCT02939131|11291136|FG001|Overall Study|Unable to get to clinic|4
7138177|NCT02939131|11291135|FG000|Overall Study|Lost to Follow-up|2
7138178|NCT02939131|11291136|FG001|Overall Study|Lost to Follow-up|4
7138179|NCT02939131|11291135|FG000|Overall Study|severe debilitation|1
7138180|NCT02939131|11291136|FG001|Overall Study|severe debilitation|0
7138181|NCT02939131|11291135|FG000|Overall Study|Other|0
7138182|NCT02939131|11291136|FG001|Overall Study|Other|1
6782217|NCT00462748|10778208|FG001|Overall Study|Discontinued after 41 days Rx|0
6782218|NCT00462748|10778209|FG002|Overall Study|Discontinued after 41 days Rx|0
6782219|NCT00418834|10778219|FG000|Overall Study|Adverse Event|16
6782220|NCT00418834|10778220|FG001|Overall Study|Adverse Event|9
6782221|NCT00418834|10778219|FG000|Overall Study|Lost to Follow-up|0
6782222|NCT00418834|10778220|FG001|Overall Study|Lost to Follow-up|1
6782223|NCT00418834|10778219|FG000|Overall Study|Protocol Violation|4
6782224|NCT00418834|10778220|FG001|Overall Study|Protocol Violation|3
6782225|NCT00418834|10778219|FG000|Overall Study|Withdrawal by Subject|3
6782226|NCT00418834|10778220|FG001|Overall Study|Withdrawal by Subject|7
6782227|NCT00409773|10778231|FG000|Overall Study|Adverse Event|3
6782228|NCT00409773|10778232|FG001|Overall Study|Adverse Event|4
6782229|NCT00409773|10778233|FG002|Overall Study|Adverse Event|4
6782230|NCT00409773|10778234|FG003|Overall Study|Adverse Event|2
6782231|NCT00409773|10778235|FG004|Overall Study|Adverse Event|6
6782232|NCT00409773|10778231|FG000|Overall Study|Lost to Follow-up|6
6782233|NCT00409773|10778232|FG001|Overall Study|Lost to Follow-up|1
6782234|NCT00409773|10778233|FG002|Overall Study|Lost to Follow-up|2
6782235|NCT00409773|10778234|FG003|Overall Study|Lost to Follow-up|3
6782236|NCT00409773|10778235|FG004|Overall Study|Lost to Follow-up|1
6782237|NCT00409773|10778231|FG000|Overall Study|Physician Decision|0
6782238|NCT00409773|10778232|FG001|Overall Study|Physician Decision|0
6782239|NCT00409773|10778233|FG002|Overall Study|Physician Decision|0
6782240|NCT00409773|10778234|FG003|Overall Study|Physician Decision|2
6782241|NCT00409773|10778235|FG004|Overall Study|Physician Decision|0
6782242|NCT00409773|10778231|FG000|Overall Study|Protocol Violation|0
6782243|NCT00409773|10778232|FG001|Overall Study|Protocol Violation|2
6782244|NCT00409773|10778233|FG002|Overall Study|Protocol Violation|3
6782245|NCT00409773|10778234|FG003|Overall Study|Protocol Violation|3
6782246|NCT00409773|10778235|FG004|Overall Study|Protocol Violation|1
7138183|NCT02939131|11291135|FG000|Overall Study|not willing to adhere to protocol|2
7138184|NCT02939131|11291136|FG001|Overall Study|not willing to adhere to protocol|0
7138185|NCT02939560|11291186|FG000|Overall Study|Withdrawal by Subject|2
7138186|NCT02939560|11291186|FG000|Overall Study|Protocol Violation|1
7138187|NCT02939599|11291192|FG000|Overall Study|Adverse Event|1
7138188|NCT02939599|11291193|FG001|Overall Study|Adverse Event|0
7138189|NCT02939599|11291192|FG000|Overall Study|Study Terminated By Sponsor|2
7138190|NCT02939599|11291193|FG001|Overall Study|Study Terminated By Sponsor|2
7138191|NCT02939716|11291204|FG000|Overall Study|scanner failure|0
7138192|NCT02939716|11291205|FG001|Overall Study|scanner failure|0
7138193|NCT02939716|11291206|FG002|Overall Study|scanner failure|0
7138194|NCT02939716|11291207|FG003|Overall Study|scanner failure|1
7138195|NCT02939716|11291208|FG004|Overall Study|scanner failure|1
7138196|NCT02939716|11291209|FG005|Overall Study|scanner failure|1
7138197|NCT02939781|11291226|FG000|Overall Study|Protocol Violation|8
7138198|NCT02939781|11291226|FG000|Overall Study|Withdrawal by Subject|1
7138199|NCT02939937|11291233|FG000|Overall Study|Adverse Event|5
7138200|NCT02939937|11291234|FG001|Overall Study|Adverse Event|0
7138201|NCT02939937|11291233|FG000|Overall Study|Lost to Follow-up|1
7138202|NCT02939937|11291234|FG001|Overall Study|Lost to Follow-up|3
7138203|NCT02939950|11291242|FG000|Overall Study|Lost to Follow-up|13
7138204|NCT02939950|11291243|FG001|Overall Study|Lost to Follow-up|16
7138205|NCT02939950|11291242|FG000|Overall Study|Positive slit lamp findings|0
7138206|NCT02939950|11291243|FG001|Overall Study|Positive slit lamp findings|1
7138207|NCT02939950|11291242|FG000|Overall Study|Chalazion upper lid|0
7138208|NCT02939950|11291243|FG001|Overall Study|Chalazion upper lid|1
7138209|NCT02939950|11291242|FG000|Overall Study|Lack of motivation|0
7138210|NCT02939950|11291243|FG001|Overall Study|Lack of motivation|2
7138211|NCT02939950|11291242|FG000|Overall Study|Unacceptable distance lens visual acuity|1
7138212|NCT02939950|11291243|FG001|Overall Study|Unacceptable distance lens visual acuity|1
7138213|NCT02939950|11291242|FG000|Overall Study|Military orders|1
6782247|NCT00409773|10778231|FG000|Overall Study|Withdrawal by Subject|0
7138214|NCT02939950|11291243|FG001|Overall Study|Military orders|0
7138215|NCT02939950|11291242|FG000|Overall Study|Participant Relocated|5
7138216|NCT02939950|11291243|FG001|Overall Study|Participant Relocated|3
7138217|NCT02939950|11291242|FG000|Overall Study|Study related symptoms|8
7138218|NCT02939950|11291243|FG001|Overall Study|Study related symptoms|8
7138219|NCT02939950|11291242|FG000|Overall Study|Unacceptable lens movement|2
7138220|NCT02939950|11291243|FG001|Overall Study|Unacceptable lens movement|0
7138221|NCT02939950|11291242|FG000|Overall Study|Protocol Violation|6
7138222|NCT02939950|11291243|FG001|Overall Study|Protocol Violation|3
7138223|NCT02939950|11291242|FG000|Overall Study|Physician Decision|2
7138224|NCT02939950|11291243|FG001|Overall Study|Physician Decision|0
7138225|NCT02939950|11291242|FG000|Overall Study|Pregnancy|6
7138226|NCT02939950|11291243|FG001|Overall Study|Pregnancy|7
7138227|NCT02939950|11291242|FG000|Overall Study|Withdrawal by Subject|12
7138228|NCT02939950|11291243|FG001|Overall Study|Withdrawal by Subject|28
7138229|NCT02939950|11291242|FG000|Overall Study|Adverse Event|7
7138230|NCT02939950|11291243|FG001|Overall Study|Adverse Event|3
7138231|NCT02939950|11291242|FG000|Overall Study|Randomized, not dispensed|1
7138232|NCT02939950|11291243|FG001|Overall Study|Randomized, not dispensed|0
7138233|NCT02939950|11291242|FG000|Overall Study|Ineligible at Baseline|2
7138234|NCT02939950|11291243|FG001|Overall Study|Ineligible at Baseline|8
7138235|NCT02940392|11291264|FG000|Overall Study|Lost to Follow-up|3
7138236|NCT02940392|11291264|FG000|Overall Study|Retreatment|3
7138237|NCT02940392|11291264|FG000|Overall Study|Death|2
7138238|NCT02940574|11291270|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1
7138239|NCT02940574|11291271|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0
7138240|NCT02940574|11291270|FG000|1-year Follow-up|Lost to Follow-up|3
7138241|NCT02940574|11291271|FG001|1-year Follow-up|Lost to Follow-up|4
7138242|NCT02940626|11291283|FG000|Overall Study|Death|40
7138243|NCT02940626|11291284|FG001|Overall Study|Death|32
7138244|NCT02940626|11291283|FG000|Overall Study|Lost to Follow-up|5
7138245|NCT02940626|11291284|FG001|Overall Study|Lost to Follow-up|2
7138246|NCT02940626|11291283|FG000|Overall Study|Withdrawal by Subject|1
7138247|NCT02940626|11291284|FG001|Overall Study|Withdrawal by Subject|0
7138248|NCT02940626|11291283|FG000|Overall Study|Transfer to Hospice Care|1
7138249|NCT02940626|11291284|FG001|Overall Study|Transfer to Hospice Care|0
7138250|NCT02940626|11291283|FG000|Overall Study|Prohibited Concomitant Medication|0
7138251|NCT02940626|11291284|FG001|Overall Study|Prohibited Concomitant Medication|1
7138252|NCT02940691|11291292|FG000|Overall Study|Lost to Follow-up|5
7138253|NCT02940691|11291292|FG000|Overall Study|Incarceration|1
7138254|NCT02940730|11291299|FG000|Intervention 2|Physician Decision|7
7138255|NCT02940730|11291300|FG001|Intervention 2|Physician Decision|0
7138256|NCT02940860|11291308|FG000|Overall Study|Non-serious AE|1
7138257|NCT02940860|11291309|FG001|Overall Study|Non-serious AE|2
7138258|NCT02940860|11291308|FG000|Overall Study|Serious AE|7
7138259|NCT02940860|11291309|FG001|Overall Study|Serious AE|3
7138260|NCT02940860|11291308|FG000|Overall Study|Withdrawal by Subject|19
7138261|NCT02940860|11291309|FG001|Overall Study|Withdrawal by Subject|9
7138262|NCT02940860|11291308|FG000|Overall Study|Lost to Follow-up|13
7138263|NCT02940860|11291309|FG001|Overall Study|Lost to Follow-up|7
7138264|NCT02940860|11291308|FG000|Overall Study|Physician Decision|5
7138265|NCT02940860|11291309|FG001|Overall Study|Physician Decision|3
7138266|NCT02940860|11291308|FG000|Overall Study|Sponsor Decision|0
7138267|NCT02940860|11291309|FG001|Overall Study|Sponsor Decision|1
7138268|NCT02940860|11291308|FG000|Overall Study|Protocol Violation|0
7138269|NCT02940860|11291309|FG001|Overall Study|Protocol Violation|2
7138270|NCT02940860|11291308|FG000|Overall Study|Death|3
7138271|NCT02940860|11291309|FG001|Overall Study|Death|2
7138272|NCT02940860|11291308|FG000|Overall Study|Moved, poor venous access, transport|6
7138273|NCT02940860|11291309|FG001|Overall Study|Moved, poor venous access, transport|4
7138274|NCT02940860|11291308|FG000|Overall Study|Not treated|2
7138275|NCT02940860|11291309|FG001|Overall Study|Not treated|2
7138276|NCT02940886|11291319|FG000|Overall Study|Adverse Event|7
7138277|NCT02940886|11291320|FG001|Overall Study|Adverse Event|3
7138278|NCT02940886|11291319|FG000|Overall Study|Protocol Violation|0
7138279|NCT02940886|11291320|FG001|Overall Study|Protocol Violation|2
7138280|NCT02940886|11291319|FG000|Overall Study|Withdrawal by Subject|28
7138281|NCT02940886|11291320|FG001|Overall Study|Withdrawal by Subject|20
7138282|NCT02940886|11291319|FG000|Overall Study|Death|1
7138283|NCT02940886|11291320|FG001|Overall Study|Death|0
7138284|NCT02940886|11291319|FG000|Overall Study|Lack of Efficacy|1
7138285|NCT02940886|11291320|FG001|Overall Study|Lack of Efficacy|0
7138286|NCT02940886|11291319|FG000|Overall Study|Lost to Follow-up|49
7138287|NCT02940886|11291320|FG001|Overall Study|Lost to Follow-up|21
7138288|NCT02940886|11291319|FG000|Overall Study|Physician Decision|9
7138289|NCT02940886|11291320|FG001|Overall Study|Physician Decision|4
7138290|NCT02940886|11291319|FG000|Overall Study|Sponsor decision|0
7138291|NCT02940886|11291320|FG001|Overall Study|Sponsor decision|1
7138292|NCT02940886|11291319|FG000|Overall Study|No treatment|7
7138293|NCT02940886|11291320|FG001|Overall Study|No treatment|2
7138294|NCT02940886|11291319|FG000|Overall Study|Enrolment error|0
7138295|NCT02940886|11291320|FG001|Overall Study|Enrolment error|1
7138296|NCT02941523|11291330|FG000|Monotherapy|Withdrawal by Subject|0
7138297|NCT02941523|11291331|FG001|Monotherapy|Withdrawal by Subject|1
7138298|NCT02941523|11291330|FG000|Carboplatin Combination Therapy|Adverse Event|0
7138299|NCT02941523|11291331|FG001|Carboplatin Combination Therapy|Adverse Event|1
7138300|NCT02941523|11291330|FG000|Carboplatin Combination Therapy|Death|1
7138301|NCT02941523|11291331|FG001|Carboplatin Combination Therapy|Death|2
7138302|NCT02941523|11291330|FG000|Carboplatin Combination Therapy|Disease progression|2
7138303|NCT02941523|11291331|FG001|Carboplatin Combination Therapy|Disease progression|0
7138304|NCT02941523|11291330|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2
7138305|NCT02941523|11291331|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1
7138306|NCT02941627|11291356|FG000|Overall Study|Death|1
7138307|NCT02941627|11291356|FG000|Overall Study|Surgical failure|1
7138308|NCT02941627|11291356|FG000|Overall Study|cholesteatoma prevented implantation|1
7138309|NCT02942264|11291409|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0
7138310|NCT02942264|11291410|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1
7138311|NCT02942264|11291411|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0
7138312|NCT02942264|11291412|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0
7138313|NCT02942264|11291413|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0
7138314|NCT02942264|11291414|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0
7138315|NCT02942264|11291415|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1
7138316|NCT02942264|11291416|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0
7138317|NCT02942264|11291417|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0
7138318|NCT02942264|11291409|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
7138319|NCT02942264|11291410|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
7138320|NCT02942264|11291411|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
7138321|NCT02942264|11291412|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
7138322|NCT02942264|11291413|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
7138323|NCT02942264|11291414|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
7138324|NCT02942264|11291415|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
7138325|NCT02942264|11291416|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
7138326|NCT02942264|11291417|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1
7138327|NCT02942407|11291444|FG000|Overall Study|Lost to Follow-up|3
7138328|NCT02942407|11291445|FG001|Overall Study|Lost to Follow-up|2
7138329|NCT02942407|11291444|FG000|Overall Study|Withdrawal by Subject|7
7138330|NCT02942407|11291445|FG001|Overall Study|Withdrawal by Subject|9
7138331|NCT02942407|11291444|FG000|Overall Study|Death|16
7138332|NCT02942407|11291445|FG001|Overall Study|Death|13
7138333|NCT02942485|11291461|FG000|Overall Study|Lost to Follow-up|1
7138334|NCT02942485|11291462|FG001|Overall Study|Lost to Follow-up|0
7138335|NCT02942576|11291470|FG000|Overall Study|Adverse Event|28
7138336|NCT02942576|11291471|FG001|Overall Study|Adverse Event|6
7138337|NCT02942576|11291470|FG000|Overall Study|Withdrawal by Subject|7
7138338|NCT02942576|11291471|FG001|Overall Study|Withdrawal by Subject|5
7138339|NCT02942576|11291470|FG000|Overall Study|Physician Decision|1
6782248|NCT00409773|10778232|FG001|Overall Study|Withdrawal by Subject|0
6782249|NCT00409773|10778233|FG002|Overall Study|Withdrawal by Subject|0
6782250|NCT00409773|10778234|FG003|Overall Study|Withdrawal by Subject|2
6782251|NCT00409773|10778235|FG004|Overall Study|Withdrawal by Subject|1
6782252|NCT00409773|10778231|FG000|Overall Study|Lack of Eligibility|0
6782253|NCT00409773|10778232|FG001|Overall Study|Lack of Eligibility|0
6782254|NCT00409773|10778233|FG002|Overall Study|Lack of Eligibility|0
6782255|NCT00409773|10778234|FG003|Overall Study|Lack of Eligibility|0
6782256|NCT00409773|10778235|FG004|Overall Study|Lack of Eligibility|1
6782257|NCT00276484|10778249|FG000|Overall Study|Adverse Event|4
6782258|NCT00276484|10778250|FG001|Overall Study|Adverse Event|7
6782259|NCT00276484|10778249|FG000|Overall Study|Lost to Follow-up|1
6782260|NCT00276484|10778250|FG001|Overall Study|Lost to Follow-up|1
6782261|NCT00276484|10778249|FG000|Overall Study|Protocol Violation|0
6782262|NCT00276484|10778250|FG001|Overall Study|Protocol Violation|1
6782263|NCT00276484|10778249|FG000|Overall Study|Withdrawal by Subject|4
6782264|NCT00276484|10778250|FG001|Overall Study|Withdrawal by Subject|3
6782265|NCT00276484|10778249|FG000|Overall Study|Could not take time off work|0
6782266|NCT00276484|10778250|FG001|Overall Study|Could not take time off work|1
6782267|NCT00276458|10778258|FG000|Overall Study|Adverse Event|0
6782268|NCT00276458|10778259|FG001|Overall Study|Adverse Event|2
6782269|NCT00276458|10778258|FG000|Overall Study|Lost to Follow-up|2
6782270|NCT00276458|10778259|FG001|Overall Study|Lost to Follow-up|2
6782271|NCT00276458|10778258|FG000|Overall Study|Protocol Violation|4
6782272|NCT00276458|10778259|FG001|Overall Study|Protocol Violation|3
6782273|NCT00271817|10778268|FG000|Part 1|Adverse Event|68
6782274|NCT00271817|10778269|FG001|Part 1|Adverse Event|25
6782275|NCT00271817|10778270|FG002|Part 1|Adverse Event|156
6782276|NCT00271817|10778268|FG000|Part 1|Lost to Follow-up|6
6782277|NCT00271817|10778269|FG001|Part 1|Lost to Follow-up|8
6782278|NCT00271817|10778270|FG002|Part 1|Lost to Follow-up|24
6782279|NCT00271817|10778268|FG000|Part 1|Protocol Violation|5
6782280|NCT00271817|10778269|FG001|Part 1|Protocol Violation|4
6782281|NCT00271817|10778270|FG002|Part 1|Protocol Violation|7
6782282|NCT00271817|10778268|FG000|Part 1|Patient Moved|3
6782283|NCT00271817|10778269|FG001|Part 1|Patient Moved|1
6782284|NCT00271817|10778270|FG002|Part 1|Patient Moved|5
6782285|NCT00271817|10778268|FG000|Part 1|Withdrawal by Subject|23
6782286|NCT00271817|10778269|FG001|Part 1|Withdrawal by Subject|17
6782287|NCT00271817|10778270|FG002|Part 1|Withdrawal by Subject|45
6782288|NCT00271817|10778268|FG000|Part 1|LDL < 50 mg/dL|1
6782289|NCT00271817|10778269|FG001|Part 1|LDL < 50 mg/dL|4
6782290|NCT00271817|10778270|FG002|Part 1|LDL < 50 mg/dL|48
6782291|NCT00271817|10778268|FG000|Part 2|Adverse Event|0
6782292|NCT00271817|10778269|FG001|Part 2|Adverse Event|17
7138340|NCT02942576|11291471|FG001|Overall Study|Physician Decision|4
7138341|NCT02942576|11291470|FG000|Overall Study|Other|10
7138342|NCT02942576|11291471|FG001|Overall Study|Other|8
7138343|NCT02942771|11291489|FG000|Overall Study|Adverse Event|1
7138344|NCT02942771|11291490|FG001|Overall Study|Adverse Event|0
7138345|NCT02942771|11291491|FG002|Overall Study|Adverse Event|0
6782293|NCT00271817|10778270|FG002|Part 2|Adverse Event|33
6782294|NCT00271817|10778268|FG000|Part 2|Lack of Efficacy|0
6782295|NCT00271817|10778269|FG001|Part 2|Lack of Efficacy|1
6782296|NCT00271817|10778270|FG002|Part 2|Lack of Efficacy|6
6782297|NCT00271817|10778268|FG000|Part 2|Lost to Follow-up|0
6782298|NCT00271817|10778269|FG001|Part 2|Lost to Follow-up|6
6782299|NCT00271817|10778270|FG002|Part 2|Lost to Follow-up|18
6782300|NCT00271817|10778268|FG000|Part 2|Protocol Violation|0
6782301|NCT00271817|10778269|FG001|Part 2|Protocol Violation|3
6782302|NCT00271817|10778270|FG002|Part 2|Protocol Violation|5
6782303|NCT00271817|10778268|FG000|Part 2|Patient Moved|0
6782304|NCT00271817|10778269|FG001|Part 2|Patient Moved|0
6782305|NCT00271817|10778270|FG002|Part 2|Patient Moved|5
6782306|NCT00271817|10778268|FG000|Part 2|Withdrawal by Subject|0
6782307|NCT00271817|10778269|FG001|Part 2|Withdrawal by Subject|2
6782308|NCT00271817|10778270|FG002|Part 2|Withdrawal by Subject|13
6782309|NCT00271817|10778268|FG000|Part 2|LDL < 50 mg/dL|0
6782310|NCT00271817|10778269|FG001|Part 2|LDL < 50 mg/dL|3
6782311|NCT00271817|10778270|FG002|Part 2|LDL < 50 mg/dL|4
6806580|NCT04084769|10809208|FG000|Overall Study|Withdrawal by parent/guardian|1
6806581|NCT04084769|10809209|FG001|Overall Study|Withdrawal by parent/guardian|0
6806582|NCT04084769|10809210|FG002|Overall Study|Withdrawal by parent/guardian|0
6806583|NCT04084769|10809211|FG003|Overall Study|Withdrawal by parent/guardian|1
6806584|NCT04084769|10809208|FG000|Overall Study|Lost to Follow-up|2
6806585|NCT04084769|10809209|FG001|Overall Study|Lost to Follow-up|0
6806586|NCT04084769|10809210|FG002|Overall Study|Lost to Follow-up|0
6806587|NCT04084769|10809211|FG003|Overall Study|Lost to Follow-up|0
6806588|NCT04024228|10809228|FG000|Overall Study|Adverse Event|1
6806589|NCT04024228|10809229|FG001|Overall Study|Adverse Event|0
6806590|NCT04024228|10809228|FG000|Overall Study|Protocol Deviation|0
6806591|NCT04024228|10809229|FG001|Overall Study|Protocol Deviation|2
6806592|NCT04024228|10809228|FG000|Overall Study|Withdrawal by Subject|3
6806593|NCT04024228|10809229|FG001|Overall Study|Withdrawal by Subject|4
6806594|NCT03980938|10809252|FG000|Treatment Period 1|Study Terminated|1
6806595|NCT03980938|10809253|FG001|Treatment Period 1|Study Terminated|1
6806596|NCT03980938|10809252|FG000|Treatment Period 2|Study Terminated|2
6806597|NCT03980938|10809253|FG001|Treatment Period 2|Study Terminated|2
6810504|NCT03764072|10814233|FG004|Overall Study|Lost to Follow-up|1
6810505|NCT03764072|10814234|FG005|Overall Study|Lost to Follow-up|0
6811184|NCT02407236|10815055|FG003|Maintenance Study (44 Weeks)|Sponsor decision|1
6811185|NCT02407236|10815056|FG004|Maintenance Study (44 Weeks)|Sponsor decision|0
6811186|NCT02407236|10815057|FG005|Maintenance Study (44 Weeks)|Sponsor decision|1
6811187|NCT02407236|10815058|FG006|Maintenance Study (44 Weeks)|Sponsor decision|0
6811188|NCT02407236|10815059|FG007|Maintenance Study (44 Weeks)|Sponsor decision|0
6811189|NCT02407236|10815052|FG000|Maintenance Study (44 Weeks)|Other|0
6811190|NCT02407236|10815053|FG001|Maintenance Study (44 Weeks)|Other|0
6811191|NCT02407236|10815054|FG002|Maintenance Study (44 Weeks)|Other|0
6811192|NCT02407236|10815055|FG003|Maintenance Study (44 Weeks)|Other|0
6811193|NCT02407236|10815056|FG004|Maintenance Study (44 Weeks)|Other|1
6811194|NCT02407236|10815057|FG005|Maintenance Study (44 Weeks)|Other|1
6811195|NCT02407236|10815058|FG006|Maintenance Study (44 Weeks)|Other|2
6811196|NCT02407236|10815059|FG007|Maintenance Study (44 Weeks)|Other|1
6811197|NCT02320396|10815079|FG000|Overall Study|Adverse Event|2
6811198|NCT02320396|10815080|FG001|Overall Study|Adverse Event|2
6811199|NCT02320396|10815079|FG000|Overall Study|Pregnancy|0
6811200|NCT02320396|10815080|FG001|Overall Study|Pregnancy|1
6811201|NCT02320396|10815079|FG000|Overall Study|Protocol Violation|0
6811202|NCT02320396|10815080|FG001|Overall Study|Protocol Violation|1
6811203|NCT02320396|10815079|FG000|Overall Study|Withdrawal by Subject|2
6811204|NCT02320396|10815080|FG001|Overall Study|Withdrawal by Subject|0
6811297|NCT01852812|10815248|FG000|Overall Study|Non-compliance With Study Drug|0
6811298|NCT01852812|10815249|FG001|Overall Study|Non-compliance With Study Drug|1
6811299|NCT01852812|10815250|FG002|Overall Study|Non-compliance With Study Drug|0
6811300|NCT01828021|10815258|FG000|Overall Study|Adverse Event|5
6811301|NCT01828021|10815258|FG000|Overall Study|Lack of Efficacy|17
6811302|NCT01828021|10815258|FG000|Overall Study|Withdrawal by Subject|2
6811303|NCT01828021|10815258|FG000|Overall Study|Ileal obstruction, unrelated|1
6811304|NCT01709318|10815269|FG000|Overall Study|Adverse Event|3
6811305|NCT01709318|10815270|FG001|Overall Study|Adverse Event|4
6811306|NCT01709318|10815271|FG002|Overall Study|Adverse Event|2
6811307|NCT01709318|10815272|FG003|Overall Study|Adverse Event|2
6811308|NCT01709318|10815273|FG004|Overall Study|Adverse Event|0
6811309|NCT01709318|10815274|FG005|Overall Study|Adverse Event|1
6811310|NCT01709318|10815275|FG006|Overall Study|Adverse Event|2
6811311|NCT01709318|10815269|FG000|Overall Study|Lost to Follow-up|2
6811312|NCT01709318|10815270|FG001|Overall Study|Lost to Follow-up|0
6811313|NCT01709318|10815271|FG002|Overall Study|Lost to Follow-up|0
6811314|NCT01709318|10815272|FG003|Overall Study|Lost to Follow-up|0
6811315|NCT01709318|10815273|FG004|Overall Study|Lost to Follow-up|1
6811316|NCT01709318|10815274|FG005|Overall Study|Lost to Follow-up|1
6811317|NCT01709318|10815275|FG006|Overall Study|Lost to Follow-up|1
6811318|NCT01709318|10815269|FG000|Overall Study|Non-compliance with Study Drug|0
6811319|NCT01709318|10815270|FG001|Overall Study|Non-compliance with Study Drug|2
6811320|NCT01709318|10815271|FG002|Overall Study|Non-compliance with Study Drug|1
6811321|NCT01709318|10815272|FG003|Overall Study|Non-compliance with Study Drug|1
6782312|NCT03420781|10778302|FG000|Treatment Period (40 Weeks)|Adverse Event|1
6782313|NCT03420781|10778303|FG001|Treatment Period (40 Weeks)|Adverse Event|6
6782314|NCT03420781|10778304|FG002|Treatment Period (40 Weeks)|Adverse Event|0
6782315|NCT03420781|10778305|FG003|Treatment Period (40 Weeks)|Adverse Event|0
6782316|NCT03420781|10778306|FG004|Treatment Period (40 Weeks)|Adverse Event|0
6782317|NCT03420781|10778302|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1
6782318|NCT03420781|10778303|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1
6782319|NCT03420781|10778304|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0
6782320|NCT03420781|10778305|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0
6782321|NCT03420781|10778306|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0
6782322|NCT03420781|10778302|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22
6782323|NCT03420781|10778303|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16
6782324|NCT03420781|10778304|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0
6782325|NCT03420781|10778305|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0
6782326|NCT03420781|10778306|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0
6782327|NCT03420781|10778302|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10
6782328|NCT03420781|10778303|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6
6782329|NCT03420781|10778304|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0
6782330|NCT03420781|10778305|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0
6782331|NCT03420781|10778306|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0
6782332|NCT03420781|10778302|FG000|Treatment Period (40 Weeks)|Death|2
6782333|NCT03420781|10778303|FG001|Treatment Period (40 Weeks)|Death|2
6782334|NCT03420781|10778304|FG002|Treatment Period (40 Weeks)|Death|0
6782335|NCT03420781|10778305|FG003|Treatment Period (40 Weeks)|Death|0
6782336|NCT03420781|10778306|FG004|Treatment Period (40 Weeks)|Death|0
6782337|NCT03420781|10778302|FG000|Treatment Period (40 Weeks)|Physician Decision|3
6782338|NCT03420781|10778303|FG001|Treatment Period (40 Weeks)|Physician Decision|4
6782339|NCT03420781|10778304|FG002|Treatment Period (40 Weeks)|Physician Decision|0
6782340|NCT03420781|10778305|FG003|Treatment Period (40 Weeks)|Physician Decision|0
6782341|NCT03420781|10778306|FG004|Treatment Period (40 Weeks)|Physician Decision|0
6782342|NCT03420781|10778302|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0
6782343|NCT03420781|10778303|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2
6782344|NCT03420781|10778304|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0
6782345|NCT03420781|10778305|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0
6782346|NCT03420781|10778306|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0
6782347|NCT03420781|10778302|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101
6782348|NCT03420781|10778303|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89
6782349|NCT03420781|10778304|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0
6782350|NCT03420781|10778305|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0
6782351|NCT03420781|10778306|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0
6782352|NCT03420781|10778302|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1
6782353|NCT03420781|10778303|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0
6782354|NCT03420781|10778304|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0
6782355|NCT03420781|10778305|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0
6782356|NCT03420781|10778306|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0
6782357|NCT03420781|10778302|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3
6782358|NCT03420781|10778303|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0
6782359|NCT03420781|10778304|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0
6782360|NCT03420781|10778305|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0
6782361|NCT03420781|10778306|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0
6782362|NCT03420781|10778302|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0
6782363|NCT03420781|10778303|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0
6782364|NCT03420781|10778304|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0
6782365|NCT03420781|10778305|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2
6782366|NCT03420781|10778306|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0
6782367|NCT03420781|10778302|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0
6782368|NCT03420781|10778303|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0
6782369|NCT03420781|10778304|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0
6782370|NCT03420781|10778305|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0
6782371|NCT03420781|10778306|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2
6782372|NCT03420781|10778302|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0
6782373|NCT03420781|10778303|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0
6782374|NCT03420781|10778304|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6
6782375|NCT03420781|10778305|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3
6782376|NCT03420781|10778306|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3
6782377|NCT03316586|10778322|FG000|Overall Study|Adverse Event|2
6782378|NCT03316586|10778322|FG000|Overall Study|Physician Decision|3
6782379|NCT03316586|10778322|FG000|Overall Study|Lack of Efficacy|10
6782380|NCT03316586|10778322|FG000|Overall Study|still on treatment|1
6782381|NCT03316586|10778322|FG000|Overall Study|Patient needed radiation therapy|1
6782382|NCT03316586|10778322|FG000|Overall Study|Physician Decision to send patient for breast surgery|1
6782383|NCT03269695|10778341|FG000|Overall Study|Adverse Event|2
6782384|NCT03269695|10778342|FG001|Overall Study|Adverse Event|1
6782385|NCT03269695|10778341|FG000|Overall Study|Lack of Efficacy|0
6782386|NCT03269695|10778342|FG001|Overall Study|Lack of Efficacy|1
6782387|NCT03269695|10778341|FG000|Overall Study|Withdrawal by Subject|0
6782388|NCT03269695|10778342|FG001|Overall Study|Withdrawal by Subject|1
6782389|NCT03268811|10778351|FG000|Overall Study|Adverse Event|0
6782390|NCT03268811|10778352|FG001|Overall Study|Adverse Event|1
6782391|NCT03227757|10778359|FG000|Overall Study|Death|7
6782392|NCT03227757|10778359|FG000|Overall Study|Withdrawal|5
6782393|NCT03227757|10778359|FG000|Overall Study|Missed visits|4
6782394|NCT03142334|10778369|FG000|Overall Study|Death|18
6782395|NCT03142334|10778370|FG001|Overall Study|Death|33
6782396|NCT03142334|10778369|FG000|Overall Study|Withdrawal by Subject|15
6782397|NCT03142334|10778370|FG001|Overall Study|Withdrawal by Subject|11
6782398|NCT03142334|10778369|FG000|Overall Study|Ongoing on trial follow up|463
6782399|NCT03142334|10778370|FG001|Overall Study|Ongoing on trial follow up|454
6806598|NCT03863353|10809261|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24
6806599|NCT03863353|10809262|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20
6806600|NCT03622593|10809271|FG000|Overall Study|Withdrawal by Subject|5
6806601|NCT03622593|10809272|FG001|Overall Study|Withdrawal by Subject|4
6806602|NCT03622593|10809273|FG002|Overall Study|Withdrawal by Subject|3
6806603|NCT03622593|10809271|FG000|Overall Study|Death|5
6806604|NCT03622593|10809272|FG001|Overall Study|Death|0
6806605|NCT03622593|10809273|FG002|Overall Study|Death|5
6806606|NCT03622593|10809271|FG000|Overall Study|Lost to Follow-up|5
6806607|NCT03622593|10809272|FG001|Overall Study|Lost to Follow-up|2
6806608|NCT03622593|10809273|FG002|Overall Study|Lost to Follow-up|3
6806609|NCT03622593|10809271|FG000|Overall Study|Adverse Event|2
6806610|NCT03622593|10809272|FG001|Overall Study|Adverse Event|1
6806611|NCT03622593|10809273|FG002|Overall Study|Adverse Event|3
6806612|NCT03622593|10809271|FG000|Overall Study|Physician Decision|1
6806613|NCT03622593|10809272|FG001|Overall Study|Physician Decision|0
6806614|NCT03622593|10809273|FG002|Overall Study|Physician Decision|1
6806615|NCT03622593|10809271|FG000|Overall Study|Other|1
6806616|NCT03622593|10809272|FG001|Overall Study|Other|0
6806617|NCT03622593|10809273|FG002|Overall Study|Other|1
6806618|NCT03622593|10809271|FG000|Overall Study|Completed up to Week 56 (study was still ongoing)|298
6806619|NCT03622593|10809272|FG001|Overall Study|Completed up to Week 56 (study was still ongoing)|312
6806620|NCT03622593|10809273|FG002|Overall Study|Completed up to Week 56 (study was still ongoing)|299
6806621|NCT03622580|10809285|FG000|Overall Study|Death|7
6806622|NCT03622580|10809286|FG001|Overall Study|Death|9
6806623|NCT03622580|10809287|FG002|Overall Study|Death|4
6806624|NCT03622580|10809285|FG000|Overall Study|Adverse Event|5
6806625|NCT03622580|10809286|FG001|Overall Study|Adverse Event|6
6806626|NCT03622580|10809287|FG002|Overall Study|Adverse Event|2
6806627|NCT03622580|10809285|FG000|Overall Study|Withdrawal by Subject|5
6806628|NCT03622580|10809286|FG001|Overall Study|Withdrawal by Subject|3
6806629|NCT03622580|10809287|FG002|Overall Study|Withdrawal by Subject|9
6806630|NCT03622580|10809285|FG000|Overall Study|Lost to Follow-up|5
6806631|NCT03622580|10809286|FG001|Overall Study|Lost to Follow-up|6
6806632|NCT03622580|10809287|FG002|Overall Study|Lost to Follow-up|2
6806633|NCT03622580|10809285|FG000|Overall Study|Protocol Violation|1
6806634|NCT03622580|10809286|FG001|Overall Study|Protocol Violation|0
6806635|NCT03622580|10809287|FG002|Overall Study|Protocol Violation|1
6806636|NCT03622580|10809285|FG000|Overall Study|Lack of Efficacy|0
6806637|NCT03622580|10809286|FG001|Overall Study|Lack of Efficacy|0
6806638|NCT03622580|10809287|FG002|Overall Study|Lack of Efficacy|1
6806639|NCT03622580|10809285|FG000|Overall Study|Physician Decision|1
6806640|NCT03622580|10809286|FG001|Overall Study|Physician Decision|0
6806641|NCT03622580|10809287|FG002|Overall Study|Physician Decision|1
6806642|NCT03622580|10809285|FG000|Overall Study|Completed up to Week 56 (study was still ongoing)|291
6806643|NCT03622580|10809286|FG001|Overall Study|Completed up to Week 56 (study was still ongoing)|289
6806644|NCT03622580|10809287|FG002|Overall Study|Completed up to Week 56 (study was still ongoing)|292
6806645|NCT03333928|10809327|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0
6806646|NCT03333928|10809328|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0
6806647|NCT03333928|10809329|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1
6806648|NCT03333928|10809327|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0
6806649|NCT03333928|10809328|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1
6806650|NCT03333928|10809329|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1
6806651|NCT03333928|10809327|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1
6806652|NCT03333928|10809328|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0
6806653|NCT03333928|10809329|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1
6806654|NCT03333928|10809327|FG000|Initial Dosing Period (Period 1)|Adverse Event|0
6806655|NCT03333928|10809328|FG001|Initial Dosing Period (Period 1)|Adverse Event|3
6806656|NCT03333928|10809329|FG002|Initial Dosing Period (Period 1)|Adverse Event|1
7138346|NCT02942771|11291492|FG003|Overall Study|Adverse Event|0
6806657|NCT03333928|10809327|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2
6806658|NCT03333928|10809328|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1
6806659|NCT03333928|10809329|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0
6806660|NCT03333928|10809327|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1
6782400|NCT02857426|10778450|FG000|Overall Study|Disease progression|34
6782401|NCT02857426|10778451|FG001|Overall Study|Disease progression|13
6782402|NCT02857426|10778450|FG000|Overall Study|Study drug toxicity|4
6782403|NCT02857426|10778451|FG001|Overall Study|Study drug toxicity|1
6782404|NCT02857426|10778450|FG000|Overall Study|Death|1
6782405|NCT02857426|10778451|FG001|Overall Study|Death|0
6782406|NCT02857426|10778450|FG000|Overall Study|Adverse event unrelated to study drug|6
6782407|NCT02857426|10778451|FG001|Overall Study|Adverse event unrelated to study drug|2
6782408|NCT02857426|10778450|FG000|Overall Study|Participant withdrew consent|1
6782409|NCT02857426|10778451|FG001|Overall Study|Participant withdrew consent|1
6782410|NCT02857426|10778450|FG000|Overall Study|Maximum clinical benefit|1
6782411|NCT02857426|10778451|FG001|Overall Study|Maximum clinical benefit|0
6782412|NCT02857426|10778450|FG000|Overall Study|Completed treatment|0
6782413|NCT02857426|10778451|FG001|Overall Study|Completed treatment|2
6782414|NCT02855125|10778459|FG000|Overall Study|Withdrawal by Subject|2
6782415|NCT02855125|10778460|FG001|Overall Study|Withdrawal by Subject|2
6782416|NCT02855125|10778459|FG000|Overall Study|Clinical Disease Progression|5
6782417|NCT02855125|10778460|FG001|Overall Study|Clinical Disease Progression|4
6782418|NCT02855125|10778459|FG000|Overall Study|Radiologic Disease Progression|36
6782419|NCT02855125|10778460|FG001|Overall Study|Radiologic Disease Progression|39
6782420|NCT02855125|10778459|FG000|Overall Study|Adverse Event|11
6782421|NCT02855125|10778460|FG001|Overall Study|Adverse Event|7
6782422|NCT02855125|10778459|FG000|Overall Study|Physician Decision|1
6782423|NCT02855125|10778460|FG001|Overall Study|Physician Decision|0
6782424|NCT02855125|10778459|FG000|Overall Study|On Treatment|9
6782425|NCT02855125|10778460|FG001|Overall Study|On Treatment|11
6782426|NCT02855125|10778459|FG000|Overall Study|Randomized but not treated|0
6782427|NCT02855125|10778460|FG001|Overall Study|Randomized but not treated|1
6782428|NCT02836236|10778468|FG000|Overall Study|Randomized but Never Treated|1
6782429|NCT02836236|10778469|FG001|Overall Study|Randomized but Never Treated|0
6782430|NCT02836236|10778468|FG000|Overall Study|Withdrew Consent|2
6782431|NCT02836236|10778469|FG001|Overall Study|Withdrew Consent|0
6782432|NCT02836236|10778468|FG000|Overall Study|Adverse Event|0
6782433|NCT02836236|10778469|FG001|Overall Study|Adverse Event|1
6782434|NCT02836236|10778468|FG000|Overall Study|Investigator's Discretion|1
6782435|NCT02836236|10778469|FG001|Overall Study|Investigator's Discretion|0
6782436|NCT02836236|10778468|FG000|Overall Study|Still on Study|101
6782437|NCT02836236|10778469|FG001|Overall Study|Still on Study|49
6782438|NCT02680587|10778487|FG000|Overall Study|Withdrawal by Subject|1
6782439|NCT02680587|10778488|FG001|Overall Study|Withdrawal by Subject|0
7138347|NCT02942771|11291493|FG004|Overall Study|Adverse Event|2
7138348|NCT02942771|11291489|FG000|Overall Study|Lost to Follow-up|1
7138349|NCT02942771|11291490|FG001|Overall Study|Lost to Follow-up|0
7138350|NCT02942771|11291491|FG002|Overall Study|Lost to Follow-up|0
7138351|NCT02942771|11291492|FG003|Overall Study|Lost to Follow-up|0
7138352|NCT02942771|11291493|FG004|Overall Study|Lost to Follow-up|0
7138353|NCT02942771|11291489|FG000|Overall Study|Withdrawal by Subject|1
7138354|NCT02942771|11291490|FG001|Overall Study|Withdrawal by Subject|0
6782448|NCT02527798|10778524|FG000|Overall Study|Physician Decision|1
6782449|NCT02527798|10778525|FG001|Overall Study|Physician Decision|0
6782450|NCT02527798|10778526|FG002|Overall Study|Physician Decision|1
6782451|NCT02527798|10778527|FG003|Overall Study|Physician Decision|1
6782452|NCT02527798|10778528|FG004|Overall Study|Physician Decision|0
6782453|NCT02527798|10778529|FG005|Overall Study|Physician Decision|0
6782454|NCT02527798|10778524|FG000|Overall Study|Death|0
6782455|NCT02527798|10778525|FG001|Overall Study|Death|0
6782456|NCT02527798|10778526|FG002|Overall Study|Death|1
6782457|NCT02527798|10778527|FG003|Overall Study|Death|0
6782458|NCT02527798|10778528|FG004|Overall Study|Death|0
6782459|NCT02527798|10778529|FG005|Overall Study|Death|0
6782460|NCT02527798|10778524|FG000|Overall Study|Withdrawal by Subject|0
6782461|NCT02527798|10778525|FG001|Overall Study|Withdrawal by Subject|1
6782462|NCT02527798|10778526|FG002|Overall Study|Withdrawal by Subject|2
6782463|NCT02527798|10778527|FG003|Overall Study|Withdrawal by Subject|0
6782464|NCT02527798|10778528|FG004|Overall Study|Withdrawal by Subject|0
6782465|NCT02527798|10778529|FG005|Overall Study|Withdrawal by Subject|0
6782466|NCT02527798|10778524|FG000|Overall Study|Reason undisclosed|1
6782467|NCT02527798|10778525|FG001|Overall Study|Reason undisclosed|0
6782468|NCT02527798|10778526|FG002|Overall Study|Reason undisclosed|1
6782469|NCT02527798|10778527|FG003|Overall Study|Reason undisclosed|0
6782470|NCT02527798|10778528|FG004|Overall Study|Reason undisclosed|0
6782471|NCT02527798|10778529|FG005|Overall Study|Reason undisclosed|0
6782472|NCT02527798|10778524|FG000|Overall Study|Did not receive intervention|1
6782473|NCT02527798|10778525|FG001|Overall Study|Did not receive intervention|1
6782474|NCT02527798|10778526|FG002|Overall Study|Did not receive intervention|0
6782475|NCT02527798|10778527|FG003|Overall Study|Did not receive intervention|0
6782476|NCT02527798|10778528|FG004|Overall Study|Did not receive intervention|0
6782477|NCT02527798|10778529|FG005|Overall Study|Did not receive intervention|0
6782478|NCT02279745|10778580|FG000|Overall Study|Adverse Event|7
6782479|NCT02279745|10778580|FG000|Overall Study|Death|6
6782480|NCT02279745|10778580|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2
6782481|NCT02279745|10778580|FG000|Overall Study|Withdrawal by Subject|2
6782482|NCT02279745|10778580|FG000|Overall Study|Pregnancy|1
6782483|NCT02279745|10778580|FG000|Overall Study|Study Non-compliance|1
6782484|NCT02279745|10778580|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1
6782485|NCT02030938|10778603|FG000|Overall Study|Lost to Follow-up|4
6782486|NCT02030938|10778603|FG000|Overall Study|Withdrawal by Subject|1
6782487|NCT02006147|10778615|FG000|Overall Study|Protocol Violation|1
6782488|NCT02006147|10778616|FG001|Overall Study|Protocol Violation|1
6782489|NCT02006147|10778617|FG002|Overall Study|Protocol Violation|0
6782490|NCT02006147|10778618|FG003|Overall Study|Protocol Violation|0
6782491|NCT02006147|10778615|FG000|Overall Study|Withdrawal by Subject|0
6782492|NCT02006147|10778616|FG001|Overall Study|Withdrawal by Subject|1
6782493|NCT02006147|10778617|FG002|Overall Study|Withdrawal by Subject|0
6782494|NCT02006147|10778618|FG003|Overall Study|Withdrawal by Subject|0
6782495|NCT02006147|10778615|FG000|Overall Study|Withdrawal by Sponsor|1
6782496|NCT02006147|10778616|FG001|Overall Study|Withdrawal by Sponsor|0
6782497|NCT02006147|10778617|FG002|Overall Study|Withdrawal by Sponsor|0
6782498|NCT02006147|10778618|FG003|Overall Study|Withdrawal by Sponsor|0
6782499|NCT01940341|10778626|FG000|Double-Blind Phase|Randomized but Never Treated|0
6782500|NCT01940341|10778627|FG001|Double-Blind Phase|Randomized but Never Treated|1
6782501|NCT01940341|10778626|FG000|Double-Blind Phase|Adverse Event|3
6782502|NCT01940341|10778627|FG001|Double-Blind Phase|Adverse Event|2
6782503|NCT01940341|10778626|FG000|Double-Blind Phase|Withdrew Consent|3
6782504|NCT01940341|10778627|FG001|Double-Blind Phase|Withdrew Consent|2
6782505|NCT01940341|10778626|FG000|Double-Blind Phase|Lost to Follow-up|4
6782506|NCT01940341|10778627|FG001|Double-Blind Phase|Lost to Follow-up|1
6782507|NCT01940341|10778626|FG000|Double-Blind Phase|Pregnancy|0
6782508|NCT01940341|10778627|FG001|Double-Blind Phase|Pregnancy|1
6782509|NCT01940341|10778626|FG000|Double-Blind Phase|Investigator's Discretion|1
6782510|NCT01940341|10778627|FG001|Double-Blind Phase|Investigator's Discretion|0
6782511|NCT01940341|10778626|FG000|Double-Blind Phase|Non-Compliance with Study Drug|0
6782512|NCT01940341|10778627|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1
6782513|NCT01940341|10778626|FG000|Double-Blind Phase|Protocol Specified Criteria|1
6782514|NCT01940341|10778627|FG001|Double-Blind Phase|Protocol Specified Criteria|0
6782515|NCT01940341|10778626|FG000|Double-Blind Phase|Still on Double-Blind Treatment|269
6782516|NCT01940341|10778627|FG001|Double-Blind Phase|Still on Double-Blind Treatment|132
6782517|NCT01940341|10778626|FG000|Open-label Extension Phase|Still on Study|4
6782518|NCT01940341|10778627|FG001|Open-label Extension Phase|Still on Study|1
6782519|NCT01925794|10778635|FG000|180 Days|Death|2
6782520|NCT01925794|10778635|FG000|180 Days|Withdrawal by Subject|2
6782521|NCT01925794|10778635|FG000|270 Days|Death|2
6782522|NCT01925794|10778635|FG000|270 Days|Protocol Violation|3
6806661|NCT03333928|10809328|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0
6806662|NCT03333928|10809329|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0
6806663|NCT03333928|10809327|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1
6806664|NCT03333928|10809328|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0
6806665|NCT03333928|10809329|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0
6806666|NCT03333928|10809327|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1
6806667|NCT03333928|10809328|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0
6806668|NCT03333928|10809329|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1
6806669|NCT03298984|10809349|FG000|Overall Study|Physician Decision|1
6806670|NCT03298984|10809350|FG001|Overall Study|Physician Decision|0
6806671|NCT03298984|10809351|FG002|Overall Study|Physician Decision|0
6806672|NCT03298984|10809352|FG003|Overall Study|Physician Decision|6
6806673|NCT03298984|10809349|FG000|Overall Study|Lack of Efficacy|0
6806674|NCT03298984|10809350|FG001|Overall Study|Lack of Efficacy|1
6806675|NCT03298984|10809351|FG002|Overall Study|Lack of Efficacy|1
6806676|NCT03298984|10809352|FG003|Overall Study|Lack of Efficacy|4
6806677|NCT03298984|10809349|FG000|Overall Study|Relapsed disease (following remission)|0
6806678|NCT03298984|10809350|FG001|Overall Study|Relapsed disease (following remission)|0
6806679|NCT03298984|10809351|FG002|Overall Study|Relapsed disease (following remission)|1
6806680|NCT03298984|10809352|FG003|Overall Study|Relapsed disease (following remission)|1
6806681|NCT03298984|10809349|FG000|Overall Study|Adverse Event|0
6806682|NCT03298984|10809350|FG001|Overall Study|Adverse Event|0
6806683|NCT03298984|10809351|FG002|Overall Study|Adverse Event|0
6806684|NCT03298984|10809352|FG003|Overall Study|Adverse Event|1
6806685|NCT03298984|10809349|FG000|Overall Study|Death|0
6806686|NCT03298984|10809350|FG001|Overall Study|Death|0
6806687|NCT03298984|10809351|FG002|Overall Study|Death|0
6806688|NCT03298984|10809352|FG003|Overall Study|Death|2
6806689|NCT03298984|10809349|FG000|Overall Study|Insurance Company Decision|0
6806690|NCT03298984|10809350|FG001|Overall Study|Insurance Company Decision|0
6806691|NCT03298984|10809351|FG002|Overall Study|Insurance Company Decision|0
6806692|NCT03298984|10809352|FG003|Overall Study|Insurance Company Decision|1
6806693|NCT03175198|10809363|FG000|Overall Study|Adverse Event|480
6806694|NCT03175198|10809363|FG000|Overall Study|No actual visit|120
6806695|NCT03175198|10809363|FG000|Overall Study|Registration rule not followed|4
6806696|NCT03175198|10809363|FG000|Overall Study|Patients received Prazaxa treatment before|5
6806697|NCT03175198|10809363|FG000|Overall Study|Other personal reason|509
6806698|NCT03175198|10809363|FG000|Overall Study|To take a contraindication/careful administration drug|8
6806699|NCT03175198|10809363|FG000|Overall Study|Lost to follow-up (changing hospital)|373
6806700|NCT03175198|10809363|FG000|Overall Study|Lost to follow-up (unknown reason)|146
6806701|NCT03175198|10809363|FG000|Overall Study|To conduct invasive treatment of operation|53
6782523|NCT01849250|10778658|FG000|Overall Study|Withdrawal by Subject|1
6782524|NCT01849250|10778659|FG001|Overall Study|Withdrawal by Subject|0
6782525|NCT01849250|10778658|FG000|Overall Study|Not Evaluable|5
6782526|NCT01849250|10778659|FG001|Overall Study|Not Evaluable|3
6782527|NCT01849250|10778658|FG000|Overall Study|Screen Failure|1
6782528|NCT01849250|10778659|FG001|Overall Study|Screen Failure|0
6782529|NCT01441115|10778670|FG000|Overall Study|Taken off study - Principal Investigator discretion|1
6782530|NCT01199302|10778681|FG000|Overall Study|Adverse Event|1
6782531|NCT01199302|10778682|FG001|Overall Study|Adverse Event|1
6782532|NCT01199302|10778683|FG002|Overall Study|Adverse Event|2
6782533|NCT01199302|10778684|FG003|Overall Study|Adverse Event|0
6782534|NCT01199302|10778681|FG000|Overall Study|Withdrawal by Subject|2
6782535|NCT01199302|10778682|FG001|Overall Study|Withdrawal by Subject|2
6782536|NCT01199302|10778683|FG002|Overall Study|Withdrawal by Subject|3
6782537|NCT01199302|10778684|FG003|Overall Study|Withdrawal by Subject|0
6782538|NCT01199302|10778681|FG000|Overall Study|Disease Progression|3
6782539|NCT01199302|10778682|FG001|Overall Study|Disease Progression|4
6782540|NCT01199302|10778683|FG002|Overall Study|Disease Progression|4
6782541|NCT01199302|10778684|FG003|Overall Study|Disease Progression|2
6782542|NCT01199302|10778681|FG000|Overall Study|Study Termination|13
6782543|NCT01199302|10778682|FG001|Overall Study|Study Termination|8
6782544|NCT01199302|10778683|FG002|Overall Study|Study Termination|11
6782545|NCT01199302|10778684|FG003|Overall Study|Study Termination|9
6782546|NCT01199302|10778681|FG000|Overall Study|Lost to Follow-up|0
6782547|NCT01199302|10778682|FG001|Overall Study|Lost to Follow-up|1
6782548|NCT01199302|10778683|FG002|Overall Study|Lost to Follow-up|0
6782549|NCT01199302|10778684|FG003|Overall Study|Lost to Follow-up|0
6782550|NCT01199302|10778681|FG000|Overall Study|Other|1
6782551|NCT01199302|10778682|FG001|Overall Study|Other|0
6782552|NCT01199302|10778683|FG002|Overall Study|Other|0
7138355|NCT02942771|11291491|FG002|Overall Study|Withdrawal by Subject|0
7138356|NCT02942771|11291492|FG003|Overall Study|Withdrawal by Subject|0
7138357|NCT02942771|11291493|FG004|Overall Study|Withdrawal by Subject|2
7138358|NCT02943070|11291514|FG000|Overall Study|Physician Decision|1
7138359|NCT02943070|11291514|FG000|Overall Study|Adverse Event|2
7138360|NCT02943070|11291514|FG000|Overall Study|Death|2
7138361|NCT02943070|11291514|FG000|Overall Study|Withdrawal by Subject|3
7138362|NCT02943070|11291514|FG000|Overall Study|Lost to Follow-up|4
7138363|NCT02943070|11291514|FG000|Overall Study|Retreatment or TURP|13
7138364|NCT02943070|11291514|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18
7138365|NCT02943096|11291527|FG000|Overall Study|Lack of Efficacy|0
7138366|NCT02943096|11291528|FG001|Overall Study|Lack of Efficacy|1
7138367|NCT02943447|11291552|FG000|Blinded Study Phase|Withdrew Consent|1
7138368|NCT02943447|11291553|FG001|Blinded Study Phase|Withdrew Consent|2
7138369|NCT02943447|11291554|FG002|Blinded Study Phase|Withdrew Consent|1
7138370|NCT02943447|11291552|FG000|Blinded Study Phase|Adverse Event|3
7138371|NCT02943447|11291553|FG001|Blinded Study Phase|Adverse Event|0
7138372|NCT02943447|11291554|FG002|Blinded Study Phase|Adverse Event|0
7138373|NCT02943447|11291552|FG000|Blinded Study Phase|Investigator's discretion|1
7138374|NCT02943447|11291553|FG001|Blinded Study Phase|Investigator's discretion|0
7138375|NCT02943447|11291554|FG002|Blinded Study Phase|Investigator's discretion|0
7138376|NCT02943447|11291552|FG000|Open-Label Extension Phase|Study terminated by sponsor|10
7138377|NCT02943447|11291553|FG001|Open-Label Extension Phase|Study terminated by sponsor|12
7138378|NCT02943447|11291554|FG002|Open-Label Extension Phase|Study terminated by sponsor|6
7138379|NCT02943447|11291552|FG000|Open-Label Extension Phase|Adverse Event|4
7138380|NCT02943447|11291553|FG001|Open-Label Extension Phase|Adverse Event|7
7138381|NCT02943447|11291554|FG002|Open-Label Extension Phase|Adverse Event|3
7138382|NCT02943447|11291552|FG000|Open-Label Extension Phase|Lack of Efficacy|3
7138383|NCT02943447|11291553|FG001|Open-Label Extension Phase|Lack of Efficacy|4
7138384|NCT02943447|11291554|FG002|Open-Label Extension Phase|Lack of Efficacy|0
7138385|NCT02943447|11291552|FG000|Open-Label Extension Phase|Withdrew consent|1
7138386|NCT02943447|11291553|FG001|Open-Label Extension Phase|Withdrew consent|1
7138387|NCT02943447|11291554|FG002|Open-Label Extension Phase|Withdrew consent|1
7138388|NCT02943447|11291552|FG000|Open-Label Extension Phase|Lost to Follow-up|0
6782553|NCT01199302|10778684|FG003|Overall Study|Other|0
6782554|NCT01123707|10778695|FG000|Overall Study|Lost to Follow-up|3
6782555|NCT01123707|10778696|FG001|Overall Study|Lost to Follow-up|1
6782556|NCT01123707|10778697|FG002|Overall Study|Lost to Follow-up|3
6782557|NCT01123707|10778698|FG003|Overall Study|Lost to Follow-up|2
6782558|NCT01123707|10778695|FG000|Overall Study|Adverse Event|5
6782559|NCT01123707|10778696|FG001|Overall Study|Adverse Event|7
6782560|NCT01123707|10778697|FG002|Overall Study|Adverse Event|5
6782561|NCT01123707|10778698|FG003|Overall Study|Adverse Event|3
6782562|NCT01123707|10778695|FG000|Overall Study|Sponsor Discontinued Study|30
6782563|NCT01123707|10778696|FG001|Overall Study|Sponsor Discontinued Study|24
6782564|NCT01123707|10778697|FG002|Overall Study|Sponsor Discontinued Study|25
6782565|NCT01123707|10778698|FG003|Overall Study|Sponsor Discontinued Study|40
6782566|NCT01123707|10778695|FG000|Overall Study|Participant Met Withdrawal Criteria|1
6782567|NCT01123707|10778696|FG001|Overall Study|Participant Met Withdrawal Criteria|1
6782568|NCT01123707|10778697|FG002|Overall Study|Participant Met Withdrawal Criteria|0
6782569|NCT01123707|10778698|FG003|Overall Study|Participant Met Withdrawal Criteria|1
6782570|NCT01123707|10778695|FG000|Overall Study|Investigator Withdrew Participant|0
6782571|NCT01123707|10778696|FG001|Overall Study|Investigator Withdrew Participant|1
6782572|NCT01123707|10778697|FG002|Overall Study|Investigator Withdrew Participant|1
6782573|NCT01123707|10778698|FG003|Overall Study|Investigator Withdrew Participant|1
6782574|NCT01123707|10778695|FG000|Overall Study|Subject Withdrew Consent|4
6782575|NCT01123707|10778696|FG001|Overall Study|Subject Withdrew Consent|5
6782576|NCT01123707|10778697|FG002|Overall Study|Subject Withdrew Consent|1
6782577|NCT01123707|10778698|FG003|Overall Study|Subject Withdrew Consent|2
6782578|NCT01123707|10778695|FG000|Overall Study|Lack of Efficacy|1
6782579|NCT01123707|10778696|FG001|Overall Study|Lack of Efficacy|2
6782580|NCT01123707|10778697|FG002|Overall Study|Lack of Efficacy|1
6782581|NCT01123707|10778698|FG003|Overall Study|Lack of Efficacy|0
6782582|NCT01123707|10778695|FG000|Overall Study|Subject Met Exclusion Criteria|0
6782583|NCT01123707|10778696|FG001|Overall Study|Subject Met Exclusion Criteria|0
6782584|NCT01123707|10778697|FG002|Overall Study|Subject Met Exclusion Criteria|2
6782585|NCT01123707|10778698|FG003|Overall Study|Subject Met Exclusion Criteria|1
6782586|NCT00462943|10778715|FG000|Overall Study|Failure to achieve a response|5
6782587|NCT00462943|10778716|FG001|Overall Study|Failure to achieve a response|5
6782588|NCT00462943|10778717|FG002|Overall Study|Failure to achieve a response|1
6782589|NCT00462943|10778715|FG000|Overall Study|Adverse Event|6
6782590|NCT00462943|10778716|FG001|Overall Study|Adverse Event|4
6782591|NCT00462943|10778717|FG002|Overall Study|Adverse Event|1
6782592|NCT00462943|10778715|FG000|Overall Study|Protocol Violation|1
6782593|NCT00462943|10778716|FG001|Overall Study|Protocol Violation|0
6782594|NCT00462943|10778717|FG002|Overall Study|Protocol Violation|0
6782595|NCT00462943|10778715|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8
6782596|NCT00462943|10778716|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2
6782597|NCT00462943|10778717|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4
6782598|NCT00462943|10778715|FG000|Overall Study|Disease Progression|15
6782599|NCT00462943|10778716|FG001|Overall Study|Disease Progression|15
6782600|NCT00462943|10778717|FG002|Overall Study|Disease Progression|9
6782601|NCT00462943|10778715|FG000|Overall Study|Death|5
6782602|NCT00462943|10778716|FG001|Overall Study|Death|2
6782603|NCT00462943|10778717|FG002|Overall Study|Death|7
6782604|NCT00462943|10778715|FG000|Overall Study|Stem Cell Transplant|1
6782605|NCT00462943|10778716|FG001|Overall Study|Stem Cell Transplant|1
6782606|NCT00462943|10778717|FG002|Overall Study|Stem Cell Transplant|0
6782607|NCT00462943|10778715|FG000|Overall Study|Bone Marrow Transplant|1
6782608|NCT00462943|10778716|FG001|Overall Study|Bone Marrow Transplant|0
6782609|NCT00462943|10778717|FG002|Overall Study|Bone Marrow Transplant|0
6782610|NCT00462943|10778715|FG000|Overall Study|Required Lymphocyte Infusion|1
6782611|NCT00462943|10778716|FG001|Overall Study|Required Lymphocyte Infusion|0
6782612|NCT00462943|10778717|FG002|Overall Study|Required Lymphocyte Infusion|0
6782613|NCT00462943|10778715|FG000|Overall Study|Transplant - not specified|1
6782614|NCT00462943|10778716|FG001|Overall Study|Transplant - not specified|0
6782615|NCT00462943|10778717|FG002|Overall Study|Transplant - not specified|1
6782616|NCT00462943|10778715|FG000|Overall Study|Physician Decision|1
6782617|NCT00462943|10778716|FG001|Overall Study|Physician Decision|0
6782618|NCT00462943|10778717|FG002|Overall Study|Physician Decision|0
6782619|NCT00462943|10778715|FG000|Overall Study|Withdrawal by Subject|0
6782620|NCT00462943|10778716|FG001|Overall Study|Withdrawal by Subject|1
6782621|NCT00462943|10778717|FG002|Overall Study|Withdrawal by Subject|0
6782622|NCT00248287|10778727|FG000|Overall Study|Adverse Event|11
6782623|NCT00248287|10778728|FG001|Overall Study|Adverse Event|10
6782624|NCT00248287|10778727|FG000|Overall Study|Death|1
6782625|NCT00248287|10778728|FG001|Overall Study|Death|0
6782626|NCT00248287|10778727|FG000|Overall Study|Lost to Follow-up|0
6782627|NCT00248287|10778728|FG001|Overall Study|Lost to Follow-up|1
6782628|NCT00248287|10778727|FG000|Overall Study|Investigator Request|4
6782629|NCT00248287|10778728|FG001|Overall Study|Investigator Request|3
6782630|NCT00248287|10778727|FG000|Overall Study|Patient Request|5
6782631|NCT00248287|10778728|FG001|Overall Study|Patient Request|3
6782632|NCT00248287|10778727|FG000|Overall Study|Other|3
6782633|NCT00248287|10778728|FG001|Overall Study|Other|2
6782634|NCT00105560|10778738|FG000|Overall Study|Lost to Follow-up|1
6806702|NCT03175198|10809363|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629
6806703|NCT03158727|10809369|FG000|Overall Study|Withdrawal by Subject|2
6806704|NCT03158727|10809370|FG001|Overall Study|Withdrawal by Subject|6
6806705|NCT03158727|10809369|FG000|Overall Study|Death|11
6806706|NCT03158727|10809370|FG001|Overall Study|Death|12
6806707|NCT03158727|10809369|FG000|Overall Study|Lost to Follow-up|1
6806708|NCT03158727|10809370|FG001|Overall Study|Lost to Follow-up|0
6806709|NCT03158727|10809369|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2
6806710|NCT03158727|10809370|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0
6806711|NCT03158727|10809369|FG000|Overall Study|Visit 11 not done by mistake|0
6806712|NCT03158727|10809370|FG001|Overall Study|Visit 11 not done by mistake|1
6806713|NCT03158727|10809369|FG000|Overall Study|Enrolled, not treated|1
6806714|NCT03158727|10809370|FG001|Overall Study|Enrolled, not treated|0
6806715|NCT03075826|10809376|FG000|Overall Study|Withdrawal by Subject|1
6806716|NCT03075826|10809376|FG000|Overall Study|Received less than 3 cycles of study drug|5
6806717|NCT02993731|10809382|FG000|Overall Study|Study Termination|101
6806718|NCT02993731|10809383|FG001|Overall Study|Study Termination|105
6806719|NCT02586025|10809409|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1
6782635|NCT04569786|10778772|FG000|Overall Study|Lost to Follow-up|1
6782636|NCT04569786|10778773|FG001|Overall Study|Lost to Follow-up|0
6782637|NCT04569786|10778774|FG002|Overall Study|Lost to Follow-up|4
6782638|NCT04569786|10778775|FG003|Overall Study|Lost to Follow-up|1
6782639|NCT04569786|10778776|FG004|Overall Study|Lost to Follow-up|0
6782640|NCT04569786|10778772|FG000|Overall Study|Withdrawal by Subject|0
6782641|NCT04569786|10778773|FG001|Overall Study|Withdrawal by Subject|0
6782642|NCT04569786|10778774|FG002|Overall Study|Withdrawal by Subject|0
6782643|NCT04569786|10778775|FG003|Overall Study|Withdrawal by Subject|5
6782644|NCT04569786|10778776|FG004|Overall Study|Withdrawal by Subject|1
6782645|NCT04569786|10778772|FG000|Overall Study|Physician Decision|0
6782646|NCT04569786|10778773|FG001|Overall Study|Physician Decision|0
6782647|NCT04569786|10778774|FG002|Overall Study|Physician Decision|0
6782648|NCT04569786|10778775|FG003|Overall Study|Physician Decision|1
6782649|NCT04569786|10778776|FG004|Overall Study|Physician Decision|0
6782650|NCT04129944|10778797|FG000|Overall Study|Death|0
6782651|NCT04129944|10778798|FG001|Overall Study|Death|0
6782652|NCT04129944|10778799|FG002|Overall Study|Death|0
6782653|NCT04129944|10778800|FG003|Overall Study|Death|1
6782654|NCT04129944|10778797|FG000|Overall Study|Lost to Follow-up|1
6782655|NCT04129944|10778798|FG001|Overall Study|Lost to Follow-up|0
6782656|NCT04129944|10778799|FG002|Overall Study|Lost to Follow-up|0
6782657|NCT04129944|10778800|FG003|Overall Study|Lost to Follow-up|0
6782658|NCT04129944|10778797|FG000|Overall Study|Withdrawal by Subject|1
6782659|NCT04129944|10778798|FG001|Overall Study|Withdrawal by Subject|0
6782660|NCT04129944|10778799|FG002|Overall Study|Withdrawal by Subject|1
6782661|NCT04129944|10778800|FG003|Overall Study|Withdrawal by Subject|2
6782662|NCT03857542|10778821|FG000|Overall Study|Adverse Event|1
6782663|NCT03857542|10778822|FG001|Overall Study|Adverse Event|3
6782664|NCT03857542|10778821|FG000|Overall Study|Withdrawal by Subject|2
6782665|NCT03857542|10778822|FG001|Overall Study|Withdrawal by Subject|1
6782666|NCT03857542|10778821|FG000|Overall Study|Lost to Follow-up|2
6782667|NCT03857542|10778822|FG001|Overall Study|Lost to Follow-up|1
6782668|NCT03857542|10778821|FG000|Overall Study|Reason not Specified|1
6782669|NCT03857542|10778822|FG001|Overall Study|Reason not Specified|0
6782670|NCT03848832|10778832|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0
6782671|NCT03848832|10778833|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0
6782672|NCT03848832|10778834|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1
6782673|NCT03848832|10778832|FG000|Overall Study|Withdrawal by Subject|0
6782674|NCT03848832|10778833|FG001|Overall Study|Withdrawal by Subject|0
6782675|NCT03848832|10778834|FG002|Overall Study|Withdrawal by Subject|1
7138389|NCT02943447|11291553|FG001|Open-Label Extension Phase|Lost to Follow-up|1
7138390|NCT02943447|11291554|FG002|Open-Label Extension Phase|Lost to Follow-up|0
7138391|NCT02943460|11291574|FG000|Blinded Study Phase|Adverse Event|3
7138392|NCT02943460|11291575|FG001|Blinded Study Phase|Adverse Event|0
7138393|NCT02943460|11291576|FG002|Blinded Study Phase|Adverse Event|0
7138394|NCT02943460|11291574|FG000|Blinded Study Phase|Withdrew Consent|0
7138395|NCT02943460|11291575|FG001|Blinded Study Phase|Withdrew Consent|1
7138396|NCT02943460|11291576|FG002|Blinded Study Phase|Withdrew Consent|0
7138397|NCT02943460|11291574|FG000|Open Label Extension (OLE) Phase|Adverse Event|2
7138398|NCT02943460|11291575|FG001|Open Label Extension (OLE) Phase|Adverse Event|5
7138399|NCT02943460|11291576|FG002|Open Label Extension (OLE) Phase|Adverse Event|2
7138400|NCT02943460|11291574|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2
7138401|NCT02943460|11291575|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1
7138402|NCT02943460|11291576|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0
7138403|NCT02943460|11291574|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1
7138404|NCT02943460|11291575|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1
7138405|NCT02943460|11291576|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0
7138406|NCT02943473|11291585|FG000|Overall Study|enrolled but not dosed|1
7138407|NCT02943473|11291585|FG000|Overall Study|screen failure|1
7138408|NCT02943473|11291585|FG000|Overall Study|Physician Decision|4
7138409|NCT02943564|11291601|FG000|Overall Study|Miscellaneous Reasons|0
7138410|NCT02943564|11291602|FG001|Overall Study|Miscellaneous Reasons|0
7138411|NCT02943564|11291603|FG002|Overall Study|Miscellaneous Reasons|3
7138412|NCT02943564|11291601|FG000|Overall Study|Site terminated by sponsor|0
7138413|NCT02943564|11291602|FG001|Overall Study|Site terminated by sponsor|1
7138414|NCT02943564|11291603|FG002|Overall Study|Site terminated by sponsor|0
7138415|NCT02943564|11291601|FG000|Overall Study|Non-compliance with study drug|0
7138416|NCT02943564|11291602|FG001|Overall Study|Non-compliance with study drug|1
7138417|NCT02943564|11291603|FG002|Overall Study|Non-compliance with study drug|0
7138418|NCT02943564|11291601|FG000|Overall Study|Pregnancy|0
7138419|NCT02943564|11291602|FG001|Overall Study|Pregnancy|1
7138420|NCT02943564|11291603|FG002|Overall Study|Pregnancy|1
7138421|NCT02943564|11291601|FG000|Overall Study|Protocol Violation|2
6782676|NCT03848832|10778832|FG000|Overall Study|Withdrawal (Covid-19)|0
6782677|NCT03848832|10778833|FG001|Overall Study|Withdrawal (Covid-19)|2
7138422|NCT02943564|11291602|FG001|Overall Study|Protocol Violation|2
7138423|NCT02943564|11291603|FG002|Overall Study|Protocol Violation|2
7138424|NCT02943564|11291601|FG000|Overall Study|Lost to Follow-up|1
7138425|NCT02943564|11291602|FG001|Overall Study|Lost to Follow-up|0
7138426|NCT02943564|11291603|FG002|Overall Study|Lost to Follow-up|0
7138427|NCT02943564|11291601|FG000|Overall Study|Withdrawal by Subject|6
6782678|NCT03848832|10778834|FG002|Overall Study|Withdrawal (Covid-19)|0
6782679|NCT03848832|10778832|FG000|Overall Study|Physician Decision|2
6782680|NCT03848832|10778833|FG001|Overall Study|Physician Decision|1
6782681|NCT03848832|10778834|FG002|Overall Study|Physician Decision|3
6782682|NCT03848832|10778832|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0
6782683|NCT03848832|10778833|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0
6782684|NCT03848832|10778834|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1
6782685|NCT03848832|10778832|FG000|Overall Study|Adverse Event|1
6782686|NCT03848832|10778833|FG001|Overall Study|Adverse Event|0
6782687|NCT03848832|10778834|FG002|Overall Study|Adverse Event|0
6782688|NCT03656744|10778856|FG000|Overall Study|Adverse Event|1
6782689|NCT03656744|10778857|FG001|Overall Study|Adverse Event|4
6782690|NCT03656744|10778858|FG002|Overall Study|Adverse Event|1
6782691|NCT03656744|10778856|FG000|Overall Study|Protocol Violation|1
6782692|NCT03656744|10778857|FG001|Overall Study|Protocol Violation|0
6782693|NCT03656744|10778858|FG002|Overall Study|Protocol Violation|0
6782694|NCT03656744|10778856|FG000|Overall Study|Lost to Follow-up|2
6782695|NCT03656744|10778857|FG001|Overall Study|Lost to Follow-up|2
6782696|NCT03656744|10778858|FG002|Overall Study|Lost to Follow-up|0
6782697|NCT03656744|10778856|FG000|Overall Study|Withdrawal by Subject|0
6782698|NCT03656744|10778857|FG001|Overall Study|Withdrawal by Subject|1
6782699|NCT03656744|10778858|FG002|Overall Study|Withdrawal by Subject|0
6782700|NCT03656744|10778856|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1
6782701|NCT03656744|10778857|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0
6782702|NCT03656744|10778858|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0
6782703|NCT03510598|10778866|FG000|Overall Study|Withdrawal by Subject|1
6782704|NCT03487796|10778874|FG000|Overall Study|Lost to Follow-up|18
6782705|NCT03487796|10778875|FG001|Overall Study|Lost to Follow-up|6
6782706|NCT03446612|10778889|FG000|Overall Study|Protocol defined stopping criteria|0
6782707|NCT03446612|10778890|FG001|Overall Study|Protocol defined stopping criteria|1
6782708|NCT03370120|10778911|FG000|Overall Study|Adverse event, non-fatal|24
6782709|NCT03370120|10778911|FG000|Overall Study|Withdrawal by Subject|6
6782710|NCT03370120|10778911|FG000|Overall Study|Lost to Follow-up|1
6782711|NCT03370120|10778911|FG000|Overall Study|Lack of Efficacy|37
6782712|NCT03370120|10778911|FG000|Overall Study|Per sponsor's instructions|1
6782713|NCT03370120|10778911|FG000|Overall Study|Study was terminated by parent company UCB|2
7138428|NCT02943564|11291602|FG001|Overall Study|Withdrawal by Subject|5
7138429|NCT02943564|11291603|FG002|Overall Study|Withdrawal by Subject|2
7138430|NCT02943564|11291601|FG000|Overall Study|Adverse Event|1
7138431|NCT02943564|11291602|FG001|Overall Study|Adverse Event|2
7138432|NCT02943564|11291603|FG002|Overall Study|Adverse Event|1
7138433|NCT02943564|11291601|FG000|Overall Study|Lack of Efficacy|0
7138434|NCT02943564|11291602|FG001|Overall Study|Lack of Efficacy|1
7138435|NCT02943564|11291603|FG002|Overall Study|Lack of Efficacy|0
7138436|NCT02943577|11291613|FG000|Overall Study|Protocol Violation|0
7138437|NCT02943577|11291614|FG001|Overall Study|Protocol Violation|1
7138438|NCT02943577|11291613|FG000|Overall Study|Adverse Event|3
7138439|NCT02943577|11291614|FG001|Overall Study|Adverse Event|2
7138440|NCT02943577|11291613|FG000|Overall Study|Lost to Follow-up|0
7138441|NCT02943577|11291614|FG001|Overall Study|Lost to Follow-up|1
7138442|NCT02943577|11291613|FG000|Overall Study|Withdrawal by Subject|1
7138443|NCT02943577|11291614|FG001|Overall Study|Withdrawal by Subject|1
7138444|NCT02943577|11291613|FG000|Overall Study|Pregnancy|1
7138445|NCT02943577|11291614|FG001|Overall Study|Pregnancy|0
7138446|NCT02943668|11291620|FG000|Overall Study|Disease Progression|1
7138447|NCT02944383|11291635|FG000|Overall Study|Lost to Follow-up|0
7138448|NCT02944383|11291636|FG001|Overall Study|Lost to Follow-up|0
7138449|NCT02944383|11291637|FG002|Overall Study|Lost to Follow-up|1
7138450|NCT02944383|11291635|FG000|Overall Study|Withdrawal by Subject|1
7138451|NCT02944383|11291636|FG001|Overall Study|Withdrawal by Subject|0
7138452|NCT02944383|11291637|FG002|Overall Study|Withdrawal by Subject|0
7138453|NCT02944448|11291649|FG000|Overall Study|Adverse Event|37
7138454|NCT02944448|11291650|FG001|Overall Study|Adverse Event|6
7138455|NCT02944448|11291649|FG000|Overall Study|Lack of Efficacy|8
7138456|NCT02944448|11291650|FG001|Overall Study|Lack of Efficacy|5
7138457|NCT02944448|11291649|FG000|Overall Study|Lost to Follow-up|3
7138458|NCT02944448|11291650|FG001|Overall Study|Lost to Follow-up|1
7138459|NCT02944448|11291649|FG000|Overall Study|Protocol Violation|25
7138460|NCT02944448|11291650|FG001|Overall Study|Protocol Violation|7
7138461|NCT02944448|11291649|FG000|Overall Study|Withdrawal by Subject|14
7138462|NCT02944448|11291650|FG001|Overall Study|Withdrawal by Subject|4
7138463|NCT02944448|11291649|FG000|Overall Study|Sponsor did not supply drug in time|0
7138464|NCT02944448|11291650|FG001|Overall Study|Sponsor did not supply drug in time|1
7138465|NCT02944448|11291649|FG000|Overall Study|Noncompliant with dosing|1
7138466|NCT02944448|11291650|FG001|Overall Study|Noncompliant with dosing|0
7138467|NCT02944448|11291649|FG000|Overall Study|Abnormal laboratory values|1
7138468|NCT02944448|11291650|FG001|Overall Study|Abnormal laboratory values|0
7138469|NCT02944656|11291668|FG000|Overall Study|No longer eligible|3
7138470|NCT02944656|11291669|FG001|Overall Study|No longer eligible|0
7138471|NCT02944656|11291668|FG000|Overall Study|Lost to Follow-up|7
7138472|NCT02944656|11291669|FG001|Overall Study|Lost to Follow-up|10
7138473|NCT02944968|11291675|FG000|Overall Study|Subject excluded before study procedure|1
6782714|NCT03370120|10778911|FG000|Overall Study|The study was ended by the promoter|3
6782715|NCT03370120|10778911|FG000|Overall Study|Discontinuation of drug development|3
6782716|NCT03370120|10778911|FG000|Overall Study|End of project|2
6782717|NCT03370120|10778911|FG000|Overall Study|Premature study closure|2
6782718|NCT03370120|10778911|FG000|Overall Study|Premature program termination|1
6782719|NCT03370120|10778911|FG000|Overall Study|Premature study termination|7
6782720|NCT03370120|10778911|FG000|Overall Study|Trial terminated by sponsor|2
6782721|NCT03370120|10778911|FG000|Overall Study|Trial discontinued by sponsor|2
6782722|NCT03370120|10778911|FG000|Overall Study|Study ended|15
6782723|NCT03370120|10778911|FG000|Overall Study|Clinical trial has been cancelled|1
6782724|NCT03370120|10778911|FG000|Overall Study|End of study per sponsor decision|2
6782725|NCT03370120|10778911|FG000|Overall Study|Promoter's decision|2
6782726|NCT03370120|10778911|FG000|Overall Study|The trial has been suspended|3
6782727|NCT03370120|10778911|FG000|Overall Study|Sponsor stopped PSL development based on data|3
6782728|NCT03370120|10778911|FG000|Overall Study|Early termination by order of sponsor|2
6782729|NCT03370120|10778911|FG000|Overall Study|Discontinuation of the study|5
6782730|NCT03370120|10778911|FG000|Overall Study|End of clinical trial discontinuation|1
6782731|NCT03370120|10778911|FG000|Overall Study|Because the clinical trial ended halfway|4
6782732|NCT03370120|10778911|FG000|Overall Study|Development discontinued|5
6782733|NCT03370120|10778911|FG000|Overall Study|Padsenovil program closed|3
6782734|NCT03370120|10778911|FG000|Overall Study|End of project|2
6782735|NCT03370120|10778911|FG000|Overall Study|Termination of project|1
6782736|NCT03370120|10778911|FG000|Overall Study|The study was interrupted by sponsor|4
6782737|NCT03370120|10778911|FG000|Overall Study|The protocol was interrupted by sponsor|1
6782738|NCT03370120|10778911|FG000|Overall Study|End of sponsor decision|1
6782739|NCT03370120|10778911|FG000|Overall Study|The study was terminated prematurely by study lead|1
6782740|NCT03370120|10778911|FG000|Overall Study|Early termination of studies|5
6782741|NCT03370120|10778911|FG000|Overall Study|This study is ended early|1
6782742|NCT03370120|10778911|FG000|Overall Study|End of padsevonil program|2
6782743|NCT03370120|10778911|FG000|Overall Study|Decision of sponsor|6
6782744|NCT03370120|10778911|FG000|Overall Study|Asked by the sponsor|3
6782745|NCT03370120|10778911|FG000|Overall Study|Sponsor decision to stop the protocol|1
6782746|NCT03370120|10778911|FG000|Overall Study|PI decision poor compliance from participant|1
6782747|NCT03370120|10778911|FG000|Overall Study|Promoter ended the study|3
6782748|NCT03370120|10778911|FG000|Overall Study|Premature study close by sponsor's decision|4
6782749|NCT03370120|10778911|FG000|Overall Study|Study terminated by sponsor|33
6782750|NCT03370120|10778911|FG000|Overall Study|Sponsor prematurely terminated this study|2
6782751|NCT03370120|10778911|FG000|Overall Study|Sponsor decision to terminate study|63
6782752|NCT03370120|10778911|FG000|Overall Study|Program closure|3
6782753|NCT03370120|10778911|FG000|Overall Study|Study ended prematurely|1
6782754|NCT03370120|10778911|FG000|Overall Study|Study stopped by sponsor|2
6782755|NCT03370120|10778911|FG000|Overall Study|Program termination|55
6782756|NCT03370120|10778911|FG000|Overall Study|Sponsor decision|62
6782757|NCT03370120|10778911|FG000|Overall Study|Sponsor study closure|10
6782758|NCT03143829|10778934|FG000|Overall Study|Withdrawal by Subject|2
6782759|NCT03143829|10778935|FG001|Overall Study|Withdrawal by Subject|5
6782760|NCT03143829|10778934|FG000|Overall Study|Lost to Follow-up|0
6782761|NCT03143829|10778935|FG001|Overall Study|Lost to Follow-up|2
6782762|NCT03143829|10778934|FG000|Overall Study|Death|1
6782763|NCT03143829|10778935|FG001|Overall Study|Death|1
6782764|NCT03143829|10778934|FG000|Overall Study|changed treatment, no longer eligible|2
6782765|NCT03143829|10778935|FG001|Overall Study|changed treatment, no longer eligible|2
6782766|NCT02963610|10778950|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3
6782767|NCT02766335|10778957|FG000|Initial Registration|Adverse Event|6
6782768|NCT02766335|10778958|FG001|Initial Registration|Adverse Event|3
6782769|NCT02766335|10778959|FG002|Initial Registration|Adverse Event|0
6782770|NCT02766335|10778957|FG000|Initial Registration|Refusal unrelated to adverse event|1
6782771|NCT02766335|10778958|FG001|Initial Registration|Refusal unrelated to adverse event|0
6782772|NCT02766335|10778959|FG002|Initial Registration|Refusal unrelated to adverse event|0
6782773|NCT02766335|10778957|FG000|Initial Registration|Progression/relapse|49
6782774|NCT02766335|10778958|FG001|Initial Registration|Progression/relapse|15
6782775|NCT02766335|10778959|FG002|Initial Registration|Progression/relapse|0
6782776|NCT02766335|10778957|FG000|Initial Registration|Death|1
6782777|NCT02766335|10778958|FG001|Initial Registration|Death|3
6782778|NCT02766335|10778959|FG002|Initial Registration|Death|0
6782779|NCT02766335|10778957|FG000|Initial Registration|not protocol specified|1
6782780|NCT02766335|10778958|FG001|Initial Registration|not protocol specified|9
6782781|NCT02766335|10778959|FG002|Initial Registration|not protocol specified|0
6782782|NCT02766335|10778957|FG000|Re-registration of Arm I to MEDI4738|Death|0
6782783|NCT02766335|10778958|FG001|Re-registration of Arm I to MEDI4738|Death|0
6782784|NCT02766335|10778959|FG002|Re-registration of Arm I to MEDI4738|Death|1
6782785|NCT02766335|10778957|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0
6782786|NCT02766335|10778958|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0
6782787|NCT02766335|10778959|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1
6806720|NCT02586025|10809410|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0
6806721|NCT02586025|10809409|FG000|Neoadjuvant Treatment|Death|1
6806722|NCT02586025|10809410|FG001|Neoadjuvant Treatment|Death|0
6782788|NCT02606136|10778965|FG000|Overall Study|Participant/Legal Guardian Decision|5
6782789|NCT02606136|10778965|FG000|Overall Study|Withdrawal by Subject|1
6782790|NCT02228382|10778974|FG000|Overall Study|Death|5
6782791|NCT02228382|10778975|FG001|Overall Study|Death|7
6782792|NCT02228382|10778976|FG002|Overall Study|Death|5
6782793|NCT02228382|10778977|FG003|Overall Study|Death|0
6782794|NCT02228382|10778978|FG004|Overall Study|Death|2
6782795|NCT02228382|10778974|FG000|Overall Study|Participant refused further follow-up|0
6782796|NCT02228382|10778975|FG001|Overall Study|Participant refused further follow-up|0
6782797|NCT02228382|10778976|FG002|Overall Study|Participant refused further follow-up|1
6782798|NCT02228382|10778977|FG003|Overall Study|Participant refused further follow-up|0
6782799|NCT02228382|10778978|FG004|Overall Study|Participant refused further follow-up|0
6782800|NCT02228382|10778974|FG000|Overall Study|Study terminated by sponsor|3
6782801|NCT02228382|10778975|FG001|Overall Study|Study terminated by sponsor|5
6782802|NCT02228382|10778976|FG002|Overall Study|Study terminated by sponsor|7
6782803|NCT02228382|10778977|FG003|Overall Study|Study terminated by sponsor|0
6782804|NCT02228382|10778978|FG004|Overall Study|Study terminated by sponsor|0
6782805|NCT02228382|10778974|FG000|Overall Study|Lost to Follow-up|0
6782806|NCT02228382|10778975|FG001|Overall Study|Lost to Follow-up|0
6782807|NCT02228382|10778976|FG002|Overall Study|Lost to Follow-up|3
6782808|NCT02228382|10778977|FG003|Overall Study|Lost to Follow-up|1
6782809|NCT02228382|10778978|FG004|Overall Study|Lost to Follow-up|0
6782810|NCT02228382|10778974|FG000|Overall Study|Withdrawal by Subject|0
6782811|NCT02228382|10778975|FG001|Overall Study|Withdrawal by Subject|3
6782812|NCT02228382|10778976|FG002|Overall Study|Withdrawal by Subject|2
6782813|NCT02228382|10778977|FG003|Overall Study|Withdrawal by Subject|1
6782814|NCT02228382|10778978|FG004|Overall Study|Withdrawal by Subject|0
6782815|NCT02228382|10778974|FG000|Overall Study|Other|2
6782816|NCT02228382|10778975|FG001|Overall Study|Other|3
6782817|NCT02228382|10778976|FG002|Overall Study|Other|3
6782818|NCT02228382|10778977|FG003|Overall Study|Other|0
6782819|NCT02228382|10778978|FG004|Overall Study|Other|0
6782820|NCT02001623|10779028|FG000|Overall Study|Disease Progression|2
6782821|NCT02001623|10779029|FG001|Overall Study|Disease Progression|2
6782822|NCT02001623|10779030|FG002|Overall Study|Disease Progression|3
6782823|NCT02001623|10779031|FG003|Overall Study|Disease Progression|2
6782824|NCT02001623|10779032|FG004|Overall Study|Disease Progression|3
6782825|NCT02001623|10779033|FG005|Overall Study|Disease Progression|2
6782826|NCT02001623|10779034|FG006|Overall Study|Disease Progression|3
6782827|NCT02001623|10779035|FG007|Overall Study|Disease Progression|3
6782828|NCT02001623|10779036|FG008|Overall Study|Disease Progression|7
6782829|NCT02001623|10779037|FG009|Overall Study|Disease Progression|40
6782830|NCT02001623|10779038|FG010|Overall Study|Disease Progression|5
6782831|NCT02001623|10779039|FG011|Overall Study|Disease Progression|9
6782832|NCT02001623|10779040|FG012|Overall Study|Disease Progression|9
6782833|NCT02001623|10779041|FG013|Overall Study|Disease Progression|20
6782834|NCT02001623|10779042|FG014|Overall Study|Disease Progression|9
6782835|NCT02001623|10779028|FG000|Overall Study|Physician Decision|0
6782836|NCT02001623|10779029|FG001|Overall Study|Physician Decision|0
6782837|NCT02001623|10779030|FG002|Overall Study|Physician Decision|0
6782838|NCT02001623|10779031|FG003|Overall Study|Physician Decision|0
6782839|NCT02001623|10779032|FG004|Overall Study|Physician Decision|0
6782840|NCT02001623|10779033|FG005|Overall Study|Physician Decision|0
6782841|NCT02001623|10779034|FG006|Overall Study|Physician Decision|0
6782842|NCT02001623|10779035|FG007|Overall Study|Physician Decision|0
6782843|NCT02001623|10779036|FG008|Overall Study|Physician Decision|3
6782844|NCT02001623|10779037|FG009|Overall Study|Physician Decision|2
6782845|NCT02001623|10779038|FG010|Overall Study|Physician Decision|3
6782846|NCT02001623|10779039|FG011|Overall Study|Physician Decision|3
6782847|NCT02001623|10779040|FG012|Overall Study|Physician Decision|1
6782848|NCT02001623|10779041|FG013|Overall Study|Physician Decision|2
6782849|NCT02001623|10779042|FG014|Overall Study|Physician Decision|1
6782850|NCT02001623|10779028|FG000|Overall Study|Death|0
6782851|NCT02001623|10779029|FG001|Overall Study|Death|1
6782852|NCT02001623|10779030|FG002|Overall Study|Death|0
6782853|NCT02001623|10779031|FG003|Overall Study|Death|0
6782854|NCT02001623|10779032|FG004|Overall Study|Death|0
6782855|NCT02001623|10779033|FG005|Overall Study|Death|0
6782856|NCT02001623|10779034|FG006|Overall Study|Death|0
6782857|NCT02001623|10779035|FG007|Overall Study|Death|0
6782858|NCT02001623|10779036|FG008|Overall Study|Death|0
6782859|NCT02001623|10779037|FG009|Overall Study|Death|0
6782860|NCT02001623|10779038|FG010|Overall Study|Death|0
6782861|NCT02001623|10779039|FG011|Overall Study|Death|0
6782862|NCT02001623|10779040|FG012|Overall Study|Death|0
6782863|NCT02001623|10779041|FG013|Overall Study|Death|0
6782864|NCT02001623|10779042|FG014|Overall Study|Death|0
6782865|NCT02001623|10779028|FG000|Overall Study|Adverse Event|0
6782866|NCT02001623|10779029|FG001|Overall Study|Adverse Event|0
6782867|NCT02001623|10779030|FG002|Overall Study|Adverse Event|0
6782868|NCT02001623|10779031|FG003|Overall Study|Adverse Event|0
6782869|NCT02001623|10779032|FG004|Overall Study|Adverse Event|0
6782870|NCT02001623|10779033|FG005|Overall Study|Adverse Event|1
6782871|NCT02001623|10779034|FG006|Overall Study|Adverse Event|0
6782872|NCT02001623|10779035|FG007|Overall Study|Adverse Event|3
6782873|NCT02001623|10779036|FG008|Overall Study|Adverse Event|4
6782874|NCT02001623|10779037|FG009|Overall Study|Adverse Event|6
6782875|NCT02001623|10779038|FG010|Overall Study|Adverse Event|4
6782876|NCT02001623|10779039|FG011|Overall Study|Adverse Event|0
6782877|NCT02001623|10779040|FG012|Overall Study|Adverse Event|3
6782878|NCT02001623|10779041|FG013|Overall Study|Adverse Event|5
6782879|NCT02001623|10779042|FG014|Overall Study|Adverse Event|6
6782880|NCT02001623|10779028|FG000|Overall Study|Other - Miscellaneous|0
6782881|NCT02001623|10779029|FG001|Overall Study|Other - Miscellaneous|0
6782882|NCT02001623|10779030|FG002|Overall Study|Other - Miscellaneous|0
6782883|NCT02001623|10779031|FG003|Overall Study|Other - Miscellaneous|0
6782884|NCT02001623|10779032|FG004|Overall Study|Other - Miscellaneous|0
6782885|NCT02001623|10779033|FG005|Overall Study|Other - Miscellaneous|0
6782886|NCT02001623|10779034|FG006|Overall Study|Other - Miscellaneous|0
6782887|NCT02001623|10779035|FG007|Overall Study|Other - Miscellaneous|0
6782888|NCT02001623|10779036|FG008|Overall Study|Other - Miscellaneous|0
6782889|NCT02001623|10779037|FG009|Overall Study|Other - Miscellaneous|1
6782890|NCT02001623|10779038|FG010|Overall Study|Other - Miscellaneous|0
6782891|NCT02001623|10779039|FG011|Overall Study|Other - Miscellaneous|0
6782892|NCT02001623|10779040|FG012|Overall Study|Other - Miscellaneous|0
6782893|NCT02001623|10779041|FG013|Overall Study|Other - Miscellaneous|1
6782894|NCT02001623|10779042|FG014|Overall Study|Other - Miscellaneous|0
6782895|NCT02001623|10779028|FG000|Overall Study|Withdrawal by Subject|1
6782896|NCT02001623|10779029|FG001|Overall Study|Withdrawal by Subject|0
6782897|NCT02001623|10779030|FG002|Overall Study|Withdrawal by Subject|0
7138474|NCT02944968|11291675|FG000|Overall Study|Subject didn't meet eligibility criteria|2
7138475|NCT02945046|11291682|FG000|Overall Study|Adverse Event|1
7138476|NCT02945046|11291683|FG001|Overall Study|Adverse Event|0
7138477|NCT02945046|11291684|FG002|Overall Study|Adverse Event|2
7138478|NCT02945046|11291682|FG000|Overall Study|Withdrawal by Subject|3
7138479|NCT02945046|11291683|FG001|Overall Study|Withdrawal by Subject|3
7138480|NCT02945046|11291684|FG002|Overall Study|Withdrawal by Subject|3
7138481|NCT02945046|11291682|FG000|Overall Study|Protocol Violation|2
7138482|NCT02945046|11291683|FG001|Overall Study|Protocol Violation|3
7138483|NCT02945046|11291684|FG002|Overall Study|Protocol Violation|2
7138484|NCT02945046|11291682|FG000|Overall Study|Lost to Follow-up|1
7138485|NCT02945046|11291683|FG001|Overall Study|Lost to Follow-up|1
7138486|NCT02945046|11291684|FG002|Overall Study|Lost to Follow-up|0
7138487|NCT02945046|11291682|FG000|Overall Study|Lack of Efficacy|1
7138488|NCT02945046|11291683|FG001|Overall Study|Lack of Efficacy|2
7138489|NCT02945046|11291684|FG002|Overall Study|Lack of Efficacy|1
7138490|NCT02945046|11291682|FG000|Overall Study|Other than specified|5
7138491|NCT02945046|11291683|FG001|Overall Study|Other than specified|4
7138492|NCT02945046|11291684|FG002|Overall Study|Other than specified|7
7138493|NCT02945254|11291698|FG000|Overall Study|Lost to Follow-up|1
7138494|NCT02945254|11291699|FG001|Overall Study|Lost to Follow-up|0
7138495|NCT02945254|11291698|FG000|Overall Study|Withdrawal by Subject|1
7138496|NCT02945254|11291699|FG001|Overall Study|Withdrawal by Subject|0
7138497|NCT02945410|11291711|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0
7138498|NCT02945410|11291712|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3
7138499|NCT02945410|11291713|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0
7138500|NCT02945410|11291714|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0
7138501|NCT02945410|11291715|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0
7138502|NCT02945410|11291716|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0
7138503|NCT02945410|11291711|FG000|Intervention 1 (5 Days)|Adverse Event|1
7138504|NCT02945410|11291712|FG001|Intervention 1 (5 Days)|Adverse Event|0
7138505|NCT02945410|11291713|FG002|Intervention 1 (5 Days)|Adverse Event|0
7138506|NCT02945410|11291714|FG003|Intervention 1 (5 Days)|Adverse Event|0
7138507|NCT02945410|11291715|FG004|Intervention 1 (5 Days)|Adverse Event|0
7138508|NCT02945410|11291716|FG005|Intervention 1 (5 Days)|Adverse Event|1
7138509|NCT02945410|11291711|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0
7138510|NCT02945410|11291712|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0
7138511|NCT02945410|11291713|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2
7138512|NCT02945410|11291714|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0
7138513|NCT02945410|11291715|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1
7138514|NCT02945410|11291716|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0
7138515|NCT02945657|11291737|FG000|Overall Study|Adverse Event|1
7138516|NCT02945657|11291737|FG000|Overall Study|Withdrawal by Parent/Guardian|3
7138517|NCT02946385|11291793|FG000|Overall Study|Lost to Follow-up|0
7138518|NCT02946385|11291794|FG001|Overall Study|Lost to Follow-up|0
7138519|NCT02946385|11291795|FG002|Overall Study|Lost to Follow-up|3
7138520|NCT02946385|11291796|FG003|Overall Study|Lost to Follow-up|0
6782898|NCT02001623|10779031|FG003|Overall Study|Withdrawal by Subject|0
6782899|NCT02001623|10779032|FG004|Overall Study|Withdrawal by Subject|0
6782900|NCT02001623|10779033|FG005|Overall Study|Withdrawal by Subject|0
6782901|NCT02001623|10779034|FG006|Overall Study|Withdrawal by Subject|0
6782902|NCT02001623|10779035|FG007|Overall Study|Withdrawal by Subject|0
6782903|NCT02001623|10779036|FG008|Overall Study|Withdrawal by Subject|1
6782904|NCT02001623|10779037|FG009|Overall Study|Withdrawal by Subject|3
6782905|NCT02001623|10779038|FG010|Overall Study|Withdrawal by Subject|2
6782906|NCT02001623|10779039|FG011|Overall Study|Withdrawal by Subject|2
6782907|NCT02001623|10779040|FG012|Overall Study|Withdrawal by Subject|1
6782908|NCT02001623|10779041|FG013|Overall Study|Withdrawal by Subject|5
6782909|NCT02001623|10779042|FG014|Overall Study|Withdrawal by Subject|2
6782910|NCT02001623|10779028|FG000|Overall Study|Lost to Follow-up|0
6782911|NCT02001623|10779029|FG001|Overall Study|Lost to Follow-up|0
6782912|NCT02001623|10779030|FG002|Overall Study|Lost to Follow-up|0
6782913|NCT02001623|10779031|FG003|Overall Study|Lost to Follow-up|0
6782914|NCT02001623|10779032|FG004|Overall Study|Lost to Follow-up|0
6782915|NCT02001623|10779033|FG005|Overall Study|Lost to Follow-up|0
6782916|NCT02001623|10779034|FG006|Overall Study|Lost to Follow-up|0
6782917|NCT02001623|10779035|FG007|Overall Study|Lost to Follow-up|0
6782918|NCT02001623|10779036|FG008|Overall Study|Lost to Follow-up|0
6782919|NCT02001623|10779037|FG009|Overall Study|Lost to Follow-up|1
6782920|NCT02001623|10779038|FG010|Overall Study|Lost to Follow-up|0
6782921|NCT02001623|10779039|FG011|Overall Study|Lost to Follow-up|0
6782922|NCT02001623|10779040|FG012|Overall Study|Lost to Follow-up|0
6782923|NCT02001623|10779041|FG013|Overall Study|Lost to Follow-up|0
6782924|NCT02001623|10779042|FG014|Overall Study|Lost to Follow-up|0
6782925|NCT02001623|10779028|FG000|Overall Study|Start of New Anti-cancer Treatment|0
6782926|NCT02001623|10779029|FG001|Overall Study|Start of New Anti-cancer Treatment|0
6782927|NCT02001623|10779030|FG002|Overall Study|Start of New Anti-cancer Treatment|0
6782928|NCT02001623|10779031|FG003|Overall Study|Start of New Anti-cancer Treatment|0
6782929|NCT02001623|10779032|FG004|Overall Study|Start of New Anti-cancer Treatment|0
6782930|NCT02001623|10779033|FG005|Overall Study|Start of New Anti-cancer Treatment|0
6782931|NCT02001623|10779034|FG006|Overall Study|Start of New Anti-cancer Treatment|0
6782932|NCT02001623|10779035|FG007|Overall Study|Start of New Anti-cancer Treatment|0
6782933|NCT02001623|10779036|FG008|Overall Study|Start of New Anti-cancer Treatment|0
6782934|NCT02001623|10779037|FG009|Overall Study|Start of New Anti-cancer Treatment|0
6782935|NCT02001623|10779038|FG010|Overall Study|Start of New Anti-cancer Treatment|0
6782936|NCT02001623|10779039|FG011|Overall Study|Start of New Anti-cancer Treatment|1
6782937|NCT02001623|10779040|FG012|Overall Study|Start of New Anti-cancer Treatment|0
6782938|NCT02001623|10779041|FG013|Overall Study|Start of New Anti-cancer Treatment|1
6782939|NCT02001623|10779042|FG014|Overall Study|Start of New Anti-cancer Treatment|0
6782940|NCT02001623|10779028|FG000|Overall Study|Dose Delay Due to Toxicity|0
6782941|NCT02001623|10779029|FG001|Overall Study|Dose Delay Due to Toxicity|0
6782942|NCT02001623|10779030|FG002|Overall Study|Dose Delay Due to Toxicity|0
6782943|NCT02001623|10779031|FG003|Overall Study|Dose Delay Due to Toxicity|0
6782944|NCT02001623|10779032|FG004|Overall Study|Dose Delay Due to Toxicity|0
6782945|NCT02001623|10779033|FG005|Overall Study|Dose Delay Due to Toxicity|0
6782946|NCT02001623|10779034|FG006|Overall Study|Dose Delay Due to Toxicity|0
6782947|NCT02001623|10779035|FG007|Overall Study|Dose Delay Due to Toxicity|0
6782948|NCT02001623|10779036|FG008|Overall Study|Dose Delay Due to Toxicity|0
6782949|NCT02001623|10779037|FG009|Overall Study|Dose Delay Due to Toxicity|0
6782950|NCT02001623|10779038|FG010|Overall Study|Dose Delay Due to Toxicity|0
6782951|NCT02001623|10779039|FG011|Overall Study|Dose Delay Due to Toxicity|0
6782952|NCT02001623|10779040|FG012|Overall Study|Dose Delay Due to Toxicity|0
6782953|NCT02001623|10779041|FG013|Overall Study|Dose Delay Due to Toxicity|1
6782954|NCT02001623|10779042|FG014|Overall Study|Dose Delay Due to Toxicity|0
6782955|NCT01900002|10779091|FG000|Overall Study|Withdrawal by Subject|2
6782956|NCT01900002|10779091|FG000|Overall Study|ineligible for Y-90|4
6782957|NCT01595061|10779095|FG000|Overall Study|Never Treated|3
6782958|NCT01595061|10779095|FG000|Overall Study|Inadequate Pathology|1
6806723|NCT02586025|10809409|FG000|Neoadjuvant Treatment|Adverse Event|1
6806724|NCT02586025|10809410|FG001|Neoadjuvant Treatment|Adverse Event|0
6806725|NCT02586025|10809409|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4
6806726|NCT02586025|10809410|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3
6806727|NCT02586025|10809409|FG000|Neoadjuvant Treatment|Physician Decision|2
6806728|NCT02586025|10809410|FG001|Neoadjuvant Treatment|Physician Decision|1
6806729|NCT02586025|10809409|FG000|Neoadjuvant Treatment|Progressive Disease|2
6806730|NCT02586025|10809410|FG001|Neoadjuvant Treatment|Progressive Disease|3
6806731|NCT02586025|10809409|FG000|Adjuvant Treatment|Remain in Adjuvant Treatment|133
6806732|NCT02586025|10809410|FG001|Adjuvant Treatment|Remain in Adjuvant Treatment|61
6806733|NCT02586025|10809409|FG000|Adjuvant Treatment|Withdrawal by Subject|5
6806734|NCT02586025|10809410|FG001|Adjuvant Treatment|Withdrawal by Subject|3
6806735|NCT02586025|10809409|FG000|Adjuvant Treatment|Physician Decision|0
6806736|NCT02586025|10809410|FG001|Adjuvant Treatment|Physician Decision|1
6806737|NCT02586025|10809409|FG000|Adjuvant Treatment|Recurrent Disease|1
6806738|NCT02586025|10809410|FG001|Adjuvant Treatment|Recurrent Disease|4
6806739|NCT02586025|10809409|FG000|Treatment-Free Follow-Up|Remain in Treatment-Free Follow-Up|56
6806740|NCT02586025|10809410|FG001|Treatment-Free Follow-Up|Remain in Treatment-Free Follow-Up|35
6806741|NCT02520011|10809419|FG000|Overall Study|Adverse Event|0
6806742|NCT02520011|10809420|FG001|Overall Study|Adverse Event|1
6806743|NCT02520011|10809421|FG002|Overall Study|Adverse Event|2
6806744|NCT02520011|10809419|FG000|Overall Study|Death|0
6806745|NCT02520011|10809420|FG001|Overall Study|Death|8
6806746|NCT02520011|10809421|FG002|Overall Study|Death|1
6806747|NCT02520011|10809419|FG000|Overall Study|Lack of Efficacy|4
6806748|NCT02520011|10809420|FG001|Overall Study|Lack of Efficacy|26
6806749|NCT02520011|10809421|FG002|Overall Study|Lack of Efficacy|4
6806750|NCT02520011|10809419|FG000|Overall Study|Physician Decision|0
6806751|NCT02520011|10809420|FG001|Overall Study|Physician Decision|2
6806752|NCT02520011|10809421|FG002|Overall Study|Physician Decision|0
6806753|NCT02520011|10809419|FG000|Overall Study|Withdrawal by Subject|1
6806754|NCT02520011|10809420|FG001|Overall Study|Withdrawal by Subject|3
6806755|NCT02520011|10809421|FG002|Overall Study|Withdrawal by Subject|0
6806756|NCT02520011|10809419|FG000|Overall Study|Protocol Deviation|0
6782959|NCT04502212|10779099|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1
6782960|NCT04502212|10779099|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1
6782961|NCT04794803|10779115|FG000|Overall Study|Death|1
6782962|NCT04794803|10779116|FG001|Overall Study|Death|3
6782963|NCT04794803|10779115|FG000|Overall Study|Lost to Follow-up|2
6782964|NCT04794803|10779116|FG001|Overall Study|Lost to Follow-up|2
6782965|NCT04794803|10779115|FG000|Overall Study|Withdrawal by Subject|1
6782966|NCT04794803|10779116|FG001|Overall Study|Withdrawal by Subject|0
6782967|NCT04794803|10779115|FG000|Overall Study|Physician Decision|1
6782968|NCT04794803|10779116|FG001|Overall Study|Physician Decision|1
6782969|NCT04794803|10779115|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4
6782970|NCT04794803|10779116|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1
6782971|NCT04794803|10779115|FG000|Overall Study|Refused to continue the treatment|1
6782972|NCT04794803|10779116|FG001|Overall Study|Refused to continue the treatment|0
6782973|NCT04794803|10779115|FG000|Overall Study|Patient admitted to ICU|0
6782974|NCT04794803|10779116|FG001|Overall Study|Patient admitted to ICU|1
6782975|NCT04706403|10779127|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0
6782976|NCT04706403|10779128|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0
6782977|NCT04706403|10779129|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1
6782978|NCT04706403|10779130|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1
6782979|NCT04706403|10779131|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2
6782980|NCT04440449|10779145|FG000|Overall Study|Lost to Follow-up|2
6782981|NCT04440449|10779146|FG001|Overall Study|Lost to Follow-up|0
6782982|NCT04369469|10779155|FG000|Overall Study|Lost to Follow-up|2
6782983|NCT04369469|10779156|FG001|Overall Study|Lost to Follow-up|4
6782984|NCT04369469|10779155|FG000|Overall Study|Physician Decision|2
6782985|NCT04369469|10779156|FG001|Overall Study|Physician Decision|1
6782986|NCT04369469|10779155|FG000|Overall Study|Withdrawal by Subject|2
6782987|NCT04369469|10779156|FG001|Overall Study|Withdrawal by Subject|3
6782988|NCT04369469|10779155|FG000|Overall Study|Adverse Event|1
6782989|NCT04369469|10779156|FG001|Overall Study|Adverse Event|0
6782990|NCT04369469|10779155|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2
6782991|NCT04369469|10779156|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0
6782992|NCT04369469|10779155|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1
6782993|NCT04369469|10779156|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0
6782994|NCT04369469|10779155|FG000|Overall Study|Unable to Provide Consent|0
6782995|NCT04369469|10779156|FG001|Overall Study|Unable to Provide Consent|1
7138521|NCT02946385|11291797|FG004|Overall Study|Lost to Follow-up|2
7138522|NCT02946385|11291798|FG005|Overall Study|Lost to Follow-up|1
7138523|NCT02946463|11291820|FG000|Primary Evaluation Period|Physician Decision|0
7138524|NCT02946463|11291821|FG001|Primary Evaluation Period|Physician Decision|1
7138525|NCT02946463|11291820|FG000|Primary Evaluation Period|Withdrawal by Subject|0
7138526|NCT02946463|11291821|FG001|Primary Evaluation Period|Withdrawal by Subject|1
7138527|NCT02946515|11291833|FG000|Overall Study|Lost to Follow-up|2
7138528|NCT02946515|11291834|FG001|Overall Study|Lost to Follow-up|1
6783004|NCT03965962|10779179|FG000|Overall Study|Adverse Event|1
6783005|NCT03965962|10779180|FG001|Overall Study|Adverse Event|0
6783006|NCT03965962|10779181|FG002|Overall Study|Adverse Event|0
6783007|NCT03965962|10779182|FG003|Overall Study|Adverse Event|0
6783008|NCT03965962|10779179|FG000|Overall Study|Protocol Violation|21
6783009|NCT03965962|10779180|FG001|Overall Study|Protocol Violation|4
6783010|NCT03965962|10779181|FG002|Overall Study|Protocol Violation|10
6783011|NCT03965962|10779182|FG003|Overall Study|Protocol Violation|5
6783012|NCT03965962|10779179|FG000|Overall Study|Lost to Follow-up|0
6783013|NCT03965962|10779180|FG001|Overall Study|Lost to Follow-up|1
6783014|NCT03965962|10779181|FG002|Overall Study|Lost to Follow-up|0
6783015|NCT03965962|10779182|FG003|Overall Study|Lost to Follow-up|0
6783016|NCT03965962|10779179|FG000|Overall Study|Withdrawal by Subject|3
6783017|NCT03965962|10779180|FG001|Overall Study|Withdrawal by Subject|0
6783018|NCT03965962|10779181|FG002|Overall Study|Withdrawal by Subject|0
6783019|NCT03965962|10779182|FG003|Overall Study|Withdrawal by Subject|1
6783020|NCT03772574|10779195|FG000|Overall Study|Protocol Violation|2
6783021|NCT03772574|10779196|FG001|Overall Study|Protocol Violation|0
6783022|NCT03772574|10779197|FG002|Overall Study|Protocol Violation|0
6783023|NCT03772574|10779195|FG000|Overall Study|Discomfort|0
6783024|NCT03772574|10779196|FG001|Overall Study|Discomfort|5
6783025|NCT03772574|10779197|FG002|Overall Study|Discomfort|4
6783026|NCT03694522|10779207|FG000|Overall Study|Ongoing|42
6783027|NCT03694522|10779208|FG001|Overall Study|Ongoing|27
6783028|NCT03694522|10779207|FG000|Overall Study|Withdrawal by Subject|6
6783029|NCT03694522|10779208|FG001|Overall Study|Withdrawal by Subject|10
6783030|NCT03694522|10779207|FG000|Overall Study|Death|28
6783031|NCT03694522|10779208|FG001|Overall Study|Death|40
6783032|NCT03694522|10779207|FG000|Overall Study|Other|1
6783033|NCT03694522|10779208|FG001|Overall Study|Other|1
7138529|NCT02946580|11291842|FG000|Overall Study|Withdrawal by Subject|1
7138530|NCT02946580|11291843|FG001|Overall Study|Withdrawal by Subject|2
7138531|NCT02946580|11291842|FG000|Overall Study|Adverse Event|0
7138532|NCT02946580|11291843|FG001|Overall Study|Adverse Event|2
7138533|NCT02946580|11291842|FG000|Overall Study|Did not undergo posterior spinal fusion|0
7138534|NCT02946580|11291843|FG001|Overall Study|Did not undergo posterior spinal fusion|1
7138535|NCT02946918|11291858|FG000|Overall Study|Patient unblinded himself|1
7138536|NCT02946918|11291859|FG001|Overall Study|Patient unblinded himself|0
7138537|NCT02946918|11291858|FG000|Overall Study|Physician Decision|0
7138538|NCT02946918|11291859|FG001|Overall Study|Physician Decision|2
7138539|NCT02946918|11291858|FG000|Overall Study|Ran out of study medication|0
7138540|NCT02946918|11291859|FG001|Overall Study|Ran out of study medication|1
6783044|NCT03594955|10779223|FG000|Overall Study|Adverse Event|1
6783045|NCT03594955|10779223|FG000|Overall Study|Progressive disease|5
6783046|NCT03594955|10779223|FG000|Overall Study|Sponsor's decision|1
6783047|NCT03548220|10779231|FG000|Overall Study|Lost to Follow-up|1
6783048|NCT03548220|10779232|FG001|Overall Study|Lost to Follow-up|0
6783049|NCT03548220|10779233|FG002|Overall Study|Lost to Follow-up|0
6783050|NCT03548220|10779234|FG003|Overall Study|Lost to Follow-up|0
7138541|NCT02948582|11291901|FG000|Washout Period 1|Adverse Event|0
7138542|NCT02948582|11291902|FG001|Washout Period 1|Adverse Event|2
7138543|NCT02948582|11291903|FG002|Washout Period 1|Adverse Event|0
7138544|NCT02948582|11291904|FG003|Washout Period 1|Adverse Event|0
7138545|NCT02948582|11291905|FG004|Washout Period 1|Adverse Event|0
7138546|NCT02948582|11291906|FG005|Washout Period 1|Adverse Event|0
7138547|NCT02948582|11291901|FG000|Washout Period 1|Protocol Violation|0
7138548|NCT02948582|11291902|FG001|Washout Period 1|Protocol Violation|0
7138549|NCT02948582|11291903|FG002|Washout Period 1|Protocol Violation|0
7138550|NCT02948582|11291904|FG003|Washout Period 1|Protocol Violation|0
7138551|NCT02948582|11291905|FG004|Washout Period 1|Protocol Violation|0
7138552|NCT02948582|11291906|FG005|Washout Period 1|Protocol Violation|1
7138553|NCT02948582|11291901|FG000|Washout Period 2|Adverse Event|0
7138554|NCT02948582|11291902|FG001|Washout Period 2|Adverse Event|1
7138555|NCT02948582|11291903|FG002|Washout Period 2|Adverse Event|0
6783067|NCT03434041|10779269|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1
6783068|NCT03434041|10779270|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0
6783069|NCT03434041|10779269|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2
6783070|NCT03434041|10779270|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1
6783071|NCT03434041|10779269|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3
6783072|NCT03434041|10779270|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14
6783073|NCT03434041|10779269|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7
6783074|NCT03434041|10779270|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2
6783075|NCT03434041|10779269|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1
6783076|NCT03434041|10779270|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0
6783077|NCT03434041|10779269|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2
6783078|NCT03434041|10779270|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2
6783079|NCT03434041|10779269|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0
6783080|NCT03434041|10779270|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1
6783081|NCT03434041|10779269|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2
6783082|NCT03434041|10779270|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0
6783083|NCT03434041|10779269|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4
6783084|NCT03434041|10779270|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3
6783085|NCT03434041|10779269|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2
6783086|NCT03434041|10779270|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0
6783087|NCT03434041|10779269|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1
6783088|NCT03434041|10779270|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0
6783089|NCT03420222|10779280|FG000|Overall Study|Withdrawal by Subject|5
6783090|NCT03420222|10779281|FG001|Overall Study|Withdrawal by Subject|0
6783091|NCT03420222|10779280|FG000|Overall Study|Physician Decision|0
6783092|NCT03420222|10779281|FG001|Overall Study|Physician Decision|1
6783093|NCT03409796|10779289|FG000|Overall Study|Adverse Event|2
6783094|NCT03409796|10779290|FG001|Overall Study|Adverse Event|0
6783095|NCT03409796|10779289|FG000|Overall Study|Other|0
6783096|NCT03409796|10779290|FG001|Overall Study|Other|1
6783097|NCT03215706|10779298|FG000|Randomization|Adverse Event unrelated to study drug|1
6783098|NCT03215706|10779299|FG001|Randomization|Adverse Event unrelated to study drug|0
6783099|NCT03215706|10779298|FG000|Randomization|participant withdrew consent|1
6783100|NCT03215706|10779299|FG001|Randomization|participant withdrew consent|3
6783101|NCT03215706|10779298|FG000|Randomization|no longer meets study criteria|1
6783102|NCT03215706|10779299|FG001|Randomization|no longer meets study criteria|4
6783103|NCT03215706|10779298|FG000|Randomization|other reasons|0
6783104|NCT03215706|10779299|FG001|Randomization|other reasons|2
6783105|NCT03215706|10779298|FG000|Treatment Period|Disease Progression|150
6783106|NCT03215706|10779299|FG001|Treatment Period|Disease Progression|142
6783107|NCT03215706|10779298|FG000|Treatment Period|Study Drug Toxicity|53
6783108|NCT03215706|10779299|FG001|Treatment Period|Study Drug Toxicity|21
6783109|NCT03215706|10779298|FG000|Treatment Period|Death|2
6783110|NCT03215706|10779299|FG001|Treatment Period|Death|1
6783111|NCT03215706|10779298|FG000|Treatment Period|Adverse event unrelated to study drug|24
6783112|NCT03215706|10779299|FG001|Treatment Period|Adverse event unrelated to study drug|23
6783113|NCT03215706|10779298|FG000|Treatment Period|Request to D/C treatment|1
6783114|NCT03215706|10779299|FG001|Treatment Period|Request to D/C treatment|6
6783115|NCT03215706|10779298|FG000|Treatment Period|Participant withdrew consent|3
6783116|NCT03215706|10779299|FG001|Treatment Period|Participant withdrew consent|4
6783117|NCT03215706|10779298|FG000|Treatment Period|Lost to Follow-up|0
6783118|NCT03215706|10779299|FG001|Treatment Period|Lost to Follow-up|1
6783119|NCT03215706|10779298|FG000|Treatment Period|Other Reasons|4
6783120|NCT03215706|10779299|FG001|Treatment Period|Other Reasons|5
6783121|NCT03215706|10779298|FG000|Treatment Period|Ongoing in the treatment period|105
6783122|NCT03215706|10779299|FG001|Treatment Period|Ongoing in the treatment period|43
6783123|NCT03144674|10779322|FG000|Overall Study|Participants Still Ongoing in the Study|1
6783124|NCT03144674|10779323|FG001|Overall Study|Participants Still Ongoing in the Study|4
6783125|NCT03144674|10779324|FG002|Overall Study|Participants Still Ongoing in the Study|24
6783126|NCT03144674|10779325|FG003|Overall Study|Participants Still Ongoing in the Study|54
6783127|NCT03144674|10779322|FG000|Overall Study|Death|3
6783128|NCT03144674|10779323|FG001|Overall Study|Death|1
6783129|NCT03144674|10779324|FG002|Overall Study|Death|1
6783130|NCT03144674|10779325|FG003|Overall Study|Death|10
6783131|NCT03144674|10779322|FG000|Overall Study|Lost to Follow-up|0
6783132|NCT03144674|10779323|FG001|Overall Study|Lost to Follow-up|1
6783133|NCT03144674|10779324|FG002|Overall Study|Lost to Follow-up|1
6783134|NCT03144674|10779325|FG003|Overall Study|Lost to Follow-up|1
6783135|NCT03144674|10779322|FG000|Overall Study|Withdrawal by Participant|0
6783136|NCT03144674|10779323|FG001|Overall Study|Withdrawal by Participant|0
6783137|NCT03144674|10779324|FG002|Overall Study|Withdrawal by Participant|0
6783138|NCT03144674|10779325|FG003|Overall Study|Withdrawal by Participant|3
6783139|NCT03144674|10779322|FG000|Overall Study|Reason not Specified|0
6783140|NCT03144674|10779323|FG001|Overall Study|Reason not Specified|0
6783141|NCT03144674|10779324|FG002|Overall Study|Reason not Specified|2
6783142|NCT03144674|10779325|FG003|Overall Study|Reason not Specified|4
7138556|NCT02948582|11291904|FG003|Washout Period 2|Adverse Event|0
7138557|NCT02948582|11291905|FG004|Washout Period 2|Adverse Event|0
7138558|NCT02948582|11291906|FG005|Washout Period 2|Adverse Event|0
7138559|NCT02948582|11291901|FG000|Washout Period 2|personal reasons|0
7138560|NCT02948582|11291902|FG001|Washout Period 2|personal reasons|0
7138561|NCT02948582|11291903|FG002|Washout Period 2|personal reasons|0
7138562|NCT02948582|11291904|FG003|Washout Period 2|personal reasons|1
7138563|NCT02948582|11291905|FG004|Washout Period 2|personal reasons|0
7138564|NCT02948582|11291906|FG005|Washout Period 2|personal reasons|0
7138565|NCT02948582|11291901|FG000|Washout Period 4|Adverse Event|1
7138566|NCT02948582|11291902|FG001|Washout Period 4|Adverse Event|0
7138567|NCT02948582|11291903|FG002|Washout Period 4|Adverse Event|1
7138568|NCT02948582|11291904|FG003|Washout Period 4|Adverse Event|0
7138569|NCT02948582|11291905|FG004|Washout Period 4|Adverse Event|0
7138570|NCT02948582|11291906|FG005|Washout Period 4|Adverse Event|0
7138571|NCT02948634|11291922|FG000|Overall Study|Lack of efficacy and study suspended|10
7138572|NCT02948634|11291923|FG001|Overall Study|Lack of efficacy and study suspended|2
7138573|NCT02948777|11291929|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1
7138574|NCT02948829|11291934|FG000|Overall Study|Withdrawal by Subject|4
7138575|NCT02948829|11291934|FG000|Overall Study|Ongoing (at data cut-off date: 29 May 2018)|195
7138576|NCT02948829|11291934|FG000|Overall Study|Non-Compliance with Study Procedures|1
7138577|NCT02949011|11291956|FG000|Overall Study|Adverse Event|6
7138578|NCT02949011|11291957|FG001|Overall Study|Adverse Event|7
7138579|NCT02949011|11291958|FG002|Overall Study|Adverse Event|3
7138580|NCT02949011|11291956|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0
7138581|NCT02949011|11291957|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0
7138582|NCT02949011|11291958|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3
7138583|NCT02949011|11291956|FG000|Overall Study|Protocol Deviation|5
7138584|NCT02949011|11291957|FG001|Overall Study|Protocol Deviation|3
7138585|NCT02949011|11291958|FG002|Overall Study|Protocol Deviation|3
7138586|NCT02949011|11291956|FG000|Overall Study|Lack of Efficacy|0
7138587|NCT02949011|11291957|FG001|Overall Study|Lack of Efficacy|2
7138588|NCT02949011|11291958|FG002|Overall Study|Lack of Efficacy|0
7138589|NCT02949011|11291956|FG000|Overall Study|Withdrawal by Subject|13
7138590|NCT02949011|11291957|FG001|Overall Study|Withdrawal by Subject|13
7138591|NCT02949011|11291958|FG002|Overall Study|Withdrawal by Subject|21
7138592|NCT02949011|11291956|FG000|Overall Study|Lost to Follow-up|7
7138593|NCT02949011|11291957|FG001|Overall Study|Lost to Follow-up|5
7138594|NCT02949011|11291958|FG002|Overall Study|Lost to Follow-up|5
7138595|NCT02949011|11291956|FG000|Overall Study|Death|0
7138596|NCT02949011|11291957|FG001|Overall Study|Death|0
7138597|NCT02949011|11291958|FG002|Overall Study|Death|1
7138598|NCT02949011|11291956|FG000|Overall Study|Miscellaneous|2
7138599|NCT02949011|11291957|FG001|Overall Study|Miscellaneous|4
7138600|NCT02949011|11291958|FG002|Overall Study|Miscellaneous|6
7138601|NCT02949024|11291968|FG000|Overall Study|Withdrawal by Subject|0
7138602|NCT02949024|11291969|FG001|Overall Study|Withdrawal by Subject|1
7138603|NCT02949271|11291986|FG000|Overall Study|Lack of Efficacy|5
7138604|NCT02949271|11291987|FG001|Overall Study|Lack of Efficacy|4
7138605|NCT02949271|11291986|FG000|Overall Study|Lost to Follow-up|3
7138606|NCT02949271|11291987|FG001|Overall Study|Lost to Follow-up|6
6783194|NCT03093350|10779353|FG000|Overall Study|Death|1
7138607|NCT02949271|11291986|FG000|Overall Study|Physician Decision|5
7138608|NCT02949271|11291987|FG001|Overall Study|Physician Decision|5
7138609|NCT02949271|11291986|FG000|Overall Study|Protocol Violation|6
6783195|NCT03093350|10779353|FG000|Overall Study|Signed consent, never began treartment|1
6783196|NCT02999854|10779366|FG000|Active Study Phase (up to 18 Months)|Screen failures|7
6783197|NCT02999854|10779367|FG001|Active Study Phase (up to 18 Months)|Screen failures|2
6783198|NCT02999854|10779366|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8
6783199|NCT02999854|10779367|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2
6783200|NCT02999854|10779366|FG000|Active Study Phase (up to 18 Months)|Death|7
6783201|NCT02999854|10779367|FG001|Active Study Phase (up to 18 Months)|Death|5
6783202|NCT02999854|10779366|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1
6783203|NCT02999854|10779367|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0
6783204|NCT02999854|10779366|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1
6783205|NCT02999854|10779367|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0
6783206|NCT02999854|10779366|FG000|Long Term Safety FU (up to 24 Months)|Death|1
6783207|NCT02999854|10779367|FG001|Long Term Safety FU (up to 24 Months)|Death|1
6783208|NCT02999854|10779366|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1
6783209|NCT02999854|10779367|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1
6783210|NCT02999854|10779366|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1
6783211|NCT02999854|10779367|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1
6783212|NCT02960763|10779378|FG000|Step 1|Withdrawal by Subject|10
6783213|NCT02960763|10779379|FG001|Step 1|Withdrawal by Subject|8
6783214|NCT02960763|10779380|FG002|Step 1|Withdrawal by Subject|13
6783215|NCT02960763|10779381|FG003|Step 1|Withdrawal by Subject|0
6783216|NCT02960763|10779382|FG004|Step 1|Withdrawal by Subject|0
6783217|NCT02960763|10779378|FG000|Step 1|Lost to Follow-up|7
6783218|NCT02960763|10779379|FG001|Step 1|Lost to Follow-up|9
6783219|NCT02960763|10779380|FG002|Step 1|Lost to Follow-up|13
6783220|NCT02960763|10779381|FG003|Step 1|Lost to Follow-up|0
6783221|NCT02960763|10779382|FG004|Step 1|Lost to Follow-up|0
6783222|NCT02960763|10779378|FG000|Step 1|Death|1
6783223|NCT02960763|10779379|FG001|Step 1|Death|1
6783224|NCT02960763|10779380|FG002|Step 1|Death|1
6783225|NCT02960763|10779381|FG003|Step 1|Death|0
6783226|NCT02960763|10779382|FG004|Step 1|Death|0
6783227|NCT02960763|10779378|FG000|Step 1|Investigator discretion|1
6783228|NCT02960763|10779379|FG001|Step 1|Investigator discretion|0
6783229|NCT02960763|10779380|FG002|Step 1|Investigator discretion|1
6783230|NCT02960763|10779381|FG003|Step 1|Investigator discretion|0
6783231|NCT02960763|10779382|FG004|Step 1|Investigator discretion|0
6783232|NCT02960763|10779378|FG000|Step 2|Withdrawal by Subject|0
6783233|NCT02960763|10779379|FG001|Step 2|Withdrawal by Subject|0
6783234|NCT02960763|10779380|FG002|Step 2|Withdrawal by Subject|0
6783235|NCT02960763|10779381|FG003|Step 2|Withdrawal by Subject|7
6783236|NCT02960763|10779382|FG004|Step 2|Withdrawal by Subject|3
6783237|NCT02960763|10779378|FG000|Step 2|Lost to Follow-up|0
6783238|NCT02960763|10779379|FG001|Step 2|Lost to Follow-up|0
6783239|NCT02960763|10779380|FG002|Step 2|Lost to Follow-up|0
6783240|NCT02960763|10779381|FG003|Step 2|Lost to Follow-up|4
6783241|NCT02960763|10779382|FG004|Step 2|Lost to Follow-up|1
6783242|NCT02960763|10779378|FG000|Step 2|Investigator discretion|0
6783243|NCT02960763|10779379|FG001|Step 2|Investigator discretion|0
6783244|NCT02960763|10779380|FG002|Step 2|Investigator discretion|0
6783245|NCT02960763|10779381|FG003|Step 2|Investigator discretion|0
6783246|NCT02960763|10779382|FG004|Step 2|Investigator discretion|1
6783247|NCT02839343|10779396|FG000|Overall Study|Withdrawal by Subject|3
6783248|NCT02839343|10779397|FG001|Overall Study|Withdrawal by Subject|1
6783249|NCT02839343|10779396|FG000|Overall Study|Disease Progression Prior to Treatment|1
6783250|NCT02839343|10779397|FG001|Overall Study|Disease Progression Prior to Treatment|0
6783251|NCT02839343|10779396|FG000|Overall Study|Adverse Event|1
6783252|NCT02839343|10779397|FG001|Overall Study|Adverse Event|0
6783253|NCT02819479|10779403|FG000|Overall Study|Adverse Event|2
6806757|NCT02520011|10809420|FG001|Overall Study|Protocol Deviation|1
6806758|NCT02520011|10809421|FG002|Overall Study|Protocol Deviation|0
6806759|NCT02520011|10809419|FG000|Overall Study|Patient went to hospice|0
6806760|NCT02520011|10809420|FG001|Overall Study|Patient went to hospice|1
6806761|NCT02520011|10809421|FG002|Overall Study|Patient went to hospice|0
6806762|NCT02520011|10809419|FG000|Overall Study|Progressive disease following response|0
6806763|NCT02520011|10809420|FG001|Overall Study|Progressive disease following response|4
6806764|NCT02520011|10809421|FG002|Overall Study|Progressive disease following response|2
6806765|NCT02279719|10809458|FG000|Overall Study|Patients randomized but never treated|0
6806766|NCT02279719|10809459|FG001|Overall Study|Patients randomized but never treated|0
6806767|NCT02279719|10809460|FG002|Overall Study|Patients randomized but never treated|0
6806768|NCT02279719|10809461|FG003|Overall Study|Patients randomized but never treated|0
6806769|NCT02279719|10809462|FG004|Overall Study|Patients randomized but never treated|3
6806770|NCT02279719|10809463|FG005|Overall Study|Patients randomized but never treated|0
6806771|NCT02279719|10809464|FG006|Overall Study|Patients randomized but never treated|3
6806772|NCT02178956|10809499|FG000|Overall Study|Lost to Follow-up|4
6806773|NCT02178956|10809500|FG001|Overall Study|Lost to Follow-up|4
6806774|NCT02178956|10809499|FG000|Overall Study|Sponsor terminated study|49
6806775|NCT02178956|10809500|FG001|Overall Study|Sponsor terminated study|58
6806776|NCT02178956|10809499|FG000|Overall Study|Withdrawal by Subject|15
6806777|NCT02178956|10809500|FG001|Overall Study|Withdrawal by Subject|11
6806778|NCT02178956|10809499|FG000|Overall Study|Various Reasons|3
6783254|NCT02601313|10779411|FG000|Overall Study|Death|2
6783255|NCT02601313|10779412|FG001|Overall Study|Death|16
6783256|NCT02601313|10779413|FG002|Overall Study|Death|4
6783257|NCT02601313|10779411|FG000|Overall Study|Enrolled, did not initiate CTE/KTE-X19|0
6783258|NCT02601313|10779412|FG001|Overall Study|Enrolled, did not initiate CTE/KTE-X19|5
6783259|NCT02601313|10779413|FG002|Overall Study|Enrolled, did not initiate CTE/KTE-X19|2
6783260|NCT02601313|10779411|FG000|Overall Study|Enrolled, did not initiate KTE-X19|0
6783261|NCT02601313|10779412|FG001|Overall Study|Enrolled, did not initiate KTE-X19|1
6783262|NCT02601313|10779413|FG002|Overall Study|Enrolled, did not initiate KTE-X19|1
6783263|NCT02601313|10779411|FG000|Overall Study|Still on study|0
6783264|NCT02601313|10779412|FG001|Overall Study|Still on study|52
6783265|NCT02601313|10779413|FG002|Overall Study|Still on study|10
6783266|NCT02601313|10779411|FG000|Overall Study|Enrolled, did not initiate AC|4
6783267|NCT02601313|10779412|FG001|Overall Study|Enrolled, did not initiate AC|0
6783268|NCT02601313|10779413|FG002|Overall Study|Enrolled, did not initiate AC|0
6783271|NCT02542293|10779427|FG000|Overall Study|Death|367
6783272|NCT02542293|10779428|FG001|Overall Study|Death|377
6783273|NCT02542293|10779427|FG000|Overall Study|Withdrawal by Subject|8
6783274|NCT02542293|10779428|FG001|Overall Study|Withdrawal by Subject|19
6783275|NCT02438722|10779447|FG000|Overall Study|Adverse Event|12
6783276|NCT02438722|10779448|FG001|Overall Study|Adverse Event|9
6783277|NCT02438722|10779447|FG000|Overall Study|Refusal unrelated to AE|2
6783278|NCT02438722|10779448|FG001|Overall Study|Refusal unrelated to AE|5
6783279|NCT02438722|10779447|FG000|Overall Study|Disease progression/relapse|46
6783280|NCT02438722|10779448|FG001|Overall Study|Disease progression/relapse|51
6783281|NCT02438722|10779447|FG000|Overall Study|Death|0
6783282|NCT02438722|10779448|FG001|Overall Study|Death|3
6783283|NCT02438722|10779447|FG000|Overall Study|Physician Decision|2
6783284|NCT02438722|10779448|FG001|Overall Study|Physician Decision|2
6783285|NCT02438722|10779447|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1
6783286|NCT02438722|10779448|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0
6783287|NCT02438722|10779447|FG000|Overall Study|Withdrawal by Subject|0
6783288|NCT02438722|10779448|FG001|Overall Study|Withdrawal by Subject|1
6783289|NCT02438722|10779447|FG000|Overall Study|On protocol treatment|15
6783290|NCT02438722|10779448|FG001|Overall Study|On protocol treatment|14
6783291|NCT02438722|10779447|FG000|Overall Study|Did not receive protocol treatment|5
6783292|NCT02438722|10779448|FG001|Overall Study|Did not receive protocol treatment|0
7138610|NCT02949271|11291987|FG001|Overall Study|Protocol Violation|3
7138611|NCT02949271|11291986|FG000|Overall Study|Withdrawal by Subject|1
7138612|NCT02949271|11291987|FG001|Overall Study|Withdrawal by Subject|0
7138613|NCT02949271|11291986|FG000|Overall Study|Delivered prior to intervention|7
7138614|NCT02949271|11291987|FG001|Overall Study|Delivered prior to intervention|9
7138615|NCT02949271|11291986|FG000|Overall Study|Outside the window for cervical dilation|2
7138616|NCT02949271|11291987|FG001|Overall Study|Outside the window for cervical dilation|3
7138617|NCT02949362|11291995|FG000|Retrospective Period|Inform consent not signed by participant|4
7138618|NCT02949362|11291996|FG001|Retrospective Period|Inform consent not signed by participant|1
7138619|NCT02949362|11291997|FG002|Retrospective Period|Inform consent not signed by participant|0
7138620|NCT02949362|11291998|FG003|Retrospective Period|Inform consent not signed by participant|0
7138621|NCT02949362|11291995|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0
7138622|NCT02949362|11291996|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0
7138623|NCT02949362|11291997|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1
7138624|NCT02949362|11291998|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0
7138625|NCT02949362|11291995|FG000|Prospective Period|Other|0
7138626|NCT02949362|11291996|FG001|Prospective Period|Other|0
7138627|NCT02949362|11291997|FG002|Prospective Period|Other|0
7138628|NCT02949362|11291998|FG003|Prospective Period|Other|4
7138629|NCT02949908|11292034|FG000|Overall Study|Study termination|2
7138630|NCT02949973|11292047|FG000|Overall Study|Physician Decision|1
7138631|NCT02950545|11292070|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0
7138632|NCT02950545|11292071|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0
7138633|NCT02950545|11292072|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0
7138634|NCT02950545|11292073|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0
7138635|NCT02950545|11292074|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0
6783329|NCT02120352|10779491|FG000|Induction Period (20 Weeks)|Adverse Event|3
6783330|NCT02120352|10779492|FG001|Induction Period (20 Weeks)|Adverse Event|0
6783331|NCT02120352|10779493|FG002|Induction Period (20 Weeks)|Adverse Event|0
6783332|NCT02120352|10779494|FG003|Induction Period (20 Weeks)|Adverse Event|0
6783333|NCT02120352|10779491|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5
6783334|NCT02120352|10779492|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0
6783335|NCT02120352|10779493|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0
6783336|NCT02120352|10779494|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0
6783337|NCT02120352|10779491|FG000|Induction Period (20 Weeks)|Protocol Violation|2
6783338|NCT02120352|10779492|FG001|Induction Period (20 Weeks)|Protocol Violation|0
6783339|NCT02120352|10779493|FG002|Induction Period (20 Weeks)|Protocol Violation|0
6783340|NCT02120352|10779494|FG003|Induction Period (20 Weeks)|Protocol Violation|0
6783341|NCT02120352|10779491|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3
6783342|NCT02120352|10779492|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0
6783343|NCT02120352|10779493|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0
6783344|NCT02120352|10779494|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0
6783345|NCT02120352|10779491|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2
6783346|NCT02120352|10779492|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0
6783347|NCT02120352|10779493|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0
6783348|NCT02120352|10779494|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0
7138636|NCT02950545|11292075|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1
7138637|NCT02950545|11292070|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1
7138638|NCT02950545|11292071|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0
7138639|NCT02950545|11292072|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0
7138640|NCT02950545|11292073|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1
7138641|NCT02950545|11292074|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0
7138642|NCT02950545|11292075|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1
7138643|NCT02950545|11292070|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0
7138644|NCT02950545|11292071|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0
7138645|NCT02950545|11292072|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0
7138646|NCT02950545|11292073|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0
7138647|NCT02950545|11292074|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1
7138648|NCT02950545|11292075|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0
7138649|NCT02950545|11292070|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1
7138650|NCT02950545|11292071|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0
7138651|NCT02950545|11292072|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0
7138652|NCT02950545|11292073|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0
7138653|NCT02950545|11292074|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0
7138654|NCT02950545|11292075|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0
7138655|NCT02950545|11292070|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0
7138656|NCT02950545|11292071|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0
7138657|NCT02950545|11292072|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0
7138658|NCT02950545|11292073|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0
7138659|NCT02950545|11292074|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0
7138660|NCT02950545|11292075|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1
7138661|NCT02950558|11292083|FG000|Overall Study|Lost to Follow-up|2
7138662|NCT02950558|11292084|FG001|Overall Study|Lost to Follow-up|0
7138663|NCT02950831|11292100|FG000|Overall Study|Lost to Follow-up|1
7138664|NCT02950831|11292100|FG000|Overall Study|Withdrawal by Subject|3
7138665|NCT02950831|11292100|FG000|Overall Study|stimulation trail failure|5
7138666|NCT02951156|11292132|FG000|Overall Study|Death|3
7138667|NCT02951156|11292133|FG001|Overall Study|Death|8
7138668|NCT02951156|11292134|FG002|Overall Study|Death|5
7138669|NCT02951156|11292132|FG000|Overall Study|Progressive disease|1
7138670|NCT02951156|11292133|FG001|Overall Study|Progressive disease|0
7138671|NCT02951156|11292134|FG002|Overall Study|Progressive disease|1
7138672|NCT02951156|11292132|FG000|Overall Study|Withdrawal by Subject|0
7138673|NCT02951156|11292133|FG001|Overall Study|Withdrawal by Subject|0
7138674|NCT02951156|11292134|FG002|Overall Study|Withdrawal by Subject|1
7138675|NCT02951156|11292132|FG000|Overall Study|Study terminated by sponsor|0
7138676|NCT02951156|11292133|FG001|Overall Study|Study terminated by sponsor|0
7138677|NCT02951156|11292134|FG002|Overall Study|Study terminated by sponsor|1
7138678|NCT02951156|11292132|FG000|Overall Study|Other|5
7138679|NCT02951156|11292133|FG001|Overall Study|Other|1
7138680|NCT02951156|11292134|FG002|Overall Study|Other|2
7138681|NCT02951429|11292259|FG000|Overall Study|Adverse Event|3
7138682|NCT02951429|11292260|FG001|Overall Study|Adverse Event|7
7138683|NCT02951429|11292259|FG000|Overall Study|Death|28
7138684|NCT02951429|11292260|FG001|Overall Study|Death|36
7138685|NCT02951429|11292259|FG000|Overall Study|Lack of Efficacy|0
7138686|NCT02951429|11292260|FG001|Overall Study|Lack of Efficacy|1
7138687|NCT02951429|11292259|FG000|Overall Study|Lost to Follow-up|0
7138688|NCT02951429|11292260|FG001|Overall Study|Lost to Follow-up|1
7138689|NCT02951429|11292259|FG000|Overall Study|Lung Transplantation|9
7138690|NCT02951429|11292260|FG001|Overall Study|Lung Transplantation|6
7138691|NCT02951429|11292259|FG000|Overall Study|Other|1
7138692|NCT02951429|11292260|FG001|Overall Study|Other|3
7138693|NCT02951429|11292259|FG000|Overall Study|Progressive Disease|1
7138694|NCT02951429|11292260|FG001|Overall Study|Progressive Disease|1
6783349|NCT02120352|10779491|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5
6783350|NCT02120352|10779492|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0
6783351|NCT02120352|10779493|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0
6783352|NCT02120352|10779494|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0
6783353|NCT02120352|10779491|FG000|Induction Period (20 Weeks)|Physician Decision|1
6783354|NCT02120352|10779492|FG001|Induction Period (20 Weeks)|Physician Decision|0
6783355|NCT02120352|10779493|FG002|Induction Period (20 Weeks)|Physician Decision|0
6783356|NCT02120352|10779494|FG003|Induction Period (20 Weeks)|Physician Decision|0
6783357|NCT02120352|10779491|FG000|Maintenance Period (32 Weeks)|Adverse Event|0
6783358|NCT02120352|10779492|FG001|Maintenance Period (32 Weeks)|Adverse Event|0
6783359|NCT02120352|10779493|FG002|Maintenance Period (32 Weeks)|Adverse Event|6
6783360|NCT02120352|10779494|FG003|Maintenance Period (32 Weeks)|Adverse Event|1
6783361|NCT02120352|10779491|FG000|Maintenance Period (32 Weeks)|Lack of Efficacy|0
6783362|NCT02120352|10779492|FG001|Maintenance Period (32 Weeks)|Lack of Efficacy|1
6783363|NCT02120352|10779493|FG002|Maintenance Period (32 Weeks)|Lack of Efficacy|0
6783364|NCT02120352|10779494|FG003|Maintenance Period (32 Weeks)|Lack of Efficacy|1
6783365|NCT02120352|10779491|FG000|Maintenance Period (32 Weeks)|Protocol Violation|0
6783366|NCT02120352|10779492|FG001|Maintenance Period (32 Weeks)|Protocol Violation|0
6783367|NCT02120352|10779493|FG002|Maintenance Period (32 Weeks)|Protocol Violation|2
6783368|NCT02120352|10779494|FG003|Maintenance Period (32 Weeks)|Protocol Violation|0
6783369|NCT02120352|10779491|FG000|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0
6783370|NCT02120352|10779492|FG001|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0
6783371|NCT02120352|10779493|FG002|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1
6783372|NCT02120352|10779494|FG003|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1
6783373|NCT02120352|10779491|FG000|Maintenance Period (32 Weeks)|Lost to Follow-up|0
6783374|NCT02120352|10779492|FG001|Maintenance Period (32 Weeks)|Lost to Follow-up|0
6783375|NCT02120352|10779493|FG002|Maintenance Period (32 Weeks)|Lost to Follow-up|0
6783376|NCT02120352|10779494|FG003|Maintenance Period (32 Weeks)|Lost to Follow-up|1
6783377|NCT02120352|10779491|FG000|Maintenance Period (32 Weeks)|Withdrawal by Subject|0
6783378|NCT02120352|10779492|FG001|Maintenance Period (32 Weeks)|Withdrawal by Subject|2
6783379|NCT02120352|10779493|FG002|Maintenance Period (32 Weeks)|Withdrawal by Subject|1
6783380|NCT02120352|10779494|FG003|Maintenance Period (32 Weeks)|Withdrawal by Subject|2
6783381|NCT02120352|10779491|FG000|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|0
6783382|NCT02120352|10779492|FG001|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|112
6783383|NCT02120352|10779493|FG002|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|105
6783384|NCT02120352|10779494|FG003|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|50
6783385|NCT02004691|10779532|FG000|PAP: Up to 52 Weeks|Poor compliance|1
6783386|NCT02004691|10779533|FG001|PAP: Up to 52 Weeks|Poor compliance|0
6783387|NCT02004691|10779532|FG000|ETP: Ongoing From Week 52|Related to Coronavirus Disease (COVID-19)|1
6783388|NCT02004691|10779533|FG001|ETP: Ongoing From Week 52|Related to Coronavirus Disease (COVID-19)|0
6783389|NCT02004691|10779532|FG000|ETP: Ongoing From Week 52|Withdrawal by Subject|0
6783390|NCT02004691|10779533|FG001|ETP: Ongoing From Week 52|Withdrawal by Subject|1
6783391|NCT02004691|10779532|FG000|ETP: Ongoing From Week 52|Other|0
6783392|NCT02004691|10779533|FG001|ETP: Ongoing From Week 52|Other|1
6783393|NCT02004691|10779532|FG000|ETP: Ongoing From Week 52|Ongoing|16
6783394|NCT02004691|10779533|FG001|ETP: Ongoing From Week 52|Ongoing|16
6783400|NCT01802632|10779570|FG000|Overall Study|Death|28
6783401|NCT01802632|10779571|FG001|Overall Study|Death|1
6783402|NCT01802632|10779572|FG002|Overall Study|Death|38
6783403|NCT01802632|10779573|FG003|Overall Study|Death|0
6783404|NCT01802632|10779574|FG004|Overall Study|Death|2
6783405|NCT01802632|10779575|FG005|Overall Study|Death|0
6783406|NCT01802632|10779570|FG000|Overall Study|Withdrawal by Subject|4
6783407|NCT01802632|10779571|FG001|Overall Study|Withdrawal by Subject|2
6783408|NCT01802632|10779572|FG002|Overall Study|Withdrawal by Subject|7
6783409|NCT01802632|10779573|FG003|Overall Study|Withdrawal by Subject|3
6783410|NCT01802632|10779574|FG004|Overall Study|Withdrawal by Subject|0
6783411|NCT01802632|10779575|FG005|Overall Study|Withdrawal by Subject|1
6783412|NCT01802632|10779570|FG000|Overall Study|Objective Disease Progression|1
6783413|NCT01802632|10779571|FG001|Overall Study|Objective Disease Progression|12
6783414|NCT01802632|10779572|FG002|Overall Study|Objective Disease Progression|104
6783415|NCT01802632|10779573|FG003|Overall Study|Objective Disease Progression|6
7138695|NCT02951429|11292259|FG000|Overall Study|Withdrawal by Subject|7
6783416|NCT01802632|10779574|FG004|Overall Study|Objective Disease Progression|4
6783417|NCT01802632|10779575|FG005|Overall Study|Objective Disease Progression|4
6783418|NCT01802632|10779570|FG000|Overall Study|Ongoing Study at Data Cut-off|168
6783419|NCT01802632|10779571|FG001|Overall Study|Ongoing Study at Data Cut-off|16
6783420|NCT01802632|10779572|FG002|Overall Study|Ongoing Study at Data Cut-off|115
6783421|NCT01802632|10779573|FG003|Overall Study|Ongoing Study at Data Cut-off|50
6783422|NCT01802632|10779574|FG004|Overall Study|Ongoing Study at Data Cut-off|6
6783423|NCT01802632|10779575|FG005|Overall Study|Ongoing Study at Data Cut-off|22
6783424|NCT01802632|10779570|FG000|Overall Study|Other (not specified)|0
6783425|NCT01802632|10779571|FG001|Overall Study|Other (not specified)|0
6783426|NCT01802632|10779572|FG002|Overall Study|Other (not specified)|7
6783427|NCT01802632|10779573|FG003|Overall Study|Other (not specified)|1
6783428|NCT01802632|10779574|FG004|Overall Study|Other (not specified)|0
6783429|NCT01802632|10779575|FG005|Overall Study|Other (not specified)|1
6783430|NCT01668719|10779590|FG000|Phase I|On treatment|1
6783431|NCT01668719|10779591|FG001|Phase I|On treatment|0
6783432|NCT01668719|10779592|FG002|Phase I|On treatment|0
6783433|NCT01668719|10779590|FG000|Phase I|Adverse Event|2
6783434|NCT01668719|10779591|FG001|Phase I|Adverse Event|0
6783435|NCT01668719|10779592|FG002|Phase I|Adverse Event|0
6783436|NCT01668719|10779590|FG000|Phase I|Progression/relapse|1
6783437|NCT01668719|10779591|FG001|Phase I|Progression/relapse|0
6783438|NCT01668719|10779592|FG002|Phase I|Progression/relapse|0
6783439|NCT01668719|10779590|FG000|Phase I|not protocol specified|2
6783440|NCT01668719|10779591|FG001|Phase I|not protocol specified|0
6783441|NCT01668719|10779592|FG002|Phase I|not protocol specified|0
6783442|NCT01668719|10779590|FG000|Phase II|On treatment|0
6783443|NCT01668719|10779591|FG001|Phase II|On treatment|4
6783444|NCT01668719|10779592|FG002|Phase II|On treatment|3
7138696|NCT02951429|11292260|FG001|Overall Study|Withdrawal by Subject|11
7138697|NCT02951429|11292259|FG000|Overall Study|Participant ongoing in the study|23
7138698|NCT02951429|11292260|FG001|Overall Study|Participant ongoing in the study|17
7138699|NCT02951533|11292268|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0
7138700|NCT02951533|11292269|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16
7138701|NCT02951533|11292270|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0
7138702|NCT02951533|11292268|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2
7138703|NCT02951533|11292269|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2
7138704|NCT02951533|11292270|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0
7138705|NCT02951533|11292268|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2
7138706|NCT02951533|11292269|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4
7138707|NCT02951533|11292270|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0
7138708|NCT02951533|11292268|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0
7138709|NCT02951533|11292269|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1
7138710|NCT02951533|11292270|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0
7138711|NCT02951533|11292268|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0
7138712|NCT02951533|11292269|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1
7138713|NCT02951533|11292270|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0
7138714|NCT02951533|11292268|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1
7138715|NCT02951533|11292269|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0
7138716|NCT02951533|11292270|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0
7138717|NCT02951533|11292268|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0
7138718|NCT02951533|11292269|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2
7138719|NCT02951533|11292270|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0
7138720|NCT02951533|11292268|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1
7138721|NCT02951533|11292269|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2
7138722|NCT02951533|11292270|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0
7138723|NCT02951533|11292268|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1
7138724|NCT02951533|11292269|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0
7138725|NCT02951533|11292270|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0
7138726|NCT02951533|11292268|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1
7138727|NCT02951533|11292269|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0
7138728|NCT02951533|11292270|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0
7138729|NCT02951533|11292268|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2
7138730|NCT02951533|11292269|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0
7138731|NCT02951533|11292270|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2
7138732|NCT02951780|11292305|FG000|Period 1|Adverse Event|0
7138733|NCT02951780|11292306|FG001|Period 1|Adverse Event|0
7138734|NCT02951780|11292307|FG002|Period 1|Adverse Event|0
7138735|NCT02951780|11292308|FG003|Period 1|Adverse Event|1
7138736|NCT02951780|11292309|FG004|Period 1|Adverse Event|0
7138737|NCT02951780|11292310|FG005|Period 1|Adverse Event|0
7138738|NCT02951780|11292311|FG006|Period 1|Adverse Event|0
7138739|NCT02951780|11292312|FG007|Period 1|Adverse Event|0
7138740|NCT02951780|11292313|FG008|Period 1|Adverse Event|0
7138741|NCT02951780|11292305|FG000|Period 1|Scheduling Conflicts|0
7138742|NCT02951780|11292306|FG001|Period 1|Scheduling Conflicts|0
7138743|NCT02951780|11292307|FG002|Period 1|Scheduling Conflicts|0
7138744|NCT02951780|11292308|FG003|Period 1|Scheduling Conflicts|0
7138745|NCT02951780|11292309|FG004|Period 1|Scheduling Conflicts|0
7138746|NCT02951780|11292310|FG005|Period 1|Scheduling Conflicts|0
7138747|NCT02951780|11292311|FG006|Period 1|Scheduling Conflicts|0
7138748|NCT02951780|11292312|FG007|Period 1|Scheduling Conflicts|1
7138749|NCT02951780|11292313|FG008|Period 1|Scheduling Conflicts|0
7138750|NCT02951780|11292305|FG000|Period 2|Scheduling Conflicts|0
7138751|NCT02951780|11292306|FG001|Period 2|Scheduling Conflicts|0
7138752|NCT02951780|11292307|FG002|Period 2|Scheduling Conflicts|0
6783445|NCT01668719|10779590|FG000|Phase II|Adverse Event|0
6783446|NCT01668719|10779591|FG001|Phase II|Adverse Event|18
6783447|NCT01668719|10779592|FG002|Phase II|Adverse Event|18
6783448|NCT01668719|10779590|FG000|Phase II|Refusal unrelated to adverse event|0
6783449|NCT01668719|10779591|FG001|Phase II|Refusal unrelated to adverse event|4
6783450|NCT01668719|10779592|FG002|Phase II|Refusal unrelated to adverse event|1
6783451|NCT01668719|10779590|FG000|Phase II|Progression/relapse|0
6783452|NCT01668719|10779591|FG001|Phase II|Progression/relapse|13
6783453|NCT01668719|10779592|FG002|Phase II|Progression/relapse|17
6783454|NCT01668719|10779590|FG000|Phase II|Death|0
6783455|NCT01668719|10779591|FG001|Phase II|Death|0
6783456|NCT01668719|10779592|FG002|Phase II|Death|2
6783457|NCT01668719|10779590|FG000|Phase II|not protocol specified|0
6783458|NCT01668719|10779591|FG001|Phase II|not protocol specified|13
6783459|NCT01668719|10779592|FG002|Phase II|not protocol specified|7
6783460|NCT01625286|10779609|FG000|Overall Study|Adverse Event|0
6783461|NCT01625286|10779610|FG001|Overall Study|Adverse Event|0
6783462|NCT01625286|10779611|FG002|Overall Study|Adverse Event|0
6783463|NCT01625286|10779612|FG003|Overall Study|Adverse Event|0
6783464|NCT01625286|10779613|FG004|Overall Study|Adverse Event|1
6783465|NCT01625286|10779614|FG005|Overall Study|Adverse Event|2
6783466|NCT01625286|10779615|FG006|Overall Study|Adverse Event|1
6783467|NCT01625286|10779609|FG000|Overall Study|Death|0
6783468|NCT01625286|10779610|FG001|Overall Study|Death|0
6783469|NCT01625286|10779611|FG002|Overall Study|Death|1
6783470|NCT01625286|10779612|FG003|Overall Study|Death|1
6783471|NCT01625286|10779613|FG004|Overall Study|Death|0
6783472|NCT01625286|10779614|FG005|Overall Study|Death|11
6783473|NCT01625286|10779615|FG006|Overall Study|Death|16
6783474|NCT01625286|10779609|FG000|Overall Study|Withdrawal by Subject|0
6783475|NCT01625286|10779610|FG001|Overall Study|Withdrawal by Subject|1
6783476|NCT01625286|10779611|FG002|Overall Study|Withdrawal by Subject|0
6783477|NCT01625286|10779612|FG003|Overall Study|Withdrawal by Subject|1
6783478|NCT01625286|10779613|FG004|Overall Study|Withdrawal by Subject|0
6783479|NCT01625286|10779614|FG005|Overall Study|Withdrawal by Subject|0
6783480|NCT01625286|10779615|FG006|Overall Study|Withdrawal by Subject|1
6783481|NCT01625286|10779609|FG000|Overall Study|Any reason not specifically recorded|0
6783482|NCT01625286|10779610|FG001|Overall Study|Any reason not specifically recorded|0
6783483|NCT01625286|10779611|FG002|Overall Study|Any reason not specifically recorded|0
6783484|NCT01625286|10779612|FG003|Overall Study|Any reason not specifically recorded|0
6783485|NCT01625286|10779613|FG004|Overall Study|Any reason not specifically recorded|0
6783486|NCT01625286|10779614|FG005|Overall Study|Any reason not specifically recorded|1
6783487|NCT01625286|10779615|FG006|Overall Study|Any reason not specifically recorded|0
6783488|NCT01625286|10779609|FG000|Overall Study|Progressive disease|6
6783489|NCT01625286|10779610|FG001|Overall Study|Progressive disease|3
6783490|NCT01625286|10779611|FG002|Overall Study|Progressive disease|4
6783491|NCT01625286|10779612|FG003|Overall Study|Progressive disease|5
6783492|NCT01625286|10779613|FG004|Overall Study|Progressive disease|5
6783493|NCT01625286|10779614|FG005|Overall Study|Progressive disease|0
6783494|NCT01625286|10779615|FG006|Overall Study|Progressive disease|0
6783495|NCT01625286|10779609|FG000|Overall Study|Lost to Follow-up|0
6783496|NCT01625286|10779610|FG001|Overall Study|Lost to Follow-up|0
6783497|NCT01625286|10779611|FG002|Overall Study|Lost to Follow-up|0
6783498|NCT01625286|10779612|FG003|Overall Study|Lost to Follow-up|0
6783499|NCT01625286|10779613|FG004|Overall Study|Lost to Follow-up|0
6783500|NCT01625286|10779614|FG005|Overall Study|Lost to Follow-up|0
6783501|NCT01625286|10779615|FG006|Overall Study|Lost to Follow-up|1
6783502|NCT01625286|10779609|FG000|Overall Study|Ongoing off-treatment at DCO|0
6783503|NCT01625286|10779610|FG001|Overall Study|Ongoing off-treatment at DCO|0
6783504|NCT01625286|10779611|FG002|Overall Study|Ongoing off-treatment at DCO|0
6783505|NCT01625286|10779612|FG003|Overall Study|Ongoing off-treatment at DCO|0
6783506|NCT01625286|10779613|FG004|Overall Study|Ongoing off-treatment at DCO|0
6783507|NCT01625286|10779614|FG005|Overall Study|Ongoing off-treatment at DCO|32
6783508|NCT01625286|10779615|FG006|Overall Study|Ongoing off-treatment at DCO|31
6783509|NCT01625286|10779609|FG000|Overall Study|Ongoing on-treatment at DCO|6
6783510|NCT01625286|10779610|FG001|Overall Study|Ongoing on-treatment at DCO|4
6783511|NCT01625286|10779611|FG002|Overall Study|Ongoing on-treatment at DCO|0
6783512|NCT01625286|10779612|FG003|Overall Study|Ongoing on-treatment at DCO|0
6783513|NCT01625286|10779613|FG004|Overall Study|Ongoing on-treatment at DCO|0
6783514|NCT01625286|10779614|FG005|Overall Study|Ongoing on-treatment at DCO|8
6783515|NCT01625286|10779615|FG006|Overall Study|Ongoing on-treatment at DCO|6
6783516|NCT01515748|10779633|FG000|Overall Study|Withdrawal by Subject|32
6783517|NCT01515748|10779634|FG001|Overall Study|Withdrawal by Subject|41
6783518|NCT01515748|10779633|FG000|Overall Study|Lost to Follow-up|2
6783519|NCT01515748|10779634|FG001|Overall Study|Lost to Follow-up|4
6783520|NCT01515748|10779633|FG000|Overall Study|Ongoing|86
6783521|NCT01515748|10779634|FG001|Overall Study|Ongoing|90
6783522|NCT01261247|10779641|FG000|Overall Study|Ineligible|2
6783523|NCT00790933|10779673|FG000|Overall Study|Adverse Event|94
6783524|NCT00790933|10779674|FG001|Overall Study|Adverse Event|119
6783525|NCT00790933|10779675|FG002|Overall Study|Adverse Event|65
6783526|NCT00790933|10779676|FG003|Overall Study|Adverse Event|5
6783527|NCT00790933|10779677|FG004|Overall Study|Adverse Event|69
6783528|NCT00790933|10779673|FG000|Overall Study|Protocol Violation(s)|8
6783529|NCT00790933|10779674|FG001|Overall Study|Protocol Violation(s)|18
6783530|NCT00790933|10779675|FG002|Overall Study|Protocol Violation(s)|7
6783531|NCT00790933|10779676|FG003|Overall Study|Protocol Violation(s)|0
6783532|NCT00790933|10779677|FG004|Overall Study|Protocol Violation(s)|12
6783533|NCT00790933|10779673|FG000|Overall Study|Lack of Efficacy|192
6783534|NCT00790933|10779674|FG001|Overall Study|Lack of Efficacy|176
6783535|NCT00790933|10779675|FG002|Overall Study|Lack of Efficacy|130
6783536|NCT00790933|10779676|FG003|Overall Study|Lack of Efficacy|1
6783537|NCT00790933|10779677|FG004|Overall Study|Lack of Efficacy|121
6783538|NCT00790933|10779673|FG000|Overall Study|Study Terminated by Sponsor|0
6783539|NCT00790933|10779674|FG001|Overall Study|Study Terminated by Sponsor|0
6783540|NCT00790933|10779675|FG002|Overall Study|Study Terminated by Sponsor|1
6783541|NCT00790933|10779676|FG003|Overall Study|Study Terminated by Sponsor|0
6783542|NCT00790933|10779677|FG004|Overall Study|Study Terminated by Sponsor|0
6783543|NCT00790933|10779673|FG000|Overall Study|Withdrawal by Subject|123
6783544|NCT00790933|10779674|FG001|Overall Study|Withdrawal by Subject|120
6783545|NCT00790933|10779675|FG002|Overall Study|Withdrawal by Subject|52
6783546|NCT00790933|10779676|FG003|Overall Study|Withdrawal by Subject|6
6783547|NCT00790933|10779677|FG004|Overall Study|Withdrawal by Subject|50
6783548|NCT00790933|10779673|FG000|Overall Study|Lost to Follow-up|13
6783549|NCT00790933|10779674|FG001|Overall Study|Lost to Follow-up|31
6783550|NCT00790933|10779675|FG002|Overall Study|Lost to Follow-up|10
6783551|NCT00790933|10779676|FG003|Overall Study|Lost to Follow-up|1
6783552|NCT00790933|10779677|FG004|Overall Study|Lost to Follow-up|15
6783553|NCT00790933|10779673|FG000|Overall Study|Reason Not Specified|8
6783554|NCT00790933|10779674|FG001|Overall Study|Reason Not Specified|16
6783555|NCT00790933|10779675|FG002|Overall Study|Reason Not Specified|4
6783556|NCT00790933|10779676|FG003|Overall Study|Reason Not Specified|1
6783557|NCT00790933|10779677|FG004|Overall Study|Reason Not Specified|9
6806779|NCT02178956|10809500|FG001|Overall Study|Various Reasons|5
6806780|NCT02167945|10809510|FG000|Overall Study|Adverse Event|16
6806781|NCT02167945|10809510|FG000|Overall Study|Withdrew Consent|42
6806782|NCT02167945|10809510|FG000|Overall Study|Lost to Follow-up|122
6806783|NCT02167945|10809510|FG000|Overall Study|COVID-19 logistical restrictions|6
6806784|NCT02167945|10809510|FG000|Overall Study|Other, not specified|63
6806785|NCT02097420|10809522|FG000|Overall Study|Death|4
6806786|NCT02097420|10809522|FG000|Overall Study|Device explanted|3
6806787|NCT02097420|10809522|FG000|Overall Study|Not reached 12-month visit|7
6810506|NCT03578809|10814266|FG000|Overall Study|Death|0
6810507|NCT03578809|10814267|FG001|Overall Study|Death|2
6810508|NCT03578809|10814268|FG002|Overall Study|Death|0
6810509|NCT03578809|10814269|FG003|Overall Study|Death|1
6810510|NCT03578809|10814266|FG000|Overall Study|Lost to Follow-up|0
6810511|NCT03578809|10814267|FG001|Overall Study|Lost to Follow-up|1
6810512|NCT03578809|10814268|FG002|Overall Study|Lost to Follow-up|0
6810513|NCT03578809|10814269|FG003|Overall Study|Lost to Follow-up|0
6810514|NCT03578809|10814266|FG000|Overall Study|Withdrawal by Subject|3
6810515|NCT03578809|10814267|FG001|Overall Study|Withdrawal by Subject|5
6810516|NCT03578809|10814268|FG002|Overall Study|Withdrawal by Subject|2
6810517|NCT03578809|10814269|FG003|Overall Study|Withdrawal by Subject|0
6810518|NCT03578809|10814266|FG000|Overall Study|Other|3
6810519|NCT03578809|10814267|FG001|Overall Study|Other|6
6810520|NCT03578809|10814268|FG002|Overall Study|Other|2
6810521|NCT03578809|10814269|FG003|Overall Study|Other|8
6810522|NCT03571204|10814285|FG000|Overall Study|Stopped due to COVID-19 pandemic|1
6810523|NCT03571204|10814286|FG001|Overall Study|Stopped due to COVID-19 pandemic|1
6810524|NCT03571204|10814287|FG002|Overall Study|Stopped due to COVID-19 pandemic|0
6810525|NCT03571204|10814285|FG000|Overall Study|Physician Decision|0
6810526|NCT03571204|10814286|FG001|Overall Study|Physician Decision|1
6810527|NCT03571204|10814287|FG002|Overall Study|Physician Decision|0
6810528|NCT03523091|10814298|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1
6810529|NCT03523091|10814299|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0
6810530|NCT03523091|10814298|FG000|Overall Study|Withdrawal by Subject|0
6810531|NCT03523091|10814299|FG001|Overall Study|Withdrawal by Subject|3
6810532|NCT03523091|10814298|FG000|Overall Study|Increase Botox dose|0
6810533|NCT03523091|10814299|FG001|Overall Study|Increase Botox dose|1
6810534|NCT03391960|10814327|FG000|Overall Study|Protocol Violation|0
6810535|NCT03391960|10814328|FG001|Overall Study|Protocol Violation|
6810536|NCT03362190|10814347|FG000|Overall Study|Adverse Event|0
6810537|NCT03362190|10814348|FG001|Overall Study|Adverse Event|0
6810538|NCT03362190|10814349|FG002|Overall Study|Adverse Event|0
6810539|NCT03362190|10814350|FG003|Overall Study|Adverse Event|1
6810540|NCT03362190|10814347|FG000|Overall Study|Withdrawal by Subject|0
6810541|NCT03362190|10814348|FG001|Overall Study|Withdrawal by Subject|0
6810542|NCT03362190|10814349|FG002|Overall Study|Withdrawal by Subject|0
6810543|NCT03362190|10814350|FG003|Overall Study|Withdrawal by Subject|1
6810544|NCT03252522|10814365|FG000|Overall Study|Adverse Event|3
6810545|NCT03252522|10814366|FG001|Overall Study|Adverse Event|1
6810546|NCT03252522|10814367|FG002|Overall Study|Adverse Event|0
6810547|NCT03252522|10814365|FG000|Overall Study|Unable to swallow pills|4
6810548|NCT03252522|10814366|FG001|Overall Study|Unable to swallow pills|1
6810549|NCT03252522|10814367|FG002|Overall Study|Unable to swallow pills|0
6810550|NCT03252522|10814365|FG000|Overall Study|Commenced stimulant medication|1
6810551|NCT03252522|10814366|FG001|Overall Study|Commenced stimulant medication|1
6810552|NCT03252522|10814367|FG002|Overall Study|Commenced stimulant medication|0
6810553|NCT03252522|10814365|FG000|Overall Study|Protocol Violation|1
6783558|NCT04388527|10779762|FG000|Overall Study|Death|14
6783559|NCT04388527|10779762|FG000|Overall Study|Withdrawal by Subject|2
6783560|NCT04388527|10779762|FG000|Overall Study|Lost to Follow-up|1
6783561|NCT04280081|10779770|FG000|Overall Study|Adverse Event|4
6783562|NCT04280081|10779770|FG000|Overall Study|Death|2
6783563|NCT04280081|10779770|FG000|Overall Study|Progressive Disease|6
6783564|NCT04126083|10779792|FG000|Overall Study|Withdrawal by Subject|1
6783565|NCT03444038|10779915|FG000|Overall Study|Adverse Event|12
6783566|NCT03444038|10779915|FG000|Overall Study|Withdrawal by Subject|7
6783567|NCT03444038|10779915|FG000|Overall Study|Lost to Follow-up|1
6783568|NCT03444038|10779915|FG000|Overall Study|Physician Decision|2
6783569|NCT03444038|10779915|FG000|Overall Study|Lack of Efficacy|7
6783570|NCT03265665|10779925|FG000|24-week Data Collection|Withdrawal by Subject|2
6783571|NCT03265665|10779926|FG001|24-week Data Collection|Withdrawal by Subject|2
6783572|NCT03265665|10779925|FG000|24-week Data Collection|Lost to Follow-up|4
6783573|NCT03265665|10779926|FG001|24-week Data Collection|Lost to Follow-up|5
6783574|NCT03265665|10779925|FG000|36-week Data Collection|Lost to Follow-up|6
6783575|NCT03265665|10779926|FG001|36-week Data Collection|Lost to Follow-up|8
6783576|NCT02725593|10779940|FG000|Blinded Treatment Period|Withdrawal by Subject|4
6783577|NCT02725593|10779941|FG001|Blinded Treatment Period|Withdrawal by Subject|3
6783578|NCT02725593|10779940|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0
6783579|NCT02725593|10779941|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2
6783580|NCT02725593|10779940|FG000|Blinded Treatment Period|Lost to Follow-up|1
6783581|NCT02725593|10779941|FG001|Blinded Treatment Period|Lost to Follow-up|1
6783582|NCT02725593|10779940|FG000|Long Term Extension|Withdrawal by Subject|1
6783583|NCT02725593|10779941|FG001|Long Term Extension|Withdrawal by Subject|3
6783584|NCT02716675|10779950|FG000|Overall Study|Death|2
6783585|NCT02716675|10779951|FG001|Overall Study|Death|3
6783586|NCT02716675|10779952|FG002|Overall Study|Death|0
6783587|NCT02716675|10779950|FG000|Overall Study|Physician Decision|2
6783588|NCT02716675|10779951|FG001|Overall Study|Physician Decision|1
6783589|NCT02716675|10779952|FG002|Overall Study|Physician Decision|1
6783590|NCT02716675|10779950|FG000|Overall Study|Lost to Follow-up|100
6783591|NCT02716675|10779951|FG001|Overall Study|Lost to Follow-up|87
6783592|NCT02716675|10779952|FG002|Overall Study|Lost to Follow-up|99
6783593|NCT02716675|10779950|FG000|Overall Study|Withdrawal by Subject|22
6783594|NCT02716675|10779951|FG001|Overall Study|Withdrawal by Subject|25
6783595|NCT02716675|10779952|FG002|Overall Study|Withdrawal by Subject|20
6783596|NCT02716675|10779950|FG000|Overall Study|Protocol Violation|0
6783597|NCT02716675|10779951|FG001|Overall Study|Protocol Violation|3
6783598|NCT02716675|10779952|FG002|Overall Study|Protocol Violation|1
6783599|NCT02716675|10779950|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36
6783600|NCT02716675|10779951|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31
6783601|NCT02716675|10779952|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42
6783602|NCT02716675|10779950|FG000|Overall Study|Other|38
6783603|NCT02716675|10779951|FG001|Overall Study|Other|47
6783604|NCT02716675|10779952|FG002|Overall Study|Other|48
6783605|NCT02636946|10779967|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0
6783606|NCT02636946|10779968|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1
6783607|NCT02636946|10779967|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1
6783608|NCT02636946|10779968|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0
6783609|NCT02636946|10779967|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0
6783610|NCT02636946|10779968|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1
6783611|NCT02636946|10779967|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0
6783612|NCT02636946|10779968|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1
6783613|NCT02636946|10779967|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0
6783614|NCT02636946|10779968|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2
6783615|NCT02636946|10779967|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2
6783616|NCT02636946|10779968|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1
6783617|NCT02631941|10779984|FG000|Overall Study|Physician Decision|0
6783618|NCT02631941|10779985|FG001|Overall Study|Physician Decision|1
6783619|NCT02631941|10779986|FG002|Overall Study|Physician Decision|0
6783620|NCT02631941|10779987|FG003|Overall Study|Physician Decision|0
6783621|NCT02631941|10779988|FG004|Overall Study|Physician Decision|0
6783622|NCT02631941|10779989|FG005|Overall Study|Physician Decision|0
6783623|NCT02631941|10779990|FG006|Overall Study|Physician Decision|0
6783624|NCT02631941|10779991|FG007|Overall Study|Physician Decision|0
6783625|NCT02631941|10779992|FG008|Overall Study|Physician Decision|0
6783626|NCT02631941|10779993|FG009|Overall Study|Physician Decision|0
6783627|NCT02631941|10779984|FG000|Overall Study|Adverse Event|0
6783628|NCT02631941|10779985|FG001|Overall Study|Adverse Event|1
6783629|NCT02631941|10779986|FG002|Overall Study|Adverse Event|0
6783630|NCT02631941|10779987|FG003|Overall Study|Adverse Event|0
6783631|NCT02631941|10779988|FG004|Overall Study|Adverse Event|0
6783632|NCT02631941|10779989|FG005|Overall Study|Adverse Event|0
6783633|NCT02631941|10779990|FG006|Overall Study|Adverse Event|0
6783634|NCT02631941|10779991|FG007|Overall Study|Adverse Event|0
6783635|NCT02631941|10779992|FG008|Overall Study|Adverse Event|0
6783636|NCT02631941|10779993|FG009|Overall Study|Adverse Event|0
6783637|NCT02631941|10779984|FG000|Overall Study|Withdrawal by Subject|0
6783638|NCT02631941|10779985|FG001|Overall Study|Withdrawal by Subject|0
6783639|NCT02631941|10779986|FG002|Overall Study|Withdrawal by Subject|0
6783640|NCT02631941|10779987|FG003|Overall Study|Withdrawal by Subject|0
6783641|NCT02631941|10779988|FG004|Overall Study|Withdrawal by Subject|1
6783642|NCT02631941|10779989|FG005|Overall Study|Withdrawal by Subject|0
6783643|NCT02631941|10779990|FG006|Overall Study|Withdrawal by Subject|0
6783644|NCT02631941|10779991|FG007|Overall Study|Withdrawal by Subject|1
6783645|NCT02631941|10779992|FG008|Overall Study|Withdrawal by Subject|0
6783646|NCT02631941|10779993|FG009|Overall Study|Withdrawal by Subject|0
6783647|NCT02631941|10779984|FG000|Overall Study|Lost to Follow-up|0
6783648|NCT02631941|10779985|FG001|Overall Study|Lost to Follow-up|0
6783649|NCT02631941|10779986|FG002|Overall Study|Lost to Follow-up|0
6783650|NCT02631941|10779987|FG003|Overall Study|Lost to Follow-up|0
6783651|NCT02631941|10779988|FG004|Overall Study|Lost to Follow-up|0
6783652|NCT02631941|10779989|FG005|Overall Study|Lost to Follow-up|0
6783653|NCT02631941|10779990|FG006|Overall Study|Lost to Follow-up|0
6783654|NCT02631941|10779991|FG007|Overall Study|Lost to Follow-up|0
6783655|NCT02631941|10779992|FG008|Overall Study|Lost to Follow-up|1
6783656|NCT02631941|10779993|FG009|Overall Study|Lost to Follow-up|0
6783657|NCT02568215|10780006|FG000|Overall Study|Death|1
6783658|NCT02568215|10780007|FG001|Overall Study|Death|2
6783659|NCT02568215|10780008|FG002|Overall Study|Death|0
6783660|NCT02568215|10780006|FG000|Overall Study|Physician Decision|2
6783661|NCT02568215|10780007|FG001|Overall Study|Physician Decision|2
6783662|NCT02568215|10780008|FG002|Overall Study|Physician Decision|2
6783663|NCT02568215|10780006|FG000|Overall Study|Lost to Follow-up|29
6783664|NCT02568215|10780007|FG001|Overall Study|Lost to Follow-up|32
6783665|NCT02568215|10780008|FG002|Overall Study|Lost to Follow-up|41
6783666|NCT02568215|10780006|FG000|Overall Study|Withdrawal by Subject|21
6783667|NCT02568215|10780007|FG001|Overall Study|Withdrawal by Subject|19
6783668|NCT02568215|10780008|FG002|Overall Study|Withdrawal by Subject|22
6783669|NCT02568215|10780006|FG000|Overall Study|Protocol Violation|1
6783670|NCT02568215|10780007|FG001|Overall Study|Protocol Violation|1
6783671|NCT02568215|10780008|FG002|Overall Study|Protocol Violation|0
6783672|NCT02568215|10780006|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25
6783673|NCT02568215|10780007|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23
6783674|NCT02568215|10780008|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21
6783675|NCT02568215|10780006|FG000|Overall Study|Other|0
6783676|NCT02568215|10780007|FG001|Overall Study|Other|1
6783677|NCT02568215|10780008|FG002|Overall Study|Other|4
6783678|NCT02528643|10780036|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5
6783679|NCT02528643|10780037|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8
6783680|NCT02528643|10780036|FG000|DB (Median Duration up to 14.65 Months)|Death|1
6783681|NCT02528643|10780037|FG001|DB (Median Duration up to 14.65 Months)|Death|6
6783682|NCT02528643|10780036|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0
6783683|NCT02528643|10780037|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1
6783684|NCT02528643|10780036|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44
6783685|NCT02528643|10780037|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82
6783686|NCT02528643|10780036|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2
6783687|NCT02528643|10780037|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8
6783688|NCT02528643|10780036|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3
6783689|NCT02528643|10780037|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5
6783690|NCT02528643|10780036|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0
6783691|NCT02528643|10780037|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1
6783692|NCT02237508|10780081|FG000|Overall Study|Withdrawal by Subject|0
6783693|NCT02237508|10780082|FG001|Overall Study|Withdrawal by Subject|2
6783694|NCT02237508|10780083|FG002|Overall Study|Withdrawal by Subject|0
6783695|NCT02237508|10780084|FG003|Overall Study|Withdrawal by Subject|1
6783696|NCT02237508|10780085|FG004|Overall Study|Withdrawal by Subject|0
6783697|NCT02237508|10780086|FG005|Overall Study|Withdrawal by Subject|1
6783698|NCT02237508|10780087|FG006|Overall Study|Withdrawal by Subject|1
6783699|NCT02237508|10780088|FG007|Overall Study|Withdrawal by Subject|0
6783700|NCT02237508|10780089|FG008|Overall Study|Withdrawal by Subject|1
6783701|NCT02237508|10780090|FG009|Overall Study|Withdrawal by Subject|0
6783702|NCT02237508|10780081|FG000|Overall Study|Physician Decision|0
6783703|NCT02237508|10780082|FG001|Overall Study|Physician Decision|1
6783704|NCT02237508|10780083|FG002|Overall Study|Physician Decision|0
6783705|NCT02237508|10780084|FG003|Overall Study|Physician Decision|0
6783706|NCT02237508|10780085|FG004|Overall Study|Physician Decision|0
6783707|NCT02237508|10780086|FG005|Overall Study|Physician Decision|0
6783708|NCT02237508|10780087|FG006|Overall Study|Physician Decision|0
6783709|NCT02237508|10780088|FG007|Overall Study|Physician Decision|0
6783710|NCT02237508|10780089|FG008|Overall Study|Physician Decision|0
6783711|NCT02237508|10780090|FG009|Overall Study|Physician Decision|0
6783712|NCT02237508|10780081|FG000|Overall Study|Protocol Violation|0
6783713|NCT02237508|10780082|FG001|Overall Study|Protocol Violation|0
6783714|NCT02237508|10780083|FG002|Overall Study|Protocol Violation|1
6783715|NCT02237508|10780084|FG003|Overall Study|Protocol Violation|0
6783716|NCT02237508|10780085|FG004|Overall Study|Protocol Violation|0
6783717|NCT02237508|10780086|FG005|Overall Study|Protocol Violation|0
6783718|NCT02237508|10780087|FG006|Overall Study|Protocol Violation|0
6783719|NCT02237508|10780088|FG007|Overall Study|Protocol Violation|0
6783720|NCT02237508|10780089|FG008|Overall Study|Protocol Violation|0
6783721|NCT02237508|10780090|FG009|Overall Study|Protocol Violation|0
7138753|NCT02951780|11292308|FG003|Period 2|Scheduling Conflicts|0
7138754|NCT02951780|11292309|FG004|Period 2|Scheduling Conflicts|0
7138755|NCT02951780|11292310|FG005|Period 2|Scheduling Conflicts|0
7138756|NCT02951780|11292311|FG006|Period 2|Scheduling Conflicts|0
7138757|NCT02951780|11292312|FG007|Period 2|Scheduling Conflicts|1
7138758|NCT02951780|11292313|FG008|Period 2|Scheduling Conflicts|0
7138759|NCT02951819|11292335|FG000|Overall Study|Death|9
7138760|NCT02951819|11292336|FG001|Overall Study|Death|7
7138761|NCT02951819|11292335|FG000|Overall Study|Withdrawal by Subject|3
7138762|NCT02951819|11292336|FG001|Overall Study|Withdrawal by Subject|0
7138763|NCT02951819|11292335|FG000|Overall Study|Adverse Event|1
7138764|NCT02951819|11292336|FG001|Overall Study|Adverse Event|0
7138765|NCT02951819|11292335|FG000|Overall Study|Lack of Efficacy|4
6806788|NCT01925131|10809579|FG000|Overall Study|Death|0
6806789|NCT01925131|10809580|FG001|Overall Study|Death|0
6806790|NCT01925131|10809581|FG002|Overall Study|Death|1
6806791|NCT01925131|10809582|FG003|Overall Study|Death|0
6806792|NCT01925131|10809583|FG004|Overall Study|Death|0
6806793|NCT01925131|10809584|FG005|Overall Study|Death|0
6806794|NCT01925131|10809579|FG000|Overall Study|Progression/Relapse|1
6806795|NCT01925131|10809580|FG001|Overall Study|Progression/Relapse|1
6806796|NCT01925131|10809581|FG002|Overall Study|Progression/Relapse|4
6806797|NCT01925131|10809582|FG003|Overall Study|Progression/Relapse|0
6806798|NCT01925131|10809583|FG004|Overall Study|Progression/Relapse|0
6806799|NCT01925131|10809584|FG005|Overall Study|Progression/Relapse|1
6806800|NCT01925131|10809579|FG000|Overall Study|Patient Refusal|1
6806801|NCT01925131|10809580|FG001|Overall Study|Patient Refusal|0
6806802|NCT01925131|10809581|FG002|Overall Study|Patient Refusal|0
6806803|NCT01925131|10809582|FG003|Overall Study|Patient Refusal|0
6806804|NCT01925131|10809583|FG004|Overall Study|Patient Refusal|0
6806805|NCT01925131|10809584|FG005|Overall Study|Patient Refusal|0
6806806|NCT01925131|10809579|FG000|Overall Study|Adverse Event|0
6806807|NCT01925131|10809580|FG001|Overall Study|Adverse Event|0
6806808|NCT01925131|10809581|FG002|Overall Study|Adverse Event|2
6806809|NCT01925131|10809582|FG003|Overall Study|Adverse Event|0
6806810|NCT01925131|10809583|FG004|Overall Study|Adverse Event|1
6806811|NCT01925131|10809584|FG005|Overall Study|Adverse Event|3
6806812|NCT01925131|10809579|FG000|Overall Study|Other - Not Protocol Specified|3
6806813|NCT01925131|10809580|FG001|Overall Study|Other - Not Protocol Specified|1
6806814|NCT01925131|10809581|FG002|Overall Study|Other - Not Protocol Specified|2
6806815|NCT01925131|10809582|FG003|Overall Study|Other - Not Protocol Specified|5
6806816|NCT01925131|10809583|FG004|Overall Study|Other - Not Protocol Specified|10
6806817|NCT01925131|10809584|FG005|Overall Study|Other - Not Protocol Specified|6
6806818|NCT01776307|10809603|FG000|Overall Study|Not dosed|0
6806819|NCT01776307|10809604|FG001|Overall Study|Not dosed|0
6806820|NCT01776307|10809605|FG002|Overall Study|Not dosed|1
6806821|NCT01535274|10809649|FG000|Overall Study|Determined to be ineligible|0
6806822|NCT01535274|10809650|FG001|Overall Study|Determined to be ineligible|1
6806823|NCT01535274|10809649|FG000|Overall Study|Misallocated to propofol intervention|0
6806824|NCT01535274|10809650|FG001|Overall Study|Misallocated to propofol intervention|1
6806825|NCT00539981|10809664|FG000|Overall Study|Adverse events (AE)|3
6806826|NCT00539981|10809665|FG001|Overall Study|Adverse events (AE)|3
6806827|NCT00539981|10809664|FG000|Overall Study|Lost to Follow-up|260
6806828|NCT00539981|10809665|FG001|Overall Study|Lost to Follow-up|251
6806829|NCT00539981|10809664|FG000|Overall Study|Withdrew consent|22
6806830|NCT00539981|10809665|FG001|Overall Study|Withdrew consent|14
6806831|NCT00539981|10809664|FG000|Overall Study|Death|1
6806832|NCT00539981|10809665|FG001|Overall Study|Death|1
6806833|NCT00539981|10809664|FG000|Overall Study|Other reason-unspecified|9
6806834|NCT00539981|10809665|FG001|Overall Study|Other reason-unspecified|13
6810554|NCT03252522|10814366|FG001|Overall Study|Protocol Violation|0
6810555|NCT03252522|10814367|FG002|Overall Study|Protocol Violation|0
6810556|NCT03235544|10814382|FG000|Overall Study|Participants Still Ongoing in the Study|1
6810557|NCT03235544|10814383|FG001|Overall Study|Participants Still Ongoing in the Study|13
6810558|NCT03235544|10814384|FG002|Overall Study|Participants Still Ongoing in the Study|19
6810559|NCT03235544|10814385|FG003|Overall Study|Participants Still Ongoing in the Study|55
6810560|NCT03235544|10814382|FG000|Overall Study|Death|11
6810561|NCT03235544|10814383|FG001|Overall Study|Death|23
6810562|NCT03235544|10814384|FG002|Overall Study|Death|11
6810563|NCT03235544|10814385|FG003|Overall Study|Death|20
6810564|NCT03235544|10814382|FG000|Overall Study|Lost to Follow-up|0
6810565|NCT03235544|10814383|FG001|Overall Study|Lost to Follow-up|1
6810566|NCT03235544|10814384|FG002|Overall Study|Lost to Follow-up|0
6810567|NCT03235544|10814385|FG003|Overall Study|Lost to Follow-up|1
6810568|NCT03235544|10814382|FG000|Overall Study|Withdrawal by Participant|0
6810569|NCT03235544|10814383|FG001|Overall Study|Withdrawal by Participant|0
6810570|NCT03235544|10814384|FG002|Overall Study|Withdrawal by Participant|1
6810571|NCT03235544|10814385|FG003|Overall Study|Withdrawal by Participant|0
6810572|NCT03235544|10814382|FG000|Overall Study|Reason not Specified|0
6810573|NCT03235544|10814383|FG001|Overall Study|Reason not Specified|4
6810574|NCT03235544|10814384|FG002|Overall Study|Reason not Specified|0
6810575|NCT03235544|10814385|FG003|Overall Study|Reason not Specified|1
7138766|NCT02951819|11292336|FG001|Overall Study|Lack of Efficacy|0
7138767|NCT02951819|11292335|FG000|Overall Study|Lost to Follow-up|1
7138768|NCT02951819|11292336|FG001|Overall Study|Lost to Follow-up|0
7138769|NCT02951819|11292335|FG000|Overall Study|Progressive Disease|1
7138770|NCT02951819|11292336|FG001|Overall Study|Progressive Disease|0
7138771|NCT02951819|11292335|FG000|Overall Study|Other|9
7138772|NCT02951819|11292336|FG001|Overall Study|Other|0
7138773|NCT02951988|11292358|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8
7138774|NCT02951988|11292359|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0
6783740|NCT01706705|10780133|FG000|Overall Study|Death|1
6783741|NCT01706705|10780133|FG000|Overall Study|Lack of Efficacy|13
6783742|NCT01706705|10780133|FG000|Overall Study|Non-clinical|6
6783743|NCT01609842|10780142|FG000|Concurrent Intervention Control|pharmacy data not available|2
6783744|NCT01609842|10780143|FG001|Concurrent Intervention Control|pharmacy data not available|0
7138775|NCT02951988|11292360|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0
7138776|NCT02951988|11292361|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0
7138777|NCT02951988|11292358|FG000|Open-Label Treatment Period|Study terminated by sponsor|9
7138778|NCT02951988|11292359|FG001|Open-Label Treatment Period|Study terminated by sponsor|0
7138779|NCT02951988|11292360|FG002|Open-Label Treatment Period|Study terminated by sponsor|0
7138780|NCT02951988|11292361|FG003|Open-Label Treatment Period|Study terminated by sponsor|0
7138781|NCT02951988|11292358|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2
7138782|NCT02951988|11292359|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0
7138783|NCT02951988|11292360|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0
7138784|NCT02951988|11292361|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0
7138785|NCT02951988|11292358|FG000|Open-Label Treatment Period|Non-compliance with study drug|5
7138786|NCT02951988|11292359|FG001|Open-Label Treatment Period|Non-compliance with study drug|0
6783757|NCT00003479|10780193|FG000|Overall Study|Not evaluable|3
6806835|NCT04732338|10809685|FG000|Overall Study|Lost to Follow-up|3
6806836|NCT04732338|10809686|FG001|Overall Study|Lost to Follow-up|3
6806852|NCT04716426|10809731|FG000|Overall Study|Vaccination|1
6806853|NCT04716426|10809732|FG001|Overall Study|Vaccination|1
6806854|NCT04716426|10809731|FG000|Overall Study|Contamination|1
6806855|NCT04716426|10809732|FG001|Overall Study|Contamination|0
6806856|NCT04698993|10809753|FG000|Overall Study|PCR results not accessible|2
6806857|NCT04698993|10809754|FG001|Overall Study|PCR results not accessible|7
6806858|NCT04698993|10809753|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1
6806859|NCT04698993|10809754|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0
6806860|NCT04674644|10809781|FG000|Overall Study|with missing data|37
6806861|NCT04668989|10809799|FG000|First Intervention|Covid-19 related self-isolation|0
6806862|NCT04668989|10809800|FG001|First Intervention|Covid-19 related self-isolation|1
6806863|NCT04668989|10809799|FG000|Second Intervention|Adverse Event|0
6806864|NCT04668989|10809800|FG001|Second Intervention|Adverse Event|1
6806865|NCT04646109|10809866|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0
6806866|NCT04646109|10809867|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6
6806867|NCT04633642|10809902|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1
6806868|NCT04633642|10809903|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2
6806869|NCT04615507|10809958|FG000|Period 1|Covid-19 exposure|2
6806870|NCT04615507|10809959|FG001|Period 1|Covid-19 exposure|1
6806871|NCT04615507|10809958|FG000|Period 2|Covid-19 exposure|0
6806872|NCT04615507|10809959|FG001|Period 2|Covid-19 exposure|1
7138787|NCT02951988|11292360|FG002|Open-Label Treatment Period|Non-compliance with study drug|0
7138788|NCT02951988|11292361|FG003|Open-Label Treatment Period|Non-compliance with study drug|0
7138789|NCT02951988|11292358|FG000|Open-Label Treatment Period|Protocol Violation|22
7138790|NCT02951988|11292359|FG001|Open-Label Treatment Period|Protocol Violation|0
7138791|NCT02951988|11292360|FG002|Open-Label Treatment Period|Protocol Violation|0
7138792|NCT02951988|11292361|FG003|Open-Label Treatment Period|Protocol Violation|0
7138793|NCT02951988|11292358|FG000|Open-Label Treatment Period|Pregnancy|2
7138794|NCT02951988|11292359|FG001|Open-Label Treatment Period|Pregnancy|0
7138795|NCT02951988|11292360|FG002|Open-Label Treatment Period|Pregnancy|0
7138796|NCT02951988|11292361|FG003|Open-Label Treatment Period|Pregnancy|0
7138797|NCT02951988|11292358|FG000|Open-Label Treatment Period|Lost to Follow-up|28
7138798|NCT02951988|11292359|FG001|Open-Label Treatment Period|Lost to Follow-up|0
7138799|NCT02951988|11292360|FG002|Open-Label Treatment Period|Lost to Follow-up|0
7138800|NCT02951988|11292361|FG003|Open-Label Treatment Period|Lost to Follow-up|0
7138801|NCT02951988|11292358|FG000|Open-Label Treatment Period|Withdrawal by Subject|78
7138802|NCT02951988|11292359|FG001|Open-Label Treatment Period|Withdrawal by Subject|0
7138803|NCT02951988|11292360|FG002|Open-Label Treatment Period|Withdrawal by Subject|0
7138804|NCT02951988|11292361|FG003|Open-Label Treatment Period|Withdrawal by Subject|0
7138805|NCT02951988|11292358|FG000|Open-Label Treatment Period|Lack of Efficacy|49
7138806|NCT02951988|11292359|FG001|Open-Label Treatment Period|Lack of Efficacy|0
7138807|NCT02951988|11292360|FG002|Open-Label Treatment Period|Lack of Efficacy|0
7138808|NCT02951988|11292361|FG003|Open-Label Treatment Period|Lack of Efficacy|0
7138809|NCT02951988|11292358|FG000|Open-Label Treatment Period|Adverse Event|45
7138810|NCT02951988|11292359|FG001|Open-Label Treatment Period|Adverse Event|0
7138811|NCT02951988|11292360|FG002|Open-Label Treatment Period|Adverse Event|0
7138812|NCT02951988|11292361|FG003|Open-Label Treatment Period|Adverse Event|0
7138813|NCT02951988|11292358|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0
7138814|NCT02951988|11292359|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0
7138815|NCT02951988|11292360|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1
6783758|NCT04160195|10780199|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1
6783759|NCT04160195|10780200|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0
6783760|NCT04159701|10780210|FG000|Period 1: Treatment Period|Pregnancy|1
6783761|NCT04159701|10780211|FG001|Period 1: Treatment Period|Pregnancy|0
6783762|NCT04159701|10780210|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4
6783763|NCT04159701|10780211|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1
6783764|NCT04159701|10780210|FG000|Period 1: Treatment Period|Withdrawal by Subject|3
6783765|NCT04159701|10780211|FG001|Period 1: Treatment Period|Withdrawal by Subject|0
6783766|NCT04159701|10780210|FG000|Washout Period|site terminated by sponsor|0
6783767|NCT04159701|10780211|FG001|Washout Period|site terminated by sponsor|1
6783768|NCT04159701|10780210|FG000|Washout Period|study terminated by sponsor|10
6783769|NCT04159701|10780211|FG001|Washout Period|study terminated by sponsor|3
6783770|NCT04159701|10780210|FG000|Washout Period|Withdrawal by Subject|1
6783771|NCT04159701|10780211|FG001|Washout Period|Withdrawal by Subject|0
6783772|NCT04159701|10780210|FG000|Washout Period|Inadvertent Enrollment|1
6783773|NCT04159701|10780211|FG001|Washout Period|Inadvertent Enrollment|0
6783774|NCT04159701|10780210|FG000|Washout Period|Miscellaneous|1
6783775|NCT04159701|10780211|FG001|Washout Period|Miscellaneous|0
6783776|NCT04159701|10780210|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0
6783777|NCT04159701|10780211|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2
6783778|NCT04159701|10780210|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0
6783779|NCT04159701|10780211|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1
6783780|NCT04159701|10780210|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6
6783781|NCT04159701|10780211|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3
6783782|NCT04159701|10780210|FG000|Post-treatment Follow-up|Withdrawal by Subject|3
6783783|NCT04159701|10780211|FG001|Post-treatment Follow-up|Withdrawal by Subject|0
6783784|NCT04159701|10780210|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1
6783785|NCT04159701|10780211|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0
6783786|NCT04152447|10780223|FG000|Overall Study|Lost to Follow-up|1
6783787|NCT04152447|10780224|FG001|Overall Study|Lost to Follow-up|0
6783788|NCT04152447|10780223|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1
6783789|NCT04152447|10780224|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1
6783790|NCT04152447|10780223|FG000|Overall Study|Withdrawal by Subject|0
6783791|NCT04152447|10780224|FG001|Overall Study|Withdrawal by Subject|1
6783792|NCT04152447|10780223|FG000|Overall Study|Found ineligible after enrolling|1
6783793|NCT04152447|10780224|FG001|Overall Study|Found ineligible after enrolling|1
6783794|NCT04152447|10780223|FG000|Overall Study|Did not receive VR headset in time.|0
6783795|NCT04152447|10780224|FG001|Overall Study|Did not receive VR headset in time.|2
7138816|NCT02951988|11292361|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1
6783801|NCT04460183|10780269|FG000|Overall Study|Lost to Follow-up|3
6783802|NCT04460183|10780270|FG001|Overall Study|Lost to Follow-up|1
6783803|NCT04460183|10780269|FG000|Overall Study|Withdrawal by Subject|1
6783804|NCT04460183|10780270|FG001|Overall Study|Withdrawal by Subject|0
6783805|NCT04421027|10780278|FG000|Overall Study|Adverse Event|5
6783806|NCT04421027|10780279|FG001|Overall Study|Adverse Event|3
6783807|NCT04421027|10780278|FG000|Overall Study|Death|98
6783808|NCT04421027|10780279|FG001|Overall Study|Death|61
6783809|NCT04421027|10780278|FG000|Overall Study|Lost to Follow-up|22
6783810|NCT04421027|10780279|FG001|Overall Study|Lost to Follow-up|20
6783811|NCT04421027|10780278|FG000|Overall Study|Other-Unknown|15
6783812|NCT04421027|10780279|FG001|Overall Study|Other-Unknown|9
6783813|NCT04421027|10780278|FG000|Overall Study|Physician Decision|1
6783814|NCT04421027|10780279|FG001|Overall Study|Physician Decision|1
6783815|NCT04421027|10780278|FG000|Overall Study|Withdrawal by Subject|7
6783816|NCT04421027|10780279|FG001|Overall Study|Withdrawal by Subject|12
6783817|NCT04421027|10780278|FG000|Overall Study|Randomized Not Dosed|9
6783818|NCT04421027|10780279|FG001|Overall Study|Randomized Not Dosed|14
7138817|NCT02951988|11292358|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0
6783820|NCT03829332|10780302|FG000|Overall Study|Death|145
6783821|NCT03829332|10780303|FG001|Overall Study|Death|135
6783822|NCT03829332|10780302|FG000|Overall Study|Withdrawal by Subject|10
6783823|NCT03829332|10780303|FG001|Overall Study|Withdrawal by Subject|4
6783824|NCT03829332|10780302|FG000|Overall Study|Ongoing in Study|154
6783825|NCT03829332|10780303|FG001|Overall Study|Ongoing in Study|175
6783828|NCT03635099|10780335|FG000|Period 1|Adverse Event|1
6783829|NCT03635099|10780336|FG001|Period 1|Adverse Event|0
6783830|NCT03635099|10780337|FG002|Period 1|Adverse Event|0
6783831|NCT03635099|10780338|FG003|Period 1|Adverse Event|1
6783832|NCT03635099|10780339|FG004|Period 1|Adverse Event|0
6783833|NCT03635099|10780340|FG005|Period 1|Adverse Event|0
6783834|NCT03635099|10780341|FG006|Period 1|Adverse Event|0
6783835|NCT03635099|10780342|FG007|Period 1|Adverse Event|0
6783836|NCT03635099|10780335|FG000|Period 1|Protocol Violation|0
6783837|NCT03635099|10780336|FG001|Period 1|Protocol Violation|0
6783838|NCT03635099|10780337|FG002|Period 1|Protocol Violation|1
6783839|NCT03635099|10780338|FG003|Period 1|Protocol Violation|0
6783840|NCT03635099|10780339|FG004|Period 1|Protocol Violation|0
6783841|NCT03635099|10780340|FG005|Period 1|Protocol Violation|0
6783796|NCT04150107|10780232|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2
6783797|NCT04150107|10780233|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0
6783798|NCT04150107|10780232|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0
6783799|NCT04150107|10780233|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1
6783842|NCT03635099|10780341|FG006|Period 1|Protocol Violation|0
6783843|NCT03635099|10780342|FG007|Period 1|Protocol Violation|0
6783844|NCT03635099|10780335|FG000|Period 1|Lost to Follow-up|0
6783845|NCT03635099|10780336|FG001|Period 1|Lost to Follow-up|0
6783846|NCT03635099|10780337|FG002|Period 1|Lost to Follow-up|1
6783847|NCT03635099|10780338|FG003|Period 1|Lost to Follow-up|2
6783848|NCT03635099|10780339|FG004|Period 1|Lost to Follow-up|1
6783849|NCT03635099|10780340|FG005|Period 1|Lost to Follow-up|0
6783850|NCT03635099|10780341|FG006|Period 1|Lost to Follow-up|1
6783851|NCT03635099|10780342|FG007|Period 1|Lost to Follow-up|2
6783852|NCT03635099|10780335|FG000|Period 1|Withdrawal by Subject|3
6783853|NCT03635099|10780336|FG001|Period 1|Withdrawal by Subject|3
6783854|NCT03635099|10780337|FG002|Period 1|Withdrawal by Subject|5
6783855|NCT03635099|10780338|FG003|Period 1|Withdrawal by Subject|2
6783856|NCT03635099|10780339|FG004|Period 1|Withdrawal by Subject|2
6783857|NCT03635099|10780340|FG005|Period 1|Withdrawal by Subject|0
6783858|NCT03635099|10780341|FG006|Period 1|Withdrawal by Subject|3
6783859|NCT03635099|10780342|FG007|Period 1|Withdrawal by Subject|0
6783860|NCT03635099|10780335|FG000|Period 1|History of suicidal ideation|0
6783861|NCT03635099|10780336|FG001|Period 1|History of suicidal ideation|0
6783862|NCT03635099|10780337|FG002|Period 1|History of suicidal ideation|1
6783863|NCT03635099|10780338|FG003|Period 1|History of suicidal ideation|0
6783864|NCT03635099|10780339|FG004|Period 1|History of suicidal ideation|0
6783865|NCT03635099|10780340|FG005|Period 1|History of suicidal ideation|0
6783866|NCT03635099|10780341|FG006|Period 1|History of suicidal ideation|0
6783867|NCT03635099|10780342|FG007|Period 1|History of suicidal ideation|0
6783868|NCT03635099|10780335|FG000|Period 1|pursue other treatment options|0
6783869|NCT03635099|10780336|FG001|Period 1|pursue other treatment options|0
6783870|NCT03635099|10780337|FG002|Period 1|pursue other treatment options|0
6783871|NCT03635099|10780338|FG003|Period 1|pursue other treatment options|0
6783872|NCT03635099|10780339|FG004|Period 1|pursue other treatment options|0
6783873|NCT03635099|10780340|FG005|Period 1|pursue other treatment options|1
6783874|NCT03635099|10780341|FG006|Period 1|pursue other treatment options|0
6783875|NCT03635099|10780342|FG007|Period 1|pursue other treatment options|0
6783876|NCT03635099|10780335|FG000|Not Eligible for Period 2|Pregnancy|0
6783877|NCT03635099|10780336|FG001|Not Eligible for Period 2|Pregnancy|0
6783878|NCT03635099|10780337|FG002|Not Eligible for Period 2|Pregnancy|0
6783879|NCT03635099|10780338|FG003|Not Eligible for Period 2|Pregnancy|1
6783880|NCT03635099|10780339|FG004|Not Eligible for Period 2|Pregnancy|0
6783881|NCT03635099|10780340|FG005|Not Eligible for Period 2|Pregnancy|0
6783882|NCT03635099|10780341|FG006|Not Eligible for Period 2|Pregnancy|0
6783883|NCT03635099|10780342|FG007|Not Eligible for Period 2|Pregnancy|0
6783884|NCT03635099|10780335|FG000|Not Eligible for Period 2|Withdrawal by Subject|1
6783885|NCT03635099|10780336|FG001|Not Eligible for Period 2|Withdrawal by Subject|0
6783886|NCT03635099|10780337|FG002|Not Eligible for Period 2|Withdrawal by Subject|0
6783887|NCT03635099|10780338|FG003|Not Eligible for Period 2|Withdrawal by Subject|0
6783888|NCT03635099|10780339|FG004|Not Eligible for Period 2|Withdrawal by Subject|0
6783889|NCT03635099|10780340|FG005|Not Eligible for Period 2|Withdrawal by Subject|0
6783890|NCT03635099|10780341|FG006|Not Eligible for Period 2|Withdrawal by Subject|0
6783891|NCT03635099|10780342|FG007|Not Eligible for Period 2|Withdrawal by Subject|0
6783892|NCT03635099|10780335|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0
6783893|NCT03635099|10780336|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0
6783894|NCT03635099|10780337|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0
6783895|NCT03635099|10780338|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0
6783896|NCT03635099|10780339|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0
6783897|NCT03635099|10780340|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9
6783898|NCT03635099|10780341|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40
6783899|NCT03635099|10780342|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40
6783900|NCT03635099|10780335|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15
6783901|NCT03635099|10780336|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35
6783902|NCT03635099|10780337|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21
6783903|NCT03635099|10780338|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25
6783904|NCT03635099|10780339|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0
6783905|NCT03635099|10780340|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0
6783906|NCT03635099|10780341|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0
6783907|NCT03635099|10780342|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0
6783908|NCT03635099|10780335|FG000|Period 2|Adverse Event|0
6783909|NCT03635099|10780336|FG001|Period 2|Adverse Event|0
6783910|NCT03635099|10780337|FG002|Period 2|Adverse Event|1
6783911|NCT03635099|10780338|FG003|Period 2|Adverse Event|0
6783912|NCT03635099|10780339|FG004|Period 2|Adverse Event|1
6783913|NCT03635099|10780340|FG005|Period 2|Adverse Event|0
6783914|NCT03635099|10780341|FG006|Period 2|Adverse Event|0
6783915|NCT03635099|10780342|FG007|Period 2|Adverse Event|0
6783916|NCT03635099|10780335|FG000|Period 2|Lost to Follow-up|0
6783917|NCT03635099|10780336|FG001|Period 2|Lost to Follow-up|0
6783918|NCT03635099|10780337|FG002|Period 2|Lost to Follow-up|1
6783919|NCT03635099|10780338|FG003|Period 2|Lost to Follow-up|0
6783920|NCT03635099|10780339|FG004|Period 2|Lost to Follow-up|4
6783921|NCT03635099|10780340|FG005|Period 2|Lost to Follow-up|0
6783922|NCT03635099|10780341|FG006|Period 2|Lost to Follow-up|0
6783923|NCT03635099|10780342|FG007|Period 2|Lost to Follow-up|0
6783924|NCT03635099|10780335|FG000|Period 2|Withdrawal by Subject|0
6783925|NCT03635099|10780336|FG001|Period 2|Withdrawal by Subject|0
6783926|NCT03635099|10780337|FG002|Period 2|Withdrawal by Subject|7
6783927|NCT03635099|10780338|FG003|Period 2|Withdrawal by Subject|4
6783928|NCT03635099|10780339|FG004|Period 2|Withdrawal by Subject|7
6783929|NCT03635099|10780340|FG005|Period 2|Withdrawal by Subject|0
6783930|NCT03635099|10780341|FG006|Period 2|Withdrawal by Subject|0
6783931|NCT03635099|10780342|FG007|Period 2|Withdrawal by Subject|0
6783932|NCT03543046|10780370|FG000|Overall Study|Adverse Event|1
6783933|NCT03543046|10780371|FG001|Overall Study|Adverse Event|1
6783934|NCT03543046|10780370|FG000|Overall Study|Physician Decision|1
6783935|NCT03543046|10780371|FG001|Overall Study|Physician Decision|1
6783936|NCT03543046|10780370|FG000|Overall Study|Protocol Violation|1
6783937|NCT03543046|10780371|FG001|Overall Study|Protocol Violation|0
6783939|NCT03100149|10780405|FG000|Overall Study|Adverse Event|0
6783940|NCT03100149|10780406|FG001|Overall Study|Adverse Event|1
6783941|NCT03100149|10780407|FG002|Overall Study|Adverse Event|0
6783942|NCT03100149|10780405|FG000|Overall Study|Participant Moved out of Country|0
6783943|NCT03100149|10780406|FG001|Overall Study|Participant Moved out of Country|0
6783944|NCT03100149|10780407|FG002|Overall Study|Participant Moved out of Country|1
6783945|NCT03100149|10780405|FG000|Overall Study|Withdrawal by Subject|0
6783946|NCT03100149|10780406|FG001|Overall Study|Withdrawal by Subject|3
6783947|NCT03100149|10780407|FG002|Overall Study|Withdrawal by Subject|1
6783948|NCT03063203|10780433|FG000|Overall Study|Chose alternative therapy|3
6783949|NCT03063203|10780433|FG000|Overall Study|Death|2
6783950|NCT03063203|10780433|FG000|Overall Study|Disease progression|4
6783951|NCT03063203|10780433|FG000|Overall Study|Physician Decision|5
6783952|NCT02831764|10780446|FG000|Overall Study|Protocol specific withdrawal criteria|0
6783953|NCT02831764|10780447|FG001|Overall Study|Protocol specific withdrawal criteria|2
6783954|NCT02831764|10780446|FG000|Overall Study|Withdrawal by Subject|7
6783955|NCT02831764|10780447|FG001|Overall Study|Withdrawal by Subject|6
6783956|NCT02831764|10780446|FG000|Overall Study|Physician Decision|2
6783957|NCT02831764|10780447|FG001|Overall Study|Physician Decision|2
6783958|NCT02831764|10780446|FG000|Overall Study|Lost to Follow-up|6
6783959|NCT02831764|10780447|FG001|Overall Study|Lost to Follow-up|5
6783960|NCT02831764|10780446|FG000|Overall Study|Adverse Event|8
6783961|NCT02831764|10780447|FG001|Overall Study|Adverse Event|5
6783962|NCT02831764|10780446|FG000|Overall Study|Lack of Efficacy|2
6783963|NCT02831764|10780447|FG001|Overall Study|Lack of Efficacy|2
6783964|NCT02831764|10780446|FG000|Overall Study|Protocol Violation|5
6783965|NCT02831764|10780447|FG001|Overall Study|Protocol Violation|2
6783966|NCT02831764|10780446|FG000|Overall Study|Ongoing at the time of the analysis|330
6783967|NCT02831764|10780447|FG001|Overall Study|Ongoing at the time of the analysis|335
6783968|NCT02623205|10780477|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4
6783969|NCT02623205|10780478|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3
6783970|NCT02574481|10780488|FG000|Overall Study|Withdrawal by Subject|6
6783971|NCT02574481|10780489|FG001|Overall Study|Withdrawal by Subject|4
6783972|NCT02574481|10780490|FG002|Overall Study|Withdrawal by Subject|1
6783973|NCT02574481|10780491|FG003|Overall Study|Withdrawal by Subject|0
6783974|NCT02574481|10780488|FG000|Overall Study|Adverse Event|2
6783975|NCT02574481|10780489|FG001|Overall Study|Adverse Event|0
6783976|NCT02574481|10780490|FG002|Overall Study|Adverse Event|0
6783977|NCT02574481|10780491|FG003|Overall Study|Adverse Event|0
6783978|NCT02574481|10780488|FG000|Overall Study|Visit Missed|12
6783979|NCT02574481|10780489|FG001|Overall Study|Visit Missed|4
6783980|NCT02574481|10780490|FG002|Overall Study|Visit Missed|2
6783981|NCT02574481|10780491|FG003|Overall Study|Visit Missed|0
6783982|NCT02574481|10780488|FG000|Overall Study|Other|1
6783983|NCT02574481|10780489|FG001|Overall Study|Other|0
6783984|NCT02574481|10780490|FG002|Overall Study|Other|0
6783985|NCT02574481|10780491|FG003|Overall Study|Other|0
6783986|NCT02574481|10780488|FG000|Overall Study|Death|6
6783987|NCT02574481|10780489|FG001|Overall Study|Death|6
6783988|NCT02574481|10780490|FG002|Overall Study|Death|0
6783989|NCT02574481|10780491|FG003|Overall Study|Death|0
6806837|NCT04728802|10809694|FG000|Overall Study|Withdrawal by Subject|4
6806838|NCT04728802|10809695|FG001|Overall Study|Withdrawal by Subject|20
6806839|NCT04728802|10809694|FG000|Overall Study|Physician Decision|7
6806840|NCT04728802|10809695|FG001|Overall Study|Physician Decision|7
6806841|NCT04728802|10809694|FG000|Overall Study|Protocol Violation|10
6806842|NCT04728802|10809695|FG001|Overall Study|Protocol Violation|4
6806843|NCT04728802|10809694|FG000|Overall Study|Transfer|1
6806844|NCT04728802|10809695|FG001|Overall Study|Transfer|0
6806845|NCT04728802|10809694|FG000|Overall Study|Death|4
6806846|NCT04728802|10809695|FG001|Overall Study|Death|5
6806847|NCT04728802|10809694|FG000|Overall Study|Other|3
6806848|NCT04728802|10809695|FG001|Overall Study|Other|0
6806873|NCT04615507|10809958|FG000|Period 2|Protocol Violation|1
7138818|NCT02951988|11292359|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58
7138819|NCT02951988|11292360|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54
7138820|NCT02951988|11292361|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69
7138821|NCT02951988|11292358|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0
7138822|NCT02951988|11292359|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1
7138823|NCT02951988|11292360|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3
7138824|NCT02951988|11292361|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0
7138825|NCT02951988|11292358|FG000|Double-Blind Treatment Period|Protocol Violation|0
7138826|NCT02951988|11292359|FG001|Double-Blind Treatment Period|Protocol Violation|4
7138827|NCT02951988|11292360|FG002|Double-Blind Treatment Period|Protocol Violation|4
7138828|NCT02951988|11292361|FG003|Double-Blind Treatment Period|Protocol Violation|8
7138829|NCT02951988|11292358|FG000|Double-Blind Treatment Period|Pregnancy|0
7138830|NCT02951988|11292359|FG001|Double-Blind Treatment Period|Pregnancy|1
7138831|NCT02951988|11292360|FG002|Double-Blind Treatment Period|Pregnancy|1
7138832|NCT02951988|11292361|FG003|Double-Blind Treatment Period|Pregnancy|0
7138833|NCT02951988|11292358|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
7138834|NCT02951988|11292359|FG001|Double-Blind Treatment Period|Lost to Follow-up|4
6784014|NCT01892722|10780578|FG000|Overall Study|Protocol deviation|0
6784015|NCT01892722|10780579|FG001|Overall Study|Protocol deviation|1
6784016|NCT01892722|10780578|FG000|Overall Study|Administrative problems|0
6784017|NCT01892722|10780579|FG001|Overall Study|Administrative problems|1
6784018|NCT01892722|10780578|FG000|Overall Study|Patient/guardian decision|0
6784019|NCT01892722|10780579|FG001|Overall Study|Patient/guardian decision|2
6784020|NCT01892722|10780578|FG000|Overall Study|Physician Decision|1
6784021|NCT01892722|10780579|FG001|Overall Study|Physician Decision|2
6784022|NCT01892722|10780578|FG000|Overall Study|Adverse Event|3
6784023|NCT01892722|10780579|FG001|Overall Study|Adverse Event|2
6784024|NCT01892722|10780578|FG000|Overall Study|Lack of Efficacy|0
6784025|NCT01892722|10780579|FG001|Overall Study|Lack of Efficacy|7
6784026|NCT01892722|10780578|FG000|Overall Study|Withdrawal by Subject|3
6784027|NCT01892722|10780579|FG001|Overall Study|Withdrawal by Subject|5
6784028|NCT01723774|10780588|FG000|Neoadjuvant|Ki67 > 10%|4
6784029|NCT01723774|10780589|FG001|Neoadjuvant|Ki67 > 10%|0
6784030|NCT01723774|10780590|FG002|Neoadjuvant|Ki67 > 10%|10
6784031|NCT01723774|10780591|FG003|Neoadjuvant|Ki67 > 10%|0
6784032|NCT01723774|10780588|FG000|Neoadjuvant|Withdrawal by Subject|3
6784033|NCT01723774|10780589|FG001|Neoadjuvant|Withdrawal by Subject|1
6784034|NCT01723774|10780590|FG002|Neoadjuvant|Withdrawal by Subject|0
6784035|NCT01723774|10780591|FG003|Neoadjuvant|Withdrawal by Subject|0
6784036|NCT01723774|10780588|FG000|Neoadjuvant|Disease progression|0
6784037|NCT01723774|10780589|FG001|Neoadjuvant|Disease progression|1
6784038|NCT01723774|10780590|FG002|Neoadjuvant|Disease progression|1
6784039|NCT01723774|10780591|FG003|Neoadjuvant|Disease progression|0
6784040|NCT01723774|10780588|FG000|Neoadjuvant|Adverse Event|0
6784041|NCT01723774|10780589|FG001|Neoadjuvant|Adverse Event|1
6784042|NCT01723774|10780590|FG002|Neoadjuvant|Adverse Event|2
6784043|NCT01723774|10780591|FG003|Neoadjuvant|Adverse Event|0
6784044|NCT01723774|10780588|FG000|Neoadjuvant|High estradiol|0
6784045|NCT01723774|10780589|FG001|Neoadjuvant|High estradiol|1
6784046|NCT01723774|10780590|FG002|Neoadjuvant|High estradiol|0
6784047|NCT01723774|10780591|FG003|Neoadjuvant|High estradiol|0
6784048|NCT01723774|10780588|FG000|Adjuvant|Still on active treatment|0
6784049|NCT01723774|10780589|FG001|Adjuvant|Still on active treatment|0
6784050|NCT01723774|10780590|FG002|Adjuvant|Still on active treatment|0
6784051|NCT01723774|10780591|FG003|Adjuvant|Still on active treatment|1
6784052|NCT01560637|10780600|FG000|Overall Study|Adverse Event|63
6784053|NCT01560637|10780600|FG000|Overall Study|Death|69
6784054|NCT01560637|10780600|FG000|Overall Study|Lost to Follow-up|8
6784055|NCT01560637|10780600|FG000|Overall Study|Protocol Violation|8
6784056|NCT01560637|10780600|FG000|Overall Study|Withdrawal by Subject|24
6784057|NCT01560637|10780600|FG000|Overall Study|Progressive Disease|20
6784058|NCT01560637|10780600|FG000|Overall Study|Other Reason Not Specified|6
6784059|NCT00999804|10780606|FG000|Overall Study|Lack of Efficacy|9
6784060|NCT00999804|10780607|FG001|Overall Study|Lack of Efficacy|2
6784061|NCT00999804|10780606|FG000|Overall Study|Adverse Event|4
6784062|NCT00999804|10780607|FG001|Overall Study|Adverse Event|3
6784063|NCT00999804|10780606|FG000|Overall Study|Withdrawal by Subject|4
6784064|NCT00999804|10780607|FG001|Overall Study|Withdrawal by Subject|0
6784065|NCT00999804|10780606|FG000|Overall Study|Death|1
6784066|NCT00999804|10780607|FG001|Overall Study|Death|0
6784067|NCT00999804|10780606|FG000|Overall Study|Ineligible|3
6784068|NCT00999804|10780607|FG001|Overall Study|Ineligible|0
6784069|NCT00458003|10780615|FG000|Overall Study|Non protocol spinal anesthesia|1
6784070|NCT00458003|10780616|FG001|Overall Study|Non protocol spinal anesthesia|1
6784071|NCT03794544|10780658|FG000|Overall Study|Withdrawal by Subject|1
6784072|NCT03794544|10780659|FG001|Overall Study|Withdrawal by Subject|1
6784073|NCT03794544|10780660|FG002|Overall Study|Withdrawal by Subject|0
6784074|NCT03794544|10780661|FG003|Overall Study|Withdrawal by Subject|0
6784075|NCT03794544|10780658|FG000|Overall Study|Death|0
6784076|NCT03794544|10780659|FG001|Overall Study|Death|0
6784077|NCT03794544|10780660|FG002|Overall Study|Death|0
6784078|NCT03794544|10780661|FG003|Overall Study|Death|1
6784079|NCT03794544|10780658|FG000|Overall Study|Lost to Follow-up|0
6784080|NCT03794544|10780659|FG001|Overall Study|Lost to Follow-up|1
6784081|NCT03794544|10780660|FG002|Overall Study|Lost to Follow-up|1
6784082|NCT03794544|10780661|FG003|Overall Study|Lost to Follow-up|0
6784083|NCT03794544|10780658|FG000|Overall Study|Other|0
6784084|NCT03794544|10780659|FG001|Overall Study|Other|1
6784085|NCT03794544|10780660|FG002|Overall Study|Other|0
6784086|NCT03794544|10780661|FG003|Overall Study|Other|0
6806849|NCT04725500|10809716|FG000|Screening|Screen Failure|26
6806850|NCT04725500|10809716|FG000|Screening|Withdrawal by Subject|1
6806851|NCT04725500|10809716|FG000|2 Week Take Home|Screen Fail|5
6806874|NCT04615507|10809959|FG001|Period 2|Protocol Violation|0
6806875|NCT04615507|10809958|FG000|Period 2|Withdrawal by Subject|1
6806876|NCT04615507|10809959|FG001|Period 2|Withdrawal by Subject|0
6806877|NCT04615507|10809958|FG000|Period 2|Adverse Event|0
6806878|NCT04615507|10809959|FG001|Period 2|Adverse Event|1
6806879|NCT04615507|10809958|FG000|Period 3|Covid-19 exposure|0
6806880|NCT04615507|10809959|FG001|Period 3|Covid-19 exposure|1
6810576|NCT03225833|10814402|FG000|Overall Study|Adverse Event|0
6810577|NCT03225833|10814403|FG001|Overall Study|Adverse Event|1
6810578|NCT03225833|10814404|FG002|Overall Study|Adverse Event|2
6810579|NCT03225833|10814405|FG003|Overall Study|Adverse Event|0
6810580|NCT03225833|10814406|FG004|Overall Study|Adverse Event|0
6810581|NCT03225833|10814407|FG005|Overall Study|Adverse Event|2
6810582|NCT03225833|10814402|FG000|Overall Study|Withdrawal by Subject|1
6810583|NCT03225833|10814403|FG001|Overall Study|Withdrawal by Subject|0
6810584|NCT03225833|10814404|FG002|Overall Study|Withdrawal by Subject|0
6810585|NCT03225833|10814405|FG003|Overall Study|Withdrawal by Subject|0
6810586|NCT03225833|10814406|FG004|Overall Study|Withdrawal by Subject|1
6810587|NCT03225833|10814407|FG005|Overall Study|Withdrawal by Subject|0
6810588|NCT03225833|10814402|FG000|Overall Study|Termination of Study by Sponsor|4
6810589|NCT03225833|10814403|FG001|Overall Study|Termination of Study by Sponsor|0
6810590|NCT03225833|10814404|FG002|Overall Study|Termination of Study by Sponsor|0
6810591|NCT03225833|10814405|FG003|Overall Study|Termination of Study by Sponsor|0
6810592|NCT03225833|10814406|FG004|Overall Study|Termination of Study by Sponsor|0
6810593|NCT03225833|10814407|FG005|Overall Study|Termination of Study by Sponsor|7
6810594|NCT03225833|10814402|FG000|Overall Study|Sponsor Decision|0
6810595|NCT03225833|10814403|FG001|Overall Study|Sponsor Decision|0
6810596|NCT03225833|10814404|FG002|Overall Study|Sponsor Decision|0
6810597|NCT03225833|10814405|FG003|Overall Study|Sponsor Decision|0
6810598|NCT03225833|10814406|FG004|Overall Study|Sponsor Decision|0
6810599|NCT03225833|10814407|FG005|Overall Study|Sponsor Decision|1
6810600|NCT03167242|10814438|FG000|Overall Study|Patient/Guardian Decision|0
6810601|NCT03167242|10814439|FG001|Overall Study|Patient/Guardian Decision|1
6810602|NCT03167242|10814440|FG002|Overall Study|Patient/Guardian Decision|2
6810603|NCT03167242|10814441|FG003|Overall Study|Patient/Guardian Decision|1
6810604|NCT03167242|10814442|FG004|Overall Study|Patient/Guardian Decision|1
6810605|NCT03167242|10814443|FG005|Overall Study|Patient/Guardian Decision|1
6810606|NCT03167242|10814444|FG006|Overall Study|Patient/Guardian Decision|0
7138835|NCT02951988|11292360|FG002|Double-Blind Treatment Period|Lost to Follow-up|12
7138836|NCT02951988|11292361|FG003|Double-Blind Treatment Period|Lost to Follow-up|3
7138837|NCT02951988|11292358|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
7138838|NCT02951988|11292359|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23
7138839|NCT02951988|11292360|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22
7138840|NCT02951988|11292361|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28
7138841|NCT02951988|11292358|FG000|Double-Blind Treatment Period|Adverse Event|0
7138842|NCT02951988|11292359|FG001|Double-Blind Treatment Period|Adverse Event|8
7138843|NCT02951988|11292360|FG002|Double-Blind Treatment Period|Adverse Event|3
7138844|NCT02951988|11292361|FG003|Double-Blind Treatment Period|Adverse Event|6
7138845|NCT02951988|11292358|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0
7138846|NCT02951988|11292359|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2
7138847|NCT02951988|11292360|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1
7138848|NCT02951988|11292361|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0
7138849|NCT02952001|11292373|FG000|Overall Study|Adverse Event|3
7138850|NCT02952001|11292374|FG001|Overall Study|Adverse Event|0
7138851|NCT02952001|11292373|FG000|Overall Study|Prohibited therapy|10
7138852|NCT02952001|11292374|FG001|Overall Study|Prohibited therapy|3
7138853|NCT02952001|11292373|FG000|Overall Study|Due to Posterior Capsular Opacity|1
7138854|NCT02952001|11292374|FG001|Overall Study|Due to Posterior Capsular Opacity|0
7138855|NCT02952261|11292383|FG000|Overall Study|Withdrawal by Subject|4
7138856|NCT02952261|11292384|FG001|Overall Study|Withdrawal by Subject|5
7138857|NCT02952261|11292383|FG000|Overall Study|Protocol Violation|1
7138858|NCT02952261|11292384|FG001|Overall Study|Protocol Violation|0
7138859|NCT02952313|11292390|FG000|Primary Endpoint|Lost to Follow-up|4
7138860|NCT02952313|11292390|FG000|Primary Endpoint|Withdrawal by Subject|1
7138861|NCT02952313|11292390|FG000|Primary Endpoint|Lack of Efficacy|1
7138862|NCT02952313|11292390|FG000|Primary Endpoint|Missed visit|1
7138863|NCT02952313|11292390|FG000|Long-term Follow-up|Lost to Follow-up|12
7138864|NCT02952313|11292390|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7
7138865|NCT02952313|11292390|FG000|Long-term Follow-up|Lack of Efficacy|6
7138866|NCT02952313|11292390|FG000|Long-term Follow-up|Withdrawal by Subject|5
7138867|NCT02952313|11292390|FG000|Long-term Follow-up|Physician Decision|1
7138868|NCT02952313|11292390|FG000|Long-term Follow-up|Death|1
7138869|NCT02952586|11292397|FG000|Lead-In Phase (7 Days)|Death|0
6784087|NCT03732807|10780678|FG000|Treatment Period (up to Week 24)|Adverse Event|3
6784088|NCT03732807|10780679|FG001|Treatment Period (up to Week 24)|Adverse Event|0
6784089|NCT03732807|10780680|FG002|Treatment Period (up to Week 24)|Adverse Event|2
6784090|NCT03732807|10780681|FG003|Treatment Period (up to Week 24)|Adverse Event|4
6784091|NCT03732807|10780682|FG004|Treatment Period (up to Week 24)|Adverse Event|2
6784092|NCT03732807|10780683|FG005|Treatment Period (up to Week 24)|Adverse Event|0
6784093|NCT03732807|10780684|FG006|Treatment Period (up to Week 24)|Adverse Event|1
6784094|NCT03732807|10780678|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1
6784095|NCT03732807|10780679|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0
6784096|NCT03732807|10780680|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1
6784097|NCT03732807|10780681|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2
6784098|NCT03732807|10780682|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1
6784099|NCT03732807|10780683|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0
6784100|NCT03732807|10780684|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0
6784101|NCT03732807|10780678|FG000|Treatment Period (up to Week 24)|Physician Decision|0
6784102|NCT03732807|10780679|FG001|Treatment Period (up to Week 24)|Physician Decision|1
6784103|NCT03732807|10780680|FG002|Treatment Period (up to Week 24)|Physician Decision|2
6784104|NCT03732807|10780681|FG003|Treatment Period (up to Week 24)|Physician Decision|5
6784105|NCT03732807|10780682|FG004|Treatment Period (up to Week 24)|Physician Decision|0
6784106|NCT03732807|10780683|FG005|Treatment Period (up to Week 24)|Physician Decision|0
6784107|NCT03732807|10780684|FG006|Treatment Period (up to Week 24)|Physician Decision|1
6784108|NCT03732807|10780678|FG000|Treatment Period (up to Week 24)|Pregnancy|1
6784109|NCT03732807|10780679|FG001|Treatment Period (up to Week 24)|Pregnancy|0
6784110|NCT03732807|10780680|FG002|Treatment Period (up to Week 24)|Pregnancy|0
6784111|NCT03732807|10780681|FG003|Treatment Period (up to Week 24)|Pregnancy|0
6784112|NCT03732807|10780682|FG004|Treatment Period (up to Week 24)|Pregnancy|1
6784113|NCT03732807|10780683|FG005|Treatment Period (up to Week 24)|Pregnancy|0
6784114|NCT03732807|10780684|FG006|Treatment Period (up to Week 24)|Pregnancy|1
6784115|NCT03732807|10780678|FG000|Treatment Period (up to Week 24)|Protocol Violation|1
6784116|NCT03732807|10780679|FG001|Treatment Period (up to Week 24)|Protocol Violation|1
6784117|NCT03732807|10780680|FG002|Treatment Period (up to Week 24)|Protocol Violation|0
6784118|NCT03732807|10780681|FG003|Treatment Period (up to Week 24)|Protocol Violation|0
6784119|NCT03732807|10780682|FG004|Treatment Period (up to Week 24)|Protocol Violation|0
6784120|NCT03732807|10780683|FG005|Treatment Period (up to Week 24)|Protocol Violation|0
6784121|NCT03732807|10780684|FG006|Treatment Period (up to Week 24)|Protocol Violation|0
6784122|NCT03732807|10780678|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4
6784123|NCT03732807|10780679|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4
6784124|NCT03732807|10780680|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4
6784125|NCT03732807|10780681|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4
6784126|NCT03732807|10780682|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1
6784127|NCT03732807|10780683|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1
6784128|NCT03732807|10780684|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2
6784129|NCT03732807|10780678|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0
6784130|NCT03732807|10780679|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0
6784131|NCT03732807|10780680|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0
6784132|NCT03732807|10780681|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0
6784133|NCT03732807|10780682|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0
6784134|NCT03732807|10780683|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1
6784135|NCT03732807|10780684|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0
6784136|NCT03732807|10780678|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0
6784137|NCT03732807|10780679|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2
6784138|NCT03732807|10780680|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2
6784139|NCT03732807|10780681|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1
6784140|NCT03732807|10780682|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0
6784141|NCT03732807|10780683|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0
6784142|NCT03732807|10780684|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2
6784143|NCT03732807|10780678|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2
6784144|NCT03732807|10780679|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1
6784145|NCT03732807|10780680|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0
6784146|NCT03732807|10780681|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3
6784147|NCT03732807|10780682|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3
6784148|NCT03732807|10780683|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0
6784149|NCT03732807|10780684|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1
6784150|NCT03732807|10780678|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0
6784151|NCT03732807|10780679|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0
6784152|NCT03732807|10780680|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2
6784153|NCT03732807|10780681|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1
6784154|NCT03732807|10780682|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1
6784155|NCT03732807|10780683|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2
6784156|NCT03732807|10780684|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0
6784157|NCT03732807|10780678|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0
6784158|NCT03732807|10780679|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1
6784159|NCT03732807|10780680|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0
6784160|NCT03732807|10780681|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0
6784161|NCT03732807|10780682|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0
6784162|NCT03732807|10780683|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0
6784163|NCT03732807|10780684|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0
6784164|NCT03732807|10780678|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0
6784165|NCT03732807|10780679|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1
6784166|NCT03732807|10780680|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0
6784167|NCT03732807|10780681|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1
6784168|NCT03732807|10780682|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1
6784169|NCT03732807|10780683|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0
6784170|NCT03732807|10780684|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0
6784171|NCT03732807|10780678|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3
6784172|NCT03732807|10780679|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2
6784173|NCT03732807|10780680|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1
6784174|NCT03732807|10780681|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1
6784175|NCT03732807|10780682|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0
6784176|NCT03732807|10780683|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1
6784177|NCT03732807|10780684|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1
6784178|NCT03732807|10780678|FG000|Treatment Extension (Week 25 up to 48)|Other|1
6784179|NCT03732807|10780679|FG001|Treatment Extension (Week 25 up to 48)|Other|4
6784180|NCT03732807|10780680|FG002|Treatment Extension (Week 25 up to 48)|Other|0
6784181|NCT03732807|10780681|FG003|Treatment Extension (Week 25 up to 48)|Other|2
6784182|NCT03732807|10780682|FG004|Treatment Extension (Week 25 up to 48)|Other|0
6784183|NCT03732807|10780683|FG005|Treatment Extension (Week 25 up to 48)|Other|0
6784184|NCT03732807|10780684|FG006|Treatment Extension (Week 25 up to 48)|Other|0
6806881|NCT04608500|10809972|FG000|Overall Study|Adverse Event|2
6806882|NCT04608500|10809973|FG001|Overall Study|Adverse Event|0
6806883|NCT04608500|10809972|FG000|Overall Study|Lost to Follow-up|15
6806884|NCT04608500|10809973|FG001|Overall Study|Lost to Follow-up|9
6806885|NCT04608500|10809972|FG000|Overall Study|Participant request|11
6806886|NCT04608500|10809973|FG001|Overall Study|Participant request|7
6806887|NCT04608500|10809972|FG000|Overall Study|Protocol Violation|1
6806888|NCT04608500|10809973|FG001|Overall Study|Protocol Violation|0
6806889|NCT04608500|10809972|FG000|Overall Study|Other|6
6806890|NCT04608500|10809973|FG001|Overall Study|Other|2
6806893|NCT04590027|10810011|FG000|Overall Study|Lost to Follow-up|17
6806894|NCT04590027|10810012|FG001|Overall Study|Lost to Follow-up|14
6806895|NCT04590027|10810011|FG000|Overall Study|Protocol Violation|0
6806896|NCT04590027|10810012|FG001|Overall Study|Protocol Violation|3
6806897|NCT04578457|10810022|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2
6806898|NCT04578457|10810022|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2
6806899|NCT04578457|10810022|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2
6806900|NCT04578457|10810022|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2
6806919|NCT04542694|10810126|FG000|Overall Study|The need for prohibited therapy|2
6806920|NCT04542694|10810127|FG001|Overall Study|The need for prohibited therapy|0
6806921|NCT04542694|10810126|FG000|Overall Study|Adverse Event|1
6806922|NCT04542694|10810127|FG001|Overall Study|Adverse Event|0
6806923|NCT04542694|10810126|FG000|Overall Study|Protocol Violation|1
6806924|NCT04542694|10810127|FG001|Overall Study|Protocol Violation|0
6806925|NCT04534491|10810169|FG000|Overall Study|Not completed end-of-study interview|24
6806926|NCT04534491|10810169|FG000|Overall Study|Non-users|70
6806927|NCT04534491|10810169|FG000|Overall Study|Non-verifiable users|58
6810607|NCT03167242|10814445|FG007|Overall Study|Patient/Guardian Decision|0
6810608|NCT03167242|10814446|FG008|Overall Study|Patient/Guardian Decision|0
6810609|NCT03167242|10814447|FG009|Overall Study|Patient/Guardian Decision|0
7138870|NCT02952586|11292398|FG001|Lead-In Phase (7 Days)|Death|1
7138871|NCT02952586|11292397|FG000|Lead-In Phase (7 Days)|Adverse Event|3
7138872|NCT02952586|11292398|FG001|Lead-In Phase (7 Days)|Adverse Event|0
7138873|NCT02952586|11292397|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0
7138874|NCT02952586|11292398|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1
7138875|NCT02952586|11292397|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2
7138876|NCT02952586|11292398|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2
7138877|NCT02952586|11292397|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5
7138878|NCT02952586|11292398|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8
7138879|NCT02952586|11292397|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12
7138880|NCT02952586|11292398|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12
7138881|NCT02952586|11292397|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2
7138882|NCT02952586|11292398|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1
7138883|NCT02952586|11292397|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1
7138884|NCT02952586|11292398|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0
7138885|NCT02952586|11292397|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10
6784185|NCT03731364|10780706|FG000|Overall Study|Adverse Event|0
6784186|NCT03731364|10780707|FG001|Overall Study|Adverse Event|0
6784187|NCT03731364|10780708|FG002|Overall Study|Adverse Event|1
6784188|NCT03731364|10780709|FG003|Overall Study|Adverse Event|2
6784189|NCT03731364|10780710|FG004|Overall Study|Adverse Event|1
6784190|NCT04598152|10780762|FG000|Overall Study|Lost to Follow-up|0
6784191|NCT04598152|10780763|FG001|Overall Study|Lost to Follow-up|1
6784192|NCT04570670|10780797|FG000|Overall Study|Withdrawal by Subject|1
6784193|NCT04570670|10780798|FG001|Overall Study|Withdrawal by Subject|0
6784194|NCT04546581|10780814|FG000|Overall Study|Adverse Event|9
6784195|NCT04546581|10780815|FG001|Overall Study|Adverse Event|3
6784196|NCT04546581|10780814|FG000|Overall Study|Physician Decision|0
6784197|NCT04546581|10780815|FG001|Overall Study|Physician Decision|1
6784198|NCT04546581|10780814|FG000|Overall Study|Protocol Violation|1
6784199|NCT04546581|10780815|FG001|Overall Study|Protocol Violation|2
6784200|NCT04546581|10780814|FG000|Overall Study|Withdrawal by Subject|3
6784201|NCT04546581|10780815|FG001|Overall Study|Withdrawal by Subject|7
6784202|NCT03915626|10780825|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1
6784203|NCT03698279|10780841|FG000|Overall Study|Withdrawal by parent/guardian|1
6784204|NCT03698279|10780842|FG001|Overall Study|Withdrawal by parent/guardian|1
6784205|NCT03698279|10780843|FG002|Overall Study|Withdrawal by parent/guardian|1
6784206|NCT03698279|10780844|FG003|Overall Study|Withdrawal by parent/guardian|1
6784207|NCT03698279|10780845|FG004|Overall Study|Withdrawal by parent/guardian|0
6784208|NCT03698279|10780846|FG005|Overall Study|Withdrawal by parent/guardian|0
6784209|NCT03698279|10780841|FG000|Overall Study|Protocol deviation|1
6784210|NCT03698279|10780842|FG001|Overall Study|Protocol deviation|0
6784211|NCT03698279|10780843|FG002|Overall Study|Protocol deviation|1
6784212|NCT03698279|10780844|FG003|Overall Study|Protocol deviation|0
6784213|NCT03698279|10780845|FG004|Overall Study|Protocol deviation|0
6784214|NCT03698279|10780846|FG005|Overall Study|Protocol deviation|0
6784215|NCT03698279|10780841|FG000|Overall Study|Withdrawal by Subject|0
6784216|NCT03698279|10780842|FG001|Overall Study|Withdrawal by Subject|0
6784217|NCT03698279|10780843|FG002|Overall Study|Withdrawal by Subject|1
6784218|NCT03698279|10780844|FG003|Overall Study|Withdrawal by Subject|0
6784219|NCT03698279|10780845|FG004|Overall Study|Withdrawal by Subject|0
6784220|NCT03698279|10780846|FG005|Overall Study|Withdrawal by Subject|0
6784221|NCT03698279|10780841|FG000|Overall Study|Lost to Follow-up|3
6784222|NCT03698279|10780842|FG001|Overall Study|Lost to Follow-up|1
6784223|NCT03698279|10780843|FG002|Overall Study|Lost to Follow-up|4
6784224|NCT03698279|10780844|FG003|Overall Study|Lost to Follow-up|5
6784225|NCT03698279|10780845|FG004|Overall Study|Lost to Follow-up|0
6784226|NCT03698279|10780846|FG005|Overall Study|Lost to Follow-up|0
6784227|NCT03478930|10780876|FG000|Overall Study|Adverse Event|0
6784228|NCT03478930|10780877|FG001|Overall Study|Adverse Event|1
6784229|NCT03478930|10780876|FG000|Overall Study|Lack of Efficacy|3
6784230|NCT03478930|10780877|FG001|Overall Study|Lack of Efficacy|3
6784231|NCT03478930|10780876|FG000|Overall Study|Withdrawal by Subject|6
6784232|NCT03478930|10780877|FG001|Overall Study|Withdrawal by Subject|5
6784233|NCT03434353|10780888|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10
6784234|NCT03434353|10780889|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3
6784235|NCT03434353|10780890|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11
6784236|NCT03434353|10780891|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3
6784237|NCT03434353|10780892|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17
6784238|NCT03434353|10780888|FG000|Overall Study|Withdrew consent|1
6784239|NCT03434353|10780889|FG001|Overall Study|Withdrew consent|0
6784240|NCT03434353|10780890|FG002|Overall Study|Withdrew consent|3
6784241|NCT03434353|10780891|FG003|Overall Study|Withdrew consent|0
6784242|NCT03434353|10780892|FG004|Overall Study|Withdrew consent|0
6784243|NCT03434353|10780888|FG000|Overall Study|Adverse Event|1
6784244|NCT03434353|10780889|FG001|Overall Study|Adverse Event|0
6784245|NCT03434353|10780890|FG002|Overall Study|Adverse Event|0
6784246|NCT03434353|10780891|FG003|Overall Study|Adverse Event|0
6784247|NCT03434353|10780892|FG004|Overall Study|Adverse Event|1
6784248|NCT03434353|10780888|FG000|Overall Study|Lost to Follow-up|2
6784249|NCT03434353|10780889|FG001|Overall Study|Lost to Follow-up|0
6784250|NCT03434353|10780890|FG002|Overall Study|Lost to Follow-up|0
6784251|NCT03434353|10780891|FG003|Overall Study|Lost to Follow-up|0
6784252|NCT03434353|10780892|FG004|Overall Study|Lost to Follow-up|0
6784253|NCT03415022|10780906|FG000|Overall Study|Withdrawal by Subject|1
6784254|NCT03415022|10780907|FG001|Overall Study|Withdrawal by Subject|2
6784255|NCT03415022|10780906|FG000|Overall Study|COVID-19 Suspension|2
6784256|NCT03415022|10780907|FG001|Overall Study|COVID-19 Suspension|3
6784257|NCT03415022|10780906|FG000|Overall Study|Lost to Follow-up|2
6784258|NCT03415022|10780907|FG001|Overall Study|Lost to Follow-up|0
6784259|NCT03283670|10780913|FG000|Placebo Gas|Withdrawal by Subject|2
6784260|NCT03283670|10780913|FG000|25% Nitrous Oxide|Withdrawal by Subject|4
6784261|NCT03283670|10780913|FG000|50% Nitrous Oxide|Withdrawal by Subject|1
6784262|NCT03219567|10780944|FG000|Overall Study|Withdrawal by Subject|0
6784263|NCT03219567|10780945|FG001|Overall Study|Withdrawal by Subject|1
6784264|NCT03153111|10780963|FG000|Overall Study|Death|2
6784265|NCT03153111|10780964|FG001|Overall Study|Death|5
6784266|NCT03153111|10780963|FG000|Overall Study|Lost to Follow-up|1
6784267|NCT03153111|10780964|FG001|Overall Study|Lost to Follow-up|0
6784268|NCT03153111|10780963|FG000|Overall Study|Physician Decision|5
6784269|NCT03153111|10780964|FG001|Overall Study|Physician Decision|1
6784270|NCT03153111|10780963|FG000|Overall Study|Withdrawal by Subject|3
6784271|NCT03153111|10780964|FG001|Overall Study|Withdrawal by Subject|3
6784272|NCT03073733|10780973|FG000|Overall Study|Lost to Follow-up|1
6784273|NCT03073733|10780974|FG001|Overall Study|Lost to Follow-up|0
6784274|NCT03073733|10780975|FG002|Overall Study|Lost to Follow-up|0
6784275|NCT03073733|10780973|FG000|Overall Study|Physician Decision|0
6784276|NCT03073733|10780974|FG001|Overall Study|Physician Decision|1
6784277|NCT03073733|10780975|FG002|Overall Study|Physician Decision|0
6784278|NCT03073733|10780973|FG000|Overall Study|Withdrawal by Subject|0
6784279|NCT03073733|10780974|FG001|Overall Study|Withdrawal by Subject|0
6784280|NCT03073733|10780975|FG002|Overall Study|Withdrawal by Subject|1
6784281|NCT02821000|10780985|FG000|Overall Study|Death|44
6784282|NCT02821000|10780985|FG000|Overall Study|Withdrawal by Subject|1
6784283|NCT02821000|10780985|FG000|Overall Study|Ongoing in Study|58
6784284|NCT02702414|10781013|FG000|Overall Study|Death|77
6784285|NCT02702414|10781014|FG001|Overall Study|Death|34
6784286|NCT02702414|10781013|FG000|Overall Study|Lost to Follow-up|0
6784287|NCT02702414|10781014|FG001|Overall Study|Lost to Follow-up|1
6784288|NCT02702414|10781013|FG000|Overall Study|Withdrawal by Subject|0
6784289|NCT02702414|10781014|FG001|Overall Study|Withdrawal by Subject|1
6784290|NCT02702414|10781013|FG000|Overall Study|Participants Ongoing in Study|27
6784291|NCT02702414|10781014|FG001|Overall Study|Participants Ongoing in Study|15
6784292|NCT02702414|10781013|FG000|Overall Study|Not Treated|1
6784293|NCT02702414|10781014|FG001|Overall Study|Not Treated|0
6806891|NCT04605588|10809985|FG000|Overall Study|Withdrawal by Subject|1
6806892|NCT04605588|10809986|FG001|Overall Study|Withdrawal by Subject|0
6806901|NCT04577183|10810034|FG000|Overall Study|Death|1
6806902|NCT04577183|10810034|FG000|Overall Study|Withdrawal by Subject|3
6806903|NCT04577183|10810034|FG000|Overall Study|Early termination|2
6806928|NCT04533204|10810191|FG000|Overall Study|Unable to understand training instructions|1
6806929|NCT04533204|10810192|FG001|Overall Study|Unable to understand training instructions|1
6806930|NCT04532164|10810198|FG000|Overall Study|Adverse Event|1
6806931|NCT04532164|10810198|FG000|Overall Study|Protocol Violation|5
6806932|NCT04532164|10810198|FG000|Overall Study|Lost to Follow-up|1
6806933|NCT04532164|10810198|FG000|Overall Study|Found to be Ineligible|3
7138886|NCT02952586|11292398|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4
7138887|NCT02952586|11292397|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1
7138888|NCT02952586|11292398|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1
7138889|NCT02952586|11292397|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2
7138890|NCT02952586|11292398|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1
7138891|NCT02952586|11292397|FG000|CRT for Cisplatin (63 Days)|Death|3
7138892|NCT02952586|11292398|FG001|CRT for Cisplatin (63 Days)|Death|8
7138893|NCT02952586|11292397|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82
7138894|NCT02952586|11292398|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81
7138895|NCT02952586|11292397|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12
7138896|NCT02952586|11292398|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10
7138897|NCT02952586|11292397|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1
7138898|NCT02952586|11292398|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0
7138899|NCT02952586|11292397|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11
7138900|NCT02952586|11292398|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3
7138901|NCT02952586|11292397|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1
7138902|NCT02952586|11292398|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1
7138903|NCT02952586|11292397|FG000|CRT for Cisplatin (63 Days)|Other|1
7138904|NCT02952586|11292398|FG001|CRT for Cisplatin (63 Days)|Other|1
7138905|NCT02952586|11292397|FG000|CRT for IMRT (63 Days)|Death|5
7138906|NCT02952586|11292398|FG001|CRT for IMRT (63 Days)|Death|8
7138907|NCT02952586|11292397|FG000|CRT for IMRT (63 Days)|Adverse Event|5
7138908|NCT02952586|11292398|FG001|CRT for IMRT (63 Days)|Adverse Event|5
7138909|NCT02952586|11292397|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1
7138910|NCT02952586|11292398|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0
7138911|NCT02952586|11292397|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10
7138912|NCT02952586|11292398|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6
7138913|NCT02952586|11292397|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1
7138914|NCT02952586|11292398|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1
7138915|NCT02952586|11292397|FG000|CRT for IMRT (63 Days)|Other|1
7138916|NCT02952586|11292398|FG001|CRT for IMRT (63 Days)|Other|0
7138917|NCT02952586|11292397|FG000|Maintenance Phase (12 Months)|Death|17
7138918|NCT02952586|11292398|FG001|Maintenance Phase (12 Months)|Death|11
7138919|NCT02952586|11292397|FG000|Maintenance Phase (12 Months)|Progressive disease|60
7138920|NCT02952586|11292398|FG001|Maintenance Phase (12 Months)|Progressive disease|54
7138921|NCT02952586|11292397|FG000|Maintenance Phase (12 Months)|Adverse Event|24
7138922|NCT02952586|11292398|FG001|Maintenance Phase (12 Months)|Adverse Event|21
7138923|NCT02952586|11292397|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1
7138924|NCT02952586|11292398|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1
7138925|NCT02952586|11292397|FG000|Maintenance Phase (12 Months)|Physician Decision|1
6806934|NCT04532164|10810198|FG000|Overall Study|Withdrawal by Subject|14
6806935|NCT04531813|10810203|FG000|Overall Study|Protocol Violation|1
6806936|NCT04531813|10810203|FG000|Overall Study|Withdrawal by Subject|1
6784294|NCT02425904|10781043|FG000|Overall Study|Lost to Follow-up|1
6784295|NCT02425904|10781044|FG001|Overall Study|Lost to Follow-up|0
6784296|NCT02425904|10781043|FG000|Overall Study|Withdrawal by Subject|2
6784297|NCT02425904|10781044|FG001|Overall Study|Withdrawal by Subject|0
6784298|NCT02425904|10781043|FG000|Overall Study|Death|0
6784299|NCT02425904|10781044|FG001|Overall Study|Death|3
6784300|NCT02420795|10781054|FG000|Overall Study|Withdrawal by Subject|1
6784301|NCT02420795|10781055|FG001|Overall Study|Withdrawal by Subject|0
6784302|NCT02420795|10781056|FG002|Overall Study|Withdrawal by Subject|0
6784303|NCT02420795|10781054|FG000|Overall Study|Adverse Event|1
6784304|NCT02420795|10781055|FG001|Overall Study|Adverse Event|0
6784305|NCT02420795|10781056|FG002|Overall Study|Adverse Event|0
6784306|NCT02420795|10781054|FG000|Overall Study|Progressive disease|2
6784307|NCT02420795|10781055|FG001|Overall Study|Progressive disease|2
6784308|NCT02420795|10781056|FG002|Overall Study|Progressive disease|4
6784309|NCT02420795|10781054|FG000|Overall Study|Death|0
6784310|NCT02420795|10781055|FG001|Overall Study|Death|0
6784311|NCT02420795|10781056|FG002|Overall Study|Death|1
6784312|NCT02240485|10781068|FG000|3 Months Post-admission|Lost to Follow-up|1
6784313|NCT02240485|10781069|FG001|3 Months Post-admission|Lost to Follow-up|5
6784314|NCT02240485|10781068|FG000|3 Months Post-admission|Withdrawal by Subject|2
6784315|NCT02240485|10781069|FG001|3 Months Post-admission|Withdrawal by Subject|1
6784316|NCT02240485|10781068|FG000|9 Months Post-admission|Lost to Follow-up|3
6784317|NCT02240485|10781069|FG001|9 Months Post-admission|Lost to Follow-up|1
6784318|NCT02240485|10781068|FG000|9 Months Post-admission|Withdrawal by Subject|0
6784319|NCT02240485|10781069|FG001|9 Months Post-admission|Withdrawal by Subject|3
6784320|NCT02240485|10781068|FG000|18 Months Post-admission|Lost to Follow-up|1
6784321|NCT02240485|10781069|FG001|18 Months Post-admission|Lost to Follow-up|1
6784322|NCT02240485|10781068|FG000|18 Months Post-admission|Withdrawal by Subject|2
6784323|NCT02240485|10781069|FG001|18 Months Post-admission|Withdrawal by Subject|4
6784324|NCT02227147|10781081|FG000|Controlled Treatment Period|Adverse Event|4
6784325|NCT02227147|10781082|FG001|Controlled Treatment Period|Adverse Event|3
6784326|NCT02227147|10781081|FG000|Controlled Treatment Period|Other|2
6784327|NCT02227147|10781082|FG001|Controlled Treatment Period|Other|0
6784328|NCT02227147|10781081|FG000|Follow-up Period|Other|3
6784329|NCT02227147|10781082|FG001|Follow-up Period|Other|5
6784330|NCT02199691|10781096|FG000|Overall Study|Protocol Violation|3
6784331|NCT02199691|10781097|FG001|Overall Study|Protocol Violation|3
6784332|NCT02199691|10781098|FG002|Overall Study|Protocol Violation|6
6784333|NCT02199691|10781099|FG003|Overall Study|Protocol Violation|7
6784334|NCT02199691|10781096|FG000|Overall Study|Withdrawal by Subject|5
6784335|NCT02199691|10781097|FG001|Overall Study|Withdrawal by Subject|3
6784336|NCT02199691|10781098|FG002|Overall Study|Withdrawal by Subject|12
6784337|NCT02199691|10781099|FG003|Overall Study|Withdrawal by Subject|13
6784338|NCT02199691|10781096|FG000|Overall Study|Lost to Follow-up|2
6784339|NCT02199691|10781097|FG001|Overall Study|Lost to Follow-up|1
6784340|NCT02199691|10781098|FG002|Overall Study|Lost to Follow-up|9
6784341|NCT02199691|10781099|FG003|Overall Study|Lost to Follow-up|10
7138926|NCT02952586|11292398|FG001|Maintenance Phase (12 Months)|Physician Decision|1
7138927|NCT02952586|11292397|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14
7138928|NCT02952586|11292398|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5
7138929|NCT02952586|11292397|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31
7138930|NCT02952586|11292398|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25
7138931|NCT02952586|11292397|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1
7138932|NCT02952586|11292398|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2
7138933|NCT02952586|11292397|FG000|Maintenance Phase (12 Months)|Other|2
7138934|NCT02952586|11292398|FG001|Maintenance Phase (12 Months)|Other|1
7138935|NCT02952586|11292397|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1
6784354|NCT01751984|10781155|FG000|Overall Study|Adverse Event|5
6784355|NCT01751984|10781156|FG001|Overall Study|Adverse Event|3
6784356|NCT01751984|10781155|FG000|Overall Study|Withdrawal by Subject|0
6784357|NCT01751984|10781156|FG001|Overall Study|Withdrawal by Subject|1
6784358|NCT01751984|10781155|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1
6784359|NCT01751984|10781156|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0
6784360|NCT01732627|10781164|FG000|Overall Study|Withdrawal by Subject|1
6784361|NCT01732627|10781165|FG001|Overall Study|Withdrawal by Subject|0
6784362|NCT01702571|10781173|FG000|Overall Study|Death|1067
6784363|NCT01702571|10781174|FG001|Overall Study|Death|76
6784364|NCT01702571|10781173|FG000|Overall Study|Lost to Follow-up|144
6784365|NCT01702571|10781174|FG001|Overall Study|Lost to Follow-up|10
6784366|NCT01702571|10781173|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4
6784367|NCT01702571|10781174|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0
6784368|NCT01702571|10781173|FG000|Overall Study|Investigator Decision|5
6784369|NCT01702571|10781174|FG001|Overall Study|Investigator Decision|0
6784370|NCT01702571|10781173|FG000|Overall Study|Not Classifiable|1
6784371|NCT01702571|10781174|FG001|Overall Study|Not Classifiable|0
6784372|NCT01702571|10781173|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93
6784373|NCT01702571|10781174|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0
6784374|NCT01702571|10781173|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0
6784375|NCT01702571|10781174|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1
6784376|NCT01702571|10781173|FG000|Overall Study|Progressive Disease|3
6784377|NCT01702571|10781174|FG001|Overall Study|Progressive Disease|0
6784378|NCT01702571|10781173|FG000|Overall Study|Protocol Violation|2
6784379|NCT01702571|10781174|FG001|Overall Study|Protocol Violation|0
6784380|NCT01702571|10781173|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9
6784381|NCT01702571|10781174|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1
6784382|NCT01702571|10781173|FG000|Overall Study|Termination By Sponsor|4
6784383|NCT01702571|10781174|FG001|Overall Study|Termination By Sponsor|0
6784384|NCT01702571|10781173|FG000|Overall Study|Withdrawal by Subject|177
6784385|NCT01702571|10781174|FG001|Overall Study|Withdrawal by Subject|29
6784386|NCT01578239|10781182|FG000|Treatment Period|Progressive Disease|19
6784387|NCT01578239|10781183|FG001|Treatment Period|Progressive Disease|64
6784388|NCT01578239|10781182|FG000|Treatment Period|Physician Decision|17
6784389|NCT01578239|10781183|FG001|Treatment Period|Physician Decision|17
6784390|NCT01578239|10781182|FG000|Treatment Period|Adverse Event|13
6784391|NCT01578239|10781183|FG001|Treatment Period|Adverse Event|10
6784392|NCT01578239|10781182|FG000|Treatment Period|Non-compliance|2
6784393|NCT01578239|10781183|FG001|Treatment Period|Non-compliance|0
6784394|NCT01578239|10781182|FG000|Treatment Period|Withdrawal by Subject|10
6784395|NCT01578239|10781183|FG001|Treatment Period|Withdrawal by Subject|9
6784396|NCT01578239|10781182|FG000|Treatment Period|Other|6
6784397|NCT01578239|10781183|FG001|Treatment Period|Other|1
6784398|NCT01578239|10781182|FG000|Long-term Follow-Up Period|Death|69
6784399|NCT01578239|10781183|FG001|Long-term Follow-Up Period|Death|64
6784400|NCT01578239|10781182|FG000|Long-term Follow-Up Period|Consent withdrawal|4
6784401|NCT01578239|10781183|FG001|Long-term Follow-Up Period|Consent withdrawal|10
6784402|NCT01578239|10781182|FG000|Long-term Follow-Up Period|Lost to Follow-up|2
6784403|NCT01578239|10781183|FG001|Long-term Follow-Up Period|Lost to Follow-up|4
6784404|NCT01578239|10781182|FG000|Long-term Follow-Up Period|Other|2
6784405|NCT01578239|10781183|FG001|Long-term Follow-Up Period|Other|2
6784406|NCT01458340|10781192|FG000|Overall Study|Adverse Event|5
6784407|NCT01458340|10781193|FG001|Overall Study|Adverse Event|4
6784408|NCT01458340|10781194|FG002|Overall Study|Adverse Event|2
6784409|NCT01458340|10781192|FG000|Overall Study|Lost to Follow-up|3
6784410|NCT01458340|10781193|FG001|Overall Study|Lost to Follow-up|3
6784411|NCT01458340|10781194|FG002|Overall Study|Lost to Follow-up|10
6784412|NCT01458340|10781192|FG000|Overall Study|Miscellaneous|0
6784413|NCT01458340|10781193|FG001|Overall Study|Miscellaneous|1
6784414|NCT01458340|10781194|FG002|Overall Study|Miscellaneous|0
6784415|NCT01458340|10781192|FG000|Overall Study|Physician Decision|1
6784416|NCT01458340|10781193|FG001|Overall Study|Physician Decision|1
6784417|NCT01458340|10781194|FG002|Overall Study|Physician Decision|2
6784418|NCT01458340|10781192|FG000|Overall Study|Protocol Violation|6
6784419|NCT01458340|10781193|FG001|Overall Study|Protocol Violation|6
6784420|NCT01458340|10781194|FG002|Overall Study|Protocol Violation|5
6784421|NCT01458340|10781192|FG000|Overall Study|Withdrawal by Subject|12
6784422|NCT01458340|10781193|FG001|Overall Study|Withdrawal by Subject|6
6784423|NCT01458340|10781194|FG002|Overall Study|Withdrawal by Subject|4
6784424|NCT01336634|10781242|FG000|Overall Study|Study closed/terminated|5
6784425|NCT01336634|10781243|FG001|Overall Study|Study closed/terminated|6
6784426|NCT01336634|10781244|FG002|Overall Study|Study closed/terminated|6
6784427|NCT01336634|10781242|FG000|Overall Study|Lost to Follow-up|2
6784428|NCT01336634|10781243|FG001|Overall Study|Lost to Follow-up|1
6784429|NCT01336634|10781244|FG002|Overall Study|Lost to Follow-up|1
6784430|NCT01336634|10781242|FG000|Overall Study|Physician Decision|1
6784431|NCT01336634|10781243|FG001|Overall Study|Physician Decision|1
6784432|NCT01336634|10781244|FG002|Overall Study|Physician Decision|0
6784433|NCT01336634|10781242|FG000|Overall Study|Withdrawal by Subject|6
6784434|NCT01336634|10781243|FG001|Overall Study|Withdrawal by Subject|0
6784435|NCT01336634|10781244|FG002|Overall Study|Withdrawal by Subject|2
6784436|NCT01155375|10781257|FG000|Overall Study|Adverse Event|1
6784437|NCT01155375|10781258|FG001|Overall Study|Adverse Event|0
6784438|NCT00628095|10781271|FG000|Overall Study|Adverse Event|5
6784439|NCT00628095|10781272|FG001|Overall Study|Adverse Event|3
6784440|NCT00628095|10781271|FG000|Overall Study|Lack of Efficacy|0
6784441|NCT00628095|10781272|FG001|Overall Study|Lack of Efficacy|3
6784442|NCT00628095|10781271|FG000|Overall Study|Withdrawal by Subject|2
6784443|NCT00628095|10781272|FG001|Overall Study|Withdrawal by Subject|0
6784444|NCT00628095|10781271|FG000|Overall Study|Other|0
6784445|NCT00628095|10781272|FG001|Overall Study|Other|1
6806904|NCT04574999|10810040|FG000|Overall Study|Adverse Event|1
6806905|NCT04574999|10810041|FG001|Overall Study|Adverse Event|0
6806906|NCT04574999|10810040|FG000|Overall Study|Lack of Efficacy|2
6806907|NCT04574999|10810041|FG001|Overall Study|Lack of Efficacy|3
6806908|NCT04574999|10810040|FG000|Overall Study|Protocol Violation|1
6806909|NCT04574999|10810041|FG001|Overall Study|Protocol Violation|0
6806910|NCT04574999|10810040|FG000|Overall Study|Withdrawal by Subject|2
6806911|NCT04574999|10810041|FG001|Overall Study|Withdrawal by Subject|2
6806912|NCT04574999|10810040|FG000|Overall Study|Lost to Follow-up|1
6806913|NCT04574999|10810041|FG001|Overall Study|Lost to Follow-up|0
6806914|NCT04574999|10810040|FG000|Overall Study|Personal problems|1
6806915|NCT04574999|10810041|FG001|Overall Study|Personal problems|0
6806916|NCT04574999|10810040|FG000|Overall Study|Previous planned surgery|1
6806917|NCT04574999|10810041|FG001|Overall Study|Previous planned surgery|0
6806937|NCT04531527|10810207|FG000|Overall Study|Found to be Ineligible|3
6806938|NCT04531540|10810211|FG000|Overall Study|Adverse Event|1
6784446|NCT03945825|10781304|FG000|Overall Study|Enrolled but treatment not administered|0
6784447|NCT03945825|10781305|FG001|Overall Study|Enrolled but treatment not administered|0
6784448|NCT03945825|10781306|FG002|Overall Study|Enrolled but treatment not administered|0
6784449|NCT03945825|10781307|FG003|Overall Study|Enrolled but treatment not administered|0
6784450|NCT03945825|10781308|FG004|Overall Study|Enrolled but treatment not administered|1
6784451|NCT03945825|10781309|FG005|Overall Study|Enrolled but treatment not administered|0
6784452|NCT03945825|10781304|FG000|Overall Study|Lost to Follow-up|1
6784453|NCT03945825|10781305|FG001|Overall Study|Lost to Follow-up|5
6784454|NCT03945825|10781306|FG002|Overall Study|Lost to Follow-up|0
6784455|NCT03945825|10781307|FG003|Overall Study|Lost to Follow-up|1
6784456|NCT03945825|10781308|FG004|Overall Study|Lost to Follow-up|2
6784457|NCT03945825|10781309|FG005|Overall Study|Lost to Follow-up|2
6784458|NCT03945825|10781304|FG000|Overall Study|Withdrawal by Subject|1
6784459|NCT03945825|10781305|FG001|Overall Study|Withdrawal by Subject|0
6784460|NCT03945825|10781306|FG002|Overall Study|Withdrawal by Subject|1
6784461|NCT03945825|10781307|FG003|Overall Study|Withdrawal by Subject|1
6784462|NCT03945825|10781308|FG004|Overall Study|Withdrawal by Subject|0
6784463|NCT03945825|10781309|FG005|Overall Study|Withdrawal by Subject|1
6784464|NCT03562767|10781356|FG000|Overall Study|Physician Decision|2
6784465|NCT03562767|10781357|FG001|Overall Study|Physician Decision|0
6784466|NCT03562767|10781358|FG002|Overall Study|Physician Decision|0
6784467|NCT03562767|10781356|FG000|Overall Study|Logistic Reason|1
6784468|NCT03562767|10781357|FG001|Overall Study|Logistic Reason|3
6784469|NCT03562767|10781358|FG002|Overall Study|Logistic Reason|0
6784470|NCT03559699|10781370|FG000|Overall Study|Withdrawal by Subject|6
6784471|NCT03559699|10781370|FG000|Overall Study|Lost to Follow-up|1
6784472|NCT03305016|10781387|FG000|Overall Study|Withdrawal by Subject|2
6784473|NCT03291067|10781404|FG000|Overall Study|Adverse Event|0
6784474|NCT03291067|10781405|FG001|Overall Study|Adverse Event|2
6784475|NCT03291067|10781406|FG002|Overall Study|Adverse Event|17
6784476|NCT03291067|10781407|FG003|Overall Study|Adverse Event|3
6784477|NCT03291067|10781404|FG000|Overall Study|Lost to Follow-up|2
6784478|NCT03291067|10781405|FG001|Overall Study|Lost to Follow-up|1
6784479|NCT03291067|10781406|FG002|Overall Study|Lost to Follow-up|0
6784480|NCT03291067|10781407|FG003|Overall Study|Lost to Follow-up|1
6784481|NCT03291067|10781404|FG000|Overall Study|Physician Decision|0
6784482|NCT03291067|10781405|FG001|Overall Study|Physician Decision|0
6784483|NCT03291067|10781406|FG002|Overall Study|Physician Decision|1
6784484|NCT03291067|10781407|FG003|Overall Study|Physician Decision|0
6784485|NCT03291067|10781404|FG000|Overall Study|Protocol Violation|5
6784486|NCT03291067|10781405|FG001|Overall Study|Protocol Violation|3
6784487|NCT03291067|10781406|FG002|Overall Study|Protocol Violation|4
6784488|NCT03291067|10781407|FG003|Overall Study|Protocol Violation|2
6784489|NCT03291067|10781404|FG000|Overall Study|Withdrawal by Subject|3
6784490|NCT03291067|10781405|FG001|Overall Study|Withdrawal by Subject|4
6784491|NCT03291067|10781406|FG002|Overall Study|Withdrawal by Subject|7
6784492|NCT03291067|10781407|FG003|Overall Study|Withdrawal by Subject|5
6784493|NCT03291067|10781404|FG000|Overall Study|Other|0
6784494|NCT03291067|10781405|FG001|Overall Study|Other|4
6784495|NCT03291067|10781406|FG002|Overall Study|Other|4
6784496|NCT03291067|10781407|FG003|Overall Study|Other|6
6784497|NCT03271047|10781421|FG000|Phase 1b: Dose Finding Period|Death|8
6784498|NCT03271047|10781422|FG001|Phase 1b: Dose Finding Period|Death|8
6784499|NCT03271047|10781423|FG002|Phase 1b: Dose Finding Period|Death|0
6784500|NCT03271047|10781424|FG003|Phase 1b: Dose Finding Period|Death|0
6784501|NCT03271047|10781421|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1
6784502|NCT03271047|10781422|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0
7138936|NCT02952586|11292398|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6
7138937|NCT02952586|11292397|FG000|Follow-Up Phase (90 Days)|Death|12
7138938|NCT02952586|11292398|FG001|Follow-Up Phase (90 Days)|Death|10
7138939|NCT02952586|11292397|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6
7138940|NCT02952586|11292398|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2
7138941|NCT02952586|11292397|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1
7138942|NCT02952586|11292398|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1
7138943|NCT02952586|11292397|FG000|Follow-Up Phase (90 Days)|Other|7
7138944|NCT02952586|11292398|FG001|Follow-Up Phase (90 Days)|Other|5
7138945|NCT02952586|11292397|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32
7138946|NCT02952586|11292398|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50
7138947|NCT02952586|11292397|FG000|LT Follow-up (up to 45 Months)|Death|51
7138948|NCT02952586|11292398|FG001|LT Follow-up (up to 45 Months)|Death|31
7138949|NCT02952586|11292397|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7
6784503|NCT03271047|10781423|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0
6784504|NCT03271047|10781424|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0
6784505|NCT03271047|10781421|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0
6784506|NCT03271047|10781422|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2
6784507|NCT03271047|10781423|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0
6784508|NCT03271047|10781424|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0
6784509|NCT03271047|10781421|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1
6784510|NCT03271047|10781422|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1
6784511|NCT03271047|10781423|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0
6806918|NCT04572997|10810047|FG000|Overall Study|Adverse Event|1
6784512|NCT03271047|10781424|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0
6784513|NCT03271047|10781421|FG000|Randomized Phase 2 Period|Other|0
6784514|NCT03271047|10781422|FG001|Randomized Phase 2 Period|Other|0
6784515|NCT03271047|10781423|FG002|Randomized Phase 2 Period|Other|0
6784516|NCT03271047|10781424|FG003|Randomized Phase 2 Period|Other|1
6784517|NCT03271047|10781421|FG000|Randomized Phase 2 Period|Death|0
6784518|NCT03271047|10781422|FG001|Randomized Phase 2 Period|Death|0
6784519|NCT03271047|10781423|FG002|Randomized Phase 2 Period|Death|20
6784520|NCT03271047|10781424|FG003|Randomized Phase 2 Period|Death|21
6784521|NCT03271047|10781421|FG000|Randomized Phase 2 Period|Lost to Follow-up|0
6784522|NCT03271047|10781422|FG001|Randomized Phase 2 Period|Lost to Follow-up|0
6784523|NCT03271047|10781423|FG002|Randomized Phase 2 Period|Lost to Follow-up|2
6784524|NCT03271047|10781424|FG003|Randomized Phase 2 Period|Lost to Follow-up|1
6784525|NCT03271047|10781421|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0
6784526|NCT03271047|10781422|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0
6784527|NCT03271047|10781423|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5
6784528|NCT03271047|10781424|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0
6784529|NCT03271047|10781421|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0
6784530|NCT03271047|10781422|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0
6784531|NCT03271047|10781423|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0
6784532|NCT03271047|10781424|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4
6784533|NCT03257436|10781436|FG000|Overall Study|Withdrawal by Subject|76
6784534|NCT03257436|10781436|FG000|Overall Study|Death|19
6784535|NCT03158285|10781453|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4
6784536|NCT03158285|10781454|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2
6784537|NCT03158285|10781455|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6
6784538|NCT03158285|10781453|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0
6784539|NCT03158285|10781454|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3
6784540|NCT03158285|10781455|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3
6784541|NCT03158285|10781453|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1
6784542|NCT03158285|10781454|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1
6784543|NCT03158285|10781455|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0
6784544|NCT03158285|10781453|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0
6784545|NCT03158285|10781454|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1
6784546|NCT03158285|10781455|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0
6784547|NCT03158285|10781453|FG000|Placebo-controlled Period: Week 0 - 24|Other|1
6784548|NCT03158285|10781454|FG001|Placebo-controlled Period: Week 0 - 24|Other|1
6784549|NCT03158285|10781455|FG002|Placebo-controlled Period: Week 0 - 24|Other|0
6784550|NCT03158285|10781453|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3
6784551|NCT03158285|10781454|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0
6784552|NCT03158285|10781455|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1
6784553|NCT03158285|10781453|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5
6784554|NCT03158285|10781454|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3
6784555|NCT03158285|10781455|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4
6784556|NCT03158285|10781453|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1
6784557|NCT03158285|10781454|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2
6784558|NCT03158285|10781455|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1
6784559|NCT03158285|10781453|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0
6784560|NCT03158285|10781454|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0
6784561|NCT03158285|10781455|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1
6784562|NCT03158285|10781453|FG000|Active Treatment Period: Week 24 - 52|Other|1
6784563|NCT03158285|10781454|FG001|Active Treatment Period: Week 24 - 52|Other|1
6784564|NCT03158285|10781455|FG002|Active Treatment Period: Week 24 - 52|Other|0
6784565|NCT03158285|10781453|FG000|Active Treatment Period: Week 52-100|Adverse Event|7
6784566|NCT03158285|10781454|FG001|Active Treatment Period: Week 52-100|Adverse Event|5
6784567|NCT03158285|10781455|FG002|Active Treatment Period: Week 52-100|Adverse Event|3
6784568|NCT03158285|10781453|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1
6784569|NCT03158285|10781454|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1
6784570|NCT03158285|10781455|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3
6784571|NCT03158285|10781453|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5
6784572|NCT03158285|10781454|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2
6784573|NCT03158285|10781455|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1
6784574|NCT03158285|10781453|FG000|Active Treatment Period: Week 52-100|Pregnancy|0
6784575|NCT03158285|10781454|FG001|Active Treatment Period: Week 52-100|Pregnancy|0
6784576|NCT03158285|10781455|FG002|Active Treatment Period: Week 52-100|Pregnancy|1
6784577|NCT03158285|10781453|FG000|Active Treatment Period: Week 52-100|Death|1
6784578|NCT03158285|10781454|FG001|Active Treatment Period: Week 52-100|Death|0
6784579|NCT03158285|10781455|FG002|Active Treatment Period: Week 52-100|Death|0
6784580|NCT03158285|10781453|FG000|Active Treatment Period: Week 52-100|Other|4
6784581|NCT03158285|10781454|FG001|Active Treatment Period: Week 52-100|Other|1
6784582|NCT03158285|10781455|FG002|Active Treatment Period: Week 52-100|Other|0
6806939|NCT04531540|10810211|FG000|Overall Study|Protocol Violation|3
6806940|NCT04531540|10810211|FG000|Overall Study|Withdrawal by Subject|4
6784583|NCT04723173|10781468|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1
6784584|NCT03683823|10781512|FG000|Post-treatment Assessment|Withdrawal by Subject|1
6784585|NCT03683823|10781513|FG001|Post-treatment Assessment|Withdrawal by Subject|1
6784586|NCT03683823|10781512|FG000|Post-treatment Assessment|Lost to Follow-up|0
6784587|NCT03683823|10781513|FG001|Post-treatment Assessment|Lost to Follow-up|1
6784588|NCT03683823|10781512|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1
6784589|NCT03683823|10781513|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1
6784590|NCT03515551|10781539|FG000|Overall Study|Death|4
6784591|NCT03515551|10781540|FG001|Overall Study|Death|1
6784592|NCT03515551|10781541|FG002|Overall Study|Death|2
6784593|NCT03515551|10781542|FG003|Overall Study|Death|2
6784594|NCT03515551|10781543|FG004|Overall Study|Death|2
6784595|NCT03515551|10781544|FG005|Overall Study|Death|4
6784596|NCT03515551|10781545|FG006|Overall Study|Death|1
6784597|NCT03515551|10781539|FG000|Overall Study|Lost to Follow-up|0
6784598|NCT03515551|10781540|FG001|Overall Study|Lost to Follow-up|0
6784599|NCT03515551|10781541|FG002|Overall Study|Lost to Follow-up|1
6784600|NCT03515551|10781542|FG003|Overall Study|Lost to Follow-up|0
6784601|NCT03515551|10781543|FG004|Overall Study|Lost to Follow-up|0
6784602|NCT03515551|10781544|FG005|Overall Study|Lost to Follow-up|0
6784603|NCT03515551|10781545|FG006|Overall Study|Lost to Follow-up|0
6784604|NCT03515551|10781539|FG000|Overall Study|Withdrawal by Subject|0
6784605|NCT03515551|10781540|FG001|Overall Study|Withdrawal by Subject|1
6784606|NCT03515551|10781541|FG002|Overall Study|Withdrawal by Subject|0
6784607|NCT03515551|10781542|FG003|Overall Study|Withdrawal by Subject|0
6784608|NCT03515551|10781543|FG004|Overall Study|Withdrawal by Subject|0
6784609|NCT03515551|10781544|FG005|Overall Study|Withdrawal by Subject|0
6784610|NCT03515551|10781545|FG006|Overall Study|Withdrawal by Subject|1
6784611|NCT03515551|10781539|FG000|Overall Study|Study ended by sponsor|0
6784612|NCT03515551|10781540|FG001|Overall Study|Study ended by sponsor|0
6784613|NCT03515551|10781541|FG002|Overall Study|Study ended by sponsor|2
6784614|NCT03515551|10781542|FG003|Overall Study|Study ended by sponsor|1
6784615|NCT03515551|10781543|FG004|Overall Study|Study ended by sponsor|3
6784616|NCT03515551|10781544|FG005|Overall Study|Study ended by sponsor|0
6784617|NCT03515551|10781545|FG006|Overall Study|Study ended by sponsor|3
6784618|NCT03515551|10781539|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0
6784619|NCT03515551|10781540|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1
6784620|NCT03515551|10781541|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0
6784621|NCT03515551|10781542|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0
6784622|NCT03515551|10781543|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0
6784623|NCT03515551|10781544|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0
6784624|NCT03515551|10781545|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0
6784625|NCT03385265|10781570|FG000|Overall Study|Withdrawal by Subject|5
6784626|NCT03385265|10781571|FG001|Overall Study|Withdrawal by Subject|2
6784627|NCT03385265|10781572|FG002|Overall Study|Withdrawal by Subject|5
6784628|NCT03385265|10781573|FG003|Overall Study|Withdrawal by Subject|2
7138950|NCT02952586|11292398|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1
7138951|NCT02952586|11292397|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2
7138952|NCT02952586|11292398|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4
7138953|NCT02952586|11292397|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187
7138954|NCT02952586|11292398|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201
7138955|NCT02952820|11292408|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8
7138956|NCT02952820|11292409|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9
7138957|NCT02952820|11292410|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16
7138958|NCT02952820|11292408|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7
7138959|NCT02952820|11292409|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7
7138960|NCT02952820|11292410|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6
7138961|NCT02952820|11292408|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15
7138962|NCT02952820|11292409|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12
7138963|NCT02952820|11292410|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17
7138964|NCT02952820|11292408|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17
7138965|NCT02952820|11292409|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12
7138966|NCT02952820|11292410|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11
7138967|NCT02952820|11292408|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0
7138968|NCT02952820|11292409|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14
7138969|NCT02952820|11292410|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13
7138970|NCT02952820|11292408|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13
7138971|NCT02952820|11292409|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11
7138972|NCT02952820|11292410|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21
7138973|NCT02952820|11292408|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4
7138974|NCT02952820|11292409|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4
7138975|NCT02952820|11292410|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4
6784661|NCT02919306|10781639|FG000|Overall Study|Withdrawal by Subject|1
6784662|NCT02919306|10781640|FG001|Overall Study|Withdrawal by Subject|0
6784663|NCT02919306|10781639|FG000|Overall Study|Protocol Violation|1
6784664|NCT02919306|10781640|FG001|Overall Study|Protocol Violation|0
6784665|NCT02763189|10781648|FG000|Overall Study|Device failure|0
6784666|NCT02763189|10781649|FG001|Overall Study|Device failure|2
6784667|NCT02659514|10781666|FG000|Overall Study|Adverse Event|3
6784668|NCT02659514|10781667|FG001|Overall Study|Adverse Event|12
6784669|NCT02659514|10781666|FG000|Overall Study|Disease Progression|23
6784670|NCT02659514|10781667|FG001|Overall Study|Disease Progression|13
6784671|NCT02659514|10781666|FG000|Overall Study|Withdrawal by Subject|0
6784672|NCT02659514|10781667|FG001|Overall Study|Withdrawal by Subject|4
6784673|NCT02659514|10781666|FG000|Overall Study|Lost to Follow-up|0
6784674|NCT02659514|10781667|FG001|Overall Study|Lost to Follow-up|1
6784675|NCT02659514|10781666|FG000|Overall Study|Death|6
6784676|NCT02659514|10781667|FG001|Overall Study|Death|1
6784677|NCT02659514|10781666|FG000|Overall Study|Reason Unspecified|0
6784678|NCT02659514|10781667|FG001|Overall Study|Reason Unspecified|3
6784679|NCT02390245|10781692|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0
6784680|NCT02390245|10781693|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104
6784681|NCT02390245|10781694|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|105
6784682|NCT02390245|10781692|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0
6784683|NCT02390245|10781693|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|94
6784684|NCT02390245|10781694|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|105
6784685|NCT02254278|10781703|FG000|Overall Study|Protocol Violation|1
6784686|NCT02254278|10781704|FG001|Overall Study|Protocol Violation|1
7138976|NCT02952820|11292408|FG000|Active Treatment Period (6 Months)|Adverse Event|0
7138977|NCT02952820|11292409|FG001|Active Treatment Period (6 Months)|Adverse Event|6
7138978|NCT02952820|11292410|FG002|Active Treatment Period (6 Months)|Adverse Event|5
7138979|NCT02952820|11292408|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0
7138980|NCT02952820|11292409|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4
7138981|NCT02952820|11292410|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6
7138982|NCT02952820|11292408|FG000|Active Treatment Period (6 Months)|Subject choice|0
7138983|NCT02952820|11292409|FG001|Active Treatment Period (6 Months)|Subject choice|10
7138984|NCT02952820|11292410|FG002|Active Treatment Period (6 Months)|Subject choice|7
7138985|NCT02952820|11292408|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0
7138986|NCT02952820|11292409|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6
7138987|NCT02952820|11292410|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2
7138988|NCT02952820|11292408|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0
7138989|NCT02952820|11292409|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6
7138990|NCT02952820|11292410|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8
7138991|NCT02952820|11292408|FG000|Active Treatment Period (6 Months)|Other than specified|0
7138992|NCT02952820|11292409|FG001|Active Treatment Period (6 Months)|Other than specified|6
7138993|NCT02952820|11292410|FG002|Active Treatment Period (6 Months)|Other than specified|2
7138994|NCT02952820|11292408|FG000|Active Treatment Period (6 Months)|Not treated|0
7138995|NCT02952820|11292409|FG001|Active Treatment Period (6 Months)|Not treated|0
7138996|NCT02952820|11292410|FG002|Active Treatment Period (6 Months)|Not treated|1
7138997|NCT02952898|11292489|FG000|Overall Study|Withdrawal by Subject|10
7138998|NCT02952898|11292490|FG001|Overall Study|Withdrawal by Subject|8
7138999|NCT02952898|11292491|FG002|Overall Study|Withdrawal by Subject|8
7139000|NCT02952898|11292489|FG000|Overall Study|Adverse Event|8
7139001|NCT02952898|11292490|FG001|Overall Study|Adverse Event|8
7139002|NCT02952898|11292491|FG002|Overall Study|Adverse Event|3
6784717|NCT01673867|10781726|FG000|Randomization|AE unrelated to study drug|1
6784718|NCT01673867|10781727|FG001|Randomization|AE unrelated to study drug|0
6784719|NCT01673867|10781726|FG000|Randomization|Requested treatment discontinuation|0
6784720|NCT01673867|10781727|FG001|Randomization|Requested treatment discontinuation|4
6784721|NCT01673867|10781726|FG000|Randomization|Withdrawal by Subject|0
6784722|NCT01673867|10781727|FG001|Randomization|Withdrawal by Subject|12
6784723|NCT01673867|10781726|FG000|Randomization|Lost to Follow-up|0
6784724|NCT01673867|10781727|FG001|Randomization|Lost to Follow-up|1
6784725|NCT01673867|10781726|FG000|Randomization|No longer meets criteria|4
6784726|NCT01673867|10781727|FG001|Randomization|No longer meets criteria|5
6784727|NCT01673867|10781726|FG000|Treatment|Disease Progression|194
6784728|NCT01673867|10781727|FG001|Treatment|Disease Progression|179
6784729|NCT01673867|10781726|FG000|Treatment|Study Drug Toxicity|17
6784730|NCT01673867|10781727|FG001|Treatment|Study Drug Toxicity|42
6784731|NCT01673867|10781726|FG000|Treatment|Death|1
6784732|NCT01673867|10781727|FG001|Treatment|Death|1
6784733|NCT01673867|10781726|FG000|Treatment|AE unrelated to study drug|19
6784734|NCT01673867|10781727|FG001|Treatment|AE unrelated to study drug|11
6784735|NCT01673867|10781726|FG000|Treatment|Requested treatment discontinuation|5
6784736|NCT01673867|10781727|FG001|Treatment|Requested treatment discontinuation|16
6784737|NCT01673867|10781726|FG000|Treatment|Withdrawal by Subject|4
6784738|NCT01673867|10781727|FG001|Treatment|Withdrawal by Subject|6
6784739|NCT01673867|10781726|FG000|Treatment|Maximum clinical benefit|0
6784740|NCT01673867|10781727|FG001|Treatment|Maximum clinical benefit|10
6784741|NCT01673867|10781726|FG000|Treatment|No longer meets criteria|2
6784742|NCT01673867|10781727|FG001|Treatment|No longer meets criteria|0
6784743|NCT01673867|10781726|FG000|Treatment|Required steroid therapy|1
6784744|NCT01673867|10781727|FG001|Treatment|Required steroid therapy|0
6784745|NCT01673867|10781726|FG000|Treatment|Health status not improved|1
6784746|NCT01673867|10781727|FG001|Treatment|Health status not improved|0
6784747|NCT01673867|10781726|FG000|Treatment|Required prolonged hospitalization|0
6784748|NCT01673867|10781727|FG001|Treatment|Required prolonged hospitalization|1
6784749|NCT01673867|10781726|FG000|Treatment|Symptomatic deterioration|0
6784750|NCT01673867|10781727|FG001|Treatment|Symptomatic deterioration|1
6784751|NCT01673867|10781726|FG000|Treatment|Physician Decision|0
6784752|NCT01673867|10781727|FG001|Treatment|Physician Decision|1
6784753|NCT00335777|10781737|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5
6784754|NCT00335777|10781737|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6
6784755|NCT00335777|10781737|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18
6784756|NCT00335777|10781737|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1
6784757|NCT00335777|10781737|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12
6784758|NCT00159588|10781745|FG000|5 Month Follow-up|Withdrawal by Subject|2
6784759|NCT00159588|10781746|FG001|5 Month Follow-up|Withdrawal by Subject|4
6784760|NCT00159588|10781747|FG002|5 Month Follow-up|Withdrawal by Subject|2
6784761|NCT03051217|10781761|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2
6784762|NCT03051217|10781762|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0
6784763|NCT03051217|10781763|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1
6784764|NCT03051217|10781764|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0
6784765|NCT03051217|10781765|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0
6784766|NCT03051217|10781766|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0
6784767|NCT03051217|10781767|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0
6784768|NCT03051217|10781761|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0
6784769|NCT03051217|10781762|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1
6784770|NCT03051217|10781763|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0
6784771|NCT03051217|10781764|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0
6784772|NCT03051217|10781765|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0
6784773|NCT03051217|10781766|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0
6784774|NCT03051217|10781767|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0
6784775|NCT03051217|10781761|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
6784776|NCT03051217|10781762|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
6784777|NCT03051217|10781763|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
6784778|NCT03051217|10781764|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
6784779|NCT03051217|10781765|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
6784780|NCT03051217|10781766|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
6784781|NCT03051217|10781767|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
6784782|NCT03051217|10781761|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
6784783|NCT03051217|10781762|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
6784784|NCT03051217|10781763|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
6784785|NCT03051217|10781764|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
6784786|NCT03051217|10781765|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2
6784787|NCT03051217|10781766|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
6784788|NCT03051217|10781767|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
6784789|NCT03051217|10781761|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
6784790|NCT03051217|10781762|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
6806941|NCT04531540|10810211|FG000|Overall Study|Found to be Ineligible|1
6810610|NCT03167242|10814448|FG010|Overall Study|Patient/Guardian Decision|1
6810611|NCT03167242|10814449|FG011|Overall Study|Patient/Guardian Decision|0
6810612|NCT03167242|10814438|FG000|Overall Study|Lost to Follow-up|0
6810613|NCT03167242|10814439|FG001|Overall Study|Lost to Follow-up|0
6810614|NCT03167242|10814440|FG002|Overall Study|Lost to Follow-up|1
6810615|NCT03167242|10814441|FG003|Overall Study|Lost to Follow-up|0
6810616|NCT03167242|10814442|FG004|Overall Study|Lost to Follow-up|0
6810617|NCT03167242|10814443|FG005|Overall Study|Lost to Follow-up|1
6810618|NCT03167242|10814444|FG006|Overall Study|Lost to Follow-up|2
7139003|NCT02952898|11292489|FG000|Overall Study|Lost to Follow-up|3
7139004|NCT02952898|11292490|FG001|Overall Study|Lost to Follow-up|2
7139005|NCT02952898|11292491|FG002|Overall Study|Lost to Follow-up|2
7139006|NCT02952898|11292489|FG000|Overall Study|Non-compliance with study drug|1
7139007|NCT02952898|11292490|FG001|Overall Study|Non-compliance with study drug|1
7139008|NCT02952898|11292491|FG002|Overall Study|Non-compliance with study drug|2
7139009|NCT02953262|11292503|FG000|Overall Study|Used portal during 6 months prior to randomization|3
7139010|NCT02953262|11292504|FG001|Overall Study|Used portal during 6 months prior to randomization|6
7139011|NCT02953262|11292505|FG002|Overall Study|Used portal during 6 months prior to randomization|3
7139012|NCT02953262|11292506|FG003|Overall Study|Used portal during 6 months prior to randomization|3
7139013|NCT02953314|11292522|FG000|Overall Study|Adverse Event|0
7139014|NCT02953314|11292523|FG001|Overall Study|Adverse Event|1
7139015|NCT02953314|11292522|FG000|Overall Study|Withdrawal of consent (not due to AE)|0
7139016|NCT02953314|11292523|FG001|Overall Study|Withdrawal of consent (not due to AE)|2
7139017|NCT02953639|11292548|FG000|Overall Study|Adverse Event|2
7139018|NCT02953639|11292549|FG001|Overall Study|Adverse Event|0
7139019|NCT02953639|11292550|FG002|Overall Study|Adverse Event|1
6810619|NCT03167242|10814445|FG007|Overall Study|Lost to Follow-up|1
6810620|NCT03167242|10814446|FG008|Overall Study|Lost to Follow-up|0
6810621|NCT03167242|10814447|FG009|Overall Study|Lost to Follow-up|0
6784791|NCT03051217|10781763|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
6784792|NCT03051217|10781764|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1
6784793|NCT03051217|10781765|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
6784794|NCT03051217|10781766|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
6784795|NCT03051217|10781767|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
6784796|NCT03051217|10781761|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
6784797|NCT03051217|10781762|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
6784798|NCT03051217|10781763|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
6784799|NCT03051217|10781764|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1
6784800|NCT03051217|10781765|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
6784801|NCT03051217|10781766|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
6784802|NCT03051217|10781767|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
6784803|NCT03051217|10781761|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
6784804|NCT03051217|10781762|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
6784805|NCT03051217|10781763|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
6784806|NCT03051217|10781764|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
6784807|NCT03051217|10781765|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1
6784808|NCT03051217|10781766|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
6784809|NCT03051217|10781767|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
6784810|NCT03051217|10781761|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
6784811|NCT03051217|10781762|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
6784812|NCT03051217|10781763|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
6784813|NCT03051217|10781764|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
6784814|NCT03051217|10781765|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
6784815|NCT03051217|10781766|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1
6784816|NCT03051217|10781767|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
6784817|NCT03025542|10781783|FG000|Overall Study|Adverse Event|0
6784818|NCT03025542|10781784|FG001|Overall Study|Adverse Event|2
6784819|NCT03025542|10781783|FG000|Overall Study|Lost to Follow-up|1
6784820|NCT03025542|10781784|FG001|Overall Study|Lost to Follow-up|0
6784821|NCT03025542|10781783|FG000|Overall Study|Withdrawal by Subject|1
6784822|NCT03025542|10781784|FG001|Overall Study|Withdrawal by Subject|0
6784823|NCT02889809|10781820|FG000|Overall Study|Withdrawal by Subject|30
6784824|NCT02889809|10781821|FG001|Overall Study|Withdrawal by Subject|21
6784825|NCT02889809|10781820|FG000|Overall Study|Lost to Follow-up|1
6784826|NCT02889809|10781821|FG001|Overall Study|Lost to Follow-up|1
6784827|NCT02889809|10781820|FG000|Overall Study|Site Closed|12
6784828|NCT02889809|10781821|FG001|Overall Study|Site Closed|11
6784829|NCT02849587|10781830|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2
6784830|NCT02849587|10781831|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3
6784831|NCT02849587|10781832|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2
6784832|NCT02849587|10781830|FG000|Overall Study|Withdrawal by Subject|0
6784833|NCT02849587|10781831|FG001|Overall Study|Withdrawal by Subject|1
6784834|NCT02849587|10781832|FG002|Overall Study|Withdrawal by Subject|0
6784835|NCT02815540|10781844|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2
6784836|NCT02781727|10781879|FG000|Pre-dosing Period|Withdrawal by Subject|1
6784837|NCT02781727|10781880|FG001|Pre-dosing Period|Withdrawal by Subject|0
6784838|NCT02781727|10781879|FG000|Treatment Period|Withdrawal by Subject|1
6784839|NCT02781727|10781880|FG001|Treatment Period|Withdrawal by Subject|0
6784840|NCT02781727|10781879|FG000|Treatment Period|Lost to Follow-up|0
6784841|NCT02781727|10781880|FG001|Treatment Period|Lost to Follow-up|1
6784842|NCT02778204|10781890|FG000|Overall Study|Adverse Event|1
6784843|NCT02778204|10781891|FG001|Overall Study|Adverse Event|0
6784844|NCT02778204|10781892|FG002|Overall Study|Adverse Event|0
6784845|NCT02778204|10781893|FG003|Overall Study|Adverse Event|0
6784846|NCT02778204|10781890|FG000|Overall Study|Withdrawal by Subject|0
6784847|NCT02778204|10781891|FG001|Overall Study|Withdrawal by Subject|0
6784848|NCT02778204|10781892|FG002|Overall Study|Withdrawal by Subject|1
6784849|NCT02778204|10781893|FG003|Overall Study|Withdrawal by Subject|2
6784850|NCT02778204|10781890|FG000|Overall Study|Lost to Follow-up|1
6784851|NCT02778204|10781891|FG001|Overall Study|Lost to Follow-up|0
6784852|NCT02778204|10781892|FG002|Overall Study|Lost to Follow-up|2
6784853|NCT02778204|10781893|FG003|Overall Study|Lost to Follow-up|1
6784854|NCT02778204|10781890|FG000|Overall Study|Protocol Violation|0
6784855|NCT02778204|10781891|FG001|Overall Study|Protocol Violation|0
6784856|NCT02778204|10781892|FG002|Overall Study|Protocol Violation|1
6784857|NCT02778204|10781893|FG003|Overall Study|Protocol Violation|0
6784858|NCT02778204|10781890|FG000|Overall Study|Eligibility Violation|0
6784859|NCT02778204|10781891|FG001|Overall Study|Eligibility Violation|0
6784860|NCT02778204|10781892|FG002|Overall Study|Eligibility Violation|0
6784861|NCT02778204|10781893|FG003|Overall Study|Eligibility Violation|1
6806942|NCT04093258|10810223|FG000|Period 2|Subject no longer meets the eligibility criteria|1
6806943|NCT04093258|10810224|FG001|Period 2|Subject no longer meets the eligibility criteria|0
6806944|NCT03993379|10810238|FG000|Overall Study|The study was terminated early due to business decision.|0
6784862|NCT02496611|10781916|FG000|Overall Study|Lost to Follow-up|2
6784863|NCT02496611|10781917|FG001|Overall Study|Lost to Follow-up|1
6784864|NCT02496611|10781916|FG000|Overall Study|Withdrawal by Subject|5
6784865|NCT02496611|10781917|FG001|Overall Study|Withdrawal by Subject|2
6784872|NCT02177695|10781952|FG000|ITT Analysis|Ineligible|5
6784873|NCT02177695|10781953|FG001|ITT Analysis|Ineligible|5
6784874|NCT02177695|10781952|FG000|Primary COXEN Analysis|inadequate tissue submitted|5
6784875|NCT02177695|10781953|FG001|Primary COXEN Analysis|inadequate tissue submitted|6
6784876|NCT02177695|10781952|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15
6784877|NCT02177695|10781953|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8
6784878|NCT02177695|10781952|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13
6784879|NCT02177695|10781953|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13
6784880|NCT02105636|10781983|FG000|Overall Study|Disease Progression|162
6784881|NCT02105636|10781984|FG001|Overall Study|Disease Progression|83
6784882|NCT02105636|10781983|FG000|Overall Study|Study Drug Toxicity|9
6784883|NCT02105636|10781984|FG001|Overall Study|Study Drug Toxicity|11
6784884|NCT02105636|10781983|FG000|Overall Study|Adverse Event Unrelated to Study Drug|12
6784885|NCT02105636|10781984|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3
6784886|NCT02105636|10781983|FG000|Overall Study|Subject Request to Discontinue Treatment|4
6784887|NCT02105636|10781984|FG001|Overall Study|Subject Request to Discontinue Treatment|6
6784888|NCT02105636|10781983|FG000|Overall Study|Subject Withdrew Consent|4
6784889|NCT02105636|10781984|FG001|Overall Study|Subject Withdrew Consent|1
6784890|NCT02105636|10781983|FG000|Overall Study|Maximum Clinical Benefit|1
6784891|NCT02105636|10781984|FG001|Overall Study|Maximum Clinical Benefit|1
6784892|NCT02105636|10781983|FG000|Overall Study|Poor/Non-compliance|0
6784893|NCT02105636|10781984|FG001|Overall Study|Poor/Non-compliance|1
6784894|NCT02105636|10781983|FG000|Overall Study|Reason Not Specified|0
6784895|NCT02105636|10781984|FG001|Overall Study|Reason Not Specified|2
6784896|NCT02105636|10781983|FG000|Overall Study|Not Reported|3
6784897|NCT02105636|10781984|FG001|Overall Study|Not Reported|0
6784898|NCT02038946|10781991|FG000|Overall Study|Death|5
6784899|NCT02038946|10781991|FG000|Overall Study|Withdrawal by Subject|3
6784900|NCT02038946|10781991|FG000|Overall Study|Lost to Follow-up|2
6784901|NCT02038946|10781991|FG000|Overall Study|Other reasons|2
6784902|NCT01988571|10781997|FG000|Overall Study|Death|3
6784903|NCT01988571|10781998|FG001|Overall Study|Death|1
6784904|NCT01988571|10781997|FG000|Overall Study|Physician Decision|2
6784905|NCT01988571|10781998|FG001|Overall Study|Physician Decision|1
6784906|NCT01988571|10781997|FG000|Overall Study|Lost to Follow-up|3
6784907|NCT01988571|10781998|FG001|Overall Study|Lost to Follow-up|0
6784908|NCT01988571|10781997|FG000|Overall Study|Withdrawal by Subject|31
6784909|NCT01988571|10781998|FG001|Overall Study|Withdrawal by Subject|33
6784910|NCT01332266|10782013|FG000|Phase 1b|Death|3
6784911|NCT01332266|10782014|FG001|Phase 1b|Death|3
6784912|NCT01332266|10782015|FG002|Phase 1b|Death|2
6784913|NCT01332266|10782016|FG003|Phase 1b|Death|0
6784914|NCT01332266|10782017|FG004|Phase 1b|Death|0
6784915|NCT01332266|10782013|FG000|Phase 1b|Lost to Follow-up|0
6784916|NCT01332266|10782014|FG001|Phase 1b|Lost to Follow-up|1
6784917|NCT01332266|10782015|FG002|Phase 1b|Lost to Follow-up|0
6784918|NCT01332266|10782016|FG003|Phase 1b|Lost to Follow-up|0
6784919|NCT01332266|10782017|FG004|Phase 1b|Lost to Follow-up|0
6784920|NCT01332266|10782013|FG000|Phase 1b|Withdrawal by Subject|1
6784921|NCT01332266|10782014|FG001|Phase 1b|Withdrawal by Subject|1
6784922|NCT01332266|10782015|FG002|Phase 1b|Withdrawal by Subject|1
6784923|NCT01332266|10782016|FG003|Phase 1b|Withdrawal by Subject|0
6784924|NCT01332266|10782017|FG004|Phase 1b|Withdrawal by Subject|0
6784925|NCT01332266|10782013|FG000|Phase 2|Death|0
6784926|NCT01332266|10782014|FG001|Phase 2|Death|0
6784927|NCT01332266|10782015|FG002|Phase 2|Death|0
6784928|NCT01332266|10782016|FG003|Phase 2|Death|33
6784929|NCT01332266|10782017|FG004|Phase 2|Death|36
6784930|NCT01332266|10782013|FG000|Phase 2|Lost to Follow-up|0
6784931|NCT01332266|10782014|FG001|Phase 2|Lost to Follow-up|0
6784932|NCT01332266|10782015|FG002|Phase 2|Lost to Follow-up|0
6784933|NCT01332266|10782016|FG003|Phase 2|Lost to Follow-up|2
6784934|NCT01332266|10782017|FG004|Phase 2|Lost to Follow-up|0
6784935|NCT01332266|10782013|FG000|Phase 2|Physician Decision|0
6784936|NCT01332266|10782014|FG001|Phase 2|Physician Decision|0
6784937|NCT01332266|10782015|FG002|Phase 2|Physician Decision|0
6784938|NCT01332266|10782016|FG003|Phase 2|Physician Decision|3
6784939|NCT01332266|10782017|FG004|Phase 2|Physician Decision|1
6784940|NCT01332266|10782013|FG000|Phase 2|Symptomatic deterioration|0
6784941|NCT01332266|10782014|FG001|Phase 2|Symptomatic deterioration|0
6784942|NCT01332266|10782015|FG002|Phase 2|Symptomatic deterioration|0
6784943|NCT01332266|10782016|FG003|Phase 2|Symptomatic deterioration|0
6784944|NCT01332266|10782017|FG004|Phase 2|Symptomatic deterioration|1
6784945|NCT01332266|10782013|FG000|Phase 2|Progression Disease|0
6784946|NCT01332266|10782014|FG001|Phase 2|Progression Disease|0
6784947|NCT01332266|10782015|FG002|Phase 2|Progression Disease|0
6784948|NCT01332266|10782016|FG003|Phase 2|Progression Disease|2
6784949|NCT01332266|10782017|FG004|Phase 2|Progression Disease|1
6784950|NCT01332266|10782013|FG000|Phase 2|Withdrawal by Subject|0
6784951|NCT01332266|10782014|FG001|Phase 2|Withdrawal by Subject|0
6784952|NCT01332266|10782015|FG002|Phase 2|Withdrawal by Subject|0
6784953|NCT01332266|10782016|FG003|Phase 2|Withdrawal by Subject|2
6784954|NCT01332266|10782017|FG004|Phase 2|Withdrawal by Subject|2
6784955|NCT01150890|10782034|FG000|Overall Study|Other|0
6784956|NCT01150890|10782035|FG001|Overall Study|Other|1
6784957|NCT01150890|10782036|FG002|Overall Study|Other|0
6784958|NCT01150890|10782037|FG003|Overall Study|Other|2
6784959|NCT01150890|10782034|FG000|Overall Study|Pregnancy|0
6784960|NCT01150890|10782035|FG001|Overall Study|Pregnancy|0
6784961|NCT01150890|10782036|FG002|Overall Study|Pregnancy|0
6784962|NCT01150890|10782037|FG003|Overall Study|Pregnancy|1
6784963|NCT01150890|10782034|FG000|Overall Study|Administrative Decision|4
6784964|NCT01150890|10782035|FG001|Overall Study|Administrative Decision|4
6784965|NCT01150890|10782036|FG002|Overall Study|Administrative Decision|5
6784966|NCT01150890|10782037|FG003|Overall Study|Administrative Decision|6
6784967|NCT01150890|10782034|FG000|Overall Study|Ineligibility determined|0
6784968|NCT01150890|10782035|FG001|Overall Study|Ineligibility determined|1
6784969|NCT01150890|10782036|FG002|Overall Study|Ineligibility determined|0
6784970|NCT01150890|10782037|FG003|Overall Study|Ineligibility determined|0
6784971|NCT01150890|10782034|FG000|Overall Study|Adverse Event|0
6784972|NCT01150890|10782035|FG001|Overall Study|Adverse Event|0
6784973|NCT01150890|10782036|FG002|Overall Study|Adverse Event|2
6784974|NCT01150890|10782037|FG003|Overall Study|Adverse Event|0
6784975|NCT01150890|10782034|FG000|Overall Study|Withdrawal by Subject|0
6784976|NCT01150890|10782035|FG001|Overall Study|Withdrawal by Subject|0
6784977|NCT01150890|10782036|FG002|Overall Study|Withdrawal by Subject|2
6784978|NCT01150890|10782037|FG003|Overall Study|Withdrawal by Subject|1
6784979|NCT01150890|10782034|FG000|Overall Study|Disease progression|0
6784980|NCT01150890|10782035|FG001|Overall Study|Disease progression|7
6784981|NCT01150890|10782036|FG002|Overall Study|Disease progression|3
6784982|NCT01150890|10782037|FG003|Overall Study|Disease progression|7
6784983|NCT01140867|10782050|FG000|Overall Study|Adverse Event|22
6784984|NCT01140867|10782050|FG000|Overall Study|Lack of Efficacy|3
6784985|NCT01140867|10782050|FG000|Overall Study|Lost to Follow-up|2
6784986|NCT01140867|10782050|FG000|Overall Study|Withdrawal by Subject|1
6784987|NCT01140867|10782050|FG000|Overall Study|Protocol Violation|1
6784988|NCT01140867|10782050|FG000|Overall Study|Uncooperative patient|2
6784989|NCT01140867|10782050|FG000|Overall Study|Medication Noncompliance|2
6784990|NCT01137773|10782056|FG000|Overall Study|Death|3
6784991|NCT01137773|10782057|FG001|Overall Study|Death|3
6784992|NCT01137773|10782056|FG000|Overall Study|Lost to Follow-up|6
6784993|NCT01137773|10782057|FG001|Overall Study|Lost to Follow-up|0
6784994|NCT01127256|10782067|FG000|Overall Study|Adverse Event|13
6784995|NCT01127256|10782068|FG001|Overall Study|Adverse Event|13
6784996|NCT01127256|10782067|FG000|Overall Study|Lack of Efficacy|4
6784997|NCT01127256|10782068|FG001|Overall Study|Lack of Efficacy|0
6784998|NCT01127256|10782067|FG000|Overall Study|Lost to Follow-up|16
6784999|NCT01127256|10782068|FG001|Overall Study|Lost to Follow-up|17
6785000|NCT01127256|10782067|FG000|Overall Study|Withdrawal by Subject|5
6785001|NCT01127256|10782068|FG001|Overall Study|Withdrawal by Subject|9
6785002|NCT01127256|10782067|FG000|Overall Study|Protocol Violation|1
6785003|NCT01127256|10782068|FG001|Overall Study|Protocol Violation|0
6785004|NCT01004861|10782087|FG000|Overall Study|Disease progression|3
6785005|NCT01004861|10782088|FG001|Overall Study|Disease progression|4
6785006|NCT01004861|10782089|FG002|Overall Study|Disease progression|5
6785007|NCT01004861|10782090|FG003|Overall Study|Disease progression|4
6785008|NCT01004861|10782091|FG004|Overall Study|Disease progression|4
6785009|NCT01004861|10782092|FG005|Overall Study|Disease progression|4
6785010|NCT01004861|10782093|FG006|Overall Study|Disease progression|5
6785011|NCT01004861|10782094|FG007|Overall Study|Disease progression|1
6785012|NCT01004861|10782095|FG008|Overall Study|Disease progression|4
6785013|NCT01004861|10782096|FG009|Overall Study|Disease progression|7
6785014|NCT01004861|10782097|FG010|Overall Study|Disease progression|6
6785015|NCT01004861|10782098|FG011|Overall Study|Disease progression|3
6785016|NCT01004861|10782099|FG012|Overall Study|Disease progression|8
6785017|NCT01004861|10782087|FG000|Overall Study|Physician Decision|0
6785018|NCT01004861|10782088|FG001|Overall Study|Physician Decision|2
6785019|NCT01004861|10782089|FG002|Overall Study|Physician Decision|1
6785020|NCT01004861|10782090|FG003|Overall Study|Physician Decision|1
6785021|NCT01004861|10782091|FG004|Overall Study|Physician Decision|1
6785022|NCT01004861|10782092|FG005|Overall Study|Physician Decision|0
6785023|NCT01004861|10782093|FG006|Overall Study|Physician Decision|0
6785024|NCT01004861|10782094|FG007|Overall Study|Physician Decision|1
6785025|NCT01004861|10782095|FG008|Overall Study|Physician Decision|0
6785026|NCT01004861|10782096|FG009|Overall Study|Physician Decision|0
6785027|NCT01004861|10782097|FG010|Overall Study|Physician Decision|0
6785028|NCT01004861|10782098|FG011|Overall Study|Physician Decision|0
6785029|NCT01004861|10782099|FG012|Overall Study|Physician Decision|3
6785030|NCT01004861|10782087|FG000|Overall Study|Adverse Event|0
6785031|NCT01004861|10782088|FG001|Overall Study|Adverse Event|0
6785032|NCT01004861|10782089|FG002|Overall Study|Adverse Event|0
6785033|NCT01004861|10782090|FG003|Overall Study|Adverse Event|1
6785034|NCT01004861|10782091|FG004|Overall Study|Adverse Event|0
6785035|NCT01004861|10782092|FG005|Overall Study|Adverse Event|2
6785036|NCT01004861|10782093|FG006|Overall Study|Adverse Event|1
6785037|NCT01004861|10782094|FG007|Overall Study|Adverse Event|1
6785038|NCT01004861|10782095|FG008|Overall Study|Adverse Event|13
6785039|NCT01004861|10782096|FG009|Overall Study|Adverse Event|1
6785040|NCT01004861|10782097|FG010|Overall Study|Adverse Event|1
6785041|NCT01004861|10782098|FG011|Overall Study|Adverse Event|0
6785042|NCT01004861|10782099|FG012|Overall Study|Adverse Event|2
6785043|NCT01004861|10782087|FG000|Overall Study|Protocol Violation|0
6785044|NCT01004861|10782088|FG001|Overall Study|Protocol Violation|0
6785045|NCT01004861|10782089|FG002|Overall Study|Protocol Violation|0
6785046|NCT01004861|10782090|FG003|Overall Study|Protocol Violation|0
6785047|NCT01004861|10782091|FG004|Overall Study|Protocol Violation|1
6785048|NCT01004861|10782092|FG005|Overall Study|Protocol Violation|0
6785049|NCT01004861|10782093|FG006|Overall Study|Protocol Violation|0
6785050|NCT01004861|10782094|FG007|Overall Study|Protocol Violation|0
6785051|NCT01004861|10782095|FG008|Overall Study|Protocol Violation|0
6785052|NCT01004861|10782096|FG009|Overall Study|Protocol Violation|0
6785053|NCT01004861|10782097|FG010|Overall Study|Protocol Violation|0
6785054|NCT01004861|10782098|FG011|Overall Study|Protocol Violation|0
6785055|NCT01004861|10782099|FG012|Overall Study|Protocol Violation|0
6785056|NCT01004861|10782087|FG000|Overall Study|Lost to Follow-up|0
6785057|NCT01004861|10782088|FG001|Overall Study|Lost to Follow-up|0
6785058|NCT01004861|10782089|FG002|Overall Study|Lost to Follow-up|0
6785059|NCT01004861|10782090|FG003|Overall Study|Lost to Follow-up|0
6785060|NCT01004861|10782091|FG004|Overall Study|Lost to Follow-up|0
6785061|NCT01004861|10782092|FG005|Overall Study|Lost to Follow-up|0
6785062|NCT01004861|10782093|FG006|Overall Study|Lost to Follow-up|0
6785063|NCT01004861|10782094|FG007|Overall Study|Lost to Follow-up|1
6785064|NCT01004861|10782095|FG008|Overall Study|Lost to Follow-up|3
6785065|NCT01004861|10782096|FG009|Overall Study|Lost to Follow-up|0
6785066|NCT01004861|10782097|FG010|Overall Study|Lost to Follow-up|0
6785067|NCT01004861|10782098|FG011|Overall Study|Lost to Follow-up|1
6785068|NCT01004861|10782099|FG012|Overall Study|Lost to Follow-up|0
6785069|NCT01004861|10782087|FG000|Overall Study|Non-compliance|0
6785070|NCT01004861|10782088|FG001|Overall Study|Non-compliance|0
6785071|NCT01004861|10782089|FG002|Overall Study|Non-compliance|0
6785072|NCT01004861|10782090|FG003|Overall Study|Non-compliance|0
6785073|NCT01004861|10782091|FG004|Overall Study|Non-compliance|0
6785074|NCT01004861|10782092|FG005|Overall Study|Non-compliance|0
6785075|NCT01004861|10782093|FG006|Overall Study|Non-compliance|0
6785076|NCT01004861|10782094|FG007|Overall Study|Non-compliance|0
6785077|NCT01004861|10782095|FG008|Overall Study|Non-compliance|5
6785078|NCT01004861|10782096|FG009|Overall Study|Non-compliance|0
6785079|NCT01004861|10782097|FG010|Overall Study|Non-compliance|0
6785080|NCT01004861|10782098|FG011|Overall Study|Non-compliance|0
6785081|NCT01004861|10782099|FG012|Overall Study|Non-compliance|1
6785082|NCT01004861|10782087|FG000|Overall Study|Other|0
6785083|NCT01004861|10782088|FG001|Overall Study|Other|0
6785084|NCT01004861|10782089|FG002|Overall Study|Other|0
6785085|NCT01004861|10782090|FG003|Overall Study|Other|0
6785086|NCT01004861|10782091|FG004|Overall Study|Other|0
6785087|NCT01004861|10782092|FG005|Overall Study|Other|0
6785088|NCT01004861|10782093|FG006|Overall Study|Other|0
6785089|NCT01004861|10782094|FG007|Overall Study|Other|0
6785090|NCT01004861|10782095|FG008|Overall Study|Other|0
6785091|NCT01004861|10782096|FG009|Overall Study|Other|2
6785092|NCT01004861|10782097|FG010|Overall Study|Other|1
6785093|NCT01004861|10782098|FG011|Overall Study|Other|2
6785094|NCT01004861|10782099|FG012|Overall Study|Other|3
6785095|NCT01004861|10782087|FG000|Overall Study|Patient decision|0
6785096|NCT01004861|10782088|FG001|Overall Study|Patient decision|0
6785097|NCT01004861|10782089|FG002|Overall Study|Patient decision|0
6785098|NCT01004861|10782090|FG003|Overall Study|Patient decision|0
6785099|NCT01004861|10782091|FG004|Overall Study|Patient decision|1
6785100|NCT01004861|10782092|FG005|Overall Study|Patient decision|0
6785101|NCT01004861|10782093|FG006|Overall Study|Patient decision|1
6785102|NCT01004861|10782094|FG007|Overall Study|Patient decision|0
6785103|NCT01004861|10782095|FG008|Overall Study|Patient decision|7
6785104|NCT01004861|10782096|FG009|Overall Study|Patient decision|1
6785105|NCT01004861|10782097|FG010|Overall Study|Patient decision|1
6785106|NCT01004861|10782098|FG011|Overall Study|Patient decision|2
6785107|NCT01004861|10782099|FG012|Overall Study|Patient decision|3
6785108|NCT01004861|10782087|FG000|Overall Study|Transitioned to Phase 4 study|0
6785109|NCT01004861|10782088|FG001|Overall Study|Transitioned to Phase 4 study|0
6785110|NCT01004861|10782089|FG002|Overall Study|Transitioned to Phase 4 study|0
6785111|NCT01004861|10782090|FG003|Overall Study|Transitioned to Phase 4 study|0
6785112|NCT01004861|10782091|FG004|Overall Study|Transitioned to Phase 4 study|0
6785113|NCT01004861|10782092|FG005|Overall Study|Transitioned to Phase 4 study|0
6785114|NCT01004861|10782093|FG006|Overall Study|Transitioned to Phase 4 study|0
6785115|NCT01004861|10782094|FG007|Overall Study|Transitioned to Phase 4 study|0
6785116|NCT01004861|10782095|FG008|Overall Study|Transitioned to Phase 4 study|2
6785117|NCT01004861|10782096|FG009|Overall Study|Transitioned to Phase 4 study|0
6785118|NCT01004861|10782097|FG010|Overall Study|Transitioned to Phase 4 study|0
6785119|NCT01004861|10782098|FG011|Overall Study|Transitioned to Phase 4 study|0
6785120|NCT01004861|10782099|FG012|Overall Study|Transitioned to Phase 4 study|0
6785121|NCT01004861|10782087|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
6785122|NCT01004861|10782088|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
6785123|NCT01004861|10782089|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
6785124|NCT01004861|10782090|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
6785125|NCT01004861|10782091|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
6785126|NCT01004861|10782092|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
6785127|NCT01004861|10782093|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
6785128|NCT01004861|10782094|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
6785129|NCT01004861|10782095|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1
6785130|NCT01004861|10782096|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
6785131|NCT01004861|10782097|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
6785132|NCT01004861|10782098|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
6785133|NCT01004861|10782099|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
6785134|NCT01004861|10782087|FG000|Overall Study|Patient withdrew|0
6785135|NCT01004861|10782088|FG001|Overall Study|Patient withdrew|0
6785136|NCT01004861|10782089|FG002|Overall Study|Patient withdrew|0
6785137|NCT01004861|10782090|FG003|Overall Study|Patient withdrew|0
6785138|NCT01004861|10782091|FG004|Overall Study|Patient withdrew|0
6785139|NCT01004861|10782092|FG005|Overall Study|Patient withdrew|0
6785140|NCT01004861|10782093|FG006|Overall Study|Patient withdrew|0
6785141|NCT01004861|10782094|FG007|Overall Study|Patient withdrew|0
6785142|NCT01004861|10782095|FG008|Overall Study|Patient withdrew|1
6785143|NCT01004861|10782096|FG009|Overall Study|Patient withdrew|0
6785144|NCT01004861|10782097|FG010|Overall Study|Patient withdrew|0
6785145|NCT01004861|10782098|FG011|Overall Study|Patient withdrew|0
6785146|NCT01004861|10782099|FG012|Overall Study|Patient withdrew|0
6785147|NCT01004861|10782087|FG000|Overall Study|Surgical resection|0
6785148|NCT01004861|10782088|FG001|Overall Study|Surgical resection|0
6785149|NCT01004861|10782089|FG002|Overall Study|Surgical resection|0
6785150|NCT01004861|10782090|FG003|Overall Study|Surgical resection|0
6785151|NCT01004861|10782091|FG004|Overall Study|Surgical resection|0
6785152|NCT01004861|10782092|FG005|Overall Study|Surgical resection|0
6785153|NCT01004861|10782093|FG006|Overall Study|Surgical resection|0
6785154|NCT01004861|10782094|FG007|Overall Study|Surgical resection|0
6785155|NCT01004861|10782095|FG008|Overall Study|Surgical resection|1
6785156|NCT01004861|10782096|FG009|Overall Study|Surgical resection|0
6785157|NCT01004861|10782097|FG010|Overall Study|Surgical resection|0
6785158|NCT01004861|10782098|FG011|Overall Study|Surgical resection|0
6785159|NCT01004861|10782099|FG012|Overall Study|Surgical resection|0
6785160|NCT01004861|10782087|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0
6785161|NCT01004861|10782088|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0
6785162|NCT01004861|10782089|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0
6785163|NCT01004861|10782090|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0
6785164|NCT01004861|10782091|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0
6785165|NCT01004861|10782092|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0
6785166|NCT01004861|10782093|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0
6785167|NCT01004861|10782094|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0
6785168|NCT01004861|10782095|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1
6785169|NCT01004861|10782096|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0
6785170|NCT01004861|10782097|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0
6785171|NCT01004861|10782098|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0
6785172|NCT01004861|10782099|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0
6785173|NCT01004861|10782087|FG000|Overall Study|Study termination by Sponsor|0
6785174|NCT01004861|10782088|FG001|Overall Study|Study termination by Sponsor|0
6785175|NCT01004861|10782089|FG002|Overall Study|Study termination by Sponsor|0
6785176|NCT01004861|10782090|FG003|Overall Study|Study termination by Sponsor|0
6785177|NCT01004861|10782091|FG004|Overall Study|Study termination by Sponsor|0
6785178|NCT01004861|10782092|FG005|Overall Study|Study termination by Sponsor|0
6785179|NCT01004861|10782093|FG006|Overall Study|Study termination by Sponsor|0
6785180|NCT01004861|10782094|FG007|Overall Study|Study termination by Sponsor|0
6785181|NCT01004861|10782095|FG008|Overall Study|Study termination by Sponsor|1
6785182|NCT01004861|10782096|FG009|Overall Study|Study termination by Sponsor|0
6785183|NCT01004861|10782097|FG010|Overall Study|Study termination by Sponsor|0
6785184|NCT01004861|10782098|FG011|Overall Study|Study termination by Sponsor|0
6785185|NCT01004861|10782099|FG012|Overall Study|Study termination by Sponsor|0
6785186|NCT00912223|10782131|FG000|Overall Study|Withdrawal by Subject|1
6785187|NCT00912223|10782131|FG000|Overall Study|Not transplanted|1
6785188|NCT00912223|10782131|FG000|Overall Study|Transformed disease|1
6785189|NCT00381381|10782135|FG000|Overall Study|Adverse Event|3
6785190|NCT00381381|10782135|FG000|Overall Study|Lost to Follow-up|52
6785191|NCT00381381|10782135|FG000|Overall Study|Withdrawal by Subject|9
6806945|NCT03993379|10810239|FG001|Overall Study|The study was terminated early due to business decision.|2
6785192|NCT03712124|10782155|FG000|Overall Study|Protocol Violation|1
6785193|NCT03712124|10782156|FG001|Overall Study|Protocol Violation|0
6785279|NCT01981850|10782286|FG007|Main Phase Stage 1|Death|0
6785280|NCT01981850|10782287|FG008|Main Phase Stage 1|Death|0
6785281|NCT01981850|10782288|FG009|Main Phase Stage 1|Death|0
6785282|NCT01981850|10782279|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1
6785283|NCT01981850|10782280|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0
6785284|NCT01981850|10782281|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0
6785285|NCT01981850|10782282|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0
6785286|NCT01981850|10782283|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0
6785287|NCT01981850|10782284|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0
6785288|NCT01981850|10782285|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0
6785289|NCT01981850|10782286|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0
6785290|NCT01981850|10782287|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0
6785291|NCT01981850|10782288|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0
6785292|NCT01981850|10782279|FG000|Main Phase Stage 1|Lack of Efficacy|0
6785293|NCT01981850|10782280|FG001|Main Phase Stage 1|Lack of Efficacy|2
6785294|NCT01981850|10782281|FG002|Main Phase Stage 1|Lack of Efficacy|0
6785295|NCT01981850|10782282|FG003|Main Phase Stage 1|Lack of Efficacy|0
6785296|NCT01981850|10782283|FG004|Main Phase Stage 1|Lack of Efficacy|0
6785297|NCT01981850|10782284|FG005|Main Phase Stage 1|Lack of Efficacy|0
6785298|NCT01981850|10782285|FG006|Main Phase Stage 1|Lack of Efficacy|0
6785299|NCT01981850|10782286|FG007|Main Phase Stage 1|Lack of Efficacy|0
6785300|NCT01981850|10782287|FG008|Main Phase Stage 1|Lack of Efficacy|0
6785301|NCT01981850|10782288|FG009|Main Phase Stage 1|Lack of Efficacy|0
6785302|NCT01981850|10782279|FG000|Main Phase Stage 1|Various reasons|0
6785303|NCT01981850|10782280|FG001|Main Phase Stage 1|Various reasons|0
6785304|NCT01981850|10782281|FG002|Main Phase Stage 1|Various reasons|2
6785305|NCT01981850|10782282|FG003|Main Phase Stage 1|Various reasons|0
6785306|NCT01981850|10782283|FG004|Main Phase Stage 1|Various reasons|0
7139020|NCT02953639|11292548|FG000|Overall Study|Lost to Follow-up|8
7139021|NCT02953639|11292549|FG001|Overall Study|Lost to Follow-up|4
7139022|NCT02953639|11292550|FG002|Overall Study|Lost to Follow-up|3
7139023|NCT02953639|11292548|FG000|Overall Study|Non-Compliance With Study Drug|0
7139024|NCT02953639|11292549|FG001|Overall Study|Non-Compliance With Study Drug|2
7139025|NCT02953639|11292550|FG002|Overall Study|Non-Compliance With Study Drug|1
7139026|NCT02953639|11292548|FG000|Overall Study|Multiple Reasons|1
7139027|NCT02953639|11292549|FG001|Overall Study|Multiple Reasons|0
7139028|NCT02953639|11292550|FG002|Overall Study|Multiple Reasons|1
7139029|NCT02953639|11292548|FG000|Overall Study|Physician Decision|1
7139030|NCT02953639|11292549|FG001|Overall Study|Physician Decision|0
7139031|NCT02953639|11292550|FG002|Overall Study|Physician Decision|0
7139032|NCT02953639|11292548|FG000|Overall Study|Withdrawal by Subject|7
7139033|NCT02953639|11292549|FG001|Overall Study|Withdrawal by Subject|8
7139034|NCT02953639|11292550|FG002|Overall Study|Withdrawal by Subject|10
7139035|NCT02953639|11292548|FG000|Overall Study|Completed or Discontinued information is missing|1
7139036|NCT02953639|11292549|FG001|Overall Study|Completed or Discontinued information is missing|0
7139037|NCT02953639|11292550|FG002|Overall Study|Completed or Discontinued information is missing|0
7139038|NCT02953678|11292560|FG000|Overall Study|Adverse Event|20
7139039|NCT02953678|11292560|FG000|Overall Study|Death|7
7139040|NCT02953678|11292560|FG000|Overall Study|Physician Decision|23
7139041|NCT02953678|11292560|FG000|Overall Study|Progressive Disease of GVHD|7
7139042|NCT02953678|11292560|FG000|Overall Study|Relapse of Underlying Malignancy|3
7139043|NCT02953678|11292560|FG000|Overall Study|Withdrawal by participant|3
7139044|NCT02953678|11292560|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5
7139045|NCT02953678|11292560|FG000|Overall Study|Participants were transferred to commercial product.|3
7139046|NCT02953782|11292573|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5
7139047|NCT02953782|11292574|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2
7139048|NCT02953782|11292575|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6
7139049|NCT02953782|11292576|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6
7139050|NCT02953782|11292577|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4
7139051|NCT02953782|11292578|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0
7139052|NCT02953782|11292579|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0
7139053|NCT02953782|11292580|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0
7139054|NCT02953782|11292573|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1
7139055|NCT02953782|11292574|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
7139056|NCT02953782|11292575|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2
7139057|NCT02953782|11292576|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
7139058|NCT02953782|11292577|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1
7139059|NCT02953782|11292578|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
7139060|NCT02953782|11292579|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
7139061|NCT02953782|11292580|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
7139062|NCT02953782|11292573|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
6785307|NCT01981850|10782284|FG005|Main Phase Stage 1|Various reasons|0
6785308|NCT01981850|10782285|FG006|Main Phase Stage 1|Various reasons|0
6785309|NCT01981850|10782286|FG007|Main Phase Stage 1|Various reasons|0
6785310|NCT01981850|10782287|FG008|Main Phase Stage 1|Various reasons|0
6785194|NCT03535740|10782168|FG000|Overall Study|Ongoing at Data Cut-off Date: 30 September 2020|55
6785195|NCT03535740|10782168|FG000|Overall Study|Death|34
6785196|NCT03535740|10782168|FG000|Overall Study|Lost to Follow-up|1
6785197|NCT03535740|10782168|FG000|Overall Study|Withdrawal by Subject|13
7139063|NCT02953782|11292574|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1
7139064|NCT02953782|11292575|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
7139065|NCT02953782|11292576|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1
7139066|NCT02953782|11292577|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1
7139067|NCT02953782|11292578|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
7139068|NCT02953782|11292579|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
7139069|NCT02953782|11292580|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
6785208|NCT02896257|10782214|FG000|Providers|Without eligible patients|21
6785209|NCT02896257|10782215|FG001|Providers|Without eligible patients|28
6785210|NCT02896257|10782214|FG000|Patients|PFT entry criteria not met|43
6785211|NCT02896257|10782215|FG001|Patients|PFT entry criteria not met|50
6785212|NCT02896257|10782214|FG000|Patients|No capacity to review|8
6785213|NCT02896257|10782215|FG001|Patients|No capacity to review|11
6785214|NCT02896257|10782214|FG000|Patients|Appointment rescheduled/cancelled|5
6785215|NCT02896257|10782215|FG001|Patients|Appointment rescheduled/cancelled|7
6785216|NCT02896257|10782214|FG000|Patients|PCP not assigned a clinic|4
6785217|NCT02896257|10782215|FG001|Patients|PCP not assigned a clinic|0
6785218|NCT02896257|10782214|FG000|Patients|No history of COPD|0
6785219|NCT02896257|10782215|FG001|Patients|No history of COPD|1
6785220|NCT02896257|10782214|FG000|Patients|Deceased between review and index date|0
6785221|NCT02896257|10782215|FG001|Patients|Deceased between review and index date|1
6785222|NCT02896257|10782214|FG000|Patients|No ICS Rx upon review|1
6785223|NCT02896257|10782215|FG001|Patients|No ICS Rx upon review|1
6785224|NCT02896257|10782214|FG000|Patients|Protocol Violation|2
6785225|NCT02896257|10782215|FG001|Patients|Protocol Violation|1
6785226|NCT02896257|10782214|FG000|Patients|Hospice care|0
6785227|NCT02896257|10782215|FG001|Patients|Hospice care|1
6785228|NCT02736617|10782231|FG000|Treatment|Adverse Event|1
6785229|NCT02736617|10782231|FG000|Treatment|Lack of Efficacy|1
6785230|NCT02736617|10782231|FG000|Treatment|Withdrawal by Subject|1
6785231|NCT02736617|10782231|FG000|Maintenance|Lack of Efficacy|4
6785232|NCT02736617|10782231|FG000|Maintenance|Physician Decision|1
6785233|NCT02579265|10782242|FG000|Overall Study|Weaned off earlier than 28 days|44
6785234|NCT02579265|10782243|FG001|Overall Study|Weaned off earlier than 28 days|43
6785235|NCT02579265|10782242|FG000|Overall Study|Adverse Event|2
6785236|NCT02579265|10782243|FG001|Overall Study|Adverse Event|0
6785237|NCT02579265|10782242|FG000|Overall Study|Any other reason not specified|0
6785238|NCT02579265|10782243|FG001|Overall Study|Any other reason not specified|2
6785239|NCT02579265|10782242|FG000|Overall Study|Withdrawal by Subject|2
6785240|NCT02579265|10782243|FG001|Overall Study|Withdrawal by Subject|0
6785241|NCT02579265|10782242|FG000|Overall Study|Physician Decision|1
6785242|NCT02579265|10782243|FG001|Overall Study|Physician Decision|0
6785243|NCT02579265|10782242|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1
6785244|NCT02579265|10782243|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0
6785245|NCT02013167|10782251|FG000|Overall Study|Withdrawal by Subject|15
6785246|NCT02013167|10782252|FG001|Overall Study|Withdrawal by Subject|14
6785247|NCT02013167|10782251|FG000|Overall Study|Sponsor Decision|1
6785248|NCT02013167|10782252|FG001|Overall Study|Sponsor Decision|3
6785249|NCT02013167|10782251|FG000|Overall Study|Lost to Follow-up|0
6785250|NCT02013167|10782252|FG001|Overall Study|Lost to Follow-up|1
6785251|NCT02013167|10782251|FG000|Overall Study|Death|85
6785252|NCT02013167|10782252|FG001|Overall Study|Death|160
6785253|NCT02004522|10782261|FG000|Overall Study|Adverse Event|55
6785254|NCT02004522|10782262|FG001|Overall Study|Adverse Event|6
6785255|NCT02004522|10782261|FG000|Overall Study|Withdrawal by Subject|13
6785256|NCT02004522|10782262|FG001|Overall Study|Withdrawal by Subject|7
6785257|NCT02004522|10782261|FG000|Overall Study|Death|12
6785258|NCT02004522|10782262|FG001|Overall Study|Death|3
6785259|NCT02004522|10782261|FG000|Overall Study|Physician Decision|3
6785260|NCT02004522|10782262|FG001|Overall Study|Physician Decision|4
6785261|NCT02004522|10782261|FG000|Overall Study|Protocol Violation|1
6785262|NCT02004522|10782262|FG001|Overall Study|Protocol Violation|0
6785263|NCT02004522|10782261|FG000|Overall Study|Other is reason listed by PI.|4
6785264|NCT02004522|10782262|FG001|Overall Study|Other is reason listed by PI.|1
6785265|NCT02004522|10782261|FG000|Overall Study|Never Dosed|2
6785266|NCT02004522|10782262|FG001|Overall Study|Never Dosed|4
6785267|NCT02004522|10782261|FG000|Overall Study|Disease Progression|35
6785268|NCT02004522|10782262|FG001|Overall Study|Disease Progression|31
6785269|NCT02004522|10782261|FG000|Overall Study|Completed Treatrment Cycles Per Protocol|1
6785270|NCT02004522|10782262|FG001|Overall Study|Completed Treatrment Cycles Per Protocol|103
6785271|NCT02000427|10782268|FG000|Overall Study|Death|22
6785272|NCT01981850|10782279|FG000|Main Phase Stage 1|Death|2
6785273|NCT01981850|10782280|FG001|Main Phase Stage 1|Death|0
6785274|NCT01981850|10782281|FG002|Main Phase Stage 1|Death|0
6785275|NCT01981850|10782282|FG003|Main Phase Stage 1|Death|0
6785276|NCT01981850|10782283|FG004|Main Phase Stage 1|Death|0
6785277|NCT01981850|10782284|FG005|Main Phase Stage 1|Death|0
6785278|NCT01981850|10782285|FG006|Main Phase Stage 1|Death|0
6785311|NCT01981850|10782288|FG009|Main Phase Stage 1|Various reasons|0
6785312|NCT01981850|10782279|FG000|Main Phase Stage 2|Adverse Event|0
6785313|NCT01981850|10782280|FG001|Main Phase Stage 2|Adverse Event|0
6785314|NCT01981850|10782281|FG002|Main Phase Stage 2|Adverse Event|0
6785315|NCT01981850|10782282|FG003|Main Phase Stage 2|Adverse Event|0
6785316|NCT01981850|10782283|FG004|Main Phase Stage 2|Adverse Event|6
6785317|NCT01981850|10782284|FG005|Main Phase Stage 2|Adverse Event|5
6785318|NCT01981850|10782285|FG006|Main Phase Stage 2|Adverse Event|7
6785319|NCT01981850|10782286|FG007|Main Phase Stage 2|Adverse Event|0
6785320|NCT01981850|10782287|FG008|Main Phase Stage 2|Adverse Event|0
6785321|NCT01981850|10782288|FG009|Main Phase Stage 2|Adverse Event|0
6785322|NCT01981850|10782279|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0
6785323|NCT01981850|10782280|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0
6785324|NCT01981850|10782281|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0
6785325|NCT01981850|10782282|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0
6785326|NCT01981850|10782283|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4
6785327|NCT01981850|10782284|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3
6785328|NCT01981850|10782285|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3
6785329|NCT01981850|10782286|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0
6785330|NCT01981850|10782287|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0
6785331|NCT01981850|10782288|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0
6785332|NCT01981850|10782279|FG000|Main Phase Stage 2|Lack of Efficacy|0
6785333|NCT01981850|10782280|FG001|Main Phase Stage 2|Lack of Efficacy|0
6785334|NCT01981850|10782281|FG002|Main Phase Stage 2|Lack of Efficacy|0
6785335|NCT01981850|10782282|FG003|Main Phase Stage 2|Lack of Efficacy|0
6785336|NCT01981850|10782283|FG004|Main Phase Stage 2|Lack of Efficacy|1
6785337|NCT01981850|10782284|FG005|Main Phase Stage 2|Lack of Efficacy|2
6785338|NCT01981850|10782285|FG006|Main Phase Stage 2|Lack of Efficacy|0
6785339|NCT01981850|10782286|FG007|Main Phase Stage 2|Lack of Efficacy|0
6785340|NCT01981850|10782287|FG008|Main Phase Stage 2|Lack of Efficacy|0
6785341|NCT01981850|10782288|FG009|Main Phase Stage 2|Lack of Efficacy|0
6785342|NCT01981850|10782279|FG000|Main Phase Stage 2|Various reasons|0
6785343|NCT01981850|10782280|FG001|Main Phase Stage 2|Various reasons|0
6785344|NCT01981850|10782281|FG002|Main Phase Stage 2|Various reasons|0
6785345|NCT01981850|10782282|FG003|Main Phase Stage 2|Various reasons|0
6785346|NCT01981850|10782283|FG004|Main Phase Stage 2|Various reasons|2
6785347|NCT01981850|10782284|FG005|Main Phase Stage 2|Various reasons|0
6785348|NCT01981850|10782285|FG006|Main Phase Stage 2|Various reasons|1
6785349|NCT01981850|10782286|FG007|Main Phase Stage 2|Various reasons|0
6785350|NCT01981850|10782287|FG008|Main Phase Stage 2|Various reasons|0
6785351|NCT01981850|10782288|FG009|Main Phase Stage 2|Various reasons|0
6785352|NCT01981850|10782279|FG000|Main Phase Stage 2|Progressive Disease|0
6785353|NCT01981850|10782280|FG001|Main Phase Stage 2|Progressive Disease|0
6785354|NCT01981850|10782281|FG002|Main Phase Stage 2|Progressive Disease|0
6785355|NCT01981850|10782282|FG003|Main Phase Stage 2|Progressive Disease|0
6785356|NCT01981850|10782283|FG004|Main Phase Stage 2|Progressive Disease|0
6785357|NCT01981850|10782284|FG005|Main Phase Stage 2|Progressive Disease|6
6785358|NCT01981850|10782285|FG006|Main Phase Stage 2|Progressive Disease|6
6785359|NCT01981850|10782286|FG007|Main Phase Stage 2|Progressive Disease|0
6785360|NCT01981850|10782287|FG008|Main Phase Stage 2|Progressive Disease|0
6785361|NCT01981850|10782288|FG009|Main Phase Stage 2|Progressive Disease|0
6785362|NCT01981850|10782279|FG000|Open Label Extension (OLE)|Adverse Event|0
6785363|NCT01981850|10782280|FG001|Open Label Extension (OLE)|Adverse Event|0
6785364|NCT01981850|10782281|FG002|Open Label Extension (OLE)|Adverse Event|0
6785365|NCT01981850|10782282|FG003|Open Label Extension (OLE)|Adverse Event|0
6785366|NCT01981850|10782283|FG004|Open Label Extension (OLE)|Adverse Event|0
6785367|NCT01981850|10782284|FG005|Open Label Extension (OLE)|Adverse Event|0
6785368|NCT01981850|10782285|FG006|Open Label Extension (OLE)|Adverse Event|0
6785369|NCT01981850|10782286|FG007|Open Label Extension (OLE)|Adverse Event|2
6785370|NCT01981850|10782287|FG008|Open Label Extension (OLE)|Adverse Event|1
6785371|NCT01981850|10782288|FG009|Open Label Extension (OLE)|Adverse Event|8
6785372|NCT01981850|10782279|FG000|Open Label Extension (OLE)|Lack of Efficacy|0
6785373|NCT01981850|10782280|FG001|Open Label Extension (OLE)|Lack of Efficacy|0
6785374|NCT01981850|10782281|FG002|Open Label Extension (OLE)|Lack of Efficacy|0
6785375|NCT01981850|10782282|FG003|Open Label Extension (OLE)|Lack of Efficacy|0
6785376|NCT01981850|10782283|FG004|Open Label Extension (OLE)|Lack of Efficacy|0
6785377|NCT01981850|10782284|FG005|Open Label Extension (OLE)|Lack of Efficacy|0
6785378|NCT01981850|10782285|FG006|Open Label Extension (OLE)|Lack of Efficacy|0
6785379|NCT01981850|10782286|FG007|Open Label Extension (OLE)|Lack of Efficacy|4
6785380|NCT01981850|10782287|FG008|Open Label Extension (OLE)|Lack of Efficacy|1
6785381|NCT01981850|10782288|FG009|Open Label Extension (OLE)|Lack of Efficacy|19
6785382|NCT01981850|10782279|FG000|Open Label Extension (OLE)|Various reasons|0
6785383|NCT01981850|10782280|FG001|Open Label Extension (OLE)|Various reasons|0
6785384|NCT01981850|10782281|FG002|Open Label Extension (OLE)|Various reasons|0
6785385|NCT01981850|10782282|FG003|Open Label Extension (OLE)|Various reasons|0
6785386|NCT01981850|10782283|FG004|Open Label Extension (OLE)|Various reasons|0
6785387|NCT01981850|10782284|FG005|Open Label Extension (OLE)|Various reasons|0
6785388|NCT01981850|10782285|FG006|Open Label Extension (OLE)|Various reasons|0
6785389|NCT01981850|10782286|FG007|Open Label Extension (OLE)|Various reasons|3
6785390|NCT01981850|10782287|FG008|Open Label Extension (OLE)|Various reasons|1
6785391|NCT01981850|10782288|FG009|Open Label Extension (OLE)|Various reasons|3
6785392|NCT01981850|10782279|FG000|Open Label Extension (OLE)|Progressive Disease|0
6785393|NCT01981850|10782280|FG001|Open Label Extension (OLE)|Progressive Disease|0
6785394|NCT01981850|10782281|FG002|Open Label Extension (OLE)|Progressive Disease|0
6785395|NCT01981850|10782282|FG003|Open Label Extension (OLE)|Progressive Disease|0
6785396|NCT01981850|10782283|FG004|Open Label Extension (OLE)|Progressive Disease|0
6785397|NCT01981850|10782284|FG005|Open Label Extension (OLE)|Progressive Disease|0
6785398|NCT01981850|10782285|FG006|Open Label Extension (OLE)|Progressive Disease|0
6785399|NCT01981850|10782286|FG007|Open Label Extension (OLE)|Progressive Disease|3
6785400|NCT01981850|10782287|FG008|Open Label Extension (OLE)|Progressive Disease|2
6785401|NCT01981850|10782288|FG009|Open Label Extension (OLE)|Progressive Disease|9
6785402|NCT01981850|10782279|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0
6785403|NCT01981850|10782280|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0
6785404|NCT01981850|10782281|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0
6785405|NCT01981850|10782282|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0
6785406|NCT01981850|10782283|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0
6785407|NCT01981850|10782284|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0
6785408|NCT01981850|10782285|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0
6785409|NCT01981850|10782286|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0
6785410|NCT01981850|10782287|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0
6785411|NCT01981850|10782288|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8
6785412|NCT01981850|10782279|FG000|Open Label Extension (OLE)|Lost to Follow-up|0
6785413|NCT01981850|10782280|FG001|Open Label Extension (OLE)|Lost to Follow-up|0
6785414|NCT01981850|10782281|FG002|Open Label Extension (OLE)|Lost to Follow-up|0
6785415|NCT01981850|10782282|FG003|Open Label Extension (OLE)|Lost to Follow-up|0
6785416|NCT01981850|10782283|FG004|Open Label Extension (OLE)|Lost to Follow-up|0
6785417|NCT01981850|10782284|FG005|Open Label Extension (OLE)|Lost to Follow-up|0
6785418|NCT01981850|10782285|FG006|Open Label Extension (OLE)|Lost to Follow-up|0
6785419|NCT01981850|10782286|FG007|Open Label Extension (OLE)|Lost to Follow-up|0
6785420|NCT01981850|10782287|FG008|Open Label Extension (OLE)|Lost to Follow-up|0
6785421|NCT01981850|10782288|FG009|Open Label Extension (OLE)|Lost to Follow-up|1
6785422|NCT01804816|10782320|FG000|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3
6785423|NCT01804816|10782320|FG000|Acupuncture (Second 5 Weeks)|Physician Decision|1
6806946|NCT03993379|10810240|FG002|Overall Study|The study was terminated early due to business decision.|0
6806947|NCT03993379|10810241|FG003|Overall Study|The study was terminated early due to business decision.|0
6806948|NCT03993379|10810238|FG000|Overall Study|Withdrawal by Subject|0
6806949|NCT03993379|10810239|FG001|Overall Study|Withdrawal by Subject|1
6806950|NCT03993379|10810240|FG002|Overall Study|Withdrawal by Subject|0
6806951|NCT03993379|10810241|FG003|Overall Study|Withdrawal by Subject|0
6806952|NCT03956615|10810251|FG000|Overall Study|No multiple myeloma confirmed|2
6806953|NCT03956615|10810251|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1
6806954|NCT03956615|10810251|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2
6806955|NCT03956615|10810251|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2
6806956|NCT03803059|10810255|FG000|Overall Study|Protocol Violation|2
6806957|NCT03803059|10810255|FG000|Overall Study|Lost to Follow-up|1
6806958|NCT03723590|10810260|FG000|Overall Study|Withdrawal by Subject|3
6806959|NCT03430895|10810283|FG000|Overall Study|Not Treated|2
6806960|NCT03230838|10810306|FG000|Overall Study|Withdrawal by Subject|3
6806961|NCT03230838|10810307|FG001|Overall Study|Withdrawal by Subject|0
6806962|NCT03230838|10810306|FG000|Overall Study|Temperature excursion|1
6806963|NCT03230838|10810307|FG001|Overall Study|Temperature excursion|0
6810622|NCT03167242|10814448|FG010|Overall Study|Lost to Follow-up|1
6810623|NCT03167242|10814449|FG011|Overall Study|Lost to Follow-up|1
6810624|NCT03167242|10814438|FG000|Overall Study|Reason not provided|0
6810625|NCT03167242|10814439|FG001|Overall Study|Reason not provided|0
6810626|NCT03167242|10814440|FG002|Overall Study|Reason not provided|0
6810627|NCT03167242|10814441|FG003|Overall Study|Reason not provided|0
6810628|NCT03167242|10814442|FG004|Overall Study|Reason not provided|0
6810629|NCT03167242|10814443|FG005|Overall Study|Reason not provided|0
6810630|NCT03167242|10814444|FG006|Overall Study|Reason not provided|0
6810631|NCT03167242|10814445|FG007|Overall Study|Reason not provided|0
6810632|NCT03167242|10814446|FG008|Overall Study|Reason not provided|1
6810633|NCT03167242|10814447|FG009|Overall Study|Reason not provided|0
6810634|NCT03167242|10814448|FG010|Overall Study|Reason not provided|0
6810635|NCT03167242|10814449|FG011|Overall Study|Reason not provided|0
6811205|NCT02282345|10815088|FG000|Overall Study|Progression|0
6811206|NCT02282345|10815089|FG001|Overall Study|Progression|1
6811207|NCT02230410|10815098|FG000|Overall Study|Screen Failure|3
6811208|NCT02053246|10815102|FG000|Overall Study|Withdrawal by Subject|3
6811209|NCT02053246|10815102|FG000|Overall Study|Physician Decision|1
6811210|NCT01980940|10815114|FG000|Overall Study|Protocol Violation|0
6811211|NCT01980940|10815115|FG001|Overall Study|Protocol Violation|0
6811212|NCT01980940|10815116|FG002|Overall Study|Protocol Violation|0
6811213|NCT01980940|10815117|FG003|Overall Study|Protocol Violation|0
6811214|NCT01980940|10815118|FG004|Overall Study|Protocol Violation|0
6811215|NCT01980940|10815119|FG005|Overall Study|Protocol Violation|2
6811216|NCT01980940|10815120|FG006|Overall Study|Protocol Violation|0
6785424|NCT01519960|10782354|FG000|Overall Study|Ongoing in Follow-Up|101
6785425|NCT01519960|10782355|FG001|Overall Study|Ongoing in Follow-Up|11
6785426|NCT01519960|10782356|FG002|Overall Study|Ongoing in Follow-Up|10
6785427|NCT01519960|10782354|FG000|Overall Study|Ongoing/Switched to PEG-IFN|0
6785428|NCT01519960|10782355|FG001|Overall Study|Ongoing/Switched to PEG-IFN|33
6785429|NCT01519960|10782356|FG002|Overall Study|Ongoing/Switched to PEG-IFN|0
6785430|NCT01519960|10782354|FG000|Overall Study|Adverse Event|0
6785431|NCT01519960|10782355|FG001|Overall Study|Adverse Event|1
6785432|NCT01519960|10782356|FG002|Overall Study|Adverse Event|0
6785433|NCT01519960|10782354|FG000|Overall Study|Withdrawal by Subject|0
6785434|NCT01519960|10782355|FG001|Overall Study|Withdrawal by Subject|4
6785435|NCT01519960|10782356|FG002|Overall Study|Withdrawal by Subject|0
6785436|NCT01519960|10782354|FG000|Overall Study|Lost to Follow-up|0
6785437|NCT01519960|10782355|FG001|Overall Study|Lost to Follow-up|1
6785438|NCT01519960|10782356|FG002|Overall Study|Lost to Follow-up|0
6785439|NCT00688376|10782369|FG000|Double-Blind Phase|Adverse Event|4
6785440|NCT00688376|10782370|FG001|Double-Blind Phase|Adverse Event|4
6785441|NCT00688376|10782369|FG000|Double-Blind Phase|Protocol Violation|1
6785442|NCT00688376|10782370|FG001|Double-Blind Phase|Protocol Violation|2
6785443|NCT00688376|10782369|FG000|Double-Blind Phase|Withdrawal by Subject|1
6785444|NCT00688376|10782370|FG001|Double-Blind Phase|Withdrawal by Subject|0
6785445|NCT00688376|10782369|FG000|Double-Blind Phase|Not treated|0
6785446|NCT00688376|10782370|FG001|Double-Blind Phase|Not treated|1
6785447|NCT00688376|10782369|FG000|Blinded Extension Phase|Adverse Event|3
6785448|NCT00688376|10782370|FG001|Blinded Extension Phase|Adverse Event|4
6785449|NCT00688376|10782369|FG000|Blinded Extension Phase|Withdrawal by Subject|0
6785450|NCT00688376|10782370|FG001|Blinded Extension Phase|Withdrawal by Subject|1
6785451|NCT00688376|10782369|FG000|Blinded Extension Phase|Physician Decision|1
6785452|NCT00688376|10782370|FG001|Blinded Extension Phase|Physician Decision|0
6785453|NCT00688376|10782369|FG000|Blinded Extension Phase|Other|1
6785454|NCT00688376|10782370|FG001|Blinded Extension Phase|Other|0
6785455|NCT00121108|10782397|FG000|Overall Study|Lost to Follow-up|10
6785456|NCT00121108|10782398|FG001|Overall Study|Lost to Follow-up|22
6785457|NCT00121108|10782397|FG000|Overall Study|Withdrawal by Subject|106
6785458|NCT00121108|10782398|FG001|Overall Study|Withdrawal by Subject|195
6785459|NCT00121108|10782397|FG000|Overall Study|Death|5
6785460|NCT00121108|10782398|FG001|Overall Study|Death|8
6785461|NCT00003102|10782408|FG000|Overall Study|Physician Decision|1
6785462|NCT00003102|10782409|FG001|Overall Study|Physician Decision|1
6785463|NCT00003102|10782410|FG002|Overall Study|Physician Decision|0
6785464|NCT00003102|10782408|FG000|Overall Study|Progressive Disease|0
6785465|NCT00003102|10782409|FG001|Overall Study|Progressive Disease|1
6785466|NCT00003102|10782410|FG002|Overall Study|Progressive Disease|0
6785467|NCT00003102|10782408|FG000|Overall Study|Adverse Event|0
6785468|NCT00003102|10782409|FG001|Overall Study|Adverse Event|1
6785469|NCT00003102|10782410|FG002|Overall Study|Adverse Event|1
6785470|NCT00003102|10782408|FG000|Overall Study|Death|0
6785471|NCT00003102|10782409|FG001|Overall Study|Death|0
6785472|NCT00003102|10782410|FG002|Overall Study|Death|1
6806964|NCT03183778|10810313|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1
6806965|NCT02700698|10810339|FG000|Overall Study|Withdrawal by Subject|1
6806966|NCT02700698|10810340|FG001|Overall Study|Withdrawal by Subject|0
6806967|NCT02698865|10810357|FG000|Overall Study|Other|11
6806968|NCT02698865|10810358|FG001|Overall Study|Other|11
6806969|NCT02698865|10810357|FG000|Overall Study|Withdrawal by Subject|20
6806970|NCT02698865|10810358|FG001|Overall Study|Withdrawal by Subject|16
6806971|NCT02698865|10810357|FG000|Overall Study|Physician Decision|0
6806972|NCT02698865|10810358|FG001|Overall Study|Physician Decision|4
6806973|NCT02698865|10810357|FG000|Overall Study|Lost to Follow-up|4
6806974|NCT02698865|10810358|FG001|Overall Study|Lost to Follow-up|2
6806975|NCT02660086|10810366|FG000|Overall Study- 12-month|Withdrawal by Subject|5
6806976|NCT02660086|10810367|FG001|Overall Study- 12-month|Withdrawal by Subject|5
6806977|NCT02660086|10810366|FG000|Overall Study- 12-month|Left full-time employment|12
6806978|NCT02660086|10810367|FG001|Overall Study- 12-month|Left full-time employment|20
6806979|NCT02660086|10810366|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8
6806980|NCT02660086|10810367|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4
7139070|NCT02953782|11292573|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
7139071|NCT02953782|11292574|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
7139072|NCT02953782|11292575|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1
7139073|NCT02953782|11292576|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1
7139074|NCT02953782|11292577|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
7139075|NCT02953782|11292578|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
7139076|NCT02953782|11292579|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
7139077|NCT02953782|11292580|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
7139078|NCT02953782|11292573|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
7139079|NCT02953782|11292574|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
7139080|NCT02953782|11292575|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
7139081|NCT02953782|11292576|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
7139082|NCT02953782|11292577|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
6785473|NCT04633837|10782420|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5
6785474|NCT04633837|10782421|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0
6785475|NCT04057937|10782429|FG000|Placebo-controlled Phase|Adverse Event|3
6785476|NCT04057937|10782430|FG001|Placebo-controlled Phase|Adverse Event|0
6785477|NCT04057937|10782429|FG000|Active-treatment Phase|Withdrawal by Subject|1
6785478|NCT04057937|10782430|FG001|Active-treatment Phase|Withdrawal by Subject|0
6785479|NCT04057937|10782429|FG000|Active-treatment Phase|Pregnancy|0
6785480|NCT04057937|10782430|FG001|Active-treatment Phase|Pregnancy|1
6785481|NCT04057937|10782429|FG000|Active-treatment Phase|Physician Decision|0
6785482|NCT04057937|10782430|FG001|Active-treatment Phase|Physician Decision|1
6785483|NCT03032510|10782443|FG000|Overall Study|Adverse Event|5
6785484|NCT03032510|10782444|FG001|Overall Study|Adverse Event|2
6785485|NCT03032510|10782443|FG000|Overall Study|Lost to Follow-up|8
6785486|NCT03032510|10782444|FG001|Overall Study|Lost to Follow-up|7
6785487|NCT03032510|10782443|FG000|Overall Study|Withdrawal by Subject|8
6785488|NCT03032510|10782444|FG001|Overall Study|Withdrawal by Subject|7
6785489|NCT03032510|10782443|FG000|Overall Study|Subject noncompliance|4
6785490|NCT03032510|10782444|FG001|Overall Study|Subject noncompliance|2
6785491|NCT03032510|10782443|FG000|Overall Study|Physician Decision|2
6785492|NCT03032510|10782444|FG001|Overall Study|Physician Decision|0
6785493|NCT02946047|10782475|FG000|Overall Study|Adverse Event|1
6785494|NCT02946047|10782476|FG001|Overall Study|Adverse Event|0
6785495|NCT02946047|10782477|FG002|Overall Study|Adverse Event|0
6785496|NCT02946047|10782478|FG003|Overall Study|Adverse Event|0
6785497|NCT02784704|10782496|FG000|Overall Study|Adverse Event|4
6785498|NCT02784704|10782497|FG001|Overall Study|Adverse Event|2
6785499|NCT02784704|10782496|FG000|Overall Study|Lost to Follow-up|6
6785500|NCT02784704|10782497|FG001|Overall Study|Lost to Follow-up|4
6785501|NCT02784704|10782496|FG000|Overall Study|Withdrawal by Subject|1
6785502|NCT02784704|10782497|FG001|Overall Study|Withdrawal by Subject|3
6785503|NCT02784704|10782496|FG000|Overall Study|Subject Non Compliance|2
6785504|NCT02784704|10782497|FG001|Overall Study|Subject Non Compliance|0
6785505|NCT04831515|10782505|FG000|First Intervention|Adverse Event|0
6785506|NCT04831515|10782506|FG001|First Intervention|Adverse Event|1
6785507|NCT03881059|10782537|FG000|Treatment Period - Part A|Adverse Event|1
6785508|NCT03881059|10782538|FG001|Treatment Period - Part A|Adverse Event|3
6785509|NCT03881059|10782539|FG002|Treatment Period - Part A|Adverse Event|4
6785510|NCT03881059|10782537|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0
6785511|NCT03881059|10782538|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1
6785512|NCT03881059|10782539|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1
6785513|NCT03881059|10782537|FG000|Treatment Period - Part A|Withdrawal by Subject|5
6785514|NCT03881059|10782538|FG001|Treatment Period - Part A|Withdrawal by Subject|2
6785515|NCT03881059|10782539|FG002|Treatment Period - Part A|Withdrawal by Subject|3
6785516|NCT03881059|10782537|FG000|Treatment Period - Part A|Other reasons|2
6785517|NCT03881059|10782538|FG001|Treatment Period - Part A|Other reasons|1
6785518|NCT03881059|10782539|FG002|Treatment Period - Part A|Other reasons|0
6785519|NCT03881059|10782537|FG000|Treatment Period - Part B|Adverse Event|0
6785520|NCT03881059|10782538|FG001|Treatment Period - Part B|Adverse Event|0
6785521|NCT03881059|10782539|FG002|Treatment Period - Part B|Adverse Event|3
6785522|NCT03881059|10782537|FG000|Treatment Period - Part B|Death|0
6785523|NCT03881059|10782538|FG001|Treatment Period - Part B|Death|1
6785524|NCT03881059|10782539|FG002|Treatment Period - Part B|Death|1
6785525|NCT03881059|10782537|FG000|Treatment Period - Part B|Lack of Efficacy|1
6785526|NCT03881059|10782538|FG001|Treatment Period - Part B|Lack of Efficacy|1
6785527|NCT03881059|10782539|FG002|Treatment Period - Part B|Lack of Efficacy|0
6785528|NCT03881059|10782537|FG000|Treatment Period - Part B|Lost to Follow-up|1
6785529|NCT03881059|10782538|FG001|Treatment Period - Part B|Lost to Follow-up|1
6785530|NCT03881059|10782539|FG002|Treatment Period - Part B|Lost to Follow-up|0
6785531|NCT03881059|10782537|FG000|Treatment Period - Part B|Site terminated by sponsor|1
6785532|NCT03881059|10782538|FG001|Treatment Period - Part B|Site terminated by sponsor|0
6785533|NCT03881059|10782539|FG002|Treatment Period - Part B|Site terminated by sponsor|3
6785534|NCT03881059|10782537|FG000|Treatment Period - Part B|Withdrawal by Subject|1
6785535|NCT03881059|10782538|FG001|Treatment Period - Part B|Withdrawal by Subject|0
6785536|NCT03881059|10782539|FG002|Treatment Period - Part B|Withdrawal by Subject|1
6785537|NCT03881059|10782537|FG000|Treatment Period - Part B|Other reasons|4
6785538|NCT03881059|10782538|FG001|Treatment Period - Part B|Other reasons|3
6785539|NCT03881059|10782539|FG002|Treatment Period - Part B|Other reasons|3
6785540|NCT03450629|10782558|FG000|Overall Study|Adverse Event|15
6785541|NCT03450629|10782559|FG001|Overall Study|Adverse Event|14
7139083|NCT02953782|11292578|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14
7139084|NCT02953782|11292579|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11
6785542|NCT03450629|10782558|FG000|Overall Study|Physician Decision|2
6785543|NCT03450629|10782559|FG001|Overall Study|Physician Decision|2
6785544|NCT03450629|10782558|FG000|Overall Study|Lack of Efficacy|2
6785545|NCT03450629|10782559|FG001|Overall Study|Lack of Efficacy|0
6785546|NCT03450629|10782558|FG000|Overall Study|Lost to Follow-up|4
6785547|NCT03450629|10782559|FG001|Overall Study|Lost to Follow-up|2
6785548|NCT03450629|10782558|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
6785549|NCT03450629|10782559|FG001|Overall Study|No Longer Meets Eligibility Criteria|1
6785550|NCT03450629|10782558|FG000|Overall Study|Non-Compliance With Study Drug|2
6785551|NCT03450629|10782559|FG001|Overall Study|Non-Compliance With Study Drug|1
6785552|NCT03450629|10782558|FG000|Overall Study|Protocol Violation|11
6785553|NCT03450629|10782559|FG001|Overall Study|Protocol Violation|8
6785554|NCT03450629|10782558|FG000|Overall Study|Withdrawal by Subject|12
6785555|NCT03450629|10782559|FG001|Overall Study|Withdrawal by Subject|6
6785556|NCT03367403|10782568|FG000|Overall Study|Adverse Event|20
6785557|NCT03367403|10782569|FG001|Overall Study|Adverse Event|6
6785558|NCT03367403|10782570|FG002|Overall Study|Adverse Event|2
6785559|NCT03367403|10782568|FG000|Overall Study|Withdrawal by Subject|12
6785560|NCT03367403|10782569|FG001|Overall Study|Withdrawal by Subject|12
6785561|NCT03367403|10782570|FG002|Overall Study|Withdrawal by Subject|1
6785562|NCT03367403|10782568|FG000|Overall Study|Death|1
6785563|NCT03367403|10782569|FG001|Overall Study|Death|2
6785564|NCT03367403|10782570|FG002|Overall Study|Death|0
6785565|NCT03367403|10782568|FG000|Overall Study|Physician Decision|0
6785566|NCT03367403|10782569|FG001|Overall Study|Physician Decision|1
6785567|NCT03367403|10782570|FG002|Overall Study|Physician Decision|0
7139085|NCT02953782|11292580|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8
7139086|NCT02953782|11292573|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
7139087|NCT02953782|11292574|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
7139088|NCT02953782|11292575|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
7139089|NCT02953782|11292576|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
7139090|NCT02953782|11292577|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
7139091|NCT02953782|11292578|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1
7139092|NCT02953782|11292579|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2
7139093|NCT02953782|11292580|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3
7139094|NCT02953782|11292573|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
7139095|NCT02953782|11292574|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
7139096|NCT02953782|11292575|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
7139097|NCT02953782|11292576|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
7139098|NCT02953782|11292577|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
7139099|NCT02953782|11292578|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1
7139100|NCT02953782|11292579|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1
7139101|NCT02953782|11292580|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4
7139102|NCT02953782|11292573|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
7139103|NCT02953782|11292574|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
7139104|NCT02953782|11292575|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
7139105|NCT02953782|11292576|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
7139106|NCT02953782|11292577|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
7139107|NCT02953782|11292578|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
7139108|NCT02953782|11292579|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1
7139109|NCT02953782|11292580|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
6785568|NCT03367403|10782568|FG000|Overall Study|Protocol Violation|1
6785569|NCT03367403|10782569|FG001|Overall Study|Protocol Violation|1
6785570|NCT03367403|10782570|FG002|Overall Study|Protocol Violation|0
6785571|NCT03367403|10782568|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0
6785572|NCT03367403|10782569|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2
6785573|NCT03367403|10782570|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0
6785574|NCT03367403|10782568|FG000|Overall Study|COVID-19|3
6785575|NCT03367403|10782569|FG001|Overall Study|COVID-19|7
6785576|NCT03367403|10782570|FG002|Overall Study|COVID-19|0
6785577|NCT03367403|10782568|FG000|Overall Study|Abuse of Alcohol Intake|0
6785578|NCT03367403|10782569|FG001|Overall Study|Abuse of Alcohol Intake|1
6785579|NCT03367403|10782570|FG002|Overall Study|Abuse of Alcohol Intake|0
6785580|NCT03367403|10782568|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0
6785581|NCT03367403|10782569|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1
6785582|NCT03367403|10782570|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0
6785583|NCT03286426|10782578|FG000|Overall Study|Physician Decision|3
6785584|NCT02809677|10782595|FG000|Overall Study|Withdrawal by Subject|8
6785585|NCT02554253|10782606|FG000|Overall Study|ineligible after enrollment|1
6785586|NCT02554253|10782607|FG001|Overall Study|ineligible after enrollment|0
6785587|NCT02554253|10782606|FG000|Overall Study|converted to transcatheter procedure|0
6785588|NCT02554253|10782607|FG001|Overall Study|converted to transcatheter procedure|1
6785589|NCT02554253|10782606|FG000|Overall Study|received both drugs|0
6785590|NCT02554253|10782607|FG001|Overall Study|received both drugs|1
6806981|NCT02660086|10810366|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1
6806982|NCT02660086|10810367|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0
6806983|NCT02660086|10810366|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17
6806984|NCT02660086|10810367|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8
6806985|NCT02660086|10810366|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9
6806986|NCT02660086|10810367|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16
6806987|NCT02129647|10810377|FG000|Overall Study|Adverse Event|2
6806988|NCT02129647|10810377|FG000|Overall Study|surgical intervention for clinically progressive disease|1
6806989|NCT01959139|10810389|FG000|Phase II|Disease progression|0
6806990|NCT01959139|10810390|FG001|Phase II|Disease progression|0
6806991|NCT01959139|10810391|FG002|Phase II|Disease progression|26
6806992|NCT01959139|10810392|FG003|Phase II|Disease progression|34
6806993|NCT01959139|10810389|FG000|Phase II|Adverse Event|0
6806994|NCT01959139|10810390|FG001|Phase II|Adverse Event|0
6806995|NCT01959139|10810391|FG002|Phase II|Adverse Event|10
6806996|NCT01959139|10810392|FG003|Phase II|Adverse Event|11
6806997|NCT01959139|10810389|FG000|Phase II|Patient Refusal|0
6806998|NCT01959139|10810390|FG001|Phase II|Patient Refusal|0
6806999|NCT01959139|10810391|FG002|Phase II|Patient Refusal|5
6807000|NCT01959139|10810392|FG003|Phase II|Patient Refusal|4
6807001|NCT01959139|10810389|FG000|Phase II|Death|0
6807002|NCT01959139|10810390|FG001|Phase II|Death|0
6807003|NCT01959139|10810391|FG002|Phase II|Death|3
6807004|NCT01959139|10810392|FG003|Phase II|Death|1
6807005|NCT01959139|10810389|FG000|Phase II|Other/Unknown|0
6807006|NCT01959139|10810390|FG001|Phase II|Other/Unknown|0
6807007|NCT01959139|10810391|FG002|Phase II|Other/Unknown|8
6807008|NCT01959139|10810392|FG003|Phase II|Other/Unknown|5
6807009|NCT01959139|10810389|FG000|Phase II|On treatment|0
6807010|NCT01959139|10810390|FG001|Phase II|On treatment|0
6807011|NCT01959139|10810391|FG002|Phase II|On treatment|4
6807012|NCT01959139|10810392|FG003|Phase II|On treatment|0
6807013|NCT01597778|10810409|FG000|Overall Study|Death|7
6807014|NCT01597778|10810410|FG001|Overall Study|Death|10
6807015|NCT01597778|10810409|FG000|Overall Study|Withdrawal by Subject|3
6807016|NCT01597778|10810410|FG001|Overall Study|Withdrawal by Subject|4
6807017|NCT01597778|10810409|FG000|Overall Study|Adverse Event|1
6807018|NCT01597778|10810410|FG001|Overall Study|Adverse Event|1
6807019|NCT01597778|10810409|FG000|Overall Study|Protocol Violation|1
6807020|NCT01597778|10810410|FG001|Overall Study|Protocol Violation|11
6807021|NCT01597778|10810409|FG000|Overall Study|Transplanted off protocol|2
6807022|NCT01597778|10810410|FG001|Overall Study|Transplanted off protocol|3
6807046|NCT00879086|10810452|FG000|Overall Study|Adverse Event|3
6807047|NCT00879086|10810453|FG001|Overall Study|Adverse Event|15
6807048|NCT00879086|10810452|FG000|Overall Study|Participant choice|2
6807049|NCT00879086|10810453|FG001|Overall Study|Participant choice|2
6807050|NCT00879086|10810452|FG000|Overall Study|Progression of disease|40
6807051|NCT00879086|10810453|FG001|Overall Study|Progression of disease|26
6807052|NCT00879086|10810452|FG000|Overall Study|Withdrawal of consent|2
6807053|NCT00879086|10810453|FG001|Overall Study|Withdrawal of consent|1
6807054|NCT00879086|10810452|FG000|Overall Study|Other|4
6807055|NCT00879086|10810453|FG001|Overall Study|Other|6
6807056|NCT00879086|10810452|FG000|Overall Study|Death|1
6807057|NCT00879086|10810453|FG001|Overall Study|Death|2
6807058|NCT00864227|10810459|FG000|Overall Study|Withdrawal by Subject|1
6807059|NCT00864227|10810459|FG000|Overall Study|Disease Relapse/Progression|3
6785591|NCT01307046|10782626|FG000|Overall Study|Adverse Event|3
6785592|NCT01307046|10782627|FG001|Overall Study|Adverse Event|3
6785593|NCT01307046|10782626|FG000|Overall Study|Lack of Efficacy|0
6785594|NCT01307046|10782627|FG001|Overall Study|Lack of Efficacy|2
6785595|NCT01307046|10782626|FG000|Overall Study|Physician Decision|2
6785596|NCT01307046|10782627|FG001|Overall Study|Physician Decision|0
6785597|NCT01307046|10782626|FG000|Overall Study|Withdrawal by Subject|1
6785598|NCT01307046|10782627|FG001|Overall Study|Withdrawal by Subject|1
6785599|NCT01307046|10782626|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4
6785600|NCT01307046|10782627|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2
6785601|NCT01307046|10782626|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2
6785602|NCT01307046|10782627|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3
6785603|NCT01307033|10782635|FG000|8-week Double-blind Period|Adverse Event|2
6785604|NCT01307033|10782636|FG001|8-week Double-blind Period|Adverse Event|0
6785605|NCT01307033|10782637|FG002|8-week Double-blind Period|Adverse Event|0
6785606|NCT01307033|10782638|FG003|8-week Double-blind Period|Adverse Event|0
6785607|NCT01307033|10782635|FG000|8-week Double-blind Period|Withdrawal by Subject|4
6785608|NCT01307033|10782636|FG001|8-week Double-blind Period|Withdrawal by Subject|1
6785609|NCT01307033|10782637|FG002|8-week Double-blind Period|Withdrawal by Subject|0
6785610|NCT01307033|10782638|FG003|8-week Double-blind Period|Withdrawal by Subject|0
6785611|NCT01307033|10782635|FG000|8-week Double-blind Period|Lack of Efficacy|1
6785612|NCT01307033|10782636|FG001|8-week Double-blind Period|Lack of Efficacy|0
6785613|NCT01307033|10782637|FG002|8-week Double-blind Period|Lack of Efficacy|0
6785614|NCT01307033|10782638|FG003|8-week Double-blind Period|Lack of Efficacy|0
6785615|NCT01307033|10782635|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
6785616|NCT01307033|10782636|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3
6785617|NCT01307033|10782637|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
6785618|NCT01307033|10782638|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
6785619|NCT01307033|10782635|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6
6785620|NCT01307033|10782636|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3
6785621|NCT01307033|10782637|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
6785622|NCT01307033|10782638|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
6785623|NCT01307033|10782635|FG000|44-week Open-label Extension|Adverse Event|0
6785624|NCT01307033|10782636|FG001|44-week Open-label Extension|Adverse Event|0
6785625|NCT01307033|10782637|FG002|44-week Open-label Extension|Adverse Event|2
6785626|NCT01307033|10782638|FG003|44-week Open-label Extension|Adverse Event|1
6785627|NCT01307033|10782635|FG000|44-week Open-label Extension|Withdrawal by Subject|0
6785628|NCT01307033|10782636|FG001|44-week Open-label Extension|Withdrawal by Subject|0
6785629|NCT01307033|10782637|FG002|44-week Open-label Extension|Withdrawal by Subject|2
6785630|NCT01307033|10782638|FG003|44-week Open-label Extension|Withdrawal by Subject|1
6785631|NCT01307033|10782635|FG000|44-week Open-label Extension|Physician Decision|0
6785632|NCT01307033|10782636|FG001|44-week Open-label Extension|Physician Decision|0
6785633|NCT01307033|10782637|FG002|44-week Open-label Extension|Physician Decision|1
6785634|NCT01307033|10782638|FG003|44-week Open-label Extension|Physician Decision|0
6785635|NCT01307033|10782635|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
6785636|NCT01307033|10782636|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
6785637|NCT01307033|10782637|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
6785638|NCT01307033|10782638|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2
6785639|NCT01307033|10782635|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
6785640|NCT01307033|10782636|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
6785641|NCT01307033|10782637|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6
6785642|NCT01307033|10782638|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7
6785643|NCT01307033|10782635|FG000|44-week Open-label Extension|Death|0
6785644|NCT01307033|10782636|FG001|44-week Open-label Extension|Death|0
6785645|NCT01307033|10782637|FG002|44-week Open-label Extension|Death|0
6785646|NCT01307033|10782638|FG003|44-week Open-label Extension|Death|1
6785647|NCT00739674|10782652|FG000|Overall Study|Screening failures|19
6785648|NCT00739674|10782653|FG001|Overall Study|Screening failures|17
6785649|NCT00739674|10782652|FG000|Overall Study|Site 212 removal|19
6785650|NCT00739674|10782653|FG001|Overall Study|Site 212 removal|13
6785651|NCT00739674|10782652|FG000|Overall Study|No follow-up data|33
6785652|NCT00739674|10782653|FG001|Overall Study|No follow-up data|18
6785653|NCT00739674|10782652|FG000|Overall Study|Dietician consultation >30 days|1
6785654|NCT00739674|10782653|FG001|Overall Study|Dietician consultation >30 days|9
6785655|NCT00739674|10782652|FG000|Overall Study|Adverse Event|22
6785656|NCT00739674|10782653|FG001|Overall Study|Adverse Event|13
6785657|NCT00739674|10782652|FG000|Overall Study|Death|1
6785658|NCT00739674|10782653|FG001|Overall Study|Death|0
6785659|NCT00739674|10782652|FG000|Overall Study|Lack of Efficacy|1
6785660|NCT00739674|10782653|FG001|Overall Study|Lack of Efficacy|0
6785661|NCT00739674|10782652|FG000|Overall Study|Lost to Follow-up|52
6785662|NCT00739674|10782653|FG001|Overall Study|Lost to Follow-up|30
6785663|NCT00739674|10782652|FG000|Overall Study|Protocol Violation|5
6785664|NCT00739674|10782653|FG001|Overall Study|Protocol Violation|5
6785665|NCT00739674|10782652|FG000|Overall Study|Withdrawal by Subject|9
6785666|NCT00739674|10782653|FG001|Overall Study|Withdrawal by Subject|9
6785667|NCT00739674|10782652|FG000|Overall Study|Reason missing|2
6785668|NCT00739674|10782653|FG001|Overall Study|Reason missing|0
6785669|NCT00739674|10782652|FG000|Overall Study|Clinic closed|6
6785670|NCT00739674|10782653|FG001|Overall Study|Clinic closed|4
6785671|NCT00739674|10782652|FG000|Overall Study|Patient moved|3
6785672|NCT00739674|10782653|FG001|Overall Study|Patient moved|2
6785673|NCT00739674|10782652|FG000|Overall Study|Non compliant|4
6785674|NCT00739674|10782653|FG001|Overall Study|Non compliant|0
6785675|NCT00739674|10782652|FG000|Overall Study|Unable to attend visit|3
6785676|NCT00739674|10782653|FG001|Overall Study|Unable to attend visit|1
6785677|NCT00739674|10782652|FG000|Overall Study|Home monitoring off meds|1
6785678|NCT00739674|10782653|FG001|Overall Study|Home monitoring off meds|0
6785679|NCT00739674|10782652|FG000|Overall Study|Erectile dysfunction|0
6785680|NCT00739674|10782653|FG001|Overall Study|Erectile dysfunction|1
6785681|NCT00546754|10782661|FG000|Overall Study|Serious Adverse Event|1
6785682|NCT00546754|10782662|FG001|Overall Study|Serious Adverse Event|1
6785683|NCT00546754|10782661|FG000|Overall Study|Adverse Event|11
6785684|NCT00546754|10782662|FG001|Overall Study|Adverse Event|16
6785685|NCT00546754|10782661|FG000|Overall Study|Lack of Efficacy|1
6785686|NCT00546754|10782662|FG001|Overall Study|Lack of Efficacy|1
6785687|NCT00546754|10782661|FG000|Overall Study|Lost to Follow-up|9
6785688|NCT00546754|10782662|FG001|Overall Study|Lost to Follow-up|15
6785689|NCT00546754|10782661|FG000|Overall Study|Protocol Violation|3
6785690|NCT00546754|10782662|FG001|Overall Study|Protocol Violation|0
6785691|NCT00546754|10782661|FG000|Overall Study|Withdrawal by Subject|6
6785692|NCT00546754|10782662|FG001|Overall Study|Withdrawal by Subject|7
6785693|NCT00546754|10782661|FG000|Overall Study|Dyspnea|1
6785694|NCT00546754|10782662|FG001|Overall Study|Dyspnea|0
6785695|NCT00546754|10782661|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1
6785696|NCT00546754|10782662|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0
6785697|NCT00546754|10782661|FG000|Overall Study|Hip Replacement|1
6785698|NCT00546754|10782662|FG001|Overall Study|Hip Replacement|0
6785699|NCT00546754|10782661|FG000|Overall Study|Suicide|1
6785700|NCT00546754|10782662|FG001|Overall Study|Suicide|0
6785701|NCT00546754|10782661|FG000|Overall Study|Missing Cooperation|1
6785702|NCT00546754|10782662|FG001|Overall Study|Missing Cooperation|0
6785703|NCT00546754|10782661|FG000|Overall Study|Elevated Creatinine and Potassium levels|0
6785704|NCT00546754|10782662|FG001|Overall Study|Elevated Creatinine and Potassium levels|1
6785705|NCT00546754|10782661|FG000|Overall Study|Patient's Decision|0
6785706|NCT00546754|10782662|FG001|Overall Study|Patient's Decision|1
6785707|NCT00546754|10782661|FG000|Overall Study|Missing|14
6785708|NCT00546754|10782662|FG001|Overall Study|Missing|7
6785709|NCT00479713|10782670|FG000|Overall Study|Adverse Event|8
6785710|NCT00479713|10782671|FG001|Overall Study|Adverse Event|6
6785711|NCT00479713|10782670|FG000|Overall Study|Death|1
6785712|NCT00479713|10782671|FG001|Overall Study|Death|0
6785713|NCT00479713|10782670|FG000|Overall Study|Lost to Follow-up|0
7139110|NCT02953821|11292603|FG000|Overall Study|Adverse Event|0
7139111|NCT02953821|11292604|FG001|Overall Study|Adverse Event|4
7139112|NCT02953821|11292603|FG000|Overall Study|Death|1
7139113|NCT02953821|11292604|FG001|Overall Study|Death|0
7139114|NCT02953821|11292603|FG000|Overall Study|Progressive Disease|5
7139115|NCT02953821|11292604|FG001|Overall Study|Progressive Disease|1
7139116|NCT02953821|11292603|FG000|Overall Study|Lost to Follow-up|2
7139117|NCT02953821|11292604|FG001|Overall Study|Lost to Follow-up|0
7139118|NCT02953821|11292603|FG000|Overall Study|Physician Decision|1
7139119|NCT02953821|11292604|FG001|Overall Study|Physician Decision|1
7139120|NCT02953821|11292603|FG000|Overall Study|Withdrawal by Subject|3
7139121|NCT02953821|11292604|FG001|Overall Study|Withdrawal by Subject|3
7139122|NCT02953821|11292603|FG000|Overall Study|Change of address|0
7139123|NCT02953821|11292604|FG001|Overall Study|Change of address|1
7139124|NCT02953821|11292603|FG000|Overall Study|Lack of Efficacy|1
7139125|NCT02953821|11292604|FG001|Overall Study|Lack of Efficacy|0
7139126|NCT02953821|11292603|FG000|Overall Study|Out of state for indeterminate time|0
7139127|NCT02953821|11292604|FG001|Overall Study|Out of state for indeterminate time|1
7139128|NCT02953821|11292603|FG000|Overall Study|No improvement|0
7139129|NCT02953821|11292604|FG001|Overall Study|No improvement|1
7139130|NCT02953821|11292603|FG000|Overall Study|Refused follow-up visit|2
7139131|NCT02953821|11292604|FG001|Overall Study|Refused follow-up visit|1
7139132|NCT02953938|11292626|FG000|Overall Study|Adverse Event|0
7139133|NCT02953938|11292627|FG001|Overall Study|Adverse Event|1
7139134|NCT02953938|11292626|FG000|Overall Study|Withdrawal by Subject|1
7139135|NCT02953938|11292627|FG001|Overall Study|Withdrawal by Subject|1
7139136|NCT02954172|11292636|FG000|Overall Study|Protocol Violation|3
7139137|NCT02954172|11292637|FG001|Overall Study|Protocol Violation|0
7139138|NCT02954172|11292636|FG000|Overall Study|allergic reaction|2
7139139|NCT02954172|11292637|FG001|Overall Study|allergic reaction|1
7139140|NCT02954172|11292636|FG000|Overall Study|non-measurable lesions at baseline|1
7139141|NCT02954172|11292637|FG001|Overall Study|non-measurable lesions at baseline|2
7139142|NCT02954354|11292656|FG000|Overall Study|Adverse Event|2
7139143|NCT02954354|11292657|FG001|Overall Study|Adverse Event|2
7139144|NCT02954354|11292658|FG002|Overall Study|Adverse Event|4
7139145|NCT02954354|11292656|FG000|Overall Study|Failure to Meet Eligibility Criteria|1
7139146|NCT02954354|11292657|FG001|Overall Study|Failure to Meet Eligibility Criteria|0
6785714|NCT00479713|10782671|FG001|Overall Study|Lost to Follow-up|1
6785715|NCT00479713|10782670|FG000|Overall Study|Protocol Violation|0
6785716|NCT00479713|10782671|FG001|Overall Study|Protocol Violation|1
6785717|NCT00479713|10782670|FG000|Overall Study|Withdrawal by Subject|4
6785718|NCT00479713|10782671|FG001|Overall Study|Withdrawal by Subject|1
6785719|NCT00406783|10782679|FG000|Overall Study|Adverse Event|4
6785720|NCT00406783|10782680|FG001|Overall Study|Adverse Event|4
6785721|NCT00406783|10782679|FG000|Overall Study|Treatment Failure|2
6785722|NCT00406783|10782680|FG001|Overall Study|Treatment Failure|3
6785723|NCT00406783|10782679|FG000|Overall Study|Lost to Follow-up|3
6785724|NCT00406783|10782680|FG001|Overall Study|Lost to Follow-up|0
6785725|NCT00406783|10782679|FG000|Overall Study|Withdrawal by Subject|1
6785726|NCT00406783|10782680|FG001|Overall Study|Withdrawal by Subject|4
6785727|NCT00406783|10782679|FG000|Overall Study|Protocol Violation|4
6785728|NCT00406783|10782680|FG001|Overall Study|Protocol Violation|4
6785729|NCT00405964|10782688|FG000|Overall Study|Treatment Failure|17
6785730|NCT00405964|10782689|FG001|Overall Study|Treatment Failure|45
6785731|NCT00405964|10782688|FG000|Overall Study|Adverse Event|7
6785732|NCT00405964|10782689|FG001|Overall Study|Adverse Event|16
6785733|NCT00405964|10782688|FG000|Overall Study|Lost to Follow-up|5
6785734|NCT00405964|10782689|FG001|Overall Study|Lost to Follow-up|5
6785735|NCT00405964|10782688|FG000|Overall Study|Withdrawal by Subject|19
6785736|NCT00405964|10782689|FG001|Overall Study|Withdrawal by Subject|23
6785737|NCT00405964|10782688|FG000|Overall Study|Protocol Violation|11
6785738|NCT00405964|10782689|FG001|Overall Study|Protocol Violation|6
6785739|NCT00383721|10782700|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11
6785740|NCT00383721|10782701|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5
6785741|NCT00383721|10782702|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7
6785742|NCT00383721|10782703|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14
6785743|NCT00383721|10782704|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13
6785744|NCT00383721|10782700|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1
6785745|NCT00383721|10782701|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
6785746|NCT00383721|10782702|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
6785747|NCT00383721|10782703|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4
6785748|NCT00383721|10782704|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
6785749|NCT00383721|10782700|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
6785750|NCT00383721|10782701|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
6785751|NCT00383721|10782702|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
6785752|NCT00383721|10782703|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
6785753|NCT00383721|10782704|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4
6785754|NCT00383721|10782700|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4
6785755|NCT00383721|10782701|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
6785756|NCT00383721|10782702|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15
6785757|NCT00383721|10782703|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
6785758|NCT00383721|10782704|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11
6785759|NCT00383721|10782700|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5
6785760|NCT00383721|10782701|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
6785761|NCT00383721|10782702|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6
6785762|NCT00383721|10782703|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8
6785763|NCT00383721|10782704|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9
6785764|NCT00383721|10782700|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7
6785765|NCT00383721|10782701|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
6785766|NCT00383721|10782702|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
6785767|NCT00383721|10782703|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
6785768|NCT00383721|10782704|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
6785769|NCT00383721|10782700|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
6785770|NCT00383721|10782701|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
6785771|NCT00383721|10782702|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11
6785772|NCT00383721|10782703|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4
6785773|NCT00383721|10782704|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13
6785774|NCT00383721|10782700|FG000|26-Week Double-Blind Treatment Period|Administrative|1
6785775|NCT00383721|10782701|FG001|26-Week Double-Blind Treatment Period|Administrative|3
6785776|NCT00383721|10782702|FG002|26-Week Double-Blind Treatment Period|Administrative|3
6785777|NCT00383721|10782703|FG003|26-Week Double-Blind Treatment Period|Administrative|3
6785778|NCT00383721|10782704|FG004|26-Week Double-Blind Treatment Period|Administrative|3
6785779|NCT00383721|10782700|FG000|26-Week Double-Blind Treatment Period|Ongoing|1
6785780|NCT00383721|10782701|FG001|26-Week Double-Blind Treatment Period|Ongoing|0
6785781|NCT00383721|10782702|FG002|26-Week Double-Blind Treatment Period|Ongoing|0
6785782|NCT00383721|10782703|FG003|26-Week Double-Blind Treatment Period|Ongoing|0
6785783|NCT00383721|10782704|FG004|26-Week Double-Blind Treatment Period|Ongoing|0
6785784|NCT00383721|10782700|FG000|26-Week Treatment Safety Extension|Adverse Event|6
6785785|NCT00383721|10782701|FG001|26-Week Treatment Safety Extension|Adverse Event|7
6785786|NCT00383721|10782702|FG002|26-Week Treatment Safety Extension|Adverse Event|10
6785787|NCT00383721|10782703|FG003|26-Week Treatment Safety Extension|Adverse Event|1
6785788|NCT00383721|10782704|FG004|26-Week Treatment Safety Extension|Adverse Event|0
6785789|NCT00383721|10782700|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0
6785790|NCT00383721|10782701|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2
6785791|NCT00383721|10782702|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4
6785792|NCT00383721|10782703|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1
6785793|NCT00383721|10782704|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0
6785794|NCT00383721|10782700|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2
6785795|NCT00383721|10782701|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0
6785796|NCT00383721|10782702|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1
6785797|NCT00383721|10782703|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1
6785798|NCT00383721|10782704|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0
6785799|NCT00383721|10782700|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
6785800|NCT00383721|10782701|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4
6785801|NCT00383721|10782702|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
6785802|NCT00383721|10782703|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7
6785803|NCT00383721|10782704|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
6785804|NCT00383721|10782700|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1
6785805|NCT00383721|10782701|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1
6785806|NCT00383721|10782702|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1
6785807|NCT00383721|10782703|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1
6785808|NCT00383721|10782704|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0
6785809|NCT00383721|10782700|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2
6785810|NCT00383721|10782701|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1
6785811|NCT00383721|10782702|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1
6785812|NCT00383721|10782703|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4
6785813|NCT00383721|10782704|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0
6785814|NCT00383721|10782700|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
6785815|NCT00383721|10782701|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
6785816|NCT00383721|10782702|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
6785817|NCT00383721|10782703|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
6785818|NCT00383721|10782704|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
6785819|NCT00383721|10782700|FG000|26-Week Treatment Safety Extension|Administrative|1
6785820|NCT00383721|10782701|FG001|26-Week Treatment Safety Extension|Administrative|2
6785821|NCT00383721|10782702|FG002|26-Week Treatment Safety Extension|Administrative|3
6785822|NCT00383721|10782703|FG003|26-Week Treatment Safety Extension|Administrative|1
6785823|NCT00383721|10782704|FG004|26-Week Treatment Safety Extension|Administrative|0
6785824|NCT00383552|10782720|FG000|Overall Study|Adverse Event|7
6785825|NCT00383552|10782721|FG001|Overall Study|Adverse Event|6
6785826|NCT00383552|10782722|FG002|Overall Study|Adverse Event|9
6785827|NCT00383552|10782723|FG003|Overall Study|Adverse Event|6
6785828|NCT00383552|10782720|FG000|Overall Study|Lack of Efficacy|4
6785829|NCT00383552|10782721|FG001|Overall Study|Lack of Efficacy|13
6785830|NCT00383552|10782722|FG002|Overall Study|Lack of Efficacy|29
6785831|NCT00383552|10782723|FG003|Overall Study|Lack of Efficacy|42
6785832|NCT00383552|10782720|FG000|Overall Study|Lost to Follow-up|0
6785833|NCT00383552|10782721|FG001|Overall Study|Lost to Follow-up|1
6785834|NCT00383552|10782722|FG002|Overall Study|Lost to Follow-up|5
6785835|NCT00383552|10782723|FG003|Overall Study|Lost to Follow-up|1
6785836|NCT00383552|10782720|FG000|Overall Study|Did not wish to continue (unrelated)|4
6785837|NCT00383552|10782721|FG001|Overall Study|Did not wish to continue (unrelated)|9
6785838|NCT00383552|10782722|FG002|Overall Study|Did not wish to continue (unrelated)|5
6785839|NCT00383552|10782723|FG003|Overall Study|Did not wish to continue (unrelated)|6
6785840|NCT00383552|10782720|FG000|Overall Study|Did not wish to continue (related)|1
6785841|NCT00383552|10782721|FG001|Overall Study|Did not wish to continue (related)|0
6785842|NCT00383552|10782722|FG002|Overall Study|Did not wish to continue (related)|2
6785843|NCT00383552|10782723|FG003|Overall Study|Did not wish to continue (related)|3
6785844|NCT00383552|10782720|FG000|Overall Study|Noncompliance with the protocol|11
6785845|NCT00383552|10782721|FG001|Overall Study|Noncompliance with the protocol|6
6785846|NCT00383552|10782722|FG002|Overall Study|Noncompliance with the protocol|8
6785847|NCT00383552|10782723|FG003|Overall Study|Noncompliance with the protocol|10
6785848|NCT00383552|10782720|FG000|Overall Study|Did not meet protocol eligibility|8
6785849|NCT00383552|10782721|FG001|Overall Study|Did not meet protocol eligibility|6
6785850|NCT00383552|10782722|FG002|Overall Study|Did not meet protocol eligibility|2
6785851|NCT00383552|10782723|FG003|Overall Study|Did not meet protocol eligibility|3
6785852|NCT00383552|10782720|FG000|Overall Study|Administrative|1
6785853|NCT00383552|10782721|FG001|Overall Study|Administrative|0
6785854|NCT00383552|10782722|FG002|Overall Study|Administrative|1
6785855|NCT00383552|10782723|FG003|Overall Study|Administrative|1
7139147|NCT02954354|11292658|FG002|Overall Study|Failure to Meet Eligibility Criteria|0
7139148|NCT02954354|11292656|FG000|Overall Study|Lack of Efficacy|0
7139149|NCT02954354|11292657|FG001|Overall Study|Lack of Efficacy|2
6785856|NCT00383435|10782743|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10
6785857|NCT00383435|10782744|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2
6785858|NCT00383435|10782745|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8
6785859|NCT00383435|10782746|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6
6785860|NCT00383435|10782747|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8
6785861|NCT00383435|10782743|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
6785862|NCT00383435|10782744|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2
6785863|NCT00383435|10782745|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
6785864|NCT00383435|10782746|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5
6785865|NCT00383435|10782747|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
6785866|NCT00383435|10782743|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
6785867|NCT00383435|10782744|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
6785868|NCT00383435|10782745|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
6785869|NCT00383435|10782746|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
6785870|NCT00383435|10782747|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
6785871|NCT00383435|10782743|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7
6785872|NCT00383435|10782744|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
6785873|NCT00383435|10782745|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14
6785874|NCT00383435|10782746|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
6785875|NCT00383435|10782747|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17
6785876|NCT00383435|10782743|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2
7139150|NCT02954354|11292658|FG002|Overall Study|Lack of Efficacy|0
7139151|NCT02954354|11292656|FG000|Overall Study|Withdrawal by Subject|17
7139152|NCT02954354|11292657|FG001|Overall Study|Withdrawal by Subject|9
7139153|NCT02954354|11292658|FG002|Overall Study|Withdrawal by Subject|11
7139154|NCT02954354|11292656|FG000|Overall Study|Lost to Follow-up|12
7139155|NCT02954354|11292657|FG001|Overall Study|Lost to Follow-up|5
7139156|NCT02954354|11292658|FG002|Overall Study|Lost to Follow-up|0
7139157|NCT02954354|11292656|FG000|Overall Study|Miscellaneous|2
7139158|NCT02954354|11292657|FG001|Overall Study|Miscellaneous|2
7139159|NCT02954354|11292658|FG002|Overall Study|Miscellaneous|1
7139160|NCT02954458|11292672|FG000|Overall Study|Adverse Event|0
7139161|NCT02954458|11292673|FG001|Overall Study|Adverse Event|0
7139162|NCT02954458|11292674|FG002|Overall Study|Adverse Event|0
7139163|NCT02954458|11292675|FG003|Overall Study|Adverse Event|1
7139164|NCT02954458|11292672|FG000|Overall Study|Withdrawal by Subject|0
7139165|NCT02954458|11292673|FG001|Overall Study|Withdrawal by Subject|0
7139166|NCT02954458|11292674|FG002|Overall Study|Withdrawal by Subject|0
7139167|NCT02954458|11292675|FG003|Overall Study|Withdrawal by Subject|1
7139168|NCT02954458|11292672|FG000|Overall Study|Physician Decision|0
7139169|NCT02954458|11292673|FG001|Overall Study|Physician Decision|0
7139170|NCT02954458|11292674|FG002|Overall Study|Physician Decision|1
7139171|NCT02954458|11292675|FG003|Overall Study|Physician Decision|1
7139172|NCT02954458|11292672|FG000|Overall Study|Lost to Follow-up|1
7139173|NCT02954458|11292673|FG001|Overall Study|Lost to Follow-up|0
7139174|NCT02954458|11292674|FG002|Overall Study|Lost to Follow-up|0
7139175|NCT02954458|11292675|FG003|Overall Study|Lost to Follow-up|1
7139176|NCT02954458|11292672|FG000|Overall Study|Death|0
7139177|NCT02954458|11292673|FG001|Overall Study|Death|0
7139178|NCT02954458|11292674|FG002|Overall Study|Death|0
7139179|NCT02954458|11292675|FG003|Overall Study|Death|1
7139180|NCT02954458|11292672|FG000|Overall Study|Other|0
7139181|NCT02954458|11292673|FG001|Overall Study|Other|0
7139182|NCT02954458|11292674|FG002|Overall Study|Other|0
7139183|NCT02954458|11292675|FG003|Overall Study|Other|7
7139184|NCT02954575|11292689|FG000|Overall Study|Withdrawal by Subject|2
7139185|NCT02954575|11292689|FG000|Overall Study|Adverse Event|1
7139186|NCT02954601|11292701|FG000|First Intervention (Five Days)|Withdrawal by Subject|0
7139187|NCT02954601|11292702|FG001|First Intervention (Five Days)|Withdrawal by Subject|0
7139188|NCT02954601|11292703|FG002|First Intervention (Five Days)|Withdrawal by Subject|1
7139189|NCT02954601|11292704|FG003|First Intervention (Five Days)|Withdrawal by Subject|0
7139190|NCT02954653|11292716|FG000|Overall Study|Death|3
7139191|NCT02954653|11292717|FG001|Overall Study|Death|1
7139192|NCT02954653|11292718|FG002|Overall Study|Death|0
7139193|NCT02954653|11292719|FG003|Overall Study|Death|0
7139194|NCT02954653|11292720|FG004|Overall Study|Death|0
7139195|NCT02954653|11292721|FG005|Overall Study|Death|0
7139196|NCT02954653|11292722|FG006|Overall Study|Death|0
7139197|NCT02954653|11292723|FG007|Overall Study|Death|0
7139198|NCT02954653|11292724|FG008|Overall Study|Death|0
7139199|NCT02954653|11292716|FG000|Overall Study|Randomized but did not receive treatment|1
7139200|NCT02954653|11292717|FG001|Overall Study|Randomized but did not receive treatment|0
7139201|NCT02954653|11292718|FG002|Overall Study|Randomized but did not receive treatment|0
7139202|NCT02954653|11292719|FG003|Overall Study|Randomized but did not receive treatment|0
7139203|NCT02954653|11292720|FG004|Overall Study|Randomized but did not receive treatment|0
7139204|NCT02954653|11292721|FG005|Overall Study|Randomized but did not receive treatment|0
7139205|NCT02954653|11292722|FG006|Overall Study|Randomized but did not receive treatment|0
7139206|NCT02954653|11292723|FG007|Overall Study|Randomized but did not receive treatment|0
7139207|NCT02954653|11292724|FG008|Overall Study|Randomized but did not receive treatment|0
6785877|NCT00383435|10782744|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
6785878|NCT00383435|10782745|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
6785879|NCT00383435|10782746|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
6785880|NCT00383435|10782747|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
6785881|NCT00383435|10782743|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1
6785882|NCT00383435|10782744|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
6785883|NCT00383435|10782745|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3
6785884|NCT00383435|10782746|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
6785885|NCT00383435|10782747|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
6785886|NCT00383435|10782743|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10
6785887|NCT00383435|10782744|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8
6785888|NCT00383435|10782745|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9
6785889|NCT00383435|10782746|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
6785890|NCT00383435|10782747|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
6785891|NCT00383435|10782743|FG000|26-Week Double-Blind Treatment Period|Administrative|5
6785892|NCT00383435|10782744|FG001|26-Week Double-Blind Treatment Period|Administrative|3
6785893|NCT00383435|10782745|FG002|26-Week Double-Blind Treatment Period|Administrative|1
6785894|NCT00383435|10782746|FG003|26-Week Double-Blind Treatment Period|Administrative|1
6785895|NCT00383435|10782747|FG004|26-Week Double-Blind Treatment Period|Administrative|1
6785896|NCT00383435|10782743|FG000|26-Week Treatment Safety Extension|Adverse Event|4
6785897|NCT00383435|10782744|FG001|26-Week Treatment Safety Extension|Adverse Event|2
6785898|NCT00383435|10782745|FG002|26-Week Treatment Safety Extension|Adverse Event|5
6785899|NCT00383435|10782746|FG003|26-Week Treatment Safety Extension|Adverse Event|5
6785900|NCT00383435|10782747|FG004|26-Week Treatment Safety Extension|Adverse Event|1
6785901|NCT00383435|10782743|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1
6785902|NCT00383435|10782744|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1
6785903|NCT00383435|10782745|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1
6785904|NCT00383435|10782746|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1
6785905|NCT00383435|10782747|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0
6785906|NCT00383435|10782743|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0
6785907|NCT00383435|10782744|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2
6785908|NCT00383435|10782745|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1
6785909|NCT00383435|10782746|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0
6785910|NCT00383435|10782747|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1
6785911|NCT00383435|10782743|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
6785912|NCT00383435|10782744|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
6785913|NCT00383435|10782745|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
6785914|NCT00383435|10782746|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
6785915|NCT00383435|10782747|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
6785916|NCT00383435|10782743|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1
6785917|NCT00383435|10782744|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0
6785918|NCT00383435|10782745|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2
6785919|NCT00383435|10782746|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0
6785920|NCT00383435|10782747|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1
6785921|NCT00383435|10782743|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4
6785922|NCT00383435|10782744|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1
6785923|NCT00383435|10782745|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1
6785924|NCT00383435|10782746|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1
6785925|NCT00383435|10782747|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0
6785926|NCT00383435|10782743|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
6785927|NCT00383435|10782744|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
6785928|NCT00383435|10782745|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
6785929|NCT00383435|10782746|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
6785930|NCT00383435|10782747|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
6785931|NCT00383435|10782743|FG000|26-Week Treatment Safety Extension|Administrative|1
6785932|NCT00383435|10782744|FG001|26-Week Treatment Safety Extension|Administrative|1
6785933|NCT00383435|10782745|FG002|26-Week Treatment Safety Extension|Administrative|0
6785934|NCT00383435|10782746|FG003|26-Week Treatment Safety Extension|Administrative|1
6785935|NCT00383435|10782747|FG004|26-Week Treatment Safety Extension|Administrative|0
6785936|NCT00381485|10782762|FG000|Open-Label Run-In Period|Adverse Event|9
6785937|NCT00381485|10782763|FG001|Open-Label Run-In Period|Adverse Event|0
6785938|NCT00381485|10782764|FG002|Open-Label Run-In Period|Adverse Event|0
6785939|NCT00381485|10782765|FG003|Open-Label Run-In Period|Adverse Event|0
6785940|NCT00381485|10782762|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76
6785941|NCT00381485|10782763|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0
6785942|NCT00381485|10782764|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0
6785943|NCT00381485|10782765|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0
6785944|NCT00381485|10782762|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16
6785945|NCT00381485|10782763|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
6785946|NCT00381485|10782764|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
6785947|NCT00381485|10782765|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
6785948|NCT00381485|10782762|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1
6785949|NCT00381485|10782763|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
6785950|NCT00381485|10782764|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
6785951|NCT00381485|10782765|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
6785952|NCT00381485|10782762|FG000|Open-Label Run-In Period|Lost to Follow-up|3
6785953|NCT00381485|10782763|FG001|Open-Label Run-In Period|Lost to Follow-up|0
6785954|NCT00381485|10782764|FG002|Open-Label Run-In Period|Lost to Follow-up|0
6785955|NCT00381485|10782765|FG003|Open-Label Run-In Period|Lost to Follow-up|0
6785956|NCT00381485|10782762|FG000|Open-Label Run-In Period|Treatment failure|1
6785957|NCT00381485|10782763|FG001|Open-Label Run-In Period|Treatment failure|0
6785958|NCT00381485|10782764|FG002|Open-Label Run-In Period|Treatment failure|0
6785959|NCT00381485|10782765|FG003|Open-Label Run-In Period|Treatment failure|0
6785960|NCT00381485|10782762|FG000|Double-Blind Treatment Period|Adverse Event|0
6785961|NCT00381485|10782763|FG001|Double-Blind Treatment Period|Adverse Event|2
6785962|NCT00381485|10782764|FG002|Double-Blind Treatment Period|Adverse Event|2
6785963|NCT00381485|10782765|FG003|Double-Blind Treatment Period|Adverse Event|5
6785964|NCT00381485|10782762|FG000|Double-Blind Treatment Period|Lack of Efficacy|0
6785965|NCT00381485|10782763|FG001|Double-Blind Treatment Period|Lack of Efficacy|8
6785966|NCT00381485|10782764|FG002|Double-Blind Treatment Period|Lack of Efficacy|11
6785967|NCT00381485|10782765|FG003|Double-Blind Treatment Period|Lack of Efficacy|13
6785968|NCT00381485|10782762|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
6785969|NCT00381485|10782763|FG001|Double-Blind Treatment Period|Lost to Follow-up|0
6785970|NCT00381485|10782764|FG002|Double-Blind Treatment Period|Lost to Follow-up|1
6785971|NCT00381485|10782765|FG003|Double-Blind Treatment Period|Lost to Follow-up|1
6785972|NCT00381485|10782762|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0
6785973|NCT00381485|10782763|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9
6785974|NCT00381485|10782764|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3
6785975|NCT00381485|10782765|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3
6785976|NCT00381485|10782762|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0
6785977|NCT00381485|10782763|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5
6785978|NCT00381485|10782764|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7
6785979|NCT00381485|10782765|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5
6785980|NCT00381485|10782762|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0
6785981|NCT00381485|10782763|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2
6785982|NCT00381485|10782764|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1
6785983|NCT00381485|10782765|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4
6785984|NCT00381485|10782762|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
6785985|NCT00381485|10782763|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
6785986|NCT00381485|10782764|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
6785987|NCT00381485|10782765|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1
6785988|NCT00381485|10782762|FG000|Double-Blind Treatment Period|Administrative|0
6785989|NCT00381485|10782763|FG001|Double-Blind Treatment Period|Administrative|1
6785990|NCT00381485|10782764|FG002|Double-Blind Treatment Period|Administrative|0
6785991|NCT00381485|10782765|FG003|Double-Blind Treatment Period|Administrative|1
6785992|NCT00379288|10782778|FG000|Overall Study|Adverse Event|5
6785993|NCT00379288|10782779|FG001|Overall Study|Adverse Event|6
6785994|NCT00379288|10782780|FG002|Overall Study|Adverse Event|2
6785995|NCT00379288|10782781|FG003|Overall Study|Adverse Event|0
6785996|NCT00379288|10782778|FG000|Overall Study|Treatment Failure|0
7139208|NCT02954653|11292716|FG000|Overall Study|Started another anti-cancer therapy|0
7139209|NCT02954653|11292717|FG001|Overall Study|Started another anti-cancer therapy|1
7139210|NCT02954653|11292718|FG002|Overall Study|Started another anti-cancer therapy|0
7139211|NCT02954653|11292719|FG003|Overall Study|Started another anti-cancer therapy|0
7139212|NCT02954653|11292720|FG004|Overall Study|Started another anti-cancer therapy|0
7139213|NCT02954653|11292721|FG005|Overall Study|Started another anti-cancer therapy|0
7139214|NCT02954653|11292722|FG006|Overall Study|Started another anti-cancer therapy|0
7139215|NCT02954653|11292723|FG007|Overall Study|Started another anti-cancer therapy|0
7139216|NCT02954653|11292724|FG008|Overall Study|Started another anti-cancer therapy|0
7139217|NCT02954653|11292716|FG000|Overall Study|Treatment failure and consent withdrawal|0
7139218|NCT02954653|11292717|FG001|Overall Study|Treatment failure and consent withdrawal|1
7139219|NCT02954653|11292718|FG002|Overall Study|Treatment failure and consent withdrawal|0
7139220|NCT02954653|11292719|FG003|Overall Study|Treatment failure and consent withdrawal|0
7139221|NCT02954653|11292720|FG004|Overall Study|Treatment failure and consent withdrawal|0
7139222|NCT02954653|11292721|FG005|Overall Study|Treatment failure and consent withdrawal|0
7139223|NCT02954653|11292722|FG006|Overall Study|Treatment failure and consent withdrawal|0
6785997|NCT00379288|10782779|FG001|Overall Study|Treatment Failure|1
6785998|NCT00379288|10782780|FG002|Overall Study|Treatment Failure|0
6785999|NCT00379288|10782781|FG003|Overall Study|Treatment Failure|1
6786000|NCT00379288|10782778|FG000|Overall Study|Lost to Follow-up|3
6786001|NCT00379288|10782779|FG001|Overall Study|Lost to Follow-up|3
6786002|NCT00379288|10782780|FG002|Overall Study|Lost to Follow-up|2
6786003|NCT00379288|10782781|FG003|Overall Study|Lost to Follow-up|0
6786004|NCT00379288|10782778|FG000|Overall Study|Subject withdrew-unrelated to study drug|0
6786005|NCT00379288|10782779|FG001|Overall Study|Subject withdrew-unrelated to study drug|3
6786006|NCT00379288|10782780|FG002|Overall Study|Subject withdrew-unrelated to study drug|4
6786007|NCT00379288|10782781|FG003|Overall Study|Subject withdrew-unrelated to study drug|2
6786008|NCT00379288|10782778|FG000|Overall Study|Subject withdrew-related to study drug|1
6786009|NCT00379288|10782779|FG001|Overall Study|Subject withdrew-related to study drug|0
6786010|NCT00379288|10782780|FG002|Overall Study|Subject withdrew-related to study drug|0
6786011|NCT00379288|10782781|FG003|Overall Study|Subject withdrew-related to study drug|1
6786012|NCT00379288|10782778|FG000|Overall Study|Noncompliance with protocol|8
6786013|NCT00379288|10782779|FG001|Overall Study|Noncompliance with protocol|6
6786014|NCT00379288|10782780|FG002|Overall Study|Noncompliance with protocol|2
6786015|NCT00379288|10782781|FG003|Overall Study|Noncompliance with protocol|1
6786016|NCT00379288|10782778|FG000|Overall Study|Did not meet protocol eligibility|0
6786017|NCT00379288|10782779|FG001|Overall Study|Did not meet protocol eligibility|1
6786018|NCT00379288|10782780|FG002|Overall Study|Did not meet protocol eligibility|0
6786019|NCT00379288|10782781|FG003|Overall Study|Did not meet protocol eligibility|2
6786020|NCT00379288|10782778|FG000|Overall Study|Administrative|2
6786021|NCT00379288|10782779|FG001|Overall Study|Administrative|2
6786022|NCT00379288|10782780|FG002|Overall Study|Administrative|0
6786023|NCT00379288|10782781|FG003|Overall Study|Administrative|1
6786024|NCT00378378|10782794|FG000|Overall Study|Withdrawal by Subject|0
6786025|NCT00378378|10782795|FG001|Overall Study|Withdrawal by Subject|1
6786026|NCT00378378|10782796|FG002|Overall Study|Withdrawal by Subject|0
6786027|NCT00378378|10782794|FG000|Overall Study|Treatment Failure|0
6786028|NCT00378378|10782795|FG001|Overall Study|Treatment Failure|0
6786029|NCT00378378|10782796|FG002|Overall Study|Treatment Failure|1
6786030|NCT00378378|10782794|FG000|Overall Study|Non-compliance with protocol|0
6786031|NCT00378378|10782795|FG001|Overall Study|Non-compliance with protocol|0
6786032|NCT00378378|10782796|FG002|Overall Study|Non-compliance with protocol|1
6786033|NCT00089895|10782806|FG000|Overall Study|Consent Withdrawn|11
6786034|NCT00089895|10782807|FG001|Overall Study|Consent Withdrawn|14
6786035|NCT00089895|10782806|FG000|Overall Study|Technical reason|7
6786036|NCT00089895|10782807|FG001|Overall Study|Technical reason|2
6786037|NCT00089895|10782806|FG000|Overall Study|Surgery|0
6786038|NCT00089895|10782807|FG001|Overall Study|Surgery|1
6786039|NCT00089895|10782806|FG000|Overall Study|Bleeding|0
6786040|NCT00089895|10782807|FG001|Overall Study|Bleeding|2
6786041|NCT00089895|10782806|FG000|Overall Study|Physician Decision|3
6786042|NCT00089895|10782807|FG001|Overall Study|Physician Decision|7
6786043|NCT00089895|10782806|FG000|Overall Study|Exclusion criteria met|6
6786044|NCT00089895|10782807|FG001|Overall Study|Exclusion criteria met|6
6786045|NCT00089895|10782806|FG000|Overall Study|Not otherwise specified|4
6786046|NCT00089895|10782807|FG001|Overall Study|Not otherwise specified|8
6786047|NCT00089895|10782806|FG000|Overall Study|Missing|4
6786048|NCT00089895|10782807|FG001|Overall Study|Missing|2
6786049|NCT02577354|10782815|FG000|Overall Study|Lack of Efficacy|4
6786050|NCT02577354|10782816|FG001|Overall Study|Lack of Efficacy|4
6786051|NCT02577354|10782815|FG000|Overall Study|Lost to Follow-up|3
6786052|NCT02577354|10782816|FG001|Overall Study|Lost to Follow-up|1
6786053|NCT02577354|10782815|FG000|Overall Study|Missed Visit|4
6786054|NCT02577354|10782816|FG001|Overall Study|Missed Visit|3
6786055|NCT02577354|10782815|FG000|Overall Study|Adverse Event|4
6786056|NCT02577354|10782816|FG001|Overall Study|Adverse Event|5
6786057|NCT02471807|10782836|FG000|Overall Study|Death|14
6786058|NCT02471807|10782836|FG000|Overall Study|Withdrawal by Subject|1
6786059|NCT02471807|10782836|FG000|Overall Study|Explant|5
6786060|NCT02471807|10782836|FG000|Overall Study|Visits not yet due|2
6786061|NCT02471807|10782836|FG000|Overall Study|Missed Visit|1
6786062|NCT02321514|10782840|FG000|Overall Study|Death|15
6786063|NCT02321514|10782840|FG000|Overall Study|Missed Visit|7
6786064|NCT02321514|10782840|FG000|Overall Study|Study Exit|3
6807066|NCT00685360|10810484|FG000|Overall Study|Lost to Follow-up|0
6807067|NCT00685360|10810485|FG001|Overall Study|Lost to Follow-up|1
6807068|NCT00685360|10810486|FG002|Overall Study|Lost to Follow-up|2
6807069|NCT00685360|10810484|FG000|Overall Study|Adverse Event|4
6807070|NCT00685360|10810485|FG001|Overall Study|Adverse Event|6
6807071|NCT00685360|10810486|FG002|Overall Study|Adverse Event|4
6807072|NCT00685360|10810484|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1
6807073|NCT00685360|10810485|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0
6807074|NCT00685360|10810486|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2
6810636|NCT03137537|10814487|FG000|Overall Study|Adverse Event|0
6786065|NCT01453946|10782862|FG000|Overall Study|Did not receive drug for the taper phase|1
6786066|NCT01453946|10782862|FG000|Overall Study|Protocol Violation|2
6786067|NCT01453946|10782862|FG000|Overall Study|Lack of Efficacy|3
6786068|NCT01453946|10782862|FG000|Overall Study|Adverse Event|3
6786069|NCT01444092|10782866|FG000|Overall Study|Adverse Event|8
6786070|NCT01444092|10782866|FG000|Overall Study|Protocol Violation|1
6786071|NCT01444092|10782866|FG000|Overall Study|Withdrawal by Subject|1
6786072|NCT01444092|10782866|FG000|Overall Study|Other Eligibility criteria|7
6786073|NCT01265784|10782873|FG000|Overall Study|Lost to Follow-up|5
6786074|NCT01265784|10782874|FG001|Overall Study|Lost to Follow-up|3
6786075|NCT01265784|10782875|FG002|Overall Study|Lost to Follow-up|2
6786076|NCT01265784|10782873|FG000|Overall Study|Withdrawal by Subject|0
6786077|NCT01265784|10782874|FG001|Overall Study|Withdrawal by Subject|5
6786078|NCT01265784|10782875|FG002|Overall Study|Withdrawal by Subject|0
6786079|NCT01265784|10782873|FG000|Overall Study|Physician Decision|1
6786080|NCT01265784|10782874|FG001|Overall Study|Physician Decision|0
6786081|NCT01265784|10782875|FG002|Overall Study|Physician Decision|1
6786082|NCT01265784|10782873|FG000|Overall Study|Adverse Event|1
6786083|NCT01265784|10782874|FG001|Overall Study|Adverse Event|0
6786084|NCT01265784|10782875|FG002|Overall Study|Adverse Event|0
6786085|NCT01265784|10782873|FG000|Overall Study|Death|3
6786086|NCT01265784|10782874|FG001|Overall Study|Death|0
6786087|NCT01265784|10782875|FG002|Overall Study|Death|0
6786088|NCT01265784|10782873|FG000|Overall Study|Protocol Violation|2
6786089|NCT01265784|10782874|FG001|Overall Study|Protocol Violation|0
6786090|NCT01265784|10782875|FG002|Overall Study|Protocol Violation|0
6786091|NCT01265784|10782873|FG000|Overall Study|Incorrectly Randomized|0
6786092|NCT01265784|10782874|FG001|Overall Study|Incorrectly Randomized|0
6786093|NCT01265784|10782875|FG002|Overall Study|Incorrectly Randomized|1
6786094|NCT00577577|10782885|FG000|Overall Study|Adverse Event|3
6786095|NCT00577577|10782886|FG001|Overall Study|Adverse Event|2
6786096|NCT00577577|10782885|FG000|Overall Study|Lost to Follow-up|1
6786097|NCT00577577|10782886|FG001|Overall Study|Lost to Follow-up|0
6786098|NCT00577577|10782885|FG000|Overall Study|Protocol Violation|0
6786099|NCT00577577|10782886|FG001|Overall Study|Protocol Violation|3
6786100|NCT00577577|10782885|FG000|Overall Study|Transportation|1
6786101|NCT00577577|10782886|FG001|Overall Study|Transportation|0
6786102|NCT00392327|10782900|FG000|Overall Study|Death|1
6786103|NCT00392327|10782901|FG001|Overall Study|Death|0
6786104|NCT00392327|10782902|FG002|Overall Study|Death|1
6786105|NCT00392327|10782903|FG003|Overall Study|Death|0
6786106|NCT00392327|10782904|FG004|Overall Study|Death|0
6786107|NCT00392327|10782905|FG005|Overall Study|Death|0
6786108|NCT00392327|10782906|FG006|Overall Study|Death|0
6786109|NCT00392327|10782907|FG007|Overall Study|Death|0
6786110|NCT00392327|10782900|FG000|Overall Study|Lack of Efficacy|8
6786111|NCT00392327|10782901|FG001|Overall Study|Lack of Efficacy|8
6786112|NCT00392327|10782902|FG002|Overall Study|Lack of Efficacy|9
6786113|NCT00392327|10782903|FG003|Overall Study|Lack of Efficacy|6
6786114|NCT00392327|10782904|FG004|Overall Study|Lack of Efficacy|3
6786115|NCT00392327|10782905|FG005|Overall Study|Lack of Efficacy|3
6786116|NCT00392327|10782906|FG006|Overall Study|Lack of Efficacy|3
6786117|NCT00392327|10782907|FG007|Overall Study|Lack of Efficacy|3
6786118|NCT00392327|10782900|FG000|Overall Study|Physician Decision|3
6786119|NCT00392327|10782901|FG001|Overall Study|Physician Decision|5
6786120|NCT00392327|10782902|FG002|Overall Study|Physician Decision|2
6786121|NCT00392327|10782903|FG003|Overall Study|Physician Decision|2
6786122|NCT00392327|10782904|FG004|Overall Study|Physician Decision|0
6786123|NCT00392327|10782905|FG005|Overall Study|Physician Decision|1
6786124|NCT00392327|10782906|FG006|Overall Study|Physician Decision|5
6786125|NCT00392327|10782907|FG007|Overall Study|Physician Decision|3
6786126|NCT00392327|10782900|FG000|Overall Study|Protocol Violation|0
6786127|NCT00392327|10782901|FG001|Overall Study|Protocol Violation|0
6786128|NCT00392327|10782902|FG002|Overall Study|Protocol Violation|1
6786129|NCT00392327|10782903|FG003|Overall Study|Protocol Violation|0
6786130|NCT00392327|10782904|FG004|Overall Study|Protocol Violation|0
6786131|NCT00392327|10782905|FG005|Overall Study|Protocol Violation|0
6786132|NCT00392327|10782906|FG006|Overall Study|Protocol Violation|0
6786133|NCT00392327|10782907|FG007|Overall Study|Protocol Violation|0
6786134|NCT00392327|10782900|FG000|Overall Study|Withdrawal by Subject|3
6786135|NCT00392327|10782901|FG001|Overall Study|Withdrawal by Subject|2
6786136|NCT00392327|10782902|FG002|Overall Study|Withdrawal by Subject|4
6786137|NCT00392327|10782903|FG003|Overall Study|Withdrawal by Subject|6
6786138|NCT00392327|10782904|FG004|Overall Study|Withdrawal by Subject|0
6786139|NCT00392327|10782905|FG005|Overall Study|Withdrawal by Subject|1
6786140|NCT00392327|10782906|FG006|Overall Study|Withdrawal by Subject|1
6786141|NCT00392327|10782907|FG007|Overall Study|Withdrawal by Subject|5
6786142|NCT00392327|10782900|FG000|Overall Study|Ineligible|0
6786143|NCT00392327|10782901|FG001|Overall Study|Ineligible|4
6786144|NCT00392327|10782902|FG002|Overall Study|Ineligible|3
6786145|NCT00392327|10782903|FG003|Overall Study|Ineligible|2
6786146|NCT00392327|10782904|FG004|Overall Study|Ineligible|0
6786147|NCT00392327|10782905|FG005|Overall Study|Ineligible|0
6786148|NCT00392327|10782906|FG006|Overall Study|Ineligible|0
6786149|NCT00392327|10782907|FG007|Overall Study|Ineligible|0
6786150|NCT00085202|10782927|FG000|Overall Study|Still on therapy|2
6786151|NCT00085202|10782928|FG001|Overall Study|Still on therapy|0
6786152|NCT00085202|10782927|FG000|Overall Study|Bone involvement confirmed by bone scan|0
6786153|NCT00085202|10782928|FG001|Overall Study|Bone involvement confirmed by bone scan|1
6786154|NCT00085202|10782927|FG000|Overall Study|Excessive toxicity|6
6786155|NCT00085202|10782928|FG001|Overall Study|Excessive toxicity|5
6786156|NCT00085202|10782927|FG000|Overall Study|Non-specified|3
6786157|NCT00085202|10782928|FG001|Overall Study|Non-specified|5
6786158|NCT00085202|10782927|FG000|Overall Study|Withdrawal by Subject|2
6786159|NCT00085202|10782928|FG001|Overall Study|Withdrawal by Subject|1
6786160|NCT00085202|10782927|FG000|Overall Study|Physician Decision|4
6786161|NCT00085202|10782928|FG001|Overall Study|Physician Decision|1
6786162|NCT00085202|10782927|FG000|Overall Study|Progressive disease|1
6786163|NCT00085202|10782928|FG001|Overall Study|Progressive disease|11
6807075|NCT00685360|10810484|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0
6807076|NCT00685360|10810485|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4
6807077|NCT00685360|10810486|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1
6807078|NCT00685360|10810484|FG000|Overall Study|Subject Withdrew Consent to Participate|13
6807079|NCT00685360|10810485|FG001|Overall Study|Subject Withdrew Consent to Participate|2
6807080|NCT00685360|10810486|FG002|Overall Study|Subject Withdrew Consent to Participate|5
6807081|NCT00685360|10810484|FG000|Overall Study|Protocol Deviation|0
6807082|NCT00685360|10810485|FG001|Overall Study|Protocol Deviation|1
6807083|NCT00685360|10810486|FG002|Overall Study|Protocol Deviation|1
6807084|NCT00299728|10810496|FG000|Overall Study|Lost to Follow-up|0
6807085|NCT00299728|10810497|FG001|Overall Study|Lost to Follow-up|1
6807086|NCT00299728|10810496|FG000|Overall Study|Withdrawal by Subject|0
6807087|NCT00299728|10810497|FG001|Overall Study|Withdrawal by Subject|1
6807088|NCT00299728|10810496|FG000|Overall Study|Progressive disease|0
6807089|NCT00299728|10810497|FG001|Overall Study|Progressive disease|1
6810637|NCT03137537|10814488|FG001|Overall Study|Adverse Event|1
6810638|NCT03126019|10814496|FG000|Overall Study|Participants Still Ongoing in the Study|17
6810639|NCT03126019|10814497|FG001|Overall Study|Participants Still Ongoing in the Study|87
6810640|NCT03126019|10814496|FG000|Overall Study|Death|2
6810641|NCT03126019|10814497|FG001|Overall Study|Death|7
6810642|NCT03126019|10814496|FG000|Overall Study|Lost to Follow-up|2
6810643|NCT03126019|10814497|FG001|Overall Study|Lost to Follow-up|3
6810644|NCT03126019|10814496|FG000|Overall Study|Withdrawal by Participant|1
6810645|NCT03126019|10814497|FG001|Overall Study|Withdrawal by Participant|3
6810646|NCT03126019|10814496|FG000|Overall Study|Reason not Specified|1
6810647|NCT03126019|10814497|FG001|Overall Study|Reason not Specified|3
6810648|NCT03113383|10814504|FG000|Overall Study|Death|4
6810649|NCT03113383|10814505|FG001|Overall Study|Death|0
6810650|NCT02978326|10814536|FG000|Part B (Up to 45 Days)|Adverse Event|0
6810651|NCT02978326|10814537|FG001|Part B (Up to 45 Days)|Adverse Event|0
6810652|NCT02978326|10814538|FG002|Part B (Up to 45 Days)|Adverse Event|1
6810653|NCT02978326|10814536|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0
6810654|NCT02978326|10814537|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3
6810655|NCT02978326|10814538|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0
6810656|NCT02978326|10814536|FG000|Part B (Up to 45 Days)|Non-compliance|0
6810657|NCT02978326|10814537|FG001|Part B (Up to 45 Days)|Non-compliance|2
6810658|NCT02978326|10814538|FG002|Part B (Up to 45 Days)|Non-compliance|0
6810659|NCT02978326|10814536|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0
6786164|NCT04386616|10783029|FG000|Overall Study|Death|22
6786165|NCT04386616|10783030|FG001|Overall Study|Death|22
6786166|NCT04386616|10783031|FG002|Overall Study|Death|21
6786167|NCT04386616|10783029|FG000|Overall Study|Lost to Follow-up|5
6786168|NCT04386616|10783030|FG001|Overall Study|Lost to Follow-up|8
6786169|NCT04386616|10783031|FG002|Overall Study|Lost to Follow-up|6
6786170|NCT04386616|10783029|FG000|Overall Study|Withdrawal by Subject|2
6786171|NCT04386616|10783030|FG001|Overall Study|Withdrawal by Subject|4
6786172|NCT04386616|10783031|FG002|Overall Study|Withdrawal by Subject|1
6786173|NCT04386616|10783029|FG000|Overall Study|Adverse Event|1
6786174|NCT04386616|10783030|FG001|Overall Study|Adverse Event|1
6786175|NCT04386616|10783031|FG002|Overall Study|Adverse Event|0
6786188|NCT03721107|10783167|FG000|Overall Study|Adverse Event|1
6786189|NCT03721107|10783168|FG001|Overall Study|Adverse Event|1
6786190|NCT03721107|10783169|FG002|Overall Study|Adverse Event|6
6786191|NCT03721107|10783170|FG003|Overall Study|Adverse Event|5
6786192|NCT03721107|10783167|FG000|Overall Study|Lost to Follow-up|2
6786193|NCT03721107|10783168|FG001|Overall Study|Lost to Follow-up|0
6786194|NCT03721107|10783169|FG002|Overall Study|Lost to Follow-up|3
6786195|NCT03721107|10783170|FG003|Overall Study|Lost to Follow-up|0
6786196|NCT03721107|10783167|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0
6786197|NCT03721107|10783168|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0
6786198|NCT03721107|10783169|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0
6786199|NCT03721107|10783170|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1
6786200|NCT03721107|10783167|FG000|Overall Study|Physician Decision|0
6786201|NCT03721107|10783168|FG001|Overall Study|Physician Decision|1
6786202|NCT03721107|10783169|FG002|Overall Study|Physician Decision|0
6786203|NCT03721107|10783170|FG003|Overall Study|Physician Decision|0
6786204|NCT03721107|10783167|FG000|Overall Study|Pregnancy|0
6786205|NCT03721107|10783168|FG001|Overall Study|Pregnancy|0
6786206|NCT03721107|10783169|FG002|Overall Study|Pregnancy|1
6786207|NCT03721107|10783170|FG003|Overall Study|Pregnancy|0
6786208|NCT03721107|10783167|FG000|Overall Study|Withdrawal by Subject|1
6786209|NCT03721107|10783168|FG001|Overall Study|Withdrawal by Subject|1
6786210|NCT03721107|10783169|FG002|Overall Study|Withdrawal by Subject|5
6786211|NCT03721107|10783170|FG003|Overall Study|Withdrawal by Subject|5
6786212|NCT03721107|10783167|FG000|Overall Study|Other|1
6786213|NCT03721107|10783168|FG001|Overall Study|Other|0
7139224|NCT02954653|11292723|FG007|Overall Study|Treatment failure and consent withdrawal|0
7139225|NCT02954653|11292724|FG008|Overall Study|Treatment failure and consent withdrawal|0
7139226|NCT02954848|11292738|FG000|Overall Study|Randomized but Not Treated|0
7139227|NCT02954848|11292739|FG001|Overall Study|Randomized but Not Treated|1
7139228|NCT02954848|11292738|FG000|Overall Study|Adverse Event|2
7139229|NCT02954848|11292739|FG001|Overall Study|Adverse Event|3
7139230|NCT02954848|11292738|FG000|Overall Study|Withdrawal by Participant|0
7139231|NCT02954848|11292739|FG001|Overall Study|Withdrawal by Participant|1
7139232|NCT02954887|11292745|FG000|Overall Study|Withdrawal by Subject|3
7139233|NCT02954887|11292745|FG000|Overall Study|Lack of Efficacy|3
7139234|NCT02954887|11292745|FG000|Overall Study|Other|1
7139235|NCT02955069|11292751|FG000|Overall Study|Adverse Event|7
7139236|NCT02955069|11292752|FG001|Overall Study|Adverse Event|2
7139237|NCT02955069|11292751|FG000|Overall Study|Death|7
7139238|NCT02955069|11292752|FG001|Overall Study|Death|3
7139239|NCT02955069|11292751|FG000|Overall Study|Physician Decision|10
7139240|NCT02955069|11292752|FG001|Overall Study|Physician Decision|2
7139241|NCT02955069|11292751|FG000|Overall Study|Progressive disease|64
7139242|NCT02955069|11292752|FG001|Overall Study|Progressive disease|13
7139243|NCT02955069|11292751|FG000|Overall Study|Study terminated by sponsor|4
7139244|NCT02955069|11292752|FG001|Overall Study|Study terminated by sponsor|0
7139245|NCT02955069|11292751|FG000|Overall Study|Subject/Guardian decision|3
7139246|NCT02955069|11292752|FG001|Overall Study|Subject/Guardian decision|1
7139247|NCT02955186|11292766|FG000|Overall Study|Withdrawal by Subject|6
7139248|NCT02955186|11292767|FG001|Overall Study|Withdrawal by Subject|2
7139249|NCT02955186|11292766|FG000|Overall Study|Protocol Violation|1
7139250|NCT02955186|11292767|FG001|Overall Study|Protocol Violation|0
7139251|NCT02955212|11292775|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4
7139252|NCT02955212|11292776|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7
7139253|NCT02955212|11292775|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8
7139254|NCT02955212|11292776|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3
7139255|NCT02955212|11292775|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1
7139256|NCT02955212|11292776|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0
7139257|NCT02955212|11292775|FG000|Period 1: Double-blind Treatment Period|Other|3
7139258|NCT02955212|11292776|FG001|Period 1: Double-blind Treatment Period|Other|2
7139259|NCT02955212|11292775|FG000|Period 2: Open-label Extension|Adverse Event|11
7139260|NCT02955212|11292776|FG001|Period 2: Open-label Extension|Adverse Event|7
7139261|NCT02955212|11292775|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1
7139262|NCT02955212|11292776|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4
7139263|NCT02955212|11292775|FG000|Period 2: Open-label Extension|Lack of Efficacy|3
7139264|NCT02955212|11292776|FG001|Period 2: Open-label Extension|Lack of Efficacy|2
6786214|NCT03721107|10783169|FG002|Overall Study|Other|0
6786215|NCT03721107|10783170|FG003|Overall Study|Other|1
6786216|NCT03644849|10783210|FG000|Overall Study|Lost to Follow-up|1
6786217|NCT03644849|10783211|FG001|Overall Study|Lost to Follow-up|3
6786176|NCT04296942|10783064|FG000|Overall Study|Study closure by sponsor|1
6786177|NCT04296942|10783065|FG001|Overall Study|Study closure by sponsor|0
6786178|NCT04296942|10783066|FG002|Overall Study|Study closure by sponsor|0
6786179|NCT04278872|10783078|FG000|Overall Study|Adverse Event|1
6786180|NCT04278872|10783079|FG001|Overall Study|Adverse Event|0
6786181|NCT04278872|10783078|FG000|Overall Study|Protocol Violation|0
6786182|NCT04278872|10783079|FG001|Overall Study|Protocol Violation|1
6786183|NCT04278872|10783078|FG000|Overall Study|Study Termination|2
6786184|NCT04278872|10783079|FG001|Overall Study|Study Termination|0
6786185|NCT04213807|10783088|FG000|Overall Study|Physician Decision|0
6786186|NCT04213807|10783089|FG001|Overall Study|Physician Decision|0
6786187|NCT04213807|10783090|FG002|Overall Study|Physician Decision|1
6786218|NCT03604159|10783219|FG000|Overall Study|Lost to Follow-up|6
6786219|NCT03604159|10783220|FG001|Overall Study|Lost to Follow-up|7
6786220|NCT03602885|10783228|FG000|Overall Study|Lost to Follow-up|3
6786221|NCT03602885|10783229|FG001|Overall Study|Lost to Follow-up|0
6786222|NCT03539601|10783239|FG000|Overall Study|Withdraw by parent/guardian|1
6786223|NCT03539601|10783240|FG001|Overall Study|Withdraw by parent/guardian|0
6786224|NCT03539601|10783241|FG002|Overall Study|Withdraw by parent/guardian|1
6786225|NCT03539601|10783242|FG003|Overall Study|Withdraw by parent/guardian|0
6786226|NCT03539601|10783239|FG000|Overall Study|Adverse Event|0
6786227|NCT03539601|10783240|FG001|Overall Study|Adverse Event|2
6786228|NCT03539601|10783241|FG002|Overall Study|Adverse Event|0
6786229|NCT03539601|10783242|FG003|Overall Study|Adverse Event|0
6786230|NCT03539601|10783239|FG000|Overall Study|Lost to Follow-up|2
6786231|NCT03539601|10783240|FG001|Overall Study|Lost to Follow-up|4
6786232|NCT03539601|10783241|FG002|Overall Study|Lost to Follow-up|5
6786233|NCT03539601|10783242|FG003|Overall Study|Lost to Follow-up|0
6786234|NCT03539601|10783239|FG000|Overall Study|Withdrawal by Subject|2
6786235|NCT03539601|10783240|FG001|Overall Study|Withdrawal by Subject|0
6786236|NCT03539601|10783241|FG002|Overall Study|Withdrawal by Subject|0
6786237|NCT03539601|10783242|FG003|Overall Study|Withdrawal by Subject|1
6786238|NCT03539601|10783239|FG000|Overall Study|Randomized but not treated|1
6786239|NCT03539601|10783240|FG001|Overall Study|Randomized but not treated|1
6786240|NCT03539601|10783241|FG002|Overall Study|Randomized but not treated|0
6786241|NCT03539601|10783242|FG003|Overall Study|Randomized but not treated|0
6786242|NCT03539458|10783260|FG000|Overall Study|Death|1
6786243|NCT03532451|10783266|FG000|Overall Study|Withdrawal by Subject|0
6786244|NCT03532451|10783267|FG001|Overall Study|Withdrawal by Subject|1
6786245|NCT03532451|10783266|FG000|Overall Study|Progression prior to the surgery|1
6786246|NCT03532451|10783267|FG001|Overall Study|Progression prior to the surgery|0
6807122|NCT04330157|10810554|FG000|Overall Study|Protocol Violation|4
6807123|NCT04330157|10810554|FG000|Overall Study|Not extubated within 24 h postoperatively|3
6807129|NCT04160988|10810596|FG000|Overall Study|poor image quality|28
6807130|NCT04079114|10810605|FG000|Overall Study|Study prematuely terminated.|166
6807131|NCT04461795|10810730|FG000|Overall Study|Lost to Follow-up|2
6807132|NCT04461795|10810730|FG000|Overall Study|Withdrawal by Subject|2
6807133|NCT04461795|10810730|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1
6807134|NCT04035473|10810751|FG000|Screening/Baseline|Death|0
6807135|NCT04035473|10810752|FG001|Screening/Baseline|Death|1
6807136|NCT04035473|10810751|FG000|Screening/Baseline|Adverse Event|0
6807137|NCT04035473|10810752|FG001|Screening/Baseline|Adverse Event|1
6807138|NCT04035473|10810751|FG000|Follow-up Period|Adverse Event|2
6807139|NCT04035473|10810752|FG001|Follow-up Period|Adverse Event|0
6807140|NCT03796676|10810761|FG000|Overall Study|Adverse Event|2
6807141|NCT03796676|10810762|FG001|Overall Study|Adverse Event|1
6807142|NCT03796676|10810763|FG002|Overall Study|Adverse Event|2
6807143|NCT03796676|10810761|FG000|Overall Study|Lost to Follow-up|2
6807144|NCT03796676|10810762|FG001|Overall Study|Lost to Follow-up|1
6807145|NCT03796676|10810763|FG002|Overall Study|Lost to Follow-up|0
6807146|NCT03796676|10810761|FG000|Overall Study|Protocol Violation|0
6807147|NCT03796676|10810762|FG001|Overall Study|Protocol Violation|0
6807148|NCT03796676|10810763|FG002|Overall Study|Protocol Violation|1
6807149|NCT03796676|10810761|FG000|Overall Study|Withdrawal by Subject|1
6807150|NCT03796676|10810762|FG001|Overall Study|Withdrawal by Subject|1
6807151|NCT03796676|10810763|FG002|Overall Study|Withdrawal by Subject|0
6807152|NCT03796676|10810761|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1
6807153|NCT03796676|10810762|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0
6807154|NCT03796676|10810763|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0
6807155|NCT02989857|10810785|FG000|Randomization Phase|Adverse Event|8
6807156|NCT02989857|10810786|FG001|Randomization Phase|Adverse Event|4
6807157|NCT02989857|10810787|FG002|Randomization Phase|Adverse Event|0
6807158|NCT02989857|10810785|FG000|Randomization Phase|Death|6
6807159|NCT02989857|10810786|FG001|Randomization Phase|Death|0
6807160|NCT02989857|10810787|FG002|Randomization Phase|Death|0
6807161|NCT02989857|10810785|FG000|Randomization Phase|Progressive Disease|98
6807162|NCT02989857|10810786|FG001|Randomization Phase|Progressive Disease|51
6807163|NCT02989857|10810787|FG002|Randomization Phase|Progressive Disease|0
6807164|NCT02989857|10810785|FG000|Randomization Phase|Withdrawal by Subject|6
6807165|NCT02989857|10810786|FG001|Randomization Phase|Withdrawal by Subject|2
6807166|NCT02989857|10810787|FG002|Randomization Phase|Withdrawal by Subject|0
6807167|NCT02989857|10810785|FG000|Randomization Phase|Withdrawal of Consent|2
6807168|NCT02989857|10810786|FG001|Randomization Phase|Withdrawal of Consent|1
6807169|NCT02989857|10810787|FG002|Randomization Phase|Withdrawal of Consent|0
7139265|NCT02955212|11292775|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0
7139266|NCT02955212|11292776|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1
7139267|NCT02955212|11292775|FG000|Period 2: Open-label Extension|Other|2
7139268|NCT02955212|11292776|FG001|Period 2: Open-label Extension|Other|4
7139269|NCT02956057|11292824|FG000|Overall Study|Discontinued intervention|14
7139270|NCT02956057|11292825|FG001|Overall Study|Discontinued intervention|10
6786255|NCT03439657|10783302|FG000|Overall Study|Adverse Event|2
6786256|NCT03439657|10783303|FG001|Overall Study|Adverse Event|3
6786257|NCT03439657|10783302|FG000|Overall Study|Lost to Follow-up|1
6786258|NCT03439657|10783303|FG001|Overall Study|Lost to Follow-up|0
6786259|NCT03439657|10783302|FG000|Overall Study|Protocol Violation|1
6786260|NCT03439657|10783303|FG001|Overall Study|Protocol Violation|1
6786261|NCT03439657|10783302|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3
6786262|NCT03439657|10783303|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0
6786263|NCT03377790|10783313|FG000|Overall Study|Withdrawal by Subject|1
6786264|NCT03377790|10783314|FG001|Overall Study|Withdrawal by Subject|0
6786265|NCT03377790|10783313|FG000|Overall Study|Adverse Event|1
6786266|NCT03377790|10783314|FG001|Overall Study|Adverse Event|0
6786267|NCT03377790|10783313|FG000|Overall Study|Lost to Follow-up|0
6786268|NCT03377790|10783314|FG001|Overall Study|Lost to Follow-up|2
6786269|NCT03377790|10783313|FG000|Overall Study|Randomized but not treated|1
6786270|NCT03377790|10783314|FG001|Overall Study|Randomized but not treated|0
6786271|NCT03377790|10783313|FG000|Overall Study|Withdrawn by Parent/Guardian|7
6786272|NCT03377790|10783314|FG001|Overall Study|Withdrawn by Parent/Guardian|4
6786273|NCT03353675|10783320|FG000|Overall Study|Adverse Event|4
6786274|NCT03294109|10783326|FG000|Overall Study|Withdrawal by Subject|6
6786275|NCT03294109|10783327|FG001|Overall Study|Withdrawal by Subject|5
6786276|NCT03268005|10783336|FG000|Overall Study|Death|2
6786277|NCT03268005|10783337|FG001|Overall Study|Death|1
6786278|NCT03268005|10783336|FG000|Overall Study|Lost to Follow-up|2
6786279|NCT03268005|10783337|FG001|Overall Study|Lost to Follow-up|2
6786280|NCT03268005|10783336|FG000|Overall Study|Withdrawal by Subject|11
6786281|NCT03268005|10783337|FG001|Overall Study|Withdrawal by Subject|11
6786282|NCT03225170|10783346|FG000|Overall Study|Lost to Follow-up|4
6786283|NCT03225170|10783347|FG001|Overall Study|Lost to Follow-up|4
6786284|NCT03225170|10783348|FG002|Overall Study|Lost to Follow-up|0
6786285|NCT03225170|10783346|FG000|Overall Study|Did not complete intervention/control writing exercise|0
6786286|NCT03225170|10783347|FG001|Overall Study|Did not complete intervention/control writing exercise|1
6786287|NCT03225170|10783348|FG002|Overall Study|Did not complete intervention/control writing exercise|0
6786288|NCT03219034|10783372|FG000|Overall Study|Lost to Follow-up|9
6786289|NCT03219034|10783373|FG001|Overall Study|Lost to Follow-up|13
6786290|NCT03219034|10783372|FG000|Overall Study|Additional dental work needed|1
6786291|NCT03219034|10783373|FG001|Overall Study|Additional dental work needed|0
6786292|NCT03219034|10783372|FG000|Overall Study|UPPP Surgery|1
6786293|NCT03219034|10783373|FG001|Overall Study|UPPP Surgery|0
6786294|NCT03219034|10783372|FG000|Overall Study|Dental sensitivity|0
6786295|NCT03219034|10783373|FG001|Overall Study|Dental sensitivity|1
6786296|NCT03219034|10783372|FG000|Overall Study|Death in family|0
6786297|NCT03219034|10783373|FG001|Overall Study|Death in family|1
6786298|NCT03168438|10783383|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0
6786299|NCT03168438|10783384|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1
6786300|NCT03110380|10783393|FG000|Double-Blind Treatment Phase|Withdrew Consent|10
6786301|NCT03110380|10783394|FG001|Double-Blind Treatment Phase|Withdrew Consent|16
6786302|NCT03110380|10783395|FG002|Double-Blind Treatment Phase|Withdrew Consent|0
6786303|NCT03110380|10783396|FG003|Double-Blind Treatment Phase|Withdrew Consent|0
6786304|NCT03110380|10783393|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4
6786305|NCT03110380|10783394|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3
6786306|NCT03110380|10783395|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0
6786307|NCT03110380|10783396|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0
6786308|NCT03110380|10783393|FG000|Double-Blind Treatment Phase|Adverse Event|3
6786309|NCT03110380|10783394|FG001|Double-Blind Treatment Phase|Adverse Event|3
6786310|NCT03110380|10783395|FG002|Double-Blind Treatment Phase|Adverse Event|0
6786311|NCT03110380|10783396|FG003|Double-Blind Treatment Phase|Adverse Event|0
6786312|NCT03110380|10783393|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1
6786313|NCT03110380|10783394|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3
6786314|NCT03110380|10783395|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0
6786315|NCT03110380|10783396|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0
6786316|NCT03110380|10783393|FG000|Double-Blind Treatment Phase|Death|2
6786317|NCT03110380|10783394|FG001|Double-Blind Treatment Phase|Death|1
6786318|NCT03110380|10783395|FG002|Double-Blind Treatment Phase|Death|0
6786319|NCT03110380|10783396|FG003|Double-Blind Treatment Phase|Death|0
6786320|NCT03110380|10783393|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1
6786321|NCT03110380|10783394|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1
6786322|NCT03110380|10783395|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0
6786323|NCT03110380|10783396|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0
6786324|NCT03110380|10783393|FG000|Double-Blind Treatment Phase|Protocol Violation|0
6786325|NCT03110380|10783394|FG001|Double-Blind Treatment Phase|Protocol Violation|1
6786326|NCT03110380|10783395|FG002|Double-Blind Treatment Phase|Protocol Violation|0
6786327|NCT03110380|10783396|FG003|Double-Blind Treatment Phase|Protocol Violation|0
6786328|NCT03110380|10783393|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0
6786329|NCT03110380|10783394|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2
6786330|NCT03110380|10783395|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0
6786331|NCT03110380|10783396|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0
6786332|NCT03110380|10783393|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0
6786333|NCT03110380|10783394|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0
6786334|NCT03110380|10783395|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3
6786335|NCT03110380|10783396|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1
6786336|NCT03110380|10783393|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0
6786337|NCT03110380|10783394|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0
6786338|NCT03110380|10783395|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1
6786339|NCT03110380|10783396|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1
6786340|NCT03110380|10783393|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0
6786341|NCT03110380|10783394|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0
6786342|NCT03110380|10783395|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0
6786343|NCT03110380|10783396|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1
6807124|NCT04317690|10810568|FG000|Overall Study|did not have complete information for primary outcome|0
6807125|NCT04317690|10810569|FG001|Overall Study|did not have complete information for primary outcome|4
6807126|NCT04317690|10810570|FG002|Overall Study|did not have complete information for primary outcome|0
6807127|NCT04317690|10810571|FG003|Overall Study|did not have complete information for primary outcome|2
6807128|NCT04317690|10810572|FG004|Overall Study|did not have complete information for primary outcome|0
6807170|NCT02989857|10810785|FG000|Randomization Phase|Reason not specified|3
6807171|NCT02989857|10810786|FG001|Randomization Phase|Reason not specified|1
6807172|NCT02989857|10810787|FG002|Randomization Phase|Reason not specified|0
6807173|NCT02989857|10810785|FG000|Randomization Phase|Not Treated|3
6807174|NCT02989857|10810786|FG001|Randomization Phase|Not Treated|2
6807175|NCT02989857|10810787|FG002|Randomization Phase|Not Treated|0
6807176|NCT02989857|10810785|FG000|Cross Over Phase|Adverse Event|0
6807177|NCT02989857|10810786|FG001|Cross Over Phase|Adverse Event|0
6807178|NCT02989857|10810787|FG002|Cross Over Phase|Adverse Event|2
6807179|NCT02989857|10810785|FG000|Cross Over Phase|Physician Decision|0
6807180|NCT02989857|10810786|FG001|Cross Over Phase|Physician Decision|0
6807181|NCT02989857|10810787|FG002|Cross Over Phase|Physician Decision|2
6807182|NCT02989857|10810785|FG000|Cross Over Phase|Progressive Disease|0
6807183|NCT02989857|10810786|FG001|Cross Over Phase|Progressive Disease|0
6807184|NCT02989857|10810787|FG002|Cross Over Phase|Progressive Disease|36
6807185|NCT02989857|10810785|FG000|Cross Over Phase|Withdrawal by Consent|0
6807186|NCT02989857|10810786|FG001|Cross Over Phase|Withdrawal by Consent|0
6807187|NCT02989857|10810787|FG002|Cross Over Phase|Withdrawal by Consent|3
6807188|NCT02983799|10810799|FG000|Overall Study|Withdrawn from study before data cut-off|28
6807189|NCT02983799|10810800|FG001|Overall Study|Withdrawn from study before data cut-off|12
6807190|NCT02983799|10810801|FG002|Overall Study|Withdrawn from study before data cut-off|23
6807191|NCT02983799|10810802|FG003|Overall Study|Withdrawn from study before data cut-off|25
6807192|NCT02983799|10810803|FG004|Overall Study|Withdrawn from study before data cut-off|1
6807193|NCT02983799|10810799|FG000|Overall Study|Death|20
6807194|NCT02983799|10810800|FG001|Overall Study|Death|5
6807195|NCT02983799|10810801|FG002|Overall Study|Death|23
6807196|NCT02983799|10810802|FG003|Overall Study|Death|47
6807197|NCT02983799|10810803|FG004|Overall Study|Death|7
6807198|NCT02983799|10810799|FG000|Overall Study|Withdrawal by Subject|1
6807199|NCT02983799|10810800|FG001|Overall Study|Withdrawal by Subject|0
6807200|NCT02983799|10810801|FG002|Overall Study|Withdrawal by Subject|3
6807201|NCT02983799|10810802|FG003|Overall Study|Withdrawal by Subject|4
6807202|NCT02983799|10810803|FG004|Overall Study|Withdrawal by Subject|1
6807203|NCT02983799|10810799|FG000|Overall Study|Protocol Violation|0
6807204|NCT02983799|10810800|FG001|Overall Study|Protocol Violation|1
6807205|NCT02983799|10810801|FG002|Overall Study|Protocol Violation|0
6807206|NCT02983799|10810802|FG003|Overall Study|Protocol Violation|0
6807207|NCT02983799|10810803|FG004|Overall Study|Protocol Violation|1
6807208|NCT02983799|10810799|FG000|Overall Study|Lost to Follow-up|1
6807209|NCT02983799|10810800|FG001|Overall Study|Lost to Follow-up|0
6807210|NCT02983799|10810801|FG002|Overall Study|Lost to Follow-up|1
6807211|NCT02983799|10810802|FG003|Overall Study|Lost to Follow-up|0
6807212|NCT02983799|10810803|FG004|Overall Study|Lost to Follow-up|0
6807213|NCT02971683|10810821|FG000|Overall Study|Other reasons|0
6807214|NCT02971683|10810822|FG001|Overall Study|Other reasons|1
6807215|NCT02971683|10810821|FG000|Overall Study|Poor/Non-Compliance|0
6807216|NCT02971683|10810822|FG001|Overall Study|Poor/Non-Compliance|1
7139271|NCT02956057|11292826|FG002|Overall Study|Discontinued intervention|7
6807217|NCT02971683|10810821|FG000|Overall Study|Lost to Follow-up|1
6807218|NCT02971683|10810822|FG001|Overall Study|Lost to Follow-up|0
6807219|NCT02971683|10810821|FG000|Overall Study|Participant withdrew consent|1
6807220|NCT02971683|10810822|FG001|Overall Study|Participant withdrew consent|1
6807221|NCT02971683|10810821|FG000|Overall Study|Participant request to discontinue study treatment|1
6807222|NCT02971683|10810822|FG001|Overall Study|Participant request to discontinue study treatment|1
6807223|NCT02971683|10810821|FG000|Overall Study|Adverse Event|1
6786344|NCT03078478|10783412|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36
6786345|NCT03078478|10783413|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36
6786346|NCT03078478|10783412|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7
6786347|NCT03078478|10783413|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4
6786348|NCT03078478|10783412|FG000|Maintenance Period 1 (36 Weeks)|Death|3
6786349|NCT03078478|10783413|FG001|Maintenance Period 1 (36 Weeks)|Death|3
6786350|NCT03078478|10783412|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1
6786351|NCT03078478|10783413|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0
6786352|NCT03078478|10783412|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18
6786353|NCT03078478|10783413|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13
6786354|NCT03078478|10783412|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3
6786355|NCT03078478|10783413|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6
6786356|NCT03078478|10783412|FG000|Maintencance Period 2 (36 Weeks)|Death|4
6786357|NCT03078478|10783413|FG001|Maintencance Period 2 (36 Weeks)|Death|6
6786358|NCT03078478|10783412|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0
6786359|NCT03078478|10783413|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2
7139272|NCT02956057|11292827|FG003|Overall Study|Discontinued intervention|14
7139273|NCT02956057|11292828|FG004|Overall Study|Discontinued intervention|4
7139274|NCT02956057|11292829|FG005|Overall Study|Discontinued intervention|17
7139275|NCT02956057|11292824|FG000|Overall Study|Lost to Follow-up|0
7139276|NCT02956057|11292825|FG001|Overall Study|Lost to Follow-up|2
7139277|NCT02956057|11292826|FG002|Overall Study|Lost to Follow-up|1
7139278|NCT02956057|11292827|FG003|Overall Study|Lost to Follow-up|1
7139279|NCT02956057|11292828|FG004|Overall Study|Lost to Follow-up|1
7139280|NCT02956057|11292829|FG005|Overall Study|Lost to Follow-up|0
7139281|NCT02956278|11292866|FG000|Overall Study|Withdrawal by Subject|6
7139282|NCT02956278|11292867|FG001|Overall Study|Withdrawal by Subject|2
7139283|NCT02956278|11292868|FG002|Overall Study|Withdrawal by Subject|0
7139284|NCT02956460|11292878|FG000|Lens 1|Lost to Follow-up|1
7139285|NCT02956460|11292879|FG001|Lens 1|Lost to Follow-up|0
7139286|NCT02956486|11292887|FG000|Core Phase|Adverse Event|51
7139287|NCT02956486|11292888|FG001|Core Phase|Adverse Event|88
7139288|NCT02956486|11292889|FG002|Core Phase|Adverse Event|0
7139289|NCT02956486|11292887|FG000|Core Phase|Lost to Follow-up|8
7139290|NCT02956486|11292888|FG001|Core Phase|Lost to Follow-up|6
7139291|NCT02956486|11292889|FG002|Core Phase|Lost to Follow-up|0
7139292|NCT02956486|11292887|FG000|Core Phase|Inadequate therapeutic effect|4
7139293|NCT02956486|11292888|FG001|Core Phase|Inadequate therapeutic effect|5
7139294|NCT02956486|11292889|FG002|Core Phase|Inadequate therapeutic effect|0
7139295|NCT02956486|11292887|FG000|Core Phase|Withdrawal by Subject|101
7139296|NCT02956486|11292888|FG001|Core Phase|Withdrawal by Subject|104
7139297|NCT02956486|11292889|FG002|Core Phase|Withdrawal by Subject|0
7139298|NCT02956486|11292887|FG000|Core Phase|Study terminated by sponsor|888
7139299|NCT02956486|11292888|FG001|Core Phase|Study terminated by sponsor|848
7139300|NCT02956486|11292889|FG002|Core Phase|Study terminated by sponsor|0
6786360|NCT02993263|10783428|FG000|Overall Study|Equipment Software failed and results were lost.|323
6786361|NCT02985684|10783432|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5
6786362|NCT02985684|10783432|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5
6786363|NCT02985684|10783432|FG000|6-Month Closure Success Evaluation|Device Removal|3
6786364|NCT02873195|10783447|FG000|Overall Study|Ineligible|5
6786365|NCT02873195|10783448|FG001|Overall Study|Ineligible|0
6786366|NCT02785952|10783465|FG000|Overall Study|Adverse Event|31
6786367|NCT02785952|10783466|FG001|Overall Study|Adverse Event|19
6786368|NCT02785952|10783465|FG000|Overall Study|Refusal unrelated to adverse events|10
6786369|NCT02785952|10783466|FG001|Overall Study|Refusal unrelated to adverse events|5
6786370|NCT02785952|10783465|FG000|Overall Study|Disease progression/relapse|61
6786371|NCT02785952|10783466|FG001|Overall Study|Disease progression/relapse|89
6786372|NCT02785952|10783465|FG000|Overall Study|Death|11
6786373|NCT02785952|10783466|FG001|Overall Study|Death|7
6786374|NCT02785952|10783465|FG000|Overall Study|Other- not protocol specified|6
6786375|NCT02785952|10783466|FG001|Overall Study|Other- not protocol specified|4
6786376|NCT02785952|10783465|FG000|Overall Study|On protocol treatment|6
6786377|NCT02785952|10783466|FG001|Overall Study|On protocol treatment|3
6786378|NCT02748616|10783478|FG000|Overall Study|Lost to Follow-up|1
6786379|NCT02748616|10783478|FG000|Overall Study|Withdrawal by Subject|2
6786380|NCT02748616|10783478|FG000|Overall Study|Physician Decision|2
6786381|NCT02748616|10783478|FG000|Overall Study|Did Not Complete Ursodial Course|2
6786382|NCT02719522|10783482|FG000|Overall Study|Implant Failure|4
6786383|NCT02719522|10783482|FG000|Overall Study|Death|2
6786384|NCT02719522|10783482|FG000|Overall Study|Lost to Follow-up|5
6786385|NCT02585232|10783503|FG000|Overall Study|Lost to Follow-up|8
6786386|NCT02585232|10783504|FG001|Overall Study|Lost to Follow-up|8
6786387|NCT02585232|10783503|FG000|Overall Study|Withdrawal by Subject|4
6786388|NCT02585232|10783504|FG001|Overall Study|Withdrawal by Subject|8
6786389|NCT02583269|10783515|FG000|Overall Study|Patient hospitalized prior to start|1
6786390|NCT02583269|10783516|FG001|Overall Study|Patient hospitalized prior to start|0
6786391|NCT02583269|10783517|FG002|Overall Study|Patient hospitalized prior to start|0
6786392|NCT02583269|10783518|FG003|Overall Study|Patient hospitalized prior to start|0
6786393|NCT02583269|10783519|FG004|Overall Study|Patient hospitalized prior to start|0
6786394|NCT02545283|10783555|FG000|Overall Study|Lost to Follow-up|2
7139301|NCT02956486|11292887|FG000|Core Phase|Other|27
6786395|NCT02545283|10783556|FG001|Overall Study|Lost to Follow-up|4
6786396|NCT02545283|10783555|FG000|Overall Study|Withdrawal by Subject|5
6786397|NCT02545283|10783556|FG001|Overall Study|Withdrawal by Subject|9
6786398|NCT02545283|10783555|FG000|Overall Study|Death|109
6786399|NCT02545283|10783556|FG001|Overall Study|Death|211
6786400|NCT02545283|10783555|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0
6786401|NCT02545283|10783556|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3
6786402|NCT02545283|10783555|FG000|Overall Study|Study Terminated By Sponsor|33
6786403|NCT02545283|10783556|FG001|Overall Study|Study Terminated By Sponsor|71
6807224|NCT02971683|10810822|FG001|Overall Study|Adverse Event|2
6807225|NCT02971683|10810821|FG000|Overall Study|Lack of Efficacy|2
7139302|NCT02956486|11292888|FG001|Core Phase|Other|18
7139303|NCT02956486|11292889|FG002|Core Phase|Other|0
7139304|NCT02956486|11292887|FG000|Core Phase|Not treated|0
7139305|NCT02956486|11292888|FG001|Core Phase|Not treated|3
7139306|NCT02956486|11292889|FG002|Core Phase|Not treated|0
7139307|NCT02956486|11292887|FG000|Extension Phase|Adverse Event|0
7139308|NCT02956486|11292888|FG001|Extension Phase|Adverse Event|0
7139309|NCT02956486|11292889|FG002|Extension Phase|Adverse Event|2
7139310|NCT02956486|11292887|FG000|Extension Phase|Study terminated by sponsor|0
7139311|NCT02956486|11292888|FG001|Extension Phase|Study terminated by sponsor|0
7139312|NCT02956486|11292889|FG002|Extension Phase|Study terminated by sponsor|16
7139313|NCT02956486|11292887|FG000|Extension Phase|Not Treated|0
7139314|NCT02956486|11292888|FG001|Extension Phase|Not Treated|0
7139315|NCT02956486|11292889|FG002|Extension Phase|Not Treated|1
7139316|NCT02956629|11292913|FG000|Overall Study|Adverse Event|0
7139317|NCT02956629|11292914|FG001|Overall Study|Adverse Event|0
7139318|NCT02956629|11292915|FG002|Overall Study|Adverse Event|1
6807226|NCT02971683|10810822|FG001|Overall Study|Lack of Efficacy|2
6807227|NCT02631577|10810834|FG000|Overall Study|Death|1
6807228|NCT02631577|10810835|FG001|Overall Study|Death|7
6807229|NCT02631577|10810834|FG000|Overall Study|Withdrawal by Subject|0
6807230|NCT02631577|10810835|FG001|Overall Study|Withdrawal by Subject|3
6807231|NCT02300233|10810862|FG000|Overall Study|Adverse Event or Serious Adverse Event|3
6807232|NCT02300233|10810863|FG001|Overall Study|Adverse Event or Serious Adverse Event|1
6807233|NCT02300233|10810864|FG002|Overall Study|Adverse Event or Serious Adverse Event|14
6807234|NCT02300233|10810862|FG000|Overall Study|Withdrawal by Subject|1
6807235|NCT02300233|10810863|FG001|Overall Study|Withdrawal by Subject|0
6807236|NCT02300233|10810864|FG002|Overall Study|Withdrawal by Subject|3
6807237|NCT02300233|10810862|FG000|Overall Study|Investigator Judgement|0
6807238|NCT02300233|10810863|FG001|Overall Study|Investigator Judgement|0
6807239|NCT02300233|10810864|FG002|Overall Study|Investigator Judgement|1
6807240|NCT02300233|10810862|FG000|Overall Study|Reason Not Specified|0
6807241|NCT02300233|10810863|FG001|Overall Study|Reason Not Specified|0
6807242|NCT02300233|10810864|FG002|Overall Study|Reason Not Specified|5
6807243|NCT02211209|10810875|FG000|Overall Study|Investigator judgment|0
6807244|NCT02211209|10810876|FG001|Overall Study|Investigator judgment|1
6807245|NCT02211209|10810875|FG000|Overall Study|Voluntary withdrawal|1
6807246|NCT02211209|10810876|FG001|Overall Study|Voluntary withdrawal|4
6807247|NCT02211209|10810875|FG000|Overall Study|Adverse Event or Serious Adverse Event|0
6807248|NCT02211209|10810876|FG001|Overall Study|Adverse Event or Serious Adverse Event|9
6807249|NCT02211209|10810875|FG000|Overall Study|Reason Not Specified|1
6807250|NCT02211209|10810876|FG001|Overall Study|Reason Not Specified|0
6807251|NCT02125461|10810884|FG000|Overall Study|Withdrawal by Subject|30
6807252|NCT02125461|10810885|FG001|Overall Study|Withdrawal by Subject|16
6807253|NCT02125461|10810884|FG000|Overall Study|Lost to Follow-up|8
6807254|NCT02125461|10810885|FG001|Overall Study|Lost to Follow-up|3
6807255|NCT02125461|10810884|FG000|Overall Study|Death|260
6807256|NCT02125461|10810885|FG001|Overall Study|Death|149
6807257|NCT02125461|10810884|FG000|Overall Study|Missing Termination Reason|0
6807258|NCT02125461|10810885|FG001|Overall Study|Missing Termination Reason|1
6810660|NCT02978326|10814537|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2
6810661|NCT02978326|10814538|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3
6810662|NCT02970929|10814548|FG000|Overall Study|Adverse Event|18
6810663|NCT02970929|10814548|FG000|Overall Study|Lack of Efficacy|8
6810664|NCT02970929|10814548|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1
6810665|NCT02970929|10814548|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1
6810666|NCT02970929|10814548|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1
6810667|NCT02970929|10814548|FG000|Overall Study|LOST TO FOLLOWUP|6
6810668|NCT02970929|10814548|FG000|Overall Study|MOVED OUT OF STATE|1
6810669|NCT02970929|10814548|FG000|Overall Study|Withdrawal by Subject|16
6810670|NCT02797951|10814582|FG000|Overall Study|Adverse Event|4
6810671|NCT02797951|10814582|FG000|Overall Study|Death|1
6810672|NCT02797951|10814582|FG000|Overall Study|Lack of Efficacy|19
6810673|NCT02797951|10814582|FG000|Overall Study|Lost to Follow-up|4
6810674|NCT02797951|10814582|FG000|Overall Study|Physician Decision|6
7139319|NCT02956629|11292916|FG003|Overall Study|Adverse Event|0
7139320|NCT02956629|11292917|FG004|Overall Study|Adverse Event|0
6810675|NCT02797951|10814582|FG000|Overall Study|Withdrawal by Subject|15
6810676|NCT02748057|10814597|FG000|Overall Study|Adverse Event|1
6810677|NCT02748057|10814598|FG001|Overall Study|Adverse Event|0
7139321|NCT02956629|11292918|FG005|Overall Study|Adverse Event|0
6786404|NCT02524171|10783566|FG000|6-month Follow-up|Lost to Follow-up|53
6786405|NCT02524171|10783567|FG001|6-month Follow-up|Lost to Follow-up|45
6786406|NCT02524171|10783566|FG000|12-month Follow-up Interview|Lost to Follow-up|45
6786407|NCT02524171|10783567|FG001|12-month Follow-up Interview|Lost to Follow-up|41
6786408|NCT02476968|10783603|FG000|Overall Study|Other|0
6786409|NCT02476968|10783604|FG001|Overall Study|Other|2
7139322|NCT02956629|11292913|FG000|Overall Study|Lost to Follow-up|2
7139323|NCT02956629|11292914|FG001|Overall Study|Lost to Follow-up|5
7139324|NCT02956629|11292915|FG002|Overall Study|Lost to Follow-up|3
7139325|NCT02956629|11292916|FG003|Overall Study|Lost to Follow-up|1
7139326|NCT02956629|11292917|FG004|Overall Study|Lost to Follow-up|0
7139327|NCT02956629|11292918|FG005|Overall Study|Lost to Follow-up|1
7139328|NCT02956629|11292913|FG000|Overall Study|Withdrawal by Subject|3
7139329|NCT02956629|11292914|FG001|Overall Study|Withdrawal by Subject|1
7139330|NCT02956629|11292915|FG002|Overall Study|Withdrawal by Subject|0
7139331|NCT02956629|11292916|FG003|Overall Study|Withdrawal by Subject|0
7139332|NCT02956629|11292917|FG004|Overall Study|Withdrawal by Subject|0
7139333|NCT02956629|11292918|FG005|Overall Study|Withdrawal by Subject|0
7139334|NCT02956837|11292954|FG000|Overall Study|Serious Adverse Events|0
7139335|NCT02956837|11292955|FG001|Overall Study|Serious Adverse Events|1
7139336|NCT02956837|11292956|FG002|Overall Study|Serious Adverse Events|0
7139337|NCT02956837|11292957|FG003|Overall Study|Serious Adverse Events|0
7139338|NCT02956837|11292954|FG000|Overall Study|Withdrawal by Subject|0
7139339|NCT02956837|11292955|FG001|Overall Study|Withdrawal by Subject|1
6786410|NCT02476968|10783605|FG002|Overall Study|Other|0
6786411|NCT02476968|10783603|FG000|Overall Study|Lost to Follow-up|10
6786412|NCT02476968|10783604|FG001|Overall Study|Lost to Follow-up|0
6786413|NCT02476968|10783605|FG002|Overall Study|Lost to Follow-up|1
6786414|NCT02476968|10783603|FG000|Overall Study|Death|34
6786415|NCT02476968|10783604|FG001|Overall Study|Death|6
6786416|NCT02476968|10783605|FG002|Overall Study|Death|0
6786417|NCT02476968|10783603|FG000|Overall Study|Eligibility criteria not fulfilled|0
6786418|NCT02476968|10783604|FG001|Overall Study|Eligibility criteria not fulfilled|0
6786419|NCT02476968|10783605|FG002|Overall Study|Eligibility criteria not fulfilled|1
6786420|NCT02476968|10783603|FG000|Overall Study|Patient decision|30
6786421|NCT02476968|10783604|FG001|Overall Study|Patient decision|7
6786422|NCT02476968|10783605|FG002|Overall Study|Patient decision|0
6786423|NCT02306122|10783622|FG000|Initial Physician Randomization|Physician Decision|0
6786424|NCT02306122|10783623|FG001|Initial Physician Randomization|Physician Decision|0
6786425|NCT02306122|10783624|FG002|Initial Physician Randomization|Physician Decision|0
6786426|NCT02306122|10783625|FG003|Initial Physician Randomization|Physician Decision|0
6786427|NCT02306122|10783626|FG004|Initial Physician Randomization|Physician Decision|0
6786428|NCT02306122|10783627|FG005|Initial Physician Randomization|Physician Decision|0
6786429|NCT02306122|10783628|FG006|Initial Physician Randomization|Physician Decision|0
6786430|NCT02306122|10783629|FG007|Initial Physician Randomization|Physician Decision|0
6786431|NCT02306122|10783630|FG008|Initial Physician Randomization|Physician Decision|1
6786432|NCT02306122|10783631|FG009|Initial Physician Randomization|Physician Decision|0
6786433|NCT02306122|10783632|FG010|Initial Physician Randomization|Physician Decision|0
6786434|NCT02147184|10783670|FG000|Overall Study|Lost to Follow-up|28
6786435|NCT02147184|10783671|FG001|Overall Study|Lost to Follow-up|15
6786436|NCT02147184|10783670|FG000|Overall Study|Study Burden|11
6786437|NCT02147184|10783671|FG001|Overall Study|Study Burden|7
6786438|NCT02147184|10783670|FG000|Overall Study|Pregnancy|6
6786439|NCT02147184|10783671|FG001|Overall Study|Pregnancy|0
6786440|NCT02147184|10783670|FG000|Overall Study|Moved out of state|3
6786441|NCT02147184|10783671|FG001|Overall Study|Moved out of state|3
6786442|NCT02147184|10783670|FG000|Overall Study|Physician Decision|0
6786443|NCT02147184|10783671|FG001|Overall Study|Physician Decision|2
6786444|NCT02147184|10783670|FG000|Overall Study|Other|1
6786445|NCT02147184|10783671|FG001|Overall Study|Other|0
6786446|NCT02000219|10783696|FG000|14-Week Study Period|Physician Decision|1
6786447|NCT02000219|10783696|FG000|14-Week Study Period|Adverse Event|1
6786448|NCT02000219|10783696|FG000|14-Week Study Period|Underwent transplantation|1
6786449|NCT02000219|10783696|FG000|Continuation Period|Withdrawal by Subject|1
6786450|NCT02000219|10783696|FG000|Continuation Period|Had liver transplant|2
6786451|NCT02000219|10783696|FG000|Continuation Period|Non-compliance with study drug|2
6786452|NCT01978938|10783702|FG000|Overall Study|Lost to Follow-up|12
6786453|NCT01978938|10783703|FG001|Overall Study|Lost to Follow-up|6
6786454|NCT01978938|10783702|FG000|Overall Study|Withdrawal by Subject|8
6786455|NCT01978938|10783703|FG001|Overall Study|Withdrawal by Subject|4
6786456|NCT01978938|10783702|FG000|Overall Study|Adverse Event, non-fatal|2
6786457|NCT01978938|10783703|FG001|Overall Study|Adverse Event, non-fatal|1
6786458|NCT01978938|10783702|FG000|Overall Study|Participant noncompliance|1
6786459|NCT01978938|10783703|FG001|Overall Study|Participant noncompliance|1
6786460|NCT01978938|10783702|FG000|Overall Study|Did not meet inclusion criteria|0
6786461|NCT01978938|10783703|FG001|Overall Study|Did not meet inclusion criteria|1
6786462|NCT01978938|10783702|FG000|Overall Study|Previously scheduled procedure|0
6786463|NCT01978938|10783703|FG001|Overall Study|Previously scheduled procedure|1
6786464|NCT01854385|10783709|FG000|Pre-Treatment|Withdrawal by Subject|4
6786465|NCT01854385|10783709|FG000|Pre-Treatment|Did not meet criteria based on headache number|15
6786466|NCT01854385|10783709|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3
6786467|NCT01854385|10783709|FG000|Pre-Treatment|Unable to come for study visits|1
6786468|NCT01854385|10783709|FG000|Treatment|Lost to Follow-up|1
6786469|NCT01844856|10783715|FG000|Overall Study|Lost to Follow-up|15
6786470|NCT01844856|10783716|FG001|Overall Study|Lost to Follow-up|3
6786471|NCT01844856|10783715|FG000|Overall Study|Adverse Event|3
6786472|NCT01844856|10783716|FG001|Overall Study|Adverse Event|6
6786473|NCT01844856|10783715|FG000|Overall Study|Withdrawal by Subject|3
6786474|NCT01844856|10783716|FG001|Overall Study|Withdrawal by Subject|2
6786475|NCT01844856|10783715|FG000|Overall Study|Noncompliance|2
6786476|NCT01844856|10783716|FG001|Overall Study|Noncompliance|3
6786477|NCT01844856|10783715|FG000|Overall Study|Enterococcus Resistant|0
6786478|NCT01844856|10783716|FG001|Overall Study|Enterococcus Resistant|1
6786479|NCT01844856|10783715|FG000|Overall Study|Inadvertently Not Scheduled|1
6786480|NCT01844856|10783716|FG001|Overall Study|Inadvertently Not Scheduled|0
6786481|NCT01844856|10783715|FG000|Overall Study|Randomized but was a Screen Failure|0
6786482|NCT01844856|10783716|FG001|Overall Study|Randomized but was a Screen Failure|1
6786483|NCT01712789|10783755|FG000|Overall Study|Lack of Efficacy|2
6786484|NCT01712789|10783755|FG000|Overall Study|Lost to Follow-up|1
6786485|NCT01712789|10783755|FG000|Overall Study|Progressive Disease|504
6786486|NCT01712789|10783755|FG000|Overall Study|Death|57
6786487|NCT01712789|10783755|FG000|Overall Study|Adverse Event|52
6786488|NCT01712789|10783755|FG000|Overall Study|Miscellaneous|31
6786489|NCT01712789|10783755|FG000|Overall Study|Withdrawal by Subject|21
6786490|NCT01712789|10783755|FG000|Overall Study|Transition to Commercial Treatment|8
6786491|NCT01712789|10783755|FG000|Overall Study|Participants Did Not Receive Study Drug|6
6786492|NCT01651403|10783761|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1
6786493|NCT01651403|10783762|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1
6786494|NCT01651403|10783761|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3
6786495|NCT01651403|10783762|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3
6786496|NCT01651403|10783761|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0
6786497|NCT01651403|10783762|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1
6786498|NCT01651403|10783761|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13
6786499|NCT01651403|10783762|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9
6786500|NCT01651403|10783761|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2
6786501|NCT01651403|10783762|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1
6786502|NCT01651403|10783761|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6
6786503|NCT01651403|10783762|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4
6807259|NCT02000115|10810894|FG000|Overall Study|Death|56
6807260|NCT02000115|10810895|FG001|Overall Study|Death|45
6807261|NCT02000115|10810896|FG002|Overall Study|Death|0
6807262|NCT02000115|10810897|FG003|Overall Study|Death|0
6807263|NCT02000115|10810894|FG000|Overall Study|Missed Visit|6
6807264|NCT02000115|10810895|FG001|Overall Study|Missed Visit|8
6807265|NCT02000115|10810896|FG002|Overall Study|Missed Visit|1
6807266|NCT02000115|10810897|FG003|Overall Study|Missed Visit|0
6807267|NCT02000115|10810894|FG000|Overall Study|Protocol Violation|2
6807268|NCT02000115|10810895|FG001|Overall Study|Protocol Violation|1
6807269|NCT02000115|10810896|FG002|Overall Study|Protocol Violation|0
6807270|NCT02000115|10810897|FG003|Overall Study|Protocol Violation|0
6807271|NCT02000115|10810894|FG000|Overall Study|Physician Decision|2
6807272|NCT02000115|10810895|FG001|Overall Study|Physician Decision|0
6807273|NCT02000115|10810896|FG002|Overall Study|Physician Decision|0
6807274|NCT02000115|10810897|FG003|Overall Study|Physician Decision|0
6807275|NCT02000115|10810894|FG000|Overall Study|Withdrawal by Subject|11
6807276|NCT02000115|10810895|FG001|Overall Study|Withdrawal by Subject|11
6807277|NCT02000115|10810896|FG002|Overall Study|Withdrawal by Subject|0
6807278|NCT02000115|10810897|FG003|Overall Study|Withdrawal by Subject|0
6807279|NCT02000115|10810894|FG000|Overall Study|Lost to Follow-up|0
6807280|NCT02000115|10810895|FG001|Overall Study|Lost to Follow-up|1
6807281|NCT02000115|10810896|FG002|Overall Study|Lost to Follow-up|0
6807282|NCT02000115|10810897|FG003|Overall Study|Lost to Follow-up|0
6807283|NCT02000115|10810894|FG000|Overall Study|Non-compliance|2
6807284|NCT02000115|10810895|FG001|Overall Study|Non-compliance|1
6807285|NCT02000115|10810896|FG002|Overall Study|Non-compliance|0
6807286|NCT02000115|10810897|FG003|Overall Study|Non-compliance|0
6807287|NCT02000115|10810894|FG000|Overall Study|Withdrawn on day of randomization|0
6807288|NCT02000115|10810895|FG001|Overall Study|Withdrawn on day of randomization|1
6807289|NCT02000115|10810896|FG002|Overall Study|Withdrawn on day of randomization|0
6807290|NCT02000115|10810897|FG003|Overall Study|Withdrawn on day of randomization|0
6807291|NCT02000115|10810894|FG000|Overall Study|Still on Study|0
6807292|NCT02000115|10810895|FG001|Overall Study|Still on Study|0
6807293|NCT02000115|10810896|FG002|Overall Study|Still on Study|0
6807294|NCT02000115|10810897|FG003|Overall Study|Still on Study|53
6807295|NCT01695317|10810921|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2
6807296|NCT01695317|10810922|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1
6807297|NCT01695317|10810921|FG000|Cross-over to Period 2|Withdrawal by Subject|4
7139340|NCT02956837|11292956|FG002|Overall Study|Withdrawal by Subject|0
6807298|NCT01695317|10810922|FG001|Cross-over to Period 2|Withdrawal by Subject|34
6807299|NCT01127451|10810953|FG000|Overall Study|Other|2
6807300|NCT01127451|10810954|FG001|Overall Study|Other|1
6810678|NCT02748057|10814597|FG000|Overall Study|Physician Decision|0
6786504|NCT01542736|10783777|FG000|Overall Study|Death|1
6786505|NCT01535807|10783783|FG000|Overall Study|Withdrawal by Subject|1
6786506|NCT01535807|10783784|FG001|Overall Study|Withdrawal by Subject|1
6786507|NCT01535807|10783783|FG000|Overall Study|Data collection error|1
6786508|NCT01535807|10783784|FG001|Overall Study|Data collection error|1
6786509|NCT01147666|10783805|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1
6786510|NCT01147666|10783806|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1
6786511|NCT01147666|10783807|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1
6786512|NCT01147666|10783808|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0
6786513|NCT01147666|10783809|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0
6786514|NCT01147666|10783810|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0
6786515|NCT01147666|10783811|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0
6786516|NCT01147666|10783812|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0
6786517|NCT01147666|10783813|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0
6786518|NCT01147666|10783814|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0
6786519|NCT01147666|10783815|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0
6786520|NCT01147666|10783816|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0
6786521|NCT01147666|10783817|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1
6786522|NCT01147666|10783818|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0
6786523|NCT01147666|10783819|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0
6786524|NCT01147666|10783805|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
6786525|NCT01147666|10783806|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1
6786526|NCT01147666|10783807|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
6786527|NCT01147666|10783808|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
6786528|NCT01147666|10783809|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3
6786529|NCT01147666|10783810|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1
6786530|NCT01147666|10783811|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2
6786531|NCT01147666|10783812|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2
6786532|NCT01147666|10783813|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
6786533|NCT01147666|10783814|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1
6786534|NCT01147666|10783815|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
6786535|NCT01147666|10783816|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
6786536|NCT01147666|10783817|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1
6786537|NCT01147666|10783818|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
6786538|NCT01147666|10783819|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3
6786539|NCT01147666|10783805|FG000|Dosing Period 1: 6-Week Treatment|Death|0
6786540|NCT01147666|10783806|FG001|Dosing Period 1: 6-Week Treatment|Death|0
6786541|NCT01147666|10783807|FG002|Dosing Period 1: 6-Week Treatment|Death|0
6786542|NCT01147666|10783808|FG003|Dosing Period 1: 6-Week Treatment|Death|0
6786543|NCT01147666|10783809|FG004|Dosing Period 1: 6-Week Treatment|Death|1
6786544|NCT01147666|10783810|FG005|Dosing Period 1: 6-Week Treatment|Death|1
6786545|NCT01147666|10783811|FG006|Dosing Period 1: 6-Week Treatment|Death|1
6786546|NCT01147666|10783812|FG007|Dosing Period 1: 6-Week Treatment|Death|0
6786547|NCT01147666|10783813|FG008|Dosing Period 1: 6-Week Treatment|Death|0
6786548|NCT01147666|10783814|FG009|Dosing Period 1: 6-Week Treatment|Death|0
6786549|NCT01147666|10783815|FG010|Dosing Period 1: 6-Week Treatment|Death|0
6786550|NCT01147666|10783816|FG011|Dosing Period 1: 6-Week Treatment|Death|0
6786551|NCT01147666|10783817|FG012|Dosing Period 1: 6-Week Treatment|Death|1
6786552|NCT01147666|10783818|FG013|Dosing Period 1: 6-Week Treatment|Death|0
6786553|NCT01147666|10783819|FG014|Dosing Period 1: 6-Week Treatment|Death|0
6786554|NCT01147666|10783805|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1
6786555|NCT01147666|10783806|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
6786556|NCT01147666|10783807|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
6786557|NCT01147666|10783808|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1
6786558|NCT01147666|10783809|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
6786559|NCT01147666|10783810|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
6786560|NCT01147666|10783811|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
6786561|NCT01147666|10783812|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
6786562|NCT01147666|10783813|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
6786563|NCT01147666|10783814|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
6786564|NCT01147666|10783815|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1
6786565|NCT01147666|10783816|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
6786566|NCT01147666|10783817|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
6786567|NCT01147666|10783818|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
6786568|NCT01147666|10783819|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
6786569|NCT01147666|10783805|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
6786570|NCT01147666|10783806|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
6786571|NCT01147666|10783807|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
6786572|NCT01147666|10783808|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
6786573|NCT01147666|10783809|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1
6786574|NCT01147666|10783810|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1
6786575|NCT01147666|10783811|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
6786576|NCT01147666|10783812|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1
6810679|NCT02748057|10814598|FG001|Overall Study|Physician Decision|1
6786577|NCT01147666|10783813|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
6786578|NCT01147666|10783814|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1
6786579|NCT01147666|10783815|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
6786580|NCT01147666|10783816|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1
6786581|NCT01147666|10783817|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
6786582|NCT01147666|10783818|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1
6786583|NCT01147666|10783819|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
6786584|NCT01147666|10783805|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0
6786585|NCT01147666|10783806|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0
6786586|NCT01147666|10783807|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0
6786587|NCT01147666|10783808|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1
6786588|NCT01147666|10783809|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0
6786589|NCT01147666|10783810|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0
6786590|NCT01147666|10783811|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0
6786591|NCT01147666|10783812|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0
6786592|NCT01147666|10783813|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0
6786593|NCT01147666|10783814|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0
6786594|NCT01147666|10783815|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2
6786595|NCT01147666|10783816|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0
6786596|NCT01147666|10783817|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0
6786597|NCT01147666|10783818|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0
6786598|NCT01147666|10783819|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0
6786599|NCT01147666|10783805|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
6786600|NCT01147666|10783806|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
6786601|NCT01147666|10783807|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
6786602|NCT01147666|10783808|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
6786603|NCT01147666|10783809|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
6786604|NCT01147666|10783810|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
6786605|NCT01147666|10783811|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
6786606|NCT01147666|10783812|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
6786607|NCT01147666|10783813|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
6786608|NCT01147666|10783814|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
6786609|NCT01147666|10783815|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
6786610|NCT01147666|10783816|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1
6786611|NCT01147666|10783817|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1
6786612|NCT01147666|10783818|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
6786613|NCT01147666|10783819|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1
6786614|NCT01147666|10783805|FG000|Dosing Period 2: 19-Week Treatment|Death|0
6786615|NCT01147666|10783806|FG001|Dosing Period 2: 19-Week Treatment|Death|0
6786616|NCT01147666|10783807|FG002|Dosing Period 2: 19-Week Treatment|Death|0
6786617|NCT01147666|10783808|FG003|Dosing Period 2: 19-Week Treatment|Death|0
6786618|NCT01147666|10783809|FG004|Dosing Period 2: 19-Week Treatment|Death|1
6786619|NCT01147666|10783810|FG005|Dosing Period 2: 19-Week Treatment|Death|1
6786620|NCT01147666|10783811|FG006|Dosing Period 2: 19-Week Treatment|Death|1
6786621|NCT01147666|10783812|FG007|Dosing Period 2: 19-Week Treatment|Death|0
6786622|NCT01147666|10783813|FG008|Dosing Period 2: 19-Week Treatment|Death|0
6786623|NCT01147666|10783814|FG009|Dosing Period 2: 19-Week Treatment|Death|0
6786624|NCT01147666|10783815|FG010|Dosing Period 2: 19-Week Treatment|Death|0
6786625|NCT01147666|10783816|FG011|Dosing Period 2: 19-Week Treatment|Death|0
6786626|NCT01147666|10783817|FG012|Dosing Period 2: 19-Week Treatment|Death|1
6786627|NCT01147666|10783818|FG013|Dosing Period 2: 19-Week Treatment|Death|0
6786628|NCT01147666|10783819|FG014|Dosing Period 2: 19-Week Treatment|Death|0
6786629|NCT01147666|10783805|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
6786630|NCT01147666|10783806|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
6786631|NCT01147666|10783807|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
6786632|NCT01147666|10783808|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
6786633|NCT01147666|10783809|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3
6786634|NCT01147666|10783810|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1
6786635|NCT01147666|10783811|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2
6786636|NCT01147666|10783812|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2
6786637|NCT01147666|10783813|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
6786638|NCT01147666|10783814|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1
6786639|NCT01147666|10783815|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
6786640|NCT01147666|10783816|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
6786641|NCT01147666|10783817|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1
6786642|NCT01147666|10783818|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
6786643|NCT01147666|10783819|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2
6786644|NCT01147666|10783805|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
6786645|NCT01147666|10783806|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
6786646|NCT01147666|10783807|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
6810680|NCT02748057|10814597|FG000|Overall Study|Protocol Violation|2
6786647|NCT01147666|10783808|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1
6786648|NCT01147666|10783809|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
6786649|NCT01147666|10783810|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
6786650|NCT01147666|10783811|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
6786651|NCT01147666|10783812|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
6786652|NCT01147666|10783813|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
6786653|NCT01147666|10783814|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
6786654|NCT01147666|10783815|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
6786655|NCT01147666|10783816|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
6786656|NCT01147666|10783817|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
6786657|NCT01147666|10783818|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
6786658|NCT01147666|10783819|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
6786659|NCT01147666|10783805|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
6786660|NCT01147666|10783806|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
6786661|NCT01147666|10783807|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
6786662|NCT01147666|10783808|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
6786663|NCT01147666|10783809|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1
6786664|NCT01147666|10783810|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1
6786665|NCT01147666|10783811|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
6786666|NCT01147666|10783812|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1
6786667|NCT01147666|10783813|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
6786668|NCT01147666|10783814|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1
6786669|NCT01147666|10783815|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
6786670|NCT01147666|10783816|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
6786671|NCT01147666|10783817|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
6786672|NCT01147666|10783818|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1
6786673|NCT01147666|10783819|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
6786674|NCT01147666|10783805|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0
6786675|NCT01147666|10783806|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0
6786676|NCT01147666|10783807|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0
6786677|NCT01147666|10783808|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1
6786678|NCT01147666|10783809|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0
6786679|NCT01147666|10783810|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0
6786680|NCT01147666|10783811|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0
6786681|NCT01147666|10783812|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0
6786682|NCT01147666|10783813|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0
6786683|NCT01147666|10783814|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0
6786684|NCT01147666|10783815|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2
6786685|NCT01147666|10783816|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0
6786686|NCT01147666|10783817|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0
6786687|NCT01147666|10783818|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0
6786688|NCT01147666|10783819|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0
6786689|NCT01147666|10783805|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0
6786690|NCT01147666|10783806|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0
6786691|NCT01147666|10783807|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0
6786692|NCT01147666|10783808|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0
6786693|NCT01147666|10783809|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0
6786694|NCT01147666|10783810|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0
6786695|NCT01147666|10783811|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0
6786696|NCT01147666|10783812|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0
6786697|NCT01147666|10783813|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0
6786698|NCT01147666|10783814|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0
6786699|NCT01147666|10783815|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0
6786700|NCT01147666|10783816|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0
6786701|NCT01147666|10783817|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1
6786702|NCT01147666|10783818|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0
6786703|NCT01147666|10783819|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0
6786704|NCT01147666|10783805|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
6786705|NCT01147666|10783806|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
6786706|NCT01147666|10783807|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
6786707|NCT01147666|10783808|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
6786708|NCT01147666|10783809|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
6786709|NCT01147666|10783810|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
6786710|NCT01147666|10783811|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
6786711|NCT01147666|10783812|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
6786712|NCT01147666|10783813|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
6786713|NCT01147666|10783814|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
6786714|NCT01147666|10783815|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
6786715|NCT01147666|10783816|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
6786716|NCT01147666|10783817|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1
6786717|NCT01147666|10783818|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
6786718|NCT01147666|10783819|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1
6786719|NCT00982111|10783883|FG000|Overall Study|Adverse Event|1
6786720|NCT00982111|10783884|FG001|Overall Study|Adverse Event|1
6786721|NCT00982111|10783883|FG000|Overall Study|Progressive Disease|46
6786722|NCT00982111|10783884|FG001|Overall Study|Progressive Disease|39
6786723|NCT00982111|10783883|FG000|Overall Study|Lost to Follow-up|9
6786724|NCT00982111|10783884|FG001|Overall Study|Lost to Follow-up|6
6786725|NCT00982111|10783883|FG000|Overall Study|New Anti-Cancer Therapy|5
6786726|NCT00982111|10783884|FG001|Overall Study|New Anti-Cancer Therapy|5
6786727|NCT00982111|10783883|FG000|Overall Study|Medical Decision|1
6786728|NCT00982111|10783884|FG001|Overall Study|Medical Decision|0
6786729|NCT00982111|10783883|FG000|Overall Study|Withdrawal by Subject|17
6786730|NCT00982111|10783884|FG001|Overall Study|Withdrawal by Subject|19
6786731|NCT00982111|10783883|FG000|Overall Study|Global Study End|0
6786732|NCT00982111|10783884|FG001|Overall Study|Global Study End|1
6786733|NCT00982111|10783883|FG000|Overall Study|Sponsor's Decision|0
6786734|NCT00982111|10783884|FG001|Overall Study|Sponsor's Decision|1
6786735|NCT00116142|10783898|FG000|Overall Study|Adverse Event|8
6786736|NCT00116142|10783899|FG001|Overall Study|Adverse Event|7
6786737|NCT00116142|10783898|FG000|Overall Study|Protocol Violation|2
6786738|NCT00116142|10783899|FG001|Overall Study|Protocol Violation|1
6786739|NCT00116142|10783898|FG000|Overall Study|Withdrawal by Subject|5
6786740|NCT00116142|10783899|FG001|Overall Study|Withdrawal by Subject|5
6786741|NCT00116142|10783898|FG000|Overall Study|Physician Decision|3
6786742|NCT00116142|10783899|FG001|Overall Study|Physician Decision|1
6786743|NCT00116142|10783898|FG000|Overall Study|Delayed Radiation Therapy|1
6786744|NCT00116142|10783899|FG001|Overall Study|Delayed Radiation Therapy|0
6786745|NCT00116142|10783898|FG000|Overall Study|Patient could not tolerate docetaxel|0
6786746|NCT00116142|10783899|FG001|Overall Study|Patient could not tolerate docetaxel|2
6786747|NCT00116142|10783898|FG000|Overall Study|Patient stopped due to depression|0
6786748|NCT00116142|10783899|FG001|Overall Study|Patient stopped due to depression|1
6786749|NCT00116142|10783898|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0
6786750|NCT00116142|10783899|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1
6786751|NCT00116142|10783898|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0
6786752|NCT00116142|10783899|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1
6786753|NCT00116142|10783898|FG000|Overall Study|Patient didn't start due to low platelet counts|0
6786754|NCT00116142|10783899|FG001|Overall Study|Patient didn't start due to low platelet counts|1
6786755|NCT00070018|10783908|FG000|Overall Study|Adverse Event|2
6786756|NCT00070018|10783908|FG000|Overall Study|Lack of Efficacy|1
6786757|NCT00070018|10783908|FG000|Overall Study|Withdrawal by Subject|1
6807301|NCT01127451|10810953|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14
6807302|NCT01127451|10810954|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12
6807303|NCT01127451|10810953|FG000|Overall Study|Death|22
6807304|NCT01127451|10810954|FG001|Overall Study|Death|17
6807305|NCT01127451|10810953|FG000|Overall Study|Lost to Follow-up|3
6807306|NCT01127451|10810954|FG001|Overall Study|Lost to Follow-up|0
6807307|NCT01127451|10810953|FG000|Overall Study|Administrative Reason by Sponsor|2
6807308|NCT01127451|10810954|FG001|Overall Study|Administrative Reason by Sponsor|2
6810681|NCT02748057|10814598|FG001|Overall Study|Protocol Violation|1
6810682|NCT02748057|10814597|FG000|Overall Study|Participant Moved|1
6810683|NCT02748057|10814598|FG001|Overall Study|Participant Moved|0
6810684|NCT02748057|10814597|FG000|Overall Study|Withdrawal by Subject|1
6810685|NCT02748057|10814598|FG001|Overall Study|Withdrawal by Subject|0
6810686|NCT02741271|10814606|FG000|Overall Study|Lost to Follow-up|2
6810687|NCT02741271|10814607|FG001|Overall Study|Lost to Follow-up|0
6810688|NCT02741271|10814606|FG000|Overall Study|Withdrawal by Parent/Guardian|0
6810689|NCT02741271|10814607|FG001|Overall Study|Withdrawal by Parent/Guardian|2
6810690|NCT02741245|10814620|FG000|Overall Study|Adverse Event|0
6810691|NCT02741245|10814621|FG001|Overall Study|Adverse Event|0
6810692|NCT02741245|10814622|FG002|Overall Study|Adverse Event|0
6810693|NCT02741245|10814623|FG003|Overall Study|Adverse Event|2
6810694|NCT02741245|10814624|FG004|Overall Study|Adverse Event|2
6810695|NCT02741245|10814620|FG000|Overall Study|Protocol Violation|0
6810696|NCT02741245|10814621|FG001|Overall Study|Protocol Violation|1
6810697|NCT02741245|10814622|FG002|Overall Study|Protocol Violation|0
6810698|NCT02741245|10814623|FG003|Overall Study|Protocol Violation|1
6810699|NCT02741245|10814624|FG004|Overall Study|Protocol Violation|0
6810700|NCT02741245|10814620|FG000|Overall Study|Withdrawal by Subject|0
6810701|NCT02741245|10814621|FG001|Overall Study|Withdrawal by Subject|0
6810702|NCT02741245|10814622|FG002|Overall Study|Withdrawal by Subject|0
6810703|NCT02741245|10814623|FG003|Overall Study|Withdrawal by Subject|1
6810704|NCT02741245|10814624|FG004|Overall Study|Withdrawal by Subject|0
6810705|NCT02688608|10814636|FG000|Overall Study|Lost to Follow-up|1
6810706|NCT02675231|10814643|FG000|Overall Study|Withdrawal by Subject|1
6810707|NCT02675231|10814644|FG001|Overall Study|Withdrawal by Subject|3
6810708|NCT02675231|10814645|FG002|Overall Study|Withdrawal by Subject|1
6810709|NCT02675231|10814643|FG000|Overall Study|Lost to Follow-up|2
6810710|NCT02675231|10814644|FG001|Overall Study|Lost to Follow-up|2
6810711|NCT02675231|10814645|FG002|Overall Study|Lost to Follow-up|2
6810712|NCT02675231|10814643|FG000|Overall Study|On study treatment/follow up|23
6786758|NCT04447287|10783921|FG000|Period 1: Run-in Period|Adverse Event|3
6786759|NCT04447287|10783922|FG001|Period 1: Run-in Period|Adverse Event|0
6786760|NCT04447287|10783923|FG002|Period 1: Run-in Period|Adverse Event|0
6786761|NCT04447287|10783921|FG000|Period 1: Run-in Period|Withdrawal by Subject|1
6786762|NCT04447287|10783922|FG001|Period 1: Run-in Period|Withdrawal by Subject|0
6786763|NCT04447287|10783923|FG002|Period 1: Run-in Period|Withdrawal by Subject|0
6786764|NCT04447287|10783921|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1
6786765|NCT04447287|10783922|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0
6786766|NCT04447287|10783923|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0
6786767|NCT04039503|10783979|FG000|Overall Study|Adverse Event|3
6786768|NCT04039503|10783980|FG001|Overall Study|Adverse Event|0
6786769|NCT04039503|10783981|FG002|Overall Study|Adverse Event|2
6786770|NCT04039503|10783982|FG003|Overall Study|Adverse Event|0
6786771|NCT04039503|10783979|FG000|Overall Study|Lost to Follow-up|0
6786772|NCT04039503|10783980|FG001|Overall Study|Lost to Follow-up|0
6786773|NCT04039503|10783981|FG002|Overall Study|Lost to Follow-up|1
6786774|NCT04039503|10783982|FG003|Overall Study|Lost to Follow-up|0
6786775|NCT04039503|10783979|FG000|Overall Study|Protocol Violation|0
6786776|NCT04039503|10783980|FG001|Overall Study|Protocol Violation|1
6786777|NCT04039503|10783981|FG002|Overall Study|Protocol Violation|2
6786778|NCT04039503|10783982|FG003|Overall Study|Protocol Violation|1
6786779|NCT04039503|10783979|FG000|Overall Study|Withdrawal by Subject|4
6786780|NCT04039503|10783980|FG001|Overall Study|Withdrawal by Subject|3
6786781|NCT04039503|10783981|FG002|Overall Study|Withdrawal by Subject|5
6786782|NCT04039503|10783982|FG003|Overall Study|Withdrawal by Subject|2
6786783|NCT03695172|10784000|FG000|Overall Study|Withdrawal by Subject|1
6786784|NCT03695172|10784001|FG001|Overall Study|Withdrawal by Subject|1
6786785|NCT03695172|10784002|FG002|Overall Study|Withdrawal by Subject|0
6786786|NCT03394027|10784026|FG000|Overall Study|Ineligible|3
6786787|NCT03394027|10784027|FG001|Overall Study|Ineligible|1
6786788|NCT03394027|10784028|FG002|Overall Study|Ineligible|3
6786789|NCT03394027|10784026|FG000|Overall Study|Participant declined to participate before treatment started|0
6786790|NCT03394027|10784027|FG001|Overall Study|Participant declined to participate before treatment started|0
6786791|NCT03394027|10784028|FG002|Overall Study|Participant declined to participate before treatment started|1
6786792|NCT03357952|10784056|FG000|Overall Study|Withdrawal by Subject|0
6786793|NCT03357952|10784057|FG001|Overall Study|Withdrawal by Subject|1
6786794|NCT03357952|10784056|FG000|Overall Study|Sponsor Decision|9
6786795|NCT03357952|10784057|FG001|Overall Study|Sponsor Decision|0
6786796|NCT03170869|10784072|FG000|Overall Study|Protocol Violation|5
6786797|NCT03170869|10784072|FG000|Overall Study|Early study termination|3
6786798|NCT03066622|10784079|FG000|Overall Study|Lost to Follow-up|24
6786799|NCT03066622|10784080|FG001|Overall Study|Lost to Follow-up|25
6786800|NCT03066622|10784079|FG000|Overall Study|Withdrawal by Subject|2
6786801|NCT03066622|10784080|FG001|Overall Study|Withdrawal by Subject|1
6786802|NCT03052920|10784086|FG000|Overall Study|Withdrawal by Subject|1
6786803|NCT03016312|10784105|FG000|Overall Study|Death|194
6786804|NCT03016312|10784106|FG001|Overall Study|Death|164
6786805|NCT03016312|10784105|FG000|Overall Study|Lost to Follow-up|11
6786806|NCT03016312|10784106|FG001|Overall Study|Lost to Follow-up|12
6786807|NCT03016312|10784105|FG000|Overall Study|Started new therapy, loss of contact|2
6786808|NCT03016312|10784106|FG001|Overall Study|Started new therapy, loss of contact|1
6786809|NCT03016312|10784105|FG000|Overall Study|Physician Decision|0
6786810|NCT03016312|10784106|FG001|Overall Study|Physician Decision|2
6786811|NCT03016312|10784105|FG000|Overall Study|Withdrawal by Subject|34
6786812|NCT03016312|10784106|FG001|Overall Study|Withdrawal by Subject|39
6786813|NCT02722434|10784124|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1
6786814|NCT02722434|10784125|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0
6786815|NCT02722434|10784124|FG000|Overall Study|Withdrawal After Beginning Treatment|0
6786816|NCT02722434|10784125|FG001|Overall Study|Withdrawal After Beginning Treatment|3
6786817|NCT02604511|10784135|FG000|Overall Study|Adverse Event|3
6786818|NCT02604511|10784135|FG000|Overall Study|Disease Progression|4
6786819|NCT02604511|10784135|FG000|Overall Study|Withdrawal by Subject|3
6786820|NCT02604511|10784135|FG000|Overall Study|Participant ineligible|1
6786821|NCT02604511|10784135|FG000|Overall Study|Intercurrent illness|1
6786822|NCT01963728|10784177|FG000|Overall Study|Study terminated early|0
6786823|NCT01963728|10784178|FG001|Overall Study|Study terminated early|1
6786824|NCT01248247|10784188|FG000|Overall Study|Adverse Event|2
6786825|NCT01248247|10784189|FG001|Overall Study|Adverse Event|4
6786826|NCT01248247|10784190|FG002|Overall Study|Adverse Event|4
6786827|NCT01248247|10784191|FG003|Overall Study|Adverse Event|2
6786828|NCT01248247|10784188|FG000|Overall Study|Death|0
6786829|NCT01248247|10784189|FG001|Overall Study|Death|1
6786830|NCT01248247|10784190|FG002|Overall Study|Death|4
6786831|NCT01248247|10784191|FG003|Overall Study|Death|7
6786832|NCT01248247|10784188|FG000|Overall Study|Lost to Follow-up|0
6786833|NCT01248247|10784189|FG001|Overall Study|Lost to Follow-up|1
6786834|NCT01248247|10784190|FG002|Overall Study|Lost to Follow-up|1
6786835|NCT01248247|10784191|FG003|Overall Study|Lost to Follow-up|0
6786836|NCT01248247|10784188|FG000|Overall Study|Alternative treatment|0
6786837|NCT01248247|10784189|FG001|Overall Study|Alternative treatment|1
6786838|NCT01248247|10784190|FG002|Overall Study|Alternative treatment|0
6786839|NCT01248247|10784191|FG003|Overall Study|Alternative treatment|0
6786840|NCT01248247|10784188|FG000|Overall Study|Other|2
6786841|NCT01248247|10784189|FG001|Overall Study|Other|8
6786842|NCT01248247|10784190|FG002|Overall Study|Other|8
6786843|NCT01248247|10784191|FG003|Overall Study|Other|5
6786844|NCT01248247|10784188|FG000|Overall Study|Progression|18
6786845|NCT01248247|10784189|FG001|Overall Study|Progression|27
6786846|NCT01248247|10784190|FG002|Overall Study|Progression|56
6786847|NCT01248247|10784191|FG003|Overall Study|Progression|44
6786848|NCT01248247|10784188|FG000|Overall Study|Refuse further treatment|0
6786849|NCT01248247|10784189|FG001|Overall Study|Refuse further treatment|0
6786850|NCT01248247|10784190|FG002|Overall Study|Refuse further treatment|1
6786851|NCT01248247|10784191|FG003|Overall Study|Refuse further treatment|2
6786852|NCT01248247|10784188|FG000|Overall Study|Complicating disease|0
6786853|NCT01248247|10784189|FG001|Overall Study|Complicating disease|0
6786854|NCT01248247|10784190|FG002|Overall Study|Complicating disease|1
6786855|NCT01248247|10784191|FG003|Overall Study|Complicating disease|1
6786856|NCT01164228|10784203|FG000|Overall Study|Progression|24
6786857|NCT01164228|10784204|FG001|Overall Study|Progression|25
6786858|NCT01164228|10784203|FG000|Overall Study|Adverse Event|13
6786859|NCT01164228|10784204|FG001|Overall Study|Adverse Event|7
6786860|NCT01164228|10784203|FG000|Overall Study|Death|1
6786861|NCT01164228|10784204|FG001|Overall Study|Death|1
6786862|NCT01164228|10784203|FG000|Overall Study|Withdrawal by Subject|2
6786863|NCT01164228|10784204|FG001|Overall Study|Withdrawal by Subject|0
6786864|NCT01164228|10784203|FG000|Overall Study|Physician Decision|1
6786865|NCT01164228|10784204|FG001|Overall Study|Physician Decision|2
6786866|NCT01164228|10784203|FG000|Overall Study|Symptomatic deterioration|1
6786867|NCT01164228|10784204|FG001|Overall Study|Symptomatic deterioration|0
6786868|NCT01164228|10784203|FG000|Overall Study|Never started treatment|1
6786869|NCT01164228|10784204|FG001|Overall Study|Never started treatment|3
6786870|NCT01164228|10784203|FG000|Overall Study|Ineligible|1
6786871|NCT01164228|10784204|FG001|Overall Study|Ineligible|0
6786872|NCT00591318|10784271|FG000|Overall Study|Lack of Efficacy|2
6786873|NCT00591318|10784272|FG001|Overall Study|Lack of Efficacy|0
7139341|NCT02956837|11292957|FG003|Overall Study|Withdrawal by Subject|3
7139342|NCT02956837|11292954|FG000|Overall Study|Lost to Follow-up|0
7139343|NCT02956837|11292955|FG001|Overall Study|Lost to Follow-up|1
7139344|NCT02956837|11292956|FG002|Overall Study|Lost to Follow-up|2
7139345|NCT02956837|11292957|FG003|Overall Study|Lost to Follow-up|0
7139346|NCT02956967|11292970|FG000|Overall Study|Adverse Event|3
7139347|NCT02956967|11292970|FG000|Overall Study|Reason non-related to neutropenia|10
7139348|NCT02956967|11292970|FG000|Overall Study|Lost to Follow-up|5
7139349|NCT02956967|11292970|FG000|Overall Study|Missing|1
7139350|NCT02956967|11292970|FG000|Overall Study|Termination of Nivestim administration|29
7139351|NCT02957136|11292980|FG000|Overall Study|Withdrawal by Subject|2
7139352|NCT02957136|11292981|FG001|Overall Study|Withdrawal by Subject|1
7139353|NCT02957331|11292998|FG000|Overall Study|Protocol Violation|1
7139354|NCT02957331|11292999|FG001|Overall Study|Protocol Violation|0
7139355|NCT02957682|11293023|FG000|Overall Study|Adverse Event|64
7139356|NCT02957682|11293024|FG001|Overall Study|Adverse Event|67
7139357|NCT02957682|11293023|FG000|Overall Study|Poor Compliance to Protocol|30
7139358|NCT02957682|11293024|FG001|Overall Study|Poor Compliance to Protocol|26
7139359|NCT02957682|11293023|FG000|Overall Study|Physician Decision|4
7139360|NCT02957682|11293024|FG001|Overall Study|Physician Decision|4
7139361|NCT02957682|11293023|FG000|Overall Study|Study Terminated by Sponsor|4
7139362|NCT02957682|11293024|FG001|Overall Study|Study Terminated by Sponsor|3
7139363|NCT02957682|11293023|FG000|Overall Study|Subject Moved|10
7139364|NCT02957682|11293024|FG001|Overall Study|Subject Moved|16
7139365|NCT02957682|11293023|FG000|Overall Study|Withdrawal by Subject|64
7139366|NCT02957682|11293024|FG001|Overall Study|Withdrawal by Subject|33
7139367|NCT02957682|11293023|FG000|Overall Study|Related to IMP Administration|3
7139368|NCT02957682|11293024|FG001|Overall Study|Related to IMP Administration|6
7139369|NCT02957682|11293023|FG000|Overall Study|Non-disclosed|16
7139370|NCT02957682|11293024|FG001|Overall Study|Non-disclosed|12
7139371|NCT02957682|11293023|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3
7139372|NCT02957682|11293024|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2
6786874|NCT00591318|10784271|FG000|Overall Study|Adverse Event|2
6786875|NCT00591318|10784272|FG001|Overall Study|Adverse Event|0
6807309|NCT04559698|10810986|FG000|Overall Study|Lost to Follow-up|14
6807310|NCT04559698|10810987|FG001|Overall Study|Lost to Follow-up|15
6807311|NCT04559698|10810986|FG000|Overall Study|Withdrawal by Subject|0
6807312|NCT04559698|10810987|FG001|Overall Study|Withdrawal by Subject|1
6807313|NCT04492475|10810995|FG000|Overall Study|Enrolled but not treated|8
6807314|NCT04492475|10810996|FG001|Overall Study|Enrolled but not treated|8
6807315|NCT04492475|10810995|FG000|Overall Study|Withdrawal by Subject|4
6807316|NCT04492475|10810996|FG001|Overall Study|Withdrawal by Subject|0
6807317|NCT04492475|10810995|FG000|Overall Study|Became ineligible after enrollment|2
6807318|NCT04492475|10810996|FG001|Overall Study|Became ineligible after enrollment|0
6807319|NCT04401579|10811011|FG000|Overall Study|Death|23
6807320|NCT04401579|10811012|FG001|Overall Study|Death|36
6807321|NCT04401579|10811011|FG000|Overall Study|Lost to Follow-up|40
6807322|NCT04401579|10811012|FG001|Overall Study|Lost to Follow-up|41
6807323|NCT04401579|10811011|FG000|Overall Study|Withdrawal by Subject|8
6786876|NCT04534517|10784293|FG000|Overall Study|Adverse Event|1
6786877|NCT04534517|10784293|FG000|Overall Study|Withdrawal by Subject|1
6786878|NCT04534517|10784293|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1
6786879|NCT04534517|10784293|FG000|Overall Study|COVID-19 Related|1
6786880|NCT04494646|10784299|FG000|Overall Study|Adverse Event|0
6786881|NCT04494646|10784300|FG001|Overall Study|Adverse Event|1
6786882|NCT04494646|10784299|FG000|Overall Study|Withdrawal by Subject|0
6786883|NCT04494646|10784300|FG001|Overall Study|Withdrawal by Subject|1
6786884|NCT04258020|10784308|FG000|Overall Study|Withdrawal by Subject|1
6786885|NCT04258020|10784309|FG001|Overall Study|Withdrawal by Subject|0
6786886|NCT04234464|10784317|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1
6786887|NCT04234464|10784318|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0
6786888|NCT03852316|10784324|FG000|Overall Study|Protocol Violation|1
6786889|NCT03852316|10784324|FG000|Overall Study|Withdrawal by Subject|2
6786890|NCT03852316|10784324|FG000|Overall Study|Enrolled but Device not Utilized|1
6786891|NCT03789318|10784333|FG000|Overall Study|Adverse Event|0
6786892|NCT03789318|10784334|FG001|Overall Study|Adverse Event|0
6786893|NCT03789318|10784335|FG002|Overall Study|Adverse Event|1
6786894|NCT03789318|10784336|FG003|Overall Study|Adverse Event|1
6786895|NCT03789318|10784337|FG004|Overall Study|Adverse Event|0
6786896|NCT03789318|10784333|FG000|Overall Study|Lost to Follow-up|0
6786897|NCT03789318|10784334|FG001|Overall Study|Lost to Follow-up|0
6786898|NCT03789318|10784335|FG002|Overall Study|Lost to Follow-up|1
6786899|NCT03789318|10784336|FG003|Overall Study|Lost to Follow-up|0
6786900|NCT03789318|10784337|FG004|Overall Study|Lost to Follow-up|0
6786901|NCT03789318|10784333|FG000|Overall Study|Withdrawal by Subject|0
6786902|NCT03789318|10784334|FG001|Overall Study|Withdrawal by Subject|0
6786903|NCT03789318|10784335|FG002|Overall Study|Withdrawal by Subject|1
6786904|NCT03789318|10784336|FG003|Overall Study|Withdrawal by Subject|0
6786905|NCT03789318|10784337|FG004|Overall Study|Withdrawal by Subject|0
7139373|NCT02957747|11293032|FG000|Overall Study|Withdrawal by Subject|0
7139374|NCT02957747|11293033|FG001|Overall Study|Withdrawal by Subject|3
7139375|NCT02957747|11293032|FG000|Overall Study|Lost to Follow-up|10
7139376|NCT02957747|11293033|FG001|Overall Study|Lost to Follow-up|5
7139377|NCT02957942|11293042|FG000|Overall Study|Withdrawal by Subject|0
7139378|NCT02957942|11293043|FG001|Overall Study|Withdrawal by Subject|1
7139379|NCT02957942|11293042|FG000|Overall Study|Practicing experiment protocol|0
7139380|NCT02957942|11293043|FG001|Overall Study|Practicing experiment protocol|6
7139381|NCT02958267|11293051|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1
7139382|NCT02958267|11293052|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0
7139383|NCT02958267|11293051|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1
6786906|NCT03774875|10784351|FG000|Overall Study|Adverse Event|8
6786907|NCT03774875|10784352|FG001|Overall Study|Adverse Event|16
6786908|NCT03774875|10784351|FG000|Overall Study|Lack of Efficacy|2
6786909|NCT03774875|10784352|FG001|Overall Study|Lack of Efficacy|4
6786910|NCT03774875|10784351|FG000|Overall Study|Withdrawal by Subject|12
6786911|NCT03774875|10784352|FG001|Overall Study|Withdrawal by Subject|10
6786912|NCT03774875|10784351|FG000|Overall Study|Lost to Follow-up|0
6786913|NCT03774875|10784352|FG001|Overall Study|Lost to Follow-up|2
6786914|NCT03774875|10784351|FG000|Overall Study|Protocol Deviation|0
6786915|NCT03774875|10784352|FG001|Overall Study|Protocol Deviation|1
6786916|NCT03774875|10784351|FG000|Overall Study|Reason Unknown|1
6786917|NCT03774875|10784352|FG001|Overall Study|Reason Unknown|0
6786918|NCT03158688|10784381|FG000|Overall Study|Continuing in study|107
6786919|NCT03158688|10784382|FG001|Overall Study|Continuing in study|233
6786920|NCT03158688|10784381|FG000|Overall Study|Death|36
6786921|NCT03158688|10784382|FG001|Overall Study|Death|59
6786922|NCT03158688|10784381|FG000|Overall Study|Withdrawal by Subject|9
6786923|NCT03158688|10784382|FG001|Overall Study|Withdrawal by Subject|14
6786924|NCT03158688|10784381|FG000|Overall Study|Decision by sponsor|2
6786925|NCT03158688|10784382|FG001|Overall Study|Decision by sponsor|3
6786926|NCT03158688|10784381|FG000|Overall Study|Lost to Follow-up|0
6786927|NCT03158688|10784382|FG001|Overall Study|Lost to Follow-up|3
6786928|NCT03103321|10784392|FG000|Overall Study|Protocol Violation|1
6786929|NCT03103321|10784393|FG001|Overall Study|Protocol Violation|1
6786930|NCT03103321|10784394|FG002|Overall Study|Protocol Violation|1
6786931|NCT03103321|10784395|FG003|Overall Study|Protocol Violation|0
6786932|NCT03079869|10784407|FG000|Overall Study|Adverse Event|6
6786933|NCT03079869|10784408|FG001|Overall Study|Adverse Event|8
6786934|NCT03079869|10784407|FG000|Overall Study|Withdrawal by Subject|4
6786935|NCT03079869|10784408|FG001|Overall Study|Withdrawal by Subject|1
6786936|NCT03079869|10784407|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3
6786937|NCT03079869|10784408|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2
6786938|NCT03033875|10784417|FG000|Overall Study|Withdrawal by Subject|5
6786939|NCT03033875|10784418|FG001|Overall Study|Withdrawal by Subject|9
6786940|NCT03033875|10784419|FG002|Overall Study|Withdrawal by Subject|4
6786941|NCT03033875|10784417|FG000|Overall Study|Other|14
6786942|NCT03033875|10784418|FG001|Overall Study|Other|15
6786943|NCT03033875|10784419|FG002|Overall Study|Other|8
6786944|NCT02887248|10784431|FG000|Overall Study|Withdrawal by Subject|1
7139384|NCT02958267|11293052|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0
6786945|NCT02887248|10784431|FG000|Overall Study|Adverse Event|1
6786946|NCT02887248|10784431|FG000|Overall Study|Progressive Disease|1
6786947|NCT02849990|10784435|FG000|Overall Study|Adverse Event|1
6786948|NCT02849990|10784435|FG000|Overall Study|Withdrawal by Subject|1
6786949|NCT02467270|10784468|FG000|Overall Study|Participants Never Treated|0
6786950|NCT02467270|10784469|FG001|Overall Study|Participants Never Treated|1
6786951|NCT02467270|10784470|FG002|Overall Study|Participants Never Treated|0
6786952|NCT02467270|10784468|FG000|Overall Study|Ongoing|50
6786953|NCT02467270|10784469|FG001|Overall Study|Ongoing|41
6786954|NCT02467270|10784470|FG002|Overall Study|Ongoing|43
6786955|NCT02467270|10784468|FG000|Overall Study|Adverse Event|16
6786956|NCT02467270|10784469|FG001|Overall Study|Adverse Event|15
6786957|NCT02467270|10784470|FG002|Overall Study|Adverse Event|14
6786958|NCT02467270|10784468|FG000|Overall Study|Progressive Disease|7
6786959|NCT02467270|10784469|FG001|Overall Study|Progressive Disease|7
6786960|NCT02467270|10784470|FG002|Overall Study|Progressive Disease|4
6786961|NCT02467270|10784468|FG000|Overall Study|Death|2
6786962|NCT02467270|10784469|FG001|Overall Study|Death|0
6786963|NCT02467270|10784470|FG002|Overall Study|Death|2
6786964|NCT02467270|10784468|FG000|Overall Study|Lack of Efficacy|12
6786965|NCT02467270|10784469|FG001|Overall Study|Lack of Efficacy|18
6786966|NCT02467270|10784470|FG002|Overall Study|Lack of Efficacy|23
6786967|NCT02467270|10784468|FG000|Overall Study|Non-compliance With Study Drug|0
6786968|NCT02467270|10784469|FG001|Overall Study|Non-compliance With Study Drug|2
6786969|NCT02467270|10784470|FG002|Overall Study|Non-compliance With Study Drug|1
6786970|NCT02467270|10784468|FG000|Overall Study|Lost to Follow-up|2
6786971|NCT02467270|10784469|FG001|Overall Study|Lost to Follow-up|1
6786972|NCT02467270|10784470|FG002|Overall Study|Lost to Follow-up|0
6786973|NCT02467270|10784468|FG000|Overall Study|Pregnancy|0
6786974|NCT02467270|10784469|FG001|Overall Study|Pregnancy|1
6786975|NCT02467270|10784470|FG002|Overall Study|Pregnancy|0
6786976|NCT02467270|10784468|FG000|Overall Study|Physician Decision|0
6786977|NCT02467270|10784469|FG001|Overall Study|Physician Decision|4
6786978|NCT02467270|10784470|FG002|Overall Study|Physician Decision|1
6786979|NCT02467270|10784468|FG000|Overall Study|Withdrawal by Subject|4
6786980|NCT02467270|10784469|FG001|Overall Study|Withdrawal by Subject|3
6786981|NCT02467270|10784470|FG002|Overall Study|Withdrawal by Subject|5
6786982|NCT02467270|10784468|FG000|Overall Study|Reason not Specified|1
6786983|NCT02467270|10784469|FG001|Overall Study|Reason not Specified|2
6786984|NCT02467270|10784470|FG002|Overall Study|Reason not Specified|1
6786985|NCT02452554|10784484|FG000|Overall Study|Death|2
6786986|NCT02452554|10784485|FG001|Overall Study|Death|1
6786987|NCT02452554|10784486|FG002|Overall Study|Death|0
6786988|NCT02452554|10784487|FG003|Overall Study|Death|0
6786989|NCT02452554|10784488|FG004|Overall Study|Death|0
6786990|NCT02452554|10784489|FG005|Overall Study|Death|0
6786991|NCT02452554|10784484|FG000|Overall Study|Lack of Efficacy|13
6786992|NCT02452554|10784485|FG001|Overall Study|Lack of Efficacy|14
6786993|NCT02452554|10784486|FG002|Overall Study|Lack of Efficacy|9
6786994|NCT02452554|10784487|FG003|Overall Study|Lack of Efficacy|1
6786995|NCT02452554|10784488|FG004|Overall Study|Lack of Efficacy|5
6786996|NCT02452554|10784489|FG005|Overall Study|Lack of Efficacy|8
6786997|NCT02452554|10784484|FG000|Overall Study|Physician Decision|0
6786998|NCT02452554|10784485|FG001|Overall Study|Physician Decision|1
6786999|NCT02452554|10784486|FG002|Overall Study|Physician Decision|0
6787000|NCT02452554|10784487|FG003|Overall Study|Physician Decision|0
6787001|NCT02452554|10784488|FG004|Overall Study|Physician Decision|0
6787002|NCT02452554|10784489|FG005|Overall Study|Physician Decision|0
6787003|NCT02452554|10784484|FG000|Overall Study|Withdrawal by Subject|1
6787004|NCT02452554|10784485|FG001|Overall Study|Withdrawal by Subject|0
6787005|NCT02452554|10784486|FG002|Overall Study|Withdrawal by Subject|2
6787006|NCT02452554|10784487|FG003|Overall Study|Withdrawal by Subject|0
6787007|NCT02452554|10784488|FG004|Overall Study|Withdrawal by Subject|0
6787008|NCT02452554|10784489|FG005|Overall Study|Withdrawal by Subject|1
6787009|NCT02452554|10784484|FG000|Overall Study|Ineligible|0
6787010|NCT02452554|10784485|FG001|Overall Study|Ineligible|1
6787011|NCT02452554|10784486|FG002|Overall Study|Ineligible|0
6787012|NCT02452554|10784487|FG003|Overall Study|Ineligible|0
6787013|NCT02452554|10784488|FG004|Overall Study|Ineligible|0
6787014|NCT02452554|10784489|FG005|Overall Study|Ineligible|0
6787015|NCT02452554|10784484|FG000|Overall Study|Never Received Treatment|1
6787016|NCT02452554|10784485|FG001|Overall Study|Never Received Treatment|0
6787017|NCT02452554|10784486|FG002|Overall Study|Never Received Treatment|0
6787018|NCT02452554|10784487|FG003|Overall Study|Never Received Treatment|0
6787019|NCT02452554|10784488|FG004|Overall Study|Never Received Treatment|0
6787020|NCT02452554|10784489|FG005|Overall Study|Never Received Treatment|0
6787021|NCT02318277|10784525|FG000|Overall Study|Physician Decision|0
6787022|NCT02318277|10784526|FG001|Overall Study|Physician Decision|0
6787023|NCT02318277|10784527|FG002|Overall Study|Physician Decision|0
6787024|NCT02318277|10784528|FG003|Overall Study|Physician Decision|0
6787025|NCT02318277|10784529|FG004|Overall Study|Physician Decision|0
6787026|NCT02318277|10784530|FG005|Overall Study|Physician Decision|0
6787027|NCT02318277|10784531|FG006|Overall Study|Physician Decision|0
6787028|NCT02318277|10784532|FG007|Overall Study|Physician Decision|1
6787029|NCT02318277|10784525|FG000|Overall Study|Other|0
6787030|NCT02318277|10784526|FG001|Overall Study|Other|0
6787031|NCT02318277|10784527|FG002|Overall Study|Other|0
6787032|NCT02318277|10784528|FG003|Overall Study|Other|0
6787033|NCT02318277|10784529|FG004|Overall Study|Other|0
6787034|NCT02318277|10784530|FG005|Overall Study|Other|0
6787035|NCT02318277|10784531|FG006|Overall Study|Other|1
6787036|NCT02318277|10784532|FG007|Overall Study|Other|0
6787037|NCT02318277|10784525|FG000|Overall Study|Withdrawal by Subject|0
6787038|NCT02318277|10784526|FG001|Overall Study|Withdrawal by Subject|0
6787039|NCT02318277|10784527|FG002|Overall Study|Withdrawal by Subject|1
6787040|NCT02318277|10784528|FG003|Overall Study|Withdrawal by Subject|0
6787041|NCT02318277|10784529|FG004|Overall Study|Withdrawal by Subject|1
6787042|NCT02318277|10784530|FG005|Overall Study|Withdrawal by Subject|1
6787043|NCT02318277|10784531|FG006|Overall Study|Withdrawal by Subject|6
6787044|NCT02318277|10784532|FG007|Overall Study|Withdrawal by Subject|14
6787045|NCT02318277|10784525|FG000|Overall Study|Participant trial terminated by sponsor|0
6787046|NCT02318277|10784526|FG001|Overall Study|Participant trial terminated by sponsor|0
6787047|NCT02318277|10784527|FG002|Overall Study|Participant trial terminated by sponsor|1
6787048|NCT02318277|10784528|FG003|Overall Study|Participant trial terminated by sponsor|0
6787049|NCT02318277|10784529|FG004|Overall Study|Participant trial terminated by sponsor|1
6787050|NCT02318277|10784530|FG005|Overall Study|Participant trial terminated by sponsor|2
6787051|NCT02318277|10784531|FG006|Overall Study|Participant trial terminated by sponsor|5
6787052|NCT02318277|10784532|FG007|Overall Study|Participant trial terminated by sponsor|16
6787053|NCT02318277|10784525|FG000|Overall Study|Lost to Follow-up|1
6787054|NCT02318277|10784526|FG001|Overall Study|Lost to Follow-up|0
6787055|NCT02318277|10784527|FG002|Overall Study|Lost to Follow-up|1
6787056|NCT02318277|10784528|FG003|Overall Study|Lost to Follow-up|0
6787057|NCT02318277|10784529|FG004|Overall Study|Lost to Follow-up|0
6787058|NCT02318277|10784530|FG005|Overall Study|Lost to Follow-up|0
6787059|NCT02318277|10784531|FG006|Overall Study|Lost to Follow-up|3
6787060|NCT02318277|10784532|FG007|Overall Study|Lost to Follow-up|4
6787061|NCT02318277|10784525|FG000|Overall Study|Death|5
6787062|NCT02318277|10784526|FG001|Overall Study|Death|3
6787063|NCT02318277|10784527|FG002|Overall Study|Death|1
6787064|NCT02318277|10784528|FG003|Overall Study|Death|4
6787065|NCT02318277|10784529|FG004|Overall Study|Death|6
6787066|NCT02318277|10784530|FG005|Overall Study|Death|5
6787067|NCT02318277|10784531|FG006|Overall Study|Death|34
6787068|NCT02318277|10784532|FG007|Overall Study|Death|58
6787069|NCT02318277|10784525|FG000|Overall Study|Transitioned to Hospice|0
6787070|NCT02318277|10784526|FG001|Overall Study|Transitioned to Hospice|0
6787071|NCT02318277|10784527|FG002|Overall Study|Transitioned to Hospice|0
6787072|NCT02318277|10784528|FG003|Overall Study|Transitioned to Hospice|0
6787073|NCT02318277|10784529|FG004|Overall Study|Transitioned to Hospice|0
6787074|NCT02318277|10784530|FG005|Overall Study|Transitioned to Hospice|1
6787075|NCT02318277|10784531|FG006|Overall Study|Transitioned to Hospice|0
6787076|NCT02318277|10784532|FG007|Overall Study|Transitioned to Hospice|0
6787077|NCT02143063|10784588|FG000|Overall Study|Lost to Follow-up|16
6787078|NCT02143063|10784589|FG001|Overall Study|Lost to Follow-up|28
6787079|NCT02143063|10784590|FG002|Overall Study|Lost to Follow-up|29
6787080|NCT02143063|10784588|FG000|Overall Study|Withdrawal by Subject|0
6787081|NCT02143063|10784589|FG001|Overall Study|Withdrawal by Subject|1
6787082|NCT02143063|10784590|FG002|Overall Study|Withdrawal by Subject|0
6787083|NCT02143063|10784588|FG000|Overall Study|Death|0
6787084|NCT02143063|10784589|FG001|Overall Study|Death|1
6787085|NCT02143063|10784590|FG002|Overall Study|Death|1
6787086|NCT02017964|10784598|FG000|Overall Study|Patient deemed ineligible|1
6787087|NCT01968785|10784604|FG000|Overall Study|Withdrawal by Subject|1
6787088|NCT01968785|10784605|FG001|Overall Study|Withdrawal by Subject|0
6787089|NCT01956110|10784613|FG000|Overall Study|Protocol Violation|25
6787090|NCT01956110|10784614|FG001|Overall Study|Protocol Violation|11
6787091|NCT01956110|10784613|FG000|Overall Study|Adverse Event|9
6787092|NCT01956110|10784614|FG001|Overall Study|Adverse Event|10
6787093|NCT01956110|10784613|FG000|Overall Study|Personal reasons|1
6787094|NCT01956110|10784614|FG001|Overall Study|Personal reasons|1
6787095|NCT01648023|10784623|FG000|Overall Study|Screen Fail Post Randomization|1
6787096|NCT01648023|10784624|FG001|Overall Study|Screen Fail Post Randomization|2
6787097|NCT01083433|10784647|FG000|Overall Study|Lost to Follow-up|2
6787098|NCT01083433|10784648|FG001|Overall Study|Lost to Follow-up|1
6787099|NCT01083433|10784649|FG002|Overall Study|Lost to Follow-up|1
6787100|NCT01083433|10784647|FG000|Overall Study|Withdrawal by Subject|0
6787101|NCT01083433|10784648|FG001|Overall Study|Withdrawal by Subject|5
6787102|NCT01083433|10784649|FG002|Overall Study|Withdrawal by Subject|3
6787103|NCT01083433|10784647|FG000|Overall Study|Pregnancy|0
6787104|NCT01083433|10784648|FG001|Overall Study|Pregnancy|0
6787105|NCT01083433|10784649|FG002|Overall Study|Pregnancy|1
6787106|NCT00787176|10784665|FG000|Overall Study|Low quality fetal heart rate tracing|7
6787107|NCT00787176|10784666|FG001|Overall Study|Low quality fetal heart rate tracing|3
6787108|NCT00787176|10784667|FG002|Overall Study|Low quality fetal heart rate tracing|6
6787109|NCT00787176|10784668|FG003|Overall Study|Low quality fetal heart rate tracing|5
6807324|NCT04401579|10811012|FG001|Overall Study|Withdrawal by Subject|16
6807325|NCT04401579|10811011|FG000|Overall Study|Physician Decision|1
6807326|NCT04401579|10811012|FG001|Overall Study|Physician Decision|2
6807327|NCT04401579|10811011|FG000|Overall Study|Became ineligible after enrollment|1
6807328|NCT04401579|10811012|FG001|Overall Study|Became ineligible after enrollment|1
6807329|NCT04401579|10811011|FG000|Overall Study|Enrolled but treatment not administered|7
6787110|NCT00352534|10784681|FG000|Initial Staging|Ineligible|8
6787111|NCT00352534|10784682|FG001|Initial Staging|Ineligible|9
6787112|NCT00352534|10784683|FG002|Initial Staging|Ineligible|0
6787113|NCT00352534|10784684|FG003|Initial Staging|Ineligible|0
6787114|NCT00352534|10784685|FG004|Initial Staging|Ineligible|0
6787115|NCT00352534|10784686|FG005|Initial Staging|Ineligible|0
6787116|NCT00352534|10784687|FG006|Initial Staging|Ineligible|0
6787117|NCT00352534|10784681|FG000|Final Risk Group Assignment|Lack of Efficacy|0
6787118|NCT00352534|10784682|FG001|Final Risk Group Assignment|Lack of Efficacy|0
6787119|NCT00352534|10784683|FG002|Final Risk Group Assignment|Lack of Efficacy|0
6787120|NCT00352534|10784684|FG003|Final Risk Group Assignment|Lack of Efficacy|2
6787121|NCT00352534|10784685|FG004|Final Risk Group Assignment|Lack of Efficacy|1
6787122|NCT00352534|10784686|FG005|Final Risk Group Assignment|Lack of Efficacy|19
6787123|NCT00352534|10784687|FG006|Final Risk Group Assignment|Lack of Efficacy|0
6787124|NCT00352534|10784681|FG000|Final Risk Group Assignment|Physician Decision|0
6787125|NCT00352534|10784682|FG001|Final Risk Group Assignment|Physician Decision|0
6787126|NCT00352534|10784683|FG002|Final Risk Group Assignment|Physician Decision|0
6787127|NCT00352534|10784684|FG003|Final Risk Group Assignment|Physician Decision|0
6787128|NCT00352534|10784685|FG004|Final Risk Group Assignment|Physician Decision|0
6787129|NCT00352534|10784686|FG005|Final Risk Group Assignment|Physician Decision|8
6787130|NCT00352534|10784687|FG006|Final Risk Group Assignment|Physician Decision|0
6787131|NCT00352534|10784681|FG000|Final Risk Group Assignment|Withdrawal by Subject|0
6787132|NCT00352534|10784682|FG001|Final Risk Group Assignment|Withdrawal by Subject|0
6787133|NCT00352534|10784683|FG002|Final Risk Group Assignment|Withdrawal by Subject|0
6787134|NCT00352534|10784684|FG003|Final Risk Group Assignment|Withdrawal by Subject|0
6787135|NCT00352534|10784685|FG004|Final Risk Group Assignment|Withdrawal by Subject|0
6787136|NCT00352534|10784686|FG005|Final Risk Group Assignment|Withdrawal by Subject|3
6787137|NCT00352534|10784687|FG006|Final Risk Group Assignment|Withdrawal by Subject|0
6787138|NCT00352534|10784681|FG000|Final Risk Group Assignment|Ineligible|0
6787139|NCT00352534|10784682|FG001|Final Risk Group Assignment|Ineligible|0
6787140|NCT00352534|10784683|FG002|Final Risk Group Assignment|Ineligible|3
6787141|NCT00352534|10784684|FG003|Final Risk Group Assignment|Ineligible|1
6787142|NCT00352534|10784685|FG004|Final Risk Group Assignment|Ineligible|0
6787143|NCT00352534|10784686|FG005|Final Risk Group Assignment|Ineligible|13
6787144|NCT00352534|10784687|FG006|Final Risk Group Assignment|Ineligible|0
6787145|NCT00352534|10784681|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0
6787146|NCT00352534|10784682|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0
6787147|NCT00352534|10784683|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0
6787148|NCT00352534|10784684|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0
6787149|NCT00352534|10784685|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0
6787150|NCT00352534|10784686|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0
6787151|NCT00352534|10784687|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28
6787152|NCT00352534|10784681|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
6787153|NCT00352534|10784682|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
6787154|NCT00352534|10784683|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
6787155|NCT00352534|10784684|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
6787156|NCT00352534|10784685|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
6787157|NCT00352534|10784686|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
6787158|NCT00352534|10784687|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11
6787159|NCT00352534|10784681|FG000|Final Risk Group Assignment|Death|0
6787160|NCT00352534|10784682|FG001|Final Risk Group Assignment|Death|0
6787161|NCT00352534|10784683|FG002|Final Risk Group Assignment|Death|0
6787162|NCT00352534|10784684|FG003|Final Risk Group Assignment|Death|0
6787163|NCT00352534|10784685|FG004|Final Risk Group Assignment|Death|0
6787164|NCT00352534|10784686|FG005|Final Risk Group Assignment|Death|2
6787165|NCT00352534|10784687|FG006|Final Risk Group Assignment|Death|0
6787166|NCT00033293|10784699|FG000|Overall Study|Death|0
6787167|NCT00033293|10784700|FG001|Overall Study|Death|1
6787168|NCT00033293|10784699|FG000|Overall Study|Lack of Efficacy|5
6787169|NCT00033293|10784700|FG001|Overall Study|Lack of Efficacy|8
6787170|NCT00033293|10784699|FG000|Overall Study|Lost to Follow-up|0
6787171|NCT00033293|10784700|FG001|Overall Study|Lost to Follow-up|1
6787172|NCT00033293|10784699|FG000|Overall Study|Physician Decision|3
6787173|NCT00033293|10784700|FG001|Overall Study|Physician Decision|1
6787174|NCT00033293|10784699|FG000|Overall Study|Withdrawal by Subject|1
6787175|NCT00033293|10784700|FG001|Overall Study|Withdrawal by Subject|0
6787176|NCT00033293|10784699|FG000|Overall Study|Could not be weaned from steroid therapy|1
6787177|NCT00033293|10784700|FG001|Overall Study|Could not be weaned from steroid therapy|1
6787178|NCT00033293|10784699|FG000|Overall Study|Treatment refused|0
6787179|NCT00033293|10784700|FG001|Overall Study|Treatment refused|6
6787180|NCT04497415|10784710|FG000|Overall Study|Lost to Follow-up|43
6787181|NCT04497415|10784711|FG001|Overall Study|Lost to Follow-up|27
6787182|NCT04594759|10784752|FG000|Overall Study|Lost to Follow-up|3
6787183|NCT04463069|10784758|FG000|Overall Study|Withdrawal by Subject|2
6787184|NCT04463069|10784759|FG001|Overall Study|Withdrawal by Subject|10
6787185|NCT04463069|10784758|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0
6787186|NCT04463069|10784759|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13
6787187|NCT04250337|10784767|FG000|Overall Study|Adverse Event|0
6787188|NCT04250337|10784768|FG001|Overall Study|Adverse Event|3
6787189|NCT04250337|10784767|FG000|Overall Study|Lack of Efficacy|1
6787190|NCT04250337|10784768|FG001|Overall Study|Lack of Efficacy|3
6787191|NCT04250337|10784767|FG000|Overall Study|Physician Decision|1
6787192|NCT04250337|10784768|FG001|Overall Study|Physician Decision|0
6787193|NCT04250337|10784767|FG000|Overall Study|Protocol Deviation|2
6787194|NCT04250337|10784768|FG001|Overall Study|Protocol Deviation|2
6787195|NCT04250337|10784767|FG000|Overall Study|Withdrawal by Subject|4
6787196|NCT04250337|10784768|FG001|Overall Study|Withdrawal by Subject|3
6787197|NCT04126733|10784775|FG000|Treatment Period|Other Reason|1
6787198|NCT04126733|10784775|FG000|Treatment Period|Death|1
6787199|NCT04126733|10784775|FG000|Treatment Period|Physician Decision|3
6787200|NCT04126733|10784775|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7
6787201|NCT04126733|10784775|FG000|Treatment Period|Adverse Event|7
6787202|NCT04126733|10784775|FG000|Treatment Period|Progressive Disease - Radiological Progression|44
6787203|NCT04126733|10784775|FG000|Treatment Period|Ongoing with Study Treatment|7
6787204|NCT04126733|10784775|FG000|Active Follow-up Period|Death|13
6787205|NCT04126733|10784775|FG000|Active Follow-up Period|Other Reason|1
6787206|NCT04126733|10784775|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4
6787207|NCT04126733|10784775|FG000|Active Follow-up Period|Withdrawal by Subject|2
6787208|NCT04126733|10784775|FG000|Long-term Follow-up Period|Withdrawal by Subject|1
6787209|NCT04126733|10784775|FG000|Long-term Follow-up Period|Death|5
6807330|NCT04401579|10811012|FG001|Overall Study|Enrolled but treatment not administered|9
6807331|NCT04401579|10811011|FG000|Overall Study|Adverse Event|2
6807332|NCT04401579|10811012|FG001|Overall Study|Adverse Event|1
6807333|NCT04401579|10811011|FG000|Overall Study|Scheduling error|1
6807334|NCT04401579|10811012|FG001|Overall Study|Scheduling error|2
6807335|NCT04401579|10811011|FG000|Overall Study|Transferred to another hospital|1
6807336|NCT04401579|10811012|FG001|Overall Study|Transferred to another hospital|2
6807337|NCT04321460|10811020|FG000|Overall Study|Participants who had no defecation or no data about it|1
6807338|NCT04321460|10811021|FG001|Overall Study|Participants who had no defecation or no data about it|1
6807339|NCT04280705|10811029|FG000|Overall Study|Enrolled but not treated|4
6807340|NCT04280705|10811030|FG001|Overall Study|Enrolled but not treated|10
6807341|NCT04280705|10811029|FG000|Overall Study|Physician Decision|1
6807342|NCT04280705|10811030|FG001|Overall Study|Physician Decision|0
6807343|NCT04280705|10811029|FG000|Overall Study|Withdrawal by Subject|7
6807344|NCT04280705|10811030|FG001|Overall Study|Withdrawal by Subject|9
6807345|NCT04280705|10811029|FG000|Overall Study|Adverse Event|0
6807346|NCT04280705|10811030|FG001|Overall Study|Adverse Event|4
6807347|NCT04280705|10811029|FG000|Overall Study|Transferred to another hospital|1
6807348|NCT04280705|10811030|FG001|Overall Study|Transferred to another hospital|1
6810713|NCT02675231|10814644|FG001|Overall Study|On study treatment/follow up|31
6810714|NCT02675231|10814645|FG002|Overall Study|On study treatment/follow up|23
6810715|NCT02605967|10814665|FG000|Overall Study|subject / guardian decision|1
6810716|NCT02605967|10814666|FG001|Overall Study|subject / guardian decision|2
6810717|NCT02605967|10814665|FG000|Overall Study|Physician Decision|10
6810718|NCT02605967|10814666|FG001|Overall Study|Physician Decision|1
6810719|NCT02605967|10814665|FG000|Overall Study|Death|4
6810720|NCT02605967|10814666|FG001|Overall Study|Death|2
6810721|NCT02605967|10814665|FG000|Overall Study|Adverse Event|1
6810722|NCT02605967|10814666|FG001|Overall Study|Adverse Event|0
6810723|NCT02605967|10814665|FG000|Overall Study|progressive disease|66
6810724|NCT02605967|10814666|FG001|Overall Study|progressive disease|35
6810725|NCT02584634|10814678|FG000|Overall Study|Adverse Event|3
6810726|NCT02584634|10814679|FG001|Overall Study|Adverse Event|3
6810727|NCT02584634|10814678|FG000|Overall Study|Death|0
6810728|NCT02584634|10814679|FG001|Overall Study|Death|1
6810729|NCT02584634|10814678|FG000|Overall Study|Lost to Follow-up|0
6810730|NCT02584634|10814679|FG001|Overall Study|Lost to Follow-up|1
6810731|NCT02584634|10814678|FG000|Overall Study|Physician Decision|1
6810732|NCT02584634|10814679|FG001|Overall Study|Physician Decision|1
6810733|NCT02584634|10814678|FG000|Overall Study|Progressive disease|7
6810734|NCT02584634|10814679|FG001|Overall Study|Progressive disease|14
6810735|NCT02584634|10814678|FG000|Overall Study|Withdrawal by Subject|1
6810736|NCT02584634|10814679|FG001|Overall Study|Withdrawal by Subject|1
6810737|NCT02584634|10814678|FG000|Overall Study|Other|0
6810738|NCT02584634|10814679|FG001|Overall Study|Other|2
6810739|NCT02584634|10814678|FG000|Overall Study|Ongoing|0
6810740|NCT02584634|10814679|FG001|Overall Study|Ongoing|8
6810741|NCT02553265|10814701|FG000|Enrollment|Death|0
6810742|NCT02553265|10814702|FG001|Enrollment|Death|0
6810743|NCT02553265|10814703|FG002|Enrollment|Death|1
6810744|NCT02553265|10814701|FG000|First Intervention (28 Days)|Adverse Event|1
6810745|NCT02553265|10814702|FG001|First Intervention (28 Days)|Adverse Event|0
6810746|NCT02553265|10814703|FG002|First Intervention (28 Days)|Adverse Event|0
6810747|NCT02553265|10814701|FG000|First Intervention (28 Days)|Withdrawal by Subject|0
6810748|NCT02553265|10814702|FG001|First Intervention (28 Days)|Withdrawal by Subject|0
6810749|NCT02553265|10814703|FG002|First Intervention (28 Days)|Withdrawal by Subject|1
6810750|NCT02553265|10814701|FG000|Second Intervention (28 Days)|Adverse Event|1
6810751|NCT02553265|10814702|FG001|Second Intervention (28 Days)|Adverse Event|0
6810752|NCT02553265|10814703|FG002|Second Intervention (28 Days)|Adverse Event|0
6810753|NCT02553265|10814701|FG000|Third Intervention (28 Days)|Adverse Event|1
6787210|NCT03662659|10784792|FG000|Pre-treatment|Participant no longer met study criteria|1
6787211|NCT03662659|10784793|FG001|Pre-treatment|Participant no longer met study criteria|1
6787212|NCT03662659|10784792|FG000|Pre-treatment|Other reasons|1
6787213|NCT03662659|10784793|FG001|Pre-treatment|Other reasons|0
6787214|NCT03662659|10784792|FG000|Treatment|Completed Treatment|0
6787215|NCT03662659|10784793|FG001|Treatment|Completed Treatment|3
6787216|NCT03662659|10784792|FG000|Treatment|Disease Progression|69
6787217|NCT03662659|10784793|FG001|Treatment|Disease Progression|78
6787218|NCT03662659|10784792|FG000|Treatment|Study Drug Toxicity|18
6787219|NCT03662659|10784793|FG001|Treatment|Study Drug Toxicity|8
6787220|NCT03662659|10784792|FG000|Treatment|Death|12
6787221|NCT03662659|10784793|FG001|Treatment|Death|7
6787222|NCT03662659|10784792|FG000|Treatment|Adverse Event unrelated to Study Drug|7
6787223|NCT03662659|10784793|FG001|Treatment|Adverse Event unrelated to Study Drug|4
6787224|NCT03662659|10784792|FG000|Treatment|Withdrawal by Subject|1
6787225|NCT03662659|10784793|FG001|Treatment|Withdrawal by Subject|1
6787226|NCT03662659|10784792|FG000|Treatment|Poor/Non-compliance|1
6787227|NCT03662659|10784793|FG001|Treatment|Poor/Non-compliance|0
6787228|NCT03662659|10784792|FG000|Treatment|Participant no longer meets study criteria|1
6787229|NCT03662659|10784793|FG001|Treatment|Participant no longer meets study criteria|0
6787230|NCT03662659|10784792|FG000|Treatment|Other reasons|6
6787231|NCT03662659|10784793|FG001|Treatment|Other reasons|5
6787232|NCT03575572|10784805|FG000|Overall Study|Withdrawal by Subject|2
6787233|NCT03575572|10784805|FG000|Overall Study|Physician Decision|2
6787234|NCT03521687|10784818|FG000|Overall Study|Adverse Event|4
6787235|NCT03521687|10784818|FG000|Overall Study|Physician Decision|1
6787236|NCT03511664|10784824|FG000|Overall Study|Treatment ongoing|49
6787237|NCT03511664|10784825|FG001|Overall Study|Treatment ongoing|5
6787238|NCT03511664|10784824|FG000|Overall Study|Entered long-term follow-up|140
6787239|NCT03511664|10784825|FG001|Overall Study|Entered long-term follow-up|50
6787240|NCT03511664|10784824|FG000|Overall Study|Withdrawal by Subject|29
6787241|NCT03511664|10784825|FG001|Overall Study|Withdrawal by Subject|53
6787242|NCT03511664|10784824|FG000|Overall Study|Lost to Follow-up|4
6787243|NCT03511664|10784825|FG001|Overall Study|Lost to Follow-up|4
6787244|NCT03511664|10784824|FG000|Overall Study|Physician Decision|0
6787245|NCT03511664|10784825|FG001|Overall Study|Physician Decision|1
6787246|NCT03461289|10784831|FG000|Overall Study|Death|1
6787247|NCT03406507|10784837|FG000|Extension Period|Lack of Efficacy|0
6787248|NCT03406507|10784838|FG001|Extension Period|Lack of Efficacy|1
6787249|NCT03406507|10784837|FG000|Extension Period|Ongoing in Extension Period|5
6787250|NCT03406507|10784838|FG001|Extension Period|Ongoing in Extension Period|5
6787251|NCT02966301|10784862|FG000|Overall Study|Death|2
6787252|NCT02966301|10784862|FG000|Overall Study|Withdrawal by Subject|1
6787253|NCT02941926|10784866|FG000|Overall Study|Progressive disease|1109
6787254|NCT02941926|10784866|FG000|Overall Study|Adverse Event|504
6787255|NCT02941926|10784866|FG000|Overall Study|Subject/guardian decision|127
6787256|NCT02941926|10784866|FG000|Overall Study|Physician Decision|112
6787257|NCT02941926|10784866|FG000|Overall Study|Death|46
6787258|NCT02941926|10784866|FG000|Overall Study|Protocol deviation|34
6787259|NCT02941926|10784866|FG000|Overall Study|Lost to Follow-up|8
6787260|NCT02941926|10784866|FG000|Overall Study|Technical problems|5
6787261|NCT02832167|10784881|FG000|Treatment Period 1|Disease progression|90
6787262|NCT02832167|10784881|FG000|Treatment Period 1|Adverse event unrelated to study drug|12
6787263|NCT02832167|10784881|FG000|Treatment Period 1|Death|2
6787264|NCT02832167|10784881|FG000|Treatment Period 1|Study Drug Toxicity|6
6787265|NCT02832167|10784881|FG000|Treatment Period 1|Participant request to discontinue|9
6787266|NCT02832167|10784881|FG000|Treatment Period 1|No longer meet study criteria|1
6787267|NCT02832167|10784881|FG000|Treatment Period 1|Participant withdrew consent|3
6787268|NCT02832167|10784881|FG000|Treatment Period 1|Other reasons|6
6787269|NCT02832167|10784881|FG000|Transition From Period 1 to Period 2|Other reasons|1
6787270|NCT02832167|10784881|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1
6787271|NCT02832167|10784881|FG000|Transition From Period 1 to Period 2|Death|2
6787272|NCT02832167|10784881|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3
6787273|NCT02832167|10784881|FG000|Treatment Period 2|Disease progression|69
6787274|NCT02832167|10784881|FG000|Treatment Period 2|Adverse event unrelated to study drug|1
6787275|NCT02832167|10784881|FG000|Treatment Period 2|Maximum clinical benefit|1
6787276|NCT02832167|10784881|FG000|Treatment Period 2|Study Drug Toxicity|5
6787277|NCT02832167|10784881|FG000|Treatment Period 2|Participant request to discontinue|2
6787278|NCT02832167|10784881|FG000|Treatment Period 2|Participant withdrew consent|3
6787279|NCT02832167|10784881|FG000|Treatment Period 2|Other reasons|3
6787280|NCT02699554|10784885|FG000|Overall Study|Lost to Follow-up|9
6787281|NCT02659020|10784896|FG000|Overall Study|Adverse Event|0
6787282|NCT02659020|10784897|FG001|Overall Study|Adverse Event|0
6787283|NCT02659020|10784898|FG002|Overall Study|Adverse Event|0
6787284|NCT02659020|10784899|FG003|Overall Study|Adverse Event|2
6787285|NCT02659020|10784900|FG004|Overall Study|Adverse Event|0
6787286|NCT02659020|10784901|FG005|Overall Study|Adverse Event|0
6787287|NCT02659020|10784902|FG006|Overall Study|Adverse Event|2
6787288|NCT02659020|10784896|FG000|Overall Study|Lost to Follow-up|1
6787289|NCT02659020|10784897|FG001|Overall Study|Lost to Follow-up|2
6787290|NCT02659020|10784898|FG002|Overall Study|Lost to Follow-up|1
6787291|NCT02659020|10784899|FG003|Overall Study|Lost to Follow-up|6
6787292|NCT02659020|10784900|FG004|Overall Study|Lost to Follow-up|1
6787293|NCT02659020|10784901|FG005|Overall Study|Lost to Follow-up|5
6787294|NCT02659020|10784902|FG006|Overall Study|Lost to Follow-up|0
6787295|NCT02659020|10784896|FG000|Overall Study|Physician Decision|0
6787296|NCT02659020|10784897|FG001|Overall Study|Physician Decision|0
6787297|NCT02659020|10784898|FG002|Overall Study|Physician Decision|0
6787298|NCT02659020|10784899|FG003|Overall Study|Physician Decision|1
6787299|NCT02659020|10784900|FG004|Overall Study|Physician Decision|1
6787300|NCT02659020|10784901|FG005|Overall Study|Physician Decision|0
6787301|NCT02659020|10784902|FG006|Overall Study|Physician Decision|1
6787302|NCT02659020|10784896|FG000|Overall Study|Withdrawal by Subject|2
6787303|NCT02659020|10784897|FG001|Overall Study|Withdrawal by Subject|1
6787304|NCT02659020|10784898|FG002|Overall Study|Withdrawal by Subject|0
6787305|NCT02659020|10784899|FG003|Overall Study|Withdrawal by Subject|3
6787306|NCT02659020|10784900|FG004|Overall Study|Withdrawal by Subject|3
6787307|NCT02659020|10784901|FG005|Overall Study|Withdrawal by Subject|6
6787308|NCT02659020|10784902|FG006|Overall Study|Withdrawal by Subject|3
6787309|NCT02659020|10784896|FG000|Overall Study|Progressive Disease|0
6787310|NCT02659020|10784897|FG001|Overall Study|Progressive Disease|0
6787311|NCT02659020|10784898|FG002|Overall Study|Progressive Disease|0
6787312|NCT02659020|10784899|FG003|Overall Study|Progressive Disease|4
6787313|NCT02659020|10784900|FG004|Overall Study|Progressive Disease|1
6787314|NCT02659020|10784901|FG005|Overall Study|Progressive Disease|0
6787315|NCT02659020|10784902|FG006|Overall Study|Progressive Disease|2
6787316|NCT02626949|10784927|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15
6787317|NCT02626949|10784928|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11
6787318|NCT02626949|10784927|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1
6787319|NCT02626949|10784928|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3
6787320|NCT02626949|10784927|FG000|Enrolled|Lost to Follow-up|7
6787321|NCT02626949|10784928|FG001|Enrolled|Lost to Follow-up|6
6787322|NCT02626949|10784927|FG000|Enrolled|Withdrawal by Subject|3
6787323|NCT02626949|10784928|FG001|Enrolled|Withdrawal by Subject|2
6787324|NCT02565914|10784943|FG000|Overall Study|Adverse Event|17
7139385|NCT02958267|11293051|FG000|Follow-up Visits|Additional treatment pursued|2
7139386|NCT02958267|11293052|FG001|Follow-up Visits|Additional treatment pursued|1
7139387|NCT02958527|11293067|FG000|Overall Study|Not collected CRFs|12
7139388|NCT02958553|11293080|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1
7139389|NCT02958553|11293080|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2
7139390|NCT02959138|11293180|FG000|Overall Study|Enrolled but Never Treated|0
7139391|NCT02959138|11293181|FG001|Overall Study|Enrolled but Never Treated|1
7139392|NCT02959138|11293182|FG002|Overall Study|Enrolled but Never Treated|0
7139393|NCT02959177|11293197|FG000|Double-Blind Treatment Phase|Adverse Event|5
7139394|NCT02959177|11293198|FG001|Double-Blind Treatment Phase|Adverse Event|2
7139395|NCT02959177|11293199|FG002|Double-Blind Treatment Phase|Adverse Event|0
7139396|NCT02959177|11293197|FG000|Double-Blind Treatment Phase|Physician Decision|1
7139397|NCT02959177|11293198|FG001|Double-Blind Treatment Phase|Physician Decision|0
7139398|NCT02959177|11293199|FG002|Double-Blind Treatment Phase|Physician Decision|0
7139399|NCT02959177|11293197|FG000|Double-Blind Treatment Phase|Protocol Violation|0
7139400|NCT02959177|11293198|FG001|Double-Blind Treatment Phase|Protocol Violation|1
7139401|NCT02959177|11293199|FG002|Double-Blind Treatment Phase|Protocol Violation|0
7139402|NCT02959177|11293197|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5
7139403|NCT02959177|11293198|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0
7139404|NCT02959177|11293199|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5
7139405|NCT02959177|11293197|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1
7139406|NCT02959177|11293198|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0
7139407|NCT02959177|11293199|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0
7139408|NCT02959177|11293197|FG000|Follow-up Post Treatment Phase|Adverse Event|0
7139409|NCT02959177|11293198|FG001|Follow-up Post Treatment Phase|Adverse Event|1
7139410|NCT02959177|11293199|FG002|Follow-up Post Treatment Phase|Adverse Event|0
7139411|NCT02959177|11293197|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0
7139412|NCT02959177|11293198|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0
7139413|NCT02959177|11293199|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2
7139414|NCT02959190|11293217|FG000|Open Label|Adverse Event|5
7139415|NCT02959190|11293218|FG001|Open Label|Adverse Event|7
7139416|NCT02959190|11293219|FG002|Open Label|Adverse Event|3
7139417|NCT02959190|11293220|FG003|Open Label|Adverse Event|4
7139418|NCT02959190|11293217|FG000|Open Label|Pregnancy|0
7139419|NCT02959190|11293218|FG001|Open Label|Pregnancy|1
7139420|NCT02959190|11293219|FG002|Open Label|Pregnancy|0
7139421|NCT02959190|11293220|FG003|Open Label|Pregnancy|0
7139422|NCT02959190|11293217|FG000|Open Label|Withdrawal by Subject|2
7139423|NCT02959190|11293218|FG001|Open Label|Withdrawal by Subject|8
7139424|NCT02959190|11293219|FG002|Open Label|Withdrawal by Subject|0
7139425|NCT02959190|11293220|FG003|Open Label|Withdrawal by Subject|0
7139426|NCT02959190|11293217|FG000|Open Label|Physician Decision|0
7139427|NCT02959190|11293218|FG001|Open Label|Physician Decision|0
7139428|NCT02959190|11293219|FG002|Open Label|Physician Decision|1
7139429|NCT02959190|11293220|FG003|Open Label|Physician Decision|0
7139430|NCT02959190|11293217|FG000|Open Label|Protocol Violation|0
7139431|NCT02959190|11293218|FG001|Open Label|Protocol Violation|0
7139432|NCT02959190|11293219|FG002|Open Label|Protocol Violation|0
7139433|NCT02959190|11293220|FG003|Open Label|Protocol Violation|2
7139434|NCT02959190|11293217|FG000|Post Treatment Follow Up|Adverse Event|1
6787325|NCT02565914|10784943|FG000|Overall Study|Withdrawal of consent (not due to AE)|25
6787326|NCT02565914|10784943|FG000|Overall Study|Lost to Follow-up|12
6787327|NCT02565914|10784943|FG000|Overall Study|Death (not treatment emergent)|1
6787328|NCT02565914|10784943|FG000|Overall Study|Other noncompliance|6
6787329|NCT02565914|10784943|FG000|Overall Study|Physician Decision|6
6787330|NCT02565914|10784943|FG000|Overall Study|Parent study termination by sponsor|1
6787331|NCT02565914|10784943|FG000|Overall Study|Commercial drug available|5
6787332|NCT02565914|10784943|FG000|Overall Study|Other|18
6787333|NCT02565914|10784943|FG000|Overall Study|Enrolled, but did not receive study drug|2
6787348|NCT02385045|10784964|FG000|Overall Study|Endoscopy could not be completed|4
6787349|NCT01845649|10784979|FG000|Overall Study|Adverse Event|7
6787350|NCT01845649|10784980|FG001|Overall Study|Adverse Event|10
6787351|NCT01845649|10784979|FG000|Overall Study|Lack of Efficacy|1
6787352|NCT01845649|10784980|FG001|Overall Study|Lack of Efficacy|1
6787353|NCT01845649|10784979|FG000|Overall Study|Lost to Follow-up|2
6787354|NCT01845649|10784980|FG001|Overall Study|Lost to Follow-up|2
6787355|NCT01845649|10784979|FG000|Overall Study|Withdrew Consent|12
6787356|NCT01845649|10784980|FG001|Overall Study|Withdrew Consent|4
6787357|NCT01845649|10784979|FG000|Overall Study|Protocol Deviation|7
6787358|NCT01845649|10784980|FG001|Overall Study|Protocol Deviation|4
6787359|NCT01845649|10784979|FG000|Overall Study|Reason not Specified|2
6787360|NCT01845649|10784980|FG001|Overall Study|Reason not Specified|1
6787361|NCT01844986|10784988|FG000|Overall Study|Severe non-compliance to protocol|1
6787362|NCT01844986|10784989|FG001|Overall Study|Severe non-compliance to protocol|0
6787363|NCT01844986|10784988|FG000|Overall Study|Withdrawal by Subject|21
6787364|NCT01844986|10784989|FG001|Overall Study|Withdrawal by Subject|14
6787365|NCT01844986|10784988|FG000|Overall Study|Death|55
6787366|NCT01844986|10784989|FG001|Overall Study|Death|26
6787367|NCT01816139|10784997|FG000|Overall Study|Adverse Event|6
6787368|NCT01816139|10784998|FG001|Overall Study|Adverse Event|8
6787369|NCT01816139|10784997|FG000|Overall Study|Lack of Efficacy|1
6787370|NCT01816139|10784998|FG001|Overall Study|Lack of Efficacy|2
6787371|NCT01816139|10784997|FG000|Overall Study|Lost to Follow-up|5
6787372|NCT01816139|10784998|FG001|Overall Study|Lost to Follow-up|3
6787373|NCT01816139|10784997|FG000|Overall Study|Withdrew Consent|6
6787374|NCT01816139|10784998|FG001|Overall Study|Withdrew Consent|4
6787375|NCT01816139|10784997|FG000|Overall Study|Protocol Violation|6
6787376|NCT01816139|10784998|FG001|Overall Study|Protocol Violation|3
6787377|NCT01816139|10784997|FG000|Overall Study|Reason not Specified|4
6787378|NCT01816139|10784998|FG001|Overall Study|Reason not Specified|2
6807349|NCT04208750|10811038|FG000|Overall Study|Lost to Follow-up|16
6807350|NCT04208750|10811039|FG001|Overall Study|Lost to Follow-up|15
6807351|NCT03713281|10811045|FG000|Overall Study|Lens handling difficuluties|2
6807352|NCT03713281|10811045|FG000|Overall Study|Subject was not dispensed enough lenses|1
6807353|NCT03608254|10811049|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2
6807354|NCT03608254|10811049|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1
6810754|NCT02553265|10814702|FG001|Third Intervention (28 Days)|Adverse Event|0
6810755|NCT02553265|10814703|FG002|Third Intervention (28 Days)|Adverse Event|0
6810756|NCT02553265|10814701|FG000|Third Intervention (28 Days)|Lost to Follow-up|0
6810757|NCT02553265|10814702|FG001|Third Intervention (28 Days)|Lost to Follow-up|0
6810758|NCT02553265|10814703|FG002|Third Intervention (28 Days)|Lost to Follow-up|1
6810759|NCT02550288|10814719|FG000|Overall Study|Adverse Event|0
6810760|NCT02550288|10814720|FG001|Overall Study|Adverse Event|1
6810761|NCT02550288|10814721|FG002|Overall Study|Adverse Event|0
6810762|NCT02550288|10814722|FG003|Overall Study|Adverse Event|0
6810763|NCT02550288|10814723|FG004|Overall Study|Adverse Event|0
6810764|NCT02550288|10814719|FG000|Overall Study|Physician Decision|0
6810765|NCT02550288|10814720|FG001|Overall Study|Physician Decision|0
6810766|NCT02550288|10814721|FG002|Overall Study|Physician Decision|0
6810767|NCT02550288|10814722|FG003|Overall Study|Physician Decision|1
6810768|NCT02550288|10814723|FG004|Overall Study|Physician Decision|0
6810769|NCT02550288|10814719|FG000|Overall Study|Protocol Violation|2
6810770|NCT02550288|10814720|FG001|Overall Study|Protocol Violation|2
6810771|NCT02550288|10814721|FG002|Overall Study|Protocol Violation|1
6810772|NCT02550288|10814722|FG003|Overall Study|Protocol Violation|0
7139435|NCT02959190|11293218|FG001|Post Treatment Follow Up|Adverse Event|1
6810773|NCT02550288|10814723|FG004|Overall Study|Protocol Violation|3
6810774|NCT02550288|10814719|FG000|Overall Study|Participant moved|0
6810775|NCT02550288|10814720|FG001|Overall Study|Participant moved|0
6787379|NCT01455597|10785004|FG000|Overall Study|Adverse Event|7
6787380|NCT01455597|10785005|FG001|Overall Study|Adverse Event|0
6787381|NCT01455597|10785006|FG002|Overall Study|Adverse Event|5
6787382|NCT01455597|10785007|FG003|Overall Study|Adverse Event|1
6787383|NCT01455597|10785004|FG000|Overall Study|Lack of Efficacy|0
6787384|NCT01455597|10785005|FG001|Overall Study|Lack of Efficacy|1
6787385|NCT01455597|10785006|FG002|Overall Study|Lack of Efficacy|2
6787386|NCT01455597|10785007|FG003|Overall Study|Lack of Efficacy|0
6787387|NCT01455597|10785004|FG000|Overall Study|Lost to Follow-up|3
6787388|NCT01455597|10785005|FG001|Overall Study|Lost to Follow-up|0
6787389|NCT01455597|10785006|FG002|Overall Study|Lost to Follow-up|2
6787390|NCT01455597|10785007|FG003|Overall Study|Lost to Follow-up|1
6787391|NCT01455597|10785004|FG000|Overall Study|Withdrew Consent|6
6787392|NCT01455597|10785005|FG001|Overall Study|Withdrew Consent|5
6787393|NCT01455597|10785006|FG002|Overall Study|Withdrew Consent|8
6787394|NCT01455597|10785007|FG003|Overall Study|Withdrew Consent|5
6787395|NCT01455597|10785004|FG000|Overall Study|Reason not Specified|1
6787396|NCT01455597|10785005|FG001|Overall Study|Reason not Specified|2
6787397|NCT01455597|10785006|FG002|Overall Study|Reason not Specified|3
6787398|NCT01455597|10785007|FG003|Overall Study|Reason not Specified|3
6787399|NCT01400776|10785023|FG000|Overall Study|Adverse Event|7
6787400|NCT01400776|10785024|FG001|Overall Study|Adverse Event|2
6787401|NCT01400776|10785025|FG002|Overall Study|Adverse Event|9
6787402|NCT01400776|10785026|FG003|Overall Study|Adverse Event|2
6787403|NCT01400776|10785023|FG000|Overall Study|Lost to Follow-up|1
6787404|NCT01400776|10785024|FG001|Overall Study|Lost to Follow-up|0
6787405|NCT01400776|10785025|FG002|Overall Study|Lost to Follow-up|4
6787406|NCT01400776|10785026|FG003|Overall Study|Lost to Follow-up|1
6787407|NCT01400776|10785023|FG000|Overall Study|Withdrew Consent|4
6787408|NCT01400776|10785024|FG001|Overall Study|Withdrew Consent|2
6787409|NCT01400776|10785025|FG002|Overall Study|Withdrew Consent|6
6787410|NCT01400776|10785026|FG003|Overall Study|Withdrew Consent|1
6787411|NCT01400776|10785023|FG000|Overall Study|Protocol Deviation|6
6787412|NCT01400776|10785024|FG001|Overall Study|Protocol Deviation|1
6787413|NCT01400776|10785025|FG002|Overall Study|Protocol Deviation|5
6787414|NCT01400776|10785026|FG003|Overall Study|Protocol Deviation|2
6787415|NCT01400776|10785023|FG000|Overall Study|Reason not Specified|3
6787416|NCT01400776|10785024|FG001|Overall Study|Reason not Specified|0
6787417|NCT01400776|10785025|FG002|Overall Study|Reason not Specified|4
6787418|NCT01400776|10785026|FG003|Overall Study|Reason not Specified|3
6787419|NCT01194570|10785038|FG000|Overall Study|Death|1
6787420|NCT01194570|10785039|FG001|Overall Study|Death|3
6787421|NCT01194570|10785038|FG000|Overall Study|Ongoing at CCOD|162
6787422|NCT01194570|10785039|FG001|Overall Study|Ongoing at CCOD|387
6787423|NCT01194570|10785038|FG000|Overall Study|Physician Decision|2
7139436|NCT02959190|11293219|FG002|Post Treatment Follow Up|Adverse Event|0
7139437|NCT02959190|11293220|FG003|Post Treatment Follow Up|Adverse Event|0
7139438|NCT02959190|11293217|FG000|Post Treatment Follow Up|Withdrawal by Subject|2
7139439|NCT02959190|11293218|FG001|Post Treatment Follow Up|Withdrawal by Subject|0
7139440|NCT02959190|11293219|FG002|Post Treatment Follow Up|Withdrawal by Subject|1
7139441|NCT02959190|11293220|FG003|Post Treatment Follow Up|Withdrawal by Subject|0
7139442|NCT02959437|11293252|FG000|Overall Study|Death|33
7139443|NCT02959437|11293253|FG001|Overall Study|Death|3
7139444|NCT02959437|11293254|FG002|Overall Study|Death|0
7139445|NCT02959437|11293255|FG003|Overall Study|Death|0
7139446|NCT02959437|11293252|FG000|Overall Study|Lost to Follow-up|3
7139447|NCT02959437|11293253|FG001|Overall Study|Lost to Follow-up|1
7139448|NCT02959437|11293254|FG002|Overall Study|Lost to Follow-up|0
7139449|NCT02959437|11293255|FG003|Overall Study|Lost to Follow-up|0
7139450|NCT02959437|11293252|FG000|Overall Study|Withdrawal by Subject|11
7139451|NCT02959437|11293253|FG001|Overall Study|Withdrawal by Subject|3
7139452|NCT02959437|11293254|FG002|Overall Study|Withdrawal by Subject|0
7139453|NCT02959437|11293255|FG003|Overall Study|Withdrawal by Subject|0
7139454|NCT02959437|11293252|FG000|Overall Study|Progressive Disease|9
7139455|NCT02959437|11293253|FG001|Overall Study|Progressive Disease|1
7139456|NCT02959437|11293254|FG002|Overall Study|Progressive Disease|0
7139457|NCT02959437|11293255|FG003|Overall Study|Progressive Disease|0
7139458|NCT02959437|11293252|FG000|Overall Study|Study Terminated by Sponsor|4
7139459|NCT02959437|11293253|FG001|Overall Study|Study Terminated by Sponsor|0
7139460|NCT02959437|11293254|FG002|Overall Study|Study Terminated by Sponsor|0
7139461|NCT02959437|11293255|FG003|Overall Study|Study Terminated by Sponsor|0
7139462|NCT02959437|11293252|FG000|Overall Study|Other Unspecified|2
7139463|NCT02959437|11293253|FG001|Overall Study|Other Unspecified|0
7139464|NCT02959437|11293254|FG002|Overall Study|Other Unspecified|0
7139465|NCT02959437|11293255|FG003|Overall Study|Other Unspecified|0
7139466|NCT02959671|11293266|FG000|Overall Study|Adverse Event|2
7139467|NCT02959671|11293266|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3
7139468|NCT02959814|11293270|FG000|Overall Study|Excluded based on diagnostic angiography|16
6787424|NCT01194570|10785039|FG001|Overall Study|Physician Decision|6
6787425|NCT01194570|10785038|FG000|Overall Study|Reason not specified|13
6787426|NCT01194570|10785039|FG001|Overall Study|Reason not specified|20
6787427|NCT01194570|10785038|FG000|Overall Study|Protocol Violation|0
6787428|NCT01194570|10785039|FG001|Overall Study|Protocol Violation|2
6787429|NCT01194570|10785038|FG000|Overall Study|Non-compliance with study drug|2
6787430|NCT01194570|10785039|FG001|Overall Study|Non-compliance with study drug|2
6787431|NCT01194570|10785038|FG000|Overall Study|Adverse Event|12
6787432|NCT01194570|10785039|FG001|Overall Study|Adverse Event|18
6787433|NCT01194570|10785038|FG000|Overall Study|Non-compliance|2
6787434|NCT01194570|10785039|FG001|Overall Study|Non-compliance|2
6787435|NCT01194570|10785038|FG000|Overall Study|Lack of Efficacy|27
6787436|NCT01194570|10785039|FG001|Overall Study|Lack of Efficacy|21
6787437|NCT01194570|10785038|FG000|Overall Study|Withdrawal by Subject|21
6787438|NCT01194570|10785039|FG001|Overall Study|Withdrawal by Subject|22
6787439|NCT01194570|10785038|FG000|Overall Study|Pregnancy|1
6787440|NCT01194570|10785039|FG001|Overall Study|Pregnancy|1
6787441|NCT01194570|10785038|FG000|Overall Study|Lost to Follow-up|1
6787442|NCT01194570|10785039|FG001|Overall Study|Lost to Follow-up|4
6787443|NCT00511134|10785047|FG000|Overall Study|Withdrawal by Subject|0
6787444|NCT00511134|10785048|FG001|Overall Study|Withdrawal by Subject|2
6787447|NCT03894540|10785080|FG000|Overall Study|Adverse Event|0
6787448|NCT03894540|10785081|FG001|Overall Study|Adverse Event|0
6787449|NCT03894540|10785082|FG002|Overall Study|Adverse Event|0
6787450|NCT03894540|10785083|FG003|Overall Study|Adverse Event|0
6787451|NCT03894540|10785084|FG004|Overall Study|Adverse Event|1
6787452|NCT03894540|10785085|FG005|Overall Study|Adverse Event|0
6787453|NCT03894540|10785080|FG000|Overall Study|Withdrawal by Subject|0
6787454|NCT03894540|10785081|FG001|Overall Study|Withdrawal by Subject|0
6787455|NCT03894540|10785082|FG002|Overall Study|Withdrawal by Subject|0
6787456|NCT03894540|10785083|FG003|Overall Study|Withdrawal by Subject|0
6787457|NCT03894540|10785084|FG004|Overall Study|Withdrawal by Subject|1
6787458|NCT03894540|10785085|FG005|Overall Study|Withdrawal by Subject|0
6787459|NCT03894540|10785080|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0
6787460|NCT03894540|10785081|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0
6787461|NCT03894540|10785082|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1
6787462|NCT03894540|10785083|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3
6787463|NCT03894540|10785084|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2
6787464|NCT03894540|10785085|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3
6787465|NCT03894540|10785080|FG000|Overall Study|Progressive Disease Clinical|1
6787466|NCT03894540|10785081|FG001|Overall Study|Progressive Disease Clinical|1
6787467|NCT03894540|10785082|FG002|Overall Study|Progressive Disease Clinical|0
6787468|NCT03894540|10785083|FG003|Overall Study|Progressive Disease Clinical|1
6787469|NCT03894540|10785084|FG004|Overall Study|Progressive Disease Clinical|5
6787470|NCT03894540|10785085|FG005|Overall Study|Progressive Disease Clinical|1
6787471|NCT03894540|10785080|FG000|Overall Study|Study termination by sponsor|0
6787472|NCT03894540|10785081|FG001|Overall Study|Study termination by sponsor|0
6787473|NCT03894540|10785082|FG002|Overall Study|Study termination by sponsor|0
6787474|NCT03894540|10785083|FG003|Overall Study|Study termination by sponsor|0
6787475|NCT03894540|10785084|FG004|Overall Study|Study termination by sponsor|2
6787476|NCT03894540|10785085|FG005|Overall Study|Study termination by sponsor|0
6787477|NCT03725293|10785109|FG000|Overall Study|Physician Decision|9
6787478|NCT03725293|10785110|FG001|Overall Study|Physician Decision|6
6787479|NCT03725293|10785109|FG000|Overall Study|alternative vascular access needs|1
6787480|NCT03725293|10785110|FG001|Overall Study|alternative vascular access needs|2
6787481|NCT03725293|10785109|FG000|Overall Study|venous anatomy screen failures|2
6787482|NCT03725293|10785110|FG001|Overall Study|venous anatomy screen failures|1
6787483|NCT03702231|10785119|FG000|Overall Study|Withdrawal by Subject|1
6787484|NCT03702231|10785120|FG001|Overall Study|Withdrawal by Subject|0
6787485|NCT03702231|10785121|FG002|Overall Study|Withdrawal by Subject|0
6787486|NCT03702231|10785119|FG000|Overall Study|Protocol Violation|0
6787487|NCT03702231|10785120|FG001|Overall Study|Protocol Violation|0
6787488|NCT03702231|10785121|FG002|Overall Study|Protocol Violation|1
6787489|NCT03702231|10785119|FG000|Overall Study|COVID Pandemic|3
6787490|NCT03702231|10785120|FG001|Overall Study|COVID Pandemic|4
6787491|NCT03702231|10785121|FG002|Overall Study|COVID Pandemic|1
6787492|NCT03556358|10785152|FG000|Overall Study|Subjects Randomized that did not Treat|3
6787493|NCT03556358|10785153|FG001|Overall Study|Subjects Randomized that did not Treat|0
6787494|NCT03556358|10785152|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7
6787495|NCT03556358|10785153|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5
6787496|NCT03556358|10785152|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0
6787497|NCT03556358|10785153|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1
6787498|NCT03556358|10785152|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0
6787499|NCT03556358|10785153|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1
6787500|NCT03556358|10785152|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0
6787501|NCT03556358|10785153|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2
6787502|NCT03556358|10785152|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0
6787503|NCT03556358|10785153|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1
6807355|NCT03512275|10811055|FG000|Overall Study|Withdrawal by Subject|1
6807356|NCT03512275|10811056|FG001|Overall Study|Withdrawal by Subject|3
6807357|NCT03512275|10811055|FG000|Overall Study|Physician Decision|0
6807358|NCT03512275|10811056|FG001|Overall Study|Physician Decision|1
6787504|NCT03556358|10785152|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1
6787505|NCT03556358|10785153|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2
6787506|NCT03290781|10785166|FG000|Overall Study|Adverse Event|5
6787507|NCT03290781|10785167|FG001|Overall Study|Adverse Event|7
6787508|NCT03290781|10785168|FG002|Overall Study|Adverse Event|4
6787509|NCT03290781|10785169|FG003|Overall Study|Adverse Event|1
6787510|NCT03290781|10785170|FG004|Overall Study|Adverse Event|0
6787511|NCT03290781|10785171|FG005|Overall Study|Adverse Event|0
6787512|NCT03290781|10785172|FG006|Overall Study|Adverse Event|0
6787513|NCT03290781|10785166|FG000|Overall Study|Death|0
6787514|NCT03290781|10785167|FG001|Overall Study|Death|0
6787515|NCT03290781|10785168|FG002|Overall Study|Death|1
6787516|NCT03290781|10785169|FG003|Overall Study|Death|0
6787517|NCT03290781|10785170|FG004|Overall Study|Death|1
6787518|NCT03290781|10785171|FG005|Overall Study|Death|0
6787519|NCT03290781|10785172|FG006|Overall Study|Death|0
6787520|NCT03290781|10785166|FG000|Overall Study|Withdrawal by Subject|6
6787521|NCT03290781|10785167|FG001|Overall Study|Withdrawal by Subject|5
6787522|NCT03290781|10785168|FG002|Overall Study|Withdrawal by Subject|9
6787523|NCT03290781|10785169|FG003|Overall Study|Withdrawal by Subject|10
6787524|NCT03290781|10785170|FG004|Overall Study|Withdrawal by Subject|1
6787525|NCT03290781|10785171|FG005|Overall Study|Withdrawal by Subject|2
6787526|NCT03290781|10785172|FG006|Overall Study|Withdrawal by Subject|0
6787527|NCT03290781|10785166|FG000|Overall Study|Physician Decision|0
6787528|NCT03290781|10785167|FG001|Overall Study|Physician Decision|1
6787529|NCT03290781|10785168|FG002|Overall Study|Physician Decision|0
6787530|NCT03290781|10785169|FG003|Overall Study|Physician Decision|0
6787531|NCT03290781|10785170|FG004|Overall Study|Physician Decision|0
6787532|NCT03290781|10785171|FG005|Overall Study|Physician Decision|0
6787533|NCT03290781|10785172|FG006|Overall Study|Physician Decision|0
6787534|NCT03290781|10785166|FG000|Overall Study|Site Terminated by Sponsor|1
6787535|NCT03290781|10785167|FG001|Overall Study|Site Terminated by Sponsor|0
6787536|NCT03290781|10785168|FG002|Overall Study|Site Terminated by Sponsor|2
6787537|NCT03290781|10785169|FG003|Overall Study|Site Terminated by Sponsor|1
6787538|NCT03290781|10785170|FG004|Overall Study|Site Terminated by Sponsor|0
6787539|NCT03290781|10785171|FG005|Overall Study|Site Terminated by Sponsor|0
6787540|NCT03290781|10785172|FG006|Overall Study|Site Terminated by Sponsor|0
6787541|NCT03290781|10785166|FG000|Overall Study|Lost to Follow-up|0
6787542|NCT03290781|10785167|FG001|Overall Study|Lost to Follow-up|0
6787543|NCT03290781|10785168|FG002|Overall Study|Lost to Follow-up|0
6787544|NCT03290781|10785169|FG003|Overall Study|Lost to Follow-up|1
6787545|NCT03290781|10785170|FG004|Overall Study|Lost to Follow-up|0
6787546|NCT03290781|10785171|FG005|Overall Study|Lost to Follow-up|0
6787547|NCT03290781|10785172|FG006|Overall Study|Lost to Follow-up|0
6787548|NCT03290781|10785166|FG000|Overall Study|Protocol Deviation|2
6787549|NCT03290781|10785167|FG001|Overall Study|Protocol Deviation|0
6787550|NCT03290781|10785168|FG002|Overall Study|Protocol Deviation|0
6787551|NCT03290781|10785169|FG003|Overall Study|Protocol Deviation|1
6787552|NCT03290781|10785170|FG004|Overall Study|Protocol Deviation|0
6787553|NCT03290781|10785171|FG005|Overall Study|Protocol Deviation|0
6787554|NCT03290781|10785172|FG006|Overall Study|Protocol Deviation|0
6787555|NCT03290781|10785166|FG000|Overall Study|Disease Relapse|32
6787556|NCT03290781|10785167|FG001|Overall Study|Disease Relapse|5
6787557|NCT03290781|10785168|FG002|Overall Study|Disease Relapse|38
6787558|NCT03290781|10785169|FG003|Overall Study|Disease Relapse|7
6787559|NCT03290781|10785170|FG004|Overall Study|Disease Relapse|3
6787560|NCT03290781|10785171|FG005|Overall Study|Disease Relapse|1
6787561|NCT03290781|10785172|FG006|Overall Study|Disease Relapse|4
6787562|NCT03290781|10785166|FG000|Overall Study|Other|3
6787563|NCT03290781|10785167|FG001|Overall Study|Other|0
6787564|NCT03290781|10785168|FG002|Overall Study|Other|2
6787565|NCT03290781|10785169|FG003|Overall Study|Other|2
6787566|NCT03290781|10785170|FG004|Overall Study|Other|0
6787567|NCT03290781|10785171|FG005|Overall Study|Other|0
6787568|NCT03290781|10785172|FG006|Overall Study|Other|0
6787569|NCT03228680|10785231|FG000|Overall Study|Adverse Event|13
6787570|NCT03228680|10785232|FG001|Overall Study|Adverse Event|18
6787571|NCT03228680|10785231|FG000|Overall Study|Randomization failure|0
6787572|NCT03228680|10785232|FG001|Overall Study|Randomization failure|1
6787573|NCT03228680|10785231|FG000|Overall Study|Withdrawal by Subject|1
6787574|NCT03228680|10785232|FG001|Overall Study|Withdrawal by Subject|0
6787575|NCT03228680|10785231|FG000|Overall Study|Other|9
6787576|NCT03228680|10785232|FG001|Overall Study|Other|16
6807359|NCT03512275|10811055|FG000|Overall Study|Lost to Follow-up|0
6807360|NCT03512275|10811056|FG001|Overall Study|Lost to Follow-up|3
6807361|NCT03512275|10811055|FG000|Overall Study|Other|1
6807362|NCT03512275|10811056|FG001|Overall Study|Other|0
6807363|NCT03414983|10811064|FG000|Pre-Treatment|Other reasons|1
6807364|NCT03414983|10811065|FG001|Pre-Treatment|Other reasons|0
6807365|NCT03414983|10811064|FG000|Pre-Treatment|Participant no longer meets study criteria|2
6807366|NCT03414983|10811065|FG001|Pre-Treatment|Participant no longer meets study criteria|3
6807367|NCT03414983|10811064|FG000|Pre-Treatment|Participant withdrew consent|1
6807368|NCT03414983|10811065|FG001|Pre-Treatment|Participant withdrew consent|3
6807369|NCT03414983|10811064|FG000|Treatment|Participant withdrew consent|4
6807370|NCT03414983|10811065|FG001|Treatment|Participant withdrew consent|3
6807371|NCT03414983|10811064|FG000|Treatment|Participant request to discontinue study treatment|8
6787577|NCT02679781|10785272|FG000|Overall Study|Lost to Follow-up|1
6787578|NCT02679781|10785273|FG001|Overall Study|Lost to Follow-up|2
6787579|NCT02679781|10785272|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6
6787580|NCT02679781|10785273|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1
6787581|NCT02624869|10785282|FG000|Overall Study|Lost to Follow-up|0
6787582|NCT02624869|10785283|FG001|Overall Study|Lost to Follow-up|0
6787583|NCT02624869|10785284|FG002|Overall Study|Lost to Follow-up|1
6787584|NCT02624869|10785282|FG000|Overall Study|Withdrawal by Subject|1
6787585|NCT02624869|10785283|FG001|Overall Study|Withdrawal by Subject|3
6787586|NCT02624869|10785284|FG002|Overall Study|Withdrawal by Subject|1
6787587|NCT02569242|10785308|FG000|Overall Study|Death|1
6787588|NCT02569242|10785309|FG001|Overall Study|Death|0
6787589|NCT02569242|10785308|FG000|Overall Study|Withdrawal by Subject|0
6787590|NCT02569242|10785309|FG001|Overall Study|Withdrawal by Subject|1
6787591|NCT02435433|10785332|FG000|Overall Study|On Treatment|11
6787592|NCT02435433|10785333|FG001|Overall Study|On Treatment|0
6787593|NCT02435433|10785334|FG002|Overall Study|On Treatment|0
6787594|NCT02435433|10785335|FG003|Overall Study|On Treatment|0
6787595|NCT02435433|10785336|FG004|Overall Study|On Treatment|0
6787596|NCT02435433|10785332|FG000|Overall Study|Withdrawal by Subject|2
6787597|NCT02435433|10785333|FG001|Overall Study|Withdrawal by Subject|3
6787598|NCT02435433|10785334|FG002|Overall Study|Withdrawal by Subject|0
6787599|NCT02435433|10785335|FG003|Overall Study|Withdrawal by Subject|0
6787600|NCT02435433|10785336|FG004|Overall Study|Withdrawal by Subject|0
6787601|NCT02435433|10785332|FG000|Overall Study|Lost to Follow-up|2
6787602|NCT02435433|10785333|FG001|Overall Study|Lost to Follow-up|2
6787603|NCT02435433|10785334|FG002|Overall Study|Lost to Follow-up|0
6787604|NCT02435433|10785335|FG003|Overall Study|Lost to Follow-up|0
6787605|NCT02435433|10785336|FG004|Overall Study|Lost to Follow-up|0
6787606|NCT02426125|10785346|FG000|Overall Study|Lost to Follow-up|12
6787607|NCT02426125|10785347|FG001|Overall Study|Lost to Follow-up|10
6787608|NCT02426125|10785346|FG000|Overall Study|Protocol Violation|1
6787609|NCT02426125|10785347|FG001|Overall Study|Protocol Violation|0
6787610|NCT02426125|10785346|FG000|Overall Study|Withdrawal by Subject|16
6787611|NCT02426125|10785347|FG001|Overall Study|Withdrawal by Subject|16
6787612|NCT02368886|10785368|FG000|Overall Study|Cancel|1
6787613|NCT02368886|10785369|FG001|Overall Study|Cancel|1
6787614|NCT02368886|10785370|FG002|Overall Study|Cancel|1
6787615|NCT02368886|10785371|FG003|Overall Study|Cancel|3
6787616|NCT02368886|10785368|FG000|Overall Study|Ineligible|0
6787617|NCT02368886|10785369|FG001|Overall Study|Ineligible|0
6787618|NCT02368886|10785370|FG002|Overall Study|Ineligible|0
6787619|NCT02368886|10785371|FG003|Overall Study|Ineligible|1
6787620|NCT02354703|10785383|FG000|Overall Study|Withdrawal by Subject|1
6787621|NCT02354703|10785384|FG001|Overall Study|Withdrawal by Subject|1
6787622|NCT02354703|10785385|FG002|Overall Study|Withdrawal by Subject|1
7139469|NCT02959814|11293270|FG000|Overall Study|Excluded based on anatomical criteria|2
7139470|NCT02959814|11293270|FG000|Overall Study|Protocol Violation|7
7139471|NCT02959814|11293270|FG000|Overall Study|FFR not measured|2
7139472|NCT02959814|11293270|FG000|Overall Study|In-procedure QFR not computed|6
7139473|NCT02959814|11293270|FG000|Overall Study|Excluded by FFR core-lab|24
7139474|NCT02959866|11293306|FG000|Overall Study|Withdrawal by Subject|1
7139475|NCT02959892|11293313|FG000|Overall Study|PET tracer synthesis failure|1
7139476|NCT02959892|11293314|FG001|Overall Study|PET tracer synthesis failure|0
7139477|NCT02959892|11293313|FG000|Overall Study|Study termination|0
7139478|NCT02959892|11293314|FG001|Overall Study|Study termination|1
7139479|NCT02959970|11293322|FG000|Overall Study|Adverse Event|1
7139480|NCT02959970|11293323|FG001|Overall Study|Adverse Event|0
7139481|NCT02959970|11293322|FG000|Overall Study|Withdrawal by Subject|0
7139482|NCT02959970|11293323|FG001|Overall Study|Withdrawal by Subject|2
7139483|NCT02959970|11293322|FG000|Overall Study|Lost to Follow-up|1
7139484|NCT02959970|11293323|FG001|Overall Study|Lost to Follow-up|5
7139485|NCT02959983|11293333|FG000|Overall Study|Protocol Violation|0
7139486|NCT02959983|11293334|FG001|Overall Study|Protocol Violation|1
7139487|NCT02959983|11293333|FG000|Overall Study|Lack of Efficacy|0
7139488|NCT02959983|11293334|FG001|Overall Study|Lack of Efficacy|1
7139489|NCT02959983|11293333|FG000|Overall Study|Lost to Follow-up|12
7139490|NCT02959983|11293334|FG001|Overall Study|Lost to Follow-up|9
7139491|NCT02959983|11293333|FG000|Overall Study|Other|1
7139492|NCT02959983|11293334|FG001|Overall Study|Other|1
7139493|NCT02959983|11293333|FG000|Overall Study|Physician Decision|1
7139494|NCT02959983|11293334|FG001|Overall Study|Physician Decision|0
6787623|NCT02354703|10785386|FG003|Overall Study|Withdrawal by Subject|1
6787624|NCT02354703|10785383|FG000|Overall Study|Lost to Follow-up|2
6787625|NCT02354703|10785384|FG001|Overall Study|Lost to Follow-up|7
6787626|NCT02354703|10785385|FG002|Overall Study|Lost to Follow-up|9
6787627|NCT02354703|10785386|FG003|Overall Study|Lost to Follow-up|2
6787628|NCT02354703|10785383|FG000|Overall Study|Adverse Event|0
6787629|NCT02354703|10785384|FG001|Overall Study|Adverse Event|0
6787630|NCT02354703|10785385|FG002|Overall Study|Adverse Event|1
6787631|NCT02354703|10785386|FG003|Overall Study|Adverse Event|0
6787632|NCT01981551|10785398|FG000|Overall Study|Refused further treatment|8
6787633|NCT01981551|10785398|FG000|Overall Study|Adverse Event|1
7139495|NCT02959983|11293333|FG000|Overall Study|Adverse Event|5
7139496|NCT02959983|11293334|FG001|Overall Study|Adverse Event|1
6787634|NCT00468130|10785408|FG000|Overall Study|Adverse Event|2
6787635|NCT00468130|10785409|FG001|Overall Study|Adverse Event|1
6787636|NCT00468130|10785408|FG000|Overall Study|Withdrawal by Subject|0
6787637|NCT00468130|10785409|FG001|Overall Study|Withdrawal by Subject|1
6787638|NCT00384111|10785417|FG000|Overall Study|Disease Progression|3
6787639|NCT00384111|10785417|FG000|Overall Study|Adverse Event|1
6787640|NCT00384111|10785417|FG000|Overall Study|Investigator Decision|3
6787641|NCT00384111|10785417|FG000|Overall Study|Study Terminated by the Sponsor|19
6807372|NCT03414983|10811065|FG001|Treatment|Participant request to discontinue study treatment|10
6807373|NCT03414983|10811064|FG000|Treatment|Adverse Event Unrelated to Study Drug|5
6807374|NCT03414983|10811065|FG001|Treatment|Adverse Event Unrelated to Study Drug|2
6807375|NCT03414983|10811064|FG000|Treatment|Death|0
6807376|NCT03414983|10811065|FG001|Treatment|Death|2
6807377|NCT03414983|10811064|FG000|Treatment|Study Drug Toxicity|11
6807378|NCT03414983|10811065|FG001|Treatment|Study Drug Toxicity|4
6807379|NCT03414983|10811064|FG000|Treatment|Disease Progression|72
6807380|NCT03414983|10811065|FG001|Treatment|Disease Progression|27
6807381|NCT03414983|10811064|FG000|Treatment|Not reported|1
6807382|NCT03414983|10811065|FG001|Treatment|Not reported|0
6807383|NCT03414983|10811064|FG000|Treatment|Other reasons|3
6807384|NCT03414983|10811065|FG001|Treatment|Other reasons|2
6807385|NCT03414983|10811064|FG000|Treatment|Completed treatment as per protocol|8
6807386|NCT03414983|10811065|FG001|Treatment|Completed treatment as per protocol|0
6807387|NCT03414983|10811064|FG000|Treatment|Poor/non-compliance|2
6807388|NCT03414983|10811065|FG001|Treatment|Poor/non-compliance|0
6807389|NCT03414983|10811064|FG000|Treatment|Maximum clinical benefit|5
6807390|NCT03414983|10811065|FG001|Treatment|Maximum clinical benefit|9
6807391|NCT03414983|10811064|FG000|Treatment|Lost to Follow-up|0
6807392|NCT03414983|10811065|FG001|Treatment|Lost to Follow-up|1
6807393|NCT03383692|10811073|FG000|Overall Study|Progressive disease as per RECIST|3
6807394|NCT03383692|10811074|FG001|Overall Study|Progressive disease as per RECIST|3
6807395|NCT03383692|10811073|FG000|Overall Study|Clinical progression|0
6807396|NCT03383692|10811074|FG001|Overall Study|Clinical progression|1
6807397|NCT03383692|10811073|FG000|Overall Study|Adverse Event|3
6807398|NCT03383692|10811074|FG001|Overall Study|Adverse Event|0
6807399|NCT03371251|10811088|FG000|Overall Study|Withdrawal by Subject|1
6807400|NCT03371251|10811089|FG001|Overall Study|Withdrawal by Subject|0
6807401|NCT03371251|10811090|FG002|Overall Study|Withdrawal by Subject|1
6807402|NCT03371251|10811091|FG003|Overall Study|Withdrawal by Subject|0
6807403|NCT03371251|10811092|FG004|Overall Study|Withdrawal by Subject|2
6807404|NCT03371251|10811093|FG005|Overall Study|Withdrawal by Subject|2
6807405|NCT03371251|10811088|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1
6807406|NCT03371251|10811089|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0
6807407|NCT03371251|10811090|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0
6807408|NCT03371251|10811091|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0
6807409|NCT03371251|10811092|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2
6807410|NCT03371251|10811093|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3
6807411|NCT03371251|10811088|FG000|Overall Study|Adverse Event|0
6807412|NCT03371251|10811089|FG001|Overall Study|Adverse Event|0
6807413|NCT03371251|10811090|FG002|Overall Study|Adverse Event|0
6807414|NCT03371251|10811091|FG003|Overall Study|Adverse Event|0
6807415|NCT03371251|10811092|FG004|Overall Study|Adverse Event|1
6807416|NCT03371251|10811093|FG005|Overall Study|Adverse Event|0
6807417|NCT03371251|10811088|FG000|Overall Study|Decision by Sponsor|0
6807418|NCT03371251|10811089|FG001|Overall Study|Decision by Sponsor|0
6807419|NCT03371251|10811090|FG002|Overall Study|Decision by Sponsor|0
6807420|NCT03371251|10811091|FG003|Overall Study|Decision by Sponsor|0
6807421|NCT03371251|10811092|FG004|Overall Study|Decision by Sponsor|2
6807422|NCT03371251|10811093|FG005|Overall Study|Decision by Sponsor|0
6807423|NCT03307785|10811133|FG000|Part A: Up to 28.5 Months|Disease progression|2
6807424|NCT03307785|10811134|FG001|Part A: Up to 28.5 Months|Disease progression|0
6807425|NCT03307785|10811135|FG002|Part A: Up to 28.5 Months|Disease progression|0
6807426|NCT03307785|10811136|FG003|Part A: Up to 28.5 Months|Disease progression|0
6807427|NCT03307785|10811137|FG004|Part A: Up to 28.5 Months|Disease progression|0
6807428|NCT03307785|10811138|FG005|Part A: Up to 28.5 Months|Disease progression|0
6807429|NCT03307785|10811139|FG006|Part A: Up to 28.5 Months|Disease progression|0
6807430|NCT03307785|10811140|FG007|Part A: Up to 28.5 Months|Disease progression|0
6807431|NCT03307785|10811141|FG008|Part A: Up to 28.5 Months|Disease progression|0
6807432|NCT03307785|10811142|FG009|Part A: Up to 28.5 Months|Disease progression|0
6807433|NCT03307785|10811143|FG010|Part A: Up to 28.5 Months|Disease progression|0
6807434|NCT03307785|10811133|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7
6807435|NCT03307785|10811134|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1
6807436|NCT03307785|10811135|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0
6807437|NCT03307785|10811136|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0
6807438|NCT03307785|10811137|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0
7139497|NCT02959983|11293333|FG000|Overall Study|Withdrawal by Subject|7
6807439|NCT03307785|10811138|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0
6807440|NCT03307785|10811139|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0
6807441|NCT03307785|10811140|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0
6787642|NCT04854642|10785421|FG000|Overall Study|Adverse Event|1
6787643|NCT04854642|10785422|FG001|Overall Study|Adverse Event|2
6787644|NCT04854642|10785421|FG000|Overall Study|Withdrawal by Subject|0
6787645|NCT04854642|10785422|FG001|Overall Study|Withdrawal by Subject|1
7139498|NCT02959983|11293334|FG001|Overall Study|Withdrawal by Subject|12
7139499|NCT02960217|11293351|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1
7139500|NCT02960217|11293352|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0
7139501|NCT02960217|11293351|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0
6787650|NCT04388787|10785460|FG000|Blinded Period|Patient could not follow instructions|1
6787651|NCT04388787|10785460|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9
6787652|NCT04377620|10785484|FG000|Overall Study|Death|42
6787653|NCT04377620|10785485|FG001|Overall Study|Death|48
6787654|NCT04377620|10785486|FG002|Overall Study|Death|36
6787655|NCT04377620|10785484|FG000|Overall Study|Withdrawal by Subject|0
6787656|NCT04377620|10785485|FG001|Overall Study|Withdrawal by Subject|2
6787657|NCT04377620|10785486|FG002|Overall Study|Withdrawal by Subject|0
6787658|NCT04310566|10785517|FG000|Period 1|Study Termination due to COVID-19|15
6787659|NCT04310566|10785518|FG001|Period 1|Study Termination due to COVID-19|17
6787660|NCT04310566|10785517|FG000|Period 1|Protocol Violation|0
6787661|NCT04310566|10785518|FG001|Period 1|Protocol Violation|1
6787662|NCT04310566|10785517|FG000|Period 1|Subject no longer meets eligbility criteria|0
6787663|NCT04310566|10785518|FG001|Period 1|Subject no longer meets eligbility criteria|1
6787664|NCT04310566|10785517|FG000|Period 1|Lost to Follow-up|1
6787665|NCT04310566|10785518|FG001|Period 1|Lost to Follow-up|0
6787666|NCT04310566|10785517|FG000|Period 1|Withdrawal by Subject|0
6787667|NCT04310566|10785518|FG001|Period 1|Withdrawal by Subject|1
6787668|NCT04310566|10785517|FG000|Period 2|Study Termination|7
6787669|NCT04310566|10785518|FG001|Period 2|Study Termination|5
6787670|NCT04206020|10785526|FG000|Overall Study|Adverse Event|1
6787671|NCT04206020|10785527|FG001|Overall Study|Adverse Event|4
6787672|NCT04206020|10785526|FG000|Overall Study|Protocol Violation|2
6787673|NCT04206020|10785527|FG001|Overall Study|Protocol Violation|0
6787674|NCT04206020|10785526|FG000|Overall Study|Withdrawal by Subject|2
6787675|NCT04206020|10785527|FG001|Overall Study|Withdrawal by Subject|0
6787676|NCT04206020|10785526|FG000|Overall Study|Lost to Follow-up|2
6787677|NCT04206020|10785527|FG001|Overall Study|Lost to Follow-up|0
6787678|NCT04206020|10785526|FG000|Overall Study|Pregnancy|0
6787679|NCT04206020|10785527|FG001|Overall Study|Pregnancy|1
6787680|NCT04206020|10785526|FG000|Overall Study|Unable to attend visits|1
6787681|NCT04206020|10785527|FG001|Overall Study|Unable to attend visits|2
6787682|NCT04097301|10785533|FG000|Overall Study|Death|1
6787683|NCT04097301|10785533|FG000|Overall Study|Withdrawal by Subject|1
6787684|NCT04097301|10785533|FG000|Overall Study|Screening Failure|5
6787685|NCT03953079|10785546|FG000|Core Study|Withdrawal by Subject|1
6787686|NCT03953079|10785547|FG001|Core Study|Withdrawal by Subject|2
6787687|NCT03953079|10785548|FG002|Core Study|Withdrawal by Subject|1
6787688|NCT03953079|10785546|FG000|Core Study|COVID-19|0
6787689|NCT03953079|10785547|FG001|Core Study|COVID-19|1
6787690|NCT03953079|10785548|FG002|Core Study|COVID-19|0
6787691|NCT03953079|10785546|FG000|Core Study|Difficulties leaving the house|0
6787692|NCT03953079|10785547|FG001|Core Study|Difficulties leaving the house|1
6787693|NCT03953079|10785548|FG002|Core Study|Difficulties leaving the house|0
6787694|NCT03953079|10785546|FG000|Extension Study|Withdrawal by Subject|1
6787695|NCT03953079|10785547|FG001|Extension Study|Withdrawal by Subject|0
6787696|NCT03953079|10785548|FG002|Extension Study|Withdrawal by Subject|0
6787697|NCT03953079|10785546|FG000|Extension Study|Received Rescue Treatment|5
6787698|NCT03953079|10785547|FG001|Extension Study|Received Rescue Treatment|6
6787699|NCT03953079|10785548|FG002|Extension Study|Received Rescue Treatment|5
6787700|NCT03922750|10785560|FG000|Overall Study|Unclassified|0
6787701|NCT03922750|10785561|FG001|Overall Study|Unclassified|0
6787702|NCT03922750|10785562|FG002|Overall Study|Unclassified|1
6787703|NCT03922750|10785560|FG000|Overall Study|Adverse Event|0
6787704|NCT03922750|10785561|FG001|Overall Study|Adverse Event|1
6787705|NCT03922750|10785562|FG002|Overall Study|Adverse Event|0
6787706|NCT03910673|10785575|FG000|Overall Study|Adverse Event|0
6787707|NCT03910673|10785576|FG001|Overall Study|Adverse Event|0
6787708|NCT03910673|10785577|FG002|Overall Study|Adverse Event|0
6787709|NCT03910673|10785578|FG003|Overall Study|Adverse Event|2
6787710|NCT03910673|10785579|FG004|Overall Study|Adverse Event|0
6787711|NCT03885999|10785583|FG000|Overall Study|Adverse Event|1
6787712|NCT03882970|10785591|FG000|Overall Study|Adverse Event|5
6787713|NCT03882970|10785592|FG001|Overall Study|Adverse Event|7
6787714|NCT03882970|10785593|FG002|Overall Study|Adverse Event|3
6787715|NCT03882970|10785594|FG003|Overall Study|Adverse Event|1
6787716|NCT03882970|10785591|FG000|Overall Study|Death|1
6787717|NCT03882970|10785592|FG001|Overall Study|Death|2
6787718|NCT03882970|10785593|FG002|Overall Study|Death|1
6787719|NCT03882970|10785594|FG003|Overall Study|Death|1
6787720|NCT03882970|10785591|FG000|Overall Study|Lost to Follow-up|8
6787721|NCT03882970|10785592|FG001|Overall Study|Lost to Follow-up|9
6787722|NCT03882970|10785593|FG002|Overall Study|Lost to Follow-up|5
6787723|NCT03882970|10785594|FG003|Overall Study|Lost to Follow-up|5
6787724|NCT03882970|10785591|FG000|Overall Study|Physician Decision|0
6787725|NCT03882970|10785592|FG001|Overall Study|Physician Decision|2
6787726|NCT03882970|10785593|FG002|Overall Study|Physician Decision|2
6787727|NCT03882970|10785594|FG003|Overall Study|Physician Decision|2
6787728|NCT03882970|10785591|FG000|Overall Study|Protocol Violation|2
6787729|NCT03882970|10785592|FG001|Overall Study|Protocol Violation|0
6787730|NCT03882970|10785593|FG002|Overall Study|Protocol Violation|0
6787731|NCT03882970|10785594|FG003|Overall Study|Protocol Violation|0
6787732|NCT03882970|10785591|FG000|Overall Study|Withdrawal by Subject|8
6787733|NCT03882970|10785592|FG001|Overall Study|Withdrawal by Subject|17
6787734|NCT03882970|10785593|FG002|Overall Study|Withdrawal by Subject|7
6787735|NCT03882970|10785594|FG003|Overall Study|Withdrawal by Subject|22
6787736|NCT03882970|10785591|FG000|Overall Study|Personal Reason|2
6787737|NCT03882970|10785592|FG001|Overall Study|Personal Reason|3
6787738|NCT03882970|10785593|FG002|Overall Study|Personal Reason|1
6787739|NCT03882970|10785594|FG003|Overall Study|Personal Reason|3
6787740|NCT03867734|10785618|FG000|Overall Study|Lost to Follow-up|2
6807442|NCT03307785|10811141|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0
6807443|NCT03307785|10811142|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0
6807444|NCT03307785|10811143|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0
6807445|NCT03307785|10811133|FG000|Part A: Up to 28.5 Months|Death|4
6807446|NCT03307785|10811134|FG001|Part A: Up to 28.5 Months|Death|4
6807447|NCT03307785|10811135|FG002|Part A: Up to 28.5 Months|Death|0
6807448|NCT03307785|10811136|FG003|Part A: Up to 28.5 Months|Death|0
6807449|NCT03307785|10811137|FG004|Part A: Up to 28.5 Months|Death|0
6807450|NCT03307785|10811138|FG005|Part A: Up to 28.5 Months|Death|0
6807451|NCT03307785|10811139|FG006|Part A: Up to 28.5 Months|Death|0
6807452|NCT03307785|10811140|FG007|Part A: Up to 28.5 Months|Death|0
6807453|NCT03307785|10811141|FG008|Part A: Up to 28.5 Months|Death|0
6807454|NCT03307785|10811142|FG009|Part A: Up to 28.5 Months|Death|0
6807455|NCT03307785|10811143|FG010|Part A: Up to 28.5 Months|Death|0
6807456|NCT03307785|10811133|FG000|Part A: Up to 28.5 Months|Physician Decision|3
6807457|NCT03307785|10811134|FG001|Part A: Up to 28.5 Months|Physician Decision|1
6807458|NCT03307785|10811135|FG002|Part A: Up to 28.5 Months|Physician Decision|0
6807459|NCT03307785|10811136|FG003|Part A: Up to 28.5 Months|Physician Decision|0
6807460|NCT03307785|10811137|FG004|Part A: Up to 28.5 Months|Physician Decision|0
6807461|NCT03307785|10811138|FG005|Part A: Up to 28.5 Months|Physician Decision|0
6807462|NCT03307785|10811139|FG006|Part A: Up to 28.5 Months|Physician Decision|0
6807463|NCT03307785|10811140|FG007|Part A: Up to 28.5 Months|Physician Decision|0
6807464|NCT03307785|10811141|FG008|Part A: Up to 28.5 Months|Physician Decision|0
6807465|NCT03307785|10811142|FG009|Part A: Up to 28.5 Months|Physician Decision|0
6807466|NCT03307785|10811143|FG010|Part A: Up to 28.5 Months|Physician Decision|0
6807467|NCT03307785|10811133|FG000|Part B: Up to 28.5 Months|Disease progression|0
6807468|NCT03307785|10811134|FG001|Part B: Up to 28.5 Months|Disease progression|0
6807469|NCT03307785|10811135|FG002|Part B: Up to 28.5 Months|Disease progression|1
6807470|NCT03307785|10811136|FG003|Part B: Up to 28.5 Months|Disease progression|0
6807471|NCT03307785|10811137|FG004|Part B: Up to 28.5 Months|Disease progression|0
6807472|NCT03307785|10811138|FG005|Part B: Up to 28.5 Months|Disease progression|0
6807473|NCT03307785|10811139|FG006|Part B: Up to 28.5 Months|Disease progression|0
6807474|NCT03307785|10811140|FG007|Part B: Up to 28.5 Months|Disease progression|0
6807475|NCT03307785|10811141|FG008|Part B: Up to 28.5 Months|Disease progression|0
6807476|NCT03307785|10811142|FG009|Part B: Up to 28.5 Months|Disease progression|0
6807477|NCT03307785|10811143|FG010|Part B: Up to 28.5 Months|Disease progression|0
6807478|NCT03307785|10811133|FG000|Part B: Up to 28.5 Months|Physician Decision|0
6807479|NCT03307785|10811134|FG001|Part B: Up to 28.5 Months|Physician Decision|0
6807480|NCT03307785|10811135|FG002|Part B: Up to 28.5 Months|Physician Decision|1
6807481|NCT03307785|10811136|FG003|Part B: Up to 28.5 Months|Physician Decision|0
6807482|NCT03307785|10811137|FG004|Part B: Up to 28.5 Months|Physician Decision|0
6807483|NCT03307785|10811138|FG005|Part B: Up to 28.5 Months|Physician Decision|0
6807484|NCT03307785|10811139|FG006|Part B: Up to 28.5 Months|Physician Decision|0
6807485|NCT03307785|10811140|FG007|Part B: Up to 28.5 Months|Physician Decision|0
6807486|NCT03307785|10811141|FG008|Part B: Up to 28.5 Months|Physician Decision|0
6807487|NCT03307785|10811142|FG009|Part B: Up to 28.5 Months|Physician Decision|0
6807488|NCT03307785|10811143|FG010|Part B: Up to 28.5 Months|Physician Decision|0
6807489|NCT03307785|10811133|FG000|Part B: Up to 28.5 Months|Death|0
6807490|NCT03307785|10811134|FG001|Part B: Up to 28.5 Months|Death|0
6807491|NCT03307785|10811135|FG002|Part B: Up to 28.5 Months|Death|7
6807492|NCT03307785|10811136|FG003|Part B: Up to 28.5 Months|Death|0
6807493|NCT03307785|10811137|FG004|Part B: Up to 28.5 Months|Death|0
6807494|NCT03307785|10811138|FG005|Part B: Up to 28.5 Months|Death|0
6807495|NCT03307785|10811139|FG006|Part B: Up to 28.5 Months|Death|0
6807496|NCT03307785|10811140|FG007|Part B: Up to 28.5 Months|Death|0
6807497|NCT03307785|10811141|FG008|Part B: Up to 28.5 Months|Death|0
6807498|NCT03307785|10811142|FG009|Part B: Up to 28.5 Months|Death|0
6807499|NCT03307785|10811143|FG010|Part B: Up to 28.5 Months|Death|0
6807500|NCT03307785|10811133|FG000|Part B: Up to 28.5 Months|Withdrawal by Subject|0
6807501|NCT03307785|10811134|FG001|Part B: Up to 28.5 Months|Withdrawal by Subject|0
6807502|NCT03307785|10811135|FG002|Part B: Up to 28.5 Months|Withdrawal by Subject|1
6807503|NCT03307785|10811136|FG003|Part B: Up to 28.5 Months|Withdrawal by Subject|0
6807504|NCT03307785|10811137|FG004|Part B: Up to 28.5 Months|Withdrawal by Subject|0
6807505|NCT03307785|10811138|FG005|Part B: Up to 28.5 Months|Withdrawal by Subject|0
6807506|NCT03307785|10811139|FG006|Part B: Up to 28.5 Months|Withdrawal by Subject|0
6807507|NCT03307785|10811140|FG007|Part B: Up to 28.5 Months|Withdrawal by Subject|0
6787741|NCT03781778|10785628|FG000|Overall Study|Withdrawal by Subject|2
6787742|NCT03781778|10785629|FG001|Overall Study|Withdrawal by Subject|2
6787743|NCT03730480|10785648|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1
6787744|NCT03713034|10785661|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5
6787745|NCT03713034|10785662|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4
6787746|NCT03654404|10785670|FG000|Overall Study|Death|1
6787747|NCT03654404|10785670|FG000|Overall Study|Lost to Follow-up|2
6787748|NCT03654404|10785670|FG000|Overall Study|Withdrawal by Subject|5
6787749|NCT03567057|10785677|FG000|Overall Study|Adverse Event|56
6787750|NCT03567057|10785678|FG001|Overall Study|Adverse Event|53
6787751|NCT03567057|10785679|FG002|Overall Study|Adverse Event|28
6787752|NCT03567057|10785677|FG000|Overall Study|Withdrawal by Subject|22
6787753|NCT03567057|10785678|FG001|Overall Study|Withdrawal by Subject|24
6787754|NCT03567057|10785679|FG002|Overall Study|Withdrawal by Subject|13
6787755|NCT03567057|10785677|FG000|Overall Study|Lost to Follow-up|3
6787756|NCT03567057|10785678|FG001|Overall Study|Lost to Follow-up|5
6787757|NCT03567057|10785679|FG002|Overall Study|Lost to Follow-up|2
6787758|NCT03567057|10785677|FG000|Overall Study|COVID-19 pandemic|4
6787759|NCT03567057|10785678|FG001|Overall Study|COVID-19 pandemic|3
6787760|NCT03567057|10785679|FG002|Overall Study|COVID-19 pandemic|0
6787761|NCT03567057|10785677|FG000|Overall Study|Non-compliance with study drug|4
6787762|NCT03567057|10785678|FG001|Overall Study|Non-compliance with study drug|2
6787763|NCT03567057|10785679|FG002|Overall Study|Non-compliance with study drug|0
6787764|NCT03567057|10785677|FG000|Overall Study|Lack of Efficacy|3
6787765|NCT03567057|10785678|FG001|Overall Study|Lack of Efficacy|0
6787766|NCT03567057|10785679|FG002|Overall Study|Lack of Efficacy|1
6787767|NCT03567057|10785677|FG000|Overall Study|Death|1
6787768|NCT03567057|10785678|FG001|Overall Study|Death|0
6787769|NCT03567057|10785679|FG002|Overall Study|Death|0
6787770|NCT03567057|10785677|FG000|Overall Study|Physician Decision|1
6787771|NCT03567057|10785678|FG001|Overall Study|Physician Decision|0
6787772|NCT03567057|10785679|FG002|Overall Study|Physician Decision|0
6787773|NCT03567057|10785677|FG000|Overall Study|Unstable medical condition|1
6787774|NCT03567057|10785678|FG001|Overall Study|Unstable medical condition|0
6787775|NCT03567057|10785679|FG002|Overall Study|Unstable medical condition|0
6787776|NCT03567057|10785677|FG000|Overall Study|Medical history event|0
6787777|NCT03567057|10785678|FG001|Overall Study|Medical history event|0
6787778|NCT03567057|10785679|FG002|Overall Study|Medical history event|1
6787779|NCT03567057|10785677|FG000|Overall Study|Other|0
7139502|NCT02960217|11293352|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1
7139503|NCT02960217|11293351|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0
7139504|NCT02960217|11293352|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1
7139505|NCT02960217|11293351|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1
7139506|NCT02960217|11293352|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0
7139507|NCT02960217|11293351|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0
7139508|NCT02960217|11293352|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1
7139509|NCT02960217|11293351|FG000|Open-Label Extension Phase|Adverse Event|1
7139510|NCT02960217|11293352|FG001|Open-Label Extension Phase|Adverse Event|0
7139511|NCT02960217|11293351|FG000|Open-Label Extension Phase|Sponsor Decision|18
7139512|NCT02960217|11293352|FG001|Open-Label Extension Phase|Sponsor Decision|11
7139513|NCT02960217|11293351|FG000|Open-Label Extension Phase|Lack of Efficacy|1
7139514|NCT02960217|11293352|FG001|Open-Label Extension Phase|Lack of Efficacy|1
7139515|NCT02960217|11293351|FG000|Open-Label Extension Phase|Other, Not Specified|0
7139516|NCT02960217|11293352|FG001|Open-Label Extension Phase|Other, Not Specified|1
6787780|NCT03567057|10785678|FG001|Overall Study|Other|0
6787781|NCT03567057|10785679|FG002|Overall Study|Other|1
6787782|NCT03548987|10785689|FG000|Run-in Period (Week 0 to Week 20)|Other|9
6787783|NCT03548987|10785690|FG001|Run-in Period (Week 0 to Week 20)|Other|0
6787784|NCT03548987|10785689|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8
7139517|NCT02960438|11293371|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2
7139518|NCT02960438|11293372|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1
7139519|NCT02960438|11293373|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2
7139520|NCT02960438|11293374|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5
7139521|NCT02960438|11293371|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2
7139522|NCT02960438|11293372|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1
7139523|NCT02960438|11293373|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0
7139524|NCT02960438|11293374|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3
7139525|NCT02960438|11293371|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2
7139526|NCT02960438|11293372|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0
7139527|NCT02960438|11293373|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0
7139528|NCT02960438|11293374|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0
7139529|NCT02960438|11293371|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1
7139530|NCT02960438|11293372|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0
7139531|NCT02960438|11293373|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1
7139532|NCT02960438|11293374|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0
7139533|NCT02960438|11293371|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0
6787785|NCT03548987|10785690|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0
6787786|NCT03548987|10785689|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11
6787787|NCT03548987|10785690|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0
6787788|NCT03548987|10785689|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2
6787789|NCT03548987|10785690|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0
6787790|NCT03548987|10785689|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19
6787791|NCT03548987|10785690|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0
6787792|NCT03548987|10785689|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1
6787793|NCT03548987|10785690|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0
6787794|NCT03548987|10785689|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1
6787795|NCT03548987|10785690|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0
6787796|NCT03548987|10785689|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48
6787797|NCT03548987|10785690|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0
6787798|NCT03548987|10785689|FG000|Maintenance Period (Week 20 to Week 68)|other|12
6787799|NCT03548987|10785690|FG001|Maintenance Period (Week 20 to Week 68)|other|23
6787800|NCT03548987|10785689|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2
6787801|NCT03548987|10785690|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1
6787802|NCT03548987|10785689|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1
6787803|NCT03548987|10785690|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1
6787804|NCT03548987|10785689|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2
6787805|NCT03548987|10785690|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0
6787806|NCT03548987|10785689|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1
6787807|NCT03548987|10785690|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0
6787808|NCT03548987|10785689|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13
6787809|NCT03548987|10785690|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6
6787810|NCT03548064|10785705|FG000|Overall Study|Withdrawal by Subject|0
6787811|NCT03548064|10785706|FG001|Overall Study|Withdrawal by Subject|0
6787812|NCT03548064|10785707|FG002|Overall Study|Withdrawal by Subject|0
6787813|NCT03548064|10785708|FG003|Overall Study|Withdrawal by Subject|1
6787814|NCT03548064|10785709|FG004|Overall Study|Withdrawal by Subject|0
6787815|NCT03548064|10785710|FG005|Overall Study|Withdrawal by Subject|0
6787816|NCT03548064|10785711|FG006|Overall Study|Withdrawal by Subject|0
6787817|NCT03548064|10785712|FG007|Overall Study|Withdrawal by Subject|0
6787818|NCT03548064|10785705|FG000|Overall Study|Lost to Follow-up|0
6787819|NCT03548064|10785706|FG001|Overall Study|Lost to Follow-up|0
6787820|NCT03548064|10785707|FG002|Overall Study|Lost to Follow-up|0
6787821|NCT03548064|10785708|FG003|Overall Study|Lost to Follow-up|0
6787822|NCT03548064|10785709|FG004|Overall Study|Lost to Follow-up|2
6787823|NCT03548064|10785710|FG005|Overall Study|Lost to Follow-up|0
6787824|NCT03548064|10785711|FG006|Overall Study|Lost to Follow-up|0
6787825|NCT03548064|10785712|FG007|Overall Study|Lost to Follow-up|0
6787826|NCT03548064|10785705|FG000|Overall Study|Covid-19 Pandemic|0
6787827|NCT03548064|10785706|FG001|Overall Study|Covid-19 Pandemic|0
6787828|NCT03548064|10785707|FG002|Overall Study|Covid-19 Pandemic|0
6787829|NCT03548064|10785708|FG003|Overall Study|Covid-19 Pandemic|0
6787830|NCT03548064|10785709|FG004|Overall Study|Covid-19 Pandemic|10
6787831|NCT03548064|10785710|FG005|Overall Study|Covid-19 Pandemic|3
6787832|NCT03548064|10785711|FG006|Overall Study|Covid-19 Pandemic|0
6787833|NCT03548064|10785712|FG007|Overall Study|Covid-19 Pandemic|0
6787834|NCT03446456|10785738|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1
6787835|NCT03446456|10785739|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1
6787836|NCT03446456|10785738|FG000|Overall Study|Lost to Follow-up|1
6787837|NCT03446456|10785739|FG001|Overall Study|Lost to Follow-up|3
6787838|NCT03446456|10785738|FG000|Overall Study|Participant failed the toxicology test|1
6787839|NCT03446456|10785739|FG001|Overall Study|Participant failed the toxicology test|0
6787840|NCT03446456|10785738|FG000|Overall Study|Break down of the experimental equipment|1
6787841|NCT03446456|10785739|FG001|Overall Study|Break down of the experimental equipment|0
6787842|NCT03382834|10785747|FG000|Overall Study|Lost to Follow-up|1
6787843|NCT03382834|10785748|FG001|Overall Study|Lost to Follow-up|0
6787844|NCT03382834|10785747|FG000|Overall Study|Withdrawal by Subject|0
6787845|NCT03382834|10785748|FG001|Overall Study|Withdrawal by Subject|1
6787846|NCT03371823|10785756|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1
6787847|NCT03371823|10785757|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0
6787848|NCT03353350|10785767|FG000|30-week Core Treatment Period|Protocol Violation|1
6787849|NCT03353350|10785768|FG001|30-week Core Treatment Period|Protocol Violation|1
6787850|NCT03353350|10785769|FG002|30-week Core Treatment Period|Protocol Violation|1
6787851|NCT03353350|10785770|FG003|30-week Core Treatment Period|Protocol Violation|0
6787852|NCT03353350|10785767|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2
6787853|NCT03353350|10785768|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2
6787854|NCT03353350|10785769|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2
6787855|NCT03353350|10785770|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0
6787856|NCT03353350|10785767|FG000|30-week Core Treatment Period|Adverse Event|0
6787857|NCT03353350|10785768|FG001|30-week Core Treatment Period|Adverse Event|4
6787858|NCT03353350|10785769|FG002|30-week Core Treatment Period|Adverse Event|2
6787859|NCT03353350|10785770|FG003|30-week Core Treatment Period|Adverse Event|3
6787860|NCT03353350|10785767|FG000|30-week Core Treatment Period|Withdrawal by Subject|19
6787861|NCT03353350|10785768|FG001|30-week Core Treatment Period|Withdrawal by Subject|12
6787862|NCT03353350|10785769|FG002|30-week Core Treatment Period|Withdrawal by Subject|19
6787863|NCT03353350|10785770|FG003|30-week Core Treatment Period|Withdrawal by Subject|19
6787864|NCT03353350|10785767|FG000|26-week Treatment Extension Period|Protocol Violation|2
6787865|NCT03353350|10785768|FG001|26-week Treatment Extension Period|Protocol Violation|0
6787866|NCT03353350|10785769|FG002|26-week Treatment Extension Period|Protocol Violation|0
6787867|NCT03353350|10785770|FG003|26-week Treatment Extension Period|Protocol Violation|0
6787868|NCT03353350|10785767|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0
6787869|NCT03353350|10785768|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0
6787870|NCT03353350|10785769|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1
6787871|NCT03353350|10785770|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1
6787872|NCT03353350|10785767|FG000|26-week Treatment Extension Period|Adverse Event|1
6787873|NCT03353350|10785768|FG001|26-week Treatment Extension Period|Adverse Event|0
6787874|NCT03353350|10785769|FG002|26-week Treatment Extension Period|Adverse Event|0
6787875|NCT03353350|10785770|FG003|26-week Treatment Extension Period|Adverse Event|1
6787876|NCT03353350|10785767|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2
6787877|NCT03353350|10785768|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3
6787878|NCT03353350|10785769|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3
6787879|NCT03353350|10785770|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12
6787880|NCT03350503|10785780|FG000|Overall Study|Adverse Event|1
6787881|NCT03350503|10785780|FG000|Overall Study|Hospital Transfer or Removal|2
6787882|NCT03350503|10785780|FG000|Overall Study|Subject Wishes|2
6787883|NCT03326193|10785784|FG000|Overall Study|Treatment ongoing at the time of analysis|26
6787884|NCT03326193|10785784|FG000|Overall Study|Death|19
6787885|NCT03326193|10785784|FG000|Overall Study|Withdrawal by Subject|8
6787886|NCT03282565|10785800|FG000|Overall Study|COVID-19 Research Shutdown|0
6787887|NCT03282565|10785801|FG001|Overall Study|COVID-19 Research Shutdown|2
6787888|NCT03282565|10785802|FG002|Overall Study|COVID-19 Research Shutdown|2
6807508|NCT03307785|10811141|FG008|Part B: Up to 28.5 Months|Withdrawal by Subject|0
6807509|NCT03307785|10811142|FG009|Part B: Up to 28.5 Months|Withdrawal by Subject|0
6807510|NCT03307785|10811143|FG010|Part B: Up to 28.5 Months|Withdrawal by Subject|0
6807511|NCT03307785|10811133|FG000|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
6807512|NCT03307785|10811134|FG001|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
6807513|NCT03307785|10811135|FG002|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|4
6807514|NCT03307785|10811136|FG003|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
6807515|NCT03307785|10811137|FG004|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
6807516|NCT03307785|10811138|FG005|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
7139534|NCT02960438|11293372|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0
7139535|NCT02960438|11293373|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1
7139536|NCT02960438|11293374|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0
7139537|NCT02960438|11293371|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2
7139538|NCT02960438|11293372|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1
7139539|NCT02960438|11293373|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0
7139540|NCT02960438|11293374|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1
7139541|NCT02960438|11293371|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1
7139542|NCT02960438|11293372|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2
7139543|NCT02960438|11293373|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4
7139544|NCT02960438|11293374|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1
7139545|NCT02960438|11293371|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0
7139546|NCT02960438|11293372|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0
7139547|NCT02960438|11293373|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1
7139548|NCT02960438|11293374|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0
7139549|NCT02960438|11293371|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1
7139550|NCT02960438|11293372|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1
7139551|NCT02960438|11293373|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0
7139552|NCT02960438|11293374|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1
7139553|NCT02960438|11293371|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7
7139554|NCT02960438|11293372|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5
7139555|NCT02960438|11293373|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7
7139556|NCT02960438|11293374|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6
7139557|NCT02960438|11293371|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2
7139558|NCT02960438|11293372|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1
6807517|NCT03307785|10811139|FG006|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
6807518|NCT03307785|10811140|FG007|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
6807519|NCT03307785|10811141|FG008|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
6807520|NCT03307785|10811142|FG009|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
6807521|NCT03307785|10811143|FG010|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
6807522|NCT03307785|10811133|FG000|Part C: Up to 22.5 Months|Disease progression|0
6787889|NCT03276936|10785812|FG000|Overall Study|Adverse Event|4
6787890|NCT03276936|10785813|FG001|Overall Study|Adverse Event|2
6787891|NCT03276936|10785812|FG000|Overall Study|Lost to Follow-up|16
6787892|NCT03276936|10785813|FG001|Overall Study|Lost to Follow-up|13
6787893|NCT03276936|10785812|FG000|Overall Study|Withdrawal by Subject|30
6787894|NCT03276936|10785813|FG001|Overall Study|Withdrawal by Subject|20
6787895|NCT03276936|10785812|FG000|Overall Study|Not mentioned|6
6787896|NCT03276936|10785813|FG001|Overall Study|Not mentioned|3
6787897|NCT03271021|10785821|FG000|Overall Study|Adverse Event|3
6787898|NCT03271021|10785822|FG001|Overall Study|Adverse Event|2
6787899|NCT03271021|10785821|FG000|Overall Study|Withdrawal by Subject|36
6787900|NCT03271021|10785822|FG001|Overall Study|Withdrawal by Subject|53
6787901|NCT03271021|10785821|FG000|Overall Study|Lost to Follow-up|34
6787902|NCT03271021|10785822|FG001|Overall Study|Lost to Follow-up|39
6787903|NCT03271021|10785821|FG000|Overall Study|Protocol Violation|6
6787904|NCT03271021|10785822|FG001|Overall Study|Protocol Violation|4
6787905|NCT03271021|10785821|FG000|Overall Study|Abnormal Lab Results|1
6787906|NCT03271021|10785822|FG001|Overall Study|Abnormal Lab Results|0
6787907|NCT03271021|10785821|FG000|Overall Study|Miscellaneous|9
6787908|NCT03271021|10785822|FG001|Overall Study|Miscellaneous|8
6787909|NCT03255083|10785832|FG000|Overall Study|Clinical progression|1
6787910|NCT03255083|10785833|FG001|Overall Study|Clinical progression|0
6787911|NCT03255083|10785834|FG002|Overall Study|Clinical progression|0
6787912|NCT03255083|10785835|FG003|Overall Study|Clinical progression|0
6787913|NCT03255083|10785832|FG000|Overall Study|Adverse Event|0
6787914|NCT03255083|10785833|FG001|Overall Study|Adverse Event|1
6787915|NCT03255083|10785834|FG002|Overall Study|Adverse Event|0
6787916|NCT03255083|10785835|FG003|Overall Study|Adverse Event|0
6787917|NCT03255083|10785832|FG000|Overall Study|Progressive disease by RECIST version 1.1|4
6787918|NCT03255083|10785833|FG001|Overall Study|Progressive disease by RECIST version 1.1|1
6787919|NCT03255083|10785834|FG002|Overall Study|Progressive disease by RECIST version 1.1|2
6787920|NCT03255083|10785835|FG003|Overall Study|Progressive disease by RECIST version 1.1|1
6787921|NCT03255083|10785832|FG000|Overall Study|Withdrawal by Subject|1
6787922|NCT03255083|10785833|FG001|Overall Study|Withdrawal by Subject|1
6787923|NCT03255083|10785834|FG002|Overall Study|Withdrawal by Subject|1
6787924|NCT03255083|10785835|FG003|Overall Study|Withdrawal by Subject|0
6787925|NCT03227471|10785860|FG000|Overall Study|Withdrawal by Subject|0
6787926|NCT03227471|10785861|FG001|Overall Study|Withdrawal by Subject|0
6787927|NCT03227471|10785862|FG002|Overall Study|Withdrawal by Subject|0
6787928|NCT03227471|10785863|FG003|Overall Study|Withdrawal by Subject|0
6787929|NCT03227471|10785864|FG004|Overall Study|Withdrawal by Subject|1
6787930|NCT03227471|10785865|FG005|Overall Study|Withdrawal by Subject|0
6787931|NCT03227471|10785866|FG006|Overall Study|Withdrawal by Subject|0
6787932|NCT03227471|10785867|FG007|Overall Study|Withdrawal by Subject|0
6787933|NCT03227471|10785868|FG008|Overall Study|Withdrawal by Subject|0
6787934|NCT03227471|10785869|FG009|Overall Study|Withdrawal by Subject|0
6787935|NCT03227471|10785870|FG010|Overall Study|Withdrawal by Subject|0
6787936|NCT03227471|10785871|FG011|Overall Study|Withdrawal by Subject|0
6787937|NCT03227471|10785872|FG012|Overall Study|Withdrawal by Subject|1
6787938|NCT03227471|10785873|FG013|Overall Study|Withdrawal by Subject|0
6787939|NCT03227471|10785874|FG014|Overall Study|Withdrawal by Subject|0
6787940|NCT03227471|10785860|FG000|Overall Study|Randomized, Never Dosed|0
6787941|NCT03227471|10785861|FG001|Overall Study|Randomized, Never Dosed|0
6787942|NCT03227471|10785862|FG002|Overall Study|Randomized, Never Dosed|0
6787943|NCT03227471|10785863|FG003|Overall Study|Randomized, Never Dosed|0
6787944|NCT03227471|10785864|FG004|Overall Study|Randomized, Never Dosed|0
6787945|NCT03227471|10785865|FG005|Overall Study|Randomized, Never Dosed|0
6787946|NCT03227471|10785866|FG006|Overall Study|Randomized, Never Dosed|0
6787947|NCT03227471|10785867|FG007|Overall Study|Randomized, Never Dosed|0
6787948|NCT03227471|10785868|FG008|Overall Study|Randomized, Never Dosed|0
6787949|NCT03227471|10785869|FG009|Overall Study|Randomized, Never Dosed|0
6787950|NCT03227471|10785870|FG010|Overall Study|Randomized, Never Dosed|0
6787951|NCT03227471|10785871|FG011|Overall Study|Randomized, Never Dosed|0
6787952|NCT03227471|10785872|FG012|Overall Study|Randomized, Never Dosed|0
6787953|NCT03227471|10785873|FG013|Overall Study|Randomized, Never Dosed|0
6787954|NCT03227471|10785874|FG014|Overall Study|Randomized, Never Dosed|1
6787955|NCT03221842|10785935|FG000|Period 1 (Open-label)|Adverse Event|4
6787956|NCT03221842|10785936|FG001|Period 1 (Open-label)|Adverse Event|0
6787957|NCT03221842|10785935|FG000|Period 1 (Open-label)|Physician Decision|2
6787958|NCT03221842|10785936|FG001|Period 1 (Open-label)|Physician Decision|0
6787959|NCT03221842|10785935|FG000|Period 1 (Open-label)|Lost to Follow-up|1
7139559|NCT02960438|11293373|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1
7139560|NCT02960438|11293374|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2
7139561|NCT02960438|11293371|FG000|Extension Phase (Open-label): 80 Weeks|Other|0
7139562|NCT02960438|11293372|FG001|Extension Phase (Open-label): 80 Weeks|Other|0
7139563|NCT02960438|11293373|FG002|Extension Phase (Open-label): 80 Weeks|Other|1
7139564|NCT02960438|11293374|FG003|Extension Phase (Open-label): 80 Weeks|Other|1
7139565|NCT02960490|11293394|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3
7139566|NCT02960490|11293395|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2
7139567|NCT02960490|11293396|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
6787960|NCT03221842|10785936|FG001|Period 1 (Open-label)|Lost to Follow-up|0
6787961|NCT03221842|10785935|FG000|Period 1 (Open-label)|Terminated by sponsor|1
6787962|NCT03221842|10785936|FG001|Period 1 (Open-label)|Terminated by sponsor|0
6787963|NCT03221842|10785935|FG000|Period 1 (Open-label)|Other|2
6787964|NCT03221842|10785936|FG001|Period 1 (Open-label)|Other|0
6787965|NCT03221842|10785935|FG000|Period 2 (Randomized, Blinded)|Death|0
6787966|NCT03221842|10785936|FG001|Period 2 (Randomized, Blinded)|Death|1
6787967|NCT03221842|10785935|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1
6787968|NCT03221842|10785936|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0
6787969|NCT03194321|10785946|FG000|Overall Study|Withdrawal by Subject|1
6787970|NCT03194321|10785946|FG000|Overall Study|Lost to Follow-up|1
6787971|NCT03194321|10785946|FG000|Overall Study|Travel for Follow-up|1
6787972|NCT03085095|10785952|FG000|Overall Study|Adverse Event|23
6787973|NCT03085095|10785953|FG001|Overall Study|Adverse Event|8
6787974|NCT03085095|10785952|FG000|Overall Study|Protocol Violation|0
6787975|NCT03085095|10785953|FG001|Overall Study|Protocol Violation|1
6787976|NCT03085095|10785952|FG000|Overall Study|Lost to Follow-up|2
6787977|NCT03085095|10785953|FG001|Overall Study|Lost to Follow-up|1
6787978|NCT03085095|10785952|FG000|Overall Study|Withdrawal by Subject|17
6787979|NCT03085095|10785953|FG001|Overall Study|Withdrawal by Subject|6
6787980|NCT03085095|10785952|FG000|Overall Study|Physician Decision|9
6787981|NCT03085095|10785953|FG001|Overall Study|Physician Decision|3
6787982|NCT03085095|10785952|FG000|Overall Study|Testosterone Suppression Level Not Met|7
6787983|NCT03085095|10785953|FG001|Overall Study|Testosterone Suppression Level Not Met|13
6787984|NCT03085095|10785952|FG000|Overall Study|Did not Receive Study Drug|2
6787985|NCT03085095|10785953|FG001|Overall Study|Did not Receive Study Drug|2
6787986|NCT03085095|10785952|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1
6787987|NCT03085095|10785953|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0
6787988|NCT03048422|10785965|FG000|Overall Study|Death|1
6787989|NCT03048422|10785966|FG001|Overall Study|Death|0
6787990|NCT03048422|10785967|FG002|Overall Study|Death|0
6787991|NCT03048422|10785965|FG000|Overall Study|Lost to Follow-up|5
6787992|NCT03048422|10785966|FG001|Overall Study|Lost to Follow-up|0
6787993|NCT03048422|10785967|FG002|Overall Study|Lost to Follow-up|1
6787994|NCT03048422|10785965|FG000|Overall Study|Withdrawal by Subject|5
6787995|NCT03048422|10785966|FG001|Overall Study|Withdrawal by Subject|7
6787996|NCT03048422|10785967|FG002|Overall Study|Withdrawal by Subject|4
6787997|NCT03048422|10785965|FG000|Overall Study|Moved|3
6787998|NCT03048422|10785966|FG001|Overall Study|Moved|2
6787999|NCT03048422|10785967|FG002|Overall Study|Moved|2
6788000|NCT03048422|10785965|FG000|Overall Study|Noncompliant with Study Requirements|2
6788001|NCT03048422|10785966|FG001|Overall Study|Noncompliant with Study Requirements|1
6788002|NCT03048422|10785967|FG002|Overall Study|Noncompliant with Study Requirements|2
6788003|NCT03048422|10785965|FG000|Overall Study|Not Able to Get to Clinic|1
6788004|NCT03048422|10785966|FG001|Overall Study|Not Able to Get to Clinic|0
6788005|NCT03048422|10785967|FG002|Overall Study|Not Able to Get to Clinic|0
6788006|NCT03032068|10785985|FG000|Overall Study|Adverse Event|1
6788007|NCT02835690|10786005|FG000|Overall Study|Death|4
6788008|NCT02835690|10786006|FG001|Overall Study|Death|6
6788009|NCT02835690|10786007|FG002|Overall Study|Death|6
6788010|NCT02835690|10786005|FG000|Overall Study|Ongoing in Study (Follow-up)|10
6788011|NCT02835690|10786006|FG001|Overall Study|Ongoing in Study (Follow-up)|7
6788012|NCT02835690|10786007|FG002|Overall Study|Ongoing in Study (Follow-up)|9
6788013|NCT02835690|10786005|FG000|Overall Study|Not Treated|0
6788014|NCT02835690|10786006|FG001|Overall Study|Not Treated|2
6788015|NCT02835690|10786007|FG002|Overall Study|Not Treated|0
6788016|NCT02828982|10786015|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1
6788017|NCT02828982|10786016|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1
6788018|NCT02815280|10786030|FG000|Double-Blind Phase|Adverse Event|1
6788019|NCT02815280|10786031|FG001|Double-Blind Phase|Adverse Event|1
6788020|NCT02815280|10786030|FG000|Double-Blind Phase|Lost to Follow-up|10
6788021|NCT02815280|10786031|FG001|Double-Blind Phase|Lost to Follow-up|9
6788022|NCT02815280|10786030|FG000|Double-Blind Phase|Withdrawal by Subject|20
6788023|NCT02815280|10786031|FG001|Double-Blind Phase|Withdrawal by Subject|11
6788024|NCT02815280|10786030|FG000|Double-Blind Phase|Protocol Violation|2
6788025|NCT02815280|10786031|FG001|Double-Blind Phase|Protocol Violation|2
6788026|NCT02815280|10786030|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3
6788027|NCT02815280|10786031|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2
6788028|NCT02815280|10786030|FG000|Open-Label Phase|Adverse Event|2
6788029|NCT02815280|10786031|FG001|Open-Label Phase|Adverse Event|3
6788030|NCT02815280|10786030|FG000|Open-Label Phase|Lost to Follow-up|18
6788031|NCT02815280|10786031|FG001|Open-Label Phase|Lost to Follow-up|9
6788032|NCT02815280|10786030|FG000|Open-Label Phase|Withdrawal by Subject|33
6788033|NCT02815280|10786031|FG001|Open-Label Phase|Withdrawal by Subject|18
6788034|NCT02815280|10786030|FG000|Open-Label Phase|Protocol Violation|3
6788035|NCT02815280|10786031|FG001|Open-Label Phase|Protocol Violation|0
6788036|NCT02815280|10786030|FG000|Open-Label Phase|Administrative|26
6788037|NCT02815280|10786031|FG001|Open-Label Phase|Administrative|12
6788038|NCT02815280|10786030|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5
6788039|NCT02815280|10786031|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2
6788040|NCT02815267|10786043|FG000|Double-Blind Phase|Adverse Event|0
6788041|NCT02815267|10786044|FG001|Double-Blind Phase|Adverse Event|3
6788042|NCT02815267|10786043|FG000|Double-Blind Phase|Lost to Follow-up|17
6788043|NCT02815267|10786044|FG001|Double-Blind Phase|Lost to Follow-up|9
6788044|NCT02815267|10786043|FG000|Double-Blind Phase|Withdrawal by Subject|11
6788045|NCT02815267|10786044|FG001|Double-Blind Phase|Withdrawal by Subject|10
6788046|NCT02815267|10786043|FG000|Double-Blind Phase|Protocol Violation|3
6788047|NCT02815267|10786044|FG001|Double-Blind Phase|Protocol Violation|2
6788048|NCT02815267|10786043|FG000|Double-Blind Phase|Site withdrawal|1
6788049|NCT02815267|10786044|FG001|Double-Blind Phase|Site withdrawal|6
6788050|NCT02815267|10786043|FG000|Double-Blind Phase|Received a disallowed medication|1
6788051|NCT02815267|10786044|FG001|Double-Blind Phase|Received a disallowed medication|1
6788052|NCT02815267|10786043|FG000|Open-Label Phase|Adverse Event|1
6788053|NCT02815267|10786044|FG001|Open-Label Phase|Adverse Event|1
6788054|NCT02815267|10786043|FG000|Open-Label Phase|Lost to Follow-up|23
6788055|NCT02815267|10786044|FG001|Open-Label Phase|Lost to Follow-up|9
6788056|NCT02815267|10786043|FG000|Open-Label Phase|Withdrawal by Subject|24
6788057|NCT02815267|10786044|FG001|Open-Label Phase|Withdrawal by Subject|13
6788058|NCT02815267|10786043|FG000|Open-Label Phase|Protocol Violation|0
6788059|NCT02815267|10786044|FG001|Open-Label Phase|Protocol Violation|1
6788060|NCT02815267|10786043|FG000|Open-Label Phase|Administrative|21
6788061|NCT02815267|10786044|FG001|Open-Label Phase|Administrative|12
6788062|NCT02815267|10786043|FG000|Open-Label Phase|Other|2
6788063|NCT02815267|10786044|FG001|Open-Label Phase|Other|5
6788064|NCT02802228|10786056|FG000|Overall Study|Withdrawal by Subject|2
6788065|NCT02802228|10786057|FG001|Overall Study|Withdrawal by Subject|0
6788066|NCT02802228|10786056|FG000|Overall Study|Lost to Follow-up|1
6788067|NCT02802228|10786057|FG001|Overall Study|Lost to Follow-up|0
6788068|NCT02802228|10786056|FG000|Overall Study|Adverse Event|1
6788069|NCT02802228|10786057|FG001|Overall Study|Adverse Event|0
6788070|NCT02802228|10786056|FG000|Overall Study|Physician Decision|1
6788071|NCT02802228|10786057|FG001|Overall Study|Physician Decision|0
6788072|NCT02674516|10786088|FG000|Overall Study|Lost to Follow-up|3
6788073|NCT02674516|10786089|FG001|Overall Study|Lost to Follow-up|0
6788074|NCT02674516|10786088|FG000|Overall Study|Protocol Violation|0
6788075|NCT02674516|10786089|FG001|Overall Study|Protocol Violation|4
6788076|NCT02674516|10786088|FG000|Overall Study|Knowledge of study hypothesis|1
6788077|NCT02674516|10786089|FG001|Overall Study|Knowledge of study hypothesis|0
6788078|NCT02655016|10786097|FG000|Overall Study|Disease progression|6
6788079|NCT02655016|10786098|FG001|Overall Study|Disease progression|4
6788080|NCT02655016|10786097|FG000|Overall Study|Site closed|0
6788081|NCT02655016|10786098|FG001|Overall Study|Site closed|1
6788082|NCT02655016|10786097|FG000|Overall Study|Death|30
6788083|NCT02655016|10786098|FG001|Overall Study|Death|48
6788084|NCT02655016|10786097|FG000|Overall Study|Lost to Follow-up|1
6788085|NCT02655016|10786098|FG001|Overall Study|Lost to Follow-up|1
6788086|NCT02655016|10786097|FG000|Overall Study|Withdrawal by Subject|18
6788087|NCT02655016|10786098|FG001|Overall Study|Withdrawal by Subject|36
6788088|NCT02505425|10786118|FG000|Overall Study|Lost to Follow-up|41
6788089|NCT02505425|10786119|FG001|Overall Study|Lost to Follow-up|61
6788090|NCT02505425|10786120|FG002|Overall Study|Lost to Follow-up|31
6788091|NCT02505425|10786121|FG003|Overall Study|Lost to Follow-up|19
6788092|NCT02505425|10786118|FG000|Overall Study|Withdrawal by Subject|39
6788093|NCT02505425|10786119|FG001|Overall Study|Withdrawal by Subject|9
6788094|NCT02505425|10786120|FG002|Overall Study|Withdrawal by Subject|19
6788095|NCT02505425|10786121|FG003|Overall Study|Withdrawal by Subject|7
6788096|NCT02505425|10786118|FG000|Overall Study|Death|8
6788097|NCT02505425|10786119|FG001|Overall Study|Death|12
6788098|NCT02505425|10786120|FG002|Overall Study|Death|0
6788099|NCT02505425|10786121|FG003|Overall Study|Death|0
6788100|NCT02487979|10786131|FG000|Overall Study|Physician Decision|2
6788101|NCT02487979|10786131|FG000|Overall Study|Withdrawal by Subject|2
6788102|NCT02487979|10786131|FG000|Overall Study|Progressive Disease|17
6788103|NCT02463448|10786135|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3
6788104|NCT02463448|10786135|FG000|6 Months Through 12 Months|Lost to Follow-up|1
6788105|NCT02463448|10786135|FG000|6 Months Through 12 Months|Withdrawal by Subject|1
6788106|NCT02463448|10786135|FG000|12 Months Through End of Study|Lost to Follow-up|1
6807523|NCT03307785|10811134|FG001|Part C: Up to 22.5 Months|Disease progression|0
6807524|NCT03307785|10811135|FG002|Part C: Up to 22.5 Months|Disease progression|0
6807525|NCT03307785|10811136|FG003|Part C: Up to 22.5 Months|Disease progression|0
6807526|NCT03307785|10811137|FG004|Part C: Up to 22.5 Months|Disease progression|1
6807527|NCT03307785|10811138|FG005|Part C: Up to 22.5 Months|Disease progression|0
6807528|NCT03307785|10811139|FG006|Part C: Up to 22.5 Months|Disease progression|0
6807529|NCT03307785|10811140|FG007|Part C: Up to 22.5 Months|Disease progression|0
6807530|NCT03307785|10811141|FG008|Part C: Up to 22.5 Months|Disease progression|0
6807531|NCT03307785|10811142|FG009|Part C: Up to 22.5 Months|Disease progression|0
6807532|NCT03307785|10811143|FG010|Part C: Up to 22.5 Months|Disease progression|0
6807533|NCT03307785|10811133|FG000|Part C: Up to 22.5 Months|Physician Decision|0
6807534|NCT03307785|10811134|FG001|Part C: Up to 22.5 Months|Physician Decision|0
6807535|NCT03307785|10811135|FG002|Part C: Up to 22.5 Months|Physician Decision|0
6807536|NCT03307785|10811136|FG003|Part C: Up to 22.5 Months|Physician Decision|3
6807537|NCT03307785|10811137|FG004|Part C: Up to 22.5 Months|Physician Decision|1
6788107|NCT02276547|10786148|FG000|Overall Study|Death|2
6788108|NCT02276547|10786148|FG000|Overall Study|Explant|2
6788109|NCT02263885|10786152|FG000|Overall Study|Withdrawal by Subject|7
6788110|NCT02263885|10786152|FG000|Overall Study|Alternative Treatment|3
6788111|NCT02213926|10786157|FG000|Overall Study|Death|59
6788112|NCT02213926|10786157|FG000|Overall Study|Withdrawal by Subject|10
6788113|NCT02213926|10786157|FG000|Overall Study|study terminated by sponsor|51
6788114|NCT02213926|10786157|FG000|Overall Study|Lost to Follow-up|3
6788115|NCT02213926|10786157|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1
6788116|NCT02008396|10786163|FG000|Overall Study|Protocol Violation|0
6788117|NCT02008396|10786164|FG001|Overall Study|Protocol Violation|1
6788118|NCT01995175|10786171|FG000|Overall Study|Withdrawal by Subject|35
6788119|NCT01995175|10786171|FG000|Overall Study|Lost to Follow-up|102
6788120|NCT01995175|10786171|FG000|Overall Study|Other|67
6788121|NCT01995175|10786171|FG000|Overall Study|Migrated / moved from the study area|49
6788122|NCT01804270|10786185|FG000|Overall Study|Withdrawal by Subject|1
6788123|NCT01804270|10786186|FG001|Overall Study|Withdrawal by Subject|1
7139568|NCT02960490|11293397|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
7139569|NCT02960490|11293398|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
7139570|NCT02960490|11293399|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
7139571|NCT02960490|11293400|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
7139572|NCT02960490|11293401|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
7139573|NCT02960490|11293402|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
7139574|NCT02960490|11293403|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
7139575|NCT02960490|11293394|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
7139576|NCT02960490|11293395|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1
7139577|NCT02960490|11293396|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
7139578|NCT02960490|11293397|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
7139579|NCT02960490|11293398|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
7139580|NCT02960490|11293399|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
7139581|NCT02960490|11293400|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
7139582|NCT02960490|11293401|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
7139583|NCT02960490|11293402|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
7139584|NCT02960490|11293403|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
7139585|NCT02960490|11293394|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1
7139586|NCT02960490|11293395|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2
7139587|NCT02960490|11293396|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
7139588|NCT02960490|11293397|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
7139589|NCT02960490|11293398|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
7139590|NCT02960490|11293399|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
7139591|NCT02960490|11293400|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
7139592|NCT02960490|11293401|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
7139593|NCT02960490|11293402|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
7139594|NCT02960490|11293403|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
7139595|NCT02960490|11293394|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1
7139596|NCT02960490|11293395|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1
7139597|NCT02960490|11293396|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
7139598|NCT02960490|11293397|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
7139599|NCT02960490|11293398|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
7139600|NCT02960490|11293399|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
7139601|NCT02960490|11293400|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
7139602|NCT02960490|11293401|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
7139603|NCT02960490|11293402|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
7139604|NCT02960490|11293403|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
7139605|NCT02960490|11293394|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
7139606|NCT02960490|11293395|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
7139607|NCT02960490|11293396|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1
7139608|NCT02960490|11293397|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1
7139609|NCT02960490|11293398|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
7139610|NCT02960490|11293399|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2
7139611|NCT02960490|11293400|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
7139612|NCT02960490|11293401|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
7139613|NCT02960490|11293402|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
7139614|NCT02960490|11293403|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
7139615|NCT02960490|11293394|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0
7139616|NCT02960490|11293395|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0
7139617|NCT02960490|11293396|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1
7139618|NCT02960490|11293397|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0
7139619|NCT02960490|11293398|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1
7139620|NCT02960490|11293399|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0
7139621|NCT02960490|11293400|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0
7139622|NCT02960490|11293401|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0
6788136|NCT01338636|10786205|FG000|Overall Study|Withdrawn due to lack of improvement|8
6788137|NCT01208974|10786209|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1
6788138|NCT01208974|10786210|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0
6788139|NCT01208974|10786211|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0
6788140|NCT01208974|10786212|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0
6788141|NCT01208974|10786209|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1
6788142|NCT01208974|10786210|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0
6788143|NCT01208974|10786211|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0
6788144|NCT01208974|10786212|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0
6788145|NCT01208974|10786209|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1
6788146|NCT01208974|10786210|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0
6788147|NCT01208974|10786211|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0
6788148|NCT01208974|10786212|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0
6788149|NCT00938912|10786219|FG000|Overall Study|Withdrawal by Subject|28
6788150|NCT00938912|10786219|FG000|Overall Study|Lost to Follow-up|4
6788151|NCT00938912|10786219|FG000|Overall Study|Lack of Efficacy|43
6788152|NCT00938912|10786219|FG000|Overall Study|Adverse event, non-fatal|24
6788153|NCT00938912|10786219|FG000|Overall Study|Adverse event, fatal|1
6788154|NCT00938912|10786219|FG000|Overall Study|Participant self adjusted antiepileptic medication|1
6788155|NCT00938912|10786219|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1
6788156|NCT00938912|10786219|FG000|Overall Study|Participant needed prohibit medication|1
6788157|NCT00938912|10786219|FG000|Overall Study|Participant was scheduled for lobal resection|1
6788158|NCT00938912|10786219|FG000|Overall Study|Did not meet Eligibility criteria|1
6788159|NCT00938912|10786219|FG000|Overall Study|Participant relocated not related to AE|1
6788160|NCT00938912|10786219|FG000|Overall Study|Participant moved to another city|1
6788161|NCT00938912|10786219|FG000|Overall Study|Participant experienced break through seizures|1
6788162|NCT00938912|10786219|FG000|Overall Study|No longer wished to participate in the study|1
6788163|NCT00938912|10786219|FG000|Overall Study|Protocol Deviation|2
6788164|NCT00676715|10786255|FG000|Overall Study|Withdrawal by Subject|7
6788165|NCT00676715|10786256|FG001|Overall Study|Withdrawal by Subject|9
6788166|NCT00676715|10786257|FG002|Overall Study|Withdrawal by Subject|10
6788167|NCT00676715|10786258|FG003|Overall Study|Withdrawal by Subject|10
6788168|NCT00676715|10786255|FG000|Overall Study|Other|2
6788169|NCT00676715|10786256|FG001|Overall Study|Other|6
6788170|NCT00676715|10786257|FG002|Overall Study|Other|4
6788171|NCT00676715|10786258|FG003|Overall Study|Other|3
6788172|NCT00676715|10786255|FG000|Overall Study|Lost to Follow-up|1
6788173|NCT00676715|10786256|FG001|Overall Study|Lost to Follow-up|1
6788174|NCT00676715|10786257|FG002|Overall Study|Lost to Follow-up|7
6788175|NCT00676715|10786258|FG003|Overall Study|Lost to Follow-up|3
6788176|NCT00676715|10786255|FG000|Overall Study|Death|1
6788177|NCT00676715|10786256|FG001|Overall Study|Death|1
6788178|NCT00676715|10786257|FG002|Overall Study|Death|1
6788179|NCT00676715|10786258|FG003|Overall Study|Death|0
6788180|NCT00676715|10786255|FG000|Overall Study|Adverse Event|0
6788181|NCT00676715|10786256|FG001|Overall Study|Adverse Event|1
6788182|NCT00676715|10786257|FG002|Overall Study|Adverse Event|2
6788183|NCT00676715|10786258|FG003|Overall Study|Adverse Event|0
6788184|NCT00676715|10786255|FG000|Overall Study|Participants Ongoing|29
6788185|NCT00676715|10786256|FG001|Overall Study|Participants Ongoing|29
6788186|NCT00676715|10786257|FG002|Overall Study|Participants Ongoing|17
6788187|NCT00676715|10786258|FG003|Overall Study|Participants Ongoing|24
6788188|NCT00579826|10786270|FG000|Overall Study|Withdrawal by Subject|5
6788189|NCT00579826|10786271|FG001|Overall Study|Withdrawal by Subject|3
6788190|NCT00322218|10786279|FG000|Overall Study|Death|3
6788191|NCT00322218|10786280|FG001|Overall Study|Death|6
6788192|NCT00186888|10786289|FG000|Overall Study|Toxicity|0
6788193|NCT00186888|10786290|FG001|Overall Study|Toxicity|1
6788194|NCT00186888|10786291|FG002|Overall Study|Toxicity|0
6788195|NCT00186888|10786289|FG000|Overall Study|Relapse or progression of disease|4
6788196|NCT00186888|10786290|FG001|Overall Study|Relapse or progression of disease|2
6788197|NCT00186888|10786291|FG002|Overall Study|Relapse or progression of disease|0
6807538|NCT03307785|10811138|FG005|Part C: Up to 22.5 Months|Physician Decision|0
6807539|NCT03307785|10811139|FG006|Part C: Up to 22.5 Months|Physician Decision|0
6807540|NCT03307785|10811140|FG007|Part C: Up to 22.5 Months|Physician Decision|0
6807541|NCT03307785|10811141|FG008|Part C: Up to 22.5 Months|Physician Decision|0
6807542|NCT03307785|10811142|FG009|Part C: Up to 22.5 Months|Physician Decision|0
6807543|NCT03307785|10811143|FG010|Part C: Up to 22.5 Months|Physician Decision|0
6807544|NCT03307785|10811133|FG000|Part C: Up to 22.5 Months|Death|0
6807545|NCT03307785|10811134|FG001|Part C: Up to 22.5 Months|Death|0
6807546|NCT03307785|10811135|FG002|Part C: Up to 22.5 Months|Death|0
6807547|NCT03307785|10811136|FG003|Part C: Up to 22.5 Months|Death|1
6807548|NCT03307785|10811137|FG004|Part C: Up to 22.5 Months|Death|4
6807549|NCT03307785|10811138|FG005|Part C: Up to 22.5 Months|Death|0
6807550|NCT03307785|10811139|FG006|Part C: Up to 22.5 Months|Death|0
6807551|NCT03307785|10811140|FG007|Part C: Up to 22.5 Months|Death|0
6807552|NCT03307785|10811141|FG008|Part C: Up to 22.5 Months|Death|0
6807553|NCT03307785|10811142|FG009|Part C: Up to 22.5 Months|Death|0
6807554|NCT03307785|10811143|FG010|Part C: Up to 22.5 Months|Death|0
6807555|NCT03307785|10811133|FG000|Part C: Up to 22.5 Months|Withdrawal by Subject|0
6788198|NCT04314284|10786336|FG000|Overall Study|Withdrawal by Subject|4
6788199|NCT04314284|10786337|FG001|Overall Study|Withdrawal by Subject|7
6788200|NCT04314284|10786336|FG000|Overall Study|Consented but did not complete survey|0
6788201|NCT04314284|10786337|FG001|Overall Study|Consented but did not complete survey|6
6788202|NCT04066491|10786346|FG000|Overall Study|Treatment ongoing|2
6788203|NCT04066491|10786347|FG001|Overall Study|Treatment ongoing|72
6788204|NCT04066491|10786348|FG002|Overall Study|Treatment ongoing|66
6788205|NCT04066491|10786346|FG000|Overall Study|Treatment completed/discontinued and in follow-up,|2
6788206|NCT04066491|10786347|FG001|Overall Study|Treatment completed/discontinued and in follow-up,|39
6788207|NCT04066491|10786348|FG002|Overall Study|Treatment completed/discontinued and in follow-up,|41
6788208|NCT04066491|10786346|FG000|Overall Study|Randomized, not treated|0
6788209|NCT04066491|10786347|FG001|Overall Study|Randomized, not treated|0
6788210|NCT04066491|10786348|FG002|Overall Study|Randomized, not treated|2
6788211|NCT03259425|10786357|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1
6788212|NCT03129100|10786366|FG000|Lead-In Period (Period 1)|Adverse Event|2
6788213|NCT03129100|10786367|FG001|Lead-In Period (Period 1)|Adverse Event|6
6788214|NCT03129100|10786368|FG002|Lead-In Period (Period 1)|Adverse Event|0
6788215|NCT03129100|10786369|FG003|Lead-In Period (Period 1)|Adverse Event|0
6788216|NCT03129100|10786370|FG004|Lead-In Period (Period 1)|Adverse Event|0
6788217|NCT03129100|10786371|FG005|Lead-In Period (Period 1)|Adverse Event|0
6788218|NCT03129100|10786372|FG006|Lead-In Period (Period 1)|Adverse Event|0
6788219|NCT03129100|10786373|FG007|Lead-In Period (Period 1)|Adverse Event|0
6788220|NCT03129100|10786374|FG008|Lead-In Period (Period 1)|Adverse Event|0
6788221|NCT03129100|10786375|FG009|Lead-In Period (Period 1)|Adverse Event|0
6788222|NCT03129100|10786376|FG010|Lead-In Period (Period 1)|Adverse Event|0
6788223|NCT03129100|10786377|FG011|Lead-In Period (Period 1)|Adverse Event|0
6788224|NCT03129100|10786378|FG012|Lead-In Period (Period 1)|Adverse Event|0
6788225|NCT03129100|10786379|FG013|Lead-In Period (Period 1)|Adverse Event|0
6788226|NCT03129100|10786380|FG014|Lead-In Period (Period 1)|Adverse Event|0
6788227|NCT03129100|10786381|FG015|Lead-In Period (Period 1)|Adverse Event|0
6788228|NCT03129100|10786382|FG016|Lead-In Period (Period 1)|Adverse Event|0
6788229|NCT03129100|10786383|FG017|Lead-In Period (Period 1)|Adverse Event|0
6788230|NCT03129100|10786384|FG018|Lead-In Period (Period 1)|Adverse Event|0
6788231|NCT03129100|10786385|FG019|Lead-In Period (Period 1)|Adverse Event|0
6788232|NCT03129100|10786386|FG020|Lead-In Period (Period 1)|Adverse Event|0
6788233|NCT03129100|10786387|FG021|Lead-In Period (Period 1)|Adverse Event|0
6788234|NCT03129100|10786388|FG022|Lead-In Period (Period 1)|Adverse Event|0
6788235|NCT03129100|10786389|FG023|Lead-In Period (Period 1)|Adverse Event|0
6788236|NCT03129100|10786390|FG024|Lead-In Period (Period 1)|Adverse Event|0
6788237|NCT03129100|10786391|FG025|Lead-In Period (Period 1)|Adverse Event|0
6788238|NCT03129100|10786366|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2
6788239|NCT03129100|10786367|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0
6788240|NCT03129100|10786368|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0
6788241|NCT03129100|10786369|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0
6788242|NCT03129100|10786370|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0
6788243|NCT03129100|10786371|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0
6788244|NCT03129100|10786372|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0
6788245|NCT03129100|10786373|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0
6788246|NCT03129100|10786374|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0
6788247|NCT03129100|10786375|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0
6788248|NCT03129100|10786376|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0
6788249|NCT03129100|10786377|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0
6788250|NCT03129100|10786378|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0
6788251|NCT03129100|10786379|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0
6788252|NCT03129100|10786380|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0
6788253|NCT03129100|10786381|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0
6788254|NCT03129100|10786382|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0
6788255|NCT03129100|10786383|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0
6788256|NCT03129100|10786384|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0
6788257|NCT03129100|10786385|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0
6788258|NCT03129100|10786386|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0
6788259|NCT03129100|10786387|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0
6788260|NCT03129100|10786388|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0
6788261|NCT03129100|10786389|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0
6788262|NCT03129100|10786390|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0
6788263|NCT03129100|10786391|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0
6788264|NCT03129100|10786366|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8
6788265|NCT03129100|10786367|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8
6788266|NCT03129100|10786368|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0
6788267|NCT03129100|10786369|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0
6788268|NCT03129100|10786370|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0
6788269|NCT03129100|10786371|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0
6788270|NCT03129100|10786372|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0
6788271|NCT03129100|10786373|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0
6788272|NCT03129100|10786374|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0
6788273|NCT03129100|10786375|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0
6788274|NCT03129100|10786376|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0
6788275|NCT03129100|10786377|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0
6788276|NCT03129100|10786378|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0
6788277|NCT03129100|10786379|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0
6788278|NCT03129100|10786380|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0
6788279|NCT03129100|10786381|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0
6788280|NCT03129100|10786382|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0
6788281|NCT03129100|10786383|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0
6788282|NCT03129100|10786384|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0
6788283|NCT03129100|10786385|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0
6788284|NCT03129100|10786386|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0
6788285|NCT03129100|10786387|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0
6788286|NCT03129100|10786388|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0
6788287|NCT03129100|10786389|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0
6788288|NCT03129100|10786390|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0
6788289|NCT03129100|10786391|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0
6788290|NCT03129100|10786366|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3
6788291|NCT03129100|10786367|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2
6788292|NCT03129100|10786368|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0
6788293|NCT03129100|10786369|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0
6788294|NCT03129100|10786370|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0
6788295|NCT03129100|10786371|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0
6788296|NCT03129100|10786372|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0
6788297|NCT03129100|10786373|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0
6788298|NCT03129100|10786374|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0
6788299|NCT03129100|10786375|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0
6788300|NCT03129100|10786376|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0
6788301|NCT03129100|10786377|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0
6788302|NCT03129100|10786378|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0
6788303|NCT03129100|10786379|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0
6788304|NCT03129100|10786380|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0
6788305|NCT03129100|10786381|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0
6788306|NCT03129100|10786382|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0
6788307|NCT03129100|10786383|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0
6788308|NCT03129100|10786384|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0
6788309|NCT03129100|10786385|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0
6788310|NCT03129100|10786386|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0
6788311|NCT03129100|10786387|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0
6788312|NCT03129100|10786388|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0
6788313|NCT03129100|10786389|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0
6788314|NCT03129100|10786390|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0
6788315|NCT03129100|10786391|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0
6788316|NCT03129100|10786366|FG000|Lead-In Period (Period 1)|Surgery Programmed|0
6788317|NCT03129100|10786367|FG001|Lead-In Period (Period 1)|Surgery Programmed|1
6788318|NCT03129100|10786368|FG002|Lead-In Period (Period 1)|Surgery Programmed|0
6788319|NCT03129100|10786369|FG003|Lead-In Period (Period 1)|Surgery Programmed|0
6788320|NCT03129100|10786370|FG004|Lead-In Period (Period 1)|Surgery Programmed|0
6788321|NCT03129100|10786371|FG005|Lead-In Period (Period 1)|Surgery Programmed|0
6788322|NCT03129100|10786372|FG006|Lead-In Period (Period 1)|Surgery Programmed|0
6788323|NCT03129100|10786373|FG007|Lead-In Period (Period 1)|Surgery Programmed|0
6788324|NCT03129100|10786374|FG008|Lead-In Period (Period 1)|Surgery Programmed|0
6788325|NCT03129100|10786375|FG009|Lead-In Period (Period 1)|Surgery Programmed|0
6788326|NCT03129100|10786376|FG010|Lead-In Period (Period 1)|Surgery Programmed|0
6788327|NCT03129100|10786377|FG011|Lead-In Period (Period 1)|Surgery Programmed|0
6788328|NCT03129100|10786378|FG012|Lead-In Period (Period 1)|Surgery Programmed|0
6788329|NCT03129100|10786379|FG013|Lead-In Period (Period 1)|Surgery Programmed|0
6788330|NCT03129100|10786380|FG014|Lead-In Period (Period 1)|Surgery Programmed|0
6788331|NCT03129100|10786381|FG015|Lead-In Period (Period 1)|Surgery Programmed|0
6788332|NCT03129100|10786382|FG016|Lead-In Period (Period 1)|Surgery Programmed|0
6788333|NCT03129100|10786383|FG017|Lead-In Period (Period 1)|Surgery Programmed|0
6788334|NCT03129100|10786384|FG018|Lead-In Period (Period 1)|Surgery Programmed|0
6788335|NCT03129100|10786385|FG019|Lead-In Period (Period 1)|Surgery Programmed|0
6788336|NCT03129100|10786386|FG020|Lead-In Period (Period 1)|Surgery Programmed|0
6788337|NCT03129100|10786387|FG021|Lead-In Period (Period 1)|Surgery Programmed|0
6788338|NCT03129100|10786388|FG022|Lead-In Period (Period 1)|Surgery Programmed|0
6788339|NCT03129100|10786389|FG023|Lead-In Period (Period 1)|Surgery Programmed|0
6788340|NCT03129100|10786390|FG024|Lead-In Period (Period 1)|Surgery Programmed|0
6788341|NCT03129100|10786391|FG025|Lead-In Period (Period 1)|Surgery Programmed|0
6788342|NCT03129100|10786366|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0
6788343|NCT03129100|10786367|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0
6788344|NCT03129100|10786368|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2
6788345|NCT03129100|10786369|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1
6788346|NCT03129100|10786370|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0
6788347|NCT03129100|10786371|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2
6788348|NCT03129100|10786372|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0
6788349|NCT03129100|10786373|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0
6788350|NCT03129100|10786374|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0
6788351|NCT03129100|10786375|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0
6788352|NCT03129100|10786376|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0
6788353|NCT03129100|10786377|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0
6788354|NCT03129100|10786378|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0
6788355|NCT03129100|10786379|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0
6788356|NCT03129100|10786380|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0
6788357|NCT03129100|10786381|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0
6788358|NCT03129100|10786382|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0
6788359|NCT03129100|10786383|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0
6788360|NCT03129100|10786384|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0
6788361|NCT03129100|10786385|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0
6788362|NCT03129100|10786386|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0
6788363|NCT03129100|10786387|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0
6788364|NCT03129100|10786388|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0
6788365|NCT03129100|10786389|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0
6788366|NCT03129100|10786390|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0
6788367|NCT03129100|10786391|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0
6788368|NCT03129100|10786366|FG000|Period2 Extension Period (Group A and B)|Death|0
6788369|NCT03129100|10786367|FG001|Period2 Extension Period (Group A and B)|Death|0
6788370|NCT03129100|10786368|FG002|Period2 Extension Period (Group A and B)|Death|1
6788371|NCT03129100|10786369|FG003|Period2 Extension Period (Group A and B)|Death|0
6788372|NCT03129100|10786370|FG004|Period2 Extension Period (Group A and B)|Death|0
6788373|NCT03129100|10786371|FG005|Period2 Extension Period (Group A and B)|Death|0
6788374|NCT03129100|10786372|FG006|Period2 Extension Period (Group A and B)|Death|0
6788375|NCT03129100|10786373|FG007|Period2 Extension Period (Group A and B)|Death|0
6788376|NCT03129100|10786374|FG008|Period2 Extension Period (Group A and B)|Death|0
6788377|NCT03129100|10786375|FG009|Period2 Extension Period (Group A and B)|Death|0
6788378|NCT03129100|10786376|FG010|Period2 Extension Period (Group A and B)|Death|0
6788379|NCT03129100|10786377|FG011|Period2 Extension Period (Group A and B)|Death|0
6788380|NCT03129100|10786378|FG012|Period2 Extension Period (Group A and B)|Death|0
6788381|NCT03129100|10786379|FG013|Period2 Extension Period (Group A and B)|Death|0
6788382|NCT03129100|10786380|FG014|Period2 Extension Period (Group A and B)|Death|0
6788383|NCT03129100|10786381|FG015|Period2 Extension Period (Group A and B)|Death|0
6788384|NCT03129100|10786382|FG016|Period2 Extension Period (Group A and B)|Death|0
6788385|NCT03129100|10786383|FG017|Period2 Extension Period (Group A and B)|Death|0
6788386|NCT03129100|10786384|FG018|Period2 Extension Period (Group A and B)|Death|0
6788387|NCT03129100|10786385|FG019|Period2 Extension Period (Group A and B)|Death|0
6788388|NCT03129100|10786386|FG020|Period2 Extension Period (Group A and B)|Death|0
6788389|NCT03129100|10786387|FG021|Period2 Extension Period (Group A and B)|Death|0
6788390|NCT03129100|10786388|FG022|Period2 Extension Period (Group A and B)|Death|0
6788391|NCT03129100|10786389|FG023|Period2 Extension Period (Group A and B)|Death|0
6788392|NCT03129100|10786390|FG024|Period2 Extension Period (Group A and B)|Death|0
6788393|NCT03129100|10786391|FG025|Period2 Extension Period (Group A and B)|Death|0
6788394|NCT03129100|10786366|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
6788395|NCT03129100|10786367|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
6788396|NCT03129100|10786368|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13
6788397|NCT03129100|10786369|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5
6788398|NCT03129100|10786370|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1
6788399|NCT03129100|10786371|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1
6788400|NCT03129100|10786372|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2
6788401|NCT03129100|10786373|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
6788402|NCT03129100|10786374|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
6788403|NCT03129100|10786375|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
6788404|NCT03129100|10786376|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
6788405|NCT03129100|10786377|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
6788406|NCT03129100|10786378|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
6788407|NCT03129100|10786379|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
6788408|NCT03129100|10786380|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
6788409|NCT03129100|10786381|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
6788410|NCT03129100|10786382|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
6788411|NCT03129100|10786383|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
6788412|NCT03129100|10786384|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
6788413|NCT03129100|10786385|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
6788414|NCT03129100|10786386|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
6788415|NCT03129100|10786387|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
6788416|NCT03129100|10786388|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
6788417|NCT03129100|10786389|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
6810776|NCT02550288|10814721|FG002|Overall Study|Participant moved|0
6788418|NCT03129100|10786390|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
6788419|NCT03129100|10786391|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
6788420|NCT03129100|10786366|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0
6788421|NCT03129100|10786367|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0
6788422|NCT03129100|10786368|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1
6788423|NCT03129100|10786369|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0
6788424|NCT03129100|10786370|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0
6788425|NCT03129100|10786371|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0
6788426|NCT03129100|10786372|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0
6788427|NCT03129100|10786373|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0
6788428|NCT03129100|10786374|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0
6788429|NCT03129100|10786375|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0
6788430|NCT03129100|10786376|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0
6788431|NCT03129100|10786377|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0
6788432|NCT03129100|10786378|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0
6788433|NCT03129100|10786379|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0
6788434|NCT03129100|10786380|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0
6788435|NCT03129100|10786381|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0
6788436|NCT03129100|10786382|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0
6788437|NCT03129100|10786383|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0
6788438|NCT03129100|10786384|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0
6788439|NCT03129100|10786385|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0
6788440|NCT03129100|10786386|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0
6788441|NCT03129100|10786387|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0
6788442|NCT03129100|10786388|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0
6788443|NCT03129100|10786389|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0
6788444|NCT03129100|10786390|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0
6788445|NCT03129100|10786391|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0
6788446|NCT03129100|10786366|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
6788447|NCT03129100|10786367|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
6788448|NCT03129100|10786368|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2
6788449|NCT03129100|10786369|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
6788450|NCT03129100|10786370|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
6788451|NCT03129100|10786371|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
6788452|NCT03129100|10786372|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
6788453|NCT03129100|10786373|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
6788454|NCT03129100|10786374|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
6788455|NCT03129100|10786375|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
6788456|NCT03129100|10786376|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
6788457|NCT03129100|10786377|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
6788458|NCT03129100|10786378|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
6788459|NCT03129100|10786379|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
6788460|NCT03129100|10786380|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
6788461|NCT03129100|10786381|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
6788462|NCT03129100|10786382|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
6788463|NCT03129100|10786383|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
6788464|NCT03129100|10786384|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
6788465|NCT03129100|10786385|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
6788466|NCT03129100|10786386|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
6788467|NCT03129100|10786387|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
6788468|NCT03129100|10786388|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
6788469|NCT03129100|10786389|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
6788470|NCT03129100|10786390|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
6788471|NCT03129100|10786391|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
6788472|NCT03129100|10786366|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
6788473|NCT03129100|10786367|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
6788474|NCT03129100|10786368|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2
6788475|NCT03129100|10786369|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
6788476|NCT03129100|10786370|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
6788477|NCT03129100|10786371|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
6788478|NCT03129100|10786372|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
6788479|NCT03129100|10786373|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
6788480|NCT03129100|10786374|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
6788481|NCT03129100|10786375|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
6788482|NCT03129100|10786376|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
6788483|NCT03129100|10786377|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
6810777|NCT02550288|10814722|FG003|Overall Study|Participant moved|1
6788484|NCT03129100|10786378|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
6788485|NCT03129100|10786379|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
6788486|NCT03129100|10786380|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
6788487|NCT03129100|10786381|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
6788488|NCT03129100|10786382|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
6788489|NCT03129100|10786383|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
6788490|NCT03129100|10786384|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
6788491|NCT03129100|10786385|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
6788492|NCT03129100|10786386|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
6788493|NCT03129100|10786387|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
6788494|NCT03129100|10786388|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
6788495|NCT03129100|10786389|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
6788496|NCT03129100|10786390|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
6788497|NCT03129100|10786391|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
6788498|NCT03129100|10786366|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0
6788499|NCT03129100|10786367|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0
6788500|NCT03129100|10786368|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0
6788501|NCT03129100|10786369|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0
6788502|NCT03129100|10786370|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5
6788503|NCT03129100|10786371|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6
6788504|NCT03129100|10786372|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19
6788505|NCT03129100|10786373|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0
6788506|NCT03129100|10786374|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0
6788507|NCT03129100|10786375|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0
6788508|NCT03129100|10786376|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0
6788509|NCT03129100|10786377|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0
6788510|NCT03129100|10786378|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0
7139623|NCT02960490|11293402|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0
7139624|NCT02960490|11293403|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0
7139625|NCT02960490|11293394|FG000|Re-randomized Participants: 12 Weeks|Other|0
7139626|NCT02960490|11293395|FG001|Re-randomized Participants: 12 Weeks|Other|0
7139627|NCT02960490|11293396|FG002|Re-randomized Participants: 12 Weeks|Other|0
7139628|NCT02960490|11293397|FG003|Re-randomized Participants: 12 Weeks|Other|1
7139629|NCT02960490|11293398|FG004|Re-randomized Participants: 12 Weeks|Other|0
7139630|NCT02960490|11293399|FG005|Re-randomized Participants: 12 Weeks|Other|0
7139631|NCT02960490|11293400|FG006|Re-randomized Participants: 12 Weeks|Other|0
7139632|NCT02960490|11293401|FG007|Re-randomized Participants: 12 Weeks|Other|0
7139633|NCT02960490|11293402|FG008|Re-randomized Participants: 12 Weeks|Other|0
7139634|NCT02960490|11293403|FG009|Re-randomized Participants: 12 Weeks|Other|0
7139635|NCT02960490|11293394|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
7139636|NCT02960490|11293395|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
7139637|NCT02960490|11293396|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
7139638|NCT02960490|11293397|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
7139639|NCT02960490|11293398|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
7139640|NCT02960490|11293399|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
7139641|NCT02960490|11293400|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3
7139642|NCT02960490|11293401|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1
7139643|NCT02960490|11293402|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1
7139644|NCT02960490|11293403|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
7139645|NCT02960490|11293394|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
7139646|NCT02960490|11293395|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
7139647|NCT02960490|11293396|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
7139648|NCT02960490|11293397|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
7139649|NCT02960490|11293398|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
7139650|NCT02960490|11293399|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
7139651|NCT02960490|11293400|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
7139652|NCT02960490|11293401|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1
7139653|NCT02960490|11293402|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
7139654|NCT02960490|11293403|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
7139655|NCT02960490|11293394|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
7139656|NCT02960490|11293395|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
7139657|NCT02960490|11293396|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
7139658|NCT02960490|11293397|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
7139659|NCT02960490|11293398|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
7139660|NCT02960490|11293399|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
7139661|NCT02960490|11293400|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4
7139662|NCT02960490|11293401|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3
6788511|NCT03129100|10786379|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0
6788512|NCT03129100|10786380|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0
6788513|NCT03129100|10786381|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0
6788514|NCT03129100|10786382|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0
6788515|NCT03129100|10786383|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0
6788516|NCT03129100|10786384|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0
6788517|NCT03129100|10786385|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0
6788518|NCT03129100|10786386|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0
6788519|NCT03129100|10786387|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0
6788520|NCT03129100|10786388|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0
6788521|NCT03129100|10786389|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0
6788522|NCT03129100|10786390|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0
6788523|NCT03129100|10786391|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0
6788524|NCT03129100|10786366|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
6788525|NCT03129100|10786367|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
6788526|NCT03129100|10786368|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
6788527|NCT03129100|10786369|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
6788528|NCT03129100|10786370|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
6788529|NCT03129100|10786371|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
6788530|NCT03129100|10786372|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
6788531|NCT03129100|10786373|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
6788532|NCT03129100|10786374|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
6788533|NCT03129100|10786375|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1
6788534|NCT03129100|10786376|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
6788535|NCT03129100|10786377|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
6788536|NCT03129100|10786378|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
6788537|NCT03129100|10786379|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
6788538|NCT03129100|10786380|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
6788539|NCT03129100|10786381|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
6788540|NCT03129100|10786382|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
6788541|NCT03129100|10786383|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
6788542|NCT03129100|10786384|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
6788543|NCT03129100|10786385|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
6788544|NCT03129100|10786386|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
6788545|NCT03129100|10786387|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
6788546|NCT03129100|10786388|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
6788547|NCT03129100|10786389|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
6788548|NCT03129100|10786390|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
6788549|NCT03129100|10786391|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
6788550|NCT03129100|10786366|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0
6788551|NCT03129100|10786367|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0
6788552|NCT03129100|10786368|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0
6788553|NCT03129100|10786369|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0
6788554|NCT03129100|10786370|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0
6788555|NCT03129100|10786371|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0
6788556|NCT03129100|10786372|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0
6788557|NCT03129100|10786373|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0
6788558|NCT03129100|10786374|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0
6788559|NCT03129100|10786375|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0
6788560|NCT03129100|10786376|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0
6788561|NCT03129100|10786377|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6
6788562|NCT03129100|10786378|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0
6788563|NCT03129100|10786379|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0
6788564|NCT03129100|10786380|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0
6788565|NCT03129100|10786381|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0
6788566|NCT03129100|10786382|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0
6788567|NCT03129100|10786383|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0
6788568|NCT03129100|10786384|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0
6788569|NCT03129100|10786385|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0
6788570|NCT03129100|10786386|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0
6788571|NCT03129100|10786387|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0
6788572|NCT03129100|10786388|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0
6788573|NCT03129100|10786389|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0
6788574|NCT03129100|10786390|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0
6788575|NCT03129100|10786391|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0
6788576|NCT03129100|10786366|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
6810778|NCT02550288|10814723|FG004|Overall Study|Participant moved|0
6788577|NCT03129100|10786367|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
6788578|NCT03129100|10786368|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
6788579|NCT03129100|10786369|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
6788580|NCT03129100|10786370|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
6788581|NCT03129100|10786371|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
6788582|NCT03129100|10786372|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
6788583|NCT03129100|10786373|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
6788584|NCT03129100|10786374|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
6788585|NCT03129100|10786375|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
6788586|NCT03129100|10786376|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
6788587|NCT03129100|10786377|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12
6788588|NCT03129100|10786378|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7
6788589|NCT03129100|10786379|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4
6788590|NCT03129100|10786380|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2
6788591|NCT03129100|10786381|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
6788592|NCT03129100|10786382|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
6788593|NCT03129100|10786383|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
6788594|NCT03129100|10786384|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
6788595|NCT03129100|10786385|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
6788596|NCT03129100|10786386|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
6788597|NCT03129100|10786387|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
6788598|NCT03129100|10786388|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
6788599|NCT03129100|10786389|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
6788600|NCT03129100|10786390|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
6788601|NCT03129100|10786391|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
6788602|NCT03129100|10786366|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
6788603|NCT03129100|10786367|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
6788604|NCT03129100|10786368|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
6788605|NCT03129100|10786369|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
6788606|NCT03129100|10786370|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
6788607|NCT03129100|10786371|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
6788608|NCT03129100|10786372|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
6788609|NCT03129100|10786373|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
6788610|NCT03129100|10786374|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
6788611|NCT03129100|10786375|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
6788612|NCT03129100|10786376|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
6788613|NCT03129100|10786377|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1
6788614|NCT03129100|10786378|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
6788615|NCT03129100|10786379|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1
6788616|NCT03129100|10786380|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1
6788617|NCT03129100|10786381|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
6788618|NCT03129100|10786382|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
6788619|NCT03129100|10786383|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
6788620|NCT03129100|10786384|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
6788621|NCT03129100|10786385|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
6788622|NCT03129100|10786386|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
6788623|NCT03129100|10786387|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
6788624|NCT03129100|10786388|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
6788625|NCT03129100|10786389|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
6788626|NCT03129100|10786390|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
6788627|NCT03129100|10786391|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
6788628|NCT03129100|10786366|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
6788629|NCT03129100|10786367|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
6788630|NCT03129100|10786368|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
6788631|NCT03129100|10786369|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
6788632|NCT03129100|10786370|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
6788633|NCT03129100|10786371|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
6788634|NCT03129100|10786372|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
6788635|NCT03129100|10786373|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
6788636|NCT03129100|10786374|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
6788637|NCT03129100|10786375|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
6788638|NCT03129100|10786376|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
6788639|NCT03129100|10786377|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
6788640|NCT03129100|10786378|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
6788641|NCT03129100|10786379|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
6788642|NCT03129100|10786380|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
6788643|NCT03129100|10786381|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1
6788644|NCT03129100|10786382|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
6788645|NCT03129100|10786383|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
6788646|NCT03129100|10786384|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
6788647|NCT03129100|10786385|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
6788648|NCT03129100|10786386|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
6788649|NCT03129100|10786387|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
6788650|NCT03129100|10786388|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
6788651|NCT03129100|10786389|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
6788652|NCT03129100|10786390|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
6788653|NCT03129100|10786391|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
6788654|NCT03129100|10786366|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
6788655|NCT03129100|10786367|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
6788656|NCT03129100|10786368|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
6788657|NCT03129100|10786369|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
6788658|NCT03129100|10786370|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
6788659|NCT03129100|10786371|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
6788660|NCT03129100|10786372|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
6788661|NCT03129100|10786373|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
6788662|NCT03129100|10786374|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
6788663|NCT03129100|10786375|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
6788664|NCT03129100|10786376|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
6788665|NCT03129100|10786377|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
6788666|NCT03129100|10786378|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24
6788667|NCT03129100|10786379|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
6788668|NCT03129100|10786380|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2
6788669|NCT03129100|10786381|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8
6788670|NCT03129100|10786382|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
6788671|NCT03129100|10786383|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
6788672|NCT03129100|10786384|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
6788673|NCT03129100|10786385|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
6788674|NCT03129100|10786386|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
6788675|NCT03129100|10786387|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
6788676|NCT03129100|10786388|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
6788677|NCT03129100|10786389|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
6788678|NCT03129100|10786390|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
6788679|NCT03129100|10786391|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
6788680|NCT03129100|10786366|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0
6788681|NCT03129100|10786367|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0
6788682|NCT03129100|10786368|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0
6788683|NCT03129100|10786369|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0
6788684|NCT03129100|10786370|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0
6788685|NCT03129100|10786371|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0
6788686|NCT03129100|10786372|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0
6788687|NCT03129100|10786373|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0
6788688|NCT03129100|10786374|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0
6788689|NCT03129100|10786375|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0
6788690|NCT03129100|10786376|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0
6788691|NCT03129100|10786377|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0
6788692|NCT03129100|10786378|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0
6788693|NCT03129100|10786379|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0
6788694|NCT03129100|10786380|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0
6788695|NCT03129100|10786381|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0
6788696|NCT03129100|10786382|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0
6788697|NCT03129100|10786383|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2
6788698|NCT03129100|10786384|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0
6788699|NCT03129100|10786385|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3
6788700|NCT03129100|10786386|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0
6788701|NCT03129100|10786387|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0
6788702|NCT03129100|10786388|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0
6788703|NCT03129100|10786389|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0
6788704|NCT03129100|10786390|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0
6788705|NCT03129100|10786391|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0
6788706|NCT03129100|10786366|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0
6788707|NCT03129100|10786367|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0
6788708|NCT03129100|10786368|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7139663|NCT02960490|11293402|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3
7139664|NCT02960490|11293403|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7
7139665|NCT02960490|11293394|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
7139666|NCT02960490|11293395|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
7139667|NCT02960490|11293396|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
6788709|NCT03129100|10786369|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0
6788710|NCT03129100|10786370|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0
6788711|NCT03129100|10786371|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0
6788712|NCT03129100|10786372|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0
6788713|NCT03129100|10786373|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0
6788714|NCT03129100|10786374|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0
6788715|NCT03129100|10786375|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0
6788716|NCT03129100|10786376|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0
6788717|NCT03129100|10786377|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0
6788718|NCT03129100|10786378|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0
6788719|NCT03129100|10786379|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0
6788720|NCT03129100|10786380|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0
6788721|NCT03129100|10786381|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0
6788722|NCT03129100|10786382|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0
6788723|NCT03129100|10786383|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0
6788724|NCT03129100|10786384|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0
6788725|NCT03129100|10786385|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0
6788726|NCT03129100|10786386|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2
6788727|NCT03129100|10786387|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0
6788728|NCT03129100|10786388|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0
6788729|NCT03129100|10786389|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0
6788730|NCT03129100|10786390|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0
6788731|NCT03129100|10786391|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0
6788732|NCT03129100|10786366|FG000|Period 3 (Dose Escalation)|Physician Decision|0
6788733|NCT03129100|10786367|FG001|Period 3 (Dose Escalation)|Physician Decision|0
7139668|NCT02960490|11293397|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
7139669|NCT02960490|11293398|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
7139670|NCT02960490|11293399|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
7139671|NCT02960490|11293400|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2
7139672|NCT02960490|11293401|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
7139673|NCT02960490|11293402|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
7139674|NCT02960490|11293403|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
7139675|NCT02960490|11293394|FG000|Extension Phase(Open-label): 80 Weeks|Other|0
7139676|NCT02960490|11293395|FG001|Extension Phase(Open-label): 80 Weeks|Other|0
7139677|NCT02960490|11293396|FG002|Extension Phase(Open-label): 80 Weeks|Other|0
7139678|NCT02960490|11293397|FG003|Extension Phase(Open-label): 80 Weeks|Other|0
7139679|NCT02960490|11293398|FG004|Extension Phase(Open-label): 80 Weeks|Other|0
7139680|NCT02960490|11293399|FG005|Extension Phase(Open-label): 80 Weeks|Other|0
7139681|NCT02960490|11293400|FG006|Extension Phase(Open-label): 80 Weeks|Other|0
7139682|NCT02960490|11293401|FG007|Extension Phase(Open-label): 80 Weeks|Other|1
7139683|NCT02960490|11293402|FG008|Extension Phase(Open-label): 80 Weeks|Other|0
7139684|NCT02960490|11293403|FG009|Extension Phase(Open-label): 80 Weeks|Other|0
7139685|NCT02960854|11293427|FG000|Overall Study|Not Disclosed|2
7139686|NCT02960854|11293428|FG001|Overall Study|Not Disclosed|2
7139687|NCT02960854|11293427|FG000|Overall Study|Subject No Longer Meets Study Criteria|1
7139688|NCT02960854|11293428|FG001|Overall Study|Subject No Longer Meets Study Criteria|0
7139689|NCT02960854|11293427|FG000|Overall Study|Subject Withdrew Consent|0
7139690|NCT02960854|11293428|FG001|Overall Study|Subject Withdrew Consent|1
7139691|NCT02960854|11293427|FG000|Overall Study|Death|4
7139692|NCT02960854|11293428|FG001|Overall Study|Death|6
7139693|NCT02961218|11293445|FG000|Overall Study|Lost to Follow-up|0
7139694|NCT02961218|11293446|FG001|Overall Study|Lost to Follow-up|2
7139695|NCT02961218|11293445|FG000|Overall Study|Physician Decision|0
7139696|NCT02961218|11293446|FG001|Overall Study|Physician Decision|2
7139697|NCT02961218|11293445|FG000|Overall Study|Subject/Guardian Decision|3
7139698|NCT02961218|11293446|FG001|Overall Study|Subject/Guardian Decision|1
7139699|NCT02961244|11293456|FG000|Overall Study|Protocol Violation|0
7139700|NCT02961244|11293457|FG001|Overall Study|Protocol Violation|1
7139701|NCT02961244|11293456|FG000|Overall Study|Withdrawal by Subject|1
7139702|NCT02961244|11293457|FG001|Overall Study|Withdrawal by Subject|2
7139703|NCT02961244|11293456|FG000|Overall Study|Surgery plan change after study approval|0
7139704|NCT02961244|11293457|FG001|Overall Study|Surgery plan change after study approval|2
7139705|NCT02961244|11293456|FG000|Overall Study|Lost to Follow-up|0
7139706|NCT02961244|11293457|FG001|Overall Study|Lost to Follow-up|2
7139707|NCT02961244|11293456|FG000|Overall Study|İnadequate data|0
7139708|NCT02961244|11293457|FG001|Overall Study|İnadequate data|2
7139709|NCT02961751|11293463|FG000|Overall Study|Lost to Follow-up|11
7139710|NCT02961751|11293463|FG000|Overall Study|Physician Decision|2
7139711|NCT02961751|11293463|FG000|Overall Study|Not Eligible at Enrollment|1
7139712|NCT02961751|11293463|FG000|Overall Study|Protocol Violation|1
7139713|NCT02961764|11293469|FG000|Overall Study|Protocol Violation|0
7139714|NCT02961764|11293470|FG001|Overall Study|Protocol Violation|1
7139715|NCT02961764|11293469|FG000|Overall Study|Death|2
7139716|NCT02961764|11293470|FG001|Overall Study|Death|0
7139717|NCT02961764|11293469|FG000|Overall Study|Lost to Follow-up|35
7139718|NCT02961764|11293470|FG001|Overall Study|Lost to Follow-up|24
7139719|NCT02961764|11293469|FG000|Overall Study|Withdrawal by Subject|2
7139720|NCT02961764|11293470|FG001|Overall Study|Withdrawal by Subject|0
7139721|NCT02961790|11293480|FG000|Overall Study|Canceled|4
6788734|NCT03129100|10786368|FG002|Period 3 (Dose Escalation)|Physician Decision|0
6788735|NCT03129100|10786369|FG003|Period 3 (Dose Escalation)|Physician Decision|0
6788736|NCT03129100|10786370|FG004|Period 3 (Dose Escalation)|Physician Decision|0
6788737|NCT03129100|10786371|FG005|Period 3 (Dose Escalation)|Physician Decision|0
6788738|NCT03129100|10786372|FG006|Period 3 (Dose Escalation)|Physician Decision|0
6788739|NCT03129100|10786373|FG007|Period 3 (Dose Escalation)|Physician Decision|0
6788740|NCT03129100|10786374|FG008|Period 3 (Dose Escalation)|Physician Decision|0
6788741|NCT03129100|10786375|FG009|Period 3 (Dose Escalation)|Physician Decision|0
6788742|NCT03129100|10786376|FG010|Period 3 (Dose Escalation)|Physician Decision|0
6788743|NCT03129100|10786377|FG011|Period 3 (Dose Escalation)|Physician Decision|0
6788744|NCT03129100|10786378|FG012|Period 3 (Dose Escalation)|Physician Decision|0
6788745|NCT03129100|10786379|FG013|Period 3 (Dose Escalation)|Physician Decision|0
6788746|NCT03129100|10786380|FG014|Period 3 (Dose Escalation)|Physician Decision|0
6788747|NCT03129100|10786381|FG015|Period 3 (Dose Escalation)|Physician Decision|0
6788748|NCT03129100|10786382|FG016|Period 3 (Dose Escalation)|Physician Decision|0
6788749|NCT03129100|10786383|FG017|Period 3 (Dose Escalation)|Physician Decision|0
6788750|NCT03129100|10786384|FG018|Period 3 (Dose Escalation)|Physician Decision|0
6788751|NCT03129100|10786385|FG019|Period 3 (Dose Escalation)|Physician Decision|0
6788752|NCT03129100|10786386|FG020|Period 3 (Dose Escalation)|Physician Decision|1
6788753|NCT03129100|10786387|FG021|Period 3 (Dose Escalation)|Physician Decision|0
6788754|NCT03129100|10786388|FG022|Period 3 (Dose Escalation)|Physician Decision|0
6788755|NCT03129100|10786389|FG023|Period 3 (Dose Escalation)|Physician Decision|0
6788756|NCT03129100|10786390|FG024|Period 3 (Dose Escalation)|Physician Decision|0
6788757|NCT03129100|10786391|FG025|Period 3 (Dose Escalation)|Physician Decision|0
6788758|NCT03129100|10786366|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0
6788759|NCT03129100|10786367|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0
6788760|NCT03129100|10786368|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0
6788761|NCT03129100|10786369|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0
6788762|NCT03129100|10786370|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0
6788763|NCT03129100|10786371|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0
6788764|NCT03129100|10786372|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0
6788765|NCT03129100|10786373|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0
6788766|NCT03129100|10786374|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0
6788767|NCT03129100|10786375|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0
6788768|NCT03129100|10786376|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0
6788769|NCT03129100|10786377|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0
6788770|NCT03129100|10786378|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0
6788771|NCT03129100|10786379|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0
6788772|NCT03129100|10786380|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0
6788773|NCT03129100|10786381|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0
6788774|NCT03129100|10786382|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0
6788775|NCT03129100|10786383|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0
6788776|NCT03129100|10786384|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0
6788777|NCT03129100|10786385|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0
6788778|NCT03129100|10786386|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1
6788779|NCT03129100|10786387|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0
6788780|NCT03129100|10786388|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0
6788781|NCT03129100|10786389|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0
6788782|NCT03129100|10786390|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0
6788783|NCT03129100|10786391|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0
6788784|NCT03129100|10786366|FG000|Period 4 (Post Treatment Follow-up)|Death|0
6788785|NCT03129100|10786367|FG001|Period 4 (Post Treatment Follow-up)|Death|0
6788786|NCT03129100|10786368|FG002|Period 4 (Post Treatment Follow-up)|Death|0
6788787|NCT03129100|10786369|FG003|Period 4 (Post Treatment Follow-up)|Death|0
6788788|NCT03129100|10786370|FG004|Period 4 (Post Treatment Follow-up)|Death|0
6788789|NCT03129100|10786371|FG005|Period 4 (Post Treatment Follow-up)|Death|0
6788790|NCT03129100|10786372|FG006|Period 4 (Post Treatment Follow-up)|Death|0
6788791|NCT03129100|10786373|FG007|Period 4 (Post Treatment Follow-up)|Death|0
6788792|NCT03129100|10786374|FG008|Period 4 (Post Treatment Follow-up)|Death|0
6788793|NCT03129100|10786375|FG009|Period 4 (Post Treatment Follow-up)|Death|0
6788794|NCT03129100|10786376|FG010|Period 4 (Post Treatment Follow-up)|Death|0
6788795|NCT03129100|10786377|FG011|Period 4 (Post Treatment Follow-up)|Death|0
6788796|NCT03129100|10786378|FG012|Period 4 (Post Treatment Follow-up)|Death|0
6788797|NCT03129100|10786379|FG013|Period 4 (Post Treatment Follow-up)|Death|0
6788798|NCT03129100|10786380|FG014|Period 4 (Post Treatment Follow-up)|Death|0
6788799|NCT03129100|10786381|FG015|Period 4 (Post Treatment Follow-up)|Death|0
6788800|NCT03129100|10786382|FG016|Period 4 (Post Treatment Follow-up)|Death|0
6788801|NCT03129100|10786383|FG017|Period 4 (Post Treatment Follow-up)|Death|0
6788802|NCT03129100|10786384|FG018|Period 4 (Post Treatment Follow-up)|Death|0
6788803|NCT03129100|10786385|FG019|Period 4 (Post Treatment Follow-up)|Death|0
6788804|NCT03129100|10786386|FG020|Period 4 (Post Treatment Follow-up)|Death|0
6788805|NCT03129100|10786387|FG021|Period 4 (Post Treatment Follow-up)|Death|0
6788806|NCT03129100|10786388|FG022|Period 4 (Post Treatment Follow-up)|Death|0
6788807|NCT03129100|10786389|FG023|Period 4 (Post Treatment Follow-up)|Death|0
6788808|NCT03129100|10786390|FG024|Period 4 (Post Treatment Follow-up)|Death|1
6788809|NCT03129100|10786391|FG025|Period 4 (Post Treatment Follow-up)|Death|0
6788810|NCT03129100|10786366|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
6788811|NCT03129100|10786367|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
6788812|NCT03129100|10786368|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
6788813|NCT03129100|10786369|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
6788814|NCT03129100|10786370|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
6788815|NCT03129100|10786371|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
6788816|NCT03129100|10786372|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
6788817|NCT03129100|10786373|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
6788818|NCT03129100|10786374|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
6788819|NCT03129100|10786375|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
6788820|NCT03129100|10786376|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
6788821|NCT03129100|10786377|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
6788822|NCT03129100|10786378|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
6788823|NCT03129100|10786379|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
6788824|NCT03129100|10786380|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
6788825|NCT03129100|10786381|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
6788826|NCT03129100|10786382|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
6788827|NCT03129100|10786383|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
6788828|NCT03129100|10786384|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
6788829|NCT03129100|10786385|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
6788830|NCT03129100|10786386|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
6788831|NCT03129100|10786387|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
6788832|NCT03129100|10786388|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
6788833|NCT03129100|10786389|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
6788834|NCT03129100|10786390|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2
6788835|NCT03129100|10786391|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2
6788836|NCT03129100|10786366|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
6788837|NCT03129100|10786367|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
6788838|NCT03129100|10786368|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
6788839|NCT03129100|10786369|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
6788840|NCT03129100|10786370|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
6788841|NCT03129100|10786371|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
6788842|NCT03129100|10786372|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
6788843|NCT03129100|10786373|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
6788844|NCT03129100|10786374|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
6788845|NCT03129100|10786375|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
6788846|NCT03129100|10786376|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
6788847|NCT03129100|10786377|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
6788848|NCT03129100|10786378|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
6788849|NCT03129100|10786379|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
6788850|NCT03129100|10786380|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
6788851|NCT03129100|10786381|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
6788852|NCT03129100|10786382|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
6788853|NCT03129100|10786383|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
6788854|NCT03129100|10786384|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
6788855|NCT03129100|10786385|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
6788856|NCT03129100|10786386|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
6788857|NCT03129100|10786387|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
6788858|NCT03129100|10786388|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
6788859|NCT03129100|10786389|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3
6788860|NCT03129100|10786390|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20
6788861|NCT03129100|10786391|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37
6788862|NCT03129100|10786366|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
6788863|NCT03129100|10786367|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
6788864|NCT03129100|10786368|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
6788865|NCT03129100|10786369|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
6788866|NCT03129100|10786370|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
6788867|NCT03129100|10786371|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
6788868|NCT03129100|10786372|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
6788869|NCT03129100|10786373|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
6788870|NCT03129100|10786374|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
6788871|NCT03129100|10786375|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
6788872|NCT03129100|10786376|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
6788873|NCT03129100|10786377|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
6788874|NCT03129100|10786378|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
6788875|NCT03129100|10786379|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
6788876|NCT03129100|10786380|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
6788877|NCT03129100|10786381|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
6788878|NCT03129100|10786382|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
6788879|NCT03129100|10786383|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
6788880|NCT03129100|10786384|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
6788881|NCT03129100|10786385|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
6788882|NCT03129100|10786386|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
6788883|NCT03129100|10786387|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
6788884|NCT03129100|10786388|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
6788885|NCT03129100|10786389|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
6788886|NCT03129100|10786390|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2
6788887|NCT03129100|10786391|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
6788888|NCT03129100|10786366|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
6788889|NCT03129100|10786367|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
6788890|NCT03129100|10786368|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
6788891|NCT03129100|10786369|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
6788892|NCT03129100|10786370|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
6788893|NCT03129100|10786371|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
6788894|NCT03129100|10786372|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
6788895|NCT03129100|10786373|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
6788896|NCT03129100|10786374|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
6788897|NCT03129100|10786375|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
6788898|NCT03129100|10786376|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
6788899|NCT03129100|10786377|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
6788900|NCT03129100|10786378|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
6788901|NCT03129100|10786379|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
6788902|NCT03129100|10786380|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
6788903|NCT03129100|10786381|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
6788904|NCT03129100|10786382|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
6788905|NCT03129100|10786383|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
6788906|NCT03129100|10786384|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
6788907|NCT03129100|10786385|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
6788908|NCT03129100|10786386|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
6788909|NCT03129100|10786387|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
6788910|NCT03129100|10786388|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
6788911|NCT03129100|10786389|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
6788912|NCT03129100|10786390|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
6788913|NCT03129100|10786391|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1
6788914|NCT03129100|10786366|FG000|Period 4 (Post Treatment Follow-up)|Other|0
6788915|NCT03129100|10786367|FG001|Period 4 (Post Treatment Follow-up)|Other|0
6788916|NCT03129100|10786368|FG002|Period 4 (Post Treatment Follow-up)|Other|0
6788917|NCT03129100|10786369|FG003|Period 4 (Post Treatment Follow-up)|Other|0
6788918|NCT03129100|10786370|FG004|Period 4 (Post Treatment Follow-up)|Other|0
6788919|NCT03129100|10786371|FG005|Period 4 (Post Treatment Follow-up)|Other|0
6788920|NCT03129100|10786372|FG006|Period 4 (Post Treatment Follow-up)|Other|0
6788921|NCT03129100|10786373|FG007|Period 4 (Post Treatment Follow-up)|Other|0
6788922|NCT03129100|10786374|FG008|Period 4 (Post Treatment Follow-up)|Other|0
6788923|NCT03129100|10786375|FG009|Period 4 (Post Treatment Follow-up)|Other|0
6788924|NCT03129100|10786376|FG010|Period 4 (Post Treatment Follow-up)|Other|0
6788925|NCT03129100|10786377|FG011|Period 4 (Post Treatment Follow-up)|Other|0
6788926|NCT03129100|10786378|FG012|Period 4 (Post Treatment Follow-up)|Other|0
6788927|NCT03129100|10786379|FG013|Period 4 (Post Treatment Follow-up)|Other|0
6788928|NCT03129100|10786380|FG014|Period 4 (Post Treatment Follow-up)|Other|0
6788929|NCT03129100|10786381|FG015|Period 4 (Post Treatment Follow-up)|Other|0
6788930|NCT03129100|10786382|FG016|Period 4 (Post Treatment Follow-up)|Other|0
6788931|NCT03129100|10786383|FG017|Period 4 (Post Treatment Follow-up)|Other|0
6788932|NCT03129100|10786384|FG018|Period 4 (Post Treatment Follow-up)|Other|0
6788933|NCT03129100|10786385|FG019|Period 4 (Post Treatment Follow-up)|Other|0
6788934|NCT03129100|10786386|FG020|Period 4 (Post Treatment Follow-up)|Other|0
6788935|NCT03129100|10786387|FG021|Period 4 (Post Treatment Follow-up)|Other|0
6788936|NCT03129100|10786388|FG022|Period 4 (Post Treatment Follow-up)|Other|0
6788937|NCT03129100|10786389|FG023|Period 4 (Post Treatment Follow-up)|Other|0
6788938|NCT03129100|10786390|FG024|Period 4 (Post Treatment Follow-up)|Other|0
6788939|NCT03129100|10786391|FG025|Period 4 (Post Treatment Follow-up)|Other|2
6788940|NCT02921763|10786428|FG000|Overall Study|Adverse Event|4
6788941|NCT02921763|10786428|FG000|Overall Study|Lost to Follow-up|4
6788942|NCT02921763|10786428|FG000|Overall Study|Lack of Efficacy|3
6788943|NCT02921763|10786428|FG000|Overall Study|Protocol Violation|2
6788944|NCT02921763|10786428|FG000|Overall Study|Withdrawal by Subject|2
6788945|NCT02921763|10786428|FG000|Overall Study|Physician Decision|1
6788946|NCT02921763|10786428|FG000|Overall Study|No data obtained|2
6788947|NCT02831257|10786446|FG000|Overall Study|Lack of Efficacy|3
6788948|NCT02831257|10786446|FG000|Overall Study|Adverse Event|2
6788949|NCT02831257|10786446|FG000|Overall Study|Physician Decision|1
6788950|NCT02831257|10786446|FG000|Overall Study|Withdrawal by Subject|6
6788951|NCT02775903|10786454|FG000|Overall Study|Ongoing|14
6788952|NCT02775903|10786455|FG001|Overall Study|Ongoing|15
6788953|NCT02775903|10786456|FG002|Overall Study|Ongoing|15
6788954|NCT02775903|10786457|FG003|Overall Study|Ongoing|19
6788955|NCT02775903|10786454|FG000|Overall Study|Death|19
6788956|NCT02775903|10786455|FG001|Overall Study|Death|18
6788957|NCT02775903|10786456|FG002|Overall Study|Death|38
6788958|NCT02775903|10786457|FG003|Overall Study|Death|35
6788959|NCT02775903|10786454|FG000|Overall Study|Withdrawal by Subject|5
6788960|NCT02775903|10786455|FG001|Overall Study|Withdrawal by Subject|5
6788961|NCT02775903|10786456|FG002|Overall Study|Withdrawal by Subject|5
6788962|NCT02775903|10786457|FG003|Overall Study|Withdrawal by Subject|4
6788963|NCT02775903|10786454|FG000|Overall Study|Adverse Event|0
6788964|NCT02775903|10786455|FG001|Overall Study|Adverse Event|0
6788965|NCT02775903|10786456|FG002|Overall Study|Adverse Event|1
6788966|NCT02775903|10786457|FG003|Overall Study|Adverse Event|1
6788967|NCT02775903|10786454|FG000|Overall Study|Lost to Follow-up|0
6788968|NCT02775903|10786455|FG001|Overall Study|Lost to Follow-up|0
6788969|NCT02775903|10786456|FG002|Overall Study|Lost to Follow-up|1
6788970|NCT02775903|10786457|FG003|Overall Study|Lost to Follow-up|1
6788971|NCT02775903|10786454|FG000|Overall Study|Other-Miscellaneous|4
6788972|NCT02775903|10786455|FG001|Overall Study|Other-Miscellaneous|3
6788973|NCT02775903|10786456|FG002|Overall Study|Other-Miscellaneous|4
6788974|NCT02775903|10786457|FG003|Overall Study|Other-Miscellaneous|5
6788975|NCT02476916|10786473|FG000|Core Period|Adverse Event|2
6788976|NCT02476916|10786474|FG001|Core Period|Adverse Event|2
6788977|NCT02476916|10786473|FG000|Core Period|Investigator decision|1
6788978|NCT02476916|10786474|FG001|Core Period|Investigator decision|1
7139722|NCT02961790|11293481|FG001|Overall Study|Canceled|5
7139723|NCT02961790|11293482|FG002|Overall Study|Canceled|1
7139724|NCT02961790|11293483|FG003|Overall Study|Canceled|4
7139725|NCT02961790|11293480|FG000|Overall Study|without baseline data|4
7139726|NCT02961790|11293481|FG001|Overall Study|without baseline data|0
7139727|NCT02961790|11293482|FG002|Overall Study|without baseline data|1
7139728|NCT02961790|11293483|FG003|Overall Study|without baseline data|0
7139729|NCT02961790|11293480|FG000|Overall Study|without post baseline data|7
7139730|NCT02961790|11293481|FG001|Overall Study|without post baseline data|6
7139731|NCT02961790|11293482|FG002|Overall Study|without post baseline data|4
7139732|NCT02961790|11293483|FG003|Overall Study|without post baseline data|1
7139733|NCT02961920|11293500|FG000|Overall Study|did not achive stydy protocol schedule|1
7139734|NCT02961920|11293501|FG001|Overall Study|did not achive stydy protocol schedule|1
7139735|NCT02962284|11293522|FG000|Overall Study|Death|2
7139736|NCT02962284|11293523|FG001|Overall Study|Death|0
7139737|NCT02962284|11293522|FG000|Overall Study|Progressive disease|2
7139738|NCT02962284|11293523|FG001|Overall Study|Progressive disease|3
7139739|NCT02962284|11293522|FG000|Overall Study|Withdrawal by Subject|1
7139740|NCT02962284|11293523|FG001|Overall Study|Withdrawal by Subject|0
7139741|NCT02962648|11293551|FG000|Overall Study|Withdrawal by Subject|3
7139742|NCT02962648|11293551|FG000|Overall Study|Lost to Follow-up|3
7139743|NCT02962648|11293551|FG000|Overall Study|Physician Decision|1
7139744|NCT02962648|11293551|FG000|Overall Study|Subject had problems with transportation|2
7139745|NCT02962674|11293555|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49
7139746|NCT02962739|11293572|FG000|Overall Study|Withdrawal by Subject|0
7139747|NCT02962739|11293573|FG001|Overall Study|Withdrawal by Subject|1
7139748|NCT02962739|11293574|FG002|Overall Study|Withdrawal by Subject|0
7139749|NCT02962739|11293575|FG003|Overall Study|Withdrawal by Subject|0
7139750|NCT02962739|11293576|FG004|Overall Study|Withdrawal by Subject|0
7139751|NCT02962739|11293577|FG005|Overall Study|Withdrawal by Subject|0
7139752|NCT02962739|11293572|FG000|Overall Study|Protocol Violation|0
7139753|NCT02962739|11293573|FG001|Overall Study|Protocol Violation|0
7139754|NCT02962739|11293574|FG002|Overall Study|Protocol Violation|1
7139755|NCT02962739|11293575|FG003|Overall Study|Protocol Violation|0
7139756|NCT02962739|11293576|FG004|Overall Study|Protocol Violation|1
7139757|NCT02962739|11293577|FG005|Overall Study|Protocol Violation|0
7139758|NCT02962765|11293583|FG000|Overall Study|Protocol Violation|9
7139759|NCT02962765|11293583|FG000|Overall Study|Withdrawal by Subject|3
7139760|NCT02962765|11293583|FG000|Overall Study|Lost to Follow-up|1
7139761|NCT02962765|11293583|FG000|Overall Study|Death|1
7139762|NCT02962765|11293583|FG000|Overall Study|Limited access to study medication|3
7139763|NCT02962882|11293594|FG000|Overall Study|Adverse Event|2
7139764|NCT02962882|11293594|FG000|Overall Study|Withdrawal by Subject|2
7139765|NCT02962882|11293594|FG000|Overall Study|Transfer from ICU|32
7139766|NCT02962908|11293603|FG000|Overall Study|Lost to Follow-up|0
7139767|NCT02962908|11293604|FG001|Overall Study|Lost to Follow-up|3
7139768|NCT02962908|11293605|FG002|Overall Study|Lost to Follow-up|0
7139769|NCT02962908|11293606|FG003|Overall Study|Lost to Follow-up|1
7139770|NCT02962908|11293603|FG000|Overall Study|Withdrawal by Subject|0
7139771|NCT02962908|11293604|FG001|Overall Study|Withdrawal by Subject|3
7139772|NCT02962908|11293605|FG002|Overall Study|Withdrawal by Subject|0
7139773|NCT02962908|11293606|FG003|Overall Study|Withdrawal by Subject|2
7139774|NCT02962908|11293603|FG000|Overall Study|Protocol Violation|0
6788979|NCT02476916|10786473|FG000|Core Period|Withdrawal by Subject|3
6788980|NCT02476916|10786474|FG001|Core Period|Withdrawal by Subject|0
6788981|NCT02476916|10786473|FG000|Extension Period|Prematurely Discontinued Treatment|6
6788982|NCT02476916|10786474|FG001|Extension Period|Prematurely Discontinued Treatment|1
6788983|NCT02476916|10786473|FG000|Extension Period|On Treatment|12
6788984|NCT02476916|10786474|FG001|Extension Period|On Treatment|17
7139775|NCT02962908|11293604|FG001|Overall Study|Protocol Violation|1
7139776|NCT02962908|11293605|FG002|Overall Study|Protocol Violation|0
7139777|NCT02962908|11293606|FG003|Overall Study|Protocol Violation|0
6788985|NCT02406027|10786484|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0
6788986|NCT02406027|10786485|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2
6788987|NCT02406027|10786486|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1
6788988|NCT02406027|10786487|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0
6788989|NCT02406027|10786488|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0
6788990|NCT02406027|10786489|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0
6788991|NCT02406027|10786490|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0
6788992|NCT02406027|10786484|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3
6788993|NCT02406027|10786485|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0
6788994|NCT02406027|10786486|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1
6788995|NCT02406027|10786487|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0
6788996|NCT02406027|10786488|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0
6788997|NCT02406027|10786489|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0
6788998|NCT02406027|10786490|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0
6788999|NCT02406027|10786484|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2
6789000|NCT02406027|10786485|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1
6789001|NCT02406027|10786486|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1
6789002|NCT02406027|10786487|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
6789003|NCT02406027|10786488|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
6789004|NCT02406027|10786489|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
6789005|NCT02406027|10786490|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
6789006|NCT02406027|10786484|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1
6789007|NCT02406027|10786485|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
6789008|NCT02406027|10786486|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1
6789009|NCT02406027|10786487|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
6789010|NCT02406027|10786488|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
6789011|NCT02406027|10786489|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
6789012|NCT02406027|10786490|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
6789013|NCT02406027|10786484|FG000|Open-label Phase (Period 2)|Adverse Event|0
6789014|NCT02406027|10786485|FG001|Open-label Phase (Period 2)|Adverse Event|0
6789015|NCT02406027|10786486|FG002|Open-label Phase (Period 2)|Adverse Event|0
6789016|NCT02406027|10786487|FG003|Open-label Phase (Period 2)|Adverse Event|2
6789017|NCT02406027|10786488|FG004|Open-label Phase (Period 2)|Adverse Event|2
6789018|NCT02406027|10786489|FG005|Open-label Phase (Period 2)|Adverse Event|0
6789019|NCT02406027|10786490|FG006|Open-label Phase (Period 2)|Adverse Event|0
6789020|NCT02406027|10786484|FG000|Open-label Phase (Period 2)|Physician Decision|0
6789021|NCT02406027|10786485|FG001|Open-label Phase (Period 2)|Physician Decision|0
6789022|NCT02406027|10786486|FG002|Open-label Phase (Period 2)|Physician Decision|0
6789023|NCT02406027|10786487|FG003|Open-label Phase (Period 2)|Physician Decision|0
6789024|NCT02406027|10786488|FG004|Open-label Phase (Period 2)|Physician Decision|0
6789025|NCT02406027|10786489|FG005|Open-label Phase (Period 2)|Physician Decision|1
6789026|NCT02406027|10786490|FG006|Open-label Phase (Period 2)|Physician Decision|1
6789027|NCT02406027|10786484|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0
6789028|NCT02406027|10786485|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0
6789029|NCT02406027|10786486|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0
6789030|NCT02406027|10786487|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2
6789031|NCT02406027|10786488|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4
6789032|NCT02406027|10786489|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0
6789033|NCT02406027|10786490|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2
6789034|NCT02406027|10786484|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
6789035|NCT02406027|10786485|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
6789036|NCT02406027|10786486|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
6789037|NCT02406027|10786487|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11
6789038|NCT02406027|10786488|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7
6789039|NCT02406027|10786489|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24
6789040|NCT02406027|10786490|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19
6789041|NCT02406027|10786484|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
6789042|NCT02406027|10786485|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
6789043|NCT02406027|10786486|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
6789044|NCT02406027|10786487|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
6789045|NCT02406027|10786488|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
6789046|NCT02406027|10786489|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1
6789047|NCT02406027|10786490|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
6789048|NCT02406027|10786484|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
6789049|NCT02406027|10786485|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
6789050|NCT02406027|10786486|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
6789051|NCT02406027|10786487|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
6789052|NCT02406027|10786488|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1
6789053|NCT02406027|10786489|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
6789054|NCT02406027|10786490|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
6789055|NCT02374814|10786512|FG000|Overall Study|Lost to Follow-up|1
6789056|NCT02374814|10786513|FG001|Overall Study|Lost to Follow-up|1
6789057|NCT02374814|10786514|FG002|Overall Study|Lost to Follow-up|0
6789058|NCT02374814|10786515|FG003|Overall Study|Lost to Follow-up|1
6789059|NCT02374814|10786516|FG004|Overall Study|Lost to Follow-up|0
6789060|NCT02374814|10786517|FG005|Overall Study|Lost to Follow-up|0
6789061|NCT02374814|10786512|FG000|Overall Study|Withdrawal by Subject|0
6789062|NCT02374814|10786513|FG001|Overall Study|Withdrawal by Subject|0
6789063|NCT02374814|10786514|FG002|Overall Study|Withdrawal by Subject|1
6789064|NCT02374814|10786515|FG003|Overall Study|Withdrawal by Subject|1
6789065|NCT02374814|10786516|FG004|Overall Study|Withdrawal by Subject|0
6789066|NCT02374814|10786517|FG005|Overall Study|Withdrawal by Subject|0
6789067|NCT02142738|10786541|FG000|Overall Study|Adverse Event|13
6789068|NCT02142738|10786542|FG001|Overall Study|Adverse Event|9
6789069|NCT02142738|10786541|FG000|Overall Study|Death|92
6789070|NCT02142738|10786542|FG001|Overall Study|Death|112
6789071|NCT02142738|10786541|FG000|Overall Study|Lost to Follow-up|0
6789072|NCT02142738|10786542|FG001|Overall Study|Lost to Follow-up|3
6789073|NCT02142738|10786541|FG000|Overall Study|Withdrawal by Subject|6
6789074|NCT02142738|10786542|FG001|Overall Study|Withdrawal by Subject|7
6789075|NCT02142738|10786541|FG000|Overall Study|Follow up ended by sponsor|43
6789076|NCT02142738|10786542|FG001|Overall Study|Follow up ended by sponsor|20
6789077|NCT02032823|10786553|FG000|Overall Study|Death|59
6789078|NCT02032823|10786554|FG001|Overall Study|Death|86
6789079|NCT02032823|10786553|FG000|Overall Study|Lost to Follow-up|12
6789080|NCT02032823|10786554|FG001|Overall Study|Lost to Follow-up|15
6789081|NCT02032823|10786553|FG000|Overall Study|Withdrawal by Subject|65
6789082|NCT02032823|10786554|FG001|Overall Study|Withdrawal by Subject|49
6789083|NCT02032823|10786553|FG000|Overall Study|Ongoing study at data cut-off|782
6789084|NCT02032823|10786554|FG001|Overall Study|Ongoing study at data cut-off|760
6789085|NCT02032823|10786553|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3
6789086|NCT02032823|10786554|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5
6789087|NCT01667133|10786583|FG000|Phase 1: Dose-escalation|Adverse Event|0
6789088|NCT01667133|10786584|FG001|Phase 1: Dose-escalation|Adverse Event|0
6789089|NCT01667133|10786585|FG002|Phase 1: Dose-escalation|Adverse Event|1
6789090|NCT01667133|10786586|FG003|Phase 1: Dose-escalation|Adverse Event|0
6789091|NCT01667133|10786587|FG004|Phase 1: Dose-escalation|Adverse Event|0
6789092|NCT01667133|10786588|FG005|Phase 1: Dose-escalation|Adverse Event|0
6789093|NCT01667133|10786589|FG006|Phase 1: Dose-escalation|Adverse Event|0
6789094|NCT01667133|10786590|FG007|Phase 1: Dose-escalation|Adverse Event|0
6789095|NCT01667133|10786591|FG008|Phase 1: Dose-escalation|Adverse Event|0
6789096|NCT01667133|10786592|FG009|Phase 1: Dose-escalation|Adverse Event|0
6789097|NCT01667133|10786593|FG010|Phase 1: Dose-escalation|Adverse Event|0
6789098|NCT01667133|10786594|FG011|Phase 1: Dose-escalation|Adverse Event|0
6789099|NCT01667133|10786583|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0
6789100|NCT01667133|10786584|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0
6789101|NCT01667133|10786585|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1
6789102|NCT01667133|10786586|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0
6789103|NCT01667133|10786587|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0
6789104|NCT01667133|10786588|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0
6789105|NCT01667133|10786589|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0
6789106|NCT01667133|10786590|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0
6789107|NCT01667133|10786591|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0
6789108|NCT01667133|10786592|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0
6789109|NCT01667133|10786593|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0
6789110|NCT01667133|10786594|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0
6789111|NCT01667133|10786583|FG000|Phase 1: Dose-escalation|Progressive Disease|0
6789112|NCT01667133|10786584|FG001|Phase 1: Dose-escalation|Progressive Disease|1
6789113|NCT01667133|10786585|FG002|Phase 1: Dose-escalation|Progressive Disease|2
6789114|NCT01667133|10786586|FG003|Phase 1: Dose-escalation|Progressive Disease|0
6789115|NCT01667133|10786587|FG004|Phase 1: Dose-escalation|Progressive Disease|1
6789116|NCT01667133|10786588|FG005|Phase 1: Dose-escalation|Progressive Disease|1
6789117|NCT01667133|10786589|FG006|Phase 1: Dose-escalation|Progressive Disease|1
6789118|NCT01667133|10786590|FG007|Phase 1: Dose-escalation|Progressive Disease|0
6789119|NCT01667133|10786591|FG008|Phase 1: Dose-escalation|Progressive Disease|0
6789120|NCT01667133|10786592|FG009|Phase 1: Dose-escalation|Progressive Disease|0
6789121|NCT01667133|10786593|FG010|Phase 1: Dose-escalation|Progressive Disease|0
6789122|NCT01667133|10786594|FG011|Phase 1: Dose-escalation|Progressive Disease|0
6789123|NCT01667133|10786583|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0
6789124|NCT01667133|10786584|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0
6789125|NCT01667133|10786585|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0
6789126|NCT01667133|10786586|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1
6789127|NCT01667133|10786587|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0
6789128|NCT01667133|10786588|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0
6789129|NCT01667133|10786589|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0
6789130|NCT01667133|10786590|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0
6789131|NCT01667133|10786591|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0
6789132|NCT01667133|10786592|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0
6789133|NCT01667133|10786593|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0
6789134|NCT01667133|10786594|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0
6789135|NCT01667133|10786583|FG000|Phase 2: Dose-expansion|Adverse Event|0
6789136|NCT01667133|10786584|FG001|Phase 2: Dose-expansion|Adverse Event|0
6789137|NCT01667133|10786585|FG002|Phase 2: Dose-expansion|Adverse Event|0
6789138|NCT01667133|10786586|FG003|Phase 2: Dose-expansion|Adverse Event|0
6789139|NCT01667133|10786587|FG004|Phase 2: Dose-expansion|Adverse Event|0
6789140|NCT01667133|10786588|FG005|Phase 2: Dose-expansion|Adverse Event|0
6789141|NCT01667133|10786589|FG006|Phase 2: Dose-expansion|Adverse Event|0
6789142|NCT01667133|10786590|FG007|Phase 2: Dose-expansion|Adverse Event|2
6789143|NCT01667133|10786591|FG008|Phase 2: Dose-expansion|Adverse Event|1
6789144|NCT01667133|10786592|FG009|Phase 2: Dose-expansion|Adverse Event|1
6789145|NCT01667133|10786593|FG010|Phase 2: Dose-expansion|Adverse Event|0
6789146|NCT01667133|10786594|FG011|Phase 2: Dose-expansion|Adverse Event|0
6789147|NCT01667133|10786583|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0
6789148|NCT01667133|10786584|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0
6789149|NCT01667133|10786585|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0
6789150|NCT01667133|10786586|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0
6789151|NCT01667133|10786587|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0
6789152|NCT01667133|10786588|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0
6789153|NCT01667133|10786589|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0
6789154|NCT01667133|10786590|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0
6789155|NCT01667133|10786591|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0
6789156|NCT01667133|10786592|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2
6789157|NCT01667133|10786593|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0
6789158|NCT01667133|10786594|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0
6789159|NCT01667133|10786583|FG000|Phase 2: Dose-expansion|Progressive Disease|0
6789160|NCT01667133|10786584|FG001|Phase 2: Dose-expansion|Progressive Disease|0
6789161|NCT01667133|10786585|FG002|Phase 2: Dose-expansion|Progressive Disease|0
6789162|NCT01667133|10786586|FG003|Phase 2: Dose-expansion|Progressive Disease|0
6789163|NCT01667133|10786587|FG004|Phase 2: Dose-expansion|Progressive Disease|0
6789164|NCT01667133|10786588|FG005|Phase 2: Dose-expansion|Progressive Disease|0
6789165|NCT01667133|10786589|FG006|Phase 2: Dose-expansion|Progressive Disease|0
6789166|NCT01667133|10786590|FG007|Phase 2: Dose-expansion|Progressive Disease|0
6789167|NCT01667133|10786591|FG008|Phase 2: Dose-expansion|Progressive Disease|0
6789168|NCT01667133|10786592|FG009|Phase 2: Dose-expansion|Progressive Disease|0
6789169|NCT01667133|10786593|FG010|Phase 2: Dose-expansion|Progressive Disease|3
6789170|NCT01667133|10786594|FG011|Phase 2: Dose-expansion|Progressive Disease|5
6789171|NCT01667133|10786583|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0
6789172|NCT01667133|10786584|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0
6789173|NCT01667133|10786585|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0
6789174|NCT01667133|10786586|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0
6789175|NCT01667133|10786587|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0
6789176|NCT01667133|10786588|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0
6789177|NCT01667133|10786589|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0
6789178|NCT01667133|10786590|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0
6789179|NCT01667133|10786591|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0
6789180|NCT01667133|10786592|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2
6789181|NCT01667133|10786593|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0
6789182|NCT01667133|10786594|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0
6789183|NCT01667133|10786583|FG000|Phase 2: Dose-expansion|Death|0
6789184|NCT01667133|10786584|FG001|Phase 2: Dose-expansion|Death|0
6789185|NCT01667133|10786585|FG002|Phase 2: Dose-expansion|Death|0
6789186|NCT01667133|10786586|FG003|Phase 2: Dose-expansion|Death|0
6789187|NCT01667133|10786587|FG004|Phase 2: Dose-expansion|Death|0
6789188|NCT01667133|10786588|FG005|Phase 2: Dose-expansion|Death|0
6789189|NCT01667133|10786589|FG006|Phase 2: Dose-expansion|Death|0
6789190|NCT01667133|10786590|FG007|Phase 2: Dose-expansion|Death|0
6789191|NCT01667133|10786591|FG008|Phase 2: Dose-expansion|Death|0
6789192|NCT01667133|10786592|FG009|Phase 2: Dose-expansion|Death|1
6789193|NCT01667133|10786593|FG010|Phase 2: Dose-expansion|Death|0
6789194|NCT01667133|10786594|FG011|Phase 2: Dose-expansion|Death|0
6789195|NCT01667133|10786583|FG000|Phase 2: Dose-expansion|Other|0
6789196|NCT01667133|10786584|FG001|Phase 2: Dose-expansion|Other|0
6789197|NCT01667133|10786585|FG002|Phase 2: Dose-expansion|Other|0
6789198|NCT01667133|10786586|FG003|Phase 2: Dose-expansion|Other|0
6789199|NCT01667133|10786587|FG004|Phase 2: Dose-expansion|Other|0
6789200|NCT01667133|10786588|FG005|Phase 2: Dose-expansion|Other|0
6789201|NCT01667133|10786589|FG006|Phase 2: Dose-expansion|Other|0
6789202|NCT01667133|10786590|FG007|Phase 2: Dose-expansion|Other|0
6789203|NCT01667133|10786591|FG008|Phase 2: Dose-expansion|Other|0
6789204|NCT01667133|10786592|FG009|Phase 2: Dose-expansion|Other|0
6789205|NCT01667133|10786593|FG010|Phase 2: Dose-expansion|Other|0
6789206|NCT01667133|10786594|FG011|Phase 2: Dose-expansion|Other|1
6789207|NCT01585103|10786655|FG000|Overall Study|Unable to swallow Cytosponge|6
6789208|NCT01427725|10786659|FG000|Overall Study|Lost to Follow-up|17
6789209|NCT01427725|10786659|FG000|Overall Study|Protocol Violation|1
6789210|NCT01427725|10786659|FG000|Overall Study|Drug not administered|1
6789211|NCT01427725|10786659|FG000|Overall Study|Failure to visit|7
6789212|NCT01427725|10786659|FG000|Overall Study|Adverse Event|46
6789213|NCT01427725|10786659|FG000|Overall Study|Failure to visit after administration|40
6789214|NCT01427725|10786659|FG000|Overall Study|Patient's rejection|27
6789215|NCT01427725|10786659|FG000|Overall Study|Transfer to a different hospital|17
6789216|NCT01427725|10786659|FG000|Overall Study|Lack of Efficacy|8
6789217|NCT01427725|10786659|FG000|Overall Study|Death|7
6789218|NCT01427725|10786659|FG000|Overall Study|Symptom improvement|6
6789219|NCT01427725|10786659|FG000|Overall Study|AE and Patient's rejection|5
6789220|NCT01427725|10786659|FG000|Overall Study|Physician Decision|5
6789221|NCT01427725|10786659|FG000|Overall Study|Exacerbation of underlying disease|5
6789222|NCT01427725|10786659|FG000|Overall Study|Oral feeding difficulty|5
6789223|NCT01427725|10786659|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1
6789224|NCT01427725|10786659|FG000|Overall Study|Forgetting prescription|1
6789225|NCT01427725|10786659|FG000|Overall Study|Other|2
6807556|NCT03307785|10811134|FG001|Part C: Up to 22.5 Months|Withdrawal by Subject|0
6807557|NCT03307785|10811135|FG002|Part C: Up to 22.5 Months|Withdrawal by Subject|0
6807558|NCT03307785|10811136|FG003|Part C: Up to 22.5 Months|Withdrawal by Subject|1
6807559|NCT03307785|10811137|FG004|Part C: Up to 22.5 Months|Withdrawal by Subject|0
6807560|NCT03307785|10811138|FG005|Part C: Up to 22.5 Months|Withdrawal by Subject|0
6807561|NCT03307785|10811139|FG006|Part C: Up to 22.5 Months|Withdrawal by Subject|0
6807562|NCT03307785|10811140|FG007|Part C: Up to 22.5 Months|Withdrawal by Subject|0
6807563|NCT03307785|10811141|FG008|Part C: Up to 22.5 Months|Withdrawal by Subject|0
6807564|NCT03307785|10811142|FG009|Part C: Up to 22.5 Months|Withdrawal by Subject|0
6807565|NCT03307785|10811143|FG010|Part C: Up to 22.5 Months|Withdrawal by Subject|0
6807566|NCT03307785|10811133|FG000|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
6807567|NCT03307785|10811134|FG001|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
6807568|NCT03307785|10811135|FG002|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
6807569|NCT03307785|10811136|FG003|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|1
6807570|NCT03307785|10811137|FG004|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|1
6807571|NCT03307785|10811138|FG005|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
6807572|NCT03307785|10811139|FG006|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
6807573|NCT03307785|10811140|FG007|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
6807574|NCT03307785|10811141|FG008|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
6807575|NCT03307785|10811142|FG009|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
6807576|NCT03307785|10811143|FG010|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
6807577|NCT03307785|10811133|FG000|Part D: Up to 9.5 Months|Physician Decision|0
6807578|NCT03307785|10811134|FG001|Part D: Up to 9.5 Months|Physician Decision|0
6807579|NCT03307785|10811135|FG002|Part D: Up to 9.5 Months|Physician Decision|0
6807580|NCT03307785|10811136|FG003|Part D: Up to 9.5 Months|Physician Decision|0
6807581|NCT03307785|10811137|FG004|Part D: Up to 9.5 Months|Physician Decision|0
6807582|NCT03307785|10811138|FG005|Part D: Up to 9.5 Months|Physician Decision|1
6807583|NCT03307785|10811139|FG006|Part D: Up to 9.5 Months|Physician Decision|0
6807584|NCT03307785|10811140|FG007|Part D: Up to 9.5 Months|Physician Decision|0
6807585|NCT03307785|10811141|FG008|Part D: Up to 9.5 Months|Physician Decision|0
6807586|NCT03307785|10811142|FG009|Part D: Up to 9.5 Months|Physician Decision|0
6807587|NCT03307785|10811143|FG010|Part D: Up to 9.5 Months|Physician Decision|0
6807588|NCT03307785|10811133|FG000|Part D: Up to 9.5 Months|Death|0
6807589|NCT03307785|10811134|FG001|Part D: Up to 9.5 Months|Death|0
6807590|NCT03307785|10811135|FG002|Part D: Up to 9.5 Months|Death|0
6807591|NCT03307785|10811136|FG003|Part D: Up to 9.5 Months|Death|0
6807592|NCT03307785|10811137|FG004|Part D: Up to 9.5 Months|Death|0
6807593|NCT03307785|10811138|FG005|Part D: Up to 9.5 Months|Death|1
6807594|NCT03307785|10811139|FG006|Part D: Up to 9.5 Months|Death|0
6807595|NCT03307785|10811140|FG007|Part D: Up to 9.5 Months|Death|0
6807596|NCT03307785|10811141|FG008|Part D: Up to 9.5 Months|Death|0
6807597|NCT03307785|10811142|FG009|Part D: Up to 9.5 Months|Death|0
6807598|NCT03307785|10811143|FG010|Part D: Up to 9.5 Months|Death|0
6807599|NCT03307785|10811133|FG000|Part D: Up to 9.5 Months|Withdrawal by Subject|0
6807600|NCT03307785|10811134|FG001|Part D: Up to 9.5 Months|Withdrawal by Subject|0
6807601|NCT03307785|10811135|FG002|Part D: Up to 9.5 Months|Withdrawal by Subject|0
6807602|NCT03307785|10811136|FG003|Part D: Up to 9.5 Months|Withdrawal by Subject|0
6807603|NCT03307785|10811137|FG004|Part D: Up to 9.5 Months|Withdrawal by Subject|0
7139778|NCT02962908|11293603|FG000|Overall Study|Physician Decision|0
7139779|NCT02962908|11293604|FG001|Overall Study|Physician Decision|1
7139780|NCT02962908|11293605|FG002|Overall Study|Physician Decision|0
7139781|NCT02962908|11293606|FG003|Overall Study|Physician Decision|0
7139782|NCT02962960|11293634|FG000|Overall Study|Withdrawal by Subject|1
7139783|NCT02962960|11293635|FG001|Overall Study|Withdrawal by Subject|1
7139784|NCT02962960|11293636|FG002|Overall Study|Withdrawal by Subject|0
7139785|NCT02962960|11293634|FG000|Overall Study|Adverse Event|1
7139786|NCT02962960|11293635|FG001|Overall Study|Adverse Event|1
7139787|NCT02962960|11293636|FG002|Overall Study|Adverse Event|0
7139788|NCT02962960|11293634|FG000|Overall Study|Protocol Violation|1
7139789|NCT02962960|11293635|FG001|Overall Study|Protocol Violation|0
7139790|NCT02962960|11293636|FG002|Overall Study|Protocol Violation|0
7139791|NCT02963311|11293646|FG000|Overall Study|Withdrawal by Subject|1
7139792|NCT02963311|11293646|FG000|Overall Study|Screen Failure|4
7139793|NCT02963441|11293681|FG000|Overall Study|Protocol violation or withdrawn|8
6789226|NCT04608344|10786670|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0
6789227|NCT04608344|10786671|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1
6789228|NCT04608344|10786670|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1
6789229|NCT04608344|10786671|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0
6789230|NCT04350372|10786690|FG000|Overall Study|Death|1
6789231|NCT04328077|10786711|FG000|Overall Study|Lost to Follow-up|0
6789232|NCT04328077|10786712|FG001|Overall Study|Lost to Follow-up|1
6789233|NCT04328077|10786713|FG002|Overall Study|Lost to Follow-up|0
6789234|NCT04328077|10786714|FG003|Overall Study|Lost to Follow-up|0
6789235|NCT04328077|10786711|FG000|Overall Study|Withdrawal by Subject|0
6789236|NCT04328077|10786712|FG001|Overall Study|Withdrawal by Subject|1
6789237|NCT04328077|10786713|FG002|Overall Study|Withdrawal by Subject|1
6789238|NCT04328077|10786714|FG003|Overall Study|Withdrawal by Subject|3
6789239|NCT04234984|10786741|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2
6789240|NCT04234984|10786741|FG000|Follow-up at the Second Time Point|Death|1
6789241|NCT04234984|10786741|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1
6789242|NCT04227197|10786749|FG000|Randomization|Protocol Violation|1
6789243|NCT04227197|10786750|FG001|Randomization|Protocol Violation|0
6789244|NCT04227197|10786749|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1
6789245|NCT04227197|10786750|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0
6789246|NCT04227197|10786749|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2
6789247|NCT04227197|10786750|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0
6789248|NCT04227197|10786749|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7
6789249|NCT04227197|10786750|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5
6789250|NCT04227197|10786749|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5
6789251|NCT04227197|10786750|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0
6789252|NCT04227197|10786749|FG000|2-week Follow-up Survey for PCP's|Not responsive|20
6789253|NCT04227197|10786750|FG001|2-week Follow-up Survey for PCP's|Not responsive|25
6789254|NCT04227197|10786749|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11
6789255|NCT04227197|10786750|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3
6789256|NCT04105725|10786761|FG000|Primary Intervention|Lost to Follow-up|0
6789257|NCT04105725|10786762|FG001|Primary Intervention|Lost to Follow-up|2
6789258|NCT04105725|10786761|FG000|Primary Intervention|Withdrawal by Subject|0
6789259|NCT04105725|10786762|FG001|Primary Intervention|Withdrawal by Subject|1
6789260|NCT04066023|10786771|FG000|Overall Study|Adverse Event|0
6789261|NCT04066023|10786772|FG001|Overall Study|Adverse Event|0
6789262|NCT04066023|10786773|FG002|Overall Study|Adverse Event|1
6789263|NCT04066023|10786771|FG000|Overall Study|Sponsor decision|3
6789264|NCT04066023|10786772|FG001|Overall Study|Sponsor decision|6
6789265|NCT04066023|10786773|FG002|Overall Study|Sponsor decision|2
6789266|NCT04066023|10786771|FG000|Overall Study|Physician Decision|0
6789267|NCT04066023|10786772|FG001|Overall Study|Physician Decision|0
6789268|NCT04066023|10786773|FG002|Overall Study|Physician Decision|1
6789269|NCT04066023|10786771|FG000|Overall Study|Lost to Follow-up|0
6789270|NCT04066023|10786772|FG001|Overall Study|Lost to Follow-up|1
6789271|NCT04066023|10786773|FG002|Overall Study|Lost to Follow-up|1
6789272|NCT04066023|10786771|FG000|Overall Study|Noncompliance|0
6789273|NCT04066023|10786772|FG001|Overall Study|Noncompliance|1
6789274|NCT04066023|10786773|FG002|Overall Study|Noncompliance|1
6789275|NCT03994120|10786796|FG000|Overall Study|Lost to Follow-up|3
6789276|NCT03994120|10786797|FG001|Overall Study|Lost to Follow-up|1
6789277|NCT03882957|10786803|FG000|Overall Study|Did not complete all three arms|1
7139794|NCT02963441|11293681|FG000|Overall Study|Ungradeable by FPRC or IDx|40
7139795|NCT02963441|11293681|FG000|Overall Study|IDx-DR insufficient quality|33
7139796|NCT02963506|11293691|FG000|Double-Blind Period|Adverse Event|0
7139797|NCT02963506|11293692|FG001|Double-Blind Period|Adverse Event|0
7139798|NCT02963506|11293693|FG002|Double-Blind Period|Adverse Event|1
7139799|NCT02963506|11293694|FG003|Double-Blind Period|Adverse Event|0
7139800|NCT02963506|11293695|FG004|Double-Blind Period|Adverse Event|0
7139801|NCT02963506|11293696|FG005|Double-Blind Period|Adverse Event|0
7139802|NCT02963506|11293697|FG006|Double-Blind Period|Adverse Event|0
7139803|NCT02963506|11293698|FG007|Double-Blind Period|Adverse Event|0
7139804|NCT02963506|11293699|FG008|Double-Blind Period|Adverse Event|0
7139805|NCT02963506|11293700|FG009|Double-Blind Period|Adverse Event|0
7139806|NCT02963506|11293701|FG010|Double-Blind Period|Adverse Event|0
7139807|NCT02963506|11293702|FG011|Double-Blind Period|Adverse Event|0
7139808|NCT02963506|11293703|FG012|Double-Blind Period|Adverse Event|0
7139809|NCT02963506|11293691|FG000|Double-Blind Period|Death|0
6789294|NCT03387852|10786860|FG000|Overall Study|Adverse event (AE)|3
6789295|NCT03387852|10786861|FG001|Overall Study|Adverse event (AE)|0
6789296|NCT03387852|10786862|FG002|Overall Study|Adverse event (AE)|2
6789297|NCT03387852|10786863|FG003|Overall Study|Adverse event (AE)|0
6789298|NCT03387852|10786860|FG000|Overall Study|Loss of asthma control (LOAC)|28
6789299|NCT03387852|10786861|FG001|Overall Study|Loss of asthma control (LOAC)|16
6789300|NCT03387852|10786862|FG002|Overall Study|Loss of asthma control (LOAC)|20
6789301|NCT03387852|10786863|FG003|Overall Study|Loss of asthma control (LOAC)|14
6789302|NCT03387852|10786860|FG000|Overall Study|Withdrawal by participant|1
6789303|NCT03387852|10786861|FG001|Overall Study|Withdrawal by participant|1
6789304|NCT03387852|10786862|FG002|Overall Study|Withdrawal by participant|3
6789305|NCT03387852|10786863|FG003|Overall Study|Withdrawal by participant|2
6789306|NCT03387852|10786860|FG000|Overall Study|Other- Unspecified|1
6789307|NCT03387852|10786861|FG001|Overall Study|Other- Unspecified|1
6789308|NCT03387852|10786862|FG002|Overall Study|Other- Unspecified|2
6789309|NCT03387852|10786863|FG003|Overall Study|Other- Unspecified|1
6789310|NCT03387852|10786860|FG000|Overall Study|Poor compliance to protocol|0
6789311|NCT03387852|10786861|FG001|Overall Study|Poor compliance to protocol|0
6789312|NCT03387852|10786862|FG002|Overall Study|Poor compliance to protocol|0
6789313|NCT03387852|10786863|FG003|Overall Study|Poor compliance to protocol|1
6789314|NCT03387852|10786860|FG000|Overall Study|Randomized and not treated|0
6789315|NCT03387852|10786861|FG001|Overall Study|Randomized and not treated|0
6789316|NCT03387852|10786862|FG002|Overall Study|Randomized and not treated|0
6789317|NCT03387852|10786863|FG003|Overall Study|Randomized and not treated|1
6789318|NCT03364673|10786880|FG000|Overall Study|Withdrawal by Subject|2
6789319|NCT03364673|10786880|FG000|Overall Study|Injury unrelated to study|3
6789320|NCT03343704|10786886|FG000|Overall Study|Refused to complete follow up|0
6789321|NCT03343704|10786887|FG001|Overall Study|Refused to complete follow up|1
6789322|NCT03343704|10786886|FG000|Overall Study|Death|0
6789323|NCT03343704|10786887|FG001|Overall Study|Death|1
6789324|NCT03343704|10786886|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1
6789325|NCT03343704|10786887|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0
6789326|NCT03265145|10786897|FG000|Overall Study|Protocol Violation|2
6789327|NCT03265145|10786898|FG001|Overall Study|Protocol Violation|0
6789328|NCT03265145|10786897|FG000|Overall Study|Adverse Event|1
6789329|NCT03265145|10786898|FG001|Overall Study|Adverse Event|0
6789330|NCT03265145|10786897|FG000|Overall Study|Withdrawal by Subject|23
6789331|NCT03265145|10786898|FG001|Overall Study|Withdrawal by Subject|19
6789332|NCT03265145|10786897|FG000|Overall Study|Death|12
6789333|NCT03265145|10786898|FG001|Overall Study|Death|12
6789334|NCT03265145|10786897|FG000|Overall Study|Lost to Follow-up|13
6789335|NCT03265145|10786898|FG001|Overall Study|Lost to Follow-up|9
6789336|NCT03265145|10786897|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0
6789337|NCT03265145|10786898|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1
6789338|NCT03265145|10786897|FG000|Overall Study|Switched back to previous medication|1
6789339|NCT03265145|10786898|FG001|Overall Study|Switched back to previous medication|0
6789340|NCT03265145|10786897|FG000|Overall Study|Did not want to take medication|1
6789341|NCT03265145|10786898|FG001|Overall Study|Did not want to take medication|0
6789342|NCT03265145|10786897|FG000|Overall Study|Subject could not afford medication|0
6789343|NCT03265145|10786898|FG001|Overall Study|Subject could not afford medication|1
6789344|NCT03265145|10786897|FG000|Overall Study|Site closed|2
6789345|NCT03265145|10786898|FG001|Overall Study|Site closed|3
6789346|NCT03265145|10786897|FG000|Overall Study|Incorrectly randomized|16
6789347|NCT03265145|10786898|FG001|Overall Study|Incorrectly randomized|6
6789348|NCT03265145|10786897|FG000|Overall Study|Entered into Electronic Data Capture in error|0
6789349|NCT03265145|10786898|FG001|Overall Study|Entered into Electronic Data Capture in error|1
6789350|NCT03265145|10786897|FG000|Overall Study|Physician Decision|0
6789351|NCT03265145|10786898|FG001|Overall Study|Physician Decision|3
6789352|NCT03265145|10786897|FG000|Overall Study|Subject transferred to another facility|0
6789353|NCT03265145|10786898|FG001|Overall Study|Subject transferred to another facility|1
6789354|NCT03219164|10786907|FG000|Overall Study|Study Terminated by Sponsor|16
6789355|NCT03219164|10786908|FG001|Overall Study|Study Terminated by Sponsor|12
6789356|NCT03219164|10786907|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5
6789357|NCT03219164|10786908|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4
6789358|NCT03219164|10786907|FG000|Overall Study|Lost to Follow-up|1
6789359|NCT03219164|10786908|FG001|Overall Study|Lost to Follow-up|1
6789360|NCT03219164|10786907|FG000|Overall Study|Adverse Event|1
6789361|NCT03219164|10786908|FG001|Overall Study|Adverse Event|0
6789362|NCT03219164|10786907|FG000|Overall Study|Non-Compliance with Study Drug|1
6789363|NCT03219164|10786908|FG001|Overall Study|Non-Compliance with Study Drug|0
6789364|NCT03219164|10786907|FG000|Overall Study|Protocol Violation|0
6789365|NCT03219164|10786908|FG001|Overall Study|Protocol Violation|1
6789366|NCT03219164|10786907|FG000|Overall Study|Withdrew Assent|1
6789367|NCT03219164|10786908|FG001|Overall Study|Withdrew Assent|0
6789368|NCT03143153|10786917|FG000|Pre-Treatment|Participant request to discontinue study treatment|0
6789369|NCT03143153|10786918|FG001|Pre-Treatment|Participant request to discontinue study treatment|0
6789370|NCT03143153|10786919|FG002|Pre-Treatment|Participant request to discontinue study treatment|2
6789371|NCT03143153|10786917|FG000|Pre-Treatment|Participant withdrew consent|0
6789372|NCT03143153|10786918|FG001|Pre-Treatment|Participant withdrew consent|1
6789373|NCT03143153|10786919|FG002|Pre-Treatment|Participant withdrew consent|12
6789374|NCT03143153|10786917|FG000|Pre-Treatment|Participant no longer meets study criteria|0
6789375|NCT03143153|10786918|FG001|Pre-Treatment|Participant no longer meets study criteria|4
6789376|NCT03143153|10786919|FG002|Pre-Treatment|Participant no longer meets study criteria|2
6789377|NCT03143153|10786917|FG000|Pre-Treatment|Other Reasons|1
6789378|NCT03143153|10786918|FG001|Pre-Treatment|Other Reasons|2
6789379|NCT03143153|10786919|FG002|Pre-Treatment|Other Reasons|1
6789380|NCT03143153|10786917|FG000|Pre-Treatment|Disease Progression|1
6789381|NCT03143153|10786918|FG001|Pre-Treatment|Disease Progression|1
6789382|NCT03143153|10786919|FG002|Pre-Treatment|Disease Progression|2
6789383|NCT03143153|10786917|FG000|Pre-Treatment|Adverse event unrelated to study drug|1
6789384|NCT03143153|10786918|FG001|Pre-Treatment|Adverse event unrelated to study drug|3
6789385|NCT03143153|10786919|FG002|Pre-Treatment|Adverse event unrelated to study drug|1
6789386|NCT03143153|10786917|FG000|Treatment|Disease progression|174
6789387|NCT03143153|10786918|FG001|Treatment|Disease progression|184
6789388|NCT03143153|10786919|FG002|Treatment|Disease progression|193
6789389|NCT03143153|10786917|FG000|Treatment|Study drug toxicity|59
6789390|NCT03143153|10786918|FG001|Treatment|Study drug toxicity|33
6789391|NCT03143153|10786919|FG002|Treatment|Study drug toxicity|40
6789392|NCT03143153|10786917|FG000|Treatment|Death|5
6789393|NCT03143153|10786918|FG001|Treatment|Death|3
6789394|NCT03143153|10786919|FG002|Treatment|Death|4
6789395|NCT03143153|10786917|FG000|Treatment|Adverse event unrelated to study drug|19
6789396|NCT03143153|10786918|FG001|Treatment|Adverse event unrelated to study drug|28
6789397|NCT03143153|10786919|FG002|Treatment|Adverse event unrelated to study drug|12
6789398|NCT03143153|10786917|FG000|Treatment|Participant request to discontinue study treatment|13
6789399|NCT03143153|10786918|FG001|Treatment|Participant request to discontinue study treatment|15
6789400|NCT03143153|10786919|FG002|Treatment|Participant request to discontinue study treatment|20
6789401|NCT03143153|10786917|FG000|Treatment|Participant withdrew consent|3
6789402|NCT03143153|10786918|FG001|Treatment|Participant withdrew consent|4
6789403|NCT03143153|10786919|FG002|Treatment|Participant withdrew consent|12
6789404|NCT03143153|10786917|FG000|Treatment|Pregnancy|1
6789405|NCT03143153|10786918|FG001|Treatment|Pregnancy|0
6789406|NCT03143153|10786919|FG002|Treatment|Pregnancy|0
6789407|NCT03143153|10786917|FG000|Treatment|Maximum clinical benefit|1
6789408|NCT03143153|10786918|FG001|Treatment|Maximum clinical benefit|3
6789409|NCT03143153|10786919|FG002|Treatment|Maximum clinical benefit|4
6789410|NCT03143153|10786917|FG000|Treatment|Completed treatment as per Protocol|13
6789411|NCT03143153|10786918|FG001|Treatment|Completed treatment as per Protocol|8
6789412|NCT03143153|10786919|FG002|Treatment|Completed treatment as per Protocol|0
6789413|NCT03143153|10786917|FG000|Treatment|Other reasons|12
6789414|NCT03143153|10786918|FG001|Treatment|Other reasons|7
6789415|NCT03143153|10786919|FG002|Treatment|Other reasons|15
6789416|NCT03143153|10786917|FG000|Treatment|Not reported|1
6789417|NCT03143153|10786918|FG001|Treatment|Not reported|0
6789418|NCT03143153|10786919|FG002|Treatment|Not reported|0
6789419|NCT02921789|10786967|FG000|Overall Study|Adverse Event|0
6789420|NCT02921789|10786968|FG001|Overall Study|Adverse Event|1
6789421|NCT02921789|10786967|FG000|Overall Study|Lost to Follow-up|1
6789422|NCT02921789|10786968|FG001|Overall Study|Lost to Follow-up|0
6789423|NCT02921789|10786967|FG000|Overall Study|Protocol Deviation|2
6789424|NCT02921789|10786968|FG001|Overall Study|Protocol Deviation|0
6789425|NCT02921789|10786967|FG000|Overall Study|Withdrawal by Subject|2
6789426|NCT02921789|10786968|FG001|Overall Study|Withdrawal by Subject|1
6789427|NCT02921789|10786967|FG000|Overall Study|Miscellaneous|3
6789428|NCT02921789|10786968|FG001|Overall Study|Miscellaneous|2
6789429|NCT02898077|10786976|FG000|Overall Study|Enrolled/randomized, but never treated|1
6789430|NCT02898077|10786977|FG001|Overall Study|Enrolled/randomized, but never treated|1
6789431|NCT02898077|10786976|FG000|Overall Study|Lost to Follow-up|4
6789432|NCT02898077|10786977|FG001|Overall Study|Lost to Follow-up|3
6789433|NCT02898077|10786976|FG000|Overall Study|Physician Decision|0
6789434|NCT02898077|10786977|FG001|Overall Study|Physician Decision|2
6789435|NCT02898077|10786976|FG000|Overall Study|Sponsor Decision|32
6789436|NCT02898077|10786977|FG001|Overall Study|Sponsor Decision|13
6789437|NCT02898077|10786976|FG000|Overall Study|Withdrawal by Subject|6
6789438|NCT02898077|10786977|FG001|Overall Study|Withdrawal by Subject|3
6789439|NCT02898077|10786976|FG000|Overall Study|Discontinued from treatment but refused follow-up|2
6789440|NCT02898077|10786977|FG001|Overall Study|Discontinued from treatment but refused follow-up|1
6789441|NCT02898077|10786976|FG000|Overall Study|Ended extension period|3
6789442|NCT02898077|10786977|FG001|Overall Study|Ended extension period|0
6789443|NCT02702271|10786985|FG000|Overall Study|Death|36
6789444|NCT02702271|10786986|FG001|Overall Study|Death|7
6789445|NCT02702271|10786985|FG000|Overall Study|Lost to Follow-up|12
6789446|NCT02702271|10786986|FG001|Overall Study|Lost to Follow-up|0
6789447|NCT02702271|10786985|FG000|Overall Study|Withdrawal by Subject|8
6789448|NCT02702271|10786986|FG001|Overall Study|Withdrawal by Subject|1
6789449|NCT02702271|10786985|FG000|Overall Study|Physician Decision|2
6789450|NCT02702271|10786986|FG001|Overall Study|Physician Decision|0
6789451|NCT02702271|10786985|FG000|Overall Study|Unsuccessful Implant Attempt|5
6789452|NCT02702271|10786986|FG001|Overall Study|Unsuccessful Implant Attempt|1
6789453|NCT02471339|10787010|FG000|Overall Study|Did not provide follow-up data|2
6789454|NCT02471339|10787011|FG001|Overall Study|Did not provide follow-up data|0
6789455|NCT02470585|10787020|FG000|Overall Study|Death|82
6789456|NCT02470585|10787021|FG001|Overall Study|Death|87
6789457|NCT02470585|10787022|FG002|Overall Study|Death|86
6789458|NCT02470585|10787020|FG000|Overall Study|Withdrawal by Subject|19
6789459|NCT02470585|10787021|FG001|Overall Study|Withdrawal by Subject|21
6789460|NCT02470585|10787022|FG002|Overall Study|Withdrawal by Subject|29
6789461|NCT02470585|10787020|FG000|Overall Study|Lost to Follow-up|2
6789462|NCT02470585|10787021|FG001|Overall Study|Lost to Follow-up|5
6789463|NCT02470585|10787022|FG002|Overall Study|Lost to Follow-up|4
6789464|NCT02470585|10787020|FG000|Overall Study|Other|4
6789465|NCT02470585|10787021|FG001|Overall Study|Other|4
6789466|NCT02470585|10787022|FG002|Overall Study|Other|6
6789467|NCT02163694|10787053|FG000|Overall Study|Adverse event- related to progression|3
6789468|NCT02163694|10787054|FG001|Overall Study|Adverse event- related to progression|8
6789469|NCT02163694|10787053|FG000|Overall Study|Adverse event- not related to progression|7
6789470|NCT02163694|10787054|FG001|Overall Study|Adverse event- not related to progression|17
6789471|NCT02163694|10787053|FG000|Overall Study|Withdrew consent|8
6789472|NCT02163694|10787054|FG001|Overall Study|Withdrew consent|21
6789473|NCT02163694|10787053|FG000|Overall Study|Lost to Follow-up|1
6789474|NCT02163694|10787054|FG001|Overall Study|Lost to Follow-up|2
6789475|NCT02163694|10787053|FG000|Overall Study|Progressive disease per protocol|122
6789476|NCT02163694|10787054|FG001|Overall Study|Progressive disease per protocol|197
6789477|NCT02163694|10787053|FG000|Overall Study|Other, not specified|13
6789478|NCT02163694|10787054|FG001|Overall Study|Other, not specified|22
6789479|NCT01966471|10787062|FG000|Overall Study|Death|44
6789480|NCT01966471|10787063|FG001|Overall Study|Death|56
6789481|NCT01966471|10787062|FG000|Overall Study|Lost to Follow-up|46
6789482|NCT01966471|10787063|FG001|Overall Study|Lost to Follow-up|39
6789483|NCT01966471|10787062|FG000|Overall Study|Various reasons|4
6789484|NCT01966471|10787063|FG001|Overall Study|Various reasons|4
6789485|NCT01966471|10787062|FG000|Overall Study|Physician Decision|7
7139810|NCT02963506|11293692|FG001|Double-Blind Period|Death|0
7139811|NCT02963506|11293693|FG002|Double-Blind Period|Death|0
7139812|NCT02963506|11293694|FG003|Double-Blind Period|Death|1
7139813|NCT02963506|11293695|FG004|Double-Blind Period|Death|0
7139814|NCT02963506|11293696|FG005|Double-Blind Period|Death|0
7139815|NCT02963506|11293697|FG006|Double-Blind Period|Death|0
7139816|NCT02963506|11293698|FG007|Double-Blind Period|Death|0
7139817|NCT02963506|11293699|FG008|Double-Blind Period|Death|0
7139818|NCT02963506|11293700|FG009|Double-Blind Period|Death|0
7139819|NCT02963506|11293701|FG010|Double-Blind Period|Death|0
7139820|NCT02963506|11293702|FG011|Double-Blind Period|Death|0
7139821|NCT02963506|11293703|FG012|Double-Blind Period|Death|0
7139822|NCT02963506|11293691|FG000|Double-Blind Period|Lost to Follow-up|0
7139823|NCT02963506|11293692|FG001|Double-Blind Period|Lost to Follow-up|1
7139824|NCT02963506|11293693|FG002|Double-Blind Period|Lost to Follow-up|0
7139825|NCT02963506|11293694|FG003|Double-Blind Period|Lost to Follow-up|0
7139826|NCT02963506|11293695|FG004|Double-Blind Period|Lost to Follow-up|0
7139827|NCT02963506|11293696|FG005|Double-Blind Period|Lost to Follow-up|0
7139828|NCT02963506|11293697|FG006|Double-Blind Period|Lost to Follow-up|0
7139829|NCT02963506|11293698|FG007|Double-Blind Period|Lost to Follow-up|0
7139830|NCT02963506|11293699|FG008|Double-Blind Period|Lost to Follow-up|0
7139831|NCT02963506|11293700|FG009|Double-Blind Period|Lost to Follow-up|0
7139832|NCT02963506|11293701|FG010|Double-Blind Period|Lost to Follow-up|0
7139833|NCT02963506|11293702|FG011|Double-Blind Period|Lost to Follow-up|0
7139834|NCT02963506|11293703|FG012|Double-Blind Period|Lost to Follow-up|0
7139835|NCT02963506|11293691|FG000|Double-Blind Period|Withdrawal by Subject|0
7139836|NCT02963506|11293692|FG001|Double-Blind Period|Withdrawal by Subject|0
7139837|NCT02963506|11293693|FG002|Double-Blind Period|Withdrawal by Subject|1
7139838|NCT02963506|11293694|FG003|Double-Blind Period|Withdrawal by Subject|1
7139839|NCT02963506|11293695|FG004|Double-Blind Period|Withdrawal by Subject|0
7139840|NCT02963506|11293696|FG005|Double-Blind Period|Withdrawal by Subject|0
7139841|NCT02963506|11293697|FG006|Double-Blind Period|Withdrawal by Subject|0
7139842|NCT02963506|11293698|FG007|Double-Blind Period|Withdrawal by Subject|0
7139843|NCT02963506|11293699|FG008|Double-Blind Period|Withdrawal by Subject|0
7139844|NCT02963506|11293700|FG009|Double-Blind Period|Withdrawal by Subject|0
7139845|NCT02963506|11293701|FG010|Double-Blind Period|Withdrawal by Subject|0
7139846|NCT02963506|11293702|FG011|Double-Blind Period|Withdrawal by Subject|0
7139847|NCT02963506|11293703|FG012|Double-Blind Period|Withdrawal by Subject|0
7139848|NCT02963506|11293691|FG000|Double-Blind Period|No compliance|0
7139849|NCT02963506|11293692|FG001|Double-Blind Period|No compliance|1
7139850|NCT02963506|11293693|FG002|Double-Blind Period|No compliance|0
7139851|NCT02963506|11293694|FG003|Double-Blind Period|No compliance|0
7139852|NCT02963506|11293695|FG004|Double-Blind Period|No compliance|0
7139853|NCT02963506|11293696|FG005|Double-Blind Period|No compliance|0
7139854|NCT02963506|11293697|FG006|Double-Blind Period|No compliance|0
6789486|NCT01966471|10787063|FG001|Overall Study|Physician Decision|5
6789487|NCT01966471|10787062|FG000|Overall Study|Study Terminated By Sponsor|758
6789488|NCT01966471|10787063|FG001|Overall Study|Study Terminated By Sponsor|773
6789489|NCT01966471|10787062|FG000|Overall Study|Withdrawal by Subject|59
6789490|NCT01966471|10787063|FG001|Overall Study|Withdrawal by Subject|51
7139855|NCT02963506|11293698|FG007|Double-Blind Period|No compliance|0
7139856|NCT02963506|11293699|FG008|Double-Blind Period|No compliance|0
7139857|NCT02963506|11293700|FG009|Double-Blind Period|No compliance|0
7139858|NCT02963506|11293701|FG010|Double-Blind Period|No compliance|0
7139859|NCT02963506|11293702|FG011|Double-Blind Period|No compliance|0
7139860|NCT02963506|11293703|FG012|Double-Blind Period|No compliance|0
7139861|NCT02963506|11293691|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0
7139862|NCT02963506|11293692|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1
7139863|NCT02963506|11293693|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0
7139864|NCT02963506|11293694|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0
7139865|NCT02963506|11293695|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0
7139866|NCT02963506|11293696|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0
7139867|NCT02963506|11293697|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0
6789507|NCT01465334|10787106|FG000|Overall Study|Disease Progression|1
6789508|NCT01465334|10787107|FG001|Overall Study|Disease Progression|0
6789509|NCT01465334|10787106|FG000|Overall Study|Adverse Event|1
6789510|NCT01465334|10787107|FG001|Overall Study|Adverse Event|0
6789511|NCT01465334|10787106|FG000|Overall Study|Richter's transformation|0
6789512|NCT01465334|10787107|FG001|Overall Study|Richter's transformation|3
6789513|NCT01465334|10787106|FG000|Overall Study|Refractory Disease|0
6789514|NCT01465334|10787107|FG001|Overall Study|Refractory Disease|3
6789515|NCT01307423|10787116|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
6789516|NCT01307423|10787117|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
6789517|NCT01307423|10787118|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6
6789518|NCT01307423|10787119|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
6789519|NCT01307423|10787120|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
6789520|NCT01307423|10787121|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
6789521|NCT01307423|10787122|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
6789522|NCT01307423|10787123|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
6789523|NCT01307423|10787124|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
6789524|NCT01307423|10787116|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1
6789525|NCT01307423|10787117|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
6789526|NCT01307423|10787118|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
6789527|NCT01307423|10787119|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
6789528|NCT01307423|10787120|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
6789529|NCT01307423|10787121|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
6789530|NCT01307423|10787122|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
6789531|NCT01307423|10787123|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
6789532|NCT01307423|10787124|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
6789533|NCT01307423|10787116|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8
7139868|NCT02963506|11293698|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0
7139869|NCT02963506|11293699|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0
7139870|NCT02963506|11293700|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0
7139871|NCT02963506|11293701|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0
7139872|NCT02963506|11293702|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0
7139873|NCT02963506|11293703|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0
7139874|NCT02963506|11293691|FG000|Dose-Blind Period|Adverse Event|0
7139875|NCT02963506|11293692|FG001|Dose-Blind Period|Adverse Event|0
7139876|NCT02963506|11293693|FG002|Dose-Blind Period|Adverse Event|0
7139877|NCT02963506|11293694|FG003|Dose-Blind Period|Adverse Event|0
7139878|NCT02963506|11293695|FG004|Dose-Blind Period|Adverse Event|0
7139879|NCT02963506|11293696|FG005|Dose-Blind Period|Adverse Event|1
7139880|NCT02963506|11293697|FG006|Dose-Blind Period|Adverse Event|3
7139881|NCT02963506|11293698|FG007|Dose-Blind Period|Adverse Event|2
7139882|NCT02963506|11293699|FG008|Dose-Blind Period|Adverse Event|2
7139883|NCT02963506|11293700|FG009|Dose-Blind Period|Adverse Event|2
7139884|NCT02963506|11293701|FG010|Dose-Blind Period|Adverse Event|1
7139885|NCT02963506|11293702|FG011|Dose-Blind Period|Adverse Event|1
7139886|NCT02963506|11293703|FG012|Dose-Blind Period|Adverse Event|6
7139887|NCT02963506|11293691|FG000|Dose-Blind Period|Lack of Efficacy|0
7139888|NCT02963506|11293692|FG001|Dose-Blind Period|Lack of Efficacy|0
7139889|NCT02963506|11293693|FG002|Dose-Blind Period|Lack of Efficacy|0
7139890|NCT02963506|11293694|FG003|Dose-Blind Period|Lack of Efficacy|0
7139891|NCT02963506|11293695|FG004|Dose-Blind Period|Lack of Efficacy|0
7139892|NCT02963506|11293696|FG005|Dose-Blind Period|Lack of Efficacy|0
7139893|NCT02963506|11293697|FG006|Dose-Blind Period|Lack of Efficacy|0
7139894|NCT02963506|11293698|FG007|Dose-Blind Period|Lack of Efficacy|1
7139895|NCT02963506|11293699|FG008|Dose-Blind Period|Lack of Efficacy|0
7139896|NCT02963506|11293700|FG009|Dose-Blind Period|Lack of Efficacy|1
7139897|NCT02963506|11293701|FG010|Dose-Blind Period|Lack of Efficacy|0
7139898|NCT02963506|11293702|FG011|Dose-Blind Period|Lack of Efficacy|0
7139899|NCT02963506|11293703|FG012|Dose-Blind Period|Lack of Efficacy|0
7139900|NCT02963506|11293691|FG000|Dose-Blind Period|Lost to Follow-up|0
7139901|NCT02963506|11293692|FG001|Dose-Blind Period|Lost to Follow-up|0
7139902|NCT02963506|11293693|FG002|Dose-Blind Period|Lost to Follow-up|0
7139903|NCT02963506|11293694|FG003|Dose-Blind Period|Lost to Follow-up|0
7139904|NCT02963506|11293695|FG004|Dose-Blind Period|Lost to Follow-up|0
7139905|NCT02963506|11293696|FG005|Dose-Blind Period|Lost to Follow-up|1
7139906|NCT02963506|11293697|FG006|Dose-Blind Period|Lost to Follow-up|0
7139907|NCT02963506|11293698|FG007|Dose-Blind Period|Lost to Follow-up|0
7139908|NCT02963506|11293699|FG008|Dose-Blind Period|Lost to Follow-up|1
7139909|NCT02963506|11293700|FG009|Dose-Blind Period|Lost to Follow-up|0
7139910|NCT02963506|11293701|FG010|Dose-Blind Period|Lost to Follow-up|0
7139911|NCT02963506|11293702|FG011|Dose-Blind Period|Lost to Follow-up|1
7139912|NCT02963506|11293703|FG012|Dose-Blind Period|Lost to Follow-up|0
7139913|NCT02963506|11293691|FG000|Dose-Blind Period|Withdrawal by Subject|0
7139914|NCT02963506|11293692|FG001|Dose-Blind Period|Withdrawal by Subject|0
7139915|NCT02963506|11293693|FG002|Dose-Blind Period|Withdrawal by Subject|0
7139916|NCT02963506|11293694|FG003|Dose-Blind Period|Withdrawal by Subject|0
7139917|NCT02963506|11293695|FG004|Dose-Blind Period|Withdrawal by Subject|0
6789534|NCT01307423|10787117|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
6789535|NCT01307423|10787118|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10
6789536|NCT01307423|10787119|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
6789537|NCT01307423|10787120|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
6789538|NCT01307423|10787121|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
6789539|NCT01307423|10787122|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
6789540|NCT01307423|10787123|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
6789541|NCT01307423|10787124|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
6789542|NCT01307423|10787116|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
6789543|NCT01307423|10787117|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
6789544|NCT01307423|10787118|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
6789545|NCT01307423|10787119|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
6789546|NCT01307423|10787120|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
6789547|NCT01307423|10787121|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
6789548|NCT01307423|10787122|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
6789549|NCT01307423|10787123|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
6789550|NCT01307423|10787124|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
6789551|NCT01307423|10787116|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5
6789552|NCT01307423|10787117|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
6789553|NCT01307423|10787118|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
6789554|NCT01307423|10787119|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
6789555|NCT01307423|10787120|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
6789556|NCT01307423|10787121|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
6789557|NCT01307423|10787122|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
6789558|NCT01307423|10787123|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
6789559|NCT01307423|10787124|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
6789560|NCT01307423|10787116|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
6789561|NCT01307423|10787117|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
6789562|NCT01307423|10787118|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
6789563|NCT01307423|10787119|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
6789564|NCT01307423|10787120|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
6789565|NCT01307423|10787121|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
6789566|NCT01307423|10787122|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
6789567|NCT01307423|10787123|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
6789568|NCT01307423|10787124|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
6789569|NCT01307423|10787116|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1
6789570|NCT01307423|10787117|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2
6789571|NCT01307423|10787118|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0
6789572|NCT01307423|10787119|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0
6789573|NCT01307423|10787120|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0
6789574|NCT01307423|10787121|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0
6789575|NCT01307423|10787122|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0
6789576|NCT01307423|10787123|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0
6789577|NCT01307423|10787124|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0
6789578|NCT01307423|10787116|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
6789579|NCT01307423|10787117|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
6789580|NCT01307423|10787118|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
6789581|NCT01307423|10787119|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
6789582|NCT01307423|10787120|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
6789583|NCT01307423|10787121|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
6789584|NCT01307423|10787122|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
6789585|NCT01307423|10787123|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
6789586|NCT01307423|10787124|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
6789587|NCT01307423|10787116|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0
6789588|NCT01307423|10787117|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3
6789589|NCT01307423|10787118|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2
6789590|NCT01307423|10787119|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2
6789591|NCT01307423|10787120|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2
6789592|NCT01307423|10787121|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0
6789593|NCT01307423|10787122|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0
6789594|NCT01307423|10787123|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0
6789595|NCT01307423|10787124|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0
6789596|NCT01307423|10787116|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
6789597|NCT01307423|10787117|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
6789598|NCT01307423|10787118|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
6789599|NCT01307423|10787119|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3
6789600|NCT01307423|10787120|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1
6789601|NCT01307423|10787121|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
6789602|NCT01307423|10787122|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
6789603|NCT01307423|10787123|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
6789604|NCT01307423|10787124|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
6789605|NCT01307423|10787116|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
6789606|NCT01307423|10787117|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
6789607|NCT01307423|10787118|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
6789608|NCT01307423|10787119|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
6789609|NCT01307423|10787120|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
6789610|NCT01307423|10787121|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1
6789611|NCT01307423|10787122|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
6789612|NCT01307423|10787123|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
6789613|NCT01307423|10787124|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
6789614|NCT01307423|10787116|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
6789615|NCT01307423|10787117|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11
6789616|NCT01307423|10787118|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2
6789617|NCT01307423|10787119|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
6789618|NCT01307423|10787120|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
6789619|NCT01307423|10787121|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
6789620|NCT01307423|10787122|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
6789621|NCT01307423|10787123|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
6789622|NCT01307423|10787124|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
6789623|NCT01307423|10787116|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
6789624|NCT01307423|10787117|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
6789625|NCT01307423|10787118|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
6789626|NCT01307423|10787119|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2
6789627|NCT01307423|10787120|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
6789628|NCT01307423|10787121|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
6789629|NCT01307423|10787122|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
6789630|NCT01307423|10787123|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
6789631|NCT01307423|10787124|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
6789632|NCT01307423|10787116|FG000|Active Treatment Phase (Week 25-52)|Other|0
6789633|NCT01307423|10787117|FG001|Active Treatment Phase (Week 25-52)|Other|0
6789634|NCT01307423|10787118|FG002|Active Treatment Phase (Week 25-52)|Other|0
6789635|NCT01307423|10787119|FG003|Active Treatment Phase (Week 25-52)|Other|1
6789636|NCT01307423|10787120|FG004|Active Treatment Phase (Week 25-52)|Other|0
6789637|NCT01307423|10787121|FG005|Active Treatment Phase (Week 25-52)|Other|0
6789638|NCT01307423|10787122|FG006|Active Treatment Phase (Week 25-52)|Other|0
6789639|NCT01307423|10787123|FG007|Active Treatment Phase (Week 25-52)|Other|0
6789640|NCT01307423|10787124|FG008|Active Treatment Phase (Week 25-52)|Other|0
6789641|NCT01307423|10787116|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0
6789642|NCT01307423|10787117|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0
6789643|NCT01307423|10787118|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0
6789644|NCT01307423|10787119|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0
6789645|NCT01307423|10787120|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0
6789646|NCT01307423|10787121|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1
6789647|NCT01307423|10787122|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0
6789648|NCT01307423|10787123|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0
6789649|NCT01307423|10787124|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0
6789650|NCT01307423|10787116|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0
6789651|NCT01307423|10787117|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2
6789652|NCT01307423|10787118|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7
6789653|NCT01307423|10787119|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0
6789654|NCT01307423|10787120|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0
6789655|NCT01307423|10787121|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0
6789656|NCT01307423|10787122|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0
6789657|NCT01307423|10787123|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1
6789658|NCT01307423|10787124|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1
6789659|NCT01307423|10787116|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
6789660|NCT01307423|10787117|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7
6789661|NCT01307423|10787118|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5
6789662|NCT01307423|10787119|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
6789663|NCT01307423|10787120|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
6789664|NCT01307423|10787121|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
6789665|NCT01307423|10787122|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
6789666|NCT01307423|10787123|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4
6789667|NCT01307423|10787124|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3
6789668|NCT01307423|10787116|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
6789669|NCT01307423|10787117|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
6789670|NCT01307423|10787118|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1
6789671|NCT01307423|10787119|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
6789672|NCT01307423|10787120|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
6789673|NCT01307423|10787121|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
6789674|NCT01307423|10787122|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
6789675|NCT01307423|10787123|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
6789676|NCT01307423|10787124|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
6789677|NCT01307423|10787116|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
6789678|NCT01307423|10787117|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13
6789679|NCT01307423|10787118|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12
6789680|NCT01307423|10787119|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
6789681|NCT01307423|10787120|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
6789682|NCT01307423|10787121|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
6789683|NCT01307423|10787122|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
6789684|NCT01307423|10787123|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3
6789685|NCT01307423|10787124|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2
6789686|NCT01307423|10787116|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0
6789687|NCT01307423|10787117|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1
6789688|NCT01307423|10787118|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0
6789689|NCT01307423|10787119|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0
6789690|NCT01307423|10787120|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0
6789691|NCT01307423|10787121|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0
6789692|NCT01307423|10787122|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0
6789693|NCT01307423|10787123|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1
6789694|NCT01307423|10787124|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1
6789695|NCT01307423|10787116|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0
6789696|NCT01307423|10787117|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1
6789697|NCT01307423|10787118|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2
6789698|NCT01307423|10787119|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0
6789699|NCT01307423|10787120|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0
6789700|NCT01307423|10787121|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0
6789701|NCT01307423|10787122|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0
6789702|NCT01307423|10787123|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3
6789703|NCT01307423|10787124|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4
6789704|NCT01307423|10787116|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
6789705|NCT01307423|10787117|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
6789706|NCT01307423|10787118|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4
6789707|NCT01307423|10787119|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
6789708|NCT01307423|10787120|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
6789709|NCT01307423|10787121|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
6789710|NCT01307423|10787122|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
6789711|NCT01307423|10787123|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1
6789712|NCT01307423|10787124|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
6789713|NCT01307423|10787116|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
6789714|NCT01307423|10787117|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1
6789715|NCT01307423|10787118|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1
6789716|NCT01307423|10787119|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
6789717|NCT01307423|10787120|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
6789718|NCT01307423|10787121|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
6789719|NCT01307423|10787122|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
6789720|NCT01307423|10787123|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
6789721|NCT01307423|10787124|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
6789722|NCT01307423|10787116|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
6789723|NCT01307423|10787117|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2
6789724|NCT01307423|10787118|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8
6789725|NCT01307423|10787119|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
6789726|NCT01307423|10787120|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
6789727|NCT01307423|10787121|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
6789728|NCT01307423|10787122|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
6789729|NCT01307423|10787123|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2
6789730|NCT01307423|10787124|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4
6789731|NCT01307423|10787116|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
6789732|NCT01307423|10787117|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2
6789733|NCT01307423|10787118|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3
6789734|NCT01307423|10787119|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
6789735|NCT01307423|10787120|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
6789736|NCT01307423|10787121|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
6789737|NCT01307423|10787122|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
6789738|NCT01307423|10787123|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
6789739|NCT01307423|10787124|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
6789740|NCT01307423|10787116|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0
6789741|NCT01307423|10787117|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1
6789742|NCT01307423|10787118|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0
6789743|NCT01307423|10787119|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0
6789744|NCT01307423|10787120|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0
6789745|NCT01307423|10787121|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0
6789746|NCT01307423|10787122|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0
6789747|NCT01307423|10787123|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1
6789748|NCT01307423|10787124|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0
6789749|NCT01307423|10787116|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0
6789750|NCT01307423|10787117|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2
6789751|NCT01307423|10787118|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0
6789752|NCT01307423|10787119|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0
6789753|NCT01307423|10787120|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0
6789754|NCT01307423|10787121|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0
6789755|NCT01307423|10787122|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0
6789756|NCT01307423|10787123|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0
6789757|NCT01307423|10787124|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0
6789758|NCT01307423|10787116|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
6789759|NCT01307423|10787117|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
6789760|NCT01307423|10787118|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
6789761|NCT01307423|10787119|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
6789762|NCT01307423|10787120|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
6789763|NCT01307423|10787121|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
6789764|NCT01307423|10787122|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
6789765|NCT01307423|10787123|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
6789766|NCT01307423|10787124|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
6789767|NCT01307423|10787116|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
6789768|NCT01307423|10787117|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5
6789769|NCT01307423|10787118|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4
6789770|NCT01307423|10787119|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
6789771|NCT01307423|10787120|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
6789772|NCT01307423|10787121|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
6789773|NCT01307423|10787122|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
6789774|NCT01307423|10787123|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1
6789775|NCT01307423|10787124|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4
6789776|NCT01307423|10787116|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
6789777|NCT01307423|10787117|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
6789778|NCT01307423|10787118|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1
6789779|NCT01307423|10787119|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
6789780|NCT01307423|10787120|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
6789781|NCT01307423|10787121|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
6789782|NCT01307423|10787122|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
6789783|NCT01307423|10787123|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
6789784|NCT01307423|10787124|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
6789785|NCT01307423|10787116|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0
6789786|NCT01307423|10787117|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0
6789787|NCT01307423|10787118|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0
6789788|NCT01307423|10787119|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0
6789789|NCT01307423|10787120|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0
6789790|NCT01307423|10787121|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0
6789791|NCT01307423|10787122|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0
6789792|NCT01307423|10787123|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1
6789793|NCT01307423|10787124|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0
6789794|NCT01307423|10787116|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0
6789795|NCT01307423|10787117|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1
6789796|NCT01307423|10787118|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1
6789797|NCT01307423|10787119|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0
6789798|NCT01307423|10787120|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0
6789799|NCT01307423|10787121|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0
6789800|NCT01307423|10787122|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0
6789801|NCT01307423|10787123|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0
6789802|NCT01307423|10787124|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1
6789803|NCT01307423|10787116|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
6789804|NCT01307423|10787117|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2
6789805|NCT01307423|10787118|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1
6789806|NCT01307423|10787119|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
6789807|NCT01307423|10787120|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
6789808|NCT01307423|10787121|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
6789809|NCT01307423|10787122|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
6789810|NCT01307423|10787123|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
6789811|NCT01307423|10787124|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
6789812|NCT01307423|10787116|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
6789813|NCT01307423|10787117|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6
6789814|NCT01307423|10787118|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2
7139918|NCT02963506|11293696|FG005|Dose-Blind Period|Withdrawal by Subject|1
7139919|NCT02963506|11293697|FG006|Dose-Blind Period|Withdrawal by Subject|2
6789815|NCT01307423|10787119|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
6789816|NCT01307423|10787120|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
6789817|NCT01307423|10787121|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
6789818|NCT01307423|10787122|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
6789819|NCT01307423|10787123|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
6789820|NCT01307423|10787124|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
6789821|NCT01307423|10787116|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
6789822|NCT01307423|10787117|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1
6789823|NCT01307423|10787118|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
6789824|NCT01307423|10787119|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
6789825|NCT01307423|10787120|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
6789826|NCT01307423|10787121|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
6789827|NCT01307423|10787122|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
6789828|NCT01307423|10787123|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
6789829|NCT01307423|10787124|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
6789830|NCT01307423|10787116|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0
6789831|NCT01307423|10787117|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0
6789832|NCT01307423|10787118|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2
6789833|NCT01307423|10787119|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0
6789834|NCT01307423|10787120|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0
6789835|NCT01307423|10787121|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0
6789836|NCT01307423|10787122|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0
6789837|NCT01307423|10787123|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1
6789838|NCT01307423|10787124|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1
6789839|NCT00655876|10787185|FG000|Overall Study|Protocol Violation|9
6789840|NCT00655876|10787186|FG001|Overall Study|Protocol Violation|7
6789841|NCT00265941|10787211|FG000|Overall Study|Protocol Violation|22
6789842|NCT00265941|10787212|FG001|Overall Study|Protocol Violation|25
6789843|NCT00265941|10787211|FG000|Overall Study|Lost to Follow-up|1
6789844|NCT00265941|10787212|FG001|Overall Study|Lost to Follow-up|1
6789845|NCT00114140|10787226|FG000|Overall Study|Protocol Violation|7
6789846|NCT00047008|10787239|FG000|Overall Study|Withdrawn consent|2
6789847|NCT00047008|10787240|FG001|Overall Study|Withdrawn consent|3
6789848|NCT00047008|10787239|FG000|Overall Study|Ineligible|9
6789849|NCT00047008|10787240|FG001|Overall Study|Ineligible|8
6807604|NCT03307785|10811138|FG005|Part D: Up to 9.5 Months|Withdrawal by Subject|1
6807605|NCT03307785|10811139|FG006|Part D: Up to 9.5 Months|Withdrawal by Subject|0
6807606|NCT03307785|10811140|FG007|Part D: Up to 9.5 Months|Withdrawal by Subject|0
6807607|NCT03307785|10811141|FG008|Part D: Up to 9.5 Months|Withdrawal by Subject|0
6807608|NCT03307785|10811142|FG009|Part D: Up to 9.5 Months|Withdrawal by Subject|0
6807609|NCT03307785|10811143|FG010|Part D: Up to 9.5 Months|Withdrawal by Subject|0
6807610|NCT03307785|10811133|FG000|Part E: Up to 4.4 Months|Death|0
6807611|NCT03307785|10811134|FG001|Part E: Up to 4.4 Months|Death|0
6807612|NCT03307785|10811135|FG002|Part E: Up to 4.4 Months|Death|0
6807613|NCT03307785|10811136|FG003|Part E: Up to 4.4 Months|Death|0
6807614|NCT03307785|10811137|FG004|Part E: Up to 4.4 Months|Death|0
6807615|NCT03307785|10811138|FG005|Part E: Up to 4.4 Months|Death|0
6807616|NCT03307785|10811139|FG006|Part E: Up to 4.4 Months|Death|1
6807617|NCT03307785|10811140|FG007|Part E: Up to 4.4 Months|Death|0
6807618|NCT03307785|10811141|FG008|Part E: Up to 4.4 Months|Death|0
6807619|NCT03307785|10811142|FG009|Part E: Up to 4.4 Months|Death|0
6807620|NCT03307785|10811143|FG010|Part E: Up to 4.4 Months|Death|0
6807621|NCT03307785|10811133|FG000|Part E: Up to 4.4 Months|Physician Decision|0
6807622|NCT03307785|10811134|FG001|Part E: Up to 4.4 Months|Physician Decision|0
6807623|NCT03307785|10811135|FG002|Part E: Up to 4.4 Months|Physician Decision|0
6807624|NCT03307785|10811136|FG003|Part E: Up to 4.4 Months|Physician Decision|0
6807625|NCT03307785|10811137|FG004|Part E: Up to 4.4 Months|Physician Decision|0
6807626|NCT03307785|10811138|FG005|Part E: Up to 4.4 Months|Physician Decision|0
6807627|NCT03307785|10811139|FG006|Part E: Up to 4.4 Months|Physician Decision|1
6807628|NCT03307785|10811140|FG007|Part E: Up to 4.4 Months|Physician Decision|0
6807629|NCT03307785|10811141|FG008|Part E: Up to 4.4 Months|Physician Decision|0
6807630|NCT03307785|10811142|FG009|Part E: Up to 4.4 Months|Physician Decision|0
6807631|NCT03307785|10811143|FG010|Part E: Up to 4.4 Months|Physician Decision|0
6807632|NCT03307785|10811133|FG000|Part F: Up to 3.5 Months|Physician Decision|0
6807633|NCT03307785|10811134|FG001|Part F: Up to 3.5 Months|Physician Decision|0
6807634|NCT03307785|10811135|FG002|Part F: Up to 3.5 Months|Physician Decision|0
6807635|NCT03307785|10811136|FG003|Part F: Up to 3.5 Months|Physician Decision|0
6807636|NCT03307785|10811137|FG004|Part F: Up to 3.5 Months|Physician Decision|0
7139920|NCT02963506|11293698|FG007|Dose-Blind Period|Withdrawal by Subject|2
6807637|NCT03307785|10811138|FG005|Part F: Up to 3.5 Months|Physician Decision|0
6807638|NCT03307785|10811139|FG006|Part F: Up to 3.5 Months|Physician Decision|0
6807639|NCT03307785|10811140|FG007|Part F: Up to 3.5 Months|Physician Decision|1
6807640|NCT03307785|10811141|FG008|Part F: Up to 3.5 Months|Physician Decision|0
6807641|NCT03307785|10811142|FG009|Part F: Up to 3.5 Months|Physician Decision|0
6807642|NCT03307785|10811143|FG010|Part F: Up to 3.5 Months|Physician Decision|0
6807643|NCT03043872|10811176|FG000|Overall Study|Withdrawal by Subject|6
6807644|NCT03043872|10811177|FG001|Overall Study|Withdrawal by Subject|6
6807645|NCT03043872|10811178|FG002|Overall Study|Withdrawal by Subject|15
6789850|NCT04392583|10787250|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1
6789851|NCT04326439|10787260|FG000|Overall Study|Withdrawal by Subject|1
6789852|NCT04326439|10787261|FG001|Overall Study|Withdrawal by Subject|0
6789853|NCT04326439|10787260|FG000|Overall Study|Proceeded to HSCT after Induction 2|0
6789854|NCT04326439|10787261|FG001|Overall Study|Proceeded to HSCT after Induction 2|2
6789855|NCT04326439|10787260|FG000|Overall Study|Relapse after Induction 2|0
6789856|NCT04326439|10787261|FG001|Overall Study|Relapse after Induction 2|1
6789857|NCT04326439|10787260|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1
6789858|NCT04326439|10787261|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0
6789859|NCT04003142|10787290|FG000|Double-blind Period (12 Weeks)|Adverse Event|1
6789860|NCT04003142|10787291|FG001|Double-blind Period (12 Weeks)|Adverse Event|1
6789861|NCT04003142|10787292|FG002|Double-blind Period (12 Weeks)|Adverse Event|2
6789862|NCT04003142|10787293|FG003|Double-blind Period (12 Weeks)|Adverse Event|0
6789863|NCT04003142|10787294|FG004|Double-blind Period (12 Weeks)|Adverse Event|0
7139921|NCT02963506|11293699|FG008|Dose-Blind Period|Withdrawal by Subject|0
7139922|NCT02963506|11293700|FG009|Dose-Blind Period|Withdrawal by Subject|1
7139923|NCT02963506|11293701|FG010|Dose-Blind Period|Withdrawal by Subject|0
7139924|NCT02963506|11293702|FG011|Dose-Blind Period|Withdrawal by Subject|0
7139925|NCT02963506|11293703|FG012|Dose-Blind Period|Withdrawal by Subject|0
7139926|NCT02963506|11293691|FG000|Dose-Blind Period|Sponsor decision|0
7139927|NCT02963506|11293692|FG001|Dose-Blind Period|Sponsor decision|0
7139928|NCT02963506|11293693|FG002|Dose-Blind Period|Sponsor decision|0
7139929|NCT02963506|11293694|FG003|Dose-Blind Period|Sponsor decision|0
7139930|NCT02963506|11293695|FG004|Dose-Blind Period|Sponsor decision|0
7139931|NCT02963506|11293696|FG005|Dose-Blind Period|Sponsor decision|1
7139932|NCT02963506|11293697|FG006|Dose-Blind Period|Sponsor decision|0
7139933|NCT02963506|11293698|FG007|Dose-Blind Period|Sponsor decision|0
7139934|NCT02963506|11293699|FG008|Dose-Blind Period|Sponsor decision|0
7139935|NCT02963506|11293700|FG009|Dose-Blind Period|Sponsor decision|0
7139936|NCT02963506|11293701|FG010|Dose-Blind Period|Sponsor decision|0
7139937|NCT02963506|11293702|FG011|Dose-Blind Period|Sponsor decision|0
7139938|NCT02963506|11293703|FG012|Dose-Blind Period|Sponsor decision|0
7139939|NCT02963506|11293691|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0
7139940|NCT02963506|11293692|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0
7139941|NCT02963506|11293693|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0
7139942|NCT02963506|11293694|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0
7139943|NCT02963506|11293695|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0
7139944|NCT02963506|11293696|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0
7139945|NCT02963506|11293697|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0
7139946|NCT02963506|11293698|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0
7139947|NCT02963506|11293699|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0
7139948|NCT02963506|11293700|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0
7139949|NCT02963506|11293701|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0
7139950|NCT02963506|11293702|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0
7139951|NCT02963506|11293703|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1
7139952|NCT02963701|11293731|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1
7139953|NCT02963701|11293732|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0
7139954|NCT02963922|11293740|FG000|Overall Study|Adverse Event|15
7139955|NCT02963922|11293741|FG001|Overall Study|Adverse Event|6
7139956|NCT02963922|11293740|FG000|Overall Study|Protocol deviation|6
7139957|NCT02963922|11293741|FG001|Overall Study|Protocol deviation|6
7139958|NCT02963922|11293740|FG000|Overall Study|Lack of Efficacy|1
7139959|NCT02963922|11293741|FG001|Overall Study|Lack of Efficacy|1
7139960|NCT02963922|11293740|FG000|Overall Study|Lost to Follow-up|2
7139961|NCT02963922|11293741|FG001|Overall Study|Lost to Follow-up|3
7139962|NCT02963922|11293740|FG000|Overall Study|Other|8
7139963|NCT02963922|11293741|FG001|Overall Study|Other|14
7139964|NCT02963935|11293749|FG000|Overall Study|Adverse Event|12
7139965|NCT02963935|11293750|FG001|Overall Study|Adverse Event|6
7139966|NCT02963935|11293749|FG000|Overall Study|Protocol Violation|2
7139967|NCT02963935|11293750|FG001|Overall Study|Protocol Violation|1
7139968|NCT02963935|11293749|FG000|Overall Study|Lack of Efficacy|0
7139969|NCT02963935|11293750|FG001|Overall Study|Lack of Efficacy|2
7139970|NCT02963935|11293749|FG000|Overall Study|Lost to Follow-up|1
7139971|NCT02963935|11293750|FG001|Overall Study|Lost to Follow-up|6
7139972|NCT02963935|11293749|FG000|Overall Study|Unclassified|13
7139973|NCT02963935|11293750|FG001|Overall Study|Unclassified|22
6789864|NCT04003142|10787290|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2
6789865|NCT04003142|10787291|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1
6789866|NCT04003142|10787292|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2
6789867|NCT04003142|10787293|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0
6789868|NCT04003142|10787294|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0
6789869|NCT04003142|10787290|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1
6789870|NCT04003142|10787291|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5
6789871|NCT04003142|10787292|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0
6789872|NCT04003142|10787293|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0
6789873|NCT04003142|10787294|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0
6789874|NCT04003142|10787290|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11
6789875|NCT04003142|10787291|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6
6789876|NCT04003142|10787292|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6
6789877|NCT04003142|10787293|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0
6789878|NCT04003142|10787294|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0
6789879|NCT04003142|10787290|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2
6789880|NCT04003142|10787291|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1
6789881|NCT04003142|10787292|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2
6789882|NCT04003142|10787293|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0
6789883|NCT04003142|10787294|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0
6789884|NCT04003142|10787290|FG000|Extension Period (40 Weeks)|Adverse Event|0
6789885|NCT04003142|10787291|FG001|Extension Period (40 Weeks)|Adverse Event|4
6789886|NCT04003142|10787292|FG002|Extension Period (40 Weeks)|Adverse Event|4
6789887|NCT04003142|10787293|FG003|Extension Period (40 Weeks)|Adverse Event|2
6789888|NCT04003142|10787294|FG004|Extension Period (40 Weeks)|Adverse Event|3
6789889|NCT04003142|10787290|FG000|Extension Period (40 Weeks)|Death|0
6789890|NCT04003142|10787291|FG001|Extension Period (40 Weeks)|Death|0
6789891|NCT04003142|10787292|FG002|Extension Period (40 Weeks)|Death|0
6789892|NCT04003142|10787293|FG003|Extension Period (40 Weeks)|Death|0
6789893|NCT04003142|10787294|FG004|Extension Period (40 Weeks)|Death|1
6789894|NCT04003142|10787290|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0
6789895|NCT04003142|10787291|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2
6789896|NCT04003142|10787292|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1
6789897|NCT04003142|10787293|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2
6789898|NCT04003142|10787294|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1
6789899|NCT04003142|10787290|FG000|Extension Period (40 Weeks)|Protocol Deviation|0
6789900|NCT04003142|10787291|FG001|Extension Period (40 Weeks)|Protocol Deviation|0
6789901|NCT04003142|10787292|FG002|Extension Period (40 Weeks)|Protocol Deviation|2
6789902|NCT04003142|10787293|FG003|Extension Period (40 Weeks)|Protocol Deviation|0
6789903|NCT04003142|10787294|FG004|Extension Period (40 Weeks)|Protocol Deviation|0
6789904|NCT04003142|10787290|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0
6789905|NCT04003142|10787291|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17
6789906|NCT04003142|10787292|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14
6789907|NCT04003142|10787293|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9
6789908|NCT04003142|10787294|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5
6789909|NCT04003142|10787290|FG000|Extension Period (40 Weeks)|Miscellaneous|0
6789910|NCT04003142|10787291|FG001|Extension Period (40 Weeks)|Miscellaneous|4
6789911|NCT04003142|10787292|FG002|Extension Period (40 Weeks)|Miscellaneous|1
6789912|NCT04003142|10787293|FG003|Extension Period (40 Weeks)|Miscellaneous|0
6789913|NCT04003142|10787294|FG004|Extension Period (40 Weeks)|Miscellaneous|2
6789914|NCT03402841|10787333|FG000|Overall Study|Withdrawal by Subject|4
6789915|NCT03402841|10787333|FG000|Overall Study|Lost to Follow-up|3
6789916|NCT03402841|10787333|FG000|Overall Study|Death|85
6789917|NCT03383666|10787337|FG000|Overall Study|Withdrawal by Subject|2
6789918|NCT03383666|10787337|FG000|Overall Study|Lost to Follow-up|2
6789919|NCT03299049|10787343|FG000|Overall Study|On-going|486
6789920|NCT03299049|10787344|FG001|Overall Study|On-going|481
6789921|NCT03299049|10787343|FG000|Overall Study|Withdrawal by Subject|6
6789922|NCT03299049|10787344|FG001|Overall Study|Withdrawal by Subject|21
6789923|NCT03299049|10787343|FG000|Overall Study|Physician Decision|5
6789924|NCT03299049|10787344|FG001|Overall Study|Physician Decision|1
6789925|NCT03299049|10787343|FG000|Overall Study|Lost to Follow-up|2
6789926|NCT03299049|10787344|FG001|Overall Study|Lost to Follow-up|0
6789927|NCT03299049|10787343|FG000|Overall Study|Pregnancy|1
7139974|NCT02964234|11293771|FG000|Overall Study|Lost to Follow-up|22
6789928|NCT03299049|10787344|FG001|Overall Study|Pregnancy|3
6789929|NCT03299049|10787343|FG000|Overall Study|Protocol Violation|1
6789930|NCT03299049|10787344|FG001|Overall Study|Protocol Violation|1
6789931|NCT03299049|10787343|FG000|Overall Study|Lack of Efficacy|9
6789932|NCT03299049|10787344|FG001|Overall Study|Lack of Efficacy|3
6789933|NCT03299049|10787343|FG000|Overall Study|Adverse Event|12
6789934|NCT03299049|10787344|FG001|Overall Study|Adverse Event|13
6789935|NCT03219333|10787359|FG000|Overall Study|Withdrawal by Subject|8
6789936|NCT03219333|10787360|FG001|Overall Study|Withdrawal by Subject|3
6789937|NCT03219333|10787359|FG000|Overall Study|Lost to Follow-up|1
6789938|NCT03219333|10787360|FG001|Overall Study|Lost to Follow-up|0
6789939|NCT03219333|10787359|FG000|Overall Study|Death|94
6789940|NCT03219333|10787360|FG001|Overall Study|Death|44
6789941|NCT03219333|10787359|FG000|Overall Study|Includes 4 participants who were enrolled and never received study treatment.|2
6807646|NCT03043872|10811176|FG000|Overall Study|Lost to Follow-up|2
6789942|NCT03219333|10787360|FG001|Overall Study|Includes 4 participants who were enrolled and never received study treatment.|2
6789943|NCT02987543|10787370|FG000|Overall Study|Ongoing study at data cut off|49
6789944|NCT02987543|10787371|FG001|Overall Study|Ongoing study at data cut off|21
6789945|NCT02987543|10787372|FG002|Overall Study|Ongoing study at data cut off|19
6789946|NCT02987543|10787373|FG003|Overall Study|Ongoing study at data cut off|12
6789947|NCT02987543|10787370|FG000|Overall Study|Death|88
6789948|NCT02987543|10787371|FG001|Overall Study|Death|54
6789949|NCT02987543|10787372|FG002|Overall Study|Death|67
6789950|NCT02987543|10787373|FG003|Overall Study|Death|28
6789951|NCT02987543|10787370|FG000|Overall Study|Lost to Follow-up|3
6789952|NCT02987543|10787371|FG001|Overall Study|Lost to Follow-up|0
6789953|NCT02987543|10787372|FG002|Overall Study|Lost to Follow-up|1
6789954|NCT02987543|10787373|FG003|Overall Study|Lost to Follow-up|0
6789955|NCT02987543|10787370|FG000|Overall Study|Screen failure|0
6789956|NCT02987543|10787371|FG001|Overall Study|Screen failure|0
6789957|NCT02987543|10787372|FG002|Overall Study|Screen failure|0
6789958|NCT02987543|10787373|FG003|Overall Study|Screen failure|1
6789959|NCT02987543|10787370|FG000|Overall Study|Withdrawal by Subject|21
6789960|NCT02987543|10787371|FG001|Overall Study|Withdrawal by Subject|7
6789961|NCT02987543|10787372|FG002|Overall Study|Withdrawal by Subject|7
6789962|NCT02987543|10787373|FG003|Overall Study|Withdrawal by Subject|6
6789963|NCT02987543|10787370|FG000|Overall Study|Study terminated by sponsor|1
6789964|NCT02987543|10787371|FG001|Overall Study|Study terminated by sponsor|0
6789965|NCT02987543|10787372|FG002|Overall Study|Study terminated by sponsor|0
6789966|NCT02987543|10787373|FG003|Overall Study|Study terminated by sponsor|0
6789967|NCT02987543|10787370|FG000|Overall Study|Investigator decision|0
6789968|NCT02987543|10787371|FG001|Overall Study|Investigator decision|1
6789969|NCT02987543|10787372|FG002|Overall Study|Investigator decision|0
6789970|NCT02987543|10787373|FG003|Overall Study|Investigator decision|0
6789971|NCT02987543|10787370|FG000|Overall Study|Disease progression|0
6789972|NCT02987543|10787371|FG001|Overall Study|Disease progression|0
6789973|NCT02987543|10787372|FG002|Overall Study|Disease progression|0
6789974|NCT02987543|10787373|FG003|Overall Study|Disease progression|1
6789975|NCT02908685|10787391|FG000|Part 1 Exploratory|Withdrawal by Subject|0
6789976|NCT02908685|10787392|FG001|Part 1 Exploratory|Withdrawal by Subject|1
6789977|NCT02908685|10787393|FG002|Part 1 Exploratory|Withdrawal by Subject|0
6789978|NCT02908685|10787394|FG003|Part 1 Exploratory|Withdrawal by Subject|0
6789979|NCT02908685|10787395|FG004|Part 1 Exploratory|Withdrawal by Subject|0
6789980|NCT02908685|10787396|FG005|Part 1 Exploratory|Withdrawal by Subject|0
6789981|NCT02908685|10787397|FG006|Part 1 Exploratory|Withdrawal by Subject|0
6789982|NCT02908685|10787398|FG007|Part 1 Exploratory|Withdrawal by Subject|0
6789983|NCT02908685|10787399|FG008|Part 1 Exploratory|Withdrawal by Subject|0
6789984|NCT02908685|10787400|FG009|Part 1 Exploratory|Withdrawal by Subject|0
6789985|NCT02908685|10787401|FG010|Part 1 Exploratory|Withdrawal by Subject|0
6789986|NCT02908685|10787402|FG011|Part 1 Exploratory|Withdrawal by Subject|0
6789987|NCT02908685|10787391|FG000|Part 2 Confirmatory|Changed to Spinraza|0
6789988|NCT02908685|10787392|FG001|Part 2 Confirmatory|Changed to Spinraza|0
6789989|NCT02908685|10787393|FG002|Part 2 Confirmatory|Changed to Spinraza|0
6789990|NCT02908685|10787394|FG003|Part 2 Confirmatory|Changed to Spinraza|0
6789991|NCT02908685|10787395|FG004|Part 2 Confirmatory|Changed to Spinraza|0
6789992|NCT02908685|10787396|FG005|Part 2 Confirmatory|Changed to Spinraza|0
6789993|NCT02908685|10787397|FG006|Part 2 Confirmatory|Changed to Spinraza|0
6789994|NCT02908685|10787398|FG007|Part 2 Confirmatory|Changed to Spinraza|0
6789995|NCT02908685|10787399|FG008|Part 2 Confirmatory|Changed to Spinraza|0
6789996|NCT02908685|10787400|FG009|Part 2 Confirmatory|Changed to Spinraza|0
6789997|NCT02908685|10787401|FG010|Part 2 Confirmatory|Changed to Spinraza|2
6789998|NCT02908685|10787402|FG011|Part 2 Confirmatory|Changed to Spinraza|1
6789999|NCT02908685|10787391|FG000|Part 2 Confirmatory|Changed to other treatment|0
6790000|NCT02908685|10787392|FG001|Part 2 Confirmatory|Changed to other treatment|0
6790001|NCT02908685|10787393|FG002|Part 2 Confirmatory|Changed to other treatment|0
6790002|NCT02908685|10787394|FG003|Part 2 Confirmatory|Changed to other treatment|0
6790003|NCT02908685|10787395|FG004|Part 2 Confirmatory|Changed to other treatment|0
6790004|NCT02908685|10787396|FG005|Part 2 Confirmatory|Changed to other treatment|0
6790005|NCT02908685|10787397|FG006|Part 2 Confirmatory|Changed to other treatment|0
6790006|NCT02908685|10787398|FG007|Part 2 Confirmatory|Changed to other treatment|0
6790007|NCT02908685|10787399|FG008|Part 2 Confirmatory|Changed to other treatment|0
6790008|NCT02908685|10787400|FG009|Part 2 Confirmatory|Changed to other treatment|0
6790009|NCT02908685|10787401|FG010|Part 2 Confirmatory|Changed to other treatment|1
6790010|NCT02908685|10787402|FG011|Part 2 Confirmatory|Changed to other treatment|0
6790011|NCT02881957|10787421|FG000|Overall Study|Comfort care|0
6790012|NCT02881957|10787422|FG001|Overall Study|Comfort care|1
6790013|NCT02881957|10787421|FG000|Overall Study|Concurrent trial enrollment|0
6790014|NCT02881957|10787422|FG001|Overall Study|Concurrent trial enrollment|1
6790015|NCT02881957|10787421|FG000|Overall Study|Discharged within 48 hours|0
6790016|NCT02881957|10787422|FG001|Overall Study|Discharged within 48 hours|1
6790017|NCT02881957|10787421|FG000|Overall Study|Withdrawal by Subject|2
6790018|NCT02881957|10787422|FG001|Overall Study|Withdrawal by Subject|1
6790019|NCT02881957|10787421|FG000|Overall Study|Protocol Violation|1
6790020|NCT02881957|10787422|FG001|Overall Study|Protocol Violation|0
6790021|NCT02761694|10787444|FG000|Overall Study|Lack of Efficacy|0
6790022|NCT02761694|10787445|FG001|Overall Study|Lack of Efficacy|0
6790023|NCT02761694|10787446|FG002|Overall Study|Lack of Efficacy|0
7139975|NCT02964234|11293772|FG001|Overall Study|Lost to Follow-up|13
7139976|NCT02964247|11293780|FG000|Overall Study|Lost to Follow-up|2
7139977|NCT02964247|11293781|FG001|Overall Study|Lost to Follow-up|0
7139978|NCT02964247|11293780|FG000|Overall Study|Withdrawal by Subject|1
7139979|NCT02964247|11293781|FG001|Overall Study|Withdrawal by Subject|2
7139980|NCT02964312|11293787|FG000|Overall Study|Lost to Follow-up|28
7139981|NCT02964312|11293787|FG000|Overall Study|Withdrawal by Subject|11
7139982|NCT02964312|11293787|FG000|Overall Study|Lack of Efficacy|10
7139983|NCT02964312|11293787|FG000|Overall Study|Did not consent to long-term FU|14
7139984|NCT02964312|11293787|FG000|Overall Study|Death|1
7139985|NCT02964325|11293796|FG000|Overall Study|Lost to Follow-up|3
7139986|NCT02964325|11293797|FG001|Overall Study|Lost to Follow-up|3
7139987|NCT02964325|11293796|FG000|Overall Study|Physician Decision|5
7139988|NCT02964325|11293797|FG001|Overall Study|Physician Decision|4
7139989|NCT02964325|11293796|FG000|Overall Study|Death|1
7139990|NCT02964325|11293797|FG001|Overall Study|Death|3
7139991|NCT02964325|11293796|FG000|Overall Study|Withdrawal by Subject|2
7139992|NCT02964325|11293797|FG001|Overall Study|Withdrawal by Subject|1
7139993|NCT02964325|11293796|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10
7139994|NCT02964325|11293797|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12
7139995|NCT02964338|11293806|FG000|Overall Study|Sponsor terminated study for futility|12
7139996|NCT02964338|11293807|FG001|Overall Study|Sponsor terminated study for futility|15
7139997|NCT02964338|11293808|FG002|Overall Study|Sponsor terminated study for futility|14
7139998|NCT02964338|11293806|FG000|Overall Study|Lack of Efficacy|0
7139999|NCT02964338|11293807|FG001|Overall Study|Lack of Efficacy|3
7140000|NCT02964338|11293808|FG002|Overall Study|Lack of Efficacy|0
7140001|NCT02964338|11293806|FG000|Overall Study|Lost to Follow-up|1
7140002|NCT02964338|11293807|FG001|Overall Study|Lost to Follow-up|0
7140003|NCT02964338|11293808|FG002|Overall Study|Lost to Follow-up|3
7140004|NCT02964338|11293806|FG000|Overall Study|Protocol Violation|0
7140005|NCT02964338|11293807|FG001|Overall Study|Protocol Violation|1
7140006|NCT02964338|11293808|FG002|Overall Study|Protocol Violation|0
7140007|NCT02964338|11293806|FG000|Overall Study|Withdrawal by Subject|1
7140008|NCT02964338|11293807|FG001|Overall Study|Withdrawal by Subject|3
7140009|NCT02964338|11293808|FG002|Overall Study|Withdrawal by Subject|1
7140010|NCT02964338|11293806|FG000|Overall Study|Adverse Event|2
7140011|NCT02964338|11293807|FG001|Overall Study|Adverse Event|1
7140012|NCT02964338|11293808|FG002|Overall Study|Adverse Event|1
7140013|NCT02964338|11293806|FG000|Overall Study|Non-compliant with e-diary|0
7140014|NCT02964338|11293807|FG001|Overall Study|Non-compliant with e-diary|1
7140015|NCT02964338|11293808|FG002|Overall Study|Non-compliant with e-diary|0
7140016|NCT02964338|11293806|FG000|Overall Study|Did not meet criteria|1
7140017|NCT02964338|11293807|FG001|Overall Study|Did not meet criteria|0
7140018|NCT02964338|11293808|FG002|Overall Study|Did not meet criteria|0
7140019|NCT02965378|11293856|FG000|Overall Study|Progression|16
7140020|NCT02965378|11293857|FG001|Overall Study|Progression|4
7140021|NCT02965378|11293856|FG000|Overall Study|Adverse Event|5
7140022|NCT02965378|11293857|FG001|Overall Study|Adverse Event|2
7140023|NCT02965378|11293856|FG000|Overall Study|Death|2
7140024|NCT02965378|11293857|FG001|Overall Study|Death|0
7140025|NCT02965378|11293856|FG000|Overall Study|Refusal|2
7140026|NCT02965378|11293857|FG001|Overall Study|Refusal|1
7140027|NCT02965378|11293856|FG000|Overall Study|Not protocol specified|0
7140028|NCT02965378|11293857|FG001|Overall Study|Not protocol specified|2
7140029|NCT02965456|11293865|FG000|Overall Study|Lost to Follow-up|40
7140030|NCT02965456|11293866|FG001|Overall Study|Lost to Follow-up|18
7140031|NCT02965456|11293865|FG000|Overall Study|Subject Request|22
7140032|NCT02965456|11293866|FG001|Overall Study|Subject Request|13
7140033|NCT02965456|11293865|FG000|Overall Study|Withdrawal by Parent or Guardian|3
7140034|NCT02965456|11293866|FG001|Overall Study|Withdrawal by Parent or Guardian|6
7140035|NCT02965456|11293865|FG000|Overall Study|Adverse Event|3
7140036|NCT02965456|11293866|FG001|Overall Study|Adverse Event|0
7140037|NCT02965456|11293865|FG000|Overall Study|Noncompliance with Study Drug|1
7140038|NCT02965456|11293866|FG001|Overall Study|Noncompliance with Study Drug|1
7140039|NCT02965456|11293865|FG000|Overall Study|Worsening Condition|0
7140040|NCT02965456|11293866|FG001|Overall Study|Worsening Condition|2
7140041|NCT02965456|11293865|FG000|Overall Study|Lack of Efficacy|1
7140042|NCT02965456|11293866|FG001|Overall Study|Lack of Efficacy|0
7140043|NCT02965456|11293865|FG000|Overall Study|Physician Decision|0
7140044|NCT02965456|11293866|FG001|Overall Study|Physician Decision|1
7140045|NCT02965456|11293865|FG000|Overall Study|Pregnancy|1
7140046|NCT02965456|11293866|FG001|Overall Study|Pregnancy|0
7140047|NCT02965456|11293865|FG000|Overall Study|Protocol Violation|0
7140048|NCT02965456|11293866|FG001|Overall Study|Protocol Violation|1
7140049|NCT02965456|11293865|FG000|Overall Study|Participant ran out of study drug|0
7140050|NCT02965456|11293866|FG001|Overall Study|Participant ran out of study drug|1
7140051|NCT02965573|11293882|FG000|Overall Study|Lack of Efficacy|1
7140052|NCT02965573|11293883|FG001|Overall Study|Lack of Efficacy|0
7140053|NCT02965599|11293891|FG000|Overall Study|Protocol-defined stop criteria reached|1
7140054|NCT02965599|11293892|FG001|Overall Study|Protocol-defined stop criteria reached|0
7140055|NCT02965820|11293912|FG000|Period 2, Second 30 Days|Adverse Event|1
6790024|NCT02761694|10787447|FG003|Overall Study|Lack of Efficacy|0
6790025|NCT02761694|10787448|FG004|Overall Study|Lack of Efficacy|0
6790026|NCT02761694|10787449|FG005|Overall Study|Lack of Efficacy|0
6790027|NCT02761694|10787450|FG006|Overall Study|Lack of Efficacy|6
6790028|NCT02761694|10787451|FG007|Overall Study|Lack of Efficacy|0
6790029|NCT02761694|10787452|FG008|Overall Study|Lack of Efficacy|0
6790030|NCT02761694|10787453|FG009|Overall Study|Lack of Efficacy|1
6790031|NCT02761694|10787454|FG010|Overall Study|Lack of Efficacy|1
6790032|NCT02761694|10787455|FG011|Overall Study|Lack of Efficacy|4
6790033|NCT02761694|10787444|FG000|Overall Study|Death|0
6790034|NCT02761694|10787445|FG001|Overall Study|Death|0
6790035|NCT02761694|10787446|FG002|Overall Study|Death|0
6790036|NCT02761694|10787447|FG003|Overall Study|Death|0
6790037|NCT02761694|10787448|FG004|Overall Study|Death|0
6790038|NCT02761694|10787449|FG005|Overall Study|Death|0
6790039|NCT02761694|10787450|FG006|Overall Study|Death|2
6790040|NCT02761694|10787451|FG007|Overall Study|Death|0
6790041|NCT02761694|10787452|FG008|Overall Study|Death|2
6790042|NCT02761694|10787453|FG009|Overall Study|Death|2
6790043|NCT02761694|10787454|FG010|Overall Study|Death|1
6790044|NCT02761694|10787455|FG011|Overall Study|Death|0
6790045|NCT02761694|10787444|FG000|Overall Study|Physician Decision|0
6790046|NCT02761694|10787445|FG001|Overall Study|Physician Decision|0
6790047|NCT02761694|10787446|FG002|Overall Study|Physician Decision|0
6790048|NCT02761694|10787447|FG003|Overall Study|Physician Decision|0
6790049|NCT02761694|10787448|FG004|Overall Study|Physician Decision|0
6790050|NCT02761694|10787449|FG005|Overall Study|Physician Decision|0
6790051|NCT02761694|10787450|FG006|Overall Study|Physician Decision|1
6790052|NCT02761694|10787451|FG007|Overall Study|Physician Decision|0
6790053|NCT02761694|10787452|FG008|Overall Study|Physician Decision|0
6790054|NCT02761694|10787453|FG009|Overall Study|Physician Decision|0
6790055|NCT02761694|10787454|FG010|Overall Study|Physician Decision|0
6790056|NCT02761694|10787455|FG011|Overall Study|Physician Decision|0
6790057|NCT02761694|10787444|FG000|Overall Study|Withdrawal by Subject|0
6790058|NCT02761694|10787445|FG001|Overall Study|Withdrawal by Subject|0
6790059|NCT02761694|10787446|FG002|Overall Study|Withdrawal by Subject|0
6790060|NCT02761694|10787447|FG003|Overall Study|Withdrawal by Subject|1
6790061|NCT02761694|10787448|FG004|Overall Study|Withdrawal by Subject|0
6790062|NCT02761694|10787449|FG005|Overall Study|Withdrawal by Subject|0
6790063|NCT02761694|10787450|FG006|Overall Study|Withdrawal by Subject|4
6790064|NCT02761694|10787451|FG007|Overall Study|Withdrawal by Subject|0
6790065|NCT02761694|10787452|FG008|Overall Study|Withdrawal by Subject|2
6790066|NCT02761694|10787453|FG009|Overall Study|Withdrawal by Subject|1
6790067|NCT02761694|10787454|FG010|Overall Study|Withdrawal by Subject|0
6790068|NCT02761694|10787455|FG011|Overall Study|Withdrawal by Subject|0
6790069|NCT02761694|10787444|FG000|Overall Study|Lost to Follow-up|0
6790070|NCT02761694|10787445|FG001|Overall Study|Lost to Follow-up|0
6790071|NCT02761694|10787446|FG002|Overall Study|Lost to Follow-up|0
6790072|NCT02761694|10787447|FG003|Overall Study|Lost to Follow-up|0
6790073|NCT02761694|10787448|FG004|Overall Study|Lost to Follow-up|0
6790074|NCT02761694|10787449|FG005|Overall Study|Lost to Follow-up|0
6790075|NCT02761694|10787450|FG006|Overall Study|Lost to Follow-up|1
6790076|NCT02761694|10787451|FG007|Overall Study|Lost to Follow-up|0
6790077|NCT02761694|10787452|FG008|Overall Study|Lost to Follow-up|0
6790078|NCT02761694|10787453|FG009|Overall Study|Lost to Follow-up|0
6790079|NCT02761694|10787454|FG010|Overall Study|Lost to Follow-up|0
6790080|NCT02761694|10787455|FG011|Overall Study|Lost to Follow-up|1
7140056|NCT02965820|11293913|FG001|Period 2, Second 30 Days|Adverse Event|1
6790081|NCT02761694|10787444|FG000|Overall Study|Adverse Event|0
6790082|NCT02761694|10787445|FG001|Overall Study|Adverse Event|0
6790083|NCT02761694|10787446|FG002|Overall Study|Adverse Event|0
6790084|NCT02761694|10787447|FG003|Overall Study|Adverse Event|0
6790085|NCT02761694|10787448|FG004|Overall Study|Adverse Event|0
6790086|NCT02761694|10787449|FG005|Overall Study|Adverse Event|0
6790087|NCT02761694|10787450|FG006|Overall Study|Adverse Event|1
6790088|NCT02761694|10787451|FG007|Overall Study|Adverse Event|0
6790089|NCT02761694|10787452|FG008|Overall Study|Adverse Event|1
6790090|NCT02761694|10787453|FG009|Overall Study|Adverse Event|0
6790091|NCT02761694|10787454|FG010|Overall Study|Adverse Event|0
6790092|NCT02761694|10787455|FG011|Overall Study|Adverse Event|1
6790093|NCT02761694|10787444|FG000|Overall Study|Other|4
6790094|NCT02761694|10787445|FG001|Overall Study|Other|4
6790095|NCT02761694|10787446|FG002|Overall Study|Other|1
6790096|NCT02761694|10787447|FG003|Overall Study|Other|2
6790097|NCT02761694|10787448|FG004|Overall Study|Other|3
6790098|NCT02761694|10787449|FG005|Overall Study|Other|3
6790099|NCT02761694|10787450|FG006|Overall Study|Other|18
6790100|NCT02761694|10787451|FG007|Overall Study|Other|8
6790101|NCT02761694|10787452|FG008|Overall Study|Other|0
6790102|NCT02761694|10787453|FG009|Overall Study|Other|1
6790103|NCT02761694|10787454|FG010|Overall Study|Other|1
6790104|NCT02761694|10787455|FG011|Overall Study|Other|0
6790105|NCT02611960|10787484|FG000|Overall Study|COVID-19 Association Unspecified Adverse Event|7
6790106|NCT02611960|10787485|FG001|Overall Study|COVID-19 Association Unspecified Adverse Event|8
6790107|NCT02611960|10787484|FG000|Overall Study|Death|87
6790108|NCT02611960|10787485|FG001|Overall Study|Death|85
6790109|NCT02611960|10787484|FG000|Overall Study|Withdrawal by Subject|0
6790110|NCT02611960|10787485|FG001|Overall Study|Withdrawal by Subject|1
6790111|NCT02611960|10787484|FG000|Overall Study|COVID-19 Association Unspecified Withdrawal By Participant|1
6790112|NCT02611960|10787485|FG001|Overall Study|COVID-19 Association Unspecified Withdrawal By Participant|4
6790113|NCT02611960|10787484|FG000|Overall Study|Participants Ongoing|22
6790114|NCT02611960|10787485|FG001|Overall Study|Participants Ongoing|18
6790115|NCT02574455|10787494|FG000|Overall Study|Death|197
6790116|NCT02574455|10787495|FG001|Overall Study|Death|210
6790117|NCT02574455|10787494|FG000|Overall Study|Withdrawal of Consent|11
6790118|NCT02574455|10787495|FG001|Overall Study|Withdrawal of Consent|28
6790119|NCT02574455|10787494|FG000|Overall Study|Lost to Follow-up|4
6790120|NCT02574455|10787495|FG001|Overall Study|Lost to Follow-up|4
6790121|NCT02574455|10787494|FG000|Overall Study|Sponsor's Decision|55
6790122|NCT02574455|10787495|FG001|Overall Study|Sponsor's Decision|20
6790123|NCT02493660|10787503|FG000|Overall Study|Physician Decision|0
6790124|NCT02493660|10787504|FG001|Overall Study|Physician Decision|1
6790125|NCT02493660|10787503|FG000|Overall Study|Adverse Event|4
6790126|NCT02493660|10787504|FG001|Overall Study|Adverse Event|2
6790127|NCT02493660|10787503|FG000|Overall Study|Withdrawal by Subject|2
6790128|NCT02493660|10787504|FG001|Overall Study|Withdrawal by Subject|3
6790129|NCT02493660|10787503|FG000|Overall Study|Subject unable to return for follow-up visits|2
6790130|NCT02493660|10787504|FG001|Overall Study|Subject unable to return for follow-up visits|0
6790131|NCT02493660|10787503|FG000|Overall Study|Protocol Violation|0
6790132|NCT02493660|10787504|FG001|Overall Study|Protocol Violation|1
6790133|NCT02493660|10787503|FG000|Overall Study|Death|0
6790134|NCT02493660|10787504|FG001|Overall Study|Death|1
6790135|NCT02493660|10787503|FG000|Overall Study|Lost to Follow-up|2
6790136|NCT02493660|10787504|FG001|Overall Study|Lost to Follow-up|4
6790137|NCT02232087|10787512|FG000|Overall Study|Withdrawal by Subject|2
6790138|NCT02232087|10787513|FG001|Overall Study|Withdrawal by Subject|0
6790139|NCT02232087|10787514|FG002|Overall Study|Withdrawal by Subject|0
6790140|NCT02232087|10787515|FG003|Overall Study|Withdrawal by Subject|0
6790141|NCT02232087|10787516|FG004|Overall Study|Withdrawal by Subject|0
6790142|NCT02232087|10787517|FG005|Overall Study|Withdrawal by Subject|1
6790143|NCT02232087|10787512|FG000|Overall Study|poor inhalation technique|0
6790144|NCT02232087|10787513|FG001|Overall Study|poor inhalation technique|1
6790145|NCT02232087|10787514|FG002|Overall Study|poor inhalation technique|0
6790146|NCT02232087|10787515|FG003|Overall Study|poor inhalation technique|0
6790147|NCT02232087|10787516|FG004|Overall Study|poor inhalation technique|0
6790148|NCT02232087|10787517|FG005|Overall Study|poor inhalation technique|2
6790149|NCT02232087|10787512|FG000|Overall Study|protocol stop criteria|0
6790150|NCT02232087|10787513|FG001|Overall Study|protocol stop criteria|1
6790151|NCT02232087|10787514|FG002|Overall Study|protocol stop criteria|0
6790152|NCT02232087|10787515|FG003|Overall Study|protocol stop criteria|1
6790153|NCT02232087|10787516|FG004|Overall Study|protocol stop criteria|0
6790154|NCT02232087|10787517|FG005|Overall Study|protocol stop criteria|0
6790155|NCT02232087|10787512|FG000|Overall Study|Adverse Event|0
6790156|NCT02232087|10787513|FG001|Overall Study|Adverse Event|0
6790157|NCT02232087|10787514|FG002|Overall Study|Adverse Event|0
6790158|NCT02232087|10787515|FG003|Overall Study|Adverse Event|0
6790159|NCT02232087|10787516|FG004|Overall Study|Adverse Event|1
6790160|NCT02232087|10787517|FG005|Overall Study|Adverse Event|0
6790161|NCT01952847|10787544|FG000|Overall Study|Ineligible|1
6790162|NCT01952847|10787545|FG001|Overall Study|Ineligible|0
6790163|NCT01952847|10787546|FG002|Overall Study|Ineligible|0
6790164|NCT01952847|10787547|FG003|Overall Study|Ineligible|0
6790165|NCT01952847|10787544|FG000|Overall Study|Lack of Insurance Coverage|0
6790166|NCT01952847|10787545|FG001|Overall Study|Lack of Insurance Coverage|1
6790167|NCT01952847|10787546|FG002|Overall Study|Lack of Insurance Coverage|0
6790168|NCT01952847|10787547|FG003|Overall Study|Lack of Insurance Coverage|0
6790169|NCT01952847|10787544|FG000|Overall Study|Withdrawal by Subject|1
6790170|NCT01952847|10787545|FG001|Overall Study|Withdrawal by Subject|1
6790171|NCT01952847|10787546|FG002|Overall Study|Withdrawal by Subject|0
6790172|NCT01952847|10787547|FG003|Overall Study|Withdrawal by Subject|1
6790173|NCT01889238|10787559|FG000|Overall Study|Treatment ongoing|9
6790174|NCT01740427|10787565|FG000|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|205
6790175|NCT01740427|10787566|FG001|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|61
6790176|NCT01740427|10787565|FG000|Overall Study|Objective progression or relapse|172
6790177|NCT01740427|10787566|FG001|Overall Study|Objective progression or relapse|125
6790178|NCT01740427|10787565|FG000|Overall Study|Adverse Event|20
6790179|NCT01740427|10787566|FG001|Overall Study|Adverse Event|9
6790180|NCT01740427|10787565|FG000|Overall Study|Global deterioration of health status|16
6790181|NCT01740427|10787566|FG001|Overall Study|Global deterioration of health status|9
6790182|NCT01740427|10787565|FG000|Overall Study|Subject refused continued treatment|12
6790183|NCT01740427|10787566|FG001|Overall Study|Subject refused continued treatment|9
6790184|NCT01740427|10787565|FG000|Overall Study|Unspecified reasons|6
6790185|NCT01740427|10787566|FG001|Overall Study|Unspecified reasons|4
6790186|NCT01740427|10787565|FG000|Overall Study|Death|6
6790187|NCT01740427|10787566|FG001|Overall Study|Death|2
6790188|NCT01740427|10787565|FG000|Overall Study|Protocol Violation|5
6790189|NCT01740427|10787566|FG001|Overall Study|Protocol Violation|3
6790190|NCT01740427|10787565|FG000|Overall Study|Lost to Follow-up|1
6790191|NCT01740427|10787566|FG001|Overall Study|Lost to Follow-up|0
6790192|NCT01740427|10787565|FG000|Overall Study|Study terminated by Sponsor|1
6790193|NCT01740427|10787566|FG001|Overall Study|Study terminated by Sponsor|0
6790194|NCT01672892|10787574|FG000|Overall Study|Protocol Violation|7
6790195|NCT01672892|10787575|FG001|Overall Study|Protocol Violation|3
6790196|NCT01560585|10787584|FG000|Overall Study|Physician Decision|3
6790197|NCT00979212|10787591|FG000|Overall Study|Protocol Violation|1
6790198|NCT00979212|10787592|FG001|Overall Study|Protocol Violation|8
6790199|NCT00979212|10787591|FG000|Overall Study|No protocol therapy received|1
6790200|NCT00979212|10787592|FG001|Overall Study|No protocol therapy received|0
6790201|NCT00777491|10787600|FG000|Overall Study|Protocol Violation|0
6790202|NCT00777491|10787601|FG001|Overall Study|Protocol Violation|2
6790203|NCT00777491|10787600|FG000|Overall Study|Did not receive any protocol treatment|2
6790204|NCT00777491|10787601|FG001|Overall Study|Did not receive any protocol treatment|0
6790205|NCT00759655|10787607|FG000|Overall Study|Termination of the study by sponsor|1
6790206|NCT00145795|10787613|FG000|Overall Study|Adverse Event|1
6790207|NCT00145795|10787614|FG001|Overall Study|Adverse Event|0
6790208|NCT00005044|10787622|FG000|Overall Study|Protocol Violation|37
6790209|NCT00005044|10787623|FG001|Overall Study|Protocol Violation|46
6790210|NCT00005044|10787622|FG000|Overall Study|Withdrawal by Subject|1
6790211|NCT00005044|10787623|FG001|Overall Study|Withdrawal by Subject|5
6790212|NCT00005044|10787622|FG000|Overall Study|No protocol treatment|0
6790213|NCT00005044|10787623|FG001|Overall Study|No protocol treatment|1
6790214|NCT00002874|10787631|FG000|Overall Study|Withdrawal by Subject|1
6790215|NCT00002874|10787632|FG001|Overall Study|Withdrawal by Subject|1
6790216|NCT00002874|10787631|FG000|Overall Study|Protocol Violation|44
6790217|NCT00002874|10787632|FG001|Overall Study|Protocol Violation|34
6807647|NCT03043872|10811177|FG001|Overall Study|Lost to Follow-up|1
6807648|NCT03043872|10811178|FG002|Overall Study|Lost to Follow-up|1
6807649|NCT03043872|10811176|FG000|Overall Study|Death|270
6807650|NCT03043872|10811177|FG001|Overall Study|Death|269
6807651|NCT03043872|10811178|FG002|Overall Study|Death|296
6807652|NCT01984346|10811215|FG000|Overall Study|Physician Decision|4
6807653|NCT01984346|10811216|FG001|Overall Study|Physician Decision|2
6807654|NCT01984346|10811215|FG000|Overall Study|Withdrawal by Subject|2
6807655|NCT01984346|10811216|FG001|Overall Study|Withdrawal by Subject|2
6807656|NCT01984346|10811215|FG000|Overall Study|Enrollment Closed|8
6807657|NCT01984346|10811216|FG001|Overall Study|Enrollment Closed|1
6807658|NCT01984346|10811215|FG000|Overall Study|Insurance Coverage|1
6807659|NCT01984346|10811216|FG001|Overall Study|Insurance Coverage|0
6807660|NCT01984346|10811215|FG000|Overall Study|Intra-operative Exclusion|2
6807661|NCT01984346|10811216|FG001|Overall Study|Intra-operative Exclusion|0
6807662|NCT01750281|10811225|FG000|Overall Study|Discontinued Selumetinib/Placebo|37
6807663|NCT01750281|10811226|FG001|Overall Study|Discontinued Selumetinib/Placebo|77
6807664|NCT01750281|10811227|FG002|Overall Study|Discontinued Selumetinib/Placebo|75
6807665|NCT01750281|10811225|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6
6807666|NCT01750281|10811226|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7
6807667|NCT01750281|10811227|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9
6807668|NCT01750281|10811225|FG000|Overall Study|Did not receive treatment|0
6807669|NCT01750281|10811226|FG001|Overall Study|Did not receive treatment|1
6807670|NCT01750281|10811227|FG002|Overall Study|Did not receive treatment|0
6807671|NCT01252953|10811246|FG000|Overall Study|Withdrawal by Subject|16
6807672|NCT01252953|10811247|FG001|Overall Study|Withdrawal by Subject|17
6807673|NCT01252953|10811246|FG000|Overall Study|Lost to Follow-up|22
6807674|NCT01252953|10811247|FG001|Overall Study|Lost to Follow-up|21
6807675|NCT01012609|10811256|FG000|Overall Study|Withdrawal by Subject|1
6807676|NCT01012609|10811257|FG001|Overall Study|Withdrawal by Subject|1
6807677|NCT00920387|10811266|FG000|Stage 1|Adverse Event|1
6807678|NCT00920387|10811267|FG001|Stage 1|Adverse Event|0
6807679|NCT00920387|10811268|FG002|Stage 1|Adverse Event|0
6807686|NCT00403559|10811309|FG000|Overall Study|Adverse Event|0
6807687|NCT00403559|10811310|FG001|Overall Study|Adverse Event|1
6807688|NCT00403559|10811309|FG000|Overall Study|Lost to Follow-up|3
6807689|NCT00403559|10811310|FG001|Overall Study|Lost to Follow-up|3
6807690|NCT00403559|10811309|FG000|Overall Study|Withdrawal by Subject|1
6807691|NCT00403559|10811310|FG001|Overall Study|Withdrawal by Subject|0
6810779|NCT02550288|10814719|FG000|Overall Study|Withdrawal by Subject|0
6810780|NCT02550288|10814720|FG001|Overall Study|Withdrawal by Subject|0
6810781|NCT02550288|10814721|FG002|Overall Study|Withdrawal by Subject|0
6810782|NCT02550288|10814722|FG003|Overall Study|Withdrawal by Subject|1
6810783|NCT02550288|10814723|FG004|Overall Study|Withdrawal by Subject|0
6810784|NCT02510040|10814738|FG000|Overall Study|Deemed no longer eligible|18
6810785|NCT02510040|10814739|FG001|Overall Study|Deemed no longer eligible|3
6810786|NCT02510040|10814740|FG002|Overall Study|Deemed no longer eligible|1
6810787|NCT02499328|10814768|FG000|Overall Study|Withdrawal by Subject|1
6810788|NCT02499328|10814769|FG001|Overall Study|Withdrawal by Subject|1
6810789|NCT02499328|10814770|FG002|Overall Study|Withdrawal by Subject|5
6810790|NCT02499328|10814771|FG003|Overall Study|Withdrawal by Subject|3
6810791|NCT02499328|10814772|FG004|Overall Study|Withdrawal by Subject|5
6790218|NCT04391894|10787643|FG000|Overall Study|Adverse Event|1
6790219|NCT04391894|10787644|FG001|Overall Study|Adverse Event|1
6790220|NCT04391894|10787645|FG002|Overall Study|Adverse Event|1
6790221|NCT04391894|10787646|FG003|Overall Study|Adverse Event|1
6790222|NCT04391894|10787647|FG004|Overall Study|Adverse Event|1
6790223|NCT04391894|10787643|FG000|Overall Study|Lost to Follow-up|1
6790224|NCT04391894|10787644|FG001|Overall Study|Lost to Follow-up|0
6790225|NCT04391894|10787645|FG002|Overall Study|Lost to Follow-up|0
6790226|NCT04391894|10787646|FG003|Overall Study|Lost to Follow-up|0
6790227|NCT04391894|10787647|FG004|Overall Study|Lost to Follow-up|0
6790228|NCT04391894|10787643|FG000|Overall Study|Protocol Violation|0
6790229|NCT04391894|10787644|FG001|Overall Study|Protocol Violation|0
6790230|NCT04391894|10787645|FG002|Overall Study|Protocol Violation|0
6790231|NCT04391894|10787646|FG003|Overall Study|Protocol Violation|1
6790232|NCT04391894|10787647|FG004|Overall Study|Protocol Violation|0
6790233|NCT04391894|10787643|FG000|Overall Study|Withdrawal by Subject|2
6790234|NCT04391894|10787644|FG001|Overall Study|Withdrawal by Subject|0
6790235|NCT04391894|10787645|FG002|Overall Study|Withdrawal by Subject|3
6790236|NCT04391894|10787646|FG003|Overall Study|Withdrawal by Subject|0
6790237|NCT04391894|10787647|FG004|Overall Study|Withdrawal by Subject|1
6790238|NCT04391894|10787643|FG000|Overall Study|Unsatisfactory Therapeutic effect|0
6790239|NCT04391894|10787644|FG001|Overall Study|Unsatisfactory Therapeutic effect|0
6790240|NCT04391894|10787645|FG002|Overall Study|Unsatisfactory Therapeutic effect|0
6790241|NCT04391894|10787646|FG003|Overall Study|Unsatisfactory Therapeutic effect|0
6790242|NCT04391894|10787647|FG004|Overall Study|Unsatisfactory Therapeutic effect|1
6790243|NCT04097925|10787669|FG000|Overall Study|Withdrawal by Subject|1
6790244|NCT03428100|10787705|FG000|Overall Study|Adverse Event|1
6790245|NCT03428100|10787706|FG001|Overall Study|Adverse Event|0
6790246|NCT03428100|10787707|FG002|Overall Study|Adverse Event|3
6790247|NCT03428100|10787708|FG003|Overall Study|Adverse Event|1
6790248|NCT03428100|10787705|FG000|Overall Study|Lack of Efficacy|16
6790249|NCT03428100|10787706|FG001|Overall Study|Lack of Efficacy|10
6790250|NCT03428100|10787707|FG002|Overall Study|Lack of Efficacy|7
6790251|NCT03428100|10787708|FG003|Overall Study|Lack of Efficacy|6
6790252|NCT03428100|10787705|FG000|Overall Study|Protocol Deviation|0
6790253|NCT03428100|10787706|FG001|Overall Study|Protocol Deviation|2
6790254|NCT03428100|10787707|FG002|Overall Study|Protocol Deviation|2
6790255|NCT03428100|10787708|FG003|Overall Study|Protocol Deviation|0
6790256|NCT03428100|10787705|FG000|Overall Study|Withdrawal by Subject|4
6790257|NCT03428100|10787706|FG001|Overall Study|Withdrawal by Subject|0
6790258|NCT03428100|10787707|FG002|Overall Study|Withdrawal by Subject|0
6790259|NCT03428100|10787708|FG003|Overall Study|Withdrawal by Subject|0
6790260|NCT03428100|10787705|FG000|Overall Study|Physician Decision|0
6790261|NCT03428100|10787706|FG001|Overall Study|Physician Decision|1
6790262|NCT03428100|10787707|FG002|Overall Study|Physician Decision|0
6790263|NCT03428100|10787708|FG003|Overall Study|Physician Decision|0
6790264|NCT03341936|10787728|FG000|Overall Study|Ineligible|1
6790265|NCT03341936|10787728|FG000|Overall Study|Disease Progression|2
6790266|NCT03341936|10787728|FG000|Overall Study|Withdrew Consent|4
6790267|NCT03341936|10787728|FG000|Overall Study|Non-Compliance|1
6790268|NCT03341936|10787728|FG000|Overall Study|Physician Decision|1
6790269|NCT03341936|10787728|FG000|Overall Study|Withdrawal by Subject|1
6790270|NCT03341936|10787728|FG000|Overall Study|Other|1
6790271|NCT03144687|10787738|FG000|Overall Study|Death|0
6790272|NCT03144687|10787739|FG001|Overall Study|Death|2
6790273|NCT03144687|10787738|FG000|Overall Study|Lost to Follow-up|0
6790274|NCT03144687|10787739|FG001|Overall Study|Lost to Follow-up|1
6790275|NCT03144687|10787738|FG000|Overall Study|Physician Decision|0
6790276|NCT03144687|10787739|FG001|Overall Study|Physician Decision|1
6790277|NCT03144687|10787738|FG000|Overall Study|Withdrawal by Subject|1
6790278|NCT03144687|10787739|FG001|Overall Study|Withdrawal by Subject|3
6790279|NCT03144687|10787738|FG000|Overall Study|Not Reported|2
6790280|NCT03144687|10787739|FG001|Overall Study|Not Reported|0
6790281|NCT03090737|10787749|FG000|Overall Study|Participant withdrew consent|4
6790282|NCT03090737|10787749|FG000|Overall Study|Death|27
6790283|NCT02880371|10787772|FG000|Phase 1b|Lost to Follow-up|1
6790284|NCT02880371|10787773|FG001|Phase 1b|Lost to Follow-up|0
6790285|NCT02880371|10787774|FG002|Phase 1b|Lost to Follow-up|0
6790286|NCT02880371|10787775|FG003|Phase 1b|Lost to Follow-up|0
6790287|NCT02880371|10787776|FG004|Phase 1b|Lost to Follow-up|0
6790288|NCT02880371|10787777|FG005|Phase 1b|Lost to Follow-up|0
6790289|NCT02880371|10787778|FG006|Phase 1b|Lost to Follow-up|0
6790290|NCT02880371|10787779|FG007|Phase 1b|Lost to Follow-up|0
6790291|NCT02880371|10787772|FG000|Phase 1b|Participants terminated by Sponsor|1
6790292|NCT02880371|10787773|FG001|Phase 1b|Participants terminated by Sponsor|0
6790293|NCT02880371|10787774|FG002|Phase 1b|Participants terminated by Sponsor|0
6790294|NCT02880371|10787775|FG003|Phase 1b|Participants terminated by Sponsor|0
6790295|NCT02880371|10787776|FG004|Phase 1b|Participants terminated by Sponsor|0
6790296|NCT02880371|10787777|FG005|Phase 1b|Participants terminated by Sponsor|0
6790297|NCT02880371|10787778|FG006|Phase 1b|Participants terminated by Sponsor|0
6790298|NCT02880371|10787779|FG007|Phase 1b|Participants terminated by Sponsor|0
6790299|NCT02880371|10787772|FG000|Phase 1b|Withdrawal by Subject|0
6790300|NCT02880371|10787773|FG001|Phase 1b|Withdrawal by Subject|0
6790301|NCT02880371|10787774|FG002|Phase 1b|Withdrawal by Subject|1
6790302|NCT02880371|10787775|FG003|Phase 1b|Withdrawal by Subject|0
6790303|NCT02880371|10787776|FG004|Phase 1b|Withdrawal by Subject|0
6790304|NCT02880371|10787777|FG005|Phase 1b|Withdrawal by Subject|0
6790305|NCT02880371|10787778|FG006|Phase 1b|Withdrawal by Subject|0
6790306|NCT02880371|10787779|FG007|Phase 1b|Withdrawal by Subject|0
6790307|NCT02880371|10787772|FG000|Phase 1b|Death|4
6790308|NCT02880371|10787773|FG001|Phase 1b|Death|6
6790309|NCT02880371|10787774|FG002|Phase 1b|Death|5
6790310|NCT02880371|10787775|FG003|Phase 1b|Death|1
6790311|NCT02880371|10787776|FG004|Phase 1b|Death|0
6790312|NCT02880371|10787777|FG005|Phase 1b|Death|0
6790313|NCT02880371|10787778|FG006|Phase 1b|Death|0
6790314|NCT02880371|10787779|FG007|Phase 1b|Death|0
6790315|NCT02880371|10787772|FG000|Phase 1b|Enrolled but not Treated|0
6790316|NCT02880371|10787773|FG001|Phase 1b|Enrolled but not Treated|1
6790317|NCT02880371|10787774|FG002|Phase 1b|Enrolled but not Treated|0
6790318|NCT02880371|10787775|FG003|Phase 1b|Enrolled but not Treated|0
6790319|NCT02880371|10787776|FG004|Phase 1b|Enrolled but not Treated|0
6790320|NCT02880371|10787777|FG005|Phase 1b|Enrolled but not Treated|0
6790321|NCT02880371|10787778|FG006|Phase 1b|Enrolled but not Treated|0
6790322|NCT02880371|10787779|FG007|Phase 1b|Enrolled but not Treated|0
6790323|NCT02880371|10787772|FG000|Phase 2|Enrolled but not Treated|0
6790324|NCT02880371|10787773|FG001|Phase 2|Enrolled but not Treated|0
6790325|NCT02880371|10787774|FG002|Phase 2|Enrolled but not Treated|0
6790326|NCT02880371|10787775|FG003|Phase 2|Enrolled but not Treated|0
6790327|NCT02880371|10787776|FG004|Phase 2|Enrolled but not Treated|0
6790328|NCT02880371|10787777|FG005|Phase 2|Enrolled but not Treated|1
6790329|NCT02880371|10787778|FG006|Phase 2|Enrolled but not Treated|1
6790330|NCT02880371|10787779|FG007|Phase 2|Enrolled but not Treated|0
6790331|NCT02880371|10787772|FG000|Phase 2|Other|0
6790332|NCT02880371|10787773|FG001|Phase 2|Other|0
6790333|NCT02880371|10787774|FG002|Phase 2|Other|0
6790334|NCT02880371|10787775|FG003|Phase 2|Other|0
6790335|NCT02880371|10787776|FG004|Phase 2|Other|0
6790336|NCT02880371|10787777|FG005|Phase 2|Other|1
6790337|NCT02880371|10787778|FG006|Phase 2|Other|2
6790338|NCT02880371|10787779|FG007|Phase 2|Other|1
6790339|NCT02880371|10787772|FG000|Phase 2|Participants terminated by Sponsor|0
6790340|NCT02880371|10787773|FG001|Phase 2|Participants terminated by Sponsor|0
6790341|NCT02880371|10787774|FG002|Phase 2|Participants terminated by Sponsor|0
6790342|NCT02880371|10787775|FG003|Phase 2|Participants terminated by Sponsor|0
6790343|NCT02880371|10787776|FG004|Phase 2|Participants terminated by Sponsor|1
6790344|NCT02880371|10787777|FG005|Phase 2|Participants terminated by Sponsor|6
6790345|NCT02880371|10787778|FG006|Phase 2|Participants terminated by Sponsor|1
6790346|NCT02880371|10787779|FG007|Phase 2|Participants terminated by Sponsor|5
6790347|NCT02880371|10787772|FG000|Phase 2|Death|0
6790348|NCT02880371|10787773|FG001|Phase 2|Death|0
6790349|NCT02880371|10787774|FG002|Phase 2|Death|0
6790350|NCT02880371|10787775|FG003|Phase 2|Death|0
6790351|NCT02880371|10787776|FG004|Phase 2|Death|1
6790352|NCT02880371|10787777|FG005|Phase 2|Death|10
6790353|NCT02880371|10787778|FG006|Phase 2|Death|20
6790354|NCT02880371|10787779|FG007|Phase 2|Death|5
6790355|NCT02880371|10787772|FG000|Phase 2|Lost to Follow-up|0
6790356|NCT02880371|10787773|FG001|Phase 2|Lost to Follow-up|0
6790357|NCT02880371|10787774|FG002|Phase 2|Lost to Follow-up|0
6790358|NCT02880371|10787775|FG003|Phase 2|Lost to Follow-up|0
6790359|NCT02880371|10787776|FG004|Phase 2|Lost to Follow-up|0
6790360|NCT02880371|10787777|FG005|Phase 2|Lost to Follow-up|0
6790361|NCT02880371|10787778|FG006|Phase 2|Lost to Follow-up|3
6790362|NCT02880371|10787779|FG007|Phase 2|Lost to Follow-up|0
6790363|NCT02880371|10787772|FG000|Phase 2|Withdrawal by Subject|0
6790364|NCT02880371|10787773|FG001|Phase 2|Withdrawal by Subject|0
6790365|NCT02880371|10787774|FG002|Phase 2|Withdrawal by Subject|0
6790366|NCT02880371|10787775|FG003|Phase 2|Withdrawal by Subject|0
6790367|NCT02880371|10787776|FG004|Phase 2|Withdrawal by Subject|0
6790368|NCT02880371|10787777|FG005|Phase 2|Withdrawal by Subject|1
6790369|NCT02880371|10787778|FG006|Phase 2|Withdrawal by Subject|1
6790370|NCT02880371|10787779|FG007|Phase 2|Withdrawal by Subject|0
6790371|NCT02880371|10787772|FG000|Phase 2|End of Study page not completed by error|0
6790372|NCT02880371|10787773|FG001|Phase 2|End of Study page not completed by error|0
6790373|NCT02880371|10787774|FG002|Phase 2|End of Study page not completed by error|0
6790374|NCT02880371|10787775|FG003|Phase 2|End of Study page not completed by error|0
6790375|NCT02880371|10787776|FG004|Phase 2|End of Study page not completed by error|0
6790376|NCT02880371|10787777|FG005|Phase 2|End of Study page not completed by error|1
6790377|NCT02880371|10787778|FG006|Phase 2|End of Study page not completed by error|0
6790378|NCT02880371|10787779|FG007|Phase 2|End of Study page not completed by error|0
6790379|NCT02562235|10787799|FG000|Overall Study|Adverse Event|3
6790380|NCT02477696|10787810|FG000|Overall Study|Adverse Event|40
6790381|NCT02477696|10787811|FG001|Overall Study|Adverse Event|59
6790382|NCT02477696|10787810|FG000|Overall Study|CLL Disease Progression|82
6790383|NCT02477696|10787811|FG001|Overall Study|CLL Disease Progression|68
6790384|NCT02477696|10787810|FG000|Overall Study|Includes Non-compliance, Relocation, Subject's Decision and Medical Monitor's Decision.|2
6790385|NCT02477696|10787811|FG001|Overall Study|Includes Non-compliance, Relocation, Subject's Decision and Medical Monitor's Decision.|10
6790386|NCT02477696|10787810|FG000|Overall Study|Death|5
6790387|NCT02477696|10787811|FG001|Overall Study|Death|6
6790388|NCT02477696|10787810|FG000|Overall Study|Withdrawal by Subject|7
6790389|NCT02477696|10787811|FG001|Overall Study|Withdrawal by Subject|7
6790390|NCT02477696|10787810|FG000|Overall Study|Physician Decision|5
6790391|NCT02477696|10787811|FG001|Overall Study|Physician Decision|5
6790392|NCT02434354|10787817|FG000|Overall Study|screen fail|3
6790393|NCT02419417|10787832|FG000|Overall Study|Disease progression|5
6790394|NCT02419417|10787833|FG001|Overall Study|Disease progression|4
6790395|NCT02419417|10787834|FG002|Overall Study|Disease progression|13
6790396|NCT02419417|10787835|FG003|Overall Study|Disease progression|10
6790397|NCT02419417|10787836|FG004|Overall Study|Disease progression|10
6790398|NCT02419417|10787837|FG005|Overall Study|Disease progression|3
6790399|NCT02419417|10787838|FG006|Overall Study|Disease progression|4
6790400|NCT02419417|10787839|FG007|Overall Study|Disease progression|5
6790401|NCT02419417|10787840|FG008|Overall Study|Disease progression|13
6790402|NCT02419417|10787841|FG009|Overall Study|Disease progression|9
6790403|NCT02419417|10787842|FG010|Overall Study|Disease progression|0
6790404|NCT02419417|10787832|FG000|Overall Study|Study drug toxicity|0
6790405|NCT02419417|10787833|FG001|Overall Study|Study drug toxicity|0
6790406|NCT02419417|10787834|FG002|Overall Study|Study drug toxicity|0
6790407|NCT02419417|10787835|FG003|Overall Study|Study drug toxicity|0
6790408|NCT02419417|10787836|FG004|Overall Study|Study drug toxicity|1
6790409|NCT02419417|10787837|FG005|Overall Study|Study drug toxicity|0
6790410|NCT02419417|10787838|FG006|Overall Study|Study drug toxicity|0
6790411|NCT02419417|10787839|FG007|Overall Study|Study drug toxicity|0
6790412|NCT02419417|10787840|FG008|Overall Study|Study drug toxicity|0
6790413|NCT02419417|10787841|FG009|Overall Study|Study drug toxicity|0
6790414|NCT02419417|10787842|FG010|Overall Study|Study drug toxicity|0
6790415|NCT02419417|10787832|FG000|Overall Study|Adverse event unrelated to study drug|0
6790416|NCT02419417|10787833|FG001|Overall Study|Adverse event unrelated to study drug|0
6790417|NCT02419417|10787834|FG002|Overall Study|Adverse event unrelated to study drug|0
6790418|NCT02419417|10787835|FG003|Overall Study|Adverse event unrelated to study drug|0
6790419|NCT02419417|10787836|FG004|Overall Study|Adverse event unrelated to study drug|2
6790420|NCT02419417|10787837|FG005|Overall Study|Adverse event unrelated to study drug|1
6790421|NCT02419417|10787838|FG006|Overall Study|Adverse event unrelated to study drug|0
6790422|NCT02419417|10787839|FG007|Overall Study|Adverse event unrelated to study drug|1
6790423|NCT02419417|10787840|FG008|Overall Study|Adverse event unrelated to study drug|0
6790424|NCT02419417|10787841|FG009|Overall Study|Adverse event unrelated to study drug|0
6790425|NCT02419417|10787842|FG010|Overall Study|Adverse event unrelated to study drug|0
6790426|NCT02419417|10787832|FG000|Overall Study|Participant request to discontinue|0
6790427|NCT02419417|10787833|FG001|Overall Study|Participant request to discontinue|0
6790428|NCT02419417|10787834|FG002|Overall Study|Participant request to discontinue|0
6790429|NCT02419417|10787835|FG003|Overall Study|Participant request to discontinue|0
6790430|NCT02419417|10787836|FG004|Overall Study|Participant request to discontinue|0
6790431|NCT02419417|10787837|FG005|Overall Study|Participant request to discontinue|0
6790432|NCT02419417|10787838|FG006|Overall Study|Participant request to discontinue|0
6790433|NCT02419417|10787839|FG007|Overall Study|Participant request to discontinue|0
6790434|NCT02419417|10787840|FG008|Overall Study|Participant request to discontinue|0
6790435|NCT02419417|10787841|FG009|Overall Study|Participant request to discontinue|1
6790436|NCT02419417|10787842|FG010|Overall Study|Participant request to discontinue|0
6790437|NCT02419417|10787832|FG000|Overall Study|Withdrawal by Subject|0
6790438|NCT02419417|10787833|FG001|Overall Study|Withdrawal by Subject|0
6790439|NCT02419417|10787834|FG002|Overall Study|Withdrawal by Subject|0
6790440|NCT02419417|10787835|FG003|Overall Study|Withdrawal by Subject|0
6790441|NCT02419417|10787836|FG004|Overall Study|Withdrawal by Subject|0
6790442|NCT02419417|10787837|FG005|Overall Study|Withdrawal by Subject|0
6790443|NCT02419417|10787838|FG006|Overall Study|Withdrawal by Subject|0
6790444|NCT02419417|10787839|FG007|Overall Study|Withdrawal by Subject|0
6790445|NCT02419417|10787840|FG008|Overall Study|Withdrawal by Subject|0
6790446|NCT02419417|10787841|FG009|Overall Study|Withdrawal by Subject|0
6790447|NCT02419417|10787842|FG010|Overall Study|Withdrawal by Subject|1
6790448|NCT02395120|10787876|FG000|Overall Study|Missed follow-up dental exam|57
6790449|NCT02395120|10787877|FG001|Overall Study|Missed follow-up dental exam|62
6790450|NCT02395120|10787878|FG002|Overall Study|Missed follow-up dental exam|6
6790451|NCT02395120|10787879|FG003|Overall Study|Missed follow-up dental exam|6
6790452|NCT02395120|10787880|FG004|Overall Study|Missed follow-up dental exam|51
6790453|NCT02075840|10787904|FG000|Overall Study|Withdrawal by Subject|13
6790454|NCT02075840|10787905|FG001|Overall Study|Withdrawal by Subject|22
6790455|NCT02075840|10787904|FG000|Overall Study|Reason not specified|1
6790456|NCT02075840|10787905|FG001|Overall Study|Reason not specified|0
6790457|NCT02075840|10787904|FG000|Overall Study|Adverse Event|0
6790458|NCT02075840|10787905|FG001|Overall Study|Adverse Event|2
6790459|NCT02075840|10787904|FG000|Overall Study|Death|35
6790460|NCT02075840|10787905|FG001|Overall Study|Death|40
6790461|NCT02075840|10787904|FG000|Overall Study|Lost to Follow-up|3
6790462|NCT02075840|10787905|FG001|Overall Study|Lost to Follow-up|2
6790463|NCT02075840|10787904|FG000|Overall Study|Physician Decision|1
6790464|NCT02075840|10787905|FG001|Overall Study|Physician Decision|3
6790465|NCT02075840|10787904|FG000|Overall Study|Ongoing at CCOD|99
6790466|NCT02075840|10787905|FG001|Overall Study|Ongoing at CCOD|82
6790467|NCT02051608|10787915|FG000|Part 1: Double Blind Treatment|Death|3
6790468|NCT02051608|10787916|FG001|Part 1: Double Blind Treatment|Death|3
6790469|NCT02051608|10787917|FG002|Part 1: Double Blind Treatment|Death|0
6790470|NCT02051608|10787918|FG003|Part 1: Double Blind Treatment|Death|0
6790471|NCT02051608|10787915|FG000|Part 1: Double Blind Treatment|Adverse Event|2
6810792|NCT02499328|10814773|FG005|Overall Study|Withdrawal by Subject|0
6790472|NCT02051608|10787916|FG001|Part 1: Double Blind Treatment|Adverse Event|8
6790473|NCT02051608|10787917|FG002|Part 1: Double Blind Treatment|Adverse Event|0
6790474|NCT02051608|10787918|FG003|Part 1: Double Blind Treatment|Adverse Event|0
6790475|NCT02051608|10787915|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42
6790476|NCT02051608|10787916|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29
6790477|NCT02051608|10787917|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0
6790478|NCT02051608|10787918|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0
6790479|NCT02051608|10787915|FG000|Part 1: Double Blind Treatment|Physician Decision|2
6790480|NCT02051608|10787916|FG001|Part 1: Double Blind Treatment|Physician Decision|4
6790481|NCT02051608|10787917|FG002|Part 1: Double Blind Treatment|Physician Decision|0
6790482|NCT02051608|10787918|FG003|Part 1: Double Blind Treatment|Physician Decision|0
6790483|NCT02051608|10787915|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1
6790484|NCT02051608|10787916|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2
6790485|NCT02051608|10787917|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0
6790486|NCT02051608|10787918|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0
6790487|NCT02051608|10787915|FG000|Part 1: Double Blind Treatment|Protocol Violation|0
6790488|NCT02051608|10787916|FG001|Part 1: Double Blind Treatment|Protocol Violation|1
6790489|NCT02051608|10787917|FG002|Part 1: Double Blind Treatment|Protocol Violation|0
6790490|NCT02051608|10787918|FG003|Part 1: Double Blind Treatment|Protocol Violation|0
6790491|NCT02051608|10787915|FG000|Part 1: Double Blind Treatment|Non-Compliance|2
6790492|NCT02051608|10787916|FG001|Part 1: Double Blind Treatment|Non-Compliance|4
6790493|NCT02051608|10787917|FG002|Part 1: Double Blind Treatment|Non-Compliance|0
6790494|NCT02051608|10787918|FG003|Part 1: Double Blind Treatment|Non-Compliance|0
6790495|NCT02051608|10787915|FG000|Part 1: Double Blind Treatment|Other|6
6790496|NCT02051608|10787916|FG001|Part 1: Double Blind Treatment|Other|3
6790497|NCT02051608|10787917|FG002|Part 1: Double Blind Treatment|Other|0
6790498|NCT02051608|10787918|FG003|Part 1: Double Blind Treatment|Other|0
6790499|NCT02051608|10787915|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3
6790500|NCT02051608|10787916|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2
6790501|NCT02051608|10787917|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0
6790502|NCT02051608|10787918|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0
6790503|NCT02051608|10787915|FG000|Part 2: Open-label Extension|Adverse Event|0
6790504|NCT02051608|10787916|FG001|Part 2: Open-label Extension|Adverse Event|0
6790505|NCT02051608|10787917|FG002|Part 2: Open-label Extension|Adverse Event|6
6790506|NCT02051608|10787918|FG003|Part 2: Open-label Extension|Adverse Event|8
6790507|NCT02051608|10787915|FG000|Part 2: Open-label Extension|Death|0
6790508|NCT02051608|10787916|FG001|Part 2: Open-label Extension|Death|0
6790509|NCT02051608|10787917|FG002|Part 2: Open-label Extension|Death|7
6790510|NCT02051608|10787918|FG003|Part 2: Open-label Extension|Death|4
6790511|NCT02051608|10787915|FG000|Part 2: Open-label Extension|Lost to Follow-up|0
6790512|NCT02051608|10787916|FG001|Part 2: Open-label Extension|Lost to Follow-up|0
6790513|NCT02051608|10787917|FG002|Part 2: Open-label Extension|Lost to Follow-up|0
6790514|NCT02051608|10787918|FG003|Part 2: Open-label Extension|Lost to Follow-up|1
6790515|NCT02051608|10787915|FG000|Part 2: Open-label Extension|Non-Compliance|0
6790516|NCT02051608|10787916|FG001|Part 2: Open-label Extension|Non-Compliance|0
6790517|NCT02051608|10787917|FG002|Part 2: Open-label Extension|Non-Compliance|1
6790518|NCT02051608|10787918|FG003|Part 2: Open-label Extension|Non-Compliance|1
6790519|NCT02051608|10787915|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0
6790520|NCT02051608|10787916|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0
6790521|NCT02051608|10787917|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39
6790522|NCT02051608|10787918|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32
6790523|NCT02051608|10787915|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0
6790524|NCT02051608|10787916|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0
6790525|NCT02051608|10787917|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0
6790526|NCT02051608|10787918|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1
6790527|NCT02051608|10787915|FG000|Part 2: Open-label Extension|Physician Decision|0
6790528|NCT02051608|10787916|FG001|Part 2: Open-label Extension|Physician Decision|0
6790529|NCT02051608|10787917|FG002|Part 2: Open-label Extension|Physician Decision|8
6790530|NCT02051608|10787918|FG003|Part 2: Open-label Extension|Physician Decision|5
6790531|NCT02051608|10787915|FG000|Part 2: Open-label Extension|Other|0
6790532|NCT02051608|10787916|FG001|Part 2: Open-label Extension|Other|0
6790533|NCT02051608|10787917|FG002|Part 2: Open-label Extension|Other|9
6790534|NCT02051608|10787918|FG003|Part 2: Open-label Extension|Other|9
6790535|NCT01850524|10787942|FG000|Overall Study|Ongoing on Treatment|57
6790536|NCT01850524|10787943|FG001|Overall Study|Ongoing on Treatment|54
6790537|NCT01850524|10787942|FG000|Overall Study|Adverse Event|96
6790538|NCT01850524|10787943|FG001|Overall Study|Adverse Event|122
6790539|NCT01850524|10787942|FG000|Overall Study|Lost to Follow-up|2
6790540|NCT01850524|10787943|FG001|Overall Study|Lost to Follow-up|0
6790541|NCT01850524|10787942|FG000|Overall Study|Progressive Disease|166
6790542|NCT01850524|10787943|FG001|Overall Study|Progressive Disease|123
6790543|NCT01850524|10787942|FG000|Overall Study|Protocol Violation|1
6790544|NCT01850524|10787943|FG001|Overall Study|Protocol Violation|2
6790545|NCT01850524|10787942|FG000|Overall Study|Withdrawal by Subject|8
6790546|NCT01850524|10787943|FG001|Overall Study|Withdrawal by Subject|19
6790547|NCT01850524|10787942|FG000|Overall Study|Participant Wished to Discontinue Treatment|15
6790548|NCT01850524|10787943|FG001|Overall Study|Participant Wished to Discontinue Treatment|22
6790549|NCT01850524|10787942|FG000|Overall Study|Investigator Decision|4
6790550|NCT01850524|10787943|FG001|Overall Study|Investigator Decision|4
6790551|NCT01850524|10787942|FG000|Overall Study|Participants Removed From Study|0
6790552|NCT01850524|10787943|FG001|Overall Study|Participants Removed From Study|1
6790553|NCT01850524|10787942|FG000|Overall Study|Medical Monitor Decision|0
6790554|NCT01850524|10787943|FG001|Overall Study|Medical Monitor Decision|1
6790555|NCT01850524|10787942|FG000|Overall Study|Participants Decision|2
6790556|NCT01850524|10787943|FG001|Overall Study|Participants Decision|2
6790557|NCT01850524|10787942|FG000|Overall Study|Progressive Disease Per Local Lab|1
6790558|NCT01850524|10787943|FG001|Overall Study|Progressive Disease Per Local Lab|0
6790559|NCT01850524|10787942|FG000|Overall Study|Lack of Improvement|0
6790560|NCT01850524|10787943|FG001|Overall Study|Lack of Improvement|1
6790561|NCT01850524|10787942|FG000|Overall Study|Minimal Response|1
6790562|NCT01850524|10787943|FG001|Overall Study|Minimal Response|0
6790563|NCT01850524|10787942|FG000|Overall Study|Comorbidities|1
6790564|NCT01850524|10787943|FG001|Overall Study|Comorbidities|0
6790565|NCT00726596|10787999|FG000|Overall Study|Adverse Event|2
6790566|NCT00726596|10788000|FG001|Overall Study|Adverse Event|1
6790567|NCT00726596|10787999|FG000|Overall Study|Withdrawal by Subject|3
6790568|NCT00726596|10788000|FG001|Overall Study|Withdrawal by Subject|3
6790569|NCT00489827|10788008|FG000|Overall Study|Intraoperative exclusion criteria|1
6790570|NCT00489827|10788009|FG001|Overall Study|Intraoperative exclusion criteria|1
6790571|NCT00489827|10788008|FG000|Overall Study|Intraoperative exclusion criteria|1
6790572|NCT00489827|10788009|FG001|Overall Study|Intraoperative exclusion criteria|1
6790573|NCT00278915|10788015|FG000|Overall Study|Lack of Efficacy|1
6807692|NCT04702984|10811351|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1
6810793|NCT02499328|10814774|FG006|Overall Study|Withdrawal by Subject|0
6810794|NCT02499328|10814775|FG007|Overall Study|Withdrawal by Subject|0
6810795|NCT02499328|10814776|FG008|Overall Study|Withdrawal by Subject|2
6810796|NCT02499328|10814777|FG009|Overall Study|Withdrawal by Subject|2
6810797|NCT02499328|10814778|FG010|Overall Study|Withdrawal by Subject|0
6810798|NCT02499328|10814779|FG011|Overall Study|Withdrawal by Subject|3
6810799|NCT02499328|10814780|FG012|Overall Study|Withdrawal by Subject|7
6810800|NCT02499328|10814781|FG013|Overall Study|Withdrawal by Subject|3
6810801|NCT02499328|10814782|FG014|Overall Study|Withdrawal by Subject|1
6810802|NCT02499328|10814783|FG015|Overall Study|Withdrawal by Subject|0
6810803|NCT02499328|10814784|FG016|Overall Study|Withdrawal by Subject|0
6810804|NCT02499328|10814785|FG017|Overall Study|Withdrawal by Subject|3
6810805|NCT02499328|10814786|FG018|Overall Study|Withdrawal by Subject|0
6810806|NCT02499328|10814768|FG000|Overall Study|Lost to Follow-up|0
6810807|NCT02499328|10814769|FG001|Overall Study|Lost to Follow-up|1
6810808|NCT02499328|10814770|FG002|Overall Study|Lost to Follow-up|1
6810809|NCT02499328|10814771|FG003|Overall Study|Lost to Follow-up|2
6810810|NCT02499328|10814772|FG004|Overall Study|Lost to Follow-up|0
6810811|NCT02499328|10814773|FG005|Overall Study|Lost to Follow-up|0
6810812|NCT02499328|10814774|FG006|Overall Study|Lost to Follow-up|0
6810813|NCT02499328|10814775|FG007|Overall Study|Lost to Follow-up|2
6810814|NCT02499328|10814776|FG008|Overall Study|Lost to Follow-up|3
6810815|NCT02499328|10814777|FG009|Overall Study|Lost to Follow-up|0
6810816|NCT02499328|10814778|FG010|Overall Study|Lost to Follow-up|0
6810817|NCT02499328|10814779|FG011|Overall Study|Lost to Follow-up|0
6810818|NCT02499328|10814780|FG012|Overall Study|Lost to Follow-up|0
6810819|NCT02499328|10814781|FG013|Overall Study|Lost to Follow-up|0
6810820|NCT02499328|10814782|FG014|Overall Study|Lost to Follow-up|0
6810821|NCT02499328|10814783|FG015|Overall Study|Lost to Follow-up|0
6810822|NCT02499328|10814784|FG016|Overall Study|Lost to Follow-up|0
6810823|NCT02499328|10814785|FG017|Overall Study|Lost to Follow-up|0
6810824|NCT02499328|10814786|FG018|Overall Study|Lost to Follow-up|1
6810825|NCT02499328|10814768|FG000|Overall Study|Death|0
6810826|NCT02499328|10814769|FG001|Overall Study|Death|3
6810827|NCT02499328|10814770|FG002|Overall Study|Death|3
6810828|NCT02499328|10814771|FG003|Overall Study|Death|2
6810829|NCT02499328|10814772|FG004|Overall Study|Death|4
6810830|NCT02499328|10814773|FG005|Overall Study|Death|7
6810831|NCT02499328|10814774|FG006|Overall Study|Death|3
6810832|NCT02499328|10814775|FG007|Overall Study|Death|0
6810833|NCT02499328|10814776|FG008|Overall Study|Death|2
6810834|NCT02499328|10814777|FG009|Overall Study|Death|6
6810835|NCT02499328|10814778|FG010|Overall Study|Death|6
6810836|NCT02499328|10814779|FG011|Overall Study|Death|20
6810837|NCT02499328|10814780|FG012|Overall Study|Death|9
6810838|NCT02499328|10814781|FG013|Overall Study|Death|7
6810839|NCT02499328|10814782|FG014|Overall Study|Death|3
6810840|NCT02499328|10814783|FG015|Overall Study|Death|1
6810841|NCT02499328|10814784|FG016|Overall Study|Death|1
6810842|NCT02499328|10814785|FG017|Overall Study|Death|16
6810843|NCT02499328|10814786|FG018|Overall Study|Death|5
6810844|NCT02499328|10814768|FG000|Overall Study|"Other"|2
6810845|NCT02499328|10814769|FG001|Overall Study|"Other"|2
6810846|NCT02499328|10814770|FG002|Overall Study|"Other"|1
6810847|NCT02499328|10814771|FG003|Overall Study|"Other"|3
6810848|NCT02499328|10814772|FG004|Overall Study|"Other"|6
6810849|NCT02499328|10814773|FG005|Overall Study|"Other"|2
6810850|NCT02499328|10814774|FG006|Overall Study|"Other"|3
6810851|NCT02499328|10814775|FG007|Overall Study|"Other"|4
6810852|NCT02499328|10814776|FG008|Overall Study|"Other"|6
6790574|NCT04505722|10788021|FG000|Overall Study|Adverse Event|1
6790575|NCT04505722|10788022|FG001|Overall Study|Adverse Event|2
6790576|NCT04505722|10788021|FG000|Overall Study|Death|34
6790577|NCT04505722|10788022|FG001|Overall Study|Death|63
6790578|NCT04505722|10788021|FG000|Overall Study|Lost to Follow-up|271
6790579|NCT04505722|10788022|FG001|Overall Study|Lost to Follow-up|333
6790580|NCT04505722|10788021|FG000|Overall Study|Physician Decision|17
6790581|NCT04505722|10788022|FG001|Overall Study|Physician Decision|17
6790582|NCT04505722|10788021|FG000|Overall Study|Protocol Violation|0
6790583|NCT04505722|10788022|FG001|Overall Study|Protocol Violation|1
6790584|NCT04505722|10788021|FG000|Overall Study|Withdrawal by Subject|376
6790585|NCT04505722|10788022|FG001|Overall Study|Withdrawal by Subject|714
6790586|NCT04505722|10788021|FG000|Overall Study|Other|61
6790587|NCT04505722|10788022|FG001|Overall Study|Other|98
6790588|NCT04505722|10788021|FG000|Overall Study|Still ongoing|21138
6790589|NCT04505722|10788022|FG001|Overall Study|Still ongoing|20662
7140057|NCT02965833|11293919|FG000|Period 1, First 30 Days of Wear|Adverse Event|0
7140058|NCT02965833|11293920|FG001|Period 1, First 30 Days of Wear|Adverse Event|1
7140059|NCT02965833|11293919|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1
7140060|NCT02965833|11293920|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1
7140061|NCT02965833|11293919|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1
7140062|NCT02965833|11293920|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0
7140063|NCT02965833|11293919|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
7140064|NCT02965833|11293920|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
7140065|NCT02965833|11293919|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2
7140066|NCT02965833|11293920|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0
7140067|NCT02966002|11293945|FG000|Overall Study|Withdrawal by Subject|2
7140068|NCT02966002|11293945|FG000|Overall Study|Adverse Event|1
7140069|NCT02966002|11293945|FG000|Overall Study|Lost to Follow-up|1
7140070|NCT02966015|11293951|FG000|Inclusion Visit|did not answer questionnaire|8
7140071|NCT02966015|11293952|FG001|Inclusion Visit|did not answer questionnaire|3
7140072|NCT02966028|11293961|FG000|Overall Study|Adverse Event|7
7140073|NCT02966028|11293962|FG001|Overall Study|Adverse Event|13
7140074|NCT02966028|11293963|FG002|Overall Study|Adverse Event|10
7140075|NCT02966028|11293961|FG000|Overall Study|Physician Decision|1
7140076|NCT02966028|11293962|FG001|Overall Study|Physician Decision|0
7140077|NCT02966028|11293963|FG002|Overall Study|Physician Decision|2
7140078|NCT02966028|11293961|FG000|Overall Study|Withdrawal by Subject|7
7140079|NCT02966028|11293962|FG001|Overall Study|Withdrawal by Subject|5
7140080|NCT02966028|11293963|FG002|Overall Study|Withdrawal by Subject|5
7140081|NCT02966028|11293961|FG000|Overall Study|Kidney transplant Changed dialysis units|9
7140082|NCT02966028|11293962|FG001|Overall Study|Kidney transplant Changed dialysis units|16
7140083|NCT02966028|11293963|FG002|Overall Study|Kidney transplant Changed dialysis units|14
7140084|NCT02966314|11293984|FG000|Overall Study|Lost to Follow-up|1
7140085|NCT02966314|11293985|FG001|Overall Study|Lost to Follow-up|0
7140086|NCT02966340|11293991|FG000|Overall Study|Adverse Event|0
7140087|NCT02966340|11293992|FG001|Overall Study|Adverse Event|1
7140088|NCT02966340|11293991|FG000|Overall Study|Lost to Follow-up|0
7140089|NCT02966340|11293992|FG001|Overall Study|Lost to Follow-up|1
7140090|NCT02966340|11293991|FG000|Overall Study|Withdrawal by Subject|1
7140091|NCT02966340|11293992|FG001|Overall Study|Withdrawal by Subject|0
7140092|NCT02966340|11293991|FG000|Overall Study|data acquisition error|1
7140093|NCT02966340|11293992|FG001|Overall Study|data acquisition error|0
7140094|NCT02966340|11293991|FG000|Overall Study|startle non-responder|1
7140095|NCT02966340|11293992|FG001|Overall Study|startle non-responder|1
7140096|NCT02966353|11293998|FG000|Overall Study|Withdrawal by Subject|7
7140097|NCT02966353|11293998|FG000|Overall Study|Adverse Event|4
7140098|NCT02966353|11293998|FG000|Overall Study|Death|4
7140099|NCT02966353|11293998|FG000|Overall Study|Physician Decision|3
7140100|NCT02966353|11293998|FG000|Overall Study|Progressive disease|2
7140101|NCT02966353|11293998|FG000|Overall Study|Protocol deviation|2
7140102|NCT02966509|11294004|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2
7140103|NCT02966509|11294005|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3
7140104|NCT02966509|11294004|FG000|Baseline Satisfaction Survey|Death|0
7140105|NCT02966509|11294005|FG001|Baseline Satisfaction Survey|Death|1
7140106|NCT02966509|11294004|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1
7140107|NCT02966509|11294005|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1
7140108|NCT02966509|11294004|FG000|Baseline Satisfaction Survey|Refused to Answer|1
7140109|NCT02966509|11294005|FG001|Baseline Satisfaction Survey|Refused to Answer|2
7140110|NCT02966509|11294004|FG000|6 Month Satisfaction Decision Survey|Death|22
7140111|NCT02966509|11294005|FG001|6 Month Satisfaction Decision Survey|Death|25
7140112|NCT02966509|11294004|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2
7140113|NCT02966509|11294005|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3
7140114|NCT02966509|11294004|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1
7140115|NCT02966509|11294005|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1
7140116|NCT02966509|11294004|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0
6790590|NCT04505722|10788021|FG000|Overall Study|Randomized not vaccinated|276
6790591|NCT04505722|10788022|FG001|Overall Study|Randomized not vaccinated|260
6807693|NCT04633564|10811359|FG000|Period 1|Adverse Event|28
6807694|NCT04633564|10811360|FG001|Period 1|Adverse Event|19
7140117|NCT02966509|11294005|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2
7140118|NCT02966509|11294004|FG000|6 Month Satisfaction Survey|Death|36
7140119|NCT02966509|11294005|FG001|6 Month Satisfaction Survey|Death|33
7140120|NCT02966509|11294004|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2
7140121|NCT02966509|11294005|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3
7140122|NCT02966509|11294004|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1
7140123|NCT02966509|11294005|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1
7140124|NCT02966509|11294004|FG000|6 Month Satisfaction Survey|Refused to Answer|8
7140125|NCT02966509|11294005|FG001|6 Month Satisfaction Survey|Refused to Answer|11
7140126|NCT02966509|11294004|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69
7140127|NCT02966509|11294005|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75
7140128|NCT02966509|11294004|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45
7140129|NCT02966509|11294005|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48
7140130|NCT02966795|11294013|FG000|Overall Study|Patient Left the Country|0
7140131|NCT02966795|11294014|FG001|Overall Study|Patient Left the Country|1
7140132|NCT02966834|11294025|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0
7140133|NCT02966834|11294026|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0
7140134|NCT02966834|11294027|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0
7140135|NCT02966834|11294028|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0
7140136|NCT02966834|11294029|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1
7140137|NCT02966834|11294030|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0
7140138|NCT02966834|11294025|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1
7140139|NCT02966834|11294026|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0
7140140|NCT02966834|11294027|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0
7140141|NCT02966834|11294028|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0
7140142|NCT02966834|11294029|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0
7140143|NCT02966834|11294030|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0
7140144|NCT02966834|11294025|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0
7140145|NCT02966834|11294026|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0
7140146|NCT02966834|11294027|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4
7140147|NCT02966834|11294028|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8
7140148|NCT02966834|11294029|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0
7140149|NCT02966834|11294030|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5
7140150|NCT02966834|11294025|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0
7140151|NCT02966834|11294026|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0
7140152|NCT02966834|11294027|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1
7140153|NCT02966834|11294028|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2
7140154|NCT02966834|11294029|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0
7140155|NCT02966834|11294030|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1
7140156|NCT02966834|11294025|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0
7140157|NCT02966834|11294026|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0
7140158|NCT02966834|11294027|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0
7140159|NCT02966834|11294028|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2
7140160|NCT02966834|11294029|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0
7140161|NCT02966834|11294030|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0
7140162|NCT02966834|11294025|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0
7140163|NCT02966834|11294026|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0
7140164|NCT02966834|11294027|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0
7140165|NCT02966834|11294028|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1
7140166|NCT02966834|11294029|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0
7140167|NCT02966834|11294030|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0
7140168|NCT02967055|11294088|FG000|Overall Study|Excluded|40
7140169|NCT02967055|11294088|FG000|Overall Study|Screen fail|3
7140170|NCT02967055|11294088|FG000|Overall Study|Lost to Follow-up|2
7140171|NCT02967055|11294088|FG000|Overall Study|Stopped due to side effects|3
7140172|NCT02967055|11294088|FG000|Overall Study|Stopped due to drug cost|1
7140173|NCT02967562|11294157|FG000|Overall Study|Consent not obtained|1
7140174|NCT02967562|11294158|FG001|Overall Study|Consent not obtained|0
7140175|NCT02967562|11294157|FG000|Overall Study|High leak precluding analysis|1
7140176|NCT02967562|11294158|FG001|Overall Study|High leak precluding analysis|1
7140177|NCT02967679|11294164|FG000|Overall Study|Adverse Event|1
7140178|NCT02968004|11294181|FG000|Overall Study|Adverse Event|1
7140179|NCT02968004|11294182|FG001|Overall Study|Adverse Event|0
7140180|NCT02968004|11294181|FG000|Overall Study|Withdrawal by Subject|0
7140181|NCT02968004|11294182|FG001|Overall Study|Withdrawal by Subject|1
7140182|NCT02968173|11294192|FG000|Overall Study|Withdrawal by Subject|1
7140183|NCT02968433|11294238|FG000|Overall Study|Withdrawal by Subject|1
7140184|NCT02968576|11294248|FG000|Overall Study|Pregnancy|0
7140185|NCT02968576|11294249|FG001|Overall Study|Pregnancy|1
7140186|NCT02968979|11294270|FG000|Overall Study|Protocol Violation|7
7140187|NCT02968979|11294270|FG000|Overall Study|Withdrawal by Subject|1
7140188|NCT02969018|11294337|FG000|Overall Study|Adverse Event|2
7140189|NCT02969018|11294338|FG001|Overall Study|Adverse Event|4
7140190|NCT02969018|11294339|FG002|Overall Study|Adverse Event|1
7140191|NCT02969018|11294340|FG003|Overall Study|Adverse Event|2
7140192|NCT02969018|11294341|FG004|Overall Study|Adverse Event|0
7140193|NCT02969018|11294342|FG005|Overall Study|Adverse Event|1
7140194|NCT02969018|11294343|FG006|Overall Study|Adverse Event|2
7140195|NCT02969018|11294344|FG007|Overall Study|Adverse Event|0
7140196|NCT02969018|11294337|FG000|Overall Study|Lack of Efficacy|0
7140197|NCT02969018|11294338|FG001|Overall Study|Lack of Efficacy|1
7140198|NCT02969018|11294339|FG002|Overall Study|Lack of Efficacy|0
7140199|NCT02969018|11294340|FG003|Overall Study|Lack of Efficacy|0
7140200|NCT02969018|11294341|FG004|Overall Study|Lack of Efficacy|1
7140201|NCT02969018|11294342|FG005|Overall Study|Lack of Efficacy|1
7140202|NCT02969018|11294343|FG006|Overall Study|Lack of Efficacy|1
7140203|NCT02969018|11294344|FG007|Overall Study|Lack of Efficacy|1
7140204|NCT02969018|11294337|FG000|Overall Study|Lost to Follow-up|1
7140205|NCT02969018|11294338|FG001|Overall Study|Lost to Follow-up|2
7140206|NCT02969018|11294339|FG002|Overall Study|Lost to Follow-up|2
7140207|NCT02969018|11294340|FG003|Overall Study|Lost to Follow-up|0
7140208|NCT02969018|11294341|FG004|Overall Study|Lost to Follow-up|1
7140209|NCT02969018|11294342|FG005|Overall Study|Lost to Follow-up|1
7140210|NCT02969018|11294343|FG006|Overall Study|Lost to Follow-up|0
7140211|NCT02969018|11294344|FG007|Overall Study|Lost to Follow-up|1
7140212|NCT02969018|11294337|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
7140213|NCT02969018|11294338|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
7140214|NCT02969018|11294339|FG002|Overall Study|No Longer Meets Eligibility Criteria|0
7140215|NCT02969018|11294340|FG003|Overall Study|No Longer Meets Eligibility Criteria|0
7140216|NCT02969018|11294341|FG004|Overall Study|No Longer Meets Eligibility Criteria|0
7140217|NCT02969018|11294342|FG005|Overall Study|No Longer Meets Eligibility Criteria|0
7140218|NCT02969018|11294343|FG006|Overall Study|No Longer Meets Eligibility Criteria|1
7140219|NCT02969018|11294344|FG007|Overall Study|No Longer Meets Eligibility Criteria|0
7140220|NCT02969018|11294337|FG000|Overall Study|Non-Compliance With Study Drug|1
7140221|NCT02969018|11294338|FG001|Overall Study|Non-Compliance With Study Drug|0
7140222|NCT02969018|11294339|FG002|Overall Study|Non-Compliance With Study Drug|0
7140223|NCT02969018|11294340|FG003|Overall Study|Non-Compliance With Study Drug|0
7140224|NCT02969018|11294341|FG004|Overall Study|Non-Compliance With Study Drug|0
7140225|NCT02969018|11294342|FG005|Overall Study|Non-Compliance With Study Drug|0
7140226|NCT02969018|11294343|FG006|Overall Study|Non-Compliance With Study Drug|0
7140227|NCT02969018|11294344|FG007|Overall Study|Non-Compliance With Study Drug|0
7140228|NCT02969018|11294337|FG000|Overall Study|Other|0
7140229|NCT02969018|11294338|FG001|Overall Study|Other|0
7140230|NCT02969018|11294339|FG002|Overall Study|Other|0
7140231|NCT02969018|11294340|FG003|Overall Study|Other|1
7140232|NCT02969018|11294341|FG004|Overall Study|Other|0
7140233|NCT02969018|11294342|FG005|Overall Study|Other|0
7140234|NCT02969018|11294343|FG006|Overall Study|Other|0
7140235|NCT02969018|11294344|FG007|Overall Study|Other|2
7140236|NCT02969018|11294337|FG000|Overall Study|Pregnancy|0
7140237|NCT02969018|11294338|FG001|Overall Study|Pregnancy|0
7140238|NCT02969018|11294339|FG002|Overall Study|Pregnancy|0
7140239|NCT02969018|11294340|FG003|Overall Study|Pregnancy|0
7140240|NCT02969018|11294341|FG004|Overall Study|Pregnancy|0
7140241|NCT02969018|11294342|FG005|Overall Study|Pregnancy|1
7140242|NCT02969018|11294343|FG006|Overall Study|Pregnancy|0
7140243|NCT02969018|11294344|FG007|Overall Study|Pregnancy|0
7140244|NCT02969018|11294337|FG000|Overall Study|Protocol Violation|0
7140245|NCT02969018|11294338|FG001|Overall Study|Protocol Violation|0
7140246|NCT02969018|11294339|FG002|Overall Study|Protocol Violation|1
7140247|NCT02969018|11294340|FG003|Overall Study|Protocol Violation|1
7140248|NCT02969018|11294341|FG004|Overall Study|Protocol Violation|0
7140249|NCT02969018|11294342|FG005|Overall Study|Protocol Violation|0
7140250|NCT02969018|11294343|FG006|Overall Study|Protocol Violation|0
7140251|NCT02969018|11294344|FG007|Overall Study|Protocol Violation|0
7140252|NCT02969018|11294337|FG000|Overall Study|Withdrawal by Subject|0
7140253|NCT02969018|11294338|FG001|Overall Study|Withdrawal by Subject|1
7140254|NCT02969018|11294339|FG002|Overall Study|Withdrawal by Subject|2
7140255|NCT02969018|11294340|FG003|Overall Study|Withdrawal by Subject|1
7140256|NCT02969018|11294341|FG004|Overall Study|Withdrawal by Subject|0
7140257|NCT02969018|11294342|FG005|Overall Study|Withdrawal by Subject|4
7140258|NCT02969018|11294343|FG006|Overall Study|Withdrawal by Subject|4
7140259|NCT02969018|11294344|FG007|Overall Study|Withdrawal by Subject|3
7140260|NCT02969044|11294376|FG000|Overall Study|Withdrawal by Subject|2
7140261|NCT02969044|11294377|FG001|Overall Study|Withdrawal by Subject|6
7140262|NCT02969044|11294376|FG000|Overall Study|Adverse Event|3
7140263|NCT02969044|11294377|FG001|Overall Study|Adverse Event|0
7140264|NCT02969187|11294385|FG000|Overall Study|Physician Decision|12
7140265|NCT02969187|11294386|FG001|Overall Study|Physician Decision|13
7140266|NCT02969356|11294399|FG000|Overall Study|Adverse Event|7
7140267|NCT02969356|11294399|FG000|Overall Study|Consent withdrawn|2
7140268|NCT02969356|11294399|FG000|Overall Study|Lost to Follow-up|3
7140269|NCT02969356|11294399|FG000|Overall Study|Did not need to be reinjected|6
7140270|NCT02969356|11294399|FG000|Overall Study|Personal reasons|5
7140271|NCT02969382|11294405|FG000|Overall Study|Adverse Event|8
7140272|NCT02969382|11294406|FG001|Overall Study|Adverse Event|10
7140273|NCT02969382|11294405|FG000|Overall Study|Lack of Efficacy|4
7140274|NCT02969382|11294406|FG001|Overall Study|Lack of Efficacy|5
7140275|NCT02969382|11294405|FG000|Overall Study|Death|0
7140276|NCT02969382|11294406|FG001|Overall Study|Death|1
7140277|NCT02969382|11294405|FG000|Overall Study|PROTOCOL DEVIATION|0
7140278|NCT02969382|11294406|FG001|Overall Study|PROTOCOL DEVIATION|1
7140279|NCT02969382|11294405|FG000|Overall Study|Withdrawal by Subject|14
7140280|NCT02969382|11294406|FG001|Overall Study|Withdrawal by Subject|9
7140281|NCT02969408|11294412|FG000|Overall Study|Adverse Event|2
7140282|NCT02969408|11294412|FG000|Overall Study|Withdrawal by Subject|8
7140283|NCT02969408|11294412|FG000|Overall Study|Lost to Follow-up|4
7140284|NCT02969408|11294412|FG000|Overall Study|Protocol Violation|1
7140285|NCT02969408|11294412|FG000|Overall Study|Other than specified|1
7140286|NCT02969525|11294434|FG000|Double-Blind Period|Adverse Event|0
7140287|NCT02969525|11294435|FG001|Double-Blind Period|Adverse Event|0
7140288|NCT02969525|11294436|FG002|Double-Blind Period|Adverse Event|1
7140289|NCT02969525|11294437|FG003|Double-Blind Period|Adverse Event|1
7140290|NCT02969525|11294438|FG004|Double-Blind Period|Adverse Event|0
7140291|NCT02969525|11294439|FG005|Double-Blind Period|Adverse Event|0
7140292|NCT02969525|11294440|FG006|Double-Blind Period|Adverse Event|0
7140293|NCT02969525|11294441|FG007|Double-Blind Period|Adverse Event|0
7140294|NCT02969525|11294442|FG008|Double-Blind Period|Adverse Event|0
7140295|NCT02969525|11294443|FG009|Double-Blind Period|Adverse Event|0
7140296|NCT02969525|11294444|FG010|Double-Blind Period|Adverse Event|0
7140297|NCT02969525|11294445|FG011|Double-Blind Period|Adverse Event|0
7140298|NCT02969525|11294434|FG000|Double-Blind Period|LOW EGFR|0
7140299|NCT02969525|11294435|FG001|Double-Blind Period|LOW EGFR|0
7140300|NCT02969525|11294436|FG002|Double-Blind Period|LOW EGFR|0
7140301|NCT02969525|11294437|FG003|Double-Blind Period|LOW EGFR|1
7140302|NCT02969525|11294438|FG004|Double-Blind Period|LOW EGFR|0
7140303|NCT02969525|11294439|FG005|Double-Blind Period|LOW EGFR|0
7140304|NCT02969525|11294440|FG006|Double-Blind Period|LOW EGFR|0
7140305|NCT02969525|11294441|FG007|Double-Blind Period|LOW EGFR|0
7140306|NCT02969525|11294442|FG008|Double-Blind Period|LOW EGFR|0
7140307|NCT02969525|11294443|FG009|Double-Blind Period|LOW EGFR|0
7140308|NCT02969525|11294444|FG010|Double-Blind Period|LOW EGFR|0
7140309|NCT02969525|11294445|FG011|Double-Blind Period|LOW EGFR|0
7140310|NCT02969525|11294434|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2
7140311|NCT02969525|11294435|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0
7140312|NCT02969525|11294436|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0
7140313|NCT02969525|11294437|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2
7140314|NCT02969525|11294438|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0
7140315|NCT02969525|11294439|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0
7140316|NCT02969525|11294440|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0
7140317|NCT02969525|11294441|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0
7140318|NCT02969525|11294442|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0
7140319|NCT02969525|11294443|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0
7140320|NCT02969525|11294444|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0
7140321|NCT02969525|11294445|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0
7140322|NCT02969525|11294434|FG000|Dose-Blind Period|Adverse Event|0
7140323|NCT02969525|11294435|FG001|Dose-Blind Period|Adverse Event|0
7140324|NCT02969525|11294436|FG002|Dose-Blind Period|Adverse Event|0
7140325|NCT02969525|11294437|FG003|Dose-Blind Period|Adverse Event|0
7140326|NCT02969525|11294438|FG004|Dose-Blind Period|Adverse Event|0
7140327|NCT02969525|11294439|FG005|Dose-Blind Period|Adverse Event|0
7140328|NCT02969525|11294440|FG006|Dose-Blind Period|Adverse Event|0
7140329|NCT02969525|11294441|FG007|Dose-Blind Period|Adverse Event|0
7140330|NCT02969525|11294442|FG008|Dose-Blind Period|Adverse Event|0
7140331|NCT02969525|11294443|FG009|Dose-Blind Period|Adverse Event|1
7140332|NCT02969525|11294444|FG010|Dose-Blind Period|Adverse Event|1
7140333|NCT02969525|11294445|FG011|Dose-Blind Period|Adverse Event|1
7140334|NCT02969525|11294434|FG000|Dose-Blind Period|Withdrawal by Subject|0
7140335|NCT02969525|11294435|FG001|Dose-Blind Period|Withdrawal by Subject|0
7140336|NCT02969525|11294436|FG002|Dose-Blind Period|Withdrawal by Subject|0
7140337|NCT02969525|11294437|FG003|Dose-Blind Period|Withdrawal by Subject|0
7140338|NCT02969525|11294438|FG004|Dose-Blind Period|Withdrawal by Subject|0
7140339|NCT02969525|11294439|FG005|Dose-Blind Period|Withdrawal by Subject|0
7140340|NCT02969525|11294440|FG006|Dose-Blind Period|Withdrawal by Subject|2
7140341|NCT02969525|11294441|FG007|Dose-Blind Period|Withdrawal by Subject|0
7140342|NCT02969525|11294442|FG008|Dose-Blind Period|Withdrawal by Subject|1
7140343|NCT02969525|11294443|FG009|Dose-Blind Period|Withdrawal by Subject|2
7140344|NCT02969525|11294444|FG010|Dose-Blind Period|Withdrawal by Subject|0
7140345|NCT02969525|11294445|FG011|Dose-Blind Period|Withdrawal by Subject|0
7140346|NCT02969525|11294434|FG000|Dose-Blind Period|Non-cooperating patient|0
7140347|NCT02969525|11294435|FG001|Dose-Blind Period|Non-cooperating patient|0
7140348|NCT02969525|11294436|FG002|Dose-Blind Period|Non-cooperating patient|0
7140349|NCT02969525|11294437|FG003|Dose-Blind Period|Non-cooperating patient|0
7140350|NCT02969525|11294438|FG004|Dose-Blind Period|Non-cooperating patient|0
7140351|NCT02969525|11294439|FG005|Dose-Blind Period|Non-cooperating patient|0
7140352|NCT02969525|11294440|FG006|Dose-Blind Period|Non-cooperating patient|0
7140353|NCT02969525|11294441|FG007|Dose-Blind Period|Non-cooperating patient|0
7140354|NCT02969525|11294442|FG008|Dose-Blind Period|Non-cooperating patient|0
7140355|NCT02969525|11294443|FG009|Dose-Blind Period|Non-cooperating patient|0
7140356|NCT02969525|11294444|FG010|Dose-Blind Period|Non-cooperating patient|0
7140357|NCT02969525|11294445|FG011|Dose-Blind Period|Non-cooperating patient|1
7140358|NCT02969525|11294434|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7140359|NCT02969525|11294435|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7140360|NCT02969525|11294436|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7140361|NCT02969525|11294437|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7140362|NCT02969525|11294438|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7140363|NCT02969525|11294439|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7140364|NCT02969525|11294440|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7140365|NCT02969525|11294441|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7140366|NCT02969525|11294442|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7140367|NCT02969525|11294443|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7140368|NCT02969525|11294444|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1
7140369|NCT02969525|11294445|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7140370|NCT02969590|11294467|FG000|Screening Period|Hormones not suppressed post Lupron|1
7140371|NCT02969590|11294468|FG001|Screening Period|Hormones not suppressed post Lupron|0
7140372|NCT02969590|11294469|FG002|Screening Period|Hormones not suppressed post Lupron|0
7140373|NCT02969655|11294481|FG000|Overall Study|Withdrawal by Subject|3
7140374|NCT02969655|11294482|FG001|Overall Study|Withdrawal by Subject|2
7140375|NCT02969655|11294481|FG000|Overall Study|Physician Decision|4
7140376|NCT02969655|11294482|FG001|Overall Study|Physician Decision|3
7140377|NCT02969655|11294481|FG000|Overall Study|Protocol-specified withdrawal criteria|4
7140378|NCT02969655|11294482|FG001|Overall Study|Protocol-specified withdrawal criteria|2
7140379|NCT02969655|11294481|FG000|Overall Study|Adverse Event|10
7140380|NCT02969655|11294482|FG001|Overall Study|Adverse Event|8
7140381|NCT02969707|11294491|FG000|Overall Study|Adverse Event|1
7140382|NCT02969707|11294492|FG001|Overall Study|Adverse Event|2
7140383|NCT02969707|11294491|FG000|Overall Study|Lost to Follow-up|3
7140384|NCT02969707|11294492|FG001|Overall Study|Lost to Follow-up|0
7140385|NCT02969707|11294491|FG000|Overall Study|Physician Decision|0
7140386|NCT02969707|11294492|FG001|Overall Study|Physician Decision|1
7140387|NCT02969707|11294491|FG000|Overall Study|Protocol Violation|1
7140388|NCT02969707|11294492|FG001|Overall Study|Protocol Violation|1
7140389|NCT02969707|11294491|FG000|Overall Study|Withdrawal by Subject|3
7140390|NCT02969707|11294492|FG001|Overall Study|Withdrawal by Subject|4
7140391|NCT02969863|11294503|FG000|Overall Study|Physician Decision|1
7140392|NCT02969863|11294504|FG001|Overall Study|Physician Decision|0
7140393|NCT02969863|11294505|FG002|Overall Study|Physician Decision|0
7140394|NCT02969863|11294506|FG003|Overall Study|Physician Decision|0
7140395|NCT02969863|11294507|FG004|Overall Study|Physician Decision|0
7140396|NCT02969863|11294508|FG005|Overall Study|Physician Decision|0
7140397|NCT02970292|11294547|FG000|Overall Study|Physician Decision|1
7140398|NCT02970292|11294548|FG001|Overall Study|Physician Decision|1
7140399|NCT02970292|11294547|FG000|Overall Study|Withdrawal by Subject|11
7140400|NCT02970292|11294548|FG001|Overall Study|Withdrawal by Subject|5
7140401|NCT02970292|11294547|FG000|Overall Study|Noncompliance with study drug|2
7140402|NCT02970292|11294548|FG001|Overall Study|Noncompliance with study drug|2
7140403|NCT02970292|11294547|FG000|Overall Study|Adverse Event|5
7140404|NCT02970292|11294548|FG001|Overall Study|Adverse Event|0
7140405|NCT02970292|11294547|FG000|Overall Study|Lack of Efficacy|1
7140406|NCT02970292|11294548|FG001|Overall Study|Lack of Efficacy|0
7140407|NCT02970292|11294547|FG000|Overall Study|Lost to Follow-up|1
7140408|NCT02970292|11294548|FG001|Overall Study|Lost to Follow-up|0
7140409|NCT02970292|11294547|FG000|Overall Study|Protocol Violation|2
7140410|NCT02970292|11294548|FG001|Overall Study|Protocol Violation|0
7140411|NCT02970292|11294547|FG000|Overall Study|Other|1
7140412|NCT02970292|11294548|FG001|Overall Study|Other|0
7140413|NCT02970305|11294556|FG000|Overall Study|Adverse Event|10
7140414|NCT02970305|11294557|FG001|Overall Study|Adverse Event|6
7140415|NCT02970305|11294556|FG000|Overall Study|Lack of Efficacy|1
7140416|NCT02970305|11294557|FG001|Overall Study|Lack of Efficacy|1
7140417|NCT02970305|11294556|FG000|Overall Study|Noncompliance with study drug|2
7140418|NCT02970305|11294557|FG001|Overall Study|Noncompliance with study drug|4
7140419|NCT02970305|11294556|FG000|Overall Study|Protocol Violation|2
7140420|NCT02970305|11294557|FG001|Overall Study|Protocol Violation|2
7140421|NCT02970305|11294556|FG000|Overall Study|Withdrawal by Subject|12
7140422|NCT02970305|11294557|FG001|Overall Study|Withdrawal by Subject|11
7140423|NCT02970305|11294556|FG000|Overall Study|Not further specified|1
7140424|NCT02970305|11294557|FG001|Overall Study|Not further specified|2
7140425|NCT02970305|11294556|FG000|Overall Study|Lost to Follow-up|1
7140426|NCT02970305|11294557|FG001|Overall Study|Lost to Follow-up|2
7140427|NCT02970669|11294601|FG000|Double-blind Period|Adverse Event|4
7140428|NCT02970669|11294602|FG001|Double-blind Period|Adverse Event|0
7140429|NCT02970669|11294601|FG000|Double-blind Period|Death|1
7140430|NCT02970669|11294602|FG001|Double-blind Period|Death|0
7140431|NCT02970669|11294601|FG000|Double-blind Period|Study terminated by sponsor|1
7140432|NCT02970669|11294602|FG001|Double-blind Period|Study terminated by sponsor|2
7140433|NCT02970669|11294601|FG000|Double-blind Period|Physician Decision|0
7140434|NCT02970669|11294602|FG001|Double-blind Period|Physician Decision|2
7140435|NCT02970669|11294601|FG000|Double-blind Period|Withdrawal by Subject|2
7140436|NCT02970669|11294602|FG001|Double-blind Period|Withdrawal by Subject|2
7140437|NCT02970669|11294601|FG000|Open-label Period|Withdrawal by Subject|2
7140438|NCT02970669|11294602|FG001|Open-label Period|Withdrawal by Subject|2
7140439|NCT02970669|11294601|FG000|Open-label Period|Adverse Event|1
7140440|NCT02970669|11294602|FG001|Open-label Period|Adverse Event|0
7140441|NCT02970669|11294601|FG000|Open-label Period|Physician Decision|1
7140442|NCT02970669|11294602|FG001|Open-label Period|Physician Decision|0
7140443|NCT02970942|11294623|FG000|Overall Study|Death|0
7140444|NCT02970942|11294624|FG001|Overall Study|Death|1
7140445|NCT02970942|11294625|FG002|Overall Study|Death|0
7140446|NCT02970942|11294626|FG003|Overall Study|Death|0
7140447|NCT02970942|11294623|FG000|Overall Study|Lost to Follow-up|1
7140448|NCT02970942|11294624|FG001|Overall Study|Lost to Follow-up|0
7140449|NCT02970942|11294625|FG002|Overall Study|Lost to Follow-up|2
7140450|NCT02970942|11294626|FG003|Overall Study|Lost to Follow-up|1
7140451|NCT02970942|11294623|FG000|Overall Study|Withdrawal by Subject|3
7140452|NCT02970942|11294624|FG001|Overall Study|Withdrawal by Subject|5
7140453|NCT02970942|11294625|FG002|Overall Study|Withdrawal by Subject|3
7140454|NCT02970942|11294626|FG003|Overall Study|Withdrawal by Subject|2
7140455|NCT02971007|11294639|FG000|Overall Study|Adverse Event|1
7140456|NCT02971007|11294640|FG001|Overall Study|Adverse Event|0
7140457|NCT02971007|11294641|FG002|Overall Study|Adverse Event|0
7140458|NCT02971007|11294639|FG000|Overall Study|Lost to Follow-up|0
7140459|NCT02971007|11294640|FG001|Overall Study|Lost to Follow-up|1
7140460|NCT02971007|11294641|FG002|Overall Study|Lost to Follow-up|1
7140461|NCT02971007|11294639|FG000|Overall Study|Withdrawal by Subject|0
7140462|NCT02971007|11294640|FG001|Overall Study|Withdrawal by Subject|1
7140463|NCT02971007|11294641|FG002|Overall Study|Withdrawal by Subject|0
7140464|NCT02971007|11294639|FG000|Overall Study|Patient had yeast at Day 5 visit|1
7140465|NCT02971007|11294640|FG001|Overall Study|Patient had yeast at Day 5 visit|0
7140466|NCT02971007|11294641|FG002|Overall Study|Patient had yeast at Day 5 visit|0
7140467|NCT02971007|11294639|FG000|Overall Study|Patient discontinued study drug|0
7140468|NCT02971007|11294640|FG001|Overall Study|Patient discontinued study drug|1
7140469|NCT02971007|11294641|FG002|Overall Study|Patient discontinued study drug|0
7140470|NCT02971163|11294651|FG000|Overall Study|Lost to Follow-up|4
7140471|NCT02971163|11294652|FG001|Overall Study|Lost to Follow-up|2
7140472|NCT02971202|11294661|FG000|Overall Study|Pregnancy|1
7140473|NCT02971202|11294662|FG001|Overall Study|Pregnancy|0
7140474|NCT02971202|11294663|FG002|Overall Study|Pregnancy|0
7140475|NCT02971202|11294661|FG000|Overall Study|screen fail after consent|1
7140476|NCT02971202|11294662|FG001|Overall Study|screen fail after consent|0
7140477|NCT02971202|11294663|FG002|Overall Study|screen fail after consent|1
7140478|NCT02971228|11294671|FG000|Overall Study|Withdrawal by Subject|1
7140479|NCT02971228|11294672|FG001|Overall Study|Withdrawal by Subject|1
7140480|NCT02971228|11294673|FG002|Overall Study|Withdrawal by Subject|0
7140481|NCT02971228|11294674|FG003|Overall Study|Withdrawal by Subject|0
7140482|NCT02971228|11294675|FG004|Overall Study|Withdrawal by Subject|0
7140483|NCT02971228|11294671|FG000|Overall Study|Logistical challenges|0
7140484|NCT02971228|11294672|FG001|Overall Study|Logistical challenges|1
7140485|NCT02971228|11294673|FG002|Overall Study|Logistical challenges|0
7140486|NCT02971228|11294674|FG003|Overall Study|Logistical challenges|0
7140487|NCT02971228|11294675|FG004|Overall Study|Logistical challenges|0
7140488|NCT02971605|11294701|FG000|Overall Study|Withdrawal by Subject|1
7140489|NCT02971670|11294719|FG000|Overall Study|Withdrawal by Subject|4
7140490|NCT02971670|11294720|FG001|Overall Study|Withdrawal by Subject|1
7140491|NCT02971670|11294721|FG002|Overall Study|Withdrawal by Subject|1
7140492|NCT02971670|11294722|FG003|Overall Study|Withdrawal by Subject|2
7140493|NCT02971800|11294741|FG000|Overall Study|Protocol Violation|1
7140494|NCT02971800|11294741|FG000|Overall Study|Withdrawal by Subject|1
7140495|NCT02971800|11294741|FG000|Overall Study|Exclusion criteria prior intervention|1
7140496|NCT02971800|11294741|FG000|Overall Study|Number evaluable participant already reached|4
7140497|NCT02972242|11294747|FG000|Overall Study|Withdrawal by Subject|1
7140498|NCT02972242|11294748|FG001|Overall Study|Withdrawal by Subject|0
7140499|NCT02972359|11294754|FG000|Overall Study|Incl. criteria not met/Exclusion met|2
7140500|NCT02972359|11294754|FG000|Overall Study|Lack of Efficacy|1
7140501|NCT02972359|11294754|FG000|Overall Study|Adverse Event|4
7140502|NCT02972359|11294754|FG000|Overall Study|Death|1
7140503|NCT02972359|11294754|FG000|Overall Study|Withdrawal by Subject|30
7140504|NCT02972359|11294754|FG000|Overall Study|Protocol Violation|1
7140505|NCT02972359|11294754|FG000|Overall Study|Lost to Follow-up|26
7140506|NCT02972359|11294754|FG000|Overall Study|Other reasons|5
7140507|NCT02972359|11294754|FG000|Overall Study|Missing|1
7140508|NCT02972502|11294760|FG000|Overall Study|Lost to Follow-up|3
7140509|NCT02972502|11294761|FG001|Overall Study|Lost to Follow-up|1
7140510|NCT02972502|11294760|FG000|Overall Study|Withdrawal by Subject|1
7140511|NCT02972502|11294761|FG001|Overall Study|Withdrawal by Subject|1
7140512|NCT02972515|11294767|FG000|Overall Study|Lost to Follow-up|78
7140513|NCT02972632|11294780|FG000|Overall Study|Pretreatment Event/Adverse Event|3
7140514|NCT02972632|11294780|FG000|Overall Study|Lost to Follow-up|4
7140515|NCT02972632|11294780|FG000|Overall Study|Voluntary Withdrawal|10
7140516|NCT02972658|11294788|FG000|Overall Study|Adverse Event|0
7140517|NCT02972658|11294789|FG001|Overall Study|Adverse Event|3
7140518|NCT02972658|11294790|FG002|Overall Study|Adverse Event|0
7140519|NCT02972658|11294791|FG003|Overall Study|Adverse Event|2
7140520|NCT02972658|11294788|FG000|Overall Study|Other-determined by Investigator|1
7140521|NCT02972658|11294789|FG001|Overall Study|Other-determined by Investigator|1
7140522|NCT02972658|11294790|FG002|Overall Study|Other-determined by Investigator|0
7140523|NCT02972658|11294791|FG003|Overall Study|Other-determined by Investigator|0
7140524|NCT02972658|11294788|FG000|Overall Study|Death|0
7140525|NCT02972658|11294789|FG001|Overall Study|Death|0
7140526|NCT02972658|11294790|FG002|Overall Study|Death|0
7140527|NCT02972658|11294791|FG003|Overall Study|Death|1
7140528|NCT02972658|11294788|FG000|Overall Study|Lost to Follow-up|0
7140529|NCT02972658|11294789|FG001|Overall Study|Lost to Follow-up|1
7140530|NCT02972658|11294790|FG002|Overall Study|Lost to Follow-up|1
7140531|NCT02972658|11294791|FG003|Overall Study|Lost to Follow-up|2
7140532|NCT02972658|11294788|FG000|Overall Study|Progressive Disease|0
7140533|NCT02972658|11294789|FG001|Overall Study|Progressive Disease|1
7140534|NCT02972658|11294790|FG002|Overall Study|Progressive Disease|0
7140535|NCT02972658|11294791|FG003|Overall Study|Progressive Disease|1
7140536|NCT02972658|11294788|FG000|Overall Study|Withdrawal by Subject|4
7140537|NCT02972658|11294789|FG001|Overall Study|Withdrawal by Subject|4
7140538|NCT02972658|11294790|FG002|Overall Study|Withdrawal by Subject|1
7140539|NCT02972658|11294791|FG003|Overall Study|Withdrawal by Subject|6
7140540|NCT02972658|11294788|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1
7140541|NCT02972658|11294789|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1
7140542|NCT02972658|11294790|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1
7140543|NCT02972658|11294791|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0
7140544|NCT02972658|11294788|FG000|Overall Study|Sponsor Decision|70
7140545|NCT02972658|11294789|FG001|Overall Study|Sponsor Decision|127
7140546|NCT02972658|11294790|FG002|Overall Study|Sponsor Decision|72
7140547|NCT02972658|11294791|FG003|Overall Study|Sponsor Decision|119
7140548|NCT02973048|11294803|FG000|Overall Study|Epidural catheter insertion failure|1
7140549|NCT02973048|11294804|FG001|Overall Study|Epidural catheter insertion failure|0
7140550|NCT02973048|11294803|FG000|Overall Study|Withdrawal by Subject|0
7140551|NCT02973048|11294804|FG001|Overall Study|Withdrawal by Subject|3
6807695|NCT04633564|10811359|FG000|Period 1|Death|8
6807696|NCT04633564|10811360|FG001|Period 1|Death|7
6807697|NCT04633564|10811359|FG000|Period 1|Lost to Follow-up|3
6807698|NCT04633564|10811360|FG001|Period 1|Lost to Follow-up|5
6807699|NCT04633564|10811359|FG000|Period 1|Physician Decision|4
6807700|NCT04633564|10811360|FG001|Period 1|Physician Decision|12
6807701|NCT04633564|10811359|FG000|Period 1|Protocol Violation|0
6807702|NCT04633564|10811360|FG001|Period 1|Protocol Violation|1
6807703|NCT04633564|10811359|FG000|Period 1|Withdrawal by Subject|10
6807704|NCT04633564|10811360|FG001|Period 1|Withdrawal by Subject|8
6807705|NCT04633564|10811359|FG000|Period 1|Progressive disease|47
6807706|NCT04633564|10811360|FG001|Period 1|Progressive disease|51
6807707|NCT04633564|10811359|FG000|Period 1|Terminated by Sponsor|8
6807708|NCT04633564|10811360|FG001|Period 1|Terminated by Sponsor|6
6807709|NCT04633564|10811359|FG000|Period 2|Adverse Event|3
6807710|NCT04633564|10811360|FG001|Period 2|Adverse Event|4
6807711|NCT04633564|10811359|FG000|Period 2|Death|0
6807712|NCT04633564|10811360|FG001|Period 2|Death|2
6807713|NCT04633564|10811359|FG000|Period 2|Lost to Follow-up|0
6807714|NCT04633564|10811360|FG001|Period 2|Lost to Follow-up|1
6807715|NCT04633564|10811359|FG000|Period 2|Physician Decision|2
6807716|NCT04633564|10811360|FG001|Period 2|Physician Decision|4
6807717|NCT04633564|10811359|FG000|Period 2|Withdrawal by Subject|5
6807718|NCT04633564|10811360|FG001|Period 2|Withdrawal by Subject|1
6807719|NCT04633564|10811359|FG000|Period 2|Progressive Disease|74
6807720|NCT04633564|10811360|FG001|Period 2|Progressive Disease|82
6807721|NCT04633564|10811359|FG000|Period 2|Terminated by Sponsor|9
6807722|NCT04633564|10811360|FG001|Period 2|Terminated by Sponsor|3
6810853|NCT02499328|10814777|FG009|Overall Study|"Other"|16
6810854|NCT02499328|10814778|FG010|Overall Study|"Other"|13
6810855|NCT02499328|10814779|FG011|Overall Study|"Other"|31
6810856|NCT02499328|10814780|FG012|Overall Study|"Other"|8
6810857|NCT02499328|10814781|FG013|Overall Study|"Other"|7
6810858|NCT02499328|10814782|FG014|Overall Study|"Other"|6
6810859|NCT02499328|10814783|FG015|Overall Study|"Other"|0
6810860|NCT02499328|10814784|FG016|Overall Study|"Other"|0
6810861|NCT02499328|10814785|FG017|Overall Study|"Other"|34
6810862|NCT02499328|10814786|FG018|Overall Study|"Other"|43
6810863|NCT02499328|10814768|FG000|Overall Study|Disease Progression|0
6810864|NCT02499328|10814769|FG001|Overall Study|Disease Progression|0
6810865|NCT02499328|10814770|FG002|Overall Study|Disease Progression|0
6810866|NCT02499328|10814771|FG003|Overall Study|Disease Progression|0
6810867|NCT02499328|10814772|FG004|Overall Study|Disease Progression|0
6810868|NCT02499328|10814773|FG005|Overall Study|Disease Progression|0
6810869|NCT02499328|10814774|FG006|Overall Study|Disease Progression|1
6810870|NCT02499328|10814775|FG007|Overall Study|Disease Progression|0
6810871|NCT02499328|10814776|FG008|Overall Study|Disease Progression|1
6810872|NCT02499328|10814777|FG009|Overall Study|Disease Progression|0
6810873|NCT02499328|10814778|FG010|Overall Study|Disease Progression|1
6810874|NCT02499328|10814779|FG011|Overall Study|Disease Progression|0
6810875|NCT02499328|10814780|FG012|Overall Study|Disease Progression|0
6810876|NCT02499328|10814781|FG013|Overall Study|Disease Progression|0
6810877|NCT02499328|10814782|FG014|Overall Study|Disease Progression|0
6810878|NCT02499328|10814783|FG015|Overall Study|Disease Progression|0
6810879|NCT02499328|10814784|FG016|Overall Study|Disease Progression|0
6810880|NCT02499328|10814785|FG017|Overall Study|Disease Progression|2
6810881|NCT02499328|10814786|FG018|Overall Study|Disease Progression|0
6810882|NCT02499328|10814768|FG000|Overall Study|Adverse Event|1
6810883|NCT02499328|10814769|FG001|Overall Study|Adverse Event|0
6810884|NCT02499328|10814770|FG002|Overall Study|Adverse Event|0
6810885|NCT02499328|10814771|FG003|Overall Study|Adverse Event|1
6810886|NCT02499328|10814772|FG004|Overall Study|Adverse Event|0
6810887|NCT02499328|10814773|FG005|Overall Study|Adverse Event|0
6810888|NCT02499328|10814774|FG006|Overall Study|Adverse Event|0
6810889|NCT02499328|10814775|FG007|Overall Study|Adverse Event|0
6810890|NCT02499328|10814776|FG008|Overall Study|Adverse Event|0
6810891|NCT02499328|10814777|FG009|Overall Study|Adverse Event|0
6810892|NCT02499328|10814778|FG010|Overall Study|Adverse Event|0
6810893|NCT02499328|10814779|FG011|Overall Study|Adverse Event|0
6810894|NCT02499328|10814780|FG012|Overall Study|Adverse Event|1
6810895|NCT02499328|10814781|FG013|Overall Study|Adverse Event|0
6810896|NCT02499328|10814782|FG014|Overall Study|Adverse Event|0
6810897|NCT02499328|10814783|FG015|Overall Study|Adverse Event|0
6810898|NCT02499328|10814784|FG016|Overall Study|Adverse Event|0
6810899|NCT02499328|10814785|FG017|Overall Study|Adverse Event|0
6810900|NCT02499328|10814786|FG018|Overall Study|Adverse Event|0
6810901|NCT02460224|10814907|FG000|Overall Study|Adverse Event|0
6810902|NCT02460224|10814908|FG001|Overall Study|Adverse Event|0
6810903|NCT02460224|10814909|FG002|Overall Study|Adverse Event|0
6810904|NCT02460224|10814910|FG003|Overall Study|Adverse Event|0
6810905|NCT02460224|10814911|FG004|Overall Study|Adverse Event|0
6810906|NCT02460224|10814912|FG005|Overall Study|Adverse Event|0
6810907|NCT02460224|10814913|FG006|Overall Study|Adverse Event|1
6810908|NCT02460224|10814914|FG007|Overall Study|Adverse Event|0
6810909|NCT02460224|10814915|FG008|Overall Study|Adverse Event|0
6810910|NCT02460224|10814916|FG009|Overall Study|Adverse Event|0
6810911|NCT02460224|10814917|FG010|Overall Study|Adverse Event|0
6807723|NCT04191148|10811381|FG000|Overall Study|Withdrawal by Subject|1
6807724|NCT04191148|10811382|FG001|Overall Study|Withdrawal by Subject|0
6807725|NCT04191148|10811381|FG000|Overall Study|Adverse Event|1
6807726|NCT04191148|10811382|FG001|Overall Study|Adverse Event|0
6807727|NCT04022733|10811415|FG000|Overall Study|conversion to open surgery|3
6807728|NCT04022733|10811416|FG001|Overall Study|conversion to open surgery|2
6807729|NCT04022733|10811415|FG000|Overall Study|bradycardia|0
6807730|NCT04022733|10811416|FG001|Overall Study|bradycardia|1
6807731|NCT04021524|10811424|FG000|Overall Study|Change in surgical intervention|0
6807732|NCT04021524|10811425|FG001|Overall Study|Change in surgical intervention|1
6807733|NCT03605680|10811449|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6
6807734|NCT03605680|10811450|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0
6807735|NCT03605680|10811451|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0
6807736|NCT03605680|10811452|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0
6807737|NCT03605680|10811449|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1
6807738|NCT03605680|10811450|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0
6807739|NCT03605680|10811451|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0
6807740|NCT03605680|10811452|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0
6807741|NCT03605680|10811449|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9
6807742|NCT03605680|10811450|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0
6807743|NCT03605680|10811451|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0
6807744|NCT03605680|10811452|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0
6807745|NCT03605680|10811449|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3
6807746|NCT03605680|10811450|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0
6807747|NCT03605680|10811451|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0
6807748|NCT03605680|10811452|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0
6807749|NCT03605680|10811449|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13
6807750|NCT03605680|10811450|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0
6807751|NCT03605680|10811451|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0
6791393|NCT04311463|10788907|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1
6791394|NCT04311463|10788908|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0
6791395|NCT04311463|10788907|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1
6791396|NCT04311463|10788908|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1
6791397|NCT04311463|10788907|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2
6791398|NCT04311463|10788908|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1
6791399|NCT03930186|10788924|FG000|Weeks 0 to 16|Adverse Event|6
6791400|NCT03930186|10788924|FG000|Weeks 0 to 16|Withdrawal by Subject|6
6791401|NCT03930186|10788924|FG000|Weeks 16 to 32|Adverse Event|1
6791402|NCT03930186|10788924|FG000|Weeks 16 to 32|Withdrawal by Subject|3
6791403|NCT03740100|10788928|FG000|Overall Study|Adverse Event|1
6791404|NCT03740100|10788928|FG000|Overall Study|Death|1
6791487|NCT02603432|10789015|FG000|Overall Study|Progressive Disease|5
6791488|NCT02603432|10789016|FG001|Overall Study|Progressive Disease|5
6791489|NCT02603432|10789015|FG000|Overall Study|Withdrawal by Subject|9
6791490|NCT02603432|10789016|FG001|Overall Study|Withdrawal by Subject|17
6791491|NCT02603432|10789015|FG000|Overall Study|No Longer Meets Eligibility Criteria|3
6791492|NCT02603432|10789016|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
6791493|NCT02603432|10789015|FG000|Overall Study|Other|0
6791494|NCT02603432|10789016|FG001|Overall Study|Other|1
6791495|NCT02600923|10789022|FG000|Overall Study|Death|10
6791496|NCT02600923|10789022|FG000|Overall Study|Adverse Event|3
6791497|NCT02600923|10789022|FG000|Overall Study|Global deterioration of health status|2
6791498|NCT02600923|10789022|FG000|Overall Study|Insufficient clinical response|6
6791499|NCT02600923|10789022|FG000|Overall Study|Lost to Follow-up|1
6791500|NCT02600923|10789022|FG000|Overall Study|Withdrawal by Subject|5
6791501|NCT02600923|10789022|FG000|Overall Study|Objective progression or relapse|50
6791502|NCT02600923|10789022|FG000|Overall Study|Study terminated by Sponsor|53
6791503|NCT02600923|10789022|FG000|Overall Study|Not treated|1
6791504|NCT02412735|10789047|FG000|Overall Study|Adverse Event|0
6791505|NCT02412735|10789048|FG001|Overall Study|Adverse Event|1
6791506|NCT02412735|10789049|FG002|Overall Study|Adverse Event|2
6791507|NCT02412735|10789047|FG000|Overall Study|Withdrawal by Subject|23
6791508|NCT02412735|10789048|FG001|Overall Study|Withdrawal by Subject|27
6791509|NCT02412735|10789049|FG002|Overall Study|Withdrawal by Subject|22
6791510|NCT02412735|10789047|FG000|Overall Study|Investigator Decision|3
6791511|NCT02412735|10789048|FG001|Overall Study|Investigator Decision|3
6791512|NCT02412735|10789049|FG002|Overall Study|Investigator Decision|2
6791513|NCT02412735|10789047|FG000|Overall Study|Lost to Follow-up|17
6791514|NCT02412735|10789048|FG001|Overall Study|Lost to Follow-up|11
6791515|NCT02412735|10789049|FG002|Overall Study|Lost to Follow-up|18
6791516|NCT02412735|10789047|FG000|Overall Study|Reason not Specified|3
6791517|NCT02412735|10789048|FG001|Overall Study|Reason not Specified|2
6791518|NCT02412735|10789049|FG002|Overall Study|Reason not Specified|2
6791519|NCT02371889|10789059|FG000|Overall Study|Adverse medication effect|11
6791520|NCT02371889|10789060|FG001|Overall Study|Adverse medication effect|2
6791521|NCT02371889|10789059|FG000|Overall Study|Lost to Follow-up|6
6791522|NCT02371889|10789060|FG001|Overall Study|Lost to Follow-up|5
6791523|NCT02371889|10789059|FG000|Overall Study|Personal time constraints|2
6791524|NCT02371889|10789060|FG001|Overall Study|Personal time constraints|4
6791525|NCT02371889|10789059|FG000|Overall Study|Lack of Efficacy|0
6791526|NCT02371889|10789060|FG001|Overall Study|Lack of Efficacy|2
6791527|NCT02371889|10789059|FG000|Overall Study|Relapse|0
6791528|NCT02371889|10789060|FG001|Overall Study|Relapse|1
6791405|NCT03597295|10788932|FG000|Overall Study|Death|37
6791406|NCT03597295|10788932|FG000|Overall Study|Lost to Follow-up|3
6791407|NCT03597295|10788932|FG000|Overall Study|Participants ongoing in the study|54
6791438|NCT02849626|10788972|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11
6791439|NCT02849626|10788973|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3
6791440|NCT02849626|10788972|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7
6791441|NCT02849626|10788973|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2
6791442|NCT02849626|10788972|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6
6791443|NCT02849626|10788973|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2
6791444|NCT02849626|10788972|FG000|Core Phase (up to 23 Weeks)|Non-specified|3
6791445|NCT02849626|10788973|FG001|Core Phase (up to 23 Weeks)|Non-specified|0
6791446|NCT02849626|10788972|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3
6791447|NCT02849626|10788973|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2
6791448|NCT02849626|10788972|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4
6791449|NCT02849626|10788973|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0
6791450|NCT02849626|10788972|FG000|Extension Phase A (up to 29 Weeks)|Inadequate therapeutic effect|3
6791451|NCT02849626|10788973|FG001|Extension Phase A (up to 29 Weeks)|Inadequate therapeutic effect|1
6791452|NCT02849626|10788972|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1
6791453|NCT02849626|10788973|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0
6791457|NCT02654132|10789005|FG000|Overall Study|Disease Progression|26
6791458|NCT02654132|10789006|FG001|Overall Study|Disease Progression|31
6791459|NCT02654132|10789005|FG000|Overall Study|Adverse Event Unrelated to Study Drug|5
6791460|NCT02654132|10789006|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5
6791461|NCT02654132|10789005|FG000|Overall Study|Switched to another tx|0
6791462|NCT02654132|10789006|FG001|Overall Study|Switched to another tx|1
6791463|NCT02654132|10789005|FG000|Overall Study|Study Drug Toxicity|1
6791464|NCT02654132|10789006|FG001|Overall Study|Study Drug Toxicity|2
6791465|NCT02654132|10789005|FG000|Overall Study|Maximum Clinical Benefit|0
6791466|NCT02654132|10789006|FG001|Overall Study|Maximum Clinical Benefit|2
6791467|NCT02654132|10789005|FG000|Overall Study|Subj Request to Discontinue Treatment|1
6791468|NCT02654132|10789006|FG001|Overall Study|Subj Request to Discontinue Treatment|0
6791469|NCT02654132|10789005|FG000|Overall Study|Not Reported|0
6791470|NCT02654132|10789006|FG001|Overall Study|Not Reported|1
6791471|NCT02654132|10789005|FG000|Overall Study|Subject Withdrew Consent|2
6791472|NCT02654132|10789006|FG001|Overall Study|Subject Withdrew Consent|1
6791473|NCT02654132|10789005|FG000|Overall Study|Inadequate response to therapy|1
6791474|NCT02654132|10789006|FG001|Overall Study|Inadequate response to therapy|0
6791475|NCT02654132|10789005|FG000|Overall Study|Clinical Progression (not protocol)|0
6791476|NCT02654132|10789006|FG001|Overall Study|Clinical Progression (not protocol)|1
6791477|NCT02654132|10789005|FG000|Overall Study|Never treated|0
6791478|NCT02654132|10789006|FG001|Overall Study|Never treated|2
6791479|NCT02603432|10789015|FG000|Overall Study|Ongoing|184
6791480|NCT02603432|10789016|FG001|Overall Study|Ongoing|144
6791481|NCT02603432|10789015|FG000|Overall Study|Adverse Event|1
6791482|NCT02603432|10789016|FG001|Overall Study|Adverse Event|0
6791483|NCT02603432|10789015|FG000|Overall Study|Death|144
6791484|NCT02603432|10789016|FG001|Overall Study|Death|177
6791485|NCT02603432|10789015|FG000|Overall Study|Lost to Follow-up|4
6791486|NCT02603432|10789016|FG001|Overall Study|Lost to Follow-up|6
6791557|NCT02100722|10789104|FG000|Overall Study|Withdrawal pre-procedure|4
6791558|NCT02100722|10789105|FG001|Overall Study|Withdrawal pre-procedure|9
6791559|NCT02100722|10789104|FG000|Overall Study|Withdrawal post-procedure|0
6791560|NCT02100722|10789105|FG001|Overall Study|Withdrawal post-procedure|3
6791561|NCT02100722|10789104|FG000|Overall Study|Lost to Follow-up|2
6791562|NCT02100722|10789105|FG001|Overall Study|Lost to Follow-up|2
6791563|NCT02100722|10789104|FG000|Overall Study|Continuing on study|751
6791564|NCT02100722|10789105|FG001|Overall Study|Continuing on study|729
6791565|NCT02046096|10789114|FG000|Overall Study|Death|28
6791566|NCT02046096|10789115|FG001|Overall Study|Death|45
6791567|NCT02046096|10789114|FG000|Overall Study|Lost to Follow-up|9
6791568|NCT02046096|10789115|FG001|Overall Study|Lost to Follow-up|20
6791569|NCT02046096|10789114|FG000|Overall Study|Withdrawal by Subject|5
6791570|NCT02046096|10789115|FG001|Overall Study|Withdrawal by Subject|17
6791571|NCT02046096|10789114|FG000|Overall Study|Other endpoint|2
6791572|NCT02046096|10789115|FG001|Overall Study|Other endpoint|19
6791573|NCT01945775|10789125|FG000|Overall Study|Death|214
6791574|NCT01945775|10789126|FG001|Overall Study|Death|98
6791575|NCT01945775|10789125|FG000|Overall Study|Lost to Follow-up|12
6791576|NCT01945775|10789126|FG001|Overall Study|Lost to Follow-up|7
6791577|NCT01945775|10789125|FG000|Overall Study|Withdrawal by Subject|11
6791578|NCT01945775|10789126|FG001|Overall Study|Withdrawal by Subject|21
6791579|NCT01945775|10789125|FG000|Overall Study|Other|50
6791580|NCT01945775|10789126|FG001|Overall Study|Other|18
6791581|NCT01781637|10789134|FG000|Overall Study|Adverse Event|1
6791582|NCT01781637|10789135|FG001|Overall Study|Adverse Event|0
6791583|NCT01781637|10789134|FG000|Overall Study|Lack of Efficacy|2
6791584|NCT01781637|10789135|FG001|Overall Study|Lack of Efficacy|6
6791585|NCT01781637|10789134|FG000|Overall Study|Withdrawal by Subject|1
6791586|NCT01781637|10789135|FG001|Overall Study|Withdrawal by Subject|0
6791597|NCT01670539|10789167|FG000|Overall Study|Death|3
6791598|NCT01670539|10789168|FG001|Overall Study|Death|5
6791599|NCT01670539|10789167|FG000|Overall Study|Withdrawal by Subject|3
6791600|NCT01670539|10789168|FG001|Overall Study|Withdrawal by Subject|0
6807752|NCT03605680|10811452|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0
6807753|NCT03605680|10811449|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12
6807754|NCT03605680|10811450|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0
6807755|NCT03605680|10811451|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0
6807756|NCT03605680|10811452|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0
6807757|NCT03605680|10811449|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1
6807758|NCT03605680|10811450|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0
6807759|NCT03605680|10811451|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0
6807760|NCT03605680|10811452|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0
6807761|NCT03605680|10811449|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6
6807762|NCT03605680|10811450|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0
6807763|NCT03605680|10811451|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0
6807764|NCT03605680|10811452|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0
6807765|NCT03605680|10811449|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87
6807766|NCT03605680|10811450|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0
6807767|NCT03605680|10811451|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0
6807768|NCT03605680|10811452|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0
6807769|NCT03605680|10811449|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0
6807770|NCT03605680|10811450|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5
6807771|NCT03605680|10811451|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7
6807772|NCT03605680|10811452|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8
6807773|NCT03605680|10811449|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0
6807774|NCT03605680|10811450|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8
6807775|NCT03605680|10811451|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8
6807776|NCT03605680|10811452|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3
6807777|NCT03605680|10811449|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0
6807778|NCT03605680|10811450|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0
6807779|NCT03605680|10811451|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0
6807780|NCT03605680|10811452|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1
6807781|NCT03605680|10811449|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0
6807782|NCT03605680|10811450|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3
6807783|NCT03605680|10811451|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4
6791601|NCT00407602|10789175|FG000|Overall Study|Death - unrelated to device|1
6791602|NCT00407602|10789175|FG000|Overall Study|Device explanted|5
6791603|NCT00407602|10789175|FG000|Overall Study|Withdrawal by Subject|1
6791604|NCT04567186|10789195|FG000|Period 1|COVID-19 related|1
6791605|NCT04567186|10789196|FG001|Period 1|COVID-19 related|0
6791606|NCT04567186|10789195|FG000|Period 1|Protocol Violation|0
6791607|NCT04567186|10789196|FG001|Period 1|Protocol Violation|1
6791608|NCT04567186|10789195|FG000|Period 1|Adverse Event|0
6791609|NCT04567186|10789196|FG001|Period 1|Adverse Event|2
6791610|NCT04567186|10789195|FG000|Period 2|COVID-19 Related|0
6791611|NCT04567186|10789196|FG001|Period 2|COVID-19 Related|1
6791612|NCT04567186|10789195|FG000|Period 2|Protocol Violation|0
6791613|NCT04567186|10789196|FG001|Period 2|Protocol Violation|1
6791614|NCT04567186|10789195|FG000|Period 2|Lost to Follow-up|0
6791615|NCT04567186|10789196|FG001|Period 2|Lost to Follow-up|1
6791616|NCT04567186|10789195|FG000|Period 3|Subject no longer meets eligibilty criteria|1
6791617|NCT04567186|10789196|FG001|Period 3|Subject no longer meets eligibilty criteria|0
6791618|NCT04065074|10789202|FG000|Overall Study|Adverse Event|1
6791619|NCT04065074|10789202|FG000|Overall Study|Protocol Non-Compliance after injection|1
6791620|NCT03980730|10789208|FG000|Overall Study|Study Terminated by Sponsor|0
6791621|NCT03980730|10789209|FG001|Overall Study|Study Terminated by Sponsor|3
6791622|NCT03980730|10789208|FG000|Overall Study|Adverse Event|2
6791623|NCT03980730|10789209|FG001|Overall Study|Adverse Event|0
6791624|NCT03980730|10789208|FG000|Overall Study|Sponsor Request|0
6791625|NCT03980730|10789209|FG001|Overall Study|Sponsor Request|1
6791626|NCT03793010|10789217|FG000|Overall Study|Withdrawal by Subject|5
6791627|NCT03793010|10789218|FG001|Overall Study|Withdrawal by Subject|7
6791628|NCT03793010|10789217|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19
6810912|NCT02460224|10814918|FG011|Overall Study|Adverse Event|0
6791629|NCT03793010|10789218|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18
6791630|NCT03793010|10789217|FG000|Overall Study|Lost to Follow-up|1
6791631|NCT03793010|10789218|FG001|Overall Study|Lost to Follow-up|2
6791632|NCT03793010|10789217|FG000|Overall Study|Patient couldn't sit still for injection|1
6791633|NCT03793010|10789218|FG001|Overall Study|Patient couldn't sit still for injection|0
6791634|NCT03793010|10789217|FG000|Overall Study|Withdrew to pursue other treatment|1
6791635|NCT03793010|10789218|FG001|Overall Study|Withdrew to pursue other treatment|0
6791636|NCT03793010|10789217|FG000|Overall Study|Did not meet eligibility criteria|1
6791637|NCT03793010|10789218|FG001|Overall Study|Did not meet eligibility criteria|0
6807784|NCT03605680|10811452|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3
6807785|NCT03605680|10811449|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0
6807786|NCT03605680|10811450|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3
6807787|NCT03605680|10811451|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1
6807788|NCT03605680|10811452|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2
6807789|NCT03605680|10811449|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0
6807790|NCT03605680|10811450|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14
6807791|NCT03605680|10811451|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7
6807792|NCT03605680|10811452|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5
6807793|NCT03605680|10811449|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0
6807794|NCT03605680|10811450|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4
6807795|NCT03605680|10811451|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4
6807796|NCT03605680|10811452|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7
6807797|NCT03605680|10811449|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0
6807798|NCT03605680|10811450|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1
6807799|NCT03605680|10811451|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2
6807800|NCT03605680|10811452|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0
6807801|NCT03605680|10811449|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0
6807802|NCT03605680|10811450|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5
6807803|NCT03605680|10811451|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4
6807804|NCT03605680|10811452|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3
6807805|NCT03605680|10811449|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0
6807806|NCT03605680|10811450|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1
6807807|NCT03605680|10811451|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2
6807808|NCT03605680|10811452|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3
6807809|NCT03485950|10811463|FG000|Overall Study|Adverse Event|1
6807810|NCT03485950|10811464|FG001|Overall Study|Adverse Event|0
6807811|NCT03485950|10811463|FG000|Overall Study|Death|3
6807812|NCT03485950|10811464|FG001|Overall Study|Death|2
6807813|NCT03485950|10811463|FG000|Overall Study|Withdrawal by Subject|3
6807814|NCT03485950|10811464|FG001|Overall Study|Withdrawal by Subject|0
6810913|NCT02460224|10814919|FG012|Overall Study|Adverse Event|1
6810914|NCT02460224|10814920|FG013|Overall Study|Adverse Event|0
6810915|NCT02460224|10814921|FG014|Overall Study|Adverse Event|0
6810916|NCT02460224|10814922|FG015|Overall Study|Adverse Event|0
6810917|NCT02460224|10814923|FG016|Overall Study|Adverse Event|1
6810918|NCT02460224|10814924|FG017|Overall Study|Adverse Event|0
6810919|NCT02460224|10814925|FG018|Overall Study|Adverse Event|1
6810920|NCT02460224|10814926|FG019|Overall Study|Adverse Event|0
6810921|NCT02460224|10814927|FG020|Overall Study|Adverse Event|1
6810922|NCT02460224|10814928|FG021|Overall Study|Adverse Event|1
6810923|NCT02460224|10814929|FG022|Overall Study|Adverse Event|1
6810924|NCT02460224|10814930|FG023|Overall Study|Adverse Event|0
6810925|NCT02460224|10814931|FG024|Overall Study|Adverse Event|0
6810926|NCT02460224|10814932|FG025|Overall Study|Adverse Event|0
6810927|NCT02460224|10814933|FG026|Overall Study|Adverse Event|11
6810928|NCT02460224|10814934|FG027|Overall Study|Adverse Event|1
6810929|NCT02460224|10814935|FG028|Overall Study|Adverse Event|6
6810930|NCT02460224|10814907|FG000|Overall Study|Death|0
6810931|NCT02460224|10814908|FG001|Overall Study|Death|0
6810932|NCT02460224|10814909|FG002|Overall Study|Death|0
6810933|NCT02460224|10814910|FG003|Overall Study|Death|0
6810934|NCT02460224|10814911|FG004|Overall Study|Death|0
6810935|NCT02460224|10814912|FG005|Overall Study|Death|2
6810936|NCT02460224|10814913|FG006|Overall Study|Death|1
6810937|NCT02460224|10814914|FG007|Overall Study|Death|0
6810938|NCT02460224|10814915|FG008|Overall Study|Death|0
6810939|NCT02460224|10814916|FG009|Overall Study|Death|1
6810940|NCT02460224|10814917|FG010|Overall Study|Death|0
6810941|NCT02460224|10814918|FG011|Overall Study|Death|0
6810942|NCT02460224|10814919|FG012|Overall Study|Death|0
6810943|NCT02460224|10814920|FG013|Overall Study|Death|1
6810944|NCT02460224|10814921|FG014|Overall Study|Death|0
6810945|NCT02460224|10814922|FG015|Overall Study|Death|0
6810946|NCT02460224|10814923|FG016|Overall Study|Death|2
6810947|NCT02460224|10814924|FG017|Overall Study|Death|1
6810948|NCT02460224|10814925|FG018|Overall Study|Death|0
6810949|NCT02460224|10814926|FG019|Overall Study|Death|2
6810950|NCT02460224|10814927|FG020|Overall Study|Death|0
6810951|NCT02460224|10814928|FG021|Overall Study|Death|0
6810952|NCT02460224|10814929|FG022|Overall Study|Death|0
6791638|NCT03644017|10789224|FG000|Overall Study|Access Abandonment|5
6791639|NCT03644017|10789224|FG000|Overall Study|Kidney Transplant|2
6791640|NCT03592186|10789230|FG000|Overall Study|Withdrawal by Subject|1
6791641|NCT03592186|10789231|FG001|Overall Study|Withdrawal by Subject|0
6791642|NCT03592186|10789230|FG000|Overall Study|Lost to Follow-up|16
6791643|NCT03592186|10789231|FG001|Overall Study|Lost to Follow-up|11
6791644|NCT03529942|10789237|FG000|Overall Study|Withdrawal by Subject|13
6791645|NCT03529942|10789237|FG000|Overall Study|Physician Decision|1
6791646|NCT03529942|10789237|FG000|Overall Study|Lost to Follow-up|7
6791647|NCT03529942|10789237|FG000|Overall Study|Needle inserted but no drug administered|1
6791648|NCT03529942|10789237|FG000|Overall Study|Personal reasons|1
6791649|NCT03349775|10789246|FG000|Overall Study|Side Effects|1
6791650|NCT03349775|10789247|FG001|Overall Study|Side Effects|2
6791651|NCT03349775|10789246|FG000|Overall Study|Withdrawal by Subject|1
6791652|NCT03349775|10789247|FG001|Overall Study|Withdrawal by Subject|1
6791653|NCT03349775|10789246|FG000|Overall Study|No primary outcome measurements|0
6791654|NCT03349775|10789247|FG001|Overall Study|No primary outcome measurements|1
6791655|NCT03256344|10789264|FG000|Overall Study|Ongoing on study|3
6791656|NCT03256344|10789265|FG001|Overall Study|Ongoing on study|3
6791657|NCT03256344|10789264|FG000|Overall Study|Death|5
6791658|NCT03256344|10789265|FG001|Overall Study|Death|19
6791659|NCT03256344|10789264|FG000|Overall Study|Withdrawal by Subject|3
6791660|NCT03256344|10789265|FG001|Overall Study|Withdrawal by Subject|3
6791661|NCT03207815|10789273|FG000|Overall Study|Protocol Violation|3
6791662|NCT03207815|10789274|FG001|Overall Study|Protocol Violation|1
6791663|NCT03207815|10789273|FG000|Overall Study|Adverse Event|1
6791664|NCT03207815|10789274|FG001|Overall Study|Adverse Event|2
6791665|NCT03207815|10789273|FG000|Overall Study|Lost to Follow-up|1
6791666|NCT03207815|10789274|FG001|Overall Study|Lost to Follow-up|2
6791667|NCT03207815|10789273|FG000|Overall Study|Investigator's Discretion|1
6791668|NCT03207815|10789274|FG001|Overall Study|Investigator's Discretion|1
6791669|NCT03207815|10789273|FG000|Overall Study|Lack of Efficacy|0
6791670|NCT03207815|10789274|FG001|Overall Study|Lack of Efficacy|1
6791671|NCT03207815|10789273|FG000|Overall Study|Pregnancy/Partner Pregnancy|1
6791672|NCT03207815|10789274|FG001|Overall Study|Pregnancy/Partner Pregnancy|0
6791673|NCT03207815|10789273|FG000|Overall Study|Withdrew Consent|1
6791674|NCT03207815|10789274|FG001|Overall Study|Withdrew Consent|0
6791675|NCT02968563|10789300|FG000|Overall Study|Adverse Event|0
6791676|NCT02968563|10789301|FG001|Overall Study|Adverse Event|6
6791677|NCT02968563|10789300|FG000|Overall Study|Death|1
6791678|NCT02968563|10789301|FG001|Overall Study|Death|1
6791679|NCT02968563|10789300|FG000|Overall Study|Lost to Follow-up|0
6791680|NCT02968563|10789301|FG001|Overall Study|Lost to Follow-up|1
6791681|NCT02915783|10789307|FG000|Overall Study|Ongoing: Receiving Treatment|6
6791682|NCT02915783|10789307|FG000|Overall Study|Ongoing: In Survival Follow Up|8
6791683|NCT02913482|10789314|FG000|Overall Study|Death|0
6791684|NCT02913482|10789315|FG001|Overall Study|Death|2
6791685|NCT02913482|10789316|FG002|Overall Study|Death|2
6791686|NCT02913482|10789314|FG000|Overall Study|Progressive Disease|1
6791687|NCT02913482|10789315|FG001|Overall Study|Progressive Disease|1
6791688|NCT02913482|10789316|FG002|Overall Study|Progressive Disease|1
6791689|NCT02787044|10789328|FG000|Overall Study|Lost to Follow-up|15
6791690|NCT02787044|10789329|FG001|Overall Study|Lost to Follow-up|19
6791691|NCT02698163|10789341|FG000|Overall Study|Lost to Follow-up|0
6791692|NCT02698163|10789342|FG001|Overall Study|Lost to Follow-up|1
6807815|NCT03404518|10811472|FG000|Overall Study|Lost to Follow-up|28
6807816|NCT03404518|10811473|FG001|Overall Study|Lost to Follow-up|30
6807817|NCT03404518|10811472|FG000|Overall Study|Protocol Violation|13
6807818|NCT03404518|10811473|FG001|Overall Study|Protocol Violation|6
6807819|NCT03289143|10811503|FG000|Overall Study|Caregiver Unavailability|1
6807820|NCT03289143|10811504|FG001|Overall Study|Caregiver Unavailability|1
6807821|NCT03289143|10811505|FG002|Overall Study|Caregiver Unavailability|0
6807822|NCT03289143|10811506|FG003|Overall Study|Caregiver Unavailability|0
6807823|NCT03289143|10811503|FG000|Overall Study|Research Department Closure|0
6807824|NCT03289143|10811504|FG001|Overall Study|Research Department Closure|0
6807825|NCT03289143|10811505|FG002|Overall Study|Research Department Closure|1
6807826|NCT03289143|10811506|FG003|Overall Study|Research Department Closure|0
6807827|NCT03289143|10811503|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0
6807828|NCT03289143|10811504|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0
6807829|NCT03289143|10811505|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1
6807830|NCT03289143|10811506|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0
6807831|NCT03289143|10811503|FG000|Overall Study|Medical Monitor Decision|1
6807832|NCT03289143|10811504|FG001|Overall Study|Medical Monitor Decision|0
6807833|NCT03289143|10811505|FG002|Overall Study|Medical Monitor Decision|0
6791693|NCT01816165|10789369|FG000|Overall Study|Adverse Event|1
6791694|NCT01816165|10789370|FG001|Overall Study|Adverse Event|0
6791695|NCT01816165|10789371|FG002|Overall Study|Adverse Event|0
6791696|NCT01816165|10789372|FG003|Overall Study|Adverse Event|0
6791697|NCT01813929|10789394|FG000|Overall Study|Withdrawal by Subject|0
6791698|NCT01813929|10789395|FG001|Overall Study|Withdrawal by Subject|1
6791699|NCT00882050|10789416|FG000|Overall Study|Physician Decision|1
6791700|NCT00882050|10789417|FG001|Overall Study|Physician Decision|0
6791701|NCT00882050|10789418|FG002|Overall Study|Physician Decision|0
6791702|NCT00070564|10789432|FG000|Overall Study|Progression|2
6791703|NCT00070564|10789433|FG001|Overall Study|Progression|4
6791704|NCT00070564|10789434|FG002|Overall Study|Progression|7
6791705|NCT00070564|10789435|FG003|Overall Study|Progression|7
6791706|NCT00070564|10789436|FG004|Overall Study|Progression|1
6791707|NCT00070564|10789437|FG005|Overall Study|Progression|0
6791708|NCT00070564|10789432|FG000|Overall Study|Delinquent|1
6791709|NCT00070564|10789433|FG001|Overall Study|Delinquent|4
6791710|NCT00070564|10789434|FG002|Overall Study|Delinquent|2
6791711|NCT00070564|10789435|FG003|Overall Study|Delinquent|0
6791712|NCT00070564|10789436|FG004|Overall Study|Delinquent|0
6791713|NCT00070564|10789437|FG005|Overall Study|Delinquent|0
6791714|NCT00070564|10789432|FG000|Overall Study|Adverse Event|150
6791715|NCT00070564|10789433|FG001|Overall Study|Adverse Event|142
6791716|NCT00070564|10789434|FG002|Overall Study|Adverse Event|120
6791717|NCT00070564|10789435|FG003|Overall Study|Adverse Event|108
6791718|NCT00070564|10789436|FG004|Overall Study|Adverse Event|63
6791719|NCT00070564|10789437|FG005|Overall Study|Adverse Event|36
6791720|NCT00070564|10789432|FG000|Overall Study|Death|4
6791721|NCT00070564|10789433|FG001|Overall Study|Death|1
6791722|NCT00070564|10789434|FG002|Overall Study|Death|5
6791723|NCT00070564|10789435|FG003|Overall Study|Death|3
6791724|NCT00070564|10789436|FG004|Overall Study|Death|0
6791725|NCT00070564|10789437|FG005|Overall Study|Death|1
6791726|NCT00070564|10789432|FG000|Overall Study|Other, not protocol specified|17
6791727|NCT00070564|10789433|FG001|Overall Study|Other, not protocol specified|15
6791728|NCT00070564|10789434|FG002|Overall Study|Other, not protocol specified|14
6791729|NCT00070564|10789435|FG003|Overall Study|Other, not protocol specified|19
6791730|NCT00070564|10789436|FG004|Overall Study|Other, not protocol specified|6
6791731|NCT00070564|10789437|FG005|Overall Study|Other, not protocol specified|7
6791732|NCT00070564|10789432|FG000|Overall Study|Withdrawal by Subject|26
6791733|NCT00070564|10789433|FG001|Overall Study|Withdrawal by Subject|37
6791734|NCT00070564|10789434|FG002|Overall Study|Withdrawal by Subject|23
6791735|NCT00070564|10789435|FG003|Overall Study|Withdrawal by Subject|30
6791736|NCT00070564|10789436|FG004|Overall Study|Withdrawal by Subject|8
6791737|NCT00070564|10789437|FG005|Overall Study|Withdrawal by Subject|8
6791738|NCT00070564|10789432|FG000|Overall Study|Not reported|0
6791739|NCT00070564|10789433|FG001|Overall Study|Not reported|0
6791740|NCT00070564|10789434|FG002|Overall Study|Not reported|0
6791741|NCT00070564|10789435|FG003|Overall Study|Not reported|0
6791742|NCT00070564|10789436|FG004|Overall Study|Not reported|1
6791743|NCT00070564|10789437|FG005|Overall Study|Not reported|0
6791744|NCT04425720|10789468|FG000|Overall Study|Withdrawal by Subject|0
6791745|NCT04425720|10789469|FG001|Overall Study|Withdrawal by Subject|20
6791746|NCT04409509|10789478|FG000|Overall Study|Failure to meet randomization requirement|1
6791747|NCT04409509|10789479|FG001|Overall Study|Failure to meet randomization requirement|0
6791748|NCT04409509|10789478|FG000|Overall Study|Adverse Event|0
6791749|NCT04409509|10789479|FG001|Overall Study|Adverse Event|1
6791750|NCT04409509|10789478|FG000|Overall Study|Death|11
6791751|NCT04409509|10789479|FG001|Overall Study|Death|10
6791752|NCT04409509|10789478|FG000|Overall Study|Non-compliance with study drug|0
6791753|NCT04409509|10789479|FG001|Overall Study|Non-compliance with study drug|1
6791754|NCT04409509|10789478|FG000|Overall Study|Lost to Follow-up|0
6791755|NCT04409509|10789479|FG001|Overall Study|Lost to Follow-up|3
6791756|NCT04409509|10789478|FG000|Overall Study|Withdrawal by Subject|0
6791757|NCT04409509|10789479|FG001|Overall Study|Withdrawal by Subject|3
6791758|NCT04409509|10789478|FG000|Overall Study|Randomized by mistake|0
6791759|NCT04409509|10789479|FG001|Overall Study|Randomized by mistake|1
6791760|NCT04409509|10789478|FG000|Overall Study|Other|1
6791761|NCT04409509|10789479|FG001|Overall Study|Other|1
6791762|NCT04380519|10789489|FG000|Overall Study|Withdrawal by Subject|4
6791763|NCT04380519|10789490|FG001|Overall Study|Withdrawal by Subject|0
6791764|NCT04380519|10789491|FG002|Overall Study|Withdrawal by Subject|1
6791765|NCT04380519|10789489|FG000|Overall Study|Death|14
6791766|NCT04380519|10789490|FG001|Overall Study|Death|9
6791767|NCT04380519|10789491|FG002|Overall Study|Death|6
6791768|NCT04380519|10789489|FG000|Overall Study|Adverse Event|0
6791769|NCT04380519|10789490|FG001|Overall Study|Adverse Event|1
6791770|NCT04380519|10789491|FG002|Overall Study|Adverse Event|0
6791771|NCT04380519|10789489|FG000|Overall Study|relatives' decision|0
6791772|NCT04380519|10789490|FG001|Overall Study|relatives' decision|1
6791773|NCT04380519|10789491|FG002|Overall Study|relatives' decision|0
6791784|NCT03922321|10789560|FG000|Overall Study|Participant Moved|1
6791785|NCT03922321|10789560|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1
6791786|NCT03911713|10789569|FG000|Overall Study|Lost to Follow-up|0
6791787|NCT03911713|10789570|FG001|Overall Study|Lost to Follow-up|2
6791788|NCT03911713|10789571|FG002|Overall Study|Lost to Follow-up|0
6791789|NCT03911713|10789572|FG003|Overall Study|Lost to Follow-up|0
6791774|NCT04362813|10789501|FG000|Overall Study|Death|12
6791775|NCT04362813|10789502|FG001|Overall Study|Death|16
6791776|NCT04362813|10789501|FG000|Overall Study|Withdrawal by Subject|3
6791777|NCT04362813|10789502|FG001|Overall Study|Withdrawal by Subject|1
6791778|NCT04362813|10789501|FG000|Overall Study|Protocol Violation|0
6791779|NCT04362813|10789502|FG001|Overall Study|Protocol Violation|3
6791780|NCT04362813|10789501|FG000|Overall Study|Lost to Follow-up|1
6791781|NCT04362813|10789502|FG001|Overall Study|Lost to Follow-up|1
6791782|NCT04362813|10789501|FG000|Overall Study|Enrolled but did not receive treatment|2
6791783|NCT04362813|10789502|FG001|Overall Study|Enrolled but did not receive treatment|4
6791790|NCT03911713|10789573|FG004|Overall Study|Lost to Follow-up|0
6791791|NCT03911713|10789569|FG000|Overall Study|Other|0
6791792|NCT03911713|10789570|FG001|Overall Study|Other|0
6791793|NCT03911713|10789571|FG002|Overall Study|Other|0
6791794|NCT03911713|10789572|FG003|Overall Study|Other|1
6791795|NCT03911713|10789573|FG004|Overall Study|Other|0
6791796|NCT03911713|10789569|FG000|Overall Study|Randomized, Never Dosed|1
6791797|NCT03911713|10789570|FG001|Overall Study|Randomized, Never Dosed|0
6791798|NCT03911713|10789571|FG002|Overall Study|Randomized, Never Dosed|0
6791799|NCT03911713|10789572|FG003|Overall Study|Randomized, Never Dosed|1
6791800|NCT03911713|10789573|FG004|Overall Study|Randomized, Never Dosed|0
6791801|NCT03852459|10789598|FG000|Overall Study|Adverse Event|2
6791802|NCT03852459|10789599|FG001|Overall Study|Adverse Event|2
6791803|NCT03852459|10789598|FG000|Overall Study|Withdrawal by Subject|1
6791804|NCT03852459|10789599|FG001|Overall Study|Withdrawal by Subject|1
6791805|NCT03740919|10789608|FG000|Lead-in Period|Lost to Follow-up|1
6791806|NCT03740919|10789609|FG001|Lead-in Period|Lost to Follow-up|0
6791807|NCT03740919|10789610|FG002|Lead-in Period|Lost to Follow-up|0
6791808|NCT03740919|10789611|FG003|Lead-in Period|Lost to Follow-up|0
6791809|NCT03740919|10789608|FG000|Lead-in Period|Physician Decision|2
6791810|NCT03740919|10789609|FG001|Lead-in Period|Physician Decision|0
6791811|NCT03740919|10789610|FG002|Lead-in Period|Physician Decision|0
6791812|NCT03740919|10789611|FG003|Lead-in Period|Physician Decision|0
6791813|NCT03740919|10789608|FG000|Lead-in Period|Protocol Violation|1
6791814|NCT03740919|10789609|FG001|Lead-in Period|Protocol Violation|0
6791815|NCT03740919|10789610|FG002|Lead-in Period|Protocol Violation|0
6791816|NCT03740919|10789611|FG003|Lead-in Period|Protocol Violation|0
6791817|NCT03740919|10789608|FG000|Lead-in Period|Withdrawal by Subject|10
6791818|NCT03740919|10789609|FG001|Lead-in Period|Withdrawal by Subject|0
6791819|NCT03740919|10789610|FG002|Lead-in Period|Withdrawal by Subject|0
6791820|NCT03740919|10789611|FG003|Lead-in Period|Withdrawal by Subject|0
6791821|NCT03740919|10789608|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18
6791822|NCT03740919|10789609|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0
6791823|NCT03740919|10789610|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0
6791824|NCT03740919|10789611|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0
6791825|NCT03740919|10789608|FG000|Lead-in Period|Study Task Too Burdensome|1
6791826|NCT03740919|10789609|FG001|Lead-in Period|Study Task Too Burdensome|0
6791827|NCT03740919|10789610|FG002|Lead-in Period|Study Task Too Burdensome|0
6791828|NCT03740919|10789611|FG003|Lead-in Period|Study Task Too Burdensome|0
6791829|NCT03740919|10789608|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1
6791830|NCT03740919|10789609|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0
6791831|NCT03740919|10789610|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0
6791832|NCT03740919|10789611|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0
6791833|NCT03740919|10789608|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1
6791834|NCT03740919|10789609|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0
6791835|NCT03740919|10789610|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0
6791836|NCT03740919|10789611|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0
6791837|NCT03740919|10789608|FG000|Treatment Period|Adverse Event|0
6791838|NCT03740919|10789609|FG001|Treatment Period|Adverse Event|0
6791839|NCT03740919|10789610|FG002|Treatment Period|Adverse Event|2
6791840|NCT03740919|10789611|FG003|Treatment Period|Adverse Event|0
6791841|NCT03740919|10789608|FG000|Treatment Period|Protocol Violation|0
6791842|NCT03740919|10789609|FG001|Treatment Period|Protocol Violation|1
6791843|NCT03740919|10789610|FG002|Treatment Period|Protocol Violation|0
6791844|NCT03740919|10789611|FG003|Treatment Period|Protocol Violation|0
6791845|NCT03740919|10789608|FG000|Treatment Period|Withdrawal by Subject|0
6791846|NCT03740919|10789609|FG001|Treatment Period|Withdrawal by Subject|7
6791847|NCT03740919|10789610|FG002|Treatment Period|Withdrawal by Subject|6
6791848|NCT03740919|10789611|FG003|Treatment Period|Withdrawal by Subject|2
6791849|NCT03740919|10789608|FG000|Treatment Period|Terminated by Sponsor|0
6791850|NCT03740919|10789609|FG001|Treatment Period|Terminated by Sponsor|1
6791851|NCT03740919|10789610|FG002|Treatment Period|Terminated by Sponsor|0
6791852|NCT03740919|10789611|FG003|Treatment Period|Terminated by Sponsor|0
6791853|NCT03740919|10789608|FG000|Treatment Period|Issue with Insulin Pump|0
6791854|NCT03740919|10789609|FG001|Treatment Period|Issue with Insulin Pump|1
6791855|NCT03740919|10789610|FG002|Treatment Period|Issue with Insulin Pump|0
6791856|NCT03740919|10789611|FG003|Treatment Period|Issue with Insulin Pump|0
6791857|NCT03740919|10789608|FG000|Treatment Period|Due to COVID-19 Pandemic|0
6791858|NCT03740919|10789609|FG001|Treatment Period|Due to COVID-19 Pandemic|0
6791859|NCT03740919|10789610|FG002|Treatment Period|Due to COVID-19 Pandemic|3
6791860|NCT03740919|10789611|FG003|Treatment Period|Due to COVID-19 Pandemic|1
6791861|NCT03740919|10789608|FG000|Treatment Period|Failure of Inclusion Criteria|0
6791862|NCT03740919|10789609|FG001|Treatment Period|Failure of Inclusion Criteria|0
6791863|NCT03740919|10789610|FG002|Treatment Period|Failure of Inclusion Criteria|1
6791864|NCT03740919|10789611|FG003|Treatment Period|Failure of Inclusion Criteria|0
6791865|NCT03740919|10789608|FG000|Treatment Period|Not Completing Diary|0
6791866|NCT03740919|10789609|FG001|Treatment Period|Not Completing Diary|0
6791867|NCT03740919|10789610|FG002|Treatment Period|Not Completing Diary|1
6791868|NCT03740919|10789611|FG003|Treatment Period|Not Completing Diary|0
6791869|NCT03740919|10789608|FG000|Treatment Period|Insulin Painful to Participant|0
6791870|NCT03740919|10789609|FG001|Treatment Period|Insulin Painful to Participant|0
6791871|NCT03740919|10789610|FG002|Treatment Period|Insulin Painful to Participant|1
6791872|NCT03740919|10789611|FG003|Treatment Period|Insulin Painful to Participant|0
6791873|NCT03647488|10789645|FG000|Overall Study|Progressive disease|10
6791874|NCT03647488|10789646|FG001|Overall Study|Progressive disease|0
6791875|NCT03647488|10789647|FG002|Overall Study|Progressive disease|0
6791876|NCT03647488|10789645|FG000|Overall Study|Adverse Event|5
6791877|NCT03647488|10789646|FG001|Overall Study|Adverse Event|0
6791878|NCT03647488|10789647|FG002|Overall Study|Adverse Event|0
6791879|NCT03647488|10789645|FG000|Overall Study|Clinical progression|2
6791880|NCT03647488|10789646|FG001|Overall Study|Clinical progression|0
6791881|NCT03647488|10789647|FG002|Overall Study|Clinical progression|0
6791882|NCT03647488|10789645|FG000|Overall Study|Participant refused to take investigational product|1
6791883|NCT03647488|10789646|FG001|Overall Study|Participant refused to take investigational product|0
6791884|NCT03647488|10789647|FG002|Overall Study|Participant refused to take investigational product|0
6791885|NCT03614923|10789656|FG000|Overall Study|Withdrawal by Subject|2
6791886|NCT03614923|10789657|FG001|Overall Study|Withdrawal by Subject|1
6791887|NCT03614923|10789658|FG002|Overall Study|Withdrawal by Subject|1
6791888|NCT03614923|10789656|FG000|Overall Study|Adverse Event|0
6791889|NCT03614923|10789657|FG001|Overall Study|Adverse Event|2
6791890|NCT03614923|10789658|FG002|Overall Study|Adverse Event|1
6791891|NCT03614923|10789656|FG000|Overall Study|Lost to Follow-up|1
6791892|NCT03614923|10789657|FG001|Overall Study|Lost to Follow-up|0
6791893|NCT03614923|10789658|FG002|Overall Study|Lost to Follow-up|1
6791894|NCT03614923|10789656|FG000|Overall Study|Lack of Efficacy|2
6791895|NCT03614923|10789657|FG001|Overall Study|Lack of Efficacy|0
6791896|NCT03614923|10789658|FG002|Overall Study|Lack of Efficacy|1
6791897|NCT03614923|10789656|FG000|Overall Study|Non-compliance|0
6791898|NCT03614923|10789657|FG001|Overall Study|Non-compliance|1
6791899|NCT03614923|10789658|FG002|Overall Study|Non-compliance|0
6791900|NCT03614923|10789656|FG000|Overall Study|Other|0
6791901|NCT03614923|10789657|FG001|Overall Study|Other|1
6791902|NCT03614923|10789658|FG002|Overall Study|Other|1
6791903|NCT03502187|10789669|FG000|Overall Study|Withdrawal by Subject|4
6791904|NCT03502187|10789670|FG001|Overall Study|Withdrawal by Subject|3
6791905|NCT03502187|10789671|FG002|Overall Study|Withdrawal by Subject|3
6791906|NCT03502187|10789669|FG000|Overall Study|Lost to Follow-up|5
6791907|NCT03502187|10789670|FG001|Overall Study|Lost to Follow-up|4
6791908|NCT03502187|10789671|FG002|Overall Study|Lost to Follow-up|5
6807834|NCT03289143|10811506|FG003|Overall Study|Medical Monitor Decision|0
6807835|NCT03289143|10811503|FG000|Overall Study|Participant Non-Compliance|0
6807836|NCT03289143|10811504|FG001|Overall Study|Participant Non-Compliance|0
6807837|NCT03289143|10811505|FG002|Overall Study|Participant Non-Compliance|1
6807838|NCT03289143|10811506|FG003|Overall Study|Participant Non-Compliance|0
6807839|NCT03289143|10811503|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0
6807840|NCT03289143|10811504|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0
6807841|NCT03289143|10811505|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1
6807842|NCT03289143|10811506|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0
6807843|NCT03289143|10811503|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0
6807844|NCT03289143|10811504|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0
6807845|NCT03289143|10811505|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1
6807846|NCT03289143|10811506|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0
6807847|NCT03289143|10811503|FG000|Overall Study|Caregiver Passed Away|1
6807848|NCT03289143|10811504|FG001|Overall Study|Caregiver Passed Away|0
6807849|NCT03289143|10811505|FG002|Overall Study|Caregiver Passed Away|0
6807850|NCT03289143|10811506|FG003|Overall Study|Caregiver Passed Away|0
6807851|NCT03289143|10811503|FG000|Overall Study|Physician Decision|0
6807852|NCT03289143|10811504|FG001|Overall Study|Physician Decision|2
6807853|NCT03289143|10811505|FG002|Overall Study|Physician Decision|2
6807854|NCT03289143|10811506|FG003|Overall Study|Physician Decision|2
6807855|NCT03289143|10811503|FG000|Overall Study|Protocol Deviation|2
6807856|NCT03289143|10811504|FG001|Overall Study|Protocol Deviation|1
6807857|NCT03289143|10811505|FG002|Overall Study|Protocol Deviation|3
6807858|NCT03289143|10811506|FG003|Overall Study|Protocol Deviation|1
6807859|NCT03289143|10811503|FG000|Overall Study|Study Terminated By Sponsor|101
6807860|NCT03289143|10811504|FG001|Overall Study|Study Terminated By Sponsor|75
6807861|NCT03289143|10811505|FG002|Overall Study|Study Terminated By Sponsor|100
6807862|NCT03289143|10811506|FG003|Overall Study|Study Terminated By Sponsor|69
6807863|NCT03289143|10811503|FG000|Overall Study|Withdrawal by Subject|14
6807864|NCT03289143|10811504|FG001|Overall Study|Withdrawal by Subject|6
6791909|NCT03447262|10789679|FG000|Overall Study|Adverse Event|7
6791910|NCT03447262|10789679|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2
6791911|NCT03447262|10789679|FG000|Overall Study|Commercial Drug is Available for Participant|9
6791912|NCT03447262|10789679|FG000|Overall Study|Death|2
6791913|NCT03447262|10789679|FG000|Overall Study|Study Termination by Sponsor|455
6791914|NCT03447262|10789679|FG000|Overall Study|Other|4
6791915|NCT03432819|10789688|FG000|Overall Study|Lost to Follow-up|2
6791916|NCT03432819|10789689|FG001|Overall Study|Lost to Follow-up|2
6791917|NCT03432819|10789688|FG000|Overall Study|Withdrawal by Subject|5
6791918|NCT03432819|10789689|FG001|Overall Study|Withdrawal by Subject|3
6791919|NCT03323749|10789697|FG000|Double-blind Period|Lost to Follow-up|4
6791920|NCT03323749|10789698|FG001|Double-blind Period|Lost to Follow-up|5
6791921|NCT03323749|10789697|FG000|Double-blind Period|Adverse Event|3
6791922|NCT03323749|10789698|FG001|Double-blind Period|Adverse Event|1
6791923|NCT03323749|10789697|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83
6791924|NCT03323749|10789698|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88
6791925|NCT03323749|10789697|FG000|Open-Label Period|Adverse Event|3
6791926|NCT03323749|10789698|FG001|Open-Label Period|Adverse Event|10
6791927|NCT03323749|10789697|FG000|Open-Label Period|Withdrawal by Subject|7
6791928|NCT03323749|10789698|FG001|Open-Label Period|Withdrawal by Subject|5
6791929|NCT03322566|10789711|FG000|Overall Study|Death|34
6791930|NCT03322566|10789712|FG001|Overall Study|Death|35
6791931|NCT03322566|10789713|FG002|Overall Study|Death|23
6791932|NCT03322566|10789711|FG000|Overall Study|Physician Decision|6
6791933|NCT03322566|10789712|FG001|Overall Study|Physician Decision|7
6791934|NCT03322566|10789713|FG002|Overall Study|Physician Decision|2
6791935|NCT03322566|10789711|FG000|Overall Study|Withdrawal by Subject|4
6791936|NCT03322566|10789712|FG001|Overall Study|Withdrawal by Subject|3
6791937|NCT03322566|10789713|FG002|Overall Study|Withdrawal by Subject|6
6791938|NCT03322566|10789711|FG000|Overall Study|Lost to Follow-up|0
6791939|NCT03322566|10789712|FG001|Overall Study|Lost to Follow-up|0
6791940|NCT03322566|10789713|FG002|Overall Study|Lost to Follow-up|1
6791941|NCT03322566|10789711|FG000|Overall Study|Study terminated by sponsor|1
6791942|NCT03322566|10789712|FG001|Overall Study|Study terminated by sponsor|0
6791943|NCT03322566|10789713|FG002|Overall Study|Study terminated by sponsor|1
6791944|NCT03322540|10789723|FG000|Overall Study|Death|21
6791945|NCT03322540|10789724|FG001|Overall Study|Death|28
6791946|NCT03322540|10789723|FG000|Overall Study|Lost to Follow-up|0
6791947|NCT03322540|10789724|FG001|Overall Study|Lost to Follow-up|1
6791948|NCT03322540|10789723|FG000|Overall Study|Physician Decision|7
6791949|NCT03322540|10789724|FG001|Overall Study|Physician Decision|6
6791950|NCT03322540|10789723|FG000|Overall Study|Withdrawal by Subject|3
6791951|NCT03322540|10789724|FG001|Overall Study|Withdrawal by Subject|1
6791952|NCT03322540|10789723|FG000|Overall Study|Study terminated by sponsor|0
6791953|NCT03322540|10789724|FG001|Overall Study|Study terminated by sponsor|1
6791954|NCT03189719|10789743|FG000|Overall Study|Death|260
6791955|NCT03189719|10789744|FG001|Overall Study|Death|308
6791956|NCT03189719|10789743|FG000|Overall Study|Withdrawal by Subject|5
6791957|NCT03189719|10789744|FG001|Overall Study|Withdrawal by Subject|3
6791958|NCT03189719|10789743|FG000|Overall Study|Ongoing in Study|108
6791959|NCT03189719|10789744|FG001|Overall Study|Ongoing in Study|65
6791960|NCT03155997|10789752|FG000|Overall Study|Withdrawal by Subject|119
6791961|NCT03155997|10789753|FG001|Overall Study|Withdrawal by Subject|134
6791962|NCT03155997|10789752|FG000|Overall Study|Lost to Follow-up|12
6791963|NCT03155997|10789753|FG001|Overall Study|Lost to Follow-up|13
6791964|NCT03155997|10789752|FG000|Overall Study|Missing disposition data|0
6791965|NCT03155997|10789753|FG001|Overall Study|Missing disposition data|1
6791966|NCT03155997|10789752|FG000|Overall Study|On study treatment|2027
6791967|NCT03155997|10789753|FG001|Overall Study|On study treatment|2074
6791968|NCT03104400|10789763|FG000|Overall Study|Adverse Event|5
6791969|NCT03104400|10789764|FG001|Overall Study|Adverse Event|7
6791970|NCT03104400|10789765|FG002|Overall Study|Adverse Event|11
6791971|NCT03104400|10789766|FG003|Overall Study|Adverse Event|9
6791972|NCT03104400|10789767|FG004|Overall Study|Adverse Event|21
6791973|NCT03104400|10789763|FG000|Overall Study|Withdrawal by Subject|17
6791974|NCT03104400|10789764|FG001|Overall Study|Withdrawal by Subject|19
6791975|NCT03104400|10789765|FG002|Overall Study|Withdrawal by Subject|29
6791976|NCT03104400|10789766|FG003|Overall Study|Withdrawal by Subject|25
6791977|NCT03104400|10789767|FG004|Overall Study|Withdrawal by Subject|24
6791978|NCT03104400|10789763|FG000|Overall Study|Lost to Follow-up|4
6791979|NCT03104400|10789764|FG001|Overall Study|Lost to Follow-up|1
6791980|NCT03104400|10789765|FG002|Overall Study|Lost to Follow-up|4
6791981|NCT03104400|10789766|FG003|Overall Study|Lost to Follow-up|8
6791982|NCT03104400|10789767|FG004|Overall Study|Lost to Follow-up|7
6791983|NCT03104400|10789763|FG000|Overall Study|Lack of Efficacy|6
6791984|NCT03104400|10789764|FG001|Overall Study|Lack of Efficacy|3
6791985|NCT03104400|10789765|FG002|Overall Study|Lack of Efficacy|8
6791986|NCT03104400|10789766|FG003|Overall Study|Lack of Efficacy|2
6791987|NCT03104400|10789767|FG004|Overall Study|Lack of Efficacy|1
6791988|NCT03104400|10789763|FG000|Overall Study|COVID Logistical Restrictions|0
6791989|NCT03104400|10789764|FG001|Overall Study|COVID Logistical Restrictions|0
6791990|NCT03104400|10789765|FG002|Overall Study|COVID Logistical Restrictions|0
6791991|NCT03104400|10789766|FG003|Overall Study|COVID Logistical Restrictions|1
6791992|NCT03104400|10789767|FG004|Overall Study|COVID Logistical Restrictions|0
6791993|NCT03104400|10789763|FG000|Overall Study|Other|2
6791994|NCT03104400|10789764|FG001|Overall Study|Other|3
6791995|NCT03104400|10789765|FG002|Overall Study|Other|7
6791996|NCT03104400|10789766|FG003|Overall Study|Other|6
6791997|NCT03104400|10789767|FG004|Overall Study|Other|4
6791998|NCT03104400|10789763|FG000|Overall Study|Other|0
6791999|NCT03104400|10789764|FG001|Overall Study|Other|1
6792000|NCT03104400|10789765|FG002|Overall Study|Other|0
6792001|NCT03104400|10789766|FG003|Overall Study|Other|0
6792002|NCT03104400|10789767|FG004|Overall Study|Other|0
6792003|NCT03104374|10789784|FG000|Overall Study|Adverse Event|7
6792004|NCT03104374|10789785|FG001|Overall Study|Adverse Event|6
6792005|NCT03104374|10789786|FG002|Overall Study|Adverse Event|12
6792006|NCT03104374|10789787|FG003|Overall Study|Adverse Event|15
6792007|NCT03104374|10789784|FG000|Overall Study|Withdrawal by Subject|18
6792008|NCT03104374|10789785|FG001|Overall Study|Withdrawal by Subject|10
6792009|NCT03104374|10789786|FG002|Overall Study|Withdrawal by Subject|10
6792010|NCT03104374|10789787|FG003|Overall Study|Withdrawal by Subject|17
6792011|NCT03104374|10789784|FG000|Overall Study|Lost to Follow-up|4
6792012|NCT03104374|10789785|FG001|Overall Study|Lost to Follow-up|4
6792013|NCT03104374|10789786|FG002|Overall Study|Lost to Follow-up|6
6792014|NCT03104374|10789787|FG003|Overall Study|Lost to Follow-up|8
6792015|NCT03104374|10789784|FG000|Overall Study|Lack of Efficacy|6
6792016|NCT03104374|10789785|FG001|Overall Study|Lack of Efficacy|7
6792017|NCT03104374|10789786|FG002|Overall Study|Lack of Efficacy|12
6792018|NCT03104374|10789787|FG003|Overall Study|Lack of Efficacy|6
6792019|NCT03104374|10789784|FG000|Overall Study|Other|2
6792020|NCT03104374|10789785|FG001|Overall Study|Other|2
6792021|NCT03104374|10789786|FG002|Overall Study|Other|4
6792022|NCT03104374|10789787|FG003|Overall Study|Other|7
6792023|NCT03072043|10789800|FG000|Overall Study|Death|0
6792024|NCT03072043|10789801|FG001|Overall Study|Death|0
6792025|NCT03072043|10789802|FG002|Overall Study|Death|3
6792026|NCT03072043|10789800|FG000|Overall Study|Adverse Event|0
6792027|NCT03072043|10789801|FG001|Overall Study|Adverse Event|0
6792028|NCT03072043|10789802|FG002|Overall Study|Adverse Event|2
6792029|NCT03072043|10789800|FG000|Overall Study|Withdrawal by Subject|0
6792030|NCT03072043|10789801|FG001|Overall Study|Withdrawal by Subject|0
6792031|NCT03072043|10789802|FG002|Overall Study|Withdrawal by Subject|4
6792032|NCT02905032|10789830|FG000|Overall Study|Withdrawal by Subject|2
6792033|NCT02905032|10789831|FG001|Overall Study|Withdrawal by Subject|0
6792034|NCT02905032|10789832|FG002|Overall Study|Withdrawal by Subject|0
6792035|NCT02905032|10789830|FG000|Overall Study|Protocol Violation|6
6792036|NCT02905032|10789831|FG001|Overall Study|Protocol Violation|12
6792037|NCT02905032|10789832|FG002|Overall Study|Protocol Violation|0
6792038|NCT02837029|10789842|FG000|Screening|Failed to meet screening requirements.|7
6792039|NCT02837029|10789843|FG001|Screening|Failed to meet screening requirements.|3
6792040|NCT02837029|10789844|FG002|Screening|Failed to meet screening requirements.|0
6792041|NCT02837029|10789842|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2
6792042|NCT02837029|10789843|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0
6792043|NCT02837029|10789844|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0
6792044|NCT02837029|10789842|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0
6792045|NCT02837029|10789843|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2
6792046|NCT02837029|10789844|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0
6792047|NCT02837029|10789842|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0
6792048|NCT02837029|10789843|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1
6792049|NCT02837029|10789844|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0
6792050|NCT02837029|10789842|FG000|Cycle 2 and Beyond|Adverse Event|1
6792051|NCT02837029|10789843|FG001|Cycle 2 and Beyond|Adverse Event|0
6792052|NCT02837029|10789844|FG002|Cycle 2 and Beyond|Adverse Event|0
6792053|NCT02837029|10789842|FG000|2 Year Follow-up|Death|6
6792054|NCT02837029|10789843|FG001|2 Year Follow-up|Death|7
6792055|NCT02837029|10789844|FG002|2 Year Follow-up|Death|0
6792056|NCT02737475|10789899|FG000|Overall Study|Other reasons|0
6792057|NCT02737475|10789900|FG001|Overall Study|Other reasons|0
6792058|NCT02737475|10789901|FG002|Overall Study|Other reasons|0
6792059|NCT02737475|10789902|FG003|Overall Study|Other reasons|0
6792060|NCT02737475|10789903|FG004|Overall Study|Other reasons|1
6792061|NCT02737475|10789904|FG005|Overall Study|Other reasons|1
6792062|NCT02737475|10789905|FG006|Overall Study|Other reasons|0
6792063|NCT02737475|10789906|FG007|Overall Study|Other reasons|0
6792064|NCT02737475|10789907|FG008|Overall Study|Other reasons|1
6792065|NCT02737475|10789908|FG009|Overall Study|Other reasons|0
6792066|NCT02737475|10789909|FG010|Overall Study|Other reasons|1
6792067|NCT02737475|10789910|FG011|Overall Study|Other reasons|0
6792068|NCT02737475|10789911|FG012|Overall Study|Other reasons|0
6792069|NCT02737475|10789912|FG013|Overall Study|Other reasons|0
6792070|NCT02737475|10789913|FG014|Overall Study|Other reasons|0
6792071|NCT02737475|10789914|FG015|Overall Study|Other reasons|0
6792072|NCT02737475|10789915|FG016|Overall Study|Other reasons|0
6792073|NCT02737475|10789916|FG017|Overall Study|Other reasons|0
6792074|NCT02737475|10789917|FG018|Overall Study|Other reasons|0
6792075|NCT02737475|10789918|FG019|Overall Study|Other reasons|0
6792076|NCT02737475|10789919|FG020|Overall Study|Other reasons|0
6792077|NCT02737475|10789920|FG021|Overall Study|Other reasons|1
6792078|NCT02737475|10789921|FG022|Overall Study|Other reasons|0
6792079|NCT02737475|10789922|FG023|Overall Study|Other reasons|1
6792080|NCT02737475|10789923|FG024|Overall Study|Other reasons|1
6792081|NCT02737475|10789924|FG025|Overall Study|Other reasons|1
6792082|NCT02737475|10789925|FG026|Overall Study|Other reasons|0
6792083|NCT02737475|10789899|FG000|Overall Study|Death|1
6792084|NCT02737475|10789900|FG001|Overall Study|Death|0
6792085|NCT02737475|10789901|FG002|Overall Study|Death|0
6792086|NCT02737475|10789902|FG003|Overall Study|Death|1
6792087|NCT02737475|10789903|FG004|Overall Study|Death|0
6792088|NCT02737475|10789904|FG005|Overall Study|Death|0
6792089|NCT02737475|10789905|FG006|Overall Study|Death|0
6792090|NCT02737475|10789906|FG007|Overall Study|Death|2
6792091|NCT02737475|10789907|FG008|Overall Study|Death|0
6792092|NCT02737475|10789908|FG009|Overall Study|Death|0
6792093|NCT02737475|10789909|FG010|Overall Study|Death|0
6792094|NCT02737475|10789910|FG011|Overall Study|Death|4
6792095|NCT02737475|10789911|FG012|Overall Study|Death|2
6792096|NCT02737475|10789912|FG013|Overall Study|Death|2
6792097|NCT02737475|10789913|FG014|Overall Study|Death|0
6792098|NCT02737475|10789914|FG015|Overall Study|Death|2
6792099|NCT02737475|10789915|FG016|Overall Study|Death|2
6792100|NCT02737475|10789916|FG017|Overall Study|Death|2
6792101|NCT02737475|10789917|FG018|Overall Study|Death|1
6792102|NCT02737475|10789918|FG019|Overall Study|Death|0
6792103|NCT02737475|10789919|FG020|Overall Study|Death|0
6792104|NCT02737475|10789920|FG021|Overall Study|Death|0
6792105|NCT02737475|10789921|FG022|Overall Study|Death|0
6792106|NCT02737475|10789922|FG023|Overall Study|Death|0
6792107|NCT02737475|10789923|FG024|Overall Study|Death|0
6792108|NCT02737475|10789924|FG025|Overall Study|Death|0
6792109|NCT02737475|10789925|FG026|Overall Study|Death|0
6792110|NCT02737475|10789899|FG000|Overall Study|Participant withdrew consent|0
6792111|NCT02737475|10789900|FG001|Overall Study|Participant withdrew consent|0
6792112|NCT02737475|10789901|FG002|Overall Study|Participant withdrew consent|0
6792113|NCT02737475|10789902|FG003|Overall Study|Participant withdrew consent|0
6792114|NCT02737475|10789903|FG004|Overall Study|Participant withdrew consent|0
6792115|NCT02737475|10789904|FG005|Overall Study|Participant withdrew consent|2
6792116|NCT02737475|10789905|FG006|Overall Study|Participant withdrew consent|0
6792117|NCT02737475|10789906|FG007|Overall Study|Participant withdrew consent|0
6792118|NCT02737475|10789907|FG008|Overall Study|Participant withdrew consent|0
6792119|NCT02737475|10789908|FG009|Overall Study|Participant withdrew consent|0
6792120|NCT02737475|10789909|FG010|Overall Study|Participant withdrew consent|0
6792121|NCT02737475|10789910|FG011|Overall Study|Participant withdrew consent|0
6792122|NCT02737475|10789911|FG012|Overall Study|Participant withdrew consent|0
6792123|NCT02737475|10789912|FG013|Overall Study|Participant withdrew consent|0
6792124|NCT02737475|10789913|FG014|Overall Study|Participant withdrew consent|1
6792125|NCT02737475|10789914|FG015|Overall Study|Participant withdrew consent|0
6792126|NCT02737475|10789915|FG016|Overall Study|Participant withdrew consent|0
6792127|NCT02737475|10789916|FG017|Overall Study|Participant withdrew consent|2
6792128|NCT02737475|10789917|FG018|Overall Study|Participant withdrew consent|1
6792129|NCT02737475|10789918|FG019|Overall Study|Participant withdrew consent|0
6792130|NCT02737475|10789919|FG020|Overall Study|Participant withdrew consent|2
6792131|NCT02737475|10789920|FG021|Overall Study|Participant withdrew consent|0
6792132|NCT02737475|10789921|FG022|Overall Study|Participant withdrew consent|0
6792133|NCT02737475|10789922|FG023|Overall Study|Participant withdrew consent|0
6792134|NCT02737475|10789923|FG024|Overall Study|Participant withdrew consent|0
6792135|NCT02737475|10789924|FG025|Overall Study|Participant withdrew consent|0
6792136|NCT02737475|10789925|FG026|Overall Study|Participant withdrew consent|0
6792137|NCT02737475|10789899|FG000|Overall Study|Lost to Follow-up|0
6792138|NCT02737475|10789900|FG001|Overall Study|Lost to Follow-up|0
6792139|NCT02737475|10789901|FG002|Overall Study|Lost to Follow-up|0
6792140|NCT02737475|10789902|FG003|Overall Study|Lost to Follow-up|0
6792141|NCT02737475|10789903|FG004|Overall Study|Lost to Follow-up|0
6792142|NCT02737475|10789904|FG005|Overall Study|Lost to Follow-up|0
6792143|NCT02737475|10789905|FG006|Overall Study|Lost to Follow-up|0
6792144|NCT02737475|10789906|FG007|Overall Study|Lost to Follow-up|0
6792145|NCT02737475|10789907|FG008|Overall Study|Lost to Follow-up|0
6792146|NCT02737475|10789908|FG009|Overall Study|Lost to Follow-up|0
6792147|NCT02737475|10789909|FG010|Overall Study|Lost to Follow-up|0
6792148|NCT02737475|10789910|FG011|Overall Study|Lost to Follow-up|0
6792149|NCT02737475|10789911|FG012|Overall Study|Lost to Follow-up|0
6792150|NCT02737475|10789912|FG013|Overall Study|Lost to Follow-up|0
6792151|NCT02737475|10789913|FG014|Overall Study|Lost to Follow-up|0
6792152|NCT02737475|10789914|FG015|Overall Study|Lost to Follow-up|1
6792153|NCT02737475|10789915|FG016|Overall Study|Lost to Follow-up|0
6792154|NCT02737475|10789916|FG017|Overall Study|Lost to Follow-up|0
6792155|NCT02737475|10789917|FG018|Overall Study|Lost to Follow-up|0
6792156|NCT02737475|10789918|FG019|Overall Study|Lost to Follow-up|0
6792157|NCT02737475|10789919|FG020|Overall Study|Lost to Follow-up|0
6792158|NCT02737475|10789920|FG021|Overall Study|Lost to Follow-up|0
6792159|NCT02737475|10789921|FG022|Overall Study|Lost to Follow-up|0
6792160|NCT02737475|10789922|FG023|Overall Study|Lost to Follow-up|0
6792161|NCT02737475|10789923|FG024|Overall Study|Lost to Follow-up|0
6792162|NCT02737475|10789924|FG025|Overall Study|Lost to Follow-up|0
6792163|NCT02737475|10789925|FG026|Overall Study|Lost to Follow-up|0
6792164|NCT02737475|10789899|FG000|Overall Study|Disease Progression|0
6792165|NCT02737475|10789900|FG001|Overall Study|Disease Progression|0
6792166|NCT02737475|10789901|FG002|Overall Study|Disease Progression|0
6792167|NCT02737475|10789902|FG003|Overall Study|Disease Progression|0
6792168|NCT02737475|10789903|FG004|Overall Study|Disease Progression|0
6792169|NCT02737475|10789904|FG005|Overall Study|Disease Progression|0
6792170|NCT02737475|10789905|FG006|Overall Study|Disease Progression|0
6792171|NCT02737475|10789906|FG007|Overall Study|Disease Progression|0
6792172|NCT02737475|10789907|FG008|Overall Study|Disease Progression|0
6792173|NCT02737475|10789908|FG009|Overall Study|Disease Progression|0
6792174|NCT02737475|10789909|FG010|Overall Study|Disease Progression|0
6792175|NCT02737475|10789910|FG011|Overall Study|Disease Progression|0
6792176|NCT02737475|10789911|FG012|Overall Study|Disease Progression|0
6792177|NCT02737475|10789912|FG013|Overall Study|Disease Progression|0
6792178|NCT02737475|10789913|FG014|Overall Study|Disease Progression|0
6792179|NCT02737475|10789914|FG015|Overall Study|Disease Progression|0
6792180|NCT02737475|10789915|FG016|Overall Study|Disease Progression|0
6792181|NCT02737475|10789916|FG017|Overall Study|Disease Progression|0
6792182|NCT02737475|10789917|FG018|Overall Study|Disease Progression|0
6792183|NCT02737475|10789918|FG019|Overall Study|Disease Progression|0
6792184|NCT02737475|10789919|FG020|Overall Study|Disease Progression|0
6792185|NCT02737475|10789920|FG021|Overall Study|Disease Progression|0
6792186|NCT02737475|10789921|FG022|Overall Study|Disease Progression|0
6792187|NCT02737475|10789922|FG023|Overall Study|Disease Progression|0
6792188|NCT02737475|10789923|FG024|Overall Study|Disease Progression|0
6792189|NCT02737475|10789924|FG025|Overall Study|Disease Progression|0
6792190|NCT02737475|10789925|FG026|Overall Study|Disease Progression|1
6792191|NCT02642965|10790017|FG000|Overall Study|Lack of Efficacy|4
6792192|NCT02642965|10790017|FG000|Overall Study|Physician Decision|9
6807865|NCT03289143|10811505|FG002|Overall Study|Withdrawal by Subject|14
6807866|NCT03289143|10811506|FG003|Overall Study|Withdrawal by Subject|12
6807867|NCT03289143|10811503|FG000|Overall Study|Adverse Event|10
6807868|NCT03289143|10811504|FG001|Overall Study|Adverse Event|7
6807869|NCT03289143|10811505|FG002|Overall Study|Adverse Event|6
6807870|NCT03289143|10811506|FG003|Overall Study|Adverse Event|5
6807871|NCT03289143|10811503|FG000|Overall Study|Death|2
6807872|NCT03289143|10811504|FG001|Overall Study|Death|0
6807873|NCT03289143|10811505|FG002|Overall Study|Death|2
6807874|NCT03289143|10811506|FG003|Overall Study|Death|1
6807875|NCT03289143|10811503|FG000|Overall Study|Lost to Follow-up|2
6807876|NCT03289143|10811504|FG001|Overall Study|Lost to Follow-up|1
6807877|NCT03289143|10811505|FG002|Overall Study|Lost to Follow-up|1
6807878|NCT03289143|10811506|FG003|Overall Study|Lost to Follow-up|0
6807879|NCT03289143|10811503|FG000|Overall Study|Participant No Longer Has Study Partner|0
6807880|NCT03289143|10811504|FG001|Overall Study|Participant No Longer Has Study Partner|0
6807881|NCT03289143|10811505|FG002|Overall Study|Participant No Longer Has Study Partner|0
6807882|NCT03289143|10811506|FG003|Overall Study|Participant No Longer Has Study Partner|1
6807883|NCT03289143|10811503|FG000|Overall Study|Withdrawal by Caregiver|0
6807884|NCT03289143|10811504|FG001|Overall Study|Withdrawal by Caregiver|1
6807885|NCT03289143|10811505|FG002|Overall Study|Withdrawal by Caregiver|0
6807886|NCT03289143|10811506|FG003|Overall Study|Withdrawal by Caregiver|0
6807887|NCT03289143|10811503|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0
6807888|NCT03289143|10811504|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0
6807889|NCT03289143|10811505|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1
6807890|NCT03289143|10811506|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0
6807891|NCT03289143|10811503|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0
6807892|NCT03289143|10811504|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0
6807893|NCT03289143|10811505|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0
6807894|NCT03289143|10811506|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1
6807895|NCT03156504|10811521|FG000|Overall Study|Withdrawal by Subject|1
6807896|NCT03006926|10811527|FG000|Overall Study|Death|0
6807897|NCT03006926|10811528|FG001|Overall Study|Death|33
6807898|NCT03006926|10811527|FG000|Overall Study|Ongoing Survival Follow-up|0
6807899|NCT03006926|10811528|FG001|Overall Study|Ongoing Survival Follow-up|26
6807900|NCT03006926|10811527|FG000|Overall Study|Ongoing-on Treatment|0
6807901|NCT03006926|10811528|FG001|Overall Study|Ongoing-on Treatment|36
6807902|NCT03006926|10811527|FG000|Overall Study|Lost to Follow-up|0
6807903|NCT03006926|10811528|FG001|Overall Study|Lost to Follow-up|1
6807904|NCT03006926|10811527|FG000|Overall Study|Withdrawal by Subject|0
6807905|NCT03006926|10811528|FG001|Overall Study|Withdrawal by Subject|2
6807906|NCT02993926|10811536|FG000|Enantone Treatment Phase|Adverse Event|1
6807907|NCT02993926|10811537|FG001|Enantone Treatment Phase|Adverse Event|0
6807908|NCT02993926|10811538|FG002|Enantone Treatment Phase|Adverse Event|0
6807909|NCT02993926|10811536|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26
6807910|NCT02993926|10811537|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0
6807911|NCT02993926|10811538|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0
6807912|NCT02993926|10811536|FG000|Enantone Treatment Phase|Investigator Judgment|1
6807913|NCT02993926|10811537|FG001|Enantone Treatment Phase|Investigator Judgment|0
6807914|NCT02993926|10811538|FG002|Enantone Treatment Phase|Investigator Judgment|0
6807915|NCT02993926|10811536|FG000|Enantone Treatment Phase|Reason Not Specified|4
6807916|NCT02993926|10811537|FG001|Enantone Treatment Phase|Reason Not Specified|0
6792193|NCT02629159|10790024|FG000|Overall Study|Adverse Event|17
6792194|NCT02629159|10790025|FG001|Overall Study|Adverse Event|20
6792195|NCT02629159|10790026|FG002|Overall Study|Adverse Event|22
6792196|NCT02629159|10790024|FG000|Overall Study|Withdrawal by Subject|22
6792197|NCT02629159|10790025|FG001|Overall Study|Withdrawal by Subject|11
6792198|NCT02629159|10790026|FG002|Overall Study|Withdrawal by Subject|15
6792199|NCT02629159|10790024|FG000|Overall Study|Lost to Follow-up|7
6792200|NCT02629159|10790025|FG001|Overall Study|Lost to Follow-up|4
6792201|NCT02629159|10790026|FG002|Overall Study|Lost to Follow-up|5
6792202|NCT02629159|10790024|FG000|Overall Study|Lack of Efficacy|4
6792203|NCT02629159|10790025|FG001|Overall Study|Lack of Efficacy|0
6792204|NCT02629159|10790026|FG002|Overall Study|Lack of Efficacy|1
6792205|NCT02629159|10790024|FG000|Overall Study|Other|6
6792206|NCT02629159|10790025|FG001|Overall Study|Other|4
6792207|NCT02629159|10790026|FG002|Overall Study|Other|8
6792208|NCT02604433|10790039|FG000|Overall Study|Withdrawal by Subject|37
6792209|NCT02604433|10790040|FG001|Overall Study|Withdrawal by Subject|16
6792210|NCT02604433|10790039|FG000|Overall Study|Adverse Event|4
6792211|NCT02604433|10790040|FG001|Overall Study|Adverse Event|0
6792212|NCT02604433|10790039|FG000|Overall Study|Other reasons|3
6792213|NCT02604433|10790040|FG001|Overall Study|Other reasons|5
6792214|NCT02604433|10790039|FG000|Overall Study|Death|4
6792215|NCT02604433|10790040|FG001|Overall Study|Death|1
6792216|NCT02604433|10790039|FG000|Overall Study|Transition to Rollover Protocol|169
6792217|NCT02604433|10790040|FG001|Overall Study|Transition to Rollover Protocol|82
6792218|NCT02604433|10790039|FG000|Overall Study|Physician Decision|1
6792219|NCT02604433|10790040|FG001|Overall Study|Physician Decision|1
6792220|NCT02604433|10790039|FG000|Overall Study|Lack of Efficacy|0
6792221|NCT02604433|10790040|FG001|Overall Study|Lack of Efficacy|1
6792222|NCT02420821|10790065|FG000|Overall Study|Lost to Follow-up|2
6792223|NCT02420821|10790066|FG001|Overall Study|Lost to Follow-up|0
6792224|NCT02420821|10790065|FG000|Overall Study|Non-compliance|1
6792225|NCT02420821|10790066|FG001|Overall Study|Non-compliance|2
6792226|NCT02420821|10790065|FG000|Overall Study|Physician Decision|5
6792227|NCT02420821|10790066|FG001|Overall Study|Physician Decision|2
6792228|NCT02420821|10790065|FG000|Overall Study|Withdrawal by Subject|31
6792229|NCT02420821|10790066|FG001|Overall Study|Withdrawal by Subject|17
6792230|NCT02420821|10790065|FG000|Overall Study|Death|129
6792231|NCT02420821|10790066|FG001|Overall Study|Death|116
6792232|NCT02412670|10790075|FG000|Overall Study|Adverse Event|4
6792233|NCT02412670|10790076|FG001|Overall Study|Adverse Event|1
6792234|NCT02412670|10790075|FG000|Overall Study|Physician Decision|1
6792235|NCT02412670|10790076|FG001|Overall Study|Physician Decision|0
6792236|NCT02412670|10790075|FG000|Overall Study|Withdrawal by Subject|1
6792237|NCT02412670|10790076|FG001|Overall Study|Withdrawal by Subject|0
6792238|NCT02412670|10790075|FG000|Overall Study|Ineligible|1
6792239|NCT02412670|10790076|FG001|Overall Study|Ineligible|0
6792240|NCT02410343|10790084|FG000|Core Period (24 Weeks)|Adverse Event|1
6792241|NCT02410343|10790085|FG001|Core Period (24 Weeks)|Adverse Event|0
6792242|NCT02410343|10790084|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4
6792243|NCT02410343|10790085|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7
6792244|NCT02410343|10790084|FG000|Extension Period (12 Months)|Adverse Event|1
6792245|NCT02410343|10790085|FG001|Extension Period (12 Months)|Adverse Event|0
6792246|NCT02410343|10790084|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0
6792247|NCT02410343|10790085|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1
6792248|NCT02339740|10790098|FG000|Overall Study|Death|1
6792249|NCT02339740|10790099|FG001|Overall Study|Death|0
6792250|NCT02339740|10790098|FG000|Overall Study|Physician Decision|0
6792251|NCT02339740|10790099|FG001|Overall Study|Physician Decision|2
6792252|NCT02339740|10790098|FG000|Overall Study|Withdrawal by Subject|5
6792253|NCT02339740|10790099|FG001|Overall Study|Withdrawal by Subject|1
6792254|NCT02339740|10790098|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3
6792255|NCT02339740|10790099|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1
6792256|NCT02045303|10790122|FG000|Overall Study|Protocol Violation|2
6792257|NCT02045303|10790123|FG001|Overall Study|Protocol Violation|1
6792258|NCT02045303|10790124|FG002|Overall Study|Protocol Violation|0
6792259|NCT02045303|10790122|FG000|Overall Study|Withdrawal by Subject|0
6792260|NCT02045303|10790123|FG001|Overall Study|Withdrawal by Subject|2
6792261|NCT02045303|10790124|FG002|Overall Study|Withdrawal by Subject|0
6792262|NCT02025556|10790136|FG000|Overall Study|Adverse Event|0
6792263|NCT02025556|10790137|FG001|Overall Study|Adverse Event|4
6792264|NCT02025556|10790138|FG002|Overall Study|Adverse Event|2
6792265|NCT02025556|10790136|FG000|Overall Study|Lack of Efficacy|2
6792266|NCT02025556|10790137|FG001|Overall Study|Lack of Efficacy|1
6792267|NCT02025556|10790138|FG002|Overall Study|Lack of Efficacy|0
6792268|NCT02025556|10790136|FG000|Overall Study|Protocol Violation|2
6792269|NCT02025556|10790137|FG001|Overall Study|Protocol Violation|1
6792270|NCT02025556|10790138|FG002|Overall Study|Protocol Violation|0
6792271|NCT02025556|10790136|FG000|Overall Study|Withdrawal by Subject|0
6792272|NCT02025556|10790137|FG001|Overall Study|Withdrawal by Subject|3
6792273|NCT02025556|10790138|FG002|Overall Study|Withdrawal by Subject|6
6792274|NCT02025556|10790136|FG000|Overall Study|Lost to Follow-up|2
6792275|NCT02025556|10790137|FG001|Overall Study|Lost to Follow-up|4
6792276|NCT02025556|10790138|FG002|Overall Study|Lost to Follow-up|0
6792277|NCT02025556|10790136|FG000|Overall Study|Reason not reported|0
6792278|NCT02025556|10790137|FG001|Overall Study|Reason not reported|0
6792279|NCT02025556|10790138|FG002|Overall Study|Reason not reported|1
6792280|NCT01986933|10790151|FG000|Placebo-controlled (Part A)|Adverse Event|1
6792281|NCT01986933|10790152|FG001|Placebo-controlled (Part A)|Adverse Event|5
6792282|NCT01986933|10790153|FG002|Placebo-controlled (Part A)|Adverse Event|2
6792283|NCT01986933|10790154|FG003|Placebo-controlled (Part A)|Adverse Event|2
6792284|NCT01986933|10790155|FG004|Placebo-controlled (Part A)|Adverse Event|4
6792285|NCT01986933|10790151|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3
6792286|NCT01986933|10790152|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1
6792287|NCT01986933|10790153|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1
6792288|NCT01986933|10790154|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2
6792289|NCT01986933|10790155|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1
6792290|NCT01986933|10790151|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5
6792291|NCT01986933|10790152|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2
6792292|NCT01986933|10790153|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6
6792293|NCT01986933|10790154|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2
6792294|NCT01986933|10790155|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7
6792295|NCT01986933|10790151|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0
6792296|NCT01986933|10790152|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1
6792297|NCT01986933|10790153|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0
6792298|NCT01986933|10790154|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1
6792299|NCT01986933|10790155|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0
6792300|NCT01986933|10790151|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0
6792301|NCT01986933|10790152|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0
6792302|NCT01986933|10790153|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0
6792303|NCT01986933|10790154|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0
6792304|NCT01986933|10790155|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2
6792305|NCT01986933|10790151|FG000|Active-to-active (Part B)|Adverse Event|0
6792306|NCT01986933|10790152|FG001|Active-to-active (Part B)|Adverse Event|2
6792307|NCT01986933|10790153|FG002|Active-to-active (Part B)|Adverse Event|0
6792308|NCT01986933|10790154|FG003|Active-to-active (Part B)|Adverse Event|1
6792309|NCT01986933|10790155|FG004|Active-to-active (Part B)|Adverse Event|3
6792310|NCT01986933|10790151|FG000|Active-to-active (Part B)|Lack of Efficacy|0
6792311|NCT01986933|10790152|FG001|Active-to-active (Part B)|Lack of Efficacy|3
6792312|NCT01986933|10790153|FG002|Active-to-active (Part B)|Lack of Efficacy|2
6792313|NCT01986933|10790154|FG003|Active-to-active (Part B)|Lack of Efficacy|0
6792314|NCT01986933|10790155|FG004|Active-to-active (Part B)|Lack of Efficacy|4
6792315|NCT01986933|10790151|FG000|Active-to-active (Part B)|Pregnancy|0
6792316|NCT01986933|10790152|FG001|Active-to-active (Part B)|Pregnancy|0
6792317|NCT01986933|10790153|FG002|Active-to-active (Part B)|Pregnancy|0
6792318|NCT01986933|10790154|FG003|Active-to-active (Part B)|Pregnancy|0
6792319|NCT01986933|10790155|FG004|Active-to-active (Part B)|Pregnancy|1
6792320|NCT01986933|10790151|FG000|Active-to-active (Part B)|Physician Decision|0
6792321|NCT01986933|10790152|FG001|Active-to-active (Part B)|Physician Decision|0
6792322|NCT01986933|10790153|FG002|Active-to-active (Part B)|Physician Decision|1
6792323|NCT01986933|10790154|FG003|Active-to-active (Part B)|Physician Decision|1
6792324|NCT01986933|10790155|FG004|Active-to-active (Part B)|Physician Decision|0
6792325|NCT01986933|10790151|FG000|Active-to-active (Part B)|Withdrawal by Subject|0
6792326|NCT01986933|10790152|FG001|Active-to-active (Part B)|Withdrawal by Subject|4
6792327|NCT01986933|10790153|FG002|Active-to-active (Part B)|Withdrawal by Subject|7
6792328|NCT01986933|10790154|FG003|Active-to-active (Part B)|Withdrawal by Subject|6
6792329|NCT01986933|10790155|FG004|Active-to-active (Part B)|Withdrawal by Subject|6
6792330|NCT01986933|10790151|FG000|Active-to-active (Part B)|Lost to Follow-up|0
6792331|NCT01986933|10790152|FG001|Active-to-active (Part B)|Lost to Follow-up|0
6792332|NCT01986933|10790153|FG002|Active-to-active (Part B)|Lost to Follow-up|0
6792333|NCT01986933|10790154|FG003|Active-to-active (Part B)|Lost to Follow-up|0
6792334|NCT01986933|10790155|FG004|Active-to-active (Part B)|Lost to Follow-up|1
6792335|NCT01986933|10790151|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0
6792336|NCT01986933|10790152|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1
6792337|NCT01986933|10790153|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0
6792338|NCT01986933|10790154|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1
6792339|NCT01986933|10790155|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1
6792340|NCT01986933|10790151|FG000|Placebo-to-active (Part B)|Adverse Event|0
6792341|NCT01986933|10790152|FG001|Placebo-to-active (Part B)|Adverse Event|1
6792342|NCT01986933|10790153|FG002|Placebo-to-active (Part B)|Adverse Event|0
6792343|NCT01986933|10790154|FG003|Placebo-to-active (Part B)|Adverse Event|1
6792344|NCT01986933|10790155|FG004|Placebo-to-active (Part B)|Adverse Event|0
6792345|NCT01986933|10790151|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0
6792346|NCT01986933|10790152|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0
6792347|NCT01986933|10790153|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0
6792348|NCT01986933|10790154|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1
6792349|NCT01986933|10790155|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0
6792350|NCT01986933|10790151|FG000|Placebo-to-active (Part B)|Protocol Violation|0
6792351|NCT01986933|10790152|FG001|Placebo-to-active (Part B)|Protocol Violation|0
6792352|NCT01986933|10790153|FG002|Placebo-to-active (Part B)|Protocol Violation|1
6792353|NCT01986933|10790154|FG003|Placebo-to-active (Part B)|Protocol Violation|0
6792354|NCT01986933|10790155|FG004|Placebo-to-active (Part B)|Protocol Violation|0
6792355|NCT01986933|10790151|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0
6792356|NCT01986933|10790152|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3
6792357|NCT01986933|10790153|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4
6792358|NCT01986933|10790154|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3
6792359|NCT01986933|10790155|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0
6792360|NCT01986933|10790151|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0
6792361|NCT01986933|10790152|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1
6792362|NCT01986933|10790153|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0
6792363|NCT01986933|10790154|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0
6792364|NCT01986933|10790155|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0
6792366|NCT01563107|10790205|FG000|Overall Study|Physician Decision|0
6792367|NCT01563107|10790206|FG001|Overall Study|Physician Decision|1
6792368|NCT01563107|10790207|FG002|Overall Study|Physician Decision|1
6792369|NCT01563107|10790208|FG003|Overall Study|Physician Decision|3
6792370|NCT01563107|10790205|FG000|Overall Study|Withdrawal by Subject|1
6792371|NCT01563107|10790206|FG001|Overall Study|Withdrawal by Subject|2
6792372|NCT01563107|10790207|FG002|Overall Study|Withdrawal by Subject|1
6792373|NCT01563107|10790208|FG003|Overall Study|Withdrawal by Subject|2
6792374|NCT01064479|10790280|FG000|Overall Study|Death|10
6792375|NCT01064479|10790281|FG001|Overall Study|Death|11
6792376|NCT01064479|10790280|FG000|Overall Study|Withdrawal by Subject|2
6792377|NCT01064479|10790281|FG001|Overall Study|Withdrawal by Subject|2
6792378|NCT01064479|10790280|FG000|Overall Study|Disease progression|1
6792379|NCT01064479|10790281|FG001|Overall Study|Disease progression|1
6792380|NCT01064479|10790280|FG000|Overall Study|Toxicity|1
6792381|NCT01064479|10790281|FG001|Overall Study|Toxicity|1
6792382|NCT01064479|10790280|FG000|Overall Study|Other|1
6792383|NCT01064479|10790281|FG001|Overall Study|Other|2
6792384|NCT01042522|10790289|FG000|Overall Study|Adverse Event|1
6792385|NCT01042522|10790290|FG001|Overall Study|Adverse Event|2
6792386|NCT01042522|10790289|FG000|Overall Study|Disease Progression|5
6792387|NCT01042522|10790290|FG001|Overall Study|Disease Progression|0
6792388|NCT01042522|10790289|FG000|Overall Study|Death|1
6792389|NCT01042522|10790290|FG001|Overall Study|Death|0
6792390|NCT01042522|10790289|FG000|Overall Study|Patient Refused|0
6792391|NCT01042522|10790290|FG001|Overall Study|Patient Refused|3
6792392|NCT01042522|10790289|FG000|Overall Study|Withdrawal by Subject|1
6792393|NCT01042522|10790290|FG001|Overall Study|Withdrawal by Subject|1
6792394|NCT00710970|10790329|FG000|Overall Study|Never took drug|3
6792395|NCT00685919|10790337|FG000|Overall Study|Withdrawal by Subject|0
6792396|NCT00685919|10790338|FG001|Overall Study|Withdrawal by Subject|0
6792397|NCT00685919|10790339|FG002|Overall Study|Withdrawal by Subject|1
6792398|NCT00685919|10790340|FG003|Overall Study|Withdrawal by Subject|0
6792399|NCT00685919|10790337|FG000|Overall Study|Physician Decision|1
6792400|NCT00685919|10790338|FG001|Overall Study|Physician Decision|0
6792401|NCT00685919|10790339|FG002|Overall Study|Physician Decision|0
6792402|NCT00685919|10790340|FG003|Overall Study|Physician Decision|0
6792403|NCT00344487|10790350|FG000|Overall Study|immunologic failure|1
6792404|NCT00281658|10790358|FG000|Double-blind, Randomized Phase|Death|120
6792405|NCT00281658|10790359|FG001|Double-blind, Randomized Phase|Death|46
6792406|NCT00281658|10790360|FG002|Double-blind, Randomized Phase|Death|0
6792407|NCT00281658|10790358|FG000|Double-blind, Randomized Phase|Lost to Follow-up|12
6792408|NCT00281658|10790359|FG001|Double-blind, Randomized Phase|Lost to Follow-up|5
6792409|NCT00281658|10790360|FG002|Double-blind, Randomized Phase|Lost to Follow-up|0
6792410|NCT00281658|10790358|FG000|Double-blind, Randomized Phase|Withdrawal by Subject|4
6792411|NCT00281658|10790359|FG001|Double-blind, Randomized Phase|Withdrawal by Subject|1
6792412|NCT00281658|10790360|FG002|Double-blind, Randomized Phase|Withdrawal by Subject|0
6792413|NCT00281658|10790358|FG000|Double-blind, Randomized Phase|Participant Entered New Protocol|1
6792414|NCT00281658|10790359|FG001|Double-blind, Randomized Phase|Participant Entered New Protocol|1
6792415|NCT00281658|10790360|FG002|Double-blind, Randomized Phase|Participant Entered New Protocol|0
6792416|NCT00281658|10790358|FG000|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
6792417|NCT00281658|10790359|FG001|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|1
6792418|NCT00281658|10790360|FG002|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
6792419|NCT00281658|10790358|FG000|Open-label Monotherapy Extension Phase|Death|0
6792420|NCT00281658|10790359|FG001|Open-label Monotherapy Extension Phase|Death|0
6792421|NCT00281658|10790360|FG002|Open-label Monotherapy Extension Phase|Death|97
6792422|NCT00281658|10790358|FG000|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
6792423|NCT00281658|10790359|FG001|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
6792424|NCT00281658|10790360|FG002|Open-label Monotherapy Extension Phase|Lost to Follow-up|3
6792425|NCT00281658|10790358|FG000|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
6792426|NCT00281658|10790359|FG001|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
6792427|NCT00281658|10790360|FG002|Open-label Monotherapy Extension Phase|Withdrawal by Subject|1
6807917|NCT02993926|10811538|FG002|Enantone Treatment Phase|Reason Not Specified|0
6807918|NCT02932579|10811550|FG000|Overall Study|Withdrawal by Subject|4
6807919|NCT02932579|10811551|FG001|Overall Study|Withdrawal by Subject|1
6807920|NCT02928224|10811561|FG000|Overall Study|Randomized, Not Treated|0
6807921|NCT02928224|10811562|FG001|Overall Study|Randomized, Not Treated|2
6807922|NCT02928224|10811563|FG002|Overall Study|Randomized, Not Treated|4
6807923|NCT02928224|10811564|FG003|Overall Study|Randomized, Not Treated|28
6807924|NCT02928224|10811561|FG000|Overall Study|Treatment Ongoing|6
6807925|NCT02928224|10811562|FG001|Overall Study|Treatment Ongoing|78
6807926|NCT02928224|10811563|FG002|Overall Study|Treatment Ongoing|78
6807927|NCT02928224|10811564|FG003|Overall Study|Treatment Ongoing|37
6807928|NCT02928224|10811561|FG000|Overall Study|Progressive Disease|23
6807929|NCT02928224|10811562|FG001|Overall Study|Progressive Disease|104
6807930|NCT02928224|10811563|FG002|Overall Study|Progressive Disease|101
6807931|NCT02928224|10811564|FG003|Overall Study|Progressive Disease|103
6807932|NCT02928224|10811561|FG000|Overall Study|Adverse Event|2
6807933|NCT02928224|10811562|FG001|Overall Study|Adverse Event|11
6807934|NCT02928224|10811563|FG002|Overall Study|Adverse Event|11
6807935|NCT02928224|10811564|FG003|Overall Study|Adverse Event|10
6807936|NCT02928224|10811561|FG000|Overall Study|Changes in Patient's Condition|3
6807937|NCT02928224|10811562|FG001|Overall Study|Changes in Patient's Condition|9
6807938|NCT02928224|10811563|FG002|Overall Study|Changes in Patient's Condition|9
6807939|NCT02928224|10811564|FG003|Overall Study|Changes in Patient's Condition|13
6807940|NCT02928224|10811561|FG000|Overall Study|Death|1
6807941|NCT02928224|10811562|FG001|Overall Study|Death|7
6807942|NCT02928224|10811563|FG002|Overall Study|Death|5
6807943|NCT02928224|10811564|FG003|Overall Study|Death|11
6807944|NCT02928224|10811561|FG000|Overall Study|Withdrawal by Subject|1
6807945|NCT02928224|10811562|FG001|Overall Study|Withdrawal by Subject|4
6807946|NCT02928224|10811563|FG002|Overall Study|Withdrawal by Subject|3
6807947|NCT02928224|10811564|FG003|Overall Study|Withdrawal by Subject|9
6807948|NCT02928224|10811561|FG000|Overall Study|Dose Interruptions>28|1
6807949|NCT02928224|10811562|FG001|Overall Study|Dose Interruptions>28|2
6807950|NCT02928224|10811563|FG002|Overall Study|Dose Interruptions>28|2
6807951|NCT02928224|10811564|FG003|Overall Study|Dose Interruptions>28|4
6807952|NCT02928224|10811561|FG000|Overall Study|Patient Decision to Discontinue Drug|0
6807953|NCT02928224|10811562|FG001|Overall Study|Patient Decision to Discontinue Drug|2
6807954|NCT02928224|10811563|FG002|Overall Study|Patient Decision to Discontinue Drug|2
6807955|NCT02928224|10811564|FG003|Overall Study|Patient Decision to Discontinue Drug|4
6807956|NCT02928224|10811561|FG000|Overall Study|Physician Decision|0
6807957|NCT02928224|10811562|FG001|Overall Study|Physician Decision|2
6807958|NCT02928224|10811563|FG002|Overall Study|Physician Decision|4
6807959|NCT02928224|10811564|FG003|Overall Study|Physician Decision|2
6807960|NCT02928224|10811561|FG000|Overall Study|not listed|0
6807961|NCT02928224|10811562|FG001|Overall Study|not listed|3
6807962|NCT02928224|10811563|FG002|Overall Study|not listed|1
6807963|NCT02928224|10811564|FG003|Overall Study|not listed|0
6807964|NCT02852967|10811589|FG000|Overall Study|Adverse Event|3
6807965|NCT02852967|10811590|FG001|Overall Study|Adverse Event|1
6807966|NCT02852967|10811591|FG002|Overall Study|Adverse Event|0
6807967|NCT02852967|10811592|FG003|Overall Study|Adverse Event|1
6807968|NCT02852967|10811593|FG004|Overall Study|Adverse Event|0
6807969|NCT02852967|10811589|FG000|Overall Study|Death|1
6807970|NCT02852967|10811590|FG001|Overall Study|Death|0
6807971|NCT02852967|10811591|FG002|Overall Study|Death|0
6807972|NCT02852967|10811592|FG003|Overall Study|Death|0
6807973|NCT02852967|10811593|FG004|Overall Study|Death|0
6807974|NCT02852967|10811589|FG000|Overall Study|Lost to Follow-up|1
6807975|NCT02852967|10811590|FG001|Overall Study|Lost to Follow-up|2
6807976|NCT02852967|10811591|FG002|Overall Study|Lost to Follow-up|3
6807977|NCT02852967|10811592|FG003|Overall Study|Lost to Follow-up|4
6807978|NCT02852967|10811593|FG004|Overall Study|Lost to Follow-up|4
6807979|NCT02852967|10811589|FG000|Overall Study|Withdrawal by Subject|6
6807980|NCT02852967|10811590|FG001|Overall Study|Withdrawal by Subject|12
6807981|NCT02852967|10811591|FG002|Overall Study|Withdrawal by Subject|7
6807982|NCT02852967|10811592|FG003|Overall Study|Withdrawal by Subject|10
6792428|NCT04034355|10790391|FG000|Overall Study|Study terminated by Sponsor|10
6792429|NCT04034355|10790392|FG001|Overall Study|Study terminated by Sponsor|17
6792430|NCT04034355|10790391|FG000|Overall Study|Withdrawal by Subject|12
6792431|NCT04034355|10790392|FG001|Overall Study|Withdrawal by Subject|11
6792432|NCT04034355|10790391|FG000|Overall Study|Site terminated by Sponsor|4
6792433|NCT04034355|10790392|FG001|Overall Study|Site terminated by Sponsor|5
6792434|NCT04034355|10790391|FG000|Overall Study|Adverse Event|2
6792435|NCT04034355|10790392|FG001|Overall Study|Adverse Event|0
6792436|NCT04034355|10790391|FG000|Overall Study|Death|1
6792437|NCT04034355|10790392|FG001|Overall Study|Death|1
6792438|NCT04034355|10790391|FG000|Overall Study|Not reported|2
6792439|NCT04034355|10790392|FG001|Overall Study|Not reported|0
6792440|NCT04034355|10790391|FG000|Overall Study|Lost to Follow-up|1
6792441|NCT04034355|10790392|FG001|Overall Study|Lost to Follow-up|0
6792442|NCT04034355|10790391|FG000|Overall Study|Physician Decision|1
6792443|NCT04034355|10790392|FG001|Overall Study|Physician Decision|0
6792444|NCT04034355|10790391|FG000|Overall Study|Protocol Violation|0
6792445|NCT04034355|10790392|FG001|Overall Study|Protocol Violation|1
6792446|NCT04034355|10790391|FG000|Overall Study|Progressive disease|1
6792447|NCT04034355|10790392|FG001|Overall Study|Progressive disease|0
6792448|NCT03721276|10790404|FG000|Overall Study|Lost to Follow-up|5
6792449|NCT03721276|10790405|FG001|Overall Study|Lost to Follow-up|3
6792450|NCT03721276|10790404|FG000|Overall Study|Adverse Event|0
6792451|NCT03721276|10790405|FG001|Overall Study|Adverse Event|1
6792533|NCT02054104|10790664|FG001|Overall Study|Inconclusive response|1
6792534|NCT01899144|10790670|FG000|Treatment Period 2|Other|1
6792535|NCT01899144|10790670|FG000|Treatment Period 3|Other|2
6792536|NCT01899144|10790670|FG000|Treatment Period 5|Other|1
6792537|NCT01793610|10790685|FG000|Overall Study|Withdrawal by Subject|1
6792538|NCT01793610|10790686|FG001|Overall Study|Withdrawal by Subject|0
6792539|NCT01793610|10790687|FG002|Overall Study|Withdrawal by Subject|1
6807983|NCT02852967|10811593|FG004|Overall Study|Withdrawal by Subject|10
6807984|NCT02852967|10811589|FG000|Overall Study|SAE|0
6807985|NCT02852967|10811590|FG001|Overall Study|SAE|0
6807986|NCT02852967|10811591|FG002|Overall Study|SAE|0
6807987|NCT02852967|10811592|FG003|Overall Study|SAE|3
6807988|NCT02852967|10811593|FG004|Overall Study|SAE|0
6807989|NCT02852967|10811589|FG000|Overall Study|Elevated Liver Enzymes|2
6807990|NCT02852967|10811590|FG001|Overall Study|Elevated Liver Enzymes|0
6807991|NCT02852967|10811591|FG002|Overall Study|Elevated Liver Enzymes|0
6807992|NCT02852967|10811592|FG003|Overall Study|Elevated Liver Enzymes|2
6807993|NCT02852967|10811593|FG004|Overall Study|Elevated Liver Enzymes|2
6807994|NCT02852967|10811589|FG000|Overall Study|Physician Decision|0
6807995|NCT02852967|10811590|FG001|Overall Study|Physician Decision|0
6807996|NCT02852967|10811591|FG002|Overall Study|Physician Decision|0
6807997|NCT02852967|10811592|FG003|Overall Study|Physician Decision|1
6807998|NCT02852967|10811593|FG004|Overall Study|Physician Decision|0
6807999|NCT02852967|10811589|FG000|Overall Study|Lack of Efficacy|0
6808000|NCT02852967|10811590|FG001|Overall Study|Lack of Efficacy|1
6808001|NCT02852967|10811591|FG002|Overall Study|Lack of Efficacy|0
6808002|NCT02852967|10811592|FG003|Overall Study|Lack of Efficacy|0
6808003|NCT02852967|10811593|FG004|Overall Study|Lack of Efficacy|0
6808004|NCT02852967|10811589|FG000|Overall Study|Non-compliance|0
6808005|NCT02852967|10811590|FG001|Overall Study|Non-compliance|0
6808006|NCT02852967|10811591|FG002|Overall Study|Non-compliance|1
6808007|NCT02852967|10811592|FG003|Overall Study|Non-compliance|1
6808008|NCT02852967|10811593|FG004|Overall Study|Non-compliance|0
6808009|NCT02852967|10811589|FG000|Overall Study|Dispensing Drug Violation|0
6808010|NCT02852967|10811590|FG001|Overall Study|Dispensing Drug Violation|0
6808011|NCT02852967|10811591|FG002|Overall Study|Dispensing Drug Violation|1
6808012|NCT02852967|10811592|FG003|Overall Study|Dispensing Drug Violation|0
6808013|NCT02852967|10811593|FG004|Overall Study|Dispensing Drug Violation|0
6808014|NCT02852967|10811589|FG000|Overall Study|Inclusion/Exclusion Violation|1
6808015|NCT02852967|10811590|FG001|Overall Study|Inclusion/Exclusion Violation|0
6808016|NCT02852967|10811591|FG002|Overall Study|Inclusion/Exclusion Violation|0
6808017|NCT02852967|10811592|FG003|Overall Study|Inclusion/Exclusion Violation|0
6808018|NCT02852967|10811593|FG004|Overall Study|Inclusion/Exclusion Violation|0
6808019|NCT02810418|10811620|FG000|Arm A Dose Escalation|Adverse Event|2
6808020|NCT02810418|10811621|FG001|Arm A Dose Escalation|Adverse Event|1
6808021|NCT02810418|10811622|FG002|Arm A Dose Escalation|Adverse Event|0
6808022|NCT02810418|10811623|FG003|Arm A Dose Escalation|Adverse Event|0
6808023|NCT02810418|10811624|FG004|Arm A Dose Escalation|Adverse Event|0
6808024|NCT02810418|10811625|FG005|Arm A Dose Escalation|Adverse Event|0
6808025|NCT02810418|10811626|FG006|Arm A Dose Escalation|Adverse Event|0
6808026|NCT02810418|10811620|FG000|Dose Expansion|Adverse Event|0
6808027|NCT02810418|10811621|FG001|Dose Expansion|Adverse Event|1
6808028|NCT02810418|10811622|FG002|Dose Expansion|Adverse Event|1
6808029|NCT02810418|10811623|FG003|Dose Expansion|Adverse Event|0
6808030|NCT02810418|10811624|FG004|Dose Expansion|Adverse Event|0
6808031|NCT02810418|10811625|FG005|Dose Expansion|Adverse Event|0
6808032|NCT02810418|10811626|FG006|Dose Expansion|Adverse Event|0
6808033|NCT02810418|10811620|FG000|Dose Expansion|Physician Decision|0
6808034|NCT02810418|10811621|FG001|Dose Expansion|Physician Decision|0
6808035|NCT02810418|10811622|FG002|Dose Expansion|Physician Decision|2
6808036|NCT02810418|10811623|FG003|Dose Expansion|Physician Decision|0
6808037|NCT02810418|10811624|FG004|Dose Expansion|Physician Decision|0
6792452|NCT03637491|10790428|FG000|Overall Study|Death|9
6792453|NCT03637491|10790429|FG001|Overall Study|Death|9
6792454|NCT03637491|10790430|FG002|Overall Study|Death|5
6792455|NCT03637491|10790431|FG003|Overall Study|Death|3
6792456|NCT03637491|10790428|FG000|Overall Study|Lost to Follow-up|0
6792457|NCT03637491|10790429|FG001|Overall Study|Lost to Follow-up|1
6792458|NCT03637491|10790430|FG002|Overall Study|Lost to Follow-up|0
6792459|NCT03637491|10790431|FG003|Overall Study|Lost to Follow-up|1
6792460|NCT03637491|10790428|FG000|Overall Study|Study Terminated By Sponsor|0
6792461|NCT03637491|10790429|FG001|Overall Study|Study Terminated By Sponsor|2
6792462|NCT03637491|10790430|FG002|Overall Study|Study Terminated By Sponsor|1
6792463|NCT03637491|10790431|FG003|Overall Study|Study Terminated By Sponsor|0
6792464|NCT03637491|10790428|FG000|Overall Study|Withdrawal by Subject|1
6792465|NCT03637491|10790429|FG001|Overall Study|Withdrawal by Subject|0
6792466|NCT03637491|10790430|FG002|Overall Study|Withdrawal by Subject|1
6792467|NCT03637491|10790431|FG003|Overall Study|Withdrawal by Subject|2
6792468|NCT03334539|10790522|FG000|Overall Study|Adverse Event|3
6792469|NCT03334539|10790523|FG001|Overall Study|Adverse Event|5
6792470|NCT03334539|10790524|FG002|Overall Study|Adverse Event|0
6792471|NCT03334539|10790522|FG000|Overall Study|Withdrawal by Subject|0
6792472|NCT03334539|10790523|FG001|Overall Study|Withdrawal by Subject|1
6792473|NCT03334539|10790524|FG002|Overall Study|Withdrawal by Subject|1
6792474|NCT03334539|10790522|FG000|Overall Study|Administrative Reasons|1
6792475|NCT03334539|10790523|FG001|Overall Study|Administrative Reasons|0
6792476|NCT03334539|10790524|FG002|Overall Study|Administrative Reasons|0
6792477|NCT03334539|10790522|FG000|Overall Study|Hypertension Not Controlled|0
6792478|NCT03334539|10790523|FG001|Overall Study|Hypertension Not Controlled|1
6792479|NCT03334539|10790524|FG002|Overall Study|Hypertension Not Controlled|0
6792480|NCT03269344|10790546|FG000|Overall Study|Protocol Violation|4
6792481|NCT03269344|10790547|FG001|Overall Study|Protocol Violation|3
6792482|NCT03076775|10790561|FG000|Overall Study|Lost to Follow-up|1
6792483|NCT03076775|10790562|FG001|Overall Study|Lost to Follow-up|0
6792484|NCT02660827|10790602|FG000|From Study to End of Continued Access|Withdrawal by Subject|21
6792485|NCT02660827|10790602|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2
6792486|NCT02660827|10790602|FG000|From Study to End of Continued Access|Adverse Event|3
6792487|NCT02660827|10790602|FG000|From Study to End of Continued Access|didn't participate continued access period|5
6792488|NCT02660827|10790602|FG000|Period 1: Study Period|Withdrawal by Subject|1
6792489|NCT02660827|10790602|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20
6792490|NCT02660827|10790602|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2
6792491|NCT02660827|10790602|FG000|Period 2: Continued Access Period|Adverse Event|3
6792492|NCT02425644|10790620|FG000|Overall Study|Lost to Follow-up|2
6792493|NCT02425644|10790621|FG001|Overall Study|Lost to Follow-up|3
6792494|NCT02425644|10790620|FG000|Overall Study|Withdrawal by Subject|41
6792495|NCT02425644|10790621|FG001|Overall Study|Withdrawal by Subject|36
6792496|NCT02425644|10790620|FG000|Overall Study|Lack of Efficacy|3
6792497|NCT02425644|10790621|FG001|Overall Study|Lack of Efficacy|10
6792498|NCT02425644|10790620|FG000|Overall Study|Adverse Event|13
6792499|NCT02425644|10790621|FG001|Overall Study|Adverse Event|3
6792500|NCT02425644|10790620|FG000|Overall Study|Death|0
6792501|NCT02425644|10790621|FG001|Overall Study|Death|2
6792502|NCT02425644|10790620|FG000|Overall Study|Other|18
6792503|NCT02425644|10790621|FG001|Overall Study|Other|17
6792504|NCT02340221|10790634|FG000|Overall Study|Death|58
6792505|NCT02340221|10790635|FG001|Overall Study|Death|101
6792506|NCT02340221|10790634|FG000|Overall Study|Withdrawal by Participant|14
6792507|NCT02340221|10790635|FG001|Overall Study|Withdrawal by Participant|22
6792508|NCT02340221|10790634|FG000|Overall Study|Lost to Follow-up|2
6792509|NCT02340221|10790635|FG001|Overall Study|Lost to Follow-up|3
6792510|NCT02340221|10790634|FG000|Overall Study|Reason Not Specified|0
6792511|NCT02340221|10790635|FG001|Overall Study|Reason Not Specified|1
6792512|NCT02340221|10790634|FG000|Overall Study|Continued on study|140
6792513|NCT02340221|10790635|FG001|Overall Study|Continued on study|290
6792514|NCT02270957|10790644|FG000|Overall Study|Lack of Efficacy|2
6792515|NCT02270957|10790645|FG001|Overall Study|Lack of Efficacy|4
6792516|NCT02270957|10790644|FG000|Overall Study|Adverse Event|2
6792517|NCT02270957|10790645|FG001|Overall Study|Adverse Event|0
6792518|NCT02134925|10790654|FG000|Overall Study|Withdrawal by Subject|1
6792519|NCT02134925|10790655|FG001|Overall Study|Withdrawal by Subject|0
6792520|NCT02134925|10790654|FG000|Overall Study|Cancel|1
6792521|NCT02134925|10790655|FG001|Overall Study|Cancel|6
6792522|NCT02054104|10790663|FG000|Overall Study|Did not want to continue due to college classes|1
6792523|NCT02054104|10790664|FG001|Overall Study|Did not want to continue due to college classes|0
6792524|NCT02054104|10790663|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1
6792525|NCT02054104|10790664|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0
6792526|NCT02054104|10790663|FG000|Overall Study|No evidence of immunologic response|2
6792527|NCT02054104|10790664|FG001|Overall Study|No evidence of immunologic response|2
6792528|NCT02054104|10790663|FG000|Overall Study|Disease Progression On Study|4
6792529|NCT02054104|10790664|FG001|Overall Study|Disease Progression On Study|5
6792530|NCT02054104|10790663|FG000|Overall Study|Diagnosis of lymphoma|0
6792531|NCT02054104|10790664|FG001|Overall Study|Diagnosis of lymphoma|1
6792532|NCT02054104|10790663|FG000|Overall Study|Inconclusive response|0
6792540|NCT01757665|10790701|FG000|Overall Study|Still on Study - Visit Completed|240
6792541|NCT01757665|10790702|FG001|Overall Study|Still on Study - Visit Completed|30
6792542|NCT01757665|10790701|FG000|Overall Study|Still on Study - Visit Pending|398
6792543|NCT01757665|10790702|FG001|Overall Study|Still on Study - Visit Pending|40
6792544|NCT01757665|10790701|FG000|Overall Study|Still on Study - Missed Visit|14
6792545|NCT01757665|10790702|FG001|Overall Study|Still on Study - Missed Visit|1
6792546|NCT01757665|10790701|FG000|Overall Study|Death|25
6792547|NCT01757665|10790702|FG001|Overall Study|Death|8
6792548|NCT01757665|10790701|FG000|Overall Study|Explant|1
6792549|NCT01757665|10790702|FG001|Overall Study|Explant|2
6792550|NCT01757665|10790701|FG000|Overall Study|Withdrawal by Subject|10
6792551|NCT01757665|10790702|FG001|Overall Study|Withdrawal by Subject|0
6792552|NCT01757665|10790701|FG000|Overall Study|Lost to Follow-up|1
6792553|NCT01757665|10790702|FG001|Overall Study|Lost to Follow-up|1
6792554|NCT01757665|10790701|FG000|Overall Study|Not Implanted with Device|5
6792555|NCT01757665|10790702|FG001|Overall Study|Not Implanted with Device|1
6792556|NCT00822120|10790743|FG000|Initial Registration|Adverse Event|1
6792557|NCT00822120|10790744|FG001|Initial Registration|Adverse Event|0
6792558|NCT00822120|10790745|FG002|Initial Registration|Adverse Event|0
6792559|NCT00822120|10790746|FG003|Initial Registration|Adverse Event|0
6792560|NCT00822120|10790747|FG004|Initial Registration|Adverse Event|0
6792561|NCT00822120|10790748|FG005|Initial Registration|Adverse Event|0
6792562|NCT00822120|10790743|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1
6792563|NCT00822120|10790744|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0
6792564|NCT00822120|10790745|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0
6792565|NCT00822120|10790746|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0
6792566|NCT00822120|10790747|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0
6792567|NCT00822120|10790748|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0
6792568|NCT00822120|10790743|FG000|Initial Registration|Reasons not Protocol Specified|2
6792569|NCT00822120|10790744|FG001|Initial Registration|Reasons not Protocol Specified|0
6792570|NCT00822120|10790745|FG002|Initial Registration|Reasons not Protocol Specified|0
6792571|NCT00822120|10790746|FG003|Initial Registration|Reasons not Protocol Specified|0
6792572|NCT00822120|10790747|FG004|Initial Registration|Reasons not Protocol Specified|0
6792573|NCT00822120|10790748|FG005|Initial Registration|Reasons not Protocol Specified|0
6792574|NCT00822120|10790743|FG000|Initial Registration|Ineligible|22
6792575|NCT00822120|10790744|FG001|Initial Registration|Ineligible|1
6792576|NCT00822120|10790745|FG002|Initial Registration|Ineligible|0
6792577|NCT00822120|10790746|FG003|Initial Registration|Ineligible|0
6792578|NCT00822120|10790747|FG004|Initial Registration|Ineligible|0
6792579|NCT00822120|10790748|FG005|Initial Registration|Ineligible|0
6792580|NCT00822120|10790743|FG000|PET-directed Therapy|Adverse Event|0
6792581|NCT00822120|10790744|FG001|PET-directed Therapy|Adverse Event|0
6792582|NCT00822120|10790745|FG002|PET-directed Therapy|Adverse Event|0
6792583|NCT00822120|10790746|FG003|PET-directed Therapy|Adverse Event|1
6792584|NCT00822120|10790747|FG004|PET-directed Therapy|Adverse Event|0
6792585|NCT00822120|10790748|FG005|PET-directed Therapy|Adverse Event|0
6792586|NCT00822120|10790743|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
6792587|NCT00822120|10790744|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
6792588|NCT00822120|10790745|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
6792589|NCT00822120|10790746|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1
6792590|NCT00822120|10790747|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
6792591|NCT00822120|10790748|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
6792592|NCT00822120|10790743|FG000|PET-directed Therapy|Death|0
6792593|NCT00822120|10790744|FG001|PET-directed Therapy|Death|0
6792594|NCT00822120|10790745|FG002|PET-directed Therapy|Death|0
6792595|NCT00822120|10790746|FG003|PET-directed Therapy|Death|2
6792596|NCT00822120|10790747|FG004|PET-directed Therapy|Death|0
6792597|NCT00822120|10790748|FG005|PET-directed Therapy|Death|0
6792598|NCT00822120|10790743|FG000|PET-directed Therapy|Protocol Violation|0
6792599|NCT00822120|10790744|FG001|PET-directed Therapy|Protocol Violation|0
6792600|NCT00822120|10790745|FG002|PET-directed Therapy|Protocol Violation|0
6792601|NCT00822120|10790746|FG003|PET-directed Therapy|Protocol Violation|6
6792602|NCT00822120|10790747|FG004|PET-directed Therapy|Protocol Violation|0
6792603|NCT00822120|10790748|FG005|PET-directed Therapy|Protocol Violation|0
6792604|NCT00603954|10790771|FG000|Overall Study|Protocol Violation|1
6792605|NCT00603954|10790772|FG001|Overall Study|Protocol Violation|2
6808038|NCT02810418|10811625|FG005|Dose Expansion|Physician Decision|0
6808039|NCT02810418|10811626|FG006|Dose Expansion|Physician Decision|0
6808040|NCT02810418|10811620|FG000|Arm B Dose Escalation|Adverse Event|0
6808041|NCT02810418|10811621|FG001|Arm B Dose Escalation|Adverse Event|0
6808042|NCT02810418|10811622|FG002|Arm B Dose Escalation|Adverse Event|0
6808043|NCT02810418|10811623|FG003|Arm B Dose Escalation|Adverse Event|0
6808044|NCT02810418|10811624|FG004|Arm B Dose Escalation|Adverse Event|1
6808045|NCT02810418|10811625|FG005|Arm B Dose Escalation|Adverse Event|2
6808046|NCT02810418|10811626|FG006|Arm B Dose Escalation|Adverse Event|0
6810953|NCT02460224|10814930|FG023|Overall Study|Death|0
6810954|NCT02460224|10814931|FG024|Overall Study|Death|1
6810955|NCT02460224|10814932|FG025|Overall Study|Death|1
6810956|NCT02460224|10814933|FG026|Overall Study|Death|5
6810957|NCT02460224|10814934|FG027|Overall Study|Death|0
6810958|NCT02460224|10814935|FG028|Overall Study|Death|1
6792606|NCT04532294|10790786|FG000|Overall Study|Withdrawal by Subject|0
6792607|NCT04532294|10790787|FG001|Overall Study|Withdrawal by Subject|0
6792608|NCT04532294|10790788|FG002|Overall Study|Withdrawal by Subject|1
6792609|NCT04532294|10790786|FG000|Overall Study|Participants Not Dosed|0
6792610|NCT04532294|10790787|FG001|Overall Study|Participants Not Dosed|0
6792611|NCT04532294|10790788|FG002|Overall Study|Participants Not Dosed|2
6792612|NCT04250077|10790801|FG000|Overall Study|Withdrawal by Subject|0
6792613|NCT04250077|10790802|FG001|Overall Study|Withdrawal by Subject|1
6792614|NCT04250077|10790803|FG002|Overall Study|Withdrawal by Subject|0
6792615|NCT04250077|10790801|FG000|Overall Study|Lost to Follow-up|2
6792616|NCT04250077|10790802|FG001|Overall Study|Lost to Follow-up|3
6792617|NCT04250077|10790803|FG002|Overall Study|Lost to Follow-up|0
6792618|NCT03505710|10790857|FG000|Overall Study|Progressive Disease|22
6792619|NCT03505710|10790858|FG001|Overall Study|Progressive Disease|9
6792620|NCT03505710|10790859|FG002|Overall Study|Progressive Disease|34
6792621|NCT03505710|10790857|FG000|Overall Study|Clinical Progression|6
6792622|NCT03505710|10790858|FG001|Overall Study|Clinical Progression|6
6792623|NCT03505710|10790859|FG002|Overall Study|Clinical Progression|3
6792624|NCT03505710|10790857|FG000|Overall Study|Adverse Event|12
6792625|NCT03505710|10790858|FG001|Overall Study|Adverse Event|5
6792626|NCT03505710|10790859|FG002|Overall Study|Adverse Event|27
6792627|NCT03505710|10790857|FG000|Overall Study|Withdrawal by Subject|1
6792628|NCT03505710|10790858|FG001|Overall Study|Withdrawal by Subject|3
6792629|NCT03505710|10790859|FG002|Overall Study|Withdrawal by Subject|3
6792630|NCT03505710|10790857|FG000|Overall Study|Physician Decision|1
6792631|NCT03505710|10790858|FG001|Overall Study|Physician Decision|0
6792632|NCT03505710|10790859|FG002|Overall Study|Physician Decision|2
6792633|NCT03505710|10790857|FG000|Overall Study|Death|4
6792634|NCT03505710|10790858|FG001|Overall Study|Death|3
6792635|NCT03505710|10790859|FG002|Overall Study|Death|6
6792636|NCT03505710|10790857|FG000|Overall Study|Other Reasons|1
6792637|NCT03505710|10790858|FG001|Overall Study|Other Reasons|1
6792638|NCT03505710|10790859|FG002|Overall Study|Other Reasons|1
6792639|NCT03296553|10790869|FG000|Overall Study|Withdrawal by Subject|1
6792640|NCT03296553|10790870|FG001|Overall Study|Withdrawal by Subject|1
6792641|NCT03296553|10790869|FG000|Overall Study|Death|1
6792642|NCT03296553|10790870|FG001|Overall Study|Death|0
6792643|NCT03148795|10790876|FG000|Overall Study|Death|6
6792644|NCT03148795|10790876|FG000|Overall Study|Adverse Event|5
6792645|NCT03148795|10790876|FG000|Overall Study|Other|15
6792646|NCT03148795|10790876|FG000|Overall Study|No Longer Clinically Benefitting|2
6792647|NCT03148795|10790876|FG000|Overall Study|Global Deterioration Of Health Status|6
6792648|NCT03148795|10790876|FG000|Overall Study|Withdrawal by Subject|2
6792649|NCT03148795|10790876|FG000|Overall Study|Progressive Disease|62
6792650|NCT03148795|10790876|FG000|Overall Study|Ongoing|30
6792651|NCT03049449|10790888|FG000|Overall Study|Did not receive treatment.|0
6792652|NCT03049449|10790889|FG001|Overall Study|Did not receive treatment.|0
6792653|NCT03049449|10790890|FG002|Overall Study|Did not receive treatment.|0
6792654|NCT03049449|10790891|FG003|Overall Study|Did not receive treatment.|0
6792655|NCT03049449|10790892|FG004|Overall Study|Did not receive treatment.|0
6792656|NCT03049449|10790893|FG005|Overall Study|Did not receive treatment.|0
6792657|NCT03049449|10790894|FG006|Overall Study|Did not receive treatment.|0
6792658|NCT03049449|10790895|FG007|Overall Study|Did not receive treatment.|0
6792659|NCT03049449|10790896|FG008|Overall Study|Did not receive treatment.|1
6792660|NCT03049449|10790897|FG009|Overall Study|Did not receive treatment.|0
6792661|NCT03049449|10790888|FG000|Overall Study|Enrolled and removed from study with no treatment|0
6792662|NCT03049449|10790889|FG001|Overall Study|Enrolled and removed from study with no treatment|0
6792663|NCT03049449|10790890|FG002|Overall Study|Enrolled and removed from study with no treatment|1
6792664|NCT03049449|10790891|FG003|Overall Study|Enrolled and removed from study with no treatment|1
6792665|NCT03049449|10790892|FG004|Overall Study|Enrolled and removed from study with no treatment|0
6792666|NCT03049449|10790893|FG005|Overall Study|Enrolled and removed from study with no treatment|0
6792667|NCT03049449|10790894|FG006|Overall Study|Enrolled and removed from study with no treatment|0
6792668|NCT03049449|10790895|FG007|Overall Study|Enrolled and removed from study with no treatment|0
6792669|NCT03049449|10790896|FG008|Overall Study|Enrolled and removed from study with no treatment|0
6792670|NCT03049449|10790897|FG009|Overall Study|Enrolled and removed from study with no treatment|0
6792671|NCT03049449|10790888|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0
6792672|NCT03049449|10790889|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0
6792673|NCT03049449|10790890|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0
6792674|NCT03049449|10790891|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0
6792675|NCT03049449|10790892|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0
6792676|NCT03049449|10790893|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0
6792677|NCT03049449|10790894|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0
6792678|NCT03049449|10790895|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1
6792679|NCT03049449|10790896|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0
6792680|NCT03049449|10790897|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1
6792681|NCT03000569|10790917|FG000|Overall Study|Withdrawal by Subject|1
6792682|NCT03000569|10790918|FG001|Overall Study|Withdrawal by Subject|0
6792683|NCT03000530|10790935|FG000|Overall Study|Adverse Event|0
6792684|NCT03000530|10790936|FG001|Overall Study|Adverse Event|0
6792685|NCT03000530|10790937|FG002|Overall Study|Adverse Event|2
6792686|NCT03000530|10790935|FG000|Overall Study|Lost to Follow-up|0
6792687|NCT03000530|10790936|FG001|Overall Study|Lost to Follow-up|3
6792688|NCT03000530|10790937|FG002|Overall Study|Lost to Follow-up|1
6792689|NCT03000530|10790935|FG000|Overall Study|Withdrawal by Subject|0
6792690|NCT03000530|10790936|FG001|Overall Study|Withdrawal by Subject|2
6792691|NCT03000530|10790937|FG002|Overall Study|Withdrawal by Subject|1
6792692|NCT02978781|10790951|FG000|Part A|Adverse Event|1
6792693|NCT02978781|10790952|FG001|Part A|Adverse Event|1
6792694|NCT02978781|10790953|FG002|Part A|Adverse Event|0
6792695|NCT02978781|10790954|FG003|Part A|Adverse Event|0
6792696|NCT02978781|10790955|FG004|Part A|Adverse Event|0
6792697|NCT02978781|10790951|FG000|Part A|Withdrawal by Subject|0
6792698|NCT02978781|10790952|FG001|Part A|Withdrawal by Subject|1
6792699|NCT02978781|10790953|FG002|Part A|Withdrawal by Subject|0
6792700|NCT02978781|10790954|FG003|Part A|Withdrawal by Subject|0
6792701|NCT02978781|10790955|FG004|Part A|Withdrawal by Subject|0
6792702|NCT02978781|10790951|FG000|Part B|Withdrawal by Subject|0
6792703|NCT02978781|10790952|FG001|Part B|Withdrawal by Subject|0
6792704|NCT02978781|10790953|FG002|Part B|Withdrawal by Subject|0
6792705|NCT02978781|10790954|FG003|Part B|Withdrawal by Subject|1
6792706|NCT02978781|10790955|FG004|Part B|Withdrawal by Subject|0
6792707|NCT02978781|10790951|FG000|Part C|Adverse Event|0
6792708|NCT02978781|10790952|FG001|Part C|Adverse Event|0
6792709|NCT02978781|10790953|FG002|Part C|Adverse Event|0
6792710|NCT02978781|10790954|FG003|Part C|Adverse Event|0
6792711|NCT02978781|10790955|FG004|Part C|Adverse Event|2
6792712|NCT02978781|10790951|FG000|Part C|Withdrawal by Subject|0
6792713|NCT02978781|10790952|FG001|Part C|Withdrawal by Subject|0
6792714|NCT02978781|10790953|FG002|Part C|Withdrawal by Subject|0
6792715|NCT02978781|10790954|FG003|Part C|Withdrawal by Subject|0
6792716|NCT02978781|10790955|FG004|Part C|Withdrawal by Subject|1
6792717|NCT02978781|10790951|FG000|Part C|Tremor not improved due to Topamax discontinuation|0
6792718|NCT02978781|10790952|FG001|Part C|Tremor not improved due to Topamax discontinuation|0
6792719|NCT02978781|10790953|FG002|Part C|Tremor not improved due to Topamax discontinuation|0
6792720|NCT02978781|10790954|FG003|Part C|Tremor not improved due to Topamax discontinuation|0
6792721|NCT02978781|10790955|FG004|Part C|Tremor not improved due to Topamax discontinuation|1
6792722|NCT02964507|10790989|FG000|Overall Study|Protocol specified Withdrawal criteria met|0
6792723|NCT02964507|10790990|FG001|Overall Study|Protocol specified Withdrawal criteria met|1
6792724|NCT02964507|10790991|FG002|Overall Study|Protocol specified Withdrawal criteria met|0
6792725|NCT02964507|10790992|FG003|Overall Study|Protocol specified Withdrawal criteria met|0
6792726|NCT02964507|10790993|FG004|Overall Study|Protocol specified Withdrawal criteria met|1
6792727|NCT02964507|10790994|FG005|Overall Study|Protocol specified Withdrawal criteria met|0
6792728|NCT02964507|10790995|FG006|Overall Study|Protocol specified Withdrawal criteria met|0
6792729|NCT02964507|10790996|FG007|Overall Study|Protocol specified Withdrawal criteria met|0
6792730|NCT02964507|10790989|FG000|Overall Study|Ongoing at the time of analysis|1
6792731|NCT02964507|10790990|FG001|Overall Study|Ongoing at the time of analysis|0
6792732|NCT02964507|10790991|FG002|Overall Study|Ongoing at the time of analysis|2
6792733|NCT02964507|10790992|FG003|Overall Study|Ongoing at the time of analysis|0
6792734|NCT02964507|10790993|FG004|Overall Study|Ongoing at the time of analysis|0
6792735|NCT02964507|10790994|FG005|Overall Study|Ongoing at the time of analysis|0
6792736|NCT02964507|10790995|FG006|Overall Study|Ongoing at the time of analysis|0
6792737|NCT02964507|10790996|FG007|Overall Study|Ongoing at the time of analysis|0
6792738|NCT02964507|10790989|FG000|Overall Study|Study terminated by Sponsor|9
6792739|NCT02964507|10790990|FG001|Overall Study|Study terminated by Sponsor|1
6792740|NCT02964507|10790991|FG002|Overall Study|Study terminated by Sponsor|9
6792741|NCT02964507|10790992|FG003|Overall Study|Study terminated by Sponsor|3
6792742|NCT02964507|10790993|FG004|Overall Study|Study terminated by Sponsor|3
6792743|NCT02964507|10790994|FG005|Overall Study|Study terminated by Sponsor|2
6792744|NCT02964507|10790995|FG006|Overall Study|Study terminated by Sponsor|0
6792745|NCT02964507|10790996|FG007|Overall Study|Study terminated by Sponsor|0
6792746|NCT02964507|10790989|FG000|Overall Study|Other|3
6792747|NCT02964507|10790990|FG001|Overall Study|Other|0
6792748|NCT02964507|10790991|FG002|Overall Study|Other|0
6792749|NCT02964507|10790992|FG003|Overall Study|Other|0
6792750|NCT02964507|10790993|FG004|Overall Study|Other|1
6792751|NCT02964507|10790994|FG005|Overall Study|Other|0
6792752|NCT02964507|10790995|FG006|Overall Study|Other|0
6792753|NCT02964507|10790996|FG007|Overall Study|Other|0
6792754|NCT02964507|10790989|FG000|Overall Study|Death|11
6792755|NCT02964507|10790990|FG001|Overall Study|Death|9
6792756|NCT02964507|10790991|FG002|Overall Study|Death|12
6792757|NCT02964507|10790992|FG003|Overall Study|Death|2
6792758|NCT02964507|10790993|FG004|Overall Study|Death|10
6792759|NCT02964507|10790994|FG005|Overall Study|Death|5
6792760|NCT02964507|10790995|FG006|Overall Study|Death|0
6792761|NCT02964507|10790996|FG007|Overall Study|Death|0
6792762|NCT02964507|10790989|FG000|Overall Study|Withdrawal by Subject|1
6792763|NCT02964507|10790990|FG001|Overall Study|Withdrawal by Subject|0
6792764|NCT02964507|10790991|FG002|Overall Study|Withdrawal by Subject|1
6792765|NCT02964507|10790992|FG003|Overall Study|Withdrawal by Subject|1
6792766|NCT02964507|10790993|FG004|Overall Study|Withdrawal by Subject|0
6792767|NCT02964507|10790994|FG005|Overall Study|Withdrawal by Subject|1
6792768|NCT02964507|10790995|FG006|Overall Study|Withdrawal by Subject|0
6792769|NCT02964507|10790996|FG007|Overall Study|Withdrawal by Subject|0
6792770|NCT02964507|10790989|FG000|Overall Study|Physician Decision|1
6792771|NCT02964507|10790990|FG001|Overall Study|Physician Decision|0
6792772|NCT02964507|10790991|FG002|Overall Study|Physician Decision|1
6792773|NCT02964507|10790992|FG003|Overall Study|Physician Decision|0
6792774|NCT02964507|10790993|FG004|Overall Study|Physician Decision|1
6792775|NCT02964507|10790994|FG005|Overall Study|Physician Decision|0
6792776|NCT02964507|10790995|FG006|Overall Study|Physician Decision|0
6792777|NCT02964507|10790996|FG007|Overall Study|Physician Decision|0
6792778|NCT02942277|10791026|FG000|Year 1|Withdrawal by Subject|0
6792779|NCT02942277|10791027|FG001|Year 1|Withdrawal by Subject|0
6792780|NCT02942277|10791028|FG002|Year 1|Withdrawal by Subject|0
6792781|NCT02942277|10791029|FG003|Year 1|Withdrawal by Subject|0
6792782|NCT02942277|10791030|FG004|Year 1|Withdrawal by Subject|1
6792783|NCT02942277|10791031|FG005|Year 1|Withdrawal by Subject|3
6792784|NCT02942277|10791032|FG006|Year 1|Withdrawal by Subject|0
6792785|NCT02942277|10791033|FG007|Year 1|Withdrawal by Subject|1
6792786|NCT02942277|10791034|FG008|Year 1|Withdrawal by Subject|0
6792787|NCT02942277|10791035|FG009|Year 1|Withdrawal by Subject|0
6792788|NCT02942277|10791036|FG010|Year 1|Withdrawal by Subject|3
6792789|NCT02942277|10791026|FG000|Year 1|Travel|0
6792790|NCT02942277|10791027|FG001|Year 1|Travel|1
6792791|NCT02942277|10791028|FG002|Year 1|Travel|0
6792792|NCT02942277|10791029|FG003|Year 1|Travel|0
6792793|NCT02942277|10791030|FG004|Year 1|Travel|4
6792794|NCT02942277|10791031|FG005|Year 1|Travel|5
6792795|NCT02942277|10791032|FG006|Year 1|Travel|0
6792796|NCT02942277|10791033|FG007|Year 1|Travel|0
6792797|NCT02942277|10791034|FG008|Year 1|Travel|0
6792798|NCT02942277|10791035|FG009|Year 1|Travel|0
6792799|NCT02942277|10791036|FG010|Year 1|Travel|8
6792800|NCT02942277|10791026|FG000|Year 1|Joined Army|0
6792801|NCT02942277|10791027|FG001|Year 1|Joined Army|1
6792802|NCT02942277|10791028|FG002|Year 1|Joined Army|0
6792803|NCT02942277|10791029|FG003|Year 1|Joined Army|0
6792804|NCT02942277|10791030|FG004|Year 1|Joined Army|0
6792805|NCT02942277|10791031|FG005|Year 1|Joined Army|0
6792806|NCT02942277|10791032|FG006|Year 1|Joined Army|0
6792807|NCT02942277|10791033|FG007|Year 1|Joined Army|0
6792808|NCT02942277|10791034|FG008|Year 1|Joined Army|0
6792809|NCT02942277|10791035|FG009|Year 1|Joined Army|0
6792810|NCT02942277|10791036|FG010|Year 1|Joined Army|0
6792811|NCT02942277|10791026|FG000|Year 1|Subject met withdrawal criteria|0
6792812|NCT02942277|10791027|FG001|Year 1|Subject met withdrawal criteria|0
6792813|NCT02942277|10791028|FG002|Year 1|Subject met withdrawal criteria|0
6792814|NCT02942277|10791029|FG003|Year 1|Subject met withdrawal criteria|1
6792815|NCT02942277|10791030|FG004|Year 1|Subject met withdrawal criteria|0
6792816|NCT02942277|10791031|FG005|Year 1|Subject met withdrawal criteria|0
6792817|NCT02942277|10791032|FG006|Year 1|Subject met withdrawal criteria|0
6792818|NCT02942277|10791033|FG007|Year 1|Subject met withdrawal criteria|0
6792819|NCT02942277|10791034|FG008|Year 1|Subject met withdrawal criteria|0
6792820|NCT02942277|10791035|FG009|Year 1|Subject met withdrawal criteria|0
6792821|NCT02942277|10791036|FG010|Year 1|Subject met withdrawal criteria|0
6792822|NCT02942277|10791026|FG000|Year 1|Lost to Follow-up|0
6792823|NCT02942277|10791027|FG001|Year 1|Lost to Follow-up|0
6792824|NCT02942277|10791028|FG002|Year 1|Lost to Follow-up|0
6792825|NCT02942277|10791029|FG003|Year 1|Lost to Follow-up|0
6792826|NCT02942277|10791030|FG004|Year 1|Lost to Follow-up|1
6792827|NCT02942277|10791031|FG005|Year 1|Lost to Follow-up|0
6792828|NCT02942277|10791032|FG006|Year 1|Lost to Follow-up|0
6792829|NCT02942277|10791033|FG007|Year 1|Lost to Follow-up|0
6792830|NCT02942277|10791034|FG008|Year 1|Lost to Follow-up|0
6792831|NCT02942277|10791035|FG009|Year 1|Lost to Follow-up|0
6792832|NCT02942277|10791036|FG010|Year 1|Lost to Follow-up|2
6792833|NCT02942277|10791026|FG000|Year 1|Protocol Violation|0
6792834|NCT02942277|10791027|FG001|Year 1|Protocol Violation|0
6792835|NCT02942277|10791028|FG002|Year 1|Protocol Violation|0
6792836|NCT02942277|10791029|FG003|Year 1|Protocol Violation|0
6792837|NCT02942277|10791030|FG004|Year 1|Protocol Violation|1
6792838|NCT02942277|10791031|FG005|Year 1|Protocol Violation|1
6792839|NCT02942277|10791032|FG006|Year 1|Protocol Violation|0
6792840|NCT02942277|10791033|FG007|Year 1|Protocol Violation|0
6792841|NCT02942277|10791034|FG008|Year 1|Protocol Violation|0
6792842|NCT02942277|10791035|FG009|Year 1|Protocol Violation|0
6792843|NCT02942277|10791036|FG010|Year 1|Protocol Violation|2
6792844|NCT02942277|10791026|FG000|Year 1|Pregnancy|0
6792845|NCT02942277|10791027|FG001|Year 1|Pregnancy|0
6792846|NCT02942277|10791028|FG002|Year 1|Pregnancy|0
6792847|NCT02942277|10791029|FG003|Year 1|Pregnancy|0
6792848|NCT02942277|10791030|FG004|Year 1|Pregnancy|0
6792849|NCT02942277|10791031|FG005|Year 1|Pregnancy|1
6792850|NCT02942277|10791032|FG006|Year 1|Pregnancy|0
6792851|NCT02942277|10791033|FG007|Year 1|Pregnancy|0
6792852|NCT02942277|10791034|FG008|Year 1|Pregnancy|0
6792853|NCT02942277|10791035|FG009|Year 1|Pregnancy|0
6792854|NCT02942277|10791036|FG010|Year 1|Pregnancy|0
6792855|NCT02942277|10791026|FG000|Year 2|Lost to Follow-up|0
6792856|NCT02942277|10791027|FG001|Year 2|Lost to Follow-up|0
6792857|NCT02942277|10791028|FG002|Year 2|Lost to Follow-up|0
6792858|NCT02942277|10791029|FG003|Year 2|Lost to Follow-up|0
6792859|NCT02942277|10791030|FG004|Year 2|Lost to Follow-up|2
6792860|NCT02942277|10791031|FG005|Year 2|Lost to Follow-up|1
6792861|NCT02942277|10791032|FG006|Year 2|Lost to Follow-up|0
6792862|NCT02942277|10791033|FG007|Year 2|Lost to Follow-up|0
6792863|NCT02942277|10791034|FG008|Year 2|Lost to Follow-up|0
6792864|NCT02942277|10791035|FG009|Year 2|Lost to Follow-up|0
6792865|NCT02942277|10791036|FG010|Year 2|Lost to Follow-up|0
6792866|NCT02942277|10791026|FG000|Year 2|Did not rescreen|0
6792867|NCT02942277|10791027|FG001|Year 2|Did not rescreen|0
6792868|NCT02942277|10791028|FG002|Year 2|Did not rescreen|1
6792869|NCT02942277|10791029|FG003|Year 2|Did not rescreen|1
6792870|NCT02942277|10791030|FG004|Year 2|Did not rescreen|9
6792871|NCT02942277|10791031|FG005|Year 2|Did not rescreen|6
6792872|NCT02942277|10791032|FG006|Year 2|Did not rescreen|0
6792873|NCT02942277|10791033|FG007|Year 2|Did not rescreen|1
6792874|NCT02942277|10791034|FG008|Year 2|Did not rescreen|0
6792875|NCT02942277|10791035|FG009|Year 2|Did not rescreen|0
6792876|NCT02942277|10791036|FG010|Year 2|Did not rescreen|21
6792877|NCT02942277|10791026|FG000|Year 2|Met withdrawal criteria|0
6792878|NCT02942277|10791027|FG001|Year 2|Met withdrawal criteria|0
6792879|NCT02942277|10791028|FG002|Year 2|Met withdrawal criteria|0
6792880|NCT02942277|10791029|FG003|Year 2|Met withdrawal criteria|0
6792881|NCT02942277|10791030|FG004|Year 2|Met withdrawal criteria|1
6792882|NCT02942277|10791031|FG005|Year 2|Met withdrawal criteria|2
6792883|NCT02942277|10791032|FG006|Year 2|Met withdrawal criteria|0
6792884|NCT02942277|10791033|FG007|Year 2|Met withdrawal criteria|0
6792885|NCT02942277|10791034|FG008|Year 2|Met withdrawal criteria|0
6792886|NCT02942277|10791035|FG009|Year 2|Met withdrawal criteria|0
6792887|NCT02942277|10791036|FG010|Year 2|Met withdrawal criteria|1
6792888|NCT02942277|10791026|FG000|Year 2|Travel|0
6792889|NCT02942277|10791027|FG001|Year 2|Travel|1
6792890|NCT02942277|10791028|FG002|Year 2|Travel|0
6792891|NCT02942277|10791029|FG003|Year 2|Travel|0
6792892|NCT02942277|10791030|FG004|Year 2|Travel|0
6792893|NCT02942277|10791031|FG005|Year 2|Travel|1
6792894|NCT02942277|10791032|FG006|Year 2|Travel|0
6792895|NCT02942277|10791033|FG007|Year 2|Travel|0
6792896|NCT02942277|10791034|FG008|Year 2|Travel|0
6792897|NCT02942277|10791035|FG009|Year 2|Travel|1
6792898|NCT02942277|10791036|FG010|Year 2|Travel|3
6792899|NCT02942277|10791026|FG000|Year 2|Non-compliant|0
6792900|NCT02942277|10791027|FG001|Year 2|Non-compliant|0
6792901|NCT02942277|10791028|FG002|Year 2|Non-compliant|0
6792902|NCT02942277|10791029|FG003|Year 2|Non-compliant|0
6792903|NCT02942277|10791030|FG004|Year 2|Non-compliant|1
6792904|NCT02942277|10791031|FG005|Year 2|Non-compliant|1
6792905|NCT02942277|10791032|FG006|Year 2|Non-compliant|0
6792906|NCT02942277|10791033|FG007|Year 2|Non-compliant|0
6792907|NCT02942277|10791034|FG008|Year 2|Non-compliant|0
6792908|NCT02942277|10791035|FG009|Year 2|Non-compliant|0
6792909|NCT02942277|10791036|FG010|Year 2|Non-compliant|0
6792910|NCT02942277|10791026|FG000|Year 2|Withdrawal by Subject|0
6792911|NCT02942277|10791027|FG001|Year 2|Withdrawal by Subject|0
6792912|NCT02942277|10791028|FG002|Year 2|Withdrawal by Subject|0
6792913|NCT02942277|10791029|FG003|Year 2|Withdrawal by Subject|0
6792914|NCT02942277|10791030|FG004|Year 2|Withdrawal by Subject|0
6792915|NCT02942277|10791031|FG005|Year 2|Withdrawal by Subject|0
6792916|NCT02942277|10791032|FG006|Year 2|Withdrawal by Subject|1
6792917|NCT02942277|10791033|FG007|Year 2|Withdrawal by Subject|0
6792918|NCT02942277|10791034|FG008|Year 2|Withdrawal by Subject|0
6792919|NCT02942277|10791035|FG009|Year 2|Withdrawal by Subject|0
6792920|NCT02942277|10791036|FG010|Year 2|Withdrawal by Subject|0
6792921|NCT02942017|10791065|FG000|Overall Study|Adverse Event|0
6792922|NCT02942017|10791066|FG001|Overall Study|Adverse Event|1
6792923|NCT02942017|10791065|FG000|Overall Study|Withdrawal by Subject|0
6792924|NCT02942017|10791066|FG001|Overall Study|Withdrawal by Subject|1
6792925|NCT02942017|10791065|FG000|Overall Study|Lost to Follow-up|1
6792926|NCT02942017|10791066|FG001|Overall Study|Lost to Follow-up|1
6792927|NCT02942017|10791065|FG000|Overall Study|Randomized but not dosed|1
6792928|NCT02942017|10791066|FG001|Overall Study|Randomized but not dosed|3
6792929|NCT02942004|10791075|FG000|Overall Study|Withdrawal by Subject|0
6792930|NCT02942004|10791076|FG001|Overall Study|Withdrawal by Subject|2
6792931|NCT02942004|10791077|FG002|Overall Study|Withdrawal by Subject|3
6792932|NCT02942004|10791075|FG000|Overall Study|Lost to Follow-up|1
6792933|NCT02942004|10791076|FG001|Overall Study|Lost to Follow-up|1
6792934|NCT02942004|10791077|FG002|Overall Study|Lost to Follow-up|2
6792935|NCT02942004|10791075|FG000|Overall Study|Randomized but not dosed|3
6792936|NCT02942004|10791076|FG001|Overall Study|Randomized but not dosed|9
6792937|NCT02942004|10791077|FG002|Overall Study|Randomized but not dosed|4
6792938|NCT02861014|10791085|FG000|Primary Analysis|Adverse Event|7
6792939|NCT02861014|10791085|FG000|Primary Analysis|Death|1
6792940|NCT02861014|10791085|FG000|Primary Analysis|Lack of Efficacy|3
6792941|NCT02861014|10791085|FG000|Primary Analysis|Physician Decision|2
6792942|NCT02861014|10791085|FG000|Primary Analysis|Pregnancy|4
6792943|NCT02861014|10791085|FG000|Primary Analysis|Protocol Violation|2
6792944|NCT02861014|10791085|FG000|Primary Analysis|Study Terminated By Sponsor|3
6792945|NCT02861014|10791085|FG000|Primary Analysis|Withdrawal by Subject|14
6792946|NCT02861014|10791085|FG000|Primary Analysis|Commercial ocrelizumab|3
6792947|NCT02861014|10791085|FG000|Safety Follow-up|Adverse Event|1
6792948|NCT02861014|10791085|FG000|Safety Follow-up|Pregnancy|1
6792949|NCT02861014|10791085|FG000|Safety Follow-up|Withdrawal by Subject|9
6792950|NCT02861014|10791085|FG000|Safety Follow-up|Study terminated by sponsor|1
6792951|NCT02861014|10791085|FG000|Safety Follow-up|Physician Decision|1
6792952|NCT02861014|10791085|FG000|Safety Follow-up|Roll-over to a long term extension study|1
6792953|NCT02861014|10791085|FG000|Safety Follow-up|Commercial ocrelizumab|36
6808047|NCT02781584|10811707|FG000|Pre-treatment Phase|Investigator's Discretion|0
6808048|NCT02781584|10811708|FG001|Pre-treatment Phase|Investigator's Discretion|0
6808049|NCT02781584|10811709|FG002|Pre-treatment Phase|Investigator's Discretion|0
6808050|NCT02781584|10811710|FG003|Pre-treatment Phase|Investigator's Discretion|0
6808051|NCT02781584|10811711|FG004|Pre-treatment Phase|Investigator's Discretion|0
6808052|NCT02781584|10811712|FG005|Pre-treatment Phase|Investigator's Discretion|0
6808053|NCT02781584|10811713|FG006|Pre-treatment Phase|Investigator's Discretion|0
6808054|NCT02781584|10811714|FG007|Pre-treatment Phase|Investigator's Discretion|0
6808055|NCT02781584|10811715|FG008|Pre-treatment Phase|Investigator's Discretion|0
6808056|NCT02781584|10811716|FG009|Pre-treatment Phase|Investigator's Discretion|0
6808057|NCT02781584|10811717|FG010|Pre-treatment Phase|Investigator's Discretion|0
6808058|NCT02781584|10811718|FG011|Pre-treatment Phase|Investigator's Discretion|2
6808059|NCT02781584|10811719|FG012|Pre-treatment Phase|Investigator's Discretion|1
6808060|NCT02781584|10811707|FG000|Pre-treatment Phase|Adverse Event|0
6808061|NCT02781584|10811708|FG001|Pre-treatment Phase|Adverse Event|0
6808062|NCT02781584|10811709|FG002|Pre-treatment Phase|Adverse Event|0
6808063|NCT02781584|10811710|FG003|Pre-treatment Phase|Adverse Event|0
6808064|NCT02781584|10811711|FG004|Pre-treatment Phase|Adverse Event|0
6808065|NCT02781584|10811712|FG005|Pre-treatment Phase|Adverse Event|0
6808066|NCT02781584|10811713|FG006|Pre-treatment Phase|Adverse Event|0
6808067|NCT02781584|10811714|FG007|Pre-treatment Phase|Adverse Event|0
6808068|NCT02781584|10811715|FG008|Pre-treatment Phase|Adverse Event|0
6808069|NCT02781584|10811716|FG009|Pre-treatment Phase|Adverse Event|0
6808070|NCT02781584|10811717|FG010|Pre-treatment Phase|Adverse Event|0
6808071|NCT02781584|10811718|FG011|Pre-treatment Phase|Adverse Event|1
6808072|NCT02781584|10811719|FG012|Pre-treatment Phase|Adverse Event|0
6792954|NCT02775435|10791093|FG000|Overall Study|Adverse Event|48
6792955|NCT02775435|10791094|FG001|Overall Study|Adverse Event|25
6792956|NCT02775435|10791093|FG000|Overall Study|Lost to Follow-up|0
6792957|NCT02775435|10791094|FG001|Overall Study|Lost to Follow-up|2
6792958|NCT02775435|10791093|FG000|Overall Study|Physician Decision|5
6792959|NCT02775435|10791094|FG001|Overall Study|Physician Decision|6
6792960|NCT02775435|10791093|FG000|Overall Study|Withdrawal by Subject|5
6792961|NCT02775435|10791094|FG001|Overall Study|Withdrawal by Subject|9
6792962|NCT02775435|10791093|FG000|Overall Study|Progressive Disease|86
6792963|NCT02775435|10791094|FG001|Overall Study|Progressive Disease|140
6792964|NCT02775435|10791093|FG000|Overall Study|Clinical Progression|13
6792965|NCT02775435|10791094|FG001|Overall Study|Clinical Progression|26
6792966|NCT02775435|10791093|FG000|Overall Study|Ongoing in Study|121
6792967|NCT02775435|10791094|FG001|Overall Study|Ongoing in Study|72
6792968|NCT02775435|10791093|FG000|Overall Study|Not Treated|0
6792969|NCT02775435|10791094|FG001|Overall Study|Not Treated|1
6792970|NCT02726880|10791109|FG000|Overall Study|Withdrawal by Subject|2
6792971|NCT02726880|10791110|FG001|Overall Study|Withdrawal by Subject|0
6792972|NCT02726880|10791109|FG000|Overall Study|Lost to Follow-up|1
6792973|NCT02726880|10791110|FG001|Overall Study|Lost to Follow-up|3
6792974|NCT02592551|10791132|FG000|Overall Study|Not evaluable|1
6792975|NCT02592551|10791133|FG001|Overall Study|Not evaluable|3
6792976|NCT02592551|10791134|FG002|Overall Study|Not evaluable|0
6792977|NCT02583048|10791146|FG000|Overall Study|Withdrawal by Subject|0
6792978|NCT02583048|10791147|FG001|Overall Study|Withdrawal by Subject|1
6792979|NCT02583048|10791148|FG002|Overall Study|Withdrawal by Subject|0
6792980|NCT02583048|10791146|FG000|Overall Study|Failed to meet eligibility criterion|0
6792981|NCT02583048|10791147|FG001|Overall Study|Failed to meet eligibility criterion|0
6792982|NCT02583048|10791148|FG002|Overall Study|Failed to meet eligibility criterion|1
6792983|NCT02546986|10791161|FG000|Treatment Period|Progressive Disease|20
6792984|NCT02546986|10791162|FG001|Treatment Period|Progressive Disease|22
6792985|NCT02546986|10791161|FG000|Treatment Period|Adverse Event|14
6792986|NCT02546986|10791162|FG001|Treatment Period|Adverse Event|6
6792987|NCT02546986|10791161|FG000|Treatment Period|Symptomatic Deterioration|4
6792988|NCT02546986|10791162|FG001|Treatment Period|Symptomatic Deterioration|3
6792989|NCT02546986|10791161|FG000|Treatment Period|Death|3
6792990|NCT02546986|10791162|FG001|Treatment Period|Death|4
6792991|NCT02546986|10791161|FG000|Treatment Period|Physician Decision|1
6792992|NCT02546986|10791162|FG001|Treatment Period|Physician Decision|2
6792993|NCT02546986|10791161|FG000|Treatment Period|Protocol Violation|1
6792994|NCT02546986|10791162|FG001|Treatment Period|Protocol Violation|0
6792995|NCT02546986|10791161|FG000|Treatment Period|Withdrawal by Subject|1
6792996|NCT02546986|10791162|FG001|Treatment Period|Withdrawal by Subject|1
6792997|NCT02546986|10791161|FG000|Treatment Period|Non-compliance with Study Drug|0
6792998|NCT02546986|10791162|FG001|Treatment Period|Non-compliance with Study Drug|1
6792999|NCT02546986|10791161|FG000|Treatment Period|Study Terminated by Sponsor|0
6793000|NCT02546986|10791162|FG001|Treatment Period|Study Terminated by Sponsor|1
6793001|NCT02546986|10791161|FG000|Treatment Period|Miscellaneous|7
6793002|NCT02546986|10791162|FG001|Treatment Period|Miscellaneous|9
6793003|NCT02546986|10791161|FG000|Survival Follow-Up Phase|Missing Status|3
6793004|NCT02546986|10791162|FG001|Survival Follow-Up Phase|Missing Status|5
6793005|NCT02546986|10791161|FG000|Survival Follow-Up Phase|Death|18
6793006|NCT02546986|10791162|FG001|Survival Follow-Up Phase|Death|12
6793007|NCT02546986|10791161|FG000|Survival Follow-Up Phase|Alive|13
6793008|NCT02546986|10791162|FG001|Survival Follow-Up Phase|Alive|16
6793009|NCT02546986|10791161|FG000|Survival Follow-Up Phase|Lost to Follow-up|2
6793010|NCT02546986|10791162|FG001|Survival Follow-Up Phase|Lost to Follow-up|2
6793011|NCT02539160|10791170|FG000|Phase 1 Pre-crossover|Adverse Event|3
6793012|NCT02539160|10791171|FG001|Phase 1 Pre-crossover|Adverse Event|3
6793013|NCT02539160|10791172|FG002|Phase 1 Pre-crossover|Adverse Event|2
6793014|NCT02539160|10791173|FG003|Phase 1 Pre-crossover|Adverse Event|1
6793015|NCT02539160|10791170|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2
6793016|NCT02539160|10791171|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1
6793017|NCT02539160|10791172|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1
6793018|NCT02539160|10791173|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0
6793019|NCT02539160|10791170|FG000|Phase 1 Pre-crossover|Protocol Violation|0
6793020|NCT02539160|10791171|FG001|Phase 1 Pre-crossover|Protocol Violation|0
6793021|NCT02539160|10791172|FG002|Phase 1 Pre-crossover|Protocol Violation|0
6793022|NCT02539160|10791173|FG003|Phase 1 Pre-crossover|Protocol Violation|2
6793023|NCT02507973|10791183|FG000|Overall Study|Adverse Event|1
6793024|NCT02477618|10791191|FG000|Overall Study|Completed Visits but Discontinued Drug|2
6793025|NCT02477618|10791192|FG001|Overall Study|Completed Visits but Discontinued Drug|1
6793026|NCT02477618|10791191|FG000|Overall Study|Died in Double-Blind Treatment Period|11
6793027|NCT02477618|10791192|FG001|Overall Study|Died in Double-Blind Treatment Period|11
6793028|NCT02477618|10791191|FG000|Overall Study|Adverse Event|1
6793029|NCT02477618|10791192|FG001|Overall Study|Adverse Event|1
6793030|NCT02477618|10791191|FG000|Overall Study|Transferred Away from Study Site|1
6793031|NCT02477618|10791192|FG001|Overall Study|Transferred Away from Study Site|0
6793032|NCT02477618|10791191|FG000|Overall Study|Left Study Site for Rehabilitation|0
6793033|NCT02477618|10791192|FG001|Overall Study|Left Study Site for Rehabilitation|1
6793034|NCT02003924|10791224|FG000|Double-blind Phase|Lost to Follow-up|2
6793035|NCT02003924|10791225|FG001|Double-blind Phase|Lost to Follow-up|1
6793036|NCT02003924|10791226|FG002|Double-blind Phase|Lost to Follow-up|0
6793037|NCT02003924|10791224|FG000|Double-blind Phase|Protocol Violation|1
6793038|NCT02003924|10791225|FG001|Double-blind Phase|Protocol Violation|2
6793039|NCT02003924|10791226|FG002|Double-blind Phase|Protocol Violation|0
6793040|NCT02003924|10791224|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71
6793041|NCT02003924|10791225|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47
6793042|NCT02003924|10791226|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0
6793043|NCT02003924|10791224|FG000|Double-blind Phase|Disease Progression|229
6793044|NCT02003924|10791225|FG001|Double-blind Phase|Disease Progression|247
6793045|NCT02003924|10791226|FG002|Double-blind Phase|Disease Progression|0
6793046|NCT02003924|10791224|FG000|Double-blind Phase|Adverse Event|120
6793047|NCT02003924|10791225|FG001|Double-blind Phase|Adverse Event|31
6793048|NCT02003924|10791226|FG002|Double-blind Phase|Adverse Event|0
6793049|NCT02003924|10791224|FG000|Double-blind Phase|Randomized But not Treated|3
6793050|NCT02003924|10791225|FG001|Double-blind Phase|Randomized But not Treated|3
6793051|NCT02003924|10791226|FG002|Double-blind Phase|Randomized But not Treated|0
6793052|NCT02003924|10791224|FG000|Double-blind Phase|Other|29
6793053|NCT02003924|10791225|FG001|Double-blind Phase|Other|50
6793054|NCT02003924|10791226|FG002|Double-blind Phase|Other|0
6793055|NCT02003924|10791224|FG000|Open-label Phase|Lost to Follow-up|0
6793056|NCT02003924|10791225|FG001|Open-label Phase|Lost to Follow-up|0
6793057|NCT02003924|10791226|FG002|Open-label Phase|Lost to Follow-up|1
6793058|NCT02003924|10791224|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9
6793059|NCT02003924|10791225|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0
6793060|NCT02003924|10791226|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1
6793061|NCT02003924|10791224|FG000|Open-label Phase|Disease Progression|59
6793062|NCT02003924|10791225|FG001|Open-label Phase|Disease Progression|0
6793063|NCT02003924|10791226|FG002|Open-label Phase|Disease Progression|5
6793064|NCT02003924|10791224|FG000|Open-label Phase|Adverse Event|25
6793065|NCT02003924|10791225|FG001|Open-label Phase|Adverse Event|0
6793066|NCT02003924|10791226|FG002|Open-label Phase|Adverse Event|10
6793067|NCT02003924|10791224|FG000|Open-label Phase|Other|7
6793068|NCT02003924|10791225|FG001|Open-label Phase|Other|0
6793069|NCT02003924|10791226|FG002|Open-label Phase|Other|0
6793070|NCT02003924|10791224|FG000|Long-term Follow-up Phase|Death|288
6793071|NCT02003924|10791225|FG001|Long-term Follow-up Phase|Death|174
6793072|NCT02003924|10791226|FG002|Long-term Follow-up Phase|Death|4
6793073|NCT02003924|10791224|FG000|Long-term Follow-up Phase|Lost to Follow-up|8
6793074|NCT02003924|10791225|FG001|Long-term Follow-up Phase|Lost to Follow-up|6
6793075|NCT02003924|10791226|FG002|Long-term Follow-up Phase|Lost to Follow-up|1
6793076|NCT02003924|10791224|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66
6793077|NCT02003924|10791225|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55
6793078|NCT02003924|10791226|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1
6793079|NCT02003924|10791224|FG000|Long-term Follow-up Phase|Other|5
6793080|NCT02003924|10791225|FG001|Long-term Follow-up Phase|Other|2
6793081|NCT02003924|10791226|FG002|Long-term Follow-up Phase|Other|1
6793082|NCT01971970|10791235|FG000|Baseline Until Week 6|Stopped anti-TNF use|1
6793083|NCT01971970|10791236|FG001|Baseline Until Week 6|Stopped anti-TNF use|0
6793084|NCT01971970|10791235|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0
6793085|NCT01971970|10791236|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1
6793086|NCT01971970|10791235|FG000|Week 14 Until Week 22|Lost to Follow-up|0
6793087|NCT01971970|10791236|FG001|Week 14 Until Week 22|Lost to Follow-up|1
6793088|NCT01971970|10791235|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7
6793089|NCT01971970|10791236|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3
6793090|NCT01971970|10791235|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1
6793091|NCT01971970|10791236|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0
6793092|NCT01971970|10791235|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0
6793093|NCT01971970|10791236|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1
6793094|NCT01971970|10791235|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1
6793095|NCT01971970|10791236|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3
6793096|NCT01969409|10791249|FG000|Overall Study|Death|2
6793097|NCT01969409|10791250|FG001|Overall Study|Death|2
6793098|NCT01969409|10791249|FG000|Overall Study|Transplant|1
6793099|NCT01969409|10791250|FG001|Overall Study|Transplant|1
6793100|NCT01969409|10791249|FG000|Overall Study|Withdrawal by Subject|0
6793101|NCT01969409|10791250|FG001|Overall Study|Withdrawal by Subject|1
6793102|NCT01459497|10791258|FG000|Overall Study|Inability to meet trial constraints.|1
6793103|NCT01459497|10791259|FG001|Overall Study|Inability to meet trial constraints.|0
6793104|NCT01459497|10791258|FG000|Overall Study|Physician Decision|1
6793105|NCT01459497|10791259|FG001|Overall Study|Physician Decision|1
6793106|NCT01459497|10791258|FG000|Overall Study|Hospitalization.|0
6793107|NCT01459497|10791259|FG001|Overall Study|Hospitalization.|3
6793108|NCT01459497|10791258|FG000|Overall Study|Disease progression.|0
6793109|NCT01459497|10791259|FG001|Overall Study|Disease progression.|1
6793110|NCT01307787|10791267|FG000|Overall Study|Withdrawal by Subject|2
6793111|NCT01307787|10791268|FG001|Overall Study|Withdrawal by Subject|0
6793112|NCT01250912|10791279|FG000|Overall Study|Lost to Follow-up|1
6793113|NCT01141712|10791295|FG000|Overall Study|Disease progression|3
6808073|NCT02781584|10811707|FG000|Treatment Phase|Withdrew Consent|0
6808074|NCT02781584|10811708|FG001|Treatment Phase|Withdrew Consent|0
6808075|NCT02781584|10811709|FG002|Treatment Phase|Withdrew Consent|0
6808076|NCT02781584|10811710|FG003|Treatment Phase|Withdrew Consent|0
6808077|NCT02781584|10811711|FG004|Treatment Phase|Withdrew Consent|0
6808078|NCT02781584|10811712|FG005|Treatment Phase|Withdrew Consent|1
6808079|NCT02781584|10811713|FG006|Treatment Phase|Withdrew Consent|0
6808080|NCT02781584|10811714|FG007|Treatment Phase|Withdrew Consent|0
6808081|NCT02781584|10811715|FG008|Treatment Phase|Withdrew Consent|0
6808082|NCT02781584|10811716|FG009|Treatment Phase|Withdrew Consent|0
6808083|NCT02781584|10811717|FG010|Treatment Phase|Withdrew Consent|1
6808084|NCT02781584|10811718|FG011|Treatment Phase|Withdrew Consent|2
6808085|NCT02781584|10811719|FG012|Treatment Phase|Withdrew Consent|0
6808086|NCT02781584|10811707|FG000|Treatment Phase|Adverse Event|0
6808087|NCT02781584|10811708|FG001|Treatment Phase|Adverse Event|0
6808088|NCT02781584|10811709|FG002|Treatment Phase|Adverse Event|0
6808089|NCT02781584|10811710|FG003|Treatment Phase|Adverse Event|0
6808090|NCT02781584|10811711|FG004|Treatment Phase|Adverse Event|0
6808091|NCT02781584|10811712|FG005|Treatment Phase|Adverse Event|0
6808092|NCT02781584|10811713|FG006|Treatment Phase|Adverse Event|0
6808093|NCT02781584|10811714|FG007|Treatment Phase|Adverse Event|1
6808094|NCT02781584|10811715|FG008|Treatment Phase|Adverse Event|0
6808095|NCT02781584|10811716|FG009|Treatment Phase|Adverse Event|0
6808096|NCT02781584|10811717|FG010|Treatment Phase|Adverse Event|0
6808097|NCT02781584|10811718|FG011|Treatment Phase|Adverse Event|0
6808098|NCT02781584|10811719|FG012|Treatment Phase|Adverse Event|0
6808099|NCT02714062|10811754|FG000|Overall Study|Adverse Event|0
6808100|NCT02714062|10811755|FG001|Overall Study|Adverse Event|0
6808101|NCT02714062|10811756|FG002|Overall Study|Adverse Event|2
6808102|NCT02714062|10811754|FG000|Overall Study|Withdrawal by Subject|1
6808103|NCT02714062|10811755|FG001|Overall Study|Withdrawal by Subject|0
6808104|NCT02714062|10811756|FG002|Overall Study|Withdrawal by Subject|1
6808105|NCT02714062|10811754|FG000|Overall Study|Protocol Violation|0
6808106|NCT02714062|10811755|FG001|Overall Study|Protocol Violation|1
6808107|NCT02714062|10811756|FG002|Overall Study|Protocol Violation|0
6808108|NCT02707055|10811768|FG000|Phase 1|Withdrawal by Subject|1
6808109|NCT02707055|10811769|FG001|Phase 1|Withdrawal by Subject|2
6808110|NCT02707055|10811768|FG000|Phase 1|Physician Decision|0
6808111|NCT02707055|10811769|FG001|Phase 1|Physician Decision|1
6808112|NCT02707055|10811768|FG000|Phase 2|Adverse Event|1
6808113|NCT02707055|10811769|FG001|Phase 2|Adverse Event|2
6808114|NCT02656290|10811779|FG000|Overall Study|Subjects Remain On Study|26
6808115|NCT02652130|10811783|FG000|Overall Study|Death|1
6808116|NCT02616393|10811790|FG000|Overall Study|Death|5
6808117|NCT02616393|10811791|FG001|Overall Study|Death|12
6808118|NCT02616393|10811792|FG002|Overall Study|Death|1
6808119|NCT02616393|10811790|FG000|Overall Study|Termination by Sponsor|4
6808120|NCT02616393|10811791|FG001|Overall Study|Termination by Sponsor|5
6808121|NCT02616393|10811792|FG002|Overall Study|Termination by Sponsor|2
6808122|NCT02616393|10811790|FG000|Overall Study|Other|3
6808123|NCT02616393|10811791|FG001|Overall Study|Other|0
6808124|NCT02616393|10811792|FG002|Overall Study|Other|0
6808125|NCT02616393|10811790|FG000|Overall Study|Withdrawal by Subject|1
6808126|NCT02616393|10811791|FG001|Overall Study|Withdrawal by Subject|1
6808127|NCT02616393|10811792|FG002|Overall Study|Withdrawal by Subject|0
6808128|NCT02616393|10811790|FG000|Overall Study|Lost to Follow-up|0
6808129|NCT02616393|10811791|FG001|Overall Study|Lost to Follow-up|2
6808130|NCT02616393|10811792|FG002|Overall Study|Lost to Follow-up|0
6808131|NCT02602288|10811818|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14
6808132|NCT02602288|10811819|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10
6808133|NCT02602288|10811818|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2
6808134|NCT02602288|10811819|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2
6808135|NCT02602288|10811818|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9
6808136|NCT02602288|10811819|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6
6808137|NCT02602288|10811818|FG000|12 Month Follow-up|Lost to Follow-up|0
6808138|NCT02602288|10811819|FG001|12 Month Follow-up|Lost to Follow-up|4
6808139|NCT02602288|10811818|FG000|12 Month Follow-up|Withdrawal by Subject|2
6808140|NCT02602288|10811819|FG001|12 Month Follow-up|Withdrawal by Subject|0
6808141|NCT02577523|10811827|FG000|Overall Study|Adverse Event|1
6808142|NCT02577523|10811828|FG001|Overall Study|Adverse Event|1
6808143|NCT02577523|10811827|FG000|Overall Study|Lack of Efficacy|1
6808144|NCT02577523|10811828|FG001|Overall Study|Lack of Efficacy|1
6808145|NCT02577523|10811827|FG000|Overall Study|Withdrawal by Subject|1
6808146|NCT02577523|10811828|FG001|Overall Study|Withdrawal by Subject|0
6808147|NCT02563002|10811836|FG000|Overall Study|Death|62
6808148|NCT02563002|10811837|FG001|Overall Study|Death|75
6808149|NCT02563002|10811836|FG000|Overall Study|Lost to Follow-up|1
6808150|NCT02563002|10811837|FG001|Overall Study|Lost to Follow-up|0
6808151|NCT02563002|10811836|FG000|Overall Study|Withdrawal by Subject|0
6808152|NCT02563002|10811837|FG001|Overall Study|Withdrawal by Subject|9
6808153|NCT02563002|10811836|FG000|Overall Study|Ongoing|90
6808154|NCT02563002|10811837|FG001|Overall Study|Ongoing|70
6793114|NCT00659646|10791312|FG000|Overall Study|Protocol Violation|12
6793115|NCT00659646|10791313|FG001|Overall Study|Protocol Violation|8
6793116|NCT00659646|10791312|FG000|Overall Study|Adverse Event|1
6793117|NCT00659646|10791313|FG001|Overall Study|Adverse Event|0
6793118|NCT00659646|10791312|FG000|Overall Study|Lost to Follow-up|1
6793119|NCT00659646|10791313|FG001|Overall Study|Lost to Follow-up|0
6793120|NCT00659646|10791312|FG000|Overall Study|protocol noncompliance after randomized|1
6793121|NCT00659646|10791313|FG001|Overall Study|protocol noncompliance after randomized|0
6793125|NCT00477412|10791341|FG000|Overall Study|Death|0
6793126|NCT00477412|10791342|FG001|Overall Study|Death|0
6793127|NCT00477412|10791343|FG002|Overall Study|Death|0
6793128|NCT00477412|10791344|FG003|Overall Study|Death|4
6793129|NCT00477412|10791341|FG000|Overall Study|Lost to Follow-up|0
6793130|NCT00477412|10791342|FG001|Overall Study|Lost to Follow-up|0
6793131|NCT00477412|10791343|FG002|Overall Study|Lost to Follow-up|0
6793132|NCT00477412|10791344|FG003|Overall Study|Lost to Follow-up|1
6793133|NCT00477412|10791341|FG000|Overall Study|Withdrawal by Subject|0
6793134|NCT00477412|10791342|FG001|Overall Study|Withdrawal by Subject|0
6793135|NCT00477412|10791343|FG002|Overall Study|Withdrawal by Subject|0
6793136|NCT00477412|10791344|FG003|Overall Study|Withdrawal by Subject|2
6793137|NCT00477412|10791341|FG000|Overall Study|Second Malignancy|0
6793138|NCT00477412|10791342|FG001|Overall Study|Second Malignancy|0
6793139|NCT00477412|10791343|FG002|Overall Study|Second Malignancy|0
6793140|NCT00477412|10791344|FG003|Overall Study|Second Malignancy|1
6793141|NCT00477412|10791341|FG000|Overall Study|Adverse Event|1
6793142|NCT00477412|10791342|FG001|Overall Study|Adverse Event|0
6793143|NCT00477412|10791343|FG002|Overall Study|Adverse Event|1
6793144|NCT00477412|10791344|FG003|Overall Study|Adverse Event|0
6793145|NCT00369317|10791352|FG000|Overall Study|Adverse Event|3
6793146|NCT00369317|10791352|FG000|Overall Study|Death|1
6793147|NCT00369317|10791352|FG000|Overall Study|Lack of Efficacy|5
6793148|NCT00369317|10791352|FG000|Overall Study|Physician Decision|2
6793149|NCT00369317|10791352|FG000|Overall Study|Withdrawal by Subject|8
6793150|NCT00369317|10791352|FG000|Overall Study|Ineligible|1
6793151|NCT00261807|10791357|FG000|Overall Study|Lost to Follow-up|2
6793152|NCT00261807|10791357|FG000|Overall Study|Adverse Event|2
6793153|NCT00261807|10791357|FG000|Overall Study|Death|1
6793154|NCT00261807|10791357|FG000|Overall Study|Protocol Violation|2
6808155|NCT02427958|10811855|FG000|Overall Study|Pretreatment Event (PTE) or AE|3
6808156|NCT02427958|10811855|FG000|Overall Study|Lost to Follow-up|6
6808157|NCT02427958|10811855|FG000|Overall Study|Withdrawal by Subject|14
6808158|NCT02427958|10811855|FG000|Overall Study|Lack of Efficacy|1
6808159|NCT02425826|10811861|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5
6808160|NCT02425826|10811862|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2
6808161|NCT02425826|10811863|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0
6808162|NCT02425826|10811861|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
6808163|NCT02425826|10811862|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1
6808164|NCT02425826|10811863|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
6808165|NCT02425826|10811861|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9
6808166|NCT02425826|10811862|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1
6808167|NCT02425826|10811863|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0
6808168|NCT02425826|10811861|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10
6808169|NCT02425826|10811862|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4
6808170|NCT02425826|10811863|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0
6808171|NCT02425826|10811861|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3
6808172|NCT02425826|10811862|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1
6808173|NCT02425826|10811863|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0
6808174|NCT02425826|10811861|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7
6808175|NCT02425826|10811862|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0
6808176|NCT02425826|10811863|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2
6808177|NCT02425826|10811861|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8
6808178|NCT02425826|10811862|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0
6808179|NCT02425826|10811863|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6
6808180|NCT02425826|10811861|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12
6808181|NCT02425826|10811862|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0
6808182|NCT02425826|10811863|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4
6808183|NCT02425826|10811861|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8
6808184|NCT02425826|10811862|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0
6808185|NCT02425826|10811863|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1
6808186|NCT02425826|10811861|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
6808187|NCT02425826|10811862|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
6808188|NCT02425826|10811863|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1
6808189|NCT02000622|10811933|FG000|Overall Study|Withdrawal by Subject|5
6808190|NCT02000622|10811934|FG001|Overall Study|Withdrawal by Subject|7
6808191|NCT02000622|10811933|FG000|Overall Study|Lost to Follow-up|4
6808192|NCT02000622|10811934|FG001|Overall Study|Lost to Follow-up|0
6808193|NCT02000622|10811933|FG000|Overall Study|Death|159
6808194|NCT02000622|10811934|FG001|Overall Study|Death|73
6808195|NCT02000622|10811933|FG000|Overall Study|Withdrawn due to site closure|1
6808196|NCT02000622|10811934|FG001|Overall Study|Withdrawn due to site closure|0
6808197|NCT01933932|10811942|FG000|Overall Study|Death|173
6808198|NCT01933932|10811943|FG001|Overall Study|Death|163
6808199|NCT01933932|10811942|FG000|Overall Study|Withdrawal by Subject|11
6808200|NCT01933932|10811943|FG001|Overall Study|Withdrawal by Subject|14
6808201|NCT01933932|10811942|FG000|Overall Study|Eligibility criteria not fulfilled|0
6808202|NCT01933932|10811943|FG001|Overall Study|Eligibility criteria not fulfilled|1
6808203|NCT01927068|10811951|FG000|Overall Study|Death|37
6808204|NCT01927068|10811952|FG001|Overall Study|Death|3
6808205|NCT01927068|10811951|FG000|Overall Study|Withdrawal by Subject|50
6808206|NCT01927068|10811952|FG001|Overall Study|Withdrawal by Subject|3
6808207|NCT01927068|10811951|FG000|Overall Study|Lost to Follow-up|10
6808208|NCT01927068|10811952|FG001|Overall Study|Lost to Follow-up|2
6808209|NCT01927068|10811951|FG000|Overall Study|Physician Decision|9
6808210|NCT01927068|10811952|FG001|Overall Study|Physician Decision|0
6808211|NCT01927068|10811951|FG000|Overall Study|Missed last follow-up visit|2
6808212|NCT01927068|10811952|FG001|Overall Study|Missed last follow-up visit|0
6808213|NCT01813435|10811970|FG000|Overall Study|did not finish experimental regimen|1902
6808214|NCT01813435|10811971|FG001|Overall Study|did not finish experimental regimen|770
6808215|NCT01813435|10811970|FG000|Overall Study|Lost to Follow-up|268
6808216|NCT01813435|10811971|FG001|Overall Study|Lost to Follow-up|237
6810959|NCT02460224|10814907|FG000|Overall Study|Lost to Follow-up|0
6810960|NCT02460224|10814908|FG001|Overall Study|Lost to Follow-up|0
6810961|NCT02460224|10814909|FG002|Overall Study|Lost to Follow-up|0
6810962|NCT02460224|10814910|FG003|Overall Study|Lost to Follow-up|0
6810963|NCT02460224|10814911|FG004|Overall Study|Lost to Follow-up|0
6810964|NCT02460224|10814912|FG005|Overall Study|Lost to Follow-up|0
6793155|NCT04620798|10791380|FG000|Overall Study|Lost to Follow-up|126
6793156|NCT04620798|10791381|FG001|Overall Study|Lost to Follow-up|138
6793157|NCT04256629|10791406|FG000|Overall Study|Adverse Event|0
6793158|NCT04256629|10791407|FG001|Overall Study|Adverse Event|0
6793159|NCT04256629|10791408|FG002|Overall Study|Adverse Event|0
6793160|NCT04256629|10791409|FG003|Overall Study|Adverse Event|0
6793161|NCT04256629|10791410|FG004|Overall Study|Adverse Event|0
6793162|NCT04256629|10791411|FG005|Overall Study|Adverse Event|1
6793163|NCT04256629|10791406|FG000|Overall Study|Protocol Violation|0
6793164|NCT04256629|10791407|FG001|Overall Study|Protocol Violation|1
6793165|NCT04256629|10791408|FG002|Overall Study|Protocol Violation|0
6793166|NCT04256629|10791409|FG003|Overall Study|Protocol Violation|0
6793167|NCT04256629|10791410|FG004|Overall Study|Protocol Violation|0
6793168|NCT04256629|10791411|FG005|Overall Study|Protocol Violation|0
6793169|NCT04014075|10791423|FG000|Overall Study|Progressive Disease|39
6793170|NCT04014075|10791423|FG000|Overall Study|Adverse Event|9
6793171|NCT04014075|10791423|FG000|Overall Study|Clinical Progression|2
6793172|NCT04014075|10791423|FG000|Overall Study|Death|2
6793173|NCT04014075|10791423|FG000|Overall Study|Withdrawal by Subject|2
6793174|NCT04014075|10791423|FG000|Overall Study|Miscellaneous|1
6793175|NCT04014075|10791423|FG000|Overall Study|Physician Decision|1
6793176|NCT03284853|10791429|FG000|Overall Study|Adverse Event|40
6793177|NCT03284853|10791430|FG001|Overall Study|Adverse Event|4
6793178|NCT03284853|10791429|FG000|Overall Study|Withdrawal by Subject|5
6793179|NCT03284853|10791430|FG001|Overall Study|Withdrawal by Subject|1
6793180|NCT03284853|10791429|FG000|Overall Study|Lost to Follow-up|1
6793181|NCT03284853|10791430|FG001|Overall Study|Lost to Follow-up|0
6793182|NCT03284853|10791429|FG000|Overall Study|Lack of Efficacy|1
6793183|NCT03284853|10791430|FG001|Overall Study|Lack of Efficacy|0
6793184|NCT03284853|10791429|FG000|Overall Study|Disallowed Concurrent Medication|1
6793185|NCT03284853|10791430|FG001|Overall Study|Disallowed Concurrent Medication|1
6793186|NCT03284853|10791429|FG000|Overall Study|Protocol Violation|3
6793187|NCT03284853|10791430|FG001|Overall Study|Protocol Violation|3
6793188|NCT03284853|10791429|FG000|Overall Study|Death|0
6793189|NCT03284853|10791430|FG001|Overall Study|Death|1
6793190|NCT03284853|10791429|FG000|Overall Study|Other - Reason not reported in CSR|4
6793191|NCT03284853|10791430|FG001|Overall Study|Other - Reason not reported in CSR|3
6808217|NCT01690299|10811985|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
6808218|NCT01690299|10811986|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
6808219|NCT01690299|10811987|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1
6808220|NCT01690299|10811988|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
6808221|NCT01690299|10811989|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
6808222|NCT01690299|10811990|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
6808223|NCT01690299|10811985|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4
6808224|NCT01690299|10811986|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
6808225|NCT01690299|10811987|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
6808226|NCT01690299|10811988|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
6808227|NCT01690299|10811989|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
6808228|NCT01690299|10811990|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
6808229|NCT01690299|10811985|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1
6808230|NCT01690299|10811986|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3
6808231|NCT01690299|10811987|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
6808232|NCT01690299|10811988|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
6808233|NCT01690299|10811989|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
6808234|NCT01690299|10811990|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
6808235|NCT01690299|10811985|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2
6808236|NCT01690299|10811986|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1
6808237|NCT01690299|10811987|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1
6808238|NCT01690299|10811988|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0
6808239|NCT01690299|10811989|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0
6808240|NCT01690299|10811990|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0
6808241|NCT01690299|10811985|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
6808242|NCT01690299|10811986|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
6808243|NCT01690299|10811987|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
6808244|NCT01690299|10811988|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
6808245|NCT01690299|10811989|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4
6808246|NCT01690299|10811990|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
6808247|NCT01690299|10811985|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
6808248|NCT01690299|10811986|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
6808249|NCT01690299|10811987|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
6808250|NCT01690299|10811988|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9
6808251|NCT01690299|10811989|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10
6808252|NCT01690299|10811990|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8
6808253|NCT01690299|10811985|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
6808254|NCT01690299|10811986|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
6808255|NCT01690299|10811987|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
6808256|NCT01690299|10811988|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
6808257|NCT01690299|10811989|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
6793192|NCT02774889|10791453|FG000|Overall Study|Lost to Follow-up|2
6793193|NCT02774889|10791454|FG001|Overall Study|Lost to Follow-up|1
6793194|NCT02297438|10791474|FG000|Overall Study|Death|79
6793195|NCT02297438|10791475|FG001|Overall Study|Death|86
6793196|NCT02297438|10791474|FG000|Overall Study|Lost to Follow-up|9
6793197|NCT02297438|10791475|FG001|Overall Study|Lost to Follow-up|7
6793198|NCT02297438|10791474|FG000|Overall Study|Withdrawal by Subject|7
6793199|NCT02297438|10791475|FG001|Overall Study|Withdrawal by Subject|0
6793200|NCT02297438|10791474|FG000|Overall Study|Other|9
6793201|NCT02297438|10791475|FG001|Overall Study|Other|5
6793202|NCT02297438|10791474|FG000|Overall Study|Ongoing|65
6793203|NCT02297438|10791475|FG001|Overall Study|Ongoing|73
6793204|NCT02297412|10791483|FG000|Overall Study|Canceled|1
6793205|NCT02297412|10791484|FG001|Overall Study|Canceled|1
6793206|NCT02250326|10791502|FG000|Treatment Period|Death|1
6793207|NCT02250326|10791503|FG001|Treatment Period|Death|12
6793208|NCT02250326|10791504|FG002|Treatment Period|Death|2
6793209|NCT02250326|10791502|FG000|Treatment Period|Adverse Event|8
6793210|NCT02250326|10791503|FG001|Treatment Period|Adverse Event|4
6793211|NCT02250326|10791504|FG002|Treatment Period|Adverse Event|8
6793212|NCT02250326|10791502|FG000|Treatment Period|Progressive Disease|42
6793213|NCT02250326|10791503|FG001|Treatment Period|Progressive Disease|36
6793214|NCT02250326|10791504|FG002|Treatment Period|Progressive Disease|45
6793215|NCT02250326|10791502|FG000|Treatment Period|Symptomatic Deterioration|9
6793216|NCT02250326|10791503|FG001|Treatment Period|Symptomatic Deterioration|4
6793217|NCT02250326|10791504|FG002|Treatment Period|Symptomatic Deterioration|10
6793218|NCT02250326|10791502|FG000|Treatment Period|Withdrawal by Subject|11
6793219|NCT02250326|10791503|FG001|Treatment Period|Withdrawal by Subject|5
6793220|NCT02250326|10791504|FG002|Treatment Period|Withdrawal by Subject|4
6793221|NCT02250326|10791502|FG000|Treatment Period|Miscellaneous|8
6793222|NCT02250326|10791503|FG001|Treatment Period|Miscellaneous|2
6793223|NCT02250326|10791504|FG002|Treatment Period|Miscellaneous|7
6793224|NCT02250326|10791502|FG000|Treatment Period|Randomized or assigned; not treated|2
6793225|NCT02250326|10791503|FG001|Treatment Period|Randomized or assigned; not treated|1
6793226|NCT02250326|10791504|FG002|Treatment Period|Randomized or assigned; not treated|1
6793227|NCT02250326|10791502|FG000|Follow-Up Period|Death|46
6793228|NCT02250326|10791503|FG001|Follow-Up Period|Death|26
6793229|NCT02250326|10791504|FG002|Follow-Up Period|Death|32
6793230|NCT02250326|10791502|FG000|Follow-Up Period|Unknown or Missing|2
6793231|NCT02250326|10791503|FG001|Follow-Up Period|Unknown or Missing|3
6793232|NCT02250326|10791504|FG002|Follow-Up Period|Unknown or Missing|3
6793233|NCT02250326|10791502|FG000|Follow-Up Period|Lost to Follow-up|1
6793234|NCT02250326|10791503|FG001|Follow-Up Period|Lost to Follow-up|1
6793235|NCT02250326|10791504|FG002|Follow-Up Period|Lost to Follow-up|3
6793236|NCT01503515|10791526|FG000|Overall Study|Adverse Event|4
6793237|NCT01503515|10791527|FG001|Overall Study|Adverse Event|5
6793238|NCT01503515|10791526|FG000|Overall Study|Death|0
6793239|NCT01503515|10791527|FG001|Overall Study|Death|1
6793240|NCT01503515|10791526|FG000|Overall Study|Physician Decision|14
6793241|NCT01503515|10791527|FG001|Overall Study|Physician Decision|23
6793242|NCT01503515|10791526|FG000|Overall Study|Withdrawal by Subject|0
6793243|NCT01503515|10791527|FG001|Overall Study|Withdrawal by Subject|1
6793244|NCT01503515|10791526|FG000|Overall Study|Institutional dx of proven/probable IFI|2
6793245|NCT01503515|10791527|FG001|Overall Study|Institutional dx of proven/probable IFI|4
6793246|NCT01503515|10791526|FG000|Overall Study|Ineligible|1
6793247|NCT01503515|10791527|FG001|Overall Study|Ineligible|1
6793248|NCT00245960|10791560|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6
6793249|NCT00245960|10791561|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7
6793250|NCT00245960|10791560|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0
6793251|NCT00245960|10791561|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1
6793252|NCT00245960|10791560|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2
6793253|NCT00245960|10791561|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0
6793254|NCT00245960|10791560|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2
6793255|NCT00245960|10791561|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1
6793256|NCT00245960|10791560|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3
6793257|NCT00245960|10791561|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0
6793258|NCT00245960|10791560|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2
6793259|NCT00245960|10791561|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2
6793260|NCT00245960|10791560|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8
6793261|NCT00245960|10791561|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4
6793262|NCT00245960|10791560|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2
6793263|NCT00245960|10791561|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2
6793264|NCT00245960|10791560|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2
6793265|NCT00245960|10791561|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5
6793266|NCT00245960|10791560|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1
6793267|NCT00245960|10791561|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3
6793268|NCT00245960|10791560|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1
6793269|NCT00245960|10791561|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3
6793270|NCT00245960|10791560|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0
6793271|NCT00245960|10791561|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1
6808258|NCT01690299|10811990|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
6808259|NCT01690299|10811985|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
6808260|NCT01690299|10811986|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
6808261|NCT01690299|10811987|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
6808262|NCT01690299|10811988|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8
6808263|NCT01690299|10811989|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5
6808264|NCT01690299|10811990|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11
6808265|NCT01690299|10811985|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
6808266|NCT01690299|10811986|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
6808267|NCT01690299|10811987|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
6808268|NCT01690299|10811988|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
6808269|NCT01690299|10811989|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13
6808270|NCT01690299|10811990|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
6808271|NCT01690299|10811985|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
6808272|NCT01690299|10811986|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
6808273|NCT01690299|10811987|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
6808274|NCT01690299|10811988|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
6808275|NCT01690299|10811989|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
6808276|NCT01690299|10811990|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1
6808277|NCT01452152|10812044|FG000|Overall Study|Study termination by sponsor|5
6808278|NCT01452152|10812045|FG001|Overall Study|Study termination by sponsor|0
6808279|NCT01452152|10812046|FG002|Overall Study|Study termination by sponsor|4
6793272|NCT04015336|10791648|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1
6793358|NCT03353922|10791814|FG004|Overall Study|Withdrawal by Subject|0
6793359|NCT03353922|10791815|FG005|Overall Study|Withdrawal by Subject|0
6793360|NCT03353922|10791810|FG000|Overall Study|Adverse Event|0
6793361|NCT03353922|10791811|FG001|Overall Study|Adverse Event|1
6793362|NCT03353922|10791812|FG002|Overall Study|Adverse Event|0
6793363|NCT03353922|10791813|FG003|Overall Study|Adverse Event|0
6793364|NCT03353922|10791814|FG004|Overall Study|Adverse Event|0
6793365|NCT03353922|10791815|FG005|Overall Study|Adverse Event|0
6793366|NCT03173456|10791850|FG000|Baseline|Medication dispensing system malfunction'|0
6793367|NCT03173456|10791851|FG001|Baseline|Medication dispensing system malfunction'|1
6793368|NCT03173456|10791852|FG002|Baseline|Medication dispensing system malfunction'|0
6793369|NCT03173456|10791853|FG003|Baseline|Medication dispensing system malfunction'|0
6793370|NCT03173456|10791854|FG004|Baseline|Medication dispensing system malfunction'|2
6793371|NCT03173456|10791850|FG000|2 Hour Follow-up|Withdrawal by Subject|0
6793372|NCT03173456|10791851|FG001|2 Hour Follow-up|Withdrawal by Subject|1
6793373|NCT03173456|10791852|FG002|2 Hour Follow-up|Withdrawal by Subject|1
6793374|NCT03173456|10791853|FG003|2 Hour Follow-up|Withdrawal by Subject|1
6793375|NCT03173456|10791854|FG004|2 Hour Follow-up|Withdrawal by Subject|2
6808367|NCT01232283|10812112|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12
6808368|NCT01232283|10812113|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8
6808369|NCT01232283|10812114|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
6808370|NCT01232283|10812115|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
6808371|NCT01232283|10812116|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
6793273|NCT03920280|10791727|FG000|Overall Study|Adverse Event|2
6793274|NCT03920280|10791728|FG001|Overall Study|Adverse Event|3
6793275|NCT03920280|10791727|FG000|Overall Study|Lost to Follow-up|0
6793276|NCT03920280|10791728|FG001|Overall Study|Lost to Follow-up|1
6793277|NCT03920280|10791727|FG000|Overall Study|Withdrawal by Subject|1
6793278|NCT03920280|10791728|FG001|Overall Study|Withdrawal by Subject|1
6793279|NCT03920280|10791727|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0
6793280|NCT03920280|10791728|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1
6793281|NCT03913091|10791739|FG000|Overall Study|Lost to Follow-up|18
6793282|NCT03913091|10791740|FG001|Overall Study|Lost to Follow-up|11
6793283|NCT03913091|10791739|FG000|Overall Study|Required additional meds/surgery|1
6793284|NCT03913091|10791740|FG001|Overall Study|Required additional meds/surgery|2
6793285|NCT03913091|10791739|FG000|Overall Study|Chronic pain/history of substance abuse|1
6793286|NCT03913091|10791740|FG001|Overall Study|Chronic pain/history of substance abuse|1
6793287|NCT03802565|10791751|FG000|Overall Study|Adverse Event|0
6793288|NCT03802565|10791752|FG001|Overall Study|Adverse Event|1
6793289|NCT03802565|10791753|FG002|Overall Study|Adverse Event|2
6793290|NCT03802565|10791754|FG003|Overall Study|Adverse Event|1
6793291|NCT03802565|10791755|FG004|Overall Study|Adverse Event|1
6793292|NCT03802565|10791751|FG000|Overall Study|Withdrawal by Subject|2
6793293|NCT03802565|10791752|FG001|Overall Study|Withdrawal by Subject|2
6793294|NCT03802565|10791753|FG002|Overall Study|Withdrawal by Subject|2
6793295|NCT03802565|10791754|FG003|Overall Study|Withdrawal by Subject|0
6793296|NCT03802565|10791755|FG004|Overall Study|Withdrawal by Subject|1
6793297|NCT03802565|10791751|FG000|Overall Study|Protocol Violation|2
6793298|NCT03802565|10791752|FG001|Overall Study|Protocol Violation|1
6793299|NCT03802565|10791753|FG002|Overall Study|Protocol Violation|4
6793300|NCT03802565|10791754|FG003|Overall Study|Protocol Violation|5
6793301|NCT03802565|10791755|FG004|Overall Study|Protocol Violation|1
6793302|NCT03802565|10791751|FG000|Overall Study|Lost to Follow-up|0
6793303|NCT03802565|10791752|FG001|Overall Study|Lost to Follow-up|0
6793304|NCT03802565|10791753|FG002|Overall Study|Lost to Follow-up|1
6793305|NCT03802565|10791754|FG003|Overall Study|Lost to Follow-up|0
6793306|NCT03802565|10791755|FG004|Overall Study|Lost to Follow-up|0
6793307|NCT03802565|10791751|FG000|Overall Study|Subjects Related to Each Other|1
6793308|NCT03802565|10791752|FG001|Overall Study|Subjects Related to Each Other|0
6793309|NCT03802565|10791753|FG002|Overall Study|Subjects Related to Each Other|0
6793310|NCT03802565|10791754|FG003|Overall Study|Subjects Related to Each Other|2
6793311|NCT03802565|10791755|FG004|Overall Study|Subjects Related to Each Other|1
6793312|NCT03802565|10791751|FG000|Overall Study|Elevated Enzymes|0
6793313|NCT03802565|10791752|FG001|Overall Study|Elevated Enzymes|0
6793314|NCT03802565|10791753|FG002|Overall Study|Elevated Enzymes|0
6793315|NCT03802565|10791754|FG003|Overall Study|Elevated Enzymes|0
6793316|NCT03802565|10791755|FG004|Overall Study|Elevated Enzymes|2
6793317|NCT03769194|10791771|FG000|Overall Study|Withdrawal by Subject|0
6793318|NCT03769194|10791772|FG001|Overall Study|Withdrawal by Subject|7
6793319|NCT03769194|10791773|FG002|Overall Study|Withdrawal by Subject|4
6793320|NCT03769194|10791774|FG003|Overall Study|Withdrawal by Subject|1
6793321|NCT03769194|10791771|FG000|Overall Study|moved from study area|0
6793322|NCT03769194|10791772|FG001|Overall Study|moved from study area|2
6793323|NCT03769194|10791773|FG002|Overall Study|moved from study area|1
6793324|NCT03769194|10791774|FG003|Overall Study|moved from study area|1
6793325|NCT03769194|10791771|FG000|Overall Study|Lost to Follow-up|3
6793326|NCT03769194|10791772|FG001|Overall Study|Lost to Follow-up|6
6793327|NCT03769194|10791773|FG002|Overall Study|Lost to Follow-up|3
6793328|NCT03769194|10791774|FG003|Overall Study|Lost to Follow-up|6
6793329|NCT03769194|10791771|FG000|Overall Study|other|1
6793330|NCT03769194|10791772|FG001|Overall Study|other|3
6793331|NCT03769194|10791773|FG002|Overall Study|other|0
6793332|NCT03769194|10791774|FG003|Overall Study|other|1
6793333|NCT03738332|10791784|FG000|Overall Study|Withdrawal by Subject|1
6793334|NCT03416179|10791797|FG000|Overall Study|Death|67
6793335|NCT03416179|10791798|FG001|Overall Study|Death|60
6793336|NCT03416179|10791799|FG002|Overall Study|Death|96
6793337|NCT03416179|10791800|FG003|Overall Study|Death|88
6793338|NCT03416179|10791797|FG000|Overall Study|Withdrawal by Subject|13
6793339|NCT03416179|10791798|FG001|Overall Study|Withdrawal by Subject|19
6793340|NCT03416179|10791799|FG002|Overall Study|Withdrawal by Subject|5
6793341|NCT03416179|10791800|FG003|Overall Study|Withdrawal by Subject|6
6793342|NCT03416179|10791797|FG000|Overall Study|Ongoing|121
6793343|NCT03416179|10791798|FG001|Overall Study|Ongoing|123
6793344|NCT03416179|10791799|FG002|Overall Study|Ongoing|62
6793345|NCT03416179|10791800|FG003|Overall Study|Ongoing|66
6793346|NCT03416179|10791797|FG000|Overall Study|Lost to Follow-up|0
6793347|NCT03416179|10791798|FG001|Overall Study|Lost to Follow-up|0
6793348|NCT03416179|10791799|FG002|Overall Study|Lost to Follow-up|0
6793349|NCT03416179|10791800|FG003|Overall Study|Lost to Follow-up|2
6793350|NCT03416179|10791797|FG000|Overall Study|Other|0
6793351|NCT03416179|10791798|FG001|Overall Study|Other|1
6793352|NCT03416179|10791799|FG002|Overall Study|Other|0
6793353|NCT03416179|10791800|FG003|Overall Study|Other|0
6793354|NCT03353922|10791810|FG000|Overall Study|Withdrawal by Subject|1
6793355|NCT03353922|10791811|FG001|Overall Study|Withdrawal by Subject|0
6793356|NCT03353922|10791812|FG002|Overall Study|Withdrawal by Subject|1
6793357|NCT03353922|10791813|FG003|Overall Study|Withdrawal by Subject|1
6793376|NCT03003520|10791877|FG000|Induction|Ongoing|1
6793377|NCT03003520|10791878|FG001|Induction|Ongoing|0
6793378|NCT03003520|10791877|FG000|Induction|Adverse Event|4
6793379|NCT03003520|10791878|FG001|Induction|Adverse Event|0
6793380|NCT03003520|10791877|FG000|Induction|Death|1
6793381|NCT03003520|10791878|FG001|Induction|Death|0
6793382|NCT03003520|10791877|FG000|Induction|Palliative care|1
6793383|NCT03003520|10791878|FG001|Induction|Palliative care|0
6793384|NCT03003520|10791877|FG000|Induction|Physician Decision|2
6793385|NCT03003520|10791878|FG001|Induction|Physician Decision|0
6793386|NCT03003520|10791877|FG000|Induction|Withdrawal by Subject|3
6793387|NCT03003520|10791878|FG001|Induction|Withdrawal by Subject|0
6793388|NCT03003520|10791877|FG000|Induction|Progressive disease|1
6793389|NCT03003520|10791878|FG001|Induction|Progressive disease|0
6793390|NCT03003520|10791877|FG000|Consolidation|Ongoing|18
6793391|NCT03003520|10791878|FG001|Consolidation|Ongoing|0
6793392|NCT03003520|10791877|FG000|Consolidation|Adverse Event|2
6793393|NCT03003520|10791878|FG001|Consolidation|Adverse Event|0
6793394|NCT03003520|10791877|FG000|Consolidation|Progressive disease|3
6793395|NCT03003520|10791878|FG001|Consolidation|Progressive disease|1
6793396|NCT03003520|10791877|FG000|Consolidation|Withdrawal by Subject|1
6793397|NCT03003520|10791878|FG001|Consolidation|Withdrawal by Subject|0
6793398|NCT03003520|10791877|FG000|Follow-up|Death|1
6793399|NCT03003520|10791878|FG001|Follow-up|Death|1
6793400|NCT03003520|10791877|FG000|Follow-up|Ongoing|12
6793401|NCT03003520|10791878|FG001|Follow-up|Ongoing|2
6793402|NCT03003520|10791877|FG000|Follow-up|Withdrawal by Subject|1
6793403|NCT03003520|10791878|FG001|Follow-up|Withdrawal by Subject|0
6793404|NCT02862457|10791899|FG000|Overall Study|Death|1
6793405|NCT02862457|10791900|FG001|Overall Study|Death|3
6793406|NCT02862457|10791901|FG002|Overall Study|Death|2
6793407|NCT02862457|10791902|FG003|Overall Study|Death|3
6793408|NCT02862457|10791903|FG004|Overall Study|Death|0
6793409|NCT02862457|10791904|FG005|Overall Study|Death|2
6793410|NCT02862457|10791905|FG006|Overall Study|Death|1
6793411|NCT02862457|10791899|FG000|Overall Study|Lost to Follow-up|1
6793412|NCT02862457|10791900|FG001|Overall Study|Lost to Follow-up|0
6793413|NCT02862457|10791901|FG002|Overall Study|Lost to Follow-up|0
6793414|NCT02862457|10791902|FG003|Overall Study|Lost to Follow-up|1
6793415|NCT02862457|10791903|FG004|Overall Study|Lost to Follow-up|0
6793416|NCT02862457|10791904|FG005|Overall Study|Lost to Follow-up|0
6793417|NCT02862457|10791905|FG006|Overall Study|Lost to Follow-up|0
6793418|NCT02862457|10791899|FG000|Overall Study|Withdrawal by Subject|0
6793419|NCT02862457|10791900|FG001|Overall Study|Withdrawal by Subject|0
6793420|NCT02862457|10791901|FG002|Overall Study|Withdrawal by Subject|1
6793421|NCT02862457|10791902|FG003|Overall Study|Withdrawal by Subject|0
6793422|NCT02862457|10791903|FG004|Overall Study|Withdrawal by Subject|0
6793423|NCT02862457|10791904|FG005|Overall Study|Withdrawal by Subject|1
6793424|NCT02862457|10791905|FG006|Overall Study|Withdrawal by Subject|0
6793425|NCT02820753|10791931|FG000|2 Month|Withdrawal by Subject|3
6793426|NCT02820753|10791932|FG001|2 Month|Withdrawal by Subject|3
6793427|NCT02820753|10791931|FG000|2 Month|Lost to Follow-up|24
6793428|NCT02820753|10791932|FG001|2 Month|Lost to Follow-up|26
6793429|NCT02820753|10791931|FG000|2 Month|Stopped per NIH Hold|51
6793430|NCT02820753|10791932|FG001|2 Month|Stopped per NIH Hold|13
6793431|NCT02820753|10791931|FG000|6 Month|Withdrawal by Subject|2
6793432|NCT02820753|10791932|FG001|6 Month|Withdrawal by Subject|2
6793433|NCT02820753|10791931|FG000|6 Month|Lost to Follow-up|20
6793434|NCT02820753|10791932|FG001|6 Month|Lost to Follow-up|27
6793435|NCT02820753|10791931|FG000|6 Month|Stopped per NIH Hold|81
6793436|NCT02820753|10791932|FG001|6 Month|Stopped per NIH Hold|81
6793437|NCT02820753|10791931|FG000|6 Month|Death|0
6793438|NCT02820753|10791932|FG001|6 Month|Death|1
6793439|NCT02733042|10791957|FG000|Treatment Period|Adverse Event|1
6793440|NCT02733042|10791958|FG001|Treatment Period|Adverse Event|0
6793441|NCT02733042|10791959|FG002|Treatment Period|Adverse Event|1
6793442|NCT02733042|10791960|FG003|Treatment Period|Adverse Event|1
6793443|NCT02733042|10791961|FG004|Treatment Period|Adverse Event|0
6793444|NCT02733042|10791962|FG005|Treatment Period|Adverse Event|0
6793445|NCT02733042|10791963|FG006|Treatment Period|Adverse Event|0
6793446|NCT02733042|10791964|FG007|Treatment Period|Adverse Event|0
6793447|NCT02733042|10791965|FG008|Treatment Period|Adverse Event|0
6793448|NCT02733042|10791966|FG009|Treatment Period|Adverse Event|0
6793449|NCT02733042|10791967|FG010|Treatment Period|Adverse Event|2
6793450|NCT02733042|10791968|FG011|Treatment Period|Adverse Event|2
6793451|NCT02733042|10791969|FG012|Treatment Period|Adverse Event|0
6793452|NCT02733042|10791970|FG013|Treatment Period|Adverse Event|2
6793453|NCT02733042|10791971|FG014|Treatment Period|Adverse Event|0
6793454|NCT02733042|10791972|FG015|Treatment Period|Adverse Event|0
6793455|NCT02733042|10791973|FG016|Treatment Period|Adverse Event|0
6793456|NCT02733042|10791974|FG017|Treatment Period|Adverse Event|1
6793457|NCT02733042|10791975|FG018|Treatment Period|Adverse Event|0
6793458|NCT02733042|10791957|FG000|Treatment Period|Progressive Disease|2
6793459|NCT02733042|10791958|FG001|Treatment Period|Progressive Disease|1
6793460|NCT02733042|10791959|FG002|Treatment Period|Progressive Disease|3
6793461|NCT02733042|10791960|FG003|Treatment Period|Progressive Disease|1
6793462|NCT02733042|10791961|FG004|Treatment Period|Progressive Disease|1
6793463|NCT02733042|10791962|FG005|Treatment Period|Progressive Disease|3
6793464|NCT02733042|10791963|FG006|Treatment Period|Progressive Disease|0
6793465|NCT02733042|10791964|FG007|Treatment Period|Progressive Disease|3
6793466|NCT02733042|10791965|FG008|Treatment Period|Progressive Disease|3
6793467|NCT02733042|10791966|FG009|Treatment Period|Progressive Disease|0
6793468|NCT02733042|10791967|FG010|Treatment Period|Progressive Disease|2
6793469|NCT02733042|10791968|FG011|Treatment Period|Progressive Disease|2
6793470|NCT02733042|10791969|FG012|Treatment Period|Progressive Disease|8
6793471|NCT02733042|10791970|FG013|Treatment Period|Progressive Disease|1
6793472|NCT02733042|10791971|FG014|Treatment Period|Progressive Disease|4
6793473|NCT02733042|10791972|FG015|Treatment Period|Progressive Disease|7
6793474|NCT02733042|10791973|FG016|Treatment Period|Progressive Disease|2
6793475|NCT02733042|10791974|FG017|Treatment Period|Progressive Disease|3
6793476|NCT02733042|10791975|FG018|Treatment Period|Progressive Disease|4
6793477|NCT02733042|10791957|FG000|Treatment Period|Withdrawal by Subject|0
6793478|NCT02733042|10791958|FG001|Treatment Period|Withdrawal by Subject|1
6793479|NCT02733042|10791959|FG002|Treatment Period|Withdrawal by Subject|2
6793480|NCT02733042|10791960|FG003|Treatment Period|Withdrawal by Subject|1
6793481|NCT02733042|10791961|FG004|Treatment Period|Withdrawal by Subject|0
6793482|NCT02733042|10791962|FG005|Treatment Period|Withdrawal by Subject|0
6793483|NCT02733042|10791963|FG006|Treatment Period|Withdrawal by Subject|0
6793484|NCT02733042|10791964|FG007|Treatment Period|Withdrawal by Subject|0
6793485|NCT02733042|10791965|FG008|Treatment Period|Withdrawal by Subject|1
6793486|NCT02733042|10791966|FG009|Treatment Period|Withdrawal by Subject|1
6793487|NCT02733042|10791967|FG010|Treatment Period|Withdrawal by Subject|0
6793488|NCT02733042|10791968|FG011|Treatment Period|Withdrawal by Subject|2
6793489|NCT02733042|10791969|FG012|Treatment Period|Withdrawal by Subject|1
6793490|NCT02733042|10791970|FG013|Treatment Period|Withdrawal by Subject|1
6793491|NCT02733042|10791971|FG014|Treatment Period|Withdrawal by Subject|0
6793492|NCT02733042|10791972|FG015|Treatment Period|Withdrawal by Subject|0
6793493|NCT02733042|10791973|FG016|Treatment Period|Withdrawal by Subject|0
6793494|NCT02733042|10791974|FG017|Treatment Period|Withdrawal by Subject|0
6793495|NCT02733042|10791975|FG018|Treatment Period|Withdrawal by Subject|0
6793496|NCT02733042|10791957|FG000|Treatment Period|Other|0
6793497|NCT02733042|10791958|FG001|Treatment Period|Other|0
6793498|NCT02733042|10791959|FG002|Treatment Period|Other|1
6793499|NCT02733042|10791960|FG003|Treatment Period|Other|0
6793500|NCT02733042|10791961|FG004|Treatment Period|Other|0
6793501|NCT02733042|10791962|FG005|Treatment Period|Other|0
6793502|NCT02733042|10791963|FG006|Treatment Period|Other|0
6793503|NCT02733042|10791964|FG007|Treatment Period|Other|0
6793504|NCT02733042|10791965|FG008|Treatment Period|Other|0
6793505|NCT02733042|10791966|FG009|Treatment Period|Other|1
6793506|NCT02733042|10791967|FG010|Treatment Period|Other|1
6793507|NCT02733042|10791968|FG011|Treatment Period|Other|0
6793508|NCT02733042|10791969|FG012|Treatment Period|Other|0
6793509|NCT02733042|10791970|FG013|Treatment Period|Other|0
6793510|NCT02733042|10791971|FG014|Treatment Period|Other|0
6793511|NCT02733042|10791972|FG015|Treatment Period|Other|1
6793512|NCT02733042|10791973|FG016|Treatment Period|Other|0
6793513|NCT02733042|10791974|FG017|Treatment Period|Other|1
6793514|NCT02733042|10791975|FG018|Treatment Period|Other|0
6793515|NCT02733042|10791957|FG000|Treatment Period|Ongoing on Assigned Treatment|0
6793516|NCT02733042|10791958|FG001|Treatment Period|Ongoing on Assigned Treatment|0
6793517|NCT02733042|10791959|FG002|Treatment Period|Ongoing on Assigned Treatment|0
6793518|NCT02733042|10791960|FG003|Treatment Period|Ongoing on Assigned Treatment|0
6793519|NCT02733042|10791961|FG004|Treatment Period|Ongoing on Assigned Treatment|3
6793520|NCT02733042|10791962|FG005|Treatment Period|Ongoing on Assigned Treatment|0
6793521|NCT02733042|10791963|FG006|Treatment Period|Ongoing on Assigned Treatment|0
6793522|NCT02733042|10791964|FG007|Treatment Period|Ongoing on Assigned Treatment|0
6793523|NCT02733042|10791965|FG008|Treatment Period|Ongoing on Assigned Treatment|0
6793524|NCT02733042|10791966|FG009|Treatment Period|Ongoing on Assigned Treatment|8
6793525|NCT02733042|10791967|FG010|Treatment Period|Ongoing on Assigned Treatment|4
6793526|NCT02733042|10791968|FG011|Treatment Period|Ongoing on Assigned Treatment|0
6793527|NCT02733042|10791969|FG012|Treatment Period|Ongoing on Assigned Treatment|0
6793528|NCT02733042|10791970|FG013|Treatment Period|Ongoing on Assigned Treatment|0
6793529|NCT02733042|10791971|FG014|Treatment Period|Ongoing on Assigned Treatment|0
6793530|NCT02733042|10791972|FG015|Treatment Period|Ongoing on Assigned Treatment|0
6793531|NCT02733042|10791973|FG016|Treatment Period|Ongoing on Assigned Treatment|0
6793532|NCT02733042|10791974|FG017|Treatment Period|Ongoing on Assigned Treatment|0
6793533|NCT02733042|10791975|FG018|Treatment Period|Ongoing on Assigned Treatment|1
6793534|NCT02733042|10791957|FG000|Treatment Period|Death|0
6793535|NCT02733042|10791958|FG001|Treatment Period|Death|0
6793536|NCT02733042|10791959|FG002|Treatment Period|Death|0
6793537|NCT02733042|10791960|FG003|Treatment Period|Death|0
6793538|NCT02733042|10791961|FG004|Treatment Period|Death|0
6793539|NCT02733042|10791962|FG005|Treatment Period|Death|0
6793540|NCT02733042|10791963|FG006|Treatment Period|Death|1
6793541|NCT02733042|10791964|FG007|Treatment Period|Death|0
6793542|NCT02733042|10791965|FG008|Treatment Period|Death|1
6793543|NCT02733042|10791966|FG009|Treatment Period|Death|0
6793544|NCT02733042|10791967|FG010|Treatment Period|Death|1
6793545|NCT02733042|10791968|FG011|Treatment Period|Death|0
6793546|NCT02733042|10791969|FG012|Treatment Period|Death|0
6793547|NCT02733042|10791970|FG013|Treatment Period|Death|0
6793548|NCT02733042|10791971|FG014|Treatment Period|Death|1
6793549|NCT02733042|10791972|FG015|Treatment Period|Death|2
6793550|NCT02733042|10791973|FG016|Treatment Period|Death|0
6793551|NCT02733042|10791974|FG017|Treatment Period|Death|0
6793552|NCT02733042|10791975|FG018|Treatment Period|Death|0
6793553|NCT02733042|10791957|FG000|Follow-up Period|Ongoing on Follow-up|2
6793554|NCT02733042|10791958|FG001|Follow-up Period|Ongoing on Follow-up|2
6793555|NCT02733042|10791959|FG002|Follow-up Period|Ongoing on Follow-up|4
6793556|NCT02733042|10791960|FG003|Follow-up Period|Ongoing on Follow-up|2
6793557|NCT02733042|10791961|FG004|Follow-up Period|Ongoing on Follow-up|0
6793558|NCT02733042|10791962|FG005|Follow-up Period|Ongoing on Follow-up|0
6793559|NCT02733042|10791963|FG006|Follow-up Period|Ongoing on Follow-up|0
6793560|NCT02733042|10791964|FG007|Follow-up Period|Ongoing on Follow-up|1
6793561|NCT02733042|10791965|FG008|Follow-up Period|Ongoing on Follow-up|0
6793562|NCT02733042|10791966|FG009|Follow-up Period|Ongoing on Follow-up|2
6793563|NCT02733042|10791967|FG010|Follow-up Period|Ongoing on Follow-up|4
6793564|NCT02733042|10791968|FG011|Follow-up Period|Ongoing on Follow-up|9
6793565|NCT02733042|10791969|FG012|Follow-up Period|Ongoing on Follow-up|1
6793566|NCT02733042|10791970|FG013|Follow-up Period|Ongoing on Follow-up|3
6793567|NCT02733042|10791971|FG014|Follow-up Period|Ongoing on Follow-up|0
6793568|NCT02733042|10791972|FG015|Follow-up Period|Ongoing on Follow-up|0
6793569|NCT02733042|10791973|FG016|Follow-up Period|Ongoing on Follow-up|0
6793570|NCT02733042|10791974|FG017|Follow-up Period|Ongoing on Follow-up|1
6793571|NCT02733042|10791975|FG018|Follow-up Period|Ongoing on Follow-up|0
6793572|NCT02733042|10791957|FG000|Follow-up Period|Death|1
6793573|NCT02733042|10791958|FG001|Follow-up Period|Death|1
6793574|NCT02733042|10791959|FG002|Follow-up Period|Death|2
6793575|NCT02733042|10791960|FG003|Follow-up Period|Death|0
6793576|NCT02733042|10791961|FG004|Follow-up Period|Death|1
6793577|NCT02733042|10791962|FG005|Follow-up Period|Death|2
6793578|NCT02733042|10791963|FG006|Follow-up Period|Death|0
6793579|NCT02733042|10791964|FG007|Follow-up Period|Death|3
6793580|NCT02733042|10791965|FG008|Follow-up Period|Death|3
6793581|NCT02733042|10791966|FG009|Follow-up Period|Death|0
6793582|NCT02733042|10791967|FG010|Follow-up Period|Death|0
6793583|NCT02733042|10791968|FG011|Follow-up Period|Death|0
6793584|NCT02733042|10791969|FG012|Follow-up Period|Death|8
6793585|NCT02733042|10791970|FG013|Follow-up Period|Death|1
6793586|NCT02733042|10791971|FG014|Follow-up Period|Death|1
6793587|NCT02733042|10791972|FG015|Follow-up Period|Death|4
6793588|NCT02733042|10791973|FG016|Follow-up Period|Death|0
6793589|NCT02733042|10791974|FG017|Follow-up Period|Death|1
6793590|NCT02733042|10791975|FG018|Follow-up Period|Death|2
6793591|NCT02733042|10791957|FG000|Follow-up Period|Other|0
6793592|NCT02733042|10791958|FG001|Follow-up Period|Other|0
6793593|NCT02733042|10791959|FG002|Follow-up Period|Other|0
6793594|NCT02733042|10791960|FG003|Follow-up Period|Other|1
6793595|NCT02733042|10791961|FG004|Follow-up Period|Other|0
6793596|NCT02733042|10791962|FG005|Follow-up Period|Other|0
6793597|NCT02733042|10791963|FG006|Follow-up Period|Other|0
6793598|NCT02733042|10791964|FG007|Follow-up Period|Other|0
6793599|NCT02733042|10791965|FG008|Follow-up Period|Other|0
6793600|NCT02733042|10791966|FG009|Follow-up Period|Other|0
6793601|NCT02733042|10791967|FG010|Follow-up Period|Other|0
6793602|NCT02733042|10791968|FG011|Follow-up Period|Other|0
6793603|NCT02733042|10791969|FG012|Follow-up Period|Other|0
6793604|NCT02733042|10791970|FG013|Follow-up Period|Other|0
6793605|NCT02733042|10791971|FG014|Follow-up Period|Other|0
6793606|NCT02733042|10791972|FG015|Follow-up Period|Other|0
6793607|NCT02733042|10791973|FG016|Follow-up Period|Other|0
6793608|NCT02733042|10791974|FG017|Follow-up Period|Other|0
6793609|NCT02733042|10791975|FG018|Follow-up Period|Other|0
6793610|NCT02733042|10791957|FG000|Follow-up Period|Withdrawal by Subject|0
6793611|NCT02733042|10791958|FG001|Follow-up Period|Withdrawal by Subject|0
6793612|NCT02733042|10791959|FG002|Follow-up Period|Withdrawal by Subject|0
6793613|NCT02733042|10791960|FG003|Follow-up Period|Withdrawal by Subject|0
6793614|NCT02733042|10791961|FG004|Follow-up Period|Withdrawal by Subject|0
6793615|NCT02733042|10791962|FG005|Follow-up Period|Withdrawal by Subject|0
6793616|NCT02733042|10791963|FG006|Follow-up Period|Withdrawal by Subject|0
6793617|NCT02733042|10791964|FG007|Follow-up Period|Withdrawal by Subject|0
6793618|NCT02733042|10791965|FG008|Follow-up Period|Withdrawal by Subject|1
6793619|NCT02733042|10791966|FG009|Follow-up Period|Withdrawal by Subject|0
6793620|NCT02733042|10791967|FG010|Follow-up Period|Withdrawal by Subject|1
6793621|NCT02733042|10791968|FG011|Follow-up Period|Withdrawal by Subject|0
6793622|NCT02733042|10791969|FG012|Follow-up Period|Withdrawal by Subject|0
6793623|NCT02733042|10791970|FG013|Follow-up Period|Withdrawal by Subject|0
6793624|NCT02733042|10791971|FG014|Follow-up Period|Withdrawal by Subject|0
6793625|NCT02733042|10791972|FG015|Follow-up Period|Withdrawal by Subject|1
6793626|NCT02733042|10791973|FG016|Follow-up Period|Withdrawal by Subject|0
6793627|NCT02733042|10791974|FG017|Follow-up Period|Withdrawal by Subject|0
6793628|NCT02733042|10791975|FG018|Follow-up Period|Withdrawal by Subject|0
6793629|NCT02574286|10792036|FG000|Overall Study|Adverse Event|3
6793630|NCT02574286|10792036|FG000|Overall Study|Withdrawal by Subject|2
6793631|NCT02471144|10792044|FG000|Induction Period (Up to Week 12)|Adverse Event|0
6793632|NCT02471144|10792045|FG001|Induction Period (Up to Week 12)|Adverse Event|1
6793633|NCT02471144|10792046|FG002|Induction Period (Up to Week 12)|Adverse Event|1
6793634|NCT02471144|10792047|FG003|Induction Period (Up to Week 12)|Adverse Event|0
6793635|NCT02471144|10792048|FG004|Induction Period (Up to Week 12)|Adverse Event|0
6793636|NCT02471144|10792049|FG005|Induction Period (Up to Week 12)|Adverse Event|0
6793637|NCT02471144|10792050|FG006|Induction Period (Up to Week 12)|Adverse Event|0
6793638|NCT02471144|10792051|FG007|Induction Period (Up to Week 12)|Adverse Event|0
6793639|NCT02471144|10792052|FG008|Induction Period (Up to Week 12)|Adverse Event|0
6793640|NCT02471144|10792053|FG009|Induction Period (Up to Week 12)|Adverse Event|0
6793641|NCT02471144|10792054|FG010|Induction Period (Up to Week 12)|Adverse Event|0
6793642|NCT02471144|10792044|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0
6793643|NCT02471144|10792045|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0
6793644|NCT02471144|10792046|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0
6793645|NCT02471144|10792047|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1
6793646|NCT02471144|10792048|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0
6793647|NCT02471144|10792049|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0
6793648|NCT02471144|10792050|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0
6793649|NCT02471144|10792051|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0
6793650|NCT02471144|10792052|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0
6793651|NCT02471144|10792053|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0
6793652|NCT02471144|10792054|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0
6793653|NCT02471144|10792044|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0
6793654|NCT02471144|10792045|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0
6793655|NCT02471144|10792046|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1
6793656|NCT02471144|10792047|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0
6793657|NCT02471144|10792048|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0
6793658|NCT02471144|10792049|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0
6793659|NCT02471144|10792050|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0
6793660|NCT02471144|10792051|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0
6793661|NCT02471144|10792052|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0
6793662|NCT02471144|10792053|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0
6793663|NCT02471144|10792054|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0
6793664|NCT02471144|10792044|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1
6793665|NCT02471144|10792045|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1
6793666|NCT02471144|10792046|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
6793667|NCT02471144|10792047|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
6793668|NCT02471144|10792048|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
6793669|NCT02471144|10792049|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
6793670|NCT02471144|10792050|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
6793671|NCT02471144|10792051|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
6793672|NCT02471144|10792052|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
6793673|NCT02471144|10792053|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
6793674|NCT02471144|10792054|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
6793675|NCT02471144|10792044|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
6793676|NCT02471144|10792045|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
6793677|NCT02471144|10792046|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
6793678|NCT02471144|10792047|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
6793679|NCT02471144|10792048|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1
6793680|NCT02471144|10792049|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
6793681|NCT02471144|10792050|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1
6793682|NCT02471144|10792051|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
6793683|NCT02471144|10792052|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1
6793684|NCT02471144|10792053|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
6793685|NCT02471144|10792054|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
6793686|NCT02471144|10792044|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
6793687|NCT02471144|10792045|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
6793688|NCT02471144|10792046|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
6793689|NCT02471144|10792047|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
6793690|NCT02471144|10792048|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
6793691|NCT02471144|10792049|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1
6793692|NCT02471144|10792050|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
6793693|NCT02471144|10792051|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
6793694|NCT02471144|10792052|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3
6793695|NCT02471144|10792053|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
6793696|NCT02471144|10792054|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
6793697|NCT02471144|10792044|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
6793698|NCT02471144|10792045|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
6793699|NCT02471144|10792046|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
6793700|NCT02471144|10792047|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
6793701|NCT02471144|10792048|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
6793702|NCT02471144|10792049|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
6793703|NCT02471144|10792050|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
6793704|NCT02471144|10792051|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
6793705|NCT02471144|10792052|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1
6793706|NCT02471144|10792053|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
6793707|NCT02471144|10792054|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
6793708|NCT02471144|10792044|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
6793709|NCT02471144|10792045|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
6793710|NCT02471144|10792046|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
6793711|NCT02471144|10792047|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
6793712|NCT02471144|10792048|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
6793713|NCT02471144|10792049|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
6793714|NCT02471144|10792050|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
6793715|NCT02471144|10792051|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2
6793716|NCT02471144|10792052|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1
6793717|NCT02471144|10792053|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
6793718|NCT02471144|10792054|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
6793719|NCT02471144|10792044|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
6793720|NCT02471144|10792045|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
6793721|NCT02471144|10792046|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
6793722|NCT02471144|10792047|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
6793723|NCT02471144|10792048|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
6793724|NCT02471144|10792049|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
6793725|NCT02471144|10792050|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
6793726|NCT02471144|10792051|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
6793727|NCT02471144|10792052|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
6793728|NCT02471144|10792053|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|5
6793729|NCT02471144|10792054|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|2
6793730|NCT02471144|10792044|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0
6793731|NCT02471144|10792045|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0
6793732|NCT02471144|10792046|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0
6793733|NCT02471144|10792047|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0
6793734|NCT02471144|10792048|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0
6793735|NCT02471144|10792049|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0
6793736|NCT02471144|10792050|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0
6793737|NCT02471144|10792051|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0
6793738|NCT02471144|10792052|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0
6793739|NCT02471144|10792053|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2
6793740|NCT02471144|10792054|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0
6793741|NCT02471144|10792044|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
6793742|NCT02471144|10792045|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
6793743|NCT02471144|10792046|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
6793744|NCT02471144|10792047|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
6793745|NCT02471144|10792048|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
6793746|NCT02471144|10792049|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
6793747|NCT02471144|10792050|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
6793748|NCT02471144|10792051|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
6793749|NCT02471144|10792052|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
6793750|NCT02471144|10792053|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
6793751|NCT02471144|10792054|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2
6793752|NCT02440464|10792072|FG000|Overall Study|Withdrawal by Subject|3
6793753|NCT02440464|10792073|FG001|Overall Study|Withdrawal by Subject|2
6793754|NCT02366728|10792090|FG000|Overall Study|Death|0
6793755|NCT02366728|10792091|FG001|Overall Study|Death|0
6793756|NCT02366728|10792092|FG002|Overall Study|Death|1
6793757|NCT02366728|10792090|FG000|Overall Study|Adverse Event|1
6793758|NCT02366728|10792091|FG001|Overall Study|Adverse Event|0
6793759|NCT02366728|10792092|FG002|Overall Study|Adverse Event|0
6793760|NCT02366728|10792090|FG000|Overall Study|Screen Failure|2
6793761|NCT02366728|10792091|FG001|Overall Study|Screen Failure|1
6793762|NCT02366728|10792092|FG002|Overall Study|Screen Failure|0
6793763|NCT02366728|10792090|FG000|Overall Study|Only yielded 2 vaccines|1
6793764|NCT02366728|10792091|FG001|Overall Study|Only yielded 2 vaccines|0
6793765|NCT02366728|10792092|FG002|Overall Study|Only yielded 2 vaccines|0
6793766|NCT02236572|10792100|FG000|Overall Study|Withdrawal by Subject|1
6793767|NCT02236572|10792100|FG000|Overall Study|Protocol Violation|1
6793768|NCT02236572|10792100|FG000|Overall Study|Lost to Follow-up|1
6793769|NCT02083354|10792104|FG000|Overall Study|Withdrawal by Subject|9
6793770|NCT02083354|10792104|FG000|Overall Study|Lost to Follow-up|1
6793771|NCT02083354|10792104|FG000|Overall Study|Adverse Event|3
6793772|NCT02083354|10792104|FG000|Overall Study|Disease progression|46
6793773|NCT02083354|10792104|FG000|Overall Study|Study closed/terminated|5
6793774|NCT01446016|10792138|FG000|Overall Study|Lost to Follow-up|3
6793775|NCT01446016|10792138|FG000|Overall Study|Withdrawal by Subject|1
6793776|NCT01446016|10792138|FG000|Overall Study|Toxicity|3
6793777|NCT01411332|10792157|FG000|Overall Study|Lost to Follow-up|1
6793778|NCT01411332|10792158|FG001|Overall Study|Lost to Follow-up|0
6793779|NCT01411332|10792157|FG000|Overall Study|Protocol Violation|1
6793780|NCT01411332|10792158|FG001|Overall Study|Protocol Violation|1
6793781|NCT01411332|10792157|FG000|Overall Study|Withdrawal by Subject|0
6793782|NCT01411332|10792158|FG001|Overall Study|Withdrawal by Subject|1
6793783|NCT01399918|10792164|FG000|Overall Study|Not eligible and not enrolled in the study|2
6793784|NCT01147653|10792174|FG000|Year 2|Withdrawal by Subject|2
6793785|NCT01147653|10792175|FG001|Year 2|Withdrawal by Subject|3
6793786|NCT01078454|10792195|FG000|Overall Study|Adverse Event|1
6793787|NCT01078454|10792196|FG001|Overall Study|Adverse Event|1
6793788|NCT01078454|10792195|FG000|Overall Study|Death|0
6793789|NCT01078454|10792196|FG001|Overall Study|Death|1
6793790|NCT00687596|10792204|FG000|Overall Study|Adverse Event (AE)|10
6793791|NCT00687596|10792205|FG001|Overall Study|Adverse Event (AE)|3
6793792|NCT00687596|10792204|FG000|Overall Study|Radiological Disease Progression|6
6793793|NCT00687596|10792205|FG001|Overall Study|Radiological Disease Progression|2
6793794|NCT00687596|10792204|FG000|Overall Study|Clinical Disease Progression|1
6793795|NCT00687596|10792205|FG001|Overall Study|Clinical Disease Progression|3
6793796|NCT00687596|10792204|FG000|Overall Study|Investigator Discretion|3
6793797|NCT00687596|10792205|FG001|Overall Study|Investigator Discretion|1
6793798|NCT00687596|10792204|FG000|Overall Study|Sponsor Terminated Study|6
6793799|NCT00687596|10792205|FG001|Overall Study|Sponsor Terminated Study|17
6793800|NCT00458536|10792211|FG000|Overall Study|Disease progression prior to treatment|7
6793801|NCT00458536|10792211|FG000|Overall Study|Unable to make vaccine|3
6793802|NCT00458536|10792211|FG000|Overall Study|No measurable disease after surgery|2
6793803|NCT00458536|10792211|FG000|Overall Study|Did not have renal cell carcinoma|2
6793804|NCT00458536|10792211|FG000|Overall Study|Patient did not have surgery|1
6793805|NCT00458536|10792211|FG000|Overall Study|Ineligible due to toxicity|1
6793806|NCT00458536|10792211|FG000|Overall Study|Withdrawal by Subject|1
6793807|NCT00458536|10792211|FG000|Overall Study|Progressive disease during treatment|2
6793808|NCT00112840|10792218|FG000|Overall Study|Physician Decision|1
6793809|NCT00112840|10792219|FG001|Overall Study|Physician Decision|0
6793810|NCT00112840|10792220|FG002|Overall Study|Physician Decision|0
6793811|NCT00112840|10792218|FG000|Overall Study|Withdrawal by Subject|1
6793812|NCT00112840|10792219|FG001|Overall Study|Withdrawal by Subject|0
6793813|NCT00112840|10792220|FG002|Overall Study|Withdrawal by Subject|1
6793814|NCT00112840|10792218|FG000|Overall Study|Protocol Violation|0
6793815|NCT00112840|10792219|FG001|Overall Study|Protocol Violation|0
6793816|NCT00112840|10792220|FG002|Overall Study|Protocol Violation|5
6808372|NCT01232283|10812117|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
6808373|NCT01232283|10812118|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
6808374|NCT01232283|10812119|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
6793817|NCT04207749|10792249|FG000|Overall Study|Lost to Follow-up|0
6793818|NCT04207749|10792250|FG001|Overall Study|Lost to Follow-up|2
6793819|NCT04207749|10792249|FG000|Overall Study|Protocol Violation|0
6793820|NCT04207749|10792250|FG001|Overall Study|Protocol Violation|1
6793821|NCT04207749|10792249|FG000|Overall Study|Withdrawal by Subject|3
6793822|NCT04207749|10792250|FG001|Overall Study|Withdrawal by Subject|0
6793823|NCT04207749|10792249|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1
6793824|NCT04207749|10792250|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4
6793854|NCT03740009|10792335|FG000|Overall Study|Physician Decision|9
6793855|NCT03740009|10792335|FG000|Overall Study|Lost to Follow-up|1
6793856|NCT03738397|10792341|FG000|Overall Study|Adverse Event|3
6793857|NCT03738397|10792342|FG001|Overall Study|Adverse Event|7
6793858|NCT03738397|10792341|FG000|Overall Study|Withdrawal by Subject|8
6793859|NCT03738397|10792342|FG001|Overall Study|Withdrawal by Subject|11
6793860|NCT03738397|10792341|FG000|Overall Study|Lost to Follow-up|8
6793861|NCT03738397|10792342|FG001|Overall Study|Lost to Follow-up|5
6793862|NCT03738397|10792341|FG000|Overall Study|COVID-19 Logistical Restrictions|1
6793863|NCT03738397|10792342|FG001|Overall Study|COVID-19 Logistical Restrictions|1
6793864|NCT03738397|10792341|FG000|Overall Study|Other|4
6793865|NCT03738397|10792342|FG001|Overall Study|Other|6
6793866|NCT03666624|10792350|FG000|Overall Study|participant grieving over recent death of parent|1
6793867|NCT03666624|10792351|FG001|Overall Study|participant grieving over recent death of parent|0
6793868|NCT03649217|10792357|FG000|Overall Study|subject had severe ataxia not initially found|1
6793869|NCT03649217|10792357|FG000|Overall Study|subject had cognitive issues not initially found|1
6793870|NCT03569293|10792376|FG000|Overall Study|Adverse Event|4
6793871|NCT03569293|10792377|FG001|Overall Study|Adverse Event|1
6793872|NCT03569293|10792378|FG002|Overall Study|Adverse Event|5
6793873|NCT03569293|10792379|FG003|Overall Study|Adverse Event|1
6793874|NCT03569293|10792380|FG004|Overall Study|Adverse Event|0
6793875|NCT03569293|10792381|FG005|Overall Study|Adverse Event|0
6793876|NCT03569293|10792376|FG000|Overall Study|Withdrawal by Subject|16
6793877|NCT03569293|10792377|FG001|Overall Study|Withdrawal by Subject|2
6793878|NCT03569293|10792378|FG002|Overall Study|Withdrawal by Subject|4
6793879|NCT03569293|10792379|FG003|Overall Study|Withdrawal by Subject|1
6793880|NCT03569293|10792380|FG004|Overall Study|Withdrawal by Subject|0
6793881|NCT03569293|10792381|FG005|Overall Study|Withdrawal by Subject|0
6793882|NCT03569293|10792376|FG000|Overall Study|Lost to Follow-up|1
6793883|NCT03569293|10792377|FG001|Overall Study|Lost to Follow-up|3
6793884|NCT03569293|10792378|FG002|Overall Study|Lost to Follow-up|1
6793885|NCT03569293|10792379|FG003|Overall Study|Lost to Follow-up|1
6793886|NCT03569293|10792380|FG004|Overall Study|Lost to Follow-up|0
6793887|NCT03569293|10792381|FG005|Overall Study|Lost to Follow-up|0
6793888|NCT03569293|10792376|FG000|Overall Study|Other|8
6793889|NCT03569293|10792377|FG001|Overall Study|Other|2
6793890|NCT03569293|10792378|FG002|Overall Study|Other|1
6793891|NCT03569293|10792379|FG003|Overall Study|Other|1
6793892|NCT03569293|10792380|FG004|Overall Study|Other|0
6793893|NCT03569293|10792381|FG005|Overall Study|Other|0
6793894|NCT03569293|10792376|FG000|Overall Study|Ongoing at Time of Analysis|8
6793895|NCT03569293|10792377|FG001|Overall Study|Ongoing at Time of Analysis|1
6793896|NCT03569293|10792378|FG002|Overall Study|Ongoing at Time of Analysis|3
6793897|NCT03569293|10792379|FG003|Overall Study|Ongoing at Time of Analysis|0
6793898|NCT03569293|10792380|FG004|Overall Study|Ongoing at Time of Analysis|0
6793899|NCT03569293|10792381|FG005|Overall Study|Ongoing at Time of Analysis|0
6793900|NCT03318003|10792466|FG000|Overall Study|Withdrawal by Subject|1
6793901|NCT03318003|10792467|FG001|Overall Study|Withdrawal by Subject|1
6793902|NCT03318003|10792466|FG000|Overall Study|fetal loss|0
6793903|NCT03318003|10792467|FG001|Overall Study|fetal loss|1
6793904|NCT03132753|10792493|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27
6793905|NCT03132753|10792494|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32
6793906|NCT03132753|10792493|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6
6793907|NCT03132753|10792494|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2
6793908|NCT03067077|10792509|FG000|Overall Study|Did not receive surgery|4
6793909|NCT03067077|10792510|FG001|Overall Study|Did not receive surgery|5
6793910|NCT03067077|10792509|FG000|Overall Study|Lost to Follow-up|3
6793911|NCT03067077|10792510|FG001|Overall Study|Lost to Follow-up|2
6793912|NCT03059446|10792516|FG000|Overall Study|Adverse Event|11
6793913|NCT03059446|10792516|FG000|Overall Study|Withdrawal of Consent|16
6793914|NCT03059446|10792516|FG000|Overall Study|Lost to Follow-up|3
6793915|NCT03059446|10792516|FG000|Overall Study|Protocol Violation|1
6793916|NCT03059446|10792516|FG000|Overall Study|Study Terminated by Sponsor|131
6793917|NCT03059446|10792516|FG000|Overall Study|Reason not Specified|5
6793918|NCT03011034|10792526|FG000|Overall Study|Adverse Event|1
6793919|NCT03011034|10792527|FG001|Overall Study|Adverse Event|0
6793920|NCT02853331|10792557|FG000|Overall Study|Death|59
6793921|NCT02853331|10792558|FG001|Overall Study|Death|95
6793922|NCT02853331|10792557|FG000|Overall Study|Withdrawal by Subject|5
6793923|NCT02853331|10792558|FG001|Overall Study|Withdrawal by Subject|9
6793924|NCT02853331|10792557|FG000|Overall Study|Ongoing in study|368
6793925|NCT02853331|10792558|FG001|Overall Study|Ongoing in study|325
6793926|NCT02601014|10792588|FG000|Overall Study|Adverse Event|3
6793927|NCT02601014|10792589|FG001|Overall Study|Adverse Event|3
6793928|NCT02601014|10792588|FG000|Overall Study|Death|3
6793929|NCT02601014|10792589|FG001|Overall Study|Death|1
6793825|NCT04167345|10792264|FG000|Overall Study|Other|1
6793826|NCT04167345|10792265|FG001|Overall Study|Other|1
6793827|NCT04167345|10792266|FG002|Overall Study|Other|0
6793828|NCT04167345|10792267|FG003|Overall Study|Other|0
6793829|NCT04167345|10792268|FG004|Overall Study|Other|0
6793830|NCT04042077|10792286|FG000|Overall Study|Adverse Event|0
6793831|NCT04042077|10792287|FG001|Overall Study|Adverse Event|1
6793832|NCT04042077|10792286|FG000|Overall Study|Death|2
6793833|NCT04042077|10792287|FG001|Overall Study|Death|1
6793834|NCT04042077|10792286|FG000|Overall Study|Physician Decision|2
6793835|NCT04042077|10792287|FG001|Overall Study|Physician Decision|0
6793836|NCT04042077|10792286|FG000|Overall Study|Withdrawal by Subject|3
6793837|NCT04042077|10792287|FG001|Overall Study|Withdrawal by Subject|2
6793838|NCT04042077|10792286|FG000|Overall Study|Lack of Efficacy|0
6793839|NCT04042077|10792287|FG001|Overall Study|Lack of Efficacy|1
6793840|NCT04001803|10792299|FG000|Overall Study|Ongoing at the time of analysis|103
6793841|NCT04001803|10792299|FG000|Overall Study|Adverse Event|2
6793842|NCT04001803|10792299|FG000|Overall Study|Protocol Violation|2
6793843|NCT04001803|10792299|FG000|Overall Study|Lost to Follow-up|2
6793844|NCT04001803|10792299|FG000|Overall Study|Physician Decision|1
6793845|NCT04001803|10792299|FG000|Overall Study|Withdrawal by Subject|4
6793846|NCT03925324|10792315|FG000|Overall Study|Death|1
6793847|NCT03925324|10792316|FG001|Overall Study|Death|1
6793848|NCT03875092|10792324|FG000|Overall Study|Adverse Event|2
6793849|NCT03875092|10792325|FG001|Overall Study|Adverse Event|5
6793850|NCT03875092|10792324|FG000|Overall Study|Death|28
6793851|NCT03875092|10792325|FG001|Overall Study|Death|41
6793852|NCT03875092|10792324|FG000|Overall Study|Ongoing in Study|35
6793853|NCT03875092|10792325|FG001|Overall Study|Ongoing in Study|14
6793930|NCT02601014|10792588|FG000|Overall Study|Disease progression|4
6793931|NCT02601014|10792589|FG001|Overall Study|Disease progression|8
6793932|NCT02579096|10792597|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10
6793933|NCT02579096|10792598|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6
6793934|NCT02579096|10792597|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2
6793935|NCT02579096|10792598|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1
6793936|NCT02579096|10792597|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32
6793937|NCT02579096|10792598|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36
6793938|NCT02579096|10792597|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9
6793939|NCT02579096|10792598|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4
6793940|NCT02579096|10792597|FG000|Phase 1, Weeks 0 - 24|Other reasons|4
6793941|NCT02579096|10792598|FG001|Phase 1, Weeks 0 - 24|Other reasons|3
6793942|NCT02579096|10792597|FG000|Phase 2, Weeks 25 - 48|Death|2
6793943|NCT02579096|10792598|FG001|Phase 2, Weeks 25 - 48|Death|4
6793944|NCT02579096|10792597|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3
6793945|NCT02579096|10792598|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1
6793946|NCT02579096|10792597|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4
6793947|NCT02579096|10792598|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0
6793948|NCT02579096|10792597|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9
6793949|NCT02579096|10792598|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12
6793950|NCT02579096|10792597|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4
6793951|NCT02579096|10792598|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9
6793952|NCT02579096|10792597|FG000|Phase 2, Weeks 25 - 48|Other reasons|0
6793953|NCT02579096|10792598|FG001|Phase 2, Weeks 25 - 48|Other reasons|5
6793954|NCT02579096|10792597|FG000|Phase 3, Weeks 49 - 72|Death|3
6793955|NCT02579096|10792598|FG001|Phase 3, Weeks 49 - 72|Death|2
6793956|NCT02579096|10792597|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0
6793957|NCT02579096|10792598|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1
6793958|NCT02579096|10792597|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0
6793959|NCT02579096|10792598|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5
6793960|NCT02579096|10792597|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6
6793961|NCT02579096|10792598|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4
6793962|NCT02579096|10792597|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10
6793963|NCT02579096|10792598|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5
6793964|NCT02579096|10792597|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0
6793965|NCT02579096|10792598|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1
6793966|NCT02579096|10792597|FG000|Phase 3, Weeks 49 - 72|Other reasons|3
6793967|NCT02579096|10792598|FG001|Phase 3, Weeks 49 - 72|Other reasons|0
6793968|NCT02538666|10792607|FG000|Overall Study|Disease progression|1
6793969|NCT02538666|10792608|FG001|Overall Study|Disease progression|0
6793970|NCT02538666|10792609|FG002|Overall Study|Disease progression|0
6793971|NCT02538666|10792607|FG000|Overall Study|no longer meets study criteria|1
6793972|NCT02538666|10792608|FG001|Overall Study|no longer meets study criteria|0
6793973|NCT02538666|10792609|FG002|Overall Study|no longer meets study criteria|0
6793974|NCT02538666|10792607|FG000|Overall Study|Withdrew Consent|0
6793975|NCT02538666|10792608|FG001|Overall Study|Withdrew Consent|1
6793976|NCT02538666|10792609|FG002|Overall Study|Withdrew Consent|1
6793977|NCT02527200|10792622|FG000|Overall Study|Withdrawal by Subject|3
6793978|NCT02527200|10792623|FG001|Overall Study|Withdrawal by Subject|2
6793979|NCT02527200|10792624|FG002|Overall Study|Withdrawal by Subject|1
6793980|NCT02527200|10792625|FG003|Overall Study|Withdrawal by Subject|0
6793981|NCT02527200|10792622|FG000|Overall Study|Unclassified|0
6793982|NCT02527200|10792623|FG001|Overall Study|Unclassified|1
6793983|NCT02527200|10792624|FG002|Overall Study|Unclassified|0
6793984|NCT02527200|10792625|FG003|Overall Study|Unclassified|0
6793985|NCT02527200|10792622|FG000|Overall Study|Lost to Follow-up|0
6793986|NCT02527200|10792623|FG001|Overall Study|Lost to Follow-up|0
6793987|NCT02527200|10792624|FG002|Overall Study|Lost to Follow-up|1
6793988|NCT02527200|10792625|FG003|Overall Study|Lost to Follow-up|0
6793989|NCT02511106|10792641|FG000|Overall Study|Lost to Follow-up|1
6793990|NCT02511106|10792642|FG001|Overall Study|Lost to Follow-up|2
6793991|NCT02511106|10792641|FG000|Overall Study|Withdrawal by Subject|19
6793992|NCT02511106|10792642|FG001|Overall Study|Withdrawal by Subject|14
6793993|NCT02511106|10792641|FG000|Overall Study|Ongoing study at data cut-off|309
6793994|NCT02511106|10792642|FG001|Overall Study|Ongoing study at data cut-off|307
6793995|NCT02511106|10792641|FG000|Overall Study|Without specified reason|1
6793996|NCT02511106|10792642|FG001|Overall Study|Without specified reason|0
6793997|NCT02511106|10792641|FG000|Overall Study|Missing|1
6793998|NCT02511106|10792642|FG001|Overall Study|Missing|0
6808375|NCT01232283|10812120|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
6808376|NCT01232283|10812121|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
6808377|NCT01232283|10812112|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3
6808378|NCT01232283|10812113|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2
6808379|NCT01232283|10812114|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
6808380|NCT01232283|10812115|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
6808381|NCT01232283|10812116|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
6808382|NCT01232283|10812117|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
6808383|NCT01232283|10812118|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
6808384|NCT01232283|10812119|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
6808385|NCT01232283|10812120|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
6808386|NCT01232283|10812121|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
6808387|NCT01232283|10812112|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1
6808388|NCT01232283|10812113|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
6808389|NCT01232283|10812114|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
6808390|NCT01232283|10812115|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
6808391|NCT01232283|10812116|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
6808392|NCT01232283|10812117|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
6808393|NCT01232283|10812118|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
6808394|NCT01232283|10812119|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
6808395|NCT01232283|10812120|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
6808396|NCT01232283|10812121|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
6808397|NCT01232283|10812112|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9
6808398|NCT01232283|10812113|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7
6808399|NCT01232283|10812114|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
6808400|NCT01232283|10812115|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
6808401|NCT01232283|10812116|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
6808402|NCT01232283|10812117|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
6808403|NCT01232283|10812118|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
6808404|NCT01232283|10812119|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
6808405|NCT01232283|10812120|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
6808406|NCT01232283|10812121|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
6808407|NCT01232283|10812112|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
6808408|NCT01232283|10812113|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
6808409|NCT01232283|10812114|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
6808410|NCT01232283|10812115|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
6808411|NCT01232283|10812116|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
6808412|NCT01232283|10812117|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
6808413|NCT01232283|10812118|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
6808414|NCT01232283|10812119|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
6808415|NCT01232283|10812120|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
6808416|NCT01232283|10812121|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
6808417|NCT01232283|10812112|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3
6808418|NCT01232283|10812113|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2
6808419|NCT01232283|10812114|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
6808420|NCT01232283|10812115|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
6808421|NCT01232283|10812116|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
6808422|NCT01232283|10812117|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
6808423|NCT01232283|10812118|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
6808424|NCT01232283|10812119|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
6808425|NCT01232283|10812120|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
6808426|NCT01232283|10812121|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
6808427|NCT01232283|10812112|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2
6808428|NCT01232283|10812113|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1
6793999|NCT02253316|10792682|FG000|Consolidation|Progression|4
6794000|NCT02253316|10792683|FG001|Consolidation|Progression|0
6794001|NCT02253316|10792684|FG002|Consolidation|Progression|0
6794002|NCT02253316|10792682|FG000|Consolidation|Non-Compliance|1
6794003|NCT02253316|10792683|FG001|Consolidation|Non-Compliance|0
6794004|NCT02253316|10792684|FG002|Consolidation|Non-Compliance|0
6794005|NCT02253316|10792682|FG000|Consolidation|Patient Withdrew Logistical Concerns|2
6794006|NCT02253316|10792683|FG001|Consolidation|Patient Withdrew Logistical Concerns|0
6794007|NCT02253316|10792684|FG002|Consolidation|Patient Withdrew Logistical Concerns|0
6794008|NCT02253316|10792682|FG000|Consolidation|Secondary Malignancy|2
6794009|NCT02253316|10792683|FG001|Consolidation|Secondary Malignancy|0
6794010|NCT02253316|10792684|FG002|Consolidation|Secondary Malignancy|0
6794011|NCT02253316|10792682|FG000|Consolidation|Adverse Event|7
6794012|NCT02253316|10792683|FG001|Consolidation|Adverse Event|0
6794013|NCT02253316|10792684|FG002|Consolidation|Adverse Event|0
6794014|NCT02253316|10792682|FG000|Maintenance|Patient Withdrew Logistical Concerns|0
6794015|NCT02253316|10792683|FG001|Maintenance|Patient Withdrew Logistical Concerns|6
6794016|NCT02253316|10792684|FG002|Maintenance|Patient Withdrew Logistical Concerns|6
6794017|NCT02253316|10792682|FG000|Maintenance|Physician Decision|0
6794018|NCT02253316|10792683|FG001|Maintenance|Physician Decision|5
6794019|NCT02253316|10792684|FG002|Maintenance|Physician Decision|16
6794020|NCT02253316|10792682|FG000|Maintenance|Non-Compliance|0
6794021|NCT02253316|10792683|FG001|Maintenance|Non-Compliance|1
6794022|NCT02253316|10792684|FG002|Maintenance|Non-Compliance|1
6794023|NCT02253316|10792682|FG000|Maintenance|Secondary Malignancy|0
6794024|NCT02253316|10792683|FG001|Maintenance|Secondary Malignancy|1
6794025|NCT02253316|10792684|FG002|Maintenance|Secondary Malignancy|5
6794026|NCT02253316|10792682|FG000|Maintenance|Adverse Event|0
6794027|NCT02253316|10792683|FG001|Maintenance|Adverse Event|8
6794028|NCT02253316|10792684|FG002|Maintenance|Adverse Event|12
6794029|NCT02253316|10792682|FG000|Maintenance|Still receiving active treatment|0
6794030|NCT02253316|10792683|FG001|Maintenance|Still receiving active treatment|25
6794031|NCT02253316|10792684|FG002|Maintenance|Still receiving active treatment|27
6794032|NCT02224573|10792694|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0
6794033|NCT02224573|10792695|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1
6794034|NCT02224573|10792694|FG000|Treatment Phase|Started on Other IMP|1
6794035|NCT02224573|10792695|FG001|Treatment Phase|Started on Other IMP|0
6794036|NCT02224573|10792694|FG000|Treatment Phase|Participant Discontinued IMP|0
6794037|NCT02224573|10792695|FG001|Treatment Phase|Participant Discontinued IMP|1
6794038|NCT02224573|10792694|FG000|Treatment Phase|Lack of Efficacy|15
6794039|NCT02224573|10792695|FG001|Treatment Phase|Lack of Efficacy|8
6794040|NCT02224573|10792694|FG000|Treatment Phase|Began Commercial Product|1
6794041|NCT02224573|10792695|FG001|Treatment Phase|Began Commercial Product|0
6794042|NCT02224573|10792694|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3
6794043|NCT02224573|10792695|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3
6794044|NCT02224573|10792694|FG000|Treatment Phase|Met Withdrawal Criteria|5
6794045|NCT02224573|10792695|FG001|Treatment Phase|Met Withdrawal Criteria|7
6794046|NCT02224573|10792694|FG000|Treatment Phase|Participant Did Not Return for Visits|0
6794047|NCT02224573|10792695|FG001|Treatment Phase|Participant Did Not Return for Visits|1
6794048|NCT02224573|10792694|FG000|Treatment Phase|Continued Compassionate Use|1
6794049|NCT02224573|10792695|FG001|Treatment Phase|Continued Compassionate Use|0
6794050|NCT02224573|10792694|FG000|Treatment Phase|Lack of Efficiency|2
6794051|NCT02224573|10792695|FG001|Treatment Phase|Lack of Efficiency|1
6794052|NCT02224573|10792694|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0
6794053|NCT02224573|10792695|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1
6794054|NCT02224573|10792694|FG000|Treatment Phase|Participant Moved|2
6794055|NCT02224573|10792695|FG001|Treatment Phase|Participant Moved|0
6794056|NCT02224573|10792694|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62
6794057|NCT02224573|10792695|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48
6794058|NCT02224573|10792694|FG000|Treatment Phase|Refused Medication|1
6794059|NCT02224573|10792695|FG001|Treatment Phase|Refused Medication|1
6794060|NCT02224573|10792694|FG000|Treatment Phase|Adverse Event|26
6794061|NCT02224573|10792695|FG001|Treatment Phase|Adverse Event|38
6794062|NCT02224573|10792694|FG000|Treatment Phase|Placed in Group Home|0
6794063|NCT02224573|10792695|FG001|Treatment Phase|Placed in Group Home|1
6794064|NCT02224573|10792694|FG000|Treatment Phase|Pursued Other Trials|1
6794065|NCT02224573|10792695|FG001|Treatment Phase|Pursued Other Trials|0
6794066|NCT02224573|10792694|FG000|Treatment Phase|Withdrawn by the Investigator|23
6794067|NCT02224573|10792695|FG001|Treatment Phase|Withdrawn by the Investigator|11
6794068|NCT02224573|10792694|FG000|Treatment Phase|Lost to Follow-up|2
6794069|NCT02224573|10792695|FG001|Treatment Phase|Lost to Follow-up|1
6794070|NCT02224573|10792694|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1
6794071|NCT02224573|10792695|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0
6794072|NCT02224573|10792694|FG000|Taper Phase|Hospitalization/Dose Reduction|1
6794073|NCT02224573|10792695|FG001|Taper Phase|Hospitalization/Dose Reduction|0
6794074|NCT02224573|10792694|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0
6794075|NCT02224573|10792695|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3
6794076|NCT02224573|10792694|FG000|Taper Phase|Adverse Event|1
6794077|NCT02224573|10792695|FG001|Taper Phase|Adverse Event|1
6794078|NCT01991067|10792704|FG000|Overall Study|Lost to Follow-up|6
6794079|NCT01991067|10792705|FG001|Overall Study|Lost to Follow-up|5
6794080|NCT01774721|10792726|FG000|Overall Study|Death|76
6794081|NCT01774721|10792727|FG001|Overall Study|Death|91
6794082|NCT01774721|10792726|FG000|Overall Study|Withdrawal by Subject|14
6794083|NCT01774721|10792727|FG001|Overall Study|Withdrawal by Subject|10
6794084|NCT01774721|10792726|FG000|Overall Study|Lost to Follow-up|1
6794085|NCT01774721|10792727|FG001|Overall Study|Lost to Follow-up|1
6794086|NCT01774721|10792726|FG000|Overall Study|Did not meet eligibility criteria|0
6794087|NCT01774721|10792727|FG001|Overall Study|Did not meet eligibility criteria|3
6794088|NCT01774721|10792726|FG000|Overall Study|Ongoing in study|136
6794089|NCT01774721|10792727|FG001|Overall Study|Ongoing in study|120
6794090|NCT01709331|10792744|FG000|Overall Study|Adverse Event|1
6794091|NCT01656434|10792765|FG000|Overall Study|Adverse Event|199
6794092|NCT01656434|10792766|FG001|Overall Study|Adverse Event|63
6794093|NCT01656434|10792765|FG000|Overall Study|Enrollment terminated at trial site|2
6794094|NCT01656434|10792766|FG001|Overall Study|Enrollment terminated at trial site|0
6794095|NCT01656434|10792765|FG000|Overall Study|Lost to Follow-up|309
6794096|NCT01656434|10792766|FG001|Overall Study|Lost to Follow-up|76
6794097|NCT01656434|10792765|FG000|Overall Study|Site discontinued study participation|24
6794098|NCT01656434|10792766|FG001|Overall Study|Site discontinued study participation|9
6794099|NCT01656434|10792765|FG000|Overall Study|Screen failure|2
6794100|NCT01656434|10792766|FG001|Overall Study|Screen failure|0
6794101|NCT01656434|10792765|FG000|Overall Study|Protocol Violation|7
6794102|NCT01656434|10792766|FG001|Overall Study|Protocol Violation|0
6794103|NCT01656434|10792765|FG000|Overall Study|Pregnancy wish|18
6794104|NCT01656434|10792766|FG001|Overall Study|Pregnancy wish|6
6794105|NCT01656434|10792765|FG000|Overall Study|Pregnancy|45
6794106|NCT01656434|10792766|FG001|Overall Study|Pregnancy|10
6794107|NCT01656434|10792765|FG000|Overall Study|Physician Decision|7
6794108|NCT01656434|10792766|FG001|Overall Study|Physician Decision|2
6794109|NCT01656434|10792765|FG000|Overall Study|Non-compliance with study drug|48
6794110|NCT01656434|10792766|FG001|Overall Study|Non-compliance with study drug|9
6794111|NCT01656434|10792765|FG000|Overall Study|Study terminated by sponsor|1501
6794112|NCT01656434|10792766|FG001|Overall Study|Study terminated by sponsor|348
6794113|NCT01656434|10792765|FG000|Overall Study|Participant discontinued; drug related|13
6794114|NCT01656434|10792766|FG001|Overall Study|Participant discontinued; drug related|4
6794115|NCT01656434|10792765|FG000|Overall Study|Part. discontinued; unrelated to drug|55
6794116|NCT01656434|10792766|FG001|Overall Study|Part. discontinued; unrelated to drug|10
6794117|NCT01656434|10792765|FG000|Overall Study|Non-compliance with protocol|39
6794118|NCT01656434|10792766|FG001|Overall Study|Non-compliance with protocol|15
6794119|NCT01656434|10792765|FG000|Overall Study|Participant moved|40
6794120|NCT01656434|10792766|FG001|Overall Study|Participant moved|12
6794121|NCT01656434|10792765|FG000|Overall Study|Participant withdrew consent|28
6794122|NCT01656434|10792766|FG001|Overall Study|Participant withdrew consent|9
6794123|NCT01656434|10792765|FG000|Overall Study|Withdrawal by Subject|64
6794124|NCT01656434|10792766|FG001|Overall Study|Withdrawal by Subject|7
6794125|NCT01496118|10792795|FG000|Overall Study|Disease progression|3
6794126|NCT01496118|10792796|FG001|Overall Study|Disease progression|2
6794127|NCT01496118|10792797|FG002|Overall Study|Disease progression|3
6794128|NCT01496118|10792798|FG003|Overall Study|Disease progression|1
6794129|NCT01496118|10792799|FG004|Overall Study|Disease progression|2
6794130|NCT01496118|10792800|FG005|Overall Study|Disease progression|2
6794131|NCT01496118|10792801|FG006|Overall Study|Disease progression|14
6794132|NCT01496118|10792802|FG007|Overall Study|Disease progression|10
6794133|NCT01496118|10792795|FG000|Overall Study|Physician Decision|0
6794134|NCT01496118|10792796|FG001|Overall Study|Physician Decision|0
6794135|NCT01496118|10792797|FG002|Overall Study|Physician Decision|0
6794136|NCT01496118|10792798|FG003|Overall Study|Physician Decision|0
6794137|NCT01496118|10792799|FG004|Overall Study|Physician Decision|1
6794138|NCT01496118|10792800|FG005|Overall Study|Physician Decision|0
6794139|NCT01496118|10792801|FG006|Overall Study|Physician Decision|3
6794140|NCT01496118|10792802|FG007|Overall Study|Physician Decision|6
6794141|NCT01496118|10792795|FG000|Overall Study|Adverse Event|1
6794142|NCT01496118|10792796|FG001|Overall Study|Adverse Event|1
6794143|NCT01496118|10792797|FG002|Overall Study|Adverse Event|0
6794144|NCT01496118|10792798|FG003|Overall Study|Adverse Event|0
6794145|NCT01496118|10792799|FG004|Overall Study|Adverse Event|0
6794146|NCT01496118|10792800|FG005|Overall Study|Adverse Event|0
6794147|NCT01496118|10792801|FG006|Overall Study|Adverse Event|6
6794148|NCT01496118|10792802|FG007|Overall Study|Adverse Event|10
6794149|NCT01496118|10792795|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0
6794150|NCT01496118|10792796|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0
6794151|NCT01496118|10792797|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0
6794152|NCT01496118|10792798|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0
6794153|NCT01496118|10792799|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0
6794154|NCT01496118|10792800|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0
6794155|NCT01496118|10792801|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1
6794156|NCT01496118|10792802|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0
6794157|NCT01496118|10792795|FG000|Overall Study|Death|0
6794158|NCT01496118|10792796|FG001|Overall Study|Death|0
6794159|NCT01496118|10792797|FG002|Overall Study|Death|0
6794160|NCT01496118|10792798|FG003|Overall Study|Death|0
6794161|NCT01496118|10792799|FG004|Overall Study|Death|0
6794162|NCT01496118|10792800|FG005|Overall Study|Death|0
6794163|NCT01496118|10792801|FG006|Overall Study|Death|1
6794164|NCT01496118|10792802|FG007|Overall Study|Death|1
6794165|NCT01496118|10792795|FG000|Overall Study|Withdrawal by Subject|0
6794166|NCT01496118|10792796|FG001|Overall Study|Withdrawal by Subject|0
6794167|NCT01496118|10792797|FG002|Overall Study|Withdrawal by Subject|0
6794168|NCT01496118|10792798|FG003|Overall Study|Withdrawal by Subject|2
6794169|NCT01496118|10792799|FG004|Overall Study|Withdrawal by Subject|0
6794170|NCT01496118|10792800|FG005|Overall Study|Withdrawal by Subject|1
6794171|NCT01496118|10792801|FG006|Overall Study|Withdrawal by Subject|6
6794172|NCT01496118|10792802|FG007|Overall Study|Withdrawal by Subject|3
6794173|NCT01350934|10792822|FG000|Base Study|Adverse Event|6
6794174|NCT01350934|10792823|FG001|Base Study|Adverse Event|0
6794175|NCT01350934|10792822|FG000|Base Study|Lost to Follow-up|1
6794176|NCT01350934|10792823|FG001|Base Study|Lost to Follow-up|0
6794177|NCT01350934|10792822|FG000|Base Study|Protocol Violation|1
6794178|NCT01350934|10792823|FG001|Base Study|Protocol Violation|1
6794179|NCT01350934|10792822|FG000|Base Study|Withdrawal by Subject|1
6794180|NCT01350934|10792823|FG001|Base Study|Withdrawal by Subject|2
6794181|NCT01350934|10792822|FG000|Base Study|Non-Compliance With Study Drug|2
6794182|NCT01350934|10792823|FG001|Base Study|Non-Compliance With Study Drug|0
6794183|NCT01350934|10792822|FG000|Extension Study|Adverse Event|2
6794184|NCT01350934|10792823|FG001|Extension Study|Adverse Event|1
6794185|NCT01350934|10792822|FG000|Extension Study|Lost to Follow-up|2
6794186|NCT01350934|10792823|FG001|Extension Study|Lost to Follow-up|0
6794187|NCT01350934|10792822|FG000|Extension Study|Protocol Violation|1
6794188|NCT01350934|10792823|FG001|Extension Study|Protocol Violation|1
6794189|NCT01350934|10792822|FG000|Extension Study|Lack of Efficacy|0
6794190|NCT01350934|10792823|FG001|Extension Study|Lack of Efficacy|1
6794191|NCT01350934|10792822|FG000|Extension Study|Withdrawal by Subject|0
6794192|NCT01350934|10792823|FG001|Extension Study|Withdrawal by Subject|1
6794193|NCT01286207|10792832|FG000|Overall Study|Adverse Event|27
6794194|NCT01286207|10792833|FG001|Overall Study|Adverse Event|41
6794195|NCT01286207|10792834|FG002|Overall Study|Adverse Event|8
6794196|NCT01286207|10792832|FG000|Overall Study|Lost to Follow-up|49
6794197|NCT01286207|10792833|FG001|Overall Study|Lost to Follow-up|43
6794198|NCT01286207|10792834|FG002|Overall Study|Lost to Follow-up|20
6794199|NCT01286207|10792832|FG000|Overall Study|Withdrawal by Subject|93
6794200|NCT01286207|10792833|FG001|Overall Study|Withdrawal by Subject|79
6794201|NCT01286207|10792834|FG002|Overall Study|Withdrawal by Subject|41
6794202|NCT01286207|10792832|FG000|Overall Study|Lack of Response|92
6794203|NCT01286207|10792833|FG001|Overall Study|Lack of Response|38
6794204|NCT01286207|10792834|FG002|Overall Study|Lack of Response|8
6794205|NCT01286207|10792832|FG000|Overall Study|Other|37
6794206|NCT01286207|10792833|FG001|Overall Study|Other|47
6794207|NCT01286207|10792834|FG002|Overall Study|Other|13
6794208|NCT01263769|10792842|FG000|Overall Study|Non-Compliant with treatment|1
6794209|NCT01227187|10792850|FG000|Overall Study|Physician Decision|0
6794210|NCT01227187|10792851|FG001|Overall Study|Physician Decision|0
6794211|NCT01227187|10792852|FG002|Overall Study|Physician Decision|0
6794212|NCT01227187|10792853|FG003|Overall Study|Physician Decision|1
6794213|NCT01222247|10792865|FG000|Overall Study|Lost to Follow-up|2
6794214|NCT01222247|10792866|FG001|Overall Study|Lost to Follow-up|2
6794215|NCT01144416|10792902|FG000|Intervention Period|Adverse Event|5
6794216|NCT01144416|10792903|FG001|Intervention Period|Adverse Event|6
6794217|NCT01144416|10792902|FG000|Intervention Period|Insufficient ovarian response|11
6794218|NCT01144416|10792903|FG001|Intervention Period|Insufficient ovarian response|17
6794219|NCT01144416|10792902|FG000|Intervention Period|Risk of OHSS|0
6794220|NCT01144416|10792903|FG001|Intervention Period|Risk of OHSS|1
6794221|NCT01144416|10792902|FG000|Intervention Period|Too high ovarian response|4
6794222|NCT01144416|10792903|FG001|Intervention Period|Too high ovarian response|2
6794223|NCT01144416|10792902|FG000|Intervention Period|No/too few/bad oocytes|7
6794224|NCT01144416|10792903|FG001|Intervention Period|No/too few/bad oocytes|5
6794225|NCT01144416|10792902|FG000|Intervention Period|No or abnormal fertilization|25
6794226|NCT01144416|10792903|FG001|Intervention Period|No or abnormal fertilization|10
6794227|NCT01144416|10792902|FG000|Intervention Period|No/too few/bad quality embryos|3
6794228|NCT01144416|10792903|FG001|Intervention Period|No/too few/bad quality embryos|3
6794229|NCT01144416|10792902|FG000|Intervention Period|Other|7
6794230|NCT01144416|10792903|FG001|Intervention Period|Other|5
6794231|NCT01140048|10792913|FG000|Overall Study|Physician Decision|1
6794232|NCT01140048|10792913|FG000|Overall Study|Withdrawal by Subject|13
6794233|NCT01140048|10792913|FG000|Overall Study|Lost to Follow-up|31
6794234|NCT01065779|10792928|FG000|Overall Study|Duplicate Investigation|1
6794235|NCT01065779|10792928|FG000|Overall Study|Investigation Before Contract Date|37
6794236|NCT01065779|10792928|FG000|Overall Study|Non-enrollment Period Administration|10
6794237|NCT01065779|10792928|FG000|Overall Study|Not Administered With Study Drug|17
6794238|NCT01065779|10792928|FG000|Overall Study|Failed to Follow-up|10
6794239|NCT01065779|10792928|FG000|Overall Study|Inclusion Criteria Violation|7
6794240|NCT00974571|10792935|FG000|Overall Study|Adverse Event|31
6794241|NCT00974571|10792936|FG001|Overall Study|Adverse Event|4
6794242|NCT00974571|10792937|FG002|Overall Study|Adverse Event|27
6794243|NCT00974571|10792935|FG000|Overall Study|Lack of Efficacy|3
6794244|NCT00974571|10792936|FG001|Overall Study|Lack of Efficacy|2
6794245|NCT00974571|10792937|FG002|Overall Study|Lack of Efficacy|9
6794246|NCT00974571|10792935|FG000|Overall Study|Lost to Follow-up|2
6794247|NCT00974571|10792936|FG001|Overall Study|Lost to Follow-up|1
6794248|NCT00974571|10792937|FG002|Overall Study|Lost to Follow-up|2
6794249|NCT00974571|10792935|FG000|Overall Study|Protocol Violation|13
6794250|NCT00974571|10792936|FG001|Overall Study|Protocol Violation|4
6794251|NCT00974571|10792937|FG002|Overall Study|Protocol Violation|18
6794252|NCT00974571|10792935|FG000|Overall Study|Withdrawal by Subject|14
6794253|NCT00974571|10792936|FG001|Overall Study|Withdrawal by Subject|5
6794254|NCT00974571|10792937|FG002|Overall Study|Withdrawal by Subject|16
6794255|NCT00974571|10792935|FG000|Overall Study|Patient Moved|1
6794256|NCT00974571|10792936|FG001|Overall Study|Patient Moved|0
6794257|NCT00974571|10792937|FG002|Overall Study|Patient Moved|1
6794258|NCT00974571|10792935|FG000|Overall Study|Other|4
6794259|NCT00974571|10792936|FG001|Overall Study|Other|0
6794260|NCT00974571|10792937|FG002|Overall Study|Other|10
6794261|NCT00972738|10792948|FG000|Overall Study|Adverse Event|7
6794262|NCT00972738|10792949|FG001|Overall Study|Adverse Event|1
6794263|NCT00972738|10792950|FG002|Overall Study|Adverse Event|8
6794264|NCT00972738|10792948|FG000|Overall Study|Protocol Violation|2
6794265|NCT00972738|10792949|FG001|Overall Study|Protocol Violation|1
6794266|NCT00972738|10792950|FG002|Overall Study|Protocol Violation|3
6794267|NCT00972738|10792948|FG000|Overall Study|Lost to Follow-up|1
6794268|NCT00972738|10792949|FG001|Overall Study|Lost to Follow-up|0
6794269|NCT00972738|10792950|FG002|Overall Study|Lost to Follow-up|1
6794270|NCT00972738|10792948|FG000|Overall Study|Lack of Efficacy|5
6794271|NCT00972738|10792949|FG001|Overall Study|Lack of Efficacy|1
6794272|NCT00972738|10792950|FG002|Overall Study|Lack of Efficacy|11
6794273|NCT00972738|10792948|FG000|Overall Study|Withdrawal by Subject|5
6794274|NCT00972738|10792949|FG001|Overall Study|Withdrawal by Subject|1
6794275|NCT00972738|10792950|FG002|Overall Study|Withdrawal by Subject|4
6794276|NCT00972738|10792948|FG000|Overall Study|Moved|0
6794277|NCT00972738|10792949|FG001|Overall Study|Moved|0
6794278|NCT00972738|10792950|FG002|Overall Study|Moved|1
6794279|NCT00972738|10792948|FG000|Overall Study|Other|1
6794280|NCT00972738|10792949|FG001|Overall Study|Other|2
6794281|NCT00972738|10792950|FG002|Overall Study|Other|1
6794282|NCT00968201|10792960|FG000|Base Study - (Period II)|Adverse Event|8
6794283|NCT00968201|10792961|FG001|Base Study - (Period II)|Adverse Event|0
6794284|NCT00968201|10792962|FG002|Base Study - (Period II)|Adverse Event|16
6794285|NCT00968201|10792960|FG000|Base Study - (Period II)|Lack of Efficacy|0
6794286|NCT00968201|10792961|FG001|Base Study - (Period II)|Lack of Efficacy|0
6794287|NCT00968201|10792962|FG002|Base Study - (Period II)|Lack of Efficacy|1
6794288|NCT00968201|10792960|FG000|Base Study - (Period II)|Lost to Follow-up|2
6794289|NCT00968201|10792961|FG001|Base Study - (Period II)|Lost to Follow-up|0
6794290|NCT00968201|10792962|FG002|Base Study - (Period II)|Lost to Follow-up|7
6794291|NCT00968201|10792960|FG000|Base Study - (Period II)|Protocol Violation|12
6794292|NCT00968201|10792961|FG001|Base Study - (Period II)|Protocol Violation|0
6794293|NCT00968201|10792962|FG002|Base Study - (Period II)|Protocol Violation|12
6794294|NCT00968201|10792960|FG000|Base Study - (Period II)|Withdrawal by Subject|4
6794295|NCT00968201|10792961|FG001|Base Study - (Period II)|Withdrawal by Subject|0
6794296|NCT00968201|10792962|FG002|Base Study - (Period II)|Withdrawal by Subject|8
6794297|NCT00968201|10792960|FG000|Base Study - (Period II)|Site Error|0
6794298|NCT00968201|10792961|FG001|Base Study - (Period II)|Site Error|0
6794299|NCT00968201|10792962|FG002|Base Study - (Period II)|Site Error|1
6794300|NCT00968201|10792960|FG000|Extension Study - (Period III)|Adverse Event|0
6794301|NCT00968201|10792961|FG001|Extension Study - (Period III)|Adverse Event|5
6794302|NCT00968201|10792962|FG002|Extension Study - (Period III)|Adverse Event|22
6794303|NCT00968201|10792960|FG000|Extension Study - (Period III)|Lost to Follow-up|0
6794304|NCT00968201|10792961|FG001|Extension Study - (Period III)|Lost to Follow-up|7
6794305|NCT00968201|10792962|FG002|Extension Study - (Period III)|Lost to Follow-up|13
6794306|NCT00968201|10792960|FG000|Extension Study - (Period III)|Protocol Violation|0
6794307|NCT00968201|10792961|FG001|Extension Study - (Period III)|Protocol Violation|17
6794308|NCT00968201|10792962|FG002|Extension Study - (Period III)|Protocol Violation|14
6794309|NCT00968201|10792960|FG000|Extension Study - (Period III)|Withdrawal by Subject|0
6794310|NCT00968201|10792961|FG001|Extension Study - (Period III)|Withdrawal by Subject|20
6794311|NCT00968201|10792962|FG002|Extension Study - (Period III)|Withdrawal by Subject|40
6794312|NCT00968201|10792960|FG000|Extension Study - (Period III)|Patient Relocated|0
6794313|NCT00968201|10792961|FG001|Extension Study - (Period III)|Patient Relocated|1
6794314|NCT00968201|10792962|FG002|Extension Study - (Period III)|Patient Relocated|1
6794315|NCT00968201|10792960|FG000|Extension Study - (Period III)|Noncompliance|0
6794316|NCT00968201|10792961|FG001|Extension Study - (Period III)|Noncompliance|0
6794317|NCT00968201|10792962|FG002|Extension Study - (Period III)|Noncompliance|3
6794318|NCT00968201|10792960|FG000|Extension Study - (Period III)|Other|0
6794319|NCT00968201|10792961|FG001|Extension Study - (Period III)|Other|0
6794320|NCT00968201|10792962|FG002|Extension Study - (Period III)|Other|2
6794321|NCT00968201|10792960|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0
6794322|NCT00968201|10792961|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74
6794323|NCT00968201|10792962|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185
6794324|NCT00968149|10792973|FG000|Overall Study|Adverse Event|5
6794325|NCT00968149|10792974|FG001|Overall Study|Adverse Event|1
6794326|NCT00968149|10792973|FG000|Overall Study|Lack of Efficacy|0
6794327|NCT00968149|10792974|FG001|Overall Study|Lack of Efficacy|4
6794328|NCT00968149|10792973|FG000|Overall Study|Lost to Follow-up|0
6794329|NCT00968149|10792974|FG001|Overall Study|Lost to Follow-up|1
6794330|NCT00968149|10792973|FG000|Overall Study|Protocol Violation|4
6794331|NCT00968149|10792974|FG001|Overall Study|Protocol Violation|0
6794332|NCT00968149|10792973|FG000|Overall Study|Withdrawal by Subject|2
6794333|NCT00968149|10792974|FG001|Overall Study|Withdrawal by Subject|0
6794334|NCT00963469|10792983|FG000|Overall Study|Adverse Event|15
6794335|NCT00963469|10792984|FG001|Overall Study|Adverse Event|11
6794336|NCT00963469|10792985|FG002|Overall Study|Adverse Event|1
6794337|NCT00963469|10792983|FG000|Overall Study|Lack of Efficacy|10
6794338|NCT00963469|10792984|FG001|Overall Study|Lack of Efficacy|7
6794339|NCT00963469|10792985|FG002|Overall Study|Lack of Efficacy|2
6794340|NCT00963469|10792983|FG000|Overall Study|Lost to Follow-up|1
6794341|NCT00963469|10792984|FG001|Overall Study|Lost to Follow-up|1
6794342|NCT00963469|10792985|FG002|Overall Study|Lost to Follow-up|0
6794343|NCT00963469|10792983|FG000|Overall Study|Protocol Violation|5
6794344|NCT00963469|10792984|FG001|Overall Study|Protocol Violation|5
6794345|NCT00963469|10792985|FG002|Overall Study|Protocol Violation|3
6794346|NCT00963469|10792983|FG000|Overall Study|Withdrawal by Subject|4
6794347|NCT00963469|10792984|FG001|Overall Study|Withdrawal by Subject|1
6794348|NCT00963469|10792985|FG002|Overall Study|Withdrawal by Subject|1
6794349|NCT00963469|10792983|FG000|Overall Study|Pre-randomization Adverse Event|1
6794350|NCT00963469|10792984|FG001|Overall Study|Pre-randomization Adverse Event|2
6794351|NCT00963469|10792985|FG002|Overall Study|Pre-randomization Adverse Event|0
6794352|NCT00963469|10792983|FG000|Overall Study|Moved|1
6794353|NCT00963469|10792984|FG001|Overall Study|Moved|0
6794354|NCT00963469|10792985|FG002|Overall Study|Moved|0
6794355|NCT00963469|10792983|FG000|Overall Study|Site closed (local pollen Season ended)|4
6794356|NCT00963469|10792984|FG001|Overall Study|Site closed (local pollen Season ended)|1
6794357|NCT00963469|10792985|FG002|Overall Study|Site closed (local pollen Season ended)|3
6794358|NCT00960141|10792996|FG000|Overall Study|Adverse Event|4
6794359|NCT00960141|10792997|FG001|Overall Study|Adverse Event|8
6794360|NCT00960141|10792998|FG002|Overall Study|Adverse Event|2
6794361|NCT00960141|10792996|FG000|Overall Study|Lack of Efficacy|3
6794362|NCT00960141|10792997|FG001|Overall Study|Lack of Efficacy|4
6794363|NCT00960141|10792998|FG002|Overall Study|Lack of Efficacy|2
6794364|NCT00960141|10792996|FG000|Overall Study|Lost to Follow-up|1
6794365|NCT00960141|10792997|FG001|Overall Study|Lost to Follow-up|0
6794366|NCT00960141|10792998|FG002|Overall Study|Lost to Follow-up|0
6794367|NCT00960141|10792996|FG000|Overall Study|Protocol Violation|1
6794368|NCT00960141|10792997|FG001|Overall Study|Protocol Violation|3
6794369|NCT00960141|10792998|FG002|Overall Study|Protocol Violation|2
6794370|NCT00960141|10792996|FG000|Overall Study|Withdrawal by Subject|1
6794371|NCT00960141|10792997|FG001|Overall Study|Withdrawal by Subject|2
6794372|NCT00960141|10792998|FG002|Overall Study|Withdrawal by Subject|1
6794373|NCT00943683|10793008|FG000|Overall Study|Adverse Event|3
6794374|NCT00943683|10793009|FG001|Overall Study|Adverse Event|3
6794375|NCT00943683|10793008|FG000|Overall Study|Lost to Follow-up|1
6794376|NCT00943683|10793009|FG001|Overall Study|Lost to Follow-up|1
6794377|NCT00943683|10793008|FG000|Overall Study|Protocol Violation|1
6794378|NCT00943683|10793009|FG001|Overall Study|Protocol Violation|2
6794379|NCT00943683|10793008|FG000|Overall Study|Withdrawal by Subject|1
6794380|NCT00943683|10793009|FG001|Overall Study|Withdrawal by Subject|0
6794381|NCT00943683|10793008|FG000|Overall Study|Patient Moved|1
6794382|NCT00943683|10793009|FG001|Overall Study|Patient Moved|0
6794383|NCT00943397|10793017|FG000|Overall Study|Adverse Event|0
6794384|NCT00943397|10793018|FG001|Overall Study|Adverse Event|6
6794385|NCT00943397|10793017|FG000|Overall Study|Lost to Follow-up|0
6794386|NCT00943397|10793018|FG001|Overall Study|Lost to Follow-up|4
6794387|NCT00943397|10793017|FG000|Overall Study|Protocol Violation|2
6794388|NCT00943397|10793018|FG001|Overall Study|Protocol Violation|5
6794389|NCT00943397|10793017|FG000|Overall Study|Withdrawal by Subject|1
6794390|NCT00943397|10793018|FG001|Overall Study|Withdrawal by Subject|1
6794391|NCT00943397|10793017|FG000|Overall Study|Site terminated and other|12
6794392|NCT00943397|10793018|FG001|Overall Study|Site terminated and other|56
6794398|NCT00911547|10793033|FG000|Overall Study|Adverse Event|8
6794399|NCT00911547|10793034|FG001|Overall Study|Adverse Event|27
6794400|NCT00911547|10793035|FG002|Overall Study|Adverse Event|11
6794401|NCT00911547|10793036|FG003|Overall Study|Adverse Event|6
6794402|NCT00911547|10793033|FG000|Overall Study|Lost to Follow-up|0
6794403|NCT00911547|10793034|FG001|Overall Study|Lost to Follow-up|0
6794404|NCT00911547|10793035|FG002|Overall Study|Lost to Follow-up|2
6794405|NCT00911547|10793036|FG003|Overall Study|Lost to Follow-up|1
6794406|NCT00911547|10793033|FG000|Overall Study|Protocol Violation|0
6794407|NCT00911547|10793034|FG001|Overall Study|Protocol Violation|5
6794408|NCT00911547|10793035|FG002|Overall Study|Protocol Violation|5
6794409|NCT00911547|10793036|FG003|Overall Study|Protocol Violation|1
6794410|NCT00911547|10793033|FG000|Overall Study|Withdrawal by Subject|3
6794411|NCT00911547|10793034|FG001|Overall Study|Withdrawal by Subject|10
6794412|NCT00911547|10793035|FG002|Overall Study|Withdrawal by Subject|4
6794413|NCT00911547|10793036|FG003|Overall Study|Withdrawal by Subject|8
6794414|NCT00899379|10793051|FG000|Overall Study|Adverse Event|2
6794415|NCT00899379|10793052|FG001|Overall Study|Adverse Event|2
6794416|NCT00899379|10793053|FG002|Overall Study|Adverse Event|1
6794417|NCT00899379|10793054|FG003|Overall Study|Adverse Event|1
6794418|NCT00899379|10793055|FG004|Overall Study|Adverse Event|2
6794419|NCT00899379|10793051|FG000|Overall Study|Lack of Efficacy|0
6794420|NCT00899379|10793052|FG001|Overall Study|Lack of Efficacy|4
6794421|NCT00899379|10793053|FG002|Overall Study|Lack of Efficacy|3
6794422|NCT00899379|10793054|FG003|Overall Study|Lack of Efficacy|0
6794423|NCT00899379|10793055|FG004|Overall Study|Lack of Efficacy|1
6794424|NCT00899379|10793051|FG000|Overall Study|Lost to Follow-up|9
6794425|NCT00899379|10793052|FG001|Overall Study|Lost to Follow-up|3
6794426|NCT00899379|10793053|FG002|Overall Study|Lost to Follow-up|0
6794427|NCT00899379|10793054|FG003|Overall Study|Lost to Follow-up|6
6794428|NCT00899379|10793055|FG004|Overall Study|Lost to Follow-up|2
6794429|NCT00899379|10793051|FG000|Overall Study|Protocol Violation|0
6794430|NCT00899379|10793052|FG001|Overall Study|Protocol Violation|0
6794431|NCT00899379|10793053|FG002|Overall Study|Protocol Violation|1
6794432|NCT00899379|10793054|FG003|Overall Study|Protocol Violation|1
6794433|NCT00899379|10793055|FG004|Overall Study|Protocol Violation|0
6794434|NCT00899379|10793051|FG000|Overall Study|Withdrawal by Subject|2
6794435|NCT00899379|10793052|FG001|Overall Study|Withdrawal by Subject|4
6794436|NCT00899379|10793053|FG002|Overall Study|Withdrawal by Subject|2
6794437|NCT00899379|10793054|FG003|Overall Study|Withdrawal by Subject|3
6794438|NCT00899379|10793055|FG004|Overall Study|Withdrawal by Subject|6
6794439|NCT00899379|10793051|FG000|Overall Study|Pregnancy|0
6794440|NCT00899379|10793052|FG001|Overall Study|Pregnancy|0
6794441|NCT00899379|10793053|FG002|Overall Study|Pregnancy|1
6794442|NCT00899379|10793054|FG003|Overall Study|Pregnancy|0
6794443|NCT00899379|10793055|FG004|Overall Study|Pregnancy|1
6794444|NCT00899379|10793051|FG000|Overall Study|Patient Uncooperative|0
6794445|NCT00899379|10793052|FG001|Overall Study|Patient Uncooperative|1
6794446|NCT00899379|10793053|FG002|Overall Study|Patient Uncooperative|0
6794447|NCT00899379|10793054|FG003|Overall Study|Patient Uncooperative|1
6794448|NCT00899379|10793055|FG004|Overall Study|Patient Uncooperative|2
6794449|NCT00899379|10793051|FG000|Overall Study|Abnormal Baseline ECG|0
6794450|NCT00899379|10793052|FG001|Overall Study|Abnormal Baseline ECG|0
6794451|NCT00899379|10793053|FG002|Overall Study|Abnormal Baseline ECG|0
6794452|NCT00899379|10793054|FG003|Overall Study|Abnormal Baseline ECG|1
6794453|NCT00899379|10793055|FG004|Overall Study|Abnormal Baseline ECG|0
6794454|NCT00899379|10793051|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1
6794455|NCT00899379|10793052|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1
6794456|NCT00899379|10793053|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1
6794457|NCT00899379|10793054|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0
6794458|NCT00899379|10793055|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0
6794459|NCT00899379|10793051|FG000|Overall Study|Not Completed/Entered Extn|5
6794460|NCT00899379|10793052|FG001|Overall Study|Not Completed/Entered Extn|1
6794461|NCT00899379|10793053|FG002|Overall Study|Not Completed/Entered Extn|6
6794462|NCT00899379|10793054|FG003|Overall Study|Not Completed/Entered Extn|4
6794463|NCT00899379|10793055|FG004|Overall Study|Not Completed/Entered Extn|3
6794464|NCT00899379|10793051|FG000|Overall Study|Study Terminated|3
6794465|NCT00899379|10793052|FG001|Overall Study|Study Terminated|0
6794466|NCT00899379|10793053|FG002|Overall Study|Study Terminated|3
6794467|NCT00899379|10793054|FG003|Overall Study|Study Terminated|3
6794468|NCT00899379|10793055|FG004|Overall Study|Study Terminated|1
6794469|NCT00899379|10793051|FG000|Overall Study|Lost to Follow-up|3
6794470|NCT00899379|10793052|FG001|Overall Study|Lost to Follow-up|1
6794471|NCT00899379|10793053|FG002|Overall Study|Lost to Follow-up|0
6794472|NCT00899379|10793054|FG003|Overall Study|Lost to Follow-up|2
6794473|NCT00899379|10793055|FG004|Overall Study|Lost to Follow-up|5
6794474|NCT00899379|10793051|FG000|Overall Study|Withdrawal by Subject|4
6794475|NCT00899379|10793052|FG001|Overall Study|Withdrawal by Subject|7
6794476|NCT00899379|10793053|FG002|Overall Study|Withdrawal by Subject|4
6794477|NCT00899379|10793054|FG003|Overall Study|Withdrawal by Subject|7
6794478|NCT00899379|10793055|FG004|Overall Study|Withdrawal by Subject|2
6794479|NCT00899379|10793051|FG000|Overall Study|Pregnancy|1
6794480|NCT00899379|10793052|FG001|Overall Study|Pregnancy|0
6794481|NCT00899379|10793053|FG002|Overall Study|Pregnancy|0
6794482|NCT00899379|10793054|FG003|Overall Study|Pregnancy|0
6794483|NCT00899379|10793055|FG004|Overall Study|Pregnancy|0
6794484|NCT00899379|10793051|FG000|Overall Study|Patient Uncooperative|0
6794485|NCT00899379|10793052|FG001|Overall Study|Patient Uncooperative|0
6794486|NCT00899379|10793053|FG002|Overall Study|Patient Uncooperative|0
6794487|NCT00899379|10793054|FG003|Overall Study|Patient Uncooperative|1
6794488|NCT00899379|10793055|FG004|Overall Study|Patient Uncooperative|0
6794489|NCT00899379|10793051|FG000|Overall Study|Abnormal Prestudy Labs|0
6794490|NCT00899379|10793052|FG001|Overall Study|Abnormal Prestudy Labs|0
6794491|NCT00899379|10793053|FG002|Overall Study|Abnormal Prestudy Labs|0
6794492|NCT00899379|10793054|FG003|Overall Study|Abnormal Prestudy Labs|0
6794493|NCT00899379|10793055|FG004|Overall Study|Abnormal Prestudy Labs|2
6794494|NCT00899379|10793051|FG000|Overall Study|Abnormal Baseline ECG|0
6794495|NCT00899379|10793052|FG001|Overall Study|Abnormal Baseline ECG|0
6794496|NCT00899379|10793053|FG002|Overall Study|Abnormal Baseline ECG|1
6794497|NCT00899379|10793054|FG003|Overall Study|Abnormal Baseline ECG|1
6794498|NCT00899379|10793055|FG004|Overall Study|Abnormal Baseline ECG|0
6794499|NCT00899379|10793051|FG000|Overall Study|No Attack Pretreatment|3
6794500|NCT00899379|10793052|FG001|Overall Study|No Attack Pretreatment|5
6794501|NCT00899379|10793053|FG002|Overall Study|No Attack Pretreatment|5
6794502|NCT00899379|10793054|FG003|Overall Study|No Attack Pretreatment|6
6794503|NCT00899379|10793055|FG004|Overall Study|No Attack Pretreatment|4
6794504|NCT00899379|10793051|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1
6794505|NCT00899379|10793052|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0
6794506|NCT00899379|10793053|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0
6794507|NCT00899379|10793054|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0
6794508|NCT00899379|10793055|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0
6794509|NCT00899379|10793051|FG000|Overall Study|Inc/Exc Criteria Not Met|0
6794510|NCT00899379|10793052|FG001|Overall Study|Inc/Exc Criteria Not Met|0
6794511|NCT00899379|10793053|FG002|Overall Study|Inc/Exc Criteria Not Met|1
6794512|NCT00899379|10793054|FG003|Overall Study|Inc/Exc Criteria Not Met|0
6794513|NCT00899379|10793055|FG004|Overall Study|Inc/Exc Criteria Not Met|0
6794514|NCT00898677|10793065|FG000|Overall Study|Adverse Event|0
6794515|NCT00898677|10793066|FG001|Overall Study|Adverse Event|0
6794516|NCT00898677|10793067|FG002|Overall Study|Adverse Event|1
6794517|NCT00898677|10793068|FG003|Overall Study|Adverse Event|0
6794518|NCT00898677|10793065|FG000|Overall Study|Lost to Follow-up|0
6794519|NCT00898677|10793066|FG001|Overall Study|Lost to Follow-up|0
6794520|NCT00898677|10793067|FG002|Overall Study|Lost to Follow-up|2
6794521|NCT00898677|10793068|FG003|Overall Study|Lost to Follow-up|0
6794522|NCT00898677|10793065|FG000|Overall Study|Protocol Violation|1
6794523|NCT00898677|10793066|FG001|Overall Study|Protocol Violation|1
6794524|NCT00898677|10793067|FG002|Overall Study|Protocol Violation|2
6794525|NCT00898677|10793068|FG003|Overall Study|Protocol Violation|0
6794526|NCT00898677|10793065|FG000|Overall Study|Withdrawal by Subject|0
6794527|NCT00898677|10793066|FG001|Overall Study|Withdrawal by Subject|0
6794528|NCT00898677|10793067|FG002|Overall Study|Withdrawal by Subject|0
6794529|NCT00898677|10793068|FG003|Overall Study|Withdrawal by Subject|1
6794530|NCT00898677|10793065|FG000|Overall Study|Not Treated: Adverse Event|0
6794531|NCT00898677|10793066|FG001|Overall Study|Not Treated: Adverse Event|2
6794532|NCT00898677|10793067|FG002|Overall Study|Not Treated: Adverse Event|1
6794533|NCT00898677|10793068|FG003|Overall Study|Not Treated: Adverse Event|0
6794534|NCT00898677|10793065|FG000|Overall Study|Not Treated: Lost to Follow-Up|0
6794535|NCT00898677|10793066|FG001|Overall Study|Not Treated: Lost to Follow-Up|5
6794536|NCT00898677|10793067|FG002|Overall Study|Not Treated: Lost to Follow-Up|5
6794537|NCT00898677|10793068|FG003|Overall Study|Not Treated: Lost to Follow-Up|2
6794538|NCT00898677|10793065|FG000|Overall Study|Not Treated: Pregnancy|0
6794539|NCT00898677|10793066|FG001|Overall Study|Not Treated: Pregnancy|0
6794540|NCT00898677|10793067|FG002|Overall Study|Not Treated: Pregnancy|1
6794541|NCT00898677|10793068|FG003|Overall Study|Not Treated: Pregnancy|0
6794542|NCT00898677|10793065|FG000|Overall Study|Not Treated: Protocol Violation|2
6794543|NCT00898677|10793066|FG001|Overall Study|Not Treated: Protocol Violation|0
6794544|NCT00898677|10793067|FG002|Overall Study|Not Treated: Protocol Violation|2
6794545|NCT00898677|10793068|FG003|Overall Study|Not Treated: Protocol Violation|0
6794546|NCT00898677|10793065|FG000|Overall Study|Not Treated: Withdraw by Subject|2
6794547|NCT00898677|10793066|FG001|Overall Study|Not Treated: Withdraw by Subject|16
6794548|NCT00898677|10793067|FG002|Overall Study|Not Treated: Withdraw by Subject|11
6794549|NCT00898677|10793068|FG003|Overall Study|Not Treated: Withdraw by Subject|3
6794550|NCT00898677|10793065|FG000|Overall Study|Not Treated: Patient uncooperative|2
6794551|NCT00898677|10793066|FG001|Overall Study|Not Treated: Patient uncooperative|3
6794552|NCT00898677|10793067|FG002|Overall Study|Not Treated: Patient uncooperative|1
6794553|NCT00898677|10793068|FG003|Overall Study|Not Treated: Patient uncooperative|0
6794554|NCT00898677|10793065|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0
6794555|NCT00898677|10793066|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0
6794556|NCT00898677|10793067|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0
6794557|NCT00898677|10793068|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1
6794558|NCT00898677|10793065|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1
6794559|NCT00898677|10793066|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0
6794560|NCT00898677|10793067|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0
6794561|NCT00898677|10793068|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0
6794562|NCT00898677|10793065|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0
6794563|NCT00898677|10793066|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3
6794564|NCT00898677|10793067|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1
6794565|NCT00898677|10793068|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0
6794566|NCT00898677|10793065|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9
6794567|NCT00898677|10793066|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39
6794568|NCT00898677|10793067|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43
6794569|NCT00898677|10793068|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12
6794570|NCT00898677|10793065|FG000|Overall Study|Not Treated: Other (Not Specified)|0
6794571|NCT00898677|10793066|FG001|Overall Study|Not Treated: Other (Not Specified)|0
6794572|NCT00898677|10793067|FG002|Overall Study|Not Treated: Other (Not Specified)|2
6794573|NCT00898677|10793068|FG003|Overall Study|Not Treated: Other (Not Specified)|0
6794574|NCT00897949|10793081|FG000|Overall Study|Adverse Event|1
6794575|NCT00897949|10793082|FG001|Overall Study|Adverse Event|1
6794576|NCT00897949|10793083|FG002|Overall Study|Adverse Event|0
6794577|NCT00897949|10793081|FG000|Overall Study|Lost to Follow-up|0
6794578|NCT00897949|10793082|FG001|Overall Study|Lost to Follow-up|2
6794579|NCT00897949|10793083|FG002|Overall Study|Lost to Follow-up|1
6794580|NCT00897949|10793081|FG000|Overall Study|Protocol Violation|6
6794581|NCT00897949|10793082|FG001|Overall Study|Protocol Violation|3
6794582|NCT00897949|10793083|FG002|Overall Study|Protocol Violation|1
6794583|NCT00897949|10793081|FG000|Overall Study|Withdrawal by Subject|1
6794584|NCT00897949|10793082|FG001|Overall Study|Withdrawal by Subject|2
6794585|NCT00897949|10793083|FG002|Overall Study|Withdrawal by Subject|0
6794586|NCT00897949|10793081|FG000|Overall Study|Patient Uncoorperative|0
6794587|NCT00897949|10793082|FG001|Overall Study|Patient Uncoorperative|2
6794588|NCT00897949|10793083|FG002|Overall Study|Patient Uncoorperative|1
6794589|NCT00897949|10793081|FG000|Overall Study|Lost to Follow-up|30
6794590|NCT00897949|10793082|FG001|Overall Study|Lost to Follow-up|23
6794591|NCT00897949|10793083|FG002|Overall Study|Lost to Follow-up|17
6794592|NCT00897949|10793081|FG000|Overall Study|Withdrawal by Subject|24
6794593|NCT00897949|10793082|FG001|Overall Study|Withdrawal by Subject|31
6794594|NCT00897949|10793083|FG002|Overall Study|Withdrawal by Subject|17
6794595|NCT00897949|10793081|FG000|Overall Study|Abnormal Prestudy Labs|2
6794596|NCT00897949|10793082|FG001|Overall Study|Abnormal Prestudy Labs|3
6794597|NCT00897949|10793083|FG002|Overall Study|Abnormal Prestudy Labs|4
6794598|NCT00897949|10793081|FG000|Overall Study|Abnormal Baseline ECG|2
6794599|NCT00897949|10793082|FG001|Overall Study|Abnormal Baseline ECG|2
6794600|NCT00897949|10793083|FG002|Overall Study|Abnormal Baseline ECG|4
6794601|NCT00897949|10793081|FG000|Overall Study|Need for Concom. Med.|0
6794602|NCT00897949|10793082|FG001|Overall Study|Need for Concom. Med.|1
6794603|NCT00897949|10793083|FG002|Overall Study|Need for Concom. Med.|1
6794604|NCT00897949|10793081|FG000|Overall Study|Lack of Migraine Attack|29
6794605|NCT00897949|10793082|FG001|Overall Study|Lack of Migraine Attack|30
6794606|NCT00897949|10793083|FG002|Overall Study|Lack of Migraine Attack|19
6794607|NCT00897949|10793081|FG000|Overall Study|Did not take study drug|9
6794608|NCT00897949|10793082|FG001|Overall Study|Did not take study drug|3
6794609|NCT00897949|10793083|FG002|Overall Study|Did not take study drug|4
6794610|NCT00897104|10793100|FG000|Overall Study|Lost to Follow-up|12
6794611|NCT00897104|10793101|FG001|Overall Study|Lost to Follow-up|17
6794612|NCT00897104|10793102|FG002|Overall Study|Lost to Follow-up|2
6794613|NCT00897104|10793100|FG000|Overall Study|Pregnancy|0
6794614|NCT00897104|10793101|FG001|Overall Study|Pregnancy|1
6794615|NCT00897104|10793102|FG002|Overall Study|Pregnancy|0
6794616|NCT00897104|10793100|FG000|Overall Study|Protocol Violation|0
6794617|NCT00897104|10793101|FG001|Overall Study|Protocol Violation|1
6794618|NCT00897104|10793102|FG002|Overall Study|Protocol Violation|0
6794619|NCT00897104|10793100|FG000|Overall Study|Withdrawal by Subject|23
6794620|NCT00897104|10793101|FG001|Overall Study|Withdrawal by Subject|27
6794621|NCT00897104|10793102|FG002|Overall Study|Withdrawal by Subject|3
6794622|NCT00897104|10793100|FG000|Overall Study|Abnormal Prestudy Labs|2
6794623|NCT00897104|10793101|FG001|Overall Study|Abnormal Prestudy Labs|0
6794624|NCT00897104|10793102|FG002|Overall Study|Abnormal Prestudy Labs|0
6794625|NCT00897104|10793100|FG000|Overall Study|Abnormal Baseline ECG|2
6794626|NCT00897104|10793101|FG001|Overall Study|Abnormal Baseline ECG|2
6794627|NCT00897104|10793102|FG002|Overall Study|Abnormal Baseline ECG|0
6794628|NCT00897104|10793100|FG000|Overall Study|Need for Concom. Med.|0
6794629|NCT00897104|10793101|FG001|Overall Study|Need for Concom. Med.|1
6794630|NCT00897104|10793102|FG002|Overall Study|Need for Concom. Med.|1
6794631|NCT00897104|10793100|FG000|Overall Study|Lack of Migraine Attack|20
6794632|NCT00897104|10793101|FG001|Overall Study|Lack of Migraine Attack|22
6794633|NCT00897104|10793102|FG002|Overall Study|Lack of Migraine Attack|1
6794634|NCT00897104|10793100|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1
6794635|NCT00897104|10793101|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0
6794636|NCT00897104|10793102|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0
6794637|NCT00897104|10793100|FG000|Overall Study|Other|3
6794638|NCT00897104|10793101|FG001|Overall Study|Other|0
6794639|NCT00897104|10793102|FG002|Overall Study|Other|0
6794640|NCT00897104|10793100|FG000|Overall Study|Protocol Violation|1
6794641|NCT00897104|10793101|FG001|Overall Study|Protocol Violation|0
6794642|NCT00897104|10793102|FG002|Overall Study|Protocol Violation|0
6794643|NCT00897104|10793100|FG000|Overall Study|Withdrawal by Subject|0
6794644|NCT00897104|10793101|FG001|Overall Study|Withdrawal by Subject|0
6794645|NCT00897104|10793102|FG002|Overall Study|Withdrawal by Subject|1
6794646|NCT00803790|10793112|FG000|Period 1|Adverse Event|0
6794647|NCT00803790|10793113|FG001|Period 1|Adverse Event|1
6794648|NCT00803790|10793114|FG002|Period 1|Adverse Event|0
6794649|NCT00803790|10793115|FG003|Period 1|Adverse Event|0
6794650|NCT00803790|10793112|FG000|Period 1|Lost to Follow-up|1
6794651|NCT00803790|10793113|FG001|Period 1|Lost to Follow-up|2
6794652|NCT00803790|10793114|FG002|Period 1|Lost to Follow-up|0
6794653|NCT00803790|10793115|FG003|Period 1|Lost to Follow-up|0
6794654|NCT00803790|10793112|FG000|Period 1|Withdrawal by Subject|8
6794655|NCT00803790|10793113|FG001|Period 1|Withdrawal by Subject|6
6794656|NCT00803790|10793114|FG002|Period 1|Withdrawal by Subject|0
6794657|NCT00803790|10793115|FG003|Period 1|Withdrawal by Subject|0
6794658|NCT00803790|10793112|FG000|Period 1|positive drug screen or personal reasons|0
6794659|NCT00803790|10793113|FG001|Period 1|positive drug screen or personal reasons|3
6794660|NCT00803790|10793114|FG002|Period 1|positive drug screen or personal reasons|0
6794661|NCT00803790|10793115|FG003|Period 1|positive drug screen or personal reasons|4
6794662|NCT00803790|10793112|FG000|Period 1|Protocol Violation|0
6794663|NCT00803790|10793113|FG001|Period 1|Protocol Violation|0
6794664|NCT00803790|10793114|FG002|Period 1|Protocol Violation|1
6794665|NCT00803790|10793115|FG003|Period 1|Protocol Violation|0
6794666|NCT00803790|10793112|FG000|Period 2|Adverse Event|0
6794667|NCT00803790|10793113|FG001|Period 2|Adverse Event|0
6794668|NCT00803790|10793114|FG002|Period 2|Adverse Event|1
6794669|NCT00803790|10793115|FG003|Period 2|Adverse Event|1
6794670|NCT00803790|10793112|FG000|Period 2|Withdrawal by Subject|1
6794671|NCT00803790|10793113|FG001|Period 2|Withdrawal by Subject|0
6794672|NCT00803790|10793114|FG002|Period 2|Withdrawal by Subject|0
6794673|NCT00803790|10793115|FG003|Period 2|Withdrawal by Subject|0
6794674|NCT00803790|10793112|FG000|Period 2|Positive Drug Screen or Personal Reasons|1
6794675|NCT00803790|10793113|FG001|Period 2|Positive Drug Screen or Personal Reasons|0
6794676|NCT00803790|10793114|FG002|Period 2|Positive Drug Screen or Personal Reasons|0
6794677|NCT00803790|10793115|FG003|Period 2|Positive Drug Screen or Personal Reasons|0
6794678|NCT00725491|10793128|FG000|Overall Study|Adverse Event|3
6794679|NCT00725491|10793129|FG001|Overall Study|Adverse Event|2
6794680|NCT00725491|10793128|FG000|Overall Study|Pregnancy|0
6794681|NCT00725491|10793129|FG001|Overall Study|Pregnancy|3
6794682|NCT00725491|10793128|FG000|Overall Study|Risk for hyperstimulation|2
6794683|NCT00725491|10793129|FG001|Overall Study|Risk for hyperstimulation|9
6794684|NCT00725491|10793128|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1
6794685|NCT00725491|10793129|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1
6794686|NCT00725491|10793128|FG000|Overall Study|Fertilization failure|0
6794687|NCT00725491|10793129|FG001|Overall Study|Fertilization failure|1
6794688|NCT00725491|10793128|FG000|Overall Study|No/too few embryos/ bad quality embryos|3
6794689|NCT00725491|10793129|FG001|Overall Study|No/too few embryos/ bad quality embryos|2
6808429|NCT01232283|10812114|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0
6808430|NCT01232283|10812115|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0
6808431|NCT01232283|10812116|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0
6808432|NCT01232283|10812117|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0
6808433|NCT01232283|10812118|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0
6808434|NCT01232283|10812119|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0
6808435|NCT01232283|10812120|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0
6808436|NCT01232283|10812121|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0
6808437|NCT01232283|10812112|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0
6808438|NCT01232283|10812113|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0
6808439|NCT01232283|10812114|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8
6808440|NCT01232283|10812115|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2
6808441|NCT01232283|10812116|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0
6808442|NCT01232283|10812117|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0
6808443|NCT01232283|10812118|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0
6808444|NCT01232283|10812119|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0
6808445|NCT01232283|10812120|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0
6808446|NCT01232283|10812121|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0
6808447|NCT01232283|10812112|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
6808448|NCT01232283|10812113|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
6808449|NCT01232283|10812114|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19
6808450|NCT01232283|10812115|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3
6808451|NCT01232283|10812116|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
6808452|NCT01232283|10812117|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
6808453|NCT01232283|10812118|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
6808454|NCT01232283|10812119|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
6808455|NCT01232283|10812120|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
6808456|NCT01232283|10812121|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
6808457|NCT01232283|10812112|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
6808458|NCT01232283|10812113|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
6808459|NCT01232283|10812114|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1
6808460|NCT01232283|10812115|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
6808461|NCT01232283|10812116|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
6808462|NCT01232283|10812117|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
6808463|NCT01232283|10812118|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
6808464|NCT01232283|10812119|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
6808465|NCT01232283|10812120|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
6808466|NCT01232283|10812121|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
6808467|NCT01232283|10812112|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
6808468|NCT01232283|10812113|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
6808469|NCT01232283|10812114|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7
6808470|NCT01232283|10812115|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1
6808471|NCT01232283|10812116|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
6808472|NCT01232283|10812117|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
6808473|NCT01232283|10812118|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
6808474|NCT01232283|10812119|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
6808475|NCT01232283|10812120|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
6808476|NCT01232283|10812121|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
6808477|NCT01232283|10812112|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
6808478|NCT01232283|10812113|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
6808479|NCT01232283|10812114|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3
6808480|NCT01232283|10812115|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2
6808481|NCT01232283|10812116|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
6808482|NCT01232283|10812117|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
6808483|NCT01232283|10812118|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
6808484|NCT01232283|10812119|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
6808485|NCT01232283|10812120|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
6808486|NCT01232283|10812121|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
6808487|NCT01232283|10812112|FG000|Maintenance Phase (Weeks16-32)|Other|0
6808488|NCT01232283|10812113|FG001|Maintenance Phase (Weeks16-32)|Other|0
6808489|NCT01232283|10812114|FG002|Maintenance Phase (Weeks16-32)|Other|2
6808490|NCT01232283|10812115|FG003|Maintenance Phase (Weeks16-32)|Other|0
6808491|NCT01232283|10812116|FG004|Maintenance Phase (Weeks16-32)|Other|0
6808492|NCT01232283|10812117|FG005|Maintenance Phase (Weeks16-32)|Other|0
6808493|NCT01232283|10812118|FG006|Maintenance Phase (Weeks16-32)|Other|0
6808494|NCT01232283|10812119|FG007|Maintenance Phase (Weeks16-32)|Other|0
6808495|NCT01232283|10812120|FG008|Maintenance Phase (Weeks16-32)|Other|0
6808496|NCT01232283|10812121|FG009|Maintenance Phase (Weeks16-32)|Other|0
6794690|NCT00703014|10793137|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33
6794691|NCT00703014|10793138|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32
6794692|NCT00703014|10793139|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
6794693|NCT00703014|10793140|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
6794694|NCT00703014|10793137|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
6794695|NCT00703014|10793138|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
6794696|NCT00703014|10793139|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47
6794697|NCT00703014|10793140|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42
6794698|NCT00702845|10793152|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2
6794699|NCT00702845|10793153|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2
6794700|NCT00702845|10793152|FG000|Overall Study|Too high ovarian response|5
6794701|NCT00702845|10793153|FG001|Overall Study|Too high ovarian response|1
6794702|NCT00702845|10793152|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1
6794703|NCT00702845|10793153|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0
6794704|NCT00702845|10793152|FG000|Overall Study|Insufficient ovarian response|1
6794705|NCT00702845|10793153|FG001|Overall Study|Insufficient ovarian response|0
6794706|NCT00702845|10793152|FG000|Overall Study|No/too few/bad quality embryos retrieved|7
6794707|NCT00702845|10793153|FG001|Overall Study|No/too few/bad quality embryos retrieved|1
6794708|NCT00702845|10793152|FG000|Overall Study|No or abnormal fertilization|4
6794709|NCT00702845|10793153|FG001|Overall Study|No or abnormal fertilization|2
6794710|NCT00702845|10793152|FG000|Overall Study|Patient's decision|2
6794711|NCT00702845|10793153|FG001|Overall Study|Patient's decision|1
6794712|NCT00702845|10793152|FG000|Overall Study|Not randomized|0
6794713|NCT00702845|10793153|FG001|Overall Study|Not randomized|1
6794714|NCT00702520|10793188|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
6794715|NCT00702520|10793189|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1
6794716|NCT00702520|10793190|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
6794717|NCT00702520|10793191|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
6794718|NCT00702520|10793188|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3
6794719|NCT00702520|10793189|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6
6794720|NCT00702520|10793190|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0
6794721|NCT00702520|10793191|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0
6794722|NCT00702520|10793188|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15
6794723|NCT00702520|10793189|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10
6794724|NCT00702520|10793190|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
6794725|NCT00702520|10793191|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
6794726|NCT00697255|10793230|FG000|Stage 1a|Insufficient ovarian response|1
6794727|NCT00697255|10793231|FG001|Stage 1a|Insufficient ovarian response|0
6794728|NCT00697255|10793230|FG000|Stage 1a|Multifollicular growth|1
6794729|NCT00697255|10793231|FG001|Stage 1a|Multifollicular growth|0
6794730|NCT00697255|10793230|FG000|Stage 1a|Not growing of dominant follicle|1
6794731|NCT00697255|10793231|FG001|Stage 1a|Not growing of dominant follicle|0
6794732|NCT00697255|10793230|FG000|Stage 1b|Not growing of dominant follicle|0
6794733|NCT00697255|10793231|FG001|Stage 1b|Not growing of dominant follicle|1
6794734|NCT00697255|10793230|FG000|Stage 1b|Insufficient ovarian response|0
6794735|NCT00697255|10793231|FG001|Stage 1b|Insufficient ovarian response|1
6794736|NCT00696878|10793237|FG000|Overall Study|Adverse Event|8
6794737|NCT00696878|10793237|FG000|Overall Study|Withdrawal by Subject|87
6794738|NCT00696878|10793237|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18
6794739|NCT00696878|10793237|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304
6794740|NCT00696878|10793237|FG000|Overall Study|Trial stopped|32
6794741|NCT00696878|10793237|FG000|Overall Study|Other reason (not specified)|55
6794742|NCT00696800|10793243|FG000|Overall Study|Adverse Event|16
6794743|NCT00696800|10793244|FG001|Overall Study|Adverse Event|3
6794744|NCT00696800|10793243|FG000|Overall Study|Insufficient compliance with medication|2
6794745|NCT00696800|10793244|FG001|Overall Study|Insufficient compliance with medication|1
6794746|NCT00696800|10793243|FG000|Overall Study|Insufficient ovarian response on Day 8|4
6794747|NCT00696800|10793244|FG001|Overall Study|Insufficient ovarian response on Day 8|1
6794748|NCT00696800|10793243|FG000|Overall Study|Insufficient ovarian response|4
6794749|NCT00696800|10793244|FG001|Overall Study|Insufficient ovarian response|1
6794750|NCT00696800|10793243|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8
6794751|NCT00696800|10793244|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2
6794752|NCT00696800|10793243|FG000|Overall Study|Too high ovarian response|6
6794753|NCT00696800|10793244|FG001|Overall Study|Too high ovarian response|1
6794754|NCT00696800|10793243|FG000|Overall Study|No/too few/bad quality oocytes|4
6794755|NCT00696800|10793244|FG001|Overall Study|No/too few/bad quality oocytes|3
6794756|NCT00696800|10793243|FG000|Overall Study|No/abnormal fertilization|11
6794757|NCT00696800|10793244|FG001|Overall Study|No/abnormal fertilization|13
6794758|NCT00696800|10793243|FG000|Overall Study|No/too few/bad quality embryos|24
6794759|NCT00696800|10793244|FG001|Overall Study|No/too few/bad quality embryos|18
6794760|NCT00696800|10793243|FG000|Overall Study|Other Reasons|5
6794761|NCT00696800|10793244|FG001|Overall Study|Other Reasons|3
6794762|NCT00696800|10793243|FG000|Overall Study|Not treated|1
6794763|NCT00696800|10793244|FG001|Overall Study|Not treated|2
6794764|NCT00616967|10793252|FG000|Overall Study|Withdrawal by Subject|0
6794765|NCT00616967|10793253|FG001|Overall Study|Withdrawal by Subject|0
6794766|NCT00616967|10793254|FG002|Overall Study|Withdrawal by Subject|1
6794767|NCT00461032|10793274|FG000|Overall Study|Adverse Event|5
6794768|NCT00461032|10793275|FG001|Overall Study|Adverse Event|6
6794769|NCT00461032|10793274|FG000|Overall Study|Lack of Efficacy|5
6794770|NCT00461032|10793275|FG001|Overall Study|Lack of Efficacy|1
6794771|NCT00461032|10793274|FG000|Overall Study|Lost to Follow-up|7
6794772|NCT00461032|10793275|FG001|Overall Study|Lost to Follow-up|12
6794773|NCT00461032|10793274|FG000|Overall Study|Protocol Violation|4
6794774|NCT00461032|10793275|FG001|Overall Study|Protocol Violation|4
6794775|NCT00461032|10793274|FG000|Overall Study|Withdrawal by Subject|7
6794776|NCT00461032|10793275|FG001|Overall Study|Withdrawal by Subject|15
6794777|NCT00461032|10793274|FG000|Overall Study|Patient Moved or Relocated|2
6794778|NCT00461032|10793275|FG001|Overall Study|Patient Moved or Relocated|1
6794779|NCT00461032|10793274|FG000|Overall Study|Other|7
6794780|NCT00461032|10793275|FG001|Overall Study|Other|5
6794781|NCT00289874|10793296|FG000|Overall Study|Adverse Event|1
6794782|NCT00289874|10793297|FG001|Overall Study|Adverse Event|5
6794783|NCT00289874|10793296|FG000|Overall Study|Lost to Follow-up|1
6794784|NCT00289874|10793297|FG001|Overall Study|Lost to Follow-up|1
6794785|NCT00289874|10793296|FG000|Overall Study|Protocol Violation|3
6794786|NCT00289874|10793297|FG001|Overall Study|Protocol Violation|2
6794787|NCT00289874|10793296|FG000|Overall Study|Did not meet eligibility|1
6794788|NCT00289874|10793297|FG001|Overall Study|Did not meet eligibility|0
6794789|NCT00250458|10793305|FG000|Overall Study|Lost to Follow-up|4
6794790|NCT00250458|10793306|FG001|Overall Study|Lost to Follow-up|2
6794791|NCT00250458|10793305|FG000|Overall Study|Protocol Violation|0
6794792|NCT00250458|10793306|FG001|Overall Study|Protocol Violation|1
6794793|NCT00250458|10793305|FG000|Overall Study|Withdrawal by Subject|4
6794794|NCT00250458|10793306|FG001|Overall Study|Withdrawal by Subject|2
6794795|NCT00250458|10793305|FG000|Overall Study|Lack of Migraine Attack|20
6794796|NCT00250458|10793306|FG001|Overall Study|Lack of Migraine Attack|9
6794797|NCT00250458|10793305|FG000|Overall Study|Qualifying migraine but did not treat|3
6794798|NCT00250458|10793306|FG001|Overall Study|Qualifying migraine but did not treat|3
6794799|NCT00250458|10793305|FG000|Overall Study|Other|1
6794800|NCT00250458|10793306|FG001|Overall Study|Other|0
6794801|NCT00245570|10793312|FG000|Washout Between Periods III and IV|Adverse Event|0
6794802|NCT00245570|10793313|FG001|Washout Between Periods III and IV|Adverse Event|1
6794803|NCT00245570|10793314|FG002|Washout Between Periods III and IV|Adverse Event|0
6794804|NCT00245570|10793315|FG003|Washout Between Periods III and IV|Adverse Event|0
6794805|NCT00245570|10793316|FG004|Washout Between Periods III and IV|Adverse Event|0
6794806|NCT00245570|10793317|FG005|Washout Between Periods III and IV|Adverse Event|0
6794807|NCT00092131|10793341|FG000|Treatment Period I|Adverse Event|1
6794808|NCT00092131|10793342|FG001|Treatment Period I|Adverse Event|0
6794809|NCT00092131|10793341|FG000|Treatment Period II|Adverse Event|0
6794810|NCT00092131|10793342|FG001|Treatment Period II|Adverse Event|1
6794811|NCT00092118|10793350|FG000|Overall Study|Adverse Event|35
6794812|NCT00092118|10793351|FG001|Overall Study|Adverse Event|32
6794813|NCT00092118|10793350|FG000|Overall Study|Lack of Efficacy|12
6794814|NCT00092118|10793351|FG001|Overall Study|Lack of Efficacy|14
6794815|NCT00092118|10793350|FG000|Overall Study|Lost to Follow-up|4
6794816|NCT00092118|10793351|FG001|Overall Study|Lost to Follow-up|3
6794817|NCT00092118|10793350|FG000|Overall Study|Protocol Violation|23
6794818|NCT00092118|10793351|FG001|Overall Study|Protocol Violation|25
6794819|NCT00092118|10793350|FG000|Overall Study|Withdrawal by Subject|4
6794820|NCT00092118|10793351|FG001|Overall Study|Withdrawal by Subject|10
6794821|NCT00092118|10793350|FG000|Overall Study|Other|6
6794822|NCT00092118|10793351|FG001|Overall Study|Other|5
6794823|NCT00090142|10793357|FG000|Treatment Period I|Lost to Follow-up|1
6794824|NCT00090142|10793358|FG001|Treatment Period I|Lost to Follow-up|2
6794825|NCT00090142|10793357|FG000|Treatment Period I|Protocol Violation|2
6794826|NCT00090142|10793358|FG001|Treatment Period I|Protocol Violation|0
6794827|NCT00090142|10793357|FG000|Treatment Period I|Withdrawal by Subject|2
6794828|NCT00090142|10793358|FG001|Treatment Period I|Withdrawal by Subject|0
6794829|NCT00090142|10793357|FG000|Treatment Period I|Other|0
6794830|NCT00090142|10793358|FG001|Treatment Period I|Other|1
6794831|NCT00090142|10793357|FG000|Treatment Period II|Other|1
6794832|NCT00090142|10793358|FG001|Treatment Period II|Other|0
6808497|NCT01232283|10812112|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
6808498|NCT01232283|10812113|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
6808499|NCT01232283|10812114|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
6808500|NCT01232283|10812115|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
6808501|NCT01232283|10812116|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2
6808502|NCT01232283|10812117|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
6808503|NCT01232283|10812118|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
6808504|NCT01232283|10812119|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
6808505|NCT01232283|10812120|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
6808506|NCT01232283|10812121|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
6808507|NCT01232283|10812112|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
6808508|NCT01232283|10812113|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
6808509|NCT01232283|10812114|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
6808510|NCT01232283|10812115|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
6808511|NCT01232283|10812116|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4
6808512|NCT01232283|10812117|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
6808513|NCT01232283|10812118|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13
6808514|NCT01232283|10812119|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5
6808515|NCT01232283|10812120|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
6808516|NCT01232283|10812121|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
6808517|NCT01232283|10812112|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
6808518|NCT01232283|10812113|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
6808519|NCT01232283|10812114|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
6808520|NCT01232283|10812115|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
6808521|NCT01232283|10812116|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
6808522|NCT01232283|10812117|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
6808523|NCT01232283|10812118|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
6808524|NCT01232283|10812119|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4
6808525|NCT01232283|10812120|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
6808526|NCT01232283|10812121|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
6808527|NCT01232283|10812112|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
6808528|NCT01232283|10812113|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
6808529|NCT01232283|10812114|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
6808530|NCT01232283|10812115|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
6808531|NCT01232283|10812116|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1
6808532|NCT01232283|10812117|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
6808533|NCT01232283|10812118|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
6808534|NCT01232283|10812119|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
6808535|NCT01232283|10812120|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
6808536|NCT01232283|10812121|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
6808537|NCT01232283|10812112|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
6808538|NCT01232283|10812113|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
6808539|NCT01232283|10812114|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
6808540|NCT01232283|10812115|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
6808541|NCT01232283|10812116|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2
6808542|NCT01232283|10812117|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
6808543|NCT01232283|10812118|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
6808544|NCT01232283|10812119|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
6808545|NCT01232283|10812120|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
6808546|NCT01232283|10812121|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
6808547|NCT01232283|10812112|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
6808548|NCT01232283|10812113|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
6808549|NCT01232283|10812114|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
6808550|NCT01232283|10812115|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
6794833|NCT04771013|10793370|FG000|Overall Study|Withdrawal by Subject|2
6794834|NCT04771013|10793371|FG001|Overall Study|Withdrawal by Subject|0
6794835|NCT04771013|10793370|FG000|Overall Study|Death|0
6794836|NCT04771013|10793371|FG001|Overall Study|Death|5
6794837|NCT04771013|10793370|FG000|Overall Study|Referred to another hospital before day 20|0
6794838|NCT04771013|10793371|FG001|Overall Study|Referred to another hospital before day 20|1
6794839|NCT04497987|10793379|FG000|Overall Study|Adverse Event|1
6794840|NCT04497987|10793380|FG001|Overall Study|Adverse Event|0
6794841|NCT04497987|10793379|FG000|Overall Study|Death|21
6794842|NCT04497987|10793380|FG001|Overall Study|Death|13
6794843|NCT04497987|10793379|FG000|Overall Study|Lost to Follow-up|19
6794844|NCT04497987|10793380|FG001|Overall Study|Lost to Follow-up|17
6794845|NCT04497987|10793379|FG000|Overall Study|Other - as reported by the investigator|22
6794846|NCT04497987|10793380|FG001|Overall Study|Other - as reported by the investigator|16
6794847|NCT04497987|10793379|FG000|Overall Study|Physician Decision|1
6794848|NCT04497987|10793380|FG001|Overall Study|Physician Decision|0
6794849|NCT04497987|10793379|FG000|Overall Study|Withdrawal by Subject|35
6794850|NCT04497987|10793380|FG001|Overall Study|Withdrawal by Subject|21
6808551|NCT01232283|10812116|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
6808552|NCT01232283|10812117|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
6808553|NCT01232283|10812118|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
6808554|NCT01232283|10812119|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1
6808555|NCT01232283|10812120|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
6808556|NCT01232283|10812121|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
6808557|NCT01232283|10812112|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
6808558|NCT01232283|10812113|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
6808559|NCT01232283|10812114|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
6808560|NCT01232283|10812115|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
6808561|NCT01232283|10812116|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
6808562|NCT01232283|10812117|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1
6808563|NCT01232283|10812118|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
6808564|NCT01232283|10812119|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
6808565|NCT01232283|10812120|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
6808566|NCT01232283|10812121|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
6808567|NCT01232283|10812112|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
6808568|NCT01232283|10812113|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
6808569|NCT01232283|10812114|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
6808570|NCT01232283|10812115|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
6808571|NCT01232283|10812116|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
6808572|NCT01232283|10812117|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
6808573|NCT01232283|10812118|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
6808574|NCT01232283|10812119|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
6808575|NCT01232283|10812120|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11
6808576|NCT01232283|10812121|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6
6808577|NCT01232283|10812112|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
6808578|NCT01232283|10812113|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
6808579|NCT01232283|10812114|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
6808580|NCT01232283|10812115|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
6808581|NCT01232283|10812116|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
6808582|NCT01232283|10812117|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
6808583|NCT01232283|10812118|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
6808584|NCT01232283|10812119|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
6808585|NCT01232283|10812120|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46
6808586|NCT01232283|10812121|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30
6808587|NCT01232283|10812112|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
6808588|NCT01232283|10812113|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
6808589|NCT01232283|10812114|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
6808590|NCT01232283|10812115|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
6808591|NCT01232283|10812116|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
6808592|NCT01232283|10812117|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
6808593|NCT01232283|10812118|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
6808594|NCT01232283|10812119|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
6808595|NCT01232283|10812120|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3
6808596|NCT01232283|10812121|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2
6808597|NCT01232283|10812112|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
6808598|NCT01232283|10812113|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
6808599|NCT01232283|10812114|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
6808600|NCT01232283|10812115|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
6808601|NCT01232283|10812116|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
6808602|NCT01232283|10812117|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
6808603|NCT01232283|10812118|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
6808604|NCT01232283|10812119|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
6808605|NCT01232283|10812120|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30
6808606|NCT01232283|10812121|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14
6808607|NCT01232283|10812112|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
6794851|NCT03512210|10793436|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3
6794852|NCT03512210|10793436|FG000|Step 1: MINMON Intervention|Protocol Violation|1
6794853|NCT03512210|10793436|FG000|Step 2:Post-MINMON|Death|2
6794854|NCT03512210|10793436|FG000|Step 2:Post-MINMON|Lost to Follow-up|30
6794855|NCT03512210|10793436|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2
6794856|NCT03180307|10793477|FG000|Overall Study|Lost to Follow-up|2
6794857|NCT03180307|10793478|FG001|Overall Study|Lost to Follow-up|0
6794858|NCT03180307|10793477|FG000|Overall Study|Death|1
6794859|NCT03180307|10793478|FG001|Overall Study|Death|0
6794860|NCT03180307|10793477|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3
6794861|NCT03180307|10793478|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0
6794862|NCT02668822|10793497|FG000|Overall Study|Protocol Violation|2
6794863|NCT02668822|10793498|FG001|Overall Study|Protocol Violation|0
6794864|NCT02668822|10793497|FG000|Overall Study|Study Terminated by Sponsor|7
6794865|NCT02668822|10793498|FG001|Overall Study|Study Terminated by Sponsor|9
6794866|NCT02668783|10793506|FG000|Overall Study|Pregnancy|0
6794867|NCT02668783|10793507|FG001|Overall Study|Pregnancy|1
6794868|NCT02668783|10793506|FG000|Overall Study|Protocol Violation|2
6794869|NCT02668783|10793507|FG001|Overall Study|Protocol Violation|1
6794870|NCT02668783|10793506|FG000|Overall Study|Study terminated by sponsor|9
6794871|NCT02668783|10793507|FG001|Overall Study|Study terminated by sponsor|10
6794872|NCT02668783|10793506|FG000|Overall Study|Subject moved|1
6794873|NCT02668783|10793507|FG001|Overall Study|Subject moved|0
6794874|NCT02668783|10793506|FG000|Overall Study|Withdrawal by Subject|1
6794875|NCT02668783|10793507|FG001|Overall Study|Withdrawal by Subject|0
6794876|NCT02616146|10793515|FG000|Overall Study|Adverse Event|64
6794877|NCT02616146|10793516|FG001|Overall Study|Adverse Event|24
6794878|NCT02616146|10793515|FG000|Overall Study|Lost to Follow-up|23
6794879|NCT02616146|10793516|FG001|Overall Study|Lost to Follow-up|13
6794880|NCT02616146|10793515|FG000|Overall Study|Non-compliance with study protocol|2
6794881|NCT02616146|10793516|FG001|Overall Study|Non-compliance with study protocol|0
6794882|NCT02616146|10793515|FG000|Overall Study|Non-compliance with study drug|4
6794883|NCT02616146|10793516|FG001|Overall Study|Non-compliance with study drug|2
6794884|NCT02616146|10793515|FG000|Overall Study|Pregnancy|2
6794885|NCT02616146|10793516|FG001|Overall Study|Pregnancy|2
6794886|NCT02616146|10793515|FG000|Overall Study|Pregnancy wish|3
6794887|NCT02616146|10793516|FG001|Overall Study|Pregnancy wish|0
6794888|NCT02616146|10793515|FG000|Overall Study|Protocol Violation|6
6794889|NCT02616146|10793516|FG001|Overall Study|Protocol Violation|3
6794890|NCT02616146|10793515|FG000|Overall Study|Study terminated by sponsor|1372
6794891|NCT02616146|10793516|FG001|Overall Study|Study terminated by sponsor|432
6794892|NCT02616146|10793515|FG000|Overall Study|Participant moved|4
6794893|NCT02616146|10793516|FG001|Overall Study|Participant moved|3
6794894|NCT02616146|10793515|FG000|Overall Study|Withdrawal by Subject|30
6794895|NCT02616146|10793516|FG001|Overall Study|Withdrawal by Subject|24
6794896|NCT02616146|10793515|FG000|Overall Study|Physician Decision|2
6794897|NCT02616146|10793516|FG001|Overall Study|Physician Decision|1
6794898|NCT02524288|10793535|FG000|Overall Study|Adverse Event|115
6794899|NCT02524288|10793535|FG000|Overall Study|Lost to Follow-up|216
6794900|NCT02524288|10793535|FG000|Overall Study|Non-Compliance With Protocol|32
6794901|NCT02524288|10793535|FG000|Overall Study|Non-Compliance With Study Drug|14
6794902|NCT02524288|10793535|FG000|Overall Study|Pregnancy Wish|6
6794903|NCT02524288|10793535|FG000|Overall Study|Protocol Violation|6
6794904|NCT02524288|10793535|FG000|Overall Study|Screen Failure|2
6794905|NCT02524288|10793535|FG000|Overall Study|Site Discontinued Study Participation|1
6794906|NCT02524288|10793535|FG000|Overall Study|Study Terminated By Sponsor|1417
6794907|NCT02524288|10793535|FG000|Overall Study|Subject Moved|32
6794908|NCT02524288|10793535|FG000|Overall Study|Withdrawal by Subject|76
6794909|NCT02524288|10793535|FG000|Overall Study|Pregnancy|22
6794910|NCT02524288|10793535|FG000|Overall Study|Physician Decision|2
6794911|NCT02489942|10793539|FG000|Overall Study|Request by patient|602
6794912|NCT02489942|10793539|FG000|Overall Study|Improvement/remission|157
6794913|NCT02489942|10793539|FG000|Overall Study|No change/Progressive disease|263
6794914|NCT02489942|10793539|FG000|Overall Study|Adverse Event|522
6794915|NCT02489942|10793539|FG000|Overall Study|Other personal reasons|1218
6794916|NCT02489942|10793539|FG000|Overall Study|Lost to Follow-up|456
6794917|NCT02489942|10793539|FG000|Overall Study|Not continuously investigated|7
6794918|NCT02489942|10793539|FG000|Overall Study|Patient started jardiance treatment out of registration period|1
6794919|NCT02489942|10793539|FG000|Overall Study|Multiple registration|1
6794920|NCT02489942|10793539|FG000|Overall Study|No patient visit after entry|100
6794921|NCT02489942|10793539|FG000|Overall Study|No treatment with Jardiance|2
6794922|NCT02489942|10793539|FG000|Overall Study|Patient received Jardiance before registration|1
6794923|NCT02489942|10793539|FG000|Overall Study|No CRF collected|86
6794924|NCT02409342|10793545|FG000|Overall Study|Death|181
6794925|NCT02409342|10793546|FG001|Overall Study|Death|174
6794926|NCT02409342|10793545|FG000|Overall Study|Withdrawal by Subject|24
6794927|NCT02409342|10793546|FG001|Overall Study|Withdrawal by Subject|16
6794928|NCT02409342|10793545|FG000|Overall Study|On-going in study|79
6794929|NCT02409342|10793546|FG001|Overall Study|On-going in study|92
6794930|NCT02409342|10793545|FG000|Overall Study|Lost to Follow-up|3
6794931|NCT02409342|10793546|FG001|Overall Study|Lost to Follow-up|3
6794932|NCT02275546|10793563|FG000|Treatment Period 2|Withdrawal by Subject|2
6794933|NCT02275546|10793564|FG001|Treatment Period 2|Withdrawal by Subject|1
6794934|NCT02275546|10793563|FG000|Treatment Period 2|Protocol Violation|0
6794935|NCT02275546|10793564|FG001|Treatment Period 2|Protocol Violation|1
6794936|NCT02077166|10793577|FG000|Overall Study|Death|6
6794937|NCT02077166|10793578|FG001|Overall Study|Death|7
6794938|NCT02077166|10793579|FG002|Overall Study|Death|5
6794939|NCT02077166|10793580|FG003|Overall Study|Death|6
6794940|NCT02077166|10793581|FG004|Overall Study|Death|4
6794941|NCT02077166|10793582|FG005|Overall Study|Death|32
6794942|NCT02077166|10793583|FG006|Overall Study|Death|22
6794943|NCT02077166|10793577|FG000|Overall Study|Study Closure by Sponsor|3
6794944|NCT02077166|10793578|FG001|Overall Study|Study Closure by Sponsor|0
6794945|NCT02077166|10793579|FG002|Overall Study|Study Closure by Sponsor|2
6794946|NCT02077166|10793580|FG003|Overall Study|Study Closure by Sponsor|2
6794947|NCT02077166|10793581|FG004|Overall Study|Study Closure by Sponsor|2
6794948|NCT02077166|10793582|FG005|Overall Study|Study Closure by Sponsor|12
6794949|NCT02077166|10793583|FG006|Overall Study|Study Closure by Sponsor|4
6794950|NCT02077166|10793577|FG000|Overall Study|Lost to Follow-up|0
6794951|NCT02077166|10793578|FG001|Overall Study|Lost to Follow-up|0
6794952|NCT02077166|10793579|FG002|Overall Study|Lost to Follow-up|0
6794953|NCT02077166|10793580|FG003|Overall Study|Lost to Follow-up|0
6794954|NCT02077166|10793581|FG004|Overall Study|Lost to Follow-up|0
6794955|NCT02077166|10793582|FG005|Overall Study|Lost to Follow-up|1
6794956|NCT02077166|10793583|FG006|Overall Study|Lost to Follow-up|0
6794957|NCT02077166|10793577|FG000|Overall Study|Withdrawal by Subject|3
6794958|NCT02077166|10793578|FG001|Overall Study|Withdrawal by Subject|0
6794959|NCT02077166|10793579|FG002|Overall Study|Withdrawal by Subject|1
6794960|NCT02077166|10793580|FG003|Overall Study|Withdrawal by Subject|1
6794961|NCT02077166|10793581|FG004|Overall Study|Withdrawal by Subject|1
6794962|NCT02077166|10793582|FG005|Overall Study|Withdrawal by Subject|3
6794963|NCT02077166|10793583|FG006|Overall Study|Withdrawal by Subject|0
6794964|NCT02077166|10793577|FG000|Overall Study|Other, Not Specified|0
6794965|NCT02077166|10793578|FG001|Overall Study|Other, Not Specified|0
6794966|NCT02077166|10793579|FG002|Overall Study|Other, Not Specified|1
6794967|NCT02077166|10793580|FG003|Overall Study|Other, Not Specified|0
6794968|NCT02077166|10793581|FG004|Overall Study|Other, Not Specified|1
6794969|NCT02077166|10793582|FG005|Overall Study|Other, Not Specified|7
6794970|NCT02077166|10793583|FG006|Overall Study|Other, Not Specified|8
6794971|NCT01891344|10793608|FG000|Overall Study|Ongoing|6
6794972|NCT01891344|10793609|FG001|Overall Study|Ongoing|2
6794973|NCT01891344|10793610|FG002|Overall Study|Ongoing|0
6794974|NCT01891344|10793611|FG003|Overall Study|Ongoing|1
6794975|NCT01891344|10793612|FG004|Overall Study|Ongoing|4
6794976|NCT01891344|10793613|FG005|Overall Study|Ongoing|1
6794977|NCT01891344|10793614|FG006|Overall Study|Ongoing|0
6794978|NCT01891344|10793615|FG007|Overall Study|Ongoing|0
6794979|NCT01847274|10793637|FG000|Overall Study|Adverse Event|17
6794980|NCT01847274|10793638|FG001|Overall Study|Adverse Event|1
6794981|NCT01847274|10793639|FG002|Overall Study|Adverse Event|33
6794982|NCT01847274|10793640|FG003|Overall Study|Adverse Event|2
6794983|NCT01847274|10793637|FG000|Overall Study|Withdrawal by Subject|8
6794984|NCT01847274|10793638|FG001|Overall Study|Withdrawal by Subject|8
6794985|NCT01847274|10793639|FG002|Overall Study|Withdrawal by Subject|11
6794986|NCT01847274|10793640|FG003|Overall Study|Withdrawal by Subject|1
6794987|NCT01847274|10793637|FG000|Overall Study|Disease Progression|63
6794988|NCT01847274|10793638|FG001|Overall Study|Disease Progression|49
6794989|NCT01847274|10793639|FG002|Overall Study|Disease Progression|129
6794990|NCT01847274|10793640|FG003|Overall Study|Disease Progression|98
6794991|NCT01847274|10793637|FG000|Overall Study|Treatment Associated Risk|0
6794992|NCT01847274|10793638|FG001|Overall Study|Treatment Associated Risk|2
6794993|NCT01847274|10793639|FG002|Overall Study|Treatment Associated Risk|2
6794994|NCT01847274|10793640|FG003|Overall Study|Treatment Associated Risk|0
6794995|NCT01847274|10793637|FG000|Overall Study|Other Reasons|3
6794996|NCT01847274|10793638|FG001|Overall Study|Other Reasons|1
6794997|NCT01847274|10793639|FG002|Overall Study|Other Reasons|11
6794998|NCT01847274|10793640|FG003|Overall Study|Other Reasons|3
6794999|NCT01847274|10793637|FG000|Overall Study|Non Compliance|0
6795000|NCT01847274|10793638|FG001|Overall Study|Non Compliance|0
6795001|NCT01847274|10793639|FG002|Overall Study|Non Compliance|2
6795002|NCT01847274|10793640|FG003|Overall Study|Non Compliance|0
6795003|NCT01670656|10793655|FG000|Overall Study|Non-compliance with study drug|0
6795004|NCT01670656|10793656|FG001|Overall Study|Non-compliance with study drug|0
6795005|NCT01670656|10793657|FG002|Overall Study|Non-compliance with study drug|3
6795006|NCT01670656|10793658|FG003|Overall Study|Non-compliance with study drug|0
6795007|NCT01670656|10793659|FG004|Overall Study|Non-compliance with study drug|1
6795008|NCT01670656|10793655|FG000|Overall Study|Pregnancy|0
6795009|NCT01670656|10793656|FG001|Overall Study|Pregnancy|0
6795010|NCT01670656|10793657|FG002|Overall Study|Pregnancy|0
6795011|NCT01670656|10793658|FG003|Overall Study|Pregnancy|0
6795012|NCT01670656|10793659|FG004|Overall Study|Pregnancy|1
6795013|NCT01670656|10793655|FG000|Overall Study|Withdrawal by Subject|1
6795014|NCT01670656|10793656|FG001|Overall Study|Withdrawal by Subject|1
6795015|NCT01670656|10793657|FG002|Overall Study|Withdrawal by Subject|0
6795016|NCT01670656|10793658|FG003|Overall Study|Withdrawal by Subject|0
6795017|NCT01670656|10793659|FG004|Overall Study|Withdrawal by Subject|0
6795018|NCT01670656|10793655|FG000|Overall Study|Non-compliance with protocol|0
6795019|NCT01670656|10793656|FG001|Overall Study|Non-compliance with protocol|3
6795020|NCT01670656|10793657|FG002|Overall Study|Non-compliance with protocol|1
6795021|NCT01670656|10793658|FG003|Overall Study|Non-compliance with protocol|1
6795022|NCT01670656|10793659|FG004|Overall Study|Non-compliance with protocol|2
6795023|NCT01670656|10793655|FG000|Overall Study|Adverse Event|2
6795024|NCT01670656|10793656|FG001|Overall Study|Adverse Event|2
6795025|NCT01670656|10793657|FG002|Overall Study|Adverse Event|2
6795026|NCT01670656|10793658|FG003|Overall Study|Adverse Event|3
6795027|NCT01670656|10793659|FG004|Overall Study|Adverse Event|3
6795028|NCT01670656|10793655|FG000|Overall Study|Subject withdrew consent|0
6795029|NCT01670656|10793656|FG001|Overall Study|Subject withdrew consent|1
6795030|NCT01670656|10793657|FG002|Overall Study|Subject withdrew consent|2
6795031|NCT01670656|10793658|FG003|Overall Study|Subject withdrew consent|1
6795032|NCT01670656|10793659|FG004|Overall Study|Subject withdrew consent|1
6795033|NCT01670656|10793655|FG000|Overall Study|Lost to Follow-up|0
6795034|NCT01670656|10793656|FG001|Overall Study|Lost to Follow-up|0
6795035|NCT01670656|10793657|FG002|Overall Study|Lost to Follow-up|0
6795036|NCT01670656|10793658|FG003|Overall Study|Lost to Follow-up|0
6795037|NCT01670656|10793659|FG004|Overall Study|Lost to Follow-up|3
6795038|NCT01670656|10793655|FG000|Overall Study|Subject moved|0
6795039|NCT01670656|10793656|FG001|Overall Study|Subject moved|0
6795040|NCT01670656|10793657|FG002|Overall Study|Subject moved|0
6795041|NCT01670656|10793658|FG003|Overall Study|Subject moved|1
6795042|NCT01670656|10793659|FG004|Overall Study|Subject moved|0
6795043|NCT01501955|10793673|FG000|Overall Study|Withdrawal by Subject|1
6795044|NCT01501955|10793674|FG001|Overall Study|Withdrawal by Subject|0
6795045|NCT01501955|10793673|FG000|Overall Study|Adverse Event|1
6795046|NCT01501955|10793674|FG001|Overall Study|Adverse Event|3
6795047|NCT01335399|10793682|FG000|Pre-treatment Period|No longer meeting study criteria|0
6795048|NCT01335399|10793683|FG001|Pre-treatment Period|No longer meeting study criteria|1
6795049|NCT01335399|10793682|FG000|Pre-treatment Period|Participant request to discontinue|0
6795050|NCT01335399|10793683|FG001|Pre-treatment Period|Participant request to discontinue|1
6795051|NCT01335399|10793682|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0
6795052|NCT01335399|10793683|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1
6795053|NCT01335399|10793682|FG000|Pre-treatment Period|Consent withdrawal|3
6795054|NCT01335399|10793683|FG001|Pre-treatment Period|Consent withdrawal|0
6795055|NCT01335399|10793682|FG000|Treatment Period|Disease progression|114
6795056|NCT01335399|10793683|FG001|Treatment Period|Disease progression|141
6795057|NCT01335399|10793682|FG000|Treatment Period|Adverse event unrelated to study drug|105
6795058|NCT01335399|10793683|FG001|Treatment Period|Adverse event unrelated to study drug|65
6795059|NCT01335399|10793682|FG000|Treatment Period|Study drug toxicity|51
6795060|NCT01335399|10793683|FG001|Treatment Period|Study drug toxicity|64
6795061|NCT01335399|10793682|FG000|Treatment Period|Participant request to discontinue|27
6795062|NCT01335399|10793683|FG001|Treatment Period|Participant request to discontinue|21
6795063|NCT01335399|10793682|FG000|Treatment Period|Other reasons|14
6795064|NCT01335399|10793683|FG001|Treatment Period|Other reasons|26
6795065|NCT01335399|10793682|FG000|Treatment Period|Consent withdrawal|10
6795066|NCT01335399|10793683|FG001|Treatment Period|Consent withdrawal|6
6795067|NCT01335399|10793682|FG000|Treatment Period|Death|7
6795068|NCT01335399|10793683|FG001|Treatment Period|Death|8
6795069|NCT01335399|10793682|FG000|Treatment Period|Poor/Non-compliance|3
6795070|NCT01335399|10793683|FG001|Treatment Period|Poor/Non-compliance|4
6795071|NCT01335399|10793682|FG000|Treatment Period|Lost to Follow-up|0
6795072|NCT01335399|10793683|FG001|Treatment Period|Lost to Follow-up|2
6795073|NCT01335399|10793682|FG000|Treatment Period|Maximum clinical benefit|1
6795074|NCT01335399|10793683|FG001|Treatment Period|Maximum clinical benefit|1
6795075|NCT01335399|10793682|FG000|Treatment Period|No longer meet study criteria|0
6795076|NCT01335399|10793683|FG001|Treatment Period|No longer meet study criteria|1
6795077|NCT01335399|10793682|FG000|Treatment Period|Not reported|1
6795078|NCT01335399|10793683|FG001|Treatment Period|Not reported|0
6795079|NCT01277211|10793691|FG000|Overall Study|Adverse Event|60
6795080|NCT01277211|10793692|FG001|Overall Study|Adverse Event|22
6795081|NCT01277211|10793691|FG000|Overall Study|Pregnancy|9
6795082|NCT01277211|10793692|FG001|Overall Study|Pregnancy|4
6795083|NCT01277211|10793691|FG000|Overall Study|Lost to Follow-up|14
6795084|NCT01277211|10793692|FG001|Overall Study|Lost to Follow-up|9
6795085|NCT01277211|10793691|FG000|Overall Study|Did not wish to continue|17
6795086|NCT01277211|10793692|FG001|Overall Study|Did not wish to continue|0
6795087|NCT01277211|10793691|FG000|Overall Study|Withdrew Consent|9
6795088|NCT01277211|10793692|FG001|Overall Study|Withdrew Consent|9
6795089|NCT01277211|10793691|FG000|Overall Study|Non-compliance with protocol|13
6795090|NCT01277211|10793692|FG001|Overall Study|Non-compliance with protocol|4
6795091|NCT01277211|10793691|FG000|Overall Study|Did not meet protocol eligibility|1
6795092|NCT01277211|10793692|FG001|Overall Study|Did not meet protocol eligibility|0
6795093|NCT01277211|10793691|FG000|Overall Study|Administrative|3
6795094|NCT01277211|10793692|FG001|Overall Study|Administrative|0
6795095|NCT01277211|10793691|FG000|Overall Study|Pregnancy wish|0
6795096|NCT01277211|10793692|FG001|Overall Study|Pregnancy wish|2
6795097|NCT01277211|10793691|FG000|Overall Study|Discontinued prior to treatment|24
6795098|NCT01277211|10793692|FG001|Overall Study|Discontinued prior to treatment|13
6795099|NCT01244828|10793702|FG000|Overall Study|Adverse Event|37
6795100|NCT01244828|10793702|FG000|Overall Study|Withdrawal by Subject|31
6795101|NCT01244828|10793702|FG000|Overall Study|Lack of Efficacy|7
6795102|NCT01244828|10793702|FG000|Overall Study|Lost to Follow-up|2
6795103|NCT01244828|10793702|FG000|Overall Study|Other reason (not specified)|1
6795104|NCT01207492|10793706|FG000|Overall Study|Still on study|1
6795105|NCT01207492|10793706|FG000|Overall Study|Withdrawal by Subject|9
6795106|NCT01207492|10793706|FG000|Overall Study|Physician Decision|1
6795107|NCT01207492|10793706|FG000|Overall Study|Progressive disease|3
6795108|NCT01207492|10793706|FG000|Overall Study|Toxicity|1
6795109|NCT01181778|10793710|FG000|Overall Study|Physician Decision|48
6795110|NCT01047540|10793721|FG000|Overall Study|Protocol Violation|1
6795111|NCT01047540|10793722|FG001|Overall Study|Protocol Violation|0
6795112|NCT01047540|10793723|FG002|Overall Study|Protocol Violation|0
6795113|NCT01047540|10793724|FG003|Overall Study|Protocol Violation|0
6795114|NCT01047540|10793725|FG004|Overall Study|Protocol Violation|0
6795115|NCT01047540|10793721|FG000|Overall Study|Lost to Follow-up|1
6795116|NCT01047540|10793722|FG001|Overall Study|Lost to Follow-up|0
6795117|NCT01047540|10793723|FG002|Overall Study|Lost to Follow-up|0
6795118|NCT01047540|10793724|FG003|Overall Study|Lost to Follow-up|0
6795119|NCT01047540|10793725|FG004|Overall Study|Lost to Follow-up|0
6795120|NCT01047540|10793721|FG000|Overall Study|Withdrawal by Subject|1
6795121|NCT01047540|10793722|FG001|Overall Study|Withdrawal by Subject|0
6795122|NCT01047540|10793723|FG002|Overall Study|Withdrawal by Subject|3
6795123|NCT01047540|10793724|FG003|Overall Study|Withdrawal by Subject|0
6795124|NCT01047540|10793725|FG004|Overall Study|Withdrawal by Subject|1
6795125|NCT01047540|10793721|FG000|Overall Study|Pregnancy|1
6795126|NCT01047540|10793722|FG001|Overall Study|Pregnancy|0
6795127|NCT01047540|10793723|FG002|Overall Study|Pregnancy|0
6795128|NCT01047540|10793724|FG003|Overall Study|Pregnancy|0
6795129|NCT01047540|10793725|FG004|Overall Study|Pregnancy|0
6795130|NCT01047540|10793721|FG000|Overall Study|Adverse Event|1
6795131|NCT01047540|10793722|FG001|Overall Study|Adverse Event|0
6795132|NCT01047540|10793723|FG002|Overall Study|Adverse Event|0
6795133|NCT01047540|10793724|FG003|Overall Study|Adverse Event|0
6795134|NCT01047540|10793725|FG004|Overall Study|Adverse Event|0
6795135|NCT00778999|10793770|FG000|Overall Study|Discontinuation: no embryo transfer|14
6795136|NCT00778999|10793771|FG001|Overall Study|Discontinuation: no embryo transfer|14
6795137|NCT00778999|10793770|FG000|Overall Study|Did not receive recFSH|14
6795138|NCT00778999|10793771|FG001|Overall Study|Did not receive recFSH|20
6795139|NCT00620464|10793779|FG000|Overall Study|Adverse Event|15
6795140|NCT00620464|10793780|FG001|Overall Study|Adverse Event|17
6795141|NCT00620464|10793779|FG000|Overall Study|Lost to Follow-up|1
6795142|NCT00620464|10793780|FG001|Overall Study|Lost to Follow-up|1
6795143|NCT00620464|10793779|FG000|Overall Study|Planning Pregnancy|1
6795144|NCT00620464|10793780|FG001|Overall Study|Planning Pregnancy|4
6795145|NCT00620464|10793779|FG000|Overall Study|Personal|2
6795146|NCT00620464|10793780|FG001|Overall Study|Personal|2
6795147|NCT00620464|10793779|FG000|Overall Study|Used prohibited medication|1
6795148|NCT00620464|10793780|FG001|Overall Study|Used prohibited medication|0
6795149|NCT00620035|10793786|FG000|Overall Study|Adverse Event|106
6795150|NCT00620035|10793786|FG000|Overall Study|Withdrawal of Informed Consent|1
6795151|NCT00620035|10793786|FG000|Overall Study|Other Reason|38
6795152|NCT00210249|10793790|FG000|Overall Study|Lost to Follow-up|5
6795153|NCT00210249|10793790|FG000|Overall Study|Protocol Violation|11
6808608|NCT01232283|10812113|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
6808609|NCT01232283|10812114|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
6808610|NCT01232283|10812115|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
6808611|NCT01232283|10812116|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
6808612|NCT01232283|10812117|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
6808613|NCT01232283|10812118|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
6808614|NCT01232283|10812119|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
6808615|NCT01232283|10812120|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9
6808616|NCT01232283|10812121|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6
6808617|NCT01232283|10812112|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0
6808618|NCT01232283|10812113|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0
6808619|NCT01232283|10812114|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0
6808620|NCT01232283|10812115|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0
6808621|NCT01232283|10812116|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0
6808622|NCT01232283|10812117|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0
6808623|NCT01232283|10812118|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0
6808624|NCT01232283|10812119|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0
6808625|NCT01232283|10812120|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1
6808626|NCT01232283|10812121|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0
6808627|NCT01232283|10812112|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
6808628|NCT01232283|10812113|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
6808629|NCT01232283|10812114|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
6808630|NCT01232283|10812115|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
6808631|NCT01232283|10812116|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
6808632|NCT01232283|10812117|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
6808633|NCT01232283|10812118|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
6808634|NCT01232283|10812119|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
6808635|NCT01232283|10812120|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1
6808636|NCT01232283|10812121|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
6808637|NCT01232283|10812112|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
6808638|NCT01232283|10812113|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
6808639|NCT01232283|10812114|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
6808640|NCT01232283|10812115|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
6808641|NCT01232283|10812116|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
6808642|NCT01232283|10812117|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
6808643|NCT01232283|10812118|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
6808644|NCT01232283|10812119|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
6808645|NCT01232283|10812120|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7
6808646|NCT01232283|10812121|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3
6808647|NCT01231516|10812145|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4
6808648|NCT01231516|10812146|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11
6808649|NCT01231516|10812145|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20
6808650|NCT01231516|10812146|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42
6808651|NCT01231516|10812145|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9
6808652|NCT01231516|10812146|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6
6808653|NCT01231516|10812145|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5
6795154|NCT03692871|10793813|FG000|Overall Study|Death|1
6795155|NCT03692871|10793814|FG001|Overall Study|Death|1
6795156|NCT03692871|10793813|FG000|Overall Study|Lost to Follow-up|24
6795157|NCT03692871|10793814|FG001|Overall Study|Lost to Follow-up|9
6795158|NCT03692871|10793813|FG000|Overall Study|Physician Decision|22
6795159|NCT03692871|10793814|FG001|Overall Study|Physician Decision|7
6795160|NCT03692871|10793813|FG000|Overall Study|Protocol Deviation|1
6795161|NCT03692871|10793814|FG001|Overall Study|Protocol Deviation|0
6795162|NCT03692871|10793813|FG000|Overall Study|Withdrawal by Parent/Guardian|77
6795163|NCT03692871|10793814|FG001|Overall Study|Withdrawal by Parent/Guardian|20
6795164|NCT03626168|10793822|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1
6795165|NCT03626168|10793823|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0
6795166|NCT03626168|10793822|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0
6795167|NCT03626168|10793823|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1
6795168|NCT03626168|10793822|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0
6795169|NCT03626168|10793823|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2
6795170|NCT04579393|10793849|FG000|Overall Study|Withdrawal by Subject|2
6795171|NCT04579393|10793850|FG001|Overall Study|Withdrawal by Subject|2
6795172|NCT04579393|10793849|FG000|Overall Study|Death|1
6795173|NCT04579393|10793850|FG001|Overall Study|Death|3
6795174|NCT04325906|10793868|FG000|Overall Study|Withdrawal by Subject|2
6795175|NCT04325906|10793869|FG001|Overall Study|Withdrawal by Subject|0
6795176|NCT04203667|10793879|FG000|Overall Study|Withdrawal by Subject|1
6795177|NCT04203667|10793879|FG000|Overall Study|Lost to Follow-up|1
6795178|NCT04203667|10793879|FG000|Overall Study|Death|1
6795179|NCT04203667|10793879|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1
6795180|NCT03679884|10793893|FG000|Overall Study|Other|12
6795181|NCT03679884|10793894|FG001|Overall Study|Other|12
6795182|NCT03679884|10793895|FG002|Overall Study|Other|12
6795183|NCT03679884|10793896|FG003|Overall Study|Other|7
6795184|NCT03679884|10793897|FG004|Overall Study|Other|8
6795185|NCT03679884|10793893|FG000|Overall Study|Lack of Efficacy|15
6795186|NCT03679884|10793894|FG001|Overall Study|Lack of Efficacy|29
6795187|NCT03679884|10793895|FG002|Overall Study|Lack of Efficacy|13
6795188|NCT03679884|10793896|FG003|Overall Study|Lack of Efficacy|29
6795189|NCT03679884|10793897|FG004|Overall Study|Lack of Efficacy|10
6795190|NCT03679884|10793893|FG000|Overall Study|Death|1
6795191|NCT03679884|10793894|FG001|Overall Study|Death|0
6795192|NCT03679884|10793895|FG002|Overall Study|Death|0
6795193|NCT03679884|10793896|FG003|Overall Study|Death|0
6795194|NCT03679884|10793897|FG004|Overall Study|Death|0
6795195|NCT03679884|10793893|FG000|Overall Study|Adverse Event|2
6795196|NCT03679884|10793894|FG001|Overall Study|Adverse Event|10
6795197|NCT03679884|10793895|FG002|Overall Study|Adverse Event|9
6795198|NCT03679884|10793896|FG003|Overall Study|Adverse Event|6
6795199|NCT03679884|10793897|FG004|Overall Study|Adverse Event|6
6795200|NCT03679884|10793893|FG000|Overall Study|Withdrawal by Subject|12
6795201|NCT03679884|10793894|FG001|Overall Study|Withdrawal by Subject|23
6795202|NCT03679884|10793895|FG002|Overall Study|Withdrawal by Subject|8
6795203|NCT03679884|10793896|FG003|Overall Study|Withdrawal by Subject|8
6795204|NCT03679884|10793897|FG004|Overall Study|Withdrawal by Subject|9
6795205|NCT03679884|10793893|FG000|Overall Study|Lost to Follow-up|1
6795206|NCT03679884|10793894|FG001|Overall Study|Lost to Follow-up|4
6795207|NCT03679884|10793895|FG002|Overall Study|Lost to Follow-up|2
6795208|NCT03679884|10793896|FG003|Overall Study|Lost to Follow-up|0
6795209|NCT03679884|10793897|FG004|Overall Study|Lost to Follow-up|3
6795210|NCT03653026|10793911|FG000|Part 1: Placebo-controlled Period|Adverse Event|5
6795211|NCT03653026|10793912|FG001|Part 1: Placebo-controlled Period|Adverse Event|6
6795212|NCT03653026|10793913|FG002|Part 1: Placebo-controlled Period|Adverse Event|0
6795213|NCT03653026|10793914|FG003|Part 1: Placebo-controlled Period|Adverse Event|0
6795214|NCT03653026|10793911|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6
6795215|NCT03653026|10793912|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4
6795216|NCT03653026|10793913|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0
6795217|NCT03653026|10793914|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0
6795218|NCT03653026|10793911|FG000|Part 1: Placebo-controlled Period|Other|0
6795219|NCT03653026|10793912|FG001|Part 1: Placebo-controlled Period|Other|3
6795220|NCT03653026|10793913|FG002|Part 1: Placebo-controlled Period|Other|0
6795221|NCT03653026|10793914|FG003|Part 1: Placebo-controlled Period|Other|0
6795222|NCT03653026|10793911|FG000|Part 2: Open-label Extension|Adverse Event|0
6795223|NCT03653026|10793912|FG001|Part 2: Open-label Extension|Adverse Event|0
6795224|NCT03653026|10793913|FG002|Part 2: Open-label Extension|Adverse Event|1
6795225|NCT03653026|10793914|FG003|Part 2: Open-label Extension|Adverse Event|1
6795226|NCT03653026|10793911|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0
6795227|NCT03653026|10793912|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0
6795228|NCT03653026|10793913|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1
6795229|NCT03653026|10793914|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2
6795230|NCT03653026|10793911|FG000|Part 2: Open-label Extension|Other|0
6795231|NCT03653026|10793912|FG001|Part 2: Open-label Extension|Other|0
6795232|NCT03653026|10793913|FG002|Part 2: Open-label Extension|Other|1
6795233|NCT03653026|10793914|FG003|Part 2: Open-label Extension|Other|2
6795234|NCT03553498|10793928|FG000|Overall Study|Missing primary outcome|1
6795235|NCT03553498|10793929|FG001|Overall Study|Missing primary outcome|2
6795236|NCT03530293|10793937|FG000|Pre-randomization|Adverse Event|12
6795237|NCT03530293|10793938|FG001|Pre-randomization|Adverse Event|0
6795238|NCT03530293|10793939|FG002|Pre-randomization|Adverse Event|0
6795239|NCT03530293|10793937|FG000|Pre-randomization|Protocol Violation|2
6795240|NCT03530293|10793938|FG001|Pre-randomization|Protocol Violation|0
6795241|NCT03530293|10793939|FG002|Pre-randomization|Protocol Violation|0
6795242|NCT03530293|10793937|FG000|Pre-randomization|Study Terminated by Sponsor|5
6795243|NCT03530293|10793938|FG001|Pre-randomization|Study Terminated by Sponsor|0
6795244|NCT03530293|10793939|FG002|Pre-randomization|Study Terminated by Sponsor|0
6795245|NCT03530293|10793937|FG000|Pre-randomization|Withdrawal by Subject|5
6795246|NCT03530293|10793938|FG001|Pre-randomization|Withdrawal by Subject|0
6795247|NCT03530293|10793939|FG002|Pre-randomization|Withdrawal by Subject|0
6795248|NCT03530293|10793937|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0
6795249|NCT03530293|10793938|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2
6795250|NCT03530293|10793939|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4
6795251|NCT03530293|10793937|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0
6795252|NCT03530293|10793938|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0
6795253|NCT03530293|10793939|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1
6795254|NCT03530293|10793937|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0
6795255|NCT03530293|10793938|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3
6795256|NCT03530293|10793939|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2
6795257|NCT03530293|10793937|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0
6795258|NCT03530293|10793938|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2
6795259|NCT03530293|10793939|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0
6795260|NCT03530293|10793937|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0
6795261|NCT03530293|10793938|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10
6795262|NCT03530293|10793939|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10
6795263|NCT03505749|10793948|FG000|Overall Study|Lost to Follow-up|7
6795264|NCT03505749|10793949|FG001|Overall Study|Lost to Follow-up|11
6795265|NCT03505749|10793948|FG000|Overall Study|Withdrawal by Subject|6
6795266|NCT03505749|10793949|FG001|Overall Study|Withdrawal by Subject|0
6795267|NCT03505749|10793948|FG000|Overall Study|Discharged from treatment|3
6795268|NCT03505749|10793949|FG001|Overall Study|Discharged from treatment|6
6808654|NCT01231516|10812146|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3
6808655|NCT01231516|10812145|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5
6808656|NCT01231516|10812146|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10
6808657|NCT01231516|10812145|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1
6808658|NCT01231516|10812146|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1
6808659|NCT01231516|10812145|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11
6808660|NCT01231516|10812146|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5
6808661|NCT01231516|10812145|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3
6808662|NCT01231516|10812146|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1
6808663|NCT01231516|10812145|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3
6808664|NCT01231516|10812146|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2
6808665|NCT01231516|10812145|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5
6808666|NCT01231516|10812146|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0
6808667|NCT01231516|10812145|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27
6808668|NCT01231516|10812146|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11
6808669|NCT01231516|10812145|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10
6808670|NCT01231516|10812146|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0
6808671|NCT01231516|10812145|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6
6808672|NCT01231516|10812146|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3
6808673|NCT01231516|10812145|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2
6808674|NCT01231516|10812146|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0
6808675|NCT01231516|10812145|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6
6808676|NCT01231516|10812146|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1
6808677|NCT01231516|10812145|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12
6808678|NCT01231516|10812146|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2
6795269|NCT03472885|10793958|FG000|Overall Study|Adverse Event|1
6795270|NCT03249376|10793973|FG000|Overall Study|Adverse Event|11
6795271|NCT03249376|10793974|FG001|Overall Study|Adverse Event|5
6795272|NCT03249376|10793973|FG000|Overall Study|Lack of Efficacy|2
6795273|NCT03249376|10793974|FG001|Overall Study|Lack of Efficacy|4
6795274|NCT03249376|10793973|FG000|Overall Study|Protocol Violation|3
6795275|NCT03249376|10793974|FG001|Overall Study|Protocol Violation|2
6795276|NCT03249376|10793973|FG000|Overall Study|Physician Decision|0
6795277|NCT03249376|10793974|FG001|Overall Study|Physician Decision|2
6795278|NCT03249376|10793973|FG000|Overall Study|Withdrawal by Subject|3
6795279|NCT03249376|10793974|FG001|Overall Study|Withdrawal by Subject|9
6795280|NCT03249376|10793973|FG000|Overall Study|LTFU|2
6795281|NCT03249376|10793974|FG001|Overall Study|LTFU|1
6808679|NCT01194219|10812165|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23
6808680|NCT01194219|10812166|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5
6808681|NCT01194219|10812167|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
6808682|NCT01194219|10812168|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
6808683|NCT01194219|10812169|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
6808684|NCT01194219|10812170|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
6808685|NCT01194219|10812171|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
6808686|NCT01194219|10812172|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
6808687|NCT01194219|10812173|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
6808688|NCT01194219|10812174|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
6808689|NCT01194219|10812165|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2
6808690|NCT01194219|10812166|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7
6808691|NCT01194219|10812167|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
6808692|NCT01194219|10812168|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
6808693|NCT01194219|10812169|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
6808694|NCT01194219|10812170|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
6808695|NCT01194219|10812171|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
6808696|NCT01194219|10812172|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
6808697|NCT01194219|10812173|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
6808698|NCT01194219|10812174|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
6808699|NCT01194219|10812165|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7
6808700|NCT01194219|10812166|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
6808701|NCT01194219|10812167|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
6808702|NCT01194219|10812168|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
6808703|NCT01194219|10812169|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
6808704|NCT01194219|10812170|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
6810965|NCT02460224|10814913|FG006|Overall Study|Lost to Follow-up|0
6795282|NCT03118570|10793985|FG000|Overall Study|Adverse Event|2
6795283|NCT03118570|10793986|FG001|Overall Study|Adverse Event|0
6795284|NCT03118570|10793987|FG002|Overall Study|Adverse Event|0
6795285|NCT03118570|10793988|FG003|Overall Study|Adverse Event|0
6795286|NCT03118570|10793989|FG004|Overall Study|Adverse Event|3
6795287|NCT03118570|10793985|FG000|Overall Study|Withdrawal by Subject|0
6795288|NCT03118570|10793986|FG001|Overall Study|Withdrawal by Subject|1
6795289|NCT03118570|10793987|FG002|Overall Study|Withdrawal by Subject|4
6795290|NCT03118570|10793988|FG003|Overall Study|Withdrawal by Subject|0
6795291|NCT03118570|10793989|FG004|Overall Study|Withdrawal by Subject|1
6795292|NCT03118570|10793985|FG000|Overall Study|Lost to Follow-up|2
6795293|NCT03118570|10793986|FG001|Overall Study|Lost to Follow-up|3
6795294|NCT03118570|10793987|FG002|Overall Study|Lost to Follow-up|1
6795295|NCT03118570|10793988|FG003|Overall Study|Lost to Follow-up|0
6795296|NCT03118570|10793989|FG004|Overall Study|Lost to Follow-up|1
6795297|NCT03118570|10793985|FG000|Overall Study|Other, Not Specified|1
6795298|NCT03118570|10793986|FG001|Overall Study|Other, Not Specified|3
6795299|NCT03118570|10793987|FG002|Overall Study|Other, Not Specified|0
6795300|NCT03118570|10793988|FG003|Overall Study|Other, Not Specified|0
6795301|NCT03118570|10793989|FG004|Overall Study|Other, Not Specified|0
6795302|NCT03094416|10794002|FG000|Run-in|Screening failure|8
6795303|NCT03094416|10794002|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8
6795304|NCT03094416|10794002|FG000|Run-in|Withdrawal by Subject|3
6795305|NCT03094416|10794002|FG000|Treatment Period|Withdrawal by Subject|2
6795306|NCT02811861|10794010|FG000|Overall Study|Radiological Disease Progression|123
6795307|NCT02811861|10794011|FG001|Overall Study|Radiological Disease Progression|97
6795308|NCT02811861|10794012|FG002|Overall Study|Radiological Disease Progression|174
6795309|NCT02811861|10794010|FG000|Overall Study|Clinical Disease Progression|20
6795310|NCT02811861|10794011|FG001|Overall Study|Clinical Disease Progression|19
6795311|NCT02811861|10794012|FG002|Overall Study|Clinical Disease Progression|22
6795312|NCT02811861|10794010|FG000|Overall Study|Adverse Event|63
6795313|NCT02811861|10794011|FG001|Overall Study|Adverse Event|60
6795314|NCT02811861|10794012|FG002|Overall Study|Adverse Event|41
6795315|NCT02811861|10794010|FG000|Overall Study|Lost to Follow-up|0
6795316|NCT02811861|10794011|FG001|Overall Study|Lost to Follow-up|0
6795317|NCT02811861|10794012|FG002|Overall Study|Lost to Follow-up|1
6795318|NCT02811861|10794010|FG000|Overall Study|Subject Choice|29
6795319|NCT02811861|10794011|FG001|Overall Study|Subject Choice|17
6795320|NCT02811861|10794012|FG002|Overall Study|Subject Choice|23
6795321|NCT02811861|10794010|FG000|Overall Study|Withdrawal by Subject|4
6795322|NCT02811861|10794011|FG001|Overall Study|Withdrawal by Subject|4
6795323|NCT02811861|10794012|FG002|Overall Study|Withdrawal by Subject|9
6795324|NCT02811861|10794010|FG000|Overall Study|Other|4
6795325|NCT02811861|10794011|FG001|Overall Study|Other|13
6795326|NCT02811861|10794012|FG002|Overall Study|Other|3
6795327|NCT02811861|10794010|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112
6795328|NCT02811861|10794011|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142
6795329|NCT02811861|10794012|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67
6795330|NCT02811861|10794010|FG000|Overall Study|Randomized but not treated|2
6795331|NCT02811861|10794011|FG001|Overall Study|Randomized but not treated|3
6795332|NCT02811861|10794012|FG002|Overall Study|Randomized but not treated|17
6795333|NCT02607930|10794040|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25
6795334|NCT02607930|10794041|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19
6795335|NCT02607930|10794042|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0
6795336|NCT02607930|10794043|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0
6795337|NCT02607930|10794040|FG000|Double-Blinded Treatment Phase|Withdrew consent|14
6795338|NCT02607930|10794041|FG001|Double-Blinded Treatment Phase|Withdrew consent|18
6795339|NCT02607930|10794042|FG002|Double-Blinded Treatment Phase|Withdrew consent|0
6795340|NCT02607930|10794043|FG003|Double-Blinded Treatment Phase|Withdrew consent|0
6795341|NCT02607930|10794040|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6
6795342|NCT02607930|10794041|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3
6795343|NCT02607930|10794042|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0
6795344|NCT02607930|10794043|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0
6795345|NCT02607930|10794040|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3
6795346|NCT02607930|10794041|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5
6795347|NCT02607930|10794042|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0
6795348|NCT02607930|10794043|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0
6795349|NCT02607930|10794040|FG000|Double-Blinded Treatment Phase|Protocol Violation|2
6795350|NCT02607930|10794041|FG001|Double-Blinded Treatment Phase|Protocol Violation|3
6795351|NCT02607930|10794042|FG002|Double-Blinded Treatment Phase|Protocol Violation|0
6795352|NCT02607930|10794043|FG003|Double-Blinded Treatment Phase|Protocol Violation|0
6795353|NCT02607930|10794040|FG000|Double-Blinded Treatment Phase|Adverse Event|0
6795354|NCT02607930|10794041|FG001|Double-Blinded Treatment Phase|Adverse Event|4
6795355|NCT02607930|10794042|FG002|Double-Blinded Treatment Phase|Adverse Event|0
6795356|NCT02607930|10794043|FG003|Double-Blinded Treatment Phase|Adverse Event|0
6795357|NCT02607930|10794040|FG000|Double-Blinded Treatment Phase|Death|2
6795358|NCT02607930|10794041|FG001|Double-Blinded Treatment Phase|Death|1
6795359|NCT02607930|10794042|FG002|Double-Blinded Treatment Phase|Death|0
6795360|NCT02607930|10794043|FG003|Double-Blinded Treatment Phase|Death|0
6795361|NCT02607930|10794040|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2
6795362|NCT02607930|10794041|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0
6795363|NCT02607930|10794042|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0
6795364|NCT02607930|10794043|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0
6795365|NCT02607930|10794040|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0
6795366|NCT02607930|10794041|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0
6795367|NCT02607930|10794042|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15
6795368|NCT02607930|10794043|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10
6795369|NCT02607930|10794040|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0
6795370|NCT02607930|10794041|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0
6795371|NCT02607930|10794042|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10
6795372|NCT02607930|10794043|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13
6795373|NCT02607930|10794040|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0
6795374|NCT02607930|10794041|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0
6795375|NCT02607930|10794042|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2
6795376|NCT02607930|10794043|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5
6795377|NCT02607930|10794040|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0
6795378|NCT02607930|10794041|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0
6795379|NCT02607930|10794042|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4
6795380|NCT02607930|10794043|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2
6795381|NCT02607930|10794040|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0
6795382|NCT02607930|10794041|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0
6795383|NCT02607930|10794042|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1
6795384|NCT02607930|10794043|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1
6795385|NCT02607930|10794040|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0
6795386|NCT02607930|10794041|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0
6795387|NCT02607930|10794042|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1
6795388|NCT02607930|10794043|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1
6795389|NCT02607930|10794040|FG000|Open-Label B/F/TAF Extension Phase|Death|0
6795390|NCT02607930|10794041|FG001|Open-Label B/F/TAF Extension Phase|Death|0
6795391|NCT02607930|10794042|FG002|Open-Label B/F/TAF Extension Phase|Death|0
6795392|NCT02607930|10794043|FG003|Open-Label B/F/TAF Extension Phase|Death|1
6795393|NCT02607930|10794040|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0
6795394|NCT02607930|10794041|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0
6795395|NCT02607930|10794042|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1
6795396|NCT02607930|10794043|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0
6795432|NCT01399658|10794269|FG000|Overall Study|Ineligible|1
6795433|NCT01399658|10794269|FG000|Overall Study|Machine Technical Issue|3
6795434|NCT01399658|10794269|FG000|Overall Study|Standard of Care better than protocol therapy|1
6795435|NCT01399658|10794269|FG000|Overall Study|No reason given|1
6808705|NCT01194219|10812171|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
6808706|NCT01194219|10812172|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
6808707|NCT01194219|10812173|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
6808708|NCT01194219|10812174|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
6808709|NCT01194219|10812165|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12
6808710|NCT01194219|10812166|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9
6808711|NCT01194219|10812167|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
6808712|NCT01194219|10812168|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
6795397|NCT02580058|10794056|FG000|Overall Study|Lost to Follow-up|4
6795398|NCT02580058|10794057|FG001|Overall Study|Lost to Follow-up|5
6795399|NCT02580058|10794058|FG002|Overall Study|Lost to Follow-up|4
6795400|NCT02580058|10794056|FG000|Overall Study|Ongoing|51
6795401|NCT02580058|10794057|FG001|Overall Study|Ongoing|55
6795402|NCT02580058|10794058|FG002|Overall Study|Ongoing|46
6795403|NCT02580058|10794056|FG000|Overall Study|Withdrawal by Subject|24
6795404|NCT02580058|10794057|FG001|Overall Study|Withdrawal by Subject|26
6795405|NCT02580058|10794058|FG002|Overall Study|Withdrawal by Subject|36
6795406|NCT02578680|10794068|FG000|Overall Study|Death|124
6795407|NCT02578680|10794069|FG001|Overall Study|Death|104
6795408|NCT02578680|10794068|FG000|Overall Study|Protocol Violation|1
6795409|NCT02578680|10794069|FG001|Overall Study|Protocol Violation|1
6795410|NCT02578680|10794068|FG000|Overall Study|Withdrawal by Parent/Guardian|1
6795411|NCT02578680|10794069|FG001|Overall Study|Withdrawal by Parent/Guardian|0
6795412|NCT02578680|10794068|FG000|Overall Study|Withdrawal by Subject|8
6795413|NCT02578680|10794069|FG001|Overall Study|Withdrawal by Subject|5
6795414|NCT02578680|10794068|FG000|Overall Study|Ongoing in Study|276
6795415|NCT02578680|10794069|FG001|Overall Study|Ongoing in Study|96
6795416|NCT02513485|10794077|FG000|Overall Study|Adverse Event|1
6795417|NCT02513485|10794078|FG001|Overall Study|Adverse Event|0
6795418|NCT02476201|10794084|FG000|Overall Study|Unable to program MPP|9
6795419|NCT02476201|10794084|FG000|Overall Study|Study echo not performed|5
6795420|NCT02476201|10794084|FG000|Overall Study|Adverse Event|4
6795421|NCT02476201|10794084|FG000|Overall Study|Death|2
6795422|NCT02476201|10794084|FG000|Overall Study|Lost to Follow-up|2
6795423|NCT02476201|10794084|FG000|Overall Study|MPP programmed to OFF|2
6795424|NCT02476201|10794084|FG000|Overall Study|Withdrawal by Subject|1
6795425|NCT02476201|10794084|FG000|Overall Study|Unsuccessful implant|1
6795436|NCT00919893|10794374|FG000|Overall Study|Protocol Violation|19
6795437|NCT00919893|10794375|FG001|Overall Study|Protocol Violation|9
6795438|NCT00909753|10794414|FG000|Period: Washout of 28 Days|Protocol Violation|2
6795439|NCT00909753|10794415|FG001|Period: Washout of 28 Days|Protocol Violation|3
6795440|NCT00909753|10794414|FG000|Period: Second Intervention|Protocol Violation|1
6795441|NCT00909753|10794415|FG001|Period: Second Intervention|Protocol Violation|0
6795442|NCT00909610|10794428|FG000|Period: First Intervention|Adverse Event|0
6795443|NCT00909610|10794429|FG001|Period: First Intervention|Adverse Event|1
6795444|NCT00909610|10794428|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3
6795445|NCT00909610|10794429|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6
6795446|NCT00909610|10794428|FG000|Period: Second Intervention|Adverse Event|1
6795447|NCT00909610|10794429|FG001|Period: Second Intervention|Adverse Event|0
6795448|NCT00905606|10794457|FG000|Period 1|Adverse Event|0
6795449|NCT00905606|10794458|FG001|Period 1|Adverse Event|1
6795450|NCT00905606|10794457|FG000|Washout|Withdrawal by Subject|1
6795451|NCT00905606|10794458|FG001|Washout|Withdrawal by Subject|0
6795452|NCT00905567|10794464|FG000|Washout|Withdrawal by Subject|0
6795453|NCT00905567|10794465|FG001|Washout|Withdrawal by Subject|1
6795454|NCT00905346|10794471|FG000|Period 1|Withdrawal by Subject|1
6795455|NCT00905346|10794472|FG001|Period 1|Withdrawal by Subject|0
6795456|NCT00905164|10794478|FG000|Period 1|Protocol Violation|0
6795457|NCT00905164|10794479|FG001|Period 1|Protocol Violation|1
6795458|NCT00890591|10794490|FG000|Overall Study|Lack of Efficacy|20
6795459|NCT00890409|10794498|FG000|Overall Study|Lost to Follow-up|20
6795460|NCT00890409|10794499|FG001|Overall Study|Lost to Follow-up|21
6795461|NCT00888355|10794507|FG000|Overall Study|Adverse Event|10
6795462|NCT00888355|10794508|FG001|Overall Study|Adverse Event|0
6795463|NCT00888355|10794509|FG002|Overall Study|Adverse Event|3
6795464|NCT00888355|10794510|FG003|Overall Study|Adverse Event|3
6795465|NCT00888355|10794507|FG000|Overall Study|Lack of Efficacy|9
6795466|NCT00888355|10794508|FG001|Overall Study|Lack of Efficacy|2
6795467|NCT00888355|10794509|FG002|Overall Study|Lack of Efficacy|5
6795468|NCT00888355|10794510|FG003|Overall Study|Lack of Efficacy|2
6795469|NCT00888355|10794507|FG000|Overall Study|Lost to Follow-up|0
6795470|NCT00888355|10794508|FG001|Overall Study|Lost to Follow-up|2
6795471|NCT00888355|10794509|FG002|Overall Study|Lost to Follow-up|2
6795472|NCT00888355|10794510|FG003|Overall Study|Lost to Follow-up|0
6795473|NCT00888355|10794507|FG000|Overall Study|Protocol Violation|3
6795474|NCT00888355|10794508|FG001|Overall Study|Protocol Violation|2
6795475|NCT00888355|10794509|FG002|Overall Study|Protocol Violation|1
6795476|NCT00888355|10794510|FG003|Overall Study|Protocol Violation|2
6795477|NCT00888355|10794507|FG000|Overall Study|Withdrawal by Subject|0
6795478|NCT00888355|10794508|FG001|Overall Study|Withdrawal by Subject|3
6795479|NCT00888355|10794509|FG002|Overall Study|Withdrawal by Subject|1
6795480|NCT00888355|10794510|FG003|Overall Study|Withdrawal by Subject|3
6795481|NCT00887250|10794519|FG000|Overall Study|Adverse Event|3
6795482|NCT00887250|10794520|FG001|Overall Study|Adverse Event|0
6795483|NCT00887250|10794521|FG002|Overall Study|Adverse Event|7
6795484|NCT00887250|10794519|FG000|Overall Study|Lack of Efficacy|9
6795485|NCT00887250|10794520|FG001|Overall Study|Lack of Efficacy|6
6795486|NCT00887250|10794521|FG002|Overall Study|Lack of Efficacy|1
6795487|NCT00887250|10794519|FG000|Overall Study|Lost to Follow-up|2
6795488|NCT00887250|10794520|FG001|Overall Study|Lost to Follow-up|3
6795489|NCT00887250|10794521|FG002|Overall Study|Lost to Follow-up|1
6795490|NCT00887250|10794519|FG000|Overall Study|Protocol Violation|2
6795491|NCT00887250|10794520|FG001|Overall Study|Protocol Violation|2
6795492|NCT00887250|10794521|FG002|Overall Study|Protocol Violation|1
6795493|NCT00887250|10794519|FG000|Overall Study|Withdrawal by Subject|2
6795494|NCT00887250|10794520|FG001|Overall Study|Withdrawal by Subject|1
6795495|NCT00887250|10794521|FG002|Overall Study|Withdrawal by Subject|2
6795496|NCT00887250|10794519|FG000|Overall Study|Patient uncooperative|0
6795497|NCT00887250|10794520|FG001|Overall Study|Patient uncooperative|0
6795498|NCT00887250|10794521|FG002|Overall Study|Patient uncooperative|1
6795499|NCT00886600|10794530|FG000|Double-blind Monotherapy|Adverse Event|1
6795500|NCT00886600|10794531|FG001|Double-blind Monotherapy|Adverse Event|1
6795501|NCT00886600|10794532|FG002|Double-blind Monotherapy|Adverse Event|1
6795502|NCT00886600|10794533|FG003|Double-blind Monotherapy|Adverse Event|1
6795503|NCT00886600|10794530|FG000|Double-blind Monotherapy|Protocol Violation|0
6795504|NCT00886600|10794531|FG001|Double-blind Monotherapy|Protocol Violation|0
6795505|NCT00886600|10794532|FG002|Double-blind Monotherapy|Protocol Violation|0
6795506|NCT00886600|10794533|FG003|Double-blind Monotherapy|Protocol Violation|1
6795507|NCT00886600|10794530|FG000|Double-blind Monotherapy|Withdrawal by Subject|1
6795508|NCT00886600|10794531|FG001|Double-blind Monotherapy|Withdrawal by Subject|0
6795509|NCT00886600|10794532|FG002|Double-blind Monotherapy|Withdrawal by Subject|0
6795510|NCT00886600|10794533|FG003|Double-blind Monotherapy|Withdrawal by Subject|0
6795511|NCT00886600|10794530|FG000|Combination Therapy Period|Adverse Event|0
6795512|NCT00886600|10794531|FG001|Combination Therapy Period|Adverse Event|0
6795513|NCT00886600|10794532|FG002|Combination Therapy Period|Adverse Event|1
6795514|NCT00886600|10794533|FG003|Combination Therapy Period|Adverse Event|0
6795515|NCT00886600|10794530|FG000|Combination Therapy Period|Protocol Violation|0
6795516|NCT00886600|10794531|FG001|Combination Therapy Period|Protocol Violation|0
6795517|NCT00886600|10794532|FG002|Combination Therapy Period|Protocol Violation|1
6795518|NCT00886600|10794533|FG003|Combination Therapy Period|Protocol Violation|0
6795519|NCT00882440|10794546|FG000|Overall Study|Adverse Event|2
6795520|NCT00882440|10794547|FG001|Overall Study|Adverse Event|2
6795521|NCT00882440|10794548|FG002|Overall Study|Adverse Event|2
6795522|NCT00882440|10794549|FG003|Overall Study|Adverse Event|1
6795523|NCT00882440|10794550|FG004|Overall Study|Adverse Event|1
6795524|NCT00882440|10794551|FG005|Overall Study|Adverse Event|4
6795525|NCT00882440|10794552|FG006|Overall Study|Adverse Event|2
6795526|NCT00882440|10794546|FG000|Overall Study|Lack of Efficacy|3
6795527|NCT00882440|10794547|FG001|Overall Study|Lack of Efficacy|5
6795528|NCT00882440|10794548|FG002|Overall Study|Lack of Efficacy|2
6795529|NCT00882440|10794549|FG003|Overall Study|Lack of Efficacy|0
6795530|NCT00882440|10794550|FG004|Overall Study|Lack of Efficacy|0
6795531|NCT00882440|10794551|FG005|Overall Study|Lack of Efficacy|3
6795532|NCT00882440|10794552|FG006|Overall Study|Lack of Efficacy|0
6795533|NCT00882440|10794546|FG000|Overall Study|Lost to Follow-up|2
6795534|NCT00882440|10794547|FG001|Overall Study|Lost to Follow-up|0
6795535|NCT00882440|10794548|FG002|Overall Study|Lost to Follow-up|1
6795536|NCT00882440|10794549|FG003|Overall Study|Lost to Follow-up|1
6795537|NCT00882440|10794550|FG004|Overall Study|Lost to Follow-up|1
6795538|NCT00882440|10794551|FG005|Overall Study|Lost to Follow-up|0
6795539|NCT00882440|10794552|FG006|Overall Study|Lost to Follow-up|1
6795540|NCT00882440|10794546|FG000|Overall Study|Protocol Violation|0
6795541|NCT00882440|10794547|FG001|Overall Study|Protocol Violation|0
6795542|NCT00882440|10794548|FG002|Overall Study|Protocol Violation|1
6795543|NCT00882440|10794549|FG003|Overall Study|Protocol Violation|1
6795544|NCT00882440|10794550|FG004|Overall Study|Protocol Violation|1
6795545|NCT00882440|10794551|FG005|Overall Study|Protocol Violation|0
6795546|NCT00882440|10794552|FG006|Overall Study|Protocol Violation|0
6795547|NCT00882440|10794546|FG000|Overall Study|Withdrawal by Subject|2
6795548|NCT00882440|10794547|FG001|Overall Study|Withdrawal by Subject|1
6795549|NCT00882440|10794548|FG002|Overall Study|Withdrawal by Subject|1
6795550|NCT00882440|10794549|FG003|Overall Study|Withdrawal by Subject|0
6795551|NCT00882440|10794550|FG004|Overall Study|Withdrawal by Subject|6
6795552|NCT00882440|10794551|FG005|Overall Study|Withdrawal by Subject|0
6795553|NCT00882440|10794552|FG006|Overall Study|Withdrawal by Subject|1
6795554|NCT00882440|10794546|FG000|Overall Study|Patient Uncooperative|2
6795555|NCT00882440|10794547|FG001|Overall Study|Patient Uncooperative|0
6795556|NCT00882440|10794548|FG002|Overall Study|Patient Uncooperative|0
6795557|NCT00882440|10794549|FG003|Overall Study|Patient Uncooperative|0
6795558|NCT00882440|10794550|FG004|Overall Study|Patient Uncooperative|1
6795559|NCT00882440|10794551|FG005|Overall Study|Patient Uncooperative|0
6795560|NCT00882440|10794552|FG006|Overall Study|Patient Uncooperative|0
6808713|NCT01194219|10812169|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
6808714|NCT01194219|10812170|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
6808715|NCT01194219|10812171|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
6808716|NCT01194219|10812172|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
6808717|NCT01194219|10812173|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
6795561|NCT00870688|10794568|FG000|Overall Study|Lost to Follow-up|2
6795562|NCT00870688|10794568|FG000|Overall Study|Death, Unrelated|1
6795563|NCT00870688|10794568|FG000|Overall Study|Granules in the Stools|1
6795564|NCT00869128|10794571|FG000|Overall Study|lack of Compliance|6
6795565|NCT00869128|10794572|FG001|Overall Study|lack of Compliance|6
6795566|NCT00861705|10794580|FG000|Overall Study|Never Began Treatment|7
6795567|NCT00861705|10794581|FG001|Overall Study|Never Began Treatment|3
6795568|NCT00861705|10794582|FG002|Overall Study|Never Began Treatment|0
6795569|NCT00861705|10794583|FG003|Overall Study|Never Began Treatment|1
6795570|NCT00859521|10794603|FG000|Washout|Withdrawal by Subject|0
6795571|NCT00859521|10794604|FG001|Washout|Withdrawal by Subject|1
6795572|NCT00859430|10794610|FG000|First Intervention|Withdrawal by Subject|0
6795573|NCT00859430|10794611|FG001|First Intervention|Withdrawal by Subject|1
6795574|NCT00858702|10794617|FG000|Overall Study|Lack of Efficacy|1
6795575|NCT00858702|10794618|FG001|Overall Study|Lack of Efficacy|0
6795576|NCT00858702|10794617|FG000|Overall Study|Protocol Violation|1
6795577|NCT00858702|10794618|FG001|Overall Study|Protocol Violation|1
6795578|NCT00858702|10794617|FG000|Overall Study|Other|2
6795579|NCT00858702|10794618|FG001|Overall Study|Other|1
6795580|NCT00858702|10794617|FG000|Overall Study|Withdrawal by Subject|1
6795581|NCT00858702|10794618|FG001|Overall Study|Withdrawal by Subject|0
6795582|NCT00857285|10794626|FG000|Overall Study|Adverse Event|4
6795583|NCT00857285|10794627|FG001|Overall Study|Adverse Event|2
6795584|NCT00857285|10794626|FG000|Overall Study|Lack of Efficacy|0
6795585|NCT00857285|10794627|FG001|Overall Study|Lack of Efficacy|2
6795586|NCT00857285|10794626|FG000|Overall Study|Protocol Violation|3
6795587|NCT00857285|10794627|FG001|Overall Study|Protocol Violation|1
6795588|NCT00857285|10794626|FG000|Overall Study|Withdrawal by Subject|4
6795589|NCT00857285|10794627|FG001|Overall Study|Withdrawal by Subject|0
6795590|NCT00857285|10794626|FG000|Overall Study|Randomization criteria not met|1
6795591|NCT00857285|10794627|FG001|Overall Study|Randomization criteria not met|1
6795592|NCT00850174|10794643|FG000|Washout: One Week|Withdrawal by Subject|0
6795593|NCT00850174|10794644|FG001|Washout: One Week|Withdrawal by Subject|2
6795594|NCT00850174|10794643|FG000|Second Intervention|Withdrawal by Subject|1
6795595|NCT00850174|10794644|FG001|Second Intervention|Withdrawal by Subject|0
6795596|NCT00849797|10794657|FG000|First Intervention|bad veins|1
6795597|NCT00849797|10794658|FG001|First Intervention|bad veins|0
6795598|NCT00849797|10794657|FG000|First Intervention|Adverse Event|0
6795599|NCT00849797|10794658|FG001|First Intervention|Adverse Event|1
6795600|NCT00849797|10794657|FG000|Washout: One Week|Withdrawal by Subject|0
6795601|NCT00849797|10794658|FG001|Washout: One Week|Withdrawal by Subject|2
6795602|NCT00847405|10794672|FG000|First Intervention|Adverse Event|0
6795603|NCT00847405|10794673|FG001|First Intervention|Adverse Event|1
6795604|NCT00847405|10794672|FG000|Washout of 7 Days|Withdrawal by Subject|1
6795605|NCT00847405|10794673|FG001|Washout of 7 Days|Withdrawal by Subject|0
6795606|NCT00841815|10794686|FG000|Washout|Withdrawal by Subject|0
6795607|NCT00841815|10794687|FG001|Washout|Withdrawal by Subject|1
6795608|NCT00841698|10794694|FG000|First Intervention|Withdrawal by Subject|1
6795609|NCT00841698|10794695|FG001|First Intervention|Withdrawal by Subject|0
6795610|NCT00841659|10794701|FG000|Washout: 2 Weeks|Protocol Violation|1
6795611|NCT00841659|10794702|FG001|Washout: 2 Weeks|Protocol Violation|0
6795612|NCT00841542|10794708|FG000|Period 1|Adverse Event|1
6795613|NCT00841542|10794709|FG001|Period 1|Adverse Event|0
6795614|NCT00840879|10794715|FG000|Second Intervention|Withdrawal by Subject|1
6795615|NCT00840879|10794716|FG001|Second Intervention|Withdrawal by Subject|0
6795616|NCT00840632|10794736|FG000|First Intervention|Withdrawal by Subject|0
6795617|NCT00840632|10794737|FG001|First Intervention|Withdrawal by Subject|1
6795618|NCT00840632|10794736|FG000|Washout|Withdrawal by Subject|1
6795619|NCT00840632|10794737|FG001|Washout|Withdrawal by Subject|1
6795620|NCT00840411|10794750|FG000|First Intervention|Adverse Event|1
6795621|NCT00840411|10794751|FG001|First Intervention|Adverse Event|0
6795622|NCT00840411|10794750|FG000|Washout|Withdrawal by Subject|1
6795623|NCT00840411|10794751|FG001|Washout|Withdrawal by Subject|0
6795624|NCT00840216|10794764|FG000|Washout: 7 Days|Withdrawal by Subject|1
6795625|NCT00840216|10794765|FG001|Washout: 7 Days|Withdrawal by Subject|0
6795626|NCT00840203|10794771|FG000|First Intervention|Protocol Violation|1
6795627|NCT00840203|10794772|FG001|First Intervention|Protocol Violation|1
6795628|NCT00840203|10794771|FG000|Washout|Protocol Violation|1
6795629|NCT00840203|10794772|FG001|Washout|Protocol Violation|0
6795630|NCT00840073|10794785|FG000|Second Intervention|Missed 72 hour blood draw|1
6795631|NCT00840073|10794786|FG001|Second Intervention|Missed 72 hour blood draw|1
6795632|NCT00838630|10794799|FG000|First Intervention|Adverse Event|1
6795633|NCT00838630|10794800|FG001|First Intervention|Adverse Event|0
6795634|NCT00838630|10794799|FG000|Washout: 7 Days|Protocol Violation|1
6795635|NCT00838630|10794800|FG001|Washout: 7 Days|Protocol Violation|0
6795636|NCT00838279|10794806|FG000|Washout|Protocol Violation|1
6795637|NCT00838279|10794807|FG001|Washout|Protocol Violation|0
6795638|NCT00838279|10794806|FG000|Washout|Withdrawal by Subject|0
6795639|NCT00838279|10794807|FG001|Washout|Withdrawal by Subject|1
6795640|NCT00836901|10794820|FG000|First Intervention|Withdrawal by Subject|1
6795641|NCT00836901|10794821|FG001|First Intervention|Withdrawal by Subject|0
6795642|NCT00836706|10794827|FG000|Washout: 7 Days|Withdrawal by Subject|0
6795643|NCT00836706|10794828|FG001|Washout: 7 Days|Withdrawal by Subject|1
6795644|NCT00836472|10794834|FG000|Washout|Adverse Event|1
6795645|NCT00836472|10794835|FG001|Washout|Adverse Event|2
6795646|NCT00836472|10794834|FG000|Washout|Withdrawal by Subject|1
6795647|NCT00836472|10794835|FG001|Washout|Withdrawal by Subject|1
6808718|NCT01194219|10812174|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
6808719|NCT01194219|10812165|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0
6808720|NCT01194219|10812166|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1
6808721|NCT01194219|10812167|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0
6808722|NCT01194219|10812168|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0
6808723|NCT01194219|10812169|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0
6808724|NCT01194219|10812170|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0
6808725|NCT01194219|10812171|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0
6808726|NCT01194219|10812172|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0
6808727|NCT01194219|10812173|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0
6808728|NCT01194219|10812174|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0
6808729|NCT01194219|10812165|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7
6808730|NCT01194219|10812166|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9
6808731|NCT01194219|10812167|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
6808732|NCT01194219|10812168|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
6808733|NCT01194219|10812169|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
6808734|NCT01194219|10812170|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
6808735|NCT01194219|10812171|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
6808736|NCT01194219|10812172|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
6808737|NCT01194219|10812173|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
6808738|NCT01194219|10812174|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
6808739|NCT01194219|10812165|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7
6808740|NCT01194219|10812166|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1
6808741|NCT01194219|10812167|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
6808742|NCT01194219|10812168|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
6808743|NCT01194219|10812169|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
6808744|NCT01194219|10812170|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
6808745|NCT01194219|10812171|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
6808746|NCT01194219|10812172|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
6808747|NCT01194219|10812173|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
6808748|NCT01194219|10812174|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
6808749|NCT01194219|10812165|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
6808750|NCT01194219|10812166|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
6808751|NCT01194219|10812167|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
6808752|NCT01194219|10812168|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
6808753|NCT01194219|10812169|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
6808754|NCT01194219|10812170|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
6808755|NCT01194219|10812171|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
6808756|NCT01194219|10812172|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
6808757|NCT01194219|10812173|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
6808758|NCT01194219|10812174|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
6808759|NCT01194219|10812165|FG000|Maintenance Phase Weeks16-32|Adverse Event|0
6808760|NCT01194219|10812166|FG001|Maintenance Phase Weeks16-32|Adverse Event|0
6808761|NCT01194219|10812167|FG002|Maintenance Phase Weeks16-32|Adverse Event|8
6808762|NCT01194219|10812168|FG003|Maintenance Phase Weeks16-32|Adverse Event|9
6808763|NCT01194219|10812169|FG004|Maintenance Phase Weeks16-32|Adverse Event|0
6808764|NCT01194219|10812170|FG005|Maintenance Phase Weeks16-32|Adverse Event|0
6808765|NCT01194219|10812171|FG006|Maintenance Phase Weeks16-32|Adverse Event|0
6808766|NCT01194219|10812172|FG007|Maintenance Phase Weeks16-32|Adverse Event|0
6808767|NCT01194219|10812173|FG008|Maintenance Phase Weeks16-32|Adverse Event|0
6808768|NCT01194219|10812174|FG009|Maintenance Phase Weeks16-32|Adverse Event|0
6808769|NCT01194219|10812165|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0
6808770|NCT01194219|10812166|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0
6808771|NCT01194219|10812167|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37
6808772|NCT01194219|10812168|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15
6808773|NCT01194219|10812169|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0
6808774|NCT01194219|10812170|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0
6808775|NCT01194219|10812171|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0
6808776|NCT01194219|10812172|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0
6808777|NCT01194219|10812173|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0
6808778|NCT01194219|10812174|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0
6808779|NCT01194219|10812165|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
6808780|NCT01194219|10812166|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
6808781|NCT01194219|10812167|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2
6808782|NCT01194219|10812168|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1
6808783|NCT01194219|10812169|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
6808784|NCT01194219|10812170|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
6808785|NCT01194219|10812171|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
6808786|NCT01194219|10812172|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
6808787|NCT01194219|10812173|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
6808788|NCT01194219|10812174|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
6795648|NCT00836056|10794841|FG000|First Intervention|Adverse Event|1
6795649|NCT00836056|10794842|FG001|First Intervention|Adverse Event|0
6795650|NCT00835991|10794855|FG000|First Intervention|Adverse Event|0
6795651|NCT00835991|10794856|FG001|First Intervention|Adverse Event|1
6795652|NCT00835991|10794855|FG000|Washout|Protocol Violation|0
6795653|NCT00835991|10794856|FG001|Washout|Protocol Violation|2
6795654|NCT00835991|10794855|FG000|Washout|Withdrawal by Subject|3
6795655|NCT00835991|10794856|FG001|Washout|Withdrawal by Subject|1
6795656|NCT00835796|10794862|FG000|First Intervention|Withdrawal by Subject|0
6795657|NCT00835796|10794863|FG001|First Intervention|Withdrawal by Subject|1
6795658|NCT00835705|10794869|FG000|First Intervention|Difficulty with vein|1
6795659|NCT00835705|10794870|FG001|First Intervention|Difficulty with vein|0
6795660|NCT00835705|10794869|FG000|Second Intervention|Difficulty with vein|1
6795661|NCT00835705|10794870|FG001|Second Intervention|Difficulty with vein|0
6795662|NCT00835692|10794876|FG000|First Intervention|Withdrawal by Subject|1
6795663|NCT00835692|10794877|FG001|First Intervention|Withdrawal by Subject|0
6795664|NCT00835666|10794883|FG000|Washout|Protocol Violation|1
6795665|NCT00835666|10794884|FG001|Washout|Protocol Violation|0
6795666|NCT00835666|10794883|FG000|Washout|Withdrawal by Subject|1
6795667|NCT00835666|10794884|FG001|Washout|Withdrawal by Subject|0
6795668|NCT00835640|10794890|FG000|Second Intervention|Protocol Violation|1
6795669|NCT00835640|10794891|FG001|Second Intervention|Protocol Violation|0
6795670|NCT00835575|10794911|FG000|Washout of 14 Days|Withdrawal by Subject|1
6795671|NCT00835575|10794912|FG001|Washout of 14 Days|Withdrawal by Subject|0
6795672|NCT00835549|10794918|FG000|Washout of 7 Days|Withdrawal by Subject|2
6795673|NCT00835549|10794919|FG001|Washout of 7 Days|Withdrawal by Subject|0
6795674|NCT00835536|10794925|FG000|Washout of 5 Weeks|Withdrawal by Subject|1
6795675|NCT00835536|10794926|FG001|Washout of 5 Weeks|Withdrawal by Subject|0
6795676|NCT00835406|10794946|FG000|Period: First Intervention|Adverse Event|0
6795677|NCT00835406|10794947|FG001|Period: First Intervention|Adverse Event|1
6795678|NCT00835406|10794946|FG000|Period: First Intervention|Withdrawal by Subject|2
6795679|NCT00835406|10794947|FG001|Period: First Intervention|Withdrawal by Subject|0
6795680|NCT00835406|10794946|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0
6795681|NCT00835406|10794947|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2
6795682|NCT00835367|10794953|FG000|Washout|Adverse Event|2
6795683|NCT00835367|10794954|FG001|Washout|Adverse Event|0
6795684|NCT00835367|10794953|FG000|Washout|Withdrawal by Subject|1
6795685|NCT00835367|10794954|FG001|Washout|Withdrawal by Subject|0
6795686|NCT00835367|10794953|FG000|Second Intervention|Adverse Event|1
6795687|NCT00835367|10794954|FG001|Second Intervention|Adverse Event|1
6795688|NCT00835354|10794960|FG000|First Intervention|Adverse Event|0
6795689|NCT00835354|10794961|FG001|First Intervention|Adverse Event|1
6795690|NCT00835263|10794974|FG000|Second Intervention|Adverse Event|1
6795691|NCT00835263|10794975|FG001|Second Intervention|Adverse Event|0
6795692|NCT00835211|10794981|FG000|First Intervention|Withdrawal by Subject|0
6795693|NCT00835211|10794982|FG001|First Intervention|Withdrawal by Subject|1
6795694|NCT00835211|10794981|FG000|Washout: 7 Days|Adverse Event|2
6795695|NCT00835211|10794982|FG001|Washout: 7 Days|Adverse Event|1
6795696|NCT00835211|10794981|FG000|Washout: 7 Days|Withdrawal by Subject|1
6795697|NCT00835211|10794982|FG001|Washout: 7 Days|Withdrawal by Subject|0
6795698|NCT00835172|10794988|FG000|Washout|Protocol Violation|0
6795699|NCT00835172|10794989|FG001|Washout|Protocol Violation|1
6795700|NCT00835081|10795002|FG000|Washout of 7 Days|Withdrawal by Subject|1
6795701|NCT00835081|10795003|FG001|Washout of 7 Days|Withdrawal by Subject|0
6795702|NCT00835042|10795009|FG000|First Intervention|Withdrawal by Subject|3
6795703|NCT00835042|10795010|FG001|First Intervention|Withdrawal by Subject|0
6795704|NCT00835042|10795009|FG000|First Intervention|Adverse Event|1
6795705|NCT00835042|10795010|FG001|First Intervention|Adverse Event|2
6795706|NCT00835042|10795009|FG000|Washout of 21 Days|Withdrawal by Subject|0
6795707|NCT00835042|10795010|FG001|Washout of 21 Days|Withdrawal by Subject|2
6795708|NCT00834873|10795037|FG000|First Intervention|Adverse Event|0
6795709|NCT00834873|10795038|FG001|First Intervention|Adverse Event|1
6795710|NCT00834795|10795044|FG000|Washout: 7 Days|Withdrawal by Subject|0
6795711|NCT00834795|10795045|FG001|Washout: 7 Days|Withdrawal by Subject|1
6795712|NCT00834795|10795044|FG000|Second Intervention|Adverse Event|1
6795713|NCT00834795|10795045|FG001|Second Intervention|Adverse Event|0
6795714|NCT00834756|10795051|FG000|First Intervention|Adverse Event|1
6795715|NCT00834756|10795052|FG001|First Intervention|Adverse Event|0
6795716|NCT00834756|10795051|FG000|Washout: 21 Days|Withdrawal by Subject|1
6795717|NCT00834756|10795052|FG001|Washout: 21 Days|Withdrawal by Subject|0
6795718|NCT00834743|10795058|FG000|Second Intervention|Withdrawal by Subject|1
6795719|NCT00834743|10795059|FG001|Second Intervention|Withdrawal by Subject|0
6795720|NCT00834717|10795065|FG000|First Intervention|Adverse Event|1
6795721|NCT00834717|10795066|FG001|First Intervention|Adverse Event|0
6795722|NCT00834717|10795065|FG000|First Intervention|Withdrawal by Subject|0
6795723|NCT00834717|10795066|FG001|First Intervention|Withdrawal by Subject|1
6795724|NCT00834639|10795072|FG000|Second Intervention|Physician Decision|0
6795725|NCT00834639|10795073|FG001|Second Intervention|Physician Decision|2
6795726|NCT00834613|10795079|FG000|First Intervention|Protocol Violation|1
6795727|NCT00834613|10795080|FG001|First Intervention|Protocol Violation|0
6795728|NCT00834587|10795086|FG000|Washout: 7 Days|Withdrawal by Subject|1
6795729|NCT00834587|10795087|FG001|Washout: 7 Days|Withdrawal by Subject|0
6795730|NCT00834522|10795114|FG000|Washout|Adverse Event|1
6795731|NCT00834522|10795115|FG001|Washout|Adverse Event|0
6795732|NCT00834522|10795114|FG000|Washout|Withdrawal by Subject|2
6795733|NCT00834522|10795115|FG001|Washout|Withdrawal by Subject|1
6795734|NCT00834444|10795121|FG000|First Intervention|Adverse Event|1
6795735|NCT00834444|10795122|FG001|First Intervention|Adverse Event|0
6795736|NCT00834444|10795121|FG000|First Intervention|Intolerance to Venopuncture|0
6795737|NCT00834444|10795122|FG001|First Intervention|Intolerance to Venopuncture|1
6795738|NCT00834444|10795121|FG000|Washout of 7 Days|Withdrawal by Subject|0
6795739|NCT00834444|10795122|FG001|Washout of 7 Days|Withdrawal by Subject|1
6795740|NCT00834444|10795121|FG000|Second Intervention|Adverse Event|1
6795741|NCT00834444|10795122|FG001|Second Intervention|Adverse Event|0
6795742|NCT00834431|10795128|FG000|First Intervention|Adverse Event|0
6795743|NCT00834431|10795129|FG001|First Intervention|Adverse Event|1
6795744|NCT00834431|10795128|FG000|Washout of 7 Days|Withdrawal by Subject|0
6795745|NCT00834431|10795129|FG001|Washout of 7 Days|Withdrawal by Subject|1
6795746|NCT00834418|10795135|FG000|Overall Study|Adverse Event|0
6795747|NCT00834418|10795136|FG001|Overall Study|Adverse Event|2
6795748|NCT00834340|10795149|FG000|Washout|Adverse Event|1
6795749|NCT00834340|10795150|FG001|Washout|Adverse Event|0
6795750|NCT00834340|10795149|FG000|Washout|Withdrawal by Subject|1
6795751|NCT00834340|10795150|FG001|Washout|Withdrawal by Subject|0
6795752|NCT00834249|10795163|FG000|Washout: 7 Days|Withdrawal by Subject|1
6795753|NCT00834249|10795164|FG001|Washout: 7 Days|Withdrawal by Subject|1
6795754|NCT00834249|10795163|FG000|Second Intervention|Adverse Event|1
6795755|NCT00834249|10795164|FG001|Second Intervention|Adverse Event|0
6795756|NCT00834067|10795184|FG000|Washout of 21 Days|Protocol Violation|0
6795757|NCT00834067|10795185|FG001|Washout of 21 Days|Protocol Violation|1
6795758|NCT00833937|10795191|FG000|Washout|Withdrawal by Subject|1
6795759|NCT00833937|10795192|FG001|Washout|Withdrawal by Subject|0
6795760|NCT00830336|10795219|FG000|Washout: 21 Days|Withdrawal by Subject|1
6795761|NCT00830336|10795220|FG001|Washout: 21 Days|Withdrawal by Subject|0
6795762|NCT00830258|10795226|FG000|First Intervention|Adverse Event|1
6795763|NCT00830258|10795227|FG001|First Intervention|Adverse Event|0
6795764|NCT00830258|10795226|FG000|Washout: 7 Days|Protocol Violation|1
6795765|NCT00830258|10795227|FG001|Washout: 7 Days|Protocol Violation|0
6795766|NCT00830219|10795233|FG000|Washout of 7 Days|Withdrawal by Subject|1
6795767|NCT00830219|10795234|FG001|Washout of 7 Days|Withdrawal by Subject|1
6795768|NCT00830206|10795240|FG000|Washout: 21 Days|Withdrawal by Subject|1
6795769|NCT00830206|10795241|FG001|Washout: 21 Days|Withdrawal by Subject|1
6795770|NCT00830024|10795247|FG000|Washout: 7 Days|Withdrawal by Subject|1
6795771|NCT00830024|10795248|FG001|Washout: 7 Days|Withdrawal by Subject|0
6795772|NCT00829998|10795254|FG000|Washout|Adverse Event|0
6795773|NCT00829998|10795255|FG001|Washout|Adverse Event|1
6795774|NCT00829868|10795261|FG000|Washout|Physician Decision|1
6795775|NCT00829868|10795262|FG001|Washout|Physician Decision|0
6795776|NCT00829790|10795268|FG000|Washout of 14 Days|Withdrawal by Subject|0
6795777|NCT00829790|10795269|FG001|Washout of 14 Days|Withdrawal by Subject|1
6795778|NCT00829764|10795275|FG000|First Intervention|Adverse Event|1
6795779|NCT00829764|10795276|FG001|First Intervention|Adverse Event|0
6795780|NCT00829764|10795275|FG000|First Intervention|Withdrawal by Subject|1
6795781|NCT00829764|10795276|FG001|First Intervention|Withdrawal by Subject|1
6795782|NCT00829712|10795282|FG000|Washout of 7 Days|Withdrawal by Subject|0
6795783|NCT00829712|10795283|FG001|Washout of 7 Days|Withdrawal by Subject|1
6795784|NCT00829673|10795296|FG000|Washout of 7 Days|Withdrawal by Subject|1
6795785|NCT00829673|10795297|FG001|Washout of 7 Days|Withdrawal by Subject|0
6795786|NCT00829530|10795303|FG000|First Intervention|Adverse Event|0
6795787|NCT00829530|10795304|FG001|First Intervention|Adverse Event|1
6795788|NCT00829530|10795303|FG000|First Intervention|Intolerance to Venopuncture|0
6795789|NCT00829530|10795304|FG001|First Intervention|Intolerance to Venopuncture|1
6795790|NCT00829530|10795303|FG000|Second Intervention|Intolerance to Venopuncture|1
6795791|NCT00829530|10795304|FG001|Second Intervention|Intolerance to Venopuncture|0
6795792|NCT00829504|10795310|FG000|First Intervention|Adverse Event|1
6795793|NCT00829504|10795311|FG001|First Intervention|Adverse Event|0
6795794|NCT00829504|10795310|FG000|Washout of 7 Days|Withdrawal by Subject|1
6795795|NCT00829504|10795311|FG001|Washout of 7 Days|Withdrawal by Subject|0
6795796|NCT00829504|10795310|FG000|Second Intervention|Physician Decision|1
6795797|NCT00829504|10795311|FG001|Second Intervention|Physician Decision|0
6795798|NCT00829452|10795317|FG000|First Intervention|Withdrawal by Subject|0
6795799|NCT00829452|10795318|FG001|First Intervention|Withdrawal by Subject|1
6795800|NCT00829452|10795317|FG000|Washout of 42 Days|Withdrawal by Subject|0
6795801|NCT00829452|10795318|FG001|Washout of 42 Days|Withdrawal by Subject|1
6795802|NCT00829452|10795317|FG000|Second Intervention|Physician Decision|0
6795803|NCT00829452|10795318|FG001|Second Intervention|Physician Decision|1
6795804|NCT00829426|10795324|FG000|Washout: 7 Days|Withdrawal by Subject|1
6795805|NCT00829426|10795325|FG001|Washout: 7 Days|Withdrawal by Subject|0
6795806|NCT00829309|10795331|FG000|Washout: 7 Days|Protocol Violation|1
6795807|NCT00829309|10795332|FG001|Washout: 7 Days|Protocol Violation|0
6795808|NCT00828321|10795338|FG000|Washout of 42 Days|Withdrawal by Subject|2
6795809|NCT00828321|10795339|FG001|Washout of 42 Days|Withdrawal by Subject|0
6795810|NCT00828321|10795338|FG000|Second Intervention|Protocol Violation|0
6795811|NCT00828321|10795339|FG001|Second Intervention|Protocol Violation|1
6808789|NCT01194219|10812165|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
6808790|NCT01194219|10812166|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
6808791|NCT01194219|10812167|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12
6795812|NCT00806403|10795345|FG000|Overall Study|Death|4
6795813|NCT00806403|10795346|FG001|Overall Study|Death|3
6795814|NCT00796523|10795386|FG000|Overall Study|Lost to Follow-up|9
6795815|NCT00796523|10795387|FG001|Overall Study|Lost to Follow-up|7
6795816|NCT00794924|10795393|FG000|Overall Study|Lost to Follow-up|6
6795817|NCT00794924|10795394|FG001|Overall Study|Lost to Follow-up|8
6795818|NCT00794924|10795393|FG000|Overall Study|Withdrawal by Subject|48
6795819|NCT00794924|10795394|FG001|Overall Study|Withdrawal by Subject|60
6795820|NCT00794924|10795393|FG000|Overall Study|Adverse Event|6
6795821|NCT00794924|10795394|FG001|Overall Study|Adverse Event|2
6795822|NCT00794677|10795400|FG000|First Intervention|Withdrawal by Subject|2
6795823|NCT00794677|10795401|FG001|First Intervention|Withdrawal by Subject|0
6795824|NCT00792116|10795407|FG000|Overall Study|Lost to Follow-up|0
6795825|NCT00792116|10795408|FG001|Overall Study|Lost to Follow-up|1
6795826|NCT00792116|10795407|FG000|Overall Study|Discontnued intervention|1
6795827|NCT00792116|10795408|FG001|Overall Study|Discontnued intervention|0
6808792|NCT01194219|10812168|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3
6808793|NCT01194219|10812169|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
6808794|NCT01194219|10812170|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
6808795|NCT01194219|10812171|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
6808796|NCT01194219|10812172|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
6808797|NCT01194219|10812173|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
6808798|NCT01194219|10812174|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
6808799|NCT01194219|10812165|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0
6808800|NCT01194219|10812166|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0
6808801|NCT01194219|10812167|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9
6808802|NCT01194219|10812168|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0
6808803|NCT01194219|10812169|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0
6808804|NCT01194219|10812170|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0
6808805|NCT01194219|10812171|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0
6808806|NCT01194219|10812172|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0
6808807|NCT01194219|10812173|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0
6808808|NCT01194219|10812174|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0
6808809|NCT01194219|10812165|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0
6808810|NCT01194219|10812166|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0
6808811|NCT01194219|10812167|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0
6808812|NCT01194219|10812168|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1
6808813|NCT01194219|10812169|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0
6808814|NCT01194219|10812170|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0
6808815|NCT01194219|10812171|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0
6808816|NCT01194219|10812172|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0
6808817|NCT01194219|10812173|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0
6808818|NCT01194219|10812174|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0
6808819|NCT01194219|10812165|FG000|Maintenance Phase Weeks16-32|Other|0
6808820|NCT01194219|10812166|FG001|Maintenance Phase Weeks16-32|Other|0
6808821|NCT01194219|10812167|FG002|Maintenance Phase Weeks16-32|Other|2
6808822|NCT01194219|10812168|FG003|Maintenance Phase Weeks16-32|Other|1
6808823|NCT01194219|10812169|FG004|Maintenance Phase Weeks16-32|Other|0
6808824|NCT01194219|10812170|FG005|Maintenance Phase Weeks16-32|Other|0
6808825|NCT01194219|10812171|FG006|Maintenance Phase Weeks16-32|Other|0
6808826|NCT01194219|10812172|FG007|Maintenance Phase Weeks16-32|Other|0
6808827|NCT01194219|10812173|FG008|Maintenance Phase Weeks16-32|Other|0
6808828|NCT01194219|10812174|FG009|Maintenance Phase Weeks16-32|Other|0
6808829|NCT01194219|10812165|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
6808830|NCT01194219|10812166|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
6808831|NCT01194219|10812167|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
6808832|NCT01194219|10812168|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
6808833|NCT01194219|10812169|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
6808834|NCT01194219|10812170|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1
6808835|NCT01194219|10812171|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6
6808836|NCT01194219|10812172|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5
6795828|NCT00756574|10795428|FG000|Overall Study|Withdrawal by Subject|9
6795829|NCT00756574|10795429|FG001|Overall Study|Withdrawal by Subject|7
6795830|NCT00756574|10795428|FG000|Overall Study|Lost to Follow-up|4
6795831|NCT00756574|10795429|FG001|Overall Study|Lost to Follow-up|4
6795832|NCT00740480|10795436|FG000|Overall Study|Adverse Event|1
6795833|NCT00740480|10795436|FG000|Overall Study|Physician Decision|1
6795834|NCT00724698|10795439|FG000|Overall Study|Adverse Event|9
6795835|NCT00724698|10795439|FG000|Overall Study|Failure of Therapy|4
6795836|NCT00724698|10795439|FG000|Overall Study|Poor Compliance|16
6795837|NCT00724698|10795439|FG000|Overall Study|Lost to Follow-up|36
6795838|NCT00724698|10795439|FG000|Overall Study|No Info|25
6795839|NCT00711555|10795442|FG000|Overall Study|Adverse Event|3
6808837|NCT01194219|10812173|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
6808838|NCT01194219|10812174|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
6808839|NCT01194219|10812165|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
6808840|NCT01194219|10812166|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
6808841|NCT01194219|10812167|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
6808842|NCT01194219|10812168|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
6808843|NCT01194219|10812169|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
6808844|NCT01194219|10812170|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
6808845|NCT01194219|10812171|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35
6808846|NCT01194219|10812172|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33
6808847|NCT01194219|10812173|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
6808848|NCT01194219|10812174|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
6808849|NCT01194219|10812165|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
6808850|NCT01194219|10812166|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
6808851|NCT01194219|10812167|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
6808852|NCT01194219|10812168|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
6808853|NCT01194219|10812169|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1
6808854|NCT01194219|10812170|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
6808855|NCT01194219|10812171|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2
6808856|NCT01194219|10812172|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
6808857|NCT01194219|10812173|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
6808858|NCT01194219|10812174|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
6808859|NCT01194219|10812165|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
6808860|NCT01194219|10812166|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
6808861|NCT01194219|10812167|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
6808862|NCT01194219|10812168|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
6808863|NCT01194219|10812169|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1
6808864|NCT01194219|10812170|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
6808865|NCT01194219|10812171|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12
6808866|NCT01194219|10812172|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6
6808867|NCT01194219|10812173|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
6808868|NCT01194219|10812174|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
6808869|NCT01194219|10812165|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
6808870|NCT01194219|10812166|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
6808871|NCT01194219|10812167|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
6808872|NCT01194219|10812168|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
6808873|NCT01194219|10812169|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1
6808874|NCT01194219|10812170|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2
6808875|NCT01194219|10812171|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5
6808876|NCT01194219|10812172|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
6808877|NCT01194219|10812173|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
6808878|NCT01194219|10812174|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
6808879|NCT01194219|10812165|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
6808880|NCT01194219|10812166|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
6808881|NCT01194219|10812167|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
6808882|NCT01194219|10812168|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
6808883|NCT01194219|10812169|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
6808884|NCT01194219|10812170|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
6808885|NCT01194219|10812171|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
6808886|NCT01194219|10812172|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1
6808887|NCT01194219|10812173|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
6808888|NCT01194219|10812174|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
6808889|NCT01194219|10812165|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0
6808890|NCT01194219|10812166|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0
6808891|NCT01194219|10812167|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0
6808892|NCT01194219|10812168|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0
6808893|NCT01194219|10812169|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0
6795840|NCT00676494|10795445|FG000|Overall Study|Missed Visit|8
6795841|NCT00676494|10795445|FG000|Overall Study|Withdrawal by Subject|6
6795844|NCT00581477|10795465|FG000|Overall Study|Physician Decision|2
6795851|NCT00495131|10795529|FG000|Overall Study|Adverse Event|6
6795852|NCT00495131|10795530|FG001|Overall Study|Adverse Event|2
6795853|NCT00495131|10795529|FG000|Overall Study|Lack of Efficacy|0
6795854|NCT00495131|10795530|FG001|Overall Study|Lack of Efficacy|2
6795855|NCT00495131|10795529|FG000|Overall Study|Lost to Follow-up|0
6795856|NCT00495131|10795530|FG001|Overall Study|Lost to Follow-up|2
6795857|NCT00495131|10795529|FG000|Overall Study|Withdrawal by Subject|1
6795858|NCT00495131|10795530|FG001|Overall Study|Withdrawal by Subject|0
6795859|NCT00484419|10795544|FG000|Overall Study|Adverse Event|3
6795860|NCT00484419|10795545|FG001|Overall Study|Adverse Event|0
6795861|NCT00484419|10795546|FG002|Overall Study|Adverse Event|0
6795862|NCT00484419|10795544|FG000|Overall Study|Lost to Follow-up|1
6795863|NCT00484419|10795545|FG001|Overall Study|Lost to Follow-up|0
6795864|NCT00484419|10795546|FG002|Overall Study|Lost to Follow-up|2
6795865|NCT00484419|10795544|FG000|Overall Study|Withdrawal by Subject|3
6795866|NCT00484419|10795545|FG001|Overall Study|Withdrawal by Subject|1
6795867|NCT00484419|10795546|FG002|Overall Study|Withdrawal by Subject|1
6795868|NCT00484419|10795544|FG000|Overall Study|subject met discontinuation criteria|2
6795869|NCT00484419|10795545|FG001|Overall Study|subject met discontinuation criteria|2
6795870|NCT00484419|10795546|FG002|Overall Study|subject met discontinuation criteria|4
6795871|NCT00484419|10795544|FG000|Overall Study|required restricted medication|1
6795872|NCT00484419|10795545|FG001|Overall Study|required restricted medication|0
6795873|NCT00484419|10795546|FG002|Overall Study|required restricted medication|1
6795874|NCT00484419|10795544|FG000|Overall Study|Physician Decision|1
6795875|NCT00484419|10795545|FG001|Overall Study|Physician Decision|1
6795876|NCT00484419|10795546|FG002|Overall Study|Physician Decision|1
6795877|NCT00484419|10795544|FG000|Overall Study|subject unable to receive medication|1
6795878|NCT00484419|10795545|FG001|Overall Study|subject unable to receive medication|0
6795879|NCT00484419|10795546|FG002|Overall Study|subject unable to receive medication|0
6795880|NCT00484419|10795544|FG000|Overall Study|subject relocated|0
6795881|NCT00484419|10795545|FG001|Overall Study|subject relocated|1
6795882|NCT00484419|10795546|FG002|Overall Study|subject relocated|0
6795883|NCT00484419|10795544|FG000|Overall Study|sponsor decision, randomized in error|0
6795884|NCT00484419|10795545|FG001|Overall Study|sponsor decision, randomized in error|0
6795885|NCT00484419|10795546|FG002|Overall Study|sponsor decision, randomized in error|2
6795886|NCT00474188|10795558|FG000|Overall Study|Withdrawal by Subject|1
6795887|NCT00474188|10795558|FG000|Overall Study|Study discontinued by sponsor|5
6795888|NCT00440531|10795564|FG000|Overall Study|Adverse Event|1
6795889|NCT00440531|10795565|FG001|Overall Study|Adverse Event|0
6795890|NCT00440531|10795566|FG002|Overall Study|Adverse Event|2
6795891|NCT00440531|10795564|FG000|Overall Study|Withdrawal by Subject|2
6795892|NCT00440531|10795565|FG001|Overall Study|Withdrawal by Subject|0
6795893|NCT00440531|10795566|FG002|Overall Study|Withdrawal by Subject|0
6795894|NCT00440531|10795564|FG000|Overall Study|Protocol Violation|1
6795895|NCT00440531|10795565|FG001|Overall Study|Protocol Violation|2
6795896|NCT00440531|10795566|FG002|Overall Study|Protocol Violation|0
6795897|NCT00440531|10795564|FG000|Overall Study|Lost to Follow-up|4
6795898|NCT00440531|10795565|FG001|Overall Study|Lost to Follow-up|3
6795899|NCT00440531|10795566|FG002|Overall Study|Lost to Follow-up|5
6795900|NCT00440531|10795564|FG000|Overall Study|see pre-assignment details|2
6795901|NCT00440531|10795565|FG001|Overall Study|see pre-assignment details|0
6795902|NCT00440531|10795566|FG002|Overall Study|see pre-assignment details|0
6795903|NCT00439738|10795574|FG000|Overall Study|Withdrawal by Subject|16
6795904|NCT00439738|10795575|FG001|Overall Study|Withdrawal by Subject|13
6795905|NCT00439738|10795574|FG000|Overall Study|Adverse Event|6
6795906|NCT00439738|10795575|FG001|Overall Study|Adverse Event|4
6795907|NCT00439738|10795574|FG000|Overall Study|Lost to Follow-up|5
6795908|NCT00439738|10795575|FG001|Overall Study|Lost to Follow-up|6
6795909|NCT00439738|10795574|FG000|Overall Study|Protocol Violation|6
6795910|NCT00439738|10795575|FG001|Overall Study|Protocol Violation|3
6795911|NCT00439738|10795574|FG000|Overall Study|Lack of Efficacy|2
6795912|NCT00439738|10795575|FG001|Overall Study|Lack of Efficacy|2
6795913|NCT00439738|10795574|FG000|Overall Study|Abnormal Lab Values|1
6795914|NCT00439738|10795575|FG001|Overall Study|Abnormal Lab Values|0
6795915|NCT00430950|10795588|FG000|Overall Study|Adverse Event|7
6795916|NCT00430950|10795589|FG001|Overall Study|Adverse Event|6
6795917|NCT00430950|10795588|FG000|Overall Study|Withdrawal by Subject|1
6795918|NCT00430950|10795589|FG001|Overall Study|Withdrawal by Subject|0
6795919|NCT00430950|10795588|FG000|Overall Study|concomitant medication,etc.|5
6795920|NCT00430950|10795589|FG001|Overall Study|concomitant medication,etc.|7
6795921|NCT00430508|10795597|FG000|Overall Study|Adverse Event|2
6795922|NCT00430508|10795598|FG001|Overall Study|Adverse Event|3
6795923|NCT00430508|10795599|FG002|Overall Study|Adverse Event|5
6795924|NCT00430508|10795600|FG003|Overall Study|Adverse Event|3
6795925|NCT00430508|10795597|FG000|Overall Study|Withdrawal by Subject|0
6795926|NCT00430508|10795598|FG001|Overall Study|Withdrawal by Subject|1
6795927|NCT00430508|10795599|FG002|Overall Study|Withdrawal by Subject|1
6795928|NCT00430508|10795600|FG003|Overall Study|Withdrawal by Subject|1
6795929|NCT00430508|10795597|FG000|Overall Study|responder at visit 4|0
6795930|NCT00430508|10795598|FG001|Overall Study|responder at visit 4|0
6795842|NCT00659061|10795453|FG000|Overall Study|Migration due to political unrest|21
6795843|NCT00659061|10795454|FG001|Overall Study|Migration due to political unrest|15
6795845|NCT00554190|10795486|FG000|Overall Study|Termination forms not completed|10
6795846|NCT00529152|10795506|FG000|Overall Study|Adverse Event|2
6795847|NCT00529152|10795506|FG000|Overall Study|Withdrawal by Subject|2
6795848|NCT00529152|10795506|FG000|Overall Study|Lost to Follow-up|1
6795849|NCT00526227|10795509|FG000|Overall Study|Device not implanted|1
6795850|NCT00526227|10795509|FG000|Overall Study|Death|1
6795931|NCT00430508|10795599|FG002|Overall Study|responder at visit 4|2
6795932|NCT00430508|10795600|FG003|Overall Study|responder at visit 4|0
6795933|NCT00430508|10795597|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0
6795934|NCT00430508|10795598|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
6795935|NCT00430508|10795599|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2
6795936|NCT00430508|10795600|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
6795937|NCT00430508|10795597|FG000|Overall Study|Other|1
6795938|NCT00430508|10795598|FG001|Overall Study|Other|1
6795939|NCT00430508|10795599|FG002|Overall Study|Other|3
6795940|NCT00430508|10795600|FG003|Overall Study|Other|0
6795941|NCT00430092|10795609|FG000|Overall Study|Adverse Event|0
6795942|NCT00430092|10795610|FG001|Overall Study|Adverse Event|0
6795943|NCT00430092|10795611|FG002|Overall Study|Adverse Event|1
6795944|NCT00430092|10795609|FG000|Overall Study|Lack of Efficacy|5
6795945|NCT00430092|10795610|FG001|Overall Study|Lack of Efficacy|2
6795946|NCT00430092|10795611|FG002|Overall Study|Lack of Efficacy|54
6795947|NCT00430092|10795609|FG000|Overall Study|Lost to Follow-up|1
6795948|NCT00430092|10795610|FG001|Overall Study|Lost to Follow-up|0
6795949|NCT00430092|10795611|FG002|Overall Study|Lost to Follow-up|0
6795950|NCT00430092|10795609|FG000|Overall Study|Protocol Violation|0
6795951|NCT00430092|10795610|FG001|Overall Study|Protocol Violation|1
6795952|NCT00430092|10795611|FG002|Overall Study|Protocol Violation|1
6795953|NCT00430092|10795609|FG000|Overall Study|Withdrawal by Subject|0
6795954|NCT00430092|10795610|FG001|Overall Study|Withdrawal by Subject|1
6795955|NCT00430092|10795611|FG002|Overall Study|Withdrawal by Subject|1
6795956|NCT00429923|10795619|FG000|Overall Study|Adverse Event|0
6795957|NCT00429923|10795620|FG001|Overall Study|Adverse Event|2
6795958|NCT00429923|10795621|FG002|Overall Study|Adverse Event|3
6795959|NCT00429923|10795619|FG000|Overall Study|Lack of Efficacy|4
6795960|NCT00429923|10795620|FG001|Overall Study|Lack of Efficacy|1
6795961|NCT00429923|10795621|FG002|Overall Study|Lack of Efficacy|33
6795962|NCT00429923|10795619|FG000|Overall Study|Lost to Follow-up|0
6795963|NCT00429923|10795620|FG001|Overall Study|Lost to Follow-up|0
6795964|NCT00429923|10795621|FG002|Overall Study|Lost to Follow-up|2
6795965|NCT00429923|10795619|FG000|Overall Study|Withdrew Consent|1
6795966|NCT00429923|10795620|FG001|Overall Study|Withdrew Consent|0
6795967|NCT00429923|10795621|FG002|Overall Study|Withdrew Consent|1
6795968|NCT00429923|10795619|FG000|Overall Study|Early Termination|0
6795969|NCT00429923|10795620|FG001|Overall Study|Early Termination|1
6795970|NCT00429923|10795621|FG002|Overall Study|Early Termination|0
6795971|NCT00425100|10795626|FG000|Overall Study|Adverse Event|36
6795972|NCT00425100|10795626|FG000|Overall Study|Lack of Efficacy|4
6795973|NCT00425100|10795626|FG000|Overall Study|Lost to Follow-up|2
6795974|NCT00425100|10795626|FG000|Overall Study|Protocol Violation|4
6795975|NCT00425100|10795626|FG000|Overall Study|Withdrawal by Subject|7
6795976|NCT00415623|10795633|FG000|Overall Study|Adverse Event|3
6795977|NCT00415623|10795634|FG001|Overall Study|Adverse Event|4
6795978|NCT00415623|10795633|FG000|Overall Study|Death|1
6795979|NCT00415623|10795634|FG001|Overall Study|Death|0
6795980|NCT00415623|10795633|FG000|Overall Study|Withdrawal by Subject|1
6795981|NCT00415623|10795634|FG001|Overall Study|Withdrawal by Subject|1
6795982|NCT00412932|10795641|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1
6795983|NCT00412932|10795641|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2
6795984|NCT00412932|10795641|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1
6795985|NCT00412932|10795641|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2
6795986|NCT00412932|10795641|FG000|Olmesartan (Olm) 20 mg|Other|1
6795987|NCT00412932|10795641|FG000|Olmesartan 40 mg|Adverse Event|4
6795988|NCT00412932|10795641|FG000|Olmesartan 40 mg|Lack of Efficacy|3
6795989|NCT00412932|10795641|FG000|Olmesartan 40 mg|Withdrawal by Subject|1
6795990|NCT00412932|10795641|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3
6795991|NCT00412932|10795641|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3
6795992|NCT00412932|10795641|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1
6795993|NCT00412932|10795641|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1
6795994|NCT00397254|10795644|FG000|Overall Study|Lost to Follow-up|2
6795995|NCT00397254|10795645|FG001|Overall Study|Lost to Follow-up|2
6808894|NCT01194219|10812170|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0
6808895|NCT01194219|10812171|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1
6808896|NCT01194219|10812172|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0
6808897|NCT01194219|10812173|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0
6808898|NCT01194219|10812174|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0
6808899|NCT01194219|10812165|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0
6808900|NCT01194219|10812166|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0
6808901|NCT01194219|10812167|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0
6808902|NCT01194219|10812168|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0
6808903|NCT01194219|10812169|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0
6795996|NCT00338104|10795673|FG000|Overall Study|Protocol Violation|2
6795997|NCT00338104|10795674|FG001|Overall Study|Protocol Violation|1
6795998|NCT00338104|10795675|FG002|Overall Study|Protocol Violation|3
6796041|NCT00235326|10795793|FG000|Overall Study|Lost to Follow-up|746
6796042|NCT00235326|10795794|FG001|Overall Study|Lost to Follow-up|1400
6796043|NCT00232141|10795800|FG000|Overall Study|Adverse Event|9
6796044|NCT00232141|10795801|FG001|Overall Study|Adverse Event|4
6796045|NCT00232141|10795800|FG000|Overall Study|Lack of Efficacy|0
6796046|NCT00232141|10795801|FG001|Overall Study|Lack of Efficacy|3
6796047|NCT00232141|10795800|FG000|Overall Study|Lost to Follow-up|9
6796048|NCT00232141|10795801|FG001|Overall Study|Lost to Follow-up|6
6796049|NCT00232141|10795800|FG000|Overall Study|Other|8
6796050|NCT00232141|10795801|FG001|Overall Study|Other|10
6796051|NCT00232141|10795800|FG000|Overall Study|Withdrawal by Subject|5
6796052|NCT00232141|10795801|FG001|Overall Study|Withdrawal by Subject|3
6796053|NCT00224003|10795812|FG000|Overall Study|Adverse Event|1
6796054|NCT00224003|10795812|FG000|Overall Study|Protocol Violation|2
6796055|NCT00224003|10795812|FG000|Overall Study|Withdrawal by Subject|1
6796056|NCT00224003|10795812|FG000|Overall Study|unk|3
6796057|NCT00162942|10795817|FG000|Overall Study|Adverse Event|10
6796058|NCT00162942|10795818|FG001|Overall Study|Adverse Event|6
6796059|NCT00162942|10795817|FG000|Overall Study|Death|1
6796060|NCT00162942|10795818|FG001|Overall Study|Death|0
6796061|NCT00162942|10795817|FG000|Overall Study|Withdrawal by Subject|3
6796062|NCT00162942|10795818|FG001|Overall Study|Withdrawal by Subject|6
6796063|NCT00162942|10795817|FG000|Overall Study|Physician Decision|1
6796064|NCT00162942|10795818|FG001|Overall Study|Physician Decision|0
6796065|NCT00162942|10795817|FG000|Overall Study|Enter Open-Label Study|76
6796066|NCT00162942|10795818|FG001|Overall Study|Enter Open-Label Study|35
6796067|NCT00162942|10795817|FG000|Overall Study|Alternate Therapy|6
6796068|NCT00162942|10795818|FG001|Overall Study|Alternate Therapy|2
6796069|NCT00162942|10795817|FG000|Overall Study|Lack of Efficacy|1
6796070|NCT00162942|10795818|FG001|Overall Study|Lack of Efficacy|0
6796071|NCT00162942|10795817|FG000|Overall Study|Flare During Active Treatment|7
6796072|NCT00162942|10795818|FG001|Overall Study|Flare During Active Treatment|3
6796073|NCT00162942|10795817|FG000|Overall Study|2 or more consecutive treatments missed|1
6796074|NCT00162942|10795818|FG001|Overall Study|2 or more consecutive treatments missed|0
6796075|NCT00126776|10795838|FG000|Overall Study|follow up complete on all patients|0
6796076|NCT00126776|10795839|FG001|Overall Study|follow up complete on all patients|0
6796077|NCT00120042|10795846|FG000|Overall Study|all completed protocl|0
6796078|NCT00120042|10795847|FG001|Overall Study|all completed protocl|0
6796079|NCT00120042|10795848|FG002|Overall Study|all completed protocl|0
6796080|NCT00106626|10795857|FG000|Overall Study|Adverse Event|5
6796081|NCT00106626|10795858|FG001|Overall Study|Adverse Event|4
6796082|NCT00106626|10795859|FG002|Overall Study|Adverse Event|3
6796083|NCT00106626|10795860|FG003|Overall Study|Adverse Event|3
6796084|NCT00106626|10795857|FG000|Overall Study|Progressive Disease|4
6796085|NCT00106626|10795858|FG001|Overall Study|Progressive Disease|1
6796086|NCT00106626|10795859|FG002|Overall Study|Progressive Disease|9
6796087|NCT00106626|10795860|FG003|Overall Study|Progressive Disease|10
6796088|NCT00106626|10795857|FG000|Overall Study|Received radiation on new therapy|1
6796089|NCT00106626|10795858|FG001|Overall Study|Received radiation on new therapy|0
6796090|NCT00106626|10795859|FG002|Overall Study|Received radiation on new therapy|0
6796091|NCT00106626|10795860|FG003|Overall Study|Received radiation on new therapy|0
6796092|NCT00106626|10795857|FG000|Overall Study|> 14 day delay in therapy start|0
6796093|NCT00106626|10795858|FG001|Overall Study|> 14 day delay in therapy start|1
6796094|NCT00106626|10795859|FG002|Overall Study|> 14 day delay in therapy start|0
6796095|NCT00106626|10795860|FG003|Overall Study|> 14 day delay in therapy start|0
6796096|NCT00089141|10795877|FG000|Overall Study|Termination of trial|18
6796097|NCT00089141|10795878|FG001|Overall Study|Termination of trial|24
6796098|NCT00083759|10795884|FG000|Overall Study|Adverse Event|5
6796099|NCT00083759|10795885|FG001|Overall Study|Adverse Event|3
6796100|NCT00083759|10795884|FG000|Overall Study|Lost to Follow-up|1
6796101|NCT00083759|10795885|FG001|Overall Study|Lost to Follow-up|0
6796102|NCT00083759|10795884|FG000|Overall Study|Death|1
6796103|NCT00083759|10795885|FG001|Overall Study|Death|1
6796104|NCT00083759|10795884|FG000|Overall Study|Inadequate Therapeutic Response|32
6796105|NCT00083759|10795885|FG001|Overall Study|Inadequate Therapeutic Response|35
6796106|NCT00083759|10795884|FG000|Overall Study|Subject Withdrew Consent|2
6796107|NCT00083759|10795885|FG001|Overall Study|Subject Withdrew Consent|2
6796108|NCT00083759|10795884|FG000|Overall Study|Non-Compliance|1
6796109|NCT00083759|10795885|FG001|Overall Study|Non-Compliance|0
6796110|NCT00083759|10795884|FG000|Overall Study|Sponsor's Discretion|28
6796111|NCT00083759|10795885|FG001|Overall Study|Sponsor's Discretion|29
6796112|NCT00083759|10795884|FG000|Overall Study|Other|14
6796113|NCT00083759|10795885|FG001|Overall Study|Other|13
6796114|NCT03513068|10795891|FG000|Overall Study|Death|1
6796115|NCT03513068|10795892|FG001|Overall Study|Death|0
6796116|NCT03513068|10795891|FG000|Overall Study|Withdrawal by Subject|4
6796117|NCT03513068|10795892|FG001|Overall Study|Withdrawal by Subject|6
6796118|NCT03507127|10795900|FG000|Overall Study|Withdrawal by Subject|1
6796119|NCT03507127|10795901|FG001|Overall Study|Withdrawal by Subject|0
6796120|NCT03507127|10795900|FG000|Overall Study|Unable to meet smoking abstinence criterion|1
6796121|NCT03507127|10795901|FG001|Overall Study|Unable to meet smoking abstinence criterion|1
6795999|NCT00326183|10795685|FG000|Overall Study|Lost to Follow-up|104
6796000|NCT00326183|10795686|FG001|Overall Study|Lost to Follow-up|56
6796001|NCT00326183|10795685|FG000|Overall Study|Protocol Violation|6
6796002|NCT00326183|10795686|FG001|Overall Study|Protocol Violation|3
6796003|NCT00326183|10795685|FG000|Overall Study|Withdrawal by Subject|35
6796004|NCT00326183|10795686|FG001|Overall Study|Withdrawal by Subject|7
6796005|NCT00326183|10795685|FG000|Overall Study|Subject Moved|7
6796006|NCT00326183|10795686|FG001|Overall Study|Subject Moved|4
6796007|NCT00326183|10795685|FG000|Overall Study|Other|47
6796008|NCT00326183|10795686|FG001|Overall Study|Other|13
6796009|NCT00326183|10795685|FG000|Overall Study|Adverse Event|1
6796010|NCT00326183|10795686|FG001|Overall Study|Adverse Event|0
6796011|NCT00318656|10795699|FG000|Overall Study|Took Avandamet instead of Glim/Met|0
6796012|NCT00318656|10795700|FG001|Overall Study|Took Avandamet instead of Glim/Met|1
6796013|NCT00318656|10795699|FG000|Overall Study|Did not receive any treatment|0
6796014|NCT00318656|10795700|FG001|Overall Study|Did not receive any treatment|1
6796015|NCT00301262|10795706|FG000|Double Blind Phase (DB)|Adverse Event|1
6796016|NCT00301262|10795707|FG001|Double Blind Phase (DB)|Adverse Event|0
6796017|NCT00301262|10795706|FG000|Double Blind Phase (DB)|Lack of Efficacy|0
6796018|NCT00301262|10795707|FG001|Double Blind Phase (DB)|Lack of Efficacy|1
6796019|NCT00301262|10795706|FG000|Double Blind Phase (DB)|Lost to Follow-up|3
6796020|NCT00301262|10795707|FG001|Double Blind Phase (DB)|Lost to Follow-up|3
6796021|NCT00301262|10795706|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5
6796022|NCT00301262|10795707|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5
6796023|NCT00301262|10795706|FG000|Double Blind Phase (DB)|Other|1
6796024|NCT00301262|10795707|FG001|Double Blind Phase (DB)|Other|4
6796025|NCT00301262|10795706|FG000|Open Label Phase (OL)|Adverse Event|1
6796026|NCT00301262|10795707|FG001|Open Label Phase (OL)|Adverse Event|0
6796027|NCT00301262|10795706|FG000|Open Label Phase (OL)|Lost to Follow-up|1
6796028|NCT00301262|10795707|FG001|Open Label Phase (OL)|Lost to Follow-up|2
6796029|NCT00301262|10795706|FG000|Open Label Phase (OL)|Other|2
6796030|NCT00301262|10795707|FG001|Open Label Phase (OL)|Other|0
6796031|NCT00283868|10795734|FG000|Overall Study|Lost to Follow-up|7
6796032|NCT00283868|10795735|FG001|Overall Study|Lost to Follow-up|8
6796033|NCT00282867|10795742|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
6796034|NCT00282867|10795743|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
6796035|NCT00282867|10795744|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0
6796036|NCT00275340|10795751|FG000|Overall Study|Lost to Follow-up|2
6796037|NCT00275340|10795752|FG001|Overall Study|Lost to Follow-up|4
6796038|NCT00271544|10795756|FG000|Overall Study|Subjects did not receive a 4196 lead|7
6796039|NCT00271544|10795756|FG000|Overall Study|Model 4196 lead not attempted|9
6796040|NCT00271544|10795756|FG000|Overall Study|Implant not attempted|4
6796122|NCT03502811|10795907|FG000|Overall Study|Death|157
6796123|NCT03502811|10795907|FG000|Overall Study|Withdrawal by Subject|105
6796124|NCT03502811|10795907|FG000|Overall Study|Lost to Follow-up|26
6796125|NCT03502811|10795907|FG000|Overall Study|No Visits (Missed)|31
6808904|NCT01194219|10812170|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0
6808905|NCT01194219|10812171|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0
6808906|NCT01194219|10812172|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0
6808907|NCT01194219|10812173|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25
6808908|NCT01194219|10812174|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14
6808909|NCT01194219|10812165|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
6808910|NCT01194219|10812166|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
6808911|NCT01194219|10812167|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
6808912|NCT01194219|10812168|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
6808913|NCT01194219|10812169|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
6808914|NCT01194219|10812170|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
6808915|NCT01194219|10812171|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
6808916|NCT01194219|10812172|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
6808917|NCT01194219|10812173|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81
6808918|NCT01194219|10812174|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49
6808919|NCT01194219|10812165|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
6808920|NCT01194219|10812166|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
6808921|NCT01194219|10812167|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
6808922|NCT01194219|10812168|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
6808923|NCT01194219|10812169|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
6808924|NCT01194219|10812170|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
6808925|NCT01194219|10812171|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
6808926|NCT01194219|10812172|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
6808927|NCT01194219|10812173|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9
6808928|NCT01194219|10812174|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4
6808929|NCT01194219|10812165|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
6808930|NCT01194219|10812166|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
6808931|NCT01194219|10812167|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
6808932|NCT01194219|10812168|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
6808933|NCT01194219|10812169|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
6808934|NCT01194219|10812170|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
6796126|NCT04428333|10795932|FG000|Overall Study|Physician Decision|2
6796127|NCT04428333|10795933|FG001|Overall Study|Physician Decision|0
6796128|NCT04428333|10795932|FG000|Overall Study|Withdrawal by Subject|0
6796129|NCT04428333|10795933|FG001|Overall Study|Withdrawal by Subject|1
6796130|NCT04428333|10795932|FG000|Overall Study|In Follow-Up|5
6796131|NCT04428333|10795933|FG001|Overall Study|In Follow-Up|10
6796132|NCT04428333|10795932|FG000|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|47
6796133|NCT04428333|10795933|FG001|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|47
6796134|NCT03530995|10795941|FG000|Part 1 Period 3|Withdrawal by Subject|2
6796135|NCT03530995|10795942|FG001|Part 1 Period 3|Withdrawal by Subject|0
6796136|NCT03530995|10795941|FG000|Part 1 Period 3|Protocol Violation|1
6796137|NCT03530995|10795942|FG001|Part 1 Period 3|Protocol Violation|0
6796138|NCT03530995|10795941|FG000|Part 1 Period 4|Physician Decision|1
6796139|NCT03530995|10795942|FG001|Part 1 Period 4|Physician Decision|0
6796140|NCT03530995|10795941|FG000|Part 1 Period 4|Withdrawal by Subject|1
6796141|NCT03530995|10795942|FG001|Part 1 Period 4|Withdrawal by Subject|0
6796142|NCT03204812|10795972|FG000|Overall Study|Adverse Event|3
6796143|NCT03199391|10795976|FG000|Overall Study|Death|1
6796144|NCT03199391|10795976|FG000|Overall Study|Lost to Follow-up|3
6796145|NCT03199391|10795976|FG000|Overall Study|Adverse Event|2
6796146|NCT03199391|10795976|FG000|Overall Study|Withdrawal by Subject|10
6796147|NCT03084471|10795980|FG000|Overall Study|Development of study specific discontinuation criteria|2
6796148|NCT03084471|10795980|FG000|Overall Study|Condition under investigation worsened|84
6796149|NCT03084471|10795980|FG000|Overall Study|Lack of therapeutic response|2
6796150|NCT03084471|10795980|FG000|Overall Study|Protocol Violation|1
6796151|NCT03084471|10795980|FG000|Overall Study|Adverse Event|73
6796152|NCT03084471|10795980|FG000|Overall Study|Withdrawal by Subject|12
6796153|NCT03084471|10795980|FG000|Overall Study|Disease relapse|181
6796154|NCT03084471|10795980|FG000|Overall Study|Subjective disease progression|359
6796155|NCT03084471|10795980|FG000|Overall Study|Other (as recorded)|33
6796156|NCT03084471|10795980|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120
6796157|NCT03072459|10795987|FG000|Overall Study|Device revised/removed|1
6796158|NCT03072459|10795987|FG000|Overall Study|Subject not able to return|1
6796159|NCT03029234|10795991|FG000|Overall Study|Sponsor Decision|1
6796160|NCT03029234|10795991|FG000|Overall Study|Withdrawal by Subject|5
6796161|NCT03029234|10795991|FG000|Overall Study|Death|91
6796162|NCT03029234|10795991|FG000|Overall Study|Lost to Follow-up|2
6796163|NCT03019406|10795999|FG000|ETP: Ongoing From Week 26|Ongoing|6
6796164|NCT03019406|10796000|FG001|ETP: Ongoing From Week 26|Ongoing|5
6796165|NCT03019406|10796001|FG002|ETP: Ongoing From Week 26|Ongoing|5
6796166|NCT03019406|10796002|FG003|ETP: Ongoing From Week 26|Ongoing|3
6796167|NCT02874144|10796017|FG000|Overall Study|Lost to Follow-up|3
6796168|NCT02874144|10796018|FG001|Overall Study|Lost to Follow-up|5
6796195|NCT02611830|10796049|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9
6796196|NCT02611830|10796050|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0
6796197|NCT02611830|10796051|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0
6796198|NCT02611830|10796052|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0
6796199|NCT02611830|10796049|FG000|OL Induction Phase|Significant Protocol Deviation|4
6796200|NCT02611830|10796050|FG001|OL Induction Phase|Significant Protocol Deviation|0
6796201|NCT02611830|10796051|FG002|OL Induction Phase|Significant Protocol Deviation|0
6796202|NCT02611830|10796052|FG003|OL Induction Phase|Significant Protocol Deviation|0
6796203|NCT02611830|10796049|FG000|OL Induction Phase|Voluntary Withdrawal|5
6796204|NCT02611830|10796050|FG001|OL Induction Phase|Voluntary Withdrawal|0
6796205|NCT02611830|10796051|FG002|OL Induction Phase|Voluntary Withdrawal|0
6796206|NCT02611830|10796052|FG003|OL Induction Phase|Voluntary Withdrawal|0
6796207|NCT02611830|10796049|FG000|OL Induction Phase|Lack of Efficacy|9
6796208|NCT02611830|10796050|FG001|OL Induction Phase|Lack of Efficacy|0
6796209|NCT02611830|10796051|FG002|OL Induction Phase|Lack of Efficacy|0
6796210|NCT02611830|10796052|FG003|OL Induction Phase|Lack of Efficacy|0
6796211|NCT02611830|10796049|FG000|OL Induction Phase|Reason not specified|3
6796212|NCT02611830|10796050|FG001|OL Induction Phase|Reason not specified|0
6796213|NCT02611830|10796051|FG002|OL Induction Phase|Reason not specified|0
6796214|NCT02611830|10796052|FG003|OL Induction Phase|Reason not specified|0
6796215|NCT02611830|10796049|FG000|Maintenance Phase|Lack of Efficacy|0
6796216|NCT02611830|10796050|FG001|Maintenance Phase|Lack of Efficacy|29
6796217|NCT02611830|10796051|FG002|Maintenance Phase|Lack of Efficacy|18
6796218|NCT02611830|10796052|FG003|Maintenance Phase|Lack of Efficacy|6
6796219|NCT02611830|10796049|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0
6796220|NCT02611830|10796050|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5
6796221|NCT02611830|10796051|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5
6796222|NCT02611830|10796052|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2
6796223|NCT02611830|10796049|FG000|Maintenance Phase|Significant Protocol Deviation|0
6796224|NCT02611830|10796050|FG001|Maintenance Phase|Significant Protocol Deviation|0
6796225|NCT02611830|10796051|FG002|Maintenance Phase|Significant Protocol Deviation|1
6796226|NCT02611830|10796052|FG003|Maintenance Phase|Significant Protocol Deviation|1
6796227|NCT02611830|10796049|FG000|Maintenance Phase|Lost to Follow-up|0
6796228|NCT02611830|10796050|FG001|Maintenance Phase|Lost to Follow-up|0
6796229|NCT02611830|10796051|FG002|Maintenance Phase|Lost to Follow-up|0
6796230|NCT02611830|10796052|FG003|Maintenance Phase|Lost to Follow-up|1
6796231|NCT02611830|10796049|FG000|Maintenance Phase|Voluntary Withdrawal|0
6796232|NCT02611830|10796050|FG001|Maintenance Phase|Voluntary Withdrawal|1
6796233|NCT02611830|10796051|FG002|Maintenance Phase|Voluntary Withdrawal|2
6796234|NCT02611830|10796052|FG003|Maintenance Phase|Voluntary Withdrawal|5
6796235|NCT02611830|10796049|FG000|Maintenance Phase|Pregnancy|0
6796236|NCT02611830|10796050|FG001|Maintenance Phase|Pregnancy|0
6796237|NCT02611830|10796051|FG002|Maintenance Phase|Pregnancy|1
6796238|NCT02611830|10796052|FG003|Maintenance Phase|Pregnancy|0
6796239|NCT02611830|10796049|FG000|Maintenance Phase|Reason not specified|0
6796240|NCT02611830|10796050|FG001|Maintenance Phase|Reason not specified|1
6796241|NCT02611830|10796051|FG002|Maintenance Phase|Reason not specified|4
6796242|NCT02611830|10796052|FG003|Maintenance Phase|Reason not specified|0
6796243|NCT02611817|10796064|FG000|Open-label Induction Phase|Reason not Specified|9
6796244|NCT02611817|10796065|FG001|Open-label Induction Phase|Reason not Specified|0
6796245|NCT02611817|10796066|FG002|Open-label Induction Phase|Reason not Specified|0
6796246|NCT02611817|10796064|FG000|Open-label Induction Phase|Lack of Efficacy|8
6796247|NCT02611817|10796065|FG001|Open-label Induction Phase|Lack of Efficacy|0
6796248|NCT02611817|10796066|FG002|Open-label Induction Phase|Lack of Efficacy|0
6796249|NCT02611817|10796064|FG000|Open-label Induction Phase|Pregnancy|1
6796250|NCT02611817|10796065|FG001|Open-label Induction Phase|Pregnancy|0
6796251|NCT02611817|10796066|FG002|Open-label Induction Phase|Pregnancy|0
6796252|NCT02611817|10796064|FG000|Open-label Induction Phase|Withdrawal by Subject|9
6796253|NCT02611817|10796065|FG001|Open-label Induction Phase|Withdrawal by Subject|0
6796254|NCT02611817|10796066|FG002|Open-label Induction Phase|Withdrawal by Subject|0
6796255|NCT02611817|10796064|FG000|Open-label Induction Phase|Lost to Follow-up|2
6796256|NCT02611817|10796065|FG001|Open-label Induction Phase|Lost to Follow-up|0
6796257|NCT02611817|10796066|FG002|Open-label Induction Phase|Lost to Follow-up|0
6796258|NCT02611817|10796064|FG000|Open-label Induction Phase|Protocol Violation|5
6796259|NCT02611817|10796065|FG001|Open-label Induction Phase|Protocol Violation|0
6796260|NCT02611817|10796066|FG002|Open-label Induction Phase|Protocol Violation|0
6796261|NCT02611817|10796064|FG000|Open-label Induction Phase|Adverse Event|16
6796262|NCT02611817|10796065|FG001|Open-label Induction Phase|Adverse Event|0
6796263|NCT02611817|10796066|FG002|Open-label Induction Phase|Adverse Event|0
6796264|NCT02611817|10796064|FG000|Double-blind Maintenance Phase|Adverse Event|0
6796265|NCT02611817|10796065|FG001|Double-blind Maintenance Phase|Adverse Event|12
6796266|NCT02611817|10796066|FG002|Double-blind Maintenance Phase|Adverse Event|11
6796267|NCT02611817|10796064|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0
6796268|NCT02611817|10796065|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1
6796269|NCT02611817|10796066|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0
6796270|NCT02611817|10796064|FG000|Double-blind Maintenance Phase|Reason not Specified|0
6796271|NCT02611817|10796065|FG001|Double-blind Maintenance Phase|Reason not Specified|1
6796272|NCT02611817|10796066|FG002|Double-blind Maintenance Phase|Reason not Specified|2
6796273|NCT02611817|10796064|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0
6796274|NCT02611817|10796065|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43
6796275|NCT02611817|10796066|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78
6796276|NCT02611817|10796064|FG000|Double-blind Maintenance Phase|Pregnancy|0
6796277|NCT02611817|10796065|FG001|Double-blind Maintenance Phase|Pregnancy|0
6796278|NCT02611817|10796066|FG002|Double-blind Maintenance Phase|Pregnancy|1
6796279|NCT02611817|10796064|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0
6796280|NCT02611817|10796065|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5
6796281|NCT02611817|10796066|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14
6796282|NCT02611817|10796064|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0
6796283|NCT02611817|10796065|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0
6796284|NCT02611817|10796066|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1
6796285|NCT02557139|10796076|FG000|Overall Study|Significant liver elevation|1
6796286|NCT02557139|10796077|FG001|Overall Study|Significant liver elevation|0
6796287|NCT02557139|10796078|FG002|Overall Study|Significant liver elevation|1
6796288|NCT02557139|10796076|FG000|Overall Study|Withdrawal by Subject|1
6796289|NCT02557139|10796077|FG001|Overall Study|Withdrawal by Subject|0
6796290|NCT02557139|10796078|FG002|Overall Study|Withdrawal by Subject|0
6796291|NCT02557139|10796076|FG000|Overall Study|Illness of prohibited medication|0
6796292|NCT02557139|10796077|FG001|Overall Study|Illness of prohibited medication|0
6796293|NCT02557139|10796078|FG002|Overall Study|Illness of prohibited medication|1
6796294|NCT02488759|10796101|FG000|Overall Study|Disease progression|74
6796295|NCT02488759|10796102|FG001|Overall Study|Disease progression|110
6796296|NCT02488759|10796103|FG002|Overall Study|Disease progression|62
6796297|NCT02488759|10796104|FG003|Overall Study|Disease progression|7
6796298|NCT02488759|10796105|FG004|Overall Study|Disease progression|4
6796299|NCT02488759|10796106|FG005|Overall Study|Disease progression|2
6796300|NCT02488759|10796101|FG000|Overall Study|Study drug toxicity|11
6796301|NCT02488759|10796102|FG001|Overall Study|Study drug toxicity|33
6796302|NCT02488759|10796103|FG002|Overall Study|Study drug toxicity|31
6796303|NCT02488759|10796104|FG003|Overall Study|Study drug toxicity|0
6796304|NCT02488759|10796105|FG004|Overall Study|Study drug toxicity|0
6796305|NCT02488759|10796106|FG005|Overall Study|Study drug toxicity|2
6796306|NCT02488759|10796101|FG000|Overall Study|Adverse event unrelated to study drug|9
6796307|NCT02488759|10796102|FG001|Overall Study|Adverse event unrelated to study drug|11
6796308|NCT02488759|10796103|FG002|Overall Study|Adverse event unrelated to study drug|7
6796309|NCT02488759|10796104|FG003|Overall Study|Adverse event unrelated to study drug|0
6796310|NCT02488759|10796105|FG004|Overall Study|Adverse event unrelated to study drug|1
6796311|NCT02488759|10796106|FG005|Overall Study|Adverse event unrelated to study drug|0
6796312|NCT02488759|10796101|FG000|Overall Study|Participant request to discontinue study treatment|7
6796313|NCT02488759|10796102|FG001|Overall Study|Participant request to discontinue study treatment|8
6796314|NCT02488759|10796103|FG002|Overall Study|Participant request to discontinue study treatment|4
6796315|NCT02488759|10796104|FG003|Overall Study|Participant request to discontinue study treatment|0
6796316|NCT02488759|10796105|FG004|Overall Study|Participant request to discontinue study treatment|0
6796317|NCT02488759|10796106|FG005|Overall Study|Participant request to discontinue study treatment|0
6796318|NCT02488759|10796101|FG000|Overall Study|Withdrawal by Subject|2
6796319|NCT02488759|10796102|FG001|Overall Study|Withdrawal by Subject|0
6796320|NCT02488759|10796103|FG002|Overall Study|Withdrawal by Subject|3
6796321|NCT02488759|10796104|FG003|Overall Study|Withdrawal by Subject|0
6796322|NCT02488759|10796105|FG004|Overall Study|Withdrawal by Subject|0
6796323|NCT02488759|10796106|FG005|Overall Study|Withdrawal by Subject|2
6796324|NCT02488759|10796101|FG000|Overall Study|Lost to Follow-up|0
6796325|NCT02488759|10796102|FG001|Overall Study|Lost to Follow-up|1
6796326|NCT02488759|10796103|FG002|Overall Study|Lost to Follow-up|2
6796327|NCT02488759|10796104|FG003|Overall Study|Lost to Follow-up|0
6796328|NCT02488759|10796105|FG004|Overall Study|Lost to Follow-up|0
6796329|NCT02488759|10796106|FG005|Overall Study|Lost to Follow-up|0
6796330|NCT02488759|10796101|FG000|Overall Study|Maximum clinical benefit|3
6796331|NCT02488759|10796102|FG001|Overall Study|Maximum clinical benefit|0
6796332|NCT02488759|10796103|FG002|Overall Study|Maximum clinical benefit|1
6796333|NCT02488759|10796104|FG003|Overall Study|Maximum clinical benefit|0
6796334|NCT02488759|10796105|FG004|Overall Study|Maximum clinical benefit|0
6796335|NCT02488759|10796106|FG005|Overall Study|Maximum clinical benefit|0
6796336|NCT02488759|10796101|FG000|Overall Study|Completed treatment|0
6796337|NCT02488759|10796102|FG001|Overall Study|Completed treatment|0
6796338|NCT02488759|10796103|FG002|Overall Study|Completed treatment|0
6796339|NCT02488759|10796104|FG003|Overall Study|Completed treatment|0
6796340|NCT02488759|10796105|FG004|Overall Study|Completed treatment|0
6796341|NCT02488759|10796106|FG005|Overall Study|Completed treatment|116
6796342|NCT02488759|10796101|FG000|Overall Study|Other reasons|5
6796343|NCT02488759|10796102|FG001|Overall Study|Other reasons|32
6796344|NCT02488759|10796103|FG002|Overall Study|Other reasons|21
6796345|NCT02488759|10796104|FG003|Overall Study|Other reasons|1
6796346|NCT02488759|10796105|FG004|Overall Study|Other reasons|1
6796347|NCT02488759|10796106|FG005|Overall Study|Other reasons|1
6796348|NCT02211131|10796122|FG000|Overall Study|Death|20
6796349|NCT02211131|10796123|FG001|Overall Study|Death|11
6796350|NCT02211131|10796122|FG000|Overall Study|Lost to Follow-up|1
6796351|NCT02211131|10796123|FG001|Overall Study|Lost to Follow-up|0
6796352|NCT02211131|10796122|FG000|Overall Study|Decision by Sponsor|1
6796353|NCT02211131|10796123|FG001|Overall Study|Decision by Sponsor|1
6796354|NCT02211131|10796122|FG000|Overall Study|Withdrawal by Subject|3
6796355|NCT02211131|10796123|FG001|Overall Study|Withdrawal by Subject|4
6796356|NCT02211131|10796122|FG000|Overall Study|Continuing on Study|49
6796357|NCT02211131|10796123|FG001|Overall Study|Continuing on Study|60
6796358|NCT02186847|10796138|FG000|Overall Study|Protocol Violation|3
6796359|NCT02186847|10796139|FG001|Overall Study|Protocol Violation|0
6796360|NCT02101034|10796150|FG000|Overall Study|Enrolled but did not start treatment|0
6796361|NCT02101034|10796151|FG001|Overall Study|Enrolled but did not start treatment|0
6796362|NCT02101034|10796152|FG002|Overall Study|Enrolled but did not start treatment|1
6796363|NCT02101034|10796153|FG003|Overall Study|Enrolled but did not start treatment|0
6796364|NCT02101034|10796154|FG004|Overall Study|Enrolled but did not start treatment|0
6796365|NCT02041533|10796174|FG000|Overall Study|Disease Progression|168
6796366|NCT02041533|10796175|FG001|Overall Study|Disease Progression|142
6796367|NCT02041533|10796174|FG000|Overall Study|Study drug toxicity|27
6796368|NCT02041533|10796175|FG001|Overall Study|Study drug toxicity|30
6796369|NCT02041533|10796174|FG000|Overall Study|Death|1
6796370|NCT02041533|10796175|FG001|Overall Study|Death|0
6796371|NCT02041533|10796174|FG000|Overall Study|Adverse Event unrelated to study drug|20
6796372|NCT02041533|10796175|FG001|Overall Study|Adverse Event unrelated to study drug|21
6796373|NCT02041533|10796174|FG000|Overall Study|Subject request to discontinue treatment|5
6796374|NCT02041533|10796175|FG001|Overall Study|Subject request to discontinue treatment|9
6796375|NCT02041533|10796174|FG000|Overall Study|Withdrawal by Subject|2
6796376|NCT02041533|10796175|FG001|Overall Study|Withdrawal by Subject|1
6796377|NCT02041533|10796174|FG000|Overall Study|Maximum clinical benefit|0
6796378|NCT02041533|10796175|FG001|Overall Study|Maximum clinical benefit|18
6796379|NCT02041533|10796174|FG000|Overall Study|Poor/non-compliance|1
6796380|NCT02041533|10796175|FG001|Overall Study|Poor/non-compliance|0
6796381|NCT02041533|10796174|FG000|Overall Study|Other reasons|0
6796382|NCT02041533|10796175|FG001|Overall Study|Other reasons|1
6796383|NCT02041533|10796174|FG000|Overall Study|Completed max number of chemo cycles|0
6796384|NCT02041533|10796175|FG001|Overall Study|Completed max number of chemo cycles|29
6796385|NCT02041533|10796174|FG000|Overall Study|Randomized, not treated|4
6796386|NCT02041533|10796175|FG001|Overall Study|Randomized, not treated|7
6796387|NCT01865617|10796194|FG000|Overall Study|Death|27
6796388|NCT01865617|10796195|FG001|Overall Study|Death|3
6796389|NCT01865617|10796196|FG002|Overall Study|Death|1
6796390|NCT01865617|10796197|FG003|Overall Study|Death|1
6796391|NCT01865617|10796198|FG004|Overall Study|Death|5
6796392|NCT01865617|10796199|FG005|Overall Study|Death|1
6796393|NCT01865617|10796200|FG006|Overall Study|Death|11
6796394|NCT01865617|10796201|FG007|Overall Study|Death|1
6796395|NCT01865617|10796202|FG008|Overall Study|Death|11
6796396|NCT01865617|10796203|FG009|Overall Study|Death|3
6796397|NCT01865617|10796204|FG010|Overall Study|Death|32
6796398|NCT01865617|10796205|FG011|Overall Study|Death|6
6796399|NCT01865617|10796206|FG012|Overall Study|Death|13
6796400|NCT01865617|10796194|FG000|Overall Study|Lost to Follow-up|2
6796401|NCT01865617|10796195|FG001|Overall Study|Lost to Follow-up|0
6796402|NCT01865617|10796196|FG002|Overall Study|Lost to Follow-up|0
6796403|NCT01865617|10796197|FG003|Overall Study|Lost to Follow-up|0
6796404|NCT01865617|10796198|FG004|Overall Study|Lost to Follow-up|0
6796405|NCT01865617|10796199|FG005|Overall Study|Lost to Follow-up|0
6796406|NCT01865617|10796200|FG006|Overall Study|Lost to Follow-up|0
6796407|NCT01865617|10796201|FG007|Overall Study|Lost to Follow-up|0
6796408|NCT01865617|10796202|FG008|Overall Study|Lost to Follow-up|0
6796409|NCT01865617|10796203|FG009|Overall Study|Lost to Follow-up|0
6796410|NCT01865617|10796204|FG010|Overall Study|Lost to Follow-up|0
6796411|NCT01865617|10796205|FG011|Overall Study|Lost to Follow-up|0
6796412|NCT01865617|10796206|FG012|Overall Study|Lost to Follow-up|0
6796413|NCT01865617|10796194|FG000|Overall Study|Withdrawal by Subject|1
6796414|NCT01865617|10796195|FG001|Overall Study|Withdrawal by Subject|0
6796415|NCT01865617|10796196|FG002|Overall Study|Withdrawal by Subject|0
6796416|NCT01865617|10796197|FG003|Overall Study|Withdrawal by Subject|0
6796417|NCT01865617|10796198|FG004|Overall Study|Withdrawal by Subject|0
6796418|NCT01865617|10796199|FG005|Overall Study|Withdrawal by Subject|0
6796419|NCT01865617|10796200|FG006|Overall Study|Withdrawal by Subject|0
6796420|NCT01865617|10796201|FG007|Overall Study|Withdrawal by Subject|0
6796421|NCT01865617|10796202|FG008|Overall Study|Withdrawal by Subject|0
6796422|NCT01865617|10796203|FG009|Overall Study|Withdrawal by Subject|0
6796423|NCT01865617|10796204|FG010|Overall Study|Withdrawal by Subject|0
6796424|NCT01865617|10796205|FG011|Overall Study|Withdrawal by Subject|0
6796425|NCT01865617|10796206|FG012|Overall Study|Withdrawal by Subject|0
6796426|NCT01865617|10796194|FG000|Overall Study|Patient proceeded to new therapy|0
6796427|NCT01865617|10796195|FG001|Overall Study|Patient proceeded to new therapy|0
6796428|NCT01865617|10796196|FG002|Overall Study|Patient proceeded to new therapy|0
6796429|NCT01865617|10796197|FG003|Overall Study|Patient proceeded to new therapy|0
6796430|NCT01865617|10796198|FG004|Overall Study|Patient proceeded to new therapy|2
6796431|NCT01865617|10796199|FG005|Overall Study|Patient proceeded to new therapy|0
6796432|NCT01865617|10796200|FG006|Overall Study|Patient proceeded to new therapy|0
6796433|NCT01865617|10796201|FG007|Overall Study|Patient proceeded to new therapy|0
6796434|NCT01865617|10796202|FG008|Overall Study|Patient proceeded to new therapy|0
6796435|NCT01865617|10796203|FG009|Overall Study|Patient proceeded to new therapy|0
6796436|NCT01865617|10796204|FG010|Overall Study|Patient proceeded to new therapy|0
6796437|NCT01865617|10796205|FG011|Overall Study|Patient proceeded to new therapy|0
6796438|NCT01865617|10796206|FG012|Overall Study|Patient proceeded to new therapy|0
6796439|NCT01865617|10796194|FG000|Overall Study|Other|0
6796440|NCT01865617|10796195|FG001|Overall Study|Other|0
6796441|NCT01865617|10796196|FG002|Overall Study|Other|0
6796442|NCT01865617|10796197|FG003|Overall Study|Other|0
6796443|NCT01865617|10796198|FG004|Overall Study|Other|0
6796444|NCT01865617|10796199|FG005|Overall Study|Other|0
6796445|NCT01865617|10796200|FG006|Overall Study|Other|1
6796446|NCT01865617|10796201|FG007|Overall Study|Other|0
6796447|NCT01865617|10796202|FG008|Overall Study|Other|0
6796448|NCT01865617|10796203|FG009|Overall Study|Other|0
6796449|NCT01865617|10796204|FG010|Overall Study|Other|0
6796450|NCT01865617|10796205|FG011|Overall Study|Other|0
6796451|NCT01865617|10796206|FG012|Overall Study|Other|0
6796452|NCT01828112|10796239|FG000|Overall Study|Adverse Event|6
6796453|NCT01828112|10796240|FG001|Overall Study|Adverse Event|8
6796454|NCT01828112|10796239|FG000|Overall Study|Death|9
6796455|NCT01828112|10796240|FG001|Overall Study|Death|5
6796456|NCT01828112|10796239|FG000|Overall Study|Physician Decision|5
6796457|NCT01828112|10796240|FG001|Overall Study|Physician Decision|5
6796458|NCT01828112|10796239|FG000|Overall Study|Progressive disease|56
6796459|NCT01828112|10796240|FG001|Overall Study|Progressive disease|82
6796460|NCT01828112|10796239|FG000|Overall Study|Subject/guardian decision|6
6796461|NCT01828112|10796240|FG001|Overall Study|Subject/guardian decision|8
6796462|NCT01670500|10796274|FG000|Overall Study|Withdrawal by Subject|1
6796463|NCT01670500|10796275|FG001|Overall Study|Withdrawal by Subject|0
6796464|NCT01593254|10796283|FG000|Treatment Period|Treatment Failure|1
6796465|NCT01593254|10796284|FG001|Treatment Period|Treatment Failure|2
6796466|NCT01593254|10796283|FG000|Treatment Period|Pregnancy|0
6796467|NCT01593254|10796284|FG001|Treatment Period|Pregnancy|1
6796468|NCT01593254|10796283|FG000|Treatment Period|Poor/Non-Compliance|2
6796469|NCT01593254|10796284|FG001|Treatment Period|Poor/Non-Compliance|1
6796470|NCT01593254|10796283|FG000|Treatment Period|Maximum clinical benefit|1
6796471|NCT01593254|10796284|FG001|Treatment Period|Maximum clinical benefit|0
6796472|NCT01593254|10796283|FG000|Treatment Period|Subject withdrew consent|0
6796473|NCT01593254|10796284|FG001|Treatment Period|Subject withdrew consent|5
6796474|NCT01593254|10796283|FG000|Treatment Period|Subject Request to Discontinue|1
6796475|NCT01593254|10796284|FG001|Treatment Period|Subject Request to Discontinue|1
6796476|NCT01593254|10796283|FG000|Treatment Period|AE unrelated to Study Drug|0
6796477|NCT01593254|10796284|FG001|Treatment Period|AE unrelated to Study Drug|1
6796478|NCT01593254|10796283|FG000|Treatment Period|Death|2
6796479|NCT01593254|10796284|FG001|Treatment Period|Death|1
6796480|NCT01593254|10796283|FG000|Treatment Period|Study Drug Toxicity|3
6796481|NCT01593254|10796284|FG001|Treatment Period|Study Drug Toxicity|9
6796482|NCT01593254|10796283|FG000|Treatment Period|Disease Progression|1
6796483|NCT01593254|10796284|FG001|Treatment Period|Disease Progression|6
6796484|NCT01593254|10796283|FG000|Treatment Period|Did Not Achieve RCC|0
6796485|NCT01593254|10796284|FG001|Treatment Period|Did Not Achieve RCC|1
6796486|NCT01593254|10796283|FG000|Treatment Period|Patient Refused to Return|0
6796487|NCT01593254|10796284|FG001|Treatment Period|Patient Refused to Return|1
6796488|NCT01593254|10796283|FG000|Treatment Period|No Response|1
6796489|NCT01593254|10796284|FG001|Treatment Period|No Response|0
6796490|NCT01593254|10796283|FG000|Treatment Period|T315I MUTATION|0
6796491|NCT01593254|10796284|FG001|Treatment Period|T315I MUTATION|1
6796492|NCT01593254|10796283|FG000|Treatment Period|Investigator Decision|2
6796493|NCT01593254|10796284|FG001|Treatment Period|Investigator Decision|1
6796494|NCT01593254|10796283|FG000|Follow-Up Period|Withdrawal by Subject|0
6796495|NCT01593254|10796284|FG001|Follow-Up Period|Withdrawal by Subject|2
6796496|NCT01593254|10796283|FG000|Follow-Up Period|Non-Compliance|1
6796497|NCT01593254|10796284|FG001|Follow-Up Period|Non-Compliance|0
6796498|NCT01593254|10796283|FG000|Follow-Up Period|Death|2
6796499|NCT01593254|10796284|FG001|Follow-Up Period|Death|2
6796500|NCT01593254|10796283|FG000|Follow-Up Period|Subject request to Discontinue|0
6796501|NCT01593254|10796284|FG001|Follow-Up Period|Subject request to Discontinue|1
6796502|NCT01593254|10796283|FG000|Follow-Up Period|Pregnancy|0
6796503|NCT01593254|10796284|FG001|Follow-Up Period|Pregnancy|1
6796504|NCT01593254|10796283|FG000|Follow-Up Period|Study Drug Toxicity|0
6796505|NCT01593254|10796284|FG001|Follow-Up Period|Study Drug Toxicity|1
6796506|NCT01593254|10796283|FG000|Follow-Up Period|Patient refused to return|0
6796507|NCT01593254|10796284|FG001|Follow-Up Period|Patient refused to return|1
6796508|NCT01593254|10796283|FG000|Follow-Up Period|Fundus Hemorrhage|0
6796509|NCT01593254|10796284|FG001|Follow-Up Period|Fundus Hemorrhage|1
6796510|NCT01593254|10796283|FG000|Follow-Up Period|Disease Progression|0
6796511|NCT01593254|10796284|FG001|Follow-Up Period|Disease Progression|1
6796512|NCT01593254|10796283|FG000|Follow-Up Period|Study Drug Side Effects|0
6796513|NCT01593254|10796284|FG001|Follow-Up Period|Study Drug Side Effects|1
6808935|NCT01194219|10812171|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
6808936|NCT01194219|10812172|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
6808937|NCT01194219|10812173|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66
6808938|NCT01194219|10812174|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32
6808939|NCT01194219|10812165|FG000|Long-Term Extension Weeks 52 to 260|Death|0
6808940|NCT01194219|10812166|FG001|Long-Term Extension Weeks 52 to 260|Death|0
6808941|NCT01194219|10812167|FG002|Long-Term Extension Weeks 52 to 260|Death|0
6808942|NCT01194219|10812168|FG003|Long-Term Extension Weeks 52 to 260|Death|0
6808943|NCT01194219|10812169|FG004|Long-Term Extension Weeks 52 to 260|Death|0
6808944|NCT01194219|10812170|FG005|Long-Term Extension Weeks 52 to 260|Death|0
6808945|NCT01194219|10812171|FG006|Long-Term Extension Weeks 52 to 260|Death|0
6808946|NCT01194219|10812172|FG007|Long-Term Extension Weeks 52 to 260|Death|0
6808947|NCT01194219|10812173|FG008|Long-Term Extension Weeks 52 to 260|Death|1
6808948|NCT01194219|10812174|FG009|Long-Term Extension Weeks 52 to 260|Death|1
6808949|NCT01194219|10812165|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
6808950|NCT01194219|10812166|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
6808951|NCT01194219|10812167|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
6808952|NCT01194219|10812168|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
6808953|NCT01194219|10812169|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
6808954|NCT01194219|10812170|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
6808955|NCT01194219|10812171|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
6808956|NCT01194219|10812172|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
6808957|NCT01194219|10812173|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24
6808958|NCT01194219|10812174|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10
6808959|NCT01194219|10812165|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
6808960|NCT01194219|10812166|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
6808961|NCT01194219|10812167|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
6808962|NCT01194219|10812168|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
6808963|NCT01194219|10812169|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
6808964|NCT01194219|10812170|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
6808965|NCT01194219|10812171|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
6808966|NCT01194219|10812172|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
6808967|NCT01194219|10812173|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3
6808968|NCT01194219|10812174|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
6808969|NCT01194219|10812165|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
6808970|NCT01194219|10812166|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
6808971|NCT01194219|10812167|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
6808972|NCT01194219|10812168|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
6808973|NCT01194219|10812169|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
6808974|NCT01194219|10812170|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
6808975|NCT01194219|10812171|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
6808976|NCT01194219|10812172|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
6808977|NCT01194219|10812173|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11
6808978|NCT01194219|10812174|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2
6808979|NCT01193842|10812202|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
6808980|NCT01193842|10812203|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1
6808981|NCT01193842|10812204|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
6808982|NCT01193842|10812205|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
6808983|NCT01193842|10812206|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
6808984|NCT01193842|10812202|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1
6808985|NCT01193842|10812203|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
6808986|NCT01193842|10812204|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
6808987|NCT01193842|10812205|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
6796514|NCT04604184|10796297|FG000|Overall Study|Adverse Event|5
6796515|NCT04604184|10796298|FG001|Overall Study|Adverse Event|5
6796516|NCT04604184|10796297|FG000|Overall Study|Death|2
6796517|NCT04604184|10796298|FG001|Overall Study|Death|1
6796518|NCT04604184|10796297|FG000|Overall Study|Withdrawal by Subject|1
6796519|NCT04604184|10796298|FG001|Overall Study|Withdrawal by Subject|3
6796520|NCT04604184|10796297|FG000|Overall Study|Not treated|2
6796521|NCT04604184|10796298|FG001|Overall Study|Not treated|2
6796522|NCT04604184|10796297|FG000|Overall Study|Due to sponsor decision|9
6796523|NCT04604184|10796298|FG001|Overall Study|Due to sponsor decision|7
6796524|NCT04604184|10796297|FG000|Overall Study|Physician Decision|0
6796525|NCT04604184|10796298|FG001|Overall Study|Physician Decision|1
6796526|NCT04604184|10796297|FG000|Overall Study|Transfer to healthcare|1
6796527|NCT04604184|10796298|FG001|Overall Study|Transfer to healthcare|0
6796528|NCT04368429|10796306|FG000|Overall Study|Adverse Event|1
6796529|NCT04368429|10796307|FG001|Overall Study|Adverse Event|0
6796530|NCT03865316|10796321|FG000|Overall Study|Procedure Cancelled|4
6796531|NCT03865316|10796321|FG000|Overall Study|Equipment failure|4
6796532|NCT03688555|10796327|FG000|Treatment Period|Adverse Event|0
6796533|NCT03688555|10796328|FG001|Treatment Period|Adverse Event|0
6796534|NCT03688555|10796329|FG002|Treatment Period|Adverse Event|1
6796535|NCT03593213|10796339|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39
6796536|NCT03593213|10796340|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0
6796537|NCT03593213|10796341|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0
6796538|NCT03593213|10796342|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0
6796539|NCT03593213|10796339|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14
6796540|NCT03593213|10796340|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0
6796541|NCT03593213|10796341|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0
6796542|NCT03593213|10796342|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0
6796543|NCT03593213|10796339|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85
6796544|NCT03593213|10796340|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0
6796545|NCT03593213|10796341|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0
6796546|NCT03593213|10796342|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0
6796547|NCT03593213|10796339|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51
6796548|NCT03593213|10796340|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0
6796549|NCT03593213|10796341|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0
6796550|NCT03593213|10796342|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0
6796551|NCT03593213|10796339|FG000|Open-label Treatment Period (18 Weeks)|Death|1
6796552|NCT03593213|10796340|FG001|Open-label Treatment Period (18 Weeks)|Death|0
6796553|NCT03593213|10796341|FG002|Open-label Treatment Period (18 Weeks)|Death|0
6796554|NCT03593213|10796342|FG003|Open-label Treatment Period (18 Weeks)|Death|0
6796555|NCT03593213|10796339|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5
6796556|NCT03593213|10796340|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0
6796557|NCT03593213|10796341|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0
6796558|NCT03593213|10796342|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0
6796559|NCT03593213|10796339|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23
6796560|NCT03593213|10796340|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0
6796561|NCT03593213|10796341|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0
6796562|NCT03593213|10796342|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0
6796563|NCT03593213|10796339|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90
6796564|NCT03593213|10796340|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0
6796565|NCT03593213|10796341|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0
6796566|NCT03593213|10796342|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0
6796567|NCT03593213|10796339|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13
6796568|NCT03593213|10796340|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0
6796569|NCT03593213|10796341|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0
6796570|NCT03593213|10796342|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0
6796571|NCT03593213|10796339|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104
6796572|NCT03593213|10796340|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0
6796573|NCT03593213|10796341|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0
6796574|NCT03593213|10796342|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0
6796575|NCT03593213|10796339|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0
6796576|NCT03593213|10796340|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15
6796577|NCT03593213|10796341|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9
6796578|NCT03593213|10796342|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8
6796579|NCT03593213|10796339|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0
6796580|NCT03593213|10796340|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2
6796581|NCT03593213|10796341|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0
6796582|NCT03593213|10796342|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4
6796583|NCT03593213|10796339|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0
6796584|NCT03593213|10796340|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4
6796585|NCT03593213|10796341|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2
6796586|NCT03593213|10796342|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3
6796587|NCT03593213|10796339|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0
6796588|NCT03593213|10796340|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5
6796589|NCT03593213|10796341|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4
6796590|NCT03593213|10796342|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1
6796591|NCT03593213|10796339|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0
6796592|NCT03593213|10796340|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0
6796593|NCT03593213|10796341|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0
6796594|NCT03593213|10796342|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1
6796595|NCT03593213|10796339|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0
6796596|NCT03593213|10796340|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3
6796597|NCT03593213|10796341|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2
6796598|NCT03593213|10796342|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5
6796599|NCT03593213|10796339|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0
6796600|NCT03593213|10796340|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1
6796601|NCT03593213|10796341|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2
6796602|NCT03593213|10796342|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0
6796603|NCT03593213|10796339|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0
6796604|NCT03593213|10796340|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9
6796605|NCT03593213|10796341|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11
6796606|NCT03593213|10796342|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13
6796607|NCT03593213|10796339|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0
6796608|NCT03593213|10796340|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1
6796609|NCT03593213|10796341|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3
6796610|NCT03593213|10796342|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0
6796611|NCT03248531|10796391|FG000|Overall Study|Adverse Event|0
6796612|NCT03248531|10796392|FG001|Overall Study|Adverse Event|0
6796613|NCT03248531|10796393|FG002|Overall Study|Adverse Event|1
6796614|NCT03248531|10796391|FG000|Overall Study|Lost to Follow-up|1
6796615|NCT03248531|10796392|FG001|Overall Study|Lost to Follow-up|0
6796616|NCT03248531|10796393|FG002|Overall Study|Lost to Follow-up|5
6796617|NCT03248531|10796391|FG000|Overall Study|Withdrawal by Subject|3
6796618|NCT03248531|10796392|FG001|Overall Study|Withdrawal by Subject|3
6796619|NCT03248531|10796393|FG002|Overall Study|Withdrawal by Subject|2
6796620|NCT03248531|10796391|FG000|Overall Study|Sponsor Request|0
6796621|NCT03248531|10796392|FG001|Overall Study|Sponsor Request|2
6796622|NCT03248531|10796393|FG002|Overall Study|Sponsor Request|0
6796623|NCT03205605|10796408|FG000|Overall Study|Withdrawal by Subject|1
6808988|NCT01193842|10812206|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
6808989|NCT01193842|10812202|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
6808990|NCT01193842|10812203|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
6808991|NCT01193842|10812204|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1
6808992|NCT01193842|10812205|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
6808993|NCT01193842|10812206|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
6808994|NCT01193842|10812202|FG000|Phase II: Randomized Groups|Death|0
6808995|NCT01193842|10812203|FG001|Phase II: Randomized Groups|Death|0
6808996|NCT01193842|10812204|FG002|Phase II: Randomized Groups|Death|0
6808997|NCT01193842|10812205|FG003|Phase II: Randomized Groups|Death|1
6808998|NCT01193842|10812206|FG004|Phase II: Randomized Groups|Death|1
6808999|NCT01193842|10812202|FG000|Phase II: Randomized Groups|Adverse Event|0
6809000|NCT01193842|10812203|FG001|Phase II: Randomized Groups|Adverse Event|0
6809001|NCT01193842|10812204|FG002|Phase II: Randomized Groups|Adverse Event|0
6809002|NCT01193842|10812205|FG003|Phase II: Randomized Groups|Adverse Event|5
6809003|NCT01193842|10812206|FG004|Phase II: Randomized Groups|Adverse Event|3
6809004|NCT01193842|10812202|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0
6809005|NCT01193842|10812203|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0
6809006|NCT01193842|10812204|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0
6809007|NCT01193842|10812205|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1
6809008|NCT01193842|10812206|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2
6809009|NCT01193842|10812202|FG000|Phase II: Randomized Groups|Ineligible|0
6809010|NCT01193842|10812203|FG001|Phase II: Randomized Groups|Ineligible|0
6809011|NCT01193842|10812204|FG002|Phase II: Randomized Groups|Ineligible|0
6809012|NCT01193842|10812205|FG003|Phase II: Randomized Groups|Ineligible|0
6809013|NCT01193842|10812206|FG004|Phase II: Randomized Groups|Ineligible|1
6809014|NCT01193842|10812202|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
6809015|NCT01193842|10812203|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
6809016|NCT01193842|10812204|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
6809017|NCT01193842|10812205|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5
6809018|NCT01193842|10812206|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3
6809019|NCT00855803|10812223|FG000|Overall Study|Death|2
6796624|NCT02484456|10796424|FG000|Washout Period|Withdrawal by Subject|0
6796625|NCT02484456|10796425|FG001|Washout Period|Withdrawal by Subject|1
6796626|NCT02484456|10796424|FG000|Second Treatment Period: Week 1|Adverse Event|1
6796627|NCT02484456|10796425|FG001|Second Treatment Period: Week 1|Adverse Event|0
6796628|NCT02484456|10796424|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0
6796629|NCT02484456|10796425|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1
6796630|NCT02484456|10796424|FG000|Second Treatment Period: Week 2|Adverse Event|0
6796631|NCT02484456|10796425|FG001|Second Treatment Period: Week 2|Adverse Event|1
6796632|NCT02481830|10796434|FG000|Overall Study|No longer meets Study Criteria|1
6796633|NCT02481830|10796435|FG001|Overall Study|No longer meets Study Criteria|4
6796634|NCT02481830|10796434|FG000|Overall Study|Withdrawal by Subject|0
6796635|NCT02481830|10796435|FG001|Overall Study|Withdrawal by Subject|14
6796636|NCT02481830|10796434|FG000|Overall Study|Disease Progression|1
6796637|NCT02481830|10796435|FG001|Overall Study|Disease Progression|1
6796638|NCT02481830|10796434|FG000|Overall Study|Participant not eligible for trial|0
6796639|NCT02481830|10796435|FG001|Overall Study|Participant not eligible for trial|1
6796640|NCT02234323|10796441|FG000|All Enrolled|Not Treated: Completed study in database|2
6796641|NCT02234323|10796441|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2
6796642|NCT02234323|10796441|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1
6796643|NCT02234323|10796441|FG000|All Treated|Death|1
6796644|NCT02234323|10796441|FG000|All Treated|Physician Decision|5
6796645|NCT02234323|10796441|FG000|All Treated|Lack of Efficacy|3
6796646|NCT02234323|10796441|FG000|All Treated|Exceeded lab value limit|2
6796647|NCT02234323|10796441|FG000|All Treated|Other|7
6796648|NCT02220855|10796447|FG000|Overall Study|Adverse Event|8
6796649|NCT02220855|10796447|FG000|Overall Study|Disease Progression|5
6796650|NCT02220855|10796447|FG000|Overall Study|Withdrawal by Subject|1
6796651|NCT01791595|10796458|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1
6796652|NCT01791595|10796459|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0
6796653|NCT01791595|10796460|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0
6796654|NCT01791595|10796461|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0
6796655|NCT01791595|10796462|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0
6796656|NCT01791595|10796463|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0
6796657|NCT01791595|10796464|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0
6796658|NCT01791595|10796458|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2
6796659|NCT01791595|10796459|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0
6796660|NCT01791595|10796460|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0
6796661|NCT01791595|10796461|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0
6796662|NCT01791595|10796462|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0
6796663|NCT01791595|10796463|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0
6796664|NCT01791595|10796464|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0
6796665|NCT01791595|10796458|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0
6796666|NCT01791595|10796459|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5
6796667|NCT01791595|10796460|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0
6796668|NCT01791595|10796461|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0
6796669|NCT01791595|10796462|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0
6796670|NCT01791595|10796463|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0
6796671|NCT01791595|10796464|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0
6796672|NCT01791595|10796458|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0
6796673|NCT01791595|10796459|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0
6796674|NCT01791595|10796460|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1
6796675|NCT01791595|10796461|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0
6796676|NCT01791595|10796462|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0
6796677|NCT01791595|10796463|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0
6796678|NCT01791595|10796464|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0
6796679|NCT01791595|10796458|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0
6796680|NCT01791595|10796459|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0
6796681|NCT01791595|10796460|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6
6796682|NCT01791595|10796461|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0
6796683|NCT01791595|10796462|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0
6796684|NCT01791595|10796463|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0
6796685|NCT01791595|10796464|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0
6796686|NCT01791595|10796458|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0
6796687|NCT01791595|10796459|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0
6796688|NCT01791595|10796460|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1
6796689|NCT01791595|10796461|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0
6796690|NCT01791595|10796462|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0
6796691|NCT01791595|10796463|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0
6796692|NCT01791595|10796464|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0
6796693|NCT01791595|10796458|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0
6796694|NCT01791595|10796459|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0
6796695|NCT01791595|10796460|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0
6796696|NCT01791595|10796461|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2
6796697|NCT01791595|10796462|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0
6796698|NCT01791595|10796463|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0
6796699|NCT01791595|10796464|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0
6796700|NCT01791595|10796458|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0
6796701|NCT01791595|10796459|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0
6796702|NCT01791595|10796460|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0
6796703|NCT01791595|10796461|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2
6796704|NCT01791595|10796462|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0
6796705|NCT01791595|10796463|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0
6796706|NCT01791595|10796464|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0
6796707|NCT01791595|10796458|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0
6796708|NCT01791595|10796459|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0
6796709|NCT01791595|10796460|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0
6796710|NCT01791595|10796461|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0
6796711|NCT01791595|10796462|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4
6796712|NCT01791595|10796463|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0
6796713|NCT01791595|10796464|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0
6796714|NCT01791595|10796458|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0
6796715|NCT01791595|10796459|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0
6796716|NCT01791595|10796460|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0
6796717|NCT01791595|10796461|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0
6796718|NCT01791595|10796462|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5
6796719|NCT01791595|10796463|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0
6796720|NCT01791595|10796464|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0
6796721|NCT01791595|10796458|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0
6796722|NCT01791595|10796459|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0
6796723|NCT01791595|10796460|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0
6796724|NCT01791595|10796461|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0
6796725|NCT01791595|10796462|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1
6796726|NCT01791595|10796463|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0
6796727|NCT01791595|10796464|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0
6796728|NCT01791595|10796458|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0
6796729|NCT01791595|10796459|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0
6796730|NCT01791595|10796460|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0
6796731|NCT01791595|10796461|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0
6796732|NCT01791595|10796462|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1
6796733|NCT01791595|10796463|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0
6796734|NCT01791595|10796464|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0
6796735|NCT01791595|10796458|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0
6796736|NCT01791595|10796459|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0
6796737|NCT01791595|10796460|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0
6796738|NCT01791595|10796461|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0
6796739|NCT01791595|10796462|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0
6796740|NCT01791595|10796463|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5
6796741|NCT01791595|10796464|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0
6796742|NCT01791595|10796458|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0
6796743|NCT01791595|10796459|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0
6796744|NCT01791595|10796460|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0
6796745|NCT01791595|10796461|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0
6796746|NCT01791595|10796462|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0
6796747|NCT01791595|10796463|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3
6796748|NCT01791595|10796464|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0
6796749|NCT01791595|10796458|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0
6796750|NCT01791595|10796459|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0
6796751|NCT01791595|10796460|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0
6796752|NCT01791595|10796461|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0
6796753|NCT01791595|10796462|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0
6796754|NCT01791595|10796463|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0
6796755|NCT01791595|10796464|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1
6796756|NCT01791595|10796458|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0
6796757|NCT01791595|10796459|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0
6796758|NCT01791595|10796460|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0
6796759|NCT01791595|10796461|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0
6796760|NCT01791595|10796462|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0
6796761|NCT01791595|10796463|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0
6796762|NCT01791595|10796464|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6
6796763|NCT01791595|10796458|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0
6796764|NCT01791595|10796459|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0
6796765|NCT01791595|10796460|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0
6796766|NCT01791595|10796461|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0
6796767|NCT01791595|10796462|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0
6796768|NCT01791595|10796463|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0
6796769|NCT01791595|10796464|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2
6796770|NCT01791595|10796458|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0
6796771|NCT01791595|10796459|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0
6796772|NCT01791595|10796460|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0
6796773|NCT01791595|10796461|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0
6796774|NCT01791595|10796462|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0
6796775|NCT01791595|10796463|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0
6796776|NCT01791595|10796464|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1
6796777|NCT01192776|10796488|FG000|Overall Study|Death|8
6796778|NCT01192776|10796489|FG001|Overall Study|Death|15
6796779|NCT01192776|10796490|FG002|Overall Study|Death|18
6796780|NCT01192776|10796491|FG003|Overall Study|Death|15
6796781|NCT01192776|10796488|FG000|Overall Study|Lost to Follow-up|3
6796782|NCT01192776|10796489|FG001|Overall Study|Lost to Follow-up|6
6796783|NCT01192776|10796490|FG002|Overall Study|Lost to Follow-up|3
6796784|NCT01192776|10796491|FG003|Overall Study|Lost to Follow-up|5
6796785|NCT00089791|10796505|FG000|Overall Study|Physician Decision|6
6796786|NCT00089791|10796506|FG001|Overall Study|Physician Decision|3
6796787|NCT00089791|10796505|FG000|Overall Study|Adverse Event|81
6796788|NCT00089791|10796506|FG001|Overall Study|Adverse Event|93
6796789|NCT00089791|10796505|FG000|Overall Study|Withdrawal by Subject|403
6796790|NCT00089791|10796506|FG001|Overall Study|Withdrawal by Subject|344
6796791|NCT00089791|10796505|FG000|Overall Study|Death|78
6796792|NCT00089791|10796506|FG001|Overall Study|Death|62
6796793|NCT00089791|10796505|FG000|Overall Study|Disease progression|7
6796794|NCT00089791|10796506|FG001|Overall Study|Disease progression|3
6796795|NCT00089791|10796505|FG000|Overall Study|Ineligibility determined|12
6796796|NCT00089791|10796506|FG001|Overall Study|Ineligibility determined|9
6796797|NCT00089791|10796505|FG000|Overall Study|Lost to Follow-up|57
6796798|NCT00089791|10796506|FG001|Overall Study|Lost to Follow-up|57
6796799|NCT00089791|10796505|FG000|Overall Study|Noncompliance|17
6796800|NCT00089791|10796506|FG001|Overall Study|Noncompliance|13
6796801|NCT00089791|10796505|FG000|Overall Study|Other|20
6796802|NCT00089791|10796506|FG001|Overall Study|Other|32
6796803|NCT00089791|10796505|FG000|Overall Study|Protocol deviation|12
6796804|NCT00089791|10796506|FG001|Overall Study|Protocol deviation|10
6796805|NCT00089791|10796505|FG000|Overall Study|Requirement for alternative therapy|7
6796806|NCT00089791|10796506|FG001|Overall Study|Requirement for alternative therapy|4
6809020|NCT00855803|10812223|FG000|Overall Study|Lost to Follow-up|2
6809021|NCT00855803|10812223|FG000|Overall Study|Technical inability to undergo procedure|2
6809022|NCT00855803|10812223|FG000|Overall Study|Not evaluable at 3 month timepoint|2
6809023|NCT00855803|10812223|FG000|Overall Study|Withdrawal by Subject|3
6809024|NCT00855803|10812223|FG000|Overall Study|Physician Decision|3
6809025|NCT00740116|10812233|FG000|Overall Study|Withdrawal by Subject|1
6809026|NCT00740116|10812234|FG001|Overall Study|Withdrawal by Subject|1
6809027|NCT00740116|10812233|FG000|Overall Study|Protocol Violation|1
6809028|NCT00740116|10812234|FG001|Overall Study|Protocol Violation|4
6809029|NCT00565617|10812242|FG000|Overall Study|Withdrawal by Subject|1
6809030|NCT00470704|10812248|FG000|Overall Study|Withdrawal by Subject|4
6809031|NCT00470704|10812249|FG001|Overall Study|Withdrawal by Subject|3
6809032|NCT00470704|10812248|FG000|Overall Study|Relapse/Progression|37
6809033|NCT00470704|10812249|FG001|Overall Study|Relapse/Progression|42
6809034|NCT00470704|10812248|FG000|Overall Study|toxicity|0
6809035|NCT00470704|10812249|FG001|Overall Study|toxicity|1
6809036|NCT00142584|10812277|FG000|Overall Study|Sponsor Termination of Study, etc.|72
6809037|NCT00142584|10812278|FG001|Overall Study|Sponsor Termination of Study, etc.|16
6809038|NCT00142584|10812277|FG000|Overall Study|Withdrawal by Subject|30
6809039|NCT00142584|10812278|FG001|Overall Study|Withdrawal by Subject|16
6809040|NCT00142584|10812277|FG000|Overall Study|Lost to Follow-up|22
6809041|NCT00142584|10812278|FG001|Overall Study|Lost to Follow-up|12
6809042|NCT00142584|10812277|FG000|Overall Study|Adverse Event|14
6809043|NCT00142584|10812278|FG001|Overall Study|Adverse Event|5
6809044|NCT00142584|10812277|FG000|Overall Study|Protocol Violation|4
6809045|NCT00142584|10812278|FG001|Overall Study|Protocol Violation|7
6809046|NCT00142584|10812277|FG000|Overall Study|Treatment Failure|2
6809047|NCT00142584|10812278|FG001|Overall Study|Treatment Failure|0
6810966|NCT02460224|10814914|FG007|Overall Study|Lost to Follow-up|0
6810967|NCT02460224|10814915|FG008|Overall Study|Lost to Follow-up|0
6810968|NCT02460224|10814916|FG009|Overall Study|Lost to Follow-up|0
6810969|NCT02460224|10814917|FG010|Overall Study|Lost to Follow-up|0
6810970|NCT02460224|10814918|FG011|Overall Study|Lost to Follow-up|0
6810971|NCT02460224|10814919|FG012|Overall Study|Lost to Follow-up|0
6810972|NCT02460224|10814920|FG013|Overall Study|Lost to Follow-up|0
6810973|NCT02460224|10814921|FG014|Overall Study|Lost to Follow-up|0
6810974|NCT02460224|10814922|FG015|Overall Study|Lost to Follow-up|0
6810975|NCT02460224|10814923|FG016|Overall Study|Lost to Follow-up|0
6810976|NCT02460224|10814924|FG017|Overall Study|Lost to Follow-up|0
6796807|NCT03392883|10796537|FG000|Overall Study|Lost to Follow-up|122
6796808|NCT03392883|10796538|FG001|Overall Study|Lost to Follow-up|13
6796809|NCT03392883|10796539|FG002|Overall Study|Lost to Follow-up|9
6796810|NCT03392883|10796537|FG000|Overall Study|Death|4
6796811|NCT03392883|10796538|FG001|Overall Study|Death|0
6796812|NCT03392883|10796539|FG002|Overall Study|Death|0
6796813|NCT03392883|10796537|FG000|Overall Study|Lack of Efficacy|29
6796814|NCT03392883|10796538|FG001|Overall Study|Lack of Efficacy|0
6796815|NCT03392883|10796539|FG002|Overall Study|Lack of Efficacy|0
6796816|NCT03392883|10796537|FG000|Overall Study|Withdrawal by Subject|180
6796817|NCT03392883|10796538|FG001|Overall Study|Withdrawal by Subject|0
6796818|NCT03392883|10796539|FG002|Overall Study|Withdrawal by Subject|0
6796819|NCT03392883|10796537|FG000|Overall Study|Adverse Event|1
6796820|NCT03392883|10796538|FG001|Overall Study|Adverse Event|0
6796821|NCT03392883|10796539|FG002|Overall Study|Adverse Event|0
6796822|NCT03376789|10796547|FG000|Overall Study|Withdrawal by Subject|3
6796823|NCT03376789|10796548|FG001|Overall Study|Withdrawal by Subject|5
6796824|NCT03376789|10796547|FG000|Overall Study|Protocol Violation|0
6796825|NCT03376789|10796548|FG001|Overall Study|Protocol Violation|1
6796826|NCT03376789|10796547|FG000|Overall Study|Adverse Event|0
6796827|NCT03376789|10796548|FG001|Overall Study|Adverse Event|1
6796828|NCT03376789|10796547|FG000|Overall Study|Lost to Follow-up|1
6796829|NCT03376789|10796548|FG001|Overall Study|Lost to Follow-up|1
6796830|NCT03376789|10796547|FG000|Overall Study|Per sponsor due to noncompliance|1
6796831|NCT03376789|10796548|FG001|Overall Study|Per sponsor due to noncompliance|0
6796832|NCT03376789|10796547|FG000|Overall Study|Subject off study medication|0
6796833|NCT03376789|10796548|FG001|Overall Study|Subject off study medication|1
6796834|NCT03307967|10796576|FG000|Overall Study|Lost to Follow-up|4
6796835|NCT03288129|10796586|FG000|Overall Study|Adverse Event|10
6796836|NCT03288129|10796586|FG000|Overall Study|Lost to Follow-up|3
6796837|NCT03288129|10796586|FG000|Overall Study|Withdrawal by Subject|3
6796838|NCT03288129|10796586|FG000|Overall Study|Withdrawal of consent/assent|1
6796839|NCT03288129|10796586|FG000|Overall Study|Other|5
6796840|NCT03241225|10796618|FG000|Overall Study|Lost to Follow-up|2
6796841|NCT03241225|10796619|FG001|Overall Study|Lost to Follow-up|1
6796842|NCT03241225|10796618|FG000|Overall Study|Protocol Violation|4
6796843|NCT03241225|10796619|FG001|Overall Study|Protocol Violation|1
6796844|NCT03241225|10796618|FG000|Overall Study|Withdrawal by Subject|1
6796845|NCT03241225|10796619|FG001|Overall Study|Withdrawal by Subject|0
6796846|NCT03225846|10796632|FG000|Overall Study|Adverse Event|0
6796847|NCT03225846|10796633|FG001|Overall Study|Adverse Event|0
6796848|NCT03225846|10796634|FG002|Overall Study|Adverse Event|0
6796849|NCT03225846|10796635|FG003|Overall Study|Adverse Event|0
6796850|NCT03225846|10796636|FG004|Overall Study|Adverse Event|0
6796851|NCT03225846|10796637|FG005|Overall Study|Adverse Event|0
6796852|NCT03225846|10796638|FG006|Overall Study|Adverse Event|6
6796853|NCT03225846|10796632|FG000|Overall Study|Withdrawal by Subject|0
6796854|NCT03225846|10796633|FG001|Overall Study|Withdrawal by Subject|1
6796855|NCT03225846|10796634|FG002|Overall Study|Withdrawal by Subject|0
6796856|NCT03225846|10796635|FG003|Overall Study|Withdrawal by Subject|0
6796857|NCT03225846|10796636|FG004|Overall Study|Withdrawal by Subject|0
6796858|NCT03225846|10796637|FG005|Overall Study|Withdrawal by Subject|0
6796859|NCT03225846|10796638|FG006|Overall Study|Withdrawal by Subject|0
6796860|NCT03225846|10796632|FG000|Overall Study|Death|0
6796861|NCT03225846|10796633|FG001|Overall Study|Death|1
6796862|NCT03225846|10796634|FG002|Overall Study|Death|0
6796863|NCT03225846|10796635|FG003|Overall Study|Death|0
6796864|NCT03225846|10796636|FG004|Overall Study|Death|0
6796865|NCT03225846|10796637|FG005|Overall Study|Death|0
6796866|NCT03225846|10796638|FG006|Overall Study|Death|0
6796867|NCT03225846|10796632|FG000|Overall Study|Patient did not wish to comply with IC/EC|0
6796868|NCT03225846|10796633|FG001|Overall Study|Patient did not wish to comply with IC/EC|0
6796869|NCT03225846|10796634|FG002|Overall Study|Patient did not wish to comply with IC/EC|1
6796870|NCT03225846|10796635|FG003|Overall Study|Patient did not wish to comply with IC/EC|0
6796871|NCT03225846|10796636|FG004|Overall Study|Patient did not wish to comply with IC/EC|0
6796872|NCT03225846|10796637|FG005|Overall Study|Patient did not wish to comply with IC/EC|0
6796873|NCT03225846|10796638|FG006|Overall Study|Patient did not wish to comply with IC/EC|0
6796874|NCT03225846|10796632|FG000|Overall Study|Patient decision|0
6796875|NCT03225846|10796633|FG001|Overall Study|Patient decision|0
6796876|NCT03225846|10796634|FG002|Overall Study|Patient decision|0
6796877|NCT03225846|10796635|FG003|Overall Study|Patient decision|0
6796878|NCT03225846|10796636|FG004|Overall Study|Patient decision|0
6796879|NCT03225846|10796637|FG005|Overall Study|Patient decision|0
6796880|NCT03225846|10796638|FG006|Overall Study|Patient decision|1
6809048|NCT04551898|10812308|FG000|Overall Study|Participant randomized but did not receive study drug|0
6809049|NCT04551898|10812309|FG001|Overall Study|Participant randomized but did not receive study drug|1
6809050|NCT04551898|10812310|FG002|Overall Study|Participant randomized but did not receive study drug|3
6809051|NCT04551898|10812311|FG003|Overall Study|Participant randomized but did not receive study drug|1
6809052|NCT04551898|10812308|FG000|Overall Study|Withdrawal by Subject|5
6809053|NCT04551898|10812309|FG001|Overall Study|Withdrawal by Subject|1
6809054|NCT04551898|10812310|FG002|Overall Study|Withdrawal by Subject|2
6809055|NCT04551898|10812311|FG003|Overall Study|Withdrawal by Subject|2
6809056|NCT04551898|10812308|FG000|Overall Study|Lost to Follow-up|2
6809057|NCT04551898|10812309|FG001|Overall Study|Lost to Follow-up|1
6809058|NCT04551898|10812310|FG002|Overall Study|Lost to Follow-up|2
6809059|NCT04551898|10812311|FG003|Overall Study|Lost to Follow-up|2
6809060|NCT04551898|10812308|FG000|Overall Study|Death|1
6809061|NCT04551898|10812309|FG001|Overall Study|Death|0
6809062|NCT04551898|10812310|FG002|Overall Study|Death|0
6809063|NCT04551898|10812311|FG003|Overall Study|Death|0
6809064|NCT04551898|10812308|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0
6809065|NCT04551898|10812309|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0
6809066|NCT04551898|10812310|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1
6809067|NCT04551898|10812311|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0
6809068|NCT04402866|10812333|FG000|Overall Study|Discontinued Prior to Treatment|0
6809069|NCT04402866|10812334|FG001|Overall Study|Discontinued Prior to Treatment|0
6809070|NCT04402866|10812335|FG002|Overall Study|Discontinued Prior to Treatment|0
6809071|NCT04402866|10812336|FG003|Overall Study|Discontinued Prior to Treatment|0
6809072|NCT04402866|10812337|FG004|Overall Study|Discontinued Prior to Treatment|2
6809073|NCT04402866|10812338|FG005|Overall Study|Discontinued Prior to Treatment|3
6809074|NCT04402866|10812333|FG000|Overall Study|Adverse Event|2
6809075|NCT04402866|10812334|FG001|Overall Study|Adverse Event|1
6809076|NCT04402866|10812335|FG002|Overall Study|Adverse Event|0
6809077|NCT04402866|10812336|FG003|Overall Study|Adverse Event|0
6809078|NCT04402866|10812337|FG004|Overall Study|Adverse Event|13
6809079|NCT04402866|10812338|FG005|Overall Study|Adverse Event|8
6809080|NCT04402866|10812333|FG000|Overall Study|Miscellaneous|0
6809081|NCT04402866|10812334|FG001|Overall Study|Miscellaneous|0
6809082|NCT04402866|10812335|FG002|Overall Study|Miscellaneous|1
6809083|NCT04402866|10812336|FG003|Overall Study|Miscellaneous|0
6809084|NCT04402866|10812337|FG004|Overall Study|Miscellaneous|0
6809085|NCT04402866|10812338|FG005|Overall Study|Miscellaneous|0
6809086|NCT04402866|10812333|FG000|Overall Study|Lost to Follow-up|0
6809087|NCT04402866|10812334|FG001|Overall Study|Lost to Follow-up|0
6809088|NCT04402866|10812335|FG002|Overall Study|Lost to Follow-up|0
6809089|NCT04402866|10812336|FG003|Overall Study|Lost to Follow-up|0
6809090|NCT04402866|10812337|FG004|Overall Study|Lost to Follow-up|0
6809091|NCT04402866|10812338|FG005|Overall Study|Lost to Follow-up|1
6809092|NCT04402866|10812333|FG000|Overall Study|Withdrawal by Subject|0
6809093|NCT04402866|10812334|FG001|Overall Study|Withdrawal by Subject|0
6809094|NCT04402866|10812335|FG002|Overall Study|Withdrawal by Subject|0
6809095|NCT04402866|10812336|FG003|Overall Study|Withdrawal by Subject|0
6809096|NCT04402866|10812337|FG004|Overall Study|Withdrawal by Subject|0
6809097|NCT04402866|10812338|FG005|Overall Study|Withdrawal by Subject|2
6809098|NCT04327388|10812351|FG000|Overall Study|Adverse Event|17
6809099|NCT04327388|10812352|FG001|Overall Study|Adverse Event|18
6809100|NCT04327388|10812353|FG002|Overall Study|Adverse Event|9
6809101|NCT04327388|10812351|FG000|Overall Study|Other|1
6809102|NCT04327388|10812352|FG001|Overall Study|Other|2
6809103|NCT04327388|10812353|FG002|Overall Study|Other|0
6809104|NCT04327388|10812351|FG000|Overall Study|Randomized and not treated|2
6809105|NCT04327388|10812352|FG001|Overall Study|Randomized and not treated|0
6809106|NCT04327388|10812353|FG002|Overall Study|Randomized and not treated|2
6809107|NCT03860259|10812363|FG000|Overall Study|Lost to Follow-up|5
6796881|NCT03191903|10796696|FG000|Overall Study|Withdrawal by Subject|6
6796882|NCT03191903|10796697|FG001|Overall Study|Withdrawal by Subject|5
6796883|NCT03191903|10796698|FG002|Overall Study|Withdrawal by Subject|4
6796884|NCT03191903|10796696|FG000|Overall Study|Adverse Event|1
6796885|NCT03191903|10796697|FG001|Overall Study|Adverse Event|0
6796886|NCT03191903|10796698|FG002|Overall Study|Adverse Event|0
6796887|NCT03186794|10796711|FG000|Overall Study|Physician Decision|2
6796888|NCT03186794|10796711|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2
6796889|NCT04289051|10796716|FG000|Overall Study|Lost to Follow-up|0
6796890|NCT04289051|10796717|FG001|Overall Study|Lost to Follow-up|0
6796891|NCT04289051|10796718|FG002|Overall Study|Lost to Follow-up|2
6796892|NCT04210180|10796726|FG000|Overall Study|Withdrawal by Subject|2
6796893|NCT03675308|10796769|FG000|Overall Study|Adverse Event|3
6796894|NCT03675308|10796770|FG001|Overall Study|Adverse Event|2
6796895|NCT03675308|10796769|FG000|Overall Study|Withdrawal by Subject|6
6796896|NCT03675308|10796770|FG001|Overall Study|Withdrawal by Subject|4
6796897|NCT03675308|10796769|FG000|Overall Study|Lost to Follow-up|3
6796898|NCT03675308|10796770|FG001|Overall Study|Lost to Follow-up|0
6796899|NCT03675308|10796769|FG000|Overall Study|Lack of Efficacy|1
6796900|NCT03675308|10796770|FG001|Overall Study|Lack of Efficacy|1
6796901|NCT03675308|10796769|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1
6796902|NCT03675308|10796770|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2
6796903|NCT03675308|10796769|FG000|Overall Study|Other|0
6796904|NCT03675308|10796770|FG001|Overall Study|Other|1
6796905|NCT03573817|10796778|FG000|Overall Study|Adverse Event|0
6796906|NCT03573817|10796779|FG001|Overall Study|Adverse Event|2
6796907|NCT03573817|10796778|FG000|Overall Study|Protocol Violation|0
6796908|NCT03573817|10796779|FG001|Overall Study|Protocol Violation|1
6796909|NCT03573817|10796778|FG000|Overall Study|Withdrawal by Subject|1
6796910|NCT03573817|10796779|FG001|Overall Study|Withdrawal by Subject|1
6796911|NCT03318861|10796795|FG000|Overall Study|Death|1
6796912|NCT03318861|10796796|FG001|Overall Study|Death|2
6796913|NCT03318861|10796797|FG002|Overall Study|Death|2
6796914|NCT03318861|10796798|FG003|Overall Study|Death|1
6796915|NCT03318861|10796799|FG004|Overall Study|Death|1
6796916|NCT03318861|10796795|FG000|Overall Study|Still on Study|2
6796917|NCT03318861|10796796|FG001|Overall Study|Still on Study|1
6796918|NCT03318861|10796797|FG002|Overall Study|Still on Study|1
6796919|NCT03318861|10796798|FG003|Overall Study|Still on Study|2
6796920|NCT03318861|10796799|FG004|Overall Study|Still on Study|1
6796921|NCT03318861|10796795|FG000|Overall Study|Enrolled But Did Not Initiate KITE-585|0
6796922|NCT03318861|10796796|FG001|Overall Study|Enrolled But Did Not Initiate KITE-585|1
6796923|NCT03318861|10796797|FG002|Overall Study|Enrolled But Did Not Initiate KITE-585|0
6796924|NCT03318861|10796798|FG003|Overall Study|Enrolled But Did Not Initiate KITE-585|1
6796925|NCT03318861|10796799|FG004|Overall Study|Enrolled But Did Not Initiate KITE-585|1
6796926|NCT03170349|10796811|FG000|At 30 Days Follow-up|Death|1
6796927|NCT03170349|10796811|FG000|At 6 Months Follow-up|Death|3
6796928|NCT03170349|10796811|FG000|At 6 Months Follow-up|Withdrawal by Subject|1
6796929|NCT03170349|10796811|FG000|At 6 Months Follow-up|Exited for Other Reasons|5
6796930|NCT02919683|10796867|FG000|Post-Surgery Follow-Up|Death|2
6796931|NCT02919683|10796868|FG001|Post-Surgery Follow-Up|Death|2
6796932|NCT02919683|10796867|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1
6796933|NCT02919683|10796868|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0
6796934|NCT02901548|10796875|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4
6796935|NCT02790138|10796881|FG000|Overall Study|Adverse Event|5
6796936|NCT02790138|10796882|FG001|Overall Study|Adverse Event|2
6796937|NCT02790138|10796881|FG000|Overall Study|Significant Protocol Deviation|0
6796938|NCT02790138|10796882|FG001|Overall Study|Significant Protocol Deviation|1
6796939|NCT02790138|10796881|FG000|Overall Study|Lost to Follow-up|1
6796940|NCT02790138|10796882|FG001|Overall Study|Lost to Follow-up|0
6796941|NCT02790138|10796881|FG000|Overall Study|Voluntary Withdrawal|8
6796942|NCT02790138|10796882|FG001|Overall Study|Voluntary Withdrawal|9
6796943|NCT02790138|10796881|FG000|Overall Study|Lack of Efficacy|6
6796944|NCT02790138|10796882|FG001|Overall Study|Lack of Efficacy|7
6796945|NCT02790138|10796881|FG000|Overall Study|Reason not Specified|1
6796946|NCT02790138|10796882|FG001|Overall Study|Reason not Specified|0
6796947|NCT02514239|10796916|FG000|Overall Study|Refused to continue trial medication|0
6796948|NCT02514239|10796917|FG001|Overall Study|Refused to continue trial medication|0
6796949|NCT02514239|10796918|FG002|Overall Study|Refused to continue trial medication|0
6796950|NCT02514239|10796919|FG003|Overall Study|Refused to continue trial medication|0
6796951|NCT02514239|10796920|FG004|Overall Study|Refused to continue trial medication|0
6796952|NCT02514239|10796921|FG005|Overall Study|Refused to continue trial medication|0
6796953|NCT02514239|10796922|FG006|Overall Study|Refused to continue trial medication|0
6796954|NCT02514239|10796923|FG007|Overall Study|Refused to continue trial medication|0
6796955|NCT02514239|10796924|FG008|Overall Study|Refused to continue trial medication|0
6796956|NCT02514239|10796925|FG009|Overall Study|Refused to continue trial medication|1
6796957|NCT02514239|10796916|FG000|Overall Study|Dose-limiting toxicity (DLT)|0
6796958|NCT02514239|10796917|FG001|Overall Study|Dose-limiting toxicity (DLT)|0
6796959|NCT02514239|10796918|FG002|Overall Study|Dose-limiting toxicity (DLT)|0
6796960|NCT02514239|10796919|FG003|Overall Study|Dose-limiting toxicity (DLT)|0
6796961|NCT02514239|10796920|FG004|Overall Study|Dose-limiting toxicity (DLT)|0
6796962|NCT02514239|10796921|FG005|Overall Study|Dose-limiting toxicity (DLT)|0
6796963|NCT02514239|10796922|FG006|Overall Study|Dose-limiting toxicity (DLT)|0
6796964|NCT02514239|10796923|FG007|Overall Study|Dose-limiting toxicity (DLT)|0
6796965|NCT02514239|10796924|FG008|Overall Study|Dose-limiting toxicity (DLT)|1
6796966|NCT02514239|10796925|FG009|Overall Study|Dose-limiting toxicity (DLT)|2
6796967|NCT02514239|10796916|FG000|Overall Study|Not treated|0
6796968|NCT02514239|10796917|FG001|Overall Study|Not treated|1
6796969|NCT02514239|10796918|FG002|Overall Study|Not treated|0
6796970|NCT02514239|10796919|FG003|Overall Study|Not treated|0
6796971|NCT02514239|10796920|FG004|Overall Study|Not treated|0
6796972|NCT02514239|10796921|FG005|Overall Study|Not treated|0
6796973|NCT02514239|10796922|FG006|Overall Study|Not treated|0
6796974|NCT02514239|10796923|FG007|Overall Study|Not treated|0
6796975|NCT02514239|10796924|FG008|Overall Study|Not treated|0
6796976|NCT02514239|10796925|FG009|Overall Study|Not treated|0
6796977|NCT02514239|10796916|FG000|Overall Study|Other Adverse Events|2
6796978|NCT02514239|10796917|FG001|Overall Study|Other Adverse Events|0
6796979|NCT02514239|10796918|FG002|Overall Study|Other Adverse Events|0
6796980|NCT02514239|10796919|FG003|Overall Study|Other Adverse Events|1
6796981|NCT02514239|10796920|FG004|Overall Study|Other Adverse Events|0
6796982|NCT02514239|10796921|FG005|Overall Study|Other Adverse Events|1
6796983|NCT02514239|10796922|FG006|Overall Study|Other Adverse Events|0
6796984|NCT02514239|10796923|FG007|Overall Study|Other Adverse Events|1
6796985|NCT02514239|10796924|FG008|Overall Study|Other Adverse Events|2
6796986|NCT02514239|10796925|FG009|Overall Study|Other Adverse Events|0
6796987|NCT02514239|10796916|FG000|Overall Study|Progressive disease|3
6796988|NCT02514239|10796917|FG001|Overall Study|Progressive disease|3
6796989|NCT02514239|10796918|FG002|Overall Study|Progressive disease|2
6796990|NCT02514239|10796919|FG003|Overall Study|Progressive disease|2
6796991|NCT02514239|10796920|FG004|Overall Study|Progressive disease|3
6796992|NCT02514239|10796921|FG005|Overall Study|Progressive disease|3
6796993|NCT02514239|10796922|FG006|Overall Study|Progressive disease|4
6796994|NCT02514239|10796923|FG007|Overall Study|Progressive disease|2
6796995|NCT02514239|10796924|FG008|Overall Study|Progressive disease|5
6796996|NCT02514239|10796925|FG009|Overall Study|Progressive disease|0
6796997|NCT02245672|10796994|FG000|Overall Study|Adverse Event|4
6796998|NCT02245672|10796995|FG001|Overall Study|Adverse Event|4
6796999|NCT02245672|10796996|FG002|Overall Study|Adverse Event|4
6797000|NCT02245672|10796994|FG000|Overall Study|Lost to Follow-up|3
6797001|NCT02245672|10796995|FG001|Overall Study|Lost to Follow-up|5
6797002|NCT02245672|10796996|FG002|Overall Study|Lost to Follow-up|1
6797003|NCT02245672|10796994|FG000|Overall Study|Withdrawal by Subject|6
6797004|NCT02245672|10796995|FG001|Overall Study|Withdrawal by Subject|3
6797005|NCT02245672|10796996|FG002|Overall Study|Withdrawal by Subject|0
6797006|NCT02245672|10796994|FG000|Overall Study|Randomized in error (not treated)|0
6797007|NCT02245672|10796995|FG001|Overall Study|Randomized in error (not treated)|1
6797008|NCT02245672|10796996|FG002|Overall Study|Randomized in error (not treated)|0
6797009|NCT02109172|10797004|FG000|Overall Study|Withdrawal by Subject|1
6797010|NCT02109172|10797005|FG001|Overall Study|Withdrawal by Subject|0
6797011|NCT02109172|10797006|FG002|Overall Study|Withdrawal by Subject|0
6797012|NCT02109172|10797007|FG003|Overall Study|Withdrawal by Subject|1
6797013|NCT02109172|10797008|FG004|Overall Study|Withdrawal by Subject|0
6797014|NCT02109172|10797009|FG005|Overall Study|Withdrawal by Subject|0
6797015|NCT02109172|10797004|FG000|Overall Study|Adverse Event|0
6797016|NCT02109172|10797005|FG001|Overall Study|Adverse Event|0
6797017|NCT02109172|10797006|FG002|Overall Study|Adverse Event|1
6797018|NCT02109172|10797007|FG003|Overall Study|Adverse Event|0
6797019|NCT02109172|10797008|FG004|Overall Study|Adverse Event|0
6797020|NCT02109172|10797009|FG005|Overall Study|Adverse Event|1
6797021|NCT02109172|10797004|FG000|Overall Study|Death|0
6797022|NCT02109172|10797005|FG001|Overall Study|Death|0
6797023|NCT02109172|10797006|FG002|Overall Study|Death|0
6797024|NCT02109172|10797007|FG003|Overall Study|Death|0
6797025|NCT02109172|10797008|FG004|Overall Study|Death|1
6797026|NCT02109172|10797009|FG005|Overall Study|Death|0
6797027|NCT00799396|10797067|FG000|Clopidogrel Treatment|Adverse Event|6
6797028|NCT00799396|10797067|FG000|Clopidogrel Treatment|Physician Decision|5
6797029|NCT00799396|10797067|FG000|Clopidogrel Treatment|Withdrawal by Subject|2
6797030|NCT00799396|10797067|FG000|Clopidogrel Plus Aspirin|Adverse Event|2
6797031|NCT00799396|10797067|FG000|Clopidogrel Plus Aspirin|Physician Decision|4
6797032|NCT00069238|10797071|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9
6797033|NCT00069238|10797072|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
6797034|NCT00069238|10797073|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
6797035|NCT00069238|10797071|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
6797036|NCT00069238|10797072|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2
6797037|NCT00069238|10797073|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
6797038|NCT00069238|10797071|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
6797039|NCT00069238|10797072|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
6797040|NCT00069238|10797073|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2
6809108|NCT03860259|10812364|FG001|Overall Study|Lost to Follow-up|5
6809109|NCT03860259|10812363|FG000|Overall Study|Protocol Violation|1
6809110|NCT03860259|10812364|FG001|Overall Study|Protocol Violation|0
6810977|NCT02460224|10814925|FG018|Overall Study|Lost to Follow-up|0
6797041|NCT03138499|10797080|FG000|Overall Study|Lost to Follow-up|1
6797042|NCT03138499|10797081|FG001|Overall Study|Lost to Follow-up|0
6797043|NCT03138499|10797080|FG000|Overall Study|Participants withdrew consent|1
6797044|NCT03138499|10797081|FG001|Overall Study|Participants withdrew consent|0
6797045|NCT03138499|10797080|FG000|Overall Study|Participant discontinued study before treatment|0
6797046|NCT03138499|10797081|FG001|Overall Study|Participant discontinued study before treatment|1
6797047|NCT03138499|10797080|FG000|Overall Study|Disease Progression|2
6797048|NCT03138499|10797081|FG001|Overall Study|Disease Progression|6
6797049|NCT03138499|10797080|FG000|Overall Study|Study drug toxicity|2
6797050|NCT03138499|10797081|FG001|Overall Study|Study drug toxicity|2
6797051|NCT03138499|10797080|FG000|Overall Study|Participant request to discontinue study treatment|1
6797052|NCT03138499|10797081|FG001|Overall Study|Participant request to discontinue study treatment|1
6797053|NCT03138499|10797080|FG000|Overall Study|Other reasons|2
6797054|NCT03138499|10797081|FG001|Overall Study|Other reasons|0
6797055|NCT04189588|10797134|FG000|Overall Study|Death|0
6797056|NCT04189588|10797135|FG001|Overall Study|Death|1
6797057|NCT04189588|10797134|FG000|Overall Study|Lost to Follow-up|0
6797058|NCT04189588|10797135|FG001|Overall Study|Lost to Follow-up|1
6797059|NCT04115748|10797150|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15
6797060|NCT04115748|10797151|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16
6797061|NCT04115748|10797152|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7
6797062|NCT04115748|10797153|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15
6797063|NCT04115748|10797154|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0
6797064|NCT04115748|10797155|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0
6797065|NCT04115748|10797156|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0
6797066|NCT04115748|10797157|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0
6797067|NCT04115748|10797158|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0
6797068|NCT04115748|10797159|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0
6797069|NCT04115748|10797150|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0
6797070|NCT04115748|10797151|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0
6797071|NCT04115748|10797152|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0
6797072|NCT04115748|10797153|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1
6797073|NCT04115748|10797154|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0
6797074|NCT04115748|10797155|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0
6797075|NCT04115748|10797156|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0
6797076|NCT04115748|10797157|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0
6797077|NCT04115748|10797158|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0
6797078|NCT04115748|10797159|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0
6797079|NCT04115748|10797150|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0
6797080|NCT04115748|10797151|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0
6797081|NCT04115748|10797152|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0
6797082|NCT04115748|10797153|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0
6797083|NCT04115748|10797154|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4
6797084|NCT04115748|10797155|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3
6797085|NCT04115748|10797156|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1
6797086|NCT04115748|10797157|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1
6797087|NCT04115748|10797158|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1
6797088|NCT04115748|10797159|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2
6797089|NCT04115748|10797150|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0
6797090|NCT04115748|10797151|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0
6797091|NCT04115748|10797152|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0
6797092|NCT04115748|10797153|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0
6797093|NCT04115748|10797154|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0
6797094|NCT04115748|10797155|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0
6797095|NCT04115748|10797156|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0
6797096|NCT04115748|10797157|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0
6797097|NCT04115748|10797158|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1
6797098|NCT04115748|10797159|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0
6797099|NCT04044664|10797184|FG000|Stage 1|Adverse Event|3
6797100|NCT04044664|10797185|FG001|Stage 1|Adverse Event|3
6797101|NCT04044664|10797186|FG002|Stage 1|Adverse Event|1
6797102|NCT04044664|10797184|FG000|Stage 1|Lost to Follow-up|3
6797103|NCT04044664|10797185|FG001|Stage 1|Lost to Follow-up|2
6797104|NCT04044664|10797186|FG002|Stage 1|Lost to Follow-up|2
6797105|NCT04044664|10797184|FG000|Stage 1|Withdrawal by Subject|9
6797106|NCT04044664|10797185|FG001|Stage 1|Withdrawal by Subject|1
6797107|NCT04044664|10797186|FG002|Stage 1|Withdrawal by Subject|0
6797108|NCT04044664|10797184|FG000|Stage 1|noncompliance, personal reason|2
6797109|NCT04044664|10797185|FG001|Stage 1|noncompliance, personal reason|0
6797110|NCT04044664|10797186|FG002|Stage 1|noncompliance, personal reason|0
6797111|NCT04044664|10797184|FG000|Stage 1|randomization error|0
6797112|NCT04044664|10797185|FG001|Stage 1|randomization error|1
6797113|NCT04044664|10797186|FG002|Stage 1|randomization error|0
6797114|NCT04044664|10797184|FG000|Stage 2|Adverse Event|2
6797115|NCT04044664|10797185|FG001|Stage 2|Adverse Event|0
6797116|NCT04044664|10797186|FG002|Stage 2|Adverse Event|0
6797117|NCT04044664|10797184|FG000|Stage 2|Lost to Follow-up|3
6797118|NCT04044664|10797185|FG001|Stage 2|Lost to Follow-up|2
6797119|NCT04044664|10797186|FG002|Stage 2|Lost to Follow-up|1
6797120|NCT04044664|10797184|FG000|Stage 2|Withdrawal by Subject|3
6797121|NCT04044664|10797185|FG001|Stage 2|Withdrawal by Subject|0
6797122|NCT04044664|10797186|FG002|Stage 2|Withdrawal by Subject|0
6797123|NCT04044664|10797184|FG000|Stage 2|protocol deviation|1
6797124|NCT04044664|10797185|FG001|Stage 2|protocol deviation|0
6797125|NCT04044664|10797186|FG002|Stage 2|protocol deviation|0
6797126|NCT03994731|10797205|FG000|Pegloticase + IMM Period|Death|2
6797127|NCT03994731|10797206|FG001|Pegloticase + IMM Period|Death|0
6797128|NCT03994731|10797205|FG000|Pegloticase + IMM Period|Lost to Follow-up|3
6797129|NCT03994731|10797206|FG001|Pegloticase + IMM Period|Lost to Follow-up|6
6797130|NCT03994731|10797205|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15
6797131|NCT03994731|10797206|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9
6809111|NCT03446573|10812386|FG000|Overall Study|Withdrawal by Subject|7
6809112|NCT03446573|10812387|FG001|Overall Study|Withdrawal by Subject|16
6809113|NCT03446573|10812386|FG000|Overall Study|Physician Decision|1
6809114|NCT03446573|10812387|FG001|Overall Study|Physician Decision|1
6809115|NCT03446573|10812386|FG000|Overall Study|Lost to Follow-up|3
6809116|NCT03446573|10812387|FG001|Overall Study|Lost to Follow-up|5
6809117|NCT03446573|10812386|FG000|Overall Study|Protocol Violation|3
6809118|NCT03446573|10812387|FG001|Overall Study|Protocol Violation|2
6809119|NCT03446573|10812386|FG000|Overall Study|Lack of Efficacy|0
6809120|NCT03446573|10812387|FG001|Overall Study|Lack of Efficacy|3
6809121|NCT03446573|10812386|FG000|Overall Study|Adverse Event|13
6809122|NCT03446573|10812387|FG001|Overall Study|Adverse Event|2
6809123|NCT03446573|10812386|FG000|Overall Study|Ongoing at the time of interim analysis|342
6809124|NCT03446573|10812387|FG001|Overall Study|Ongoing at the time of interim analysis|343
6809125|NCT03388138|10812398|FG000|Overall Study|Protocol Violation|1
6809126|NCT03388138|10812399|FG001|Overall Study|Protocol Violation|0
6809127|NCT02981082|10812465|FG000|Overall Study|Withdrawal by Subject|2
6809128|NCT02981082|10812466|FG001|Overall Study|Withdrawal by Subject|0
6809129|NCT02981082|10812465|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1
6809130|NCT02981082|10812466|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0
6809131|NCT02981082|10812465|FG000|Overall Study|Adverse Event|0
6809132|NCT02981082|10812466|FG001|Overall Study|Adverse Event|1
6809133|NCT02924129|10812474|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2
6809134|NCT02924129|10812475|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1
6809135|NCT02924129|10812474|FG000|Overall Study|Withdrawal by Subject|2
6809136|NCT02924129|10812475|FG001|Overall Study|Withdrawal by Subject|2
6809137|NCT02924129|10812474|FG000|Overall Study|Physician Decision|1
6809138|NCT02924129|10812475|FG001|Overall Study|Physician Decision|0
6809139|NCT02924129|10812474|FG000|Overall Study|Missed Visit|0
6809140|NCT02924129|10812475|FG001|Overall Study|Missed Visit|1
6809141|NCT02741700|10812483|FG000|Overall Study|Lost to Follow-up|17
6809142|NCT02741700|10812484|FG001|Overall Study|Lost to Follow-up|8
6809143|NCT02741700|10812483|FG000|Overall Study|Withdrawal by Subject|2
6809144|NCT02741700|10812484|FG001|Overall Study|Withdrawal by Subject|5
6809145|NCT02741700|10812483|FG000|Overall Study|Physician Decision|3
6809146|NCT02741700|10812484|FG001|Overall Study|Physician Decision|0
6809147|NCT02741700|10812483|FG000|Overall Study|Moved out of State|0
6809148|NCT02741700|10812484|FG001|Overall Study|Moved out of State|1
6809149|NCT02741700|10812483|FG000|Overall Study|Death|4
6809150|NCT02741700|10812484|FG001|Overall Study|Death|5
6809151|NCT02635776|10812492|FG000|Overall Study|Physician Decision|1
6809152|NCT02635776|10812493|FG001|Overall Study|Physician Decision|0
6809153|NCT02635776|10812492|FG000|Overall Study|Adverse Event|51
6809154|NCT02635776|10812493|FG001|Overall Study|Adverse Event|3
6809155|NCT02635776|10812492|FG000|Overall Study|Withdrawal by Subject|41
6809156|NCT02635776|10812493|FG001|Overall Study|Withdrawal by Subject|7
6809157|NCT02635776|10812492|FG000|Overall Study|Lost to Follow-up|4
6809158|NCT02635776|10812493|FG001|Overall Study|Lost to Follow-up|0
6809159|NCT02635776|10812492|FG000|Overall Study|Other reasons|5
6809160|NCT02635776|10812493|FG001|Overall Study|Other reasons|1
6809161|NCT02609724|10812504|FG000|Overall Study|Death|2
6809162|NCT02609724|10812505|FG001|Overall Study|Death|0
6809163|NCT02609724|10812506|FG002|Overall Study|Death|1
6809164|NCT02609724|10812504|FG000|Overall Study|Withdrawal by Subject|1
6809165|NCT02609724|10812505|FG001|Overall Study|Withdrawal by Subject|2
6809166|NCT02609724|10812506|FG002|Overall Study|Withdrawal by Subject|3
6809167|NCT02609724|10812504|FG000|Overall Study|Illness|2
6809168|NCT02609724|10812505|FG001|Overall Study|Illness|1
6809169|NCT02609724|10812506|FG002|Overall Study|Illness|0
6809170|NCT02359994|10812516|FG000|Overall Population Study|Adverse Event|1
6809171|NCT02359994|10812517|FG001|Overall Population Study|Adverse Event|1
6809172|NCT02359994|10812516|FG000|Overall Population Study|Death|1
6809173|NCT02359994|10812517|FG001|Overall Population Study|Death|5
6809174|NCT02359994|10812516|FG000|Overall Population Study|Lost to Follow-up|1
6809175|NCT02359994|10812517|FG001|Overall Population Study|Lost to Follow-up|1
6809176|NCT02359994|10812516|FG000|Overall Population Study|Withdrawal by Subject|1
6809177|NCT02359994|10812517|FG001|Overall Population Study|Withdrawal by Subject|0
6809178|NCT02359994|10812516|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1
6809179|NCT02359994|10812517|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0
6797132|NCT03924622|10797234|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2
6797133|NCT03924622|10797235|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3
6797134|NCT03924622|10797236|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3
6797135|NCT03924622|10797237|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4
6797136|NCT03924622|10797238|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3
6797137|NCT03924622|10797239|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3
6797138|NCT03807843|10797280|FG000|Overall Study|Lost to Follow-up|1
6797139|NCT03807843|10797281|FG001|Overall Study|Lost to Follow-up|0
6797140|NCT03802513|10797287|FG000|Overall Study|Lost to Follow-up|1
6797141|NCT03681184|10797293|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0
6797142|NCT03681184|10797294|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1
6797143|NCT03681184|10797293|FG000|3-Month Blinded Extension Period|Remained in this Period at Time of Data Cut|12
6797144|NCT03681184|10797294|FG001|3-Month Blinded Extension Period|Remained in this Period at Time of Data Cut|23
6797145|NCT03681184|10797293|FG000|Open-Label Extension Period|Remained in this Period at Time of Data Cut|1
6797146|NCT03681184|10797294|FG001|Open-Label Extension Period|Remained in this Period at Time of Data Cut|1
6797147|NCT03679767|10797304|FG000|Overall Study|Death|16
6797148|NCT03679767|10797305|FG001|Overall Study|Death|10
6797149|NCT03679767|10797306|FG002|Overall Study|Death|16
6797150|NCT03679767|10797307|FG003|Overall Study|Death|10
6797151|NCT03679767|10797304|FG000|Overall Study|Lost to Follow-up|1
6797152|NCT03679767|10797305|FG001|Overall Study|Lost to Follow-up|0
6797153|NCT03679767|10797306|FG002|Overall Study|Lost to Follow-up|1
6797154|NCT03679767|10797307|FG003|Overall Study|Lost to Follow-up|1
6797155|NCT03679767|10797304|FG000|Overall Study|Withdrawal by Subject|0
6797156|NCT03679767|10797305|FG001|Overall Study|Withdrawal by Subject|0
6797157|NCT03679767|10797306|FG002|Overall Study|Withdrawal by Subject|0
6797158|NCT03679767|10797307|FG003|Overall Study|Withdrawal by Subject|1
6797159|NCT03679767|10797304|FG000|Overall Study|Follow-up Completed|4
6797160|NCT03679767|10797305|FG001|Overall Study|Follow-up Completed|1
6797161|NCT03679767|10797306|FG002|Overall Study|Follow-up Completed|3
6797162|NCT03679767|10797307|FG003|Overall Study|Follow-up Completed|5
6797163|NCT03679767|10797304|FG000|Overall Study|Ongoing|14
6797164|NCT03679767|10797305|FG001|Overall Study|Ongoing|12
6797165|NCT03679767|10797306|FG002|Overall Study|Ongoing|9
6797166|NCT03679767|10797307|FG003|Overall Study|Ongoing|17
6797167|NCT03576716|10797321|FG000|Overall Study|Withdrawal by Subject|0
6797168|NCT03576716|10797322|FG001|Overall Study|Withdrawal by Subject|1
6797169|NCT03500692|10797328|FG000|Overall Study|Death|76
6797170|NCT03500692|10797328|FG000|Overall Study|Missed visit|30
6797171|NCT03500692|10797328|FG000|Overall Study|Termination Reasons|3
6797172|NCT03367819|10797334|FG000|Overall Study|Adverse Event|4
6797173|NCT03367819|10797335|FG001|Overall Study|Adverse Event|4
6797174|NCT03367819|10797334|FG000|Overall Study|Progressive Disease|15
6797175|NCT03367819|10797335|FG001|Overall Study|Progressive Disease|13
6797176|NCT03367819|10797334|FG000|Overall Study|Withdrawal by Subject|1
6797177|NCT03367819|10797335|FG001|Overall Study|Withdrawal by Subject|0
6797178|NCT03367819|10797334|FG000|Overall Study|Other|4
6797179|NCT03367819|10797335|FG001|Overall Study|Other|2
6797180|NCT03182868|10797351|FG000|Overall Study|Protocol Violation|3
6797181|NCT03182868|10797352|FG001|Overall Study|Protocol Violation|0
6797182|NCT03182868|10797353|FG002|Overall Study|Protocol Violation|4
6797183|NCT03182868|10797354|FG003|Overall Study|Protocol Violation|1
6797184|NCT03182868|10797355|FG004|Overall Study|Protocol Violation|8
6797185|NCT03125902|10797368|FG000|Overall Study|Death|52
6797186|NCT03125902|10797369|FG001|Overall Study|Death|123
6797187|NCT03125902|10797368|FG000|Overall Study|Lost to Follow-up|1
6797188|NCT03125902|10797369|FG001|Overall Study|Lost to Follow-up|0
6797189|NCT03125902|10797368|FG000|Overall Study|Mastectomy|0
6797190|NCT03125902|10797369|FG001|Overall Study|Mastectomy|1
6797191|NCT03125902|10797368|FG000|Overall Study|Physician Decision|1
6797192|NCT03125902|10797369|FG001|Overall Study|Physician Decision|0
6797193|NCT03125902|10797368|FG000|Overall Study|Withdrawal by Subject|13
6797194|NCT03125902|10797369|FG001|Overall Study|Withdrawal by Subject|25
6797195|NCT03125902|10797368|FG000|Overall Study|Study is ongoing|153
6797196|NCT03125902|10797369|FG001|Overall Study|Study is ongoing|282
6797197|NCT03077620|10797380|FG000|Overall Study|Unable to place lumbar catheter|1
6797198|NCT03077620|10797381|FG001|Overall Study|Unable to place lumbar catheter|0
6797199|NCT03077620|10797382|FG002|Overall Study|Unable to place lumbar catheter|1
6797200|NCT03077620|10797383|FG003|Overall Study|Unable to place lumbar catheter|0
6797201|NCT03077620|10797380|FG000|Overall Study|Withdrawal by Subject|0
6797202|NCT03077620|10797381|FG001|Overall Study|Withdrawal by Subject|1
6797203|NCT03077620|10797382|FG002|Overall Study|Withdrawal by Subject|0
6797204|NCT03077620|10797383|FG003|Overall Study|Withdrawal by Subject|0
6797205|NCT03077620|10797380|FG000|Overall Study|Physician Decision|0
6797206|NCT03077620|10797381|FG001|Overall Study|Physician Decision|0
6797207|NCT03077620|10797382|FG002|Overall Study|Physician Decision|1
6797208|NCT03077620|10797383|FG003|Overall Study|Physician Decision|0
6797209|NCT02951052|10797408|FG000|Overall Study|Adverse Event|13
6797210|NCT02951052|10797409|FG001|Overall Study|Adverse Event|5
6797211|NCT02951052|10797408|FG000|Overall Study|Withdrawal by Subject|1
6797212|NCT02951052|10797409|FG001|Overall Study|Withdrawal by Subject|5
6797213|NCT02951052|10797408|FG000|Overall Study|Physician Decision|2
6797214|NCT02951052|10797409|FG001|Overall Study|Physician Decision|0
6797215|NCT02951052|10797408|FG000|Overall Study|Lost to Follow-up|1
6797216|NCT02951052|10797409|FG001|Overall Study|Lost to Follow-up|1
6797217|NCT02951052|10797408|FG000|Overall Study|Protocol-specified withdrawal criterion|1
6797218|NCT02951052|10797409|FG001|Overall Study|Protocol-specified withdrawal criterion|0
6797219|NCT02951052|10797408|FG000|Overall Study|Protocol Violation|5
6797220|NCT02951052|10797409|FG001|Overall Study|Protocol Violation|3
6797221|NCT02951052|10797408|FG000|Overall Study|Lack of Efficacy|3
6797222|NCT02951052|10797409|FG001|Overall Study|Lack of Efficacy|4
6797223|NCT02951052|10797408|FG000|Overall Study|Ongoing|1
6797224|NCT02951052|10797409|FG001|Overall Study|Ongoing|0
6797225|NCT02598583|10797430|FG000|Extension Period|Withdrawal by Subject|1
6797226|NCT02598583|10797431|FG001|Extension Period|Withdrawal by Subject|0
6797227|NCT02536794|10797446|FG000|Reached 1st Response Assessment|Adverse Event|2
6797228|NCT02536794|10797446|FG000|Reached 1st Response Assessment|Progressive Disease|2
6797229|NCT02536794|10797446|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1
6797230|NCT02536794|10797446|FG000|Reached 1st Response Assessment|Protocol Violation|1
6797231|NCT02536794|10797446|FG000|Continued Treatment After 1st Response|Progressive disease|7
6797232|NCT02536794|10797446|FG000|Continued Treatment After 1st Response|Adverse Event|1
6809180|NCT02359994|10812516|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0
6809181|NCT02359994|10812517|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1
6809182|NCT02359994|10812516|FG000|Extended Oncology 24-Month Survival|Death|19
6809183|NCT02359994|10812517|FG001|Extended Oncology 24-Month Survival|Death|21
6809184|NCT02359994|10812516|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1
6809185|NCT02359994|10812517|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0
6809186|NCT02336230|10812523|FG000|Overall Study|Adverse Event|1
6809187|NCT02336230|10812523|FG000|Overall Study|Withdrawal of consent|1
6809188|NCT02336230|10812523|FG000|Overall Study|Death|9
6809189|NCT02336230|10812523|FG000|Overall Study|Dose not received due to shipping delay|1
6809190|NCT02336230|10812523|FG000|Overall Study|Discontinuation of MSC infusion|1
6809191|NCT01557751|10812527|FG000|Overall Study|Physician Decision|3
6810978|NCT02460224|10814926|FG019|Overall Study|Lost to Follow-up|0
6810979|NCT02460224|10814927|FG020|Overall Study|Lost to Follow-up|0
6810980|NCT02460224|10814928|FG021|Overall Study|Lost to Follow-up|0
6810981|NCT02460224|10814929|FG022|Overall Study|Lost to Follow-up|1
6810982|NCT02460224|10814930|FG023|Overall Study|Lost to Follow-up|0
6810983|NCT02460224|10814931|FG024|Overall Study|Lost to Follow-up|0
6810984|NCT02460224|10814932|FG025|Overall Study|Lost to Follow-up|0
6810985|NCT02460224|10814933|FG026|Overall Study|Lost to Follow-up|0
6810986|NCT02460224|10814934|FG027|Overall Study|Lost to Follow-up|0
6810987|NCT02460224|10814935|FG028|Overall Study|Lost to Follow-up|0
6810988|NCT02460224|10814907|FG000|Overall Study|Physician Decision|0
6810989|NCT02460224|10814908|FG001|Overall Study|Physician Decision|1
6810990|NCT02460224|10814909|FG002|Overall Study|Physician Decision|0
6810991|NCT02460224|10814910|FG003|Overall Study|Physician Decision|0
6810992|NCT02460224|10814911|FG004|Overall Study|Physician Decision|1
6810993|NCT02460224|10814912|FG005|Overall Study|Physician Decision|0
6810994|NCT02460224|10814913|FG006|Overall Study|Physician Decision|0
6810995|NCT02460224|10814914|FG007|Overall Study|Physician Decision|1
6810996|NCT02460224|10814915|FG008|Overall Study|Physician Decision|0
6810997|NCT02460224|10814916|FG009|Overall Study|Physician Decision|0
6810998|NCT02460224|10814917|FG010|Overall Study|Physician Decision|0
6810999|NCT02460224|10814918|FG011|Overall Study|Physician Decision|1
6811000|NCT02460224|10814919|FG012|Overall Study|Physician Decision|0
6811001|NCT02460224|10814920|FG013|Overall Study|Physician Decision|1
6811002|NCT02460224|10814921|FG014|Overall Study|Physician Decision|0
6811003|NCT02460224|10814922|FG015|Overall Study|Physician Decision|0
6811004|NCT02460224|10814923|FG016|Overall Study|Physician Decision|2
6811005|NCT02460224|10814924|FG017|Overall Study|Physician Decision|1
6811006|NCT02460224|10814925|FG018|Overall Study|Physician Decision|1
6811007|NCT02460224|10814926|FG019|Overall Study|Physician Decision|2
6811008|NCT02460224|10814927|FG020|Overall Study|Physician Decision|1
6811009|NCT02460224|10814928|FG021|Overall Study|Physician Decision|1
6811010|NCT02460224|10814929|FG022|Overall Study|Physician Decision|0
6811011|NCT02460224|10814930|FG023|Overall Study|Physician Decision|0
6811012|NCT02460224|10814931|FG024|Overall Study|Physician Decision|1
6811013|NCT02460224|10814932|FG025|Overall Study|Physician Decision|0
6811014|NCT02460224|10814933|FG026|Overall Study|Physician Decision|14
6811015|NCT02460224|10814934|FG027|Overall Study|Physician Decision|1
6811016|NCT02460224|10814935|FG028|Overall Study|Physician Decision|6
6811017|NCT02460224|10814907|FG000|Overall Study|Progressive disease|15
6811018|NCT02460224|10814908|FG001|Overall Study|Progressive disease|11
6811019|NCT02460224|10814909|FG002|Overall Study|Progressive disease|5
6811020|NCT02460224|10814910|FG003|Overall Study|Progressive disease|6
6811021|NCT02460224|10814911|FG004|Overall Study|Progressive disease|3
6811022|NCT02460224|10814912|FG005|Overall Study|Progressive disease|26
6811023|NCT02460224|10814913|FG006|Overall Study|Progressive disease|28
6811024|NCT02460224|10814914|FG007|Overall Study|Progressive disease|4
6811025|NCT02460224|10814915|FG008|Overall Study|Progressive disease|5
6811026|NCT02460224|10814916|FG009|Overall Study|Progressive disease|9
6811027|NCT02460224|10814917|FG010|Overall Study|Progressive disease|5
6811028|NCT02460224|10814918|FG011|Overall Study|Progressive disease|4
6811029|NCT02460224|10814919|FG012|Overall Study|Progressive disease|5
6797233|NCT02285114|10797466|FG000|Overall Study|Investigator's Discretion|0
6797234|NCT02285114|10797467|FG001|Overall Study|Investigator's Discretion|2
6797235|NCT02285114|10797468|FG002|Overall Study|Investigator's Discretion|0
6797236|NCT02285114|10797466|FG000|Overall Study|Withdrew Consent|0
6797237|NCT02285114|10797467|FG001|Overall Study|Withdrew Consent|0
6797238|NCT02285114|10797468|FG002|Overall Study|Withdrew Consent|1
6797239|NCT02285114|10797466|FG000|Overall Study|Enrolled but not treated|1
6797240|NCT02285114|10797467|FG001|Overall Study|Enrolled but not treated|0
6797241|NCT02285114|10797468|FG002|Overall Study|Enrolled but not treated|0
6797242|NCT02285114|10797466|FG000|Overall Study|Still on study|21
6797243|NCT02285114|10797467|FG001|Overall Study|Still on study|5
6797244|NCT02285114|10797468|FG002|Overall Study|Still on study|2
6797245|NCT02263508|10797485|FG000|Overall Study|Withdrawal by Subject|1
6797246|NCT02263508|10797486|FG001|Overall Study|Withdrawal by Subject|23
6797247|NCT02263508|10797487|FG002|Overall Study|Withdrawal by Subject|17
6797248|NCT02263508|10797485|FG000|Overall Study|Sponsor Decision|12
6797249|NCT02263508|10797486|FG001|Overall Study|Sponsor Decision|165
6797250|NCT02263508|10797487|FG002|Overall Study|Sponsor Decision|182
6797251|NCT02263508|10797485|FG000|Overall Study|Lost to Follow-up|2
6797252|NCT02263508|10797486|FG001|Overall Study|Lost to Follow-up|7
6797253|NCT02263508|10797487|FG002|Overall Study|Lost to Follow-up|7
6797254|NCT02263508|10797485|FG000|Overall Study|Death|6
6797255|NCT02263508|10797486|FG001|Overall Study|Death|151
6797256|NCT02263508|10797487|FG002|Overall Study|Death|140
6797257|NCT02246530|10797500|FG000|Overall Study|Lost to Follow-up|4
6797258|NCT02246530|10797501|FG001|Overall Study|Lost to Follow-up|0
6797259|NCT01936857|10797534|FG000|Overall Study|Sent to prison or 06 center|11
6797260|NCT01936857|10797535|FG001|Overall Study|Sent to prison or 06 center|12
6797261|NCT01936857|10797534|FG000|Overall Study|Lost to Follow-up|10
6797262|NCT01936857|10797535|FG001|Overall Study|Lost to Follow-up|7
6797263|NCT01936857|10797534|FG000|Overall Study|Death|7
6797264|NCT01936857|10797535|FG001|Overall Study|Death|3
6797265|NCT01936857|10797534|FG000|Overall Study|Moved|2
6797266|NCT01936857|10797535|FG001|Overall Study|Moved|1
6797267|NCT01936857|10797534|FG000|Overall Study|Withdrawal by Subject|1
6797268|NCT01936857|10797535|FG001|Overall Study|Withdrawal by Subject|0
6797269|NCT01936857|10797534|FG000|Overall Study|Side effect of medication|1
6797270|NCT01936857|10797535|FG001|Overall Study|Side effect of medication|0
6797271|NCT01936857|10797534|FG000|Overall Study|Other|2
6797272|NCT01936857|10797535|FG001|Overall Study|Other|2
6797297|NCT01715285|10797561|FG000|Treatment Period|Adverse Event|60
6797298|NCT01715285|10797562|FG001|Treatment Period|Adverse Event|33
6797299|NCT01715285|10797563|FG002|Treatment Period|Adverse Event|0
6797300|NCT01715285|10797561|FG000|Treatment Period|Lost to Follow-up|3
6797301|NCT01715285|10797562|FG001|Treatment Period|Lost to Follow-up|2
6797302|NCT01715285|10797563|FG002|Treatment Period|Lost to Follow-up|0
6797303|NCT01715285|10797561|FG000|Treatment Period|Death|36
6797304|NCT01715285|10797562|FG001|Treatment Period|Death|23
6797305|NCT01715285|10797563|FG002|Treatment Period|Death|0
6797306|NCT01715285|10797561|FG000|Treatment Period|Noncompliance With Study Drug|4
6797307|NCT01715285|10797562|FG001|Treatment Period|Noncompliance With Study Drug|2
6797308|NCT01715285|10797563|FG002|Treatment Period|Noncompliance With Study Drug|0
6797309|NCT01715285|10797561|FG000|Treatment Period|Progressive Disease|254
6797310|NCT01715285|10797562|FG001|Treatment Period|Progressive Disease|388
6797311|NCT01715285|10797563|FG002|Treatment Period|Progressive Disease|0
6797312|NCT01715285|10797561|FG000|Treatment Period|Withdrawal Of Consent|52
6797313|NCT01715285|10797562|FG001|Treatment Period|Withdrawal Of Consent|47
6797314|NCT01715285|10797563|FG002|Treatment Period|Withdrawal Of Consent|0
6797315|NCT01715285|10797561|FG000|Treatment Period|Physician Decision|21
6797316|NCT01715285|10797562|FG001|Treatment Period|Physician Decision|23
6797317|NCT01715285|10797563|FG002|Treatment Period|Physician Decision|0
6797318|NCT01715285|10797561|FG000|Treatment Period|Ongoing|157
6797319|NCT01715285|10797562|FG001|Treatment Period|Ongoing|0
6797320|NCT01715285|10797563|FG002|Treatment Period|Ongoing|0
6797321|NCT01715285|10797561|FG000|Treatment Period|Other|10
6797322|NCT01715285|10797562|FG001|Treatment Period|Other|12
6797323|NCT01715285|10797563|FG002|Treatment Period|Other|0
6797324|NCT01715285|10797561|FG000|Treatment Period|Placebo Cross-over|0
6797325|NCT01715285|10797562|FG001|Treatment Period|Placebo Cross-over|72
6797326|NCT01715285|10797563|FG002|Treatment Period|Placebo Cross-over|0
6797327|NCT01715285|10797561|FG000|Open-label (OL) Extension Phase|Ongoing|157
6797328|NCT01715285|10797562|FG001|Open-label (OL) Extension Phase|Ongoing|0
6797329|NCT01715285|10797563|FG002|Open-label (OL) Extension Phase|Ongoing|72
6809197|NCT03790917|10812570|FG000|Overall Study|Death|1
6809198|NCT05017493|10812586|FG000|Overall Study|Withdrawal by Subject|26
6809199|NCT05017493|10812587|FG001|Overall Study|Withdrawal by Subject|0
6809200|NCT05017493|10812586|FG000|Overall Study|Physician Decision|15
6809201|NCT05017493|10812587|FG001|Overall Study|Physician Decision|0
6809202|NCT05017493|10812586|FG000|Overall Study|Protocol Violation|81
6809203|NCT05017493|10812587|FG001|Overall Study|Protocol Violation|0
6809204|NCT04348500|10812620|FG000|Overall Study|Death|2
6809205|NCT04348500|10812621|FG001|Overall Study|Death|2
6809206|NCT04348500|10812620|FG000|Overall Study|Withdrawn by subject due to dementia|0
6809207|NCT04348500|10812621|FG001|Overall Study|Withdrawn by subject due to dementia|1
6809208|NCT03799198|10812664|FG000|Overall Study|Lost to Follow-up|4
6809209|NCT03799198|10812665|FG001|Overall Study|Lost to Follow-up|8
6809210|NCT03799198|10812664|FG000|Overall Study|Death|0
6809211|NCT03799198|10812665|FG001|Overall Study|Death|1
6809212|NCT03770728|10812675|FG000|Overall Study|Adverse Event|1
6809213|NCT03770728|10812676|FG001|Overall Study|Adverse Event|0
6809214|NCT03770728|10812677|FG002|Overall Study|Adverse Event|1
6809215|NCT03770728|10812678|FG003|Overall Study|Adverse Event|0
6809216|NCT03770728|10812675|FG000|Overall Study|Poor compliance to protocol|0
6809217|NCT03770728|10812676|FG001|Overall Study|Poor compliance to protocol|0
6809218|NCT03770728|10812677|FG002|Overall Study|Poor compliance to protocol|1
6809219|NCT03770728|10812678|FG003|Overall Study|Poor compliance to protocol|0
6809220|NCT03770728|10812675|FG000|Overall Study|Withdrawal by Subject|13
6809221|NCT03770728|10812676|FG001|Overall Study|Withdrawal by Subject|8
6809222|NCT03770728|10812677|FG002|Overall Study|Withdrawal by Subject|9
6809223|NCT03770728|10812678|FG003|Overall Study|Withdrawal by Subject|13
6809224|NCT03770728|10812675|FG000|Overall Study|Other than specified|24
6809225|NCT03770728|10812676|FG001|Overall Study|Other than specified|23
6809226|NCT03770728|10812677|FG002|Overall Study|Other than specified|21
6809227|NCT03770728|10812678|FG003|Overall Study|Other than specified|22
6809228|NCT03760146|10812696|FG000|Overall Study|Adverse Event|11
6809229|NCT03760146|10812697|FG001|Overall Study|Adverse Event|8
6809230|NCT03760146|10812698|FG002|Overall Study|Adverse Event|0
6809231|NCT03760146|10812699|FG003|Overall Study|Adverse Event|0
6809232|NCT03760146|10812700|FG004|Overall Study|Adverse Event|0
6809233|NCT03760146|10812701|FG005|Overall Study|Adverse Event|0
6809234|NCT03760146|10812696|FG000|Overall Study|Death|1
6809235|NCT03760146|10812697|FG001|Overall Study|Death|0
6809236|NCT03760146|10812698|FG002|Overall Study|Death|0
6809237|NCT03760146|10812699|FG003|Overall Study|Death|0
6809238|NCT03760146|10812700|FG004|Overall Study|Death|0
6809239|NCT03760146|10812701|FG005|Overall Study|Death|0
6809240|NCT03760146|10812696|FG000|Overall Study|Lost to Follow-up|41
6809241|NCT03760146|10812697|FG001|Overall Study|Lost to Follow-up|28
6809242|NCT03760146|10812698|FG002|Overall Study|Lost to Follow-up|9
6809243|NCT03760146|10812699|FG003|Overall Study|Lost to Follow-up|2
6809244|NCT03760146|10812700|FG004|Overall Study|Lost to Follow-up|14
6809245|NCT03760146|10812701|FG005|Overall Study|Lost to Follow-up|8
6809246|NCT03760146|10812696|FG000|Overall Study|No longer met eligibility criteria|3
6809247|NCT03760146|10812697|FG001|Overall Study|No longer met eligibility criteria|9
6809248|NCT03760146|10812698|FG002|Overall Study|No longer met eligibility criteria|0
6797330|NCT04209725|10797592|FG000|Overall Study|Adverse Event|1
6797331|NCT04185909|10797596|FG000|Overall Study|Lost to Follow-up|1
6797332|NCT04076943|10797600|FG000|Overall Study|Withdrawal by Subject|12
6797333|NCT04076943|10797600|FG000|Overall Study|Adverse Event|1
6797334|NCT04076943|10797600|FG000|Overall Study|Progressive Disease|2
6797335|NCT04076943|10797600|FG000|Overall Study|Death|13
6797336|NCT04076943|10797600|FG000|Overall Study|Other than specified|6
6797337|NCT03905694|10797614|FG000|Long-term Extension Period|Remained in this Period at Time of Data Cut|18
6797338|NCT03332498|10797621|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0
6797339|NCT03332498|10797622|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0
6797340|NCT03332498|10797623|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2
6797341|NCT02900976|10797641|FG000|Overall Study|Adverse Event|0
6797342|NCT02900976|10797642|FG001|Overall Study|Adverse Event|1
6797343|NCT02900976|10797641|FG000|Overall Study|Physician Decision|0
6797344|NCT02900976|10797642|FG001|Overall Study|Physician Decision|2
6797345|NCT02900976|10797641|FG000|Overall Study|Progressive disease|0
6797346|NCT02900976|10797642|FG001|Overall Study|Progressive disease|6
6797347|NCT02720185|10797658|FG000|Overall Study|Lost to Follow-up|1
6797348|NCT02710669|10797665|FG000|Overall Study|Physician Decision|2
6797349|NCT02710669|10797666|FG001|Overall Study|Physician Decision|1
6797350|NCT02710669|10797667|FG002|Overall Study|Physician Decision|0
6797351|NCT02710669|10797665|FG000|Overall Study|Institutional delays (including COVID)|2
6797352|NCT02710669|10797666|FG001|Overall Study|Institutional delays (including COVID)|2
6797353|NCT02710669|10797667|FG002|Overall Study|Institutional delays (including COVID)|0
6797354|NCT02710669|10797665|FG000|Overall Study|arrived in afib/aflutter|10
6797355|NCT02710669|10797666|FG001|Overall Study|arrived in afib/aflutter|8
6797356|NCT02710669|10797667|FG002|Overall Study|arrived in afib/aflutter|2
6797357|NCT02684461|10797678|FG000|Overall Study|Adverse Event|1
6797358|NCT02684461|10797679|FG001|Overall Study|Adverse Event|0
6797359|NCT02684461|10797680|FG002|Overall Study|Adverse Event|0
6797360|NCT02684461|10797678|FG000|Overall Study|Lack of Efficacy|1
6797361|NCT02684461|10797679|FG001|Overall Study|Lack of Efficacy|2
6797362|NCT02684461|10797680|FG002|Overall Study|Lack of Efficacy|0
6797363|NCT02657343|10797700|FG000|Overall Study|Death|0
6797364|NCT02657343|10797701|FG001|Overall Study|Death|2
6797365|NCT02657343|10797702|FG002|Overall Study|Death|0
6797366|NCT02657343|10797703|FG003|Overall Study|Death|0
6797367|NCT02657343|10797704|FG004|Overall Study|Death|0
6797368|NCT02657343|10797705|FG005|Overall Study|Death|0
6797369|NCT02657343|10797700|FG000|Overall Study|Patient went to hospice|1
6797370|NCT02657343|10797701|FG001|Overall Study|Patient went to hospice|0
6797371|NCT02657343|10797702|FG002|Overall Study|Patient went to hospice|0
6797372|NCT02657343|10797703|FG003|Overall Study|Patient went to hospice|0
6797373|NCT02657343|10797704|FG004|Overall Study|Patient went to hospice|0
6797374|NCT02657343|10797705|FG005|Overall Study|Patient went to hospice|0
6797375|NCT02657343|10797700|FG000|Overall Study|Withdrawal by Subject|0
6797376|NCT02657343|10797701|FG001|Overall Study|Withdrawal by Subject|0
6797377|NCT02657343|10797702|FG002|Overall Study|Withdrawal by Subject|0
6797378|NCT02657343|10797703|FG003|Overall Study|Withdrawal by Subject|0
6797379|NCT02657343|10797704|FG004|Overall Study|Withdrawal by Subject|1
6797380|NCT02657343|10797705|FG005|Overall Study|Withdrawal by Subject|0
6797381|NCT02063724|10797732|FG000|Overall Study|Disease progression|1
6797382|NCT00601900|10797776|FG000|Overall Study|Withdrawal by Subject|0
6797383|NCT00601900|10797777|FG001|Overall Study|Withdrawal by Subject|3
6797384|NCT01295944|10797783|FG000|Overall Study|Switched to alternative treatment|1
6797385|NCT01295944|10797783|FG000|Overall Study|Ineligible|9
6797386|NCT01295944|10797783|FG000|Overall Study|Withdrawal by Subject|4
6797387|NCT01295944|10797783|FG000|Overall Study|Participant chose to be treated in Peru|1
6797388|NCT01295944|10797783|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1
6797389|NCT01295944|10797783|FG000|Overall Study|Participant was diagnosed with stage 1 infiltrated ductal carcinoma of the right breast(10/03/2013).|1
6797390|NCT01295944|10797783|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1
6797391|NCT01285557|10797789|FG000|Overall Study|Death|173
6797392|NCT01285557|10797790|FG001|Overall Study|Death|90
6797393|NCT01285557|10797789|FG000|Overall Study|Lost to Follow-up|6
6797394|NCT01285557|10797790|FG001|Overall Study|Lost to Follow-up|2
6797395|NCT01285557|10797789|FG000|Overall Study|Withdrew Consent|6
6797396|NCT01285557|10797790|FG001|Overall Study|Withdrew Consent|1
6797397|NCT01285557|10797789|FG000|Overall Study|Sponsor Study Termination|23
6797398|NCT01285557|10797790|FG001|Overall Study|Sponsor Study Termination|13
6797399|NCT01285557|10797789|FG000|Overall Study|Randomized but not treated|1
6797400|NCT01285557|10797790|FG001|Overall Study|Randomized but not treated|1
6797401|NCT01285557|10797789|FG000|Overall Study|Study follow-up ongoing|28
6797402|NCT01285557|10797790|FG001|Overall Study|Study follow-up ongoing|14
6797403|NCT01285557|10797789|FG000|Overall Study|Sponsor Decision|2
6797404|NCT01285557|10797790|FG001|Overall Study|Sponsor Decision|1
6797405|NCT00964002|10797820|FG000|Overall Study|Protocol Violation|8
6797406|NCT00790218|10797833|FG000|Overall Study|Death|1
6797407|NCT00790218|10797834|FG001|Overall Study|Death|0
6797408|NCT00790218|10797835|FG002|Overall Study|Death|0
6797409|NCT00145600|10797900|FG000|Overall Study|Death|1
6797410|NCT00145600|10797901|FG001|Overall Study|Death|2
6797411|NCT00145600|10797902|FG002|Overall Study|Death|2
6797412|NCT00145600|10797903|FG003|Overall Study|Death|6
6797413|NCT00145600|10797900|FG000|Overall Study|Ineligible|3
6797414|NCT00145600|10797901|FG001|Overall Study|Ineligible|0
6797415|NCT00145600|10797902|FG002|Overall Study|Ineligible|1
6797416|NCT00145600|10797903|FG003|Overall Study|Ineligible|5
6797417|NCT00145600|10797900|FG000|Overall Study|Lost to Follow-up|2
6797418|NCT00145600|10797901|FG001|Overall Study|Lost to Follow-up|6
6797419|NCT00145600|10797902|FG002|Overall Study|Lost to Follow-up|2
6797420|NCT00145600|10797903|FG003|Overall Study|Lost to Follow-up|4
6797421|NCT00145600|10797900|FG000|Overall Study|Noncompliance|1
6797422|NCT00145600|10797901|FG001|Overall Study|Noncompliance|0
6797423|NCT00145600|10797902|FG002|Overall Study|Noncompliance|0
6797424|NCT00145600|10797903|FG003|Overall Study|Noncompliance|0
6797425|NCT00145600|10797900|FG000|Overall Study|Withdrawal by Subject|1
6797426|NCT00145600|10797901|FG001|Overall Study|Withdrawal by Subject|2
6797427|NCT00145600|10797902|FG002|Overall Study|Withdrawal by Subject|0
6797428|NCT00145600|10797903|FG003|Overall Study|Withdrawal by Subject|1
6809249|NCT03760146|10812699|FG003|Overall Study|No longer met eligibility criteria|0
6809250|NCT03760146|10812700|FG004|Overall Study|No longer met eligibility criteria|1
6809251|NCT03760146|10812701|FG005|Overall Study|No longer met eligibility criteria|0
6809252|NCT03760146|10812696|FG000|Overall Study|Protocol Violation|21
6809253|NCT03760146|10812697|FG001|Overall Study|Protocol Violation|13
6809254|NCT03760146|10812698|FG002|Overall Study|Protocol Violation|1
6809255|NCT03760146|10812699|FG003|Overall Study|Protocol Violation|0
6809256|NCT03760146|10812700|FG004|Overall Study|Protocol Violation|1
6809257|NCT03760146|10812701|FG005|Overall Study|Protocol Violation|0
6809258|NCT03760146|10812696|FG000|Overall Study|Withdrawal by Subject|19
6809259|NCT03760146|10812697|FG001|Overall Study|Withdrawal by Subject|20
6809260|NCT03760146|10812698|FG002|Overall Study|Withdrawal by Subject|1
6809261|NCT03760146|10812699|FG003|Overall Study|Withdrawal by Subject|0
6809262|NCT03760146|10812700|FG004|Overall Study|Withdrawal by Subject|1
6809263|NCT03760146|10812701|FG005|Overall Study|Withdrawal by Subject|0
6809264|NCT03760081|10812721|FG000|Overall Study|Miscellaneous|0
6809265|NCT03760081|10812722|FG001|Overall Study|Miscellaneous|1
6809266|NCT03760081|10812721|FG000|Overall Study|Progressive Disease|5
6809267|NCT03760081|10812722|FG001|Overall Study|Progressive Disease|10
6809268|NCT03760081|10812721|FG000|Overall Study|Death|1
6809269|NCT03760081|10812722|FG001|Overall Study|Death|1
6809270|NCT03737110|10812732|FG000|Run-in (RI) Period|Lack of Efficacy|3
6809271|NCT03737110|10812733|FG001|Run-in (RI) Period|Lack of Efficacy|0
6809272|NCT03737110|10812734|FG002|Run-in (RI) Period|Lack of Efficacy|0
6809273|NCT03737110|10812732|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3
6809274|NCT03737110|10812733|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0
6809275|NCT03737110|10812734|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0
6809276|NCT03737110|10812732|FG000|Run-in (RI) Period|Adverse Event|4
6809277|NCT03737110|10812733|FG001|Run-in (RI) Period|Adverse Event|0
6809278|NCT03737110|10812734|FG002|Run-in (RI) Period|Adverse Event|0
6809279|NCT03737110|10812732|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0
6809280|NCT03737110|10812733|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1
6809281|NCT03737110|10812734|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0
6809282|NCT03737110|10812732|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0
6809283|NCT03737110|10812733|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0
6809284|NCT03737110|10812734|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1
6809285|NCT03713684|10812756|FG000|Overall Study|Adverse Event|1
6809286|NCT03713684|10812757|FG001|Overall Study|Adverse Event|3
6809287|NCT03713684|10812758|FG002|Overall Study|Adverse Event|1
6809288|NCT03713684|10812759|FG003|Overall Study|Adverse Event|0
6809289|NCT03713684|10812756|FG000|Overall Study|Poor compliance to protocol|2
6809290|NCT03713684|10812757|FG001|Overall Study|Poor compliance to protocol|1
6809291|NCT03713684|10812758|FG002|Overall Study|Poor compliance to protocol|0
6809292|NCT03713684|10812759|FG003|Overall Study|Poor compliance to protocol|1
6809293|NCT03713684|10812756|FG000|Overall Study|Withdrawal by Subject|14
6809294|NCT03713684|10812757|FG001|Overall Study|Withdrawal by Subject|6
6809295|NCT03713684|10812758|FG002|Overall Study|Withdrawal by Subject|14
6809296|NCT03713684|10812759|FG003|Overall Study|Withdrawal by Subject|16
6809297|NCT03713684|10812756|FG000|Overall Study|Other than specified|69
6809298|NCT03713684|10812757|FG001|Overall Study|Other than specified|77
6809299|NCT03713684|10812758|FG002|Overall Study|Other than specified|73
6809300|NCT03713684|10812759|FG003|Overall Study|Other than specified|70
6809301|NCT03644550|10812769|FG000|Overall Study|Withdrawal by Subject|3
6809302|NCT03644550|10812769|FG000|Overall Study|Progressive disease|15
6809303|NCT03557970|10812776|FG000|Overall Study|Study closure|1
6809304|NCT03557970|10812777|FG001|Overall Study|Study closure|0
6809305|NCT03557970|10812776|FG000|Overall Study|Physician Decision|0
6809306|NCT03557970|10812777|FG001|Overall Study|Physician Decision|1
6809307|NCT03557970|10812776|FG000|Overall Study|Death|0
6809308|NCT03557970|10812777|FG001|Overall Study|Death|1
6811030|NCT02460224|10814920|FG013|Overall Study|Progressive disease|4
6811031|NCT02460224|10814921|FG014|Overall Study|Progressive disease|5
6811032|NCT02460224|10814922|FG015|Overall Study|Progressive disease|5
6811033|NCT02460224|10814923|FG016|Overall Study|Progressive disease|15
6811034|NCT02460224|10814924|FG017|Overall Study|Progressive disease|3
6811035|NCT02460224|10814925|FG018|Overall Study|Progressive disease|8
6811036|NCT02460224|10814926|FG019|Overall Study|Progressive disease|3
6797429|NCT03084367|10797949|FG000|Overall Study|Lost to Follow-up|32
6797430|NCT03084367|10797949|FG000|Overall Study|Withdrawal by Subject|4
6797431|NCT03084367|10797949|FG000|Overall Study|Other|1
6797432|NCT04980040|10798047|FG000|Overall Study|Violated the Inclusion Criteria|260
6797433|NCT04980040|10798047|FG000|Overall Study|Violated the Administration & Dosage|225
6797434|NCT04980040|10798047|FG000|Overall Study|Lost to Safety-Follow-up|4
6797435|NCT04980040|10798047|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3
6797436|NCT04167670|10798063|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1
6797437|NCT04167670|10798064|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7
6797438|NCT04167670|10798065|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4
6797439|NCT04167670|10798063|FG000|Overall Study|Significant protocol deviation|3
6797440|NCT04167670|10798064|FG001|Overall Study|Significant protocol deviation|1
6797441|NCT04167670|10798065|FG002|Overall Study|Significant protocol deviation|0
6797442|NCT04167670|10798063|FG000|Overall Study|Lost to Follow-up|0
6797443|NCT04167670|10798064|FG001|Overall Study|Lost to Follow-up|3
6797444|NCT04167670|10798065|FG002|Overall Study|Lost to Follow-up|3
6797445|NCT04167670|10798063|FG000|Overall Study|Voluntary Withdrawal|0
6797446|NCT04167670|10798064|FG001|Overall Study|Voluntary Withdrawal|1
6797447|NCT04167670|10798065|FG002|Overall Study|Voluntary Withdrawal|1
6797448|NCT04167670|10798063|FG000|Overall Study|Withdrawal of Consent|4
6797449|NCT04167670|10798064|FG001|Overall Study|Withdrawal of Consent|1
6797450|NCT04167670|10798065|FG002|Overall Study|Withdrawal of Consent|3
6797451|NCT04167670|10798063|FG000|Overall Study|Miscellaneous|7
6797452|NCT04167670|10798064|FG001|Overall Study|Miscellaneous|5
6797453|NCT04167670|10798065|FG002|Overall Study|Miscellaneous|3
6797454|NCT04076917|10798073|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49
6797455|NCT04076917|10798073|FG000|Overall Study|Study closure|13
6797456|NCT04076917|10798073|FG000|Overall Study|Physician Decision|3
6797457|NCT04076917|10798073|FG000|Overall Study|Death|1
6797458|NCT04076917|10798073|FG000|Overall Study|Lost to Follow-up|1
6797459|NCT04076917|10798073|FG000|Overall Study|Withdrawal by Subject|1
6797460|NCT04076917|10798073|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1
6797461|NCT04000009|10798077|FG000|Overall Study|Adverse Event|13
6797462|NCT04000009|10798077|FG000|Overall Study|Lack of Efficacy|7
6797463|NCT04000009|10798077|FG000|Overall Study|Lost to Follow-up|8
6797464|NCT04000009|10798077|FG000|Overall Study|Noncompliance with study drug|4
6797465|NCT04000009|10798077|FG000|Overall Study|Physician Decision|1
6797466|NCT04000009|10798077|FG000|Overall Study|Use of prohibited medication|3
6797467|NCT04000009|10798077|FG000|Overall Study|Pregnancy|1
6797468|NCT04000009|10798077|FG000|Overall Study|Withdrawal by Subject|22
6797469|NCT04000009|10798077|FG000|Overall Study|Study terminated by sponsor|98
6797470|NCT04000009|10798077|FG000|Overall Study|Not further specified|8
6797471|NCT03674112|10798105|FG000|Overall Study|Adverse Event|1
6797472|NCT03674112|10798106|FG001|Overall Study|Adverse Event|0
6797473|NCT03674112|10798105|FG000|Overall Study|Ongoing in the Study|79
6797474|NCT03674112|10798106|FG001|Overall Study|Ongoing in the Study|80
6797475|NCT03205371|10798158|FG000|Overall Study|Withdrawal by Subject|4
6797476|NCT03205371|10798159|FG001|Overall Study|Withdrawal by Subject|1
6797477|NCT03205371|10798160|FG002|Overall Study|Withdrawal by Subject|0
6797478|NCT03205371|10798161|FG003|Overall Study|Withdrawal by Subject|0
6797479|NCT03205371|10798162|FG004|Overall Study|Withdrawal by Subject|0
6797480|NCT03205371|10798163|FG005|Overall Study|Withdrawal by Subject|0
6797481|NCT03205371|10798164|FG006|Overall Study|Withdrawal by Subject|4
6797482|NCT03205371|10798165|FG007|Overall Study|Withdrawal by Subject|0
6797483|NCT03205371|10798166|FG008|Overall Study|Withdrawal by Subject|2
6797484|NCT03205371|10798167|FG009|Overall Study|Withdrawal by Subject|0
6797485|NCT03205371|10798168|FG010|Overall Study|Withdrawal by Subject|0
6797486|NCT03205371|10798169|FG011|Overall Study|Withdrawal by Subject|1
6797487|NCT03205371|10798158|FG000|Overall Study|Lost to Follow-up|0
6797488|NCT03205371|10798159|FG001|Overall Study|Lost to Follow-up|0
6797489|NCT03205371|10798160|FG002|Overall Study|Lost to Follow-up|0
6797490|NCT03205371|10798161|FG003|Overall Study|Lost to Follow-up|0
6797491|NCT03205371|10798162|FG004|Overall Study|Lost to Follow-up|0
6797492|NCT03205371|10798163|FG005|Overall Study|Lost to Follow-up|0
6797493|NCT03205371|10798164|FG006|Overall Study|Lost to Follow-up|5
6797494|NCT03205371|10798165|FG007|Overall Study|Lost to Follow-up|2
6797495|NCT03205371|10798166|FG008|Overall Study|Lost to Follow-up|3
6797496|NCT03205371|10798167|FG009|Overall Study|Lost to Follow-up|0
6797497|NCT03205371|10798168|FG010|Overall Study|Lost to Follow-up|0
6797498|NCT03205371|10798169|FG011|Overall Study|Lost to Follow-up|0
6797499|NCT03205371|10798158|FG000|Overall Study|Protocol Violation|0
6797500|NCT03205371|10798159|FG001|Overall Study|Protocol Violation|0
6797501|NCT03205371|10798160|FG002|Overall Study|Protocol Violation|0
6797502|NCT03205371|10798161|FG003|Overall Study|Protocol Violation|0
6797503|NCT03205371|10798162|FG004|Overall Study|Protocol Violation|0
6797504|NCT03205371|10798163|FG005|Overall Study|Protocol Violation|0
6797505|NCT03205371|10798164|FG006|Overall Study|Protocol Violation|1
6797506|NCT03205371|10798165|FG007|Overall Study|Protocol Violation|0
6797507|NCT03205371|10798166|FG008|Overall Study|Protocol Violation|0
6797508|NCT03205371|10798167|FG009|Overall Study|Protocol Violation|0
6797509|NCT03205371|10798168|FG010|Overall Study|Protocol Violation|0
6797510|NCT03205371|10798169|FG011|Overall Study|Protocol Violation|0
6797511|NCT03205371|10798158|FG000|Overall Study|Adverse Event|0
6797512|NCT03205371|10798159|FG001|Overall Study|Adverse Event|0
6797513|NCT03205371|10798160|FG002|Overall Study|Adverse Event|0
6797514|NCT03205371|10798161|FG003|Overall Study|Adverse Event|0
6797515|NCT03205371|10798162|FG004|Overall Study|Adverse Event|0
6797516|NCT03205371|10798163|FG005|Overall Study|Adverse Event|0
6797517|NCT03205371|10798164|FG006|Overall Study|Adverse Event|0
6797518|NCT03205371|10798165|FG007|Overall Study|Adverse Event|1
6797519|NCT03205371|10798166|FG008|Overall Study|Adverse Event|0
6797520|NCT03205371|10798167|FG009|Overall Study|Adverse Event|0
6797521|NCT03205371|10798168|FG010|Overall Study|Adverse Event|0
6797522|NCT03205371|10798169|FG011|Overall Study|Adverse Event|0
6797523|NCT03165721|10798218|FG000|Overall Study|Refused further treatment|3
6797524|NCT03165721|10798219|FG001|Overall Study|Refused further treatment|0
6797525|NCT03165721|10798220|FG002|Overall Study|Refused further treatment|0
6797526|NCT03165721|10798218|FG000|Overall Study|Physician Decision|1
6797527|NCT03165721|10798219|FG001|Overall Study|Physician Decision|0
6797528|NCT03165721|10798220|FG002|Overall Study|Physician Decision|0
6797529|NCT03130959|10798240|FG000|Treatment Period|Disease progression|18
6797530|NCT03130959|10798241|FG001|Treatment Period|Disease progression|15
6797531|NCT03130959|10798242|FG002|Treatment Period|Disease progression|12
6797532|NCT03130959|10798243|FG003|Treatment Period|Disease progression|8
6797533|NCT03130959|10798244|FG004|Treatment Period|Disease progression|12
6797534|NCT03130959|10798245|FG005|Treatment Period|Disease progression|11
6797535|NCT03130959|10798246|FG006|Treatment Period|Disease progression|6
6797536|NCT03130959|10798247|FG007|Treatment Period|Disease progression|9
6797537|NCT03130959|10798248|FG008|Treatment Period|Disease progression|15
6797538|NCT03130959|10798249|FG009|Treatment Period|Disease progression|9
6797539|NCT03130959|10798240|FG000|Treatment Period|Study drug toxicity|2
6797540|NCT03130959|10798241|FG001|Treatment Period|Study drug toxicity|3
6797541|NCT03130959|10798242|FG002|Treatment Period|Study drug toxicity|1
6797542|NCT03130959|10798243|FG003|Treatment Period|Study drug toxicity|2
6797543|NCT03130959|10798244|FG004|Treatment Period|Study drug toxicity|1
6797544|NCT03130959|10798245|FG005|Treatment Period|Study drug toxicity|2
6797545|NCT03130959|10798246|FG006|Treatment Period|Study drug toxicity|3
6797546|NCT03130959|10798247|FG007|Treatment Period|Study drug toxicity|0
6797547|NCT03130959|10798248|FG008|Treatment Period|Study drug toxicity|3
6797548|NCT03130959|10798249|FG009|Treatment Period|Study drug toxicity|4
6797549|NCT03130959|10798240|FG000|Treatment Period|Other reasons|1
6797550|NCT03130959|10798241|FG001|Treatment Period|Other reasons|0
6797551|NCT03130959|10798242|FG002|Treatment Period|Other reasons|0
6797552|NCT03130959|10798243|FG003|Treatment Period|Other reasons|0
6797553|NCT03130959|10798244|FG004|Treatment Period|Other reasons|0
6797554|NCT03130959|10798245|FG005|Treatment Period|Other reasons|0
6797555|NCT03130959|10798246|FG006|Treatment Period|Other reasons|1
6797556|NCT03130959|10798247|FG007|Treatment Period|Other reasons|0
6797557|NCT03130959|10798248|FG008|Treatment Period|Other reasons|0
6797558|NCT03130959|10798249|FG009|Treatment Period|Other reasons|0
6797559|NCT03130959|10798240|FG000|Treatment Period|Participant request to stop therapy|0
6797560|NCT03130959|10798241|FG001|Treatment Period|Participant request to stop therapy|1
6797561|NCT03130959|10798242|FG002|Treatment Period|Participant request to stop therapy|1
6797562|NCT03130959|10798243|FG003|Treatment Period|Participant request to stop therapy|1
6797563|NCT03130959|10798244|FG004|Treatment Period|Participant request to stop therapy|0
6797564|NCT03130959|10798245|FG005|Treatment Period|Participant request to stop therapy|0
6797565|NCT03130959|10798246|FG006|Treatment Period|Participant request to stop therapy|1
6797566|NCT03130959|10798247|FG007|Treatment Period|Participant request to stop therapy|1
6797567|NCT03130959|10798248|FG008|Treatment Period|Participant request to stop therapy|0
6797568|NCT03130959|10798249|FG009|Treatment Period|Participant request to stop therapy|0
6797569|NCT03130959|10798240|FG000|Treatment Period|Not reported|0
6797570|NCT03130959|10798241|FG001|Treatment Period|Not reported|2
6797571|NCT03130959|10798242|FG002|Treatment Period|Not reported|0
6797572|NCT03130959|10798243|FG003|Treatment Period|Not reported|1
6797573|NCT03130959|10798244|FG004|Treatment Period|Not reported|0
6797574|NCT03130959|10798245|FG005|Treatment Period|Not reported|2
6797575|NCT03130959|10798246|FG006|Treatment Period|Not reported|0
6797576|NCT03130959|10798247|FG007|Treatment Period|Not reported|0
6797577|NCT03130959|10798248|FG008|Treatment Period|Not reported|0
6797578|NCT03130959|10798249|FG009|Treatment Period|Not reported|2
6797579|NCT03130959|10798240|FG000|Treatment Period|Adverse Event unrelated to drug|0
6797580|NCT03130959|10798241|FG001|Treatment Period|Adverse Event unrelated to drug|0
6797581|NCT03130959|10798242|FG002|Treatment Period|Adverse Event unrelated to drug|1
6797582|NCT03130959|10798243|FG003|Treatment Period|Adverse Event unrelated to drug|1
6797583|NCT03130959|10798244|FG004|Treatment Period|Adverse Event unrelated to drug|1
6797584|NCT03130959|10798245|FG005|Treatment Period|Adverse Event unrelated to drug|0
6797585|NCT03130959|10798246|FG006|Treatment Period|Adverse Event unrelated to drug|1
6797586|NCT03130959|10798247|FG007|Treatment Period|Adverse Event unrelated to drug|0
6797587|NCT03130959|10798248|FG008|Treatment Period|Adverse Event unrelated to drug|1
6797588|NCT03130959|10798249|FG009|Treatment Period|Adverse Event unrelated to drug|1
6797589|NCT03130959|10798240|FG000|Treatment Period|Participant withdrew consent|0
6797590|NCT03130959|10798241|FG001|Treatment Period|Participant withdrew consent|0
6797591|NCT03130959|10798242|FG002|Treatment Period|Participant withdrew consent|0
6797592|NCT03130959|10798243|FG003|Treatment Period|Participant withdrew consent|2
6797593|NCT03130959|10798244|FG004|Treatment Period|Participant withdrew consent|1
6797594|NCT03130959|10798245|FG005|Treatment Period|Participant withdrew consent|0
6797595|NCT03130959|10798246|FG006|Treatment Period|Participant withdrew consent|0
6797596|NCT03130959|10798247|FG007|Treatment Period|Participant withdrew consent|0
6797597|NCT03130959|10798248|FG008|Treatment Period|Participant withdrew consent|0
6797598|NCT03130959|10798249|FG009|Treatment Period|Participant withdrew consent|2
6797599|NCT03130959|10798240|FG000|Follow-up Period|Death|16
6797600|NCT03130959|10798241|FG001|Follow-up Period|Death|17
6797601|NCT03130959|10798242|FG002|Follow-up Period|Death|12
6797602|NCT03130959|10798243|FG003|Follow-up Period|Death|10
6797603|NCT03130959|10798244|FG004|Follow-up Period|Death|11
6797604|NCT03130959|10798245|FG005|Follow-up Period|Death|8
6797605|NCT03130959|10798246|FG006|Follow-up Period|Death|9
6797606|NCT03130959|10798247|FG007|Follow-up Period|Death|7
6797607|NCT03130959|10798248|FG008|Follow-up Period|Death|17
6797608|NCT03130959|10798249|FG009|Follow-up Period|Death|10
6797609|NCT03130959|10798240|FG000|Follow-up Period|Participant withdrew consent|3
6797610|NCT03130959|10798241|FG001|Follow-up Period|Participant withdrew consent|1
6797611|NCT03130959|10798242|FG002|Follow-up Period|Participant withdrew consent|0
6797612|NCT03130959|10798243|FG003|Follow-up Period|Participant withdrew consent|3
6797613|NCT03130959|10798244|FG004|Follow-up Period|Participant withdrew consent|3
6797614|NCT03130959|10798245|FG005|Follow-up Period|Participant withdrew consent|0
6797615|NCT03130959|10798246|FG006|Follow-up Period|Participant withdrew consent|0
6797616|NCT03130959|10798247|FG007|Follow-up Period|Participant withdrew consent|1
6797617|NCT03130959|10798248|FG008|Follow-up Period|Participant withdrew consent|1
6797618|NCT03130959|10798249|FG009|Follow-up Period|Participant withdrew consent|3
6797619|NCT03130959|10798240|FG000|Follow-up Period|Lost to Follow-up|1
6797620|NCT03130959|10798241|FG001|Follow-up Period|Lost to Follow-up|1
6797621|NCT03130959|10798242|FG002|Follow-up Period|Lost to Follow-up|0
6797622|NCT03130959|10798243|FG003|Follow-up Period|Lost to Follow-up|0
6797623|NCT03130959|10798244|FG004|Follow-up Period|Lost to Follow-up|0
6797624|NCT03130959|10798245|FG005|Follow-up Period|Lost to Follow-up|2
6797625|NCT03130959|10798246|FG006|Follow-up Period|Lost to Follow-up|0
6797626|NCT03130959|10798247|FG007|Follow-up Period|Lost to Follow-up|0
6797627|NCT03130959|10798248|FG008|Follow-up Period|Lost to Follow-up|0
6797628|NCT03130959|10798249|FG009|Follow-up Period|Lost to Follow-up|1
6797629|NCT03130959|10798240|FG000|Follow-up Period|Other reasons|0
6797630|NCT03130959|10798241|FG001|Follow-up Period|Other reasons|1
6797631|NCT03130959|10798242|FG002|Follow-up Period|Other reasons|0
6797632|NCT03130959|10798243|FG003|Follow-up Period|Other reasons|1
6797633|NCT03130959|10798244|FG004|Follow-up Period|Other reasons|0
6797634|NCT03130959|10798245|FG005|Follow-up Period|Other reasons|0
6797635|NCT03130959|10798246|FG006|Follow-up Period|Other reasons|0
6797636|NCT03130959|10798247|FG007|Follow-up Period|Other reasons|0
6797637|NCT03130959|10798248|FG008|Follow-up Period|Other reasons|0
6797638|NCT03130959|10798249|FG009|Follow-up Period|Other reasons|2
6797639|NCT02955797|10798288|FG000|Overall Study|Protocol Violation|1
6797640|NCT02955797|10798289|FG001|Overall Study|Protocol Violation|0
6797641|NCT02955797|10798290|FG002|Overall Study|Protocol Violation|0
6797642|NCT02955797|10798291|FG003|Overall Study|Protocol Violation|1
6797643|NCT02955797|10798288|FG000|Overall Study|Withdrawal by Subject|2
6797644|NCT02955797|10798289|FG001|Overall Study|Withdrawal by Subject|2
6797645|NCT02955797|10798290|FG002|Overall Study|Withdrawal by Subject|0
6797646|NCT02955797|10798291|FG003|Overall Study|Withdrawal by Subject|1
6797647|NCT02955797|10798288|FG000|Overall Study|Lost to Follow-up|0
6797648|NCT02955797|10798289|FG001|Overall Study|Lost to Follow-up|1
6797649|NCT02955797|10798290|FG002|Overall Study|Lost to Follow-up|0
6797650|NCT02955797|10798291|FG003|Overall Study|Lost to Follow-up|0
6797651|NCT02859415|10798306|FG000|Overall Study|Physician Decision|1
6797652|NCT02859415|10798307|FG001|Overall Study|Physician Decision|0
6797653|NCT02859415|10798306|FG000|Overall Study|Off treatment due to cardiac event|0
6797654|NCT02859415|10798307|FG001|Overall Study|Off treatment due to cardiac event|1
6797655|NCT02842866|10798316|FG000|Overall Study|Serious Adverse Event|0
6797656|NCT02842866|10798317|FG001|Overall Study|Serious Adverse Event|1
6797657|NCT02842866|10798316|FG000|Overall Study|Protocol Violation|4
6797658|NCT02842866|10798317|FG001|Overall Study|Protocol Violation|2
6797659|NCT02842866|10798316|FG000|Overall Study|Lost to Follow-up|2
6797660|NCT02842866|10798317|FG001|Overall Study|Lost to Follow-up|0
6797661|NCT02842866|10798316|FG000|Overall Study|Withdrawal by Subject|1
6797662|NCT02842866|10798317|FG001|Overall Study|Withdrawal by Subject|0
6797663|NCT02842853|10798327|FG000|Overall Study|Non-compliance with the protocol|3
6797664|NCT02842853|10798328|FG001|Overall Study|Non-compliance with the protocol|7
6797665|NCT02842853|10798329|FG002|Overall Study|Non-compliance with the protocol|2
6797666|NCT02842853|10798330|FG003|Overall Study|Non-compliance with the protocol|5
6797667|NCT02842853|10798327|FG000|Overall Study|Subject met exclusion criteria|0
6797668|NCT02842853|10798328|FG001|Overall Study|Subject met exclusion criteria|1
6797669|NCT02842853|10798329|FG002|Overall Study|Subject met exclusion criteria|0
6797670|NCT02842853|10798330|FG003|Overall Study|Subject met exclusion criteria|0
6797671|NCT02842853|10798327|FG000|Overall Study|Withdrawal by Subject|11
6797672|NCT02842853|10798328|FG001|Overall Study|Withdrawal by Subject|13
6797673|NCT02842853|10798329|FG002|Overall Study|Withdrawal by Subject|9
6797674|NCT02842853|10798330|FG003|Overall Study|Withdrawal by Subject|8
6797675|NCT02842853|10798327|FG000|Overall Study|Lost to Follow-up|9
6797676|NCT02842853|10798328|FG001|Overall Study|Lost to Follow-up|13
6797677|NCT02842853|10798329|FG002|Overall Study|Lost to Follow-up|10
6797678|NCT02842853|10798330|FG003|Overall Study|Lost to Follow-up|11
6797679|NCT02752906|10798344|FG000|Overall Study|Protocol Violation|2
6797680|NCT02752906|10798345|FG001|Overall Study|Protocol Violation|1
6797681|NCT02752906|10798344|FG000|Overall Study|Withdrawal by Subject|2
6797682|NCT02752906|10798345|FG001|Overall Study|Withdrawal by Subject|2
6797683|NCT02752906|10798344|FG000|Overall Study|Lost to Follow-up|3
6797684|NCT02752906|10798345|FG001|Overall Study|Lost to Follow-up|2
6797685|NCT02693691|10798351|FG000|Primary Endpoint Analysis (First 12M)|Death|30
6797686|NCT02693691|10798351|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12
6797687|NCT02693691|10798351|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7
6797688|NCT02693691|10798351|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1
6797689|NCT02693691|10798351|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12
6797690|NCT02693691|10798351|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11
6797691|NCT02693691|10798351|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1
6797692|NCT02388906|10798373|FG000|Pre-Treatment Period|Participant withdrew consent|1
6797693|NCT02388906|10798374|FG001|Pre-Treatment Period|Participant withdrew consent|0
6797694|NCT02388906|10798373|FG000|Treatment Period|Disease progression|121
6797695|NCT02388906|10798374|FG001|Treatment Period|Disease progression|101
6797696|NCT02388906|10798373|FG000|Treatment Period|Study drug toxicity|41
6797697|NCT02388906|10798374|FG001|Treatment Period|Study drug toxicity|208
6797698|NCT02388906|10798373|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5
6797699|NCT02388906|10798374|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5
6797700|NCT02388906|10798373|FG000|Treatment Period|Participant request to stop treatment|5
6797701|NCT02388906|10798374|FG001|Treatment Period|Participant request to stop treatment|9
6797702|NCT02388906|10798373|FG000|Treatment Period|Participant withdrew consent|2
6797703|NCT02388906|10798374|FG001|Treatment Period|Participant withdrew consent|3
6797704|NCT02388906|10798373|FG000|Treatment Period|Poor/non-compliance|0
6797705|NCT02388906|10798374|FG001|Treatment Period|Poor/non-compliance|1
6797706|NCT02388906|10798373|FG000|Treatment Period|Participant no longer meets study criteria|0
6797707|NCT02388906|10798374|FG001|Treatment Period|Participant no longer meets study criteria|1
6797708|NCT02388906|10798373|FG000|Treatment Period|Other reasons|3
6797709|NCT02388906|10798374|FG001|Treatment Period|Other reasons|3
6797710|NCT02384993|10798382|FG000|Overall Study|Adverse Event|0
6797711|NCT02384993|10798383|FG001|Overall Study|Adverse Event|1
6809310|NCT02964039|10812812|FG000|Overall Study|Medical reason unrelated to study participation|1
6809311|NCT02964039|10812813|FG001|Overall Study|Medical reason unrelated to study participation|0
6809312|NCT02964039|10812814|FG002|Overall Study|Medical reason unrelated to study participation|3
6809313|NCT02964039|10812812|FG000|Overall Study|Research shutdown due to pandemic|2
6809314|NCT02964039|10812813|FG001|Overall Study|Research shutdown due to pandemic|0
6809315|NCT02964039|10812814|FG002|Overall Study|Research shutdown due to pandemic|1
6809316|NCT02964039|10812812|FG000|Overall Study|Withdrawal by Subject|0
6809317|NCT02964039|10812813|FG001|Overall Study|Withdrawal by Subject|1
6809318|NCT02964039|10812814|FG002|Overall Study|Withdrawal by Subject|0
6809319|NCT02964039|10812812|FG000|Overall Study|Lost to Follow-up|1
6809320|NCT02964039|10812813|FG001|Overall Study|Lost to Follow-up|0
6809321|NCT02964039|10812814|FG002|Overall Study|Lost to Follow-up|1
6809322|NCT02930889|10812822|FG000|Overall Study|Lost to Follow-up|2
6809323|NCT02930889|10812822|FG000|Overall Study|Withdrawal by Subject|6
6809324|NCT02930889|10812822|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8
6809325|NCT02919618|10812826|FG000|Overall Study|Death|1
6809326|NCT02844946|10812843|FG000|Overall Study|Lost to Follow-up|7
6809327|NCT02844946|10812844|FG001|Overall Study|Lost to Follow-up|0
6809328|NCT02564796|10812861|FG000|Overall Study|Physician Decision|2
6809329|NCT02564796|10812862|FG001|Overall Study|Physician Decision|2
6809330|NCT02562716|10812870|FG000|Overall Study|Adverse Event|7
6809331|NCT02562716|10812871|FG001|Overall Study|Adverse Event|14
6809332|NCT02562716|10812870|FG000|Overall Study|Withdrawal unrelated to AE|7
6809333|NCT02562716|10812871|FG001|Overall Study|Withdrawal unrelated to AE|1
6809334|NCT02562716|10812870|FG000|Overall Study|Progression|8
6809335|NCT02562716|10812871|FG001|Overall Study|Progression|10
6809336|NCT02562716|10812870|FG000|Overall Study|Death|2
6809337|NCT02562716|10812871|FG001|Overall Study|Death|1
6809338|NCT02562716|10812870|FG000|Overall Study|Not protocol specified|4
6809339|NCT02562716|10812871|FG001|Overall Study|Not protocol specified|2
6809340|NCT01472081|10812890|FG000|Overall Study|Continuing treatment at time of analysis|1
6809341|NCT01472081|10812891|FG001|Overall Study|Continuing treatment at time of analysis|4
6809342|NCT01472081|10812892|FG002|Overall Study|Continuing treatment at time of analysis|1
6809343|NCT01472081|10812893|FG003|Overall Study|Continuing treatment at time of analysis|8
6809344|NCT01472081|10812894|FG004|Overall Study|Continuing treatment at time of analysis|9
6809345|NCT01472081|10812895|FG005|Overall Study|Continuing treatment at time of analysis|0
6809346|NCT01472081|10812890|FG000|Overall Study|Disease Progression|4
6809347|NCT01472081|10812891|FG001|Overall Study|Disease Progression|10
6809348|NCT01472081|10812892|FG002|Overall Study|Disease Progression|12
6797712|NCT02304302|10798392|FG000|Overall Study|Adverse Event|2
6797713|NCT02304302|10798393|FG001|Overall Study|Adverse Event|3
6797714|NCT02304302|10798392|FG000|Overall Study|Lost to Follow-up|1
6797715|NCT02304302|10798393|FG001|Overall Study|Lost to Follow-up|4
6797716|NCT02304302|10798392|FG000|Overall Study|Removed from analysis due to low medication compliance|0
6797717|NCT02304302|10798393|FG001|Overall Study|Removed from analysis due to low medication compliance|1
6797718|NCT02269670|10798403|FG000|Overall Study|All subjects have not completed all research related interventions|3
6797719|NCT01860976|10798413|FG000|Blinded Treatment|Adverse Event|1
6797720|NCT01860976|10798414|FG001|Blinded Treatment|Adverse Event|3
6797721|NCT01860976|10798413|FG000|Blinded Treatment|Lack of Efficacy|5
6797722|NCT01860976|10798414|FG001|Blinded Treatment|Lack of Efficacy|12
6797723|NCT01860976|10798413|FG000|Blinded Treatment|Subject request to discontinue treatment|2
6797724|NCT01860976|10798414|FG001|Blinded Treatment|Subject request to discontinue treatment|3
6797725|NCT01860976|10798413|FG000|Blinded Treatment|Withdrawal by Subject|3
6797726|NCT01860976|10798414|FG001|Blinded Treatment|Withdrawal by Subject|5
6797727|NCT01860976|10798413|FG000|Blinded Treatment|Subject no longer met criteria|1
6797728|NCT01860976|10798414|FG001|Blinded Treatment|Subject no longer met criteria|0
6797729|NCT01860976|10798413|FG000|Blinded Treatment|Entered Open-Label in error|0
6797730|NCT01860976|10798414|FG001|Blinded Treatment|Entered Open-Label in error|1
6797731|NCT01860976|10798413|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76
6797732|NCT01860976|10798414|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89
6797733|NCT01860976|10798413|FG000|Open-Label|Adverse Event|2
6797734|NCT01860976|10798414|FG001|Open-Label|Adverse Event|4
6797735|NCT01860976|10798413|FG000|Open-Label|Lack of Efficacy|16
6797736|NCT01860976|10798414|FG001|Open-Label|Lack of Efficacy|8
6797737|NCT01860976|10798413|FG000|Open-Label|Lost to Follow-up|1
6797738|NCT01860976|10798414|FG001|Open-Label|Lost to Follow-up|2
6797739|NCT01860976|10798413|FG000|Open-Label|Subject request discontinue treatment|4
6797740|NCT01860976|10798414|FG001|Open-Label|Subject request discontinue treatment|3
6797741|NCT01860976|10798413|FG000|Open-Label|Withdrawal by Subject|4
6797742|NCT01860976|10798414|FG001|Open-Label|Withdrawal by Subject|1
6797743|NCT01860976|10798413|FG000|Open-Label|Other Reasons|1
6797744|NCT01860976|10798414|FG001|Open-Label|Other Reasons|1
6797745|NCT01860976|10798413|FG000|Long Term Extension|Adverse Event|4
6797746|NCT01860976|10798414|FG001|Long Term Extension|Adverse Event|0
6797747|NCT01860976|10798413|FG000|Long Term Extension|Lack of Efficacy|2
6797748|NCT01860976|10798414|FG001|Long Term Extension|Lack of Efficacy|0
6797749|NCT01860976|10798413|FG000|Long Term Extension|Subject request to discontinue treatment|10
6797750|NCT01860976|10798414|FG001|Long Term Extension|Subject request to discontinue treatment|0
6797751|NCT01860976|10798413|FG000|Long Term Extension|Lost to Follow-up|2
6797752|NCT01860976|10798414|FG001|Long Term Extension|Lost to Follow-up|0
6797753|NCT01860976|10798413|FG000|Long Term Extension|subject withdrew consent|7
6797754|NCT01860976|10798414|FG001|Long Term Extension|subject withdrew consent|0
6797755|NCT01761266|10798425|FG000|Overall Study|Death|415
6797756|NCT01761266|10798426|FG001|Overall Study|Death|402
6797757|NCT01761266|10798425|FG000|Overall Study|Lost to Follow-up|8
6797758|NCT01761266|10798426|FG001|Overall Study|Lost to Follow-up|12
6797759|NCT01761266|10798425|FG000|Overall Study|Withdrawal by Subject|14
6797760|NCT01761266|10798426|FG001|Overall Study|Withdrawal by Subject|10
6797761|NCT01761266|10798425|FG000|Overall Study|Sponsor Decision|41
6797762|NCT01761266|10798426|FG001|Overall Study|Sponsor Decision|52
6797763|NCT01550289|10798437|FG000|Overall Study|Protocol Violation|1
6797764|NCT01550289|10798438|FG001|Overall Study|Protocol Violation|0
6797765|NCT01550289|10798437|FG000|Overall Study|Lost to Follow-up|1
6797766|NCT01550289|10798438|FG001|Overall Study|Lost to Follow-up|1
6797767|NCT01550289|10798437|FG000|Overall Study|Withdrawal by Subject|11
6797768|NCT01550289|10798438|FG001|Overall Study|Withdrawal by Subject|3
6797769|NCT01346709|10798446|FG000|Overall Study|Protocol Violation|35
6797770|NCT01346709|10798446|FG000|Overall Study|Lost to Follow-up|31
6797771|NCT01346709|10798446|FG000|Overall Study|Missing data in candidate risk factor|285
6797772|NCT01081951|10798452|FG000|Overall Study|Death|54
6797773|NCT01081951|10798453|FG001|Overall Study|Death|47
6797774|NCT01081951|10798452|FG000|Overall Study|Withdrawal by Subject|2
6797775|NCT01081951|10798453|FG001|Overall Study|Withdrawal by Subject|6
6797776|NCT01081951|10798452|FG000|Overall Study|Allocated treatment but did not take it|0
6797777|NCT01081951|10798453|FG001|Overall Study|Allocated treatment but did not take it|1
6797778|NCT01081951|10798452|FG000|Overall Study|Lost to Follow-up|0
6797779|NCT01081951|10798453|FG001|Overall Study|Lost to Follow-up|1
6797780|NCT01074190|10798462|FG000|Overall Study|Emergency Cesarean Delivery|1
6797781|NCT01074190|10798463|FG001|Overall Study|Emergency Cesarean Delivery|2
6797782|NCT01074190|10798464|FG002|Overall Study|Emergency Cesarean Delivery|1
6797783|NCT01074190|10798462|FG000|Overall Study|Protocol Violation|2
6797784|NCT01074190|10798463|FG001|Overall Study|Protocol Violation|1
6797785|NCT01074190|10798464|FG002|Overall Study|Protocol Violation|0
6797786|NCT01074190|10798462|FG000|Overall Study|Delivered in under 90 minutes|0
6797787|NCT01074190|10798463|FG001|Overall Study|Delivered in under 90 minutes|2
6797788|NCT01074190|10798464|FG002|Overall Study|Delivered in under 90 minutes|1
6797789|NCT01074190|10798462|FG000|Overall Study|Subject withdrew consent|1
6797790|NCT01074190|10798463|FG001|Overall Study|Subject withdrew consent|1
6797791|NCT01074190|10798464|FG002|Overall Study|Subject withdrew consent|1
6797792|NCT00875524|10798477|FG000|Overall Study|Serious adverse event|0
6797793|NCT00875524|10798478|FG001|Overall Study|Serious adverse event|1
6797794|NCT00875524|10798477|FG000|Overall Study|Protocol Violation|4
6797795|NCT00875524|10798478|FG001|Overall Study|Protocol Violation|0
6797796|NCT00875524|10798477|FG000|Overall Study|Lost to Follow-up|1
6797797|NCT00875524|10798478|FG001|Overall Study|Lost to Follow-up|0
6797798|NCT00875524|10798477|FG000|Overall Study|Withdrawal by Subject|3
6797799|NCT00875524|10798478|FG001|Overall Study|Withdrawal by Subject|5
6797800|NCT00842530|10798486|FG000|Overall Study|Serious adverse event|0
6797801|NCT00842530|10798487|FG001|Overall Study|Serious adverse event|6
6797802|NCT00842530|10798486|FG000|Overall Study|Other adverse event|6
6797803|NCT00842530|10798487|FG001|Overall Study|Other adverse event|1
6797804|NCT00842530|10798486|FG000|Overall Study|Protocol Violation|32
6797805|NCT00842530|10798487|FG001|Overall Study|Protocol Violation|14
6797806|NCT00842530|10798486|FG000|Overall Study|Lost to Follow-up|6
6797807|NCT00842530|10798487|FG001|Overall Study|Lost to Follow-up|8
6797808|NCT00842530|10798486|FG000|Overall Study|Withdrawal by Subject|73
6797809|NCT00842530|10798487|FG001|Overall Study|Withdrawal by Subject|28
6797810|NCT00788151|10798496|FG000|Overall Study|Other adverse event|0
6797811|NCT00788151|10798497|FG001|Overall Study|Other adverse event|2
6797812|NCT00788151|10798496|FG000|Overall Study|Protocol Violation|0
6797813|NCT00788151|10798497|FG001|Overall Study|Protocol Violation|1
6797814|NCT00788151|10798496|FG000|Overall Study|Withdrawal by Subject|13
6797815|NCT00788151|10798497|FG001|Overall Study|Withdrawal by Subject|6
6797816|NCT00788151|10798496|FG000|Overall Study|Enrolled but not treated|1
6797817|NCT00788151|10798497|FG001|Overall Study|Enrolled but not treated|1
6797818|NCT00539591|10798506|FG000|Overall Study|Toxicity|3
6797819|NCT00539591|10798507|FG001|Overall Study|Toxicity|0
6797820|NCT00539591|10798508|FG002|Overall Study|Toxicity|0
6797821|NCT00539591|10798506|FG000|Overall Study|Disease progression|2
6797822|NCT00539591|10798507|FG001|Overall Study|Disease progression|2
6797823|NCT00539591|10798508|FG002|Overall Study|Disease progression|3
6809349|NCT01472081|10812893|FG003|Overall Study|Disease Progression|31
6809350|NCT01472081|10812894|FG004|Overall Study|Disease Progression|22
6809351|NCT01472081|10812895|FG005|Overall Study|Disease Progression|3
6809352|NCT01472081|10812890|FG000|Overall Study|Study drug toxicity|2
6809353|NCT01472081|10812891|FG001|Overall Study|Study drug toxicity|9
6809354|NCT01472081|10812892|FG002|Overall Study|Study drug toxicity|4
6809355|NCT01472081|10812893|FG003|Overall Study|Study drug toxicity|6
6809356|NCT01472081|10812894|FG004|Overall Study|Study drug toxicity|13
6809357|NCT01472081|10812895|FG005|Overall Study|Study drug toxicity|2
6809358|NCT01472081|10812890|FG000|Overall Study|Death|0
6809359|NCT01472081|10812891|FG001|Overall Study|Death|0
6809360|NCT01472081|10812892|FG002|Overall Study|Death|0
6809361|NCT01472081|10812893|FG003|Overall Study|Death|0
6809362|NCT01472081|10812894|FG004|Overall Study|Death|1
6809363|NCT01472081|10812895|FG005|Overall Study|Death|0
6809364|NCT01472081|10812890|FG000|Overall Study|Adverse Event unrelated to study drug|0
6809365|NCT01472081|10812891|FG001|Overall Study|Adverse Event unrelated to study drug|0
6809366|NCT01472081|10812892|FG002|Overall Study|Adverse Event unrelated to study drug|0
6809367|NCT01472081|10812893|FG003|Overall Study|Adverse Event unrelated to study drug|0
6809368|NCT01472081|10812894|FG004|Overall Study|Adverse Event unrelated to study drug|1
6809369|NCT01472081|10812895|FG005|Overall Study|Adverse Event unrelated to study drug|0
6809370|NCT01472081|10812890|FG000|Overall Study|Withdrawal by Subject|0
6809371|NCT01472081|10812891|FG001|Overall Study|Withdrawal by Subject|0
6809372|NCT01472081|10812892|FG002|Overall Study|Withdrawal by Subject|0
6809373|NCT01472081|10812893|FG003|Overall Study|Withdrawal by Subject|0
6809374|NCT01472081|10812894|FG004|Overall Study|Withdrawal by Subject|0
6809375|NCT01472081|10812895|FG005|Overall Study|Withdrawal by Subject|1
6809376|NCT01472081|10812890|FG000|Overall Study|Poor/non-compliance|0
6809377|NCT01472081|10812891|FG001|Overall Study|Poor/non-compliance|0
6809378|NCT01472081|10812892|FG002|Overall Study|Poor/non-compliance|1
6809379|NCT01472081|10812893|FG003|Overall Study|Poor/non-compliance|0
6809380|NCT01472081|10812894|FG004|Overall Study|Poor/non-compliance|1
6809381|NCT01472081|10812895|FG005|Overall Study|Poor/non-compliance|0
6809382|NCT01472081|10812890|FG000|Overall Study|No longer meets study criteria|0
6809383|NCT01472081|10812891|FG001|Overall Study|No longer meets study criteria|0
6809384|NCT01472081|10812892|FG002|Overall Study|No longer meets study criteria|1
6809385|NCT01472081|10812893|FG003|Overall Study|No longer meets study criteria|0
6809386|NCT01472081|10812894|FG004|Overall Study|No longer meets study criteria|0
6809387|NCT01472081|10812895|FG005|Overall Study|No longer meets study criteria|0
6809388|NCT01472081|10812890|FG000|Overall Study|Subject request to discontinue treatment|0
6809389|NCT01472081|10812891|FG001|Overall Study|Subject request to discontinue treatment|3
6809390|NCT01472081|10812892|FG002|Overall Study|Subject request to discontinue treatment|1
6809391|NCT01472081|10812893|FG003|Overall Study|Subject request to discontinue treatment|1
6809392|NCT01472081|10812894|FG004|Overall Study|Subject request to discontinue treatment|0
6809393|NCT01472081|10812895|FG005|Overall Study|Subject request to discontinue treatment|0
6809394|NCT01309672|10812908|FG000|Overall Study|Lack of Efficacy|20
6809395|NCT01309672|10812908|FG000|Overall Study|Other|9
6809396|NCT01309672|10812908|FG000|Overall Study|Adverse Event|5
6809397|NCT01309672|10812908|FG000|Overall Study|Withdrawal by Subject|3
6809398|NCT00774345|10812925|FG000|Pre-treatment|Other reasons|2
6809399|NCT00774345|10812926|FG001|Pre-treatment|Other reasons|0
6809400|NCT00774345|10812925|FG000|Treatment|Adverse Event|61
6797824|NCT04794751|10798544|FG000|Period 1|incorrect fitting guide was used to fit subject|2
6797825|NCT04794751|10798545|FG001|Period 1|incorrect fitting guide was used to fit subject|1
6797826|NCT04794751|10798544|FG000|Period 1|Subject no longer meets eligibility criteria|0
6797827|NCT04794751|10798545|FG001|Period 1|Subject no longer meets eligibility criteria|1
6797828|NCT04794751|10798544|FG000|Period 1|Protocol Violation|0
6797829|NCT04794751|10798545|FG001|Period 1|Protocol Violation|2
6797830|NCT04794751|10798544|FG000|Period 1|Withdrawal by Subject|0
6797831|NCT04794751|10798545|FG001|Period 1|Withdrawal by Subject|1
6797832|NCT04794751|10798544|FG000|Period 2|Withdrawal by Subject|0
6797833|NCT04794751|10798545|FG001|Period 2|Withdrawal by Subject|1
6797834|NCT04794751|10798544|FG000|Period 2|incorrect fitting guide was used to fit subject|0
6797835|NCT04794751|10798545|FG001|Period 2|incorrect fitting guide was used to fit subject|2
6797836|NCT04794751|10798544|FG000|Period 2|Protocol Violation|1
6797837|NCT04794751|10798545|FG001|Period 2|Protocol Violation|0
6797838|NCT04584645|10798553|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995
6797839|NCT04584645|10798554|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906
6797840|NCT04538170|10798580|FG000|Overall Study|Withdrawal by Subject|104
6797841|NCT04538170|10798581|FG001|Overall Study|Withdrawal by Subject|210
6797842|NCT04461015|10798593|FG000|Overall Study|IV access lost during the study|0
6797843|NCT04461015|10798594|FG001|Overall Study|IV access lost during the study|1
6797844|NCT04461015|10798593|FG000|Overall Study|Withdrawal by Subject|0
6797845|NCT04461015|10798594|FG001|Overall Study|Withdrawal by Subject|1
6797846|NCT04380961|10798602|FG000|Overall Study|Lost to Follow-up|17
6797847|NCT04380961|10798603|FG001|Overall Study|Lost to Follow-up|11
6797848|NCT04380961|10798602|FG000|Overall Study|Withdrawal by Subject|3
6797849|NCT04380961|10798603|FG001|Overall Study|Withdrawal by Subject|0
6797850|NCT04380961|10798602|FG000|Overall Study|Death|22
6797851|NCT04380961|10798603|FG001|Overall Study|Death|16
6797852|NCT04380961|10798602|FG000|Overall Study|Other|1
6797853|NCT04380961|10798603|FG001|Overall Study|Other|0
6797854|NCT04380961|10798602|FG000|Overall Study|Randomized but Not Treated|1
6797855|NCT04380961|10798603|FG001|Overall Study|Randomized but Not Treated|2
6797871|NCT04332419|10798644|FG000|Overall Study|Withdrawal by Subject|1
6797872|NCT04239872|10798648|FG000|Overall Study|Lost to Follow-up|0
6797873|NCT04239872|10798649|FG001|Overall Study|Lost to Follow-up|1
6797874|NCT04128696|10798668|FG000|Overall Study|Lost to Follow-up|0
6797875|NCT04128696|10798669|FG001|Overall Study|Lost to Follow-up|1
6797876|NCT04128696|10798668|FG000|Overall Study|Withdrawal by Subject|8
6797877|NCT04128696|10798669|FG001|Overall Study|Withdrawal by Subject|5
6797878|NCT04128696|10798668|FG000|Overall Study|In Follow-up|47
6797879|NCT04128696|10798669|FG001|Overall Study|In Follow-up|51
6797880|NCT04128696|10798668|FG000|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|52
6797881|NCT04128696|10798669|FG001|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|62
6797882|NCT04091581|10798677|FG000|Overall Study|Lost to Follow-up|0
6797883|NCT04091581|10798678|FG001|Overall Study|Lost to Follow-up|1
6797884|NCT03839628|10798714|FG000|Overall Study|Withdrawal by Subject|1
6797885|NCT03791398|10798721|FG000|Overall Study|Progression of Disease Under Study|2
6797886|NCT03791398|10798722|FG001|Overall Study|Progression of Disease Under Study|0
6797887|NCT03791398|10798723|FG002|Overall Study|Progression of Disease Under Study|0
6797888|NCT03759041|10798730|FG000|Overall Study|Withdrawal by Subject|4
6797889|NCT03759041|10798731|FG001|Overall Study|Withdrawal by Subject|10
6797890|NCT03759041|10798732|FG002|Overall Study|Withdrawal by Subject|10
6797891|NCT03759041|10798730|FG000|Overall Study|Adverse Event|1
6797892|NCT03759041|10798731|FG001|Overall Study|Adverse Event|3
6797893|NCT03759041|10798732|FG002|Overall Study|Adverse Event|4
6797894|NCT03759041|10798730|FG000|Overall Study|Lack of Efficacy|0
6797895|NCT03759041|10798731|FG001|Overall Study|Lack of Efficacy|0
6797896|NCT03759041|10798732|FG002|Overall Study|Lack of Efficacy|1
6797897|NCT03759041|10798730|FG000|Overall Study|Study Terminated by Sponsor|15
6797898|NCT03759041|10798731|FG001|Overall Study|Study Terminated by Sponsor|16
6797899|NCT03759041|10798732|FG002|Overall Study|Study Terminated by Sponsor|10
6797900|NCT03759041|10798730|FG000|Overall Study|Other reason for discontinuation|0
6797901|NCT03759041|10798731|FG001|Overall Study|Other reason for discontinuation|2
6797902|NCT03759041|10798732|FG002|Overall Study|Other reason for discontinuation|1
6797903|NCT03759041|10798730|FG000|Overall Study|Lost to Follow-up|7
6797904|NCT03759041|10798731|FG001|Overall Study|Lost to Follow-up|2
6797905|NCT03759041|10798732|FG002|Overall Study|Lost to Follow-up|2
6797906|NCT03759041|10798730|FG000|Overall Study|Subjects did not have a discontinuation page completed|0
6797907|NCT03759041|10798731|FG001|Overall Study|Subjects did not have a discontinuation page completed|1
6797908|NCT03759041|10798732|FG002|Overall Study|Subjects did not have a discontinuation page completed|0
6797909|NCT03726879|10798742|FG000|Overall Study|Death|6
6797910|NCT03726879|10798743|FG001|Overall Study|Death|4
6797911|NCT03726879|10798742|FG000|Overall Study|Physician Decision|0
6797912|NCT03726879|10798743|FG001|Overall Study|Physician Decision|2
6797913|NCT03726879|10798742|FG000|Overall Study|Protocol Violation|0
6797914|NCT03726879|10798743|FG001|Overall Study|Protocol Violation|1
6797915|NCT03726879|10798742|FG000|Overall Study|Withdrawal by Subject|5
6797916|NCT03726879|10798743|FG001|Overall Study|Withdrawal by Subject|5
6797917|NCT03726879|10798742|FG000|Overall Study|TSH result is unstable|0
6797918|NCT03726879|10798743|FG001|Overall Study|TSH result is unstable|1
6797919|NCT03726879|10798742|FG000|Overall Study|Continuing on Study|215
6797920|NCT03726879|10798743|FG001|Overall Study|Continuing on Study|215
6797921|NCT03703882|10798764|FG000|Overall Study|Adverse Event|1
6797922|NCT03703882|10798765|FG001|Overall Study|Adverse Event|0
6797923|NCT03703882|10798764|FG000|Overall Study|Lost to Follow-up|0
6797924|NCT03703882|10798765|FG001|Overall Study|Lost to Follow-up|2
6797925|NCT03703882|10798764|FG000|Overall Study|Non-compliance with study drug|0
6797926|NCT03703882|10798765|FG001|Overall Study|Non-compliance with study drug|1
6797927|NCT03703882|10798764|FG000|Overall Study|Physician Decision|0
6797928|NCT03703882|10798765|FG001|Overall Study|Physician Decision|1
6797929|NCT03703882|10798764|FG000|Overall Study|Progressive disease|1
6797930|NCT03703882|10798765|FG001|Overall Study|Progressive disease|0
6797931|NCT03703882|10798764|FG000|Overall Study|Withdrawal by parent/guardian|1
6797932|NCT03703882|10798765|FG001|Overall Study|Withdrawal by parent/guardian|0
6797933|NCT03703882|10798764|FG000|Overall Study|Starting another treatment|0
6797934|NCT03703882|10798765|FG001|Overall Study|Starting another treatment|1
6797935|NCT03703882|10798764|FG000|Overall Study|noncompliance with study procedures|0
6797936|NCT03703882|10798765|FG001|Overall Study|noncompliance with study procedures|1
6797937|NCT03615040|10798773|FG000|Overall Study|Withdrawal by Subject|2
6797938|NCT03615040|10798774|FG001|Overall Study|Withdrawal by Subject|1
6797939|NCT03615040|10798773|FG000|Overall Study|Physician Decision|2
6797940|NCT03615040|10798774|FG001|Overall Study|Physician Decision|2
6797941|NCT03615040|10798773|FG000|Overall Study|Clinical diagnosis of lung cancer|1
6797942|NCT03615040|10798774|FG001|Overall Study|Clinical diagnosis of lung cancer|0
6797943|NCT03615040|10798773|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1
6797944|NCT03615040|10798774|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0
6797945|NCT03615040|10798773|FG000|Overall Study|Death|0
6797946|NCT03615040|10798774|FG001|Overall Study|Death|2
6797947|NCT03611075|10798789|FG000|Overall Study|Physician Decision|0
6797948|NCT03611075|10798790|FG001|Overall Study|Physician Decision|1
6797949|NCT03611075|10798791|FG002|Overall Study|Physician Decision|1
6797950|NCT03611075|10798792|FG003|Overall Study|Physician Decision|0
6797951|NCT03611075|10798793|FG004|Overall Study|Physician Decision|0
6797952|NCT03611075|10798794|FG005|Overall Study|Physician Decision|0
6797953|NCT03611075|10798795|FG006|Overall Study|Physician Decision|0
6797954|NCT03611075|10798796|FG007|Overall Study|Physician Decision|0
6797955|NCT03611075|10798797|FG008|Overall Study|Physician Decision|0
6797956|NCT03611075|10798789|FG000|Overall Study|Lost to Follow-up|1
6797957|NCT03611075|10798790|FG001|Overall Study|Lost to Follow-up|0
6797958|NCT03611075|10798791|FG002|Overall Study|Lost to Follow-up|0
6797959|NCT03611075|10798792|FG003|Overall Study|Lost to Follow-up|2
6797960|NCT03611075|10798793|FG004|Overall Study|Lost to Follow-up|0
6797961|NCT03611075|10798794|FG005|Overall Study|Lost to Follow-up|0
6797962|NCT03611075|10798795|FG006|Overall Study|Lost to Follow-up|0
6797963|NCT03611075|10798796|FG007|Overall Study|Lost to Follow-up|0
6797964|NCT03611075|10798797|FG008|Overall Study|Lost to Follow-up|0
6797965|NCT03611075|10798789|FG000|Overall Study|Withdrawal by Subject|0
6797966|NCT03611075|10798790|FG001|Overall Study|Withdrawal by Subject|1
6797967|NCT03611075|10798791|FG002|Overall Study|Withdrawal by Subject|1
6797968|NCT03611075|10798792|FG003|Overall Study|Withdrawal by Subject|1
6797969|NCT03611075|10798793|FG004|Overall Study|Withdrawal by Subject|0
6797970|NCT03611075|10798794|FG005|Overall Study|Withdrawal by Subject|0
6797971|NCT03611075|10798795|FG006|Overall Study|Withdrawal by Subject|1
6797972|NCT03611075|10798796|FG007|Overall Study|Withdrawal by Subject|0
6797973|NCT03611075|10798797|FG008|Overall Study|Withdrawal by Subject|0
6797974|NCT03611075|10798789|FG000|Overall Study|Reason unknown|0
6797975|NCT03611075|10798790|FG001|Overall Study|Reason unknown|0
6797976|NCT03611075|10798791|FG002|Overall Study|Reason unknown|0
6797977|NCT03611075|10798792|FG003|Overall Study|Reason unknown|1
6797978|NCT03611075|10798793|FG004|Overall Study|Reason unknown|0
6797979|NCT03611075|10798794|FG005|Overall Study|Reason unknown|0
6797980|NCT03611075|10798795|FG006|Overall Study|Reason unknown|1
6797981|NCT03611075|10798796|FG007|Overall Study|Reason unknown|0
6797982|NCT03611075|10798797|FG008|Overall Study|Reason unknown|0
6797983|NCT03595176|10798842|FG000|Overall Study|Death|0
6797984|NCT03595176|10798843|FG001|Overall Study|Death|2
6797985|NCT03595176|10798842|FG000|Overall Study|Lost to Follow-up|0
6797986|NCT03595176|10798843|FG001|Overall Study|Lost to Follow-up|1
6797987|NCT03541317|10798851|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1
6797988|NCT03541317|10798852|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0
6797989|NCT03541317|10798853|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0
6797990|NCT03541317|10798854|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0
6797991|NCT03541317|10798855|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0
6797992|NCT03541317|10798856|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0
6797993|NCT03412565|10798881|FG000|Overall Study|Other|0
6797994|NCT03412565|10798882|FG001|Overall Study|Other|0
6797995|NCT03412565|10798883|FG002|Overall Study|Other|0
6797996|NCT03412565|10798884|FG003|Overall Study|Other|3
6797997|NCT03412565|10798881|FG000|Overall Study|Withdrawal by Subject|0
6797998|NCT03412565|10798882|FG001|Overall Study|Withdrawal by Subject|0
6797999|NCT03412565|10798883|FG002|Overall Study|Withdrawal by Subject|1
6798000|NCT03412565|10798884|FG003|Overall Study|Withdrawal by Subject|5
6798001|NCT03412565|10798881|FG000|Overall Study|Physician Decision|0
6798002|NCT03412565|10798882|FG001|Overall Study|Physician Decision|1
6798003|NCT03412565|10798883|FG002|Overall Study|Physician Decision|0
6798004|NCT03412565|10798884|FG003|Overall Study|Physician Decision|1
6798005|NCT03412565|10798881|FG000|Overall Study|Death|1
6798006|NCT03412565|10798882|FG001|Overall Study|Death|2
6798007|NCT03412565|10798883|FG002|Overall Study|Death|2
6798008|NCT03412565|10798884|FG003|Overall Study|Death|4
6798009|NCT03412565|10798881|FG000|Overall Study|Still ongoing|0
6798010|NCT03412565|10798882|FG001|Overall Study|Still ongoing|62
6798011|NCT03412565|10798883|FG002|Overall Study|Still ongoing|59
6798012|NCT03412565|10798884|FG003|Overall Study|Still ongoing|41
6798013|NCT03400943|10798903|FG000|Treatment Period 1|Adverse Event|0
6798014|NCT03400943|10798904|FG001|Treatment Period 1|Adverse Event|0
6798015|NCT03400943|10798905|FG002|Treatment Period 1|Adverse Event|0
6798016|NCT03400943|10798906|FG003|Treatment Period 1|Adverse Event|1
6798017|NCT03400943|10798903|FG000|Treatment Period 1|Lost to Follow-up|1
6798018|NCT03400943|10798904|FG001|Treatment Period 1|Lost to Follow-up|0
6798019|NCT03400943|10798905|FG002|Treatment Period 1|Lost to Follow-up|0
6798020|NCT03400943|10798906|FG003|Treatment Period 1|Lost to Follow-up|0
6798021|NCT03400943|10798903|FG000|Treatment Period 1|Protocol Violation|0
6798022|NCT03400943|10798904|FG001|Treatment Period 1|Protocol Violation|1
6798023|NCT03400943|10798905|FG002|Treatment Period 1|Protocol Violation|1
6798024|NCT03400943|10798906|FG003|Treatment Period 1|Protocol Violation|0
6798025|NCT03400943|10798903|FG000|Treatment Period 1|Study terminated by sponsor|2
6798026|NCT03400943|10798904|FG001|Treatment Period 1|Study terminated by sponsor|0
6798027|NCT03400943|10798905|FG002|Treatment Period 1|Study terminated by sponsor|0
6798028|NCT03400943|10798906|FG003|Treatment Period 1|Study terminated by sponsor|1
6798029|NCT03400943|10798903|FG000|Treatment Period 1|Withdrawal by Subject|0
6798030|NCT03400943|10798904|FG001|Treatment Period 1|Withdrawal by Subject|0
6798031|NCT03400943|10798905|FG002|Treatment Period 1|Withdrawal by Subject|3
6798032|NCT03400943|10798906|FG003|Treatment Period 1|Withdrawal by Subject|1
6798033|NCT03400943|10798903|FG000|Treatment Period 1|Other|2
6798034|NCT03400943|10798904|FG001|Treatment Period 1|Other|1
6798035|NCT03400943|10798905|FG002|Treatment Period 1|Other|2
6798036|NCT03400943|10798906|FG003|Treatment Period 1|Other|2
6798037|NCT03400943|10798903|FG000|Post-treatment Period 1|Adverse Event|2
6798038|NCT03400943|10798904|FG001|Post-treatment Period 1|Adverse Event|0
6798039|NCT03400943|10798905|FG002|Post-treatment Period 1|Adverse Event|0
6798040|NCT03400943|10798906|FG003|Post-treatment Period 1|Adverse Event|0
6798041|NCT03400943|10798903|FG000|Post-treatment Period 1|Protocol Violation|1
6798042|NCT03400943|10798904|FG001|Post-treatment Period 1|Protocol Violation|0
6798043|NCT03400943|10798905|FG002|Post-treatment Period 1|Protocol Violation|0
6798044|NCT03400943|10798906|FG003|Post-treatment Period 1|Protocol Violation|0
6798045|NCT03400943|10798903|FG000|Post-treatment Period 1|Study terminated by sponsor|5
6798046|NCT03400943|10798904|FG001|Post-treatment Period 1|Study terminated by sponsor|0
6798047|NCT03400943|10798905|FG002|Post-treatment Period 1|Study terminated by sponsor|5
6798048|NCT03400943|10798906|FG003|Post-treatment Period 1|Study terminated by sponsor|6
6798049|NCT03400943|10798903|FG000|Post-treatment Period 1|Withdrawal by Subject|1
6798050|NCT03400943|10798904|FG001|Post-treatment Period 1|Withdrawal by Subject|0
6798051|NCT03400943|10798905|FG002|Post-treatment Period 1|Withdrawal by Subject|2
6798052|NCT03400943|10798906|FG003|Post-treatment Period 1|Withdrawal by Subject|2
6798053|NCT03400943|10798903|FG000|Post-treatment Period 1|Other|2
6798054|NCT03400943|10798904|FG001|Post-treatment Period 1|Other|0
6798055|NCT03400943|10798905|FG002|Post-treatment Period 1|Other|4
6798056|NCT03400943|10798906|FG003|Post-treatment Period 1|Other|5
6798057|NCT03400943|10798903|FG000|Treatment Period 2|Study terminated by sponsor|0
6798058|NCT03400943|10798904|FG001|Treatment Period 2|Study terminated by sponsor|1
6798059|NCT03400943|10798905|FG002|Treatment Period 2|Study terminated by sponsor|0
6798060|NCT03400943|10798906|FG003|Treatment Period 2|Study terminated by sponsor|0
6798061|NCT03400943|10798903|FG000|Treatment Period 2|Withdrawal by Subject|0
6798062|NCT03400943|10798904|FG001|Treatment Period 2|Withdrawal by Subject|1
6798063|NCT03400943|10798905|FG002|Treatment Period 2|Withdrawal by Subject|0
6798064|NCT03400943|10798906|FG003|Treatment Period 2|Withdrawal by Subject|0
6798065|NCT03400943|10798903|FG000|Treatment Period 2|Other|1
6798066|NCT03400943|10798904|FG001|Treatment Period 2|Other|6
6798067|NCT03400943|10798905|FG002|Treatment Period 2|Other|0
6798068|NCT03400943|10798906|FG003|Treatment Period 2|Other|0
6798069|NCT03400943|10798903|FG000|Follow-up Period|Withdrawal by Subject|1
6798070|NCT03400943|10798904|FG001|Follow-up Period|Withdrawal by Subject|0
6798071|NCT03400943|10798905|FG002|Follow-up Period|Withdrawal by Subject|0
6798072|NCT03400943|10798906|FG003|Follow-up Period|Withdrawal by Subject|0
6798113|NCT03302234|10798941|FG000|Overall Study|Death|137
6798114|NCT03302234|10798942|FG001|Overall Study|Death|135
6798115|NCT03302234|10798941|FG000|Overall Study|Withdrawal by Subject|1
6798116|NCT03302234|10798942|FG001|Overall Study|Withdrawal by Subject|1
6798117|NCT03302234|10798941|FG000|Overall Study|Laryngeal carcinoma|0
6798118|NCT03302234|10798942|FG001|Overall Study|Laryngeal carcinoma|1
6798119|NCT03292588|10798951|FG000|Overall Study|Death|1
6798120|NCT03292588|10798952|FG001|Overall Study|Death|0
6798121|NCT03292588|10798951|FG000|Overall Study|Lost to Follow-up|12
6798122|NCT03292588|10798952|FG001|Overall Study|Lost to Follow-up|16
6798123|NCT03292588|10798951|FG000|Overall Study|Physician Decision|0
6798124|NCT03292588|10798952|FG001|Overall Study|Physician Decision|1
6798125|NCT03292588|10798951|FG000|Overall Study|Withdrawal by Subject|4
6798126|NCT03292588|10798952|FG001|Overall Study|Withdrawal by Subject|4
6798127|NCT03292588|10798951|FG000|Overall Study|Move out of town|1
6798128|NCT03292588|10798952|FG001|Overall Study|Move out of town|0
6798129|NCT03292588|10798951|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2
6798130|NCT03292588|10798952|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1
6798131|NCT03277105|10798962|FG000|Overall Study|Death|77
6798132|NCT03277105|10798963|FG001|Overall Study|Death|73
6798133|NCT03277105|10798962|FG000|Overall Study|Lost to Follow-up|0
6798134|NCT03277105|10798963|FG001|Overall Study|Lost to Follow-up|3
6798135|NCT03277105|10798962|FG000|Overall Study|Withdrawal by Subject|10
6798136|NCT03277105|10798963|FG001|Overall Study|Withdrawal by Subject|9
6798137|NCT03277105|10798962|FG000|Overall Study|Other|1
6798138|NCT03277105|10798963|FG001|Overall Study|Other|3
6798139|NCT03277105|10798962|FG000|Overall Study|Ongoing|171
6798140|NCT03277105|10798963|FG001|Overall Study|Ongoing|175
6798141|NCT03208244|10798995|FG000|Overall Study|Death|1
6798142|NCT03201965|10799002|FG000|Overall Study|Death|5
6798143|NCT03201965|10799003|FG001|Overall Study|Death|27
6798144|NCT03201965|10799004|FG002|Overall Study|Death|27
6798145|NCT03201965|10799002|FG000|Overall Study|Lost to Follow-up|0
6798146|NCT03201965|10799003|FG001|Overall Study|Lost to Follow-up|1
6798147|NCT03201965|10799004|FG002|Overall Study|Lost to Follow-up|0
6798148|NCT03201965|10799002|FG000|Overall Study|Withdrawal by Subject|3
6798149|NCT03201965|10799003|FG001|Overall Study|Withdrawal by Subject|13
6798150|NCT03201965|10799004|FG002|Overall Study|Withdrawal by Subject|4
6798151|NCT03201965|10799002|FG000|Overall Study|Ongoing|20
6798152|NCT03201965|10799003|FG001|Overall Study|Ongoing|152
6798153|NCT03201965|10799004|FG002|Overall Study|Ongoing|164
6798154|NCT03122886|10799022|FG000|Overall Study|Withdrawal by Subject|1
6798155|NCT03122886|10799023|FG001|Overall Study|Withdrawal by Subject|2
6798156|NCT03050060|10799043|FG000|Overall Study|Adverse Event|7
6798157|NCT03050060|10799043|FG000|Overall Study|Withdrawal by Subject|1
6798158|NCT03050060|10799043|FG000|Overall Study|Progression|7
6798159|NCT02847637|10799060|FG000|Overall Study|Withdrew from treatment due to AE|0
6798160|NCT02847637|10799061|FG001|Overall Study|Withdrew from treatment due to AE|0
6798161|NCT02847637|10799062|FG002|Overall Study|Withdrew from treatment due to AE|1
6798162|NCT02847637|10799063|FG003|Overall Study|Withdrew from treatment due to AE|0
6798163|NCT02847637|10799060|FG000|Overall Study|Ongoing treatment with emicizumab|16
6798164|NCT02847637|10799061|FG001|Overall Study|Ongoing treatment with emicizumab|35
6798165|NCT02847637|10799062|FG002|Overall Study|Ongoing treatment with emicizumab|34
6798166|NCT02847637|10799063|FG003|Overall Study|Ongoing treatment with emicizumab|63
6798167|NCT02847637|10799060|FG000|Overall Study|First emicizumab dose delayed|1
6798168|NCT02847637|10799061|FG001|Overall Study|First emicizumab dose delayed|0
6798169|NCT02847637|10799062|FG002|Overall Study|First emicizumab dose delayed|0
6798170|NCT02847637|10799063|FG003|Overall Study|First emicizumab dose delayed|0
6798171|NCT02770391|10799087|FG000|Overall Study|Lost to Follow-up|2
6798172|NCT02770391|10799087|FG000|Overall Study|Withdrawal by Subject|1
6798173|NCT02770391|10799087|FG000|Overall Study|Surgery delayed unevaluable|2
6798174|NCT02770391|10799087|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1
6798175|NCT02648724|10799115|FG000|Overall Study|Withdrawal by Subject|0
6798176|NCT02648724|10799116|FG001|Overall Study|Withdrawal by Subject|1
6798177|NCT02648724|10799117|FG002|Overall Study|Withdrawal by Subject|1
6798178|NCT02648724|10799118|FG003|Overall Study|Withdrawal by Subject|0
6798179|NCT02648724|10799119|FG004|Overall Study|Withdrawal by Subject|1
6798180|NCT02648724|10799120|FG005|Overall Study|Withdrawal by Subject|0
6798181|NCT02648724|10799121|FG006|Overall Study|Withdrawal by Subject|0
6798182|NCT02648724|10799115|FG000|Overall Study|Progressive disease|2
6798183|NCT02648724|10799116|FG001|Overall Study|Progressive disease|2
6798184|NCT02648724|10799117|FG002|Overall Study|Progressive disease|2
6798185|NCT02648724|10799118|FG003|Overall Study|Progressive disease|3
6798186|NCT02648724|10799119|FG004|Overall Study|Progressive disease|22
6798187|NCT02648724|10799120|FG005|Overall Study|Progressive disease|7
6798188|NCT02648724|10799121|FG006|Overall Study|Progressive disease|8
6798189|NCT02648724|10799115|FG000|Overall Study|Other reason (unknown)|1
6798190|NCT02648724|10799116|FG001|Overall Study|Other reason (unknown)|0
6798191|NCT02648724|10799117|FG002|Overall Study|Other reason (unknown)|0
6798192|NCT02648724|10799118|FG003|Overall Study|Other reason (unknown)|0
6798193|NCT02648724|10799119|FG004|Overall Study|Other reason (unknown)|0
6798194|NCT02648724|10799120|FG005|Overall Study|Other reason (unknown)|0
6798195|NCT02648724|10799121|FG006|Overall Study|Other reason (unknown)|0
6798196|NCT02648724|10799115|FG000|Overall Study|Protocol Violation|0
6798197|NCT02648724|10799116|FG001|Overall Study|Protocol Violation|0
6798198|NCT02648724|10799117|FG002|Overall Study|Protocol Violation|0
6798199|NCT02648724|10799118|FG003|Overall Study|Protocol Violation|0
6798200|NCT02648724|10799119|FG004|Overall Study|Protocol Violation|1
6798201|NCT02648724|10799120|FG005|Overall Study|Protocol Violation|0
6798202|NCT02648724|10799121|FG006|Overall Study|Protocol Violation|0
6798203|NCT02648724|10799115|FG000|Overall Study|Death|0
6798204|NCT02648724|10799116|FG001|Overall Study|Death|0
6798205|NCT02648724|10799117|FG002|Overall Study|Death|0
6798206|NCT02648724|10799118|FG003|Overall Study|Death|0
6798207|NCT02648724|10799119|FG004|Overall Study|Death|0
6798208|NCT02648724|10799120|FG005|Overall Study|Death|0
6798209|NCT02648724|10799121|FG006|Overall Study|Death|3
6798210|NCT02648724|10799115|FG000|Overall Study|Physician Decision|0
6798211|NCT02648724|10799116|FG001|Overall Study|Physician Decision|0
6798212|NCT02648724|10799117|FG002|Overall Study|Physician Decision|0
6798213|NCT02648724|10799118|FG003|Overall Study|Physician Decision|0
6798214|NCT02648724|10799119|FG004|Overall Study|Physician Decision|1
6798215|NCT02648724|10799120|FG005|Overall Study|Physician Decision|0
6798216|NCT02648724|10799121|FG006|Overall Study|Physician Decision|1
6798217|NCT02648724|10799115|FG000|Overall Study|Transferred to named patient program|0
6798218|NCT02648724|10799116|FG001|Overall Study|Transferred to named patient program|0
6798219|NCT02648724|10799117|FG002|Overall Study|Transferred to named patient program|0
6798220|NCT02648724|10799118|FG003|Overall Study|Transferred to named patient program|0
6798221|NCT02648724|10799119|FG004|Overall Study|Transferred to named patient program|0
6798222|NCT02648724|10799120|FG005|Overall Study|Transferred to named patient program|1
6798223|NCT02648724|10799121|FG006|Overall Study|Transferred to named patient program|0
6798224|NCT02614794|10799155|FG000|Overall Study|On treatment|118
6798225|NCT02614794|10799156|FG001|Overall Study|On treatment|27
6798226|NCT02614794|10799155|FG000|Overall Study|In long term follow up|148
6798227|NCT02614794|10799156|FG001|Overall Study|In long term follow up|85
6798228|NCT02614794|10799155|FG000|Overall Study|Death|126
6798229|NCT02614794|10799156|FG001|Overall Study|Death|84
6798230|NCT02614794|10799155|FG000|Overall Study|Withdrawal by Subject|16
6798231|NCT02614794|10799156|FG001|Overall Study|Withdrawal by Subject|5
6798232|NCT02614794|10799155|FG000|Overall Study|Lost to Follow-up|2
6798233|NCT02614794|10799156|FG001|Overall Study|Lost to Follow-up|0
6798234|NCT02614794|10799155|FG000|Overall Study|Physician Decision|0
6798235|NCT02614794|10799156|FG001|Overall Study|Physician Decision|1
6798236|NCT02554474|10799164|FG000|Overall Study|Protocol Violation|1
6798237|NCT02554474|10799165|FG001|Overall Study|Protocol Violation|1
6798238|NCT02554474|10799164|FG000|Overall Study|Health issue not related to the study|1
6798239|NCT02554474|10799165|FG001|Overall Study|Health issue not related to the study|0
6798240|NCT02554474|10799164|FG000|Overall Study|Withdrawal by Subject|1
6798241|NCT02554474|10799165|FG001|Overall Study|Withdrawal by Subject|1
6798242|NCT02554318|10799173|FG000|Overall Study|Withdrawal by Subject|10
6798243|NCT02554318|10799174|FG001|Overall Study|Withdrawal by Subject|8
6798244|NCT02508532|10799202|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
6798245|NCT02508532|10799203|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
6798246|NCT02508532|10799204|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
6798247|NCT02508532|10799205|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
6798248|NCT02508532|10799206|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
6798249|NCT02508532|10799207|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
6798250|NCT02508532|10799208|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1
6798251|NCT02508532|10799209|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
6798252|NCT02508532|10799210|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
6798253|NCT02508532|10799202|FG000|Part 1 - Dose Determining Period|Not Evaluable|0
6798254|NCT02508532|10799203|FG001|Part 1 - Dose Determining Period|Not Evaluable|0
6798255|NCT02508532|10799204|FG002|Part 1 - Dose Determining Period|Not Evaluable|0
6798256|NCT02508532|10799205|FG003|Part 1 - Dose Determining Period|Not Evaluable|0
6798257|NCT02508532|10799206|FG004|Part 1 - Dose Determining Period|Not Evaluable|0
6798258|NCT02508532|10799207|FG005|Part 1 - Dose Determining Period|Not Evaluable|0
6798259|NCT02508532|10799208|FG006|Part 1 - Dose Determining Period|Not Evaluable|0
6798260|NCT02508532|10799209|FG007|Part 1 - Dose Determining Period|Not Evaluable|1
6798261|NCT02508532|10799210|FG008|Part 1 - Dose Determining Period|Not Evaluable|0
6798262|NCT02508532|10799202|FG000|Part 2 - Treatment|Disease Progression|0
6798263|NCT02508532|10799203|FG001|Part 2 - Treatment|Disease Progression|0
6798264|NCT02508532|10799204|FG002|Part 2 - Treatment|Disease Progression|0
6798265|NCT02508532|10799205|FG003|Part 2 - Treatment|Disease Progression|0
6798266|NCT02508532|10799206|FG004|Part 2 - Treatment|Disease Progression|0
6798267|NCT02508532|10799207|FG005|Part 2 - Treatment|Disease Progression|0
6798268|NCT02508532|10799208|FG006|Part 2 - Treatment|Disease Progression|0
6798269|NCT02508532|10799209|FG007|Part 2 - Treatment|Disease Progression|0
6798270|NCT02508532|10799210|FG008|Part 2 - Treatment|Disease Progression|118
6798271|NCT02508532|10799202|FG000|Part 2 - Treatment|Adverse Event|0
6798272|NCT02508532|10799203|FG001|Part 2 - Treatment|Adverse Event|0
6798273|NCT02508532|10799204|FG002|Part 2 - Treatment|Adverse Event|0
6798274|NCT02508532|10799205|FG003|Part 2 - Treatment|Adverse Event|0
6798275|NCT02508532|10799206|FG004|Part 2 - Treatment|Adverse Event|0
6798276|NCT02508532|10799207|FG005|Part 2 - Treatment|Adverse Event|0
6798277|NCT02508532|10799208|FG006|Part 2 - Treatment|Adverse Event|0
6798278|NCT02508532|10799209|FG007|Part 2 - Treatment|Adverse Event|0
6798279|NCT02508532|10799210|FG008|Part 2 - Treatment|Adverse Event|49
6798280|NCT02508532|10799202|FG000|Part 2 - Treatment|Physician Decision|0
6798281|NCT02508532|10799203|FG001|Part 2 - Treatment|Physician Decision|0
6798282|NCT02508532|10799204|FG002|Part 2 - Treatment|Physician Decision|0
6798283|NCT02508532|10799205|FG003|Part 2 - Treatment|Physician Decision|0
6798284|NCT02508532|10799206|FG004|Part 2 - Treatment|Physician Decision|0
6798285|NCT02508532|10799207|FG005|Part 2 - Treatment|Physician Decision|0
6798286|NCT02508532|10799208|FG006|Part 2 - Treatment|Physician Decision|0
6798287|NCT02508532|10799209|FG007|Part 2 - Treatment|Physician Decision|0
6798288|NCT02508532|10799210|FG008|Part 2 - Treatment|Physician Decision|12
6798289|NCT02508532|10799202|FG000|Part 2 - Treatment|Administrative|0
6798290|NCT02508532|10799203|FG001|Part 2 - Treatment|Administrative|0
6798291|NCT02508532|10799204|FG002|Part 2 - Treatment|Administrative|0
6798292|NCT02508532|10799205|FG003|Part 2 - Treatment|Administrative|0
6798293|NCT02508532|10799206|FG004|Part 2 - Treatment|Administrative|0
6798294|NCT02508532|10799207|FG005|Part 2 - Treatment|Administrative|0
6798295|NCT02508532|10799208|FG006|Part 2 - Treatment|Administrative|0
6798296|NCT02508532|10799209|FG007|Part 2 - Treatment|Administrative|0
6798297|NCT02508532|10799210|FG008|Part 2 - Treatment|Administrative|3
6798298|NCT02508532|10799202|FG000|Part 2 - Treatment|Sponsor Decision|0
6798299|NCT02508532|10799203|FG001|Part 2 - Treatment|Sponsor Decision|0
6798300|NCT02508532|10799204|FG002|Part 2 - Treatment|Sponsor Decision|0
6798301|NCT02508532|10799205|FG003|Part 2 - Treatment|Sponsor Decision|0
6798302|NCT02508532|10799206|FG004|Part 2 - Treatment|Sponsor Decision|0
6798303|NCT02508532|10799207|FG005|Part 2 - Treatment|Sponsor Decision|0
6798304|NCT02508532|10799208|FG006|Part 2 - Treatment|Sponsor Decision|0
6798305|NCT02508532|10799209|FG007|Part 2 - Treatment|Sponsor Decision|0
6798306|NCT02508532|10799210|FG008|Part 2 - Treatment|Sponsor Decision|28
6798307|NCT02508532|10799202|FG000|Part 2 - Treatment|Death|0
6798308|NCT02508532|10799203|FG001|Part 2 - Treatment|Death|0
6798309|NCT02508532|10799204|FG002|Part 2 - Treatment|Death|0
6798310|NCT02508532|10799205|FG003|Part 2 - Treatment|Death|0
6798311|NCT02508532|10799206|FG004|Part 2 - Treatment|Death|0
6798312|NCT02508532|10799207|FG005|Part 2 - Treatment|Death|0
6798313|NCT02508532|10799208|FG006|Part 2 - Treatment|Death|0
6798314|NCT02508532|10799209|FG007|Part 2 - Treatment|Death|0
6798315|NCT02508532|10799210|FG008|Part 2 - Treatment|Death|1
6798316|NCT02508532|10799202|FG000|Part 2 - Treatment|Withdrawal by Subject|0
6798317|NCT02508532|10799203|FG001|Part 2 - Treatment|Withdrawal by Subject|0
6798318|NCT02508532|10799204|FG002|Part 2 - Treatment|Withdrawal by Subject|0
6798319|NCT02508532|10799205|FG003|Part 2 - Treatment|Withdrawal by Subject|0
6798320|NCT02508532|10799206|FG004|Part 2 - Treatment|Withdrawal by Subject|0
6798321|NCT02508532|10799207|FG005|Part 2 - Treatment|Withdrawal by Subject|0
6798322|NCT02508532|10799208|FG006|Part 2 - Treatment|Withdrawal by Subject|0
6798323|NCT02508532|10799209|FG007|Part 2 - Treatment|Withdrawal by Subject|0
6798324|NCT02508532|10799210|FG008|Part 2 - Treatment|Withdrawal by Subject|6
6798325|NCT02508532|10799202|FG000|Part 1 and Part 2 End of Study|Disease Progression|2
6798326|NCT02508532|10799203|FG001|Part 1 and Part 2 End of Study|Disease Progression|0
6798327|NCT02508532|10799204|FG002|Part 1 and Part 2 End of Study|Disease Progression|0
6798328|NCT02508532|10799205|FG003|Part 1 and Part 2 End of Study|Disease Progression|0
6798329|NCT02508532|10799206|FG004|Part 1 and Part 2 End of Study|Disease Progression|0
6798330|NCT02508532|10799207|FG005|Part 1 and Part 2 End of Study|Disease Progression|0
6798331|NCT02508532|10799208|FG006|Part 1 and Part 2 End of Study|Disease Progression|0
6798332|NCT02508532|10799209|FG007|Part 1 and Part 2 End of Study|Disease Progression|1
6798333|NCT02508532|10799210|FG008|Part 1 and Part 2 End of Study|Disease Progression|6
6798334|NCT02508532|10799202|FG000|Part 1 and Part 2 End of Study|Adverse Event|1
6798335|NCT02508532|10799203|FG001|Part 1 and Part 2 End of Study|Adverse Event|0
6798336|NCT02508532|10799204|FG002|Part 1 and Part 2 End of Study|Adverse Event|1
6798337|NCT02508532|10799205|FG003|Part 1 and Part 2 End of Study|Adverse Event|0
6798338|NCT02508532|10799206|FG004|Part 1 and Part 2 End of Study|Adverse Event|0
6798339|NCT02508532|10799207|FG005|Part 1 and Part 2 End of Study|Adverse Event|0
6798340|NCT02508532|10799208|FG006|Part 1 and Part 2 End of Study|Adverse Event|0
6798341|NCT02508532|10799209|FG007|Part 1 and Part 2 End of Study|Adverse Event|0
6798342|NCT02508532|10799210|FG008|Part 1 and Part 2 End of Study|Adverse Event|2
6798343|NCT02508532|10799202|FG000|Part 1 and Part 2 End of Study|Death|0
6798344|NCT02508532|10799203|FG001|Part 1 and Part 2 End of Study|Death|4
6798345|NCT02508532|10799204|FG002|Part 1 and Part 2 End of Study|Death|2
6798346|NCT02508532|10799205|FG003|Part 1 and Part 2 End of Study|Death|4
6798347|NCT02508532|10799206|FG004|Part 1 and Part 2 End of Study|Death|3
6798348|NCT02508532|10799207|FG005|Part 1 and Part 2 End of Study|Death|0
6798349|NCT02508532|10799208|FG006|Part 1 and Part 2 End of Study|Death|0
6798350|NCT02508532|10799209|FG007|Part 1 and Part 2 End of Study|Death|1
6798351|NCT02508532|10799210|FG008|Part 1 and Part 2 End of Study|Death|111
6798352|NCT02508532|10799202|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1
6798353|NCT02508532|10799203|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1
6798354|NCT02508532|10799204|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1
6798355|NCT02508532|10799205|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0
6798356|NCT02508532|10799206|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0
6798357|NCT02508532|10799207|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0
6798358|NCT02508532|10799208|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0
6798359|NCT02508532|10799209|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0
6798360|NCT02508532|10799210|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6
6798361|NCT02508532|10799202|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
6798362|NCT02508532|10799203|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
6798363|NCT02508532|10799204|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
6798364|NCT02508532|10799205|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
6798365|NCT02508532|10799206|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
6798366|NCT02508532|10799207|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
6798367|NCT02508532|10799208|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
6798368|NCT02508532|10799209|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
6798369|NCT02508532|10799210|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15
6798370|NCT02508532|10799202|FG000|Part 1 and Part 2 End of Study|Physician Decision|0
6798371|NCT02508532|10799203|FG001|Part 1 and Part 2 End of Study|Physician Decision|0
6798372|NCT02508532|10799204|FG002|Part 1 and Part 2 End of Study|Physician Decision|1
6798373|NCT02508532|10799205|FG003|Part 1 and Part 2 End of Study|Physician Decision|0
6798374|NCT02508532|10799206|FG004|Part 1 and Part 2 End of Study|Physician Decision|1
6798375|NCT02508532|10799207|FG005|Part 1 and Part 2 End of Study|Physician Decision|0
6798376|NCT02508532|10799208|FG006|Part 1 and Part 2 End of Study|Physician Decision|0
6798377|NCT02508532|10799209|FG007|Part 1 and Part 2 End of Study|Physician Decision|0
6798378|NCT02508532|10799210|FG008|Part 1 and Part 2 End of Study|Physician Decision|8
6798379|NCT02508532|10799202|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0
6798380|NCT02508532|10799203|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0
6798381|NCT02508532|10799204|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0
6798382|NCT02508532|10799205|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0
6798383|NCT02508532|10799206|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0
6798384|NCT02508532|10799207|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0
6798385|NCT02508532|10799208|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0
6798386|NCT02508532|10799209|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0
6798387|NCT02508532|10799210|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1
6798388|NCT02508532|10799202|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2
6798389|NCT02508532|10799203|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1
6798390|NCT02508532|10799204|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1
6798391|NCT02508532|10799205|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2
6798392|NCT02508532|10799206|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2
6798393|NCT02508532|10799207|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0
6798394|NCT02508532|10799208|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0
6798395|NCT02508532|10799209|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1
6798396|NCT02508532|10799210|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68
6798397|NCT02489318|10799241|FG000|Randomized|Withdrawal by Subject|0
6798398|NCT02489318|10799242|FG001|Randomized|Withdrawal by Subject|1
6798399|NCT02489318|10799241|FG000|Treated|Adverse Event|19
6798400|NCT02489318|10799242|FG001|Treated|Adverse Event|62
6798401|NCT02489318|10799241|FG000|Treated|Death|13
6798402|NCT02489318|10799242|FG001|Treated|Death|11
6798403|NCT02489318|10799241|FG000|Treated|Physician Decision|4
6798404|NCT02489318|10799242|FG001|Treated|Physician Decision|6
6798405|NCT02489318|10799241|FG000|Treated|Protocol Violation|1
6798406|NCT02489318|10799242|FG001|Treated|Protocol Violation|2
6798407|NCT02489318|10799241|FG000|Treated|Withdrawal by Subject|37
6798408|NCT02489318|10799242|FG001|Treated|Withdrawal by Subject|36
6798409|NCT02489318|10799241|FG000|Treated|Other: Progressive Disease|245
6798410|NCT02489318|10799242|FG001|Treated|Other: Progressive Disease|138
6798411|NCT02489318|10799241|FG000|Treated|Other|0
6798412|NCT02489318|10799242|FG001|Treated|Other|2
6798413|NCT02489318|10799241|FG000|Treated|Ongoing|0
6798414|NCT02489318|10799242|FG001|Treated|Ongoing|267
6798415|NCT02454933|10794106|FG000|Overall Study|Progressive disease|7
6798416|NCT02454933|10794107|FG001|Overall Study|Progressive disease|5
6798417|NCT02454933|10794106|FG000|Overall Study|Adverse Event|1
6798418|NCT02454933|10794107|FG001|Overall Study|Adverse Event|1
6798419|NCT02454933|10794106|FG000|Overall Study|Withdrawal by Subject|0
6798420|NCT02454933|10794107|FG001|Overall Study|Withdrawal by Subject|2
6798421|NCT02426684|10794112|FG000|Overall Study|Physician Decision|1
6798422|NCT02421939|10799251|FG000|Overall Study|Progressive disease|70
6798423|NCT02421939|10799252|FG001|Overall Study|Progressive disease|16
6798424|NCT02421939|10799251|FG000|Overall Study|Lack of Efficacy|21
6798425|NCT02421939|10799252|FG001|Overall Study|Lack of Efficacy|31
6798426|NCT02421939|10799251|FG000|Overall Study|Death|36
6798427|NCT02421939|10799252|FG001|Overall Study|Death|10
6798428|NCT02421939|10799251|FG000|Overall Study|Disease relapse|33
6798429|NCT02421939|10799252|FG001|Overall Study|Disease relapse|2
6798430|NCT02421939|10799251|FG000|Overall Study|Adverse Event|28
6798431|NCT02421939|10799252|FG001|Overall Study|Adverse Event|5
6798432|NCT02421939|10799251|FG000|Overall Study|Withdrawal by Subject|5
6798433|NCT02421939|10799252|FG001|Overall Study|Withdrawal by Subject|24
6798434|NCT02421939|10799251|FG000|Overall Study|Physician Decision|11
6798435|NCT02421939|10799252|FG001|Overall Study|Physician Decision|11
6798436|NCT02421939|10799251|FG000|Overall Study|Completed 1 or 2 chemo cycles with CRs|0
6798437|NCT02421939|10799252|FG001|Overall Study|Completed 1 or 2 chemo cycles with CRs|19
6798438|NCT02421939|10799251|FG000|Overall Study|Miscellaneous|4
6798439|NCT02421939|10799252|FG001|Overall Study|Miscellaneous|5
6798440|NCT02421939|10799251|FG000|Overall Study|Protocol deviation|1
6798441|NCT02421939|10799252|FG001|Overall Study|Protocol deviation|1
6798442|NCT02358031|10799261|FG000|Overall Study|Death|226
6798443|NCT02358031|10799262|FG001|Overall Study|Death|204
6798444|NCT02358031|10799263|FG002|Overall Study|Death|249
6798445|NCT02358031|10799261|FG000|Overall Study|Lost to Follow-up|0
6798446|NCT02358031|10799262|FG001|Overall Study|Lost to Follow-up|1
6798447|NCT02358031|10799263|FG002|Overall Study|Lost to Follow-up|1
6798448|NCT02358031|10799261|FG000|Overall Study|Withdrawal by Subject|14
6798449|NCT02358031|10799262|FG001|Overall Study|Withdrawal by Subject|12
6798450|NCT02358031|10799263|FG002|Overall Study|Withdrawal by Subject|17
6798451|NCT02358031|10799261|FG000|Overall Study|Ongoing in Study|61
6798452|NCT02358031|10799262|FG001|Overall Study|Ongoing in Study|64
6798453|NCT02358031|10799263|FG002|Overall Study|Ongoing in Study|33
6798454|NCT02337751|10794118|FG000|Overall Study|Pretreatment Event/Adverse Event|2
6798455|NCT02337751|10794119|FG001|Overall Study|Pretreatment Event/Adverse Event|3
6798456|NCT02337751|10794118|FG000|Overall Study|Voluntary Withdrawal|6
6798457|NCT02337751|10794119|FG001|Overall Study|Voluntary Withdrawal|8
6798458|NCT02337751|10794118|FG000|Overall Study|Lack of Efficacy|2
6798459|NCT02337751|10794119|FG001|Overall Study|Lack of Efficacy|5
6798460|NCT02337751|10794118|FG000|Overall Study|Investigator's Judgement|1
6798461|NCT02337751|10794119|FG001|Overall Study|Investigator's Judgement|0
6798462|NCT02337725|10794128|FG000|Overall Study|Pretreatment Event/AE before Treatment|0
6798463|NCT02337725|10794129|FG001|Overall Study|Pretreatment Event/AE before Treatment|1
6798464|NCT02337725|10794128|FG000|Overall Study|Pretreatment Event/AE in Treatment|8
6798465|NCT02337725|10794129|FG001|Overall Study|Pretreatment Event/AE in Treatment|3
6798466|NCT02337725|10794128|FG000|Overall Study|Major Protocol Deviation|0
6798467|NCT02337725|10794129|FG001|Overall Study|Major Protocol Deviation|1
6798468|NCT02337725|10794128|FG000|Overall Study|Voluntary Withdrawal|14
6798469|NCT02337725|10794129|FG001|Overall Study|Voluntary Withdrawal|3
6798470|NCT02337725|10794128|FG000|Overall Study|Lack of Efficacy|4
6798471|NCT02337725|10794129|FG001|Overall Study|Lack of Efficacy|0
6798472|NCT02332655|10794135|FG000|Overall Study|Lack of Efficacy|1
6798473|NCT02317705|10799271|FG000|Overall Study|Withdrawal by Subject|3
6798474|NCT02317705|10799271|FG000|Overall Study|Physician Decision|1
6798475|NCT02317705|10799271|FG000|Overall Study|Drug not usable|1
6798476|NCT02277444|10799275|FG000|Overall Study|Adverse Event|10
6798477|NCT02277444|10799275|FG000|Overall Study|Withdrawal by Subject|3
6798478|NCT02277444|10799275|FG000|Overall Study|Other|1
6798479|NCT02277444|10799275|FG000|Overall Study|Enrolled and not Treated|3
6798480|NCT02277444|10799275|FG000|Overall Study|Ongoing|113
6798481|NCT02272803|10799281|FG000|Overall Study|Disease progression|16
6798482|NCT02272803|10799282|FG001|Overall Study|Disease progression|8
6798483|NCT02272803|10799281|FG000|Overall Study|Adverse Event unrelated to study drug|3
6798484|NCT02272803|10799282|FG001|Overall Study|Adverse Event unrelated to study drug|5
6798485|NCT02272803|10799281|FG000|Overall Study|Study drug toxicity|4
6798486|NCT02272803|10799282|FG001|Overall Study|Study drug toxicity|9
6798487|NCT02272803|10799281|FG000|Overall Study|Participant request to discontinue study treatment|3
6798488|NCT02272803|10799282|FG001|Overall Study|Participant request to discontinue study treatment|7
6798489|NCT02272803|10799281|FG000|Overall Study|Maximum clinical benefit|4
6798490|NCT02272803|10799282|FG001|Overall Study|Maximum clinical benefit|2
6798491|NCT02272803|10799281|FG000|Overall Study|Poor/non-compliance|2
6798492|NCT02272803|10799282|FG001|Overall Study|Poor/non-compliance|2
6798493|NCT02272803|10799281|FG000|Overall Study|Withdrawal by Subject|2
6798494|NCT02272803|10799282|FG001|Overall Study|Withdrawal by Subject|1
6798495|NCT02272803|10799281|FG000|Overall Study|Death|0
6798496|NCT02272803|10799282|FG001|Overall Study|Death|1
6798497|NCT02272803|10799281|FG000|Overall Study|Other reasons|1
6798498|NCT02272803|10799282|FG001|Overall Study|Other reasons|3
6798499|NCT02272803|10799281|FG000|Overall Study|Administrative reason by sponsor|5
6798500|NCT02272803|10799282|FG001|Overall Study|Administrative reason by sponsor|4
6798501|NCT02257736|10799290|FG000|Overall Study|Progressive disease|365
6798502|NCT02257736|10799291|FG001|Overall Study|Progressive disease|327
6798503|NCT02257736|10799290|FG000|Overall Study|Adverse Event|45
6798504|NCT02257736|10799291|FG001|Overall Study|Adverse Event|56
6798505|NCT02257736|10799290|FG000|Overall Study|Withdrawal by Subject|21
6798506|NCT02257736|10799291|FG001|Overall Study|Withdrawal by Subject|38
6798507|NCT02257736|10799290|FG000|Overall Study|Death|11
6798508|NCT02257736|10799291|FG001|Overall Study|Death|6
6798509|NCT02257736|10799290|FG000|Overall Study|Physician Decision|5
6798510|NCT02257736|10799291|FG001|Overall Study|Physician Decision|9
6798511|NCT02257736|10799290|FG000|Overall Study|Non-Compliance with study drug|1
6798512|NCT02257736|10799291|FG001|Overall Study|Non-Compliance with study drug|2
6798513|NCT02257736|10799290|FG000|Overall Study|Protocol Violation|1
6798514|NCT02257736|10799291|FG001|Overall Study|Protocol Violation|0
6798515|NCT02257736|10799290|FG000|Overall Study|Other|1
6798516|NCT02257736|10799291|FG001|Overall Study|Other|7
6798517|NCT02257736|10799290|FG000|Overall Study|Randomized, not treated|1
6798518|NCT02257736|10799291|FG001|Overall Study|Randomized, not treated|2
6798519|NCT02252172|10799299|FG000|Overall Study|Lost to Follow-up|3
6798520|NCT02252172|10799300|FG001|Overall Study|Lost to Follow-up|1
6798521|NCT02252172|10799299|FG000|Overall Study|Ongoing|276
6798522|NCT02252172|10799300|FG001|Overall Study|Ongoing|298
6798523|NCT02197234|10799319|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1
6798524|NCT02197234|10799319|FG000|Part A: Day 3-30 (AZD9291 Alone)|Adverse Event|1
6798525|NCT02197234|10799319|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1
6798526|NCT02197234|10799319|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1
6798527|NCT02197234|10799319|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1
6798528|NCT02197234|10799319|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6
6798529|NCT02197234|10799319|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22
6798530|NCT02195479|10799328|FG000|Overall Study|Lost to Follow-up|3
6798531|NCT02195479|10799329|FG001|Overall Study|Lost to Follow-up|0
6798532|NCT02195479|10799328|FG000|Overall Study|Death|48
6798533|NCT02195479|10799329|FG001|Overall Study|Death|45
6798534|NCT02195479|10799328|FG000|Overall Study|Physician Decision|1
6798535|NCT02195479|10799329|FG001|Overall Study|Physician Decision|0
6798536|NCT02195479|10799328|FG000|Overall Study|Withdrawal by Subject|11
6798537|NCT02195479|10799329|FG001|Overall Study|Withdrawal by Subject|6
6798538|NCT02195479|10799328|FG000|Overall Study|Other|2
6798539|NCT02195479|10799329|FG001|Overall Study|Other|2
6798540|NCT02195479|10799328|FG000|Overall Study|Ongoing|291
6798541|NCT02195479|10799329|FG001|Overall Study|Ongoing|297
6798542|NCT02136134|10799347|FG000|Overall Study|Death|35
6798543|NCT02136134|10799348|FG001|Overall Study|Death|29
6798544|NCT02136134|10799347|FG000|Overall Study|Withdrawal by Subject|14
6798545|NCT02136134|10799348|FG001|Overall Study|Withdrawal by Subject|4
6798546|NCT02136134|10799347|FG000|Overall Study|Other|3
6798547|NCT02136134|10799348|FG001|Overall Study|Other|3
6798548|NCT02136134|10799347|FG000|Overall Study|Ongoing|185
6798549|NCT02136134|10799348|FG001|Overall Study|Ongoing|207
6798550|NCT02136134|10799347|FG000|Overall Study|Subjects randomized but not treated|10
6798551|NCT02136134|10799348|FG001|Overall Study|Subjects randomized but not treated|8
6798552|NCT02076009|10799356|FG000|Overall Study|Death|44
6798553|NCT02076009|10799357|FG001|Overall Study|Death|30
6798554|NCT02076009|10799356|FG000|Overall Study|Withdrawal by Subject|9
6798555|NCT02076009|10799357|FG001|Overall Study|Withdrawal by Subject|3
6798556|NCT02076009|10799356|FG000|Overall Study|Lost to Follow-up|1
6798557|NCT02076009|10799357|FG001|Overall Study|Lost to Follow-up|1
6798558|NCT02076009|10799356|FG000|Overall Study|Progressive disease|1
6798559|NCT02076009|10799357|FG001|Overall Study|Progressive disease|0
6798560|NCT02076009|10799356|FG000|Overall Study|Ongoing|226
6798561|NCT02076009|10799357|FG001|Overall Study|Ongoing|249
6798562|NCT02076009|10799356|FG000|Overall Study|Subjects randomized but not treated|2
6798563|NCT02076009|10799357|FG001|Overall Study|Subjects randomized but not treated|3
6798564|NCT02043678|10799365|FG000|Overall Study|Never treated|11
6798565|NCT02043678|10799366|FG001|Overall Study|Never treated|9
6798566|NCT02043678|10799365|FG000|Overall Study|AE with clinical progressive disease(PD)|18
6798567|NCT02043678|10799366|FG001|Overall Study|AE with clinical progressive disease(PD)|18
6798568|NCT02043678|10799365|FG000|Overall Study|AE without clinical PD|51
6798569|NCT02043678|10799366|FG001|Overall Study|AE without clinical PD|34
6798570|NCT02043678|10799365|FG000|Overall Study|Lost to Follow-up|1
6798571|NCT02043678|10799366|FG001|Overall Study|Lost to Follow-up|1
6798572|NCT02043678|10799365|FG000|Overall Study|Other|19
6798573|NCT02043678|10799366|FG001|Overall Study|Other|16
6798574|NCT02043678|10799365|FG000|Overall Study|Clinical PD|108
6798575|NCT02043678|10799366|FG001|Overall Study|Clinical PD|138
6798576|NCT02043678|10799365|FG000|Overall Study|Radiological PD|91
6798577|NCT02043678|10799366|FG001|Overall Study|Radiological PD|80
6798578|NCT02043678|10799365|FG000|Overall Study|Protocol-driven decision point|56
6798579|NCT02043678|10799366|FG001|Overall Study|Protocol-driven decision point|56
6798580|NCT02043678|10799365|FG000|Overall Study|Withdrawal by Subject|12
6798581|NCT02043678|10799366|FG001|Overall Study|Withdrawal by Subject|15
6798582|NCT02043678|10799365|FG000|Overall Study|Ongoing with treatment|34
6798583|NCT02043678|10799366|FG001|Overall Study|Ongoing with treatment|38
6798584|NCT01994382|10794187|FG000|Overall Study|Informed consent withdrawn|0
6798585|NCT01994382|10794188|FG001|Overall Study|Informed consent withdrawn|0
6798586|NCT01994382|10794189|FG002|Overall Study|Informed consent withdrawn|0
6798587|NCT01994382|10794190|FG003|Overall Study|Informed consent withdrawn|0
6798588|NCT01994382|10794191|FG004|Overall Study|Informed consent withdrawn|0
6798589|NCT01994382|10794192|FG005|Overall Study|Informed consent withdrawn|0
6798590|NCT01994382|10794193|FG006|Overall Study|Informed consent withdrawn|1
6798591|NCT01994382|10794194|FG007|Overall Study|Informed consent withdrawn|0
6798592|NCT01994382|10794195|FG008|Overall Study|Informed consent withdrawn|0
6798593|NCT01994382|10794196|FG009|Overall Study|Informed consent withdrawn|0
6798594|NCT01994382|10794197|FG010|Overall Study|Informed consent withdrawn|0
6798595|NCT01994382|10794198|FG011|Overall Study|Informed consent withdrawn|0
6798596|NCT01994382|10794199|FG012|Overall Study|Informed consent withdrawn|0
6798597|NCT01994382|10794200|FG013|Overall Study|Informed consent withdrawn|0
6798598|NCT01994382|10794201|FG014|Overall Study|Informed consent withdrawn|0
6798599|NCT01994382|10794202|FG015|Overall Study|Informed consent withdrawn|0
6798600|NCT01994382|10794203|FG016|Overall Study|Informed consent withdrawn|0
6798601|NCT01994382|10794187|FG000|Overall Study|Progressive disease|3
6798602|NCT01994382|10794188|FG001|Overall Study|Progressive disease|4
6798603|NCT01994382|10794189|FG002|Overall Study|Progressive disease|4
6798604|NCT01994382|10794190|FG003|Overall Study|Progressive disease|3
6798605|NCT01994382|10794191|FG004|Overall Study|Progressive disease|2
6798606|NCT01994382|10794192|FG005|Overall Study|Progressive disease|3
6798607|NCT01994382|10794193|FG006|Overall Study|Progressive disease|3
6798608|NCT01994382|10794194|FG007|Overall Study|Progressive disease|6
6798609|NCT01994382|10794195|FG008|Overall Study|Progressive disease|2
6798610|NCT01994382|10794196|FG009|Overall Study|Progressive disease|2
6798611|NCT01994382|10794197|FG010|Overall Study|Progressive disease|13
6798612|NCT01994382|10794198|FG011|Overall Study|Progressive disease|8
6798613|NCT01994382|10794199|FG012|Overall Study|Progressive disease|7
6798614|NCT01994382|10794200|FG013|Overall Study|Progressive disease|3
6798615|NCT01994382|10794201|FG014|Overall Study|Progressive disease|6
6798616|NCT01994382|10794202|FG015|Overall Study|Progressive disease|44
6798617|NCT01994382|10794203|FG016|Overall Study|Progressive disease|28
6798618|NCT01994382|10794187|FG000|Overall Study|Physician Decision|0
6798619|NCT01994382|10794188|FG001|Overall Study|Physician Decision|1
6798620|NCT01994382|10794189|FG002|Overall Study|Physician Decision|0
6798621|NCT01994382|10794190|FG003|Overall Study|Physician Decision|0
6798622|NCT01994382|10794191|FG004|Overall Study|Physician Decision|0
6798623|NCT01994382|10794192|FG005|Overall Study|Physician Decision|0
6798624|NCT01994382|10794193|FG006|Overall Study|Physician Decision|0
6798625|NCT01994382|10794194|FG007|Overall Study|Physician Decision|0
6798626|NCT01994382|10794195|FG008|Overall Study|Physician Decision|0
6798627|NCT01994382|10794196|FG009|Overall Study|Physician Decision|0
6798628|NCT01994382|10794197|FG010|Overall Study|Physician Decision|3
6798629|NCT01994382|10794198|FG011|Overall Study|Physician Decision|1
6798630|NCT01994382|10794199|FG012|Overall Study|Physician Decision|1
6798631|NCT01994382|10794200|FG013|Overall Study|Physician Decision|0
6798632|NCT01994382|10794201|FG014|Overall Study|Physician Decision|1
6798633|NCT01994382|10794202|FG015|Overall Study|Physician Decision|4
6798634|NCT01994382|10794203|FG016|Overall Study|Physician Decision|2
6798635|NCT01994382|10794187|FG000|Overall Study|Death|0
6798636|NCT01994382|10794188|FG001|Overall Study|Death|0
6798637|NCT01994382|10794189|FG002|Overall Study|Death|0
6798638|NCT01994382|10794190|FG003|Overall Study|Death|0
6798639|NCT01994382|10794191|FG004|Overall Study|Death|1
6798640|NCT01994382|10794192|FG005|Overall Study|Death|0
6798641|NCT01994382|10794193|FG006|Overall Study|Death|0
6798642|NCT01994382|10794194|FG007|Overall Study|Death|0
6798643|NCT01994382|10794195|FG008|Overall Study|Death|1
6798644|NCT01994382|10794196|FG009|Overall Study|Death|1
6798645|NCT01994382|10794197|FG010|Overall Study|Death|0
6798646|NCT01994382|10794198|FG011|Overall Study|Death|0
6798647|NCT01994382|10794199|FG012|Overall Study|Death|0
6798648|NCT01994382|10794200|FG013|Overall Study|Death|0
6798649|NCT01994382|10794201|FG014|Overall Study|Death|0
6798650|NCT01994382|10794202|FG015|Overall Study|Death|1
6798651|NCT01994382|10794203|FG016|Overall Study|Death|0
6798652|NCT01994382|10794187|FG000|Overall Study|Adverse Event|0
6798653|NCT01994382|10794188|FG001|Overall Study|Adverse Event|1
6798654|NCT01994382|10794189|FG002|Overall Study|Adverse Event|2
6798655|NCT01994382|10794190|FG003|Overall Study|Adverse Event|0
6798656|NCT01994382|10794191|FG004|Overall Study|Adverse Event|0
6798657|NCT01994382|10794192|FG005|Overall Study|Adverse Event|0
6798658|NCT01994382|10794193|FG006|Overall Study|Adverse Event|0
6798659|NCT01994382|10794194|FG007|Overall Study|Adverse Event|0
6798660|NCT01994382|10794195|FG008|Overall Study|Adverse Event|0
6798661|NCT01994382|10794196|FG009|Overall Study|Adverse Event|0
6798662|NCT01994382|10794197|FG010|Overall Study|Adverse Event|15
6798663|NCT01994382|10794198|FG011|Overall Study|Adverse Event|2
6798664|NCT01994382|10794199|FG012|Overall Study|Adverse Event|7
6798665|NCT01994382|10794200|FG013|Overall Study|Adverse Event|3
6798666|NCT01994382|10794201|FG014|Overall Study|Adverse Event|17
6798667|NCT01994382|10794202|FG015|Overall Study|Adverse Event|6
6798668|NCT01994382|10794203|FG016|Overall Study|Adverse Event|3
6798669|NCT01994382|10794187|FG000|Overall Study|Other than specified|0
6798670|NCT01994382|10794188|FG001|Overall Study|Other than specified|0
6798671|NCT01994382|10794189|FG002|Overall Study|Other than specified|0
6798672|NCT01994382|10794190|FG003|Overall Study|Other than specified|0
6798673|NCT01994382|10794191|FG004|Overall Study|Other than specified|0
6798674|NCT01994382|10794192|FG005|Overall Study|Other than specified|0
6798675|NCT01994382|10794193|FG006|Overall Study|Other than specified|0
6798676|NCT01994382|10794194|FG007|Overall Study|Other than specified|0
6798677|NCT01994382|10794195|FG008|Overall Study|Other than specified|0
6798678|NCT01994382|10794196|FG009|Overall Study|Other than specified|0
6798679|NCT01994382|10794197|FG010|Overall Study|Other than specified|2
6798680|NCT01994382|10794198|FG011|Overall Study|Other than specified|0
6798681|NCT01994382|10794199|FG012|Overall Study|Other than specified|2
6798682|NCT01994382|10794200|FG013|Overall Study|Other than specified|0
6798683|NCT01994382|10794201|FG014|Overall Study|Other than specified|0
6798684|NCT01994382|10794202|FG015|Overall Study|Other than specified|4
6798685|NCT01994382|10794203|FG016|Overall Study|Other than specified|4
6798686|NCT01994382|10794187|FG000|Overall Study|Withdrawal by Subject|0
6798687|NCT01994382|10794188|FG001|Overall Study|Withdrawal by Subject|0
6798688|NCT01994382|10794189|FG002|Overall Study|Withdrawal by Subject|0
6798689|NCT01994382|10794190|FG003|Overall Study|Withdrawal by Subject|0
6798690|NCT01994382|10794191|FG004|Overall Study|Withdrawal by Subject|0
6798691|NCT01994382|10794192|FG005|Overall Study|Withdrawal by Subject|0
6798692|NCT01994382|10794193|FG006|Overall Study|Withdrawal by Subject|0
6798693|NCT01994382|10794194|FG007|Overall Study|Withdrawal by Subject|0
6798694|NCT01994382|10794195|FG008|Overall Study|Withdrawal by Subject|0
6798695|NCT01994382|10794196|FG009|Overall Study|Withdrawal by Subject|0
6798696|NCT01994382|10794197|FG010|Overall Study|Withdrawal by Subject|6
6798697|NCT01994382|10794198|FG011|Overall Study|Withdrawal by Subject|0
6798698|NCT01994382|10794199|FG012|Overall Study|Withdrawal by Subject|2
6798699|NCT01994382|10794200|FG013|Overall Study|Withdrawal by Subject|0
6798700|NCT01994382|10794201|FG014|Overall Study|Withdrawal by Subject|4
6798701|NCT01994382|10794202|FG015|Overall Study|Withdrawal by Subject|3
6798702|NCT01994382|10794203|FG016|Overall Study|Withdrawal by Subject|0
6798703|NCT01994382|10794187|FG000|Overall Study|Lost to Follow-up|0
6798704|NCT01994382|10794188|FG001|Overall Study|Lost to Follow-up|0
6798705|NCT01994382|10794189|FG002|Overall Study|Lost to Follow-up|0
6798706|NCT01994382|10794190|FG003|Overall Study|Lost to Follow-up|0
6798707|NCT01994382|10794191|FG004|Overall Study|Lost to Follow-up|0
6798708|NCT01994382|10794192|FG005|Overall Study|Lost to Follow-up|0
6798709|NCT01994382|10794193|FG006|Overall Study|Lost to Follow-up|0
6798710|NCT01994382|10794194|FG007|Overall Study|Lost to Follow-up|0
6798711|NCT01994382|10794195|FG008|Overall Study|Lost to Follow-up|0
6798712|NCT01994382|10794196|FG009|Overall Study|Lost to Follow-up|0
6798713|NCT01994382|10794197|FG010|Overall Study|Lost to Follow-up|1
6798714|NCT01994382|10794198|FG011|Overall Study|Lost to Follow-up|0
6798715|NCT01994382|10794199|FG012|Overall Study|Lost to Follow-up|0
6798716|NCT01994382|10794200|FG013|Overall Study|Lost to Follow-up|0
6798717|NCT01994382|10794201|FG014|Overall Study|Lost to Follow-up|0
6798718|NCT01994382|10794202|FG015|Overall Study|Lost to Follow-up|0
6798719|NCT01994382|10794203|FG016|Overall Study|Lost to Follow-up|0
6798720|NCT01994382|10794187|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
6798721|NCT01994382|10794188|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
6798722|NCT01994382|10794189|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
6798723|NCT01994382|10794190|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
6798724|NCT01994382|10794191|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
6798725|NCT01994382|10794192|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
6798726|NCT01994382|10794193|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
6798727|NCT01994382|10794194|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
6798728|NCT01994382|10794195|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
6798729|NCT01994382|10794196|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
6798730|NCT01994382|10794197|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2
6798731|NCT01994382|10794198|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
6798732|NCT01994382|10794199|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7
6798733|NCT01994382|10794200|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
6798734|NCT01994382|10794201|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
6798735|NCT01994382|10794202|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3
6798736|NCT01994382|10794203|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2
6798737|NCT01994382|10794187|FG000|Overall Study|Protocol violation/noncompliance|0
6798738|NCT01994382|10794188|FG001|Overall Study|Protocol violation/noncompliance|0
6798739|NCT01994382|10794189|FG002|Overall Study|Protocol violation/noncompliance|0
6798740|NCT01994382|10794190|FG003|Overall Study|Protocol violation/noncompliance|0
6798741|NCT01994382|10794191|FG004|Overall Study|Protocol violation/noncompliance|0
6798742|NCT01994382|10794192|FG005|Overall Study|Protocol violation/noncompliance|0
6798743|NCT01994382|10794193|FG006|Overall Study|Protocol violation/noncompliance|0
6798744|NCT01994382|10794194|FG007|Overall Study|Protocol violation/noncompliance|0
6798745|NCT01994382|10794195|FG008|Overall Study|Protocol violation/noncompliance|0
6798746|NCT01994382|10794196|FG009|Overall Study|Protocol violation/noncompliance|0
6798747|NCT01994382|10794197|FG010|Overall Study|Protocol violation/noncompliance|0
6798748|NCT01994382|10794198|FG011|Overall Study|Protocol violation/noncompliance|1
6798749|NCT01994382|10794199|FG012|Overall Study|Protocol violation/noncompliance|0
6798750|NCT01994382|10794200|FG013|Overall Study|Protocol violation/noncompliance|0
6798751|NCT01994382|10794201|FG014|Overall Study|Protocol violation/noncompliance|0
6798752|NCT01994382|10794202|FG015|Overall Study|Protocol violation/noncompliance|0
6798753|NCT01994382|10794203|FG016|Overall Study|Protocol violation/noncompliance|2
6798754|NCT01994382|10794187|FG000|Overall Study|Rolled over to Phase 2a|0
6798755|NCT01994382|10794188|FG001|Overall Study|Rolled over to Phase 2a|0
6798756|NCT01994382|10794189|FG002|Overall Study|Rolled over to Phase 2a|1
6798757|NCT01994382|10794190|FG003|Overall Study|Rolled over to Phase 2a|0
6798758|NCT01994382|10794191|FG004|Overall Study|Rolled over to Phase 2a|0
6798759|NCT01994382|10794192|FG005|Overall Study|Rolled over to Phase 2a|0
6798760|NCT01994382|10794193|FG006|Overall Study|Rolled over to Phase 2a|0
6798761|NCT01994382|10794194|FG007|Overall Study|Rolled over to Phase 2a|0
6798762|NCT01994382|10794195|FG008|Overall Study|Rolled over to Phase 2a|0
6798763|NCT01994382|10794196|FG009|Overall Study|Rolled over to Phase 2a|2
6798764|NCT01994382|10794197|FG010|Overall Study|Rolled over to Phase 2a|0
6798765|NCT01994382|10794198|FG011|Overall Study|Rolled over to Phase 2a|0
6798766|NCT01994382|10794199|FG012|Overall Study|Rolled over to Phase 2a|0
6798767|NCT01994382|10794200|FG013|Overall Study|Rolled over to Phase 2a|0
6798768|NCT01994382|10794201|FG014|Overall Study|Rolled over to Phase 2a|0
6798769|NCT01994382|10794202|FG015|Overall Study|Rolled over to Phase 2a|0
6798770|NCT01994382|10794203|FG016|Overall Study|Rolled over to Phase 2a|0
6798771|NCT01896531|10794248|FG000|Overall Study|Death|57
6798772|NCT01896531|10794249|FG001|Overall Study|Death|59
6798773|NCT01896531|10794248|FG000|Overall Study|Lost to Follow-up|3
6798774|NCT01896531|10794249|FG001|Overall Study|Lost to Follow-up|0
6798775|NCT01896531|10794248|FG000|Overall Study|Non-compliance|0
6798776|NCT01896531|10794249|FG001|Overall Study|Non-compliance|1
6798777|NCT01896531|10794248|FG000|Overall Study|Study Ended by Sponsor|7
6798778|NCT01896531|10794249|FG001|Overall Study|Study Ended by Sponsor|20
6798779|NCT01896531|10794248|FG000|Overall Study|Withdrawal by Subject|3
6798780|NCT01896531|10794249|FG001|Overall Study|Withdrawal by Subject|2
6798781|NCT01896531|10794248|FG000|Overall Study|Death Prior to Treatment|1
6798782|NCT01896531|10794249|FG001|Overall Study|Death Prior to Treatment|0
6798783|NCT01864603|10794257|FG000|Stage 2|DSMB design modification|86056
6798784|NCT01864603|10794258|FG001|Stage 2|DSMB design modification|92558
6798785|NCT01828099|10799374|FG000|Overall Study|Adverse Event|15
6798786|NCT01828099|10799375|FG001|Overall Study|Adverse Event|18
6798787|NCT01828099|10799374|FG000|Overall Study|Death|9
6798788|NCT01828099|10799375|FG001|Overall Study|Death|11
6798789|NCT01828099|10799374|FG000|Overall Study|Lost to Follow-up|2
6798790|NCT01828099|10799375|FG001|Overall Study|Lost to Follow-up|0
6798791|NCT01828099|10799374|FG000|Overall Study|Non-compliance with study treatment|2
6798792|NCT01828099|10799375|FG001|Overall Study|Non-compliance with study treatment|0
6798793|NCT01828099|10799374|FG000|Overall Study|Physician Decision|7
6798794|NCT01828099|10799375|FG001|Overall Study|Physician Decision|11
6798795|NCT01828099|10799374|FG000|Overall Study|Progressive disease|51
6798796|NCT01828099|10799375|FG001|Overall Study|Progressive disease|94
6798797|NCT01828099|10799374|FG000|Overall Study|Protocol Violation|1
6798798|NCT01828099|10799375|FG001|Overall Study|Protocol Violation|0
6798799|NCT01828099|10799374|FG000|Overall Study|Subject/guardian decision|7
6798800|NCT01828099|10799375|FG001|Overall Study|Subject/guardian decision|23
6798801|NCT01757535|10799383|FG000|Overall Study|Disease Relapse|143
6798802|NCT01757535|10799384|FG001|Overall Study|Disease Relapse|180
6798803|NCT01757535|10799383|FG000|Overall Study|Adverse Event|29
6798804|NCT01757535|10799384|FG001|Overall Study|Adverse Event|11
6798805|NCT01757535|10799383|FG000|Overall Study|Withdrawal by Subject|9
6798806|NCT01757535|10799384|FG001|Overall Study|Withdrawal by Subject|13
6798807|NCT01757535|10799383|FG000|Overall Study|Miscellaneous|5
6798808|NCT01757535|10799384|FG001|Overall Study|Miscellaneous|2
6798809|NCT01757535|10799383|FG000|Overall Study|Physician Decision|6
6798810|NCT01757535|10799384|FG001|Overall Study|Physician Decision|0
6798811|NCT01757535|10799383|FG000|Overall Study|Death|1
6798812|NCT01757535|10799384|FG001|Overall Study|Death|2
6798813|NCT01684722|10799398|FG000|Overall Study|Lost to Follow-up|78
6798814|NCT01684722|10799399|FG001|Overall Study|Lost to Follow-up|56
6798815|NCT01684722|10799400|FG002|Overall Study|Lost to Follow-up|75
6798816|NCT01684722|10799401|FG003|Overall Study|Lost to Follow-up|89
6798817|NCT01684722|10799398|FG000|Overall Study|Death|19
6798818|NCT01684722|10799399|FG001|Overall Study|Death|21
6798819|NCT01684722|10799400|FG002|Overall Study|Death|19
6798820|NCT01684722|10799401|FG003|Overall Study|Death|21
6798821|NCT01615029|10799421|FG000|Overall Study|Adverse Event|0
6798822|NCT01615029|10799422|FG001|Overall Study|Adverse Event|0
6798823|NCT01615029|10799423|FG002|Overall Study|Adverse Event|0
6798824|NCT01615029|10799424|FG003|Overall Study|Adverse Event|0
6798825|NCT01615029|10799425|FG004|Overall Study|Adverse Event|1
6798826|NCT01615029|10799421|FG000|Overall Study|Death|0
6798827|NCT01615029|10799422|FG001|Overall Study|Death|0
6798828|NCT01615029|10799423|FG002|Overall Study|Death|0
6798829|NCT01615029|10799424|FG003|Overall Study|Death|0
6798830|NCT01615029|10799425|FG004|Overall Study|Death|1
6798831|NCT01615029|10799421|FG000|Overall Study|Lost to Follow-up|0
6798832|NCT01615029|10799422|FG001|Overall Study|Lost to Follow-up|0
6798833|NCT01615029|10799423|FG002|Overall Study|Lost to Follow-up|0
6798834|NCT01615029|10799424|FG003|Overall Study|Lost to Follow-up|0
6798835|NCT01615029|10799425|FG004|Overall Study|Lost to Follow-up|1
6798836|NCT01615029|10799421|FG000|Overall Study|Progressive disease|2
6798837|NCT01615029|10799422|FG001|Overall Study|Progressive disease|1
6798838|NCT01615029|10799423|FG002|Overall Study|Progressive disease|1
6798839|NCT01615029|10799424|FG003|Overall Study|Progressive disease|1
6798840|NCT01615029|10799425|FG004|Overall Study|Progressive disease|5
6798841|NCT01615029|10799421|FG000|Overall Study|Physician Decision|0
6798842|NCT01615029|10799422|FG001|Overall Study|Physician Decision|0
6798843|NCT01615029|10799423|FG002|Overall Study|Physician Decision|0
6798844|NCT01615029|10799424|FG003|Overall Study|Physician Decision|0
6798845|NCT01615029|10799425|FG004|Overall Study|Physician Decision|1
6798846|NCT01615029|10799421|FG000|Overall Study|Ongoing|1
6798847|NCT01615029|10799422|FG001|Overall Study|Ongoing|2
6798848|NCT01615029|10799423|FG002|Overall Study|Ongoing|3
6798849|NCT01615029|10799424|FG003|Overall Study|Ongoing|2
6798850|NCT01615029|10799425|FG004|Overall Study|Ongoing|23
6798851|NCT01399372|10799452|FG000|Overall Study|Protocol Violation|3
6798852|NCT01399372|10799453|FG001|Overall Study|Protocol Violation|1
6798853|NCT01314118|10799459|FG000|Overall Study|Adverse Event|9
6798854|NCT01314118|10799459|FG000|Overall Study|Progressive disease|27
6798855|NCT01314118|10799459|FG000|Overall Study|Physician Decision|11
6798856|NCT01314118|10799459|FG000|Overall Study|Death|4
6798857|NCT01314118|10799459|FG000|Overall Study|Protocol Violation|5
6798858|NCT01314118|10799459|FG000|Overall Study|Withdrawal by Subject|11
6798859|NCT01314118|10799459|FG000|Overall Study|Other|2
6798860|NCT01314118|10799459|FG000|Overall Study|Ongoing|62
6798861|NCT01171898|10799487|FG000|Overall Study|Death|0
6798862|NCT01171898|10799488|FG001|Overall Study|Death|0
6798863|NCT01171898|10799489|FG002|Overall Study|Death|2
6798864|NCT01171898|10799490|FG003|Overall Study|Death|0
6798865|NCT01171898|10799487|FG000|Overall Study|Lost to Follow-up|0
6798866|NCT01171898|10799488|FG001|Overall Study|Lost to Follow-up|1
6798867|NCT01171898|10799489|FG002|Overall Study|Lost to Follow-up|1
6798868|NCT01171898|10799490|FG003|Overall Study|Lost to Follow-up|1
6798869|NCT01171898|10799487|FG000|Overall Study|Withdrawal by Subject|1
6798870|NCT01171898|10799488|FG001|Overall Study|Withdrawal by Subject|4
6798871|NCT01171898|10799489|FG002|Overall Study|Withdrawal by Subject|6
6798872|NCT01171898|10799490|FG003|Overall Study|Withdrawal by Subject|3
6798873|NCT01171898|10799487|FG000|Overall Study|Terminated by Sponsor|1
6798874|NCT01171898|10799488|FG001|Overall Study|Terminated by Sponsor|0
6798875|NCT01171898|10799489|FG002|Overall Study|Terminated by Sponsor|0
6798876|NCT01171898|10799490|FG003|Overall Study|Terminated by Sponsor|0
6798877|NCT01171898|10799487|FG000|Overall Study|Ongoing|1
6798878|NCT01171898|10799488|FG001|Overall Study|Ongoing|9
6798879|NCT01171898|10799489|FG002|Overall Study|Ongoing|3
6798880|NCT01171898|10799490|FG003|Overall Study|Ongoing|0
6798881|NCT01171898|10799487|FG000|Overall Study|Other|1
6798882|NCT01171898|10799488|FG001|Overall Study|Other|5
6798883|NCT01171898|10799489|FG002|Overall Study|Other|0
6798884|NCT01171898|10799490|FG003|Overall Study|Other|2
6798885|NCT01120964|10799505|FG000|Overall Study|Did not receive full treatment|1
6798886|NCT01120964|10799506|FG001|Overall Study|Did not receive full treatment|0
6798887|NCT01082211|10799512|FG000|Overall Study|Protocol Violation|4
6798888|NCT01082211|10799512|FG000|Overall Study|No protocol treatment received|3
6798889|NCT00976911|10799532|FG000|Overall Study|Withdrawal by Subject|4
6798890|NCT00976911|10799533|FG001|Overall Study|Withdrawal by Subject|6
6798891|NCT00976911|10799532|FG000|Overall Study|Death|138
6798892|NCT00976911|10799533|FG001|Overall Study|Death|126
6798893|NCT00976911|10799532|FG000|Overall Study|Adverse Event|0
6798894|NCT00976911|10799533|FG001|Overall Study|Adverse Event|1
6798895|NCT00976911|10799532|FG000|Overall Study|Protocol Violation|2
6798896|NCT00976911|10799533|FG001|Overall Study|Protocol Violation|0
6798897|NCT00976911|10799532|FG000|Overall Study|Other|8
6798898|NCT00976911|10799533|FG001|Overall Study|Other|9
6798899|NCT00976911|10799532|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30
6798900|NCT00976911|10799533|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37
6798901|NCT00746590|10799539|FG000|Overall Study|Death|1
6798902|NCT00679783|10799572|FG000|Overall Study|Adverse Event|0
6798903|NCT00679783|10799573|FG001|Overall Study|Adverse Event|0
6798904|NCT00679783|10799574|FG002|Overall Study|Adverse Event|0
6798905|NCT00679783|10799575|FG003|Overall Study|Adverse Event|3
6798906|NCT00679783|10799576|FG004|Overall Study|Adverse Event|0
6798907|NCT00679783|10799577|FG005|Overall Study|Adverse Event|0
6798908|NCT00679783|10799578|FG006|Overall Study|Adverse Event|1
6798909|NCT00679783|10799572|FG000|Overall Study|Lack of Efficacy|0
6798910|NCT00679783|10799573|FG001|Overall Study|Lack of Efficacy|1
6798911|NCT00679783|10799574|FG002|Overall Study|Lack of Efficacy|0
6798912|NCT00679783|10799575|FG003|Overall Study|Lack of Efficacy|2
6798913|NCT00679783|10799576|FG004|Overall Study|Lack of Efficacy|0
6798914|NCT00679783|10799577|FG005|Overall Study|Lack of Efficacy|0
6798915|NCT00679783|10799578|FG006|Overall Study|Lack of Efficacy|0
6798916|NCT00679783|10799572|FG000|Overall Study|Withdrawal by Subject|0
6798917|NCT00679783|10799573|FG001|Overall Study|Withdrawal by Subject|0
6798918|NCT00679783|10799574|FG002|Overall Study|Withdrawal by Subject|1
6798919|NCT00679783|10799575|FG003|Overall Study|Withdrawal by Subject|1
6798920|NCT00679783|10799576|FG004|Overall Study|Withdrawal by Subject|0
6798921|NCT00679783|10799577|FG005|Overall Study|Withdrawal by Subject|0
6798922|NCT00679783|10799578|FG006|Overall Study|Withdrawal by Subject|0
6798923|NCT00679783|10799572|FG000|Overall Study|Not Captured|0
6798924|NCT00679783|10799573|FG001|Overall Study|Not Captured|0
6798925|NCT00679783|10799574|FG002|Overall Study|Not Captured|0
6798926|NCT00679783|10799575|FG003|Overall Study|Not Captured|5
6798927|NCT00679783|10799576|FG004|Overall Study|Not Captured|0
6798928|NCT00679783|10799577|FG005|Overall Study|Not Captured|0
6798929|NCT00679783|10799578|FG006|Overall Study|Not Captured|0
6798930|NCT00679783|10799572|FG000|Overall Study|Ongoing at data cut-off|2
6798931|NCT00679783|10799573|FG001|Overall Study|Ongoing at data cut-off|2
6798932|NCT00679783|10799574|FG002|Overall Study|Ongoing at data cut-off|0
6798933|NCT00679783|10799575|FG003|Overall Study|Ongoing at data cut-off|9
6798934|NCT00679783|10799576|FG004|Overall Study|Ongoing at data cut-off|1
6798935|NCT00679783|10799577|FG005|Overall Study|Ongoing at data cut-off|0
6798936|NCT00679783|10799578|FG006|Overall Study|Ongoing at data cut-off|0
6798937|NCT00573131|10799596|FG000|Overall Study|Withdrawal by Subject|10
6798938|NCT00573131|10799597|FG001|Overall Study|Withdrawal by Subject|8
6798939|NCT00533949|10799607|FG000|Overall Study|Protocol Violation|12
6798940|NCT00533949|10799608|FG001|Overall Study|Protocol Violation|12
6798941|NCT00533949|10799609|FG002|Overall Study|Protocol Violation|9
6798942|NCT00533949|10799610|FG003|Overall Study|Protocol Violation|9
6798943|NCT00533949|10799607|FG000|Overall Study|Withdrawal by Subject|3
6798944|NCT00533949|10799608|FG001|Overall Study|Withdrawal by Subject|2
6798945|NCT00533949|10799609|FG002|Overall Study|Withdrawal by Subject|1
6798946|NCT00533949|10799610|FG003|Overall Study|Withdrawal by Subject|1
6798947|NCT00529763|10799631|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1
6798948|NCT00529763|10799632|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3
6798949|NCT00529763|10799633|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1
6798950|NCT00529763|10799631|FG000|Overall Study|Death|0
6798951|NCT00529763|10799632|FG001|Overall Study|Death|1
6798952|NCT00529763|10799633|FG002|Overall Study|Death|1
6798953|NCT00529763|10799631|FG000|Overall Study|Disease Progression|6
6798954|NCT00529763|10799632|FG001|Overall Study|Disease Progression|16
6798955|NCT00529763|10799633|FG002|Overall Study|Disease Progression|1
6798956|NCT00529763|10799631|FG000|Overall Study|Lost to Follow-up|0
6798957|NCT00529763|10799632|FG001|Overall Study|Lost to Follow-up|1
6798958|NCT00529763|10799633|FG002|Overall Study|Lost to Follow-up|1
6798959|NCT00529763|10799631|FG000|Overall Study|Stem Cell Transplant|0
6798960|NCT00529763|10799632|FG001|Overall Study|Stem Cell Transplant|3
6798961|NCT00529763|10799633|FG002|Overall Study|Stem Cell Transplant|0
6798962|NCT00529763|10799631|FG000|Overall Study|Study Drug Toxicity|1
6798963|NCT00529763|10799632|FG001|Overall Study|Study Drug Toxicity|6
6798964|NCT00529763|10799633|FG002|Overall Study|Study Drug Toxicity|1
6798965|NCT00529763|10799631|FG000|Overall Study|Patient Withdrew Consent|2
6798966|NCT00529763|10799632|FG001|Overall Study|Patient Withdrew Consent|3
6798967|NCT00529763|10799633|FG002|Overall Study|Patient Withdrew Consent|2
6798968|NCT00479765|10799648|FG000|Overall Study|study terminated|4
6798969|NCT00450411|10799652|FG000|Overall Study|Protocol Violation|6
6798970|NCT00450411|10799652|FG000|Overall Study|No protocol treatment|2
6798971|NCT00412880|10799656|FG000|Overall Study|Withdrew, overdose of study treatment|1
6798972|NCT00412880|10799656|FG000|Overall Study|Consent withdrawn|1
6798973|NCT00412880|10799656|FG000|Overall Study|Adverse Event|1
6798974|NCT00412880|10799656|FG000|Overall Study|Progressive disease|20
6798975|NCT00376623|10799663|FG000|Overall Study|Progressive disease|35
6798976|NCT00376623|10799664|FG001|Overall Study|Progressive disease|22
6798977|NCT00376623|10799665|FG002|Overall Study|Progressive disease|17
6798978|NCT00376623|10799663|FG000|Overall Study|Lost to Follow-up|0
6798979|NCT00376623|10799664|FG001|Overall Study|Lost to Follow-up|1
6798980|NCT00376623|10799665|FG002|Overall Study|Lost to Follow-up|0
6798981|NCT00376623|10799663|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6
6798982|NCT00376623|10799664|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1
6798983|NCT00376623|10799665|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2
6798984|NCT00376623|10799663|FG000|Overall Study|Not treated with BI 2536|1
6798985|NCT00376623|10799664|FG001|Overall Study|Not treated with BI 2536|0
6798986|NCT00376623|10799665|FG002|Overall Study|Not treated with BI 2536|0
6809401|NCT00774345|10812926|FG001|Treatment|Adverse Event|15
6798987|NCT00376623|10799663|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1
6798988|NCT00376623|10799664|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0
6798989|NCT00376623|10799665|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0
6798990|NCT00376623|10799663|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1
6798991|NCT00376623|10799664|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0
6798992|NCT00376623|10799665|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0
6798993|NCT00376623|10799663|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2
6798994|NCT00376623|10799664|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0
6798995|NCT00376623|10799665|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0
6798996|NCT00376623|10799663|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0
6798997|NCT00376623|10799664|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1
6798998|NCT00376623|10799665|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0
6798999|NCT00376623|10799663|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0
6799000|NCT00376623|10799664|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0
6799001|NCT00376623|10799665|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1
6799002|NCT00376623|10799663|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2
6799003|NCT00376623|10799664|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0
6799004|NCT00376623|10799665|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1
6799005|NCT00376623|10799663|FG000|Overall Study|Increase of tumour markers|0
6799006|NCT00376623|10799664|FG001|Overall Study|Increase of tumour markers|1
6799007|NCT00376623|10799665|FG002|Overall Study|Increase of tumour markers|0
6799008|NCT00376623|10799663|FG000|Overall Study|Bone metastasis|1
6799009|NCT00376623|10799664|FG001|Overall Study|Bone metastasis|0
6799010|NCT00376623|10799665|FG002|Overall Study|Bone metastasis|0
6799011|NCT00288080|10799681|FG000|Overall Study|Withdrawal by Subject|1
6799012|NCT00288080|10799682|FG001|Overall Study|Withdrawal by Subject|3
6799013|NCT00288080|10799681|FG000|Overall Study|Protocol Violation|25
6799014|NCT00288080|10799682|FG001|Overall Study|Protocol Violation|20
6799015|NCT00099437|10799694|FG000|Overall Study|Lost to Follow-up|30
6799016|NCT00099437|10799695|FG001|Overall Study|Lost to Follow-up|33
6799017|NCT00099437|10799694|FG000|Overall Study|Death|293
6799018|NCT00099437|10799695|FG001|Overall Study|Death|261
6799019|NCT00099437|10799694|FG000|Overall Study|Withdrawal by Subject|6
6799020|NCT00099437|10799695|FG001|Overall Study|Withdrawal by Subject|10
6799021|NCT00099437|10799694|FG000|Overall Study|Ongoing in FU but not on treatment|37
6799022|NCT00099437|10799695|FG001|Overall Study|Ongoing in FU but not on treatment|45
6809402|NCT00774345|10812925|FG000|Treatment|Progressive Disease without histologic transformation|51
6809403|NCT00774345|10812926|FG001|Treatment|Progressive Disease without histologic transformation|111
6809404|NCT00774345|10812925|FG000|Treatment|Progressive Disease with histologic transformation|4
6809405|NCT00774345|10812926|FG001|Treatment|Progressive Disease with histologic transformation|2
6809406|NCT00774345|10812925|FG000|Treatment|Withdrawal by Subject|5
6809407|NCT00774345|10812926|FG001|Treatment|Withdrawal by Subject|2
6809408|NCT00774345|10812925|FG000|Treatment|Lost to Follow-up|1
6809409|NCT00774345|10812926|FG001|Treatment|Lost to Follow-up|1
6809410|NCT00774345|10812925|FG000|Treatment|Death|4
6809411|NCT00774345|10812926|FG001|Treatment|Death|0
6809412|NCT00774345|10812925|FG000|Treatment|Other Reasons|32
6809413|NCT00774345|10812926|FG001|Treatment|Other Reasons|26
6811037|NCT02460224|10814927|FG020|Overall Study|Progressive disease|4
6811038|NCT02460224|10814928|FG021|Overall Study|Progressive disease|9
6811039|NCT02460224|10814929|FG022|Overall Study|Progressive disease|4
6811040|NCT02460224|10814930|FG023|Overall Study|Progressive disease|11
6811041|NCT02460224|10814931|FG024|Overall Study|Progressive disease|4
6811042|NCT02460224|10814932|FG025|Overall Study|Progressive disease|5
6811043|NCT02460224|10814933|FG026|Overall Study|Progressive disease|85
6811044|NCT02460224|10814934|FG027|Overall Study|Progressive disease|17
6811045|NCT02460224|10814935|FG028|Overall Study|Progressive disease|77
6811046|NCT02460224|10814907|FG000|Overall Study|Subject/guardian decision|2
6811047|NCT02460224|10814908|FG001|Overall Study|Subject/guardian decision|0
6811048|NCT02460224|10814909|FG002|Overall Study|Subject/guardian decision|1
6811049|NCT02460224|10814910|FG003|Overall Study|Subject/guardian decision|0
6811050|NCT02460224|10814911|FG004|Overall Study|Subject/guardian decision|2
6811051|NCT02460224|10814912|FG005|Overall Study|Subject/guardian decision|2
6811052|NCT02460224|10814913|FG006|Overall Study|Subject/guardian decision|0
6811053|NCT02460224|10814914|FG007|Overall Study|Subject/guardian decision|0
6811054|NCT02460224|10814915|FG008|Overall Study|Subject/guardian decision|1
6811055|NCT02460224|10814916|FG009|Overall Study|Subject/guardian decision|1
6811056|NCT02460224|10814917|FG010|Overall Study|Subject/guardian decision|0
6811057|NCT02460224|10814918|FG011|Overall Study|Subject/guardian decision|1
6811058|NCT02460224|10814919|FG012|Overall Study|Subject/guardian decision|0
6811059|NCT02460224|10814920|FG013|Overall Study|Subject/guardian decision|0
6811060|NCT02460224|10814921|FG014|Overall Study|Subject/guardian decision|0
6811061|NCT02460224|10814922|FG015|Overall Study|Subject/guardian decision|1
6811062|NCT02460224|10814923|FG016|Overall Study|Subject/guardian decision|0
6799023|NCT04794270|10799740|FG000|Period 1|Non Compliance|1
6799024|NCT04794270|10799741|FG001|Period 1|Non Compliance|0
6799025|NCT04794270|10799740|FG000|Period 1|Adverse Event|1
6799026|NCT04794270|10799741|FG001|Period 1|Adverse Event|0
6799027|NCT04794270|10799740|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1
6799028|NCT04794270|10799741|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0
6799029|NCT04327986|10799789|FG000|Overall Study|Physician Decision|2
6799030|NCT04327986|10799790|FG001|Overall Study|Physician Decision|0
6799031|NCT04327986|10799791|FG002|Overall Study|Physician Decision|0
6799032|NCT04327986|10799789|FG000|Overall Study|Death|1
6799033|NCT04327986|10799790|FG001|Overall Study|Death|0
6799034|NCT04327986|10799791|FG002|Overall Study|Death|0
6799035|NCT04086121|10799795|FG000|Overall Study|Other than listed|7
6799036|NCT04086121|10799795|FG000|Overall Study|Withdrawal by Subject|3
6799037|NCT04086121|10799795|FG000|Overall Study|Lost to Follow-up|2
6799038|NCT04086121|10799795|FG000|Overall Study|Adverse Event|1
6799039|NCT03655054|10799826|FG000|Overall Study|Lost to Follow-up|1
6799093|NCT03253627|10799901|FG000|Overall Study|Lost to Follow-up|1
6799094|NCT03253627|10799902|FG001|Overall Study|Lost to Follow-up|2
6799095|NCT03253627|10799901|FG000|Overall Study|Withdrawal by Subject|0
6799096|NCT03253627|10799902|FG001|Overall Study|Withdrawal by Subject|2
6799097|NCT03253627|10799901|FG000|Overall Study|Inability to complete MRI|1
6799098|NCT03253627|10799902|FG001|Overall Study|Inability to complete MRI|0
6799099|NCT03168555|10799912|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1
6799100|NCT03168555|10799912|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1
6799101|NCT03168555|10799912|FG000|Visit 2 (Post-operative)|Adverse Event|1
6799102|NCT03168555|10799912|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2
6799103|NCT03135119|10799921|FG000|Overall Study|Lost to Follow-up|2
6799104|NCT03135119|10799922|FG001|Overall Study|Lost to Follow-up|0
6799105|NCT03135119|10799921|FG000|Overall Study|Physician Decision|1
6799106|NCT03135119|10799922|FG001|Overall Study|Physician Decision|1
6799107|NCT03135119|10799921|FG000|Overall Study|COVID-19 Shutdown|2
6799108|NCT03135119|10799922|FG001|Overall Study|COVID-19 Shutdown|2
6799109|NCT03128411|10799928|FG000|Treatment Phase|Adverse Event|21
6799110|NCT03128411|10799928|FG000|Treatment Phase|Physician Decision|1
6799111|NCT03128411|10799928|FG000|Treatment Phase|Other|2
6799112|NCT03128411|10799928|FG000|Long Term Follow-up Phase|Death|2
6799113|NCT03097328|10799932|FG000|Overall Study|Still on Therapy|2
6799114|NCT03097328|10799932|FG000|Overall Study|Progressive Disease|29
6799115|NCT03097328|10799932|FG000|Overall Study|Adverse Event|4
6799116|NCT03097328|10799932|FG000|Overall Study|Withdrawal by Subject|1
6799117|NCT03097328|10799932|FG000|Overall Study|Physician Decision|1
6799118|NCT03097328|10799932|FG000|Overall Study|Patient Decision|1
6799119|NCT03097328|10799932|FG000|Overall Study|Ineligible for Study Drug|1
6799120|NCT03068715|10799951|FG000|Overall Study|No longer met inclusion criteria|1
6799121|NCT03068715|10799952|FG001|Overall Study|No longer met inclusion criteria|0
6799122|NCT02981472|10799962|FG000|Pre-Treatment Period|Participant withdrew consent|2
6799123|NCT02981472|10799963|FG001|Pre-Treatment Period|Participant withdrew consent|1
6799124|NCT02981472|10799962|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1
6799125|NCT02981472|10799963|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0
6799126|NCT02981472|10799962|FG000|Treatment Period|Adverse Event|6
6799127|NCT02981472|10799963|FG001|Treatment Period|Adverse Event|1
6799128|NCT02981472|10799962|FG000|Treatment Period|Participant withdrew consent|1
6799129|NCT02981472|10799963|FG001|Treatment Period|Participant withdrew consent|0
6799130|NCT02981472|10799962|FG000|Treatment Period|Lost to Follow-up|0
6799131|NCT02981472|10799963|FG001|Treatment Period|Lost to Follow-up|1
6799132|NCT02853760|10799975|FG000|Washout (1 Week)|acute illness (not connected with the study)|0
6799133|NCT02853760|10799976|FG001|Washout (1 Week)|acute illness (not connected with the study)|0
6799134|NCT02853760|10799977|FG002|Washout (1 Week)|acute illness (not connected with the study)|1
6799135|NCT02853760|10799978|FG003|Washout (1 Week)|acute illness (not connected with the study)|2
6799136|NCT02853760|10799979|FG004|Washout (1 Week)|acute illness (not connected with the study)|0
6799137|NCT02853760|10799980|FG005|Washout (1 Week)|acute illness (not connected with the study)|2
6799138|NCT02789657|10799992|FG000|Overall Study|Withdrawal by Subject|2
6799139|NCT02789657|10799993|FG001|Overall Study|Withdrawal by Subject|0
6799140|NCT02789657|10799994|FG002|Overall Study|Withdrawal by Subject|0
6799141|NCT02789657|10799995|FG003|Overall Study|Withdrawal by Subject|0
6799142|NCT02743871|10800018|FG000|Overall Study|Lost to Follow-up|0
6799143|NCT02743871|10800019|FG001|Overall Study|Lost to Follow-up|0
6799144|NCT02743871|10800020|FG002|Overall Study|Lost to Follow-up|0
6799145|NCT02743871|10800021|FG003|Overall Study|Lost to Follow-up|1
6799146|NCT02743871|10800022|FG004|Overall Study|Lost to Follow-up|0
6799147|NCT02743871|10800023|FG005|Overall Study|Lost to Follow-up|0
6799148|NCT02743871|10800024|FG006|Overall Study|Lost to Follow-up|1
6799149|NCT02743871|10800025|FG007|Overall Study|Lost to Follow-up|0
6799150|NCT02743871|10800026|FG008|Overall Study|Lost to Follow-up|0
6799151|NCT02743871|10800027|FG009|Overall Study|Lost to Follow-up|0
6799152|NCT02743871|10800028|FG010|Overall Study|Lost to Follow-up|0
6799153|NCT02743871|10800029|FG011|Overall Study|Lost to Follow-up|2
6799154|NCT02743871|10800030|FG012|Overall Study|Lost to Follow-up|0
6799155|NCT02743871|10800031|FG013|Overall Study|Lost to Follow-up|0
6799156|NCT02743871|10800018|FG000|Overall Study|Withdrawal by Subject|0
6799157|NCT02743871|10800019|FG001|Overall Study|Withdrawal by Subject|0
6799040|NCT03542266|10799841|FG000|Treatment Phase|Withdrawal by Subject|1
6799041|NCT03542266|10799841|FG000|Treatment Phase|Adverse Event|1
6799042|NCT03542266|10799841|FG000|Treatment Phase|PD|1
6799043|NCT03529409|10799848|FG000|Randomized|Lost to Follow-up|0
6799044|NCT03529409|10799849|FG001|Randomized|Lost to Follow-up|0
6799045|NCT03529409|10799850|FG002|Randomized|Lost to Follow-up|4
6799046|NCT03529409|10799848|FG000|Randomized|Excluded|0
6799047|NCT03529409|10799849|FG001|Randomized|Excluded|0
6799048|NCT03529409|10799850|FG002|Randomized|Excluded|1
6799049|NCT03529409|10799848|FG000|Post-treatment Assessment|Death|1
6799050|NCT03529409|10799849|FG001|Post-treatment Assessment|Death|0
6799051|NCT03529409|10799850|FG002|Post-treatment Assessment|Death|0
6799052|NCT03529409|10799848|FG000|Post-treatment Assessment|Lost to Follow-up|1
6799053|NCT03529409|10799849|FG001|Post-treatment Assessment|Lost to Follow-up|1
6799054|NCT03529409|10799850|FG002|Post-treatment Assessment|Lost to Follow-up|0
6799055|NCT03529409|10799848|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2
6799056|NCT03529409|10799849|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4
6799057|NCT03529409|10799850|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0
6799058|NCT03529409|10799848|FG000|Follow-up Assessment|Death|1
6799059|NCT03529409|10799849|FG001|Follow-up Assessment|Death|0
6799060|NCT03529409|10799850|FG002|Follow-up Assessment|Death|0
6799061|NCT03529409|10799848|FG000|Follow-up Assessment|Withdrawal by Subject|0
6799062|NCT03529409|10799849|FG001|Follow-up Assessment|Withdrawal by Subject|1
6799063|NCT03529409|10799850|FG002|Follow-up Assessment|Withdrawal by Subject|0
6799064|NCT03516812|10799857|FG000|Overall Study|Adverse Event|4
6799065|NCT03516812|10799857|FG000|Overall Study|Lack of Efficacy|2
6799066|NCT03463577|10799871|FG000|Overall Study|Lost to Follow-up|238
6799067|NCT03463577|10799872|FG001|Overall Study|Lost to Follow-up|435
6799068|NCT03463577|10799873|FG002|Overall Study|Lost to Follow-up|0
6799069|NCT03463577|10799874|FG003|Overall Study|Lost to Follow-up|0
6799070|NCT03463577|10799875|FG004|Overall Study|Lost to Follow-up|0
6799071|NCT03463577|10799876|FG005|Overall Study|Lost to Follow-up|0
6799072|NCT03463577|10799871|FG000|Overall Study|With unknown pregnancy outcome|0
6799073|NCT03463577|10799872|FG001|Overall Study|With unknown pregnancy outcome|5
6799074|NCT03463577|10799873|FG002|Overall Study|With unknown pregnancy outcome|0
6799075|NCT03463577|10799874|FG003|Overall Study|With unknown pregnancy outcome|0
6799076|NCT03463577|10799875|FG004|Overall Study|With unknown pregnancy outcome|0
6799077|NCT03463577|10799876|FG005|Overall Study|With unknown pregnancy outcome|0
6799078|NCT03463577|10799871|FG000|Overall Study|Maternal death|2
6799079|NCT03463577|10799872|FG001|Overall Study|Maternal death|0
6799080|NCT03463577|10799873|FG002|Overall Study|Maternal death|0
6799081|NCT03463577|10799874|FG003|Overall Study|Maternal death|0
6799082|NCT03463577|10799875|FG004|Overall Study|Maternal death|0
6799083|NCT03463577|10799876|FG005|Overall Study|Maternal death|0
6799084|NCT03463577|10799871|FG000|Overall Study|Neonatal death|0
6799085|NCT03463577|10799872|FG001|Overall Study|Neonatal death|0
6799086|NCT03463577|10799873|FG002|Overall Study|Neonatal death|0
6799087|NCT03463577|10799874|FG003|Overall Study|Neonatal death|15
6799088|NCT03463577|10799875|FG004|Overall Study|Neonatal death|17
6799089|NCT03463577|10799876|FG005|Overall Study|Neonatal death|0
6799090|NCT03373760|10799892|FG000|Overall Study|Adverse Event|8
6799091|NCT03373760|10799892|FG000|Overall Study|Disease Progression|46
6799092|NCT03373760|10799892|FG000|Overall Study|Death|4
6799158|NCT02743871|10800020|FG002|Overall Study|Withdrawal by Subject|0
6799159|NCT02743871|10800021|FG003|Overall Study|Withdrawal by Subject|0
6799160|NCT02743871|10800022|FG004|Overall Study|Withdrawal by Subject|0
6799161|NCT02743871|10800023|FG005|Overall Study|Withdrawal by Subject|0
6799162|NCT02743871|10800024|FG006|Overall Study|Withdrawal by Subject|0
6799163|NCT02743871|10800025|FG007|Overall Study|Withdrawal by Subject|0
6799164|NCT02743871|10800026|FG008|Overall Study|Withdrawal by Subject|0
6799165|NCT02743871|10800027|FG009|Overall Study|Withdrawal by Subject|0
6799166|NCT02743871|10800028|FG010|Overall Study|Withdrawal by Subject|1
6799167|NCT02743871|10800029|FG011|Overall Study|Withdrawal by Subject|0
6799168|NCT02743871|10800030|FG012|Overall Study|Withdrawal by Subject|12
6799169|NCT02743871|10800031|FG013|Overall Study|Withdrawal by Subject|6
6799170|NCT02743871|10800018|FG000|Overall Study|Adverse Event|1
6799171|NCT02743871|10800019|FG001|Overall Study|Adverse Event|0
6799172|NCT02743871|10800020|FG002|Overall Study|Adverse Event|0
6799173|NCT02743871|10800021|FG003|Overall Study|Adverse Event|0
6799174|NCT02743871|10800022|FG004|Overall Study|Adverse Event|0
6799175|NCT02743871|10800023|FG005|Overall Study|Adverse Event|0
6799176|NCT02743871|10800024|FG006|Overall Study|Adverse Event|0
6799177|NCT02743871|10800025|FG007|Overall Study|Adverse Event|0
6799178|NCT02743871|10800026|FG008|Overall Study|Adverse Event|0
6799179|NCT02743871|10800027|FG009|Overall Study|Adverse Event|0
6799180|NCT02743871|10800028|FG010|Overall Study|Adverse Event|0
6799181|NCT02743871|10800029|FG011|Overall Study|Adverse Event|0
6799182|NCT02743871|10800030|FG012|Overall Study|Adverse Event|0
6799183|NCT02743871|10800031|FG013|Overall Study|Adverse Event|0
6799184|NCT02743871|10800018|FG000|Overall Study|Other|0
6799185|NCT02743871|10800019|FG001|Overall Study|Other|0
6799186|NCT02743871|10800020|FG002|Overall Study|Other|0
6799187|NCT02743871|10800021|FG003|Overall Study|Other|0
6799188|NCT02743871|10800022|FG004|Overall Study|Other|0
6799189|NCT02743871|10800023|FG005|Overall Study|Other|0
6799190|NCT02743871|10800024|FG006|Overall Study|Other|0
6799191|NCT02743871|10800025|FG007|Overall Study|Other|0
6799192|NCT02743871|10800026|FG008|Overall Study|Other|0
6799193|NCT02743871|10800027|FG009|Overall Study|Other|0
6799194|NCT02743871|10800028|FG010|Overall Study|Other|0
6799195|NCT02743871|10800029|FG011|Overall Study|Other|1
6799196|NCT02743871|10800030|FG012|Overall Study|Other|1
6799197|NCT02743871|10800031|FG013|Overall Study|Other|1
6799198|NCT02743871|10800018|FG000|Overall Study|Protocol Violation|0
6799199|NCT02743871|10800019|FG001|Overall Study|Protocol Violation|0
6799200|NCT02743871|10800020|FG002|Overall Study|Protocol Violation|0
6799201|NCT02743871|10800021|FG003|Overall Study|Protocol Violation|0
6799202|NCT02743871|10800022|FG004|Overall Study|Protocol Violation|0
6799203|NCT02743871|10800023|FG005|Overall Study|Protocol Violation|0
6799204|NCT02743871|10800024|FG006|Overall Study|Protocol Violation|0
6799205|NCT02743871|10800025|FG007|Overall Study|Protocol Violation|0
6799206|NCT02743871|10800026|FG008|Overall Study|Protocol Violation|0
6799207|NCT02743871|10800027|FG009|Overall Study|Protocol Violation|0
6799208|NCT02743871|10800028|FG010|Overall Study|Protocol Violation|0
6799209|NCT02743871|10800029|FG011|Overall Study|Protocol Violation|0
6799210|NCT02743871|10800030|FG012|Overall Study|Protocol Violation|2
6799211|NCT02743871|10800031|FG013|Overall Study|Protocol Violation|0
6799212|NCT02614261|10800093|FG000|Double-Blind Treatment Phase|Adverse Event|7
6799213|NCT02614261|10800094|FG001|Double-Blind Treatment Phase|Adverse Event|3
6799214|NCT02614261|10800095|FG002|Double-Blind Treatment Phase|Adverse Event|2
6799215|NCT02614261|10800096|FG003|Double-Blind Treatment Phase|Adverse Event|0
6799216|NCT02614261|10800093|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4
6799217|NCT02614261|10800094|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0
6799218|NCT02614261|10800095|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0
6799219|NCT02614261|10800096|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0
6799220|NCT02614261|10800093|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9
6799221|NCT02614261|10800094|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4
6799222|NCT02614261|10800095|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1
6799223|NCT02614261|10800096|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0
6799224|NCT02614261|10800093|FG000|Double-Blind Treatment Phase|Physician Decision|2
6799225|NCT02614261|10800094|FG001|Double-Blind Treatment Phase|Physician Decision|1
6799226|NCT02614261|10800095|FG002|Double-Blind Treatment Phase|Physician Decision|1
6799227|NCT02614261|10800096|FG003|Double-Blind Treatment Phase|Physician Decision|0
6799228|NCT02614261|10800093|FG000|Double-Blind Treatment Phase|Pregnancy|2
6799229|NCT02614261|10800094|FG001|Double-Blind Treatment Phase|Pregnancy|2
6799230|NCT02614261|10800095|FG002|Double-Blind Treatment Phase|Pregnancy|0
6799231|NCT02614261|10800096|FG003|Double-Blind Treatment Phase|Pregnancy|0
6799232|NCT02614261|10800093|FG000|Double-Blind Treatment Phase|Protocol Violation|6
6799233|NCT02614261|10800094|FG001|Double-Blind Treatment Phase|Protocol Violation|1
6799234|NCT02614261|10800095|FG002|Double-Blind Treatment Phase|Protocol Violation|0
6799235|NCT02614261|10800096|FG003|Double-Blind Treatment Phase|Protocol Violation|0
6799236|NCT02614261|10800093|FG000|Double-Blind Treatment Phase|Screen failure|0
6799237|NCT02614261|10800094|FG001|Double-Blind Treatment Phase|Screen failure|1
6799238|NCT02614261|10800095|FG002|Double-Blind Treatment Phase|Screen failure|2
6799239|NCT02614261|10800096|FG003|Double-Blind Treatment Phase|Screen failure|0
6799240|NCT02614261|10800093|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20
6799241|NCT02614261|10800094|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5
6799242|NCT02614261|10800095|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7
6799243|NCT02614261|10800096|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0
6799244|NCT02614261|10800093|FG000|Open-Label Extension Phase|Adverse Event|23
6799245|NCT02614261|10800094|FG001|Open-Label Extension Phase|Adverse Event|12
6799246|NCT02614261|10800095|FG002|Open-Label Extension Phase|Adverse Event|11
6799247|NCT02614261|10800096|FG003|Open-Label Extension Phase|Adverse Event|0
6799248|NCT02614261|10800093|FG000|Open-Label Extension Phase|Lack of Efficacy|14
6799249|NCT02614261|10800094|FG001|Open-Label Extension Phase|Lack of Efficacy|12
6799250|NCT02614261|10800095|FG002|Open-Label Extension Phase|Lack of Efficacy|14
6799251|NCT02614261|10800096|FG003|Open-Label Extension Phase|Lack of Efficacy|0
6799252|NCT02614261|10800093|FG000|Open-Label Extension Phase|Lost to Follow-up|15
6799253|NCT02614261|10800094|FG001|Open-Label Extension Phase|Lost to Follow-up|7
6799254|NCT02614261|10800095|FG002|Open-Label Extension Phase|Lost to Follow-up|9
6799255|NCT02614261|10800096|FG003|Open-Label Extension Phase|Lost to Follow-up|0
6799256|NCT02614261|10800093|FG000|Open-Label Extension Phase|Physician Decision|2
6799257|NCT02614261|10800094|FG001|Open-Label Extension Phase|Physician Decision|0
6799258|NCT02614261|10800095|FG002|Open-Label Extension Phase|Physician Decision|0
6799259|NCT02614261|10800096|FG003|Open-Label Extension Phase|Physician Decision|0
6799260|NCT02614261|10800093|FG000|Open-Label Extension Phase|Pregnancy|1
6799261|NCT02614261|10800094|FG001|Open-Label Extension Phase|Pregnancy|2
6799262|NCT02614261|10800095|FG002|Open-Label Extension Phase|Pregnancy|1
6799263|NCT02614261|10800096|FG003|Open-Label Extension Phase|Pregnancy|0
6799264|NCT02614261|10800093|FG000|Open-Label Extension Phase|Protocol Violation|3
6799265|NCT02614261|10800094|FG001|Open-Label Extension Phase|Protocol Violation|4
6799266|NCT02614261|10800095|FG002|Open-Label Extension Phase|Protocol Violation|1
6799267|NCT02614261|10800096|FG003|Open-Label Extension Phase|Protocol Violation|0
6799268|NCT02614261|10800093|FG000|Open-Label Extension Phase|Withdrawal by Subject|30
6799269|NCT02614261|10800094|FG001|Open-Label Extension Phase|Withdrawal by Subject|18
6799270|NCT02614261|10800095|FG002|Open-Label Extension Phase|Withdrawal by Subject|18
6799271|NCT02614261|10800096|FG003|Open-Label Extension Phase|Withdrawal by Subject|0
6799272|NCT02614261|10800093|FG000|Follow-up Phase|Adverse Event|2
6799273|NCT02614261|10800094|FG001|Follow-up Phase|Adverse Event|0
6799274|NCT02614261|10800095|FG002|Follow-up Phase|Adverse Event|1
6799275|NCT02614261|10800096|FG003|Follow-up Phase|Adverse Event|0
6799276|NCT02614261|10800093|FG000|Follow-up Phase|Lost to Follow-up|12
6799277|NCT02614261|10800094|FG001|Follow-up Phase|Lost to Follow-up|5
6799278|NCT02614261|10800095|FG002|Follow-up Phase|Lost to Follow-up|2
6799279|NCT02614261|10800096|FG003|Follow-up Phase|Lost to Follow-up|0
6799280|NCT02614261|10800093|FG000|Follow-up Phase|Physician Decision|5
6799281|NCT02614261|10800094|FG001|Follow-up Phase|Physician Decision|1
6799282|NCT02614261|10800095|FG002|Follow-up Phase|Physician Decision|0
6799283|NCT02614261|10800096|FG003|Follow-up Phase|Physician Decision|0
6799284|NCT02614261|10800093|FG000|Follow-up Phase|Pregnancy|0
6799285|NCT02614261|10800094|FG001|Follow-up Phase|Pregnancy|1
6799286|NCT02614261|10800095|FG002|Follow-up Phase|Pregnancy|0
6799287|NCT02614261|10800096|FG003|Follow-up Phase|Pregnancy|0
6799288|NCT02614261|10800093|FG000|Follow-up Phase|Protocol Violation|1
6799289|NCT02614261|10800094|FG001|Follow-up Phase|Protocol Violation|0
6799290|NCT02614261|10800095|FG002|Follow-up Phase|Protocol Violation|0
6799291|NCT02614261|10800096|FG003|Follow-up Phase|Protocol Violation|0
6799292|NCT02614261|10800093|FG000|Follow-up Phase|Withdrawal by Subject|12
6799293|NCT02614261|10800094|FG001|Follow-up Phase|Withdrawal by Subject|4
6799294|NCT02614261|10800095|FG002|Follow-up Phase|Withdrawal by Subject|11
6799295|NCT02614261|10800096|FG003|Follow-up Phase|Withdrawal by Subject|0
6799296|NCT02614261|10800093|FG000|Israel Addendum|Withdrawal by Subject|0
6799297|NCT02614261|10800094|FG001|Israel Addendum|Withdrawal by Subject|0
6799298|NCT02614261|10800095|FG002|Israel Addendum|Withdrawal by Subject|0
6799299|NCT02614261|10800096|FG003|Israel Addendum|Withdrawal by Subject|4
6799300|NCT02527434|10800125|FG000|Overall Study|Lost to Follow-up|2
6799301|NCT02527434|10800126|FG001|Overall Study|Lost to Follow-up|2
6799302|NCT02527434|10800127|FG002|Overall Study|Lost to Follow-up|0
6799303|NCT02527434|10800125|FG000|Overall Study|Death|19
6799304|NCT02527434|10800126|FG001|Overall Study|Death|6
6799305|NCT02527434|10800127|FG002|Overall Study|Death|17
6799306|NCT02527434|10800125|FG000|Overall Study|Withdrawal by Subject|5
6799307|NCT02527434|10800126|FG001|Overall Study|Withdrawal by Subject|3
6799308|NCT02527434|10800127|FG002|Overall Study|Withdrawal by Subject|3
6799309|NCT02527434|10800125|FG000|Overall Study|Reason Not Specified|1
6799310|NCT02527434|10800126|FG001|Overall Study|Reason Not Specified|0
6799311|NCT02527434|10800127|FG002|Overall Study|Reason Not Specified|0
6799312|NCT02527434|10800125|FG000|Overall Study|Site closure|1
6799313|NCT02527434|10800126|FG001|Overall Study|Site closure|0
6799314|NCT02527434|10800127|FG002|Overall Study|Site closure|0
6799315|NCT02513667|10800147|FG000|Overall Study|Withdrawal by Subject|0
6799316|NCT02513667|10800148|FG001|Overall Study|Withdrawal by Subject|1
6799333|NCT02415556|10800175|FG000|Overall Study|Adverse Event|3
6799334|NCT02415556|10800176|FG001|Overall Study|Adverse Event|4
6799335|NCT02415556|10800177|FG002|Overall Study|Adverse Event|2
6799336|NCT02415556|10800178|FG003|Overall Study|Adverse Event|4
6799337|NCT02415556|10800175|FG000|Overall Study|Lost to Follow-up|4
6799338|NCT02415556|10800176|FG001|Overall Study|Lost to Follow-up|5
6799339|NCT02415556|10800177|FG002|Overall Study|Lost to Follow-up|4
6799340|NCT02415556|10800178|FG003|Overall Study|Lost to Follow-up|1
6799341|NCT02415556|10800175|FG000|Overall Study|Withdrawal by Subject|13
6799342|NCT02415556|10800176|FG001|Overall Study|Withdrawal by Subject|4
6799343|NCT02415556|10800177|FG002|Overall Study|Withdrawal by Subject|14
6799344|NCT02415556|10800178|FG003|Overall Study|Withdrawal by Subject|12
6799345|NCT02415556|10800175|FG000|Overall Study|Physician Decision|1
6799346|NCT02415556|10800176|FG001|Overall Study|Physician Decision|3
6799347|NCT02415556|10800177|FG002|Overall Study|Physician Decision|1
6799348|NCT02415556|10800178|FG003|Overall Study|Physician Decision|2
6799349|NCT02415556|10800175|FG000|Overall Study|Censored - study completion|4
6799350|NCT02415556|10800176|FG001|Overall Study|Censored - study completion|5
6799351|NCT02415556|10800177|FG002|Overall Study|Censored - study completion|1
6799352|NCT02415556|10800178|FG003|Overall Study|Censored - study completion|0
6799353|NCT02415556|10800175|FG000|Overall Study|Family-related issues|0
6799354|NCT02415556|10800176|FG001|Overall Study|Family-related issues|0
6799355|NCT02415556|10800177|FG002|Overall Study|Family-related issues|0
6799356|NCT02415556|10800178|FG003|Overall Study|Family-related issues|1
6799357|NCT02386839|10800204|FG000|Overall Study|Death|1
6799358|NCT02386839|10800205|FG001|Overall Study|Death|0
6799359|NCT02386839|10800204|FG000|Overall Study|Withdrawal by Subject|9
6799360|NCT02386839|10800205|FG001|Overall Study|Withdrawal by Subject|10
6799361|NCT02386839|10800204|FG000|Overall Study|Lost to Follow-up|4
6799362|NCT02386839|10800205|FG001|Overall Study|Lost to Follow-up|4
6799363|NCT02386839|10800204|FG000|Overall Study|Other (Site Terminated by Sponsor)|1
6799364|NCT02386839|10800205|FG001|Overall Study|Other (Site Terminated by Sponsor)|0
6799365|NCT02386839|10800204|FG000|Overall Study|Other (Covid 19 Pandemic)|0
6799366|NCT02386839|10800205|FG001|Overall Study|Other (Covid 19 Pandemic)|1
6799367|NCT02386839|10800204|FG000|Overall Study|Other (unspecified)|1
6799368|NCT02386839|10800205|FG001|Overall Study|Other (unspecified)|0
6799369|NCT02362503|10800218|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0
6799370|NCT02362503|10800219|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2
6799371|NCT02362503|10800220|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0
6799372|NCT02362503|10800218|FG000|Double-blind Period-Up to 8 Days|Death|1
6799373|NCT02362503|10800219|FG001|Double-blind Period-Up to 8 Days|Death|0
6799374|NCT02362503|10800220|FG002|Double-blind Period-Up to 8 Days|Death|0
6799375|NCT02362503|10800218|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0
6799376|NCT02362503|10800219|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1
6799377|NCT02362503|10800220|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0
6799378|NCT02362503|10800218|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0
6799379|NCT02362503|10800219|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1
6799380|NCT02362503|10800220|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0
6799381|NCT02362503|10800218|FG000|Open Label Period-Up to 96 Weeks|Other|0
6799382|NCT02362503|10800219|FG001|Open Label Period-Up to 96 Weeks|Other|1
6799383|NCT02362503|10800220|FG002|Open Label Period-Up to 96 Weeks|Other|1
6799384|NCT02362503|10800218|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0
6799385|NCT02362503|10800219|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4
6799386|NCT02362503|10800220|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4
6799387|NCT02362503|10800218|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0
6799388|NCT02362503|10800219|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1
6799389|NCT02362503|10800220|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0
6799390|NCT02362503|10800218|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3
6799391|NCT02362503|10800219|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8
6799392|NCT02362503|10800220|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6
6799393|NCT02362503|10800218|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4
6799394|NCT02362503|10800219|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3
6799395|NCT02362503|10800220|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1
6799396|NCT02362503|10800218|FG000|Open Label Period-Up to 96 Weeks|Death|1
6799397|NCT02362503|10800219|FG001|Open Label Period-Up to 96 Weeks|Death|7
6799398|NCT02362503|10800220|FG002|Open Label Period-Up to 96 Weeks|Death|15
6799399|NCT02362503|10800218|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0
6799400|NCT02362503|10800219|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5
6799401|NCT02362503|10800220|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1
6799402|NCT02362503|10800218|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3
6799403|NCT02362503|10800219|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2
6799404|NCT02362503|10800220|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4
6799405|NCT02362503|10800218|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3
6799406|NCT02362503|10800219|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9
6799407|NCT02362503|10800220|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6
6799408|NCT02362503|10800218|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54
6799409|NCT02362503|10800219|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159
6799410|NCT02362503|10800220|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61
6809414|NCT00000135|10813010|FG000|Overall Study|Death|27
6809415|NCT00000135|10813011|FG001|Overall Study|Death|14
6809416|NCT00000378|10813059|FG000|Overall Study|Lack of Efficacy|16
6809417|NCT00000378|10813060|FG001|Overall Study|Lack of Efficacy|14
6809418|NCT00000620|10813107|FG000|Overall Study|Death|86
6809419|NCT00000620|10813108|FG001|Overall Study|Death|67
6809420|NCT00000620|10813109|FG002|Overall Study|Death|112
6809421|NCT00000620|10813110|FG003|Overall Study|Death|126
6809422|NCT00000620|10813111|FG004|Overall Study|Death|64
6809423|NCT00000620|10813112|FG005|Overall Study|Death|77
6809424|NCT00000620|10813113|FG006|Overall Study|Death|91
6809425|NCT00000620|10813114|FG007|Overall Study|Death|95
6809426|NCT00000620|10813107|FG000|Overall Study|Lost to Follow-up|14
6809427|NCT00000620|10813108|FG001|Overall Study|Lost to Follow-up|14
6809428|NCT00000620|10813109|FG002|Overall Study|Lost to Follow-up|14
6809429|NCT00000620|10813110|FG003|Overall Study|Lost to Follow-up|14
6809430|NCT00000620|10813111|FG004|Overall Study|Lost to Follow-up|15
6809431|NCT00000620|10813112|FG005|Overall Study|Lost to Follow-up|15
6809432|NCT00000620|10813113|FG006|Overall Study|Lost to Follow-up|13
6809433|NCT00000620|10813114|FG007|Overall Study|Lost to Follow-up|14
6809434|NCT00000620|10813107|FG000|Overall Study|Withdrawal by Subject|40
6809435|NCT00000620|10813108|FG001|Overall Study|Withdrawal by Subject|27
6799411|NCT02312258|10800233|FG000|Overall Study|Adverse Event|15
6799412|NCT02312258|10800234|FG001|Overall Study|Adverse Event|47
6799413|NCT02312258|10800233|FG000|Overall Study|Lost to Follow-up|0
6799414|NCT02312258|10800234|FG001|Overall Study|Lost to Follow-up|1
6799415|NCT02312258|10800233|FG000|Overall Study|Progressive Disease|174
6799416|NCT02312258|10800234|FG001|Overall Study|Progressive Disease|188
6799417|NCT02312258|10800233|FG000|Overall Study|Withdrawal by Subject|8
6799418|NCT02312258|10800234|FG001|Overall Study|Withdrawal by Subject|9
6799419|NCT02312258|10800233|FG000|Overall Study|Reason not Specified|11
6799420|NCT02312258|10800234|FG001|Overall Study|Reason not Specified|31
6799421|NCT02312258|10800233|FG000|Overall Study|Participants Ongoing Treatment|43
6799422|NCT02312258|10800234|FG001|Overall Study|Participants Ongoing Treatment|83
6799423|NCT02243605|10800242|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1
6799424|NCT02243605|10800243|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1
6799425|NCT02243605|10800242|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1
6799426|NCT02243605|10800243|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0
6799427|NCT02243605|10800242|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5
6799428|NCT02243605|10800243|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1
6799429|NCT02243605|10800242|FG000|Stage 2 - Final Analysis Population|Adverse Event|1
6799430|NCT02243605|10800243|FG001|Stage 2 - Final Analysis Population|Adverse Event|1
6799431|NCT02243605|10800242|FG000|Stage 2 - Final Analysis Population|Progression|0
6799432|NCT02243605|10800243|FG001|Stage 2 - Final Analysis Population|Progression|1
6799433|NCT02213380|10800255|FG000|Underwent Randomization|Withdrawal by Subject|2
6799434|NCT02213380|10800256|FG001|Underwent Randomization|Withdrawal by Subject|0
6799435|NCT02213380|10800255|FG000|Underwent Randomization|Not treated|3
6799436|NCT02213380|10800256|FG001|Underwent Randomization|Not treated|3
6799437|NCT02213380|10800255|FG000|Per-protocol Analysis|Protocol Violation|32
6799438|NCT02213380|10800256|FG001|Per-protocol Analysis|Protocol Violation|36
6799439|NCT02184195|10800264|FG000|Overall Study|Patient decision|3
6799440|NCT02184195|10800265|FG001|Overall Study|Patient decision|1
6799441|NCT02184195|10800264|FG000|Overall Study|Eligibility criteria not fulfilled|0
6799442|NCT02184195|10800265|FG001|Overall Study|Eligibility criteria not fulfilled|1
6799443|NCT02184195|10800264|FG000|Overall Study|Death|40
6799444|NCT02184195|10800265|FG001|Overall Study|Death|29
6799445|NCT02184195|10800264|FG000|Overall Study|Lost to Follow-up|0
6799446|NCT02184195|10800265|FG001|Overall Study|Lost to Follow-up|2
6799447|NCT02184195|10800264|FG000|Overall Study|Other|0
6799448|NCT02184195|10800265|FG001|Overall Study|Other|2
6799449|NCT02089685|10800286|FG000|Overall Study|Adverse Event|1
6799450|NCT02089685|10800287|FG001|Overall Study|Adverse Event|0
6799451|NCT02089685|10800288|FG002|Overall Study|Adverse Event|0
6799452|NCT02089685|10800289|FG003|Overall Study|Adverse Event|0
6799453|NCT02089685|10800290|FG004|Overall Study|Adverse Event|1
6799454|NCT02089685|10800291|FG005|Overall Study|Adverse Event|0
6799455|NCT02089685|10800286|FG000|Overall Study|Clinical Progression|4
6799456|NCT02089685|10800287|FG001|Overall Study|Clinical Progression|0
6799457|NCT02089685|10800288|FG002|Overall Study|Clinical Progression|0
6799458|NCT02089685|10800289|FG003|Overall Study|Clinical Progression|5
6799459|NCT02089685|10800290|FG004|Overall Study|Clinical Progression|1
6799460|NCT02089685|10800291|FG005|Overall Study|Clinical Progression|2
6799461|NCT02089685|10800286|FG000|Overall Study|Excluded Medication|1
6799462|NCT02089685|10800287|FG001|Overall Study|Excluded Medication|0
6799463|NCT02089685|10800288|FG002|Overall Study|Excluded Medication|0
6799464|NCT02089685|10800289|FG003|Overall Study|Excluded Medication|11
6799465|NCT02089685|10800290|FG004|Overall Study|Excluded Medication|2
6799466|NCT02089685|10800291|FG005|Overall Study|Excluded Medication|1
6799467|NCT02089685|10800286|FG000|Overall Study|Progressive disease|13
6799468|NCT02089685|10800287|FG001|Overall Study|Progressive disease|10
6799469|NCT02089685|10800288|FG002|Overall Study|Progressive disease|3
6799470|NCT02089685|10800289|FG003|Overall Study|Progressive disease|51
6799471|NCT02089685|10800290|FG004|Overall Study|Progressive disease|17
6799472|NCT02089685|10800291|FG005|Overall Study|Progressive disease|12
6799473|NCT02089685|10800286|FG000|Overall Study|Follow up ended by sponsor|2
6799474|NCT02089685|10800287|FG001|Overall Study|Follow up ended by sponsor|2
6799475|NCT02089685|10800288|FG002|Overall Study|Follow up ended by sponsor|0
6799476|NCT02089685|10800289|FG003|Overall Study|Follow up ended by sponsor|70
6799477|NCT02089685|10800290|FG004|Overall Study|Follow up ended by sponsor|26
6799478|NCT02089685|10800291|FG005|Overall Study|Follow up ended by sponsor|26
6799479|NCT02089685|10800286|FG000|Overall Study|Withdrawal by Subject|0
6799480|NCT02089685|10800287|FG001|Overall Study|Withdrawal by Subject|2
6799481|NCT02089685|10800288|FG002|Overall Study|Withdrawal by Subject|0
6799482|NCT02089685|10800289|FG003|Overall Study|Withdrawal by Subject|8
6799483|NCT02089685|10800290|FG004|Overall Study|Withdrawal by Subject|1
6799484|NCT02089685|10800291|FG005|Overall Study|Withdrawal by Subject|1
6799485|NCT02089685|10800286|FG000|Overall Study|Status not recorded|1
6799486|NCT02089685|10800287|FG001|Overall Study|Status not recorded|0
6799487|NCT02089685|10800288|FG002|Overall Study|Status not recorded|0
6799488|NCT02089685|10800289|FG003|Overall Study|Status not recorded|0
6799489|NCT02089685|10800290|FG004|Overall Study|Status not recorded|1
6799490|NCT02089685|10800291|FG005|Overall Study|Status not recorded|0
6799491|NCT02089685|10800286|FG000|Overall Study|Death|0
6799492|NCT02089685|10800287|FG001|Overall Study|Death|0
6799493|NCT02089685|10800288|FG002|Overall Study|Death|0
6799494|NCT02089685|10800289|FG003|Overall Study|Death|7
6799495|NCT02089685|10800290|FG004|Overall Study|Death|2
6799496|NCT02089685|10800291|FG005|Overall Study|Death|5
6799497|NCT02089685|10800286|FG000|Overall Study|Lost to Follow-up|0
6799498|NCT02089685|10800287|FG001|Overall Study|Lost to Follow-up|0
6799499|NCT02089685|10800288|FG002|Overall Study|Lost to Follow-up|0
6799500|NCT02089685|10800289|FG003|Overall Study|Lost to Follow-up|1
6799501|NCT02089685|10800290|FG004|Overall Study|Lost to Follow-up|0
6799502|NCT02089685|10800291|FG005|Overall Study|Lost to Follow-up|0
6799503|NCT02089685|10800286|FG000|Overall Study|Physician Decision|0
6799504|NCT02089685|10800287|FG001|Overall Study|Physician Decision|0
6799505|NCT02089685|10800288|FG002|Overall Study|Physician Decision|0
6799506|NCT02089685|10800289|FG003|Overall Study|Physician Decision|0
6799507|NCT02089685|10800290|FG004|Overall Study|Physician Decision|0
6799508|NCT02089685|10800291|FG005|Overall Study|Physician Decision|4
6799509|NCT02089685|10800286|FG000|Overall Study|Screen failure|1
6799510|NCT02089685|10800287|FG001|Overall Study|Screen failure|0
6799511|NCT02089685|10800288|FG002|Overall Study|Screen failure|0
6799512|NCT02089685|10800289|FG003|Overall Study|Screen failure|0
6799513|NCT02089685|10800290|FG004|Overall Study|Screen failure|0
6799514|NCT02089685|10800291|FG005|Overall Study|Screen failure|0
6799515|NCT02075320|10800315|FG000|Overall Study|Withdrawal by Subject|2
6799516|NCT02007512|10800323|FG000|Double Blind Treatment Period|Adverse Event|4
6799517|NCT02007512|10800324|FG001|Double Blind Treatment Period|Adverse Event|2
6799518|NCT02007512|10800325|FG002|Double Blind Treatment Period|Adverse Event|6
6799519|NCT02007512|10800326|FG003|Double Blind Treatment Period|Adverse Event|2
6799520|NCT02007512|10800323|FG000|Double Blind Treatment Period|Death|1
6799521|NCT02007512|10800324|FG001|Double Blind Treatment Period|Death|0
6799522|NCT02007512|10800325|FG002|Double Blind Treatment Period|Death|0
6799523|NCT02007512|10800326|FG003|Double Blind Treatment Period|Death|0
6799524|NCT02007512|10800323|FG000|Double Blind Treatment Period|Disease progression|44
6799525|NCT02007512|10800324|FG001|Double Blind Treatment Period|Disease progression|49
6799526|NCT02007512|10800325|FG002|Double Blind Treatment Period|Disease progression|45
6799527|NCT02007512|10800326|FG003|Double Blind Treatment Period|Disease progression|51
6799528|NCT02007512|10800323|FG000|Double Blind Treatment Period|Withdrawal by Subject|4
6799529|NCT02007512|10800324|FG001|Double Blind Treatment Period|Withdrawal by Subject|2
6799530|NCT02007512|10800325|FG002|Double Blind Treatment Period|Withdrawal by Subject|3
6799531|NCT02007512|10800326|FG003|Double Blind Treatment Period|Withdrawal by Subject|3
6799532|NCT02007512|10800323|FG000|Double Blind Treatment Period|Protocol Violation|0
6799533|NCT02007512|10800324|FG001|Double Blind Treatment Period|Protocol Violation|0
6799534|NCT02007512|10800325|FG002|Double Blind Treatment Period|Protocol Violation|0
6799535|NCT02007512|10800326|FG003|Double Blind Treatment Period|Protocol Violation|1
6799536|NCT02007512|10800323|FG000|Double Blind Treatment Period|Other|0
6799537|NCT02007512|10800324|FG001|Double Blind Treatment Period|Other|0
6799538|NCT02007512|10800325|FG002|Double Blind Treatment Period|Other|1
6799539|NCT02007512|10800326|FG003|Double Blind Treatment Period|Other|2
6799540|NCT02007512|10800323|FG000|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10
6799541|NCT02007512|10800324|FG001|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11
6799542|NCT02007512|10800325|FG002|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5
6799543|NCT02007512|10800326|FG003|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1
6799544|NCT02007512|10800323|FG000|Open Label Treatment Period|Adverse Event|0
6799545|NCT02007512|10800324|FG001|Open Label Treatment Period|Adverse Event|1
6799546|NCT02007512|10800325|FG002|Open Label Treatment Period|Adverse Event|0
6799547|NCT02007512|10800326|FG003|Open Label Treatment Period|Adverse Event|0
6799548|NCT02007512|10800323|FG000|Open Label Treatment Period|Other|0
6799549|NCT02007512|10800324|FG001|Open Label Treatment Period|Other|0
6799550|NCT02007512|10800325|FG002|Open Label Treatment Period|Other|0
6799551|NCT02007512|10800326|FG003|Open Label Treatment Period|Other|1
6799552|NCT02007512|10800323|FG000|Open Label Treatment Period|Disease progression|0
6799553|NCT02007512|10800324|FG001|Open Label Treatment Period|Disease progression|17
6799554|NCT02007512|10800325|FG002|Open Label Treatment Period|Disease progression|0
6799555|NCT02007512|10800326|FG003|Open Label Treatment Period|Disease progression|11
6799556|NCT02007512|10800323|FG000|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
6809436|NCT00000620|10813109|FG002|Overall Study|Withdrawal by Subject|28
6809437|NCT00000620|10813110|FG003|Overall Study|Withdrawal by Subject|27
6809438|NCT00000620|10813111|FG004|Overall Study|Withdrawal by Subject|30
6809439|NCT00000620|10813112|FG005|Overall Study|Withdrawal by Subject|32
6809440|NCT00000620|10813113|FG006|Overall Study|Withdrawal by Subject|32
6809441|NCT00000620|10813114|FG007|Overall Study|Withdrawal by Subject|21
6809442|NCT00000620|10813107|FG000|Overall Study|missed closeout visit|22
6809443|NCT00000620|10813108|FG001|Overall Study|missed closeout visit|28
6809444|NCT00000620|10813109|FG002|Overall Study|missed closeout visit|16
6809445|NCT00000620|10813110|FG003|Overall Study|missed closeout visit|11
6809446|NCT00000620|10813111|FG004|Overall Study|missed closeout visit|26
6809447|NCT00000620|10813112|FG005|Overall Study|missed closeout visit|28
6809448|NCT00000620|10813113|FG006|Overall Study|missed closeout visit|13
6809449|NCT00000620|10813114|FG007|Overall Study|missed closeout visit|16
6809450|NCT00001213|10813130|FG000|Overall Study|Death|18
6809451|NCT00001262|10813137|FG000|Overall Study|Death|10
6809452|NCT00001262|10813138|FG001|Overall Study|Death|11
6799557|NCT02007512|10800324|FG001|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3
6799558|NCT02007512|10800325|FG002|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
6799559|NCT02007512|10800326|FG003|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
6799560|NCT01999179|10800339|FG000|Overall Study|Adverse Event|1
6799561|NCT01999179|10800339|FG000|Overall Study|Lost to Follow-up|1
6799562|NCT01999179|10800339|FG000|Overall Study|Change in Therapy|3
6799563|NCT01999179|10800339|FG000|Overall Study|New catheter|2
6799564|NCT01858688|10800343|FG000|Overall Study|Withdrawal by Subject|8
6799565|NCT01858688|10800343|FG000|Overall Study|Participant began another therapy|3
6799566|NCT01858688|10800343|FG000|Overall Study|Physician Decision|2
6799567|NCT01858688|10800343|FG000|Overall Study|Progressive Disease|2
6799568|NCT01858688|10800343|FG000|Overall Study|Reason not reproted|5
6799569|NCT01796197|10800347|FG000|Overall Study|Lost to Follow-up|1
6799570|NCT01796197|10800347|FG000|Overall Study|Lack of Efficacy|1
6799571|NCT01751906|10800353|FG000|Overall Study|Lost to Follow-up|151
6799572|NCT01751906|10800354|FG001|Overall Study|Lost to Follow-up|68
6799573|NCT01751906|10800353|FG000|Overall Study|Withdrawal by Subject|22
6799574|NCT01751906|10800354|FG001|Overall Study|Withdrawal by Subject|18
6799575|NCT01751906|10800353|FG000|Overall Study|Physician Decision|5
6799576|NCT01751906|10800354|FG001|Overall Study|Physician Decision|2
6799577|NCT01751906|10800353|FG000|Overall Study|Death|84
6799578|NCT01751906|10800354|FG001|Overall Study|Death|43
6799579|NCT01751906|10800353|FG000|Overall Study|Denied on premises for follow-up by law|1
6799580|NCT01751906|10800354|FG001|Overall Study|Denied on premises for follow-up by law|0
6799581|NCT01665144|10800362|FG000|Overall Study|New therapy for study indication|2
6799582|NCT01665144|10800363|FG001|Overall Study|New therapy for study indication|1
6799583|NCT01665144|10800362|FG000|Overall Study|Technical problems|2
6799584|NCT01665144|10800363|FG001|Overall Study|Technical problems|0
6799585|NCT01665144|10800362|FG000|Overall Study|Death|3
6799586|NCT01665144|10800363|FG001|Overall Study|Death|1
6799587|NCT01665144|10800362|FG000|Overall Study|Protocol deviation|3
6799588|NCT01665144|10800363|FG001|Overall Study|Protocol deviation|1
6799589|NCT01665144|10800362|FG000|Overall Study|Non-compliance w/study treatment|5
6799590|NCT01665144|10800363|FG001|Overall Study|Non-compliance w/study treatment|0
6799591|NCT01665144|10800362|FG000|Overall Study|Progressive disease|8
6799592|NCT01665144|10800363|FG001|Overall Study|Progressive disease|4
6799593|NCT01665144|10800362|FG000|Overall Study|Lost to Follow-up|9
6799594|NCT01665144|10800363|FG001|Overall Study|Lost to Follow-up|8
6799595|NCT01665144|10800362|FG000|Overall Study|Physician Decision|13
6799596|NCT01665144|10800363|FG001|Overall Study|Physician Decision|1
6799597|NCT01665144|10800362|FG000|Overall Study|Lack of Efficacy|16
6799598|NCT01665144|10800363|FG001|Overall Study|Lack of Efficacy|11
6799599|NCT01665144|10800362|FG000|Overall Study|Adverse Event|45
6799600|NCT01665144|10800363|FG001|Overall Study|Adverse Event|18
6799601|NCT01665144|10800362|FG000|Overall Study|Withdrawal by Subject|96
6799602|NCT01665144|10800363|FG001|Overall Study|Withdrawal by Subject|77
6809453|NCT00001262|10813139|FG002|Overall Study|Death|0
6809454|NCT00001262|10813137|FG000|Overall Study|Withdrawal by Subject|0
6809455|NCT00001262|10813138|FG001|Overall Study|Withdrawal by Subject|3
6809456|NCT00001262|10813139|FG002|Overall Study|Withdrawal by Subject|0
6809457|NCT00001566|10813160|FG000|Overall Study|patients' choice to discontinue protocol|3
6809458|NCT00001566|10813160|FG000|Overall Study|stopped after C3 due to symptomatic PD|1
6809459|NCT00001566|10813160|FG000|Overall Study|Death|13
6809460|NCT00001566|10813160|FG000|Overall Study|Lost to Follow-up|1
6809461|NCT00001566|10813160|FG000|Overall Study|unable to complete initial apheresis|1
6809462|NCT00001575|10813164|FG000|Overall Study|Screening failures-Ph I portion|22
6809463|NCT00001575|10813164|FG000|Overall Study|Withdrawn/deaths|23
6809464|NCT00001596|10813179|FG000|Overall Study|Death|1
6809465|NCT00001596|10813180|FG001|Overall Study|Death|0
6809466|NCT00001596|10813179|FG000|Overall Study|Withdrawal by Subject|3
6809467|NCT00001596|10813180|FG001|Overall Study|Withdrawal by Subject|1
6809468|NCT00001596|10813179|FG000|Overall Study|Study Termination|12
6809469|NCT00001596|10813180|FG001|Overall Study|Study Termination|9
6809470|NCT00001596|10813179|FG000|Overall Study|Adverse Event|1
6809471|NCT00001596|10813180|FG001|Overall Study|Adverse Event|0
6809472|NCT00001703|10813195|FG000|Overall Study|progressed disease|2
6809473|NCT00001703|10813195|FG000|Overall Study|No evidence of disease|1
6809474|NCT00001703|10813195|FG000|Overall Study|recurrent disease|2
6809475|NCT00001723|10813201|FG000|Overall Study|Lack of Efficacy|6
6809476|NCT00001723|10813202|FG001|Overall Study|Lack of Efficacy|7
6809477|NCT00001723|10813201|FG000|Overall Study|Lack of family interest|4
6809478|NCT00001723|10813202|FG001|Overall Study|Lack of family interest|5
6809479|NCT00001723|10813201|FG000|Overall Study|Lost to Follow-up|2
6809480|NCT00001723|10813202|FG001|Overall Study|Lost to Follow-up|2
6809481|NCT00001723|10813201|FG000|Overall Study|medication intolerance|1
6809482|NCT00001723|10813202|FG001|Overall Study|medication intolerance|2
6809483|NCT00001832|10813226|FG000|Apheresis Period|not able to manufacture treatment cells|60
6809484|NCT00001832|10813227|FG001|Apheresis Period|not able to manufacture treatment cells|0
6809485|NCT00001832|10813228|FG002|Apheresis Period|not able to manufacture treatment cells|0
6809486|NCT00001832|10813229|FG003|Apheresis Period|not able to manufacture treatment cells|0
6809487|NCT00001832|10813230|FG004|Apheresis Period|not able to manufacture treatment cells|0
6809488|NCT00001832|10813231|FG005|Apheresis Period|not able to manufacture treatment cells|0
6799603|NCT00669669|10800404|FG000|Overall Study|To late to start treatment|1
6799604|NCT00549848|10800411|FG000|Overall Study|Death|1
6799605|NCT00549848|10800412|FG001|Overall Study|Death|4
6799606|NCT00549848|10800413|FG002|Overall Study|Death|13
6799607|NCT00549848|10800411|FG000|Overall Study|Physician Decision|0
6799608|NCT00549848|10800412|FG001|Overall Study|Physician Decision|0
6799609|NCT00549848|10800413|FG002|Overall Study|Physician Decision|4
6799610|NCT00549848|10800411|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3
6799611|NCT00549848|10800412|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4
6799612|NCT00549848|10800413|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4
6799613|NCT00549848|10800411|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1
6799614|NCT00549848|10800412|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0
6799615|NCT00549848|10800413|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1
6799616|NCT00549848|10800411|FG000|Overall Study|Participant/Family Withdraw|2
6799617|NCT00549848|10800412|FG001|Overall Study|Participant/Family Withdraw|3
6799618|NCT00549848|10800413|FG002|Overall Study|Participant/Family Withdraw|5
6799619|NCT00549848|10800411|FG000|Overall Study|Second Malignancy|1
6799620|NCT00549848|10800412|FG001|Overall Study|Second Malignancy|0
6799621|NCT00549848|10800413|FG002|Overall Study|Second Malignancy|0
6799622|NCT00549848|10800411|FG000|Overall Study|Transplant|3
6799623|NCT00549848|10800412|FG001|Overall Study|Transplant|3
6799624|NCT00549848|10800413|FG002|Overall Study|Transplant|18
6799625|NCT00549848|10800411|FG000|Overall Study|Unacceptable Toxicity|1
6799626|NCT00549848|10800412|FG001|Overall Study|Unacceptable Toxicity|6
6799627|NCT00549848|10800413|FG002|Overall Study|Unacceptable Toxicity|6
6799628|NCT00433511|10800432|FG000|Step 1|Adverse Event|50
6799629|NCT00433511|10800433|FG001|Step 1|Adverse Event|157
6799630|NCT00433511|10800434|FG002|Step 1|Adverse Event|153
6799631|NCT00433511|10800432|FG000|Step 1|Withdrawal by Subject|45
6799632|NCT00433511|10800433|FG001|Step 1|Withdrawal by Subject|143
6799633|NCT00433511|10800434|FG002|Step 1|Withdrawal by Subject|154
6799634|NCT00433511|10800432|FG000|Step 1|Death|3
6799635|NCT00433511|10800433|FG001|Step 1|Death|1
6799636|NCT00433511|10800434|FG002|Step 1|Death|1
6799637|NCT00433511|10800432|FG000|Step 1|Physician Decision|1
6799638|NCT00433511|10800433|FG001|Step 1|Physician Decision|4
6799639|NCT00433511|10800434|FG002|Step 1|Physician Decision|3
6799640|NCT00433511|10800432|FG000|Step 1|Never started protocol therapy|28
6799641|NCT00433511|10800433|FG001|Step 1|Never started protocol therapy|64
6799642|NCT00433511|10800434|FG002|Step 1|Never started protocol therapy|66
6799643|NCT00433511|10800432|FG000|Step 1|Alternative therapy|2
6799644|NCT00433511|10800433|FG001|Step 1|Alternative therapy|1
6799645|NCT00433511|10800434|FG002|Step 1|Alternative therapy|3
6799646|NCT00433511|10800432|FG000|Step 1|Disease progression, relapse|5
6799647|NCT00433511|10800433|FG001|Step 1|Disease progression, relapse|3
6799648|NCT00433511|10800434|FG002|Step 1|Disease progression, relapse|3
6799649|NCT00433511|10800432|FG000|Step 1|Other complicating disease|2
6799650|NCT00433511|10800433|FG001|Step 1|Other complicating disease|6
6799651|NCT00433511|10800434|FG002|Step 1|Other complicating disease|3
6799652|NCT00433511|10800432|FG000|Step 1|Non-breast cancer surgery/wound issues|0
6799653|NCT00433511|10800433|FG001|Step 1|Non-breast cancer surgery/wound issues|4
6799654|NCT00433511|10800434|FG002|Step 1|Non-breast cancer surgery/wound issues|1
6799655|NCT00433511|10800432|FG000|Step 1|Suspected recurrence|0
6799656|NCT00433511|10800433|FG001|Step 1|Suspected recurrence|1
6799657|NCT00433511|10800434|FG002|Step 1|Suspected recurrence|0
6799658|NCT00433511|10800432|FG000|Step 1|Insurance/drug distribution issues|0
6799659|NCT00433511|10800433|FG001|Step 1|Insurance/drug distribution issues|1
6799660|NCT00433511|10800434|FG002|Step 1|Insurance/drug distribution issues|2
6799661|NCT00433511|10800432|FG000|Step 1|Patient moved|0
6799662|NCT00433511|10800433|FG001|Step 1|Patient moved|0
6799663|NCT00433511|10800434|FG002|Step 1|Patient moved|1
6799664|NCT00433511|10800432|FG000|Step 2 (Arm D)|Adverse Event|0
6799665|NCT00433511|10800433|FG001|Step 2 (Arm D)|Adverse Event|0
6799666|NCT00433511|10800434|FG002|Step 2 (Arm D)|Adverse Event|135
6799667|NCT00433511|10800432|FG000|Step 2 (Arm D)|Withdrawal by Subject|0
6799668|NCT00433511|10800433|FG001|Step 2 (Arm D)|Withdrawal by Subject|0
6799669|NCT00433511|10800434|FG002|Step 2 (Arm D)|Withdrawal by Subject|181
6799670|NCT00433511|10800432|FG000|Step 2 (Arm D)|Never started protocol therapy|0
6799671|NCT00433511|10800433|FG001|Step 2 (Arm D)|Never started protocol therapy|0
6799672|NCT00433511|10800434|FG002|Step 2 (Arm D)|Never started protocol therapy|148
6799673|NCT00433511|10800432|FG000|Step 2 (Arm D)|Physician Decision|0
6799674|NCT00433511|10800433|FG001|Step 2 (Arm D)|Physician Decision|0
6799675|NCT00433511|10800434|FG002|Step 2 (Arm D)|Physician Decision|9
6799676|NCT00433511|10800432|FG000|Step 2 (Arm D)|Disease progression, relapse|0
6799677|NCT00433511|10800433|FG001|Step 2 (Arm D)|Disease progression, relapse|0
6799678|NCT00433511|10800434|FG002|Step 2 (Arm D)|Disease progression, relapse|7
6799679|NCT00433511|10800432|FG000|Step 2 (Arm D)|Other complicating disease|0
6799680|NCT00433511|10800433|FG001|Step 2 (Arm D)|Other complicating disease|0
6799681|NCT00433511|10800434|FG002|Step 2 (Arm D)|Other complicating disease|3
6799682|NCT00433511|10800432|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0
6799683|NCT00433511|10800433|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0
6799684|NCT00433511|10800434|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2
6799685|NCT00433511|10800432|FG000|Step 2 (Arm D)|Suspected recurrence|0
6799686|NCT00433511|10800433|FG001|Step 2 (Arm D)|Suspected recurrence|0
6799687|NCT00433511|10800434|FG002|Step 2 (Arm D)|Suspected recurrence|1
6799688|NCT00433511|10800432|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0
6799689|NCT00433511|10800433|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0
6799690|NCT00433511|10800434|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4
6799691|NCT00433511|10800432|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0
6799692|NCT00433511|10800433|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0
6799693|NCT00433511|10800434|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1
6799694|NCT00314366|10800460|FG000|Overall Study|not treated due to patient medical condi|1
6799695|NCT00314366|10800461|FG001|Overall Study|not treated due to patient medical condi|0
6809489|NCT00001832|10813232|FG006|Apheresis Period|not able to manufacture treatment cells|0
6809490|NCT00001832|10813233|FG007|Apheresis Period|not able to manufacture treatment cells|0
6809491|NCT00001832|10813234|FG008|Apheresis Period|not able to manufacture treatment cells|0
6809492|NCT00001832|10813235|FG009|Apheresis Period|not able to manufacture treatment cells|0
6809493|NCT00001832|10813236|FG010|Apheresis Period|not able to manufacture treatment cells|0
6809494|NCT00001832|10813237|FG011|Apheresis Period|not able to manufacture treatment cells|0
6809495|NCT00001832|10813238|FG012|Apheresis Period|not able to manufacture treatment cells|0
6809496|NCT00001832|10813239|FG013|Apheresis Period|not able to manufacture treatment cells|0
6809497|NCT00001832|10813240|FG014|Apheresis Period|not able to manufacture treatment cells|0
6809498|NCT00001832|10813226|FG000|Treatment Period|Death during treatment|0
6809499|NCT00001832|10813227|FG001|Treatment Period|Death during treatment|0
6809500|NCT00001832|10813228|FG002|Treatment Period|Death during treatment|0
6809501|NCT00001832|10813229|FG003|Treatment Period|Death during treatment|0
6809502|NCT00001832|10813230|FG004|Treatment Period|Death during treatment|0
6809503|NCT00001832|10813231|FG005|Treatment Period|Death during treatment|1
6809504|NCT00001832|10813232|FG006|Treatment Period|Death during treatment|0
6809505|NCT00001832|10813233|FG007|Treatment Period|Death during treatment|0
6809506|NCT00001832|10813234|FG008|Treatment Period|Death during treatment|0
6809507|NCT00001832|10813235|FG009|Treatment Period|Death during treatment|0
6809508|NCT00001832|10813236|FG010|Treatment Period|Death during treatment|0
6809509|NCT00001832|10813237|FG011|Treatment Period|Death during treatment|0
6809510|NCT00001832|10813238|FG012|Treatment Period|Death during treatment|0
6809511|NCT00001832|10813239|FG013|Treatment Period|Death during treatment|0
6809512|NCT00001832|10813240|FG014|Treatment Period|Death during treatment|0
6809513|NCT00001832|10813226|FG000|Treatment Period|Not treated|0
6809514|NCT00001832|10813227|FG001|Treatment Period|Not treated|0
6809515|NCT00001832|10813228|FG002|Treatment Period|Not treated|0
6809516|NCT00001832|10813229|FG003|Treatment Period|Not treated|0
6809517|NCT00001832|10813230|FG004|Treatment Period|Not treated|0
6809518|NCT00001832|10813231|FG005|Treatment Period|Not treated|0
6809519|NCT00001832|10813232|FG006|Treatment Period|Not treated|0
6809520|NCT00001832|10813233|FG007|Treatment Period|Not treated|1
6809521|NCT00001832|10813234|FG008|Treatment Period|Not treated|0
6809522|NCT00001832|10813235|FG009|Treatment Period|Not treated|0
6809523|NCT00001832|10813236|FG010|Treatment Period|Not treated|0
6809524|NCT00001832|10813237|FG011|Treatment Period|Not treated|0
6809525|NCT00001832|10813238|FG012|Treatment Period|Not treated|0
6809526|NCT00001832|10813239|FG013|Treatment Period|Not treated|0
6809527|NCT00001832|10813240|FG014|Treatment Period|Not treated|0
6809528|NCT00001849|10813270|FG000|Overall Study|Death|4
6809529|NCT00001849|10813270|FG000|Overall Study|Lost to Follow-up|2
6809530|NCT00001849|10813270|FG000|Overall Study|Withdrawal by Subject|2
6809531|NCT00001849|10813270|FG000|Overall Study|tumor remained occult|6
6809532|NCT00001880|10813283|FG000|Overall Study|Death|14
6809533|NCT00001941|10813287|FG000|Overall Study|not treated- rapidly progressing disease|0
6809534|NCT00001941|10813288|FG001|Overall Study|not treated- rapidly progressing disease|0
6809535|NCT00001941|10813289|FG002|Overall Study|not treated- rapidly progressing disease|0
6809536|NCT00001941|10813290|FG003|Overall Study|not treated- rapidly progressing disease|0
6809537|NCT00001941|10813291|FG004|Overall Study|not treated- rapidly progressing disease|1
6809538|NCT00001959|10813296|FG000|Overall Study|newly diagnosed colon cancer|1
6809539|NCT00001959|10813296|FG000|Overall Study|disabling sedation|1
6809540|NCT00001959|10813296|FG000|Overall Study|non-compliance|1
6809541|NCT00001962|10813300|FG000|Overall Study|Lack of Efficacy|18
6809542|NCT00001962|10813300|FG000|Overall Study|Lack of Accrual|6
6809543|NCT00001962|10813300|FG000|Overall Study|Death|1
6809544|NCT00001962|10813300|FG000|Overall Study|Lost to Follow-up|2
6809545|NCT00001962|10813300|FG000|Overall Study|Adverse Event|1
6809546|NCT00002525|10813310|FG000|Overall Study|Adverse Event|36
6809547|NCT00002525|10813311|FG001|Overall Study|Adverse Event|0
6809548|NCT00002525|10813310|FG000|Overall Study|Death|5
6809549|NCT00002525|10813311|FG001|Overall Study|Death|0
6809550|NCT00002525|10813310|FG000|Overall Study|Withdrawal by Subject|11
6809551|NCT00002525|10813311|FG001|Overall Study|Withdrawal by Subject|0
6809552|NCT00002525|10813310|FG000|Overall Study|Start non-protocol therapy|1
6809553|NCT00002525|10813311|FG001|Overall Study|Start non-protocol therapy|0
6809554|NCT00002525|10813310|FG000|Overall Study|Other complicating disease|1
6809555|NCT00002525|10813311|FG001|Overall Study|Other complicating disease|0
6809556|NCT00002525|10813310|FG000|Overall Study|Duke's A, B1, D disease|92
6809557|NCT00002525|10813311|FG001|Overall Study|Duke's A, B1, D disease|0
6809558|NCT00002525|10813310|FG000|Overall Study|Error|6
6809559|NCT00002525|10813311|FG001|Overall Study|Error|0
6809560|NCT00002525|10813310|FG000|Overall Study|Other|26
6799696|NCT04482647|10800526|FG000|Overall Study|Time constraints|2
6799697|NCT04482647|10800526|FG000|Overall Study|Health issues|1
6799698|NCT04482647|10800526|FG000|Overall Study|Death in the family|1
6799699|NCT04482647|10800526|FG000|Overall Study|Disliked the intervention|1
6799700|NCT04482647|10800526|FG000|Overall Study|No reasons specified|7
6799701|NCT04405570|10800534|FG000|Overall Study|Adverse Event|0
6799702|NCT04405570|10800535|FG001|Overall Study|Adverse Event|1
6799703|NCT04405570|10800536|FG002|Overall Study|Adverse Event|1
6799704|NCT04405570|10800537|FG003|Overall Study|Adverse Event|1
6799705|NCT04405570|10800534|FG000|Overall Study|Lost to Follow-up|0
6799706|NCT04405570|10800535|FG001|Overall Study|Lost to Follow-up|1
6799707|NCT04405570|10800536|FG002|Overall Study|Lost to Follow-up|0
6799708|NCT04405570|10800537|FG003|Overall Study|Lost to Follow-up|0
6799709|NCT04405570|10800534|FG000|Overall Study|Physician Decision|0
6799710|NCT04405570|10800535|FG001|Overall Study|Physician Decision|0
6799711|NCT04405570|10800536|FG002|Overall Study|Physician Decision|1
6799712|NCT04405570|10800537|FG003|Overall Study|Physician Decision|0
6799713|NCT04405570|10800534|FG000|Overall Study|Withdrawal by Subject|0
6799714|NCT04405570|10800535|FG001|Overall Study|Withdrawal by Subject|1
6799715|NCT04405570|10800536|FG002|Overall Study|Withdrawal by Subject|1
6799716|NCT04405570|10800537|FG003|Overall Study|Withdrawal by Subject|0
6799717|NCT04405570|10800534|FG000|Overall Study|Randomized not dosed|0
6799718|NCT04405570|10800535|FG001|Overall Study|Randomized not dosed|2
6799719|NCT04405570|10800536|FG002|Overall Study|Randomized not dosed|0
6799720|NCT04405570|10800537|FG003|Overall Study|Randomized not dosed|0
6799721|NCT04135937|10800550|FG000|Overall Study|Lost to Follow-up|2
6799722|NCT04135937|10800550|FG000|Overall Study|Withdrawal by Subject|1
6799723|NCT03989232|10800556|FG000|Overall Study|Lost to Follow-up|3
6799724|NCT03989232|10800557|FG001|Overall Study|Lost to Follow-up|10
6799725|NCT03989232|10800556|FG000|Overall Study|Withdrawal by Subject|6
6799726|NCT03989232|10800557|FG001|Overall Study|Withdrawal by Subject|6
6799727|NCT03989232|10800556|FG000|Overall Study|Death|1
6799728|NCT03989232|10800557|FG001|Overall Study|Death|2
6799729|NCT03896295|10800565|FG000|Overall Study|Adverse Event|0
6799730|NCT03896295|10800566|FG001|Overall Study|Adverse Event|1
6799731|NCT03896295|10800565|FG000|Overall Study|COVID-19|7
6799732|NCT03896295|10800566|FG001|Overall Study|COVID-19|29
6799733|NCT03213457|10800580|FG000|Overall Study|Not Treated|1
6799734|NCT03213457|10800581|FG001|Overall Study|Not Treated|1
6799735|NCT03213457|10800582|FG002|Overall Study|Not Treated|0
6799736|NCT03213457|10800580|FG000|Overall Study|Adverse Event|16
6799737|NCT03213457|10800581|FG001|Overall Study|Adverse Event|9
6799738|NCT03213457|10800582|FG002|Overall Study|Adverse Event|41
6799739|NCT03213457|10800580|FG000|Overall Study|Non-Compliance With Study Drug|1
6799740|NCT03213457|10800581|FG001|Overall Study|Non-Compliance With Study Drug|2
6799741|NCT03213457|10800582|FG002|Overall Study|Non-Compliance With Study Drug|7
6799742|NCT03213457|10800580|FG000|Overall Study|Non-Compliance Other, Not Specified|0
6799743|NCT03213457|10800581|FG001|Overall Study|Non-Compliance Other, Not Specified|1
6799744|NCT03213457|10800582|FG002|Overall Study|Non-Compliance Other, Not Specified|5
6799745|NCT03213457|10800580|FG000|Overall Study|Withdrawal by Subject|18
6799746|NCT03213457|10800581|FG001|Overall Study|Withdrawal by Subject|7
6799747|NCT03213457|10800582|FG002|Overall Study|Withdrawal by Subject|35
6799748|NCT03213457|10800580|FG000|Overall Study|Lost to Follow-up|12
6799749|NCT03213457|10800581|FG001|Overall Study|Lost to Follow-up|12
6799750|NCT03213457|10800582|FG002|Overall Study|Lost to Follow-up|33
6799751|NCT03213457|10800580|FG000|Overall Study|Pregnancy|11
6799752|NCT03213457|10800581|FG001|Overall Study|Pregnancy|0
6799753|NCT03213457|10800582|FG002|Overall Study|Pregnancy|7
6799754|NCT03213457|10800580|FG000|Overall Study|Protocol Violation|1
6799755|NCT03213457|10800581|FG001|Overall Study|Protocol Violation|1
6799756|NCT03213457|10800582|FG002|Overall Study|Protocol Violation|6
6799757|NCT03213457|10800580|FG000|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|4
6799758|NCT03213457|10800581|FG001|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|0
6799759|NCT03213457|10800582|FG002|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|2
6799760|NCT03213457|10800580|FG000|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1
6799761|NCT03213457|10800581|FG001|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1
6799762|NCT03213457|10800582|FG002|Overall Study|Dual Energy X-Ray Absorptiometry Finding|3
6799763|NCT03213457|10800580|FG000|Overall Study|Lack of Efficacy|12
6799764|NCT03213457|10800581|FG001|Overall Study|Lack of Efficacy|2
6799765|NCT03213457|10800582|FG002|Overall Study|Lack of Efficacy|9
6799766|NCT03213457|10800580|FG000|Overall Study|Other, Not Specified|11
6799767|NCT03213457|10800581|FG001|Overall Study|Other, Not Specified|3
6799768|NCT03213457|10800582|FG002|Overall Study|Other, Not Specified|26
6799769|NCT02982720|10800590|FG000|Overall Study|Adverse Event|3
6799770|NCT02982720|10800590|FG000|Overall Study|Death|1
6799771|NCT02375672|10800603|FG000|Overall Study|remain on follow up|20
6799772|NCT02329327|10800609|FG000|Overall Study|Death|78
6799773|NCT02329327|10800610|FG001|Overall Study|Death|0
6799774|NCT02329327|10800609|FG000|Overall Study|Withdrawal by Subject|3
6799775|NCT02329327|10800610|FG001|Overall Study|Withdrawal by Subject|0
6799776|NCT02329327|10800609|FG000|Overall Study|Lost to Follow-up|4
6799777|NCT02329327|10800610|FG001|Overall Study|Lost to Follow-up|0
6799778|NCT01566149|10800668|FG000|Overall Study|Adverse Event|0
6799779|NCT01566149|10800669|FG001|Overall Study|Adverse Event|1
6799780|NCT01566149|10800668|FG000|Overall Study|Non-compliance with study medication|2
6799781|NCT01566149|10800669|FG001|Overall Study|Non-compliance with study medication|0
6799782|NCT01566149|10800668|FG000|Overall Study|Protocol Violation|0
6799783|NCT01566149|10800669|FG001|Overall Study|Protocol Violation|1
6799784|NCT01566149|10800668|FG000|Overall Study|Withdrawal by Subject|1
6799785|NCT01566149|10800669|FG001|Overall Study|Withdrawal by Subject|0
6799786|NCT01386125|10800686|FG000|Overall Study|Lost to Follow-up|3
6799787|NCT01386125|10800687|FG001|Overall Study|Lost to Follow-up|9
6799788|NCT01386125|10800686|FG000|Overall Study|Physician Decision|0
6799789|NCT01386125|10800687|FG001|Overall Study|Physician Decision|1
6799790|NCT01386125|10800686|FG000|Overall Study|Protocol Violation|5
6799791|NCT01386125|10800687|FG001|Overall Study|Protocol Violation|7
6799792|NCT01386125|10800686|FG000|Overall Study|Disease Progress|1
6799793|NCT01386125|10800687|FG001|Overall Study|Disease Progress|2
6799794|NCT01386125|10800686|FG000|Overall Study|Withdrawal by Subject|13
6799795|NCT01386125|10800687|FG001|Overall Study|Withdrawal by Subject|12
6799796|NCT01386125|10800686|FG000|Overall Study|Adverse Event|2
6799797|NCT01386125|10800687|FG001|Overall Study|Adverse Event|5
6799798|NCT01386125|10800686|FG000|Overall Study|Lack of Efficacy|0
6799799|NCT01386125|10800687|FG001|Overall Study|Lack of Efficacy|1
6799800|NCT01386125|10800686|FG000|Overall Study|Participant Leaving Country|1
6799801|NCT01386125|10800687|FG001|Overall Study|Participant Leaving Country|0
6799802|NCT01257568|10800693|FG000|Overall Study|Lost to Follow-up|2
6799803|NCT01257568|10800693|FG000|Overall Study|Withdrawal by Subject|6
6799804|NCT01257568|10800693|FG000|Overall Study|Terminated|1
6799805|NCT01257568|10800693|FG000|Overall Study|Component Revision|24
6799806|NCT01165424|10800699|FG000|Overall Study|Clinical adverse experiences|1
6799807|NCT01165424|10800699|FG000|Overall Study|Laboratory adverse experiences|1
6799808|NCT01165424|10800699|FG000|Overall Study|Did not meet entry criteria|1
6799809|NCT01165424|10800699|FG000|Overall Study|Participant moved (relocated)|1
6799810|NCT01135134|10800705|FG000|Overall Study|Adverse Event|1
6799811|NCT01135134|10800706|FG001|Overall Study|Adverse Event|1
6799812|NCT01135134|10800705|FG000|Overall Study|Did not meet protocol eligibility|1
6799813|NCT01135134|10800706|FG001|Overall Study|Did not meet protocol eligibility|0
6799814|NCT00867165|10800714|FG000|Overall Study|Adverse Event|3
6799815|NCT00867165|10800715|FG001|Overall Study|Adverse Event|0
6799816|NCT00867165|10800714|FG000|Overall Study|Withdrawal by Subject|1
6799817|NCT00867165|10800715|FG001|Overall Study|Withdrawal by Subject|0
6799818|NCT00733005|10800723|FG000|Overall Study|Adverse Event|0
6799819|NCT00733005|10800724|FG001|Overall Study|Adverse Event|1
6799820|NCT00733005|10800723|FG000|Overall Study|Treatment Failure|0
6799821|NCT00733005|10800724|FG001|Overall Study|Treatment Failure|1
6799822|NCT00733005|10800723|FG000|Overall Study|Withdrawal by Subject|0
6799823|NCT00733005|10800724|FG001|Overall Study|Withdrawal by Subject|1
6799824|NCT00733005|10800723|FG000|Overall Study|Protocol Violation|2
6799825|NCT00733005|10800724|FG001|Overall Study|Protocol Violation|0
6799826|NCT00732381|10800732|FG000|Overall Study|Adverse Event|1
6799827|NCT00732381|10800733|FG001|Overall Study|Adverse Event|0
6799828|NCT00732381|10800732|FG000|Overall Study|Treatment Failure|1
6799829|NCT00732381|10800733|FG001|Overall Study|Treatment Failure|1
6799830|NCT00654095|10800739|FG000|Overall Study|Drop in low density lipoprotein (1)|2
6799831|NCT00654095|10800739|FG000|Overall Study|Elevated triglyceride level (2)|1
6799832|NCT00654095|10800739|FG000|Overall Study|Elevated alanine aminotransferase (3)|1
6799833|NCT00654095|10800739|FG000|Overall Study|Adverse Event|11
6799834|NCT00654095|10800739|FG000|Overall Study|Withdrawal by Subject|5
6799835|NCT00654095|10800739|FG000|Overall Study|Elevated alanine aminotransferase (4)|7
6799836|NCT00654095|10800739|FG000|Overall Study|Adverse reaction did not improve (5)|4
6799837|NCT00654095|10800739|FG000|Overall Study|Did not meet inclusion criteria|1
6799838|NCT00653523|10800743|FG000|Overall Study|Drop in low density lipoprotein (1)|2
6799839|NCT00653523|10800743|FG000|Overall Study|Elevated creatine phosphokinase (2)|1
6799840|NCT00653523|10800743|FG000|Overall Study|Adverse Event|7
6799841|NCT00653523|10800743|FG000|Overall Study|Withdrawal by Subject|6
6799842|NCT00653523|10800743|FG000|Overall Study|Elevated alanine aminotransferase (3)|2
6799843|NCT00653523|10800743|FG000|Overall Study|Adverse reaction did not improve (4)|1
6799844|NCT00599027|10800749|FG000|Overall Study|Withdrawal by Subject|1
6799845|NCT00599027|10800750|FG001|Overall Study|Withdrawal by Subject|1
6799846|NCT00599027|10800749|FG000|Overall Study|Adverse Event|0
6799847|NCT00599027|10800750|FG001|Overall Study|Adverse Event|1
6799848|NCT00599027|10800749|FG000|Overall Study|Treatment Failure|0
6799849|NCT00599027|10800750|FG001|Overall Study|Treatment Failure|1
6799850|NCT00552032|10800758|FG000|Overall Study|Withdrawal by Subject|2
6799851|NCT00552032|10800759|FG001|Overall Study|Withdrawal by Subject|2
6799852|NCT00552032|10800758|FG000|Overall Study|Protocol Violation|7
6799853|NCT00552032|10800759|FG001|Overall Study|Protocol Violation|12
6799854|NCT00552032|10800758|FG000|Overall Study|Lost to Follow-up|8
6799855|NCT00552032|10800759|FG001|Overall Study|Lost to Follow-up|5
6799856|NCT00546052|10800765|FG000|Overall Study|Adverse Event|47
6799857|NCT00546052|10800765|FG000|Overall Study|Lost to Follow-up|144
6799858|NCT00546052|10800765|FG000|Overall Study|Protocol Violation|9
6799859|NCT00546052|10800765|FG000|Overall Study|Withdrawal by Subject|20
6799860|NCT00546052|10800765|FG000|Overall Study|Non Compliance|7
6799861|NCT00442117|10800774|FG000|Overall Study|Adverse Event|3
6799862|NCT00442117|10800775|FG001|Overall Study|Adverse Event|2
6799863|NCT00442117|10800774|FG000|Overall Study|Lack of Efficacy|2
6799864|NCT00442117|10800775|FG001|Overall Study|Lack of Efficacy|6
6799865|NCT00442117|10800774|FG000|Overall Study|Lost to Follow-up|1
6799866|NCT00442117|10800775|FG001|Overall Study|Lost to Follow-up|2
6799867|NCT00442117|10800774|FG000|Overall Study|Withdrawal by Subject|2
6799868|NCT00442117|10800775|FG001|Overall Study|Withdrawal by Subject|2
6799869|NCT00442117|10800774|FG000|Overall Study|Major Deviation|25
6799870|NCT00442117|10800775|FG001|Overall Study|Major Deviation|20
6799871|NCT00442117|10800774|FG000|Overall Study|Non compliance with protocol|3
6799872|NCT00442117|10800775|FG001|Overall Study|Non compliance with protocol|5
6799873|NCT00442117|10800774|FG000|Overall Study|Met Withdrawal Criteria|2
6799874|NCT00442117|10800775|FG001|Overall Study|Met Withdrawal Criteria|1
6799875|NCT00424008|10800783|FG000|Overall Study|Adverse Event|8
6799876|NCT00424008|10800784|FG001|Overall Study|Adverse Event|6
6799877|NCT00424008|10800783|FG000|Overall Study|Lack of Efficacy|40
6799878|NCT00424008|10800784|FG001|Overall Study|Lack of Efficacy|34
6799879|NCT00424008|10800783|FG000|Overall Study|Lost to Follow-up|1
6799880|NCT00424008|10800784|FG001|Overall Study|Lost to Follow-up|2
6799881|NCT00424008|10800783|FG000|Overall Study|Withdrawal by Subject|5
6799882|NCT00424008|10800784|FG001|Overall Study|Withdrawal by Subject|8
6799883|NCT00424008|10800783|FG000|Overall Study|Noncompliance with protocol|13
6799884|NCT00424008|10800784|FG001|Overall Study|Noncompliance with protocol|7
6799885|NCT00424008|10800783|FG000|Overall Study|Did not meet protocol eligibility|16
6799886|NCT00424008|10800784|FG001|Overall Study|Did not meet protocol eligibility|21
6799887|NCT00424008|10800783|FG000|Overall Study|Administrative|266
6799888|NCT00424008|10800784|FG001|Overall Study|Administrative|257
6799889|NCT00423176|10800793|FG000|Overall Study|Adverse Event|4
6799890|NCT00423176|10800794|FG001|Overall Study|Adverse Event|6
6799891|NCT00423176|10800793|FG000|Overall Study|Treatment Failure|1
6799892|NCT00423176|10800794|FG001|Overall Study|Treatment Failure|6
6799893|NCT00423176|10800793|FG000|Overall Study|Lost to Follow-up|4
6799894|NCT00423176|10800794|FG001|Overall Study|Lost to Follow-up|7
6799895|NCT00423176|10800793|FG000|Overall Study|Withdrawal by Subject|4
6799896|NCT00423176|10800794|FG001|Overall Study|Withdrawal by Subject|3
6799897|NCT00423176|10800793|FG000|Overall Study|Protocol Violation|1
6799898|NCT00423176|10800794|FG001|Overall Study|Protocol Violation|3
6799899|NCT00423176|10800793|FG000|Overall Study|Did not meet protocol eligibility|2
6799900|NCT00423176|10800794|FG001|Overall Study|Did not meet protocol eligibility|4
6799901|NCT00383240|10800804|FG000|Overall Study|Adverse Event|4
6799902|NCT00383240|10800805|FG001|Overall Study|Adverse Event|6
6799903|NCT00383240|10800806|FG002|Overall Study|Adverse Event|9
6799904|NCT00383240|10800807|FG003|Overall Study|Adverse Event|7
6799905|NCT00383240|10800804|FG000|Overall Study|Treatment Failure|8
6799906|NCT00383240|10800805|FG001|Overall Study|Treatment Failure|13
6799907|NCT00383240|10800806|FG002|Overall Study|Treatment Failure|47
6799908|NCT00383240|10800807|FG003|Overall Study|Treatment Failure|46
6799909|NCT00383240|10800804|FG000|Overall Study|Lost to Follow-up|3
6799910|NCT00383240|10800805|FG001|Overall Study|Lost to Follow-up|0
6799911|NCT00383240|10800806|FG002|Overall Study|Lost to Follow-up|0
6799912|NCT00383240|10800807|FG003|Overall Study|Lost to Follow-up|2
6799913|NCT00383240|10800804|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6
6799914|NCT00383240|10800805|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3
6799915|NCT00383240|10800806|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8
6799916|NCT00383240|10800807|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8
6799917|NCT00383240|10800804|FG000|Overall Study|Withdrawal by subjects, reasons related|0
6799918|NCT00383240|10800805|FG001|Overall Study|Withdrawal by subjects, reasons related|1
6799919|NCT00383240|10800806|FG002|Overall Study|Withdrawal by subjects, reasons related|3
6799920|NCT00383240|10800807|FG003|Overall Study|Withdrawal by subjects, reasons related|5
6799921|NCT00383240|10800804|FG000|Overall Study|Protocol Violation|4
6799922|NCT00383240|10800805|FG001|Overall Study|Protocol Violation|5
6799923|NCT00383240|10800806|FG002|Overall Study|Protocol Violation|9
6799924|NCT00383240|10800807|FG003|Overall Study|Protocol Violation|6
6799925|NCT00383240|10800804|FG000|Overall Study|Did not meet protocol eligibility|9
6799926|NCT00383240|10800805|FG001|Overall Study|Did not meet protocol eligibility|4
6799927|NCT00383240|10800806|FG002|Overall Study|Did not meet protocol eligibility|9
6799928|NCT00383240|10800807|FG003|Overall Study|Did not meet protocol eligibility|3
6799929|NCT00383240|10800804|FG000|Overall Study|Administrative|1
6799930|NCT00383240|10800805|FG001|Overall Study|Administrative|1
6799931|NCT00383240|10800806|FG002|Overall Study|Administrative|0
6799932|NCT00383240|10800807|FG003|Overall Study|Administrative|0
6809561|NCT00002525|10813311|FG001|Overall Study|Other|0
6809562|NCT00002525|10813310|FG000|Overall Study|Never start protocol therapy|8
6809563|NCT00002525|10813311|FG001|Overall Study|Never start protocol therapy|0
6799933|NCT02765399|10800838|FG000|Overall Study|Nausea|1
6799934|NCT02765399|10800839|FG001|Overall Study|Nausea|0
6799935|NCT04529096|10800847|FG000|Overall Study|Adverse Event|6
6799936|NCT04529096|10800848|FG001|Overall Study|Adverse Event|1
6799937|NCT04529096|10800847|FG000|Overall Study|Lack of Efficacy|1
6799938|NCT04529096|10800848|FG001|Overall Study|Lack of Efficacy|0
6799939|NCT04529096|10800847|FG000|Overall Study|Lost to Follow-up|1
6799940|NCT04529096|10800848|FG001|Overall Study|Lost to Follow-up|1
6799941|NCT04529096|10800847|FG000|Overall Study|Non-Compliance With Study Drug|0
6799942|NCT04529096|10800848|FG001|Overall Study|Non-Compliance With Study Drug|1
6799943|NCT04529096|10800847|FG000|Overall Study|Physician Decision|1
6799944|NCT04529096|10800848|FG001|Overall Study|Physician Decision|3
6799945|NCT04529096|10800847|FG000|Overall Study|Withdrawal by Subject|5
6799946|NCT04529096|10800848|FG001|Overall Study|Withdrawal by Subject|0
6799947|NCT04456686|10800865|FG000|Overall Study|Adverse Event|2
6799948|NCT04456686|10800866|FG001|Overall Study|Adverse Event|1
6799949|NCT04456686|10800865|FG000|Overall Study|Lack of Efficacy|3
6799950|NCT04456686|10800866|FG001|Overall Study|Lack of Efficacy|1
6799951|NCT04456686|10800865|FG000|Overall Study|Withdrew consent|3
6799952|NCT04456686|10800866|FG001|Overall Study|Withdrew consent|1
6799953|NCT04456686|10800865|FG000|Overall Study|Physician Decision|2
6799954|NCT04456686|10800866|FG001|Overall Study|Physician Decision|2
6799955|NCT04456686|10800865|FG000|Overall Study|Withdrawal by Subject|5
6799956|NCT04456686|10800866|FG001|Overall Study|Withdrawal by Subject|1
6799957|NCT04456686|10800865|FG000|Overall Study|Protocol Violation|0
6799958|NCT04456686|10800866|FG001|Overall Study|Protocol Violation|1
6799959|NCT03894969|10800877|FG000|Overall Study|Adverse Event|0
6799960|NCT03894969|10800878|FG001|Overall Study|Adverse Event|2
6799961|NCT03894969|10800879|FG002|Overall Study|Adverse Event|0
6799962|NCT03894969|10800880|FG003|Overall Study|Adverse Event|1
6799963|NCT03894969|10800881|FG004|Overall Study|Adverse Event|2
6799964|NCT03894969|10800877|FG000|Overall Study|Lost to Follow-up|3
6799965|NCT03894969|10800878|FG001|Overall Study|Lost to Follow-up|1
6799966|NCT03894969|10800879|FG002|Overall Study|Lost to Follow-up|1
6799967|NCT03894969|10800880|FG003|Overall Study|Lost to Follow-up|0
6799968|NCT03894969|10800881|FG004|Overall Study|Lost to Follow-up|0
6799969|NCT03894969|10800877|FG000|Overall Study|Withdrawal by Subject|2
6799970|NCT03894969|10800878|FG001|Overall Study|Withdrawal by Subject|1
6799971|NCT03894969|10800879|FG002|Overall Study|Withdrawal by Subject|3
6799972|NCT03894969|10800880|FG003|Overall Study|Withdrawal by Subject|4
6799973|NCT03894969|10800881|FG004|Overall Study|Withdrawal by Subject|8
6799974|NCT03894969|10800877|FG000|Overall Study|Other|0
6799975|NCT03894969|10800878|FG001|Overall Study|Other|0
6799976|NCT03894969|10800879|FG002|Overall Study|Other|0
6799977|NCT03894969|10800880|FG003|Overall Study|Other|0
6799978|NCT03894969|10800881|FG004|Overall Study|Other|3
6799979|NCT03894969|10800877|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0
6799980|NCT03894969|10800878|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0
6799981|NCT03894969|10800879|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0
6799982|NCT03894969|10800880|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2
6799983|NCT03894969|10800881|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1
6799984|NCT03894969|10800877|FG000|Overall Study|Solicited Adverse Event|0
6799985|NCT03894969|10800878|FG001|Overall Study|Solicited Adverse Event|1
6799986|NCT03894969|10800879|FG002|Overall Study|Solicited Adverse Event|0
6799987|NCT03894969|10800880|FG003|Overall Study|Solicited Adverse Event|0
6799988|NCT03894969|10800881|FG004|Overall Study|Solicited Adverse Event|0
6799989|NCT03464136|10800906|FG000|Overall Study|Lost to Follow-up|5
6799990|NCT03464136|10800907|FG001|Overall Study|Lost to Follow-up|8
6799991|NCT03464136|10800906|FG000|Overall Study|Withdrawal by Subject|16
6799992|NCT03464136|10800907|FG001|Overall Study|Withdrawal by Subject|13
6799993|NCT03464136|10800906|FG000|Overall Study|Death|1
6799994|NCT03464136|10800907|FG001|Overall Study|Death|0
6799995|NCT03464136|10800906|FG000|Overall Study|Other|8
6799996|NCT03464136|10800907|FG001|Overall Study|Other|4
6799997|NCT03338816|10800915|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0
6799998|NCT03338816|10800916|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0
6799999|NCT03338816|10800917|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2
6800000|NCT03338816|10800918|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0
6800001|NCT03338816|10800915|FG000|6-Month DB + Open-Label Extension Period|Death|0
6800002|NCT03338816|10800916|FG001|6-Month DB + Open-Label Extension Period|Death|0
6800003|NCT03338816|10800917|FG002|6-Month DB + Open-Label Extension Period|Death|0
6800004|NCT03338816|10800918|FG003|6-Month DB + Open-Label Extension Period|Death|1
6800005|NCT03338816|10800915|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0
6800006|NCT03338816|10800916|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0
6800007|NCT03338816|10800917|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1
6800008|NCT03338816|10800918|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0
6800009|NCT03338816|10800915|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0
6800010|NCT03338816|10800916|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0
6800011|NCT03338816|10800917|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1
6800012|NCT03338816|10800918|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0
6800013|NCT03338816|10800915|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0
6800014|NCT03338816|10800916|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0
6800015|NCT03338816|10800917|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1
6800016|NCT03338816|10800918|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1
6800017|NCT03338816|10800915|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0
6800018|NCT03338816|10800916|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0
6800019|NCT03338816|10800917|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3
6800020|NCT03338816|10800918|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3
6800021|NCT03338816|10800915|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0
6800022|NCT03338816|10800916|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0
6800023|NCT03338816|10800917|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0
6800024|NCT03338816|10800918|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1
6800025|NCT03317496|10800940|FG000|Phase 1b Lead-in: Treatment|Adverse Event|2
6800026|NCT03317496|10800941|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4
6800027|NCT03317496|10800942|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1
6800028|NCT03317496|10800943|FG003|Phase 1b Lead-in: Treatment|Adverse Event|0
6800029|NCT03317496|10800944|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0
6800030|NCT03317496|10800940|FG000|Phase 1b Lead-in: Treatment|Physician Decision|1
6800031|NCT03317496|10800941|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1
6800032|NCT03317496|10800942|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0
6800033|NCT03317496|10800943|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0
6800034|NCT03317496|10800944|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0
6800035|NCT03317496|10800940|FG000|Phase 1b Lead-in: Treatment|Death|0
6800036|NCT03317496|10800941|FG001|Phase 1b Lead-in: Treatment|Death|0
6800037|NCT03317496|10800942|FG002|Phase 1b Lead-in: Treatment|Death|1
6800038|NCT03317496|10800943|FG003|Phase 1b Lead-in: Treatment|Death|0
6800039|NCT03317496|10800944|FG004|Phase 1b Lead-in: Treatment|Death|0
6800040|NCT03317496|10800940|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1
6800041|NCT03317496|10800941|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6
6800042|NCT03317496|10800942|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3
6800043|NCT03317496|10800943|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4
6800044|NCT03317496|10800944|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0
6800045|NCT03317496|10800940|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0
6800046|NCT03317496|10800941|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0
6800047|NCT03317496|10800942|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1
6800048|NCT03317496|10800943|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0
6800049|NCT03317496|10800944|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0
6800050|NCT03317496|10800940|FG000|Phase 1b Lead-in: Treatment|Other|0
6800051|NCT03317496|10800941|FG001|Phase 1b Lead-in: Treatment|Other|1
6800052|NCT03317496|10800942|FG002|Phase 1b Lead-in: Treatment|Other|0
6800053|NCT03317496|10800943|FG003|Phase 1b Lead-in: Treatment|Other|0
6800054|NCT03317496|10800944|FG004|Phase 1b Lead-in: Treatment|Other|0
6800055|NCT03317496|10800940|FG000|Phase 1b Lead-in: Treatment|Ongoing|2
6800056|NCT03317496|10800941|FG001|Phase 1b Lead-in: Treatment|Ongoing|1
6800057|NCT03317496|10800942|FG002|Phase 1b Lead-in: Treatment|Ongoing|0
6800058|NCT03317496|10800943|FG003|Phase 1b Lead-in: Treatment|Ongoing|2
6800059|NCT03317496|10800944|FG004|Phase 1b Lead-in: Treatment|Ongoing|0
6800060|NCT03317496|10800940|FG000|Phase 1b Lead-in: Follow-up|Death|2
6800061|NCT03317496|10800941|FG001|Phase 1b Lead-in: Follow-up|Death|7
6800062|NCT03317496|10800942|FG002|Phase 1b Lead-in: Follow-up|Death|4
6800063|NCT03317496|10800943|FG003|Phase 1b Lead-in: Follow-up|Death|3
6800064|NCT03317496|10800944|FG004|Phase 1b Lead-in: Follow-up|Death|0
6800065|NCT03317496|10800940|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1
6800066|NCT03317496|10800941|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0
6800067|NCT03317496|10800942|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0
6800068|NCT03317496|10800943|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0
6800069|NCT03317496|10800944|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0
6800070|NCT03317496|10800940|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0
6800071|NCT03317496|10800941|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0
6800072|NCT03317496|10800942|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1
6800073|NCT03317496|10800943|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0
6800074|NCT03317496|10800944|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0
6800075|NCT03317496|10800940|FG000|Phase 1b Lead-in: Follow-up|Other|1
6800076|NCT03317496|10800941|FG001|Phase 1b Lead-in: Follow-up|Other|3
6800077|NCT03317496|10800942|FG002|Phase 1b Lead-in: Follow-up|Other|0
6800078|NCT03317496|10800943|FG003|Phase 1b Lead-in: Follow-up|Other|1
6800079|NCT03317496|10800944|FG004|Phase 1b Lead-in: Follow-up|Other|0
6800080|NCT03317496|10800940|FG000|Phase 1b Lead-in: Follow-up|Ongoing|0
6800081|NCT03317496|10800941|FG001|Phase 1b Lead-in: Follow-up|Ongoing|1
6800082|NCT03317496|10800942|FG002|Phase 1b Lead-in: Follow-up|Ongoing|0
6800083|NCT03317496|10800943|FG003|Phase 1b Lead-in: Follow-up|Ongoing|0
6800084|NCT03317496|10800944|FG004|Phase 1b Lead-in: Follow-up|Ongoing|0
6800085|NCT03317496|10800940|FG000|Phase 2: Treatment|Adverse Event|0
6800086|NCT03317496|10800941|FG001|Phase 2: Treatment|Adverse Event|0
6800087|NCT03317496|10800942|FG002|Phase 2: Treatment|Adverse Event|0
6800088|NCT03317496|10800943|FG003|Phase 2: Treatment|Adverse Event|0
6800089|NCT03317496|10800944|FG004|Phase 2: Treatment|Adverse Event|4
6800090|NCT03317496|10800940|FG000|Phase 2: Treatment|Death|0
6800091|NCT03317496|10800941|FG001|Phase 2: Treatment|Death|0
6800092|NCT03317496|10800942|FG002|Phase 2: Treatment|Death|0
6800093|NCT03317496|10800943|FG003|Phase 2: Treatment|Death|0
6800094|NCT03317496|10800944|FG004|Phase 2: Treatment|Death|1
6800095|NCT03317496|10800940|FG000|Phase 2: Treatment|Physician Decision|0
6800096|NCT03317496|10800941|FG001|Phase 2: Treatment|Physician Decision|0
6800097|NCT03317496|10800942|FG002|Phase 2: Treatment|Physician Decision|0
6800098|NCT03317496|10800943|FG003|Phase 2: Treatment|Physician Decision|0
6800099|NCT03317496|10800944|FG004|Phase 2: Treatment|Physician Decision|1
6800100|NCT03317496|10800940|FG000|Phase 2: Treatment|Progressive Disease|0
6800101|NCT03317496|10800941|FG001|Phase 2: Treatment|Progressive Disease|0
6800102|NCT03317496|10800942|FG002|Phase 2: Treatment|Progressive Disease|0
6800103|NCT03317496|10800943|FG003|Phase 2: Treatment|Progressive Disease|0
6800104|NCT03317496|10800944|FG004|Phase 2: Treatment|Progressive Disease|18
6800105|NCT03317496|10800940|FG000|Phase 2: Treatment|Withdrawal by Subject|0
6800106|NCT03317496|10800941|FG001|Phase 2: Treatment|Withdrawal by Subject|0
6800107|NCT03317496|10800942|FG002|Phase 2: Treatment|Withdrawal by Subject|0
6800108|NCT03317496|10800943|FG003|Phase 2: Treatment|Withdrawal by Subject|0
6800109|NCT03317496|10800944|FG004|Phase 2: Treatment|Withdrawal by Subject|1
6800110|NCT03317496|10800940|FG000|Phase 2: Treatment|Other|0
6800111|NCT03317496|10800941|FG001|Phase 2: Treatment|Other|0
6800112|NCT03317496|10800942|FG002|Phase 2: Treatment|Other|0
6800113|NCT03317496|10800943|FG003|Phase 2: Treatment|Other|0
6800114|NCT03317496|10800944|FG004|Phase 2: Treatment|Other|2
6800115|NCT03317496|10800940|FG000|Phase 2: Treatment|Ongoing|0
6800116|NCT03317496|10800941|FG001|Phase 2: Treatment|Ongoing|0
6800117|NCT03317496|10800942|FG002|Phase 2: Treatment|Ongoing|0
6800118|NCT03317496|10800943|FG003|Phase 2: Treatment|Ongoing|0
6800119|NCT03317496|10800944|FG004|Phase 2: Treatment|Ongoing|8
6800120|NCT03317496|10800940|FG000|Phase 2: Follow-up|Death|0
6800121|NCT03317496|10800941|FG001|Phase 2: Follow-up|Death|0
6800122|NCT03317496|10800942|FG002|Phase 2: Follow-up|Death|0
6800123|NCT03317496|10800943|FG003|Phase 2: Follow-up|Death|0
6800124|NCT03317496|10800944|FG004|Phase 2: Follow-up|Death|16
6800125|NCT03317496|10800940|FG000|Phase 2: Follow-up|Withdrawal by Subject|0
6800126|NCT03317496|10800941|FG001|Phase 2: Follow-up|Withdrawal by Subject|0
6800127|NCT03317496|10800942|FG002|Phase 2: Follow-up|Withdrawal by Subject|0
6800128|NCT03317496|10800943|FG003|Phase 2: Follow-up|Withdrawal by Subject|0
6800129|NCT03317496|10800944|FG004|Phase 2: Follow-up|Withdrawal by Subject|1
6800130|NCT03317496|10800940|FG000|Phase 2: Follow-up|Lost to Follow-up|0
6800131|NCT03317496|10800941|FG001|Phase 2: Follow-up|Lost to Follow-up|0
6800132|NCT03317496|10800942|FG002|Phase 2: Follow-up|Lost to Follow-up|0
6800133|NCT03317496|10800943|FG003|Phase 2: Follow-up|Lost to Follow-up|0
6800134|NCT03317496|10800944|FG004|Phase 2: Follow-up|Lost to Follow-up|1
6800135|NCT03317496|10800940|FG000|Phase 2: Follow-up|Other|0
6800136|NCT03317496|10800941|FG001|Phase 2: Follow-up|Other|0
6800137|NCT03317496|10800942|FG002|Phase 2: Follow-up|Other|0
6800138|NCT03317496|10800943|FG003|Phase 2: Follow-up|Other|0
6800139|NCT03317496|10800944|FG004|Phase 2: Follow-up|Other|6
6800140|NCT03317496|10800940|FG000|Phase 2: Follow-up|Ongoing|0
6800141|NCT03317496|10800941|FG001|Phase 2: Follow-up|Ongoing|0
6800142|NCT03317496|10800942|FG002|Phase 2: Follow-up|Ongoing|0
6800143|NCT03317496|10800943|FG003|Phase 2: Follow-up|Ongoing|0
6800144|NCT03317496|10800944|FG004|Phase 2: Follow-up|Ongoing|1
6800145|NCT03260894|10800957|FG000|Overall Study|Death|6
6800146|NCT03260894|10800958|FG001|Overall Study|Death|8
6800147|NCT03260894|10800957|FG000|Overall Study|Withdrawal by Subject|4
6800148|NCT03260894|10800958|FG001|Overall Study|Withdrawal by Subject|11
6800149|NCT03260894|10800957|FG000|Overall Study|On-going at clinical cut off date|36
6800150|NCT03260894|10800958|FG001|Overall Study|On-going at clinical cut off date|31
6800151|NCT03215810|10800964|FG000|Overall Study|Still responding to nivolumab|1
6800152|NCT03215810|10800964|FG000|Overall Study|Insufficient TIL growth|1
6800153|NCT03215810|10800964|FG000|Overall Study|Decline in performance status|1
6800154|NCT03215810|10800964|FG000|Overall Study|Withdrawal by Subject|1
6800155|NCT03067129|10800985|FG000|Overall Study|Ongoing|45
6800156|NCT03067129|10800986|FG001|Overall Study|Ongoing|28
6800157|NCT03067129|10800987|FG002|Overall Study|Ongoing|27
6800158|NCT03067129|10800988|FG003|Overall Study|Ongoing|23
6800159|NCT03067129|10800985|FG000|Overall Study|Partially dosed; refused to swallow entire dose|0
6800160|NCT03067129|10800986|FG001|Overall Study|Partially dosed; refused to swallow entire dose|0
6800161|NCT03067129|10800987|FG002|Overall Study|Partially dosed; refused to swallow entire dose|0
6800162|NCT03067129|10800988|FG003|Overall Study|Partially dosed; refused to swallow entire dose|1
6800163|NCT03053102|10801006|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1
6800164|NCT03053102|10801006|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1
6800165|NCT02937818|10801019|FG000|Overall Study|Participants decision|1
6800166|NCT02937818|10801020|FG001|Overall Study|Participants decision|0
6800167|NCT02937818|10801021|FG002|Overall Study|Participants decision|1
6800168|NCT02937818|10801022|FG003|Overall Study|Participants decision|1
6800169|NCT02937818|10801019|FG000|Overall Study|Adverse Event|2
6800170|NCT02937818|10801020|FG001|Overall Study|Adverse Event|4
6800171|NCT02937818|10801021|FG002|Overall Study|Adverse Event|1
6800172|NCT02937818|10801022|FG003|Overall Study|Adverse Event|1
6800173|NCT02937818|10801019|FG000|Overall Study|Disease progression|17
6800174|NCT02937818|10801020|FG001|Overall Study|Disease progression|14
6800175|NCT02937818|10801021|FG002|Overall Study|Disease progression|7
6800176|NCT02937818|10801022|FG003|Overall Study|Disease progression|18
6800177|NCT02937818|10801019|FG000|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|1
6800178|NCT02937818|10801020|FG001|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|2
6800179|NCT02937818|10801021|FG002|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|0
6800180|NCT02937818|10801022|FG003|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|0
6800181|NCT02937818|10801019|FG000|Overall Study|Condition under investigation worsened|0
6800182|NCT02937818|10801020|FG001|Overall Study|Condition under investigation worsened|0
6800183|NCT02937818|10801021|FG002|Overall Study|Condition under investigation worsened|1
6800184|NCT02937818|10801022|FG003|Overall Study|Condition under investigation worsened|0
6800185|NCT02937818|10801019|FG000|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0
6800186|NCT02937818|10801020|FG001|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0
6800187|NCT02937818|10801021|FG002|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0
6800188|NCT02937818|10801022|FG003|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|1
6800189|NCT02875860|10801041|FG000|Overall Study|Withdrawal by Subject|0
6800190|NCT02875860|10801042|FG001|Overall Study|Withdrawal by Subject|1
6800191|NCT02833844|10801050|FG000|Double-Blind Period|Withdrawal by Subject|2
6800192|NCT02833844|10801051|FG001|Double-Blind Period|Withdrawal by Subject|3
6800193|NCT02833844|10801050|FG000|Double-Blind Period|Protocol Violation|0
6800194|NCT02833844|10801051|FG001|Double-Blind Period|Protocol Violation|4
6800195|NCT02833844|10801050|FG000|Open-Label Period|Death|0
6800196|NCT02833844|10801051|FG001|Open-Label Period|Death|2
6800197|NCT02833844|10801050|FG000|Open-Label Period|Lost to Follow-up|1
6800198|NCT02833844|10801051|FG001|Open-Label Period|Lost to Follow-up|0
6800199|NCT02833844|10801050|FG000|Open-Label Period|Withdrawal by Subject|1
6800200|NCT02833844|10801051|FG001|Open-Label Period|Withdrawal by Subject|0
6800201|NCT02779855|10801062|FG000|Overall Study|Withdrawal by patient prior to treatment|1
6800202|NCT02779855|10801063|FG001|Overall Study|Withdrawal by patient prior to treatment|0
6800203|NCT02779855|10801064|FG002|Overall Study|Withdrawal by patient prior to treatment|0
6800204|NCT02663271|10801073|FG000|Overall Study|Withdrawal by Subject|5
6800205|NCT02663271|10801073|FG000|Overall Study|Lack of Efficacy|1
6800206|NCT02573493|10801090|FG000|Overall Study|Determined to not be eligible after enrollment|0
6800207|NCT02573493|10801091|FG001|Overall Study|Determined to not be eligible after enrollment|0
6800208|NCT02573493|10801092|FG002|Overall Study|Determined to not be eligible after enrollment|0
6800209|NCT02573493|10801093|FG003|Overall Study|Determined to not be eligible after enrollment|1
6800210|NCT02279173|10801126|FG000|Overall Study|Protocol-specified Criteria|67
6800211|NCT02279173|10801126|FG000|Overall Study|Withdrawal by Subject|20
6800212|NCT02279173|10801126|FG000|Overall Study|Decision by Sponsor|4
6800213|NCT02279173|10801126|FG000|Overall Study|Lost to Follow-up|3
6800214|NCT02258451|10801134|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|88
6800215|NCT02258451|10801135|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|95
6800216|NCT02258451|10801134|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|6
6800217|NCT02258451|10801135|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7
6800218|NCT02258451|10801134|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8
6800219|NCT02258451|10801135|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1
6800220|NCT02258451|10801134|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8
6800221|NCT02258451|10801135|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6
6800222|NCT02258451|10801134|FG000|Overall Study|Death|4
6800223|NCT02258451|10801135|FG001|Overall Study|Death|3
6800224|NCT02258451|10801134|FG000|Overall Study|Withdrawal by Subject|21
6800225|NCT02258451|10801135|FG001|Overall Study|Withdrawal by Subject|12
6800226|NCT02258451|10801134|FG000|Overall Study|Discontinuation all treatment due to TS-1 started|1
6800227|NCT02258451|10801135|FG001|Overall Study|Discontinuation all treatment due to TS-1 started|0
6800228|NCT02258451|10801134|FG000|Overall Study|Discontinuation all treatment due to event point reached|1
6800229|NCT02258451|10801135|FG001|Overall Study|Discontinuation all treatment due to event point reached|1
6800230|NCT02258451|10801134|FG000|Overall Study|Physician Decision|0
6800231|NCT02258451|10801135|FG001|Overall Study|Physician Decision|2
6800232|NCT02258451|10801134|FG000|Overall Study|Never treated|2
6800233|NCT02258451|10801135|FG001|Overall Study|Never treated|3
6800234|NCT02258451|10801134|FG000|Overall Study|Ongoing with any Treatment of radium 223 or placebo, exemestane, or everolimus|3
6800235|NCT02258451|10801135|FG001|Overall Study|Ongoing with any Treatment of radium 223 or placebo, exemestane, or everolimus|11
6800236|NCT02186834|10801143|FG000|Dose Escalation|Death|0
6800237|NCT02186834|10801144|FG001|Dose Escalation|Death|0
6800238|NCT02186834|10801145|FG002|Dose Escalation|Death|0
6800239|NCT02186834|10801146|FG003|Dose Escalation|Death|1
6800240|NCT02186834|10801147|FG004|Dose Escalation|Death|0
6800241|NCT02186834|10801148|FG005|Dose Escalation|Death|0
6800242|NCT02186834|10801143|FG000|Treatment at RP2D|Died prior to treatment|0
6800243|NCT02186834|10801144|FG001|Treatment at RP2D|Died prior to treatment|0
6800244|NCT02186834|10801145|FG002|Treatment at RP2D|Died prior to treatment|0
6800245|NCT02186834|10801146|FG003|Treatment at RP2D|Died prior to treatment|0
6800246|NCT02186834|10801147|FG004|Treatment at RP2D|Died prior to treatment|0
6800247|NCT02186834|10801148|FG005|Treatment at RP2D|Died prior to treatment|1
6800248|NCT02163733|10801159|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0
6800249|NCT02163733|10801160|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0
6800250|NCT02163733|10801161|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5
6800251|NCT02163733|10801159|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
6800252|NCT02163733|10801160|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
6800253|NCT02163733|10801161|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19
6800254|NCT01844505|10801171|FG000|Overall Study|Disease progression|170
6800255|NCT01844505|10801172|FG001|Overall Study|Disease progression|88
6800256|NCT01844505|10801173|FG002|Overall Study|Disease progression|224
6800257|NCT01844505|10801171|FG000|Overall Study|Study drug toxicity|40
6800258|NCT01844505|10801172|FG001|Overall Study|Study drug toxicity|131
6800259|NCT01844505|10801173|FG002|Overall Study|Study drug toxicity|50
6800260|NCT01844505|10801171|FG000|Overall Study|Death|1
6800261|NCT01844505|10801172|FG001|Overall Study|Death|3
6800262|NCT01844505|10801173|FG002|Overall Study|Death|1
6800263|NCT01844505|10801171|FG000|Overall Study|Adverse event unrelated to study drug|7
6800264|NCT01844505|10801172|FG001|Overall Study|Adverse event unrelated to study drug|15
6800265|NCT01844505|10801173|FG002|Overall Study|Adverse event unrelated to study drug|6
6800266|NCT01844505|10801171|FG000|Overall Study|Subject request discontinue treatment|17
6800267|NCT01844505|10801172|FG001|Overall Study|Subject request discontinue treatment|14
6800268|NCT01844505|10801173|FG002|Overall Study|Subject request discontinue treatment|8
6800269|NCT01844505|10801171|FG000|Overall Study|Withdrawal by Subject|0
6800270|NCT01844505|10801172|FG001|Overall Study|Withdrawal by Subject|3
6800271|NCT01844505|10801173|FG002|Overall Study|Withdrawal by Subject|0
6800272|NCT01844505|10801171|FG000|Overall Study|Lost to Follow-up|1
6800273|NCT01844505|10801172|FG001|Overall Study|Lost to Follow-up|0
6800274|NCT01844505|10801173|FG002|Overall Study|Lost to Follow-up|0
6800275|NCT01844505|10801171|FG000|Overall Study|Maximum clinical benefit|8
6800276|NCT01844505|10801172|FG001|Overall Study|Maximum clinical benefit|11
6800277|NCT01844505|10801173|FG002|Overall Study|Maximum clinical benefit|2
6800278|NCT01844505|10801171|FG000|Overall Study|Poor/non-compliance|1
6800279|NCT01844505|10801172|FG001|Overall Study|Poor/non-compliance|1
6800280|NCT01844505|10801173|FG002|Overall Study|Poor/non-compliance|1
6800281|NCT01844505|10801171|FG000|Overall Study|Subject no longer meets criteria|0
6800282|NCT01844505|10801172|FG001|Overall Study|Subject no longer meets criteria|1
6800283|NCT01844505|10801173|FG002|Overall Study|Subject no longer meets criteria|0
6800284|NCT01844505|10801171|FG000|Overall Study|Other Reasons|4
6800285|NCT01844505|10801172|FG001|Overall Study|Other Reasons|2
6800286|NCT01844505|10801173|FG002|Overall Study|Other Reasons|2
6800287|NCT01844505|10801171|FG000|Overall Study|Not Reported|0
6800288|NCT01844505|10801172|FG001|Overall Study|Not Reported|0
6800289|NCT01844505|10801173|FG002|Overall Study|Not Reported|1
6800290|NCT01781390|10801184|FG000|Overall Study|Withdrawal of Consent|0
6800291|NCT01781390|10801185|FG001|Overall Study|Withdrawal of Consent|3
6800292|NCT01781390|10801186|FG002|Overall Study|Withdrawal of Consent|1
6800293|NCT01781390|10801184|FG000|Overall Study|Lost to Follow-up|1
6800294|NCT01781390|10801185|FG001|Overall Study|Lost to Follow-up|1
6800295|NCT01781390|10801186|FG002|Overall Study|Lost to Follow-up|1
6800296|NCT01781390|10801184|FG000|Overall Study|Adverse Event|1
6800297|NCT01781390|10801185|FG001|Overall Study|Adverse Event|2
6800298|NCT01781390|10801186|FG002|Overall Study|Adverse Event|1
6800299|NCT01781390|10801184|FG000|Overall Study|Participants who were Randomized and Not Treated|1
6800300|NCT01781390|10801185|FG001|Overall Study|Participants who were Randomized and Not Treated|1
6800301|NCT01781390|10801186|FG002|Overall Study|Participants who were Randomized and Not Treated|1
6800302|NCT01701674|10801194|FG000|Overall Study|Unable to safely complete treatment|1
6800303|NCT01640301|10801200|FG000|Overall Study|Death|0
6800304|NCT01640301|10801201|FG001|Overall Study|Death|8
6800305|NCT01575860|10801209|FG000|Overall Study|Withdrawal by Subject|1
6800306|NCT01575860|10801209|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1
6800307|NCT01402908|10801216|FG000|Overall Study|Withdrawal by Subject|30
6800308|NCT01402908|10801217|FG001|Overall Study|Withdrawal by Subject|17
6800309|NCT01402908|10801216|FG000|Overall Study|Lost to Follow-up|3
6800310|NCT01402908|10801217|FG001|Overall Study|Lost to Follow-up|1
6800311|NCT01402908|10801216|FG000|Overall Study|Physician Decision|1
6800312|NCT01402908|10801217|FG001|Overall Study|Physician Decision|0
6800313|NCT01397201|10801228|FG000|Overall Study|Not treated|0
6800314|NCT01397201|10801229|FG001|Overall Study|Not treated|0
6800315|NCT01397201|10801230|FG002|Overall Study|Not treated|1
6800316|NCT01397201|10801231|FG003|Overall Study|Not treated|0
6800317|NCT01397201|10801232|FG004|Overall Study|Not treated|0
6800318|NCT01397201|10801228|FG000|Overall Study|Not yet defined|3
6800319|NCT01397201|10801229|FG001|Overall Study|Not yet defined|6
6800320|NCT01397201|10801230|FG002|Overall Study|Not yet defined|5
6800321|NCT01397201|10801231|FG003|Overall Study|Not yet defined|5
6800322|NCT01397201|10801232|FG004|Overall Study|Not yet defined|4
6800323|NCT01397201|10801228|FG000|Overall Study|Adverse Event|2
6800324|NCT01397201|10801229|FG001|Overall Study|Adverse Event|0
6800325|NCT01397201|10801230|FG002|Overall Study|Adverse Event|0
6800326|NCT01397201|10801231|FG003|Overall Study|Adverse Event|0
6800327|NCT01397201|10801232|FG004|Overall Study|Adverse Event|0
6800328|NCT01397162|10801249|FG000|Overall Study|Adverse Event|4
6800329|NCT01397162|10801250|FG001|Overall Study|Adverse Event|0
6800330|NCT01397162|10801251|FG002|Overall Study|Adverse Event|0
6800331|NCT01397162|10801252|FG003|Overall Study|Adverse Event|0
6800332|NCT01397162|10801253|FG004|Overall Study|Adverse Event|0
6800333|NCT01397162|10801249|FG000|Overall Study|Not yet defined|3
6800334|NCT01397162|10801250|FG001|Overall Study|Not yet defined|4
6800335|NCT01397162|10801251|FG002|Overall Study|Not yet defined|3
6800336|NCT01397162|10801252|FG003|Overall Study|Not yet defined|5
6800337|NCT01397162|10801253|FG004|Overall Study|Not yet defined|3
6800338|NCT01396278|10801275|FG000|Overall Study|Adverse Event|0
6800339|NCT01396278|10801276|FG001|Overall Study|Adverse Event|0
6800340|NCT01396278|10801277|FG002|Overall Study|Adverse Event|0
6800341|NCT01396278|10801278|FG003|Overall Study|Adverse Event|2
6800342|NCT01396278|10801279|FG004|Overall Study|Adverse Event|0
6800343|NCT01396278|10801275|FG000|Overall Study|Withdraw due to trial termination|2
6800344|NCT01396278|10801276|FG001|Overall Study|Withdraw due to trial termination|1
6800345|NCT01396278|10801277|FG002|Overall Study|Withdraw due to trial termination|1
6800346|NCT01396278|10801278|FG003|Overall Study|Withdraw due to trial termination|0
6800347|NCT01396278|10801279|FG004|Overall Study|Withdraw due to trial termination|2
6800348|NCT00130442|10801317|FG000|Overall Study|Withdrawal by Subject|0
6800349|NCT00130442|10801318|FG001|Overall Study|Withdrawal by Subject|1
6800350|NCT00130442|10801317|FG000|Overall Study|did not meet criteria|1
6800351|NCT00130442|10801318|FG001|Overall Study|did not meet criteria|1
6809574|NCT00002558|10813330|FG000|Overall Study|Withdrawal by Subject|0
6809575|NCT00002558|10813331|FG001|Overall Study|Withdrawal by Subject|1
6809576|NCT00002597|10813339|FG000|Overall Study|Protocol Violation|19
6809577|NCT00002597|10813340|FG001|Overall Study|Protocol Violation|17
6809578|NCT00002597|10813339|FG000|Overall Study|Withdrawal by Subject|7
6809579|NCT00002597|10813340|FG001|Overall Study|Withdrawal by Subject|6
6809580|NCT00002651|10813354|FG000|Induction|Adverse Event|44
6809581|NCT00002651|10813355|FG001|Induction|Adverse Event|0
6809582|NCT00002651|10813356|FG002|Induction|Adverse Event|0
6809583|NCT00002651|10813354|FG000|Induction|Refusal unrelated to adverse event|50
6809584|NCT00002651|10813355|FG001|Induction|Refusal unrelated to adverse event|0
6809585|NCT00002651|10813356|FG002|Induction|Refusal unrelated to adverse event|0
6809586|NCT00002651|10813354|FG000|Induction|Progression/relapse|274
6809587|NCT00002651|10813355|FG001|Induction|Progression/relapse|0
6809588|NCT00002651|10813356|FG002|Induction|Progression/relapse|0
6809589|NCT00002651|10813354|FG000|Induction|Death|62
6809590|NCT00002651|10813355|FG001|Induction|Death|0
6809591|NCT00002651|10813356|FG002|Induction|Death|0
6809592|NCT00002651|10813354|FG000|Induction|Other|823
6809593|NCT00002651|10813355|FG001|Induction|Other|0
6809594|NCT00002651|10813356|FG002|Induction|Other|0
6809595|NCT00002651|10813354|FG000|Induction|not eligible|90
6809596|NCT00002651|10813355|FG001|Induction|not eligible|0
6809597|NCT00002651|10813356|FG002|Induction|not eligible|0
6809598|NCT00002651|10813354|FG000|Consolidation and Randomization|Adverse Event|0
6809599|NCT00002651|10813355|FG001|Consolidation and Randomization|Adverse Event|36
6809600|NCT00002651|10813356|FG002|Consolidation and Randomization|Adverse Event|14
6809601|NCT00002651|10813354|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0
6809602|NCT00002651|10813355|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53
6809603|NCT00002651|10813356|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75
6809604|NCT00002651|10813354|FG000|Consolidation and Randomization|Progression/relapse|0
6809605|NCT00002651|10813355|FG001|Consolidation and Randomization|Progression/relapse|295
6809606|NCT00002651|10813356|FG002|Consolidation and Randomization|Progression/relapse|298
6809607|NCT00002651|10813354|FG000|Consolidation and Randomization|Death|0
6809608|NCT00002651|10813355|FG001|Consolidation and Randomization|Death|38
6809609|NCT00002651|10813356|FG002|Consolidation and Randomization|Death|48
6809610|NCT00002651|10813354|FG000|Consolidation and Randomization|Other|0
6809611|NCT00002651|10813355|FG001|Consolidation and Randomization|Other|314
6809612|NCT00002651|10813356|FG002|Consolidation and Randomization|Other|313
6809613|NCT00002651|10813354|FG000|Consolidation and Randomization|not eligible|0
6809614|NCT00002651|10813355|FG001|Consolidation and Randomization|not eligible|102
6809615|NCT00002651|10813356|FG002|Consolidation and Randomization|not eligible|112
6809616|NCT00002766|10813366|FG000|Overall Study|Withdrawal by Subject|0
6809617|NCT00002766|10813367|FG001|Overall Study|Withdrawal by Subject|1
6809618|NCT00002766|10813366|FG000|Overall Study|Patient Not Treated|1
6809619|NCT00002766|10813367|FG001|Overall Study|Patient Not Treated|2
6809620|NCT00002766|10813366|FG000|Overall Study|Adverse Event|1
6809621|NCT00002766|10813367|FG001|Overall Study|Adverse Event|1
6809622|NCT00002766|10813366|FG000|Overall Study|Protocol Violation|1
6809623|NCT00002766|10813367|FG001|Overall Study|Protocol Violation|0
6809624|NCT00002842|10813373|FG000|Overall Study|ineligible for surgical resection|27
6809625|NCT00002850|10813380|FG000|Overall Study|Death|4
6809626|NCT00002850|10813381|FG001|Overall Study|Death|1
6800352|NCT04539262|10801334|FG000|Overall Study|Adverse Event|0
6800353|NCT04539262|10801335|FG001|Overall Study|Adverse Event|0
6800354|NCT04539262|10801336|FG002|Overall Study|Adverse Event|1
6800355|NCT04539262|10801337|FG003|Overall Study|Adverse Event|0
6800356|NCT04539262|10801338|FG004|Overall Study|Adverse Event|0
6800357|NCT04539262|10801339|FG005|Overall Study|Adverse Event|0
6800358|NCT04539262|10801340|FG006|Overall Study|Adverse Event|0
6800359|NCT04539262|10801341|FG007|Overall Study|Adverse Event|0
6800360|NCT04539262|10801334|FG000|Overall Study|Withdrew Consent|0
6800361|NCT04539262|10801335|FG001|Overall Study|Withdrew Consent|0
6800362|NCT04539262|10801336|FG002|Overall Study|Withdrew Consent|0
6800363|NCT04539262|10801337|FG003|Overall Study|Withdrew Consent|1
6800364|NCT04539262|10801338|FG004|Overall Study|Withdrew Consent|0
6800365|NCT04539262|10801339|FG005|Overall Study|Withdrew Consent|0
6800366|NCT04539262|10801340|FG006|Overall Study|Withdrew Consent|0
6800367|NCT04539262|10801341|FG007|Overall Study|Withdrew Consent|0
6800368|NCT04539262|10801334|FG000|Overall Study|Randomized, Not treated|0
6800369|NCT04539262|10801335|FG001|Overall Study|Randomized, Not treated|1
6800370|NCT04539262|10801336|FG002|Overall Study|Randomized, Not treated|0
6800371|NCT04539262|10801337|FG003|Overall Study|Randomized, Not treated|0
6800372|NCT04539262|10801338|FG004|Overall Study|Randomized, Not treated|0
6800373|NCT04539262|10801339|FG005|Overall Study|Randomized, Not treated|0
6800374|NCT04539262|10801340|FG006|Overall Study|Randomized, Not treated|1
6800375|NCT04539262|10801341|FG007|Overall Study|Randomized, Not treated|0
6800376|NCT04482439|10801362|FG000|Overall Study|Lost to Follow-up|1
6800377|NCT04482439|10801362|FG000|Overall Study|Unrelated illness|1
6800378|NCT04404725|10801371|FG000|First Intervention|Withdrawal by Subject|0
6800379|NCT04404725|10801372|FG001|First Intervention|Withdrawal by Subject|2
6800380|NCT04404725|10801371|FG000|Second Intervention|Adverse Event|1
6800381|NCT04404725|10801372|FG001|Second Intervention|Adverse Event|1
6800382|NCT04404725|10801371|FG000|Second Intervention|Withdrawal by Subject|0
6800383|NCT04404725|10801372|FG001|Second Intervention|Withdrawal by Subject|1
6800384|NCT04382586|10801380|FG000|Overall Study|Death|3
6800385|NCT04382586|10801381|FG001|Overall Study|Death|4
6800386|NCT04382586|10801380|FG000|Overall Study|Lost to Follow-up|11
6800387|NCT04382586|10801381|FG001|Overall Study|Lost to Follow-up|8
6800388|NCT04382586|10801380|FG000|Overall Study|Withdrawal by Subject|3
6800389|NCT04382586|10801381|FG001|Overall Study|Withdrawal by Subject|1
6800390|NCT04382586|10801380|FG000|Overall Study|Physician Decision|0
6800391|NCT04382586|10801381|FG001|Overall Study|Physician Decision|3
6800392|NCT04348656|10801389|FG000|Overall Study|Withdrawal by Subject|2
6800393|NCT04348656|10801390|FG001|Overall Study|Withdrawal by Subject|0
6800394|NCT04348656|10801389|FG000|Overall Study|Lost to Follow-up|11
6800395|NCT04348656|10801390|FG001|Overall Study|Lost to Follow-up|6
6800396|NCT03950674|10801421|FG000|Overall Study|Death|3
6800397|NCT03950674|10801422|FG001|Overall Study|Death|7
6800398|NCT03950674|10801421|FG000|Overall Study|Ongoing in Study|22
6800399|NCT03950674|10801422|FG001|Overall Study|Ongoing in Study|8
6800400|NCT03847974|10801433|FG000|Overall Study|relocated out of region|3
6800401|NCT03847974|10801433|FG000|Overall Study|Withdrawal by Subject|2
6800402|NCT03847974|10801433|FG000|Overall Study|Adverse Event|1
6800406|NCT03671148|10801466|FG000|Overall Study|Adverse Event|3
6800407|NCT03671148|10801467|FG001|Overall Study|Adverse Event|2
6800408|NCT03671148|10801466|FG000|Overall Study|Withdrawal by Subject|8
6800409|NCT03671148|10801467|FG001|Overall Study|Withdrawal by Subject|2
6800410|NCT03671148|10801466|FG000|Overall Study|Lost to Follow-up|1
6800411|NCT03671148|10801467|FG001|Overall Study|Lost to Follow-up|2
6800412|NCT03671148|10801466|FG000|Overall Study|Lack of Efficacy|7
6800413|NCT03671148|10801467|FG001|Overall Study|Lack of Efficacy|2
6800414|NCT03671148|10801466|FG000|Overall Study|COVID-19 Logistical Restrictions|0
6800415|NCT03671148|10801467|FG001|Overall Study|COVID-19 Logistical Restrictions|1
6800416|NCT03671148|10801466|FG000|Overall Study|Other|1
6800417|NCT03671148|10801467|FG001|Overall Study|Other|0
6800418|NCT03671148|10801466|FG000|Overall Study|Incomplete Randomization Visit|1
6800419|NCT03671148|10801467|FG001|Overall Study|Incomplete Randomization Visit|0
6800420|NCT03607487|10801490|FG000|Overall Study|Withdrawal by Subject|2
6800421|NCT03607487|10801491|FG001|Overall Study|Withdrawal by Subject|0
6800422|NCT03607487|10801492|FG002|Overall Study|Withdrawal by Subject|0
6800423|NCT03607487|10801493|FG003|Overall Study|Withdrawal by Subject|1
6800424|NCT03529773|10801558|FG000|Overall Study|Adverse Event|0
6800425|NCT03529773|10801559|FG001|Overall Study|Adverse Event|0
6800426|NCT03529773|10801560|FG002|Overall Study|Adverse Event|0
6800427|NCT03529773|10801561|FG003|Overall Study|Adverse Event|0
6800428|NCT03529773|10801562|FG004|Overall Study|Adverse Event|0
6800429|NCT03529773|10801563|FG005|Overall Study|Adverse Event|0
6800430|NCT03529773|10801564|FG006|Overall Study|Adverse Event|0
6800431|NCT03529773|10801565|FG007|Overall Study|Adverse Event|0
6800432|NCT03529773|10801566|FG008|Overall Study|Adverse Event|0
6800433|NCT03529773|10801567|FG009|Overall Study|Adverse Event|0
6800434|NCT03529773|10801568|FG010|Overall Study|Adverse Event|0
6800435|NCT03529773|10801569|FG011|Overall Study|Adverse Event|0
6800436|NCT03529773|10801570|FG012|Overall Study|Adverse Event|0
6800437|NCT03529773|10801571|FG013|Overall Study|Adverse Event|0
6800438|NCT03529773|10801572|FG014|Overall Study|Adverse Event|0
6800439|NCT03529773|10801573|FG015|Overall Study|Adverse Event|0
6800440|NCT03529773|10801574|FG016|Overall Study|Adverse Event|0
6800441|NCT03529773|10801575|FG017|Overall Study|Adverse Event|0
6800442|NCT03529773|10801576|FG018|Overall Study|Adverse Event|0
6800443|NCT03529773|10801577|FG019|Overall Study|Adverse Event|0
6800444|NCT03529773|10801578|FG020|Overall Study|Adverse Event|0
6800445|NCT03529773|10801579|FG021|Overall Study|Adverse Event|0
6800446|NCT03529773|10801580|FG022|Overall Study|Adverse Event|0
6800447|NCT03529773|10801581|FG023|Overall Study|Adverse Event|0
6800448|NCT03529773|10801582|FG024|Overall Study|Adverse Event|0
6800449|NCT03529773|10801583|FG025|Overall Study|Adverse Event|0
6800450|NCT03529773|10801584|FG026|Overall Study|Adverse Event|0
6800451|NCT03529773|10801585|FG027|Overall Study|Adverse Event|0
6800452|NCT03529773|10801586|FG028|Overall Study|Adverse Event|0
6800453|NCT03529773|10801587|FG029|Overall Study|Adverse Event|0
6800454|NCT03529773|10801588|FG030|Overall Study|Adverse Event|1
6800455|NCT03529773|10801589|FG031|Overall Study|Adverse Event|0
6800456|NCT03529773|10801590|FG032|Overall Study|Adverse Event|0
6800457|NCT03529773|10801591|FG033|Overall Study|Adverse Event|0
6800458|NCT03529773|10801592|FG034|Overall Study|Adverse Event|0
6800459|NCT03529773|10801593|FG035|Overall Study|Adverse Event|1
6800460|NCT03529773|10801594|FG036|Overall Study|Adverse Event|0
6800461|NCT03529773|10801595|FG037|Overall Study|Adverse Event|0
6800462|NCT03529773|10801596|FG038|Overall Study|Adverse Event|1
6800463|NCT03529773|10801597|FG039|Overall Study|Adverse Event|1
6800464|NCT03529773|10801558|FG000|Overall Study|Death|0
6800465|NCT03529773|10801559|FG001|Overall Study|Death|0
6800466|NCT03529773|10801560|FG002|Overall Study|Death|0
6800467|NCT03529773|10801561|FG003|Overall Study|Death|0
6800468|NCT03529773|10801562|FG004|Overall Study|Death|0
6800469|NCT03529773|10801563|FG005|Overall Study|Death|0
6800470|NCT03529773|10801564|FG006|Overall Study|Death|0
6800471|NCT03529773|10801565|FG007|Overall Study|Death|0
6800472|NCT03529773|10801566|FG008|Overall Study|Death|0
6800473|NCT03529773|10801567|FG009|Overall Study|Death|0
6800474|NCT03529773|10801568|FG010|Overall Study|Death|0
6800475|NCT03529773|10801569|FG011|Overall Study|Death|0
6800476|NCT03529773|10801570|FG012|Overall Study|Death|1
6800477|NCT03529773|10801571|FG013|Overall Study|Death|0
6800478|NCT03529773|10801572|FG014|Overall Study|Death|0
6800479|NCT03529773|10801573|FG015|Overall Study|Death|0
6800480|NCT03529773|10801574|FG016|Overall Study|Death|0
6800481|NCT03529773|10801575|FG017|Overall Study|Death|0
6800482|NCT03529773|10801576|FG018|Overall Study|Death|0
6800483|NCT03529773|10801577|FG019|Overall Study|Death|1
6800484|NCT03529773|10801578|FG020|Overall Study|Death|0
6800485|NCT03529773|10801579|FG021|Overall Study|Death|0
6800486|NCT03529773|10801580|FG022|Overall Study|Death|1
6800487|NCT03529773|10801581|FG023|Overall Study|Death|0
6800488|NCT03529773|10801582|FG024|Overall Study|Death|0
6800489|NCT03529773|10801583|FG025|Overall Study|Death|0
6800490|NCT03529773|10801584|FG026|Overall Study|Death|0
6800491|NCT03529773|10801585|FG027|Overall Study|Death|0
6800492|NCT03529773|10801586|FG028|Overall Study|Death|0
6800493|NCT03529773|10801587|FG029|Overall Study|Death|0
6800494|NCT03529773|10801588|FG030|Overall Study|Death|0
6800495|NCT03529773|10801589|FG031|Overall Study|Death|0
6800496|NCT03529773|10801590|FG032|Overall Study|Death|0
6800497|NCT03529773|10801591|FG033|Overall Study|Death|1
6800498|NCT03529773|10801592|FG034|Overall Study|Death|1
6800499|NCT03529773|10801593|FG035|Overall Study|Death|0
6800500|NCT03529773|10801594|FG036|Overall Study|Death|1
6800501|NCT03529773|10801595|FG037|Overall Study|Death|0
6800502|NCT03529773|10801596|FG038|Overall Study|Death|0
6800503|NCT03529773|10801597|FG039|Overall Study|Death|0
6800504|NCT03529773|10801558|FG000|Overall Study|Lost to Follow-up|0
6800505|NCT03529773|10801559|FG001|Overall Study|Lost to Follow-up|0
6800506|NCT03529773|10801560|FG002|Overall Study|Lost to Follow-up|1
6800507|NCT03529773|10801561|FG003|Overall Study|Lost to Follow-up|0
6800508|NCT03529773|10801562|FG004|Overall Study|Lost to Follow-up|1
6800509|NCT03529773|10801563|FG005|Overall Study|Lost to Follow-up|1
6800510|NCT03529773|10801564|FG006|Overall Study|Lost to Follow-up|0
6800511|NCT03529773|10801565|FG007|Overall Study|Lost to Follow-up|0
6800512|NCT03529773|10801566|FG008|Overall Study|Lost to Follow-up|0
6800513|NCT03529773|10801567|FG009|Overall Study|Lost to Follow-up|0
6800514|NCT03529773|10801568|FG010|Overall Study|Lost to Follow-up|0
6800515|NCT03529773|10801569|FG011|Overall Study|Lost to Follow-up|0
6800516|NCT03529773|10801570|FG012|Overall Study|Lost to Follow-up|0
6800517|NCT03529773|10801571|FG013|Overall Study|Lost to Follow-up|1
6800518|NCT03529773|10801572|FG014|Overall Study|Lost to Follow-up|4
6800519|NCT03529773|10801573|FG015|Overall Study|Lost to Follow-up|1
6800520|NCT03529773|10801574|FG016|Overall Study|Lost to Follow-up|1
6800521|NCT03529773|10801575|FG017|Overall Study|Lost to Follow-up|0
6800522|NCT03529773|10801576|FG018|Overall Study|Lost to Follow-up|1
6800523|NCT03529773|10801577|FG019|Overall Study|Lost to Follow-up|1
6800524|NCT03529773|10801578|FG020|Overall Study|Lost to Follow-up|2
6800525|NCT03529773|10801579|FG021|Overall Study|Lost to Follow-up|4
6800526|NCT03529773|10801580|FG022|Overall Study|Lost to Follow-up|3
6800527|NCT03529773|10801581|FG023|Overall Study|Lost to Follow-up|4
6800528|NCT03529773|10801582|FG024|Overall Study|Lost to Follow-up|3
6800529|NCT03529773|10801583|FG025|Overall Study|Lost to Follow-up|5
6800530|NCT03529773|10801584|FG026|Overall Study|Lost to Follow-up|5
6800531|NCT03529773|10801585|FG027|Overall Study|Lost to Follow-up|0
6800532|NCT03529773|10801586|FG028|Overall Study|Lost to Follow-up|0
6800533|NCT03529773|10801587|FG029|Overall Study|Lost to Follow-up|0
6800534|NCT03529773|10801588|FG030|Overall Study|Lost to Follow-up|1
6800535|NCT03529773|10801589|FG031|Overall Study|Lost to Follow-up|0
6800536|NCT03529773|10801590|FG032|Overall Study|Lost to Follow-up|0
6800537|NCT03529773|10801591|FG033|Overall Study|Lost to Follow-up|1
6800538|NCT03529773|10801592|FG034|Overall Study|Lost to Follow-up|1
6800539|NCT03529773|10801593|FG035|Overall Study|Lost to Follow-up|0
6800540|NCT03529773|10801594|FG036|Overall Study|Lost to Follow-up|0
6800541|NCT03529773|10801595|FG037|Overall Study|Lost to Follow-up|3
6800542|NCT03529773|10801596|FG038|Overall Study|Lost to Follow-up|1
6800543|NCT03529773|10801597|FG039|Overall Study|Lost to Follow-up|1
6800544|NCT03529773|10801558|FG000|Overall Study|No longer meets eligibility criteria|0
6800545|NCT03529773|10801559|FG001|Overall Study|No longer meets eligibility criteria|0
6800546|NCT03529773|10801560|FG002|Overall Study|No longer meets eligibility criteria|0
6800547|NCT03529773|10801561|FG003|Overall Study|No longer meets eligibility criteria|0
6800548|NCT03529773|10801562|FG004|Overall Study|No longer meets eligibility criteria|0
6800549|NCT03529773|10801563|FG005|Overall Study|No longer meets eligibility criteria|0
6800550|NCT03529773|10801564|FG006|Overall Study|No longer meets eligibility criteria|0
6800551|NCT03529773|10801565|FG007|Overall Study|No longer meets eligibility criteria|0
6800552|NCT03529773|10801566|FG008|Overall Study|No longer meets eligibility criteria|0
6800553|NCT03529773|10801567|FG009|Overall Study|No longer meets eligibility criteria|0
6800554|NCT03529773|10801568|FG010|Overall Study|No longer meets eligibility criteria|0
6800555|NCT03529773|10801569|FG011|Overall Study|No longer meets eligibility criteria|0
6800556|NCT03529773|10801570|FG012|Overall Study|No longer meets eligibility criteria|0
6800557|NCT03529773|10801571|FG013|Overall Study|No longer meets eligibility criteria|0
6800558|NCT03529773|10801572|FG014|Overall Study|No longer meets eligibility criteria|0
6800559|NCT03529773|10801573|FG015|Overall Study|No longer meets eligibility criteria|0
6800560|NCT03529773|10801574|FG016|Overall Study|No longer meets eligibility criteria|0
6800561|NCT03529773|10801575|FG017|Overall Study|No longer meets eligibility criteria|0
6800562|NCT03529773|10801576|FG018|Overall Study|No longer meets eligibility criteria|0
6800563|NCT03529773|10801577|FG019|Overall Study|No longer meets eligibility criteria|0
6800564|NCT03529773|10801578|FG020|Overall Study|No longer meets eligibility criteria|0
6800565|NCT03529773|10801579|FG021|Overall Study|No longer meets eligibility criteria|0
6800566|NCT03529773|10801580|FG022|Overall Study|No longer meets eligibility criteria|1
6800567|NCT03529773|10801581|FG023|Overall Study|No longer meets eligibility criteria|0
6800568|NCT03529773|10801582|FG024|Overall Study|No longer meets eligibility criteria|0
6800569|NCT03529773|10801583|FG025|Overall Study|No longer meets eligibility criteria|0
6800570|NCT03529773|10801584|FG026|Overall Study|No longer meets eligibility criteria|0
6800571|NCT03529773|10801585|FG027|Overall Study|No longer meets eligibility criteria|0
6800572|NCT03529773|10801586|FG028|Overall Study|No longer meets eligibility criteria|0
6800573|NCT03529773|10801587|FG029|Overall Study|No longer meets eligibility criteria|0
6800574|NCT03529773|10801588|FG030|Overall Study|No longer meets eligibility criteria|0
6800575|NCT03529773|10801589|FG031|Overall Study|No longer meets eligibility criteria|0
6800576|NCT03529773|10801590|FG032|Overall Study|No longer meets eligibility criteria|0
6800577|NCT03529773|10801591|FG033|Overall Study|No longer meets eligibility criteria|0
6800578|NCT03529773|10801592|FG034|Overall Study|No longer meets eligibility criteria|0
6800579|NCT03529773|10801593|FG035|Overall Study|No longer meets eligibility criteria|0
6800580|NCT03529773|10801594|FG036|Overall Study|No longer meets eligibility criteria|0
6800581|NCT03529773|10801595|FG037|Overall Study|No longer meets eligibility criteria|0
6800582|NCT03529773|10801596|FG038|Overall Study|No longer meets eligibility criteria|1
6800583|NCT03529773|10801597|FG039|Overall Study|No longer meets eligibility criteria|0
6800584|NCT03529773|10801558|FG000|Overall Study|Other|0
6800585|NCT03529773|10801559|FG001|Overall Study|Other|0
6800586|NCT03529773|10801560|FG002|Overall Study|Other|0
6800587|NCT03529773|10801561|FG003|Overall Study|Other|0
6800588|NCT03529773|10801562|FG004|Overall Study|Other|0
6800589|NCT03529773|10801563|FG005|Overall Study|Other|0
6800590|NCT03529773|10801564|FG006|Overall Study|Other|0
6800591|NCT03529773|10801565|FG007|Overall Study|Other|0
6800592|NCT03529773|10801566|FG008|Overall Study|Other|0
6800593|NCT03529773|10801567|FG009|Overall Study|Other|0
6800594|NCT03529773|10801568|FG010|Overall Study|Other|0
6800595|NCT03529773|10801569|FG011|Overall Study|Other|0
6800596|NCT03529773|10801570|FG012|Overall Study|Other|1
6800597|NCT03529773|10801571|FG013|Overall Study|Other|0
6800598|NCT03529773|10801572|FG014|Overall Study|Other|2
6800599|NCT03529773|10801573|FG015|Overall Study|Other|0
6800600|NCT03529773|10801574|FG016|Overall Study|Other|0
6800601|NCT03529773|10801575|FG017|Overall Study|Other|3
6800602|NCT03529773|10801576|FG018|Overall Study|Other|0
6800603|NCT03529773|10801577|FG019|Overall Study|Other|0
6800604|NCT03529773|10801578|FG020|Overall Study|Other|1
6800605|NCT03529773|10801579|FG021|Overall Study|Other|0
6800606|NCT03529773|10801580|FG022|Overall Study|Other|1
6800607|NCT03529773|10801581|FG023|Overall Study|Other|0
6800608|NCT03529773|10801582|FG024|Overall Study|Other|3
6800609|NCT03529773|10801583|FG025|Overall Study|Other|2
6800610|NCT03529773|10801584|FG026|Overall Study|Other|2
6800611|NCT03529773|10801585|FG027|Overall Study|Other|0
6800612|NCT03529773|10801586|FG028|Overall Study|Other|0
6800613|NCT03529773|10801587|FG029|Overall Study|Other|0
6800614|NCT03529773|10801588|FG030|Overall Study|Other|0
6800615|NCT03529773|10801589|FG031|Overall Study|Other|0
6800616|NCT03529773|10801590|FG032|Overall Study|Other|0
6800617|NCT03529773|10801591|FG033|Overall Study|Other|0
6800618|NCT03529773|10801592|FG034|Overall Study|Other|1
6800619|NCT03529773|10801593|FG035|Overall Study|Other|1
6800620|NCT03529773|10801594|FG036|Overall Study|Other|0
6800621|NCT03529773|10801595|FG037|Overall Study|Other|0
6800622|NCT03529773|10801596|FG038|Overall Study|Other|0
6800623|NCT03529773|10801597|FG039|Overall Study|Other|0
6800624|NCT03529773|10801558|FG000|Overall Study|Physician Decision|0
6800625|NCT03529773|10801559|FG001|Overall Study|Physician Decision|0
6800626|NCT03529773|10801560|FG002|Overall Study|Physician Decision|0
6800627|NCT03529773|10801561|FG003|Overall Study|Physician Decision|0
6800628|NCT03529773|10801562|FG004|Overall Study|Physician Decision|0
6800629|NCT03529773|10801563|FG005|Overall Study|Physician Decision|0
6800630|NCT03529773|10801564|FG006|Overall Study|Physician Decision|0
6800631|NCT03529773|10801565|FG007|Overall Study|Physician Decision|0
6800632|NCT03529773|10801566|FG008|Overall Study|Physician Decision|0
6800633|NCT03529773|10801567|FG009|Overall Study|Physician Decision|0
6800634|NCT03529773|10801568|FG010|Overall Study|Physician Decision|0
6800635|NCT03529773|10801569|FG011|Overall Study|Physician Decision|0
6800636|NCT03529773|10801570|FG012|Overall Study|Physician Decision|0
6800637|NCT03529773|10801571|FG013|Overall Study|Physician Decision|0
6800638|NCT03529773|10801572|FG014|Overall Study|Physician Decision|0
6800639|NCT03529773|10801573|FG015|Overall Study|Physician Decision|0
6800640|NCT03529773|10801574|FG016|Overall Study|Physician Decision|0
6800641|NCT03529773|10801575|FG017|Overall Study|Physician Decision|0
6800642|NCT03529773|10801576|FG018|Overall Study|Physician Decision|0
6800643|NCT03529773|10801577|FG019|Overall Study|Physician Decision|1
6800644|NCT03529773|10801578|FG020|Overall Study|Physician Decision|1
6800645|NCT03529773|10801579|FG021|Overall Study|Physician Decision|0
6800646|NCT03529773|10801580|FG022|Overall Study|Physician Decision|0
6800647|NCT03529773|10801581|FG023|Overall Study|Physician Decision|0
6800648|NCT03529773|10801582|FG024|Overall Study|Physician Decision|0
6800649|NCT03529773|10801583|FG025|Overall Study|Physician Decision|0
6800650|NCT03529773|10801584|FG026|Overall Study|Physician Decision|0
6800651|NCT03529773|10801585|FG027|Overall Study|Physician Decision|0
6800652|NCT03529773|10801586|FG028|Overall Study|Physician Decision|0
6800653|NCT03529773|10801587|FG029|Overall Study|Physician Decision|0
6800654|NCT03529773|10801588|FG030|Overall Study|Physician Decision|0
6800655|NCT03529773|10801589|FG031|Overall Study|Physician Decision|0
6800656|NCT03529773|10801590|FG032|Overall Study|Physician Decision|0
6800657|NCT03529773|10801591|FG033|Overall Study|Physician Decision|0
6800658|NCT03529773|10801592|FG034|Overall Study|Physician Decision|0
6800659|NCT03529773|10801593|FG035|Overall Study|Physician Decision|0
6800660|NCT03529773|10801594|FG036|Overall Study|Physician Decision|0
6800661|NCT03529773|10801595|FG037|Overall Study|Physician Decision|0
6800662|NCT03529773|10801596|FG038|Overall Study|Physician Decision|0
6800663|NCT03529773|10801597|FG039|Overall Study|Physician Decision|0
6800664|NCT03529773|10801558|FG000|Overall Study|Protocol Violation|0
6800665|NCT03529773|10801559|FG001|Overall Study|Protocol Violation|0
6800666|NCT03529773|10801560|FG002|Overall Study|Protocol Violation|0
6800667|NCT03529773|10801561|FG003|Overall Study|Protocol Violation|0
6800668|NCT03529773|10801562|FG004|Overall Study|Protocol Violation|0
6800669|NCT03529773|10801563|FG005|Overall Study|Protocol Violation|0
6800670|NCT03529773|10801564|FG006|Overall Study|Protocol Violation|0
6800671|NCT03529773|10801565|FG007|Overall Study|Protocol Violation|0
6800672|NCT03529773|10801566|FG008|Overall Study|Protocol Violation|0
6800673|NCT03529773|10801567|FG009|Overall Study|Protocol Violation|0
6800674|NCT03529773|10801568|FG010|Overall Study|Protocol Violation|0
6800675|NCT03529773|10801569|FG011|Overall Study|Protocol Violation|0
6800676|NCT03529773|10801570|FG012|Overall Study|Protocol Violation|0
6800677|NCT03529773|10801571|FG013|Overall Study|Protocol Violation|0
6800678|NCT03529773|10801572|FG014|Overall Study|Protocol Violation|0
6800679|NCT03529773|10801573|FG015|Overall Study|Protocol Violation|0
6800680|NCT03529773|10801574|FG016|Overall Study|Protocol Violation|0
6800681|NCT03529773|10801575|FG017|Overall Study|Protocol Violation|0
6800682|NCT03529773|10801576|FG018|Overall Study|Protocol Violation|0
6800683|NCT03529773|10801577|FG019|Overall Study|Protocol Violation|0
6800684|NCT03529773|10801578|FG020|Overall Study|Protocol Violation|0
6800685|NCT03529773|10801579|FG021|Overall Study|Protocol Violation|0
6800686|NCT03529773|10801580|FG022|Overall Study|Protocol Violation|0
6800687|NCT03529773|10801581|FG023|Overall Study|Protocol Violation|0
6800688|NCT03529773|10801582|FG024|Overall Study|Protocol Violation|0
6800689|NCT03529773|10801583|FG025|Overall Study|Protocol Violation|0
6800690|NCT03529773|10801584|FG026|Overall Study|Protocol Violation|0
6800691|NCT03529773|10801585|FG027|Overall Study|Protocol Violation|0
6800692|NCT03529773|10801586|FG028|Overall Study|Protocol Violation|0
6800693|NCT03529773|10801587|FG029|Overall Study|Protocol Violation|0
6800694|NCT03529773|10801588|FG030|Overall Study|Protocol Violation|1
6800695|NCT03529773|10801589|FG031|Overall Study|Protocol Violation|0
6800696|NCT03529773|10801590|FG032|Overall Study|Protocol Violation|0
6800697|NCT03529773|10801591|FG033|Overall Study|Protocol Violation|0
6800698|NCT03529773|10801592|FG034|Overall Study|Protocol Violation|0
6800699|NCT03529773|10801593|FG035|Overall Study|Protocol Violation|0
6800700|NCT03529773|10801594|FG036|Overall Study|Protocol Violation|0
6800701|NCT03529773|10801595|FG037|Overall Study|Protocol Violation|0
6800702|NCT03529773|10801596|FG038|Overall Study|Protocol Violation|0
6800703|NCT03529773|10801597|FG039|Overall Study|Protocol Violation|0
6800704|NCT03529773|10801558|FG000|Overall Study|Withdrawal by Subject|0
6800705|NCT03529773|10801559|FG001|Overall Study|Withdrawal by Subject|0
6800706|NCT03529773|10801560|FG002|Overall Study|Withdrawal by Subject|0
6800707|NCT03529773|10801561|FG003|Overall Study|Withdrawal by Subject|0
6800708|NCT03529773|10801562|FG004|Overall Study|Withdrawal by Subject|0
6800709|NCT03529773|10801563|FG005|Overall Study|Withdrawal by Subject|0
6800710|NCT03529773|10801564|FG006|Overall Study|Withdrawal by Subject|0
6800711|NCT03529773|10801565|FG007|Overall Study|Withdrawal by Subject|1
6800712|NCT03529773|10801566|FG008|Overall Study|Withdrawal by Subject|0
6800713|NCT03529773|10801567|FG009|Overall Study|Withdrawal by Subject|1
6800714|NCT03529773|10801568|FG010|Overall Study|Withdrawal by Subject|1
6800715|NCT03529773|10801569|FG011|Overall Study|Withdrawal by Subject|0
6800716|NCT03529773|10801570|FG012|Overall Study|Withdrawal by Subject|0
6800717|NCT03529773|10801571|FG013|Overall Study|Withdrawal by Subject|0
6800718|NCT03529773|10801572|FG014|Overall Study|Withdrawal by Subject|0
6800719|NCT03529773|10801573|FG015|Overall Study|Withdrawal by Subject|3
6800720|NCT03529773|10801574|FG016|Overall Study|Withdrawal by Subject|0
6800721|NCT03529773|10801575|FG017|Overall Study|Withdrawal by Subject|2
6800722|NCT03529773|10801576|FG018|Overall Study|Withdrawal by Subject|3
6800723|NCT03529773|10801577|FG019|Overall Study|Withdrawal by Subject|1
6800724|NCT03529773|10801578|FG020|Overall Study|Withdrawal by Subject|3
6800725|NCT03529773|10801579|FG021|Overall Study|Withdrawal by Subject|1
6800726|NCT03529773|10801580|FG022|Overall Study|Withdrawal by Subject|1
6800727|NCT03529773|10801581|FG023|Overall Study|Withdrawal by Subject|2
6800728|NCT03529773|10801582|FG024|Overall Study|Withdrawal by Subject|2
6800729|NCT03529773|10801583|FG025|Overall Study|Withdrawal by Subject|4
6800730|NCT03529773|10801584|FG026|Overall Study|Withdrawal by Subject|2
6800731|NCT03529773|10801585|FG027|Overall Study|Withdrawal by Subject|1
6800732|NCT03529773|10801586|FG028|Overall Study|Withdrawal by Subject|1
6800733|NCT03529773|10801587|FG029|Overall Study|Withdrawal by Subject|0
6800734|NCT03529773|10801588|FG030|Overall Study|Withdrawal by Subject|0
6800735|NCT03529773|10801589|FG031|Overall Study|Withdrawal by Subject|0
6800736|NCT03529773|10801590|FG032|Overall Study|Withdrawal by Subject|0
6800737|NCT03529773|10801591|FG033|Overall Study|Withdrawal by Subject|0
6800738|NCT03529773|10801592|FG034|Overall Study|Withdrawal by Subject|1
6800739|NCT03529773|10801593|FG035|Overall Study|Withdrawal by Subject|2
6800740|NCT03529773|10801594|FG036|Overall Study|Withdrawal by Subject|0
6800741|NCT03529773|10801595|FG037|Overall Study|Withdrawal by Subject|2
6800742|NCT03529773|10801596|FG038|Overall Study|Withdrawal by Subject|1
6800743|NCT03529773|10801597|FG039|Overall Study|Withdrawal by Subject|1
6800744|NCT03529773|10801558|FG000|Overall Study|Screen Failure|0
6800745|NCT03529773|10801559|FG001|Overall Study|Screen Failure|0
6800746|NCT03529773|10801560|FG002|Overall Study|Screen Failure|0
6800747|NCT03529773|10801561|FG003|Overall Study|Screen Failure|0
6800748|NCT03529773|10801562|FG004|Overall Study|Screen Failure|0
6800749|NCT03529773|10801563|FG005|Overall Study|Screen Failure|0
6800750|NCT03529773|10801564|FG006|Overall Study|Screen Failure|0
6800751|NCT03529773|10801565|FG007|Overall Study|Screen Failure|0
6800752|NCT03529773|10801566|FG008|Overall Study|Screen Failure|0
6800753|NCT03529773|10801567|FG009|Overall Study|Screen Failure|0
6800754|NCT03529773|10801568|FG010|Overall Study|Screen Failure|0
6800755|NCT03529773|10801569|FG011|Overall Study|Screen Failure|0
6800756|NCT03529773|10801570|FG012|Overall Study|Screen Failure|0
6800757|NCT03529773|10801571|FG013|Overall Study|Screen Failure|0
6800758|NCT03529773|10801572|FG014|Overall Study|Screen Failure|0
6800759|NCT03529773|10801573|FG015|Overall Study|Screen Failure|0
6800760|NCT03529773|10801574|FG016|Overall Study|Screen Failure|0
6800761|NCT03529773|10801575|FG017|Overall Study|Screen Failure|0
6800762|NCT03529773|10801576|FG018|Overall Study|Screen Failure|0
6800763|NCT03529773|10801577|FG019|Overall Study|Screen Failure|0
6800764|NCT03529773|10801578|FG020|Overall Study|Screen Failure|0
6800765|NCT03529773|10801579|FG021|Overall Study|Screen Failure|0
6800766|NCT03529773|10801580|FG022|Overall Study|Screen Failure|0
6800767|NCT03529773|10801581|FG023|Overall Study|Screen Failure|0
6800768|NCT03529773|10801582|FG024|Overall Study|Screen Failure|0
6800769|NCT03529773|10801583|FG025|Overall Study|Screen Failure|0
6800770|NCT03529773|10801584|FG026|Overall Study|Screen Failure|0
6800771|NCT03529773|10801585|FG027|Overall Study|Screen Failure|0
6800772|NCT03529773|10801586|FG028|Overall Study|Screen Failure|0
6800773|NCT03529773|10801587|FG029|Overall Study|Screen Failure|0
6800774|NCT03529773|10801588|FG030|Overall Study|Screen Failure|0
6800775|NCT03529773|10801589|FG031|Overall Study|Screen Failure|0
6800776|NCT03529773|10801590|FG032|Overall Study|Screen Failure|0
6800777|NCT03529773|10801591|FG033|Overall Study|Screen Failure|0
6800778|NCT03529773|10801592|FG034|Overall Study|Screen Failure|0
6800779|NCT03529773|10801593|FG035|Overall Study|Screen Failure|0
6800780|NCT03529773|10801594|FG036|Overall Study|Screen Failure|1
6800781|NCT03529773|10801595|FG037|Overall Study|Screen Failure|1
6800782|NCT03529773|10801596|FG038|Overall Study|Screen Failure|0
6800783|NCT03529773|10801597|FG039|Overall Study|Screen Failure|1
6800784|NCT03529773|10801558|FG000|Overall Study|Randomized but not vaccinated|0
6800785|NCT03529773|10801559|FG001|Overall Study|Randomized but not vaccinated|0
6800786|NCT03529773|10801560|FG002|Overall Study|Randomized but not vaccinated|0
6800787|NCT03529773|10801561|FG003|Overall Study|Randomized but not vaccinated|0
6800788|NCT03529773|10801562|FG004|Overall Study|Randomized but not vaccinated|0
6800789|NCT03529773|10801563|FG005|Overall Study|Randomized but not vaccinated|0
6800790|NCT03529773|10801564|FG006|Overall Study|Randomized but not vaccinated|0
6800791|NCT03529773|10801565|FG007|Overall Study|Randomized but not vaccinated|0
6800792|NCT03529773|10801566|FG008|Overall Study|Randomized but not vaccinated|0
6800793|NCT03529773|10801567|FG009|Overall Study|Randomized but not vaccinated|0
6800794|NCT03529773|10801568|FG010|Overall Study|Randomized but not vaccinated|0
6800795|NCT03529773|10801569|FG011|Overall Study|Randomized but not vaccinated|0
6800796|NCT03529773|10801570|FG012|Overall Study|Randomized but not vaccinated|0
6800797|NCT03529773|10801571|FG013|Overall Study|Randomized but not vaccinated|0
6800798|NCT03529773|10801572|FG014|Overall Study|Randomized but not vaccinated|0
6800799|NCT03529773|10801573|FG015|Overall Study|Randomized but not vaccinated|0
6800800|NCT03529773|10801574|FG016|Overall Study|Randomized but not vaccinated|0
6800801|NCT03529773|10801575|FG017|Overall Study|Randomized but not vaccinated|1
6800802|NCT03529773|10801576|FG018|Overall Study|Randomized but not vaccinated|0
6800803|NCT03529773|10801577|FG019|Overall Study|Randomized but not vaccinated|0
6800804|NCT03529773|10801578|FG020|Overall Study|Randomized but not vaccinated|0
6800805|NCT03529773|10801579|FG021|Overall Study|Randomized but not vaccinated|0
6800806|NCT03529773|10801580|FG022|Overall Study|Randomized but not vaccinated|0
6800807|NCT03529773|10801581|FG023|Overall Study|Randomized but not vaccinated|0
6800808|NCT03529773|10801582|FG024|Overall Study|Randomized but not vaccinated|0
6800809|NCT03529773|10801583|FG025|Overall Study|Randomized but not vaccinated|0
6800810|NCT03529773|10801584|FG026|Overall Study|Randomized but not vaccinated|0
6800811|NCT03529773|10801585|FG027|Overall Study|Randomized but not vaccinated|1
6800812|NCT03529773|10801586|FG028|Overall Study|Randomized but not vaccinated|0
6800813|NCT03529773|10801587|FG029|Overall Study|Randomized but not vaccinated|0
6800814|NCT03529773|10801588|FG030|Overall Study|Randomized but not vaccinated|0
6800815|NCT03529773|10801589|FG031|Overall Study|Randomized but not vaccinated|0
6800816|NCT03529773|10801590|FG032|Overall Study|Randomized but not vaccinated|0
6800817|NCT03529773|10801591|FG033|Overall Study|Randomized but not vaccinated|0
6800818|NCT03529773|10801592|FG034|Overall Study|Randomized but not vaccinated|0
6800819|NCT03529773|10801593|FG035|Overall Study|Randomized but not vaccinated|0
6800820|NCT03529773|10801594|FG036|Overall Study|Randomized but not vaccinated|0
6800821|NCT03529773|10801595|FG037|Overall Study|Randomized but not vaccinated|0
6800822|NCT03529773|10801596|FG038|Overall Study|Randomized but not vaccinated|0
6800823|NCT03529773|10801597|FG039|Overall Study|Randomized but not vaccinated|0
6800824|NCT03502070|10801700|FG000|Overall Study|Withdrawal by Subject|1
6800825|NCT03502070|10801700|FG000|Overall Study|Screen Failure|1
6800826|NCT03485911|10801707|FG000|Overall Study|Withdrawal by Subject|0
6800827|NCT03485911|10801708|FG001|Overall Study|Withdrawal by Subject|2
6800828|NCT03485911|10801709|FG002|Overall Study|Withdrawal by Subject|2
6800829|NCT03485911|10801707|FG000|Overall Study|Adverse Event|1
6800830|NCT03485911|10801708|FG001|Overall Study|Adverse Event|0
6800831|NCT03485911|10801709|FG002|Overall Study|Adverse Event|1
6800832|NCT03485911|10801707|FG000|Overall Study|High frequency of HAE attacks|0
6800833|NCT03485911|10801708|FG001|Overall Study|High frequency of HAE attacks|0
6800834|NCT03485911|10801709|FG002|Overall Study|High frequency of HAE attacks|1
6800835|NCT03403634|10801717|FG000|Overall Study|Disease progression|3
6800836|NCT03403634|10801717|FG000|Overall Study|Did not meet eligibility criteria|4
6800837|NCT03382041|10801723|FG000|Overall Study|Consent Form Lost|2
6800838|NCT03382041|10801724|FG001|Overall Study|Consent Form Lost|1
6800839|NCT03382041|10801723|FG000|Overall Study|Withdrawal by Subject|1
6800840|NCT03382041|10801724|FG001|Overall Study|Withdrawal by Subject|4
6800841|NCT03382041|10801723|FG000|Overall Study|Lost to Follow-up|1
6800842|NCT03382041|10801724|FG001|Overall Study|Lost to Follow-up|4
6800843|NCT03332095|10801732|FG000|Overall Study|Lost to Follow-up|1
6800844|NCT03332095|10801733|FG001|Overall Study|Lost to Follow-up|0
6800845|NCT03332095|10801732|FG000|Overall Study|Pregnancy|0
6800846|NCT03332095|10801733|FG001|Overall Study|Pregnancy|1
6800847|NCT03201419|10801748|FG000|Overall Study|Adverse Event|3
6800848|NCT03201419|10801749|FG001|Overall Study|Adverse Event|1
6800849|NCT03201419|10801750|FG002|Overall Study|Adverse Event|0
6800850|NCT03201419|10801751|FG003|Overall Study|Adverse Event|0
6800851|NCT03201419|10801752|FG004|Overall Study|Adverse Event|1
6800852|NCT03201419|10801753|FG005|Overall Study|Adverse Event|1
6800853|NCT03201419|10801754|FG006|Overall Study|Adverse Event|5
6800854|NCT03201419|10801755|FG007|Overall Study|Adverse Event|0
6800855|NCT03201419|10801756|FG008|Overall Study|Adverse Event|0
6800856|NCT03201419|10801748|FG000|Overall Study|Lost to Follow-up|1
6800857|NCT03201419|10801749|FG001|Overall Study|Lost to Follow-up|0
6800858|NCT03201419|10801750|FG002|Overall Study|Lost to Follow-up|0
6800859|NCT03201419|10801751|FG003|Overall Study|Lost to Follow-up|0
6800860|NCT03201419|10801752|FG004|Overall Study|Lost to Follow-up|0
6800861|NCT03201419|10801753|FG005|Overall Study|Lost to Follow-up|0
6800862|NCT03201419|10801754|FG006|Overall Study|Lost to Follow-up|0
6800863|NCT03201419|10801755|FG007|Overall Study|Lost to Follow-up|0
6800864|NCT03201419|10801756|FG008|Overall Study|Lost to Follow-up|0
6800865|NCT03201419|10801748|FG000|Overall Study|Protocol Deviation|0
6800866|NCT03201419|10801749|FG001|Overall Study|Protocol Deviation|0
6800867|NCT03201419|10801750|FG002|Overall Study|Protocol Deviation|0
6800868|NCT03201419|10801751|FG003|Overall Study|Protocol Deviation|0
6800869|NCT03201419|10801752|FG004|Overall Study|Protocol Deviation|0
6800870|NCT03201419|10801753|FG005|Overall Study|Protocol Deviation|0
6800871|NCT03201419|10801754|FG006|Overall Study|Protocol Deviation|1
6800872|NCT03201419|10801755|FG007|Overall Study|Protocol Deviation|0
6800873|NCT03201419|10801756|FG008|Overall Study|Protocol Deviation|0
6800874|NCT03201419|10801748|FG000|Overall Study|Withdrawal by Subject|4
6800875|NCT03201419|10801749|FG001|Overall Study|Withdrawal by Subject|2
6800876|NCT03201419|10801750|FG002|Overall Study|Withdrawal by Subject|1
6800877|NCT03201419|10801751|FG003|Overall Study|Withdrawal by Subject|0
6800878|NCT03201419|10801752|FG004|Overall Study|Withdrawal by Subject|0
6800879|NCT03201419|10801753|FG005|Overall Study|Withdrawal by Subject|0
6800880|NCT03201419|10801754|FG006|Overall Study|Withdrawal by Subject|0
6800881|NCT03201419|10801755|FG007|Overall Study|Withdrawal by Subject|1
6800882|NCT03201419|10801756|FG008|Overall Study|Withdrawal by Subject|2
6800883|NCT03201419|10801748|FG000|Overall Study|Other|0
6800884|NCT03201419|10801749|FG001|Overall Study|Other|0
6800885|NCT03201419|10801750|FG002|Overall Study|Other|1
6800886|NCT03201419|10801751|FG003|Overall Study|Other|0
6800887|NCT03201419|10801752|FG004|Overall Study|Other|0
6800888|NCT03201419|10801753|FG005|Overall Study|Other|0
6800889|NCT03201419|10801754|FG006|Overall Study|Other|0
6800890|NCT03201419|10801755|FG007|Overall Study|Other|0
6800891|NCT03201419|10801756|FG008|Overall Study|Other|0
6800892|NCT03197766|10801792|FG000|Overall Study|Withdrawal by Subject|2
6800893|NCT03197766|10801793|FG001|Overall Study|Withdrawal by Subject|0
6809627|NCT00002850|10813382|FG002|Overall Study|Death|3
6809628|NCT00002850|10813380|FG000|Overall Study|Protocol Violation|1
6809629|NCT00002850|10813381|FG001|Overall Study|Protocol Violation|0
6809630|NCT00002850|10813382|FG002|Overall Study|Protocol Violation|1
6809631|NCT00002850|10813380|FG000|Overall Study|Withdrawal by Subject|0
6809632|NCT00002850|10813381|FG001|Overall Study|Withdrawal by Subject|1
6809633|NCT00002850|10813382|FG002|Overall Study|Withdrawal by Subject|0
6811063|NCT02460224|10814924|FG017|Overall Study|Subject/guardian decision|1
6811064|NCT02460224|10814925|FG018|Overall Study|Subject/guardian decision|2
6811065|NCT02460224|10814926|FG019|Overall Study|Subject/guardian decision|0
6811066|NCT02460224|10814927|FG020|Overall Study|Subject/guardian decision|0
6811067|NCT02460224|10814928|FG021|Overall Study|Subject/guardian decision|1
6811068|NCT02460224|10814929|FG022|Overall Study|Subject/guardian decision|0
6811069|NCT02460224|10814930|FG023|Overall Study|Subject/guardian decision|0
6811070|NCT02460224|10814931|FG024|Overall Study|Subject/guardian decision|0
6811071|NCT02460224|10814932|FG025|Overall Study|Subject/guardian decision|0
6811072|NCT02460224|10814933|FG026|Overall Study|Subject/guardian decision|6
6811073|NCT02460224|10814934|FG027|Overall Study|Subject/guardian decision|2
6811074|NCT02460224|10814935|FG028|Overall Study|Subject/guardian decision|3
6811075|NCT02460159|10815009|FG000|Overall Study|Adverse Event|4
6811076|NCT02460159|10815010|FG001|Overall Study|Adverse Event|1
6811077|NCT02460159|10815009|FG000|Overall Study|Withdrawal by Subject|2
6811078|NCT02460159|10815010|FG001|Overall Study|Withdrawal by Subject|0
6811079|NCT02457910|10815022|FG000|Overall Study|Withdrawal by Subject|0
6811080|NCT02457910|10815023|FG001|Overall Study|Withdrawal by Subject|0
6811081|NCT02457910|10815024|FG002|Overall Study|Withdrawal by Subject|0
6811082|NCT02457910|10815025|FG003|Overall Study|Withdrawal by Subject|0
6811083|NCT02457910|10815026|FG004|Overall Study|Withdrawal by Subject|0
6811084|NCT02457910|10815027|FG005|Overall Study|Withdrawal by Subject|1
6811085|NCT02457910|10815022|FG000|Overall Study|Adverse Event|0
6811086|NCT02457910|10815023|FG001|Overall Study|Adverse Event|2
6811087|NCT02457910|10815024|FG002|Overall Study|Adverse Event|1
6811088|NCT02457910|10815025|FG003|Overall Study|Adverse Event|1
6811089|NCT02457910|10815026|FG004|Overall Study|Adverse Event|1
6811090|NCT02457910|10815027|FG005|Overall Study|Adverse Event|3
6811091|NCT02457910|10815022|FG000|Overall Study|Disease progression|3
6811092|NCT02457910|10815023|FG001|Overall Study|Disease progression|3
6811093|NCT02457910|10815024|FG002|Overall Study|Disease progression|1
6811094|NCT02457910|10815025|FG003|Overall Study|Disease progression|1
6811095|NCT02457910|10815026|FG004|Overall Study|Disease progression|4
6811096|NCT02457910|10815027|FG005|Overall Study|Disease progression|6
6811097|NCT02457910|10815022|FG000|Overall Study|Other complicating illness|0
6811098|NCT02457910|10815023|FG001|Overall Study|Other complicating illness|0
6811099|NCT02457910|10815024|FG002|Overall Study|Other complicating illness|0
6811100|NCT02457910|10815025|FG003|Overall Study|Other complicating illness|0
6811101|NCT02457910|10815026|FG004|Overall Study|Other complicating illness|0
6811102|NCT02457910|10815027|FG005|Overall Study|Other complicating illness|1
6811103|NCT02457910|10815022|FG000|Overall Study|Death|0
6811104|NCT02457910|10815023|FG001|Overall Study|Death|0
6811105|NCT02457910|10815024|FG002|Overall Study|Death|1
6811106|NCT02457910|10815025|FG003|Overall Study|Death|0
6811107|NCT02457910|10815026|FG004|Overall Study|Death|0
6811108|NCT02457910|10815027|FG005|Overall Study|Death|0
6811109|NCT02407236|10815052|FG000|Induction Study (8 Weeks)|Adverse Event|3
6811110|NCT02407236|10815053|FG001|Induction Study (8 Weeks)|Adverse Event|0
6800894|NCT04516759|10801811|FG000|Overall Study|Withdrawal by Subject|1
6800895|NCT04516759|10801812|FG001|Overall Study|Withdrawal by Subject|1
6800896|NCT04516759|10801811|FG000|Overall Study|Other|0
6800897|NCT04516759|10801812|FG001|Overall Study|Other|1
6800898|NCT03409276|10801837|FG000|Overall Study|Withdrawal by Subject|0
6800899|NCT03409276|10801838|FG001|Overall Study|Withdrawal by Subject|0
6800900|NCT03409276|10801839|FG002|Overall Study|Withdrawal by Subject|0
6800901|NCT03409276|10801840|FG003|Overall Study|Withdrawal by Subject|0
6800902|NCT03409276|10801841|FG004|Overall Study|Withdrawal by Subject|1
6800903|NCT03409276|10801837|FG000|Overall Study|Lost to Follow-up|0
6800904|NCT03409276|10801838|FG001|Overall Study|Lost to Follow-up|0
6800905|NCT03409276|10801839|FG002|Overall Study|Lost to Follow-up|0
6800906|NCT03409276|10801840|FG003|Overall Study|Lost to Follow-up|2
6800907|NCT03409276|10801841|FG004|Overall Study|Lost to Follow-up|2
6800908|NCT03312907|10801860|FG000|Overall Study|Adverse Event|1
6800909|NCT03312907|10801861|FG001|Overall Study|Adverse Event|6
6800910|NCT03312907|10801862|FG002|Overall Study|Adverse Event|1
6800911|NCT03312907|10801860|FG000|Overall Study|Protocol Violation|2
6800912|NCT03312907|10801861|FG001|Overall Study|Protocol Violation|3
6800913|NCT03312907|10801862|FG002|Overall Study|Protocol Violation|4
6800914|NCT03312907|10801860|FG000|Overall Study|Lost to Follow-up|2
6800915|NCT03312907|10801861|FG001|Overall Study|Lost to Follow-up|3
6800916|NCT03312907|10801862|FG002|Overall Study|Lost to Follow-up|2
6800917|NCT03312907|10801860|FG000|Overall Study|Physician Decision|3
6800918|NCT03312907|10801861|FG001|Overall Study|Physician Decision|4
6800919|NCT03312907|10801862|FG002|Overall Study|Physician Decision|2
6800920|NCT03312907|10801860|FG000|Overall Study|Withdrawal by Subject|9
6800921|NCT03312907|10801861|FG001|Overall Study|Withdrawal by Subject|14
6800922|NCT03312907|10801862|FG002|Overall Study|Withdrawal by Subject|10
6800923|NCT03148756|10801872|FG000|Overall Study|Study Terminated|0
6800924|NCT03148756|10801873|FG001|Overall Study|Study Terminated|1
6800925|NCT03079102|10801881|FG000|Overall Study|Physician Decision|0
6800926|NCT03079102|10801882|FG001|Overall Study|Physician Decision|1
6800927|NCT02944513|10801890|FG000|Overall Study|Withdrawal by Subject|4
6800928|NCT02944513|10801891|FG001|Overall Study|Withdrawal by Subject|1
6800929|NCT02734433|10801908|FG000|Overall Study|Disease progression|1
6800930|NCT02734433|10801909|FG001|Overall Study|Disease progression|5
6800931|NCT02734433|10801908|FG000|Overall Study|Clinical progression|0
6800932|NCT02734433|10801909|FG001|Overall Study|Clinical progression|1
6800933|NCT02734433|10801908|FG000|Overall Study|Withdrawal by Subject|1
6800934|NCT02734433|10801909|FG001|Overall Study|Withdrawal by Subject|2
6800935|NCT02120469|10801936|FG000|Overall Study|HER-2/neu-amplified|1
6800936|NCT02120469|10801937|FG001|Overall Study|HER-2/neu-amplified|0
6800937|NCT02120469|10801938|FG002|Overall Study|HER-2/neu-amplified|1
6800938|NCT02048722|10801948|FG000|2 Cycles of Treatment|Adverse Event|2
6800939|NCT02048722|10801948|FG000|2 Cycles of Treatment|Withdrawal by Subject|4
6800940|NCT02048722|10801948|FG000|2 Cycles of Treatment|Progressive Disease|2
6800941|NCT02048722|10801948|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10
6800942|NCT02048722|10801948|FG000|Follow up 5 Years or Cut of Timepoint|Death|24
6800943|NCT02048722|10801948|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3
6800944|NCT01896102|10801952|FG000|Overall Study|Death|1
6800945|NCT01896102|10801952|FG000|Overall Study|Participant to receive allogenic transplant|2
6800946|NCT01885078|10801965|FG000|Treatment Period|Adverse Event|52
6800947|NCT01885078|10801966|FG001|Treatment Period|Adverse Event|136
6800948|NCT01885078|10801967|FG002|Treatment Period|Adverse Event|30
6800949|NCT01885078|10801968|FG003|Treatment Period|Adverse Event|73
6800950|NCT01885078|10801969|FG004|Treatment Period|Adverse Event|17
6800951|NCT01885078|10801970|FG005|Treatment Period|Adverse Event|72
6800952|NCT01885078|10801971|FG006|Treatment Period|Adverse Event|24
6800953|NCT01885078|10801972|FG007|Treatment Period|Adverse Event|5
6800954|NCT01885078|10801973|FG008|Treatment Period|Adverse Event|0
6800955|NCT01885078|10801974|FG009|Treatment Period|Adverse Event|0
6800956|NCT01885078|10801965|FG000|Treatment Period|Death|13
6800957|NCT01885078|10801966|FG001|Treatment Period|Death|33
6800958|NCT01885078|10801967|FG002|Treatment Period|Death|5
6800959|NCT01885078|10801968|FG003|Treatment Period|Death|9
6800960|NCT01885078|10801969|FG004|Treatment Period|Death|2
6800961|NCT01885078|10801970|FG005|Treatment Period|Death|10
6800962|NCT01885078|10801971|FG006|Treatment Period|Death|3
6800963|NCT01885078|10801972|FG007|Treatment Period|Death|2
6800964|NCT01885078|10801973|FG008|Treatment Period|Death|0
6800965|NCT01885078|10801974|FG009|Treatment Period|Death|0
6800966|NCT01885078|10801965|FG000|Treatment Period|Lack of Efficacy|12
6800967|NCT01885078|10801966|FG001|Treatment Period|Lack of Efficacy|33
6800968|NCT01885078|10801967|FG002|Treatment Period|Lack of Efficacy|10
6800969|NCT01885078|10801968|FG003|Treatment Period|Lack of Efficacy|23
6800970|NCT01885078|10801969|FG004|Treatment Period|Lack of Efficacy|24
6800971|NCT01885078|10801970|FG005|Treatment Period|Lack of Efficacy|58
6800972|NCT01885078|10801971|FG006|Treatment Period|Lack of Efficacy|9
6800973|NCT01885078|10801972|FG007|Treatment Period|Lack of Efficacy|5
6800974|NCT01885078|10801973|FG008|Treatment Period|Lack of Efficacy|0
6800975|NCT01885078|10801974|FG009|Treatment Period|Lack of Efficacy|0
6800976|NCT01885078|10801965|FG000|Treatment Period|Lost to Follow-up|16
6800977|NCT01885078|10801966|FG001|Treatment Period|Lost to Follow-up|19
6800978|NCT01885078|10801967|FG002|Treatment Period|Lost to Follow-up|7
6800979|NCT01885078|10801968|FG003|Treatment Period|Lost to Follow-up|9
6800980|NCT01885078|10801969|FG004|Treatment Period|Lost to Follow-up|2
6800981|NCT01885078|10801970|FG005|Treatment Period|Lost to Follow-up|8
6800982|NCT01885078|10801971|FG006|Treatment Period|Lost to Follow-up|2
6800983|NCT01885078|10801972|FG007|Treatment Period|Lost to Follow-up|0
6800984|NCT01885078|10801973|FG008|Treatment Period|Lost to Follow-up|0
6800985|NCT01885078|10801974|FG009|Treatment Period|Lost to Follow-up|0
6800986|NCT01885078|10801965|FG000|Treatment Period|Physician Decision|19
6800987|NCT01885078|10801966|FG001|Treatment Period|Physician Decision|21
6800988|NCT01885078|10801967|FG002|Treatment Period|Physician Decision|5
6800989|NCT01885078|10801968|FG003|Treatment Period|Physician Decision|12
6800990|NCT01885078|10801969|FG004|Treatment Period|Physician Decision|9
6800991|NCT01885078|10801970|FG005|Treatment Period|Physician Decision|24
6800992|NCT01885078|10801971|FG006|Treatment Period|Physician Decision|4
6800993|NCT01885078|10801972|FG007|Treatment Period|Physician Decision|3
6800994|NCT01885078|10801973|FG008|Treatment Period|Physician Decision|0
6800995|NCT01885078|10801974|FG009|Treatment Period|Physician Decision|0
6800996|NCT01885078|10801965|FG000|Treatment Period|Protocol Violation|3
6800997|NCT01885078|10801966|FG001|Treatment Period|Protocol Violation|5
6800998|NCT01885078|10801967|FG002|Treatment Period|Protocol Violation|0
6800999|NCT01885078|10801968|FG003|Treatment Period|Protocol Violation|3
6801000|NCT01885078|10801969|FG004|Treatment Period|Protocol Violation|1
6801001|NCT01885078|10801970|FG005|Treatment Period|Protocol Violation|6
6801002|NCT01885078|10801971|FG006|Treatment Period|Protocol Violation|0
6801003|NCT01885078|10801972|FG007|Treatment Period|Protocol Violation|0
6801004|NCT01885078|10801973|FG008|Treatment Period|Protocol Violation|0
6801005|NCT01885078|10801974|FG009|Treatment Period|Protocol Violation|0
6801006|NCT01885078|10801965|FG000|Treatment Period|Sponsor Decision|245
6801007|NCT01885078|10801966|FG001|Treatment Period|Sponsor Decision|648
6801008|NCT01885078|10801967|FG002|Treatment Period|Sponsor Decision|49
6801009|NCT01885078|10801968|FG003|Treatment Period|Sponsor Decision|90
6801010|NCT01885078|10801969|FG004|Treatment Period|Sponsor Decision|20
6801011|NCT01885078|10801970|FG005|Treatment Period|Sponsor Decision|38
6801012|NCT01885078|10801971|FG006|Treatment Period|Sponsor Decision|162
6801013|NCT01885078|10801972|FG007|Treatment Period|Sponsor Decision|3
6801014|NCT01885078|10801973|FG008|Treatment Period|Sponsor Decision|0
6801015|NCT01885078|10801974|FG009|Treatment Period|Sponsor Decision|0
6801016|NCT01885078|10801965|FG000|Treatment Period|Withdrawal by Subject|72
6801017|NCT01885078|10801966|FG001|Treatment Period|Withdrawal by Subject|132
6801018|NCT01885078|10801967|FG002|Treatment Period|Withdrawal by Subject|25
6801019|NCT01885078|10801968|FG003|Treatment Period|Withdrawal by Subject|63
6801020|NCT01885078|10801969|FG004|Treatment Period|Withdrawal by Subject|15
6801021|NCT01885078|10801970|FG005|Treatment Period|Withdrawal by Subject|34
6801022|NCT01885078|10801971|FG006|Treatment Period|Withdrawal by Subject|17
6801023|NCT01885078|10801972|FG007|Treatment Period|Withdrawal by Subject|10
6801024|NCT01885078|10801973|FG008|Treatment Period|Withdrawal by Subject|0
6801025|NCT01885078|10801974|FG009|Treatment Period|Withdrawal by Subject|0
6801026|NCT01885078|10801965|FG000|Treatment Period|Other|0
6801027|NCT01885078|10801966|FG001|Treatment Period|Other|0
6801028|NCT01885078|10801967|FG002|Treatment Period|Other|0
6801029|NCT01885078|10801968|FG003|Treatment Period|Other|1
6801030|NCT01885078|10801969|FG004|Treatment Period|Other|0
6801031|NCT01885078|10801970|FG005|Treatment Period|Other|0
6801032|NCT01885078|10801971|FG006|Treatment Period|Other|0
6801033|NCT01885078|10801972|FG007|Treatment Period|Other|0
6801034|NCT01885078|10801973|FG008|Treatment Period|Other|0
6801035|NCT01885078|10801974|FG009|Treatment Period|Other|0
6801036|NCT01885078|10801965|FG000|Step-down Period|Sponsor Decision|0
6801037|NCT01885078|10801966|FG001|Step-down Period|Sponsor Decision|0
6801038|NCT01885078|10801967|FG002|Step-down Period|Sponsor Decision|0
6801039|NCT01885078|10801968|FG003|Step-down Period|Sponsor Decision|0
6801040|NCT01885078|10801969|FG004|Step-down Period|Sponsor Decision|0
6801041|NCT01885078|10801970|FG005|Step-down Period|Sponsor Decision|0
6801042|NCT01885078|10801971|FG006|Step-down Period|Sponsor Decision|0
6801043|NCT01885078|10801972|FG007|Step-down Period|Sponsor Decision|0
6801044|NCT01885078|10801973|FG008|Step-down Period|Sponsor Decision|1
6801045|NCT01885078|10801974|FG009|Step-down Period|Sponsor Decision|1
6801046|NCT01885078|10801965|FG000|Step-down Period|Adverse Event|0
6801047|NCT01885078|10801966|FG001|Step-down Period|Adverse Event|0
6801048|NCT01885078|10801967|FG002|Step-down Period|Adverse Event|0
6801049|NCT01885078|10801968|FG003|Step-down Period|Adverse Event|0
6801050|NCT01885078|10801969|FG004|Step-down Period|Adverse Event|0
6801051|NCT01885078|10801970|FG005|Step-down Period|Adverse Event|0
6801052|NCT01885078|10801971|FG006|Step-down Period|Adverse Event|0
6801053|NCT01885078|10801972|FG007|Step-down Period|Adverse Event|0
6801054|NCT01885078|10801973|FG008|Step-down Period|Adverse Event|29
6801055|NCT01885078|10801974|FG009|Step-down Period|Adverse Event|38
6801056|NCT01885078|10801965|FG000|Step-down Period|Withdrawal by Subject|0
6801057|NCT01885078|10801966|FG001|Step-down Period|Withdrawal by Subject|0
6801058|NCT01885078|10801967|FG002|Step-down Period|Withdrawal by Subject|0
6801059|NCT01885078|10801968|FG003|Step-down Period|Withdrawal by Subject|0
6801060|NCT01885078|10801969|FG004|Step-down Period|Withdrawal by Subject|0
6801061|NCT01885078|10801970|FG005|Step-down Period|Withdrawal by Subject|0
6801062|NCT01885078|10801971|FG006|Step-down Period|Withdrawal by Subject|0
6801063|NCT01885078|10801972|FG007|Step-down Period|Withdrawal by Subject|0
6801064|NCT01885078|10801973|FG008|Step-down Period|Withdrawal by Subject|25
6801065|NCT01885078|10801974|FG009|Step-down Period|Withdrawal by Subject|15
6801066|NCT01885078|10801965|FG000|Step-down Period|Physician Decision|0
6801067|NCT01885078|10801966|FG001|Step-down Period|Physician Decision|0
6801068|NCT01885078|10801967|FG002|Step-down Period|Physician Decision|0
6801069|NCT01885078|10801968|FG003|Step-down Period|Physician Decision|0
6801070|NCT01885078|10801969|FG004|Step-down Period|Physician Decision|0
6801071|NCT01885078|10801970|FG005|Step-down Period|Physician Decision|0
6801072|NCT01885078|10801971|FG006|Step-down Period|Physician Decision|0
6801073|NCT01885078|10801972|FG007|Step-down Period|Physician Decision|0
6801074|NCT01885078|10801973|FG008|Step-down Period|Physician Decision|7
6801075|NCT01885078|10801974|FG009|Step-down Period|Physician Decision|2
6801076|NCT01885078|10801965|FG000|Step-down Period|Death|0
6801077|NCT01885078|10801966|FG001|Step-down Period|Death|0
6801078|NCT01885078|10801967|FG002|Step-down Period|Death|0
6801079|NCT01885078|10801968|FG003|Step-down Period|Death|0
6801080|NCT01885078|10801969|FG004|Step-down Period|Death|0
6801081|NCT01885078|10801970|FG005|Step-down Period|Death|0
6801082|NCT01885078|10801971|FG006|Step-down Period|Death|0
6801083|NCT01885078|10801972|FG007|Step-down Period|Death|0
6801084|NCT01885078|10801973|FG008|Step-down Period|Death|4
6801085|NCT01885078|10801974|FG009|Step-down Period|Death|3
6801086|NCT01885078|10801965|FG000|Step-down Period|Lost to Follow-up|0
6801087|NCT01885078|10801966|FG001|Step-down Period|Lost to Follow-up|0
6801088|NCT01885078|10801967|FG002|Step-down Period|Lost to Follow-up|0
6801089|NCT01885078|10801968|FG003|Step-down Period|Lost to Follow-up|0
6801090|NCT01885078|10801969|FG004|Step-down Period|Lost to Follow-up|0
6801091|NCT01885078|10801970|FG005|Step-down Period|Lost to Follow-up|0
6801092|NCT01885078|10801971|FG006|Step-down Period|Lost to Follow-up|0
6801093|NCT01885078|10801972|FG007|Step-down Period|Lost to Follow-up|0
6801094|NCT01885078|10801973|FG008|Step-down Period|Lost to Follow-up|1
6801095|NCT01885078|10801974|FG009|Step-down Period|Lost to Follow-up|1
6801096|NCT01885078|10801965|FG000|Step-down Period|Lack of Efficacy|0
6801097|NCT01885078|10801966|FG001|Step-down Period|Lack of Efficacy|0
6801098|NCT01885078|10801967|FG002|Step-down Period|Lack of Efficacy|0
6801099|NCT01885078|10801968|FG003|Step-down Period|Lack of Efficacy|0
6801100|NCT01885078|10801969|FG004|Step-down Period|Lack of Efficacy|0
6801101|NCT01885078|10801970|FG005|Step-down Period|Lack of Efficacy|0
6801102|NCT01885078|10801971|FG006|Step-down Period|Lack of Efficacy|0
6801103|NCT01885078|10801972|FG007|Step-down Period|Lack of Efficacy|0
6801104|NCT01885078|10801973|FG008|Step-down Period|Lack of Efficacy|1
6801105|NCT01885078|10801974|FG009|Step-down Period|Lack of Efficacy|0
6801106|NCT01885078|10801965|FG000|Step-down Period|Protocol Violation|0
6801107|NCT01885078|10801966|FG001|Step-down Period|Protocol Violation|0
6801108|NCT01885078|10801967|FG002|Step-down Period|Protocol Violation|0
6801109|NCT01885078|10801968|FG003|Step-down Period|Protocol Violation|0
6801110|NCT01885078|10801969|FG004|Step-down Period|Protocol Violation|0
6801111|NCT01885078|10801970|FG005|Step-down Period|Protocol Violation|0
6801112|NCT01885078|10801971|FG006|Step-down Period|Protocol Violation|0
6801113|NCT01885078|10801972|FG007|Step-down Period|Protocol Violation|0
6801114|NCT01885078|10801973|FG008|Step-down Period|Protocol Violation|1
6801115|NCT01885078|10801974|FG009|Step-down Period|Protocol Violation|1
6801116|NCT01047683|10801998|FG000|Overall Study|Adverse Event|3
6801117|NCT01047683|10801999|FG001|Overall Study|Adverse Event|1
6801118|NCT01047683|10802000|FG002|Overall Study|Adverse Event|0
6801119|NCT01047683|10801998|FG000|Overall Study|Withdrew Consent|1
6801120|NCT01047683|10801999|FG001|Overall Study|Withdrew Consent|4
6801121|NCT01047683|10802000|FG002|Overall Study|Withdrew Consent|2
6801122|NCT01047683|10801998|FG000|Overall Study|Lost to Follow-up|0
6801123|NCT01047683|10801999|FG001|Overall Study|Lost to Follow-up|1
6801124|NCT01047683|10802000|FG002|Overall Study|Lost to Follow-up|0
6801125|NCT01047683|10801998|FG000|Overall Study|Triglycerides >2000 mg/dL|1
6801126|NCT01047683|10801999|FG001|Overall Study|Triglycerides >2000 mg/dL|0
6801127|NCT01047683|10802000|FG002|Overall Study|Triglycerides >2000 mg/dL|1
6801128|NCT01047501|10802011|FG000|Overall Study|Adverse Event|7
6801129|NCT01047501|10802012|FG001|Overall Study|Adverse Event|8
6801130|NCT01047501|10802013|FG002|Overall Study|Adverse Event|5
6801131|NCT01047501|10802011|FG000|Overall Study|Withdrew Consent|6
6801132|NCT01047501|10802012|FG001|Overall Study|Withdrew Consent|2
6801133|NCT01047501|10802013|FG002|Overall Study|Withdrew Consent|4
6801134|NCT01047501|10802011|FG000|Overall Study|Lost to Follow-up|0
6801135|NCT01047501|10802012|FG001|Overall Study|Lost to Follow-up|1
6801136|NCT01047501|10802013|FG002|Overall Study|Lost to Follow-up|1
6801137|NCT01047501|10802011|FG000|Overall Study|Triglycerides >800 mg/dL|1
6801138|NCT01047501|10802012|FG001|Overall Study|Triglycerides >800 mg/dL|0
6801139|NCT01047501|10802013|FG002|Overall Study|Triglycerides >800 mg/dL|0
6801140|NCT01047501|10802011|FG000|Overall Study|Death|1
6801141|NCT01047501|10802012|FG001|Overall Study|Death|0
6801142|NCT01047501|10802013|FG002|Overall Study|Death|0
6801143|NCT01047501|10802011|FG000|Overall Study|Other discontinuation|1
6801144|NCT01047501|10802012|FG001|Overall Study|Other discontinuation|0
6801145|NCT01047501|10802013|FG002|Overall Study|Other discontinuation|1
6801146|NCT01047501|10802011|FG000|Overall Study|Investigator judgement|0
6801147|NCT01047501|10802012|FG001|Overall Study|Investigator judgement|0
6801148|NCT01047501|10802013|FG002|Overall Study|Investigator judgement|1
6801149|NCT00981656|10802021|FG000|Overall Study|Protocol Violation|1
6801150|NCT00981656|10802021|FG000|Overall Study|Did not start protocol treatment|2
6809634|NCT03666988|10813396|FG000|Part 1 (Up to 28 Months)|Adverse Event|0
6809635|NCT03666988|10813397|FG001|Part 1 (Up to 28 Months)|Adverse Event|1
6809636|NCT03666988|10813398|FG002|Part 1 (Up to 28 Months)|Adverse Event|3
6809637|NCT03666988|10813399|FG003|Part 1 (Up to 28 Months)|Adverse Event|0
6809638|NCT03666988|10813400|FG004|Part 1 (Up to 28 Months)|Adverse Event|0
6809639|NCT03666988|10813401|FG005|Part 1 (Up to 28 Months)|Adverse Event|0
6809640|NCT03666988|10813396|FG000|Part 1 (Up to 28 Months)|Other|0
6809641|NCT03666988|10813397|FG001|Part 1 (Up to 28 Months)|Other|1
6809642|NCT03666988|10813398|FG002|Part 1 (Up to 28 Months)|Other|1
6809643|NCT03666988|10813399|FG003|Part 1 (Up to 28 Months)|Other|0
6809644|NCT03666988|10813400|FG004|Part 1 (Up to 28 Months)|Other|0
6809645|NCT03666988|10813401|FG005|Part 1 (Up to 28 Months)|Other|0
6809646|NCT03666988|10813396|FG000|Part 1 (Up to 28 Months)|Disease Progression|2
6809647|NCT03666988|10813397|FG001|Part 1 (Up to 28 Months)|Disease Progression|14
6809648|NCT03666988|10813398|FG002|Part 1 (Up to 28 Months)|Disease Progression|7
6809649|NCT03666988|10813399|FG003|Part 1 (Up to 28 Months)|Disease Progression|0
6809650|NCT03666988|10813400|FG004|Part 1 (Up to 28 Months)|Disease Progression|0
6809651|NCT03666988|10813401|FG005|Part 1 (Up to 28 Months)|Disease Progression|0
6809652|NCT03666988|10813396|FG000|Part 1 (Up to 28 Months)|Physician Decision|0
6809653|NCT03666988|10813397|FG001|Part 1 (Up to 28 Months)|Physician Decision|0
6809654|NCT03666988|10813398|FG002|Part 1 (Up to 28 Months)|Physician Decision|1
6809655|NCT03666988|10813399|FG003|Part 1 (Up to 28 Months)|Physician Decision|0
6809656|NCT03666988|10813400|FG004|Part 1 (Up to 28 Months)|Physician Decision|0
6809657|NCT03666988|10813401|FG005|Part 1 (Up to 28 Months)|Physician Decision|0
6809658|NCT03666988|10813396|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1
6809659|NCT03666988|10813397|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0
6809660|NCT03666988|10813398|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0
6809661|NCT03666988|10813399|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0
6809662|NCT03666988|10813400|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0
6809663|NCT03666988|10813401|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0
6809664|NCT03552029|10813421|FG000|Overall Study|Death|3
6809665|NCT03552029|10813422|FG001|Overall Study|Death|0
6809666|NCT03552029|10813421|FG000|Overall Study|Adverse Event|1
6809667|NCT03552029|10813422|FG001|Overall Study|Adverse Event|0
6809668|NCT03552029|10813421|FG000|Overall Study|Lack of Efficacy|0
6809669|NCT03552029|10813422|FG001|Overall Study|Lack of Efficacy|2
6809670|NCT03552029|10813421|FG000|Overall Study|Physician Decision|0
6809671|NCT03552029|10813422|FG001|Overall Study|Physician Decision|1
6809672|NCT03552029|10813421|FG000|Overall Study|Study terminated by Sponsor|0
6809673|NCT03552029|10813422|FG001|Overall Study|Study terminated by Sponsor|1
6809674|NCT03552029|10813421|FG000|Overall Study|Other|0
6809675|NCT03552029|10813422|FG001|Overall Study|Other|2
6809676|NCT03549104|10813430|FG000|Overall Study|Physician Decision|2
6809677|NCT03549104|10813431|FG001|Overall Study|Physician Decision|0
6809678|NCT03549104|10813430|FG000|Overall Study|Withdrawal by Subject|5
6809679|NCT03549104|10813431|FG001|Overall Study|Withdrawal by Subject|2
6809680|NCT03549104|10813430|FG000|Overall Study|Covid shelter in place|1
6809681|NCT03549104|10813431|FG001|Overall Study|Covid shelter in place|2
6809682|NCT03462719|10813439|FG000|Overall Study|Withdrawal by Subject|2
6809683|NCT03462719|10813440|FG001|Overall Study|Withdrawal by Subject|3
6809684|NCT03462719|10813439|FG000|Overall Study|Ongoing|93
6809685|NCT03462719|10813440|FG001|Overall Study|Ongoing|91
6809686|NCT03332589|10813449|FG000|Overall Study|Lack of Efficacy|2
6809687|NCT03332589|10813450|FG001|Overall Study|Lack of Efficacy|0
6809688|NCT03332589|10813451|FG002|Overall Study|Lack of Efficacy|0
6809689|NCT03332589|10813449|FG000|Overall Study|Adverse Event|1
6809690|NCT03332589|10813450|FG001|Overall Study|Adverse Event|0
6809691|NCT03332589|10813451|FG002|Overall Study|Adverse Event|0
6809692|NCT03332589|10813449|FG000|Overall Study|Death|1
6809693|NCT03332589|10813450|FG001|Overall Study|Death|0
6809694|NCT03332589|10813451|FG002|Overall Study|Death|0
6809695|NCT03091192|10813461|FG000|Overall Study|Study terminated by sponsor|21
6809696|NCT03091192|10813462|FG001|Overall Study|Study terminated by sponsor|14
6809697|NCT03091192|10813461|FG000|Overall Study|Death|9
6809698|NCT03091192|10813462|FG001|Overall Study|Death|13
6801151|NCT00838526|10802027|FG000|Overall Study|Adverse Event|3
6801152|NCT00838526|10802028|FG001|Overall Study|Adverse Event|12
6801153|NCT00838526|10802027|FG000|Overall Study|Lost to Follow-up|4
6801154|NCT00838526|10802028|FG001|Overall Study|Lost to Follow-up|12
6801155|NCT00838526|10802027|FG000|Overall Study|Withdrawal by Subject|4
6801156|NCT00838526|10802028|FG001|Overall Study|Withdrawal by Subject|5
6801157|NCT00838526|10802027|FG000|Overall Study|Lack of Efficacy|2
6801158|NCT00838526|10802028|FG001|Overall Study|Lack of Efficacy|3
6801159|NCT00838526|10802027|FG000|Overall Study|Other|11
6801160|NCT00838526|10802028|FG001|Overall Study|Other|7
6801161|NCT00126672|10802034|FG000|Overall Study|Adverse Event|4
6801162|NCT00126672|10802034|FG000|Overall Study|Lost to Follow-up|4
6801163|NCT03151304|10802051|FG000|Overall Study|Termination of study by Sponsor|23
6801164|NCT03151304|10802051|FG000|Overall Study|missing|3
6801165|NCT03151304|10802051|FG000|Overall Study|Withdrawal by Subject|8
6801166|NCT03151304|10802051|FG000|Overall Study|multiple reasons|30
6801167|NCT03113409|10802055|FG000|Overall Study|Withdrawal by Subject|5
6801168|NCT03113409|10802056|FG001|Overall Study|Withdrawal by Subject|0
6801169|NCT03113409|10802057|FG002|Overall Study|Withdrawal by Subject|0
6801170|NCT03007979|10802061|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1
6801171|NCT02953340|10802067|FG000|Overall Study|Death|0
6801172|NCT02953340|10802068|FG001|Overall Study|Death|1
6801173|NCT02953340|10802067|FG000|Overall Study|Investigator Decision|3
6801174|NCT02953340|10802068|FG001|Overall Study|Investigator Decision|3
6801175|NCT02953340|10802067|FG000|Overall Study|Initiated Non-Protocol Therapy|5
6801176|NCT02953340|10802068|FG001|Overall Study|Initiated Non-Protocol Therapy|14
6801177|NCT02953340|10802067|FG000|Overall Study|Myeloid Growth Factors Treatment|0
6801178|NCT02953340|10802068|FG001|Overall Study|Myeloid Growth Factors Treatment|1
6801179|NCT02953340|10802067|FG000|Overall Study|Withdrawal by Subject|9
6801180|NCT02953340|10802068|FG001|Overall Study|Withdrawal by Subject|9
6801181|NCT02953340|10802067|FG000|Overall Study|Sponsor decision|0
6801182|NCT02953340|10802068|FG001|Overall Study|Sponsor decision|2
6801183|NCT02953340|10802067|FG000|Overall Study|Lost to Follow-up|3
6801184|NCT02953340|10802068|FG001|Overall Study|Lost to Follow-up|2
6801185|NCT02953340|10802067|FG000|Overall Study|Reason not specified|2
6801186|NCT02953340|10802068|FG001|Overall Study|Reason not specified|2
6801187|NCT02855944|10802091|FG000|Period 1: Treatment|Ongoing|44
6801188|NCT02855944|10802092|FG001|Period 1: Treatment|Ongoing|5
6801189|NCT02855944|10802091|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1
6801190|NCT02855944|10802092|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3
6801191|NCT02855944|10802091|FG000|Period 2: Crossover to Rucaparib|Ongoing|0
6801192|NCT02855944|10802092|FG001|Period 2: Crossover to Rucaparib|Ongoing|27
6801193|NCT02851407|10802101|FG000|Overall Study|Withdrawal by parent/guardian|2
6801194|NCT02851407|10802102|FG001|Overall Study|Withdrawal by parent/guardian|7
6801195|NCT02851407|10802101|FG000|Overall Study|Protocol deviation|0
6801196|NCT02851407|10802102|FG001|Overall Study|Protocol deviation|1
6801197|NCT02851407|10802101|FG000|Overall Study|Transferred to another hospital to continue|1
6801198|NCT02851407|10802102|FG001|Overall Study|Transferred to another hospital to continue|0
6801199|NCT02851407|10802101|FG000|Overall Study|Other Death|30
6801200|NCT02851407|10802102|FG001|Overall Study|Other Death|20
6801201|NCT02851407|10802101|FG000|Overall Study|Adverse event, serious fatal|6
6801202|NCT02851407|10802102|FG001|Overall Study|Adverse event, serious fatal|8
6801203|NCT02851407|10802101|FG000|Overall Study|Consent withdrawn by participant|5
6801204|NCT02851407|10802102|FG001|Overall Study|Consent withdrawn by participant|3
6801205|NCT02851407|10802101|FG000|Overall Study|Screen failure|2
6801206|NCT02851407|10802102|FG001|Overall Study|Screen failure|1
6801207|NCT02851407|10802101|FG000|Overall Study|Disease relapse|9
6801208|NCT02851407|10802102|FG001|Overall Study|Disease relapse|6
6801209|NCT02851407|10802101|FG000|Overall Study|Physician Decision|7
6801210|NCT02851407|10802102|FG001|Overall Study|Physician Decision|6
6801211|NCT02851407|10802101|FG000|Overall Study|Transferred to hospital closer to home|0
6801212|NCT02851407|10802102|FG001|Overall Study|Transferred to hospital closer to home|1
6801213|NCT02851407|10802101|FG000|Overall Study|Enrolled in an investigational study|0
6801214|NCT02851407|10802102|FG001|Overall Study|Enrolled in an investigational study|1
6801215|NCT02851407|10802101|FG000|Overall Study|Early recovery|1
6801216|NCT02851407|10802102|FG001|Overall Study|Early recovery|0
6801217|NCT02851407|10802101|FG000|Overall Study|Adverse event, non-fatal|7
6801218|NCT02851407|10802102|FG001|Overall Study|Adverse event, non-fatal|5
6801219|NCT02851407|10802101|FG000|Overall Study|Lost to Follow-up|0
6801220|NCT02851407|10802102|FG001|Overall Study|Lost to Follow-up|2
6801221|NCT02666430|10802127|FG000|Period 1|Lost to Follow-up|1
6801222|NCT02666430|10802128|FG001|Period 1|Lost to Follow-up|0
6801223|NCT02666430|10802127|FG000|Period 1|Adverse Event|0
6801224|NCT02666430|10802128|FG001|Period 1|Adverse Event|1
6801225|NCT02666430|10802127|FG000|Period 2|Withdrawal by Subject|1
6801226|NCT02666430|10802128|FG001|Period 2|Withdrawal by Subject|4
6801227|NCT02666430|10802127|FG000|Period 3|Lost to Follow-up|1
6801228|NCT02666430|10802128|FG001|Period 3|Lost to Follow-up|0
6801229|NCT02643420|10802136|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6
6801230|NCT02643420|10802137|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12
6801231|NCT02643420|10802136|FG000|Overall Study|Withdrawal by Subject|25
6801232|NCT02643420|10802137|FG001|Overall Study|Withdrawal by Subject|19
6801233|NCT02643420|10802136|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6
6801234|NCT02643420|10802137|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10
6801235|NCT02643420|10802136|FG000|Overall Study|Lost to Follow-up|6
6801236|NCT02643420|10802137|FG001|Overall Study|Lost to Follow-up|10
6801237|NCT02643420|10802136|FG000|Overall Study|Investigator Decision|2
6801238|NCT02643420|10802137|FG001|Overall Study|Investigator Decision|4
6801239|NCT02643420|10802136|FG000|Overall Study|Sponsor decision|1
6801240|NCT02643420|10802137|FG001|Overall Study|Sponsor decision|1
6801241|NCT02643420|10802136|FG000|Overall Study|Death|0
6801242|NCT02643420|10802137|FG001|Overall Study|Death|2
6801243|NCT02643420|10802136|FG000|Overall Study|Reason not Specified|8
6801244|NCT02643420|10802137|FG001|Overall Study|Reason not Specified|7
6801245|NCT02639559|10802151|FG000|Overall Study|Mobilization failure|0
6801246|NCT02639559|10802152|FG001|Overall Study|Mobilization failure|3
6801247|NCT02639559|10802151|FG000|Overall Study|Issues with vascular acess|1
6801248|NCT02639559|10802152|FG001|Overall Study|Issues with vascular acess|0
6801249|NCT02569476|10802158|FG000|Overall Study|Roll over to Long-Term Extension Study|73
6801250|NCT02569476|10802158|FG000|Overall Study|Death|33
6801251|NCT02569476|10802158|FG000|Overall Study|Withdrawal by Subject|9
6801252|NCT02569476|10802158|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1
6801253|NCT02569476|10802158|FG000|Overall Study|Palliative care|1
6801254|NCT02569476|10802158|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1
6801255|NCT02569476|10802158|FG000|Overall Study|Transitioned to Long Term Extension Study|1
6801256|NCT02496676|10802174|FG000|Phase 1 - Period 1|Adverse Event|0
6801257|NCT02496676|10802175|FG001|Phase 1 - Period 1|Adverse Event|1
6801258|NCT02496676|10802174|FG000|Phase 2 - IV MgSO4|Adverse Event|0
6801259|NCT02496676|10802175|FG001|Phase 2 - IV MgSO4|Adverse Event|1
6801260|NCT02412618|10802200|FG000|Overall Study|Withdrawal by Subject|1
6801261|NCT02412618|10802201|FG001|Overall Study|Withdrawal by Subject|1
6801262|NCT02412618|10802200|FG000|Overall Study|Expulsion|1
6801263|NCT02412618|10802201|FG001|Overall Study|Expulsion|1
6801264|NCT02351180|10802218|FG000|Overall Study|Withdrawal by Subject|1
6801265|NCT02351180|10802219|FG001|Overall Study|Withdrawal by Subject|0
6801266|NCT02337764|10802225|FG000|Overall Study|Pretreatment Event/Adverse Event|46
6801267|NCT02337764|10802225|FG000|Overall Study|Voluntary Withdrawal|12
6801268|NCT02337764|10802225|FG000|Overall Study|Lack of Efficacy|2
6801269|NCT02337738|10802232|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0
6801270|NCT02337738|10802233|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1
6801271|NCT02337738|10802234|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0
6801272|NCT02337738|10802232|FG000|Overall Study|Pretreatment Event/Adverse Event|9
6801273|NCT02337738|10802233|FG001|Overall Study|Pretreatment Event/Adverse Event|18
6801274|NCT02337738|10802234|FG002|Overall Study|Pretreatment Event/Adverse Event|21
6801275|NCT02337738|10802232|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0
6801276|NCT02337738|10802233|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1
6801277|NCT02337738|10802234|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0
6801278|NCT02337738|10802232|FG000|Overall Study|Voluntary Withdrawal|10
6801279|NCT02337738|10802233|FG001|Overall Study|Voluntary Withdrawal|5
6801280|NCT02337738|10802234|FG002|Overall Study|Voluntary Withdrawal|2
6801281|NCT02337738|10802232|FG000|Overall Study|Lack of Efficacy|2
6801282|NCT02337738|10802233|FG001|Overall Study|Lack of Efficacy|4
6801283|NCT02337738|10802234|FG002|Overall Study|Lack of Efficacy|0
6801284|NCT02337738|10802232|FG000|Overall Study|Investigator's Judgment|1
6801285|NCT02337738|10802233|FG001|Overall Study|Investigator's Judgment|1
6801286|NCT02337738|10802234|FG002|Overall Study|Investigator's Judgment|3
6801287|NCT02332187|10802244|FG000|Overall Study|Withdrawal by Subject|2
6801288|NCT02332187|10802245|FG001|Overall Study|Withdrawal by Subject|2
6801289|NCT02332187|10802244|FG000|Overall Study|Adverse Event|0
6801290|NCT02332187|10802245|FG001|Overall Study|Adverse Event|1
6809699|NCT03091192|10813461|FG000|Overall Study|Withdrawal by Subject|2
6809700|NCT03091192|10813462|FG001|Overall Study|Withdrawal by Subject|0
6809701|NCT03091192|10813461|FG000|Overall Study|Lost to Follow-up|1
6809702|NCT03091192|10813462|FG001|Overall Study|Lost to Follow-up|0
6809703|NCT02717611|10813468|FG000|Overall Study|Death|13
6809704|NCT02717611|10813468|FG000|Overall Study|Withdrawal by Subject|6
6809705|NCT02717611|10813468|FG000|Overall Study|Active, not recruiting|40
6809706|NCT02717611|10813468|FG000|Overall Study|Complicating disease|1
6809707|NCT02301156|10813474|FG000|Overall Study|Adverse Event|13
6809708|NCT02301156|10813475|FG001|Overall Study|Adverse Event|14
6809709|NCT02301156|10813474|FG000|Overall Study|Death|1
6809710|NCT02301156|10813475|FG001|Overall Study|Death|5
6809711|NCT02301156|10813474|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2
6809712|NCT02301156|10813475|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2
6809713|NCT02301156|10813474|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27
6809714|NCT02301156|10813475|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16
6809715|NCT02301156|10813474|FG000|Overall Study|Withdrawal of Consent by Subject|4
6809716|NCT02301156|10813475|FG001|Overall Study|Withdrawal of Consent by Subject|12
6809717|NCT02301156|10813474|FG000|Overall Study|Reason not Specified|6
6809718|NCT02301156|10813475|FG001|Overall Study|Reason not Specified|3
6809719|NCT02296125|10813483|FG000|Overall Study|Withdrawal by Subject|18
6809720|NCT02296125|10813484|FG001|Overall Study|Withdrawal by Subject|8
6809721|NCT02296125|10813485|FG002|Overall Study|Withdrawal by Subject|6
6809722|NCT02296125|10813486|FG003|Overall Study|Withdrawal by Subject|2
6809723|NCT02296125|10813483|FG000|Overall Study|Adverse Event|41
6809724|NCT02296125|10813484|FG001|Overall Study|Adverse Event|52
6809725|NCT02296125|10813485|FG002|Overall Study|Adverse Event|9
6809726|NCT02296125|10813486|FG003|Overall Study|Adverse Event|4
6809727|NCT02296125|10813483|FG000|Overall Study|Severe non-compliance to protocol|0
6809728|NCT02296125|10813484|FG001|Overall Study|Severe non-compliance to protocol|1
6809729|NCT02296125|10813485|FG002|Overall Study|Severe non-compliance to protocol|0
6809730|NCT02296125|10813486|FG003|Overall Study|Severe non-compliance to protocol|0
6809731|NCT02296125|10813483|FG000|Overall Study|Condition under investigation worsened|153
6809732|NCT02296125|10813484|FG001|Overall Study|Condition under investigation worsened|199
6809733|NCT02296125|10813485|FG002|Overall Study|Condition under investigation worsened|39
6809734|NCT02296125|10813486|FG003|Overall Study|Condition under investigation worsened|56
6809735|NCT02296125|10813483|FG000|Overall Study|Any reason not specifically recorded|6
6809736|NCT02296125|10813484|FG001|Overall Study|Any reason not specifically recorded|4
6801291|NCT02227875|10802253|FG000|Overall Study|Protocol Violation|10
6801292|NCT02227875|10802254|FG001|Overall Study|Protocol Violation|7
6801293|NCT02227875|10802253|FG000|Overall Study|Other|1
6801294|NCT02227875|10802254|FG001|Overall Study|Other|3
6801295|NCT02227875|10802253|FG000|Overall Study|Physician Decision|1
6801296|NCT02227875|10802254|FG001|Overall Study|Physician Decision|0
6801297|NCT02227875|10802253|FG000|Overall Study|Adverse Event|3
6801298|NCT02227875|10802254|FG001|Overall Study|Adverse Event|0
6801299|NCT02227875|10802253|FG000|Overall Study|Withdrawal by Subject|12
6801300|NCT02227875|10802254|FG001|Overall Study|Withdrawal by Subject|13
6801301|NCT02227875|10802253|FG000|Overall Study|Lost to Follow-up|10
6801302|NCT02227875|10802254|FG001|Overall Study|Lost to Follow-up|10
6801303|NCT02227862|10802262|FG000|Overall Study|Protocol Violation|7
6801304|NCT02227862|10802263|FG001|Overall Study|Protocol Violation|9
6801305|NCT02227862|10802262|FG000|Overall Study|Other|0
6801306|NCT02227862|10802263|FG001|Overall Study|Other|2
6801307|NCT02227862|10802262|FG000|Overall Study|Adverse Event|4
6801308|NCT02227862|10802263|FG001|Overall Study|Adverse Event|3
6801309|NCT02227862|10802262|FG000|Overall Study|Withdrawal by Subject|7
6801310|NCT02227862|10802263|FG001|Overall Study|Withdrawal by Subject|6
6801311|NCT02227862|10802262|FG000|Overall Study|Lost to Follow-up|1
6801312|NCT02227862|10802263|FG001|Overall Study|Lost to Follow-up|2
6801313|NCT02200939|10802271|FG000|Overall Study|Participant withdrew consent|0
6801314|NCT02200939|10802272|FG001|Overall Study|Participant withdrew consent|1
6801315|NCT02200939|10802271|FG000|Overall Study|Lost to Follow-up|2
6801316|NCT02200939|10802272|FG001|Overall Study|Lost to Follow-up|9
6801317|NCT02200939|10802271|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0
6801318|NCT02200939|10802272|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1
6801319|NCT02108964|10802290|FG000|Overall Study|Progressive disease|12
6801320|NCT02108964|10802291|FG001|Overall Study|Progressive disease|25
6801321|NCT02108964|10802292|FG002|Overall Study|Progressive disease|50
6801322|NCT02108964|10802293|FG003|Overall Study|Progressive disease|6
6801323|NCT02108964|10802294|FG004|Overall Study|Progressive disease|18
6801324|NCT02108964|10802295|FG005|Overall Study|Progressive disease|5
6801325|NCT02108964|10802296|FG006|Overall Study|Progressive disease|7
6801326|NCT02108964|10802297|FG007|Overall Study|Progressive disease|9
6801327|NCT02108964|10802290|FG000|Overall Study|Physician Decision|1
6801328|NCT02108964|10802291|FG001|Overall Study|Physician Decision|5
6801329|NCT02108964|10802292|FG002|Overall Study|Physician Decision|6
6801330|NCT02108964|10802293|FG003|Overall Study|Physician Decision|0
6801331|NCT02108964|10802294|FG004|Overall Study|Physician Decision|1
6801332|NCT02108964|10802295|FG005|Overall Study|Physician Decision|0
6801333|NCT02108964|10802296|FG006|Overall Study|Physician Decision|0
6801334|NCT02108964|10802297|FG007|Overall Study|Physician Decision|0
6801335|NCT02108964|10802290|FG000|Overall Study|Adverse Event|0
6801336|NCT02108964|10802291|FG001|Overall Study|Adverse Event|0
6801337|NCT02108964|10802292|FG002|Overall Study|Adverse Event|4
6801338|NCT02108964|10802293|FG003|Overall Study|Adverse Event|0
6801339|NCT02108964|10802294|FG004|Overall Study|Adverse Event|1
6801340|NCT02108964|10802295|FG005|Overall Study|Adverse Event|0
6801341|NCT02108964|10802296|FG006|Overall Study|Adverse Event|3
6801342|NCT02108964|10802297|FG007|Overall Study|Adverse Event|1
6801343|NCT02108964|10802290|FG000|Overall Study|Death|1
6801344|NCT02108964|10802291|FG001|Overall Study|Death|1
6801345|NCT02108964|10802292|FG002|Overall Study|Death|2
6801346|NCT02108964|10802293|FG003|Overall Study|Death|0
6801347|NCT02108964|10802294|FG004|Overall Study|Death|3
6801348|NCT02108964|10802295|FG005|Overall Study|Death|0
6801349|NCT02108964|10802296|FG006|Overall Study|Death|0
6801350|NCT02108964|10802297|FG007|Overall Study|Death|1
6801351|NCT02108964|10802290|FG000|Overall Study|Subject/Guardian decision|0
6801352|NCT02108964|10802291|FG001|Overall Study|Subject/Guardian decision|1
6801353|NCT02108964|10802292|FG002|Overall Study|Subject/Guardian decision|3
6801354|NCT02108964|10802293|FG003|Overall Study|Subject/Guardian decision|0
6801355|NCT02108964|10802294|FG004|Overall Study|Subject/Guardian decision|2
6801356|NCT02108964|10802295|FG005|Overall Study|Subject/Guardian decision|0
6801357|NCT02108964|10802296|FG006|Overall Study|Subject/Guardian decision|1
6801358|NCT02108964|10802297|FG007|Overall Study|Subject/Guardian decision|1
6801359|NCT01922895|10802340|FG000|Overall Study|Death|0
6801360|NCT01922895|10802341|FG001|Overall Study|Death|1
6801361|NCT01922895|10802340|FG000|Overall Study|Withdrawal by Subject|1
6801362|NCT01922895|10802341|FG001|Overall Study|Withdrawal by Subject|2
6801363|NCT01922895|10802340|FG000|Overall Study|Lost to Follow-up|5
6801364|NCT01922895|10802341|FG001|Overall Study|Lost to Follow-up|11
6801365|NCT01901289|10802347|FG000|Overall Study|Death|32
6801366|NCT01901289|10802347|FG000|Overall Study|Lost to Follow-up|16
6801367|NCT01901289|10802347|FG000|Overall Study|Withdrawal by Subject|35
6801368|NCT01901289|10802347|FG000|Overall Study|Other type of endpoint met|2
6801369|NCT01595581|10802366|FG000|Overall Study|Withdrawal by Subject|1
6801370|NCT01595581|10802367|FG001|Overall Study|Withdrawal by Subject|0
6801371|NCT01514682|10802377|FG000|Overall Study|Withdrawal by Subject|2
6801372|NCT01514682|10802378|FG001|Overall Study|Withdrawal by Subject|3
6801373|NCT01514682|10802377|FG000|Overall Study|Physician Decision|4
6801374|NCT01514682|10802378|FG001|Overall Study|Physician Decision|3
6801375|NCT01453140|10802384|FG000|Overall Study|Adverse Event|3
6801376|NCT01408641|10802394|FG000|Overall Study|Physician Decision|1
6801377|NCT01408641|10802395|FG001|Overall Study|Physician Decision|0
6801378|NCT00653068|10802414|FG000|Overall Study|Death|9
6801379|NCT00653068|10802414|FG000|Overall Study|Lack of Efficacy|34
6801380|NCT00653068|10802414|FG000|Overall Study|Physician Decision|4
6801381|NCT00653068|10802414|FG000|Overall Study|Withdrawal by Subject|1
6801382|NCT00653068|10802414|FG000|Overall Study|Ineligible|2
6801383|NCT00193479|10802421|FG000|Induction Chemotherapy|Adverse Event|2
6801384|NCT00193479|10802421|FG000|Induction Chemotherapy|Disease Progression|1
6801385|NCT00193479|10802421|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2
6801386|NCT00193479|10802421|FG000|Maintenance Rituximab|Withdrawal by Subject|2
6801387|NCT00085735|10802440|FG000|Overall Study|Adverse Event|1
6801388|NCT00085735|10802441|FG001|Overall Study|Adverse Event|0
6801389|NCT00085735|10802442|FG002|Overall Study|Adverse Event|0
6801390|NCT00085735|10802443|FG003|Overall Study|Adverse Event|0
6801391|NCT00085735|10802444|FG004|Overall Study|Adverse Event|0
6801392|NCT00085735|10802445|FG005|Overall Study|Adverse Event|0
6801393|NCT00085735|10802440|FG000|Overall Study|Lack of Efficacy|2
6801394|NCT00085735|10802441|FG001|Overall Study|Lack of Efficacy|4
6801395|NCT00085735|10802442|FG002|Overall Study|Lack of Efficacy|6
6801396|NCT00085735|10802443|FG003|Overall Study|Lack of Efficacy|3
6801397|NCT00085735|10802444|FG004|Overall Study|Lack of Efficacy|4
6801398|NCT00085735|10802445|FG005|Overall Study|Lack of Efficacy|3
6801399|NCT00085735|10802440|FG000|Overall Study|Lost to Follow-up|0
6801400|NCT00085735|10802441|FG001|Overall Study|Lost to Follow-up|1
6801401|NCT00085735|10802442|FG002|Overall Study|Lost to Follow-up|0
6801402|NCT00085735|10802443|FG003|Overall Study|Lost to Follow-up|0
6801403|NCT00085735|10802444|FG004|Overall Study|Lost to Follow-up|1
6801404|NCT00085735|10802445|FG005|Overall Study|Lost to Follow-up|0
6801405|NCT00085735|10802440|FG000|Overall Study|Physician Decision|2
6801406|NCT00085735|10802441|FG001|Overall Study|Physician Decision|3
6801407|NCT00085735|10802442|FG002|Overall Study|Physician Decision|2
6801408|NCT00085735|10802443|FG003|Overall Study|Physician Decision|3
6801409|NCT00085735|10802444|FG004|Overall Study|Physician Decision|11
6801410|NCT00085735|10802445|FG005|Overall Study|Physician Decision|8
6801411|NCT00085735|10802440|FG000|Overall Study|Protocol Violation|1
6801412|NCT00085735|10802441|FG001|Overall Study|Protocol Violation|0
6801413|NCT00085735|10802442|FG002|Overall Study|Protocol Violation|0
6801414|NCT00085735|10802443|FG003|Overall Study|Protocol Violation|0
6801415|NCT00085735|10802444|FG004|Overall Study|Protocol Violation|0
6801416|NCT00085735|10802445|FG005|Overall Study|Protocol Violation|0
6801417|NCT00085735|10802440|FG000|Overall Study|Withdrawal by Subject|1
6801418|NCT00085735|10802441|FG001|Overall Study|Withdrawal by Subject|0
6801419|NCT00085735|10802442|FG002|Overall Study|Withdrawal by Subject|4
6801420|NCT00085735|10802443|FG003|Overall Study|Withdrawal by Subject|5
6801421|NCT00085735|10802444|FG004|Overall Study|Withdrawal by Subject|7
6801422|NCT00085735|10802445|FG005|Overall Study|Withdrawal by Subject|8
6801423|NCT00085735|10802440|FG000|Overall Study|Patient ineligible|1
6801424|NCT00085735|10802441|FG001|Overall Study|Patient ineligible|0
6801425|NCT00085735|10802442|FG002|Overall Study|Patient ineligible|3
6801426|NCT00085735|10802443|FG003|Overall Study|Patient ineligible|7
6801427|NCT00085735|10802444|FG004|Overall Study|Patient ineligible|17
6801428|NCT00085735|10802445|FG005|Overall Study|Patient ineligible|8
6801429|NCT00085735|10802440|FG000|Overall Study|Excess residual disease|2
6801430|NCT00085735|10802441|FG001|Overall Study|Excess residual disease|2
6801431|NCT00085735|10802442|FG002|Overall Study|Excess residual disease|1
6801432|NCT00085735|10802443|FG003|Overall Study|Excess residual disease|1
6801433|NCT00085735|10802444|FG004|Overall Study|Excess residual disease|1
6801434|NCT00085735|10802445|FG005|Overall Study|Excess residual disease|4
6801435|NCT00085735|10802440|FG000|Overall Study|Reason not documented|1
6801436|NCT00085735|10802441|FG001|Overall Study|Reason not documented|0
6801437|NCT00085735|10802442|FG002|Overall Study|Reason not documented|1
6801438|NCT00085735|10802443|FG003|Overall Study|Reason not documented|0
6801439|NCT00085735|10802444|FG004|Overall Study|Reason not documented|1
6801440|NCT00085735|10802445|FG005|Overall Study|Reason not documented|0
6801441|NCT00085735|10802440|FG000|Overall Study|Pt transferred to inst w/out study open|1
6801442|NCT00085735|10802441|FG001|Overall Study|Pt transferred to inst w/out study open|0
6801443|NCT00085735|10802442|FG002|Overall Study|Pt transferred to inst w/out study open|0
6801444|NCT00085735|10802443|FG003|Overall Study|Pt transferred to inst w/out study open|0
6801445|NCT00085735|10802444|FG004|Overall Study|Pt transferred to inst w/out study open|0
6801446|NCT00085735|10802445|FG005|Overall Study|Pt transferred to inst w/out study open|0
6809737|NCT02296125|10813485|FG002|Overall Study|Any reason not specifically recorded|2
6809738|NCT02296125|10813486|FG003|Overall Study|Any reason not specifically recorded|0
6809739|NCT02087423|10813500|FG000|Overall Study|Withdrawal by Subject|20
6809740|NCT02087423|10813501|FG001|Overall Study|Withdrawal by Subject|20
6809741|NCT02087423|10813502|FG002|Overall Study|Withdrawal by Subject|3
6809742|NCT02087423|10813500|FG000|Overall Study|Death|68
6809743|NCT02087423|10813501|FG001|Overall Study|Death|207
6809744|NCT02087423|10813502|FG002|Overall Study|Death|40
6809745|NCT02087423|10813500|FG000|Overall Study|Lost to Follow-up|0
6809746|NCT02087423|10813501|FG001|Overall Study|Lost to Follow-up|2
6809747|NCT02087423|10813502|FG002|Overall Study|Lost to Follow-up|0
6809748|NCT02087423|10813500|FG000|Overall Study|Terminated from study at final DCO|23
6809749|NCT02087423|10813501|FG001|Overall Study|Terminated from study at final DCO|36
6809750|NCT02087423|10813502|FG002|Overall Study|Terminated from study at final DCO|25
6809751|NCT01946204|10813514|FG000|Overall Study|Death|38
6809752|NCT01946204|10813515|FG001|Overall Study|Death|59
6809753|NCT01946204|10813514|FG000|Overall Study|Withdrawal by Subject|37
6809754|NCT01946204|10813515|FG001|Overall Study|Withdrawal by Subject|50
6809755|NCT01946204|10813514|FG000|Overall Study|Lost to Follow-up|3
6801447|NCT04399356|10802483|FG000|Overall Study|Lost to Follow-up|1
6801448|NCT04399356|10802484|FG001|Overall Study|Lost to Follow-up|1
6801449|NCT04399356|10802483|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1
6801450|NCT04399356|10802484|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2
6801451|NCT04399356|10802483|FG000|Overall Study|Withdrawal by Subject|1
6801452|NCT04399356|10802484|FG001|Overall Study|Withdrawal by Subject|0
6801471|NCT03933449|10802542|FG000|Overall Study|Adverse Event|6
6801472|NCT03933449|10802543|FG001|Overall Study|Adverse Event|4
6801473|NCT03933449|10802542|FG000|Overall Study|Death|36
6801474|NCT03933449|10802543|FG001|Overall Study|Death|51
6801475|NCT03933449|10802542|FG000|Overall Study|Ongoing in Study|20
6801476|NCT03933449|10802543|FG001|Overall Study|Ongoing in Study|6
6801477|NCT03826667|10802549|FG000|Overall Study|Protocol deviation|21
6801478|NCT03600909|10802562|FG000|Overall Study|Not treated|0
6801479|NCT03600909|10802563|FG001|Overall Study|Not treated|3
6801480|NCT03600909|10802564|FG002|Overall Study|Not treated|0
6801520|NCT02335658|10802693|FG000|Overall Study|non-compliance|2
6801521|NCT02335658|10802694|FG001|Overall Study|non-compliance|3
6801522|NCT02335658|10802693|FG000|Overall Study|other reason|2
6801523|NCT02335658|10802694|FG001|Overall Study|other reason|3
6801524|NCT02287584|10802705|FG000|the Double-blind Phase|Adverse Event|17
6801525|NCT02287584|10802706|FG001|the Double-blind Phase|Adverse Event|17
6801526|NCT02287584|10802707|FG002|the Double-blind Phase|Adverse Event|12
6801527|NCT02287584|10802708|FG003|the Double-blind Phase|Adverse Event|0
6801528|NCT02287584|10802709|FG004|the Double-blind Phase|Adverse Event|0
6801529|NCT02287584|10802710|FG005|the Double-blind Phase|Adverse Event|0
6801530|NCT02287584|10802705|FG000|the Double-blind Phase|Lack of Efficacy|18
6801531|NCT02287584|10802706|FG001|the Double-blind Phase|Lack of Efficacy|8
6801532|NCT02287584|10802707|FG002|the Double-blind Phase|Lack of Efficacy|8
6801533|NCT02287584|10802708|FG003|the Double-blind Phase|Lack of Efficacy|0
6801534|NCT02287584|10802709|FG004|the Double-blind Phase|Lack of Efficacy|0
6801535|NCT02287584|10802710|FG005|the Double-blind Phase|Lack of Efficacy|0
6801536|NCT02287584|10802705|FG000|the Double-blind Phase|Lost to Follow-up|0
6801537|NCT02287584|10802706|FG001|the Double-blind Phase|Lost to Follow-up|1
6801538|NCT02287584|10802707|FG002|the Double-blind Phase|Lost to Follow-up|1
6801539|NCT02287584|10802708|FG003|the Double-blind Phase|Lost to Follow-up|0
6801540|NCT02287584|10802709|FG004|the Double-blind Phase|Lost to Follow-up|0
6801541|NCT02287584|10802710|FG005|the Double-blind Phase|Lost to Follow-up|0
6801542|NCT02287584|10802705|FG000|the Double-blind Phase|Withdrawal by Subject|17
6801543|NCT02287584|10802706|FG001|the Double-blind Phase|Withdrawal by Subject|17
6801544|NCT02287584|10802707|FG002|the Double-blind Phase|Withdrawal by Subject|11
6801545|NCT02287584|10802708|FG003|the Double-blind Phase|Withdrawal by Subject|0
6801546|NCT02287584|10802709|FG004|the Double-blind Phase|Withdrawal by Subject|0
6801547|NCT02287584|10802710|FG005|the Double-blind Phase|Withdrawal by Subject|0
6801548|NCT02287584|10802705|FG000|the Double-blind Phase|Pregnancy|0
6801549|NCT02287584|10802706|FG001|the Double-blind Phase|Pregnancy|1
6801550|NCT02287584|10802707|FG002|the Double-blind Phase|Pregnancy|0
6801551|NCT02287584|10802708|FG003|the Double-blind Phase|Pregnancy|0
6801552|NCT02287584|10802709|FG004|the Double-blind Phase|Pregnancy|0
6801553|NCT02287584|10802710|FG005|the Double-blind Phase|Pregnancy|0
6801554|NCT02287584|10802705|FG000|the Double-blind Phase|Protocol Violation|0
6801453|NCT04156399|10802514|FG000|Overall Study|hospitalization unrelated to acupuncture|1
6801454|NCT04156399|10802514|FG000|Overall Study|study suspension due to COVID pandemic|3
6801455|NCT04052620|10802533|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1
6801456|NCT04052620|10802534|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0
6801457|NCT04052620|10802533|FG000|Overall Study|Withdrawal by Subject|1
6801458|NCT04052620|10802534|FG001|Overall Study|Withdrawal by Subject|0
6801459|NCT04052620|10802533|FG000|Overall Study|Lost to Follow-up|1
6801460|NCT04052620|10802534|FG001|Overall Study|Lost to Follow-up|1
6801461|NCT04052620|10802533|FG000|Overall Study|Adverse Event|1
6801462|NCT04052620|10802534|FG001|Overall Study|Adverse Event|0
6801463|NCT04052620|10802533|FG000|Overall Study|Subject did not meet study Criteria|0
6801464|NCT04052620|10802534|FG001|Overall Study|Subject did not meet study Criteria|1
6801465|NCT04052620|10802533|FG000|Overall Study|Screened failure, randomized by mistake|0
6801466|NCT04052620|10802534|FG001|Overall Study|Screened failure, randomized by mistake|1
6801467|NCT04052620|10802533|FG000|Overall Study|Personal reasons|2
6801468|NCT04052620|10802534|FG001|Overall Study|Personal reasons|4
6801469|NCT04052620|10802533|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1
6801470|NCT04052620|10802534|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0
6801481|NCT03366428|10802580|FG000|Overall Study|Progressive disease per RECIST v1.1|33
6801482|NCT03366428|10802580|FG000|Overall Study|Adverse Event|12
6801483|NCT03366428|10802580|FG000|Overall Study|Clinical progression|2
6801484|NCT03366428|10802580|FG000|Overall Study|Withdrawal by Subject|4
6801485|NCT03131219|10802592|FG000|Initial Evaluation Period|Adverse Event|1
6801486|NCT03131219|10802593|FG001|Initial Evaluation Period|Adverse Event|0
6801487|NCT03131219|10802592|FG000|Initial Evaluation Period|Protocol Violation|1
6801488|NCT03131219|10802593|FG001|Initial Evaluation Period|Protocol Violation|0
6801489|NCT03131219|10802592|FG000|Initial Evaluation Period|Deemed ineligible post treatment|2
6801490|NCT03131219|10802593|FG001|Initial Evaluation Period|Deemed ineligible post treatment|0
6801491|NCT03075527|10802599|FG000|Overall Study|Ongoing treatment|2
6801492|NCT02756611|10802603|FG000|Overall Study|Death|39
6801493|NCT02756611|10802603|FG000|Overall Study|Withdrawal by Subject|1
6801494|NCT02756611|10802603|FG000|Overall Study|Lost to Follow-up|2
6801495|NCT02756611|10802603|FG000|Overall Study|Other|7
6801496|NCT02756611|10802603|FG000|Overall Study|Missing|2
6801497|NCT02756611|10802603|FG000|Overall Study|Active on Study|205
6801498|NCT02724878|10802607|FG000|Overall Study|Still on Active Therapy|15
6801499|NCT02724878|10802607|FG000|Overall Study|Disease Progression|31
6801500|NCT02724878|10802607|FG000|Overall Study|Toxicity|5
6801501|NCT02724878|10802607|FG000|Overall Study|Death|1
6801502|NCT02724878|10802607|FG000|Overall Study|Withdrawal by Subject|4
6801503|NCT02724878|10802607|FG000|Overall Study|Lost to Follow-up|2
6801504|NCT02724878|10802607|FG000|Overall Study|Protocol Violation|1
6801505|NCT02724878|10802607|FG000|Overall Study|Ineligible for Study Drug|5
6801506|NCT02724878|10802607|FG000|Overall Study|not started|1
6801507|NCT02487095|10802642|FG000|Dose Expansion|Unable to scan/restage participant|0
6801508|NCT02487095|10802643|FG001|Dose Expansion|Unable to scan/restage participant|0
6801509|NCT02487095|10802644|FG002|Dose Expansion|Unable to scan/restage participant|0
6801510|NCT02487095|10802645|FG003|Dose Expansion|Unable to scan/restage participant|0
6801511|NCT02487095|10802646|FG004|Dose Expansion|Unable to scan/restage participant|1
6801512|NCT02335658|10802693|FG000|Overall Study|Adverse Event|18
6801513|NCT02335658|10802694|FG001|Overall Study|Adverse Event|12
6801514|NCT02335658|10802693|FG000|Overall Study|Lack of Efficacy|4
6801515|NCT02335658|10802694|FG001|Overall Study|Lack of Efficacy|5
6801516|NCT02335658|10802693|FG000|Overall Study|Pregnancy|1
6801517|NCT02335658|10802694|FG001|Overall Study|Pregnancy|0
6801518|NCT02335658|10802693|FG000|Overall Study|Withdrawal by Subject|13
6801519|NCT02335658|10802694|FG001|Overall Study|Withdrawal by Subject|21
6801555|NCT02287584|10802706|FG001|the Double-blind Phase|Protocol Violation|3
6801556|NCT02287584|10802707|FG002|the Double-blind Phase|Protocol Violation|0
6801557|NCT02287584|10802708|FG003|the Double-blind Phase|Protocol Violation|0
6801558|NCT02287584|10802709|FG004|the Double-blind Phase|Protocol Violation|0
6801559|NCT02287584|10802710|FG005|the Double-blind Phase|Protocol Violation|0
6801560|NCT02287584|10802705|FG000|the Double-blind Phase|other reasons|0
6801561|NCT02287584|10802706|FG001|the Double-blind Phase|other reasons|0
6801562|NCT02287584|10802707|FG002|the Double-blind Phase|other reasons|1
6801563|NCT02287584|10802708|FG003|the Double-blind Phase|other reasons|0
6801564|NCT02287584|10802709|FG004|the Double-blind Phase|other reasons|0
6801565|NCT02287584|10802710|FG005|the Double-blind Phase|other reasons|0
6801566|NCT02287584|10802705|FG000|the Open-label Phase|Did not receive drug|0
6801567|NCT02287584|10802706|FG001|the Open-label Phase|Did not receive drug|0
6801568|NCT02287584|10802707|FG002|the Open-label Phase|Did not receive drug|0
6801569|NCT02287584|10802708|FG003|the Open-label Phase|Did not receive drug|7
6801570|NCT02287584|10802709|FG004|the Open-label Phase|Did not receive drug|6
6801571|NCT02287584|10802710|FG005|the Open-label Phase|Did not receive drug|4
6801572|NCT02287584|10802705|FG000|the Open-label Phase|Adverse Event|0
6801573|NCT02287584|10802706|FG001|the Open-label Phase|Adverse Event|0
6801574|NCT02287584|10802707|FG002|the Open-label Phase|Adverse Event|0
6801575|NCT02287584|10802708|FG003|the Open-label Phase|Adverse Event|15
6801576|NCT02287584|10802709|FG004|the Open-label Phase|Adverse Event|12
6801577|NCT02287584|10802710|FG005|the Open-label Phase|Adverse Event|16
6801578|NCT02287584|10802705|FG000|the Open-label Phase|Lack of Efficacy|0
6801579|NCT02287584|10802706|FG001|the Open-label Phase|Lack of Efficacy|0
6801580|NCT02287584|10802707|FG002|the Open-label Phase|Lack of Efficacy|0
6801581|NCT02287584|10802708|FG003|the Open-label Phase|Lack of Efficacy|8
6801582|NCT02287584|10802709|FG004|the Open-label Phase|Lack of Efficacy|3
6801583|NCT02287584|10802710|FG005|the Open-label Phase|Lack of Efficacy|7
6801584|NCT02287584|10802705|FG000|the Open-label Phase|Lost to Follow-up|0
6801585|NCT02287584|10802706|FG001|the Open-label Phase|Lost to Follow-up|0
6801586|NCT02287584|10802707|FG002|the Open-label Phase|Lost to Follow-up|0
6801587|NCT02287584|10802708|FG003|the Open-label Phase|Lost to Follow-up|4
6801588|NCT02287584|10802709|FG004|the Open-label Phase|Lost to Follow-up|1
6801589|NCT02287584|10802710|FG005|the Open-label Phase|Lost to Follow-up|2
6801590|NCT02287584|10802705|FG000|the Open-label Phase|Withdrawal by Subject|0
6801591|NCT02287584|10802706|FG001|the Open-label Phase|Withdrawal by Subject|0
6801592|NCT02287584|10802707|FG002|the Open-label Phase|Withdrawal by Subject|0
6801593|NCT02287584|10802708|FG003|the Open-label Phase|Withdrawal by Subject|18
6801594|NCT02287584|10802709|FG004|the Open-label Phase|Withdrawal by Subject|29
6801595|NCT02287584|10802710|FG005|the Open-label Phase|Withdrawal by Subject|21
6801596|NCT02287584|10802705|FG000|the Open-label Phase|non-compliance|0
6801597|NCT02287584|10802706|FG001|the Open-label Phase|non-compliance|0
6801598|NCT02287584|10802707|FG002|the Open-label Phase|non-compliance|0
6801599|NCT02287584|10802708|FG003|the Open-label Phase|non-compliance|2
6801600|NCT02287584|10802709|FG004|the Open-label Phase|non-compliance|5
6801601|NCT02287584|10802710|FG005|the Open-label Phase|non-compliance|1
6801602|NCT02287584|10802705|FG000|the Open-label Phase|other reasons|0
6801603|NCT02287584|10802706|FG001|the Open-label Phase|other reasons|0
6801604|NCT02287584|10802707|FG002|the Open-label Phase|other reasons|0
6801605|NCT02287584|10802708|FG003|the Open-label Phase|other reasons|3
6801606|NCT02287584|10802709|FG004|the Open-label Phase|other reasons|6
6801607|NCT02287584|10802710|FG005|the Open-label Phase|other reasons|6
6801608|NCT02178566|10802726|FG000|Overall Study|patient did not complete due to noncompliance|0
6801609|NCT02178566|10802727|FG001|Overall Study|patient did not complete due to noncompliance|1
6801610|NCT02173301|10802737|FG000|Overall Study|Adverse Event|7
6801611|NCT02173301|10802738|FG001|Overall Study|Adverse Event|8
6801612|NCT02173301|10802739|FG002|Overall Study|Adverse Event|13
6801613|NCT02173301|10802740|FG003|Overall Study|Adverse Event|5
6801614|NCT02173301|10802737|FG000|Overall Study|Withdrawal by Subject|8
6801615|NCT02173301|10802738|FG001|Overall Study|Withdrawal by Subject|10
6801616|NCT02173301|10802739|FG002|Overall Study|Withdrawal by Subject|4
6801617|NCT02173301|10802740|FG003|Overall Study|Withdrawal by Subject|8
6801618|NCT02173301|10802737|FG000|Overall Study|Lost to Follow-up|4
6801619|NCT02173301|10802738|FG001|Overall Study|Lost to Follow-up|4
6801620|NCT02173301|10802739|FG002|Overall Study|Lost to Follow-up|2
6801621|NCT02173301|10802740|FG003|Overall Study|Lost to Follow-up|2
6801622|NCT02173301|10802737|FG000|Overall Study|Protocol Violation|0
6801623|NCT02173301|10802738|FG001|Overall Study|Protocol Violation|1
6801624|NCT02173301|10802739|FG002|Overall Study|Protocol Violation|0
6801625|NCT02173301|10802740|FG003|Overall Study|Protocol Violation|0
6801626|NCT02173301|10802737|FG000|Overall Study|Physician Decision|0
6801627|NCT02173301|10802738|FG001|Overall Study|Physician Decision|0
6801628|NCT02173301|10802739|FG002|Overall Study|Physician Decision|1
6801629|NCT02173301|10802740|FG003|Overall Study|Physician Decision|0
6801630|NCT02173301|10802737|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1
6801631|NCT02173301|10802738|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0
6801632|NCT02173301|10802739|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0
6809756|NCT01946204|10813515|FG001|Overall Study|Lost to Follow-up|7
6809757|NCT01946204|10813514|FG000|Overall Study|Ongoing|316
6809758|NCT01946204|10813515|FG001|Overall Study|Ongoing|687
6809759|NCT01946204|10813514|FG000|Overall Study|Other|7
6809760|NCT01946204|10813515|FG001|Overall Study|Other|3
6809761|NCT01626079|10813524|FG000|Overall Study|Death|117
6809762|NCT01626079|10813525|FG001|Overall Study|Death|153
6809763|NCT01626079|10813526|FG002|Overall Study|Death|39
6809764|NCT01626079|10813524|FG000|Overall Study|Withdrawal by Subject|15
6809765|NCT01626079|10813525|FG001|Overall Study|Withdrawal by Subject|39
6809766|NCT01626079|10813526|FG002|Overall Study|Withdrawal by Subject|5
6809767|NCT01626079|10813524|FG000|Overall Study|Lost to Follow-up|5
6809768|NCT01626079|10813525|FG001|Overall Study|Lost to Follow-up|4
6809769|NCT01626079|10813526|FG002|Overall Study|Lost to Follow-up|2
6809770|NCT01626079|10813524|FG000|Overall Study|Missed Visits|13
6809771|NCT01626079|10813525|FG001|Overall Study|Missed Visits|5
6809772|NCT01626079|10813526|FG002|Overall Study|Missed Visits|6
6809773|NCT01590628|10813548|FG000|Overall Study|Death|2
6809774|NCT01590628|10813549|FG001|Overall Study|Death|0
6809775|NCT01533714|10813565|FG000|Overall Study|Adverse Event|0
6809776|NCT01533714|10813566|FG001|Overall Study|Adverse Event|1
6809777|NCT01533714|10813567|FG002|Overall Study|Adverse Event|2
6809778|NCT01533714|10813568|FG003|Overall Study|Adverse Event|2
6809779|NCT01533714|10813569|FG004|Overall Study|Adverse Event|2
6809780|NCT01533714|10813570|FG005|Overall Study|Adverse Event|1
6809781|NCT01533714|10813565|FG000|Overall Study|Lack of Efficacy|0
6809782|NCT01533714|10813566|FG001|Overall Study|Lack of Efficacy|0
6809783|NCT01533714|10813567|FG002|Overall Study|Lack of Efficacy|0
6809784|NCT01533714|10813568|FG003|Overall Study|Lack of Efficacy|0
6809785|NCT01533714|10813569|FG004|Overall Study|Lack of Efficacy|0
6809786|NCT01533714|10813570|FG005|Overall Study|Lack of Efficacy|1
6809787|NCT01533714|10813565|FG000|Overall Study|Withdrawal by Subject|0
6809788|NCT01533714|10813566|FG001|Overall Study|Withdrawal by Subject|1
6809789|NCT01533714|10813567|FG002|Overall Study|Withdrawal by Subject|0
6809790|NCT01533714|10813568|FG003|Overall Study|Withdrawal by Subject|1
6809791|NCT01533714|10813569|FG004|Overall Study|Withdrawal by Subject|1
6809792|NCT01533714|10813570|FG005|Overall Study|Withdrawal by Subject|0
6809793|NCT01533714|10813565|FG000|Overall Study|Exclusion criteria|0
6809794|NCT01533714|10813566|FG001|Overall Study|Exclusion criteria|1
6809795|NCT01533714|10813567|FG002|Overall Study|Exclusion criteria|0
6809796|NCT01533714|10813568|FG003|Overall Study|Exclusion criteria|0
6809797|NCT01533714|10813569|FG004|Overall Study|Exclusion criteria|0
6809798|NCT01533714|10813570|FG005|Overall Study|Exclusion criteria|0
6809799|NCT01533714|10813565|FG000|Overall Study|Positive for purified protein derivative|0
6809800|NCT01533714|10813566|FG001|Overall Study|Positive for purified protein derivative|0
6809801|NCT01533714|10813567|FG002|Overall Study|Positive for purified protein derivative|1
6809802|NCT01533714|10813568|FG003|Overall Study|Positive for purified protein derivative|0
6809803|NCT01533714|10813569|FG004|Overall Study|Positive for purified protein derivative|1
6801633|NCT02173301|10802740|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0
6801634|NCT01986114|10802750|FG000|Overall Study|Adverse Event|59
6801635|NCT01986114|10802750|FG000|Overall Study|Lack of Efficacy|23
6801636|NCT01986114|10802750|FG000|Overall Study|Withdrawal by Subject|58
6801637|NCT01986114|10802750|FG000|Overall Study|Noncompliance|3
6801638|NCT01986114|10802750|FG000|Overall Study|Protocol Violation|1
6801639|NCT01986114|10802750|FG000|Overall Study|Lost to Follow-up|5
6801640|NCT01986114|10802750|FG000|Overall Study|Other reason|7
6801641|NCT01813305|10802815|FG000|Overall Study|Withdrawal by Subject|12
6801642|NCT01813305|10802816|FG001|Overall Study|Withdrawal by Subject|5
6801643|NCT01813305|10802815|FG000|Overall Study|Safety Concern|4
6801644|NCT01813305|10802816|FG001|Overall Study|Safety Concern|0
6801645|NCT01813305|10802815|FG000|Overall Study|Ulcer became worse|4
6801646|NCT01813305|10802816|FG001|Overall Study|Ulcer became worse|0
6801647|NCT01813305|10802815|FG000|Overall Study|Physician Decision|4
6801648|NCT01813305|10802816|FG001|Overall Study|Physician Decision|0
6801649|NCT01813305|10802815|FG000|Overall Study|Lost to Follow-up|3
6801650|NCT01813305|10802816|FG001|Overall Study|Lost to Follow-up|1
6801651|NCT01813305|10802815|FG000|Overall Study|Protocol Violation|1
6801652|NCT01813305|10802816|FG001|Overall Study|Protocol Violation|0
6801653|NCT01813305|10802815|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7
6801654|NCT01813305|10802816|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2
6809804|NCT01533714|10813570|FG005|Overall Study|Positive for purified protein derivative|0
6809805|NCT01533714|10813565|FG000|Overall Study|Withdrawal criteria|0
6809806|NCT01533714|10813566|FG001|Overall Study|Withdrawal criteria|0
6809807|NCT01533714|10813567|FG002|Overall Study|Withdrawal criteria|1
6809808|NCT01533714|10813568|FG003|Overall Study|Withdrawal criteria|0
6809809|NCT01533714|10813569|FG004|Overall Study|Withdrawal criteria|3
6809810|NCT01533714|10813570|FG005|Overall Study|Withdrawal criteria|1
6809811|NCT01533714|10813565|FG000|Overall Study|Ineligibility reason|0
6809812|NCT01533714|10813566|FG001|Overall Study|Ineligibility reason|0
6809813|NCT01533714|10813567|FG002|Overall Study|Ineligibility reason|0
6809814|NCT01533714|10813568|FG003|Overall Study|Ineligibility reason|1
6809815|NCT01533714|10813569|FG004|Overall Study|Ineligibility reason|0
6809816|NCT01533714|10813570|FG005|Overall Study|Ineligibility reason|0
6809817|NCT00002931|10813584|FG000|Overall Study|rapidly progressing disease during|2
6809818|NCT00003138|10813590|FG000|Step 1|Reasons off treatment not documented|60
6809819|NCT00003138|10813591|FG001|Step 1|Reasons off treatment not documented|57
6809820|NCT00003138|10813590|FG000|Step 1|Never started treatment|1
6809821|NCT00003138|10813591|FG001|Step 1|Never started treatment|0
6809822|NCT00003138|10813590|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26
6809823|NCT00003138|10813591|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0
6809824|NCT00003138|10813590|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12
6809825|NCT00003138|10813591|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19
6809826|NCT00003138|10813590|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0
6809827|NCT00003138|10813591|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1
6809828|NCT00003138|10813590|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6
6809829|NCT00003138|10813591|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7
6809830|NCT00003199|10813600|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5
6809831|NCT00003199|10813600|FG000|Overall Study|Lack of insurance clearance|2
6809832|NCT00003199|10813600|FG000|Overall Study|Screen fail|15
6809833|NCT00003222|10813606|FG000|Overall Study|Physician Decision|0
6809834|NCT00003222|10813607|FG001|Overall Study|Physician Decision|1
6811111|NCT02407236|10815054|FG002|Induction Study (8 Weeks)|Adverse Event|1
6811112|NCT02407236|10815055|FG003|Induction Study (8 Weeks)|Adverse Event|0
6811113|NCT02407236|10815056|FG004|Induction Study (8 Weeks)|Adverse Event|0
6811114|NCT02407236|10815057|FG005|Induction Study (8 Weeks)|Adverse Event|0
6811115|NCT02407236|10815058|FG006|Induction Study (8 Weeks)|Adverse Event|0
6811116|NCT02407236|10815059|FG007|Induction Study (8 Weeks)|Adverse Event|0
6811117|NCT02407236|10815052|FG000|Induction Study (8 Weeks)|Death|0
6811118|NCT02407236|10815053|FG001|Induction Study (8 Weeks)|Death|0
6811119|NCT02407236|10815054|FG002|Induction Study (8 Weeks)|Death|1
6811120|NCT02407236|10815055|FG003|Induction Study (8 Weeks)|Death|0
6811121|NCT02407236|10815056|FG004|Induction Study (8 Weeks)|Death|0
6811122|NCT02407236|10815057|FG005|Induction Study (8 Weeks)|Death|0
6811123|NCT02407236|10815058|FG006|Induction Study (8 Weeks)|Death|0
6811124|NCT02407236|10815059|FG007|Induction Study (8 Weeks)|Death|0
6811125|NCT02407236|10815052|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17
6811126|NCT02407236|10815053|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9
6811127|NCT02407236|10815054|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7
6811128|NCT02407236|10815055|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0
6811129|NCT02407236|10815056|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0
6811130|NCT02407236|10815057|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0
6811131|NCT02407236|10815058|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0
6811132|NCT02407236|10815059|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0
6811133|NCT02407236|10815052|FG000|Induction Study (8 Weeks)|Lost to Follow-up|0
6811134|NCT02407236|10815053|FG001|Induction Study (8 Weeks)|Lost to Follow-up|0
6811135|NCT02407236|10815054|FG002|Induction Study (8 Weeks)|Lost to Follow-up|1
6811136|NCT02407236|10815055|FG003|Induction Study (8 Weeks)|Lost to Follow-up|0
6811137|NCT02407236|10815056|FG004|Induction Study (8 Weeks)|Lost to Follow-up|0
6811138|NCT02407236|10815057|FG005|Induction Study (8 Weeks)|Lost to Follow-up|0
6811139|NCT02407236|10815058|FG006|Induction Study (8 Weeks)|Lost to Follow-up|0
6811140|NCT02407236|10815059|FG007|Induction Study (8 Weeks)|Lost to Follow-up|0
6811141|NCT02407236|10815052|FG000|Induction Study (8 Weeks)|Physician Decision|1
6811142|NCT02407236|10815053|FG001|Induction Study (8 Weeks)|Physician Decision|1
6811143|NCT02407236|10815054|FG002|Induction Study (8 Weeks)|Physician Decision|0
6811144|NCT02407236|10815055|FG003|Induction Study (8 Weeks)|Physician Decision|0
6801655|NCT01680965|10802828|FG000|Overall Study|Death|0
6801656|NCT01680965|10802829|FG001|Overall Study|Death|0
6801657|NCT01680965|10802830|FG002|Overall Study|Death|0
6801658|NCT01680965|10802831|FG003|Overall Study|Death|6
6801659|NCT01592370|10802863|FG000|Overall Study|Disease Progression|62
6801660|NCT01592370|10802864|FG001|Overall Study|Disease Progression|16
6801661|NCT01592370|10802865|FG002|Overall Study|Disease Progression|52
6801662|NCT01592370|10802866|FG003|Overall Study|Disease Progression|3
6801663|NCT01592370|10802867|FG004|Overall Study|Disease Progression|3
6801664|NCT01592370|10802868|FG005|Overall Study|Disease Progression|31
6801665|NCT01592370|10802869|FG006|Overall Study|Disease Progression|14
6801666|NCT01592370|10802863|FG000|Overall Study|Study Drug Toxicity|14
6801667|NCT01592370|10802864|FG001|Overall Study|Study Drug Toxicity|3
6801668|NCT01592370|10802865|FG002|Overall Study|Study Drug Toxicity|0
6801669|NCT01592370|10802866|FG003|Overall Study|Study Drug Toxicity|0
6801670|NCT01592370|10802867|FG004|Overall Study|Study Drug Toxicity|0
6801671|NCT01592370|10802868|FG005|Overall Study|Study Drug Toxicity|0
6801672|NCT01592370|10802869|FG006|Overall Study|Study Drug Toxicity|1
6801673|NCT01592370|10802863|FG000|Overall Study|AE unrelated to study drug|4
6801674|NCT01592370|10802864|FG001|Overall Study|AE unrelated to study drug|3
6801675|NCT01592370|10802865|FG002|Overall Study|AE unrelated to study drug|0
6801676|NCT01592370|10802866|FG003|Overall Study|AE unrelated to study drug|0
6801677|NCT01592370|10802867|FG004|Overall Study|AE unrelated to study drug|0
6801678|NCT01592370|10802868|FG005|Overall Study|AE unrelated to study drug|0
6801679|NCT01592370|10802869|FG006|Overall Study|AE unrelated to study drug|1
6801680|NCT01592370|10802863|FG000|Overall Study|Request to discontinue study treatment|5
6809837|NCT03969719|10813656|FG000|Overall Study|Other reasons not specified|1
6809838|NCT03969719|10813657|FG001|Overall Study|Other reasons not specified|1
6809839|NCT03969719|10813658|FG002|Overall Study|Other reasons not specified|3
6809840|NCT03969719|10813656|FG000|Overall Study|Withdrawal by Subject|2
6809841|NCT03969719|10813657|FG001|Overall Study|Withdrawal by Subject|3
6809842|NCT03969719|10813658|FG002|Overall Study|Withdrawal by Subject|2
6809843|NCT03969719|10813656|FG000|Overall Study|Protocol Violation|1
6809844|NCT03969719|10813657|FG001|Overall Study|Protocol Violation|2
6809845|NCT03969719|10813658|FG002|Overall Study|Protocol Violation|0
6809846|NCT03969719|10813656|FG000|Overall Study|Adverse Event|0
6809847|NCT03969719|10813657|FG001|Overall Study|Adverse Event|2
6809848|NCT03969719|10813658|FG002|Overall Study|Adverse Event|0
6809849|NCT03969719|10813656|FG000|Overall Study|Lost to Follow-up|0
6809850|NCT03969719|10813657|FG001|Overall Study|Lost to Follow-up|1
6809851|NCT03969719|10813658|FG002|Overall Study|Lost to Follow-up|0
6809852|NCT03883477|10813668|FG000|Overall Study|Death|1
6809853|NCT03883477|10813669|FG001|Overall Study|Death|0
6809854|NCT03883477|10813668|FG000|Overall Study|Protocol Violation|0
6809855|NCT03883477|10813669|FG001|Overall Study|Protocol Violation|1
6809856|NCT03809611|10813698|FG000|Overall Study|Withdrawal by Subject|1
6809857|NCT03809611|10813699|FG001|Overall Study|Withdrawal by Subject|1
6811217|NCT01980940|10815121|FG007|Overall Study|Protocol Violation|0
6811218|NCT01918033|10815152|FG000|Overall Study|Adverse Event|1
6811219|NCT01918033|10815153|FG001|Overall Study|Adverse Event|0
6811220|NCT01918033|10815154|FG002|Overall Study|Adverse Event|2
6811221|NCT01918033|10815152|FG000|Overall Study|Lost to Follow-up|0
6811222|NCT01918033|10815153|FG001|Overall Study|Lost to Follow-up|1
6811223|NCT01918033|10815154|FG002|Overall Study|Lost to Follow-up|0
6811224|NCT01918033|10815152|FG000|Overall Study|Protocol Violation|2
6811225|NCT01918033|10815153|FG001|Overall Study|Protocol Violation|0
6811226|NCT01918033|10815154|FG002|Overall Study|Protocol Violation|1
6811227|NCT01918033|10815152|FG000|Overall Study|Withdrawal by Subject|2
6811228|NCT01918033|10815153|FG001|Overall Study|Withdrawal by Subject|1
6811229|NCT01918033|10815154|FG002|Overall Study|Withdrawal by Subject|0
6811230|NCT01916980|10815164|FG000|Overall Study|Adverse Event|4
6811231|NCT01916980|10815165|FG001|Overall Study|Adverse Event|2
6811232|NCT01916980|10815164|FG000|Overall Study|Lack of Efficacy|2
6811233|NCT01916980|10815165|FG001|Overall Study|Lack of Efficacy|2
6811234|NCT01916980|10815164|FG000|Overall Study|Withdrawal by Subject|1
6811235|NCT01916980|10815165|FG001|Overall Study|Withdrawal by Subject|0
6811236|NCT01916967|10815174|FG000|Overall Study|Adverse Event|0
6811237|NCT01916967|10815175|FG001|Overall Study|Adverse Event|0
6811238|NCT01916967|10815176|FG002|Overall Study|Adverse Event|2
6811239|NCT01916967|10815174|FG000|Overall Study|Lack of Efficacy|0
6811240|NCT01916967|10815175|FG001|Overall Study|Lack of Efficacy|0
6811241|NCT01916967|10815176|FG002|Overall Study|Lack of Efficacy|6
6811242|NCT01916967|10815174|FG000|Overall Study|Physician Decision|0
6811243|NCT01916967|10815175|FG001|Overall Study|Physician Decision|0
6811244|NCT01916967|10815176|FG002|Overall Study|Physician Decision|1
6811245|NCT01916967|10815174|FG000|Overall Study|Protocol Violation|0
6811246|NCT01916967|10815175|FG001|Overall Study|Protocol Violation|1
6811247|NCT01916967|10815176|FG002|Overall Study|Protocol Violation|0
6811248|NCT01910402|10815188|FG000|Randomized Phase|Adverse Event|10
6811249|NCT01910402|10815189|FG001|Randomized Phase|Adverse Event|18
6811250|NCT01910402|10815188|FG000|Randomized Phase|Physician Decision|1
6811251|NCT01910402|10815189|FG001|Randomized Phase|Physician Decision|0
6811252|NCT01910402|10815188|FG000|Randomized Phase|Lack of Efficacy|5
6811253|NCT01910402|10815189|FG001|Randomized Phase|Lack of Efficacy|4
6811254|NCT01910402|10815188|FG000|Randomized Phase|Lost to Follow-up|11
6811255|NCT01910402|10815189|FG001|Randomized Phase|Lost to Follow-up|13
6811256|NCT01910402|10815188|FG000|Randomized Phase|Protocol Violation|10
6811257|NCT01910402|10815189|FG001|Randomized Phase|Protocol Violation|13
6811258|NCT01910402|10815188|FG000|Randomized Phase|Withdrawal by Subject|5
6811259|NCT01910402|10815189|FG001|Randomized Phase|Withdrawal by Subject|7
6811260|NCT01910402|10815188|FG000|Continuation Phase|Ongoing|84
6811261|NCT01910402|10815189|FG001|Continuation Phase|Ongoing|0
6811262|NCT01910402|10815188|FG000|Continuation Phase|Adverse Event|1
6811263|NCT01910402|10815189|FG001|Continuation Phase|Adverse Event|0
6811264|NCT01910402|10815188|FG000|Continuation Phase|Protocol Violation|3
6811265|NCT01910402|10815189|FG001|Continuation Phase|Protocol Violation|0
6811266|NCT01910402|10815188|FG000|Continuation Phase|Withdrawal by Subject|2
6811267|NCT01910402|10815189|FG001|Continuation Phase|Withdrawal by Subject|0
6811268|NCT01870401|10815208|FG000|Overall Study|Death|48
6811269|NCT01870401|10815209|FG001|Overall Study|Death|24
6811270|NCT01870401|10815208|FG000|Overall Study|Withdrawal by Subject|39
6811271|NCT01870401|10815209|FG001|Overall Study|Withdrawal by Subject|26
6811272|NCT01870401|10815208|FG000|Overall Study|Lost to Follow-up|19
6811273|NCT01870401|10815209|FG001|Overall Study|Lost to Follow-up|14
6811274|NCT01870401|10815208|FG000|Overall Study|Other|9
6811275|NCT01870401|10815209|FG001|Overall Study|Other|7
6811276|NCT01870401|10815208|FG000|Overall Study|On-going in the Study|35
6811277|NCT01870401|10815209|FG001|Overall Study|On-going in the Study|25
6811278|NCT01867606|10815219|FG000|Overall Study|Withdrawal by Subject|10
6801681|NCT01592370|10802864|FG001|Overall Study|Request to discontinue study treatment|0
6801682|NCT01592370|10802865|FG002|Overall Study|Request to discontinue study treatment|2
6801683|NCT01592370|10802866|FG003|Overall Study|Request to discontinue study treatment|0
6801684|NCT01592370|10802867|FG004|Overall Study|Request to discontinue study treatment|1
6801685|NCT01592370|10802868|FG005|Overall Study|Request to discontinue study treatment|2
6801686|NCT01592370|10802869|FG006|Overall Study|Request to discontinue study treatment|0
6801687|NCT01592370|10802863|FG000|Overall Study|Withdrew consent|1
6801688|NCT01592370|10802864|FG001|Overall Study|Withdrew consent|2
6801689|NCT01592370|10802865|FG002|Overall Study|Withdrew consent|1
6801690|NCT01592370|10802866|FG003|Overall Study|Withdrew consent|1
6801691|NCT01592370|10802867|FG004|Overall Study|Withdrew consent|0
6801692|NCT01592370|10802868|FG005|Overall Study|Withdrew consent|0
6801693|NCT01592370|10802869|FG006|Overall Study|Withdrew consent|0
6801694|NCT01592370|10802863|FG000|Overall Study|Maximum clinical benefit|11
6801695|NCT01592370|10802864|FG001|Overall Study|Maximum clinical benefit|1
6801696|NCT01592370|10802865|FG002|Overall Study|Maximum clinical benefit|7
6801697|NCT01592370|10802866|FG003|Overall Study|Maximum clinical benefit|1
6801698|NCT01592370|10802867|FG004|Overall Study|Maximum clinical benefit|0
6801699|NCT01592370|10802868|FG005|Overall Study|Maximum clinical benefit|0
6801700|NCT01592370|10802869|FG006|Overall Study|Maximum clinical benefit|0
6801701|NCT01592370|10802863|FG000|Overall Study|No longer meets study criteria|1
6801702|NCT01592370|10802864|FG001|Overall Study|No longer meets study criteria|0
6801703|NCT01592370|10802865|FG002|Overall Study|No longer meets study criteria|0
6801704|NCT01592370|10802866|FG003|Overall Study|No longer meets study criteria|0
6801705|NCT01592370|10802867|FG004|Overall Study|No longer meets study criteria|0
6801706|NCT01592370|10802868|FG005|Overall Study|No longer meets study criteria|0
6801707|NCT01592370|10802869|FG006|Overall Study|No longer meets study criteria|0
6801708|NCT01592370|10802863|FG000|Overall Study|Other Reasons|6
6801709|NCT01592370|10802864|FG001|Overall Study|Other Reasons|0
6801710|NCT01592370|10802865|FG002|Overall Study|Other Reasons|10
6801711|NCT01592370|10802866|FG003|Overall Study|Other Reasons|0
6801712|NCT01592370|10802867|FG004|Overall Study|Other Reasons|0
6801713|NCT01592370|10802868|FG005|Overall Study|Other Reasons|1
6801714|NCT01592370|10802869|FG006|Overall Study|Other Reasons|0
6801715|NCT00152477|10802910|FG000|Chemotherapy Period|Adverse Event|9
6801716|NCT00152477|10802911|FG001|Chemotherapy Period|Adverse Event|4
6801717|NCT00152477|10802912|FG002|Chemotherapy Period|Adverse Event|5
6801718|NCT00152477|10802910|FG000|Chemotherapy Period|Death|1
6801719|NCT00152477|10802911|FG001|Chemotherapy Period|Death|3
6801720|NCT00152477|10802912|FG002|Chemotherapy Period|Death|3
6801721|NCT00152477|10802910|FG000|Chemotherapy Period|Lack of Efficacy|4
6801722|NCT00152477|10802911|FG001|Chemotherapy Period|Lack of Efficacy|5
6801723|NCT00152477|10802912|FG002|Chemotherapy Period|Lack of Efficacy|6
6801724|NCT00152477|10802910|FG000|Chemotherapy Period|Lost to Follow-up|1
6801725|NCT00152477|10802911|FG001|Chemotherapy Period|Lost to Follow-up|0
6801726|NCT00152477|10802912|FG002|Chemotherapy Period|Lost to Follow-up|1
6801727|NCT00152477|10802910|FG000|Chemotherapy Period|Protocol Violation|1
6801728|NCT00152477|10802911|FG001|Chemotherapy Period|Protocol Violation|1
6801729|NCT00152477|10802912|FG002|Chemotherapy Period|Protocol Violation|0
6801730|NCT00152477|10802910|FG000|Chemotherapy Period|Withdrawal by Subject|5
6801731|NCT00152477|10802911|FG001|Chemotherapy Period|Withdrawal by Subject|1
6801732|NCT00152477|10802912|FG002|Chemotherapy Period|Withdrawal by Subject|0
6801733|NCT00152477|10802910|FG000|Chemotherapy Period|Progression of Disease|6
6801734|NCT00152477|10802911|FG001|Chemotherapy Period|Progression of Disease|8
6801735|NCT00152477|10802912|FG002|Chemotherapy Period|Progression of Disease|4
6801736|NCT00152477|10802910|FG000|Chemotherapy Period|Investigator decision|0
6801737|NCT00152477|10802911|FG001|Chemotherapy Period|Investigator decision|0
6801738|NCT00152477|10802912|FG002|Chemotherapy Period|Investigator decision|1
6801739|NCT00152477|10802910|FG000|Chemotherapy Period|Patient condition worsened|1
6801740|NCT00152477|10802911|FG001|Chemotherapy Period|Patient condition worsened|0
6801741|NCT00152477|10802912|FG002|Chemotherapy Period|Patient condition worsened|0
6801742|NCT00152477|10802910|FG000|Monotherapy Period|Adverse Event|1
6801743|NCT00152477|10802911|FG001|Monotherapy Period|Adverse Event|0
6801744|NCT00152477|10802912|FG002|Monotherapy Period|Adverse Event|5
6801745|NCT00152477|10802910|FG000|Monotherapy Period|Death|2
6801746|NCT00152477|10802911|FG001|Monotherapy Period|Death|0
6801747|NCT00152477|10802912|FG002|Monotherapy Period|Death|1
6801748|NCT00152477|10802910|FG000|Monotherapy Period|Lack of Efficacy|7
6801749|NCT00152477|10802911|FG001|Monotherapy Period|Lack of Efficacy|16
6801750|NCT00152477|10802912|FG002|Monotherapy Period|Lack of Efficacy|10
6801751|NCT00152477|10802910|FG000|Monotherapy Period|Protocol Violation|0
6801752|NCT00152477|10802911|FG001|Monotherapy Period|Protocol Violation|1
6801753|NCT00152477|10802912|FG002|Monotherapy Period|Protocol Violation|0
6801754|NCT00152477|10802910|FG000|Monotherapy Period|Withdrawal by Subject|0
6801755|NCT00152477|10802911|FG001|Monotherapy Period|Withdrawal by Subject|0
6801756|NCT00152477|10802912|FG002|Monotherapy Period|Withdrawal by Subject|4
6801757|NCT00152477|10802910|FG000|Monotherapy Period|Progression of Disease|5
6801758|NCT00152477|10802911|FG001|Monotherapy Period|Progression of Disease|11
6801759|NCT00152477|10802912|FG002|Monotherapy Period|Progression of Disease|12
6801760|NCT00152477|10802910|FG000|Monotherapy Period|Patient decision|0
6801761|NCT00152477|10802911|FG001|Monotherapy Period|Patient decision|1
6801762|NCT00152477|10802912|FG002|Monotherapy Period|Patient decision|1
6801763|NCT00152477|10802910|FG000|Monotherapy Period|Study personel decision|0
6801764|NCT00152477|10802911|FG001|Monotherapy Period|Study personel decision|0
6801765|NCT00152477|10802912|FG002|Monotherapy Period|Study personel decision|1
6809835|NCT04848662|10813642|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1
6809836|NCT04848662|10813643|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0
6809858|NCT03721705|10813708|FG000|Overall Study|Adverse Event|2
6809859|NCT03721705|10813709|FG001|Overall Study|Adverse Event|0
6809860|NCT03721705|10813708|FG000|Overall Study|Withdrawal by Subject|4
6809861|NCT03721705|10813709|FG001|Overall Study|Withdrawal by Subject|10
6809862|NCT03721705|10813708|FG000|Overall Study|No Suitable Study Partner|1
6809863|NCT03721705|10813709|FG001|Overall Study|No Suitable Study Partner|0
6809864|NCT03721705|10813708|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3
6809865|NCT03721705|10813709|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7
6809866|NCT03721705|10813708|FG000|Overall Study|Death|0
6809867|NCT03721705|10813709|FG001|Overall Study|Death|1
6809868|NCT03505021|10813717|FG000|Overall Study|Protocol Violation|1
6809869|NCT03505021|10813718|FG001|Overall Study|Protocol Violation|0
6809870|NCT03505021|10813717|FG000|Overall Study|Death|9
6809871|NCT03505021|10813718|FG001|Overall Study|Death|8
6809872|NCT03505021|10813717|FG000|Overall Study|Consent withdrawn by subject|6
6809873|NCT03505021|10813718|FG001|Overall Study|Consent withdrawn by subject|1
6809874|NCT03505021|10813717|FG000|Overall Study|Lost to Follow-up|5
6809875|NCT03505021|10813718|FG001|Overall Study|Lost to Follow-up|3
6809876|NCT03505021|10813717|FG000|Overall Study|Adverse Event|26
6809877|NCT03505021|10813718|FG001|Overall Study|Adverse Event|9
6809878|NCT03505021|10813717|FG000|Overall Study|Disease progression|33
6809879|NCT03505021|10813718|FG001|Overall Study|Disease progression|17
6809880|NCT03505021|10813717|FG000|Overall Study|Other|11
6809881|NCT03505021|10813718|FG001|Overall Study|Other|5
6809882|NCT03505021|10813717|FG000|Overall Study|Personal reason|21
6809883|NCT03505021|10813718|FG001|Overall Study|Personal reason|12
6809884|NCT03366194|10813747|FG000|Overall Study|Lost to Follow-up|2
6809885|NCT03203473|10813761|FG000|Induction Phase|Never started primary treatment|2
6809886|NCT03203473|10813762|FG001|Induction Phase|Never started primary treatment|0
6809887|NCT03203473|10813763|FG002|Induction Phase|Never started primary treatment|0
6809888|NCT03203473|10813761|FG000|Induction Phase|Withdrew from study due to progressive disease|7
6809889|NCT03203473|10813762|FG001|Induction Phase|Withdrew from study due to progressive disease|0
6809890|NCT03203473|10813763|FG002|Induction Phase|Withdrew from study due to progressive disease|0
6809891|NCT03203473|10813761|FG000|Induction Phase|Withdrew from study due to toxicity|7
6809892|NCT03203473|10813762|FG001|Induction Phase|Withdrew from study due to toxicity|0
6809893|NCT03203473|10813763|FG002|Induction Phase|Withdrew from study due to toxicity|0
6809894|NCT03203473|10813761|FG000|Arm Allocation Phase|Still on Arm A-observation|0
6801766|NCT04585646|10802923|FG000|First Intervention|Physician Decision|1
6801767|NCT04585646|10802924|FG001|First Intervention|Physician Decision|0
6801768|NCT04585646|10802923|FG000|First Intervention|Lost to Follow-up|0
6801769|NCT04585646|10802924|FG001|First Intervention|Lost to Follow-up|3
6801770|NCT04585646|10802923|FG000|First Intervention|Withdrawal by Subject|0
6801771|NCT04585646|10802924|FG001|First Intervention|Withdrawal by Subject|1
6801784|NCT03828383|10803013|FG000|Overall Study|Lost to Follow-up|3
6801785|NCT03828383|10803014|FG001|Overall Study|Lost to Follow-up|2
6801786|NCT03828383|10803013|FG000|Overall Study|Withdrawal by Subject|4
6801787|NCT03828383|10803014|FG001|Overall Study|Withdrawal by Subject|5
6801788|NCT03817853|10803020|FG000|Induction Phase|Adverse Event|5
6801789|NCT03817853|10803021|FG001|Induction Phase|Adverse Event|0
6801790|NCT03817853|10803022|FG002|Induction Phase|Adverse Event|0
6801791|NCT03817853|10803020|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3
6801792|NCT03817853|10803021|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0
6801793|NCT03817853|10803022|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0
6801794|NCT03817853|10803020|FG000|Induction Phase|Physician Decision|2
6801795|NCT03817853|10803021|FG001|Induction Phase|Physician Decision|0
6801796|NCT03817853|10803022|FG002|Induction Phase|Physician Decision|0
6801797|NCT03817853|10803020|FG000|Induction Phase|Progressive Disease|4
6801798|NCT03817853|10803021|FG001|Induction Phase|Progressive Disease|0
6801799|NCT03817853|10803022|FG002|Induction Phase|Progressive Disease|0
6801800|NCT03817853|10803020|FG000|Induction Phase|Withdrawal by Subject|3
6801801|NCT03817853|10803021|FG001|Induction Phase|Withdrawal by Subject|0
6801802|NCT03817853|10803022|FG002|Induction Phase|Withdrawal by Subject|0
6801803|NCT03817853|10803020|FG000|Induction Phase|Continuing on Study|34
6801804|NCT03817853|10803021|FG001|Induction Phase|Continuing on Study|0
6801805|NCT03817853|10803022|FG002|Induction Phase|Continuing on Study|0
6801806|NCT03817853|10803020|FG000|Maintenance/ Follow-up Phase|Adverse Event|0
6801807|NCT03817853|10803021|FG001|Maintenance/ Follow-up Phase|Adverse Event|1
6801808|NCT03817853|10803022|FG002|Maintenance/ Follow-up Phase|Adverse Event|0
6801809|NCT03817853|10803020|FG000|Maintenance/ Follow-up Phase|Death|0
6801810|NCT03817853|10803021|FG001|Maintenance/ Follow-up Phase|Death|1
6801811|NCT03817853|10803022|FG002|Maintenance/ Follow-up Phase|Death|1
6801812|NCT03817853|10803020|FG000|Maintenance/ Follow-up Phase|Progressive Disease|0
6801813|NCT03817853|10803021|FG001|Maintenance/ Follow-up Phase|Progressive Disease|1
6801814|NCT03817853|10803022|FG002|Maintenance/ Follow-up Phase|Progressive Disease|3
6801815|NCT03817853|10803020|FG000|Maintenance/ Follow-up Phase|Withdrawal by Subject|0
6801816|NCT03817853|10803021|FG001|Maintenance/ Follow-up Phase|Withdrawal by Subject|1
6801817|NCT03817853|10803022|FG002|Maintenance/ Follow-up Phase|Withdrawal by Subject|0
6801818|NCT03817853|10803020|FG000|Maintenance/ Follow-up Phase|Continuing on Study|0
6801819|NCT03817853|10803021|FG001|Maintenance/ Follow-up Phase|Continuing on Study|52
6801820|NCT03817853|10803022|FG002|Maintenance/ Follow-up Phase|Continuing on Study|2
6801821|NCT03717480|10803030|FG000|Overall Study|Never received investigational product due to product viability limitations.|1
6801822|NCT03615066|10803037|FG000|Main Study|Withdrew Consent|0
6801823|NCT03615066|10803038|FG001|Main Study|Withdrew Consent|1
6801824|NCT03615066|10803039|FG002|Main Study|Withdrew Consent|1
6801825|NCT03615066|10803037|FG000|Main Study|Lost to Follow-up|0
6801826|NCT03615066|10803038|FG001|Main Study|Lost to Follow-up|0
6801827|NCT03615066|10803039|FG002|Main Study|Lost to Follow-up|1
6801828|NCT03615066|10803037|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1
6801829|NCT03615066|10803038|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0
6801830|NCT03615066|10803039|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0
6801831|NCT03615066|10803037|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1
6801832|NCT03615066|10803038|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0
6801833|NCT03615066|10803039|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0
6801834|NCT03615066|10803037|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0
6801835|NCT03615066|10803038|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1
6801836|NCT03615066|10803039|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0
6801837|NCT03557931|10803054|FG000|Overall Study|Adverse Event|4
6801838|NCT03557931|10803055|FG001|Overall Study|Adverse Event|6
6801839|NCT03557931|10803056|FG002|Overall Study|Adverse Event|1
6801840|NCT03557931|10803054|FG000|Overall Study|Lost to Follow-up|4
6801841|NCT03557931|10803055|FG001|Overall Study|Lost to Follow-up|4
6801842|NCT03557931|10803056|FG002|Overall Study|Lost to Follow-up|1
6801843|NCT03557931|10803054|FG000|Overall Study|Protocol Violation|1
6801844|NCT03557931|10803055|FG001|Overall Study|Protocol Violation|4
6801845|NCT03557931|10803056|FG002|Overall Study|Protocol Violation|1
6801846|NCT03557931|10803054|FG000|Overall Study|Withdrawal by Subject|14
6801847|NCT03557931|10803055|FG001|Overall Study|Withdrawal by Subject|0
6801848|NCT03557931|10803056|FG002|Overall Study|Withdrawal by Subject|7
6801772|NCT04451330|10802933|FG000|Overall Study|Adverse Event|1
6801773|NCT04451330|10802934|FG001|Overall Study|Adverse Event|2
6801774|NCT04451330|10802933|FG000|Overall Study|Lost to Follow-up|5
6801775|NCT04451330|10802934|FG001|Overall Study|Lost to Follow-up|0
6801776|NCT04451330|10802933|FG000|Overall Study|Withdrawal by Subject|3
6801777|NCT04451330|10802934|FG001|Overall Study|Withdrawal by Subject|1
6801778|NCT04451330|10802933|FG000|Overall Study|Withdrawal by parent/guardian|1
6801779|NCT04451330|10802934|FG001|Overall Study|Withdrawal by parent/guardian|0
6801780|NCT04451330|10802933|FG000|Overall Study|Other than specified|0
6801781|NCT04451330|10802934|FG001|Overall Study|Other than specified|1
6801782|NCT04003623|10802994|FG000|Overall Study|Withdrawal by Subject|1
6801783|NCT04003623|10802995|FG001|Overall Study|Withdrawal by Subject|0
6801849|NCT03557931|10803054|FG000|Overall Study|Miscellaneous|8
6801850|NCT03557931|10803055|FG001|Overall Study|Miscellaneous|5
6801851|NCT03557931|10803056|FG002|Overall Study|Miscellaneous|3
6801852|NCT02596035|10803078|FG000|Overall Study|Disease Progression|62
6801853|NCT02596035|10803079|FG001|Overall Study|Disease Progression|32
6801854|NCT02596035|10803080|FG002|Overall Study|Disease Progression|1
6801855|NCT02596035|10803078|FG000|Overall Study|Study Drug Toxicity|11
6801856|NCT02596035|10803079|FG001|Overall Study|Study Drug Toxicity|3
6801857|NCT02596035|10803080|FG002|Overall Study|Study Drug Toxicity|0
6801858|NCT02596035|10803078|FG000|Overall Study|Adverse Event|6
6801859|NCT02596035|10803079|FG001|Overall Study|Adverse Event|2
6801860|NCT02596035|10803080|FG002|Overall Study|Adverse Event|0
6801861|NCT02596035|10803078|FG000|Overall Study|Withdrawal by Subject|4
6801862|NCT02596035|10803079|FG001|Overall Study|Withdrawal by Subject|2
6801863|NCT02596035|10803080|FG002|Overall Study|Withdrawal by Subject|0
6801864|NCT02596035|10803078|FG000|Overall Study|Poor/Non-Compliance|0
6801865|NCT02596035|10803079|FG001|Overall Study|Poor/Non-Compliance|1
6801866|NCT02596035|10803080|FG002|Overall Study|Poor/Non-Compliance|0
6801867|NCT02596035|10803078|FG000|Overall Study|Other Reasons|3
6801868|NCT02596035|10803079|FG001|Overall Study|Other Reasons|4
6801869|NCT02596035|10803080|FG002|Overall Study|Other Reasons|0
6801870|NCT02576509|10803089|FG000|Pre-Treatment Period|Participant request to stop therapy|0
6801871|NCT02576509|10803090|FG001|Pre-Treatment Period|Participant request to stop therapy|2
6801872|NCT02576509|10803089|FG000|Pre-Treatment Period|Participant withdrew consent|1
6801873|NCT02576509|10803090|FG001|Pre-Treatment Period|Participant withdrew consent|5
6801874|NCT02576509|10803089|FG000|Pre-Treatment Period|Participant no longer meets criteria|3
6801875|NCT02576509|10803090|FG001|Pre-Treatment Period|Participant no longer meets criteria|2
6801876|NCT02576509|10803089|FG000|Treatment Period|Disease progression|245
6801877|NCT02576509|10803090|FG001|Treatment Period|Disease progression|240
6801878|NCT02576509|10803089|FG000|Treatment Period|Study drug toxicity|32
6801879|NCT02576509|10803090|FG001|Treatment Period|Study drug toxicity|41
6801880|NCT02576509|10803089|FG000|Treatment Period|Death|1
6801881|NCT02576509|10803090|FG001|Treatment Period|Death|1
6801882|NCT02576509|10803089|FG000|Treatment Period|Adverse event unrelated to study drug|37
6801883|NCT02576509|10803090|FG001|Treatment Period|Adverse event unrelated to study drug|40
6801884|NCT02576509|10803089|FG000|Treatment Period|Participant request to stop treatment|8
6801885|NCT02576509|10803090|FG001|Treatment Period|Participant request to stop treatment|17
6801886|NCT02576509|10803089|FG000|Treatment Period|Participant withdrew consent|2
6801887|NCT02576509|10803090|FG001|Treatment Period|Participant withdrew consent|7
6801888|NCT02576509|10803089|FG000|Treatment Period|Lost to Follow-up|0
6801889|NCT02576509|10803090|FG001|Treatment Period|Lost to Follow-up|1
6801890|NCT02576509|10803089|FG000|Treatment Period|Maximum clinical benefit|1
6801891|NCT02576509|10803090|FG001|Treatment Period|Maximum clinical benefit|0
6801892|NCT02576509|10803089|FG000|Treatment Period|Poor/non-compliance|0
6801893|NCT02576509|10803090|FG001|Treatment Period|Poor/non-compliance|1
6801894|NCT02576509|10803089|FG000|Treatment Period|Participant no longer meets criteria|1
6801895|NCT02576509|10803090|FG001|Treatment Period|Participant no longer meets criteria|0
6801896|NCT02576509|10803089|FG000|Treatment Period|Other reason|2
6801897|NCT02576509|10803090|FG001|Treatment Period|Other reason|7
6801898|NCT02576509|10803089|FG000|Follow-up Period|Death|41
6801899|NCT02576509|10803090|FG001|Follow-up Period|Death|35
6801900|NCT02576509|10803089|FG000|Follow-up Period|Participant withdrew consent|7
6801901|NCT02576509|10803090|FG001|Follow-up Period|Participant withdrew consent|14
6801902|NCT02576509|10803089|FG000|Follow-up Period|Lost to Follow-up|0
6801903|NCT02576509|10803090|FG001|Follow-up Period|Lost to Follow-up|1
6801904|NCT02576509|10803089|FG000|Follow-up Period|Other reason|1
6801905|NCT02576509|10803090|FG001|Follow-up Period|Other reason|2
6801906|NCT02448225|10803105|FG000|Overall Study|Withdrawal by Subject|1
6801907|NCT02448225|10803105|FG000|Overall Study|Did not get FSPG scan|18
6801908|NCT02448225|10803105|FG000|Overall Study|Treated between the FDG and FSPG scan|1
6801909|NCT02352948|10803118|FG000|Overall Study|Death|47
6801910|NCT02352948|10803119|FG001|Overall Study|Death|48
6801911|NCT02352948|10803120|FG002|Overall Study|Death|114
6801912|NCT02352948|10803121|FG003|Overall Study|Death|74
6801913|NCT02352948|10803122|FG004|Overall Study|Death|77
6801914|NCT02352948|10803123|FG005|Overall Study|Death|44
6801915|NCT02352948|10803118|FG000|Overall Study|Lost to Follow-up|1
6801916|NCT02352948|10803119|FG001|Overall Study|Lost to Follow-up|0
6801917|NCT02352948|10803120|FG002|Overall Study|Lost to Follow-up|2
6801918|NCT02352948|10803121|FG003|Overall Study|Lost to Follow-up|1
6801919|NCT02352948|10803122|FG004|Overall Study|Lost to Follow-up|2
6801920|NCT02352948|10803123|FG005|Overall Study|Lost to Follow-up|1
6801921|NCT02352948|10803118|FG000|Overall Study|Withdrawal by Subject|1
6801922|NCT02352948|10803119|FG001|Overall Study|Withdrawal by Subject|10
6801923|NCT02352948|10803120|FG002|Overall Study|Withdrawal by Subject|11
6801924|NCT02352948|10803121|FG003|Overall Study|Withdrawal by Subject|23
6801925|NCT02352948|10803122|FG004|Overall Study|Withdrawal by Subject|9
6801926|NCT02352948|10803123|FG005|Overall Study|Withdrawal by Subject|4
6801927|NCT02352948|10803118|FG000|Overall Study|Eligibility criteria not fulfilled|0
6801928|NCT02352948|10803119|FG001|Overall Study|Eligibility criteria not fulfilled|1
6801929|NCT02352948|10803120|FG002|Overall Study|Eligibility criteria not fulfilled|0
6801930|NCT02352948|10803121|FG003|Overall Study|Eligibility criteria not fulfilled|1
6801931|NCT02352948|10803122|FG004|Overall Study|Eligibility criteria not fulfilled|0
6801932|NCT02352948|10803123|FG005|Overall Study|Eligibility criteria not fulfilled|0
6801933|NCT02352948|10803118|FG000|Overall Study|Other|0
6801934|NCT02352948|10803119|FG001|Overall Study|Other|0
6801935|NCT02352948|10803120|FG002|Overall Study|Other|2
6801936|NCT02352948|10803121|FG003|Overall Study|Other|0
6801937|NCT02352948|10803122|FG004|Overall Study|Other|0
6801938|NCT02352948|10803123|FG005|Overall Study|Other|0
6801939|NCT02318095|10803143|FG000|Overall Study|Adverse Event|1
6801940|NCT02257528|10803148|FG000|Overall Study|Never received study treatment|1
6801941|NCT02155647|10803154|FG000|Overall Study|Still on Treatment|26
6801942|NCT02155647|10803155|FG001|Overall Study|Still on Treatment|26
6801943|NCT02155647|10803154|FG000|Overall Study|Off-Treatment, but follow up ongoing|15
6801944|NCT02155647|10803155|FG001|Overall Study|Off-Treatment, but follow up ongoing|26
6809895|NCT03203473|10813762|FG001|Arm Allocation Phase|Still on Arm A-observation|7
6809896|NCT03203473|10813763|FG002|Arm Allocation Phase|Still on Arm A-observation|0
6809897|NCT03203473|10813761|FG000|Arm Allocation Phase|started salvage therapy|0
6809898|NCT03203473|10813762|FG001|Arm Allocation Phase|started salvage therapy|5
6809899|NCT03203473|10813763|FG002|Arm Allocation Phase|started salvage therapy|0
6809900|NCT03203473|10813761|FG000|Arm Allocation Phase|Disease progression|0
6809901|NCT03203473|10813762|FG001|Arm Allocation Phase|Disease progression|0
6809902|NCT03203473|10813763|FG002|Arm Allocation Phase|Disease progression|37
6809903|NCT03203473|10813761|FG000|Arm Allocation Phase|Adverse Event|0
6809904|NCT03203473|10813762|FG001|Arm Allocation Phase|Adverse Event|0
6809905|NCT03203473|10813763|FG002|Arm Allocation Phase|Adverse Event|11
6809906|NCT03203473|10813761|FG000|Arm Allocation Phase|Physician Decision|0
6809907|NCT03203473|10813762|FG001|Arm Allocation Phase|Physician Decision|0
6809908|NCT03203473|10813763|FG002|Arm Allocation Phase|Physician Decision|3
6809909|NCT03203473|10813761|FG000|Arm Allocation Phase|Death|0
6809910|NCT03203473|10813762|FG001|Arm Allocation Phase|Death|0
6809911|NCT03203473|10813763|FG002|Arm Allocation Phase|Death|1
6809912|NCT03203473|10813761|FG000|Arm Allocation Phase|Developed 2nd cancer|0
6809913|NCT03203473|10813762|FG001|Arm Allocation Phase|Developed 2nd cancer|0
6809914|NCT03203473|10813763|FG002|Arm Allocation Phase|Developed 2nd cancer|1
6809915|NCT03203473|10813761|FG000|Arm Allocation Phase|Intercurrent illness|0
6809916|NCT03203473|10813762|FG001|Arm Allocation Phase|Intercurrent illness|0
6809917|NCT03203473|10813763|FG002|Arm Allocation Phase|Intercurrent illness|1
6801946|NCT01904903|10803182|FG000|Overall Study|Withdrawal by Subject|1
6801947|NCT01827384|10803200|FG000|Overall Study|Switched to alternative treatment|0
6801948|NCT01827384|10803201|FG001|Overall Study|Switched to alternative treatment|0
6801949|NCT01827384|10803202|FG002|Overall Study|Switched to alternative treatment|0
6801950|NCT01827384|10803203|FG003|Overall Study|Switched to alternative treatment|0
6801951|NCT01827384|10803204|FG004|Overall Study|Switched to alternative treatment|0
6801952|NCT01827384|10803205|FG005|Overall Study|Switched to alternative treatment|0
6801953|NCT01827384|10803206|FG006|Overall Study|Switched to alternative treatment|0
6801954|NCT01827384|10803207|FG007|Overall Study|Switched to alternative treatment|0
6801955|NCT01827384|10803208|FG008|Overall Study|Switched to alternative treatment|0
6801956|NCT01827384|10803209|FG009|Overall Study|Switched to alternative treatment|0
6801957|NCT01827384|10803210|FG010|Overall Study|Switched to alternative treatment|0
6801958|NCT01827384|10803211|FG011|Overall Study|Switched to alternative treatment|0
6801959|NCT01827384|10803212|FG012|Overall Study|Switched to alternative treatment|0
6801960|NCT01827384|10803213|FG013|Overall Study|Switched to alternative treatment|2
6801961|NCT01827384|10803200|FG000|Overall Study|Disease progression before treatment|0
6801962|NCT01827384|10803201|FG001|Overall Study|Disease progression before treatment|0
6801963|NCT01827384|10803202|FG002|Overall Study|Disease progression before treatment|0
6801964|NCT01827384|10803203|FG003|Overall Study|Disease progression before treatment|0
6801965|NCT01827384|10803204|FG004|Overall Study|Disease progression before treatment|0
6801966|NCT01827384|10803205|FG005|Overall Study|Disease progression before treatment|0
6801967|NCT01827384|10803206|FG006|Overall Study|Disease progression before treatment|0
6801968|NCT01827384|10803207|FG007|Overall Study|Disease progression before treatment|0
6801969|NCT01827384|10803208|FG008|Overall Study|Disease progression before treatment|0
6801970|NCT01827384|10803209|FG009|Overall Study|Disease progression before treatment|0
6801971|NCT01827384|10803210|FG010|Overall Study|Disease progression before treatment|0
6801972|NCT01827384|10803211|FG011|Overall Study|Disease progression before treatment|0
6801973|NCT01827384|10803212|FG012|Overall Study|Disease progression before treatment|0
6801974|NCT01827384|10803213|FG013|Overall Study|Disease progression before treatment|4
6801975|NCT01827384|10803200|FG000|Overall Study|Ineligible|0
6801976|NCT01827384|10803201|FG001|Overall Study|Ineligible|0
6801977|NCT01827384|10803202|FG002|Overall Study|Ineligible|0
6801978|NCT01827384|10803203|FG003|Overall Study|Ineligible|0
6801979|NCT01827384|10803204|FG004|Overall Study|Ineligible|0
6801980|NCT01827384|10803205|FG005|Overall Study|Ineligible|0
6801981|NCT01827384|10803206|FG006|Overall Study|Ineligible|0
6801982|NCT01827384|10803207|FG007|Overall Study|Ineligible|0
6801983|NCT01827384|10803208|FG008|Overall Study|Ineligible|0
6801984|NCT01827384|10803209|FG009|Overall Study|Ineligible|0
6801985|NCT01827384|10803210|FG010|Overall Study|Ineligible|0
6801986|NCT01827384|10803211|FG011|Overall Study|Ineligible|0
6801987|NCT01827384|10803212|FG012|Overall Study|Ineligible|0
6801988|NCT01827384|10803213|FG013|Overall Study|Ineligible|19
6801989|NCT01827384|10803200|FG000|Overall Study|Participant died before treatment|0
6801990|NCT01827384|10803201|FG001|Overall Study|Participant died before treatment|0
6801991|NCT01827384|10803202|FG002|Overall Study|Participant died before treatment|0
6801992|NCT01827384|10803203|FG003|Overall Study|Participant died before treatment|0
6801993|NCT01827384|10803204|FG004|Overall Study|Participant died before treatment|0
6801994|NCT01827384|10803205|FG005|Overall Study|Participant died before treatment|0
6801995|NCT01827384|10803206|FG006|Overall Study|Participant died before treatment|0
6801996|NCT01827384|10803207|FG007|Overall Study|Participant died before treatment|0
6801997|NCT01827384|10803208|FG008|Overall Study|Participant died before treatment|0
6801998|NCT01827384|10803209|FG009|Overall Study|Participant died before treatment|0
6801999|NCT01827384|10803210|FG010|Overall Study|Participant died before treatment|0
6802000|NCT01827384|10803211|FG011|Overall Study|Participant died before treatment|0
6802001|NCT01827384|10803212|FG012|Overall Study|Participant died before treatment|0
6802002|NCT01827384|10803213|FG013|Overall Study|Participant died before treatment|5
6802003|NCT01827384|10803200|FG000|Overall Study|Insufficient tumor cells|0
6802004|NCT01827384|10803201|FG001|Overall Study|Insufficient tumor cells|0
6802005|NCT01827384|10803202|FG002|Overall Study|Insufficient tumor cells|0
6802006|NCT01827384|10803203|FG003|Overall Study|Insufficient tumor cells|0
6802007|NCT01827384|10803204|FG004|Overall Study|Insufficient tumor cells|0
6802008|NCT01827384|10803205|FG005|Overall Study|Insufficient tumor cells|0
6802009|NCT01827384|10803206|FG006|Overall Study|Insufficient tumor cells|0
6802010|NCT01827384|10803207|FG007|Overall Study|Insufficient tumor cells|0
6802011|NCT01827384|10803208|FG008|Overall Study|Insufficient tumor cells|0
6802012|NCT01827384|10803209|FG009|Overall Study|Insufficient tumor cells|0
6802013|NCT01827384|10803210|FG010|Overall Study|Insufficient tumor cells|0
6802014|NCT01827384|10803211|FG011|Overall Study|Insufficient tumor cells|0
6802015|NCT01827384|10803212|FG012|Overall Study|Insufficient tumor cells|0
6802016|NCT01827384|10803213|FG013|Overall Study|Insufficient tumor cells|13
6802017|NCT01827384|10803200|FG000|Overall Study|No actionable mutation|0
6802018|NCT01827384|10803201|FG001|Overall Study|No actionable mutation|0
6802019|NCT01827384|10803202|FG002|Overall Study|No actionable mutation|0
6802020|NCT01827384|10803203|FG003|Overall Study|No actionable mutation|0
6802021|NCT01827384|10803204|FG004|Overall Study|No actionable mutation|0
6802022|NCT01827384|10803205|FG005|Overall Study|No actionable mutation|0
6802023|NCT01827384|10803206|FG006|Overall Study|No actionable mutation|0
6802024|NCT01827384|10803207|FG007|Overall Study|No actionable mutation|0
6802025|NCT01827384|10803208|FG008|Overall Study|No actionable mutation|0
6802026|NCT01827384|10803209|FG009|Overall Study|No actionable mutation|0
6802027|NCT01827384|10803210|FG010|Overall Study|No actionable mutation|0
6802028|NCT01827384|10803211|FG011|Overall Study|No actionable mutation|0
6802029|NCT01827384|10803212|FG012|Overall Study|No actionable mutation|0
6802030|NCT01827384|10803213|FG013|Overall Study|No actionable mutation|73
6802031|NCT01827384|10803200|FG000|Overall Study|Participant declined to participate (before treatment started)|0
6802032|NCT01827384|10803201|FG001|Overall Study|Participant declined to participate (before treatment started)|0
6802033|NCT01827384|10803202|FG002|Overall Study|Participant declined to participate (before treatment started)|0
6802034|NCT01827384|10803203|FG003|Overall Study|Participant declined to participate (before treatment started)|0
6802035|NCT01827384|10803204|FG004|Overall Study|Participant declined to participate (before treatment started)|0
6802036|NCT01827384|10803205|FG005|Overall Study|Participant declined to participate (before treatment started)|0
6802037|NCT01827384|10803206|FG006|Overall Study|Participant declined to participate (before treatment started)|0
6802038|NCT01827384|10803207|FG007|Overall Study|Participant declined to participate (before treatment started)|0
6802039|NCT01827384|10803208|FG008|Overall Study|Participant declined to participate (before treatment started)|0
6802040|NCT01827384|10803209|FG009|Overall Study|Participant declined to participate (before treatment started)|0
6802041|NCT01827384|10803210|FG010|Overall Study|Participant declined to participate (before treatment started)|0
6802042|NCT01827384|10803211|FG011|Overall Study|Participant declined to participate (before treatment started)|0
6802043|NCT01827384|10803212|FG012|Overall Study|Participant declined to participate (before treatment started)|0
6802044|NCT01827384|10803213|FG013|Overall Study|Participant declined to participate (before treatment started)|15
6802045|NCT01636258|10803249|FG000|Overall Study|Lost to Follow-up|1
6802046|NCT01636258|10803250|FG001|Overall Study|Lost to Follow-up|0
6802047|NCT01517802|10803311|FG000|Overall Study|Death|1
6802086|NCT00455325|10803351|FG000|Cohort 1: Placebo|Started exclusionary drug|1
6802087|NCT00455325|10803352|FG001|Cohort 1: Placebo|Started exclusionary drug|0
6802088|NCT00455325|10803353|FG002|Cohort 1: Placebo|Started exclusionary drug|0
6802089|NCT00455325|10803354|FG003|Cohort 1: Placebo|Started exclusionary drug|0
6802090|NCT00455325|10803351|FG000|Cohort 1: Placebo|Withdrawal by Subject|4
6802091|NCT00455325|10803352|FG001|Cohort 1: Placebo|Withdrawal by Subject|0
6802092|NCT00455325|10803353|FG002|Cohort 1: Placebo|Withdrawal by Subject|0
6802093|NCT00455325|10803354|FG003|Cohort 1: Placebo|Withdrawal by Subject|0
6802094|NCT00455325|10803351|FG000|Cohort 1: Placebo|Lost to Follow-up|1
6802095|NCT00455325|10803352|FG001|Cohort 1: Placebo|Lost to Follow-up|0
6802096|NCT00455325|10803353|FG002|Cohort 1: Placebo|Lost to Follow-up|0
6802097|NCT00455325|10803354|FG003|Cohort 1: Placebo|Lost to Follow-up|0
6802098|NCT00455325|10803351|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1
6802099|NCT00455325|10803352|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0
6802100|NCT00455325|10803353|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0
6802101|NCT00455325|10803354|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0
6802102|NCT00455325|10803351|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1
6802103|NCT00455325|10803352|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0
6802104|NCT00455325|10803353|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0
6811279|NCT01867606|10815220|FG001|Overall Study|Withdrawal by Subject|14
6811280|NCT01867606|10815219|FG000|Overall Study|Protocol Violation|0
6811281|NCT01867606|10815220|FG001|Overall Study|Protocol Violation|1
6811282|NCT01857063|10815234|FG000|Period 1 (7 Days)|Adverse Event|0
6811283|NCT01857063|10815235|FG001|Period 1 (7 Days)|Adverse Event|1
6811284|NCT01857063|10815234|FG000|Period 1 (7 Days)|Physician Decision|1
6811285|NCT01857063|10815235|FG001|Period 1 (7 Days)|Physician Decision|0
6811286|NCT01857063|10815234|FG000|Period 1 (7 Days)|Withdrawal by Subject|1
6811287|NCT01857063|10815235|FG001|Period 1 (7 Days)|Withdrawal by Subject|3
6811288|NCT01857063|10815234|FG000|Period 2 (7 Days)|Adverse Event|2
6811289|NCT01857063|10815235|FG001|Period 2 (7 Days)|Adverse Event|1
6811290|NCT01857063|10815234|FG000|Period 2 (7 Days)|Physician Decision|1
6811291|NCT01857063|10815235|FG001|Period 2 (7 Days)|Physician Decision|1
6811292|NCT01857063|10815234|FG000|Period 2 (7 Days)|Withdrawal by Subject|1
6811293|NCT01857063|10815235|FG001|Period 2 (7 Days)|Withdrawal by Subject|0
6811294|NCT01852812|10815248|FG000|Overall Study|Adverse Event|0
6811295|NCT01852812|10815249|FG001|Overall Study|Adverse Event|0
6811296|NCT01852812|10815250|FG002|Overall Study|Adverse Event|1
6811478|NCT01502371|10815392|FG001|Overall Study|Treatment Failure|20
6802105|NCT00455325|10803354|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0
6802106|NCT00455325|10803351|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0
6802107|NCT00455325|10803352|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1
6802108|NCT00455325|10803353|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0
6802109|NCT00455325|10803354|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0
6802110|NCT00455325|10803351|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0
6802111|NCT00455325|10803352|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0
6802112|NCT00455325|10803353|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1
6802113|NCT00455325|10803354|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0
6802114|NCT00321555|10803365|FG000|Overall Study|Developed antibodies|1
6802115|NCT00321555|10803365|FG000|Overall Study|Switched to alternative treatment|3
6802116|NCT00321555|10803365|FG000|Overall Study|Physician Decision|1
6802117|NCT00321555|10803365|FG000|Overall Study|Disease progression on study|1
6809918|NCT03203473|10813761|FG000|Arm Allocation Phase|Still on arm-B treatment|0
6809919|NCT03203473|10813762|FG001|Arm Allocation Phase|Still on arm-B treatment|0
6809920|NCT03203473|10813763|FG002|Arm Allocation Phase|Still on arm-B treatment|3
6809921|NCT03180736|10813776|FG000|Overall Study|Adverse Event|3
6809922|NCT03180736|10813777|FG001|Overall Study|Adverse Event|4
6809923|NCT03180736|10813776|FG000|Overall Study|Death|10
6809924|NCT03180736|10813777|FG001|Overall Study|Death|7
6809925|NCT03180736|10813776|FG000|Overall Study|Withdrawal by Subject|5
6802234|NCT04471935|10803384|FG000|Overall Study|Withdrawal by Subject|1
6802235|NCT04471935|10803384|FG000|Overall Study|Deemed ineligible to participate|1
6802264|NCT04498832|10803432|FG000|Overall Study|Adverse Event|1
6802265|NCT04498832|10803433|FG001|Overall Study|Adverse Event|3
6802266|NCT04498832|10803432|FG000|Overall Study|Withdrawal by Subject|0
6802267|NCT04498832|10803433|FG001|Overall Study|Withdrawal by Subject|1
6802268|NCT04109222|10803442|FG000|Overall Study|Adverse Event|1
6802269|NCT04109222|10803443|FG001|Overall Study|Adverse Event|0
6802270|NCT04109222|10803444|FG002|Overall Study|Adverse Event|0
6802271|NCT04046939|10803456|FG000|Primary Assessment Period|Adverse Event|1
6802272|NCT04046939|10803457|FG001|Primary Assessment Period|Adverse Event|0
6802273|NCT04046939|10803458|FG002|Primary Assessment Period|Adverse Event|0
6802274|NCT04046939|10803459|FG003|Primary Assessment Period|Adverse Event|0
6802275|NCT04046939|10803456|FG000|Primary Assessment Period|Withdrawal by Subject|1
6802276|NCT04046939|10803457|FG001|Primary Assessment Period|Withdrawal by Subject|0
6802277|NCT04046939|10803458|FG002|Primary Assessment Period|Withdrawal by Subject|1
6802278|NCT04046939|10803459|FG003|Primary Assessment Period|Withdrawal by Subject|0
6802279|NCT04046939|10803456|FG000|Primary Assessment Period|Physician Decision|0
6802280|NCT04046939|10803457|FG001|Primary Assessment Period|Physician Decision|0
6802281|NCT04046939|10803458|FG002|Primary Assessment Period|Physician Decision|1
6802282|NCT04046939|10803459|FG003|Primary Assessment Period|Physician Decision|0
6802283|NCT04046939|10803456|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1
6802284|NCT04046939|10803457|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0
6802285|NCT04046939|10803458|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0
6802286|NCT04046939|10803459|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1
6802287|NCT03912259|10803477|FG000|Overall Study|Adverse Event (AE)|2
6802288|NCT03912259|10803478|FG001|Overall Study|Adverse Event (AE)|4
6802289|NCT03912259|10803477|FG000|Overall Study|Lack of Efficacy|4
6802290|NCT03912259|10803478|FG001|Overall Study|Lack of Efficacy|1
6802291|NCT03912259|10803477|FG000|Overall Study|Withdrawal by Subject|11
6802292|NCT03912259|10803478|FG001|Overall Study|Withdrawal by Subject|1
6802293|NCT03890367|10803488|FG000|Overall Study|Withdrawal by parent/guardian|1
6802294|NCT03890367|10803489|FG001|Overall Study|Withdrawal by parent/guardian|3
6802295|NCT03890367|10803490|FG002|Overall Study|Withdrawal by parent/guardian|0
6802296|NCT03890367|10803488|FG000|Overall Study|Protocol deviation|2
6802297|NCT03890367|10803489|FG001|Overall Study|Protocol deviation|2
6802298|NCT03890367|10803490|FG002|Overall Study|Protocol deviation|1
6802299|NCT03890367|10803488|FG000|Overall Study|Lost to Follow-up|1
6802300|NCT03890367|10803489|FG001|Overall Study|Lost to Follow-up|1
6802301|NCT03890367|10803490|FG002|Overall Study|Lost to Follow-up|0
6809926|NCT03180736|10813777|FG001|Overall Study|Withdrawal by Subject|12
6809927|NCT03180736|10813776|FG000|Overall Study|Lost to Follow-up|1
6809928|NCT03180736|10813777|FG001|Overall Study|Lost to Follow-up|0
6809929|NCT03180736|10813776|FG000|Overall Study|Lack of Efficacy|66
6809930|NCT03180736|10813777|FG001|Overall Study|Lack of Efficacy|87
6809931|NCT03180736|10813776|FG000|Overall Study|Physician Decision|4
6809932|NCT03180736|10813777|FG001|Overall Study|Physician Decision|7
6809933|NCT03180736|10813776|FG000|Overall Study|randomized but not treated|2
6809934|NCT03180736|10813777|FG001|Overall Study|randomized but not treated|3
6809935|NCT03051659|10813790|FG000|Treatment Period|Withdrawal by Subject|0
6809936|NCT03051659|10813791|FG001|Treatment Period|Withdrawal by Subject|2
6809937|NCT03051659|10813790|FG000|Survival Follow-up|Lost to Follow-up|23
6809938|NCT03051659|10813791|FG001|Survival Follow-up|Lost to Follow-up|22
6809939|NCT02949219|10813814|FG000|Overall Study|Withdrawal by Subject|1
6809940|NCT02886884|10813822|FG000|Follow-up|Withdrawal by Subject|0
6809941|NCT02886884|10813823|FG001|Follow-up|Withdrawal by Subject|0
6809942|NCT02886884|10813824|FG002|Follow-up|Withdrawal by Subject|0
6809943|NCT02886884|10813825|FG003|Follow-up|Withdrawal by Subject|1
6809944|NCT02717832|10813853|FG000|Overall Study|Inability to place IV|3
6811145|NCT02407236|10815056|FG004|Induction Study (8 Weeks)|Physician Decision|0
6811146|NCT02407236|10815057|FG005|Induction Study (8 Weeks)|Physician Decision|0
6811147|NCT02407236|10815058|FG006|Induction Study (8 Weeks)|Physician Decision|0
6811148|NCT02407236|10815059|FG007|Induction Study (8 Weeks)|Physician Decision|0
6811149|NCT02407236|10815052|FG000|Induction Study (8 Weeks)|Other|2
6811150|NCT02407236|10815053|FG001|Induction Study (8 Weeks)|Other|1
6811151|NCT02407236|10815054|FG002|Induction Study (8 Weeks)|Other|5
6811152|NCT02407236|10815055|FG003|Induction Study (8 Weeks)|Other|0
6811153|NCT02407236|10815056|FG004|Induction Study (8 Weeks)|Other|0
6811154|NCT02407236|10815057|FG005|Induction Study (8 Weeks)|Other|0
6811155|NCT02407236|10815058|FG006|Induction Study (8 Weeks)|Other|0
6811156|NCT02407236|10815059|FG007|Induction Study (8 Weeks)|Other|0
6811157|NCT02407236|10815052|FG000|Maintenance Study (44 Weeks)|Lost to Follow-up|0
6811158|NCT02407236|10815053|FG001|Maintenance Study (44 Weeks)|Lost to Follow-up|0
6811159|NCT02407236|10815054|FG002|Maintenance Study (44 Weeks)|Lost to Follow-up|0
6811160|NCT02407236|10815055|FG003|Maintenance Study (44 Weeks)|Lost to Follow-up|1
6811161|NCT02407236|10815056|FG004|Maintenance Study (44 Weeks)|Lost to Follow-up|0
6811162|NCT02407236|10815057|FG005|Maintenance Study (44 Weeks)|Lost to Follow-up|1
6811479|NCT01502371|10815393|FG002|Overall Study|Treatment Failure|12
6802302|NCT03607422|10803508|FG000|Overall Study|Adverse Event|7
6802303|NCT03607422|10803509|FG001|Overall Study|Adverse Event|3
6802304|NCT03607422|10803510|FG002|Overall Study|Adverse Event|2
6802305|NCT03607422|10803511|FG003|Overall Study|Adverse Event|0
6802306|NCT03607422|10803512|FG004|Overall Study|Adverse Event|2
6802307|NCT03607422|10803513|FG005|Overall Study|Adverse Event|0
6802308|NCT03607422|10803508|FG000|Overall Study|Withdrawal by Subject|11
6802309|NCT03607422|10803509|FG001|Overall Study|Withdrawal by Subject|3
6802310|NCT03607422|10803510|FG002|Overall Study|Withdrawal by Subject|6
6802311|NCT03607422|10803511|FG003|Overall Study|Withdrawal by Subject|2
6802312|NCT03607422|10803512|FG004|Overall Study|Withdrawal by Subject|0
6802313|NCT03607422|10803513|FG005|Overall Study|Withdrawal by Subject|0
6802314|NCT03607422|10803508|FG000|Overall Study|Lost to Follow-up|0
6802315|NCT03607422|10803509|FG001|Overall Study|Lost to Follow-up|0
6802316|NCT03607422|10803510|FG002|Overall Study|Lost to Follow-up|1
6802317|NCT03607422|10803511|FG003|Overall Study|Lost to Follow-up|0
6802318|NCT03607422|10803512|FG004|Overall Study|Lost to Follow-up|0
6802319|NCT03607422|10803513|FG005|Overall Study|Lost to Follow-up|0
6802320|NCT03607422|10803508|FG000|Overall Study|Other|12
6802321|NCT03607422|10803509|FG001|Overall Study|Other|4
6802322|NCT03607422|10803510|FG002|Overall Study|Other|1
6802323|NCT03607422|10803511|FG003|Overall Study|Other|2
6802324|NCT03607422|10803512|FG004|Overall Study|Other|0
6802325|NCT03607422|10803513|FG005|Overall Study|Other|2
6802326|NCT03607422|10803508|FG000|Overall Study|Ongoing at Time of Analysis|8
6802327|NCT03607422|10803509|FG001|Overall Study|Ongoing at Time of Analysis|0
6802328|NCT03607422|10803510|FG002|Overall Study|Ongoing at Time of Analysis|2
6802329|NCT03607422|10803511|FG003|Overall Study|Ongoing at Time of Analysis|1
6802330|NCT03607422|10803512|FG004|Overall Study|Ongoing at Time of Analysis|1
6802331|NCT03607422|10803513|FG005|Overall Study|Ongoing at Time of Analysis|1
6802332|NCT03600805|10803531|FG000|Overall Study|Adverse Event|2
6802333|NCT03600805|10803532|FG001|Overall Study|Adverse Event|1
6802334|NCT03600805|10803533|FG002|Overall Study|Adverse Event|1
6802335|NCT03600805|10803534|FG003|Overall Study|Adverse Event|7
6802336|NCT03600805|10803531|FG000|Overall Study|Lack of Efficacy|2
6802337|NCT03600805|10803532|FG001|Overall Study|Lack of Efficacy|1
6802338|NCT03600805|10803533|FG002|Overall Study|Lack of Efficacy|0
6802339|NCT03600805|10803534|FG003|Overall Study|Lack of Efficacy|0
6802340|NCT03600805|10803531|FG000|Overall Study|Withdrawal by Subject|1
6802341|NCT03600805|10803532|FG001|Overall Study|Withdrawal by Subject|0
6802342|NCT03600805|10803533|FG002|Overall Study|Withdrawal by Subject|0
6802343|NCT03600805|10803534|FG003|Overall Study|Withdrawal by Subject|1
6802344|NCT03600805|10803531|FG000|Overall Study|Other unspecified|14
6802345|NCT03600805|10803532|FG001|Overall Study|Other unspecified|6
6802346|NCT03600805|10803533|FG002|Overall Study|Other unspecified|7
6802347|NCT03600805|10803534|FG003|Overall Study|Other unspecified|11
6802348|NCT03434119|10803557|FG000|Overall Study|Randomized but not treated|1
6802349|NCT03434119|10803558|FG001|Overall Study|Randomized but not treated|0
6802350|NCT03434119|10803557|FG000|Overall Study|Adverse Event|1
6802351|NCT03434119|10803558|FG001|Overall Study|Adverse Event|0
6802352|NCT03434119|10803557|FG000|Overall Study|Poor Compliance to Protocol|0
6802353|NCT03434119|10803558|FG001|Overall Study|Poor Compliance to Protocol|1
6802354|NCT03434119|10803557|FG000|Overall Study|Study Terminated by Sponsor|91
6802355|NCT03434119|10803558|FG001|Overall Study|Study Terminated by Sponsor|102
6802356|NCT03434119|10803557|FG000|Overall Study|Withdrawal by Subject|7
6802357|NCT03434119|10803558|FG001|Overall Study|Withdrawal by Subject|5
6802358|NCT03434119|10803557|FG000|Overall Study|Other than specified|7
6802359|NCT03434119|10803558|FG001|Overall Study|Other than specified|5
6802360|NCT03417245|10803566|FG000|Overall Study|Adverse Event|1
6802361|NCT03417245|10803567|FG001|Overall Study|Adverse Event|0
6802362|NCT03417245|10803566|FG000|Overall Study|Protocol Violation|1
6802363|NCT03417245|10803567|FG001|Overall Study|Protocol Violation|0
6802364|NCT03417245|10803566|FG000|Overall Study|Withdrawal by Subject|1
6802365|NCT03417245|10803567|FG001|Overall Study|Withdrawal by Subject|1
6802366|NCT03417102|10803575|FG000|Overall Study|Adverse Event|0
6802367|NCT03417102|10803576|FG001|Overall Study|Adverse Event|1
6802368|NCT03417102|10803575|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0
6802369|NCT03417102|10803576|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3
6802370|NCT03417102|10803575|FG000|Overall Study|Other|0
6802371|NCT03417102|10803576|FG001|Overall Study|Other|1
6802372|NCT03278626|10803588|FG000|Overall Study|Death|2
6802373|NCT03278626|10803588|FG000|Overall Study|Toxicity|1
6802374|NCT03278626|10803588|FG000|Overall Study|Disease Progression|2
6802375|NCT03211858|10803594|FG000|Overall Study|Adverse Event|8
6802376|NCT03211858|10803595|FG001|Overall Study|Adverse Event|6
6802377|NCT03211858|10803594|FG000|Overall Study|Lack of Efficacy|0
6802378|NCT03211858|10803595|FG001|Overall Study|Lack of Efficacy|4
6802379|NCT03211858|10803594|FG000|Overall Study|Poor compliance to protocol|6
6802380|NCT03211858|10803595|FG001|Overall Study|Poor compliance to protocol|2
6802381|NCT03211858|10803594|FG000|Overall Study|Non-serious Hypoglycemia|1
6802382|NCT03211858|10803595|FG001|Overall Study|Non-serious Hypoglycemia|0
6802383|NCT03211858|10803594|FG000|Overall Study|Other than specified above|22
6802384|NCT03211858|10803595|FG001|Overall Study|Other than specified above|21
6802385|NCT03077438|10803611|FG000|Overall Study|Protocol Violation|3
6802386|NCT03077438|10803612|FG001|Overall Study|Protocol Violation|5
6802387|NCT03077438|10803611|FG000|Overall Study|Withdrawal by Subject|3
6802388|NCT03077438|10803612|FG001|Overall Study|Withdrawal by Subject|6
6802389|NCT03077438|10803611|FG000|Overall Study|Lost to Follow-up|6
6802390|NCT03077438|10803612|FG001|Overall Study|Lost to Follow-up|3
6802391|NCT02948959|10803628|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0
6802392|NCT02948959|10803629|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2
6802393|NCT02948959|10803628|FG000|52 Weeks Treatment Period|Adverse Event|2
6802394|NCT02948959|10803629|FG001|52 Weeks Treatment Period|Adverse Event|5
6802395|NCT02948959|10803628|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2
6802396|NCT02948959|10803629|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2
6802397|NCT02948959|10803628|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1
6802398|NCT02948959|10803629|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6
6802399|NCT02948959|10803628|FG000|52 Weeks Treatment Period|Randomized by error|0
6802400|NCT02948959|10803629|FG001|52 Weeks Treatment Period|Randomized by error|5
6802401|NCT02948959|10803628|FG000|52 Weeks Treatment Period|Randomized and not treated|0
6802402|NCT02948959|10803629|FG001|52 Weeks Treatment Period|Randomized and not treated|3
6802403|NCT02948959|10803628|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0
6802404|NCT02948959|10803629|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1
6802405|NCT02948959|10803628|FG000|52 Weeks Treatment Period|Change of residence location|0
6802406|NCT02948959|10803629|FG001|52 Weeks Treatment Period|Change of residence location|1
6802407|NCT02948959|10803628|FG000|12 Weeks Follow-up Period|Adverse Event|0
6802408|NCT02948959|10803629|FG001|12 Weeks Follow-up Period|Adverse Event|2
6802409|NCT02948959|10803628|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1
6802410|NCT02948959|10803629|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2
6802411|NCT02948959|10803628|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3
6802412|NCT02948959|10803629|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3
6802413|NCT02948959|10803628|FG000|12 Weeks Follow-up Period|Randomized by error|0
6802414|NCT02948959|10803629|FG001|12 Weeks Follow-up Period|Randomized by error|3
6802415|NCT02948959|10803628|FG000|12 Weeks Follow-up Period|Change of residence location|0
6802416|NCT02948959|10803629|FG001|12 Weeks Follow-up Period|Change of residence location|2
6802417|NCT02948959|10803628|FG000|12 Weeks Follow-up Period|Study site closure|1
6802418|NCT02948959|10803629|FG001|12 Weeks Follow-up Period|Study site closure|0
6802419|NCT02878603|10803645|FG000|Overall Study|Lost to Follow-up|4
6802420|NCT02878603|10803646|FG001|Overall Study|Lost to Follow-up|1
6802421|NCT02878603|10803645|FG000|Overall Study|Withdrawal by Subject|1
6802422|NCT02878603|10803646|FG001|Overall Study|Withdrawal by Subject|1
6802423|NCT02878603|10803645|FG000|Overall Study|Death|1
6802424|NCT02878603|10803646|FG001|Overall Study|Death|0
6802425|NCT02878603|10803645|FG000|Overall Study|Physician Decision|0
6802426|NCT02878603|10803646|FG001|Overall Study|Physician Decision|3
6802427|NCT02864407|10803652|FG000|Overall Study|Protocol Violation|3
6802428|NCT02864407|10803652|FG000|Overall Study|Lost to Follow-up|115
6802429|NCT02864407|10803652|FG000|Overall Study|Not treated with Vahelva® Respimat®|1
6802430|NCT02864407|10803652|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3
6802431|NCT02864407|10803652|FG000|Overall Study|Consent prior to the contract date|1
6802432|NCT02846532|10803659|FG000|Overall Study|Lost to Follow-up|0
6802433|NCT02846532|10803660|FG001|Overall Study|Lost to Follow-up|1
6802434|NCT02846532|10803661|FG002|Overall Study|Lost to Follow-up|1
6802435|NCT02846532|10803659|FG000|Overall Study|Withdrawal by Subject|1
6802436|NCT02846532|10803660|FG001|Overall Study|Withdrawal by Subject|2
6802437|NCT02846532|10803661|FG002|Overall Study|Withdrawal by Subject|0
6802438|NCT02688933|10803671|FG000|Overall Study|Adverse Event|3
6802439|NCT02688933|10803672|FG001|Overall Study|Adverse Event|1
6802440|NCT02688933|10803671|FG000|Overall Study|Lack of Efficacy|2
6802441|NCT02688933|10803672|FG001|Overall Study|Lack of Efficacy|2
6802442|NCT02688933|10803671|FG000|Overall Study|Poor compliance to protocol|7
6802443|NCT02688933|10803672|FG001|Overall Study|Poor compliance to protocol|4
6802444|NCT02688933|10803671|FG000|Overall Study|Hypoglycemia|2
6802445|NCT02688933|10803672|FG001|Overall Study|Hypoglycemia|0
6802446|NCT02688933|10803671|FG000|Overall Study|Other than Specified|14
6802447|NCT02688933|10803672|FG001|Overall Study|Other than Specified|25
6802448|NCT02688933|10803671|FG000|Overall Study|Lost to Follow-up|1
6802449|NCT02688933|10803672|FG001|Overall Study|Lost to Follow-up|5
6802450|NCT02492165|10803691|FG000|Overall Study|Withdrawal by Subject|0
6802451|NCT02492165|10803692|FG001|Overall Study|Withdrawal by Subject|1
6802452|NCT02492165|10803693|FG002|Overall Study|Withdrawal by Subject|0
6802453|NCT02492165|10803694|FG003|Overall Study|Withdrawal by Subject|0
6802454|NCT02476006|10803704|FG000|Overall Study|Death|4
6802455|NCT02476006|10803704|FG000|Overall Study|Lack of treatment efficacy|2
6802456|NCT02476006|10803704|FG000|Overall Study|Pregnancy|1
6802457|NCT02476006|10803704|FG000|Overall Study|Participant did not wish to continue|39
6802458|NCT02476006|10803704|FG000|Overall Study|Adverse Event|41
6802459|NCT02476006|10803704|FG000|Overall Study|Poor compliance to study protocol|3
6802460|NCT02476006|10803704|FG000|Overall Study|Sponsor decision|6
6802461|NCT02476006|10803704|FG000|Overall Study|Lost to Follow-up|5
6802462|NCT02476006|10803704|FG000|Overall Study|Physician Decision|5
6802463|NCT02476006|10803704|FG000|Overall Study|Study ended treatment not available|4
6802464|NCT02476006|10803704|FG000|Overall Study|Switched to commercial drug|4
6802465|NCT02476006|10803704|FG000|Overall Study|Excluded from study|1
6802466|NCT02476006|10803704|FG000|Overall Study|Protocol Violation|1
6802467|NCT02476006|10803704|FG000|Overall Study|Enrolled but not treated|4
6802468|NCT02468414|10803710|FG000|Overall Study|Early Study Termination by Sponsor|1
6802469|NCT02468414|10803711|FG001|Overall Study|Early Study Termination by Sponsor|0
6802470|NCT02468414|10803710|FG000|Overall Study|Poor in-vitro secreting TARGTs|1
6802471|NCT02468414|10803711|FG001|Overall Study|Poor in-vitro secreting TARGTs|0
6802472|NCT02468414|10803710|FG000|Overall Study|Screen Failure|1
6802473|NCT02468414|10803711|FG001|Overall Study|Screen Failure|0
6802474|NCT02462876|10803717|FG000|Overall Study|Death|3
6802475|NCT02462876|10803717|FG000|Overall Study|Lost to Follow-up|7
6802476|NCT02462876|10803717|FG000|Overall Study|Surgical Bypass|9
6802477|NCT02462876|10803717|FG000|Overall Study|Amputation Above the Metatarsals|1
6802478|NCT02462876|10803717|FG000|Overall Study|36 months follow-up visit missed|1
6802479|NCT02462876|10803717|FG000|Overall Study|Patient did not come back since 4 months follow-up|1
6802480|NCT02462876|10803717|FG000|Overall Study|Patient did not come back to the vascular department|1
6802481|NCT02462876|10803717|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1
6802482|NCT02462876|10803717|FG000|Overall Study|Patient refused to come back|1
6802483|NCT02462876|10803717|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1
6802484|NCT02462876|10803717|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1
6802485|NCT02332590|10803723|FG000|DB Period (up to 24 Weeks)|Adverse Event|15
6802486|NCT02332590|10803724|FG001|DB Period (up to 24 Weeks)|Adverse Event|11
6802487|NCT02332590|10803723|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4
6802488|NCT02332590|10803724|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2
6802489|NCT02332590|10803723|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3
6802490|NCT02332590|10803724|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1
6802491|NCT02332590|10803723|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1
6802492|NCT02332590|10803724|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0
6802493|NCT02332590|10803723|FG000|DB Period (up to 24 Weeks)|Other than specified above|6
6802494|NCT02332590|10803724|FG001|DB Period (up to 24 Weeks)|Other than specified above|5
6802495|NCT02332590|10803723|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20
6802496|NCT02332590|10803724|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23
6802497|NCT02332590|10803723|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2
6802498|NCT02332590|10803724|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6
6802499|NCT02332590|10803723|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5
6802500|NCT02332590|10803724|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1
6802501|NCT02332590|10803723|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20
6802502|NCT02332590|10803724|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15
6802503|NCT02255656|10803732|FG000|Overall Study|Adverse Event|11
6802504|NCT02255656|10803732|FG000|Overall Study|Poor compliance to protocol|3
6802505|NCT02255656|10803732|FG000|Overall Study|Lost to Follow-up|30
6802506|NCT02255656|10803732|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300
6802507|NCT02255656|10803732|FG000|Overall Study|Other|126
6802508|NCT02134028|10803751|FG000|Overall Study|Lack of Efficacy|1
6802509|NCT02134028|10803752|FG001|Overall Study|Lack of Efficacy|0
6802510|NCT02134028|10803753|FG002|Overall Study|Lack of Efficacy|3
6802511|NCT02134028|10803754|FG003|Overall Study|Lack of Efficacy|2
6802512|NCT02134028|10803755|FG004|Overall Study|Lack of Efficacy|1
6802513|NCT02134028|10803756|FG005|Overall Study|Lack of Efficacy|2
6802514|NCT02134028|10803757|FG006|Overall Study|Lack of Efficacy|1
6802515|NCT02134028|10803758|FG007|Overall Study|Lack of Efficacy|0
6802516|NCT02134028|10803751|FG000|Overall Study|Poor compliance to protocol|1
6802517|NCT02134028|10803752|FG001|Overall Study|Poor compliance to protocol|1
6802518|NCT02134028|10803753|FG002|Overall Study|Poor compliance to protocol|3
6802519|NCT02134028|10803754|FG003|Overall Study|Poor compliance to protocol|7
6802520|NCT02134028|10803755|FG004|Overall Study|Poor compliance to protocol|1
6802521|NCT02134028|10803756|FG005|Overall Study|Poor compliance to protocol|1
6802522|NCT02134028|10803757|FG006|Overall Study|Poor compliance to protocol|0
6802523|NCT02134028|10803758|FG007|Overall Study|Poor compliance to protocol|0
6802524|NCT02134028|10803751|FG000|Overall Study|Other unspecified|4
6802525|NCT02134028|10803752|FG001|Overall Study|Other unspecified|22
6802526|NCT02134028|10803753|FG002|Overall Study|Other unspecified|33
6802527|NCT02134028|10803754|FG003|Overall Study|Other unspecified|64
6802528|NCT02134028|10803755|FG004|Overall Study|Other unspecified|8
6802529|NCT02134028|10803756|FG005|Overall Study|Other unspecified|6
6802530|NCT02134028|10803757|FG006|Overall Study|Other unspecified|2
6802531|NCT02134028|10803758|FG007|Overall Study|Other unspecified|1
6802532|NCT02134028|10803751|FG000|Overall Study|Adverse Event|3
6802533|NCT02134028|10803752|FG001|Overall Study|Adverse Event|19
6802534|NCT02134028|10803753|FG002|Overall Study|Adverse Event|13
6802535|NCT02134028|10803754|FG003|Overall Study|Adverse Event|32
6802536|NCT02134028|10803755|FG004|Overall Study|Adverse Event|4
6802537|NCT02134028|10803756|FG005|Overall Study|Adverse Event|5
6802538|NCT02134028|10803757|FG006|Overall Study|Adverse Event|1
6802539|NCT02134028|10803758|FG007|Overall Study|Adverse Event|2
6809945|NCT02677324|10813858|FG000|Overall Study|Disease Progression|6
6809946|NCT02677324|10813858|FG000|Overall Study|Inability to Swallow pills|1
6809947|NCT02677324|10813858|FG000|Overall Study|Non-compliance|1
6809948|NCT02677324|10813858|FG000|Overall Study|Lack of Efficacy|1
6809949|NCT02677324|10813858|FG000|Overall Study|Medical insurance coverage|1
6809950|NCT02677324|10813858|FG000|Overall Study|Adverse Event|1
6809951|NCT02677324|10813858|FG000|Overall Study|IgM Myeloma diagnosis|1
6809952|NCT02563028|10813864|FG000|Overall Study|Lack of equipment|1
6809953|NCT02563028|10813864|FG000|Overall Study|Unable to elicit VEP post induction|1
6809954|NCT02552212|10813870|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6
6809955|NCT02552212|10813871|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3
6809956|NCT02552212|10813872|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0
6809957|NCT02552212|10813870|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2
6809958|NCT02552212|10813871|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2
6809959|NCT02552212|10813872|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0
6809960|NCT02552212|10813870|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1
6809961|NCT02552212|10813871|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1
6809962|NCT02552212|10813872|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0
6809963|NCT02552212|10813870|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1
6809964|NCT02552212|10813871|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0
6809965|NCT02552212|10813872|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0
6809966|NCT02552212|10813870|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3
6809967|NCT02552212|10813871|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7
6809968|NCT02552212|10813872|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0
6809969|NCT02552212|10813870|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1
6809970|NCT02552212|10813871|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1
6809971|NCT02552212|10813872|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0
6809972|NCT02552212|10813870|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0
6809973|NCT02552212|10813871|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1
6809974|NCT02552212|10813872|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0
6809975|NCT02552212|10813870|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0
6809976|NCT02552212|10813871|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1
6809977|NCT02552212|10813872|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0
6809978|NCT02552212|10813870|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0
6809979|NCT02552212|10813871|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1
6809980|NCT02552212|10813872|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0
6811480|NCT01502371|10815394|FG003|Overall Study|Treatment Failure|19
6811481|NCT01502371|10815395|FG004|Overall Study|Treatment Failure|30
6811482|NCT01502371|10815391|FG000|Overall Study|Lack of Efficacy|3
6811483|NCT01502371|10815392|FG001|Overall Study|Lack of Efficacy|3
6811484|NCT01502371|10815393|FG002|Overall Study|Lack of Efficacy|2
6811485|NCT01502371|10815394|FG003|Overall Study|Lack of Efficacy|2
6811486|NCT01502371|10815395|FG004|Overall Study|Lack of Efficacy|4
6811487|NCT01502371|10815391|FG000|Overall Study|Physician Decision|3
6811488|NCT01502371|10815392|FG001|Overall Study|Physician Decision|0
6811489|NCT01502371|10815393|FG002|Overall Study|Physician Decision|0
6811490|NCT01502371|10815394|FG003|Overall Study|Physician Decision|0
6811491|NCT01502371|10815395|FG004|Overall Study|Physician Decision|1
6802624|NCT01900444|10803810|FG000|Overall Study|Protocol Violation|2
6802625|NCT01900444|10803810|FG000|Overall Study|Lost to Follow-up|1
6802626|NCT01887912|10803816|FG000|Overall Study|Serious adverse event|400
6802627|NCT01887912|10803817|FG001|Overall Study|Serious adverse event|198
6802628|NCT01887912|10803816|FG000|Overall Study|Other Adverse Event|34
6802629|NCT01887912|10803817|FG001|Overall Study|Other Adverse Event|15
6802630|NCT01887912|10803816|FG000|Overall Study|Protocol Violation|67
6802631|NCT01887912|10803817|FG001|Overall Study|Protocol Violation|37
6802632|NCT01887912|10803816|FG000|Overall Study|Lost to Follow-up|163
6802633|NCT01887912|10803817|FG001|Overall Study|Lost to Follow-up|74
6802634|NCT01887912|10803816|FG000|Overall Study|Withdrawal by Subject|606
6802635|NCT01887912|10803817|FG001|Overall Study|Withdrawal by Subject|349
6802636|NCT01887912|10803816|FG000|Overall Study|Other|122
6802637|NCT01887912|10803817|FG001|Overall Study|Other|58
6802638|NCT01437423|10803860|FG000|Overall Study|Lost to Follow-up|12
6802639|NCT01437423|10803860|FG000|Overall Study|Off label usage|3
6802640|NCT01410890|10803866|FG000|Overall Study|Withdrawal by Subject|0
6802641|NCT01410890|10803867|FG001|Overall Study|Withdrawal by Subject|1
6802662|NCT01190228|10803887|FG000|Overall Study|Protocol Violation|4
6802663|NCT01190228|10803888|FG001|Overall Study|Protocol Violation|0
6802664|NCT01190228|10803889|FG002|Overall Study|Protocol Violation|0
6802665|NCT01190228|10803887|FG000|Overall Study|Withdrawal by Subject|1
6802666|NCT01190228|10803888|FG001|Overall Study|Withdrawal by Subject|0
6802667|NCT01190228|10803889|FG002|Overall Study|Withdrawal by Subject|0
6802668|NCT01146652|10803901|FG000|Overall Study|Adverse Event|506
6802669|NCT01146652|10803902|FG001|Overall Study|Adverse Event|15
6802670|NCT01146652|10803901|FG000|Overall Study|Lack of Efficacy|91
6802671|NCT01146652|10803902|FG001|Overall Study|Lack of Efficacy|7
6802672|NCT01146652|10803901|FG000|Overall Study|Poor compliance to protocol|38
6802673|NCT01146652|10803902|FG001|Overall Study|Poor compliance to protocol|1
6802674|NCT01146652|10803901|FG000|Overall Study|Other unspecified reasons|314
6802675|NCT01146652|10803902|FG001|Overall Study|Other unspecified reasons|22
6802676|NCT01146652|10803901|FG000|Overall Study|Enrolled but not treated|2
6802677|NCT01146652|10803902|FG001|Overall Study|Enrolled but not treated|0
6802678|NCT01049035|10803922|FG000|Overall Study|Serious adverse event|0
6802679|NCT01049035|10803923|FG001|Overall Study|Serious adverse event|1
6802680|NCT01049035|10803924|FG002|Overall Study|Serious adverse event|1
6802681|NCT01049035|10803925|FG003|Overall Study|Serious adverse event|2
6802682|NCT01049035|10803926|FG004|Overall Study|Serious adverse event|0
6802683|NCT01049035|10803927|FG005|Overall Study|Serious adverse event|0
6802684|NCT01049035|10803928|FG006|Overall Study|Serious adverse event|0
6802685|NCT01049035|10803922|FG000|Overall Study|Other adverse event (AE)|0
6802686|NCT01049035|10803923|FG001|Overall Study|Other adverse event (AE)|0
6802687|NCT01049035|10803924|FG002|Overall Study|Other adverse event (AE)|0
6802688|NCT01049035|10803925|FG003|Overall Study|Other adverse event (AE)|1
6802689|NCT01049035|10803926|FG004|Overall Study|Other adverse event (AE)|0
6802690|NCT01049035|10803927|FG005|Overall Study|Other adverse event (AE)|0
6802691|NCT01049035|10803928|FG006|Overall Study|Other adverse event (AE)|0
6802692|NCT01049035|10803922|FG000|Overall Study|Non-compliance with the protocol|12
6802693|NCT01049035|10803923|FG001|Overall Study|Non-compliance with the protocol|6
6802694|NCT01049035|10803924|FG002|Overall Study|Non-compliance with the protocol|14
6802695|NCT01049035|10803925|FG003|Overall Study|Non-compliance with the protocol|5
6802696|NCT01049035|10803926|FG004|Overall Study|Non-compliance with the protocol|3
6802697|NCT01049035|10803927|FG005|Overall Study|Non-compliance with the protocol|4
6802698|NCT01049035|10803928|FG006|Overall Study|Non-compliance with the protocol|10
6802699|NCT01049035|10803922|FG000|Overall Study|Lost to Follow-up|5
6802700|NCT01049035|10803923|FG001|Overall Study|Lost to Follow-up|4
6802701|NCT01049035|10803924|FG002|Overall Study|Lost to Follow-up|4
6802702|NCT01049035|10803925|FG003|Overall Study|Lost to Follow-up|1
6802703|NCT01049035|10803926|FG004|Overall Study|Lost to Follow-up|0
6802704|NCT01049035|10803927|FG005|Overall Study|Lost to Follow-up|3
6802705|NCT01049035|10803928|FG006|Overall Study|Lost to Follow-up|3
6802706|NCT01049035|10803922|FG000|Overall Study|Voluntary withdrawal not due to an AE|16
6802707|NCT01049035|10803923|FG001|Overall Study|Voluntary withdrawal not due to an AE|10
6802708|NCT01049035|10803924|FG002|Overall Study|Voluntary withdrawal not due to an AE|8
6802709|NCT01049035|10803925|FG003|Overall Study|Voluntary withdrawal not due to an AE|2
6802710|NCT01049035|10803926|FG004|Overall Study|Voluntary withdrawal not due to an AE|1
6802711|NCT01049035|10803927|FG005|Overall Study|Voluntary withdrawal not due to an AE|5
6802712|NCT01049035|10803928|FG006|Overall Study|Voluntary withdrawal not due to an AE|2
6802713|NCT00728884|10803954|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13
6802714|NCT00728884|10803954|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4
6802715|NCT00726063|10803971|FG000|Overall Study|Adverse Event|9
6802716|NCT00726063|10803972|FG001|Overall Study|Adverse Event|7
6802717|NCT00713206|10803989|FG000|Overall Study|Lost to Follow-up|4
6802718|NCT00713206|10803990|FG001|Overall Study|Lost to Follow-up|4
6802719|NCT00713206|10803989|FG000|Overall Study|Death|1
6802720|NCT00713206|10803990|FG001|Overall Study|Death|0
6802743|NCT00569127|10804011|FG000|Overall Study|Adverse Event|57
6802744|NCT00569127|10804012|FG001|Overall Study|Adverse Event|47
6802745|NCT00569127|10804011|FG000|Overall Study|Withdrawal by Subject|13
6802746|NCT00569127|10804012|FG001|Overall Study|Withdrawal by Subject|27
6802747|NCT00569127|10804011|FG000|Overall Study|Progression|99
6802748|NCT00569127|10804012|FG001|Overall Study|Progression|100
6802749|NCT00569127|10804011|FG000|Overall Study|Death|4
6802750|NCT00569127|10804012|FG001|Overall Study|Death|3
6802751|NCT00569127|10804011|FG000|Overall Study|Other|20
6802752|NCT00569127|10804012|FG001|Overall Study|Other|19
6802753|NCT00569127|10804011|FG000|Overall Study|Lost to Follow-up|0
6802754|NCT00569127|10804012|FG001|Overall Study|Lost to Follow-up|3
6802755|NCT00569127|10804011|FG000|Overall Study|Not Eligible|14
6802756|NCT00569127|10804012|FG001|Overall Study|Not Eligible|11
6802757|NCT00569127|10804011|FG000|Overall Study|Still on Treatment|7
6802758|NCT00569127|10804012|FG001|Overall Study|Still on Treatment|3
6809981|NCT02552212|10813870|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1
6809982|NCT02552212|10813871|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0
6809983|NCT02552212|10813872|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0
6809984|NCT02552212|10813870|FG000|SFE Period (Week 52 - 156)|Adverse Event|0
6809985|NCT02552212|10813871|FG001|SFE Period (Week 52 - 156)|Adverse Event|0
6809986|NCT02552212|10813872|FG002|SFE Period (Week 52 - 156)|Adverse Event|5
6809987|NCT02552212|10813870|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0
6809988|NCT02552212|10813871|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0
6809989|NCT02552212|10813872|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4
6809990|NCT02552212|10813870|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0
6809991|NCT02552212|10813871|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0
6809992|NCT02552212|10813872|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2
6809993|NCT02552212|10813870|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0
6809994|NCT02552212|10813871|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0
6809995|NCT02552212|10813872|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18
6809996|NCT02552212|10813870|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0
6809997|NCT02552212|10813871|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0
6809998|NCT02552212|10813872|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1
6809999|NCT02552212|10813870|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0
6810000|NCT02552212|10813871|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0
6810001|NCT02552212|10813872|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1
6810002|NCT02552212|10813870|FG000|SFE Period (Week 52 - 156)|Investigator decision|0
6810003|NCT02552212|10813871|FG001|SFE Period (Week 52 - 156)|Investigator decision|0
6810004|NCT02552212|10813872|FG002|SFE Period (Week 52 - 156)|Investigator decision|1
6810005|NCT02552212|10813870|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0
6810006|NCT02552212|10813871|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0
6810007|NCT02552212|10813872|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1
6802759|NCT04422990|10804025|FG000|Overall Study|Withdrawal by Subject|0
6802760|NCT04422990|10804026|FG001|Overall Study|Withdrawal by Subject|1
6802761|NCT04422990|10804025|FG000|Overall Study|Travel|3
6802762|NCT04422990|10804026|FG001|Overall Study|Travel|0
6802763|NCT04358549|10804041|FG000|Overall Study|Adverse Event|0
6802764|NCT04358549|10804042|FG001|Overall Study|Adverse Event|1
6802765|NCT04358549|10804041|FG000|Overall Study|Death|1
6802766|NCT04358549|10804042|FG001|Overall Study|Death|0
6802767|NCT04358549|10804041|FG000|Overall Study|Lost to Follow-up|2
6802768|NCT04358549|10804042|FG001|Overall Study|Lost to Follow-up|1
6802769|NCT04358549|10804041|FG000|Overall Study|Withdrawal by Subject|6
6802770|NCT04358549|10804042|FG001|Overall Study|Withdrawal by Subject|6
6802771|NCT04358549|10804041|FG000|Overall Study|Start remdesivir|1
6802772|NCT04358549|10804042|FG001|Overall Study|Start remdesivir|0
6802773|NCT04532099|10804071|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1
6802774|NCT04532099|10804072|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0
6802775|NCT04532099|10804073|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0
6802776|NCT04385199|10804087|FG000|Overall Study|Withdrawal by Subject|1
6802777|NCT04385199|10804088|FG001|Overall Study|Withdrawal by Subject|0
6802778|NCT04382053|10804096|FG000|Overall Study|Death|6
6802779|NCT04382053|10804097|FG001|Overall Study|Death|8
6802780|NCT04382053|10804096|FG000|Overall Study|Lost to Follow-up|0
6802781|NCT04382053|10804097|FG001|Overall Study|Lost to Follow-up|2
6802782|NCT04382053|10804096|FG000|Overall Study|Protocol Deviation|1
6802783|NCT04382053|10804097|FG001|Overall Study|Protocol Deviation|2
6802784|NCT04382053|10804096|FG000|Overall Study|Withdrawal by Subject|2
6802785|NCT04382053|10804097|FG001|Overall Study|Withdrawal by Subject|1
6802786|NCT04311177|10804106|FG000|Overall Study|Adverse Event|3
6802787|NCT04311177|10804107|FG001|Overall Study|Adverse Event|1
6802788|NCT04311177|10804106|FG000|Overall Study|Physician Decision|4
6802789|NCT04311177|10804107|FG001|Overall Study|Physician Decision|3
6802790|NCT04311177|10804106|FG000|Overall Study|Withdrawal by Subject|1
6802791|NCT04311177|10804107|FG001|Overall Study|Withdrawal by Subject|0
6802792|NCT04241133|10804115|FG000|Overall Study|COVID19 Precautions|14
6802793|NCT04241133|10804116|FG001|Overall Study|COVID19 Precautions|34
6802794|NCT04150068|10804146|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24
6802795|NCT04150068|10804147|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12
6802796|NCT04150068|10804148|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35
6802797|NCT04150068|10804146|FG000|Maintenance Period (Week 26 Analysis)|Death|0
6802798|NCT04150068|10804147|FG001|Maintenance Period (Week 26 Analysis)|Death|0
6802799|NCT04150068|10804148|FG002|Maintenance Period (Week 26 Analysis)|Death|1
6802800|NCT04133519|10804157|FG000|Overall Study|Withdrawal by Subject|5
6802801|NCT04133519|10804158|FG001|Overall Study|Withdrawal by Subject|4
6802802|NCT04133519|10804157|FG000|Overall Study|Protocol Violation|0
6802803|NCT04133519|10804158|FG001|Overall Study|Protocol Violation|1
6802804|NCT04133519|10804157|FG000|Overall Study|Never started treatment|1
6802805|NCT04133519|10804158|FG001|Overall Study|Never started treatment|1
6802806|NCT04098367|10804178|FG000|Overall Study|Adverse Event|0
6802807|NCT04098367|10804179|FG001|Overall Study|Adverse Event|0
6802808|NCT04098367|10804180|FG002|Overall Study|Adverse Event|1
6802809|NCT04098367|10804178|FG000|Overall Study|Lost to Follow-up|1
6802810|NCT04098367|10804179|FG001|Overall Study|Lost to Follow-up|5
6802811|NCT04098367|10804180|FG002|Overall Study|Lost to Follow-up|2
6802812|NCT04098367|10804178|FG000|Overall Study|Withdrawal by Subject|0
6802813|NCT04098367|10804179|FG001|Overall Study|Withdrawal by Subject|0
6802814|NCT04098367|10804180|FG002|Overall Study|Withdrawal by Subject|1
6802815|NCT04098367|10804178|FG000|Overall Study|Sick . Could not attend visit|1
6802816|NCT04098367|10804179|FG001|Overall Study|Sick . Could not attend visit|0
6802817|NCT04098367|10804180|FG002|Overall Study|Sick . Could not attend visit|0
6802818|NCT04091087|10804197|FG000|Overall Study|Not treated|1
6802819|NCT04091087|10804198|FG001|Overall Study|Not treated|0
6802820|NCT04091087|10804197|FG000|Overall Study|Adverse Event|4
6802821|NCT04091087|10804198|FG001|Overall Study|Adverse Event|4
6802822|NCT04091087|10804197|FG000|Overall Study|Protocol Violation|0
6802823|NCT04091087|10804198|FG001|Overall Study|Protocol Violation|1
6802824|NCT04091087|10804197|FG000|Overall Study|Withdrawal by Subject|5
6802825|NCT04091087|10804198|FG001|Overall Study|Withdrawal by Subject|2
6802826|NCT04009629|10804206|FG000|Overall Study|Withdrawal by Subject|2
6802827|NCT04009629|10804207|FG001|Overall Study|Withdrawal by Subject|0
6802828|NCT03937908|10804216|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0
6802829|NCT03937908|10804217|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1
6802830|NCT03891264|10804223|FG000|Overall Study|Adverse Event|1
6802831|NCT03891264|10804223|FG000|Overall Study|Withdrawal by Subject|2
6802832|NCT03891264|10804223|FG000|Overall Study|Physician Decision|2
6802833|NCT03823300|10804247|FG000|Overall Study|Withdrawal by Subject|5
6802834|NCT03823300|10804248|FG001|Overall Study|Withdrawal by Subject|8
6802835|NCT03823300|10804247|FG000|Overall Study|Death|2
6802836|NCT03823300|10804248|FG001|Overall Study|Death|5
6802837|NCT03823300|10804247|FG000|Overall Study|Adverse Event|2
6802838|NCT03823300|10804248|FG001|Overall Study|Adverse Event|0
6802839|NCT03823300|10804247|FG000|Overall Study|Physician Decision|0
6802840|NCT03823300|10804248|FG001|Overall Study|Physician Decision|2
6802841|NCT03823300|10804247|FG000|Overall Study|Protocol Violation|1
6802842|NCT03823300|10804248|FG001|Overall Study|Protocol Violation|1
6802843|NCT03823300|10804247|FG000|Overall Study|Lost to Follow-up|0
6802844|NCT03823300|10804248|FG001|Overall Study|Lost to Follow-up|1
6802845|NCT03823300|10804247|FG000|Overall Study|Not Eligible|0
6802846|NCT03823300|10804248|FG001|Overall Study|Not Eligible|1
6802847|NCT03823300|10804247|FG000|Overall Study|Ongoing in the study at Primary Completion Date|321
6802848|NCT03823300|10804248|FG001|Overall Study|Ongoing in the study at Primary Completion Date|309
6802849|NCT03823287|10804256|FG000|Overall Study|Withdrawal by Subject|7
6802850|NCT03823287|10804257|FG001|Overall Study|Withdrawal by Subject|6
6802851|NCT03823287|10804256|FG000|Overall Study|Death|4
6802852|NCT03823287|10804257|FG001|Overall Study|Death|1
6802853|NCT03823287|10804256|FG000|Overall Study|Lost to Follow-up|2
6802854|NCT03823287|10804257|FG001|Overall Study|Lost to Follow-up|3
6802855|NCT03823287|10804256|FG000|Overall Study|Physician Decision|2
6802856|NCT03823287|10804257|FG001|Overall Study|Physician Decision|1
6802857|NCT03823287|10804256|FG000|Overall Study|Adverse Event|0
6802858|NCT03823287|10804257|FG001|Overall Study|Adverse Event|3
6802859|NCT03823287|10804256|FG000|Overall Study|Ongoing in the study at Primary Completion Date|319
6802860|NCT03823287|10804257|FG001|Overall Study|Ongoing in the study at Primary Completion Date|323
6802861|NCT03815175|10804263|FG000|Overall Study|Subject Lost to Follow-up|6
6802862|NCT03815175|10804263|FG000|Overall Study|Subject Withdrew Consent|48
6802863|NCT03815175|10804263|FG000|Overall Study|Subject Withdrawn by Physician/Site|10
6802864|NCT03815175|10804263|FG000|Overall Study|Death|86
6802865|NCT03815175|10804263|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1
6802866|NCT03815175|10804263|FG000|Overall Study|Subject Discontinued by Sponsor|2
6802867|NCT03815175|10804263|FG000|Overall Study|Other Status Change Reason|1
6802868|NCT03815175|10804263|FG000|Overall Study|Missed Visit|12
6802869|NCT03812224|10804269|FG000|Double-blind Treatment Period|Withdrawal by Subject|4
6802870|NCT03812224|10804270|FG001|Double-blind Treatment Period|Withdrawal by Subject|2
6802871|NCT03812224|10804269|FG000|Double-blind Treatment Period|Decision by Sponsor|0
6802872|NCT03812224|10804270|FG001|Double-blind Treatment Period|Decision by Sponsor|1
6802873|NCT03812224|10804269|FG000|Open-label Treatment Period|Withdrawal by Subject|2
6802874|NCT03812224|10804270|FG001|Open-label Treatment Period|Withdrawal by Subject|2
6802875|NCT03812224|10804269|FG000|Open-label Treatment Period|Decision by Sponsor|0
6802876|NCT03812224|10804270|FG001|Open-label Treatment Period|Decision by Sponsor|1
6810008|NCT02552212|10813870|FG000|SFE Period (Week 52 - 156)|Compassionate access|0
6810009|NCT02552212|10813871|FG001|SFE Period (Week 52 - 156)|Compassionate access|0
6810010|NCT02552212|10813872|FG002|SFE Period (Week 52 - 156)|Compassionate access|2
6810011|NCT02552212|10813870|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0
6810012|NCT02552212|10813871|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0
6810013|NCT02552212|10813872|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1
6810014|NCT02552212|10813870|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0
6810015|NCT02552212|10813871|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0
6810016|NCT02552212|10813872|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1
6810017|NCT02411448|10813909|FG000|Overall Study|Withdrawal by Subject|1
6810018|NCT02411448|10813910|FG001|Overall Study|Withdrawal by Subject|14
6810019|NCT02411448|10813911|FG002|Overall Study|Withdrawal by Subject|9
6810020|NCT02411448|10813909|FG000|Overall Study|Other|0
6810021|NCT02411448|10813910|FG001|Overall Study|Other|2
6810022|NCT02411448|10813911|FG002|Overall Study|Other|0
6810023|NCT02411448|10813909|FG000|Overall Study|Did not receive study treatment|0
6810024|NCT02411448|10813910|FG001|Overall Study|Did not receive study treatment|3
6810025|NCT02411448|10813911|FG002|Overall Study|Did not receive study treatment|0
6810026|NCT02411448|10813909|FG000|Overall Study|Alive on study treatment|3
6810027|NCT02411448|10813910|FG001|Overall Study|Alive on study treatment|64
6810028|NCT02411448|10813911|FG002|Overall Study|Alive on study treatment|43
6810029|NCT02371369|10813925|FG000|Part 1|Physician Decision|0
6810030|NCT02371369|10813926|FG001|Part 1|Physician Decision|3
6810031|NCT02371369|10813925|FG000|Part 1|Adverse Event|8
6810032|NCT02371369|10813926|FG001|Part 1|Adverse Event|0
6810033|NCT02371369|10813925|FG000|Part 1|Withdrawal by Subject|1
6810034|NCT02371369|10813926|FG001|Part 1|Withdrawal by Subject|6
6810035|NCT02371369|10813925|FG000|Part 1|Disease progression|0
6810036|NCT02371369|10813926|FG001|Part 1|Disease progression|1
6810037|NCT02371369|10813925|FG000|Part 1|Protocol Violation|0
6810038|NCT02371369|10813926|FG001|Part 1|Protocol Violation|1
6810039|NCT02371369|10813925|FG000|Part 2|Adverse Event|6
6810040|NCT02371369|10813926|FG001|Part 2|Adverse Event|5
6810041|NCT02371369|10813925|FG000|Part 2|Withdrawal by Subject|16
6810042|NCT02371369|10813926|FG001|Part 2|Withdrawal by Subject|6
6810043|NCT02371369|10813925|FG000|Part 2|Investigator decision|1
6810044|NCT02371369|10813926|FG001|Part 2|Investigator decision|2
6810045|NCT02371369|10813925|FG000|Part 2|Death|0
6810046|NCT02371369|10813926|FG001|Part 2|Death|1
6810047|NCT02371369|10813925|FG000|Part 2|Disease progression|1
6810048|NCT02371369|10813926|FG001|Part 2|Disease progression|0
6810049|NCT02371369|10813925|FG000|Part 2|Subject Noncompliance|1
6810050|NCT02371369|10813926|FG001|Part 2|Subject Noncompliance|0
6810051|NCT02371369|10813925|FG000|Part 2|Lost to Follow-up|1
6810052|NCT02371369|10813926|FG001|Part 2|Lost to Follow-up|1
6810053|NCT02371369|10813925|FG000|Part 2|Subject transitioned to commercial supply|6
6810054|NCT02371369|10813926|FG001|Part 2|Subject transitioned to commercial supply|4
6811664|NCT01244763|10815544|FG004|Overall Study|Withdrawal by Subject|1
6802877|NCT03689374|10804328|FG000|Run-in Period (12 Weeks)|Run-in failure|526
6802878|NCT03689374|10804329|FG001|Run-in Period (12 Weeks)|Run-in failure|0
6802879|NCT03689374|10804330|FG002|Run-in Period (12 Weeks)|Run-in failure|0
6802880|NCT03689374|10804328|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0
6802881|NCT03689374|10804329|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10
6802882|NCT03689374|10804330|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38
6802883|NCT03689374|10804328|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0
6802884|NCT03689374|10804329|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3
6802885|NCT03689374|10804330|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4
6802886|NCT03689374|10804328|FG000|Treatment Period (Week 0 to 52)|Death|0
6802887|NCT03689374|10804329|FG001|Treatment Period (Week 0 to 52)|Death|11
6802888|NCT03689374|10804330|FG002|Treatment Period (Week 0 to 52)|Death|1
6802889|NCT03603639|10804345|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0
6802890|NCT03603639|10804346|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0
6802891|NCT03603639|10804347|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0
6802892|NCT03603639|10804348|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1
6802893|NCT03603639|10804349|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0
6802894|NCT03603639|10804350|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0
6802895|NCT03603639|10804345|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0
6802896|NCT03603639|10804346|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0
6802897|NCT03603639|10804347|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1
6802898|NCT03603639|10804348|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0
6802899|NCT03603639|10804349|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1
6802900|NCT03603639|10804350|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1
6802901|NCT03587636|10804362|FG000|Overall Study|Lost to Follow-up|2
6802902|NCT03587636|10804363|FG001|Overall Study|Lost to Follow-up|5
6802903|NCT03573336|10804393|FG000|Overall Study|Study terminated|2
6802904|NCT03573336|10804394|FG001|Overall Study|Study terminated|4
6802905|NCT03573336|10804395|FG002|Overall Study|Study terminated|2
6802906|NCT03570697|10804405|FG000|Overall Study|Lost to Follow-up|0
6802907|NCT03570697|10804406|FG001|Overall Study|Lost to Follow-up|1
6802908|NCT03570697|10804405|FG000|Overall Study|Death|2
6802909|NCT03570697|10804406|FG001|Overall Study|Death|0
6802910|NCT03570697|10804405|FG000|Overall Study|Withdrawal by Subject|4
6802911|NCT03570697|10804406|FG001|Overall Study|Withdrawal by Subject|2
6802912|NCT03548051|10804414|FG000|Overall Study|Death|1
6802913|NCT03548051|10804415|FG001|Overall Study|Death|1
6802914|NCT03548051|10804414|FG000|Overall Study|Withdrawal by Subject|1
6802915|NCT03548051|10804415|FG001|Overall Study|Withdrawal by Subject|0
6802916|NCT03503318|10804441|FG000|Overall Study|Death|1
6802917|NCT03503318|10804442|FG001|Overall Study|Death|0
6802918|NCT03503318|10804443|FG002|Overall Study|Death|4
6802919|NCT03503318|10804441|FG000|Overall Study|Adverse Event|3
6802920|NCT03503318|10804442|FG001|Overall Study|Adverse Event|4
6802921|NCT03503318|10804443|FG002|Overall Study|Adverse Event|2
6802922|NCT03503318|10804441|FG000|Overall Study|Withdrawal by Subject|12
6802923|NCT03503318|10804442|FG001|Overall Study|Withdrawal by Subject|17
6802924|NCT03503318|10804443|FG002|Overall Study|Withdrawal by Subject|16
6802925|NCT03503318|10804441|FG000|Overall Study|Protocol Violation|5
6802926|NCT03503318|10804442|FG001|Overall Study|Protocol Violation|0
6802927|NCT03503318|10804443|FG002|Overall Study|Protocol Violation|3
6802928|NCT03503318|10804441|FG000|Overall Study|Lost to Follow-up|17
6802929|NCT03503318|10804442|FG001|Overall Study|Lost to Follow-up|15
6802930|NCT03503318|10804443|FG002|Overall Study|Lost to Follow-up|12
6802931|NCT03503318|10804441|FG000|Overall Study|Other than specified|1
6802932|NCT03503318|10804442|FG001|Overall Study|Other than specified|3
6802933|NCT03503318|10804443|FG002|Overall Study|Other than specified|3
6802934|NCT03493854|10804453|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3
6802935|NCT03493854|10804454|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5
6802936|NCT03493854|10804453|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1
6802937|NCT03493854|10804454|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1
6802938|NCT03493854|10804453|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0
6802939|NCT03493854|10804454|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1
6802940|NCT03493854|10804453|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1
6802941|NCT03493854|10804454|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2
6802942|NCT03493854|10804453|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3
6802943|NCT03493854|10804454|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3
6802944|NCT03493854|10804453|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1
6802945|NCT03493854|10804454|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2
6802946|NCT03493854|10804453|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1
6802947|NCT03493854|10804454|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0
6802948|NCT03493854|10804453|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|229
6802949|NCT03493854|10804454|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|228
6802950|NCT03493854|10804453|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2
6802951|NCT03493854|10804454|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2
6802952|NCT03493854|10804453|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0
6802953|NCT03493854|10804454|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|1
6802954|NCT03493854|10804453|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|3
6802955|NCT03493854|10804454|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0
6802956|NCT03493854|10804453|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|1
6802957|NCT03493854|10804454|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|0
6802958|NCT03493854|10804453|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2
6802959|NCT03493854|10804454|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|0
6802960|NCT03493854|10804453|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|5
6802961|NCT03493854|10804454|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|3
6802962|NCT03493854|10804453|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1
6802963|NCT03493854|10804454|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1
6802964|NCT03493854|10804453|FG000|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|18
6802965|NCT03493854|10804454|FG001|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|16
6802966|NCT03493451|10804463|FG000|Overall Study|Death|11
6802967|NCT03493451|10804464|FG001|Overall Study|Death|26
6802968|NCT03493451|10804465|FG002|Overall Study|Death|3
6802969|NCT03493451|10804463|FG000|Overall Study|Lost to Follow-up|1
6802970|NCT03493451|10804464|FG001|Overall Study|Lost to Follow-up|4
6802971|NCT03493451|10804465|FG002|Overall Study|Lost to Follow-up|1
6802972|NCT03493451|10804463|FG000|Overall Study|Withdrawal by Subject|1
6802973|NCT03493451|10804464|FG001|Overall Study|Withdrawal by Subject|1
6802974|NCT03493451|10804465|FG002|Overall Study|Withdrawal by Subject|2
6802975|NCT03493451|10804463|FG000|Overall Study|Progressive Disease|1
6802976|NCT03493451|10804464|FG001|Overall Study|Progressive Disease|0
6802977|NCT03493451|10804465|FG002|Overall Study|Progressive Disease|0
6802978|NCT03493451|10804463|FG000|Overall Study|Transferred to long term extension study|8
6802979|NCT03493451|10804464|FG001|Overall Study|Transferred to long term extension study|13
6802980|NCT03493451|10804465|FG002|Overall Study|Transferred to long term extension study|5
6802981|NCT03476239|10804473|FG000|Overall Study|Withdrawal by Subject|10
6802982|NCT03476239|10804473|FG000|Overall Study|Death|80
6802983|NCT03476239|10804473|FG000|Overall Study|Lost to Follow-up|8
6802984|NCT03401749|10804489|FG000|Overall Study|Lost to Follow-up|20
6802985|NCT03401749|10804490|FG001|Overall Study|Lost to Follow-up|16
6802986|NCT03401749|10804491|FG002|Overall Study|Lost to Follow-up|26
6802987|NCT03337113|10804503|FG000|Overall Study|Adverse Event|1
6802988|NCT03337113|10804504|FG001|Overall Study|Adverse Event|1
6802989|NCT03337113|10804505|FG002|Overall Study|Adverse Event|0
6802990|NCT03337113|10804506|FG003|Overall Study|Adverse Event|1
6802991|NCT03337113|10804503|FG000|Overall Study|Physician Decision|0
6802992|NCT03337113|10804504|FG001|Overall Study|Physician Decision|2
6802993|NCT03337113|10804505|FG002|Overall Study|Physician Decision|0
6802994|NCT03337113|10804506|FG003|Overall Study|Physician Decision|1
6802995|NCT03337113|10804503|FG000|Overall Study|Withdrawal by Subject|0
6802996|NCT03337113|10804504|FG001|Overall Study|Withdrawal by Subject|0
6802997|NCT03337113|10804505|FG002|Overall Study|Withdrawal by Subject|1
6802998|NCT03337113|10804506|FG003|Overall Study|Withdrawal by Subject|0
6810055|NCT02371369|10813925|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15
6810056|NCT02371369|10813926|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9
6810057|NCT02371369|10813925|FG000|Part 2|Surgical resection of tumor|1
6810058|NCT02371369|10813926|FG001|Part 2|Surgical resection of tumor|1
6810059|NCT02371369|10813925|FG000|Part 2|Other|0
6810060|NCT02371369|10813926|FG001|Part 2|Other|1
6810061|NCT02282917|10813948|FG000|Overall Study|Withdrawal by Subject|1
6810062|NCT02282917|10813948|FG000|Overall Study|Screen Failure/Not Eligible|1
6810063|NCT01849783|10813952|FG000|Overall Study|Adverse Event|5
6810064|NCT01849783|10813952|FG000|Overall Study|Death|2
6810065|NCT01849783|10813952|FG000|Overall Study|Physician Decision|1
6810066|NCT01849783|10813952|FG000|Overall Study|Withdrawal by Subject|1
6810067|NCT01849783|10813952|FG000|Overall Study|Unable to comply|2
6810068|NCT01849783|10813952|FG000|Overall Study|Disease progression|11
6810069|NCT01737021|10813973|FG000|Overall Study|Lost to Follow-up|5
6810070|NCT01737021|10813974|FG001|Overall Study|Lost to Follow-up|3
6810071|NCT01333943|10813991|FG000|Overall Study|Known neuropathy|1
6810072|NCT01333943|10813992|FG001|Overall Study|Known neuropathy|0
6810073|NCT01090024|10814007|FG000|Period 1|Met exclusion criteria|0
6810074|NCT01090024|10814008|FG001|Period 1|Met exclusion criteria|0
6810075|NCT01090024|10814009|FG002|Period 1|Met exclusion criteria|0
6810076|NCT01090024|10814010|FG003|Period 1|Met exclusion criteria|0
6810077|NCT01090024|10814011|FG004|Period 1|Met exclusion criteria|0
6810078|NCT01090024|10814012|FG005|Period 1|Met exclusion criteria|0
6810079|NCT01090024|10814013|FG006|Period 1|Met exclusion criteria|0
6810080|NCT01090024|10814014|FG007|Period 1|Met exclusion criteria|0
6810081|NCT01090024|10814015|FG008|Period 1|Met exclusion criteria|0
6810082|NCT01090024|10814016|FG009|Period 1|Met exclusion criteria|0
6810083|NCT01090024|10814017|FG010|Period 1|Met exclusion criteria|0
6810084|NCT01090024|10814018|FG011|Period 1|Met exclusion criteria|0
6810085|NCT01090024|10814019|FG012|Period 1|Met exclusion criteria|0
6810086|NCT01090024|10814020|FG013|Period 1|Met exclusion criteria|0
6810087|NCT01090024|10814021|FG014|Period 1|Met exclusion criteria|1
6810088|NCT01090024|10814022|FG015|Period 1|Met exclusion criteria|0
6810089|NCT01090024|10814023|FG016|Period 1|Met exclusion criteria|0
6810090|NCT01090024|10814024|FG017|Period 1|Met exclusion criteria|0
6810091|NCT01090024|10814007|FG000|Period 1|Adverse Event|0
6810092|NCT01090024|10814008|FG001|Period 1|Adverse Event|0
6802999|NCT03257631|10804520|FG000|Overall Study|Death|8
6803000|NCT03257631|10804521|FG001|Overall Study|Death|5
6803001|NCT03257631|10804522|FG002|Overall Study|Death|13
6803002|NCT03257631|10804523|FG003|Overall Study|Death|5
6803003|NCT03257631|10804520|FG000|Overall Study|Progressive Disease|0
6803004|NCT03257631|10804521|FG001|Overall Study|Progressive Disease|0
6803005|NCT03257631|10804522|FG002|Overall Study|Progressive Disease|1
6803006|NCT03257631|10804523|FG003|Overall Study|Progressive Disease|0
6803007|NCT03257631|10804520|FG000|Overall Study|Withdrawal by Parent/Guardian|0
6803008|NCT03257631|10804521|FG001|Overall Study|Withdrawal by Parent/Guardian|2
6803009|NCT03257631|10804522|FG002|Overall Study|Withdrawal by Parent/Guardian|4
6803010|NCT03257631|10804523|FG003|Overall Study|Withdrawal by Parent/Guardian|1
6803011|NCT03257631|10804520|FG000|Overall Study|Lost to Follow-up|0
6803012|NCT03257631|10804521|FG001|Overall Study|Lost to Follow-up|0
6803013|NCT03257631|10804522|FG002|Overall Study|Lost to Follow-up|1
6803014|NCT03257631|10804523|FG003|Overall Study|Lost to Follow-up|0
6803015|NCT03257631|10804520|FG000|Overall Study|Still on Study|3
6803016|NCT03257631|10804521|FG001|Overall Study|Still on Study|2
6803017|NCT03257631|10804522|FG002|Overall Study|Still on Study|4
6803018|NCT03257631|10804523|FG003|Overall Study|Still on Study|4
6803019|NCT03253796|10804538|FG000|Period 1: Run-In|Adverse Event|4
6803020|NCT03253796|10804539|FG001|Period 1: Run-In|Adverse Event|0
6803021|NCT03253796|10804540|FG002|Period 1: Run-In|Adverse Event|0
6803022|NCT03253796|10804541|FG003|Period 1: Run-In|Adverse Event|0
6803023|NCT03253796|10804542|FG004|Period 1: Run-In|Adverse Event|0
6803024|NCT03253796|10804538|FG000|Period 1: Run-In|Lack of Efficacy|1
6803025|NCT03253796|10804539|FG001|Period 1: Run-In|Lack of Efficacy|0
6803026|NCT03253796|10804540|FG002|Period 1: Run-In|Lack of Efficacy|0
6803027|NCT03253796|10804541|FG003|Period 1: Run-In|Lack of Efficacy|0
6803028|NCT03253796|10804542|FG004|Period 1: Run-In|Lack of Efficacy|0
6803029|NCT03253796|10804538|FG000|Period 1: Run-In|Lack of Qualifying Event|98
6803030|NCT03253796|10804539|FG001|Period 1: Run-In|Lack of Qualifying Event|0
6803031|NCT03253796|10804540|FG002|Period 1: Run-In|Lack of Qualifying Event|0
6803032|NCT03253796|10804541|FG003|Period 1: Run-In|Lack of Qualifying Event|0
6803033|NCT03253796|10804542|FG004|Period 1: Run-In|Lack of Qualifying Event|0
6803034|NCT03253796|10804538|FG000|Period 1: Run-In|Protocol Violation|5
6803035|NCT03253796|10804539|FG001|Period 1: Run-In|Protocol Violation|0
6803036|NCT03253796|10804540|FG002|Period 1: Run-In|Protocol Violation|0
6803037|NCT03253796|10804541|FG003|Period 1: Run-In|Protocol Violation|0
6803038|NCT03253796|10804542|FG004|Period 1: Run-In|Protocol Violation|0
6803039|NCT03253796|10804538|FG000|Period 1: Run-In|Withdrawal by Subject|8
6803040|NCT03253796|10804539|FG001|Period 1: Run-In|Withdrawal by Subject|0
6803041|NCT03253796|10804540|FG002|Period 1: Run-In|Withdrawal by Subject|0
6803042|NCT03253796|10804541|FG003|Period 1: Run-In|Withdrawal by Subject|0
6803043|NCT03253796|10804542|FG004|Period 1: Run-In|Withdrawal by Subject|0
6803044|NCT03253796|10804538|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0
6803045|NCT03253796|10804539|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0
6803046|NCT03253796|10804540|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2
6803047|NCT03253796|10804541|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0
6803048|NCT03253796|10804542|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0
6803049|NCT03253796|10804538|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0
6803050|NCT03253796|10804539|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0
6803051|NCT03253796|10804540|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1
6803052|NCT03253796|10804541|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0
6803053|NCT03253796|10804542|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0
6803054|NCT03253796|10804538|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0
6803055|NCT03253796|10804539|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0
6803056|NCT03253796|10804540|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2
6803057|NCT03253796|10804541|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3
6803058|NCT03253796|10804542|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0
6803059|NCT03253796|10804538|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0
6803060|NCT03253796|10804539|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0
6803061|NCT03253796|10804540|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1
6803062|NCT03253796|10804541|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0
6803063|NCT03253796|10804542|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0
6803064|NCT03253796|10804538|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0
6803065|NCT03253796|10804539|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10
6803066|NCT03253796|10804540|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15
6803067|NCT03253796|10804541|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38
6803068|NCT03253796|10804542|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0
6803069|NCT03253796|10804538|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0
6803070|NCT03253796|10804539|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0
6803071|NCT03253796|10804540|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0
6803072|NCT03253796|10804541|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0
6810093|NCT01090024|10814009|FG002|Period 1|Adverse Event|0
6803073|NCT03253796|10804542|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5
6803074|NCT03233048|10804557|FG000|Overall Study|Withdrawal by Subject|1
6803075|NCT03116399|10804572|FG000|Overall Study|Death|8
6803076|NCT03116399|10804573|FG001|Overall Study|Death|3
6803077|NCT03116399|10804572|FG000|Overall Study|Lost to Follow-up|7
6803078|NCT03116399|10804573|FG001|Overall Study|Lost to Follow-up|11
6803079|NCT03116399|10804572|FG000|Overall Study|Investigator Decision|1
6803080|NCT03116399|10804573|FG001|Overall Study|Investigator Decision|1
6803081|NCT03116399|10804572|FG000|Overall Study|Withdrawal by Subject|24
6803082|NCT03116399|10804573|FG001|Overall Study|Withdrawal by Subject|9
6803083|NCT03064126|10804583|FG000|Overall Study|Death|6
6803084|NCT03064126|10804584|FG001|Overall Study|Death|2
6803085|NCT03064126|10804585|FG002|Overall Study|Death|2
6803086|NCT03064126|10804586|FG003|Overall Study|Death|1
6803087|NCT03064126|10804583|FG000|Overall Study|Investigator Discretion|1
6803088|NCT03064126|10804584|FG001|Overall Study|Investigator Discretion|0
6803089|NCT03064126|10804585|FG002|Overall Study|Investigator Discretion|0
6803090|NCT03064126|10804586|FG003|Overall Study|Investigator Discretion|0
6803091|NCT03064126|10804583|FG000|Overall Study|Withdrawal by Subject|7
6803092|NCT03064126|10804584|FG001|Overall Study|Withdrawal by Subject|4
6803093|NCT03064126|10804585|FG002|Overall Study|Withdrawal by Subject|0
6803094|NCT03064126|10804586|FG003|Overall Study|Withdrawal by Subject|0
6803095|NCT03064126|10804583|FG000|Overall Study|Subject moved|1
6803096|NCT03064126|10804584|FG001|Overall Study|Subject moved|0
6803097|NCT03064126|10804585|FG002|Overall Study|Subject moved|0
6803098|NCT03064126|10804586|FG003|Overall Study|Subject moved|0
6803099|NCT03064126|10804583|FG000|Overall Study|Protocol Violation|11
6803100|NCT03064126|10804584|FG001|Overall Study|Protocol Violation|1
6803101|NCT03064126|10804585|FG002|Overall Study|Protocol Violation|1
6803102|NCT03064126|10804586|FG003|Overall Study|Protocol Violation|0
6803103|NCT03020160|10804599|FG000|Overall Study|Continuing to receive emicizumab|7
6803104|NCT03020160|10804600|FG001|Overall Study|Continuing to receive emicizumab|41
6803105|NCT02943993|10804607|FG000|Overall Study|Withdrawal by Subject|52
6803106|NCT02943993|10804607|FG000|Overall Study|Transfer to another institution|6
6803107|NCT02943993|10804607|FG000|Overall Study|Lost to Follow-up|135
6803108|NCT02943993|10804607|FG000|Overall Study|Death|98
6803109|NCT02943993|10804607|FG000|Overall Study|Other reason for premature termination|32
6803110|NCT02943993|10804607|FG000|Overall Study|Missing reason for termination|7
6803125|NCT02877134|10804644|FG000|Overall Study|Death|0
6803126|NCT02877134|10804645|FG001|Overall Study|Death|1
6803127|NCT02877134|10804646|FG002|Overall Study|Death|0
6803128|NCT02877134|10804647|FG003|Overall Study|Death|0
6803129|NCT02877134|10804648|FG004|Overall Study|Death|0
6803130|NCT02877134|10804649|FG005|Overall Study|Death|1
6803131|NCT02877134|10804650|FG006|Overall Study|Death|0
6803132|NCT02877134|10804644|FG000|Overall Study|Lost to Follow-up|0
6803133|NCT02877134|10804645|FG001|Overall Study|Lost to Follow-up|4
6803134|NCT02877134|10804646|FG002|Overall Study|Lost to Follow-up|0
6803135|NCT02877134|10804647|FG003|Overall Study|Lost to Follow-up|1
6803136|NCT02877134|10804648|FG004|Overall Study|Lost to Follow-up|0
6803137|NCT02877134|10804649|FG005|Overall Study|Lost to Follow-up|0
6803138|NCT02877134|10804650|FG006|Overall Study|Lost to Follow-up|0
6803139|NCT02877134|10804644|FG000|Overall Study|Withdrawal by Subject|13
6803140|NCT02877134|10804645|FG001|Overall Study|Withdrawal by Subject|19
6803141|NCT02877134|10804646|FG002|Overall Study|Withdrawal by Subject|4
6803142|NCT02877134|10804647|FG003|Overall Study|Withdrawal by Subject|6
6803143|NCT02877134|10804648|FG004|Overall Study|Withdrawal by Subject|3
6803144|NCT02877134|10804649|FG005|Overall Study|Withdrawal by Subject|5
6803145|NCT02877134|10804650|FG006|Overall Study|Withdrawal by Subject|0
6803146|NCT02877134|10804644|FG000|Overall Study|Other|1
6803147|NCT02877134|10804645|FG001|Overall Study|Other|1
6803148|NCT02877134|10804646|FG002|Overall Study|Other|2
6803149|NCT02877134|10804647|FG003|Overall Study|Other|6
6803150|NCT02877134|10804648|FG004|Overall Study|Other|3
6803151|NCT02877134|10804649|FG005|Overall Study|Other|1
6803152|NCT02877134|10804650|FG006|Overall Study|Other|1
6810094|NCT01090024|10814010|FG003|Period 1|Adverse Event|0
6810095|NCT01090024|10814011|FG004|Period 1|Adverse Event|0
6810096|NCT01090024|10814012|FG005|Period 1|Adverse Event|0
6810097|NCT01090024|10814013|FG006|Period 1|Adverse Event|0
6810098|NCT01090024|10814014|FG007|Period 1|Adverse Event|0
6810099|NCT01090024|10814015|FG008|Period 1|Adverse Event|0
6810100|NCT01090024|10814016|FG009|Period 1|Adverse Event|1
6803153|NCT02763579|10804670|FG000|Overall Study|Death|101
6803154|NCT02763579|10804671|FG001|Overall Study|Death|132
6803155|NCT02763579|10804670|FG000|Overall Study|Lost to Follow-up|3
6803156|NCT02763579|10804671|FG001|Overall Study|Lost to Follow-up|1
6803157|NCT02763579|10804670|FG000|Overall Study|Withdrawal by Subject|18
6803158|NCT02763579|10804671|FG001|Overall Study|Withdrawal by Subject|9
6803159|NCT02763579|10804670|FG000|Overall Study|Physician Decision|2
6803160|NCT02763579|10804671|FG001|Overall Study|Physician Decision|0
6803161|NCT02763579|10804670|FG000|Overall Study|On-going in study|77
6803162|NCT02763579|10804671|FG001|Overall Study|On-going in study|60
6803163|NCT02762708|10804681|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0
6803164|NCT02762708|10804682|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2
6803165|NCT02762708|10804683|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0
6803166|NCT02762708|10804684|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0
6803167|NCT02743494|10804696|FG000|Pre-treatment Period|Participant request to discontinue treatment|0
6803168|NCT02743494|10804697|FG001|Pre-treatment Period|Participant request to discontinue treatment|1
6803169|NCT02743494|10804696|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0
6803170|NCT02743494|10804697|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1
6803171|NCT02743494|10804696|FG000|Treatment Period|Completed treatment|229
6803172|NCT02743494|10804697|FG001|Treatment Period|Completed treatment|99
6803173|NCT02743494|10804696|FG000|Treatment Period|Disease recurrence|149
6803174|NCT02743494|10804697|FG001|Treatment Period|Disease recurrence|113
6803175|NCT02743494|10804696|FG000|Treatment Period|Study drug toxicity|57
6803176|NCT02743494|10804697|FG001|Treatment Period|Study drug toxicity|8
6803177|NCT02743494|10804696|FG000|Treatment Period|Death|1
6803178|NCT02743494|10804697|FG001|Treatment Period|Death|0
6803179|NCT02743494|10804696|FG000|Treatment Period|Adverse event unrelated to study drug|15
6803180|NCT02743494|10804697|FG001|Treatment Period|Adverse event unrelated to study drug|9
6803181|NCT02743494|10804696|FG000|Treatment Period|Participant request to discontinue treatment|30
6803182|NCT02743494|10804697|FG001|Treatment Period|Participant request to discontinue treatment|5
6803183|NCT02743494|10804696|FG000|Treatment Period|Participant withdrew consent|12
6803184|NCT02743494|10804697|FG001|Treatment Period|Participant withdrew consent|4
6803185|NCT02743494|10804696|FG000|Treatment Period|Lost to Follow-up|0
6803186|NCT02743494|10804697|FG001|Treatment Period|Lost to Follow-up|1
6803187|NCT02743494|10804696|FG000|Treatment Period|Poor/Non-compliance|1
6803188|NCT02743494|10804697|FG001|Treatment Period|Poor/Non-compliance|0
6803189|NCT02743494|10804696|FG000|Treatment Period|Other reasons|7
6803190|NCT02743494|10804697|FG001|Treatment Period|Other reasons|2
6803191|NCT02741570|10804705|FG000|Pre-Treatment Period|Other reasons|0
6803192|NCT02741570|10804706|FG001|Pre-Treatment Period|Other reasons|3
6803193|NCT02741570|10804705|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3
6803194|NCT02741570|10804706|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6
6803195|NCT02741570|10804705|FG000|Pre-Treatment Period|Poor/non-compliance|0
6803196|NCT02741570|10804706|FG001|Pre-Treatment Period|Poor/non-compliance|1
6803197|NCT02741570|10804705|FG000|Pre-Treatment Period|Lost to Follow-up|0
6803198|NCT02741570|10804706|FG001|Pre-Treatment Period|Lost to Follow-up|2
6803199|NCT02741570|10804705|FG000|Pre-Treatment Period|Participant withdrew consent|0
6803200|NCT02741570|10804706|FG001|Pre-Treatment Period|Participant withdrew consent|18
6803201|NCT02741570|10804705|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0
6803202|NCT02741570|10804706|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2
6803203|NCT02741570|10804705|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1
6803204|NCT02741570|10804706|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0
6803205|NCT02741570|10804705|FG000|Pre-Treatment Period|Death|0
6803206|NCT02741570|10804706|FG001|Pre-Treatment Period|Death|1
6803207|NCT02741570|10804705|FG000|Pre-Treatment Period|Disease progression|0
6803208|NCT02741570|10804706|FG001|Pre-Treatment Period|Disease progression|1
6803209|NCT02741570|10804705|FG000|Treatment Period|Other reasons|47
6803210|NCT02741570|10804706|FG001|Treatment Period|Other reasons|8
6803211|NCT02741570|10804705|FG000|Treatment Period|Poor/non-compliance|0
6803212|NCT02741570|10804706|FG001|Treatment Period|Poor/non-compliance|1
6803213|NCT02741570|10804705|FG000|Treatment Period|Maximum clinical benefit|3
6803214|NCT02741570|10804706|FG001|Treatment Period|Maximum clinical benefit|5
6803215|NCT02741570|10804705|FG000|Treatment Period|Lost to Follow-up|1
6803216|NCT02741570|10804706|FG001|Treatment Period|Lost to Follow-up|3
6803217|NCT02741570|10804705|FG000|Treatment Period|Participant withdrew consent|9
6803218|NCT02741570|10804706|FG001|Treatment Period|Participant withdrew consent|13
6803219|NCT02741570|10804705|FG000|Treatment Period|Participant request to discontinue treatment|8
6803220|NCT02741570|10804706|FG001|Treatment Period|Participant request to discontinue treatment|23
6803221|NCT02741570|10804705|FG000|Treatment Period|Adverse event unrelated to study drug|41
6803222|NCT02741570|10804706|FG001|Treatment Period|Adverse event unrelated to study drug|25
6803223|NCT02741570|10804705|FG000|Treatment Period|Death|9
6803224|NCT02741570|10804706|FG001|Treatment Period|Death|7
6803225|NCT02741570|10804705|FG000|Treatment Period|Study drug toxicity|55
6803226|NCT02741570|10804706|FG001|Treatment Period|Study drug toxicity|45
6803227|NCT02741570|10804705|FG000|Treatment Period|Disease progression|295
6803228|NCT02741570|10804706|FG001|Treatment Period|Disease progression|304
6803229|NCT02667587|10804722|FG000|Pre-Treatment|Not reported|1
6803230|NCT02667587|10804723|FG001|Pre-Treatment|Not reported|0
6803231|NCT02667587|10804722|FG000|Pre-Treatment|Participant no longer meets study criteria|2
6803232|NCT02667587|10804723|FG001|Pre-Treatment|Participant no longer meets study criteria|2
6803233|NCT02667587|10804722|FG000|Pre-Treatment|Participant withdrew consent|0
6803234|NCT02667587|10804723|FG001|Pre-Treatment|Participant withdrew consent|1
6803235|NCT02667587|10804722|FG000|Pre-Treatment|Adverse event unrelated to study drug|1
6803236|NCT02667587|10804723|FG001|Pre-Treatment|Adverse event unrelated to study drug|0
6803237|NCT02667587|10804722|FG000|End of Treatment|Other reasons|11
6803238|NCT02667587|10804723|FG001|End of Treatment|Other reasons|8
6803239|NCT02667587|10804722|FG000|End of Treatment|Participant no Longer Meets Study Criteria|1
6803240|NCT02667587|10804723|FG001|End of Treatment|Participant no Longer Meets Study Criteria|2
6803241|NCT02667587|10804722|FG000|End of Treatment|Poor/Non-Compliance|0
6803242|NCT02667587|10804723|FG001|End of Treatment|Poor/Non-Compliance|1
6803243|NCT02667587|10804722|FG000|End of Treatment|Maximum Clinical Benefit|3
6803244|NCT02667587|10804723|FG001|End of Treatment|Maximum Clinical Benefit|3
6803245|NCT02667587|10804722|FG000|End of Treatment|Participant Withdrew Consent|5
6803246|NCT02667587|10804723|FG001|End of Treatment|Participant Withdrew Consent|6
6803247|NCT02667587|10804722|FG000|End of Treatment|Participants Request to Discontinue Study Treatment|25
6803248|NCT02667587|10804723|FG001|End of Treatment|Participants Request to Discontinue Study Treatment|26
6803249|NCT02667587|10804722|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19
6803250|NCT02667587|10804723|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20
6803251|NCT02667587|10804722|FG000|End of Treatment|Death|2
6803252|NCT02667587|10804723|FG001|End of Treatment|Death|1
6803253|NCT02667587|10804722|FG000|End of Treatment|Study Drug Toxicity|74
6803254|NCT02667587|10804723|FG001|End of Treatment|Study Drug Toxicity|18
6803255|NCT02667587|10804722|FG000|End of Treatment|Disease progression|177
6803256|NCT02667587|10804723|FG001|End of Treatment|Disease progression|222
6803257|NCT02667587|10804722|FG000|End of Treatment|Lost to Follow-up|1
6803258|NCT02667587|10804723|FG001|End of Treatment|Lost to Follow-up|3
6803259|NCT02621606|10804732|FG000|Overall Study|Withdrawal by Subject|0
6803260|NCT02621606|10804733|FG001|Overall Study|Withdrawal by Subject|1
6803261|NCT02621606|10804734|FG002|Overall Study|Withdrawal by Subject|0
6803262|NCT02613507|10804744|FG000|Overall Study|Disease Progression|237
6803263|NCT02613507|10804745|FG001|Overall Study|Disease Progression|109
6803264|NCT02613507|10804744|FG000|Overall Study|Study Drug Toxicity|15
6803265|NCT02613507|10804745|FG001|Overall Study|Study Drug Toxicity|14
6803266|NCT02613507|10804744|FG000|Overall Study|Death|3
6803267|NCT02613507|10804745|FG001|Overall Study|Death|0
6803268|NCT02613507|10804744|FG000|Overall Study|Adverse Event Unrelated to Study Drug|17
6803269|NCT02613507|10804745|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2
6803270|NCT02613507|10804744|FG000|Overall Study|Request to Discontinue Study Treatment|8
6803271|NCT02613507|10804745|FG001|Overall Study|Request to Discontinue Study Treatment|17
6803272|NCT02613507|10804744|FG000|Overall Study|Participant Withdrew Consent|0
6803273|NCT02613507|10804745|FG001|Overall Study|Participant Withdrew Consent|2
6803274|NCT02613507|10804744|FG000|Overall Study|Lost to Follow-up|1
6803275|NCT02613507|10804745|FG001|Overall Study|Lost to Follow-up|0
6803276|NCT02613507|10804744|FG000|Overall Study|Maximum Clinical Benefit|4
6803277|NCT02613507|10804745|FG001|Overall Study|Maximum Clinical Benefit|10
6803278|NCT02613507|10804744|FG000|Overall Study|Brain Radiotherapy Activity Limited|1
6803279|NCT02613507|10804745|FG001|Overall Study|Brain Radiotherapy Activity Limited|0
6803280|NCT02613507|10804744|FG000|Overall Study|Subject no Longer Meets Study Criteria|1
6803281|NCT02613507|10804745|FG001|Overall Study|Subject no Longer Meets Study Criteria|0
6803282|NCT02613507|10804744|FG000|Overall Study|Randomized but not Treated|1
6803283|NCT02613507|10804745|FG001|Overall Study|Randomized but not Treated|10
6803284|NCT02550873|10804783|FG000|Randomized Double Blind|Adverse Event|3
6803285|NCT02550873|10804784|FG001|Randomized Double Blind|Adverse Event|1
6803286|NCT02550873|10804785|FG002|Randomized Double Blind|Adverse Event|0
6803287|NCT02550873|10804783|FG000|Randomized Double Blind|Disease progression|1
6803288|NCT02550873|10804784|FG001|Randomized Double Blind|Disease progression|1
6803289|NCT02550873|10804785|FG002|Randomized Double Blind|Disease progression|0
6803290|NCT02550873|10804783|FG000|Open Label Extension|Study ongoing|0
6803291|NCT02550873|10804784|FG001|Open Label Extension|Study ongoing|0
6803292|NCT02550873|10804785|FG002|Open Label Extension|Study ongoing|111
6803293|NCT02542267|10804807|FG000|Overall Study|Withdrawal by Subject|10
6803294|NCT02542267|10804807|FG000|Overall Study|Physician Decision|6
6803295|NCT02542267|10804807|FG000|Overall Study|Lost to Follow-up|4
6803296|NCT02542267|10804807|FG000|Overall Study|Death|13
6803297|NCT02542267|10804807|FG000|Overall Study|Surgical Bypass of All Study Devices|13
6803298|NCT02542267|10804807|FG000|Overall Study|Other|9
6803315|NCT02483585|10804853|FG000|Double-blind Treatment Phase|Decision by Sponsor|1
6803316|NCT02483585|10804854|FG001|Double-blind Treatment Phase|Decision by Sponsor|1
6803317|NCT02483585|10804853|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12
6803318|NCT02483585|10804854|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12
6803319|NCT02483585|10804853|FG000|Double-blind Treatment Phase|Lost to Follow-up|3
6803320|NCT02483585|10804854|FG001|Double-blind Treatment Phase|Lost to Follow-up|2
6803321|NCT02483585|10804853|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6
6803322|NCT02483585|10804854|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5
6803323|NCT02483585|10804853|FG000|Open-label Treatment Phase|Decision by Sponsor|0
6803324|NCT02483585|10804854|FG001|Open-label Treatment Phase|Decision by Sponsor|1
6803325|NCT02483585|10804853|FG000|Open-label Treatment Phase|Withdrawal by Subject|18
6803326|NCT02483585|10804854|FG001|Open-label Treatment Phase|Withdrawal by Subject|14
6803327|NCT02483585|10804853|FG000|Open-label Treatment Phase|Lost to Follow-up|3
6803328|NCT02483585|10804854|FG001|Open-label Treatment Phase|Lost to Follow-up|5
6803329|NCT02462603|10804864|FG000|Overall Study|Investigator Decision|1
6803330|NCT02462603|10804864|FG000|Overall Study|Non-Compliance|1
6803331|NCT02462603|10804864|FG000|Overall Study|Withdrawal by Subject|2
6803332|NCT02456740|10804871|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
6803333|NCT02456740|10804872|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
6803334|NCT02456740|10804873|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
6803335|NCT02456740|10804874|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
6803336|NCT02456740|10804875|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
6803337|NCT02456740|10804876|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
6803338|NCT02456740|10804877|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
6803339|NCT02456740|10804878|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
6803340|NCT02456740|10804879|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
6803341|NCT02456740|10804871|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27
6803342|NCT02456740|10804872|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28
6803343|NCT02456740|10804873|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21
6803344|NCT02456740|10804874|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
6803345|NCT02456740|10804875|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
6803346|NCT02456740|10804876|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
6803347|NCT02456740|10804877|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
6803348|NCT02456740|10804878|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
6803349|NCT02456740|10804879|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
6803350|NCT02456740|10804871|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9
6803351|NCT02456740|10804872|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4
6803352|NCT02456740|10804873|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5
6803353|NCT02456740|10804874|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
6803354|NCT02456740|10804875|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
6803355|NCT02456740|10804876|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
6803356|NCT02456740|10804877|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
6803357|NCT02456740|10804878|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
6803358|NCT02456740|10804879|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
6803359|NCT02456740|10804871|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
6803360|NCT02456740|10804872|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
6803361|NCT02456740|10804873|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
6803362|NCT02456740|10804874|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1
6803363|NCT02456740|10804875|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4
6803364|NCT02456740|10804876|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
6803365|NCT02456740|10804877|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
6803366|NCT02456740|10804878|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
6803367|NCT02456740|10804879|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5
6803368|NCT02456740|10804871|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
6803369|NCT02456740|10804872|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
6803370|NCT02456740|10804873|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
6803371|NCT02456740|10804874|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10
6803372|NCT02456740|10804875|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11
6803373|NCT02456740|10804876|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9
6803374|NCT02456740|10804877|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8
6803375|NCT02456740|10804878|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8
6803376|NCT02456740|10804879|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9
6803377|NCT02456740|10804871|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0
6803378|NCT02456740|10804872|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0
6803379|NCT02456740|10804873|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0
6803380|NCT02456740|10804874|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0
6803381|NCT02456740|10804875|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0
6803382|NCT02456740|10804876|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0
6803383|NCT02456740|10804877|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0
6803384|NCT02456740|10804878|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1
6803385|NCT02456740|10804879|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0
6803386|NCT02456740|10804871|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
6803387|NCT02456740|10804872|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
6803388|NCT02456740|10804873|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
6803389|NCT02456740|10804874|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3
6803390|NCT02456740|10804875|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2
6803391|NCT02456740|10804876|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4
6803392|NCT02456740|10804877|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
6803393|NCT02456740|10804878|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3
6803394|NCT02456740|10804879|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4
6803395|NCT02420717|10804906|FG000|Overall Study|Did not receive all study medication|2
6803396|NCT02420717|10804907|FG001|Overall Study|Did not receive all study medication|0
6803397|NCT02420717|10804908|FG002|Overall Study|Did not receive all study medication|0
6803398|NCT02408068|10804916|FG000|Treatment 3 (1.5 Days)|Adverse Event|0
6803399|NCT02408068|10804917|FG001|Treatment 3 (1.5 Days)|Adverse Event|0
6803400|NCT02408068|10804918|FG002|Treatment 3 (1.5 Days)|Adverse Event|1
6803401|NCT02408068|10804919|FG003|Treatment 3 (1.5 Days)|Adverse Event|0
6803402|NCT02408068|10804920|FG004|Treatment 3 (1.5 Days)|Adverse Event|0
6803403|NCT02408068|10804921|FG005|Treatment 3 (1.5 Days)|Adverse Event|0
6803404|NCT02315703|10804940|FG000|Overall Study|Adverse Event|0
6803405|NCT02315703|10804941|FG001|Overall Study|Adverse Event|0
6803406|NCT02315703|10804942|FG002|Overall Study|Adverse Event|0
6803407|NCT02315703|10804943|FG003|Overall Study|Adverse Event|1
6803408|NCT02315703|10804944|FG004|Overall Study|Adverse Event|1
6803409|NCT02315703|10804945|FG005|Overall Study|Adverse Event|0
6803410|NCT02315703|10804946|FG006|Overall Study|Adverse Event|1
6803411|NCT02315703|10804947|FG007|Overall Study|Adverse Event|0
6803412|NCT02315703|10804940|FG000|Overall Study|Lost to Follow-up|1
6803413|NCT02315703|10804941|FG001|Overall Study|Lost to Follow-up|5
6803414|NCT02315703|10804942|FG002|Overall Study|Lost to Follow-up|3
6803415|NCT02315703|10804943|FG003|Overall Study|Lost to Follow-up|3
6803416|NCT02315703|10804944|FG004|Overall Study|Lost to Follow-up|2
6803417|NCT02315703|10804945|FG005|Overall Study|Lost to Follow-up|1
6803418|NCT02315703|10804946|FG006|Overall Study|Lost to Follow-up|2
6803419|NCT02315703|10804947|FG007|Overall Study|Lost to Follow-up|2
6803420|NCT02315703|10804940|FG000|Overall Study|Pregnancy|0
6803421|NCT02315703|10804941|FG001|Overall Study|Pregnancy|0
6803422|NCT02315703|10804942|FG002|Overall Study|Pregnancy|0
6803423|NCT02315703|10804943|FG003|Overall Study|Pregnancy|0
6803424|NCT02315703|10804944|FG004|Overall Study|Pregnancy|0
6803425|NCT02315703|10804945|FG005|Overall Study|Pregnancy|0
6803426|NCT02315703|10804946|FG006|Overall Study|Pregnancy|0
6803427|NCT02315703|10804947|FG007|Overall Study|Pregnancy|1
6803428|NCT02315703|10804940|FG000|Overall Study|Withdrawal by Subject|1
6803429|NCT02315703|10804941|FG001|Overall Study|Withdrawal by Subject|3
6803430|NCT02315703|10804942|FG002|Overall Study|Withdrawal by Subject|0
6803431|NCT02315703|10804943|FG003|Overall Study|Withdrawal by Subject|3
6803432|NCT02315703|10804944|FG004|Overall Study|Withdrawal by Subject|4
6803433|NCT02315703|10804945|FG005|Overall Study|Withdrawal by Subject|1
6803434|NCT02315703|10804946|FG006|Overall Study|Withdrawal by Subject|1
6803435|NCT02315703|10804947|FG007|Overall Study|Withdrawal by Subject|2
6803436|NCT02315703|10804940|FG000|Overall Study|Physician Decision|0
6803437|NCT02315703|10804941|FG001|Overall Study|Physician Decision|0
6803438|NCT02315703|10804942|FG002|Overall Study|Physician Decision|0
6803439|NCT02315703|10804943|FG003|Overall Study|Physician Decision|0
6803440|NCT02315703|10804944|FG004|Overall Study|Physician Decision|0
6803441|NCT02315703|10804945|FG005|Overall Study|Physician Decision|2
6803442|NCT02315703|10804946|FG006|Overall Study|Physician Decision|1
6803443|NCT02315703|10804947|FG007|Overall Study|Physician Decision|0
6803444|NCT02315703|10804940|FG000|Overall Study|Other|4
6803445|NCT02315703|10804941|FG001|Overall Study|Other|2
6803446|NCT02315703|10804942|FG002|Overall Study|Other|2
6803447|NCT02315703|10804943|FG003|Overall Study|Other|2
6803448|NCT02315703|10804944|FG004|Overall Study|Other|1
6803449|NCT02315703|10804945|FG005|Overall Study|Other|2
6803450|NCT02315703|10804946|FG006|Overall Study|Other|8
6803451|NCT02315703|10804947|FG007|Overall Study|Other|2
6810101|NCT01090024|10814017|FG010|Period 1|Adverse Event|0
6810102|NCT01090024|10814018|FG011|Period 1|Adverse Event|1
6810103|NCT01090024|10814019|FG012|Period 1|Adverse Event|0
6810104|NCT01090024|10814020|FG013|Period 1|Adverse Event|0
6810105|NCT01090024|10814021|FG014|Period 1|Adverse Event|0
6810106|NCT01090024|10814022|FG015|Period 1|Adverse Event|0
6810107|NCT01090024|10814023|FG016|Period 1|Adverse Event|0
6810108|NCT01090024|10814024|FG017|Period 1|Adverse Event|1
6810109|NCT01090024|10814007|FG000|Period 1|Withdrawal by Subject|0
6803464|NCT02174861|10804974|FG000|Overall Study|Decision by sponsor|8
6803465|NCT02174861|10804974|FG000|Overall Study|Withdrawal by Subject|124
6803466|NCT02174861|10804974|FG000|Overall Study|Lost to Follow-up|26
6803467|NCT02052739|10804982|FG000|Overall Study|Withdrew due to Adverse Event|3
6803468|NCT02052739|10804983|FG001|Overall Study|Withdrew due to Adverse Event|0
6803469|NCT02052739|10804982|FG000|Overall Study|Participant Died|2
6803470|NCT02052739|10804983|FG001|Overall Study|Participant Died|1
6803483|NCT01944020|10805002|FG000|Overall Study|Withdrawal by Subject|5
6803484|NCT01944020|10805003|FG001|Overall Study|Withdrawal by Subject|0
6803485|NCT01689519|10805023|FG000|Intent to Treat|Death|157
6803486|NCT01689519|10805024|FG001|Intent to Treat|Death|167
6803487|NCT01689519|10805023|FG000|Intent to Treat|Lost to Follow-up|4
6803488|NCT01689519|10805024|FG001|Intent to Treat|Lost to Follow-up|8
6803489|NCT01689519|10805023|FG000|Intent to Treat|Other|2
6803490|NCT01689519|10805024|FG001|Intent to Treat|Other|4
6803491|NCT01689519|10805023|FG000|Intent to Treat|Physician Decision|4
6803492|NCT01689519|10805024|FG001|Intent to Treat|Physician Decision|1
6803493|NCT01689519|10805023|FG000|Intent to Treat|Study terminated by Spon6sor|59
6803494|NCT01689519|10805024|FG001|Intent to Treat|Study terminated by Spon6sor|48
6803495|NCT01689519|10805023|FG000|Intent to Treat|Withdrawal by Subject|21
6803496|NCT01689519|10805024|FG001|Intent to Treat|Withdrawal by Subject|20
6803497|NCT01689519|10805023|FG000|Safety Population|Death|158
6803498|NCT01689519|10805024|FG001|Safety Population|Death|165
6803499|NCT01689519|10805023|FG000|Safety Population|Lost to Follow-up|4
6803500|NCT01689519|10805024|FG001|Safety Population|Lost to Follow-up|8
6803501|NCT01689519|10805023|FG000|Safety Population|Other|2
6803502|NCT01689519|10805024|FG001|Safety Population|Other|4
6803503|NCT01689519|10805023|FG000|Safety Population|Physician Decision|4
6803504|NCT01689519|10805024|FG001|Safety Population|Physician Decision|1
6803505|NCT01689519|10805023|FG000|Safety Population|Study Terminated By Sponsor|60
6803506|NCT01689519|10805024|FG001|Safety Population|Study Terminated By Sponsor|47
6803507|NCT01689519|10805023|FG000|Safety Population|Withdrawal by Subject|20
6803508|NCT01689519|10805024|FG001|Safety Population|Withdrawal by Subject|20
6803509|NCT01622088|10805030|FG000|Overall Study|Adverse Event|20
6803510|NCT01622088|10805030|FG000|Overall Study|Lost to Follow-up|1
6803511|NCT01622088|10805030|FG000|Overall Study|Withdrawal by Subject|20
6803512|NCT01622088|10805030|FG000|Overall Study|Investigator Decision|1
6803513|NCT01622088|10805030|FG000|Overall Study|Death|53
6803514|NCT01622088|10805030|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521
6803515|NCT01486264|10805037|FG000|Overall Study|Death|1
6803516|NCT01486264|10805038|FG001|Overall Study|Death|1
6803517|NCT01486264|10805037|FG000|Overall Study|Adverse Event|3
6803518|NCT01486264|10805038|FG001|Overall Study|Adverse Event|3
6803519|NCT01486264|10805037|FG000|Overall Study|Lack of Efficacy|6
6803520|NCT01486264|10805038|FG001|Overall Study|Lack of Efficacy|10
6803521|NCT01486264|10805037|FG000|Overall Study|Withdrawal by Subject|7
6803522|NCT01486264|10805038|FG001|Overall Study|Withdrawal by Subject|18
6803523|NCT01486264|10805037|FG000|Overall Study|Physician Decision|1
6803524|NCT01486264|10805038|FG001|Overall Study|Physician Decision|1
6803525|NCT01486264|10805037|FG000|Overall Study|Protocol Violation|3
6803526|NCT01486264|10805038|FG001|Overall Study|Protocol Violation|0
6803527|NCT01486264|10805037|FG000|Overall Study|Lost to Follow-up|3
6803528|NCT01486264|10805038|FG001|Overall Study|Lost to Follow-up|2
6803529|NCT01486264|10805037|FG000|Overall Study|Other|5
6803530|NCT01486264|10805038|FG001|Overall Study|Other|11
6803531|NCT01486264|10805037|FG000|Overall Study|Not treated|0
6803532|NCT01486264|10805038|FG001|Overall Study|Not treated|1
6803533|NCT01419080|10805044|FG000|Overall Study|Withdrawal by Subject|75
6803534|NCT01419080|10805044|FG000|Overall Study|Death|30
6803535|NCT01419080|10805044|FG000|Overall Study|Lost to Follow-up|23
6803536|NCT01419080|10805044|FG000|Overall Study|Too Ill|3
6803537|NCT01317160|10805052|FG000|Overall Study|Incorrect inclusion|1
6803538|NCT01317160|10805053|FG001|Overall Study|Incorrect inclusion|1
6803539|NCT01317160|10805052|FG000|Overall Study|Lost to Follow-up|3
6803540|NCT01317160|10805053|FG001|Overall Study|Lost to Follow-up|3
6803541|NCT01317160|10805052|FG000|Overall Study|Withdrawal by Subject|0
6803542|NCT01317160|10805053|FG001|Overall Study|Withdrawal by Subject|2
6803563|NCT01094782|10805162|FG000|Overall Study|Withdrawal by Subject|5
6803564|NCT01094782|10805163|FG001|Overall Study|Withdrawal by Subject|5
6803565|NCT01094782|10805164|FG002|Overall Study|Withdrawal by Subject|1
6803566|NCT01094782|10805165|FG003|Overall Study|Withdrawal by Subject|5
6803567|NCT01094782|10805166|FG004|Overall Study|Withdrawal by Subject|5
6803568|NCT01094782|10805167|FG005|Overall Study|Withdrawal by Subject|0
6803569|NCT01094782|10805162|FG000|Overall Study|Lost to Follow-up|1
6803570|NCT01094782|10805163|FG001|Overall Study|Lost to Follow-up|0
6803571|NCT01094782|10805164|FG002|Overall Study|Lost to Follow-up|0
6803572|NCT01094782|10805165|FG003|Overall Study|Lost to Follow-up|2
6803573|NCT01094782|10805166|FG004|Overall Study|Lost to Follow-up|1
6803574|NCT01094782|10805167|FG005|Overall Study|Lost to Follow-up|4
6803575|NCT01094782|10805162|FG000|Overall Study|Positive Drug Screen|2
6803576|NCT01094782|10805163|FG001|Overall Study|Positive Drug Screen|2
6803577|NCT01094782|10805164|FG002|Overall Study|Positive Drug Screen|1
6803578|NCT01094782|10805165|FG003|Overall Study|Positive Drug Screen|1
6803579|NCT01094782|10805166|FG004|Overall Study|Positive Drug Screen|3
6803580|NCT01094782|10805167|FG005|Overall Study|Positive Drug Screen|2
6803581|NCT01094782|10805162|FG000|Overall Study|Sensory Deficit at Site of QST|0
6803582|NCT01094782|10805163|FG001|Overall Study|Sensory Deficit at Site of QST|1
6803583|NCT01094782|10805164|FG002|Overall Study|Sensory Deficit at Site of QST|0
6803584|NCT01094782|10805165|FG003|Overall Study|Sensory Deficit at Site of QST|0
6803585|NCT01094782|10805166|FG004|Overall Study|Sensory Deficit at Site of QST|0
6803586|NCT01094782|10805167|FG005|Overall Study|Sensory Deficit at Site of QST|0
6803587|NCT01094782|10805162|FG000|Overall Study|Unable to Complete Questionnaires|0
6803588|NCT01094782|10805163|FG001|Overall Study|Unable to Complete Questionnaires|1
6803589|NCT01094782|10805164|FG002|Overall Study|Unable to Complete Questionnaires|0
6803590|NCT01094782|10805165|FG003|Overall Study|Unable to Complete Questionnaires|0
6803591|NCT01094782|10805166|FG004|Overall Study|Unable to Complete Questionnaires|0
6803592|NCT01094782|10805167|FG005|Overall Study|Unable to Complete Questionnaires|0
6803593|NCT01094782|10805162|FG000|Overall Study|Healthy Subject Had Pain|0
6803594|NCT01094782|10805163|FG001|Overall Study|Healthy Subject Had Pain|1
6803595|NCT01094782|10805164|FG002|Overall Study|Healthy Subject Had Pain|0
6803596|NCT01094782|10805165|FG003|Overall Study|Healthy Subject Had Pain|0
6803597|NCT01094782|10805166|FG004|Overall Study|Healthy Subject Had Pain|0
6803598|NCT01094782|10805167|FG005|Overall Study|Healthy Subject Had Pain|0
6803599|NCT01094782|10805162|FG000|Overall Study|Hypertension|0
6803600|NCT01094782|10805163|FG001|Overall Study|Hypertension|0
6803601|NCT01094782|10805164|FG002|Overall Study|Hypertension|1
6803602|NCT01094782|10805165|FG003|Overall Study|Hypertension|0
6803603|NCT01094782|10805166|FG004|Overall Study|Hypertension|0
6803604|NCT01094782|10805167|FG005|Overall Study|Hypertension|0
6803605|NCT01094782|10805162|FG000|Overall Study|Wrong Pain Condition|0
6803606|NCT01094782|10805163|FG001|Overall Study|Wrong Pain Condition|0
6803607|NCT01094782|10805164|FG002|Overall Study|Wrong Pain Condition|0
6803608|NCT01094782|10805165|FG003|Overall Study|Wrong Pain Condition|2
6803609|NCT01094782|10805166|FG004|Overall Study|Wrong Pain Condition|1
6803610|NCT01094782|10805167|FG005|Overall Study|Wrong Pain Condition|1
6803611|NCT01094782|10805162|FG000|Overall Study|Recent Interventional Injection|0
6803612|NCT01094782|10805163|FG001|Overall Study|Recent Interventional Injection|0
6803613|NCT01094782|10805164|FG002|Overall Study|Recent Interventional Injection|0
6803614|NCT01094782|10805165|FG003|Overall Study|Recent Interventional Injection|0
6803615|NCT01094782|10805166|FG004|Overall Study|Recent Interventional Injection|0
6803616|NCT01094782|10805167|FG005|Overall Study|Recent Interventional Injection|1
6803617|NCT01094782|10805162|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0
6803618|NCT01094782|10805163|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0
6803619|NCT01094782|10805164|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0
6803620|NCT01094782|10805165|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0
6803621|NCT01094782|10805166|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1
6803622|NCT01094782|10805167|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0
6803623|NCT01094782|10805162|FG000|Overall Study|Noncompliance With Study Schedule|0
6803624|NCT01094782|10805163|FG001|Overall Study|Noncompliance With Study Schedule|0
6803625|NCT01094782|10805164|FG002|Overall Study|Noncompliance With Study Schedule|0
6803626|NCT01094782|10805165|FG003|Overall Study|Noncompliance With Study Schedule|1
6803627|NCT01094782|10805166|FG004|Overall Study|Noncompliance With Study Schedule|0
6803628|NCT01094782|10805167|FG005|Overall Study|Noncompliance With Study Schedule|0
6803645|NCT00942331|10805212|FG000|Overall Study|Did not start treatment|15
6803646|NCT00942331|10805213|FG001|Overall Study|Did not start treatment|22
6803647|NCT00932737|10805221|FG000|Overall Study|Not treated in second episode|1
6803648|NCT00932737|10805222|FG001|Overall Study|Not treated in second episode|0
6803649|NCT00932737|10805221|FG000|Overall Study|Adverse Event|0
6803650|NCT00932737|10805222|FG001|Overall Study|Adverse Event|1
6803660|NCT00710710|10805264|FG000|Overall Study|Consent withdrawn|2
6803661|NCT00710710|10805265|FG001|Overall Study|Consent withdrawn|2
6803662|NCT00710710|10805264|FG000|Overall Study|Protocol Violation|0
6803663|NCT00710710|10805265|FG001|Overall Study|Protocol Violation|1
6803664|NCT00710710|10805264|FG000|Overall Study|Adverse Event|3
6803665|NCT00710710|10805265|FG001|Overall Study|Adverse Event|3
6803666|NCT00710710|10805264|FG000|Overall Study|Progressive disease|40
6803667|NCT00710710|10805265|FG001|Overall Study|Progressive disease|38
6803668|NCT00608023|10805274|FG000|Overall Study|Withdrawal by Subject|8
6803669|NCT00608023|10805275|FG001|Overall Study|Withdrawal by Subject|10
6803670|NCT00608023|10805276|FG002|Overall Study|Withdrawal by Subject|7
6803671|NCT00608023|10805274|FG000|Overall Study|Adverse Event|1
6803672|NCT00608023|10805275|FG001|Overall Study|Adverse Event|4
6803673|NCT00608023|10805276|FG002|Overall Study|Adverse Event|5
6803674|NCT00608023|10805274|FG000|Overall Study|Lost to Follow-up|2
6803675|NCT00608023|10805275|FG001|Overall Study|Lost to Follow-up|2
6803676|NCT00608023|10805276|FG002|Overall Study|Lost to Follow-up|1
6803677|NCT00608023|10805274|FG000|Overall Study|Protocol Violation|1
6803678|NCT00608023|10805275|FG001|Overall Study|Protocol Violation|3
6803679|NCT00608023|10805276|FG002|Overall Study|Protocol Violation|1
6803680|NCT00608023|10805274|FG000|Overall Study|Unknown reason|0
6803681|NCT00608023|10805275|FG001|Overall Study|Unknown reason|3
6803682|NCT00608023|10805276|FG002|Overall Study|Unknown reason|0
6803683|NCT00551616|10805289|FG000|Overall Study|Lost to Follow-up|48
6803684|NCT00551616|10805290|FG001|Overall Study|Lost to Follow-up|40
6803685|NCT00520767|10805296|FG000|Overall Study|Death|2
6810110|NCT01090024|10814008|FG001|Period 1|Withdrawal by Subject|0
6810111|NCT01090024|10814009|FG002|Period 1|Withdrawal by Subject|0
6810112|NCT01090024|10814010|FG003|Period 1|Withdrawal by Subject|1
6810113|NCT01090024|10814011|FG004|Period 1|Withdrawal by Subject|0
6810114|NCT01090024|10814012|FG005|Period 1|Withdrawal by Subject|0
6810115|NCT01090024|10814013|FG006|Period 1|Withdrawal by Subject|0
6810116|NCT01090024|10814014|FG007|Period 1|Withdrawal by Subject|0
6810117|NCT01090024|10814015|FG008|Period 1|Withdrawal by Subject|0
6810118|NCT01090024|10814016|FG009|Period 1|Withdrawal by Subject|0
6810119|NCT01090024|10814017|FG010|Period 1|Withdrawal by Subject|0
6810120|NCT01090024|10814018|FG011|Period 1|Withdrawal by Subject|0
6810121|NCT01090024|10814019|FG012|Period 1|Withdrawal by Subject|0
6810122|NCT01090024|10814020|FG013|Period 1|Withdrawal by Subject|0
6810123|NCT01090024|10814021|FG014|Period 1|Withdrawal by Subject|0
6810124|NCT01090024|10814022|FG015|Period 1|Withdrawal by Subject|0
6810125|NCT01090024|10814023|FG016|Period 1|Withdrawal by Subject|0
6810126|NCT01090024|10814024|FG017|Period 1|Withdrawal by Subject|0
6810127|NCT01090024|10814007|FG000|Period 1|Lost to Follow-up|0
6803686|NCT00492050|10805300|FG000|Overall Study|Adverse Event|1
6803687|NCT00492050|10805300|FG000|Overall Study|Lack of Efficacy|1
6803688|NCT00492050|10805300|FG000|Overall Study|Withdrawal by Subject|3
6803689|NCT00492050|10805300|FG000|Overall Study|Unable to collect SCT|2
6803690|NCT00492050|10805300|FG000|Overall Study|Progressive Disease|2
6803691|NCT00127127|10805339|FG000|Overall Study|Adverse Event|0
6803692|NCT00127127|10805340|FG001|Overall Study|Adverse Event|2
6803693|NCT00127127|10805341|FG002|Overall Study|Adverse Event|0
6803694|NCT00127127|10805342|FG003|Overall Study|Adverse Event|1
6803695|NCT00127127|10805339|FG000|Overall Study|Lack of Efficacy|1
6803696|NCT00127127|10805340|FG001|Overall Study|Lack of Efficacy|3
6803697|NCT00127127|10805341|FG002|Overall Study|Lack of Efficacy|0
6803698|NCT00127127|10805342|FG003|Overall Study|Lack of Efficacy|2
6803699|NCT00061945|10805385|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18
6803700|NCT00061945|10805386|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25
6803701|NCT00061945|10805385|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76
6803702|NCT00061945|10805386|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90
6803703|NCT00061945|10805385|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1
6803704|NCT00061945|10805386|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1
6803705|NCT00061945|10805385|FG000|Course IV: Alemtuzumab|Early exits|6
6803706|NCT00061945|10805386|FG001|Course IV: Alemtuzumab|Early exits|15
6803707|NCT04018612|10805398|FG000|Overall Study|Withdrawal by Subject|1
6803708|NCT04018612|10805399|FG001|Overall Study|Withdrawal by Subject|0
6803709|NCT04018612|10805400|FG002|Overall Study|Withdrawal by Subject|1
6803710|NCT03976648|10805410|FG000|Overall Study|Adverse Event|0
6803711|NCT03976648|10805411|FG001|Overall Study|Adverse Event|2
6803712|NCT03976648|10805410|FG000|Overall Study|Study terminated by sponsor|21
6803713|NCT03976648|10805411|FG001|Overall Study|Study terminated by sponsor|8
6803714|NCT03619902|10805421|FG000|Overall Study|Termination of Study by Investigator|1
6803715|NCT03619902|10805421|FG000|Overall Study|Use of Excluded/Prohibited Medication|1
6803716|NCT03517449|10805462|FG000|Overall Study|Death|184
6803717|NCT03517449|10805463|FG001|Overall Study|Death|236
6803718|NCT03517449|10805462|FG000|Overall Study|Lost to Follow-up|0
6803719|NCT03517449|10805463|FG001|Overall Study|Lost to Follow-up|2
6803720|NCT03517449|10805462|FG000|Overall Study|Withdrawal by Subject|7
6803721|NCT03517449|10805463|FG001|Overall Study|Withdrawal by Subject|26
6803722|NCT03517449|10805462|FG000|Overall Study|Participants Ongoing|220
6803723|NCT03517449|10805463|FG001|Overall Study|Participants Ongoing|152
6803724|NCT03470922|10805471|FG000|Overall Study|Death|107
6803725|NCT03470922|10805472|FG001|Overall Study|Death|118
6803726|NCT03470922|10805471|FG000|Overall Study|Lost to Follow-up|5
6803727|NCT03470922|10805472|FG001|Overall Study|Lost to Follow-up|5
6803728|NCT03470922|10805471|FG000|Overall Study|Participant Withdrew Consent|4
6803729|NCT03470922|10805472|FG001|Overall Study|Participant Withdrew Consent|9
6803730|NCT03470922|10805471|FG000|Overall Study|Other reasons|1
6803731|NCT03470922|10805472|FG001|Overall Study|Other reasons|0
6803732|NCT03470922|10805471|FG000|Overall Study|Not reported|1
6803733|NCT03470922|10805472|FG001|Overall Study|Not reported|0
6803734|NCT03308825|10805482|FG000|Overall Study|Lost to Follow-up|2
6803735|NCT03308825|10805483|FG001|Overall Study|Lost to Follow-up|2
6803736|NCT03308825|10805484|FG002|Overall Study|Lost to Follow-up|1
6803737|NCT03308825|10805485|FG003|Overall Study|Lost to Follow-up|0
6803738|NCT03308825|10805482|FG000|Overall Study|Protocol Violation|0
6803739|NCT03308825|10805483|FG001|Overall Study|Protocol Violation|2
6803740|NCT03308825|10805484|FG002|Overall Study|Protocol Violation|0
6803741|NCT03308825|10805485|FG003|Overall Study|Protocol Violation|0
6803742|NCT02915302|10805501|FG000|Overall Study|Adverse Event|3
6803743|NCT02915302|10805502|FG001|Overall Study|Adverse Event|0
6803744|NCT02915302|10805501|FG000|Overall Study|Protocol Violation|20
6803745|NCT02915302|10805502|FG001|Overall Study|Protocol Violation|27
6803746|NCT02915302|10805501|FG000|Overall Study|Lost to Follow-up|19
6803747|NCT02915302|10805502|FG001|Overall Study|Lost to Follow-up|22
6803748|NCT02915302|10805501|FG000|Overall Study|Withdrawal by Subject|22
6803749|NCT02915302|10805502|FG001|Overall Study|Withdrawal by Subject|29
6803750|NCT02915302|10805501|FG000|Overall Study|Other|1
6803751|NCT02915302|10805502|FG001|Overall Study|Other|0
6803752|NCT02744040|10805525|FG000|Overall Study|Withdrawal by Subject|3
6803753|NCT02744040|10805526|FG001|Overall Study|Withdrawal by Subject|2
6803754|NCT02744040|10805527|FG002|Overall Study|Withdrawal by Subject|2
6803755|NCT02744040|10805525|FG000|Overall Study|Physician Decision|0
6803756|NCT02744040|10805526|FG001|Overall Study|Physician Decision|8
6803757|NCT02744040|10805527|FG002|Overall Study|Physician Decision|13
6803758|NCT02744040|10805525|FG000|Overall Study|Lost to Follow-up|3
6803759|NCT02744040|10805526|FG001|Overall Study|Lost to Follow-up|1
6803760|NCT02744040|10805527|FG002|Overall Study|Lost to Follow-up|7
6803761|NCT02698826|10805535|FG000|Overall Study|Death|13
6803762|NCT02698826|10805535|FG000|Overall Study|Adverse Event|1
6803763|NCT02617589|10805543|FG000|All Randomized|Request to discontinue study treatment|1
6803764|NCT02617589|10805544|FG001|All Randomized|Request to discontinue study treatment|3
6803765|NCT02617589|10805543|FG000|All Randomized|Participant Withdrew Consent|1
6803766|NCT02617589|10805544|FG001|All Randomized|Participant Withdrew Consent|2
6803767|NCT02617589|10805543|FG000|Treatment Period|Other Reasons|2
6803768|NCT02617589|10805544|FG001|Treatment Period|Other Reasons|2
6803769|NCT02617589|10805543|FG000|Treatment Period|Not reported|1
6811323|NCT01709318|10815274|FG005|Overall Study|Non-compliance with Study Drug|0
6811324|NCT01709318|10815275|FG006|Overall Study|Non-compliance with Study Drug|2
6811325|NCT01709318|10815269|FG000|Overall Study|Physician Decision|0
6811326|NCT01709318|10815270|FG001|Overall Study|Physician Decision|0
6811327|NCT01709318|10815271|FG002|Overall Study|Physician Decision|0
6811328|NCT01709318|10815272|FG003|Overall Study|Physician Decision|0
6811329|NCT01709318|10815273|FG004|Overall Study|Physician Decision|0
6811330|NCT01709318|10815274|FG005|Overall Study|Physician Decision|0
6811331|NCT01709318|10815275|FG006|Overall Study|Physician Decision|1
6811332|NCT01709318|10815269|FG000|Overall Study|Pregnancy|0
6811333|NCT01709318|10815270|FG001|Overall Study|Pregnancy|0
6811334|NCT01709318|10815271|FG002|Overall Study|Pregnancy|0
6811335|NCT01709318|10815272|FG003|Overall Study|Pregnancy|0
6811336|NCT01709318|10815273|FG004|Overall Study|Pregnancy|1
6811337|NCT01709318|10815274|FG005|Overall Study|Pregnancy|0
6811338|NCT01709318|10815275|FG006|Overall Study|Pregnancy|0
6811339|NCT01709318|10815269|FG000|Overall Study|Protocol Violation|0
6811340|NCT01709318|10815270|FG001|Overall Study|Protocol Violation|0
6811341|NCT01709318|10815271|FG002|Overall Study|Protocol Violation|0
6811342|NCT01709318|10815272|FG003|Overall Study|Protocol Violation|0
6811343|NCT01709318|10815273|FG004|Overall Study|Protocol Violation|2
6811344|NCT01709318|10815274|FG005|Overall Study|Protocol Violation|0
6811345|NCT01709318|10815275|FG006|Overall Study|Protocol Violation|1
6811346|NCT01709318|10815269|FG000|Overall Study|Technical Problems|1
6811347|NCT01709318|10815270|FG001|Overall Study|Technical Problems|0
6811348|NCT01709318|10815271|FG002|Overall Study|Technical Problems|0
6811349|NCT01709318|10815272|FG003|Overall Study|Technical Problems|0
6811350|NCT01709318|10815273|FG004|Overall Study|Technical Problems|0
6811351|NCT01709318|10815274|FG005|Overall Study|Technical Problems|0
6811352|NCT01709318|10815275|FG006|Overall Study|Technical Problems|0
6811353|NCT01709318|10815269|FG000|Overall Study|Withdrawal by Subject|3
6811354|NCT01709318|10815270|FG001|Overall Study|Withdrawal by Subject|0
6811355|NCT01709318|10815271|FG002|Overall Study|Withdrawal by Subject|3
6811356|NCT01709318|10815272|FG003|Overall Study|Withdrawal by Subject|3
6811357|NCT01709318|10815273|FG004|Overall Study|Withdrawal by Subject|0
6811358|NCT01709318|10815274|FG005|Overall Study|Withdrawal by Subject|2
6811359|NCT01709318|10815275|FG006|Overall Study|Withdrawal by Subject|4
6811360|NCT01709318|10815269|FG000|Overall Study|Other Protocol Specified Criteria|0
6811361|NCT01709318|10815270|FG001|Overall Study|Other Protocol Specified Criteria|1
6811362|NCT01709318|10815271|FG002|Overall Study|Other Protocol Specified Criteria|0
6811363|NCT01709318|10815272|FG003|Overall Study|Other Protocol Specified Criteria|0
6811364|NCT01709318|10815273|FG004|Overall Study|Other Protocol Specified Criteria|0
6811365|NCT01709318|10815274|FG005|Overall Study|Other Protocol Specified Criteria|0
6811366|NCT01709318|10815275|FG006|Overall Study|Other Protocol Specified Criteria|0
6811367|NCT01698918|10815291|FG000|First Line Treatment (Core+Extension)|Adverse Event|33
6811368|NCT01698918|10815291|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11
6811369|NCT01698918|10815291|FG000|First Line Treatment (Core+Extension)|Death|2
6811370|NCT01698918|10815291|FG000|First Line Treatment (Core+Extension)|Disease progression|120
6811371|NCT01698918|10815291|FG000|First Line Treatment (Core+Extension)|Physician Decision|7
6811372|NCT01698918|10815291|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3
6811373|NCT01698918|10815291|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1
6811374|NCT01698918|10815291|FG000|Second Line Treatment (Core+Extension)|Death|1
6811375|NCT01698918|10815291|FG000|Second Line Treatment (Core+Extension)|Disease progression|38
6811376|NCT01698918|10815291|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3
6811377|NCT01673620|10815305|FG000|Overall Study|Adverse Event|1
6811378|NCT01673620|10815306|FG001|Overall Study|Adverse Event|0
6811379|NCT01660243|10815316|FG000|Overall Study|Adverse Event|1
6811380|NCT01660243|10815317|FG001|Overall Study|Adverse Event|0
6811381|NCT01660243|10815318|FG002|Overall Study|Adverse Event|1
6811382|NCT01660243|10815319|FG003|Overall Study|Adverse Event|0
6811383|NCT01660243|10815316|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1
6811384|NCT01660243|10815317|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0
6811385|NCT01660243|10815318|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0
6811386|NCT01660243|10815319|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0
6811387|NCT01660243|10815316|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0
6811388|NCT01660243|10815317|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0
6811389|NCT01660243|10815318|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1
6811390|NCT01660243|10815319|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0
6811391|NCT01660243|10815316|FG000|Overall Study|Randomization error|0
6811392|NCT01660243|10815317|FG001|Overall Study|Randomization error|0
6811393|NCT01660243|10815318|FG002|Overall Study|Randomization error|0
6811394|NCT01660243|10815319|FG003|Overall Study|Randomization error|1
6811395|NCT01617187|10815333|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
6811396|NCT01617187|10815334|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
6811397|NCT01617187|10815335|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
6811398|NCT01617187|10815336|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1
6811399|NCT01617187|10815333|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0
6811400|NCT01617187|10815334|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0
6811401|NCT01617187|10815335|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0
6811402|NCT01617187|10815336|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1
6811403|NCT01617187|10815333|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1
6811404|NCT01617187|10815334|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0
6811405|NCT01617187|10815335|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0
6811406|NCT01617187|10815336|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0
6811407|NCT01617187|10815333|FG000|Treatment Through Study Completion|Adverse Event|1
6811408|NCT01617187|10815334|FG001|Treatment Through Study Completion|Adverse Event|1
6811409|NCT01617187|10815335|FG002|Treatment Through Study Completion|Adverse Event|0
6811410|NCT01617187|10815336|FG003|Treatment Through Study Completion|Adverse Event|1
6811411|NCT01617187|10815333|FG000|Treatment Through Study Completion|Lost to Follow-up|4
6811412|NCT01617187|10815334|FG001|Treatment Through Study Completion|Lost to Follow-up|2
6811413|NCT01617187|10815335|FG002|Treatment Through Study Completion|Lost to Follow-up|2
6811414|NCT01617187|10815336|FG003|Treatment Through Study Completion|Lost to Follow-up|2
6811415|NCT01617187|10815333|FG000|Treatment Through Study Completion|Withdrawal by Subject|5
6811416|NCT01617187|10815334|FG001|Treatment Through Study Completion|Withdrawal by Subject|8
6811417|NCT01617187|10815335|FG002|Treatment Through Study Completion|Withdrawal by Subject|3
6811418|NCT01617187|10815336|FG003|Treatment Through Study Completion|Withdrawal by Subject|6
6811419|NCT01617187|10815333|FG000|Treatment Through Study Completion|Protocol Violation|1
6811420|NCT01617187|10815334|FG001|Treatment Through Study Completion|Protocol Violation|0
6811421|NCT01617187|10815335|FG002|Treatment Through Study Completion|Protocol Violation|0
6811422|NCT01617187|10815336|FG003|Treatment Through Study Completion|Protocol Violation|1
6811423|NCT01611883|10815348|FG000|Overall Study|Adverse Event|1
6811424|NCT01611883|10815349|FG001|Overall Study|Adverse Event|1
6811425|NCT01572675|10815357|FG000|Overall Study|End of prescribed treatment|140
6811426|NCT01572675|10815358|FG001|Overall Study|End of prescribed treatment|118
6811427|NCT01572675|10815357|FG000|Overall Study|Recovery|16
6811428|NCT01572675|10815358|FG001|Overall Study|Recovery|23
6811429|NCT01572675|10815357|FG000|Overall Study|Lack of Efficacy|31
6811430|NCT01572675|10815358|FG001|Overall Study|Lack of Efficacy|31
6811431|NCT01572675|10815357|FG000|Overall Study|Intolerance|6
6811432|NCT01572675|10815358|FG001|Overall Study|Intolerance|5
6811433|NCT01572675|10815357|FG000|Overall Study|Improved symptoms|8
6811434|NCT01572675|10815358|FG001|Overall Study|Improved symptoms|2
6811435|NCT01572675|10815357|FG000|Overall Study|Surgical intervention|3
6811436|NCT01572675|10815358|FG001|Overall Study|Surgical intervention|6
6811437|NCT01572675|10815357|FG000|Overall Study|Withdrawal by Subject|5
6811438|NCT01572675|10815358|FG001|Overall Study|Withdrawal by Subject|1
6811439|NCT01572675|10815357|FG000|Overall Study|Physician Decision|2
6811440|NCT01572675|10815358|FG001|Overall Study|Physician Decision|2
6811441|NCT01572675|10815357|FG000|Overall Study|Death unrelated to coxibs|1
6811442|NCT01572675|10815358|FG001|Overall Study|Death unrelated to coxibs|1
6811443|NCT01572675|10815357|FG000|Overall Study|Other disease detected|1
6811444|NCT01572675|10815358|FG001|Overall Study|Other disease detected|1
6811445|NCT01572675|10815357|FG000|Overall Study|Unknown reason|1
6811446|NCT01572675|10815358|FG001|Overall Study|Unknown reason|1
6811447|NCT01572675|10815357|FG000|Overall Study|Rheumatologist new evaluation|0
6811448|NCT01572675|10815358|FG001|Overall Study|Rheumatologist new evaluation|1
6811449|NCT01572675|10815357|FG000|Overall Study|Missing data|1
6811450|NCT01572675|10815358|FG001|Overall Study|Missing data|4
6811451|NCT01572675|10815357|FG000|Overall Study|Lost to Follow-up|22
6811452|NCT01572675|10815358|FG001|Overall Study|Lost to Follow-up|27
6811453|NCT01554163|10815379|FG000|Overall Study|Adverse Event|3
6811454|NCT01554163|10815380|FG001|Overall Study|Adverse Event|0
6811455|NCT01554163|10815379|FG000|Overall Study|Lack of Efficacy|1
6811456|NCT01554163|10815380|FG001|Overall Study|Lack of Efficacy|0
6811457|NCT01554163|10815379|FG000|Overall Study|Lost to Follow-up|1
6811458|NCT01554163|10815380|FG001|Overall Study|Lost to Follow-up|0
6811459|NCT01554163|10815379|FG000|Overall Study|Non-Compliance With Study Drug|1
6811460|NCT01554163|10815380|FG001|Overall Study|Non-Compliance With Study Drug|1
6811461|NCT01554163|10815379|FG000|Overall Study|Protocol Violation|0
6811462|NCT01554163|10815380|FG001|Overall Study|Protocol Violation|4
6811463|NCT01554163|10815379|FG000|Overall Study|Withdrawal by Subject|1
6811464|NCT01554163|10815380|FG001|Overall Study|Withdrawal by Subject|5
6811465|NCT01554163|10815379|FG000|Overall Study|Not Treated|1
6811466|NCT01554163|10815380|FG001|Overall Study|Not Treated|0
6811467|NCT01502371|10815391|FG000|Overall Study|Withdrawal by Subject|1
6811468|NCT01502371|10815392|FG001|Overall Study|Withdrawal by Subject|2
6811469|NCT01502371|10815393|FG002|Overall Study|Withdrawal by Subject|1
6811470|NCT01502371|10815394|FG003|Overall Study|Withdrawal by Subject|1
6811471|NCT01502371|10815395|FG004|Overall Study|Withdrawal by Subject|1
6811472|NCT01502371|10815391|FG000|Overall Study|Adverse Event|2
6811473|NCT01502371|10815392|FG001|Overall Study|Adverse Event|1
6811474|NCT01502371|10815393|FG002|Overall Study|Adverse Event|0
6811475|NCT01502371|10815394|FG003|Overall Study|Adverse Event|4
6811476|NCT01502371|10815395|FG004|Overall Study|Adverse Event|3
6811477|NCT01502371|10815391|FG000|Overall Study|Treatment Failure|22
6811492|NCT01502371|10815391|FG000|Overall Study|Noncompliance with Study Drug|0
6811493|NCT01502371|10815392|FG001|Overall Study|Noncompliance with Study Drug|0
6811494|NCT01502371|10815393|FG002|Overall Study|Noncompliance with Study Drug|1
6811495|NCT01502371|10815394|FG003|Overall Study|Noncompliance with Study Drug|2
6811496|NCT01502371|10815395|FG004|Overall Study|Noncompliance with Study Drug|1
6811497|NCT01502371|10815391|FG000|Overall Study|Technical Problems|1
6811498|NCT01502371|10815392|FG001|Overall Study|Technical Problems|0
6811499|NCT01502371|10815393|FG002|Overall Study|Technical Problems|2
6811500|NCT01502371|10815394|FG003|Overall Study|Technical Problems|4
6811501|NCT01502371|10815395|FG004|Overall Study|Technical Problems|1
6811502|NCT01502371|10815391|FG000|Overall Study|Protocol Violation|9
6811503|NCT01502371|10815392|FG001|Overall Study|Protocol Violation|5
6811504|NCT01502371|10815393|FG002|Overall Study|Protocol Violation|6
6811505|NCT01502371|10815394|FG003|Overall Study|Protocol Violation|5
6811506|NCT01502371|10815395|FG004|Overall Study|Protocol Violation|10
6811507|NCT01502371|10815391|FG000|Overall Study|Excluded Medication|0
6811508|NCT01502371|10815392|FG001|Overall Study|Excluded Medication|1
6811509|NCT01502371|10815393|FG002|Overall Study|Excluded Medication|1
6811510|NCT01502371|10815394|FG003|Overall Study|Excluded Medication|0
6811511|NCT01502371|10815395|FG004|Overall Study|Excluded Medication|1
6811512|NCT01490190|10815408|FG000|Overall Study|Withdrawal by Subject|9
6811513|NCT01490190|10815408|FG000|Overall Study|Adverse Event|17
6811514|NCT01490190|10815408|FG000|Overall Study|Protocol Violation|5
6811515|NCT01490190|10815408|FG000|Overall Study|Lost to Follow-up|13
6811516|NCT01490190|10815408|FG000|Overall Study|Relocation|1
6811517|NCT01490190|10815408|FG000|Overall Study|Inconvenience|1
6811518|NCT01490190|10815408|FG000|Overall Study|Ring expulsion|2
6811519|NCT01471340|10815414|FG000|Overall Study|Death|5
6811520|NCT01471340|10815415|FG001|Overall Study|Death|4
6811521|NCT01471340|10815414|FG000|Overall Study|Lost to Follow-up|0
6811522|NCT01471340|10815415|FG001|Overall Study|Lost to Follow-up|1
6811523|NCT01471340|10815414|FG000|Overall Study|Investigational site closure|0
6811524|NCT01471340|10815415|FG001|Overall Study|Investigational site closure|1
6811525|NCT01471340|10815414|FG000|Overall Study|Invalid informed consent|1
6811526|NCT01471340|10815415|FG001|Overall Study|Invalid informed consent|0
6811527|NCT01462370|10815421|FG000|Overall Study|Lack of Qualifying Event|1
6811528|NCT01462370|10815422|FG001|Overall Study|Lack of Qualifying Event|1
6811529|NCT01462370|10815421|FG000|Overall Study|Physician Decision|0
6811530|NCT01462370|10815422|FG001|Overall Study|Physician Decision|1
6811531|NCT01462370|10815421|FG000|Overall Study|Withdrawal by Subject|0
6811532|NCT01462370|10815422|FG001|Overall Study|Withdrawal by Subject|3
6811533|NCT01436253|10815428|FG000|Overall Study|Lost to Follow-up|182
6811534|NCT01436253|10815428|FG000|Overall Study|Not meeting all eligibility criteria|117
6811535|NCT01381679|10815462|FG000|Overall Study|Adverse Event|3
6811536|NCT01381679|10815462|FG000|Overall Study|Lost to Follow-up|885
6811537|NCT01370603|10815468|FG000|Period 1|Adverse Event|5
6811538|NCT01370603|10815469|FG001|Period 1|Adverse Event|3
6811539|NCT01370603|10815468|FG000|Period 1|Lost to Follow-up|2
6811540|NCT01370603|10815469|FG001|Period 1|Lost to Follow-up|0
6811541|NCT01370603|10815468|FG000|Period 1|Protocol Violation|2
6811542|NCT01370603|10815469|FG001|Period 1|Protocol Violation|2
6811543|NCT01370603|10815468|FG000|Period 1|Withdrawal by Subject|5
6811544|NCT01370603|10815469|FG001|Period 1|Withdrawal by Subject|5
6811545|NCT01370603|10815468|FG000|Crossover Washout|Adverse Event|2
6811546|NCT01370603|10815469|FG001|Crossover Washout|Adverse Event|1
6811547|NCT01370603|10815468|FG000|Crossover Washout|Lost to Follow-up|2
6811548|NCT01370603|10815469|FG001|Crossover Washout|Lost to Follow-up|0
6811549|NCT01370603|10815468|FG000|Crossover Washout|Protocol Violation|1
6811550|NCT01370603|10815469|FG001|Crossover Washout|Protocol Violation|0
6811551|NCT01370603|10815468|FG000|Crossover Washout|Withdrawal by Subject|4
6811552|NCT01370603|10815469|FG001|Crossover Washout|Withdrawal by Subject|1
6811553|NCT01370603|10815468|FG000|Crossover Washout|Non-compliance with Study Drug|0
6811554|NCT01370603|10815469|FG001|Crossover Washout|Non-compliance with Study Drug|2
6811555|NCT01370603|10815468|FG000|Period 2|Adverse Event|1
6811556|NCT01370603|10815469|FG001|Period 2|Adverse Event|4
6811557|NCT01370603|10815468|FG000|Period 2|Lost to Follow-up|1
6811558|NCT01370603|10815469|FG001|Period 2|Lost to Follow-up|0
6811559|NCT01370603|10815468|FG000|Period 2|Withdrawal by Subject|1
6811560|NCT01370603|10815469|FG001|Period 2|Withdrawal by Subject|0
6811561|NCT01370590|10815477|FG000|Period 1|Adverse Event|8
6811562|NCT01370590|10815478|FG001|Period 1|Adverse Event|4
6811563|NCT01370590|10815477|FG000|Period 1|Lost to Follow-up|2
6811564|NCT01370590|10815478|FG001|Period 1|Lost to Follow-up|2
6811565|NCT01370590|10815477|FG000|Period 1|Protocol Violation|2
6811566|NCT01370590|10815478|FG001|Period 1|Protocol Violation|2
6811567|NCT01370590|10815477|FG000|Period 1|Withdrawal by Subject|4
6811568|NCT01370590|10815478|FG001|Period 1|Withdrawal by Subject|2
6811569|NCT01370590|10815477|FG000|Period 1|Could not access randomization system|0
6811570|NCT01370590|10815478|FG001|Period 1|Could not access randomization system|1
6811571|NCT01370590|10815477|FG000|Crossover Washout Period|Adverse Event|1
6811572|NCT01370590|10815478|FG001|Crossover Washout Period|Adverse Event|4
6811573|NCT01370590|10815477|FG000|Crossover Washout Period|Lost to Follow-up|2
6811574|NCT01370590|10815478|FG001|Crossover Washout Period|Lost to Follow-up|0
6811575|NCT01370590|10815477|FG000|Crossover Washout Period|Non-compliance with Study Drug|1
6811576|NCT01370590|10815478|FG001|Crossover Washout Period|Non-compliance with Study Drug|0
6811577|NCT01370590|10815477|FG000|Crossover Washout Period|Withdrawal by Subject|2
6811578|NCT01370590|10815478|FG001|Crossover Washout Period|Withdrawal by Subject|2
6811579|NCT01370590|10815477|FG000|Period 2|Adverse Event|0
6811580|NCT01370590|10815478|FG001|Period 2|Adverse Event|1
6811581|NCT01370590|10815477|FG000|Period 2|Withdrawal by Subject|1
6811582|NCT01370590|10815478|FG001|Period 2|Withdrawal by Subject|1
6811583|NCT01349907|10815490|FG000|Overall Study|Adverse Event|37
6811584|NCT01349907|10815491|FG001|Overall Study|Adverse Event|11
6811585|NCT01349907|10815490|FG000|Overall Study|Treatment failure|13
6811586|NCT01349907|10815491|FG001|Overall Study|Treatment failure|4
6811587|NCT01349907|10815490|FG000|Overall Study|Lost to Follow-up|25
6811588|NCT01349907|10815491|FG001|Overall Study|Lost to Follow-up|6
6811589|NCT01349907|10815490|FG000|Overall Study|Withdrawal by Subject|30
6811590|NCT01349907|10815491|FG001|Overall Study|Withdrawal by Subject|8
6811591|NCT01349907|10815490|FG000|Overall Study|Protocol Violation|33
6811592|NCT01349907|10815491|FG001|Overall Study|Protocol Violation|13
6811593|NCT01349907|10815490|FG000|Overall Study|Administrative|1
6811594|NCT01349907|10815491|FG001|Overall Study|Administrative|1
6811595|NCT01345786|10815501|FG000|Overall Study|Adverse Event|0
6811596|NCT01345786|10815502|FG001|Overall Study|Adverse Event|1
6811597|NCT01345786|10815503|FG002|Overall Study|Adverse Event|3
6811598|NCT01345786|10815504|FG003|Overall Study|Adverse Event|1
6811599|NCT01345786|10815501|FG000|Overall Study|Subject withdrew consent|2
6811600|NCT01345786|10815502|FG001|Overall Study|Subject withdrew consent|2
6811601|NCT01345786|10815503|FG002|Overall Study|Subject withdrew consent|1
6811602|NCT01345786|10815504|FG003|Overall Study|Subject withdrew consent|0
6811603|NCT01345786|10815501|FG000|Overall Study|Noncompliance with protocol|1
6811604|NCT01345786|10815502|FG001|Overall Study|Noncompliance with protocol|0
6811605|NCT01345786|10815503|FG002|Overall Study|Noncompliance with protocol|1
6811606|NCT01345786|10815504|FG003|Overall Study|Noncompliance with protocol|0
6811607|NCT01345786|10815501|FG000|Overall Study|Administrative|3
6811608|NCT01345786|10815502|FG001|Overall Study|Administrative|5
6811609|NCT01345786|10815503|FG002|Overall Study|Administrative|0
6811610|NCT01345786|10815504|FG003|Overall Study|Administrative|0
6811611|NCT01345786|10815501|FG000|Overall Study|Lost to Follow-up|0
6811612|NCT01345786|10815502|FG001|Overall Study|Lost to Follow-up|0
6811613|NCT01345786|10815503|FG002|Overall Study|Lost to Follow-up|0
6811614|NCT01345786|10815504|FG003|Overall Study|Lost to Follow-up|2
6811615|NCT01306929|10815514|FG000|Overall Study|Withdrawal by Subject|23
6811616|NCT01306929|10815514|FG000|Overall Study|Adverse Event|21
6811617|NCT01306929|10815514|FG000|Overall Study|Physician Decision|13
6811618|NCT01306929|10815514|FG000|Overall Study|Death|8
6811619|NCT01306929|10815514|FG000|Overall Study|Withdrawal by parent/guardian|5
6811620|NCT01306929|10815514|FG000|Overall Study|Protocol Violation|3
6811621|NCT01306929|10815514|FG000|Overall Study|Non-compliance with study drug|2
6811622|NCT01306929|10815514|FG000|Overall Study|Lost to Follow-up|2
6811623|NCT01306929|10815514|FG000|Overall Study|Various|17
6811624|NCT01294696|10815520|FG000|Overall Study|Screening failures|7
6811625|NCT01294696|10815520|FG000|Overall Study|Protocol Violation|8
6811626|NCT01294696|10815520|FG000|Overall Study|Missing BPI Response|7
6811627|NCT01294696|10815520|FG000|Overall Study|Site closure|52
6811628|NCT01277822|10815527|FG000|Overall Study|Adverse Event|2
6811629|NCT01277822|10815528|FG001|Overall Study|Adverse Event|1
6811630|NCT01277822|10815527|FG000|Overall Study|Withdrawal by Subject|6
6811631|NCT01277822|10815528|FG001|Overall Study|Withdrawal by Subject|7
6811632|NCT01277822|10815527|FG000|Overall Study|Physician Decision|1
6811633|NCT01277822|10815528|FG001|Overall Study|Physician Decision|1
6811634|NCT01277822|10815527|FG000|Overall Study|Protocol Violation|1
6811635|NCT01277822|10815528|FG001|Overall Study|Protocol Violation|0
6811636|NCT01277822|10815527|FG000|Overall Study|Lost to Follow-up|2
6811637|NCT01277822|10815528|FG001|Overall Study|Lost to Follow-up|1
6811638|NCT01277822|10815527|FG000|Overall Study|Contraindicated medication used|2
6811639|NCT01277822|10815528|FG001|Overall Study|Contraindicated medication used|1
6811640|NCT01277822|10815527|FG000|Overall Study|Participant moved|1
6811641|NCT01277822|10815528|FG001|Overall Study|Participant moved|0
6811642|NCT01244763|10815540|FG000|Overall Study|Adverse Event|1
6811643|NCT01244763|10815541|FG001|Overall Study|Adverse Event|0
6811644|NCT01244763|10815542|FG002|Overall Study|Adverse Event|0
6811645|NCT01244763|10815543|FG003|Overall Study|Adverse Event|0
6811646|NCT01244763|10815544|FG004|Overall Study|Adverse Event|0
6811647|NCT01244763|10815545|FG005|Overall Study|Adverse Event|1
6811648|NCT01244763|10815540|FG000|Overall Study|Death|1
6811649|NCT01244763|10815541|FG001|Overall Study|Death|0
6811650|NCT01244763|10815542|FG002|Overall Study|Death|1
6811651|NCT01244763|10815543|FG003|Overall Study|Death|0
6811652|NCT01244763|10815544|FG004|Overall Study|Death|2
6811653|NCT01244763|10815545|FG005|Overall Study|Death|0
6811654|NCT01244763|10815540|FG000|Overall Study|Physician Decision|0
6811655|NCT01244763|10815541|FG001|Overall Study|Physician Decision|0
6811656|NCT01244763|10815542|FG002|Overall Study|Physician Decision|1
6811657|NCT01244763|10815543|FG003|Overall Study|Physician Decision|0
6811658|NCT01244763|10815544|FG004|Overall Study|Physician Decision|0
6811659|NCT01244763|10815545|FG005|Overall Study|Physician Decision|0
6811660|NCT01244763|10815540|FG000|Overall Study|Withdrawal by Subject|1
6811661|NCT01244763|10815541|FG001|Overall Study|Withdrawal by Subject|2
6811662|NCT01244763|10815542|FG002|Overall Study|Withdrawal by Subject|0
6811663|NCT01244763|10815543|FG003|Overall Study|Withdrawal by Subject|1
6811738|NCT01208207|10815566|FG004|Part II|Withdrawal by Subject|9
6811739|NCT01208207|10815567|FG005|Part II|Withdrawal by Subject|3
6811740|NCT01208207|10815568|FG006|Part II|Withdrawal by Subject|5
6811741|NCT01208207|10815562|FG000|Part II|Adverse Event|0
6811742|NCT01208207|10815563|FG001|Part II|Adverse Event|0
6811743|NCT01208207|10815564|FG002|Part II|Adverse Event|0
6811744|NCT01208207|10815565|FG003|Part II|Adverse Event|5
6811745|NCT01208207|10815566|FG004|Part II|Adverse Event|9
6811746|NCT01208207|10815567|FG005|Part II|Adverse Event|4
6811747|NCT01208207|10815568|FG006|Part II|Adverse Event|2
6811748|NCT01208207|10815562|FG000|Part II|Lack of Efficacy|0
6811749|NCT01208207|10815563|FG001|Part II|Lack of Efficacy|0
6811750|NCT01208207|10815564|FG002|Part II|Lack of Efficacy|0
6811751|NCT01208207|10815565|FG003|Part II|Lack of Efficacy|6
6811752|NCT01208207|10815566|FG004|Part II|Lack of Efficacy|4
6811753|NCT01208207|10815567|FG005|Part II|Lack of Efficacy|3
6811754|NCT01208207|10815568|FG006|Part II|Lack of Efficacy|3
6811755|NCT01208207|10815562|FG000|Part II|Lost to Follow-up|0
6811756|NCT01208207|10815563|FG001|Part II|Lost to Follow-up|0
6811757|NCT01208207|10815564|FG002|Part II|Lost to Follow-up|0
6811758|NCT01208207|10815565|FG003|Part II|Lost to Follow-up|4
6811759|NCT01208207|10815566|FG004|Part II|Lost to Follow-up|0
6811760|NCT01208207|10815567|FG005|Part II|Lost to Follow-up|2
6811761|NCT01208207|10815568|FG006|Part II|Lost to Follow-up|1
6811762|NCT01208207|10815562|FG000|Part II|Non-Compliance With Study Drug|0
6811763|NCT01208207|10815563|FG001|Part II|Non-Compliance With Study Drug|0
6811764|NCT01208207|10815564|FG002|Part II|Non-Compliance With Study Drug|0
6811765|NCT01208207|10815565|FG003|Part II|Non-Compliance With Study Drug|4
6811766|NCT01208207|10815566|FG004|Part II|Non-Compliance With Study Drug|1
6811767|NCT01208207|10815567|FG005|Part II|Non-Compliance With Study Drug|1
6811768|NCT01208207|10815568|FG006|Part II|Non-Compliance With Study Drug|0
6811769|NCT01208207|10815562|FG000|Part II|Physician Decision|0
6811770|NCT01208207|10815563|FG001|Part II|Physician Decision|0
6811771|NCT01208207|10815564|FG002|Part II|Physician Decision|0
6811772|NCT01208207|10815565|FG003|Part II|Physician Decision|1
6811773|NCT01208207|10815566|FG004|Part II|Physician Decision|0
6811774|NCT01208207|10815567|FG005|Part II|Physician Decision|2
6811775|NCT01208207|10815568|FG006|Part II|Physician Decision|0
6811776|NCT01208207|10815562|FG000|Part II|Protocol Violation|0
6811777|NCT01208207|10815563|FG001|Part II|Protocol Violation|0
6811778|NCT01208207|10815564|FG002|Part II|Protocol Violation|0
6811779|NCT01208207|10815565|FG003|Part II|Protocol Violation|1
6811780|NCT01208207|10815566|FG004|Part II|Protocol Violation|0
6811781|NCT01208207|10815567|FG005|Part II|Protocol Violation|0
6811782|NCT01208207|10815568|FG006|Part II|Protocol Violation|0
6811783|NCT01208207|10815562|FG000|Part II|Technical Problems|0
6811784|NCT01208207|10815563|FG001|Part II|Technical Problems|0
6811785|NCT01208207|10815564|FG002|Part II|Technical Problems|0
6811786|NCT01208207|10815565|FG003|Part II|Technical Problems|1
6811787|NCT01208207|10815566|FG004|Part II|Technical Problems|0
6811788|NCT01208207|10815567|FG005|Part II|Technical Problems|1
6811789|NCT01208207|10815568|FG006|Part II|Technical Problems|0
6811790|NCT01208181|10815593|FG000|Part 1|Withdrawal by Subject|11
6811791|NCT01208181|10815594|FG001|Part 1|Withdrawal by Subject|10
6811792|NCT01208181|10815595|FG002|Part 1|Withdrawal by Subject|0
6811793|NCT01208181|10815596|FG003|Part 1|Withdrawal by Subject|0
6811794|NCT01208181|10815597|FG004|Part 1|Withdrawal by Subject|0
6811795|NCT01208181|10815593|FG000|Part 1|Technical problem|5
6811796|NCT01208181|10815594|FG001|Part 1|Technical problem|0
6811797|NCT01208181|10815595|FG002|Part 1|Technical problem|0
6811798|NCT01208181|10815596|FG003|Part 1|Technical problem|0
6811799|NCT01208181|10815597|FG004|Part 1|Technical problem|0
6811800|NCT01208181|10815593|FG000|Part 1|Protocol Violation|10
6811801|NCT01208181|10815594|FG001|Part 1|Protocol Violation|5
6811802|NCT01208181|10815595|FG002|Part 1|Protocol Violation|0
6811803|NCT01208181|10815596|FG003|Part 1|Protocol Violation|0
6811804|NCT01208181|10815597|FG004|Part 1|Protocol Violation|0
6811805|NCT01208181|10815593|FG000|Part 1|Physician Decision|4
6811806|NCT01208181|10815594|FG001|Part 1|Physician Decision|0
6811807|NCT01208181|10815595|FG002|Part 1|Physician Decision|0
6811808|NCT01208181|10815596|FG003|Part 1|Physician Decision|0
6811809|NCT01208181|10815597|FG004|Part 1|Physician Decision|0
6811810|NCT01208181|10815593|FG000|Part 1|Non-compliance with study drug|1
6811811|NCT01208181|10815594|FG001|Part 1|Non-compliance with study drug|1
6811812|NCT01208181|10815595|FG002|Part 1|Non-compliance with study drug|0
6811813|NCT01208181|10815596|FG003|Part 1|Non-compliance with study drug|0
6811814|NCT01208181|10815597|FG004|Part 1|Non-compliance with study drug|0
6811815|NCT01208181|10815593|FG000|Part 1|Lost to Follow-up|5
6811816|NCT01208181|10815594|FG001|Part 1|Lost to Follow-up|3
6811817|NCT01208181|10815595|FG002|Part 1|Lost to Follow-up|0
6811818|NCT01208181|10815596|FG003|Part 1|Lost to Follow-up|0
6811819|NCT01208181|10815597|FG004|Part 1|Lost to Follow-up|1
6811820|NCT01208181|10815593|FG000|Part 1|Lack of Efficacy|37
6811821|NCT01208181|10815594|FG001|Part 1|Lack of Efficacy|12
6811822|NCT01208181|10815595|FG002|Part 1|Lack of Efficacy|0
6811823|NCT01208181|10815596|FG003|Part 1|Lack of Efficacy|0
6811824|NCT01208181|10815597|FG004|Part 1|Lack of Efficacy|17
6811825|NCT01208181|10815593|FG000|Part 1|Adverse Event|26
6811826|NCT01208181|10815594|FG001|Part 1|Adverse Event|24
6811827|NCT01208181|10815595|FG002|Part 1|Adverse Event|0
6811828|NCT01208181|10815596|FG003|Part 1|Adverse Event|0
6811829|NCT01208181|10815597|FG004|Part 1|Adverse Event|4
6811830|NCT01208181|10815593|FG000|Part 2|Adverse Event|0
6811831|NCT01208181|10815594|FG001|Part 2|Adverse Event|0
6811832|NCT01208181|10815595|FG002|Part 2|Adverse Event|6
6811833|NCT01208181|10815596|FG003|Part 2|Adverse Event|7
6811834|NCT01208181|10815597|FG004|Part 2|Adverse Event|0
6811835|NCT01208181|10815593|FG000|Part 2|Withdrawal by Subject|0
6811836|NCT01208181|10815594|FG001|Part 2|Withdrawal by Subject|0
6811837|NCT01208181|10815595|FG002|Part 2|Withdrawal by Subject|1
6811838|NCT01208181|10815596|FG003|Part 2|Withdrawal by Subject|1
6811839|NCT01208181|10815597|FG004|Part 2|Withdrawal by Subject|0
6811840|NCT01208181|10815593|FG000|Part 2|Protocol Violation|0
6811841|NCT01208181|10815594|FG001|Part 2|Protocol Violation|0
6811842|NCT01208181|10815595|FG002|Part 2|Protocol Violation|1
6811843|NCT01208181|10815596|FG003|Part 2|Protocol Violation|0
6811844|NCT01208181|10815597|FG004|Part 2|Protocol Violation|0
6811845|NCT01208181|10815593|FG000|Part 2|Physician Decision|0
6811846|NCT01208181|10815594|FG001|Part 2|Physician Decision|0
6811847|NCT01208181|10815595|FG002|Part 2|Physician Decision|1
6811848|NCT01208181|10815596|FG003|Part 2|Physician Decision|2
6811849|NCT01208181|10815597|FG004|Part 2|Physician Decision|0
6811850|NCT01208181|10815593|FG000|Part 2|Non-compliance with study drug|0
6811851|NCT01208181|10815594|FG001|Part 2|Non-compliance with study drug|0
6811852|NCT01208181|10815595|FG002|Part 2|Non-compliance with study drug|1
6811853|NCT01208181|10815596|FG003|Part 2|Non-compliance with study drug|1
6811854|NCT01208181|10815597|FG004|Part 2|Non-compliance with study drug|0
6811855|NCT01208181|10815593|FG000|Part 2|Lost to Follow-up|0
6811856|NCT01208181|10815594|FG001|Part 2|Lost to Follow-up|0
6811857|NCT01208181|10815595|FG002|Part 2|Lost to Follow-up|1
6811858|NCT01208181|10815596|FG003|Part 2|Lost to Follow-up|2
6811859|NCT01208181|10815597|FG004|Part 2|Lost to Follow-up|0
6811860|NCT01208181|10815593|FG000|Part 2|Lack of Efficacy|0
6811861|NCT01208181|10815594|FG001|Part 2|Lack of Efficacy|0
6811862|NCT01208181|10815595|FG002|Part 2|Lack of Efficacy|5
6811863|NCT01208181|10815596|FG003|Part 2|Lack of Efficacy|7
6811864|NCT01208181|10815597|FG004|Part 2|Lack of Efficacy|0
6811865|NCT01206517|10815620|FG000|Overall Study|Withdrawal by Subject|0
6811866|NCT01206517|10815621|FG001|Overall Study|Withdrawal by Subject|0
6811867|NCT01206517|10815622|FG002|Overall Study|Withdrawal by Subject|2
6811868|NCT01206517|10815623|FG003|Overall Study|Withdrawal by Subject|0
6811869|NCT01206517|10815624|FG004|Overall Study|Withdrawal by Subject|1
6811870|NCT01206517|10815625|FG005|Overall Study|Withdrawal by Subject|0
6811871|NCT01190267|10815638|FG000|Overall Study|Adverse Event|10
6811872|NCT01190267|10815639|FG001|Overall Study|Adverse Event|0
6811873|NCT01190267|10815638|FG000|Overall Study|Treatment Failure|8
6811874|NCT01190267|10815639|FG001|Overall Study|Treatment Failure|2
6811875|NCT01190267|10815638|FG000|Overall Study|Lost to Follow-up|2
6811876|NCT01190267|10815639|FG001|Overall Study|Lost to Follow-up|0
6811877|NCT01190267|10815638|FG000|Overall Study|Withdrawal by Subject|13
6811878|NCT01190267|10815639|FG001|Overall Study|Withdrawal by Subject|1
6811879|NCT01190267|10815638|FG000|Overall Study|Protocol Violation|8
6811880|NCT01190267|10815639|FG001|Overall Study|Protocol Violation|1
6811881|NCT01190254|10815648|FG000|Overall Study|Adverse Event|3
6811882|NCT01190254|10815649|FG001|Overall Study|Adverse Event|6
6811883|NCT01190254|10815650|FG002|Overall Study|Adverse Event|8
6811884|NCT01190254|10815648|FG000|Overall Study|Lack of Efficacy|7
6811885|NCT01190254|10815649|FG001|Overall Study|Lack of Efficacy|4
6811886|NCT01190254|10815650|FG002|Overall Study|Lack of Efficacy|5
6811887|NCT01190254|10815648|FG000|Overall Study|Lost to Follow-up|4
6811888|NCT01190254|10815649|FG001|Overall Study|Lost to Follow-up|2
6811889|NCT01190254|10815650|FG002|Overall Study|Lost to Follow-up|0
6811890|NCT01190254|10815648|FG000|Overall Study|Withdrawal by Subject|4
6811891|NCT01190254|10815649|FG001|Overall Study|Withdrawal by Subject|5
6811892|NCT01190254|10815650|FG002|Overall Study|Withdrawal by Subject|7
6811893|NCT01190254|10815648|FG000|Overall Study|Protocol Violation|2
6811894|NCT01190254|10815649|FG001|Overall Study|Protocol Violation|0
6811895|NCT01190254|10815650|FG002|Overall Study|Protocol Violation|2
6811896|NCT01190254|10815648|FG000|Overall Study|Did not meet protocol eligibility|1
6811897|NCT01190254|10815649|FG001|Overall Study|Did not meet protocol eligibility|0
6811898|NCT01190254|10815650|FG002|Overall Study|Did not meet protocol eligibility|0
6811899|NCT01154036|10815661|FG000|Phase I|Physician Decision|0
6811900|NCT01154036|10815662|FG001|Phase I|Physician Decision|1
6811901|NCT01154036|10815663|FG002|Phase I|Physician Decision|0
6811902|NCT01154036|10815664|FG003|Phase I|Physician Decision|0
6811903|NCT01154036|10815665|FG004|Phase I|Physician Decision|0
6811904|NCT01154036|10815666|FG005|Phase I|Physician Decision|0
6811905|NCT01154036|10815667|FG006|Phase I|Physician Decision|0
6811906|NCT01154036|10815668|FG007|Phase I|Physician Decision|0
6811907|NCT01154036|10815661|FG000|Phase I|Lost to Follow-up|0
6811908|NCT01154036|10815662|FG001|Phase I|Lost to Follow-up|3
6811909|NCT01154036|10815663|FG002|Phase I|Lost to Follow-up|6
6811910|NCT01154036|10815664|FG003|Phase I|Lost to Follow-up|0
6811911|NCT01154036|10815665|FG004|Phase I|Lost to Follow-up|0
6811912|NCT01154036|10815666|FG005|Phase I|Lost to Follow-up|0
6811913|NCT01154036|10815667|FG006|Phase I|Lost to Follow-up|0
6811914|NCT01154036|10815668|FG007|Phase I|Lost to Follow-up|0
6811915|NCT01154036|10815661|FG000|Phase I|Protocol Violation|0
6811916|NCT01154036|10815662|FG001|Phase I|Protocol Violation|3
6811917|NCT01154036|10815663|FG002|Phase I|Protocol Violation|9
6811918|NCT01154036|10815664|FG003|Phase I|Protocol Violation|0
6811919|NCT01154036|10815665|FG004|Phase I|Protocol Violation|0
6811920|NCT01154036|10815666|FG005|Phase I|Protocol Violation|0
6811921|NCT01154036|10815667|FG006|Phase I|Protocol Violation|0
6811922|NCT01154036|10815668|FG007|Phase I|Protocol Violation|0
6811923|NCT01154036|10815661|FG000|Phase I|Withdrawal by Subject|2
6811924|NCT01154036|10815662|FG001|Phase I|Withdrawal by Subject|10
6811925|NCT01154036|10815663|FG002|Phase I|Withdrawal by Subject|29
6811926|NCT01154036|10815664|FG003|Phase I|Withdrawal by Subject|0
6811927|NCT01154036|10815665|FG004|Phase I|Withdrawal by Subject|0
6811928|NCT01154036|10815666|FG005|Phase I|Withdrawal by Subject|0
6811929|NCT01154036|10815667|FG006|Phase I|Withdrawal by Subject|0
6811930|NCT01154036|10815668|FG007|Phase I|Withdrawal by Subject|0
6811931|NCT01154036|10815661|FG000|Phase I|Adverse Event|1
6811932|NCT01154036|10815662|FG001|Phase I|Adverse Event|11
6811933|NCT01154036|10815663|FG002|Phase I|Adverse Event|12
6811934|NCT01154036|10815664|FG003|Phase I|Adverse Event|0
6811935|NCT01154036|10815665|FG004|Phase I|Adverse Event|0
6811936|NCT01154036|10815666|FG005|Phase I|Adverse Event|0
6811937|NCT01154036|10815667|FG006|Phase I|Adverse Event|0
6811938|NCT01154036|10815668|FG007|Phase I|Adverse Event|0
6811939|NCT01154036|10815661|FG000|Phase II|Adverse Event|0
6811940|NCT01154036|10815662|FG001|Phase II|Adverse Event|0
6811941|NCT01154036|10815663|FG002|Phase II|Adverse Event|0
6811942|NCT01154036|10815664|FG003|Phase II|Adverse Event|0
6811943|NCT01154036|10815665|FG004|Phase II|Adverse Event|1
6811944|NCT01154036|10815666|FG005|Phase II|Adverse Event|1
6811945|NCT01154036|10815667|FG006|Phase II|Adverse Event|1
6811946|NCT01154036|10815668|FG007|Phase II|Adverse Event|1
6811947|NCT01154036|10815661|FG000|Phase II|Physician Decision|0
6811948|NCT01154036|10815662|FG001|Phase II|Physician Decision|0
6811949|NCT01154036|10815663|FG002|Phase II|Physician Decision|0
6811950|NCT01154036|10815664|FG003|Phase II|Physician Decision|0
6811951|NCT01154036|10815665|FG004|Phase II|Physician Decision|0
6811952|NCT01154036|10815666|FG005|Phase II|Physician Decision|0
6811953|NCT01154036|10815667|FG006|Phase II|Physician Decision|1
6811954|NCT01154036|10815668|FG007|Phase II|Physician Decision|0
6811955|NCT01154036|10815661|FG000|Phase II|Lost to Follow-up|0
6811956|NCT01154036|10815662|FG001|Phase II|Lost to Follow-up|0
6811957|NCT01154036|10815663|FG002|Phase II|Lost to Follow-up|0
6811958|NCT01154036|10815664|FG003|Phase II|Lost to Follow-up|1
6811959|NCT01154036|10815665|FG004|Phase II|Lost to Follow-up|2
6811960|NCT01154036|10815666|FG005|Phase II|Lost to Follow-up|0
6811961|NCT01154036|10815667|FG006|Phase II|Lost to Follow-up|2
6811962|NCT01154036|10815668|FG007|Phase II|Lost to Follow-up|1
6811963|NCT01154036|10815661|FG000|Phase II|Protocol Violation|0
6811964|NCT01154036|10815662|FG001|Phase II|Protocol Violation|0
6811965|NCT01154036|10815663|FG002|Phase II|Protocol Violation|0
6811966|NCT01154036|10815664|FG003|Phase II|Protocol Violation|0
6811967|NCT01154036|10815665|FG004|Phase II|Protocol Violation|1
6811968|NCT01154036|10815666|FG005|Phase II|Protocol Violation|2
6811969|NCT01154036|10815667|FG006|Phase II|Protocol Violation|0
6811970|NCT01154036|10815668|FG007|Phase II|Protocol Violation|0
6811971|NCT01154036|10815661|FG000|Phase II|Withdrawal by Subject|0
6811972|NCT01154036|10815662|FG001|Phase II|Withdrawal by Subject|0
6811973|NCT01154036|10815663|FG002|Phase II|Withdrawal by Subject|0
6811974|NCT01154036|10815664|FG003|Phase II|Withdrawal by Subject|0
6811975|NCT01154036|10815665|FG004|Phase II|Withdrawal by Subject|4
6811976|NCT01154036|10815666|FG005|Phase II|Withdrawal by Subject|2
6811977|NCT01154036|10815667|FG006|Phase II|Withdrawal by Subject|5
6811978|NCT01154036|10815668|FG007|Phase II|Withdrawal by Subject|4
6811979|NCT01098071|10815699|FG000|Overall Study|Surgery (adenoidectomy)|2
6811980|NCT01098071|10815699|FG000|Overall Study|Lost to Follow-up|13
6811981|NCT01070966|10815712|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59
6811982|NCT01070966|10815712|FG000|Participants for Safety Evaluation|Off-label use|9
6811983|NCT01070966|10815712|FG000|Participants for Safety Evaluation|Duplicate Participants|4
6811984|NCT01070966|10815712|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3
6811985|NCT01070966|10815712|FG000|Participants for Safety Evaluation|TMT given before date of contract|3
6811986|NCT01070966|10815712|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61
6811987|NCT01070966|10815712|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19
6811988|NCT01070966|10815712|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2
6811989|NCT01070953|10815723|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612
6811990|NCT01070953|10815723|FG000|Participants for Safety Evaluation|Off-label use|283
6811991|NCT01070953|10815723|FG000|Participants for Safety Evaluation|Duplicated participants|22
6811992|NCT01070953|10815723|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8
6811993|NCT01070953|10815723|FG000|Participants for Safety Evaluation|Uncontracted participants|4
6811994|NCT01070953|10815723|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1
6811995|NCT01070953|10815723|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1
6811996|NCT01070953|10815723|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119
6811997|NCT01070953|10815723|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106
6811998|NCT01070953|10815723|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2
6811999|NCT01030341|10815733|FG000|Overall Study|Withdrawal by Subject|1
6812000|NCT01030341|10815733|FG000|Overall Study|Lost to Follow-up|2
6812001|NCT00979901|10815741|FG000|Overall Study|Adverse Event|1
6812002|NCT00979901|10815742|FG001|Overall Study|Adverse Event|3
6812003|NCT00979901|10815743|FG002|Overall Study|Adverse Event|9
6812004|NCT00979901|10815744|FG003|Overall Study|Adverse Event|2
6812005|NCT00979901|10815741|FG000|Overall Study|Lack of Efficacy|8
6812006|NCT00979901|10815742|FG001|Overall Study|Lack of Efficacy|4
6812007|NCT00979901|10815743|FG002|Overall Study|Lack of Efficacy|9
6812008|NCT00979901|10815744|FG003|Overall Study|Lack of Efficacy|0
6812009|NCT00979901|10815741|FG000|Overall Study|Lost to Follow-up|1
6812010|NCT00979901|10815742|FG001|Overall Study|Lost to Follow-up|1
6812011|NCT00979901|10815743|FG002|Overall Study|Lost to Follow-up|2
6812012|NCT00979901|10815744|FG003|Overall Study|Lost to Follow-up|0
6812013|NCT00979901|10815741|FG000|Overall Study|Protocol Violation|2
6812014|NCT00979901|10815742|FG001|Overall Study|Protocol Violation|2
6812015|NCT00979901|10815743|FG002|Overall Study|Protocol Violation|7
6812016|NCT00979901|10815744|FG003|Overall Study|Protocol Violation|1
6812017|NCT00979901|10815741|FG000|Overall Study|Withdrawal by Subject|2
6812018|NCT00979901|10815742|FG001|Overall Study|Withdrawal by Subject|1
6812019|NCT00979901|10815743|FG002|Overall Study|Withdrawal by Subject|1
6812020|NCT00979901|10815744|FG003|Overall Study|Withdrawal by Subject|1
6812021|NCT00979901|10815741|FG000|Overall Study|Noncompliance|1
6812022|NCT00979901|10815742|FG001|Overall Study|Noncompliance|0
6812023|NCT00979901|10815743|FG002|Overall Study|Noncompliance|0
6812024|NCT00979901|10815744|FG003|Overall Study|Noncompliance|0
6812025|NCT00979901|10815741|FG000|Overall Study|out-of-state|1
6812026|NCT00979901|10815742|FG001|Overall Study|out-of-state|0
6812027|NCT00979901|10815743|FG002|Overall Study|out-of-state|0
6812028|NCT00979901|10815744|FG003|Overall Study|out-of-state|0
6812029|NCT00979901|10815741|FG000|Overall Study|vacation|1
6812030|NCT00979901|10815742|FG001|Overall Study|vacation|0
6812031|NCT00979901|10815743|FG002|Overall Study|vacation|0
6812032|NCT00979901|10815744|FG003|Overall Study|vacation|0
6812033|NCT00979901|10815741|FG000|Overall Study|elevated lab values pre-randomization|1
6812034|NCT00979901|10815742|FG001|Overall Study|elevated lab values pre-randomization|0
6812035|NCT00979901|10815743|FG002|Overall Study|elevated lab values pre-randomization|0
6812036|NCT00979901|10815744|FG003|Overall Study|elevated lab values pre-randomization|0
6812037|NCT00979901|10815741|FG000|Overall Study|Discontinued in Error|0
6812038|NCT00979901|10815742|FG001|Overall Study|Discontinued in Error|1
6812039|NCT00979901|10815743|FG002|Overall Study|Discontinued in Error|0
6812040|NCT00979901|10815744|FG003|Overall Study|Discontinued in Error|0
6812041|NCT00979901|10815741|FG000|Overall Study|Left Country|0
6812042|NCT00979901|10815742|FG001|Overall Study|Left Country|0
6812043|NCT00979901|10815743|FG002|Overall Study|Left Country|1
6812044|NCT00979901|10815744|FG003|Overall Study|Left Country|0
6812045|NCT00979901|10815741|FG000|Overall Study|Treatment Group Terminated by Sponsor|0
6812046|NCT00979901|10815742|FG001|Overall Study|Treatment Group Terminated by Sponsor|0
6812047|NCT00979901|10815743|FG002|Overall Study|Treatment Group Terminated by Sponsor|0
6812048|NCT00979901|10815744|FG003|Overall Study|Treatment Group Terminated by Sponsor|112
6812049|NCT00963599|10815757|FG000|Overall Study|Adverse Event|2
6812050|NCT00963599|10815758|FG001|Overall Study|Adverse Event|0
6812051|NCT00963599|10815759|FG002|Overall Study|Adverse Event|1
6812052|NCT00963599|10815760|FG003|Overall Study|Adverse Event|2
6812053|NCT00963599|10815757|FG000|Overall Study|Lack of Efficacy|0
6812054|NCT00963599|10815758|FG001|Overall Study|Lack of Efficacy|2
6812055|NCT00963599|10815759|FG002|Overall Study|Lack of Efficacy|1
6812056|NCT00963599|10815760|FG003|Overall Study|Lack of Efficacy|4
6812057|NCT00963599|10815757|FG000|Overall Study|Lost to Follow-up|0
6812058|NCT00963599|10815758|FG001|Overall Study|Lost to Follow-up|1
6812059|NCT00963599|10815759|FG002|Overall Study|Lost to Follow-up|1
6812060|NCT00963599|10815760|FG003|Overall Study|Lost to Follow-up|1
6812061|NCT00963599|10815757|FG000|Overall Study|Protocol Violation|2
6812062|NCT00963599|10815758|FG001|Overall Study|Protocol Violation|2
6812063|NCT00963599|10815759|FG002|Overall Study|Protocol Violation|3
6812064|NCT00963599|10815760|FG003|Overall Study|Protocol Violation|4
6812065|NCT00963599|10815757|FG000|Overall Study|Withdrawal by Subject|2
6812066|NCT00963599|10815758|FG001|Overall Study|Withdrawal by Subject|1
6812067|NCT00963599|10815759|FG002|Overall Study|Withdrawal by Subject|3
6812068|NCT00963599|10815760|FG003|Overall Study|Withdrawal by Subject|3
6812069|NCT00953680|10815775|FG000|Period 1|Withdrawal by Subject|0
6812070|NCT00953680|10815776|FG001|Period 1|Withdrawal by Subject|1
6812071|NCT00943852|10815789|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
6812072|NCT00943852|10815790|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
6812073|NCT00943852|10815791|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
6812074|NCT00943852|10815792|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1
6812075|NCT00943852|10815793|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
6812076|NCT00943852|10815794|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
6812077|NCT00943852|10815795|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
6812078|NCT00943852|10815796|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
6812079|NCT00943852|10815797|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
6812080|NCT00943852|10815798|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
6812081|NCT00943852|10815789|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0
6812082|NCT00943852|10815790|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0
6812083|NCT00943852|10815791|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0
6812084|NCT00943852|10815792|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0
6812085|NCT00943852|10815793|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0
6812086|NCT00943852|10815794|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1
6812087|NCT00943852|10815795|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0
6812088|NCT00943852|10815796|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0
6812089|NCT00943852|10815797|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0
6812090|NCT00943852|10815798|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0
6812091|NCT00943852|10815789|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
6812092|NCT00943852|10815790|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
6812093|NCT00943852|10815791|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
6812094|NCT00943852|10815792|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
6812095|NCT00943852|10815793|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
6812096|NCT00943852|10815794|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
6812097|NCT00943852|10815795|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1
6812098|NCT00943852|10815796|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
6812099|NCT00943852|10815797|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
6812100|NCT00943852|10815798|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
6812101|NCT00943852|10815789|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
6812102|NCT00943852|10815790|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
6812103|NCT00943852|10815791|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
6812104|NCT00943852|10815792|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
6812105|NCT00943852|10815793|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
6812106|NCT00943852|10815794|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
6812107|NCT00943852|10815795|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
6812108|NCT00943852|10815796|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1
6812109|NCT00943852|10815797|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
6812110|NCT00943852|10815798|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
6812111|NCT00943852|10815789|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1
6812112|NCT00943852|10815790|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0
6812113|NCT00943852|10815791|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1
6812114|NCT00943852|10815792|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1
6812115|NCT00943852|10815793|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0
6812116|NCT00943852|10815794|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0
6812117|NCT00943852|10815795|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1
6812118|NCT00943852|10815796|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0
6812119|NCT00943852|10815797|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0
6812120|NCT00943852|10815798|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0
6812121|NCT00927953|10815810|FG000|Overall Study|Death|2
6812122|NCT00927953|10815811|FG001|Overall Study|Death|1
6812123|NCT00909389|10815818|FG000|Overall Study|Adverse Event|6
6812124|NCT00909389|10815818|FG000|Overall Study|Death|4
6812125|NCT00909389|10815818|FG000|Overall Study|Poor Compliance|16
6812126|NCT00909389|10815818|FG000|Overall Study|Lost to Follow-up|4
6812127|NCT00909389|10815818|FG000|Overall Study|No Information|103
6812128|NCT00820027|10815826|FG000|Overall Study|Adverse Event|15
6812129|NCT00820027|10815827|FG001|Overall Study|Adverse Event|8
6812130|NCT00820027|10815828|FG002|Overall Study|Adverse Event|10
6812131|NCT00820027|10815829|FG003|Overall Study|Adverse Event|5
6812132|NCT00820027|10815826|FG000|Overall Study|Lack of Efficacy|2
6812133|NCT00820027|10815827|FG001|Overall Study|Lack of Efficacy|1
6812134|NCT00820027|10815828|FG002|Overall Study|Lack of Efficacy|2
6812135|NCT00820027|10815829|FG003|Overall Study|Lack of Efficacy|2
6812136|NCT00820027|10815826|FG000|Overall Study|Physician Decision|0
6812137|NCT00820027|10815827|FG001|Overall Study|Physician Decision|1
6812138|NCT00820027|10815828|FG002|Overall Study|Physician Decision|1
6812139|NCT00820027|10815829|FG003|Overall Study|Physician Decision|0
6812140|NCT00820027|10815826|FG000|Overall Study|Protocol Violation|3
6812141|NCT00820027|10815827|FG001|Overall Study|Protocol Violation|0
6812142|NCT00820027|10815828|FG002|Overall Study|Protocol Violation|4
6812143|NCT00820027|10815829|FG003|Overall Study|Protocol Violation|0
6812144|NCT00820027|10815826|FG000|Overall Study|Withdrawal by Subject|6
6812145|NCT00820027|10815827|FG001|Overall Study|Withdrawal by Subject|4
6812146|NCT00820027|10815828|FG002|Overall Study|Withdrawal by Subject|4
6812147|NCT00820027|10815829|FG003|Overall Study|Withdrawal by Subject|6
6812148|NCT00788710|10815843|FG000|Overall Study|Adverse Event|1
6812149|NCT00788710|10815844|FG001|Overall Study|Adverse Event|3
6812150|NCT00788710|10815845|FG002|Overall Study|Adverse Event|4
6812151|NCT00788710|10815843|FG000|Overall Study|Lack of Efficacy|0
6812152|NCT00788710|10815844|FG001|Overall Study|Lack of Efficacy|0
6812153|NCT00788710|10815845|FG002|Overall Study|Lack of Efficacy|1
6812154|NCT00788710|10815843|FG000|Overall Study|Lost to Follow-up|0
6812155|NCT00788710|10815844|FG001|Overall Study|Lost to Follow-up|1
6812156|NCT00788710|10815845|FG002|Overall Study|Lost to Follow-up|0
6812157|NCT00788710|10815843|FG000|Overall Study|Physician Decision|2
6812158|NCT00788710|10815844|FG001|Overall Study|Physician Decision|1
6812159|NCT00788710|10815845|FG002|Overall Study|Physician Decision|0
6812160|NCT00788710|10815843|FG000|Overall Study|Protocol Violation|0
6812161|NCT00788710|10815844|FG001|Overall Study|Protocol Violation|1
6812162|NCT00788710|10815845|FG002|Overall Study|Protocol Violation|1
6812163|NCT00788710|10815843|FG000|Overall Study|Withdrawal by Subject|2
6812164|NCT00788710|10815844|FG001|Overall Study|Withdrawal by Subject|2
6812165|NCT00788710|10815845|FG002|Overall Study|Withdrawal by Subject|0
6812166|NCT00783224|10815857|FG000|Overall Study|Adverse Event|0
6812167|NCT00783224|10815858|FG001|Overall Study|Adverse Event|0
6812168|NCT00783224|10815859|FG002|Overall Study|Adverse Event|1
6812169|NCT00783224|10815860|FG003|Overall Study|Adverse Event|0
6812170|NCT00783224|10815857|FG000|Overall Study|Discarded the Investigational Drug Used|0
6812171|NCT00783224|10815858|FG001|Overall Study|Discarded the Investigational Drug Used|0
6812172|NCT00783224|10815859|FG002|Overall Study|Discarded the Investigational Drug Used|0
6812173|NCT00783224|10815860|FG003|Overall Study|Discarded the Investigational Drug Used|1
6812174|NCT00783224|10815857|FG000|Overall Study|Inappropriate as a study subject|0
6812175|NCT00783224|10815858|FG001|Overall Study|Inappropriate as a study subject|0
6812176|NCT00783224|10815859|FG002|Overall Study|Inappropriate as a study subject|0
6812177|NCT00783224|10815860|FG003|Overall Study|Inappropriate as a study subject|1
6812178|NCT00778700|10815889|FG000|Overall Study|Adverse Event|6
6812179|NCT00778700|10815890|FG001|Overall Study|Adverse Event|1
6812180|NCT00778700|10815891|FG002|Overall Study|Adverse Event|3
6812181|NCT00778700|10815892|FG003|Overall Study|Adverse Event|5
6812182|NCT00778700|10815889|FG000|Overall Study|Protocol Violation|1
6812183|NCT00778700|10815890|FG001|Overall Study|Protocol Violation|1
6812184|NCT00778700|10815891|FG002|Overall Study|Protocol Violation|0
6812185|NCT00778700|10815892|FG003|Overall Study|Protocol Violation|0
6812186|NCT00778700|10815889|FG000|Overall Study|Subject Withdrew Consent|6
6812187|NCT00778700|10815890|FG001|Overall Study|Subject Withdrew Consent|4
6812188|NCT00778700|10815891|FG002|Overall Study|Subject Withdrew Consent|1
6812189|NCT00778700|10815892|FG003|Overall Study|Subject Withdrew Consent|4
6812190|NCT00778700|10815889|FG000|Overall Study|Lost to Follow-up|3
6812191|NCT00778700|10815890|FG001|Overall Study|Lost to Follow-up|1
6812192|NCT00778700|10815891|FG002|Overall Study|Lost to Follow-up|0
6812193|NCT00778700|10815892|FG003|Overall Study|Lost to Follow-up|1
6812194|NCT00778700|10815889|FG000|Overall Study|Reason not Specified|2
6812195|NCT00778700|10815890|FG001|Overall Study|Reason not Specified|0
6812196|NCT00778700|10815891|FG002|Overall Study|Reason not Specified|1
6812197|NCT00778700|10815892|FG003|Overall Study|Reason not Specified|3
6812198|NCT00778700|10815889|FG000|Overall Study|Other|0
6812199|NCT00778700|10815890|FG001|Overall Study|Other|0
6812200|NCT00778700|10815891|FG002|Overall Study|Other|1
6812201|NCT00778700|10815892|FG003|Overall Study|Other|0
6812202|NCT00764478|10815909|FG000|Overall Study|Adverse Event|1
6812203|NCT00764478|10815910|FG001|Overall Study|Adverse Event|1
6812204|NCT00764478|10815911|FG002|Overall Study|Adverse Event|1
6812205|NCT00764478|10815909|FG000|Overall Study|Withdrawal by Subject|7
6812206|NCT00764478|10815910|FG001|Overall Study|Withdrawal by Subject|12
6812207|NCT00764478|10815911|FG002|Overall Study|Withdrawal by Subject|1
6812208|NCT00764478|10815909|FG000|Overall Study|Lost to Follow-up|7
6812209|NCT00764478|10815910|FG001|Overall Study|Lost to Follow-up|8
6812210|NCT00764478|10815911|FG002|Overall Study|Lost to Follow-up|5
6812211|NCT00764478|10815909|FG000|Overall Study|Protocol Violation|0
6812212|NCT00764478|10815910|FG001|Overall Study|Protocol Violation|1
6812213|NCT00764478|10815911|FG002|Overall Study|Protocol Violation|1
6812214|NCT00761527|10815919|FG000|Overall Study|Adverse Event|3
6812215|NCT00761527|10815919|FG000|Overall Study|Poor Compliance|8
6812216|NCT00761527|10815919|FG000|Overall Study|Lost to Follow-up|9
6812217|NCT00761527|10815919|FG000|Overall Study|Unknown reason|2
6812218|NCT00757627|10815923|FG000|Overall Study|Adverse Event|15
6812219|NCT00757627|10815923|FG000|Overall Study|Lack of Efficacy|10
6812220|NCT00757627|10815923|FG000|Overall Study|Lost to Follow-up|28
6812221|NCT00757627|10815923|FG000|Overall Study|Withdrawal by Subject|27
6812222|NCT00757627|10815923|FG000|Overall Study|Other|1
6812223|NCT00756938|10815935|FG000|12-week Base Study|Protocol-specific Criteria Met|1
6812224|NCT00756938|10815936|FG001|12-week Base Study|Protocol-specific Criteria Met|0
6812225|NCT00756938|10815937|FG002|12-week Base Study|Protocol-specific Criteria Met|1
6812226|NCT00756938|10815938|FG003|12-week Base Study|Protocol-specific Criteria Met|0
6812227|NCT00756938|10815935|FG000|12-week Base Study|Protocol Violation|0
6812228|NCT00756938|10815936|FG001|12-week Base Study|Protocol Violation|0
6812229|NCT00756938|10815937|FG002|12-week Base Study|Protocol Violation|1
6812230|NCT00756938|10815938|FG003|12-week Base Study|Protocol Violation|0
6812231|NCT00756938|10815935|FG000|12-week Base Study|Lost to Follow-up|1
6812232|NCT00756938|10815936|FG001|12-week Base Study|Lost to Follow-up|0
6812233|NCT00756938|10815937|FG002|12-week Base Study|Lost to Follow-up|0
6812234|NCT00756938|10815938|FG003|12-week Base Study|Lost to Follow-up|0
6812235|NCT00756938|10815935|FG000|Optional Extension|Lack of Efficacy|0
6812236|NCT00756938|10815936|FG001|Optional Extension|Lack of Efficacy|0
6812237|NCT00756938|10815937|FG002|Optional Extension|Lack of Efficacy|0
6812238|NCT00756938|10815938|FG003|Optional Extension|Lack of Efficacy|1
6812239|NCT00756938|10815935|FG000|Optional Extension|End of Study|0
6812240|NCT00756938|10815936|FG001|Optional Extension|End of Study|0
6812241|NCT00756938|10815937|FG002|Optional Extension|End of Study|0
6812242|NCT00756938|10815938|FG003|Optional Extension|End of Study|11
6812243|NCT00756938|10815935|FG000|Optional Extension|Protocol-specific criteria met|0
6812244|NCT00756938|10815936|FG001|Optional Extension|Protocol-specific criteria met|0
6812245|NCT00756938|10815937|FG002|Optional Extension|Protocol-specific criteria met|0
6812246|NCT00756938|10815938|FG003|Optional Extension|Protocol-specific criteria met|9
6812247|NCT00756938|10815935|FG000|Optional Extension|Physician Decision|0
6812248|NCT00756938|10815936|FG001|Optional Extension|Physician Decision|0
6812249|NCT00756938|10815937|FG002|Optional Extension|Physician Decision|0
6812250|NCT00756938|10815938|FG003|Optional Extension|Physician Decision|3
6812251|NCT00756938|10815935|FG000|Optional Extension|Lost to Follow-up|0
6812252|NCT00756938|10815936|FG001|Optional Extension|Lost to Follow-up|0
6812253|NCT00756938|10815937|FG002|Optional Extension|Lost to Follow-up|0
6812254|NCT00756938|10815938|FG003|Optional Extension|Lost to Follow-up|1
6812255|NCT00756938|10815935|FG000|Optional Extension|Protocol Violation|0
6812256|NCT00756938|10815936|FG001|Optional Extension|Protocol Violation|0
6812257|NCT00756938|10815937|FG002|Optional Extension|Protocol Violation|0
6812258|NCT00756938|10815938|FG003|Optional Extension|Protocol Violation|1
6812259|NCT00756938|10815935|FG000|Optional Extension|Withdrawal by Subject|0
6812260|NCT00756938|10815936|FG001|Optional Extension|Withdrawal by Subject|0
6812261|NCT00756938|10815937|FG002|Optional Extension|Withdrawal by Subject|0
6812262|NCT00756938|10815938|FG003|Optional Extension|Withdrawal by Subject|10
6812263|NCT00756938|10815935|FG000|Optional Extension|Adverse Event|0
6812264|NCT00756938|10815936|FG001|Optional Extension|Adverse Event|0
6812265|NCT00756938|10815937|FG002|Optional Extension|Adverse Event|0
6812266|NCT00756938|10815938|FG003|Optional Extension|Adverse Event|1
6812267|NCT00730132|10815956|FG000|Overall Study|Protocol Violation|154
6812268|NCT00730132|10815956|FG000|Overall Study|Death|1
6812269|NCT00728416|10815965|FG000|Overall Study|Adverse Event|1
6812270|NCT00728416|10815966|FG001|Overall Study|Adverse Event|1
6812271|NCT00728416|10815965|FG000|Overall Study|Treatment Failure|0
6812272|NCT00728416|10815966|FG001|Overall Study|Treatment Failure|1
6812273|NCT00728416|10815965|FG000|Overall Study|Withdrawal by Subject|1
6812274|NCT00728416|10815966|FG001|Overall Study|Withdrawal by Subject|0
6812275|NCT00704535|10815993|FG000|Overall Study|Adverse Event|2
6812276|NCT00704535|10815993|FG000|Overall Study|Death|2
6812277|NCT00704535|10815993|FG000|Overall Study|Lost to Follow-up|8
6812278|NCT00704535|10815993|FG000|Overall Study|Protocol Violation|10
6812279|NCT00704535|10815993|FG000|Overall Study|Completed status not on Case Report Form|124
6812280|NCT00694369|10816002|FG000|Overall Study|Adverse Event|0
6812281|NCT00694369|10816003|FG001|Overall Study|Adverse Event|1
6812282|NCT00694369|10816004|FG002|Overall Study|Adverse Event|0
6812283|NCT00694369|10816005|FG003|Overall Study|Adverse Event|1
6812284|NCT00694369|10816006|FG004|Overall Study|Adverse Event|3
6812285|NCT00694369|10816002|FG000|Overall Study|Lost to Follow-up|0
6812286|NCT00694369|10816003|FG001|Overall Study|Lost to Follow-up|0
6812287|NCT00694369|10816004|FG002|Overall Study|Lost to Follow-up|1
6812288|NCT00694369|10816005|FG003|Overall Study|Lost to Follow-up|1
6812289|NCT00694369|10816006|FG004|Overall Study|Lost to Follow-up|0
6812290|NCT00694369|10816002|FG000|Overall Study|Physician Decision|0
6812291|NCT00694369|10816003|FG001|Overall Study|Physician Decision|0
6812292|NCT00694369|10816004|FG002|Overall Study|Physician Decision|0
6812293|NCT00694369|10816005|FG003|Overall Study|Physician Decision|0
6812294|NCT00694369|10816006|FG004|Overall Study|Physician Decision|1
6812295|NCT00694369|10816002|FG000|Overall Study|Protocol Violation|0
6812296|NCT00694369|10816003|FG001|Overall Study|Protocol Violation|1
6812297|NCT00694369|10816004|FG002|Overall Study|Protocol Violation|0
6812298|NCT00694369|10816005|FG003|Overall Study|Protocol Violation|0
6812299|NCT00694369|10816006|FG004|Overall Study|Protocol Violation|0
6812300|NCT00694369|10816002|FG000|Overall Study|Withdrawal by Subject|1
6812301|NCT00694369|10816003|FG001|Overall Study|Withdrawal by Subject|1
6812302|NCT00694369|10816004|FG002|Overall Study|Withdrawal by Subject|1
6812303|NCT00694369|10816005|FG003|Overall Study|Withdrawal by Subject|1
6812304|NCT00694369|10816006|FG004|Overall Study|Withdrawal by Subject|2
6812305|NCT00667823|10816031|FG000|Overall Study|Lost to Follow-up|5
6812306|NCT00667823|10816031|FG000|Overall Study|Adverse Event|7
6812307|NCT00667823|10816031|FG000|Overall Study|Death|182
6812308|NCT00667823|10816031|FG000|Overall Study|Withdrawal by Subject|12
6812309|NCT00667823|10816031|FG000|Overall Study|Other|8
6812310|NCT00667823|10816031|FG000|Overall Study|Missing (completion page missing)|2
6812311|NCT00652327|10816037|FG000|Overall Study|Adverse Event|0
6812312|NCT00652327|10816038|FG001|Overall Study|Adverse Event|2
6812313|NCT00652327|10816037|FG000|Overall Study|Lost to Follow-up|0
6812314|NCT00652327|10816038|FG001|Overall Study|Lost to Follow-up|3
6812315|NCT00604500|10816044|FG000|Overall Study|Adverse Event|2
6812316|NCT00604500|10816044|FG000|Overall Study|Protocol Violation|2
6812317|NCT00604500|10816044|FG000|Overall Study|Treatment Failure|1
6812318|NCT00604500|10816044|FG000|Overall Study|Withdrawal by Subject|4
6812319|NCT00604500|10816044|FG000|Overall Study|Administrative|1
6812320|NCT00604500|10816044|FG000|Overall Study|Did not meet protocol eligibility|1
6812321|NCT00568178|10816050|FG000|Double Blind Base Study|Adverse Event|0
6812322|NCT00568178|10816051|FG001|Double Blind Base Study|Adverse Event|2
6812323|NCT00568178|10816052|FG002|Double Blind Base Study|Adverse Event|1
6812324|NCT00568178|10816053|FG003|Double Blind Base Study|Adverse Event|2
6812325|NCT00568178|10816054|FG004|Double Blind Base Study|Adverse Event|0
6812326|NCT00568178|10816055|FG005|Double Blind Base Study|Adverse Event|0
6812327|NCT00568178|10816050|FG000|Double Blind Base Study|Lost to Follow-up|1
6812328|NCT00568178|10816051|FG001|Double Blind Base Study|Lost to Follow-up|0
6812329|NCT00568178|10816052|FG002|Double Blind Base Study|Lost to Follow-up|0
6812330|NCT00568178|10816053|FG003|Double Blind Base Study|Lost to Follow-up|1
6812331|NCT00568178|10816054|FG004|Double Blind Base Study|Lost to Follow-up|0
6812332|NCT00568178|10816055|FG005|Double Blind Base Study|Lost to Follow-up|0
6812333|NCT00568178|10816050|FG000|Double Blind Base Study|Physician Decision|1
6812334|NCT00568178|10816051|FG001|Double Blind Base Study|Physician Decision|1
6812335|NCT00568178|10816052|FG002|Double Blind Base Study|Physician Decision|0
6812336|NCT00568178|10816053|FG003|Double Blind Base Study|Physician Decision|1
6812337|NCT00568178|10816054|FG004|Double Blind Base Study|Physician Decision|0
6812338|NCT00568178|10816055|FG005|Double Blind Base Study|Physician Decision|0
6812339|NCT00568178|10816050|FG000|Double Blind Base Study|Protocol Violation|3
6812340|NCT00568178|10816051|FG001|Double Blind Base Study|Protocol Violation|2
6812341|NCT00568178|10816052|FG002|Double Blind Base Study|Protocol Violation|0
6812342|NCT00568178|10816053|FG003|Double Blind Base Study|Protocol Violation|0
6812343|NCT00568178|10816054|FG004|Double Blind Base Study|Protocol Violation|0
6812344|NCT00568178|10816055|FG005|Double Blind Base Study|Protocol Violation|0
6812345|NCT00568178|10816050|FG000|Double Blind Base Study|Withdrawal by Subject|1
6812346|NCT00568178|10816051|FG001|Double Blind Base Study|Withdrawal by Subject|1
6812347|NCT00568178|10816052|FG002|Double Blind Base Study|Withdrawal by Subject|0
6812348|NCT00568178|10816053|FG003|Double Blind Base Study|Withdrawal by Subject|0
6812349|NCT00568178|10816054|FG004|Double Blind Base Study|Withdrawal by Subject|0
6812350|NCT00568178|10816055|FG005|Double Blind Base Study|Withdrawal by Subject|0
6812351|NCT00568178|10816050|FG000|Double Blind Base Study|Progressive Disease|0
6812352|NCT00568178|10816051|FG001|Double Blind Base Study|Progressive Disease|0
6812353|NCT00568178|10816052|FG002|Double Blind Base Study|Progressive Disease|0
6812354|NCT00568178|10816053|FG003|Double Blind Base Study|Progressive Disease|1
6812355|NCT00568178|10816054|FG004|Double Blind Base Study|Progressive Disease|0
6812356|NCT00568178|10816055|FG005|Double Blind Base Study|Progressive Disease|0
6812357|NCT00568178|10816050|FG000|Open Label Extension|Adverse Event|0
6812358|NCT00568178|10816051|FG001|Open Label Extension|Adverse Event|0
6812359|NCT00568178|10816052|FG002|Open Label Extension|Adverse Event|0
6812360|NCT00568178|10816053|FG003|Open Label Extension|Adverse Event|0
6812361|NCT00568178|10816054|FG004|Open Label Extension|Adverse Event|11
6812362|NCT00568178|10816055|FG005|Open Label Extension|Adverse Event|8
6812363|NCT00568178|10816050|FG000|Open Label Extension|Protocol Violation|0
6812364|NCT00568178|10816051|FG001|Open Label Extension|Protocol Violation|0
6812365|NCT00568178|10816052|FG002|Open Label Extension|Protocol Violation|0
6812366|NCT00568178|10816053|FG003|Open Label Extension|Protocol Violation|0
6812367|NCT00568178|10816054|FG004|Open Label Extension|Protocol Violation|1
6812368|NCT00568178|10816055|FG005|Open Label Extension|Protocol Violation|0
6812369|NCT00568178|10816050|FG000|Open Label Extension|Lost to Follow-up|0
6812370|NCT00568178|10816051|FG001|Open Label Extension|Lost to Follow-up|0
6812371|NCT00568178|10816052|FG002|Open Label Extension|Lost to Follow-up|0
6812372|NCT00568178|10816053|FG003|Open Label Extension|Lost to Follow-up|0
6812373|NCT00568178|10816054|FG004|Open Label Extension|Lost to Follow-up|6
6812374|NCT00568178|10816055|FG005|Open Label Extension|Lost to Follow-up|11
6812375|NCT00568178|10816050|FG000|Open Label Extension|Physician Decision|0
6812376|NCT00568178|10816051|FG001|Open Label Extension|Physician Decision|0
6812377|NCT00568178|10816052|FG002|Open Label Extension|Physician Decision|0
6812378|NCT00568178|10816053|FG003|Open Label Extension|Physician Decision|0
6812379|NCT00568178|10816054|FG004|Open Label Extension|Physician Decision|9
6812380|NCT00568178|10816055|FG005|Open Label Extension|Physician Decision|8
6812381|NCT00568178|10816050|FG000|Open Label Extension|Pregnancy|0
6812382|NCT00568178|10816051|FG001|Open Label Extension|Pregnancy|0
6812383|NCT00568178|10816052|FG002|Open Label Extension|Pregnancy|0
6812384|NCT00568178|10816053|FG003|Open Label Extension|Pregnancy|0
6812385|NCT00568178|10816054|FG004|Open Label Extension|Pregnancy|0
6812386|NCT00568178|10816055|FG005|Open Label Extension|Pregnancy|1
6812387|NCT00568178|10816050|FG000|Open Label Extension|Progressive Disease|0
6812388|NCT00568178|10816051|FG001|Open Label Extension|Progressive Disease|0
6812389|NCT00568178|10816052|FG002|Open Label Extension|Progressive Disease|0
6812390|NCT00568178|10816053|FG003|Open Label Extension|Progressive Disease|0
6812391|NCT00568178|10816054|FG004|Open Label Extension|Progressive Disease|3
6812392|NCT00568178|10816055|FG005|Open Label Extension|Progressive Disease|1
6812393|NCT00568178|10816050|FG000|Open Label Extension|Termination of Trial|0
6812394|NCT00568178|10816051|FG001|Open Label Extension|Termination of Trial|0
6812395|NCT00568178|10816052|FG002|Open Label Extension|Termination of Trial|0
6812396|NCT00568178|10816053|FG003|Open Label Extension|Termination of Trial|0
6812397|NCT00568178|10816054|FG004|Open Label Extension|Termination of Trial|45
6812398|NCT00568178|10816055|FG005|Open Label Extension|Termination of Trial|47
6812399|NCT00568178|10816050|FG000|Open Label Extension|Withdrawal by Subject|0
6812400|NCT00568178|10816051|FG001|Open Label Extension|Withdrawal by Subject|0
6812401|NCT00568178|10816052|FG002|Open Label Extension|Withdrawal by Subject|0
6812402|NCT00568178|10816053|FG003|Open Label Extension|Withdrawal by Subject|0
6812403|NCT00568178|10816054|FG004|Open Label Extension|Withdrawal by Subject|4
6812404|NCT00568178|10816055|FG005|Open Label Extension|Withdrawal by Subject|4
6812405|NCT00545844|10816069|FG000|Overall Study|Lost to Follow-up|9
6812406|NCT00545844|10816069|FG000|Overall Study|Protocol Violation|1
6812407|NCT00545844|10816069|FG000|Overall Study|Withdrawal by Subject|2
6812408|NCT00511433|10816077|FG000|Overall Study|Adverse Event|5
6812409|NCT00511433|10816078|FG001|Overall Study|Adverse Event|0
6812410|NCT00511433|10816077|FG000|Overall Study|Other Reason|1
6812411|NCT00511433|10816078|FG001|Overall Study|Other Reason|1
6812412|NCT00511355|10816088|FG000|Overall Study|Adverse Event|4
6812413|NCT00511355|10816089|FG001|Overall Study|Adverse Event|4
6812414|NCT00511355|10816088|FG000|Overall Study|Pregnancy Wish|1
6812415|NCT00511355|10816089|FG001|Overall Study|Pregnancy Wish|0
6812416|NCT00511355|10816088|FG000|Overall Study|Lost to Follow-up|2
6812417|NCT00511355|10816089|FG001|Overall Study|Lost to Follow-up|1
6812418|NCT00511355|10816088|FG000|Overall Study|Other Reason|0
6812419|NCT00511355|10816089|FG001|Overall Study|Other Reason|1
6812420|NCT00511355|10816088|FG000|Overall Study|Pre-treatment (serious) adverse event|0
6812421|NCT00511355|10816089|FG001|Overall Study|Pre-treatment (serious) adverse event|1
6812422|NCT00511355|10816088|FG000|Overall Study|Withdrawal of informed consent|0
6812423|NCT00511355|10816089|FG001|Overall Study|Withdrawal of informed consent|1
6812424|NCT00511355|10816088|FG000|Overall Study|Other reason pre-treatment|0
6812425|NCT00511355|10816089|FG001|Overall Study|Other reason pre-treatment|1
6812426|NCT00511342|10816099|FG000|Overall Study|Unacceptable vaginal bleeding|2
6812427|NCT00511342|10816100|FG001|Overall Study|Unacceptable vaginal bleeding|1
6812428|NCT00511342|10816099|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8
6812429|NCT00511342|10816100|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12
6812430|NCT00511342|10816099|FG000|Overall Study|Pregnancy|0
6812431|NCT00511342|10816100|FG001|Overall Study|Pregnancy|1
6812432|NCT00511342|10816099|FG000|Overall Study|Pregnancy wish|0
6812433|NCT00511342|10816100|FG001|Overall Study|Pregnancy wish|1
6812434|NCT00511342|10816099|FG000|Overall Study|Lost to Follow-up|1
6812435|NCT00511342|10816100|FG001|Overall Study|Lost to Follow-up|5
6812436|NCT00511342|10816099|FG000|Overall Study|Other Reason|2
6812437|NCT00511342|10816100|FG001|Overall Study|Other Reason|2
6812438|NCT00511199|10816108|FG000|Overall Study|Unacceptable Vaginal Bleeding|63
6812439|NCT00511199|10816109|FG001|Overall Study|Unacceptable Vaginal Bleeding|4
6812440|NCT00511199|10816108|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227
6812441|NCT00511199|10816109|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52
6812442|NCT00511199|10816108|FG000|Overall Study|Withdrawal of Informed Consent|19
6812443|NCT00511199|10816109|FG001|Overall Study|Withdrawal of Informed Consent|4
6812444|NCT00511199|10816108|FG000|Overall Study|Pregnancy|6
6812445|NCT00511199|10816109|FG001|Overall Study|Pregnancy|3
6812446|NCT00511199|10816108|FG000|Overall Study|Pregnancy Wish|16
6812447|NCT00511199|10816109|FG001|Overall Study|Pregnancy Wish|8
6812448|NCT00511199|10816108|FG000|Overall Study|Lost to Follow-up|40
6812449|NCT00511199|10816109|FG001|Overall Study|Lost to Follow-up|17
6812450|NCT00511199|10816108|FG000|Overall Study|Other Reason|78
6812451|NCT00511199|10816109|FG001|Overall Study|Other Reason|37
6812452|NCT00491504|10816121|FG000|Overall Study|Adverse Event|0
6812453|NCT00491504|10816122|FG001|Overall Study|Adverse Event|1
6812454|NCT00491504|10816123|FG002|Overall Study|Adverse Event|0
6812455|NCT00491504|10816124|FG003|Overall Study|Adverse Event|0
6812456|NCT00491504|10816121|FG000|Overall Study|Withdrawal by Subject|0
6812457|NCT00491504|10816122|FG001|Overall Study|Withdrawal by Subject|0
6812458|NCT00491504|10816123|FG002|Overall Study|Withdrawal by Subject|1
6812459|NCT00491504|10816124|FG003|Overall Study|Withdrawal by Subject|2
6812460|NCT00491504|10816121|FG000|Overall Study|Protocol Violation|0
6812461|NCT00491504|10816122|FG001|Overall Study|Protocol Violation|0
6812462|NCT00491504|10816123|FG002|Overall Study|Protocol Violation|3
6812463|NCT00491504|10816124|FG003|Overall Study|Protocol Violation|2
6812464|NCT00468312|10816134|FG000|Overall Study|Adverse Event|2
6812465|NCT00468312|10816135|FG001|Overall Study|Adverse Event|1
6812466|NCT00468312|10816134|FG000|Overall Study|Lack of Efficacy|0
6812467|NCT00468312|10816135|FG001|Overall Study|Lack of Efficacy|1
6812468|NCT00468312|10816134|FG000|Overall Study|Withdrawal by Subject|0
6812469|NCT00468312|10816135|FG001|Overall Study|Withdrawal by Subject|1
6812470|NCT00468312|10816134|FG000|Overall Study|Protocol Violation|2
6812471|NCT00468312|10816135|FG001|Overall Study|Protocol Violation|1
6812472|NCT00468312|10816134|FG000|Overall Study|Did not meet protocol eligibility|0
6812473|NCT00468312|10816135|FG001|Overall Study|Did not meet protocol eligibility|1
6812474|NCT00453063|10816143|FG000|Overall Study|Adverse Event|1
6812475|NCT00453063|10816144|FG001|Overall Study|Adverse Event|2
6812476|NCT00453063|10816143|FG000|Overall Study|Withdrawal by Subject|1
6812477|NCT00453063|10816144|FG001|Overall Study|Withdrawal by Subject|1
6812478|NCT00453063|10816143|FG000|Overall Study|Protocol Violation|1
6812479|NCT00453063|10816144|FG001|Overall Study|Protocol Violation|0
6812480|NCT00447603|10816150|FG000|Screening|Withdrawal by Subject|1
6812481|NCT00447603|10816151|FG001|Screening|Withdrawal by Subject|0
6812482|NCT00447603|10816152|FG002|Screening|Withdrawal by Subject|0
6812483|NCT00447603|10816150|FG000|Screening|Protocol Violation|1
6812484|NCT00447603|10816151|FG001|Screening|Protocol Violation|0
6812485|NCT00447603|10816152|FG002|Screening|Protocol Violation|0
6812486|NCT00447603|10816150|FG000|Screening|Screen Failure|4
6812487|NCT00447603|10816151|FG001|Screening|Screen Failure|0
6812488|NCT00447603|10816152|FG002|Screening|Screen Failure|0
6812489|NCT00447603|10816150|FG000|Screening|Study Terminated by Sponsor|15
6812490|NCT00447603|10816151|FG001|Screening|Study Terminated by Sponsor|0
6812491|NCT00447603|10816152|FG002|Screening|Study Terminated by Sponsor|0
6812492|NCT00447603|10816150|FG000|Filter Period|Adverse Event|0
6812493|NCT00447603|10816151|FG001|Filter Period|Adverse Event|0
6812494|NCT00447603|10816152|FG002|Filter Period|Adverse Event|1
6812495|NCT00447603|10816150|FG000|Filter Period|Screen Failure|0
6812496|NCT00447603|10816151|FG001|Filter Period|Screen Failure|3
6812497|NCT00447603|10816152|FG002|Filter Period|Screen Failure|4
6812498|NCT00447603|10816150|FG000|Filter Period|Study terminated by Sponsor|0
6812499|NCT00447603|10816151|FG001|Filter Period|Study terminated by Sponsor|1
6812500|NCT00447603|10816152|FG002|Filter Period|Study terminated by Sponsor|10
6812501|NCT00442351|10816162|FG000|Overall Study|Administrative|6
6812502|NCT00442351|10816163|FG001|Overall Study|Administrative|5
6812503|NCT00442351|10816162|FG000|Overall Study|Did not meet protocol eligibility|1
6812504|NCT00442351|10816163|FG001|Overall Study|Did not meet protocol eligibility|0
6812505|NCT00442351|10816162|FG000|Overall Study|Other|0
6812506|NCT00442351|10816163|FG001|Overall Study|Other|1
6812507|NCT00423488|10816171|FG000|Overall Study|No evidence of study drug intake|2
6812508|NCT00423488|10816172|FG001|Overall Study|No evidence of study drug intake|1
6812509|NCT00423488|10816171|FG000|Overall Study|No post baseline data|3
6812510|NCT00423488|10816172|FG001|Overall Study|No post baseline data|0
6812511|NCT00413972|10816182|FG000|Overall Study|Adverse Event|2
6812512|NCT00413972|10816183|FG001|Overall Study|Adverse Event|1
6812513|NCT00413972|10816184|FG002|Overall Study|Adverse Event|0
6812514|NCT00413972|10816185|FG003|Overall Study|Adverse Event|0
6812515|NCT00413972|10816182|FG000|Overall Study|Lost to Follow-up|1
6812516|NCT00413972|10816183|FG001|Overall Study|Lost to Follow-up|2
6812517|NCT00413972|10816184|FG002|Overall Study|Lost to Follow-up|1
6812518|NCT00413972|10816185|FG003|Overall Study|Lost to Follow-up|0
6812519|NCT00413972|10816182|FG000|Overall Study|Withdrawal by Subject|4
6812520|NCT00413972|10816183|FG001|Overall Study|Withdrawal by Subject|5
6812521|NCT00413972|10816184|FG002|Overall Study|Withdrawal by Subject|7
6812522|NCT00413972|10816185|FG003|Overall Study|Withdrawal by Subject|2
6812523|NCT00413972|10816182|FG000|Overall Study|Protocol Violation|0
6812524|NCT00413972|10816183|FG001|Overall Study|Protocol Violation|0
6812525|NCT00413972|10816184|FG002|Overall Study|Protocol Violation|2
6812526|NCT00413972|10816185|FG003|Overall Study|Protocol Violation|0
6812527|NCT00413972|10816182|FG000|Overall Study|Other|0
6812528|NCT00413972|10816183|FG001|Overall Study|Other|0
6812529|NCT00413972|10816184|FG002|Overall Study|Other|0
6812530|NCT00413972|10816185|FG003|Overall Study|Other|1
6812531|NCT00413062|10816197|FG000|Overall Study|Adverse event/serious adverse event|289
6812532|NCT00413062|10816198|FG001|Overall Study|Adverse event/serious adverse event|56
6812533|NCT00413062|10816197|FG000|Overall Study|Pre-treatment (serious) adverse event|1
6812534|NCT00413062|10816198|FG001|Overall Study|Pre-treatment (serious) adverse event|0
6812535|NCT00413062|10816197|FG000|Overall Study|Withdrawal of informed consent|111
6812536|NCT00413062|10816198|FG001|Overall Study|Withdrawal of informed consent|36
6812537|NCT00413062|10816197|FG000|Overall Study|Pregnancy|15
6812538|NCT00413062|10816198|FG001|Overall Study|Pregnancy|5
6812539|NCT00413062|10816197|FG000|Overall Study|Pregnancy wish|17
6812540|NCT00413062|10816198|FG001|Overall Study|Pregnancy wish|6
6812541|NCT00413062|10816197|FG000|Overall Study|Lost to Follow-up|175
6812542|NCT00413062|10816198|FG001|Overall Study|Lost to Follow-up|73
6812543|NCT00413062|10816197|FG000|Overall Study|Other reason|70
6812544|NCT00413062|10816198|FG001|Overall Study|Other reason|34
6812545|NCT00391170|10816208|FG000|Overall Study|Withdrawal by Subject|1
6812546|NCT00391170|10816209|FG001|Overall Study|Withdrawal by Subject|0
6812547|NCT00391170|10816208|FG000|Overall Study|Adverse Event|3
6812548|NCT00391170|10816209|FG001|Overall Study|Adverse Event|2
6812549|NCT00391170|10816208|FG000|Overall Study|Physician Decision|2
6812550|NCT00391170|10816209|FG001|Overall Study|Physician Decision|2
6812551|NCT00319449|10816243|FG000|Overall Study|Subject did not wish to continue|1
6812552|NCT00319449|10816244|FG001|Overall Study|Subject did not wish to continue|0
6812553|NCT00319449|10816243|FG000|Overall Study|Noncompliance with the protocol|1
6812554|NCT00319449|10816244|FG001|Overall Study|Noncompliance with the protocol|0
6812555|NCT00289887|10816256|FG000|Overall Study|Adverse Event|3
6812556|NCT00289887|10816257|FG001|Overall Study|Adverse Event|3
6812557|NCT00289887|10816256|FG000|Overall Study|Lack of Efficacy|3
6812558|NCT00289887|10816257|FG001|Overall Study|Lack of Efficacy|11
6812559|NCT00289887|10816256|FG000|Overall Study|Lost to Follow-up|3
6812560|NCT00289887|10816257|FG001|Overall Study|Lost to Follow-up|3
6812561|NCT00289887|10816256|FG000|Overall Study|Protocol Violation|3
6812562|NCT00289887|10816257|FG001|Overall Study|Protocol Violation|1
6812563|NCT00289887|10816256|FG000|Overall Study|Withdrawal by Subject|3
6812564|NCT00289887|10816257|FG001|Overall Study|Withdrawal by Subject|8
6812565|NCT00289887|10816256|FG000|Overall Study|Other|7
6812566|NCT00289887|10816257|FG001|Overall Study|Other|3
6812567|NCT00281320|10816265|FG000|Overall Study|Adverse Event|12
6812568|NCT00281320|10816266|FG001|Overall Study|Adverse Event|9
6812569|NCT00281320|10816265|FG000|Overall Study|Lack of Efficacy|4
6812570|NCT00281320|10816266|FG001|Overall Study|Lack of Efficacy|3
6812571|NCT00281320|10816265|FG000|Overall Study|Withdrawal by Subject|5
6812572|NCT00281320|10816266|FG001|Overall Study|Withdrawal by Subject|6
6812573|NCT00281320|10816265|FG000|Overall Study|Lost to Follow-up|1
6812574|NCT00281320|10816266|FG001|Overall Study|Lost to Follow-up|2
6812575|NCT00281320|10816265|FG000|Overall Study|Other|3
6812576|NCT00281320|10816266|FG001|Overall Study|Other|1
6812577|NCT00276016|10816284|FG000|Intervention 1|Withdrawal by Subject|0
6812578|NCT00276016|10816285|FG001|Intervention 1|Withdrawal by Subject|1
6812579|NCT00276016|10816286|FG002|Intervention 1|Withdrawal by Subject|0
6812580|NCT00276016|10816287|FG003|Intervention 1|Withdrawal by Subject|0
6812581|NCT00276016|10816288|FG004|Intervention 1|Withdrawal by Subject|0
6812582|NCT00276016|10816289|FG005|Intervention 1|Withdrawal by Subject|0
6812583|NCT00265343|10816300|FG000|Overall Study|Adverse Event|10
6812584|NCT00265343|10816301|FG001|Overall Study|Adverse Event|7
6812585|NCT00265343|10816300|FG000|Overall Study|Withdrawal by Subject|3
6812586|NCT00265343|10816301|FG001|Overall Study|Withdrawal by Subject|9
6812587|NCT00265343|10816300|FG000|Overall Study|Other|8
6812588|NCT00265343|10816301|FG001|Overall Study|Other|3
6812589|NCT00264147|10816312|FG000|Treatment I Period|Adverse Event|3
6812590|NCT00264147|10816313|FG001|Treatment I Period|Adverse Event|6
6812591|NCT00264147|10816314|FG002|Treatment I Period|Adverse Event|3
6812592|NCT00264147|10816315|FG003|Treatment I Period|Adverse Event|5
6812593|NCT00264147|10816316|FG004|Treatment I Period|Adverse Event|7
6812594|NCT00264147|10816317|FG005|Treatment I Period|Adverse Event|0
6812595|NCT00264147|10816312|FG000|Treatment I Period|Laboratory Adverse Event|0
6812596|NCT00264147|10816313|FG001|Treatment I Period|Laboratory Adverse Event|0
6812597|NCT00264147|10816314|FG002|Treatment I Period|Laboratory Adverse Event|0
6812598|NCT00264147|10816315|FG003|Treatment I Period|Laboratory Adverse Event|1
6812599|NCT00264147|10816316|FG004|Treatment I Period|Laboratory Adverse Event|0
6812600|NCT00264147|10816317|FG005|Treatment I Period|Laboratory Adverse Event|0
6812601|NCT00264147|10816312|FG000|Treatment I Period|Lack of Efficacy|6
6812602|NCT00264147|10816313|FG001|Treatment I Period|Lack of Efficacy|2
6812603|NCT00264147|10816314|FG002|Treatment I Period|Lack of Efficacy|8
6812604|NCT00264147|10816315|FG003|Treatment I Period|Lack of Efficacy|0
6812605|NCT00264147|10816316|FG004|Treatment I Period|Lack of Efficacy|1
6812606|NCT00264147|10816317|FG005|Treatment I Period|Lack of Efficacy|0
6812607|NCT00264147|10816312|FG000|Treatment I Period|Lost to Follow-up|1
6812608|NCT00264147|10816313|FG001|Treatment I Period|Lost to Follow-up|0
6812609|NCT00264147|10816314|FG002|Treatment I Period|Lost to Follow-up|0
6812610|NCT00264147|10816315|FG003|Treatment I Period|Lost to Follow-up|1
6812611|NCT00264147|10816316|FG004|Treatment I Period|Lost to Follow-up|1
6812612|NCT00264147|10816317|FG005|Treatment I Period|Lost to Follow-up|0
6812613|NCT00264147|10816312|FG000|Treatment I Period|Protocol Violation|2
6812614|NCT00264147|10816313|FG001|Treatment I Period|Protocol Violation|2
6812615|NCT00264147|10816314|FG002|Treatment I Period|Protocol Violation|0
6812616|NCT00264147|10816315|FG003|Treatment I Period|Protocol Violation|0
6812617|NCT00264147|10816316|FG004|Treatment I Period|Protocol Violation|0
6812618|NCT00264147|10816317|FG005|Treatment I Period|Protocol Violation|0
6812619|NCT00264147|10816312|FG000|Treatment I Period|Withdrawal by Subject|2
6812620|NCT00264147|10816313|FG001|Treatment I Period|Withdrawal by Subject|0
6812621|NCT00264147|10816314|FG002|Treatment I Period|Withdrawal by Subject|0
6812622|NCT00264147|10816315|FG003|Treatment I Period|Withdrawal by Subject|2
6812623|NCT00264147|10816316|FG004|Treatment I Period|Withdrawal by Subject|2
6812624|NCT00264147|10816317|FG005|Treatment I Period|Withdrawal by Subject|0
6812625|NCT00264147|10816312|FG000|Treatment I Period|Patient out of town for an extended time|0
6812626|NCT00264147|10816313|FG001|Treatment I Period|Patient out of town for an extended time|1
6812627|NCT00264147|10816314|FG002|Treatment I Period|Patient out of town for an extended time|0
6812628|NCT00264147|10816315|FG003|Treatment I Period|Patient out of town for an extended time|0
6812629|NCT00264147|10816316|FG004|Treatment I Period|Patient out of town for an extended time|0
6812630|NCT00264147|10816317|FG005|Treatment I Period|Patient out of town for an extended time|0
6812631|NCT00264147|10816312|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0
6812632|NCT00264147|10816313|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0
6812633|NCT00264147|10816314|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1
6812634|NCT00264147|10816315|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0
6812635|NCT00264147|10816316|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0
6812636|NCT00264147|10816317|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0
6812637|NCT00264147|10816312|FG000|Treatment I Period|Reassigned to Treatment II Period|84
6812638|NCT00264147|10816313|FG001|Treatment I Period|Reassigned to Treatment II Period|72
6812639|NCT00264147|10816314|FG002|Treatment I Period|Reassigned to Treatment II Period|65
6812640|NCT00264147|10816315|FG003|Treatment I Period|Reassigned to Treatment II Period|63
6812641|NCT00264147|10816316|FG004|Treatment I Period|Reassigned to Treatment II Period|45
6812642|NCT00264147|10816317|FG005|Treatment I Period|Reassigned to Treatment II Period|0
6812643|NCT00264147|10816312|FG000|Treatment II Period|Adverse Event|0
6812644|NCT00264147|10816313|FG001|Treatment II Period|Adverse Event|0
6812645|NCT00264147|10816314|FG002|Treatment II Period|Adverse Event|0
6812646|NCT00264147|10816315|FG003|Treatment II Period|Adverse Event|0
6812647|NCT00264147|10816316|FG004|Treatment II Period|Adverse Event|9
6812648|NCT00264147|10816317|FG005|Treatment II Period|Adverse Event|9
6812649|NCT00264147|10816312|FG000|Treatment II Period|Laboratory Adverse Event|0
6812650|NCT00264147|10816313|FG001|Treatment II Period|Laboratory Adverse Event|0
6812651|NCT00264147|10816314|FG002|Treatment II Period|Laboratory Adverse Event|0
6812652|NCT00264147|10816315|FG003|Treatment II Period|Laboratory Adverse Event|0
6812653|NCT00264147|10816316|FG004|Treatment II Period|Laboratory Adverse Event|0
6812654|NCT00264147|10816317|FG005|Treatment II Period|Laboratory Adverse Event|1
6812655|NCT00264147|10816312|FG000|Treatment II Period|Lack of Efficacy|0
6812656|NCT00264147|10816313|FG001|Treatment II Period|Lack of Efficacy|0
6812657|NCT00264147|10816314|FG002|Treatment II Period|Lack of Efficacy|0
6812658|NCT00264147|10816315|FG003|Treatment II Period|Lack of Efficacy|0
6812659|NCT00264147|10816316|FG004|Treatment II Period|Lack of Efficacy|20
6812660|NCT00264147|10816317|FG005|Treatment II Period|Lack of Efficacy|19
6812661|NCT00264147|10816312|FG000|Treatment II Period|Lost to Follow-up|0
6812662|NCT00264147|10816313|FG001|Treatment II Period|Lost to Follow-up|0
6812663|NCT00264147|10816314|FG002|Treatment II Period|Lost to Follow-up|0
6812664|NCT00264147|10816315|FG003|Treatment II Period|Lost to Follow-up|0
6812665|NCT00264147|10816316|FG004|Treatment II Period|Lost to Follow-up|1
6812666|NCT00264147|10816317|FG005|Treatment II Period|Lost to Follow-up|1
6812667|NCT00264147|10816312|FG000|Treatment II Period|Withdrawal by Subject|0
6812668|NCT00264147|10816313|FG001|Treatment II Period|Withdrawal by Subject|0
6812669|NCT00264147|10816314|FG002|Treatment II Period|Withdrawal by Subject|0
6812670|NCT00264147|10816315|FG003|Treatment II Period|Withdrawal by Subject|0
6812671|NCT00264147|10816316|FG004|Treatment II Period|Withdrawal by Subject|3
6812672|NCT00264147|10816317|FG005|Treatment II Period|Withdrawal by Subject|2
6812673|NCT00264147|10816312|FG000|Treatment II Period|Pre-scheduled total hip replacement|0
6812674|NCT00264147|10816313|FG001|Treatment II Period|Pre-scheduled total hip replacement|0
6812675|NCT00264147|10816314|FG002|Treatment II Period|Pre-scheduled total hip replacement|0
6812676|NCT00264147|10816315|FG003|Treatment II Period|Pre-scheduled total hip replacement|0
6812677|NCT00264147|10816316|FG004|Treatment II Period|Pre-scheduled total hip replacement|0
6812678|NCT00264147|10816317|FG005|Treatment II Period|Pre-scheduled total hip replacement|1
6812679|NCT00202878|10816333|FG000|Overall Study|Death|964
6812680|NCT00202878|10816334|FG001|Overall Study|Death|968
6812681|NCT00202878|10816333|FG000|Overall Study|Only Vital Status Known|357
6812682|NCT00202878|10816334|FG001|Overall Study|Only Vital Status Known|356
6812683|NCT00202878|10816333|FG000|Overall Study|Lost to Follow-up|44
6812684|NCT00202878|10816334|FG001|Overall Study|Lost to Follow-up|49
6812685|NCT00202878|10816333|FG000|Overall Study|Site Closure|39
6812686|NCT00202878|10816334|FG001|Overall Study|Site Closure|36
6812687|NCT00202878|10816333|FG000|Overall Study|Withdrawal by Subject|795
6812688|NCT00202878|10816334|FG001|Overall Study|Withdrawal by Subject|808
6812689|NCT00174265|10816342|FG000|Overall Study|Adverse Event|7
6812690|NCT00174265|10816343|FG001|Overall Study|Adverse Event|4
6812691|NCT00174265|10816342|FG000|Overall Study|Lack of Efficacy|2
6812692|NCT00174265|10816343|FG001|Overall Study|Lack of Efficacy|2
6812693|NCT00174265|10816342|FG000|Overall Study|Withdrawal by Subject|3
6812694|NCT00174265|10816343|FG001|Overall Study|Withdrawal by Subject|5
6812695|NCT00174265|10816342|FG000|Overall Study|Lost to Follow-up|1
6812696|NCT00174265|10816343|FG001|Overall Study|Lost to Follow-up|0
6812697|NCT00174265|10816342|FG000|Overall Study|Other (Not specified)|16
6812698|NCT00174265|10816343|FG001|Overall Study|Other (Not specified)|10
6812699|NCT00159783|10816352|FG000|Overall Study|Adverse Event|5
6812700|NCT00159783|10816353|FG001|Overall Study|Adverse Event|7
6812701|NCT00159783|10816354|FG002|Overall Study|Adverse Event|9
6812702|NCT00159783|10816352|FG000|Overall Study|Lack of Efficacy|1
6812703|NCT00159783|10816353|FG001|Overall Study|Lack of Efficacy|2
6812704|NCT00159783|10816354|FG002|Overall Study|Lack of Efficacy|3
6812705|NCT00159783|10816352|FG000|Overall Study|Withdrawal by Subject|7
6812706|NCT00159783|10816353|FG001|Overall Study|Withdrawal by Subject|11
6812707|NCT00159783|10816354|FG002|Overall Study|Withdrawal by Subject|12
6812708|NCT00159783|10816352|FG000|Overall Study|Lost to Follow-up|6
6812709|NCT00159783|10816353|FG001|Overall Study|Lost to Follow-up|5
6812710|NCT00159783|10816354|FG002|Overall Study|Lost to Follow-up|11
6812711|NCT00159783|10816352|FG000|Overall Study|Other|0
6812712|NCT00159783|10816353|FG001|Overall Study|Other|2
6812713|NCT00159783|10816354|FG002|Overall Study|Other|4
6812714|NCT00092677|10816376|FG000|Overall Study|Lost to Follow-up|0
6812715|NCT00092677|10816377|FG001|Overall Study|Lost to Follow-up|2
6812716|NCT00092677|10816376|FG000|Overall Study|Adminstrative|5
6812717|NCT00092677|10816377|FG001|Overall Study|Adminstrative|9
6812718|NCT00090259|10816385|FG000|Overall Study|Lost to Follow-up|30
6812719|NCT00090259|10816386|FG001|Overall Study|Lost to Follow-up|26
6812720|NCT00090259|10816385|FG000|Overall Study|Withdrawal by Subject|21
6812721|NCT00090259|10816386|FG001|Overall Study|Withdrawal by Subject|15
6812722|NCT00090259|10816385|FG000|Overall Study|Investigator site closed|11
6812723|NCT00090259|10816386|FG001|Overall Study|Investigator site closed|7
6812724|NCT00003298|10816392|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1
6812725|NCT00003298|10816392|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3
6812726|NCT00003298|10816392|FG000|Surgery|Unresectable at surgery|3
6812727|NCT00003298|10816392|FG000|Surgery|Progression before surgery|2
6812728|NCT00003298|10816392|FG000|Surgery|Unevaluable and off study|2
6812729|NCT00003298|10816392|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7
6812730|NCT00003298|10816392|FG000|Re-register to Step 2 After Surgery|Positive margins|5
6812731|NCT00003298|10816392|FG000|Re-register to Step 2 After Surgery|Other complications|2
6812732|NCT00003298|10816392|FG000|Re-register to Step 2 After Surgery|Reason unknown|1
6812733|NCT00003298|10816392|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3
6812734|NCT00003298|10816392|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1
6812735|NCT00003298|10816392|FG000|Step 2 (Adjuvant Therapy)|Death|1
6812736|NCT00003298|10816392|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1
6812737|NCT00003298|10816392|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1
6812738|NCT00003298|10816392|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2
6812739|NCT00003377|10816402|FG000|Period I|Dose Limiting Toxicity(DLT)|0
6812740|NCT00003377|10816403|FG001|Period I|Dose Limiting Toxicity(DLT)|0
6812741|NCT00003377|10816404|FG002|Period I|Dose Limiting Toxicity(DLT)|1
6812742|NCT00003377|10816405|FG003|Period I|Dose Limiting Toxicity(DLT)|1
6812743|NCT00003377|10816406|FG004|Period I|Dose Limiting Toxicity(DLT)|0
6812744|NCT00003377|10816402|FG000|Period II|Ureteral stent complications|0
6812745|NCT00003377|10816403|FG001|Period II|Ureteral stent complications|0
6812746|NCT00003377|10816404|FG002|Period II|Ureteral stent complications|0
6812747|NCT00003377|10816405|FG003|Period II|Ureteral stent complications|0
6812748|NCT00003377|10816406|FG004|Period II|Ureteral stent complications|1
6812749|NCT00003389|10816421|FG000|Overall Study|Disease progression|6
6812750|NCT00003389|10816422|FG001|Overall Study|Disease progression|1
6812751|NCT00003389|10816421|FG000|Overall Study|Adverse Event|13
6812752|NCT00003389|10816422|FG001|Overall Study|Adverse Event|2
6812753|NCT00003389|10816421|FG000|Overall Study|Death|0
6812754|NCT00003389|10816422|FG001|Overall Study|Death|3
6812755|NCT00003389|10816421|FG000|Overall Study|Withdrawal by Subject|12
6812756|NCT00003389|10816422|FG001|Overall Study|Withdrawal by Subject|5
6812757|NCT00003389|10816421|FG000|Overall Study|Alternative therapy|2
6812758|NCT00003389|10816422|FG001|Overall Study|Alternative therapy|1
6812759|NCT00003389|10816421|FG000|Overall Study|Complicating disease|1
6812760|NCT00003389|10816422|FG001|Overall Study|Complicating disease|0
6812761|NCT00003389|10816421|FG000|Overall Study|Off-treatment reason missing|31
6812762|NCT00003389|10816422|FG001|Overall Study|Off-treatment reason missing|21
6812763|NCT00003389|10816421|FG000|Overall Study|Ineligible|33
6812764|NCT00003389|10816422|FG001|Overall Study|Ineligible|27
6812765|NCT00003456|10816437|FG000|Overall Study|Not evaluable|8
6812766|NCT00003457|10816441|FG000|Overall Study|Not evaluable|9
6812767|NCT00003470|10816461|FG000|Overall Study|Not evaluable|6
6812768|NCT00003471|10816465|FG000|Overall Study|Not evaluable|4
6812769|NCT00003472|10816469|FG000|Overall Study|Not evaluable|3
6812770|NCT00003473|10816473|FG000|Overall Study|Three patients were not evaluable.|3
6812771|NCT00003474|10816477|FG000|Overall Study|Not Evaluable|14
6812772|NCT00003475|10816481|FG000|Overall Study|Not evaluable|13
6812773|NCT00003476|10816486|FG000|Overall Study|Not evaluable|1
6812774|NCT00003477|10816490|FG000|Overall Study|Not evalauable|4
6812775|NCT00003483|10816494|FG000|Overall Study|Not evaluable|1
6812776|NCT00003487|10816498|FG000|Overall Study|Not evaluable|2
6812777|NCT00003492|10816502|FG000|Overall Study|Not evaluable|6
6812778|NCT00003498|10816506|FG000|Overall Study|Not evaluable.|4
6812779|NCT00003499|10816510|FG000|Overall Study|Not evaluable|8
6812780|NCT00003508|10816514|FG000|Overall Study|Not evaluable|5
6812781|NCT00003509|10816518|FG000|Overall Study|Not evaluable|5
6812782|NCT00003511|10816522|FG000|Overall Study|Not evaluable|4
6812783|NCT00003526|10816526|FG000|Overall Study|Not evaluable|6
6812784|NCT00003531|10816530|FG000|Overall Study|Not evaluable|10
6812785|NCT00003535|10816534|FG000|Overall Study|Not evaluable|5
6812786|NCT00003537|10816538|FG000|Overall Study|Not evalauable|1
6812787|NCT00003590|10816542|FG000|Overall Study|Ineligible Patient|1
6812788|NCT00003590|10816542|FG000|Overall Study|Adverse Event|7
6812789|NCT00003590|10816542|FG000|Overall Study|Withdrawal by Subject|1
6812790|NCT00003590|10816542|FG000|Overall Study|Lack of Efficacy|11
6812791|NCT00003590|10816542|FG000|Overall Study|Death|1
6812792|NCT00003590|10816542|FG000|Overall Study|Physician Decision|1
6812793|NCT00003631|10816549|FG000|Overall Study|Patient not treated|1
6812794|NCT00003631|10816550|FG001|Overall Study|Patient not treated|0
6812795|NCT00003631|10816551|FG002|Overall Study|Patient not treated|1
6812796|NCT00003631|10816549|FG000|Overall Study|Protocol Violation|1
6812797|NCT00003631|10816550|FG001|Overall Study|Protocol Violation|0
6812798|NCT00003631|10816551|FG002|Overall Study|Protocol Violation|0
6812799|NCT00003631|10816549|FG000|Overall Study|Adverse Event|1
6812800|NCT00003631|10816550|FG001|Overall Study|Adverse Event|1
6812801|NCT00003631|10816551|FG002|Overall Study|Adverse Event|5
6812802|NCT00003631|10816549|FG000|Overall Study|Death|0
6812803|NCT00003631|10816550|FG001|Overall Study|Death|0
6812804|NCT00003631|10816551|FG002|Overall Study|Death|1
6812805|NCT00003631|10816549|FG000|Overall Study|Evaluable for toxicity only|0
6812806|NCT00003631|10816550|FG001|Overall Study|Evaluable for toxicity only|0
6812807|NCT00003631|10816551|FG002|Overall Study|Evaluable for toxicity only|2
6812808|NCT00003645|10816572|FG000|Overall Study|Death|4
6812809|NCT00003645|10816573|FG001|Overall Study|Death|1
6812810|NCT00003645|10816572|FG000|Overall Study|Lost to Follow-up|7
6812811|NCT00003645|10816573|FG001|Overall Study|Lost to Follow-up|8
6812812|NCT00003645|10816572|FG000|Overall Study|Withdrawal by Subject|1
6812813|NCT00003645|10816573|FG001|Overall Study|Withdrawal by Subject|3
6812814|NCT00003659|10816581|FG000|Overall Study|Withdrawal by Subject|3
6812815|NCT00003702|10816587|FG000|Overall Study|Ineligible cell types|2
6812816|NCT00003702|10816588|FG001|Overall Study|Ineligible cell types|2
6812817|NCT00003702|10816587|FG000|Overall Study|Did not meet criteria for persistence|8
6812818|NCT00003702|10816588|FG001|Overall Study|Did not meet criteria for persistence|5
6812819|NCT00003702|10816587|FG000|Overall Study|WHO score > 6|2
6812820|NCT00003702|10816588|FG001|Overall Study|WHO score > 6|1
6812821|NCT00003702|10816587|FG000|Overall Study|Inadequate documentation of disease|1
6812822|NCT00003702|10816588|FG001|Overall Study|Inadequate documentation of disease|3
6812823|NCT00003782|10816598|FG000|Overall Study|No follow up data|30
6812824|NCT00003782|10816599|FG001|Overall Study|No follow up data|31
6812825|NCT00003782|10816600|FG002|Overall Study|No follow up data|26
6812826|NCT00003830|10816638|FG000|Overall Study|No follow up data|3
6812827|NCT00003830|10816639|FG001|Overall Study|No follow up data|0
6812828|NCT00003830|10816638|FG000|Overall Study|Sentinel node positive patients|829
6812829|NCT00003830|10816639|FG001|Overall Study|Sentinel node positive patients|793
6812830|NCT00003869|10816649|FG000|Overall Study|Adverse Event|14
6812831|NCT00003869|10816650|FG001|Overall Study|Adverse Event|3
6812832|NCT00003869|10816649|FG000|Overall Study|Withdrawal by Subject|21
6812833|NCT00003869|10816650|FG001|Overall Study|Withdrawal by Subject|3
6812834|NCT00003869|10816649|FG000|Overall Study|Death|1
6812835|NCT00003869|10816650|FG001|Overall Study|Death|2
6812836|NCT00003869|10816649|FG000|Overall Study|Alternative treatmnt, medical problems|5
6812837|NCT00003869|10816650|FG001|Overall Study|Alternative treatmnt, medical problems|4
6812838|NCT00003875|10816656|FG000|Overall Study|Screen Failed|1
6812839|NCT00003895|10816662|FG000|Overall Study|Adverse Event|4
6812840|NCT00003895|10816663|FG001|Overall Study|Adverse Event|0
6812841|NCT00003895|10816662|FG000|Overall Study|Lack of Efficacy|1
6812842|NCT00003895|10816663|FG001|Overall Study|Lack of Efficacy|1
6812843|NCT00003895|10816662|FG000|Overall Study|Patient Vacation|2
6812844|NCT00003895|10816663|FG001|Overall Study|Patient Vacation|0
6812845|NCT00003895|10816662|FG000|Overall Study|Withdrawal by Subject|0
6812846|NCT00003895|10816663|FG001|Overall Study|Withdrawal by Subject|3
6812847|NCT00003896|10816669|FG000|Overall Study|Adverse Event|16
6812848|NCT00003896|10816669|FG000|Overall Study|Withdrawal by Subject|1
6812849|NCT00003896|10816669|FG000|Overall Study|Lack of Efficacy|1
6812850|NCT00003896|10816669|FG000|Overall Study|Death|3
6812851|NCT00003896|10816669|FG000|Overall Study|not protocol specified|3
6812852|NCT00003896|10816669|FG000|Overall Study|ineligible|5
6812853|NCT00003901|10816674|FG000|Overall Study|Adverse Event|1
6812854|NCT00003901|10816674|FG000|Overall Study|Withdrawal by Subject|1
6812855|NCT00003901|10816674|FG000|Overall Study|Ineligible|6
6812856|NCT00003901|10816674|FG000|Overall Study|CT Scan not within protocol requirement|2
6812857|NCT00003901|10816674|FG000|Overall Study|Chest X-Ray not done prior registration|1
6812858|NCT00003901|10816674|FG000|Overall Study|Medical problems|6
6812859|NCT00003907|10816683|FG000|Overall Study|Adverse Event|2
6812860|NCT00003907|10816684|FG001|Overall Study|Adverse Event|11
6812861|NCT00003907|10816683|FG000|Overall Study|Death|2
6812862|NCT00003907|10816684|FG001|Overall Study|Death|0
6812863|NCT00003907|10816683|FG000|Overall Study|Withdrawal by Subject|1
6812864|NCT00003907|10816684|FG001|Overall Study|Withdrawal by Subject|3
6812865|NCT00003907|10816683|FG000|Overall Study|Progressive disease|4
6812866|NCT00003907|10816684|FG001|Overall Study|Progressive disease|4
6812867|NCT00003907|10816683|FG000|Overall Study|Complicating disease|1
6812868|NCT00003907|10816684|FG001|Overall Study|Complicating disease|0
6812869|NCT00003907|10816683|FG000|Overall Study|Other|1
6812870|NCT00003907|10816684|FG001|Overall Study|Other|3
6812871|NCT00003907|10816683|FG000|Overall Study|ineligible or not treated|2
6812872|NCT00003907|10816684|FG001|Overall Study|ineligible or not treated|2
6812873|NCT00004031|10816699|FG000|Overall Study|Adverse Event|5
6812874|NCT00004031|10816700|FG001|Overall Study|Adverse Event|0
6812875|NCT00004031|10816699|FG000|Overall Study|Refusal unrelated to adverse events|2
6812876|NCT00004031|10816700|FG001|Overall Study|Refusal unrelated to adverse events|11
6812877|NCT00004031|10816699|FG000|Overall Study|Progression/relapse|9
6812878|NCT00004031|10816700|FG001|Overall Study|Progression/relapse|4
6812879|NCT00004031|10816699|FG000|Overall Study|Death|3
6812880|NCT00004031|10816700|FG001|Overall Study|Death|1
6812881|NCT00004031|10816699|FG000|Overall Study|Other- not protocol specified|3
6812882|NCT00004031|10816700|FG001|Overall Study|Other- not protocol specified|3
6812883|NCT00004031|10816699|FG000|Overall Study|Reason under review|3
6812884|NCT00004031|10816700|FG001|Overall Study|Reason under review|2
6812885|NCT00004088|10816717|FG000|Overall Study|No C2 given due to study on hold by IRB|4
6812886|NCT00004088|10816717|FG000|Overall Study|Withdrawal by Subject|1
6812887|NCT00004088|10816717|FG000|Overall Study|Protocol Violation|3
6812888|NCT00004088|10816717|FG000|Overall Study|Physician Decision|1
6812889|NCT00004124|10816732|FG000|Overall Study|Received no protocol therapy|12
6812890|NCT00004124|10816733|FG001|Overall Study|Received no protocol therapy|20
6812891|NCT00004228|10816756|FG000|Overall Study|Adverse Event|0
6812892|NCT00004228|10816757|FG001|Overall Study|Adverse Event|1
6812893|NCT00004228|10816758|FG002|Overall Study|Adverse Event|0
6812894|NCT00004228|10816759|FG003|Overall Study|Adverse Event|0
6812895|NCT00004228|10816760|FG004|Overall Study|Adverse Event|1
6812896|NCT00004228|10816761|FG005|Overall Study|Adverse Event|0
6812897|NCT00004228|10816762|FG006|Overall Study|Adverse Event|0
6812898|NCT00004228|10816756|FG000|Overall Study|Death|0
6812899|NCT00004228|10816757|FG001|Overall Study|Death|1
6812900|NCT00004228|10816758|FG002|Overall Study|Death|2
6812901|NCT00004228|10816759|FG003|Overall Study|Death|0
6812902|NCT00004228|10816760|FG004|Overall Study|Death|1
6812903|NCT00004228|10816761|FG005|Overall Study|Death|0
6812904|NCT00004228|10816762|FG006|Overall Study|Death|0
6812905|NCT00004228|10816756|FG000|Overall Study|Lack of Efficacy|1
6812906|NCT00004228|10816757|FG001|Overall Study|Lack of Efficacy|6
6812907|NCT00004228|10816758|FG002|Overall Study|Lack of Efficacy|5
6812908|NCT00004228|10816759|FG003|Overall Study|Lack of Efficacy|3
6812909|NCT00004228|10816760|FG004|Overall Study|Lack of Efficacy|9
6812910|NCT00004228|10816761|FG005|Overall Study|Lack of Efficacy|8
6812911|NCT00004228|10816762|FG006|Overall Study|Lack of Efficacy|4
6812912|NCT00004228|10816756|FG000|Overall Study|Lost to Follow-up|0
6812913|NCT00004228|10816757|FG001|Overall Study|Lost to Follow-up|0
6812914|NCT00004228|10816758|FG002|Overall Study|Lost to Follow-up|1
6812915|NCT00004228|10816759|FG003|Overall Study|Lost to Follow-up|0
6812916|NCT00004228|10816760|FG004|Overall Study|Lost to Follow-up|0
6812917|NCT00004228|10816761|FG005|Overall Study|Lost to Follow-up|0
6812918|NCT00004228|10816762|FG006|Overall Study|Lost to Follow-up|0
6812919|NCT00004228|10816756|FG000|Overall Study|Physician Decision|1
6812920|NCT00004228|10816757|FG001|Overall Study|Physician Decision|0
6812921|NCT00004228|10816758|FG002|Overall Study|Physician Decision|3
6812922|NCT00004228|10816759|FG003|Overall Study|Physician Decision|2
6812923|NCT00004228|10816760|FG004|Overall Study|Physician Decision|1
6812924|NCT00004228|10816761|FG005|Overall Study|Physician Decision|1
6812925|NCT00004228|10816762|FG006|Overall Study|Physician Decision|1
6812926|NCT00004228|10816756|FG000|Overall Study|Protocol Violation|0
6812927|NCT00004228|10816757|FG001|Overall Study|Protocol Violation|5
6812928|NCT00004228|10816758|FG002|Overall Study|Protocol Violation|2
6812929|NCT00004228|10816759|FG003|Overall Study|Protocol Violation|1
6812930|NCT00004228|10816760|FG004|Overall Study|Protocol Violation|1
6812931|NCT00004228|10816761|FG005|Overall Study|Protocol Violation|2
6812932|NCT00004228|10816762|FG006|Overall Study|Protocol Violation|0
6812933|NCT00004228|10816756|FG000|Overall Study|Withdrawal by Subject|3
6812934|NCT00004228|10816757|FG001|Overall Study|Withdrawal by Subject|0
6812935|NCT00004228|10816758|FG002|Overall Study|Withdrawal by Subject|1
6812936|NCT00004228|10816759|FG003|Overall Study|Withdrawal by Subject|0
6812937|NCT00004228|10816760|FG004|Overall Study|Withdrawal by Subject|2
6812938|NCT00004228|10816761|FG005|Overall Study|Withdrawal by Subject|1
6812939|NCT00004228|10816762|FG006|Overall Study|Withdrawal by Subject|2
6812940|NCT00004228|10816756|FG000|Overall Study|Other|0
6812941|NCT00004228|10816757|FG001|Overall Study|Other|0
6812942|NCT00004228|10816758|FG002|Overall Study|Other|1
6812943|NCT00004228|10816759|FG003|Overall Study|Other|0
6812944|NCT00004228|10816760|FG004|Overall Study|Other|0
6812945|NCT00004228|10816761|FG005|Overall Study|Other|0
6812946|NCT00004228|10816762|FG006|Overall Study|Other|0
6812947|NCT00004228|10816756|FG000|Overall Study|ineligible|4
6812948|NCT00004228|10816757|FG001|Overall Study|ineligible|2
6812949|NCT00004228|10816758|FG002|Overall Study|ineligible|4
6812950|NCT00004228|10816759|FG003|Overall Study|ineligible|1
6812951|NCT00004228|10816760|FG004|Overall Study|ineligible|1
6812952|NCT00004228|10816761|FG005|Overall Study|ineligible|2
6812953|NCT00004228|10816762|FG006|Overall Study|ineligible|5
6812954|NCT00004259|10816783|FG000|Overall Study|Protocol Violation|1
6812955|NCT00004259|10816784|FG001|Overall Study|Protocol Violation|2
6812956|NCT00004259|10816785|FG002|Overall Study|Protocol Violation|0
6812957|NCT00004259|10816786|FG003|Overall Study|Protocol Violation|0
6812958|NCT00004259|10816783|FG000|Overall Study|Withdrawal by Subject|0
6812959|NCT00004259|10816784|FG001|Overall Study|Withdrawal by Subject|2
6812960|NCT00004259|10816785|FG002|Overall Study|Withdrawal by Subject|0
6812961|NCT00004259|10816786|FG003|Overall Study|Withdrawal by Subject|0
6812962|NCT00004412|10816802|FG000|Randomized Period|Moved to Crossover Period|3
6812963|NCT00004412|10816803|FG001|Randomized Period|Moved to Crossover Period|0
6812964|NCT00004412|10816804|FG002|Randomized Period|Moved to Crossover Period|0
6812965|NCT00004445|10816814|FG000|Overall Study|Physician Decision|2
6812966|NCT00004445|10816814|FG000|Overall Study|Withdrawal by Subject|1
6812967|NCT00004562|10816843|FG000|Overall Study|Lost to Follow-up|102
6812968|NCT00004562|10816844|FG001|Overall Study|Lost to Follow-up|91
6812969|NCT00004563|10816852|FG000|Overall Study|Withdrawal by Subject|20
6812970|NCT00004563|10816853|FG001|Overall Study|Withdrawal by Subject|16
6812971|NCT00004563|10816852|FG000|Overall Study|Lack of Efficacy|3
6812972|NCT00004563|10816853|FG001|Overall Study|Lack of Efficacy|5
6812973|NCT00004563|10816852|FG000|Overall Study|Death|2
6812974|NCT00004563|10816853|FG001|Overall Study|Death|3
6812975|NCT00004635|10816861|FG000|Period One|refused|2
6812976|NCT00004635|10816862|FG001|Period One|refused|1
6812977|NCT00004635|10816861|FG000|Period One|Withdrawal by Subject|1
6812978|NCT00004635|10816862|FG001|Period One|Withdrawal by Subject|1
6812979|NCT00004635|10816861|FG000|Period One|Protocol Violation|1
6812980|NCT00004635|10816862|FG001|Period One|Protocol Violation|0
6812981|NCT00004635|10816861|FG000|Period One|PSA did not go <5 ng/mL|1
6812982|NCT00004635|10816862|FG001|Period One|PSA did not go <5 ng/mL|0
6812983|NCT00004635|10816861|FG000|Period One|second malignancy|1
6812984|NCT00004635|10816862|FG001|Period One|second malignancy|0
6812985|NCT00004635|10816861|FG000|Period One|progressed|0
6812986|NCT00004635|10816862|FG001|Period One|progressed|2
6812987|NCT00004635|10816861|FG000|Period One|health problem|0
6812988|NCT00004635|10816862|FG001|Period One|health problem|1
6812989|NCT00004635|10816861|FG000|Period One|discrepancy in data entry|0
6812990|NCT00004635|10816862|FG001|Period One|discrepancy in data entry|1
6812991|NCT00004635|10816861|FG000|Period Two|progression|2
6812992|NCT00004635|10816862|FG001|Period Two|progression|3
6812993|NCT00004635|10816861|FG000|Period Two|Adverse Event|1
6812994|NCT00004635|10816862|FG001|Period Two|Adverse Event|0
6812995|NCT00004635|10816861|FG000|Period Two|refused|0
6812996|NCT00004635|10816862|FG001|Period Two|refused|2
6812997|NCT00004635|10816861|FG000|Period Two|health problem|1
6812998|NCT00004635|10816862|FG001|Period Two|health problem|1
6812999|NCT00004635|10816861|FG000|Period Two|travel issues|0
6813000|NCT00004635|10816862|FG001|Period Two|travel issues|1
6813001|NCT00004635|10816861|FG000|Period Two|secondary malignancy|1
6813002|NCT00004635|10816862|FG001|Period Two|secondary malignancy|1
6813003|NCT00004635|10816861|FG000|Period Two|Lost to Follow-up|1
6813004|NCT00004635|10816862|FG001|Period Two|Lost to Follow-up|0
6813005|NCT00004635|10816861|FG000|Period Two|discrepancy in data entry|0
6813006|NCT00004635|10816862|FG001|Period Two|discrepancy in data entry|1
6813007|NCT00004732|10816873|FG000|Overall Study|Withdrawal by Subject|36
6813008|NCT00004732|10816874|FG001|Overall Study|Withdrawal by Subject|64
6813009|NCT00004732|10816873|FG000|Overall Study|Lost to Follow-up|33
6813010|NCT00004732|10816874|FG001|Overall Study|Lost to Follow-up|47
6813011|NCT00004859|10816884|FG000|Overall Study|Lack of Efficacy|43
6813012|NCT00004859|10816885|FG001|Overall Study|Lack of Efficacy|113
6813013|NCT00004859|10816884|FG000|Overall Study|Adverse Event|31
6813014|NCT00004859|10816885|FG001|Overall Study|Adverse Event|93
6813015|NCT00004859|10816884|FG000|Overall Study|Death|5
6813016|NCT00004859|10816885|FG001|Overall Study|Death|5
6813017|NCT00004859|10816884|FG000|Overall Study|Withdrawal by Subject|7
6813018|NCT00004859|10816885|FG001|Overall Study|Withdrawal by Subject|33
6813019|NCT00004859|10816884|FG000|Overall Study|Protocol Violation|2
6813020|NCT00004859|10816885|FG001|Overall Study|Protocol Violation|2
6813021|NCT00004859|10816884|FG000|Overall Study|other disease|0
6813022|NCT00004859|10816885|FG001|Overall Study|other disease|3
6813023|NCT00004859|10816884|FG000|Overall Study|error|3
6813024|NCT00004859|10816885|FG001|Overall Study|error|1
6813025|NCT00004859|10816884|FG000|Overall Study|missing data|14
6813026|NCT00004859|10816885|FG001|Overall Study|missing data|11
6813027|NCT00004859|10816884|FG000|Overall Study|Other|13
6813028|NCT00004859|10816885|FG001|Overall Study|Other|21
6813029|NCT00004888|10816895|FG000|Overall Study|Adverse Event|5
6813030|NCT00004888|10816896|FG001|Overall Study|Adverse Event|10
6813031|NCT00004888|10816895|FG000|Overall Study|Withdrawal by Subject|0
6813032|NCT00004888|10816896|FG001|Overall Study|Withdrawal by Subject|3
6813033|NCT00004888|10816895|FG000|Overall Study|Physician Decision|1
6813034|NCT00004888|10816896|FG001|Overall Study|Physician Decision|1
6813035|NCT00004888|10816895|FG000|Overall Study|Progressive Disease|4
6813036|NCT00004888|10816896|FG001|Overall Study|Progressive Disease|9
6813037|NCT00004888|10816895|FG000|Overall Study|Death without progressive disease|0
6813038|NCT00004888|10816896|FG001|Overall Study|Death without progressive disease|1
6813039|NCT00004888|10816895|FG000|Overall Study|Toxic death|1
6813040|NCT00004888|10816896|FG001|Overall Study|Toxic death|0
6813041|NCT00004978|10816904|FG000|Overall Study|Death|107
6813042|NCT00004978|10816905|FG001|Overall Study|Death|116
6813043|NCT00004978|10816904|FG000|Overall Study|Lost to Follow-up|101
6813044|NCT00004978|10816905|FG001|Overall Study|Lost to Follow-up|108
6813045|NCT00004978|10816904|FG000|Overall Study|Withdrawal by Subject|17
6813046|NCT00004978|10816905|FG001|Overall Study|Withdrawal by Subject|26
6813047|NCT00004978|10816904|FG000|Overall Study|site closure - not in analysis cohort|19
6813048|NCT00004978|10816905|FG001|Overall Study|site closure - not in analysis cohort|20
6813049|NCT00004980|10816913|FG000|Overall Study|Withdrawal by Subject|1
6813050|NCT00004980|10816914|FG001|Overall Study|Withdrawal by Subject|0
6813051|NCT00004980|10816913|FG000|Overall Study|memory difficulties|1
6813052|NCT00004980|10816914|FG001|Overall Study|memory difficulties|1
6813053|NCT00004980|10816913|FG000|Overall Study|Physician Decision|0
6813054|NCT00004980|10816914|FG001|Overall Study|Physician Decision|1
6813055|NCT00005047|10816924|FG000|Overall Study|Withdrawal by Subject|12
6813056|NCT00005047|10816925|FG001|Overall Study|Withdrawal by Subject|0
6813057|NCT00005047|10816926|FG002|Overall Study|Withdrawal by Subject|0
6813058|NCT00005047|10816927|FG003|Overall Study|Withdrawal by Subject|0
6813059|NCT00005047|10816924|FG000|Overall Study|Adverse Event|5
6813060|NCT00005047|10816925|FG001|Overall Study|Adverse Event|0
6813061|NCT00005047|10816926|FG002|Overall Study|Adverse Event|0
6813062|NCT00005047|10816927|FG003|Overall Study|Adverse Event|0
6813063|NCT00005047|10816924|FG000|Overall Study|Lost to Follow-up|1
6813064|NCT00005047|10816925|FG001|Overall Study|Lost to Follow-up|0
6813065|NCT00005047|10816926|FG002|Overall Study|Lost to Follow-up|0
6813066|NCT00005047|10816927|FG003|Overall Study|Lost to Follow-up|0
6813067|NCT00005047|10816924|FG000|Overall Study|Lack of Efficacy|1
6813068|NCT00005047|10816925|FG001|Overall Study|Lack of Efficacy|0
6813069|NCT00005047|10816926|FG002|Overall Study|Lack of Efficacy|0
6813070|NCT00005047|10816927|FG003|Overall Study|Lack of Efficacy|0
6813071|NCT00005879|10816955|FG000|Overall Study|Withdrawal by Subject|8
6813072|NCT00005879|10816956|FG001|Overall Study|Withdrawal by Subject|10
6813073|NCT00005906|10816971|FG000|Overall Study|Lack of Efficacy|3
6813074|NCT00005908|10816975|FG000|Overall Study|Withdrawal by Subject|1
6813075|NCT00005908|10816976|FG001|Overall Study|Withdrawal by Subject|0
6813076|NCT00005937|10816985|FG000|Overall Study|Lack of Efficacy|5
6813077|NCT00005947|10816991|FG000|Overall Study|Death|54
6813078|NCT00005947|10816992|FG001|Overall Study|Death|40
6813079|NCT00005947|10816991|FG000|Overall Study|Patient Refused to Continue|2
6813080|NCT00005947|10816992|FG001|Overall Study|Patient Refused to Continue|1
6813081|NCT00005947|10816991|FG000|Overall Study|Site Closure|1
6813082|NCT00005947|10816992|FG001|Overall Study|Site Closure|0
6813083|NCT00005957|10817002|FG000|Overall Study|No treated|3
6813084|NCT00005957|10817003|FG001|Overall Study|No treated|9
6813085|NCT00005957|10817002|FG000|Overall Study|Crossover to the other arm|5
6813086|NCT00005957|10817003|FG001|Overall Study|Crossover to the other arm|19
6813087|NCT00006011|10817012|FG000|Overall Study|Disease progression|13
6813088|NCT00006011|10817013|FG001|Overall Study|Disease progression|6
6813089|NCT00006011|10817014|FG002|Overall Study|Disease progression|26
6813090|NCT00006011|10817012|FG000|Overall Study|Refused further treatment|15
6813091|NCT00006011|10817013|FG001|Overall Study|Refused further treatment|13
6813092|NCT00006011|10817014|FG002|Overall Study|Refused further treatment|26
6813093|NCT00006011|10817012|FG000|Overall Study|Adverse Event|15
6813094|NCT00006011|10817013|FG001|Overall Study|Adverse Event|39
6813095|NCT00006011|10817014|FG002|Overall Study|Adverse Event|5
6813096|NCT00006011|10817012|FG000|Overall Study|Death|0
6813097|NCT00006011|10817013|FG001|Overall Study|Death|1
6813098|NCT00006011|10817014|FG002|Overall Study|Death|2
6813099|NCT00006011|10817012|FG000|Overall Study|Other|4
6813100|NCT00006011|10817013|FG001|Overall Study|Other|2
6813101|NCT00006011|10817014|FG002|Overall Study|Other|5
6813102|NCT00006011|10817012|FG000|Overall Study|Ineligible|18
6813103|NCT00006011|10817013|FG001|Overall Study|Ineligible|16
6813104|NCT00006011|10817014|FG002|Overall Study|Ineligible|9
6813105|NCT00006046|10817025|FG000|Overall Study|Adverse Event|3
6813106|NCT00006046|10817026|FG001|Overall Study|Adverse Event|0
6813107|NCT00006046|10817027|FG002|Overall Study|Adverse Event|0
6813108|NCT00006046|10817028|FG003|Overall Study|Adverse Event|0
6813109|NCT00006046|10817029|FG004|Overall Study|Adverse Event|0
6813110|NCT00006046|10817025|FG000|Overall Study|Disease Progression|2
6813111|NCT00006046|10817026|FG001|Overall Study|Disease Progression|0
6813112|NCT00006046|10817027|FG002|Overall Study|Disease Progression|0
6813113|NCT00006046|10817028|FG003|Overall Study|Disease Progression|0
6813114|NCT00006046|10817029|FG004|Overall Study|Disease Progression|0
6813115|NCT00006164|10817093|FG000|Overall Study|Withdrew or lost to follow-up|70
6813116|NCT00006164|10817094|FG001|Overall Study|Withdrew or lost to follow-up|81
6813117|NCT04323800|10817119|FG000|Overall Study|Withdrawal by Subject|4
6813118|NCT04323800|10817120|FG001|Overall Study|Withdrawal by Subject|4
6813119|NCT04323800|10817119|FG000|Overall Study|Incomplete transfusion|1
6813120|NCT04323800|10817120|FG001|Overall Study|Incomplete transfusion|0
6813121|NCT04323800|10817119|FG000|Overall Study|Other|0
6813122|NCT04323800|10817120|FG001|Overall Study|Other|1
6813123|NCT04323800|10817119|FG000|Overall Study|Positive RT-PCR at transfusion|1
6813124|NCT04323800|10817120|FG001|Overall Study|Positive RT-PCR at transfusion|1
6813125|NCT04110145|10817140|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0
6813126|NCT04110145|10817141|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0
6813127|NCT04110145|10817142|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0
6813128|NCT04110145|10817143|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1
6813129|NCT04110145|10817144|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0
6813130|NCT03986866|10817158|FG000|Overall Study|Withdrawal by Subject|0
6813131|NCT03986866|10817159|FG001|Overall Study|Withdrawal by Subject|3
6813132|NCT03986866|10817158|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2
6813133|NCT03986866|10817159|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2
6813134|NCT03636269|10817167|FG000|Period 1: Double-blind Phase|Adverse Event|13
6813135|NCT03636269|10817168|FG001|Period 1: Double-blind Phase|Adverse Event|7
6813136|NCT03636269|10817169|FG002|Period 1: Double-blind Phase|Adverse Event|0
6813137|NCT03636269|10817167|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1
6813138|NCT03636269|10817168|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0
6813139|NCT03636269|10817169|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0
6813140|NCT03636269|10817167|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2
6813141|NCT03636269|10817168|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0
6813142|NCT03636269|10817169|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0
6813143|NCT03636269|10817167|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5
6813144|NCT03636269|10817168|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1
6813145|NCT03636269|10817169|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0
6813146|NCT03636269|10817167|FG000|Period 1: Double-blind Phase|Other|6
6813147|NCT03636269|10817168|FG001|Period 1: Double-blind Phase|Other|3
6813148|NCT03636269|10817169|FG002|Period 1: Double-blind Phase|Other|0
6813149|NCT03636269|10817167|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1
6813150|NCT03636269|10817168|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0
6813151|NCT03636269|10817169|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0
6813152|NCT03636269|10817167|FG000|Period 1: Double-blind Phase|Subject non-compliance|1
6813153|NCT03636269|10817168|FG001|Period 1: Double-blind Phase|Subject non-compliance|2
6813154|NCT03636269|10817169|FG002|Period 1: Double-blind Phase|Subject non-compliance|0
6813155|NCT03636269|10817167|FG000|Period 2: Open-label Phase|Adverse Event|0
6813156|NCT03636269|10817168|FG001|Period 2: Open-label Phase|Adverse Event|0
6813157|NCT03636269|10817169|FG002|Period 2: Open-label Phase|Adverse Event|21
6813158|NCT03636269|10817167|FG000|Period 2: Open-label Phase|Lack of Efficacy|0
6813159|NCT03636269|10817168|FG001|Period 2: Open-label Phase|Lack of Efficacy|0
6813160|NCT03636269|10817169|FG002|Period 2: Open-label Phase|Lack of Efficacy|2
6813161|NCT03636269|10817167|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0
6813162|NCT03636269|10817168|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0
6813163|NCT03636269|10817169|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2
6813164|NCT03636269|10817167|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0
6813165|NCT03636269|10817168|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0
6813166|NCT03636269|10817169|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11
6813167|NCT03636269|10817167|FG000|Period 2: Open-label Phase|Administrative|0
6813168|NCT03636269|10817168|FG001|Period 2: Open-label Phase|Administrative|0
6813169|NCT03636269|10817169|FG002|Period 2: Open-label Phase|Administrative|36
6813170|NCT03636269|10817167|FG000|Period 2: Open-label Phase|Other|0
6813171|NCT03636269|10817168|FG001|Period 2: Open-label Phase|Other|0
6813172|NCT03636269|10817169|FG002|Period 2: Open-label Phase|Other|9
6813173|NCT03636269|10817167|FG000|Period 2: Open-label Phase|Sponsor stopping study|0
6813174|NCT03636269|10817168|FG001|Period 2: Open-label Phase|Sponsor stopping study|0
6813175|NCT03636269|10817169|FG002|Period 2: Open-label Phase|Sponsor stopping study|313
6813176|NCT03447314|10817209|FG000|Part 1 (Up to 27 Months)|Death|6
6813177|NCT03447314|10817210|FG001|Part 1 (Up to 27 Months)|Death|5
6813178|NCT03447314|10817211|FG002|Part 1 (Up to 27 Months)|Death|3
6813179|NCT03447314|10817212|FG003|Part 1 (Up to 27 Months)|Death|3
6813180|NCT03447314|10817213|FG004|Part 1 (Up to 27 Months)|Death|0
6813181|NCT03447314|10817214|FG005|Part 1 (Up to 27 Months)|Death|4
6813182|NCT03447314|10817215|FG006|Part 1 (Up to 27 Months)|Death|3
6813183|NCT03447314|10817216|FG007|Part 1 (Up to 27 Months)|Death|0
6813184|NCT03447314|10817217|FG008|Part 1 (Up to 27 Months)|Death|0
6813185|NCT03447314|10817218|FG009|Part 1 (Up to 27 Months)|Death|0
6813186|NCT03447314|10817219|FG010|Part 1 (Up to 27 Months)|Death|4
6813187|NCT03447314|10817220|FG011|Part 1 (Up to 27 Months)|Death|2
6813188|NCT03447314|10817221|FG012|Part 1 (Up to 27 Months)|Death|0
6813189|NCT03447314|10817222|FG013|Part 1 (Up to 27 Months)|Death|0
6813190|NCT03447314|10817223|FG014|Part 1 (Up to 27 Months)|Death|0
6813191|NCT03447314|10817224|FG015|Part 1 (Up to 27 Months)|Death|0
6813192|NCT03447314|10817225|FG016|Part 1 (Up to 27 Months)|Death|0
6813193|NCT03447314|10817226|FG017|Part 1 (Up to 27 Months)|Death|0
6813194|NCT03447314|10817209|FG000|Part 1 (Up to 27 Months)|Ongoing in the study|2
6813195|NCT03447314|10817210|FG001|Part 1 (Up to 27 Months)|Ongoing in the study|1
6813196|NCT03447314|10817211|FG002|Part 1 (Up to 27 Months)|Ongoing in the study|3
6813197|NCT03447314|10817212|FG003|Part 1 (Up to 27 Months)|Ongoing in the study|1
6813198|NCT03447314|10817213|FG004|Part 1 (Up to 27 Months)|Ongoing in the study|2
6813199|NCT03447314|10817214|FG005|Part 1 (Up to 27 Months)|Ongoing in the study|1
6813200|NCT03447314|10817215|FG006|Part 1 (Up to 27 Months)|Ongoing in the study|2
6813201|NCT03447314|10817216|FG007|Part 1 (Up to 27 Months)|Ongoing in the study|0
6813202|NCT03447314|10817217|FG008|Part 1 (Up to 27 Months)|Ongoing in the study|0
6813203|NCT03447314|10817218|FG009|Part 1 (Up to 27 Months)|Ongoing in the study|0
6813204|NCT03447314|10817219|FG010|Part 1 (Up to 27 Months)|Ongoing in the study|3
6813205|NCT03447314|10817220|FG011|Part 1 (Up to 27 Months)|Ongoing in the study|4
6813206|NCT03447314|10817221|FG012|Part 1 (Up to 27 Months)|Ongoing in the study|0
6813207|NCT03447314|10817222|FG013|Part 1 (Up to 27 Months)|Ongoing in the study|0
6813208|NCT03447314|10817223|FG014|Part 1 (Up to 27 Months)|Ongoing in the study|0
6813209|NCT03447314|10817224|FG015|Part 1 (Up to 27 Months)|Ongoing in the study|0
6813210|NCT03447314|10817225|FG016|Part 1 (Up to 27 Months)|Ongoing in the study|0
6813211|NCT03447314|10817226|FG017|Part 1 (Up to 27 Months)|Ongoing in the study|0
6813212|NCT03447314|10817209|FG000|Part 1 (Up to 27 Months)|Withdrawal by Subject|1
6813213|NCT03447314|10817210|FG001|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
6813214|NCT03447314|10817211|FG002|Part 1 (Up to 27 Months)|Withdrawal by Subject|1
6813215|NCT03447314|10817212|FG003|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
6813216|NCT03447314|10817213|FG004|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
6813217|NCT03447314|10817214|FG005|Part 1 (Up to 27 Months)|Withdrawal by Subject|1
6813218|NCT03447314|10817215|FG006|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
6813219|NCT03447314|10817216|FG007|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
6813220|NCT03447314|10817217|FG008|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
6813221|NCT03447314|10817218|FG009|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
6813222|NCT03447314|10817219|FG010|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
6813223|NCT03447314|10817220|FG011|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
6813224|NCT03447314|10817221|FG012|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
6813225|NCT03447314|10817222|FG013|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
6813226|NCT03447314|10817223|FG014|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
6813227|NCT03447314|10817224|FG015|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
6813228|NCT03447314|10817225|FG016|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
6813229|NCT03447314|10817226|FG017|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
6813230|NCT03447314|10817209|FG000|Part 1 (Up to 27 Months)|Disease progression|0
6813231|NCT03447314|10817210|FG001|Part 1 (Up to 27 Months)|Disease progression|0
6813232|NCT03447314|10817211|FG002|Part 1 (Up to 27 Months)|Disease progression|1
6813233|NCT03447314|10817212|FG003|Part 1 (Up to 27 Months)|Disease progression|0
6813234|NCT03447314|10817213|FG004|Part 1 (Up to 27 Months)|Disease progression|0
6813235|NCT03447314|10817214|FG005|Part 1 (Up to 27 Months)|Disease progression|0
6813236|NCT03447314|10817215|FG006|Part 1 (Up to 27 Months)|Disease progression|0
6813237|NCT03447314|10817216|FG007|Part 1 (Up to 27 Months)|Disease progression|0
6813238|NCT03447314|10817217|FG008|Part 1 (Up to 27 Months)|Disease progression|0
6813239|NCT03447314|10817218|FG009|Part 1 (Up to 27 Months)|Disease progression|0
6813240|NCT03447314|10817219|FG010|Part 1 (Up to 27 Months)|Disease progression|0
6813241|NCT03447314|10817220|FG011|Part 1 (Up to 27 Months)|Disease progression|0
6813242|NCT03447314|10817221|FG012|Part 1 (Up to 27 Months)|Disease progression|0
6813243|NCT03447314|10817222|FG013|Part 1 (Up to 27 Months)|Disease progression|0
6813244|NCT03447314|10817223|FG014|Part 1 (Up to 27 Months)|Disease progression|0
6813245|NCT03447314|10817224|FG015|Part 1 (Up to 27 Months)|Disease progression|0
6813246|NCT03447314|10817225|FG016|Part 1 (Up to 27 Months)|Disease progression|0
6813247|NCT03447314|10817226|FG017|Part 1 (Up to 27 Months)|Disease progression|0
6813248|NCT03447314|10817209|FG000|Part 1 (Up to 27 Months)|Lost to Follow-up|0
6813249|NCT03447314|10817210|FG001|Part 1 (Up to 27 Months)|Lost to Follow-up|0
6813250|NCT03447314|10817211|FG002|Part 1 (Up to 27 Months)|Lost to Follow-up|1
6813251|NCT03447314|10817212|FG003|Part 1 (Up to 27 Months)|Lost to Follow-up|0
6813252|NCT03447314|10817213|FG004|Part 1 (Up to 27 Months)|Lost to Follow-up|0
6813253|NCT03447314|10817214|FG005|Part 1 (Up to 27 Months)|Lost to Follow-up|0
6813254|NCT03447314|10817215|FG006|Part 1 (Up to 27 Months)|Lost to Follow-up|0
6813255|NCT03447314|10817216|FG007|Part 1 (Up to 27 Months)|Lost to Follow-up|0
6813256|NCT03447314|10817217|FG008|Part 1 (Up to 27 Months)|Lost to Follow-up|0
6813257|NCT03447314|10817218|FG009|Part 1 (Up to 27 Months)|Lost to Follow-up|0
6813258|NCT03447314|10817219|FG010|Part 1 (Up to 27 Months)|Lost to Follow-up|0
6813259|NCT03447314|10817220|FG011|Part 1 (Up to 27 Months)|Lost to Follow-up|0
6813260|NCT03447314|10817221|FG012|Part 1 (Up to 27 Months)|Lost to Follow-up|0
6813261|NCT03447314|10817222|FG013|Part 1 (Up to 27 Months)|Lost to Follow-up|0
6813262|NCT03447314|10817223|FG014|Part 1 (Up to 27 Months)|Lost to Follow-up|0
6813263|NCT03447314|10817224|FG015|Part 1 (Up to 27 Months)|Lost to Follow-up|0
6813264|NCT03447314|10817225|FG016|Part 1 (Up to 27 Months)|Lost to Follow-up|0
6813265|NCT03447314|10817226|FG017|Part 1 (Up to 27 Months)|Lost to Follow-up|0
6813266|NCT03320330|10817283|FG000|Overall Study|Lack of Efficacy|5
6813267|NCT03320330|10817284|FG001|Overall Study|Lack of Efficacy|5
6813268|NCT03320330|10817285|FG002|Overall Study|Lack of Efficacy|14
6813269|NCT03320330|10817283|FG000|Overall Study|Physician Decision|1
6813270|NCT03320330|10817284|FG001|Overall Study|Physician Decision|0
6813271|NCT03320330|10817285|FG002|Overall Study|Physician Decision|0
6813272|NCT03271151|10817296|FG000|Overall Study|Lost to Follow-up|1
6813273|NCT03271151|10817297|FG001|Overall Study|Lost to Follow-up|3
6813274|NCT03271151|10817296|FG000|Overall Study|Withdrawal by Subject|1
6813275|NCT03271151|10817297|FG001|Overall Study|Withdrawal by Subject|0
6813276|NCT03141177|10817306|FG000|Overall Study|Death|62
6813277|NCT03141177|10817307|FG001|Overall Study|Death|13
6813278|NCT03141177|10817308|FG002|Overall Study|Death|84
6813279|NCT03141177|10817306|FG000|Overall Study|Participant withdrew consent|9
6813280|NCT03141177|10817307|FG001|Overall Study|Participant withdrew consent|2
6813281|NCT03141177|10817308|FG002|Overall Study|Participant withdrew consent|13
6813282|NCT03141177|10817306|FG000|Overall Study|Not reported|1
6813283|NCT03141177|10817307|FG001|Overall Study|Not reported|0
6813284|NCT03141177|10817308|FG002|Overall Study|Not reported|1
6813285|NCT03141177|10817306|FG000|Overall Study|Lost to Follow-up|2
6813286|NCT03141177|10817307|FG001|Overall Study|Lost to Follow-up|1
6813287|NCT03141177|10817308|FG002|Overall Study|Lost to Follow-up|1
6813288|NCT03141177|10817306|FG000|Overall Study|Other reasons|4
6813289|NCT03141177|10817307|FG001|Overall Study|Other reasons|0
6813290|NCT03141177|10817308|FG002|Overall Study|Other reasons|11
6813291|NCT03141177|10817306|FG000|Overall Study|Participants did not start treatment period|3
6813292|NCT03141177|10817307|FG001|Overall Study|Participants did not start treatment period|0
6813293|NCT03141177|10817308|FG002|Overall Study|Participants did not start treatment period|8
6813294|NCT03117049|10817319|FG000|Overall Study|Continued the follow-up period|109
6813295|NCT03117049|10817320|FG001|Overall Study|Continued the follow-up period|129
6813296|NCT03117049|10817319|FG000|Overall Study|Died|82
6813297|NCT03117049|10817320|FG001|Overall Study|Died|93
6813298|NCT03117049|10817319|FG000|Overall Study|Consent withdrawal|7
6813299|NCT03117049|10817320|FG001|Overall Study|Consent withdrawal|6
6813300|NCT03117049|10817319|FG000|Overall Study|Missing contact|3
6813301|NCT03117049|10817320|FG001|Overall Study|Missing contact|3
6813302|NCT03023813|10817329|FG000|Overall Study|Lost to Follow-up|1
6813303|NCT03023813|10817330|FG001|Overall Study|Lost to Follow-up|2
6813304|NCT03023813|10817331|FG002|Overall Study|Lost to Follow-up|0
6813305|NCT02993822|10817344|FG000|Overall Study|Lack of Efficacy|1
6813306|NCT02993822|10817345|FG001|Overall Study|Lack of Efficacy|1
6813307|NCT02993822|10817346|FG002|Overall Study|Lack of Efficacy|0
6813308|NCT02993822|10817347|FG003|Overall Study|Lack of Efficacy|0
6813309|NCT02993822|10817344|FG000|Overall Study|Protocol Violation|1
6813310|NCT02993822|10817345|FG001|Overall Study|Protocol Violation|0
6813311|NCT02993822|10817346|FG002|Overall Study|Protocol Violation|0
6813312|NCT02993822|10817347|FG003|Overall Study|Protocol Violation|0
6813313|NCT02993822|10817344|FG000|Overall Study|Unable to attend follow-up due to illness|0
6813314|NCT02993822|10817345|FG001|Overall Study|Unable to attend follow-up due to illness|0
6813315|NCT02993822|10817346|FG002|Overall Study|Unable to attend follow-up due to illness|0
6813316|NCT02993822|10817347|FG003|Overall Study|Unable to attend follow-up due to illness|1
6813317|NCT02993822|10817344|FG000|Overall Study|Adverse Event|3
6813318|NCT02993822|10817345|FG001|Overall Study|Adverse Event|1
6813319|NCT02993822|10817346|FG002|Overall Study|Adverse Event|7
6813320|NCT02993822|10817347|FG003|Overall Study|Adverse Event|0
6813321|NCT02993822|10817344|FG000|Overall Study|Withdrawal by Subject|4
6813322|NCT02993822|10817345|FG001|Overall Study|Withdrawal by Subject|2
6813323|NCT02993822|10817346|FG002|Overall Study|Withdrawal by Subject|2
6813324|NCT02993822|10817347|FG003|Overall Study|Withdrawal by Subject|3
6813325|NCT02993822|10817344|FG000|Overall Study|Lost to Follow-up|1
6813326|NCT02993822|10817345|FG001|Overall Study|Lost to Follow-up|0
6813327|NCT02993822|10817346|FG002|Overall Study|Lost to Follow-up|1
6813328|NCT02993822|10817347|FG003|Overall Study|Lost to Follow-up|0
6813329|NCT02753127|10817372|FG000|Overall Study|Lost to Follow-up|13
6813330|NCT02753127|10817373|FG001|Overall Study|Lost to Follow-up|11
6813331|NCT02753127|10817372|FG000|Overall Study|Withdrawal by Subject|37
6813332|NCT02753127|10817373|FG001|Overall Study|Withdrawal by Subject|47
6813333|NCT02753127|10817372|FG000|Overall Study|Other|3
6813334|NCT02753127|10817373|FG001|Overall Study|Other|8
6813335|NCT02753127|10817372|FG000|Overall Study|Hospice|0
6813336|NCT02753127|10817373|FG001|Overall Study|Hospice|2
6813337|NCT02460198|10817398|FG000|Overall Study|Adverse Event|1
6813338|NCT02460198|10817399|FG001|Overall Study|Adverse Event|3
6813339|NCT02460198|10817398|FG000|Overall Study|Death|36
6813340|NCT02460198|10817399|FG001|Overall Study|Death|28
6813341|NCT02460198|10817398|FG000|Overall Study|Lost to Follow-up|1
6813342|NCT02460198|10817399|FG001|Overall Study|Lost to Follow-up|1
6813343|NCT02460198|10817398|FG000|Overall Study|Transferred to Extension Study|15
6813344|NCT02460198|10817399|FG001|Overall Study|Transferred to Extension Study|15
6813345|NCT02460198|10817398|FG000|Overall Study|Withdrawal by Subject|2
6813346|NCT02460198|10817399|FG001|Overall Study|Withdrawal by Subject|4
6813347|NCT02460198|10817398|FG000|Overall Study|Site Terminated By Sponsor|0
6813348|NCT02460198|10817399|FG001|Overall Study|Site Terminated By Sponsor|1
6813349|NCT02460198|10817398|FG000|Overall Study|Did Not Continue on Extension Study|6
6813350|NCT02460198|10817399|FG001|Overall Study|Did Not Continue on Extension Study|11
6813351|NCT01516216|10817463|FG000|Overall Study|Adverse Event|2
6813352|NCT01516216|10817464|FG001|Overall Study|Adverse Event|4
6813353|NCT01516216|10817463|FG000|Overall Study|Disease Progression|38
6813354|NCT01516216|10817464|FG001|Overall Study|Disease Progression|34
6813355|NCT01516216|10817463|FG000|Overall Study|Withdrawal by Subject|9
6813356|NCT01516216|10817464|FG001|Overall Study|Withdrawal by Subject|11
6813357|NCT01516216|10817463|FG000|Overall Study|Potentially Curative Resection|6
6813358|NCT01516216|10817464|FG001|Overall Study|Potentially Curative Resection|12
6813359|NCT01516216|10817463|FG000|Overall Study|Nonadherence|2
6813360|NCT01516216|10817464|FG001|Overall Study|Nonadherence|3
6813361|NCT01516216|10817463|FG000|Overall Study|Physician Decision|6
6813362|NCT01516216|10817464|FG001|Overall Study|Physician Decision|3
6813363|NCT01516216|10817463|FG000|Overall Study|Prolonged Treatment Delay|5
6813364|NCT01516216|10817464|FG001|Overall Study|Prolonged Treatment Delay|1
6813365|NCT01516216|10817463|FG000|Overall Study|Intercurrent Illness|1
6813366|NCT01516216|10817464|FG001|Overall Study|Intercurrent Illness|0
6813367|NCT01516216|10817463|FG000|Overall Study|Death|1
6813368|NCT01516216|10817464|FG001|Overall Study|Death|1
6813371|NCT00006184|10817493|FG000|Overall Study|Death|1
6813372|NCT00006184|10817494|FG001|Overall Study|Death|0
6813373|NCT00006237|10817506|FG000|Overall Study|Adverse Event|39
6813374|NCT00006237|10817507|FG001|Overall Study|Adverse Event|29
6813375|NCT00006237|10817506|FG000|Overall Study|Death|1
6813376|NCT00006237|10817507|FG001|Overall Study|Death|0
6813377|NCT00006237|10817506|FG000|Overall Study|Refusal unrelated to adverse effects|8
6813378|NCT00006237|10817507|FG001|Overall Study|Refusal unrelated to adverse effects|4
6813379|NCT00006237|10817506|FG000|Overall Study|Progression/relapse|54
6813380|NCT00006237|10817507|FG001|Overall Study|Progression/relapse|2
6813381|NCT00006237|10817506|FG000|Overall Study|Not eligible|9
6813382|NCT00006237|10817507|FG001|Overall Study|Not eligible|20
6813383|NCT00006237|10817506|FG000|Overall Study|Withdrawal by Subject|0
6813384|NCT00006237|10817507|FG001|Overall Study|Withdrawal by Subject|1
6813385|NCT00006237|10817506|FG000|Overall Study|Not protocol specified|14
6813386|NCT00006237|10817507|FG001|Overall Study|Not protocol specified|5
6813387|NCT00006289|10817522|FG000|First Intervention (5 Weeks)|Adverse Event|1
6813388|NCT00006289|10817523|FG001|First Intervention (5 Weeks)|Adverse Event|0
6813389|NCT00006289|10817522|FG000|Second Intervention (5 Weeks)|Protocol Violation|1
6813390|NCT00006289|10817523|FG001|Second Intervention (5 Weeks)|Protocol Violation|1
6813391|NCT00006305|10817543|FG000|Overall Study|Withdrawal by Subject|17
6813392|NCT00006305|10817544|FG001|Overall Study|Withdrawal by Subject|10
6813393|NCT00006305|10817545|FG002|Overall Study|Withdrawal by Subject|15
6813394|NCT00006305|10817546|FG003|Overall Study|Withdrawal by Subject|14
6813395|NCT00006389|10817556|FG000|Overall Study|Adverse Event|1
6813396|NCT00006392|10817565|FG000|Overall Study|Ineligible|11
6813397|NCT00006392|10817566|FG001|Overall Study|Ineligible|3
6813398|NCT00006392|10817567|FG002|Overall Study|Ineligible|5
6813399|NCT00006392|10817568|FG003|Overall Study|Ineligible|5
6813400|NCT00006392|10817565|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156
6813401|NCT00006392|10817566|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155
6813402|NCT00006392|10817567|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155
6813403|NCT00006392|10817568|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155
6813404|NCT00006409|10817593|FG000|Baseline|Protocol Violation|48
6813405|NCT00006409|10817594|FG001|Baseline|Protocol Violation|70
6813406|NCT00006409|10817595|FG002|Baseline|Protocol Violation|0
6813407|NCT00006409|10817596|FG003|Baseline|Protocol Violation|0
6813408|NCT00006409|10817597|FG004|Baseline|Protocol Violation|0
6813409|NCT00006409|10817598|FG005|Baseline|Protocol Violation|0
6813410|NCT00006409|10817593|FG000|Post-2 Year Intervention|Protocol Violation|0
6813411|NCT00006409|10817594|FG001|Post-2 Year Intervention|Protocol Violation|0
6813412|NCT00006409|10817595|FG002|Post-2 Year Intervention|Protocol Violation|251
6813413|NCT00006409|10817596|FG003|Post-2 Year Intervention|Protocol Violation|168
6813414|NCT00006409|10817597|FG004|Post-2 Year Intervention|Protocol Violation|0
6813415|NCT00006409|10817598|FG005|Post-2 Year Intervention|Protocol Violation|0
6813416|NCT00006409|10817593|FG000|Post-3 Year Intervention|Protocol Violation|0
6813417|NCT00006409|10817594|FG001|Post-3 Year Intervention|Protocol Violation|0
6813418|NCT00006409|10817595|FG002|Post-3 Year Intervention|Protocol Violation|0
6813419|NCT00006409|10817596|FG003|Post-3 Year Intervention|Protocol Violation|0
6813420|NCT00006409|10817597|FG004|Post-3 Year Intervention|Protocol Violation|62
6813421|NCT00006409|10817598|FG005|Post-3 Year Intervention|Protocol Violation|62
6813422|NCT00006489|10817625|FG000|Overall Study|Adverse Event|3
6813423|NCT00006489|10817626|FG001|Overall Study|Adverse Event|2
6813424|NCT00006489|10817627|FG002|Overall Study|Adverse Event|4
6813425|NCT00006489|10817628|FG003|Overall Study|Adverse Event|3
6813426|NCT00006489|10817625|FG000|Overall Study|Withdrawal by Subject|10
6813427|NCT00006489|10817626|FG001|Overall Study|Withdrawal by Subject|9
6813428|NCT00006489|10817627|FG002|Overall Study|Withdrawal by Subject|9
6813429|NCT00006489|10817628|FG003|Overall Study|Withdrawal by Subject|6
6813430|NCT00006489|10817625|FG000|Overall Study|Scheduling Conflict|0
6813431|NCT00006489|10817626|FG001|Overall Study|Scheduling Conflict|3
6813432|NCT00006489|10817627|FG002|Overall Study|Scheduling Conflict|2
6813433|NCT00006489|10817628|FG003|Overall Study|Scheduling Conflict|1
6813434|NCT00006489|10817625|FG000|Overall Study|Death|0
6813435|NCT00006489|10817626|FG001|Overall Study|Death|0
6813436|NCT00006489|10817627|FG002|Overall Study|Death|0
6813437|NCT00006489|10817628|FG003|Overall Study|Death|1
6813438|NCT00006604|10817645|FG000|Overall Study|Met study objective - no further FU|1
6813439|NCT00006604|10817646|FG001|Overall Study|Met study objective - no further FU|0
6813440|NCT00006604|10817647|FG002|Overall Study|Met study objective - no further FU|0
6813441|NCT00006604|10817648|FG003|Overall Study|Met study objective - no further FU|0
6813442|NCT00006604|10817649|FG004|Overall Study|Met study objective - no further FU|0
6813443|NCT00006604|10817650|FG005|Overall Study|Met study objective - no further FU|0
6813444|NCT00006604|10817651|FG006|Overall Study|Met study objective - no further FU|0
6813445|NCT00006604|10817652|FG007|Overall Study|Met study objective - no further FU|0
6813446|NCT00006604|10817653|FG008|Overall Study|Met study objective - no further FU|0
6813447|NCT00006604|10817654|FG009|Overall Study|Met study objective - no further FU|0
6813448|NCT00006604|10817655|FG010|Overall Study|Met study objective - no further FU|0
6813449|NCT00006604|10817656|FG011|Overall Study|Met study objective - no further FU|0
6813450|NCT00006604|10817657|FG012|Overall Study|Met study objective - no further FU|0
6813451|NCT00006604|10817658|FG013|Overall Study|Met study objective - no further FU|0
6813452|NCT00006604|10817659|FG014|Overall Study|Met study objective - no further FU|1
6813453|NCT00006604|10817660|FG015|Overall Study|Met study objective - no further FU|1
6813454|NCT00006604|10817661|FG016|Overall Study|Met study objective - no further FU|0
6813455|NCT00006604|10817645|FG000|Overall Study|Randomization entry error-no RX, no FU|0
6813456|NCT00006604|10817646|FG001|Overall Study|Randomization entry error-no RX, no FU|0
6813457|NCT00006604|10817647|FG002|Overall Study|Randomization entry error-no RX, no FU|0
6813458|NCT00006604|10817648|FG003|Overall Study|Randomization entry error-no RX, no FU|0
6813459|NCT00006604|10817649|FG004|Overall Study|Randomization entry error-no RX, no FU|0
6813460|NCT00006604|10817650|FG005|Overall Study|Randomization entry error-no RX, no FU|0
6813461|NCT00006604|10817651|FG006|Overall Study|Randomization entry error-no RX, no FU|0
6813462|NCT00006604|10817652|FG007|Overall Study|Randomization entry error-no RX, no FU|0
6813463|NCT00006604|10817653|FG008|Overall Study|Randomization entry error-no RX, no FU|0
6813464|NCT00006604|10817654|FG009|Overall Study|Randomization entry error-no RX, no FU|0
6813465|NCT00006604|10817655|FG010|Overall Study|Randomization entry error-no RX, no FU|0
6813466|NCT00006604|10817656|FG011|Overall Study|Randomization entry error-no RX, no FU|1
6813467|NCT00006604|10817657|FG012|Overall Study|Randomization entry error-no RX, no FU|0
6813468|NCT00006604|10817658|FG013|Overall Study|Randomization entry error-no RX, no FU|0
6813469|NCT00006604|10817659|FG014|Overall Study|Randomization entry error-no RX, no FU|0
6813470|NCT00006604|10817660|FG015|Overall Study|Randomization entry error-no RX, no FU|0
6813471|NCT00006604|10817661|FG016|Overall Study|Randomization entry error-no RX, no FU|0
6813472|NCT00006604|10817645|FG000|Overall Study|Death|0
6813473|NCT00006604|10817646|FG001|Overall Study|Death|0
6813474|NCT00006604|10817647|FG002|Overall Study|Death|0
6813475|NCT00006604|10817648|FG003|Overall Study|Death|0
6813476|NCT00006604|10817649|FG004|Overall Study|Death|0
6813477|NCT00006604|10817650|FG005|Overall Study|Death|0
6813478|NCT00006604|10817651|FG006|Overall Study|Death|0
6813479|NCT00006604|10817652|FG007|Overall Study|Death|0
6813480|NCT00006604|10817653|FG008|Overall Study|Death|0
6813481|NCT00006604|10817654|FG009|Overall Study|Death|1
6813482|NCT00006604|10817655|FG010|Overall Study|Death|1
6813483|NCT00006604|10817656|FG011|Overall Study|Death|1
6813484|NCT00006604|10817657|FG012|Overall Study|Death|0
6813485|NCT00006604|10817658|FG013|Overall Study|Death|0
6813486|NCT00006604|10817659|FG014|Overall Study|Death|0
6813487|NCT00006604|10817660|FG015|Overall Study|Death|0
6813488|NCT00006604|10817661|FG016|Overall Study|Death|0
6813489|NCT00006604|10817645|FG000|Overall Study|Severe debilitation, unable to continue|0
6813490|NCT00006604|10817646|FG001|Overall Study|Severe debilitation, unable to continue|0
6813491|NCT00006604|10817647|FG002|Overall Study|Severe debilitation, unable to continue|0
6813492|NCT00006604|10817648|FG003|Overall Study|Severe debilitation, unable to continue|0
6813493|NCT00006604|10817649|FG004|Overall Study|Severe debilitation, unable to continue|0
6813494|NCT00006604|10817650|FG005|Overall Study|Severe debilitation, unable to continue|0
6813495|NCT00006604|10817651|FG006|Overall Study|Severe debilitation, unable to continue|3
6813496|NCT00006604|10817652|FG007|Overall Study|Severe debilitation, unable to continue|0
6813497|NCT00006604|10817653|FG008|Overall Study|Severe debilitation, unable to continue|0
6813498|NCT00006604|10817654|FG009|Overall Study|Severe debilitation, unable to continue|5
6813499|NCT00006604|10817655|FG010|Overall Study|Severe debilitation, unable to continue|0
6813500|NCT00006604|10817656|FG011|Overall Study|Severe debilitation, unable to continue|2
6813501|NCT00006604|10817657|FG012|Overall Study|Severe debilitation, unable to continue|1
6813502|NCT00006604|10817658|FG013|Overall Study|Severe debilitation, unable to continue|0
6813503|NCT00006604|10817659|FG014|Overall Study|Severe debilitation, unable to continue|2
6813504|NCT00006604|10817660|FG015|Overall Study|Severe debilitation, unable to continue|0
6813505|NCT00006604|10817661|FG016|Overall Study|Severe debilitation, unable to continue|0
6813506|NCT00006604|10817645|FG000|Overall Study|Subj/Parent not able to get to clinic|0
6813507|NCT00006604|10817646|FG001|Overall Study|Subj/Parent not able to get to clinic|0
6813508|NCT00006604|10817647|FG002|Overall Study|Subj/Parent not able to get to clinic|0
6813509|NCT00006604|10817648|FG003|Overall Study|Subj/Parent not able to get to clinic|1
6813510|NCT00006604|10817649|FG004|Overall Study|Subj/Parent not able to get to clinic|1
6813511|NCT00006604|10817650|FG005|Overall Study|Subj/Parent not able to get to clinic|0
6813512|NCT00006604|10817651|FG006|Overall Study|Subj/Parent not able to get to clinic|1
6813513|NCT00006604|10817652|FG007|Overall Study|Subj/Parent not able to get to clinic|0
6813514|NCT00006604|10817653|FG008|Overall Study|Subj/Parent not able to get to clinic|0
6813515|NCT00006604|10817654|FG009|Overall Study|Subj/Parent not able to get to clinic|1
6813516|NCT00006604|10817655|FG010|Overall Study|Subj/Parent not able to get to clinic|2
6813517|NCT00006604|10817656|FG011|Overall Study|Subj/Parent not able to get to clinic|1
6813518|NCT00006604|10817657|FG012|Overall Study|Subj/Parent not able to get to clinic|1
6813519|NCT00006604|10817658|FG013|Overall Study|Subj/Parent not able to get to clinic|1
6813520|NCT00006604|10817659|FG014|Overall Study|Subj/Parent not able to get to clinic|3
6813521|NCT00006604|10817660|FG015|Overall Study|Subj/Parent not able to get to clinic|0
6813522|NCT00006604|10817661|FG016|Overall Study|Subj/Parent not able to get to clinic|0
6813523|NCT00006604|10817645|FG000|Overall Study|Site closing|0
6813524|NCT00006604|10817646|FG001|Overall Study|Site closing|0
6813525|NCT00006604|10817647|FG002|Overall Study|Site closing|1
6813526|NCT00006604|10817648|FG003|Overall Study|Site closing|1
6813527|NCT00006604|10817649|FG004|Overall Study|Site closing|0
6813528|NCT00006604|10817650|FG005|Overall Study|Site closing|0
6813529|NCT00006604|10817651|FG006|Overall Study|Site closing|0
6813530|NCT00006604|10817652|FG007|Overall Study|Site closing|1
6813531|NCT00006604|10817653|FG008|Overall Study|Site closing|0
6813532|NCT00006604|10817654|FG009|Overall Study|Site closing|0
6813533|NCT00006604|10817655|FG010|Overall Study|Site closing|0
6813534|NCT00006604|10817656|FG011|Overall Study|Site closing|1
6813535|NCT00006604|10817657|FG012|Overall Study|Site closing|1
6813536|NCT00006604|10817658|FG013|Overall Study|Site closing|1
6813537|NCT00006604|10817659|FG014|Overall Study|Site closing|0
6813538|NCT00006604|10817660|FG015|Overall Study|Site closing|0
6813539|NCT00006604|10817661|FG016|Overall Study|Site closing|1
6813540|NCT00006604|10817645|FG000|Overall Study|Withdrawal by Subject|1
6813541|NCT00006604|10817646|FG001|Overall Study|Withdrawal by Subject|0
6813542|NCT00006604|10817647|FG002|Overall Study|Withdrawal by Subject|2
6813543|NCT00006604|10817648|FG003|Overall Study|Withdrawal by Subject|0
6813544|NCT00006604|10817649|FG004|Overall Study|Withdrawal by Subject|1
6813545|NCT00006604|10817650|FG005|Overall Study|Withdrawal by Subject|2
6813546|NCT00006604|10817651|FG006|Overall Study|Withdrawal by Subject|2
6813547|NCT00006604|10817652|FG007|Overall Study|Withdrawal by Subject|0
6813548|NCT00006604|10817653|FG008|Overall Study|Withdrawal by Subject|1
6813549|NCT00006604|10817654|FG009|Overall Study|Withdrawal by Subject|3
6813550|NCT00006604|10817655|FG010|Overall Study|Withdrawal by Subject|2
6813551|NCT00006604|10817656|FG011|Overall Study|Withdrawal by Subject|0
6813552|NCT00006604|10817657|FG012|Overall Study|Withdrawal by Subject|1
6813553|NCT00006604|10817658|FG013|Overall Study|Withdrawal by Subject|2
6813554|NCT00006604|10817659|FG014|Overall Study|Withdrawal by Subject|1
6813555|NCT00006604|10817660|FG015|Overall Study|Withdrawal by Subject|0
6813556|NCT00006604|10817661|FG016|Overall Study|Withdrawal by Subject|1
6813557|NCT00006604|10817645|FG000|Overall Study|Subj/parent not willing to adhere to req|0
6813558|NCT00006604|10817646|FG001|Overall Study|Subj/parent not willing to adhere to req|0
6813559|NCT00006604|10817647|FG002|Overall Study|Subj/parent not willing to adhere to req|1
6813560|NCT00006604|10817648|FG003|Overall Study|Subj/parent not willing to adhere to req|3
6813561|NCT00006604|10817649|FG004|Overall Study|Subj/parent not willing to adhere to req|0
6813562|NCT00006604|10817650|FG005|Overall Study|Subj/parent not willing to adhere to req|0
6813563|NCT00006604|10817651|FG006|Overall Study|Subj/parent not willing to adhere to req|3
6813564|NCT00006604|10817652|FG007|Overall Study|Subj/parent not willing to adhere to req|1
6813565|NCT00006604|10817653|FG008|Overall Study|Subj/parent not willing to adhere to req|0
6813566|NCT00006604|10817654|FG009|Overall Study|Subj/parent not willing to adhere to req|6
6813567|NCT00006604|10817655|FG010|Overall Study|Subj/parent not willing to adhere to req|3
6813568|NCT00006604|10817656|FG011|Overall Study|Subj/parent not willing to adhere to req|0
6813569|NCT00006604|10817657|FG012|Overall Study|Subj/parent not willing to adhere to req|0
6813570|NCT00006604|10817658|FG013|Overall Study|Subj/parent not willing to adhere to req|2
6813571|NCT00006604|10817659|FG014|Overall Study|Subj/parent not willing to adhere to req|3
6813572|NCT00006604|10817660|FG015|Overall Study|Subj/parent not willing to adhere to req|3
6813573|NCT00006604|10817661|FG016|Overall Study|Subj/parent not willing to adhere to req|4
6813574|NCT00006604|10817645|FG000|Overall Study|Lost to Follow-up|0
6813575|NCT00006604|10817646|FG001|Overall Study|Lost to Follow-up|0
6813576|NCT00006604|10817647|FG002|Overall Study|Lost to Follow-up|0
6813577|NCT00006604|10817648|FG003|Overall Study|Lost to Follow-up|0
6813578|NCT00006604|10817649|FG004|Overall Study|Lost to Follow-up|0
6813579|NCT00006604|10817650|FG005|Overall Study|Lost to Follow-up|0
6813580|NCT00006604|10817651|FG006|Overall Study|Lost to Follow-up|0
6813581|NCT00006604|10817652|FG007|Overall Study|Lost to Follow-up|1
6813582|NCT00006604|10817653|FG008|Overall Study|Lost to Follow-up|0
6813583|NCT00006604|10817654|FG009|Overall Study|Lost to Follow-up|2
6813584|NCT00006604|10817655|FG010|Overall Study|Lost to Follow-up|0
6813585|NCT00006604|10817656|FG011|Overall Study|Lost to Follow-up|0
6813586|NCT00006604|10817657|FG012|Overall Study|Lost to Follow-up|0
6813587|NCT00006604|10817658|FG013|Overall Study|Lost to Follow-up|0
6813588|NCT00006604|10817659|FG014|Overall Study|Lost to Follow-up|0
6813589|NCT00006604|10817660|FG015|Overall Study|Lost to Follow-up|1
6813590|NCT00006604|10817661|FG016|Overall Study|Lost to Follow-up|3
6813591|NCT00006604|10817645|FG000|Overall Study|Other Reason|0
6813592|NCT00006604|10817646|FG001|Overall Study|Other Reason|0
6813593|NCT00006604|10817647|FG002|Overall Study|Other Reason|0
6813594|NCT00006604|10817648|FG003|Overall Study|Other Reason|0
6813595|NCT00006604|10817649|FG004|Overall Study|Other Reason|0
6813596|NCT00006604|10817650|FG005|Overall Study|Other Reason|1
6813597|NCT00006604|10817651|FG006|Overall Study|Other Reason|0
6813598|NCT00006604|10817652|FG007|Overall Study|Other Reason|0
6813599|NCT00006604|10817653|FG008|Overall Study|Other Reason|0
6813600|NCT00006604|10817654|FG009|Overall Study|Other Reason|1
6813601|NCT00006604|10817655|FG010|Overall Study|Other Reason|0
6813602|NCT00006604|10817656|FG011|Overall Study|Other Reason|0
6813603|NCT00006604|10817657|FG012|Overall Study|Other Reason|0
6813604|NCT00006604|10817658|FG013|Overall Study|Other Reason|0
6813605|NCT00006604|10817659|FG014|Overall Study|Other Reason|0
6813606|NCT00006604|10817660|FG015|Overall Study|Other Reason|0
6813607|NCT00006604|10817661|FG016|Overall Study|Other Reason|0
6813608|NCT00006721|10817687|FG000|Overall Study|Adverse Event|0
6813609|NCT00006721|10817688|FG001|Overall Study|Adverse Event|4
6813610|NCT00006721|10817689|FG002|Overall Study|Adverse Event|4
6813611|NCT00006721|10817687|FG000|Overall Study|Refusal Unrelated to Adverse Event|1
6813612|NCT00006721|10817688|FG001|Overall Study|Refusal Unrelated to Adverse Event|0
6813613|NCT00006721|10817689|FG002|Overall Study|Refusal Unrelated to Adverse Event|8
6813614|NCT00006721|10817687|FG000|Overall Study|Progression/Relapse|0
6813615|NCT00006721|10817688|FG001|Overall Study|Progression/Relapse|1
6813616|NCT00006721|10817689|FG002|Overall Study|Progression/Relapse|2
6813617|NCT00006721|10817687|FG000|Overall Study|Death|0
6813618|NCT00006721|10817688|FG001|Overall Study|Death|1
6813619|NCT00006721|10817689|FG002|Overall Study|Death|2
6813620|NCT00006721|10817687|FG000|Overall Study|Other - Not Protocol Specified|0
6813621|NCT00006721|10817688|FG001|Overall Study|Other - Not Protocol Specified|7
6813622|NCT00006721|10817689|FG002|Overall Study|Other - Not Protocol Specified|7
6813623|NCT00006721|10817687|FG000|Overall Study|Ineligible|2
6813624|NCT00006721|10817688|FG001|Overall Study|Ineligible|12
6813625|NCT00006721|10817689|FG002|Overall Study|Ineligible|10
6813626|NCT00006721|10817687|FG000|Overall Study|Eligible but no Treatment Received|1
6813627|NCT00006721|10817688|FG001|Overall Study|Eligible but no Treatment Received|0
6813628|NCT00006721|10817689|FG002|Overall Study|Eligible but no Treatment Received|0
6813629|NCT00006903|10817701|FG000|Overall Study|Still receiving treatment|0
6813630|NCT00006903|10817702|FG001|Overall Study|Still receiving treatment|0
6813631|NCT00006903|10817703|FG002|Overall Study|Still receiving treatment|1
6813632|NCT00006903|10817701|FG000|Overall Study|Refused further treatment|0
6813633|NCT00006903|10817702|FG001|Overall Study|Refused further treatment|2
6813634|NCT00006903|10817703|FG002|Overall Study|Refused further treatment|1
6813635|NCT00006903|10817701|FG000|Overall Study|Adverse Event|0
6813636|NCT00006903|10817702|FG001|Overall Study|Adverse Event|0
6813637|NCT00006903|10817703|FG002|Overall Study|Adverse Event|1
6813638|NCT00006903|10817701|FG000|Overall Study|Death|0
6813639|NCT00006903|10817702|FG001|Overall Study|Death|1
6813640|NCT00006903|10817703|FG002|Overall Study|Death|0
6813641|NCT00006903|10817701|FG000|Overall Study|Patient never treated|0
6813642|NCT00006903|10817702|FG001|Overall Study|Patient never treated|0
6813643|NCT00006903|10817703|FG002|Overall Study|Patient never treated|1
6813644|NCT00006903|10817701|FG000|Overall Study|Ineligible|10
6813645|NCT00006903|10817702|FG001|Overall Study|Ineligible|1
6813646|NCT00006903|10817703|FG002|Overall Study|Ineligible|2
6813647|NCT00007020|10817711|FG000|Overall Study|Death|16
6813648|NCT00007020|10817711|FG000|Overall Study|Lost to Follow-up|13
6813649|NCT00007020|10817711|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1
6813650|NCT00007020|10817711|FG000|Overall Study|Pt withdrawn (liver transplant)|4
6813651|NCT00007020|10817711|FG000|Overall Study|Pt cared for by outside physician|4
6813652|NCT00007020|10817711|FG000|Overall Study|No evidence of treatment|6
6813653|NCT00007345|10817719|FG000|Overall Study|Refused further treatment|0
6813654|NCT00007345|10817720|FG001|Overall Study|Refused further treatment|7
6813655|NCT00007345|10817719|FG000|Overall Study|Switched to alternative treatment|0
6813656|NCT00007345|10817720|FG001|Overall Study|Switched to alternative treatment|3
6813657|NCT00007345|10817719|FG000|Overall Study|Intercurrent illness|1
6813658|NCT00007345|10817720|FG001|Overall Study|Intercurrent illness|0
6813659|NCT00007345|10817719|FG000|Overall Study|Death on study|1
6813660|NCT00007345|10817720|FG001|Overall Study|Death on study|1
6813661|NCT00007475|10817729|FG000|Overall Study|Withdrawal by Subject|1
6813662|NCT00007475|10817730|FG001|Overall Study|Withdrawal by Subject|0
6813663|NCT00007475|10817731|FG002|Overall Study|Withdrawal by Subject|0
6813664|NCT00007475|10817732|FG003|Overall Study|Withdrawal by Subject|0
6813665|NCT00007475|10817729|FG000|Overall Study|Adverse Event|3
6813666|NCT00007475|10817730|FG001|Overall Study|Adverse Event|0
6813667|NCT00007475|10817731|FG002|Overall Study|Adverse Event|0
6813668|NCT00007475|10817732|FG003|Overall Study|Adverse Event|0
6813669|NCT00008138|10817751|FG000|Neoadjuvant Chemotherapy|Adverse Event|3
6813670|NCT00008138|10817751|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3
6813671|NCT00008138|10817751|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6
6813672|NCT00008138|10817751|FG000|Neoadjuvant Chemotherapy|not protocol specified|8
6813673|NCT00008138|10817751|FG000|Interval Debulking|Withdrawal by Subject|2
6813674|NCT00008138|10817751|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6
6813675|NCT00008138|10817751|FG000|Post-Cytoreduction Chemotherapy|Progression|1
6813676|NCT00008138|10817751|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1
6813677|NCT00008385|10817758|FG000|Overall Study|Off treatment reasons not reported|79
6813678|NCT00008385|10817759|FG001|Overall Study|Off treatment reasons not reported|70
6813679|NCT00008385|10817758|FG000|Overall Study|Progressive disease|52
6813680|NCT00008385|10817759|FG001|Overall Study|Progressive disease|117
6813681|NCT00008385|10817758|FG000|Overall Study|Adverse Event|8
6813682|NCT00008385|10817759|FG001|Overall Study|Adverse Event|20
6813683|NCT00008385|10817758|FG000|Overall Study|Death|12
6813684|NCT00008385|10817759|FG001|Overall Study|Death|18
6813685|NCT00008385|10817758|FG000|Overall Study|Withdrawal by Subject|67
6813686|NCT00008385|10817759|FG001|Overall Study|Withdrawal by Subject|157
6813687|NCT00008385|10817758|FG000|Overall Study|Start non-protocol therapy|3
6813688|NCT00008385|10817759|FG001|Overall Study|Start non-protocol therapy|1
6813689|NCT00008385|10817758|FG000|Overall Study|Other complicating disease|17
6813690|NCT00008385|10817759|FG001|Overall Study|Other complicating disease|30
6813691|NCT00008385|10817758|FG000|Overall Study|Maximum dose reached|0
6813692|NCT00008385|10817759|FG001|Overall Study|Maximum dose reached|2
6813693|NCT00008385|10817758|FG000|Overall Study|Other|105
6813694|NCT00008385|10817759|FG001|Overall Study|Other|212
6813695|NCT00008385|10817758|FG000|Overall Study|Not start protocol therapy|44
6813696|NCT00008385|10817759|FG001|Overall Study|Not start protocol therapy|175
6813697|NCT00009737|10817767|FG000|Overall Study|Adverse Event|112
6813698|NCT00009737|10817768|FG001|Overall Study|Adverse Event|75
6813699|NCT00009737|10817767|FG000|Overall Study|Death|4
6813700|NCT00009737|10817768|FG001|Overall Study|Death|6
6813701|NCT00009737|10817767|FG000|Overall Study|Lack of Efficacy|17
6813702|NCT00009737|10817768|FG001|Overall Study|Lack of Efficacy|15
6813703|NCT00009737|10817767|FG000|Overall Study|Violation of Selection Criteria at Entry|13
6813704|NCT00009737|10817768|FG001|Overall Study|Violation of Selection Criteria at Entry|9
6813705|NCT00009737|10817767|FG000|Overall Study|Other Protocol Violation|1
6813706|NCT00009737|10817768|FG001|Overall Study|Other Protocol Violation|0
6813707|NCT00009737|10817767|FG000|Overall Study|Refused Treatment|15
6813708|NCT00009737|10817768|FG001|Overall Study|Refused Treatment|16
6813709|NCT00009737|10817767|FG000|Overall Study|Lost to Follow-up|1
6813710|NCT00009737|10817768|FG001|Overall Study|Lost to Follow-up|1
6813711|NCT00009737|10817767|FG000|Overall Study|Administrative/Other Reasons|7
6813712|NCT00009737|10817768|FG001|Overall Study|Administrative/Other Reasons|1
6813713|NCT00009945|10817776|FG000|Overall Study|no follow up data|7
6813714|NCT00009945|10817777|FG001|Overall Study|no follow up data|5
6813715|NCT00010257|10817785|FG000|Overall Study|Withdrawal by Subject|1
6813716|NCT00010257|10817786|FG001|Overall Study|Withdrawal by Subject|0
6813717|NCT00010374|10817792|FG000|Overall Study|False positive phrenic nerve test|1
6813718|NCT00010803|10817803|FG000|Overall Study|Withdrawal by Subject|97
6813719|NCT00010803|10817804|FG001|Overall Study|Withdrawal by Subject|98
6813720|NCT00012012|10817838|FG000|Overall Study|Protocol Violation|1
6813721|NCT00012012|10817839|FG001|Overall Study|Protocol Violation|1
6813722|NCT00012012|10817838|FG000|Overall Study|Withdrawal by Subject|0
6813723|NCT00012012|10817839|FG001|Overall Study|Withdrawal by Subject|2
6813724|NCT00013611|10817878|FG000|Overall Study|Lost to Follow-up|91
6813725|NCT00013611|10817879|FG001|Overall Study|Lost to Follow-up|100
6813726|NCT00014495|10817902|FG000|Overall Study|Death|0
6813727|NCT00014495|10817903|FG001|Overall Study|Death|0
6813728|NCT00014495|10817904|FG002|Overall Study|Death|1
6813729|NCT00014495|10817905|FG003|Overall Study|Death|0
6813730|NCT00014495|10817902|FG000|Overall Study|Clinical deterioration|0
6813731|NCT00014495|10817903|FG001|Overall Study|Clinical deterioration|0
6813732|NCT00014495|10817904|FG002|Overall Study|Clinical deterioration|0
6813733|NCT00014495|10817905|FG003|Overall Study|Clinical deterioration|1
6813734|NCT00014911|10817912|FG000|Overall Study|Adverse Event|1
6813735|NCT00014911|10817912|FG000|Overall Study|Lost to Follow-up|1
6813736|NCT00014911|10817912|FG000|Overall Study|Withdrawal by Subject|6
6813737|NCT00014911|10817912|FG000|Overall Study|Unknown Reasons|2
6813738|NCT00014911|10817912|FG000|Overall Study|Immunosuppression-related Side Effects|1
6813739|NCT00015457|10817916|FG000|First Intervention|Adverse Event|0
6813740|NCT00015457|10817917|FG001|First Intervention|Adverse Event|2
6813741|NCT00015457|10817916|FG000|First Intervention|Lack of Efficacy|0
6813742|NCT00015457|10817917|FG001|First Intervention|Lack of Efficacy|1
6813743|NCT00015457|10817916|FG000|Second Intervention|Withdrawal by Subject|1
6813744|NCT00015457|10817917|FG001|Second Intervention|Withdrawal by Subject|0
6813745|NCT00016354|10817927|FG000|Overall Study|Lack of Efficacy|0
6813746|NCT00016354|10817928|FG001|Overall Study|Lack of Efficacy|0
6813747|NCT00016354|10817929|FG002|Overall Study|Lack of Efficacy|0
6813748|NCT00016354|10817930|FG003|Overall Study|Lack of Efficacy|0
6813749|NCT00016354|10817931|FG004|Overall Study|Lack of Efficacy|0
6813750|NCT00016354|10817932|FG005|Overall Study|Lack of Efficacy|0
6813751|NCT00016354|10817933|FG006|Overall Study|Lack of Efficacy|0
6813752|NCT00016354|10817934|FG007|Overall Study|Lack of Efficacy|1
6813753|NCT00019604|10817963|FG000|Overall Study|Death|1
6813754|NCT00019604|10817963|FG000|Overall Study|Progressive disease|23
6813755|NCT00019604|10817963|FG000|Overall Study|Refused treatment|1
6813756|NCT00019604|10817963|FG000|Overall Study|Carcinoid tumor, not treatable|1
6813757|NCT00019604|10817963|FG000|Overall Study|Going to have liver transplant|1
6813758|NCT00019604|10817963|FG000|Overall Study|Move to a different study|1
6813759|NCT00019604|10817963|FG000|Overall Study|Non compliant on systemic CH|1
6813760|NCT00019604|10817963|FG000|Overall Study|Non compliant|1
6813761|NCT00019604|10817963|FG000|Overall Study|Resectable disease|1
6813762|NCT00019604|10817963|FG000|Overall Study|Started new chemo regimen|1
6813763|NCT00019604|10817963|FG000|Overall Study|Pt going to immunotherapy study|1
6813764|NCT00019604|10817963|FG000|Overall Study|Too much disease|1
6813765|NCT00019604|10817963|FG000|Overall Study|Unable to evaluate|1
6813766|NCT00019604|10817963|FG000|Overall Study|Details for other not available|4
6813767|NCT00021229|10817979|FG000|Overall Study|Adverse Event|10
6813768|NCT00021229|10817980|FG001|Overall Study|Adverse Event|5
6813769|NCT00021229|10817981|FG002|Overall Study|Adverse Event|2
6813770|NCT00021229|10817979|FG000|Overall Study|Death|0
6813771|NCT00021229|10817980|FG001|Overall Study|Death|1
6813772|NCT00021229|10817981|FG002|Overall Study|Death|0
6813773|NCT00021229|10817979|FG000|Overall Study|Withdrawal by Subject|7
6813774|NCT00021229|10817980|FG001|Overall Study|Withdrawal by Subject|7
6813775|NCT00021229|10817981|FG002|Overall Study|Withdrawal by Subject|1
6813776|NCT00021229|10817979|FG000|Overall Study|Progressive Disease|15
6813777|NCT00021229|10817980|FG001|Overall Study|Progressive Disease|19
6813778|NCT00021229|10817981|FG002|Overall Study|Progressive Disease|12
6813779|NCT00021229|10817979|FG000|Overall Study|Protocol Violation|1
6813780|NCT00021229|10817980|FG001|Overall Study|Protocol Violation|1
6813781|NCT00021229|10817981|FG002|Overall Study|Protocol Violation|0
6813782|NCT00021229|10817979|FG000|Overall Study|Physician Decision|0
6813783|NCT00021229|10817980|FG001|Overall Study|Physician Decision|0
6813784|NCT00021229|10817981|FG002|Overall Study|Physician Decision|1
6813785|NCT00021229|10817979|FG000|Overall Study|Punctate hemmorrhage post RT|2
6813786|NCT00021229|10817980|FG001|Overall Study|Punctate hemmorrhage post RT|0
6813787|NCT00021229|10817981|FG002|Overall Study|Punctate hemmorrhage post RT|0
6813788|NCT00021255|10817994|FG000|Overall Study|Death|1
6813789|NCT00021255|10817995|FG001|Overall Study|Death|0
6813790|NCT00021255|10817996|FG002|Overall Study|Death|2
6813791|NCT00021255|10817994|FG000|Overall Study|Breast cancer relapse|5
6813792|NCT00021255|10817995|FG001|Overall Study|Breast cancer relapse|18
6813793|NCT00021255|10817996|FG002|Overall Study|Breast cancer relapse|11
6813794|NCT00021255|10817994|FG000|Overall Study|Second primary malignancy|0
6813795|NCT00021255|10817995|FG001|Overall Study|Second primary malignancy|4
6813796|NCT00021255|10817996|FG002|Overall Study|Second primary malignancy|1
6813797|NCT00021255|10817994|FG000|Overall Study|Withdrawal by Subject|41
6813798|NCT00021255|10817995|FG001|Overall Study|Withdrawal by Subject|64
6813799|NCT00021255|10817996|FG002|Overall Study|Withdrawal by Subject|26
6813800|NCT00021255|10817994|FG000|Overall Study|Lost to Follow-up|0
6813801|NCT00021255|10817995|FG001|Overall Study|Lost to Follow-up|2
6813802|NCT00021255|10817996|FG002|Overall Study|Lost to Follow-up|3
6813803|NCT00021255|10817994|FG000|Overall Study|Cardiac toxicity|0
6813804|NCT00021255|10817995|FG001|Overall Study|Cardiac toxicity|61
6813805|NCT00021255|10817996|FG002|Overall Study|Cardiac toxicity|32
6813806|NCT00021255|10817994|FG000|Overall Study|Herceptin toxicity|0
6813807|NCT00021255|10817995|FG001|Overall Study|Herceptin toxicity|22
6813808|NCT00021255|10817996|FG002|Overall Study|Herceptin toxicity|6
6813809|NCT00021255|10817994|FG000|Overall Study|Adverse Event|46
6813810|NCT00021255|10817995|FG001|Overall Study|Adverse Event|30
6813811|NCT00021255|10817996|FG002|Overall Study|Adverse Event|18
6813812|NCT00021255|10817994|FG000|Overall Study|Protocol Violation|0
6813813|NCT00021255|10817995|FG001|Overall Study|Protocol Violation|2
6813814|NCT00021255|10817996|FG002|Overall Study|Protocol Violation|0
6813815|NCT00021255|10817994|FG000|Overall Study|Other than specified above|0
6813816|NCT00021255|10817995|FG001|Overall Study|Other than specified above|38
6813817|NCT00021255|10817996|FG002|Overall Study|Other than specified above|19
6813818|NCT00021255|10817994|FG000|Overall Study|Missing|0
6813819|NCT00021255|10817995|FG001|Overall Study|Missing|27
6813820|NCT00021255|10817996|FG002|Overall Study|Missing|13
6813821|NCT00021255|10817994|FG000|Overall Study|Randomized but not treated|28
6813822|NCT00021255|10817995|FG001|Overall Study|Randomized but not treated|2
6813823|NCT00021255|10817996|FG002|Overall Study|Randomized but not treated|18
6813824|NCT00021541|10818006|FG000|Period 1-First Treatment|Withdrawal by Subject|3
6813825|NCT00021541|10818007|FG001|Period 1-First Treatment|Withdrawal by Subject|3
6813826|NCT00021541|10818006|FG000|Period 1-First Treatment|Adverse Event|2
6813827|NCT00021541|10818007|FG001|Period 1-First Treatment|Adverse Event|1
6813828|NCT00021541|10818006|FG000|Period 1-First Treatment|non-adherence|3
6813829|NCT00021541|10818007|FG001|Period 1-First Treatment|non-adherence|0
6813830|NCT00021541|10818006|FG000|Period 1-First Treatment|Death|1
6813831|NCT00021541|10818007|FG001|Period 1-First Treatment|Death|0
6813832|NCT00021541|10818006|FG000|Period 1-First Treatment|Pts that did not progress|2
6813833|NCT00021541|10818007|FG001|Period 1-First Treatment|Pts that did not progress|2
6813834|NCT00021541|10818006|FG000|Period 1-First Treatment|Ineligible|0
6813835|NCT00021541|10818007|FG001|Period 1-First Treatment|Ineligible|2
6813836|NCT00021541|10818006|FG000|Period 2-crossover|refused phase B|2
6813837|NCT00021541|10818007|FG001|Period 2-crossover|refused phase B|2
6813838|NCT00021541|10818006|FG000|Period 2-crossover|Withdrawal by Subject|3
6813839|NCT00021541|10818007|FG001|Period 2-crossover|Withdrawal by Subject|4
6813840|NCT00021541|10818006|FG000|Period 2-crossover|Adverse Event|2
6813841|NCT00021541|10818007|FG001|Period 2-crossover|Adverse Event|2
6813842|NCT00021541|10818006|FG000|Period 2-crossover|non-adherence|1
6813843|NCT00021541|10818007|FG001|Period 2-crossover|non-adherence|0
6813844|NCT00021541|10818006|FG000|Period 2-crossover|Pts that did not progress|2
6813845|NCT00021541|10818007|FG001|Period 2-crossover|Pts that did not progress|3
6813846|NCT00022516|10818021|FG000|Overall Study|Adverse Event|0
6813847|NCT00022516|10818022|FG001|Overall Study|Adverse Event|59
6813848|NCT00022516|10818021|FG000|Overall Study|Lack of Efficacy|0
6813849|NCT00022516|10818022|FG001|Overall Study|Lack of Efficacy|27
6813850|NCT00022516|10818021|FG000|Overall Study|Physician Decision|0
6813851|NCT00022516|10818022|FG001|Overall Study|Physician Decision|1
6813852|NCT00022516|10818021|FG000|Overall Study|Protocol Violation|1
6813853|NCT00022516|10818022|FG001|Overall Study|Protocol Violation|3
6813854|NCT00022516|10818021|FG000|Overall Study|Withdrawal by Subject|2
6813855|NCT00022516|10818022|FG001|Overall Study|Withdrawal by Subject|113
6813856|NCT00022516|10818021|FG000|Overall Study|Incomplete documentation|0
6813857|NCT00022516|10818022|FG001|Overall Study|Incomplete documentation|27
6813858|NCT00022633|10818030|FG000|Overall Study|Adverse Event|11
6813859|NCT00022633|10818031|FG001|Overall Study|Adverse Event|1
6813860|NCT00022633|10818030|FG000|Overall Study|Refusal unrelated to adverse event|1
6813861|NCT00022633|10818031|FG001|Overall Study|Refusal unrelated to adverse event|0
6813862|NCT00022633|10818030|FG000|Overall Study|Progression/relapse|9
6813863|NCT00022633|10818031|FG001|Overall Study|Progression/relapse|2
6813864|NCT00022633|10818030|FG000|Overall Study|Death|4
6813865|NCT00022633|10818031|FG001|Overall Study|Death|0
6813866|NCT00022633|10818030|FG000|Overall Study|Other - not protocol specified|3
6813867|NCT00022633|10818031|FG001|Overall Study|Other - not protocol specified|2
6813868|NCT00022633|10818030|FG000|Overall Study|Ineligible|4
6813869|NCT00022633|10818031|FG001|Overall Study|Ineligible|0
6813870|NCT00022659|10818036|FG000|Overall Study|Ineligible: wrong primary|1
6813871|NCT00022659|10818036|FG000|Overall Study|Never treated|1
6813872|NCT00022672|10818046|FG000|Main Phase: 24 Months|Adverse Event|6
6813873|NCT00022672|10818047|FG001|Main Phase: 24 Months|Adverse Event|0
6813874|NCT00022672|10818046|FG000|Main Phase: 24 Months|Death|0
6813875|NCT00022672|10818047|FG001|Main Phase: 24 Months|Death|3
6813876|NCT00022672|10818046|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75
6813877|NCT00022672|10818047|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91
6813878|NCT00022672|10818046|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0
6813879|NCT00022672|10818047|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1
6813880|NCT00022672|10818046|FG000|Main Phase: 24 Months|Other Protocol Violation|1
6813881|NCT00022672|10818047|FG001|Main Phase: 24 Months|Other Protocol Violation|0
6813882|NCT00022672|10818046|FG000|Main Phase: 24 Months|Refused Treatment|3
6813883|NCT00022672|10818047|FG001|Main Phase: 24 Months|Refused Treatment|4
6813884|NCT00022672|10818046|FG000|Main Phase: 24 Months|Failure to Return|1
6813885|NCT00022672|10818047|FG001|Main Phase: 24 Months|Failure to Return|1
6813886|NCT00022672|10818046|FG000|Main Phase: 24 Months|Other|1
6813887|NCT00022672|10818047|FG001|Main Phase: 24 Months|Other|0
6813888|NCT00022672|10818046|FG000|Extension Phase|Adverse Event|1
6813889|NCT00022672|10818047|FG001|Extension Phase|Adverse Event|3
6813890|NCT00022672|10818046|FG000|Extension Phase|Death|0
6813891|NCT00022672|10818047|FG001|Extension Phase|Death|1
6813892|NCT00022672|10818046|FG000|Extension Phase|Insufficient Therapeutic Response|1
6813893|NCT00022672|10818047|FG001|Extension Phase|Insufficient Therapeutic Response|44
6813894|NCT00022672|10818046|FG000|Extension Phase|Refused Treatment|0
6813895|NCT00022672|10818047|FG001|Extension Phase|Refused Treatment|2
6813896|NCT00022672|10818046|FG000|Extension Phase|Other|1
6813897|NCT00022672|10818047|FG001|Extension Phase|Other|1
6813898|NCT00022698|10818056|FG000|Overall Study|Adverse Event|5
6813899|NCT00022698|10818057|FG001|Overall Study|Adverse Event|9
6813900|NCT00022698|10818056|FG000|Overall Study|Death|0
6813901|NCT00022698|10818057|FG001|Overall Study|Death|2
6813902|NCT00022698|10818056|FG000|Overall Study|Failure to return|0
6813903|NCT00022698|10818057|FG001|Overall Study|Failure to return|1
6813904|NCT00022698|10818056|FG000|Overall Study|Refused treatment|0
6813905|NCT00022698|10818057|FG001|Overall Study|Refused treatment|2
6813906|NCT00022698|10818056|FG000|Overall Study|Insufficient therapeutic response|2
6813907|NCT00022698|10818057|FG001|Overall Study|Insufficient therapeutic response|14
6813908|NCT00022698|10818056|FG000|Overall Study|Administrative /other|1
6813909|NCT00022698|10818057|FG001|Overall Study|Administrative /other|7
6813910|NCT00022763|10818067|FG000|Overall Study|Adverse Event|1
6813911|NCT00022763|10818068|FG001|Overall Study|Adverse Event|2
6813912|NCT00022763|10818067|FG000|Overall Study|Injection Site Reactions|0
6813913|NCT00022763|10818068|FG001|Overall Study|Injection Site Reactions|2
6813914|NCT00022763|10818067|FG000|Overall Study|Death|0
6813915|NCT00022763|10818068|FG001|Overall Study|Death|1
6813916|NCT00022763|10818067|FG000|Overall Study|Lost to Follow-up|0
6813917|NCT00022763|10818068|FG001|Overall Study|Lost to Follow-up|3
6813918|NCT00022763|10818067|FG000|Overall Study|Withdrawal by Subject|4
6813919|NCT00022763|10818068|FG001|Overall Study|Withdrawal by Subject|7
6813920|NCT00022763|10818067|FG000|Overall Study|Insufficient Therapy|1
6813921|NCT00022763|10818068|FG001|Overall Study|Insufficient Therapy|0
6813922|NCT00022763|10818067|FG000|Overall Study|Admin|3
6813923|NCT00022763|10818068|FG001|Overall Study|Admin|2
6813924|NCT00023322|10818082|FG000|Overall Study|Lost to Follow-up|1
6813925|NCT00023452|10818088|FG000|Overall Study|Ineligible for Study|163
6813926|NCT00023452|10818089|FG001|Overall Study|Ineligible for Study|159
6813927|NCT00023452|10818088|FG000|Overall Study|Out of Window|129
6813928|NCT00023452|10818089|FG001|Overall Study|Out of Window|69
6813929|NCT00023452|10818088|FG000|Overall Study|Death|2
6813930|NCT00023452|10818089|FG001|Overall Study|Death|0
6813931|NCT00023452|10818088|FG000|Overall Study|Withdrawal by Subject|66
6813932|NCT00023452|10818089|FG001|Overall Study|Withdrawal by Subject|54
6813933|NCT00023452|10818088|FG000|Overall Study|Adverse Event|139
6813934|NCT00023452|10818089|FG001|Overall Study|Adverse Event|196
6813935|NCT00023452|10818088|FG000|Overall Study|Lost to Follow-up|293
6813936|NCT00023452|10818089|FG001|Overall Study|Lost to Follow-up|60
6813937|NCT00023452|10818088|FG000|Overall Study|Physician Decision|49
6813938|NCT00023452|10818089|FG001|Overall Study|Physician Decision|21
6813939|NCT00023452|10818088|FG000|Overall Study|Refused Treatment (continued follow-up)|225
6813940|NCT00023452|10818089|FG001|Overall Study|Refused Treatment (continued follow-up)|224
6813941|NCT00023452|10818088|FG000|Overall Study|Pregnant|53
6813942|NCT00023452|10818089|FG001|Overall Study|Pregnant|20
6813943|NCT00023452|10818088|FG000|Overall Study|Other|204
6813944|NCT00023452|10818089|FG001|Overall Study|Other|69
6813945|NCT00023595|10818104|FG000|5 Year Follow up|Lost to Follow-up|2
6813946|NCT00023595|10818105|FG001|5 Year Follow up|Lost to Follow-up|2
6813947|NCT00023595|10818106|FG002|5 Year Follow up|Lost to Follow-up|1
6813948|NCT00023595|10818107|FG003|5 Year Follow up|Lost to Follow-up|7
6813949|NCT00023595|10818108|FG004|5 Year Follow up|Lost to Follow-up|3
6813950|NCT00023595|10818104|FG000|10 Year Follow up|Lost to Follow-up|12
6813951|NCT00023595|10818105|FG001|10 Year Follow up|Lost to Follow-up|10
6813952|NCT00023595|10818106|FG002|10 Year Follow up|Lost to Follow-up|3
6813953|NCT00023595|10818107|FG003|10 Year Follow up|Lost to Follow-up|0
6813954|NCT00023595|10818108|FG004|10 Year Follow up|Lost to Follow-up|0
6813955|NCT00023673|10818134|FG000|Overall Study|Ineligible / no protocol treatment|0
6813956|NCT00023673|10818135|FG001|Overall Study|Ineligible / no protocol treatment|0
6813957|NCT00023673|10818136|FG002|Overall Study|Ineligible / no protocol treatment|0
6813958|NCT00023673|10818137|FG003|Overall Study|Ineligible / no protocol treatment|1
6813959|NCT00023673|10818134|FG000|Overall Study|Patient withdrew consent|0
6813960|NCT00023673|10818135|FG001|Overall Study|Patient withdrew consent|0
6813961|NCT00023673|10818136|FG002|Overall Study|Patient withdrew consent|0
6813962|NCT00023673|10818137|FG003|Overall Study|Patient withdrew consent|1
6813963|NCT00023712|10818149|FG000|Overall Study|Not platinum sensitive|1
6813964|NCT00023712|10818150|FG001|Overall Study|Not platinum sensitive|0
6813965|NCT00023712|10818149|FG000|Overall Study|Never treated|1
6813966|NCT00023712|10818150|FG001|Overall Study|Never treated|1
6813967|NCT00023764|10818166|FG000|Overall Study|Other|1
6813968|NCT00023764|10818166|FG000|Overall Study|Adverse Event|4
6813969|NCT00023764|10818166|FG000|Overall Study|Withdrawal by Subject|1
6813970|NCT00023764|10818166|FG000|Overall Study|Progression of disease|6
6813971|NCT00023764|10818166|FG000|Overall Study|patient received other treatment|1
6813972|NCT00023764|10818166|FG000|Overall Study|delay in obtaining staging images|1
6813973|NCT00024167|10818187|FG000|Overall Study|Death|53
6813974|NCT00024167|10818188|FG001|Overall Study|Death|47
6813975|NCT00024258|10818195|FG000|Overall Study|Withdrawal by Subject|1
6813976|NCT00024258|10818195|FG000|Overall Study|Disease Progression|8
6813977|NCT00025155|10818199|FG000|Overall Study|Ineligible: Wrong primary cancer site|1
6813978|NCT00025155|10818199|FG000|Overall Study|Ineligible: Second primary cancer site|1
6813979|NCT00025233|10818208|FG000|Overall Study|Ineligible: wrong cell type|1
6813980|NCT00025233|10818208|FG000|Overall Study|Ineligible: wrong primary|1
6813981|NCT00025233|10818208|FG000|Overall Study|Ineligible: improper prior treatment|1
6813982|NCT00025233|10818208|FG000|Overall Study|Never treated|1
6813983|NCT00025259|10818225|FG000|Overall Study|Death|1
6813984|NCT00025259|10818226|FG001|Overall Study|Death|3
6813985|NCT00025259|10818227|FG002|Overall Study|Death|0
6813986|NCT00025259|10818228|FG003|Overall Study|Death|3
6813987|NCT00025259|10818229|FG004|Overall Study|Death|0
6813988|NCT00025259|10818230|FG005|Overall Study|Death|1
6813989|NCT00025259|10818231|FG006|Overall Study|Death|2
6813990|NCT00025259|10818225|FG000|Overall Study|Lack of Efficacy|2
6813991|NCT00025259|10818226|FG001|Overall Study|Lack of Efficacy|46
6813992|NCT00025259|10818227|FG002|Overall Study|Lack of Efficacy|60
6813993|NCT00025259|10818228|FG003|Overall Study|Lack of Efficacy|78
6813994|NCT00025259|10818229|FG004|Overall Study|Lack of Efficacy|11
6813995|NCT00025259|10818230|FG005|Overall Study|Lack of Efficacy|30
6813996|NCT00025259|10818231|FG006|Overall Study|Lack of Efficacy|38
6813997|NCT00025259|10818225|FG000|Overall Study|Lost to Follow-up|2
6813998|NCT00025259|10818226|FG001|Overall Study|Lost to Follow-up|9
6813999|NCT00025259|10818227|FG002|Overall Study|Lost to Follow-up|13
6814000|NCT00025259|10818228|FG003|Overall Study|Lost to Follow-up|13
6814001|NCT00025259|10818229|FG004|Overall Study|Lost to Follow-up|1
6814002|NCT00025259|10818230|FG005|Overall Study|Lost to Follow-up|3
6814003|NCT00025259|10818231|FG006|Overall Study|Lost to Follow-up|1
6814004|NCT00025259|10818225|FG000|Overall Study|Physician Decision|12
6814005|NCT00025259|10818226|FG001|Overall Study|Physician Decision|1
6814006|NCT00025259|10818227|FG002|Overall Study|Physician Decision|0
6814007|NCT00025259|10818228|FG003|Overall Study|Physician Decision|5
6814008|NCT00025259|10818229|FG004|Overall Study|Physician Decision|4
6814009|NCT00025259|10818230|FG005|Overall Study|Physician Decision|2
6814010|NCT00025259|10818231|FG006|Overall Study|Physician Decision|1
6814011|NCT00025259|10818225|FG000|Overall Study|Protocol Violation|3
6814012|NCT00025259|10818226|FG001|Overall Study|Protocol Violation|2
6814013|NCT00025259|10818227|FG002|Overall Study|Protocol Violation|2
6814014|NCT00025259|10818228|FG003|Overall Study|Protocol Violation|1
6814015|NCT00025259|10818229|FG004|Overall Study|Protocol Violation|2
6814016|NCT00025259|10818230|FG005|Overall Study|Protocol Violation|1
6814017|NCT00025259|10818231|FG006|Overall Study|Protocol Violation|3
6814018|NCT00025259|10818225|FG000|Overall Study|Withdrawal by Subject|9
6814019|NCT00025259|10818226|FG001|Overall Study|Withdrawal by Subject|27
6814020|NCT00025259|10818227|FG002|Overall Study|Withdrawal by Subject|6
6814021|NCT00025259|10818228|FG003|Overall Study|Withdrawal by Subject|14
6814022|NCT00025259|10818229|FG004|Overall Study|Withdrawal by Subject|11
6814023|NCT00025259|10818230|FG005|Overall Study|Withdrawal by Subject|8
6814024|NCT00025259|10818231|FG006|Overall Study|Withdrawal by Subject|3
6814025|NCT00025259|10818225|FG000|Overall Study|Ineligible|14
6814026|NCT00025259|10818226|FG001|Overall Study|Ineligible|1
6814027|NCT00025259|10818227|FG002|Overall Study|Ineligible|0
6814028|NCT00025259|10818228|FG003|Overall Study|Ineligible|0
6814029|NCT00025259|10818229|FG004|Overall Study|Ineligible|6
6814030|NCT00025259|10818230|FG005|Overall Study|Ineligible|0
6814031|NCT00025259|10818231|FG006|Overall Study|Ineligible|1
6814032|NCT00025259|10818225|FG000|Overall Study|Randomization error|1
6814033|NCT00025259|10818226|FG001|Overall Study|Randomization error|0
6814034|NCT00025259|10818227|FG002|Overall Study|Randomization error|0
6814035|NCT00025259|10818228|FG003|Overall Study|Randomization error|0
6814036|NCT00025259|10818229|FG004|Overall Study|Randomization error|1
6814037|NCT00025259|10818230|FG005|Overall Study|Randomization error|7
6814038|NCT00025259|10818231|FG006|Overall Study|Randomization error|2
6814039|NCT00025259|10818225|FG000|Overall Study|Adverse Event|1
6814040|NCT00025259|10818226|FG001|Overall Study|Adverse Event|0
6814041|NCT00025259|10818227|FG002|Overall Study|Adverse Event|0
6814042|NCT00025259|10818228|FG003|Overall Study|Adverse Event|0
6814043|NCT00025259|10818229|FG004|Overall Study|Adverse Event|0
6814044|NCT00025259|10818230|FG005|Overall Study|Adverse Event|0
6814045|NCT00025259|10818231|FG006|Overall Study|Adverse Event|0
6814046|NCT00025506|10818250|FG000|Overall Study|Ineligible: clerical error|1
6814047|NCT00025506|10818250|FG000|Overall Study|Ineligible: wrong cell type|5
6814048|NCT00025506|10818250|FG000|Overall Study|Ineligible: inadequate pathology|2
6814049|NCT00025506|10818250|FG000|Overall Study|Never Treated|2
6814050|NCT00025662|10818259|FG000|Overall Study|Withdrawal by Subject|2
6814051|NCT00025662|10818259|FG000|Overall Study|Technical failure of manipulation|1
6814052|NCT00025883|10818265|FG000|Overall Study|had atypical progeriod lipodystrophy|4
6814053|NCT00025883|10818265|FG000|Overall Study|no baseline data|1
6814054|NCT00025883|10818265|FG000|Overall Study|Death|1
6814055|NCT00025883|10818265|FG000|Overall Study|Adverse Event|1
6814056|NCT00025883|10818265|FG000|Overall Study|didn't reach 6 months of Metreleptin|10
6814057|NCT00026208|10818272|FG000|Overall Study|Complications of auto accident|1
6814058|NCT00026208|10818273|FG001|Overall Study|Complications of auto accident|0
6814059|NCT00026494|10818296|FG000|Overall Study|Withdrawal by Subject|1
6814060|NCT00026494|10818297|FG001|Overall Study|Withdrawal by Subject|0
6814061|NCT00026494|10818298|FG002|Overall Study|Withdrawal by Subject|1
6814062|NCT00026494|10818299|FG003|Overall Study|Withdrawal by Subject|0
6814063|NCT00026494|10818296|FG000|Overall Study|Patient non-compliance|1
6814064|NCT00026494|10818297|FG001|Overall Study|Patient non-compliance|0
6814065|NCT00026494|10818298|FG002|Overall Study|Patient non-compliance|0
6814066|NCT00026494|10818299|FG003|Overall Study|Patient non-compliance|0
6814067|NCT00026494|10818296|FG000|Overall Study|Patient not treated|0
6814068|NCT00026494|10818297|FG001|Overall Study|Patient not treated|0
6814069|NCT00026494|10818298|FG002|Overall Study|Patient not treated|2
6814070|NCT00026494|10818299|FG003|Overall Study|Patient not treated|0
6814071|NCT00026494|10818296|FG000|Overall Study|Clinical progression|0
6814072|NCT00026494|10818297|FG001|Overall Study|Clinical progression|0
6814073|NCT00026494|10818298|FG002|Overall Study|Clinical progression|3
6814074|NCT00026494|10818299|FG003|Overall Study|Clinical progression|0
6814075|NCT00026793|10818309|FG000|Overall Study|Death on study due to underlying disease|4
6814076|NCT00026793|10818309|FG000|Overall Study|Physician Decision|2
6814077|NCT00026793|10818309|FG000|Overall Study|Off study|2
6814078|NCT00027027|10818318|FG000|Overall Study|Adverse Event|0
6814079|NCT00027027|10818319|FG001|Overall Study|Adverse Event|0
6814080|NCT00027027|10818320|FG002|Overall Study|Adverse Event|1
6814081|NCT00027027|10818321|FG003|Overall Study|Adverse Event|0
6814082|NCT00027027|10818322|FG004|Overall Study|Adverse Event|1
6814083|NCT00027027|10818318|FG000|Overall Study|Admitted for Signs of PD|0
6814084|NCT00027027|10818319|FG001|Overall Study|Admitted for Signs of PD|0
6814085|NCT00027027|10818320|FG002|Overall Study|Admitted for Signs of PD|0
6814086|NCT00027027|10818321|FG003|Overall Study|Admitted for Signs of PD|0
6814087|NCT00027027|10818322|FG004|Overall Study|Admitted for Signs of PD|1
6814088|NCT00027027|10818318|FG000|Overall Study|Clinical Symptoms Progression not PD|1
6814089|NCT00027027|10818319|FG001|Overall Study|Clinical Symptoms Progression not PD|0
6814090|NCT00027027|10818320|FG002|Overall Study|Clinical Symptoms Progression not PD|0
6814091|NCT00027027|10818321|FG003|Overall Study|Clinical Symptoms Progression not PD|0
6814092|NCT00027027|10818322|FG004|Overall Study|Clinical Symptoms Progression not PD|0
6814093|NCT00027027|10818318|FG000|Overall Study|PD Requiring Surgery|0
6814094|NCT00027027|10818319|FG001|Overall Study|PD Requiring Surgery|0
6814095|NCT00027027|10818320|FG002|Overall Study|PD Requiring Surgery|1
6814096|NCT00027027|10818321|FG003|Overall Study|PD Requiring Surgery|0
6814097|NCT00027027|10818322|FG004|Overall Study|PD Requiring Surgery|0
6814098|NCT00027027|10818318|FG000|Overall Study|Physician Decision Due To PD|2
6814099|NCT00027027|10818319|FG001|Overall Study|Physician Decision Due To PD|3
6814100|NCT00027027|10818320|FG002|Overall Study|Physician Decision Due To PD|2
6814101|NCT00027027|10818321|FG003|Overall Study|Physician Decision Due To PD|3
6814102|NCT00027027|10818322|FG004|Overall Study|Physician Decision Due To PD|5
6814103|NCT00027027|10818318|FG000|Overall Study|Withdrawal by Subject|0
6814104|NCT00027027|10818319|FG001|Overall Study|Withdrawal by Subject|0
6814105|NCT00027027|10818320|FG002|Overall Study|Withdrawal by Subject|0
6814106|NCT00027027|10818321|FG003|Overall Study|Withdrawal by Subject|0
6814107|NCT00027027|10818322|FG004|Overall Study|Withdrawal by Subject|1
6814108|NCT00027378|10818340|FG000|Overall Study|Physician Decision|0
6814109|NCT00027378|10818341|FG001|Overall Study|Physician Decision|3
6814110|NCT00027560|10818347|FG000|Overall Study|Withdrawal by Subject|1
6814111|NCT00027846|10818356|FG000|Overall Study|Lost to Follow-up|0
6814112|NCT00027846|10818357|FG001|Overall Study|Lost to Follow-up|41
6814113|NCT00027846|10818358|FG002|Overall Study|Lost to Follow-up|9
6814114|NCT00027846|10818356|FG000|Overall Study|Withdrawal by Subject|0
6814115|NCT00027846|10818357|FG001|Overall Study|Withdrawal by Subject|14
6814116|NCT00027846|10818358|FG002|Overall Study|Withdrawal by Subject|7
6814117|NCT00027846|10818356|FG000|Overall Study|Ineligible for study|2
6814118|NCT00027846|10818357|FG001|Overall Study|Ineligible for study|6
6814119|NCT00027846|10818358|FG002|Overall Study|Ineligible for study|14
6814120|NCT00027846|10818356|FG000|Overall Study|Entry into another COG therapeutic study|0
6814121|NCT00027846|10818357|FG001|Overall Study|Entry into another COG therapeutic study|5
6814122|NCT00027846|10818358|FG002|Overall Study|Entry into another COG therapeutic study|2
6814123|NCT00027846|10818356|FG000|Overall Study|Neuraxis dissemination during/after ther|0
6814124|NCT00027846|10818357|FG001|Overall Study|Neuraxis dissemination during/after ther|2
6814125|NCT00027846|10818358|FG002|Overall Study|Neuraxis dissemination during/after ther|5
6814126|NCT00028002|10818368|FG000|Overall Study|Withdrawal by Subject|3
6814127|NCT00028002|10818368|FG000|Overall Study|Ineligible|8
6814128|NCT00028769|10818386|FG000|Overall Study|Adverse Event|2
6814129|NCT00028769|10818386|FG000|Overall Study|Refusal Unrelated to Adverse Events|1
6814130|NCT00028769|10818386|FG000|Overall Study|Progression or Death|31
6814131|NCT00028769|10818386|FG000|Overall Study|Other - Not Protocol Specified|1
6814132|NCT00028769|10818386|FG000|Overall Study|Ineligible|5
6814133|NCT00028769|10818386|FG000|Overall Study|Not Analyzable|1
6814134|NCT00029146|10818401|FG000|Overall Study|Lost to Follow-up|2
6814135|NCT00029146|10818402|FG001|Overall Study|Lost to Follow-up|1
6814136|NCT00030823|10818452|FG000|Overall Study|Withdrawal by Subject|1
6814137|NCT00030901|10818458|FG000|Initial Registration|Ineligible|167
6814138|NCT00030901|10818459|FG001|Initial Registration|Ineligible|0
6814139|NCT00030901|10818460|FG002|Initial Registration|Ineligible|0
6814140|NCT00030901|10818458|FG000|Randomization|Adverse Event|0
6814141|NCT00030901|10818459|FG001|Randomization|Adverse Event|11
6814142|NCT00030901|10818460|FG002|Randomization|Adverse Event|7
6814143|NCT00030901|10818458|FG000|Randomization|Refusal Unrelated to Adverse Event|0
6814144|NCT00030901|10818459|FG001|Randomization|Refusal Unrelated to Adverse Event|16
6814145|NCT00030901|10818460|FG002|Randomization|Refusal Unrelated to Adverse Event|10
6814146|NCT00030901|10818458|FG000|Randomization|Progression/Relapse|0
6814147|NCT00030901|10818459|FG001|Randomization|Progression/Relapse|22
6814148|NCT00030901|10818460|FG002|Randomization|Progression/Relapse|21
6814149|NCT00030901|10818458|FG000|Randomization|Death|0
6814150|NCT00030901|10818459|FG001|Randomization|Death|1
6814151|NCT00030901|10818460|FG002|Randomization|Death|3
6814152|NCT00030901|10818458|FG000|Randomization|Other|0
6814153|NCT00030901|10818459|FG001|Randomization|Other|36
6814154|NCT00030901|10818460|FG002|Randomization|Other|33
6814155|NCT00030901|10818458|FG000|Randomization|Ineligible|0
6814156|NCT00030901|10818459|FG001|Randomization|Ineligible|15
6814157|NCT00030901|10818460|FG002|Randomization|Ineligible|14
6814158|NCT00031447|10818472|FG000|Overall Study|Lost to Follow-up|0
6814159|NCT00031447|10818473|FG001|Overall Study|Lost to Follow-up|1
6814160|NCT00031447|10818472|FG000|Overall Study|Non-compliant|1
6814161|NCT00031447|10818473|FG001|Overall Study|Non-compliant|1
6814162|NCT00031447|10818472|FG000|Overall Study|Re-activation of Disease|2
6814163|NCT00031447|10818473|FG001|Overall Study|Re-activation of Disease|1
6814164|NCT00031447|10818472|FG000|Overall Study|Disruption of blinded study drug supply|7
6814165|NCT00031447|10818473|FG001|Overall Study|Disruption of blinded study drug supply|4
6814166|NCT00031460|10818481|FG000|Overall Study|Lost to Follow-up|0
6814167|NCT00031460|10818482|FG001|Overall Study|Lost to Follow-up|1
6814168|NCT00031460|10818481|FG000|Overall Study|Withdrawal by Subject|1
6814169|NCT00031460|10818482|FG001|Overall Study|Withdrawal by Subject|1
6814170|NCT00031460|10818481|FG000|Overall Study|Non-Compliant|1
6814171|NCT00031460|10818482|FG001|Overall Study|Non-Compliant|1
6814172|NCT00031460|10818481|FG000|Overall Study|Death|0
6814173|NCT00031460|10818482|FG001|Overall Study|Death|1
6814174|NCT00031460|10818481|FG000|Overall Study|Reactivation of Disease|5
6814175|NCT00031460|10818482|FG001|Overall Study|Reactivation of Disease|9
6814176|NCT00031460|10818481|FG000|Overall Study|Disruption of blinded drug supply|2
6814177|NCT00031460|10818482|FG001|Overall Study|Disruption of blinded drug supply|0
6814178|NCT00031460|10818481|FG000|Overall Study|Confirmed unevaluable|0
6814179|NCT00031460|10818482|FG001|Overall Study|Confirmed unevaluable|1
6814180|NCT00031486|10818490|FG000|Overall Study|Adverse Event|1
6814181|NCT00031486|10818491|FG001|Overall Study|Adverse Event|0
6814182|NCT00031486|10818490|FG000|Overall Study|Lost to Follow-up|0
6814183|NCT00031486|10818491|FG001|Overall Study|Lost to Follow-up|1
6814184|NCT00031486|10818490|FG000|Overall Study|Withdrawal by Subject|3
6814185|NCT00031486|10818491|FG001|Overall Study|Withdrawal by Subject|2
6814186|NCT00031486|10818490|FG000|Overall Study|Death|0
6814187|NCT00031486|10818491|FG001|Overall Study|Death|3
6814188|NCT00031486|10818490|FG000|Overall Study|Non-compliant|0
6814189|NCT00031486|10818491|FG001|Overall Study|Non-compliant|4
6814190|NCT00031486|10818490|FG000|Overall Study|Did not meet eligibility requirement|2
6814191|NCT00031486|10818491|FG001|Overall Study|Did not meet eligibility requirement|1
6814192|NCT00031486|10818490|FG000|Overall Study|Other|1
6814193|NCT00031486|10818491|FG001|Overall Study|Other|1
6814194|NCT00031551|10818501|FG000|Overall Study|Withdrew due to chemotherapy effects|2
6814195|NCT00031551|10818502|FG001|Overall Study|Withdrew due to chemotherapy effects|0
6814196|NCT00031590|10818512|FG000|Overall Study|Adverse Event|1
6814197|NCT00031590|10818512|FG000|Overall Study|Withdrawal by parents|2
6814198|NCT00031694|10818517|FG000|Overall Study|Adverse Event|12
6814199|NCT00031694|10818517|FG000|Overall Study|Death|2
6814200|NCT00031694|10818517|FG000|Overall Study|Withdrawal by Subject|5
6814201|NCT00032487|10818524|FG000|Overall Study|Withdrawal by Subject|67
6814202|NCT00032487|10818525|FG001|Overall Study|Withdrawal by Subject|43
6814203|NCT00032487|10818524|FG000|Overall Study|Adverse Event|3
6814204|NCT00032487|10818525|FG001|Overall Study|Adverse Event|7
6814205|NCT00032487|10818524|FG000|Overall Study|Lost to Follow-up|57
6814206|NCT00032487|10818525|FG001|Overall Study|Lost to Follow-up|58
6814207|NCT00032487|10818524|FG000|Overall Study|Had other reason|12
6814208|NCT00032487|10818525|FG001|Overall Study|Had other reason|12
6814209|NCT00033371|10818551|FG000|Overall Study|Adverse Event|1
6814210|NCT00033371|10818552|FG001|Overall Study|Adverse Event|5
6814211|NCT00033371|10818551|FG000|Overall Study|Lost to Follow-up|2
6814212|NCT00033371|10818552|FG001|Overall Study|Lost to Follow-up|1
6814213|NCT00033371|10818551|FG000|Overall Study|Withdrawal by Subject|3
6814214|NCT00033371|10818552|FG001|Overall Study|Withdrawal by Subject|3
6814215|NCT00033371|10818551|FG000|Overall Study|Disease Progression|0
6814216|NCT00033371|10818552|FG001|Overall Study|Disease Progression|1
6814217|NCT00033514|10818564|FG000|Overall Study|Lost to Follow-up|1
6814218|NCT00033514|10818565|FG001|Overall Study|Lost to Follow-up|1
6814219|NCT00033514|10818564|FG000|Overall Study|Withdrawal by Subject|0
6814220|NCT00033514|10818565|FG001|Overall Study|Withdrawal by Subject|3
6814221|NCT00033540|10818572|FG000|Overall Study|Adverse Event|14
6814222|NCT00033540|10818572|FG000|Overall Study|Death|1
6814223|NCT00033540|10818572|FG000|Overall Study|Progression|26
6814224|NCT00033540|10818572|FG000|Overall Study|Withdrawal by Subject|6
6814225|NCT00033540|10818572|FG000|Overall Study|Other|5
6814226|NCT00033540|10818572|FG000|Overall Study|Ineligible|3
6814227|NCT00033540|10818572|FG000|Overall Study|Never received treatment|2
6814228|NCT00033631|10818579|FG000|Overall Study|Protocol Violation|14
6814229|NCT00033631|10818580|FG001|Overall Study|Protocol Violation|11
6814230|NCT00033631|10818579|FG000|Overall Study|Withdrawal by Subject|4
6814231|NCT00033631|10818580|FG001|Overall Study|Withdrawal by Subject|4
6814232|NCT00033657|10818589|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1
6814233|NCT00033657|10818590|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2
6814234|NCT00033657|10818589|FG000|Neoadjuvant Chemotherapy|Adverse Event|0
6814235|NCT00033657|10818590|FG001|Neoadjuvant Chemotherapy|Adverse Event|2
6814236|NCT00033657|10818589|FG000|Neoadjuvant Chemotherapy|Death|1
6814237|NCT00033657|10818590|FG001|Neoadjuvant Chemotherapy|Death|1
6814238|NCT00033657|10818589|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
6814239|NCT00033657|10818590|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0
6814240|NCT00033657|10818589|FG000|Neoadjuvant Chemotherapy|other complicating disease|0
6814241|NCT00033657|10818590|FG001|Neoadjuvant Chemotherapy|other complicating disease|1
6814242|NCT00033657|10818589|FG000|Neoadjuvant Chemotherapy|Ineligible|8
6814243|NCT00033657|10818590|FG001|Neoadjuvant Chemotherapy|Ineligible|4
6814244|NCT00033657|10818589|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3
6814245|NCT00033657|10818590|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1
6814246|NCT00033657|10818589|FG000|Surgical Resection|not complete resection|0
6814247|NCT00033657|10818590|FG001|Surgical Resection|not complete resection|3
6814248|NCT00033657|10818589|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3
6814249|NCT00033657|10818590|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1
6814250|NCT00033657|10818589|FG000|Adjuvant Chemotherapy|Adverse Event|7
6814251|NCT00033657|10818590|FG001|Adjuvant Chemotherapy|Adverse Event|10
6814252|NCT00033657|10818589|FG000|Adjuvant Chemotherapy|Death|2
6814253|NCT00033657|10818590|FG001|Adjuvant Chemotherapy|Death|1
6814254|NCT00033657|10818589|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5
6814255|NCT00033657|10818590|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3
6814256|NCT00033657|10818589|FG000|Adjuvant Chemotherapy|alternative therapy|1
6814257|NCT00033657|10818590|FG001|Adjuvant Chemotherapy|alternative therapy|0
6814258|NCT00033657|10818589|FG000|Adjuvant Chemotherapy|Other|0
6814259|NCT00033657|10818590|FG001|Adjuvant Chemotherapy|Other|2
6814260|NCT00035555|10818614|FG000|Overall Study|Adverse Event|5
6814261|NCT00035555|10818615|FG001|Overall Study|Adverse Event|8
6814262|NCT00035555|10818616|FG002|Overall Study|Adverse Event|9
6814263|NCT00035555|10818614|FG000|Overall Study|Allograft loss|1
6814264|NCT00035555|10818615|FG001|Overall Study|Allograft loss|1
6814265|NCT00035555|10818616|FG002|Overall Study|Allograft loss|2
6814266|NCT00035555|10818614|FG000|Overall Study|Death|0
6814267|NCT00035555|10818615|FG001|Overall Study|Death|0
6814268|NCT00035555|10818616|FG002|Overall Study|Death|2
6814269|NCT00035555|10818614|FG000|Overall Study|Lost to Follow-up|0
6814270|NCT00035555|10818615|FG001|Overall Study|Lost to Follow-up|0
6814271|NCT00035555|10818616|FG002|Overall Study|Lost to Follow-up|1
6814272|NCT00035555|10818614|FG000|Overall Study|Noncompliance|0
6814273|NCT00035555|10818615|FG001|Overall Study|Noncompliance|1
6814274|NCT00035555|10818616|FG002|Overall Study|Noncompliance|1
6814275|NCT00035555|10818614|FG000|Overall Study|Prohibited medication|1
6814276|NCT00035555|10818615|FG001|Overall Study|Prohibited medication|1
6814277|NCT00035555|10818616|FG002|Overall Study|Prohibited medication|0
6814278|NCT00035555|10818614|FG000|Overall Study|Treatment failure/lack of efficacy|7
6814279|NCT00035555|10818615|FG001|Overall Study|Treatment failure/lack of efficacy|5
6814280|NCT00035555|10818616|FG002|Overall Study|Treatment failure/lack of efficacy|3
6814281|NCT00035555|10818614|FG000|Overall Study|Withdrawal by Subject|2
6814282|NCT00035555|10818615|FG001|Overall Study|Withdrawal by Subject|0
6814283|NCT00035555|10818616|FG002|Overall Study|Withdrawal by Subject|2
6814284|NCT00035555|10818614|FG000|Overall Study|Investigator deemed not a good candidate|0
6814285|NCT00035555|10818615|FG001|Overall Study|Investigator deemed not a good candidate|0
6814286|NCT00035555|10818616|FG002|Overall Study|Investigator deemed not a good candidate|1
6814287|NCT00035555|10818614|FG000|Overall Study|Received cyclosporin in error|0
6814288|NCT00035555|10818615|FG001|Overall Study|Received cyclosporin in error|0
6814289|NCT00035555|10818616|FG002|Overall Study|Received cyclosporin in error|1
6814290|NCT00035815|10818627|FG000|Overall Study|Withdrawal by Subject|17
6814291|NCT00035815|10818628|FG001|Overall Study|Withdrawal by Subject|11
6814292|NCT00035932|10818637|FG000|Overall Study|Adverse Event|10
6814293|NCT00035932|10818638|FG001|Overall Study|Adverse Event|9
6814294|NCT00035932|10818639|FG002|Overall Study|Adverse Event|9
6814295|NCT00035932|10818637|FG000|Overall Study|Death|0
6814296|NCT00035932|10818638|FG001|Overall Study|Death|0
6814297|NCT00035932|10818639|FG002|Overall Study|Death|1
6814298|NCT00035932|10818637|FG000|Overall Study|Disease Progression / Relapse|1
6814299|NCT00035932|10818638|FG001|Overall Study|Disease Progression / Relapse|1
6814300|NCT00035932|10818639|FG002|Overall Study|Disease Progression / Relapse|0
6814301|NCT00035932|10818637|FG000|Overall Study|Lost to Follow-up|4
6814302|NCT00035932|10818638|FG001|Overall Study|Lost to Follow-up|4
6814303|NCT00035932|10818639|FG002|Overall Study|Lost to Follow-up|3
6814304|NCT00035932|10818637|FG000|Overall Study|Noncompliance|6
6814305|NCT00035932|10818638|FG001|Overall Study|Noncompliance|7
6814306|NCT00035932|10818639|FG002|Overall Study|Noncompliance|6
6814307|NCT00035932|10818637|FG000|Overall Study|Protocol Violation While on Study|0
6814308|NCT00035932|10818638|FG001|Overall Study|Protocol Violation While on Study|1
6814309|NCT00035932|10818639|FG002|Overall Study|Protocol Violation While on Study|2
6814310|NCT00035932|10818637|FG000|Overall Study|Withdrawal by Subject|1
6814311|NCT00035932|10818638|FG001|Overall Study|Withdrawal by Subject|5
6814312|NCT00035932|10818639|FG002|Overall Study|Withdrawal by Subject|0
6814313|NCT00035932|10818637|FG000|Overall Study|Study Termination by Sponsor|1
6814314|NCT00035932|10818638|FG001|Overall Study|Study Termination by Sponsor|0
6814315|NCT00035932|10818639|FG002|Overall Study|Study Termination by Sponsor|0
6814316|NCT00035932|10818637|FG000|Overall Study|Lack of Efficacy|33
6814317|NCT00035932|10818638|FG001|Overall Study|Lack of Efficacy|33
6814318|NCT00035932|10818639|FG002|Overall Study|Lack of Efficacy|28
6814319|NCT00036270|10818654|FG000|Randomized to Study Treatment|Withdrawal by Subject|6
6814320|NCT00036270|10818655|FG001|Randomized to Study Treatment|Withdrawal by Subject|7
6814321|NCT00036270|10818654|FG000|Study Treatment to 5 Year Report|Ongoing|1081
6814322|NCT00036270|10818655|FG001|Study Treatment to 5 Year Report|Ongoing|736
6814323|NCT00036270|10818654|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507
6814324|NCT00036270|10818655|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447
6814325|NCT00036270|10818654|FG000|Study Treatment to 5 Year Report|Adverse Event|501
6814326|NCT00036270|10818655|FG001|Study Treatment to 5 Year Report|Adverse Event|782
6814327|NCT00036270|10818654|FG000|Study Treatment to 5 Year Report|Other|277
6814328|NCT00036270|10818655|FG001|Study Treatment to 5 Year Report|Other|288
6814329|NCT00036270|10818654|FG000|Study Treatment to 5 Year Report|Treatment refusal|113
6814330|NCT00036270|10818655|FG001|Study Treatment to 5 Year Report|Treatment refusal|208
6814331|NCT00036270|10818654|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46
6814332|NCT00036270|10818655|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54
6814333|NCT00036270|10818654|FG000|Study Treatment to 5 Year Report|Protocol Violation|23
6814334|NCT00036270|10818655|FG001|Study Treatment to 5 Year Report|Protocol Violation|91
6814335|NCT00036270|10818654|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17
6814336|NCT00036270|10818655|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29
6814337|NCT00036270|10818654|FG000|Study Treatment to 5 Year Report|Too early switch|0
6814338|NCT00036270|10818655|FG001|Study Treatment to 5 Year Report|Too early switch|103
6814339|NCT00036270|10818654|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0
6814340|NCT00036270|10818655|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750
6814341|NCT00037830|10818674|FG000|Overall Study|Adverse Event|2
6814342|NCT00037830|10818675|FG001|Overall Study|Adverse Event|0
6814343|NCT00037830|10818676|FG002|Overall Study|Adverse Event|0
6814344|NCT00037830|10818674|FG000|Overall Study|Withdrawal by Subject|4
6814345|NCT00037830|10818675|FG001|Overall Study|Withdrawal by Subject|5
6814346|NCT00037830|10818676|FG002|Overall Study|Withdrawal by Subject|1
6814347|NCT00037830|10818674|FG000|Overall Study|Protocol Violation|2
6814348|NCT00037830|10818675|FG001|Overall Study|Protocol Violation|2
6814349|NCT00037830|10818676|FG002|Overall Study|Protocol Violation|0
6814350|NCT00037830|10818674|FG000|Overall Study|Unrelated Medical Problem|2
6814351|NCT00037830|10818675|FG001|Overall Study|Unrelated Medical Problem|0
6814352|NCT00037830|10818676|FG002|Overall Study|Unrelated Medical Problem|0
6814353|NCT00038103|10818686|FG000|Overall Study|Adverse Event|5
6814354|NCT00038103|10818687|FG001|Overall Study|Adverse Event|6
6814355|NCT00038103|10818686|FG000|Overall Study|Lack of Efficacy|48
6814356|NCT00038103|10818687|FG001|Overall Study|Lack of Efficacy|41
6814357|NCT00038103|10818686|FG000|Overall Study|Withdrawal by Subject|0
6814358|NCT00038103|10818687|FG001|Overall Study|Withdrawal by Subject|3
6814359|NCT00038103|10818686|FG000|Overall Study|Lost to Follow-up|0
6814360|NCT00038103|10818687|FG001|Overall Study|Lost to Follow-up|3
6814361|NCT00038103|10818686|FG000|Overall Study|Protocol Violation|0
6814362|NCT00038103|10818687|FG001|Overall Study|Protocol Violation|2
6814363|NCT00038103|10818686|FG000|Overall Study|Sponsor Decision|0
6814364|NCT00038103|10818687|FG001|Overall Study|Sponsor Decision|1
6814365|NCT00038103|10818686|FG000|Overall Study|Randomized/never treated|2
6814366|NCT00038103|10818687|FG001|Overall Study|Randomized/never treated|0
6814367|NCT00038467|10818695|FG000|Overall Study|Adverse Event|170
6814368|NCT00038467|10818696|FG001|Overall Study|Adverse Event|145
6814369|NCT00038467|10818695|FG000|Overall Study|Withdrawal by Subject|150
6814370|NCT00038467|10818696|FG001|Overall Study|Withdrawal by Subject|107
6814371|NCT00038467|10818695|FG000|Overall Study|Protocol Violation|19
6814372|NCT00038467|10818696|FG001|Overall Study|Protocol Violation|22
6814373|NCT00038467|10818695|FG000|Overall Study|Death|22
6814374|NCT00038467|10818696|FG001|Overall Study|Death|16
6814375|NCT00038467|10818695|FG000|Overall Study|Lost to Follow-up|15
6814376|NCT00038467|10818696|FG001|Overall Study|Lost to Follow-up|10
6814377|NCT00038467|10818695|FG000|Overall Study|Recurrence|109
6814378|NCT00038467|10818696|FG001|Overall Study|Recurrence|179
6814379|NCT00038467|10818695|FG000|Overall Study|Randomized, but not treated|31
6814380|NCT00038467|10818696|FG001|Overall Study|Randomized, but not treated|35
6814381|NCT00038467|10818695|FG000|Overall Study|Other|26
6814382|NCT00038467|10818696|FG001|Overall Study|Other|28
6814383|NCT00038649|10818706|FG000|Overall Study|Adverse Event|9
6814384|NCT00038948|10818716|FG000|Overall Study|Adverse Event|131
6814385|NCT00038948|10818717|FG001|Overall Study|Adverse Event|43
6814386|NCT00038948|10818716|FG000|Overall Study|Lost to Follow-up|4
6814387|NCT00038948|10818717|FG001|Overall Study|Lost to Follow-up|4
6814388|NCT00038948|10818716|FG000|Overall Study|Nonmedical event|5
6814389|NCT00038948|10818717|FG001|Overall Study|Nonmedical event|7
6814390|NCT00038948|10818716|FG000|Overall Study|Withdrawal by Subject|23
6814391|NCT00038948|10818717|FG001|Overall Study|Withdrawal by Subject|10
6814392|NCT00038948|10818716|FG000|Overall Study|Protocol Violation|3
6814393|NCT00038948|10818717|FG001|Overall Study|Protocol Violation|7
6814394|NCT00038948|10818716|FG000|Overall Study|Lack of Efficacy|3
6814395|NCT00038948|10818717|FG001|Overall Study|Lack of Efficacy|6
6814396|NCT00039130|10818729|FG000|Overall Study|Adverse Event|11
6814397|NCT00039130|10818729|FG000|Overall Study|Death|9
6814398|NCT00039130|10818729|FG000|Overall Study|Withdrawal by Subject|3
6814399|NCT00039130|10818729|FG000|Overall Study|Progression|2
6814400|NCT00039130|10818729|FG000|Overall Study|Subsequent treatment|2
6814401|NCT00039130|10818729|FG000|Overall Study|Physician Decision|3
6814402|NCT00039377|10818737|FG000|Initial Registration|Adverse Event|2
6814403|NCT00039377|10818738|FG001|Initial Registration|Adverse Event|0
6814404|NCT00039377|10818739|FG002|Initial Registration|Adverse Event|0
6814405|NCT00039377|10818740|FG003|Initial Registration|Adverse Event|0
6814406|NCT00039377|10818737|FG000|Initial Registration|Relapsed|6
6814407|NCT00039377|10818738|FG001|Initial Registration|Relapsed|0
6814408|NCT00039377|10818739|FG002|Initial Registration|Relapsed|0
6814409|NCT00039377|10818740|FG003|Initial Registration|Relapsed|0
6814410|NCT00039377|10818737|FG000|Initial Registration|Received non-protocol therapy|11
6814411|NCT00039377|10818738|FG001|Initial Registration|Received non-protocol therapy|0
6814412|NCT00039377|10818739|FG002|Initial Registration|Received non-protocol therapy|0
6814413|NCT00039377|10818740|FG003|Initial Registration|Received non-protocol therapy|0
6814414|NCT00039377|10818737|FG000|Initial Registration|Withdrawal by Subject|3
6814415|NCT00039377|10818738|FG001|Initial Registration|Withdrawal by Subject|0
6814416|NCT00039377|10818739|FG002|Initial Registration|Withdrawal by Subject|0
6814417|NCT00039377|10818740|FG003|Initial Registration|Withdrawal by Subject|0
6814418|NCT00039741|10818752|FG000|Overall Study|Death|0
6814419|NCT00039741|10818753|FG001|Overall Study|Death|1
6814420|NCT00039741|10818754|FG002|Overall Study|Death|0
6814421|NCT00039741|10818755|FG003|Overall Study|Death|0
6814422|NCT00039741|10818752|FG000|Overall Study|Lost to Follow-up|3
6814423|NCT00039741|10818753|FG001|Overall Study|Lost to Follow-up|1
6814424|NCT00039741|10818754|FG002|Overall Study|Lost to Follow-up|5
6814425|NCT00039741|10818755|FG003|Overall Study|Lost to Follow-up|2
6814426|NCT00039741|10818752|FG000|Overall Study|Confounding medical condition|1
6814427|NCT00039741|10818753|FG001|Overall Study|Confounding medical condition|0
6814428|NCT00039741|10818754|FG002|Overall Study|Confounding medical condition|0
6814429|NCT00039741|10818755|FG003|Overall Study|Confounding medical condition|0
6814430|NCT00039741|10818752|FG000|Overall Study|Not able to get to clinic|5
6814431|NCT00039741|10818753|FG001|Overall Study|Not able to get to clinic|2
6814432|NCT00039741|10818754|FG002|Overall Study|Not able to get to clinic|0
6814433|NCT00039741|10818755|FG003|Overall Study|Not able to get to clinic|3
6814434|NCT00039741|10818752|FG000|Overall Study|Moved|3
6814435|NCT00039741|10818753|FG001|Overall Study|Moved|2
6814436|NCT00039741|10818754|FG002|Overall Study|Moved|3
6814437|NCT00039741|10818755|FG003|Overall Study|Moved|6
6814438|NCT00039741|10818752|FG000|Overall Study|Non-compliance with protocol|1
6814439|NCT00039741|10818753|FG001|Overall Study|Non-compliance with protocol|0
6814440|NCT00039741|10818754|FG002|Overall Study|Non-compliance with protocol|1
6814441|NCT00039741|10818755|FG003|Overall Study|Non-compliance with protocol|0
6814442|NCT00039741|10818752|FG000|Overall Study|Withdrew consent|0
6814443|NCT00039741|10818753|FG001|Overall Study|Withdrew consent|5
6814444|NCT00039741|10818754|FG002|Overall Study|Withdrew consent|0
6814445|NCT00039741|10818755|FG003|Overall Study|Withdrew consent|1
6814446|NCT00039741|10818752|FG000|Overall Study|Missed final visit|2
6814447|NCT00039741|10818753|FG001|Overall Study|Missed final visit|1
6814448|NCT00039741|10818754|FG002|Overall Study|Missed final visit|2
6814449|NCT00039741|10818755|FG003|Overall Study|Missed final visit|2
6814450|NCT00039871|10818765|FG000|Overall Study|Adverse Event|165
6814451|NCT00039871|10818765|FG000|Overall Study|Lost to Follow-up|18
6814452|NCT00039871|10818765|FG000|Overall Study|Protocol Violation|24
6814453|NCT00039871|10818765|FG000|Overall Study|Withdrawal by Subject|97
6814454|NCT00039871|10818765|FG000|Overall Study|Did not meet eligibility criteria|11
6814455|NCT00039871|10818765|FG000|Overall Study|Administrative|1
6814456|NCT00039871|10818765|FG000|Overall Study|Discontinued at Week 12 per protocol|1061
6814457|NCT00039871|10818765|FG000|Overall Study|Never entered follow-up|7
6814458|NCT00040365|10818769|FG000|Overall Study|Death|1
6814459|NCT00040365|10818769|FG000|Overall Study|Progressive disease|7
6814460|NCT00040365|10818769|FG000|Overall Study|Lost to Follow-up|3
6814461|NCT00040664|10818782|FG000|Overall Study|Adverse Event|12
6814462|NCT00040664|10818783|FG001|Overall Study|Adverse Event|3
6814463|NCT00040664|10818784|FG002|Overall Study|Adverse Event|2
6814464|NCT00040664|10818785|FG003|Overall Study|Adverse Event|7
6814465|NCT00040664|10818782|FG000|Overall Study|Lack of Efficacy|9
6814466|NCT00040664|10818783|FG001|Overall Study|Lack of Efficacy|2
6814467|NCT00040664|10818784|FG002|Overall Study|Lack of Efficacy|3
6814468|NCT00040664|10818785|FG003|Overall Study|Lack of Efficacy|4
6814469|NCT00040664|10818782|FG000|Overall Study|Insufficient CD4 response|1
6814470|NCT00040664|10818783|FG001|Overall Study|Insufficient CD4 response|0
6814471|NCT00040664|10818784|FG002|Overall Study|Insufficient CD4 response|1
6814472|NCT00040664|10818785|FG003|Overall Study|Insufficient CD4 response|0
6814473|NCT00040664|10818782|FG000|Overall Study|Lost to Follow-up|4
6814474|NCT00040664|10818783|FG001|Overall Study|Lost to Follow-up|2
6814475|NCT00040664|10818784|FG002|Overall Study|Lost to Follow-up|0
6814476|NCT00040664|10818785|FG003|Overall Study|Lost to Follow-up|2
6814477|NCT00040664|10818782|FG000|Overall Study|Protocol Violation|2
6814478|NCT00040664|10818783|FG001|Overall Study|Protocol Violation|1
6814479|NCT00040664|10818784|FG002|Overall Study|Protocol Violation|0
6814480|NCT00040664|10818785|FG003|Overall Study|Protocol Violation|1
6814481|NCT00040664|10818782|FG000|Overall Study|Withdrawal by Subject|7
6814482|NCT00040664|10818783|FG001|Overall Study|Withdrawal by Subject|0
6814483|NCT00040664|10818784|FG002|Overall Study|Withdrawal by Subject|3
6814484|NCT00040664|10818785|FG003|Overall Study|Withdrawal by Subject|4
6814485|NCT00040664|10818782|FG000|Overall Study|Pregnancy|3
6814486|NCT00040664|10818783|FG001|Overall Study|Pregnancy|0
6814487|NCT00040664|10818784|FG002|Overall Study|Pregnancy|0
6814488|NCT00040664|10818785|FG003|Overall Study|Pregnancy|3
6814489|NCT00040664|10818782|FG000|Overall Study|Medication adherence/compliance problems|8
6814490|NCT00040664|10818783|FG001|Overall Study|Medication adherence/compliance problems|2
6814491|NCT00040664|10818784|FG002|Overall Study|Medication adherence/compliance problems|1
6814492|NCT00040664|10818785|FG003|Overall Study|Medication adherence/compliance problems|5
6814493|NCT00040664|10818782|FG000|Overall Study|Poor taste|2
6814494|NCT00040664|10818783|FG001|Overall Study|Poor taste|0
6814495|NCT00040664|10818784|FG002|Overall Study|Poor taste|2
6814496|NCT00040664|10818785|FG003|Overall Study|Poor taste|0
6814497|NCT00040664|10818782|FG000|Overall Study|Pharmacokinetic target not achieved|2
6814498|NCT00040664|10818783|FG001|Overall Study|Pharmacokinetic target not achieved|1
6814499|NCT00040664|10818784|FG002|Overall Study|Pharmacokinetic target not achieved|0
6814500|NCT00040664|10818785|FG003|Overall Study|Pharmacokinetic target not achieved|1
6814501|NCT00040664|10818782|FG000|Overall Study|Change of formulation|2
6814502|NCT00040664|10818783|FG001|Overall Study|Change of formulation|2
6814503|NCT00040664|10818784|FG002|Overall Study|Change of formulation|0
6814504|NCT00040664|10818785|FG003|Overall Study|Change of formulation|0
6814505|NCT00040664|10818782|FG000|Overall Study|Non-viability of oral suspension|1
6814506|NCT00040664|10818783|FG001|Overall Study|Non-viability of oral suspension|0
6814507|NCT00040664|10818784|FG002|Overall Study|Non-viability of oral suspension|1
6814508|NCT00040664|10818785|FG003|Overall Study|Non-viability of oral suspension|0
6814509|NCT00040742|10818807|FG000|Overall Study|Death|0
6814510|NCT00040742|10818808|FG001|Overall Study|Death|0
6814511|NCT00040742|10818809|FG002|Overall Study|Death|1
6814512|NCT00040742|10818810|FG003|Overall Study|Death|0
6814513|NCT00040742|10818807|FG000|Overall Study|Adverse Event|15
6814514|NCT00040742|10818808|FG001|Overall Study|Adverse Event|16
6814515|NCT00040742|10818809|FG002|Overall Study|Adverse Event|21
6814516|NCT00040742|10818810|FG003|Overall Study|Adverse Event|9
6814517|NCT00040742|10818807|FG000|Overall Study|Withdrawal by Subject|7
6814518|NCT00040742|10818808|FG001|Overall Study|Withdrawal by Subject|15
6814519|NCT00040742|10818809|FG002|Overall Study|Withdrawal by Subject|10
6814520|NCT00040742|10818810|FG003|Overall Study|Withdrawal by Subject|13
6814521|NCT00040742|10818807|FG000|Overall Study|Chemotoxicity|4
6814522|NCT00040742|10818808|FG001|Overall Study|Chemotoxicity|3
6814523|NCT00040742|10818809|FG002|Overall Study|Chemotoxicity|5
6814524|NCT00040742|10818810|FG003|Overall Study|Chemotoxicity|2
6814525|NCT00040742|10818807|FG000|Overall Study|Incomplete Forms|6
6814526|NCT00040742|10818808|FG001|Overall Study|Incomplete Forms|10
6814527|NCT00040742|10818809|FG002|Overall Study|Incomplete Forms|4
6814528|NCT00040742|10818810|FG003|Overall Study|Incomplete Forms|5
6814529|NCT00040742|10818807|FG000|Overall Study|Other medical|7
6814530|NCT00040742|10818808|FG001|Overall Study|Other medical|5
6814531|NCT00040742|10818809|FG002|Overall Study|Other medical|5
6814532|NCT00040742|10818810|FG003|Overall Study|Other medical|5
6814533|NCT00041067|10818852|FG000|Overall Study|Adverse Event|20
6814534|NCT00041067|10818852|FG000|Overall Study|Progression|19
6814535|NCT00041067|10818852|FG000|Overall Study|Patient refusal|12
6814536|NCT00041067|10818852|FG000|Overall Study|Other reasons|23
6814537|NCT00041067|10818852|FG000|Overall Study|Ineligible|2
6814538|NCT00041080|10818859|FG000|Overall Study|Adverse Event|21
6814539|NCT00041080|10818860|FG001|Overall Study|Adverse Event|1
6814540|NCT00041080|10818859|FG000|Overall Study|Withdrawal by Subject|6
6814541|NCT00041080|10818860|FG001|Overall Study|Withdrawal by Subject|6
6814542|NCT00041080|10818859|FG000|Overall Study|Concommitant Illness/Other|1
6814543|NCT00041080|10818860|FG001|Overall Study|Concommitant Illness/Other|2
6814544|NCT00041080|10818859|FG000|Overall Study|Did not start therapy|1
6814545|NCT00041080|10818860|FG001|Overall Study|Did not start therapy|1
6814546|NCT00041080|10818859|FG000|Overall Study|Ineligible|1
6814547|NCT00041080|10818860|FG001|Overall Study|Ineligible|0
6814548|NCT00041132|10818887|FG000|Overall Study|Adverse Event|19
6814549|NCT00041132|10818887|FG000|Overall Study|Death|1
6814550|NCT00041132|10818887|FG000|Overall Study|Not Eligible|7
6814551|NCT00041132|10818887|FG000|Overall Study|Withdrawal by Subject|1
6814552|NCT00041132|10818887|FG000|Overall Study|Physician Decision|2
6814553|NCT00041470|10818891|FG000|Overall Study|Loss of Funding|38
6814554|NCT00041756|10818909|FG000|Overall Study|Adverse Event|4
6814555|NCT00041756|10818910|FG001|Overall Study|Adverse Event|10
6814556|NCT00041756|10818911|FG002|Overall Study|Adverse Event|6
6814557|NCT00041756|10818912|FG003|Overall Study|Adverse Event|11
6814558|NCT00041756|10818913|FG004|Overall Study|Adverse Event|34
6814559|NCT00041756|10818909|FG000|Overall Study|Protocol Violation|1
6814560|NCT00041756|10818910|FG001|Overall Study|Protocol Violation|1
6814561|NCT00041756|10818911|FG002|Overall Study|Protocol Violation|2
6814562|NCT00041756|10818912|FG003|Overall Study|Protocol Violation|2
6814563|NCT00041756|10818913|FG004|Overall Study|Protocol Violation|1
6814564|NCT00041756|10818909|FG000|Overall Study|Withdrawal by Subject|3
6814565|NCT00041756|10818910|FG001|Overall Study|Withdrawal by Subject|3
6814566|NCT00041756|10818911|FG002|Overall Study|Withdrawal by Subject|4
6814567|NCT00041756|10818912|FG003|Overall Study|Withdrawal by Subject|2
6814568|NCT00041756|10818913|FG004|Overall Study|Withdrawal by Subject|3
6814569|NCT00041756|10818909|FG000|Overall Study|Lost to Follow-up|0
6814570|NCT00041756|10818910|FG001|Overall Study|Lost to Follow-up|1
6814571|NCT00041756|10818911|FG002|Overall Study|Lost to Follow-up|0
6814572|NCT00041756|10818912|FG003|Overall Study|Lost to Follow-up|1
6814573|NCT00041756|10818913|FG004|Overall Study|Lost to Follow-up|0
6814574|NCT00041756|10818909|FG000|Overall Study|Unable to meet protocol criteria|0
6814575|NCT00041756|10818910|FG001|Overall Study|Unable to meet protocol criteria|0
6814576|NCT00041756|10818911|FG002|Overall Study|Unable to meet protocol criteria|1
6814577|NCT00041756|10818912|FG003|Overall Study|Unable to meet protocol criteria|0
6814578|NCT00041756|10818913|FG004|Overall Study|Unable to meet protocol criteria|1
6814579|NCT00041756|10818909|FG000|Overall Study|Data Monitoring Committee Recommendation|0
6814580|NCT00041756|10818910|FG001|Overall Study|Data Monitoring Committee Recommendation|0
6814581|NCT00041756|10818911|FG002|Overall Study|Data Monitoring Committee Recommendation|0
6814582|NCT00041756|10818912|FG003|Overall Study|Data Monitoring Committee Recommendation|0
6814583|NCT00041756|10818913|FG004|Overall Study|Data Monitoring Committee Recommendation|21
6814584|NCT00042432|10818945|FG000|Overall Study|Adverse Event|4
6814585|NCT00042432|10818946|FG001|Overall Study|Adverse Event|1
6814586|NCT00042432|10818945|FG000|Overall Study|Withdrawal by Subject|1
6814587|NCT00042432|10818946|FG001|Overall Study|Withdrawal by Subject|3
6814588|NCT00042432|10818945|FG000|Overall Study|Death|0
6814589|NCT00042432|10818946|FG001|Overall Study|Death|2
6814590|NCT00042432|10818945|FG000|Overall Study|Ineligibility determined|1
6814591|NCT00042432|10818946|FG001|Overall Study|Ineligibility determined|0
6814592|NCT00042432|10818945|FG000|Overall Study|Initiation of maintenance dialysis|1
6814593|NCT00042432|10818946|FG001|Overall Study|Initiation of maintenance dialysis|1
6814594|NCT00042432|10818945|FG000|Overall Study|Other|2
6814595|NCT00042432|10818946|FG001|Overall Study|Other|0
6814596|NCT00042666|10818952|FG000|Overall Study|Adverse Event|2
6814597|NCT00042666|10818952|FG000|Overall Study|Death|4
6814598|NCT00042666|10818952|FG000|Overall Study|Protocol Violation|1
6814599|NCT00042666|10818952|FG000|Overall Study|Participant/Physician Perception|1
6814600|NCT00042666|10818952|FG000|Overall Study|Progressive Disease|41
6814601|NCT00042666|10818952|FG000|Overall Study|Other|1
6814602|NCT00042666|10818952|FG000|Overall Study|Other|4
6814603|NCT00042939|10818959|FG000|Overall Study|Adverse Event|6
6814604|NCT00042939|10818960|FG001|Overall Study|Adverse Event|7
6814605|NCT00042939|10818959|FG000|Overall Study|Death|3
6814606|NCT00042939|10818960|FG001|Overall Study|Death|2
6814607|NCT00042939|10818959|FG000|Overall Study|Withdrawal by Subject|3
6814608|NCT00042939|10818960|FG001|Overall Study|Withdrawal by Subject|4
6814609|NCT00042939|10818959|FG000|Overall Study|Other disease|1
6814610|NCT00042939|10818960|FG001|Overall Study|Other disease|0
6814611|NCT00042939|10818959|FG000|Overall Study|Ineligible|2
6814612|NCT00042939|10818960|FG001|Overall Study|Ineligible|2
6814613|NCT00042939|10818959|FG000|Overall Study|Deterioration of health|3
6814614|NCT00042939|10818960|FG001|Overall Study|Deterioration of health|4
6814615|NCT00042939|10818959|FG000|Overall Study|QOL diminished|1
6814616|NCT00042939|10818960|FG001|Overall Study|QOL diminished|0
6814617|NCT00042939|10818959|FG000|Overall Study|Rising ca 19-9|1
6814618|NCT00042939|10818960|FG001|Overall Study|Rising ca 19-9|0
6814619|NCT00042939|10818959|FG000|Overall Study|Patient non-compliance|1
6814620|NCT00042939|10818960|FG001|Overall Study|Patient non-compliance|0
6814621|NCT00042939|10818959|FG000|Overall Study|Still on treatment|1
6814622|NCT00042939|10818960|FG001|Overall Study|Still on treatment|0
6814623|NCT00042939|10818959|FG000|Overall Study|Treatment break > 4 weeks|0
6814624|NCT00042939|10818960|FG001|Overall Study|Treatment break > 4 weeks|1
6814625|NCT00042939|10818959|FG000|Overall Study|Did not start treatment|2
6814626|NCT00042939|10818960|FG001|Overall Study|Did not start treatment|1
6814627|NCT00042991|10818973|FG000|Overall Study|Adverse Event|1
6814628|NCT00042991|10818974|FG001|Overall Study|Adverse Event|4
6814629|NCT00042991|10818975|FG002|Overall Study|Adverse Event|2
6814630|NCT00042991|10818976|FG003|Overall Study|Adverse Event|0
6814631|NCT00042991|10818977|FG004|Overall Study|Adverse Event|0
6814632|NCT00042991|10818978|FG005|Overall Study|Adverse Event|1
6814633|NCT00042991|10818979|FG006|Overall Study|Adverse Event|0
6814634|NCT00042991|10818973|FG000|Overall Study|Withdrawal by Subject|0
6814635|NCT00042991|10818974|FG001|Overall Study|Withdrawal by Subject|7
6814636|NCT00042991|10818975|FG002|Overall Study|Withdrawal by Subject|2
6814637|NCT00042991|10818976|FG003|Overall Study|Withdrawal by Subject|0
6814638|NCT00042991|10818977|FG004|Overall Study|Withdrawal by Subject|1
6814639|NCT00042991|10818978|FG005|Overall Study|Withdrawal by Subject|0
6814640|NCT00042991|10818979|FG006|Overall Study|Withdrawal by Subject|0
6814641|NCT00042991|10818973|FG000|Overall Study|Disease Progression|5
6814642|NCT00042991|10818974|FG001|Overall Study|Disease Progression|29
6814643|NCT00042991|10818975|FG002|Overall Study|Disease Progression|2
6814644|NCT00042991|10818976|FG003|Overall Study|Disease Progression|2
6814645|NCT00042991|10818977|FG004|Overall Study|Disease Progression|1
6814646|NCT00042991|10818978|FG005|Overall Study|Disease Progression|4
6814647|NCT00042991|10818979|FG006|Overall Study|Disease Progression|2
6814648|NCT00042991|10818973|FG000|Overall Study|Alternative Therapy|0
6814649|NCT00042991|10818974|FG001|Overall Study|Alternative Therapy|0
6814650|NCT00042991|10818975|FG002|Overall Study|Alternative Therapy|0
6814651|NCT00042991|10818976|FG003|Overall Study|Alternative Therapy|0
6814652|NCT00042991|10818977|FG004|Overall Study|Alternative Therapy|1
6814653|NCT00042991|10818978|FG005|Overall Study|Alternative Therapy|0
6814654|NCT00042991|10818979|FG006|Overall Study|Alternative Therapy|0
6814655|NCT00043186|10819006|FG000|Overall Study|Physician Decision|0
6814656|NCT00043186|10819007|FG001|Overall Study|Physician Decision|0
6814657|NCT00043186|10819008|FG002|Overall Study|Physician Decision|3
6814658|NCT00043186|10819009|FG003|Overall Study|Physician Decision|0
6814659|NCT00043186|10819010|FG004|Overall Study|Physician Decision|1
6814660|NCT00043186|10819011|FG005|Overall Study|Physician Decision|0
6814661|NCT00043186|10819012|FG006|Overall Study|Physician Decision|0
6814662|NCT00043186|10819013|FG007|Overall Study|Physician Decision|1
6814663|NCT00043186|10819014|FG008|Overall Study|Physician Decision|1
6814664|NCT00043186|10819006|FG000|Overall Study|Adverse Event|2
6814665|NCT00043186|10819007|FG001|Overall Study|Adverse Event|2
6814666|NCT00043186|10819008|FG002|Overall Study|Adverse Event|2
6814667|NCT00043186|10819009|FG003|Overall Study|Adverse Event|3
6814668|NCT00043186|10819010|FG004|Overall Study|Adverse Event|2
6814669|NCT00043186|10819011|FG005|Overall Study|Adverse Event|1
6814670|NCT00043186|10819012|FG006|Overall Study|Adverse Event|2
6814671|NCT00043186|10819013|FG007|Overall Study|Adverse Event|1
6814672|NCT00043186|10819014|FG008|Overall Study|Adverse Event|3
6814673|NCT00043186|10819006|FG000|Overall Study|Withdrawal by Subject|11
6814674|NCT00043186|10819007|FG001|Overall Study|Withdrawal by Subject|8
6814675|NCT00043186|10819008|FG002|Overall Study|Withdrawal by Subject|11
6814676|NCT00043186|10819009|FG003|Overall Study|Withdrawal by Subject|13
6814677|NCT00043186|10819010|FG004|Overall Study|Withdrawal by Subject|14
6814678|NCT00043186|10819011|FG005|Overall Study|Withdrawal by Subject|6
6814679|NCT00043186|10819012|FG006|Overall Study|Withdrawal by Subject|12
6814680|NCT00043186|10819013|FG007|Overall Study|Withdrawal by Subject|9
6814681|NCT00043186|10819014|FG008|Overall Study|Withdrawal by Subject|10
6814682|NCT00043186|10819006|FG000|Overall Study|Death|0
6814683|NCT00043186|10819007|FG001|Overall Study|Death|0
6814684|NCT00043186|10819008|FG002|Overall Study|Death|1
6814685|NCT00043186|10819009|FG003|Overall Study|Death|0
6814686|NCT00043186|10819010|FG004|Overall Study|Death|0
6814687|NCT00043186|10819011|FG005|Overall Study|Death|0
6814688|NCT00043186|10819012|FG006|Overall Study|Death|2
6814689|NCT00043186|10819013|FG007|Overall Study|Death|0
6814690|NCT00043186|10819014|FG008|Overall Study|Death|0
6814691|NCT00043186|10819006|FG000|Overall Study|Disease progression|1
6814692|NCT00043186|10819007|FG001|Overall Study|Disease progression|0
6814693|NCT00043186|10819008|FG002|Overall Study|Disease progression|0
6814694|NCT00043186|10819009|FG003|Overall Study|Disease progression|3
6814695|NCT00043186|10819010|FG004|Overall Study|Disease progression|0
6814696|NCT00043186|10819011|FG005|Overall Study|Disease progression|0
6814697|NCT00043186|10819012|FG006|Overall Study|Disease progression|0
6814698|NCT00043186|10819013|FG007|Overall Study|Disease progression|4
6814699|NCT00043186|10819014|FG008|Overall Study|Disease progression|0
6814700|NCT00043186|10819006|FG000|Overall Study|Ineligibility determined|0
6814701|NCT00043186|10819007|FG001|Overall Study|Ineligibility determined|0
6814702|NCT00043186|10819008|FG002|Overall Study|Ineligibility determined|0
6814703|NCT00043186|10819009|FG003|Overall Study|Ineligibility determined|0
6814704|NCT00043186|10819010|FG004|Overall Study|Ineligibility determined|0
6814705|NCT00043186|10819011|FG005|Overall Study|Ineligibility determined|0
6814706|NCT00043186|10819012|FG006|Overall Study|Ineligibility determined|0
6814707|NCT00043186|10819013|FG007|Overall Study|Ineligibility determined|0
6814708|NCT00043186|10819014|FG008|Overall Study|Ineligibility determined|1
6814709|NCT00043186|10819006|FG000|Overall Study|Lost to Follow-up|3
6814710|NCT00043186|10819007|FG001|Overall Study|Lost to Follow-up|5
6814711|NCT00043186|10819008|FG002|Overall Study|Lost to Follow-up|1
6814712|NCT00043186|10819009|FG003|Overall Study|Lost to Follow-up|1
6814713|NCT00043186|10819010|FG004|Overall Study|Lost to Follow-up|1
6814714|NCT00043186|10819011|FG005|Overall Study|Lost to Follow-up|1
6814715|NCT00043186|10819012|FG006|Overall Study|Lost to Follow-up|1
6814716|NCT00043186|10819013|FG007|Overall Study|Lost to Follow-up|1
6814717|NCT00043186|10819014|FG008|Overall Study|Lost to Follow-up|2
6814718|NCT00043186|10819006|FG000|Overall Study|Noncompliance|0
6814719|NCT00043186|10819007|FG001|Overall Study|Noncompliance|0
6814720|NCT00043186|10819008|FG002|Overall Study|Noncompliance|1
6814721|NCT00043186|10819009|FG003|Overall Study|Noncompliance|1
6814722|NCT00043186|10819010|FG004|Overall Study|Noncompliance|0
6814723|NCT00043186|10819011|FG005|Overall Study|Noncompliance|0
6814724|NCT00043186|10819012|FG006|Overall Study|Noncompliance|0
6814725|NCT00043186|10819013|FG007|Overall Study|Noncompliance|0
6814726|NCT00043186|10819014|FG008|Overall Study|Noncompliance|0
6814727|NCT00043186|10819006|FG000|Overall Study|Other|0
6814728|NCT00043186|10819007|FG001|Overall Study|Other|0
6814729|NCT00043186|10819008|FG002|Overall Study|Other|1
6814730|NCT00043186|10819009|FG003|Overall Study|Other|1
6814731|NCT00043186|10819010|FG004|Overall Study|Other|0
6814732|NCT00043186|10819011|FG005|Overall Study|Other|0
6814733|NCT00043186|10819012|FG006|Overall Study|Other|0
6814734|NCT00043186|10819013|FG007|Overall Study|Other|0
6814735|NCT00043186|10819014|FG008|Overall Study|Other|0
6814736|NCT00043550|10819038|FG000|Overall Study|Withdrawal by Subject|22
6814737|NCT00043550|10819039|FG001|Overall Study|Withdrawal by Subject|12
6814738|NCT00043550|10819040|FG002|Overall Study|Withdrawal by Subject|20
6814739|NCT00043979|10819050|FG000|Period 1|recipient with progressive disease|7
6814740|NCT00043979|10819051|FG001|Period 1|recipient with progressive disease|4
6814741|NCT00043979|10819052|FG002|Period 1|recipient with progressive disease|3
6814742|NCT00044083|10819094|FG000|First Intervention (One Week)- HV's|Adverse Event|1
6814743|NCT00044083|10819095|FG001|First Intervention (One Week)- HV's|Adverse Event|0
6814744|NCT00044083|10819094|FG000|First Intervention (One Week)- HV's|Not follow directions|2
6814745|NCT00044083|10819095|FG001|First Intervention (One Week)- HV's|Not follow directions|2
6814746|NCT00044083|10819094|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5
6814747|NCT00044083|10819095|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3
6814748|NCT00044083|10819094|FG000|First Intervention (One Week)- HV's|Pregnancy|1
6814749|NCT00044083|10819095|FG001|First Intervention (One Week)- HV's|Pregnancy|0
6814750|NCT00044083|10819094|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1
6814751|NCT00044083|10819095|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0
6814752|NCT00044083|10819094|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0
6814753|NCT00044083|10819095|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1
6814754|NCT00044083|10819094|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0
6814755|NCT00044083|10819095|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1
6814756|NCT00044083|10819094|FG000|First Intervention (One Week) Patients|Not follow directions|0
6814757|NCT00044083|10819095|FG001|First Intervention (One Week) Patients|Not follow directions|2
6814758|NCT00044083|10819094|FG000|First Intervention (One Week) Patients|Used illegal drug|1
6814759|NCT00044083|10819095|FG001|First Intervention (One Week) Patients|Used illegal drug|0
6814760|NCT00044083|10819094|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0
6814761|NCT00044083|10819095|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1
6814762|NCT00044213|10819132|FG000|Overall Study|Withdrawal by Subject|50
6814763|NCT00044213|10819133|FG001|Overall Study|Withdrawal by Subject|65
6814764|NCT00044213|10819134|FG002|Overall Study|Withdrawal by Subject|91
6814765|NCT00044213|10819135|FG003|Overall Study|Withdrawal by Subject|83
6814766|NCT00044213|10819132|FG000|Overall Study|Death|42
6814767|NCT00044213|10819133|FG001|Overall Study|Death|42
6814768|NCT00044213|10819134|FG002|Overall Study|Death|42
6814769|NCT00044213|10819135|FG003|Overall Study|Death|49
6814770|NCT00044213|10819132|FG000|Overall Study|Lost to Follow-up|8
6814771|NCT00044213|10819133|FG001|Overall Study|Lost to Follow-up|5
6814772|NCT00044213|10819134|FG002|Overall Study|Lost to Follow-up|5
6814773|NCT00044213|10819135|FG003|Overall Study|Lost to Follow-up|4
6814774|NCT00044512|10819145|FG000|Follow Up|Lost to Follow-up|2
6814775|NCT00045032|10819161|FG000|Overall Study|Adverse Event/Intercurrent Illness|2
6814776|NCT00045032|10819162|FG001|Overall Study|Adverse Event/Intercurrent Illness|2
6814777|NCT00045032|10819163|FG002|Overall Study|Adverse Event/Intercurrent Illness|7
6814778|NCT00045032|10819161|FG000|Overall Study|Death|22
6814779|NCT00045032|10819162|FG001|Overall Study|Death|24
6814780|NCT00045032|10819163|FG002|Overall Study|Death|17
6814781|NCT00045032|10819161|FG000|Overall Study|Insufficient Therapeutic Response|542
6814782|NCT00045032|10819162|FG001|Overall Study|Insufficient Therapeutic Response|437
6814783|NCT00045032|10819163|FG002|Overall Study|Insufficient Therapeutic Response|445
6814784|NCT00045032|10819161|FG000|Overall Study|Violation of Selection Criteria at Entry|3
6814785|NCT00045032|10819162|FG001|Overall Study|Violation of Selection Criteria at Entry|6
6814786|NCT00045032|10819163|FG002|Overall Study|Violation of Selection Criteria at Entry|6
6814787|NCT00045032|10819161|FG000|Overall Study|Other Protocol Violation|2
6814788|NCT00045032|10819162|FG001|Overall Study|Other Protocol Violation|0
6814789|NCT00045032|10819163|FG002|Overall Study|Other Protocol Violation|1
6814790|NCT00045032|10819161|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142
6814791|NCT00045032|10819162|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93
6814792|NCT00045032|10819163|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84
6814793|NCT00045032|10819161|FG000|Overall Study|Failure to Return|57
6814794|NCT00045032|10819162|FG001|Overall Study|Failure to Return|62
6814795|NCT00045032|10819163|FG002|Overall Study|Failure to Return|61
6814796|NCT00045032|10819161|FG000|Overall Study|Other|93
6814797|NCT00045032|10819162|FG001|Overall Study|Other|84
6814798|NCT00045032|10819163|FG002|Overall Study|Other|105
6814799|NCT00045110|10819176|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0
6814800|NCT00045110|10819177|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2
6814801|NCT00045110|10819178|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1
6814802|NCT00045110|10819176|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0
6814803|NCT00045110|10819177|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4
6814804|NCT00045110|10819178|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0
6814805|NCT00045110|10819176|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0
6814806|NCT00045110|10819177|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0
6814807|NCT00045110|10819178|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1
6814808|NCT00045162|10819197|FG000|Overall Study|Ineligible|12
6814809|NCT00045162|10819198|FG001|Overall Study|Ineligible|8
6814810|NCT00045162|10819197|FG000|Overall Study|Not treated|7
6814811|NCT00045162|10819198|FG001|Overall Study|Not treated|2
6814812|NCT00045162|10819197|FG000|Overall Study|Adverse Event|55
6814813|NCT00045162|10819198|FG001|Overall Study|Adverse Event|50
6814814|NCT00045162|10819197|FG000|Overall Study|Lack of Efficacy|32
6814815|NCT00045162|10819198|FG001|Overall Study|Lack of Efficacy|29
6814816|NCT00045162|10819197|FG000|Overall Study|Death|10
6814817|NCT00045162|10819198|FG001|Overall Study|Death|10
6814818|NCT00045162|10819197|FG000|Overall Study|Withdrawal by Subject|5
6814819|NCT00045162|10819198|FG001|Overall Study|Withdrawal by Subject|3
6814820|NCT00045162|10819197|FG000|Overall Study|Other|21
6814821|NCT00045162|10819198|FG001|Overall Study|Other|16
6814822|NCT00045305|10819204|FG000|Overall Study|Lack of Efficacy|6
6814823|NCT00045305|10819204|FG000|Overall Study|Adverse Event|3
6814824|NCT00045305|10819204|FG000|Overall Study|Death|3
6814825|NCT00045305|10819204|FG000|Overall Study|site error|2
6814826|NCT00045630|10819216|FG000|Overall Study|Adverse Event|1
6814827|NCT00045630|10819216|FG000|Overall Study|Refusal unrelated to adverse event|1
6814828|NCT00045630|10819216|FG000|Overall Study|Progression/relapse|1
6814829|NCT00045630|10819216|FG000|Overall Study|Death|1
6814830|NCT00045630|10819216|FG000|Overall Study|Ineligible|2
6814831|NCT00045708|10819223|FG000|Phase 1|early progressive disease|0
6814832|NCT00045708|10819224|FG001|Phase 1|early progressive disease|1
6814833|NCT00045708|10819225|FG002|Phase 1|early progressive disease|0
6814834|NCT00045734|10819242|FG000|Overall Study|Protocol Violation|1
6814835|NCT00045942|10819255|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1
6814836|NCT00045942|10819256|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0
6814837|NCT00045942|10819257|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0
6814838|NCT00045942|10819258|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0
6814839|NCT00045942|10819259|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0
6814840|NCT00045942|10819260|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0
6814841|NCT00045942|10819261|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0
6814842|NCT00045942|10819262|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0
6814843|NCT00045942|10819263|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0
6814844|NCT00045942|10819255|FG000|PKC412A2104 (Core)|Adverse Event|5
6814845|NCT00045942|10819256|FG001|PKC412A2104 (Core)|Adverse Event|0
6814846|NCT00045942|10819257|FG002|PKC412A2104 (Core)|Adverse Event|0
6814847|NCT00045942|10819258|FG003|PKC412A2104 (Core)|Adverse Event|0
6814848|NCT00045942|10819259|FG004|PKC412A2104 (Core)|Adverse Event|0
6814849|NCT00045942|10819260|FG005|PKC412A2104 (Core)|Adverse Event|0
6814850|NCT00045942|10819261|FG006|PKC412A2104 (Core)|Adverse Event|0
6814851|NCT00045942|10819262|FG007|PKC412A2104 (Core)|Adverse Event|0
6814852|NCT00045942|10819263|FG008|PKC412A2104 (Core)|Adverse Event|0
6814853|NCT00045942|10819255|FG000|PKC412A2104 (Core)|Lack of Efficacy|13
6814854|NCT00045942|10819256|FG001|PKC412A2104 (Core)|Lack of Efficacy|0
6814855|NCT00045942|10819257|FG002|PKC412A2104 (Core)|Lack of Efficacy|0
6814856|NCT00045942|10819258|FG003|PKC412A2104 (Core)|Lack of Efficacy|0
6814857|NCT00045942|10819259|FG004|PKC412A2104 (Core)|Lack of Efficacy|0
6814858|NCT00045942|10819260|FG005|PKC412A2104 (Core)|Lack of Efficacy|0
6814859|NCT00045942|10819261|FG006|PKC412A2104 (Core)|Lack of Efficacy|0
6814860|NCT00045942|10819262|FG007|PKC412A2104 (Core)|Lack of Efficacy|0
6814861|NCT00045942|10819263|FG008|PKC412A2104 (Core)|Lack of Efficacy|0
6814862|NCT00045942|10819255|FG000|PKC412A2104 (Core)|Death|1
6814863|NCT00045942|10819256|FG001|PKC412A2104 (Core)|Death|0
6814864|NCT00045942|10819257|FG002|PKC412A2104 (Core)|Death|0
6814865|NCT00045942|10819258|FG003|PKC412A2104 (Core)|Death|0
6814866|NCT00045942|10819259|FG004|PKC412A2104 (Core)|Death|0
6814867|NCT00045942|10819260|FG005|PKC412A2104 (Core)|Death|0
6814868|NCT00045942|10819261|FG006|PKC412A2104 (Core)|Death|0
6814869|NCT00045942|10819262|FG007|PKC412A2104 (Core)|Death|0
6814870|NCT00045942|10819263|FG008|PKC412A2104 (Core)|Death|0
6814871|NCT00045942|10819255|FG000|PKC412A2104E1|Withdrawal by Subject|0
6814872|NCT00045942|10819256|FG001|PKC412A2104E1|Withdrawal by Subject|0
6814873|NCT00045942|10819257|FG002|PKC412A2104E1|Withdrawal by Subject|2
6814874|NCT00045942|10819258|FG003|PKC412A2104E1|Withdrawal by Subject|5
6814875|NCT00045942|10819259|FG004|PKC412A2104E1|Withdrawal by Subject|2
6814876|NCT00045942|10819260|FG005|PKC412A2104E1|Withdrawal by Subject|0
6814877|NCT00045942|10819261|FG006|PKC412A2104E1|Withdrawal by Subject|0
6814878|NCT00045942|10819262|FG007|PKC412A2104E1|Withdrawal by Subject|0
6814879|NCT00045942|10819263|FG008|PKC412A2104E1|Withdrawal by Subject|0
6814880|NCT00045942|10819255|FG000|PKC412A2104E1|Condition no longer requires study drug|0
6814881|NCT00045942|10819256|FG001|PKC412A2104E1|Condition no longer requires study drug|1
6814882|NCT00045942|10819257|FG002|PKC412A2104E1|Condition no longer requires study drug|1
6814883|NCT00045942|10819258|FG003|PKC412A2104E1|Condition no longer requires study drug|0
6814884|NCT00045942|10819259|FG004|PKC412A2104E1|Condition no longer requires study drug|1
6814885|NCT00045942|10819260|FG005|PKC412A2104E1|Condition no longer requires study drug|0
6814886|NCT00045942|10819261|FG006|PKC412A2104E1|Condition no longer requires study drug|0
6814887|NCT00045942|10819262|FG007|PKC412A2104E1|Condition no longer requires study drug|0
6814888|NCT00045942|10819263|FG008|PKC412A2104E1|Condition no longer requires study drug|0
6814889|NCT00045942|10819255|FG000|PKC412A2104E1|Lack of Efficacy|0
6814890|NCT00045942|10819256|FG001|PKC412A2104E1|Lack of Efficacy|11
6814891|NCT00045942|10819257|FG002|PKC412A2104E1|Lack of Efficacy|11
6814892|NCT00045942|10819258|FG003|PKC412A2104E1|Lack of Efficacy|23
6814893|NCT00045942|10819259|FG004|PKC412A2104E1|Lack of Efficacy|17
6814894|NCT00045942|10819260|FG005|PKC412A2104E1|Lack of Efficacy|0
6814895|NCT00045942|10819261|FG006|PKC412A2104E1|Lack of Efficacy|0
6814896|NCT00045942|10819262|FG007|PKC412A2104E1|Lack of Efficacy|0
6814897|NCT00045942|10819263|FG008|PKC412A2104E1|Lack of Efficacy|0
6814898|NCT00045942|10819255|FG000|PKC412A2104E1|Abnormal laboratory value|0
6814899|NCT00045942|10819256|FG001|PKC412A2104E1|Abnormal laboratory value|1
6814900|NCT00045942|10819257|FG002|PKC412A2104E1|Abnormal laboratory value|0
6814901|NCT00045942|10819258|FG003|PKC412A2104E1|Abnormal laboratory value|0
6814902|NCT00045942|10819259|FG004|PKC412A2104E1|Abnormal laboratory value|0
6814903|NCT00045942|10819260|FG005|PKC412A2104E1|Abnormal laboratory value|0
6814904|NCT00045942|10819261|FG006|PKC412A2104E1|Abnormal laboratory value|0
6814905|NCT00045942|10819262|FG007|PKC412A2104E1|Abnormal laboratory value|0
6814906|NCT00045942|10819263|FG008|PKC412A2104E1|Abnormal laboratory value|0
6814907|NCT00045942|10819255|FG000|PKC412A2104E1|Adverse Event|0
6814908|NCT00045942|10819256|FG001|PKC412A2104E1|Adverse Event|1
6814909|NCT00045942|10819257|FG002|PKC412A2104E1|Adverse Event|1
6814910|NCT00045942|10819258|FG003|PKC412A2104E1|Adverse Event|3
6814911|NCT00045942|10819259|FG004|PKC412A2104E1|Adverse Event|6
6814912|NCT00045942|10819260|FG005|PKC412A2104E1|Adverse Event|0
6814913|NCT00045942|10819261|FG006|PKC412A2104E1|Adverse Event|0
6814914|NCT00045942|10819262|FG007|PKC412A2104E1|Adverse Event|0
6814915|NCT00045942|10819263|FG008|PKC412A2104E1|Adverse Event|0
6814916|NCT00045942|10819255|FG000|PKC412A2104E1|Death|0
6814917|NCT00045942|10819256|FG001|PKC412A2104E1|Death|4
6814918|NCT00045942|10819257|FG002|PKC412A2104E1|Death|1
6814919|NCT00045942|10819258|FG003|PKC412A2104E1|Death|1
6814920|NCT00045942|10819259|FG004|PKC412A2104E1|Death|1
6814921|NCT00045942|10819260|FG005|PKC412A2104E1|Death|0
6814922|NCT00045942|10819261|FG006|PKC412A2104E1|Death|0
6814923|NCT00045942|10819262|FG007|PKC412A2104E1|Death|0
6814924|NCT00045942|10819263|FG008|PKC412A2104E1|Death|0
6814925|NCT00045942|10819255|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0
6814926|NCT00045942|10819256|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0
6814927|NCT00045942|10819257|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1
6814928|NCT00045942|10819258|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1
6814929|NCT00045942|10819259|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0
6814930|NCT00045942|10819260|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0
6814931|NCT00045942|10819261|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0
6814932|NCT00045942|10819262|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0
6814933|NCT00045942|10819263|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0
6814934|NCT00045942|10819255|FG000|PKC412A2104E2|Lost to Follow-up|0
6814935|NCT00045942|10819256|FG001|PKC412A2104E2|Lost to Follow-up|0
6814936|NCT00045942|10819257|FG002|PKC412A2104E2|Lost to Follow-up|0
6814937|NCT00045942|10819258|FG003|PKC412A2104E2|Lost to Follow-up|0
6814938|NCT00045942|10819259|FG004|PKC412A2104E2|Lost to Follow-up|0
6814939|NCT00045942|10819260|FG005|PKC412A2104E2|Lost to Follow-up|0
6814940|NCT00045942|10819261|FG006|PKC412A2104E2|Lost to Follow-up|0
6814941|NCT00045942|10819262|FG007|PKC412A2104E2|Lost to Follow-up|3
6814942|NCT00045942|10819263|FG008|PKC412A2104E2|Lost to Follow-up|0
6814943|NCT00045942|10819255|FG000|PKC412A2104E2|Withdrawal by Subject|0
6814944|NCT00045942|10819256|FG001|PKC412A2104E2|Withdrawal by Subject|0
6814945|NCT00045942|10819257|FG002|PKC412A2104E2|Withdrawal by Subject|0
6814946|NCT00045942|10819258|FG003|PKC412A2104E2|Withdrawal by Subject|0
6814947|NCT00045942|10819259|FG004|PKC412A2104E2|Withdrawal by Subject|0
6814948|NCT00045942|10819260|FG005|PKC412A2104E2|Withdrawal by Subject|1
6814949|NCT00045942|10819261|FG006|PKC412A2104E2|Withdrawal by Subject|0
6814950|NCT00045942|10819262|FG007|PKC412A2104E2|Withdrawal by Subject|1
6814951|NCT00045942|10819263|FG008|PKC412A2104E2|Withdrawal by Subject|0
6814952|NCT00045942|10819255|FG000|PKC412A2104E2|Lack of Efficacy|0
6814953|NCT00045942|10819256|FG001|PKC412A2104E2|Lack of Efficacy|0
6814954|NCT00045942|10819257|FG002|PKC412A2104E2|Lack of Efficacy|0
6814955|NCT00045942|10819258|FG003|PKC412A2104E2|Lack of Efficacy|0
6814956|NCT00045942|10819259|FG004|PKC412A2104E2|Lack of Efficacy|0
6814957|NCT00045942|10819260|FG005|PKC412A2104E2|Lack of Efficacy|3
6814958|NCT00045942|10819261|FG006|PKC412A2104E2|Lack of Efficacy|2
6814959|NCT00045942|10819262|FG007|PKC412A2104E2|Lack of Efficacy|2
6814960|NCT00045942|10819263|FG008|PKC412A2104E2|Lack of Efficacy|6
6814961|NCT00045942|10819255|FG000|PKC412A2104E2|Adverse Event|0
6814962|NCT00045942|10819256|FG001|PKC412A2104E2|Adverse Event|0
6814963|NCT00045942|10819257|FG002|PKC412A2104E2|Adverse Event|0
6814964|NCT00045942|10819258|FG003|PKC412A2104E2|Adverse Event|0
6814965|NCT00045942|10819259|FG004|PKC412A2104E2|Adverse Event|0
6814966|NCT00045942|10819260|FG005|PKC412A2104E2|Adverse Event|4
6814967|NCT00045942|10819261|FG006|PKC412A2104E2|Adverse Event|3
6814968|NCT00045942|10819262|FG007|PKC412A2104E2|Adverse Event|1
6814969|NCT00045942|10819263|FG008|PKC412A2104E2|Adverse Event|0
6814970|NCT00045942|10819255|FG000|PKC412A2104E2|Death|0
6814971|NCT00045942|10819256|FG001|PKC412A2104E2|Death|0
6814972|NCT00045942|10819257|FG002|PKC412A2104E2|Death|0
6814973|NCT00045942|10819258|FG003|PKC412A2104E2|Death|0
6814974|NCT00045942|10819259|FG004|PKC412A2104E2|Death|0
6814975|NCT00045942|10819260|FG005|PKC412A2104E2|Death|1
6814976|NCT00045942|10819261|FG006|PKC412A2104E2|Death|2
6814977|NCT00045942|10819262|FG007|PKC412A2104E2|Death|0
6814978|NCT00045942|10819263|FG008|PKC412A2104E2|Death|0
6814979|NCT00046839|10819330|FG000|Overall Study|Ineligible / No protocol treatment|0
6814980|NCT00046839|10819331|FG001|Overall Study|Ineligible / No protocol treatment|2
6814981|NCT00046839|10819330|FG000|Overall Study|Withdrawal of consent|1
6814982|NCT00046839|10819331|FG001|Overall Study|Withdrawal of consent|0
6814983|NCT00046891|10819340|FG000|Overall Study|Cancels|5
6814984|NCT00046891|10819341|FG001|Overall Study|Cancels|9
6814985|NCT00046891|10819340|FG000|Overall Study|Ineligible|1
6814986|NCT00046891|10819341|FG001|Overall Study|Ineligible|1
6814987|NCT00046891|10819340|FG000|Overall Study|Withdrawal by Subject|18
6814988|NCT00046891|10819341|FG001|Overall Study|Withdrawal by Subject|15
6814989|NCT00046891|10819340|FG000|Overall Study|Adverse Event|5
6814990|NCT00046891|10819341|FG001|Overall Study|Adverse Event|5
6814991|NCT00046930|10819357|FG000|Overall Study|Ineligible|12
6814992|NCT00046930|10819358|FG001|Overall Study|Ineligible|4
6814993|NCT00047320|10819371|FG000|Overall Study|Lack of Efficacy|8
6814994|NCT00047320|10819371|FG000|Overall Study|Lost to Follow-up|1
6814995|NCT00047320|10819371|FG000|Overall Study|Physician Decision|8
6814996|NCT00047320|10819371|FG000|Overall Study|Withdrawal by Subject|9
6814997|NCT00047320|10819371|FG000|Overall Study|Ineligible|2
6814998|NCT00047385|10819377|FG000|Overall Study|Death before any screening|2
6814999|NCT00047385|10819378|FG001|Overall Study|Death before any screening|5
6815000|NCT00047385|10819377|FG000|Overall Study|Lung Cancer diagnosed before screening|5
6815001|NCT00047385|10819378|FG001|Overall Study|Lung Cancer diagnosed before screening|3
6815002|NCT00047385|10819377|FG000|Overall Study|Eligible for screening but had no screen|260
6815003|NCT00047385|10819378|FG001|Overall Study|Eligible for screening but had no screen|492
6815004|NCT00047463|10819386|FG000|Overall Study|Withdrawal by Subject|0
6815005|NCT00047463|10819387|FG001|Overall Study|Withdrawal by Subject|3
6815006|NCT00047879|10819417|FG000|Overall Study|Progressive disease|4
6815007|NCT00047879|10819418|FG001|Overall Study|Progressive disease|3
6815008|NCT00048035|10819430|FG000|Core Period|Early Withdrawals|4
6815009|NCT00048035|10819431|FG001|Core Period|Early Withdrawals|2
6815010|NCT00048035|10819432|FG002|Core Period|Early Withdrawals|1
6815011|NCT00048035|10819433|FG003|Core Period|Early Withdrawals|1
6815012|NCT00048035|10819434|FG004|Core Period|Early Withdrawals|1
6815013|NCT00048035|10819435|FG005|Core Period|Early Withdrawals|1
6815014|NCT00048035|10819436|FG006|Core Period|Early Withdrawals|0
6815015|NCT00048035|10819437|FG007|Core Period|Early Withdrawals|0
6815016|NCT00048035|10819430|FG000|Extension Year 1|Early Withdrawals|0
6815017|NCT00048035|10819431|FG001|Extension Year 1|Early Withdrawals|0
6815018|NCT00048035|10819432|FG002|Extension Year 1|Early Withdrawals|0
6815019|NCT00048035|10819433|FG003|Extension Year 1|Early Withdrawals|0
6815020|NCT00048035|10819434|FG004|Extension Year 1|Early Withdrawals|0
6815021|NCT00048035|10819435|FG005|Extension Year 1|Early Withdrawals|0
6815022|NCT00048035|10819436|FG006|Extension Year 1|Early Withdrawals|11
6815023|NCT00048035|10819437|FG007|Extension Year 1|Early Withdrawals|11
6815024|NCT00048035|10819430|FG000|Extension Year 2|Early Withdrawals|0
6815025|NCT00048035|10819431|FG001|Extension Year 2|Early Withdrawals|0
6815026|NCT00048035|10819432|FG002|Extension Year 2|Early Withdrawals|0
6815027|NCT00048035|10819433|FG003|Extension Year 2|Early Withdrawals|0
6815028|NCT00048035|10819434|FG004|Extension Year 2|Early Withdrawals|0
6815029|NCT00048035|10819435|FG005|Extension Year 2|Early Withdrawals|0
6815030|NCT00048035|10819436|FG006|Extension Year 2|Early Withdrawals|3
6815031|NCT00048035|10819437|FG007|Extension Year 2|Early Withdrawals|3
6815032|NCT00048048|10819461|FG000|Core Treatment|Withdrawal by Subject|0
6815033|NCT00048048|10819462|FG001|Core Treatment|Withdrawal by Subject|0
6815034|NCT00048048|10819463|FG002|Core Treatment|Withdrawal by Subject|1
6815035|NCT00048048|10819464|FG003|Core Treatment|Withdrawal by Subject|0
6815036|NCT00048048|10819465|FG004|Core Treatment|Withdrawal by Subject|0
6815037|NCT00048048|10819466|FG005|Core Treatment|Withdrawal by Subject|0
6815038|NCT00048048|10819467|FG006|Core Treatment|Withdrawal by Subject|0
6815039|NCT00048048|10819468|FG007|Core Treatment|Withdrawal by Subject|0
6815040|NCT00048048|10819469|FG008|Core Treatment|Withdrawal by Subject|0
6815041|NCT00048048|10819470|FG009|Core Treatment|Withdrawal by Subject|0
6815042|NCT00048048|10819471|FG010|Core Treatment|Withdrawal by Subject|0
6815043|NCT00048048|10819472|FG011|Core Treatment|Withdrawal by Subject|0
6815044|NCT00048048|10819461|FG000|Core Treatment|Adverse Event|0
6815045|NCT00048048|10819462|FG001|Core Treatment|Adverse Event|0
6815046|NCT00048048|10819463|FG002|Core Treatment|Adverse Event|0
6815047|NCT00048048|10819464|FG003|Core Treatment|Adverse Event|0
6815048|NCT00048048|10819465|FG004|Core Treatment|Adverse Event|0
6815049|NCT00048048|10819466|FG005|Core Treatment|Adverse Event|0
6815050|NCT00048048|10819467|FG006|Core Treatment|Adverse Event|0
6815051|NCT00048048|10819468|FG007|Core Treatment|Adverse Event|1
6815052|NCT00048048|10819469|FG008|Core Treatment|Adverse Event|0
6815053|NCT00048048|10819470|FG009|Core Treatment|Adverse Event|0
6815054|NCT00048048|10819471|FG010|Core Treatment|Adverse Event|0
6815055|NCT00048048|10819472|FG011|Core Treatment|Adverse Event|0
6815056|NCT00048048|10819461|FG000|Extension Year 1|Early withdrawals|0
6815057|NCT00048048|10819462|FG001|Extension Year 1|Early withdrawals|0
6815058|NCT00048048|10819463|FG002|Extension Year 1|Early withdrawals|0
6815059|NCT00048048|10819464|FG003|Extension Year 1|Early withdrawals|0
6815060|NCT00048048|10819465|FG004|Extension Year 1|Early withdrawals|0
6815061|NCT00048048|10819466|FG005|Extension Year 1|Early withdrawals|0
6815062|NCT00048048|10819467|FG006|Extension Year 1|Early withdrawals|0
6815063|NCT00048048|10819468|FG007|Extension Year 1|Early withdrawals|0
6815064|NCT00048048|10819469|FG008|Extension Year 1|Early withdrawals|0
6815065|NCT00048048|10819470|FG009|Extension Year 1|Early withdrawals|2
6815066|NCT00048048|10819471|FG010|Extension Year 1|Early withdrawals|2
6815067|NCT00048048|10819472|FG011|Extension Year 1|Early withdrawals|4
6815068|NCT00048048|10819461|FG000|Extension Year 2|Early withdrawals|0
6815069|NCT00048048|10819462|FG001|Extension Year 2|Early withdrawals|0
6815070|NCT00048048|10819463|FG002|Extension Year 2|Early withdrawals|0
6815071|NCT00048048|10819464|FG003|Extension Year 2|Early withdrawals|0
6815072|NCT00048048|10819465|FG004|Extension Year 2|Early withdrawals|0
6815073|NCT00048048|10819466|FG005|Extension Year 2|Early withdrawals|0
6815074|NCT00048048|10819467|FG006|Extension Year 2|Early withdrawals|0
6815075|NCT00048048|10819468|FG007|Extension Year 2|Early withdrawals|0
6815076|NCT00048048|10819469|FG008|Extension Year 2|Early withdrawals|0
6815077|NCT00048048|10819470|FG009|Extension Year 2|Early withdrawals|0
6815078|NCT00048048|10819471|FG010|Extension Year 2|Early withdrawals|4
6815079|NCT00048048|10819472|FG011|Extension Year 2|Early withdrawals|2
6815080|NCT00048061|10819503|FG000|Overall Study|Adverse Event|41
6815081|NCT00048061|10819504|FG001|Overall Study|Adverse Event|32
6815082|NCT00048061|10819505|FG002|Overall Study|Adverse Event|44
6815083|NCT00048061|10819506|FG003|Overall Study|Adverse Event|37
6815084|NCT00048061|10819503|FG000|Overall Study|Lost to Follow-up|3
6815085|NCT00048061|10819504|FG001|Overall Study|Lost to Follow-up|2
6815086|NCT00048061|10819505|FG002|Overall Study|Lost to Follow-up|4
6815087|NCT00048061|10819506|FG003|Overall Study|Lost to Follow-up|5
6815088|NCT00048061|10819503|FG000|Overall Study|Withdrawal by Subject|20
6815089|NCT00048061|10819504|FG001|Overall Study|Withdrawal by Subject|29
6815090|NCT00048061|10819505|FG002|Overall Study|Withdrawal by Subject|29
6815091|NCT00048061|10819506|FG003|Overall Study|Withdrawal by Subject|32
6815092|NCT00048061|10819503|FG000|Overall Study|Did not follow-up|5
6815093|NCT00048061|10819504|FG001|Overall Study|Did not follow-up|5
6815094|NCT00048061|10819505|FG002|Overall Study|Did not follow-up|4
6815095|NCT00048061|10819506|FG003|Overall Study|Did not follow-up|5
6815096|NCT00048061|10819503|FG000|Overall Study|Early improvement|6
6815097|NCT00048061|10819504|FG001|Overall Study|Early improvement|5
6815098|NCT00048061|10819505|FG002|Overall Study|Early improvement|3
6815099|NCT00048061|10819506|FG003|Overall Study|Early improvement|0
6815100|NCT00048074|10819519|FG000|Overall Study|Adverse Event|46
6815101|NCT00048074|10819520|FG001|Overall Study|Adverse Event|41
6815102|NCT00048074|10819521|FG002|Overall Study|Adverse Event|53
6815103|NCT00048074|10819519|FG000|Overall Study|Death|3
6815104|NCT00048074|10819520|FG001|Overall Study|Death|3
6815105|NCT00048074|10819521|FG002|Overall Study|Death|2
6815106|NCT00048074|10819519|FG000|Overall Study|Lost to Follow-up|2
6815107|NCT00048074|10819520|FG001|Overall Study|Lost to Follow-up|6
6815108|NCT00048074|10819521|FG002|Overall Study|Lost to Follow-up|6
6815109|NCT00048074|10819519|FG000|Overall Study|Withdrawal by Subject|28
6815110|NCT00048074|10819520|FG001|Overall Study|Withdrawal by Subject|30
6815111|NCT00048074|10819521|FG002|Overall Study|Withdrawal by Subject|35
6815112|NCT00048074|10819519|FG000|Overall Study|Protocol Violation|1
6815113|NCT00048074|10819520|FG001|Overall Study|Protocol Violation|3
6815114|NCT00048074|10819521|FG002|Overall Study|Protocol Violation|0
6815115|NCT00048074|10819519|FG000|Overall Study|Study participation was terminated|0
6815116|NCT00048074|10819520|FG001|Overall Study|Study participation was terminated|1
6815117|NCT00048074|10819521|FG002|Overall Study|Study participation was terminated|0
6815118|NCT00048074|10819519|FG000|Overall Study|Husband ill|0
6815119|NCT00048074|10819520|FG001|Overall Study|Husband ill|1
6815120|NCT00048074|10819521|FG002|Overall Study|Husband ill|0
6815121|NCT00048074|10819519|FG000|Overall Study|Poor compliance|0
6815122|NCT00048074|10819520|FG001|Overall Study|Poor compliance|1
6815123|NCT00048074|10819521|FG002|Overall Study|Poor compliance|0
6815124|NCT00048074|10819519|FG000|Overall Study|Out of station|0
6815125|NCT00048074|10819520|FG001|Overall Study|Out of station|1
6815126|NCT00048074|10819521|FG002|Overall Study|Out of station|1
6815127|NCT00048074|10819519|FG000|Overall Study|Social reasons|1
6815128|NCT00048074|10819520|FG001|Overall Study|Social reasons|0
6815129|NCT00048074|10819521|FG002|Overall Study|Social reasons|0
6815130|NCT00048165|10819531|FG000|Completed 6 Months Study|Administration/Other|8
6815131|NCT00048165|10819532|FG001|Completed 6 Months Study|Administration/Other|8
6815132|NCT00048165|10819531|FG000|Completed 6 Months Study|Abnormality of laboratory test|1
6815133|NCT00048165|10819532|FG001|Completed 6 Months Study|Abnormality of laboratory test|0
6815134|NCT00048165|10819531|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14
6815135|NCT00048165|10819532|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11
6815136|NCT00048165|10819531|FG000|Completed 6 Months Study|Death|12
6815137|NCT00048165|10819532|FG001|Completed 6 Months Study|Death|6
6815138|NCT00048165|10819531|FG000|Completed 6 Months Study|Insufficient therapy|1
6815139|NCT00048165|10819532|FG001|Completed 6 Months Study|Insufficient therapy|4
6815140|NCT00048165|10819531|FG000|Completed 6 Months Study|Other violation|4
6815141|NCT00048165|10819532|FG001|Completed 6 Months Study|Other violation|6
6815142|NCT00048165|10819531|FG000|Completed 6 Months Study|Refused treatment|5
6815143|NCT00048165|10819532|FG001|Completed 6 Months Study|Refused treatment|5
6815144|NCT00048165|10819531|FG000|Completed 6 Months Study|Violation criteria|0
6815145|NCT00048165|10819532|FG001|Completed 6 Months Study|Violation criteria|2
6815146|NCT00048165|10819531|FG000|Completed 6 Months Study|Did not receive study drug|6
6815147|NCT00048165|10819532|FG001|Completed 6 Months Study|Did not receive study drug|6
6815148|NCT00048165|10819531|FG000|Completed 12 Months Study|Administration/Other|0
6815149|NCT00048165|10819532|FG001|Completed 12 Months Study|Administration/Other|2
6815150|NCT00048165|10819531|FG000|Completed 12 Months Study|Death|2
6815151|NCT00048165|10819532|FG001|Completed 12 Months Study|Death|1
6815152|NCT00048165|10819531|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1
6815153|NCT00048165|10819532|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0
6815154|NCT00048347|10819540|FG000|Overall Study|Screen failure|2
6815155|NCT00048542|10819548|FG000|Double-Blind Phase|Withdrawal by Subject|0
6815156|NCT00048542|10819549|FG001|Double-Blind Phase|Withdrawal by Subject|1
6815157|NCT00048542|10819550|FG002|Double-Blind Phase|Withdrawal by Subject|0
6815158|NCT00048542|10819551|FG003|Double-Blind Phase|Withdrawal by Subject|0
6815159|NCT00048542|10819552|FG004|Double-Blind Phase|Withdrawal by Subject|0
6815160|NCT00048542|10819553|FG005|Double-Blind Phase|Withdrawal by Subject|0
6815161|NCT00048542|10819554|FG006|Double-Blind Phase|Withdrawal by Subject|0
6815162|NCT00048542|10819555|FG007|Double-Blind Phase|Withdrawal by Subject|0
6815163|NCT00048542|10819548|FG000|Double-Blind Phase|Protocol Violation|0
6815164|NCT00048542|10819549|FG001|Double-Blind Phase|Protocol Violation|0
6815165|NCT00048542|10819550|FG002|Double-Blind Phase|Protocol Violation|1
6815166|NCT00048542|10819551|FG003|Double-Blind Phase|Protocol Violation|0
6815167|NCT00048542|10819552|FG004|Double-Blind Phase|Protocol Violation|0
6815168|NCT00048542|10819553|FG005|Double-Blind Phase|Protocol Violation|0
6815169|NCT00048542|10819554|FG006|Double-Blind Phase|Protocol Violation|0
6815170|NCT00048542|10819555|FG007|Double-Blind Phase|Protocol Violation|0
6815171|NCT00048542|10819548|FG000|Double-Blind Phase|Sponsor request or decision|2
6815172|NCT00048542|10819549|FG001|Double-Blind Phase|Sponsor request or decision|0
6815173|NCT00048542|10819550|FG002|Double-Blind Phase|Sponsor request or decision|0
6815174|NCT00048542|10819551|FG003|Double-Blind Phase|Sponsor request or decision|0
6815175|NCT00048542|10819552|FG004|Double-Blind Phase|Sponsor request or decision|0
6815176|NCT00048542|10819553|FG005|Double-Blind Phase|Sponsor request or decision|0
6815177|NCT00048542|10819554|FG006|Double-Blind Phase|Sponsor request or decision|0
6815178|NCT00048542|10819555|FG007|Double-Blind Phase|Sponsor request or decision|0
6815179|NCT00048542|10819548|FG000|Double-Blind Phase|Randomized in error|1
6815180|NCT00048542|10819549|FG001|Double-Blind Phase|Randomized in error|0
6815181|NCT00048542|10819550|FG002|Double-Blind Phase|Randomized in error|0
6815182|NCT00048542|10819551|FG003|Double-Blind Phase|Randomized in error|0
6815183|NCT00048542|10819552|FG004|Double-Blind Phase|Randomized in error|0
6815184|NCT00048542|10819553|FG005|Double-Blind Phase|Randomized in error|0
6815185|NCT00048542|10819554|FG006|Double-Blind Phase|Randomized in error|0
6815186|NCT00048542|10819555|FG007|Double-Blind Phase|Randomized in error|0
6815187|NCT00048542|10819548|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0
6815188|NCT00048542|10819549|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0
6815189|NCT00048542|10819550|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0
6815190|NCT00048542|10819551|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0
6815191|NCT00048542|10819552|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3
6815192|NCT00048542|10819553|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6
6815193|NCT00048542|10819554|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0
6815194|NCT00048542|10819555|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0
6815195|NCT00048542|10819548|FG000|Open-Label Extension BSA Phase|Protocol Violation|0
6815196|NCT00048542|10819549|FG001|Open-Label Extension BSA Phase|Protocol Violation|0
6815197|NCT00048542|10819550|FG002|Open-Label Extension BSA Phase|Protocol Violation|0
6815198|NCT00048542|10819551|FG003|Open-Label Extension BSA Phase|Protocol Violation|0
6815199|NCT00048542|10819552|FG004|Open-Label Extension BSA Phase|Protocol Violation|0
6815200|NCT00048542|10819553|FG005|Open-Label Extension BSA Phase|Protocol Violation|1
6815201|NCT00048542|10819554|FG006|Open-Label Extension BSA Phase|Protocol Violation|0
6815202|NCT00048542|10819555|FG007|Open-Label Extension BSA Phase|Protocol Violation|0
6815203|NCT00048542|10819548|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0
6815204|NCT00048542|10819549|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0
6815205|NCT00048542|10819550|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0
6815206|NCT00048542|10819551|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0
6815207|NCT00048542|10819552|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5
6815208|NCT00048542|10819553|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1
6815209|NCT00048542|10819554|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0
6815210|NCT00048542|10819555|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0
6815211|NCT00048542|10819548|FG000|Open-Label Extension BSA Phase|Adverse Event|0
6815212|NCT00048542|10819549|FG001|Open-Label Extension BSA Phase|Adverse Event|0
6815213|NCT00048542|10819550|FG002|Open-Label Extension BSA Phase|Adverse Event|0
6815214|NCT00048542|10819551|FG003|Open-Label Extension BSA Phase|Adverse Event|0
6815215|NCT00048542|10819552|FG004|Open-Label Extension BSA Phase|Adverse Event|1
6815216|NCT00048542|10819553|FG005|Open-Label Extension BSA Phase|Adverse Event|1
6815217|NCT00048542|10819554|FG006|Open-Label Extension BSA Phase|Adverse Event|0
6815218|NCT00048542|10819555|FG007|Open-Label Extension BSA Phase|Adverse Event|0
6815219|NCT00048542|10819548|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0
6815220|NCT00048542|10819549|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0
6815221|NCT00048542|10819550|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0
6815222|NCT00048542|10819551|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0
6815223|NCT00048542|10819552|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3
6815224|NCT00048542|10819553|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1
6815374|NCT00048581|10819611|FG000|Open-Label Period|Poor/Non-compliance|0
6815225|NCT00048542|10819554|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0
6815226|NCT00048542|10819555|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0
6815227|NCT00048542|10819548|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
6815228|NCT00048542|10819549|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
6815229|NCT00048542|10819550|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
6815230|NCT00048542|10819551|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
6815231|NCT00048542|10819552|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
6815232|NCT00048542|10819553|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
6815233|NCT00048542|10819554|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6
6815234|NCT00048542|10819555|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3
6815235|NCT00048542|10819548|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
6815236|NCT00048542|10819549|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
6815237|NCT00048542|10819550|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
6815238|NCT00048542|10819551|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
6815239|NCT00048542|10819552|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
6815240|NCT00048542|10819553|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
6815241|NCT00048542|10819554|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
6815242|NCT00048542|10819555|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
6815243|NCT00048542|10819548|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
6815244|NCT00048542|10819549|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
6815245|NCT00048542|10819550|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
6815246|NCT00048542|10819551|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
6815247|NCT00048542|10819552|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
6815248|NCT00048542|10819553|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
6815249|NCT00048542|10819554|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6
6815250|NCT00048542|10819555|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7
6815251|NCT00048542|10819548|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0
6815252|NCT00048542|10819549|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0
6815253|NCT00048542|10819550|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0
6815254|NCT00048542|10819551|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0
6815255|NCT00048542|10819552|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0
6815256|NCT00048542|10819553|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0
6815257|NCT00048542|10819554|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2
6815258|NCT00048542|10819555|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2
6815259|NCT00048542|10819548|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
6815260|NCT00048542|10819549|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
6815261|NCT00048542|10819550|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
6815262|NCT00048542|10819551|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
6815263|NCT00048542|10819552|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
6815264|NCT00048542|10819553|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
6815265|NCT00048542|10819554|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2
6815266|NCT00048542|10819555|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1
6815267|NCT00048542|10819548|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
6815268|NCT00048542|10819549|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
6815269|NCT00048542|10819550|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
6815270|NCT00048542|10819551|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
6815271|NCT00048542|10819552|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
6815272|NCT00048542|10819553|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
6815273|NCT00048542|10819554|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5
6815274|NCT00048542|10819555|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8
6815275|NCT00048568|10819586|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11
6815276|NCT00048568|10819587|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3
6815277|NCT00048568|10819588|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0
6815278|NCT00048568|10819586|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11
6815279|NCT00048568|10819587|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33
6815280|NCT00048568|10819588|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0
6815281|NCT00048568|10819586|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
6815282|NCT00048568|10819587|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
6815283|NCT00048568|10819588|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0
6815284|NCT00048568|10819586|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7
6815285|NCT00048568|10819587|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4
6815286|NCT00048568|10819588|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0
6815287|NCT00048568|10819586|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2
6815288|NCT00048568|10819587|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4
6815289|NCT00048568|10819588|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0
6815290|NCT00048568|10819586|FG000|Double-Blind Period Days 170 to 365|Death|1
6815291|NCT00048568|10819587|FG001|Double-Blind Period Days 170 to 365|Death|1
6815292|NCT00048568|10819588|FG002|Double-Blind Period Days 170 to 365|Death|0
6815293|NCT00048568|10819586|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7
6815294|NCT00048568|10819587|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1
6815295|NCT00048568|10819588|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0
6815296|NCT00048568|10819586|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2
6815297|NCT00048568|10819587|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7
6815298|NCT00048568|10819588|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0
6815299|NCT00048568|10819586|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3
6815300|NCT00048568|10819587|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1
6815301|NCT00048568|10819588|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0
6815302|NCT00048568|10819586|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
6815303|NCT00048568|10819587|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1
6815304|NCT00048568|10819588|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
6815305|NCT00048568|10819586|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2
6815306|NCT00048568|10819587|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0
6815307|NCT00048568|10819588|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0
6815308|NCT00048568|10819586|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
6815309|NCT00048568|10819587|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
6815310|NCT00048568|10819588|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0
6815311|NCT00048568|10819586|FG000|Open-Label Period|Death|0
6815312|NCT00048568|10819587|FG001|Open-Label Period|Death|0
6815313|NCT00048568|10819588|FG002|Open-Label Period|Death|13
6815314|NCT00048568|10819586|FG000|Open-Label Period|Adverse Event|0
6815315|NCT00048568|10819587|FG001|Open-Label Period|Adverse Event|0
6815316|NCT00048568|10819588|FG002|Open-Label Period|Adverse Event|49
6815317|NCT00048568|10819586|FG000|Open-Label Period|Lack of Efficacy|0
6815318|NCT00048568|10819587|FG001|Open-Label Period|Lack of Efficacy|0
6815319|NCT00048568|10819588|FG002|Open-Label Period|Lack of Efficacy|32
6815320|NCT00048568|10819586|FG000|Open-Label Period|Withdrawal by Subject|0
6815321|NCT00048568|10819587|FG001|Open-Label Period|Withdrawal by Subject|0
6815322|NCT00048568|10819588|FG002|Open-Label Period|Withdrawal by Subject|26
6815323|NCT00048568|10819586|FG000|Open-Label Period|Pregnancy|0
6815324|NCT00048568|10819587|FG001|Open-Label Period|Pregnancy|0
6815325|NCT00048568|10819588|FG002|Open-Label Period|Pregnancy|5
6815326|NCT00048568|10819586|FG000|Open-Label Period|No Longer Met Study Criteria|0
6815327|NCT00048568|10819587|FG001|Open-Label Period|No Longer Met Study Criteria|0
6815328|NCT00048568|10819588|FG002|Open-Label Period|No Longer Met Study Criteria|2
6815329|NCT00048568|10819586|FG000|Open-Label Period|Administrative Decision By Sponsor|0
6815330|NCT00048568|10819587|FG001|Open-Label Period|Administrative Decision By Sponsor|0
6815331|NCT00048568|10819588|FG002|Open-Label Period|Administrative Decision By Sponsor|1
6815332|NCT00048568|10819586|FG000|Open-Label Period|Unknown Reasons|0
6815333|NCT00048568|10819587|FG001|Open-Label Period|Unknown Reasons|0
6815334|NCT00048568|10819588|FG002|Open-Label Period|Unknown Reasons|25
6815335|NCT00048568|10819586|FG000|Open-Label Period|Lost to Follow-up|0
6815336|NCT00048568|10819587|FG001|Open-Label Period|Lost to Follow-up|0
6815337|NCT00048568|10819588|FG002|Open-Label Period|Lost to Follow-up|7
6815338|NCT00048581|10819611|FG000|Double-Blind Period|Adverse Event|9
6815339|NCT00048581|10819612|FG001|Double-Blind Period|Adverse Event|5
6815340|NCT00048581|10819613|FG002|Double-Blind Period|Adverse Event|0
6815341|NCT00048581|10819611|FG000|Double-Blind Period|Lack of Efficacy|14
6815342|NCT00048581|10819612|FG001|Double-Blind Period|Lack of Efficacy|27
6815343|NCT00048581|10819613|FG002|Double-Blind Period|Lack of Efficacy|0
6815344|NCT00048581|10819611|FG000|Double-Blind Period|Lost to Follow-up|5
6815345|NCT00048581|10819612|FG001|Double-Blind Period|Lost to Follow-up|0
6815346|NCT00048581|10819613|FG002|Double-Blind Period|Lost to Follow-up|0
6815347|NCT00048581|10819611|FG000|Double-Blind Period|Withdrawal by Subject|5
6815348|NCT00048581|10819612|FG001|Double-Blind Period|Withdrawal by Subject|2
6815349|NCT00048581|10819613|FG002|Double-Blind Period|Withdrawal by Subject|0
6815350|NCT00048581|10819611|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1
6815351|NCT00048581|10819612|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0
6815352|NCT00048581|10819613|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0
6815353|NCT00048581|10819611|FG000|Double-Blind Period|Investigator Decision|1
6815354|NCT00048581|10819612|FG001|Double-Blind Period|Investigator Decision|0
6815355|NCT00048581|10819613|FG002|Double-Blind Period|Investigator Decision|0
6815356|NCT00048581|10819611|FG000|Open-Label Period|Death|0
6815357|NCT00048581|10819612|FG001|Open-Label Period|Death|0
6815358|NCT00048581|10819613|FG002|Open-Label Period|Death|4
6815359|NCT00048581|10819611|FG000|Open-Label Period|Adverse Event|0
6815360|NCT00048581|10819612|FG001|Open-Label Period|Adverse Event|0
6815361|NCT00048581|10819613|FG002|Open-Label Period|Adverse Event|37
6815362|NCT00048581|10819611|FG000|Open-Label Period|Lack of Efficacy|0
6815363|NCT00048581|10819612|FG001|Open-Label Period|Lack of Efficacy|0
6815364|NCT00048581|10819613|FG002|Open-Label Period|Lack of Efficacy|69
6815365|NCT00048581|10819611|FG000|Open-Label Period|Lost to Follow-up|0
6815366|NCT00048581|10819612|FG001|Open-Label Period|Lost to Follow-up|0
6815367|NCT00048581|10819613|FG002|Open-Label Period|Lost to Follow-up|14
6815368|NCT00048581|10819611|FG000|Open-Label Period|Withdrawal by Subject|0
6815369|NCT00048581|10819612|FG001|Open-Label Period|Withdrawal by Subject|0
6815370|NCT00048581|10819613|FG002|Open-Label Period|Withdrawal by Subject|20
6815371|NCT00048581|10819611|FG000|Open-Label Period|No Longer Meets Study Criteria|0
6815372|NCT00048581|10819612|FG001|Open-Label Period|No Longer Meets Study Criteria|0
6815373|NCT00048581|10819613|FG002|Open-Label Period|No Longer Meets Study Criteria|2
6815375|NCT00048581|10819612|FG001|Open-Label Period|Poor/Non-compliance|0
6815376|NCT00048581|10819613|FG002|Open-Label Period|Poor/Non-compliance|5
6815377|NCT00048581|10819611|FG000|Open-Label Period|Pregnancy|0
6815378|NCT00048581|10819612|FG001|Open-Label Period|Pregnancy|0
6815379|NCT00048581|10819613|FG002|Open-Label Period|Pregnancy|7
6815380|NCT00048581|10819611|FG000|Open-Label Period|Study Site Closure|0
6815381|NCT00048581|10819612|FG001|Open-Label Period|Study Site Closure|0
6815382|NCT00048581|10819613|FG002|Open-Label Period|Study Site Closure|2
6815383|NCT00048581|10819611|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0
6815384|NCT00048581|10819612|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0
6815385|NCT00048581|10819613|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3
6815386|NCT00048581|10819611|FG000|Open-Label Period|Problem With Transportation To Site|0
6815387|NCT00048581|10819612|FG001|Open-Label Period|Problem With Transportation To Site|0
6815388|NCT00048581|10819613|FG002|Open-Label Period|Problem With Transportation To Site|1
6815389|NCT00048581|10819611|FG000|Open-Label Period|Primary Investigator Retired|0
6815390|NCT00048581|10819612|FG001|Open-Label Period|Primary Investigator Retired|0
6815391|NCT00048581|10819613|FG002|Open-Label Period|Primary Investigator Retired|2
6815392|NCT00048581|10819611|FG000|Open-Label Period|Study Ended By Sponsor|0
6815393|NCT00048581|10819612|FG001|Open-Label Period|Study Ended By Sponsor|0
6815394|NCT00048581|10819613|FG002|Open-Label Period|Study Ended By Sponsor|1
6815395|NCT00048724|10819628|FG000|Overall Study|Adverse Event|53
6815396|NCT00048724|10819629|FG001|Overall Study|Adverse Event|12
6815397|NCT00048724|10819628|FG000|Overall Study|Withdrawal by Subject|34
6815398|NCT00048724|10819629|FG001|Overall Study|Withdrawal by Subject|54
6815399|NCT00048724|10819628|FG000|Overall Study|Lost to Follow-up|5
6815400|NCT00048724|10819629|FG001|Overall Study|Lost to Follow-up|5
6815401|NCT00048724|10819628|FG000|Overall Study|Protocol-defined Clinical Event|17
6815402|NCT00048724|10819629|FG001|Overall Study|Protocol-defined Clinical Event|32
6815403|NCT00048724|10819628|FG000|Overall Study|Noncompliance With Protocol|4
6815404|NCT00048724|10819629|FG001|Overall Study|Noncompliance With Protocol|12
6815405|NCT00048724|10819628|FG000|Overall Study|Did Not Meet Protocol Eligibility|2
6815406|NCT00048724|10819629|FG001|Overall Study|Did Not Meet Protocol Eligibility|2
6815407|NCT00048724|10819628|FG000|Overall Study|Administrative|1
6815408|NCT00048724|10819629|FG001|Overall Study|Administrative|1
6815409|NCT00048932|10819658|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1
6815410|NCT00048932|10819659|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0
6815411|NCT00048932|10819660|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0
6815412|NCT00048932|10819658|FG000|Double Blind Period (DB)|Adverse Event|51
6815413|NCT00048932|10819659|FG001|Double Blind Period (DB)|Adverse Event|19
6815414|NCT00048932|10819660|FG002|Double Blind Period (DB)|Adverse Event|0
6815415|NCT00048932|10819658|FG000|Double Blind Period (DB)|Death|5
6815416|NCT00048932|10819659|FG001|Double Blind Period (DB)|Death|3
6815417|NCT00048932|10819660|FG002|Double Blind Period (DB)|Death|0
6815418|NCT00048932|10819658|FG000|Double Blind Period (DB)|Lack of Efficacy|26
6815419|NCT00048932|10819659|FG001|Double Blind Period (DB)|Lack of Efficacy|44
6815420|NCT00048932|10819660|FG002|Double Blind Period (DB)|Lack of Efficacy|0
6815421|NCT00048932|10819658|FG000|Double Blind Period (DB)|Lost to Follow-up|3
6815422|NCT00048932|10819659|FG001|Double Blind Period (DB)|Lost to Follow-up|4
6815423|NCT00048932|10819660|FG002|Double Blind Period (DB)|Lost to Follow-up|0
6815424|NCT00048932|10819658|FG000|Double Blind Period (DB)|Relocation|1
6815425|NCT00048932|10819659|FG001|Double Blind Period (DB)|Relocation|0
6815426|NCT00048932|10819660|FG002|Double Blind Period (DB)|Relocation|0
6815427|NCT00048932|10819658|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0
6815428|NCT00048932|10819659|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1
6815429|NCT00048932|10819660|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0
6815430|NCT00048932|10819658|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1
6815431|NCT00048932|10819659|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
6815432|NCT00048932|10819660|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
6815433|NCT00048932|10819658|FG000|Double Blind Period (DB)|Pregnancy|1
6815434|NCT00048932|10819659|FG001|Double Blind Period (DB)|Pregnancy|0
6815435|NCT00048932|10819660|FG002|Double Blind Period (DB)|Pregnancy|0
6815436|NCT00048932|10819658|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8
6815437|NCT00048932|10819659|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2
6815438|NCT00048932|10819660|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0
6815439|NCT00048932|10819658|FG000|Double Blind Period (DB)|Withdrawal by Subject|24
6815440|NCT00048932|10819659|FG001|Double Blind Period (DB)|Withdrawal by Subject|10
6815441|NCT00048932|10819660|FG002|Double Blind Period (DB)|Withdrawal by Subject|0
6815442|NCT00048932|10819658|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2
6815443|NCT00048932|10819659|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4
6815444|NCT00048932|10819660|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0
6815445|NCT00048932|10819658|FG000|Open Label Period (OL)|Death|0
6815446|NCT00048932|10819659|FG001|Open Label Period (OL)|Death|0
6815447|NCT00048932|10819660|FG002|Open Label Period (OL)|Death|25
6815448|NCT00048932|10819658|FG000|Open Label Period (OL)|Adverse Event|0
6815449|NCT00048932|10819659|FG001|Open Label Period (OL)|Adverse Event|0
6815450|NCT00048932|10819660|FG002|Open Label Period (OL)|Adverse Event|103
6815451|NCT00048932|10819658|FG000|Open Label Period (OL)|Lack of Efficacy|0
6815452|NCT00048932|10819659|FG001|Open Label Period (OL)|Lack of Efficacy|0
6815453|NCT00048932|10819660|FG002|Open Label Period (OL)|Lack of Efficacy|81
6815454|NCT00048932|10819658|FG000|Open Label Period (OL)|Lost to Follow-up|0
6815455|NCT00048932|10819659|FG001|Open Label Period (OL)|Lost to Follow-up|0
6815456|NCT00048932|10819660|FG002|Open Label Period (OL)|Lost to Follow-up|27
6815457|NCT00048932|10819658|FG000|Open Label Period (OL)|Withdrawal by Subject|0
6815458|NCT00048932|10819659|FG001|Open Label Period (OL)|Withdrawal by Subject|0
6815459|NCT00048932|10819660|FG002|Open Label Period (OL)|Withdrawal by Subject|117
6815460|NCT00048932|10819658|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0
6815461|NCT00048932|10819659|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0
6815462|NCT00048932|10819660|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5
6815463|NCT00048932|10819658|FG000|Open Label Period (OL)|Poor/Non-Compliance|0
6815464|NCT00048932|10819659|FG001|Open Label Period (OL)|Poor/Non-Compliance|0
6815465|NCT00048932|10819660|FG002|Open Label Period (OL)|Poor/Non-Compliance|13
6815466|NCT00048932|10819658|FG000|Open Label Period (OL)|Pregnancy|0
6815467|NCT00048932|10819659|FG001|Open Label Period (OL)|Pregnancy|0
6815468|NCT00048932|10819660|FG002|Open Label Period (OL)|Pregnancy|6
6815469|NCT00048932|10819658|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0
6815470|NCT00048932|10819659|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0
6815471|NCT00048932|10819660|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20
6815472|NCT00048932|10819658|FG000|Open Label Period (OL)|Investigator Retiring|0
6815473|NCT00048932|10819659|FG001|Open Label Period (OL)|Investigator Retiring|0
6815474|NCT00048932|10819660|FG002|Open Label Period (OL)|Investigator Retiring|2
6815475|NCT00048932|10819658|FG000|Open Label Period (OL)|Participant Transportation Issues|0
6815476|NCT00048932|10819659|FG001|Open Label Period (OL)|Participant Transportation Issues|0
6815477|NCT00048932|10819660|FG002|Open Label Period (OL)|Participant Transportation Issues|1
6815478|NCT00048932|10819658|FG000|Open Label Period (OL)|Participant Relocated|0
6815479|NCT00048932|10819659|FG001|Open Label Period (OL)|Participant Relocated|0
6815480|NCT00048932|10819660|FG002|Open Label Period (OL)|Participant Relocated|6
6815481|NCT00048932|10819658|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0
6815482|NCT00048932|10819659|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0
6815483|NCT00048932|10819660|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1
6815484|NCT00048932|10819658|FG000|Open Label Period (OL)|Site Closure|0
6815485|NCT00048932|10819659|FG001|Open Label Period (OL)|Site Closure|0
6815486|NCT00048932|10819660|FG002|Open Label Period (OL)|Site Closure|3
6815487|NCT00048932|10819658|FG000|Open Label Period (OL)|Trial Terminated|0
6815488|NCT00048932|10819659|FG001|Open Label Period (OL)|Trial Terminated|0
6815489|NCT00048932|10819660|FG002|Open Label Period (OL)|Trial Terminated|1
6815490|NCT00048932|10819658|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0
6815491|NCT00048932|10819659|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0
6815492|NCT00048932|10819660|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1
6815493|NCT00048932|10819658|FG000|Open Label Period (OL)|Patient Decision|0
6815494|NCT00048932|10819659|FG001|Open Label Period (OL)|Patient Decision|0
6815495|NCT00048932|10819660|FG002|Open Label Period (OL)|Patient Decision|4
6815496|NCT00048932|10819658|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0
6815497|NCT00048932|10819659|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0
6815498|NCT00048932|10819660|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1
6815499|NCT00048932|10819658|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0
6815500|NCT00048932|10819659|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0
6815501|NCT00048932|10819660|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2
6815502|NCT00048932|10819658|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0
6815503|NCT00048932|10819659|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0
6815504|NCT00048932|10819660|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5
6815505|NCT00048932|10819658|FG000|Open Label Period (OL)|Medication Lost Efficacy|0
6815506|NCT00048932|10819659|FG001|Open Label Period (OL)|Medication Lost Efficacy|0
6815507|NCT00048932|10819660|FG002|Open Label Period (OL)|Medication Lost Efficacy|1
6815508|NCT00048932|10819658|FG000|Open Label Period (OL)|Investigator Decision|0
6815509|NCT00048932|10819659|FG001|Open Label Period (OL)|Investigator Decision|0
6815510|NCT00048932|10819660|FG002|Open Label Period (OL)|Investigator Decision|4
6815511|NCT00048932|10819658|FG000|Open Label Period (OL)|Site Staff Issues|0
6815512|NCT00048932|10819659|FG001|Open Label Period (OL)|Site Staff Issues|0
6815513|NCT00048932|10819660|FG002|Open Label Period (OL)|Site Staff Issues|2
6815514|NCT00048932|10819658|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0
6815515|NCT00048932|10819659|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0
6815516|NCT00048932|10819660|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9
6815517|NCT00048932|10819658|FG000|Open Label Period (OL)|Participant Surgery|0
6815518|NCT00048932|10819659|FG001|Open Label Period (OL)|Participant Surgery|0
6815519|NCT00048932|10819660|FG002|Open Label Period (OL)|Participant Surgery|1
6815520|NCT00048997|10819671|FG000|Overall Study|Protocol Violation|7
6815521|NCT00048997|10819672|FG001|Overall Study|Protocol Violation|2
6815522|NCT00048997|10819671|FG000|Overall Study|Withdrawal by Subject|6
6815523|NCT00048997|10819672|FG001|Overall Study|Withdrawal by Subject|1
6815524|NCT00049127|10819691|FG000|Overall Study|Withdrawal by Subject|0
6815525|NCT00049127|10819692|FG001|Overall Study|Withdrawal by Subject|0
6815526|NCT00049127|10819693|FG002|Overall Study|Withdrawal by Subject|1
6815527|NCT00049127|10819694|FG003|Overall Study|Withdrawal by Subject|0
6815528|NCT00049127|10819695|FG004|Overall Study|Withdrawal by Subject|0
6815529|NCT00049257|10819707|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10
6815530|NCT00049257|10819707|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1
6815531|NCT00049257|10819707|FG000|Carboplatin, Paclitaxel|Death|2
6815532|NCT00049257|10819707|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4
6815533|NCT00049322|10819713|FG000|Overall Study|disease burden|0
6815534|NCT00049322|10819714|FG001|Overall Study|disease burden|3
6815535|NCT00049322|10819713|FG000|Overall Study|Adverse Event|1
6815536|NCT00049322|10819714|FG001|Overall Study|Adverse Event|0
6815537|NCT00049322|10819713|FG000|Overall Study|refused angio|0
6815538|NCT00049322|10819714|FG001|Overall Study|refused angio|3
6815539|NCT00049517|10819728|FG000|Induction|Disease progression|0
6815540|NCT00049517|10819729|FG001|Induction|Disease progression|0
6815541|NCT00049517|10819730|FG002|Induction|Disease progression|0
6815542|NCT00049517|10819731|FG003|Induction|Disease progression|0
6815543|NCT00049517|10819732|FG004|Induction|Disease progression|18
6815544|NCT00049517|10819733|FG005|Induction|Disease progression|11
6815545|NCT00049517|10819728|FG000|Induction|Adverse Event|0
6815546|NCT00049517|10819729|FG001|Induction|Adverse Event|0
6815547|NCT00049517|10819730|FG002|Induction|Adverse Event|0
6815548|NCT00049517|10819731|FG003|Induction|Adverse Event|0
6815549|NCT00049517|10819732|FG004|Induction|Adverse Event|5
6815550|NCT00049517|10819733|FG005|Induction|Adverse Event|7
6815551|NCT00049517|10819728|FG000|Induction|Death|0
6815552|NCT00049517|10819729|FG001|Induction|Death|0
6815553|NCT00049517|10819730|FG002|Induction|Death|0
6815554|NCT00049517|10819731|FG003|Induction|Death|0
6815555|NCT00049517|10819732|FG004|Induction|Death|9
6815556|NCT00049517|10819733|FG005|Induction|Death|6
6815557|NCT00049517|10819728|FG000|Induction|Withdrawal by Subject|0
6815558|NCT00049517|10819729|FG001|Induction|Withdrawal by Subject|0
6815559|NCT00049517|10819730|FG002|Induction|Withdrawal by Subject|0
6815560|NCT00049517|10819731|FG003|Induction|Withdrawal by Subject|0
6815561|NCT00049517|10819732|FG004|Induction|Withdrawal by Subject|1
6815562|NCT00049517|10819733|FG005|Induction|Withdrawal by Subject|3
6815563|NCT00049517|10819728|FG000|Induction|Alternative therapy|0
6815564|NCT00049517|10819729|FG001|Induction|Alternative therapy|0
6815565|NCT00049517|10819730|FG002|Induction|Alternative therapy|0
6815566|NCT00049517|10819731|FG003|Induction|Alternative therapy|0
6815567|NCT00049517|10819732|FG004|Induction|Alternative therapy|2
6815568|NCT00049517|10819733|FG005|Induction|Alternative therapy|2
6815569|NCT00049517|10819728|FG000|Induction|Other complicating disease|0
6815570|NCT00049517|10819729|FG001|Induction|Other complicating disease|0
6815571|NCT00049517|10819730|FG002|Induction|Other complicating disease|0
6815572|NCT00049517|10819731|FG003|Induction|Other complicating disease|0
6815573|NCT00049517|10819732|FG004|Induction|Other complicating disease|3
6815574|NCT00049517|10819733|FG005|Induction|Other complicating disease|0
6815575|NCT00049517|10819728|FG000|Induction|Reasons not reported|0
6815576|NCT00049517|10819729|FG001|Induction|Reasons not reported|0
6815577|NCT00049517|10819730|FG002|Induction|Reasons not reported|0
6815578|NCT00049517|10819731|FG003|Induction|Reasons not reported|0
6815579|NCT00049517|10819732|FG004|Induction|Reasons not reported|22
6815580|NCT00049517|10819733|FG005|Induction|Reasons not reported|25
6815581|NCT00049517|10819728|FG000|Conditioning/Transplant|Disease progression|14
6815582|NCT00049517|10819729|FG001|Conditioning/Transplant|Disease progression|6
6815583|NCT00049517|10819730|FG002|Conditioning/Transplant|Disease progression|10
6815584|NCT00049517|10819731|FG003|Conditioning/Transplant|Disease progression|6
6815585|NCT00049517|10819732|FG004|Conditioning/Transplant|Disease progression|0
6815586|NCT00049517|10819733|FG005|Conditioning/Transplant|Disease progression|0
6815587|NCT00049517|10819728|FG000|Conditioning/Transplant|Adverse Event|2
6815588|NCT00049517|10819729|FG001|Conditioning/Transplant|Adverse Event|1
6815589|NCT00049517|10819730|FG002|Conditioning/Transplant|Adverse Event|4
6815590|NCT00049517|10819731|FG003|Conditioning/Transplant|Adverse Event|8
6815591|NCT00049517|10819732|FG004|Conditioning/Transplant|Adverse Event|0
6815592|NCT00049517|10819733|FG005|Conditioning/Transplant|Adverse Event|0
6815593|NCT00049517|10819728|FG000|Conditioning/Transplant|Death|1
6815594|NCT00049517|10819729|FG001|Conditioning/Transplant|Death|0
6815595|NCT00049517|10819730|FG002|Conditioning/Transplant|Death|0
6815596|NCT00049517|10819731|FG003|Conditioning/Transplant|Death|2
6815597|NCT00049517|10819732|FG004|Conditioning/Transplant|Death|0
6815598|NCT00049517|10819733|FG005|Conditioning/Transplant|Death|0
6815599|NCT00049517|10819728|FG000|Conditioning/Transplant|Withdrawal by Subject|4
6815600|NCT00049517|10819729|FG001|Conditioning/Transplant|Withdrawal by Subject|8
6815601|NCT00049517|10819730|FG002|Conditioning/Transplant|Withdrawal by Subject|4
6815602|NCT00049517|10819731|FG003|Conditioning/Transplant|Withdrawal by Subject|7
6815603|NCT00049517|10819732|FG004|Conditioning/Transplant|Withdrawal by Subject|0
6815604|NCT00049517|10819733|FG005|Conditioning/Transplant|Withdrawal by Subject|0
6815605|NCT00049517|10819728|FG000|Conditioning/Transplant|Alternative therapy|4
6815606|NCT00049517|10819729|FG001|Conditioning/Transplant|Alternative therapy|4
6815607|NCT00049517|10819730|FG002|Conditioning/Transplant|Alternative therapy|2
6815608|NCT00049517|10819731|FG003|Conditioning/Transplant|Alternative therapy|1
6815609|NCT00049517|10819732|FG004|Conditioning/Transplant|Alternative therapy|1
6815610|NCT00049517|10819733|FG005|Conditioning/Transplant|Alternative therapy|0
6815611|NCT00049517|10819728|FG000|Conditioning/Transplant|Other complicating disease|2
6815612|NCT00049517|10819729|FG001|Conditioning/Transplant|Other complicating disease|0
6815613|NCT00049517|10819730|FG002|Conditioning/Transplant|Other complicating disease|0
6815614|NCT00049517|10819731|FG003|Conditioning/Transplant|Other complicating disease|4
6815615|NCT00049517|10819732|FG004|Conditioning/Transplant|Other complicating disease|0
6815616|NCT00049517|10819733|FG005|Conditioning/Transplant|Other complicating disease|1
6815617|NCT00049517|10819728|FG000|Conditioning/Transplant|Reasons not reported|25
6815618|NCT00049517|10819729|FG001|Conditioning/Transplant|Reasons not reported|31
6815619|NCT00049517|10819730|FG002|Conditioning/Transplant|Reasons not reported|18
6815620|NCT00049517|10819731|FG003|Conditioning/Transplant|Reasons not reported|15
6815621|NCT00049517|10819732|FG004|Conditioning/Transplant|Reasons not reported|5
6815622|NCT00049517|10819733|FG005|Conditioning/Transplant|Reasons not reported|5
6815623|NCT00049530|10819741|FG000|Overall Study|Lack of Efficacy|25
6815624|NCT00049530|10819741|FG000|Overall Study|Adverse Event|2
6815625|NCT00049530|10819741|FG000|Overall Study|Death|1
6815626|NCT00049530|10819741|FG000|Overall Study|symptomatic deterioration|1
6815627|NCT00049530|10819741|FG000|Overall Study|ineligible|3
6815628|NCT00049543|10819747|FG000|Overall Study|still on treatment|2
6815629|NCT00049543|10819748|FG001|Overall Study|still on treatment|9
6815630|NCT00049673|10819756|FG000|Overall Study|No receive treatment/lost to follow-up|1
6815631|NCT00049673|10819757|FG001|Overall Study|No receive treatment/lost to follow-up|3
6815632|NCT00049842|10819765|FG000|Treatment Phase|Adverse Event|47
6815633|NCT00049842|10819766|FG001|Treatment Phase|Adverse Event|12
6815634|NCT00049842|10819765|FG000|Treatment Phase|Withdrawal by Subject|35
6815635|NCT00049842|10819766|FG001|Treatment Phase|Withdrawal by Subject|46
6815636|NCT00049842|10819765|FG000|Treatment Phase|Non-compliance with protocol|7
6815637|NCT00049842|10819766|FG001|Treatment Phase|Non-compliance with protocol|8
6815638|NCT00049842|10819765|FG000|Treatment Phase|Lost to Follow-up|4
6815639|NCT00049842|10819766|FG001|Treatment Phase|Lost to Follow-up|8
6815640|NCT00049842|10819765|FG000|Treatment Phase|Administrative|0
6815641|NCT00049842|10819766|FG001|Treatment Phase|Administrative|3
6815642|NCT00049842|10819765|FG000|Treatment Phase|Did not meet protocol eligibility|0
6815643|NCT00049842|10819766|FG001|Treatment Phase|Did not meet protocol eligibility|1
6815644|NCT00049842|10819765|FG000|Follow-up Phase|Adverse Event|6
6815645|NCT00049842|10819766|FG001|Follow-up Phase|Adverse Event|1
6815646|NCT00049842|10819765|FG000|Follow-up Phase|Other|1
6815647|NCT00049842|10819766|FG001|Follow-up Phase|Other|4
6815648|NCT00050011|10819774|FG000|Overall Study|Adverse Event|41
6815649|NCT00050011|10819775|FG001|Overall Study|Adverse Event|46
6815650|NCT00050011|10819774|FG000|Overall Study|Abnormal laboratory value(s)|1
6815651|NCT00050011|10819775|FG001|Overall Study|Abnormal laboratory value(s)|1
6815652|NCT00050011|10819774|FG000|Overall Study|Abnormal test procedure results|0
6815653|NCT00050011|10819775|FG001|Overall Study|Abnormal test procedure results|1
6815654|NCT00050011|10819774|FG000|Overall Study|Lack of Efficacy|16
6815655|NCT00050011|10819775|FG001|Overall Study|Lack of Efficacy|21
6815656|NCT00050011|10819774|FG000|Overall Study|Participant condition no longer required|1
6815657|NCT00050011|10819775|FG001|Overall Study|Participant condition no longer required|0
6815658|NCT00050011|10819774|FG000|Overall Study|Protocol Violation|4
6815659|NCT00050011|10819775|FG001|Overall Study|Protocol Violation|10
6815660|NCT00050011|10819774|FG000|Overall Study|Withdrawal by Subject|34
6815661|NCT00050011|10819775|FG001|Overall Study|Withdrawal by Subject|26
6815662|NCT00050011|10819774|FG000|Overall Study|Lost to Follow-up|7
6815663|NCT00050011|10819775|FG001|Overall Study|Lost to Follow-up|9
6815664|NCT00050011|10819774|FG000|Overall Study|Administrative problems|10
6815665|NCT00050011|10819775|FG001|Overall Study|Administrative problems|6
6815666|NCT00050011|10819774|FG000|Overall Study|Death|7
6815667|NCT00050011|10819775|FG001|Overall Study|Death|4
6815668|NCT00050011|10819774|FG000|Overall Study|Unknown - Reason is missing|0
6815669|NCT00050011|10819775|FG001|Overall Study|Unknown - Reason is missing|2
6815670|NCT00050167|10819805|FG000|Overall Study|not eligible not invasive|1
6815671|NCT00050167|10819806|FG001|Overall Study|not eligible not invasive|1
6815672|NCT00050622|10819812|FG000|Overall Study|Adverse Event|1
6815673|NCT00050778|10819839|FG000|Overall Study|Adverse Event|13
6815674|NCT00050778|10819840|FG001|Overall Study|Adverse Event|3
6815675|NCT00050778|10819841|FG002|Overall Study|Adverse Event|2
6815676|NCT00050778|10819839|FG000|Overall Study|Death|0
6815677|NCT00050778|10819840|FG001|Overall Study|Death|1
6815678|NCT00050778|10819841|FG002|Overall Study|Death|1
6815679|NCT00050778|10819839|FG000|Overall Study|Lack of Efficacy|16
6815680|NCT00050778|10819840|FG001|Overall Study|Lack of Efficacy|2
6815681|NCT00050778|10819841|FG002|Overall Study|Lack of Efficacy|2
6815682|NCT00050778|10819839|FG000|Overall Study|Lost to Follow-up|0
6815683|NCT00050778|10819840|FG001|Overall Study|Lost to Follow-up|2
6815684|NCT00050778|10819841|FG002|Overall Study|Lost to Follow-up|4
6815685|NCT00050778|10819839|FG000|Overall Study|Physician Decision|3
6815686|NCT00050778|10819840|FG001|Overall Study|Physician Decision|0
6815687|NCT00050778|10819841|FG002|Overall Study|Physician Decision|2
6815688|NCT00050778|10819839|FG000|Overall Study|Protocol Violation|2
6815689|NCT00050778|10819840|FG001|Overall Study|Protocol Violation|0
6815690|NCT00050778|10819841|FG002|Overall Study|Protocol Violation|1
6815691|NCT00050778|10819839|FG000|Overall Study|Withdrawal by Subject|6
6815692|NCT00050778|10819840|FG001|Overall Study|Withdrawal by Subject|8
6815693|NCT00050778|10819841|FG002|Overall Study|Withdrawal by Subject|4
6815694|NCT00050778|10819839|FG000|Overall Study|Randomized but not treated|4
6815695|NCT00050778|10819840|FG001|Overall Study|Randomized but not treated|5
6815696|NCT00050778|10819841|FG002|Overall Study|Randomized but not treated|2
6815697|NCT00050778|10819839|FG000|Overall Study|Familial and personal reasons|1
6815698|NCT00050778|10819840|FG001|Overall Study|Familial and personal reasons|0
6815699|NCT00050778|10819841|FG002|Overall Study|Familial and personal reasons|0
6815700|NCT00050960|10819853|FG000|Overall Study|Progressive Disease|137
6815701|NCT00050960|10819854|FG001|Overall Study|Progressive Disease|93
6815702|NCT00050960|10819853|FG000|Overall Study|Stable Disease|19
6815703|NCT00050960|10819854|FG001|Overall Study|Stable Disease|48
6815704|NCT00050960|10819853|FG000|Overall Study|Partial Response|14
6815705|NCT00050960|10819854|FG001|Overall Study|Partial Response|19
6815706|NCT00050960|10819853|FG000|Overall Study|Complete Response|0
6815707|NCT00050960|10819854|FG001|Overall Study|Complete Response|2
6815708|NCT00050960|10819853|FG000|Overall Study|Adverse Event|62
6815709|NCT00050960|10819854|FG001|Overall Study|Adverse Event|61
6815710|NCT00050960|10819853|FG000|Overall Study|Lost to Follow-up|0
6815711|NCT00050960|10819854|FG001|Overall Study|Lost to Follow-up|1
6815712|NCT00050960|10819853|FG000|Overall Study|Withdrawal by Subject|23
6815713|NCT00050960|10819854|FG001|Overall Study|Withdrawal by Subject|18
6815714|NCT00050960|10819853|FG000|Overall Study|Administrative|31
6815715|NCT00050960|10819854|FG001|Overall Study|Administrative|46
6815716|NCT00050960|10819853|FG000|Overall Study|Non-compliance|3
6815717|NCT00050960|10819854|FG001|Overall Study|Non-compliance|1
6815718|NCT00050960|10819853|FG000|Overall Study|Death|13
6815719|NCT00050960|10819854|FG001|Overall Study|Death|15
6815720|NCT00051025|10819866|FG000|Overall Study|Progressive Disease|1
6815721|NCT00051025|10819867|FG001|Overall Study|Progressive Disease|1
6815722|NCT00051025|10819866|FG000|Overall Study|Adverse Event|1
6815723|NCT00051025|10819867|FG001|Overall Study|Adverse Event|1
6815724|NCT00051025|10819866|FG000|Overall Study|Withdrawal by Subject|0
6815725|NCT00051025|10819867|FG001|Overall Study|Withdrawal by Subject|1
6815726|NCT00051025|10819866|FG000|Overall Study|Death|0
6815727|NCT00051025|10819867|FG001|Overall Study|Death|1
6815728|NCT00051311|10819879|FG000|Overall Study|Starting new study|0
6815729|NCT00051311|10819880|FG001|Overall Study|Starting new study|1
6815730|NCT00051311|10819879|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0
6815731|NCT00051311|10819880|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1
6815732|NCT00051311|10819879|FG000|Overall Study|Death of recipient|8
6815733|NCT00051311|10819880|FG001|Overall Study|Death of recipient|8
6815734|NCT00051311|10819879|FG000|Overall Study|Recipient taken off study|4
6815735|NCT00051311|10819880|FG001|Overall Study|Recipient taken off study|4
6815736|NCT00051363|10819886|FG000|Overall Study|Dropped Post-Rand for Any Reason|102
6815737|NCT00051363|10819887|FG001|Overall Study|Dropped Post-Rand for Any Reason|126
6815738|NCT00051363|10819886|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9
6815739|NCT00051363|10819887|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11
6815740|NCT00051363|10819886|FG000|Overall Study|Death|2
6815741|NCT00051363|10819887|FG001|Overall Study|Death|2
6815742|NCT00051363|10819886|FG000|Overall Study|Excluded Pre-Randomization|2
6815743|NCT00051363|10819887|FG001|Overall Study|Excluded Pre-Randomization|5
6815744|NCT00051558|10819895|FG000|Overall Study|Adverse Event|30
6815745|NCT00051558|10819896|FG001|Overall Study|Adverse Event|18
6815746|NCT00051558|10819895|FG000|Overall Study|Withdrawal by Subject|29
6815747|NCT00051558|10819896|FG001|Overall Study|Withdrawal by Subject|42
6815748|NCT00051558|10819895|FG000|Overall Study|Death|9
6815749|NCT00051558|10819896|FG001|Overall Study|Death|15
6815750|NCT00051558|10819895|FG000|Overall Study|Lost to Follow-up|4
6815751|NCT00051558|10819896|FG001|Overall Study|Lost to Follow-up|13
6815752|NCT00051558|10819895|FG000|Overall Study|Protocol Violation|3
6815753|NCT00051558|10819896|FG001|Overall Study|Protocol Violation|4
6815754|NCT00051558|10819895|FG000|Overall Study|Protocol Entry Criteria Unmet|1
6815755|NCT00051558|10819896|FG001|Overall Study|Protocol Entry Criteria Unmet|2
6815756|NCT00051558|10819895|FG000|Overall Study|Sponsor Decision|6
6815757|NCT00051558|10819896|FG001|Overall Study|Sponsor Decision|1
6815758|NCT00051558|10819895|FG000|Overall Study|Other|2
6815759|NCT00051558|10819896|FG001|Overall Study|Other|1
6815760|NCT00051558|10819895|FG000|Overall Study|Significant Lab Value|2
6815761|NCT00051558|10819896|FG001|Overall Study|Significant Lab Value|0
6815762|NCT00051558|10819895|FG000|Overall Study|Physician Decision|5
6815763|NCT00051558|10819896|FG001|Overall Study|Physician Decision|0
6815764|NCT00051636|10819904|FG000|Period 1 - Core|Adverse Event|2
6815765|NCT00051636|10819905|FG001|Period 1 - Core|Adverse Event|2
6815766|NCT00051636|10819904|FG000|Period 1 - Core|Protocol Violation|1
6815767|NCT00051636|10819905|FG001|Period 1 - Core|Protocol Violation|0
6815768|NCT00051636|10819904|FG000|Period 1 - Core|Withdrawal by Subject|1
6815769|NCT00051636|10819905|FG001|Period 1 - Core|Withdrawal by Subject|2
6815770|NCT00051636|10819904|FG000|Period 1 - Core|Lost to Follow-up|0
6815771|NCT00051636|10819905|FG001|Period 1 - Core|Lost to Follow-up|2
6815772|NCT00051636|10819904|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5
6815773|NCT00051636|10819905|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4
6815774|NCT00051636|10819904|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12
6815775|NCT00051636|10819905|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7
6815776|NCT00051636|10819904|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9
6815777|NCT00051636|10819905|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2
6815778|NCT00051636|10819904|FG000|Period 2- Extended Observation Period|Death|4
6815779|NCT00051636|10819905|FG001|Period 2- Extended Observation Period|Death|5
6815780|NCT00051636|10819904|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40
6815781|NCT00051636|10819905|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12
6815782|NCT00052715|10819953|FG000|Overall Study|wrong histology|1
6815783|NCT00052962|10819968|FG000|Overall Study|Not evaluable|0
6815784|NCT00052962|10819969|FG001|Overall Study|Not evaluable|2
6815785|NCT00052962|10819968|FG000|Overall Study|Not randomized/not evaluable|1
6815786|NCT00052962|10819969|FG001|Overall Study|Not randomized/not evaluable|0
6815787|NCT00053352|10819981|FG000|Overall Study|Lost to Follow-up|0
6815788|NCT00053352|10819982|FG001|Overall Study|Lost to Follow-up|1
6815789|NCT00053352|10819981|FG000|Overall Study|Physician Decision|11
6815790|NCT00053352|10819982|FG001|Overall Study|Physician Decision|1
6815791|NCT00053352|10819981|FG000|Overall Study|Withdrawal by Subject|1
6815792|NCT00053352|10819982|FG001|Overall Study|Withdrawal by Subject|0
6815793|NCT00053352|10819981|FG000|Overall Study|Ineligible|8
6815794|NCT00053352|10819982|FG001|Overall Study|Ineligible|8
6815795|NCT00053352|10819981|FG000|Overall Study|Disease at new site|1
6815796|NCT00053352|10819982|FG001|Overall Study|Disease at new site|0
6815797|NCT00053365|10819989|FG000|Overall Study|Incorrect cell type|1
6815798|NCT00053365|10819989|FG000|Overall Study|Platinum-sensitive interval >12 months|1
6815799|NCT00053365|10819989|FG000|Overall Study|Never treated|4
6815800|NCT00053417|10819999|FG000|Overall Study|Adverse Event|1
6815801|NCT00053417|10820000|FG001|Overall Study|Adverse Event|0
6815802|NCT00053417|10820001|FG002|Overall Study|Adverse Event|1
6815803|NCT00053417|10820002|FG003|Overall Study|Adverse Event|5
6815804|NCT00053417|10819999|FG000|Overall Study|Non-Compliance|0
6815805|NCT00053417|10820000|FG001|Overall Study|Non-Compliance|0
6815806|NCT00053417|10820001|FG002|Overall Study|Non-Compliance|0
6815807|NCT00053417|10820002|FG003|Overall Study|Non-Compliance|1
6815808|NCT00053417|10819999|FG000|Overall Study|Withdrawal by Subject|0
6815809|NCT00053417|10820000|FG001|Overall Study|Withdrawal by Subject|1
6815810|NCT00053417|10820001|FG002|Overall Study|Withdrawal by Subject|0
6815811|NCT00053417|10820002|FG003|Overall Study|Withdrawal by Subject|0
6815812|NCT00053417|10819999|FG000|Overall Study|Lost to Follow-up|1
6815813|NCT00053417|10820000|FG001|Overall Study|Lost to Follow-up|1
6815814|NCT00053417|10820001|FG002|Overall Study|Lost to Follow-up|0
6815815|NCT00053417|10820002|FG003|Overall Study|Lost to Follow-up|0
6815816|NCT00053846|10820087|FG000|Overall Study|Changed mind|8
6815817|NCT00053846|10820088|FG001|Overall Study|Changed mind|13
6815818|NCT00053846|10820087|FG000|Overall Study|Became too ill|8
6815819|NCT00053846|10820088|FG001|Overall Study|Became too ill|7
6815820|NCT00053846|10820087|FG000|Overall Study|Expired|5
6815821|NCT00053846|10820088|FG001|Overall Study|Expired|0
6815822|NCT00053846|10820087|FG000|Overall Study|Became ineligible|3
6815823|NCT00053846|10820088|FG001|Overall Study|Became ineligible|1
6815824|NCT00053846|10820087|FG000|Overall Study|Did not return data|1
6815825|NCT00053846|10820088|FG001|Overall Study|Did not return data|2
6815826|NCT00053846|10820087|FG000|Overall Study|Quit due to side effects|1
6815827|NCT00053846|10820088|FG001|Overall Study|Quit due to side effects|3
6815828|NCT00053846|10820087|FG000|Overall Study|Pills too large|0
6815829|NCT00053846|10820088|FG001|Overall Study|Pills too large|1
6815830|NCT00053898|10820096|FG000|Overall Study|No follow-up data from any source|9
6815831|NCT00053898|10820097|FG001|Overall Study|No follow-up data from any source|12
6815832|NCT00053898|10820096|FG000|Overall Study|Follow-up from telephone contact only|5
6815833|NCT00053898|10820097|FG001|Overall Study|Follow-up from telephone contact only|1
6815834|NCT00054132|10820114|FG000|Overall Study|Not Treated|1
6815835|NCT00054275|10820119|FG000|Overall Study|Withdrawal by Subject|4
6815836|NCT00054275|10820119|FG000|Overall Study|Adverse Event|5
6815837|NCT00054275|10820119|FG000|Overall Study|Progressive disease in cycle 1|1
6815838|NCT00054275|10820119|FG000|Overall Study|Physician Decision|1
6815839|NCT00054327|10820129|FG000|Overall Study|Engraftment failure|1
6815840|NCT00054327|10820130|FG001|Overall Study|Engraftment failure|0
6815841|NCT00054327|10820131|FG002|Overall Study|Engraftment failure|0
6815842|NCT00054327|10820132|FG003|Overall Study|Engraftment failure|0
6815843|NCT00054327|10820133|FG004|Overall Study|Engraftment failure|0
6815844|NCT00054327|10820134|FG005|Overall Study|Engraftment failure|0
6815845|NCT00054639|10820161|FG000|Overall Study|Lack of Efficacy|1
6815846|NCT00054639|10820161|FG000|Overall Study|Physician Decision|1
6815847|NCT00054691|10820174|FG000|Overall Study|Unmeasurable Disease|2
6815848|NCT00054691|10820174|FG000|Overall Study|Noncompliant|1
6815849|NCT00054704|10820180|FG000|Overall Study|Lack of Efficacy|2
6815850|NCT00054704|10820181|FG001|Overall Study|Lack of Efficacy|3
6815851|NCT00054704|10820180|FG000|Overall Study|Adverse Event|3
6815852|NCT00054704|10820181|FG001|Overall Study|Adverse Event|1
6815853|NCT00054704|10820180|FG000|Overall Study|Lost to Follow-up|0
6815854|NCT00054704|10820181|FG001|Overall Study|Lost to Follow-up|1
6815855|NCT00054717|10820189|FG000|Overall Study|Randomized but not treated|2
6815856|NCT00054717|10820190|FG001|Overall Study|Randomized but not treated|8
6815857|NCT00054717|10820189|FG000|Overall Study|Adverse Event|70
6815858|NCT00054717|10820190|FG001|Overall Study|Adverse Event|22
6815859|NCT00054717|10820189|FG000|Overall Study|Protocol Violation|18
6815860|NCT00054717|10820190|FG001|Overall Study|Protocol Violation|19
6815861|NCT00054717|10820189|FG000|Overall Study|Lost to Follow-up|23
6815862|NCT00054717|10820190|FG001|Overall Study|Lost to Follow-up|13
6815863|NCT00054717|10820189|FG000|Overall Study|Withdrawal by Subject|32
6815864|NCT00054717|10820190|FG001|Overall Study|Withdrawal by Subject|20
6815865|NCT00054717|10820189|FG000|Overall Study|Other reason not defined above|117
6815866|NCT00054717|10820190|FG001|Overall Study|Other reason not defined above|217
6815867|NCT00055471|10820224|FG000|Period 1: Dose Escalation Period|Adverse Event|0
6815868|NCT00055471|10820225|FG001|Period 1: Dose Escalation Period|Adverse Event|1
6815869|NCT00055471|10820226|FG002|Period 1: Dose Escalation Period|Adverse Event|2
6815870|NCT00055471|10820224|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
6815871|NCT00055471|10820225|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
6815872|NCT00055471|10820226|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1
6815873|NCT00055471|10820224|FG000|Period 1: Dose Escalation Period|Disease progression|0
6815874|NCT00055471|10820225|FG001|Period 1: Dose Escalation Period|Disease progression|1
6815875|NCT00055471|10820226|FG002|Period 1: Dose Escalation Period|Disease progression|0
6815876|NCT00055497|10820238|FG000|Overall Study|Adverse Event|1
6815877|NCT00055497|10820239|FG001|Overall Study|Adverse Event|1
6815878|NCT00055497|10820240|FG002|Overall Study|Adverse Event|1
6815879|NCT00055497|10820241|FG003|Overall Study|Adverse Event|28
6815880|NCT00055497|10820238|FG000|Overall Study|Withdrawal by Subject|3
6815881|NCT00055497|10820239|FG001|Overall Study|Withdrawal by Subject|1
6815882|NCT00055497|10820240|FG002|Overall Study|Withdrawal by Subject|1
6815883|NCT00055497|10820241|FG003|Overall Study|Withdrawal by Subject|15
6815884|NCT00055497|10820238|FG000|Overall Study|Lost to Follow-up|0
6815885|NCT00055497|10820239|FG001|Overall Study|Lost to Follow-up|1
6815886|NCT00055497|10820240|FG002|Overall Study|Lost to Follow-up|0
6815887|NCT00055497|10820241|FG003|Overall Study|Lost to Follow-up|5
6815888|NCT00055497|10820238|FG000|Overall Study|Protocol Violation|0
6815889|NCT00055497|10820239|FG001|Overall Study|Protocol Violation|0
6815890|NCT00055497|10820240|FG002|Overall Study|Protocol Violation|0
6815891|NCT00055497|10820241|FG003|Overall Study|Protocol Violation|3
6815892|NCT00055497|10820238|FG000|Overall Study|Lack of Efficacy|1
6815893|NCT00055497|10820239|FG001|Overall Study|Lack of Efficacy|0
6815894|NCT00055497|10820240|FG002|Overall Study|Lack of Efficacy|0
6815895|NCT00055497|10820241|FG003|Overall Study|Lack of Efficacy|27
6815896|NCT00055497|10820238|FG000|Overall Study|Administrative Reasons|0
6815897|NCT00055497|10820239|FG001|Overall Study|Administrative Reasons|0
6815898|NCT00055497|10820240|FG002|Overall Study|Administrative Reasons|0
6815899|NCT00055497|10820241|FG003|Overall Study|Administrative Reasons|1
6815900|NCT00055497|10820238|FG000|Overall Study|Other|0
6815901|NCT00055497|10820239|FG001|Overall Study|Other|0
6815902|NCT00055497|10820240|FG002|Overall Study|Other|0
6815903|NCT00055497|10820241|FG003|Overall Study|Other|11
6815904|NCT00055601|10820258|FG000|Overall Study|Protocol Violation|1
6815905|NCT00055601|10820259|FG001|Overall Study|Protocol Violation|1
6815906|NCT00055601|10820258|FG000|Overall Study|No protocol treatment received|1
6815907|NCT00055601|10820259|FG001|Overall Study|No protocol treatment received|1
6815908|NCT00056160|10820273|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35
6815909|NCT00056160|10820274|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18
6815910|NCT00056160|10820273|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57
6815911|NCT00056160|10820274|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124
6815912|NCT00056160|10820273|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3
6815913|NCT00056160|10820274|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5
6815914|NCT00056160|10820273|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
6815915|NCT00056160|10820274|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
6815916|NCT00056160|10820273|FG000|Up to Unblinding (07 Jun 2005)|Death|2
6815917|NCT00056160|10820274|FG001|Up to Unblinding (07 Jun 2005)|Death|1
6815918|NCT00056160|10820273|FG000|Up to Unblinding (07 Jun 2005)|Other|8
6815919|NCT00056160|10820274|FG001|Up to Unblinding (07 Jun 2005)|Other|7
6815920|NCT00056160|10820273|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44
6815921|NCT00056160|10820274|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0
6815922|NCT00056160|10820273|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87
6815923|NCT00056160|10820274|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0
6815924|NCT00056160|10820273|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3
6815925|NCT00056160|10820274|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0
6815926|NCT00056160|10820273|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11
6815927|NCT00056160|10820274|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0
6815928|NCT00056160|10820273|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5
6815929|NCT00056160|10820274|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0
6815930|NCT00056160|10820273|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21
6815931|NCT00056160|10820274|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0
6815932|NCT00056160|10820273|FG000|Final Follow-up|Transferred into expanded access study.|3
6815933|NCT00056160|10820274|FG001|Final Follow-up|Transferred into expanded access study.|0
6815934|NCT00056160|10820273|FG000|Final Follow-up|Transferred into RevAssist Program|2
6815935|NCT00056160|10820274|FG001|Final Follow-up|Transferred into RevAssist Program|0
6815936|NCT00056160|10820273|FG000|Final Follow-up|Adverse Event|1
6815937|NCT00056160|10820274|FG001|Final Follow-up|Adverse Event|0
6815938|NCT00056316|10820282|FG000|Overall Study|Withdrawal by Subject|2
6815939|NCT00056316|10820283|FG001|Overall Study|Withdrawal by Subject|2
6815940|NCT00056316|10820282|FG000|Overall Study|Death/NH placement of pt|1
6815941|NCT00056316|10820283|FG001|Overall Study|Death/NH placement of pt|1
6815942|NCT00056407|10820291|FG000|Overall Study|Adverse Event|282
6815943|NCT00056407|10820292|FG001|Overall Study|Adverse Event|364
6815944|NCT00056407|10820291|FG000|Overall Study|Withdrawal by Subject|377
6815945|NCT00056407|10820292|FG001|Overall Study|Withdrawal by Subject|361
6815946|NCT00056407|10820291|FG000|Overall Study|Lost to Follow-up|123
6815947|NCT00056407|10820292|FG001|Overall Study|Lost to Follow-up|113
6815948|NCT00056407|10820291|FG000|Overall Study|Protocol Violation|104
6815949|NCT00056407|10820292|FG001|Overall Study|Protocol Violation|95
6815950|NCT00056407|10820291|FG000|Overall Study|Diagnosed with Prostate Cancer|202
6815951|NCT00056407|10820292|FG001|Overall Study|Diagnosed with Prostate Cancer|166
6815952|NCT00056407|10820291|FG000|Overall Study|"Listed as Other on Case Report Form"|98
6815953|NCT00056407|10820292|FG001|Overall Study|"Listed as Other on Case Report Form"|60
6815954|NCT00056407|10820291|FG000|Overall Study|Missing|25
6815955|NCT00056407|10820292|FG001|Overall Study|Missing|34
6815956|NCT00056862|10820332|FG000|Overall Study|Protocol Violation|1
6815957|NCT00056862|10820333|FG001|Overall Study|Protocol Violation|0
6815958|NCT00057330|10820341|FG000|Overall Study|Adverse Event|9
6815959|NCT00057330|10820342|FG001|Overall Study|Adverse Event|12
6815960|NCT00057330|10820341|FG000|Overall Study|Death|1
6815961|NCT00057330|10820342|FG001|Overall Study|Death|0
6815962|NCT00057330|10820341|FG000|Overall Study|Protocol Violation|1
6815963|NCT00057330|10820342|FG001|Overall Study|Protocol Violation|1
6815964|NCT00057330|10820341|FG000|Overall Study|Withdrawal by Subject|115
6815965|NCT00057330|10820342|FG001|Overall Study|Withdrawal by Subject|84
6815966|NCT00057330|10820341|FG000|Overall Study|Lost to Follow-up|745
6815967|NCT00057330|10820342|FG001|Overall Study|Lost to Follow-up|617
6815968|NCT00057330|10820341|FG000|Overall Study|Physician Decision|1
6815969|NCT00057330|10820342|FG001|Overall Study|Physician Decision|0
6815970|NCT00057330|10820341|FG000|Overall Study|Other|260
6815971|NCT00057330|10820342|FG001|Overall Study|Other|206
6815972|NCT00057746|10820391|FG000|Overall Study|Withdrawal by Subject|0
6815973|NCT00057746|10820392|FG001|Overall Study|Withdrawal by Subject|0
6815974|NCT00057746|10820393|FG002|Overall Study|Withdrawal by Subject|1
6815975|NCT00057811|10820407|FG000|Overall Study|Lack of Efficacy|1
6815976|NCT00057811|10820408|FG001|Overall Study|Lack of Efficacy|4
6815977|NCT00057811|10820407|FG000|Overall Study|Physician Decision|1
6815978|NCT00057811|10820408|FG001|Overall Study|Physician Decision|0
6815979|NCT00057811|10820407|FG000|Overall Study|Withdrawal by Subject|3
6815980|NCT00057811|10820408|FG001|Overall Study|Withdrawal by Subject|4
6815981|NCT00057811|10820407|FG000|Overall Study|Ineligible|4
6815982|NCT00057811|10820408|FG001|Overall Study|Ineligible|2
6815983|NCT00057811|10820407|FG000|Overall Study|Inevaluable|1
6815984|NCT00057811|10820408|FG001|Overall Study|Inevaluable|2
6815985|NCT00057837|10820416|FG000|Overall Study|Progression/relapse|12
6815986|NCT00057837|10820417|FG001|Overall Study|Progression/relapse|14
6815987|NCT00057837|10820416|FG000|Overall Study|Adverse Event|2
6815988|NCT00057837|10820417|FG001|Overall Study|Adverse Event|12
6815989|NCT00057837|10820416|FG000|Overall Study|Death|5
6815990|NCT00057837|10820417|FG001|Overall Study|Death|4
6815991|NCT00057837|10820416|FG000|Overall Study|Withdrawal by Subject|5
6815992|NCT00057837|10820417|FG001|Overall Study|Withdrawal by Subject|3
6815993|NCT00057837|10820416|FG000|Overall Study|Alternative therapy|0
6815994|NCT00057837|10820417|FG001|Overall Study|Alternative therapy|1
6815995|NCT00057837|10820416|FG000|Overall Study|Other complicating disease|2
6815996|NCT00057837|10820417|FG001|Overall Study|Other complicating disease|1
6815997|NCT00057837|10820416|FG000|Overall Study|Physician Decision|1
6815998|NCT00057837|10820417|FG001|Overall Study|Physician Decision|0
6815999|NCT00057837|10820416|FG000|Overall Study|Ineligible|3
6816000|NCT00057837|10820417|FG001|Overall Study|Ineligible|3
6816001|NCT00057837|10820416|FG000|Overall Study|Never started treatment|1
6816002|NCT00057837|10820417|FG001|Overall Study|Never started treatment|1
6816003|NCT00057863|10820423|FG000|Overall Study|Death|1
6816004|NCT00057863|10820423|FG000|Overall Study|Withdrawal by Subject|2
6816005|NCT00057876|10820429|FG000|Overall Study|Adverse Event|8
6816006|NCT00057876|10820430|FG001|Overall Study|Adverse Event|8
6816007|NCT00057876|10820429|FG000|Overall Study|Death|2
6816008|NCT00057876|10820430|FG001|Overall Study|Death|1
6816009|NCT00057876|10820429|FG000|Overall Study|Withdrawal by Subject|5
6816010|NCT00057876|10820430|FG001|Overall Study|Withdrawal by Subject|6
6816011|NCT00057876|10820429|FG000|Overall Study|Lack of Efficacy|10
6816012|NCT00057876|10820430|FG001|Overall Study|Lack of Efficacy|8
6816013|NCT00057876|10820429|FG000|Overall Study|Ineligible|1
6816014|NCT00057876|10820430|FG001|Overall Study|Ineligible|2
6816015|NCT00057876|10820429|FG000|Overall Study|other reason|2
6816016|NCT00057876|10820430|FG001|Overall Study|other reason|2
6816017|NCT00057876|10820429|FG000|Overall Study|other complicating disease|1
6816018|NCT00057876|10820430|FG001|Overall Study|other complicating disease|0
6816019|NCT00057941|10820438|FG000|Overall Study|Death|1
6816020|NCT00057941|10820439|FG001|Overall Study|Death|2
6816021|NCT00057941|10820438|FG000|Overall Study|Adverse Event|7
6816022|NCT00057941|10820439|FG001|Overall Study|Adverse Event|9
6816023|NCT00057941|10820438|FG000|Overall Study|Lack of Efficacy|54
6816024|NCT00057941|10820439|FG001|Overall Study|Lack of Efficacy|53
6816025|NCT00057941|10820438|FG000|Overall Study|Withdrawal by Subject|6
6816026|NCT00057941|10820439|FG001|Overall Study|Withdrawal by Subject|1
6816027|NCT00057941|10820438|FG000|Overall Study|still on treatment|3
6816028|NCT00057941|10820439|FG001|Overall Study|still on treatment|1
6816029|NCT00057941|10820438|FG000|Overall Study|insurance, symptomatic deterioration|1
6816030|NCT00057941|10820439|FG001|Overall Study|insurance, symptomatic deterioration|3
6816031|NCT00057941|10820438|FG000|Overall Study|Ineligible|2
6816032|NCT00057941|10820439|FG001|Overall Study|Ineligible|5
6816033|NCT00057954|10820445|FG000|Overall Study|Death|1
6816034|NCT00057954|10820445|FG000|Overall Study|Disease progression|1
6816035|NCT00058058|10820457|FG000|Overall Study|Withdrawal by Subject|4
6816036|NCT00058058|10820457|FG000|Overall Study|Ineligible|20
6816037|NCT00058058|10820457|FG000|Overall Study|Claustrophobic|5
6816038|NCT00058058|10820457|FG000|Overall Study|technical issues|6
6816039|NCT00058058|10820457|FG000|Overall Study|Poor positioning, illness,pain|3
6816040|NCT00058123|10820462|FG000|Overall Study|Wrong histology|9
6816041|NCT00058123|10820462|FG000|Overall Study|Received >3 prior treatments|1
6816042|NCT00058214|10820467|FG000|Overall Study|Adverse Event|1
6816043|NCT00058422|10820492|FG000|Overall Study|Not treated|2
6816044|NCT00058539|10820496|FG000|Overall Study|Disease progression|24
6816045|NCT00058539|10820496|FG000|Overall Study|Adverse Event|3
6816046|NCT00058539|10820496|FG000|Overall Study|Withdrawal by Subject|5
6816047|NCT00058539|10820496|FG000|Overall Study|Physician Decision|9
6816048|NCT00058539|10820496|FG000|Overall Study|Death|1
6816049|NCT00058552|10820502|FG000|Overall Study|Died prior to receiving treatment|4
6816050|NCT00058552|10820503|FG001|Overall Study|Died prior to receiving treatment|2
6816051|NCT00058552|10820502|FG000|Overall Study|Disease progression|52
6816052|NCT00058552|10820503|FG001|Overall Study|Disease progression|44
6816053|NCT00058552|10820502|FG000|Overall Study|Adverse Event|4
6816054|NCT00058552|10820503|FG001|Overall Study|Adverse Event|2
6816055|NCT00058552|10820502|FG000|Overall Study|Withdrawal by Subject|3
6816056|NCT00058552|10820503|FG001|Overall Study|Withdrawal by Subject|5
6816057|NCT00058552|10820502|FG000|Overall Study|Physician Decision|2
6816058|NCT00058552|10820503|FG001|Overall Study|Physician Decision|5
6816059|NCT00058552|10820502|FG000|Overall Study|Clinical disease progression|0
6816060|NCT00058552|10820503|FG001|Overall Study|Clinical disease progression|4
6816061|NCT00058825|10820511|FG000|Overall Study|Relapse|9
6816062|NCT00058825|10820511|FG000|Overall Study|Progressive Disease|5
6816063|NCT00058825|10820511|FG000|Overall Study|Graft Failure|5
6816064|NCT00058825|10820511|FG000|Overall Study|Death|3
6816065|NCT00059202|10820519|FG000|Overall Study|Withdrawal by Subject|5
6816066|NCT00059202|10820520|FG001|Overall Study|Withdrawal by Subject|9
6816067|NCT00059202|10820519|FG000|Overall Study|Protocol Violation|1
6816068|NCT00059202|10820520|FG001|Overall Study|Protocol Violation|3
6816069|NCT00059202|10820519|FG000|Overall Study|drug toxicity|0
6816070|NCT00059202|10820520|FG001|Overall Study|drug toxicity|3
6816071|NCT00059215|10820533|FG000|Overall Study|Adverse Event|5
6816072|NCT00059215|10820534|FG001|Overall Study|Adverse Event|5
6816073|NCT00059215|10820535|FG002|Overall Study|Adverse Event|9
6816074|NCT00059215|10820536|FG003|Overall Study|Adverse Event|9
6816075|NCT00059215|10820533|FG000|Overall Study|Death|0
6816076|NCT00059215|10820534|FG001|Overall Study|Death|0
6816077|NCT00059215|10820535|FG002|Overall Study|Death|3
6816078|NCT00059215|10820536|FG003|Overall Study|Death|0
6816079|NCT00059215|10820533|FG000|Overall Study|Lost to Follow-up|1
6816080|NCT00059215|10820534|FG001|Overall Study|Lost to Follow-up|2
6816081|NCT00059215|10820535|FG002|Overall Study|Lost to Follow-up|0
6816082|NCT00059215|10820536|FG003|Overall Study|Lost to Follow-up|0
6816083|NCT00059215|10820533|FG000|Overall Study|Withdrawal by Subject|4
6816084|NCT00059215|10820534|FG001|Overall Study|Withdrawal by Subject|4
6816085|NCT00059215|10820535|FG002|Overall Study|Withdrawal by Subject|1
6816086|NCT00059215|10820536|FG003|Overall Study|Withdrawal by Subject|3
6816087|NCT00059215|10820533|FG000|Overall Study|Protocol Violation|1
6816088|NCT00059215|10820534|FG001|Overall Study|Protocol Violation|0
6816089|NCT00059215|10820535|FG002|Overall Study|Protocol Violation|1
6816090|NCT00059215|10820536|FG003|Overall Study|Protocol Violation|0
6816091|NCT00059215|10820533|FG000|Overall Study|Protocol entry criteria not met|1
6816092|NCT00059215|10820534|FG001|Overall Study|Protocol entry criteria not met|1
6816093|NCT00059215|10820535|FG002|Overall Study|Protocol entry criteria not met|0
6816094|NCT00059215|10820536|FG003|Overall Study|Protocol entry criteria not met|2
6816095|NCT00059215|10820533|FG000|Overall Study|Physician Decision|1
6816096|NCT00059215|10820534|FG001|Overall Study|Physician Decision|2
6816097|NCT00059215|10820535|FG002|Overall Study|Physician Decision|1
6816098|NCT00059215|10820536|FG003|Overall Study|Physician Decision|1
6816099|NCT00059332|10820558|FG000|Overall Study|Withdrawal by Subject|2
6816100|NCT00059332|10820559|FG001|Overall Study|Withdrawal by Subject|1
6816101|NCT00059332|10820558|FG000|Overall Study|Lost to Follow-up|1
6816102|NCT00059332|10820559|FG001|Overall Study|Lost to Follow-up|1
6816103|NCT00059787|10820605|FG000|Overall Study|Adverse Event|13
6816104|NCT00059787|10820605|FG000|Overall Study|disease progression|2
6816105|NCT00059787|10820605|FG000|Overall Study|ineligible|1
6816106|NCT00059787|10820605|FG000|Overall Study|Other|4
6816107|NCT00059839|10820612|FG000|Overall Study|Death|1
6816108|NCT00059839|10820613|FG001|Overall Study|Death|1
6816109|NCT00059839|10820612|FG000|Overall Study|Lack of Efficacy|6
6816110|NCT00059839|10820613|FG001|Overall Study|Lack of Efficacy|5
6816111|NCT00059839|10820612|FG000|Overall Study|Lost to Follow-up|2
6816112|NCT00059839|10820613|FG001|Overall Study|Lost to Follow-up|0
6816113|NCT00059839|10820612|FG000|Overall Study|Physician Decision|1
6816114|NCT00059839|10820613|FG001|Overall Study|Physician Decision|2
6816115|NCT00059839|10820612|FG000|Overall Study|Withdrawal by Subject|1
6816116|NCT00059839|10820613|FG001|Overall Study|Withdrawal by Subject|6
6816117|NCT00059839|10820612|FG000|Overall Study|Ineligible|1
6816118|NCT00059839|10820613|FG001|Overall Study|Ineligible|3
6816119|NCT00060840|10820666|FG000|Overall Study|Change in surgical plan|2
6816120|NCT00060840|10820667|FG001|Overall Study|Change in surgical plan|6
6816121|NCT00060840|10820666|FG000|Overall Study|Death|0
6816122|NCT00060840|10820667|FG001|Overall Study|Death|1
6816123|NCT00060840|10820666|FG000|Overall Study|Withdrawal by Subject|0
6816124|NCT00060840|10820667|FG001|Overall Study|Withdrawal by Subject|1
6816125|NCT00060840|10820666|FG000|Overall Study|Subinvestigator unavailable|0
6816126|NCT00060840|10820667|FG001|Overall Study|Subinvestigator unavailable|1
6816127|NCT00060840|10820666|FG000|Overall Study|Physician Decision|1
6816128|NCT00060840|10820667|FG001|Overall Study|Physician Decision|0
6816129|NCT00060840|10820666|FG000|Overall Study|Other|1
6816130|NCT00060840|10820667|FG001|Overall Study|Other|0
6816131|NCT00060944|10820675|FG000|Overall Study|Adverse Event|12
6816132|NCT00060944|10820676|FG001|Overall Study|Adverse Event|10
6816133|NCT00060944|10820675|FG000|Overall Study|Death|2
6816134|NCT00060944|10820676|FG001|Overall Study|Death|3
6816135|NCT00060944|10820675|FG000|Overall Study|Withdrawal by Subject|18
6816136|NCT00060944|10820676|FG001|Overall Study|Withdrawal by Subject|5
6816137|NCT00060944|10820675|FG000|Overall Study|Disease Progression|93
6816138|NCT00060944|10820676|FG001|Overall Study|Disease Progression|94
6816139|NCT00060944|10820675|FG000|Overall Study|Lost to Follow-up|1
6816140|NCT00060944|10820676|FG001|Overall Study|Lost to Follow-up|0
6816141|NCT00060944|10820675|FG000|Overall Study|Subject Ineligible To Continue|2
6816142|NCT00060944|10820676|FG001|Overall Study|Subject Ineligible To Continue|1
6816143|NCT00060944|10820675|FG000|Overall Study|Treatment Switch|0
6816144|NCT00060944|10820676|FG001|Overall Study|Treatment Switch|13
6816145|NCT00060944|10820675|FG000|Overall Study|Other|2
6816146|NCT00060944|10820676|FG001|Overall Study|Other|4
6816147|NCT00060944|10820675|FG000|Overall Study|randomized but not treated|6
6816148|NCT00060944|10820676|FG001|Overall Study|randomized but not treated|4
6816149|NCT00061048|10820682|FG000|Overall Study|Adverse Event|2
6816150|NCT00061048|10820682|FG000|Overall Study|disease progression|20
6816151|NCT00061633|10820697|FG000|Overall Study|Adverse Event|1
6816152|NCT00061633|10820698|FG001|Overall Study|Adverse Event|2
6816153|NCT00061633|10820697|FG000|Overall Study|Withdrawal by Subject|2
6816154|NCT00061633|10820698|FG001|Overall Study|Withdrawal by Subject|2
6816155|NCT00061633|10820697|FG000|Overall Study|Lost to Follow-up|1
6816156|NCT00061633|10820698|FG001|Overall Study|Lost to Follow-up|4
6816157|NCT00061633|10820697|FG000|Overall Study|Other|1
6816158|NCT00061633|10820698|FG001|Overall Study|Other|1
6816159|NCT00061633|10820697|FG000|Overall Study|Never received study treatment|0
6816160|NCT00061633|10820698|FG001|Overall Study|Never received study treatment|2
6816161|NCT00061932|10820710|FG000|Overall Study|Withdrawal by Subject|13
6816162|NCT00061932|10820711|FG001|Overall Study|Withdrawal by Subject|4
6816163|NCT00062010|10820718|FG000|Overall Study|Ineligible|3
6816164|NCT00062166|10820722|FG000|Overall Study|Withdrawal by Subject|6
6816165|NCT00062374|10820727|FG000|Overall Study|Not treated|12
6816166|NCT00062439|10820731|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1
6816167|NCT00062439|10820731|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1
6816168|NCT00062439|10820731|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3
6816169|NCT00062439|10820731|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3
6816170|NCT00062439|10820731|FG000|Post Chemoradiation Assessment|Death|1
6816171|NCT00062439|10820731|FG000|Post Chemoradiation Assessment|Disease progression|2
6816172|NCT00062439|10820731|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1
6816173|NCT00062439|10820731|FG000|Post Chemoradiation Assessment|Physician Decision|1
6816174|NCT00062439|10820731|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4
6816175|NCT00062439|10820731|FG000|Surgery|Physician Decision|4
6816176|NCT00062439|10820731|FG000|Surgery|Death|1
6816177|NCT00062439|10820731|FG000|Surgery|Adverse Event|2
6816178|NCT00062439|10820731|FG000|Consolidation Chemotherapy|Adverse Event|2
6816179|NCT00062647|10820742|FG000|Overall Study|Death|2
6816180|NCT00062647|10820743|FG001|Overall Study|Death|2
6816181|NCT00062647|10820742|FG000|Overall Study|Adverse Event|1
6816182|NCT00062647|10820743|FG001|Overall Study|Adverse Event|1
6816183|NCT00062647|10820742|FG000|Overall Study|Withdrawal by Subject|2
6816184|NCT00062647|10820743|FG001|Overall Study|Withdrawal by Subject|1
6816185|NCT00062647|10820742|FG000|Overall Study|Protocol Violation|1
6816186|NCT00062647|10820743|FG001|Overall Study|Protocol Violation|0
6816187|NCT00062647|10820742|FG000|Overall Study|Lost to Follow-up|1
6816188|NCT00062647|10820743|FG001|Overall Study|Lost to Follow-up|2
6816189|NCT00062647|10820742|FG000|Overall Study|Failed continuation criteria|4
6816190|NCT00062647|10820743|FG001|Overall Study|Failed continuation criteria|2
6816191|NCT00062647|10820742|FG000|Overall Study|Other|4
6816192|NCT00062647|10820743|FG001|Overall Study|Other|4
6816193|NCT00062647|10820742|FG000|Overall Study|Never received study treatment|1
6816194|NCT00062647|10820743|FG001|Overall Study|Never received study treatment|1
6816195|NCT00062868|10820790|FG000|Dose Level 1|Death|2
6816196|NCT00062868|10820791|FG001|Dose Level 1|Death|0
6816197|NCT00062868|10820792|FG002|Dose Level 1|Death|0
6816198|NCT00062868|10820793|FG003|Dose Level 1|Death|2
6816199|NCT00062868|10820794|FG004|Dose Level 1|Death|0
6816200|NCT00062868|10820795|FG005|Dose Level 1|Death|0
6816201|NCT00062868|10820796|FG006|Dose Level 1|Death|3
6816202|NCT00062868|10820797|FG007|Dose Level 1|Death|0
6816203|NCT00062868|10820798|FG008|Dose Level 1|Death|0
6816204|NCT00062868|10820799|FG009|Dose Level 1|Death|0
6816205|NCT00062868|10820800|FG010|Dose Level 1|Death|0
6816206|NCT00062868|10820801|FG011|Dose Level 1|Death|0
6816207|NCT00062868|10820802|FG012|Dose Level 1|Death|0
6816208|NCT00062868|10820803|FG013|Dose Level 1|Death|0
6816209|NCT00062868|10820804|FG014|Dose Level 1|Death|0
6816210|NCT00062868|10820805|FG015|Dose Level 1|Death|0
6816211|NCT00062868|10820806|FG016|Dose Level 1|Death|0
6816212|NCT00062868|10820807|FG017|Dose Level 1|Death|0
6816213|NCT00062868|10820808|FG018|Dose Level 1|Death|7
6816214|NCT00062868|10820809|FG019|Dose Level 1|Death|0
6816215|NCT00062868|10820810|FG020|Dose Level 1|Death|1
6816216|NCT00062868|10820790|FG000|Dose Level 1|Lost to Follow-up|0
6816217|NCT00062868|10820791|FG001|Dose Level 1|Lost to Follow-up|0
6816218|NCT00062868|10820792|FG002|Dose Level 1|Lost to Follow-up|0
6816219|NCT00062868|10820793|FG003|Dose Level 1|Lost to Follow-up|0
6816220|NCT00062868|10820794|FG004|Dose Level 1|Lost to Follow-up|0
6816221|NCT00062868|10820795|FG005|Dose Level 1|Lost to Follow-up|0
6816222|NCT00062868|10820796|FG006|Dose Level 1|Lost to Follow-up|0
6816223|NCT00062868|10820797|FG007|Dose Level 1|Lost to Follow-up|0
6816224|NCT00062868|10820798|FG008|Dose Level 1|Lost to Follow-up|0
6816225|NCT00062868|10820799|FG009|Dose Level 1|Lost to Follow-up|0
6816226|NCT00062868|10820800|FG010|Dose Level 1|Lost to Follow-up|0
6816227|NCT00062868|10820801|FG011|Dose Level 1|Lost to Follow-up|0
6816228|NCT00062868|10820802|FG012|Dose Level 1|Lost to Follow-up|1
6816229|NCT00062868|10820803|FG013|Dose Level 1|Lost to Follow-up|0
6816230|NCT00062868|10820804|FG014|Dose Level 1|Lost to Follow-up|0
6816231|NCT00062868|10820805|FG015|Dose Level 1|Lost to Follow-up|0
6816232|NCT00062868|10820806|FG016|Dose Level 1|Lost to Follow-up|0
6816233|NCT00062868|10820807|FG017|Dose Level 1|Lost to Follow-up|0
6816234|NCT00062868|10820808|FG018|Dose Level 1|Lost to Follow-up|2
6816235|NCT00062868|10820809|FG019|Dose Level 1|Lost to Follow-up|0
6816236|NCT00062868|10820810|FG020|Dose Level 1|Lost to Follow-up|1
6816237|NCT00062868|10820790|FG000|Dose Level 2|Death|0
6816238|NCT00062868|10820791|FG001|Dose Level 2|Death|3
6816239|NCT00062868|10820792|FG002|Dose Level 2|Death|0
6816240|NCT00062868|10820793|FG003|Dose Level 2|Death|0
6816241|NCT00062868|10820794|FG004|Dose Level 2|Death|2
6816242|NCT00062868|10820795|FG005|Dose Level 2|Death|0
6816243|NCT00062868|10820796|FG006|Dose Level 2|Death|0
6816244|NCT00062868|10820797|FG007|Dose Level 2|Death|0
6816245|NCT00062868|10820798|FG008|Dose Level 2|Death|0
6816246|NCT00062868|10820799|FG009|Dose Level 2|Death|0
6816247|NCT00062868|10820800|FG010|Dose Level 2|Death|1
6816248|NCT00062868|10820801|FG011|Dose Level 2|Death|0
6816249|NCT00062868|10820802|FG012|Dose Level 2|Death|0
6816250|NCT00062868|10820803|FG013|Dose Level 2|Death|0
6816251|NCT00062868|10820804|FG014|Dose Level 2|Death|0
6816252|NCT00062868|10820805|FG015|Dose Level 2|Death|0
6816253|NCT00062868|10820806|FG016|Dose Level 2|Death|2
6816254|NCT00062868|10820807|FG017|Dose Level 2|Death|0
6816255|NCT00062868|10820808|FG018|Dose Level 2|Death|0
6816256|NCT00062868|10820809|FG019|Dose Level 2|Death|0
6816257|NCT00062868|10820810|FG020|Dose Level 2|Death|0
6816258|NCT00062868|10820790|FG000|Dose Level 2|Lost to Follow-up|0
6816259|NCT00062868|10820791|FG001|Dose Level 2|Lost to Follow-up|0
6816260|NCT00062868|10820792|FG002|Dose Level 2|Lost to Follow-up|0
6816261|NCT00062868|10820793|FG003|Dose Level 2|Lost to Follow-up|0
6816262|NCT00062868|10820794|FG004|Dose Level 2|Lost to Follow-up|0
6816263|NCT00062868|10820795|FG005|Dose Level 2|Lost to Follow-up|0
6816264|NCT00062868|10820796|FG006|Dose Level 2|Lost to Follow-up|0
6816265|NCT00062868|10820797|FG007|Dose Level 2|Lost to Follow-up|0
6816266|NCT00062868|10820798|FG008|Dose Level 2|Lost to Follow-up|0
6816267|NCT00062868|10820799|FG009|Dose Level 2|Lost to Follow-up|0
6816268|NCT00062868|10820800|FG010|Dose Level 2|Lost to Follow-up|0
6816269|NCT00062868|10820801|FG011|Dose Level 2|Lost to Follow-up|0
6816270|NCT00062868|10820802|FG012|Dose Level 2|Lost to Follow-up|0
6816271|NCT00062868|10820803|FG013|Dose Level 2|Lost to Follow-up|1
6816272|NCT00062868|10820804|FG014|Dose Level 2|Lost to Follow-up|0
6816273|NCT00062868|10820805|FG015|Dose Level 2|Lost to Follow-up|0
6816274|NCT00062868|10820806|FG016|Dose Level 2|Lost to Follow-up|1
6816275|NCT00062868|10820807|FG017|Dose Level 2|Lost to Follow-up|0
6816276|NCT00062868|10820808|FG018|Dose Level 2|Lost to Follow-up|0
6816277|NCT00062868|10820809|FG019|Dose Level 2|Lost to Follow-up|0
6816278|NCT00062868|10820810|FG020|Dose Level 2|Lost to Follow-up|0
6816279|NCT00062868|10820790|FG000|Dose Level 3|Death|0
6816280|NCT00062868|10820791|FG001|Dose Level 3|Death|0
6816281|NCT00062868|10820792|FG002|Dose Level 3|Death|0
6816282|NCT00062868|10820793|FG003|Dose Level 3|Death|0
6816283|NCT00062868|10820794|FG004|Dose Level 3|Death|0
6816284|NCT00062868|10820795|FG005|Dose Level 3|Death|0
6816285|NCT00062868|10820796|FG006|Dose Level 3|Death|0
6816286|NCT00062868|10820797|FG007|Dose Level 3|Death|0
6816287|NCT00062868|10820798|FG008|Dose Level 3|Death|0
6816288|NCT00062868|10820799|FG009|Dose Level 3|Death|0
6816289|NCT00062868|10820800|FG010|Dose Level 3|Death|0
6816290|NCT00062868|10820801|FG011|Dose Level 3|Death|1
6816291|NCT00062868|10820802|FG012|Dose Level 3|Death|0
6816292|NCT00062868|10820803|FG013|Dose Level 3|Death|0
6816293|NCT00062868|10820804|FG014|Dose Level 3|Death|0
6816294|NCT00062868|10820805|FG015|Dose Level 3|Death|0
6816295|NCT00062868|10820806|FG016|Dose Level 3|Death|0
6816296|NCT00062868|10820807|FG017|Dose Level 3|Death|1
6816297|NCT00062868|10820808|FG018|Dose Level 3|Death|0
6816298|NCT00062868|10820809|FG019|Dose Level 3|Death|0
6816299|NCT00062868|10820810|FG020|Dose Level 3|Death|0
6816300|NCT00062868|10820790|FG000|Dose Level 3|Lost to Follow-up|0
6816301|NCT00062868|10820791|FG001|Dose Level 3|Lost to Follow-up|0
6816302|NCT00062868|10820792|FG002|Dose Level 3|Lost to Follow-up|0
6816303|NCT00062868|10820793|FG003|Dose Level 3|Lost to Follow-up|0
6816304|NCT00062868|10820794|FG004|Dose Level 3|Lost to Follow-up|0
6816305|NCT00062868|10820795|FG005|Dose Level 3|Lost to Follow-up|0
6816306|NCT00062868|10820796|FG006|Dose Level 3|Lost to Follow-up|0
6816307|NCT00062868|10820797|FG007|Dose Level 3|Lost to Follow-up|0
6816308|NCT00062868|10820798|FG008|Dose Level 3|Lost to Follow-up|0
6816309|NCT00062868|10820799|FG009|Dose Level 3|Lost to Follow-up|0
6816310|NCT00062868|10820800|FG010|Dose Level 3|Lost to Follow-up|0
6816311|NCT00062868|10820801|FG011|Dose Level 3|Lost to Follow-up|0
6816312|NCT00062868|10820802|FG012|Dose Level 3|Lost to Follow-up|0
6816313|NCT00062868|10820803|FG013|Dose Level 3|Lost to Follow-up|0
6816314|NCT00062868|10820804|FG014|Dose Level 3|Lost to Follow-up|1
6816315|NCT00062868|10820805|FG015|Dose Level 3|Lost to Follow-up|0
6816316|NCT00062868|10820806|FG016|Dose Level 3|Lost to Follow-up|0
6816317|NCT00062868|10820807|FG017|Dose Level 3|Lost to Follow-up|0
6816318|NCT00062868|10820808|FG018|Dose Level 3|Lost to Follow-up|0
6816319|NCT00062868|10820809|FG019|Dose Level 3|Lost to Follow-up|0
6816320|NCT00062868|10820810|FG020|Dose Level 3|Lost to Follow-up|0
6816321|NCT00062868|10820790|FG000|Dose Level 3|Withdrew|0
6816322|NCT00062868|10820791|FG001|Dose Level 3|Withdrew|0
6816323|NCT00062868|10820792|FG002|Dose Level 3|Withdrew|2
6816324|NCT00062868|10820793|FG003|Dose Level 3|Withdrew|0
6816325|NCT00062868|10820794|FG004|Dose Level 3|Withdrew|0
6816326|NCT00062868|10820795|FG005|Dose Level 3|Withdrew|0
6816327|NCT00062868|10820796|FG006|Dose Level 3|Withdrew|0
6816328|NCT00062868|10820797|FG007|Dose Level 3|Withdrew|0
6816329|NCT00062868|10820798|FG008|Dose Level 3|Withdrew|0
6816330|NCT00062868|10820799|FG009|Dose Level 3|Withdrew|0
6816331|NCT00062868|10820800|FG010|Dose Level 3|Withdrew|0
6816332|NCT00062868|10820801|FG011|Dose Level 3|Withdrew|0
6816333|NCT00062868|10820802|FG012|Dose Level 3|Withdrew|0
6816334|NCT00062868|10820803|FG013|Dose Level 3|Withdrew|0
6816335|NCT00062868|10820804|FG014|Dose Level 3|Withdrew|0
6816336|NCT00062868|10820805|FG015|Dose Level 3|Withdrew|0
6816337|NCT00062868|10820806|FG016|Dose Level 3|Withdrew|0
6816338|NCT00062868|10820807|FG017|Dose Level 3|Withdrew|0
6816339|NCT00062868|10820808|FG018|Dose Level 3|Withdrew|0
6816340|NCT00062868|10820809|FG019|Dose Level 3|Withdrew|0
6816341|NCT00062868|10820810|FG020|Dose Level 3|Withdrew|0
6816342|NCT00063154|10820854|FG000|Overall Study|Disease progression|27
6816343|NCT00063154|10820854|FG000|Overall Study|Adverse Event|2
6816344|NCT00063154|10820854|FG000|Overall Study|Physician Decision|10
6816345|NCT00063154|10820854|FG000|Overall Study|Death|3
6816346|NCT00063154|10820854|FG000|Overall Study|Reason unspecified|1
6816347|NCT00063154|10820854|FG000|Overall Study|Did not receive treatment|8
6816348|NCT00063258|10820864|FG000|Overall Study|Physician Decision|2
6816349|NCT00063258|10820865|FG001|Overall Study|Physician Decision|0
6816350|NCT00063258|10820864|FG000|Overall Study|Lack of Efficacy|2
6816351|NCT00063258|10820865|FG001|Overall Study|Lack of Efficacy|0
6816352|NCT00063882|10820917|FG000|Overall Study|Protocol Violation|3
6816353|NCT00063882|10820918|FG001|Overall Study|Protocol Violation|3
6816354|NCT00063882|10820917|FG000|Overall Study|Withdrawal by Subject|2
6816355|NCT00063882|10820918|FG001|Overall Study|Withdrawal by Subject|1
6816356|NCT00063934|10820924|FG000|Overall Study|Ineligible|1
6816357|NCT00063986|10820928|FG000|Overall Study|Withdrawal by Subject|1
6816358|NCT00063986|10820928|FG000|Overall Study|Ineligible|1
6816359|NCT00063986|10820928|FG000|Overall Study|Intra-operatively ineligible|4
6816360|NCT00063999|10820934|FG000|Overall Study|Withdrawal by Subject|1
6816361|NCT00063999|10820935|FG001|Overall Study|Withdrawal by Subject|0
6816362|NCT00063999|10820934|FG000|Overall Study|Ineligible|44
6816363|NCT00063999|10820935|FG001|Overall Study|Ineligible|24
6816364|NCT00064025|10820948|FG000|Overall Study|Ineligible|4
6816365|NCT00064025|10820948|FG000|Overall Study|Inevaluable|3
6816366|NCT00064077|10820971|FG000|Overall Study|Improper prior treatment|1
6816367|NCT00064077|10820972|FG001|Overall Study|Improper prior treatment|0
6816368|NCT00064077|10820973|FG002|Overall Study|Improper prior treatment|0
6816369|NCT00064077|10820974|FG003|Overall Study|Improper prior treatment|0
6816370|NCT00064077|10820971|FG000|Overall Study|Poor risk|2
6816371|NCT00064077|10820972|FG001|Overall Study|Poor risk|0
6816372|NCT00064077|10820973|FG002|Overall Study|Poor risk|1
6816373|NCT00064077|10820974|FG003|Overall Study|Poor risk|1
6816374|NCT00064077|10820971|FG000|Overall Study|Pathology|10
6816375|NCT00064077|10820972|FG001|Overall Study|Pathology|7
6816376|NCT00064077|10820973|FG002|Overall Study|Pathology|3
6816377|NCT00064077|10820974|FG003|Overall Study|Pathology|4
6816378|NCT00064077|10820971|FG000|Overall Study|No surgery|0
6816379|NCT00064077|10820972|FG001|Overall Study|No surgery|0
6816380|NCT00064077|10820973|FG002|Overall Study|No surgery|1
6816381|NCT00064077|10820974|FG003|Overall Study|No surgery|0
6816382|NCT00064077|10820971|FG000|Overall Study|No tumor|0
6816383|NCT00064077|10820972|FG001|Overall Study|No tumor|0
6816384|NCT00064077|10820973|FG002|Overall Study|No tumor|1
6816385|NCT00064077|10820974|FG003|Overall Study|No tumor|0
6816386|NCT00064077|10820971|FG000|Overall Study|Other reasons|2
6816387|NCT00064077|10820972|FG001|Overall Study|Other reasons|2
6816388|NCT00064077|10820973|FG002|Overall Study|Other reasons|1
6816389|NCT00064077|10820974|FG003|Overall Study|Other reasons|2
6816390|NCT00064259|10820984|FG000|Overall Study|Adverse Event|1
6816391|NCT00064259|10820985|FG001|Overall Study|Adverse Event|0
6816392|NCT00064259|10820986|FG002|Overall Study|Adverse Event|0
6816393|NCT00064259|10820987|FG003|Overall Study|Adverse Event|1
6816394|NCT00064298|10820994|FG000|Overall Study|Withdrawal by Subject|2
6816395|NCT00064298|10820995|FG001|Overall Study|Withdrawal by Subject|1
6816396|NCT00064298|10820994|FG000|Overall Study|Lost to Follow-up|2
6816397|NCT00064298|10820995|FG001|Overall Study|Lost to Follow-up|2
6816398|NCT00064298|10820994|FG000|Overall Study|Death|0
6816399|NCT00064298|10820995|FG001|Overall Study|Death|1
6816400|NCT00064298|10820994|FG000|Overall Study|Disease Progression|2
6816401|NCT00064298|10820995|FG001|Overall Study|Disease Progression|1
6816402|NCT00064337|10821001|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7
6816403|NCT00064337|10821001|FG000|PBSCC or Induction/PBSCC|Adverse Event|6
6816404|NCT00064337|10821001|FG000|PBSCC or Induction/PBSCC|Progression|3
6816405|NCT00064337|10821001|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2
6816406|NCT00064337|10821001|FG000|PBSCC or Induction/PBSCC|Death|2
6816407|NCT00064337|10821001|FG000|Transplant|Adverse Event|9
6816408|NCT00064337|10821001|FG000|Transplant|Not protocol-specified|5
6816409|NCT00064337|10821001|FG000|Transplant|Death|3
6816410|NCT00064337|10821001|FG000|Transplant|Patient Refusal|2
6816411|NCT00064337|10821001|FG000|Transplant|Progression|2
6816412|NCT00064337|10821001|FG000|Maintenance|Adverse Event|3
6816413|NCT00064337|10821001|FG000|Maintenance|Progression|2
6816414|NCT00064337|10821001|FG000|Maintenance|On treatment at time of analysis|2
6816415|NCT00064337|10821001|FG000|Maintenance|Not protocol-specified|2
6816416|NCT00064337|10821001|FG000|Maintenance|Death|1
6816417|NCT00064350|10821011|FG000|Induction Treatment|Disease Progression|5
6816418|NCT00064350|10821012|FG001|Induction Treatment|Disease Progression|1
6816419|NCT00064350|10821013|FG002|Induction Treatment|Disease Progression|110
6816420|NCT00064350|10821011|FG000|Induction Treatment|Adverse Event|0
6816421|NCT00064350|10821012|FG001|Induction Treatment|Adverse Event|2
6816422|NCT00064350|10821013|FG002|Induction Treatment|Adverse Event|49
6816423|NCT00064350|10821011|FG000|Induction Treatment|Death|0
6816424|NCT00064350|10821012|FG001|Induction Treatment|Death|0
6816425|NCT00064350|10821013|FG002|Induction Treatment|Death|9
6816426|NCT00064350|10821011|FG000|Induction Treatment|Withdrawal by Subject|0
6816427|NCT00064350|10821012|FG001|Induction Treatment|Withdrawal by Subject|0
6816428|NCT00064350|10821013|FG002|Induction Treatment|Withdrawal by Subject|21
6816429|NCT00064350|10821011|FG000|Induction Treatment|Ineligible or never started treatment|3
6816430|NCT00064350|10821012|FG001|Induction Treatment|Ineligible or never started treatment|6
6816431|NCT00064350|10821013|FG002|Induction Treatment|Ineligible or never started treatment|34
6816432|NCT00064350|10821011|FG000|Induction Treatment|Other|0
6816433|NCT00064350|10821012|FG001|Induction Treatment|Other|0
6816434|NCT00064350|10821013|FG002|Induction Treatment|Other|13
6816435|NCT00064350|10821011|FG000|Randomization|Adverse Event|8
6816436|NCT00064350|10821012|FG001|Randomization|Adverse Event|3
6816437|NCT00064350|10821013|FG002|Randomization|Adverse Event|0
6816438|NCT00064350|10821011|FG000|Randomization|Death|3
6816439|NCT00064350|10821012|FG001|Randomization|Death|0
6816440|NCT00064350|10821013|FG002|Randomization|Death|0
6816441|NCT00064350|10821011|FG000|Randomization|Withdrawal by Subject|1
6816442|NCT00064350|10821012|FG001|Randomization|Withdrawal by Subject|0
6816443|NCT00064350|10821013|FG002|Randomization|Withdrawal by Subject|0
6816444|NCT00064350|10821011|FG000|Randomization|Ineligible or never started treatment|9
6816445|NCT00064350|10821012|FG001|Randomization|Ineligible or never started treatment|15
6816446|NCT00064350|10821013|FG002|Randomization|Ineligible or never started treatment|0
6816447|NCT00064350|10821011|FG000|Randomization|Other|5
6816448|NCT00064350|10821012|FG001|Randomization|Other|0
6816449|NCT00064350|10821013|FG002|Randomization|Other|0
6816450|NCT00064350|10821011|FG000|Cross-Over|Adverse Event|0
6816451|NCT00064350|10821012|FG001|Cross-Over|Adverse Event|1
6816452|NCT00064350|10821013|FG002|Cross-Over|Adverse Event|0
6816453|NCT00064350|10821011|FG000|Cross-Over|Death|1
6816454|NCT00064350|10821012|FG001|Cross-Over|Death|3
6816455|NCT00064350|10821013|FG002|Cross-Over|Death|0
6816456|NCT00064350|10821011|FG000|Cross-Over|Withdrawal by Subject|2
6816457|NCT00064350|10821012|FG001|Cross-Over|Withdrawal by Subject|2
6816458|NCT00064350|10821013|FG002|Cross-Over|Withdrawal by Subject|0
6816459|NCT00064350|10821011|FG000|Cross-Over|Ineligible or never started treatment|3
6816460|NCT00064350|10821012|FG001|Cross-Over|Ineligible or never started treatment|6
6816461|NCT00064350|10821013|FG002|Cross-Over|Ineligible or never started treatment|0
6816462|NCT00064350|10821011|FG000|Cross-Over|Other|0
6816463|NCT00064350|10821012|FG001|Cross-Over|Other|2
6816464|NCT00064350|10821013|FG002|Cross-Over|Other|0
6816465|NCT00064662|10821024|FG000|Overall Study|Death|1
6816466|NCT00064662|10821025|FG001|Overall Study|Death|1
6816467|NCT00064662|10821024|FG000|Overall Study|Lost to Follow-up|57
6816468|NCT00064662|10821025|FG001|Overall Study|Lost to Follow-up|44
6816469|NCT00064662|10821024|FG000|Overall Study|Withdrawal by Subject|14
6816470|NCT00064662|10821025|FG001|Overall Study|Withdrawal by Subject|14
6816471|NCT00064662|10821024|FG000|Overall Study|Administratively withdrawn|2
6816472|NCT00064662|10821025|FG001|Overall Study|Administratively withdrawn|2
